id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
124532797|NCT03053180|447901945|FG000|Overall Study|Failure to Return|1|||
124532798|NCT01465958|447901948|FG000|Run-in Phase|Protocol Violation|1|||
124532799|NCT01465958|447901949|FG001|Run-in Phase|Protocol Violation|0|||
124532800|NCT01465958|447901948|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
124532801|NCT01465958|447901949|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
124532802|NCT00669240|447901954|FG000|Overall Study|Lack of Efficacy|33|||
124532803|NCT00669240|447901954|FG000|Overall Study|Withdrawal by Subject|42|||
124532804|NCT00669240|447901954|FG000|Overall Study|Lost to Follow-up|34|||
124532805|NCT00669240|447901954|FG000|Overall Study|Adverse Event|21|||
124532806|NCT00669240|447901954|FG000|Overall Study|Other|19|||
124532807|NCT00669240|447901954|FG000|Overall Study|Enrolled but not treated|15|||
124532808|NCT00669240|447901954|FG000|Overall Study|Enrolled but no dosing record|1|||
124532809|NCT00532441|447901957|FG000|Overall Study|Death|1|||
124532810|NCT00532441|447901958|FG001|Overall Study|Death|0|||
124532811|NCT04397757|447901960|FG000|Overall Study|Death|3|||
124532812|NCT04397757|447901961|FG001|Overall Study|Death|11|||
124532813|NCT04397757|447901960|FG000|Overall Study|Withdrawal by Subject|2|||
124532814|NCT04397757|447901961|FG001|Overall Study|Withdrawal by Subject|0|||
124532815|NCT04397757|447901960|FG000|Overall Study|Lost to Follow-up|4|||
124532816|NCT04397757|447901961|FG001|Overall Study|Lost to Follow-up|3|||
124532817|NCT00626327|447901962|FG000|Overall Study|Withdrawal by Subject|21|||
124532818|NCT00626327|447901963|FG001|Overall Study|Withdrawal by Subject|29|||
124532819|NCT00626327|447901964|FG002|Overall Study|Withdrawal by Subject|30|||
124532820|NCT00626327|447901962|FG000|Overall Study|Adverse Event|1|||
124532821|NCT00626327|447901963|FG001|Overall Study|Adverse Event|0|||
124532822|NCT00626327|447901964|FG002|Overall Study|Adverse Event|0|||
124532823|NCT00626327|447901962|FG000|Overall Study|Lost to Follow-up|24|||
124532824|NCT00626327|447901963|FG001|Overall Study|Lost to Follow-up|21|||
124532825|NCT00626327|447901964|FG002|Overall Study|Lost to Follow-up|23|||
124532826|NCT00626327|447901962|FG000|Overall Study|Inappropriate enrollment|4|||
124532827|NCT00626327|447901963|FG001|Overall Study|Inappropriate enrollment|5|||
124532828|NCT00626327|447901964|FG002|Overall Study|Inappropriate enrollment|3|||
124532829|NCT00626327|447901962|FG000|Overall Study|Administrative Reason|2|||
124532830|NCT00626327|447901963|FG001|Overall Study|Administrative Reason|0|||
124532831|NCT00626327|447901964|FG002|Overall Study|Administrative Reason|6|||
124532832|NCT00626327|447901962|FG000|Overall Study|Protocol Violation|26|||
124532833|NCT00626327|447901963|FG001|Overall Study|Protocol Violation|4|||
124532834|NCT00626327|447901964|FG002|Overall Study|Protocol Violation|26|||
124532835|NCT00808028|447901966|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
124532836|NCT00808028|447901967|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
124532837|NCT00808028|447901968|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
124532838|NCT00808028|447901969|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
124532839|NCT00808028|447901966|FG000|Stage 1 (6 Months)|Other|1|||
124532840|NCT00808028|447901967|FG001|Stage 1 (6 Months)|Other|0|||
124532841|NCT00808028|447901968|FG002|Stage 1 (6 Months)|Other|2|||
124532842|NCT00808028|447901969|FG003|Stage 1 (6 Months)|Other|4|||
124532843|NCT00808028|447901966|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
124532844|NCT00808028|447901967|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
124532845|NCT00808028|447901968|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
124532846|NCT00808028|447901969|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
124532847|NCT00808028|447901966|FG000|Stage 1 (6 Months)|Adverse Event|0|||
124532848|NCT00808028|447901967|FG001|Stage 1 (6 Months)|Adverse Event|0|||
124532849|NCT00808028|447901968|FG002|Stage 1 (6 Months)|Adverse Event|1|||
124532850|NCT00808028|447901969|FG003|Stage 1 (6 Months)|Adverse Event|2|||
124532851|NCT00808028|447901966|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
124532852|NCT00808028|447901967|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
124532853|NCT00808028|447901968|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
124532854|NCT00808028|447901969|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
124532855|NCT00808028|447901966|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
124532856|NCT00808028|447901967|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
124532857|NCT00808028|447901968|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
124532858|NCT00808028|447901969|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
124532859|NCT00808028|447901966|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
124532860|NCT00808028|447901967|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
124532861|NCT00808028|447901968|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
124532862|NCT00808028|447901969|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
124532863|NCT00808028|447901966|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
124976632|NCT03838731|449541849|FG000|Overall Study|Pregnancy|0|||
124865365|NCT02119260|449128732|FG000|Overall Study|Adverse Event|1|||
124532864|NCT00808028|447901967|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
124865366|NCT02119260|449128733|FG001|Overall Study|Adverse Event|0|||
124865367|NCT02119260|449128734|FG002|Overall Study|Adverse Event|0|||
124532865|NCT00808028|447901968|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
124532866|NCT00808028|447901969|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
124532867|NCT00808028|447901966|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
124532868|NCT00808028|447901967|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
124976633|NCT03838731|449541850|FG001|Overall Study|Pregnancy|1|||
124532869|NCT00808028|447901968|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
124532870|NCT00808028|447901969|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
124532871|NCT00808028|447901966|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
124532872|NCT00808028|447901967|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
124532873|NCT00808028|447901968|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
124532874|NCT00808028|447901969|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
124532875|NCT00808028|447901966|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
124532876|NCT00808028|447901967|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
124532877|NCT00808028|447901968|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
124532878|NCT00808028|447901969|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
124532879|NCT00808028|447901966|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
124532880|NCT00808028|447901967|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
124865368|NCT02119260|449128735|FG003|Overall Study|Adverse Event|0|||
124865369|NCT02119260|449128736|FG004|Overall Study|Adverse Event|0|||
124865370|NCT02119260|449128737|FG005|Overall Study|Adverse Event|0|||
124865371|NCT02119260|449128738|FG006|Overall Study|Adverse Event|0|||
124865372|NCT02119260|449128732|FG000|Overall Study|Withdrew consent|0|||
124865373|NCT02119260|449128733|FG001|Overall Study|Withdrew consent|1|||
124865374|NCT02119260|449128734|FG002|Overall Study|Withdrew consent|1|||
124865375|NCT02119260|449128735|FG003|Overall Study|Withdrew consent|0|||
124865376|NCT02119260|449128736|FG004|Overall Study|Withdrew consent|0|||
124865377|NCT02119260|449128737|FG005|Overall Study|Withdrew consent|0|||
124865378|NCT02119260|449128738|FG006|Overall Study|Withdrew consent|0|||
124865379|NCT01738984|449128739|FG000|Overall Study|Pregnancy|4|||
124865380|NCT01738984|449128740|FG001|Overall Study|Pregnancy|0|||
124865381|NCT01738984|449128739|FG000|Overall Study|Withdrawal by Subject|1|||
124865382|NCT01738984|449128740|FG001|Overall Study|Withdrawal by Subject|0|||
124865383|NCT01738984|449128739|FG000|Overall Study|Lost to Follow-up|59|||
124865384|NCT01738984|449128740|FG001|Overall Study|Lost to Follow-up|39|||
124865385|NCT00857207|449128741|FG000|Overall Study|Withdrawal by Subject|13|||
124865386|NCT00857207|449128742|FG001|Overall Study|Withdrawal by Subject|0|||
124865387|NCT00857207|449128741|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
124865388|NCT00857207|449128742|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
124865389|NCT00857207|449128741|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
124865390|NCT00857207|449128742|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
124865391|NCT00447057|449128747|FG000|Overall Study|Adverse Event|4|||
124865392|NCT00447057|449128748|FG001|Overall Study|Adverse Event|10|||
124865393|NCT00447057|449128749|FG002|Overall Study|Adverse Event|0|||
124865394|NCT00447057|449128750|FG003|Overall Study|Adverse Event|3|||
124865395|NCT00447057|449128747|FG000|Overall Study|Death due to study disease|6|||
124865396|NCT00447057|449128748|FG001|Overall Study|Death due to study disease|4|||
124865397|NCT00447057|449128749|FG002|Overall Study|Death due to study disease|1|||
124865398|NCT00447057|449128750|FG003|Overall Study|Death due to study disease|1|||
124865399|NCT00447057|449128747|FG000|Overall Study|Lost to Follow-up|0|||
124865400|NCT00447057|449128748|FG001|Overall Study|Lost to Follow-up|1|||
124865401|NCT00447057|449128749|FG002|Overall Study|Lost to Follow-up|0|||
124865402|NCT00447057|449128750|FG003|Overall Study|Lost to Follow-up|0|||
124865403|NCT00447057|449128747|FG000|Overall Study|Entry criteria not met|1|||
124865404|NCT00447057|449128748|FG001|Overall Study|Entry criteria not met|1|||
124865405|NCT00447057|449128749|FG002|Overall Study|Entry criteria not met|0|||
124865406|NCT00447057|449128750|FG003|Overall Study|Entry criteria not met|0|||
124865407|NCT00447057|449128747|FG000|Overall Study|Protocol Violation|0|||
124865408|NCT00447057|449128748|FG001|Overall Study|Protocol Violation|1|||
124865409|NCT00447057|449128749|FG002|Overall Study|Protocol Violation|0|||
124865410|NCT00447057|449128750|FG003|Overall Study|Protocol Violation|0|||
124865411|NCT00447057|449128747|FG000|Overall Study|Withdrawal by Subject|4|||
124865412|NCT00447057|449128748|FG001|Overall Study|Withdrawal by Subject|5|||
124865413|NCT00447057|449128749|FG002|Overall Study|Withdrawal by Subject|1|||
124865414|NCT00447057|449128750|FG003|Overall Study|Withdrawal by Subject|1|||
124865415|NCT00447057|449128747|FG000|Overall Study|Physician Decision|9|||
124865416|NCT00447057|449128748|FG001|Overall Study|Physician Decision|6|||
124865417|NCT00447057|449128749|FG002|Overall Study|Physician Decision|3|||
124865418|NCT00447057|449128750|FG003|Overall Study|Physician Decision|1|||
124865419|NCT00447057|449128747|FG000|Overall Study|Sponsor decision|1|||
124865420|NCT00447057|449128748|FG001|Overall Study|Sponsor decision|1|||
124865421|NCT00447057|449128749|FG002|Overall Study|Sponsor decision|0|||
124865422|NCT00447057|449128750|FG003|Overall Study|Sponsor decision|0|||
124865423|NCT00447057|449128747|FG000|Overall Study|Progressive disease|58|||
124865424|NCT00447057|449128748|FG001|Overall Study|Progressive disease|43|||
124865425|NCT00447057|449128749|FG002|Overall Study|Progressive disease|13|||
124865426|NCT00447057|449128750|FG003|Overall Study|Progressive disease|18|||
124865427|NCT00447057|449128747|FG000|Overall Study|Death due to adverse event|0|||
124865428|NCT00447057|449128748|FG001|Overall Study|Death due to adverse event|0|||
124865429|NCT00447057|449128749|FG002|Overall Study|Death due to adverse event|1|||
124969460|NCT01377389|449517397|FG000|Overall Study|Screen failure|2|||
124865430|NCT00447057|449128750|FG003|Overall Study|Death due to adverse event|2|||
124865431|NCT00447057|449128747|FG000|Overall Study|Death, study drug related|0|||
124865432|NCT00447057|449128748|FG001|Overall Study|Death, study drug related|1|||
124865433|NCT00447057|449128749|FG002|Overall Study|Death, study drug related|0|||
124865434|NCT00447057|449128750|FG003|Overall Study|Death, study drug related|0|||
124865435|NCT00440531|449128751|FG000|Overall Study|Adverse Event|1|||
124976634|NCT03838731|449541849|FG000|Overall Study|Withdrawal of consent|1|||
124532881|NCT00808028|447901968|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
124532882|NCT00808028|447901969|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
124532883|NCT00808028|447901966|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
124532884|NCT00808028|447901967|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
124532885|NCT00808028|447901968|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
124532886|NCT00808028|447901969|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
124532887|NCT00808028|447901966|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
124532888|NCT00808028|447901967|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
124532889|NCT00808028|447901968|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
124532890|NCT00808028|447901969|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
124532891|NCT00808028|447901966|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
124532892|NCT00808028|447901967|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
124532893|NCT00808028|447901968|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
124551153|NCT00267020|447974672|FG000|Overall Study|Physician Decision|3|||
124754488|NCT03526146|448723901|FG000|Overall Study|Lost to Follow-up|5|||
124754489|NCT03526146|448723901|FG000|Overall Study|Withdrawal by Subject|6|||
124754490|NCT03526146|448723901|FG000|Overall Study|class canceled due to COVID-19|4|||
124754491|NCT02517541|448723906|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
124754492|NCT02517541|448723906|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
124754493|NCT02517541|448723906|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
124754494|NCT02517541|448723906|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
124754495|NCT02517541|448723906|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
124754496|NCT02517541|448723906|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
124754497|NCT01510158|448723907|FG000|Overall Study|Adverse Event|7|||
124754498|NCT01510158|448723908|FG001|Overall Study|Adverse Event|8|||
124754499|NCT01510158|448723909|FG002|Overall Study|Adverse Event|5|||
124754500|NCT01510158|448723907|FG000|Overall Study|Gout flare|1|||
124754501|NCT01510158|448723908|FG001|Overall Study|Gout flare|0|||
124754502|NCT01510158|448723909|FG002|Overall Study|Gout flare|0|||
124754503|NCT01510158|448723907|FG000|Overall Study|Protocol Violation|17|||
124754504|NCT01510158|448723908|FG001|Overall Study|Protocol Violation|16|||
124754505|NCT01510158|448723909|FG002|Overall Study|Protocol Violation|24|||
124754506|NCT01510158|448723907|FG000|Overall Study|Sponsor terminated study.|2|||
124754507|NCT01510158|448723908|FG001|Overall Study|Sponsor terminated study.|0|||
124754508|NCT01510158|448723909|FG002|Overall Study|Sponsor terminated study.|2|||
124754509|NCT01510158|448723907|FG000|Overall Study|Lost to Follow-up|13|||
124754510|NCT01510158|448723908|FG001|Overall Study|Lost to Follow-up|16|||
124754511|NCT01510158|448723909|FG002|Overall Study|Lost to Follow-up|9|||
124754512|NCT01510158|448723907|FG000|Overall Study|Withdrawal by Subject|10|||
124754513|NCT01510158|448723908|FG001|Overall Study|Withdrawal by Subject|13|||
124754514|NCT01510158|448723909|FG002|Overall Study|Withdrawal by Subject|10|||
124754515|NCT01510158|448723907|FG000|Overall Study|Death|1|||
124754516|NCT01510158|448723908|FG001|Overall Study|Death|0|||
124754517|NCT01510158|448723909|FG002|Overall Study|Death|0|||
124754518|NCT03078556|448723910|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
124754519|NCT03078556|448723911|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
124754520|NCT03078556|448723912|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
124754521|NCT03078556|448723913|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
124754522|NCT03078556|448723910|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
124754523|NCT03078556|448723911|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
124754524|NCT03078556|448723912|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
124754525|NCT03078556|448723913|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
124754526|NCT03078556|448723910|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
124754527|NCT03078556|448723911|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
124754528|NCT03078556|448723912|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
124754529|NCT03078556|448723913|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
124754530|NCT03078556|448723910|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
124754531|NCT03078556|448723911|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
124754532|NCT03078556|448723912|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
124754533|NCT03078556|448723913|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
124754534|NCT03314987|448723914|FG000|Overall Study|Lost to Follow-up|13|||
124754535|NCT03314987|448723915|FG001|Overall Study|Lost to Follow-up|13|||
124754536|NCT03574779|448723916|FG000|Overall Study|Screening failure|13|||
124754537|NCT03574779|448723917|FG001|Overall Study|Screening failure|83|||
124754538|NCT02751580|448723918|FG000|Overall Study|Lost to Follow-up|4|||
124865436|NCT00440531|449128752|FG001|Overall Study|Adverse Event|0|||
124865437|NCT00440531|449128753|FG002|Overall Study|Adverse Event|2|||
124865438|NCT00440531|449128751|FG000|Overall Study|Withdrawal by Subject|2|||
124865439|NCT00440531|449128752|FG001|Overall Study|Withdrawal by Subject|0|||
124865440|NCT00440531|449128753|FG002|Overall Study|Withdrawal by Subject|0|||
124532894|NCT00808028|447901969|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
124532895|NCT02773849|447901971|FG000|Overall Study|Lost to Follow-up|11|||
124865441|NCT00440531|449128751|FG000|Overall Study|Protocol Violation|1|||
124976635|NCT03838731|449541850|FG001|Overall Study|Withdrawal of consent|0|||
124976636|NCT00603525|449541856|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
124976637|NCT00603525|449541857|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
124865442|NCT00440531|449128752|FG001|Overall Study|Protocol Violation|2|||
124865443|NCT00440531|449128753|FG002|Overall Study|Protocol Violation|0|||
124865444|NCT00440531|449128751|FG000|Overall Study|Lost to Follow-up|4|||
124865445|NCT00440531|449128752|FG001|Overall Study|Lost to Follow-up|3|||
124865446|NCT00440531|449128753|FG002|Overall Study|Lost to Follow-up|5|||
124865447|NCT00440531|449128751|FG000|Overall Study|see pre-assignment details|2|||
124865448|NCT00440531|449128752|FG001|Overall Study|see pre-assignment details|0|||
124865449|NCT00440531|449128753|FG002|Overall Study|see pre-assignment details|0|||
124865450|NCT02181803|449128756|FG000|Overall Study|Withdrawal by Subject|0|||
124865451|NCT02181803|449128757|FG001|Overall Study|Withdrawal by Subject|2|||
124532896|NCT02773849|447901971|FG000|Overall Study|Death|26|||
124532897|NCT02773849|447901971|FG000|Overall Study|Withdrawal by Subject|5|||
124532898|NCT02773849|447901971|FG000|Overall Study|Withdrawal of Consent|9|||
124532899|NCT02773849|447901971|FG000|Overall Study|Other: not due to lack of tolerability|11|||
124532900|NCT02418000|447901972|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
124532901|NCT02418000|447901973|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
124532902|NCT02418000|447901974|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
124532903|NCT02418000|447901975|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
124532904|NCT02418000|447901976|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
124532905|NCT02418000|447901972|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
124532906|NCT02418000|447901973|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
124532907|NCT02418000|447901974|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
124865452|NCT02181803|449128758|FG002|Overall Study|Withdrawal by Subject|0|||
124865453|NCT02181803|449128759|FG003|Overall Study|Withdrawal by Subject|0|||
124976638|NCT00603525|449541858|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
124976639|NCT00603525|449541856|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
124976640|NCT00603525|449541857|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
124976641|NCT00603525|449541858|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
124976642|NCT00603525|449541856|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
124976643|NCT00603525|449541857|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
124976644|NCT00603525|449541858|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
124976645|NCT00603525|449541856|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
124976646|NCT00603525|449541857|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
124976647|NCT00603525|449541858|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124976648|NCT00603525|449541856|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
124976649|NCT00603525|449541857|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
124976650|NCT00603525|449541858|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124976651|NCT00603525|449541856|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
124976652|NCT00603525|449541857|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
124976653|NCT00603525|449541858|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
124976654|NCT00603525|449541856|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
124976655|NCT00603525|449541857|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
124865454|NCT02181803|449128760|FG004|Overall Study|Withdrawal by Subject|0|||
124865455|NCT02181803|449128761|FG005|Overall Study|Withdrawal by Subject|0|||
124865456|NCT02181803|449128762|FG006|Overall Study|Withdrawal by Subject|0|||
124976656|NCT00603525|449541858|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
124976657|NCT00603525|449541856|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
124976658|NCT00603525|449541857|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
124976659|NCT00603525|449541858|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
124976660|NCT00603525|449541856|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
124976661|NCT00603525|449541857|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
124976662|NCT00603525|449541858|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
124976663|NCT00603525|449541856|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
124976664|NCT00603525|449541857|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
124976665|NCT00603525|449541858|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
124532908|NCT02418000|447901975|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
124551154|NCT00267020|447974673|FG001|Overall Study|Physician Decision|2|||
124865457|NCT02181803|449128763|FG007|Overall Study|Withdrawal by Subject|0|||
124865458|NCT02181803|449128764|FG008|Overall Study|Withdrawal by Subject|0|||
124865459|NCT02181803|449128756|FG000|Overall Study|Physician Decision|0|||
124865460|NCT02181803|449128757|FG001|Overall Study|Physician Decision|0|||
124865461|NCT02181803|449128758|FG002|Overall Study|Physician Decision|0|||
124532909|NCT02418000|447901976|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
124865462|NCT02181803|449128759|FG003|Overall Study|Physician Decision|1|||
124532910|NCT02418000|447901972|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
124532911|NCT02418000|447901973|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
124532912|NCT02418000|447901974|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
124532913|NCT02418000|447901975|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
124532914|NCT02418000|447901976|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
124532915|NCT02418000|447901972|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
124532916|NCT02418000|447901973|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
124532917|NCT02418000|447901974|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
124532918|NCT02418000|447901975|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
124532919|NCT02418000|447901976|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
124532920|NCT02418000|447901972|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
124532921|NCT02418000|447901973|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
124532922|NCT02418000|447901974|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
124532923|NCT02418000|447901975|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
124532924|NCT02418000|447901976|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
124532925|NCT02418000|447901972|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
124532926|NCT02418000|447901973|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
124532927|NCT02418000|447901974|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
124532928|NCT02418000|447901975|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
124532929|NCT02418000|447901976|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
124532930|NCT02418000|447901972|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
124532931|NCT02418000|447901973|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
124532932|NCT02418000|447901974|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
124532933|NCT02418000|447901975|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
124532934|NCT02418000|447901976|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
124532935|NCT02418000|447901972|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
124532936|NCT02418000|447901973|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
124532937|NCT02418000|447901974|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
124532938|NCT02418000|447901975|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
124532939|NCT02418000|447901976|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
124532940|NCT02418000|447901972|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
124532941|NCT02418000|447901973|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
124532942|NCT02418000|447901974|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
124532943|NCT02418000|447901975|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
124532944|NCT02418000|447901976|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
124532945|NCT00508001|447901977|FG000|Overall Study|Adverse Event|2|||
124532946|NCT00508001|447901978|FG001|Overall Study|Adverse Event|0|||
124532947|NCT00508001|447901979|FG002|Overall Study|Adverse Event|4|||
124532948|NCT00508001|447901977|FG000|Overall Study|condition under investigation worsened|13|||
124532949|NCT00508001|447901978|FG001|Overall Study|condition under investigation worsened|7|||
124532950|NCT00508001|447901979|FG002|Overall Study|condition under investigation worsened|1|||
124532951|NCT00508001|447901977|FG000|Overall Study|Death|0|||
124532952|NCT00508001|447901978|FG001|Overall Study|Death|1|||
124532953|NCT00508001|447901979|FG002|Overall Study|Death|1|||
124532954|NCT00508001|447901977|FG000|Overall Study|Withdrawal by Subject|4|||
124532955|NCT00508001|447901978|FG001|Overall Study|Withdrawal by Subject|4|||
124532956|NCT00508001|447901979|FG002|Overall Study|Withdrawal by Subject|1|||
124532957|NCT02381795|447901985|FG000|Overall Study|Withdrawal by Subject|1|||
124532958|NCT02381795|447901985|FG000|Overall Study|Study Terminated|2|||
124532959|NCT02176226|447901988|FG000|Overall Study|Lost to Follow-up|3|||
124532960|NCT02176226|447901988|FG000|Overall Study|Withdrew prior to treatment|6|||
124532961|NCT01412333|447901994|FG000|Overall Study|Adverse Event|40|||
124532962|NCT01412333|447901995|FG001|Overall Study|Adverse Event|42|||
124532963|NCT01412333|447901994|FG000|Overall Study|Death|5|||
124532964|NCT01412333|447901995|FG001|Overall Study|Death|6|||
124865463|NCT02181803|449128760|FG004|Overall Study|Physician Decision|0|||
124865464|NCT02181803|449128761|FG005|Overall Study|Physician Decision|0|||
124865465|NCT02181803|449128762|FG006|Overall Study|Physician Decision|0|||
124865466|NCT02181803|449128763|FG007|Overall Study|Physician Decision|1|||
124865467|NCT02181803|449128764|FG008|Overall Study|Physician Decision|0|||
124865468|NCT02181803|449128756|FG000|Overall Study|Adverse Event|0|||
124865469|NCT02181803|449128757|FG001|Overall Study|Adverse Event|2|||
124865470|NCT02181803|449128758|FG002|Overall Study|Adverse Event|0|||
124865471|NCT02181803|449128759|FG003|Overall Study|Adverse Event|1|||
124865472|NCT02181803|449128760|FG004|Overall Study|Adverse Event|0|||
124865473|NCT02181803|449128761|FG005|Overall Study|Adverse Event|0|||
124865474|NCT02181803|449128762|FG006|Overall Study|Adverse Event|1|||
124532965|NCT01412333|447901994|FG000|Overall Study|Lack of Efficacy|22|||
124532966|NCT01412333|447901995|FG001|Overall Study|Lack of Efficacy|10|||
124643867|NCT00378508|448313766|FG000|Overall Study|Withdrawal by Subject|1|||
124532967|NCT01412333|447901994|FG000|Overall Study|Lost to Follow-up|15|||
124532968|NCT01412333|447901995|FG001|Overall Study|Lost to Follow-up|12|||
124532969|NCT01412333|447901994|FG000|Overall Study|Non-Compliance|3|||
124532970|NCT01412333|447901995|FG001|Overall Study|Non-Compliance|7|||
124532971|NCT01412333|447901994|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124532972|NCT01412333|447901995|FG001|Overall Study|Non-Compliance With Study Drug|1|||
124532973|NCT01412333|447901994|FG000|Overall Study|Other|30|||
124532974|NCT01412333|447901995|FG001|Overall Study|Other|33|||
124532975|NCT01412333|447901994|FG000|Overall Study|Physician Decision|11|||
124532976|NCT01412333|447901995|FG001|Overall Study|Physician Decision|16|||
124865475|NCT02181803|449128763|FG007|Overall Study|Adverse Event|0|||
124865476|NCT02181803|449128764|FG008|Overall Study|Adverse Event|0|||
124865477|NCT03151005|449128765|FG000|Overall Study|Lost to Follow-up|5|||
124865478|NCT03151005|449128766|FG001|Overall Study|Lost to Follow-up|5|||
124865479|NCT04786444|449128769|FG000|Overall Study|Withdrawal by Subject|4|||
124865480|NCT04786444|449128770|FG001|Overall Study|Withdrawal by Subject|7|||
124865481|NCT04786444|449128771|FG002|Overall Study|Withdrawal by Subject|2|||
124865482|NCT04786444|449128769|FG000|Overall Study|Lost to Follow-up|11|||
124976666|NCT00603525|449541856|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
124976667|NCT00603525|449541857|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
124865483|NCT04786444|449128770|FG001|Overall Study|Lost to Follow-up|9|||
124865484|NCT04786444|449128771|FG002|Overall Study|Lost to Follow-up|10|||
124865485|NCT04786444|449128769|FG000|Overall Study|Subject would like to become pregnant|0|||
124865486|NCT04786444|449128770|FG001|Overall Study|Subject would like to become pregnant|1|||
124865487|NCT04786444|449128771|FG002|Overall Study|Subject would like to become pregnant|0|||
124976668|NCT00603525|449541858|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
124532977|NCT01412333|447901994|FG000|Overall Study|Pregnancy|6|||
124532978|NCT01412333|447901995|FG001|Overall Study|Pregnancy|4|||
124532979|NCT01412333|447901994|FG000|Overall Study|Protocol Violation|1|||
124532980|NCT01412333|447901995|FG001|Overall Study|Protocol Violation|2|||
124532981|NCT01412333|447901994|FG000|Overall Study|Study Terminated By Sponsor|3|||
124976669|NCT00603525|449541856|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
124976670|NCT00603525|449541857|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
124532982|NCT01412333|447901995|FG001|Overall Study|Study Terminated By Sponsor|2|||
124532983|NCT01412333|447901994|FG000|Overall Study|Withdrawal by Subject|51|||
124532984|NCT01412333|447901995|FG001|Overall Study|Withdrawal by Subject|54|||
124532985|NCT01412333|447901994|FG000|Overall Study|Missing|1|||
124532986|NCT01412333|447901995|FG001|Overall Study|Missing|3|||
124532987|NCT02718625|447901996|FG000|Overall Study|Adverse Event|0|||
124532988|NCT02718625|447901997|FG001|Overall Study|Adverse Event|1|||
124532989|NCT02718625|447901996|FG000|Overall Study|Termination of Study by Sponsor|0|||
124532990|NCT02718625|447901997|FG001|Overall Study|Termination of Study by Sponsor|1|||
124532991|NCT01060150|447902002|FG000|Overall Study|Adverse Event|6|||
124532992|NCT01060150|447902002|FG000|Overall Study|Lost to Follow-up|1|||
124532993|NCT01060150|447902002|FG000|Overall Study|Protocol Violation|6|||
124976671|NCT00603525|449541858|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
124976672|NCT00603525|449541856|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
124976673|NCT00603525|449541857|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
124976674|NCT00603525|449541858|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
124532994|NCT01060150|447902002|FG000|Overall Study|Withdrawal by Subject|8|||
124532995|NCT01060150|447902002|FG000|Overall Study|Enrolled, but not treated|2|||
124532996|NCT01947127|447902003|FG000|Overall Study|Protocol Violation|18|||
124532997|NCT01947127|447902004|FG001|Overall Study|Protocol Violation|38|||
124532998|NCT01947127|447902003|FG000|Overall Study|Withdrawal by Subject|1|||
124532999|NCT01947127|447902004|FG001|Overall Study|Withdrawal by Subject|1|||
124533000|NCT01947127|447902003|FG000|Overall Study|Data loss|4|||
124533001|NCT01947127|447902004|FG001|Overall Study|Data loss|4|||
124533002|NCT01836549|447902005|FG000|Overall Study|Did not receive study drug|0|||
124533003|NCT01836549|447902006|FG001|Overall Study|Did not receive study drug|0|||
124533004|NCT01836549|447902007|FG002|Overall Study|Did not receive study drug|1|||
124533005|NCT01836549|447902008|FG003|Overall Study|Did not receive study drug|0|||
124711965|NCT01127633|448570697|FG000|Overall Study|Physician Decision|60|||
124754539|NCT02751580|448723918|FG000|Overall Study|Death|2|||
124754540|NCT02152761|448723925|FG000|Epoch: Treatment Epoch|Technical problems|0|||
124865488|NCT02131272|449128772|FG000|Overall Study|Withdrawal by parent|0|||
124865489|NCT02131272|449128773|FG001|Overall Study|Withdrawal by parent|1|||
124865490|NCT02131272|449128772|FG000|Overall Study|Withdrawal by Subject|0|||
124865491|NCT02131272|449128773|FG001|Overall Study|Withdrawal by Subject|1|||
124865492|NCT02131272|449128772|FG000|Overall Study|Withdrawal Criteria|1|||
124533006|NCT01836549|447902009|FG004|Overall Study|Did not receive study drug|0|||
124533007|NCT01836549|447902010|FG005|Overall Study|Did not receive study drug|0|||
124533008|NCT01836549|447902011|FG006|Overall Study|Did not receive study drug|0|||
124533009|NCT01836549|447902005|FG000|Overall Study|Patient declared ineligible|0|||
124533010|NCT01836549|447902006|FG001|Overall Study|Patient declared ineligible|0|||
124533011|NCT01836549|447902007|FG002|Overall Study|Patient declared ineligible|0|||
124533012|NCT01836549|447902008|FG003|Overall Study|Patient declared ineligible|1|||
124533013|NCT01836549|447902009|FG004|Overall Study|Patient declared ineligible|0|||
124533014|NCT01836549|447902010|FG005|Overall Study|Patient declared ineligible|0|||
124533015|NCT01836549|447902011|FG006|Overall Study|Patient declared ineligible|0|||
124533016|NCT01836549|447902005|FG000|Overall Study|Patient inevaluable to start therapy|0|||
124533017|NCT01836549|447902006|FG001|Overall Study|Patient inevaluable to start therapy|0|||
124533018|NCT01836549|447902007|FG002|Overall Study|Patient inevaluable to start therapy|0|||
124533019|NCT01836549|447902008|FG003|Overall Study|Patient inevaluable to start therapy|0|||
124533020|NCT01836549|447902009|FG004|Overall Study|Patient inevaluable to start therapy|0|||
124533021|NCT01836549|447902010|FG005|Overall Study|Patient inevaluable to start therapy|0|||
124533022|NCT01836549|447902011|FG006|Overall Study|Patient inevaluable to start therapy|1|||
124533023|NCT02516306|447902012|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
124533024|NCT02516306|447902013|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
124533025|NCT00242710|447902017|FG000|Core Study (up to Year 1)|Adverse Event|30|||
124533026|NCT00242710|447902018|FG001|Core Study (up to Year 1)|Adverse Event|25|||
124533027|NCT00242710|447902019|FG002|Core Study (up to Year 1)|Adverse Event|23|||
124533028|NCT00242710|447902020|FG003|Core Study (up to Year 1)|Adverse Event|14|||
124533029|NCT00242710|447902017|FG000|Core Study (up to Year 1)|Death|0|||
124533030|NCT00242710|447902018|FG001|Core Study (up to Year 1)|Death|0|||
124533031|NCT00242710|447902019|FG002|Core Study (up to Year 1)|Death|1|||
124533032|NCT00242710|447902020|FG003|Core Study (up to Year 1)|Death|0|||
124533033|NCT00242710|447902017|FG000|Core Study (up to Year 1)|Physician Decision|0|||
124533034|NCT00242710|447902018|FG001|Core Study (up to Year 1)|Physician Decision|1|||
124533035|NCT00242710|447902019|FG002|Core Study (up to Year 1)|Physician Decision|0|||
124533036|NCT00242710|447902020|FG003|Core Study (up to Year 1)|Physician Decision|1|||
124533037|NCT00242710|447902017|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
124533038|NCT00242710|447902018|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
124533039|NCT00242710|447902019|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
124533040|NCT00242710|447902020|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
124533041|NCT00242710|447902017|FG000|Core Study (up to Year 1)|Other|6|||
124533042|NCT00242710|447902018|FG001|Core Study (up to Year 1)|Other|1|||
124533043|NCT00242710|447902019|FG002|Core Study (up to Year 1)|Other|0|||
124533044|NCT00242710|447902020|FG003|Core Study (up to Year 1)|Other|2|||
124533045|NCT00242710|447902017|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
124533046|NCT00242710|447902018|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
124533047|NCT00242710|447902019|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
124533048|NCT00242710|447902020|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
124533049|NCT00242710|447902017|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
124533050|NCT00242710|447902018|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
124533051|NCT00242710|447902019|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
124533052|NCT00242710|447902020|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
124533053|NCT00242710|447902017|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
124533054|NCT00242710|447902018|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
124533055|NCT00242710|447902019|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
124533056|NCT00242710|447902020|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
124533057|NCT00242710|447902017|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
124533058|NCT00242710|447902018|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
124533059|NCT00242710|447902019|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
124533060|NCT00242710|447902020|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
124533061|NCT00242710|447902017|FG000|Period Between Core Study and Extension|Adverse Event|2|||
124533062|NCT00242710|447902018|FG001|Period Between Core Study and Extension|Adverse Event|3|||
124533063|NCT00242710|447902019|FG002|Period Between Core Study and Extension|Adverse Event|5|||
124533064|NCT00242710|447902020|FG003|Period Between Core Study and Extension|Adverse Event|2|||
124533065|NCT00242710|447902017|FG000|Period Between Core Study and Extension|Physician Decision|1|||
124533066|NCT00242710|447902018|FG001|Period Between Core Study and Extension|Physician Decision|1|||
124533067|NCT00242710|447902019|FG002|Period Between Core Study and Extension|Physician Decision|0|||
124533068|NCT00242710|447902020|FG003|Period Between Core Study and Extension|Physician Decision|0|||
124533069|NCT00242710|447902017|FG000|Period Between Core Study and Extension|Other|24|||
124533070|NCT00242710|447902018|FG001|Period Between Core Study and Extension|Other|24|||
124533071|NCT00242710|447902019|FG002|Period Between Core Study and Extension|Other|9|||
124533072|NCT00242710|447902020|FG003|Period Between Core Study and Extension|Other|11|||
124533073|NCT00242710|447902017|FG000|Period Between Core Study and Extension|Extension not Available|17|||
124533074|NCT00242710|447902018|FG001|Period Between Core Study and Extension|Extension not Available|21|||
124533075|NCT00242710|447902019|FG002|Period Between Core Study and Extension|Extension not Available|8|||
124533076|NCT00242710|447902020|FG003|Period Between Core Study and Extension|Extension not Available|7|||
124533077|NCT00242710|447902017|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
124533078|NCT00242710|447902018|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
124533079|NCT00242710|447902019|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
124533080|NCT00242710|447902020|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
124533081|NCT00242710|447902017|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
124533082|NCT00242710|447902018|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
124533083|NCT00242710|447902019|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
124533084|NCT00242710|447902020|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
124533085|NCT00242710|447902017|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
124533086|NCT00242710|447902018|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
124976675|NCT00603525|449541856|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
124533087|NCT00242710|447902019|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
124533088|NCT00242710|447902020|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
124533089|NCT00242710|447902017|FG000|Study Extension (up to Year 2)|Death|0|||
124533090|NCT00242710|447902018|FG001|Study Extension (up to Year 2)|Death|0|||
124533091|NCT00242710|447902019|FG002|Study Extension (up to Year 2)|Death|0|||
124533092|NCT00242710|447902020|FG003|Study Extension (up to Year 2)|Death|1|||
124533093|NCT00242710|447902017|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
124533094|NCT00242710|447902018|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
124533095|NCT00242710|447902019|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
124533096|NCT00242710|447902020|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
124533097|NCT00242710|447902017|FG000|Study Extension (up to Year 2)|Other|3|||
124533098|NCT00242710|447902018|FG001|Study Extension (up to Year 2)|Other|5|||
124533099|NCT00242710|447902019|FG002|Study Extension (up to Year 2)|Other|4|||
124533100|NCT00242710|447902020|FG003|Study Extension (up to Year 2)|Other|3|||
124533101|NCT00242710|447902017|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
124533102|NCT00242710|447902018|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
124533103|NCT00242710|447902019|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
124533104|NCT00242710|447902020|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
124533105|NCT00242710|447902017|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
124533106|NCT00242710|447902018|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
124533107|NCT00242710|447902019|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
124533108|NCT00242710|447902020|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
124533109|NCT00579527|447902021|FG000|Overall Study|Death|4|||
124533110|NCT03961529|447902022|FG000|Overall Study|Adverse Event|13|||
124533111|NCT03961529|447902023|FG001|Overall Study|Adverse Event|5|||
124533112|NCT03961529|447902024|FG002|Overall Study|Adverse Event|2|||
124533113|NCT03961529|447902022|FG000|Overall Study|Withdrawal by Subject|17|||
124533114|NCT03961529|447902023|FG001|Overall Study|Withdrawal by Subject|2|||
124533115|NCT03961529|447902024|FG002|Overall Study|Withdrawal by Subject|1|||
124533116|NCT03961529|447902022|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124533117|NCT03961529|447902023|FG001|Overall Study|Withdrawal by parent/guardian|7|||
124533118|NCT03961529|447902024|FG002|Overall Study|Withdrawal by parent/guardian|0|||
124533119|NCT03961529|447902022|FG000|Overall Study|Physician Decision|2|||
124533120|NCT03961529|447902023|FG001|Overall Study|Physician Decision|1|||
124533121|NCT03961529|447902024|FG002|Overall Study|Physician Decision|1|||
124533122|NCT03961529|447902022|FG000|Overall Study|Lost to Follow-up|2|||
124533123|NCT03961529|447902023|FG001|Overall Study|Lost to Follow-up|1|||
124533124|NCT03961529|447902024|FG002|Overall Study|Lost to Follow-up|0|||
124533125|NCT03961529|447902022|FG000|Overall Study|Lack of Efficacy|2|||
124533126|NCT03961529|447902023|FG001|Overall Study|Lack of Efficacy|0|||
124976676|NCT00603525|449541857|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
124533127|NCT03961529|447902024|FG002|Overall Study|Lack of Efficacy|1|||
124533128|NCT03961529|447902022|FG000|Overall Study|Other|6|||
124533129|NCT03961529|447902023|FG001|Overall Study|Other|1|||
124976677|NCT00603525|449541858|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
124976678|NCT00603525|449541856|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
124976679|NCT00603525|449541857|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
124533130|NCT03961529|447902024|FG002|Overall Study|Other|0|||
124533131|NCT03644173|447902025|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
124533132|NCT03644173|447902025|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
124533133|NCT03644173|447902025|FG000|Participants at the 1-month Follow up|Death|2|||
124533134|NCT03644173|447902025|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
124533135|NCT00381706|447902028|FG000|Overall Study|Never treated|7|||
124533136|NCT00381706|447902029|FG001|Overall Study|Never treated|2|||
124533137|NCT00381706|447902030|FG002|Overall Study|Never treated|1|||
124533138|NCT04554394|447902031|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
124976680|NCT00603525|449541858|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
124533139|NCT04554394|447902032|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
124533140|NCT04554394|447902031|FG000|Overall Study|Withdrawal by Subject|2|||
124533141|NCT04554394|447902032|FG001|Overall Study|Withdrawal by Subject|2|||
124533142|NCT04554394|447902031|FG000|Overall Study|Lost to Follow-up|2|||
124533143|NCT04554394|447902032|FG001|Overall Study|Lost to Follow-up|2|||
124533144|NCT04554394|447902031|FG000|Overall Study|Physician Decision|1|||
124533145|NCT04554394|447902032|FG001|Overall Study|Physician Decision|1|||
124533146|NCT00886587|447902036|FG000|Overall Study|Adverse Event|2|||
124533147|NCT00886587|447902037|FG001|Overall Study|Adverse Event|1|||
124533148|NCT00886587|447902036|FG000|Overall Study|Protocol Violation|2|||
124533149|NCT00886587|447902037|FG001|Overall Study|Protocol Violation|0|||
124533150|NCT00886587|447902036|FG000|Overall Study|Withdrawal by Subject|0|||
124533151|NCT00886587|447902037|FG001|Overall Study|Withdrawal by Subject|1|||
124533152|NCT03490734|447902038|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
124533153|NCT03490734|447902039|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
124533154|NCT03490734|447902040|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
124533155|NCT03490734|447902041|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
124533156|NCT03490734|447902038|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
124533157|NCT03490734|447902039|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
124533158|NCT03490734|447902040|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
124533159|NCT03490734|447902041|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
124533160|NCT03490734|447902038|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
124533161|NCT03490734|447902039|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
124533162|NCT03490734|447902040|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
124533163|NCT03490734|447902041|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
124533164|NCT03490734|447902038|FG000|Post-intervention Scan Visit|Adverse Event|2|||
124533165|NCT03490734|447902039|FG001|Post-intervention Scan Visit|Adverse Event|0|||
124533166|NCT03490734|447902040|FG002|Post-intervention Scan Visit|Adverse Event|0|||
124533167|NCT03490734|447902041|FG003|Post-intervention Scan Visit|Adverse Event|0|||
124533168|NCT03490734|447902038|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
124533169|NCT03490734|447902039|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
124533170|NCT03490734|447902040|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
124533171|NCT03490734|447902041|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
124533172|NCT03490734|447902038|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
124865493|NCT02131272|449128773|FG001|Overall Study|Withdrawal Criteria|0|||
124865494|NCT02462876|449128774|FG000|Overall Study|Death|3|||
124865495|NCT02462876|449128774|FG000|Overall Study|Lost to Follow-up|7|||
124865496|NCT02462876|449128774|FG000|Overall Study|Surgical Bypass|9|||
124865497|NCT02462876|449128774|FG000|Overall Study|Amputation Above the Metatarsals|1|||
124865498|NCT02462876|449128774|FG000|Overall Study|36 months follow-up visit missed|1|||
124865499|NCT02462876|449128774|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
124865500|NCT02462876|449128774|FG000|Overall Study|Patient did not come back to the vascular department|1|||
124865501|NCT02462876|449128774|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
124865502|NCT02462876|449128774|FG000|Overall Study|Patient refused to come back|1|||
124865503|NCT02462876|449128774|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
124865504|NCT02462876|449128774|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
124865505|NCT01786512|449128777|FG000|Overall Study|Lost to Follow-up|0|||
124865506|NCT01786512|449128778|FG001|Overall Study|Lost to Follow-up|0|||
124865507|NCT01786512|449128779|FG002|Overall Study|Lost to Follow-up|0|||
124865508|NCT01786512|449128780|FG003|Overall Study|Lost to Follow-up|0|||
124865509|NCT01786512|449128781|FG004|Overall Study|Lost to Follow-up|0|||
124865510|NCT01786512|449128782|FG005|Overall Study|Lost to Follow-up|0|||
124865511|NCT01786512|449128783|FG006|Overall Study|Lost to Follow-up|0|||
124865512|NCT01786512|449128784|FG007|Overall Study|Lost to Follow-up|0|||
124865513|NCT01786512|449128785|FG008|Overall Study|Lost to Follow-up|0|||
124865514|NCT01786512|449128786|FG009|Overall Study|Lost to Follow-up|1|||
124865515|NCT01786512|449128787|FG010|Overall Study|Lost to Follow-up|0|||
124865516|NCT01786512|449128777|FG000|Overall Study|Decision by sponsor|0|||
124865517|NCT01786512|449128778|FG001|Overall Study|Decision by sponsor|0|||
124865518|NCT01786512|449128779|FG002|Overall Study|Decision by sponsor|0|||
124865519|NCT01786512|449128780|FG003|Overall Study|Decision by sponsor|0|||
124865520|NCT01786512|449128781|FG004|Overall Study|Decision by sponsor|0|||
124865521|NCT01786512|449128782|FG005|Overall Study|Decision by sponsor|0|||
124865522|NCT01786512|449128783|FG006|Overall Study|Decision by sponsor|0|||
124865523|NCT01786512|449128784|FG007|Overall Study|Decision by sponsor|0|||
124865524|NCT01786512|449128785|FG008|Overall Study|Decision by sponsor|0|||
124865525|NCT01786512|449128786|FG009|Overall Study|Decision by sponsor|0|||
124865526|NCT01786512|449128787|FG010|Overall Study|Decision by sponsor|2|||
124865527|NCT01786512|449128777|FG000|Overall Study|Withdrawal by Subject|0|||
124865528|NCT01786512|449128778|FG001|Overall Study|Withdrawal by Subject|1|||
124865529|NCT01786512|449128779|FG002|Overall Study|Withdrawal by Subject|0|||
124865530|NCT01786512|449128780|FG003|Overall Study|Withdrawal by Subject|0|||
124865531|NCT01786512|449128781|FG004|Overall Study|Withdrawal by Subject|0|||
124865532|NCT01786512|449128782|FG005|Overall Study|Withdrawal by Subject|0|||
124865533|NCT01786512|449128783|FG006|Overall Study|Withdrawal by Subject|1|||
124865534|NCT01786512|449128784|FG007|Overall Study|Withdrawal by Subject|0|||
124865535|NCT01786512|449128785|FG008|Overall Study|Withdrawal by Subject|0|||
124865536|NCT01786512|449128786|FG009|Overall Study|Withdrawal by Subject|3|||
124865537|NCT01786512|449128787|FG010|Overall Study|Withdrawal by Subject|7|||
124865538|NCT01786512|449128777|FG000|Overall Study|Death|0|||
124865539|NCT01786512|449128778|FG001|Overall Study|Death|0|||
124865540|NCT01786512|449128779|FG002|Overall Study|Death|0|||
124533173|NCT03490734|447902039|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
124533174|NCT03490734|447902040|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
124533175|NCT03490734|447902041|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
124533176|NCT00374452|447902045|FG000|Overall Study|Left clinic before intervention started|4|||
124533177|NCT00374452|447902046|FG001|Overall Study|Left clinic before intervention started|1|||
124533178|NCT00374452|447902045|FG000|Overall Study|Change in job role before intervention|0|||
124533179|NCT00374452|447902046|FG001|Overall Study|Change in job role before intervention|1|||
124533180|NCT00374452|447902045|FG000|Overall Study|Left clinic after intervention started|1|||
124533181|NCT00374452|447902046|FG001|Overall Study|Left clinic after intervention started|1|||
124865541|NCT01786512|449128780|FG003|Overall Study|Death|0|||
124865542|NCT01786512|449128781|FG004|Overall Study|Death|0|||
124865543|NCT01786512|449128782|FG005|Overall Study|Death|0|||
124865544|NCT01786512|449128783|FG006|Overall Study|Death|0|||
124533182|NCT00374452|447902045|FG000|Overall Study|Withdrawal by Subject|0|||
124533183|NCT00374452|447902046|FG001|Overall Study|Withdrawal by Subject|2|||
124533184|NCT00523744|447902047|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
124533185|NCT00523744|447902047|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
124533186|NCT00523744|447902047|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
124533187|NCT00523744|447902047|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
124533188|NCT00523744|447902047|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
124533189|NCT00523744|447902047|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
124533190|NCT03099304|447902050|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
124533191|NCT03099304|447902051|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
124533192|NCT03099304|447902052|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
124533193|NCT03099304|447902053|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
124533194|NCT03099304|447902054|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
124533195|NCT03099304|447902055|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
124533196|NCT03099304|447902050|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
124533197|NCT03099304|447902051|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
124533198|NCT03099304|447902052|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
124533199|NCT03099304|447902053|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
124865545|NCT01786512|449128784|FG007|Overall Study|Death|0|||
124865546|NCT01786512|449128785|FG008|Overall Study|Death|4|||
124865547|NCT01786512|449128786|FG009|Overall Study|Death|1|||
124865548|NCT01786512|449128787|FG010|Overall Study|Death|3|||
124865549|NCT03166618|449128788|FG000|Overall Study|Study was Terminated|0|||
124865550|NCT03166618|449128789|FG001|Overall Study|Study was Terminated|1|||
124533200|NCT03099304|447902054|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
124533201|NCT03099304|447902055|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
124533202|NCT03099304|447902050|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
124533203|NCT03099304|447902051|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
124533204|NCT03099304|447902052|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
124533205|NCT03099304|447902053|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
124533206|NCT03099304|447902054|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
124533207|NCT03099304|447902055|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
124533208|NCT03099304|447902050|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
124533209|NCT03099304|447902051|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
124865551|NCT01925950|449128790|FG000|Part 2|Withdrawal by Subject|1|||
124865552|NCT01925950|449128791|FG001|Part 2|Withdrawal by Subject|0|||
124865553|NCT00605293|449128794|FG000|Overall Study|Death|2|||
124865554|NCT00605293|449128795|FG001|Overall Study|Death|1|||
124865555|NCT00605293|449128794|FG000|Overall Study|Insufficient Therapeutic Response|2|||
124865556|NCT00605293|449128795|FG001|Overall Study|Insufficient Therapeutic Response|0|||
124865557|NCT00605293|449128794|FG000|Overall Study|Adverse Event|1|||
124865558|NCT00605293|449128795|FG001|Overall Study|Adverse Event|0|||
124865559|NCT00605293|449128794|FG000|Overall Study|Holidays Dialysis Out|1|||
124533210|NCT03099304|447902052|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
124533211|NCT03099304|447902053|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
124533212|NCT03099304|447902054|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
124533213|NCT03099304|447902055|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
124533214|NCT03099304|447902050|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
124533215|NCT03099304|447902051|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
124865560|NCT00605293|449128795|FG001|Overall Study|Holidays Dialysis Out|0|||
124865561|NCT00605293|449128794|FG000|Overall Study|Blood Transfusion|7|||
124533216|NCT03099304|447902052|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
124533217|NCT03099304|447902053|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
124533218|NCT03099304|447902054|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
124533219|NCT03099304|447902055|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
124533220|NCT03099304|447902050|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
124865562|NCT00605293|449128795|FG001|Overall Study|Blood Transfusion|1|||
124865563|NCT00605293|449128794|FG000|Overall Study|Renal Transplantation|3|||
124551155|NCT00267020|447974672|FG000|Overall Study|Disease Progression|39|||
124865564|NCT00605293|449128795|FG001|Overall Study|Renal Transplantation|1|||
124533221|NCT03099304|447902051|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
124533222|NCT03099304|447902052|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
124976681|NCT02304705|449541859|FG000|Overall Study|Withdrawal by Subject|2|||
124976682|NCT02304705|449541860|FG001|Overall Study|Withdrawal by Subject|0|||
124976683|NCT02304705|449541859|FG000|Overall Study|Physician Decision|2|||
124533223|NCT03099304|447902053|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
124533224|NCT03099304|447902054|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
124533225|NCT03099304|447902055|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
124533226|NCT03099304|447902050|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
124533227|NCT03099304|447902051|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
124533228|NCT03099304|447902052|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
124533229|NCT03099304|447902053|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
124533230|NCT03099304|447902054|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
124533231|NCT03099304|447902055|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
124533232|NCT03099304|447902050|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
124533233|NCT03099304|447902051|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
124976684|NCT02304705|449541860|FG001|Overall Study|Physician Decision|4|||
124533234|NCT03099304|447902052|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
124533235|NCT03099304|447902053|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
124533236|NCT03099304|447902054|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
124533237|NCT03099304|447902055|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
124533238|NCT03099304|447902050|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
124533239|NCT03099304|447902051|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
124533240|NCT03099304|447902052|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
124533241|NCT03099304|447902053|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
124533242|NCT03099304|447902054|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
124533243|NCT03099304|447902055|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
124533244|NCT03099304|447902050|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
124533245|NCT03099304|447902051|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
124533246|NCT03099304|447902052|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
124533247|NCT03099304|447902053|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
124533248|NCT03099304|447902054|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
124533249|NCT03099304|447902055|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
124533250|NCT03099304|447902050|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
124533251|NCT03099304|447902051|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
124533252|NCT03099304|447902052|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
124533253|NCT03099304|447902053|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
124533254|NCT03099304|447902054|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
124533255|NCT03099304|447902055|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
124533256|NCT03099304|447902050|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
124533257|NCT03099304|447902051|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
124533258|NCT03099304|447902052|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
124533259|NCT03099304|447902053|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
124533260|NCT03099304|447902054|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
124976685|NCT02304705|449541859|FG000|Overall Study|Death|0|||
124976686|NCT02304705|449541860|FG001|Overall Study|Death|1|||
124976687|NCT02304705|449541859|FG000|Overall Study|Lost to Follow-up|0|||
124533261|NCT03099304|447902055|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
124533262|NCT03099304|447902050|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
124533263|NCT03099304|447902051|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
124533264|NCT03099304|447902052|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
124533265|NCT03099304|447902053|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
124533266|NCT03099304|447902054|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
124533267|NCT03099304|447902055|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
124533268|NCT03099304|447902050|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
124533269|NCT03099304|447902051|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
124533270|NCT03099304|447902052|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
124533271|NCT03099304|447902053|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
124533272|NCT03099304|447902054|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
124533273|NCT03099304|447902055|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
124533274|NCT03099304|447902050|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
124533275|NCT03099304|447902051|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
124533276|NCT03099304|447902052|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
124976688|NCT02304705|449541860|FG001|Overall Study|Lost to Follow-up|2|||
124533277|NCT03099304|447902053|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
124533278|NCT03099304|447902054|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
124533279|NCT03099304|447902055|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
124976689|NCT01195948|449541861|FG000|Overall Study|Lost to Follow-up|0|||
124976690|NCT01195948|449541862|FG001|Overall Study|Lost to Follow-up|1|||
124976691|NCT01195948|449541863|FG002|Overall Study|Lost to Follow-up|2|||
124533280|NCT03099304|447902050|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
124533281|NCT03099304|447902051|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
124533282|NCT03099304|447902052|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
124533283|NCT03099304|447902053|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
124533284|NCT03099304|447902054|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
124533285|NCT03099304|447902055|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
124533286|NCT03099304|447902050|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
124533287|NCT03099304|447902051|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
124533288|NCT03099304|447902052|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
124533289|NCT03099304|447902053|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
124533290|NCT03099304|447902054|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
124533291|NCT03099304|447902055|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
124533292|NCT00715949|447902058|FG000|Overall Study|could not finish first test|4|||
124533293|NCT01024946|447902059|FG000|Overall Study|Screen Failure|3|||
124533294|NCT01024946|447902059|FG000|Overall Study|Withdrawal by Subject|1|||
124533295|NCT01024946|447902059|FG000|Overall Study|Adverse Event|1|||
124533296|NCT05375838|447902060|FG000|Overall Study|Other|0|||
124533297|NCT05375838|447902061|FG001|Overall Study|Other|0|||
124533298|NCT05375838|447902062|FG002|Overall Study|Other|0|||
124533299|NCT05375838|447902063|FG003|Overall Study|Other|1|||
124533300|NCT05375838|447902064|FG004|Overall Study|Other|1|||
124533301|NCT05375838|447902065|FG005|Overall Study|Other|0|||
124533302|NCT05375838|447902060|FG000|Overall Study|Withdrawal by Subject|2|||
124533303|NCT05375838|447902061|FG001|Overall Study|Withdrawal by Subject|1|||
124533304|NCT05375838|447902062|FG002|Overall Study|Withdrawal by Subject|3|||
124533305|NCT05375838|447902063|FG003|Overall Study|Withdrawal by Subject|2|||
124533306|NCT05375838|447902064|FG004|Overall Study|Withdrawal by Subject|2|||
124533307|NCT05375838|447902065|FG005|Overall Study|Withdrawal by Subject|0|||
124533308|NCT05375838|447902060|FG000|Overall Study|Protocol Violation|0|||
124533309|NCT05375838|447902061|FG001|Overall Study|Protocol Violation|0|||
124533310|NCT05375838|447902062|FG002|Overall Study|Protocol Violation|0|||
124533311|NCT05375838|447902063|FG003|Overall Study|Protocol Violation|0|||
124533312|NCT05375838|447902064|FG004|Overall Study|Protocol Violation|1|||
124533313|NCT05375838|447902065|FG005|Overall Study|Protocol Violation|0|||
124533314|NCT05375838|447902060|FG000|Overall Study|Physician Decision|0|||
124533315|NCT05375838|447902061|FG001|Overall Study|Physician Decision|1|||
124533316|NCT05375838|447902062|FG002|Overall Study|Physician Decision|0|||
124533317|NCT05375838|447902063|FG003|Overall Study|Physician Decision|0|||
124533318|NCT05375838|447902064|FG004|Overall Study|Physician Decision|0|||
124533319|NCT05375838|447902065|FG005|Overall Study|Physician Decision|1|||
124533320|NCT05375838|447902060|FG000|Overall Study|Lost to Follow-up|2|||
124533321|NCT05375838|447902061|FG001|Overall Study|Lost to Follow-up|7|||
124533322|NCT05375838|447902062|FG002|Overall Study|Lost to Follow-up|0|||
124533323|NCT05375838|447902063|FG003|Overall Study|Lost to Follow-up|4|||
124533324|NCT05375838|447902064|FG004|Overall Study|Lost to Follow-up|2|||
124533325|NCT05375838|447902065|FG005|Overall Study|Lost to Follow-up|3|||
124533326|NCT02993783|447902074|FG000|Overall Study|Reason not Specified|6|||
124533327|NCT02993783|447902075|FG001|Overall Study|Reason not Specified|9|||
124533328|NCT03049852|447902081|FG000|Overall Study|Lost to Follow-up|0|||
124533329|NCT03049852|447902082|FG001|Overall Study|Lost to Follow-up|1|||
124533330|NCT03049852|447902083|FG002|Overall Study|Lost to Follow-up|0|||
124533331|NCT02067104|447902084|FG000|Overall Study|Study termination due to low accrual|4|||
124533332|NCT02067104|447902085|FG001|Overall Study|Study termination due to low accrual|5|||
124533333|NCT01385098|447902099|FG000|Overall Study|Adverse Event|10|||
124533334|NCT01385098|447902099|FG000|Overall Study|Lost to Follow-up|4|||
124533335|NCT00554840|447902100|FG000|Overall Study|Physician Decision|0|||
124533336|NCT00554840|447902101|FG001|Overall Study|Physician Decision|1|||
124533337|NCT00925522|447902102|FG000|Overall Study|study closed -- business decision|20|||
124533338|NCT00410514|447902103|FG000|Overall Study|Adverse Event|2|||
124533339|NCT00410514|447902104|FG001|Overall Study|Adverse Event|2|||
124533340|NCT00410514|447902105|FG002|Overall Study|Adverse Event|2|||
124533341|NCT00410514|447902103|FG000|Overall Study|Protocol Violation|0|||
124533342|NCT00410514|447902104|FG001|Overall Study|Protocol Violation|1|||
124976692|NCT00770029|449541864|FG000|Overall Study|Lost to Follow-up|2|||
124533343|NCT00410514|447902105|FG002|Overall Study|Protocol Violation|1|||
124533344|NCT00410514|447902103|FG000|Overall Study|Lost to Follow-up|0|||
124533345|NCT00410514|447902104|FG001|Overall Study|Lost to Follow-up|0|||
124533346|NCT00410514|447902105|FG002|Overall Study|Lost to Follow-up|2|||
124533347|NCT00410514|447902103|FG000|Overall Study|Non-compliant with study procedures|0|||
124533348|NCT00410514|447902104|FG001|Overall Study|Non-compliant with study procedures|0|||
124533349|NCT00410514|447902105|FG002|Overall Study|Non-compliant with study procedures|2|||
124533350|NCT00656799|447902107|FG000|Overall Study|Death|2|||
124551156|NCT00267020|447974673|FG001|Overall Study|Disease Progression|25|||
124551157|NCT00267020|447974672|FG000|Overall Study|Unrelated Complication|1|||
124551158|NCT00267020|447974673|FG001|Overall Study|Unrelated Complication|1|||
124551159|NCT00267020|447974672|FG000|Overall Study|Sponsor Request|1|||
124533351|NCT04144140|447904143|FG000|Overall Study|Other|0|||
124533352|NCT04144140|447904144|FG001|Overall Study|Other|0|||
124533353|NCT04144140|447904145|FG002|Overall Study|Other|0|||
124533354|NCT04144140|447904146|FG003|Overall Study|Other|0|||
124533355|NCT04144140|447904147|FG004|Overall Study|Other|0|||
124533356|NCT04144140|447904148|FG005|Overall Study|Other|1|||
124533357|NCT04144140|447904149|FG006|Overall Study|Other|0|||
124533358|NCT00959192|447904154|FG000|Overall Study|Adverse Event|1|||
124533359|NCT00959192|447904155|FG001|Overall Study|Adverse Event|1|||
124533360|NCT00959192|447904156|FG002|Overall Study|Adverse Event|1|||
124533361|NCT00959192|447904157|FG003|Overall Study|Adverse Event|0|||
124533362|NCT00959192|447904154|FG000|Overall Study|Investigator Request|1|||
124533363|NCT00959192|447904155|FG001|Overall Study|Investigator Request|0|||
124533364|NCT00959192|447904156|FG002|Overall Study|Investigator Request|0|||
124533365|NCT00959192|447904157|FG003|Overall Study|Investigator Request|0|||
124533366|NCT00959192|447904154|FG000|Overall Study|Caregiver Request|0|||
124533367|NCT00959192|447904155|FG001|Overall Study|Caregiver Request|0|||
124533368|NCT00959192|447904156|FG002|Overall Study|Caregiver Request|2|||
124533369|NCT00959192|447904157|FG003|Overall Study|Caregiver Request|1|||
124533370|NCT01967134|447904158|FG000|Overall Study|Lost to Follow-up|0|||
124533371|NCT01967134|447904159|FG001|Overall Study|Lost to Follow-up|1|||
124533372|NCT01967134|447904160|FG002|Overall Study|Lost to Follow-up|0|||
124533373|NCT00443534|447904161|FG000|Overall Study|Lack of Efficacy|67|||
124533374|NCT00443534|447904161|FG000|Overall Study|Adverse Event|16|||
124533375|NCT00443534|447904161|FG000|Overall Study|Death|9|||
124533376|NCT00443534|447904161|FG000|Overall Study|Withdrawal by Subject|8|||
124533377|NCT00443534|447904161|FG000|Overall Study|Study Terminated by Sponsor|12|||
124533378|NCT00443534|447904161|FG000|Overall Study|Other|10|||
124533379|NCT00443534|447904161|FG000|Overall Study|Enrolled, Not Treated|1|||
124533380|NCT00364611|447904162|FG000|Overall Study|Did not receive study medication|0|||
124533381|NCT00364611|447904163|FG001|Overall Study|Did not receive study medication|1|||
124533382|NCT00364611|447904162|FG000|Overall Study|Adverse Event|7|||
124533383|NCT00364611|447904163|FG001|Overall Study|Adverse Event|4|||
124533384|NCT00364611|447904162|FG000|Overall Study|Participant's Request|3|||
124533385|NCT00364611|447904163|FG001|Overall Study|Participant's Request|4|||
124533386|NCT00364611|447904162|FG000|Overall Study|Disease Progression|38|||
124533387|NCT00364611|447904163|FG001|Overall Study|Disease Progression|8|||
124533388|NCT00364611|447904162|FG000|Overall Study|Investigator decision|2|||
124533389|NCT00364611|447904163|FG001|Overall Study|Investigator decision|2|||
124533390|NCT00364611|447904162|FG000|Overall Study|Found Ineligible|1|||
124533391|NCT00364611|447904163|FG001|Overall Study|Found Ineligible|0|||
124533392|NCT00364611|447904162|FG000|Overall Study|Presumed CR on Study|0|||
124533393|NCT00364611|447904163|FG001|Overall Study|Presumed CR on Study|1|||
124533394|NCT00364611|447904162|FG000|Overall Study|Receiving Liver Ablation|0|||
124533395|NCT00364611|447904163|FG001|Overall Study|Receiving Liver Ablation|1|||
124533396|NCT05466240|447904164|FG000|Overall Study|Adverse Event|1|||
124533397|NCT05466240|447904165|FG001|Overall Study|Adverse Event|0|||
124533398|NCT05466240|447904164|FG000|Overall Study|Withdrawal by Subject|1|||
124533399|NCT05466240|447904165|FG001|Overall Study|Withdrawal by Subject|0|||
124533400|NCT00305773|447904166|FG000|Overall Study|Death|3|||
124533401|NCT00305773|447904167|FG001|Overall Study|Death|2|||
124533402|NCT00305773|447904166|FG000|Overall Study|Adverse Event|1|||
124533403|NCT00305773|447904167|FG001|Overall Study|Adverse Event|2|||
124533404|NCT00305773|447904166|FG000|Overall Study|Alternative Treatment|4|||
124533405|NCT00305773|447904167|FG001|Overall Study|Alternative Treatment|4|||
124533406|NCT00305773|447904166|FG000|Overall Study|Physician Decision|1|||
124533407|NCT00305773|447904167|FG001|Overall Study|Physician Decision|1|||
124533408|NCT00305773|447904166|FG000|Overall Study|Withdrawal by Subject|1|||
124533409|NCT00305773|447904167|FG001|Overall Study|Withdrawal by Subject|4|||
124533410|NCT00305773|447904166|FG000|Overall Study|Disease Progression|1|||
124533411|NCT00305773|447904167|FG001|Overall Study|Disease Progression|3|||
124976693|NCT00770029|449541865|FG001|Overall Study|Lost to Follow-up|0|||
124976694|NCT00770029|449541864|FG000|Overall Study|Withdrawal by Subject|3|||
124976695|NCT00770029|449541865|FG001|Overall Study|Withdrawal by Subject|3|||
124533412|NCT00305773|447904166|FG000|Overall Study|All other reasons|3|||
124533413|NCT00305773|447904167|FG001|Overall Study|All other reasons|2|||
124533414|NCT04097925|447904168|FG000|Overall Study|Withdrawal by Subject|1|||
124533415|NCT02679222|447904169|FG000|Overall Study|No time for project|1|||
124865565|NCT00605293|449128794|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
124533416|NCT04735432|447904173|FG000|Overall Study|Other - due to personal reason|1|||
124533417|NCT04735432|447904174|FG001|Overall Study|Other - due to personal reason|0|||
124533418|NCT04735432|447904173|FG000|Overall Study|Adverse Event|2|||
124533419|NCT04735432|447904174|FG001|Overall Study|Adverse Event|0|||
124533420|NCT00413231|447904175|FG000|0 to 30-day Post Treatment|Death|5|||
124533421|NCT00413231|447904175|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
124533422|NCT00413231|447904175|FG000|30-day to 365-day Post Treatment|Death|13|||
124643868|NCT00378508|448313767|FG001|Overall Study|Withdrawal by Subject|3|||
124976696|NCT00770029|449541864|FG000|Overall Study|Adverse Event|1|||
124533423|NCT00413231|447904175|FG000|365-day to 60-month Post Treatment|Death|36|||
124533424|NCT00413231|447904175|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
124533425|NCT00413231|447904175|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
124533426|NCT00413231|447904175|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
124533427|NCT00945945|447904176|FG000|Overall Study|Adverse Event|15|||
124533428|NCT00945945|447904177|FG001|Overall Study|Adverse Event|35|||
124533429|NCT00945945|447904176|FG000|Overall Study|Withdrawal by Subject|7|||
124533430|NCT00945945|447904177|FG001|Overall Study|Withdrawal by Subject|10|||
124533431|NCT00945945|447904176|FG000|Overall Study|Lost to Follow-up|4|||
124533432|NCT00945945|447904177|FG001|Overall Study|Lost to Follow-up|5|||
124533433|NCT00945945|447904176|FG000|Overall Study|Lack of Efficacy|6|||
124533434|NCT00945945|447904177|FG001|Overall Study|Lack of Efficacy|2|||
124533435|NCT00945945|447904176|FG000|Overall Study|Protocol Violation|4|||
124533436|NCT00945945|447904177|FG001|Overall Study|Protocol Violation|2|||
124533437|NCT00945945|447904176|FG000|Overall Study|Entry Criteria Not Met|0|||
124533438|NCT00945945|447904177|FG001|Overall Study|Entry Criteria Not Met|1|||
124533439|NCT01823991|447904178|FG000|Overall Study|Withdrawal by Subject|8|||
124533440|NCT01823991|447904179|FG001|Overall Study|Withdrawal by Subject|5|||
124533441|NCT05158244|447904180|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
124533442|NCT05158244|447904181|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
124533443|NCT05158244|447904182|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
124533444|NCT05158244|447904183|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
124533445|NCT05158244|447904184|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
124533446|NCT05158244|447904180|FG000|Overall Study|Withdrawal by Subject|0|||
124533447|NCT05158244|447904181|FG001|Overall Study|Withdrawal by Subject|0|||
124533448|NCT05158244|447904182|FG002|Overall Study|Withdrawal by Subject|1|||
124533449|NCT05158244|447904183|FG003|Overall Study|Withdrawal by Subject|0|||
124533450|NCT05158244|447904184|FG004|Overall Study|Withdrawal by Subject|0|||
124533451|NCT01066819|447904185|FG000|Overall Study|Adverse Event|18|||
124533452|NCT01066819|447904186|FG001|Overall Study|Adverse Event|1|||
124533453|NCT01066819|447904187|FG002|Overall Study|Adverse Event|6|||
124533454|NCT01066819|447904188|FG003|Overall Study|Adverse Event|0|||
124533455|NCT01066819|447904189|FG004|Overall Study|Adverse Event|0|||
124533456|NCT01066819|447904190|FG005|Overall Study|Adverse Event|0|||
124533457|NCT01066819|447904185|FG000|Overall Study|Death|5|||
124533458|NCT01066819|447904186|FG001|Overall Study|Death|0|||
124533459|NCT01066819|447904187|FG002|Overall Study|Death|1|||
124533460|NCT01066819|447904188|FG003|Overall Study|Death|0|||
124533461|NCT01066819|447904189|FG004|Overall Study|Death|0|||
124533462|NCT01066819|447904190|FG005|Overall Study|Death|0|||
124533463|NCT01066819|447904185|FG000|Overall Study|Lack of Efficacy|22|||
124533464|NCT01066819|447904186|FG001|Overall Study|Lack of Efficacy|1|||
124754541|NCT02152761|448723926|FG001|Epoch: Treatment Epoch|Technical problems|0|||
124754542|NCT02152761|448723927|FG002|Epoch: Treatment Epoch|Technical problems|0|||
124754543|NCT02152761|448723928|FG003|Epoch: Treatment Epoch|Technical problems|1|||
124754544|NCT02152761|448723925|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
124754545|NCT02152761|448723926|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
124754546|NCT02152761|448723927|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
124754547|NCT02152761|448723928|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
124754548|NCT02152761|448723925|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
124754549|NCT02152761|448723926|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
124754550|NCT02152761|448723927|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
124754551|NCT02152761|448723928|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
124754552|NCT02152761|448723925|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
124754553|NCT02152761|448723926|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
124754554|NCT02152761|448723927|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
124754555|NCT02152761|448723928|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
124754556|NCT02152761|448723925|FG000|Epoch: Treatment Epoch|Death|0|||
124754557|NCT02152761|448723926|FG001|Epoch: Treatment Epoch|Death|3|||
124754558|NCT02152761|448723927|FG002|Epoch: Treatment Epoch|Death|1|||
124754559|NCT02152761|448723928|FG003|Epoch: Treatment Epoch|Death|0|||
124754560|NCT02152761|448723925|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
124754561|NCT02152761|448723926|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
124754562|NCT02152761|448723927|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
124754563|NCT02152761|448723928|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
124754564|NCT02152761|448723925|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
124754565|NCT02152761|448723926|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
124754566|NCT02152761|448723927|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
124754567|NCT02152761|448723928|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
124754568|NCT02152761|448723925|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
124754569|NCT02152761|448723926|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
124754570|NCT02152761|448723927|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
124754571|NCT02152761|448723928|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
124754572|NCT02152761|448723925|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
124754573|NCT02152761|448723926|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
124754574|NCT02152761|448723927|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
124754575|NCT02152761|448723928|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
124754576|NCT02152761|448723925|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
124754577|NCT02152761|448723926|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
124754578|NCT02152761|448723927|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
124754579|NCT02152761|448723928|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
124754580|NCT03755882|448723929|FG000|Period 1|Protocol Violation|1|||
124754581|NCT03755882|448723930|FG001|Period 1|Protocol Violation|0|||
124754582|NCT03755882|448723929|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
124754583|NCT03755882|448723930|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
124754584|NCT02292446|448723931|FG000|Overall Study|Adverse Event|12|||
124754585|NCT02292446|448723931|FG000|Overall Study|Death|1|||
124754586|NCT02292446|448723931|FG000|Overall Study|Disease progression|2|||
124754587|NCT02292446|448723931|FG000|Overall Study|Subject/guardian decision|2|||
124754588|NCT02292446|448723931|FG000|Overall Study|Withdrawal by Subject|3|||
124754589|NCT03329846|448723935|FG000|Overall Study|Disease progression|4|||
124754590|NCT03329846|448723936|FG001|Overall Study|Disease progression|6|||
124754591|NCT03329846|448723935|FG000|Overall Study|Study drug toxicity|1|||
124533465|NCT01066819|447904187|FG002|Overall Study|Lack of Efficacy|2|||
124754592|NCT03329846|448723936|FG001|Overall Study|Study drug toxicity|0|||
124754593|NCT03329846|448723935|FG000|Overall Study|Participant request to discontinue treatment|0|||
124754594|NCT03329846|448723936|FG001|Overall Study|Participant request to discontinue treatment|1|||
124754595|NCT03329846|448723935|FG000|Overall Study|Participant withdrew consent|1|||
124754596|NCT03329846|448723936|FG001|Overall Study|Participant withdrew consent|0|||
124754597|NCT03329846|448723935|FG000|Overall Study|Other reasons|2|||
124754598|NCT03329846|448723936|FG001|Overall Study|Other reasons|2|||
124754599|NCT03066193|448723937|FG000|Overall Study|Withdrawal by Subject|1|||
124754600|NCT02631551|448723938|FG000|Overall Study|Adverse Event|1|||
124754601|NCT02631551|448723939|FG001|Overall Study|Adverse Event|2|||
124754602|NCT02631551|448723940|FG002|Overall Study|Adverse Event|4|||
124754603|NCT02631551|448723941|FG003|Overall Study|Adverse Event|0|||
124754604|NCT02631551|448723938|FG000|Overall Study|Lack of Efficacy|0|||
124754605|NCT02631551|448723939|FG001|Overall Study|Lack of Efficacy|0|||
124754606|NCT02631551|448723940|FG002|Overall Study|Lack of Efficacy|1|||
124754607|NCT02631551|448723941|FG003|Overall Study|Lack of Efficacy|0|||
124754608|NCT02631551|448723938|FG000|Overall Study|Lost to Follow-up|1|||
124754609|NCT02631551|448723939|FG001|Overall Study|Lost to Follow-up|2|||
124754610|NCT02631551|448723940|FG002|Overall Study|Lost to Follow-up|0|||
124754611|NCT02631551|448723941|FG003|Overall Study|Lost to Follow-up|3|||
124754612|NCT02631551|448723938|FG000|Overall Study|Withdrawal by Subject|2|||
124754613|NCT02631551|448723939|FG001|Overall Study|Withdrawal by Subject|2|||
124754614|NCT02631551|448723940|FG002|Overall Study|Withdrawal by Subject|0|||
124754615|NCT02631551|448723941|FG003|Overall Study|Withdrawal by Subject|5|||
124754616|NCT02631551|448723938|FG000|Overall Study|Protocol deviation|3|||
124754617|NCT02631551|448723939|FG001|Overall Study|Protocol deviation|6|||
124754618|NCT02631551|448723940|FG002|Overall Study|Protocol deviation|3|||
124754619|NCT02631551|448723941|FG003|Overall Study|Protocol deviation|0|||
124754620|NCT02631551|448723938|FG000|Overall Study|Non-compliance with study procedures|0|||
124754621|NCT02631551|448723939|FG001|Overall Study|Non-compliance with study procedures|0|||
124754622|NCT02631551|448723940|FG002|Overall Study|Non-compliance with study procedures|1|||
124754623|NCT02631551|448723941|FG003|Overall Study|Non-compliance with study procedures|1|||
124754624|NCT02631551|448723938|FG000|Overall Study|Non-compliance with study drug|1|||
124754625|NCT02631551|448723939|FG001|Overall Study|Non-compliance with study drug|0|||
124754626|NCT02631551|448723940|FG002|Overall Study|Non-compliance with study drug|0|||
124754627|NCT02631551|448723941|FG003|Overall Study|Non-compliance with study drug|0|||
124754628|NCT02631551|448723938|FG000|Overall Study|Other, specific reasons not collected|5|||
124754629|NCT02631551|448723939|FG001|Overall Study|Other, specific reasons not collected|7|||
124754630|NCT02631551|448723940|FG002|Overall Study|Other, specific reasons not collected|2|||
124754631|NCT02631551|448723941|FG003|Overall Study|Other, specific reasons not collected|2|||
124754632|NCT05636852|448723949|FG000|Overall Study|Withdrawal by Subject|1|||
124754633|NCT05636852|448723949|FG000|Overall Study|Other than specified|1|||
124754634|NCT00377858|448723950|FG000|Overall Study|Withdrawal by Subject|12|||
124754635|NCT00377858|448723951|FG001|Overall Study|Withdrawal by Subject|11|||
124754636|NCT00377858|448723950|FG000|Overall Study|Lost to Follow-up|6|||
124754637|NCT00377858|448723951|FG001|Overall Study|Lost to Follow-up|1|||
124754638|NCT00377858|448723950|FG000|Overall Study|Physician Decision|5|||
124754639|NCT00377858|448723951|FG001|Overall Study|Physician Decision|5|||
124754640|NCT00377858|448723950|FG000|Overall Study|Protocol Violation|3|||
124754641|NCT00377858|448723951|FG001|Overall Study|Protocol Violation|4|||
124754642|NCT00377858|448723950|FG000|Overall Study|Adverse Event|2|||
124754643|NCT00377858|448723951|FG001|Overall Study|Adverse Event|1|||
124754644|NCT00377858|448723950|FG000|Overall Study|Entry Criteria Not Met|2|||
124754645|NCT00377858|448723951|FG001|Overall Study|Entry Criteria Not Met|0|||
124754646|NCT00377858|448723950|FG000|Overall Study|Sponsor Decision|1|||
124976697|NCT00770029|449541865|FG001|Overall Study|Adverse Event|0|||
124533466|NCT01066819|447904188|FG003|Overall Study|Lack of Efficacy|1|||
124533467|NCT01066819|447904189|FG004|Overall Study|Lack of Efficacy|0|||
124533468|NCT01066819|447904190|FG005|Overall Study|Lack of Efficacy|0|||
124533469|NCT01066819|447904185|FG000|Overall Study|Physician Decision|6|||
124533470|NCT01066819|447904186|FG001|Overall Study|Physician Decision|2|||
124533471|NCT01066819|447904187|FG002|Overall Study|Physician Decision|3|||
124533472|NCT01066819|447904188|FG003|Overall Study|Physician Decision|0|||
124533473|NCT01066819|447904189|FG004|Overall Study|Physician Decision|0|||
124533474|NCT01066819|447904190|FG005|Overall Study|Physician Decision|0|||
124533475|NCT01066819|447904185|FG000|Overall Study|Protocol Violation|12|||
124533476|NCT01066819|447904186|FG001|Overall Study|Protocol Violation|6|||
124533477|NCT01066819|447904187|FG002|Overall Study|Protocol Violation|0|||
124533478|NCT01066819|447904188|FG003|Overall Study|Protocol Violation|0|||
124533479|NCT01066819|447904189|FG004|Overall Study|Protocol Violation|0|||
124533480|NCT01066819|447904190|FG005|Overall Study|Protocol Violation|0|||
124533481|NCT01066819|447904185|FG000|Overall Study|Withdrawal by Subject|29|||
124533482|NCT01066819|447904186|FG001|Overall Study|Withdrawal by Subject|11|||
124533483|NCT01066819|447904187|FG002|Overall Study|Withdrawal by Subject|6|||
124533484|NCT01066819|447904188|FG003|Overall Study|Withdrawal by Subject|0|||
124533485|NCT01066819|447904189|FG004|Overall Study|Withdrawal by Subject|0|||
124533486|NCT01066819|447904190|FG005|Overall Study|Withdrawal by Subject|0|||
124533487|NCT01066819|447904185|FG000|Overall Study|Administrative|6|||
124533488|NCT01066819|447904186|FG001|Overall Study|Administrative|4|||
124533489|NCT01066819|447904187|FG002|Overall Study|Administrative|2|||
124533490|NCT01066819|447904188|FG003|Overall Study|Administrative|0|||
124533491|NCT01066819|447904189|FG004|Overall Study|Administrative|0|||
124533492|NCT01066819|447904190|FG005|Overall Study|Administrative|0|||
124533493|NCT01066819|447904185|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
124533494|NCT01066819|447904186|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
124533495|NCT01066819|447904187|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
124533496|NCT01066819|447904188|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
124533497|NCT01066819|447904189|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
124533498|NCT01066819|447904190|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
124533499|NCT01066819|447904185|FG000|Overall Study|Early termination|2|||
124533500|NCT01066819|447904186|FG001|Overall Study|Early termination|0|||
124533501|NCT01066819|447904187|FG002|Overall Study|Early termination|0|||
124533502|NCT01066819|447904188|FG003|Overall Study|Early termination|0|||
124533503|NCT01066819|447904189|FG004|Overall Study|Early termination|0|||
124533504|NCT01066819|447904190|FG005|Overall Study|Early termination|0|||
124533505|NCT01066819|447904185|FG000|Overall Study|Failed to return|298|||
124533506|NCT01066819|447904186|FG001|Overall Study|Failed to return|107|||
124533507|NCT01066819|447904187|FG002|Overall Study|Failed to return|68|||
124533508|NCT01066819|447904188|FG003|Overall Study|Failed to return|7|||
124533509|NCT01066819|447904189|FG004|Overall Study|Failed to return|2|||
124533510|NCT01066819|447904190|FG005|Overall Study|Failed to return|3|||
124533511|NCT01066819|447904185|FG000|Overall Study|Lab test not done|9|||
124533512|NCT01066819|447904186|FG001|Overall Study|Lab test not done|0|||
124533513|NCT01066819|447904187|FG002|Overall Study|Lab test not done|2|||
124533514|NCT01066819|447904188|FG003|Overall Study|Lab test not done|1|||
124533515|NCT01066819|447904189|FG004|Overall Study|Lab test not done|0|||
124533516|NCT01066819|447904190|FG005|Overall Study|Lab test not done|0|||
124533517|NCT01066819|447904185|FG000|Overall Study|Miscellaneous|28|||
124533518|NCT01066819|447904186|FG001|Overall Study|Miscellaneous|10|||
124533519|NCT01066819|447904187|FG002|Overall Study|Miscellaneous|18|||
124533520|NCT01066819|447904188|FG003|Overall Study|Miscellaneous|1|||
124533521|NCT01066819|447904189|FG004|Overall Study|Miscellaneous|0|||
124533522|NCT01066819|447904190|FG005|Overall Study|Miscellaneous|0|||
124533523|NCT01066819|447904185|FG000|Overall Study|Non responders|123|||
124533524|NCT01066819|447904186|FG001|Overall Study|Non responders|2|||
124533525|NCT01066819|447904187|FG002|Overall Study|Non responders|7|||
124533526|NCT01066819|447904188|FG003|Overall Study|Non responders|2|||
124533527|NCT01066819|447904189|FG004|Overall Study|Non responders|0|||
124533528|NCT01066819|447904190|FG005|Overall Study|Non responders|1|||
124533529|NCT01066819|447904185|FG000|Overall Study|Not categorised|9|||
124533530|NCT01066819|447904186|FG001|Overall Study|Not categorised|2|||
124533531|NCT01066819|447904187|FG002|Overall Study|Not categorised|6|||
124533532|NCT01066819|447904188|FG003|Overall Study|Not categorised|1|||
124533533|NCT01066819|447904189|FG004|Overall Study|Not categorised|0|||
124533534|NCT01066819|447904190|FG005|Overall Study|Not categorised|0|||
124533535|NCT01066819|447904185|FG000|Overall Study|Relapse|16|||
124533536|NCT01066819|447904186|FG001|Overall Study|Relapse|4|||
124533537|NCT01066819|447904187|FG002|Overall Study|Relapse|3|||
124533538|NCT01066819|447904188|FG003|Overall Study|Relapse|0|||
124533539|NCT01066819|447904189|FG004|Overall Study|Relapse|0|||
124533540|NCT01066819|447904190|FG005|Overall Study|Relapse|0|||
124533541|NCT01066819|447904185|FG000|Overall Study|Results not available|1|||
124533542|NCT01066819|447904186|FG001|Overall Study|Results not available|0|||
124533543|NCT01066819|447904187|FG002|Overall Study|Results not available|0|||
124533544|NCT01066819|447904188|FG003|Overall Study|Results not available|0|||
124533545|NCT01066819|447904189|FG004|Overall Study|Results not available|0|||
124533546|NCT01066819|447904190|FG005|Overall Study|Results not available|0|||
124533547|NCT01066819|447904185|FG000|Overall Study|Screen failure|1|||
124533548|NCT01066819|447904186|FG001|Overall Study|Screen failure|0|||
124533549|NCT01066819|447904187|FG002|Overall Study|Screen failure|0|||
124533550|NCT01066819|447904188|FG003|Overall Study|Screen failure|0|||
124533551|NCT01066819|447904189|FG004|Overall Study|Screen failure|0|||
124533552|NCT01066819|447904190|FG005|Overall Study|Screen failure|0|||
124533553|NCT01066819|447904185|FG000|Overall Study|Spontaneous cure|1|||
124533554|NCT01066819|447904186|FG001|Overall Study|Spontaneous cure|0|||
124533555|NCT01066819|447904187|FG002|Overall Study|Spontaneous cure|0|||
124533556|NCT01066819|447904188|FG003|Overall Study|Spontaneous cure|0|||
124533557|NCT01066819|447904189|FG004|Overall Study|Spontaneous cure|0|||
124533558|NCT01066819|447904190|FG005|Overall Study|Spontaneous cure|0|||
124533559|NCT01066819|447904185|FG000|Overall Study|Treatment never started|85|||
124533560|NCT01066819|447904186|FG001|Overall Study|Treatment never started|19|||
124533561|NCT01066819|447904187|FG002|Overall Study|Treatment never started|19|||
124533562|NCT01066819|447904188|FG003|Overall Study|Treatment never started|3|||
124533563|NCT01066819|447904189|FG004|Overall Study|Treatment never started|2|||
124533564|NCT01066819|447904190|FG005|Overall Study|Treatment never started|2|||
124533565|NCT01066819|447904185|FG000|Overall Study|Treatment stopped|12|||
124533566|NCT01066819|447904186|FG001|Overall Study|Treatment stopped|1|||
124533567|NCT01066819|447904187|FG002|Overall Study|Treatment stopped|2|||
124533568|NCT01066819|447904188|FG003|Overall Study|Treatment stopped|1|||
124533569|NCT01066819|447904189|FG004|Overall Study|Treatment stopped|0|||
124533570|NCT01066819|447904190|FG005|Overall Study|Treatment stopped|0|||
124533571|NCT01066819|447904185|FG000|Overall Study|Other|5|||
124533572|NCT01066819|447904186|FG001|Overall Study|Other|1|||
124533573|NCT01066819|447904187|FG002|Overall Study|Other|1|||
124533574|NCT01066819|447904188|FG003|Overall Study|Other|0|||
124533575|NCT01066819|447904189|FG004|Overall Study|Other|0|||
124533576|NCT01066819|447904190|FG005|Overall Study|Other|0|||
124533577|NCT00805194|447904192|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
124533578|NCT00805194|447904193|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
124533579|NCT00805194|447904192|FG000|Overall Study|Worsening or AE of underlying disease|64|||
124533580|NCT00805194|447904193|FG001|Overall Study|Worsening or AE of underlying disease|70|||
124533581|NCT00805194|447904192|FG000|Overall Study|Other AE|84|||
124533582|NCT00805194|447904193|FG001|Overall Study|Other AE|73|||
124533583|NCT00805194|447904192|FG000|Overall Study|Protocol Violation|9|||
124533584|NCT00805194|447904193|FG001|Overall Study|Protocol Violation|9|||
124533585|NCT00805194|447904192|FG000|Overall Study|Lost to Follow-up|5|||
124533586|NCT00805194|447904193|FG001|Overall Study|Lost to Follow-up|5|||
124533587|NCT00805194|447904192|FG000|Overall Study|Withdrawal by Subject|60|||
124533588|NCT00805194|447904193|FG001|Overall Study|Withdrawal by Subject|42|||
124533589|NCT00805194|447904192|FG000|Overall Study|Not treated|3|||
124533590|NCT00805194|447904193|FG001|Overall Study|Not treated|4|||
124533591|NCT00805194|447904192|FG000|Overall Study|Reasons other than stated above|20|||
124533592|NCT00805194|447904193|FG001|Overall Study|Reasons other than stated above|16|||
124533593|NCT02275052|447904199|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124533594|NCT02275052|447904200|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
124533595|NCT02275052|447904201|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124533596|NCT02275052|447904202|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124533597|NCT02275052|447904199|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
124533598|NCT02275052|447904200|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
124533599|NCT02275052|447904201|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
124533600|NCT02275052|447904202|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
124533601|NCT02275052|447904199|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
124533602|NCT02275052|447904200|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
124533603|NCT02275052|447904201|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
124533604|NCT02275052|447904202|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
124533605|NCT02275052|447904199|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
124533606|NCT02275052|447904200|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
124533607|NCT02275052|447904201|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
124533608|NCT02275052|447904202|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
124533609|NCT02275052|447904199|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
124533610|NCT02275052|447904200|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
124533611|NCT02275052|447904201|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
124533612|NCT02275052|447904202|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
124533613|NCT02275052|447904199|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
124533614|NCT02275052|447904200|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
124865566|NCT00605293|449128795|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
124533615|NCT02275052|447904201|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
124754647|NCT00377858|448723951|FG001|Overall Study|Sponsor Decision|2|||
124754648|NCT00377858|448723950|FG000|Overall Study|Death|0|||
124754649|NCT00377858|448723951|FG001|Overall Study|Death|3|||
124754650|NCT01685697|448723952|FG000|Overall Study|Protocol Violation|3|||
124754651|NCT01685697|448723953|FG001|Overall Study|Protocol Violation|3|||
124754652|NCT04034004|448723958|FG000|Overall Study|Withdrawal by Subject|1|||
124533616|NCT02275052|447904202|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
124533617|NCT02275052|447904199|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
124533618|NCT02275052|447904200|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
124754653|NCT04034004|448723959|FG001|Overall Study|Withdrawal by Subject|2|||
124754654|NCT04034004|448723960|FG002|Overall Study|Withdrawal by Subject|2|||
124754655|NCT04034004|448723961|FG003|Overall Study|Withdrawal by Subject|3|||
124754656|NCT04034004|448723958|FG000|Overall Study|could not find vein to administer IV|2|||
124754657|NCT04034004|448723959|FG001|Overall Study|could not find vein to administer IV|1|||
124754658|NCT04034004|448723960|FG002|Overall Study|could not find vein to administer IV|0|||
124754659|NCT04034004|448723961|FG003|Overall Study|could not find vein to administer IV|0|||
124754660|NCT04034004|448723958|FG000|Overall Study|nurse accidentally unblinded subject|0|||
124754661|NCT04034004|448723959|FG001|Overall Study|nurse accidentally unblinded subject|0|||
124754662|NCT04034004|448723960|FG002|Overall Study|nurse accidentally unblinded subject|0|||
124754663|NCT04034004|448723961|FG003|Overall Study|nurse accidentally unblinded subject|1|||
124754664|NCT01345188|448723962|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
124754665|NCT01345188|448723962|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
124754666|NCT01397461|448723963|FG000|Overall Study|Withdrawal by Subject|2|||
124754667|NCT01397461|448723964|FG001|Overall Study|Withdrawal by Subject|1|||
124754668|NCT01397461|448723965|FG002|Overall Study|Withdrawal by Subject|0|||
124754669|NCT01397461|448723963|FG000|Overall Study|Lost to Follow-up|0|||
124754670|NCT01397461|448723964|FG001|Overall Study|Lost to Follow-up|2|||
124754671|NCT01397461|448723965|FG002|Overall Study|Lost to Follow-up|1|||
124754672|NCT01397461|448723963|FG000|Overall Study|Lack of Efficacy|0|||
124754673|NCT01397461|448723964|FG001|Overall Study|Lack of Efficacy|3|||
124754674|NCT01397461|448723965|FG002|Overall Study|Lack of Efficacy|0|||
124754675|NCT01397461|448723963|FG000|Overall Study|Not treated|0|||
124754676|NCT01397461|448723964|FG001|Overall Study|Not treated|0|||
124754677|NCT01397461|448723965|FG002|Overall Study|Not treated|1|||
124754678|NCT05729568|448723982|FG000|Overall Study|Still on Study|52|||
124754679|NCT05729568|448723983|FG001|Overall Study|Still on Study|26|||
124754680|NCT05729568|448723982|FG000|Overall Study|Randomized but Never Treated|3|||
124754681|NCT05729568|448723983|FG001|Overall Study|Randomized but Never Treated|0|||
124754682|NCT05729568|448723982|FG000|Overall Study|Adverse Event|0|||
124754683|NCT05729568|448723983|FG001|Overall Study|Adverse Event|1|||
124754684|NCT05729568|448723982|FG000|Overall Study|Investigator's Discretion|1|||
124754685|NCT05729568|448723983|FG001|Overall Study|Investigator's Discretion|0|||
124976698|NCT01174446|449541870|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
124533619|NCT02275052|447904201|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
124533620|NCT02275052|447904202|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
124533621|NCT02275052|447904199|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
124533622|NCT02275052|447904200|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
124533623|NCT02275052|447904201|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
124533624|NCT02275052|447904202|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
124533625|NCT02275052|447904199|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124533626|NCT02275052|447904200|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124533627|NCT02275052|447904201|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
124533628|NCT02275052|447904202|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
124533629|NCT02275052|447904199|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
124533630|NCT02275052|447904200|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
124533631|NCT02275052|447904201|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
124533632|NCT02275052|447904202|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
124533633|NCT02275052|447904199|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
124533634|NCT02275052|447904200|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
124533635|NCT02275052|447904201|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
124533636|NCT02275052|447904202|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
124533637|NCT00948389|447904205|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
124533638|NCT00948389|447904206|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
124533639|NCT00948389|447904207|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
124533640|NCT00948389|447904208|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
124533641|NCT00948389|447904209|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
124533642|NCT00948389|447904205|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
124533643|NCT00948389|447904206|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
124533644|NCT00948389|447904207|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
124754686|NCT04526145|448723984|FG000|Overall Study|Withdrawal by Subject|5|||
124533645|NCT00948389|447904208|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
124533646|NCT00948389|447904209|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
124533647|NCT00948389|447904205|FG000|Overall Study|Both Progression and Toxicity|1|||
124533648|NCT00948389|447904206|FG001|Overall Study|Both Progression and Toxicity|0|||
124533649|NCT00948389|447904207|FG002|Overall Study|Both Progression and Toxicity|0|||
124533650|NCT00948389|447904208|FG003|Overall Study|Both Progression and Toxicity|0|||
124533651|NCT00948389|447904209|FG004|Overall Study|Both Progression and Toxicity|0|||
124533652|NCT00732199|447904219|FG000|Overall Study|Withdrawal by Subject|25|||
124533653|NCT00732199|447904220|FG001|Overall Study|Withdrawal by Subject|18|||
124533654|NCT00732199|447904219|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
124533655|NCT00732199|447904220|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
124533656|NCT01051856|447904235|FG000|Overall Study|Withdrawal by Subject|1|||
124533657|NCT01051856|447904236|FG001|Overall Study|Withdrawal by Subject|0|||
124533658|NCT00750867|447904237|FG000|Overall Study|Adverse Event|2|||
124533659|NCT01969565|447904238|FG000|Overall Study|Withdrawal by Subject|1|||
124533660|NCT01683058|447904239|FG000|Overall Study|Lost to Follow-up|9|||
124533661|NCT01683058|447904239|FG000|Overall Study|Adverse Event|6|||
124533662|NCT01683058|447904239|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
124533663|NCT01683058|447904239|FG000|Overall Study|Withdrawal by Subject|7|||
124533664|NCT01683058|447904239|FG000|Overall Study|Lack of Efficacy|2|||
124533665|NCT04062240|447904240|FG000|Overall Study|equipment malfunction|1|||
124533666|NCT01957111|447904241|FG000|Overall Study|Withdrawal by Subject|1|||
124533667|NCT01957111|447904242|FG001|Overall Study|Withdrawal by Subject|1|||
124533668|NCT01057394|447904243|FG000|Overall Study|Not eligible|0|||
124533669|NCT01057394|447904244|FG001|Overall Study|Not eligible|2|||
124533670|NCT03500419|447904245|FG000|Overall Study|Withdrawal by Subject|2|||
124533671|NCT03500419|447904246|FG001|Overall Study|Withdrawal by Subject|25|||
124533672|NCT01948791|447904251|FG000|Overall Study|Adverse Event|12|||
124533673|NCT01948791|447904251|FG000|Overall Study|Lack of Efficacy|3|||
124533674|NCT01948791|447904251|FG000|Overall Study|Protocol Violation|2|||
124533675|NCT01948791|447904251|FG000|Overall Study|Withdrawal by Subject|5|||
124533676|NCT01948791|447904251|FG000|Overall Study|Lost to Follow-up|6|||
124533677|NCT01948791|447904251|FG000|Overall Study|Management issues|1|||
124533678|NCT01948791|447904251|FG000|Overall Study|Others|7|||
124533679|NCT01948791|447904251|FG000|Overall Study|Screening failure|35|||
124533680|NCT03481634|447904252|FG000|Overall Study|Withdrawal by Subject|16|||
124533681|NCT03481634|447904253|FG001|Overall Study|Withdrawal by Subject|19|||
124533682|NCT03481634|447904254|FG002|Overall Study|Withdrawal by Subject|14|||
124533683|NCT03481634|447904252|FG000|Overall Study|Protocol Violation|1|||
124533684|NCT03481634|447904253|FG001|Overall Study|Protocol Violation|0|||
124533685|NCT03481634|447904254|FG002|Overall Study|Protocol Violation|1|||
124533686|NCT03481634|447904252|FG000|Overall Study|Progressive disease|0|||
124533687|NCT03481634|447904253|FG001|Overall Study|Progressive disease|1|||
124533688|NCT03481634|447904254|FG002|Overall Study|Progressive disease|0|||
124533689|NCT03481634|447904252|FG000|Overall Study|Physician Decision|3|||
124533690|NCT03481634|447904253|FG001|Overall Study|Physician Decision|0|||
124533691|NCT03481634|447904254|FG002|Overall Study|Physician Decision|1|||
124533692|NCT03481634|447904252|FG000|Overall Study|Lost to Follow-up|3|||
124533693|NCT03481634|447904253|FG001|Overall Study|Lost to Follow-up|4|||
124533694|NCT03481634|447904254|FG002|Overall Study|Lost to Follow-up|4|||
124533695|NCT03481634|447904252|FG000|Overall Study|Death|4|||
124533696|NCT03481634|447904253|FG001|Overall Study|Death|8|||
124533697|NCT03481634|447904254|FG002|Overall Study|Death|7|||
124533698|NCT03481634|447904252|FG000|Overall Study|Adverse Event|6|||
124533699|NCT03481634|447904253|FG001|Overall Study|Adverse Event|3|||
124533700|NCT03481634|447904254|FG002|Overall Study|Adverse Event|7|||
124533701|NCT00994890|447904255|FG000|Overall Study|Adverse Event|13|||
124533702|NCT00994890|447904256|FG001|Overall Study|Adverse Event|9|||
124533703|NCT00994890|447904257|FG002|Overall Study|Adverse Event|11|||
124533704|NCT00994890|447904255|FG000|Overall Study|Lack of Efficacy|0|||
124533705|NCT00994890|447904256|FG001|Overall Study|Lack of Efficacy|0|||
124533706|NCT00994890|447904257|FG002|Overall Study|Lack of Efficacy|1|||
124533707|NCT00994890|447904255|FG000|Overall Study|Lost to Follow-up|6|||
124533708|NCT00994890|447904256|FG001|Overall Study|Lost to Follow-up|1|||
124533709|NCT00994890|447904257|FG002|Overall Study|Lost to Follow-up|3|||
124533710|NCT00994890|447904255|FG000|Overall Study|No longer willing to participate|8|||
124865567|NCT00605293|449128794|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
124865568|NCT00605293|449128795|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
124533711|NCT00994890|447904256|FG001|Overall Study|No longer willing to participate|5|||
124533712|NCT00994890|447904257|FG002|Overall Study|No longer willing to participate|13|||
124969461|NCT01439867|449517398|FG000|Overall Study|Non-compliance|0|||
124533713|NCT00994890|447904255|FG000|Overall Study|Protocol Violation|2|||
124533714|NCT00994890|447904256|FG001|Overall Study|Protocol Violation|4|||
124533715|NCT00994890|447904257|FG002|Overall Study|Protocol Violation|0|||
124533716|NCT00994890|447904255|FG000|Overall Study|Study terminated by sponsor|199|||
124533717|NCT00994890|447904256|FG001|Overall Study|Study terminated by sponsor|201|||
124533718|NCT00994890|447904257|FG002|Overall Study|Study terminated by sponsor|197|||
124533719|NCT00994890|447904255|FG000|Overall Study|Randomized, but not treated|1|||
124533720|NCT00994890|447904256|FG001|Overall Study|Randomized, but not treated|0|||
124533721|NCT00994890|447904257|FG002|Overall Study|Randomized, but not treated|0|||
124533722|NCT00994890|447904255|FG000|Overall Study|Other|2|||
124533723|NCT00994890|447904256|FG001|Overall Study|Other|2|||
124533724|NCT00994890|447904257|FG002|Overall Study|Other|1|||
124533725|NCT01469637|447904258|FG000|First Intervention|Unacceptable behavior|0|||
124533726|NCT01469637|447904259|FG001|First Intervention|Unacceptable behavior|1|||
124533727|NCT01469637|447904258|FG000|Second Intervention|Incarcerated|1|||
124533728|NCT01469637|447904259|FG001|Second Intervention|Incarcerated|0|||
124533729|NCT04491591|447904260|FG000|Overall Study|Accidently randomized|3|||
124533730|NCT04491591|447904261|FG001|Overall Study|Accidently randomized|1|||
124533731|NCT04491591|447904262|FG002|Overall Study|Accidently randomized|0|||
124533732|NCT04491591|447904260|FG000|Overall Study|Did not complete survey|28|||
124533733|NCT04491591|447904261|FG001|Overall Study|Did not complete survey|20|||
124533734|NCT04491591|447904262|FG002|Overall Study|Did not complete survey|3|||
124533735|NCT00472043|447904263|FG000|Overall Study|Withdrawal by Subject|1|||
124865569|NCT00605293|449128794|FG000|Overall Study|Principal Investigator Decision|0|||
124865570|NCT00605293|449128795|FG001|Overall Study|Principal Investigator Decision|1|||
124865571|NCT00381940|449128796|FG000|Overall Study|Lack of Efficacy|3|||
124865572|NCT00381940|449128796|FG000|Overall Study|Protocol Violation|1|||
124865573|NCT00381940|449128796|FG000|Overall Study|Ineligible|1|||
124865574|NCT03137303|449128798|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
124865575|NCT03137303|449128799|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
124865576|NCT03137303|449128798|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
124865577|NCT03137303|449128799|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
124865578|NCT03137303|449128798|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
124865579|NCT03137303|449128799|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
124865580|NCT03137303|449128798|FG000|T3: 9-month Follow-up|Death|1|||
124865581|NCT03137303|449128799|FG001|T3: 9-month Follow-up|Death|0|||
124865582|NCT03137303|449128798|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
124865583|NCT03137303|449128799|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
124865584|NCT03137303|449128798|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
124865585|NCT03137303|449128799|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
124865586|NCT03137303|449128798|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
124865587|NCT03137303|449128799|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
124865588|NCT03561090|449128802|FG000|Overall Study|Adverse Event|11|||
124865589|NCT03561090|449128803|FG001|Overall Study|Adverse Event|7|||
124865590|NCT03561090|449128802|FG000|Overall Study|Non-Compliance With Study Drug|2|||
124865591|NCT03561090|449128803|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124865592|NCT03561090|449128802|FG000|Overall Study|Protocol Violation|2|||
124865593|NCT03561090|449128803|FG001|Overall Study|Protocol Violation|2|||
124865594|NCT03561090|449128802|FG000|Overall Study|Withdrawal by Subject|7|||
124865595|NCT03561090|449128803|FG001|Overall Study|Withdrawal by Subject|7|||
124865596|NCT03561090|449128802|FG000|Overall Study|Lost to Follow-up|7|||
124865597|NCT03561090|449128803|FG001|Overall Study|Lost to Follow-up|2|||
124865598|NCT03561090|449128802|FG000|Overall Study|Study Terminated by Sponsor|10|||
124865599|NCT03561090|449128803|FG001|Overall Study|Study Terminated by Sponsor|15|||
124865600|NCT03561090|449128802|FG000|Overall Study|Randomized by Mistake|1|||
124865601|NCT03561090|449128803|FG001|Overall Study|Randomized by Mistake|1|||
124865602|NCT03561090|449128802|FG000|Overall Study|Other Not Specified|0|||
124865603|NCT03561090|449128803|FG001|Overall Study|Other Not Specified|2|||
124865604|NCT04162769|449128810|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
124865605|NCT04162769|449128811|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
124865606|NCT04162769|449128812|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
124865607|NCT04162769|449128813|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
124865608|NCT04162769|449128810|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
124865609|NCT04162769|449128811|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
124865610|NCT04162769|449128812|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
124754687|NCT01502228|448723985|FG000|Overall Study|Death|1|||
124754688|NCT00048347|448723993|FG000|Overall Study|Screen failure|2|||
124754689|NCT00958165|448723994|FG000|Overall Study|Lost to Follow-up|5|||
124754690|NCT00958165|448723994|FG000|Overall Study|Not eligible|9|||
124754691|NCT00195663|448723995|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
124754692|NCT00195663|448723996|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
124865611|NCT04162769|449128813|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
124865612|NCT04162769|449128810|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
124865613|NCT04162769|449128811|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
124865614|NCT04162769|449128812|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
124865615|NCT04162769|449128813|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
124865616|NCT04162769|449128810|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
124533736|NCT00472043|447904264|FG001|Overall Study|Withdrawal by Subject|0|||
124533737|NCT00472043|447904263|FG000|Overall Study|Death|1|||
124533738|NCT00472043|447904264|FG001|Overall Study|Death|0|||
124533739|NCT02802735|447904265|FG000|Overall Study|Withdrawal by Subject|0|||
124551160|NCT00267020|447974673|FG001|Overall Study|Sponsor Request|0|||
124865617|NCT04162769|449128811|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
124865618|NCT04162769|449128812|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
124865619|NCT04162769|449128813|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
124865620|NCT04162769|449128810|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
124865621|NCT04162769|449128811|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
124865622|NCT04162769|449128812|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
124976699|NCT01174446|449541871|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
124976700|NCT01174446|449541872|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
124976701|NCT01174446|449541873|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
124976702|NCT01174446|449541870|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
124976703|NCT01174446|449541871|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
124976704|NCT01174446|449541872|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
124976705|NCT01174446|449541873|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
124533740|NCT02802735|447904266|FG001|Overall Study|Withdrawal by Subject|1|||
124533741|NCT02802735|447904267|FG002|Overall Study|Withdrawal by Subject|0|||
124533742|NCT02802735|447904268|FG003|Overall Study|Withdrawal by Subject|0|||
124754693|NCT00195663|448723997|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
124754694|NCT00195663|448723995|FG000|2-year Double-blind Treatment Period|Death|0|||
124754695|NCT00195663|448723996|FG001|2-year Double-blind Treatment Period|Death|2|||
124754696|NCT00195663|448723997|FG002|2-year Double-blind Treatment Period|Death|0|||
124754697|NCT00195663|448723995|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
124754698|NCT00195663|448723996|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
124754699|NCT00195663|448723997|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
124754700|NCT00195663|448723995|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
124754701|NCT00195663|448723996|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
124754702|NCT00195663|448723997|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
124754703|NCT00195663|448723995|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
124754704|NCT00195663|448723996|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
124754705|NCT00195663|448723997|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
124754706|NCT00195663|448723995|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
124754707|NCT00195663|448723996|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
124754708|NCT00195663|448723997|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
124754709|NCT00195663|448723995|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
124754710|NCT00195663|448723996|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
124754711|NCT00195663|448723997|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
124754712|NCT00195663|448723995|FG000|2-year Double-blind Treatment Period|Recovery|1|||
124754713|NCT00195663|448723996|FG001|2-year Double-blind Treatment Period|Recovery|0|||
124754714|NCT00195663|448723997|FG002|2-year Double-blind Treatment Period|Recovery|1|||
124754715|NCT00195663|448723995|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
124754716|NCT00195663|448723996|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
124754717|NCT00195663|448723997|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
124754718|NCT00195663|448723995|FG000|Open-Label Extension Period|Adverse Event|21|||
124754719|NCT00195663|448723996|FG001|Open-Label Extension Period|Adverse Event|32|||
124754720|NCT00195663|448723997|FG002|Open-Label Extension Period|Adverse Event|36|||
124754721|NCT00195663|448723995|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
124754722|NCT00195663|448723996|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
124754723|NCT00195663|448723997|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
124754724|NCT00195663|448723995|FG000|Open-Label Extension Period|Recovery|0|||
124533743|NCT02802735|447904269|FG004|Overall Study|Withdrawal by Subject|0|||
124533744|NCT02975206|447904271|FG000|Overall Study|Withdrawal by Subject|14|||
124533745|NCT02975206|447904272|FG001|Overall Study|Withdrawal by Subject|11|||
124533746|NCT02975206|447904273|FG002|Overall Study|Withdrawal by Subject|11|||
124533747|NCT02975206|447904271|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
124533748|NCT02975206|447904272|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
124533749|NCT02975206|447904273|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
124533750|NCT00866606|447904274|FG000|Overall Study|Lost to Follow-up|3|||
124533751|NCT00866606|447904274|FG000|Overall Study|Adverse Event|1|||
124533752|NCT01058356|447904278|FG000|Overall Study|Adverse Event|5|||
124533753|NCT01058356|447904278|FG000|Overall Study|Administration of contraindicated drugs|12|||
124533754|NCT01058356|447904278|FG000|Overall Study|Withdrawal by Subject|21|||
124533755|NCT01058356|447904278|FG000|Overall Study|Lost to Follow-up|4|||
124533756|NCT00606021|447904281|FG000|Induction Phase|Death|73|||
124643869|NCT00378508|448313766|FG000|Overall Study|Lost to Follow-up|1|||
124754725|NCT00195663|448723996|FG001|Open-Label Extension Period|Recovery|2|||
124754726|NCT00195663|448723997|FG002|Open-Label Extension Period|Recovery|2|||
124865623|NCT04162769|449128813|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
124865624|NCT04162769|449128810|FG000|Double-blind Treatment (12-Week)|Other|0|||
124533757|NCT00606021|447904282|FG001|Induction Phase|Death|0|||
124533758|NCT00606021|447904283|FG002|Induction Phase|Death|0|||
124754727|NCT00195663|448723995|FG000|Open-Label Extension Period|Protocol Violation|3|||
124754728|NCT00195663|448723996|FG001|Open-Label Extension Period|Protocol Violation|4|||
124754729|NCT00195663|448723997|FG002|Open-Label Extension Period|Protocol Violation|4|||
124754730|NCT00195663|448723995|FG000|Open-Label Extension Period|Death|2|||
124754731|NCT00195663|448723996|FG001|Open-Label Extension Period|Death|2|||
124754732|NCT00195663|448723997|FG002|Open-Label Extension Period|Death|2|||
124754733|NCT00195663|448723995|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
124754734|NCT00195663|448723996|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
124754735|NCT00195663|448723997|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
124865625|NCT04162769|449128811|FG001|Double-blind Treatment (12-Week)|Other|1|||
124865626|NCT04162769|449128812|FG002|Double-blind Treatment (12-Week)|Other|1|||
124865627|NCT04162769|449128813|FG003|Double-blind Treatment (12-Week)|Other|0|||
124865628|NCT04162769|449128810|FG000|OLE Period (52-Week)|Adverse Event|0|||
124865629|NCT04162769|449128811|FG001|OLE Period (52-Week)|Adverse Event|0|||
124865630|NCT04162769|449128812|FG002|OLE Period (52-Week)|Adverse Event|0|||
124865631|NCT04162769|449128813|FG003|OLE Period (52-Week)|Adverse Event|5|||
124865632|NCT04162769|449128810|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
124865633|NCT04162769|449128811|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
124865634|NCT04162769|449128812|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
124865635|NCT04162769|449128813|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
124865636|NCT04162769|449128810|FG000|OLE Period (52-Week)|Physician Decision|0|||
124865637|NCT04162769|449128811|FG001|OLE Period (52-Week)|Physician Decision|0|||
124865638|NCT04162769|449128812|FG002|OLE Period (52-Week)|Physician Decision|0|||
124865639|NCT04162769|449128813|FG003|OLE Period (52-Week)|Physician Decision|1|||
124865640|NCT04162769|449128810|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
124865641|NCT04162769|449128811|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
124865642|NCT04162769|449128812|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
124865643|NCT04162769|449128813|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
124865644|NCT04162769|449128810|FG000|OLE Period (52-Week)|Protocol deviation|0|||
124865645|NCT04162769|449128811|FG001|OLE Period (52-Week)|Protocol deviation|0|||
124865646|NCT04162769|449128812|FG002|OLE Period (52-Week)|Protocol deviation|0|||
124865647|NCT04162769|449128813|FG003|OLE Period (52-Week)|Protocol deviation|2|||
124865648|NCT02163733|449128814|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
124865649|NCT02163733|449128815|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
124865650|NCT02163733|449128816|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
124865651|NCT02163733|449128814|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
124865652|NCT02163733|449128815|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
124865653|NCT02163733|449128816|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
124865654|NCT02633800|449128817|FG000|Overall Study|Death|3|||
124865655|NCT02633800|449128818|FG001|Overall Study|Death|3|||
124865656|NCT02633800|449128817|FG000|Overall Study|Reason not provided|1|||
124865657|NCT02633800|449128818|FG001|Overall Study|Reason not provided|0|||
124865658|NCT02633800|449128817|FG000|Overall Study|Radiologic(al) progression|23|||
124865659|NCT02633800|449128818|FG001|Overall Study|Radiologic(al) progression|23|||
124865660|NCT02633800|449128817|FG000|Overall Study|Clinical progression|3|||
124865661|NCT02633800|449128818|FG001|Overall Study|Clinical progression|6|||
124865662|NCT02633800|449128817|FG000|Overall Study|Study terminated by sponsor|6|||
124865663|NCT02633800|449128818|FG001|Overall Study|Study terminated by sponsor|5|||
124865664|NCT02633800|449128817|FG000|Overall Study|Adverse event, non-fatal|7|||
124865665|NCT02633800|449128818|FG001|Overall Study|Adverse event, non-fatal|2|||
124865666|NCT02633800|449128817|FG000|Overall Study|Withdrawal by Subject|0|||
124865667|NCT02633800|449128818|FG001|Overall Study|Withdrawal by Subject|3|||
124865668|NCT02633800|449128817|FG000|Overall Study|Patient Request|1|||
124865669|NCT02633800|449128818|FG001|Overall Study|Patient Request|1|||
124865670|NCT01358968|449128826|FG000|Period 2|Adverse Event|0|||
124865671|NCT01358968|449128827|FG001|Period 2|Adverse Event|1|||
124865672|NCT01358968|449128828|FG002|Period 2|Adverse Event|0|||
124865673|NCT01358968|449128829|FG003|Period 2|Adverse Event|0|||
124865674|NCT01358968|449128826|FG000|Continued Access Phase|Progression of Disease|0|||
124865675|NCT01358968|449128827|FG001|Continued Access Phase|Progression of Disease|0|||
124754736|NCT00195663|448723995|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
124865676|NCT01358968|449128828|FG002|Continued Access Phase|Progression of Disease|8|||
124865677|NCT01358968|449128829|FG003|Continued Access Phase|Progression of Disease|4|||
124865678|NCT01358968|449128826|FG000|Continued Access Phase|Protocol Violation|0|||
124865679|NCT01358968|449128827|FG001|Continued Access Phase|Protocol Violation|0|||
124865680|NCT01358968|449128828|FG002|Continued Access Phase|Protocol Violation|0|||
124865681|NCT01358968|449128829|FG003|Continued Access Phase|Protocol Violation|2|||
124865682|NCT01358968|449128826|FG000|Continued Access Phase|Withdrawal by Subject|0|||
124865683|NCT01358968|449128827|FG001|Continued Access Phase|Withdrawal by Subject|0|||
124865684|NCT01358968|449128828|FG002|Continued Access Phase|Withdrawal by Subject|3|||
124865685|NCT01358968|449128829|FG003|Continued Access Phase|Withdrawal by Subject|0|||
124754737|NCT00195663|448723996|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
124754738|NCT00195663|448723997|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
124466356|NCT03445000|447666368|FG000|Overall Study|Disease progression|8|||
124754739|NCT00195663|448723995|FG000|Open-Label Extension Period|Administrative reasons|11|||
124754740|NCT00195663|448723996|FG001|Open-Label Extension Period|Administrative reasons|11|||
124754741|NCT00195663|448723997|FG002|Open-Label Extension Period|Administrative reasons|13|||
124754742|NCT00604695|448723998|FG000|Overall Study|Did not receive first bolus.|0|||
124754743|NCT00604695|448723999|FG001|Overall Study|Did not receive first bolus.|4|||
124754744|NCT02058563|448724003|FG000|Overall Study|Lost to Follow-up|26|||
124754745|NCT02058563|448724004|FG001|Overall Study|Lost to Follow-up|22|||
124754746|NCT02058563|448724003|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
124754747|NCT02058563|448724004|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
124754748|NCT02058563|448724003|FG000|Overall Study|Consent Withdrawal|1|||
124754749|NCT02058563|448724004|FG001|Overall Study|Consent Withdrawal|1|||
124754750|NCT02058563|448724003|FG000|Overall Study|Other (patient incarcerated)|0|||
124754751|NCT02058563|448724004|FG001|Overall Study|Other (patient incarcerated)|1|||
124754752|NCT00166439|448724005|FG000|Overall Study|Ineligible|5|||
124754753|NCT04039217|448724006|FG000|Overall Study|Lost to Follow-up|1|||
124754754|NCT00615992|448724007|FG000|Overall Study|Protocol Violation|67|||
124754755|NCT04522141|448724008|FG000|Overall Study|Withdrawal by Subject|1|||
124754756|NCT04522141|448724009|FG001|Overall Study|Withdrawal by Subject|0|||
124754757|NCT03508609|448724010|FG000|Overall Study|Withdrawal by Subject|1|||
124754758|NCT00555217|448724011|FG000|Overall Study|Withdrawal by Subject|35|||
124754759|NCT00555217|448724012|FG001|Overall Study|Withdrawal by Subject|31|||
124754760|NCT00555217|448724011|FG000|Overall Study|Lost to Follow-up|19|||
124754761|NCT00555217|448724012|FG001|Overall Study|Lost to Follow-up|20|||
124754762|NCT00555217|448724011|FG000|Overall Study|close out sites|21|||
124754763|NCT00555217|448724012|FG001|Overall Study|close out sites|17|||
124754764|NCT00367835|448724014|FG000|Overall Study|Adverse Event|14|||
124533759|NCT00606021|447904281|FG000|Induction Phase|Physician Decision|2|||
124533760|NCT00606021|447904282|FG001|Induction Phase|Physician Decision|0|||
124533761|NCT00606021|447904283|FG002|Induction Phase|Physician Decision|0|||
124754765|NCT00367835|448724015|FG001|Overall Study|Adverse Event|1|||
124754766|NCT00367835|448724014|FG000|Overall Study|Protocol Violation|1|||
124754767|NCT00367835|448724015|FG001|Overall Study|Protocol Violation|7|||
124754768|NCT00367835|448724014|FG000|Overall Study|Withdrawal by Subject|7|||
124754769|NCT00367835|448724015|FG001|Overall Study|Withdrawal by Subject|6|||
124754770|NCT00367835|448724014|FG000|Overall Study|Lost to Follow-up|1|||
124754771|NCT00367835|448724015|FG001|Overall Study|Lost to Follow-up|4|||
124754772|NCT00367835|448724014|FG000|Overall Study|Lack of Efficacy|3|||
124754773|NCT00367835|448724015|FG001|Overall Study|Lack of Efficacy|12|||
124754774|NCT00367835|448724014|FG000|Overall Study|Subject in juvenile detention center|1|||
124754775|NCT00367835|448724015|FG001|Overall Study|Subject in juvenile detention center|0|||
124754776|NCT00367835|448724014|FG000|Overall Study|refused blood collection|1|||
124865686|NCT01358968|449128826|FG000|Continued Access Phase|Death|0|||
124865687|NCT01358968|449128827|FG001|Continued Access Phase|Death|0|||
124865688|NCT01358968|449128828|FG002|Continued Access Phase|Death|1|||
124865689|NCT01358968|449128829|FG003|Continued Access Phase|Death|1|||
124865690|NCT00476476|449128836|FG000|Overall Study|Adverse Event|2|||
124865691|NCT00476476|449128837|FG001|Overall Study|Adverse Event|7|||
124865692|NCT00476476|449128836|FG000|Overall Study|Progressive Disease|0|||
124865693|NCT00476476|449128837|FG001|Overall Study|Progressive Disease|17|||
124865694|NCT00423176|449128842|FG000|Overall Study|Adverse Event|4|||
124865695|NCT00423176|449128843|FG001|Overall Study|Adverse Event|6|||
124865696|NCT00423176|449128842|FG000|Overall Study|Treatment Failure|1|||
124865697|NCT00423176|449128843|FG001|Overall Study|Treatment Failure|6|||
124865698|NCT00423176|449128842|FG000|Overall Study|Lost to Follow-up|4|||
124865699|NCT00423176|449128843|FG001|Overall Study|Lost to Follow-up|7|||
124865700|NCT00423176|449128842|FG000|Overall Study|Withdrawal by Subject|4|||
124865701|NCT00423176|449128843|FG001|Overall Study|Withdrawal by Subject|3|||
124865702|NCT00423176|449128842|FG000|Overall Study|Protocol Violation|1|||
124865703|NCT00423176|449128843|FG001|Overall Study|Protocol Violation|3|||
124865704|NCT00423176|449128842|FG000|Overall Study|Did not meet protocol eligibility|2|||
124865705|NCT00423176|449128843|FG001|Overall Study|Did not meet protocol eligibility|4|||
124865706|NCT01654549|449128844|FG000|Overall Study|H.pylori eradication not successful|0|||
124865707|NCT01654549|449128845|FG001|Overall Study|H.pylori eradication not successful|1|||
124865708|NCT05072080|449128846|FG000|Overall Study|Death|0|||
124865709|NCT05072080|449128847|FG001|Overall Study|Death|0|||
124865710|NCT05072080|449128848|FG002|Overall Study|Death|1|||
124865711|NCT05072080|449128849|FG003|Overall Study|Death|0|||
124865712|NCT05072080|449128846|FG000|Overall Study|Lost to Follow-up|65|||
124865713|NCT05072080|449128847|FG001|Overall Study|Lost to Follow-up|70|||
124533762|NCT00606021|447904281|FG000|Induction Phase|Withdrawal by Subject|2|||
124533763|NCT00606021|447904282|FG001|Induction Phase|Withdrawal by Subject|0|||
124533764|NCT00606021|447904283|FG002|Induction Phase|Withdrawal by Subject|0|||
124533765|NCT00606021|447904281|FG000|Induction Phase|Lost to Follow-up|10|||
124754777|NCT00367835|448724015|FG001|Overall Study|refused blood collection|0|||
124754778|NCT00367835|448724014|FG000|Overall Study|Did not respond to calls|1|||
124754779|NCT00367835|448724015|FG001|Overall Study|Did not respond to calls|0|||
124865714|NCT05072080|449128848|FG002|Overall Study|Lost to Follow-up|58|||
124865715|NCT05072080|449128849|FG003|Overall Study|Lost to Follow-up|23|||
124865716|NCT05072080|449128846|FG000|Overall Study|Physician Decision|2|||
124865717|NCT05072080|449128847|FG001|Overall Study|Physician Decision|1|||
124865718|NCT05072080|449128848|FG002|Overall Study|Physician Decision|1|||
124865719|NCT05072080|449128849|FG003|Overall Study|Physician Decision|0|||
124865720|NCT05072080|449128846|FG000|Overall Study|Withdrawal by Subject|45|||
124865721|NCT05072080|449128847|FG001|Overall Study|Withdrawal by Subject|30|||
124865722|NCT05072080|449128848|FG002|Overall Study|Withdrawal by Subject|27|||
124865723|NCT05072080|449128849|FG003|Overall Study|Withdrawal by Subject|7|||
124865724|NCT05072080|449128846|FG000|Overall Study|Sponsor Decision|0|||
124865725|NCT05072080|449128847|FG001|Overall Study|Sponsor Decision|1|||
124865726|NCT05072080|449128848|FG002|Overall Study|Sponsor Decision|0|||
124865727|NCT05072080|449128849|FG003|Overall Study|Sponsor Decision|0|||
124865728|NCT05072080|449128846|FG000|Overall Study|Subject moved|1|||
124865729|NCT05072080|449128847|FG001|Overall Study|Subject moved|3|||
124865730|NCT05072080|449128848|FG002|Overall Study|Subject moved|5|||
124865731|NCT05072080|449128849|FG003|Overall Study|Subject moved|2|||
124865732|NCT05072080|449128846|FG000|Overall Study|Withdrawal by parent|0|||
124865733|NCT05072080|449128847|FG001|Overall Study|Withdrawal by parent|0|||
124865734|NCT05072080|449128848|FG002|Overall Study|Withdrawal by parent|1|||
124865735|NCT05072080|449128849|FG003|Overall Study|Withdrawal by parent|0|||
124865736|NCT05072080|449128846|FG000|Overall Study|Subject was deployed|0|||
124976706|NCT01174446|449541870|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
124976707|NCT01174446|449541871|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
124976708|NCT01174446|449541872|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
124976709|NCT01174446|449541873|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
124976710|NCT01174446|449541870|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
124976711|NCT01174446|449541871|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
124976712|NCT01174446|449541872|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
124976713|NCT01174446|449541873|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
124976714|NCT00847626|449541876|FG000|Overall Study|Adverse Event|10|||
124976715|NCT00847626|449541877|FG001|Overall Study|Adverse Event|10|||
124976716|NCT00847626|449541878|FG002|Overall Study|Adverse Event|6|||
124976717|NCT00847626|449541879|FG003|Overall Study|Adverse Event|19|||
124976718|NCT00847626|449541880|FG004|Overall Study|Adverse Event|11|||
124533766|NCT00606021|447904282|FG001|Induction Phase|Lost to Follow-up|0|||
124533767|NCT00606021|447904283|FG002|Induction Phase|Lost to Follow-up|0|||
124976719|NCT00847626|449541881|FG005|Overall Study|Adverse Event|22|||
124976720|NCT00847626|449541882|FG006|Overall Study|Adverse Event|4|||
124976721|NCT00847626|449541883|FG007|Overall Study|Adverse Event|6|||
124976722|NCT00847626|449541884|FG008|Overall Study|Adverse Event|3|||
124976723|NCT00847626|449541885|FG009|Overall Study|Adverse Event|6|||
124976724|NCT00847626|449541886|FG010|Overall Study|Adverse Event|6|||
124976725|NCT00847626|449541876|FG000|Overall Study|Protocol Violation|2|||
124976726|NCT00847626|449541877|FG001|Overall Study|Protocol Violation|1|||
124976727|NCT00847626|449541878|FG002|Overall Study|Protocol Violation|2|||
124533768|NCT00606021|447904281|FG000|Maintenance Phase|Death|0|||
124533769|NCT00606021|447904282|FG001|Maintenance Phase|Death|17|||
124533770|NCT00606021|447904283|FG002|Maintenance Phase|Death|15|||
124533771|NCT00606021|447904281|FG000|Maintenance Phase|Physician Decision|0|||
124533772|NCT00606021|447904282|FG001|Maintenance Phase|Physician Decision|1|||
124533773|NCT00606021|447904283|FG002|Maintenance Phase|Physician Decision|0|||
124533774|NCT00606021|447904281|FG000|Maintenance Phase|Lost to Follow-up|0|||
124533775|NCT00606021|447904282|FG001|Maintenance Phase|Lost to Follow-up|5|||
124533776|NCT00606021|447904283|FG002|Maintenance Phase|Lost to Follow-up|2|||
124533777|NCT01230827|447904290|FG000|Overall Study|Lost to Follow-up|0|||
124533778|NCT01230827|447904291|FG001|Overall Study|Lost to Follow-up|0|||
124533779|NCT01230827|447904292|FG002|Overall Study|Lost to Follow-up|1|||
124533780|NCT01230827|447904293|FG003|Overall Study|Lost to Follow-up|3|||
124533781|NCT01230827|447904290|FG000|Overall Study|Withdrawal by Subject|1|||
124533782|NCT01230827|447904291|FG001|Overall Study|Withdrawal by Subject|0|||
124533783|NCT01230827|447904292|FG002|Overall Study|Withdrawal by Subject|3|||
124533784|NCT01230827|447904293|FG003|Overall Study|Withdrawal by Subject|2|||
124533785|NCT01230827|447904290|FG000|Overall Study|Lack of Efficacy|14|||
124533786|NCT01230827|447904291|FG001|Overall Study|Lack of Efficacy|1|||
124533787|NCT01230827|447904292|FG002|Overall Study|Lack of Efficacy|2|||
124533788|NCT01230827|447904293|FG003|Overall Study|Lack of Efficacy|3|||
124533789|NCT01230827|447904290|FG000|Overall Study|Adverse Event|4|||
124533790|NCT01230827|447904291|FG001|Overall Study|Adverse Event|2|||
124533791|NCT01230827|447904292|FG002|Overall Study|Adverse Event|3|||
124533792|NCT01230827|447904293|FG003|Overall Study|Adverse Event|7|||
124533793|NCT01230827|447904290|FG000|Overall Study|Recovery|0|||
124533794|NCT01230827|447904291|FG001|Overall Study|Recovery|6|||
124533795|NCT01230827|447904292|FG002|Overall Study|Recovery|0|||
124533796|NCT01230827|447904293|FG003|Overall Study|Recovery|0|||
124533797|NCT01230827|447904290|FG000|Overall Study|Study terminated by Sponsor|0|||
124551161|NCT00267020|447974672|FG000|Overall Study|Other|1|||
124865737|NCT05072080|449128847|FG001|Overall Study|Subject was deployed|1|||
124865738|NCT05072080|449128848|FG002|Overall Study|Subject was deployed|0|||
124865739|NCT05072080|449128849|FG003|Overall Study|Subject was deployed|0|||
124865740|NCT05072080|449128846|FG000|Overall Study|Subject left site without receiving dose|0|||
124865741|NCT05072080|449128847|FG001|Overall Study|Subject left site without receiving dose|1|||
124865742|NCT05072080|449128848|FG002|Overall Study|Subject left site without receiving dose|0|||
124865743|NCT05072080|449128849|FG003|Overall Study|Subject left site without receiving dose|0|||
124865744|NCT05072080|449128846|FG000|Overall Study|Subject incarcerated|0|||
124865745|NCT05072080|449128847|FG001|Overall Study|Subject incarcerated|1|||
124865746|NCT05072080|449128848|FG002|Overall Study|Subject incarcerated|0|||
124865747|NCT05072080|449128849|FG003|Overall Study|Subject incarcerated|1|||
124865748|NCT05072080|449128846|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
124865749|NCT05072080|449128847|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
124865750|NCT05072080|449128848|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
124865751|NCT05072080|449128849|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
124865752|NCT05072080|449128846|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
124865753|NCT05072080|449128847|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
124865754|NCT05072080|449128848|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
124865755|NCT05072080|449128849|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
124865756|NCT02633137|449128850|FG000|Overall Study|Adverse Event|1|||
124865757|NCT02633137|449128850|FG000|Overall Study|Lack of Efficacy|2|||
124865758|NCT02633137|449128850|FG000|Overall Study|Withdrawal by Subject|1|||
124865759|NCT05554237|449128851|FG000|Part 2 (7 Days)|Adverse Event|0|||
124865760|NCT05554237|449128852|FG001|Part 2 (7 Days)|Adverse Event|0|||
124865761|NCT05554237|449128853|FG002|Part 2 (7 Days)|Adverse Event|0|||
124865762|NCT05554237|449128854|FG003|Part 2 (7 Days)|Adverse Event|0|||
124865763|NCT05554237|449128855|FG004|Part 2 (7 Days)|Adverse Event|2|||
124865764|NCT05554237|449128856|FG005|Part 2 (7 Days)|Adverse Event|0|||
124865765|NCT05554237|449128857|FG006|Part 2 (7 Days)|Adverse Event|0|||
124865766|NCT05554237|449128858|FG007|Part 2 (7 Days)|Adverse Event|0|||
124865767|NCT05554237|449128859|FG008|Part 2 (7 Days)|Adverse Event|0|||
124865768|NCT05554237|449128860|FG009|Part 2 (7 Days)|Adverse Event|1|||
124865769|NCT05554237|449128861|FG010|Part 2 (7 Days)|Adverse Event|0|||
124865770|NCT05554237|449128862|FG011|Part 2 (7 Days)|Adverse Event|0|||
124865771|NCT05554237|449128863|FG012|Part 2 (7 Days)|Adverse Event|1|||
124865772|NCT05554237|449128864|FG013|Part 2 (7 Days)|Adverse Event|0|||
124865773|NCT02395042|449128867|FG000|Treatment 1 Period|Adverse Event|1|||
124865774|NCT02395042|449128868|FG001|Treatment 1 Period|Adverse Event|3|||
124865775|NCT02395042|449128869|FG002|Treatment 1 Period|Adverse Event|1|||
124865776|NCT02395042|449128867|FG000|Treatment 1 Period|Lack of Efficacy|1|||
124865777|NCT02395042|449128868|FG001|Treatment 1 Period|Lack of Efficacy|1|||
124865778|NCT02395042|449128869|FG002|Treatment 1 Period|Lack of Efficacy|0|||
124865779|NCT02395042|449128867|FG000|Treatment 1 Period|Lost to Follow-up|1|||
124865780|NCT02395042|449128868|FG001|Treatment 1 Period|Lost to Follow-up|0|||
124865781|NCT02395042|449128869|FG002|Treatment 1 Period|Lost to Follow-up|0|||
124865782|NCT02395042|449128867|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
124865783|NCT02395042|449128868|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
124865784|NCT02395042|449128869|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
124865785|NCT02395042|449128867|FG000|Treatment 2 Period|Lack of Efficacy|1|||
124976728|NCT00847626|449541879|FG003|Overall Study|Protocol Violation|1|||
124976729|NCT00847626|449541880|FG004|Overall Study|Protocol Violation|1|||
124976730|NCT00847626|449541881|FG005|Overall Study|Protocol Violation|1|||
124976731|NCT00847626|449541882|FG006|Overall Study|Protocol Violation|1|||
124976732|NCT00847626|449541883|FG007|Overall Study|Protocol Violation|1|||
124976733|NCT00847626|449541884|FG008|Overall Study|Protocol Violation|0|||
124976734|NCT00847626|449541885|FG009|Overall Study|Protocol Violation|1|||
124976735|NCT00847626|449541886|FG010|Overall Study|Protocol Violation|1|||
124976736|NCT00847626|449541876|FG000|Overall Study|Lost to Follow-up|0|||
124976737|NCT00847626|449541877|FG001|Overall Study|Lost to Follow-up|1|||
124976738|NCT00847626|449541878|FG002|Overall Study|Lost to Follow-up|1|||
124976739|NCT00847626|449541879|FG003|Overall Study|Lost to Follow-up|1|||
124976740|NCT00847626|449541880|FG004|Overall Study|Lost to Follow-up|0|||
124976741|NCT00847626|449541881|FG005|Overall Study|Lost to Follow-up|3|||
124976742|NCT00847626|449541882|FG006|Overall Study|Lost to Follow-up|1|||
124976743|NCT00847626|449541883|FG007|Overall Study|Lost to Follow-up|3|||
124976744|NCT00847626|449541884|FG008|Overall Study|Lost to Follow-up|1|||
124976745|NCT00847626|449541885|FG009|Overall Study|Lost to Follow-up|0|||
124976746|NCT00847626|449541886|FG010|Overall Study|Lost to Follow-up|1|||
124976747|NCT00847626|449541876|FG000|Overall Study|Withdrawal by Subject|5|||
124976748|NCT00847626|449541877|FG001|Overall Study|Withdrawal by Subject|5|||
124976749|NCT00847626|449541878|FG002|Overall Study|Withdrawal by Subject|3|||
124976750|NCT00847626|449541879|FG003|Overall Study|Withdrawal by Subject|8|||
124976751|NCT00847626|449541880|FG004|Overall Study|Withdrawal by Subject|12|||
124976752|NCT00847626|449541881|FG005|Overall Study|Withdrawal by Subject|9|||
124976753|NCT00847626|449541882|FG006|Overall Study|Withdrawal by Subject|8|||
124976754|NCT00847626|449541883|FG007|Overall Study|Withdrawal by Subject|4|||
124865786|NCT02395042|449128868|FG001|Treatment 2 Period|Lack of Efficacy|1|||
124976755|NCT00847626|449541884|FG008|Overall Study|Withdrawal by Subject|4|||
124976756|NCT00847626|449541885|FG009|Overall Study|Withdrawal by Subject|5|||
124976757|NCT00847626|449541886|FG010|Overall Study|Withdrawal by Subject|2|||
124976758|NCT00847626|449541876|FG000|Overall Study|Lack of Efficacy|3|||
124976759|NCT00847626|449541877|FG001|Overall Study|Lack of Efficacy|1|||
124976760|NCT00847626|449541878|FG002|Overall Study|Lack of Efficacy|0|||
124976761|NCT00847626|449541879|FG003|Overall Study|Lack of Efficacy|1|||
124976762|NCT00847626|449541880|FG004|Overall Study|Lack of Efficacy|2|||
124976763|NCT00847626|449541881|FG005|Overall Study|Lack of Efficacy|0|||
124976764|NCT00847626|449541882|FG006|Overall Study|Lack of Efficacy|6|||
124976765|NCT00847626|449541883|FG007|Overall Study|Lack of Efficacy|2|||
124976766|NCT00847626|449541884|FG008|Overall Study|Lack of Efficacy|5|||
124533798|NCT01230827|447904291|FG001|Overall Study|Study terminated by Sponsor|2|||
124865787|NCT02395042|449128869|FG002|Treatment 2 Period|Lack of Efficacy|0|||
124865788|NCT01324271|449128870|FG000|Overall Study|Lost to Follow-up|3|||
124865789|NCT01324271|449128871|FG001|Overall Study|Lost to Follow-up|0|||
124865790|NCT01324271|449128870|FG000|Overall Study|Physician Decision|1|||
124865791|NCT01324271|449128871|FG001|Overall Study|Physician Decision|0|||
124865792|NCT05130970|449128872|FG000|Overall Study|Adverse Event|1|||
124865793|NCT05130970|449128873|FG001|Overall Study|Adverse Event|1|||
124865794|NCT05130970|449128872|FG000|Overall Study|Death|0|||
124865795|NCT05130970|449128873|FG001|Overall Study|Death|1|||
124865796|NCT05130970|449128872|FG000|Overall Study|Lost to Follow-up|0|||
124865797|NCT05130970|449128873|FG001|Overall Study|Lost to Follow-up|1|||
124865798|NCT05130970|449128872|FG000|Overall Study|Physician Decision|0|||
124865799|NCT05130970|449128873|FG001|Overall Study|Physician Decision|1|||
124865800|NCT05130970|449128872|FG000|Overall Study|Withdrawal by Subject|1|||
124865801|NCT05130970|449128873|FG001|Overall Study|Withdrawal by Subject|1|||
124865802|NCT02308748|449128874|FG000|Period 1|Withdrawal by Subject|0|||
124865803|NCT02308748|449128875|FG001|Period 1|Withdrawal by Subject|0|||
124865804|NCT02308748|449128876|FG002|Period 1|Withdrawal by Subject|1|||
124865805|NCT02308748|449128877|FG003|Period 1|Withdrawal by Subject|0|||
124865806|NCT02308748|449128878|FG004|Period 1|Withdrawal by Subject|0|||
124865807|NCT02308748|449128879|FG005|Period 1|Withdrawal by Subject|0|||
124865808|NCT02308748|449128880|FG006|Period 1|Withdrawal by Subject|0|||
124865809|NCT02308748|449128881|FG007|Period 1|Withdrawal by Subject|0|||
124865810|NCT02308748|449128882|FG008|Period 1|Withdrawal by Subject|0|||
124865811|NCT02308748|449128883|FG009|Period 1|Withdrawal by Subject|0|||
124865812|NCT02308748|449128874|FG000|Period 2|Adverse Event|0|||
124865813|NCT02308748|449128875|FG001|Period 2|Adverse Event|0|||
124865814|NCT02308748|449128876|FG002|Period 2|Adverse Event|0|||
124976767|NCT00847626|449541885|FG009|Overall Study|Lack of Efficacy|1|||
124976768|NCT00847626|449541886|FG010|Overall Study|Lack of Efficacy|7|||
124976769|NCT00847626|449541876|FG000|Overall Study|Other|1|||
124976770|NCT00847626|449541877|FG001|Overall Study|Other|5|||
124976771|NCT00847626|449541878|FG002|Overall Study|Other|4|||
124976772|NCT00847626|449541879|FG003|Overall Study|Other|1|||
124976773|NCT00847626|449541880|FG004|Overall Study|Other|2|||
124976774|NCT00847626|449541881|FG005|Overall Study|Other|2|||
124976775|NCT00847626|449541882|FG006|Overall Study|Other|2|||
124976776|NCT00847626|449541883|FG007|Overall Study|Other|3|||
124976777|NCT00847626|449541884|FG008|Overall Study|Other|1|||
124976778|NCT00847626|449541885|FG009|Overall Study|Other|1|||
124976779|NCT00847626|449541886|FG010|Overall Study|Other|3|||
124976780|NCT03057847|449541887|FG000|Overall Study|Lost to Follow-up|16|||
124976781|NCT05627258|449541890|FG000|Overall Study|Lost to Follow-up|1|||
124976782|NCT05627258|449541891|FG001|Overall Study|Lost to Follow-up|0|||
124976783|NCT05627258|449541892|FG002|Overall Study|Lost to Follow-up|0|||
124976784|NCT05627258|449541893|FG003|Overall Study|Lost to Follow-up|0|||
124976785|NCT05627258|449541894|FG004|Overall Study|Lost to Follow-up|0|||
124976786|NCT05627258|449541895|FG005|Overall Study|Lost to Follow-up|0|||
124976787|NCT05627258|449541890|FG000|Overall Study|Withdrawal by Subject|0|||
124976788|NCT05627258|449541891|FG001|Overall Study|Withdrawal by Subject|0|||
124976789|NCT05627258|449541892|FG002|Overall Study|Withdrawal by Subject|0|||
124976790|NCT05627258|449541893|FG003|Overall Study|Withdrawal by Subject|0|||
124976791|NCT05627258|449541894|FG004|Overall Study|Withdrawal by Subject|2|||
124976792|NCT05627258|449541895|FG005|Overall Study|Withdrawal by Subject|0|||
124976793|NCT05627258|449541890|FG000|Overall Study|Enrolled, but product not administered|1|||
124976794|NCT05627258|449541891|FG001|Overall Study|Enrolled, but product not administered|0|||
124976795|NCT05627258|449541892|FG002|Overall Study|Enrolled, but product not administered|0|||
124976796|NCT05627258|449541893|FG003|Overall Study|Enrolled, but product not administered|0|||
124976797|NCT05627258|449541894|FG004|Overall Study|Enrolled, but product not administered|0|||
124976798|NCT05627258|449541895|FG005|Overall Study|Enrolled, but product not administered|0|||
124976799|NCT05627258|449541890|FG000|Overall Study|Other subject illness/injury|1|||
124976800|NCT05627258|449541891|FG001|Overall Study|Other subject illness/injury|0|||
124976801|NCT05627258|449541892|FG002|Overall Study|Other subject illness/injury|0|||
124533799|NCT01230827|447904292|FG002|Overall Study|Study terminated by Sponsor|56|||
124976802|NCT05627258|449541893|FG003|Overall Study|Other subject illness/injury|0|||
124976803|NCT05627258|449541894|FG004|Overall Study|Other subject illness/injury|0|||
124865815|NCT02308748|449128877|FG003|Period 2|Adverse Event|0|||
124865816|NCT02308748|449128878|FG004|Period 2|Adverse Event|0|||
124865817|NCT02308748|449128879|FG005|Period 2|Adverse Event|0|||
124865818|NCT02308748|449128880|FG006|Period 2|Adverse Event|0|||
124865819|NCT02308748|449128881|FG007|Period 2|Adverse Event|1|||
124865820|NCT02308748|449128882|FG008|Period 2|Adverse Event|0|||
124865821|NCT02308748|449128883|FG009|Period 2|Adverse Event|0|||
124865822|NCT02308748|449128874|FG000|Period 3|Protocol Violation|0|||
124865823|NCT02308748|449128875|FG001|Period 3|Protocol Violation|0|||
124865824|NCT02308748|449128876|FG002|Period 3|Protocol Violation|0|||
124865825|NCT02308748|449128877|FG003|Period 3|Protocol Violation|0|||
124865826|NCT02308748|449128878|FG004|Period 3|Protocol Violation|0|||
124865827|NCT02308748|449128879|FG005|Period 3|Protocol Violation|0|||
124865828|NCT02308748|449128880|FG006|Period 3|Protocol Violation|0|||
124865829|NCT02308748|449128881|FG007|Period 3|Protocol Violation|0|||
124865830|NCT02308748|449128882|FG008|Period 3|Protocol Violation|0|||
124865831|NCT02308748|449128883|FG009|Period 3|Protocol Violation|1|||
124865832|NCT02308748|449128874|FG000|Period 5|Adverse Event|1|||
124865833|NCT02308748|449128875|FG001|Period 5|Adverse Event|0|||
124865834|NCT02308748|449128876|FG002|Period 5|Adverse Event|0|||
124865835|NCT02308748|449128877|FG003|Period 5|Adverse Event|0|||
124865836|NCT02308748|449128878|FG004|Period 5|Adverse Event|0|||
124865837|NCT02308748|449128879|FG005|Period 5|Adverse Event|0|||
124865838|NCT02308748|449128880|FG006|Period 5|Adverse Event|0|||
124865839|NCT02308748|449128881|FG007|Period 5|Adverse Event|0|||
124865840|NCT02308748|449128882|FG008|Period 5|Adverse Event|1|||
124865841|NCT02308748|449128883|FG009|Period 5|Adverse Event|0|||
124865842|NCT05207813|449128886|FG000|Overall Study|Lost to Follow-up|2|||
124865843|NCT04988308|449128890|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
124865844|NCT04988308|449128891|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
124865845|NCT04988308|449128892|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
124865846|NCT04988308|449128893|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
124865847|NCT04988308|449128894|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
124865848|NCT04988308|449128895|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
124865849|NCT04988308|449128890|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
124865850|NCT04988308|449128891|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
124865851|NCT04988308|449128892|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
124865852|NCT04988308|449128893|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
124865853|NCT04988308|449128894|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
124865854|NCT04988308|449128895|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
124865855|NCT04988308|449128890|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
124976804|NCT05627258|449541895|FG005|Overall Study|Other subject illness/injury|0|||
124976805|NCT05627258|449541890|FG000|Overall Study|Subject moved from area|0|||
124976806|NCT05627258|449541891|FG001|Overall Study|Subject moved from area|0|||
124976807|NCT05627258|449541892|FG002|Overall Study|Subject moved from area|1|||
124976808|NCT05627258|449541893|FG003|Overall Study|Subject moved from area|0|||
124976809|NCT05627258|449541894|FG004|Overall Study|Subject moved from area|0|||
124976810|NCT05627258|449541895|FG005|Overall Study|Subject moved from area|0|||
124976811|NCT01294397|449541898|FG000|Overall Study|Withdrawal by Subject|1|||
124976812|NCT01294397|449541898|FG000|Overall Study|Administrative Decision|1|||
124976813|NCT01199068|449541899|FG000|Overall Study|Unacceptable toxicity|0|||
124976814|NCT01199068|449541900|FG001|Overall Study|Unacceptable toxicity|0|||
124976815|NCT01199068|449541901|FG002|Overall Study|Unacceptable toxicity|2|||
124976816|NCT01199068|449541899|FG000|Overall Study|Progressive disease|3|||
124976817|NCT01199068|449541900|FG001|Overall Study|Progressive disease|3|||
124976818|NCT01199068|449541901|FG002|Overall Study|Progressive disease|6|||
124976819|NCT01199068|449541899|FG000|Overall Study|Withdrawal by Subject|0|||
124976820|NCT01199068|449541900|FG001|Overall Study|Withdrawal by Subject|0|||
124976821|NCT01199068|449541901|FG002|Overall Study|Withdrawal by Subject|1|||
124976822|NCT01250925|449541902|FG000|Overall Study|Lost to Follow-up|1|||
124976823|NCT01250925|449541903|FG001|Overall Study|Lost to Follow-up|1|||
124976824|NCT01250925|449541904|FG002|Overall Study|Lost to Follow-up|0|||
124976825|NCT01250925|449541902|FG000|Overall Study|Withdrawal by Subject|2|||
124976826|NCT01250925|449541903|FG001|Overall Study|Withdrawal by Subject|0|||
124976827|NCT01250925|449541904|FG002|Overall Study|Withdrawal by Subject|0|||
124976828|NCT01250925|449541902|FG000|Overall Study|Protocol Violation|2|||
124976829|NCT01250925|449541903|FG001|Overall Study|Protocol Violation|0|||
124976830|NCT01250925|449541904|FG002|Overall Study|Protocol Violation|0|||
124976831|NCT01250925|449541902|FG000|Overall Study|Physician Decision|0|||
124976832|NCT01250925|449541903|FG001|Overall Study|Physician Decision|2|||
124976833|NCT01250925|449541904|FG002|Overall Study|Physician Decision|1|||
124865856|NCT04988308|449128891|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
124865857|NCT04988308|449128892|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
124976834|NCT01250925|449541902|FG000|Overall Study|Adverse Event|0|||
124976835|NCT01250925|449541903|FG001|Overall Study|Adverse Event|0|||
124976836|NCT01250925|449541904|FG002|Overall Study|Adverse Event|1|||
124865858|NCT04988308|449128893|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
124976837|NCT00678301|449541905|FG000|Overall Study|Non-compliance with study procedures|0|||
124976838|NCT00678301|449541906|FG001|Overall Study|Non-compliance with study procedures|1|||
124976839|NCT00678301|449541905|FG000|Overall Study|Adverse Event|1|||
124976840|NCT00678301|449541906|FG001|Overall Study|Adverse Event|0|||
124976841|NCT00678301|449541905|FG000|Overall Study|Withdrawal by Subject|4|||
124976842|NCT00678301|449541906|FG001|Overall Study|Withdrawal by Subject|0|||
124976843|NCT00678301|449541905|FG000|Overall Study|Lost to Follow-up|3|||
124976844|NCT00678301|449541906|FG001|Overall Study|Lost to Follow-up|1|||
124976845|NCT03338296|449541907|FG000|Overall Study|Adverse Event|0|||
124976846|NCT03338296|449541908|FG001|Overall Study|Adverse Event|1|||
124976847|NCT03338296|449541907|FG000|Overall Study|Withdrawal by Subject|14|||
124976848|NCT03338296|449541908|FG001|Overall Study|Withdrawal by Subject|13|||
124976849|NCT03338296|449541907|FG000|Overall Study|Lost to Follow-up|10|||
124976850|NCT03338296|449541908|FG001|Overall Study|Lost to Follow-up|10|||
124976851|NCT03338296|449541907|FG000|Overall Study|Study Terminated by Sponsor|77|||
124976852|NCT03338296|449541908|FG001|Overall Study|Study Terminated by Sponsor|76|||
124865859|NCT04988308|449128894|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
124865860|NCT04988308|449128895|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
124865861|NCT04988308|449128890|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
124865862|NCT04988308|449128891|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
124976853|NCT03338296|449541907|FG000|Overall Study|Other|2|||
124976854|NCT03338296|449541908|FG001|Overall Study|Other|7|||
124976855|NCT03338296|449541907|FG000|Overall Study|Missing|0|||
124976856|NCT03338296|449541908|FG001|Overall Study|Missing|1|||
124976857|NCT04421950|449541909|FG000|Overall Study|Dropped or lost to follow up|4|||
124976858|NCT04421950|449541910|FG001|Overall Study|Dropped or lost to follow up|2|||
124976859|NCT01725126|449541912|FG000|Overall Study|Protocol Violation|0|||
124976860|NCT01725126|449541913|FG001|Overall Study|Protocol Violation|1|||
124976861|NCT01725126|449541914|FG002|Overall Study|Protocol Violation|0|||
124976862|NCT01725126|449541915|FG003|Overall Study|Protocol Violation|0|||
124976863|NCT01725126|449541916|FG004|Overall Study|Protocol Violation|0|||
124976864|NCT01725126|449541917|FG005|Overall Study|Protocol Violation|0|||
124976865|NCT01725126|449541912|FG000|Overall Study|Withdrawal by Subject|0|||
124976866|NCT01725126|449541913|FG001|Overall Study|Withdrawal by Subject|0|||
124976867|NCT01725126|449541914|FG002|Overall Study|Withdrawal by Subject|0|||
124976868|NCT01725126|449541915|FG003|Overall Study|Withdrawal by Subject|1|||
124976869|NCT01725126|449541916|FG004|Overall Study|Withdrawal by Subject|0|||
124976870|NCT01725126|449541917|FG005|Overall Study|Withdrawal by Subject|0|||
124976871|NCT00677534|449541922|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
124976872|NCT00677534|449541922|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
124976873|NCT00677534|449541922|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
124976874|NCT02687035|449541923|FG000|Overall Study|Withdrawal by Subject|1|||
124976875|NCT02687035|449541923|FG000|Overall Study|Death|87|||
124976876|NCT02687035|449541923|FG000|Overall Study|Lost to Follow-up|1|||
124976877|NCT02687035|449541923|FG000|Overall Study|Missed Visit|87|||
124976878|NCT02687035|449541923|FG000|Overall Study|Did not receive Study Device|8|||
124976879|NCT04076943|449541932|FG000|Overall Study|Withdrawal by Subject|12|||
124976880|NCT04076943|449541932|FG000|Overall Study|Adverse Event|1|||
124976881|NCT04076943|449541932|FG000|Overall Study|Progressive Disease|2|||
124976882|NCT04076943|449541932|FG000|Overall Study|Death|13|||
124976883|NCT04076943|449541932|FG000|Overall Study|Other than specified|6|||
124976884|NCT01031628|449541933|FG000|Overall Study|Study terminated early|0|||
124976885|NCT01031628|449541934|FG001|Overall Study|Study terminated early|1|||
124976886|NCT01031628|449541935|FG002|Overall Study|Study terminated early|3|||
124976887|NCT01031628|449541936|FG003|Overall Study|Study terminated early|0|||
124976888|NCT00967005|449541939|FG000|Overall Study|Lost to Follow-up|7|||
124976889|NCT00967005|449541940|FG001|Overall Study|Lost to Follow-up|10|||
124976890|NCT01371825|449541943|FG000|Overall Study|Death|4|||
124976891|NCT00895895|449541944|FG000|Period 1|Adverse Event|7|||
124976892|NCT00895895|449541945|FG001|Period 1|Adverse Event|6|||
124976893|NCT00895895|449541946|FG002|Period 1|Adverse Event|4|||
124976894|NCT00895895|449541947|FG003|Period 1|Adverse Event|6|||
124976895|NCT00895895|449541948|FG004|Period 1|Adverse Event|7|||
124976896|NCT00895895|449541944|FG000|Period 1|Death|0|||
124976897|NCT00895895|449541945|FG001|Period 1|Death|0|||
124976898|NCT00895895|449541946|FG002|Period 1|Death|0|||
124976899|NCT00895895|449541947|FG003|Period 1|Death|0|||
124976900|NCT00895895|449541948|FG004|Period 1|Death|1|||
124976901|NCT00895895|449541944|FG000|Period 1|discontinued by sponsor|2|||
124976902|NCT00895895|449541945|FG001|Period 1|discontinued by sponsor|1|||
124976903|NCT00895895|449541946|FG002|Period 1|discontinued by sponsor|2|||
124976904|NCT00895895|449541947|FG003|Period 1|discontinued by sponsor|1|||
124976905|NCT00895895|449541948|FG004|Period 1|discontinued by sponsor|1|||
124976906|NCT00895895|449541944|FG000|Period 1|failed to return|0|||
124976907|NCT00895895|449541945|FG001|Period 1|failed to return|0|||
124976908|NCT00895895|449541946|FG002|Period 1|failed to return|1|||
124976909|NCT00895895|449541947|FG003|Period 1|failed to return|0|||
124976910|NCT00895895|449541948|FG004|Period 1|failed to return|1|||
124976911|NCT00895895|449541944|FG000|Period 1|investigator request|0|||
124976912|NCT00895895|449541945|FG001|Period 1|investigator request|1|||
124976913|NCT00895895|449541946|FG002|Period 1|investigator request|0|||
124976914|NCT00895895|449541947|FG003|Period 1|investigator request|0|||
124976915|NCT00895895|449541948|FG004|Period 1|investigator request|0|||
124976916|NCT00895895|449541944|FG000|Period 1|Lost to Follow-up|2|||
124976917|NCT00895895|449541945|FG001|Period 1|Lost to Follow-up|1|||
124976918|NCT00895895|449541946|FG002|Period 1|Lost to Follow-up|3|||
124976919|NCT00895895|449541947|FG003|Period 1|Lost to Follow-up|2|||
124976920|NCT00895895|449541948|FG004|Period 1|Lost to Follow-up|3|||
124976921|NCT00895895|449541944|FG000|Period 1|Other|1|||
124976922|NCT00895895|449541945|FG001|Period 1|Other|2|||
124976923|NCT00895895|449541946|FG002|Period 1|Other|1|||
124976924|NCT00895895|449541947|FG003|Period 1|Other|1|||
124976925|NCT00895895|449541948|FG004|Period 1|Other|1|||
124976926|NCT00895895|449541944|FG000|Period 1|Protocol Violation|0|||
124976927|NCT00895895|449541945|FG001|Period 1|Protocol Violation|1|||
124976928|NCT00895895|449541946|FG002|Period 1|Protocol Violation|0|||
124976929|NCT00895895|449541947|FG003|Period 1|Protocol Violation|0|||
124976930|NCT00895895|449541948|FG004|Period 1|Protocol Violation|0|||
124976931|NCT00895895|449541944|FG000|Period 1|Withdrawal by Subject|6|||
124976932|NCT00895895|449541945|FG001|Period 1|Withdrawal by Subject|6|||
124976933|NCT00895895|449541946|FG002|Period 1|Withdrawal by Subject|8|||
124976934|NCT00895895|449541947|FG003|Period 1|Withdrawal by Subject|2|||
124976935|NCT00895895|449541948|FG004|Period 1|Withdrawal by Subject|4|||
124976936|NCT00895895|449541944|FG000|Period 1|unsatisfactory response-efficacy|2|||
124976937|NCT00895895|449541945|FG001|Period 1|unsatisfactory response-efficacy|0|||
124976938|NCT00895895|449541946|FG002|Period 1|unsatisfactory response-efficacy|0|||
124976939|NCT00895895|449541947|FG003|Period 1|unsatisfactory response-efficacy|0|||
124976940|NCT00895895|449541948|FG004|Period 1|unsatisfactory response-efficacy|0|||
124976941|NCT00895895|449541944|FG000|Period 1|randomized and not treated|1|||
124976942|NCT00895895|449541945|FG001|Period 1|randomized and not treated|3|||
124976943|NCT00895895|449541946|FG002|Period 1|randomized and not treated|1|||
124976944|NCT00895895|449541947|FG003|Period 1|randomized and not treated|1|||
124976945|NCT00895895|449541948|FG004|Period 1|randomized and not treated|2|||
124976946|NCT00895895|449541944|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
124976947|NCT00895895|449541945|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
124976948|NCT00895895|449541946|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
124976949|NCT00895895|449541947|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
124976950|NCT00895895|449541948|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
124976951|NCT00895895|449541944|FG000|After Period 1, Prior to Period 2|Other|0|||
124976952|NCT00895895|449541945|FG001|After Period 1, Prior to Period 2|Other|0|||
124976953|NCT00895895|449541946|FG002|After Period 1, Prior to Period 2|Other|1|||
124976954|NCT00895895|449541947|FG003|After Period 1, Prior to Period 2|Other|0|||
124976955|NCT00895895|449541948|FG004|After Period 1, Prior to Period 2|Other|0|||
124976956|NCT00895895|449541944|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
124976957|NCT00895895|449541945|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
124976958|NCT00895895|449541946|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
124754780|NCT00367835|448724014|FG000|Overall Study|History of lead poisoning|0|||
124865863|NCT04988308|449128892|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
124865864|NCT04988308|449128893|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
124865865|NCT04988308|449128894|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
124865866|NCT04988308|449128895|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
124865867|NCT04988308|449128890|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
124865868|NCT04988308|449128891|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
124865869|NCT04988308|449128892|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
124865870|NCT04988308|449128893|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
124865871|NCT04988308|449128894|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
124865872|NCT04988308|449128895|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
124865873|NCT04988308|449128890|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
124865874|NCT04988308|449128891|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
124865875|NCT04988308|449128892|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
124865876|NCT04988308|449128893|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
124865877|NCT04988308|449128894|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
124865878|NCT04988308|449128895|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
124865879|NCT04988308|449128890|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
124976959|NCT00895895|449541947|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
124976960|NCT00895895|449541948|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
124976961|NCT00895895|449541944|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
124976962|NCT00895895|449541945|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
124976963|NCT00895895|449541946|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
124976964|NCT00895895|449541947|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
124976965|NCT00895895|449541948|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
124976966|NCT00895895|449541944|FG000|Period 2|Adverse Event|3|||
124865880|NCT04988308|449128891|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
124865881|NCT04988308|449128892|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
124865882|NCT04988308|449128893|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
124865883|NCT04988308|449128894|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
124865884|NCT04988308|449128895|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
124865885|NCT04988308|449128890|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
124865886|NCT04988308|449128891|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
124865887|NCT04988308|449128892|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
124865888|NCT04988308|449128893|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
124865889|NCT04988308|449128894|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
124865890|NCT04988308|449128895|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
124865891|NCT04988308|449128890|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
124865892|NCT04988308|449128891|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
124865893|NCT04988308|449128892|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
124865894|NCT04988308|449128893|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
124865895|NCT04988308|449128894|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
124865896|NCT04988308|449128895|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
124865897|NCT02625623|449128897|FG000|Overall Study|Participants randomized but not treated|9|||
124865898|NCT02625623|449128898|FG001|Overall Study|Participants randomized but not treated|1|||
124865899|NCT00808808|449128899|FG000|Overall Study|Vaccinated; survey not completed|131|||
124865900|NCT00808808|449128900|FG001|Overall Study|Vaccinated; survey not completed|169|||
124865901|NCT00808808|449128901|FG002|Overall Study|Vaccinated; survey not completed|302|||
124865902|NCT00808808|449128899|FG000|Overall Study|Employee was not vaccinated.|2686|||
124865903|NCT00808808|449128900|FG001|Overall Study|Employee was not vaccinated.|2268|||
124865904|NCT00808808|449128901|FG002|Overall Study|Employee was not vaccinated.|2255|||
124865905|NCT02352948|449128903|FG000|Overall Study|Death|47|||
124865906|NCT02352948|449128904|FG001|Overall Study|Death|48|||
124865907|NCT02352948|449128905|FG002|Overall Study|Death|114|||
124865908|NCT02352948|449128906|FG003|Overall Study|Death|74|||
124865909|NCT02352948|449128907|FG004|Overall Study|Death|77|||
124865910|NCT02352948|449128908|FG005|Overall Study|Death|44|||
124865911|NCT02352948|449128903|FG000|Overall Study|Lost to Follow-up|1|||
124865912|NCT02352948|449128904|FG001|Overall Study|Lost to Follow-up|0|||
124865913|NCT02352948|449128905|FG002|Overall Study|Lost to Follow-up|2|||
124865914|NCT02352948|449128906|FG003|Overall Study|Lost to Follow-up|1|||
124865915|NCT02352948|449128907|FG004|Overall Study|Lost to Follow-up|2|||
124865916|NCT02352948|449128908|FG005|Overall Study|Lost to Follow-up|1|||
124865917|NCT02352948|449128903|FG000|Overall Study|Withdrawal by Subject|1|||
124865918|NCT02352948|449128904|FG001|Overall Study|Withdrawal by Subject|10|||
124865919|NCT02352948|449128905|FG002|Overall Study|Withdrawal by Subject|11|||
124865920|NCT02352948|449128906|FG003|Overall Study|Withdrawal by Subject|23|||
124865921|NCT02352948|449128907|FG004|Overall Study|Withdrawal by Subject|9|||
124865922|NCT02352948|449128908|FG005|Overall Study|Withdrawal by Subject|4|||
124865923|NCT02352948|449128903|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124865924|NCT02352948|449128904|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
124865925|NCT02352948|449128905|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
124865926|NCT02352948|449128906|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
124865927|NCT02352948|449128907|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
124865928|NCT02352948|449128908|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
124865929|NCT02352948|449128903|FG000|Overall Study|Other|0|||
124865930|NCT02352948|449128904|FG001|Overall Study|Other|0|||
124865931|NCT02352948|449128905|FG002|Overall Study|Other|2|||
124865932|NCT02352948|449128906|FG003|Overall Study|Other|0|||
124865933|NCT02352948|449128907|FG004|Overall Study|Other|0|||
124865934|NCT02352948|449128908|FG005|Overall Study|Other|0|||
124865935|NCT00490646|449128909|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
124865936|NCT00490646|449128910|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
124865937|NCT00490646|449128909|FG000|Overall Study|Never Treated (had an adverse event)|1|||
124865938|NCT00490646|449128910|FG001|Overall Study|Never Treated (had an adverse event)|0|||
124865939|NCT00490646|449128909|FG000|Overall Study|Never Treated (withdrew consent)|0|||
124865940|NCT00490646|449128910|FG001|Overall Study|Never Treated (withdrew consent)|1|||
124865941|NCT01178086|449128911|FG000|Overall Study|Participant refusal|7|||
124865942|NCT01178086|449128911|FG000|Overall Study|Physician Decision|44|||
124865943|NCT01178086|449128911|FG000|Overall Study|Switch to other CLL therapy|113|||
124754781|NCT00367835|448724015|FG001|Overall Study|History of lead poisoning|1|||
124754782|NCT03761810|448724019|FG000|Overall Study|Adverse Event|12|||
124865944|NCT01178086|449128911|FG000|Overall Study|Death|59|||
124865945|NCT01178086|449128911|FG000|Overall Study|Other unspecified|89|||
124865946|NCT01178086|449128911|FG000|Overall Study|Excluded from EAS|20|||
124865947|NCT02313428|449128912|FG000|Overall Study|Lost to Follow-up|1|||
124865948|NCT02313428|449128913|FG001|Overall Study|Lost to Follow-up|1|||
124865949|NCT02057874|449131353|FG000|Overall Study|participant did not return for scan|1|||
124865950|NCT01258608|449131358|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
124865951|NCT01258608|449131359|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
124865952|NCT01258608|449131358|FG000|Overall Study|Clinical progression|1|||
124865953|NCT01258608|449131359|FG001|Overall Study|Clinical progression|0|||
124865954|NCT01258608|449131358|FG000|Overall Study|Sponsor decision|0|||
124865955|NCT01258608|449131359|FG001|Overall Study|Sponsor decision|1|||
124865956|NCT01258608|449131358|FG000|Overall Study|Physician Decision|6|||
124865957|NCT01258608|449131359|FG001|Overall Study|Physician Decision|1|||
124865958|NCT01258608|449131358|FG000|Overall Study|Lost to Follow-up|0|||
124865959|NCT01258608|449131359|FG001|Overall Study|Lost to Follow-up|1|||
124865960|NCT01258608|449131358|FG000|Overall Study|Lack of compliance|1|||
124865961|NCT01258608|449131359|FG001|Overall Study|Lack of compliance|0|||
124865962|NCT01258608|449131358|FG000|Overall Study|Lack of Efficacy|0|||
124865963|NCT01258608|449131359|FG001|Overall Study|Lack of Efficacy|1|||
124865964|NCT01258608|449131358|FG000|Overall Study|Adverse Event|6|||
124865965|NCT01258608|449131359|FG001|Overall Study|Adverse Event|10|||
124865966|NCT01258608|449131358|FG000|Overall Study|Withdrawal by Subject|6|||
124976967|NCT00895895|449541945|FG001|Period 2|Adverse Event|3|||
124976968|NCT00895895|449541946|FG002|Period 2|Adverse Event|5|||
124865967|NCT01258608|449131359|FG001|Overall Study|Withdrawal by Subject|5|||
124865968|NCT02943408|449131361|FG000|Overall Study|Lost to Follow-up|7|||
124865969|NCT02943408|449131362|FG001|Overall Study|Lost to Follow-up|1|||
124865970|NCT02943408|449131361|FG000|Overall Study|Withdrawal by Subject|0|||
124865971|NCT02943408|449131362|FG001|Overall Study|Withdrawal by Subject|1|||
124865972|NCT01621126|449131365|FG000|Overall Study|Physician Decision|6|||
124976969|NCT00895895|449541947|FG003|Period 2|Adverse Event|2|||
124976970|NCT00895895|449541948|FG004|Period 2|Adverse Event|5|||
124865973|NCT00886340|449131366|FG000|Overall Study|Withdrawal by Subject|0|||
124865974|NCT00886340|449131367|FG001|Overall Study|Withdrawal by Subject|7|||
124865975|NCT01949311|449131369|FG000|Overall Study|Lost to Follow-up|73|||
124865976|NCT01949311|449131369|FG000|Overall Study|Terminated by Sponsor|708|||
124865977|NCT01949311|449131369|FG000|Overall Study|Withdrawal by Subject|375|||
124865978|NCT01949311|449131369|FG000|Overall Study|Lack of Efficacy|50|||
124865979|NCT01949311|449131369|FG000|Overall Study|Protocol Deviation|34|||
124865980|NCT01949311|449131369|FG000|Overall Study|Pregnancy|20|||
124865981|NCT01949311|449131369|FG000|Overall Study|Physician Decision|9|||
124865982|NCT01949311|449131369|FG000|Overall Study|Other|4|||
124865983|NCT01949311|449131369|FG000|Overall Study|Adverse Event|107|||
124865984|NCT02338154|449131370|FG000|Overall Study|Death|46|||
124865985|NCT02338154|449131370|FG000|Overall Study|Valve Implant Failure|17|||
124865986|NCT02338154|449131370|FG000|Overall Study|Valve Explant|11|||
124865987|NCT02338154|449131370|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
124865988|NCT02338154|449131370|FG000|Overall Study|Lost to Follow-up|8|||
124865989|NCT02338154|449131370|FG000|Overall Study|Other Reason|3|||
124865990|NCT02338154|449131370|FG000|Overall Study|Patients Without Exit Form|47|||
124865991|NCT02338154|449131370|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
124865992|NCT02120027|449131371|FG000|Overall Study|Adverse Event|4|||
124865993|NCT02120027|449131372|FG001|Overall Study|Adverse Event|5|||
124865994|NCT02120027|449131371|FG000|Overall Study|Lack of Efficacy|3|||
124865995|NCT02120027|449131372|FG001|Overall Study|Lack of Efficacy|5|||
124865996|NCT02120027|449131371|FG000|Overall Study|Lost to Follow-up|5|||
124865997|NCT02120027|449131372|FG001|Overall Study|Lost to Follow-up|13|||
124865998|NCT02120027|449131371|FG000|Overall Study|Other|4|||
124865999|NCT02120027|449131372|FG001|Overall Study|Other|0|||
124866000|NCT02120027|449131371|FG000|Overall Study|Physician Decision|4|||
124866001|NCT02120027|449131372|FG001|Overall Study|Physician Decision|3|||
124866002|NCT02120027|449131371|FG000|Overall Study|Protocol Violation|18|||
124866003|NCT02120027|449131372|FG001|Overall Study|Protocol Violation|21|||
124866004|NCT02120027|449131371|FG000|Overall Study|Study terminated by Sponsor|45|||
124866005|NCT02120027|449131372|FG001|Overall Study|Study terminated by Sponsor|47|||
124866006|NCT02120027|449131371|FG000|Overall Study|Withdrawal by Subject|33|||
124866007|NCT02120027|449131372|FG001|Overall Study|Withdrawal by Subject|25|||
124866008|NCT03393000|449131383|FG000|Overall Study|Death|11|||
124866009|NCT03393000|449131383|FG000|Overall Study|Withdrawal by Subject|2|||
124866010|NCT03393000|449131383|FG000|Overall Study|Physician Decision|1|||
124866011|NCT01773070|449131384|FG000|Overall Study|Withdrawal by Subject|24|||
124866012|NCT01773070|449131384|FG000|Overall Study|Lost to Follow-up|39|||
124866013|NCT01773070|449131384|FG000|Overall Study|Other|15|||
124866014|NCT01773070|449131384|FG000|Overall Study|Death (unrelated to study procedures)|3|||
124866015|NCT01471054|449131385|FG000|Overall Study|Study terminated prematurely|4|||
124866016|NCT01471054|449131386|FG001|Overall Study|Study terminated prematurely|0|||
124866017|NCT01843192|449131387|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
124866018|NCT01843192|449131388|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
124866019|NCT01843192|449131389|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
124866020|NCT01559844|449131390|FG000|Overall Study|Consent Withdrawn|7|||
124866021|NCT01559844|449131390|FG000|Overall Study|Death|5|||
124866022|NCT01559844|449131390|FG000|Overall Study|Efficacy Failure|10|||
124866023|NCT01559844|449131390|FG000|Overall Study|No Longer A Transplant Candidate|3|||
124866024|NCT00951041|449131391|FG000|Overall Study|Withdrawal by Subject|1|||
124976971|NCT00895895|449541944|FG000|Period 2|Death|0|||
124866025|NCT00951041|449131392|FG001|Overall Study|Withdrawal by Subject|1|||
124866026|NCT00951041|449131391|FG000|Overall Study|Lost to Follow-up|1|||
124866027|NCT00951041|449131392|FG001|Overall Study|Lost to Follow-up|0|||
124866028|NCT00951041|449131391|FG000|Overall Study|Other|3|||
124866029|NCT00951041|449131392|FG001|Overall Study|Other|0|||
124866030|NCT01514448|449131393|FG000|Overall Study|Death|7|||
124866031|NCT01514448|449131394|FG001|Overall Study|Death|8|||
124866032|NCT01514448|449131393|FG000|Overall Study|Withdrawal by Subject|2|||
124866033|NCT01514448|449131394|FG001|Overall Study|Withdrawal by Subject|0|||
124866034|NCT01514448|449131393|FG000|Overall Study|Lost to Follow-up|2|||
124866035|NCT01514448|449131394|FG001|Overall Study|Lost to Follow-up|0|||
124866036|NCT01514448|449131393|FG000|Overall Study|New Cancer Therapy|1|||
124866037|NCT01514448|449131394|FG001|Overall Study|New Cancer Therapy|0|||
124866038|NCT02314624|449131395|FG000|Overall Study|No participating patient|16|||
124866039|NCT02314624|449131396|FG001|Overall Study|No participating patient|13|||
124866040|NCT02314624|449131395|FG000|Overall Study|Participant withdrew|7|||
124866041|NCT02314624|449131396|FG001|Overall Study|Participant withdrew|2|||
124866042|NCT02314624|449131395|FG000|Overall Study|Lost to Follow-up|2|||
124866043|NCT02314624|449131396|FG001|Overall Study|Lost to Follow-up|5|||
124866044|NCT02314624|449131395|FG000|Overall Study|Dropped/Excluded by PI|6|||
124866045|NCT02314624|449131396|FG001|Overall Study|Dropped/Excluded by PI|6|||
124866046|NCT00725452|449131398|FG000|Overall Study|Adverse Event|3|||
124866047|NCT00725452|449131398|FG000|Overall Study|Lack of Efficacy|2|||
124866048|NCT00725452|449131398|FG000|Overall Study|Reason not specified|1|||
124866049|NCT00725452|449131398|FG000|Overall Study|Physician Decision|1|||
124866050|NCT00725452|449131398|FG000|Overall Study|Withdrawal by Subject|3|||
124866051|NCT00725452|449131398|FG000|Overall Study|Lost to Follow-up|1|||
124866052|NCT00620750|449131399|FG000|Overall Study|Lost to Follow-up|25|||
124866053|NCT04477187|449131400|FG000|Overall Study|Lost to Follow-up|2|||
124866054|NCT00713648|449131405|FG000|Overall Study|Adverse Event|1|||
124866055|NCT00713648|449131405|FG000|Overall Study|Unclassified|2|||
124866056|NCT00713648|449131405|FG000|Overall Study|According to Protocol|2|||
124866057|NCT00713648|449131405|FG000|Overall Study|Development of antibodies|3|||
124866058|NCT00082173|449131406|FG000|Overall Study|Withdrawal by Subject|3|||
124866059|NCT00082173|449131407|FG001|Overall Study|Withdrawal by Subject|5|||
124866060|NCT00082173|449131406|FG000|Overall Study|Lost to Follow-up|1|||
124866061|NCT00082173|449131407|FG001|Overall Study|Lost to Follow-up|0|||
124866062|NCT00082173|449131406|FG000|Overall Study|Adverse Event|1|||
124866063|NCT00082173|449131407|FG001|Overall Study|Adverse Event|0|||
124866064|NCT00082173|449131406|FG000|Overall Study|Culture negative or resistant at baselin|5|||
124866065|NCT00082173|449131407|FG001|Overall Study|Culture negative or resistant at baselin|6|||
124866066|NCT01733732|449131408|FG000|Overall Study|Adverse Event|1|||
124866067|NCT01733732|449131409|FG001|Overall Study|Adverse Event|0|||
124866068|NCT01733732|449131408|FG000|Overall Study|Did not attend all study visits|1|||
124866069|NCT01733732|449131409|FG001|Overall Study|Did not attend all study visits|0|||
124866070|NCT00746590|449131410|FG000|Overall Study|Death|1|||
124866071|NCT00464815|449131414|FG000|Overall Study|Withdrawal by Subject|6|||
124866072|NCT00464815|449131415|FG001|Overall Study|Withdrawal by Subject|3|||
124866073|NCT01260350|449131422|FG000|Overall Study|Lack of Efficacy|0|||
124866074|NCT01260350|449131423|FG001|Overall Study|Lack of Efficacy|0|||
124866075|NCT01260350|449131424|FG002|Overall Study|Lack of Efficacy|0|||
124866076|NCT01260350|449131425|FG003|Overall Study|Lack of Efficacy|0|||
124866077|NCT01260350|449131426|FG004|Overall Study|Lack of Efficacy|0|||
124866078|NCT01260350|449131427|FG005|Overall Study|Lack of Efficacy|0|||
124866079|NCT01260350|449131428|FG006|Overall Study|Lack of Efficacy|0|||
124866080|NCT01260350|449131429|FG007|Overall Study|Lack of Efficacy|0|||
124866081|NCT01260350|449131430|FG008|Overall Study|Lack of Efficacy|0|||
124866082|NCT01260350|449131431|FG009|Overall Study|Lack of Efficacy|0|||
124866083|NCT01260350|449131432|FG010|Overall Study|Lack of Efficacy|0|||
124866084|NCT01260350|449131433|FG011|Overall Study|Lack of Efficacy|0|||
124866085|NCT01260350|449131434|FG012|Overall Study|Lack of Efficacy|0|||
124866086|NCT01260350|449131435|FG013|Overall Study|Lack of Efficacy|0|||
124866087|NCT01260350|449131436|FG014|Overall Study|Lack of Efficacy|0|||
124866088|NCT01260350|449131437|FG015|Overall Study|Lack of Efficacy|0|||
124866089|NCT01260350|449131438|FG016|Overall Study|Lack of Efficacy|0|||
124866090|NCT01260350|449131439|FG017|Overall Study|Lack of Efficacy|1|||
124866091|NCT01260350|449131440|FG018|Overall Study|Lack of Efficacy|0|||
124866092|NCT01260350|449131441|FG019|Overall Study|Lack of Efficacy|0|||
124866093|NCT01260350|449131442|FG020|Overall Study|Lack of Efficacy|3|||
124866094|NCT01260350|449131443|FG021|Overall Study|Lack of Efficacy|0|||
124866095|NCT01260350|449131422|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866096|NCT01260350|449131423|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866097|NCT01260350|449131424|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866098|NCT01260350|449131425|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866099|NCT01260350|449131426|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866100|NCT01260350|449131427|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866101|NCT01260350|449131428|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866102|NCT01260350|449131429|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866103|NCT01260350|449131430|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
124866104|NCT01260350|449131431|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866105|NCT01260350|449131432|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866106|NCT01260350|449131433|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866107|NCT01260350|449131434|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866108|NCT01260350|449131435|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866109|NCT01260350|449131436|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866110|NCT01260350|449131437|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866111|NCT01260350|449131438|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866112|NCT01260350|449131439|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866113|NCT01260350|449131440|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866114|NCT01260350|449131441|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866115|NCT01260350|449131442|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866116|NCT01260350|449131443|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
124866117|NCT04402866|449131444|FG000|Overall Study|Discontinued Prior to Treatment|0|||
124866118|NCT04402866|449131445|FG001|Overall Study|Discontinued Prior to Treatment|0|||
124866119|NCT04402866|449131446|FG002|Overall Study|Discontinued Prior to Treatment|0|||
124866120|NCT04402866|449131447|FG003|Overall Study|Discontinued Prior to Treatment|0|||
124866121|NCT04402866|449131448|FG004|Overall Study|Discontinued Prior to Treatment|2|||
124866122|NCT04402866|449131449|FG005|Overall Study|Discontinued Prior to Treatment|3|||
124866123|NCT04402866|449131444|FG000|Overall Study|Adverse Event|2|||
124866124|NCT04402866|449131445|FG001|Overall Study|Adverse Event|1|||
124866125|NCT04402866|449131446|FG002|Overall Study|Adverse Event|0|||
124866126|NCT04402866|449131447|FG003|Overall Study|Adverse Event|0|||
124866127|NCT04402866|449131448|FG004|Overall Study|Adverse Event|13|||
124866128|NCT04402866|449131449|FG005|Overall Study|Adverse Event|8|||
124866129|NCT04402866|449131444|FG000|Overall Study|Miscellaneous|0|||
124866130|NCT04402866|449131445|FG001|Overall Study|Miscellaneous|0|||
124866131|NCT04402866|449131446|FG002|Overall Study|Miscellaneous|1|||
124866132|NCT04402866|449131447|FG003|Overall Study|Miscellaneous|0|||
124866133|NCT04402866|449131448|FG004|Overall Study|Miscellaneous|0|||
124866134|NCT04402866|449131449|FG005|Overall Study|Miscellaneous|0|||
124866135|NCT04402866|449131444|FG000|Overall Study|Lost to Follow-up|0|||
124866136|NCT04402866|449131445|FG001|Overall Study|Lost to Follow-up|0|||
124866137|NCT04402866|449131446|FG002|Overall Study|Lost to Follow-up|0|||
124866138|NCT04402866|449131447|FG003|Overall Study|Lost to Follow-up|0|||
124866139|NCT04402866|449131448|FG004|Overall Study|Lost to Follow-up|0|||
124866140|NCT04402866|449131449|FG005|Overall Study|Lost to Follow-up|1|||
124866141|NCT04402866|449131444|FG000|Overall Study|Withdrawal by Subject|0|||
124866142|NCT04402866|449131445|FG001|Overall Study|Withdrawal by Subject|0|||
124866143|NCT04402866|449131446|FG002|Overall Study|Withdrawal by Subject|0|||
124866144|NCT04402866|449131447|FG003|Overall Study|Withdrawal by Subject|0|||
124866145|NCT04402866|449131448|FG004|Overall Study|Withdrawal by Subject|0|||
124866146|NCT04402866|449131449|FG005|Overall Study|Withdrawal by Subject|2|||
124866147|NCT01814371|449131450|FG000|Overall Study|Lost to Follow-up|30|||
124866148|NCT01814371|449131451|FG001|Overall Study|Lost to Follow-up|27|||
124866149|NCT02794285|449131452|FG000|Overall Study|Adverse Event|11|||
124866150|NCT02794285|449131453|FG001|Overall Study|Adverse Event|4|||
124866151|NCT02794285|449131454|FG002|Overall Study|Adverse Event|5|||
124866152|NCT02794285|449131455|FG003|Overall Study|Adverse Event|8|||
124866153|NCT02794285|449131452|FG000|Overall Study|Condition Under Investigation Improved|1|||
124866154|NCT02794285|449131453|FG001|Overall Study|Condition Under Investigation Improved|0|||
124866155|NCT02794285|449131454|FG002|Overall Study|Condition Under Investigation Improved|0|||
124866156|NCT02794285|449131455|FG003|Overall Study|Condition Under Investigation Improved|0|||
124866157|NCT02794285|449131452|FG000|Overall Study|Condition Under Investigation Worsened|0|||
124866158|NCT02794285|449131453|FG001|Overall Study|Condition Under Investigation Worsened|2|||
124866159|NCT02794285|449131454|FG002|Overall Study|Condition Under Investigation Worsened|1|||
124866160|NCT02794285|449131455|FG003|Overall Study|Condition Under Investigation Worsened|0|||
124866161|NCT02794285|449131452|FG000|Overall Study|Death|2|||
124866162|NCT02794285|449131453|FG001|Overall Study|Death|1|||
124754783|NCT03761810|448724020|FG001|Overall Study|Adverse Event|0|||
124754784|NCT03761810|448724019|FG000|Overall Study|Lost to Follow-up|15|||
124754785|NCT03761810|448724020|FG001|Overall Study|Lost to Follow-up|7|||
124866163|NCT02794285|449131454|FG002|Overall Study|Death|2|||
124866164|NCT02794285|449131455|FG003|Overall Study|Death|0|||
124866165|NCT02794285|449131452|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
124866166|NCT02794285|449131453|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
124866167|NCT02794285|449131454|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
124866168|NCT02794285|449131455|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
124866169|NCT02794285|449131452|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
124866170|NCT02794285|449131453|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
124866171|NCT02794285|449131454|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
124754786|NCT03761810|448724019|FG000|Overall Study|Pregnancy|1|||
124976972|NCT00895895|449541945|FG001|Period 2|Death|0|||
124754787|NCT03761810|448724020|FG001|Overall Study|Pregnancy|0|||
124754788|NCT03761810|448724019|FG000|Overall Study|Withdrawal by Subject|14|||
124754789|NCT03761810|448724020|FG001|Overall Study|Withdrawal by Subject|5|||
124754790|NCT03761810|448724019|FG000|Overall Study|Physician Decision|1|||
124754791|NCT03761810|448724020|FG001|Overall Study|Physician Decision|0|||
124754792|NCT03761810|448724019|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
124754793|NCT03761810|448724020|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124754794|NCT03761810|448724019|FG000|Overall Study|Other Than Specified|1|||
124754795|NCT03761810|448724020|FG001|Overall Study|Other Than Specified|0|||
124866172|NCT02794285|449131455|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
124866173|NCT02794285|449131452|FG000|Overall Study|Lack of Efficacy|10|||
124866174|NCT02794285|449131453|FG001|Overall Study|Lack of Efficacy|6|||
124866175|NCT02794285|449131454|FG002|Overall Study|Lack of Efficacy|3|||
124866176|NCT02794285|449131455|FG003|Overall Study|Lack of Efficacy|3|||
124866177|NCT02794285|449131452|FG000|Overall Study|Lost to Follow-up|5|||
124866178|NCT02794285|449131453|FG001|Overall Study|Lost to Follow-up|6|||
124866179|NCT02794285|449131454|FG002|Overall Study|Lost to Follow-up|3|||
124866180|NCT02794285|449131455|FG003|Overall Study|Lost to Follow-up|1|||
124866181|NCT02794285|449131452|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
124866182|NCT02794285|449131453|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
124866183|NCT02794285|449131454|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
124866184|NCT02794285|449131455|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
124866185|NCT02794285|449131452|FG000|Overall Study|Withdrawal by Subject|38|||
124866186|NCT02794285|449131453|FG001|Overall Study|Withdrawal by Subject|29|||
124866187|NCT02794285|449131454|FG002|Overall Study|Withdrawal by Subject|20|||
124866188|NCT02794285|449131455|FG003|Overall Study|Withdrawal by Subject|12|||
124866189|NCT02794285|449131452|FG000|Overall Study|Missing|1|||
124866190|NCT02794285|449131453|FG001|Overall Study|Missing|0|||
124866191|NCT02794285|449131454|FG002|Overall Study|Missing|0|||
124866192|NCT02794285|449131455|FG003|Overall Study|Missing|0|||
124866193|NCT02794285|449131452|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
124866194|NCT02794285|449131453|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
124866195|NCT02794285|449131454|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
124866196|NCT02794285|449131455|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
124866197|NCT02794285|449131452|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
124866198|NCT02794285|449131453|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
124866199|NCT02794285|449131454|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
124866200|NCT02794285|449131455|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
124866201|NCT03996473|449131458|FG000|Treatment Assignment|Withdrawal by Subject|1|||
124866202|NCT03996473|449131458|FG000|Treatment Assignment|Progressive disease|6|||
124866203|NCT03996473|449131458|FG000|Treatment Assignment|Study drug never administered|1|||
124866204|NCT03996473|449131458|FG000|Active Follow-up|Death|1|||
124866205|NCT03996473|449131458|FG000|Long-term Follow-up|Death|5|||
124866206|NCT06116591|449131459|FG000|Overall Study|No longer met eligibility criteria|0|||
124866207|NCT06116591|449131460|FG001|Overall Study|No longer met eligibility criteria|1|||
124866208|NCT06116591|449131459|FG000|Overall Study|Other: Change in life situation|0|||
124866209|NCT06116591|449131460|FG001|Overall Study|Other: Change in life situation|1|||
124866210|NCT01972841|449131461|FG000|Overall Study|Randomized but Never Received Treatment|2|||
124866211|NCT01972841|449131462|FG001|Overall Study|Randomized but Never Received Treatment|5|||
124866212|NCT01972841|449131463|FG002|Overall Study|Randomized but Never Received Treatment|4|||
124866213|NCT01972841|449131464|FG003|Overall Study|Randomized but Never Received Treatment|2|||
124866214|NCT01972841|449131465|FG004|Overall Study|Randomized but Never Received Treatment|6|||
124866215|NCT01972841|449131466|FG005|Overall Study|Randomized but Never Received Treatment|13|||
124866216|NCT01972841|449131461|FG000|Overall Study|Adverse Event|13|||
124976973|NCT00895895|449541946|FG002|Period 2|Death|1|||
124976974|NCT00895895|449541947|FG003|Period 2|Death|0|||
124866217|NCT01972841|449131462|FG001|Overall Study|Adverse Event|8|||
124866218|NCT01972841|449131463|FG002|Overall Study|Adverse Event|12|||
124866219|NCT01972841|449131464|FG003|Overall Study|Adverse Event|9|||
124866220|NCT01972841|449131465|FG004|Overall Study|Adverse Event|21|||
124866221|NCT01972841|449131466|FG005|Overall Study|Adverse Event|26|||
124866222|NCT01972841|449131461|FG000|Overall Study|Lack of Efficacy|1|||
124754796|NCT01574651|448724021|FG000|Overall Study|Lost to Follow-up|2|||
124754797|NCT01574651|448724022|FG001|Overall Study|Lost to Follow-up|4|||
124866223|NCT01972841|449131462|FG001|Overall Study|Lack of Efficacy|0|||
124866224|NCT01972841|449131463|FG002|Overall Study|Lack of Efficacy|0|||
124866225|NCT01972841|449131464|FG003|Overall Study|Lack of Efficacy|2|||
124866226|NCT01972841|449131465|FG004|Overall Study|Lack of Efficacy|4|||
124866227|NCT01972841|449131466|FG005|Overall Study|Lack of Efficacy|1|||
124754798|NCT01574651|448724021|FG000|Overall Study|Administrative problems|0|||
124866228|NCT01972841|449131461|FG000|Overall Study|Lost to Follow-up|4|||
124866229|NCT01972841|449131462|FG001|Overall Study|Lost to Follow-up|2|||
124866230|NCT01972841|449131463|FG002|Overall Study|Lost to Follow-up|4|||
124866231|NCT01972841|449131464|FG003|Overall Study|Lost to Follow-up|2|||
124976975|NCT00895895|449541948|FG004|Period 2|Death|0|||
124754799|NCT01574651|448724022|FG001|Overall Study|Administrative problems|1|||
124866232|NCT01972841|449131465|FG004|Overall Study|Lost to Follow-up|9|||
124866233|NCT01972841|449131466|FG005|Overall Study|Lost to Follow-up|3|||
124866234|NCT01972841|449131461|FG000|Overall Study|Protocol Violation|2|||
124866235|NCT01972841|449131462|FG001|Overall Study|Protocol Violation|2|||
124866236|NCT01972841|449131463|FG002|Overall Study|Protocol Violation|3|||
124866237|NCT01972841|449131464|FG003|Overall Study|Protocol Violation|5|||
124866238|NCT01972841|449131465|FG004|Overall Study|Protocol Violation|9|||
124866239|NCT01972841|449131466|FG005|Overall Study|Protocol Violation|4|||
124866240|NCT01972841|449131461|FG000|Overall Study|Withdrawal by participants|21|||
124866241|NCT01972841|449131462|FG001|Overall Study|Withdrawal by participants|27|||
124866242|NCT01972841|449131463|FG002|Overall Study|Withdrawal by participants|23|||
124866243|NCT01972841|449131464|FG003|Overall Study|Withdrawal by participants|16|||
124866244|NCT01972841|449131465|FG004|Overall Study|Withdrawal by participants|33|||
124866245|NCT01972841|449131466|FG005|Overall Study|Withdrawal by participants|34|||
124866246|NCT01972841|449131461|FG000|Overall Study|Miscellaneous|0|||
124866247|NCT01972841|449131462|FG001|Overall Study|Miscellaneous|0|||
124866248|NCT01972841|449131463|FG002|Overall Study|Miscellaneous|4|||
124866249|NCT01972841|449131464|FG003|Overall Study|Miscellaneous|1|||
124866250|NCT01972841|449131465|FG004|Overall Study|Miscellaneous|0|||
124866251|NCT01972841|449131466|FG005|Overall Study|Miscellaneous|4|||
124866252|NCT01972841|449131461|FG000|Overall Study|Did not have end of treatment page|0|||
124866253|NCT01972841|449131462|FG001|Overall Study|Did not have end of treatment page|0|||
124866254|NCT01972841|449131463|FG002|Overall Study|Did not have end of treatment page|0|||
124866255|NCT01972841|449131464|FG003|Overall Study|Did not have end of treatment page|0|||
124866256|NCT01972841|449131465|FG004|Overall Study|Did not have end of treatment page|1|||
124866257|NCT01972841|449131466|FG005|Overall Study|Did not have end of treatment page|0|||
124866258|NCT04969198|449131469|FG000|Overall Study|Withdrawal by Subject|20|||
124866259|NCT04969198|449131469|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
124866260|NCT04969198|449131469|FG000|Overall Study|Lost to Follow-up|20|||
124866261|NCT05553808|449131473|FG000|Overall Study|Death|25|||
124866262|NCT05553808|449131474|FG001|Overall Study|Death|62|||
124866263|NCT05553808|449131473|FG000|Overall Study|Site Closed|6|||
124866264|NCT05553808|449131474|FG001|Overall Study|Site Closed|6|||
124866265|NCT05553808|449131473|FG000|Overall Study|Lost to Follow-up|1|||
124866266|NCT05553808|449131474|FG001|Overall Study|Lost to Follow-up|0|||
124866267|NCT05553808|449131473|FG000|Overall Study|Withdrawal by Subject|3|||
124866268|NCT05553808|449131474|FG001|Overall Study|Withdrawal by Subject|2|||
124866269|NCT01328574|449131485|FG000|Overall Study|Refused further treatment|1|||
124866270|NCT01483924|449131486|FG000|Overall Study|Withdrawal by Subject|2|||
124866271|NCT01483924|449131487|FG001|Overall Study|Withdrawal by Subject|0|||
124866272|NCT01483924|449131488|FG002|Overall Study|Withdrawal by Subject|0|||
124866273|NCT01483924|449131489|FG003|Overall Study|Withdrawal by Subject|1|||
124866274|NCT01483924|449131490|FG004|Overall Study|Withdrawal by Subject|1|||
124754800|NCT01574651|448724021|FG000|Overall Study|Death|3|||
124754801|NCT01574651|448724022|FG001|Overall Study|Death|3|||
124754802|NCT01574651|448724021|FG000|Overall Study|Patient's inability to use the device|0|||
124754803|NCT01574651|448724022|FG001|Overall Study|Patient's inability to use the device|1|||
124754804|NCT01574651|448724021|FG000|Overall Study|Adverse Event|36|||
124754805|NCT01574651|448724022|FG001|Overall Study|Adverse Event|27|||
124754806|NCT01574651|448724021|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124754807|NCT01574651|448724022|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124754808|NCT01574651|448724021|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124754809|NCT01574651|448724022|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124754810|NCT01574651|448724021|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
124754811|NCT01574651|448724022|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124754812|NCT01574651|448724021|FG000|Overall Study|Protocol Violation|3|||
124754813|NCT01574651|448724022|FG001|Overall Study|Protocol Violation|5|||
124754814|NCT01574651|448724021|FG000|Overall Study|Withdrawal by Subject|9|||
124754815|NCT01574651|448724022|FG001|Overall Study|Withdrawal by Subject|10|||
124754816|NCT03887221|448724023|FG000|Overall Study|Protocol Violation|1|||
124754817|NCT03887221|448724024|FG001|Overall Study|Protocol Violation|0|||
124754818|NCT02487030|448724025|FG000|Overall Study|Lack of Efficacy|2|||
124754819|NCT02487030|448724026|FG001|Overall Study|Lack of Efficacy|4|||
124866275|NCT01483924|449131486|FG000|Overall Study|Adverse Event|0|||
124866276|NCT01483924|449131487|FG001|Overall Study|Adverse Event|0|||
124866277|NCT01483924|449131488|FG002|Overall Study|Adverse Event|1|||
124866278|NCT01483924|449131489|FG003|Overall Study|Adverse Event|1|||
124866279|NCT01483924|449131490|FG004|Overall Study|Adverse Event|0|||
124866280|NCT01483924|449131486|FG000|Overall Study|Non-compliance|0|||
124866281|NCT01483924|449131487|FG001|Overall Study|Non-compliance|0|||
124866282|NCT01483924|449131488|FG002|Overall Study|Non-compliance|0|||
124754820|NCT02487030|448724027|FG002|Overall Study|Lack of Efficacy|1|||
124754821|NCT02487030|448724028|FG003|Overall Study|Lack of Efficacy|0|||
124754822|NCT02487030|448724029|FG004|Overall Study|Lack of Efficacy|1|||
124754823|NCT02487030|448724030|FG005|Overall Study|Lack of Efficacy|0|||
124754824|NCT02487030|448724031|FG006|Overall Study|Lack of Efficacy|0|||
124866283|NCT01483924|449131489|FG003|Overall Study|Non-compliance|1|||
124866284|NCT01483924|449131490|FG004|Overall Study|Non-compliance|1|||
124866285|NCT01483924|449131486|FG000|Overall Study|Sponsor concern over ECG result|0|||
124866286|NCT01483924|449131487|FG001|Overall Study|Sponsor concern over ECG result|0|||
124866287|NCT01483924|449131488|FG002|Overall Study|Sponsor concern over ECG result|0|||
124866288|NCT01483924|449131489|FG003|Overall Study|Sponsor concern over ECG result|1|||
124866289|NCT01483924|449131490|FG004|Overall Study|Sponsor concern over ECG result|0|||
124866290|NCT01994954|449131496|FG000|Overall Study|Death|1|||
124866291|NCT01994954|449131497|FG001|Overall Study|Death|0|||
124866292|NCT01994954|449131496|FG000|Overall Study|Withdrawal by Subject|9|||
124866293|NCT01994954|449131497|FG001|Overall Study|Withdrawal by Subject|14|||
124866294|NCT01994954|449131496|FG000|Overall Study|Physician Decision|2|||
124866295|NCT01994954|449131497|FG001|Overall Study|Physician Decision|2|||
124866296|NCT01994954|449131496|FG000|Overall Study|Lost to Follow-up|8|||
124866297|NCT01994954|449131497|FG001|Overall Study|Lost to Follow-up|10|||
124866298|NCT01994954|449131496|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
124866299|NCT01994954|449131497|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
124866300|NCT00449176|449131499|FG000|Overall Study|Withdrawal by Subject|39|||
124866301|NCT00449176|449131500|FG001|Overall Study|Withdrawal by Subject|43|||
124866302|NCT00449176|449131501|FG002|Overall Study|Withdrawal by Subject|59|||
124866303|NCT00449176|449131499|FG000|Overall Study|Lost to Follow-up|13|||
124866304|NCT00449176|449131500|FG001|Overall Study|Lost to Follow-up|8|||
124866305|NCT00449176|449131501|FG002|Overall Study|Lost to Follow-up|12|||
124866306|NCT00449176|449131499|FG000|Overall Study|Adverse Event|51|||
124866307|NCT00449176|449131500|FG001|Overall Study|Adverse Event|107|||
124866308|NCT00449176|449131501|FG002|Overall Study|Adverse Event|15|||
124866309|NCT00449176|449131499|FG000|Overall Study|Lack of Efficacy|13|||
124866310|NCT00449176|449131500|FG001|Overall Study|Lack of Efficacy|7|||
124866311|NCT00449176|449131501|FG002|Overall Study|Lack of Efficacy|50|||
124866312|NCT00449176|449131499|FG000|Overall Study|Study drug non-compliant|14|||
124866313|NCT00449176|449131500|FG001|Overall Study|Study drug non-compliant|11|||
124976976|NCT00895895|449541944|FG000|Period 2|discontinued by sponsor|44|||
124976977|NCT00895895|449541945|FG001|Period 2|discontinued by sponsor|44|||
124976978|NCT00895895|449541946|FG002|Period 2|discontinued by sponsor|38|||
124976979|NCT00895895|449541947|FG003|Period 2|discontinued by sponsor|46|||
124976980|NCT00895895|449541948|FG004|Period 2|discontinued by sponsor|37|||
124976981|NCT00895895|449541944|FG000|Period 2|failed to return|2|||
124866314|NCT00449176|449131501|FG002|Overall Study|Study drug non-compliant|11|||
124866315|NCT00449176|449131499|FG000|Overall Study|all other|22|||
124866316|NCT00449176|449131500|FG001|Overall Study|all other|19|||
124866317|NCT00449176|449131501|FG002|Overall Study|all other|20|||
124866318|NCT02363946|449131509|FG000|Overall Study|Lost to Follow-up|0|||
124866319|NCT02363946|449131510|FG001|Overall Study|Lost to Follow-up|0|||
124866320|NCT02363946|449131511|FG002|Overall Study|Lost to Follow-up|0|||
124866321|NCT02363946|449131512|FG003|Overall Study|Lost to Follow-up|0|||
124866322|NCT02363946|449131513|FG004|Overall Study|Lost to Follow-up|0|||
124866323|NCT02363946|449131514|FG005|Overall Study|Lost to Follow-up|0|||
124866324|NCT02363946|449131515|FG006|Overall Study|Lost to Follow-up|0|||
124866325|NCT02363946|449131516|FG007|Overall Study|Lost to Follow-up|1|||
124866326|NCT02363946|449131517|FG008|Overall Study|Lost to Follow-up|0|||
124866327|NCT02363946|449131518|FG009|Overall Study|Lost to Follow-up|0|||
124866328|NCT02363946|449131519|FG010|Overall Study|Lost to Follow-up|0|||
124866329|NCT02363946|449131520|FG011|Overall Study|Lost to Follow-up|0|||
124866330|NCT02363946|449131521|FG012|Overall Study|Lost to Follow-up|0|||
124866331|NCT00262821|449131522|FG000|Overall Study|Ineligible - wrong stage|0|||
124866332|NCT00262821|449131523|FG001|Overall Study|Ineligible - wrong stage|3|||
124866333|NCT00262821|449131522|FG000|Overall Study|Ineligible - wrong cell type|2|||
124866334|NCT00262821|449131523|FG001|Overall Study|Ineligible - wrong cell type|2|||
124866335|NCT00262821|449131522|FG000|Overall Study|Ineligible - wrong primary|0|||
124866336|NCT00262821|449131523|FG001|Overall Study|Ineligible - wrong primary|1|||
124866337|NCT00262821|449131522|FG000|Overall Study|Ineligible - inadequate pathology|1|||
124866338|NCT00262821|449131523|FG001|Overall Study|Ineligible - inadequate pathology|3|||
124866339|NCT00262821|449131522|FG000|Overall Study|Ineligible - elevated creatinine|0|||
124866340|NCT00262821|449131523|FG001|Overall Study|Ineligible - elevated creatinine|2|||
124866341|NCT00262821|449131522|FG000|Overall Study|Ineligible - required test not done|1|||
124866342|NCT00262821|449131523|FG001|Overall Study|Ineligible - required test not done|4|||
124866343|NCT00262821|449131522|FG000|Overall Study|Inevaluable - inadequate data|0|||
124866344|NCT00262821|449131523|FG001|Overall Study|Inevaluable - inadequate data|4|||
124866345|NCT01988779|449131524|FG000|Overall Study|Withdrawal by Subject|2|||
124866346|NCT01988779|449131525|FG001|Overall Study|Withdrawal by Subject|2|||
124866347|NCT01988779|449131524|FG000|Overall Study|Protocol Violation|1|||
124866348|NCT01988779|449131525|FG001|Overall Study|Protocol Violation|0|||
124866349|NCT01041638|449131526|FG000|Overall Study|Adverse Event|4|||
124866350|NCT01041638|449131526|FG000|Overall Study|Death|1|||
124866351|NCT01041638|449131526|FG000|Overall Study|Lack of Efficacy|7|||
124866352|NCT01041638|449131526|FG000|Overall Study|Physician Decision|4|||
124866353|NCT01041638|449131526|FG000|Overall Study|Withdrawal by Subject|11|||
124866354|NCT01922076|449131530|FG000|Overall Study|Adverse Event|0|||
124866355|NCT01922076|449131531|FG001|Overall Study|Adverse Event|0|||
124976982|NCT00895895|449541945|FG001|Period 2|failed to return|0|||
124866356|NCT01922076|449131532|FG002|Overall Study|Adverse Event|0|||
124866357|NCT01922076|449131533|FG003|Overall Study|Adverse Event|0|||
124866358|NCT01922076|449131534|FG004|Overall Study|Adverse Event|1|||
124866359|NCT01922076|449131535|FG005|Overall Study|Adverse Event|0|||
124866360|NCT01922076|449131536|FG006|Overall Study|Adverse Event|0|||
124866361|NCT01922076|449131530|FG000|Overall Study|Physician Decision|0|||
124866362|NCT01922076|449131531|FG001|Overall Study|Physician Decision|0|||
124866363|NCT01922076|449131532|FG002|Overall Study|Physician Decision|1|||
124866364|NCT01922076|449131533|FG003|Overall Study|Physician Decision|0|||
124866365|NCT01922076|449131534|FG004|Overall Study|Physician Decision|0|||
124866366|NCT01922076|449131535|FG005|Overall Study|Physician Decision|0|||
124866367|NCT01922076|449131536|FG006|Overall Study|Physician Decision|0|||
124866368|NCT01922076|449131530|FG000|Overall Study|Withdrawal by Subject|0|||
124866369|NCT01922076|449131531|FG001|Overall Study|Withdrawal by Subject|0|||
124866370|NCT01922076|449131532|FG002|Overall Study|Withdrawal by Subject|0|||
124866371|NCT01922076|449131533|FG003|Overall Study|Withdrawal by Subject|1|||
124866372|NCT01922076|449131534|FG004|Overall Study|Withdrawal by Subject|0|||
124866373|NCT01922076|449131535|FG005|Overall Study|Withdrawal by Subject|1|||
124866374|NCT01922076|449131536|FG006|Overall Study|Withdrawal by Subject|1|||
124866375|NCT04493216|449133474|FG000|Overall Study|Study terminated by sponsor|30|||
124866376|NCT04493216|449133475|FG001|Overall Study|Study terminated by sponsor|33|||
124866377|NCT04493216|449133476|FG002|Overall Study|Study terminated by sponsor|28|||
124866378|NCT04493216|449133477|FG003|Overall Study|Study terminated by sponsor|27|||
124976983|NCT00895895|449541946|FG002|Period 2|failed to return|0|||
124976984|NCT00895895|449541947|FG003|Period 2|failed to return|0|||
124976985|NCT00895895|449541948|FG004|Period 2|failed to return|0|||
124976986|NCT00895895|449541944|FG000|Period 2|investigator request|2|||
124976987|NCT00895895|449541945|FG001|Period 2|investigator request|0|||
124976988|NCT00895895|449541946|FG002|Period 2|investigator request|0|||
124976989|NCT00895895|449541947|FG003|Period 2|investigator request|0|||
124976990|NCT00895895|449541948|FG004|Period 2|investigator request|0|||
124976991|NCT00895895|449541944|FG000|Period 2|Lost to Follow-up|1|||
124976992|NCT00895895|449541945|FG001|Period 2|Lost to Follow-up|2|||
124976993|NCT00895895|449541946|FG002|Period 2|Lost to Follow-up|1|||
124976994|NCT00895895|449541947|FG003|Period 2|Lost to Follow-up|1|||
124976995|NCT00895895|449541948|FG004|Period 2|Lost to Follow-up|0|||
124976996|NCT00895895|449541944|FG000|Period 2|Other|1|||
124976997|NCT00895895|449541945|FG001|Period 2|Other|1|||
124976998|NCT00895895|449541946|FG002|Period 2|Other|3|||
124976999|NCT00895895|449541947|FG003|Period 2|Other|1|||
124977000|NCT00895895|449541948|FG004|Period 2|Other|1|||
124977001|NCT00895895|449541944|FG000|Period 2|Protocol Violation|1|||
124977002|NCT00895895|449541945|FG001|Period 2|Protocol Violation|0|||
124977003|NCT00895895|449541946|FG002|Period 2|Protocol Violation|1|||
124977004|NCT00895895|449541947|FG003|Period 2|Protocol Violation|1|||
124977005|NCT00895895|449541948|FG004|Period 2|Protocol Violation|1|||
124977006|NCT00895895|449541944|FG000|Period 2|Withdrawal by Subject|0|||
124977007|NCT00895895|449541945|FG001|Period 2|Withdrawal by Subject|2|||
124977008|NCT00895895|449541946|FG002|Period 2|Withdrawal by Subject|0|||
124977009|NCT00895895|449541947|FG003|Period 2|Withdrawal by Subject|3|||
124977010|NCT00895895|449541948|FG004|Period 2|Withdrawal by Subject|5|||
124977011|NCT00895895|449541944|FG000|Period 2|unsatisfactory response-efficacy|2|||
124977012|NCT00895895|449541945|FG001|Period 2|unsatisfactory response-efficacy|1|||
124533800|NCT01230827|447904293|FG003|Overall Study|Study terminated by Sponsor|63|||
124866379|NCT04493216|449133474|FG000|Overall Study|Withdrawal by Subject|2|||
124866380|NCT04493216|449133475|FG001|Overall Study|Withdrawal by Subject|1|||
124866381|NCT04493216|449133476|FG002|Overall Study|Withdrawal by Subject|1|||
124866382|NCT04493216|449133477|FG003|Overall Study|Withdrawal by Subject|2|||
124866383|NCT04493216|449133474|FG000|Overall Study|Protocol Violation|1|||
124866384|NCT04493216|449133475|FG001|Overall Study|Protocol Violation|2|||
124866385|NCT04493216|449133476|FG002|Overall Study|Protocol Violation|0|||
124866386|NCT04493216|449133477|FG003|Overall Study|Protocol Violation|2|||
124866387|NCT04493216|449133474|FG000|Overall Study|Physician Decision|0|||
124866388|NCT04493216|449133475|FG001|Overall Study|Physician Decision|0|||
124866389|NCT04493216|449133476|FG002|Overall Study|Physician Decision|1|||
124866390|NCT04493216|449133477|FG003|Overall Study|Physician Decision|0|||
124866391|NCT04493216|449133474|FG000|Overall Study|Lost to Follow-up|2|||
124866392|NCT04493216|449133475|FG001|Overall Study|Lost to Follow-up|1|||
124866393|NCT04493216|449133476|FG002|Overall Study|Lost to Follow-up|0|||
124866394|NCT04493216|449133477|FG003|Overall Study|Lost to Follow-up|1|||
124866395|NCT04493216|449133474|FG000|Overall Study|Adverse Event|1|||
124977013|NCT00895895|449541946|FG002|Period 2|unsatisfactory response-efficacy|0|||
124866396|NCT04493216|449133475|FG001|Overall Study|Adverse Event|4|||
124866397|NCT04493216|449133476|FG002|Overall Study|Adverse Event|5|||
124866398|NCT04493216|449133477|FG003|Overall Study|Adverse Event|2|||
124866399|NCT04493216|449133474|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
124977014|NCT00895895|449541947|FG003|Period 2|unsatisfactory response-efficacy|0|||
124977015|NCT00895895|449541948|FG004|Period 2|unsatisfactory response-efficacy|0|||
124977016|NCT01261000|449541949|FG000|Overall Study|Screen failure|1|||
124977017|NCT00504777|449541950|FG000|Overall Study|Adverse Event|1|||
124977018|NCT03552523|449541957|FG000|Overall Study|Withdrawal by Subject|1|||
124977019|NCT03552523|449541958|FG001|Overall Study|Withdrawal by Subject|1|||
124977020|NCT00755105|449541961|FG000|Overall Study|Withdrawal by Subject|9|||
124977021|NCT00755105|449541962|FG001|Overall Study|Withdrawal by Subject|11|||
124977022|NCT00755105|449541963|FG002|Overall Study|Withdrawal by Subject|4|||
124977023|NCT03995316|449541964|FG000|Overall Study|Lost to Follow-up|10|||
124977024|NCT03995316|449541965|FG001|Overall Study|Lost to Follow-up|3|||
124977025|NCT01250509|449541969|FG000|Overall Study|Lost to Follow-up|5|||
124977026|NCT01250509|449541970|FG001|Overall Study|Lost to Follow-up|2|||
124977027|NCT00203268|449541976|FG000|Early Treatment|only treated one headache|2|||
124977028|NCT00203268|449541976|FG000|Early Treatment|Lost to Follow-up|1|||
124977029|NCT00203268|449541976|FG000|Early Treatment|Withdrawal by Subject|1|||
124977030|NCT00600613|449541977|FG000|Overall Study|Protocol Deviation|1|||
124977031|NCT02807883|449541979|FG000|Overall Study|Withdrawal by Subject|2|||
124977032|NCT01399918|449541985|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
124977033|NCT05415748|449541988|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
124977034|NCT05415748|449541989|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
124977035|NCT05415748|449541990|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
124977036|NCT05415748|449541991|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
124977037|NCT05415748|449541988|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
124977038|NCT05415748|449541989|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
124977039|NCT05415748|449541990|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
124977040|NCT05415748|449541991|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
124977041|NCT04520659|449541992|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
124977042|NCT04520659|449541993|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
124977043|NCT04520659|449541994|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
124977044|NCT04520659|449541995|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
124977045|NCT03852719|449541996|FG000|Overall Study|Withdrawal of consent|8|||
124977046|NCT03852719|449541997|FG001|Overall Study|Withdrawal of consent|8|||
124977047|NCT03852719|449541998|FG002|Overall Study|Withdrawal of consent|9|||
124977048|NCT03852719|449541996|FG000|Overall Study|Physician Decision|5|||
124977049|NCT03852719|449541997|FG001|Overall Study|Physician Decision|4|||
124977050|NCT03852719|449541998|FG002|Overall Study|Physician Decision|1|||
124977051|NCT03852719|449541996|FG000|Overall Study|Pregnancy|2|||
124977052|NCT03852719|449541997|FG001|Overall Study|Pregnancy|1|||
124977053|NCT03852719|449541998|FG002|Overall Study|Pregnancy|0|||
124977054|NCT03852719|449541996|FG000|Overall Study|Death|1|||
124977055|NCT03852719|449541997|FG001|Overall Study|Death|0|||
124977056|NCT03852719|449541998|FG002|Overall Study|Death|0|||
124533801|NCT00805142|447904294|FG000|Titration Period|Adverse Event|3|||
124533802|NCT00805142|447904295|FG001|Titration Period|Adverse Event|3|||
124533803|NCT00805142|447904294|FG000|Titration Period|Lack of Efficacy|1|||
124533804|NCT00805142|447904295|FG001|Titration Period|Lack of Efficacy|1|||
124533805|NCT00805142|447904294|FG000|Titration Period|Lost to Follow-up|0|||
124533806|NCT00805142|447904295|FG001|Titration Period|Lost to Follow-up|1|||
124533807|NCT00805142|447904294|FG000|Titration Period|Disease Progression|2|||
124533808|NCT00805142|447904295|FG001|Titration Period|Disease Progression|1|||
124533809|NCT00805142|447904294|FG000|Titration Period|Withdrawal of consent|0|||
124533810|NCT00805142|447904295|FG001|Titration Period|Withdrawal of consent|1|||
124533811|NCT00805142|447904294|FG000|Titration Period|Other|0|||
124533812|NCT00805142|447904295|FG001|Titration Period|Other|3|||
124533813|NCT00805142|447904294|FG000|Maintenance Period|Adverse Event|0|||
124533814|NCT00805142|447904295|FG001|Maintenance Period|Adverse Event|1|||
124533815|NCT00805142|447904294|FG000|Maintenance Period|Other|0|||
124533816|NCT00805142|447904295|FG001|Maintenance Period|Other|1|||
124533817|NCT01021423|447904297|FG000|Overall Study|Study terminated|4|||
124533818|NCT01021423|447904298|FG001|Overall Study|Study terminated|5|||
124533819|NCT00394654|447904299|FG000|Overall Study|Lost to Follow-up|1|||
124533820|NCT00394654|447904300|FG001|Overall Study|Lost to Follow-up|0|||
124533821|NCT00394654|447904299|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
124533822|NCT00394654|447904300|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
124533823|NCT00122317|447904301|FG000|Overall Study|Death|3|||
124533824|NCT00122317|447904301|FG000|Overall Study|Adverse Event|4|||
124533825|NCT00122317|447904301|FG000|Overall Study|Physician Decision|2|||
124533826|NCT00122317|447904301|FG000|Overall Study|patient non-compliance|1|||
124533827|NCT00122317|447904301|FG000|Overall Study|Withdrawal by Subject|1|||
124533828|NCT02886338|447904302|FG000|Overall Study|Withdrawal by Subject|1|||
124533829|NCT03756285|447904304|FG000|Overall Study|Lost to Follow-up|0|||
124533830|NCT03756285|447904305|FG001|Overall Study|Lost to Follow-up|1|||
124533831|NCT03756285|447904304|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
124533832|NCT03756285|447904305|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
124533833|NCT03756285|447904304|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
124977057|NCT03852719|449541996|FG000|Overall Study|Reason not Specified|3|||
124533834|NCT03756285|447904305|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
124533835|NCT01021293|447904306|FG000|Overall Study|Serious Adverse Event|2|||
124977058|NCT03852719|449541997|FG001|Overall Study|Reason not Specified|3|||
124977059|NCT03852719|449541998|FG002|Overall Study|Reason not Specified|5|||
124977060|NCT03852719|449541996|FG000|Overall Study|Adverse Event|2|||
124977061|NCT03852719|449541997|FG001|Overall Study|Adverse Event|1|||
124977062|NCT03852719|449541998|FG002|Overall Study|Adverse Event|4|||
124977063|NCT03852719|449541996|FG000|Overall Study|Progressive disease|1|||
124977064|NCT03852719|449541997|FG001|Overall Study|Progressive disease|4|||
124977065|NCT03852719|449541998|FG002|Overall Study|Progressive disease|1|||
124977066|NCT03852719|449541996|FG000|Overall Study|Lost to Follow-up|1|||
124977067|NCT03852719|449541997|FG001|Overall Study|Lost to Follow-up|0|||
124977068|NCT03852719|449541998|FG002|Overall Study|Lost to Follow-up|0|||
124977069|NCT02819024|449541999|FG000|Overall Study|Withdrawal by Subject|1|||
124977070|NCT00792948|449542000|FG000|Overall Study|Adverse Event|6|||
124977071|NCT00792948|449542000|FG000|Overall Study|Death|4|||
124977072|NCT00792948|449542000|FG000|Overall Study|Withdrawal by Subject|3|||
124977073|NCT00792948|449542000|FG000|Overall Study|Ineligible|2|||
124977074|NCT00792948|449542000|FG000|Overall Study|Insurance denial - not treated|1|||
124977075|NCT00792948|449542000|FG000|Overall Study|Physician Decision|11|||
124977076|NCT00792948|449542000|FG000|Overall Study|Protocol Violation|1|||
124533836|NCT01021293|447904307|FG001|Overall Study|Serious Adverse Event|1|||
124533837|NCT01021293|447904306|FG000|Overall Study|Adverse Event|2|||
124533838|NCT01021293|447904307|FG001|Overall Study|Adverse Event|1|||
124533839|NCT01021293|447904306|FG000|Overall Study|Withdrawal by Subject|1|||
124533840|NCT01021293|447904307|FG001|Overall Study|Withdrawal by Subject|3|||
124533841|NCT01021293|447904306|FG000|Overall Study|Migrated/moved from study area|6|||
124533842|NCT01021293|447904307|FG001|Overall Study|Migrated/moved from study area|18|||
124533843|NCT01021293|447904306|FG000|Overall Study|Lost to Follow-up|1|||
124533844|NCT01021293|447904307|FG001|Overall Study|Lost to Follow-up|1|||
124533845|NCT02390167|447906536|FG000|Overall Study|Lost to Follow-up|1|||
124533846|NCT01084096|447906537|FG000|Overall Study|Lost to Follow-up|1501|||
124533847|NCT01084096|447906538|FG001|Overall Study|Lost to Follow-up|1833|||
124533848|NCT01084096|447906537|FG000|Overall Study|Withdrawal by Subject|3|||
124533849|NCT01084096|447906538|FG001|Overall Study|Withdrawal by Subject|0|||
124533850|NCT01084096|447906537|FG000|Overall Study|Woman had a miscarriage|21|||
124533851|NCT01084096|447906538|FG001|Overall Study|Woman had a miscarriage|17|||
124533852|NCT01354964|447906540|FG000|Overall Study|Lost to Follow-up|2|||
124533853|NCT01354964|447906541|FG001|Overall Study|Lost to Follow-up|0|||
124533854|NCT01354964|447906540|FG000|Overall Study|IV access issues|1|||
124533855|NCT01354964|447906541|FG001|Overall Study|IV access issues|1|||
124533856|NCT01354964|447906540|FG000|Overall Study|Physician Decision|1|||
124533857|NCT01354964|447906541|FG001|Overall Study|Physician Decision|0|||
124533858|NCT01265719|447906546|FG000|Overall Study|Does not meet entrance criteria|0|||
124533859|NCT01265719|447906547|FG001|Overall Study|Does not meet entrance criteria|3|||
124533860|NCT01265719|447906546|FG000|Overall Study|Other reasons|2|||
124533861|NCT01265719|447906547|FG001|Overall Study|Other reasons|0|||
124533862|NCT01265719|447906546|FG000|Overall Study|Withdrawal by Subject|8|||
124533863|NCT01265719|447906547|FG001|Overall Study|Withdrawal by Subject|3|||
124533864|NCT01265719|447906546|FG000|Overall Study|Lost to Follow-up|2|||
124533865|NCT01265719|447906547|FG001|Overall Study|Lost to Follow-up|7|||
124533866|NCT01265719|447906546|FG000|Overall Study|Adverse Event|2|||
124533867|NCT01265719|447906547|FG001|Overall Study|Adverse Event|0|||
124533868|NCT04335929|447906548|FG000|Overall Study|Lost to Follow-up|10|||
124533869|NCT05604781|447906553|FG000|Overall Study|Lost to Follow-up|3|||
124533870|NCT05604781|447906553|FG000|Overall Study|Adverse Event|1|||
124533871|NCT00303329|447906556|FG000|Overall Study|Adverse Event|7|||
124533872|NCT00303329|447906557|FG001|Overall Study|Adverse Event|14|||
124533873|NCT00303329|447906556|FG000|Overall Study|Abnormal Laboratory Values|0|||
124533874|NCT00303329|447906557|FG001|Overall Study|Abnormal Laboratory Values|1|||
124533875|NCT00303329|447906556|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
124533876|NCT00303329|447906557|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124533877|NCT00303329|447906556|FG000|Overall Study|Condition no longer requires study drug|0|||
124466357|NCT03445000|447666368|FG000|Overall Study|Adverse Event|3|||
124754825|NCT02487030|448724025|FG000|Overall Study|Lost to Follow-up|0|||
124754826|NCT02487030|448724026|FG001|Overall Study|Lost to Follow-up|0|||
124754827|NCT02487030|448724027|FG002|Overall Study|Lost to Follow-up|1|||
124754828|NCT02487030|448724028|FG003|Overall Study|Lost to Follow-up|1|||
124754829|NCT02487030|448724029|FG004|Overall Study|Lost to Follow-up|0|||
124754830|NCT02487030|448724030|FG005|Overall Study|Lost to Follow-up|1|||
124754831|NCT02487030|448724031|FG006|Overall Study|Lost to Follow-up|0|||
124866400|NCT04493216|449133475|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
124866401|NCT04493216|449133476|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
124866402|NCT04493216|449133477|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
124866403|NCT03643952|449133484|FG000|Overall Study|Lack of Efficacy|1|||
124866404|NCT01597050|449133485|FG000|Overall Study|Withdrawal by Subject|1|||
124754832|NCT02487030|448724025|FG000|Overall Study|Adverse Event|0|||
124754833|NCT02487030|448724026|FG001|Overall Study|Adverse Event|0|||
124754834|NCT02487030|448724027|FG002|Overall Study|Adverse Event|0|||
124754835|NCT02487030|448724028|FG003|Overall Study|Adverse Event|1|||
124754836|NCT02487030|448724029|FG004|Overall Study|Adverse Event|0|||
124533878|NCT00303329|447906557|FG001|Overall Study|Condition no longer requires study drug|8|||
124643870|NCT00378508|448313767|FG001|Overall Study|Lost to Follow-up|0|||
124643871|NCT01283334|448313768|FG000|Overall Study|Withdrawal by Subject|1|||
124643872|NCT01283334|448313768|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
124643873|NCT01283334|448313768|FG000|Overall Study|Adverse Event|4|||
124643874|NCT01283334|448313768|FG000|Overall Study|Physician Decision|1|||
124643875|NCT03467217|448313769|FG000|Overall Study|Trial stopped early|5|||
124643876|NCT03467217|448313770|FG001|Overall Study|Trial stopped early|2|||
124754837|NCT02487030|448724030|FG005|Overall Study|Adverse Event|0|||
124643877|NCT03467217|448313769|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
124643878|NCT03467217|448313770|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
124754838|NCT02487030|448724031|FG006|Overall Study|Adverse Event|0|||
124754839|NCT02487030|448724025|FG000|Overall Study|Death|0|||
124754840|NCT02487030|448724026|FG001|Overall Study|Death|0|||
124754841|NCT02487030|448724027|FG002|Overall Study|Death|0|||
124754842|NCT02487030|448724028|FG003|Overall Study|Death|0|||
124866405|NCT01597050|449133486|FG001|Overall Study|Withdrawal by Subject|0|||
124866406|NCT00483184|449133487|FG000|Overall Study|Withdrawal by Subject|2|||
124866407|NCT00483184|449133488|FG001|Overall Study|Withdrawal by Subject|2|||
124866408|NCT00483184|449133489|FG002|Overall Study|Withdrawal by Subject|0|||
124866409|NCT00483184|449133487|FG000|Overall Study|Lost to Follow-up|1|||
124866410|NCT00483184|449133488|FG001|Overall Study|Lost to Follow-up|0|||
124866411|NCT00483184|449133489|FG002|Overall Study|Lost to Follow-up|0|||
124866412|NCT00483184|449133487|FG000|Overall Study|Adverse Event|1|||
124866413|NCT00483184|449133488|FG001|Overall Study|Adverse Event|2|||
124866414|NCT00483184|449133489|FG002|Overall Study|Adverse Event|2|||
124977077|NCT03809039|449543723|FG000|Part 1|Withdrawal by Subject|1|||
124977078|NCT03809039|449543724|FG001|Part 1|Withdrawal by Subject|0|||
124977079|NCT03809039|449543725|FG002|Part 1|Withdrawal by Subject|0|||
124977080|NCT03809039|449543726|FG003|Part 1|Withdrawal by Subject|1|||
124643879|NCT03467217|448313769|FG000|Overall Study|Lost to Follow-up|0|||
124643880|NCT03467217|448313770|FG001|Overall Study|Lost to Follow-up|2|||
124643881|NCT03233529|448313774|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
124643882|NCT03233529|448313774|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
124643883|NCT01177293|448313775|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
124643884|NCT01177293|448313776|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
124643885|NCT00348595|448313777|FG000|Overall Study|Adverse Event|5|||
124643886|NCT00348595|448313778|FG001|Overall Study|Adverse Event|8|||
124643887|NCT03991299|448313781|FG000|Overall Study|Study closed, sponsor decision|3|||
124643888|NCT03991299|448313781|FG000|Overall Study|Withdrawal by Subject|1|||
124643889|NCT04304235|448313782|FG000|Overall Study|incomplete triage data|0|||
124643890|NCT04304235|448313783|FG001|Overall Study|incomplete triage data|69|||
124643891|NCT04304235|448313784|FG002|Overall Study|incomplete triage data|0|||
124643892|NCT04304235|448313785|FG003|Overall Study|incomplete triage data|0|||
124643893|NCT04304235|448313786|FG004|Overall Study|incomplete triage data|289|||
124643894|NCT04304235|448313787|FG005|Overall Study|incomplete triage data|123|||
124643895|NCT04304235|448313788|FG006|Overall Study|incomplete triage data|65|||
124643896|NCT01194999|448313796|FG000|Overall Study|Lost to Follow-up|17|||
124754843|NCT02487030|448724029|FG004|Overall Study|Death|1|||
124754844|NCT02487030|448724030|FG005|Overall Study|Death|0|||
124977081|NCT03809039|449543727|FG004|Part 1|Withdrawal by Subject|0|||
124977082|NCT03809039|449543728|FG005|Part 1|Withdrawal by Subject|0|||
124977083|NCT03809039|449543729|FG006|Part 1|Withdrawal by Subject|0|||
124977084|NCT03809039|449543730|FG007|Part 1|Withdrawal by Subject|0|||
124754845|NCT02487030|448724031|FG006|Overall Study|Death|0|||
124754846|NCT02092025|448724032|FG000|Overall Study|Case Report Forms Uncollected|44|||
124754847|NCT02092025|448724032|FG000|Overall Study|Protocol Deviation|24|||
124754848|NCT00264537|448724033|FG000|Overall Study|Death|0|||
124754849|NCT00264537|448724034|FG001|Overall Study|Death|3|||
124977085|NCT03809039|449543731|FG008|Part 1|Withdrawal by Subject|0|||
124977086|NCT03809039|449543723|FG000|Part 3|Withdrawn by study termination|0|||
124977087|NCT03809039|449543724|FG001|Part 3|Withdrawn by study termination|0|||
124977088|NCT03809039|449543725|FG002|Part 3|Withdrawn by study termination|0|||
124977089|NCT03809039|449543726|FG003|Part 3|Withdrawn by study termination|0|||
124977090|NCT03809039|449543727|FG004|Part 3|Withdrawn by study termination|0|||
124533879|NCT00303329|447906556|FG000|Overall Study|Protocol Violation|3|||
124533880|NCT00303329|447906557|FG001|Overall Study|Protocol Violation|0|||
124533881|NCT00303329|447906556|FG000|Overall Study|Withdrawal by Subject|9|||
124533882|NCT00303329|447906557|FG001|Overall Study|Withdrawal by Subject|15|||
124533883|NCT00303329|447906556|FG000|Overall Study|Lost to Follow-up|0|||
124533884|NCT00303329|447906557|FG001|Overall Study|Lost to Follow-up|1|||
124533885|NCT00303329|447906556|FG000|Overall Study|Administrative problems|1|||
124533886|NCT00303329|447906557|FG001|Overall Study|Administrative problems|0|||
124533887|NCT00303329|447906556|FG000|Overall Study|Death|2|||
124533888|NCT00303329|447906557|FG001|Overall Study|Death|12|||
124533889|NCT00303329|447906556|FG000|Overall Study|Stopped at end of core|3|||
124533890|NCT00303329|447906557|FG001|Overall Study|Stopped at end of core|9|||
124533891|NCT00303329|447906556|FG000|Overall Study|Stopped at end of extension 1|1|||
124533892|NCT00303329|447906557|FG001|Overall Study|Stopped at end of extension 1|0|||
124533893|NCT02408016|447906558|FG000|Overall Study|Death|6|||
124533894|NCT02408016|447906559|FG001|Overall Study|Death|1|||
124533895|NCT02408016|447906560|FG002|Overall Study|Death|0|||
124533896|NCT02408016|447906558|FG000|Overall Study|Physician Decision|0|||
124533897|NCT02408016|447906559|FG001|Overall Study|Physician Decision|2|||
124533898|NCT02408016|447906560|FG002|Overall Study|Physician Decision|0|||
124533899|NCT02967562|447906562|FG000|Overall Study|Consent not obtained|1|||
124533900|NCT02967562|447906563|FG001|Overall Study|Consent not obtained|0|||
124866415|NCT00483184|449133487|FG000|Overall Study|Protocol Violation|1|||
124866416|NCT00483184|449133488|FG001|Overall Study|Protocol Violation|0|||
124866417|NCT00483184|449133489|FG002|Overall Study|Protocol Violation|1|||
124866418|NCT00558428|449133490|FG000|Overall Study|Adverse Event|6|||
124866419|NCT00558428|449133491|FG001|Overall Study|Adverse Event|22|||
124866420|NCT00558428|449133492|FG002|Overall Study|Adverse Event|3|||
124866421|NCT00558428|449133493|FG003|Overall Study|Adverse Event|4|||
124866422|NCT00558428|449133490|FG000|Overall Study|Lost to Follow-up|0|||
124866423|NCT00558428|449133491|FG001|Overall Study|Lost to Follow-up|1|||
124866424|NCT00558428|449133492|FG002|Overall Study|Lost to Follow-up|0|||
124866425|NCT00558428|449133493|FG003|Overall Study|Lost to Follow-up|0|||
124866426|NCT00558428|449133490|FG000|Overall Study|Lack of Efficacy|0|||
124866427|NCT00558428|449133491|FG001|Overall Study|Lack of Efficacy|0|||
124866428|NCT00558428|449133492|FG002|Overall Study|Lack of Efficacy|1|||
124866429|NCT00558428|449133493|FG003|Overall Study|Lack of Efficacy|2|||
124533901|NCT02967562|447906562|FG000|Overall Study|High leak precluding analysis|1|||
124533902|NCT02967562|447906563|FG001|Overall Study|High leak precluding analysis|1|||
124533903|NCT00106626|447906564|FG000|Overall Study|Adverse Event|5|||
124533904|NCT00106626|447906565|FG001|Overall Study|Adverse Event|4|||
124533905|NCT00106626|447906566|FG002|Overall Study|Adverse Event|3|||
124533906|NCT00106626|447906567|FG003|Overall Study|Adverse Event|3|||
124866430|NCT00558428|449133490|FG000|Overall Study|Non compliant with protocol|1|||
124866431|NCT00558428|449133491|FG001|Overall Study|Non compliant with protocol|0|||
124866432|NCT00558428|449133492|FG002|Overall Study|Non compliant with protocol|0|||
124866433|NCT00558428|449133493|FG003|Overall Study|Non compliant with protocol|3|||
124866434|NCT00558428|449133490|FG000|Overall Study|Consent withdrawn|2|||
124866435|NCT00558428|449133491|FG001|Overall Study|Consent withdrawn|1|||
124533907|NCT00106626|447906564|FG000|Overall Study|Progressive Disease|4|||
124533908|NCT00106626|447906565|FG001|Overall Study|Progressive Disease|1|||
124866436|NCT00558428|449133492|FG002|Overall Study|Consent withdrawn|0|||
124866437|NCT00558428|449133493|FG003|Overall Study|Consent withdrawn|1|||
124866438|NCT00558428|449133490|FG000|Overall Study|Other|3|||
124866439|NCT00558428|449133491|FG001|Overall Study|Other|0|||
124866440|NCT00558428|449133492|FG002|Overall Study|Other|0|||
124866441|NCT00558428|449133493|FG003|Overall Study|Other|1|||
124866442|NCT05224050|449133494|FG000|Overall Study|Withdrawal by Subject|9|||
124866443|NCT05224050|449133494|FG000|Overall Study|Lost to Follow-up|3|||
124866444|NCT01292876|449133495|FG000|Overall Study|Physician Decision|4|||
124866445|NCT01627327|449133496|FG000|Overall Study|Adverse Event|6|||
124866446|NCT01627327|449133497|FG001|Overall Study|Adverse Event|12|||
124866447|NCT01627327|449133496|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
124533909|NCT00106626|447906566|FG002|Overall Study|Progressive Disease|9|||
124533910|NCT00106626|447906567|FG003|Overall Study|Progressive Disease|10|||
124533911|NCT00106626|447906564|FG000|Overall Study|Received radiation on new therapy|1|||
124533912|NCT00106626|447906565|FG001|Overall Study|Received radiation on new therapy|0|||
124533913|NCT00106626|447906566|FG002|Overall Study|Received radiation on new therapy|0|||
124866448|NCT01627327|449133497|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
124866449|NCT01627327|449133496|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
124866450|NCT01627327|449133497|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
124533914|NCT00106626|447906567|FG003|Overall Study|Received radiation on new therapy|0|||
124866451|NCT01627327|449133496|FG000|Overall Study|Protocol Violation|4|||
124866452|NCT01627327|449133497|FG001|Overall Study|Protocol Violation|10|||
124866453|NCT01627327|449133496|FG000|Overall Study|Lost to Follow-up|1|||
124866454|NCT01627327|449133497|FG001|Overall Study|Lost to Follow-up|3|||
124866455|NCT01627327|449133496|FG000|Overall Study|Physician Decision|1|||
124866456|NCT01627327|449133497|FG001|Overall Study|Physician Decision|0|||
124866457|NCT01627327|449133496|FG000|Overall Study|Withdrawal by Subject|3|||
124866458|NCT01627327|449133497|FG001|Overall Study|Withdrawal by Subject|3|||
124866459|NCT04528069|449133503|FG000|Overall Study|Adverse Event|1|||
124866460|NCT04528069|449133503|FG000|Overall Study|Lost to Follow-up|1|||
124866461|NCT04528069|449133503|FG000|Overall Study|Patient Unable to Come|1|||
124866462|NCT04528069|449133503|FG000|Overall Study|Patient Unable to Attend|1|||
124866463|NCT02525874|449133508|FG000|Overall Study|Other|1|||
124866464|NCT02525874|449133508|FG000|Overall Study|Investigator Decision|1|||
124866465|NCT02525874|449133508|FG000|Overall Study|Consent withdrawn|22|||
124866466|NCT02525874|449133508|FG000|Overall Study|Non-compliance with study drug|3|||
124866467|NCT02525874|449133508|FG000|Overall Study|Adverse Event|17|||
124866468|NCT02525874|449133508|FG000|Overall Study|Lost to Follow-up|7|||
124866469|NCT02525874|449133508|FG000|Overall Study|Disease progression, defined by protocol|2|||
124866470|NCT02525874|449133508|FG000|Overall Study|Disease relapse|4|||
124866471|NCT02525874|449133508|FG000|Overall Study|Alternative Treatment for MS|2|||
124866472|NCT02525874|449133508|FG000|Overall Study|New lesions in Brain|1|||
124866473|NCT01692782|449133509|FG000|Overall Study|Adverse Event|12|||
124866474|NCT01692782|449133510|FG001|Overall Study|Adverse Event|32|||
124866475|NCT01692782|449133511|FG002|Overall Study|Adverse Event|2|||
124866476|NCT01692782|449133509|FG000|Overall Study|Lack of Efficacy|1|||
124866477|NCT01692782|449133510|FG001|Overall Study|Lack of Efficacy|2|||
124866478|NCT01692782|449133511|FG002|Overall Study|Lack of Efficacy|0|||
124866479|NCT01692782|449133509|FG000|Overall Study|Lost to Follow-up|2|||
124866480|NCT01692782|449133510|FG001|Overall Study|Lost to Follow-up|7|||
124866481|NCT01692782|449133511|FG002|Overall Study|Lost to Follow-up|1|||
124866482|NCT01692782|449133509|FG000|Overall Study|Pregnancy|1|||
124866483|NCT01692782|449133510|FG001|Overall Study|Pregnancy|0|||
124866484|NCT01692782|449133511|FG002|Overall Study|Pregnancy|0|||
124866485|NCT01692782|449133509|FG000|Overall Study|Protocol Violation|1|||
124866486|NCT01692782|449133510|FG001|Overall Study|Protocol Violation|0|||
124866487|NCT01692782|449133511|FG002|Overall Study|Protocol Violation|2|||
124866488|NCT01692782|449133509|FG000|Overall Study|Non-complance with study drug|0|||
124866489|NCT01692782|449133510|FG001|Overall Study|Non-complance with study drug|4|||
124866490|NCT01692782|449133511|FG002|Overall Study|Non-complance with study drug|1|||
124533915|NCT00106626|447906564|FG000|Overall Study|> 14 day delay in therapy start|0|||
124533916|NCT00106626|447906565|FG001|Overall Study|> 14 day delay in therapy start|1|||
124533917|NCT00106626|447906566|FG002|Overall Study|> 14 day delay in therapy start|0|||
124533918|NCT00106626|447906567|FG003|Overall Study|> 14 day delay in therapy start|0|||
124533919|NCT02870348|447906572|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
124533920|NCT00672139|447906573|FG000|Overall Study|Death|14|||
124533921|NCT00672139|447906574|FG001|Overall Study|Death|23|||
124533922|NCT00672139|447906573|FG000|Overall Study|Withdrawal by Subject|2|||
124533923|NCT00672139|447906574|FG001|Overall Study|Withdrawal by Subject|11|||
124533924|NCT00672139|447906573|FG000|Overall Study|Adverse Event|4|||
124533925|NCT00672139|447906574|FG001|Overall Study|Adverse Event|7|||
124533926|NCT00672139|447906573|FG000|Overall Study|Physician Decision|2|||
124533927|NCT00672139|447906574|FG001|Overall Study|Physician Decision|0|||
124533928|NCT00672139|447906573|FG000|Overall Study|Lack of Efficacy|4|||
124533929|NCT00672139|447906574|FG001|Overall Study|Lack of Efficacy|1|||
124533930|NCT00672139|447906573|FG000|Overall Study|Protocol Violation|1|||
124533931|NCT00672139|447906574|FG001|Overall Study|Protocol Violation|1|||
124533932|NCT00672139|447906573|FG000|Overall Study|hospice discharge, caregiver requests|3|||
124533933|NCT00672139|447906574|FG001|Overall Study|hospice discharge, caregiver requests|2|||
124533934|NCT01038635|447906578|FG000|Overall Study|Disease Progression|2|||
124533935|NCT01038635|447906579|FG001|Overall Study|Disease Progression|0|||
124533936|NCT01038635|447906580|FG002|Overall Study|Disease Progression|0|||
124533937|NCT01038635|447906581|FG003|Overall Study|Disease Progression|0|||
124533938|NCT01038635|447906582|FG004|Overall Study|Disease Progression|0|||
124866491|NCT01692782|449133509|FG000|Overall Study|Non-compliant with study visits|0|||
124866492|NCT01692782|449133510|FG001|Overall Study|Non-compliant with study visits|0|||
124866493|NCT01692782|449133511|FG002|Overall Study|Non-compliant with study visits|1|||
124866494|NCT01692782|449133509|FG000|Overall Study|SAE not related to study drug|0|||
124533939|NCT01038635|447906583|FG005|Overall Study|Disease Progression|0|||
124533940|NCT01038635|447906584|FG006|Overall Study|Disease Progression|1|||
124533941|NCT01038635|447906585|FG007|Overall Study|Disease Progression|4|||
124866495|NCT01692782|449133510|FG001|Overall Study|SAE not related to study drug|1|||
124533942|NCT01038635|447906586|FG008|Overall Study|Disease Progression|0|||
124533943|NCT01038635|447906578|FG000|Overall Study|Death|0|||
124533944|NCT01038635|447906579|FG001|Overall Study|Death|0|||
124533945|NCT01038635|447906580|FG002|Overall Study|Death|0|||
124866496|NCT01692782|449133511|FG002|Overall Study|SAE not related to study drug|0|||
124866497|NCT01692782|449133509|FG000|Overall Study|Withdrawal by Subject|3|||
124866498|NCT01692782|449133510|FG001|Overall Study|Withdrawal by Subject|10|||
124754850|NCT00264537|448724035|FG002|Overall Study|Death|3|||
124754851|NCT00264537|448724036|FG003|Overall Study|Death|2|||
124754852|NCT00264537|448724033|FG000|Overall Study|Lost to Follow-up|3|||
124754853|NCT00264537|448724034|FG001|Overall Study|Lost to Follow-up|4|||
124754854|NCT00264537|448724035|FG002|Overall Study|Lost to Follow-up|7|||
124754855|NCT00264537|448724036|FG003|Overall Study|Lost to Follow-up|6|||
124754856|NCT00264537|448724033|FG000|Overall Study|Adverse Event|21|||
124754857|NCT00264537|448724034|FG001|Overall Study|Adverse Event|32|||
124754858|NCT00264537|448724035|FG002|Overall Study|Adverse Event|24|||
124754859|NCT00264537|448724036|FG003|Overall Study|Adverse Event|34|||
124754860|NCT00264537|448724033|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
124754861|NCT00264537|448724034|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
124754862|NCT00264537|448724035|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
124866499|NCT01692782|449133511|FG002|Overall Study|Withdrawal by Subject|3|||
124866500|NCT03252587|449133512|FG000|Overall Study|Adverse Event|3|||
124866501|NCT03252587|449133513|FG001|Overall Study|Adverse Event|8|||
124866502|NCT03252587|449133514|FG002|Overall Study|Adverse Event|6|||
124866503|NCT03252587|449133515|FG003|Overall Study|Adverse Event|12|||
124866504|NCT03252587|449133512|FG000|Overall Study|Lack of Efficacy|7|||
124866505|NCT03252587|449133513|FG001|Overall Study|Lack of Efficacy|2|||
124866506|NCT03252587|449133514|FG002|Overall Study|Lack of Efficacy|2|||
124754863|NCT00264537|448724036|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
124754864|NCT00264537|448724033|FG000|Overall Study|Other|21|||
124754865|NCT00264537|448724034|FG001|Overall Study|Other|11|||
124754866|NCT00264537|448724035|FG002|Overall Study|Other|10|||
124754867|NCT00264537|448724036|FG003|Overall Study|Other|11|||
124754868|NCT00264537|448724033|FG000|Overall Study|Not treated|0|||
124754869|NCT00264537|448724034|FG001|Overall Study|Not treated|2|||
124754870|NCT00264537|448724035|FG002|Overall Study|Not treated|1|||
124754871|NCT00264537|448724036|FG003|Overall Study|Not treated|0|||
124754872|NCT03228212|448724038|FG000|Period 1|Adverse Event|1|||
124866507|NCT03252587|449133515|FG003|Overall Study|Lack of Efficacy|4|||
124866508|NCT03252587|449133512|FG000|Overall Study|Lost to Follow-up|2|||
124866509|NCT03252587|449133513|FG001|Overall Study|Lost to Follow-up|0|||
124866510|NCT03252587|449133514|FG002|Overall Study|Lost to Follow-up|0|||
124866511|NCT03252587|449133515|FG003|Overall Study|Lost to Follow-up|2|||
124866512|NCT03252587|449133512|FG000|Overall Study|Pregnancy|2|||
124866513|NCT03252587|449133513|FG001|Overall Study|Pregnancy|1|||
124866514|NCT03252587|449133514|FG002|Overall Study|Pregnancy|0|||
124866515|NCT03252587|449133515|FG003|Overall Study|Pregnancy|1|||
124866516|NCT03252587|449133512|FG000|Overall Study|Withdrawal by Subject|8|||
124866517|NCT03252587|449133513|FG001|Overall Study|Withdrawal by Subject|4|||
124866518|NCT03252587|449133514|FG002|Overall Study|Withdrawal by Subject|4|||
124866519|NCT03252587|449133515|FG003|Overall Study|Withdrawal by Subject|4|||
124866520|NCT03252587|449133512|FG000|Overall Study|Other Reasons|2|||
124866521|NCT03252587|449133513|FG001|Overall Study|Other Reasons|5|||
124866522|NCT03252587|449133514|FG002|Overall Study|Other Reasons|5|||
124866523|NCT03252587|449133515|FG003|Overall Study|Other Reasons|4|||
124866524|NCT04052204|449133516|FG000|Overall Study|Death|1|||
124866525|NCT04052204|449133517|FG001|Overall Study|Death|0|||
124866526|NCT04052204|449133518|FG002|Overall Study|Death|0|||
124866527|NCT04052204|449133516|FG000|Overall Study|Progressive disease|1|||
124866528|NCT04052204|449133517|FG001|Overall Study|Progressive disease|0|||
124866529|NCT04052204|449133518|FG002|Overall Study|Progressive disease|0|||
124866530|NCT04052204|449133516|FG000|Overall Study|Other|1|||
124866531|NCT04052204|449133517|FG001|Overall Study|Other|0|||
124866532|NCT04052204|449133518|FG002|Overall Study|Other|0|||
124866533|NCT03945188|449133524|FG000|Overall Study|Protocol Violation|1|||
124866534|NCT03945188|449133525|FG001|Overall Study|Protocol Violation|0|||
124866535|NCT03945188|449133524|FG000|Overall Study|Disease worsening|79|||
124866536|NCT03945188|449133525|FG001|Overall Study|Disease worsening|73|||
124866537|NCT03945188|449133524|FG000|Overall Study|Physician Decision|2|||
124866538|NCT03945188|449133525|FG001|Overall Study|Physician Decision|2|||
124866539|NCT03945188|449133524|FG000|Overall Study|Lack of Efficacy|7|||
124866540|NCT03945188|449133525|FG001|Overall Study|Lack of Efficacy|4|||
124866541|NCT03945188|449133524|FG000|Overall Study|Pregnancy|2|||
124866542|NCT03945188|449133525|FG001|Overall Study|Pregnancy|0|||
124866543|NCT03945188|449133524|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
124866544|NCT03945188|449133525|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
124754873|NCT03228212|448724039|FG001|Period 1|Adverse Event|0|||
124754874|NCT03228212|448724038|FG000|Period 1|no longer meets eligibility criteria|0|||
124754875|NCT03228212|448724039|FG001|Period 1|no longer meets eligibility criteria|1|||
124754876|NCT03228212|448724038|FG000|Period 2|Lost to Follow-up|1|||
124754877|NCT03228212|448724039|FG001|Period 2|Lost to Follow-up|0|||
124754878|NCT01807299|448724040|FG000|Overall Study|Protocol Violation|3|||
124754879|NCT01807299|448724041|FG001|Overall Study|Protocol Violation|1|||
124754880|NCT01807299|448724042|FG002|Overall Study|Protocol Violation|0|||
124866545|NCT03945188|449133524|FG000|Overall Study|Adverse Event|10|||
124866546|NCT03945188|449133525|FG001|Overall Study|Adverse Event|5|||
124866547|NCT03945188|449133524|FG000|Overall Study|Other|2|||
124866548|NCT03945188|449133525|FG001|Overall Study|Other|2|||
124754881|NCT01807299|448724043|FG003|Overall Study|Protocol Violation|2|||
124866549|NCT03945188|449133524|FG000|Overall Study|Lost to Follow-up|1|||
124866550|NCT03945188|449133525|FG001|Overall Study|Lost to Follow-up|2|||
124866551|NCT02807558|449133551|FG000|Overall Study|Consent withdrawn by participant|4|||
124866552|NCT02807558|449133552|FG001|Overall Study|Consent withdrawn by participant|0|||
124866553|NCT02807558|449133553|FG002|Overall Study|Consent withdrawn by participant|4|||
124866554|NCT02807558|449133554|FG003|Overall Study|Consent withdrawn by participant|2|||
124866555|NCT02807558|449133555|FG004|Overall Study|Consent withdrawn by participant|1|||
124866556|NCT02807558|449133556|FG005|Overall Study|Consent withdrawn by participant|0|||
124866557|NCT02807558|449133551|FG000|Overall Study|Non-compliance with Study Drug|0|||
124866558|NCT02807558|449133552|FG001|Overall Study|Non-compliance with Study Drug|0|||
124866559|NCT02807558|449133553|FG002|Overall Study|Non-compliance with Study Drug|1|||
124866560|NCT02807558|449133554|FG003|Overall Study|Non-compliance with Study Drug|0|||
124866561|NCT02807558|449133555|FG004|Overall Study|Non-compliance with Study Drug|0|||
124866562|NCT02807558|449133556|FG005|Overall Study|Non-compliance with Study Drug|0|||
124866563|NCT02807558|449133551|FG000|Overall Study|Adverse Event|0|||
124866564|NCT02807558|449133552|FG001|Overall Study|Adverse Event|0|||
124866565|NCT02807558|449133553|FG002|Overall Study|Adverse Event|9|||
124866566|NCT02807558|449133554|FG003|Overall Study|Adverse Event|0|||
124866567|NCT02807558|449133555|FG004|Overall Study|Adverse Event|0|||
124866568|NCT02807558|449133556|FG005|Overall Study|Adverse Event|0|||
124866569|NCT02807558|449133551|FG000|Overall Study|Death|23|||
124866570|NCT02807558|449133552|FG001|Overall Study|Death|2|||
124866571|NCT02807558|449133553|FG002|Overall Study|Death|3|||
124866572|NCT02807558|449133554|FG003|Overall Study|Death|43|||
124866573|NCT02807558|449133555|FG004|Overall Study|Death|24|||
124866574|NCT02807558|449133556|FG005|Overall Study|Death|15|||
124866575|NCT02807558|449133551|FG000|Overall Study|Progressive Disease|0|||
124866576|NCT02807558|449133552|FG001|Overall Study|Progressive Disease|0|||
124866577|NCT02807558|449133553|FG002|Overall Study|Progressive Disease|1|||
124866578|NCT02807558|449133554|FG003|Overall Study|Progressive Disease|0|||
124866579|NCT02807558|449133555|FG004|Overall Study|Progressive Disease|0|||
124866580|NCT02807558|449133556|FG005|Overall Study|Progressive Disease|0|||
124866581|NCT02807558|449133551|FG000|Overall Study|Other than specified|1|||
124866582|NCT02807558|449133552|FG001|Overall Study|Other than specified|0|||
124866583|NCT02807558|449133553|FG002|Overall Study|Other than specified|2|||
124866584|NCT02807558|449133554|FG003|Overall Study|Other than specified|0|||
124866585|NCT02807558|449133555|FG004|Overall Study|Other than specified|1|||
124866586|NCT02807558|449133556|FG005|Overall Study|Other than specified|1|||
124866587|NCT02807558|449133551|FG000|Overall Study|Lack of Efficacy|0|||
124866588|NCT02807558|449133552|FG001|Overall Study|Lack of Efficacy|0|||
124866589|NCT02807558|449133553|FG002|Overall Study|Lack of Efficacy|9|||
124866590|NCT02807558|449133554|FG003|Overall Study|Lack of Efficacy|0|||
124866591|NCT02807558|449133555|FG004|Overall Study|Lack of Efficacy|0|||
124866592|NCT02807558|449133556|FG005|Overall Study|Lack of Efficacy|0|||
124866593|NCT04575467|449133557|FG000|Overall Study|Adverse Event|0|||
124866594|NCT04575467|449133558|FG001|Overall Study|Adverse Event|1|||
124866595|NCT04575467|449133559|FG002|Overall Study|Adverse Event|0|||
124866596|NCT04575467|449133560|FG003|Overall Study|Adverse Event|0|||
124866597|NCT00003298|449133561|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
124866598|NCT00003298|449133561|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
124866599|NCT00003298|449133561|FG000|Surgery|Unresectable at surgery|3|||
124866600|NCT00003298|449133561|FG000|Surgery|Progression before surgery|2|||
124866601|NCT00003298|449133561|FG000|Surgery|Unevaluable and off study|2|||
124866602|NCT00003298|449133561|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
124866603|NCT00003298|449133561|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
124866604|NCT00003298|449133561|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
124866605|NCT00003298|449133561|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
124866606|NCT00003298|449133561|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
124866607|NCT00003298|449133561|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
124866608|NCT00003298|449133561|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
124866609|NCT00003298|449133561|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
124866610|NCT00003298|449133561|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
124866611|NCT00003298|449133561|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
124866612|NCT03565887|449133566|FG000|Overall Study|Adverse Event|1|||
124866613|NCT03565887|449133567|FG001|Overall Study|Adverse Event|0|||
124866614|NCT03565887|449133566|FG000|Overall Study|Withdrawal by Subject|0|||
124866615|NCT03565887|449133567|FG001|Overall Study|Withdrawal by Subject|2|||
124866616|NCT01454583|449133568|FG000|1st Year|Lost to Follow-up|1057|||
124866617|NCT01454583|449133569|FG001|1st Year|Lost to Follow-up|318|||
124866618|NCT01454583|449133570|FG002|1st Year|Lost to Follow-up|180|||
124866619|NCT01454583|449133568|FG000|2nd Year|Lost to Follow-up|3965|||
124866620|NCT01454583|449133569|FG001|2nd Year|Lost to Follow-up|1049|||
124866621|NCT01454583|449133570|FG002|2nd Year|Lost to Follow-up|737|||
124866622|NCT01454583|449133568|FG000|3rd Year|Lost to Follow-up|1959|||
124866623|NCT01454583|449133569|FG001|3rd Year|Lost to Follow-up|512|||
124866624|NCT01454583|449133570|FG002|3rd Year|Lost to Follow-up|297|||
124866625|NCT02677116|449133573|FG000|Overall Study|Adverse Event|0|||
124866626|NCT02677116|449133574|FG001|Overall Study|Adverse Event|1|||
124866627|NCT02677116|449133575|FG002|Overall Study|Adverse Event|0|||
124866628|NCT02677116|449133576|FG003|Overall Study|Adverse Event|0|||
124866629|NCT02677116|449133577|FG004|Overall Study|Adverse Event|0|||
124866630|NCT02677116|449133578|FG005|Overall Study|Adverse Event|1|||
124866631|NCT02677116|449133579|FG006|Overall Study|Adverse Event|1|||
124866632|NCT02677116|449133580|FG007|Overall Study|Adverse Event|0|||
124866633|NCT02677116|449133581|FG008|Overall Study|Adverse Event|0|||
124866634|NCT02677116|449133573|FG000|Overall Study|Physician Decision|0|||
124866635|NCT02677116|449133574|FG001|Overall Study|Physician Decision|2|||
124866636|NCT02677116|449133575|FG002|Overall Study|Physician Decision|3|||
124866637|NCT02677116|449133576|FG003|Overall Study|Physician Decision|2|||
124866638|NCT02677116|449133577|FG004|Overall Study|Physician Decision|1|||
124866639|NCT02677116|449133578|FG005|Overall Study|Physician Decision|3|||
124866640|NCT02677116|449133579|FG006|Overall Study|Physician Decision|1|||
124866641|NCT02677116|449133580|FG007|Overall Study|Physician Decision|1|||
124866642|NCT02677116|449133581|FG008|Overall Study|Physician Decision|2|||
124866643|NCT02677116|449133573|FG000|Overall Study|Withdrawal by parent or guardian|2|||
124866644|NCT02677116|449133574|FG001|Overall Study|Withdrawal by parent or guardian|1|||
124866645|NCT02677116|449133575|FG002|Overall Study|Withdrawal by parent or guardian|0|||
124866646|NCT02677116|449133576|FG003|Overall Study|Withdrawal by parent or guardian|1|||
124866647|NCT02677116|449133577|FG004|Overall Study|Withdrawal by parent or guardian|0|||
124866648|NCT02677116|449133578|FG005|Overall Study|Withdrawal by parent or guardian|0|||
124866649|NCT02677116|449133579|FG006|Overall Study|Withdrawal by parent or guardian|2|||
124866650|NCT02677116|449133580|FG007|Overall Study|Withdrawal by parent or guardian|1|||
124866651|NCT02677116|449133581|FG008|Overall Study|Withdrawal by parent or guardian|0|||
124866652|NCT02677116|449133573|FG000|Overall Study|Withdrawal by Subject|1|||
124866653|NCT02677116|449133574|FG001|Overall Study|Withdrawal by Subject|0|||
124866654|NCT02677116|449133575|FG002|Overall Study|Withdrawal by Subject|0|||
124866655|NCT02677116|449133576|FG003|Overall Study|Withdrawal by Subject|0|||
124866656|NCT02677116|449133577|FG004|Overall Study|Withdrawal by Subject|0|||
124866657|NCT02677116|449133578|FG005|Overall Study|Withdrawal by Subject|0|||
124866658|NCT02677116|449133579|FG006|Overall Study|Withdrawal by Subject|0|||
124866659|NCT02677116|449133580|FG007|Overall Study|Withdrawal by Subject|0|||
124866660|NCT02677116|449133581|FG008|Overall Study|Withdrawal by Subject|0|||
124866661|NCT03182868|449133582|FG000|Overall Study|Protocol Violation|3|||
124866662|NCT03182868|449133583|FG001|Overall Study|Protocol Violation|0|||
124866663|NCT03182868|449133584|FG002|Overall Study|Protocol Violation|4|||
124866664|NCT03182868|449133585|FG003|Overall Study|Protocol Violation|1|||
124866665|NCT03182868|449133586|FG004|Overall Study|Protocol Violation|8|||
124866666|NCT01967732|449133587|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
124866667|NCT01967732|449133588|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
124866668|NCT01967732|449133589|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
124866669|NCT01967732|449133590|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
124866670|NCT01967732|449133587|FG000|First Intervention (Day 1)|Poor venous access|0|||
124866671|NCT01967732|449133588|FG001|First Intervention (Day 1)|Poor venous access|1|||
124866672|NCT01967732|449133589|FG002|First Intervention (Day 1)|Poor venous access|0|||
124866673|NCT01967732|449133590|FG003|First Intervention (Day 1)|Poor venous access|0|||
124866674|NCT03342638|449133591|FG000|Overall Study|Withdrawal by Subject|1|||
124866675|NCT03342638|449133592|FG001|Overall Study|Withdrawal by Subject|0|||
124866676|NCT03342638|449133591|FG000|Overall Study|Physician Decision|0|||
124866677|NCT03342638|449133592|FG001|Overall Study|Physician Decision|1|||
124866678|NCT01292239|449133608|FG000|Overall Study|Other|1|||
124866679|NCT01292239|449133609|FG001|Overall Study|Other|1|||
124866680|NCT01292239|449133608|FG000|Overall Study|Withdrawal by Subject|3|||
124866681|NCT01292239|449133609|FG001|Overall Study|Withdrawal by Subject|6|||
124866682|NCT00113568|449133610|FG000|Overall Study|Adverse Event|97|||
124866683|NCT00113568|449133610|FG000|Overall Study|Death|1|||
124866684|NCT00113568|449133610|FG000|Overall Study|Lack of Efficacy|30|||
124866685|NCT00113568|449133610|FG000|Overall Study|Lost to Follow-up|156|||
124866686|NCT00113568|449133610|FG000|Overall Study|Protocol Violation|32|||
124866687|NCT00113568|449133610|FG000|Overall Study|Withdrawal by Subject|117|||
124866688|NCT00113568|449133610|FG000|Overall Study|Other|112|||
124866689|NCT00584727|449133612|FG000|First Intervention|Discontinuation|0|||
124866690|NCT00584727|449133613|FG001|First Intervention|Discontinuation|0|||
124866691|NCT00584727|449133614|FG002|First Intervention|Discontinuation|1|||
124866692|NCT00584727|449133615|FG003|First Intervention|Discontinuation|0|||
124866693|NCT00584727|449133616|FG004|First Intervention|Discontinuation|0|||
124866694|NCT00584727|449133617|FG005|First Intervention|Discontinuation|0|||
124866695|NCT00584727|449133612|FG000|Third Intervention|Protocol Violation|0|||
124866696|NCT00584727|449133613|FG001|Third Intervention|Protocol Violation|0|||
124866697|NCT00584727|449133614|FG002|Third Intervention|Protocol Violation|1|||
124866698|NCT00584727|449133615|FG003|Third Intervention|Protocol Violation|0|||
124866699|NCT00584727|449133616|FG004|Third Intervention|Protocol Violation|4|||
124866700|NCT00584727|449133617|FG005|Third Intervention|Protocol Violation|2|||
124866701|NCT00377403|449133619|FG000|Overall Study|Unable to contact for telephone intervie|4|||
124866702|NCT00377403|449133620|FG001|Overall Study|Unable to contact for telephone intervie|7|||
124866703|NCT01687257|449133621|FG000|Overall Study|Efficacy Failure|6|||
124866704|NCT01687257|449133622|FG001|Overall Study|Efficacy Failure|0|||
124866705|NCT01687257|449133623|FG002|Overall Study|Efficacy Failure|5|||
124866706|NCT01687257|449133621|FG000|Overall Study|Subject Withdrew Consent|1|||
124866707|NCT01687257|449133622|FG001|Overall Study|Subject Withdrew Consent|1|||
124866708|NCT01687257|449133623|FG002|Overall Study|Subject Withdrew Consent|1|||
124866709|NCT01687257|449133621|FG000|Overall Study|Adverse Event|1|||
124866710|NCT01687257|449133622|FG001|Overall Study|Adverse Event|0|||
124866711|NCT01687257|449133623|FG002|Overall Study|Adverse Event|0|||
124866712|NCT01687257|449133621|FG000|Overall Study|Investigator's Discretion|0|||
124866713|NCT01687257|449133622|FG001|Overall Study|Investigator's Discretion|3|||
124866714|NCT01687257|449133623|FG002|Overall Study|Investigator's Discretion|0|||
124866715|NCT00736645|449133625|FG000|Overall Study|Adverse Event|0|||
124866716|NCT00736645|449133626|FG001|Overall Study|Adverse Event|2|||
124866717|NCT00736645|449133627|FG002|Overall Study|Adverse Event|0|||
124866718|NCT00736645|449133628|FG003|Overall Study|Adverse Event|0|||
124866719|NCT00295022|449133629|FG000|Overall Study|Adverse Event|1|||
124866720|NCT00295022|449133630|FG001|Overall Study|Adverse Event|1|||
124866721|NCT00295022|449133631|FG002|Overall Study|Adverse Event|2|||
124866722|NCT00295022|449133629|FG000|Overall Study|Lost to Follow-up|0|||
124866723|NCT00295022|449133630|FG001|Overall Study|Lost to Follow-up|0|||
124866724|NCT00295022|449133631|FG002|Overall Study|Lost to Follow-up|1|||
124866725|NCT00295022|449133629|FG000|Overall Study|Withdrawal by Subject|0|||
124866726|NCT00295022|449133630|FG001|Overall Study|Withdrawal by Subject|0|||
124866727|NCT00295022|449133631|FG002|Overall Study|Withdrawal by Subject|2|||
124866728|NCT00734630|449133632|FG000|Overall Study|Lack of Efficacy|4|||
124866729|NCT00734630|449133633|FG001|Overall Study|Lack of Efficacy|4|||
124866730|NCT00734630|449133632|FG000|Overall Study|Withdrawal by Subject|7|||
124866731|NCT00734630|449133633|FG001|Overall Study|Withdrawal by Subject|9|||
124866732|NCT00734630|449133632|FG000|Overall Study|Lost to Follow-up|13|||
124866733|NCT00734630|449133633|FG001|Overall Study|Lost to Follow-up|7|||
124866734|NCT00734630|449133632|FG000|Overall Study|Protocol Violation|0|||
124866735|NCT00734630|449133633|FG001|Overall Study|Protocol Violation|3|||
124643897|NCT05835011|448313797|FG000|Overall Study|Study Terminated by the Sponsor|1|||
124643898|NCT05835011|448313797|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
124643899|NCT04720911|448313802|FG000|Overall Study|Withdrawal by Subject|0|||
124643900|NCT04720911|448313803|FG001|Overall Study|Withdrawal by Subject|1|||
124643901|NCT04720911|448313804|FG002|Overall Study|Withdrawal by Subject|0|||
124643902|NCT00090220|448313805|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
124643903|NCT00090220|448313806|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
124643904|NCT00090220|448313807|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
124643905|NCT00090220|448313808|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
124643906|NCT00090220|448313809|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
124643907|NCT00090220|448313810|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
124643908|NCT00090220|448313805|FG000|Base Study Vaccination Period|Adverse Event|6|||
124643909|NCT00090220|448313806|FG001|Base Study Vaccination Period|Adverse Event|1|||
124643910|NCT00090220|448313807|FG002|Base Study Vaccination Period|Adverse Event|0|||
124643911|NCT00090220|448313808|FG003|Base Study Vaccination Period|Adverse Event|0|||
124643912|NCT00090220|448313809|FG004|Base Study Vaccination Period|Adverse Event|0|||
124643913|NCT00090220|448313810|FG005|Base Study Vaccination Period|Adverse Event|0|||
124643914|NCT00090220|448313805|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
124643915|NCT00090220|448313806|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
124643916|NCT00090220|448313807|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
124643917|NCT00090220|448313808|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
124643918|NCT00090220|448313809|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
124533946|NCT01038635|447906581|FG003|Overall Study|Death|0|||
124533947|NCT01038635|447906582|FG004|Overall Study|Death|1|||
124643919|NCT00090220|448313810|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
124643920|NCT00090220|448313805|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
124643921|NCT00090220|448313806|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
124643922|NCT00090220|448313807|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
124866736|NCT00734630|449133632|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
124866737|NCT00734630|449133633|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
124866738|NCT00734630|449133632|FG000|Overall Study|Adverse Event|3|||
124866739|NCT00734630|449133633|FG001|Overall Study|Adverse Event|6|||
124866740|NCT00734630|449133632|FG000|Overall Study|Randomized in Error|0|||
124866741|NCT00734630|449133633|FG001|Overall Study|Randomized in Error|1|||
124866742|NCT00734630|449133632|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
124866743|NCT00734630|449133633|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
124866744|NCT00734630|449133632|FG000|Overall Study|Poor Compliance|1|||
124866745|NCT00734630|449133633|FG001|Overall Study|Poor Compliance|1|||
124866746|NCT01018394|449133636|FG000|Overall Study|Withdrawal by Subject|5|||
124866747|NCT01018394|449133637|FG001|Overall Study|Withdrawal by Subject|5|||
124866748|NCT01018394|449133636|FG000|Overall Study|Lost to Follow-up|4|||
124533948|NCT01038635|447906583|FG005|Overall Study|Death|0|||
124533949|NCT01038635|447906584|FG006|Overall Study|Death|1|||
124533950|NCT01038635|447906585|FG007|Overall Study|Death|1|||
124533951|NCT01038635|447906586|FG008|Overall Study|Death|2|||
124533952|NCT01034709|447906587|FG000|Overall Study|Protocol Violation|9|||
124533953|NCT01034709|447906588|FG001|Overall Study|Protocol Violation|16|||
124533954|NCT01562327|447906591|FG000|Overall Study|Adverse Event|2|||
124533955|NCT01562327|447906591|FG000|Overall Study|Lack of Efficacy|1|||
124533956|NCT01562327|447906591|FG000|Overall Study|Participant drop-out|1|||
124533957|NCT01562327|447906591|FG000|Overall Study|Infusion not received at 6 month window|4|||
124533958|NCT03018340|447906592|FG000|Overall Study|Adverse Event|1|||
124533959|NCT03018340|447906593|FG001|Overall Study|Adverse Event|2|||
124533960|NCT03018340|447906592|FG000|Overall Study|Withdrawal by Subject|0|||
124533961|NCT03018340|447906593|FG001|Overall Study|Withdrawal by Subject|8|||
124533962|NCT03018340|447906592|FG000|Overall Study|Lack of Efficacy|0|||
124533963|NCT03018340|447906593|FG001|Overall Study|Lack of Efficacy|1|||
124533964|NCT03018340|447906592|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
124533965|NCT03018340|447906593|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
124533966|NCT03018340|447906592|FG000|Overall Study|Lost to Follow-up|1|||
124533967|NCT03018340|447906593|FG001|Overall Study|Lost to Follow-up|7|||
124533968|NCT03018340|447906592|FG000|Overall Study|Protocol Violation|3|||
124533969|NCT03018340|447906593|FG001|Overall Study|Protocol Violation|7|||
124533970|NCT03018340|447906592|FG000|Overall Study|Not further specified|0|||
124533971|NCT03018340|447906593|FG001|Overall Study|Not further specified|1|||
124533972|NCT01195636|447906598|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
124533973|NCT01195636|447906599|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
124533974|NCT01195636|447906598|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
124533975|NCT01195636|447906599|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
124533976|NCT01195636|447906598|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
124533977|NCT01195636|447906599|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
124533978|NCT01195636|447906598|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
124533979|NCT01195636|447906599|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
124533980|NCT01195636|447906598|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
124533981|NCT01195636|447906599|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
124533982|NCT01195636|447906598|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
124533983|NCT01195636|447906599|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
124533984|NCT01195636|447906598|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
124533985|NCT01195636|447906599|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
124533986|NCT01195636|447906598|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
124533987|NCT01195636|447906599|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
124533988|NCT00203294|447906600|FG000|Overall Study|Withdrawal by Subject|8|||
124533989|NCT00203294|447906601|FG001|Overall Study|Withdrawal by Subject|13|||
124533990|NCT00256204|447906602|FG000|Overall Study|Adverse Event|10|||
124866749|NCT01018394|449133637|FG001|Overall Study|Lost to Follow-up|3|||
124866750|NCT03240692|449133638|FG000|Overall Study|Physician Decision|1|||
124866751|NCT03240692|449133638|FG000|Overall Study|Withdrawal by Subject|1|||
124866752|NCT00683644|449133639|FG000|Overall Study|Withdrawal by Subject|4|||
124866753|NCT00683644|449133640|FG001|Overall Study|Withdrawal by Subject|2|||
124866754|NCT00683644|449133639|FG000|Overall Study|Lost to Follow-up|1|||
124866755|NCT00683644|449133640|FG001|Overall Study|Lost to Follow-up|4|||
124866756|NCT00683644|449133639|FG000|Overall Study|Adverse Event|1|||
124866757|NCT00683644|449133640|FG001|Overall Study|Adverse Event|2|||
124866758|NCT00683644|449133639|FG000|Overall Study|Low copper, other health problems,|7|||
124866759|NCT00683644|449133640|FG001|Overall Study|Low copper, other health problems,|6|||
124866760|NCT04123067|449133642|FG000|Overall Study|Lost to Follow-up|0|||
124866761|NCT04123067|449133643|FG001|Overall Study|Lost to Follow-up|1|||
124866762|NCT00127101|449133644|FG000|Base Protocol|Adverse Event|0|||
124866763|NCT00127101|449133645|FG001|Base Protocol|Adverse Event|2|||
124866764|NCT00127101|449133646|FG002|Base Protocol|Adverse Event|1|||
124866765|NCT00127101|449133647|FG003|Base Protocol|Adverse Event|0|||
124977091|NCT03809039|449543728|FG005|Part 3|Withdrawn by study termination|0|||
124977092|NCT03809039|449543729|FG006|Part 3|Withdrawn by study termination|0|||
124977093|NCT03809039|449543730|FG007|Part 3|Withdrawn by study termination|2|||
124977094|NCT03809039|449543731|FG008|Part 3|Withdrawn by study termination|6|||
124977095|NCT01252355|449543732|FG000|Overall Study|Adverse Event|9|||
124977096|NCT01252355|449543733|FG001|Overall Study|Adverse Event|17|||
124977097|NCT01252355|449543734|FG002|Overall Study|Adverse Event|22|||
124977098|NCT01252355|449543732|FG000|Overall Study|Lack of Efficacy|6|||
124977099|NCT01252355|449543733|FG001|Overall Study|Lack of Efficacy|4|||
124977100|NCT01252355|449543734|FG002|Overall Study|Lack of Efficacy|2|||
124977101|NCT01252355|449543732|FG000|Overall Study|Lost to Follow-up|0|||
124977102|NCT01252355|449543733|FG001|Overall Study|Lost to Follow-up|0|||
124977103|NCT01252355|449543734|FG002|Overall Study|Lost to Follow-up|1|||
124533991|NCT00256204|447906603|FG001|Overall Study|Adverse Event|14|||
124533992|NCT00256204|447906604|FG002|Overall Study|Adverse Event|16|||
124533993|NCT00256204|447906605|FG003|Overall Study|Adverse Event|14|||
124533994|NCT00256204|447906602|FG000|Overall Study|Death|0|||
124533995|NCT00256204|447906603|FG001|Overall Study|Death|1|||
124533996|NCT00256204|447906604|FG002|Overall Study|Death|0|||
124533997|NCT00256204|447906605|FG003|Overall Study|Death|0|||
124533998|NCT00256204|447906602|FG000|Overall Study|Lost to Follow-up|1|||
124533999|NCT00256204|447906603|FG001|Overall Study|Lost to Follow-up|1|||
124534000|NCT00256204|447906604|FG002|Overall Study|Lost to Follow-up|1|||
124534001|NCT00256204|447906605|FG003|Overall Study|Lost to Follow-up|2|||
124534002|NCT00256204|447906602|FG000|Overall Study|Protocol Violation|1|||
124534003|NCT00256204|447906603|FG001|Overall Study|Protocol Violation|0|||
124534004|NCT00256204|447906604|FG002|Overall Study|Protocol Violation|2|||
124534005|NCT00256204|447906605|FG003|Overall Study|Protocol Violation|1|||
124534006|NCT00256204|447906602|FG000|Overall Study|Physician Decision|0|||
124534007|NCT00256204|447906603|FG001|Overall Study|Physician Decision|0|||
124534008|NCT00256204|447906604|FG002|Overall Study|Physician Decision|1|||
124534009|NCT00256204|447906605|FG003|Overall Study|Physician Decision|2|||
124534010|NCT00256204|447906602|FG000|Overall Study|Withdrawal by Subject|17|||
124534011|NCT00256204|447906603|FG001|Overall Study|Withdrawal by Subject|6|||
124534012|NCT00256204|447906604|FG002|Overall Study|Withdrawal by Subject|7|||
124534013|NCT00256204|447906605|FG003|Overall Study|Withdrawal by Subject|5|||
124534014|NCT00256204|447906602|FG000|Overall Study|Need for additional prohibited treatment|38|||
124534015|NCT00256204|447906603|FG001|Overall Study|Need for additional prohibited treatment|28|||
124534016|NCT00256204|447906604|FG002|Overall Study|Need for additional prohibited treatment|27|||
124534017|NCT00256204|447906605|FG003|Overall Study|Need for additional prohibited treatment|25|||
124534018|NCT00808132|447906608|FG000|Overall Study|Adverse Event|34|||
124534019|NCT00808132|447906609|FG001|Overall Study|Adverse Event|33|||
124534020|NCT00808132|447906610|FG002|Overall Study|Adverse Event|16|||
124534021|NCT00808132|447906611|FG003|Overall Study|Adverse Event|31|||
124534022|NCT00808132|447906612|FG004|Overall Study|Adverse Event|33|||
124534023|NCT00808132|447906608|FG000|Overall Study|Death|0|||
124534024|NCT00808132|447906609|FG001|Overall Study|Death|0|||
124534025|NCT00808132|447906610|FG002|Overall Study|Death|0|||
124534026|NCT00808132|447906611|FG003|Overall Study|Death|0|||
124534027|NCT00808132|447906612|FG004|Overall Study|Death|1|||
124534028|NCT00808132|447906608|FG000|Overall Study|Physician Decision|0|||
124534029|NCT00808132|447906609|FG001|Overall Study|Physician Decision|1|||
124534030|NCT00808132|447906610|FG002|Overall Study|Physician Decision|0|||
124534031|NCT00808132|447906611|FG003|Overall Study|Physician Decision|0|||
124534032|NCT00808132|447906612|FG004|Overall Study|Physician Decision|0|||
124534033|NCT00808132|447906608|FG000|Overall Study|Lost to Follow-up|8|||
124534034|NCT00808132|447906609|FG001|Overall Study|Lost to Follow-up|10|||
124534035|NCT00808132|447906610|FG002|Overall Study|Lost to Follow-up|11|||
124534036|NCT00808132|447906611|FG003|Overall Study|Lost to Follow-up|8|||
124534037|NCT00808132|447906612|FG004|Overall Study|Lost to Follow-up|9|||
124534038|NCT00808132|447906608|FG000|Overall Study|Protocol Violation|8|||
124534039|NCT00808132|447906609|FG001|Overall Study|Protocol Violation|9|||
124534040|NCT00808132|447906610|FG002|Overall Study|Protocol Violation|4|||
124534041|NCT00808132|447906611|FG003|Overall Study|Protocol Violation|9|||
124534042|NCT00808132|447906612|FG004|Overall Study|Protocol Violation|5|||
124534043|NCT00808132|447906608|FG000|Overall Study|Withdrawal by Subject|27|||
124534044|NCT00808132|447906609|FG001|Overall Study|Withdrawal by Subject|18|||
124534045|NCT00808132|447906610|FG002|Overall Study|Withdrawal by Subject|2|||
124534046|NCT00808132|447906611|FG003|Overall Study|Withdrawal by Subject|7|||
124534047|NCT00808132|447906612|FG004|Overall Study|Withdrawal by Subject|16|||
124534048|NCT00808132|447906608|FG000|Overall Study|Other|6|||
124534049|NCT00808132|447906609|FG001|Overall Study|Other|4|||
124534050|NCT00808132|447906610|FG002|Overall Study|Other|6|||
124534051|NCT00808132|447906611|FG003|Overall Study|Other|2|||
124534052|NCT00808132|447906612|FG004|Overall Study|Other|15|||
124534053|NCT00808132|447906608|FG000|Overall Study|Randomized, but not treated|10|||
124534054|NCT00808132|447906609|FG001|Overall Study|Randomized, but not treated|7|||
124534055|NCT00808132|447906610|FG002|Overall Study|Randomized, but not treated|9|||
124534056|NCT00808132|447906611|FG003|Overall Study|Randomized, but not treated|8|||
124534057|NCT00808132|447906612|FG004|Overall Study|Randomized, but not treated|9|||
124534058|NCT00808132|447906608|FG000|Overall Study|Unsatisfactory response|5|||
124534059|NCT00808132|447906609|FG001|Overall Study|Unsatisfactory response|6|||
124534060|NCT00808132|447906610|FG002|Overall Study|Unsatisfactory response|6|||
124534061|NCT00808132|447906611|FG003|Overall Study|Unsatisfactory response|4|||
124534062|NCT00808132|447906612|FG004|Overall Study|Unsatisfactory response|12|||
124534063|NCT00550615|447906613|FG000|Overall Study|Withdrawal by Subject|0|||
124534064|NCT00550615|447906614|FG001|Overall Study|Withdrawal by Subject|0|||
124534065|NCT00550615|447906615|FG002|Overall Study|Withdrawal by Subject|2|||
124534066|NCT00550615|447906616|FG003|Overall Study|Withdrawal by Subject|3|||
124534067|NCT00550615|447906613|FG000|Overall Study|Not evaluable|0|||
124534068|NCT00550615|447906614|FG001|Overall Study|Not evaluable|0|||
124534069|NCT00550615|447906615|FG002|Overall Study|Not evaluable|2|||
124534070|NCT00550615|447906616|FG003|Overall Study|Not evaluable|7|||
124534071|NCT02405091|447906617|FG000|Overall Study|Adverse Event|16|||
124534072|NCT02405091|447906618|FG001|Overall Study|Adverse Event|10|||
124534073|NCT02405091|447906619|FG002|Overall Study|Adverse Event|0|||
124534074|NCT02405091|447906617|FG000|Overall Study|Protocol Violation|1|||
124534075|NCT02405091|447906618|FG001|Overall Study|Protocol Violation|0|||
124534076|NCT02405091|447906619|FG002|Overall Study|Protocol Violation|0|||
124534077|NCT02405091|447906617|FG000|Overall Study|Noncompliance|1|||
124534078|NCT02405091|447906618|FG001|Overall Study|Noncompliance|6|||
124534079|NCT02405091|447906619|FG002|Overall Study|Noncompliance|2|||
124534080|NCT02405091|447906617|FG000|Overall Study|Withdrawal by Subject|4|||
124977104|NCT01252355|449543732|FG000|Overall Study|Poor Compliance to Protocol|1|||
124977105|NCT01252355|449543733|FG001|Overall Study|Poor Compliance to Protocol|1|||
124977106|NCT01252355|449543734|FG002|Overall Study|Poor Compliance to Protocol|1|||
124977107|NCT01252355|449543732|FG000|Overall Study|Progressive Disease|2|||
124977108|NCT01252355|449543733|FG001|Overall Study|Progressive Disease|0|||
124977109|NCT01252355|449543734|FG002|Overall Study|Progressive Disease|0|||
124977110|NCT01252355|449543732|FG000|Overall Study|Sponsor Early Termination of Study|149|||
124977111|NCT01252355|449543733|FG001|Overall Study|Sponsor Early Termination of Study|149|||
124977112|NCT01252355|449543734|FG002|Overall Study|Sponsor Early Termination of Study|146|||
124977113|NCT01252355|449543732|FG000|Overall Study|Randomized but not Treated|2|||
124977114|NCT01252355|449543733|FG001|Overall Study|Randomized but not Treated|0|||
124977115|NCT01252355|449543734|FG002|Overall Study|Randomized but not Treated|0|||
124977116|NCT01252355|449543732|FG000|Overall Study|Other Than Above|8|||
124977117|NCT01252355|449543733|FG001|Overall Study|Other Than Above|7|||
124977118|NCT01252355|449543734|FG002|Overall Study|Other Than Above|7|||
124977119|NCT02224703|449543742|FG000|Overall Study|Adverse Event|0|||
124977120|NCT02224703|449543743|FG001|Overall Study|Adverse Event|5|||
124977121|NCT02224703|449543744|FG002|Overall Study|Adverse Event|0|||
124977122|NCT02224703|449543742|FG000|Overall Study|Withdrawn by investigator|1|||
124977123|NCT02224703|449543743|FG001|Overall Study|Withdrawn by investigator|0|||
124977124|NCT02224703|449543744|FG002|Overall Study|Withdrawn by investigator|0|||
124977125|NCT02224703|449543742|FG000|Overall Study|Advised by medical monitor|1|||
124977126|NCT02224703|449543743|FG001|Overall Study|Advised by medical monitor|0|||
124977127|NCT02224703|449543744|FG002|Overall Study|Advised by medical monitor|0|||
124977128|NCT02224703|449543742|FG000|Overall Study|Withdrawn by parent/guardian|0|||
124977129|NCT02224703|449543743|FG001|Overall Study|Withdrawn by parent/guardian|1|||
124977130|NCT02224703|449543744|FG002|Overall Study|Withdrawn by parent/guardian|0|||
124977131|NCT02224703|449543742|FG000|Overall Study|Lack of Efficacy|1|||
124977132|NCT02224703|449543743|FG001|Overall Study|Lack of Efficacy|0|||
124977133|NCT02224703|449543744|FG002|Overall Study|Lack of Efficacy|0|||
124977134|NCT02922023|449543745|FG000|Overall Study|Lost to Follow-up|2|||
124977135|NCT02922023|449543746|FG001|Overall Study|Lost to Follow-up|0|||
124977136|NCT00863681|449543747|FG000|Overall Study|Other|2|||
124977137|NCT00863681|449543748|FG001|Overall Study|Other|0|||
124977138|NCT00863681|449543749|FG002|Overall Study|Other|0|||
124977139|NCT00863681|449543747|FG000|Overall Study|Missing|1|||
124977140|NCT00863681|449543748|FG001|Overall Study|Missing|0|||
124977141|NCT00863681|449543749|FG002|Overall Study|Missing|0|||
124977142|NCT00863681|449543747|FG000|Overall Study|Death|40|||
124977143|NCT00863681|449543748|FG001|Overall Study|Death|23|||
124977144|NCT00863681|449543749|FG002|Overall Study|Death|6|||
124977145|NCT00863681|449543747|FG000|Overall Study|Withdrawal by Subject|12|||
124977146|NCT00863681|449543748|FG001|Overall Study|Withdrawal by Subject|5|||
124977147|NCT00863681|449543749|FG002|Overall Study|Withdrawal by Subject|2|||
124534081|NCT02405091|447906618|FG001|Overall Study|Withdrawal by Subject|8|||
124534082|NCT02405091|447906619|FG002|Overall Study|Withdrawal by Subject|0|||
124534083|NCT02405091|447906617|FG000|Overall Study|Death|0|||
124534084|NCT02405091|447906618|FG001|Overall Study|Death|1|||
124534085|NCT02405091|447906619|FG002|Overall Study|Death|0|||
124534086|NCT02405091|447906617|FG000|Overall Study|Lost to Follow-up|5|||
124534087|NCT02405091|447906618|FG001|Overall Study|Lost to Follow-up|6|||
124643923|NCT00090220|448313808|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
124977148|NCT00863681|449543747|FG000|Overall Study|Protocol Violation|2|||
124977149|NCT00863681|449543748|FG001|Overall Study|Protocol Violation|0|||
124977150|NCT00863681|449543749|FG002|Overall Study|Protocol Violation|0|||
124977151|NCT00863681|449543747|FG000|Overall Study|Lost to Follow-up|3|||
124977152|NCT00863681|449543748|FG001|Overall Study|Lost to Follow-up|0|||
124977153|NCT00863681|449543749|FG002|Overall Study|Lost to Follow-up|3|||
124977154|NCT00863681|449543747|FG000|Overall Study|Adverse Event|28|||
124977155|NCT00863681|449543748|FG001|Overall Study|Adverse Event|10|||
124977156|NCT00863681|449543749|FG002|Overall Study|Adverse Event|6|||
124977157|NCT00863681|449543747|FG000|Overall Study|Lack of Efficacy|2|||
124977158|NCT00863681|449543748|FG001|Overall Study|Lack of Efficacy|2|||
124977159|NCT00863681|449543749|FG002|Overall Study|Lack of Efficacy|1|||
124977160|NCT00863681|449543747|FG000|Overall Study|Non-compliance with study drug|1|||
124977161|NCT00863681|449543748|FG001|Overall Study|Non-compliance with study drug|3|||
124977162|NCT00863681|449543749|FG002|Overall Study|Non-compliance with study drug|0|||
124977163|NCT03031496|449543750|FG000|Period 1|Adverse Event|2|||
124977164|NCT03031496|449543751|FG001|Period 1|Adverse Event|0|||
124534088|NCT02405091|447906619|FG002|Overall Study|Lost to Follow-up|0|||
124534089|NCT02405091|447906617|FG000|Overall Study|Physician Decision|2|||
124534090|NCT02405091|447906618|FG001|Overall Study|Physician Decision|2|||
124534091|NCT02405091|447906619|FG002|Overall Study|Physician Decision|0|||
124534092|NCT00247962|447906639|FG000|Overall Study|Adverse Event|15|||
124534093|NCT00247962|447906640|FG001|Overall Study|Adverse Event|12|||
124534094|NCT00247962|447906639|FG000|Overall Study|Lost to Follow-up|3|||
124534095|NCT00247962|447906640|FG001|Overall Study|Lost to Follow-up|1|||
124534096|NCT00247962|447906639|FG000|Overall Study|Physician Decision|0|||
124534097|NCT00247962|447906640|FG001|Overall Study|Physician Decision|1|||
124534098|NCT00247962|447906639|FG000|Overall Study|Protocol Violation|1|||
124534099|NCT00247962|447906640|FG001|Overall Study|Protocol Violation|1|||
124534100|NCT00247962|447906639|FG000|Overall Study|Withdrawal by Subject|3|||
124534101|NCT00247962|447906640|FG001|Overall Study|Withdrawal by Subject|2|||
124534102|NCT00247962|447906639|FG000|Overall Study|Lack of Efficacy|4|||
124534103|NCT00247962|447906640|FG001|Overall Study|Lack of Efficacy|2|||
124534104|NCT01955005|447906641|FG000|Overall Study|Withdrawal by Subject|3|||
124534105|NCT01955005|447906642|FG001|Overall Study|Withdrawal by Subject|5|||
124977165|NCT03031496|449543750|FG000|Period 1|Withdrawal by Subject|0|||
124977166|NCT03031496|449543751|FG001|Period 1|Withdrawal by Subject|2|||
124977167|NCT02766777|449543757|FG000|Overall Study|Adverse Event|12|||
124977168|NCT02766777|449543757|FG000|Overall Study|Lost to Follow-up|16|||
124977169|NCT02766777|449543757|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124977170|NCT02766777|449543757|FG000|Overall Study|Protocol Violation|1|||
124977171|NCT02766777|449543757|FG000|Overall Study|Withdrawal by Subject|4|||
124977172|NCT01886287|449543758|FG000|Overall Study|Radiographic disease progression|1|||
124977173|NCT01886287|449543758|FG000|Overall Study|Clinical progression due to disease|1|||
124977174|NCT03596762|449543759|FG000|Overall Study|Protocol Violation|0|||
124977175|NCT03596762|449543760|FG001|Overall Study|Protocol Violation|0|||
124977176|NCT03596762|449543761|FG002|Overall Study|Protocol Violation|0|||
124977177|NCT03596762|449543762|FG003|Overall Study|Protocol Violation|0|||
124977178|NCT03596762|449543763|FG004|Overall Study|Protocol Violation|1|||
124977179|NCT03596762|449543759|FG000|Overall Study|Adverse Event|2|||
124977180|NCT03596762|449543760|FG001|Overall Study|Adverse Event|0|||
124977181|NCT03596762|449543761|FG002|Overall Study|Adverse Event|1|||
124977182|NCT03596762|449543762|FG003|Overall Study|Adverse Event|0|||
124977183|NCT03596762|449543763|FG004|Overall Study|Adverse Event|5|||
124977184|NCT03596762|449543759|FG000|Overall Study|Withdrawal by Subject|2|||
124977185|NCT03596762|449543760|FG001|Overall Study|Withdrawal by Subject|1|||
124977186|NCT03596762|449543761|FG002|Overall Study|Withdrawal by Subject|0|||
124977187|NCT03596762|449543762|FG003|Overall Study|Withdrawal by Subject|1|||
124977188|NCT03596762|449543763|FG004|Overall Study|Withdrawal by Subject|1|||
124977189|NCT01263509|449543764|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
124977190|NCT01263509|449543765|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
124977191|NCT01263509|449543766|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
124977192|NCT01263509|449543767|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
124977193|NCT01263509|449543764|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
124977194|NCT01263509|449543765|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
124977195|NCT01263509|449543766|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
124977196|NCT01263509|449543767|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
124977197|NCT01263509|449543764|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
124977198|NCT01263509|449543765|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
124977199|NCT01263509|449543766|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
124977200|NCT01263509|449543767|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
124977201|NCT01263509|449543764|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
124977202|NCT01263509|449543765|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
124977203|NCT01263509|449543766|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124977204|NCT01263509|449543767|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124977205|NCT01263509|449543764|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
124977206|NCT01263509|449543765|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
124977207|NCT01263509|449543766|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
124977208|NCT01263509|449543767|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
124977209|NCT02593123|449543768|FG000|Overall Study|Physician Decision|2|||
124977210|NCT02593123|449543769|FG001|Overall Study|Physician Decision|1|||
124977211|NCT02593123|449543768|FG000|Overall Study|Relapse|1|||
124977212|NCT02593123|449543769|FG001|Overall Study|Relapse|1|||
124977213|NCT02440425|449543770|FG000|Overall Study|Death likely due to disease progression|1|||
124977214|NCT02440425|449543770|FG000|Overall Study|Withdrawal by Subject|2|||
124977215|NCT02440425|449543770|FG000|Overall Study|Adverse Event|1|||
124534106|NCT02555722|447906647|FG000|Week 2|Adverse Event|0|||
124534107|NCT02555722|447906648|FG001|Week 2|Adverse Event|1|||
124534108|NCT02555722|447906647|FG000|Week 2|Withdrawal by Subject|1|||
124534109|NCT02555722|447906648|FG001|Week 2|Withdrawal by Subject|0|||
124534110|NCT02555722|447906647|FG000|Month 1|Lens Discomfort|1|||
124977216|NCT02440425|449543770|FG000|Overall Study|Adverse Event/Ineligible|1|||
124977217|NCT02807272|449543771|FG000|Overall Study|Death|9|||
124977218|NCT02807272|449543772|FG001|Overall Study|Death|5|||
124977219|NCT02807272|449543773|FG002|Overall Study|Death|2|||
124977220|NCT02807272|449543774|FG003|Overall Study|Death|0|||
124977221|NCT02807272|449543775|FG004|Overall Study|Death|1|||
124977222|NCT02807272|449543771|FG000|Overall Study|Lost to Follow-up|1|||
124977223|NCT02807272|449543772|FG001|Overall Study|Lost to Follow-up|0|||
124977224|NCT02807272|449543773|FG002|Overall Study|Lost to Follow-up|0|||
124977225|NCT02807272|449543774|FG003|Overall Study|Lost to Follow-up|0|||
124977226|NCT02807272|449543775|FG004|Overall Study|Lost to Follow-up|0|||
124977227|NCT02807272|449543771|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
124977228|NCT02807272|449543772|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
124977229|NCT02807272|449543773|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
124977230|NCT02807272|449543774|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
124977231|NCT02807272|449543775|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
124977232|NCT02807272|449543771|FG000|Overall Study|Protocol-defined Disease Progression|0|||
124977233|NCT02807272|449543772|FG001|Overall Study|Protocol-defined Disease Progression|1|||
124977234|NCT02807272|449543773|FG002|Overall Study|Protocol-defined Disease Progression|0|||
124977235|NCT02807272|449543774|FG003|Overall Study|Protocol-defined Disease Progression|0|||
124977236|NCT02807272|449543775|FG004|Overall Study|Protocol-defined Disease Progression|1|||
124977237|NCT02807272|449543771|FG000|Overall Study|Study Terminated by Sponsor|1|||
124977238|NCT02807272|449543772|FG001|Overall Study|Study Terminated by Sponsor|0|||
124977239|NCT02807272|449543773|FG002|Overall Study|Study Terminated by Sponsor|0|||
124977240|NCT02807272|449543774|FG003|Overall Study|Study Terminated by Sponsor|1|||
124977241|NCT02807272|449543775|FG004|Overall Study|Study Terminated by Sponsor|0|||
124977242|NCT02807272|449543771|FG000|Overall Study|Other|1|||
124977243|NCT02807272|449543772|FG001|Overall Study|Other|0|||
124977244|NCT02807272|449543773|FG002|Overall Study|Other|0|||
124977245|NCT02807272|449543774|FG003|Overall Study|Other|0|||
124977246|NCT02807272|449543775|FG004|Overall Study|Other|1|||
124977247|NCT01038427|449543776|FG000|Overall Study|Lost to follow up|1|||
124977248|NCT01038427|449543777|FG001|Overall Study|Lost to follow up|1|||
124977249|NCT01038427|449543778|FG002|Overall Study|Lost to follow up|0|||
124977250|NCT01038427|449543776|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
124977251|NCT01038427|449543777|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
124977252|NCT01038427|449543778|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
124977253|NCT01038427|449543776|FG000|Overall Study|Withdrew consent|0|||
124977254|NCT01038427|449543777|FG001|Overall Study|Withdrew consent|0|||
124977255|NCT01038427|449543778|FG002|Overall Study|Withdrew consent|1|||
124977256|NCT01038427|449543776|FG000|Overall Study|Adverse Event|2|||
124977257|NCT01038427|449543777|FG001|Overall Study|Adverse Event|2|||
124977258|NCT01038427|449543778|FG002|Overall Study|Adverse Event|1|||
124977259|NCT01038427|449543776|FG000|Overall Study|Enrolled in error|0|||
124977260|NCT01038427|449543777|FG001|Overall Study|Enrolled in error|1|||
124977261|NCT01038427|449543778|FG002|Overall Study|Enrolled in error|1|||
124977262|NCT01038427|449543776|FG000|Overall Study|Other|0|||
124977263|NCT01038427|449543777|FG001|Overall Study|Other|2|||
124977264|NCT01038427|449543778|FG002|Overall Study|Other|0|||
124977265|NCT01162863|449543779|FG000|Overall Study|Lack of Efficacy|1|||
124977266|NCT01162863|449543780|FG001|Overall Study|Lack of Efficacy|0|||
124977267|NCT01162863|449543781|FG002|Overall Study|Lack of Efficacy|0|||
124977268|NCT01162863|449543779|FG000|Overall Study|Adverse Event|0|||
124977269|NCT01162863|449543780|FG001|Overall Study|Adverse Event|1|||
124977270|NCT01162863|449543781|FG002|Overall Study|Adverse Event|0|||
124977271|NCT00588692|449543782|FG000|Overall Study|Withdrawal by Subject|4|||
124977272|NCT00588692|449543783|FG001|Overall Study|Withdrawal by Subject|2|||
124977273|NCT00588692|449543782|FG000|Overall Study|Hip Surgery|0|||
124977274|NCT00588692|449543783|FG001|Overall Study|Hip Surgery|1|||
124977275|NCT00588692|449543782|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
124977276|NCT00588692|449543783|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
124977277|NCT00588692|449543782|FG000|Overall Study|Cancer|1|||
124977278|NCT00588692|449543783|FG001|Overall Study|Cancer|0|||
124977279|NCT00588692|449543782|FG000|Overall Study|Death|1|||
124977280|NCT00588692|449543783|FG001|Overall Study|Death|0|||
124977281|NCT01374568|449543784|FG000|Overall Study|Lab unable to analyze BTM|0|||
124977282|NCT01374568|449543785|FG001|Overall Study|Lab unable to analyze BTM|2|||
124977283|NCT01912404|449543786|FG000|Overall Study|Due to personal reasons|1|||
124977284|NCT01912404|449543787|FG001|Overall Study|Due to personal reasons|0|||
124534111|NCT02555722|447906648|FG001|Month 1|Lens Discomfort|0|||
124977285|NCT00820170|449543789|FG000|Overall Study|Adverse Event|0|||
124977286|NCT00820170|449543790|FG001|Overall Study|Adverse Event|0|||
124977287|NCT00820170|449543791|FG002|Overall Study|Adverse Event|0|||
124977288|NCT00820170|449543792|FG003|Overall Study|Adverse Event|0|||
124977289|NCT00820170|449543793|FG004|Overall Study|Adverse Event|2|||
124977290|NCT00820170|449543789|FG000|Overall Study|Progressive Disease|0|||
124977291|NCT00820170|449543790|FG001|Overall Study|Progressive Disease|0|||
124977292|NCT00820170|449543791|FG002|Overall Study|Progressive Disease|0|||
124977293|NCT00820170|449543792|FG003|Overall Study|Progressive Disease|0|||
124977294|NCT00820170|449543793|FG004|Overall Study|Progressive Disease|2|||
124977295|NCT03538938|449543794|FG000|Overall Study|Death|0|||
124977296|NCT03538938|449543795|FG001|Overall Study|Death|0|||
124977297|NCT03538938|449543796|FG002|Overall Study|Death|2|||
124977298|NCT03538938|449543797|FG003|Overall Study|Death|0|||
124977299|NCT03538938|449543798|FG004|Overall Study|Death|0|||
124977300|NCT03538938|449543799|FG005|Overall Study|Death|1|||
124977301|NCT03538938|449543800|FG006|Overall Study|Death|0|||
124977302|NCT03538938|449543801|FG007|Overall Study|Death|1|||
124977303|NCT03538938|449543802|FG008|Overall Study|Death|1|||
124977304|NCT03538938|449543803|FG009|Overall Study|Death|1|||
124977305|NCT03538938|449543804|FG010|Overall Study|Death|0|||
124977306|NCT03538938|449543805|FG011|Overall Study|Death|0|||
124977307|NCT03538938|449543806|FG012|Overall Study|Death|1|||
124977308|NCT03538938|449543807|FG013|Overall Study|Death|1|||
124977309|NCT03538938|449543808|FG014|Overall Study|Death|0|||
124977310|NCT03538938|449543809|FG015|Overall Study|Death|1|||
124977311|NCT03538938|449543794|FG000|Overall Study|Withdrawal by Subject|4|||
124977312|NCT03538938|449543795|FG001|Overall Study|Withdrawal by Subject|6|||
124977313|NCT03538938|449543796|FG002|Overall Study|Withdrawal by Subject|5|||
124977314|NCT03538938|449543797|FG003|Overall Study|Withdrawal by Subject|3|||
124977315|NCT03538938|449543798|FG004|Overall Study|Withdrawal by Subject|0|||
124977316|NCT03538938|449543799|FG005|Overall Study|Withdrawal by Subject|0|||
124977317|NCT03538938|449543800|FG006|Overall Study|Withdrawal by Subject|3|||
124977318|NCT03538938|449543801|FG007|Overall Study|Withdrawal by Subject|1|||
124977319|NCT03538938|449543802|FG008|Overall Study|Withdrawal by Subject|5|||
124977320|NCT03538938|449543803|FG009|Overall Study|Withdrawal by Subject|1|||
124977321|NCT03538938|449543804|FG010|Overall Study|Withdrawal by Subject|2|||
124977322|NCT03538938|449543805|FG011|Overall Study|Withdrawal by Subject|1|||
124977323|NCT03538938|449543806|FG012|Overall Study|Withdrawal by Subject|3|||
124977324|NCT03538938|449543807|FG013|Overall Study|Withdrawal by Subject|0|||
124977325|NCT03538938|449543808|FG014|Overall Study|Withdrawal by Subject|2|||
124977326|NCT03538938|449543809|FG015|Overall Study|Withdrawal by Subject|4|||
124977327|NCT03538938|449543794|FG000|Overall Study|Incarcerated|0|||
124977328|NCT03538938|449543795|FG001|Overall Study|Incarcerated|0|||
124977329|NCT03538938|449543796|FG002|Overall Study|Incarcerated|0|||
124977330|NCT03538938|449543797|FG003|Overall Study|Incarcerated|0|||
124977331|NCT03538938|449543798|FG004|Overall Study|Incarcerated|0|||
124977332|NCT03538938|449543799|FG005|Overall Study|Incarcerated|0|||
124977333|NCT03538938|449543800|FG006|Overall Study|Incarcerated|0|||
124977334|NCT03538938|449543801|FG007|Overall Study|Incarcerated|0|||
124977335|NCT03538938|449543802|FG008|Overall Study|Incarcerated|0|||
124977336|NCT03538938|449543803|FG009|Overall Study|Incarcerated|0|||
124977337|NCT03538938|449543804|FG010|Overall Study|Incarcerated|0|||
124977338|NCT03538938|449543805|FG011|Overall Study|Incarcerated|1|||
124977339|NCT03538938|449543806|FG012|Overall Study|Incarcerated|0|||
124977340|NCT03538938|449543807|FG013|Overall Study|Incarcerated|0|||
124977341|NCT03538938|449543808|FG014|Overall Study|Incarcerated|0|||
124977342|NCT03538938|449543809|FG015|Overall Study|Incarcerated|0|||
124977343|NCT00604708|449543810|FG000|Overall Study|Withdrawal by Subject|9|||
124977344|NCT00604708|449543811|FG001|Overall Study|Withdrawal by Subject|10|||
124977345|NCT00604708|449543810|FG000|Overall Study|Protocol Violation|2|||
124977346|NCT00604708|449543811|FG001|Overall Study|Protocol Violation|8|||
124977347|NCT00604708|449543810|FG000|Overall Study|Lost to Follow-up|5|||
124977348|NCT00604708|449543811|FG001|Overall Study|Lost to Follow-up|5|||
124977349|NCT00604708|449543810|FG000|Overall Study|administrative reasons|9|||
124977350|NCT00604708|449543811|FG001|Overall Study|administrative reasons|11|||
124977351|NCT00604708|449543810|FG000|Overall Study|Adverse Event|6|||
124977352|NCT00604708|449543811|FG001|Overall Study|Adverse Event|6|||
124977353|NCT01361594|449543812|FG000|Overall Study|Withdrawal by Subject|1|||
124977354|NCT01361594|449543813|FG001|Overall Study|Withdrawal by Subject|2|||
124977355|NCT01754753|449543814|FG000|Overall Study|Study close|43|||
124977356|NCT01754753|449543815|FG001|Overall Study|Study close|44|||
124977357|NCT01754753|449543814|FG000|Overall Study|Lost to Follow-up|9|||
124977358|NCT01754753|449543815|FG001|Overall Study|Lost to Follow-up|5|||
124977359|NCT03197766|449543820|FG000|Overall Study|Withdrawal by Subject|2|||
124977360|NCT03197766|449543821|FG001|Overall Study|Withdrawal by Subject|0|||
124977361|NCT04485611|449543824|FG000|Prehabilitation|Physician Decision|1|||
124977362|NCT03361865|449543825|FG000|Overall Study|Death|17|||
124977363|NCT03361865|449543826|FG001|Overall Study|Death|18|||
124977364|NCT03361865|449543825|FG000|Overall Study|Physician Decision|1|||
124977365|NCT03361865|449543826|FG001|Overall Study|Physician Decision|9|||
124977366|NCT03361865|449543825|FG000|Overall Study|Withdrawal by Subject|1|||
124977367|NCT03361865|449543826|FG001|Overall Study|Withdrawal by Subject|0|||
124977368|NCT05543187|449543827|FG000|Overall Study|Ongoing|3|||
124466358|NCT03445000|447666368|FG000|Overall Study|Death|2|||
124977369|NCT05543187|449543828|FG001|Overall Study|Ongoing|2|||
124977370|NCT01647542|449543830|FG000|Overall Study|Major Protocol Deviation|1|||
124977371|NCT01647542|449543831|FG001|Overall Study|Major Protocol Deviation|0|||
124977372|NCT01647542|449543832|FG002|Overall Study|Major Protocol Deviation|0|||
124977373|NCT01647542|449543830|FG000|Overall Study|Adverse Event|4|||
124977374|NCT01647542|449543831|FG001|Overall Study|Adverse Event|5|||
124977375|NCT01647542|449543832|FG002|Overall Study|Adverse Event|4|||
124977376|NCT01647542|449543830|FG000|Overall Study|Lost to Follow-up|0|||
124977377|NCT01647542|449543831|FG001|Overall Study|Lost to Follow-up|2|||
124977378|NCT01647542|449543832|FG002|Overall Study|Lost to Follow-up|2|||
124977379|NCT01647542|449543830|FG000|Overall Study|Withdrawal by Subject|6|||
124977380|NCT01647542|449543831|FG001|Overall Study|Withdrawal by Subject|4|||
124977381|NCT01647542|449543832|FG002|Overall Study|Withdrawal by Subject|0|||
124977382|NCT01647542|449543830|FG000|Overall Study|Study Termination|64|||
124977383|NCT01647542|449543831|FG001|Overall Study|Study Termination|61|||
124977384|NCT01647542|449543832|FG002|Overall Study|Study Termination|65|||
124977385|NCT01647542|449543830|FG000|Overall Study|Lack of Efficacy|1|||
124977386|NCT01647542|449543831|FG001|Overall Study|Lack of Efficacy|1|||
124977387|NCT01647542|449543832|FG002|Overall Study|Lack of Efficacy|0|||
124977388|NCT01647542|449543830|FG000|Overall Study|Death|0|||
124977389|NCT01647542|449543831|FG001|Overall Study|Death|0|||
124977390|NCT01647542|449543832|FG002|Overall Study|Death|1|||
124977391|NCT03086655|449543833|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
124977392|NCT03086655|449543834|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
124977393|NCT03086655|449543833|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
124977394|NCT03086655|449543834|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
124977395|NCT03086655|449543833|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
124977396|NCT03086655|449543834|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
124977397|NCT03086655|449543833|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
124977398|NCT03086655|449543834|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
124977399|NCT03086655|449543833|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
124977400|NCT03086655|449543834|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
124977401|NCT03086655|449543833|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
124977402|NCT03086655|449543834|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
124977403|NCT03086655|449543833|FG000|12 Month Follow-up = Final Assessment|Death|0|||
124977404|NCT03086655|449543834|FG001|12 Month Follow-up = Final Assessment|Death|1|||
124977405|NCT03008005|449543835|FG000|Overall Study|Physician Decision|1|||
124977406|NCT03008005|449543836|FG001|Overall Study|Physician Decision|0|||
124977407|NCT03008005|449543837|FG002|Overall Study|Physician Decision|0|||
124977408|NCT03008005|449543835|FG000|Overall Study|Withdrawal by Subject|1|||
124977409|NCT03008005|449543836|FG001|Overall Study|Withdrawal by Subject|0|||
124977410|NCT03008005|449543837|FG002|Overall Study|Withdrawal by Subject|0|||
124977411|NCT03008005|449543835|FG000|Overall Study|Ineligible|0|||
124977412|NCT03008005|449543836|FG001|Overall Study|Ineligible|1|||
124977413|NCT03008005|449543837|FG002|Overall Study|Ineligible|0|||
124977414|NCT01040169|449543853|FG000|Overall Study|Lost to Follow-up|3|||
124977415|NCT01040169|449543854|FG001|Overall Study|Lost to Follow-up|8|||
124977416|NCT03633799|449543859|FG000|Overall Study|Adverse Event|349|||
124977417|NCT03633799|449543859|FG000|Overall Study|Withdrawal by Subject|288|||
124977418|NCT03633799|449543859|FG000|Overall Study|Lost to Follow-up|97|||
124977419|NCT03633799|449543859|FG000|Overall Study|Physician Decision|9|||
124977420|NCT03633799|449543859|FG000|Overall Study|Protocol Violation|4|||
124977421|NCT03633799|449543859|FG000|Overall Study|Pregnancy|20|||
124977422|NCT03633799|449543859|FG000|Overall Study|other|39|||
124977423|NCT03633799|449543859|FG000|Overall Study|ongoing within third year of study|106|||
124977424|NCT03633799|449543859|FG000|Overall Study|unsuccessful study drug placement|19|||
124977425|NCT03551691|449543860|FG000|Overall Study|Withdrawal by Subject|3|||
124977426|NCT03551691|449543861|FG001|Overall Study|Withdrawal by Subject|3|||
124977427|NCT05855967|449543862|FG000|Overall Study|Withdrawal by Subject|7|||
124977428|NCT05855967|449543863|FG001|Overall Study|Withdrawal by Subject|5|||
124977429|NCT05855967|449543862|FG000|Overall Study|Lost to Follow-up|2|||
124977430|NCT05855967|449543863|FG001|Overall Study|Lost to Follow-up|1|||
124977431|NCT02446821|449543864|FG000|Overall Study|Adverse Event|28|||
124977432|NCT02446821|449543864|FG000|Overall Study|Withdrawal by Subject|6|||
124977433|NCT02446821|449543864|FG000|Overall Study|Lost to Follow-up|22|||
124977434|NCT02446821|449543864|FG000|Overall Study|other|9|||
124977435|NCT02446821|449543864|FG000|Overall Study|insertion failure|3|||
124977436|NCT02284009|449543866|FG000|Overall Study|Adverse Event|3|||
124977437|NCT02284009|449543867|FG001|Overall Study|Adverse Event|0|||
124977438|NCT02284009|449543866|FG000|Overall Study|Lost to Follow-up|1|||
124977439|NCT02284009|449543867|FG001|Overall Study|Lost to Follow-up|3|||
124977440|NCT02284009|449543866|FG000|Overall Study|Physician Decision|0|||
124977441|NCT02284009|449543867|FG001|Overall Study|Physician Decision|2|||
124977442|NCT02284009|449543866|FG000|Overall Study|Withdrawal by Subject|2|||
124977443|NCT02284009|449543867|FG001|Overall Study|Withdrawal by Subject|5|||
124977444|NCT04942366|449545373|FG000|Overall Study|Withdrawal by Subject|5|||
124866766|NCT00127101|449133648|FG004|Base Protocol|Adverse Event|0|||
124977445|NCT04942366|449545374|FG001|Overall Study|Withdrawal by Subject|5|||
124977446|NCT03301155|449545375|FG000|Overall Study|Сompliance with exclusion criteria|8|||
124866767|NCT00127101|449133649|FG005|Base Protocol|Adverse Event|0|||
124977447|NCT03301155|449545376|FG001|Overall Study|Сompliance with exclusion criteria|7|||
124977448|NCT00384189|449545378|FG000|Overall Study|Reason Not Specified|50|||
124977449|NCT00384189|449545379|FG001|Overall Study|Reason Not Specified|57|||
124977450|NCT00384189|449545380|FG002|Overall Study|Reason Not Specified|58|||
124977451|NCT00384189|449545381|FG003|Overall Study|Reason Not Specified|40|||
124977452|NCT00608868|449545382|FG000|Overall Study|Withdrawal by Subject|7|||
124977453|NCT00608868|449545382|FG000|Overall Study|Protocol Violation|3|||
124977454|NCT00608868|449545382|FG000|Overall Study|Lost to Follow-up|2|||
124977455|NCT00608868|449545382|FG000|Overall Study|Adverse Event|1|||
124466359|NCT03445000|447666368|FG000|Overall Study|Physician Decision|1|||
124466360|NCT03409744|447666369|FG000|Overall Study|Death|2|||
124466361|NCT03409744|447666369|FG000|Overall Study|Physician Decision|5|||
124466362|NCT03409744|447666369|FG000|Overall Study|Pregnancy|1|||
124466363|NCT03409744|447666369|FG000|Overall Study|Lost to Follow-up|1|||
124466364|NCT03409744|447666369|FG000|Overall Study|Protocol Violation|1|||
124466365|NCT03269344|447666377|FG000|Overall Study|Protocol Violation|4|||
124466366|NCT03269344|447666378|FG001|Overall Study|Protocol Violation|3|||
124466367|NCT02597855|447666379|FG000|Overall Study|Lost to Follow-up|2|||
124466368|NCT02597855|447666380|FG001|Overall Study|Lost to Follow-up|1|||
124466369|NCT00559507|447666381|FG000|Overall Study|Not treated, patient ineligible|3|||
124466370|NCT02889796|447666382|FG000|Overall Study|Withdrew Consent|18|||
124466371|NCT02889796|447666383|FG001|Overall Study|Withdrew Consent|29|||
124466372|NCT02889796|447666384|FG002|Overall Study|Withdrew Consent|20|||
124466373|NCT02889796|447666385|FG003|Overall Study|Withdrew Consent|1|||
124466374|NCT02889796|447666386|FG004|Overall Study|Withdrew Consent|2|||
124466375|NCT02889796|447666387|FG005|Overall Study|Withdrew Consent|35|||
124466376|NCT02889796|447666382|FG000|Overall Study|Investigator's Discretion|10|||
124466377|NCT02889796|447666383|FG001|Overall Study|Investigator's Discretion|9|||
124466378|NCT02889796|447666384|FG002|Overall Study|Investigator's Discretion|10|||
124466379|NCT02889796|447666385|FG003|Overall Study|Investigator's Discretion|3|||
124466380|NCT02889796|447666386|FG004|Overall Study|Investigator's Discretion|0|||
124466381|NCT02889796|447666387|FG005|Overall Study|Investigator's Discretion|15|||
124466382|NCT02889796|447666382|FG000|Overall Study|Adverse Event|17|||
124466383|NCT02889796|447666383|FG001|Overall Study|Adverse Event|8|||
124466384|NCT02889796|447666384|FG002|Overall Study|Adverse Event|8|||
124466385|NCT02889796|447666385|FG003|Overall Study|Adverse Event|4|||
124466386|NCT02889796|447666386|FG004|Overall Study|Adverse Event|1|||
124466387|NCT02889796|447666387|FG005|Overall Study|Adverse Event|7|||
124466388|NCT02889796|447666382|FG000|Overall Study|Lost to Follow-up|5|||
124466389|NCT02889796|447666383|FG001|Overall Study|Lost to Follow-up|7|||
124466390|NCT02889796|447666384|FG002|Overall Study|Lost to Follow-up|2|||
124466391|NCT02889796|447666385|FG003|Overall Study|Lost to Follow-up|0|||
124466392|NCT02889796|447666386|FG004|Overall Study|Lost to Follow-up|2|||
124466393|NCT02889796|447666387|FG005|Overall Study|Lost to Follow-up|6|||
124466394|NCT02889796|447666382|FG000|Overall Study|Protocol Violation|0|||
124466395|NCT02889796|447666383|FG001|Overall Study|Protocol Violation|1|||
124466396|NCT02889796|447666384|FG002|Overall Study|Protocol Violation|3|||
124466397|NCT02889796|447666385|FG003|Overall Study|Protocol Violation|0|||
124466398|NCT02889796|447666386|FG004|Overall Study|Protocol Violation|0|||
124466399|NCT02889796|447666387|FG005|Overall Study|Protocol Violation|4|||
124466400|NCT02889796|447666382|FG000|Overall Study|Non-compliance With Study Drug|0|||
124466401|NCT02889796|447666383|FG001|Overall Study|Non-compliance With Study Drug|2|||
124466402|NCT02889796|447666384|FG002|Overall Study|Non-compliance With Study Drug|0|||
124466403|NCT02889796|447666385|FG003|Overall Study|Non-compliance With Study Drug|0|||
124466404|NCT02889796|447666386|FG004|Overall Study|Non-compliance With Study Drug|1|||
124466405|NCT02889796|447666387|FG005|Overall Study|Non-compliance With Study Drug|2|||
124466406|NCT02889796|447666382|FG000|Overall Study|Death|1|||
124466407|NCT02889796|447666383|FG001|Overall Study|Death|1|||
124466408|NCT02889796|447666384|FG002|Overall Study|Death|0|||
124466409|NCT02889796|447666385|FG003|Overall Study|Death|1|||
124466410|NCT02889796|447666386|FG004|Overall Study|Death|0|||
124977456|NCT00608868|449545382|FG000|Overall Study|Physician Decision|2|||
124977457|NCT00335140|449545385|FG000|Overall Study|Ineligible|1|||
124977458|NCT04546425|449545386|FG000|Overall Study|Protocol Violation|1|||
124977459|NCT04546425|449545387|FG001|Overall Study|Protocol Violation|1|||
124977460|NCT04546425|449545388|FG002|Overall Study|Protocol Violation|0|||
124466411|NCT02889796|447666387|FG005|Overall Study|Death|1|||
124466412|NCT02889796|447666382|FG000|Overall Study|Pregnancy|0|||
124466413|NCT02889796|447666383|FG001|Overall Study|Pregnancy|1|||
124466414|NCT02889796|447666384|FG002|Overall Study|Pregnancy|1|||
124466415|NCT02889796|447666385|FG003|Overall Study|Pregnancy|0|||
124466416|NCT02889796|447666386|FG004|Overall Study|Pregnancy|0|||
124466417|NCT02889796|447666387|FG005|Overall Study|Pregnancy|0|||
124466418|NCT02889796|447666382|FG000|Overall Study|Randomized but not Dosed|2|||
124466419|NCT02889796|447666383|FG001|Overall Study|Randomized but not Dosed|0|||
124466420|NCT02889796|447666384|FG002|Overall Study|Randomized but not Dosed|0|||
124466421|NCT02889796|447666385|FG003|Overall Study|Randomized but not Dosed|0|||
124466422|NCT02889796|447666386|FG004|Overall Study|Randomized but not Dosed|0|||
124466423|NCT02889796|447666387|FG005|Overall Study|Randomized but not Dosed|2|||
124466424|NCT01407926|447666393|FG000|Overall Study|Lost to Follow-up|55|||
124466425|NCT02814565|447666394|FG000|Overall Study|Lack of Efficacy|0|||
124977461|NCT04546425|449545389|FG003|Overall Study|Protocol Violation|0|||
124977462|NCT04546425|449545386|FG000|Overall Study|Adverse Event|3|||
124977463|NCT04546425|449545387|FG001|Overall Study|Adverse Event|0|||
124977464|NCT04546425|449545388|FG002|Overall Study|Adverse Event|0|||
124977465|NCT04546425|449545389|FG003|Overall Study|Adverse Event|0|||
124977466|NCT04546425|449545386|FG000|Overall Study|Lost to Follow-up|5|||
124977467|NCT04546425|449545387|FG001|Overall Study|Lost to Follow-up|4|||
124977468|NCT04546425|449545388|FG002|Overall Study|Lost to Follow-up|0|||
124977469|NCT04546425|449545389|FG003|Overall Study|Lost to Follow-up|0|||
124977470|NCT04546425|449545386|FG000|Overall Study|No Longer met eligibility criteria|3|||
124534112|NCT02555722|447906647|FG000|Month 2|Withdrawal by Subject|3|||
124534113|NCT02555722|447906648|FG001|Month 2|Withdrawal by Subject|0|||
124534114|NCT02555722|447906647|FG000|Month 2|Lost to Follow-up|1|||
124534115|NCT02555722|447906648|FG001|Month 2|Lost to Follow-up|0|||
124534116|NCT00352027|447906649|FG000|Overall Study|Progressive disease|3|||
124534117|NCT00702949|447906650|FG000|Overall Study|Refusal|3|||
124534118|NCT00702949|447906651|FG001|Overall Study|Refusal|2|||
124534119|NCT00702949|447906652|FG002|Overall Study|Refusal|2|||
124534120|NCT00702949|447906650|FG000|Overall Study|Adverse Event|1|||
124534121|NCT00702949|447906651|FG001|Overall Study|Adverse Event|6|||
124534122|NCT00702949|447906652|FG002|Overall Study|Adverse Event|3|||
124534123|NCT00702949|447906650|FG000|Overall Study|Other Medical Reason/unknown|1|||
124534124|NCT00702949|447906651|FG001|Overall Study|Other Medical Reason/unknown|1|||
124534125|NCT00702949|447906652|FG002|Overall Study|Other Medical Reason/unknown|3|||
124534126|NCT00598585|447906653|FG000|Overall Study|Lost to Follow-up|1|||
124534127|NCT00598585|447906654|FG001|Overall Study|Lost to Follow-up|0|||
124534128|NCT00135694|447906656|FG000|Overall Study|Adverse Event|17|||
124534129|NCT00135694|447906657|FG001|Overall Study|Adverse Event|4|||
124534130|NCT00135694|447906658|FG002|Overall Study|Adverse Event|0|||
124534131|NCT00135694|447906656|FG000|Overall Study|Death|14|||
124534132|NCT00135694|447906657|FG001|Overall Study|Death|1|||
124534133|NCT00135694|447906658|FG002|Overall Study|Death|2|||
124534134|NCT00135694|447906656|FG000|Overall Study|Lost to Follow-up|8|||
124534135|NCT00135694|447906657|FG001|Overall Study|Lost to Follow-up|7|||
124534136|NCT00135694|447906658|FG002|Overall Study|Lost to Follow-up|1|||
124534137|NCT00135694|447906656|FG000|Overall Study|Withdrawal by Subject|41|||
124534138|NCT00135694|447906657|FG001|Overall Study|Withdrawal by Subject|7|||
124534139|NCT00135694|447906658|FG002|Overall Study|Withdrawal by Subject|4|||
124534140|NCT00135694|447906656|FG000|Overall Study|Protocol Violation|19|||
124534141|NCT00135694|447906657|FG001|Overall Study|Protocol Violation|1|||
124534142|NCT00135694|447906658|FG002|Overall Study|Protocol Violation|0|||
124534143|NCT00135694|447906656|FG000|Overall Study|Hepatitis C related reasons|39|||
124534144|NCT00135694|447906657|FG001|Overall Study|Hepatitis C related reasons|1|||
124534145|NCT00135694|447906658|FG002|Overall Study|Hepatitis C related reasons|0|||
124534146|NCT00135694|447906656|FG000|Overall Study|Ineligible for Random assignment|42|||
124534147|NCT00135694|447906657|FG001|Overall Study|Ineligible for Random assignment|0|||
124534148|NCT00135694|447906658|FG002|Overall Study|Ineligible for Random assignment|0|||
124534149|NCT03922711|447906662|FG000|Overall Study|Adverse Event|3|||
124534150|NCT03922711|447906663|FG001|Overall Study|Adverse Event|2|||
124534151|NCT03922711|447906664|FG002|Overall Study|Adverse Event|2|||
124534152|NCT03922711|447906662|FG000|Overall Study|Protocol Violation|1|||
124534153|NCT03922711|447906663|FG001|Overall Study|Protocol Violation|0|||
124534154|NCT03922711|447906664|FG002|Overall Study|Protocol Violation|0|||
124534155|NCT03922711|447906662|FG000|Overall Study|Withdrawal by Subject|0|||
124534156|NCT03922711|447906663|FG001|Overall Study|Withdrawal by Subject|3|||
124534157|NCT03922711|447906664|FG002|Overall Study|Withdrawal by Subject|1|||
124534158|NCT03922711|447906662|FG000|Overall Study|Not further specified|0|||
124534159|NCT03922711|447906663|FG001|Overall Study|Not further specified|0|||
124534160|NCT03922711|447906664|FG002|Overall Study|Not further specified|1|||
124534161|NCT03147495|447906665|FG000|Overall Study|Physician Decision|0|||
124534162|NCT03147495|447906666|FG001|Overall Study|Physician Decision|6|||
124534163|NCT02607735|447906667|FG000|Primary Study|Randomized but Never Treated|1|||
124534164|NCT02607735|447906668|FG001|Primary Study|Randomized but Never Treated|0|||
124534165|NCT02607735|447906669|FG002|Primary Study|Randomized but Never Treated|0|||
124534166|NCT02607735|447906667|FG000|Primary Study|Lost to Follow-up|4|||
124534167|NCT02607735|447906668|FG001|Primary Study|Lost to Follow-up|0|||
124534168|NCT02607735|447906669|FG002|Primary Study|Lost to Follow-up|0|||
124534169|NCT02607735|447906667|FG000|Primary Study|Withdrew Consent|2|||
124977471|NCT04546425|449545387|FG001|Overall Study|No Longer met eligibility criteria|3|||
124534170|NCT02607735|447906668|FG001|Primary Study|Withdrew Consent|0|||
124534171|NCT02607735|447906669|FG002|Primary Study|Withdrew Consent|0|||
124534172|NCT02607735|447906667|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
124534173|NCT02607735|447906668|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
124534174|NCT02607735|447906669|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
124534175|NCT02607735|447906667|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
124534176|NCT02607735|447906668|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
124534177|NCT02607735|447906669|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
124534178|NCT00877890|447906674|FG000|Overall Study|Adverse Event|6|||
124534179|NCT00877890|447906675|FG001|Overall Study|Adverse Event|6|||
124534180|NCT00877890|447906674|FG000|Overall Study|Lost to Follow-up|5|||
124534181|NCT00877890|447906675|FG001|Overall Study|Lost to Follow-up|5|||
124534182|NCT00877890|447906674|FG000|Overall Study|Protocol Violation|0|||
124534183|NCT00877890|447906675|FG001|Overall Study|Protocol Violation|1|||
124534184|NCT00877890|447906674|FG000|Overall Study|Withdrawal of Consent|6|||
124534185|NCT00877890|447906675|FG001|Overall Study|Withdrawal of Consent|12|||
124534186|NCT00877890|447906674|FG000|Overall Study|Investigator Decision|0|||
124534187|NCT00877890|447906675|FG001|Overall Study|Investigator Decision|2|||
124534188|NCT00877890|447906674|FG000|Overall Study|Loss of Glucose Control|3|||
124534189|NCT00877890|447906675|FG001|Overall Study|Loss of Glucose Control|4|||
124534190|NCT00742391|447906676|FG000|Overall Study|Adverse Event|2|||
124534191|NCT00742391|447906677|FG001|Overall Study|Adverse Event|1|||
124977472|NCT04546425|449545388|FG002|Overall Study|No Longer met eligibility criteria|1|||
124977473|NCT04546425|449545389|FG003|Overall Study|No Longer met eligibility criteria|1|||
124977474|NCT04546425|449545386|FG000|Overall Study|Withdrawal by parent/guardian|6|||
124977475|NCT04546425|449545387|FG001|Overall Study|Withdrawal by parent/guardian|5|||
124977476|NCT04546425|449545388|FG002|Overall Study|Withdrawal by parent/guardian|1|||
124977477|NCT04546425|449545389|FG003|Overall Study|Withdrawal by parent/guardian|1|||
124977478|NCT02979249|449545392|FG000|Overall Study|Lost to Follow-up|2|||
124977479|NCT02979249|449545392|FG000|Overall Study|Withdrawal by Subject|4|||
124977480|NCT01125046|449545393|FG000|First 6 Months of Treatment|Death|1|||
124977481|NCT01125046|449545393|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
124977482|NCT01125046|449545393|FG000|First 6 Months of Treatment|Non-compliance|1|||
124977483|NCT01125046|449545393|FG000|First 6 Months of Treatment|Surgery|1|||
124977484|NCT01125046|449545393|FG000|First 6 Months of Treatment|Progressive Disease|7|||
124977485|NCT01125046|449545393|FG000|First 6 Months of Treatment|Adverse Event|2|||
124977486|NCT01125046|449545393|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
124977487|NCT01125046|449545393|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
124534192|NCT00742391|447906676|FG000|Overall Study|Lost to Follow-up|1|||
124534193|NCT00742391|447906677|FG001|Overall Study|Lost to Follow-up|0|||
124534194|NCT00742391|447906676|FG000|Overall Study|Protocol Violation|1|||
124534195|NCT00742391|447906677|FG001|Overall Study|Protocol Violation|0|||
124534196|NCT02355665|447906687|FG000|Overall Study|Adverse Event|16|||
124534197|NCT02355665|447906688|FG001|Overall Study|Adverse Event|24|||
124534198|NCT02355665|447906687|FG000|Overall Study|Protocol Violation|2|||
124534199|NCT02355665|447906688|FG001|Overall Study|Protocol Violation|0|||
124534200|NCT02355665|447906687|FG000|Overall Study|Withdrawal by Subject|90|||
124534201|NCT02355665|447906688|FG001|Overall Study|Withdrawal by Subject|100|||
124534202|NCT02355665|447906687|FG000|Overall Study|Lost to Follow-up|131|||
124534203|NCT02355665|447906688|FG001|Overall Study|Lost to Follow-up|103|||
124534204|NCT02355665|447906687|FG000|Overall Study|Death|4|||
124534205|NCT02355665|447906688|FG001|Overall Study|Death|2|||
124534206|NCT02355665|447906687|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
124534207|NCT02355665|447906688|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
124534208|NCT00095836|447906690|FG000|Overall Study|Lost to Follow-up|1|||
124534209|NCT00095836|447906690|FG000|Overall Study|Adverse Event|1|||
124534210|NCT00095836|447906690|FG000|Overall Study|Death|2|||
124534211|NCT00989664|447906691|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
124534212|NCT00989664|447906691|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
124534213|NCT00989664|447906691|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
124534214|NCT00989664|447906691|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
124534215|NCT00989664|447906691|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
124534216|NCT00989664|447906691|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
124534217|NCT00989664|447906691|FG000|Long-Term Follow-Up|Death|3|||
124534218|NCT02363322|447906692|FG000|Overall Study|Lost to Follow-up|1|||
124534219|NCT02363322|447906693|FG001|Overall Study|Lost to Follow-up|0|||
124534220|NCT02705755|447906694|FG000|Part A (6 Days)|Adverse Event|1|||
124534221|NCT02705755|447906695|FG001|Part A (6 Days)|Adverse Event|0|||
124534222|NCT02705755|447906696|FG002|Part A (6 Days)|Adverse Event|0|||
124534223|NCT02705755|447906697|FG003|Part A (6 Days)|Adverse Event|0|||
124534224|NCT02705755|447906694|FG000|Part A (6 Days)|Physician Decision|3|||
124534225|NCT02705755|447906695|FG001|Part A (6 Days)|Physician Decision|0|||
124534226|NCT02705755|447906696|FG002|Part A (6 Days)|Physician Decision|0|||
124534227|NCT02705755|447906697|FG003|Part A (6 Days)|Physician Decision|0|||
124534228|NCT02705755|447906694|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
124534229|NCT02705755|447906695|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
124534230|NCT02705755|447906696|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
124534231|NCT02705755|447906697|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
124534232|NCT02705755|447906694|FG000|Part C (20 Weeks)|Physician Decision|0|||
124534233|NCT02705755|447906695|FG001|Part C (20 Weeks)|Physician Decision|0|||
124534234|NCT02705755|447906696|FG002|Part C (20 Weeks)|Physician Decision|0|||
124534235|NCT02705755|447906697|FG003|Part C (20 Weeks)|Physician Decision|2|||
124534236|NCT02705755|447906694|FG000|Part C (20 Weeks)|Adverse Event|0|||
124534237|NCT02705755|447906695|FG001|Part C (20 Weeks)|Adverse Event|0|||
124534238|NCT02705755|447906696|FG002|Part C (20 Weeks)|Adverse Event|0|||
124534239|NCT02705755|447906697|FG003|Part C (20 Weeks)|Adverse Event|6|||
124977488|NCT01125046|449545393|FG000|Follow-up/Data Cut Off Point|Death|29|||
124977489|NCT01125046|449545393|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
124977490|NCT03868787|449545395|FG000|Overall Study|Withdrawal by Subject|2|||
124977491|NCT03868787|449545396|FG001|Overall Study|Withdrawal by Subject|1|||
124977492|NCT01685229|449545397|FG000|Overall Study|Subjects missing Study Exit form|3|||
124977493|NCT01685229|449545398|FG001|Overall Study|Subjects missing Study Exit form|1|||
124977494|NCT01685229|449545397|FG000|Overall Study|Lost to Follow-up|16|||
124977495|NCT01685229|449545398|FG001|Overall Study|Lost to Follow-up|10|||
124977496|NCT01685229|449545397|FG000|Overall Study|Withdrawal by Subject|6|||
124977497|NCT01685229|449545398|FG001|Overall Study|Withdrawal by Subject|5|||
124977498|NCT01685229|449545397|FG000|Overall Study|Death|1|||
124977499|NCT01685229|449545398|FG001|Overall Study|Death|0|||
124977500|NCT01399697|449545411|FG000|Overall Study|Adverse Event|13|||
124977501|NCT01399697|449545412|FG001|Overall Study|Adverse Event|3|||
124977502|NCT01399697|449545413|FG002|Overall Study|Adverse Event|1|||
124977503|NCT01399697|449545411|FG000|Overall Study|Lost to Follow-up|2|||
124977504|NCT01399697|449545412|FG001|Overall Study|Lost to Follow-up|0|||
124977505|NCT01399697|449545413|FG002|Overall Study|Lost to Follow-up|0|||
124977506|NCT01399697|449545411|FG000|Overall Study|Withdrawal by Subject|8|||
124977507|NCT01399697|449545412|FG001|Overall Study|Withdrawal by Subject|0|||
124977508|NCT01399697|449545413|FG002|Overall Study|Withdrawal by Subject|0|||
124977509|NCT01399697|449545411|FG000|Overall Study|Investigator Decisión|1|||
124977510|NCT01399697|449545412|FG001|Overall Study|Investigator Decisión|0|||
124977511|NCT01399697|449545413|FG002|Overall Study|Investigator Decisión|2|||
124977512|NCT01399697|449545411|FG000|Overall Study|Lack of Efficacy|9|||
124977513|NCT01399697|449545412|FG001|Overall Study|Lack of Efficacy|0|||
124977514|NCT01399697|449545413|FG002|Overall Study|Lack of Efficacy|1|||
124977515|NCT01399697|449545411|FG000|Overall Study|Protocol Violation|2|||
124977516|NCT01399697|449545412|FG001|Overall Study|Protocol Violation|0|||
124977517|NCT01399697|449545413|FG002|Overall Study|Protocol Violation|0|||
124977518|NCT01399697|449545411|FG000|Overall Study|Non-Compliant|1|||
124977519|NCT01399697|449545412|FG001|Overall Study|Non-Compliant|0|||
124977520|NCT01399697|449545413|FG002|Overall Study|Non-Compliant|0|||
124977521|NCT01399697|449545411|FG000|Overall Study|Inclusion Error|2|||
124977522|NCT01399697|449545412|FG001|Overall Study|Inclusion Error|0|||
124977523|NCT01399697|449545413|FG002|Overall Study|Inclusion Error|0|||
124977524|NCT01399697|449545411|FG000|Overall Study|Positive result for hepatitis B|1|||
124977525|NCT01399697|449545412|FG001|Overall Study|Positive result for hepatitis B|0|||
124977526|NCT01399697|449545413|FG002|Overall Study|Positive result for hepatitis B|0|||
124977527|NCT01399697|449545411|FG000|Overall Study|Clinical RA remission|1|||
124977528|NCT01399697|449545412|FG001|Overall Study|Clinical RA remission|0|||
124977529|NCT01399697|449545413|FG002|Overall Study|Clinical RA remission|0|||
124977530|NCT01399697|449545411|FG000|Overall Study|Sponsor Decision|1|||
124977531|NCT01399697|449545412|FG001|Overall Study|Sponsor Decision|0|||
124977532|NCT01399697|449545413|FG002|Overall Study|Sponsor Decision|0|||
124977533|NCT04313608|449545414|FG000|Overall Study|Death|12|||
124977534|NCT04313608|449545415|FG001|Overall Study|Death|3|||
124977535|NCT03019640|449545417|FG000|Overall Study|Screen Failures|4|||
124977536|NCT03019640|449545417|FG000|Overall Study|Adverse Event|3|||
124977537|NCT03019640|449545417|FG000|Overall Study|Participant Relapsed|1|||
124977538|NCT02817906|449545426|FG000|Overall Study|Adverse Event|3|||
124977539|NCT02817906|449545427|FG001|Overall Study|Adverse Event|0|||
124977540|NCT02817906|449545426|FG000|Overall Study|Lack of Efficacy|1|||
124977541|NCT02817906|449545427|FG001|Overall Study|Lack of Efficacy|0|||
124977542|NCT02817906|449545426|FG000|Overall Study|Protocol Violation|1|||
124977543|NCT02817906|449545427|FG001|Overall Study|Protocol Violation|1|||
124977544|NCT02817906|449545426|FG000|Overall Study|Study Terminated by Sponsor|2|||
124977545|NCT02817906|449545427|FG001|Overall Study|Study Terminated by Sponsor|2|||
124977546|NCT02817906|449545426|FG000|Overall Study|Withdrawal by Subject|7|||
124977547|NCT02817906|449545427|FG001|Overall Study|Withdrawal by Subject|0|||
124977548|NCT02817906|449545426|FG000|Overall Study|Other|2|||
124977549|NCT02817906|449545427|FG001|Overall Study|Other|2|||
124977550|NCT03686423|449545428|FG000|Overall Study|Withdrawal by Subject|9|||
124977551|NCT03686423|449545428|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
124977552|NCT02833077|449545429|FG000|Overall Study|Adverse Event|1|||
124977553|NCT02833077|449545430|FG001|Overall Study|Adverse Event|2|||
124977554|NCT02833077|449545429|FG000|Overall Study|Lost to Follow-up|10|||
124977555|NCT02833077|449545430|FG001|Overall Study|Lost to Follow-up|1|||
124977556|NCT02833077|449545429|FG000|Overall Study|Personal Reasons|6|||
124977557|NCT02833077|449545430|FG001|Overall Study|Personal Reasons|4|||
124977558|NCT02833077|449545429|FG000|Overall Study|Protocol Deviation|0|||
124977559|NCT02833077|449545430|FG001|Overall Study|Protocol Deviation|1|||
124977560|NCT00972322|449545431|FG000|Overall Study|Adverse Event|2|||
124977561|NCT00972322|449545432|FG001|Overall Study|Adverse Event|1|||
124977562|NCT00972322|449545431|FG000|Overall Study|Positive drug screen|0|||
124977563|NCT00972322|449545432|FG001|Overall Study|Positive drug screen|1|||
124977564|NCT00972322|449545431|FG000|Overall Study|Lost to Follow-up|0|||
124977565|NCT00972322|449545432|FG001|Overall Study|Lost to Follow-up|1|||
124977566|NCT00972322|449545431|FG000|Overall Study|Consistently high glucose values|1|||
124977567|NCT00972322|449545432|FG001|Overall Study|Consistently high glucose values|0|||
124977568|NCT01077518|449545433|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
124534240|NCT02705755|447906694|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
124534241|NCT02705755|447906695|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
124534242|NCT02705755|447906696|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
124534243|NCT02705755|447906697|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
124534244|NCT00027846|447909331|FG000|Overall Study|Lost to Follow-up|0|||
124534245|NCT00027846|447909332|FG001|Overall Study|Lost to Follow-up|41|||
124534246|NCT00027846|447909333|FG002|Overall Study|Lost to Follow-up|9|||
124534247|NCT00027846|447909331|FG000|Overall Study|Withdrawal by Subject|0|||
124977569|NCT01077518|449545434|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
124977570|NCT01077518|449545435|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
124977571|NCT01077518|449545433|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
124977572|NCT01077518|449545434|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
124977573|NCT01077518|449545435|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
124977574|NCT01077518|449545433|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
124977575|NCT01077518|449545434|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
124977576|NCT01077518|449545435|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
124534248|NCT00027846|447909332|FG001|Overall Study|Withdrawal by Subject|14|||
124534249|NCT00027846|447909333|FG002|Overall Study|Withdrawal by Subject|7|||
124534250|NCT00027846|447909331|FG000|Overall Study|Ineligible for study|2|||
124534251|NCT00027846|447909332|FG001|Overall Study|Ineligible for study|6|||
124534252|NCT00027846|447909333|FG002|Overall Study|Ineligible for study|14|||
124534253|NCT00027846|447909331|FG000|Overall Study|Entry into another COG therapeutic study|0|||
124534254|NCT00027846|447909332|FG001|Overall Study|Entry into another COG therapeutic study|5|||
124534255|NCT00027846|447909333|FG002|Overall Study|Entry into another COG therapeutic study|2|||
124534256|NCT00027846|447909331|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
124534257|NCT00027846|447909332|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
124534258|NCT00027846|447909333|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
124534259|NCT02033369|447909334|FG000|Overall Study|Physician Decision|1|||
124534260|NCT02033369|447909335|FG001|Overall Study|Physician Decision|2|||
124534261|NCT02033369|447909334|FG000|Overall Study|Not a good demographic match|0|||
124534262|NCT02033369|447909335|FG001|Overall Study|Not a good demographic match|2|||
124534263|NCT02033369|447909334|FG000|Overall Study|Withdrawal by Subject|1|||
124534264|NCT02033369|447909335|FG001|Overall Study|Withdrawal by Subject|1|||
124534265|NCT02033369|447909334|FG000|Overall Study|Lost to Follow-up|1|||
124534266|NCT02033369|447909335|FG001|Overall Study|Lost to Follow-up|0|||
124534267|NCT02033369|447909334|FG000|Overall Study|Protocol Violation|2|||
124534268|NCT02033369|447909335|FG001|Overall Study|Protocol Violation|0|||
124534269|NCT02889861|447909346|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
124534270|NCT01864746|447909347|FG000|Overall Study|Disease recurrence|25|||
124534271|NCT01864746|447909348|FG001|Overall Study|Disease recurrence|40|||
124534272|NCT01864746|447909347|FG000|Overall Study|Second primary invasive nonbreast|2|||
124534273|NCT01864746|447909348|FG001|Overall Study|Second primary invasive nonbreast|3|||
124534274|NCT01864746|447909347|FG000|Overall Study|Death|2|||
124534275|NCT01864746|447909348|FG001|Overall Study|Death|1|||
124534276|NCT01864746|447909347|FG000|Overall Study|Adverse Event|33|||
124534277|NCT01864746|447909348|FG001|Overall Study|Adverse Event|5|||
124534278|NCT01864746|447909347|FG000|Overall Study|Withdrawal by Subject|56|||
124534279|NCT01864746|447909348|FG001|Overall Study|Withdrawal by Subject|41|||
124534280|NCT01864746|447909347|FG000|Overall Study|Physician Decision|5|||
124534281|NCT01864746|447909348|FG001|Overall Study|Physician Decision|6|||
124534282|NCT01005966|447909349|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
124534283|NCT01005966|447909350|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
124534284|NCT01005966|447909351|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
124977577|NCT01077518|449545433|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
124977578|NCT01077518|449545434|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
124977579|NCT01077518|449545435|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
124977580|NCT01077518|449545433|FG000|Optional Ofa Phase|Physician Decision|0|||
124977581|NCT01077518|449545434|FG001|Optional Ofa Phase|Physician Decision|0|||
124977582|NCT01077518|449545435|FG002|Optional Ofa Phase|Physician Decision|1|||
124977583|NCT01077518|449545433|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
124977584|NCT01077518|449545434|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
124534285|NCT01005966|447909352|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
124534286|NCT01005966|447909353|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
124534287|NCT01005966|447909349|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
124534288|NCT01005966|447909350|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
124534289|NCT01005966|447909351|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
124534290|NCT01005966|447909352|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
124551162|NCT00267020|447974673|FG001|Overall Study|Other|2|||
124534291|NCT01005966|447909353|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
124534292|NCT01005966|447909349|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
124534293|NCT01005966|447909350|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
124534294|NCT01005966|447909351|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
124534295|NCT01005966|447909352|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
124534296|NCT01005966|447909353|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
124534297|NCT01005966|447909349|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
124534298|NCT01005966|447909350|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
124534299|NCT01005966|447909351|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
124534300|NCT01005966|447909352|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
124534301|NCT01005966|447909353|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
124534302|NCT01005966|447909349|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
124534303|NCT01005966|447909350|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
124534304|NCT01005966|447909351|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
124534305|NCT01005966|447909352|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
124534306|NCT01005966|447909353|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
124534307|NCT01005966|447909349|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
124534308|NCT01005966|447909350|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
124534309|NCT01005966|447909351|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
124534310|NCT01005966|447909352|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
124534311|NCT01005966|447909353|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
124534312|NCT01005966|447909349|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
124534313|NCT01005966|447909350|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
124534314|NCT01005966|447909351|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
124534315|NCT01005966|447909352|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
124534316|NCT01005966|447909353|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
124534317|NCT01005966|447909349|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
124534318|NCT01005966|447909350|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
124534319|NCT01005966|447909351|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
124534320|NCT01005966|447909352|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
124534321|NCT01005966|447909353|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
124534322|NCT01005966|447909349|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
124534323|NCT01005966|447909350|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
124534324|NCT01005966|447909351|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
124534325|NCT01005966|447909352|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
124534326|NCT01005966|447909353|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
124534327|NCT01451203|447909354|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
124534328|NCT01451203|447909355|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
124534329|NCT01451203|447909354|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
124643924|NCT00090220|448313809|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
124643925|NCT00090220|448313810|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
124643926|NCT00090220|448313805|FG000|Base Study Vaccination Period|Patient Moved|6|||
124643927|NCT00090220|448313806|FG001|Base Study Vaccination Period|Patient Moved|2|||
124643928|NCT00090220|448313807|FG002|Base Study Vaccination Period|Patient Moved|0|||
124643929|NCT00090220|448313808|FG003|Base Study Vaccination Period|Patient Moved|0|||
124643930|NCT00090220|448313809|FG004|Base Study Vaccination Period|Patient Moved|0|||
124643931|NCT00090220|448313810|FG005|Base Study Vaccination Period|Patient Moved|0|||
124643932|NCT00090220|448313805|FG000|Base Study Vaccination Period|Other|4|||
124643933|NCT00090220|448313806|FG001|Base Study Vaccination Period|Other|4|||
124643934|NCT00090220|448313807|FG002|Base Study Vaccination Period|Other|0|||
124643935|NCT00090220|448313808|FG003|Base Study Vaccination Period|Other|0|||
124643936|NCT00090220|448313809|FG004|Base Study Vaccination Period|Other|0|||
124643937|NCT00090220|448313810|FG005|Base Study Vaccination Period|Other|0|||
124643938|NCT00090220|448313805|FG000|Base Study Follow-up Period|Adverse Event|6|||
124643939|NCT00090220|448313806|FG001|Base Study Follow-up Period|Adverse Event|1|||
124643940|NCT00090220|448313807|FG002|Base Study Follow-up Period|Adverse Event|0|||
124643941|NCT00090220|448313808|FG003|Base Study Follow-up Period|Adverse Event|0|||
124643942|NCT00090220|448313809|FG004|Base Study Follow-up Period|Adverse Event|0|||
124643943|NCT00090220|448313810|FG005|Base Study Follow-up Period|Adverse Event|0|||
124643944|NCT00090220|448313805|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
124643945|NCT00090220|448313806|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
124643946|NCT00090220|448313807|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
124643947|NCT00090220|448313808|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
124643948|NCT00090220|448313809|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
124643949|NCT00090220|448313810|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
124643950|NCT00090220|448313805|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
124643951|NCT00090220|448313806|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
124643952|NCT00090220|448313807|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
124643953|NCT00090220|448313808|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
124643954|NCT00090220|448313809|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
124711966|NCT01127633|448570698|FG001|Overall Study|Physician Decision|45|||
124643955|NCT00090220|448313810|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
124643956|NCT00090220|448313805|FG000|Base Study Follow-up Period|Patient Moved|20|||
124643957|NCT00090220|448313806|FG001|Base Study Follow-up Period|Patient Moved|28|||
124643958|NCT00090220|448313807|FG002|Base Study Follow-up Period|Patient Moved|0|||
124643959|NCT00090220|448313808|FG003|Base Study Follow-up Period|Patient Moved|0|||
124643960|NCT00090220|448313809|FG004|Base Study Follow-up Period|Patient Moved|0|||
124643961|NCT00090220|448313810|FG005|Base Study Follow-up Period|Patient Moved|0|||
124643962|NCT00090220|448313805|FG000|Base Study Follow-up Period|Other|19|||
124643963|NCT00090220|448313806|FG001|Base Study Follow-up Period|Other|21|||
124643964|NCT00090220|448313807|FG002|Base Study Follow-up Period|Other|0|||
124643965|NCT00090220|448313808|FG003|Base Study Follow-up Period|Other|0|||
124643966|NCT00090220|448313809|FG004|Base Study Follow-up Period|Other|0|||
124643967|NCT00090220|448313810|FG005|Base Study Follow-up Period|Other|0|||
124643968|NCT00090220|448313805|FG000|Extension 1 (EXT1)|Adverse Event|0|||
124643969|NCT00090220|448313806|FG001|Extension 1 (EXT1)|Adverse Event|0|||
124534330|NCT01451203|447909355|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
124534331|NCT01451203|447909354|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
124534332|NCT01451203|447909355|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
124534333|NCT01451203|447909354|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
124534334|NCT01451203|447909355|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
124534335|NCT01451203|447909354|FG000|Double-blind Treatment Period|Adverse Event|6|||
124534336|NCT01451203|447909355|FG001|Double-blind Treatment Period|Adverse Event|9|||
124534337|NCT01451203|447909354|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
124534338|NCT01451203|447909355|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
124534339|NCT01451203|447909354|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
124534340|NCT01451203|447909355|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
124534341|NCT01451203|447909354|FG000|Double-blind Treatment Period|Investigator decision|2|||
124643970|NCT00090220|448313807|FG002|Extension 1 (EXT1)|Adverse Event|4|||
124643971|NCT00090220|448313808|FG003|Extension 1 (EXT1)|Adverse Event|0|||
124643972|NCT00090220|448313809|FG004|Extension 1 (EXT1)|Adverse Event|0|||
124643973|NCT00090220|448313810|FG005|Extension 1 (EXT1)|Adverse Event|0|||
124643974|NCT00090220|448313805|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
124643975|NCT00090220|448313806|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
124643976|NCT00090220|448313807|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
124643977|NCT00090220|448313808|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
124643978|NCT00090220|448313809|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
124643979|NCT00090220|448313810|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
124643980|NCT00090220|448313805|FG000|Extension 1 (EXT1)|Moved|0|||
124643981|NCT00090220|448313806|FG001|Extension 1 (EXT1)|Moved|0|||
124643982|NCT00090220|448313807|FG002|Extension 1 (EXT1)|Moved|2|||
124643983|NCT00090220|448313808|FG003|Extension 1 (EXT1)|Moved|1|||
124643984|NCT00090220|448313809|FG004|Extension 1 (EXT1)|Moved|0|||
124643985|NCT00090220|448313810|FG005|Extension 1 (EXT1)|Moved|0|||
124643986|NCT00090220|448313805|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
124643987|NCT00090220|448313806|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
124534342|NCT01451203|447909355|FG001|Double-blind Treatment Period|Investigator decision|0|||
124534343|NCT01451203|447909354|FG000|Post-treatment Period|Consent withdrawn|2|||
124534344|NCT01451203|447909355|FG001|Post-treatment Period|Consent withdrawn|4|||
124534345|NCT01451203|447909354|FG000|Post-treatment Period|Lack of Efficacy|12|||
124534346|NCT01451203|447909355|FG001|Post-treatment Period|Lack of Efficacy|28|||
124534347|NCT01451203|447909354|FG000|Post-treatment Period|Adverse Event|0|||
124534348|NCT01451203|447909355|FG001|Post-treatment Period|Adverse Event|1|||
124534349|NCT01451203|447909354|FG000|Post-treatment Period|Investigator decision|0|||
124534350|NCT01451203|447909355|FG001|Post-treatment Period|Investigator decision|1|||
124534351|NCT03890731|447909356|FG000|Overall Study|Progressive disease|1|||
124534352|NCT03890731|447909356|FG000|Overall Study|Patient's decision|1|||
124534353|NCT03890731|447909356|FG000|Overall Study|Adverse Event|4|||
124534354|NCT00027027|447909360|FG000|Overall Study|Adverse Event|0|||
124534355|NCT00027027|447909361|FG001|Overall Study|Adverse Event|0|||
124534356|NCT00027027|447909362|FG002|Overall Study|Adverse Event|1|||
124534357|NCT00027027|447909363|FG003|Overall Study|Adverse Event|0|||
124534358|NCT00027027|447909364|FG004|Overall Study|Adverse Event|1|||
124534359|NCT00027027|447909360|FG000|Overall Study|Admitted for Signs of PD|0|||
124534360|NCT00027027|447909361|FG001|Overall Study|Admitted for Signs of PD|0|||
124643988|NCT00090220|448313807|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
124643989|NCT00090220|448313808|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
124643990|NCT00090220|448313809|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
124643991|NCT00090220|448313810|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
124643992|NCT00090220|448313805|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
124643993|NCT00090220|448313806|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
124643994|NCT00090220|448313807|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
124643995|NCT00090220|448313808|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
124643996|NCT00090220|448313809|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
124643997|NCT00090220|448313810|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
124643998|NCT00090220|448313805|FG000|Extension 1 (EXT1)|Other reason|0|||
124643999|NCT00090220|448313806|FG001|Extension 1 (EXT1)|Other reason|0|||
124644000|NCT00090220|448313807|FG002|Extension 1 (EXT1)|Other reason|2|||
124644001|NCT00090220|448313808|FG003|Extension 1 (EXT1)|Other reason|0|||
124644002|NCT00090220|448313809|FG004|Extension 1 (EXT1)|Other reason|0|||
124644003|NCT00090220|448313810|FG005|Extension 1 (EXT1)|Other reason|0|||
124644004|NCT00090220|448313805|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
124644005|NCT00090220|448313806|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
124644006|NCT00090220|448313807|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
124644007|NCT00090220|448313808|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
124644008|NCT00090220|448313809|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
124644009|NCT00090220|448313810|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
124644010|NCT00090220|448313805|FG000|Long-term Follow-up (EXT2)|Death|0|||
124644011|NCT00090220|448313806|FG001|Long-term Follow-up (EXT2)|Death|0|||
124644012|NCT00090220|448313807|FG002|Long-term Follow-up (EXT2)|Death|0|||
124644013|NCT00090220|448313808|FG003|Long-term Follow-up (EXT2)|Death|0|||
124644014|NCT00090220|448313809|FG004|Long-term Follow-up (EXT2)|Death|1|||
124644015|NCT00090220|448313810|FG005|Long-term Follow-up (EXT2)|Death|1|||
124644016|NCT00090220|448313805|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
124644017|NCT00090220|448313806|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
124644018|NCT00090220|448313807|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
124644019|NCT00090220|448313808|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
124644020|NCT00090220|448313809|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
124644021|NCT00090220|448313810|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
124644022|NCT00090220|448313805|FG000|Long-term Follow-up (EXT2)|Other|0|||
124644023|NCT00090220|448313806|FG001|Long-term Follow-up (EXT2)|Other|0|||
124644024|NCT00090220|448313807|FG002|Long-term Follow-up (EXT2)|Other|0|||
124644025|NCT00090220|448313808|FG003|Long-term Follow-up (EXT2)|Other|0|||
124644026|NCT00090220|448313809|FG004|Long-term Follow-up (EXT2)|Other|1|||
124644027|NCT00090220|448313810|FG005|Long-term Follow-up (EXT2)|Other|0|||
124644028|NCT00941863|448313811|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
124644029|NCT00941863|448313812|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
124644030|NCT00941863|448313813|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
124644031|NCT00941863|448313814|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
124644032|NCT00941863|448313815|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
124644033|NCT00941863|448313811|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
124644034|NCT00941863|448313812|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
124644035|NCT00941863|448313813|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
124644036|NCT00941863|448313814|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
124644037|NCT00941863|448313815|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
124644038|NCT00941863|448313811|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
124644039|NCT00941863|448313812|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
124644040|NCT00941863|448313813|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
124644041|NCT00941863|448313814|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
124644042|NCT00941863|448313815|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
124644043|NCT00941863|448313811|FG000|Until Primary Completion Date (PCD)|Death|0|||
124644044|NCT00941863|448313812|FG001|Until Primary Completion Date (PCD)|Death|0|||
124644045|NCT00941863|448313813|FG002|Until Primary Completion Date (PCD)|Death|1|||
124644046|NCT00941863|448313814|FG003|Until Primary Completion Date (PCD)|Death|2|||
124644047|NCT00941863|448313815|FG004|Until Primary Completion Date (PCD)|Death|7|||
124644048|NCT00941863|448313811|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
124644049|NCT00941863|448313812|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
124644050|NCT00941863|448313813|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
124644051|NCT00941863|448313814|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
124644052|NCT00941863|448313815|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
124644053|NCT00941863|448313811|FG000|Continued After PCD|Withdrawal by Subject|0|||
124644054|NCT00941863|448313812|FG001|Continued After PCD|Withdrawal by Subject|0|||
124644055|NCT00941863|448313813|FG002|Continued After PCD|Withdrawal by Subject|0|||
124644056|NCT00941863|448313814|FG003|Continued After PCD|Withdrawal by Subject|0|||
124644057|NCT00941863|448313815|FG004|Continued After PCD|Withdrawal by Subject|1|||
124644058|NCT00941863|448313811|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
124644059|NCT00941863|448313812|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
124644060|NCT00941863|448313813|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
124644061|NCT00941863|448313814|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
124644062|NCT00941863|448313815|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
124644063|NCT05113979|448313818|FG000|Overall Study|Death|2|||
124644064|NCT05113979|448313818|FG000|Overall Study|Lost to Follow-up|1|||
124644065|NCT00281632|448313821|FG000|Overall Study|Adverse Event|7|||
124644066|NCT00281632|448313821|FG000|Overall Study|Withdrawal by Subject|2|||
124644067|NCT00281632|448313821|FG000|Overall Study|Disease Progression|22|||
124644068|NCT00281632|448313821|FG000|Overall Study|Death|1|||
124644069|NCT00281632|448313821|FG000|Overall Study|Physician Decision|1|||
124644070|NCT00281632|448313821|FG000|Overall Study|Ongoing|3|||
124534361|NCT00027027|447909362|FG002|Overall Study|Admitted for Signs of PD|0|||
124534362|NCT00027027|447909363|FG003|Overall Study|Admitted for Signs of PD|0|||
124754882|NCT00811174|448724044|FG000|Overall Study|Protocol Violation|2|||
124866768|NCT00127101|449133644|FG000|Base Protocol|Lack of Efficacy|1|||
124866769|NCT00127101|449133645|FG001|Base Protocol|Lack of Efficacy|0|||
124866770|NCT00127101|449133646|FG002|Base Protocol|Lack of Efficacy|0|||
124534363|NCT00027027|447909364|FG004|Overall Study|Admitted for Signs of PD|1|||
124534364|NCT00027027|447909360|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
124534365|NCT00027027|447909361|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
124534366|NCT00027027|447909362|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
124534367|NCT00027027|447909363|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
124534368|NCT00027027|447909364|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
124534369|NCT00027027|447909360|FG000|Overall Study|PD Requiring Surgery|0|||
124534370|NCT00027027|447909361|FG001|Overall Study|PD Requiring Surgery|0|||
124534371|NCT00027027|447909362|FG002|Overall Study|PD Requiring Surgery|1|||
124534372|NCT00027027|447909363|FG003|Overall Study|PD Requiring Surgery|0|||
124534373|NCT00027027|447909364|FG004|Overall Study|PD Requiring Surgery|0|||
124534374|NCT00027027|447909360|FG000|Overall Study|Physician Decision Due To PD|2|||
124534375|NCT00027027|447909361|FG001|Overall Study|Physician Decision Due To PD|3|||
124534376|NCT00027027|447909362|FG002|Overall Study|Physician Decision Due To PD|2|||
124534377|NCT00027027|447909363|FG003|Overall Study|Physician Decision Due To PD|3|||
124534378|NCT00027027|447909364|FG004|Overall Study|Physician Decision Due To PD|5|||
124534379|NCT00027027|447909360|FG000|Overall Study|Withdrawal by Subject|0|||
124534380|NCT00027027|447909361|FG001|Overall Study|Withdrawal by Subject|0|||
124534381|NCT00027027|447909362|FG002|Overall Study|Withdrawal by Subject|0|||
124534382|NCT00027027|447909363|FG003|Overall Study|Withdrawal by Subject|0|||
124534383|NCT00027027|447909364|FG004|Overall Study|Withdrawal by Subject|1|||
124534384|NCT02039687|447909370|FG000|Overall Study|Adverse Event|0|||
124534385|NCT02039687|447909371|FG001|Overall Study|Adverse Event|0|||
124534386|NCT02039687|447909372|FG002|Overall Study|Adverse Event|1|||
124534387|NCT02039687|447909373|FG003|Overall Study|Adverse Event|0|||
124534388|NCT02039687|447909370|FG000|Overall Study|Withdrawal by Subject|0|||
124534389|NCT02039687|447909371|FG001|Overall Study|Withdrawal by Subject|1|||
124534390|NCT02039687|447909372|FG002|Overall Study|Withdrawal by Subject|0|||
124534391|NCT02039687|447909373|FG003|Overall Study|Withdrawal by Subject|0|||
124534392|NCT02039687|447909370|FG000|Overall Study|treatment assignment could not be confir|0|||
124534393|NCT02039687|447909371|FG001|Overall Study|treatment assignment could not be confir|0|||
124534394|NCT02039687|447909372|FG002|Overall Study|treatment assignment could not be confir|2|||
124534395|NCT02039687|447909373|FG003|Overall Study|treatment assignment could not be confir|0|||
124534396|NCT03812224|447909383|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
124534397|NCT03812224|447909384|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
124534398|NCT03812224|447909383|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
124534399|NCT03812224|447909384|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
124534400|NCT03812224|447909383|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
124534401|NCT03812224|447909384|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
124534402|NCT03812224|447909383|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
124534403|NCT03812224|447909384|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
124534404|NCT01641952|447909385|FG000|Overall Study|Lost to Follow-up|28|||
124534405|NCT01641952|447909385|FG000|Overall Study|Adverse Event|6|||
124534406|NCT02500901|447909386|FG000|Overall Study|Disease ProgressionDD|2|||
124534407|NCT00561912|447909391|FG000|Overall Study|ineligible|1|||
124534408|NCT02643420|447909394|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
124534409|NCT02643420|447909395|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
124534410|NCT02643420|447909394|FG000|Overall Study|Withdrawal by Subject|25|||
124534411|NCT02643420|447909395|FG001|Overall Study|Withdrawal by Subject|19|||
124534412|NCT02643420|447909394|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
124534413|NCT02643420|447909395|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
124534414|NCT02643420|447909394|FG000|Overall Study|Lost to Follow-up|6|||
124534415|NCT02643420|447909395|FG001|Overall Study|Lost to Follow-up|10|||
124534416|NCT02643420|447909394|FG000|Overall Study|Investigator Decision|2|||
124534417|NCT02643420|447909395|FG001|Overall Study|Investigator Decision|4|||
124534418|NCT02643420|447909394|FG000|Overall Study|Sponsor decision|1|||
124534419|NCT02643420|447909395|FG001|Overall Study|Sponsor decision|1|||
124534420|NCT02643420|447909394|FG000|Overall Study|Death|0|||
124534421|NCT02643420|447909395|FG001|Overall Study|Death|2|||
124534422|NCT02643420|447909394|FG000|Overall Study|Reason not Specified|8|||
124534423|NCT02643420|447909395|FG001|Overall Study|Reason not Specified|7|||
124534424|NCT01710709|447909396|FG000|Overall Study|Lost to Follow-up|29|||
124534425|NCT01710709|447909396|FG000|Overall Study|Adverse Event|48|||
124534426|NCT01710709|447909396|FG000|Overall Study|Participant met withdrawal criteria|33|||
124534427|NCT01710709|447909396|FG000|Overall Study|Participant withdrawn by investigator|2|||
124534428|NCT01710709|447909396|FG000|Overall Study|Withdrawal by Subject|53|||
124866771|NCT00127101|449133647|FG003|Base Protocol|Lack of Efficacy|0|||
124644071|NCT03990571|448313822|FG000|Overall Study|Withdrawal by Subject|1|||
124644072|NCT03990571|448313822|FG000|Overall Study|Insurance Issues|3|||
124644073|NCT03990571|448313822|FG000|Overall Study|Covid Restrictions|2|||
124644074|NCT00638443|448313825|FG000|First Intervention|Adverse Event|2|||
124644075|NCT00638443|448313826|FG001|First Intervention|Adverse Event|1|||
124644076|NCT00179673|448313827|FG000|Overall Study|Adverse Event|7|||
124644077|NCT00179673|448313827|FG000|Overall Study|Lack of Efficacy|15|||
124644078|NCT00179673|448313827|FG000|Overall Study|Withdrawal by Subject|3|||
124644079|NCT00179673|448313827|FG000|Overall Study|Death|4|||
124644080|NCT00179673|448313827|FG000|Overall Study|Other Observations and options|14|||
124644081|NCT02949843|448313828|FG000|Overall Study|Withdrawal by Subject|0|||
124644082|NCT02949843|448313829|FG001|Overall Study|Withdrawal by Subject|1|||
124644083|NCT02949843|448313830|FG002|Overall Study|Withdrawal by Subject|1|||
124644084|NCT03226769|448313834|FG000|Overall Study|Withdrawal by Subject|0|||
124644085|NCT03226769|448313835|FG001|Overall Study|Withdrawal by Subject|1|||
124644086|NCT01827267|448313836|FG000|Overall Study|Did not receive study drug|1|||
124644087|NCT01827267|448313837|FG001|Overall Study|Did not receive study drug|1|||
124644088|NCT01827267|448313836|FG000|Overall Study|Physician Decision|1|||
124644089|NCT01827267|448313837|FG001|Overall Study|Physician Decision|0|||
124644090|NCT01827267|448313836|FG000|Overall Study|Disease Progression|1|||
124644091|NCT01827267|448313837|FG001|Overall Study|Disease Progression|1|||
124644092|NCT01827267|448313836|FG000|Overall Study|Sponsor Discontinued Study|2|||
124644093|NCT01827267|448313837|FG001|Overall Study|Sponsor Discontinued Study|8|||
124644094|NCT01827267|448313836|FG000|Overall Study|Still on study|0|||
124644095|NCT01827267|448313837|FG001|Overall Study|Still on study|2|||
124644096|NCT02640677|448313840|FG000|Overall Study|Lost to Follow-up|1|||
124644097|NCT02640677|448313840|FG000|Overall Study|Withdrawal by Subject|1|||
124644098|NCT01516008|448313847|FG000|Overall Study|Adverse Event|0|||
124644099|NCT01516008|448313848|FG001|Overall Study|Adverse Event|2|||
124644100|NCT01516008|448313849|FG002|Overall Study|Adverse Event|7|||
124644101|NCT01516008|448313847|FG000|Overall Study|Lack of Efficacy|44|||
124644102|NCT01516008|448313848|FG001|Overall Study|Lack of Efficacy|14|||
124644103|NCT01516008|448313849|FG002|Overall Study|Lack of Efficacy|10|||
124644104|NCT01516008|448313847|FG000|Overall Study|Protocol Violation|1|||
124644105|NCT01516008|448313848|FG001|Overall Study|Protocol Violation|0|||
124644106|NCT01516008|448313849|FG002|Overall Study|Protocol Violation|0|||
124644107|NCT01516008|448313847|FG000|Overall Study|Reason not specified|0|||
124644108|NCT01516008|448313848|FG001|Overall Study|Reason not specified|0|||
124644109|NCT01516008|448313849|FG002|Overall Study|Reason not specified|1|||
124644110|NCT04553471|448313850|FG000|Overall Study|Did not start treatment on protocol|3|||
124644111|NCT04553471|448313850|FG000|Overall Study|Death|1|||
124644112|NCT00813813|448313856|FG000|Overall Study|Withdrawal by Subject|1|||
124644113|NCT00813813|448313857|FG001|Overall Study|Withdrawal by Subject|1|||
124644114|NCT00813813|448313856|FG000|Overall Study|Lost to Follow-up|2|||
124644115|NCT00813813|448313857|FG001|Overall Study|Lost to Follow-up|7|||
124644116|NCT00813813|448313856|FG000|Overall Study|Other|0|||
124644117|NCT00813813|448313857|FG001|Overall Study|Other|1|||
124644118|NCT00986921|448313858|FG000|Overall Study|Physician Decision|1|||
124644119|NCT00986921|448313859|FG001|Overall Study|Physician Decision|0|||
124644120|NCT00833482|448313860|FG000|Days 11-20|Adverse Event|0|||
124644121|NCT00833482|448313861|FG001|Days 11-20|Adverse Event|2|||
124644122|NCT00833482|448313862|FG002|Days 11-20|Adverse Event|0|||
124644123|NCT00833482|448313863|FG003|Days 11-20|Adverse Event|0|||
124644124|NCT00833482|448313864|FG004|Days 11-20|Adverse Event|0|||
124644125|NCT00833482|448313865|FG005|Days 11-20|Adverse Event|0|||
124644126|NCT00833482|448313860|FG000|Days 11-20|Withdrawal by Subject|0|||
124644127|NCT00833482|448313861|FG001|Days 11-20|Withdrawal by Subject|1|||
124644128|NCT00833482|448313862|FG002|Days 11-20|Withdrawal by Subject|0|||
124644129|NCT00833482|448313863|FG003|Days 11-20|Withdrawal by Subject|0|||
124644130|NCT00833482|448313864|FG004|Days 11-20|Withdrawal by Subject|0|||
124644131|NCT00833482|448313865|FG005|Days 11-20|Withdrawal by Subject|0|||
124644132|NCT00833482|448313860|FG000|Days 21-30|Adverse Event|0|||
124644133|NCT00833482|448313861|FG001|Days 21-30|Adverse Event|0|||
124644134|NCT00833482|448313862|FG002|Days 21-30|Adverse Event|1|||
124644135|NCT00833482|448313863|FG003|Days 21-30|Adverse Event|0|||
124644136|NCT00833482|448313864|FG004|Days 21-30|Adverse Event|0|||
124644137|NCT00833482|448313865|FG005|Days 21-30|Adverse Event|0|||
124644138|NCT00833482|448313860|FG000|Days 21-30|Withdrawal by Subject|0|||
124644139|NCT00833482|448313861|FG001|Days 21-30|Withdrawal by Subject|0|||
124644140|NCT00833482|448313862|FG002|Days 21-30|Withdrawal by Subject|0|||
124644141|NCT00833482|448313863|FG003|Days 21-30|Withdrawal by Subject|0|||
124644142|NCT00833482|448313864|FG004|Days 21-30|Withdrawal by Subject|1|||
124644143|NCT00833482|448313865|FG005|Days 21-30|Withdrawal by Subject|0|||
124644144|NCT02778074|448313866|FG000|Overall Study|Lost to Follow-up|7|||
124644145|NCT02778074|448313867|FG001|Overall Study|Lost to Follow-up|10|||
124644146|NCT03489707|448313874|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
124644147|NCT03489707|448313875|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
124644148|NCT03489707|448313874|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
124866772|NCT00127101|449133648|FG004|Base Protocol|Lack of Efficacy|2|||
124534429|NCT01710709|447909396|FG000|Overall Study|Protocol Violation|5|||
124534430|NCT01710709|447909396|FG000|Overall Study|Lack of Efficacy|3|||
124534431|NCT01398176|447909398|FG000|Overall Study|Lost to Follow-up|1|||
124534432|NCT01398176|447909399|FG001|Overall Study|Lost to Follow-up|3|||
124534433|NCT01398176|447909398|FG000|Overall Study|Physician Decision|2|||
124534434|NCT01398176|447909399|FG001|Overall Study|Physician Decision|3|||
124534435|NCT00348686|447909400|FG000|Overall Study|Withdrawal by Subject|45|||
124534436|NCT00348686|447909400|FG000|Overall Study|Adverse Event|5|||
124534437|NCT00348686|447909400|FG000|Overall Study|Protocol Violation|6|||
124534438|NCT00348686|447909400|FG000|Overall Study|Lost to Follow-up|2|||
124534439|NCT00348686|447909400|FG000|Overall Study|Multiple Reasons|8|||
124534440|NCT01258738|447909401|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
124534441|NCT01258738|447909402|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
124534442|NCT01258738|447909401|FG000|Double-blind Period|Withdrawal by Subject|2|||
124534443|NCT01258738|447909402|FG001|Double-blind Period|Withdrawal by Subject|2|||
124534444|NCT01258738|447909401|FG000|Double-blind Period|Protocol Violation|1|||
124534445|NCT01258738|447909402|FG001|Double-blind Period|Protocol Violation|1|||
124534446|NCT01258738|447909401|FG000|Double-blind Period|Adverse Event|3|||
124534447|NCT01258738|447909402|FG001|Double-blind Period|Adverse Event|1|||
124534448|NCT01258738|447909401|FG000|Open-label Period|Did not meet inclusion criteria|0|||
124534449|NCT01258738|447909402|FG001|Open-label Period|Did not meet inclusion criteria|1|||
124534450|NCT01258738|447909401|FG000|Open-label Period|Insufficient clinical response|5|||
124534451|NCT01258738|447909402|FG001|Open-label Period|Insufficient clinical response|3|||
124534452|NCT01258738|447909401|FG000|Open-label Period|Lost to Follow-up|0|||
124534453|NCT01258738|447909402|FG001|Open-label Period|Lost to Follow-up|2|||
124534454|NCT01258738|447909401|FG000|Open-label Period|Withdrawal by Subject|5|||
124534455|NCT01258738|447909402|FG001|Open-label Period|Withdrawal by Subject|6|||
124534456|NCT01258738|447909401|FG000|Open-label Period|Protocol Violation|2|||
124534457|NCT01258738|447909402|FG001|Open-label Period|Protocol Violation|2|||
124534458|NCT01258738|447909401|FG000|Open-label Period|Adverse Event|4|||
124534459|NCT01258738|447909402|FG001|Open-label Period|Adverse Event|5|||
124534460|NCT01258738|447909401|FG000|Open-label Period|Other Reasons|0|||
124534461|NCT01258738|447909402|FG001|Open-label Period|Other Reasons|1|||
124534462|NCT01258738|447909401|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
124534463|NCT01258738|447909402|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
124534464|NCT00689611|447909403|FG000|Overall Study|Death|6|||
124534465|NCT00689611|447909404|FG001|Overall Study|Death|9|||
124534466|NCT00689611|447909403|FG000|Overall Study|Withdrawal by Subject|8|||
124534467|NCT00689611|447909404|FG001|Overall Study|Withdrawal by Subject|9|||
124534468|NCT00689611|447909403|FG000|Overall Study|Lost to Follow-up|27|||
124534469|NCT00689611|447909404|FG001|Overall Study|Lost to Follow-up|28|||
124534470|NCT00568399|447909405|FG000|Overall Study|Death|2|||
124534471|NCT00568399|447909405|FG000|Overall Study|Adverse Event|5|||
124534472|NCT00568399|447909405|FG000|Overall Study|Withdrawal by Subject|8|||
124534473|NCT01904760|447909406|FG000|Overall Study|Protocol Violation|1|||
124534474|NCT01904760|447909407|FG001|Overall Study|Protocol Violation|0|||
124534475|NCT00783263|447909408|FG000|Overall Study|Adverse Event|3|||
124534476|NCT00783263|447909409|FG001|Overall Study|Adverse Event|0|||
124534477|NCT00783263|447909410|FG002|Overall Study|Adverse Event|2|||
124534478|NCT00783263|447909411|FG003|Overall Study|Adverse Event|1|||
124534479|NCT00783263|447909408|FG000|Overall Study|Lost to Follow-up|1|||
124534480|NCT00783263|447909409|FG001|Overall Study|Lost to Follow-up|1|||
124534481|NCT00783263|447909410|FG002|Overall Study|Lost to Follow-up|0|||
124534482|NCT00783263|447909411|FG003|Overall Study|Lost to Follow-up|0|||
124534483|NCT00783263|447909408|FG000|Overall Study|Withdrawal by Subject|0|||
124534484|NCT00783263|447909409|FG001|Overall Study|Withdrawal by Subject|1|||
124534485|NCT00783263|447909410|FG002|Overall Study|Withdrawal by Subject|1|||
124534486|NCT00783263|447909411|FG003|Overall Study|Withdrawal by Subject|2|||
124644149|NCT03489707|448313875|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
124644150|NCT01817582|448313876|FG000|Overall Study|Withdrawal by Subject|0|||
124644151|NCT01817582|448313877|FG001|Overall Study|Withdrawal by Subject|1|||
124644152|NCT01817582|448313878|FG002|Overall Study|Withdrawal by Subject|0|||
124644153|NCT01817582|448313876|FG000|Overall Study|Participant revealed masked treatment|1|||
124644154|NCT01817582|448313877|FG001|Overall Study|Participant revealed masked treatment|0|||
124644155|NCT01817582|448313878|FG002|Overall Study|Participant revealed masked treatment|0|||
124644156|NCT01817582|448313876|FG000|Overall Study|Randomized but exclusion criteria met|1|||
124644157|NCT01817582|448313877|FG001|Overall Study|Randomized but exclusion criteria met|0|||
124644158|NCT01817582|448313878|FG002|Overall Study|Randomized but exclusion criteria met|0|||
124644159|NCT00356135|448313881|FG000|Overall Study|Protocol Violation|1|||
124644160|NCT00356135|448313882|FG001|Overall Study|Protocol Violation|0|||
124644161|NCT00356135|448313883|FG002|Overall Study|Protocol Violation|0|||
124644162|NCT00356135|448313881|FG000|Overall Study|Adverse Event|1|||
124644163|NCT00356135|448313882|FG001|Overall Study|Adverse Event|0|||
124644164|NCT00356135|448313883|FG002|Overall Study|Adverse Event|0|||
124644165|NCT00356135|448313881|FG000|Overall Study|Lost to Follow-up|0|||
124644166|NCT00356135|448313882|FG001|Overall Study|Lost to Follow-up|0|||
124644167|NCT00356135|448313883|FG002|Overall Study|Lost to Follow-up|1|||
124644168|NCT00356135|448313881|FG000|Overall Study|Physician Decision|1|||
124644169|NCT00356135|448313882|FG001|Overall Study|Physician Decision|1|||
124644170|NCT00356135|448313883|FG002|Overall Study|Physician Decision|1|||
124644171|NCT00356135|448313881|FG000|Overall Study|Subject non-compliance|1|||
124644172|NCT00356135|448313882|FG001|Overall Study|Subject non-compliance|1|||
124644173|NCT00356135|448313883|FG002|Overall Study|Subject non-compliance|3|||
124644174|NCT03617770|448313884|FG000|Overall Study|Lost to Follow-up|1|||
124644175|NCT03617770|448313885|FG001|Overall Study|Lost to Follow-up|0|||
124644176|NCT03963232|448313886|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
124644177|NCT03963232|448313887|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
124644178|NCT03963232|448313886|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
124644179|NCT03963232|448313887|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
124644180|NCT03963232|448313886|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
124644181|NCT03963232|448313887|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
124644182|NCT03963232|448313886|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
124644183|NCT03963232|448313887|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
124644184|NCT03963232|448313886|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
124644185|NCT03963232|448313887|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
124644186|NCT03963232|448313886|FG000|Open-Label Treatment Phase|Adverse Event|1|||
124644187|NCT03963232|448313887|FG001|Open-Label Treatment Phase|Adverse Event|2|||
124644188|NCT03963232|448313886|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
124644189|NCT03963232|448313887|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
124644190|NCT03963232|448313886|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
124644191|NCT03963232|448313887|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
124644192|NCT03963232|448313886|FG000|Open-Label Treatment Phase|Pregnancy|1|||
124644193|NCT03963232|448313887|FG001|Open-Label Treatment Phase|Pregnancy|0|||
124644194|NCT03963232|448313886|FG000|Follow-up Phase|Withdrawal by Subject|7|||
124644195|NCT03963232|448313887|FG001|Follow-up Phase|Withdrawal by Subject|5|||
124644196|NCT03963232|448313886|FG000|Follow-up Phase|Protocol Violation|0|||
124644197|NCT03963232|448313887|FG001|Follow-up Phase|Protocol Violation|2|||
124644198|NCT03963232|448313886|FG000|Follow-up Phase|Adverse Event|0|||
124644199|NCT03963232|448313887|FG001|Follow-up Phase|Adverse Event|1|||
124644200|NCT03963232|448313886|FG000|Follow-up Phase|Lost to Follow-up|0|||
124644201|NCT03963232|448313887|FG001|Follow-up Phase|Lost to Follow-up|1|||
124644202|NCT03512210|448313889|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
124644203|NCT03512210|448313889|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
124644204|NCT03512210|448313889|FG000|Step 2:Post-MINMON|Death|2|||
124644205|NCT03512210|448313889|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
124644206|NCT03512210|448313889|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
124644207|NCT04250350|448316380|FG000|Overall Study|Withdrawal by Subject|13|||
124644208|NCT04250350|448316380|FG000|Overall Study|Lost to Follow-up|8|||
124644209|NCT04250350|448316380|FG000|Overall Study|Adverse Event|5|||
124644210|NCT04250350|448316380|FG000|Overall Study|Lack of Efficacy|4|||
124644211|NCT04250350|448316380|FG000|Overall Study|Physician Decision|1|||
124644212|NCT04250350|448316380|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
124644213|NCT02836236|448316383|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
124644214|NCT02836236|448316384|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
124644215|NCT02836236|448316385|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
124644216|NCT02836236|448316386|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
124644217|NCT02836236|448316383|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
124644218|NCT02836236|448316384|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
124644219|NCT02836236|448316385|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
124644220|NCT02836236|448316386|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
124644221|NCT02836236|448316383|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
124644222|NCT02836236|448316384|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
124644223|NCT02836236|448316385|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
124644224|NCT02836236|448316386|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
124644225|NCT02836236|448316383|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
124644226|NCT02836236|448316384|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
124644227|NCT02836236|448316385|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
124644228|NCT02836236|448316386|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
124644229|NCT02836236|448316383|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
124644230|NCT02836236|448316384|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
124644231|NCT02836236|448316385|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
124644232|NCT02836236|448316386|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
124644233|NCT02836236|448316383|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
124644234|NCT02836236|448316384|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
124644235|NCT02836236|448316385|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
124644236|NCT02836236|448316386|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
124644237|NCT02836236|448316383|FG000|Open-Label TAF Treatment Phase|Death|0|||
124644238|NCT02836236|448316384|FG001|Open-Label TAF Treatment Phase|Death|0|||
124644239|NCT02836236|448316385|FG002|Open-Label TAF Treatment Phase|Death|1|||
124644240|NCT02836236|448316386|FG003|Open-Label TAF Treatment Phase|Death|1|||
124644241|NCT02836236|448316383|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
124644242|NCT02836236|448316384|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
124644243|NCT02836236|448316385|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
124644244|NCT02836236|448316386|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
124644245|NCT01806961|448316387|FG000|Overall Study|sponsor decision|16|||
124644246|NCT04420585|448316391|FG000|Overall Study|Adverse Event|1|||
124644247|NCT04420585|448316391|FG000|Overall Study|Never initiated medication|2|||
124644248|NCT00972816|448316392|FG000|Overall Study|Adverse Event|0|||
124644249|NCT00972816|448316393|FG001|Overall Study|Adverse Event|0|||
124644250|NCT00972816|448316394|FG002|Overall Study|Adverse Event|1|||
124644251|NCT00972816|448316395|FG003|Overall Study|Adverse Event|0|||
124644252|NCT00972816|448316396|FG004|Overall Study|Adverse Event|0|||
124644253|NCT00972816|448316397|FG005|Overall Study|Adverse Event|0|||
124644254|NCT00972816|448316398|FG006|Overall Study|Adverse Event|0|||
124644255|NCT00972816|448316399|FG007|Overall Study|Adverse Event|0|||
124644256|NCT00972816|448316392|FG000|Overall Study|Withdrawal by Subject|4|||
124644257|NCT00972816|448316393|FG001|Overall Study|Withdrawal by Subject|2|||
124644258|NCT00972816|448316394|FG002|Overall Study|Withdrawal by Subject|1|||
124644259|NCT00972816|448316395|FG003|Overall Study|Withdrawal by Subject|3|||
124644260|NCT00972816|448316396|FG004|Overall Study|Withdrawal by Subject|0|||
124644261|NCT00972816|448316397|FG005|Overall Study|Withdrawal by Subject|1|||
124644262|NCT00972816|448316398|FG006|Overall Study|Withdrawal by Subject|1|||
124644263|NCT00972816|448316399|FG007|Overall Study|Withdrawal by Subject|2|||
124644264|NCT00972816|448316392|FG000|Overall Study|Lost to Follow-up|11|||
124644265|NCT00972816|448316393|FG001|Overall Study|Lost to Follow-up|9|||
124644266|NCT00972816|448316394|FG002|Overall Study|Lost to Follow-up|7|||
124644267|NCT00972816|448316395|FG003|Overall Study|Lost to Follow-up|5|||
124644268|NCT00972816|448316396|FG004|Overall Study|Lost to Follow-up|11|||
124644269|NCT00972816|448316397|FG005|Overall Study|Lost to Follow-up|10|||
124644270|NCT00972816|448316398|FG006|Overall Study|Lost to Follow-up|7|||
124644271|NCT00972816|448316399|FG007|Overall Study|Lost to Follow-up|7|||
124644272|NCT00972816|448316392|FG000|Overall Study|Inappropriate enrolment|0|||
124644273|NCT00972816|448316393|FG001|Overall Study|Inappropriate enrolment|0|||
124644274|NCT00972816|448316394|FG002|Overall Study|Inappropriate enrolment|0|||
124644275|NCT00972816|448316395|FG003|Overall Study|Inappropriate enrolment|0|||
124644276|NCT00972816|448316396|FG004|Overall Study|Inappropriate enrolment|0|||
124644277|NCT00972816|448316397|FG005|Overall Study|Inappropriate enrolment|0|||
124644278|NCT00972816|448316398|FG006|Overall Study|Inappropriate enrolment|2|||
124644279|NCT00972816|448316399|FG007|Overall Study|Inappropriate enrolment|0|||
124644280|NCT00972816|448316392|FG000|Overall Study|Unable to classify|2|||
124644281|NCT00972816|448316393|FG001|Overall Study|Unable to classify|0|||
124644282|NCT00972816|448316394|FG002|Overall Study|Unable to classify|0|||
124644283|NCT00972816|448316395|FG003|Overall Study|Unable to classify|0|||
124644284|NCT00972816|448316396|FG004|Overall Study|Unable to classify|1|||
124644285|NCT00972816|448316397|FG005|Overall Study|Unable to classify|0|||
124644286|NCT00972816|448316398|FG006|Overall Study|Unable to classify|0|||
124644287|NCT00972816|448316399|FG007|Overall Study|Unable to classify|0|||
124644288|NCT04114357|448316400|FG000|Baseline-Randomization|Adverse Event|2|||
124644289|NCT04114357|448316401|FG001|Baseline-Randomization|Adverse Event|1|||
124644290|NCT04114357|448316400|FG000|Baseline-Randomization|Lost to Follow-up|1|||
124644291|NCT04114357|448316401|FG001|Baseline-Randomization|Lost to Follow-up|1|||
124644292|NCT04114357|448316400|FG000|Cross-over|Adverse Event|0|||
124644293|NCT04114357|448316401|FG001|Cross-over|Adverse Event|1|||
124644294|NCT03558152|448316402|FG000|Overall Study|Adverse Event|0|||
124644295|NCT03558152|448316403|FG001|Overall Study|Adverse Event|0|||
124644296|NCT03558152|448316404|FG002|Overall Study|Adverse Event|1|||
124644297|NCT03558152|448316405|FG003|Overall Study|Adverse Event|1|||
124644298|NCT03558152|448316406|FG004|Overall Study|Adverse Event|2|||
124644299|NCT03558152|448316407|FG005|Overall Study|Adverse Event|1|||
124644300|NCT03558152|448316408|FG006|Overall Study|Adverse Event|1|||
124644301|NCT03558152|448316409|FG007|Overall Study|Adverse Event|0|||
124644302|NCT03558152|448316402|FG000|Overall Study|Death|0|||
124644303|NCT03558152|448316403|FG001|Overall Study|Death|0|||
124644304|NCT03558152|448316404|FG002|Overall Study|Death|0|||
124644305|NCT03558152|448316405|FG003|Overall Study|Death|0|||
124644306|NCT03558152|448316406|FG004|Overall Study|Death|1|||
124644307|NCT03558152|448316407|FG005|Overall Study|Death|0|||
124644308|NCT03558152|448316408|FG006|Overall Study|Death|0|||
124644309|NCT03558152|448316409|FG007|Overall Study|Death|0|||
124644310|NCT03558152|448316402|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
124466426|NCT02814565|447666395|FG001|Overall Study|Lack of Efficacy|1|||
124644311|NCT03558152|448316403|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
124644312|NCT03558152|448316404|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
124644313|NCT03558152|448316405|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
124644314|NCT03558152|448316406|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
124644315|NCT03558152|448316407|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
124644316|NCT03558152|448316408|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
124644317|NCT03558152|448316409|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
124644318|NCT03558152|448316402|FG000|Overall Study|Miscalculation in mmcs|0|||
124644319|NCT03558152|448316403|FG001|Overall Study|Miscalculation in mmcs|0|||
124644320|NCT03558152|448316404|FG002|Overall Study|Miscalculation in mmcs|0|||
124644321|NCT03558152|448316405|FG003|Overall Study|Miscalculation in mmcs|0|||
124644322|NCT03558152|448316406|FG004|Overall Study|Miscalculation in mmcs|0|||
124644323|NCT03558152|448316407|FG005|Overall Study|Miscalculation in mmcs|0|||
124644324|NCT03558152|448316408|FG006|Overall Study|Miscalculation in mmcs|1|||
124644325|NCT03558152|448316409|FG007|Overall Study|Miscalculation in mmcs|0|||
124644326|NCT03558152|448316402|FG000|Overall Study|Mistake in calculation|0|||
124644327|NCT03558152|448316403|FG001|Overall Study|Mistake in calculation|0|||
124644328|NCT03558152|448316404|FG002|Overall Study|Mistake in calculation|0|||
124644329|NCT03558152|448316405|FG003|Overall Study|Mistake in calculation|1|||
124644330|NCT03558152|448316406|FG004|Overall Study|Mistake in calculation|0|||
124644331|NCT03558152|448316407|FG005|Overall Study|Mistake in calculation|0|||
124644332|NCT03558152|448316408|FG006|Overall Study|Mistake in calculation|0|||
124644333|NCT03558152|448316409|FG007|Overall Study|Mistake in calculation|0|||
124754883|NCT00811174|448724044|FG000|Overall Study|Sponsors Decision|1|||
124754884|NCT00999544|448725447|FG000|Overall Study|Withdrawal by Subject|1|||
124754885|NCT02407223|448725449|FG000|Overall Study|Adverse Event|1|||
124754886|NCT02407223|448725450|FG001|Overall Study|Adverse Event|0|||
124754887|NCT02407223|448725451|FG002|Overall Study|Adverse Event|1|||
124754888|NCT02407223|448725449|FG000|Overall Study|Lack of Efficacy|6|||
124754889|NCT02407223|448725450|FG001|Overall Study|Lack of Efficacy|6|||
124754890|NCT02407223|448725451|FG002|Overall Study|Lack of Efficacy|4|||
124754891|NCT02407223|448725449|FG000|Overall Study|Lost to Follow-up|1|||
124754892|NCT02407223|448725450|FG001|Overall Study|Lost to Follow-up|0|||
124754893|NCT02407223|448725451|FG002|Overall Study|Lost to Follow-up|2|||
124754894|NCT02407223|448725449|FG000|Overall Study|Withdrawal by Subject|2|||
124754895|NCT02407223|448725450|FG001|Overall Study|Withdrawal by Subject|4|||
124754896|NCT02407223|448725451|FG002|Overall Study|Withdrawal by Subject|4|||
124754897|NCT02407223|448725449|FG000|Overall Study|Study Terminated by Sponsor|77|||
124754898|NCT02407223|448725450|FG001|Overall Study|Study Terminated by Sponsor|80|||
124754899|NCT02407223|448725451|FG002|Overall Study|Study Terminated by Sponsor|86|||
124754900|NCT02407223|448725449|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
124754901|NCT02407223|448725450|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
124754902|NCT02407223|448725451|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
124754903|NCT02407223|448725449|FG000|Overall Study|Other|29|||
124754904|NCT02407223|448725450|FG001|Overall Study|Other|27|||
124754905|NCT02407223|448725451|FG002|Overall Study|Other|25|||
124754906|NCT04864639|448725452|FG000|Overall Study|Death|1|||
124754907|NCT04864639|448725452|FG000|Overall Study|Lost to Follow-up|1|||
124754908|NCT00615017|448725453|FG000|Overall Study|Adverse Event|0|||
124754909|NCT00615017|448725454|FG001|Overall Study|Adverse Event|1|||
124754910|NCT00615017|448725455|FG002|Overall Study|Adverse Event|2|||
124754911|NCT00615017|448725456|FG003|Overall Study|Adverse Event|0|||
124754912|NCT00615017|448725457|FG004|Overall Study|Adverse Event|0|||
124754913|NCT00615017|448725458|FG005|Overall Study|Adverse Event|1|||
124754914|NCT00615017|448725453|FG000|Overall Study|Death|0|||
124754915|NCT00615017|448725454|FG001|Overall Study|Death|0|||
124754916|NCT00615017|448725455|FG002|Overall Study|Death|2|||
124754917|NCT00615017|448725456|FG003|Overall Study|Death|0|||
124754918|NCT00615017|448725457|FG004|Overall Study|Death|1|||
124754919|NCT00615017|448725458|FG005|Overall Study|Death|1|||
124754920|NCT00615017|448725453|FG000|Overall Study|Sepsis resolved|0|||
124754921|NCT00615017|448725454|FG001|Overall Study|Sepsis resolved|0|||
124754922|NCT00615017|448725455|FG002|Overall Study|Sepsis resolved|1|||
124754923|NCT00615017|448725456|FG003|Overall Study|Sepsis resolved|0|||
124754924|NCT00615017|448725457|FG004|Overall Study|Sepsis resolved|0|||
124754925|NCT00615017|448725458|FG005|Overall Study|Sepsis resolved|0|||
124754926|NCT00615017|448725453|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
124977585|NCT01077518|449545435|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
124977586|NCT01077518|449545433|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
124977587|NCT01077518|449545434|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
124977588|NCT01077518|449545435|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
124977589|NCT01495598|449545436|FG000|Overall Study|Death during follow up period|2|||
124977590|NCT01495598|449545436|FG000|Overall Study|Death on study|1|||
124977591|NCT01495598|449545436|FG000|Overall Study|Lost to Follow-up|3|||
124754927|NCT00615017|448725454|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
124754928|NCT00615017|448725455|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
124754929|NCT00615017|448725456|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
124754930|NCT00615017|448725457|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
124754931|NCT00615017|448725458|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
124754932|NCT00615017|448725453|FG000|Overall Study|Physician discontinued drug|0|||
124754933|NCT00615017|448725454|FG001|Overall Study|Physician discontinued drug|0|||
124977592|NCT01495598|449545436|FG000|Overall Study|Physician Decision|8|||
124644334|NCT03558152|448316402|FG000|Overall Study|Mistake in evaluation of disease status|0|||
124644335|NCT03558152|448316403|FG001|Overall Study|Mistake in evaluation of disease status|0|||
124644336|NCT03558152|448316404|FG002|Overall Study|Mistake in evaluation of disease status|0|||
124644337|NCT03558152|448316405|FG003|Overall Study|Mistake in evaluation of disease status|0|||
124644338|NCT03558152|448316406|FG004|Overall Study|Mistake in evaluation of disease status|0|||
124644339|NCT03558152|448316407|FG005|Overall Study|Mistake in evaluation of disease status|0|||
124644340|NCT03558152|448316408|FG006|Overall Study|Mistake in evaluation of disease status|0|||
124644341|NCT03558152|448316409|FG007|Overall Study|Mistake in evaluation of disease status|1|||
124644342|NCT03558152|448316402|FG000|Overall Study|Physician Decision|0|||
124644343|NCT03558152|448316403|FG001|Overall Study|Physician Decision|0|||
124644344|NCT03558152|448316404|FG002|Overall Study|Physician Decision|0|||
124644345|NCT03558152|448316405|FG003|Overall Study|Physician Decision|0|||
124644346|NCT03558152|448316406|FG004|Overall Study|Physician Decision|0|||
124644347|NCT03558152|448316407|FG005|Overall Study|Physician Decision|0|||
124644348|NCT03558152|448316408|FG006|Overall Study|Physician Decision|1|||
124644349|NCT03558152|448316409|FG007|Overall Study|Physician Decision|0|||
124644350|NCT03558152|448316402|FG000|Overall Study|Withdrawal by Subject|2|||
124644351|NCT03558152|448316403|FG001|Overall Study|Withdrawal by Subject|3|||
124644352|NCT03558152|448316404|FG002|Overall Study|Withdrawal by Subject|2|||
124644353|NCT03558152|448316405|FG003|Overall Study|Withdrawal by Subject|1|||
124644354|NCT03558152|448316406|FG004|Overall Study|Withdrawal by Subject|1|||
124644355|NCT03558152|448316407|FG005|Overall Study|Withdrawal by Subject|1|||
124644356|NCT03558152|448316408|FG006|Overall Study|Withdrawal by Subject|3|||
124644357|NCT03558152|448316409|FG007|Overall Study|Withdrawal by Subject|2|||
124644358|NCT03558152|448316402|FG000|Overall Study|Lack of Efficacy|11|||
124644359|NCT03558152|448316403|FG001|Overall Study|Lack of Efficacy|11|||
124644360|NCT03558152|448316404|FG002|Overall Study|Lack of Efficacy|10|||
124644361|NCT03558152|448316405|FG003|Overall Study|Lack of Efficacy|11|||
124644362|NCT03558152|448316406|FG004|Overall Study|Lack of Efficacy|14|||
124644363|NCT03558152|448316407|FG005|Overall Study|Lack of Efficacy|12|||
124644364|NCT03558152|448316408|FG006|Overall Study|Lack of Efficacy|14|||
124644365|NCT03558152|448316409|FG007|Overall Study|Lack of Efficacy|13|||
124644366|NCT03558152|448316402|FG000|Overall Study|Protocol Violation|1|||
124644367|NCT03558152|448316403|FG001|Overall Study|Protocol Violation|1|||
124644368|NCT03558152|448316404|FG002|Overall Study|Protocol Violation|0|||
124644369|NCT03558152|448316405|FG003|Overall Study|Protocol Violation|1|||
124644370|NCT03558152|448316406|FG004|Overall Study|Protocol Violation|1|||
124644371|NCT03558152|448316407|FG005|Overall Study|Protocol Violation|0|||
124644372|NCT03558152|448316408|FG006|Overall Study|Protocol Violation|2|||
124644373|NCT03558152|448316409|FG007|Overall Study|Protocol Violation|0|||
124644374|NCT03693612|448316410|FG000|Overall Study|Lost to Follow-up|0|||
124644375|NCT03693612|448316411|FG001|Overall Study|Lost to Follow-up|0|||
124644376|NCT03693612|448316412|FG002|Overall Study|Lost to Follow-up|0|||
124644377|NCT03693612|448316413|FG003|Overall Study|Lost to Follow-up|0|||
124644378|NCT03693612|448316414|FG004|Overall Study|Lost to Follow-up|1|||
124644379|NCT03693612|448316415|FG005|Overall Study|Lost to Follow-up|0|||
124644380|NCT03693612|448316416|FG006|Overall Study|Lost to Follow-up|0|||
124644381|NCT03693612|448316410|FG000|Overall Study|Withdrawal by Subject|0|||
124644382|NCT03693612|448316411|FG001|Overall Study|Withdrawal by Subject|0|||
124644383|NCT03693612|448316412|FG002|Overall Study|Withdrawal by Subject|1|||
124644384|NCT03693612|448316413|FG003|Overall Study|Withdrawal by Subject|0|||
124644385|NCT03693612|448316414|FG004|Overall Study|Withdrawal by Subject|2|||
124644386|NCT03693612|448316415|FG005|Overall Study|Withdrawal by Subject|0|||
124644387|NCT03693612|448316416|FG006|Overall Study|Withdrawal by Subject|0|||
124644388|NCT03693612|448316410|FG000|Overall Study|Study Terminated by Sponsor|0|||
124644389|NCT03693612|448316411|FG001|Overall Study|Study Terminated by Sponsor|1|||
124866773|NCT00127101|449133649|FG005|Base Protocol|Lack of Efficacy|0|||
124644390|NCT03693612|448316412|FG002|Overall Study|Study Terminated by Sponsor|0|||
124644391|NCT03693612|448316413|FG003|Overall Study|Study Terminated by Sponsor|0|||
124644392|NCT03693612|448316414|FG004|Overall Study|Study Terminated by Sponsor|3|||
124866774|NCT00127101|449133644|FG000|Base Protocol|Withdrawal by Subject|1|||
124866775|NCT00127101|449133645|FG001|Base Protocol|Withdrawal by Subject|2|||
124866776|NCT00127101|449133646|FG002|Base Protocol|Withdrawal by Subject|1|||
124866777|NCT00127101|449133647|FG003|Base Protocol|Withdrawal by Subject|0|||
124866778|NCT00127101|449133648|FG004|Base Protocol|Withdrawal by Subject|0|||
124866779|NCT00127101|449133649|FG005|Base Protocol|Withdrawal by Subject|1|||
124866780|NCT00127101|449133644|FG000|Continuation Phase|Adverse Event|0|||
124866781|NCT00127101|449133645|FG001|Continuation Phase|Adverse Event|0|||
124866782|NCT00127101|449133646|FG002|Continuation Phase|Adverse Event|0|||
124866783|NCT00127101|449133647|FG003|Continuation Phase|Adverse Event|0|||
124866784|NCT00127101|449133648|FG004|Continuation Phase|Adverse Event|1|||
124866785|NCT00127101|449133649|FG005|Continuation Phase|Adverse Event|1|||
124866786|NCT00127101|449133644|FG000|Continuation Phase|Lack of Efficacy|0|||
124866787|NCT00127101|449133645|FG001|Continuation Phase|Lack of Efficacy|0|||
124866788|NCT00127101|449133646|FG002|Continuation Phase|Lack of Efficacy|0|||
124866789|NCT00127101|449133647|FG003|Continuation Phase|Lack of Efficacy|0|||
124977593|NCT05511038|449545440|FG000|Overall|Withdrawal by Subject|5|||
124977594|NCT05511038|449545441|FG001|Overall|Withdrawal by Subject|3|||
124977595|NCT05511038|449545440|FG000|Overall|Screen Failure|20|||
124977596|NCT05511038|449545441|FG001|Overall|Screen Failure|1|||
124977597|NCT05511038|449545440|FG000|Overall|Physician Decision|3|||
124977598|NCT05511038|449545441|FG001|Overall|Physician Decision|0|||
124977599|NCT05511038|449545440|FG000|Overall|Lost to Follow-up|3|||
124977600|NCT05511038|449545441|FG001|Overall|Lost to Follow-up|0|||
124977601|NCT05511038|449545440|FG000|Overall|Death|1|||
124644393|NCT03693612|448316415|FG005|Overall Study|Study Terminated by Sponsor|0|||
124644394|NCT03693612|448316416|FG006|Overall Study|Study Terminated by Sponsor|0|||
124644395|NCT04310397|448316424|FG000|Overall Study|Lack of Efficacy|3|||
124644396|NCT04310397|448316424|FG000|Overall Study|Withdrawal by Subject|1|||
124644397|NCT01936181|448316434|FG000|Randomised, Double-blind|Adverse Event|27|||
124644398|NCT01936181|448316435|FG001|Randomised, Double-blind|Adverse Event|21|||
124644399|NCT01936181|448316436|FG002|Randomised, Double-blind|Adverse Event|0|||
124644400|NCT01936181|448316437|FG003|Randomised, Double-blind|Adverse Event|0|||
124644401|NCT01936181|448316434|FG000|Randomised, Double-blind|Protocol Violation|1|||
124644402|NCT01936181|448316435|FG001|Randomised, Double-blind|Protocol Violation|5|||
124644403|NCT01936181|448316436|FG002|Randomised, Double-blind|Protocol Violation|0|||
124644404|NCT01936181|448316437|FG003|Randomised, Double-blind|Protocol Violation|0|||
124644405|NCT01936181|448316434|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
124644406|NCT01936181|448316435|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
124644407|NCT01936181|448316436|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
124644408|NCT01936181|448316437|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
124644409|NCT01936181|448316434|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
124644410|NCT01936181|448316435|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
124644411|NCT01936181|448316436|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
124644412|NCT01936181|448316437|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
124644413|NCT01936181|448316434|FG000|Randomised, Double-blind|Pregnancy|0|||
124644414|NCT01936181|448316435|FG001|Randomised, Double-blind|Pregnancy|1|||
124644415|NCT01936181|448316436|FG002|Randomised, Double-blind|Pregnancy|0|||
124644416|NCT01936181|448316437|FG003|Randomised, Double-blind|Pregnancy|0|||
124644417|NCT01936181|448316434|FG000|Randomised, Double-blind|Physician Decision|4|||
124644418|NCT01936181|448316435|FG001|Randomised, Double-blind|Physician Decision|4|||
124644419|NCT01936181|448316436|FG002|Randomised, Double-blind|Physician Decision|0|||
124644420|NCT01936181|448316437|FG003|Randomised, Double-blind|Physician Decision|0|||
124644421|NCT01936181|448316434|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
124644422|NCT01936181|448316435|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
124644423|NCT01936181|448316436|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
124644424|NCT01936181|448316437|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
124644425|NCT01936181|448316434|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
124644426|NCT01936181|448316435|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
124644427|NCT01936181|448316436|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
124644428|NCT01936181|448316437|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
124644429|NCT01936181|448316434|FG000|Transition-extension|Adverse Event|3|||
124644430|NCT01936181|448316435|FG001|Transition-extension|Adverse Event|0|||
124644431|NCT01936181|448316436|FG002|Transition-extension|Adverse Event|3|||
124644432|NCT01936181|448316437|FG003|Transition-extension|Adverse Event|1|||
124644433|NCT01936181|448316434|FG000|Transition-extension|Lost to Follow-up|3|||
124644434|NCT01936181|448316435|FG001|Transition-extension|Lost to Follow-up|0|||
124644435|NCT01936181|448316436|FG002|Transition-extension|Lost to Follow-up|1|||
124644436|NCT01936181|448316437|FG003|Transition-extension|Lost to Follow-up|2|||
124644437|NCT01936181|448316434|FG000|Transition-extension|Physician Decision|2|||
124644438|NCT01936181|448316435|FG001|Transition-extension|Physician Decision|0|||
124644439|NCT01936181|448316436|FG002|Transition-extension|Physician Decision|0|||
124644440|NCT01936181|448316437|FG003|Transition-extension|Physician Decision|1|||
124644441|NCT01936181|448316434|FG000|Transition-extension|Withdrawal by Subject|7|||
124644442|NCT01936181|448316435|FG001|Transition-extension|Withdrawal by Subject|0|||
124644443|NCT01936181|448316436|FG002|Transition-extension|Withdrawal by Subject|2|||
124644444|NCT01936181|448316437|FG003|Transition-extension|Withdrawal by Subject|1|||
124644445|NCT00970632|448316438|FG000|Overall Study|Adverse Event|2|||
124977602|NCT05511038|449545441|FG001|Overall|Death|0|||
124977603|NCT05511038|449545440|FG000|Screening|Withdrawal by Subject|1|||
124977604|NCT05511038|449545441|FG001|Screening|Withdrawal by Subject|0|||
124644446|NCT00970632|448316439|FG001|Overall Study|Adverse Event|2|||
124644447|NCT00970632|448316440|FG002|Overall Study|Adverse Event|1|||
124644448|NCT00970632|448316438|FG000|Overall Study|Lack of Efficacy|3|||
124644449|NCT00970632|448316439|FG001|Overall Study|Lack of Efficacy|0|||
124644450|NCT00970632|448316440|FG002|Overall Study|Lack of Efficacy|0|||
124644451|NCT00970632|448316438|FG000|Overall Study|Lost to Follow-up|3|||
124644452|NCT00970632|448316439|FG001|Overall Study|Lost to Follow-up|0|||
124644453|NCT00970632|448316440|FG002|Overall Study|Lost to Follow-up|2|||
124644454|NCT00970632|448316438|FG000|Overall Study|Protocol Violation|8|||
124977605|NCT05511038|449545440|FG000|Screening|Lost to Follow Up (1 participant)|1|||
124644455|NCT00970632|448316439|FG001|Overall Study|Protocol Violation|5|||
124644456|NCT00970632|448316440|FG002|Overall Study|Protocol Violation|8|||
124644457|NCT00970632|448316438|FG000|Overall Study|Withdrawal by Subject|7|||
124644458|NCT00970632|448316439|FG001|Overall Study|Withdrawal by Subject|6|||
124644459|NCT00970632|448316440|FG002|Overall Study|Withdrawal by Subject|4|||
124644460|NCT00970632|448316438|FG000|Overall Study|Entry criteria not met|0|||
124644461|NCT00970632|448316439|FG001|Overall Study|Entry criteria not met|2|||
124644462|NCT00970632|448316440|FG002|Overall Study|Entry criteria not met|2|||
124644463|NCT00970632|448316438|FG000|Overall Study|Sponsor decision|1|||
124644464|NCT00970632|448316439|FG001|Overall Study|Sponsor decision|0|||
124644465|NCT00970632|448316440|FG002|Overall Study|Sponsor decision|1|||
124644466|NCT02817516|448316441|FG000|Overall Study|Other|0|||
124644467|NCT02817516|448316442|FG001|Overall Study|Other|0|||
124644468|NCT02817516|448316443|FG002|Overall Study|Other|1|||
124644469|NCT02817516|448316444|FG003|Overall Study|Other|0|||
124644470|NCT00748189|448316445|FG000|Overall Study|Death|99|||
124644471|NCT00748189|448316446|FG001|Overall Study|Death|84|||
124644472|NCT00748189|448316445|FG000|Overall Study|Withdrawal by Subject|23|||
124644473|NCT00748189|448316446|FG001|Overall Study|Withdrawal by Subject|29|||
124644474|NCT00748189|448316445|FG000|Overall Study|Physician Decision|16|||
124644475|NCT00748189|448316446|FG001|Overall Study|Physician Decision|5|||
124644476|NCT00748189|448316445|FG000|Overall Study|Lost to Follow-up|8|||
124644477|NCT00748189|448316446|FG001|Overall Study|Lost to Follow-up|15|||
124644478|NCT00748189|448316445|FG000|Overall Study|Study terminated by Sponsor|70|||
124644479|NCT00748189|448316446|FG001|Overall Study|Study terminated by Sponsor|79|||
124644480|NCT01424514|448316447|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
124644481|NCT01424514|448316448|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
124644482|NCT01424514|448316447|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
124644483|NCT01424514|448316448|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
124644484|NCT02653170|448316449|FG000|Overall Study|Withdrawal by Subject|3|||
124644485|NCT02653170|448316450|FG001|Overall Study|Withdrawal by Subject|8|||
124644486|NCT02653170|448316451|FG002|Overall Study|Withdrawal by Subject|3|||
124644487|NCT02653170|448316449|FG000|Overall Study|withdrawn by study team|2|||
124644488|NCT02653170|448316450|FG001|Overall Study|withdrawn by study team|4|||
124644489|NCT02653170|448316451|FG002|Overall Study|withdrawn by study team|5|||
124644490|NCT02653170|448316449|FG000|Overall Study|Lost to Follow-up|12|||
124644491|NCT02653170|448316450|FG001|Overall Study|Lost to Follow-up|4|||
124644492|NCT02653170|448316451|FG002|Overall Study|Lost to Follow-up|10|||
124644493|NCT03557931|448316454|FG000|Overall Study|Adverse Event|4|||
124644494|NCT03557931|448316455|FG001|Overall Study|Adverse Event|6|||
124644495|NCT03557931|448316456|FG002|Overall Study|Adverse Event|1|||
124644496|NCT03557931|448316454|FG000|Overall Study|Lost to Follow-up|4|||
124644497|NCT03557931|448316455|FG001|Overall Study|Lost to Follow-up|4|||
124644498|NCT03557931|448316456|FG002|Overall Study|Lost to Follow-up|1|||
124644499|NCT03557931|448316454|FG000|Overall Study|Protocol Violation|1|||
124644500|NCT03557931|448316455|FG001|Overall Study|Protocol Violation|4|||
124644501|NCT03557931|448316456|FG002|Overall Study|Protocol Violation|1|||
124644502|NCT03557931|448316454|FG000|Overall Study|Withdrawal by Subject|14|||
124644503|NCT03557931|448316455|FG001|Overall Study|Withdrawal by Subject|0|||
124644504|NCT03557931|448316456|FG002|Overall Study|Withdrawal by Subject|7|||
124644505|NCT03557931|448316454|FG000|Overall Study|Miscellaneous|8|||
124644506|NCT03557931|448316455|FG001|Overall Study|Miscellaneous|5|||
124644507|NCT03557931|448316456|FG002|Overall Study|Miscellaneous|3|||
124644508|NCT02829723|448316459|FG000|Overall Study|Adverse Event|0|||
124644509|NCT02829723|448316460|FG001|Overall Study|Adverse Event|0|||
124644510|NCT02829723|448316461|FG002|Overall Study|Adverse Event|1|||
124644511|NCT02829723|448316462|FG003|Overall Study|Adverse Event|1|||
124644512|NCT02829723|448316463|FG004|Overall Study|Adverse Event|0|||
124644513|NCT02829723|448316464|FG005|Overall Study|Adverse Event|0|||
124644514|NCT02829723|448316465|FG006|Overall Study|Adverse Event|0|||
124644515|NCT02829723|448316466|FG007|Overall Study|Adverse Event|1|||
124644516|NCT02829723|448316467|FG008|Overall Study|Adverse Event|0|||
124644517|NCT02829723|448316468|FG009|Overall Study|Adverse Event|0|||
124644518|NCT02829723|448316469|FG010|Overall Study|Adverse Event|0|||
124644519|NCT02829723|448316470|FG011|Overall Study|Adverse Event|0|||
124644520|NCT02829723|448316471|FG012|Overall Study|Adverse Event|0|||
124644521|NCT02829723|448316472|FG013|Overall Study|Adverse Event|0|||
124644522|NCT02829723|448316473|FG014|Overall Study|Adverse Event|1|||
124644523|NCT02829723|448316474|FG015|Overall Study|Adverse Event|1|||
124644524|NCT02829723|448316475|FG016|Overall Study|Adverse Event|1|||
124644525|NCT02829723|448316476|FG017|Overall Study|Adverse Event|2|||
124644526|NCT02829723|448316477|FG018|Overall Study|Adverse Event|1|||
124644527|NCT02829723|448316478|FG019|Overall Study|Adverse Event|1|||
124644528|NCT02829723|448316479|FG020|Overall Study|Adverse Event|3|||
124644529|NCT02829723|448316480|FG021|Overall Study|Adverse Event|0|||
124644530|NCT02829723|448316481|FG022|Overall Study|Adverse Event|0|||
124644531|NCT02829723|448316482|FG023|Overall Study|Adverse Event|1|||
124644532|NCT02829723|448316483|FG024|Overall Study|Adverse Event|1|||
124644533|NCT02829723|448316484|FG025|Overall Study|Adverse Event|3|||
124644534|NCT02829723|448316485|FG026|Overall Study|Adverse Event|5|||
124644535|NCT02829723|448316459|FG000|Overall Study|Death|1|||
124644536|NCT02829723|448316460|FG001|Overall Study|Death|0|||
124644537|NCT02829723|448316461|FG002|Overall Study|Death|1|||
124644538|NCT02829723|448316462|FG003|Overall Study|Death|1|||
124644539|NCT02829723|448316463|FG004|Overall Study|Death|0|||
124644540|NCT02829723|448316464|FG005|Overall Study|Death|0|||
124644541|NCT02829723|448316465|FG006|Overall Study|Death|2|||
124644542|NCT02829723|448316466|FG007|Overall Study|Death|0|||
124644543|NCT02829723|448316467|FG008|Overall Study|Death|1|||
124644544|NCT02829723|448316468|FG009|Overall Study|Death|0|||
124644545|NCT02829723|448316469|FG010|Overall Study|Death|0|||
124644546|NCT02829723|448316470|FG011|Overall Study|Death|0|||
124644547|NCT02829723|448316471|FG012|Overall Study|Death|2|||
124644548|NCT02829723|448316472|FG013|Overall Study|Death|1|||
124644549|NCT02829723|448316473|FG014|Overall Study|Death|0|||
124644550|NCT02829723|448316474|FG015|Overall Study|Death|0|||
124644551|NCT02829723|448316475|FG016|Overall Study|Death|0|||
124644552|NCT02829723|448316476|FG017|Overall Study|Death|0|||
124644553|NCT02829723|448316477|FG018|Overall Study|Death|0|||
124644554|NCT02829723|448316478|FG019|Overall Study|Death|0|||
124644555|NCT02829723|448316479|FG020|Overall Study|Death|0|||
124644556|NCT02829723|448316480|FG021|Overall Study|Death|2|||
124644557|NCT02829723|448316481|FG022|Overall Study|Death|0|||
124644558|NCT02829723|448316482|FG023|Overall Study|Death|0|||
124644559|NCT02829723|448316483|FG024|Overall Study|Death|0|||
124644560|NCT02829723|448316484|FG025|Overall Study|Death|1|||
124644561|NCT02829723|448316485|FG026|Overall Study|Death|2|||
124644562|NCT02829723|448316459|FG000|Overall Study|Physician Decision|0|||
124644563|NCT02829723|448316460|FG001|Overall Study|Physician Decision|0|||
124644564|NCT02829723|448316461|FG002|Overall Study|Physician Decision|0|||
124644565|NCT02829723|448316462|FG003|Overall Study|Physician Decision|0|||
124644566|NCT02829723|448316463|FG004|Overall Study|Physician Decision|0|||
124644567|NCT02829723|448316464|FG005|Overall Study|Physician Decision|0|||
124644568|NCT02829723|448316465|FG006|Overall Study|Physician Decision|0|||
124644569|NCT02829723|448316466|FG007|Overall Study|Physician Decision|0|||
124644570|NCT02829723|448316467|FG008|Overall Study|Physician Decision|0|||
124644571|NCT02829723|448316468|FG009|Overall Study|Physician Decision|1|||
124644572|NCT02829723|448316469|FG010|Overall Study|Physician Decision|1|||
124644573|NCT02829723|448316470|FG011|Overall Study|Physician Decision|0|||
124644574|NCT02829723|448316471|FG012|Overall Study|Physician Decision|0|||
124644575|NCT02829723|448316472|FG013|Overall Study|Physician Decision|1|||
124644576|NCT02829723|448316473|FG014|Overall Study|Physician Decision|0|||
124644577|NCT02829723|448316474|FG015|Overall Study|Physician Decision|0|||
124644578|NCT02829723|448316475|FG016|Overall Study|Physician Decision|2|||
124644579|NCT02829723|448316476|FG017|Overall Study|Physician Decision|0|||
124644580|NCT02829723|448316477|FG018|Overall Study|Physician Decision|0|||
124644581|NCT02829723|448316478|FG019|Overall Study|Physician Decision|0|||
124644582|NCT02829723|448316479|FG020|Overall Study|Physician Decision|0|||
124644583|NCT02829723|448316480|FG021|Overall Study|Physician Decision|0|||
124644584|NCT02829723|448316481|FG022|Overall Study|Physician Decision|1|||
124644585|NCT02829723|448316482|FG023|Overall Study|Physician Decision|1|||
124644586|NCT02829723|448316483|FG024|Overall Study|Physician Decision|1|||
124644587|NCT02829723|448316484|FG025|Overall Study|Physician Decision|1|||
124644588|NCT02829723|448316485|FG026|Overall Study|Physician Decision|3|||
124644589|NCT02829723|448316459|FG000|Overall Study|Progressive disease|4|||
124644590|NCT02829723|448316460|FG001|Overall Study|Progressive disease|6|||
124644591|NCT02829723|448316461|FG002|Overall Study|Progressive disease|3|||
124644592|NCT02829723|448316462|FG003|Overall Study|Progressive disease|3|||
124644593|NCT02829723|448316463|FG004|Overall Study|Progressive disease|3|||
124644594|NCT02829723|448316464|FG005|Overall Study|Progressive disease|5|||
124644595|NCT02829723|448316465|FG006|Overall Study|Progressive disease|4|||
124644596|NCT02829723|448316466|FG007|Overall Study|Progressive disease|6|||
124644597|NCT02829723|448316467|FG008|Overall Study|Progressive disease|8|||
124977606|NCT05511038|449545441|FG001|Screening|Lost to Follow Up (1 participant)|0|||
124977607|NCT05511038|449545440|FG000|Screening|Screen Failure|3|||
124644598|NCT02829723|448316468|FG009|Overall Study|Progressive disease|4|||
124644599|NCT02829723|448316469|FG010|Overall Study|Progressive disease|9|||
124644600|NCT02829723|448316470|FG011|Overall Study|Progressive disease|0|||
124977608|NCT05511038|449545441|FG001|Screening|Screen Failure|0|||
124977609|NCT05511038|449545440|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
124644601|NCT02829723|448316471|FG012|Overall Study|Progressive disease|3|||
124644602|NCT02829723|448316472|FG013|Overall Study|Progressive disease|4|||
124644603|NCT02829723|448316473|FG014|Overall Study|Progressive disease|2|||
124644604|NCT02829723|448316474|FG015|Overall Study|Progressive disease|4|||
124644605|NCT02829723|448316475|FG016|Overall Study|Progressive disease|5|||
124644606|NCT02829723|448316476|FG017|Overall Study|Progressive disease|3|||
124644607|NCT02829723|448316477|FG018|Overall Study|Progressive disease|4|||
124644608|NCT02829723|448316478|FG019|Overall Study|Progressive disease|4|||
124644609|NCT02829723|448316479|FG020|Overall Study|Progressive disease|7|||
124644610|NCT02829723|448316480|FG021|Overall Study|Progressive disease|6|||
124644611|NCT02829723|448316481|FG022|Overall Study|Progressive disease|3|||
124644612|NCT02829723|448316482|FG023|Overall Study|Progressive disease|3|||
124644613|NCT02829723|448316483|FG024|Overall Study|Progressive disease|3|||
124644614|NCT02829723|448316484|FG025|Overall Study|Progressive disease|16|||
124644615|NCT02829723|448316485|FG026|Overall Study|Progressive disease|10|||
124644616|NCT02829723|448316459|FG000|Overall Study|Subject/guardian decision|0|||
124644617|NCT02829723|448316460|FG001|Overall Study|Subject/guardian decision|1|||
124644618|NCT02829723|448316461|FG002|Overall Study|Subject/guardian decision|0|||
124644619|NCT02829723|448316462|FG003|Overall Study|Subject/guardian decision|1|||
124644620|NCT02829723|448316463|FG004|Overall Study|Subject/guardian decision|0|||
124644621|NCT02829723|448316464|FG005|Overall Study|Subject/guardian decision|0|||
124644622|NCT02829723|448316465|FG006|Overall Study|Subject/guardian decision|0|||
124644623|NCT02829723|448316466|FG007|Overall Study|Subject/guardian decision|1|||
124644624|NCT02829723|448316467|FG008|Overall Study|Subject/guardian decision|0|||
124644625|NCT02829723|448316468|FG009|Overall Study|Subject/guardian decision|0|||
124644626|NCT02829723|448316469|FG010|Overall Study|Subject/guardian decision|0|||
124644627|NCT02829723|448316470|FG011|Overall Study|Subject/guardian decision|0|||
124644628|NCT02829723|448316471|FG012|Overall Study|Subject/guardian decision|0|||
124644629|NCT02829723|448316472|FG013|Overall Study|Subject/guardian decision|0|||
124644630|NCT02829723|448316473|FG014|Overall Study|Subject/guardian decision|1|||
124644631|NCT02829723|448316474|FG015|Overall Study|Subject/guardian decision|0|||
124644632|NCT02829723|448316475|FG016|Overall Study|Subject/guardian decision|1|||
124644633|NCT02829723|448316476|FG017|Overall Study|Subject/guardian decision|0|||
124644634|NCT02829723|448316477|FG018|Overall Study|Subject/guardian decision|1|||
124644635|NCT02829723|448316478|FG019|Overall Study|Subject/guardian decision|0|||
124644636|NCT02829723|448316479|FG020|Overall Study|Subject/guardian decision|1|||
124644637|NCT02829723|448316480|FG021|Overall Study|Subject/guardian decision|0|||
124644638|NCT02829723|448316481|FG022|Overall Study|Subject/guardian decision|0|||
124644639|NCT02829723|448316482|FG023|Overall Study|Subject/guardian decision|1|||
124644640|NCT02829723|448316483|FG024|Overall Study|Subject/guardian decision|0|||
124644641|NCT02829723|448316484|FG025|Overall Study|Subject/guardian decision|1|||
124644642|NCT02829723|448316485|FG026|Overall Study|Subject/guardian decision|1|||
124644643|NCT02829723|448316459|FG000|Overall Study|Study terminated by sponsor|0|||
124644644|NCT02829723|448316460|FG001|Overall Study|Study terminated by sponsor|0|||
124644645|NCT02829723|448316461|FG002|Overall Study|Study terminated by sponsor|0|||
124644646|NCT02829723|448316462|FG003|Overall Study|Study terminated by sponsor|0|||
124644647|NCT02829723|448316463|FG004|Overall Study|Study terminated by sponsor|0|||
124644648|NCT02829723|448316464|FG005|Overall Study|Study terminated by sponsor|0|||
124644649|NCT02829723|448316465|FG006|Overall Study|Study terminated by sponsor|0|||
124644650|NCT02829723|448316466|FG007|Overall Study|Study terminated by sponsor|0|||
124644651|NCT02829723|448316467|FG008|Overall Study|Study terminated by sponsor|0|||
124644652|NCT02829723|448316468|FG009|Overall Study|Study terminated by sponsor|0|||
124644653|NCT02829723|448316469|FG010|Overall Study|Study terminated by sponsor|0|||
124644654|NCT02829723|448316470|FG011|Overall Study|Study terminated by sponsor|0|||
124644655|NCT02829723|448316471|FG012|Overall Study|Study terminated by sponsor|0|||
124644656|NCT02829723|448316472|FG013|Overall Study|Study terminated by sponsor|0|||
124644657|NCT02829723|448316473|FG014|Overall Study|Study terminated by sponsor|0|||
124644658|NCT02829723|448316474|FG015|Overall Study|Study terminated by sponsor|0|||
124644659|NCT02829723|448316475|FG016|Overall Study|Study terminated by sponsor|0|||
124644660|NCT02829723|448316476|FG017|Overall Study|Study terminated by sponsor|0|||
124644661|NCT02829723|448316477|FG018|Overall Study|Study terminated by sponsor|0|||
124644662|NCT02829723|448316478|FG019|Overall Study|Study terminated by sponsor|0|||
124754934|NCT00615017|448725455|FG002|Overall Study|Physician discontinued drug|0|||
124754935|NCT00615017|448725456|FG003|Overall Study|Physician discontinued drug|0|||
124754936|NCT00615017|448725457|FG004|Overall Study|Physician discontinued drug|0|||
124754937|NCT00615017|448725458|FG005|Overall Study|Physician discontinued drug|1|||
124754938|NCT00806988|448725459|FG000|Overall Study|Death|15|||
124754939|NCT00806988|448725460|FG001|Overall Study|Death|16|||
124754940|NCT00806988|448725459|FG000|Overall Study|Withdrawal by Subject|8|||
124754941|NCT00806988|448725460|FG001|Overall Study|Withdrawal by Subject|8|||
124754942|NCT00806988|448725459|FG000|Overall Study|Lost to Follow-up|4|||
124754943|NCT00806988|448725460|FG001|Overall Study|Lost to Follow-up|19|||
124754944|NCT01478971|448725461|FG000|Standard of Care Period|Adverse Event|1|||
124754945|NCT01478971|448725461|FG000|Standard of Care Period|Withdrawal by Subject|3|||
124754946|NCT01478971|448725461|FG000|Standard of Care Period|Death|8|||
124754947|NCT01478971|448725461|FG000|Standard of Care Period|Lost to Follow-up|9|||
124754948|NCT01478971|448725461|FG000|Standard of Care Period|Other|4|||
124754949|NCT01478971|448725461|FG000|Peginesatide Treatment Period|Adverse Event|1|||
124754950|NCT01478971|448725461|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
124754951|NCT01478971|448725461|FG000|Peginesatide Treatment Period|Death|4|||
124754952|NCT01478971|448725461|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
124754953|NCT01478971|448725461|FG000|Peginesatide Treatment Period|Other|4|||
124754954|NCT00584012|448725462|FG000|Overall Study|Withdrawal by Subject|1|||
124644663|NCT02829723|448316479|FG020|Overall Study|Study terminated by sponsor|0|||
124644664|NCT02829723|448316480|FG021|Overall Study|Study terminated by sponsor|1|||
124754955|NCT01525615|448725463|FG000|Overall Study|Adverse Event|11|||
124754956|NCT01525615|448725464|FG001|Overall Study|Adverse Event|7|||
124754957|NCT01525615|448725465|FG002|Overall Study|Adverse Event|5|||
124754958|NCT01525615|448725463|FG000|Overall Study|Lost to Follow-up|1|||
124754959|NCT01525615|448725464|FG001|Overall Study|Lost to Follow-up|0|||
124754960|NCT01525615|448725465|FG002|Overall Study|Lost to Follow-up|0|||
124754961|NCT01525615|448725463|FG000|Overall Study|Withdrawal by Subject|1|||
124754962|NCT01525615|448725464|FG001|Overall Study|Withdrawal by Subject|0|||
124754963|NCT01525615|448725465|FG002|Overall Study|Withdrawal by Subject|0|||
124754964|NCT01525615|448725463|FG000|Overall Study|Other reason not described above|1|||
124754965|NCT01525615|448725464|FG001|Overall Study|Other reason not described above|0|||
124754966|NCT01525615|448725465|FG002|Overall Study|Other reason not described above|1|||
124754967|NCT04050618|448725466|FG000|First Intervention|Withdrawal by Subject|2|||
124754968|NCT04050618|448725467|FG001|First Intervention|Withdrawal by Subject|0|||
124754969|NCT04050618|448725466|FG000|Second Intervention|Withdrawal by Subject|1|||
124754970|NCT04050618|448725467|FG001|Second Intervention|Withdrawal by Subject|0|||
124754971|NCT04404556|448725468|FG000|Intervention|Withdrawal by Subject|15|||
124754972|NCT04404556|448725469|FG001|Intervention|Withdrawal by Subject|3|||
124754973|NCT04404556|448725468|FG000|Intervention|Did not complete all intervention sessions|2|||
124754974|NCT04404556|448725469|FG001|Intervention|Did not complete all intervention sessions|1|||
124754975|NCT04404556|448725468|FG000|Post-Intervention|Missing Data|1|||
124754976|NCT04404556|448725469|FG001|Post-Intervention|Missing Data|2|||
124754977|NCT04404556|448725468|FG000|Follow-up 1|Withdrawal by Subject|5|||
124754978|NCT04404556|448725469|FG001|Follow-up 1|Withdrawal by Subject|1|||
124754979|NCT04404556|448725468|FG000|Follow-up 1|Missing Data|4|||
124754980|NCT04404556|448725469|FG001|Follow-up 1|Missing Data|7|||
124754981|NCT04404556|448725468|FG000|Follow-up 2|Withdrawal by Subject|1|||
124754982|NCT04404556|448725469|FG001|Follow-up 2|Withdrawal by Subject|1|||
124754983|NCT04404556|448725468|FG000|Follow-up 2|Missing Data|6|||
124754984|NCT04404556|448725469|FG001|Follow-up 2|Missing Data|5|||
124754985|NCT04775953|448725470|FG000|Overall Study|Lost to Follow-up|6|||
124754986|NCT04775953|448725471|FG001|Overall Study|Lost to Follow-up|11|||
124754987|NCT04775953|448725470|FG000|Overall Study|Death|5|||
124754988|NCT04775953|448725471|FG001|Overall Study|Death|4|||
124754989|NCT04775953|448725470|FG000|Overall Study|Withdrawal by Subject|3|||
124754990|NCT04775953|448725471|FG001|Overall Study|Withdrawal by Subject|3|||
124754991|NCT04775953|448725470|FG000|Overall Study|Protocol Violation|2|||
124754992|NCT04775953|448725471|FG001|Overall Study|Protocol Violation|0|||
124754993|NCT04775953|448725470|FG000|Overall Study|Participant non-compliance|0|||
124754994|NCT04775953|448725471|FG001|Overall Study|Participant non-compliance|1|||
124754995|NCT00855959|448725472|FG000|Overall Study|Adverse Event|2|||
124977610|NCT05511038|449545441|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
124754996|NCT00855959|448725472|FG000|Overall Study|Lost to Follow-up|2|||
124754997|NCT00855959|448725472|FG000|Overall Study|Withdrawal by Subject|3|||
124754998|NCT00855959|448725472|FG000|Overall Study|Pregnancy|1|||
124754999|NCT00855959|448725472|FG000|Overall Study|Incorrect enrolment|1|||
124755000|NCT02451943|448725473|FG000|Overall Study|Withdrawal by Subject|13|||
124755001|NCT02451943|448725474|FG001|Overall Study|Withdrawal by Subject|16|||
124755002|NCT02451943|448725473|FG000|Overall Study|Lost to Follow-up|3|||
124755003|NCT02451943|448725474|FG001|Overall Study|Lost to Follow-up|4|||
124755004|NCT02451943|448725473|FG000|Overall Study|Sponsor Decision|0|||
124755005|NCT02451943|448725474|FG001|Overall Study|Sponsor Decision|4|||
124755006|NCT00368641|448725475|FG000|Overall Study|Adverse Event|2|||
124755007|NCT00368641|448725476|FG001|Overall Study|Adverse Event|1|||
124755008|NCT00368641|448725475|FG000|Overall Study|Death|1|||
124755009|NCT00368641|448725476|FG001|Overall Study|Death|0|||
124755010|NCT00368641|448725475|FG000|Overall Study|Withdrawal by Subject|1|||
124755011|NCT00368641|448725476|FG001|Overall Study|Withdrawal by Subject|0|||
124755012|NCT00368641|448725475|FG000|Overall Study|Sponsor decision to terminate study|2|||
124755013|NCT00368641|448725476|FG001|Overall Study|Sponsor decision to terminate study|5|||
124755014|NCT00763386|448725478|FG000|Overall Study|Adverse Event|43|||
124755015|NCT00763386|448725479|FG001|Overall Study|Adverse Event|33|||
124755016|NCT00763386|448725478|FG000|Overall Study|Death|1|||
124755017|NCT00763386|448725479|FG001|Overall Study|Death|2|||
124755018|NCT00763386|448725478|FG000|Overall Study|Lost to Follow-up|3|||
124755019|NCT00763386|448725479|FG001|Overall Study|Lost to Follow-up|3|||
124755020|NCT00763386|448725478|FG000|Overall Study|Withdrawal by Subject|0|||
124755021|NCT00763386|448725479|FG001|Overall Study|Withdrawal by Subject|1|||
124755022|NCT00763386|448725478|FG000|Overall Study|CRF missing|0|||
124755023|NCT00763386|448725479|FG001|Overall Study|CRF missing|1|||
124755024|NCT00763386|448725478|FG000|Overall Study|Study Prosthesis Removed|1|||
124755025|NCT00763386|448725479|FG001|Overall Study|Study Prosthesis Removed|0|||
124755026|NCT01290757|448725482|FG000|Overall Study|Adverse Event|1|||
124755027|NCT01290757|448725483|FG001|Overall Study|Adverse Event|0|||
124755028|NCT01290757|448725482|FG000|Overall Study|Protocol Violation|1|||
124755029|NCT01290757|448725483|FG001|Overall Study|Protocol Violation|1|||
124755030|NCT01290757|448725482|FG000|Overall Study|Other|0|||
124755031|NCT01290757|448725483|FG001|Overall Study|Other|1|||
124755032|NCT00887549|448725484|FG000|Induction Therapy|Adverse Event|8|||
124755033|NCT00887549|448725484|FG000|Induction Therapy|Physician Decision|1|||
124755034|NCT00887549|448725484|FG000|Induction Therapy|Progressive Disease|13|||
124755035|NCT00887549|448725484|FG000|Induction Therapy|Death due to Study Disease|4|||
124755036|NCT00887549|448725484|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
124755037|NCT00887549|448725484|FG000|Maintenance Therapy|Adverse Event|16|||
124755038|NCT00887549|448725484|FG000|Maintenance Therapy|Physician Decision|1|||
124755039|NCT00887549|448725484|FG000|Maintenance Therapy|Progressive Disease|25|||
124755040|NCT00887549|448725484|FG000|Maintenance Therapy|Death due to adverse event|1|||
124755041|NCT00479336|448725486|FG000|Overall Study|Adverse Event|1|||
124755042|NCT00479336|448725487|FG001|Overall Study|Adverse Event|1|||
124755043|NCT00479336|448725488|FG002|Overall Study|Adverse Event|1|||
124755044|NCT00479336|448725489|FG003|Overall Study|Adverse Event|3|||
124755045|NCT00479336|448725486|FG000|Overall Study|Lack of Efficacy|1|||
124755046|NCT00479336|448725487|FG001|Overall Study|Lack of Efficacy|0|||
124755047|NCT00479336|448725488|FG002|Overall Study|Lack of Efficacy|0|||
124755048|NCT00479336|448725489|FG003|Overall Study|Lack of Efficacy|0|||
124755049|NCT00479336|448725486|FG000|Overall Study|Protocol Violation|0|||
124755050|NCT00479336|448725487|FG001|Overall Study|Protocol Violation|1|||
124755051|NCT00479336|448725488|FG002|Overall Study|Protocol Violation|0|||
124755052|NCT00479336|448725489|FG003|Overall Study|Protocol Violation|0|||
124755053|NCT00479336|448725486|FG000|Overall Study|Withdrawal by Subject|1|||
124755054|NCT00479336|448725487|FG001|Overall Study|Withdrawal by Subject|2|||
124755055|NCT00479336|448725488|FG002|Overall Study|Withdrawal by Subject|0|||
124755056|NCT00479336|448725489|FG003|Overall Study|Withdrawal by Subject|0|||
124755057|NCT00479336|448725486|FG000|Overall Study|Physician Decision|0|||
124755058|NCT00479336|448725487|FG001|Overall Study|Physician Decision|1|||
124755059|NCT00479336|448725488|FG002|Overall Study|Physician Decision|0|||
124755060|NCT00479336|448725489|FG003|Overall Study|Physician Decision|2|||
124755061|NCT00479336|448725486|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
124755062|NCT00479336|448725487|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
124755063|NCT00479336|448725488|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
124755064|NCT00479336|448725489|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
124755065|NCT02021643|448725490|FG000|Overall Study|Enrolled but Never Treated|1|||
124755066|NCT02021643|448725491|FG001|Overall Study|Enrolled but Never Treated|0|||
124755067|NCT02021643|448725492|FG002|Overall Study|Enrolled but Never Treated|0|||
124755068|NCT02021643|448725493|FG003|Overall Study|Enrolled but Never Treated|0|||
124755069|NCT02021643|448725490|FG000|Overall Study|Adverse Event|0|||
124755070|NCT02021643|448725491|FG001|Overall Study|Adverse Event|1|||
124755071|NCT02021643|448725492|FG002|Overall Study|Adverse Event|0|||
124755072|NCT02021643|448725493|FG003|Overall Study|Adverse Event|0|||
124755073|NCT02021643|448725490|FG000|Overall Study|Death|0|||
124755074|NCT02021643|448725491|FG001|Overall Study|Death|1|||
124755075|NCT02021643|448725492|FG002|Overall Study|Death|0|||
124755076|NCT02021643|448725493|FG003|Overall Study|Death|0|||
124755077|NCT02021643|448725490|FG000|Overall Study|Investigator's Discretion|1|||
124755078|NCT02021643|448725491|FG001|Overall Study|Investigator's Discretion|0|||
124755079|NCT02021643|448725492|FG002|Overall Study|Investigator's Discretion|0|||
124755080|NCT02021643|448725493|FG003|Overall Study|Investigator's Discretion|0|||
124755081|NCT02021643|448725490|FG000|Overall Study|Lack of Efficacy|7|||
124755082|NCT02021643|448725491|FG001|Overall Study|Lack of Efficacy|6|||
124755083|NCT02021643|448725492|FG002|Overall Study|Lack of Efficacy|0|||
124755084|NCT02021643|448725493|FG003|Overall Study|Lack of Efficacy|12|||
124755085|NCT02021643|448725490|FG000|Overall Study|Lost to Follow-up|0|||
124755086|NCT02021643|448725491|FG001|Overall Study|Lost to Follow-up|1|||
124755087|NCT02021643|448725492|FG002|Overall Study|Lost to Follow-up|0|||
124755088|NCT02021643|448725493|FG003|Overall Study|Lost to Follow-up|0|||
124755089|NCT02021643|448725490|FG000|Overall Study|Withdrew Consent|0|||
124755090|NCT02021643|448725491|FG001|Overall Study|Withdrew Consent|1|||
124755091|NCT02021643|448725492|FG002|Overall Study|Withdrew Consent|0|||
124755092|NCT02021643|448725493|FG003|Overall Study|Withdrew Consent|0|||
124755093|NCT04854551|448725496|FG000|Overall Study|Withdrawal by Subject|1|||
124755094|NCT04854551|448725497|FG001|Overall Study|Withdrawal by Subject|1|||
124755095|NCT04112303|448725498|FG000|Overall Study|Death|1|||
124755096|NCT00726232|448725499|FG000|Initial Phase (Dose-finding)|Death|0|||
124755097|NCT00726232|448725500|FG001|Initial Phase (Dose-finding)|Death|0|||
124755098|NCT00726232|448725501|FG002|Initial Phase (Dose-finding)|Death|0|||
124755099|NCT00726232|448725502|FG003|Initial Phase (Dose-finding)|Death|0|||
124755100|NCT00726232|448725503|FG004|Initial Phase (Dose-finding)|Death|1|||
124755101|NCT00726232|448725504|FG005|Initial Phase (Dose-finding)|Death|0|||
124755102|NCT00726232|448725505|FG006|Initial Phase (Dose-finding)|Death|0|||
124866790|NCT00127101|449133648|FG004|Continuation Phase|Lack of Efficacy|0|||
124755103|NCT00726232|448725506|FG007|Initial Phase (Dose-finding)|Death|0|||
124755104|NCT00726232|448725499|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
124755105|NCT00726232|448725500|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
124755106|NCT00726232|448725501|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
124755107|NCT00726232|448725502|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
124755108|NCT00726232|448725503|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
124755109|NCT00726232|448725504|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
124755110|NCT00726232|448725505|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
124755111|NCT00726232|448725506|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
124755112|NCT00726232|448725499|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
124755113|NCT00726232|448725500|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
124755114|NCT00726232|448725501|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
124755115|NCT00726232|448725502|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
124755116|NCT00726232|448725503|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
124755117|NCT00726232|448725504|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
124755118|NCT00726232|448725505|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
124755119|NCT00726232|448725506|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
124755120|NCT00726232|448725499|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
124755121|NCT00726232|448725500|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
124755122|NCT00726232|448725501|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
124755123|NCT00726232|448725502|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
124755124|NCT00726232|448725503|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
124755125|NCT00726232|448725504|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
124755126|NCT00726232|448725505|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
124755127|NCT00726232|448725506|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
124755128|NCT00726232|448725499|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
124755129|NCT00726232|448725500|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
124755130|NCT00726232|448725501|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
124755131|NCT00726232|448725502|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
124755132|NCT00726232|448725503|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
124755133|NCT00726232|448725504|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
124755134|NCT00726232|448725505|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
124755135|NCT00726232|448725506|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
124755136|NCT00726232|448725499|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
124755137|NCT00726232|448725500|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
124755138|NCT00726232|448725501|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
124755139|NCT00726232|448725502|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
124755140|NCT00726232|448725503|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
124755141|NCT00726232|448725504|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
124755142|NCT00726232|448725505|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
124755143|NCT00726232|448725506|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
124755144|NCT00726232|448725499|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
124755145|NCT00726232|448725500|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
124755146|NCT00726232|448725501|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
124755147|NCT00726232|448725502|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
124755148|NCT00726232|448725503|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
124755149|NCT00726232|448725504|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
124755150|NCT00726232|448725505|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
124755151|NCT00726232|448725506|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
124755152|NCT00726232|448725499|FG000|Expansion Phase|Death|0|||
124755153|NCT00726232|448725500|FG001|Expansion Phase|Death|0|||
124755154|NCT00726232|448725501|FG002|Expansion Phase|Death|0|||
124755155|NCT00726232|448725502|FG003|Expansion Phase|Death|0|||
124755156|NCT00726232|448725503|FG004|Expansion Phase|Death|0|||
124755157|NCT00726232|448725504|FG005|Expansion Phase|Death|0|||
124755158|NCT00726232|448725505|FG006|Expansion Phase|Death|0|||
124755159|NCT00726232|448725506|FG007|Expansion Phase|Death|1|||
124755160|NCT00726232|448725499|FG000|Expansion Phase|Adverse Event|0|||
124755161|NCT00726232|448725500|FG001|Expansion Phase|Adverse Event|0|||
124755162|NCT00726232|448725501|FG002|Expansion Phase|Adverse Event|0|||
124755163|NCT00726232|448725502|FG003|Expansion Phase|Adverse Event|0|||
124755164|NCT00726232|448725503|FG004|Expansion Phase|Adverse Event|0|||
124755165|NCT00726232|448725504|FG005|Expansion Phase|Adverse Event|0|||
124755166|NCT00726232|448725505|FG006|Expansion Phase|Adverse Event|6|||
124755167|NCT00726232|448725506|FG007|Expansion Phase|Adverse Event|11|||
124755168|NCT00726232|448725499|FG000|Expansion Phase|Withdrawal by Subject|0|||
124755169|NCT00726232|448725500|FG001|Expansion Phase|Withdrawal by Subject|0|||
124755170|NCT00726232|448725501|FG002|Expansion Phase|Withdrawal by Subject|0|||
124755171|NCT00726232|448725502|FG003|Expansion Phase|Withdrawal by Subject|0|||
124755172|NCT00726232|448725503|FG004|Expansion Phase|Withdrawal by Subject|0|||
124755173|NCT00726232|448725504|FG005|Expansion Phase|Withdrawal by Subject|0|||
124755174|NCT00726232|448725505|FG006|Expansion Phase|Withdrawal by Subject|2|||
124755175|NCT00726232|448725506|FG007|Expansion Phase|Withdrawal by Subject|3|||
124755176|NCT00726232|448725499|FG000|Expansion Phase|Disease progression|0|||
124755177|NCT00726232|448725500|FG001|Expansion Phase|Disease progression|0|||
124755178|NCT00726232|448725501|FG002|Expansion Phase|Disease progression|0|||
124755179|NCT00726232|448725502|FG003|Expansion Phase|Disease progression|0|||
124755180|NCT00726232|448725503|FG004|Expansion Phase|Disease progression|0|||
124755181|NCT00726232|448725504|FG005|Expansion Phase|Disease progression|0|||
124755182|NCT00726232|448725505|FG006|Expansion Phase|Disease progression|4|||
124755183|NCT00726232|448725506|FG007|Expansion Phase|Disease progression|0|||
124755184|NCT00726232|448725499|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
124755185|NCT00726232|448725500|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
124755186|NCT00726232|448725501|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
124755187|NCT00726232|448725502|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
124755188|NCT00726232|448725503|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
124755189|NCT00726232|448725504|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
124755190|NCT00726232|448725505|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
124755191|NCT00726232|448725506|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
124755192|NCT00726232|448725499|FG000|Expansion Phase|Per Investigator: lack of response|0|||
124755193|NCT00726232|448725500|FG001|Expansion Phase|Per Investigator: lack of response|0|||
124755194|NCT00726232|448725501|FG002|Expansion Phase|Per Investigator: lack of response|0|||
124755195|NCT00726232|448725502|FG003|Expansion Phase|Per Investigator: lack of response|0|||
124755196|NCT00726232|448725503|FG004|Expansion Phase|Per Investigator: lack of response|0|||
124755197|NCT00726232|448725504|FG005|Expansion Phase|Per Investigator: lack of response|0|||
124755198|NCT00726232|448725505|FG006|Expansion Phase|Per Investigator: lack of response|1|||
124755199|NCT00726232|448725506|FG007|Expansion Phase|Per Investigator: lack of response|7|||
124755200|NCT00726232|448725499|FG000|Expansion Phase|Unspecified reason|0|||
124755201|NCT00726232|448725500|FG001|Expansion Phase|Unspecified reason|0|||
124755202|NCT00726232|448725501|FG002|Expansion Phase|Unspecified reason|0|||
124755203|NCT00726232|448725502|FG003|Expansion Phase|Unspecified reason|0|||
124755204|NCT00726232|448725503|FG004|Expansion Phase|Unspecified reason|0|||
124755205|NCT00726232|448725504|FG005|Expansion Phase|Unspecified reason|0|||
124755206|NCT00726232|448725505|FG006|Expansion Phase|Unspecified reason|1|||
124755207|NCT00726232|448725506|FG007|Expansion Phase|Unspecified reason|0|||
124755208|NCT03088917|448725507|FG000|Overall Study|In care/cured elsewhere|15|||
124755209|NCT03088917|448725507|FG000|Overall Study|Refuse re-evaluation|13|||
124755210|NCT03088917|448725507|FG000|Overall Study|Contact not established|13|||
124755211|NCT03088917|448725507|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
124755212|NCT03088917|448725507|FG000|Overall Study|Moved outside study region|50|||
124755213|NCT05447663|448725509|FG000|Overall Study|Study terminated by Sponsor|5|||
124755214|NCT05447663|448725509|FG000|Overall Study|Death|2|||
124755215|NCT05447663|448725509|FG000|Overall Study|Withdrawal by Subject|1|||
124755216|NCT06041919|448725510|FG000|Overall Study|Lost to Follow-up|1|||
124755217|NCT06041919|448725511|FG001|Overall Study|Lost to Follow-up|0|||
124755218|NCT06041919|448725512|FG002|Overall Study|Lost to Follow-up|0|||
124755219|NCT06041919|448725513|FG003|Overall Study|Lost to Follow-up|0|||
124755220|NCT06041919|448725514|FG004|Overall Study|Lost to Follow-up|0|||
124755221|NCT06041919|448725510|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
124755222|NCT06041919|448725511|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
124755223|NCT06041919|448725512|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
124755224|NCT06041919|448725513|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
124755225|NCT06041919|448725514|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
124755226|NCT01221350|448725517|FG000|Overall Study|Discontinued intervention (GERD)|1|||
124755227|NCT01221350|448725518|FG001|Overall Study|Discontinued intervention (GERD)|0|||
124755228|NCT01221350|448725517|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
124755229|NCT01221350|448725518|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
124755230|NCT01221350|448725517|FG000|Overall Study|Withdrawal by Subject|4|||
124755231|NCT01221350|448725518|FG001|Overall Study|Withdrawal by Subject|2|||
124755232|NCT04209205|448725526|FG000|Overall Study|Adverse Event|2|||
124755233|NCT04209205|448725527|FG001|Overall Study|Adverse Event|3|||
124755234|NCT04209205|448725526|FG000|Overall Study|Lost to Follow-up|3|||
124755235|NCT04209205|448725527|FG001|Overall Study|Lost to Follow-up|1|||
124755236|NCT04209205|448725526|FG000|Overall Study|Physician Decision|1|||
124755237|NCT04209205|448725527|FG001|Overall Study|Physician Decision|1|||
124755238|NCT04209205|448725526|FG000|Overall Study|Subject decision|10|||
124755239|NCT04209205|448725527|FG001|Overall Study|Subject decision|10|||
124755240|NCT04209205|448725526|FG000|Overall Study|Progressive disease|1|||
124755241|NCT04209205|448725527|FG001|Overall Study|Progressive disease|0|||
124755242|NCT04209205|448725526|FG000|Overall Study|Protocol deviation|0|||
124755243|NCT04209205|448725527|FG001|Overall Study|Protocol deviation|1|||
124755244|NCT04209205|448725526|FG000|Overall Study|New therapy for study indication|1|||
124755245|NCT04209205|448725527|FG001|Overall Study|New therapy for study indication|0|||
124755246|NCT04209205|448725526|FG000|Overall Study|Adverse event - placebo not switched|0|||
124755247|NCT04209205|448725527|FG001|Overall Study|Adverse event - placebo not switched|1|||
124755248|NCT04209205|448725526|FG000|Overall Study|Subject decision - placebo not switched|0|||
124755249|NCT04209205|448725527|FG001|Overall Study|Subject decision - placebo not switched|5|||
124755250|NCT04209205|448725526|FG000|Overall Study|Death - placebo not switched|0|||
124755251|NCT04209205|448725527|FG001|Overall Study|Death - placebo not switched|1|||
124755252|NCT05236257|448725560|FG000|Overall Study|Ongoing with study treatment|29|||
124969462|NCT01439867|449517399|FG001|Overall Study|Non-compliance|1|||
124755253|NCT05236257|448725561|FG001|Overall Study|Ongoing with study treatment|1|||
124755254|NCT05236257|448725560|FG000|Overall Study|Discontinued study treatment|22|||
124755255|NCT05236257|448725561|FG001|Overall Study|Discontinued study treatment|41|||
124755256|NCT00924443|448725565|FG000|Overall Study|Physician Decision|2|||
124755257|NCT00924443|448725565|FG000|Overall Study|Protocol Violation|1|||
124755258|NCT01746225|448725567|FG000|Overall Study|Death|1|||
124755259|NCT01746225|448725568|FG001|Overall Study|Death|0|||
124755260|NCT01746225|448725569|FG002|Overall Study|Death|1|||
124755261|NCT01746225|448725567|FG000|Overall Study|Withdrawal by Subject|5|||
124755262|NCT01746225|448725568|FG001|Overall Study|Withdrawal by Subject|15|||
124755263|NCT01746225|448725569|FG002|Overall Study|Withdrawal by Subject|19|||
124755264|NCT01746225|448725567|FG000|Overall Study|Physician Decision|14|||
124755265|NCT01746225|448725568|FG001|Overall Study|Physician Decision|11|||
124755266|NCT01746225|448725569|FG002|Overall Study|Physician Decision|3|||
124755267|NCT01746225|448725567|FG000|Overall Study|Adverse Event|15|||
124755268|NCT01746225|448725568|FG001|Overall Study|Adverse Event|12|||
124755269|NCT01746225|448725569|FG002|Overall Study|Adverse Event|17|||
124755270|NCT01746225|448725567|FG000|Overall Study|Continuing Treatment|5|||
124755271|NCT01746225|448725568|FG001|Overall Study|Continuing Treatment|8|||
124755272|NCT01746225|448725569|FG002|Overall Study|Continuing Treatment|3|||
124755273|NCT03405818|448725570|FG000|Overall Study|Withdrawal by Subject|4|||
124755274|NCT03405818|448725570|FG000|Overall Study|Lost to Follow-up|4|||
124755275|NCT03197376|448725574|FG000|Primary and Booster Phase|Adverse Event|0|||
124755276|NCT03197376|448725575|FG001|Primary and Booster Phase|Adverse Event|0|||
124755277|NCT03197376|448725576|FG002|Primary and Booster Phase|Adverse Event|0|||
124755278|NCT03197376|448725577|FG003|Primary and Booster Phase|Adverse Event|1|||
124755279|NCT03197376|448725574|FG000|Primary and Booster Phase|Death|1|||
124755280|NCT03197376|448725575|FG001|Primary and Booster Phase|Death|0|||
124755281|NCT03197376|448725576|FG002|Primary and Booster Phase|Death|0|||
124755282|NCT03197376|448725577|FG003|Primary and Booster Phase|Death|2|||
124755283|NCT03197376|448725574|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
124755284|NCT03197376|448725575|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
124755285|NCT03197376|448725576|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
124755286|NCT03197376|448725577|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
124755287|NCT03197376|448725574|FG000|Primary and Booster Phase|Physician Decision|1|||
124755288|NCT03197376|448725575|FG001|Primary and Booster Phase|Physician Decision|0|||
124755289|NCT03197376|448725576|FG002|Primary and Booster Phase|Physician Decision|1|||
124755290|NCT03197376|448725577|FG003|Primary and Booster Phase|Physician Decision|3|||
124755291|NCT03197376|448725574|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
124755292|NCT03197376|448725575|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
124755293|NCT03197376|448725576|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
124755294|NCT03197376|448725577|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
124755295|NCT03197376|448725574|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
124755296|NCT03197376|448725575|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
124755297|NCT03197376|448725576|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
124755298|NCT03197376|448725577|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
124755299|NCT03197376|448725574|FG000|Primary and Booster Phase|Not vaccine related|1|||
124755300|NCT03197376|448725575|FG001|Primary and Booster Phase|Not vaccine related|2|||
124755301|NCT03197376|448725576|FG002|Primary and Booster Phase|Not vaccine related|0|||
124755302|NCT03197376|448725577|FG003|Primary and Booster Phase|Not vaccine related|6|||
124755303|NCT03197376|448725574|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
124755304|NCT03197376|448725575|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
124755305|NCT03197376|448725576|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
124755306|NCT03197376|448725577|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
124755307|NCT03197376|448725574|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
124755308|NCT03197376|448725575|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
124755309|NCT03197376|448725576|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
124755310|NCT03197376|448725577|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
124755311|NCT03197376|448725574|FG000|Immune Persistence Phase|Not vaccine related|1|||
124755312|NCT03197376|448725575|FG001|Immune Persistence Phase|Not vaccine related|0|||
124755313|NCT03197376|448725576|FG002|Immune Persistence Phase|Not vaccine related|1|||
124755314|NCT03197376|448725577|FG003|Immune Persistence Phase|Not vaccine related|1|||
124755315|NCT00003199|448725578|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
124755316|NCT00003199|448725578|FG000|Overall Study|Lack of insurance clearance|2|||
124755317|NCT00003199|448725578|FG000|Overall Study|Screen fail|15|||
124755318|NCT01223183|448725580|FG000|Imaging Day 1|Physician Decision|0|||
124755319|NCT01223183|448725581|FG001|Imaging Day 1|Physician Decision|1|||
124755320|NCT01223183|448725580|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
124755321|NCT01223183|448725581|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
124755322|NCT01223183|448725580|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
124755323|NCT01223183|448725581|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
124755324|NCT03777059|448727414|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
124755325|NCT03777059|448727415|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
124755326|NCT03777059|448727416|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
124755327|NCT03777059|448727417|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
124755328|NCT03777059|448727414|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
124755329|NCT03777059|448727415|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
124755330|NCT03777059|448727416|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
124755331|NCT03777059|448727417|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
124755332|NCT03777059|448727414|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
124755333|NCT03777059|448727415|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
124755334|NCT03777059|448727416|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
124755335|NCT03777059|448727417|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
124755336|NCT03777059|448727414|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
124755337|NCT03777059|448727415|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
124755338|NCT03777059|448727416|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
124755339|NCT03777059|448727417|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
124755340|NCT03777059|448727414|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
124755341|NCT03777059|448727415|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
124755342|NCT03777059|448727416|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
124755343|NCT03777059|448727417|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
124755344|NCT03777059|448727414|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
124755345|NCT03777059|448727415|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
124755346|NCT03777059|448727416|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
124755347|NCT03777059|448727417|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
124755348|NCT03777059|448727414|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
124755349|NCT03777059|448727415|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
124755350|NCT03777059|448727416|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
124755351|NCT03777059|448727417|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
124755352|NCT03777059|448727414|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
124755353|NCT03777059|448727415|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
124755354|NCT03777059|448727416|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
124755355|NCT03777059|448727417|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
124755356|NCT03777059|448727414|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
124755357|NCT03777059|448727415|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
124755358|NCT03777059|448727416|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
124755359|NCT03777059|448727417|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
124755360|NCT03777059|448727414|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
124755361|NCT03777059|448727415|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
124755362|NCT03777059|448727416|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
124755363|NCT03777059|448727417|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
124755364|NCT03777059|448727414|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
124755365|NCT03777059|448727415|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
124755366|NCT03777059|448727416|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
124755367|NCT03777059|448727417|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
124755368|NCT02813889|448727418|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
124755369|NCT02813889|448727419|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
124755370|NCT01101035|448727426|FG000|Overall Study|Adverse Event|191|||
124755371|NCT01101035|448727427|FG001|Overall Study|Adverse Event|172|||
124755372|NCT01101035|448727426|FG000|Overall Study|Major Protocol Deviation|52|||
124755373|NCT01101035|448727427|FG001|Overall Study|Major Protocol Deviation|46|||
124755374|NCT01101035|448727426|FG000|Overall Study|Lost to Follow-up|226|||
124755375|NCT01101035|448727427|FG001|Overall Study|Lost to Follow-up|223|||
124755376|NCT01101035|448727426|FG000|Overall Study|Voluntary Withdrawal|595|||
124755377|NCT01101035|448727427|FG001|Overall Study|Voluntary Withdrawal|587|||
124755378|NCT01101035|448727426|FG000|Overall Study|Reason not Specified|333|||
124755379|NCT01101035|448727427|FG001|Overall Study|Reason not Specified|363|||
124755380|NCT00681629|448727428|FG000|Overall Study|Study termination|4|||
124755381|NCT00681629|448727429|FG001|Overall Study|Study termination|2|||
124755382|NCT00681629|448727428|FG000|Overall Study|Adverse Event|1|||
124755383|NCT00681629|448727429|FG001|Overall Study|Adverse Event|0|||
124755384|NCT00411671|448727430|FG000|Overall Study|Adverse Event|15|||
124755385|NCT00411671|448727430|FG000|Overall Study|Death|2|||
124755386|NCT00411671|448727430|FG000|Overall Study|Lost to Follow-up|3|||
124755387|NCT01173601|448727434|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
124755388|NCT01173601|448727435|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124755389|NCT01173601|448727436|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124755390|NCT01173601|448727437|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124755391|NCT01173601|448727438|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124755392|NCT01173601|448727434|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
124755393|NCT01173601|448727435|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124755394|NCT01173601|448727436|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124755395|NCT01173601|448727437|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124755396|NCT01173601|448727438|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124755397|NCT01173601|448727434|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
124755398|NCT01173601|448727435|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124755399|NCT01173601|448727436|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124755400|NCT01173601|448727437|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124755401|NCT01173601|448727438|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124755402|NCT01173601|448727434|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
124755403|NCT01173601|448727435|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124755404|NCT01173601|448727436|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124755405|NCT01173601|448727437|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124755406|NCT01173601|448727438|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124755407|NCT01173601|448727434|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
124755408|NCT01173601|448727435|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124755409|NCT01173601|448727436|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124755410|NCT01173601|448727437|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124755411|NCT01173601|448727438|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124755412|NCT01173601|448727434|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
124755413|NCT01173601|448727435|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124755414|NCT01173601|448727436|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124755415|NCT01173601|448727437|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124755416|NCT01173601|448727438|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124755417|NCT01173601|448727434|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
124755418|NCT01173601|448727435|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124755419|NCT01173601|448727436|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124755420|NCT01173601|448727437|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124755421|NCT01173601|448727438|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124755422|NCT01173601|448727434|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
124755423|NCT01173601|448727435|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
124755424|NCT01173601|448727436|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
124755425|NCT01173601|448727437|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
124755426|NCT01173601|448727438|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
124755427|NCT01173601|448727434|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
124755428|NCT01173601|448727435|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
124755429|NCT01173601|448727436|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
124755430|NCT01173601|448727437|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
124755431|NCT01173601|448727438|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
124755432|NCT01173601|448727434|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
124755433|NCT01173601|448727435|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
124755434|NCT01173601|448727436|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
124755435|NCT01173601|448727437|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
124755436|NCT01173601|448727438|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
124755437|NCT01173601|448727434|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
124755438|NCT01173601|448727435|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
124755439|NCT01173601|448727436|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
124755440|NCT01173601|448727437|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
124755441|NCT01173601|448727438|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
124755442|NCT01173601|448727434|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
124755443|NCT01173601|448727435|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
124755444|NCT01173601|448727436|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
124755445|NCT01173601|448727437|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
124755446|NCT01173601|448727438|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
124755447|NCT01173601|448727434|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
124755448|NCT01173601|448727435|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
124755449|NCT01173601|448727436|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
124755450|NCT01173601|448727437|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
124755451|NCT01173601|448727438|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
124755452|NCT01173601|448727434|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
124755453|NCT01173601|448727435|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
124755454|NCT01173601|448727436|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
124755455|NCT01173601|448727437|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
124755456|NCT01173601|448727438|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
124755457|NCT03951077|448727439|FG000|Overall Study|Adverse Event|1|||
124755458|NCT03951077|448727440|FG001|Overall Study|Adverse Event|0|||
124755459|NCT03951077|448727441|FG002|Overall Study|Adverse Event|0|||
124977611|NCT05511038|449545440|FG000|Treatment|Withdrawal by Subject|5|||
124977612|NCT05511038|449545441|FG001|Treatment|Withdrawal by Subject|3|||
124977613|NCT05511038|449545440|FG000|Treatment|Physician Decision|4|||
124977614|NCT05511038|449545441|FG001|Treatment|Physician Decision|0|||
124977615|NCT05511038|449545440|FG000|Treatment|Lost to Follow-up|2|||
124977616|NCT05511038|449545441|FG001|Treatment|Lost to Follow-up|0|||
124755460|NCT03951077|448727442|FG003|Overall Study|Adverse Event|0|||
124755461|NCT03951077|448727443|FG004|Overall Study|Adverse Event|0|||
124755462|NCT03951077|448727444|FG005|Overall Study|Adverse Event|0|||
124755463|NCT03951077|448727439|FG000|Overall Study|Withdrawal by Subject|3|||
124755464|NCT03951077|448727440|FG001|Overall Study|Withdrawal by Subject|3|||
124755465|NCT03951077|448727441|FG002|Overall Study|Withdrawal by Subject|0|||
124755466|NCT03951077|448727442|FG003|Overall Study|Withdrawal by Subject|3|||
124755467|NCT03951077|448727443|FG004|Overall Study|Withdrawal by Subject|3|||
124755468|NCT03951077|448727444|FG005|Overall Study|Withdrawal by Subject|2|||
124755469|NCT03951077|448727439|FG000|Overall Study|Lost to Follow-up|1|||
124755470|NCT03951077|448727440|FG001|Overall Study|Lost to Follow-up|1|||
124755471|NCT03951077|448727441|FG002|Overall Study|Lost to Follow-up|2|||
124755472|NCT03951077|448727442|FG003|Overall Study|Lost to Follow-up|3|||
124755473|NCT03951077|448727443|FG004|Overall Study|Lost to Follow-up|2|||
124755474|NCT03951077|448727444|FG005|Overall Study|Lost to Follow-up|3|||
124755475|NCT03951077|448727439|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
124755476|NCT03951077|448727440|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
124755477|NCT03951077|448727441|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
124755478|NCT03951077|448727442|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
124755479|NCT03951077|448727443|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
124755480|NCT03951077|448727444|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
124755481|NCT03951077|448727439|FG000|Overall Study|Other, Not Specified|12|||
124755482|NCT03951077|448727440|FG001|Overall Study|Other, Not Specified|10|||
124755483|NCT03951077|448727441|FG002|Overall Study|Other, Not Specified|10|||
124755484|NCT03951077|448727442|FG003|Overall Study|Other, Not Specified|5|||
124755485|NCT03951077|448727443|FG004|Overall Study|Other, Not Specified|9|||
124755486|NCT03951077|448727444|FG005|Overall Study|Other, Not Specified|6|||
124755487|NCT03951077|448727439|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
124755488|NCT03951077|448727440|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
124755489|NCT03951077|448727441|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
124755490|NCT03951077|448727442|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
124977617|NCT05511038|449545440|FG000|Treatment|Death|1|||
124755491|NCT03951077|448727443|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
124755492|NCT03951077|448727444|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
124755493|NCT01395901|448727447|FG000|Overall Study|Lost to Follow-up|4|||
124755494|NCT01395901|448727448|FG001|Overall Study|Lost to Follow-up|0|||
124755495|NCT01395901|448727447|FG000|Overall Study|Randomized but not received study drug|5|||
124755496|NCT01395901|448727448|FG001|Overall Study|Randomized but not received study drug|4|||
124755497|NCT01395901|448727447|FG000|Overall Study|Adverse Event|0|||
124755498|NCT01395901|448727448|FG001|Overall Study|Adverse Event|1|||
124755499|NCT01395901|448727447|FG000|Overall Study|Withdrawal of consent|1|||
124755500|NCT01395901|448727448|FG001|Overall Study|Withdrawal of consent|0|||
124755501|NCT00713544|448727454|FG000|Overall Study|Adverse Event|5|||
124755502|NCT00713544|448727455|FG001|Overall Study|Adverse Event|3|||
124755503|NCT00713544|448727456|FG002|Overall Study|Adverse Event|7|||
124755504|NCT00713544|448727457|FG003|Overall Study|Adverse Event|7|||
124755505|NCT00713544|448727458|FG004|Overall Study|Adverse Event|3|||
124755506|NCT00713544|448727459|FG005|Overall Study|Adverse Event|5|||
124755507|NCT00713544|448727454|FG000|Overall Study|Withdrawal by Subject|2|||
124755508|NCT00713544|448727455|FG001|Overall Study|Withdrawal by Subject|0|||
124755509|NCT00713544|448727456|FG002|Overall Study|Withdrawal by Subject|3|||
124755510|NCT00713544|448727457|FG003|Overall Study|Withdrawal by Subject|2|||
124755511|NCT00713544|448727458|FG004|Overall Study|Withdrawal by Subject|3|||
124755512|NCT00713544|448727459|FG005|Overall Study|Withdrawal by Subject|1|||
124644665|NCT02829723|448316481|FG022|Overall Study|Study terminated by sponsor|0|||
124644666|NCT02829723|448316482|FG023|Overall Study|Study terminated by sponsor|0|||
124644667|NCT02829723|448316483|FG024|Overall Study|Study terminated by sponsor|0|||
124644668|NCT02829723|448316484|FG025|Overall Study|Study terminated by sponsor|0|||
124644669|NCT02829723|448316485|FG026|Overall Study|Study terminated by sponsor|0|||
124644670|NCT02989649|448316486|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
124644671|NCT02989649|448316486|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
124644672|NCT02989649|448316486|FG000|Overall Study|Lost For Observation During Study|3|||
124644673|NCT02989649|448316486|FG000|Overall Study|Reason Not Specified|13|||
124977618|NCT05511038|449545441|FG001|Treatment|Death|0|||
124644674|NCT00330343|448316487|FG000|Overall Study|Lost to Follow-up|5|||
124755513|NCT00713544|448727454|FG000|Overall Study|Protocol Violation|0|||
124755514|NCT00713544|448727455|FG001|Overall Study|Protocol Violation|0|||
124755515|NCT00713544|448727456|FG002|Overall Study|Protocol Violation|0|||
124755516|NCT00713544|448727457|FG003|Overall Study|Protocol Violation|0|||
124644675|NCT03614078|448316488|FG000|Overall Study|Withdrawal by Subject|2|||
124644676|NCT03614078|448316489|FG001|Overall Study|Withdrawal by Subject|2|||
124644677|NCT03614078|448316490|FG002|Overall Study|Withdrawal by Subject|3|||
124644678|NCT03614078|448316488|FG000|Overall Study|Participant Did Not Return for Visit|0|||
124644679|NCT03614078|448316489|FG001|Overall Study|Participant Did Not Return for Visit|1|||
124644680|NCT03614078|448316490|FG002|Overall Study|Participant Did Not Return for Visit|0|||
124644681|NCT03614078|448316488|FG000|Overall Study|High Neutrophils|0|||
124644682|NCT03614078|448316489|FG001|Overall Study|High Neutrophils|0|||
124644683|NCT03614078|448316490|FG002|Overall Study|High Neutrophils|2|||
124644684|NCT03614078|448316488|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
124644685|NCT03614078|448316489|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
124644686|NCT03614078|448316490|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
124644687|NCT03614078|448316488|FG000|Overall Study|Exacerbation of Psoriasis|0|||
124755517|NCT00713544|448727458|FG004|Overall Study|Protocol Violation|0|||
124755518|NCT00713544|448727459|FG005|Overall Study|Protocol Violation|1|||
124755519|NCT00713544|448727454|FG000|Overall Study|Physician Decision|0|||
124755520|NCT00713544|448727455|FG001|Overall Study|Physician Decision|0|||
124755521|NCT00713544|448727456|FG002|Overall Study|Physician Decision|0|||
124755522|NCT00713544|448727457|FG003|Overall Study|Physician Decision|0|||
124755523|NCT00713544|448727458|FG004|Overall Study|Physician Decision|0|||
124755524|NCT00713544|448727459|FG005|Overall Study|Physician Decision|2|||
124755525|NCT00713544|448727454|FG000|Overall Study|Lack of Efficacy|0|||
124755526|NCT00713544|448727455|FG001|Overall Study|Lack of Efficacy|1|||
124755527|NCT00713544|448727456|FG002|Overall Study|Lack of Efficacy|0|||
124755528|NCT00713544|448727457|FG003|Overall Study|Lack of Efficacy|1|||
124755529|NCT00713544|448727458|FG004|Overall Study|Lack of Efficacy|1|||
124755530|NCT00713544|448727459|FG005|Overall Study|Lack of Efficacy|0|||
124755531|NCT00713544|448727454|FG000|Overall Study|Lost to Follow-up|0|||
124755532|NCT00713544|448727455|FG001|Overall Study|Lost to Follow-up|0|||
124755533|NCT00713544|448727456|FG002|Overall Study|Lost to Follow-up|1|||
124755534|NCT00713544|448727457|FG003|Overall Study|Lost to Follow-up|0|||
124755535|NCT00713544|448727458|FG004|Overall Study|Lost to Follow-up|0|||
124755536|NCT00713544|448727459|FG005|Overall Study|Lost to Follow-up|0|||
124755537|NCT00713544|448727454|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
124755538|NCT00713544|448727455|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
124755539|NCT00713544|448727456|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
124755540|NCT00713544|448727457|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
124755541|NCT00713544|448727458|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
124755542|NCT00713544|448727459|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
124755543|NCT00713544|448727454|FG000|Overall Study|Incorrect enrollment|0|||
124755544|NCT00713544|448727455|FG001|Overall Study|Incorrect enrollment|1|||
124755545|NCT00713544|448727456|FG002|Overall Study|Incorrect enrollment|0|||
124755546|NCT00713544|448727457|FG003|Overall Study|Incorrect enrollment|0|||
124755547|NCT00713544|448727458|FG004|Overall Study|Incorrect enrollment|0|||
124755548|NCT00713544|448727459|FG005|Overall Study|Incorrect enrollment|0|||
124755549|NCT00713544|448727454|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
124755550|NCT00713544|448727455|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
124755551|NCT00713544|448727456|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
124755552|NCT00713544|448727457|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
124755553|NCT00713544|448727458|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
124755554|NCT00713544|448727459|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
124755555|NCT02380287|448727460|FG000|Overall Study|Adverse Event|0|||
124755556|NCT02380287|448727461|FG001|Overall Study|Adverse Event|0|||
124755557|NCT02380287|448727462|FG002|Overall Study|Adverse Event|1|||
124755558|NCT02380287|448727463|FG003|Overall Study|Adverse Event|0|||
124755559|NCT02380287|448727464|FG004|Overall Study|Adverse Event|0|||
124755560|NCT02380287|448727465|FG005|Overall Study|Adverse Event|0|||
124755561|NCT02380287|448727466|FG006|Overall Study|Adverse Event|0|||
124755562|NCT02380287|448727467|FG007|Overall Study|Adverse Event|0|||
124755563|NCT01641601|448727468|FG000|Overall Study|Study discontinued.|3|||
124755564|NCT01641601|448727469|FG001|Overall Study|Study discontinued.|5|||
124755565|NCT00950846|448727473|FG000|Overall Study|Death|6|||
124755566|NCT00950846|448727473|FG000|Overall Study|Lost to Follow-up|3|||
124755567|NCT00950846|448727473|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
124755568|NCT02178995|448727474|FG000|Double Blind|Adverse Event|0|||
124755569|NCT02178995|448727475|FG001|Double Blind|Adverse Event|0|||
124755570|NCT02178995|448727476|FG002|Double Blind|Adverse Event|0|||
124755571|NCT02178995|448727477|FG003|Double Blind|Adverse Event|0|||
124755572|NCT02178995|448727478|FG004|Double Blind|Adverse Event|0|||
124755573|NCT02178995|448727479|FG005|Double Blind|Adverse Event|1|||
124755574|NCT02178995|448727480|FG006|Double Blind|Adverse Event|0|||
124755575|NCT02178995|448727481|FG007|Double Blind|Adverse Event|1|||
124755576|NCT02178995|448727482|FG008|Double Blind|Adverse Event|1|||
124755577|NCT02178995|448727474|FG000|Double Blind|Lost to Follow-up|0|||
124755578|NCT02178995|448727475|FG001|Double Blind|Lost to Follow-up|1|||
124755579|NCT02178995|448727476|FG002|Double Blind|Lost to Follow-up|0|||
124755580|NCT02178995|448727477|FG003|Double Blind|Lost to Follow-up|0|||
124755581|NCT02178995|448727478|FG004|Double Blind|Lost to Follow-up|0|||
124755582|NCT02178995|448727479|FG005|Double Blind|Lost to Follow-up|0|||
124755583|NCT02178995|448727480|FG006|Double Blind|Lost to Follow-up|0|||
124755584|NCT02178995|448727481|FG007|Double Blind|Lost to Follow-up|1|||
124755585|NCT02178995|448727482|FG008|Double Blind|Lost to Follow-up|0|||
124755586|NCT02178995|448727474|FG000|Open Label|Adverse Event|2|||
124755587|NCT02178995|448727475|FG001|Open Label|Adverse Event|0|||
124755588|NCT02178995|448727476|FG002|Open Label|Adverse Event|0|||
124755589|NCT02178995|448727477|FG003|Open Label|Adverse Event|0|||
124755590|NCT02178995|448727478|FG004|Open Label|Adverse Event|0|||
124755591|NCT02178995|448727479|FG005|Open Label|Adverse Event|0|||
124755592|NCT02178995|448727480|FG006|Open Label|Adverse Event|0|||
124755593|NCT02178995|448727481|FG007|Open Label|Adverse Event|0|||
124755594|NCT02178995|448727482|FG008|Open Label|Adverse Event|0|||
124755595|NCT00587158|448727483|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
124755596|NCT00587158|448727484|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
124755597|NCT00587158|448727483|FG000|Overall Study|Physician Decision|0|||
124755598|NCT00587158|448727484|FG001|Overall Study|Physician Decision|1|||
124755599|NCT00587158|448727483|FG000|Overall Study|Lost to Follow-up|1|||
124755600|NCT00587158|448727484|FG001|Overall Study|Lost to Follow-up|2|||
124755601|NCT00587158|448727483|FG000|Overall Study|Death|0|||
124755602|NCT00587158|448727484|FG001|Overall Study|Death|1|||
124755603|NCT00587158|448727483|FG000|Overall Study|Subject did not want to take study med|0|||
124755604|NCT00587158|448727484|FG001|Overall Study|Subject did not want to take study med|1|||
124755605|NCT05258149|448727485|FG000|Period 1|Protocol Deviation|1|||
124755606|NCT05258149|448727486|FG001|Period 1|Protocol Deviation|0|||
124755607|NCT05258149|448727485|FG000|Period 1|Adverse Event|0|||
124755608|NCT05258149|448727486|FG001|Period 1|Adverse Event|1|||
124755609|NCT05258149|448727485|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
124755610|NCT05258149|448727486|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
124755611|NCT05258149|448727485|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
124755612|NCT05258149|448727486|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
124755613|NCT05258149|448727485|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
124755614|NCT05258149|448727486|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
124755615|NCT00832416|448727487|FG000|Overall Study|Lack of Efficacy|17|||
124755616|NCT00832416|448727488|FG001|Overall Study|Lack of Efficacy|15|||
124755617|NCT00832416|448727489|FG002|Overall Study|Lack of Efficacy|13|||
124755618|NCT00832416|448727490|FG003|Overall Study|Lack of Efficacy|52|||
124755619|NCT00832416|448727487|FG000|Overall Study|Withdrawal by Subject|5|||
124755620|NCT00832416|448727488|FG001|Overall Study|Withdrawal by Subject|7|||
124755621|NCT00832416|448727489|FG002|Overall Study|Withdrawal by Subject|2|||
124755622|NCT00832416|448727490|FG003|Overall Study|Withdrawal by Subject|10|||
124755623|NCT00832416|448727487|FG000|Overall Study|Physician Decision|2|||
124755624|NCT00832416|448727488|FG001|Overall Study|Physician Decision|12|||
124755625|NCT00832416|448727489|FG002|Overall Study|Physician Decision|5|||
124755626|NCT00832416|448727490|FG003|Overall Study|Physician Decision|10|||
124755627|NCT00832416|448727487|FG000|Overall Study|Administrative|0|||
124755628|NCT00832416|448727488|FG001|Overall Study|Administrative|0|||
124755629|NCT00832416|448727489|FG002|Overall Study|Administrative|0|||
124755630|NCT00832416|448727490|FG003|Overall Study|Administrative|1|||
124755631|NCT00832416|448727487|FG000|Overall Study|Adverse Event|21|||
124755632|NCT00832416|448727488|FG001|Overall Study|Adverse Event|19|||
124755633|NCT00832416|448727489|FG002|Overall Study|Adverse Event|41|||
124755634|NCT00832416|448727490|FG003|Overall Study|Adverse Event|10|||
124755635|NCT00832416|448727487|FG000|Overall Study|Death|1|||
124755636|NCT00832416|448727488|FG001|Overall Study|Death|0|||
124755637|NCT00832416|448727489|FG002|Overall Study|Death|0|||
124755638|NCT00832416|448727490|FG003|Overall Study|Death|0|||
124755639|NCT02114606|448727491|FG000|Overall Study|Unable to swallow Cytosponge|6|||
124755640|NCT00981461|448727492|FG000|Overall Study|Lost to Follow-up|5|||
124755641|NCT00981461|448727493|FG001|Overall Study|Lost to Follow-up|2|||
124755642|NCT01910402|448727504|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
124755643|NCT01910402|448727505|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
124755644|NCT01910402|448727506|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
124755645|NCT01910402|448727504|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
124755646|NCT01910402|448727505|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
124755647|NCT01910402|448727506|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
124755648|NCT01910402|448727504|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
124755649|NCT01910402|448727505|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
124755650|NCT01910402|448727506|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
124755651|NCT01910402|448727504|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
124755652|NCT01910402|448727505|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
124755653|NCT01910402|448727506|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
124755654|NCT01910402|448727504|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
124755655|NCT01910402|448727505|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
124755656|NCT01910402|448727506|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
124755657|NCT01910402|448727504|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
124755658|NCT01910402|448727505|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
124755659|NCT01910402|448727506|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
124755660|NCT01910402|448727504|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
124755661|NCT01910402|448727505|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
124755662|NCT01910402|448727506|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
124755663|NCT01910402|448727504|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
124755664|NCT01910402|448727505|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
124755665|NCT01910402|448727506|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
124755666|NCT01910402|448727504|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
124755667|NCT01910402|448727505|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
124755668|NCT01910402|448727506|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
124755669|NCT01910402|448727504|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
124755670|NCT01910402|448727505|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
124755671|NCT01910402|448727506|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
124755672|NCT01910402|448727504|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
124755673|NCT01910402|448727505|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
124755674|NCT01910402|448727506|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
124755675|NCT01910402|448727504|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
124755676|NCT01910402|448727505|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
124755677|NCT01910402|448727506|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
124755678|NCT01910402|448727504|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
124755679|NCT01910402|448727505|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
124755680|NCT01910402|448727506|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
124755681|NCT00483405|448727507|FG000|Overall Study|Adverse Event|8|||
124755682|NCT00483405|448727507|FG000|Overall Study|Lack of Efficacy|14|||
124755683|NCT00483405|448727507|FG000|Overall Study|Death|3|||
124755684|NCT00483405|448727507|FG000|Overall Study|Withdrawal by Subject|2|||
124755685|NCT00483405|448727507|FG000|Overall Study|Other complicating disease|1|||
124755686|NCT00571038|448727508|FG000|Overall Study|Lost to Follow-up|1|||
124755687|NCT00571038|448727509|FG001|Overall Study|Lost to Follow-up|4|||
124755688|NCT00571038|448727508|FG000|Overall Study|Death|7|||
124755689|NCT00571038|448727509|FG001|Overall Study|Death|5|||
124755690|NCT00571038|448727508|FG000|Overall Study|Withdrawal by Subject|1|||
124755691|NCT00571038|448727509|FG001|Overall Study|Withdrawal by Subject|3|||
124755692|NCT00571038|448727508|FG000|Overall Study|Moved out of state|2|||
124755693|NCT00571038|448727509|FG001|Overall Study|Moved out of state|2|||
124755694|NCT01442714|448727510|FG000|Overall Study|Death|11|||
124755695|NCT01442714|448727510|FG000|Overall Study|Withdrawal by Subject|1|||
124755696|NCT04306510|448727511|FG000|Overall Study|Voluntarily withdrawal|1|||
124755697|NCT04306510|448727511|FG000|Overall Study|Enrolled but Not Treated|1|||
124755698|NCT04829916|448727518|FG000|Overall Study|Withdrawal by Subject|1|||
124755699|NCT04829916|448727519|FG001|Overall Study|Withdrawal by Subject|0|||
124755700|NCT04343755|448727520|FG000|Overall Study|Death|11|||
124755701|NCT04343755|448727520|FG000|Overall Study|Screen Failure|1|||
124755702|NCT00193206|448727521|FG000|Preoperative Therapy|Lack of Efficacy|2|||
124755703|NCT00193206|448727521|FG000|Preoperative Therapy|Adverse Event|2|||
124755704|NCT00193206|448727521|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
124755705|NCT00193206|448727521|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
124755706|NCT00193206|448727521|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
124755707|NCT00193206|448727521|FG000|Postoperative Therapy|Physician Decision|3|||
124755708|NCT00193206|448727521|FG000|Postoperative Therapy|Intercurrent Illness|2|||
124755709|NCT00193206|448727521|FG000|Postoperative Therapy|Lack of Efficacy|1|||
124755710|NCT00193206|448727521|FG000|Postoperative Therapy|Protocol Violation|1|||
124755711|NCT02940496|448727522|FG000|Overall Study|Adverse Event|1|||
124755712|NCT02940496|448727523|FG001|Overall Study|Adverse Event|0|||
124755713|NCT02940496|448727522|FG000|Overall Study|Death|2|||
124755714|NCT02940496|448727523|FG001|Overall Study|Death|0|||
124755715|NCT02940496|448727522|FG000|Overall Study|Hospice Care|1|||
124755716|NCT02940496|448727523|FG001|Overall Study|Hospice Care|0|||
124755717|NCT02940496|448727522|FG000|Overall Study|No MRE Done|1|||
124755718|NCT02940496|448727523|FG001|Overall Study|No MRE Done|0|||
124755719|NCT02940496|448727522|FG000|Overall Study|MRE Failure|1|||
124755720|NCT02940496|448727523|FG001|Overall Study|MRE Failure|0|||
124755721|NCT01147055|448727531|FG000|First Intervention Period|Lost to Follow-up|1|||
124755722|NCT01147055|448727532|FG001|First Intervention Period|Lost to Follow-up|0|||
124755723|NCT00132808|448727533|FG000|Stratum I|Adverse Event|2|||
124755724|NCT00132808|448727534|FG001|Stratum I|Adverse Event|1|||
124755725|NCT00132808|448727535|FG002|Stratum I|Adverse Event|0|||
124755726|NCT00132808|448727533|FG000|Stratum I|Lost to Follow-up|3|||
124755727|NCT00132808|448727534|FG001|Stratum I|Lost to Follow-up|4|||
124755728|NCT00132808|448727535|FG002|Stratum I|Lost to Follow-up|1|||
124755729|NCT00132808|448727533|FG000|Stratum I|Withdrawal by Subject|4|||
124755730|NCT00132808|448727534|FG001|Stratum I|Withdrawal by Subject|7|||
124755731|NCT00132808|448727535|FG002|Stratum I|Withdrawal by Subject|3|||
124755732|NCT00132808|448727533|FG000|Stratum I|Abnormal test procedure result (s)|0|||
124755733|NCT00132808|448727534|FG001|Stratum I|Abnormal test procedure result (s)|0|||
124755734|NCT00132808|448727535|FG002|Stratum I|Abnormal test procedure result (s)|1|||
124755735|NCT00132808|448727533|FG000|Stratum II|Adverse Event|1|||
124755736|NCT00132808|448727534|FG001|Stratum II|Adverse Event|2|||
124755737|NCT00132808|448727535|FG002|Stratum II|Adverse Event|1|||
124755738|NCT00132808|448727533|FG000|Stratum II|Death|1|||
124755739|NCT00132808|448727534|FG001|Stratum II|Death|0|||
124755740|NCT00132808|448727535|FG002|Stratum II|Death|0|||
124755741|NCT00132808|448727533|FG000|Stratum II|Lost to Follow-up|2|||
124755742|NCT00132808|448727534|FG001|Stratum II|Lost to Follow-up|2|||
124755743|NCT00132808|448727535|FG002|Stratum II|Lost to Follow-up|1|||
124755744|NCT00132808|448727533|FG000|Stratum II|Protocol Violation|0|||
124755745|NCT00132808|448727534|FG001|Stratum II|Protocol Violation|2|||
124755746|NCT00132808|448727535|FG002|Stratum II|Protocol Violation|1|||
124755747|NCT00132808|448727533|FG000|Stratum II|Withdrawal by Subject|4|||
124755748|NCT00132808|448727534|FG001|Stratum II|Withdrawal by Subject|9|||
124755749|NCT00132808|448727535|FG002|Stratum II|Withdrawal by Subject|6|||
124755750|NCT02204072|448727542|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
124755751|NCT02204072|448727543|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
124755752|NCT02204072|448727544|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
124755753|NCT02204072|448727545|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
124755754|NCT02204072|448727546|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
124755755|NCT02204072|448727542|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
124755756|NCT02204072|448727543|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
124755757|NCT02204072|448727544|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
124755758|NCT02204072|448727545|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
124755759|NCT02204072|448727546|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
124755760|NCT02204072|448727542|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
124755761|NCT02204072|448727543|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
124755762|NCT02204072|448727544|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
124755763|NCT02204072|448727545|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
124755764|NCT02204072|448727546|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
124755765|NCT02204072|448727542|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
124755766|NCT02204072|448727543|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
124755767|NCT02204072|448727544|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
124755768|NCT02204072|448727545|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
124755769|NCT02204072|448727546|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
124755770|NCT00874848|448727551|FG000|Overall Study|Adverse Event|13|||
124755771|NCT00874848|448727552|FG001|Overall Study|Adverse Event|2|||
124755772|NCT00874848|448727551|FG000|Overall Study|Progressive neoplastic disease|38|||
124755773|NCT00874848|448727552|FG001|Overall Study|Progressive neoplastic disease|18|||
124755774|NCT00874848|448727551|FG000|Overall Study|Withdrawal by Subject|7|||
124755775|NCT00874848|448727552|FG001|Overall Study|Withdrawal by Subject|4|||
124755776|NCT00874848|448727551|FG000|Overall Study|Noncompliance|1|||
124755777|NCT00874848|448727552|FG001|Overall Study|Noncompliance|1|||
124755778|NCT00874848|448727551|FG000|Overall Study|Failure to comply with protocol|0|||
124755779|NCT00874848|448727552|FG001|Overall Study|Failure to comply with protocol|1|||
124755780|NCT00874848|448727551|FG000|Overall Study|Physician Decision|0|||
124755781|NCT00874848|448727552|FG001|Overall Study|Physician Decision|2|||
124755782|NCT01870726|448727557|FG000|Overall Study|Withdrawal of informed consent|0|||
124755783|NCT01870726|448727558|FG001|Overall Study|Withdrawal of informed consent|0|||
124755784|NCT01870726|448727559|FG002|Overall Study|Withdrawal of informed consent|0|||
124755785|NCT01870726|448727560|FG003|Overall Study|Withdrawal of informed consent|1|||
124755786|NCT01870726|448727561|FG004|Overall Study|Withdrawal of informed consent|0|||
124755787|NCT01870726|448727562|FG005|Overall Study|Withdrawal of informed consent|0|||
124755788|NCT01870726|448727563|FG006|Overall Study|Withdrawal of informed consent|0|||
124755789|NCT01870726|448727557|FG000|Overall Study|Withdrawal by Subject|0|||
124755790|NCT01870726|448727558|FG001|Overall Study|Withdrawal by Subject|1|||
124755791|NCT01870726|448727559|FG002|Overall Study|Withdrawal by Subject|0|||
124755792|NCT01870726|448727560|FG003|Overall Study|Withdrawal by Subject|0|||
124755793|NCT01870726|448727561|FG004|Overall Study|Withdrawal by Subject|0|||
124755794|NCT01870726|448727562|FG005|Overall Study|Withdrawal by Subject|0|||
124755795|NCT01870726|448727563|FG006|Overall Study|Withdrawal by Subject|0|||
124755796|NCT01870726|448727557|FG000|Overall Study|Adverse Event|0|||
124755797|NCT01870726|448727558|FG001|Overall Study|Adverse Event|0|||
124755798|NCT01870726|448727559|FG002|Overall Study|Adverse Event|0|||
124755799|NCT01870726|448727560|FG003|Overall Study|Adverse Event|0|||
124755800|NCT01870726|448727561|FG004|Overall Study|Adverse Event|1|||
124755801|NCT01870726|448727562|FG005|Overall Study|Adverse Event|1|||
124755802|NCT01870726|448727563|FG006|Overall Study|Adverse Event|0|||
124755803|NCT01870726|448727557|FG000|Overall Study|Progressive disease|5|||
124755804|NCT01870726|448727558|FG001|Overall Study|Progressive disease|5|||
124755805|NCT01870726|448727559|FG002|Overall Study|Progressive disease|4|||
124755806|NCT01870726|448727560|FG003|Overall Study|Progressive disease|5|||
124755807|NCT01870726|448727561|FG004|Overall Study|Progressive disease|6|||
124755808|NCT01870726|448727562|FG005|Overall Study|Progressive disease|4|||
124755809|NCT01870726|448727563|FG006|Overall Study|Progressive disease|10|||
124755810|NCT00286429|448727564|FG000|Overall Study|Adverse Event|4|||
124755811|NCT00286429|448727565|FG001|Overall Study|Adverse Event|1|||
124755812|NCT00286429|448727566|FG002|Overall Study|Adverse Event|6|||
124755813|NCT00286429|448727564|FG000|Overall Study|Lack of Efficacy|52|||
124755814|NCT00286429|448727565|FG001|Overall Study|Lack of Efficacy|27|||
124755815|NCT00286429|448727566|FG002|Overall Study|Lack of Efficacy|25|||
124755816|NCT00286429|448727564|FG000|Overall Study|Lost to Follow-up|2|||
124755817|NCT00286429|448727565|FG001|Overall Study|Lost to Follow-up|4|||
124755818|NCT00286429|448727566|FG002|Overall Study|Lost to Follow-up|3|||
124755819|NCT00286429|448727564|FG000|Overall Study|Physician Decision|10|||
124755820|NCT00286429|448727565|FG001|Overall Study|Physician Decision|7|||
124755821|NCT00286429|448727566|FG002|Overall Study|Physician Decision|7|||
124755822|NCT00286429|448727564|FG000|Overall Study|Protocol Violation|3|||
124755823|NCT00286429|448727565|FG001|Overall Study|Protocol Violation|5|||
124755824|NCT00286429|448727566|FG002|Overall Study|Protocol Violation|4|||
124755825|NCT00286429|448727564|FG000|Overall Study|Withdrawal by Subject|3|||
124755826|NCT00286429|448727565|FG001|Overall Study|Withdrawal by Subject|2|||
124755827|NCT00286429|448727566|FG002|Overall Study|Withdrawal by Subject|6|||
124755828|NCT00286429|448727564|FG000|Overall Study|Administrative Error|1|||
124755829|NCT00286429|448727565|FG001|Overall Study|Administrative Error|1|||
124755830|NCT00286429|448727566|FG002|Overall Study|Administrative Error|1|||
124755831|NCT00286429|448727564|FG000|Overall Study|Administrative Decision|0|||
124755832|NCT00286429|448727565|FG001|Overall Study|Administrative Decision|1|||
124755833|NCT00286429|448727566|FG002|Overall Study|Administrative Decision|0|||
124755834|NCT00595478|448727569|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
124755835|NCT00595478|448727570|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
124755836|NCT00595478|448727569|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
124755837|NCT00595478|448727570|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
124755838|NCT01123395|448727572|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
124755839|NCT01123395|448727573|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
124755840|NCT03691571|448727574|FG000|Overall Study|Withdrawal by Subject|9|||
124755841|NCT03691571|448727575|FG001|Overall Study|Withdrawal by Subject|2|||
124755842|NCT00186901|448727577|FG000|Overall Study|Pregnancy|6|||
124755843|NCT00186901|448727578|FG001|Overall Study|Pregnancy|3|||
124755844|NCT00186901|448727579|FG002|Overall Study|Pregnancy|0|||
124755845|NCT00186901|448727577|FG000|Overall Study|Lost to Follow-up|6|||
124755846|NCT00186901|448727578|FG001|Overall Study|Lost to Follow-up|3|||
124755847|NCT00186901|448727579|FG002|Overall Study|Lost to Follow-up|0|||
124755848|NCT00186901|448727577|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
124755849|NCT00186901|448727578|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
124755850|NCT00186901|448727579|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
124755851|NCT00186901|448727577|FG000|Overall Study|ALL relapse or second malignancy|1|||
124755852|NCT00186901|448727578|FG001|Overall Study|ALL relapse or second malignancy|2|||
124755853|NCT00186901|448727579|FG002|Overall Study|ALL relapse or second malignancy|0|||
124755854|NCT00186901|448727577|FG000|Overall Study|Withdrawal by Subject|4|||
124755855|NCT00186901|448727578|FG001|Overall Study|Withdrawal by Subject|5|||
124755856|NCT00186901|448727579|FG002|Overall Study|Withdrawal by Subject|0|||
124755857|NCT00186901|448727577|FG000|Overall Study|Open label|3|||
124755858|NCT00186901|448727578|FG001|Overall Study|Open label|2|||
124755859|NCT00186901|448727579|FG002|Overall Study|Open label|0|||
124755860|NCT00186901|448727577|FG000|Overall Study|Limited adherence to study requirements|20|||
124755861|NCT00186901|448727578|FG001|Overall Study|Limited adherence to study requirements|23|||
124755862|NCT00186901|448727579|FG002|Overall Study|Limited adherence to study requirements|0|||
124755863|NCT00186901|448727577|FG000|Overall Study|Bone Mineral Density > 0|0|||
124755864|NCT00186901|448727578|FG001|Overall Study|Bone Mineral Density > 0|0|||
124755865|NCT00186901|448727579|FG002|Overall Study|Bone Mineral Density > 0|149|||
124755866|NCT02363959|448727584|FG000|Overall Study|Medical instability|1|||
124755867|NCT02363959|448727585|FG001|Overall Study|Medical instability|0|||
124755868|NCT00950248|448727588|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
124755869|NCT00950248|448727589|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
124755870|NCT00950248|448727590|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
124755871|NCT00950248|448727588|FG000|Year 1: Baseline|worsening of symptoms|2|||
124755872|NCT00950248|448727589|FG001|Year 1: Baseline|worsening of symptoms|0|||
124977619|NCT05511038|449545440|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
124755873|NCT00950248|448727590|FG002|Year 1: Baseline|worsening of symptoms|0|||
124755874|NCT00950248|448727588|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
124755875|NCT00950248|448727589|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
124755876|NCT00950248|448727590|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
124755877|NCT00950248|448727588|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
124755878|NCT00950248|448727589|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
124755879|NCT00950248|448727590|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
124755880|NCT00950248|448727588|FG000|Year 2&3 Treatment Randomization|Death|0|||
124755881|NCT00950248|448727589|FG001|Year 2&3 Treatment Randomization|Death|0|||
124755882|NCT00950248|448727590|FG002|Year 2&3 Treatment Randomization|Death|1|||
124755883|NCT00950248|448727588|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
124755884|NCT00950248|448727589|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
124755885|NCT00950248|448727590|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
124755886|NCT00869518|448727594|FG000|Overall Study|Lost to Follow-up|1|||
124755887|NCT00869518|448727595|FG001|Overall Study|Lost to Follow-up|1|||
124755888|NCT00947115|448727596|FG000|Overall Study|Missed reporting interval|3|||
124755889|NCT00947115|448727597|FG001|Overall Study|Missed reporting interval|4|||
124755890|NCT00947115|448727598|FG002|Overall Study|Missed reporting interval|2|||
124755891|NCT00947115|448727596|FG000|Overall Study|Physician Decision|0|||
124755892|NCT00947115|448727597|FG001|Overall Study|Physician Decision|2|||
124755893|NCT00947115|448727598|FG002|Overall Study|Physician Decision|0|||
124755894|NCT00947115|448727596|FG000|Overall Study|Death|0|||
124755895|NCT00947115|448727597|FG001|Overall Study|Death|1|||
124755896|NCT00947115|448727598|FG002|Overall Study|Death|1|||
124755897|NCT00947115|448727596|FG000|Overall Study|Migrated from study area|2|||
124755898|NCT00947115|448727597|FG001|Overall Study|Migrated from study area|0|||
124755899|NCT00947115|448727598|FG002|Overall Study|Migrated from study area|0|||
124755900|NCT00947115|448727596|FG000|Overall Study|Withdrawal by Subject|1|||
124755901|NCT00947115|448727597|FG001|Overall Study|Withdrawal by Subject|3|||
124755902|NCT00947115|448727598|FG002|Overall Study|Withdrawal by Subject|4|||
124755903|NCT00947115|448727596|FG000|Overall Study|Lost to Follow-up|11|||
124755904|NCT00947115|448727597|FG001|Overall Study|Lost to Follow-up|12|||
124755905|NCT00947115|448727598|FG002|Overall Study|Lost to Follow-up|8|||
124755906|NCT00511238|448727601|FG000|Overall Study|Adverse Event|13|||
124755907|NCT00511238|448727602|FG001|Overall Study|Adverse Event|33|||
124755908|NCT00511238|448727601|FG000|Overall Study|Withdrawal by Subject|2|||
124755909|NCT00511238|448727602|FG001|Overall Study|Withdrawal by Subject|22|||
124755910|NCT00511238|448727601|FG000|Overall Study|Progressive Disease|23|||
124755911|NCT00511238|448727602|FG001|Overall Study|Progressive Disease|157|||
124755912|NCT00511238|448727601|FG000|Overall Study|various reasons|4|||
124755913|NCT00511238|448727602|FG001|Overall Study|various reasons|14|||
124755914|NCT02587819|448727603|FG000|Overall Study|Adverse Event|1|||
124755915|NCT02587819|448727603|FG000|Overall Study|Lost to Follow-up|1|||
124755916|NCT03772665|448727604|FG000|Overall Study|Protocol Violation|1|||
124755917|NCT03772665|448727605|FG001|Overall Study|Protocol Violation|0|||
124755918|NCT02871635|448729359|FG000|Overall Study|Primary lack of efficacy|4|||
124755919|NCT02871635|448729360|FG001|Overall Study|Primary lack of efficacy|4|||
124755920|NCT02871635|448729359|FG000|Overall Study|Protocol Violation|3|||
124755921|NCT02871635|448729360|FG001|Overall Study|Protocol Violation|1|||
124755922|NCT02871635|448729359|FG000|Overall Study|Lost to Follow-up|1|||
124755923|NCT02871635|448729360|FG001|Overall Study|Lost to Follow-up|2|||
124755924|NCT02871635|448729359|FG000|Overall Study|Pregnancy|0|||
124755925|NCT02871635|448729360|FG001|Overall Study|Pregnancy|2|||
124755926|NCT02871635|448729359|FG000|Overall Study|Physician Decision|1|||
124755927|NCT02871635|448729360|FG001|Overall Study|Physician Decision|1|||
124755928|NCT02871635|448729359|FG000|Overall Study|Withdrawal by Subject|3|||
124755929|NCT02871635|448729360|FG001|Overall Study|Withdrawal by Subject|4|||
124755930|NCT02871635|448729359|FG000|Overall Study|Adverse Event|4|||
124755931|NCT02871635|448729360|FG001|Overall Study|Adverse Event|4|||
124755932|NCT02871635|448729359|FG000|Overall Study|Secondary lack of efficacy|2|||
124755933|NCT02871635|448729360|FG001|Overall Study|Secondary lack of efficacy|1|||
124755934|NCT02420379|448729361|FG000|Overall Study|Withdrawal by Subject|0|||
124755935|NCT02420379|448729362|FG001|Overall Study|Withdrawal by Subject|3|||
124755936|NCT02420379|448729361|FG000|Overall Study|Unable to complete due to schooling|0|||
124755937|NCT02420379|448729362|FG001|Overall Study|Unable to complete due to schooling|1|||
124755938|NCT02420379|448729361|FG000|Overall Study|Transitioned to commercial drug|1|||
124755939|NCT02420379|448729362|FG001|Overall Study|Transitioned to commercial drug|0|||
124755940|NCT00502671|448729363|FG000|Overall Study|Disease Progression|13|||
124755941|NCT00502671|448729363|FG000|Overall Study|Personal Reasons|22|||
124755942|NCT00502671|448729363|FG000|Overall Study|Lost to Follow-up|7|||
124755943|NCT00502671|448729363|FG000|Overall Study|Protocol Violation|16|||
124755944|NCT00502671|448729363|FG000|Overall Study|Adverse Event|19|||
124755945|NCT00412893|448729372|FG000|Overall Study|Adverse Event|31|||
124755946|NCT00412893|448729373|FG001|Overall Study|Adverse Event|53|||
124755947|NCT00412893|448729372|FG000|Overall Study|Death|17|||
124755948|NCT00412893|448729373|FG001|Overall Study|Death|21|||
124755949|NCT00412893|448729372|FG000|Overall Study|Insufficient Therapeutic Response|39|||
124755950|NCT00412893|448729373|FG001|Overall Study|Insufficient Therapeutic Response|23|||
124755951|NCT00412893|448729372|FG000|Overall Study|Lost to Follow-up|2|||
124755952|NCT00412893|448729373|FG001|Overall Study|Lost to Follow-up|1|||
124755953|NCT00412893|448729372|FG000|Overall Study|Violation of Selection at Entry|17|||
124755954|NCT00412893|448729373|FG001|Overall Study|Violation of Selection at Entry|10|||
124755955|NCT00412893|448729372|FG000|Overall Study|Other Protocol Violation|10|||
124755956|NCT00412893|448729373|FG001|Overall Study|Other Protocol Violation|6|||
124755957|NCT00412893|448729372|FG000|Overall Study|Did Not Cooperate|12|||
124755958|NCT00412893|448729373|FG001|Overall Study|Did Not Cooperate|9|||
124755959|NCT00412893|448729372|FG000|Overall Study|Administrative Reason|12|||
124755960|NCT00412893|448729373|FG001|Overall Study|Administrative Reason|15|||
124755961|NCT00412893|448729372|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
124755962|NCT00412893|448729373|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
124755963|NCT00853151|448729374|FG000|Overall Study|Adverse Event|1|||
124755964|NCT00853151|448729375|FG001|Overall Study|Adverse Event|4|||
124755965|NCT00853151|448729376|FG002|Overall Study|Adverse Event|2|||
124755966|NCT00853151|448729377|FG003|Overall Study|Adverse Event|0|||
124755967|NCT00853151|448729374|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
124755968|NCT00853151|448729375|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124755969|NCT00853151|448729376|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124755970|NCT00853151|448729377|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124755971|NCT00853151|448729374|FG000|Overall Study|Lost to Follow-up|2|||
124755972|NCT00853151|448729375|FG001|Overall Study|Lost to Follow-up|0|||
124755973|NCT00853151|448729376|FG002|Overall Study|Lost to Follow-up|3|||
124755974|NCT00853151|448729377|FG003|Overall Study|Lost to Follow-up|0|||
124755975|NCT00853151|448729374|FG000|Overall Study|Death|1|||
124755976|NCT00853151|448729375|FG001|Overall Study|Death|0|||
124755977|NCT00853151|448729376|FG002|Overall Study|Death|0|||
124755978|NCT00853151|448729377|FG003|Overall Study|Death|1|||
124755979|NCT00853151|448729374|FG000|Overall Study|Protocol Violation|0|||
124755980|NCT00853151|448729375|FG001|Overall Study|Protocol Violation|0|||
124755981|NCT00853151|448729376|FG002|Overall Study|Protocol Violation|0|||
124755982|NCT00853151|448729377|FG003|Overall Study|Protocol Violation|1|||
124755983|NCT00853151|448729374|FG000|Overall Study|Withdrawal by Subject|5|||
124755984|NCT00853151|448729375|FG001|Overall Study|Withdrawal by Subject|4|||
124755985|NCT00853151|448729376|FG002|Overall Study|Withdrawal by Subject|2|||
124755986|NCT00853151|448729377|FG003|Overall Study|Withdrawal by Subject|1|||
124755987|NCT00853151|448729374|FG000|Overall Study|Physician Decision|0|||
124755988|NCT00853151|448729375|FG001|Overall Study|Physician Decision|2|||
124755989|NCT00853151|448729376|FG002|Overall Study|Physician Decision|1|||
124755990|NCT00853151|448729377|FG003|Overall Study|Physician Decision|0|||
124755991|NCT00853151|448729374|FG000|Overall Study|Sponsor Decision|0|||
124755992|NCT00853151|448729375|FG001|Overall Study|Sponsor Decision|3|||
124755993|NCT00853151|448729376|FG002|Overall Study|Sponsor Decision|0|||
124755994|NCT00853151|448729377|FG003|Overall Study|Sponsor Decision|0|||
124755995|NCT00269919|448729378|FG000|Overall Study|Other|26|||
124755996|NCT00269919|448729378|FG000|Overall Study|Started but not treated|1|||
124755997|NCT04473963|448729381|FG000|Overall Study|Withdrawal by Subject|1|||
124755998|NCT04473963|448729382|FG001|Overall Study|Withdrawal by Subject|1|||
124755999|NCT04473963|448729383|FG002|Overall Study|Withdrawal by Subject|0|||
124756000|NCT04473963|448729381|FG000|Overall Study|Not inducible in AF|0|||
124756001|NCT04473963|448729382|FG001|Overall Study|Not inducible in AF|0|||
124756002|NCT04473963|448729383|FG002|Overall Study|Not inducible in AF|2|||
124756003|NCT01799226|448729386|FG000|Overall Study|Withdrawal by Subject|1|||
124756004|NCT01799226|448729387|FG001|Overall Study|Withdrawal by Subject|0|||
124756005|NCT01799226|448729386|FG000|Overall Study|Disqualified at Day 14|1|||
124756006|NCT01799226|448729387|FG001|Overall Study|Disqualified at Day 14|0|||
124756007|NCT02274792|448729388|FG000|Overall Study|Withdrawal by Subject|13|||
124756008|NCT02274792|448729388|FG000|Overall Study|Lost to Follow-up|8|||
124756009|NCT02274792|448729388|FG000|Overall Study|Protocol Specified Criteria|2|||
124756010|NCT02274792|448729388|FG000|Overall Study|Sponsor Decision|2|||
124756011|NCT01388907|448729397|FG000|Overall Study|Adverse Event|2|||
124756012|NCT01388907|448729398|FG001|Overall Study|Adverse Event|0|||
124756013|NCT03361293|448729399|FG000|Overall Study|Lost to Follow-up|0|||
124756014|NCT03361293|448729400|FG001|Overall Study|Lost to Follow-up|2|||
124756015|NCT03361293|448729399|FG000|Overall Study|Withdrawal by Subject|1|||
124756016|NCT03361293|448729400|FG001|Overall Study|Withdrawal by Subject|3|||
124756017|NCT03187132|448729404|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
124756018|NCT03187132|448729405|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
124756019|NCT03187132|448729404|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
124756020|NCT03187132|448729405|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
124756021|NCT03187132|448729404|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
124756022|NCT03187132|448729405|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
124756023|NCT03187132|448729404|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
124756024|NCT03187132|448729405|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
124756025|NCT03187132|448729404|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
124756026|NCT03187132|448729405|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
124756027|NCT03187132|448729404|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
124756028|NCT03187132|448729405|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
124977620|NCT05511038|449545441|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
124977621|NCT05511038|449545440|FG000|Treatment|Refuse by subject|1|||
124977622|NCT05511038|449545441|FG001|Treatment|Refuse by subject|0|||
124977623|NCT05511038|449545440|FG000|Treatment|Subject did not go to the site for visit|1|||
124977624|NCT05511038|449545441|FG001|Treatment|Subject did not go to the site for visit|0|||
124977625|NCT05140915|449545442|FG000|Overall Study|Lost to Follow-up|2|||
124977626|NCT05140915|449545443|FG001|Overall Study|Lost to Follow-up|1|||
124977627|NCT04879849|449545444|FG000|Overall Study|Lost to Follow-up|0|||
124977628|NCT04879849|449545445|FG001|Overall Study|Lost to Follow-up|0|||
124977629|NCT04879849|449545446|FG002|Overall Study|Lost to Follow-up|0|||
124977630|NCT04879849|449545447|FG003|Overall Study|Lost to Follow-up|1|||
124977631|NCT04879849|449545448|FG004|Overall Study|Lost to Follow-up|0|||
124977632|NCT04879849|449545449|FG005|Overall Study|Lost to Follow-up|0|||
124977633|NCT04879849|449545450|FG006|Overall Study|Lost to Follow-up|0|||
124977634|NCT04879849|449545451|FG007|Overall Study|Lost to Follow-up|0|||
124977635|NCT04879849|449545444|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
124977636|NCT04879849|449545445|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
124977637|NCT04879849|449545446|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
124977638|NCT04879849|449545447|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
124977639|NCT04879849|449545448|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
124977640|NCT04879849|449545449|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
124756029|NCT03187132|448729404|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
124756030|NCT03187132|448729405|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
124756031|NCT03187132|448729404|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
124977641|NCT04879849|449545450|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
124977642|NCT04879849|449545451|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
124977643|NCT04879849|449545444|FG000|Overall Study|Withdrawal by Subject|0|||
124756032|NCT03187132|448729405|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
124756033|NCT03187132|448729404|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
124756034|NCT03187132|448729405|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
124756035|NCT03187132|448729404|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
124756036|NCT03187132|448729405|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
124756037|NCT03187132|448729404|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
124756038|NCT03187132|448729405|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
124756039|NCT03594773|448729406|FG000|Overall Study|Withdrawal by Subject|3|||
124756040|NCT03594773|448729407|FG001|Overall Study|Withdrawal by Subject|2|||
124756041|NCT03594773|448729406|FG000|Overall Study|Lost to Follow-up|3|||
124756042|NCT03594773|448729407|FG001|Overall Study|Lost to Follow-up|4|||
124756043|NCT01550757|448729408|FG000|Overall Study|Lost to Follow-up|21|||
124756044|NCT01550757|448729409|FG001|Overall Study|Lost to Follow-up|14|||
124756045|NCT01550757|448729410|FG002|Overall Study|Lost to Follow-up|42|||
124756046|NCT01550757|448729411|FG003|Overall Study|Lost to Follow-up|53|||
124756047|NCT01550757|448729408|FG000|Overall Study|Withdrawal by Subject|2|||
124756048|NCT01550757|448729409|FG001|Overall Study|Withdrawal by Subject|0|||
124756049|NCT01550757|448729410|FG002|Overall Study|Withdrawal by Subject|3|||
124756050|NCT01550757|448729411|FG003|Overall Study|Withdrawal by Subject|1|||
124756051|NCT04098809|448729413|FG000|Overall Study|Withdrawal by Subject|1|||
124756052|NCT04098809|448729414|FG001|Overall Study|Withdrawal by Subject|3|||
124756053|NCT04098809|448729413|FG000|Overall Study|Physician Decision|2|||
124756054|NCT04098809|448729414|FG001|Overall Study|Physician Decision|1|||
124756055|NCT02741596|448729416|FG000|Overall Study|Adverse Event|1|||
124756056|NCT02741596|448729417|FG001|Overall Study|Adverse Event|5|||
124756057|NCT02741596|448729416|FG000|Overall Study|Lost to Follow-up|1|||
124756058|NCT02741596|448729417|FG001|Overall Study|Lost to Follow-up|1|||
124756059|NCT02741596|448729416|FG000|Overall Study|Physician Decision|2|||
124756060|NCT02741596|448729417|FG001|Overall Study|Physician Decision|1|||
124756061|NCT02741596|448729416|FG000|Overall Study|Pregnancy|3|||
124756062|NCT02741596|448729417|FG001|Overall Study|Pregnancy|1|||
124756063|NCT02741596|448729416|FG000|Overall Study|Other (Unspecified)|0|||
124756064|NCT02741596|448729417|FG001|Overall Study|Other (Unspecified)|3|||
124756065|NCT02741596|448729416|FG000|Overall Study|Subject withdrawn-Other|17|||
124756066|NCT02741596|448729417|FG001|Overall Study|Subject withdrawn-Other|4|||
124756067|NCT02741596|448729416|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
124756068|NCT02741596|448729417|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
124756069|NCT01426958|448729418|FG000|Overall Study|Adverse Event|2|||
124756070|NCT02859246|448729421|FG000|Overall Study|Screen fails|3|||
124756071|NCT02859246|448729421|FG000|Overall Study|Adverse Event|1|||
124977644|NCT04879849|449545445|FG001|Overall Study|Withdrawal by Subject|0|||
124977645|NCT04879849|449545446|FG002|Overall Study|Withdrawal by Subject|0|||
124977646|NCT04879849|449545447|FG003|Overall Study|Withdrawal by Subject|0|||
124756072|NCT02859246|448729421|FG000|Overall Study|Withdrawal by Subject|1|||
124756073|NCT00100789|448729422|FG000|Overall Study|Adverse Event|10|||
124756074|NCT00100789|448729422|FG000|Overall Study|Withdrawal by Subject|1|||
124977647|NCT04879849|449545448|FG004|Overall Study|Withdrawal by Subject|2|||
124756075|NCT00100789|448729422|FG000|Overall Study|Progression/relapse|42|||
124756076|NCT00100789|448729422|FG000|Overall Study|Death|2|||
124756077|NCT00100789|448729422|FG000|Overall Study|Not protocol specified|5|||
124756078|NCT00100789|448729422|FG000|Overall Study|Ineligible|3|||
124756079|NCT00100789|448729422|FG000|Overall Study|Never received treatment|1|||
124756080|NCT01746368|448729423|FG000|Overall Study|Lost to Follow-up|2|||
124756081|NCT01746368|448729424|FG001|Overall Study|Lost to Follow-up|0|||
124756082|NCT01746368|448729423|FG000|Overall Study|Withdrawal by Subject|0|||
124756083|NCT01746368|448729424|FG001|Overall Study|Withdrawal by Subject|1|||
124756084|NCT05280717|448729425|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
124866791|NCT00127101|449133649|FG005|Continuation Phase|Lack of Efficacy|1|||
124866792|NCT00127101|449133644|FG000|Continuation Phase|Withdrawal by Subject|0|||
124866793|NCT00127101|449133645|FG001|Continuation Phase|Withdrawal by Subject|0|||
124866794|NCT00127101|449133646|FG002|Continuation Phase|Withdrawal by Subject|1|||
124756085|NCT05280717|448729426|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
124756086|NCT05280717|448729427|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
124756087|NCT05280717|448729428|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
124756088|NCT05280717|448729429|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
124756089|NCT05280717|448729430|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
124756090|NCT05280717|448729431|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
124756091|NCT05280717|448729425|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
124756092|NCT05280717|448729426|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
124756093|NCT05280717|448729427|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
124756094|NCT05280717|448729428|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
124756095|NCT05280717|448729429|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
124756096|NCT05280717|448729430|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
124756097|NCT05280717|448729431|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
124756098|NCT05280717|448729425|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
124756099|NCT05280717|448729426|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
124756100|NCT05280717|448729427|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
124756101|NCT05280717|448729428|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
124756102|NCT05280717|448729429|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
124756103|NCT05280717|448729430|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
124756104|NCT05280717|448729431|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
124756105|NCT05280717|448729425|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
124756106|NCT05280717|448729426|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
124756107|NCT05280717|448729427|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
124756108|NCT05280717|448729428|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
124756109|NCT05280717|448729429|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
124756110|NCT05280717|448729430|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
124756111|NCT05280717|448729431|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
124756112|NCT05280717|448729425|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
124756113|NCT05280717|448729426|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
124756114|NCT05280717|448729427|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
124756115|NCT05280717|448729428|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
124756116|NCT05280717|448729429|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
124756117|NCT05280717|448729430|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
124756118|NCT05280717|448729431|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
124756119|NCT05280717|448729425|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
124756120|NCT05280717|448729426|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
124866795|NCT00127101|449133647|FG003|Continuation Phase|Withdrawal by Subject|0|||
124866796|NCT00127101|449133648|FG004|Continuation Phase|Withdrawal by Subject|2|||
124866797|NCT00127101|449133649|FG005|Continuation Phase|Withdrawal by Subject|1|||
124866798|NCT00843167|449133650|FG000|Treatment Period|Adverse Event|1|||
124866799|NCT00843167|449133651|FG001|Treatment Period|Adverse Event|5|||
124866800|NCT00843167|449133650|FG000|Treatment Period|Withdrawal by Subject|2|||
124866801|NCT00843167|449133651|FG001|Treatment Period|Withdrawal by Subject|3|||
124866802|NCT01565707|449133652|FG000|Overall Study|Adverse Event|1|||
124866803|NCT01565707|449133653|FG001|Overall Study|Adverse Event|6|||
124866804|NCT01565707|449133654|FG002|Overall Study|Adverse Event|2|||
124866805|NCT01565707|449133655|FG003|Overall Study|Adverse Event|1|||
124866806|NCT01565707|449133652|FG000|Overall Study|Lost to Follow-up|1|||
124866807|NCT01565707|449133653|FG001|Overall Study|Lost to Follow-up|0|||
124866808|NCT01565707|449133654|FG002|Overall Study|Lost to Follow-up|0|||
124866809|NCT01565707|449133655|FG003|Overall Study|Lost to Follow-up|0|||
124866810|NCT01565707|449133652|FG000|Overall Study|Protocol Violation|1|||
124866811|NCT01565707|449133653|FG001|Overall Study|Protocol Violation|0|||
124866812|NCT01565707|449133654|FG002|Overall Study|Protocol Violation|0|||
124866813|NCT01565707|449133655|FG003|Overall Study|Protocol Violation|1|||
124866814|NCT01565707|449133652|FG000|Overall Study|Withdrawal by Subject|3|||
124866815|NCT01565707|449133653|FG001|Overall Study|Withdrawal by Subject|1|||
124866816|NCT01565707|449133654|FG002|Overall Study|Withdrawal by Subject|1|||
124866817|NCT01565707|449133655|FG003|Overall Study|Withdrawal by Subject|1|||
124866818|NCT01565707|449133652|FG000|Overall Study|Randomized but not evaluable|2|||
124866819|NCT01565707|449133653|FG001|Overall Study|Randomized but not evaluable|0|||
124866820|NCT01565707|449133654|FG002|Overall Study|Randomized but not evaluable|0|||
124866821|NCT01565707|449133655|FG003|Overall Study|Randomized but not evaluable|0|||
124866822|NCT01565707|449133652|FG000|Overall Study|Miscellaneous|1|||
124756121|NCT05280717|448729427|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
124756122|NCT05280717|448729428|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
124756123|NCT05280717|448729429|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
124756124|NCT05280717|448729430|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
124756125|NCT05280717|448729431|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
124756126|NCT00080301|448729432|FG000|Overall Study|Randomized but Never Treated|5|||
124756127|NCT00080301|448729433|FG001|Overall Study|Randomized but Never Treated|10|||
124756128|NCT00080301|448729432|FG000|Overall Study|Still on Treatment as of CSR date|0|||
124756129|NCT00080301|448729433|FG001|Overall Study|Still on Treatment as of CSR date|1|||
124756130|NCT00740584|448729434|FG000|Overall Study|Withdrawal by Subject|1|||
124756131|NCT02073682|448729442|FG000|Overall Study|Low Creatinine Clearance|1|||
124756132|NCT02073682|448729443|FG001|Overall Study|Low Creatinine Clearance|2|||
124756133|NCT02073682|448729442|FG000|Overall Study|Death|86|||
124756134|NCT02073682|448729443|FG001|Overall Study|Death|100|||
124756135|NCT02073682|448729442|FG000|Overall Study|Cancer Cured|10|||
124756136|NCT02073682|448729443|FG001|Overall Study|Cancer Cured|15|||
124756137|NCT02073682|448729442|FG000|Overall Study|ID: Patient Noncompliance|1|||
124756138|NCT02073682|448729443|FG001|Overall Study|ID: Patient Noncompliance|2|||
124756139|NCT02073682|448729442|FG000|Overall Study|ID: Palliative Treatment Only|10|||
124756140|NCT02073682|448729443|FG001|Overall Study|ID: Palliative Treatment Only|7|||
124756141|NCT02073682|448729442|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
124756142|NCT02073682|448729443|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
124756143|NCT02073682|448729442|FG000|Overall Study|Platelet Count <50,000/mL|1|||
124756144|NCT02073682|448729443|FG001|Overall Study|Platelet Count <50,000/mL|2|||
124756145|NCT02073682|448729442|FG000|Overall Study|Surgery/Medical Procedure|3|||
124756146|NCT02073682|448729443|FG001|Overall Study|Surgery/Medical Procedure|1|||
124756147|NCT02073682|448729442|FG000|Overall Study|Withdrawal by Subject|6|||
124756148|NCT02073682|448729443|FG001|Overall Study|Withdrawal by Subject|8|||
124756149|NCT02073682|448729442|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
124756150|NCT02073682|448729443|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
124756151|NCT02073682|448729442|FG000|Overall Study|Cancer Progression|53|||
124756152|NCT02073682|448729443|FG001|Overall Study|Cancer Progression|33|||
124756153|NCT02073682|448729442|FG000|Overall Study|Protocol Violation|1|||
124756154|NCT02073682|448729443|FG001|Overall Study|Protocol Violation|0|||
124756155|NCT02073682|448729442|FG000|Overall Study|Adverse Event|79|||
124756156|NCT02073682|448729443|FG001|Overall Study|Adverse Event|62|||
124756157|NCT02073682|448729442|FG000|Overall Study|No reason provided|11|||
124756158|NCT02073682|448729443|FG001|Overall Study|No reason provided|9|||
124756159|NCT02073682|448729442|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
124756160|NCT02073682|448729443|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
124756161|NCT02073682|448729442|FG000|Overall Study|Lost to Follow-up|1|||
124756162|NCT02073682|448729443|FG001|Overall Study|Lost to Follow-up|1|||
124756163|NCT02073682|448729442|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
124756164|NCT02073682|448729443|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
124756165|NCT03461146|448729444|FG000|Overall Study|Adverse Event|2|||
124756166|NCT03461146|448729444|FG000|Overall Study|Physician Decision|1|||
124756167|NCT00181766|448729445|FG000|Overall Study|Lost to Follow-up|6|||
124756168|NCT00181766|448729445|FG000|Overall Study|Adverse Event|4|||
124756169|NCT00181766|448729445|FG000|Overall Study|non-compliance|2|||
124756170|NCT00855816|448729446|FG000|Overall Study|Withdrawal by Subject|22|||
124756171|NCT00855816|448729447|FG001|Overall Study|Withdrawal by Subject|15|||
124756172|NCT00855816|448729446|FG000|Overall Study|Lost to Follow-up|3|||
124756173|NCT00855816|448729447|FG001|Overall Study|Lost to Follow-up|5|||
124756174|NCT00855816|448729446|FG000|Overall Study|Death|1|||
124756175|NCT00855816|448729447|FG001|Overall Study|Death|0|||
124756176|NCT00855816|448729446|FG000|Overall Study|Became ineligible|0|||
124756177|NCT00855816|448729447|FG001|Overall Study|Became ineligible|1|||
124756178|NCT01965704|448729451|FG000|Overall Study|Withdrawal by Subject|2|||
124756179|NCT01965704|448729452|FG001|Overall Study|Withdrawal by Subject|2|||
124756180|NCT01965704|448729453|FG002|Overall Study|Withdrawal by Subject|1|||
124866823|NCT01565707|449133653|FG001|Overall Study|Miscellaneous|1|||
124756181|NCT01965704|448729454|FG003|Overall Study|Withdrawal by Subject|1|||
124866824|NCT01565707|449133654|FG002|Overall Study|Miscellaneous|0|||
124866825|NCT01565707|449133655|FG003|Overall Study|Miscellaneous|2|||
124866826|NCT04302350|449133656|FG000|Overall Study|Physician Decision|1|||
124866827|NCT04302350|449133657|FG001|Overall Study|Physician Decision|1|||
124866828|NCT04302350|449133658|FG002|Overall Study|Physician Decision|2|||
124866829|NCT04302350|449133656|FG000|Overall Study|Lack of Efficacy|1|||
124866830|NCT04302350|449133657|FG001|Overall Study|Lack of Efficacy|1|||
124866831|NCT04302350|449133658|FG002|Overall Study|Lack of Efficacy|4|||
124977648|NCT04879849|449545449|FG005|Overall Study|Withdrawal by Subject|0|||
124977649|NCT04879849|449545450|FG006|Overall Study|Withdrawal by Subject|1|||
124977650|NCT04879849|449545451|FG007|Overall Study|Withdrawal by Subject|0|||
124977651|NCT04879849|449545444|FG000|Overall Study|Progressive Disease|0|||
124977652|NCT04879849|449545445|FG001|Overall Study|Progressive Disease|0|||
124977653|NCT04879849|449545446|FG002|Overall Study|Progressive Disease|1|||
124977654|NCT04879849|449545447|FG003|Overall Study|Progressive Disease|0|||
124977655|NCT04879849|449545448|FG004|Overall Study|Progressive Disease|0|||
124977656|NCT04879849|449545449|FG005|Overall Study|Progressive Disease|0|||
124977657|NCT04879849|449545450|FG006|Overall Study|Progressive Disease|0|||
124977658|NCT04879849|449545451|FG007|Overall Study|Progressive Disease|0|||
124977659|NCT04879849|449545444|FG000|Overall Study|Death|0|||
124866832|NCT04302350|449133656|FG000|Overall Study|Adverse Event|0|||
124977660|NCT04879849|449545445|FG001|Overall Study|Death|0|||
124977661|NCT04879849|449545446|FG002|Overall Study|Death|1|||
124866833|NCT04302350|449133657|FG001|Overall Study|Adverse Event|1|||
124866834|NCT04302350|449133658|FG002|Overall Study|Adverse Event|2|||
124866835|NCT02012491|449133659|FG000|Overall Study|Lost to Follow-up|1|||
124866836|NCT02012491|449133660|FG001|Overall Study|Lost to Follow-up|0|||
124866837|NCT02012491|449133659|FG000|Overall Study|Protocol Violation|0|||
124866838|NCT02012491|449133660|FG001|Overall Study|Protocol Violation|1|||
124866839|NCT02012491|449133659|FG000|Overall Study|Withdrawal by Subject|1|||
124866840|NCT02012491|449133660|FG001|Overall Study|Withdrawal by Subject|0|||
124866841|NCT03762473|449133661|FG000|Overall Study|Death|1|||
124866842|NCT03762473|449133662|FG001|Overall Study|Death|0|||
124866843|NCT00126438|449133663|FG000|Overall Study|Withdrawal due to adverse event|1|||
124866844|NCT00126438|449133664|FG001|Overall Study|Withdrawal due to adverse event|0|||
124866845|NCT00126438|449133663|FG000|Overall Study|Lost to Follow-up|22|||
124866846|NCT00126438|449133664|FG001|Overall Study|Lost to Follow-up|0|||
124866847|NCT00126438|449133663|FG000|Overall Study|Protocol Violation|8|||
124866848|NCT00126438|449133664|FG001|Overall Study|Protocol Violation|8|||
124977662|NCT04879849|449545447|FG003|Overall Study|Death|1|||
124977663|NCT04879849|449545448|FG004|Overall Study|Death|1|||
124977664|NCT04879849|449545449|FG005|Overall Study|Death|2|||
124977665|NCT04879849|449545450|FG006|Overall Study|Death|1|||
124977666|NCT04879849|449545451|FG007|Overall Study|Death|2|||
124977667|NCT04879849|449545444|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
124977668|NCT04879849|449545445|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
124977669|NCT04879849|449545446|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
124977670|NCT04879849|449545447|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
124977671|NCT04879849|449545448|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
124977672|NCT04879849|449545449|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
124977673|NCT04879849|449545450|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
124977674|NCT04879849|449545451|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
124977675|NCT04879849|449545444|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
124977676|NCT04879849|449545445|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
124977677|NCT04879849|449545446|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
124977678|NCT04879849|449545447|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
124977679|NCT04879849|449545448|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
124977680|NCT04879849|449545449|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
124977681|NCT04879849|449545450|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
124977682|NCT04879849|449545451|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
124977683|NCT04879849|449545444|FG000|Overall Study|Reason Not Specified|1|||
124977684|NCT04879849|449545445|FG001|Overall Study|Reason Not Specified|0|||
124977685|NCT04879849|449545446|FG002|Overall Study|Reason Not Specified|0|||
124977686|NCT04879849|449545447|FG003|Overall Study|Reason Not Specified|0|||
124977687|NCT04879849|449545448|FG004|Overall Study|Reason Not Specified|0|||
124866849|NCT00126438|449133663|FG000|Overall Study|Withdrawal by Subject|3|||
124866850|NCT00126438|449133664|FG001|Overall Study|Withdrawal by Subject|2|||
124866851|NCT01389973|449133668|FG000|Overall Study|Lost to Follow-up|1|||
124866852|NCT01389973|449133668|FG000|Overall Study|Trial Stopped by Sponsor|9|||
124866853|NCT01389973|449133668|FG000|Overall Study|Other|10|||
124866854|NCT02626780|449133669|FG000|Overall Study|Withdrawal by Subject|3|||
124866855|NCT03456700|449133670|FG000|Overall Study|Withdrawal by Subject|1|||
124977688|NCT04879849|449545449|FG005|Overall Study|Reason Not Specified|0|||
124977689|NCT04879849|449545450|FG006|Overall Study|Reason Not Specified|0|||
124977690|NCT04879849|449545451|FG007|Overall Study|Reason Not Specified|0|||
124977691|NCT03810235|449545454|FG000|Overall Study|Withdrawal by Subject|2|||
124977692|NCT03810235|449545455|FG001|Overall Study|Withdrawal by Subject|0|||
124977693|NCT04777864|449545456|FG000|Overall Study|Lost to Follow-up|8|||
124977694|NCT04777864|449545457|FG001|Overall Study|Lost to Follow-up|19|||
124977695|NCT05576662|449545458|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
124977696|NCT05576662|449545459|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
124977697|NCT05576662|449545458|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
124977698|NCT05576662|449545459|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
124977699|NCT05576662|449545458|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
124977700|NCT05576662|449545459|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
124977701|NCT05576662|449545458|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
124977702|NCT05576662|449545459|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
124756182|NCT01965704|448729451|FG000|Overall Study|Delivered at home|1|||
124756183|NCT01965704|448729452|FG001|Overall Study|Delivered at home|1|||
124756184|NCT01965704|448729453|FG002|Overall Study|Delivered at home|0|||
124866856|NCT04154787|449133671|FG000|Overall Study|Adverse Event|0|||
124866857|NCT04154787|449133672|FG001|Overall Study|Adverse Event|1|||
124866858|NCT04154787|449133673|FG002|Overall Study|Adverse Event|0|||
124866859|NCT04154787|449133671|FG000|Overall Study|Patient Requires Other Treatment|0|||
124866860|NCT04154787|449133672|FG001|Overall Study|Patient Requires Other Treatment|1|||
124866861|NCT04154787|449133673|FG002|Overall Study|Patient Requires Other Treatment|0|||
124866862|NCT04154787|449133671|FG000|Overall Study|Study Terminated By Sponsor|0|||
124866863|NCT04154787|449133672|FG001|Overall Study|Study Terminated By Sponsor|6|||
124866864|NCT04154787|449133673|FG002|Overall Study|Study Terminated By Sponsor|1|||
124866865|NCT04154787|449133671|FG000|Overall Study|Subject Decision|0|||
124866866|NCT04154787|449133672|FG001|Overall Study|Subject Decision|1|||
124866867|NCT04154787|449133673|FG002|Overall Study|Subject Decision|0|||
124866868|NCT04154787|449133671|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
124866869|NCT04154787|449133672|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
124866870|NCT04154787|449133673|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
124866871|NCT02858895|449133678|FG000|Overall Study|Disease progression|31|||
124866872|NCT02858895|449133678|FG000|Overall Study|Death|2|||
124866873|NCT02858895|449133678|FG000|Overall Study|Adverse Event|1|||
124866874|NCT02858895|449133678|FG000|Overall Study|Withdrawal by Subject|3|||
124866875|NCT02858895|449133678|FG000|Overall Study|hospice,|1|||
124866876|NCT02858895|449133678|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
124866877|NCT02277444|449133690|FG000|Overall Study|Adverse Event|10|||
124866878|NCT02277444|449133690|FG000|Overall Study|Withdrawal by Subject|3|||
124866879|NCT02277444|449133690|FG000|Overall Study|Other|1|||
124866880|NCT02277444|449133690|FG000|Overall Study|Enrolled and not Treated|3|||
124756185|NCT01965704|448729454|FG003|Overall Study|Delivered at home|0|||
124756186|NCT01965704|448729451|FG000|Overall Study|Experienced complications|0|||
124756187|NCT01965704|448729452|FG001|Overall Study|Experienced complications|0|||
124756188|NCT01965704|448729453|FG002|Overall Study|Experienced complications|2|||
124756189|NCT01965704|448729454|FG003|Overall Study|Experienced complications|2|||
124756190|NCT01965704|448729451|FG000|Overall Study|Adverse Event|0|||
124756191|NCT01965704|448729452|FG001|Overall Study|Adverse Event|0|||
124756192|NCT01965704|448729453|FG002|Overall Study|Adverse Event|1|||
124756193|NCT01965704|448729454|FG003|Overall Study|Adverse Event|1|||
124756194|NCT01965704|448729451|FG000|Overall Study|Did not meet inclusion criteria|0|||
124756195|NCT01965704|448729452|FG001|Overall Study|Did not meet inclusion criteria|0|||
124756196|NCT01965704|448729453|FG002|Overall Study|Did not meet inclusion criteria|1|||
124756197|NCT01965704|448729454|FG003|Overall Study|Did not meet inclusion criteria|1|||
124756198|NCT00687804|448729462|FG000|Core Study|Adverse Event|5|||
124756199|NCT00687804|448729463|FG001|Core Study|Adverse Event|3|||
124756200|NCT00687804|448729464|FG002|Core Study|Adverse Event|3|||
124756201|NCT00687804|448729462|FG000|Core Study|Abnormal laboratory value(s)|1|||
124756202|NCT00687804|448729463|FG001|Core Study|Abnormal laboratory value(s)|0|||
124756203|NCT00687804|448729464|FG002|Core Study|Abnormal laboratory value(s)|0|||
124866881|NCT02277444|449133690|FG000|Overall Study|Ongoing|113|||
124969463|NCT01439867|449517398|FG000|Overall Study|Withdrawal by Subject|1|||
124969464|NCT01439867|449517399|FG001|Overall Study|Withdrawal by Subject|2|||
124969465|NCT01439867|449517398|FG000|Overall Study|Administrative Decision|4|||
124969466|NCT01439867|449517399|FG001|Overall Study|Administrative Decision|5|||
124756204|NCT00687804|448729462|FG000|Core Study|Lack of Efficacy|1|||
124969467|NCT01439867|449517398|FG000|Overall Study|Protocol-specified Criteria|1|||
124969468|NCT01439867|449517399|FG001|Overall Study|Protocol-specified Criteria|0|||
124969469|NCT00334542|449517400|FG000|Overall Study|Adverse Event|3|||
124969470|NCT00334542|449517400|FG000|Overall Study|Withdrawal by Subject|1|||
124756205|NCT00687804|448729463|FG001|Core Study|Lack of Efficacy|1|||
124756206|NCT00687804|448729464|FG002|Core Study|Lack of Efficacy|1|||
124756207|NCT00687804|448729462|FG000|Core Study|Withdrawal by Subject|4|||
124977703|NCT01217437|449545460|FG000|Overall Study|Adverse Event|0|||
124756208|NCT00687804|448729463|FG001|Core Study|Withdrawal by Subject|7|||
124756209|NCT00687804|448729464|FG002|Core Study|Withdrawal by Subject|7|||
124756210|NCT00687804|448729462|FG000|Core Study|Lost to Follow-up|0|||
124866882|NCT04918784|449135367|FG000|Overall Study|Amputation - no longer eligible|1|||
124866883|NCT04918784|449135368|FG001|Overall Study|Amputation - no longer eligible|2|||
124866884|NCT04918784|449135367|FG000|Overall Study|Death|1|||
124866885|NCT04918784|449135368|FG001|Overall Study|Death|0|||
124866886|NCT04918784|449135367|FG000|Overall Study|patient non-compliance|3|||
124866887|NCT04918784|449135368|FG001|Overall Study|patient non-compliance|1|||
124866888|NCT04918784|449135367|FG000|Overall Study|Adverse Event|1|||
124866889|NCT04918784|449135368|FG001|Overall Study|Adverse Event|0|||
124866890|NCT02160314|449135369|FG000|Overall Study|Adverse Event|0|||
124866891|NCT02160314|449135370|FG001|Overall Study|Adverse Event|6|||
124866892|NCT02160314|449135369|FG000|Overall Study|Protocol Violation|0|||
124866893|NCT02160314|449135370|FG001|Overall Study|Protocol Violation|4|||
124866894|NCT02160314|449135369|FG000|Overall Study|Withdrawal by Subject|1|||
124866895|NCT02160314|449135370|FG001|Overall Study|Withdrawal by Subject|2|||
124866896|NCT02160314|449135369|FG000|Overall Study|Lost to Follow-up|0|||
124866897|NCT02160314|449135370|FG001|Overall Study|Lost to Follow-up|1|||
124866898|NCT02586025|449135379|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
124866899|NCT02586025|449135380|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
124866900|NCT02586025|449135379|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
124866901|NCT02586025|449135380|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
124866902|NCT02586025|449135379|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
124866903|NCT02586025|449135380|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
124866904|NCT02586025|449135379|FG000|Neoadjuvant Treatment|Death|1|||
124866905|NCT02586025|449135380|FG001|Neoadjuvant Treatment|Death|0|||
124866906|NCT02586025|449135379|FG000|Neoadjuvant Treatment|Adverse Event|1|||
124866907|NCT02586025|449135380|FG001|Neoadjuvant Treatment|Adverse Event|0|||
124866908|NCT02586025|449135379|FG000|Neoadjuvant Treatment|Physician Decision|2|||
124866909|NCT02586025|449135380|FG001|Neoadjuvant Treatment|Physician Decision|1|||
124866910|NCT02586025|449135379|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
124866911|NCT02586025|449135380|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
124866912|NCT02586025|449135379|FG000|Adjuvant Treatment|Recurrent Disease|4|||
124866913|NCT02586025|449135380|FG001|Adjuvant Treatment|Recurrent Disease|5|||
124866914|NCT02586025|449135379|FG000|Adjuvant Treatment|Physician Decision|0|||
124866915|NCT02586025|449135380|FG001|Adjuvant Treatment|Physician Decision|1|||
124866916|NCT02586025|449135379|FG000|Adjuvant Treatment|Pregnancy|1|||
124756211|NCT00687804|448729463|FG001|Core Study|Lost to Follow-up|1|||
124756212|NCT00687804|448729464|FG002|Core Study|Lost to Follow-up|0|||
124756213|NCT00687804|448729462|FG000|Core Study|Death|2|||
124756214|NCT00687804|448729463|FG001|Core Study|Death|2|||
124756215|NCT00687804|448729464|FG002|Core Study|Death|2|||
124756216|NCT00687804|448729462|FG000|Core Study|Protocol Violation|1|||
124756217|NCT00687804|448729463|FG001|Core Study|Protocol Violation|1|||
124756218|NCT00687804|448729464|FG002|Core Study|Protocol Violation|0|||
124756219|NCT00687804|448729462|FG000|Open-Label Extension Study|Adverse Event|2|||
124756220|NCT00687804|448729463|FG001|Open-Label Extension Study|Adverse Event|2|||
124756221|NCT00687804|448729464|FG002|Open-Label Extension Study|Adverse Event|2|||
124756222|NCT00687804|448729462|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
124756223|NCT00687804|448729463|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
124756224|NCT00687804|448729464|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
124756225|NCT00687804|448729462|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
124756226|NCT00687804|448729463|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
124756227|NCT00687804|448729464|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
124756228|NCT00687804|448729462|FG000|Open-Label Extension Study|Administrative problems|1|||
124756229|NCT00687804|448729463|FG001|Open-Label Extension Study|Administrative problems|1|||
124756230|NCT00687804|448729464|FG002|Open-Label Extension Study|Administrative problems|0|||
124756231|NCT00687804|448729462|FG000|Open-Label Extension Study|Death|2|||
124756232|NCT00687804|448729463|FG001|Open-Label Extension Study|Death|3|||
124756233|NCT00687804|448729464|FG002|Open-Label Extension Study|Death|3|||
124756234|NCT04390243|448729465|FG000|Overall Study|Death|1|||
124756235|NCT04390243|448729465|FG000|Overall Study|Disease Progression|4|||
124756236|NCT04390243|448729465|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
124756237|NCT00413218|448729468|FG000|Overall Study|Randomized but didn't receive study drug|2|||
124756238|NCT00413218|448729469|FG001|Overall Study|Randomized but didn't receive study drug|8|||
124756239|NCT00413218|448729468|FG000|Overall Study|Death|57|||
124756240|NCT00413218|448729469|FG001|Overall Study|Death|56|||
124756241|NCT00413218|448729468|FG000|Overall Study|Lost to Follow-up|14|||
124756242|NCT00413218|448729469|FG001|Overall Study|Lost to Follow-up|17|||
124756243|NCT00413218|448729468|FG000|Overall Study|Admin|20|||
124866917|NCT02586025|449135380|FG001|Adjuvant Treatment|Pregnancy|0|||
124866918|NCT02586025|449135379|FG000|Treatment-Free Follow-Up|Death|11|||
124756244|NCT00413218|448729469|FG001|Overall Study|Admin|14|||
124756245|NCT00413218|448729468|FG000|Overall Study|Missing|1|||
124756246|NCT00413218|448729469|FG001|Overall Study|Missing|0|||
124977704|NCT01217437|449545461|FG001|Overall Study|Adverse Event|8|||
124977705|NCT01217437|449545460|FG000|Overall Study|Death|5|||
124977706|NCT01217437|449545461|FG001|Overall Study|Death|0|||
124977707|NCT01217437|449545460|FG000|Overall Study|Lack of Efficacy|29|||
124977708|NCT01217437|449545461|FG001|Overall Study|Lack of Efficacy|25|||
124977709|NCT01217437|449545460|FG000|Overall Study|Physician Decision|8|||
124977710|NCT01217437|449545461|FG001|Overall Study|Physician Decision|5|||
124977711|NCT01217437|449545460|FG000|Overall Study|Withdrawal by Subject|0|||
124977712|NCT01217437|449545461|FG001|Overall Study|Withdrawal by Subject|2|||
124977713|NCT01217437|449545460|FG000|Overall Study|Ineligible|1|||
124977714|NCT01217437|449545461|FG001|Overall Study|Ineligible|1|||
124977715|NCT03682185|449545464|FG000|Overall Study|Lost to Follow-up|4|||
124977716|NCT03682185|449545465|FG001|Overall Study|Lost to Follow-up|7|||
124977717|NCT03682185|449545466|FG002|Overall Study|Lost to Follow-up|4|||
124977718|NCT03682185|449545467|FG003|Overall Study|Lost to Follow-up|7|||
124977719|NCT03682185|449545468|FG004|Overall Study|Lost to Follow-up|1|||
124977720|NCT03682185|449545464|FG000|Overall Study|Withdrawal by Subject|7|||
124977721|NCT03682185|449545465|FG001|Overall Study|Withdrawal by Subject|3|||
124977722|NCT03682185|449545466|FG002|Overall Study|Withdrawal by Subject|7|||
124977723|NCT03682185|449545467|FG003|Overall Study|Withdrawal by Subject|3|||
124977724|NCT03682185|449545468|FG004|Overall Study|Withdrawal by Subject|0|||
124977725|NCT00350727|449545469|FG000|Phase I: Dose Escalation|Adverse Event|4|||
124977726|NCT00350727|449545470|FG001|Phase I: Dose Escalation|Adverse Event|0|||
124977727|NCT00350727|449545471|FG002|Phase I: Dose Escalation|Adverse Event|0|||
124977728|NCT00350727|449545469|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
124977729|NCT00350727|449545470|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
124977730|NCT00350727|449545471|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
124977731|NCT00350727|449545469|FG000|Phase I: Dose Escalation|Death|1|||
124977732|NCT00350727|449545470|FG001|Phase I: Dose Escalation|Death|0|||
124977733|NCT00350727|449545471|FG002|Phase I: Dose Escalation|Death|0|||
124977734|NCT00350727|449545469|FG000|Phase I: Dose Escalation|Physician Decision|1|||
124977735|NCT00350727|449545470|FG001|Phase I: Dose Escalation|Physician Decision|0|||
124756247|NCT00413218|448729468|FG000|Overall Study|Withdrawal by Subject|9|||
124756248|NCT00413218|448729469|FG001|Overall Study|Withdrawal by Subject|1|||
124756249|NCT01196026|448729471|FG000|Overall Study|Withdrawal by Subject|1|||
124756250|NCT01196026|448729472|FG001|Overall Study|Withdrawal by Subject|4|||
124756251|NCT01196026|448729473|FG002|Overall Study|Withdrawal by Subject|0|||
124756252|NCT01196026|448729474|FG003|Overall Study|Withdrawal by Subject|0|||
124756253|NCT01196026|448729475|FG004|Overall Study|Withdrawal by Subject|0|||
124756254|NCT01196026|448729476|FG005|Overall Study|Withdrawal by Subject|0|||
124756255|NCT01196026|448729471|FG000|Overall Study|Lost to Follow-up|0|||
124756256|NCT01196026|448729472|FG001|Overall Study|Lost to Follow-up|3|||
124756257|NCT01196026|448729473|FG002|Overall Study|Lost to Follow-up|0|||
124756258|NCT01196026|448729474|FG003|Overall Study|Lost to Follow-up|0|||
124756259|NCT01196026|448729475|FG004|Overall Study|Lost to Follow-up|1|||
124756260|NCT01196026|448729476|FG005|Overall Study|Lost to Follow-up|0|||
124756261|NCT01196026|448729471|FG000|Overall Study|Other|0|||
124756262|NCT01196026|448729472|FG001|Overall Study|Other|1|||
124756263|NCT01196026|448729473|FG002|Overall Study|Other|0|||
124756264|NCT01196026|448729474|FG003|Overall Study|Other|0|||
124756265|NCT01196026|448729475|FG004|Overall Study|Other|0|||
124756266|NCT01196026|448729476|FG005|Overall Study|Other|0|||
124756267|NCT01687296|448729477|FG000|Overall Study|Lack of Efficacy|1|||
124756268|NCT01687296|448729478|FG001|Overall Study|Lack of Efficacy|1|||
124756269|NCT01687296|448729477|FG000|Overall Study|Protocol Violation|0|||
124756270|NCT01687296|448729478|FG001|Overall Study|Protocol Violation|1|||
124756271|NCT01687296|448729477|FG000|Overall Study|Withdrawal by Subject|6|||
124756272|NCT01687296|448729478|FG001|Overall Study|Withdrawal by Subject|3|||
124756273|NCT03672292|448729482|FG000|Overall Study|Adverse Event|3|||
124756274|NCT03672292|448729483|FG001|Overall Study|Adverse Event|1|||
124756275|NCT03672292|448729482|FG000|Overall Study|Physician Decision|0|||
124756276|NCT03672292|448729483|FG001|Overall Study|Physician Decision|1|||
124756277|NCT03672292|448729482|FG000|Overall Study|Withdrawal by Subject|1|||
124756278|NCT03672292|448729483|FG001|Overall Study|Withdrawal by Subject|2|||
124756279|NCT00799903|448729484|FG000|Overall Study|Investigator Site Closed|25|||
124756280|NCT00799903|448729485|FG001|Overall Study|Investigator Site Closed|23|||
124756281|NCT00799903|448729484|FG000|Overall Study|Withdrawal by Subject|179|||
124756282|NCT00799903|448729485|FG001|Overall Study|Withdrawal by Subject|175|||
124756283|NCT00799903|448729484|FG000|Overall Study|Lost to Follow-up|69|||
124756284|NCT00799903|448729485|FG001|Overall Study|Lost to Follow-up|80|||
124756285|NCT02518971|448729486|FG000|Overall Study|Lost to Follow-up|0|||
124756286|NCT02518971|448729487|FG001|Overall Study|Lost to Follow-up|1|||
124866919|NCT02586025|449135380|FG001|Treatment-Free Follow-Up|Death|11|||
124756287|NCT02518971|448729486|FG000|Overall Study|Physician Decision|6|||
124756288|NCT02518971|448729487|FG001|Overall Study|Physician Decision|6|||
124977736|NCT00350727|449545471|FG002|Phase I: Dose Escalation|Physician Decision|0|||
124756289|NCT02518971|448729486|FG000|Overall Study|Protocol Violation|6|||
124756290|NCT02518971|448729487|FG001|Overall Study|Protocol Violation|4|||
124977737|NCT00350727|449545469|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
124977738|NCT00350727|449545470|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
124977739|NCT00350727|449545471|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
124977740|NCT00350727|449545469|FG000|Phase II|Disease Progression|0|||
124977741|NCT00350727|449545470|FG001|Phase II|Disease Progression|15|||
124977742|NCT00350727|449545471|FG002|Phase II|Disease Progression|16|||
124977743|NCT00350727|449545469|FG000|Phase II|Clinical Deterioration|0|||
124977744|NCT00350727|449545470|FG001|Phase II|Clinical Deterioration|1|||
124977745|NCT00350727|449545471|FG002|Phase II|Clinical Deterioration|0|||
124977746|NCT00350727|449545469|FG000|Phase II|Withdrawal by Subject|0|||
124977747|NCT00350727|449545470|FG001|Phase II|Withdrawal by Subject|2|||
124977748|NCT00350727|449545471|FG002|Phase II|Withdrawal by Subject|1|||
124977749|NCT00350727|449545469|FG000|Phase II|Adverse Event|0|||
124977750|NCT00350727|449545470|FG001|Phase II|Adverse Event|1|||
124977751|NCT00350727|449545471|FG002|Phase II|Adverse Event|1|||
124977752|NCT00350727|449545469|FG000|Phase II|Death|0|||
124977753|NCT00350727|449545470|FG001|Phase II|Death|0|||
124977754|NCT00350727|449545471|FG002|Phase II|Death|2|||
124977755|NCT00350727|449545469|FG000|Phase II|Sponsor Terminated Study|0|||
124977756|NCT00350727|449545470|FG001|Phase II|Sponsor Terminated Study|0|||
124977757|NCT00350727|449545471|FG002|Phase II|Sponsor Terminated Study|1|||
124977758|NCT00350727|449545469|FG000|Phase II|Enrolled in Rollover Study|0|||
124977759|NCT00350727|449545470|FG001|Phase II|Enrolled in Rollover Study|0|||
124977760|NCT00350727|449545471|FG002|Phase II|Enrolled in Rollover Study|1|||
124977761|NCT04908631|449545472|FG000|Overall Study|Lost to Follow-up|1|||
124977762|NCT04908631|449545472|FG000|Overall Study|Physician Decision|1|||
124977763|NCT04908631|449545472|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
124977764|NCT03520712|449545473|FG000|Overall Study|Early termination of the study by Sponsor|2|||
124977765|NCT03841526|449545474|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
124977766|NCT03841526|449545475|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
124977767|NCT03841526|449545476|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
124977768|NCT03841526|449545477|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
124977769|NCT03841526|449545478|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
124977770|NCT03841526|449545479|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
124977771|NCT03841526|449545474|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
124977772|NCT03841526|449545475|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
124977773|NCT03841526|449545476|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
124977774|NCT03841526|449545477|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
124977775|NCT03841526|449545478|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
124977776|NCT03841526|449545479|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
124977777|NCT03841526|449545474|FG000|Outpatient Phase Treatment|Physician Decision|0|||
124977778|NCT03841526|449545475|FG001|Outpatient Phase Treatment|Physician Decision|1|||
124977779|NCT03841526|449545476|FG002|Outpatient Phase Treatment|Physician Decision|0|||
124977780|NCT03841526|449545477|FG003|Outpatient Phase Treatment|Physician Decision|0|||
124977781|NCT03841526|449545478|FG004|Outpatient Phase Treatment|Physician Decision|0|||
124977782|NCT03841526|449545479|FG005|Outpatient Phase Treatment|Physician Decision|0|||
124977783|NCT03841526|449545474|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
124977784|NCT03841526|449545475|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
124977785|NCT03841526|449545476|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
124977786|NCT03841526|449545477|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
124977787|NCT03841526|449545478|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
124977788|NCT03841526|449545479|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
124977789|NCT04047862|449545480|FG000|Overall Study|Death|0|||
124977790|NCT04047862|449545481|FG001|Overall Study|Death|0|||
124977791|NCT04047862|449545482|FG002|Overall Study|Death|4|||
124977792|NCT04047862|449545483|FG003|Overall Study|Death|7|||
124977793|NCT04047862|449545484|FG004|Overall Study|Death|2|||
124977794|NCT04047862|449545485|FG005|Overall Study|Death|4|||
124977795|NCT04047862|449545486|FG006|Overall Study|Death|3|||
124977796|NCT04047862|449545487|FG007|Overall Study|Death|24|||
124977797|NCT04047862|449545488|FG008|Overall Study|Death|24|||
124977798|NCT04047862|449545489|FG009|Overall Study|Death|22|||
124977799|NCT04047862|449545490|FG010|Overall Study|Death|35|||
124977800|NCT04047862|449545491|FG011|Overall Study|Death|18|||
124977801|NCT04047862|449545492|FG012|Overall Study|Death|14|||
124977802|NCT04047862|449545493|FG013|Overall Study|Death|6|||
124977803|NCT04047862|449545494|FG014|Overall Study|Death|19|||
124977804|NCT04047862|449545495|FG015|Overall Study|Death|42|||
124977805|NCT04047862|449545496|FG016|Overall Study|Death|9|||
124977806|NCT04047862|449545497|FG017|Overall Study|Death|8|||
124977807|NCT04047862|449545498|FG018|Overall Study|Death|10|||
124977808|NCT04047862|449545480|FG000|Overall Study|Withdrawal by Subject|0|||
124977809|NCT04047862|449545481|FG001|Overall Study|Withdrawal by Subject|0|||
124977810|NCT04047862|449545482|FG002|Overall Study|Withdrawal by Subject|0|||
124977811|NCT04047862|449545483|FG003|Overall Study|Withdrawal by Subject|5|||
124977812|NCT04047862|449545484|FG004|Overall Study|Withdrawal by Subject|2|||
124977813|NCT04047862|449545485|FG005|Overall Study|Withdrawal by Subject|0|||
124977814|NCT04047862|449545486|FG006|Overall Study|Withdrawal by Subject|1|||
124977815|NCT04047862|449545487|FG007|Overall Study|Withdrawal by Subject|0|||
124977816|NCT04047862|449545488|FG008|Overall Study|Withdrawal by Subject|4|||
124977817|NCT04047862|449545489|FG009|Overall Study|Withdrawal by Subject|4|||
124977818|NCT04047862|449545490|FG010|Overall Study|Withdrawal by Subject|4|||
124977819|NCT04047862|449545491|FG011|Overall Study|Withdrawal by Subject|2|||
124977820|NCT04047862|449545492|FG012|Overall Study|Withdrawal by Subject|3|||
124977821|NCT04047862|449545493|FG013|Overall Study|Withdrawal by Subject|0|||
124977822|NCT04047862|449545494|FG014|Overall Study|Withdrawal by Subject|9|||
124977823|NCT04047862|449545495|FG015|Overall Study|Withdrawal by Subject|5|||
124977824|NCT04047862|449545496|FG016|Overall Study|Withdrawal by Subject|1|||
124977825|NCT04047862|449545497|FG017|Overall Study|Withdrawal by Subject|3|||
124977826|NCT04047862|449545498|FG018|Overall Study|Withdrawal by Subject|1|||
124977827|NCT04047862|449545480|FG000|Overall Study|Lost to Follow-up|0|||
124977828|NCT04047862|449545481|FG001|Overall Study|Lost to Follow-up|0|||
124977829|NCT04047862|449545482|FG002|Overall Study|Lost to Follow-up|1|||
124977830|NCT04047862|449545483|FG003|Overall Study|Lost to Follow-up|0|||
124977831|NCT04047862|449545484|FG004|Overall Study|Lost to Follow-up|0|||
124977832|NCT04047862|449545485|FG005|Overall Study|Lost to Follow-up|0|||
124977833|NCT04047862|449545486|FG006|Overall Study|Lost to Follow-up|0|||
124977834|NCT04047862|449545487|FG007|Overall Study|Lost to Follow-up|1|||
124977835|NCT04047862|449545488|FG008|Overall Study|Lost to Follow-up|0|||
124977836|NCT04047862|449545489|FG009|Overall Study|Lost to Follow-up|1|||
124977837|NCT04047862|449545490|FG010|Overall Study|Lost to Follow-up|0|||
124977838|NCT04047862|449545491|FG011|Overall Study|Lost to Follow-up|3|||
124977839|NCT04047862|449545492|FG012|Overall Study|Lost to Follow-up|0|||
124977840|NCT04047862|449545493|FG013|Overall Study|Lost to Follow-up|0|||
124977841|NCT04047862|449545494|FG014|Overall Study|Lost to Follow-up|2|||
124977842|NCT04047862|449545495|FG015|Overall Study|Lost to Follow-up|2|||
124977843|NCT04047862|449545496|FG016|Overall Study|Lost to Follow-up|1|||
124977844|NCT04047862|449545497|FG017|Overall Study|Lost to Follow-up|0|||
124977845|NCT04047862|449545498|FG018|Overall Study|Lost to Follow-up|0|||
124977846|NCT04047862|449545480|FG000|Overall Study|Physician Decision|0|||
124977847|NCT04047862|449545481|FG001|Overall Study|Physician Decision|0|||
124977848|NCT04047862|449545482|FG002|Overall Study|Physician Decision|0|||
124977849|NCT04047862|449545483|FG003|Overall Study|Physician Decision|1|||
124977850|NCT04047862|449545484|FG004|Overall Study|Physician Decision|0|||
124977851|NCT04047862|449545485|FG005|Overall Study|Physician Decision|0|||
124977852|NCT04047862|449545486|FG006|Overall Study|Physician Decision|0|||
124977853|NCT04047862|449545487|FG007|Overall Study|Physician Decision|0|||
124977854|NCT04047862|449545488|FG008|Overall Study|Physician Decision|0|||
124977855|NCT04047862|449545489|FG009|Overall Study|Physician Decision|0|||
124977856|NCT04047862|449545490|FG010|Overall Study|Physician Decision|0|||
124977857|NCT04047862|449545491|FG011|Overall Study|Physician Decision|0|||
124977858|NCT04047862|449545492|FG012|Overall Study|Physician Decision|0|||
124977859|NCT04047862|449545493|FG013|Overall Study|Physician Decision|0|||
124977860|NCT04047862|449545494|FG014|Overall Study|Physician Decision|1|||
124977861|NCT04047862|449545495|FG015|Overall Study|Physician Decision|0|||
124977862|NCT04047862|449545496|FG016|Overall Study|Physician Decision|1|||
124977863|NCT04047862|449545497|FG017|Overall Study|Physician Decision|0|||
124977864|NCT04047862|449545498|FG018|Overall Study|Physician Decision|0|||
124977865|NCT04047862|449545480|FG000|Overall Study|Completed all Assessments|1|||
124977866|NCT04047862|449545481|FG001|Overall Study|Completed all Assessments|3|||
124977867|NCT04047862|449545482|FG002|Overall Study|Completed all Assessments|1|||
124977868|NCT04047862|449545483|FG003|Overall Study|Completed all Assessments|3|||
124977869|NCT04047862|449545484|FG004|Overall Study|Completed all Assessments|2|||
124977870|NCT04047862|449545485|FG005|Overall Study|Completed all Assessments|5|||
124977871|NCT04047862|449545486|FG006|Overall Study|Completed all Assessments|7|||
124977872|NCT04047862|449545487|FG007|Overall Study|Completed all Assessments|0|||
124977873|NCT04047862|449545488|FG008|Overall Study|Completed all Assessments|0|||
124977874|NCT04047862|449545489|FG009|Overall Study|Completed all Assessments|0|||
124977875|NCT04047862|449545490|FG010|Overall Study|Completed all Assessments|0|||
124977876|NCT04047862|449545491|FG011|Overall Study|Completed all Assessments|0|||
124977877|NCT04047862|449545492|FG012|Overall Study|Completed all Assessments|0|||
124977878|NCT04047862|449545493|FG013|Overall Study|Completed all Assessments|0|||
124977879|NCT04047862|449545494|FG014|Overall Study|Completed all Assessments|0|||
124977880|NCT04047862|449545495|FG015|Overall Study|Completed all Assessments|0|||
124977881|NCT04047862|449545496|FG016|Overall Study|Completed all Assessments|0|||
124977882|NCT04047862|449545497|FG017|Overall Study|Completed all Assessments|0|||
124977883|NCT04047862|449545498|FG018|Overall Study|Completed all Assessments|0|||
124977884|NCT04047862|449545480|FG000|Overall Study|Sponsor Decision|0|||
124977885|NCT04047862|449545481|FG001|Overall Study|Sponsor Decision|0|||
124977886|NCT04047862|449545482|FG002|Overall Study|Sponsor Decision|0|||
124977887|NCT04047862|449545483|FG003|Overall Study|Sponsor Decision|0|||
124977888|NCT04047862|449545484|FG004|Overall Study|Sponsor Decision|0|||
124977889|NCT04047862|449545485|FG005|Overall Study|Sponsor Decision|0|||
124977890|NCT04047862|449545486|FG006|Overall Study|Sponsor Decision|0|||
124977891|NCT04047862|449545487|FG007|Overall Study|Sponsor Decision|13|||
124977892|NCT04047862|449545488|FG008|Overall Study|Sponsor Decision|10|||
124977893|NCT04047862|449545489|FG009|Overall Study|Sponsor Decision|18|||
124977894|NCT04047862|449545490|FG010|Overall Study|Sponsor Decision|3|||
124977895|NCT04047862|449545491|FG011|Overall Study|Sponsor Decision|3|||
124977896|NCT04047862|449545492|FG012|Overall Study|Sponsor Decision|4|||
124977897|NCT04047862|449545493|FG013|Overall Study|Sponsor Decision|0|||
124977898|NCT04047862|449545494|FG014|Overall Study|Sponsor Decision|7|||
124977899|NCT04047862|449545495|FG015|Overall Study|Sponsor Decision|8|||
124977900|NCT04047862|449545496|FG016|Overall Study|Sponsor Decision|9|||
124977901|NCT04047862|449545497|FG017|Overall Study|Sponsor Decision|7|||
124977902|NCT04047862|449545498|FG018|Overall Study|Sponsor Decision|8|||
124977903|NCT04047862|449545480|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977904|NCT04047862|449545481|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977905|NCT04047862|449545482|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977906|NCT04047862|449545483|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977907|NCT04047862|449545484|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977908|NCT04047862|449545485|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977909|NCT04047862|449545486|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977910|NCT04047862|449545487|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
124977911|NCT04047862|449545488|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
124977912|NCT04047862|449545489|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977913|NCT04047862|449545490|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
124977914|NCT04047862|449545491|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977915|NCT04047862|449545492|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977916|NCT04047862|449545493|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
124977917|NCT04047862|449545494|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
124977918|NCT04047862|449545495|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
124977919|NCT04047862|449545496|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
124977920|NCT04047862|449545497|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
124977921|NCT04047862|449545498|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
124977922|NCT04047862|449545480|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977923|NCT04047862|449545481|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977924|NCT04047862|449545482|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977925|NCT04047862|449545483|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977926|NCT04047862|449545484|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977927|NCT04047862|449545485|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977928|NCT04047862|449545486|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977929|NCT04047862|449545487|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977930|NCT04047862|449545488|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977931|NCT04047862|449545489|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977932|NCT04047862|449545490|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977933|NCT04047862|449545491|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977934|NCT04047862|449545492|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977935|NCT04047862|449545493|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977936|NCT04047862|449545494|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977937|NCT04047862|449545495|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
124977938|NCT04047862|449545496|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977939|NCT04047862|449545497|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
124977940|NCT04047862|449545498|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
124977941|NCT04047862|449545480|FG000|Overall Study|Other|0|||
124977942|NCT04047862|449545481|FG001|Overall Study|Other|0|||
124977943|NCT04047862|449545482|FG002|Overall Study|Other|0|||
124977944|NCT04047862|449545483|FG003|Overall Study|Other|0|||
124977945|NCT04047862|449545484|FG004|Overall Study|Other|0|||
124977946|NCT04047862|449545485|FG005|Overall Study|Other|0|||
124977947|NCT04047862|449545486|FG006|Overall Study|Other|0|||
124977948|NCT04047862|449545487|FG007|Overall Study|Other|0|||
124977949|NCT04047862|449545488|FG008|Overall Study|Other|0|||
124977950|NCT04047862|449545489|FG009|Overall Study|Other|0|||
124977951|NCT04047862|449545490|FG010|Overall Study|Other|0|||
124977952|NCT04047862|449545491|FG011|Overall Study|Other|0|||
124977953|NCT04047862|449545492|FG012|Overall Study|Other|0|||
124977954|NCT04047862|449545493|FG013|Overall Study|Other|0|||
124977955|NCT04047862|449545494|FG014|Overall Study|Other|2|||
124977956|NCT04047862|449545495|FG015|Overall Study|Other|1|||
124977957|NCT04047862|449545496|FG016|Overall Study|Other|1|||
124977958|NCT04047862|449545497|FG017|Overall Study|Other|1|||
124977959|NCT04047862|449545498|FG018|Overall Study|Other|0|||
124977960|NCT04996004|449546778|FG000|Phase I|Death|1|||
124977961|NCT04996004|449546779|FG001|Phase I|Death|2|||
124977962|NCT04996004|449546780|FG002|Phase I|Death|1|||
124977963|NCT04996004|449546781|FG003|Phase I|Death|0|||
124977964|NCT04996004|449546782|FG004|Phase I|Death|0|||
124977965|NCT04996004|449546783|FG005|Phase I|Death|0|||
124977966|NCT04996004|449546778|FG000|Phase I|Study terminated by sponsor|2|||
124977967|NCT04996004|449546779|FG001|Phase I|Study terminated by sponsor|1|||
124977968|NCT04996004|449546780|FG002|Phase I|Study terminated by sponsor|2|||
124977969|NCT04996004|449546781|FG003|Phase I|Study terminated by sponsor|0|||
124977970|NCT04996004|449546782|FG004|Phase I|Study terminated by sponsor|0|||
124977971|NCT04996004|449546783|FG005|Phase I|Study terminated by sponsor|0|||
124977972|NCT04996004|449546778|FG000|Phase II|Study terminated by sponsor|0|||
124977973|NCT04996004|449546779|FG001|Phase II|Study terminated by sponsor|0|||
124977974|NCT04996004|449546780|FG002|Phase II|Study terminated by sponsor|0|||
124977975|NCT04996004|449546781|FG003|Phase II|Study terminated by sponsor|20|||
124977976|NCT04996004|449546782|FG004|Phase II|Study terminated by sponsor|10|||
124977977|NCT04996004|449546783|FG005|Phase II|Study terminated by sponsor|10|||
124977978|NCT04996004|449546778|FG000|Phase II|Withdrawal by Subject|0|||
124977979|NCT04996004|449546779|FG001|Phase II|Withdrawal by Subject|0|||
124977980|NCT04996004|449546780|FG002|Phase II|Withdrawal by Subject|0|||
124977981|NCT04996004|449546781|FG003|Phase II|Withdrawal by Subject|0|||
124977982|NCT04996004|449546782|FG004|Phase II|Withdrawal by Subject|1|||
124977983|NCT04996004|449546783|FG005|Phase II|Withdrawal by Subject|2|||
124977984|NCT04996004|449546778|FG000|Phase II|Death|0|||
124977985|NCT04996004|449546779|FG001|Phase II|Death|0|||
124977986|NCT04996004|449546780|FG002|Phase II|Death|0|||
124977987|NCT04996004|449546781|FG003|Phase II|Death|12|||
124977988|NCT04996004|449546782|FG004|Phase II|Death|2|||
124977989|NCT04996004|449546783|FG005|Phase II|Death|9|||
124977990|NCT04996004|449546778|FG000|Phase II|Other|0|||
124977991|NCT04996004|449546779|FG001|Phase II|Other|0|||
124977992|NCT04996004|449546780|FG002|Phase II|Other|0|||
124977993|NCT04996004|449546781|FG003|Phase II|Other|0|||
124977994|NCT04996004|449546782|FG004|Phase II|Other|0|||
124977995|NCT04996004|449546783|FG005|Phase II|Other|1|||
124977996|NCT02942277|449546784|FG000|Year 1|Withdrawal by Subject|0|||
124977997|NCT02942277|449546785|FG001|Year 1|Withdrawal by Subject|0|||
124977998|NCT02942277|449546786|FG002|Year 1|Withdrawal by Subject|0|||
124977999|NCT02942277|449546787|FG003|Year 1|Withdrawal by Subject|0|||
124978000|NCT02942277|449546788|FG004|Year 1|Withdrawal by Subject|1|||
124978001|NCT02942277|449546789|FG005|Year 1|Withdrawal by Subject|3|||
124978002|NCT02942277|449546790|FG006|Year 1|Withdrawal by Subject|0|||
124978003|NCT02942277|449546791|FG007|Year 1|Withdrawal by Subject|1|||
124978004|NCT02942277|449546792|FG008|Year 1|Withdrawal by Subject|0|||
124978005|NCT02942277|449546793|FG009|Year 1|Withdrawal by Subject|0|||
124978006|NCT02942277|449546794|FG010|Year 1|Withdrawal by Subject|3|||
124978007|NCT02942277|449546784|FG000|Year 1|Travel|0|||
124978008|NCT02942277|449546785|FG001|Year 1|Travel|1|||
124978009|NCT02942277|449546786|FG002|Year 1|Travel|0|||
124978010|NCT02942277|449546787|FG003|Year 1|Travel|0|||
124978011|NCT02942277|449546788|FG004|Year 1|Travel|4|||
124978012|NCT02942277|449546789|FG005|Year 1|Travel|5|||
124978013|NCT02942277|449546790|FG006|Year 1|Travel|0|||
124978014|NCT02942277|449546791|FG007|Year 1|Travel|0|||
124978015|NCT02942277|449546792|FG008|Year 1|Travel|0|||
124978016|NCT02942277|449546793|FG009|Year 1|Travel|0|||
124978017|NCT02942277|449546794|FG010|Year 1|Travel|8|||
124978018|NCT02942277|449546784|FG000|Year 1|Joined Army|0|||
124978019|NCT02942277|449546785|FG001|Year 1|Joined Army|1|||
124978020|NCT02942277|449546786|FG002|Year 1|Joined Army|0|||
124978021|NCT02942277|449546787|FG003|Year 1|Joined Army|0|||
124978022|NCT02942277|449546788|FG004|Year 1|Joined Army|0|||
124978023|NCT02942277|449546789|FG005|Year 1|Joined Army|0|||
124978024|NCT02942277|449546790|FG006|Year 1|Joined Army|0|||
124978025|NCT02942277|449546791|FG007|Year 1|Joined Army|0|||
124978026|NCT02942277|449546792|FG008|Year 1|Joined Army|0|||
124978027|NCT02942277|449546793|FG009|Year 1|Joined Army|0|||
124978028|NCT02942277|449546794|FG010|Year 1|Joined Army|0|||
124978029|NCT02942277|449546784|FG000|Year 1|Subject met withdrawal criteria|0|||
124978030|NCT02942277|449546785|FG001|Year 1|Subject met withdrawal criteria|0|||
124978031|NCT02942277|449546786|FG002|Year 1|Subject met withdrawal criteria|0|||
124978032|NCT02942277|449546787|FG003|Year 1|Subject met withdrawal criteria|1|||
124978033|NCT02942277|449546788|FG004|Year 1|Subject met withdrawal criteria|0|||
124978034|NCT02942277|449546789|FG005|Year 1|Subject met withdrawal criteria|0|||
124978035|NCT02942277|449546790|FG006|Year 1|Subject met withdrawal criteria|0|||
124978036|NCT02942277|449546791|FG007|Year 1|Subject met withdrawal criteria|0|||
124978037|NCT02942277|449546792|FG008|Year 1|Subject met withdrawal criteria|0|||
124978038|NCT02942277|449546793|FG009|Year 1|Subject met withdrawal criteria|0|||
124978039|NCT02942277|449546794|FG010|Year 1|Subject met withdrawal criteria|0|||
124978040|NCT02942277|449546784|FG000|Year 1|Lost to Follow-up|0|||
124978041|NCT02942277|449546785|FG001|Year 1|Lost to Follow-up|0|||
124978042|NCT02942277|449546786|FG002|Year 1|Lost to Follow-up|0|||
124978043|NCT02942277|449546787|FG003|Year 1|Lost to Follow-up|0|||
124978044|NCT02942277|449546788|FG004|Year 1|Lost to Follow-up|1|||
124978045|NCT02942277|449546789|FG005|Year 1|Lost to Follow-up|0|||
124978046|NCT02942277|449546790|FG006|Year 1|Lost to Follow-up|0|||
124978047|NCT02942277|449546791|FG007|Year 1|Lost to Follow-up|0|||
124978048|NCT02942277|449546792|FG008|Year 1|Lost to Follow-up|0|||
124978049|NCT02942277|449546793|FG009|Year 1|Lost to Follow-up|0|||
124978050|NCT02942277|449546794|FG010|Year 1|Lost to Follow-up|2|||
124978051|NCT02942277|449546784|FG000|Year 1|Protocol Violation|0|||
124978052|NCT02942277|449546785|FG001|Year 1|Protocol Violation|0|||
124978053|NCT02942277|449546786|FG002|Year 1|Protocol Violation|0|||
124978054|NCT02942277|449546787|FG003|Year 1|Protocol Violation|0|||
124978055|NCT02942277|449546788|FG004|Year 1|Protocol Violation|1|||
124978056|NCT02942277|449546789|FG005|Year 1|Protocol Violation|1|||
124978057|NCT02942277|449546790|FG006|Year 1|Protocol Violation|0|||
124978058|NCT02942277|449546791|FG007|Year 1|Protocol Violation|0|||
124978059|NCT02942277|449546792|FG008|Year 1|Protocol Violation|0|||
124978060|NCT02942277|449546793|FG009|Year 1|Protocol Violation|0|||
124978061|NCT02942277|449546794|FG010|Year 1|Protocol Violation|2|||
124978062|NCT02942277|449546784|FG000|Year 1|Pregnancy|0|||
124978063|NCT02942277|449546785|FG001|Year 1|Pregnancy|0|||
124978064|NCT02942277|449546786|FG002|Year 1|Pregnancy|0|||
124978065|NCT02942277|449546787|FG003|Year 1|Pregnancy|0|||
124978066|NCT02942277|449546788|FG004|Year 1|Pregnancy|0|||
124978067|NCT02942277|449546789|FG005|Year 1|Pregnancy|1|||
124978068|NCT02942277|449546790|FG006|Year 1|Pregnancy|0|||
124978069|NCT02942277|449546791|FG007|Year 1|Pregnancy|0|||
124978070|NCT02942277|449546792|FG008|Year 1|Pregnancy|0|||
124978071|NCT02942277|449546793|FG009|Year 1|Pregnancy|0|||
124978072|NCT02942277|449546794|FG010|Year 1|Pregnancy|0|||
124978073|NCT02942277|449546784|FG000|Year 2|Lost to Follow-up|0|||
124978074|NCT02942277|449546785|FG001|Year 2|Lost to Follow-up|0|||
124978075|NCT02942277|449546786|FG002|Year 2|Lost to Follow-up|0|||
124978076|NCT02942277|449546787|FG003|Year 2|Lost to Follow-up|0|||
124978077|NCT02942277|449546788|FG004|Year 2|Lost to Follow-up|2|||
124978078|NCT02942277|449546789|FG005|Year 2|Lost to Follow-up|1|||
124978079|NCT02942277|449546790|FG006|Year 2|Lost to Follow-up|0|||
124978080|NCT02942277|449546791|FG007|Year 2|Lost to Follow-up|0|||
124978081|NCT02942277|449546792|FG008|Year 2|Lost to Follow-up|0|||
124978082|NCT02942277|449546793|FG009|Year 2|Lost to Follow-up|0|||
124978083|NCT02942277|449546794|FG010|Year 2|Lost to Follow-up|0|||
124978084|NCT02942277|449546784|FG000|Year 2|Did not rescreen|0|||
124978085|NCT02942277|449546785|FG001|Year 2|Did not rescreen|0|||
124978086|NCT02942277|449546786|FG002|Year 2|Did not rescreen|1|||
124978087|NCT02942277|449546787|FG003|Year 2|Did not rescreen|1|||
124978088|NCT02942277|449546788|FG004|Year 2|Did not rescreen|9|||
124978089|NCT02942277|449546789|FG005|Year 2|Did not rescreen|6|||
124978090|NCT02942277|449546790|FG006|Year 2|Did not rescreen|0|||
124978091|NCT02942277|449546791|FG007|Year 2|Did not rescreen|1|||
124978092|NCT02942277|449546792|FG008|Year 2|Did not rescreen|0|||
124978093|NCT02942277|449546793|FG009|Year 2|Did not rescreen|0|||
124978094|NCT02942277|449546794|FG010|Year 2|Did not rescreen|21|||
124978095|NCT02942277|449546784|FG000|Year 2|Met withdrawal criteria|0|||
124978096|NCT02942277|449546785|FG001|Year 2|Met withdrawal criteria|0|||
124978097|NCT02942277|449546786|FG002|Year 2|Met withdrawal criteria|0|||
124978098|NCT02942277|449546787|FG003|Year 2|Met withdrawal criteria|0|||
124978099|NCT02942277|449546788|FG004|Year 2|Met withdrawal criteria|1|||
124978100|NCT02942277|449546789|FG005|Year 2|Met withdrawal criteria|2|||
124978101|NCT02942277|449546790|FG006|Year 2|Met withdrawal criteria|0|||
124978102|NCT02942277|449546791|FG007|Year 2|Met withdrawal criteria|0|||
124978103|NCT02942277|449546792|FG008|Year 2|Met withdrawal criteria|0|||
124978104|NCT02942277|449546793|FG009|Year 2|Met withdrawal criteria|0|||
124978105|NCT02942277|449546794|FG010|Year 2|Met withdrawal criteria|1|||
124978106|NCT02942277|449546784|FG000|Year 2|Travel|0|||
124978107|NCT02942277|449546785|FG001|Year 2|Travel|1|||
124978108|NCT02942277|449546786|FG002|Year 2|Travel|0|||
124978109|NCT02942277|449546787|FG003|Year 2|Travel|0|||
124978110|NCT02942277|449546788|FG004|Year 2|Travel|0|||
124978111|NCT02942277|449546789|FG005|Year 2|Travel|1|||
124978112|NCT02942277|449546790|FG006|Year 2|Travel|0|||
124978113|NCT02942277|449546791|FG007|Year 2|Travel|0|||
124978114|NCT02942277|449546792|FG008|Year 2|Travel|0|||
124978115|NCT02942277|449546793|FG009|Year 2|Travel|1|||
124978116|NCT02942277|449546794|FG010|Year 2|Travel|3|||
124978117|NCT02942277|449546784|FG000|Year 2|Non-compliant|0|||
124978118|NCT02942277|449546785|FG001|Year 2|Non-compliant|0|||
124978119|NCT02942277|449546786|FG002|Year 2|Non-compliant|0|||
124978120|NCT02942277|449546787|FG003|Year 2|Non-compliant|0|||
124978121|NCT02942277|449546788|FG004|Year 2|Non-compliant|1|||
124978122|NCT02942277|449546789|FG005|Year 2|Non-compliant|1|||
124978123|NCT02942277|449546790|FG006|Year 2|Non-compliant|0|||
124978124|NCT02942277|449546791|FG007|Year 2|Non-compliant|0|||
124978125|NCT02942277|449546792|FG008|Year 2|Non-compliant|0|||
124978126|NCT02942277|449546793|FG009|Year 2|Non-compliant|0|||
124978127|NCT02942277|449546794|FG010|Year 2|Non-compliant|0|||
124978128|NCT02942277|449546784|FG000|Year 2|Withdrawal by Subject|0|||
124978129|NCT02942277|449546785|FG001|Year 2|Withdrawal by Subject|0|||
124978130|NCT02942277|449546786|FG002|Year 2|Withdrawal by Subject|0|||
124978131|NCT02942277|449546787|FG003|Year 2|Withdrawal by Subject|0|||
124978132|NCT02942277|449546788|FG004|Year 2|Withdrawal by Subject|0|||
124978133|NCT02942277|449546789|FG005|Year 2|Withdrawal by Subject|0|||
124978134|NCT02942277|449546790|FG006|Year 2|Withdrawal by Subject|1|||
124978135|NCT02942277|449546791|FG007|Year 2|Withdrawal by Subject|0|||
124978136|NCT02942277|449546792|FG008|Year 2|Withdrawal by Subject|0|||
124978137|NCT02942277|449546793|FG009|Year 2|Withdrawal by Subject|0|||
124978138|NCT02942277|449546794|FG010|Year 2|Withdrawal by Subject|0|||
124978139|NCT05577715|449546795|FG000|Overall Study|Withdrawal by Subject|1|||
124978140|NCT05577715|449546795|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
124978141|NCT05577715|449546795|FG000|Overall Study|Lost to Follow-up|1|||
124978142|NCT05577715|449546795|FG000|Overall Study|Death|6|||
124978143|NCT04833127|449546800|FG000|Overall Study|Lost to Follow-up|1|||
124978144|NCT04833127|449546801|FG001|Overall Study|Lost to Follow-up|1|||
124978145|NCT04552899|449546804|FG000|Overall Study|Adverse Event|4|||
124978146|NCT04552899|449546805|FG001|Overall Study|Adverse Event|3|||
124978147|NCT04552899|449546804|FG000|Overall Study|Death|4|||
124978148|NCT04552899|449546805|FG001|Overall Study|Death|4|||
124978149|NCT04552899|449546804|FG000|Overall Study|Lost to Follow-up|8|||
124978150|NCT04552899|449546805|FG001|Overall Study|Lost to Follow-up|13|||
124978151|NCT04552899|449546804|FG000|Overall Study|Lung Transplant|4|||
124978152|NCT04552899|449546805|FG001|Overall Study|Lung Transplant|3|||
124978153|NCT04552899|449546804|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
124978154|NCT04552899|449546805|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
124978155|NCT04552899|449546804|FG000|Overall Study|Physician Decision|3|||
124978156|NCT04552899|449546805|FG001|Overall Study|Physician Decision|4|||
124978157|NCT04552899|449546804|FG000|Overall Study|Study Terminated By Sponsor|237|||
124978158|NCT04552899|449546805|FG001|Overall Study|Study Terminated By Sponsor|239|||
124978159|NCT04552899|449546804|FG000|Overall Study|Withdrawal by Subject|15|||
124978160|NCT04552899|449546805|FG001|Overall Study|Withdrawal by Subject|17|||
124978161|NCT05282121|449546806|FG000|Overall Study|Adverse Event|1|||
124978162|NCT05282121|449546807|FG001|Overall Study|Adverse Event|1|||
124978163|NCT05282121|449546808|FG002|Overall Study|Adverse Event|4|||
124978164|NCT05282121|449546809|FG003|Overall Study|Adverse Event|1|||
124978165|NCT05282121|449546806|FG000|Overall Study|Study Terminated by Sponsor|1|||
124978166|NCT05282121|449546807|FG001|Overall Study|Study Terminated by Sponsor|2|||
124978167|NCT05282121|449546808|FG002|Overall Study|Study Terminated by Sponsor|2|||
124978168|NCT05282121|449546809|FG003|Overall Study|Study Terminated by Sponsor|2|||
124978169|NCT05282121|449546806|FG000|Overall Study|Other than listed|0|||
124978170|NCT05282121|449546807|FG001|Overall Study|Other than listed|0|||
124978171|NCT05282121|449546808|FG002|Overall Study|Other than listed|1|||
124978172|NCT05282121|449546809|FG003|Overall Study|Other than listed|0|||
124978173|NCT05282121|449546806|FG000|Overall Study|No reason available|0|||
124978174|NCT05282121|449546807|FG001|Overall Study|No reason available|0|||
124978175|NCT05282121|449546808|FG002|Overall Study|No reason available|1|||
124978176|NCT05282121|449546809|FG003|Overall Study|No reason available|0|||
124978177|NCT01736189|449546810|FG000|Overall Study|Violation of registration criteria|41|||
124978178|NCT01736189|449546810|FG000|Overall Study|Protocol Violation|4|||
124978179|NCT01736189|449546810|FG000|Overall Study|Criteria and protocol violations|1|||
124978180|NCT00731133|449546817|FG000|Overall Study|Withdrawal by Subject|10|||
124978181|NCT03510455|449546818|FG000|Overall Study|Physician Decision|1|||
124978182|NCT02964325|449546827|FG000|Overall Study|Lost to Follow-up|3|||
124978183|NCT02964325|449546828|FG001|Overall Study|Lost to Follow-up|3|||
124978184|NCT02964325|449546827|FG000|Overall Study|Physician Decision|5|||
124978185|NCT02964325|449546828|FG001|Overall Study|Physician Decision|4|||
124978186|NCT02964325|449546827|FG000|Overall Study|Death|1|||
124978187|NCT02964325|449546828|FG001|Overall Study|Death|3|||
124978188|NCT02964325|449546827|FG000|Overall Study|Withdrawal by Subject|2|||
124978189|NCT02964325|449546828|FG001|Overall Study|Withdrawal by Subject|1|||
124978190|NCT02964325|449546827|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
124978191|NCT02964325|449546828|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
124978192|NCT02510040|449546829|FG000|Overall Study|Deemed no longer eligible|18|||
124978193|NCT02510040|449546830|FG001|Overall Study|Deemed no longer eligible|3|||
124978194|NCT02510040|449546831|FG002|Overall Study|Deemed no longer eligible|1|||
124978195|NCT00643617|449546832|FG000|Overall Study|Death|6|||
124978196|NCT00643617|449546833|FG001|Overall Study|Death|9|||
124978197|NCT00643617|449546832|FG000|Overall Study|Lost to Follow-up|42|||
124978198|NCT00643617|449546833|FG001|Overall Study|Lost to Follow-up|51|||
124978199|NCT02202785|449546843|FG000|Overall Study|Study Terminated by Sponsor|1|||
124978200|NCT02202785|449546844|FG001|Overall Study|Study Terminated by Sponsor|6|||
124756291|NCT02518971|448729486|FG000|Overall Study|Withdrawal by Subject|4|||
124978201|NCT02202785|449546845|FG002|Overall Study|Study Terminated by Sponsor|4|||
124978202|NCT02202785|449546843|FG000|Overall Study|Withdrawal by Subject|0|||
124978203|NCT02202785|449546844|FG001|Overall Study|Withdrawal by Subject|1|||
124978204|NCT02202785|449546845|FG002|Overall Study|Withdrawal by Subject|0|||
124978205|NCT02202785|449546843|FG000|Overall Study|Lost to Follow-up|0|||
124978206|NCT02202785|449546844|FG001|Overall Study|Lost to Follow-up|1|||
124978207|NCT02202785|449546845|FG002|Overall Study|Lost to Follow-up|0|||
124978208|NCT02202785|449546843|FG000|Overall Study|Reason not Specified|10|||
124978209|NCT02202785|449546844|FG001|Overall Study|Reason not Specified|7|||
124978210|NCT02202785|449546845|FG002|Overall Study|Reason not Specified|13|||
124978211|NCT02180243|449546846|FG000|Overall Study|Withdrawal by Subject|12|||
124978212|NCT02180243|449546847|FG001|Overall Study|Withdrawal by Subject|12|||
124756292|NCT02518971|448729487|FG001|Overall Study|Withdrawal by Subject|5|||
124756293|NCT02518971|448729486|FG000|Overall Study|Side effects|1|||
124978213|NCT02180243|449546846|FG000|Overall Study|Lost to Follow-up|12|||
124978214|NCT02180243|449546847|FG001|Overall Study|Lost to Follow-up|2|||
124978215|NCT01137578|449546848|FG000|Overall Study|Participant requested to Discontinue|3|||
124978216|NCT01137578|449546849|FG001|Overall Study|Participant requested to Discontinue|0|||
124978217|NCT01137578|449546850|FG002|Overall Study|Participant requested to Discontinue|0|||
124978218|NCT01137578|449546848|FG000|Overall Study|Withdrawal by Subject|1|||
124978219|NCT01137578|449546849|FG001|Overall Study|Withdrawal by Subject|0|||
124978220|NCT01137578|449546850|FG002|Overall Study|Withdrawal by Subject|0|||
124978221|NCT01137578|449546848|FG000|Overall Study|Other|12|||
124978222|NCT01137578|449546849|FG001|Overall Study|Other|2|||
124978223|NCT01137578|449546850|FG002|Overall Study|Other|6|||
124978224|NCT04145700|449546852|FG000|Overall Study|Withdrawal by Subject|8|||
124978225|NCT04145700|449546853|FG001|Overall Study|Withdrawal by Subject|3|||
124978226|NCT00818779|449546854|FG000|Overall Study|Protocol Violation|1|||
124978227|NCT00818779|449546855|FG001|Overall Study|Protocol Violation|0|||
124978228|NCT00818779|449546854|FG000|Overall Study|Lost to Follow-up|1|||
124978229|NCT00818779|449546855|FG001|Overall Study|Lost to Follow-up|0|||
124978230|NCT00818779|449546854|FG000|Overall Study|Adverse Event|4|||
124978231|NCT00818779|449546855|FG001|Overall Study|Adverse Event|1|||
124978232|NCT04978493|449546856|FG000|Overall Study|No reason available|0|||
124978233|NCT04978493|449546857|FG001|Overall Study|No reason available|1|||
124978234|NCT04978493|449546856|FG000|Overall Study|Adverse Event|1|||
124978235|NCT04978493|449546857|FG001|Overall Study|Adverse Event|0|||
124978236|NCT01327846|449546858|FG000|Core Phase|Subject decision (vital status: missing)|1|||
124978237|NCT01327846|449546859|FG001|Core Phase|Subject decision (vital status: missing)|2|||
124978238|NCT01327846|449546860|FG002|Core Phase|Subject decision (vital status: missing)|2|||
124978239|NCT01327846|449546861|FG003|Core Phase|Subject decision (vital status: missing)|1|||
124978240|NCT01327846|449546858|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
124978241|NCT01327846|449546859|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
124978242|NCT01327846|449546860|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
124978243|NCT01327846|449546861|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
124978244|NCT01327846|449546858|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
124978245|NCT01327846|449546859|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
124978246|NCT01327846|449546860|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
124978247|NCT01327846|449546861|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
124978248|NCT01327846|449546858|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
124978249|NCT01327846|449546859|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
124978250|NCT01327846|449546860|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
124978251|NCT01327846|449546861|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
124978252|NCT01327846|449546858|FG000|Core Phase|Lost to Follow-up|3|||
124978253|NCT01327846|449546859|FG001|Core Phase|Lost to Follow-up|3|||
124978254|NCT01327846|449546860|FG002|Core Phase|Lost to Follow-up|4|||
124978255|NCT01327846|449546861|FG003|Core Phase|Lost to Follow-up|5|||
124978256|NCT01327846|449546858|FG000|Extension Phase|Study terminated by sponsor|1073|||
124978257|NCT01327846|449546859|FG001|Extension Phase|Study terminated by sponsor|1124|||
124978258|NCT01327846|449546860|FG002|Extension Phase|Study terminated by sponsor|1067|||
124978259|NCT01327846|449546861|FG003|Extension Phase|Study terminated by sponsor|1660|||
124978260|NCT01327846|449546858|FG000|Extension Phase|Withdrawal by Subject|20|||
124978261|NCT01327846|449546859|FG001|Extension Phase|Withdrawal by Subject|13|||
124978262|NCT01327846|449546860|FG002|Extension Phase|Withdrawal by Subject|19|||
124978263|NCT01327846|449546861|FG003|Extension Phase|Withdrawal by Subject|37|||
124978264|NCT01327846|449546858|FG000|Extension Phase|Lost to Follow-up|4|||
124978265|NCT01327846|449546859|FG001|Extension Phase|Lost to Follow-up|3|||
124978266|NCT01327846|449546860|FG002|Extension Phase|Lost to Follow-up|4|||
124978267|NCT01327846|449546861|FG003|Extension Phase|Lost to Follow-up|7|||
124978268|NCT01327846|449546858|FG000|Extension Phase|Technical Problems|2|||
124978269|NCT01327846|449546859|FG001|Extension Phase|Technical Problems|4|||
124978270|NCT01327846|449546860|FG002|Extension Phase|Technical Problems|2|||
124978271|NCT01327846|449546861|FG003|Extension Phase|Technical Problems|2|||
124978272|NCT04343976|449546862|FG000|Overall Study|Withdrawal by Subject|0|||
124978273|NCT04343976|449546863|FG001|Overall Study|Withdrawal by Subject|1|||
124978274|NCT00594880|449546864|FG000|Overall Study|Withdrawal by Subject|1|||
124978275|NCT00594880|449546865|FG001|Overall Study|Withdrawal by Subject|1|||
124978276|NCT00594880|449546864|FG000|Overall Study|Lost to Follow-up|1|||
124978277|NCT00594880|449546865|FG001|Overall Study|Lost to Follow-up|0|||
124978278|NCT01371708|449546866|FG000|Overall Study|Insufficient clinical response|3|||
124978279|NCT01371708|449546867|FG001|Overall Study|Insufficient clinical response|2|||
124978280|NCT01371708|449546868|FG002|Overall Study|Insufficient clinical response|0|||
124978281|NCT01371708|449546866|FG000|Overall Study|Lost to Follow-up|5|||
124978282|NCT01371708|449546867|FG001|Overall Study|Lost to Follow-up|9|||
124978283|NCT01371708|449546868|FG002|Overall Study|Lost to Follow-up|7|||
124978284|NCT01371708|449546866|FG000|Overall Study|Protocol Violation|2|||
124978285|NCT01371708|449546867|FG001|Overall Study|Protocol Violation|1|||
124978286|NCT01371708|449546868|FG002|Overall Study|Protocol Violation|2|||
124978287|NCT01371708|449546866|FG000|Overall Study|No longer willing to participate|7|||
124978288|NCT01371708|449546867|FG001|Overall Study|No longer willing to participate|7|||
124978289|NCT01371708|449546868|FG002|Overall Study|No longer willing to participate|13|||
124978290|NCT01371708|449546866|FG000|Overall Study|Medication error/not related to AE|0|||
124978291|NCT01371708|449546867|FG001|Overall Study|Medication error/not related to AE|1|||
124978292|NCT01371708|449546868|FG002|Overall Study|Medication error/not related to AE|0|||
124978293|NCT01371708|449546866|FG000|Overall Study|Other|3|||
124978294|NCT01371708|449546867|FG001|Overall Study|Other|2|||
124978295|NCT01371708|449546868|FG002|Overall Study|Other|4|||
124978296|NCT01371708|449546866|FG000|Overall Study|Adverse Event|5|||
124978297|NCT01371708|449546867|FG001|Overall Study|Adverse Event|8|||
124978298|NCT01371708|449546868|FG002|Overall Study|Adverse Event|12|||
124978299|NCT01371708|449546866|FG000|Overall Study|Started but did not receive treatment|1|||
124978300|NCT01371708|449546867|FG001|Overall Study|Started but did not receive treatment|0|||
124978301|NCT01371708|449546868|FG002|Overall Study|Started but did not receive treatment|1|||
124978302|NCT00694109|449546869|FG000|Overall Study|Physician Decision|3|||
124978303|NCT00694109|449546869|FG000|Overall Study|Adverse Event|74|||
124978304|NCT00694109|449546869|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
124978305|NCT00694109|449546869|FG000|Overall Study|Lack of Efficacy|2|||
124978306|NCT00694109|449546869|FG000|Overall Study|Withdrawal by Subject|13|||
124978307|NCT00694109|449546869|FG000|Overall Study|Pregnancy|1|||
124978308|NCT00694109|449546869|FG000|Overall Study|Enrolled but not treated|1|||
124978309|NCT00694109|449546869|FG000|Overall Study|Other|2|||
124978310|NCT00694109|449546869|FG000|Overall Study|Consented but no additional treatment|3|||
124978311|NCT01254747|449546870|FG000|Overall Study|Unacceptable subjective vision|0|||
124978312|NCT01254747|449546871|FG001|Overall Study|Unacceptable subjective vision|0|||
124978313|NCT01254747|449546872|FG002|Overall Study|Unacceptable subjective vision|0|||
124978314|NCT01254747|449546873|FG003|Overall Study|Unacceptable subjective vision|2|||
124978315|NCT01254747|449546870|FG000|Overall Study|Difficult removal handling|0|||
124978316|NCT01254747|449546871|FG001|Overall Study|Difficult removal handling|0|||
124978317|NCT01254747|449546872|FG002|Overall Study|Difficult removal handling|1|||
124978318|NCT01254747|449546873|FG003|Overall Study|Difficult removal handling|0|||
124978319|NCT01254747|449546870|FG000|Overall Study|Symptoms and problems|0|||
124978320|NCT01254747|449546871|FG001|Overall Study|Symptoms and problems|2|||
124978321|NCT01254747|449546872|FG002|Overall Study|Symptoms and problems|1|||
124978322|NCT01254747|449546873|FG003|Overall Study|Symptoms and problems|0|||
124978323|NCT01254747|449546870|FG000|Overall Study|Lost to Follow-up|0|||
124978324|NCT01254747|449546871|FG001|Overall Study|Lost to Follow-up|0|||
124978325|NCT01254747|449546872|FG002|Overall Study|Lost to Follow-up|1|||
124978326|NCT01254747|449546873|FG003|Overall Study|Lost to Follow-up|0|||
124978327|NCT01254747|449546870|FG000|Overall Study|Biomicroscopy|0|||
124978328|NCT01254747|449546871|FG001|Overall Study|Biomicroscopy|0|||
124978329|NCT01254747|449546872|FG002|Overall Study|Biomicroscopy|1|||
124978330|NCT01254747|449546873|FG003|Overall Study|Biomicroscopy|0|||
124978331|NCT01254747|449546870|FG000|Overall Study|Discomfort|0|||
124978332|NCT01254747|449546871|FG001|Overall Study|Discomfort|4|||
124978333|NCT01254747|449546872|FG002|Overall Study|Discomfort|0|||
124978334|NCT01254747|449546873|FG003|Overall Study|Discomfort|0|||
124978335|NCT00846807|449546874|FG000|Overall Study|Adverse Event|270|||
124978336|NCT00846807|449546874|FG000|Overall Study|Lost to Follow-up|94|||
124978337|NCT00846807|449546874|FG000|Overall Study|Withdrawal by Subject|56|||
124978338|NCT00846807|449546874|FG000|Overall Study|Non compliant with European label|7|||
124978339|NCT00846807|449546874|FG000|Overall Study|Switch to other anticoagulants|89|||
124978340|NCT00846807|449546874|FG000|Overall Study|No prescription after hospital discharge|56|||
124978341|NCT00846807|449546874|FG000|Overall Study|Other|60|||
124978342|NCT00245960|449546875|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
124978343|NCT00245960|449546876|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
124978344|NCT00245960|449546875|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
124978345|NCT00245960|449546876|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
124978346|NCT00245960|449546875|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
124978347|NCT00245960|449546876|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
124978348|NCT00245960|449546875|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
124978349|NCT00245960|449546876|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
124978350|NCT00245960|449546875|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
124978351|NCT00245960|449546876|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
124978352|NCT00245960|449546875|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
124978353|NCT00245960|449546876|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
124978354|NCT00245960|449546875|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
124978355|NCT00245960|449546876|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
124978356|NCT00245960|449546875|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
124978357|NCT00245960|449546876|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
124978358|NCT00245960|449546875|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
124756294|NCT02518971|448729487|FG001|Overall Study|Side effects|0|||
124978359|NCT00245960|449546876|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
124978360|NCT00245960|449546875|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
124978361|NCT00245960|449546876|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
124978362|NCT00245960|449546875|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
124978363|NCT00245960|449546876|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
124978364|NCT00245960|449546875|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
124756295|NCT02518971|448729486|FG000|Overall Study|medication lost in mail|0|||
124756296|NCT02518971|448729487|FG001|Overall Study|medication lost in mail|1|||
124756297|NCT02518971|448729486|FG000|Overall Study|eligibility criteria no longer met|6|||
124756298|NCT02518971|448729487|FG001|Overall Study|eligibility criteria no longer met|3|||
124756299|NCT02336230|448729488|FG000|Overall Study|Adverse Event|1|||
124756300|NCT02336230|448729488|FG000|Overall Study|Withdrawal of consent|1|||
124756301|NCT02336230|448729488|FG000|Overall Study|Death|9|||
124756302|NCT02336230|448729488|FG000|Overall Study|Dose not received due to shipping delay|1|||
124756303|NCT02336230|448729488|FG000|Overall Study|Discontinuation of MSC infusion|1|||
124756304|NCT02524171|448729489|FG000|6-month Follow-up|Lost to Follow-up|53|||
124756305|NCT02524171|448729490|FG001|6-month Follow-up|Lost to Follow-up|45|||
124756306|NCT02524171|448729489|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
124756307|NCT02524171|448729490|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
124756308|NCT00757237|448729493|FG000|Overall Study|Lost to Follow-up|0|||
124756309|NCT00757237|448729494|FG001|Overall Study|Lost to Follow-up|1|||
124756310|NCT00757237|448729493|FG000|Overall Study|Protocol Violation|0|||
124756311|NCT00757237|448729494|FG001|Overall Study|Protocol Violation|2|||
124756312|NCT00757237|448729493|FG000|Overall Study|Physician Decision|2|||
124756313|NCT00757237|448729494|FG001|Overall Study|Physician Decision|3|||
124756314|NCT00757237|448729493|FG000|Overall Study|Withdrawal by Subject|8|||
124756315|NCT00757237|448729494|FG001|Overall Study|Withdrawal by Subject|12|||
124756316|NCT00757237|448729493|FG000|Overall Study|Safety or Tolerability|3|||
124756317|NCT00757237|448729494|FG001|Overall Study|Safety or Tolerability|5|||
124756318|NCT00757237|448729493|FG000|Overall Study|Other|0|||
124756319|NCT00757237|448729494|FG001|Overall Study|Other|2|||
124756320|NCT05150990|448729495|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
124756321|NCT05150990|448729496|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
124756322|NCT05150990|448729495|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
124769771|NCT02383576|448785168|FG000|Overall Study|Investigator's Decision|0|||
124978365|NCT00245960|449546876|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
124978366|NCT00737698|449546877|FG000|Overall Study|Withdrawal by Subject|6|||
124978367|NCT00737698|449546878|FG001|Overall Study|Withdrawal by Subject|5|||
124978368|NCT00737698|449546879|FG002|Overall Study|Withdrawal by Subject|3|||
124978369|NCT00737698|449546877|FG000|Overall Study|Death|0|||
124978370|NCT00737698|449546878|FG001|Overall Study|Death|0|||
124978371|NCT00737698|449546879|FG002|Overall Study|Death|1|||
124978372|NCT01067846|449546880|FG000|Overall Study|Lost to Follow-up|17|||
124978373|NCT01067846|449546881|FG001|Overall Study|Lost to Follow-up|19|||
124978374|NCT01067846|449546880|FG000|Overall Study|Withdrawal by Subject|1|||
124978375|NCT01067846|449546881|FG001|Overall Study|Withdrawal by Subject|0|||
124978376|NCT01067846|449546880|FG000|Overall Study|participation in other tx study|1|||
124978377|NCT01067846|449546881|FG001|Overall Study|participation in other tx study|0|||
124978378|NCT04608773|449546885|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
124978379|NCT04608773|449546886|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
124978380|NCT04608773|449546885|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
124978381|NCT04608773|449546886|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
124978382|NCT04608773|449546885|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
124978383|NCT04608773|449546886|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
124978384|NCT04608773|449546885|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
124978385|NCT04608773|449546886|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
124978386|NCT04608773|449546885|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
124978387|NCT04608773|449546886|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
124978388|NCT02387970|449546887|FG000|Overall Study|Did not complete 1-year follow up|1|||
124978389|NCT02387970|449546888|FG001|Overall Study|Did not complete 1-year follow up|2|||
124978390|NCT01436253|449546893|FG000|Overall Study|Lost to Follow-up|182|||
124978391|NCT01436253|449546893|FG000|Overall Study|Not meeting all eligibility criteria|117|||
124978392|NCT00316017|449546895|FG000|Overall Study|Protocol Violation|11|||
124978393|NCT00316017|449546896|FG001|Overall Study|Protocol Violation|13|||
124978394|NCT00316017|449546897|FG002|Overall Study|Protocol Violation|19|||
124978395|NCT04531982|449546900|FG000|Overall Study|Withdrawal by Subject|10|||
124978396|NCT04531982|449546901|FG001|Overall Study|Withdrawal by Subject|11|||
124978397|NCT04531982|449546900|FG000|Overall Study|Adverse Event|6|||
124978398|NCT04531982|449546901|FG001|Overall Study|Adverse Event|14|||
124978399|NCT04531982|449546900|FG000|Overall Study|Protocol Violation|6|||
124978400|NCT04531982|449546901|FG001|Overall Study|Protocol Violation|9|||
124978401|NCT04531982|449546900|FG000|Overall Study|Non-compliance with study drug|3|||
124978402|NCT04531982|449546901|FG001|Overall Study|Non-compliance with study drug|2|||
124978403|NCT04531982|449546900|FG000|Overall Study|Use of prohibited medication|2|||
124978404|NCT04531982|449546901|FG001|Overall Study|Use of prohibited medication|0|||
124978405|NCT04531982|449546900|FG000|Overall Study|Lost to Follow-up|0|||
124978406|NCT04531982|449546901|FG001|Overall Study|Lost to Follow-up|1|||
124978407|NCT04531982|449546900|FG000|Overall Study|Geopolitical conflict|2|||
124978408|NCT04531982|449546901|FG001|Overall Study|Geopolitical conflict|0|||
124978409|NCT04531982|449546900|FG000|Overall Study|Lack of Efficacy|3|||
124978410|NCT04531982|449546901|FG001|Overall Study|Lack of Efficacy|1|||
124978411|NCT04266795|449546906|FG000|Overall Study|Adverse Event|10|||
124978412|NCT04266795|449546907|FG001|Overall Study|Adverse Event|19|||
124978413|NCT04266795|449546906|FG000|Overall Study|Death|7|||
124978414|NCT04266795|449546907|FG001|Overall Study|Death|8|||
124978415|NCT04266795|449546906|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
124978416|NCT04266795|449546907|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
124978417|NCT04266795|449546906|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
124978418|NCT04266795|449546907|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
124978419|NCT04266795|449546906|FG000|Overall Study|Progressive Disease|12|||
124978420|NCT04266795|449546907|FG001|Overall Study|Progressive Disease|9|||
124978421|NCT04266795|449546906|FG000|Overall Study|Withdrawal by Patient|5|||
124978422|NCT04266795|449546907|FG001|Overall Study|Withdrawal by Patient|6|||
124978423|NCT04266795|449546906|FG000|Overall Study|Disease Relapse|3|||
124978424|NCT04266795|449546907|FG001|Overall Study|Disease Relapse|6|||
124978425|NCT04266795|449546906|FG000|Overall Study|Reason not Specified|12|||
124978426|NCT04266795|449546907|FG001|Overall Study|Reason not Specified|10|||
124978427|NCT04266795|449546906|FG000|Overall Study|Participants Ongoing on Treatment|25|||
124978428|NCT04266795|449546907|FG001|Overall Study|Participants Ongoing on Treatment|23|||
124978429|NCT03570892|449546908|FG000|Overall Study|Death|51|||
124978430|NCT03570892|449546909|FG001|Overall Study|Death|45|||
124978431|NCT03570892|449546908|FG000|Overall Study|Subject decision|5|||
124978432|NCT03570892|449546909|FG001|Overall Study|Subject decision|3|||
124978433|NCT03570892|449546908|FG000|Overall Study|Protocol Violation|1|||
124978434|NCT03570892|449546909|FG001|Overall Study|Protocol Violation|4|||
124978435|NCT03570892|449546908|FG000|Overall Study|Physician Decision|0|||
124978436|NCT03570892|449546909|FG001|Overall Study|Physician Decision|2|||
124978437|NCT01876082|449548481|FG000|Overall Study|Withdrawal by Subject|0|||
124978438|NCT01876082|449548482|FG001|Overall Study|Withdrawal by Subject|2|||
124978439|NCT01876082|449548481|FG000|Overall Study|Protocol Violation|1|||
124978440|NCT01876082|449548482|FG001|Overall Study|Protocol Violation|0|||
124978441|NCT01876082|449548481|FG000|Overall Study|Adverse Event|1|||
124978442|NCT01876082|449548482|FG001|Overall Study|Adverse Event|1|||
124978443|NCT01876082|449548481|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
124978444|NCT01876082|449548482|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
124978445|NCT04427280|449548484|FG000|Overall Study|Withdrawal by Subject|0|||
124978446|NCT04427280|449548485|FG001|Overall Study|Withdrawal by Subject|2|||
124978447|NCT03829501|449548488|FG000|Overall Study|Withdrawal of Consent|2|||
124978448|NCT03829501|449548489|FG001|Overall Study|Withdrawal of Consent|0|||
124978449|NCT03829501|449548490|FG002|Overall Study|Withdrawal of Consent|3|||
124978450|NCT03829501|449548491|FG003|Overall Study|Withdrawal of Consent|0|||
124978451|NCT03829501|449548492|FG004|Overall Study|Withdrawal of Consent|1|||
124978452|NCT03829501|449548493|FG005|Overall Study|Withdrawal of Consent|1|||
124978453|NCT03829501|449548494|FG006|Overall Study|Withdrawal of Consent|0|||
124978454|NCT03829501|449548495|FG007|Overall Study|Withdrawal of Consent|10|||
124978455|NCT03829501|449548496|FG008|Overall Study|Withdrawal of Consent|10|||
124978456|NCT03829501|449548497|FG009|Overall Study|Withdrawal of Consent|3|||
124978457|NCT03829501|449548498|FG010|Overall Study|Withdrawal of Consent|4|||
124978458|NCT03829501|449548499|FG011|Overall Study|Withdrawal of Consent|4|||
124978459|NCT03829501|449548500|FG012|Overall Study|Withdrawal of Consent|4|||
124978460|NCT03829501|449548501|FG013|Overall Study|Withdrawal of Consent|0|||
124978461|NCT03829501|449548502|FG014|Overall Study|Withdrawal of Consent|3|||
124978462|NCT03829501|449548503|FG015|Overall Study|Withdrawal of Consent|0|||
124978463|NCT03829501|449548504|FG016|Overall Study|Withdrawal of Consent|1|||
124978464|NCT03829501|449548505|FG017|Overall Study|Withdrawal of Consent|1|||
124978465|NCT03829501|449548506|FG018|Overall Study|Withdrawal of Consent|0|||
124978466|NCT03829501|449548507|FG019|Overall Study|Withdrawal of Consent|0|||
124978467|NCT03829501|449548508|FG020|Overall Study|Withdrawal of Consent|3|||
124978468|NCT03829501|449548509|FG021|Overall Study|Withdrawal of Consent|0|||
124978469|NCT03829501|449548510|FG022|Overall Study|Withdrawal of Consent|1|||
124978470|NCT03829501|449548488|FG000|Overall Study|PD|0|||
124978471|NCT03829501|449548489|FG001|Overall Study|PD|0|||
124978472|NCT03829501|449548490|FG002|Overall Study|PD|0|||
124978473|NCT03829501|449548491|FG003|Overall Study|PD|2|||
124978474|NCT03829501|449548492|FG004|Overall Study|PD|0|||
124978475|NCT03829501|449548493|FG005|Overall Study|PD|0|||
124978476|NCT03829501|449548494|FG006|Overall Study|PD|0|||
124978477|NCT03829501|449548495|FG007|Overall Study|PD|0|||
124978478|NCT03829501|449548496|FG008|Overall Study|PD|0|||
124644688|NCT03614078|448316489|FG001|Overall Study|Exacerbation of Psoriasis|1|||
124644689|NCT03614078|448316490|FG002|Overall Study|Exacerbation of Psoriasis|0|||
124756323|NCT05150990|448729496|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
124756324|NCT05150990|448729495|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
124756325|NCT05150990|448729496|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
124756326|NCT05150990|448729495|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
124756327|NCT05150990|448729496|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
124756328|NCT05150990|448729495|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
124756329|NCT05150990|448729496|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
124756330|NCT05150990|448729495|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
124756331|NCT05150990|448729496|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
124756332|NCT05150990|448729495|FG000|Overall Study|Death (unrelated to the intervention)|1|||
124756333|NCT05150990|448729496|FG001|Overall Study|Death (unrelated to the intervention)|2|||
124756334|NCT00466921|448729497|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
124756335|NCT00466921|448729497|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
124756336|NCT00466921|448729497|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
124756337|NCT00466921|448729497|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
124756338|NCT00466921|448729497|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
124756339|NCT00466921|448729497|FG000|Follow up for a Minimum of 1 Year|Death|6|||
124756340|NCT02864901|448729498|FG000|Overall Study|Withdrawal by Subject|1|||
124756341|NCT02864901|448729499|FG001|Overall Study|Withdrawal by Subject|0|||
124756342|NCT01219985|448729500|FG000|Overall Study|Physician Decision|20|||
124756343|NCT04797780|448729501|FG000|Overall Study|Lost to Follow-up|1|||
124756344|NCT04797780|448729502|FG001|Overall Study|Lost to Follow-up|1|||
124756345|NCT04797780|448729501|FG000|Overall Study|Withdrawal by Subject|14|||
124534487|NCT00405756|447909412|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
124534488|NCT00405756|447909413|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
124534489|NCT00405756|447909414|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
124534490|NCT00405756|447909412|FG000|Double-blind Treatment|Adverse Event|31|||
124534491|NCT00405756|447909413|FG001|Double-blind Treatment|Adverse Event|27|||
124534492|NCT00405756|447909414|FG002|Double-blind Treatment|Adverse Event|12|||
124534493|NCT00405756|447909412|FG000|Double-blind Treatment|Disease Progression|47|||
124534494|NCT00405756|447909413|FG001|Double-blind Treatment|Disease Progression|81|||
124534495|NCT00405756|447909414|FG002|Double-blind Treatment|Disease Progression|102|||
124756346|NCT04797780|448729502|FG001|Overall Study|Withdrawal by Subject|9|||
124756347|NCT04797780|448729501|FG000|Overall Study|Death|49|||
124756348|NCT04797780|448729502|FG001|Overall Study|Death|20|||
124756349|NCT04669301|448729503|FG000|Overall Study|Lost to Follow-up|0|||
124756350|NCT04669301|448729504|FG001|Overall Study|Lost to Follow-up|1|||
124756351|NCT04669301|448729505|FG002|Overall Study|Lost to Follow-up|0|||
124756352|NCT04669301|448729503|FG000|Overall Study|Withdrawal by Subject|3|||
124756353|NCT04669301|448729504|FG001|Overall Study|Withdrawal by Subject|2|||
124756354|NCT04669301|448729505|FG002|Overall Study|Withdrawal by Subject|0|||
124756355|NCT02863328|448729506|FG000|Overall Study|Lost to Follow-up|4|||
124756356|NCT02863328|448729507|FG001|Overall Study|Lost to Follow-up|10|||
124756357|NCT02863328|448729506|FG000|Overall Study|Withdrawal by Subject|7|||
124756358|NCT02863328|448729507|FG001|Overall Study|Withdrawal by Subject|12|||
124756359|NCT02863328|448729506|FG000|Overall Study|Died|0|||
124756360|NCT02863328|448729507|FG001|Overall Study|Died|1|||
124756361|NCT00398320|448729508|FG000|Overall Study|Death|1|||
124756362|NCT00398320|448729508|FG000|Overall Study|Adverse Event|4|||
124756363|NCT00398320|448729508|FG000|Overall Study|Physician Decision|1|||
124756364|NCT00163020|448729512|FG000|Overall Study|Lost to Follow-up|0|||
124756365|NCT00163020|448729513|FG001|Overall Study|Lost to Follow-up|2|||
124769772|NCT02383576|448785169|FG001|Overall Study|Investigator's Decision|1|||
124769773|NCT02383576|448785168|FG000|Overall Study|Administrative/Other|2|||
124769774|NCT02383576|448785169|FG001|Overall Study|Administrative/Other|4|||
124769775|NCT02340026|448785170|FG000|Treatment Phase|Withdrawal by Subject|2|||
124769776|NCT02340026|448785171|FG001|Treatment Phase|Withdrawal by Subject|2|||
124769777|NCT02340026|448785170|FG000|Follow-up Phase|Lost to Follow-up|1|||
124769778|NCT02340026|448785171|FG001|Follow-up Phase|Lost to Follow-up|0|||
124769779|NCT02738801|448785184|FG000|Overall Study|Adverse Event|1|||
124769780|NCT02738801|448785185|FG001|Overall Study|Adverse Event|1|||
124769781|NCT02738801|448785184|FG000|Overall Study|Withdrawal by Subject|0|||
124769782|NCT02738801|448785185|FG001|Overall Study|Withdrawal by Subject|1|||
124769783|NCT03279081|448785186|FG000|Overall Study|Withdrawal by Subject|12|||
124769784|NCT03279081|448785187|FG001|Overall Study|Withdrawal by Subject|20|||
124769785|NCT03279081|448785186|FG000|Overall Study|Physician Decision|4|||
124769786|NCT03279081|448785187|FG001|Overall Study|Physician Decision|1|||
124769787|NCT03279081|448785186|FG000|Overall Study|Lost to Follow-up|8|||
124769788|NCT03279081|448785187|FG001|Overall Study|Lost to Follow-up|8|||
124769789|NCT03279081|448785186|FG000|Overall Study|Death|0|||
124769790|NCT03279081|448785187|FG001|Overall Study|Death|1|||
124769791|NCT03279081|448785186|FG000|Overall Study|Adverse Event|1|||
124769792|NCT03279081|448785187|FG001|Overall Study|Adverse Event|0|||
124769793|NCT03279081|448785186|FG000|Overall Study|Reason not Specified|14|||
124769794|NCT03279081|448785187|FG001|Overall Study|Reason not Specified|4|||
124769795|NCT01210313|448785196|FG000|Overall Study|Withdrawal by Subject|3|||
124769796|NCT01210313|448785196|FG000|Overall Study|Adverse Event|2|||
124769797|NCT01210313|448785196|FG000|Overall Study|Distant recurrence|4|||
124769798|NCT01210313|448785196|FG000|Overall Study|Non-compliance|7|||
124769799|NCT01710345|448785197|FG000|Overall Study|Adverse Event|0|||
124769800|NCT01710345|448785198|FG001|Overall Study|Adverse Event|2|||
124769801|NCT01710345|448785199|FG002|Overall Study|Adverse Event|0|||
124769802|NCT01710345|448785197|FG000|Overall Study|Lack of Efficacy|2|||
124769803|NCT01710345|448785198|FG001|Overall Study|Lack of Efficacy|3|||
124769804|NCT01710345|448785199|FG002|Overall Study|Lack of Efficacy|1|||
124769805|NCT01710345|448785197|FG000|Overall Study|Drug Dosing Error|1|||
124769806|NCT01710345|448785198|FG001|Overall Study|Drug Dosing Error|0|||
124769807|NCT01710345|448785199|FG002|Overall Study|Drug Dosing Error|0|||
124769808|NCT01502293|448785204|FG000|Overall Study|Progressive Disease|20|||
124769809|NCT01502293|448785205|FG001|Overall Study|Progressive Disease|12|||
124769810|NCT01502293|448785206|FG002|Overall Study|Progressive Disease|2|||
124769811|NCT01502293|448785204|FG000|Overall Study|Withdrawal by Subject|3|||
124769812|NCT01502293|448785205|FG001|Overall Study|Withdrawal by Subject|3|||
124769813|NCT01502293|448785206|FG002|Overall Study|Withdrawal by Subject|1|||
124756366|NCT03553758|448730709|FG000|Overall Study|Lost to Follow-up|1|||
124756367|NCT00447226|448730711|FG000|12-Week Open-label Phase|Adverse Event|0|||
124756368|NCT00447226|448730712|FG001|12-Week Open-label Phase|Adverse Event|3|||
124756369|NCT00447226|448730711|FG000|12-Week Open-label Phase|Protocol Violation|0|||
124756370|NCT00447226|448730712|FG001|12-Week Open-label Phase|Protocol Violation|1|||
124756371|NCT00447226|448730711|FG000|12-Week Open-label Phase|Disease Progression|0|||
124756372|NCT00447226|448730712|FG001|12-Week Open-label Phase|Disease Progression|20|||
124756373|NCT00447226|448730711|FG000|12-Week Open-label Phase|Physician Decision|0|||
124756374|NCT00447226|448730712|FG001|12-Week Open-label Phase|Physician Decision|1|||
124756375|NCT00447226|448730711|FG000|Double-blind Phase|Disease Progression|4|||
124756376|NCT00447226|448730712|FG001|Double-blind Phase|Disease Progression|3|||
124756377|NCT00991939|448730726|FG000|Overall Study|Lost to Follow-up|0|||
124756378|NCT00991939|448730727|FG001|Overall Study|Lost to Follow-up|1|||
124756379|NCT00991939|448730726|FG000|Overall Study|Withdrawal by Subject|1|||
124756380|NCT00991939|448730727|FG001|Overall Study|Withdrawal by Subject|0|||
124756381|NCT00991939|448730726|FG000|Overall Study|Entire study terminated|4|||
124756382|NCT00991939|448730727|FG001|Overall Study|Entire study terminated|1|||
124756383|NCT00714415|448730730|FG000|Overall Study|Lack of Efficacy|1|||
124756384|NCT00714415|448730731|FG001|Overall Study|Lack of Efficacy|0|||
124756385|NCT00714415|448730730|FG000|Overall Study|Death|1|||
124756386|NCT00714415|448730731|FG001|Overall Study|Death|0|||
124756387|NCT01461707|448730734|FG000|Overall Study|Withdrawal by Subject|1|||
124756388|NCT01461707|448730735|FG001|Overall Study|Withdrawal by Subject|0|||
124756389|NCT01100320|448730752|FG000|Period 1|Withdrawal by Subject|2|||
124756390|NCT01100320|448730753|FG001|Period 1|Withdrawal by Subject|4|||
124756391|NCT01100320|448730752|FG000|Period 1|Positive Drug Screen|1|||
124756392|NCT01100320|448730753|FG001|Period 1|Positive Drug Screen|1|||
124756393|NCT01100320|448730752|FG000|Period 1|Adverse Event|2|||
124756394|NCT01100320|448730753|FG001|Period 1|Adverse Event|2|||
124756395|NCT01100320|448730752|FG000|Period 2|Withdrawal by Subject|1|||
124756396|NCT01100320|448730753|FG001|Period 2|Withdrawal by Subject|1|||
124756397|NCT03797586|448730754|FG000|Overall Study|Lost to Follow-up|3|||
124756398|NCT03797586|448730755|FG001|Overall Study|Lost to Follow-up|6|||
124756399|NCT03797586|448730754|FG000|Overall Study|Death|1|||
124756400|NCT03797586|448730755|FG001|Overall Study|Death|1|||
124756401|NCT03797586|448730754|FG000|Overall Study|Adverse Event|0|||
124756402|NCT03797586|448730755|FG001|Overall Study|Adverse Event|2|||
124756403|NCT04980612|448730756|FG000|Overall Study|Withdrawal by Subject|7|||
124756404|NCT04980612|448730757|FG001|Overall Study|Withdrawal by Subject|5|||
124756405|NCT05730387|448730758|FG000|Overall Study|Stillbirth|0|||
124756406|NCT05730387|448730759|FG001|Overall Study|Stillbirth|262|||
124756407|NCT05730387|448730758|FG000|Overall Study|Died during or after delivery|2|||
124756408|NCT05730387|448730759|FG001|Overall Study|Died during or after delivery|85|||
124756409|NCT05730387|448730758|FG000|Overall Study|Died after being admitted|0|||
124756410|NCT05730387|448730759|FG001|Overall Study|Died after being admitted|44|||
124756411|NCT05730387|448730758|FG000|Overall Study|Lost to Follow-up|69|||
124756412|NCT05730387|448730759|FG001|Overall Study|Lost to Follow-up|77|||
124756413|NCT01369784|448730762|FG000|Overall Study|Protocol Violation|12|||
124756414|NCT02680665|448730763|FG000|Overall Study|No visit after the first prescription|5|||
124756415|NCT02905266|448730764|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
124756416|NCT02905266|448730765|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
124756417|NCT02905266|448730764|FG000|Treatment Phase Part 1|Disease Progression|6|||
124756418|NCT02905266|448730765|FG001|Treatment Phase Part 1|Disease Progression|7|||
124756419|NCT02905266|448730764|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
124756420|NCT02905266|448730765|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
124756421|NCT02905266|448730764|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
124756422|NCT02905266|448730765|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
124756423|NCT02905266|448730764|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
124756424|NCT02905266|448730765|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
124756425|NCT02905266|448730764|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
124756426|NCT02905266|448730765|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
124756427|NCT02905266|448730764|FG000|Transition From Part 1 to Part 2|Death|0|||
124756428|NCT02905266|448730765|FG001|Transition From Part 1 to Part 2|Death|1|||
124756429|NCT02905266|448730764|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
124756430|NCT02905266|448730765|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
124756431|NCT02905266|448730764|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
124756432|NCT02905266|448730765|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
124756433|NCT02905266|448730764|FG000|Maintenance Phase Part 2|Disease Progression|9|||
124756434|NCT02905266|448730765|FG001|Maintenance Phase Part 2|Disease Progression|2|||
124756435|NCT02905266|448730764|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
124756436|NCT02905266|448730765|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
124756437|NCT02905266|448730764|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
124756438|NCT02905266|448730765|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
124756439|NCT00596752|448730771|FG000|Overall Study|Other Reason|44|||
124756440|NCT00596752|448730772|FG001|Overall Study|Other Reason|49|||
124756441|NCT00596752|448730771|FG000|Overall Study|Adverse Event|34|||
124756442|NCT00596752|448730772|FG001|Overall Study|Adverse Event|34|||
124756443|NCT00596752|448730771|FG000|Overall Study|Lost to Follow-up|22|||
124756444|NCT00596752|448730772|FG001|Overall Study|Lost to Follow-up|38|||
124756445|NCT00596752|448730771|FG000|Overall Study|Withdrawal by Subject|12|||
124756446|NCT00596752|448730772|FG001|Overall Study|Withdrawal by Subject|9|||
124756447|NCT00596752|448730771|FG000|Overall Study|Unsatisfactory Compliance|9|||
124756448|NCT00596752|448730772|FG001|Overall Study|Unsatisfactory Compliance|6|||
124756449|NCT00596752|448730771|FG000|Overall Study|Lack of Efficacy|4|||
124756450|NCT00596752|448730772|FG001|Overall Study|Lack of Efficacy|7|||
124756451|NCT00596752|448730771|FG000|Overall Study|Protocol Violation|1|||
124756452|NCT00596752|448730772|FG001|Overall Study|Protocol Violation|0|||
124756453|NCT05973006|448730773|FG000|Overall Study|Early termination|3|||
124756454|NCT05973006|448730774|FG001|Overall Study|Early termination|9|||
124756455|NCT04378270|448730776|FG000|Overall Study|Lack of Efficacy|1|||
124756456|NCT04378270|448730776|FG000|Overall Study|Withdrawal by Subject|1|||
124756457|NCT04378270|448730776|FG000|Overall Study|Screen Failure|1|||
124756458|NCT04378270|448730776|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
124756459|NCT01327599|448730777|FG000|Overall Study|Adverse Event|1|||
124756460|NCT01327599|448730777|FG000|Overall Study|Could Not Attend Visit|1|||
124756461|NCT01327599|448730777|FG000|Overall Study|Withdrawal of Consent|1|||
124756462|NCT04544956|448730780|FG000|Overall Study|Withdrawal by Subject|1|||
124756463|NCT00548145|448730783|FG000|Overall Study|Death|0|||
124756464|NCT00548145|448730784|FG001|Overall Study|Death|1|||
124756465|NCT00548145|448730783|FG000|Overall Study|Withdrawal by Subject|0|||
124756466|NCT00548145|448730784|FG001|Overall Study|Withdrawal by Subject|2|||
124756467|NCT00548145|448730783|FG000|Overall Study|Physician Decision|1|||
124756468|NCT00548145|448730784|FG001|Overall Study|Physician Decision|1|||
124756469|NCT02119663|448730785|FG000|Overall Study|Disease progression|26|||
124756470|NCT02119663|448730786|FG001|Overall Study|Disease progression|27|||
124756471|NCT02119663|448730785|FG000|Overall Study|Adverse Event|5|||
124756472|NCT02119663|448730786|FG001|Overall Study|Adverse Event|5|||
124756473|NCT02119663|448730785|FG000|Overall Study|Death|3|||
124756474|NCT02119663|448730786|FG001|Overall Study|Death|2|||
124756475|NCT02119663|448730785|FG000|Overall Study|Physician Decision|1|||
124756476|NCT02119663|448730786|FG001|Overall Study|Physician Decision|2|||
124756477|NCT02119663|448730785|FG000|Overall Study|Other unspecified|2|||
124756478|NCT02119663|448730786|FG001|Overall Study|Other unspecified|0|||
124756479|NCT02119663|448730785|FG000|Overall Study|Subject decision|0|||
124756480|NCT02119663|448730786|FG001|Overall Study|Subject decision|1|||
124756481|NCT02119663|448730785|FG000|Overall Study|Study Terminated by the Sponsor|3|||
124756482|NCT02119663|448730786|FG001|Overall Study|Study Terminated by the Sponsor|4|||
124756483|NCT00892775|448730787|FG000|Overall Study|Protocol Violation|1|||
124756484|NCT00892775|448730788|FG001|Overall Study|Protocol Violation|0|||
124756485|NCT00892775|448730787|FG000|Overall Study|Subject difficulties with blood drawing|1|||
124756486|NCT00892775|448730788|FG001|Overall Study|Subject difficulties with blood drawing|0|||
124756487|NCT00892775|448730787|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
124756488|NCT00892775|448730788|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
124756489|NCT00892775|448730787|FG000|Overall Study|Migrated/ moved from study area|1|||
124756490|NCT00892775|448730788|FG001|Overall Study|Migrated/ moved from study area|0|||
124756491|NCT00892775|448730787|FG000|Overall Study|Withdrawal by Subject|0|||
124756492|NCT00892775|448730788|FG001|Overall Study|Withdrawal by Subject|1|||
124756493|NCT00892775|448730787|FG000|Overall Study|Lost to Follow-up|1|||
124756494|NCT00892775|448730788|FG001|Overall Study|Lost to Follow-up|0|||
124756495|NCT00699660|448730789|FG000|Overall Study|Lost to Follow-up|4|||
124756496|NCT00699660|448730790|FG001|Overall Study|Lost to Follow-up|2|||
124756497|NCT00699660|448730789|FG000|Overall Study|missing reports and recording failures|10|||
124756498|NCT00699660|448730790|FG001|Overall Study|missing reports and recording failures|6|||
124756499|NCT00064792|448730791|FG000|Overall Study|Withdrawal by Subject|2|||
124756500|NCT00064792|448730792|FG001|Overall Study|Withdrawal by Subject|0|||
124756501|NCT00064792|448730791|FG000|Overall Study|Adverse Event|3|||
124756502|NCT00064792|448730792|FG001|Overall Study|Adverse Event|0|||
124756503|NCT03301350|448730793|FG000|Overall Study|Withdrawal by Subject|4|||
124756504|NCT03301350|448730793|FG000|Overall Study|Adverse Event|1|||
124756505|NCT03301350|448730793|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
124756506|NCT03301350|448730793|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
124756507|NCT03301350|448730793|FG000|Overall Study|no detail provided|1|||
124756508|NCT01248949|448730796|FG000|Overall Study|Lost to Follow-up|2|||
124756509|NCT01248949|448730797|FG001|Overall Study|Lost to Follow-up|2|||
124756510|NCT01248949|448730798|FG002|Overall Study|Lost to Follow-up|2|||
124756511|NCT01248949|448730799|FG003|Overall Study|Lost to Follow-up|1|||
124756512|NCT01248949|448730800|FG004|Overall Study|Lost to Follow-up|0|||
124756513|NCT01248949|448730796|FG000|Overall Study|Withdrawal by Subject|5|||
124756514|NCT01248949|448730797|FG001|Overall Study|Withdrawal by Subject|3|||
124756515|NCT01248949|448730798|FG002|Overall Study|Withdrawal by Subject|11|||
124756516|NCT01248949|448730799|FG003|Overall Study|Withdrawal by Subject|3|||
124756517|NCT01248949|448730800|FG004|Overall Study|Withdrawal by Subject|1|||
124756518|NCT01248949|448730796|FG000|Overall Study|Death|22|||
124756519|NCT01248949|448730797|FG001|Overall Study|Death|7|||
124756520|NCT01248949|448730798|FG002|Overall Study|Death|21|||
124756521|NCT01248949|448730799|FG003|Overall Study|Death|6|||
124756522|NCT01248949|448730800|FG004|Overall Study|Death|2|||
124756523|NCT01248949|448730796|FG000|Overall Study|Alternative Therapy|1|||
124756524|NCT01248949|448730797|FG001|Overall Study|Alternative Therapy|0|||
124756525|NCT01248949|448730798|FG002|Overall Study|Alternative Therapy|0|||
124756526|NCT01248949|448730799|FG003|Overall Study|Alternative Therapy|0|||
124756527|NCT01248949|448730800|FG004|Overall Study|Alternative Therapy|0|||
124756528|NCT01248949|448730796|FG000|Overall Study|Alternative Therapy.|1|||
124756529|NCT01248949|448730797|FG001|Overall Study|Alternative Therapy.|0|||
124756530|NCT01248949|448730798|FG002|Overall Study|Alternative Therapy.|0|||
124756531|NCT01248949|448730799|FG003|Overall Study|Alternative Therapy.|0|||
124756532|NCT01248949|448730800|FG004|Overall Study|Alternative Therapy.|0|||
124756533|NCT01248949|448730796|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
124756534|NCT01248949|448730797|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
124756535|NCT01248949|448730798|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
124756536|NCT01248949|448730799|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
124756537|NCT01248949|448730800|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
124756538|NCT01248949|448730796|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
124756539|NCT01248949|448730797|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
124756540|NCT01248949|448730798|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
124756541|NCT01248949|448730799|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
124756542|NCT01248949|448730800|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
124756543|NCT01248949|448730796|FG000|Overall Study|Participant Went To Hospice|0|||
124756544|NCT01248949|448730797|FG001|Overall Study|Participant Went To Hospice|0|||
124756545|NCT01248949|448730798|FG002|Overall Study|Participant Went To Hospice|1|||
124756546|NCT01248949|448730799|FG003|Overall Study|Participant Went To Hospice|0|||
124756547|NCT01248949|448730800|FG004|Overall Study|Participant Went To Hospice|0|||
124756548|NCT01248949|448730796|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
124756549|NCT01248949|448730797|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
124756550|NCT01248949|448730798|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
124756551|NCT01248949|448730799|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
124756552|NCT01248949|448730800|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
124756553|NCT01248949|448730796|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
124756554|NCT01248949|448730797|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
124756555|NCT01248949|448730798|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
124756556|NCT01248949|448730799|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
124756557|NCT01248949|448730800|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
124756558|NCT01248949|448730796|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
124756559|NCT01248949|448730797|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
124756560|NCT01248949|448730798|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
124756561|NCT01248949|448730799|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
124756562|NCT01248949|448730800|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
124756563|NCT01248949|448730796|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
124756564|NCT01248949|448730797|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
124756565|NCT01248949|448730798|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
124756566|NCT01248949|448730799|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
124756567|NCT01248949|448730800|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
124756568|NCT03915470|448730803|FG000|Overall Study|Death|3|||
124756569|NCT03915470|448730804|FG001|Overall Study|Death|1|||
124756570|NCT03915470|448730803|FG000|Overall Study|Adverse Event|1|||
124756571|NCT03915470|448730804|FG001|Overall Study|Adverse Event|0|||
124756572|NCT03915470|448730803|FG000|Overall Study|Physician Decision|1|||
124756573|NCT03915470|448730804|FG001|Overall Study|Physician Decision|0|||
124756574|NCT03915470|448730803|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
124756575|NCT03915470|448730804|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
124756576|NCT03245775|448730807|FG000|Overall Study|Lost to Follow-up|25|||
124756577|NCT03245775|448730808|FG001|Overall Study|Lost to Follow-up|26|||
124756578|NCT03245775|448730809|FG002|Overall Study|Lost to Follow-up|16|||
124756579|NCT03245775|448730810|FG003|Overall Study|Lost to Follow-up|16|||
124756580|NCT02713828|448730811|FG000|Overall Study|Death|2|||
124756581|NCT02713828|448730812|FG001|Overall Study|Death|0|||
124756582|NCT02713828|448730811|FG000|Overall Study|Withdrawal by Subject|1|||
124756583|NCT02713828|448730812|FG001|Overall Study|Withdrawal by Subject|0|||
124756584|NCT02713828|448730811|FG000|Overall Study|study terminated but patient allowed to|2|||
124756585|NCT02713828|448730812|FG001|Overall Study|study terminated but patient allowed to|0|||
124756586|NCT00434109|448730813|FG000|Overall Study|Physician Decision|9|||
124756587|NCT00434109|448730813|FG000|Overall Study|Adverse Event|5|||
124756588|NCT00434109|448730813|FG000|Overall Study|Protocol Violation|1|||
124756589|NCT00434109|448730813|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
124756590|NCT02978833|448730816|FG000|Overall Study|Study terminated|1|||
124756591|NCT02978833|448730817|FG001|Overall Study|Study terminated|1|||
124756592|NCT00103740|448730818|FG000|Period 1 - Core|Adverse Event|1|||
124756593|NCT00103740|448730819|FG001|Period 1 - Core|Adverse Event|0|||
124756594|NCT00103740|448730818|FG000|Period 1 - Core|Protocol Violation|3|||
124756595|NCT00103740|448730819|FG001|Period 1 - Core|Protocol Violation|2|||
124756596|NCT00103740|448730818|FG000|Period 1 - Core|Patient withdrew consent|3|||
124756597|NCT00103740|448730819|FG001|Period 1 - Core|Patient withdrew consent|2|||
124756598|NCT00103740|448730818|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
124756599|NCT00103740|448730819|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
124756600|NCT00103740|448730818|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
124756601|NCT00103740|448730819|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
124756602|NCT00103740|448730818|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
124756603|NCT00103740|448730819|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
124756604|NCT00103740|448730818|FG000|Period 2 - Extended Observation Period|Death|6|||
124756605|NCT00103740|448730819|FG001|Period 2 - Extended Observation Period|Death|2|||
124756606|NCT00103740|448730818|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
124756607|NCT00103740|448730819|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
124756608|NCT00291486|448730824|FG000|Overall Study|Adverse Event|0|||
124756609|NCT00291486|448730825|FG001|Overall Study|Adverse Event|3|||
124756610|NCT00291486|448730826|FG002|Overall Study|Adverse Event|0|||
124756611|NCT00291486|448730827|FG003|Overall Study|Adverse Event|1|||
124756612|NCT00291486|448730828|FG004|Overall Study|Adverse Event|0|||
124756613|NCT00291486|448730824|FG000|Overall Study|Withdrawal by Subject|0|||
124756614|NCT00291486|448730825|FG001|Overall Study|Withdrawal by Subject|0|||
124756615|NCT00291486|448730826|FG002|Overall Study|Withdrawal by Subject|0|||
124756616|NCT00291486|448730827|FG003|Overall Study|Withdrawal by Subject|0|||
124756617|NCT00291486|448730828|FG004|Overall Study|Withdrawal by Subject|1|||
124756618|NCT00291486|448730824|FG000|Overall Study|Disease progression|1|||
124756619|NCT00291486|448730825|FG001|Overall Study|Disease progression|0|||
124756620|NCT00291486|448730826|FG002|Overall Study|Disease progression|1|||
124756621|NCT00291486|448730827|FG003|Overall Study|Disease progression|0|||
124756622|NCT00291486|448730828|FG004|Overall Study|Disease progression|0|||
124756623|NCT01099397|448730829|FG000|Overall Study|Lost to Follow-up|4|||
124756624|NCT01099397|448730829|FG000|Overall Study|Protocol Violation|4|||
124756625|NCT01099397|448730829|FG000|Overall Study|Withdrawal by Subject|5|||
124756626|NCT01900652|448730832|FG000|Overall Study|Progressive Disease|1|||
124756627|NCT01900652|448730833|FG001|Overall Study|Progressive Disease|0|||
124756628|NCT01900652|448730832|FG000|Overall Study|Consent withdrawn by subject|1|||
124756629|NCT01900652|448730833|FG001|Overall Study|Consent withdrawn by subject|1|||
124756630|NCT01900652|448730832|FG000|Overall Study|Death|3|||
124756631|NCT01900652|448730833|FG001|Overall Study|Death|0|||
124756632|NCT01900652|448730832|FG000|Overall Study|Adverse Event|2|||
124866920|NCT02586025|449135379|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
124978479|NCT03829501|449548497|FG009|Overall Study|PD|0|||
124756633|NCT01900652|448730833|FG001|Overall Study|Adverse Event|1|||
124466427|NCT02814565|447666394|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
124756634|NCT01900652|448730832|FG000|Overall Study|Physician Decision|1|||
124756635|NCT01900652|448730833|FG001|Overall Study|Physician Decision|1|||
124756636|NCT02663622|448730836|FG000|Overall Study|Death|3|||
124756637|NCT02663622|448730837|FG001|Overall Study|Death|1|||
124756638|NCT02663622|448730838|FG002|Overall Study|Death|1|||
124756639|NCT02663622|448730839|FG003|Overall Study|Death|8|||
124756640|NCT02663622|448730836|FG000|Overall Study|Protocol Violation|0|||
124756641|NCT02663622|448730837|FG001|Overall Study|Protocol Violation|0|||
124756642|NCT02663622|448730838|FG002|Overall Study|Protocol Violation|0|||
124756643|NCT02663622|448730839|FG003|Overall Study|Protocol Violation|1|||
124756644|NCT01792115|448730840|FG000|Overall Study|Lost to Follow-up|0|||
124756645|NCT01792115|448730841|FG001|Overall Study|Lost to Follow-up|1|||
124756646|NCT01792115|448730842|FG002|Overall Study|Lost to Follow-up|0|||
124756647|NCT00900029|448730843|FG000|Overall Study|Lost to Follow-up|0|||
124756648|NCT00900029|448730844|FG001|Overall Study|Lost to Follow-up|2|||
124756649|NCT00900029|448730845|FG002|Overall Study|Lost to Follow-up|1|||
124756650|NCT00900029|448730846|FG003|Overall Study|Lost to Follow-up|4|||
124756651|NCT00900029|448730847|FG004|Overall Study|Lost to Follow-up|4|||
124756652|NCT00900029|448730843|FG000|Overall Study|Withdrawal by Subject|2|||
124756653|NCT00900029|448730844|FG001|Overall Study|Withdrawal by Subject|2|||
124756654|NCT00900029|448730845|FG002|Overall Study|Withdrawal by Subject|1|||
124756655|NCT00900029|448730846|FG003|Overall Study|Withdrawal by Subject|1|||
124756656|NCT00900029|448730847|FG004|Overall Study|Withdrawal by Subject|1|||
124756657|NCT00900029|448730843|FG000|Overall Study|Adverse Event|0|||
124756658|NCT00900029|448730844|FG001|Overall Study|Adverse Event|0|||
124756659|NCT00900029|448730845|FG002|Overall Study|Adverse Event|1|||
124756660|NCT00900029|448730846|FG003|Overall Study|Adverse Event|1|||
124756661|NCT00900029|448730847|FG004|Overall Study|Adverse Event|1|||
124756662|NCT00900029|448730843|FG000|Overall Study|Death|1|||
124756663|NCT00900029|448730844|FG001|Overall Study|Death|0|||
124756664|NCT00900029|448730845|FG002|Overall Study|Death|0|||
124756665|NCT00900029|448730846|FG003|Overall Study|Death|1|||
124756666|NCT00900029|448730847|FG004|Overall Study|Death|0|||
124756667|NCT01594931|448733920|FG000|Overall Study|Adverse Event|3|||
124756668|NCT01594931|448733921|FG001|Overall Study|Adverse Event|1|||
124756669|NCT01594931|448733922|FG002|Overall Study|Adverse Event|1|||
124756670|NCT01594931|448733920|FG000|Overall Study|Withdrawal by Subject|2|||
124756671|NCT01594931|448733921|FG001|Overall Study|Withdrawal by Subject|1|||
124756672|NCT01594931|448733922|FG002|Overall Study|Withdrawal by Subject|1|||
124756673|NCT01594931|448733920|FG000|Overall Study|Lack of Efficacy|7|||
124756674|NCT01594931|448733921|FG001|Overall Study|Lack of Efficacy|2|||
124756675|NCT01594931|448733922|FG002|Overall Study|Lack of Efficacy|2|||
124756676|NCT01594931|448733920|FG000|Overall Study|Lost to Follow-up|4|||
124756677|NCT01594931|448733921|FG001|Overall Study|Lost to Follow-up|3|||
124756678|NCT01594931|448733922|FG002|Overall Study|Lost to Follow-up|3|||
124756679|NCT01594931|448733920|FG000|Overall Study|Protocol Violation|2|||
124756680|NCT01594931|448733921|FG001|Overall Study|Protocol Violation|1|||
124756681|NCT01594931|448733922|FG002|Overall Study|Protocol Violation|0|||
124756682|NCT01594931|448733920|FG000|Overall Study|No defiined|11|||
124756683|NCT01594931|448733921|FG001|Overall Study|No defiined|4|||
124756684|NCT01594931|448733922|FG002|Overall Study|No defiined|7|||
124756685|NCT02936635|448733931|FG000|Overall Study|Adverse Event|43|||
124756686|NCT02936635|448733932|FG001|Overall Study|Adverse Event|25|||
124756687|NCT02936635|448733931|FG000|Overall Study|Progressive Disease|10|||
124756688|NCT02936635|448733932|FG001|Overall Study|Progressive Disease|18|||
124756689|NCT02936635|448733931|FG000|Overall Study|Sponsor Discretion|10|||
124756690|NCT02936635|448733932|FG001|Overall Study|Sponsor Discretion|16|||
124756691|NCT02936635|448733931|FG000|Overall Study|Death|9|||
124756692|NCT02936635|448733932|FG001|Overall Study|Death|15|||
124756693|NCT02936635|448733931|FG000|Overall Study|Withdrawal by Subject|8|||
124756694|NCT02936635|448733932|FG001|Overall Study|Withdrawal by Subject|15|||
124756695|NCT02936635|448733931|FG000|Overall Study|Physician Decision|2|||
124756696|NCT02936635|448733932|FG001|Overall Study|Physician Decision|9|||
124756697|NCT02936635|448733931|FG000|Overall Study|Lost to Follow-up|1|||
124756698|NCT02936635|448733932|FG001|Overall Study|Lost to Follow-up|2|||
124756699|NCT02936635|448733931|FG000|Overall Study|Protocol Violation|1|||
124756700|NCT02936635|448733932|FG001|Overall Study|Protocol Violation|0|||
124756701|NCT02936635|448733931|FG000|Overall Study|Lack of effect/Entry into other study|31|||
124756702|NCT02936635|448733932|FG001|Overall Study|Lack of effect/Entry into other study|65|||
124756703|NCT01633788|448733933|FG000|Overall Study|Adverse Event|1|||
124756704|NCT01633788|448733934|FG001|Overall Study|Adverse Event|3|||
124756705|NCT01633788|448733935|FG002|Overall Study|Adverse Event|3|||
124756706|NCT01633788|448733936|FG003|Overall Study|Adverse Event|3|||
124756707|NCT01633788|448733933|FG000|Overall Study|Lost to Follow-up|2|||
124756708|NCT01633788|448733934|FG001|Overall Study|Lost to Follow-up|2|||
124756709|NCT01633788|448733935|FG002|Overall Study|Lost to Follow-up|2|||
124756710|NCT01633788|448733936|FG003|Overall Study|Lost to Follow-up|0|||
124756711|NCT01633788|448733933|FG000|Overall Study|Personal Reasons|3|||
124756712|NCT01633788|448733934|FG001|Overall Study|Personal Reasons|1|||
124756713|NCT01633788|448733935|FG002|Overall Study|Personal Reasons|1|||
124756714|NCT01633788|448733936|FG003|Overall Study|Personal Reasons|3|||
124756715|NCT01633788|448733933|FG000|Overall Study|Protocol Violation|1|||
124756716|NCT01633788|448733934|FG001|Overall Study|Protocol Violation|0|||
124756717|NCT01633788|448733935|FG002|Overall Study|Protocol Violation|1|||
124756718|NCT01633788|448733936|FG003|Overall Study|Protocol Violation|0|||
124756719|NCT01633788|448733933|FG000|Overall Study|Other Reasons|0|||
124756720|NCT01633788|448733934|FG001|Overall Study|Other Reasons|2|||
124756721|NCT01633788|448733935|FG002|Overall Study|Other Reasons|3|||
124756722|NCT01633788|448733936|FG003|Overall Study|Other Reasons|7|||
124756723|NCT01929226|448733937|FG000|Overall Study|Lost to Follow-up|4|||
124756724|NCT01929226|448733938|FG001|Overall Study|Lost to Follow-up|0|||
124756725|NCT01929226|448733937|FG000|Overall Study|Withdrawal by Subject|1|||
124756726|NCT01929226|448733938|FG001|Overall Study|Withdrawal by Subject|1|||
124756727|NCT01473732|448733940|FG000|Overall Study|Adverse Event|1|||
124756728|NCT01473732|448733941|FG001|Overall Study|Adverse Event|0|||
124756729|NCT01473732|448733940|FG000|Overall Study|Death|1|||
124756730|NCT01473732|448733941|FG001|Overall Study|Death|0|||
124756731|NCT03579940|448733948|FG000|Period 2|Withdrawal by Subject|0|||
124756732|NCT03579940|448733949|FG001|Period 2|Withdrawal by Subject|0|||
124756733|NCT03579940|448733950|FG002|Period 2|Withdrawal by Subject|1|||
124756734|NCT03579940|448733951|FG003|Period 2|Withdrawal by Subject|0|||
124756735|NCT03579940|448733952|FG004|Period 2|Withdrawal by Subject|0|||
124756736|NCT03579940|448733953|FG005|Period 2|Withdrawal by Subject|0|||
124756737|NCT03579940|448733954|FG006|Period 2|Withdrawal by Subject|0|||
124756738|NCT03579940|448733955|FG007|Period 2|Withdrawal by Subject|0|||
124756739|NCT03579940|448733956|FG008|Period 2|Withdrawal by Subject|0|||
124756740|NCT03579940|448733957|FG009|Period 2|Withdrawal by Subject|0|||
124756741|NCT03579940|448733958|FG010|Period 2|Withdrawal by Subject|0|||
124756742|NCT01217944|448733959|FG000|Overall Study|Protocol Violation|1|||
124756743|NCT01217944|448733960|FG001|Overall Study|Protocol Violation|1|||
124756744|NCT01217944|448733961|FG002|Overall Study|Protocol Violation|0|||
124756745|NCT01217944|448733959|FG000|Overall Study|Lost to Follow-up|3|||
124756746|NCT01217944|448733960|FG001|Overall Study|Lost to Follow-up|1|||
124756747|NCT01217944|448733961|FG002|Overall Study|Lost to Follow-up|0|||
124756748|NCT01217944|448733959|FG000|Overall Study|Withdrawal by Subject|1|||
124756749|NCT01217944|448733960|FG001|Overall Study|Withdrawal by Subject|2|||
124756750|NCT01217944|448733961|FG002|Overall Study|Withdrawal by Subject|0|||
124756751|NCT01217944|448733959|FG000|Overall Study|Lack of Efficacy|1|||
124756752|NCT01217944|448733960|FG001|Overall Study|Lack of Efficacy|0|||
124756753|NCT01217944|448733961|FG002|Overall Study|Lack of Efficacy|0|||
124756754|NCT00671034|448733962|FG000|Overall Study|Adverse Event|5|||
124756755|NCT00671034|448733963|FG001|Overall Study|Adverse Event|7|||
124756756|NCT00671034|448733964|FG002|Overall Study|Adverse Event|1|||
124756757|NCT00671034|448733962|FG000|Overall Study|Death|3|||
124756758|NCT00671034|448733963|FG001|Overall Study|Death|2|||
124756759|NCT00671034|448733964|FG002|Overall Study|Death|1|||
124756760|NCT00671034|448733962|FG000|Overall Study|Physician Decision|12|||
124756761|NCT00671034|448733963|FG001|Overall Study|Physician Decision|4|||
124756762|NCT00671034|448733964|FG002|Overall Study|Physician Decision|5|||
124756763|NCT00671034|448733962|FG000|Overall Study|VHR ALL feature|8|||
124756764|NCT00671034|448733963|FG001|Overall Study|VHR ALL feature|3|||
124756765|NCT00671034|448733964|FG002|Overall Study|VHR ALL feature|5|||
124756766|NCT00671034|448733962|FG000|Overall Study|Refusal|5|||
124756767|NCT00671034|448733963|FG001|Overall Study|Refusal|3|||
124756768|NCT00671034|448733964|FG002|Overall Study|Refusal|5|||
124756769|NCT00671034|448733962|FG000|Overall Study|includes Alternative therapy, etc.|6|||
124756770|NCT00671034|448733963|FG001|Overall Study|includes Alternative therapy, etc.|1|||
124756771|NCT00671034|448733964|FG002|Overall Study|includes Alternative therapy, etc.|7|||
124756772|NCT01751984|448733965|FG000|Overall Study|Adverse Event|5|||
124756773|NCT01751984|448733966|FG001|Overall Study|Adverse Event|3|||
124756774|NCT01751984|448733965|FG000|Overall Study|Withdrawal by Subject|0|||
124756775|NCT01751984|448733966|FG001|Overall Study|Withdrawal by Subject|1|||
124756776|NCT01751984|448733965|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
124756777|NCT01751984|448733966|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
124756778|NCT01797263|448733967|FG000|Overall Study|Withdrawal by Subject|21|||
124756779|NCT01797263|448733968|FG001|Overall Study|Withdrawal by Subject|25|||
124756780|NCT01797263|448733967|FG000|Overall Study|Death|1|||
124756781|NCT01797263|448733968|FG001|Overall Study|Death|0|||
124756782|NCT01797263|448733967|FG000|Overall Study|Lost to Follow-up|15|||
124756783|NCT01797263|448733968|FG001|Overall Study|Lost to Follow-up|15|||
124756784|NCT02045095|448733969|FG000|Overall Study|Other|0|||
124756785|NCT02045095|448733970|FG001|Overall Study|Other|0|||
124756786|NCT02045095|448733971|FG002|Overall Study|Other|1|||
124756787|NCT02045095|448733972|FG003|Overall Study|Other|0|||
124756788|NCT02045095|448733973|FG004|Overall Study|Other|0|||
124756789|NCT02045095|448733974|FG005|Overall Study|Other|2|||
124756790|NCT02045095|448733975|FG006|Overall Study|Other|0|||
124756791|NCT02045095|448733969|FG000|Overall Study|Progressive Disease|3|||
124756792|NCT02045095|448733970|FG001|Overall Study|Progressive Disease|3|||
124756793|NCT02045095|448733971|FG002|Overall Study|Progressive Disease|2|||
124756794|NCT02045095|448733972|FG003|Overall Study|Progressive Disease|4|||
124756795|NCT02045095|448733973|FG004|Overall Study|Progressive Disease|2|||
124756796|NCT02045095|448733974|FG005|Overall Study|Progressive Disease|4|||
124756797|NCT02045095|448733975|FG006|Overall Study|Progressive Disease|1|||
124756798|NCT02045095|448733969|FG000|Overall Study|Withdrawal by Subject|0|||
124756799|NCT02045095|448733970|FG001|Overall Study|Withdrawal by Subject|0|||
124756800|NCT02045095|448733971|FG002|Overall Study|Withdrawal by Subject|0|||
124756801|NCT02045095|448733972|FG003|Overall Study|Withdrawal by Subject|0|||
124756802|NCT02045095|448733973|FG004|Overall Study|Withdrawal by Subject|3|||
124756803|NCT02045095|448733974|FG005|Overall Study|Withdrawal by Subject|0|||
124756804|NCT02045095|448733975|FG006|Overall Study|Withdrawal by Subject|0|||
124756805|NCT02045095|448733969|FG000|Overall Study|Adverse Event|0|||
124756806|NCT02045095|448733970|FG001|Overall Study|Adverse Event|1|||
124756807|NCT02045095|448733971|FG002|Overall Study|Adverse Event|1|||
124756808|NCT02045095|448733972|FG003|Overall Study|Adverse Event|0|||
124756809|NCT02045095|448733973|FG004|Overall Study|Adverse Event|0|||
124756810|NCT02045095|448733974|FG005|Overall Study|Adverse Event|2|||
124756811|NCT02045095|448733975|FG006|Overall Study|Adverse Event|0|||
124756812|NCT01450761|448733976|FG000|Randomization|Subject no longer meets study criteria|1|||
124756813|NCT01450761|448733977|FG001|Randomization|Subject no longer meets study criteria|2|||
124756814|NCT01450761|448733976|FG000|Randomization|Withdrawal by Subject|2|||
124756815|NCT01450761|448733977|FG001|Randomization|Withdrawal by Subject|0|||
124756816|NCT01450761|448733976|FG000|Randomization|Disease progression|0|||
124756817|NCT01450761|448733977|FG001|Randomization|Disease progression|2|||
124756818|NCT01450761|448733976|FG000|Randomization|Adverse Event unrelated to study drug|1|||
124756819|NCT01450761|448733977|FG001|Randomization|Adverse Event unrelated to study drug|0|||
124756820|NCT01450761|448733976|FG000|Randomization|Other|0|||
124756821|NCT01450761|448733977|FG001|Randomization|Other|1|||
124756822|NCT01450761|448733976|FG000|Lead-in Chemotherapy|Disease progression|33|||
124756823|NCT01450761|448733977|FG001|Lead-in Chemotherapy|Disease progression|32|||
124756824|NCT01450761|448733976|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
124756825|NCT01450761|448733977|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
124756826|NCT01450761|448733976|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
124756827|NCT01450761|448733977|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
124756828|NCT01450761|448733976|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
124756829|NCT01450761|448733977|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
124756830|NCT01450761|448733976|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
124756831|NCT01450761|448733977|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
124756832|NCT01450761|448733976|FG000|Lead-in Chemotherapy|Death|3|||
124756833|NCT01450761|448733977|FG001|Lead-in Chemotherapy|Death|3|||
124756834|NCT01450761|448733976|FG000|Lead-in Chemotherapy|Other|2|||
124756835|NCT01450761|448733977|FG001|Lead-in Chemotherapy|Other|2|||
124756836|NCT01450761|448733976|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
124756837|NCT01450761|448733977|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
124756838|NCT01450761|448733976|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
124756839|NCT01450761|448733977|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
124756840|NCT01450761|448733976|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
124756841|NCT01450761|448733977|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
124756842|NCT01450761|448733976|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
124756843|NCT01450761|448733977|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
124756844|NCT01450761|448733976|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
124756845|NCT01450761|448733977|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
124756846|NCT01450761|448733976|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
124756847|NCT01450761|448733977|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
124756848|NCT01450761|448733976|FG000|Treatment With Blinded Study Therapy|Death|5|||
124756849|NCT01450761|448733977|FG001|Treatment With Blinded Study Therapy|Death|6|||
124756850|NCT01450761|448733976|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
124756851|NCT01450761|448733977|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
124756852|NCT01450761|448733976|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
124756853|NCT01450761|448733977|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
124756854|NCT01450761|448733976|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
124756855|NCT01450761|448733977|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
124756856|NCT01450761|448733976|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
124756857|NCT01450761|448733977|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
124756858|NCT01450761|448733976|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
124756859|NCT01450761|448733977|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
124756860|NCT01450761|448733976|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
124756861|NCT01450761|448733977|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
124756862|NCT01450761|448733976|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
124756863|NCT01450761|448733977|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
124756864|NCT00337207|448733978|FG000|Overall Study|Withdrawal by Subject|3|||
124756865|NCT03573323|448733979|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
124756866|NCT03573323|448733980|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
124756867|NCT03573323|448733979|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
124756868|NCT03573323|448733980|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
124756869|NCT03573323|448733979|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
124756870|NCT03573323|448733980|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
124756871|NCT03573323|448733979|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
124756872|NCT03573323|448733980|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
124756873|NCT03573323|448733979|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
124756874|NCT03573323|448733980|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
124756875|NCT03573323|448733979|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
124756876|NCT03573323|448733980|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
124756877|NCT03573323|448733979|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
124756878|NCT03573323|448733980|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
124756879|NCT03573323|448733979|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
124756880|NCT03573323|448733980|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
124756881|NCT03573323|448733979|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
124756882|NCT03573323|448733980|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
124756883|NCT03573323|448733979|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
124756884|NCT03573323|448733980|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
124756885|NCT03573323|448733979|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
124756886|NCT03573323|448733980|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
124756887|NCT03573323|448733979|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
124756888|NCT03573323|448733980|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
124756889|NCT03573323|448733979|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
124756890|NCT03573323|448733980|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
124756891|NCT03573323|448733979|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
124756892|NCT03573323|448733980|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
124756893|NCT03573323|448733979|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
124756894|NCT03573323|448733980|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
124756895|NCT03573323|448733979|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
124756896|NCT03573323|448733980|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
124756897|NCT03573323|448733979|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
124756898|NCT03573323|448733980|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
124756899|NCT03573323|448733979|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
124756900|NCT03573323|448733980|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
124756901|NCT03573323|448733979|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
124756902|NCT03573323|448733980|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
124756903|NCT00837213|448733984|FG000|Overall Study|Lost to Follow-up|3|||
124756904|NCT00837213|448733985|FG001|Overall Study|Lost to Follow-up|2|||
124756905|NCT00837213|448733984|FG000|Overall Study|Withdrawal by Subject|2|||
124756906|NCT00837213|448733985|FG001|Overall Study|Withdrawal by Subject|2|||
124756907|NCT00837213|448733984|FG000|Overall Study|not stated|1|||
124756908|NCT00837213|448733985|FG001|Overall Study|not stated|1|||
124756909|NCT02698826|448733989|FG000|Overall Study|Death|13|||
124756910|NCT02698826|448733989|FG000|Overall Study|Adverse Event|1|||
124756911|NCT00216671|448733993|FG000|Overall Study|Adverse Event|4|||
124756912|NCT00216671|448733994|FG001|Overall Study|Adverse Event|9|||
124756913|NCT00216671|448733993|FG000|Overall Study|Pregnancy|0|||
124756914|NCT00216671|448733994|FG001|Overall Study|Pregnancy|1|||
124756915|NCT00216671|448733993|FG000|Overall Study|Withdrawal by Subject|4|||
124756916|NCT00216671|448733994|FG001|Overall Study|Withdrawal by Subject|2|||
124756917|NCT00216671|448733993|FG000|Overall Study|Refused Injections|3|||
124756918|NCT00216671|448733994|FG001|Overall Study|Refused Injections|13|||
124756919|NCT00216671|448733993|FG000|Overall Study|No Need to Continue Medication|1|||
124756920|NCT00216671|448733994|FG001|Overall Study|No Need to Continue Medication|1|||
124756921|NCT00216671|448733993|FG000|Overall Study|Insufficient Response|9|||
124756922|NCT00216671|448733994|FG001|Overall Study|Insufficient Response|4|||
124756923|NCT00216671|448733993|FG000|Overall Study|Lost to Follow-up|3|||
124756924|NCT00216671|448733994|FG001|Overall Study|Lost to Follow-up|5|||
124756925|NCT00216671|448733993|FG000|Overall Study|Non compliant|2|||
124756926|NCT00216671|448733994|FG001|Overall Study|Non compliant|2|||
124756927|NCT00216671|448733993|FG000|Overall Study|Ineligible|0|||
124756928|NCT00216671|448733994|FG001|Overall Study|Ineligible|2|||
124756929|NCT00216671|448733993|FG000|Overall Study|Physician Decision|1|||
124756930|NCT00216671|448733994|FG001|Overall Study|Physician Decision|1|||
124756931|NCT00216671|448733993|FG000|Overall Study|Protocol Violation|3|||
124756932|NCT00216671|448733994|FG001|Overall Study|Protocol Violation|5|||
124756933|NCT00216671|448733993|FG000|Overall Study|Relapse|1|||
124756934|NCT00216671|448733994|FG001|Overall Study|Relapse|0|||
124756935|NCT00216671|448733993|FG000|Overall Study|Investigator Illness|0|||
124756936|NCT00216671|448733994|FG001|Overall Study|Investigator Illness|1|||
124756937|NCT00216671|448733993|FG000|Overall Study|Patient Moved|0|||
124756938|NCT00216671|448733994|FG001|Overall Study|Patient Moved|1|||
124756939|NCT00216671|448733993|FG000|Overall Study|Ineligible, no efficacy data|2|||
124756940|NCT00216671|448733994|FG001|Overall Study|Ineligible, no efficacy data|2|||
124756941|NCT00216671|448733993|FG000|Overall Study|Insufficient Response Adverse Event|2|||
124756942|NCT00216671|448733994|FG001|Overall Study|Insufficient Response Adverse Event|1|||
124756943|NCT04961541|448733995|FG000|Overall Study|Adverse Event|0|||
124756944|NCT04961541|448733996|FG001|Overall Study|Adverse Event|0|||
124756945|NCT04961541|448733997|FG002|Overall Study|Adverse Event|0|||
124756946|NCT04961541|448733998|FG003|Overall Study|Adverse Event|0|||
124756947|NCT04961541|448733999|FG004|Overall Study|Adverse Event|0|||
124756948|NCT04961541|448734000|FG005|Overall Study|Adverse Event|1|||
124756949|NCT04961541|448734001|FG006|Overall Study|Adverse Event|0|||
124756950|NCT04961541|448734002|FG007|Overall Study|Adverse Event|0|||
124756951|NCT04961541|448734003|FG008|Overall Study|Adverse Event|0|||
124756952|NCT04961541|448734004|FG009|Overall Study|Adverse Event|0|||
124756953|NCT04961541|448734005|FG010|Overall Study|Adverse Event|0|||
124756954|NCT04961541|448734006|FG011|Overall Study|Adverse Event|0|||
124756955|NCT04961541|448734007|FG012|Overall Study|Adverse Event|0|||
124756956|NCT04961541|448734008|FG013|Overall Study|Adverse Event|0|||
124756957|NCT04961541|448733995|FG000|Overall Study|Lost to Follow-up|0|||
124756958|NCT04961541|448733996|FG001|Overall Study|Lost to Follow-up|0|||
124756959|NCT04961541|448733997|FG002|Overall Study|Lost to Follow-up|3|||
124756960|NCT04961541|448733998|FG003|Overall Study|Lost to Follow-up|0|||
124756961|NCT04961541|448733999|FG004|Overall Study|Lost to Follow-up|0|||
124756962|NCT04961541|448734000|FG005|Overall Study|Lost to Follow-up|0|||
124756963|NCT04961541|448734001|FG006|Overall Study|Lost to Follow-up|1|||
124756964|NCT04961541|448734002|FG007|Overall Study|Lost to Follow-up|1|||
124756965|NCT04961541|448734003|FG008|Overall Study|Lost to Follow-up|0|||
124756966|NCT04961541|448734004|FG009|Overall Study|Lost to Follow-up|1|||
124756967|NCT04961541|448734005|FG010|Overall Study|Lost to Follow-up|0|||
124756968|NCT04961541|448734006|FG011|Overall Study|Lost to Follow-up|0|||
124756969|NCT04961541|448734007|FG012|Overall Study|Lost to Follow-up|1|||
124756970|NCT04961541|448734008|FG013|Overall Study|Lost to Follow-up|0|||
124756971|NCT04961541|448733995|FG000|Overall Study|Withdrawal by Subject|0|||
124756972|NCT04961541|448733996|FG001|Overall Study|Withdrawal by Subject|0|||
124756973|NCT04961541|448733997|FG002|Overall Study|Withdrawal by Subject|1|||
124756974|NCT04961541|448733998|FG003|Overall Study|Withdrawal by Subject|1|||
124756975|NCT04961541|448733999|FG004|Overall Study|Withdrawal by Subject|0|||
124756976|NCT04961541|448734000|FG005|Overall Study|Withdrawal by Subject|0|||
124756977|NCT04961541|448734001|FG006|Overall Study|Withdrawal by Subject|0|||
124756978|NCT04961541|448734002|FG007|Overall Study|Withdrawal by Subject|0|||
124756979|NCT04961541|448734003|FG008|Overall Study|Withdrawal by Subject|0|||
124756980|NCT04961541|448734004|FG009|Overall Study|Withdrawal by Subject|1|||
124756981|NCT04961541|448734005|FG010|Overall Study|Withdrawal by Subject|0|||
124756982|NCT04961541|448734006|FG011|Overall Study|Withdrawal by Subject|0|||
124756983|NCT04961541|448734007|FG012|Overall Study|Withdrawal by Subject|0|||
124756984|NCT04961541|448734008|FG013|Overall Study|Withdrawal by Subject|0|||
124756985|NCT01684202|448734009|FG000|Dose-escalation Period|Adverse Event|0|||
124756986|NCT01684202|448734010|FG001|Dose-escalation Period|Adverse Event|1|||
124756987|NCT01684202|448734011|FG002|Dose-escalation Period|Adverse Event|0|||
124756988|NCT01684202|448734012|FG003|Dose-escalation Period|Adverse Event|0|||
124756989|NCT01684202|448734009|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
124756990|NCT01684202|448734010|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
124756991|NCT01684202|448734011|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
124756992|NCT01684202|448734012|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
124756993|NCT01684202|448734009|FG000|Maintenance Period|Adverse Event|1|||
124756994|NCT01684202|448734010|FG001|Maintenance Period|Adverse Event|1|||
124756995|NCT01684202|448734011|FG002|Maintenance Period|Adverse Event|1|||
124756996|NCT01684202|448734012|FG003|Maintenance Period|Adverse Event|1|||
124756997|NCT01684202|448734009|FG000|Maintenance Period|Physician Decision|0|||
124756998|NCT01684202|448734010|FG001|Maintenance Period|Physician Decision|1|||
124756999|NCT01684202|448734011|FG002|Maintenance Period|Physician Decision|0|||
124757000|NCT01684202|448734012|FG003|Maintenance Period|Physician Decision|0|||
124757001|NCT01684202|448734009|FG000|Maintenance Period|Withdrawal by Subject|0|||
124757002|NCT01684202|448734010|FG001|Maintenance Period|Withdrawal by Subject|1|||
124757003|NCT01684202|448734011|FG002|Maintenance Period|Withdrawal by Subject|0|||
124757004|NCT01684202|448734012|FG003|Maintenance Period|Withdrawal by Subject|0|||
124757005|NCT00191308|448734013|FG000|Overall Study|Adverse Event|1|||
124757006|NCT01843023|448734015|FG000|Overall Study|Death|1|||
124757007|NCT01843023|448734016|FG001|Overall Study|Death|0|||
124757008|NCT01843023|448734015|FG000|Overall Study|Lost to Follow-up|24|||
124757009|NCT01843023|448734016|FG001|Overall Study|Lost to Follow-up|29|||
124757010|NCT01843023|448734015|FG000|Overall Study|Withdrawal by Subject|8|||
124757011|NCT01843023|448734016|FG001|Overall Study|Withdrawal by Subject|6|||
124757012|NCT00779025|448734017|FG000|Overall Study|Withdrawal by Subject|1|||
124757013|NCT03305770|448734018|FG000|Overall Study|Physician Decision - prior to dispense|0|||
124757014|NCT03305770|448734019|FG001|Overall Study|Physician Decision - prior to dispense|1|||
124757015|NCT03305770|448734018|FG000|Overall Study|Subject moved|1|||
124757016|NCT03305770|448734019|FG001|Overall Study|Subject moved|0|||
124757017|NCT03539601|448734020|FG000|Overall Study|Withdraw by parent/guardian|1|||
124757018|NCT03539601|448734021|FG001|Overall Study|Withdraw by parent/guardian|0|||
124757019|NCT03539601|448734022|FG002|Overall Study|Withdraw by parent/guardian|1|||
124757020|NCT03539601|448734023|FG003|Overall Study|Withdraw by parent/guardian|0|||
124757021|NCT03539601|448734020|FG000|Overall Study|Adverse Event|0|||
124757022|NCT03539601|448734021|FG001|Overall Study|Adverse Event|2|||
124757023|NCT03539601|448734022|FG002|Overall Study|Adverse Event|0|||
124757024|NCT03539601|448734023|FG003|Overall Study|Adverse Event|0|||
124757025|NCT03539601|448734020|FG000|Overall Study|Lost to Follow-up|2|||
124757026|NCT03539601|448734021|FG001|Overall Study|Lost to Follow-up|4|||
124757027|NCT03539601|448734022|FG002|Overall Study|Lost to Follow-up|5|||
124757028|NCT03539601|448734023|FG003|Overall Study|Lost to Follow-up|0|||
124757029|NCT03539601|448734020|FG000|Overall Study|Withdrawal by Subject|2|||
124757030|NCT03539601|448734021|FG001|Overall Study|Withdrawal by Subject|0|||
124757031|NCT03539601|448734022|FG002|Overall Study|Withdrawal by Subject|0|||
124757032|NCT03539601|448734023|FG003|Overall Study|Withdrawal by Subject|1|||
124757033|NCT03539601|448734020|FG000|Overall Study|Randomized but not treated|1|||
124757034|NCT03539601|448734021|FG001|Overall Study|Randomized but not treated|1|||
124757035|NCT03539601|448734022|FG002|Overall Study|Randomized but not treated|0|||
124757036|NCT03539601|448734023|FG003|Overall Study|Randomized but not treated|0|||
124757037|NCT03710642|448734024|FG000|Overall Study|Adverse Event|5|||
124757038|NCT03710642|448734025|FG001|Overall Study|Adverse Event|1|||
124757039|NCT03710642|448734024|FG000|Overall Study|non-site physician recommendation|1|||
124757040|NCT03710642|448734025|FG001|Overall Study|non-site physician recommendation|0|||
124757041|NCT03710642|448734024|FG000|Overall Study|Participant unwilling or unable to participate|1|||
124757042|NCT03710642|448734025|FG001|Overall Study|Participant unwilling or unable to participate|1|||
124757043|NCT03710642|448734024|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
124757044|NCT03710642|448734025|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
124757045|NCT03710642|448734024|FG000|Overall Study|NA-no code provided|1|||
124757046|NCT03710642|448734025|FG001|Overall Study|NA-no code provided|0|||
124757047|NCT03710642|448734024|FG000|Overall Study|Withdrawal by Subject|1|||
124757048|NCT03710642|448734025|FG001|Overall Study|Withdrawal by Subject|0|||
124757049|NCT01970306|448734026|FG000|Overall Study|Not eligible|3|||
124757050|NCT01970306|448734026|FG000|Overall Study|Not able to be treated|9|||
124757051|NCT00226811|448734027|FG000|Overall Study|Death|8|||
124757052|NCT00226811|448734027|FG000|Overall Study|Adverse Event|11|||
124757053|NCT00226811|448734027|FG000|Overall Study|Lack of Efficacy|55|||
124757054|NCT00226811|448734027|FG000|Overall Study|Withdrawal by Subject|2|||
124757055|NCT02741635|448734028|FG000|Overall Study|Withdrawal by Subject|1|||
124757056|NCT01427933|448734029|FG000|Overall Study|Withdrawal by Subject|5|||
124757057|NCT01427933|448734030|FG001|Overall Study|Withdrawal by Subject|8|||
124757058|NCT01427933|448734029|FG000|Overall Study|Lost to Follow-up|1|||
124757059|NCT01427933|448734030|FG001|Overall Study|Lost to Follow-up|5|||
124757060|NCT01427933|448734029|FG000|Overall Study|Other|1|||
124757061|NCT01427933|448734030|FG001|Overall Study|Other|0|||
124757062|NCT01427933|448734029|FG000|Overall Study|Investigator's Decision|1|||
124757063|NCT01427933|448734030|FG001|Overall Study|Investigator's Decision|0|||
124757064|NCT01633541|448734033|FG000|Overall Study|Death|1|||
124757065|NCT01633541|448734034|FG001|Overall Study|Death|0|||
124757066|NCT01010971|448734035|FG000|Overall Study|Adverse Event|2|||
124757067|NCT01010971|448734036|FG001|Overall Study|Adverse Event|4|||
124757068|NCT01010971|448734037|FG002|Overall Study|Adverse Event|3|||
124757069|NCT01010971|448734035|FG000|Overall Study|Withdrawal by Subject|0|||
124757070|NCT01010971|448734036|FG001|Overall Study|Withdrawal by Subject|2|||
124757071|NCT01010971|448734037|FG002|Overall Study|Withdrawal by Subject|5|||
124757072|NCT01010971|448734035|FG000|Overall Study|Lost to Follow-up|0|||
124757073|NCT01010971|448734036|FG001|Overall Study|Lost to Follow-up|2|||
124757074|NCT01010971|448734037|FG002|Overall Study|Lost to Follow-up|3|||
124757075|NCT01010971|448734035|FG000|Overall Study|Other|1|||
124757076|NCT01010971|448734036|FG001|Overall Study|Other|0|||
124757077|NCT01010971|448734037|FG002|Overall Study|Other|2|||
124757078|NCT03472326|448734038|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
124757079|NCT03472326|448734039|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
124757080|NCT03472326|448734040|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
124757081|NCT03472326|448734041|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
124757082|NCT03472326|448734038|FG000|Part 2: Combination Therapy|Pregnancy|0|||
124757083|NCT03472326|448734039|FG001|Part 2: Combination Therapy|Pregnancy|0|||
124757084|NCT03472326|448734040|FG002|Part 2: Combination Therapy|Pregnancy|0|||
124757085|NCT03472326|448734041|FG003|Part 2: Combination Therapy|Pregnancy|1|||
124757086|NCT03386721|448734042|FG000|Overall Study|Death|12|||
124757087|NCT03386721|448734043|FG001|Overall Study|Death|21|||
124757088|NCT03386721|448734044|FG002|Overall Study|Death|2|||
124757089|NCT03386721|448734045|FG003|Overall Study|Death|5|||
124757090|NCT03386721|448734046|FG004|Overall Study|Death|1|||
124757091|NCT03386721|448734047|FG005|Overall Study|Death|12|||
124757092|NCT03386721|448734048|FG006|Overall Study|Death|1|||
124757093|NCT03386721|448734049|FG007|Overall Study|Death|1|||
124757094|NCT03386721|448734050|FG008|Overall Study|Death|12|||
124757095|NCT03386721|448734051|FG009|Overall Study|Death|20|||
124757096|NCT03386721|448734052|FG010|Overall Study|Death|21|||
124757097|NCT03386721|448734053|FG011|Overall Study|Death|21|||
124757098|NCT03386721|448734054|FG012|Overall Study|Death|14|||
124757099|NCT03386721|448734055|FG013|Overall Study|Death|2|||
124757100|NCT03386721|448734056|FG014|Overall Study|Death|1|||
124757101|NCT03386721|448734042|FG000|Overall Study|Lost to Follow-up|1|||
124757102|NCT03386721|448734043|FG001|Overall Study|Lost to Follow-up|3|||
124757103|NCT03386721|448734044|FG002|Overall Study|Lost to Follow-up|0|||
124757104|NCT03386721|448734045|FG003|Overall Study|Lost to Follow-up|0|||
124978480|NCT03829501|449548498|FG010|Overall Study|PD|0|||
124757105|NCT03386721|448734046|FG004|Overall Study|Lost to Follow-up|0|||
124757106|NCT03386721|448734047|FG005|Overall Study|Lost to Follow-up|2|||
124757107|NCT03386721|448734048|FG006|Overall Study|Lost to Follow-up|1|||
124757108|NCT03386721|448734049|FG007|Overall Study|Lost to Follow-up|0|||
124757109|NCT03386721|448734050|FG008|Overall Study|Lost to Follow-up|1|||
124757110|NCT03386721|448734051|FG009|Overall Study|Lost to Follow-up|2|||
124757111|NCT03386721|448734052|FG010|Overall Study|Lost to Follow-up|1|||
124757112|NCT03386721|448734053|FG011|Overall Study|Lost to Follow-up|0|||
124757113|NCT03386721|448734054|FG012|Overall Study|Lost to Follow-up|0|||
124757114|NCT03386721|448734055|FG013|Overall Study|Lost to Follow-up|0|||
124757115|NCT03386721|448734056|FG014|Overall Study|Lost to Follow-up|0|||
124757116|NCT03386721|448734042|FG000|Overall Study|Reason not specified|3|||
124757117|NCT03386721|448734043|FG001|Overall Study|Reason not specified|0|||
124757118|NCT03386721|448734044|FG002|Overall Study|Reason not specified|0|||
124757119|NCT03386721|448734045|FG003|Overall Study|Reason not specified|0|||
124757120|NCT03386721|448734046|FG004|Overall Study|Reason not specified|0|||
124757121|NCT03386721|448734047|FG005|Overall Study|Reason not specified|3|||
124757122|NCT03386721|448734048|FG006|Overall Study|Reason not specified|1|||
124757123|NCT03386721|448734049|FG007|Overall Study|Reason not specified|0|||
124757124|NCT03386721|448734050|FG008|Overall Study|Reason not specified|0|||
124757125|NCT03386721|448734051|FG009|Overall Study|Reason not specified|1|||
124757126|NCT03386721|448734052|FG010|Overall Study|Reason not specified|2|||
124757127|NCT03386721|448734053|FG011|Overall Study|Reason not specified|6|||
124757128|NCT03386721|448734054|FG012|Overall Study|Reason not specified|1|||
124757129|NCT03386721|448734055|FG013|Overall Study|Reason not specified|0|||
124757130|NCT03386721|448734056|FG014|Overall Study|Reason not specified|0|||
124757131|NCT03386721|448734042|FG000|Overall Study|Progressive Disease|0|||
124757132|NCT03386721|448734043|FG001|Overall Study|Progressive Disease|0|||
124757133|NCT03386721|448734044|FG002|Overall Study|Progressive Disease|1|||
124757134|NCT03386721|448734045|FG003|Overall Study|Progressive Disease|0|||
124757135|NCT03386721|448734046|FG004|Overall Study|Progressive Disease|0|||
124757136|NCT03386721|448734047|FG005|Overall Study|Progressive Disease|1|||
124757137|NCT03386721|448734048|FG006|Overall Study|Progressive Disease|0|||
124757138|NCT03386721|448734049|FG007|Overall Study|Progressive Disease|0|||
124757139|NCT03386721|448734050|FG008|Overall Study|Progressive Disease|2|||
124757140|NCT03386721|448734051|FG009|Overall Study|Progressive Disease|1|||
124757141|NCT03386721|448734052|FG010|Overall Study|Progressive Disease|1|||
124757142|NCT03386721|448734053|FG011|Overall Study|Progressive Disease|0|||
124757143|NCT03386721|448734054|FG012|Overall Study|Progressive Disease|1|||
124757144|NCT03386721|448734055|FG013|Overall Study|Progressive Disease|0|||
124757145|NCT03386721|448734056|FG014|Overall Study|Progressive Disease|0|||
124757146|NCT03386721|448734042|FG000|Overall Study|Site Terminated by Sponsor|5|||
124757147|NCT03386721|448734043|FG001|Overall Study|Site Terminated by Sponsor|5|||
124757148|NCT03386721|448734044|FG002|Overall Study|Site Terminated by Sponsor|0|||
124757149|NCT03386721|448734045|FG003|Overall Study|Site Terminated by Sponsor|0|||
124757150|NCT03386721|448734046|FG004|Overall Study|Site Terminated by Sponsor|1|||
124757151|NCT03386721|448734047|FG005|Overall Study|Site Terminated by Sponsor|3|||
124757152|NCT03386721|448734048|FG006|Overall Study|Site Terminated by Sponsor|0|||
124757153|NCT03386721|448734049|FG007|Overall Study|Site Terminated by Sponsor|1|||
124757154|NCT03386721|448734050|FG008|Overall Study|Site Terminated by Sponsor|4|||
124757155|NCT03386721|448734051|FG009|Overall Study|Site Terminated by Sponsor|5|||
124757156|NCT03386721|448734052|FG010|Overall Study|Site Terminated by Sponsor|3|||
124757157|NCT03386721|448734053|FG011|Overall Study|Site Terminated by Sponsor|11|||
124757158|NCT03386721|448734054|FG012|Overall Study|Site Terminated by Sponsor|6|||
124757159|NCT03386721|448734055|FG013|Overall Study|Site Terminated by Sponsor|0|||
124757160|NCT03386721|448734056|FG014|Overall Study|Site Terminated by Sponsor|0|||
124757161|NCT03386721|448734042|FG000|Overall Study|Symptomatic Deterioration|0|||
124757162|NCT03386721|448734043|FG001|Overall Study|Symptomatic Deterioration|0|||
124757163|NCT03386721|448734044|FG002|Overall Study|Symptomatic Deterioration|0|||
124757164|NCT03386721|448734045|FG003|Overall Study|Symptomatic Deterioration|0|||
124757165|NCT03386721|448734046|FG004|Overall Study|Symptomatic Deterioration|0|||
124757166|NCT03386721|448734047|FG005|Overall Study|Symptomatic Deterioration|0|||
124757167|NCT03386721|448734048|FG006|Overall Study|Symptomatic Deterioration|0|||
124757168|NCT03386721|448734049|FG007|Overall Study|Symptomatic Deterioration|0|||
124757169|NCT03386721|448734050|FG008|Overall Study|Symptomatic Deterioration|1|||
124757170|NCT03386721|448734051|FG009|Overall Study|Symptomatic Deterioration|0|||
124757171|NCT03386721|448734052|FG010|Overall Study|Symptomatic Deterioration|0|||
124757172|NCT03386721|448734053|FG011|Overall Study|Symptomatic Deterioration|1|||
124757173|NCT03386721|448734054|FG012|Overall Study|Symptomatic Deterioration|0|||
124757174|NCT03386721|448734055|FG013|Overall Study|Symptomatic Deterioration|0|||
124757175|NCT03386721|448734056|FG014|Overall Study|Symptomatic Deterioration|0|||
124757176|NCT03386721|448734042|FG000|Overall Study|Withdrawal by Subject|1|||
124757177|NCT03386721|448734043|FG001|Overall Study|Withdrawal by Subject|2|||
124757178|NCT03386721|448734044|FG002|Overall Study|Withdrawal by Subject|0|||
124757179|NCT03386721|448734045|FG003|Overall Study|Withdrawal by Subject|0|||
124757180|NCT03386721|448734046|FG004|Overall Study|Withdrawal by Subject|0|||
124757181|NCT03386721|448734047|FG005|Overall Study|Withdrawal by Subject|0|||
124757182|NCT03386721|448734048|FG006|Overall Study|Withdrawal by Subject|0|||
124757183|NCT03386721|448734049|FG007|Overall Study|Withdrawal by Subject|0|||
124757184|NCT03386721|448734050|FG008|Overall Study|Withdrawal by Subject|2|||
124757185|NCT03386721|448734051|FG009|Overall Study|Withdrawal by Subject|1|||
124757186|NCT03386721|448734052|FG010|Overall Study|Withdrawal by Subject|3|||
124757187|NCT03386721|448734053|FG011|Overall Study|Withdrawal by Subject|2|||
124757188|NCT03386721|448734054|FG012|Overall Study|Withdrawal by Subject|3|||
124757189|NCT03386721|448734055|FG013|Overall Study|Withdrawal by Subject|0|||
124757190|NCT03386721|448734056|FG014|Overall Study|Withdrawal by Subject|0|||
124757191|NCT03081884|448734057|FG000|Overall Study|deferred prostate cancer treatment|1|||
124757192|NCT03081884|448734057|FG000|Overall Study|metastasis managed with systemic therapy|3|||
124757193|NCT03948334|448734059|FG000|Overall Study|Adverse Event|1|||
124757194|NCT03948334|448734060|FG001|Overall Study|Adverse Event|4|||
124757195|NCT03948334|448734059|FG000|Overall Study|Lack of Efficacy|2|||
124757196|NCT03948334|448734060|FG001|Overall Study|Lack of Efficacy|0|||
124757197|NCT03948334|448734059|FG000|Overall Study|Lost to Follow-up|1|||
124757198|NCT03948334|448734060|FG001|Overall Study|Lost to Follow-up|0|||
124757199|NCT03948334|448734059|FG000|Overall Study|Physician Decision|1|||
124757200|NCT03948334|448734060|FG001|Overall Study|Physician Decision|0|||
124757201|NCT03948334|448734059|FG000|Overall Study|Pregnancy|0|||
124757202|NCT03948334|448734060|FG001|Overall Study|Pregnancy|1|||
124757203|NCT03948334|448734059|FG000|Overall Study|Protocol Deviation|1|||
124757204|NCT03948334|448734060|FG001|Overall Study|Protocol Deviation|0|||
124757205|NCT03948334|448734059|FG000|Overall Study|Study terminated by Sponsor|50|||
124757206|NCT03948334|448734060|FG001|Overall Study|Study terminated by Sponsor|51|||
124757207|NCT03948334|448734059|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
124757208|NCT03948334|448734060|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
124757209|NCT05114473|448734061|FG000|Overall Study|Lost to Follow-up|2|||
124757210|NCT05114473|448734062|FG001|Overall Study|Lost to Follow-up|2|||
124757211|NCT05114473|448734063|FG002|Overall Study|Lost to Follow-up|0|||
124757212|NCT00700713|448734064|FG000|Overall Study|Protocol Violation|1|||
124757213|NCT00700713|448734065|FG001|Overall Study|Protocol Violation|0|||
124757214|NCT00700713|448734066|FG002|Overall Study|Protocol Violation|1|||
124757215|NCT00700713|448734064|FG000|Overall Study|Withdrawal by Subject|0|||
124757216|NCT00700713|448734065|FG001|Overall Study|Withdrawal by Subject|0|||
124757217|NCT00700713|448734066|FG002|Overall Study|Withdrawal by Subject|1|||
124757218|NCT00550953|448734068|FG000|Overall Study|Adverse Event|4|||
124757219|NCT00550953|448734069|FG001|Overall Study|Adverse Event|3|||
124757220|NCT00550953|448734068|FG000|Overall Study|Not able to visit the site|2|||
124757221|NCT00550953|448734069|FG001|Overall Study|Not able to visit the site|3|||
124757222|NCT02446717|448734070|FG000|Overall Study|Adverse Event|0|||
124757223|NCT02446717|448734071|FG001|Overall Study|Adverse Event|0|||
124757224|NCT02446717|448734072|FG002|Overall Study|Adverse Event|1|||
124757225|NCT02446717|448734073|FG003|Overall Study|Adverse Event|0|||
124757226|NCT02446717|448734074|FG004|Overall Study|Adverse Event|0|||
124757227|NCT02446717|448734070|FG000|Overall Study|Lost to Follow-up|0|||
124757228|NCT02446717|448734071|FG001|Overall Study|Lost to Follow-up|1|||
124757229|NCT02446717|448734072|FG002|Overall Study|Lost to Follow-up|1|||
124757230|NCT02446717|448734073|FG003|Overall Study|Lost to Follow-up|0|||
124757231|NCT02446717|448734074|FG004|Overall Study|Lost to Follow-up|1|||
124757232|NCT02446717|448734070|FG000|Overall Study|Withdrew consent|0|||
124757233|NCT02446717|448734071|FG001|Overall Study|Withdrew consent|0|||
124757234|NCT02446717|448734072|FG002|Overall Study|Withdrew consent|0|||
124757235|NCT02446717|448734073|FG003|Overall Study|Withdrew consent|1|||
124757236|NCT02446717|448734074|FG004|Overall Study|Withdrew consent|0|||
124757237|NCT02777827|448734075|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
124757238|NCT02777827|448734076|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
124757239|NCT02777827|448734077|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
124757240|NCT02777827|448734078|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
124757241|NCT02777827|448734079|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
124757242|NCT02777827|448734080|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
124757243|NCT03160898|448734081|FG000|Overall Study|Adverse Event|4|||
124757244|NCT03160898|448734082|FG001|Overall Study|Adverse Event|8|||
124757245|NCT03160898|448734083|FG002|Overall Study|Adverse Event|7|||
124757246|NCT03160898|448734084|FG003|Overall Study|Adverse Event|10|||
124757247|NCT03160898|448734081|FG000|Overall Study|Death|1|||
124757248|NCT03160898|448734082|FG001|Overall Study|Death|0|||
124757249|NCT03160898|448734083|FG002|Overall Study|Death|0|||
124757250|NCT03160898|448734084|FG003|Overall Study|Death|1|||
124757251|NCT03160898|448734081|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
124757252|NCT03160898|448734082|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
124757253|NCT03160898|448734083|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
124757254|NCT03160898|448734084|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
124757255|NCT03160898|448734081|FG000|Overall Study|Lost to Follow-up|1|||
124757256|NCT03160898|448734082|FG001|Overall Study|Lost to Follow-up|1|||
124757257|NCT03160898|448734083|FG002|Overall Study|Lost to Follow-up|1|||
124757258|NCT03160898|448734084|FG003|Overall Study|Lost to Follow-up|2|||
124757259|NCT03160898|448734081|FG000|Overall Study|Physician Decision|1|||
124757260|NCT03160898|448734082|FG001|Overall Study|Physician Decision|0|||
124757261|NCT03160898|448734083|FG002|Overall Study|Physician Decision|0|||
124757262|NCT03160898|448734084|FG003|Overall Study|Physician Decision|1|||
124757263|NCT03160898|448734081|FG000|Overall Study|Progressive Disease|4|||
124757264|NCT03160898|448734082|FG001|Overall Study|Progressive Disease|1|||
124757265|NCT03160898|448734083|FG002|Overall Study|Progressive Disease|2|||
124757266|NCT03160898|448734084|FG003|Overall Study|Progressive Disease|1|||
124757267|NCT03160898|448734081|FG000|Overall Study|Protocol Violation|1|||
124757268|NCT03160898|448734082|FG001|Overall Study|Protocol Violation|0|||
124757269|NCT03160898|448734083|FG002|Overall Study|Protocol Violation|2|||
124757270|NCT03160898|448734084|FG003|Overall Study|Protocol Violation|0|||
124757271|NCT03160898|448734081|FG000|Overall Study|Sponsor Discretion|2|||
124757272|NCT03160898|448734082|FG001|Overall Study|Sponsor Discretion|0|||
124757273|NCT03160898|448734083|FG002|Overall Study|Sponsor Discretion|0|||
124757274|NCT03160898|448734084|FG003|Overall Study|Sponsor Discretion|0|||
124757275|NCT03160898|448734081|FG000|Overall Study|Withdrawal by Subject|1|||
124757276|NCT03160898|448734082|FG001|Overall Study|Withdrawal by Subject|3|||
124757277|NCT03160898|448734083|FG002|Overall Study|Withdrawal by Subject|2|||
124757278|NCT03160898|448734084|FG003|Overall Study|Withdrawal by Subject|1|||
124757279|NCT03160898|448734081|FG000|Overall Study|Other|2|||
124757280|NCT03160898|448734082|FG001|Overall Study|Other|0|||
124757281|NCT03160898|448734083|FG002|Overall Study|Other|2|||
124757282|NCT03160898|448734084|FG003|Overall Study|Other|2|||
124757283|NCT04178720|448734091|FG000|Overall Study|Withdrawal by Subject|2|||
124757284|NCT04178720|448734092|FG001|Overall Study|Withdrawal by Subject|0|||
124757285|NCT04178720|448734091|FG000|Overall Study|Relocation|0|||
124757286|NCT04178720|448734092|FG001|Overall Study|Relocation|1|||
124757287|NCT04177212|448734094|FG000|Overall Study|Withdrawal by Subject|9|||
124757288|NCT04177212|448734095|FG001|Overall Study|Withdrawal by Subject|7|||
124757289|NCT04177212|448734094|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
124757290|NCT04177212|448734095|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
124757291|NCT04177212|448734094|FG000|Overall Study|Physician Decision|1|||
124757292|NCT04177212|448734095|FG001|Overall Study|Physician Decision|0|||
124757293|NCT04177212|448734094|FG000|Overall Study|Lost to Follow-up|0|||
124757294|NCT04177212|448734095|FG001|Overall Study|Lost to Follow-up|3|||
124757295|NCT04177212|448734094|FG000|Overall Study|Adverse Event|0|||
124757296|NCT04177212|448734095|FG001|Overall Study|Adverse Event|1|||
124757297|NCT04177212|448734094|FG000|Overall Study|Other|1|||
124757298|NCT04177212|448734095|FG001|Overall Study|Other|2|||
124757299|NCT04725500|448734096|FG000|Screening|Screen Failure|26|||
124757300|NCT04725500|448734096|FG000|Screening|Withdrawal by Subject|1|||
124757301|NCT04725500|448734096|FG000|2 Week Take Home|Screen Fail|5|||
124757302|NCT00930930|448734098|FG000|Overall Study|Death|1|||
124757303|NCT00930930|448734099|FG001|Overall Study|Death|0|||
124757304|NCT00930930|448734098|FG000|Overall Study|Physician Decision|1|||
124757305|NCT00930930|448734099|FG001|Overall Study|Physician Decision|0|||
124757306|NCT00930930|448734098|FG000|Overall Study|Adverse Event|13|||
124757307|NCT00930930|448734099|FG001|Overall Study|Adverse Event|3|||
124757308|NCT00930930|448734098|FG000|Overall Study|Withdrawal by Subject|3|||
124757309|NCT00930930|448734099|FG001|Overall Study|Withdrawal by Subject|1|||
124757310|NCT00930930|448734098|FG000|Overall Study|Disease progression|2|||
124757311|NCT00930930|448734099|FG001|Overall Study|Disease progression|3|||
124757312|NCT00930930|448734098|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
124757313|NCT00930930|448734099|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
124757314|NCT00930930|448734098|FG000|Overall Study|patients not compliant|1|||
124757315|NCT00930930|448734099|FG001|Overall Study|patients not compliant|1|||
124757316|NCT04618744|448734100|FG000|Overall Study|Adverse Event|0|||
124757317|NCT04618744|448734101|FG001|Overall Study|Adverse Event|1|||
124757318|NCT04618744|448734100|FG000|Overall Study|Withdrawal by Subject|0|||
124757319|NCT04618744|448734101|FG001|Overall Study|Withdrawal by Subject|1|||
124757320|NCT02709330|448734102|FG000|Overall Study|Death|5|||
124757321|NCT02709330|448734103|FG001|Overall Study|Death|0|||
124757322|NCT02709330|448734102|FG000|Overall Study|Lost to Follow-up|2|||
124757323|NCT02709330|448734103|FG001|Overall Study|Lost to Follow-up|0|||
124757324|NCT02709330|448734102|FG000|Overall Study|Physician Decision|2|||
124757325|NCT02709330|448734103|FG001|Overall Study|Physician Decision|0|||
124757326|NCT02709330|448734102|FG000|Overall Study|Withdrawal by Subject|4|||
124757327|NCT02709330|448734103|FG001|Overall Study|Withdrawal by Subject|0|||
124757328|NCT01172535|448736200|FG000|Overall Study|Death|3|||
124757329|NCT01172535|448736200|FG000|Overall Study|Withdrawal by Subject|2|||
124757330|NCT01172535|448736200|FG000|Overall Study|Lost to Follow-up|1|||
124757331|NCT01172535|448736200|FG000|Overall Study|Ineligible at study entry|1|||
124757332|NCT01172535|448736200|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
124757333|NCT00988598|448736201|FG000|Overall Study|Withdrawal by Subject|2|||
124757334|NCT00988598|448736202|FG001|Overall Study|Withdrawal by Subject|0|||
124757335|NCT04317040|448736209|FG000|Overall Study|Lost to Follow-up|2|||
124757336|NCT04317040|448736210|FG001|Overall Study|Lost to Follow-up|0|||
124757337|NCT04317040|448736209|FG000|Overall Study|Death|16|||
124757338|NCT04317040|448736210|FG001|Overall Study|Death|18|||
124757339|NCT04317040|448736209|FG000|Overall Study|Withdrawal by Subject|0|||
124757340|NCT04317040|448736210|FG001|Overall Study|Withdrawal by Subject|1|||
124757341|NCT04317040|448736209|FG000|Overall Study|Incomplete assessments|0|||
124757342|NCT04317040|448736210|FG001|Overall Study|Incomplete assessments|1|||
124757343|NCT01177007|448736213|FG000|Overall Study|Lost to Follow-up|2|||
124757344|NCT01177007|448736213|FG000|Overall Study|Death|4|||
124757345|NCT01177007|448736213|FG000|Overall Study|Entered hospice care|5|||
124757346|NCT01177007|448736213|FG000|Overall Study|Required additional Y90 treatment|6|||
124757347|NCT01177007|448736213|FG000|Overall Study|Change in treatment modality|21|||
124757348|NCT03259087|448736217|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
124757349|NCT03259087|448736218|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
124757350|NCT03259087|448736219|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
124757351|NCT03259087|448736220|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
124757352|NCT03259087|448736221|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
124757353|NCT03259087|448736217|FG000|Period 2 of Part 2|Adverse Event|0|||
124757354|NCT03259087|448736218|FG001|Period 2 of Part 2|Adverse Event|0|||
124757355|NCT03259087|448736219|FG002|Period 2 of Part 2|Adverse Event|0|||
124757356|NCT03259087|448736220|FG003|Period 2 of Part 2|Adverse Event|0|||
124757357|NCT03259087|448736221|FG004|Period 2 of Part 2|Adverse Event|1|||
124757358|NCT02366195|448736228|FG000|Overall Study|Protocol-specified criteria|3|||
124757359|NCT02366195|448736228|FG000|Overall Study|Withdrawal by Subject|9|||
124757360|NCT02366195|448736228|FG000|Overall Study|Lost to Follow-up|1|||
124757361|NCT02366195|448736228|FG000|Overall Study|Death|41|||
124757362|NCT01338818|448736229|FG000|Overall Study|Adverse Event|8|||
124757363|NCT01338818|448736229|FG000|Overall Study|Lack of Efficacy|5|||
124757364|NCT01338818|448736229|FG000|Overall Study|no longer require study drug|1|||
124757365|NCT01338818|448736229|FG000|Overall Study|Withdrawal by Subject|11|||
124757366|NCT01338818|448736229|FG000|Overall Study|Lost to Follow-up|4|||
124757367|NCT01338818|448736229|FG000|Overall Study|Administrative problems|3|||
124757368|NCT01338818|448736229|FG000|Overall Study|Protocol Deviation|4|||
124757369|NCT00556998|448736234|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
124757370|NCT00556998|448736234|FG000|Voriconazole Intravenous (IV)|Other|4|||
124757371|NCT00556998|448736234|FG000|Voriconazole Oral|Adverse Event|1|||
124757372|NCT00556998|448736234|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
124757373|NCT03030417|448736243|FG000|Dose Expansion|Disease progression before treatment|0|||
124757374|NCT03030417|448736244|FG001|Dose Expansion|Disease progression before treatment|0|||
124757375|NCT03030417|448736245|FG002|Dose Expansion|Disease progression before treatment|0|||
124757376|NCT03030417|448736246|FG003|Dose Expansion|Disease progression before treatment|0|||
124757377|NCT03030417|448736247|FG004|Dose Expansion|Disease progression before treatment|0|||
124757378|NCT03030417|448736248|FG005|Dose Expansion|Disease progression before treatment|0|||
124757379|NCT03030417|448736249|FG006|Dose Expansion|Disease progression before treatment|0|||
124757380|NCT03030417|448736250|FG007|Dose Expansion|Disease progression before treatment|0|||
124757381|NCT03030417|448736251|FG008|Dose Expansion|Disease progression before treatment|0|||
124757382|NCT03030417|448736252|FG009|Dose Expansion|Disease progression before treatment|0|||
124757383|NCT03030417|448736253|FG010|Dose Expansion|Disease progression before treatment|0|||
124757384|NCT03030417|448736254|FG011|Dose Expansion|Disease progression before treatment|0|||
124757385|NCT03030417|448736255|FG012|Dose Expansion|Disease progression before treatment|1|||
124757386|NCT00782717|448736256|FG000|Overall Study|Adverse Event|2|||
124757387|NCT00782717|448736257|FG001|Overall Study|Adverse Event|5|||
124757388|NCT00782717|448736256|FG000|Overall Study|Patient decision unrelated to AE|6|||
124757389|NCT00782717|448736257|FG001|Overall Study|Patient decision unrelated to AE|3|||
124757390|NCT00782717|448736256|FG000|Overall Study|Noncompliance|2|||
124757391|NCT00782717|448736257|FG001|Overall Study|Noncompliance|1|||
124757392|NCT00782717|448736256|FG000|Overall Study|Treatment failure|3|||
124757393|NCT00782717|448736257|FG001|Overall Study|Treatment failure|14|||
124757394|NCT00782717|448736256|FG000|Overall Study|Enrollment close prior to surgery|1|||
124757395|NCT00782717|448736257|FG001|Overall Study|Enrollment close prior to surgery|0|||
124757396|NCT00782717|448736256|FG000|Overall Study|Did not meet entrance criteria|1|||
124757397|NCT00782717|448736257|FG001|Overall Study|Did not meet entrance criteria|3|||
124757398|NCT00782717|448736256|FG000|Overall Study|Exited in error|0|||
124757399|NCT00782717|448736257|FG001|Overall Study|Exited in error|2|||
124757400|NCT02292719|448736258|FG000|Overall Study|Withdrawal by Subject|0|||
124757401|NCT02292719|448736259|FG001|Overall Study|Withdrawal by Subject|0|||
124757402|NCT02292719|448736260|FG002|Overall Study|Withdrawal by Subject|0|||
124757403|NCT02292719|448736261|FG003|Overall Study|Withdrawal by Subject|1|||
124757404|NCT02292719|448736262|FG004|Overall Study|Withdrawal by Subject|1|||
124757405|NCT02292719|448736263|FG005|Overall Study|Withdrawal by Subject|0|||
124757406|NCT02292719|448736258|FG000|Overall Study|Subject enrolled in new study.|0|||
124757407|NCT02292719|448736259|FG001|Overall Study|Subject enrolled in new study.|0|||
124757408|NCT02292719|448736260|FG002|Overall Study|Subject enrolled in new study.|1|||
124757409|NCT02292719|448736261|FG003|Overall Study|Subject enrolled in new study.|0|||
124757410|NCT02292719|448736262|FG004|Overall Study|Subject enrolled in new study.|0|||
124757411|NCT02292719|448736263|FG005|Overall Study|Subject enrolled in new study.|0|||
124757412|NCT02586727|448736269|FG000|Overall Study|Lost to Follow-up|1|||
124757413|NCT02586727|448736270|FG001|Overall Study|Lost to Follow-up|0|||
124757414|NCT04628780|448736275|FG000|Overall Study|Death|0|||
124757415|NCT04628780|448736276|FG001|Overall Study|Death|1|||
124757416|NCT04628780|448736277|FG002|Overall Study|Death|0|||
124757417|NCT04628780|448736278|FG003|Overall Study|Death|0|||
124757418|NCT04628780|448736279|FG004|Overall Study|Death|1|||
124757419|NCT04628780|448736280|FG005|Overall Study|Death|0|||
124866921|NCT02586025|449135380|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
124757420|NCT04628780|448736275|FG000|Overall Study|Physician Decision|2|||
124757421|NCT04628780|448736276|FG001|Overall Study|Physician Decision|0|||
124757422|NCT04628780|448736277|FG002|Overall Study|Physician Decision|0|||
124757423|NCT04628780|448736278|FG003|Overall Study|Physician Decision|0|||
124757424|NCT04628780|448736279|FG004|Overall Study|Physician Decision|2|||
124757425|NCT04628780|448736280|FG005|Overall Study|Physician Decision|0|||
124757426|NCT04628780|448736275|FG000|Overall Study|Progressive disease|2|||
124757427|NCT04628780|448736276|FG001|Overall Study|Progressive disease|2|||
124757428|NCT04628780|448736277|FG002|Overall Study|Progressive disease|2|||
124757429|NCT04628780|448736278|FG003|Overall Study|Progressive disease|3|||
124757430|NCT04628780|448736279|FG004|Overall Study|Progressive disease|9|||
124757431|NCT04628780|448736280|FG005|Overall Study|Progressive disease|4|||
124757432|NCT04628780|448736275|FG000|Overall Study|Withdrawal by Subject|0|||
124757433|NCT04628780|448736276|FG001|Overall Study|Withdrawal by Subject|1|||
124757434|NCT04628780|448736277|FG002|Overall Study|Withdrawal by Subject|2|||
124757435|NCT04628780|448736278|FG003|Overall Study|Withdrawal by Subject|0|||
124757436|NCT04628780|448736279|FG004|Overall Study|Withdrawal by Subject|3|||
124757437|NCT04628780|448736280|FG005|Overall Study|Withdrawal by Subject|1|||
124757438|NCT04628780|448736275|FG000|Overall Study|Global deterioration of health status|0|||
124757439|NCT04628780|448736276|FG001|Overall Study|Global deterioration of health status|0|||
124757440|NCT04628780|448736277|FG002|Overall Study|Global deterioration of health status|0|||
124757441|NCT04628780|448736278|FG003|Overall Study|Global deterioration of health status|0|||
124757442|NCT04628780|448736279|FG004|Overall Study|Global deterioration of health status|1|||
124757443|NCT04628780|448736280|FG005|Overall Study|Global deterioration of health status|1|||
124757444|NCT03622814|448736282|FG000|Overall Study|Lost to Follow-up|8|||
124757445|NCT03622814|448736283|FG001|Overall Study|Lost to Follow-up|14|||
124757446|NCT01288989|448736286|FG000|Overall Study|Death|0|||
124757447|NCT01288989|448736287|FG001|Overall Study|Death|0|||
124757448|NCT01288989|448736288|FG002|Overall Study|Death|0|||
124757449|NCT01288989|448736289|FG003|Overall Study|Death|1|||
124757450|NCT01288989|448736290|FG004|Overall Study|Death|0|||
124757451|NCT01288989|448736286|FG000|Overall Study|Dose limiting toxicity|1|||
124757452|NCT01288989|448736287|FG001|Overall Study|Dose limiting toxicity|0|||
124757453|NCT01288989|448736288|FG002|Overall Study|Dose limiting toxicity|0|||
124757454|NCT01288989|448736289|FG003|Overall Study|Dose limiting toxicity|0|||
124757455|NCT01288989|448736290|FG004|Overall Study|Dose limiting toxicity|0|||
124757456|NCT01288989|448736286|FG000|Overall Study|Adverse Event|0|||
124757457|NCT01288989|448736287|FG001|Overall Study|Adverse Event|0|||
124757458|NCT01288989|448736288|FG002|Overall Study|Adverse Event|0|||
124757459|NCT01288989|448736289|FG003|Overall Study|Adverse Event|0|||
124757460|NCT01288989|448736290|FG004|Overall Study|Adverse Event|2|||
124757461|NCT01288989|448736286|FG000|Overall Study|Physician Decision|0|||
124757462|NCT01288989|448736287|FG001|Overall Study|Physician Decision|0|||
124757463|NCT01288989|448736288|FG002|Overall Study|Physician Decision|0|||
124757464|NCT01288989|448736289|FG003|Overall Study|Physician Decision|0|||
124757465|NCT01288989|448736290|FG004|Overall Study|Physician Decision|1|||
124757466|NCT01288989|448736286|FG000|Overall Study|Withdrawal by Subject|0|||
124757467|NCT01288989|448736287|FG001|Overall Study|Withdrawal by Subject|0|||
124757468|NCT01288989|448736288|FG002|Overall Study|Withdrawal by Subject|0|||
124757469|NCT01288989|448736289|FG003|Overall Study|Withdrawal by Subject|0|||
124757470|NCT01288989|448736290|FG004|Overall Study|Withdrawal by Subject|3|||
124757471|NCT01132313|448736291|FG000|Overall Study|Lack of Efficacy|1|||
124757472|NCT01132313|448736292|FG001|Overall Study|Lack of Efficacy|0|||
124757473|NCT01132313|448736293|FG002|Overall Study|Lack of Efficacy|0|||
124757474|NCT01132313|448736294|FG003|Overall Study|Lack of Efficacy|0|||
124757475|NCT01132313|448736295|FG004|Overall Study|Lack of Efficacy|0|||
124757476|NCT01132313|448736296|FG005|Overall Study|Lack of Efficacy|0|||
124757477|NCT01132313|448736297|FG006|Overall Study|Lack of Efficacy|0|||
124757478|NCT01132313|448736298|FG007|Overall Study|Lack of Efficacy|3|||
124757479|NCT01132313|448736299|FG008|Overall Study|Lack of Efficacy|14|||
124757480|NCT01132313|448736300|FG009|Overall Study|Lack of Efficacy|16|||
124757481|NCT01132313|448736301|FG010|Overall Study|Lack of Efficacy|0|||
124757482|NCT01132313|448736302|FG011|Overall Study|Lack of Efficacy|0|||
124757483|NCT01132313|448736291|FG000|Overall Study|Not treated|2|||
124757484|NCT01132313|448736292|FG001|Overall Study|Not treated|0|||
124757485|NCT01132313|448736293|FG002|Overall Study|Not treated|0|||
124757486|NCT01132313|448736294|FG003|Overall Study|Not treated|0|||
124757487|NCT01132313|448736295|FG004|Overall Study|Not treated|2|||
124757488|NCT01132313|448736296|FG005|Overall Study|Not treated|1|||
124757489|NCT01132313|448736297|FG006|Overall Study|Not treated|3|||
124757490|NCT01132313|448736298|FG007|Overall Study|Not treated|0|||
124757491|NCT01132313|448736299|FG008|Overall Study|Not treated|0|||
124757492|NCT01132313|448736300|FG009|Overall Study|Not treated|0|||
124757493|NCT01132313|448736301|FG010|Overall Study|Not treated|0|||
124978481|NCT03829501|449548499|FG011|Overall Study|PD|0|||
124757494|NCT01132313|448736302|FG011|Overall Study|Not treated|0|||
124757495|NCT01132313|448736291|FG000|Overall Study|Adverse Event|0|||
124757496|NCT01132313|448736292|FG001|Overall Study|Adverse Event|0|||
124757497|NCT01132313|448736293|FG002|Overall Study|Adverse Event|4|||
124757498|NCT01132313|448736294|FG003|Overall Study|Adverse Event|10|||
124757499|NCT01132313|448736295|FG004|Overall Study|Adverse Event|19|||
124757500|NCT01132313|448736296|FG005|Overall Study|Adverse Event|6|||
124757501|NCT01132313|448736297|FG006|Overall Study|Adverse Event|5|||
124757502|NCT01132313|448736298|FG007|Overall Study|Adverse Event|3|||
124757503|NCT01132313|448736299|FG008|Overall Study|Adverse Event|7|||
124757504|NCT01132313|448736300|FG009|Overall Study|Adverse Event|2|||
124757505|NCT01132313|448736301|FG010|Overall Study|Adverse Event|0|||
124757506|NCT01132313|448736302|FG011|Overall Study|Adverse Event|0|||
124757507|NCT01132313|448736291|FG000|Overall Study|Protocol Violation|0|||
124757508|NCT01132313|448736292|FG001|Overall Study|Protocol Violation|0|||
124757509|NCT01132313|448736293|FG002|Overall Study|Protocol Violation|0|||
124757510|NCT01132313|448736294|FG003|Overall Study|Protocol Violation|1|||
124757511|NCT01132313|448736295|FG004|Overall Study|Protocol Violation|0|||
124757512|NCT01132313|448736296|FG005|Overall Study|Protocol Violation|0|||
124757513|NCT01132313|448736297|FG006|Overall Study|Protocol Violation|0|||
124757514|NCT01132313|448736298|FG007|Overall Study|Protocol Violation|0|||
124757515|NCT01132313|448736299|FG008|Overall Study|Protocol Violation|0|||
124757516|NCT01132313|448736300|FG009|Overall Study|Protocol Violation|0|||
124757517|NCT01132313|448736301|FG010|Overall Study|Protocol Violation|0|||
124757518|NCT01132313|448736302|FG011|Overall Study|Protocol Violation|0|||
124757519|NCT01132313|448736291|FG000|Overall Study|Lost to Follow-up|0|||
124757520|NCT01132313|448736292|FG001|Overall Study|Lost to Follow-up|0|||
124757521|NCT01132313|448736293|FG002|Overall Study|Lost to Follow-up|1|||
124757522|NCT01132313|448736294|FG003|Overall Study|Lost to Follow-up|0|||
124757523|NCT01132313|448736295|FG004|Overall Study|Lost to Follow-up|0|||
124757524|NCT01132313|448736296|FG005|Overall Study|Lost to Follow-up|0|||
124757525|NCT01132313|448736297|FG006|Overall Study|Lost to Follow-up|0|||
124757526|NCT01132313|448736298|FG007|Overall Study|Lost to Follow-up|1|||
124757527|NCT01132313|448736299|FG008|Overall Study|Lost to Follow-up|0|||
124757528|NCT01132313|448736300|FG009|Overall Study|Lost to Follow-up|0|||
124757529|NCT01132313|448736301|FG010|Overall Study|Lost to Follow-up|0|||
124757530|NCT01132313|448736302|FG011|Overall Study|Lost to Follow-up|0|||
124757531|NCT01132313|448736291|FG000|Overall Study|Withdrawal by Subject|0|||
124757532|NCT01132313|448736292|FG001|Overall Study|Withdrawal by Subject|0|||
124757533|NCT01132313|448736293|FG002|Overall Study|Withdrawal by Subject|3|||
124757534|NCT01132313|448736294|FG003|Overall Study|Withdrawal by Subject|3|||
124757535|NCT01132313|448736295|FG004|Overall Study|Withdrawal by Subject|6|||
124757536|NCT01132313|448736296|FG005|Overall Study|Withdrawal by Subject|0|||
124757537|NCT01132313|448736297|FG006|Overall Study|Withdrawal by Subject|1|||
124757538|NCT01132313|448736298|FG007|Overall Study|Withdrawal by Subject|0|||
124757539|NCT01132313|448736299|FG008|Overall Study|Withdrawal by Subject|0|||
124757540|NCT01132313|448736300|FG009|Overall Study|Withdrawal by Subject|2|||
124757541|NCT01132313|448736301|FG010|Overall Study|Withdrawal by Subject|0|||
124757542|NCT01132313|448736302|FG011|Overall Study|Withdrawal by Subject|0|||
124757543|NCT01132313|448736291|FG000|Overall Study|Lack of antiviral response|0|||
124757544|NCT01132313|448736292|FG001|Overall Study|Lack of antiviral response|0|||
124757545|NCT01132313|448736293|FG002|Overall Study|Lack of antiviral response|12|||
124757546|NCT01132313|448736294|FG003|Overall Study|Lack of antiviral response|18|||
124757547|NCT01132313|448736295|FG004|Overall Study|Lack of antiviral response|18|||
124757548|NCT01132313|448736296|FG005|Overall Study|Lack of antiviral response|18|||
124757549|NCT01132313|448736297|FG006|Overall Study|Lack of antiviral response|21|||
124757550|NCT01132313|448736298|FG007|Overall Study|Lack of antiviral response|0|||
124757551|NCT01132313|448736299|FG008|Overall Study|Lack of antiviral response|0|||
124757552|NCT01132313|448736300|FG009|Overall Study|Lack of antiviral response|0|||
124757553|NCT01132313|448736301|FG010|Overall Study|Lack of antiviral response|1|||
124757554|NCT01132313|448736302|FG011|Overall Study|Lack of antiviral response|0|||
124757555|NCT01132313|448736291|FG000|Overall Study|Other reason not defined above|0|||
124757556|NCT01132313|448736292|FG001|Overall Study|Other reason not defined above|0|||
124757557|NCT01132313|448736293|FG002|Overall Study|Other reason not defined above|0|||
124757558|NCT01132313|448736294|FG003|Overall Study|Other reason not defined above|0|||
124757559|NCT01132313|448736295|FG004|Overall Study|Other reason not defined above|0|||
124757560|NCT01132313|448736296|FG005|Overall Study|Other reason not defined above|0|||
124757561|NCT01132313|448736297|FG006|Overall Study|Other reason not defined above|0|||
124757562|NCT01132313|448736298|FG007|Overall Study|Other reason not defined above|1|||
124757563|NCT01132313|448736299|FG008|Overall Study|Other reason not defined above|0|||
124757564|NCT01132313|448736300|FG009|Overall Study|Other reason not defined above|0|||
124757565|NCT01132313|448736301|FG010|Overall Study|Other reason not defined above|0|||
124757566|NCT01132313|448736302|FG011|Overall Study|Other reason not defined above|0|||
124757567|NCT01156714|448736303|FG000|Overall Study|Withdrawal by Subject|9|||
124866922|NCT02586025|449135379|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
124757568|NCT01156714|448736304|FG001|Overall Study|Withdrawal by Subject|4|||
124757569|NCT01156714|448736305|FG002|Overall Study|Withdrawal by Subject|3|||
124757570|NCT00165672|448736310|FG000|Overall Study|Adverse Event|0|||
124757571|NCT00165672|448736311|FG001|Overall Study|Adverse Event|1|||
124757572|NCT02715609|448736313|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
124757573|NCT02715609|448736314|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
124757574|NCT02715609|448736315|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
124757575|NCT02715609|448736313|FG000|Overall Study|Withdrawal by Subject|0|||
124757576|NCT02715609|448736314|FG001|Overall Study|Withdrawal by Subject|0|||
124757577|NCT02715609|448736315|FG002|Overall Study|Withdrawal by Subject|1|||
124757578|NCT03201419|448736316|FG000|Overall Study|Adverse Event|3|||
124757579|NCT03201419|448736317|FG001|Overall Study|Adverse Event|1|||
124757580|NCT03201419|448736318|FG002|Overall Study|Adverse Event|0|||
124757581|NCT03201419|448736319|FG003|Overall Study|Adverse Event|0|||
124757582|NCT03201419|448736320|FG004|Overall Study|Adverse Event|1|||
124757583|NCT03201419|448736321|FG005|Overall Study|Adverse Event|1|||
124757584|NCT03201419|448736322|FG006|Overall Study|Adverse Event|5|||
124757585|NCT03201419|448736323|FG007|Overall Study|Adverse Event|0|||
124757586|NCT03201419|448736324|FG008|Overall Study|Adverse Event|0|||
124757587|NCT03201419|448736316|FG000|Overall Study|Lost to Follow-up|1|||
124757588|NCT03201419|448736317|FG001|Overall Study|Lost to Follow-up|0|||
124757589|NCT03201419|448736318|FG002|Overall Study|Lost to Follow-up|0|||
124757590|NCT03201419|448736319|FG003|Overall Study|Lost to Follow-up|0|||
124757591|NCT03201419|448736320|FG004|Overall Study|Lost to Follow-up|0|||
124757592|NCT03201419|448736321|FG005|Overall Study|Lost to Follow-up|0|||
124757593|NCT03201419|448736322|FG006|Overall Study|Lost to Follow-up|0|||
124757594|NCT03201419|448736323|FG007|Overall Study|Lost to Follow-up|0|||
124757595|NCT03201419|448736324|FG008|Overall Study|Lost to Follow-up|0|||
124757596|NCT03201419|448736316|FG000|Overall Study|Protocol Deviation|0|||
124757597|NCT03201419|448736317|FG001|Overall Study|Protocol Deviation|0|||
124757598|NCT03201419|448736318|FG002|Overall Study|Protocol Deviation|0|||
124757599|NCT03201419|448736319|FG003|Overall Study|Protocol Deviation|0|||
124757600|NCT03201419|448736320|FG004|Overall Study|Protocol Deviation|0|||
124757601|NCT03201419|448736321|FG005|Overall Study|Protocol Deviation|0|||
124757602|NCT03201419|448736322|FG006|Overall Study|Protocol Deviation|1|||
124757603|NCT03201419|448736323|FG007|Overall Study|Protocol Deviation|0|||
124757604|NCT03201419|448736324|FG008|Overall Study|Protocol Deviation|0|||
124757605|NCT03201419|448736316|FG000|Overall Study|Withdrawal by Subject|4|||
124757606|NCT03201419|448736317|FG001|Overall Study|Withdrawal by Subject|2|||
124757607|NCT03201419|448736318|FG002|Overall Study|Withdrawal by Subject|1|||
124757608|NCT03201419|448736319|FG003|Overall Study|Withdrawal by Subject|0|||
124757609|NCT03201419|448736320|FG004|Overall Study|Withdrawal by Subject|0|||
124757610|NCT03201419|448736321|FG005|Overall Study|Withdrawal by Subject|0|||
124757611|NCT03201419|448736322|FG006|Overall Study|Withdrawal by Subject|0|||
124757612|NCT03201419|448736323|FG007|Overall Study|Withdrawal by Subject|1|||
124757613|NCT03201419|448736324|FG008|Overall Study|Withdrawal by Subject|2|||
124757614|NCT03201419|448736316|FG000|Overall Study|Other|0|||
124757615|NCT03201419|448736317|FG001|Overall Study|Other|0|||
124757616|NCT03201419|448736318|FG002|Overall Study|Other|1|||
124757617|NCT03201419|448736319|FG003|Overall Study|Other|0|||
124757618|NCT03201419|448736320|FG004|Overall Study|Other|0|||
124757619|NCT03201419|448736321|FG005|Overall Study|Other|0|||
124757620|NCT03201419|448736322|FG006|Overall Study|Other|0|||
124757621|NCT03201419|448736323|FG007|Overall Study|Other|0|||
124757622|NCT03201419|448736324|FG008|Overall Study|Other|0|||
124757623|NCT05907395|448736327|FG000|Period 1|No longer met eligibility criteria|0|||
124757624|NCT05907395|448736328|FG001|Period 1|No longer met eligibility criteria|1|||
124757625|NCT05907395|448736329|FG002|Period 1|No longer met eligibility criteria|0|||
124757626|NCT05907395|448736330|FG003|Period 1|No longer met eligibility criteria|0|||
124757627|NCT05907395|448736331|FG004|Period 1|No longer met eligibility criteria|0|||
124757628|NCT05907395|448736332|FG005|Period 1|No longer met eligibility criteria|1|||
124757629|NCT05907395|448736333|FG006|Period 1|No longer met eligibility criteria|1|||
124757630|NCT05907395|448736334|FG007|Period 1|No longer met eligibility criteria|0|||
124757631|NCT05907395|448736335|FG008|Period 1|No longer met eligibility criteria|0|||
124757632|NCT05907395|448736336|FG009|Period 1|No longer met eligibility criteria|0|||
124757633|NCT05907395|448736337|FG010|Period 1|No longer met eligibility criteria|0|||
124757634|NCT05907395|448736338|FG011|Period 1|No longer met eligibility criteria|0|||
124757635|NCT05907395|448736327|FG000|Period 2|Adverse Event|0|||
124757636|NCT05907395|448736328|FG001|Period 2|Adverse Event|0|||
124757637|NCT05907395|448736329|FG002|Period 2|Adverse Event|0|||
124757638|NCT05907395|448736330|FG003|Period 2|Adverse Event|1|||
124757639|NCT05907395|448736331|FG004|Period 2|Adverse Event|0|||
124757640|NCT05907395|448736332|FG005|Period 2|Adverse Event|0|||
124757641|NCT05907395|448736333|FG006|Period 2|Adverse Event|0|||
124757642|NCT05907395|448736334|FG007|Period 2|Adverse Event|1|||
124757643|NCT05907395|448736335|FG008|Period 2|Adverse Event|0|||
124757644|NCT05907395|448736336|FG009|Period 2|Adverse Event|0|||
124757645|NCT05907395|448736337|FG010|Period 2|Adverse Event|0|||
124757646|NCT05907395|448736338|FG011|Period 2|Adverse Event|0|||
124757647|NCT05907395|448736327|FG000|Period 2|Personal reason|0|||
124757648|NCT05907395|448736328|FG001|Period 2|Personal reason|0|||
124757649|NCT05907395|448736329|FG002|Period 2|Personal reason|0|||
124757650|NCT05907395|448736330|FG003|Period 2|Personal reason|0|||
124757651|NCT05907395|448736331|FG004|Period 2|Personal reason|0|||
124757652|NCT05907395|448736332|FG005|Period 2|Personal reason|0|||
124757653|NCT05907395|448736333|FG006|Period 2|Personal reason|0|||
124757654|NCT05907395|448736334|FG007|Period 2|Personal reason|0|||
124757655|NCT05907395|448736335|FG008|Period 2|Personal reason|0|||
124757656|NCT05907395|448736336|FG009|Period 2|Personal reason|1|||
124757657|NCT05907395|448736337|FG010|Period 2|Personal reason|0|||
124757658|NCT05907395|448736338|FG011|Period 2|Personal reason|0|||
124757659|NCT05907395|448736327|FG000|Period 3|Adverse Event|0|||
124757660|NCT05907395|448736328|FG001|Period 3|Adverse Event|0|||
124757661|NCT05907395|448736329|FG002|Period 3|Adverse Event|0|||
124757662|NCT05907395|448736330|FG003|Period 3|Adverse Event|0|||
124757663|NCT05907395|448736331|FG004|Period 3|Adverse Event|1|||
124757664|NCT05907395|448736332|FG005|Period 3|Adverse Event|0|||
124757665|NCT05907395|448736333|FG006|Period 3|Adverse Event|0|||
124757666|NCT05907395|448736334|FG007|Period 3|Adverse Event|0|||
124757667|NCT05907395|448736335|FG008|Period 3|Adverse Event|0|||
124757668|NCT05907395|448736336|FG009|Period 3|Adverse Event|0|||
124757669|NCT05907395|448736337|FG010|Period 3|Adverse Event|0|||
124757670|NCT05907395|448736338|FG011|Period 3|Adverse Event|0|||
124757671|NCT04896593|448736339|FG000|Overall Study|Withdrawal by Subject|2|||
124757672|NCT04896593|448736339|FG000|Overall Study|Lost to Follow-up|1|||
124757673|NCT04896593|448736339|FG000|Overall Study|Did not complete onboarding|2|||
124757674|NCT00369577|448736341|FG000|Overall Study|Withdrawal by Subject|0|||
124757675|NCT00369577|448736342|FG001|Overall Study|Withdrawal by Subject|0|||
124757676|NCT00369577|448736343|FG002|Overall Study|Withdrawal by Subject|1|||
124757677|NCT02360228|448736352|FG000|Overall Study|Withdrawal by Subject|1|||
124757678|NCT02360228|448736353|FG001|Overall Study|Withdrawal by Subject|0|||
124757679|NCT02360228|448736354|FG002|Overall Study|Withdrawal by Subject|0|||
124757680|NCT02360228|448736352|FG000|Overall Study|Self-discontinued medication|0|||
124757681|NCT02360228|448736353|FG001|Overall Study|Self-discontinued medication|1|||
124757682|NCT02360228|448736354|FG002|Overall Study|Self-discontinued medication|0|||
124757683|NCT02360228|448736352|FG000|Overall Study|Unstable symptoms during screening|0|||
124757684|NCT02360228|448736353|FG001|Overall Study|Unstable symptoms during screening|0|||
124757685|NCT02360228|448736354|FG002|Overall Study|Unstable symptoms during screening|1|||
124757686|NCT01059318|448736357|FG000|Core Study (26 Week)|Adverse Event|3|||
124757687|NCT01059318|448736357|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
124757688|NCT01059318|448736357|FG000|Extension (36 Week)|Adverse Event|3|||
124757689|NCT03790917|448736358|FG000|Overall Study|Death|1|||
124757690|NCT04186871|448736359|FG000|Overall Study|Lack of Efficacy|0|||
124757691|NCT04186871|448736360|FG001|Overall Study|Lack of Efficacy|1|||
124757692|NCT04186871|448736361|FG002|Overall Study|Lack of Efficacy|0|||
124757693|NCT04186871|448736362|FG003|Overall Study|Lack of Efficacy|0|||
124757694|NCT04186871|448736363|FG004|Overall Study|Lack of Efficacy|1|||
124757695|NCT04186871|448736364|FG005|Overall Study|Lack of Efficacy|1|||
124757696|NCT04186871|448736359|FG000|Overall Study|Adverse Event|1|||
124757697|NCT04186871|448736360|FG001|Overall Study|Adverse Event|1|||
124757698|NCT04186871|448736361|FG002|Overall Study|Adverse Event|0|||
124757699|NCT04186871|448736362|FG003|Overall Study|Adverse Event|0|||
124757700|NCT04186871|448736363|FG004|Overall Study|Adverse Event|0|||
124757701|NCT04186871|448736364|FG005|Overall Study|Adverse Event|2|||
124757702|NCT04186871|448736359|FG000|Overall Study|Study terminated by sponsor|1|||
124757703|NCT04186871|448736360|FG001|Overall Study|Study terminated by sponsor|2|||
124757704|NCT04186871|448736361|FG002|Overall Study|Study terminated by sponsor|0|||
124757705|NCT04186871|448736362|FG003|Overall Study|Study terminated by sponsor|1|||
124757706|NCT04186871|448736363|FG004|Overall Study|Study terminated by sponsor|0|||
124757707|NCT04186871|448736364|FG005|Overall Study|Study terminated by sponsor|0|||
124757708|NCT04186871|448736359|FG000|Overall Study|Other reasons|0|||
124757709|NCT04186871|448736360|FG001|Overall Study|Other reasons|0|||
124757710|NCT04186871|448736361|FG002|Overall Study|Other reasons|0|||
124757711|NCT04186871|448736362|FG003|Overall Study|Other reasons|0|||
124757712|NCT04186871|448736363|FG004|Overall Study|Other reasons|0|||
124757713|NCT04186871|448736364|FG005|Overall Study|Other reasons|1|||
124757714|NCT04186871|448736359|FG000|Overall Study|Withdrawal by Subject|0|||
124757715|NCT04186871|448736360|FG001|Overall Study|Withdrawal by Subject|0|||
124757716|NCT04186871|448736361|FG002|Overall Study|Withdrawal by Subject|0|||
124757717|NCT04186871|448736362|FG003|Overall Study|Withdrawal by Subject|0|||
124757718|NCT04186871|448736363|FG004|Overall Study|Withdrawal by Subject|0|||
124757719|NCT04186871|448736364|FG005|Overall Study|Withdrawal by Subject|1|||
124757720|NCT04186871|448736359|FG000|Overall Study|Lost to Follow-up|0|||
124757721|NCT04186871|448736360|FG001|Overall Study|Lost to Follow-up|0|||
124757722|NCT04186871|448736361|FG002|Overall Study|Lost to Follow-up|0|||
124757723|NCT04186871|448736362|FG003|Overall Study|Lost to Follow-up|0|||
124757724|NCT04186871|448736363|FG004|Overall Study|Lost to Follow-up|0|||
124757725|NCT04186871|448736364|FG005|Overall Study|Lost to Follow-up|1|||
124757726|NCT02464410|448736365|FG000|Overall Study|Death|3|||
124757727|NCT02464410|448736366|FG001|Overall Study|Death|4|||
124757728|NCT02464410|448736365|FG000|Overall Study|Lost to Follow-up|7|||
124757729|NCT02464410|448736366|FG001|Overall Study|Lost to Follow-up|9|||
124757730|NCT02464410|448736365|FG000|Overall Study|Withdrawal by Subject|12|||
124757731|NCT02464410|448736366|FG001|Overall Study|Withdrawal by Subject|3|||
124757732|NCT00176462|448736370|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
124757733|NCT00176462|448736371|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
124757734|NCT00176462|448736370|FG000|Induction (4 Weeks)|Death|1|||
124757735|NCT00176462|448736371|FG001|Induction (4 Weeks)|Death|2|||
124757736|NCT00176462|448736370|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
124757737|NCT00176462|448736371|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
124757738|NCT00176462|448736370|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
124757739|NCT00176462|448736371|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
124757740|NCT00176462|448736370|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
124757741|NCT00176462|448736371|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
124757742|NCT00176462|448736370|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
124757743|NCT00176462|448736371|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
124757744|NCT00176462|448736370|FG000|Consolidation (12 Weeks)|Not documented|0|||
124757745|NCT00176462|448736371|FG001|Consolidation (12 Weeks)|Not documented|1|||
124757746|NCT00176462|448736370|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
124757747|NCT00176462|448736371|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
124757748|NCT00176462|448736370|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
124757749|NCT00176462|448736371|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
124757750|NCT01408459|448736372|FG000|Overall Study|Withdrawal by Subject|1|||
124757751|NCT01408459|448736373|FG001|Overall Study|Withdrawal by Subject|1|||
124757752|NCT01657292|448736378|FG000|Overall Study|Adverse Event|6|||
124757753|NCT01657292|448736378|FG000|Overall Study|Withdrawal by Subject|2|||
124757754|NCT01657292|448736378|FG000|Overall Study|Violation of eligibility criteria|1|||
124757755|NCT01657292|448736378|FG000|Overall Study|Change of therapy|1|||
124757756|NCT00650845|448736379|FG000|Overall Study|Withdrawal by Subject|5|||
124757757|NCT00650845|448736380|FG001|Overall Study|Withdrawal by Subject|0|||
124757758|NCT00650845|448736379|FG000|Overall Study|Protocol Violation|0|||
124757759|NCT00650845|448736380|FG001|Overall Study|Protocol Violation|13|||
124757760|NCT03932760|448736381|FG000|Overall Study|Became Ineligible|2|||
124757761|NCT03932760|448736382|FG001|Overall Study|Became Ineligible|5|||
124757762|NCT03932760|448736381|FG000|Overall Study|Withdrawal by Subject|6|||
124757763|NCT03932760|448736382|FG001|Overall Study|Withdrawal by Subject|6|||
124757764|NCT01301833|448736383|FG000|Overall Study|Adverse Event|7|||
124757765|NCT01301833|448736384|FG001|Overall Study|Adverse Event|5|||
124757766|NCT01301833|448736385|FG002|Overall Study|Adverse Event|5|||
124757767|NCT01301833|448736386|FG003|Overall Study|Adverse Event|5|||
124757768|NCT01301833|448736383|FG000|Overall Study|Lack of Efficacy|1|||
124757769|NCT01301833|448736384|FG001|Overall Study|Lack of Efficacy|1|||
124757770|NCT01301833|448736385|FG002|Overall Study|Lack of Efficacy|0|||
124757771|NCT01301833|448736386|FG003|Overall Study|Lack of Efficacy|0|||
124757772|NCT01301833|448736383|FG000|Overall Study|Physician Decision|3|||
124757773|NCT01301833|448736384|FG001|Overall Study|Physician Decision|1|||
124757774|NCT01301833|448736385|FG002|Overall Study|Physician Decision|1|||
124757775|NCT01301833|448736386|FG003|Overall Study|Physician Decision|0|||
124757776|NCT01301833|448736383|FG000|Overall Study|Withdrawal by Subject|3|||
124757777|NCT01301833|448736384|FG001|Overall Study|Withdrawal by Subject|1|||
124757778|NCT01301833|448736385|FG002|Overall Study|Withdrawal by Subject|1|||
124757779|NCT01301833|448736386|FG003|Overall Study|Withdrawal by Subject|2|||
124757780|NCT01301833|448736383|FG000|Overall Study|Personal matter|1|||
124757781|NCT01301833|448736384|FG001|Overall Study|Personal matter|0|||
124757782|NCT01301833|448736385|FG002|Overall Study|Personal matter|0|||
124757783|NCT01301833|448736386|FG003|Overall Study|Personal matter|0|||
124757784|NCT03566082|448736387|FG000|Overall Study|Death|7|||
124757785|NCT03566082|448736387|FG000|Overall Study|Failures (revision required)|2|||
124757786|NCT03566082|448736387|FG000|Overall Study|Lost to Follow-up|8|||
124757787|NCT03922620|448736388|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
124757788|NCT03922620|448736389|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
124757789|NCT00983385|448736392|FG000|Observation Period|Not eligible to be dosed|20|||
124757790|NCT00983385|448736392|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
124757791|NCT01279681|448736394|FG000|Overall Study|Disease Progression|9|||
124757792|NCT01279681|448736395|FG001|Overall Study|Disease Progression|6|||
124757793|NCT01279681|448736394|FG000|Overall Study|Withdrawal by Subject|3|||
124757794|NCT01279681|448736395|FG001|Overall Study|Withdrawal by Subject|4|||
124757795|NCT01279681|448736394|FG000|Overall Study|Adverse Event|2|||
124757796|NCT01279681|448736395|FG001|Overall Study|Adverse Event|3|||
124757797|NCT01279681|448736394|FG000|Overall Study|Death|0|||
124757798|NCT01279681|448736395|FG001|Overall Study|Death|1|||
124757799|NCT01279681|448736394|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
124757800|NCT01279681|448736395|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
124757801|NCT01279681|448736394|FG000|Overall Study|Physician Decision|1|||
124757802|NCT01279681|448736395|FG001|Overall Study|Physician Decision|0|||
124757803|NCT01279681|448736394|FG000|Overall Study|Other Reason|0|||
124757804|NCT01279681|448736395|FG001|Overall Study|Other Reason|2|||
124757805|NCT01467505|448738009|FG000|Overall Study|Adverse Event|1|||
124757806|NCT01467505|448738010|FG001|Overall Study|Adverse Event|0|||
124757807|NCT01467505|448738009|FG000|Overall Study|Withdrawal by Subject|4|||
124757808|NCT01467505|448738010|FG001|Overall Study|Withdrawal by Subject|0|||
124757809|NCT01467505|448738009|FG000|Overall Study|Study Terminated by Sponsor|28|||
124757810|NCT01467505|448738010|FG001|Overall Study|Study Terminated by Sponsor|3|||
124757811|NCT02807623|448738011|FG000|Overall Study|Lost to Follow-up|23|||
124757812|NCT02807623|448738012|FG001|Overall Study|Lost to Follow-up|18|||
124757813|NCT02807623|448738013|FG002|Overall Study|Lost to Follow-up|22|||
124757814|NCT02807623|448738011|FG000|Overall Study|Drug intolerance|0|||
124757815|NCT02807623|448738012|FG001|Overall Study|Drug intolerance|1|||
124757816|NCT02807623|448738013|FG002|Overall Study|Drug intolerance|0|||
124757817|NCT02807623|448738011|FG000|Overall Study|incomplete blood draw|0|||
124757818|NCT02807623|448738012|FG001|Overall Study|incomplete blood draw|2|||
124757819|NCT02807623|448738013|FG002|Overall Study|incomplete blood draw|1|||
124757820|NCT02098746|448738014|FG000|Overall Study|Changes of Investigator|2|||
124757821|NCT02098746|448738014|FG000|Overall Study|Other Miscellaneous Reasons|1|||
124757822|NCT02098746|448738014|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
124757823|NCT02098746|448738014|FG000|Overall Study|Data Not Available After Treatment|1|||
124757824|NCT00217425|448738015|FG000|Overall Study|Never started treatment|2|||
124757825|NCT00217425|448738015|FG000|Overall Study|Patient ineligible|5|||
124757826|NCT00217425|448738015|FG000|Overall Study|Lack of Efficacy|13|||
124757827|NCT00217425|448738015|FG000|Overall Study|Adverse Event|8|||
124757828|NCT00217425|448738015|FG000|Overall Study|Withdrawal by Subject|4|||
124757829|NCT00217425|448738015|FG000|Overall Study|Other complicating disease|1|||
124757830|NCT00217425|448738015|FG000|Overall Study|Other|4|||
124757831|NCT00086047|448738018|FG000|Overall Study|Lost to Follow-up|7|||
124757832|NCT00086047|448738019|FG001|Overall Study|Lost to Follow-up|6|||
124757833|NCT00086047|448738018|FG000|Overall Study|Physician Decision|0|||
124757834|NCT00086047|448738019|FG001|Overall Study|Physician Decision|1|||
124757835|NCT02471014|448738020|FG000|Overall Study|Lost to Follow-up|2|||
124757836|NCT02471014|448738021|FG001|Overall Study|Lost to Follow-up|2|||
124757837|NCT04640311|448738022|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
124757838|NCT04640311|448738023|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757839|NCT04640311|448738024|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757840|NCT04640311|448738025|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757841|NCT04640311|448738026|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757842|NCT04640311|448738027|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757843|NCT04640311|448738028|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757844|NCT04640311|448738029|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757845|NCT04640311|448738030|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757846|NCT04640311|448738031|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757847|NCT04640311|448738032|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757848|NCT04640311|448738033|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757849|NCT04640311|448738034|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757850|NCT04640311|448738022|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
124757851|NCT04640311|448738023|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
124757852|NCT04640311|448738024|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
124757853|NCT04640311|448738025|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
124757854|NCT04640311|448738026|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
124757855|NCT04640311|448738027|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
124757856|NCT04640311|448738028|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
124757857|NCT04640311|448738029|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
124757858|NCT04640311|448738030|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
124757859|NCT04640311|448738031|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
124757860|NCT04640311|448738032|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
124757861|NCT04640311|448738033|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
124757862|NCT04640311|448738034|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
124757863|NCT04640311|448738022|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757864|NCT04640311|448738023|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
124757865|NCT04640311|448738024|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757866|NCT04640311|448738025|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757867|NCT04640311|448738026|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757868|NCT04640311|448738027|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757869|NCT04640311|448738028|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757870|NCT04640311|448738029|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757871|NCT04640311|448738030|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757872|NCT04640311|448738031|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757873|NCT04640311|448738032|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757874|NCT04640311|448738033|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757875|NCT04640311|448738034|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757876|NCT04640311|448738022|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
124757877|NCT04640311|448738023|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
124757878|NCT04640311|448738024|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
124757879|NCT04640311|448738025|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757880|NCT04640311|448738026|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757881|NCT04640311|448738027|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757882|NCT04640311|448738028|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757883|NCT04640311|448738029|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757884|NCT04640311|448738030|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757885|NCT04640311|448738031|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757886|NCT04640311|448738032|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757887|NCT04640311|448738033|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757888|NCT04640311|448738034|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
124757889|NCT04640311|448738022|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
124757890|NCT04640311|448738023|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
124757891|NCT04640311|448738024|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
124757892|NCT04640311|448738025|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
124757893|NCT04640311|448738026|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
124757894|NCT04640311|448738027|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
124757895|NCT04640311|448738028|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
124757896|NCT04640311|448738029|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
124757897|NCT04640311|448738030|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
124757898|NCT04640311|448738031|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
124757899|NCT04640311|448738032|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
124757900|NCT04640311|448738033|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
124757901|NCT04640311|448738034|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
124757902|NCT04640311|448738022|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
124757903|NCT04640311|448738023|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
124757904|NCT04640311|448738024|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
124757905|NCT04640311|448738025|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
124757906|NCT04640311|448738026|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
124757907|NCT04640311|448738027|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
124757908|NCT04640311|448738028|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
124757909|NCT04640311|448738029|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
124757910|NCT04640311|448738030|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
124757911|NCT04640311|448738031|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
124757912|NCT04640311|448738032|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
124757913|NCT04640311|448738033|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
124757914|NCT04640311|448738034|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
124757915|NCT04640311|448738022|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757916|NCT04640311|448738023|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757917|NCT04640311|448738024|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757918|NCT04640311|448738025|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757919|NCT04640311|448738026|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757920|NCT04640311|448738027|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
124757921|NCT04640311|448738028|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757922|NCT04640311|448738029|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757923|NCT04640311|448738030|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
124757924|NCT04640311|448738031|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757925|NCT04640311|448738032|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757926|NCT04640311|448738033|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757927|NCT04640311|448738034|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
124757928|NCT04640311|448738022|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
124757929|NCT04640311|448738023|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
124866923|NCT02586025|449135380|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
124866924|NCT02586025|449135379|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
124757930|NCT04640311|448738024|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
124757931|NCT04640311|448738025|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
124757932|NCT04640311|448738026|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
124757933|NCT04640311|448738027|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
124757934|NCT04640311|448738028|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
124757935|NCT04640311|448738029|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
124757936|NCT04640311|448738030|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
124757937|NCT04640311|448738031|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
124757938|NCT04640311|448738032|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
124757939|NCT04640311|448738033|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
124757940|NCT04640311|448738034|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
124757941|NCT04640311|448738022|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
124757942|NCT04640311|448738023|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
124757943|NCT04640311|448738024|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
124757944|NCT04640311|448738025|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
124757945|NCT04640311|448738026|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
124757946|NCT04640311|448738027|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
124757947|NCT04640311|448738028|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
124757948|NCT04640311|448738029|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
124757949|NCT04640311|448738030|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
124757950|NCT04640311|448738031|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
124757951|NCT04640311|448738032|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
124757952|NCT04640311|448738033|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
124757953|NCT04640311|448738034|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
124757954|NCT00592904|448738035|FG000|Overall Study|Adverse Event|15|||
124757955|NCT00592904|448738036|FG001|Overall Study|Adverse Event|25|||
124757956|NCT00592904|448738037|FG002|Overall Study|Adverse Event|13|||
124757957|NCT00592904|448738038|FG003|Overall Study|Adverse Event|5|||
124757958|NCT00592904|448738035|FG000|Overall Study|Protocol Violation|1|||
124757959|NCT00592904|448738036|FG001|Overall Study|Protocol Violation|1|||
124757960|NCT00592904|448738037|FG002|Overall Study|Protocol Violation|0|||
124757961|NCT00592904|448738038|FG003|Overall Study|Protocol Violation|1|||
124757962|NCT00592904|448738035|FG000|Overall Study|Withdrawal by Subject|4|||
124757963|NCT00592904|448738036|FG001|Overall Study|Withdrawal by Subject|16|||
124757964|NCT00592904|448738037|FG002|Overall Study|Withdrawal by Subject|1|||
124757965|NCT00592904|448738038|FG003|Overall Study|Withdrawal by Subject|2|||
124757966|NCT00592904|448738035|FG000|Overall Study|Lack of Efficacy|2|||
124757967|NCT00592904|448738036|FG001|Overall Study|Lack of Efficacy|7|||
124757968|NCT00592904|448738037|FG002|Overall Study|Lack of Efficacy|2|||
124757969|NCT00592904|448738038|FG003|Overall Study|Lack of Efficacy|3|||
124757970|NCT00592904|448738035|FG000|Overall Study|Physician Decision|0|||
124757971|NCT00592904|448738036|FG001|Overall Study|Physician Decision|3|||
124757972|NCT00592904|448738037|FG002|Overall Study|Physician Decision|1|||
124757973|NCT00592904|448738038|FG003|Overall Study|Physician Decision|0|||
124757974|NCT00592904|448738035|FG000|Overall Study|Other|3|||
124757975|NCT00592904|448738036|FG001|Overall Study|Other|3|||
124757976|NCT00592904|448738037|FG002|Overall Study|Other|0|||
124757977|NCT00592904|448738038|FG003|Overall Study|Other|0|||
124757978|NCT03191630|448738039|FG000|Overall Study|Lost to Follow-up|7|||
124757979|NCT03191630|448738040|FG001|Overall Study|Lost to Follow-up|7|||
124757980|NCT01367834|448738047|FG000|Overall Study|Withdrawal by Subject|2|||
124757981|NCT01367834|448738048|FG001|Overall Study|Withdrawal by Subject|2|||
124757982|NCT01367834|448738047|FG000|Overall Study|Study was ended.|0|||
124757983|NCT01367834|448738048|FG001|Overall Study|Study was ended.|1|||
124757984|NCT01020786|448738053|FG000|Induction Period|Entry Criteria Not Met|2|||
124757985|NCT01020786|448738053|FG000|Induction Period|Adverse Event|10|||
124757986|NCT01020786|448738053|FG000|Induction Period|Progressive Disease|31|||
124757987|NCT01020786|448738053|FG000|Induction Period|Investigator Decision|3|||
124757988|NCT01020786|448738053|FG000|Induction Period|Withdrawal by Subject|3|||
124757989|NCT01020786|448738053|FG000|Maintenance Period|Adverse Event|8|||
124757990|NCT01020786|448738053|FG000|Maintenance Period|Progressive Disease|43|||
124757991|NCT01020786|448738053|FG000|Maintenance Period|Withdrawal by Subject|8|||
124757992|NCT01020786|448738053|FG000|Maintenance Period|Sponsor Decision|1|||
124757993|NCT01818596|448738060|FG000|Overall Study|Enrolled but Not Treated|4|||
124757994|NCT01818596|448738061|FG001|Overall Study|Enrolled but Not Treated|0|||
124757995|NCT01818596|448738060|FG000|Overall Study|Adverse Event|7|||
124757996|NCT01818596|448738061|FG001|Overall Study|Adverse Event|0|||
124757997|NCT01818596|448738060|FG000|Overall Study|Death|3|||
124757998|NCT01818596|448738061|FG001|Overall Study|Death|0|||
124757999|NCT01818596|448738060|FG000|Overall Study|Investigator's Discretion|4|||
124758000|NCT01818596|448738061|FG001|Overall Study|Investigator's Discretion|0|||
124758001|NCT01818596|448738060|FG000|Overall Study|Protocol Violation|1|||
124758002|NCT01818596|448738061|FG001|Overall Study|Protocol Violation|0|||
124758003|NCT01818596|448738060|FG000|Overall Study|Withdrew Consent|5|||
124758004|NCT01818596|448738061|FG001|Overall Study|Withdrew Consent|0|||
124758005|NCT01818596|448738060|FG000|Overall Study|Lost to Follow-up|7|||
124758006|NCT01818596|448738061|FG001|Overall Study|Lost to Follow-up|0|||
124758007|NCT03801174|448738062|FG000|Overall Study|Withdrawal by Subject|14|||
124758008|NCT03801174|448738063|FG001|Overall Study|Withdrawal by Subject|15|||
124758009|NCT03801174|448738062|FG000|Overall Study|Death|1|||
124758010|NCT03801174|448738063|FG001|Overall Study|Death|0|||
124758011|NCT03801174|448738062|FG000|Overall Study|Pregnancy|2|||
124758012|NCT03801174|448738063|FG001|Overall Study|Pregnancy|2|||
124758013|NCT03801174|448738062|FG000|Overall Study|Lost to Follow-up|19|||
124758014|NCT03801174|448738063|FG001|Overall Study|Lost to Follow-up|10|||
124758015|NCT03801174|448738062|FG000|Overall Study|Other|4|||
124758016|NCT03801174|448738063|FG001|Overall Study|Other|3|||
124758017|NCT03801174|448738062|FG000|Overall Study|Lack of Efficacy|4|||
124758018|NCT03801174|448738063|FG001|Overall Study|Lack of Efficacy|0|||
124758019|NCT03801174|448738062|FG000|Overall Study|Unwilling to complete activities|5|||
124758020|NCT03801174|448738063|FG001|Overall Study|Unwilling to complete activities|6|||
124758021|NCT03801174|448738062|FG000|Overall Study|Moved out of area|3|||
124758022|NCT03801174|448738063|FG001|Overall Study|Moved out of area|0|||
124758023|NCT02915263|448738072|FG000|Overall Study|Covid|3|||
124758024|NCT02915263|448738073|FG001|Overall Study|Covid|2|||
124758025|NCT01879683|448738074|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
124758026|NCT01618669|448738075|FG000|Overall Study|Lost to Follow-up|1|||
124758027|NCT01618669|448738076|FG001|Overall Study|Lost to Follow-up|1|||
124758028|NCT01618669|448738075|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
124758029|NCT01618669|448738076|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
124758030|NCT01618669|448738075|FG000|Overall Study|Adverse Event|16|||
124758031|NCT01618669|448738076|FG001|Overall Study|Adverse Event|7|||
124758032|NCT01618669|448738075|FG000|Overall Study|Protocol Violation|5|||
124758033|NCT01618669|448738076|FG001|Overall Study|Protocol Violation|3|||
124758034|NCT01618669|448738075|FG000|Overall Study|Withdrawal by Subject|9|||
124758035|NCT01618669|448738076|FG001|Overall Study|Withdrawal by Subject|9|||
124758036|NCT01618669|448738075|FG000|Overall Study|Miscellaneous Reason|0|||
124758037|NCT01618669|448738076|FG001|Overall Study|Miscellaneous Reason|1|||
124758038|NCT01702558|448738079|FG000|Overall Study|Withdrawal by Subject|0|||
124758039|NCT01702558|448738080|FG001|Overall Study|Withdrawal by Subject|0|||
124758040|NCT01702558|448738081|FG002|Overall Study|Withdrawal by Subject|0|||
124758041|NCT01702558|448738082|FG003|Overall Study|Withdrawal by Subject|12|||
124758042|NCT01702558|448738083|FG004|Overall Study|Withdrawal by Subject|4|||
124758043|NCT01702558|448738079|FG000|Overall Study|Lost to Follow-up|0|||
124758044|NCT01702558|448738080|FG001|Overall Study|Lost to Follow-up|0|||
124758045|NCT01702558|448738081|FG002|Overall Study|Lost to Follow-up|0|||
124758046|NCT01702558|448738082|FG003|Overall Study|Lost to Follow-up|3|||
124758047|NCT01702558|448738083|FG004|Overall Study|Lost to Follow-up|0|||
124758048|NCT01702558|448738079|FG000|Overall Study|Death|4|||
124758049|NCT01702558|448738080|FG001|Overall Study|Death|3|||
124758050|NCT01702558|448738081|FG002|Overall Study|Death|3|||
124758051|NCT01702558|448738082|FG003|Overall Study|Death|16|||
124758052|NCT01702558|448738083|FG004|Overall Study|Death|20|||
124758053|NCT01702558|448738079|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
124758054|NCT01702558|448738080|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
124758055|NCT01702558|448738081|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
124758056|NCT01702558|448738082|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
124758057|NCT01702558|448738083|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
124758058|NCT01702558|448738079|FG000|Overall Study|Study Terminated by Sponsor|0|||
124758059|NCT01702558|448738080|FG001|Overall Study|Study Terminated by Sponsor|1|||
124758060|NCT01702558|448738081|FG002|Overall Study|Study Terminated by Sponsor|0|||
124758061|NCT01702558|448738082|FG003|Overall Study|Study Terminated by Sponsor|0|||
124758062|NCT01702558|448738083|FG004|Overall Study|Study Terminated by Sponsor|1|||
124758063|NCT01702558|448738079|FG000|Overall Study|Other|0|||
124758064|NCT01702558|448738080|FG001|Overall Study|Other|0|||
124758065|NCT01702558|448738081|FG002|Overall Study|Other|0|||
124758066|NCT01702558|448738082|FG003|Overall Study|Other|16|||
124758067|NCT01702558|448738083|FG004|Overall Study|Other|17|||
124758068|NCT04950465|448738086|FG000|Overall Study|Lost to Follow-up|1|||
124758069|NCT04950465|448738087|FG001|Overall Study|Lost to Follow-up|0|||
124758070|NCT04950465|448738088|FG002|Overall Study|Lost to Follow-up|0|||
124758071|NCT01788566|448738089|FG000|Overall Study|Death|4|||
124758072|NCT01788566|448738089|FG000|Overall Study|Adverse Event|1|||
124758073|NCT01788566|448738089|FG000|Overall Study|Clinical Progressive Disease|3|||
124758074|NCT01620086|448738092|FG000|Overall Study|Withdrawal by Subject|3|||
124758075|NCT01620086|448738093|FG001|Overall Study|Withdrawal by Subject|3|||
124758076|NCT01620086|448738094|FG002|Overall Study|Withdrawal by Subject|0|||
124758077|NCT01620086|448738092|FG000|Overall Study|failed study criteria|1|||
124758078|NCT01620086|448738093|FG001|Overall Study|failed study criteria|4|||
124758079|NCT01620086|448738094|FG002|Overall Study|failed study criteria|0|||
124758080|NCT01620086|448738092|FG000|Overall Study|Physician Decision|1|||
124758081|NCT01620086|448738093|FG001|Overall Study|Physician Decision|0|||
124758082|NCT01620086|448738094|FG002|Overall Study|Physician Decision|0|||
124758083|NCT01695135|448738095|FG000|Double-blind Treatment Phase|Progressive disease|50|||
124758084|NCT01695135|448738096|FG001|Double-blind Treatment Phase|Progressive disease|110|||
124758085|NCT01695135|448738097|FG002|Double-blind Treatment Phase|Progressive disease|0|||
124758086|NCT01695135|448738098|FG003|Double-blind Treatment Phase|Progressive disease|0|||
124758087|NCT01695135|448738095|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
124758088|NCT01695135|448738096|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
124758089|NCT01695135|448738097|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124758090|NCT01695135|448738098|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124758091|NCT01695135|448738095|FG000|Double-blind Treatment Phase|Adverse Event|7|||
124758092|NCT01695135|448738096|FG001|Double-blind Treatment Phase|Adverse Event|7|||
124758093|NCT01695135|448738097|FG002|Double-blind Treatment Phase|Adverse Event|0|||
124758094|NCT01695135|448738098|FG003|Double-blind Treatment Phase|Adverse Event|0|||
124758095|NCT01695135|448738095|FG000|Double-blind Treatment Phase|Other|1|||
124758096|NCT01695135|448738096|FG001|Double-blind Treatment Phase|Other|3|||
124758097|NCT01695135|448738097|FG002|Double-blind Treatment Phase|Other|0|||
124758098|NCT01695135|448738098|FG003|Double-blind Treatment Phase|Other|0|||
124758099|NCT01695135|448738095|FG000|Double-blind Treatment Phase|Physician Decision|6|||
124758100|NCT01695135|448738096|FG001|Double-blind Treatment Phase|Physician Decision|3|||
124758101|NCT01695135|448738097|FG002|Double-blind Treatment Phase|Physician Decision|0|||
124758102|NCT01695135|448738098|FG003|Double-blind Treatment Phase|Physician Decision|0|||
124758103|NCT01695135|448738095|FG000|Double-blind Treatment Phase|Death|1|||
124758104|NCT01695135|448738096|FG001|Double-blind Treatment Phase|Death|1|||
124758105|NCT01695135|448738097|FG002|Double-blind Treatment Phase|Death|0|||
124758106|NCT01695135|448738098|FG003|Double-blind Treatment Phase|Death|0|||
124758107|NCT01695135|448738095|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
124758108|NCT01695135|448738096|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
124758109|NCT01695135|448738097|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
124758110|NCT01695135|448738098|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
124758111|NCT01695135|448738095|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
124758112|NCT01695135|448738096|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
124758113|NCT01695135|448738097|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
124758114|NCT01695135|448738098|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
124758115|NCT01695135|448738095|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
124758116|NCT01695135|448738096|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
124758117|NCT01695135|448738097|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
124758118|NCT01695135|448738098|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
124758119|NCT01695135|448738095|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
124758120|NCT01695135|448738096|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
124758121|NCT01695135|448738097|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
124758122|NCT01695135|448738098|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
124758123|NCT01695135|448738095|FG000|Open Label Extension Treatment Phase|Other|0|||
124758124|NCT01695135|448738096|FG001|Open Label Extension Treatment Phase|Other|0|||
124758125|NCT01695135|448738097|FG002|Open Label Extension Treatment Phase|Other|4|||
124758126|NCT01695135|448738098|FG003|Open Label Extension Treatment Phase|Other|7|||
124758127|NCT01695135|448738095|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
124758128|NCT01695135|448738096|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
124758129|NCT01695135|448738097|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
124758130|NCT01695135|448738098|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
124758131|NCT01695135|448738095|FG000|Open Label Extension Treatment Phase|Death|0|||
124758132|NCT01695135|448738096|FG001|Open Label Extension Treatment Phase|Death|0|||
124758133|NCT01695135|448738097|FG002|Open Label Extension Treatment Phase|Death|2|||
124758134|NCT01695135|448738098|FG003|Open Label Extension Treatment Phase|Death|7|||
124758135|NCT01695135|448738095|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
124758136|NCT01695135|448738096|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
124758137|NCT01695135|448738097|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
124758138|NCT01695135|448738098|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
124758139|NCT02562716|448738099|FG000|Overall Study|Adverse Event|7|||
124758140|NCT02562716|448738100|FG001|Overall Study|Adverse Event|14|||
124758141|NCT02562716|448738099|FG000|Overall Study|Withdrawal unrelated to AE|7|||
124758142|NCT02562716|448738100|FG001|Overall Study|Withdrawal unrelated to AE|1|||
124758143|NCT02562716|448738099|FG000|Overall Study|Progression|8|||
124758144|NCT02562716|448738100|FG001|Overall Study|Progression|10|||
124758145|NCT02562716|448738099|FG000|Overall Study|Death|2|||
124758146|NCT02562716|448738100|FG001|Overall Study|Death|1|||
124758147|NCT02562716|448738099|FG000|Overall Study|Not protocol specified|4|||
124758148|NCT02562716|448738100|FG001|Overall Study|Not protocol specified|2|||
124758149|NCT00684996|448738101|FG000|Overall Study|Adverse Event|1|||
124758150|NCT00684996|448738101|FG000|Overall Study|Refusal unrelated to adverse event|1|||
124758151|NCT00684996|448738101|FG000|Overall Study|Progression/relapse|2|||
124758152|NCT00684996|448738101|FG000|Overall Study|Other reasons not protocol specified|1|||
124758153|NCT01076959|448738104|FG000|Overall Study|Adverse Event|767|||
124866925|NCT02586025|449135380|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
124866926|NCT02586025|449135379|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
124758154|NCT01076959|448738104|FG000|Overall Study|Lack of Efficacy|849|||
124758155|NCT01076959|448738104|FG000|Overall Study|Non-compliance|274|||
124758156|NCT01076959|448738104|FG000|Overall Study|Lost to Follow-up|241|||
124758157|NCT01076959|448738104|FG000|Overall Study|Other|119|||
124758158|NCT01078441|448738105|FG000|Overall Study|Withdrawal by Subject|1|||
124758159|NCT01425801|448738106|FG000|Period 1|Withdrawal by Subject|0|||
124866927|NCT02586025|449135380|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
124866928|NCT04205630|449135381|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
124866929|NCT04205630|449135381|FG000|Overall Study|Disease clinical progression|7|||
124866930|NCT04205630|449135381|FG000|Overall Study|Withdrawal by Subject|2|||
124866931|NCT04205630|449135381|FG000|Overall Study|Adverse Event|17|||
124866932|NCT04205630|449135381|FG000|Overall Study|Other|1|||
124866933|NCT01618162|449135382|FG000|Overall Study|Protocol Violation|13|||
124866934|NCT01618162|449135383|FG001|Overall Study|Protocol Violation|10|||
124866935|NCT01618162|449135382|FG000|Overall Study|Adverse Event|9|||
124866936|NCT01618162|449135383|FG001|Overall Study|Adverse Event|2|||
124866937|NCT01618162|449135382|FG000|Overall Study|Withdrawal Criteria|2|||
124866938|NCT01618162|449135383|FG001|Overall Study|Withdrawal Criteria|10|||
124866939|NCT01618162|449135382|FG000|Overall Study|Unclassified|14|||
124866940|NCT01618162|449135383|FG001|Overall Study|Unclassified|13|||
124866941|NCT04124926|449135384|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
124866942|NCT04124926|449135385|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
124866943|NCT04124926|449135386|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
124866944|NCT04124926|449135387|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
124758160|NCT01425801|448738107|FG001|Period 1|Withdrawal by Subject|0|||
124758161|NCT01425801|448738108|FG002|Period 1|Withdrawal by Subject|0|||
124758162|NCT01425801|448738109|FG003|Period 1|Withdrawal by Subject|0|||
124758163|NCT01425801|448738110|FG004|Period 1|Withdrawal by Subject|1|||
124758164|NCT01425801|448738111|FG005|Period 1|Withdrawal by Subject|0|||
124758165|NCT01425801|448738106|FG000|Period 2|Withdrawal by Subject|0|||
124758166|NCT01425801|448738107|FG001|Period 2|Withdrawal by Subject|0|||
124758167|NCT01425801|448738108|FG002|Period 2|Withdrawal by Subject|0|||
124758168|NCT01425801|448738109|FG003|Period 2|Withdrawal by Subject|0|||
124758169|NCT01425801|448738110|FG004|Period 2|Withdrawal by Subject|1|||
124758170|NCT01425801|448738111|FG005|Period 2|Withdrawal by Subject|0|||
124758171|NCT01425801|448738106|FG000|Period 3|Stability criteria not fullfilled|0|||
124758172|NCT01425801|448738107|FG001|Period 3|Stability criteria not fullfilled|0|||
124758173|NCT01425801|448738108|FG002|Period 3|Stability criteria not fullfilled|1|||
124758174|NCT01425801|448738109|FG003|Period 3|Stability criteria not fullfilled|0|||
124758175|NCT01425801|448738110|FG004|Period 3|Stability criteria not fullfilled|0|||
124758176|NCT01425801|448738111|FG005|Period 3|Stability criteria not fullfilled|0|||
124758177|NCT01425801|448738106|FG000|Period 4|Not able to maintain visit schedule|0|||
124758178|NCT01425801|448738107|FG001|Period 4|Not able to maintain visit schedule|0|||
124866945|NCT04124926|449135388|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
124866946|NCT04124926|449135384|FG000|Healing Phase|Protocol Violation|0|||
124866947|NCT04124926|449135385|FG001|Healing Phase|Protocol Violation|1|||
124758179|NCT01425801|448738108|FG002|Period 4|Not able to maintain visit schedule|1|||
124758180|NCT01425801|448738109|FG003|Period 4|Not able to maintain visit schedule|0|||
124758181|NCT01425801|448738110|FG004|Period 4|Not able to maintain visit schedule|0|||
124758182|NCT01425801|448738111|FG005|Period 4|Not able to maintain visit schedule|0|||
124758183|NCT02868554|448738112|FG000|Overall Study|Lost to Follow-up|3|||
124758184|NCT02868554|448738113|FG001|Overall Study|Lost to Follow-up|0|||
124758185|NCT02868554|448738114|FG002|Overall Study|Lost to Follow-up|1|||
124758186|NCT02175017|448738115|FG000|Overall Study|Did not receive the investigational product|1|||
124758187|NCT02175017|448738116|FG001|Overall Study|Did not receive the investigational product|2|||
124758188|NCT02175017|448738115|FG000|Overall Study|Withdrawal by Subject|6|||
124758189|NCT02175017|448738116|FG001|Overall Study|Withdrawal by Subject|3|||
124758190|NCT02175017|448738115|FG000|Overall Study|Met an exclusion criteria|0|||
124758191|NCT02175017|448738116|FG001|Overall Study|Met an exclusion criteria|1|||
124758192|NCT02175017|448738115|FG000|Overall Study|Adverse Event|3|||
124758193|NCT02175017|448738116|FG001|Overall Study|Adverse Event|10|||
124758194|NCT02175017|448738115|FG000|Overall Study|Disease progression|20|||
124758195|NCT02175017|448738116|FG001|Overall Study|Disease progression|27|||
124758196|NCT02175017|448738115|FG000|Overall Study|Other than above reasons|3|||
124758197|NCT02175017|448738116|FG001|Overall Study|Other than above reasons|0|||
124758198|NCT04915729|448738117|FG000|Overall Study|Lost to Follow-up|20|||
124758199|NCT04915729|448738118|FG001|Overall Study|Lost to Follow-up|10|||
124758200|NCT04915729|448738117|FG000|Overall Study|Withdrawal by Subject|12|||
124758201|NCT04915729|448738118|FG001|Overall Study|Withdrawal by Subject|5|||
124758202|NCT04915729|448738117|FG000|Overall Study|Death|34|||
124758203|NCT04915729|448738118|FG001|Overall Study|Death|44|||
124758204|NCT04915729|448738117|FG000|Overall Study|not treated|3|||
124758205|NCT04915729|448738118|FG001|Overall Study|not treated|6|||
124758206|NCT04915729|448738117|FG000|Overall Study|Investigator removed subject|1|||
124758207|NCT04915729|448738118|FG001|Overall Study|Investigator removed subject|2|||
124758208|NCT04915729|448738117|FG000|Overall Study|questionnaire result not evaluated|1|||
124866948|NCT04124926|449135386|FG002|Healing Phase|Protocol Violation|0|||
124866949|NCT04124926|449135387|FG003|Healing Phase|Protocol Violation|0|||
124866950|NCT04124926|449135388|FG004|Healing Phase|Protocol Violation|0|||
124866951|NCT04124926|449135384|FG000|Healing Phase|Lost to Follow-up|5|||
124866952|NCT04124926|449135385|FG001|Healing Phase|Lost to Follow-up|4|||
124866953|NCT04124926|449135386|FG002|Healing Phase|Lost to Follow-up|0|||
124758209|NCT04915729|448738118|FG001|Overall Study|questionnaire result not evaluated|0|||
124758210|NCT04915729|448738117|FG000|Overall Study|refuse of hospital visit|1|||
124758211|NCT04915729|448738118|FG001|Overall Study|refuse of hospital visit|3|||
124758212|NCT04915729|448738117|FG000|Overall Study|Subject withdrew|1|||
124758213|NCT04915729|448738118|FG001|Overall Study|Subject withdrew|0|||
124758214|NCT02294058|448738126|FG000|Overall Study|Adverse Event|16|||
124758215|NCT02294058|448738127|FG001|Overall Study|Adverse Event|7|||
124758216|NCT02294058|448738128|FG002|Overall Study|Adverse Event|13|||
124758217|NCT02294058|448738126|FG000|Overall Study|Lack of Efficacy|3|||
124758218|NCT02294058|448738127|FG001|Overall Study|Lack of Efficacy|3|||
124758219|NCT02294058|448738128|FG002|Overall Study|Lack of Efficacy|0|||
124758220|NCT02294058|448738126|FG000|Overall Study|Lost to Follow-up|1|||
124758221|NCT02294058|448738127|FG001|Overall Study|Lost to Follow-up|0|||
124758222|NCT02294058|448738128|FG002|Overall Study|Lost to Follow-up|2|||
124758223|NCT02294058|448738126|FG000|Overall Study|Withdrawal by Subject|10|||
124758224|NCT02294058|448738127|FG001|Overall Study|Withdrawal by Subject|14|||
124758225|NCT02294058|448738128|FG002|Overall Study|Withdrawal by Subject|13|||
124758226|NCT02294058|448738126|FG000|Overall Study|Physician Decision|2|||
124758227|NCT02294058|448738127|FG001|Overall Study|Physician Decision|1|||
124758228|NCT02294058|448738128|FG002|Overall Study|Physician Decision|0|||
124758229|NCT02294058|448738126|FG000|Overall Study|Miscellaneous|4|||
124758230|NCT02294058|448738127|FG001|Overall Study|Miscellaneous|1|||
124866954|NCT04124926|449135387|FG003|Healing Phase|Lost to Follow-up|0|||
124866955|NCT04124926|449135388|FG004|Healing Phase|Lost to Follow-up|0|||
124866956|NCT04124926|449135384|FG000|Healing Phase|Voluntary Withdrawal|10|||
124866957|NCT04124926|449135385|FG001|Healing Phase|Voluntary Withdrawal|7|||
124866958|NCT04124926|449135386|FG002|Healing Phase|Voluntary Withdrawal|0|||
124866959|NCT04124926|449135387|FG003|Healing Phase|Voluntary Withdrawal|0|||
124866960|NCT04124926|449135388|FG004|Healing Phase|Voluntary Withdrawal|0|||
124866961|NCT04124926|449135384|FG000|Healing Phase|Withdrawal of Consent|5|||
124866962|NCT04124926|449135385|FG001|Healing Phase|Withdrawal of Consent|3|||
124866963|NCT04124926|449135386|FG002|Healing Phase|Withdrawal of Consent|0|||
124866964|NCT04124926|449135387|FG003|Healing Phase|Withdrawal of Consent|0|||
124866965|NCT04124926|449135388|FG004|Healing Phase|Withdrawal of Consent|0|||
124866966|NCT04124926|449135384|FG000|Healing Phase|Miscellaneous|8|||
124866967|NCT04124926|449135385|FG001|Healing Phase|Miscellaneous|7|||
124866968|NCT04124926|449135386|FG002|Healing Phase|Miscellaneous|0|||
124866969|NCT04124926|449135387|FG003|Healing Phase|Miscellaneous|0|||
124866970|NCT04124926|449135388|FG004|Healing Phase|Miscellaneous|0|||
124866971|NCT04124926|449135384|FG000|Healing Phase|Randomized but not Treated|0|||
124866972|NCT04124926|449135385|FG001|Healing Phase|Randomized but not Treated|3|||
124866973|NCT04124926|449135386|FG002|Healing Phase|Randomized but not Treated|0|||
124866974|NCT04124926|449135387|FG003|Healing Phase|Randomized but not Treated|0|||
124866975|NCT04124926|449135388|FG004|Healing Phase|Randomized but not Treated|0|||
124866976|NCT04124926|449135384|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
124866977|NCT04124926|449135385|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
124866978|NCT04124926|449135386|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
124866979|NCT04124926|449135387|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
124866980|NCT04124926|449135388|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
124866981|NCT04124926|449135384|FG000|Maintenance Phase|Protocol Violation|0|||
124866982|NCT04124926|449135385|FG001|Maintenance Phase|Protocol Violation|0|||
124866983|NCT04124926|449135386|FG002|Maintenance Phase|Protocol Violation|3|||
124866984|NCT04124926|449135387|FG003|Maintenance Phase|Protocol Violation|0|||
124866985|NCT04124926|449135388|FG004|Maintenance Phase|Protocol Violation|0|||
124866986|NCT04124926|449135384|FG000|Maintenance Phase|Lost to Follow-up|0|||
124866987|NCT04124926|449135385|FG001|Maintenance Phase|Lost to Follow-up|0|||
124866988|NCT04124926|449135386|FG002|Maintenance Phase|Lost to Follow-up|7|||
124866989|NCT04124926|449135387|FG003|Maintenance Phase|Lost to Follow-up|8|||
124866990|NCT04124926|449135388|FG004|Maintenance Phase|Lost to Follow-up|9|||
124866991|NCT04124926|449135384|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
124866992|NCT04124926|449135385|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
124866993|NCT04124926|449135386|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
124866994|NCT04124926|449135387|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
124866995|NCT04124926|449135388|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
124866996|NCT04124926|449135384|FG000|Maintenance Phase|Pregnancy|0|||
124866997|NCT04124926|449135385|FG001|Maintenance Phase|Pregnancy|0|||
124866998|NCT04124926|449135386|FG002|Maintenance Phase|Pregnancy|0|||
124866999|NCT04124926|449135387|FG003|Maintenance Phase|Pregnancy|1|||
124867000|NCT04124926|449135388|FG004|Maintenance Phase|Pregnancy|0|||
124867001|NCT04124926|449135384|FG000|Maintenance Phase|Lack of Efficacy|0|||
124867002|NCT04124926|449135385|FG001|Maintenance Phase|Lack of Efficacy|0|||
124867003|NCT04124926|449135386|FG002|Maintenance Phase|Lack of Efficacy|0|||
124867004|NCT04124926|449135387|FG003|Maintenance Phase|Lack of Efficacy|0|||
124867005|NCT04124926|449135388|FG004|Maintenance Phase|Lack of Efficacy|1|||
124867006|NCT04124926|449135384|FG000|Maintenance Phase|Withdrawal of Consent|0|||
124867007|NCT04124926|449135385|FG001|Maintenance Phase|Withdrawal of Consent|0|||
124867008|NCT04124926|449135386|FG002|Maintenance Phase|Withdrawal of Consent|5|||
124867009|NCT04124926|449135387|FG003|Maintenance Phase|Withdrawal of Consent|5|||
124867010|NCT04124926|449135388|FG004|Maintenance Phase|Withdrawal of Consent|5|||
124867011|NCT04124926|449135384|FG000|Maintenance Phase|Miscellaneous|0|||
124867012|NCT04124926|449135385|FG001|Maintenance Phase|Miscellaneous|0|||
124867013|NCT04124926|449135386|FG002|Maintenance Phase|Miscellaneous|1|||
124867014|NCT04124926|449135387|FG003|Maintenance Phase|Miscellaneous|2|||
124867015|NCT04124926|449135388|FG004|Maintenance Phase|Miscellaneous|4|||
124867016|NCT04124926|449135384|FG000|Maintenance Phase|Randomized but not Treated|0|||
124867017|NCT04124926|449135385|FG001|Maintenance Phase|Randomized but not Treated|0|||
124867018|NCT04124926|449135386|FG002|Maintenance Phase|Randomized but not Treated|2|||
124867019|NCT04124926|449135387|FG003|Maintenance Phase|Randomized but not Treated|2|||
124867020|NCT04124926|449135388|FG004|Maintenance Phase|Randomized but not Treated|0|||
124867021|NCT00911534|449135393|FG000|Overall Study|Adverse Event|4|||
124867022|NCT00911534|449135394|FG001|Overall Study|Adverse Event|4|||
124867023|NCT00911534|449135393|FG000|Overall Study|Lost to Follow-up|2|||
124867024|NCT00911534|449135394|FG001|Overall Study|Lost to Follow-up|4|||
124867025|NCT00911534|449135393|FG000|Overall Study|Withdrawal by Subject|2|||
124867026|NCT00911534|449135394|FG001|Overall Study|Withdrawal by Subject|1|||
124867027|NCT00911534|449135393|FG000|Overall Study|Lack of Efficacy|4|||
124867028|NCT00911534|449135394|FG001|Overall Study|Lack of Efficacy|1|||
124867029|NCT00911534|449135393|FG000|Overall Study|Withdrawal of consent|1|||
124867030|NCT00911534|449135394|FG001|Overall Study|Withdrawal of consent|4|||
124867031|NCT00911534|449135393|FG000|Overall Study|Other|2|||
124867032|NCT00911534|449135394|FG001|Overall Study|Other|2|||
124867033|NCT03152526|449135395|FG000|Overall Study|Withdrawal by Subject|0|||
124867034|NCT03152526|449135396|FG001|Overall Study|Withdrawal by Subject|1|||
124867035|NCT04867369|449135397|FG000|Overall Study|Withdrawal by Subject|1|||
124867036|NCT04867369|449135398|FG001|Overall Study|Withdrawal by Subject|0|||
124867037|NCT04435366|449135399|FG000|Year 1 (12 Months)|Adverse Event|3|||
124867038|NCT04435366|449135400|FG001|Year 1 (12 Months)|Adverse Event|0|||
124867039|NCT04435366|449135401|FG002|Year 1 (12 Months)|Adverse Event|2|||
124867040|NCT04435366|449135399|FG000|Year 1 (12 Months)|Death|2|||
124867041|NCT04435366|449135400|FG001|Year 1 (12 Months)|Death|0|||
124867042|NCT04435366|449135401|FG002|Year 1 (12 Months)|Death|1|||
124867043|NCT04435366|449135399|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
124867044|NCT04435366|449135400|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
124867045|NCT04435366|449135401|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
124867046|NCT04435366|449135399|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
124867047|NCT04435366|449135400|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
124867048|NCT04435366|449135401|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
124867049|NCT04435366|449135399|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
124867050|NCT04435366|449135400|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
124867051|NCT04435366|449135401|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
124867052|NCT04435366|449135399|FG000|Year 1 (12 Months)|Not treated|0|||
124867053|NCT04435366|449135400|FG001|Year 1 (12 Months)|Not treated|0|||
124867054|NCT04435366|449135401|FG002|Year 1 (12 Months)|Not treated|1|||
124867055|NCT04435366|449135399|FG000|Year 2 (12 Months)|Death|1|||
124867056|NCT04435366|449135400|FG001|Year 2 (12 Months)|Death|4|||
124867057|NCT04435366|449135401|FG002|Year 2 (12 Months)|Death|6|||
124867058|NCT04435366|449135399|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
124867059|NCT04435366|449135400|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
124867060|NCT04435366|449135401|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
124867061|NCT04435366|449135399|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
124867062|NCT04435366|449135400|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
124867063|NCT04435366|449135401|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
124867064|NCT04435366|449135399|FG000|Year 2 (12 Months)|Adverse Event|2|||
124867065|NCT04435366|449135400|FG001|Year 2 (12 Months)|Adverse Event|1|||
124867066|NCT04435366|449135401|FG002|Year 2 (12 Months)|Adverse Event|6|||
124867067|NCT05711641|449135402|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
124867068|NCT05711641|449135403|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
124867069|NCT05711641|449135402|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
124978482|NCT03829501|449548500|FG012|Overall Study|PD|0|||
124978483|NCT03829501|449548501|FG013|Overall Study|PD|0|||
124867070|NCT05711641|449135403|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
124867071|NCT02477111|449135404|FG000|Overall Study|Death|28|||
124867072|NCT02477111|449135404|FG000|Overall Study|Withdrawal by Subject|19|||
124867073|NCT02477111|449135404|FG000|Overall Study|Lost to Follow-up|4|||
124867074|NCT00162370|449135406|FG000|Efficacy Population|Lost to Follow-up|51|||
124867075|NCT03896035|449135410|FG000|Overall Study|Lost to Follow-up|2|||
124758231|NCT02294058|448738128|FG002|Overall Study|Miscellaneous|1|||
124758232|NCT03575403|448738130|FG000|Overall Study|Adverse Event|1|||
124867076|NCT03896035|449135411|FG001|Overall Study|Lost to Follow-up|6|||
124867077|NCT03896035|449135410|FG000|Overall Study|Withdrawal by Subject|0|||
124867078|NCT03896035|449135411|FG001|Overall Study|Withdrawal by Subject|1|||
124867079|NCT03896035|449135410|FG000|Overall Study|Health/family health issues during COVID|0|||
124867080|NCT03896035|449135411|FG001|Overall Study|Health/family health issues during COVID|4|||
124867081|NCT03492281|449135412|FG000|Overall Study|Withdrawal by Subject|21|||
124867082|NCT03492281|449135413|FG001|Overall Study|Withdrawal by Subject|14|||
124867083|NCT03492281|449135414|FG002|Overall Study|Withdrawal by Subject|13|||
124867084|NCT03492281|449135412|FG000|Overall Study|Lost to Follow-up|14|||
124758233|NCT03575403|448738131|FG001|Overall Study|Adverse Event|0|||
124758234|NCT03575403|448738132|FG002|Overall Study|Adverse Event|0|||
124758235|NCT03575403|448738130|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
124758236|NCT03575403|448738131|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
124758237|NCT03575403|448738132|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
124758238|NCT02330055|448738133|FG000|Overall Study|technical issues|2|||
124758239|NCT02330055|448738134|FG001|Overall Study|technical issues|0|||
124758240|NCT02330055|448738133|FG000|Overall Study|participant forgot to wear device|5|||
124758241|NCT02330055|448738134|FG001|Overall Study|participant forgot to wear device|5|||
124758242|NCT02330055|448738133|FG000|Overall Study|data for less than 60 minutes|3|||
124758243|NCT02330055|448738134|FG001|Overall Study|data for less than 60 minutes|3|||
124758244|NCT02330055|448738133|FG000|Overall Study|participant did not sleep|0|||
124758245|NCT02330055|448738134|FG001|Overall Study|participant did not sleep|1|||
124758246|NCT03359174|448738137|FG000|Overall Study|Adverse Event|1|||
124758247|NCT01332994|448738141|FG000|Overall Study|Adverse Event|34|||
124758248|NCT01332994|448738141|FG000|Overall Study|Death|1|||
124758249|NCT01332994|448738141|FG000|Overall Study|Lack of Efficacy|1|||
124758250|NCT01332994|448738141|FG000|Overall Study|Lost to Follow-up|4|||
124758251|NCT01332994|448738141|FG000|Overall Study|Protocol Violation|6|||
124758252|NCT01332994|448738141|FG000|Overall Study|Withdrawal by Subject|15|||
124758253|NCT01332994|448738141|FG000|Overall Study|Administrative Problem|2|||
124758254|NCT01332994|448738141|FG000|Overall Study|Other|8|||
124758255|NCT02800863|448738142|FG000|Overall Study|Adverse Event|14|||
124758256|NCT02800863|448738142|FG000|Overall Study|Another Device Implanted|1|||
124758257|NCT02800863|448738142|FG000|Overall Study|Device Explanted|1|||
124758258|NCT02800863|448738142|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
124758259|NCT02800863|448738142|FG000|Overall Study|Health Issues|1|||
124758260|NCT02800863|448738142|FG000|Overall Study|Insurance Denial|8|||
124758261|NCT02800863|448738142|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
124758262|NCT02800863|448738142|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
124758263|NCT02800863|448738142|FG000|Overall Study|Screen Failure|1|||
124758264|NCT02800863|448738142|FG000|Overall Study|Sponsor Request|6|||
124758265|NCT02800863|448738142|FG000|Overall Study|Death|3|||
124758266|NCT02800863|448738142|FG000|Overall Study|Subject Implant at Another Facility|1|||
124758267|NCT02800863|448738142|FG000|Overall Study|Lost to Follow-up|26|||
124758268|NCT02800863|448738142|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
124758269|NCT02800863|448738142|FG000|Overall Study|Subject and/or Family Request|64|||
124758270|NCT02800863|448738142|FG000|Overall Study|Trial Failure|81|||
124758271|NCT02800863|448738142|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
124758272|NCT00279916|448738143|FG000|Overall Study|Withdrawal by Subject|4|||
124758273|NCT00279916|448738144|FG001|Overall Study|Withdrawal by Subject|3|||
124758274|NCT00279916|448738143|FG000|Overall Study|Lost to Follow-up|3|||
124758275|NCT00279916|448738144|FG001|Overall Study|Lost to Follow-up|2|||
124758276|NCT01807598|448738145|FG000|Overall Study|Withdrawal by Subject|4|||
124758277|NCT01807598|448738145|FG000|Overall Study|Adverse Event|1|||
124758278|NCT01807598|448738145|FG000|Overall Study|Other Physician Decision|1|||
124758279|NCT02717494|448738147|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
124758280|NCT02717494|448738148|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
124758281|NCT02717494|448738149|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
124758282|NCT02717494|448738147|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
124867085|NCT03492281|449135413|FG001|Overall Study|Lost to Follow-up|15|||
124867086|NCT03492281|449135414|FG002|Overall Study|Lost to Follow-up|10|||
124867087|NCT03492281|449135412|FG000|Overall Study|Adverse Event|6|||
124758283|NCT02717494|448738148|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
124758284|NCT02717494|448738149|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
124758285|NCT02717494|448738147|FG000|First Intervention (Step 1)|Death|0|||
124758286|NCT02717494|448738148|FG001|First Intervention (Step 1)|Death|0|||
124758287|NCT02717494|448738149|FG002|First Intervention (Step 1)|Death|1|||
124758288|NCT02717494|448738147|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
124758289|NCT02717494|448738148|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
124758290|NCT02717494|448738149|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
124758291|NCT00731679|448738154|FG000|Overall Study|Adverse Event|7|||
124758292|NCT00731679|448738155|FG001|Overall Study|Adverse Event|8|||
124758293|NCT00731679|448738154|FG000|Overall Study|Withdrawal by Subject|8|||
124758294|NCT00731679|448738155|FG001|Overall Study|Withdrawal by Subject|8|||
124758295|NCT00731679|448738154|FG000|Overall Study|Lost to Follow-up|7|||
124758296|NCT00731679|448738155|FG001|Overall Study|Lost to Follow-up|8|||
124758297|NCT00731679|448738154|FG000|Overall Study|Noncompliance|0|||
124758298|NCT00731679|448738155|FG001|Overall Study|Noncompliance|1|||
124758299|NCT00731679|448738154|FG000|Overall Study|Pregnancy|0|||
124758300|NCT00731679|448738155|FG001|Overall Study|Pregnancy|1|||
124758301|NCT02488005|448738156|FG000|Overall Study|Lost to Follow-up|2|||
124758302|NCT02326597|448738159|FG000|Overall Study|Lost to Follow-up|42|||
124758303|NCT02326597|448738160|FG001|Overall Study|Lost to Follow-up|32|||
124758304|NCT04089761|448738163|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
124758305|NCT04089761|448738163|FG000|"Run In Phase"|Lost to Follow-up|1|||
124758306|NCT04089761|448738163|FG000|"Treatment Phase"|No evaluable data|5|||
124758307|NCT04089761|448738163|FG000|"Treatment Phase"|Lost to Follow-up|1|||
124758308|NCT04739436|448738165|FG000|Overall Study|Lost to Follow-up|21|||
124758309|NCT04739436|448738166|FG001|Overall Study|Lost to Follow-up|23|||
124758310|NCT04739436|448738165|FG000|Overall Study|Withdrawal by Subject|4|||
124758311|NCT04739436|448738166|FG001|Overall Study|Withdrawal by Subject|6|||
124758312|NCT04739436|448738165|FG000|Overall Study|not randomized properly|1|||
124758313|NCT04739436|448738166|FG001|Overall Study|not randomized properly|0|||
124758314|NCT00428948|448738168|FG000|Overall Study|Lost to Follow-up|15|||
124758315|NCT00428948|448738169|FG001|Overall Study|Lost to Follow-up|8|||
124758316|NCT00428948|448738168|FG000|Overall Study|Adverse Event|148|||
124758317|NCT00428948|448738169|FG001|Overall Study|Adverse Event|24|||
124758318|NCT00428948|448738168|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
124758319|NCT00428948|448738169|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
124758320|NCT00428948|448738168|FG000|Overall Study|Investigator Withdrew Subject|3|||
124758321|NCT00428948|448738169|FG001|Overall Study|Investigator Withdrew Subject|4|||
124758322|NCT00428948|448738168|FG000|Overall Study|Subject Withdrew Consent|50|||
124758323|NCT00428948|448738169|FG001|Overall Study|Subject Withdrew Consent|30|||
124758324|NCT00428948|448738168|FG000|Overall Study|Protocol Deviation|1|||
124758325|NCT00428948|448738169|FG001|Overall Study|Protocol Deviation|1|||
124758326|NCT03449758|448739707|FG000|Overall Study|Major protocol deviation|1|||
124758327|NCT03449758|448739707|FG000|Overall Study|Treatment inefficacy|5|||
124758328|NCT03449758|448739707|FG000|Overall Study|Adverse Event|9|||
124758329|NCT03449758|448739707|FG000|Overall Study|Consent withdrawal|1|||
124758330|NCT03449758|448739707|FG000|Overall Study|Other unspecified reason|3|||
124758331|NCT00922623|448739711|FG000|Overall Study|Other|4|||
124758332|NCT00922623|448739711|FG000|Overall Study|Lost to Follow-up|1|||
124758333|NCT01402817|448739712|FG000|Overall Study|Withdrawal by Subject|3|||
124758334|NCT01402817|448739712|FG000|Overall Study|Study Suspended by FDA|8|||
124758335|NCT03310723|448739714|FG000|Overall Study|Withdrawal by Subject|0|||
124758336|NCT03310723|448739715|FG001|Overall Study|Withdrawal by Subject|1|||
124758337|NCT03310723|448739714|FG000|Overall Study|Protocol Violation|0|||
124867088|NCT03492281|449135413|FG001|Overall Study|Adverse Event|8|||
124867089|NCT03492281|449135414|FG002|Overall Study|Adverse Event|13|||
124867090|NCT03492281|449135412|FG000|Overall Study|Lack of Efficacy|3|||
124867091|NCT03492281|449135413|FG001|Overall Study|Lack of Efficacy|0|||
124867092|NCT03492281|449135414|FG002|Overall Study|Lack of Efficacy|1|||
124867093|NCT03492281|449135412|FG000|Overall Study|Physician Decision|1|||
124867094|NCT03492281|449135413|FG001|Overall Study|Physician Decision|0|||
124867095|NCT03492281|449135414|FG002|Overall Study|Physician Decision|3|||
124867096|NCT03492281|449135412|FG000|Overall Study|Protocol Violation|0|||
124867097|NCT03492281|449135413|FG001|Overall Study|Protocol Violation|2|||
124867098|NCT03492281|449135414|FG002|Overall Study|Protocol Violation|1|||
124867099|NCT03492281|449135412|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
124867100|NCT03492281|449135413|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
124758338|NCT03310723|448739715|FG001|Overall Study|Protocol Violation|2|||
124758339|NCT01410890|448739716|FG000|Overall Study|Withdrawal by Subject|0|||
124758340|NCT01410890|448739717|FG001|Overall Study|Withdrawal by Subject|1|||
124758341|NCT01121146|448739718|FG000|Overall Study|Death|17|||
124758342|NCT01121146|448739719|FG001|Overall Study|Death|15|||
124867101|NCT03492281|449135414|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
124867102|NCT03492281|449135412|FG000|Overall Study|Death|0|||
124867103|NCT03492281|449135413|FG001|Overall Study|Death|0|||
124867104|NCT03492281|449135414|FG002|Overall Study|Death|1|||
124867105|NCT03492281|449135412|FG000|Overall Study|Captured as Other in Database|8|||
124867106|NCT03492281|449135413|FG001|Overall Study|Captured as Other in Database|6|||
124867107|NCT03492281|449135414|FG002|Overall Study|Captured as Other in Database|3|||
124867108|NCT01506193|449135415|FG000|Overall Study|Protocol Violation|1|||
124867109|NCT01506193|449135416|FG001|Overall Study|Protocol Violation|0|||
124867110|NCT01506193|449135417|FG002|Overall Study|Protocol Violation|1|||
124867111|NCT01506193|449135415|FG000|Overall Study|Migrated/moved from study area|0|||
124867112|NCT01506193|449135416|FG001|Overall Study|Migrated/moved from study area|0|||
124867113|NCT01506193|449135417|FG002|Overall Study|Migrated/moved from study area|1|||
124867114|NCT01506193|449135415|FG000|Overall Study|Adverse event, non-fatal|0|||
124867115|NCT01506193|449135416|FG001|Overall Study|Adverse event, non-fatal|0|||
124867116|NCT01506193|449135417|FG002|Overall Study|Adverse event, non-fatal|1|||
124867117|NCT01506193|449135415|FG000|Overall Study|Withdrawal by Subject|5|||
124867118|NCT01506193|449135416|FG001|Overall Study|Withdrawal by Subject|1|||
124867119|NCT01506193|449135417|FG002|Overall Study|Withdrawal by Subject|8|||
124867120|NCT01506193|449135415|FG000|Overall Study|Lost to Follow-up|8|||
124867121|NCT01506193|449135416|FG001|Overall Study|Lost to Follow-up|3|||
124867122|NCT01506193|449135417|FG002|Overall Study|Lost to Follow-up|3|||
124867123|NCT00743366|449135418|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
124867124|NCT00743366|449135419|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
124867125|NCT03206203|449135420|FG000|Treatment|Death|38|||
124867126|NCT03206203|449135421|FG001|Treatment|Death|26|||
124867127|NCT03206203|449135422|FG002|Treatment|Death|0|||
124867128|NCT03206203|449135420|FG000|Treatment|Withdrawal by Subject|1|||
124867129|NCT03206203|449135421|FG001|Treatment|Withdrawal by Subject|0|||
124867130|NCT03206203|449135422|FG002|Treatment|Withdrawal by Subject|0|||
124867131|NCT03206203|449135420|FG000|Treatment|Lost to Follow-up|4|||
124867132|NCT03206203|449135421|FG001|Treatment|Lost to Follow-up|0|||
124867133|NCT03206203|449135422|FG002|Treatment|Lost to Follow-up|0|||
124867134|NCT03206203|449135420|FG000|Treatment|N/A in Follow-Up|8|||
124867135|NCT03206203|449135421|FG001|Treatment|N/A in Follow-Up|1|||
124867136|NCT03206203|449135422|FG002|Treatment|N/A in Follow-Up|0|||
124867137|NCT03206203|449135420|FG000|Treatment|Disease progression|0|||
124867138|NCT03206203|449135421|FG001|Treatment|Disease progression|1|||
124867139|NCT03206203|449135422|FG002|Treatment|Disease progression|0|||
124867140|NCT03206203|449135420|FG000|Treatment|Refused follow-up|0|||
124867141|NCT03206203|449135421|FG001|Treatment|Refused follow-up|1|||
124867142|NCT03206203|449135422|FG002|Treatment|Refused follow-up|0|||
124867143|NCT03206203|449135420|FG000|Treatment|Cross over to Arm 1|0|||
124867144|NCT03206203|449135421|FG001|Treatment|Cross over to Arm 1|19|||
124867145|NCT03206203|449135422|FG002|Treatment|Cross over to Arm 1|0|||
124867146|NCT03206203|449135420|FG000|Optional Cross-Over|Death|0|||
124867147|NCT03206203|449135421|FG001|Optional Cross-Over|Death|0|||
124867148|NCT03206203|449135422|FG002|Optional Cross-Over|Death|14|||
124867149|NCT03206203|449135420|FG000|Optional Cross-Over|Refused follow-up|0|||
124867150|NCT03206203|449135421|FG001|Optional Cross-Over|Refused follow-up|0|||
124867151|NCT03206203|449135422|FG002|Optional Cross-Over|Refused follow-up|2|||
124867152|NCT00335322|449135423|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
124867153|NCT00335322|449135424|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
124867154|NCT00335322|449135425|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
124867155|NCT01152580|449135426|FG000|Overall Study|Withdrawal by Subject|0|||
124867156|NCT01152580|449135427|FG001|Overall Study|Withdrawal by Subject|1|||
124867157|NCT03364751|449135430|FG000|Overall Study|Withdrawal by Subject|1|||
124867158|NCT03364751|449135431|FG001|Overall Study|Withdrawal by Subject|0|||
124867159|NCT03364751|449135432|FG002|Overall Study|Withdrawal by Subject|0|||
124867160|NCT03364751|449135433|FG003|Overall Study|Withdrawal by Subject|0|||
124867161|NCT03364751|449135430|FG000|Overall Study|Lost to Follow-up|0|||
124867162|NCT03364751|449135431|FG001|Overall Study|Lost to Follow-up|1|||
124867163|NCT03364751|449135432|FG002|Overall Study|Lost to Follow-up|0|||
124758343|NCT01121146|448739718|FG000|Overall Study|Adverse Event|2|||
124758344|NCT01121146|448739719|FG001|Overall Study|Adverse Event|11|||
124758345|NCT01121146|448739718|FG000|Overall Study|Lost to Follow-up|7|||
124758346|NCT01121146|448739719|FG001|Overall Study|Lost to Follow-up|16|||
124758347|NCT00997035|448739722|FG000|3-week Followup Visit|Lost to Follow-up|9|||
124758348|NCT00997035|448739723|FG001|3-week Followup Visit|Lost to Follow-up|6|||
124758349|NCT00997035|448739722|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
124758350|NCT00997035|448739723|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
124758351|NCT01380769|448739724|FG000|Overall Study|Withdrawal by Subject|7|||
124758352|NCT01380769|448739725|FG001|Overall Study|Withdrawal by Subject|11|||
124758353|NCT01380769|448739724|FG000|Overall Study|Physician Decision|1|||
124758354|NCT01380769|448739725|FG001|Overall Study|Physician Decision|1|||
124758355|NCT01380769|448739724|FG000|Overall Study|Adverse Event|1|||
124758356|NCT01380769|448739725|FG001|Overall Study|Adverse Event|1|||
124758357|NCT01380769|448739724|FG000|Overall Study|Protocol Violation|0|||
124758358|NCT01380769|448739725|FG001|Overall Study|Protocol Violation|1|||
124758359|NCT02640547|448739726|FG000|Overall Study|Failure to Return|1|||
124867164|NCT03364751|449135433|FG003|Overall Study|Lost to Follow-up|0|||
124867165|NCT00675766|449135434|FG000|Overall Study|Lost to Follow-up|6|||
124758360|NCT02640547|448739726|FG000|Overall Study|Withdrawal by Subject|1|||
124758361|NCT02640547|448739726|FG000|Overall Study|Death|6|||
124758362|NCT02640547|448739726|FG000|Overall Study|Miscellaneous|3|||
124758363|NCT02753946|448739740|FG000|Overall Study|Adverse Event|7|||
124758364|NCT02753946|448739741|FG001|Overall Study|Adverse Event|6|||
124758365|NCT02753946|448739740|FG000|Overall Study|Withdrawal by Subject|6|||
124867166|NCT00675766|449135435|FG001|Overall Study|Lost to Follow-up|5|||
124867167|NCT00675766|449135436|FG002|Overall Study|Lost to Follow-up|21|||
124867168|NCT00675766|449135437|FG003|Overall Study|Lost to Follow-up|26|||
124867169|NCT02275065|449135439|FG000|Overall Study|Randomized but not treated|1|||
124867170|NCT02275065|449135440|FG001|Overall Study|Randomized but not treated|0|||
124867171|NCT02275065|449135441|FG002|Overall Study|Randomized but not treated|1|||
124867172|NCT02275065|449135442|FG003|Overall Study|Randomized but not treated|1|||
124867173|NCT02275065|449135443|FG004|Overall Study|Randomized but not treated|0|||
124867174|NCT03213158|449135444|FG000|Overall Study|Withdrawal by Subject|1|||
124758366|NCT02753946|448739741|FG001|Overall Study|Withdrawal by Subject|1|||
124867175|NCT03213158|449135444|FG000|Overall Study|Physician Decision|2|||
124867176|NCT01777854|449135445|FG000|Overall Study|Physician Decision|3|||
124867177|NCT01777854|449135446|FG001|Overall Study|Physician Decision|3|||
124867178|NCT01239030|449135451|FG000|Double Blind|Adverse Event|0|||
124867179|NCT01239030|449135452|FG001|Double Blind|Adverse Event|1|||
124867180|NCT01239030|449135453|FG002|Double Blind|Adverse Event|0|||
124867181|NCT01239030|449135454|FG003|Double Blind|Adverse Event|2|||
124867182|NCT01239030|449135455|FG004|Double Blind|Adverse Event|0|||
124867183|NCT01239030|449135451|FG000|Double Blind|Withdrawal by Subject|0|||
124867184|NCT01239030|449135452|FG001|Double Blind|Withdrawal by Subject|1|||
124867185|NCT01239030|449135453|FG002|Double Blind|Withdrawal by Subject|1|||
124867186|NCT01239030|449135454|FG003|Double Blind|Withdrawal by Subject|0|||
124867187|NCT01239030|449135455|FG004|Double Blind|Withdrawal by Subject|1|||
124867188|NCT01239030|449135451|FG000|Double Blind|Lost to Follow-up|1|||
124867189|NCT01239030|449135452|FG001|Double Blind|Lost to Follow-up|1|||
124867190|NCT01239030|449135453|FG002|Double Blind|Lost to Follow-up|0|||
124867191|NCT01239030|449135454|FG003|Double Blind|Lost to Follow-up|0|||
124867192|NCT01239030|449135455|FG004|Double Blind|Lost to Follow-up|0|||
124867193|NCT01239030|449135451|FG000|Double Blind|Physician Decision|0|||
124867194|NCT01239030|449135452|FG001|Double Blind|Physician Decision|1|||
124867195|NCT01239030|449135453|FG002|Double Blind|Physician Decision|0|||
124867196|NCT01239030|449135454|FG003|Double Blind|Physician Decision|0|||
124867197|NCT01239030|449135455|FG004|Double Blind|Physician Decision|0|||
124867198|NCT01239030|449135451|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
124867199|NCT01239030|449135452|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
124867200|NCT01239030|449135453|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
124867201|NCT01239030|449135454|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
124867202|NCT01239030|449135455|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
124867203|NCT01239030|449135451|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
124867204|NCT01239030|449135452|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
124867205|NCT01239030|449135453|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
124867206|NCT01239030|449135454|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
124867207|NCT01239030|449135455|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
124867208|NCT01239030|449135451|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
124867209|NCT01239030|449135452|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
124867210|NCT01239030|449135453|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
124867211|NCT01239030|449135454|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
124867212|NCT01239030|449135455|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
124867213|NCT01239030|449135451|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
124867214|NCT01239030|449135452|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
124867215|NCT01239030|449135453|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
124867216|NCT01239030|449135454|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
124758367|NCT02753946|448739740|FG000|Overall Study|Lack of Efficacy|1|||
124758368|NCT02753946|448739741|FG001|Overall Study|Lack of Efficacy|0|||
124758369|NCT02753946|448739740|FG000|Overall Study|Physician Decision|0|||
124758370|NCT02753946|448739741|FG001|Overall Study|Physician Decision|2|||
124758371|NCT02519439|448739742|FG000|Overall Study|Study Termination|19|||
124758372|NCT02519439|448739742|FG000|Overall Study|Withdrawal by Subject|1|||
124758373|NCT02519439|448739742|FG000|Overall Study|Adverse Event|1|||
124758374|NCT01539759|448739747|FG000|Overall Study|Lost to Follow-up|6|||
124758375|NCT01539759|448739748|FG001|Overall Study|Lost to Follow-up|8|||
124758376|NCT03901144|448739749|FG000|Overall Study|Lost to Follow-up|1|||
124758377|NCT03901144|448739750|FG001|Overall Study|Lost to Follow-up|1|||
124758378|NCT03901144|448739751|FG002|Overall Study|Lost to Follow-up|1|||
124758379|NCT03901144|448739752|FG003|Overall Study|Lost to Follow-up|1|||
124758380|NCT02491983|448739753|FG000|Overall Study|Physician Decision|1|||
124758381|NCT02491983|448739754|FG001|Overall Study|Physician Decision|0|||
124758382|NCT02491983|448739753|FG000|Overall Study|Not meet selection criteria|1|||
124758383|NCT02491983|448739754|FG001|Overall Study|Not meet selection criteria|0|||
124758384|NCT02491983|448739753|FG000|Overall Study|Withdrawal by Subject|0|||
124867217|NCT01239030|449135455|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
124867218|NCT03085485|449135463|FG000|Overall Study|Death|1|||
124867219|NCT03085485|449135464|FG001|Overall Study|Death|0|||
124867220|NCT03085485|449135463|FG000|Overall Study|Lost to Follow-up|1|||
124867221|NCT03085485|449135464|FG001|Overall Study|Lost to Follow-up|0|||
124867222|NCT01775904|449135468|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
124867223|NCT01775904|449135468|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
124867224|NCT00518115|449135469|FG000|Overall Study|Adverse Event|6|||
124867225|NCT00518115|449135470|FG001|Overall Study|Adverse Event|1|||
124867226|NCT00518115|449135471|FG002|Overall Study|Adverse Event|5|||
124867227|NCT00518115|449135472|FG003|Overall Study|Adverse Event|6|||
124867228|NCT00518115|449135473|FG004|Overall Study|Adverse Event|5|||
124867229|NCT00518115|449135474|FG005|Overall Study|Adverse Event|5|||
124867230|NCT00518115|449135475|FG006|Overall Study|Adverse Event|5|||
124867231|NCT00518115|449135476|FG007|Overall Study|Adverse Event|10|||
124867232|NCT00518115|449135477|FG008|Overall Study|Adverse Event|2|||
124867233|NCT00518115|449135478|FG009|Overall Study|Adverse Event|9|||
124867234|NCT00518115|449135469|FG000|Overall Study|Lost to Follow-up|0|||
124867235|NCT00518115|449135470|FG001|Overall Study|Lost to Follow-up|0|||
124867236|NCT00518115|449135471|FG002|Overall Study|Lost to Follow-up|2|||
124867237|NCT00518115|449135472|FG003|Overall Study|Lost to Follow-up|3|||
124867238|NCT00518115|449135473|FG004|Overall Study|Lost to Follow-up|1|||
124867239|NCT00518115|449135474|FG005|Overall Study|Lost to Follow-up|3|||
124867240|NCT00518115|449135475|FG006|Overall Study|Lost to Follow-up|0|||
124867241|NCT00518115|449135476|FG007|Overall Study|Lost to Follow-up|1|||
124867242|NCT00518115|449135477|FG008|Overall Study|Lost to Follow-up|1|||
124867243|NCT00518115|449135478|FG009|Overall Study|Lost to Follow-up|1|||
124867244|NCT00518115|449135469|FG000|Overall Study|Protocol Violation|1|||
124867245|NCT00518115|449135470|FG001|Overall Study|Protocol Violation|3|||
124867246|NCT00518115|449135471|FG002|Overall Study|Protocol Violation|1|||
124867247|NCT00518115|449135472|FG003|Overall Study|Protocol Violation|0|||
124867248|NCT00518115|449135473|FG004|Overall Study|Protocol Violation|0|||
124867249|NCT00518115|449135474|FG005|Overall Study|Protocol Violation|0|||
124867250|NCT00518115|449135475|FG006|Overall Study|Protocol Violation|0|||
124867251|NCT00518115|449135476|FG007|Overall Study|Protocol Violation|0|||
124867252|NCT00518115|449135477|FG008|Overall Study|Protocol Violation|0|||
124867253|NCT00518115|449135478|FG009|Overall Study|Protocol Violation|0|||
124867254|NCT00518115|449135469|FG000|Overall Study|Withdrawal by Subject|1|||
124867255|NCT00518115|449135470|FG001|Overall Study|Withdrawal by Subject|1|||
124867256|NCT00518115|449135471|FG002|Overall Study|Withdrawal by Subject|5|||
124867257|NCT00518115|449135472|FG003|Overall Study|Withdrawal by Subject|0|||
124867258|NCT00518115|449135473|FG004|Overall Study|Withdrawal by Subject|2|||
124867259|NCT00518115|449135474|FG005|Overall Study|Withdrawal by Subject|1|||
124867260|NCT00518115|449135475|FG006|Overall Study|Withdrawal by Subject|0|||
124867261|NCT00518115|449135476|FG007|Overall Study|Withdrawal by Subject|2|||
124867262|NCT00518115|449135477|FG008|Overall Study|Withdrawal by Subject|1|||
124867263|NCT00518115|449135478|FG009|Overall Study|Withdrawal by Subject|3|||
124867264|NCT00518115|449135469|FG000|Overall Study|Lack of Efficacy|1|||
124867265|NCT00518115|449135470|FG001|Overall Study|Lack of Efficacy|0|||
124867266|NCT00518115|449135471|FG002|Overall Study|Lack of Efficacy|1|||
124867267|NCT00518115|449135472|FG003|Overall Study|Lack of Efficacy|1|||
124867268|NCT00518115|449135473|FG004|Overall Study|Lack of Efficacy|0|||
124867269|NCT00518115|449135474|FG005|Overall Study|Lack of Efficacy|0|||
124867270|NCT00518115|449135475|FG006|Overall Study|Lack of Efficacy|0|||
124867271|NCT00518115|449135476|FG007|Overall Study|Lack of Efficacy|1|||
124867272|NCT00518115|449135477|FG008|Overall Study|Lack of Efficacy|0|||
124867273|NCT00518115|449135478|FG009|Overall Study|Lack of Efficacy|0|||
124867274|NCT00518115|449135469|FG000|Overall Study|Non-Compliance|1|||
124867275|NCT00518115|449135470|FG001|Overall Study|Non-Compliance|0|||
124867276|NCT00518115|449135471|FG002|Overall Study|Non-Compliance|1|||
124867277|NCT00518115|449135472|FG003|Overall Study|Non-Compliance|0|||
124867278|NCT00518115|449135473|FG004|Overall Study|Non-Compliance|1|||
124867279|NCT00518115|449135474|FG005|Overall Study|Non-Compliance|1|||
124867280|NCT00518115|449135475|FG006|Overall Study|Non-Compliance|1|||
124867281|NCT00518115|449135476|FG007|Overall Study|Non-Compliance|1|||
124867282|NCT00518115|449135477|FG008|Overall Study|Non-Compliance|0|||
124867283|NCT00518115|449135478|FG009|Overall Study|Non-Compliance|1|||
124867284|NCT00518115|449135469|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
124867285|NCT00518115|449135470|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
124867286|NCT00518115|449135471|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
124867287|NCT00518115|449135472|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
124867288|NCT00518115|449135473|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
124867289|NCT00518115|449135474|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
124867290|NCT00518115|449135475|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
124867291|NCT00518115|449135476|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
124867292|NCT00518115|449135477|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
124867293|NCT00518115|449135478|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
124978484|NCT03829501|449548502|FG014|Overall Study|PD|0|||
124867294|NCT00518115|449135469|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
124867295|NCT00518115|449135470|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867296|NCT00518115|449135471|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867297|NCT00518115|449135472|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867298|NCT00518115|449135473|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867299|NCT00518115|449135474|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867300|NCT00518115|449135475|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867301|NCT00518115|449135476|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867302|NCT00518115|449135477|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867303|NCT00518115|449135478|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
124867304|NCT00518115|449135469|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
124867305|NCT00518115|449135470|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
124867306|NCT00518115|449135471|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
124867307|NCT00518115|449135472|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
124867308|NCT00518115|449135473|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
124867309|NCT00518115|449135474|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
124867310|NCT00518115|449135475|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
124867311|NCT00518115|449135476|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
124867312|NCT00518115|449135477|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
124867313|NCT00518115|449135478|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
124867314|NCT00518115|449135469|FG000|Overall Study|Wrong Monotherapy Administered|0|||
124867315|NCT00518115|449135470|FG001|Overall Study|Wrong Monotherapy Administered|0|||
124867316|NCT00518115|449135471|FG002|Overall Study|Wrong Monotherapy Administered|1|||
124867317|NCT00518115|449135472|FG003|Overall Study|Wrong Monotherapy Administered|0|||
124867318|NCT00518115|449135473|FG004|Overall Study|Wrong Monotherapy Administered|0|||
124867319|NCT00518115|449135474|FG005|Overall Study|Wrong Monotherapy Administered|0|||
124867320|NCT00518115|449135475|FG006|Overall Study|Wrong Monotherapy Administered|1|||
124867321|NCT00518115|449135476|FG007|Overall Study|Wrong Monotherapy Administered|0|||
124867322|NCT00518115|449135477|FG008|Overall Study|Wrong Monotherapy Administered|0|||
124644690|NCT03614078|448316488|FG000|Overall Study|Adverse Event|0|||
124867323|NCT00518115|449135478|FG009|Overall Study|Wrong Monotherapy Administered|0|||
124867324|NCT00518115|449135469|FG000|Overall Study|Violation of Exclusion Criteria|0|||
124867325|NCT00518115|449135470|FG001|Overall Study|Violation of Exclusion Criteria|0|||
124867326|NCT00518115|449135471|FG002|Overall Study|Violation of Exclusion Criteria|0|||
124867327|NCT00518115|449135472|FG003|Overall Study|Violation of Exclusion Criteria|1|||
124867328|NCT00518115|449135473|FG004|Overall Study|Violation of Exclusion Criteria|0|||
124867329|NCT00518115|449135474|FG005|Overall Study|Violation of Exclusion Criteria|0|||
124867330|NCT00518115|449135475|FG006|Overall Study|Violation of Exclusion Criteria|1|||
124867331|NCT00518115|449135476|FG007|Overall Study|Violation of Exclusion Criteria|0|||
124867332|NCT00518115|449135477|FG008|Overall Study|Violation of Exclusion Criteria|0|||
124867333|NCT00518115|449135478|FG009|Overall Study|Violation of Exclusion Criteria|0|||
124867334|NCT00518115|449135469|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
124867335|NCT00518115|449135470|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
124867336|NCT00518115|449135471|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
124867337|NCT00518115|449135472|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
124867338|NCT00518115|449135473|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
124867339|NCT00518115|449135474|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
124867340|NCT00518115|449135475|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
124867341|NCT00518115|449135476|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
124867342|NCT00518115|449135477|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
124867343|NCT00518115|449135478|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
124867344|NCT00518115|449135469|FG000|Overall Study|Withdrew Consent|0|||
124867345|NCT00518115|449135470|FG001|Overall Study|Withdrew Consent|0|||
124867346|NCT00518115|449135471|FG002|Overall Study|Withdrew Consent|0|||
124867347|NCT00518115|449135472|FG003|Overall Study|Withdrew Consent|0|||
124867348|NCT00518115|449135473|FG004|Overall Study|Withdrew Consent|0|||
124867349|NCT00518115|449135474|FG005|Overall Study|Withdrew Consent|1|||
124867350|NCT00518115|449135475|FG006|Overall Study|Withdrew Consent|0|||
124867351|NCT00518115|449135476|FG007|Overall Study|Withdrew Consent|0|||
124867352|NCT00518115|449135477|FG008|Overall Study|Withdrew Consent|0|||
124867353|NCT00518115|449135478|FG009|Overall Study|Withdrew Consent|0|||
124867354|NCT00518115|449135469|FG000|Overall Study|Moved Out of State|0|||
124867355|NCT00518115|449135470|FG001|Overall Study|Moved Out of State|0|||
124867356|NCT00518115|449135471|FG002|Overall Study|Moved Out of State|0|||
124867357|NCT00518115|449135472|FG003|Overall Study|Moved Out of State|0|||
124867358|NCT00518115|449135473|FG004|Overall Study|Moved Out of State|0|||
124867359|NCT00518115|449135474|FG005|Overall Study|Moved Out of State|0|||
124867360|NCT00518115|449135475|FG006|Overall Study|Moved Out of State|0|||
124867361|NCT00518115|449135476|FG007|Overall Study|Moved Out of State|0|||
124867362|NCT00518115|449135477|FG008|Overall Study|Moved Out of State|0|||
124867363|NCT00518115|449135478|FG009|Overall Study|Moved Out of State|1|||
124867364|NCT04891419|449135479|FG000|Overall Study|Withdrawal by Subject|4|||
124867365|NCT04891419|449135480|FG001|Overall Study|Withdrawal by Subject|0|||
124867366|NCT04891419|449135479|FG000|Overall Study|Lost to Follow-up|1|||
124867367|NCT04891419|449135480|FG001|Overall Study|Lost to Follow-up|3|||
124867368|NCT00827918|449135481|FG000|Overall Study|Adverse Event|4|||
124867369|NCT00827918|449135482|FG001|Overall Study|Adverse Event|0|||
124867370|NCT00827918|449135483|FG002|Overall Study|Adverse Event|0|||
124867371|NCT00827918|449135481|FG000|Overall Study|Lack of Efficacy|16|||
124867372|NCT00827918|449135482|FG001|Overall Study|Lack of Efficacy|4|||
124867373|NCT00827918|449135483|FG002|Overall Study|Lack of Efficacy|15|||
124867374|NCT00827918|449135481|FG000|Overall Study|Physician Decision|1|||
124867375|NCT00827918|449135482|FG001|Overall Study|Physician Decision|0|||
124867376|NCT00827918|449135483|FG002|Overall Study|Physician Decision|0|||
124867377|NCT00827918|449135481|FG000|Overall Study|Pregnancy|0|||
124867378|NCT00827918|449135482|FG001|Overall Study|Pregnancy|1|||
124867379|NCT00827918|449135483|FG002|Overall Study|Pregnancy|0|||
124867380|NCT00827918|449135481|FG000|Overall Study|Progressive Disease|1|||
124867381|NCT00827918|449135482|FG001|Overall Study|Progressive Disease|1|||
124867382|NCT00827918|449135483|FG002|Overall Study|Progressive Disease|0|||
124867383|NCT00827918|449135481|FG000|Overall Study|Protocol Violation|0|||
124867384|NCT00827918|449135482|FG001|Overall Study|Protocol Violation|1|||
124867385|NCT00827918|449135483|FG002|Overall Study|Protocol Violation|0|||
124867386|NCT00827918|449135481|FG000|Overall Study|Withdrawal by Subject|6|||
124867387|NCT00827918|449135482|FG001|Overall Study|Withdrawal by Subject|2|||
124867388|NCT00827918|449135483|FG002|Overall Study|Withdrawal by Subject|6|||
124867389|NCT00450411|449135491|FG000|Overall Study|Protocol Violation|6|||
124867390|NCT00450411|449135491|FG000|Overall Study|No protocol treatment|2|||
124867391|NCT02137369|449135502|FG000|Overall Study|Withdrawal by Subject|3|||
124867392|NCT02137369|449135503|FG001|Overall Study|Withdrawal by Subject|2|||
124867393|NCT02137369|449135502|FG000|Overall Study|Adverse Event|2|||
124867394|NCT02137369|449135503|FG001|Overall Study|Adverse Event|0|||
124867395|NCT02137369|449135502|FG000|Overall Study|Lost to Follow-up|1|||
124867396|NCT02137369|449135503|FG001|Overall Study|Lost to Follow-up|0|||
124867397|NCT02137369|449135502|FG000|Overall Study|Moved away|2|||
124867398|NCT02137369|449135503|FG001|Overall Study|Moved away|0|||
124867399|NCT01297959|449135505|FG000|Overall Study|Adverse Event|0|||
124867400|NCT01297959|449135506|FG001|Overall Study|Adverse Event|1|||
124867401|NCT01297959|449135505|FG000|Overall Study|Protocol Violation|2|||
124867402|NCT01297959|449135506|FG001|Overall Study|Protocol Violation|1|||
124867403|NCT01297959|449135505|FG000|Overall Study|Withdrawal by Subject|5|||
124867404|NCT01297959|449135506|FG001|Overall Study|Withdrawal by Subject|4|||
124867405|NCT01297959|449135505|FG000|Overall Study|Physician Decision|0|||
124867406|NCT01297959|449135506|FG001|Overall Study|Physician Decision|1|||
124867407|NCT01297959|449135505|FG000|Overall Study|Unrelated medical illness / complication|0|||
124867408|NCT01297959|449135506|FG001|Overall Study|Unrelated medical illness / complication|2|||
124867409|NCT01297959|449135505|FG000|Overall Study|Other|13|||
124867410|NCT01297959|449135506|FG001|Overall Study|Other|7|||
124867411|NCT01667432|449135509|FG000|Overall Study|Premature Study Termination|26|||
124867412|NCT01667432|449135509|FG000|Overall Study|Failure to Return|10|||
124867413|NCT01667432|449135509|FG000|Overall Study|Moved to Another Center|3|||
124867414|NCT01667432|449135509|FG000|Overall Study|Lost to Follow-up|3|||
124867415|NCT01667432|449135509|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
124867416|NCT01667432|449135509|FG000|Overall Study|Insufficient Therapeutic Response|4|||
124867417|NCT01667432|449135509|FG000|Overall Study|Adverse Event|1|||
124867418|NCT01667432|449135509|FG000|Overall Study|Protocol Deviation|2|||
124867419|NCT01667432|449135509|FG000|Overall Study|Principal Investigator Decision|1|||
124867420|NCT01667432|449135509|FG000|Overall Study|Reason Not Specified|2|||
124867421|NCT01667432|449135509|FG000|Overall Study|Missing Information|4|||
124867422|NCT02077166|449135512|FG000|Overall Study|Death|6|||
124867423|NCT02077166|449135513|FG001|Overall Study|Death|7|||
124867424|NCT02077166|449135514|FG002|Overall Study|Death|5|||
124867425|NCT02077166|449135515|FG003|Overall Study|Death|6|||
124867426|NCT02077166|449135516|FG004|Overall Study|Death|4|||
124867427|NCT02077166|449135517|FG005|Overall Study|Death|32|||
124867428|NCT02077166|449135518|FG006|Overall Study|Death|22|||
124867429|NCT02077166|449135512|FG000|Overall Study|Study Closure by Sponsor|3|||
124867430|NCT02077166|449135513|FG001|Overall Study|Study Closure by Sponsor|0|||
124867431|NCT02077166|449135514|FG002|Overall Study|Study Closure by Sponsor|2|||
124867432|NCT02077166|449135515|FG003|Overall Study|Study Closure by Sponsor|2|||
124867433|NCT02077166|449135516|FG004|Overall Study|Study Closure by Sponsor|2|||
124867434|NCT02077166|449135517|FG005|Overall Study|Study Closure by Sponsor|12|||
124867435|NCT02077166|449135518|FG006|Overall Study|Study Closure by Sponsor|4|||
124867436|NCT02077166|449135512|FG000|Overall Study|Lost to Follow-up|0|||
124867437|NCT02077166|449135513|FG001|Overall Study|Lost to Follow-up|0|||
124867438|NCT02077166|449135514|FG002|Overall Study|Lost to Follow-up|0|||
124867439|NCT02077166|449135515|FG003|Overall Study|Lost to Follow-up|0|||
124867440|NCT02077166|449135516|FG004|Overall Study|Lost to Follow-up|0|||
124867441|NCT02077166|449135517|FG005|Overall Study|Lost to Follow-up|1|||
124867442|NCT02077166|449135518|FG006|Overall Study|Lost to Follow-up|0|||
124867443|NCT02077166|449135512|FG000|Overall Study|Withdrawal by Subject|3|||
124867444|NCT02077166|449135513|FG001|Overall Study|Withdrawal by Subject|0|||
124867445|NCT02077166|449135514|FG002|Overall Study|Withdrawal by Subject|1|||
124867446|NCT02077166|449135515|FG003|Overall Study|Withdrawal by Subject|1|||
124867447|NCT02077166|449135516|FG004|Overall Study|Withdrawal by Subject|1|||
124867448|NCT02077166|449135517|FG005|Overall Study|Withdrawal by Subject|3|||
124867449|NCT02077166|449135518|FG006|Overall Study|Withdrawal by Subject|0|||
124867450|NCT02077166|449135512|FG000|Overall Study|Other, Not Specified|0|||
124867451|NCT02077166|449135513|FG001|Overall Study|Other, Not Specified|0|||
124867452|NCT02077166|449135514|FG002|Overall Study|Other, Not Specified|1|||
124867453|NCT02077166|449135515|FG003|Overall Study|Other, Not Specified|0|||
124867454|NCT02077166|449135516|FG004|Overall Study|Other, Not Specified|1|||
124867455|NCT02077166|449135517|FG005|Overall Study|Other, Not Specified|7|||
124867456|NCT02077166|449135518|FG006|Overall Study|Other, Not Specified|8|||
124867457|NCT03519854|449135519|FG000|Overall Study|Technical Error|0|||
124867458|NCT03519854|449135520|FG001|Overall Study|Technical Error|0|||
124867459|NCT03519854|449135521|FG002|Overall Study|Technical Error|1|||
124867460|NCT03519854|449135522|FG003|Overall Study|Technical Error|0|||
124867461|NCT03519854|449135523|FG004|Overall Study|Technical Error|0|||
124867462|NCT03519854|449135524|FG005|Overall Study|Technical Error|0|||
124867463|NCT03519854|449135525|FG006|Overall Study|Technical Error|0|||
124867464|NCT03519854|449135526|FG007|Overall Study|Technical Error|0|||
124867465|NCT03519854|449135527|FG008|Overall Study|Technical Error|0|||
124867466|NCT03519854|449135528|FG009|Overall Study|Technical Error|0|||
124867467|NCT03519854|449135529|FG010|Overall Study|Technical Error|0|||
124867468|NCT03519854|449135530|FG011|Overall Study|Technical Error|0|||
124867469|NCT03519854|449135531|FG012|Overall Study|Technical Error|0|||
124867470|NCT03519854|449135532|FG013|Overall Study|Technical Error|0|||
124867471|NCT03519854|449135533|FG014|Overall Study|Technical Error|0|||
124867472|NCT03519854|449135534|FG015|Overall Study|Technical Error|0|||
124867473|NCT03519854|449135535|FG016|Overall Study|Technical Error|0|||
124867474|NCT03519854|449135536|FG017|Overall Study|Technical Error|0|||
124867475|NCT00818753|449135540|FG000|Overall Study|Protocol Violation|1|||
124867476|NCT00818753|449135541|FG001|Overall Study|Protocol Violation|0|||
124867477|NCT00818753|449135542|FG002|Overall Study|Protocol Violation|0|||
124867478|NCT00818753|449135540|FG000|Overall Study|Other reason (not specified)|0|||
124867479|NCT00818753|449135541|FG001|Overall Study|Other reason (not specified)|0|||
124867480|NCT00818753|449135542|FG002|Overall Study|Other reason (not specified)|1|||
124867481|NCT00818753|449135540|FG000|Overall Study|Randomised and not treated|2|||
124867482|NCT00818753|449135541|FG001|Overall Study|Randomised and not treated|0|||
124867483|NCT00818753|449135542|FG002|Overall Study|Randomised and not treated|0|||
124867484|NCT01712009|449137961|FG000|Overall Study|Withdrawal by Subject|24|||
124867485|NCT01712009|449137962|FG001|Overall Study|Withdrawal by Subject|15|||
124867486|NCT01712009|449137963|FG002|Overall Study|Withdrawal by Subject|8|||
124867487|NCT01712009|449137961|FG000|Overall Study|Lost to Follow-up|2|||
124867488|NCT01712009|449137962|FG001|Overall Study|Lost to Follow-up|0|||
124867489|NCT01712009|449137963|FG002|Overall Study|Lost to Follow-up|1|||
124867490|NCT01712009|449137961|FG000|Overall Study|Decision by Sponsor|12|||
124867491|NCT01712009|449137962|FG001|Overall Study|Decision by Sponsor|14|||
124867492|NCT01712009|449137963|FG002|Overall Study|Decision by Sponsor|12|||
124867493|NCT00593567|449137964|FG000|Overall Study|Adverse Event|2|||
124867494|NCT00593567|449137965|FG001|Overall Study|Adverse Event|0|||
124867495|NCT00593567|449137964|FG000|Overall Study|Physician Decision|2|||
124867496|NCT00593567|449137965|FG001|Overall Study|Physician Decision|0|||
124867497|NCT00593567|449137964|FG000|Overall Study|Protocol Violation|13|||
124867498|NCT00593567|449137965|FG001|Overall Study|Protocol Violation|7|||
124867499|NCT00593567|449137964|FG000|Overall Study|Lack of Efficacy|2|||
124867500|NCT00593567|449137965|FG001|Overall Study|Lack of Efficacy|1|||
124867501|NCT00593567|449137964|FG000|Overall Study|Withdrawal by Subject|1|||
124867502|NCT00593567|449137965|FG001|Overall Study|Withdrawal by Subject|2|||
124867503|NCT00590902|449137968|FG000|Overall Study|Death|1|||
124867504|NCT00785291|449137970|FG000|Overall Study|Never began treatment|8|||
124867505|NCT00785291|449137971|FG001|Overall Study|Never began treatment|4|||
124867506|NCT00785291|449137972|FG002|Overall Study|Never began treatment|4|||
124867507|NCT00785291|449137970|FG000|Overall Study|Adverse Event|39|||
124867508|NCT00785291|449137971|FG001|Overall Study|Adverse Event|70|||
124867509|NCT00785291|449137972|FG002|Overall Study|Adverse Event|56|||
124867510|NCT00785291|449137970|FG000|Overall Study|Death|7|||
124867511|NCT00785291|449137971|FG001|Overall Study|Death|4|||
124867512|NCT00785291|449137972|FG002|Overall Study|Death|3|||
124867513|NCT00785291|449137970|FG000|Overall Study|Withdrawal by Subject|35|||
124867514|NCT00785291|449137971|FG001|Overall Study|Withdrawal by Subject|36|||
124867515|NCT00785291|449137972|FG002|Overall Study|Withdrawal by Subject|17|||
124867516|NCT00785291|449137970|FG000|Overall Study|Alternative Therapy|12|||
124867517|NCT00785291|449137971|FG001|Overall Study|Alternative Therapy|6|||
124867518|NCT00785291|449137972|FG002|Overall Study|Alternative Therapy|7|||
124867519|NCT00785291|449137970|FG000|Overall Study|Complicating illness|6|||
124867520|NCT00785291|449137971|FG001|Overall Study|Complicating illness|4|||
124867521|NCT00785291|449137972|FG002|Overall Study|Complicating illness|4|||
124867522|NCT00785291|449137970|FG000|Overall Study|Other Medical Reasons|29|||
124867523|NCT00785291|449137971|FG001|Overall Study|Other Medical Reasons|25|||
124867524|NCT00785291|449137972|FG002|Overall Study|Other Medical Reasons|15|||
124867525|NCT00844857|449137973|FG000|Overall Study|Adverse Event|24|||
124867526|NCT00844857|449137974|FG001|Overall Study|Adverse Event|5|||
124867527|NCT00844857|449137973|FG000|Overall Study|Sponsor Decision|1|||
124867528|NCT00844857|449137974|FG001|Overall Study|Sponsor Decision|1|||
124867529|NCT00844857|449137973|FG000|Overall Study|Physician Decision|2|||
124867530|NCT00844857|449137974|FG001|Overall Study|Physician Decision|0|||
124867531|NCT00844857|449137973|FG000|Overall Study|Parent/Caregiver Decision|6|||
124867532|NCT00844857|449137974|FG001|Overall Study|Parent/Caregiver Decision|2|||
124867533|NCT00844857|449137973|FG000|Overall Study|Withdrawal by Subject|8|||
124867534|NCT00844857|449137974|FG001|Overall Study|Withdrawal by Subject|7|||
124867535|NCT00844857|449137973|FG000|Overall Study|Protocol Violation|6|||
124867536|NCT00844857|449137974|FG001|Overall Study|Protocol Violation|0|||
124867537|NCT00844857|449137973|FG000|Overall Study|Lack of Efficacy|5|||
124867538|NCT00844857|449137974|FG001|Overall Study|Lack of Efficacy|5|||
124867539|NCT00844857|449137973|FG000|Overall Study|Clinical Relapse|0|||
124867540|NCT00844857|449137974|FG001|Overall Study|Clinical Relapse|1|||
124867541|NCT00844857|449137973|FG000|Overall Study|Entry Criteria Not Met|0|||
124867542|NCT00844857|449137974|FG001|Overall Study|Entry Criteria Not Met|1|||
124867543|NCT00844857|449137973|FG000|Overall Study|Lost to Follow-up|2|||
124867544|NCT00844857|449137974|FG001|Overall Study|Lost to Follow-up|3|||
124867545|NCT00844857|449137973|FG000|Overall Study|Did Not Take Study Drug|3|||
124867546|NCT00844857|449137974|FG001|Overall Study|Did Not Take Study Drug|1|||
124867547|NCT00844857|449137973|FG000|Overall Study|Good Clinical Practice Violations|21|||
124867548|NCT00844857|449137974|FG001|Overall Study|Good Clinical Practice Violations|11|||
124867549|NCT00570674|449137975|FG000|Overall Study|Withdrawal by Subject|0|||
124867550|NCT00570674|449137976|FG001|Overall Study|Withdrawal by Subject|0|||
124867551|NCT00570674|449137977|FG002|Overall Study|Withdrawal by Subject|1|||
124867552|NCT00570674|449137978|FG003|Overall Study|Withdrawal by Subject|0|||
124867553|NCT00570674|449137979|FG004|Overall Study|Withdrawal by Subject|0|||
124867554|NCT00570674|449137980|FG005|Overall Study|Withdrawal by Subject|0|||
124867555|NCT00570674|449137981|FG006|Overall Study|Withdrawal by Subject|0|||
124867556|NCT02979639|449137983|FG000|Overall Study|Withdrawal based on medical judgement|1|||
124867557|NCT02979639|449137983|FG000|Overall Study|Lost to Follow-up|8|||
124867558|NCT02979639|449137983|FG000|Overall Study|Withdrawal by Subject|3|||
124867559|NCT02979639|449137983|FG000|Overall Study|Adverse Event|2|||
124867560|NCT04050865|449137987|FG000|Overall Study|Adverse Event|1|||
124867561|NCT04050865|449137988|FG001|Overall Study|Adverse Event|0|||
124867562|NCT04050865|449137987|FG000|Overall Study|no insert|1|||
124867563|NCT04050865|449137988|FG001|Overall Study|no insert|0|||
124867564|NCT04050865|449137987|FG000|Overall Study|Only 1 insert|2|||
124867565|NCT04050865|449137988|FG001|Overall Study|Only 1 insert|3|||
124867566|NCT04050865|449137987|FG000|Overall Study|Physician Decision|0|||
124867567|NCT04050865|449137988|FG001|Overall Study|Physician Decision|1|||
124867568|NCT04050865|449137987|FG000|Overall Study|Withdrawal by Subject|0|||
124867569|NCT04050865|449137988|FG001|Overall Study|Withdrawal by Subject|1|||
124867570|NCT00175825|449137995|FG000|Overall Study|Adverse Event|3|||
124867571|NCT00175825|449137996|FG001|Overall Study|Adverse Event|2|||
124867572|NCT00175825|449137997|FG002|Overall Study|Adverse Event|1|||
124867573|NCT00175825|449137998|FG003|Overall Study|Adverse Event|1|||
124867574|NCT00175825|449137995|FG000|Overall Study|Lost to Follow-up|1|||
124867575|NCT00175825|449137996|FG001|Overall Study|Lost to Follow-up|2|||
124867576|NCT00175825|449137997|FG002|Overall Study|Lost to Follow-up|0|||
124867577|NCT00175825|449137998|FG003|Overall Study|Lost to Follow-up|0|||
124867578|NCT00175825|449137995|FG000|Overall Study|Withdrawal by Subject|1|||
124867579|NCT00175825|449137996|FG001|Overall Study|Withdrawal by Subject|0|||
124867580|NCT00175825|449137997|FG002|Overall Study|Withdrawal by Subject|0|||
124867581|NCT00175825|449137998|FG003|Overall Study|Withdrawal by Subject|0|||
124867582|NCT00608582|449137999|FG000|Overall Study|Lost to Follow-up|2|||
124867583|NCT00608582|449138000|FG001|Overall Study|Lost to Follow-up|0|||
124867584|NCT00608582|449137999|FG000|Overall Study|No Best Response in Phase 1 located|1|||
124867585|NCT00608582|449138000|FG001|Overall Study|No Best Response in Phase 1 located|1|||
124867586|NCT00608582|449137999|FG000|Overall Study|Illicit Drug Use|1|||
124867587|NCT00608582|449138000|FG001|Overall Study|Illicit Drug Use|0|||
124867588|NCT00608582|449137999|FG000|Overall Study|Early stage Design Change|0|||
124867589|NCT00608582|449138000|FG001|Overall Study|Early stage Design Change|3|||
124867590|NCT00160680|449138003|FG000|Overall Study|Adverse Event|0|||
124867591|NCT00160680|449138004|FG001|Overall Study|Adverse Event|1|||
124867592|NCT00160680|449138003|FG000|Overall Study|Lack of Efficacy|2|||
124867593|NCT00160680|449138004|FG001|Overall Study|Lack of Efficacy|1|||
124867594|NCT00160680|449138003|FG000|Overall Study|Lost to Follow-up|3|||
124867595|NCT00160680|449138004|FG001|Overall Study|Lost to Follow-up|2|||
124867596|NCT00160680|449138003|FG000|Overall Study|Withdrawal by Subject|4|||
124867597|NCT00160680|449138004|FG001|Overall Study|Withdrawal by Subject|9|||
124867598|NCT00985725|449138008|FG000|Overall Study|Adverse Event|4|||
124867599|NCT00985725|449138009|FG001|Overall Study|Adverse Event|1|||
124867600|NCT00985725|449138008|FG000|Overall Study|Protocol Violation|1|||
124867601|NCT00985725|449138009|FG001|Overall Study|Protocol Violation|3|||
124867602|NCT00985725|449138008|FG000|Overall Study|Withdrawal by Subject|4|||
124867603|NCT00985725|449138009|FG001|Overall Study|Withdrawal by Subject|4|||
124867604|NCT00985725|449138008|FG000|Overall Study|Lost to Follow-up|1|||
124867605|NCT00985725|449138009|FG001|Overall Study|Lost to Follow-up|1|||
124867606|NCT00985725|449138008|FG000|Overall Study|Lack of Efficacy|0|||
124867607|NCT00985725|449138009|FG001|Overall Study|Lack of Efficacy|1|||
124867608|NCT00985725|449138008|FG000|Overall Study|Non-compliance|1|||
124867609|NCT00985725|449138009|FG001|Overall Study|Non-compliance|2|||
124867610|NCT00985725|449138008|FG000|Overall Study|Out-of-window visits|0|||
124867611|NCT00985725|449138009|FG001|Overall Study|Out-of-window visits|1|||
124867612|NCT02450331|449138013|FG000|Overall Study|Death|162|||
124867613|NCT02450331|449138014|FG001|Overall Study|Death|171|||
124867614|NCT02450331|449138013|FG000|Overall Study|Lost to Follow-up|14|||
124867615|NCT02450331|449138014|FG001|Overall Study|Lost to Follow-up|12|||
124867616|NCT02450331|449138013|FG000|Overall Study|Withdrawal by Subject|55|||
124867617|NCT02450331|449138014|FG001|Overall Study|Withdrawal by Subject|44|||
124867618|NCT02450331|449138013|FG000|Overall Study|Non-specified other|1|||
124867619|NCT02450331|449138014|FG001|Overall Study|Non-specified other|1|||
124867620|NCT01410474|449138015|FG000|Overall Study|Withdrawal by Subject|0|||
124867621|NCT01410474|449138016|FG001|Overall Study|Withdrawal by Subject|1|||
124867622|NCT03232983|449138017|FG000|Period 1|Physician Decision|0|||
124867623|NCT03232983|449138018|FG001|Period 1|Physician Decision|0|||
124867624|NCT03232983|449138019|FG002|Period 1|Physician Decision|1|||
124867625|NCT03232983|449138020|FG003|Period 1|Physician Decision|0|||
124867626|NCT03232983|449138017|FG000|Washout Period 2|Physician Decision|0|||
124867627|NCT03232983|449138018|FG001|Washout Period 2|Physician Decision|0|||
124534496|NCT00405756|447909412|FG000|Double-blind Treatment|Lack of Efficacy|1|||
124534497|NCT00405756|447909413|FG001|Double-blind Treatment|Lack of Efficacy|4|||
124534498|NCT00405756|447909414|FG002|Double-blind Treatment|Lack of Efficacy|2|||
124534499|NCT00405756|447909412|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
124534500|NCT00405756|447909413|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
124534501|NCT00405756|447909414|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
124534502|NCT00405756|447909412|FG000|Double-blind Treatment|Lost to Follow-up|1|||
124534503|NCT00405756|447909413|FG001|Double-blind Treatment|Lost to Follow-up|0|||
124534504|NCT00405756|447909414|FG002|Double-blind Treatment|Lost to Follow-up|0|||
124534505|NCT00405756|447909412|FG000|Double-blind Treatment|Death|4|||
124534506|NCT00405756|447909413|FG001|Double-blind Treatment|Death|4|||
124534507|NCT00405756|447909414|FG002|Double-blind Treatment|Death|4|||
124534508|NCT00405756|447909412|FG000|Double-blind Treatment|Protocol Violation|1|||
124534509|NCT00405756|447909413|FG001|Double-blind Treatment|Protocol Violation|0|||
124534510|NCT00405756|447909414|FG002|Double-blind Treatment|Protocol Violation|2|||
124534511|NCT00405756|447909412|FG000|Double-blind Treatment|Other|7|||
124534512|NCT00405756|447909413|FG001|Double-blind Treatment|Other|4|||
124534513|NCT00405756|447909414|FG002|Double-blind Treatment|Other|4|||
124534514|NCT00405756|447909412|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
124534515|NCT00405756|447909413|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
124867628|NCT03232983|449138019|FG002|Washout Period 2|Physician Decision|1|||
124867629|NCT03232983|449138020|FG003|Washout Period 2|Physician Decision|0|||
124867630|NCT03232983|449138017|FG000|Washout Period 2|Withdrawal by Subject|0|||
124867631|NCT03232983|449138018|FG001|Washout Period 2|Withdrawal by Subject|0|||
124867632|NCT03232983|449138019|FG002|Washout Period 2|Withdrawal by Subject|0|||
124867633|NCT03232983|449138020|FG003|Washout Period 2|Withdrawal by Subject|1|||
124867634|NCT03232983|449138017|FG000|Period 4|Withdrawal by Subject|1|||
124867635|NCT03232983|449138018|FG001|Period 4|Withdrawal by Subject|0|||
124534516|NCT00405756|447909414|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
124534517|NCT00405756|447909412|FG000|Open-label Extension|Adverse Event|1|||
124534518|NCT00405756|447909413|FG001|Open-label Extension|Adverse Event|3|||
124534519|NCT00405756|447909414|FG002|Open-label Extension|Adverse Event|7|||
124534520|NCT00405756|447909412|FG000|Open-label Extension|Disease Progression|8|||
124534521|NCT00405756|447909413|FG001|Open-label Extension|Disease Progression|23|||
124534522|NCT00405756|447909414|FG002|Open-label Extension|Disease Progression|26|||
124534523|NCT00405756|447909412|FG000|Open-label Extension|Withdrawal by Subject|2|||
124534524|NCT00405756|447909413|FG001|Open-label Extension|Withdrawal by Subject|3|||
124534525|NCT00405756|447909414|FG002|Open-label Extension|Withdrawal by Subject|3|||
124534526|NCT00405756|447909412|FG000|Open-label Extension|Death|1|||
124534527|NCT00405756|447909413|FG001|Open-label Extension|Death|2|||
124534528|NCT00405756|447909414|FG002|Open-label Extension|Death|4|||
124534529|NCT00405756|447909412|FG000|Open-label Extension|Other|0|||
124534530|NCT00405756|447909413|FG001|Open-label Extension|Other|1|||
124534531|NCT00405756|447909414|FG002|Open-label Extension|Other|7|||
124867636|NCT03232983|449138019|FG002|Period 4|Withdrawal by Subject|0|||
124867637|NCT03232983|449138020|FG003|Period 4|Withdrawal by Subject|0|||
124867638|NCT02261493|449138023|FG000|Overall Study|Noncompliance|0|||
124867639|NCT02261493|449138024|FG001|Overall Study|Noncompliance|0|||
124867640|NCT02261493|449138025|FG002|Overall Study|Noncompliance|2|||
124867641|NCT02261493|449138023|FG000|Overall Study|Physician Decision|0|||
124867642|NCT02261493|449138024|FG001|Overall Study|Physician Decision|1|||
124867643|NCT02261493|449138025|FG002|Overall Study|Physician Decision|0|||
124867644|NCT02261493|449138023|FG000|Overall Study|Undisclosed alcohol abuse|0|||
124867645|NCT02261493|449138024|FG001|Overall Study|Undisclosed alcohol abuse|1|||
124867646|NCT02261493|449138025|FG002|Overall Study|Undisclosed alcohol abuse|0|||
124867647|NCT02261493|449138023|FG000|Overall Study|Protocol Violation|1|||
124867648|NCT02261493|449138024|FG001|Overall Study|Protocol Violation|0|||
124867649|NCT02261493|449138025|FG002|Overall Study|Protocol Violation|0|||
124867650|NCT02261493|449138023|FG000|Overall Study|Personal Reasons|14|||
124867651|NCT02261493|449138024|FG001|Overall Study|Personal Reasons|14|||
124867652|NCT02261493|449138025|FG002|Overall Study|Personal Reasons|16|||
124867653|NCT02261493|449138023|FG000|Overall Study|Lost to Follow-up|14|||
124867654|NCT02261493|449138024|FG001|Overall Study|Lost to Follow-up|27|||
124867655|NCT02261493|449138025|FG002|Overall Study|Lost to Follow-up|8|||
124867656|NCT02261493|449138023|FG000|Overall Study|Pregnancy|1|||
124867657|NCT02261493|449138024|FG001|Overall Study|Pregnancy|2|||
124867658|NCT02261493|449138025|FG002|Overall Study|Pregnancy|0|||
124867659|NCT02261493|449138023|FG000|Overall Study|Lack of Efficacy|0|||
124867660|NCT02261493|449138024|FG001|Overall Study|Lack of Efficacy|1|||
124867661|NCT02261493|449138025|FG002|Overall Study|Lack of Efficacy|0|||
124867662|NCT02261493|449138023|FG000|Overall Study|Adverse Event|0|||
124867663|NCT02261493|449138024|FG001|Overall Study|Adverse Event|1|||
124867664|NCT02261493|449138025|FG002|Overall Study|Adverse Event|0|||
124867665|NCT00530855|449138026|FG000|Overall Study|Lack of Efficacy|20|||
124867666|NCT00530855|449138026|FG000|Overall Study|Withdrawal by Subject|30|||
124867667|NCT00530855|449138026|FG000|Overall Study|Fatal Serious AE|3|||
124867668|NCT00530855|449138026|FG000|Overall Study|Non Fatal Serious AE|7|||
124867669|NCT00530855|449138026|FG000|Overall Study|Non Fatal Non Serious AE|12|||
124867670|NCT00530855|449138026|FG000|Overall Study|Protocol Violation|3|||
124867671|NCT00530855|449138026|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
124867672|NCT00530855|449138026|FG000|Overall Study|Lost to Follow-up|9|||
124867673|NCT00530855|449138026|FG000|Overall Study|Other reason for premature termination|17|||
124867674|NCT00815295|449138027|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
124867675|NCT00815295|449138028|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
124867676|NCT00815295|449138029|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
124867677|NCT01137474|449138030|FG000|Overall Study|Adverse Event|3|||
124867678|NCT01137474|449138031|FG001|Overall Study|Adverse Event|5|||
124867679|NCT01137474|449138032|FG002|Overall Study|Adverse Event|1|||
124867680|NCT01137474|449138033|FG003|Overall Study|Adverse Event|3|||
124867681|NCT01137474|449138030|FG000|Overall Study|Withdrawal by Subject|7|||
124867682|NCT01137474|449138031|FG001|Overall Study|Withdrawal by Subject|2|||
124867683|NCT01137474|449138032|FG002|Overall Study|Withdrawal by Subject|6|||
124867684|NCT01137474|449138033|FG003|Overall Study|Withdrawal by Subject|9|||
124867685|NCT01137474|449138030|FG000|Overall Study|No longer met study criteria|6|||
124867686|NCT01137474|449138031|FG001|Overall Study|No longer met study criteria|1|||
124867687|NCT01137474|449138032|FG002|Overall Study|No longer met study criteria|0|||
124867688|NCT01137474|449138033|FG003|Overall Study|No longer met study criteria|5|||
124867689|NCT01137474|449138030|FG000|Overall Study|Lost to Follow-up|5|||
124867690|NCT01137474|449138031|FG001|Overall Study|Lost to Follow-up|1|||
124867691|NCT01137474|449138032|FG002|Overall Study|Lost to Follow-up|0|||
124867692|NCT01137474|449138033|FG003|Overall Study|Lost to Follow-up|2|||
124867693|NCT01137474|449138030|FG000|Overall Study|Lack of Efficacy|0|||
124867694|NCT01137474|449138031|FG001|Overall Study|Lack of Efficacy|0|||
124867695|NCT01137474|449138032|FG002|Overall Study|Lack of Efficacy|0|||
124867696|NCT01137474|449138033|FG003|Overall Study|Lack of Efficacy|2|||
124867697|NCT01137474|449138030|FG000|Overall Study|Other|3|||
124867698|NCT01137474|449138031|FG001|Overall Study|Other|1|||
124867699|NCT01137474|449138032|FG002|Overall Study|Other|0|||
124867700|NCT01137474|449138033|FG003|Overall Study|Other|0|||
124867701|NCT01137474|449138030|FG000|Overall Study|Pregnancy|0|||
124867702|NCT01137474|449138031|FG001|Overall Study|Pregnancy|1|||
124867703|NCT01137474|449138032|FG002|Overall Study|Pregnancy|0|||
124867704|NCT01137474|449138033|FG003|Overall Study|Pregnancy|0|||
124867705|NCT01137474|449138030|FG000|Overall Study|Administrative reason by sponsor|0|||
124867706|NCT01137474|449138031|FG001|Overall Study|Administrative reason by sponsor|1|||
124867707|NCT01137474|449138032|FG002|Overall Study|Administrative reason by sponsor|0|||
124867708|NCT01137474|449138033|FG003|Overall Study|Administrative reason by sponsor|0|||
124867709|NCT02219048|449138034|FG000|Overall Study|Adverse Event|2|||
124867710|NCT02219048|449138035|FG001|Overall Study|Adverse Event|5|||
124867711|NCT02219048|449138034|FG000|Overall Study|No longer meets eligibility criteria|1|||
124867712|NCT02219048|449138035|FG001|Overall Study|No longer meets eligibility criteria|0|||
124867713|NCT02219048|449138034|FG000|Overall Study|Study terminated by sponsor|16|||
124867714|NCT02219048|449138035|FG001|Overall Study|Study terminated by sponsor|15|||
124867715|NCT02219048|449138034|FG000|Overall Study|Withdrawal by Subject|2|||
124534532|NCT00405756|447909412|FG000|Follow-up|Ongoing in Follow-up Period|52|||
124534533|NCT00405756|447909413|FG001|Follow-up|Ongoing in Follow-up Period|51|||
124867716|NCT02219048|449138035|FG001|Overall Study|Withdrawal by Subject|0|||
124867717|NCT02219048|449138034|FG000|Overall Study|Other|0|||
124867718|NCT02219048|449138035|FG001|Overall Study|Other|1|||
124867719|NCT04794803|449138036|FG000|Overall Study|Death|1|||
124867720|NCT04794803|449138037|FG001|Overall Study|Death|3|||
124867721|NCT04794803|449138036|FG000|Overall Study|Lost to Follow-up|2|||
124867722|NCT04794803|449138037|FG001|Overall Study|Lost to Follow-up|2|||
124867723|NCT04794803|449138036|FG000|Overall Study|Withdrawal by Subject|1|||
124867724|NCT04794803|449138037|FG001|Overall Study|Withdrawal by Subject|0|||
124867725|NCT04794803|449138036|FG000|Overall Study|Physician Decision|1|||
124867726|NCT04794803|449138037|FG001|Overall Study|Physician Decision|1|||
124867727|NCT04794803|449138036|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
124867728|NCT04794803|449138037|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
124867729|NCT04794803|449138036|FG000|Overall Study|Refused to continue the treatment|1|||
124534534|NCT00405756|447909414|FG002|Follow-up|Ongoing in Follow-up Period|60|||
124534535|NCT00405756|447909412|FG000|Follow-up|Death|21|||
124534536|NCT00405756|447909413|FG001|Follow-up|Death|31|||
124534537|NCT00405756|447909414|FG002|Follow-up|Death|24|||
124534538|NCT00405756|447909412|FG000|Follow-up|Lost to Follow-up|2|||
124534539|NCT00405756|447909413|FG001|Follow-up|Lost to Follow-up|8|||
124534540|NCT00405756|447909414|FG002|Follow-up|Lost to Follow-up|4|||
124534541|NCT03018028|447909415|FG000|Overall Study|Withdrawal by Subject|3|||
124534542|NCT03018028|447909416|FG001|Overall Study|Withdrawal by Subject|0|||
124534543|NCT03018028|447909417|FG002|Overall Study|Withdrawal by Subject|1|||
124534544|NCT03018028|447909418|FG003|Overall Study|Withdrawal by Subject|2|||
124534545|NCT03018028|447909419|FG004|Overall Study|Withdrawal by Subject|0|||
124534546|NCT02543801|447909420|FG000|Overall Study|Protocol Violation|1|||
124534547|NCT02543801|447909421|FG001|Overall Study|Protocol Violation|2|||
124534548|NCT02543801|447909422|FG002|Overall Study|Protocol Violation|0|||
124534549|NCT02543801|447909423|FG003|Overall Study|Protocol Violation|0|||
124534550|NCT02364999|447909433|FG000|Overall Study|Death|136|||
124534551|NCT02364999|447909434|FG001|Overall Study|Death|138|||
124867730|NCT04794803|449138037|FG001|Overall Study|Refused to continue the treatment|0|||
124867731|NCT04794803|449138036|FG000|Overall Study|Patient admitted to ICU|0|||
124867732|NCT04794803|449138037|FG001|Overall Study|Patient admitted to ICU|1|||
124867733|NCT04040751|449138039|FG000|Overall Study|Withdrawal by Subject|2|||
124867734|NCT04040751|449138040|FG001|Overall Study|Withdrawal by Subject|0|||
124867735|NCT04040751|449138041|FG002|Overall Study|Withdrawal by Subject|2|||
124867736|NCT04040751|449138042|FG003|Overall Study|Withdrawal by Subject|0|||
124867737|NCT03624504|449138043|FG000|Overall Study|Unsuccessful Implant|1|||
124867738|NCT02862457|449138044|FG000|Overall Study|Death|1|||
124867739|NCT02862457|449138045|FG001|Overall Study|Death|3|||
124867740|NCT02862457|449138046|FG002|Overall Study|Death|2|||
124867741|NCT02862457|449138047|FG003|Overall Study|Death|3|||
124534552|NCT02364999|447909433|FG000|Overall Study|Lost to Follow-up|10|||
124534553|NCT02364999|447909434|FG001|Overall Study|Lost to Follow-up|15|||
124534554|NCT02364999|447909433|FG000|Overall Study|Protocol Violation|3|||
124534555|NCT02364999|447909434|FG001|Overall Study|Protocol Violation|2|||
124534556|NCT02364999|447909433|FG000|Overall Study|Withdrawal by Subject|14|||
124534557|NCT02364999|447909434|FG001|Overall Study|Withdrawal by Subject|14|||
124534558|NCT02364999|447909433|FG000|Overall Study|Other|0|||
124534559|NCT02364999|447909434|FG001|Overall Study|Other|1|||
124534560|NCT02364999|447909433|FG000|Overall Study|Randomized but did not receive treatment|2|||
124534561|NCT02364999|447909434|FG001|Overall Study|Randomized but did not receive treatment|3|||
124534562|NCT01566981|447909435|FG000|Overall Study|Lost to Follow-up|5|||
124534563|NCT01566981|447909436|FG001|Overall Study|Lost to Follow-up|8|||
124534564|NCT03323385|447909443|FG000|Overall Study|Withdrawal by Subject|1|||
124534565|NCT03323385|447909444|FG001|Overall Study|Withdrawal by Subject|2|||
124534566|NCT03323385|447909443|FG000|Overall Study|Noncompliance|0|||
124534567|NCT03323385|447909444|FG001|Overall Study|Noncompliance|1|||
124534568|NCT01849289|447909447|FG000|Overall Study|Adverse Event|3|||
124534569|NCT01849289|447909448|FG001|Overall Study|Adverse Event|3|||
124534570|NCT01849289|447909447|FG000|Overall Study|Protocol Violation|3|||
124534571|NCT01849289|447909448|FG001|Overall Study|Protocol Violation|3|||
124534572|NCT01849289|447909447|FG000|Overall Study|Withdrawal criteria|1|||
124534573|NCT01849289|447909448|FG001|Overall Study|Withdrawal criteria|0|||
124867742|NCT02862457|449138048|FG004|Overall Study|Death|0|||
124867743|NCT02862457|449138049|FG005|Overall Study|Death|2|||
124867744|NCT02862457|449138050|FG006|Overall Study|Death|1|||
124867745|NCT02862457|449138044|FG000|Overall Study|Lost to Follow-up|1|||
124534574|NCT01849289|447909447|FG000|Overall Study|Unclassified|25|||
124534575|NCT01849289|447909448|FG001|Overall Study|Unclassified|18|||
124534576|NCT00660816|447909454|FG000|Overall Study|Adverse Event|1|||
124534577|NCT00660816|447909455|FG001|Overall Study|Adverse Event|2|||
124534578|NCT00660816|447909454|FG000|Overall Study|Withdrawal by Subject|1|||
124534579|NCT00660816|447909455|FG001|Overall Study|Withdrawal by Subject|0|||
124867746|NCT02862457|449138045|FG001|Overall Study|Lost to Follow-up|0|||
124534580|NCT00660816|447909454|FG000|Overall Study|Death|0|||
124867747|NCT02862457|449138046|FG002|Overall Study|Lost to Follow-up|0|||
124867748|NCT02862457|449138047|FG003|Overall Study|Lost to Follow-up|1|||
124867749|NCT02862457|449138048|FG004|Overall Study|Lost to Follow-up|0|||
124867750|NCT02862457|449138049|FG005|Overall Study|Lost to Follow-up|0|||
124867751|NCT02862457|449138050|FG006|Overall Study|Lost to Follow-up|0|||
124867752|NCT02862457|449138044|FG000|Overall Study|Withdrawal by Subject|0|||
124867753|NCT02862457|449138045|FG001|Overall Study|Withdrawal by Subject|0|||
124867754|NCT02862457|449138046|FG002|Overall Study|Withdrawal by Subject|1|||
124867755|NCT02862457|449138047|FG003|Overall Study|Withdrawal by Subject|0|||
124867756|NCT02862457|449138048|FG004|Overall Study|Withdrawal by Subject|0|||
124867757|NCT02862457|449138049|FG005|Overall Study|Withdrawal by Subject|1|||
124867758|NCT02862457|449138050|FG006|Overall Study|Withdrawal by Subject|0|||
124867759|NCT01388816|449138051|FG000|Overall Study|Adverse Event|0|||
124867760|NCT01388816|449138052|FG001|Overall Study|Adverse Event|2|||
124867761|NCT01388816|449138053|FG002|Overall Study|Adverse Event|0|||
124867762|NCT01388816|449138054|FG003|Overall Study|Adverse Event|0|||
124867763|NCT01388816|449138051|FG000|Overall Study|Lost to Follow-up|0|||
124867764|NCT01388816|449138052|FG001|Overall Study|Lost to Follow-up|1|||
124867765|NCT01388816|449138053|FG002|Overall Study|Lost to Follow-up|0|||
124867766|NCT01388816|449138054|FG003|Overall Study|Lost to Follow-up|0|||
124867767|NCT01388816|449138051|FG000|Overall Study|Withdrawal by Subject|2|||
124867768|NCT01388816|449138052|FG001|Overall Study|Withdrawal by Subject|1|||
124867769|NCT01388816|449138053|FG002|Overall Study|Withdrawal by Subject|1|||
124867770|NCT01388816|449138054|FG003|Overall Study|Withdrawal by Subject|0|||
124867771|NCT01388816|449138051|FG000|Overall Study|Protocol Violation|0|||
124867772|NCT01388816|449138052|FG001|Overall Study|Protocol Violation|0|||
124867773|NCT01388816|449138053|FG002|Overall Study|Protocol Violation|2|||
124867774|NCT01388816|449138054|FG003|Overall Study|Protocol Violation|0|||
124867775|NCT00951483|449138055|FG000|Overall Study|Physician Decision|4|||
124867776|NCT00951483|449138056|FG001|Overall Study|Physician Decision|0|||
124867777|NCT00951483|449138055|FG000|Overall Study|Withdrawal by Subject|15|||
124867778|NCT00951483|449138056|FG001|Overall Study|Withdrawal by Subject|0|||
124867779|NCT03015402|449138057|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
124867780|NCT03015402|449138058|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
124867781|NCT03015402|449138057|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
124867782|NCT03015402|449138058|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
124867783|NCT01813474|449138059|FG000|Overall Study|Withdrawal by Subject|0|||
124867784|NCT01813474|449138060|FG001|Overall Study|Withdrawal by Subject|0|||
124867785|NCT01813474|449138061|FG002|Overall Study|Withdrawal by Subject|1|||
124867786|NCT01813474|449138059|FG000|Overall Study|Adverse Event|1|||
124867787|NCT01813474|449138060|FG001|Overall Study|Adverse Event|1|||
124867788|NCT01813474|449138061|FG002|Overall Study|Adverse Event|0|||
124867789|NCT01813474|449138059|FG000|Overall Study|Lack of Efficacy|2|||
124867790|NCT01813474|449138060|FG001|Overall Study|Lack of Efficacy|6|||
124867791|NCT01813474|449138061|FG002|Overall Study|Lack of Efficacy|9|||
124867792|NCT01813474|449138059|FG000|Overall Study|Death|0|||
124867793|NCT01813474|449138060|FG001|Overall Study|Death|0|||
124867794|NCT01813474|449138061|FG002|Overall Study|Death|1|||
124867795|NCT01995461|449138064|FG000|Overall Study|Death|1|||
124867796|NCT01995461|449138064|FG000|Overall Study|Lost to Follow-up|2|||
124867797|NCT01995461|449138064|FG000|Overall Study|Withdrawal by Subject|2|||
124867798|NCT00540124|449138071|FG000|Overall Study|Adverse Event|0|||
124867799|NCT00540124|449138072|FG001|Overall Study|Adverse Event|2|||
124867800|NCT00540124|449138073|FG002|Overall Study|Adverse Event|1|||
124867801|NCT00540124|449138071|FG000|Overall Study|Entry Criteria Not Met|2|||
124867802|NCT00540124|449138072|FG001|Overall Study|Entry Criteria Not Met|0|||
124867803|NCT00540124|449138073|FG002|Overall Study|Entry Criteria Not Met|0|||
124867804|NCT00540124|449138071|FG000|Overall Study|Lack of Efficacy|1|||
124867805|NCT00540124|449138072|FG001|Overall Study|Lack of Efficacy|0|||
124867806|NCT00540124|449138073|FG002|Overall Study|Lack of Efficacy|0|||
124867807|NCT00540124|449138071|FG000|Overall Study|Withdrawal by Subject|1|||
124867808|NCT00540124|449138072|FG001|Overall Study|Withdrawal by Subject|1|||
124867809|NCT00540124|449138073|FG002|Overall Study|Withdrawal by Subject|0|||
124867810|NCT01207102|449138077|FG000|Overall Study|Withdrawal by Subject|5|||
124867811|NCT01207102|449138077|FG000|Overall Study|Adverse Event|2|||
124867812|NCT01207102|449138077|FG000|Overall Study|progression|2|||
124867813|NCT01207102|449138077|FG000|Overall Study|Withdrawal by Treating Physician|1|||
124534581|NCT00660816|447909455|FG001|Overall Study|Death|2|||
124867814|NCT03792126|449138078|FG000|Overall Study|Adverse Event|1|||
124867815|NCT03792126|449138079|FG001|Overall Study|Adverse Event|2|||
124867816|NCT03792126|449138078|FG000|Overall Study|Death|0|||
124867817|NCT03792126|449138079|FG001|Overall Study|Death|1|||
124867818|NCT03792126|449138078|FG000|Overall Study|Lost to Follow-up|1|||
124867819|NCT03792126|449138079|FG001|Overall Study|Lost to Follow-up|0|||
124867820|NCT03792126|449138078|FG000|Overall Study|Withdrawal by Subject|0|||
124867821|NCT03792126|449138079|FG001|Overall Study|Withdrawal by Subject|1|||
124867822|NCT03792126|449138078|FG000|Overall Study|COVID-19 Restrictions|1|||
124867823|NCT03792126|449138079|FG001|Overall Study|COVID-19 Restrictions|3|||
124534582|NCT00660816|447909454|FG000|Overall Study|Lack of Efficacy|1|||
124534583|NCT00660816|447909455|FG001|Overall Study|Lack of Efficacy|0|||
124534584|NCT00660816|447909454|FG000|Overall Study|Physician Decision|0|||
124534585|NCT00660816|447909455|FG001|Overall Study|Physician Decision|2|||
124534586|NCT00660816|447909454|FG000|Overall Study|Protocol Violation|1|||
124534587|NCT00660816|447909455|FG001|Overall Study|Protocol Violation|0|||
124534588|NCT00660816|447909454|FG000|Overall Study|Disease Progression|16|||
124534589|NCT00660816|447909455|FG001|Overall Study|Disease Progression|12|||
124534590|NCT00660816|447909454|FG000|Overall Study|Complicating Disease|0|||
124534591|NCT00660816|447909455|FG001|Overall Study|Complicating Disease|1|||
124534592|NCT02692560|447909456|FG000|Overall Study|Withdrawal by Subject|0|||
124534593|NCT02692560|447909457|FG001|Overall Study|Withdrawal by Subject|6|||
124534594|NCT00420212|447909460|FG000|Overall Study|Adverse Event|22|||
124534595|NCT00420212|447909461|FG001|Overall Study|Adverse Event|40|||
124534596|NCT00420212|447909462|FG002|Overall Study|Adverse Event|36|||
124534597|NCT00420212|447909460|FG000|Overall Study|Lost to Follow-up|9|||
124534598|NCT00420212|447909461|FG001|Overall Study|Lost to Follow-up|11|||
124534599|NCT00420212|447909462|FG002|Overall Study|Lost to Follow-up|11|||
124534600|NCT00420212|447909460|FG000|Overall Study|Withdrawal by Subject|31|||
124534601|NCT00420212|447909461|FG001|Overall Study|Withdrawal by Subject|22|||
124534602|NCT00420212|447909462|FG002|Overall Study|Withdrawal by Subject|19|||
124534603|NCT00420212|447909460|FG000|Overall Study|Physician Decision|4|||
124534604|NCT00420212|447909461|FG001|Overall Study|Physician Decision|4|||
124534605|NCT00420212|447909462|FG002|Overall Study|Physician Decision|3|||
124534606|NCT00420212|447909460|FG000|Overall Study|Protocol Violation|4|||
124534607|NCT00420212|447909461|FG001|Overall Study|Protocol Violation|4|||
124534608|NCT00420212|447909462|FG002|Overall Study|Protocol Violation|8|||
124534609|NCT00420212|447909460|FG000|Overall Study|Death|0|||
124534610|NCT00420212|447909461|FG001|Overall Study|Death|0|||
124534611|NCT00420212|447909462|FG002|Overall Study|Death|1|||
124534612|NCT00420212|447909460|FG000|Overall Study|Other-Unspecified|21|||
124534613|NCT00420212|447909461|FG001|Overall Study|Other-Unspecified|14|||
124534614|NCT00420212|447909462|FG002|Overall Study|Other-Unspecified|18|||
124534615|NCT01326910|447909463|FG000|Overall Study|Withdrawal by Subject|3|||
124534616|NCT01326910|447909464|FG001|Overall Study|Withdrawal by Subject|2|||
124534617|NCT01326910|447909463|FG000|Overall Study|Protocol Violation|1|||
124534618|NCT01326910|447909464|FG001|Overall Study|Protocol Violation|1|||
124534619|NCT01681836|447909465|FG000|Second Intervention|Withdrawal by Subject|0|||
124534620|NCT01681836|447909466|FG001|Second Intervention|Withdrawal by Subject|1|||
124534621|NCT02394028|447909467|FG000|Induction Phase|Adverse Event|2|||
124534622|NCT02394028|447909468|FG001|Induction Phase|Adverse Event|4|||
124534623|NCT02394028|447909469|FG002|Induction Phase|Adverse Event|1|||
124534624|NCT02394028|447909470|FG003|Induction Phase|Adverse Event|2|||
124534625|NCT02394028|447909471|FG004|Induction Phase|Adverse Event|5|||
124534626|NCT02394028|447909472|FG005|Induction Phase|Adverse Event|2|||
124534627|NCT02394028|447909473|FG006|Induction Phase|Adverse Event|0|||
124534628|NCT02394028|447909474|FG007|Induction Phase|Adverse Event|0|||
124534629|NCT02394028|447909475|FG008|Induction Phase|Adverse Event|0|||
124534630|NCT02394028|447909476|FG009|Induction Phase|Adverse Event|0|||
124534631|NCT02394028|447909477|FG010|Induction Phase|Adverse Event|0|||
124534632|NCT02394028|447909467|FG000|Induction Phase|Lack of Efficacy|3|||
124534633|NCT02394028|447909468|FG001|Induction Phase|Lack of Efficacy|6|||
124534634|NCT02394028|447909469|FG002|Induction Phase|Lack of Efficacy|2|||
124867824|NCT03792126|449138078|FG000|Overall Study|Symptoms resolved|0|||
124867825|NCT03792126|449138079|FG001|Overall Study|Symptoms resolved|3|||
124867826|NCT02300220|449138080|FG000|Overall Study|Lost to Follow-up|1|||
124867827|NCT02300220|449138081|FG001|Overall Study|Lost to Follow-up|2|||
124867828|NCT02300220|449138080|FG000|Overall Study|Death|1|||
124867829|NCT02300220|449138081|FG001|Overall Study|Death|1|||
124867830|NCT02300220|449138080|FG000|Overall Study|Adverse Event|1|||
124867831|NCT02300220|449138081|FG001|Overall Study|Adverse Event|1|||
124867832|NCT02300220|449138080|FG000|Overall Study|Protocol Violation|1|||
124867833|NCT02300220|449138081|FG001|Overall Study|Protocol Violation|0|||
124867834|NCT02300220|449138080|FG000|Overall Study|Withdrawal by Subject|0|||
124867835|NCT02300220|449138081|FG001|Overall Study|Withdrawal by Subject|2|||
124867836|NCT02300220|449138080|FG000|Overall Study|Did not tolerate IMP|0|||
124867837|NCT02300220|449138081|FG001|Overall Study|Did not tolerate IMP|1|||
124867838|NCT04322682|449138082|FG000|Overall Study|Withdrawal by Subject|33|||
124867839|NCT04322682|449138083|FG001|Overall Study|Withdrawal by Subject|47|||
124867840|NCT04322682|449138082|FG000|Overall Study|Death|5|||
124534635|NCT02394028|447909470|FG003|Induction Phase|Lack of Efficacy|17|||
124867841|NCT04322682|449138083|FG001|Overall Study|Death|9|||
124867842|NCT04322682|449138082|FG000|Overall Study|Lost to Follow-up|4|||
124867843|NCT04322682|449138083|FG001|Overall Study|Lost to Follow-up|8|||
124867844|NCT04322682|449138082|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
124867845|NCT04322682|449138083|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
124867846|NCT02238379|449138084|FG000|Overall Study|Lost to Follow-up|1|||
124534636|NCT02394028|447909471|FG004|Induction Phase|Lack of Efficacy|14|||
124534637|NCT02394028|447909472|FG005|Induction Phase|Lack of Efficacy|8|||
124534638|NCT02394028|447909473|FG006|Induction Phase|Lack of Efficacy|17|||
124867847|NCT02238379|449138085|FG001|Overall Study|Lost to Follow-up|0|||
124867848|NCT00441090|449138086|FG000|Overall Study|Adverse Event|0|||
124867849|NCT00441090|449138087|FG001|Overall Study|Adverse Event|1|||
124867850|NCT00441090|449138088|FG002|Overall Study|Adverse Event|1|||
124867851|NCT00441090|449138089|FG003|Overall Study|Adverse Event|0|||
124867852|NCT00441090|449138090|FG004|Overall Study|Adverse Event|0|||
124867853|NCT00441090|449138086|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
124867854|NCT00441090|449138087|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
124867855|NCT00441090|449138088|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
124867856|NCT00441090|449138089|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
124867857|NCT00441090|449138090|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
124867858|NCT00441090|449138086|FG000|Overall Study|Withdrawal by Subject|1|||
124867859|NCT00441090|449138087|FG001|Overall Study|Withdrawal by Subject|0|||
124867860|NCT00441090|449138088|FG002|Overall Study|Withdrawal by Subject|1|||
124867861|NCT00441090|449138089|FG003|Overall Study|Withdrawal by Subject|0|||
124867862|NCT00441090|449138090|FG004|Overall Study|Withdrawal by Subject|0|||
124867863|NCT00441090|449138086|FG000|Overall Study|Lack of Efficacy|1|||
124867864|NCT00441090|449138087|FG001|Overall Study|Lack of Efficacy|0|||
124867865|NCT00441090|449138088|FG002|Overall Study|Lack of Efficacy|0|||
124867866|NCT00441090|449138089|FG003|Overall Study|Lack of Efficacy|0|||
124867867|NCT00441090|449138090|FG004|Overall Study|Lack of Efficacy|0|||
124867868|NCT01441102|449138091|FG000|Overall Study|Adverse Event|1|||
124867869|NCT01441102|449138091|FG000|Overall Study|Withdrawal by Subject|2|||
124867870|NCT00605280|449138092|FG000|Year 1|Protocol Violation|0|||
124867871|NCT00605280|449138093|FG001|Year 1|Protocol Violation|0|||
124867872|NCT00605280|449138094|FG002|Year 1|Protocol Violation|0|||
124867873|NCT00605280|449138095|FG003|Year 1|Protocol Violation|1|||
124867874|NCT00605280|449138092|FG000|Year 1|Adverse Event|3|||
124867875|NCT00605280|449138093|FG001|Year 1|Adverse Event|1|||
124867876|NCT00605280|449138094|FG002|Year 1|Adverse Event|1|||
124867877|NCT00605280|449138095|FG003|Year 1|Adverse Event|5|||
124867878|NCT00605280|449138092|FG000|Year 1|Physician Decision|7|||
124867879|NCT00605280|449138093|FG001|Year 1|Physician Decision|4|||
124867880|NCT00605280|449138094|FG002|Year 1|Physician Decision|0|||
124867881|NCT00605280|449138095|FG003|Year 1|Physician Decision|6|||
124867882|NCT00605280|449138092|FG000|Year 1|Withdrawal by Subject|2|||
124867883|NCT00605280|449138093|FG001|Year 1|Withdrawal by Subject|4|||
124867884|NCT00605280|449138094|FG002|Year 1|Withdrawal by Subject|0|||
124867885|NCT00605280|449138095|FG003|Year 1|Withdrawal by Subject|4|||
124867886|NCT00605280|449138092|FG000|Year 1|Other|2|||
124867887|NCT00605280|449138093|FG001|Year 1|Other|1|||
124867888|NCT00605280|449138094|FG002|Year 1|Other|0|||
124867889|NCT00605280|449138095|FG003|Year 1|Other|1|||
124867890|NCT00605280|449138092|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
124867891|NCT00605280|449138093|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
124867892|NCT00605280|449138094|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
124867893|NCT00605280|449138095|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
124867894|NCT00605280|449138092|FG000|Year 2|Adverse Event|4|||
124867895|NCT00605280|449138093|FG001|Year 2|Adverse Event|0|||
124867896|NCT00605280|449138094|FG002|Year 2|Adverse Event|2|||
124867897|NCT00605280|449138095|FG003|Year 2|Adverse Event|4|||
124867898|NCT00605280|449138092|FG000|Year 2|Physician Decision|11|||
124867899|NCT00605280|449138093|FG001|Year 2|Physician Decision|6|||
124867900|NCT00605280|449138094|FG002|Year 2|Physician Decision|4|||
124867901|NCT00605280|449138095|FG003|Year 2|Physician Decision|11|||
124867902|NCT00605280|449138092|FG000|Year 2|Withdrawal by Subject|4|||
124867903|NCT00605280|449138093|FG001|Year 2|Withdrawal by Subject|0|||
124867904|NCT00605280|449138094|FG002|Year 2|Withdrawal by Subject|0|||
124867905|NCT00605280|449138095|FG003|Year 2|Withdrawal by Subject|4|||
124867906|NCT00605280|449138092|FG000|Year 2|Other|1|||
124867907|NCT00605280|449138093|FG001|Year 2|Other|0|||
124867908|NCT00605280|449138094|FG002|Year 2|Other|0|||
124867909|NCT00605280|449138095|FG003|Year 2|Other|1|||
124867910|NCT00605280|449138092|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
124867911|NCT00605280|449138093|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
124867912|NCT00605280|449138094|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
124867913|NCT00605280|449138095|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
124867914|NCT00605280|449138092|FG000|Year 3 Extension|Adverse Event|2|||
124867915|NCT00605280|449138093|FG001|Year 3 Extension|Adverse Event|0|||
124867916|NCT00605280|449138094|FG002|Year 3 Extension|Adverse Event|0|||
124867917|NCT00605280|449138095|FG003|Year 3 Extension|Adverse Event|2|||
124867918|NCT00605280|449138092|FG000|Year 3 Extension|Physician Decision|0|||
124867919|NCT00605280|449138093|FG001|Year 3 Extension|Physician Decision|0|||
124867920|NCT00605280|449138094|FG002|Year 3 Extension|Physician Decision|0|||
124867921|NCT00605280|449138095|FG003|Year 3 Extension|Physician Decision|2|||
124867922|NCT00605280|449138092|FG000|Year 3 Extension|Withdrawal by Subject|2|||
124867923|NCT00605280|449138093|FG001|Year 3 Extension|Withdrawal by Subject|0|||
124867924|NCT00605280|449138094|FG002|Year 3 Extension|Withdrawal by Subject|0|||
124867925|NCT00605280|449138095|FG003|Year 3 Extension|Withdrawal by Subject|5|||
124867926|NCT00605280|449138092|FG000|Year 3 Extension|Other|2|||
124867927|NCT00605280|449138093|FG001|Year 3 Extension|Other|0|||
124867928|NCT00605280|449138094|FG002|Year 3 Extension|Other|0|||
124867929|NCT00605280|449138095|FG003|Year 3 Extension|Other|0|||
124867930|NCT00605280|449138092|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
124867931|NCT00605280|449138093|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
124867932|NCT00605280|449138094|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
124867933|NCT00605280|449138095|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
124867934|NCT02291614|449138096|FG000|Overall Study|Lost to Follow-up|0|||
124867935|NCT02291614|449138097|FG001|Overall Study|Lost to Follow-up|0|||
124867936|NCT02291614|449138098|FG002|Overall Study|Lost to Follow-up|0|||
124867937|NCT02291614|449138099|FG003|Overall Study|Lost to Follow-up|0|||
124867938|NCT02291614|449138100|FG004|Overall Study|Lost to Follow-up|0|||
124867939|NCT02291614|449138101|FG005|Overall Study|Lost to Follow-up|0|||
124867940|NCT02291614|449138102|FG006|Overall Study|Lost to Follow-up|0|||
124867941|NCT02291614|449138103|FG007|Overall Study|Lost to Follow-up|1|||
124867942|NCT02291614|449138104|FG008|Overall Study|Lost to Follow-up|0|||
124867943|NCT02291614|449138105|FG009|Overall Study|Lost to Follow-up|0|||
124867944|NCT02291614|449138106|FG010|Overall Study|Lost to Follow-up|0|||
124867945|NCT02291614|449138096|FG000|Overall Study|Withdrawal by Subject|0|||
124867946|NCT02291614|449138097|FG001|Overall Study|Withdrawal by Subject|1|||
124867947|NCT02291614|449138098|FG002|Overall Study|Withdrawal by Subject|0|||
124867948|NCT02291614|449138099|FG003|Overall Study|Withdrawal by Subject|0|||
124867949|NCT02291614|449138100|FG004|Overall Study|Withdrawal by Subject|0|||
124534639|NCT02394028|447909474|FG007|Induction Phase|Lack of Efficacy|23|||
124534640|NCT02394028|447909475|FG008|Induction Phase|Lack of Efficacy|0|||
124534641|NCT02394028|447909476|FG009|Induction Phase|Lack of Efficacy|0|||
124534642|NCT02394028|447909477|FG010|Induction Phase|Lack of Efficacy|0|||
124534643|NCT02394028|447909467|FG000|Induction Phase|Lost to Follow-up|1|||
124534644|NCT02394028|447909468|FG001|Induction Phase|Lost to Follow-up|0|||
124534645|NCT02394028|447909469|FG002|Induction Phase|Lost to Follow-up|0|||
124534646|NCT02394028|447909470|FG003|Induction Phase|Lost to Follow-up|1|||
124534647|NCT02394028|447909471|FG004|Induction Phase|Lost to Follow-up|0|||
124534648|NCT02394028|447909472|FG005|Induction Phase|Lost to Follow-up|0|||
124534649|NCT02394028|447909473|FG006|Induction Phase|Lost to Follow-up|1|||
124534650|NCT02394028|447909474|FG007|Induction Phase|Lost to Follow-up|0|||
124534651|NCT02394028|447909475|FG008|Induction Phase|Lost to Follow-up|0|||
124534652|NCT02394028|447909476|FG009|Induction Phase|Lost to Follow-up|0|||
124534653|NCT02394028|447909477|FG010|Induction Phase|Lost to Follow-up|0|||
124534654|NCT02394028|447909467|FG000|Induction Phase|Non-compliance|0|||
124867950|NCT02291614|449138101|FG005|Overall Study|Withdrawal by Subject|0|||
124867951|NCT02291614|449138102|FG006|Overall Study|Withdrawal by Subject|0|||
124867952|NCT02291614|449138103|FG007|Overall Study|Withdrawal by Subject|0|||
124867953|NCT02291614|449138104|FG008|Overall Study|Withdrawal by Subject|0|||
124867954|NCT02291614|449138105|FG009|Overall Study|Withdrawal by Subject|2|||
124867955|NCT02291614|449138106|FG010|Overall Study|Withdrawal by Subject|2|||
124867956|NCT02291614|449138096|FG000|Overall Study|Decision by sponsor|0|||
124867957|NCT02291614|449138097|FG001|Overall Study|Decision by sponsor|0|||
124867958|NCT02291614|449138098|FG002|Overall Study|Decision by sponsor|0|||
124867959|NCT02291614|449138099|FG003|Overall Study|Decision by sponsor|1|||
124867960|NCT02291614|449138100|FG004|Overall Study|Decision by sponsor|0|||
124867961|NCT02291614|449138101|FG005|Overall Study|Decision by sponsor|0|||
124867962|NCT02291614|449138102|FG006|Overall Study|Decision by sponsor|0|||
124867963|NCT02291614|449138103|FG007|Overall Study|Decision by sponsor|0|||
124867964|NCT02291614|449138104|FG008|Overall Study|Decision by sponsor|0|||
124867965|NCT02291614|449138105|FG009|Overall Study|Decision by sponsor|0|||
124867966|NCT02291614|449138106|FG010|Overall Study|Decision by sponsor|0|||
124867967|NCT02291614|449138096|FG000|Overall Study|Death|0|||
124534655|NCT02394028|447909468|FG001|Induction Phase|Non-compliance|1|||
124534656|NCT02394028|447909469|FG002|Induction Phase|Non-compliance|3|||
124534657|NCT02394028|447909470|FG003|Induction Phase|Non-compliance|1|||
124534658|NCT02394028|447909471|FG004|Induction Phase|Non-compliance|3|||
124534659|NCT02394028|447909472|FG005|Induction Phase|Non-compliance|0|||
124534660|NCT02394028|447909473|FG006|Induction Phase|Non-compliance|1|||
124534661|NCT02394028|447909474|FG007|Induction Phase|Non-compliance|1|||
124867968|NCT02291614|449138097|FG001|Overall Study|Death|0|||
124867969|NCT02291614|449138098|FG002|Overall Study|Death|1|||
124534662|NCT02394028|447909475|FG008|Induction Phase|Non-compliance|0|||
124534663|NCT02394028|447909476|FG009|Induction Phase|Non-compliance|0|||
124534664|NCT02394028|447909477|FG010|Induction Phase|Non-compliance|0|||
124534665|NCT02394028|447909467|FG000|Induction Phase|Physician Decision|0|||
124534666|NCT02394028|447909468|FG001|Induction Phase|Physician Decision|0|||
124534667|NCT02394028|447909469|FG002|Induction Phase|Physician Decision|1|||
124534668|NCT02394028|447909470|FG003|Induction Phase|Physician Decision|4|||
124867970|NCT02291614|449138099|FG003|Overall Study|Death|0|||
124867971|NCT02291614|449138100|FG004|Overall Study|Death|1|||
124867972|NCT02291614|449138101|FG005|Overall Study|Death|1|||
124867973|NCT02291614|449138102|FG006|Overall Study|Death|1|||
124867974|NCT02291614|449138103|FG007|Overall Study|Death|0|||
124867975|NCT02291614|449138104|FG008|Overall Study|Death|0|||
124867976|NCT02291614|449138105|FG009|Overall Study|Death|0|||
124867977|NCT02291614|449138106|FG010|Overall Study|Death|0|||
124867978|NCT01662310|449138107|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
124867979|NCT01662310|449138108|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
124867980|NCT01662310|449138109|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
124867981|NCT01662310|449138110|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
124867982|NCT01662310|449138111|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
124867983|NCT01662310|449138107|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
124867984|NCT01662310|449138108|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
124867985|NCT01662310|449138109|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
124867986|NCT01662310|449138110|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
124867987|NCT01662310|449138111|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
124867988|NCT01662310|449138107|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
124867989|NCT01662310|449138108|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
124867990|NCT01662310|449138109|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
124867991|NCT01662310|449138110|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
124534669|NCT02394028|447909471|FG004|Induction Phase|Physician Decision|0|||
124534670|NCT02394028|447909472|FG005|Induction Phase|Physician Decision|2|||
124534671|NCT02394028|447909473|FG006|Induction Phase|Physician Decision|1|||
124534672|NCT02394028|447909474|FG007|Induction Phase|Physician Decision|0|||
124534673|NCT02394028|447909475|FG008|Induction Phase|Physician Decision|0|||
124534674|NCT02394028|447909476|FG009|Induction Phase|Physician Decision|0|||
124534675|NCT02394028|447909477|FG010|Induction Phase|Physician Decision|0|||
124534676|NCT02394028|447909467|FG000|Induction Phase|Protocol Violation|0|||
124534677|NCT02394028|447909468|FG001|Induction Phase|Protocol Violation|2|||
124534678|NCT02394028|447909469|FG002|Induction Phase|Protocol Violation|0|||
124534679|NCT02394028|447909470|FG003|Induction Phase|Protocol Violation|3|||
124534680|NCT02394028|447909471|FG004|Induction Phase|Protocol Violation|0|||
124534681|NCT02394028|447909472|FG005|Induction Phase|Protocol Violation|1|||
124534682|NCT02394028|447909473|FG006|Induction Phase|Protocol Violation|1|||
124534683|NCT02394028|447909474|FG007|Induction Phase|Protocol Violation|0|||
124534684|NCT02394028|447909475|FG008|Induction Phase|Protocol Violation|0|||
124534685|NCT02394028|447909476|FG009|Induction Phase|Protocol Violation|0|||
124534686|NCT02394028|447909477|FG010|Induction Phase|Protocol Violation|0|||
124534687|NCT02394028|447909467|FG000|Induction Phase|Withdrawal by Subject|1|||
124534688|NCT02394028|447909468|FG001|Induction Phase|Withdrawal by Subject|2|||
124534689|NCT02394028|447909469|FG002|Induction Phase|Withdrawal by Subject|4|||
124534690|NCT02394028|447909470|FG003|Induction Phase|Withdrawal by Subject|6|||
124534691|NCT02394028|447909471|FG004|Induction Phase|Withdrawal by Subject|7|||
124534692|NCT02394028|447909472|FG005|Induction Phase|Withdrawal by Subject|4|||
124534693|NCT02394028|447909473|FG006|Induction Phase|Withdrawal by Subject|3|||
124534694|NCT02394028|447909474|FG007|Induction Phase|Withdrawal by Subject|6|||
124534695|NCT02394028|447909475|FG008|Induction Phase|Withdrawal by Subject|0|||
124534696|NCT02394028|447909476|FG009|Induction Phase|Withdrawal by Subject|0|||
124534697|NCT02394028|447909477|FG010|Induction Phase|Withdrawal by Subject|0|||
124534698|NCT02394028|447909467|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
124534699|NCT02394028|447909468|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
124534700|NCT02394028|447909469|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
124534701|NCT02394028|447909470|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
124534702|NCT02394028|447909471|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
124534703|NCT02394028|447909472|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
124534704|NCT02394028|447909473|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
124534705|NCT02394028|447909474|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
124534706|NCT02394028|447909475|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
124534707|NCT02394028|447909476|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
124534708|NCT02394028|447909477|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
124534709|NCT02394028|447909467|FG000|Induction Phase|Sponsor decision|0|||
124534710|NCT02394028|447909468|FG001|Induction Phase|Sponsor decision|1|||
124534711|NCT02394028|447909469|FG002|Induction Phase|Sponsor decision|2|||
124534712|NCT02394028|447909470|FG003|Induction Phase|Sponsor decision|0|||
124534713|NCT02394028|447909471|FG004|Induction Phase|Sponsor decision|0|||
124534714|NCT02394028|447909472|FG005|Induction Phase|Sponsor decision|0|||
124534715|NCT02394028|447909473|FG006|Induction Phase|Sponsor decision|0|||
124534716|NCT02394028|447909474|FG007|Induction Phase|Sponsor decision|0|||
124534717|NCT02394028|447909475|FG008|Induction Phase|Sponsor decision|0|||
124534718|NCT02394028|447909476|FG009|Induction Phase|Sponsor decision|0|||
124534719|NCT02394028|447909477|FG010|Induction Phase|Sponsor decision|0|||
124867992|NCT01662310|449138111|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
124867993|NCT01662310|449138107|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
124534720|NCT02394028|447909467|FG000|Induction Phase|Technical reason|0|||
124534721|NCT02394028|447909468|FG001|Induction Phase|Technical reason|0|||
124534722|NCT02394028|447909469|FG002|Induction Phase|Technical reason|0|||
124534723|NCT02394028|447909470|FG003|Induction Phase|Technical reason|1|||
124534724|NCT02394028|447909471|FG004|Induction Phase|Technical reason|0|||
124867994|NCT01662310|449138108|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
124867995|NCT01662310|449138109|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
124867996|NCT01662310|449138110|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
124867997|NCT01662310|449138111|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
124867998|NCT01662310|449138107|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
124867999|NCT01662310|449138108|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
124868000|NCT01662310|449138109|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
124534725|NCT02394028|447909472|FG005|Induction Phase|Technical reason|0|||
124534726|NCT02394028|447909473|FG006|Induction Phase|Technical reason|0|||
124534727|NCT02394028|447909474|FG007|Induction Phase|Technical reason|0|||
124534728|NCT02394028|447909475|FG008|Induction Phase|Technical reason|0|||
124534729|NCT02394028|447909476|FG009|Induction Phase|Technical reason|0|||
124534730|NCT02394028|447909477|FG010|Induction Phase|Technical reason|0|||
124534731|NCT02394028|447909467|FG000|Induction Phase|:ack of calculation|0|||
124534732|NCT02394028|447909468|FG001|Induction Phase|:ack of calculation|0|||
124534733|NCT02394028|447909469|FG002|Induction Phase|:ack of calculation|0|||
124534734|NCT02394028|447909470|FG003|Induction Phase|:ack of calculation|0|||
124534735|NCT02394028|447909471|FG004|Induction Phase|:ack of calculation|0|||
124534736|NCT02394028|447909472|FG005|Induction Phase|:ack of calculation|0|||
124534737|NCT02394028|447909473|FG006|Induction Phase|:ack of calculation|0|||
124534738|NCT02394028|447909474|FG007|Induction Phase|:ack of calculation|1|||
124534739|NCT02394028|447909475|FG008|Induction Phase|:ack of calculation|0|||
124534740|NCT02394028|447909476|FG009|Induction Phase|:ack of calculation|0|||
124534741|NCT02394028|447909477|FG010|Induction Phase|:ack of calculation|0|||
124534742|NCT02394028|447909467|FG000|Maintenance Phase|Protocol Violation|0|||
124534743|NCT02394028|447909468|FG001|Maintenance Phase|Protocol Violation|0|||
124534744|NCT02394028|447909469|FG002|Maintenance Phase|Protocol Violation|0|||
124534745|NCT02394028|447909470|FG003|Maintenance Phase|Protocol Violation|0|||
124534746|NCT02394028|447909471|FG004|Maintenance Phase|Protocol Violation|0|||
124534747|NCT02394028|447909472|FG005|Maintenance Phase|Protocol Violation|0|||
124534748|NCT02394028|447909473|FG006|Maintenance Phase|Protocol Violation|0|||
124534749|NCT02394028|447909474|FG007|Maintenance Phase|Protocol Violation|0|||
124534750|NCT02394028|447909475|FG008|Maintenance Phase|Protocol Violation|0|||
124534751|NCT02394028|447909476|FG009|Maintenance Phase|Protocol Violation|0|||
124534752|NCT02394028|447909477|FG010|Maintenance Phase|Protocol Violation|1|||
124534753|NCT02394028|447909467|FG000|Maintenance Phase|Physician Decision|0|||
124534754|NCT02394028|447909468|FG001|Maintenance Phase|Physician Decision|0|||
124534755|NCT02394028|447909469|FG002|Maintenance Phase|Physician Decision|0|||
124534756|NCT02394028|447909470|FG003|Maintenance Phase|Physician Decision|0|||
124534757|NCT02394028|447909471|FG004|Maintenance Phase|Physician Decision|0|||
124534758|NCT02394028|447909472|FG005|Maintenance Phase|Physician Decision|0|||
124534759|NCT02394028|447909473|FG006|Maintenance Phase|Physician Decision|0|||
124534760|NCT02394028|447909474|FG007|Maintenance Phase|Physician Decision|0|||
124534761|NCT02394028|447909475|FG008|Maintenance Phase|Physician Decision|1|||
124534762|NCT02394028|447909476|FG009|Maintenance Phase|Physician Decision|3|||
124534763|NCT02394028|447909477|FG010|Maintenance Phase|Physician Decision|2|||
124534764|NCT02394028|447909467|FG000|Maintenance Phase|Lack of Efficacy|0|||
124534765|NCT02394028|447909468|FG001|Maintenance Phase|Lack of Efficacy|0|||
124534766|NCT02394028|447909469|FG002|Maintenance Phase|Lack of Efficacy|0|||
124534767|NCT02394028|447909470|FG003|Maintenance Phase|Lack of Efficacy|0|||
124534768|NCT02394028|447909471|FG004|Maintenance Phase|Lack of Efficacy|0|||
124534769|NCT02394028|447909472|FG005|Maintenance Phase|Lack of Efficacy|0|||
124534770|NCT02394028|447909473|FG006|Maintenance Phase|Lack of Efficacy|0|||
124868001|NCT01662310|449138110|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
124868002|NCT01662310|449138111|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
124868003|NCT01662310|449138107|FG000|Run-In or Stabilization Phase|Other|1|||
124868004|NCT01662310|449138108|FG001|Run-In or Stabilization Phase|Other|0|||
124868005|NCT01662310|449138109|FG002|Run-In or Stabilization Phase|Other|0|||
124868006|NCT01662310|449138110|FG003|Run-In or Stabilization Phase|Other|0|||
124868007|NCT01662310|449138111|FG004|Run-In or Stabilization Phase|Other|0|||
124868008|NCT01662310|449138107|FG000|Double-Blind Phase|Adverse Event|0|||
124534771|NCT02394028|447909474|FG007|Maintenance Phase|Lack of Efficacy|0|||
124534772|NCT02394028|447909475|FG008|Maintenance Phase|Lack of Efficacy|7|||
124534773|NCT02394028|447909476|FG009|Maintenance Phase|Lack of Efficacy|25|||
124534774|NCT02394028|447909477|FG010|Maintenance Phase|Lack of Efficacy|33|||
124534775|NCT02394028|447909467|FG000|Maintenance Phase|Death|0|||
124534776|NCT02394028|447909468|FG001|Maintenance Phase|Death|0|||
124534777|NCT02394028|447909469|FG002|Maintenance Phase|Death|0|||
124534778|NCT02394028|447909470|FG003|Maintenance Phase|Death|0|||
124534779|NCT02394028|447909471|FG004|Maintenance Phase|Death|0|||
124534780|NCT02394028|447909472|FG005|Maintenance Phase|Death|0|||
124534781|NCT02394028|447909473|FG006|Maintenance Phase|Death|0|||
124534782|NCT02394028|447909474|FG007|Maintenance Phase|Death|0|||
124534783|NCT02394028|447909475|FG008|Maintenance Phase|Death|0|||
124868009|NCT01662310|449138108|FG001|Double-Blind Phase|Adverse Event|0|||
124868010|NCT01662310|449138109|FG002|Double-Blind Phase|Adverse Event|1|||
124868011|NCT01662310|449138110|FG003|Double-Blind Phase|Adverse Event|0|||
124868012|NCT01662310|449138111|FG004|Double-Blind Phase|Adverse Event|0|||
124868013|NCT01662310|449138107|FG000|Double-Blind Phase|Lost to Follow-up|0|||
124868014|NCT01662310|449138108|FG001|Double-Blind Phase|Lost to Follow-up|3|||
124868015|NCT01662310|449138109|FG002|Double-Blind Phase|Lost to Follow-up|0|||
124868016|NCT01662310|449138110|FG003|Double-Blind Phase|Lost to Follow-up|0|||
124868017|NCT01662310|449138111|FG004|Double-Blind Phase|Lost to Follow-up|0|||
124868018|NCT01662310|449138107|FG000|Double-Blind Phase|Pregnancy|0|||
124868019|NCT01662310|449138108|FG001|Double-Blind Phase|Pregnancy|2|||
124868020|NCT01662310|449138109|FG002|Double-Blind Phase|Pregnancy|0|||
124868021|NCT01662310|449138110|FG003|Double-Blind Phase|Pregnancy|0|||
124868022|NCT01662310|449138111|FG004|Double-Blind Phase|Pregnancy|0|||
124868023|NCT01662310|449138107|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
124868024|NCT01662310|449138108|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
124868025|NCT01662310|449138109|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
124868026|NCT01662310|449138110|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
124868027|NCT01662310|449138111|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
124868028|NCT01662310|449138107|FG000|Double-Blind Phase|Other|0|||
124868029|NCT01662310|449138108|FG001|Double-Blind Phase|Other|0|||
124868030|NCT01662310|449138109|FG002|Double-Blind Phase|Other|1|||
124868031|NCT01662310|449138110|FG003|Double-Blind Phase|Other|0|||
124868032|NCT01662310|449138111|FG004|Double-Blind Phase|Other|0|||
124868033|NCT01662310|449138107|FG000|Double-Blind Phase|Randomized but not treated|0|||
124868034|NCT01662310|449138108|FG001|Double-Blind Phase|Randomized but not treated|1|||
124868035|NCT01662310|449138109|FG002|Double-Blind Phase|Randomized but not treated|0|||
124868036|NCT01662310|449138110|FG003|Double-Blind Phase|Randomized but not treated|0|||
124868037|NCT01662310|449138111|FG004|Double-Blind Phase|Randomized but not treated|0|||
124868038|NCT01662310|449138107|FG000|Open-Label Extension Phase|Adverse Event|0|||
124868039|NCT01662310|449138108|FG001|Open-Label Extension Phase|Adverse Event|0|||
124868040|NCT01662310|449138109|FG002|Open-Label Extension Phase|Adverse Event|0|||
124868041|NCT01662310|449138110|FG003|Open-Label Extension Phase|Adverse Event|3|||
124868042|NCT01662310|449138111|FG004|Open-Label Extension Phase|Adverse Event|0|||
124868043|NCT01662310|449138107|FG000|Open-Label Extension Phase|Death|0|||
124868044|NCT01662310|449138108|FG001|Open-Label Extension Phase|Death|0|||
124868045|NCT01662310|449138109|FG002|Open-Label Extension Phase|Death|0|||
124868046|NCT01662310|449138110|FG003|Open-Label Extension Phase|Death|1|||
124868047|NCT01662310|449138111|FG004|Open-Label Extension Phase|Death|0|||
124868048|NCT01662310|449138107|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
124868049|NCT01662310|449138108|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
124868050|NCT01662310|449138109|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
124868051|NCT01662310|449138110|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
124868052|NCT01662310|449138111|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
124868053|NCT01662310|449138107|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
124868054|NCT01662310|449138108|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
124868055|NCT01662310|449138109|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
124868056|NCT01662310|449138110|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
124868057|NCT01662310|449138111|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
124868058|NCT01662310|449138107|FG000|Open-Label Extension Phase|Pregnancy|0|||
124868059|NCT01662310|449138108|FG001|Open-Label Extension Phase|Pregnancy|0|||
124868060|NCT01662310|449138109|FG002|Open-Label Extension Phase|Pregnancy|0|||
124868061|NCT01662310|449138110|FG003|Open-Label Extension Phase|Pregnancy|1|||
124868062|NCT01662310|449138111|FG004|Open-Label Extension Phase|Pregnancy|0|||
124868063|NCT01662310|449138107|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
124868064|NCT01662310|449138108|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
124868065|NCT01662310|449138109|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
124868066|NCT01662310|449138110|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
124868067|NCT01662310|449138111|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
124868068|NCT01302847|449138113|FG000|Overall Study|Death|0|||
124868069|NCT01302847|449138114|FG001|Overall Study|Death|1|||
124868070|NCT01302847|449138115|FG002|Overall Study|Death|0|||
124868071|NCT01302847|449138116|FG003|Overall Study|Death|0|||
124868072|NCT01302847|449138117|FG004|Overall Study|Death|0|||
124868073|NCT01302847|449138118|FG005|Overall Study|Death|1|||
124868074|NCT01302847|449138119|FG006|Overall Study|Death|1|||
124868075|NCT01302847|449138120|FG007|Overall Study|Death|0|||
124868076|NCT01302847|449138113|FG000|Overall Study|Pregnancy|2|||
124868077|NCT01302847|449138114|FG001|Overall Study|Pregnancy|0|||
124868078|NCT01302847|449138115|FG002|Overall Study|Pregnancy|0|||
124868079|NCT01302847|449138116|FG003|Overall Study|Pregnancy|0|||
124868080|NCT01302847|449138117|FG004|Overall Study|Pregnancy|0|||
124868081|NCT01302847|449138118|FG005|Overall Study|Pregnancy|0|||
124868082|NCT01302847|449138119|FG006|Overall Study|Pregnancy|0|||
124868083|NCT01302847|449138120|FG007|Overall Study|Pregnancy|0|||
124868084|NCT01302847|449138113|FG000|Overall Study|Virologic failure|0|||
124868085|NCT01302847|449138114|FG001|Overall Study|Virologic failure|2|||
124868086|NCT01302847|449138115|FG002|Overall Study|Virologic failure|0|||
124534784|NCT02394028|447909476|FG009|Maintenance Phase|Death|0|||
124868087|NCT01302847|449138116|FG003|Overall Study|Virologic failure|2|||
124868088|NCT01302847|449138117|FG004|Overall Study|Virologic failure|1|||
124534785|NCT02394028|447909477|FG010|Maintenance Phase|Death|1|||
124534786|NCT02394028|447909467|FG000|Maintenance Phase|Adverse Event|0|||
124534787|NCT02394028|447909468|FG001|Maintenance Phase|Adverse Event|0|||
124534788|NCT02394028|447909469|FG002|Maintenance Phase|Adverse Event|0|||
124534789|NCT02394028|447909470|FG003|Maintenance Phase|Adverse Event|0|||
124534790|NCT02394028|447909471|FG004|Maintenance Phase|Adverse Event|0|||
124534791|NCT02394028|447909472|FG005|Maintenance Phase|Adverse Event|0|||
124534792|NCT02394028|447909473|FG006|Maintenance Phase|Adverse Event|0|||
124534793|NCT02394028|447909474|FG007|Maintenance Phase|Adverse Event|0|||
124534794|NCT02394028|447909475|FG008|Maintenance Phase|Adverse Event|1|||
124534795|NCT02394028|447909476|FG009|Maintenance Phase|Adverse Event|1|||
124534796|NCT02394028|447909477|FG010|Maintenance Phase|Adverse Event|3|||
124534797|NCT02394028|447909467|FG000|Maintenance Phase|Site closure|0|||
124534798|NCT02394028|447909468|FG001|Maintenance Phase|Site closure|0|||
124534799|NCT02394028|447909469|FG002|Maintenance Phase|Site closure|0|||
124534800|NCT02394028|447909470|FG003|Maintenance Phase|Site closure|0|||
124534801|NCT02394028|447909471|FG004|Maintenance Phase|Site closure|0|||
124534802|NCT02394028|447909472|FG005|Maintenance Phase|Site closure|0|||
124534803|NCT02394028|447909473|FG006|Maintenance Phase|Site closure|0|||
124534804|NCT02394028|447909474|FG007|Maintenance Phase|Site closure|0|||
124534805|NCT02394028|447909475|FG008|Maintenance Phase|Site closure|0|||
124534806|NCT02394028|447909476|FG009|Maintenance Phase|Site closure|1|||
124534807|NCT02394028|447909477|FG010|Maintenance Phase|Site closure|0|||
124534808|NCT02394028|447909467|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124534809|NCT02394028|447909468|FG001|Maintenance Phase|Withdrawal by Subject|0|||
124534810|NCT02394028|447909469|FG002|Maintenance Phase|Withdrawal by Subject|0|||
124534811|NCT02394028|447909470|FG003|Maintenance Phase|Withdrawal by Subject|0|||
124534812|NCT02394028|447909471|FG004|Maintenance Phase|Withdrawal by Subject|0|||
124534813|NCT02394028|447909472|FG005|Maintenance Phase|Withdrawal by Subject|0|||
124534814|NCT02394028|447909473|FG006|Maintenance Phase|Withdrawal by Subject|0|||
124534815|NCT02394028|447909474|FG007|Maintenance Phase|Withdrawal by Subject|0|||
124534816|NCT02394028|447909475|FG008|Maintenance Phase|Withdrawal by Subject|3|||
124534817|NCT02394028|447909476|FG009|Maintenance Phase|Withdrawal by Subject|12|||
124534818|NCT02394028|447909477|FG010|Maintenance Phase|Withdrawal by Subject|12|||
124534819|NCT02142712|447909480|FG000|Overall Study|Lost to Follow-up|1|||
124534820|NCT02142712|447909481|FG001|Overall Study|Lost to Follow-up|1|||
124534821|NCT02142712|447909482|FG002|Overall Study|Lost to Follow-up|1|||
124534822|NCT02142712|447909483|FG003|Overall Study|Lost to Follow-up|0|||
124534823|NCT01981096|447909490|FG000|Overall Study|Parent illness|1|||
124534824|NCT01981096|447909491|FG001|Overall Study|Parent illness|0|||
124534825|NCT01981096|447909490|FG000|Overall Study|Withdrawal by Subject|0|||
124534826|NCT01981096|447909491|FG001|Overall Study|Withdrawal by Subject|1|||
124534827|NCT01981096|447909490|FG000|Overall Study|Lost to Follow-up|2|||
124534828|NCT01981096|447909491|FG001|Overall Study|Lost to Follow-up|0|||
124534829|NCT01225211|447909492|FG000|Overall Study|Adverse Event|0|||
124534830|NCT01225211|447909493|FG001|Overall Study|Adverse Event|0|||
124534831|NCT01225211|447909494|FG002|Overall Study|Adverse Event|1|||
124534832|NCT01225211|447909495|FG003|Overall Study|Adverse Event|0|||
124534833|NCT01225211|447909496|FG004|Overall Study|Adverse Event|0|||
124534834|NCT01225211|447909497|FG005|Overall Study|Adverse Event|0|||
124534835|NCT01225211|447909498|FG006|Overall Study|Adverse Event|0|||
124534836|NCT01225211|447909499|FG007|Overall Study|Adverse Event|0|||
124534837|NCT01225211|447909500|FG008|Overall Study|Adverse Event|0|||
124534838|NCT01225211|447909501|FG009|Overall Study|Adverse Event|1|||
124534839|NCT01225211|447909492|FG000|Overall Study|Withdrawal by Subject|0|||
124534840|NCT01225211|447909493|FG001|Overall Study|Withdrawal by Subject|0|||
124534841|NCT01225211|447909494|FG002|Overall Study|Withdrawal by Subject|0|||
124534842|NCT01225211|447909495|FG003|Overall Study|Withdrawal by Subject|0|||
124534843|NCT01225211|447909496|FG004|Overall Study|Withdrawal by Subject|0|||
124534844|NCT01225211|447909497|FG005|Overall Study|Withdrawal by Subject|0|||
124534845|NCT01225211|447909498|FG006|Overall Study|Withdrawal by Subject|1|||
124534846|NCT01225211|447909499|FG007|Overall Study|Withdrawal by Subject|0|||
124534847|NCT01225211|447909500|FG008|Overall Study|Withdrawal by Subject|1|||
124534848|NCT01225211|447909501|FG009|Overall Study|Withdrawal by Subject|3|||
124534849|NCT01225211|447909492|FG000|Overall Study|Other|0|||
124534850|NCT01225211|447909493|FG001|Overall Study|Other|0|||
124868089|NCT01302847|449138118|FG005|Overall Study|Virologic failure|3|||
124534851|NCT01225211|447909494|FG002|Overall Study|Other|0|||
124534852|NCT01225211|447909495|FG003|Overall Study|Other|0|||
124534853|NCT01225211|447909496|FG004|Overall Study|Other|0|||
124534854|NCT01225211|447909497|FG005|Overall Study|Other|0|||
124534855|NCT01225211|447909498|FG006|Overall Study|Other|0|||
124534856|NCT01225211|447909499|FG007|Overall Study|Other|0|||
124534857|NCT01225211|447909500|FG008|Overall Study|Other|0|||
124534858|NCT01225211|447909501|FG009|Overall Study|Other|1|||
124534859|NCT01241318|447909504|FG000|Overall Study|Woman: false pregnancies|27|||
124534860|NCT01241318|447909505|FG001|Overall Study|Woman: false pregnancies|15|||
124534861|NCT01241318|447909504|FG000|Overall Study|Woman: miscarriage/abortion|46|||
124534862|NCT01241318|447909505|FG001|Overall Study|Woman: miscarriage/abortion|38|||
124868090|NCT01302847|449138119|FG006|Overall Study|Virologic failure|1|||
124868091|NCT01302847|449138120|FG007|Overall Study|Virologic failure|2|||
124868092|NCT01302847|449138113|FG000|Overall Study|Severe debilitation, unable to continue|0|||
124868093|NCT01302847|449138114|FG001|Overall Study|Severe debilitation, unable to continue|0|||
124868094|NCT01302847|449138115|FG002|Overall Study|Severe debilitation, unable to continue|0|||
124868095|NCT01302847|449138116|FG003|Overall Study|Severe debilitation, unable to continue|0|||
124868096|NCT01302847|449138117|FG004|Overall Study|Severe debilitation, unable to continue|0|||
124868097|NCT01302847|449138118|FG005|Overall Study|Severe debilitation, unable to continue|1|||
124868098|NCT01302847|449138119|FG006|Overall Study|Severe debilitation, unable to continue|1|||
124868099|NCT01302847|449138120|FG007|Overall Study|Severe debilitation, unable to continue|0|||
124868100|NCT01302847|449138113|FG000|Overall Study|Not able to get to clinic|1|||
124868101|NCT01302847|449138114|FG001|Overall Study|Not able to get to clinic|1|||
124868102|NCT01302847|449138115|FG002|Overall Study|Not able to get to clinic|0|||
124868103|NCT01302847|449138116|FG003|Overall Study|Not able to get to clinic|0|||
124868104|NCT01302847|449138117|FG004|Overall Study|Not able to get to clinic|0|||
124868105|NCT01302847|449138118|FG005|Overall Study|Not able to get to clinic|0|||
124868106|NCT01302847|449138119|FG006|Overall Study|Not able to get to clinic|0|||
124868107|NCT01302847|449138120|FG007|Overall Study|Not able to get to clinic|0|||
124868108|NCT01302847|449138113|FG000|Overall Study|Site closing|2|||
124868109|NCT01302847|449138114|FG001|Overall Study|Site closing|2|||
124534863|NCT01241318|447909504|FG000|Overall Study|Withdrawal by Subject|175|||
124534864|NCT01241318|447909505|FG001|Overall Study|Withdrawal by Subject|46|||
124534865|NCT01241318|447909504|FG000|Overall Study|Lost to Follow-up|740|||
124534866|NCT01241318|447909505|FG001|Overall Study|Lost to Follow-up|455|||
124534867|NCT01241318|447909504|FG000|Overall Study|Death|2|||
124534868|NCT01241318|447909505|FG001|Overall Study|Death|4|||
124534869|NCT01241318|447909504|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
124534870|NCT01241318|447909505|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
124534871|NCT01241318|447909504|FG000|Overall Study|Woman: Stillborn infant|129|||
124534872|NCT01241318|447909505|FG001|Overall Study|Woman: Stillborn infant|146|||
124534873|NCT04129242|447909513|FG000|Overall Study|Physician Decision|1|||
124534874|NCT04129242|447909514|FG001|Overall Study|Physician Decision|1|||
124534875|NCT04129242|447909513|FG000|Overall Study|Protocol Violation|0|||
124534876|NCT04129242|447909514|FG001|Overall Study|Protocol Violation|1|||
124534877|NCT00392210|447909518|FG000|First Voiding Trial|Physician Decision|2|||
124534878|NCT00392210|447909519|FG001|First Voiding Trial|Physician Decision|2|||
124534879|NCT02140762|447909520|FG000|Overall Study|Adverse Event|1|||
124534880|NCT02140762|447909521|FG001|Overall Study|Adverse Event|1|||
124534881|NCT02140762|447909520|FG000|Overall Study|Lost to Follow-up|9|||
124534882|NCT02140762|447909521|FG001|Overall Study|Lost to Follow-up|5|||
124534883|NCT02140762|447909520|FG000|Overall Study|Protocol Violation|1|||
124534884|NCT02140762|447909521|FG001|Overall Study|Protocol Violation|1|||
124534885|NCT02140762|447909520|FG000|Overall Study|Withdrawal by Subject|6|||
124534886|NCT02140762|447909521|FG001|Overall Study|Withdrawal by Subject|4|||
124534887|NCT02140762|447909520|FG000|Overall Study|Other|0|||
124534888|NCT02140762|447909521|FG001|Overall Study|Other|1|||
124534889|NCT04815291|447909522|FG000|Overall Study|Lost to Follow-up|1|||
124534890|NCT04815291|447909522|FG000|Overall Study|Physician Decision|4|||
124534891|NCT04815291|447909522|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
124534892|NCT00962780|447909526|FG000|Overall Study|Death|0|||
124534893|NCT00962780|447909527|FG001|Overall Study|Death|1|||
124534894|NCT00962780|447909526|FG000|Overall Study|Protocol Violation|9|||
124534895|NCT00962780|447909527|FG001|Overall Study|Protocol Violation|4|||
124534896|NCT00962780|447909526|FG000|Overall Study|Withdrawal by Subject|1|||
124534897|NCT00962780|447909527|FG001|Overall Study|Withdrawal by Subject|8|||
124534898|NCT00962780|447909526|FG000|Overall Study|Other|0|||
124534899|NCT00962780|447909527|FG001|Overall Study|Other|1|||
124534900|NCT01775995|447909528|FG000|Overall Study|Lost to Follow-up|1|||
124534901|NCT01775995|447909529|FG001|Overall Study|Lost to Follow-up|1|||
124534902|NCT02055976|447909530|FG000|Overall Study|Other|0|||
124534903|NCT02055976|447909531|FG001|Overall Study|Other|0|||
124534904|NCT02055976|447909532|FG002|Overall Study|Other|1|||
124534905|NCT02055976|447909533|FG003|Overall Study|Other|0|||
124534906|NCT02055976|447909534|FG004|Overall Study|Other|0|||
124534907|NCT02055976|447909535|FG005|Overall Study|Other|0|||
124534908|NCT02055976|447909536|FG006|Overall Study|Other|0|||
124534909|NCT02055976|447909537|FG007|Overall Study|Other|0|||
124534910|NCT02055976|447909538|FG008|Overall Study|Other|0|||
124534911|NCT02055976|447909530|FG000|Overall Study|Adverse Event|0|||
124534912|NCT02055976|447909531|FG001|Overall Study|Adverse Event|0|||
124868110|NCT01302847|449138115|FG002|Overall Study|Site closing|0|||
124868111|NCT01302847|449138116|FG003|Overall Study|Site closing|0|||
124868112|NCT01302847|449138117|FG004|Overall Study|Site closing|0|||
124868113|NCT01302847|449138118|FG005|Overall Study|Site closing|0|||
124534913|NCT02055976|447909532|FG002|Overall Study|Adverse Event|0|||
124534914|NCT02055976|447909533|FG003|Overall Study|Adverse Event|0|||
124534915|NCT02055976|447909534|FG004|Overall Study|Adverse Event|0|||
124868114|NCT01302847|449138119|FG006|Overall Study|Site closing|0|||
124534916|NCT02055976|447909535|FG005|Overall Study|Adverse Event|1|||
124534917|NCT02055976|447909536|FG006|Overall Study|Adverse Event|1|||
124534918|NCT02055976|447909537|FG007|Overall Study|Adverse Event|0|||
124534919|NCT02055976|447909538|FG008|Overall Study|Adverse Event|0|||
124534920|NCT02055976|447909530|FG000|Overall Study|Does not meet entrance criteria|0|||
124534921|NCT02055976|447909531|FG001|Overall Study|Does not meet entrance criteria|0|||
124534922|NCT02055976|447909532|FG002|Overall Study|Does not meet entrance criteria|0|||
124534923|NCT02055976|447909533|FG003|Overall Study|Does not meet entrance criteria|0|||
124534924|NCT02055976|447909534|FG004|Overall Study|Does not meet entrance criteria|0|||
124534925|NCT02055976|447909535|FG005|Overall Study|Does not meet entrance criteria|0|||
124534926|NCT02055976|447909536|FG006|Overall Study|Does not meet entrance criteria|1|||
124868115|NCT01302847|449138120|FG007|Overall Study|Site closing|0|||
124868116|NCT01302847|449138113|FG000|Overall Study|Withdrawal by Subject|1|||
124534927|NCT02055976|447909537|FG007|Overall Study|Does not meet entrance criteria|0|||
124534928|NCT02055976|447909538|FG008|Overall Study|Does not meet entrance criteria|0|||
124534929|NCT02055976|447909530|FG000|Overall Study|Lost to Follow-up|0|||
124868117|NCT01302847|449138114|FG001|Overall Study|Withdrawal by Subject|0|||
124534930|NCT02055976|447909531|FG001|Overall Study|Lost to Follow-up|0|||
124534931|NCT02055976|447909532|FG002|Overall Study|Lost to Follow-up|0|||
124534932|NCT02055976|447909533|FG003|Overall Study|Lost to Follow-up|1|||
124534933|NCT02055976|447909534|FG004|Overall Study|Lost to Follow-up|0|||
124534934|NCT02055976|447909535|FG005|Overall Study|Lost to Follow-up|0|||
124534935|NCT02055976|447909536|FG006|Overall Study|Lost to Follow-up|0|||
124534936|NCT02055976|447909537|FG007|Overall Study|Lost to Follow-up|0|||
124534937|NCT02055976|447909538|FG008|Overall Study|Lost to Follow-up|0|||
124534938|NCT03458234|447909546|FG000|Overall Study|Withdrawal by Subject|1|||
124534939|NCT01640353|447911614|FG000|Overall Study|Withdrew prior to treatment|10|||
124534940|NCT01640353|447911614|FG000|Overall Study|Withdrawn from analysis at term site|12|||
124534941|NCT01640353|447911614|FG000|Overall Study|Withdrawal by Subject|5|||
124534942|NCT01640353|447911614|FG000|Overall Study|Death|2|||
124534943|NCT01640353|447911614|FG000|Overall Study|Early site termination|3|||
124534944|NCT01640353|447911614|FG000|Overall Study|Lost to Follow-up|12|||
124534945|NCT01640353|447911614|FG000|Overall Study|Physician Decision|1|||
124534946|NCT03758612|447911615|FG000|Washout Period|Withdrawal by Subject|0|||
124534947|NCT03758612|447911616|FG001|Washout Period|Withdrawal by Subject|0|||
124534948|NCT03758612|447911617|FG002|Washout Period|Withdrawal by Subject|2|||
124534949|NCT03758612|447911618|FG003|Washout Period|Withdrawal by Subject|0|||
124868118|NCT01302847|449138115|FG002|Overall Study|Withdrawal by Subject|0|||
124868119|NCT01302847|449138116|FG003|Overall Study|Withdrawal by Subject|0|||
124868120|NCT01302847|449138117|FG004|Overall Study|Withdrawal by Subject|1|||
124868121|NCT01302847|449138118|FG005|Overall Study|Withdrawal by Subject|0|||
124868122|NCT01302847|449138119|FG006|Overall Study|Withdrawal by Subject|0|||
124868123|NCT01302847|449138120|FG007|Overall Study|Withdrawal by Subject|1|||
124868124|NCT01302847|449138113|FG000|Overall Study|Not willing to adhere to requirements|5|||
124868125|NCT01302847|449138114|FG001|Overall Study|Not willing to adhere to requirements|0|||
124868126|NCT01302847|449138115|FG002|Overall Study|Not willing to adhere to requirements|1|||
124868127|NCT01302847|449138116|FG003|Overall Study|Not willing to adhere to requirements|0|||
124868128|NCT01302847|449138117|FG004|Overall Study|Not willing to adhere to requirements|0|||
124868129|NCT01302847|449138118|FG005|Overall Study|Not willing to adhere to requirements|0|||
124868130|NCT01302847|449138119|FG006|Overall Study|Not willing to adhere to requirements|0|||
124868131|NCT01302847|449138120|FG007|Overall Study|Not willing to adhere to requirements|2|||
124868132|NCT01302847|449138113|FG000|Overall Study|Site unable to contact participant|2|||
124868133|NCT01302847|449138114|FG001|Overall Study|Site unable to contact participant|1|||
124868134|NCT01302847|449138115|FG002|Overall Study|Site unable to contact participant|0|||
124868135|NCT01302847|449138116|FG003|Overall Study|Site unable to contact participant|0|||
124868136|NCT01302847|449138117|FG004|Overall Study|Site unable to contact participant|0|||
124868137|NCT01302847|449138118|FG005|Overall Study|Site unable to contact participant|0|||
124868138|NCT01302847|449138119|FG006|Overall Study|Site unable to contact participant|2|||
124868139|NCT01302847|449138120|FG007|Overall Study|Site unable to contact participant|0|||
124868140|NCT00374322|449138122|FG000|Overall Study|Lost to Follow-up|92|||
124868141|NCT00374322|449138123|FG001|Overall Study|Lost to Follow-up|90|||
124868142|NCT00374322|449138122|FG000|Overall Study|Protocol Violation|8|||
124868143|NCT00374322|449138123|FG001|Overall Study|Protocol Violation|3|||
124868144|NCT00374322|449138122|FG000|Overall Study|Withdrawal by Subject|235|||
124868145|NCT00374322|449138123|FG001|Overall Study|Withdrawal by Subject|167|||
124868146|NCT00374322|449138122|FG000|Overall Study|Sponsor Terminated Study|866|||
124868147|NCT00374322|449138123|FG001|Overall Study|Sponsor Terminated Study|990|||
124534950|NCT03758612|447911619|FG004|Washout Period|Withdrawal by Subject|0|||
124534951|NCT03758612|447911620|FG005|Washout Period|Withdrawal by Subject|0|||
124534952|NCT03758612|447911621|FG006|Washout Period|Withdrawal by Subject|0|||
124534953|NCT03758612|447911622|FG007|Washout Period|Withdrawal by Subject|0|||
124534954|NCT03758612|447911623|FG008|Washout Period|Withdrawal by Subject|0|||
124534955|NCT03758612|447911624|FG009|Washout Period|Withdrawal by Subject|0|||
124534956|NCT03758612|447911625|FG010|Washout Period|Withdrawal by Subject|0|||
124868148|NCT00374322|449138122|FG000|Overall Study|Physician Decision|36|||
124868149|NCT00374322|449138123|FG001|Overall Study|Physician Decision|32|||
124868150|NCT00374322|449138122|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
124868151|NCT00374322|449138123|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
124868152|NCT00374322|449138122|FG000|Overall Study|Sponsor Decision|2|||
124868153|NCT00374322|449138123|FG001|Overall Study|Sponsor Decision|3|||
124868154|NCT00374322|449138122|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
124868155|NCT00374322|449138123|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
124534957|NCT03758612|447911626|FG011|Washout Period|Withdrawal by Subject|0|||
124534958|NCT03758612|447911615|FG000|Period 2|Protocol Violation|0|||
124534959|NCT03758612|447911616|FG001|Period 2|Protocol Violation|0|||
124534960|NCT03758612|447911617|FG002|Period 2|Protocol Violation|0|||
124534961|NCT03758612|447911618|FG003|Period 2|Protocol Violation|0|||
124534962|NCT03758612|447911619|FG004|Period 2|Protocol Violation|1|||
124534963|NCT03758612|447911620|FG005|Period 2|Protocol Violation|0|||
124534964|NCT03758612|447911621|FG006|Period 2|Protocol Violation|0|||
124534965|NCT03758612|447911622|FG007|Period 2|Protocol Violation|0|||
124534966|NCT03758612|447911623|FG008|Period 2|Protocol Violation|0|||
124534967|NCT03758612|447911624|FG009|Period 2|Protocol Violation|0|||
124534968|NCT03758612|447911625|FG010|Period 2|Protocol Violation|0|||
124534969|NCT03758612|447911626|FG011|Period 2|Protocol Violation|0|||
124534970|NCT01603615|447911628|FG000|Overall Study|Did not Receive Treatment|7|||
124534971|NCT01603615|447911628|FG000|Overall Study|Lost to Follow-up|9|||
124534972|NCT01603615|447911628|FG000|Overall Study|Personal Reasons|17|||
124534973|NCT01603615|447911628|FG000|Overall Study|Other Miscellaneous|1|||
124534974|NCT03419741|447911629|FG000|Overall Study|Adverse Event|1|||
124534975|NCT03419741|447911630|FG001|Overall Study|Adverse Event|0|||
124534976|NCT03419741|447911629|FG000|Overall Study|Withdrawal by Subject|1|||
124534977|NCT03419741|447911630|FG001|Overall Study|Withdrawal by Subject|2|||
124534978|NCT04354870|447911631|FG000|Overall Study|Lost to Follow-up|32|||
124534979|NCT04354870|447911632|FG001|Overall Study|Lost to Follow-up|12|||
124534980|NCT04354870|447911631|FG000|Overall Study|Withdrawal by Subject|10|||
124534981|NCT04354870|447911632|FG001|Overall Study|Withdrawal by Subject|16|||
124534982|NCT04354870|447911631|FG000|Overall Study|Did not complete all study visits|6|||
124534983|NCT04354870|447911632|FG001|Overall Study|Did not complete all study visits|5|||
124534984|NCT03384316|447911633|FG000|Overall Study|Screen failure|0|||
124534985|NCT03384316|447911634|FG001|Overall Study|Screen failure|1|||
124534986|NCT04450394|447911645|FG000|Overall Study|Adverse Event|2|||
124534987|NCT04450394|447911646|FG001|Overall Study|Adverse Event|0|||
124534988|NCT04450394|447911647|FG002|Overall Study|Adverse Event|0|||
124534989|NCT04450394|447911645|FG000|Overall Study|Death|0|||
124534990|NCT04450394|447911646|FG001|Overall Study|Death|1|||
124534991|NCT04450394|447911647|FG002|Overall Study|Death|0|||
124534992|NCT04450394|447911645|FG000|Overall Study|Lost to Follow-up|0|||
124534993|NCT04450394|447911646|FG001|Overall Study|Lost to Follow-up|3|||
124534994|NCT04450394|447911647|FG002|Overall Study|Lost to Follow-up|0|||
124534995|NCT04450394|447911645|FG000|Overall Study|Physician Decision|0|||
124534996|NCT04450394|447911646|FG001|Overall Study|Physician Decision|1|||
124534997|NCT04450394|447911647|FG002|Overall Study|Physician Decision|0|||
124534998|NCT04450394|447911645|FG000|Overall Study|Protocol Violation|2|||
124534999|NCT04450394|447911646|FG001|Overall Study|Protocol Violation|0|||
124535000|NCT04450394|447911647|FG002|Overall Study|Protocol Violation|0|||
124535001|NCT04450394|447911645|FG000|Overall Study|Withdrawal by Subject|6|||
124535002|NCT04450394|447911646|FG001|Overall Study|Withdrawal by Subject|9|||
124535003|NCT04450394|447911647|FG002|Overall Study|Withdrawal by Subject|0|||
124535004|NCT02194699|447911648|FG000|Randomised|Did not receive treatment|1|||
124535005|NCT02194699|447911649|FG001|Randomised|Did not receive treatment|5|||
124535006|NCT02194699|447911648|FG000|Randomised|Without potential for 52 weeks of IP|5|||
124535007|NCT02194699|447911649|FG001|Randomised|Without potential for 52 weeks of IP|5|||
124535008|NCT02194699|447911648|FG000|Randomised|Duplicate patient|2|||
124535009|NCT02194699|447911649|FG001|Randomised|Duplicate patient|1|||
124535010|NCT02194699|447911648|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
124535011|NCT02194699|447911649|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
124535012|NCT02194699|447911648|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
124535013|NCT02194699|447911649|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
124535014|NCT02194699|447911648|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
124535015|NCT02194699|447911649|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
124535016|NCT02194699|447911648|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
124535017|NCT02194699|447911649|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
124535018|NCT02194699|447911648|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
124535019|NCT02194699|447911649|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
124535020|NCT02194699|447911648|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
124535021|NCT02194699|447911649|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
124868156|NCT00374322|449138122|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
124868157|NCT00374322|449138123|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
124868158|NCT00374322|449138122|FG000|Overall Study|Severe Toxicity|1|||
124868159|NCT00374322|449138123|FG001|Overall Study|Severe Toxicity|0|||
124868160|NCT00374322|449138122|FG000|Overall Study|Site Closed|2|||
124868161|NCT00374322|449138123|FG001|Overall Study|Site Closed|2|||
124868162|NCT00374322|449138122|FG000|Overall Study|Participant Changed Physician|1|||
124868163|NCT00374322|449138123|FG001|Overall Study|Participant Changed Physician|0|||
124868164|NCT00374322|449138122|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
124868165|NCT00374322|449138123|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
124868166|NCT00374322|449138122|FG000|Overall Study|Noncompliance with Study Requirements|0|||
124868167|NCT00374322|449138123|FG001|Overall Study|Noncompliance with Study Requirements|1|||
124868168|NCT00374322|449138122|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
124868169|NCT00374322|449138123|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
124868170|NCT00374322|449138122|FG000|Overall Study|Did Not Receive Study Medication|8|||
124868171|NCT00374322|449138123|FG001|Overall Study|Did Not Receive Study Medication|6|||
124868172|NCT03969719|449138124|FG000|Overall Study|Other reasons not specified|1|||
124868173|NCT03969719|449138125|FG001|Overall Study|Other reasons not specified|1|||
124868174|NCT03969719|449138126|FG002|Overall Study|Other reasons not specified|3|||
124868175|NCT03969719|449138124|FG000|Overall Study|Withdrawal by Subject|2|||
124868176|NCT03969719|449138125|FG001|Overall Study|Withdrawal by Subject|3|||
124868177|NCT03969719|449138126|FG002|Overall Study|Withdrawal by Subject|2|||
124868178|NCT03969719|449138124|FG000|Overall Study|Protocol Violation|1|||
124868179|NCT03969719|449138125|FG001|Overall Study|Protocol Violation|2|||
124868180|NCT03969719|449138126|FG002|Overall Study|Protocol Violation|0|||
124868181|NCT03969719|449138124|FG000|Overall Study|Adverse Event|0|||
124868182|NCT03969719|449138125|FG001|Overall Study|Adverse Event|2|||
124868183|NCT03969719|449138126|FG002|Overall Study|Adverse Event|0|||
124868184|NCT03969719|449138124|FG000|Overall Study|Lost to Follow-up|0|||
124868185|NCT03969719|449138125|FG001|Overall Study|Lost to Follow-up|1|||
124868186|NCT03969719|449138126|FG002|Overall Study|Lost to Follow-up|0|||
124868187|NCT02130193|449138129|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
124868188|NCT02130193|449138130|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
124868189|NCT02130193|449138131|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
124868190|NCT02130193|449138129|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
124868191|NCT02130193|449138130|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
124868192|NCT02130193|449138131|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
124868193|NCT02130193|449138129|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
124868194|NCT02130193|449138130|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
124868195|NCT02130193|449138131|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
124868196|NCT02130193|449138129|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
124868197|NCT02130193|449138130|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
124868198|NCT02130193|449138131|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
124868199|NCT01212770|449138132|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
124868200|NCT01212770|449138133|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
124868201|NCT01212770|449138134|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
124868202|NCT01212770|449138135|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124868203|NCT01212770|449138136|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124868204|NCT01212770|449138137|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124868205|NCT01212770|449138138|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124868206|NCT01212770|449138139|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124868207|NCT01212770|449138140|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124868208|NCT01212770|449138132|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
124868209|NCT01212770|449138133|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
124868210|NCT01212770|449138134|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
124868211|NCT01212770|449138135|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124868212|NCT01212770|449138136|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124868213|NCT01212770|449138137|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124868214|NCT01212770|449138138|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124868215|NCT01212770|449138139|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124868216|NCT01212770|449138140|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124868217|NCT01212770|449138132|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
124868218|NCT01212770|449138133|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
124868219|NCT01212770|449138134|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
124868220|NCT01212770|449138135|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124868221|NCT01212770|449138136|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124868222|NCT01212770|449138137|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124535022|NCT02155660|447911654|FG000|Overall Study|Other Reason|8|||
124535023|NCT02155660|447911655|FG001|Overall Study|Other Reason|6|||
124535024|NCT02155660|447911656|FG002|Overall Study|Other Reason|10|||
124868223|NCT01212770|449138138|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124868224|NCT01212770|449138139|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124868225|NCT01212770|449138140|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124868226|NCT01212770|449138132|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
124868227|NCT01212770|449138133|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124868228|NCT01212770|449138134|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
124868229|NCT01212770|449138135|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124868230|NCT01212770|449138136|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124868231|NCT01212770|449138137|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124868232|NCT01212770|449138138|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124868233|NCT01212770|449138139|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124868234|NCT01212770|449138140|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124868235|NCT01212770|449138132|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124868236|NCT01212770|449138133|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124868237|NCT01212770|449138134|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
124868238|NCT01212770|449138135|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124868239|NCT01212770|449138136|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124868240|NCT01212770|449138137|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124868241|NCT01212770|449138138|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124868242|NCT01212770|449138139|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124868243|NCT01212770|449138140|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124868244|NCT01212770|449138132|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
124868245|NCT01212770|449138133|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
124868246|NCT01212770|449138134|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
124868247|NCT01212770|449138135|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
124868248|NCT01212770|449138136|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
124868249|NCT01212770|449138137|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
124868250|NCT01212770|449138138|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
124868251|NCT01212770|449138139|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
124868252|NCT01212770|449138140|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
124868253|NCT01212770|449138132|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
124868254|NCT01212770|449138133|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
124868255|NCT01212770|449138134|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
124868256|NCT01212770|449138135|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
124868257|NCT01212770|449138136|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
124868258|NCT01212770|449138137|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
124868259|NCT01212770|449138138|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
124868260|NCT01212770|449138139|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
124868261|NCT01212770|449138140|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
124868262|NCT01212770|449138132|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
124868263|NCT01212770|449138133|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
124868264|NCT01212770|449138134|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
124868265|NCT01212770|449138135|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
124868266|NCT01212770|449138136|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
124868267|NCT01212770|449138137|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
124868268|NCT01212770|449138138|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
124868269|NCT01212770|449138139|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
124868270|NCT01212770|449138140|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
124868271|NCT01212770|449138132|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
124868272|NCT01212770|449138133|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
124868273|NCT01212770|449138134|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
124868274|NCT01212770|449138135|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
124868275|NCT01212770|449138136|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
124868276|NCT01212770|449138137|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
124868277|NCT01212770|449138138|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
124868278|NCT01212770|449138139|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
124868279|NCT01212770|449138140|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
124868280|NCT01212770|449138132|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
124868281|NCT01212770|449138133|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
124868282|NCT01212770|449138134|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
124868283|NCT01212770|449138135|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
124868284|NCT01212770|449138136|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
124868285|NCT01212770|449138137|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
124868286|NCT01212770|449138138|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
124868287|NCT01212770|449138139|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
124868288|NCT01212770|449138140|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
124868289|NCT01212770|449138132|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
124868290|NCT01212770|449138133|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
124868291|NCT01212770|449138134|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
124868292|NCT01212770|449138135|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
124868293|NCT01212770|449138136|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
124868294|NCT01212770|449138137|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
124868295|NCT01212770|449138138|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
124868296|NCT01212770|449138139|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
124868297|NCT01212770|449138140|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
124868298|NCT01212770|449138132|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
124868299|NCT01212770|449138133|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
124868300|NCT01212770|449138134|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
124868301|NCT01212770|449138135|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
124868302|NCT01212770|449138136|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
124868303|NCT01212770|449138137|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
124868304|NCT01212770|449138138|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
124868305|NCT01212770|449138139|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
124868306|NCT01212770|449138140|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
124868307|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
124868308|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
124868309|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
124868310|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
124868311|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
124868312|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
124868313|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
124868314|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
124868315|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
124868316|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
124868317|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
124868318|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
124868319|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
124868320|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
124868321|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
124868322|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
124868323|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
124868324|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
124868325|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
124868326|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
124868327|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
124868328|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
124868329|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
124868330|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
124868331|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
124868332|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
124868333|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
124868334|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124868335|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
124868336|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
124868337|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124868338|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124868339|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124868340|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124868341|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
124868342|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
124868343|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
124868344|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
124868345|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
124868346|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
124868347|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
124868348|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
124868349|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
124868350|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
124868351|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
124868352|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124868353|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
124868354|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
124868355|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124868356|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124868357|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124868358|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124868359|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124868360|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
124868361|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
124868362|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
124868363|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
124868364|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
124868365|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
124868366|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
124868367|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
124868368|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
124868369|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
124868370|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
124868371|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
124868372|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
124868373|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
124868374|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
124868375|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
124868376|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
124868377|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
124868378|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
124868379|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124868380|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
124868381|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
124868382|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124868383|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124868384|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124868385|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124868386|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
124868387|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
124868388|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124868389|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
124868390|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124868391|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124868392|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124868393|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124868394|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124868395|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124868396|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124868397|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
124868398|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
124868399|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
124868400|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
124868401|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
124868402|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
124868403|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
124868404|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
124868405|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
124868406|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
124868407|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
124868408|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
124868409|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
124868410|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
124868411|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
124868412|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
124868413|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
124868414|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
124535025|NCT02155660|447911657|FG003|Overall Study|Other Reason|10|||
124535026|NCT02155660|447911654|FG000|Overall Study|Study-specific withdrawal criteria|0|||
124535027|NCT02155660|447911655|FG001|Overall Study|Study-specific withdrawal criteria|1|||
124868415|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124868416|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
124868417|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
124868418|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124868419|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124868420|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124868421|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124868422|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124868423|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
124868424|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124868425|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
124868426|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
124868427|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124868428|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124868429|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124868430|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124868431|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
124868432|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124868433|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
124868434|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
124868435|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
124868436|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
124868437|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
124868438|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
124868439|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
124868440|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
124868441|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
124868442|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124868443|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
124868444|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
124868445|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124868446|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124868447|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124868448|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124868449|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124868450|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124868451|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124868452|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124868453|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
124868454|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124868455|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124868456|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124868457|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124868458|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124868459|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124868460|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124868461|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
124868462|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124868463|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124868464|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124868465|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124868466|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124868467|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124868468|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
124868469|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
124868470|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
124868471|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
124868472|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
124868473|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
124868474|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
124868475|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
124868476|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
124868477|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
124868478|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124868479|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124868480|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
124868481|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124868482|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124868483|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124868484|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124868485|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124868486|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124868487|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124868488|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124868489|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
124868490|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124868491|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124868492|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124868493|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124868494|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124868495|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
124868496|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124868497|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124868498|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
124868499|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124868500|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124868501|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124868502|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124868503|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124868504|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124868505|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124868506|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
124868507|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
124868508|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124868509|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124868510|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124868511|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124868512|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
124868513|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124868514|NCT01212770|449138132|FG000|Long-term Safety Phase (Year 5)|Death|0|||
124868515|NCT01212770|449138133|FG001|Long-term Safety Phase (Year 5)|Death|0|||
124868516|NCT01212770|449138134|FG002|Long-term Safety Phase (Year 5)|Death|0|||
124868517|NCT01212770|449138135|FG003|Long-term Safety Phase (Year 5)|Death|0|||
124868518|NCT01212770|449138136|FG004|Long-term Safety Phase (Year 5)|Death|0|||
124868519|NCT01212770|449138137|FG005|Long-term Safety Phase (Year 5)|Death|0|||
124868520|NCT01212770|449138138|FG006|Long-term Safety Phase (Year 5)|Death|0|||
124868521|NCT01212770|449138139|FG007|Long-term Safety Phase (Year 5)|Death|1|||
124868522|NCT01212770|449138140|FG008|Long-term Safety Phase (Year 5)|Death|0|||
124868523|NCT00829387|449138141|FG000|Overall Study|Withdrawal by Subject|2|||
124868524|NCT00829387|449138142|FG001|Overall Study|Withdrawal by Subject|3|||
124868525|NCT00829387|449138141|FG000|Overall Study|Disqualified by PI|1|||
124868526|NCT00829387|449138142|FG001|Overall Study|Disqualified by PI|0|||
124868527|NCT00707031|449138150|FG000|Overall Study|Adverse Event|45|||
124868528|NCT00707031|449138151|FG001|Overall Study|Adverse Event|45|||
124868529|NCT00707031|449138150|FG000|Overall Study|Lack of Efficacy|19|||
124868530|NCT00707031|449138151|FG001|Overall Study|Lack of Efficacy|6|||
124868531|NCT00707031|449138150|FG000|Overall Study|Lost to Follow-up|2|||
124868532|NCT00707031|449138151|FG001|Overall Study|Lost to Follow-up|1|||
124868533|NCT00707031|449138150|FG000|Overall Study|Protocol Violation|1|||
124868534|NCT00707031|449138151|FG001|Overall Study|Protocol Violation|0|||
124868535|NCT00707031|449138150|FG000|Overall Study|Withdrawal by Subject|7|||
124868536|NCT00707031|449138151|FG001|Overall Study|Withdrawal by Subject|8|||
124868537|NCT00707031|449138150|FG000|Overall Study|Poor Compliance to Protocol|7|||
124868538|NCT00707031|449138151|FG001|Overall Study|Poor Compliance to Protocol|13|||
124868539|NCT00707031|449138150|FG000|Overall Study|Familial or Personal Reasons|12|||
124868540|NCT00707031|449138151|FG001|Overall Study|Familial or Personal Reasons|15|||
124868541|NCT00707031|449138150|FG000|Overall Study|Serious Noncompliance|2|||
124868542|NCT00707031|449138151|FG001|Overall Study|Serious Noncompliance|3|||
124868543|NCT00707031|449138150|FG000|Overall Study|Sponsor Decision|9|||
124868544|NCT00707031|449138151|FG001|Overall Study|Sponsor Decision|8|||
124868545|NCT02747238|449138158|FG000|Overall Study|Lack of Efficacy|0|||
124868546|NCT02747238|449138159|FG001|Overall Study|Lack of Efficacy|1|||
124868547|NCT02747238|449138158|FG000|Overall Study|Data lost|3|||
124868548|NCT02747238|449138159|FG001|Overall Study|Data lost|5|||
124868549|NCT02085252|449138160|FG000|Overall Study|Withdrawal of Consent|1|||
124868550|NCT02085252|449138161|FG001|Overall Study|Withdrawal of Consent|0|||
124868551|NCT02085252|449138160|FG000|Overall Study|Adverse Event|0|||
124868552|NCT02085252|449138161|FG001|Overall Study|Adverse Event|1|||
124868553|NCT02085252|449138160|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
124868554|NCT02085252|449138161|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
124868555|NCT02085252|449138160|FG000|Overall Study|Reason Not Specified|0|||
124868556|NCT02085252|449138161|FG001|Overall Study|Reason Not Specified|1|||
124868557|NCT02085252|449138160|FG000|Overall Study|Reason Unknown|0|||
124868558|NCT02085252|449138161|FG001|Overall Study|Reason Unknown|1|||
124868559|NCT00951275|449138162|FG000|Overall Study|Administrative Reason|1|||
124868560|NCT00951275|449138162|FG000|Overall Study|Adverse Event|7|||
124868561|NCT00951275|449138162|FG000|Overall Study|Withdrawal by Subject|4|||
124868562|NCT00951275|449138162|FG000|Overall Study|Protocol Violation|1|||
124868563|NCT01112579|449138164|FG000|Overall Study|Missed Visit|1|||
124868564|NCT01112579|449138165|FG001|Overall Study|Missed Visit|1|||
124868565|NCT01112579|449138164|FG000|Overall Study|Death|0|||
124868566|NCT01112579|449138165|FG001|Overall Study|Death|2|||
124868567|NCT04304833|449138166|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
124868568|NCT04304833|449138167|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
124868569|NCT01951625|449138168|FG000|Treatment Period|Protocol Violation|2|||
124868570|NCT01951625|449138169|FG001|Treatment Period|Protocol Violation|0|||
124868571|NCT01951625|449138170|FG002|Treatment Period|Protocol Violation|1|||
124868572|NCT01951625|449138171|FG003|Treatment Period|Protocol Violation|3|||
124868573|NCT01951625|449138172|FG004|Treatment Period|Protocol Violation|2|||
124868574|NCT01951625|449138168|FG000|Treatment Period|Physician Decision|0|||
124868575|NCT01951625|449138169|FG001|Treatment Period|Physician Decision|0|||
124535028|NCT02155660|447911656|FG002|Overall Study|Study-specific withdrawal criteria|1|||
124535029|NCT02155660|447911657|FG003|Overall Study|Study-specific withdrawal criteria|1|||
124868576|NCT01951625|449138170|FG002|Treatment Period|Physician Decision|0|||
124868577|NCT01951625|449138171|FG003|Treatment Period|Physician Decision|0|||
124868578|NCT01951625|449138172|FG004|Treatment Period|Physician Decision|1|||
124868579|NCT01951625|449138168|FG000|Treatment Period|Protocol driven decision point|0|||
124535030|NCT02155660|447911654|FG000|Overall Study|Severe non-compliance|0|||
124868580|NCT01951625|449138169|FG001|Treatment Period|Protocol driven decision point|5|||
124868581|NCT01951625|449138170|FG002|Treatment Period|Protocol driven decision point|0|||
124868582|NCT01951625|449138171|FG003|Treatment Period|Protocol driven decision point|2|||
124868583|NCT01951625|449138172|FG004|Treatment Period|Protocol driven decision point|1|||
124868584|NCT01951625|449138168|FG000|Treatment Period|Non compliance with study drug|1|||
124868585|NCT01951625|449138169|FG001|Treatment Period|Non compliance with study drug|2|||
124868586|NCT01951625|449138170|FG002|Treatment Period|Non compliance with study drug|2|||
124868587|NCT01951625|449138171|FG003|Treatment Period|Non compliance with study drug|0|||
124868588|NCT01951625|449138172|FG004|Treatment Period|Non compliance with study drug|0|||
124868589|NCT01951625|449138168|FG000|Treatment Period|Death|3|||
124868590|NCT01951625|449138169|FG001|Treatment Period|Death|2|||
124868591|NCT01951625|449138170|FG002|Treatment Period|Death|2|||
124868592|NCT01951625|449138171|FG003|Treatment Period|Death|1|||
124868593|NCT01951625|449138172|FG004|Treatment Period|Death|2|||
124868594|NCT01951625|449138168|FG000|Treatment Period|Adverse Event|7|||
124868595|NCT01951625|449138169|FG001|Treatment Period|Adverse Event|10|||
124868596|NCT01951625|449138170|FG002|Treatment Period|Adverse Event|9|||
124868597|NCT01951625|449138171|FG003|Treatment Period|Adverse Event|8|||
124868598|NCT01951625|449138172|FG004|Treatment Period|Adverse Event|8|||
124868599|NCT01951625|449138168|FG000|Treatment Period|Withdrawal by Subject|5|||
124868600|NCT01951625|449138169|FG001|Treatment Period|Withdrawal by Subject|2|||
124868601|NCT01951625|449138170|FG002|Treatment Period|Withdrawal by Subject|1|||
124868602|NCT01951625|449138171|FG003|Treatment Period|Withdrawal by Subject|7|||
124868603|NCT01951625|449138172|FG004|Treatment Period|Withdrawal by Subject|3|||
124868604|NCT01951625|449138168|FG000|Treatment Period|Lost to Follow-up|1|||
124868605|NCT01951625|449138169|FG001|Treatment Period|Lost to Follow-up|0|||
124868606|NCT01951625|449138170|FG002|Treatment Period|Lost to Follow-up|0|||
124868607|NCT01951625|449138171|FG003|Treatment Period|Lost to Follow-up|1|||
124868608|NCT01951625|449138172|FG004|Treatment Period|Lost to Follow-up|0|||
124868609|NCT01951625|449138168|FG000|Follow Up Period|Non-compliance with study drug|1|||
124868610|NCT01951625|449138169|FG001|Follow Up Period|Non-compliance with study drug|0|||
124868611|NCT01951625|449138170|FG002|Follow Up Period|Non-compliance with study drug|0|||
124868612|NCT01951625|449138171|FG003|Follow Up Period|Non-compliance with study drug|0|||
124868613|NCT01951625|449138172|FG004|Follow Up Period|Non-compliance with study drug|0|||
124868614|NCT01951625|449138168|FG000|Follow Up Period|Death|1|||
124868615|NCT01951625|449138169|FG001|Follow Up Period|Death|3|||
124868616|NCT01951625|449138170|FG002|Follow Up Period|Death|2|||
124868617|NCT01951625|449138171|FG003|Follow Up Period|Death|2|||
124868618|NCT01951625|449138172|FG004|Follow Up Period|Death|1|||
124868619|NCT01951625|449138168|FG000|Follow Up Period|Logistical difficulties|1|||
124868620|NCT01951625|449138169|FG001|Follow Up Period|Logistical difficulties|2|||
124868621|NCT01951625|449138170|FG002|Follow Up Period|Logistical difficulties|0|||
124868622|NCT01951625|449138171|FG003|Follow Up Period|Logistical difficulties|0|||
124868623|NCT01951625|449138172|FG004|Follow Up Period|Logistical difficulties|0|||
124868624|NCT01951625|449138168|FG000|Follow Up Period|Adverse Event|0|||
124868625|NCT01951625|449138169|FG001|Follow Up Period|Adverse Event|3|||
124868626|NCT01951625|449138170|FG002|Follow Up Period|Adverse Event|2|||
124868627|NCT01951625|449138171|FG003|Follow Up Period|Adverse Event|3|||
124868628|NCT01951625|449138172|FG004|Follow Up Period|Adverse Event|5|||
124868629|NCT01951625|449138168|FG000|Follow Up Period|Withdrawal by Subject|4|||
124868630|NCT01951625|449138169|FG001|Follow Up Period|Withdrawal by Subject|1|||
124868631|NCT01951625|449138170|FG002|Follow Up Period|Withdrawal by Subject|0|||
124868632|NCT01951625|449138171|FG003|Follow Up Period|Withdrawal by Subject|5|||
124868633|NCT01951625|449138172|FG004|Follow Up Period|Withdrawal by Subject|3|||
124868634|NCT01951625|449138168|FG000|Follow Up Period|Lost to Follow-up|1|||
124868635|NCT01951625|449138169|FG001|Follow Up Period|Lost to Follow-up|0|||
124868636|NCT01951625|449138170|FG002|Follow Up Period|Lost to Follow-up|0|||
124868637|NCT01951625|449138171|FG003|Follow Up Period|Lost to Follow-up|1|||
124868638|NCT01951625|449138172|FG004|Follow Up Period|Lost to Follow-up|1|||
124868639|NCT04866017|449138173|FG000|Overall Study|Study Terminated by Sponsor|13|||
124868640|NCT04866017|449138174|FG001|Overall Study|Study Terminated by Sponsor|14|||
124868641|NCT04866017|449138175|FG002|Overall Study|Study Terminated by Sponsor|13|||
124868642|NCT04866017|449138173|FG000|Overall Study|Death|8|||
124868643|NCT04866017|449138174|FG001|Overall Study|Death|4|||
124868644|NCT04866017|449138175|FG002|Overall Study|Death|8|||
124868645|NCT04866017|449138173|FG000|Overall Study|Withdrawal by Subject|1|||
124535031|NCT02155660|447911655|FG001|Overall Study|Severe non-compliance|4|||
124535032|NCT02155660|447911656|FG002|Overall Study|Severe non-compliance|0|||
124868646|NCT04866017|449138174|FG001|Overall Study|Withdrawal by Subject|0|||
124868647|NCT04866017|449138175|FG002|Overall Study|Withdrawal by Subject|1|||
124868648|NCT04866017|449138173|FG000|Overall Study|Physician Decision|0|||
124868649|NCT04866017|449138174|FG001|Overall Study|Physician Decision|1|||
124868650|NCT04866017|449138175|FG002|Overall Study|Physician Decision|0|||
124868651|NCT01475136|449138176|FG000|Overall Study|Sponsor Decision|0|||
124868652|NCT01475136|449138177|FG001|Overall Study|Sponsor Decision|1|||
124868653|NCT01475136|449138178|FG002|Overall Study|Sponsor Decision|0|||
124868654|NCT01475136|449138179|FG003|Overall Study|Sponsor Decision|0|||
124535033|NCT02155660|447911657|FG003|Overall Study|Severe non-compliance|1|||
124535034|NCT02155660|447911654|FG000|Overall Study|Adverse Event|2|||
124535035|NCT02155660|447911655|FG001|Overall Study|Adverse Event|6|||
124535036|NCT02155660|447911656|FG002|Overall Study|Adverse Event|3|||
124758385|NCT02491983|448739754|FG001|Overall Study|Withdrawal by Subject|1|||
124758386|NCT02714569|448739755|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
124758387|NCT02714569|448739756|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
124758388|NCT02714569|448739757|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
124758389|NCT02714569|448739758|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
124758390|NCT02714569|448739759|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
124758391|NCT02714569|448739760|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
124758392|NCT02714569|448739761|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
124758393|NCT02714569|448739762|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
124758394|NCT02714569|448739763|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
124758395|NCT02714569|448739764|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
124758396|NCT02714569|448739765|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
124758397|NCT02714569|448739755|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
124758398|NCT02714569|448739756|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
124758399|NCT02714569|448739757|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
124758400|NCT02714569|448739758|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
124758401|NCT02714569|448739759|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
124758402|NCT02714569|448739760|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
124758403|NCT02714569|448739761|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
124758404|NCT02714569|448739762|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
124758405|NCT02714569|448739763|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
124758406|NCT02714569|448739764|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
124758407|NCT02714569|448739765|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
124758408|NCT02714569|448739755|FG000|Part A Third Intervention|Adverse Event|0|||
124758409|NCT02714569|448739756|FG001|Part A Third Intervention|Adverse Event|0|||
124758410|NCT02714569|448739757|FG002|Part A Third Intervention|Adverse Event|1|||
124758411|NCT02714569|448739758|FG003|Part A Third Intervention|Adverse Event|0|||
124758412|NCT02714569|448739759|FG004|Part A Third Intervention|Adverse Event|0|||
124758413|NCT02714569|448739760|FG005|Part A Third Intervention|Adverse Event|0|||
124758414|NCT02714569|448739761|FG006|Part A Third Intervention|Adverse Event|0|||
124758415|NCT02714569|448739762|FG007|Part A Third Intervention|Adverse Event|0|||
124758416|NCT02714569|448739763|FG008|Part A Third Intervention|Adverse Event|0|||
124758417|NCT02714569|448739764|FG009|Part A Third Intervention|Adverse Event|0|||
124758418|NCT02714569|448739765|FG010|Part A Third Intervention|Adverse Event|0|||
124758419|NCT02714569|448739755|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
124758420|NCT02714569|448739756|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
124758421|NCT02714569|448739757|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
124758422|NCT02714569|448739758|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
124758423|NCT02714569|448739759|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
124758424|NCT02714569|448739760|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
124758425|NCT02714569|448739761|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
124758426|NCT02714569|448739762|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
124758427|NCT02714569|448739763|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
124758428|NCT02714569|448739764|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
124758429|NCT02714569|448739765|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
124758430|NCT02714569|448739755|FG000|Part B (Overall)|Lost to Follow-up|0|||
124758431|NCT02714569|448739756|FG001|Part B (Overall)|Lost to Follow-up|0|||
124758432|NCT02714569|448739757|FG002|Part B (Overall)|Lost to Follow-up|0|||
124758433|NCT02714569|448739758|FG003|Part B (Overall)|Lost to Follow-up|0|||
124758434|NCT02714569|448739759|FG004|Part B (Overall)|Lost to Follow-up|0|||
124758435|NCT02714569|448739760|FG005|Part B (Overall)|Lost to Follow-up|0|||
124758436|NCT02714569|448739761|FG006|Part B (Overall)|Lost to Follow-up|1|||
124758437|NCT02714569|448739762|FG007|Part B (Overall)|Lost to Follow-up|0|||
124758438|NCT02714569|448739763|FG008|Part B (Overall)|Lost to Follow-up|0|||
124758439|NCT02714569|448739764|FG009|Part B (Overall)|Lost to Follow-up|0|||
124758440|NCT02714569|448739765|FG010|Part B (Overall)|Lost to Follow-up|0|||
124758441|NCT02714569|448739755|FG000|Part B (Overall)|Withdrawal by Subject|0|||
124758442|NCT02714569|448739756|FG001|Part B (Overall)|Withdrawal by Subject|0|||
124758443|NCT02714569|448739757|FG002|Part B (Overall)|Withdrawal by Subject|0|||
124758444|NCT02714569|448739758|FG003|Part B (Overall)|Withdrawal by Subject|0|||
124758445|NCT02714569|448739759|FG004|Part B (Overall)|Withdrawal by Subject|0|||
124758446|NCT02714569|448739760|FG005|Part B (Overall)|Withdrawal by Subject|0|||
124758447|NCT02714569|448739761|FG006|Part B (Overall)|Withdrawal by Subject|0|||
124758448|NCT02714569|448739762|FG007|Part B (Overall)|Withdrawal by Subject|1|||
124758449|NCT02714569|448739763|FG008|Part B (Overall)|Withdrawal by Subject|0|||
124758450|NCT02714569|448739764|FG009|Part B (Overall)|Withdrawal by Subject|1|||
124868655|NCT01475136|449138176|FG000|Overall Study|Entry Criteria Not Met|0|||
124868656|NCT01475136|449138177|FG001|Overall Study|Entry Criteria Not Met|2|||
124868657|NCT01475136|449138178|FG002|Overall Study|Entry Criteria Not Met|3|||
124868658|NCT01475136|449138179|FG003|Overall Study|Entry Criteria Not Met|1|||
124868659|NCT01475136|449138176|FG000|Overall Study|Withdrawal by Subject|0|||
124868660|NCT01475136|449138177|FG001|Overall Study|Withdrawal by Subject|0|||
124868661|NCT01475136|449138178|FG002|Overall Study|Withdrawal by Subject|0|||
124868662|NCT01475136|449138179|FG003|Overall Study|Withdrawal by Subject|2|||
124868663|NCT01475136|449138176|FG000|Overall Study|Adverse Event|1|||
124868664|NCT01475136|449138177|FG001|Overall Study|Adverse Event|0|||
124868665|NCT01475136|449138178|FG002|Overall Study|Adverse Event|0|||
124868666|NCT01475136|449138179|FG003|Overall Study|Adverse Event|1|||
124868667|NCT01475136|449138176|FG000|Overall Study|Death|0|||
124868668|NCT01475136|449138177|FG001|Overall Study|Death|0|||
124868669|NCT01475136|449138178|FG002|Overall Study|Death|0|||
124868670|NCT01475136|449138179|FG003|Overall Study|Death|1|||
124868671|NCT03355326|449138182|FG000|Overall Study|Protocol Violation|3|||
124868672|NCT03355326|449138183|FG001|Overall Study|Protocol Violation|3|||
124868673|NCT00003508|449140169|FG000|Overall Study|Not evaluable|5|||
124868674|NCT01377480|449140170|FG000|Overall Study|Protocol Violation|0|||
124868675|NCT01377480|449140171|FG001|Overall Study|Protocol Violation|0|||
124868676|NCT01377480|449140172|FG002|Overall Study|Protocol Violation|0|||
124868677|NCT01377480|449140173|FG003|Overall Study|Protocol Violation|4|||
124868678|NCT01377480|449140170|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
124868679|NCT01377480|449140171|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
124868680|NCT01377480|449140172|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
124868681|NCT01377480|449140173|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
124868682|NCT01377480|449140170|FG000|Overall Study|Withdrawal by Subject|0|||
124868683|NCT01377480|449140171|FG001|Overall Study|Withdrawal by Subject|0|||
124868684|NCT01377480|449140172|FG002|Overall Study|Withdrawal by Subject|1|||
124868685|NCT01377480|449140173|FG003|Overall Study|Withdrawal by Subject|0|||
124868686|NCT01377480|449140170|FG000|Overall Study|Serious adverse event|0|||
124868687|NCT01377480|449140171|FG001|Overall Study|Serious adverse event|0|||
124868688|NCT01377480|449140172|FG002|Overall Study|Serious adverse event|1|||
124868689|NCT01377480|449140173|FG003|Overall Study|Serious adverse event|1|||
124868690|NCT01377480|449140170|FG000|Overall Study|Other|0|||
124868691|NCT01377480|449140171|FG001|Overall Study|Other|0|||
124868692|NCT01377480|449140172|FG002|Overall Study|Other|7|||
124868693|NCT01377480|449140173|FG003|Overall Study|Other|6|||
124868694|NCT03576768|449140175|FG000|Overall Study|Lost to Follow-up|3|||
124868695|NCT03576768|449140176|FG001|Overall Study|Lost to Follow-up|3|||
124868696|NCT03576768|449140177|FG002|Overall Study|Lost to Follow-up|0|||
124868697|NCT03576768|449140178|FG003|Overall Study|Lost to Follow-up|0|||
124868698|NCT01986881|449140181|FG000|Overall Study|Death|228|||
124868699|NCT01986881|449140182|FG001|Overall Study|Death|233|||
124868700|NCT01986881|449140183|FG002|Overall Study|Death|247|||
124868701|NCT01986881|449140181|FG000|Overall Study|Lost to Follow-up|51|||
124868702|NCT01986881|449140182|FG001|Overall Study|Lost to Follow-up|44|||
124868703|NCT01986881|449140183|FG002|Overall Study|Lost to Follow-up|55|||
124868704|NCT01986881|449140181|FG000|Overall Study|Physician Decision|7|||
124868705|NCT01986881|449140182|FG001|Overall Study|Physician Decision|4|||
124868706|NCT01986881|449140183|FG002|Overall Study|Physician Decision|6|||
124868707|NCT01986881|449140181|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
124868708|NCT01986881|449140182|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
124868709|NCT01986881|449140183|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
124868710|NCT01986881|449140181|FG000|Overall Study|Withdrawal by Subject|41|||
124868711|NCT01986881|449140182|FG001|Overall Study|Withdrawal by Subject|60|||
124868712|NCT01986881|449140183|FG002|Overall Study|Withdrawal by Subject|45|||
124868713|NCT01986881|449140181|FG000|Overall Study|Subject Moved|0|||
124868714|NCT01986881|449140182|FG001|Overall Study|Subject Moved|1|||
124868715|NCT01986881|449140183|FG002|Overall Study|Subject Moved|0|||
124868716|NCT01986881|449140181|FG000|Overall Study|Other|1|||
124868717|NCT01986881|449140182|FG001|Overall Study|Other|2|||
124868718|NCT01986881|449140183|FG002|Overall Study|Other|2|||
124868719|NCT04179175|449140188|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
124868720|NCT04179175|449140189|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
124868721|NCT04179175|449140190|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
124868722|NCT04179175|449140191|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
124868723|NCT04179175|449140192|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
124868724|NCT04179175|449140193|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
124868725|NCT04179175|449140188|FG000|Overall Study|Adverse Event|5|||
124868726|NCT04179175|449140189|FG001|Overall Study|Adverse Event|3|||
124868727|NCT04179175|449140190|FG002|Overall Study|Adverse Event|3|||
124868728|NCT04179175|449140191|FG003|Overall Study|Adverse Event|4|||
124868729|NCT04179175|449140192|FG004|Overall Study|Adverse Event|6|||
124868730|NCT04179175|449140193|FG005|Overall Study|Adverse Event|6|||
124868731|NCT04179175|449140188|FG000|Overall Study|Lack of Efficacy|5|||
124868732|NCT04179175|449140189|FG001|Overall Study|Lack of Efficacy|1|||
124868733|NCT04179175|449140190|FG002|Overall Study|Lack of Efficacy|3|||
124868734|NCT04179175|449140191|FG003|Overall Study|Lack of Efficacy|2|||
124868735|NCT04179175|449140192|FG004|Overall Study|Lack of Efficacy|18|||
124868736|NCT04179175|449140193|FG005|Overall Study|Lack of Efficacy|7|||
124868737|NCT04179175|449140188|FG000|Overall Study|Lost to Follow-up|5|||
124868738|NCT04179175|449140189|FG001|Overall Study|Lost to Follow-up|3|||
124868739|NCT04179175|449140190|FG002|Overall Study|Lost to Follow-up|2|||
124868740|NCT04179175|449140191|FG003|Overall Study|Lost to Follow-up|2|||
124868741|NCT04179175|449140192|FG004|Overall Study|Lost to Follow-up|4|||
124868742|NCT04179175|449140193|FG005|Overall Study|Lost to Follow-up|5|||
124868743|NCT04179175|449140188|FG000|Overall Study|Physician Decision|2|||
124868744|NCT04179175|449140189|FG001|Overall Study|Physician Decision|0|||
124868745|NCT04179175|449140190|FG002|Overall Study|Physician Decision|2|||
124868746|NCT04179175|449140191|FG003|Overall Study|Physician Decision|3|||
124868747|NCT04179175|449140192|FG004|Overall Study|Physician Decision|1|||
124868748|NCT04179175|449140193|FG005|Overall Study|Physician Decision|1|||
124868749|NCT04179175|449140188|FG000|Overall Study|Pregnancy|3|||
124868750|NCT04179175|449140189|FG001|Overall Study|Pregnancy|0|||
124868751|NCT04179175|449140190|FG002|Overall Study|Pregnancy|3|||
124868752|NCT04179175|449140191|FG003|Overall Study|Pregnancy|0|||
124868753|NCT04179175|449140192|FG004|Overall Study|Pregnancy|1|||
124868754|NCT04179175|449140193|FG005|Overall Study|Pregnancy|2|||
124868755|NCT04179175|449140188|FG000|Overall Study|Withdrawal by Subject|22|||
124868756|NCT04179175|449140189|FG001|Overall Study|Withdrawal by Subject|10|||
124868757|NCT04179175|449140190|FG002|Overall Study|Withdrawal by Subject|12|||
124868758|NCT04179175|449140191|FG003|Overall Study|Withdrawal by Subject|8|||
124868759|NCT04179175|449140192|FG004|Overall Study|Withdrawal by Subject|23|||
124868760|NCT04179175|449140193|FG005|Overall Study|Withdrawal by Subject|31|||
124868761|NCT04179175|449140188|FG000|Overall Study|Technical problems|0|||
124868762|NCT04179175|449140189|FG001|Overall Study|Technical problems|0|||
124868763|NCT04179175|449140190|FG002|Overall Study|Technical problems|1|||
124868764|NCT04179175|449140191|FG003|Overall Study|Technical problems|1|||
124868765|NCT04179175|449140192|FG004|Overall Study|Technical problems|0|||
124868766|NCT04179175|449140193|FG005|Overall Study|Technical problems|0|||
124868767|NCT02030015|449140199|FG000|Overall Study|Withdrawal by Subject|3|||
124868768|NCT02030015|449140199|FG000|Overall Study|Death|13|||
124868769|NCT03014674|449140201|FG000|Overall Study|Withdrawal by Subject|1|||
124868770|NCT03014674|449140202|FG001|Overall Study|Withdrawal by Subject|0|||
124868771|NCT03014674|449140203|FG002|Overall Study|Withdrawal by Subject|0|||
124868772|NCT03224182|449140216|FG000|Overall Study|Study Drug Not Instilled|6|||
124868773|NCT03224182|449140217|FG001|Overall Study|Study Drug Not Instilled|1|||
124868774|NCT03224182|449140216|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
124868775|NCT03224182|449140217|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
124868776|NCT03224182|449140216|FG000|Overall Study|Withdrew of Consent|4|||
124868777|NCT03224182|449140217|FG001|Overall Study|Withdrew of Consent|2|||
124868778|NCT03224182|449140216|FG000|Overall Study|Investigator Decision|3|||
124868779|NCT03224182|449140217|FG001|Overall Study|Investigator Decision|1|||
124868780|NCT03224182|449140216|FG000|Overall Study|Sponsor Decision|26|||
124868781|NCT03224182|449140217|FG001|Overall Study|Sponsor Decision|12|||
124868782|NCT03224182|449140216|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
124868783|NCT03224182|449140217|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
124868784|NCT03224182|449140216|FG000|Overall Study|Lost to Follow-up|1|||
124868785|NCT03224182|449140217|FG001|Overall Study|Lost to Follow-up|0|||
124868786|NCT03224182|449140216|FG000|Overall Study|Participant Had Recurrence|11|||
124868787|NCT03224182|449140217|FG001|Overall Study|Participant Had Recurrence|5|||
124868788|NCT03224182|449140216|FG000|Overall Study|Death|0|||
124868789|NCT03224182|449140217|FG001|Overall Study|Death|1|||
124868790|NCT03224182|449140216|FG000|Overall Study|Reason not Specified|3|||
124868791|NCT03224182|449140217|FG001|Overall Study|Reason not Specified|3|||
124868792|NCT03224182|449140216|FG000|Overall Study|Other|1|||
124868793|NCT03224182|449140217|FG001|Overall Study|Other|0|||
124868794|NCT02822222|449140218|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
124868795|NCT02822222|449140219|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
124868796|NCT04279314|449140220|FG000|Overall Study|Adverse Event|55|||
124868797|NCT04279314|449140220|FG000|Overall Study|Withdrawal by Subject|5|||
124868798|NCT04279314|449140220|FG000|Overall Study|Lack of Efficacy|5|||
124868799|NCT04279314|449140220|FG000|Overall Study|Protocol Violation|3|||
124868800|NCT04279314|449140220|FG000|Overall Study|Other (not COVID-19 related)|2|||
124868801|NCT02481310|449140221|FG000|Follow up|Still in follow up|0|||
124868802|NCT02481310|449140222|FG001|Follow up|Still in follow up|3|||
124868803|NCT02481310|449140223|FG002|Follow up|Still in follow up|0|||
124868804|NCT00833560|449140224|FG000|Overall Study|Toxicity|13|||
124868805|NCT00833560|449140224|FG000|Overall Study|Adverse Event|11|||
124868806|NCT00833560|449140224|FG000|Overall Study|Protocol Violation|6|||
124868807|NCT00833560|449140224|FG000|Overall Study|Lack of Efficacy|4|||
124868808|NCT00833560|449140224|FG000|Overall Study|Death|2|||
124868809|NCT00833560|449140224|FG000|Overall Study|Pregression of other disease|1|||
124868810|NCT00833560|449140224|FG000|Overall Study|Other|5|||
124868811|NCT00643916|449140225|FG000|Overall Study|Protocol Violation|0|||
124868812|NCT00643916|449140226|FG001|Overall Study|Protocol Violation|1|||
124868813|NCT00643916|449140227|FG002|Overall Study|Protocol Violation|1|||
124868814|NCT00643916|449140228|FG003|Overall Study|Protocol Violation|1|||
124868815|NCT00643916|449140229|FG004|Overall Study|Protocol Violation|0|||
124868816|NCT00643916|449140230|FG005|Overall Study|Protocol Violation|0|||
124868817|NCT00643916|449140225|FG000|Overall Study|Lost to Follow-up|0|||
124868818|NCT00643916|449140226|FG001|Overall Study|Lost to Follow-up|1|||
124868819|NCT00643916|449140227|FG002|Overall Study|Lost to Follow-up|0|||
124868820|NCT00643916|449140228|FG003|Overall Study|Lost to Follow-up|0|||
124868821|NCT00643916|449140229|FG004|Overall Study|Lost to Follow-up|0|||
124868822|NCT00643916|449140230|FG005|Overall Study|Lost to Follow-up|0|||
124868823|NCT00643916|449140225|FG000|Overall Study|Withdrawal by Subject|2|||
124868824|NCT00643916|449140226|FG001|Overall Study|Withdrawal by Subject|2|||
124868825|NCT00643916|449140227|FG002|Overall Study|Withdrawal by Subject|2|||
124868826|NCT00643916|449140228|FG003|Overall Study|Withdrawal by Subject|1|||
124868827|NCT00643916|449140229|FG004|Overall Study|Withdrawal by Subject|0|||
124868828|NCT00643916|449140230|FG005|Overall Study|Withdrawal by Subject|1|||
124868829|NCT00643916|449140225|FG000|Overall Study|Not Vaccinated|2|||
124868830|NCT00643916|449140226|FG001|Overall Study|Not Vaccinated|2|||
124868831|NCT00643916|449140227|FG002|Overall Study|Not Vaccinated|3|||
124868832|NCT00643916|449140228|FG003|Overall Study|Not Vaccinated|0|||
124868833|NCT00643916|449140229|FG004|Overall Study|Not Vaccinated|2|||
124868834|NCT00643916|449140230|FG005|Overall Study|Not Vaccinated|0|||
124868835|NCT01791725|449140231|FG000|Overall Study|Withdrawal by Subject|0|||
124868836|NCT01791725|449140232|FG001|Overall Study|Withdrawal by Subject|1|||
124868837|NCT01791725|449140233|FG002|Overall Study|Withdrawal by Subject|0|||
124868838|NCT00512148|449140234|FG000|Primay Study Period|Withdrawal by Subject|1|||
124868839|NCT00677833|449140235|FG000|Overall Study|Withdrawal by Subject|4|||
124868840|NCT00677833|449140236|FG001|Overall Study|Withdrawal by Subject|0|||
124868841|NCT00677833|449140237|FG002|Overall Study|Withdrawal by Subject|1|||
124868842|NCT00677833|449140238|FG003|Overall Study|Withdrawal by Subject|3|||
124868843|NCT00677833|449140235|FG000|Overall Study|Lost to Follow-up|0|||
124868844|NCT00677833|449140236|FG001|Overall Study|Lost to Follow-up|0|||
124868845|NCT00677833|449140237|FG002|Overall Study|Lost to Follow-up|1|||
124868846|NCT00677833|449140238|FG003|Overall Study|Lost to Follow-up|0|||
124868847|NCT02001194|449140240|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
124868848|NCT02001194|449140241|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
124868849|NCT02001194|449140242|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
124868850|NCT02001194|449140243|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
124868851|NCT02001194|449140240|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
124868852|NCT02001194|449140241|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
124868853|NCT02001194|449140242|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
124868854|NCT02001194|449140243|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
124868855|NCT02606279|449140248|FG000|Overall Study|Lost to Follow-up|0|||
124868856|NCT02606279|449140249|FG001|Overall Study|Lost to Follow-up|1|||
124868857|NCT02690974|449140250|FG000|Overall Study|Adverse Event|16|||
124868858|NCT02690974|449140250|FG000|Overall Study|Death|9|||
124868859|NCT02690974|449140250|FG000|Overall Study|Subject/guardian decision|4|||
124868860|NCT02690974|449140250|FG000|Overall Study|Lost to Follow-up|3|||
124868861|NCT02690974|449140250|FG000|Overall Study|Withdrawal of Informed Consent|3|||
124868862|NCT02690974|449140250|FG000|Overall Study|Physician Decision|2|||
124868863|NCT02690974|449140250|FG000|Overall Study|Non-compliance with study treatment|1|||
124868864|NCT02690974|449140250|FG000|Overall Study|Protocol-defined stopping criteria|1|||
124868865|NCT02690974|449140250|FG000|Overall Study|Protocol Deviation|1|||
124868866|NCT02184611|449140256|FG000|Overall Study|Lack of Efficacy|11|||
124868867|NCT02184611|449140257|FG001|Overall Study|Lack of Efficacy|15|||
124868868|NCT02184611|449140256|FG000|Overall Study|Withdrawal by Subject|5|||
124868869|NCT02184611|449140257|FG001|Overall Study|Withdrawal by Subject|6|||
124868870|NCT02184611|449140256|FG000|Overall Study|Adverse Event|4|||
124868871|NCT02184611|449140257|FG001|Overall Study|Adverse Event|5|||
124868872|NCT02184611|449140256|FG000|Overall Study|Protocol Violation|1|||
124868873|NCT02184611|449140257|FG001|Overall Study|Protocol Violation|1|||
124535037|NCT02155660|447911657|FG003|Overall Study|Adverse Event|1|||
124868874|NCT02184611|449140256|FG000|Overall Study|Protocol defined stopping criteria|0|||
124535038|NCT02155660|447911654|FG000|Overall Study|Lost to Follow-up|3|||
124868875|NCT02184611|449140257|FG001|Overall Study|Protocol defined stopping criteria|1|||
124868876|NCT00522301|449140258|FG000|Overall Study|Withdrawal by Subject|1|||
124868877|NCT00522301|449140258|FG000|Overall Study|Adverse Event|5|||
124868878|NCT01666951|449140259|FG000|Overall Study|Not dosed|1|||
124868879|NCT01666951|449140260|FG001|Overall Study|Not dosed|1|||
124868880|NCT02366910|449140261|FG000|Overall Study|Withdrawal by Subject|2|||
124868881|NCT02366910|449140261|FG000|Overall Study|Screen Failure|3|||
124868882|NCT02623322|449140264|FG000|Overall Study|Lost to Follow-up|2|||
124868883|NCT02623322|449140265|FG001|Overall Study|Lost to Follow-up|1|||
124868884|NCT02623322|449140266|FG002|Overall Study|Lost to Follow-up|0|||
124535039|NCT02155660|447911655|FG001|Overall Study|Lost to Follow-up|6|||
124868885|NCT03563716|449140267|FG000|Overall Study|Death|20|||
124868886|NCT03563716|449140268|FG001|Overall Study|Death|14|||
124868887|NCT03563716|449140267|FG000|Overall Study|Withdrawal by Subject|3|||
124868888|NCT03563716|449140268|FG001|Overall Study|Withdrawal by Subject|3|||
124868889|NCT03563716|449140267|FG000|Overall Study|Still on Study|45|||
124868890|NCT03563716|449140268|FG001|Overall Study|Still on Study|50|||
124868891|NCT04605978|449140272|FG000|Overall Study|Adverse Event|2|||
124868892|NCT04605978|449140273|FG001|Overall Study|Adverse Event|1|||
124868893|NCT04605978|449140272|FG000|Overall Study|Withdrawal nonmedical reason|1|||
124868894|NCT04605978|449140273|FG001|Overall Study|Withdrawal nonmedical reason|1|||
124868895|NCT03813238|449140274|FG000|Overall Study|Adverse Event|0|||
124868896|NCT03813238|449140275|FG001|Overall Study|Adverse Event|6|||
124868897|NCT03813238|449140274|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124868898|NCT03813238|449140275|FG001|Overall Study|Withdrawal by parent/guardian|2|||
124868899|NCT03813238|449140274|FG000|Overall Study|Lost to Follow-up|0|||
124868900|NCT03813238|449140275|FG001|Overall Study|Lost to Follow-up|1|||
124868901|NCT03813238|449140274|FG000|Overall Study|Other than specified|1|||
124868902|NCT03813238|449140275|FG001|Overall Study|Other than specified|2|||
124868903|NCT02583425|449140276|FG000|Screening|Did not meet entry criteria|12|||
124868904|NCT02583425|449140276|FG000|Baseline|Did not meet continued criteria|5|||
124868905|NCT02583425|449140276|FG000|Treatment Period|Adverse Event|1|||
124868906|NCT03318523|449140277|FG000|PC Period: Up to Year 1|Adverse Event|1|||
124868907|NCT03318523|449140278|FG001|PC Period: Up to Year 1|Adverse Event|0|||
124868908|NCT03318523|449140279|FG002|PC Period: Up to Year 1|Adverse Event|2|||
124868909|NCT03318523|449140280|FG003|PC Period: Up to Year 1|Adverse Event|0|||
124868910|NCT03318523|449140281|FG004|PC Period: Up to Year 1|Adverse Event|0|||
124868911|NCT03318523|449140282|FG005|PC Period: Up to Year 1|Adverse Event|0|||
124868912|NCT03318523|449140283|FG006|PC Period: Up to Year 1|Adverse Event|0|||
124868913|NCT03318523|449140284|FG007|PC Period: Up to Year 1|Adverse Event|0|||
124868914|NCT03318523|449140285|FG008|PC Period: Up to Year 1|Adverse Event|0|||
124868915|NCT03318523|449140286|FG009|PC Period: Up to Year 1|Adverse Event|0|||
124868916|NCT03318523|449140277|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
124868917|NCT03318523|449140278|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
124868918|NCT03318523|449140279|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
124868919|NCT03318523|449140280|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
124868920|NCT03318523|449140281|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
124868921|NCT03318523|449140282|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
124868922|NCT03318523|449140283|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
124868923|NCT03318523|449140284|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
124868924|NCT03318523|449140285|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
124868925|NCT03318523|449140286|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
124868926|NCT03318523|449140277|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
124868927|NCT03318523|449140278|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
124868928|NCT03318523|449140279|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
124868929|NCT03318523|449140280|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
124868930|NCT03318523|449140281|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
124868931|NCT03318523|449140282|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
124868932|NCT03318523|449140283|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
124868933|NCT03318523|449140284|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
124868934|NCT03318523|449140285|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
124868935|NCT03318523|449140286|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
124868936|NCT03318523|449140277|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
124868937|NCT03318523|449140278|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
124868938|NCT03318523|449140279|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
124868939|NCT03318523|449140280|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
124868940|NCT03318523|449140281|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
124868941|NCT03318523|449140282|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
124868942|NCT03318523|449140283|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
124868943|NCT03318523|449140284|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
124868944|NCT03318523|449140285|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
124868945|NCT03318523|449140286|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
124868946|NCT03318523|449140277|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868947|NCT03318523|449140278|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868948|NCT03318523|449140279|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868949|NCT03318523|449140280|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868950|NCT03318523|449140281|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868951|NCT03318523|449140282|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
124868952|NCT03318523|449140283|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868953|NCT03318523|449140284|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868954|NCT03318523|449140285|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868955|NCT03318523|449140286|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
124868956|NCT03318523|449140277|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868957|NCT03318523|449140278|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868958|NCT03318523|449140279|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868959|NCT03318523|449140280|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868960|NCT03318523|449140281|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868961|NCT03318523|449140282|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868962|NCT03318523|449140283|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868963|NCT03318523|449140284|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868964|NCT03318523|449140285|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
124868965|NCT03318523|449140286|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
124868966|NCT03318523|449140277|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
124868967|NCT03318523|449140278|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
124868968|NCT03318523|449140279|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
124868969|NCT03318523|449140280|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
124868970|NCT03318523|449140281|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
124868971|NCT03318523|449140282|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
124868972|NCT03318523|449140283|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
124868973|NCT03318523|449140284|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
124868974|NCT03318523|449140285|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
124868975|NCT03318523|449140286|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
124868976|NCT03318523|449140277|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
124868977|NCT03318523|449140278|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
124868978|NCT03318523|449140279|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
124868979|NCT03318523|449140280|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
124868980|NCT03318523|449140281|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
124868981|NCT03318523|449140282|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
124868982|NCT03318523|449140283|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
124868983|NCT03318523|449140284|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
124868984|NCT03318523|449140285|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
124868985|NCT03318523|449140286|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
124868986|NCT03581981|449140287|FG000|Overall Study|Withdrawal by Subject|12|||
124868987|NCT03581981|449140288|FG001|Overall Study|Withdrawal by Subject|13|||
124868988|NCT03581981|449140287|FG000|Overall Study|Physician Decision|1|||
124868989|NCT03581981|449140288|FG001|Overall Study|Physician Decision|2|||
124868990|NCT03581981|449140287|FG000|Overall Study|Lost to Follow-up|0|||
124868991|NCT03581981|449140288|FG001|Overall Study|Lost to Follow-up|4|||
124868992|NCT02080871|449140289|FG000|Overall Study|Death|1|||
124868993|NCT02080871|449140289|FG000|Overall Study|Lost to Follow-up|1|||
124868994|NCT00234052|449140290|FG000|Treatment|Withdrawal by Subject|3|||
124868995|NCT00234052|449140290|FG000|Treatment|Adverse Event|5|||
124868996|NCT00234052|449140290|FG000|Treatment|Death|2|||
124868997|NCT00234052|449140290|FG000|Treatment|Progressive Disease|11|||
124868998|NCT00234052|449140290|FG000|Follow-up for 5 Years|Death|41|||
124868999|NCT00234052|449140290|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
124869000|NCT00234052|449140290|FG000|Follow-up for 5 Years|Other|7|||
124869001|NCT02428296|449140291|FG000|Overall Study|Adverse Event|7|||
124869002|NCT02428296|449140291|FG000|Overall Study|Withdrawal by Subject|2|||
124869003|NCT02723864|449140292|FG000|Overall Study|Refused further treatment|1|||
124869004|NCT02723864|449140293|FG001|Overall Study|Refused further treatment|0|||
124869005|NCT02723864|449140294|FG002|Overall Study|Refused further treatment|0|||
124869006|NCT02723864|449140295|FG003|Overall Study|Refused further treatment|0|||
124869007|NCT02723864|449140296|FG004|Overall Study|Refused further treatment|1|||
124869008|NCT02723864|449140297|FG005|Overall Study|Refused further treatment|2|||
124869009|NCT02723864|449140298|FG006|Overall Study|Refused further treatment|0|||
124869010|NCT02723864|449140292|FG000|Overall Study|Exceed treatment hold time|0|||
124869011|NCT02723864|449140293|FG001|Overall Study|Exceed treatment hold time|1|||
124869012|NCT02723864|449140294|FG002|Overall Study|Exceed treatment hold time|0|||
124869013|NCT02723864|449140295|FG003|Overall Study|Exceed treatment hold time|0|||
124869014|NCT02723864|449140296|FG004|Overall Study|Exceed treatment hold time|0|||
124869015|NCT02723864|449140297|FG005|Overall Study|Exceed treatment hold time|0|||
124869016|NCT02723864|449140298|FG006|Overall Study|Exceed treatment hold time|0|||
124869017|NCT02723864|449140292|FG000|Overall Study|Clinical progression|0|||
124869018|NCT02723864|449140293|FG001|Overall Study|Clinical progression|0|||
124869019|NCT02723864|449140294|FG002|Overall Study|Clinical progression|1|||
124869020|NCT02723864|449140295|FG003|Overall Study|Clinical progression|0|||
124869021|NCT02723864|449140296|FG004|Overall Study|Clinical progression|0|||
124869022|NCT02723864|449140297|FG005|Overall Study|Clinical progression|3|||
124869023|NCT02723864|449140298|FG006|Overall Study|Clinical progression|1|||
124869024|NCT02723864|449140292|FG000|Overall Study|Physician Decision|0|||
124869025|NCT02723864|449140293|FG001|Overall Study|Physician Decision|0|||
124869026|NCT02723864|449140294|FG002|Overall Study|Physician Decision|0|||
124869027|NCT02723864|449140295|FG003|Overall Study|Physician Decision|0|||
124869028|NCT02723864|449140296|FG004|Overall Study|Physician Decision|0|||
124869029|NCT02723864|449140297|FG005|Overall Study|Physician Decision|0|||
124869030|NCT02723864|449140298|FG006|Overall Study|Physician Decision|1|||
124869031|NCT02723864|449140292|FG000|Overall Study|Changes in patient condition|0|||
124869032|NCT02723864|449140293|FG001|Overall Study|Changes in patient condition|0|||
124869033|NCT02723864|449140294|FG002|Overall Study|Changes in patient condition|0|||
124869034|NCT02723864|449140295|FG003|Overall Study|Changes in patient condition|0|||
124869035|NCT02723864|449140296|FG004|Overall Study|Changes in patient condition|0|||
124869036|NCT02723864|449140297|FG005|Overall Study|Changes in patient condition|1|||
124869037|NCT02723864|449140298|FG006|Overall Study|Changes in patient condition|0|||
124869038|NCT02723864|449140292|FG000|Overall Study|Patient choice|0|||
124869039|NCT02723864|449140293|FG001|Overall Study|Patient choice|0|||
124869040|NCT02723864|449140294|FG002|Overall Study|Patient choice|0|||
124869041|NCT02723864|449140295|FG003|Overall Study|Patient choice|0|||
124869042|NCT02723864|449140296|FG004|Overall Study|Patient choice|0|||
124869043|NCT02723864|449140297|FG005|Overall Study|Patient choice|1|||
124869044|NCT02723864|449140298|FG006|Overall Study|Patient choice|0|||
124869045|NCT02723864|449140292|FG000|Overall Study|Adverse Event|0|||
124869046|NCT02723864|449140293|FG001|Overall Study|Adverse Event|0|||
124869047|NCT02723864|449140294|FG002|Overall Study|Adverse Event|0|||
124869048|NCT02723864|449140295|FG003|Overall Study|Adverse Event|0|||
124869049|NCT02723864|449140296|FG004|Overall Study|Adverse Event|0|||
124869050|NCT02723864|449140297|FG005|Overall Study|Adverse Event|1|||
124869051|NCT02723864|449140298|FG006|Overall Study|Adverse Event|0|||
124869052|NCT02723864|449140292|FG000|Overall Study|Started new treatment|0|||
124869053|NCT02723864|449140293|FG001|Overall Study|Started new treatment|0|||
124869054|NCT02723864|449140294|FG002|Overall Study|Started new treatment|0|||
124869055|NCT02723864|449140295|FG003|Overall Study|Started new treatment|0|||
124869056|NCT02723864|449140296|FG004|Overall Study|Started new treatment|0|||
124869057|NCT02723864|449140297|FG005|Overall Study|Started new treatment|1|||
124869058|NCT02723864|449140298|FG006|Overall Study|Started new treatment|0|||
124869059|NCT02723864|449140292|FG000|Overall Study|Switched to alternative treatment|0|||
124869060|NCT02723864|449140293|FG001|Overall Study|Switched to alternative treatment|0|||
124869061|NCT02723864|449140294|FG002|Overall Study|Switched to alternative treatment|0|||
124869062|NCT02723864|449140295|FG003|Overall Study|Switched to alternative treatment|0|||
124869063|NCT02723864|449140296|FG004|Overall Study|Switched to alternative treatment|0|||
124869064|NCT02723864|449140297|FG005|Overall Study|Switched to alternative treatment|1|||
124869065|NCT02723864|449140298|FG006|Overall Study|Switched to alternative treatment|0|||
124869066|NCT02723864|449140292|FG000|Overall Study|Late determination of ineligibility|0|||
124869067|NCT02723864|449140293|FG001|Overall Study|Late determination of ineligibility|0|||
124869068|NCT02723864|449140294|FG002|Overall Study|Late determination of ineligibility|0|||
124869069|NCT02723864|449140295|FG003|Overall Study|Late determination of ineligibility|0|||
124869070|NCT02723864|449140296|FG004|Overall Study|Late determination of ineligibility|0|||
124869071|NCT02723864|449140297|FG005|Overall Study|Late determination of ineligibility|1|||
124869072|NCT02723864|449140298|FG006|Overall Study|Late determination of ineligibility|0|||
124869073|NCT00828984|449140299|FG000|Overall Study|Adverse Event|2|||
124869074|NCT00828984|449140300|FG001|Overall Study|Adverse Event|3|||
124869075|NCT00828984|449140301|FG002|Overall Study|Adverse Event|0|||
124869076|NCT00828984|449140299|FG000|Overall Study|Lost to Follow-up|5|||
124869077|NCT00828984|449140300|FG001|Overall Study|Lost to Follow-up|3|||
124869078|NCT00828984|449140301|FG002|Overall Study|Lost to Follow-up|1|||
124869079|NCT00828984|449140299|FG000|Overall Study|Withdrawal by Subject|4|||
124869080|NCT00828984|449140300|FG001|Overall Study|Withdrawal by Subject|4|||
124869081|NCT00828984|449140301|FG002|Overall Study|Withdrawal by Subject|4|||
124869082|NCT00828984|449140299|FG000|Overall Study|Ineligable|1|||
124869083|NCT00828984|449140300|FG001|Overall Study|Ineligable|2|||
124869084|NCT00828984|449140301|FG002|Overall Study|Ineligable|0|||
124869085|NCT00828984|449140299|FG000|Overall Study|Medical Contraindication|0|||
124869086|NCT00828984|449140300|FG001|Overall Study|Medical Contraindication|1|||
124869087|NCT00828984|449140301|FG002|Overall Study|Medical Contraindication|0|||
124869088|NCT00828984|449140299|FG000|Overall Study|Noncompliant|1|||
124869089|NCT00828984|449140300|FG001|Overall Study|Noncompliant|2|||
124869090|NCT00828984|449140301|FG002|Overall Study|Noncompliant|3|||
124869091|NCT00828984|449140299|FG000|Overall Study|ConMed|1|||
124869092|NCT00828984|449140300|FG001|Overall Study|ConMed|1|||
124869093|NCT00828984|449140301|FG002|Overall Study|ConMed|1|||
124869094|NCT04465357|449140302|FG000|Overall Study|Adverse Event|2|||
124869095|NCT04465357|449140302|FG000|Overall Study|Lack of Efficacy|1|||
124869096|NCT04465357|449140302|FG000|Overall Study|Lost to Follow-up|2|||
124869097|NCT04465357|449140302|FG000|Overall Study|Withdrawal by Subject|6|||
124869098|NCT04465357|449140302|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
124869099|NCT02548455|449140305|FG000|Overall Study|Withdrawal by Subject|27|||
124869100|NCT02548455|449140305|FG000|Overall Study|Death|26|||
124869101|NCT02548455|449140305|FG000|Overall Study|Lost to Follow-up|14|||
124869102|NCT02548455|449140305|FG000|Overall Study|Visit not completed|173|||
124869103|NCT00831779|449140307|FG000|Overall Study|Lost to Follow-up|1|||
124869104|NCT00831779|449140308|FG001|Overall Study|Lost to Follow-up|0|||
124869105|NCT00831779|449140307|FG000|Overall Study|No longer met criteria|0|||
124869106|NCT00831779|449140308|FG001|Overall Study|No longer met criteria|1|||
124869107|NCT02436330|449140309|FG000|Cohort 1|Lost to Follow-up|5|||
124869108|NCT02436330|449140310|FG001|Cohort 1|Lost to Follow-up|2|||
124869109|NCT02436330|449140309|FG000|Cohort 1|Withdrawal by Subject|0|||
124869110|NCT02436330|449140310|FG001|Cohort 1|Withdrawal by Subject|1|||
124869111|NCT02436330|449140309|FG000|Cohort 2|Lost to Follow-up|2|||
124869112|NCT02436330|449140310|FG001|Cohort 2|Lost to Follow-up|0|||
124869113|NCT02436330|449140309|FG000|Cohort 2|Withdrawal by Subject|2|||
124869114|NCT02436330|449140310|FG001|Cohort 2|Withdrawal by Subject|3|||
124869115|NCT02436330|449140309|FG000|Cohort 3|Lost to Follow-up|1|||
124869116|NCT02436330|449140310|FG001|Cohort 3|Lost to Follow-up|0|||
124869117|NCT02436330|449140309|FG000|Cohort 3|Withdrawal by Subject|4|||
124869118|NCT02436330|449140310|FG001|Cohort 3|Withdrawal by Subject|0|||
124869119|NCT02436330|449140309|FG000|Cohort 4|Lost to Follow-up|1|||
124869120|NCT02436330|449140310|FG001|Cohort 4|Lost to Follow-up|0|||
124869121|NCT02436330|449140309|FG000|Cohort 4|Withdrawal by Subject|1|||
124869122|NCT02436330|449140310|FG001|Cohort 4|Withdrawal by Subject|0|||
124869123|NCT02436330|449140309|FG000|Cohort 5|Lost to Follow-up|3|||
124869124|NCT02436330|449140310|FG001|Cohort 5|Lost to Follow-up|2|||
124869125|NCT02436330|449140309|FG000|Cohort 5|Withdrawal by Subject|3|||
124869126|NCT02436330|449140310|FG001|Cohort 5|Withdrawal by Subject|2|||
124869127|NCT02436330|449140309|FG000|Cohort 6|Lost to Follow-up|2|||
124869128|NCT02436330|449140310|FG001|Cohort 6|Lost to Follow-up|0|||
124869129|NCT02436330|449140309|FG000|Cohort 6|Withdrawal by Subject|1|||
124869130|NCT02436330|449140310|FG001|Cohort 6|Withdrawal by Subject|1|||
124869131|NCT02230956|449140311|FG000|Overall Study|Adverse Event|1|||
124869132|NCT02230956|449140312|FG001|Overall Study|Adverse Event|1|||
124869133|NCT02230956|449140313|FG002|Overall Study|Adverse Event|0|||
124869134|NCT02230956|449140311|FG000|Overall Study|Lack of Efficacy|1|||
124869135|NCT02230956|449140312|FG001|Overall Study|Lack of Efficacy|1|||
124869136|NCT02230956|449140313|FG002|Overall Study|Lack of Efficacy|1|||
124869137|NCT02230956|449140311|FG000|Overall Study|Lost to Follow-up|1|||
124869138|NCT02230956|449140312|FG001|Overall Study|Lost to Follow-up|1|||
124869139|NCT02230956|449140313|FG002|Overall Study|Lost to Follow-up|2|||
124869140|NCT02230956|449140311|FG000|Overall Study|Personal Reasons|2|||
124869141|NCT02230956|449140312|FG001|Overall Study|Personal Reasons|1|||
124869142|NCT02230956|449140313|FG002|Overall Study|Personal Reasons|1|||
124869143|NCT02230956|449140311|FG000|Overall Study|Protocol Violation|0|||
124869144|NCT02230956|449140312|FG001|Overall Study|Protocol Violation|1|||
124869145|NCT02230956|449140313|FG002|Overall Study|Protocol Violation|1|||
124869146|NCT02230956|449140311|FG000|Overall Study|Other Miscellaneous Reason|0|||
124869147|NCT02230956|449140312|FG001|Overall Study|Other Miscellaneous Reason|1|||
124869148|NCT02230956|449140313|FG002|Overall Study|Other Miscellaneous Reason|2|||
124869149|NCT00338884|449140314|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
124869150|NCT00338884|449140314|FG000|Overall Study|Adverse Event|14|||
124869151|NCT00338884|449140314|FG000|Overall Study|Death|8|||
124869152|NCT00338884|449140314|FG000|Overall Study|Other|4|||
124869153|NCT00338884|449140314|FG000|Overall Study|Global Deterioration of Health Status|3|||
124869154|NCT00338884|449140314|FG000|Overall Study|Withdrawal by Subject|3|||
124869155|NCT00338884|449140314|FG000|Overall Study|Lost to Follow-up|1|||
124869156|NCT00338884|449140314|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
124869157|NCT01970982|449140316|FG000|Overall Study|Withdrawal by Subject|0|||
124869158|NCT01970982|449140317|FG001|Overall Study|Withdrawal by Subject|0|||
124869159|NCT01970982|449140318|FG002|Overall Study|Withdrawal by Subject|2|||
124869160|NCT00765674|449140323|FG000|Overall Study|Adverse Event|7|||
124869161|NCT00765674|449140324|FG001|Overall Study|Adverse Event|2|||
124869162|NCT00765674|449140325|FG002|Overall Study|Adverse Event|8|||
124869163|NCT00765674|449140326|FG003|Overall Study|Adverse Event|11|||
124869164|NCT00765674|449140323|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
124869165|NCT00765674|449140324|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
124869166|NCT00765674|449140325|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
124869167|NCT00765674|449140326|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
124869168|NCT00765674|449140323|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
124869169|NCT00765674|449140324|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
124869170|NCT00765674|449140325|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
124869171|NCT00765674|449140326|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
124869172|NCT00765674|449140323|FG000|Overall Study|Lack of Efficacy|2|||
124869173|NCT00765674|449140324|FG001|Overall Study|Lack of Efficacy|3|||
124869174|NCT00765674|449140325|FG002|Overall Study|Lack of Efficacy|1|||
124869175|NCT00765674|449140326|FG003|Overall Study|Lack of Efficacy|2|||
124869176|NCT00765674|449140323|FG000|Overall Study|Protocol Violation|2|||
124869177|NCT00765674|449140324|FG001|Overall Study|Protocol Violation|0|||
124869178|NCT00765674|449140325|FG002|Overall Study|Protocol Violation|1|||
124869179|NCT00765674|449140326|FG003|Overall Study|Protocol Violation|0|||
124869180|NCT00765674|449140323|FG000|Overall Study|Withdrawal by Subject|5|||
124869181|NCT00765674|449140324|FG001|Overall Study|Withdrawal by Subject|7|||
124869182|NCT00765674|449140325|FG002|Overall Study|Withdrawal by Subject|3|||
124869183|NCT00765674|449140326|FG003|Overall Study|Withdrawal by Subject|8|||
124869184|NCT00765674|449140323|FG000|Overall Study|Lost to Follow-up|4|||
124869185|NCT00765674|449140324|FG001|Overall Study|Lost to Follow-up|6|||
124869186|NCT00765674|449140325|FG002|Overall Study|Lost to Follow-up|2|||
124869187|NCT00765674|449140326|FG003|Overall Study|Lost to Follow-up|1|||
124869188|NCT00765674|449140323|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
124869189|NCT00765674|449140324|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
124869190|NCT00765674|449140325|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
124869191|NCT00765674|449140326|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
124869192|NCT02432105|449140327|FG000|Overall Study|Lost to Follow-up|1|||
124869193|NCT02432105|449140328|FG001|Overall Study|Lost to Follow-up|1|||
124869194|NCT02432105|449140329|FG002|Overall Study|Lost to Follow-up|0|||
124869195|NCT02432105|449140327|FG000|Overall Study|Withdrawal by Subject|1|||
124869196|NCT02432105|449140328|FG001|Overall Study|Withdrawal by Subject|0|||
124869197|NCT02432105|449140329|FG002|Overall Study|Withdrawal by Subject|1|||
124869198|NCT02432105|449140327|FG000|Overall Study|Culture positive for yeast|0|||
124869199|NCT02432105|449140328|FG001|Overall Study|Culture positive for yeast|1|||
124869200|NCT02432105|449140329|FG002|Overall Study|Culture positive for yeast|0|||
124869201|NCT02432105|449140327|FG000|Overall Study|Randomized in error|0|||
124869202|NCT02432105|449140328|FG001|Overall Study|Randomized in error|0|||
124869203|NCT02432105|449140329|FG002|Overall Study|Randomized in error|2|||
124869204|NCT03053050|449140330|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
124869205|NCT03053050|449140331|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
124869206|NCT03053050|449140332|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
124869207|NCT03053050|449140333|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
124869208|NCT03053050|449140330|FG000|Randomized Phase|Withdrew Consent|16|||
124869209|NCT03053050|449140331|FG001|Randomized Phase|Withdrew Consent|8|||
124869210|NCT03053050|449140332|FG002|Randomized Phase|Withdrew Consent|9|||
124869211|NCT03053050|449140333|FG003|Randomized Phase|Withdrew Consent|0|||
124869212|NCT03053050|449140330|FG000|Randomized Phase|Investigator's Discretion|6|||
124869213|NCT03053050|449140331|FG001|Randomized Phase|Investigator's Discretion|6|||
124869214|NCT03053050|449140332|FG002|Randomized Phase|Investigator's Discretion|3|||
124869215|NCT03053050|449140333|FG003|Randomized Phase|Investigator's Discretion|0|||
124869216|NCT03053050|449140330|FG000|Randomized Phase|Lost to Follow-up|5|||
124869217|NCT03053050|449140331|FG001|Randomized Phase|Lost to Follow-up|1|||
124869218|NCT03053050|449140332|FG002|Randomized Phase|Lost to Follow-up|1|||
124869219|NCT03053050|449140333|FG003|Randomized Phase|Lost to Follow-up|0|||
124869220|NCT03053050|449140330|FG000|Randomized Phase|Adverse Event|0|||
124869221|NCT03053050|449140331|FG001|Randomized Phase|Adverse Event|1|||
124869222|NCT03053050|449140332|FG002|Randomized Phase|Adverse Event|0|||
124869223|NCT03053050|449140333|FG003|Randomized Phase|Adverse Event|0|||
124869224|NCT03053050|449140330|FG000|Randomized Phase|Randomized but Never Treated|2|||
124869225|NCT03053050|449140331|FG001|Randomized Phase|Randomized but Never Treated|2|||
124869226|NCT03053050|449140332|FG002|Randomized Phase|Randomized but Never Treated|2|||
124869227|NCT03053050|449140333|FG003|Randomized Phase|Randomized but Never Treated|0|||
124869228|NCT03053050|449140330|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
124869229|NCT03053050|449140331|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
124869230|NCT03053050|449140332|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
124869231|NCT03053050|449140333|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
124869232|NCT03053050|449140330|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
124869233|NCT03053050|449140331|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
124869234|NCT03053050|449140332|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
124869235|NCT03053050|449140333|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
124869236|NCT03053050|449140330|FG000|Open-label Phase|Withdrew Consent|0|||
124869237|NCT03053050|449140331|FG001|Open-label Phase|Withdrew Consent|0|||
124869238|NCT03053050|449140332|FG002|Open-label Phase|Withdrew Consent|0|||
124869239|NCT03053050|449140333|FG003|Open-label Phase|Withdrew Consent|6|||
124869240|NCT03053050|449140330|FG000|Open-label Phase|Investigator's Discretion|0|||
124869241|NCT03053050|449140331|FG001|Open-label Phase|Investigator's Discretion|0|||
124869242|NCT03053050|449140332|FG002|Open-label Phase|Investigator's Discretion|0|||
124869243|NCT03053050|449140333|FG003|Open-label Phase|Investigator's Discretion|4|||
124869244|NCT02459574|449140334|FG000|Overall Study|Withdrawal by Subject|6|||
124869245|NCT02459574|449140335|FG001|Overall Study|Withdrawal by Subject|6|||
124869246|NCT02459574|449140336|FG002|Overall Study|Withdrawal by Subject|2|||
124869247|NCT02459574|449140334|FG000|Overall Study|Lost to Follow-up|1|||
124869248|NCT02459574|449140335|FG001|Overall Study|Lost to Follow-up|1|||
124869249|NCT02459574|449140336|FG002|Overall Study|Lost to Follow-up|0|||
124869250|NCT02459574|449140334|FG000|Overall Study|Death|0|||
124869251|NCT02459574|449140335|FG001|Overall Study|Death|1|||
124869252|NCT02459574|449140336|FG002|Overall Study|Death|0|||
124869253|NCT00251745|449140337|FG000|Overall Study|Adverse Event|7|||
124869254|NCT00251745|449140338|FG001|Overall Study|Adverse Event|9|||
124869255|NCT00251745|449140339|FG002|Overall Study|Adverse Event|11|||
124869256|NCT00251745|449140337|FG000|Overall Study|Lost to Follow-up|4|||
124869257|NCT00251745|449140338|FG001|Overall Study|Lost to Follow-up|2|||
124869258|NCT00251745|449140339|FG002|Overall Study|Lost to Follow-up|5|||
124869259|NCT00251745|449140337|FG000|Overall Study|Withdrawal by Subject|13|||
124869260|NCT00251745|449140338|FG001|Overall Study|Withdrawal by Subject|7|||
124869261|NCT00251745|449140339|FG002|Overall Study|Withdrawal by Subject|3|||
124869262|NCT00251745|449140337|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
124869263|NCT00251745|449140338|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
124869264|NCT00251745|449140339|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
124869265|NCT00251745|449140337|FG000|Overall Study|Lack of Efficacy|3|||
124869266|NCT00251745|449140338|FG001|Overall Study|Lack of Efficacy|0|||
124869267|NCT00251745|449140339|FG002|Overall Study|Lack of Efficacy|0|||
124869268|NCT00251745|449140337|FG000|Overall Study|Noncompliant|0|||
124869269|NCT00251745|449140338|FG001|Overall Study|Noncompliant|2|||
124869270|NCT00251745|449140339|FG002|Overall Study|Noncompliant|2|||
124869271|NCT00251745|449140337|FG000|Overall Study|Pregnancy|0|||
124869272|NCT00251745|449140338|FG001|Overall Study|Pregnancy|1|||
124869273|NCT00251745|449140339|FG002|Overall Study|Pregnancy|0|||
124869274|NCT00251745|449140337|FG000|Overall Study|Per Subject Request|0|||
124869275|NCT00251745|449140338|FG001|Overall Study|Per Subject Request|0|||
124869276|NCT00251745|449140339|FG002|Overall Study|Per Subject Request|1|||
124869277|NCT00251745|449140337|FG000|Overall Study|Per Investigator Request|1|||
124869278|NCT00251745|449140338|FG001|Overall Study|Per Investigator Request|0|||
124869279|NCT00251745|449140339|FG002|Overall Study|Per Investigator Request|0|||
124869280|NCT04508699|449140342|FG000|Overall Study|Lack of Efficacy|2|||
124869281|NCT04508699|449140343|FG001|Overall Study|Lack of Efficacy|15|||
124869282|NCT04508699|449140342|FG000|Overall Study|Withdrawal by Subject|0|||
124869283|NCT04508699|449140343|FG001|Overall Study|Withdrawal by Subject|2|||
124869284|NCT00499031|449141642|FG000|Overall Study|Improper pre-protocol treatment|1|||
124869285|NCT00499031|449141642|FG000|Overall Study|Required test not done|1|||
124869286|NCT00499031|449141642|FG000|Overall Study|Never treated|1|||
124869287|NCT03409666|449141648|FG000|Overall Study|Physician Decision|0|||
124869288|NCT03409666|449141649|FG001|Overall Study|Physician Decision|1|||
124869289|NCT03409666|449141648|FG000|Overall Study|Protocol Violation|0|||
124869290|NCT03409666|449141649|FG001|Overall Study|Protocol Violation|3|||
124869291|NCT03432364|449141653|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
124869292|NCT03320018|449141657|FG000|Treatment Period|Withdrawal by Subject|1|||
124869293|NCT03320018|449141658|FG001|Treatment Period|Withdrawal by Subject|0|||
124869294|NCT03320018|449141657|FG000|Day 90 Follow up|Death|0|||
124869295|NCT03320018|449141658|FG001|Day 90 Follow up|Death|1|||
124869296|NCT03284788|449141662|FG000|Overall Study|Withdrawal by Subject|2|||
124869297|NCT03104699|449141667|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
124869298|NCT03104699|449141668|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
124869299|NCT03104699|449141669|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
124869300|NCT03104699|449141670|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
124869301|NCT03104699|449141671|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
124869302|NCT03104699|449141672|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124869303|NCT03104699|449141667|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
124869304|NCT03104699|449141668|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
124869305|NCT03104699|449141669|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
124869306|NCT03104699|449141670|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
124869307|NCT03104699|449141671|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
124869308|NCT03104699|449141672|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
124869309|NCT03104699|449141667|FG000|Phase 1: Dose Escalation|Death|6|||
124869310|NCT03104699|449141668|FG001|Phase 1: Dose Escalation|Death|3|||
124869311|NCT03104699|449141669|FG002|Phase 1: Dose Escalation|Death|0|||
124869312|NCT03104699|449141670|FG003|Phase 1: Dose Escalation|Death|1|||
124869313|NCT03104699|449141671|FG004|Phase 1: Dose Escalation|Death|1|||
124869314|NCT03104699|449141672|FG005|Phase 1: Dose Escalation|Death|0|||
124869315|NCT03104699|449141667|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
124869316|NCT03104699|449141668|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
124869317|NCT03104699|449141669|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
124869318|NCT03104699|449141670|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
124869319|NCT03104699|449141671|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
124869320|NCT03104699|449141672|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
124869321|NCT03104699|449141667|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
124869322|NCT03104699|449141668|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
124869323|NCT03104699|449141669|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
124869324|NCT03104699|449141670|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
124869325|NCT03104699|449141671|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
124869326|NCT03104699|449141672|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
124869327|NCT03104699|449141667|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
124869328|NCT03104699|449141668|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
124869329|NCT03104699|449141669|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
124869330|NCT03104699|449141670|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
124869331|NCT03104699|449141671|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
124869332|NCT03104699|449141672|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
124869333|NCT03104699|449141667|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
124869334|NCT03104699|449141668|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
124869335|NCT03104699|449141669|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
124869336|NCT03104699|449141670|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
124869337|NCT03104699|449141671|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
124869338|NCT03104699|449141672|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
124869339|NCT03104699|449141667|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
124869340|NCT03104699|449141668|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
124869341|NCT03104699|449141669|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
124869342|NCT03104699|449141670|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
124869343|NCT03104699|449141671|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
124869344|NCT03104699|449141672|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
124869345|NCT03104699|449141667|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124869346|NCT03104699|449141668|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124869347|NCT03104699|449141669|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124869348|NCT03104699|449141670|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124869349|NCT03104699|449141671|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124869350|NCT03104699|449141672|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
124869351|NCT03104699|449141667|FG000|Phase 2: Dose Expansion|Death|0|||
124869352|NCT03104699|449141668|FG001|Phase 2: Dose Expansion|Death|0|||
124869353|NCT03104699|449141669|FG002|Phase 2: Dose Expansion|Death|0|||
124869354|NCT03104699|449141670|FG003|Phase 2: Dose Expansion|Death|0|||
124869355|NCT03104699|449141671|FG004|Phase 2: Dose Expansion|Death|0|||
124869356|NCT03104699|449141672|FG005|Phase 2: Dose Expansion|Death|107|||
124869357|NCT03104699|449141667|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
124869358|NCT03104699|449141668|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
124869359|NCT03104699|449141669|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
124869360|NCT03104699|449141670|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
124869361|NCT03104699|449141671|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
124869362|NCT03104699|449141672|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
124869363|NCT03104699|449141667|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
124869364|NCT03104699|449141668|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
124869365|NCT03104699|449141669|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
124869366|NCT03104699|449141670|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
124869367|NCT03104699|449141671|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
124869368|NCT03104699|449141672|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
124869369|NCT03104699|449141667|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124869370|NCT03104699|449141668|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124869371|NCT03104699|449141669|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124869372|NCT03104699|449141670|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124869373|NCT03104699|449141671|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124869374|NCT03104699|449141672|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
124869375|NCT03104699|449141667|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
124869376|NCT03104699|449141668|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
124869377|NCT03104699|449141669|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
124869378|NCT03104699|449141670|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
124869379|NCT03104699|449141671|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
124869380|NCT03104699|449141672|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
124869381|NCT01690130|449141673|FG000|Overall Study|Subject have cancelled visit.|1|||
124869382|NCT01690130|449141674|FG001|Overall Study|Subject have cancelled visit.|0|||
124869383|NCT00152464|449141675|FG000|Overall Study|Adverse Event|3|||
124869384|NCT00152464|449141676|FG001|Overall Study|Adverse Event|6|||
124869385|NCT00152464|449141675|FG000|Overall Study|Lost to Follow-up|8|||
124869386|NCT00152464|449141676|FG001|Overall Study|Lost to Follow-up|4|||
124869387|NCT00152464|449141675|FG000|Overall Study|Protocol Violation|3|||
124869388|NCT00152464|449141676|FG001|Overall Study|Protocol Violation|1|||
124869389|NCT00152464|449141675|FG000|Overall Study|Withdrawal by Subject|21|||
124869390|NCT00152464|449141676|FG001|Overall Study|Withdrawal by Subject|22|||
124869391|NCT00152464|449141675|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
124869392|NCT00152464|449141676|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
124869393|NCT00152464|449141675|FG000|Overall Study|Eczema deterioration|0|||
124535040|NCT02155660|447911656|FG002|Overall Study|Lost to Follow-up|5|||
124869394|NCT00152464|449141676|FG001|Overall Study|Eczema deterioration|1|||
124535041|NCT02155660|447911657|FG003|Overall Study|Lost to Follow-up|8|||
124869395|NCT00152464|449141675|FG000|Overall Study|Parent decision|1|||
124869396|NCT00152464|449141676|FG001|Overall Study|Parent decision|1|||
124869397|NCT00152464|449141675|FG000|Overall Study|Investigator decision|1|||
124869398|NCT00152464|449141676|FG001|Overall Study|Investigator decision|0|||
124869399|NCT00152464|449141675|FG000|Overall Study|Lack of Efficacy|1|||
124869400|NCT00152464|449141676|FG001|Overall Study|Lack of Efficacy|0|||
124869401|NCT00152464|449141675|FG000|Overall Study|Eczema poorly controlled|1|||
124869402|NCT00152464|449141676|FG001|Overall Study|Eczema poorly controlled|0|||
124869403|NCT00152464|449141675|FG000|Overall Study|Patient relocated|1|||
124758451|NCT02714569|448739765|FG010|Part B (Overall)|Withdrawal by Subject|0|||
124758452|NCT02714569|448739755|FG000|Part B (Overall)|Adverse Event|0|||
124758453|NCT02714569|448739756|FG001|Part B (Overall)|Adverse Event|0|||
124758454|NCT02714569|448739757|FG002|Part B (Overall)|Adverse Event|0|||
124758455|NCT02714569|448739758|FG003|Part B (Overall)|Adverse Event|0|||
124758456|NCT02714569|448739759|FG004|Part B (Overall)|Adverse Event|0|||
124758457|NCT02714569|448739760|FG005|Part B (Overall)|Adverse Event|0|||
124758458|NCT02714569|448739761|FG006|Part B (Overall)|Adverse Event|0|||
124758459|NCT02714569|448739762|FG007|Part B (Overall)|Adverse Event|0|||
124758460|NCT02714569|448739763|FG008|Part B (Overall)|Adverse Event|0|||
124758461|NCT02714569|448739764|FG009|Part B (Overall)|Adverse Event|1|||
124758462|NCT02714569|448739765|FG010|Part B (Overall)|Adverse Event|0|||
124758463|NCT00104650|448739769|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
124758464|NCT00104650|448739770|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
124758465|NCT00104650|448739771|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
124758466|NCT00104650|448739769|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
124758467|NCT00104650|448739770|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
124758468|NCT00104650|448739771|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
124758469|NCT00104650|448739769|FG000|Treatment Period (25 Weeks)|Death|7|||
124758470|NCT00104650|448739770|FG001|Treatment Period (25 Weeks)|Death|5|||
124758471|NCT00104650|448739771|FG002|Treatment Period (25 Weeks)|Death|6|||
124758472|NCT00104650|448739769|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
124758473|NCT00104650|448739770|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
124758474|NCT00104650|448739771|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
124758475|NCT00104650|448739769|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
124758476|NCT00104650|448739770|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
124758477|NCT00104650|448739771|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
124758478|NCT00104650|448739769|FG000|Treatment Period (25 Weeks)|Other|1|||
124758479|NCT00104650|448739770|FG001|Treatment Period (25 Weeks)|Other|0|||
124758480|NCT00104650|448739771|FG002|Treatment Period (25 Weeks)|Other|0|||
124758481|NCT00104650|448739769|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
124758482|NCT00104650|448739770|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
124758483|NCT00104650|448739771|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
124758484|NCT00104650|448739769|FG000|Follow-up Period|Physician Decision|1|||
124758485|NCT00104650|448739770|FG001|Follow-up Period|Physician Decision|1|||
124758486|NCT00104650|448739771|FG002|Follow-up Period|Physician Decision|0|||
124758487|NCT00104650|448739769|FG000|Follow-up Period|Adverse Event|1|||
124758488|NCT00104650|448739770|FG001|Follow-up Period|Adverse Event|0|||
124758489|NCT00104650|448739771|FG002|Follow-up Period|Adverse Event|1|||
124758490|NCT00104650|448739769|FG000|Follow-up Period|Withdrawal by Subject|0|||
124758491|NCT00104650|448739770|FG001|Follow-up Period|Withdrawal by Subject|3|||
124758492|NCT00104650|448739771|FG002|Follow-up Period|Withdrawal by Subject|3|||
124758493|NCT00104650|448739769|FG000|Follow-up Period|Death|6|||
124758494|NCT00104650|448739770|FG001|Follow-up Period|Death|6|||
124758495|NCT00104650|448739771|FG002|Follow-up Period|Death|4|||
124758496|NCT00104650|448739769|FG000|Follow-up Period|Disease progression|3|||
124758497|NCT00104650|448739770|FG001|Follow-up Period|Disease progression|1|||
124758498|NCT00104650|448739771|FG002|Follow-up Period|Disease progression|0|||
124758499|NCT00104650|448739769|FG000|Follow-up Period|Lost to Follow-up|0|||
124758500|NCT00104650|448739770|FG001|Follow-up Period|Lost to Follow-up|1|||
124758501|NCT00104650|448739771|FG002|Follow-up Period|Lost to Follow-up|2|||
124758502|NCT00104650|448739769|FG000|Follow-up Period|Other|0|||
124758503|NCT00104650|448739770|FG001|Follow-up Period|Other|1|||
124758504|NCT00104650|448739771|FG002|Follow-up Period|Other|0|||
124758505|NCT00773513|448739772|FG000|Overall Study|Renal Transplant|254|||
124758506|NCT00773513|448739773|FG001|Overall Study|Renal Transplant|263|||
124758507|NCT00773513|448739772|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
124758508|NCT00773513|448739773|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
124758509|NCT00773513|448739772|FG000|Overall Study|Withdrew Consent|68|||
124758510|NCT00773513|448739773|FG001|Overall Study|Withdrew Consent|69|||
124758511|NCT00773513|448739772|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
124758512|NCT00773513|448739773|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
124758513|NCT00773513|448739772|FG000|Overall Study|Failure to Return|22|||
124758514|NCT00773513|448739773|FG001|Overall Study|Failure to Return|8|||
124758515|NCT00773513|448739772|FG000|Overall Study|Insufficient Therapeutic Response|1|||
124758516|NCT00773513|448739773|FG001|Overall Study|Insufficient Therapeutic Response|18|||
124758517|NCT00773513|448739772|FG000|Overall Study|Reason Not Specified|159|||
124758518|NCT00773513|448739773|FG001|Overall Study|Reason Not Specified|126|||
124758519|NCT00773513|448739772|FG000|Overall Study|Death|531|||
124758520|NCT00773513|448739773|FG001|Overall Study|Death|545|||
124758521|NCT02728089|448739775|FG000|Overall Study|Physician Decision|2|||
124758522|NCT02728089|448739775|FG000|Overall Study|Withdrawal by Subject|1|||
124758523|NCT03384940|448739778|FG000|Overall Study|Progressive disease|36|||
124758524|NCT03384940|448739779|FG001|Overall Study|Progressive disease|11|||
124758525|NCT03384940|448739780|FG002|Overall Study|Progressive disease|13|||
124758526|NCT03384940|448739778|FG000|Overall Study|Clinical progression|4|||
124869404|NCT00152464|449141676|FG001|Overall Study|Patient relocated|0|||
124869405|NCT01644734|449141677|FG000|Overall Study|Adverse Event|4|||
124869406|NCT01644734|449141677|FG000|Overall Study|Lost to Follow-up|17|||
124869407|NCT01644734|449141677|FG000|Overall Study|Reasons other than stated above|7|||
124869408|NCT01644734|449141677|FG000|Overall Study|Missing documentation|238|||
124869409|NCT05159622|449141678|FG000|Overall Study|Lost to Follow-up|4|||
124869410|NCT05159622|449141679|FG001|Overall Study|Lost to Follow-up|5|||
124869411|NCT01615328|449141687|FG000|Overall Study|Lost to Follow-up|3|||
124869412|NCT01615328|449141688|FG001|Overall Study|Lost to Follow-up|5|||
124869413|NCT03338894|449141689|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
124869414|NCT00626028|449141690|FG000|Overall Study|Adverse Event|1|||
124869415|NCT00626028|449141691|FG001|Overall Study|Adverse Event|1|||
124869416|NCT00626028|449141690|FG000|Overall Study|Device Failure|0|||
124869417|NCT00626028|449141691|FG001|Overall Study|Device Failure|1|||
124869418|NCT00626028|449141690|FG000|Overall Study|Physician Decision|2|||
124869419|NCT00626028|449141691|FG001|Overall Study|Physician Decision|1|||
124869420|NCT00626028|449141690|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
124869421|NCT00626028|449141691|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
124869422|NCT01984684|449141694|FG000|Overall Study|Lost to Follow-up|25|||
124869423|NCT01984684|449141695|FG001|Overall Study|Lost to Follow-up|24|||
124869424|NCT01984684|449141694|FG000|Overall Study|Adverse Event|8|||
124869425|NCT01984684|449141695|FG001|Overall Study|Adverse Event|12|||
124869426|NCT01984684|449141694|FG000|Overall Study|Withdrawal by Subject|9|||
124869427|NCT01984684|449141695|FG001|Overall Study|Withdrawal by Subject|9|||
124869428|NCT01984684|449141694|FG000|Overall Study|Lack of Efficacy|3|||
124869429|NCT01984684|449141695|FG001|Overall Study|Lack of Efficacy|6|||
124869430|NCT01984684|449141694|FG000|Overall Study|Physician Decision|4|||
124869431|NCT01984684|449141695|FG001|Overall Study|Physician Decision|2|||
124869432|NCT01984684|449141694|FG000|Overall Study|Protocol Violation|4|||
124869433|NCT01984684|449141695|FG001|Overall Study|Protocol Violation|2|||
124869434|NCT01984684|449141694|FG000|Overall Study|Death|0|||
124869435|NCT01984684|449141695|FG001|Overall Study|Death|1|||
124869436|NCT01984684|449141694|FG000|Overall Study|Noncompliance with study drug|2|||
124869437|NCT01984684|449141695|FG001|Overall Study|Noncompliance with study drug|1|||
124869438|NCT01984684|449141694|FG000|Overall Study|Subject incarcerated|1|||
124869439|NCT01984684|449141695|FG001|Overall Study|Subject incarcerated|0|||
124869440|NCT01984684|449141694|FG000|Overall Study|Study drug not available at site|1|||
124869441|NCT01984684|449141695|FG001|Overall Study|Study drug not available at site|1|||
124869442|NCT01984684|449141694|FG000|Overall Study|Subject had inadequate IV access|0|||
124869443|NCT01984684|449141695|FG001|Overall Study|Subject had inadequate IV access|1|||
124869444|NCT04575051|449141696|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
124869445|NCT04575051|449141697|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
124869446|NCT04575051|449141698|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
124869447|NCT04575051|449141699|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
124869448|NCT04575051|449141700|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
124869449|NCT04575051|449141696|FG000|Time Period 1|Missing follow up|1|||
124869450|NCT04575051|449141697|FG001|Time Period 1|Missing follow up|3|||
124869451|NCT04575051|449141698|FG002|Time Period 1|Missing follow up|1|||
124869452|NCT04575051|449141699|FG003|Time Period 1|Missing follow up|3|||
124869453|NCT04575051|449141700|FG004|Time Period 1|Missing follow up|2|||
124869454|NCT04575051|449141696|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
124869455|NCT04575051|449141697|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
124869456|NCT04575051|449141698|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
124869457|NCT04575051|449141699|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
124869458|NCT04575051|449141700|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
124869459|NCT04575051|449141696|FG000|Time Period 2|Missing follow up|1|||
124869460|NCT04575051|449141697|FG001|Time Period 2|Missing follow up|8|||
124869461|NCT04575051|449141698|FG002|Time Period 2|Missing follow up|7|||
124869462|NCT04575051|449141699|FG003|Time Period 2|Missing follow up|0|||
124869463|NCT04575051|449141700|FG004|Time Period 2|Missing follow up|1|||
124869464|NCT04575051|449141696|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
124869465|NCT04575051|449141697|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
124869466|NCT04575051|449141698|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
124869467|NCT04575051|449141699|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
124869468|NCT04575051|449141700|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
124869469|NCT04575051|449141696|FG000|Time Period 3|Missing follow up|8|||
124869470|NCT04575051|449141697|FG001|Time Period 3|Missing follow up|6|||
124869471|NCT04575051|449141698|FG002|Time Period 3|Missing follow up|4|||
124869472|NCT04575051|449141699|FG003|Time Period 3|Missing follow up|3|||
124869473|NCT04575051|449141700|FG004|Time Period 3|Missing follow up|0|||
124869474|NCT04575051|449141696|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
124869475|NCT04575051|449141697|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
124869476|NCT04575051|449141698|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
124869477|NCT04575051|449141699|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
124869478|NCT04575051|449141700|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
124869479|NCT04575051|449141696|FG000|Time Period 4|Missing follow up|17|||
124869480|NCT04575051|449141697|FG001|Time Period 4|Missing follow up|3|||
124869481|NCT04575051|449141698|FG002|Time Period 4|Missing follow up|4|||
124869482|NCT04575051|449141699|FG003|Time Period 4|Missing follow up|2|||
124869483|NCT04575051|449141700|FG004|Time Period 4|Missing follow up|1|||
124869484|NCT04575051|449141696|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
124869485|NCT04575051|449141697|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
124869486|NCT04575051|449141698|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
124869487|NCT04575051|449141699|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
124869488|NCT04575051|449141700|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
124869489|NCT04575051|449141696|FG000|Time Period 5|Missing follow up|11|||
124869490|NCT04575051|449141697|FG001|Time Period 5|Missing follow up|8|||
124869491|NCT04575051|449141698|FG002|Time Period 5|Missing follow up|12|||
124869492|NCT04575051|449141699|FG003|Time Period 5|Missing follow up|3|||
124869493|NCT04575051|449141700|FG004|Time Period 5|Missing follow up|11|||
124869494|NCT03583554|449141703|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
124869495|NCT03583554|449141704|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
124869496|NCT03583554|449141705|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
124869497|NCT03178266|449141706|FG000|Overall Study|Death|0|||
124869498|NCT03178266|449141707|FG001|Overall Study|Death|1|||
124869499|NCT03178266|449141706|FG000|Overall Study|Disont. Early|0|||
124869500|NCT03178266|449141707|FG001|Overall Study|Disont. Early|1|||
124869501|NCT03178266|449141706|FG000|Overall Study|Withdrawal by Subject|0|||
124869502|NCT03178266|449141707|FG001|Overall Study|Withdrawal by Subject|2|||
124869503|NCT02472964|449141708|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
124869504|NCT02472964|449141709|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
124869505|NCT02472964|449141708|FG000|Part 1 (up to Week 24)|disease progression|58|||
124869506|NCT02472964|449141709|FG001|Part 1 (up to Week 24)|disease progression|47|||
124869507|NCT02472964|449141708|FG000|Part 1 (up to Week 24)|Death|3|||
124869508|NCT02472964|449141709|FG001|Part 1 (up to Week 24)|Death|6|||
124869509|NCT02472964|449141708|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
124869510|NCT02472964|449141709|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
124869511|NCT02472964|449141708|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
124869512|NCT02472964|449141709|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
124869513|NCT02472964|449141708|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
124869514|NCT02472964|449141709|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
124869515|NCT02472964|449141708|FG000|Part 1 (up to Week 24)|Other|2|||
124869516|NCT02472964|449141709|FG001|Part 1 (up to Week 24)|Other|1|||
124869517|NCT02472964|449141708|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
124869518|NCT02472964|449141709|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
124869519|NCT02472964|449141708|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
124869520|NCT02472964|449141709|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
124869521|NCT02472964|449141708|FG000|Part 2 (Week 24-week 48)|Death|0|||
124869522|NCT02472964|449141709|FG001|Part 2 (Week 24-week 48)|Death|1|||
124869523|NCT02472964|449141708|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
124869524|NCT02472964|449141709|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
124535042|NCT02155660|447911654|FG000|Overall Study|Death|17|||
124535043|NCT02155660|447911655|FG001|Overall Study|Death|19|||
124535044|NCT02155660|447911656|FG002|Overall Study|Death|17|||
124869525|NCT02472964|449141708|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
124869526|NCT02472964|449141709|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
124869527|NCT02472964|449141708|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
124869528|NCT02472964|449141709|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
124869529|NCT02472964|449141708|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
124869530|NCT02472964|449141709|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
124869531|NCT04672941|449141715|FG000|Overall Study|Investigator decision|1|||
124869532|NCT04672941|449141715|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
124869533|NCT04672941|449141715|FG000|Overall Study|COVID-19 related but no adverse event|1|||
124869534|NCT04672941|449141715|FG000|Overall Study|Adverse Event|2|||
124869535|NCT04672941|449141715|FG000|Overall Study|Lost to Follow-up|2|||
124869536|NCT00765388|449141717|FG000|Period 1|Lack of Efficacy|1|||
124869537|NCT00765388|449141718|FG001|Period 1|Lack of Efficacy|2|||
124869538|NCT00765388|449141717|FG000|Period 1|Lost to Follow-up|0|||
124869539|NCT00765388|449141718|FG001|Period 1|Lost to Follow-up|1|||
124869540|NCT00765388|449141717|FG000|Period 1|Herpes Zoster|0|||
124869541|NCT00765388|449141718|FG001|Period 1|Herpes Zoster|1|||
124869542|NCT00765388|449141717|FG000|Period 1|Hip operation|0|||
124869543|NCT00765388|449141718|FG001|Period 1|Hip operation|1|||
124869544|NCT02342886|449141722|FG000|Overall Study|Treatment non-compliance|1|||
124535045|NCT02155660|447911657|FG003|Overall Study|Death|19|||
124869545|NCT02342886|449141723|FG001|Overall Study|Treatment non-compliance|0|||
124869546|NCT02342886|449141724|FG002|Overall Study|Treatment non-compliance|0|||
124869547|NCT02342886|449141725|FG003|Overall Study|Treatment non-compliance|1|||
124869548|NCT02342886|449141726|FG004|Overall Study|Treatment non-compliance|0|||
124869549|NCT02342886|449141722|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
124869550|NCT02342886|449141723|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
124869551|NCT02342886|449141724|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
124869552|NCT02342886|449141725|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
124869553|NCT02342886|449141726|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
124869554|NCT02342886|449141722|FG000|Overall Study|Adverse event/specific toxicity|4|||
124869555|NCT02342886|449141723|FG001|Overall Study|Adverse event/specific toxicity|3|||
124978485|NCT03829501|449548503|FG015|Overall Study|PD|1|||
124978486|NCT03829501|449548504|FG016|Overall Study|PD|0|||
124978487|NCT03829501|449548505|FG017|Overall Study|PD|0|||
124978488|NCT03829501|449548506|FG018|Overall Study|PD|0|||
124978489|NCT03829501|449548507|FG019|Overall Study|PD|0|||
124978490|NCT03829501|449548508|FG020|Overall Study|PD|1|||
124978491|NCT03829501|449548509|FG021|Overall Study|PD|0|||
124978492|NCT03829501|449548510|FG022|Overall Study|PD|0|||
124978493|NCT03829501|449548488|FG000|Overall Study|Study Terminated by Sponsor|0|||
124978494|NCT03829501|449548489|FG001|Overall Study|Study Terminated by Sponsor|0|||
124978495|NCT03829501|449548490|FG002|Overall Study|Study Terminated by Sponsor|0|||
124978496|NCT03829501|449548491|FG003|Overall Study|Study Terminated by Sponsor|0|||
124978497|NCT03829501|449548492|FG004|Overall Study|Study Terminated by Sponsor|0|||
124978498|NCT03829501|449548493|FG005|Overall Study|Study Terminated by Sponsor|0|||
124978499|NCT03829501|449548494|FG006|Overall Study|Study Terminated by Sponsor|0|||
124978500|NCT03829501|449548495|FG007|Overall Study|Study Terminated by Sponsor|3|||
124978501|NCT03829501|449548496|FG008|Overall Study|Study Terminated by Sponsor|1|||
124978502|NCT03829501|449548497|FG009|Overall Study|Study Terminated by Sponsor|0|||
124978503|NCT03829501|449548498|FG010|Overall Study|Study Terminated by Sponsor|0|||
124978504|NCT03829501|449548499|FG011|Overall Study|Study Terminated by Sponsor|0|||
124978505|NCT03829501|449548500|FG012|Overall Study|Study Terminated by Sponsor|0|||
124978506|NCT03829501|449548501|FG013|Overall Study|Study Terminated by Sponsor|0|||
124978507|NCT03829501|449548502|FG014|Overall Study|Study Terminated by Sponsor|3|||
124978508|NCT03829501|449548503|FG015|Overall Study|Study Terminated by Sponsor|2|||
124978509|NCT03829501|449548504|FG016|Overall Study|Study Terminated by Sponsor|2|||
124978510|NCT03829501|449548505|FG017|Overall Study|Study Terminated by Sponsor|0|||
124978511|NCT03829501|449548506|FG018|Overall Study|Study Terminated by Sponsor|0|||
124978512|NCT03829501|449548507|FG019|Overall Study|Study Terminated by Sponsor|0|||
124978513|NCT03829501|449548508|FG020|Overall Study|Study Terminated by Sponsor|1|||
124978514|NCT03829501|449548509|FG021|Overall Study|Study Terminated by Sponsor|0|||
124978515|NCT03829501|449548510|FG022|Overall Study|Study Terminated by Sponsor|3|||
124978516|NCT03829501|449548488|FG000|Overall Study|Lost to Follow Up|0|||
124978517|NCT03829501|449548489|FG001|Overall Study|Lost to Follow Up|0|||
124978518|NCT03829501|449548490|FG002|Overall Study|Lost to Follow Up|0|||
124978519|NCT03829501|449548491|FG003|Overall Study|Lost to Follow Up|0|||
124978520|NCT03829501|449548492|FG004|Overall Study|Lost to Follow Up|1|||
124978521|NCT03829501|449548493|FG005|Overall Study|Lost to Follow Up|0|||
124978522|NCT03829501|449548494|FG006|Overall Study|Lost to Follow Up|0|||
124978523|NCT03829501|449548495|FG007|Overall Study|Lost to Follow Up|2|||
124978524|NCT03829501|449548496|FG008|Overall Study|Lost to Follow Up|2|||
124978525|NCT03829501|449548497|FG009|Overall Study|Lost to Follow Up|0|||
124978526|NCT03829501|449548498|FG010|Overall Study|Lost to Follow Up|2|||
124978527|NCT03829501|449548499|FG011|Overall Study|Lost to Follow Up|1|||
124978528|NCT03829501|449548500|FG012|Overall Study|Lost to Follow Up|0|||
124978529|NCT03829501|449548501|FG013|Overall Study|Lost to Follow Up|1|||
124978530|NCT03829501|449548502|FG014|Overall Study|Lost to Follow Up|1|||
124978531|NCT03829501|449548503|FG015|Overall Study|Lost to Follow Up|0|||
124978532|NCT03829501|449548504|FG016|Overall Study|Lost to Follow Up|0|||
124978533|NCT03829501|449548505|FG017|Overall Study|Lost to Follow Up|0|||
124978534|NCT03829501|449548506|FG018|Overall Study|Lost to Follow Up|0|||
124978535|NCT03829501|449548507|FG019|Overall Study|Lost to Follow Up|0|||
124978536|NCT03829501|449548508|FG020|Overall Study|Lost to Follow Up|0|||
124978537|NCT03829501|449548509|FG021|Overall Study|Lost to Follow Up|0|||
124978538|NCT03829501|449548510|FG022|Overall Study|Lost to Follow Up|1|||
124978539|NCT03829501|449548488|FG000|Overall Study|Death|2|||
124978540|NCT03829501|449548489|FG001|Overall Study|Death|4|||
124978541|NCT03829501|449548490|FG002|Overall Study|Death|5|||
124535046|NCT02155660|447911654|FG000|Overall Study|Withdrawal by Subject|28|||
124978542|NCT03829501|449548491|FG003|Overall Study|Death|6|||
124978543|NCT03829501|449548492|FG004|Overall Study|Death|5|||
124978544|NCT03829501|449548493|FG005|Overall Study|Death|4|||
124978545|NCT03829501|449548494|FG006|Overall Study|Death|5|||
124978546|NCT03829501|449548495|FG007|Overall Study|Death|24|||
124978547|NCT03829501|449548496|FG008|Overall Study|Death|22|||
124978548|NCT03829501|449548497|FG009|Overall Study|Death|6|||
124978549|NCT03829501|449548498|FG010|Overall Study|Death|3|||
124978550|NCT03829501|449548499|FG011|Overall Study|Death|10|||
124978551|NCT03829501|449548500|FG012|Overall Study|Death|10|||
124978552|NCT03829501|449548501|FG013|Overall Study|Death|5|||
124869556|NCT02342886|449141724|FG002|Overall Study|Adverse event/specific toxicity|11|||
124869557|NCT02342886|449141725|FG003|Overall Study|Adverse event/specific toxicity|2|||
124869558|NCT02342886|449141726|FG004|Overall Study|Adverse event/specific toxicity|1|||
124869559|NCT02342886|449141722|FG000|Overall Study|Lost to Follow-up|1|||
124869560|NCT02342886|449141723|FG001|Overall Study|Lost to Follow-up|0|||
124869561|NCT02342886|449141724|FG002|Overall Study|Lost to Follow-up|0|||
124869562|NCT02342886|449141725|FG003|Overall Study|Lost to Follow-up|0|||
124869563|NCT02342886|449141726|FG004|Overall Study|Lost to Follow-up|0|||
124869564|NCT02342886|449141722|FG000|Overall Study|Death|1|||
124869565|NCT02342886|449141723|FG001|Overall Study|Death|2|||
124869566|NCT02342886|449141724|FG002|Overall Study|Death|1|||
124869567|NCT02342886|449141725|FG003|Overall Study|Death|0|||
124869568|NCT02342886|449141726|FG004|Overall Study|Death|1|||
124869569|NCT02342886|449141722|FG000|Overall Study|Withdrawal by Subject|0|||
124869570|NCT02342886|449141723|FG001|Overall Study|Withdrawal by Subject|1|||
124869571|NCT02342886|449141724|FG002|Overall Study|Withdrawal by Subject|0|||
124869572|NCT02342886|449141725|FG003|Overall Study|Withdrawal by Subject|1|||
124869573|NCT02342886|449141726|FG004|Overall Study|Withdrawal by Subject|0|||
124869574|NCT02342886|449141722|FG000|Overall Study|Investigator/sponsor decision|0|||
124869575|NCT02342886|449141723|FG001|Overall Study|Investigator/sponsor decision|2|||
124869576|NCT02342886|449141724|FG002|Overall Study|Investigator/sponsor decision|0|||
124869577|NCT02342886|449141725|FG003|Overall Study|Investigator/sponsor decision|3|||
124869578|NCT02342886|449141726|FG004|Overall Study|Investigator/sponsor decision|1|||
124869579|NCT02342886|449141722|FG000|Overall Study|Pregnancy|0|||
124869580|NCT02342886|449141723|FG001|Overall Study|Pregnancy|0|||
124869581|NCT02342886|449141724|FG002|Overall Study|Pregnancy|2|||
124869582|NCT02342886|449141725|FG003|Overall Study|Pregnancy|0|||
124869583|NCT02342886|449141726|FG004|Overall Study|Pregnancy|0|||
124869584|NCT02342886|449141722|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
124869585|NCT02342886|449141723|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
124869586|NCT02342886|449141724|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
124869587|NCT02342886|449141725|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
124869588|NCT02342886|449141726|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
124869589|NCT02342886|449141722|FG000|Overall Study|Protocol Violation|0|||
124869590|NCT02342886|449141723|FG001|Overall Study|Protocol Violation|0|||
124869591|NCT02342886|449141724|FG002|Overall Study|Protocol Violation|0|||
124869592|NCT02342886|449141725|FG003|Overall Study|Protocol Violation|2|||
124869593|NCT02342886|449141726|FG004|Overall Study|Protocol Violation|0|||
124869594|NCT01328080|449141727|FG000|Overall Study|Lost to Follow-up|5|||
124869595|NCT00862134|449141728|FG000|Overall Study|Death|1|||
124869596|NCT00862134|449141729|FG001|Overall Study|Death|0|||
124869597|NCT00862134|449141728|FG000|Overall Study|Physician Decision|0|||
124869598|NCT00862134|449141729|FG001|Overall Study|Physician Decision|1|||
124869599|NCT00862134|449141728|FG000|Overall Study|Withdrawal by Subject|1|||
124869600|NCT00862134|449141729|FG001|Overall Study|Withdrawal by Subject|2|||
124869601|NCT00862134|449141728|FG000|Overall Study|Sponsor terminated study|5|||
124869602|NCT00862134|449141729|FG001|Overall Study|Sponsor terminated study|7|||
124869603|NCT00862134|449141728|FG000|Overall Study|Adverse Event|2|||
124869604|NCT00862134|449141729|FG001|Overall Study|Adverse Event|2|||
124869605|NCT00862134|449141728|FG000|Overall Study|Withdrew prior to dosing|2|||
124869606|NCT00862134|449141729|FG001|Overall Study|Withdrew prior to dosing|0|||
124869607|NCT02191267|449141730|FG000|Overall Study|Withdrawal by Subject|1|||
124869608|NCT02191267|449141731|FG001|Overall Study|Withdrawal by Subject|0|||
124869609|NCT02191267|449141732|FG002|Overall Study|Withdrawal by Subject|0|||
124869610|NCT00316082|449141733|FG000|Overall Study|Lack of Efficacy|2|||
124869611|NCT00316082|449141734|FG001|Overall Study|Lack of Efficacy|3|||
124869612|NCT00316082|449141735|FG002|Overall Study|Lack of Efficacy|3|||
124869613|NCT00316082|449141736|FG003|Overall Study|Lack of Efficacy|4|||
124869614|NCT00316082|449141737|FG004|Overall Study|Lack of Efficacy|6|||
124869615|NCT00316082|449141733|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
124869616|NCT00316082|449141734|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
124869617|NCT00316082|449141735|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
124869618|NCT00316082|449141736|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
124869619|NCT00316082|449141737|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
124869620|NCT00316082|449141733|FG000|Overall Study|Lost to Follow-up|7|||
124869621|NCT00316082|449141734|FG001|Overall Study|Lost to Follow-up|6|||
124869622|NCT00316082|449141735|FG002|Overall Study|Lost to Follow-up|7|||
124869623|NCT00316082|449141736|FG003|Overall Study|Lost to Follow-up|8|||
124869624|NCT00316082|449141737|FG004|Overall Study|Lost to Follow-up|6|||
124869625|NCT00316082|449141733|FG000|Overall Study|Poor/noncompliance|6|||
124869626|NCT00316082|449141734|FG001|Overall Study|Poor/noncompliance|1|||
124869627|NCT00316082|449141735|FG002|Overall Study|Poor/noncompliance|4|||
124869628|NCT00316082|449141736|FG003|Overall Study|Poor/noncompliance|1|||
124869629|NCT00316082|449141737|FG004|Overall Study|Poor/noncompliance|4|||
124869630|NCT00316082|449141733|FG000|Overall Study|Adverse Event|4|||
124869631|NCT00316082|449141734|FG001|Overall Study|Adverse Event|2|||
124869632|NCT00316082|449141735|FG002|Overall Study|Adverse Event|5|||
124869633|NCT00316082|449141736|FG003|Overall Study|Adverse Event|1|||
124869634|NCT00316082|449141737|FG004|Overall Study|Adverse Event|3|||
124869635|NCT00316082|449141733|FG000|Overall Study|Subject no longer meets study criteria|3|||
124869636|NCT00316082|449141734|FG001|Overall Study|Subject no longer meets study criteria|1|||
124869637|NCT00316082|449141735|FG002|Overall Study|Subject no longer meets study criteria|2|||
124869638|NCT00316082|449141736|FG003|Overall Study|Subject no longer meets study criteria|2|||
124869639|NCT00316082|449141737|FG004|Overall Study|Subject no longer meets study criteria|1|||
124869640|NCT00316082|449141733|FG000|Overall Study|Physician Decision|1|||
124869641|NCT00316082|449141734|FG001|Overall Study|Physician Decision|1|||
124869642|NCT00316082|449141735|FG002|Overall Study|Physician Decision|2|||
124869643|NCT00316082|449141736|FG003|Overall Study|Physician Decision|1|||
124869644|NCT00316082|449141737|FG004|Overall Study|Physician Decision|1|||
124869645|NCT00316082|449141733|FG000|Overall Study|Death|0|||
124869646|NCT00316082|449141734|FG001|Overall Study|Death|0|||
124869647|NCT00316082|449141735|FG002|Overall Study|Death|1|||
124869648|NCT00316082|449141736|FG003|Overall Study|Death|0|||
124869649|NCT00316082|449141737|FG004|Overall Study|Death|0|||
124869650|NCT00316082|449141733|FG000|Overall Study|Administrative reason by sponsor|0|||
124869651|NCT00316082|449141734|FG001|Overall Study|Administrative reason by sponsor|0|||
124869652|NCT00316082|449141735|FG002|Overall Study|Administrative reason by sponsor|1|||
124869653|NCT00316082|449141736|FG003|Overall Study|Administrative reason by sponsor|0|||
124869654|NCT00316082|449141737|FG004|Overall Study|Administrative reason by sponsor|0|||
124869655|NCT00528775|449141738|FG000|Overall Study|Other not specified|1|||
124869656|NCT00587964|449141741|FG000|Overall Study|Withdrawal by Subject|1|||
124869657|NCT00587964|449141741|FG000|Overall Study|Lost to Follow-up|1|||
124869658|NCT00587964|449141741|FG000|Overall Study|Patient found to be ineligible|1|||
124869659|NCT00587964|449141741|FG000|Overall Study|Patient did not receive intervention|5|||
124869660|NCT00587964|449141741|FG000|Overall Study|Progression of Disease|4|||
124869661|NCT01569438|449141745|FG000|Overall Study|Lack of Efficacy|1|||
124869662|NCT01569438|449141746|FG001|Overall Study|Lack of Efficacy|2|||
124869663|NCT01569438|449141745|FG000|Overall Study|Withdrawal by Subject|0|||
124869664|NCT01569438|449141746|FG001|Overall Study|Withdrawal by Subject|3|||
124869665|NCT01569438|449141745|FG000|Overall Study|Adverse Event|2|||
124869666|NCT01569438|449141746|FG001|Overall Study|Adverse Event|15|||
124869667|NCT01569438|449141745|FG000|Overall Study|Protocol Violation|2|||
124869668|NCT01569438|449141746|FG001|Overall Study|Protocol Violation|0|||
124869669|NCT01569438|449141745|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
124869670|NCT01569438|449141746|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
124869671|NCT01569438|449141745|FG000|Overall Study|Sponsor/Physician decision|1|||
124869672|NCT01569438|449141746|FG001|Overall Study|Sponsor/Physician decision|1|||
124869673|NCT01569438|449141745|FG000|Overall Study|Unable to adhere to study schedule|0|||
124869674|NCT01569438|449141746|FG001|Overall Study|Unable to adhere to study schedule|1|||
124869675|NCT03649230|449141748|FG000|Overall Study|Adverse Event|12|||
124869676|NCT03649230|449141748|FG000|Overall Study|Death|8|||
124869677|NCT03649230|449141748|FG000|Overall Study|Withdrawal by Subject|6|||
124869678|NCT03649230|449141748|FG000|Overall Study|Physician Decision|5|||
124869679|NCT03649230|449141748|FG000|Overall Study|Disease progression|5|||
124869680|NCT03649230|449141748|FG000|Overall Study|Switched to non-HEC|5|||
124869681|NCT03649230|449141748|FG000|Overall Study|Chemotherapy discontinued|4|||
124869682|NCT03649230|449141748|FG000|Overall Study|Received only 3 HEC cycles|4|||
124869683|NCT03649230|449141748|FG000|Overall Study|Screen Failure|3|||
124869684|NCT03649230|449141748|FG000|Overall Study|Patient stopped treatment|2|||
124869685|NCT03649230|449141748|FG000|Overall Study|Protocol Violation|1|||
124869686|NCT03649230|449141748|FG000|Overall Study|Non-compliance|1|||
124869687|NCT03649230|449141748|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
124869688|NCT01693068|449141749|FG000|Randomization Period|On-study|2|||
124869689|NCT01693068|449141750|FG001|Randomization Period|On-study|5|||
124869690|NCT01693068|449141751|FG002|Randomization Period|On-study|0|||
124869691|NCT01693068|449141749|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
124869692|NCT01693068|449141750|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
124869693|NCT01693068|449141751|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
124869694|NCT00977665|449141757|FG000|Overall Study|Withdrawal by Subject|1|||
124869695|NCT00977665|449141758|FG001|Overall Study|Withdrawal by Subject|3|||
124978553|NCT03829501|449548502|FG014|Overall Study|Death|7|||
124978554|NCT03829501|449548503|FG015|Overall Study|Death|2|||
124869696|NCT00977665|449141757|FG000|Overall Study|Physician Decision|2|||
124869697|NCT00977665|449141758|FG001|Overall Study|Physician Decision|1|||
124869698|NCT00977665|449141757|FG000|Overall Study|Sponsor requested withdrawal|0|||
124869699|NCT00977665|449141758|FG001|Overall Study|Sponsor requested withdrawal|1|||
124869700|NCT00977665|449141757|FG000|Overall Study|Lost to Follow-up|1|||
124869701|NCT00977665|449141758|FG001|Overall Study|Lost to Follow-up|0|||
124869702|NCT00977665|449141757|FG000|Overall Study|Death|3|||
124869703|NCT00977665|449141758|FG001|Overall Study|Death|2|||
124869704|NCT00977665|449141757|FG000|Overall Study|Adverse Event|14|||
124869705|NCT00977665|449141758|FG001|Overall Study|Adverse Event|7|||
124869706|NCT00977665|449141757|FG000|Overall Study|Treatment failure|0|||
124869707|NCT00977665|449141758|FG001|Overall Study|Treatment failure|1|||
124978555|NCT03829501|449548504|FG016|Overall Study|Death|2|||
124758527|NCT03384940|448739779|FG001|Overall Study|Clinical progression|0|||
124758528|NCT03384940|448739780|FG002|Overall Study|Clinical progression|3|||
124758529|NCT03384940|448739778|FG000|Overall Study|Adverse Event|7|||
124758530|NCT03384940|448739779|FG001|Overall Study|Adverse Event|1|||
124758531|NCT03384940|448739780|FG002|Overall Study|Adverse Event|1|||
124758532|NCT03384940|448739778|FG000|Overall Study|Withdrawal by Subject|3|||
124758533|NCT03384940|448739779|FG001|Overall Study|Withdrawal by Subject|1|||
124758534|NCT03384940|448739780|FG002|Overall Study|Withdrawal by Subject|0|||
124758535|NCT03384940|448739778|FG000|Overall Study|Physician Decision|1|||
124758536|NCT03384940|448739779|FG001|Overall Study|Physician Decision|1|||
124758537|NCT03384940|448739780|FG002|Overall Study|Physician Decision|0|||
124758538|NCT03384940|448739778|FG000|Overall Study|Death|2|||
124758539|NCT03384940|448739779|FG001|Overall Study|Death|1|||
124758540|NCT03384940|448739780|FG002|Overall Study|Death|0|||
124758541|NCT03384940|448739778|FG000|Overall Study|Other|0|||
124758542|NCT03384940|448739779|FG001|Overall Study|Other|0|||
124758543|NCT03384940|448739780|FG002|Overall Study|Other|1|||
124758544|NCT03089580|448739786|FG000|Overall Study|Lost to Follow-up|2|||
124758545|NCT03087513|448739787|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
124758546|NCT00770601|448739788|FG000|Overall Study|Withdrawal by Subject|1|||
124758547|NCT04417361|448739790|FG000|Overall Study|Withdrawal by Subject|1|||
124758548|NCT04417361|448739791|FG001|Overall Study|Withdrawal by Subject|0|||
124758549|NCT04417361|448739790|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
124758550|NCT04417361|448739791|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
124758551|NCT04965688|448739797|FG000|Overall Study|Withdrawal by Subject|2|||
124758552|NCT05864586|448739798|FG000|Overall Study|Ineligible|4|||
124758553|NCT05864586|448739799|FG001|Overall Study|Ineligible|12|||
124758554|NCT05864586|448739798|FG000|Overall Study|Pregnancy|0|||
124758555|NCT05864586|448739799|FG001|Overall Study|Pregnancy|1|||
124758556|NCT05864586|448739798|FG000|Overall Study|Withdrawal by Subject|0|||
124758557|NCT05864586|448739799|FG001|Overall Study|Withdrawal by Subject|1|||
124758558|NCT00801216|448739800|FG000|Overall Study|Screening Failure|2|||
124758559|NCT00319254|448739804|FG000|Overall Study|Withdrawal by Subject|4|||
124758560|NCT00319254|448739804|FG000|Overall Study|Death|46|||
124758561|NCT00319254|448739804|FG000|Overall Study|Lost to Follow-up|2|||
124758562|NCT00319254|448739804|FG000|Overall Study|Enrolled, Not Treated|2|||
124758563|NCT01505374|448739805|FG000|Overall Study|Lost to Follow-up|1|||
124758564|NCT01505374|448739806|FG001|Overall Study|Lost to Follow-up|0|||
124758565|NCT02452424|448739809|FG000|Overall Study|Death|2|||
124758566|NCT02452424|448739810|FG001|Overall Study|Death|2|||
124758567|NCT02452424|448739811|FG002|Overall Study|Death|2|||
124758568|NCT02452424|448739812|FG003|Overall Study|Death|6|||
124758569|NCT02452424|448739813|FG004|Overall Study|Death|2|||
124758570|NCT02452424|448739814|FG005|Overall Study|Death|0|||
124758571|NCT02452424|448739815|FG006|Overall Study|Death|5|||
124758572|NCT02452424|448739816|FG007|Overall Study|Death|1|||
124758573|NCT02452424|448739817|FG008|Overall Study|Death|3|||
124758574|NCT02452424|448739818|FG009|Overall Study|Death|1|||
124758575|NCT02452424|448739819|FG010|Overall Study|Death|0|||
124758576|NCT02452424|448739809|FG000|Overall Study|Lost to Follow-up|0|||
124758577|NCT02452424|448739810|FG001|Overall Study|Lost to Follow-up|1|||
124758578|NCT02452424|448739811|FG002|Overall Study|Lost to Follow-up|1|||
124758579|NCT02452424|448739812|FG003|Overall Study|Lost to Follow-up|0|||
124758580|NCT02452424|448739813|FG004|Overall Study|Lost to Follow-up|0|||
124758581|NCT02452424|448739814|FG005|Overall Study|Lost to Follow-up|0|||
124758582|NCT02452424|448739815|FG006|Overall Study|Lost to Follow-up|0|||
124758583|NCT02452424|448739816|FG007|Overall Study|Lost to Follow-up|0|||
124758584|NCT02452424|448739817|FG008|Overall Study|Lost to Follow-up|0|||
124758585|NCT02452424|448739818|FG009|Overall Study|Lost to Follow-up|0|||
124758586|NCT02452424|448739819|FG010|Overall Study|Lost to Follow-up|0|||
124758587|NCT02452424|448739809|FG000|Overall Study|Withdrawal by Subject|0|||
124758588|NCT02452424|448739810|FG001|Overall Study|Withdrawal by Subject|0|||
124758589|NCT02452424|448739811|FG002|Overall Study|Withdrawal by Subject|3|||
124758590|NCT02452424|448739812|FG003|Overall Study|Withdrawal by Subject|2|||
124758591|NCT02452424|448739813|FG004|Overall Study|Withdrawal by Subject|0|||
124758592|NCT02452424|448739814|FG005|Overall Study|Withdrawal by Subject|0|||
124758593|NCT02452424|448739815|FG006|Overall Study|Withdrawal by Subject|1|||
124758594|NCT02452424|448739816|FG007|Overall Study|Withdrawal by Subject|0|||
124758595|NCT02452424|448739817|FG008|Overall Study|Withdrawal by Subject|1|||
124758596|NCT02452424|448739818|FG009|Overall Study|Withdrawal by Subject|1|||
124758597|NCT02452424|448739819|FG010|Overall Study|Withdrawal by Subject|0|||
124758598|NCT02452424|448739809|FG000|Overall Study|Other|0|||
124758599|NCT02452424|448739810|FG001|Overall Study|Other|0|||
124758600|NCT02452424|448739811|FG002|Overall Study|Other|1|||
124758601|NCT02452424|448739812|FG003|Overall Study|Other|0|||
124758602|NCT02452424|448739813|FG004|Overall Study|Other|0|||
124758603|NCT02452424|448739814|FG005|Overall Study|Other|1|||
124758604|NCT02452424|448739815|FG006|Overall Study|Other|4|||
124535047|NCT02155660|447911655|FG001|Overall Study|Withdrawal by Subject|31|||
124535048|NCT02155660|447911656|FG002|Overall Study|Withdrawal by Subject|24|||
124535049|NCT02155660|447911657|FG003|Overall Study|Withdrawal by Subject|21|||
124535050|NCT00303719|447911664|FG000|Overall Study|Not evaluable, prior therapies|0|||
124535051|NCT00303719|447911665|FG001|Overall Study|Not evaluable, prior therapies|30|||
124535052|NCT00303719|447911664|FG000|Overall Study|Lost to Follow-up|0|||
124869708|NCT01400503|449141765|FG000|Overall Study|Withdrawal by Subject|1|||
124869709|NCT01400503|449141765|FG000|Overall Study|Study Terminated by Sponsor|58|||
124869710|NCT01400503|449141765|FG000|Overall Study|Other|1|||
124869711|NCT00058123|449141766|FG000|Overall Study|Wrong histology|9|||
124869712|NCT00058123|449141766|FG000|Overall Study|Received >3 prior treatments|1|||
124869713|NCT02925676|449141767|FG000|Overall Study|Withdrawal by Subject|1|||
124869714|NCT02151266|449141768|FG000|Overall Study|Lost to Follow-up|1|||
124869715|NCT02151266|449141769|FG001|Overall Study|Lost to Follow-up|4|||
124869716|NCT02151266|449141770|FG002|Overall Study|Lost to Follow-up|1|||
124869717|NCT02151266|449141768|FG000|Overall Study|Did NOT receive intervention|3|||
124869718|NCT02151266|449141769|FG001|Overall Study|Did NOT receive intervention|6|||
124869719|NCT02151266|449141770|FG002|Overall Study|Did NOT receive intervention|2|||
124869720|NCT02151266|449141768|FG000|Overall Study|Not able to exercise|4|||
124869721|NCT02151266|449141769|FG001|Overall Study|Not able to exercise|5|||
124869722|NCT02151266|449141770|FG002|Overall Study|Not able to exercise|4|||
124869723|NCT01169675|449141771|FG000|Overall Study|Progressive disease|13|||
124869724|NCT01169675|449141772|FG001|Overall Study|Progressive disease|2|||
124869725|NCT01169675|449141773|FG002|Overall Study|Progressive disease|5|||
124869726|NCT01169675|449141774|FG003|Overall Study|Progressive disease|15|||
124869727|NCT01169675|449141775|FG004|Overall Study|Progressive disease|1|||
124869728|NCT01169675|449141771|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
124869729|NCT01169675|449141772|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124869730|NCT01169675|449141773|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124869731|NCT01169675|449141774|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124869732|NCT01169675|449141775|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
124869733|NCT01169675|449141771|FG000|Overall Study|Adverse Event|5|||
124869734|NCT01169675|449141772|FG001|Overall Study|Adverse Event|1|||
124869735|NCT01169675|449141773|FG002|Overall Study|Adverse Event|2|||
124869736|NCT01169675|449141774|FG003|Overall Study|Adverse Event|0|||
124869737|NCT01169675|449141775|FG004|Overall Study|Adverse Event|0|||
124869738|NCT01169675|449141771|FG000|Overall Study|Withdrawal by Subject|1|||
124869739|NCT01169675|449141772|FG001|Overall Study|Withdrawal by Subject|0|||
124869740|NCT01169675|449141773|FG002|Overall Study|Withdrawal by Subject|0|||
124869741|NCT01169675|449141774|FG003|Overall Study|Withdrawal by Subject|1|||
124869742|NCT01169675|449141775|FG004|Overall Study|Withdrawal by Subject|2|||
124869743|NCT01169675|449141771|FG000|Overall Study|Other Reason Not Defined Above|0|||
124869744|NCT01169675|449141772|FG001|Overall Study|Other Reason Not Defined Above|0|||
124869745|NCT01169675|449141773|FG002|Overall Study|Other Reason Not Defined Above|0|||
124869746|NCT01169675|449141774|FG003|Overall Study|Other Reason Not Defined Above|1|||
124869747|NCT01169675|449141775|FG004|Overall Study|Other Reason Not Defined Above|1|||
124869748|NCT02365519|449141779|FG000|Randomized and Treated|Adverse Event|0|||
124869749|NCT02365519|449141780|FG001|Randomized and Treated|Adverse Event|1|||
124869750|NCT02365519|449141781|FG002|Randomized and Treated|Adverse Event|0|||
124869751|NCT02365519|449141779|FG000|Randomized and Treated|Withdrawal by Subject|0|||
124869752|NCT02365519|449141780|FG001|Randomized and Treated|Withdrawal by Subject|1|||
124869753|NCT02365519|449141781|FG002|Randomized and Treated|Withdrawal by Subject|1|||
124869754|NCT02291679|449141782|FG000|Overall Study|Adverse Event|2|||
124869755|NCT02291679|449141783|FG001|Overall Study|Adverse Event|12|||
124869756|NCT02291679|449141784|FG002|Overall Study|Adverse Event|19|||
124869757|NCT02291679|449141782|FG000|Overall Study|Protocol Violation|5|||
124869758|NCT02291679|449141783|FG001|Overall Study|Protocol Violation|1|||
124869759|NCT02291679|449141784|FG002|Overall Study|Protocol Violation|7|||
124869760|NCT02291679|449141782|FG000|Overall Study|Withdrew Consent|18|||
124869761|NCT02291679|449141783|FG001|Overall Study|Withdrew Consent|10|||
124869762|NCT02291679|449141784|FG002|Overall Study|Withdrew Consent|15|||
124869763|NCT02291679|449141782|FG000|Overall Study|Lost to Follow-up|12|||
124869764|NCT02291679|449141783|FG001|Overall Study|Lost to Follow-up|10|||
124869765|NCT02291679|449141784|FG002|Overall Study|Lost to Follow-up|9|||
124869766|NCT02291679|449141782|FG000|Overall Study|Insufficient Therapeutic Response|5|||
124869767|NCT02291679|449141783|FG001|Overall Study|Insufficient Therapeutic Response|5|||
124869768|NCT02291679|449141784|FG002|Overall Study|Insufficient Therapeutic Response|7|||
124869769|NCT02291679|449141782|FG000|Overall Study|Other|2|||
124869770|NCT02291679|449141783|FG001|Overall Study|Other|4|||
124869771|NCT02291679|449141784|FG002|Overall Study|Other|2|||
124869772|NCT02048072|449141785|FG000|Overall Study|Adverse Event|3|||
124869773|NCT02048072|449141785|FG000|Overall Study|Lost to Follow-up|1|||
124535053|NCT00303719|447911665|FG001|Overall Study|Lost to Follow-up|7|||
124869774|NCT00725296|449141787|FG000|Overall Study|Adverse Event|11|||
124869775|NCT00725296|449141787|FG000|Overall Study|Lack of Efficacy|7|||
124869776|NCT00725296|449141787|FG000|Overall Study|Withdrawal by Subject|3|||
124869777|NCT00725296|449141787|FG000|Overall Study|Non-Compliance|2|||
124869778|NCT00725296|449141787|FG000|Overall Study|Lost to Follow-up|1|||
124869779|NCT00725296|449141787|FG000|Overall Study|Other|38|||
124869780|NCT03657277|449141788|FG000|Overall Study|Physician Decision|2|||
124869781|NCT03657277|449141788|FG000|Overall Study|Lost to Follow-up|1|||
124869782|NCT03657277|449141788|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
124869783|NCT03360942|449141790|FG000|Overall Study|Device explanted|2|||
124869784|NCT03360942|449141790|FG000|Overall Study|Study closure|1|||
124869785|NCT03360942|449141790|FG000|Overall Study|Withdrawal by Subject|2|||
124869786|NCT00657618|449141795|FG000|Overall Study|Adverse Event|32|||
124869787|NCT00657618|449141795|FG000|Overall Study|Withdrawal by Subject|8|||
124869788|NCT00657618|449141795|FG000|Overall Study|negative for leishmaniasis|2|||
124869789|NCT00657618|449141795|FG000|Overall Study|didn't start due to schedule conflicts|1|||
124869790|NCT03703466|449141798|FG000|Overall Study|Death|2|||
124869791|NCT03703466|449141799|FG001|Overall Study|Death|1|||
124869792|NCT03703466|449141800|FG002|Overall Study|Death|0|||
124869793|NCT03703466|449141798|FG000|Overall Study|Withdrawal by Subject|0|||
124869794|NCT03703466|449141799|FG001|Overall Study|Withdrawal by Subject|3|||
124869795|NCT03703466|449141800|FG002|Overall Study|Withdrawal by Subject|0|||
124869796|NCT03703466|449141798|FG000|Overall Study|Completed < 3 Cycles|2|||
124869797|NCT03703466|449141799|FG001|Overall Study|Completed < 3 Cycles|2|||
124869798|NCT03703466|449141800|FG002|Overall Study|Completed < 3 Cycles|2|||
124869799|NCT05338333|449141801|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
124869800|NCT05338333|449141802|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
124869801|NCT05073133|449141806|FG000|Overall Study|Death|2|||
124869802|NCT03751631|449143558|FG000|Overall Study|Withdrawal by Subject|0|||
124869803|NCT03751631|449143559|FG001|Overall Study|Withdrawal by Subject|0|||
124869804|NCT03751631|449143560|FG002|Overall Study|Withdrawal by Subject|1|||
124869805|NCT03751631|449143561|FG003|Overall Study|Withdrawal by Subject|1|||
124869806|NCT03751631|449143562|FG004|Overall Study|Withdrawal by Subject|0|||
124869807|NCT03751631|449143563|FG005|Overall Study|Withdrawal by Subject|0|||
124869808|NCT00428090|449143564|FG000|Overall Study|Adverse Event|10|||
124869809|NCT00428090|449143565|FG001|Overall Study|Adverse Event|8|||
124869810|NCT00428090|449143566|FG002|Overall Study|Adverse Event|10|||
124869811|NCT00428090|449143567|FG003|Overall Study|Adverse Event|11|||
124869812|NCT00428090|449143564|FG000|Overall Study|Lost to Follow-up|3|||
124869813|NCT00428090|449143565|FG001|Overall Study|Lost to Follow-up|6|||
124869814|NCT00428090|449143566|FG002|Overall Study|Lost to Follow-up|1|||
124869815|NCT00428090|449143567|FG003|Overall Study|Lost to Follow-up|4|||
124869816|NCT00428090|449143564|FG000|Overall Study|Protocol Violation|3|||
124869817|NCT00428090|449143565|FG001|Overall Study|Protocol Violation|1|||
124869818|NCT00428090|449143566|FG002|Overall Study|Protocol Violation|3|||
124869819|NCT00428090|449143567|FG003|Overall Study|Protocol Violation|3|||
124869820|NCT00428090|449143564|FG000|Overall Study|Withdrawal by Subject|10|||
124869821|NCT00428090|449143565|FG001|Overall Study|Withdrawal by Subject|12|||
124869822|NCT00428090|449143566|FG002|Overall Study|Withdrawal by Subject|15|||
124869823|NCT00428090|449143567|FG003|Overall Study|Withdrawal by Subject|5|||
124869824|NCT00428090|449143564|FG000|Overall Study|Sponsor terminated study|0|||
124869825|NCT00428090|449143565|FG001|Overall Study|Sponsor terminated study|1|||
124869826|NCT00428090|449143566|FG002|Overall Study|Sponsor terminated study|0|||
124869827|NCT00428090|449143567|FG003|Overall Study|Sponsor terminated study|0|||
124869828|NCT00428090|449143564|FG000|Overall Study|Non-compliance|4|||
124869829|NCT00428090|449143565|FG001|Overall Study|Non-compliance|0|||
124869830|NCT00428090|449143566|FG002|Overall Study|Non-compliance|1|||
124869831|NCT00428090|449143567|FG003|Overall Study|Non-compliance|3|||
124869832|NCT00428090|449143564|FG000|Overall Study|Par. did not returned to visit|1|||
124869833|NCT00428090|449143565|FG001|Overall Study|Par. did not returned to visit|0|||
124869834|NCT00428090|449143566|FG002|Overall Study|Par. did not returned to visit|0|||
124869835|NCT00428090|449143567|FG003|Overall Study|Par. did not returned to visit|1|||
124869836|NCT00428090|449143564|FG000|Overall Study|Follow-Up visit not possible|1|||
124869837|NCT00428090|449143565|FG001|Overall Study|Follow-Up visit not possible|0|||
124869838|NCT00428090|449143566|FG002|Overall Study|Follow-Up visit not possible|0|||
124869839|NCT00428090|449143567|FG003|Overall Study|Follow-Up visit not possible|0|||
124869840|NCT00428090|449143564|FG000|Overall Study|Prohibited medication used for SAE|1|||
124535054|NCT02127970|447911680|FG000|Overall Study|Adverse Event|2|||
124535055|NCT02127970|447911681|FG001|Overall Study|Adverse Event|1|||
124869841|NCT00428090|449143565|FG001|Overall Study|Prohibited medication used for SAE|0|||
124869842|NCT00428090|449143566|FG002|Overall Study|Prohibited medication used for SAE|0|||
124869843|NCT00428090|449143567|FG003|Overall Study|Prohibited medication used for SAE|0|||
124869844|NCT00428090|449143564|FG000|Overall Study|Death of par.|1|||
124869845|NCT00428090|449143565|FG001|Overall Study|Death of par.|0|||
124869846|NCT00428090|449143566|FG002|Overall Study|Death of par.|1|||
124869847|NCT00428090|449143567|FG003|Overall Study|Death of par.|0|||
124869848|NCT00428090|449143564|FG000|Overall Study|Visit 7 exceed the visit window|0|||
124869849|NCT00428090|449143565|FG001|Overall Study|Visit 7 exceed the visit window|1|||
124869850|NCT00428090|449143566|FG002|Overall Study|Visit 7 exceed the visit window|0|||
124535056|NCT02127970|447911680|FG000|Overall Study|Death|1|||
124869851|NCT00428090|449143567|FG003|Overall Study|Visit 7 exceed the visit window|0|||
124869852|NCT00428090|449143564|FG000|Overall Study|Medical monitor terminated par.|0|||
124869853|NCT00428090|449143565|FG001|Overall Study|Medical monitor terminated par.|1|||
124869854|NCT00428090|449143566|FG002|Overall Study|Medical monitor terminated par.|0|||
124869855|NCT00428090|449143567|FG003|Overall Study|Medical monitor terminated par.|0|||
124869856|NCT00428090|449143564|FG000|Overall Study|Mental status of par. was|0|||
124869857|NCT00428090|449143565|FG001|Overall Study|Mental status of par. was|1|||
124869858|NCT00428090|449143566|FG002|Overall Study|Mental status of par. was|0|||
124869859|NCT00428090|449143567|FG003|Overall Study|Mental status of par. was|0|||
124869860|NCT00428090|449143564|FG000|Overall Study|Worsening of AD|0|||
124869861|NCT00428090|449143565|FG001|Overall Study|Worsening of AD|0|||
124869862|NCT00428090|449143566|FG002|Overall Study|Worsening of AD|1|||
124869863|NCT00428090|449143567|FG003|Overall Study|Worsening of AD|0|||
124869864|NCT00428090|449143564|FG000|Overall Study|Excluded for concerning QTc value|0|||
124869865|NCT00428090|449143565|FG001|Overall Study|Excluded for concerning QTc value|0|||
124869866|NCT00428090|449143566|FG002|Overall Study|Excluded for concerning QTc value|1|||
124869867|NCT00428090|449143567|FG003|Overall Study|Excluded for concerning QTc value|0|||
124869868|NCT00428090|449143564|FG000|Overall Study|Insufficient AD documentation|0|||
124869869|NCT00428090|449143565|FG001|Overall Study|Insufficient AD documentation|0|||
124869870|NCT00428090|449143566|FG002|Overall Study|Insufficient AD documentation|1|||
124869871|NCT00428090|449143567|FG003|Overall Study|Insufficient AD documentation|0|||
124869872|NCT00428090|449143564|FG000|Overall Study|High MMSE scores|0|||
124869873|NCT00428090|449143565|FG001|Overall Study|High MMSE scores|0|||
124869874|NCT00428090|449143566|FG002|Overall Study|High MMSE scores|1|||
124869875|NCT00428090|449143567|FG003|Overall Study|High MMSE scores|0|||
124869876|NCT00428090|449143564|FG000|Overall Study|Deterioration of cognitive status|0|||
124869877|NCT00428090|449143565|FG001|Overall Study|Deterioration of cognitive status|0|||
124869878|NCT00428090|449143566|FG002|Overall Study|Deterioration of cognitive status|1|||
124869879|NCT00428090|449143567|FG003|Overall Study|Deterioration of cognitive status|0|||
124869880|NCT00428090|449143564|FG000|Overall Study|Serious adverse event|0|||
124869881|NCT00428090|449143565|FG001|Overall Study|Serious adverse event|0|||
124869882|NCT00428090|449143566|FG002|Overall Study|Serious adverse event|1|||
124869883|NCT00428090|449143567|FG003|Overall Study|Serious adverse event|0|||
124869884|NCT00428090|449143564|FG000|Overall Study|Excluded for heart insufficiency|0|||
124869885|NCT00428090|449143565|FG001|Overall Study|Excluded for heart insufficiency|0|||
124869886|NCT00428090|449143566|FG002|Overall Study|Excluded for heart insufficiency|1|||
124869887|NCT00428090|449143567|FG003|Overall Study|Excluded for heart insufficiency|0|||
124869888|NCT00428090|449143564|FG000|Overall Study|Raised Creatinine Value|0|||
124869889|NCT00428090|449143565|FG001|Overall Study|Raised Creatinine Value|0|||
124869890|NCT00428090|449143566|FG002|Overall Study|Raised Creatinine Value|0|||
124869891|NCT00428090|449143567|FG003|Overall Study|Raised Creatinine Value|1|||
124869892|NCT03255824|449143568|FG000|Overall Study|Under-sedation|2|||
124869893|NCT03255824|449143569|FG001|Overall Study|Under-sedation|1|||
124869894|NCT00863655|449143572|FG000|Overall Study|Protocol Violation|4|||
124869895|NCT00863655|449143573|FG001|Overall Study|Protocol Violation|0|||
124869896|NCT00863655|449143572|FG000|Overall Study|Adverse Event|52|||
124869897|NCT00863655|449143573|FG001|Overall Study|Adverse Event|8|||
124869898|NCT00863655|449143572|FG000|Overall Study|Withdrawal by Subject|47|||
124869899|NCT00863655|449143573|FG001|Overall Study|Withdrawal by Subject|7|||
124869900|NCT00863655|449143572|FG000|Overall Study|Administrative problems|1|||
124869901|NCT00863655|449143573|FG001|Overall Study|Administrative problems|0|||
124869902|NCT00863655|449143572|FG000|Overall Study|Death|7|||
124869903|NCT00863655|449143573|FG001|Overall Study|Death|1|||
124535057|NCT02127970|447911681|FG001|Overall Study|Death|1|||
124535058|NCT02127970|447911680|FG000|Overall Study|Lost to Follow-up|14|||
124535059|NCT02127970|447911681|FG001|Overall Study|Lost to Follow-up|14|||
124535060|NCT02127970|447911680|FG000|Overall Study|Reason not Specified|4|||
124535061|NCT02127970|447911681|FG001|Overall Study|Reason not Specified|7|||
124535062|NCT02127970|447911680|FG000|Overall Study|Pregnancy|0|||
124535063|NCT02127970|447911681|FG001|Overall Study|Pregnancy|1|||
124535064|NCT02127970|447911680|FG000|Overall Study|Subject Withdrew Consent|5|||
124535065|NCT02127970|447911681|FG001|Overall Study|Subject Withdrew Consent|3|||
124535066|NCT00542321|447911682|FG000|Overall Study|Death|0|||
124535067|NCT00542321|447911683|FG001|Overall Study|Death|1|||
124535068|NCT00718887|447911696|FG000|Overall Study|Withdrawal by Subject|3|||
124535069|NCT00718887|447911697|FG001|Overall Study|Withdrawal by Subject|2|||
124535070|NCT00718887|447911696|FG000|Overall Study|Not identified|2|||
124535071|NCT00718887|447911697|FG001|Overall Study|Not identified|7|||
124535072|NCT05102734|447911698|FG000|Overall Study|Did not require vasopressors|1|||
124535073|NCT05102734|447911699|FG001|Overall Study|Did not require vasopressors|0|||
124535074|NCT05102734|447911698|FG000|Overall Study|Did not have functioning PA catheter|1|||
124535075|NCT05102734|447911699|FG001|Overall Study|Did not have functioning PA catheter|0|||
124869904|NCT00863655|449143572|FG000|Overall Study|New cancer therapy|5|||
124869905|NCT00863655|449143573|FG001|Overall Study|New cancer therapy|1|||
124869906|NCT00863655|449143572|FG000|Overall Study|Disease progression|364|||
124869907|NCT00863655|449143573|FG001|Overall Study|Disease progression|221|||
124535076|NCT05102734|447911698|FG000|Overall Study|Inadequate video quality|2|||
124535077|NCT05102734|447911699|FG001|Overall Study|Inadequate video quality|0|||
124535078|NCT03055806|447911700|FG000|Overall Study|Adverse Event|0|||
124535079|NCT03055806|447911701|FG001|Overall Study|Adverse Event|0|||
124535080|NCT03055806|447911702|FG002|Overall Study|Adverse Event|1|||
124535081|NCT03055806|447911703|FG003|Overall Study|Adverse Event|1|||
124535082|NCT03055806|447911700|FG000|Overall Study|Lost to Follow-up|0|||
124535083|NCT03055806|447911701|FG001|Overall Study|Lost to Follow-up|3|||
124535084|NCT03055806|447911702|FG002|Overall Study|Lost to Follow-up|6|||
124535085|NCT03055806|447911703|FG003|Overall Study|Lost to Follow-up|7|||
124535086|NCT03055806|447911700|FG000|Overall Study|Physician Decision|1|||
124535087|NCT03055806|447911701|FG001|Overall Study|Physician Decision|0|||
124535088|NCT03055806|447911702|FG002|Overall Study|Physician Decision|0|||
124535089|NCT03055806|447911703|FG003|Overall Study|Physician Decision|1|||
124535090|NCT03055806|447911700|FG000|Overall Study|Protocol Violation|1|||
124535091|NCT03055806|447911701|FG001|Overall Study|Protocol Violation|0|||
124535092|NCT03055806|447911702|FG002|Overall Study|Protocol Violation|0|||
124535093|NCT03055806|447911703|FG003|Overall Study|Protocol Violation|0|||
124535094|NCT03055806|447911700|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
124535095|NCT03055806|447911701|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
124535096|NCT03055806|447911702|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
124535097|NCT03055806|447911703|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
124535098|NCT03055806|447911700|FG000|Overall Study|Withdrawal of consent to continue study|2|||
124535099|NCT03055806|447911701|FG001|Overall Study|Withdrawal of consent to continue study|3|||
124535100|NCT03055806|447911702|FG002|Overall Study|Withdrawal of consent to continue study|4|||
124535101|NCT03055806|447911703|FG003|Overall Study|Withdrawal of consent to continue study|6|||
124535102|NCT03055806|447911700|FG000|Overall Study|Partner not willing to try intercourse|1|||
124535103|NCT03055806|447911701|FG001|Overall Study|Partner not willing to try intercourse|0|||
124535104|NCT03055806|447911702|FG002|Overall Study|Partner not willing to try intercourse|0|||
124535105|NCT03055806|447911703|FG003|Overall Study|Partner not willing to try intercourse|0|||
124535106|NCT04601194|447911704|FG000|Overall Study|Lost to Follow-up|7|||
124535107|NCT00125138|447911705|FG000|Overall Study|Adverse Event|1|||
124535108|NCT00125138|447911706|FG001|Overall Study|Adverse Event|0|||
124535109|NCT00125138|447911707|FG002|Overall Study|Adverse Event|3|||
124535110|NCT00125138|447911708|FG003|Overall Study|Adverse Event|2|||
124535111|NCT00125138|447911705|FG000|Overall Study|Withdrawal by Subject|2|||
124535112|NCT00125138|447911706|FG001|Overall Study|Withdrawal by Subject|3|||
124535113|NCT00125138|447911707|FG002|Overall Study|Withdrawal by Subject|1|||
124535114|NCT00125138|447911708|FG003|Overall Study|Withdrawal by Subject|1|||
124535115|NCT00125138|447911705|FG000|Overall Study|Lack of Efficacy|0|||
124535116|NCT00125138|447911706|FG001|Overall Study|Lack of Efficacy|0|||
124535117|NCT00125138|447911707|FG002|Overall Study|Lack of Efficacy|0|||
124535118|NCT00125138|447911708|FG003|Overall Study|Lack of Efficacy|1|||
124535119|NCT00125138|447911705|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
124535120|NCT00125138|447911706|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
124535121|NCT00125138|447911707|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
124535122|NCT00125138|447911708|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
124535123|NCT04249076|447911730|FG000|Overall Study|Adverse Event|1|||
124535124|NCT04249076|447911731|FG001|Overall Study|Adverse Event|1|||
124535125|NCT04249076|447911730|FG000|Overall Study|Protocol Violation|1|||
124535126|NCT04249076|447911731|FG001|Overall Study|Protocol Violation|2|||
124535127|NCT04249076|447911730|FG000|Overall Study|Lack of Efficacy|0|||
124535128|NCT04249076|447911731|FG001|Overall Study|Lack of Efficacy|1|||
124535129|NCT04249076|447911730|FG000|Overall Study|Withdrawal by Subject|0|||
124535130|NCT04249076|447911731|FG001|Overall Study|Withdrawal by Subject|1|||
124535131|NCT00089505|447911732|FG000|Overall Study|Death|4|||
124535132|NCT00089505|447911733|FG001|Overall Study|Death|1|||
124535133|NCT00089505|447911734|FG002|Overall Study|Death|5|||
124535134|NCT00089505|447911735|FG003|Overall Study|Death|8|||
124535135|NCT00089505|447911732|FG000|Overall Study|Withdrawal by Subject|3|||
124535136|NCT00089505|447911733|FG001|Overall Study|Withdrawal by Subject|0|||
124535137|NCT00089505|447911734|FG002|Overall Study|Withdrawal by Subject|6|||
124535138|NCT00089505|447911735|FG003|Overall Study|Withdrawal by Subject|6|||
124535139|NCT00089505|447911732|FG000|Overall Study|Lost to Follow-up|1|||
124535140|NCT00089505|447911733|FG001|Overall Study|Lost to Follow-up|1|||
124535141|NCT00089505|447911734|FG002|Overall Study|Lost to Follow-up|9|||
124535142|NCT00089505|447911735|FG003|Overall Study|Lost to Follow-up|7|||
124535143|NCT00089505|447911732|FG000|Overall Study|Physician Decision|1|||
124535144|NCT00089505|447911733|FG001|Overall Study|Physician Decision|0|||
124535145|NCT00089505|447911734|FG002|Overall Study|Physician Decision|0|||
124535146|NCT00089505|447911735|FG003|Overall Study|Physician Decision|0|||
124535147|NCT00089505|447911732|FG000|Overall Study|Protocol Violation|0|||
124535148|NCT00089505|447911733|FG001|Overall Study|Protocol Violation|0|||
124535149|NCT00089505|447911734|FG002|Overall Study|Protocol Violation|1|||
124535150|NCT00089505|447911735|FG003|Overall Study|Protocol Violation|0|||
124535151|NCT01117428|447911736|FG000|Overall Study|Lack of Efficacy|1|||
124535152|NCT01117428|447911737|FG001|Overall Study|Lack of Efficacy|0|||
124535153|NCT01117428|447911738|FG002|Overall Study|Lack of Efficacy|0|||
124535154|NCT01117428|447911739|FG003|Overall Study|Lack of Efficacy|0|||
124535155|NCT01117428|447911740|FG004|Overall Study|Lack of Efficacy|0|||
124535156|NCT01117428|447911741|FG005|Overall Study|Lack of Efficacy|0|||
124535157|NCT01117428|447911736|FG000|Overall Study|Adverse Event|4|||
124535158|NCT01117428|447911737|FG001|Overall Study|Adverse Event|0|||
124535159|NCT01117428|447911738|FG002|Overall Study|Adverse Event|0|||
124535160|NCT01117428|447911739|FG003|Overall Study|Adverse Event|0|||
124535161|NCT01117428|447911740|FG004|Overall Study|Adverse Event|1|||
124535162|NCT01117428|447911741|FG005|Overall Study|Adverse Event|2|||
124535163|NCT01117428|447911736|FG000|Overall Study|Death|0|||
124535164|NCT01117428|447911737|FG001|Overall Study|Death|1|||
124535165|NCT01117428|447911738|FG002|Overall Study|Death|2|||
124535166|NCT01117428|447911739|FG003|Overall Study|Death|0|||
124535167|NCT01117428|447911740|FG004|Overall Study|Death|0|||
124535168|NCT01117428|447911741|FG005|Overall Study|Death|1|||
124535169|NCT01117428|447911736|FG000|Overall Study|Physician Decision|0|||
124535170|NCT01117428|447911737|FG001|Overall Study|Physician Decision|1|||
124535171|NCT01117428|447911738|FG002|Overall Study|Physician Decision|0|||
124535172|NCT01117428|447911739|FG003|Overall Study|Physician Decision|0|||
124535173|NCT01117428|447911740|FG004|Overall Study|Physician Decision|0|||
124535174|NCT01117428|447911741|FG005|Overall Study|Physician Decision|0|||
124535175|NCT01117428|447911736|FG000|Overall Study|Withdrawal by Subject|0|||
124535176|NCT01117428|447911737|FG001|Overall Study|Withdrawal by Subject|0|||
124535177|NCT01117428|447911738|FG002|Overall Study|Withdrawal by Subject|1|||
124535178|NCT01117428|447911739|FG003|Overall Study|Withdrawal by Subject|0|||
124535179|NCT01117428|447911740|FG004|Overall Study|Withdrawal by Subject|0|||
124535180|NCT01117428|447911741|FG005|Overall Study|Withdrawal by Subject|0|||
124535181|NCT01117428|447911736|FG000|Overall Study|Progressive disease|15|||
124535182|NCT01117428|447911737|FG001|Overall Study|Progressive disease|27|||
124535183|NCT01117428|447911738|FG002|Overall Study|Progressive disease|10|||
124535184|NCT01117428|447911739|FG003|Overall Study|Progressive disease|12|||
124535185|NCT01117428|447911740|FG004|Overall Study|Progressive disease|16|||
124535186|NCT01117428|447911741|FG005|Overall Study|Progressive disease|17|||
124535187|NCT02519777|447911744|FG000|Overall Study|Death|1|||
124535188|NCT02519777|447911745|FG001|Overall Study|Death|0|||
124535189|NCT02519777|447911746|FG002|Overall Study|Death|0|||
124535190|NCT02519777|447911744|FG000|Overall Study|Lost to Follow-up|0|||
124535191|NCT02519777|447911745|FG001|Overall Study|Lost to Follow-up|4|||
124535192|NCT02519777|447911746|FG002|Overall Study|Lost to Follow-up|2|||
124535193|NCT02519777|447911744|FG000|Overall Study|Withdrawal by Subject|3|||
124535194|NCT02519777|447911745|FG001|Overall Study|Withdrawal by Subject|1|||
124535195|NCT02519777|447911746|FG002|Overall Study|Withdrawal by Subject|0|||
124535196|NCT02519777|447911744|FG000|Overall Study|Severe Debilitation|1|||
124535197|NCT02519777|447911745|FG001|Overall Study|Severe Debilitation|1|||
124535198|NCT02519777|447911746|FG002|Overall Study|Severe Debilitation|1|||
124535199|NCT02519777|447911744|FG000|Overall Study|Not able to get to clinic|1|||
124535200|NCT02519777|447911745|FG001|Overall Study|Not able to get to clinic|2|||
124535201|NCT02519777|447911746|FG002|Overall Study|Not able to get to clinic|1|||
124535202|NCT02195531|447911747|FG000|Overall Study|Withdrawal by Subject|1|||
124535203|NCT02195531|447911748|FG001|Overall Study|Withdrawal by Subject|1|||
124535204|NCT02195531|447911749|FG002|Overall Study|Withdrawal by Subject|1|||
124535205|NCT00545740|447911754|FG000|Overall Study|Lack of Efficacy|34|||
124535206|NCT00545740|447911755|FG001|Overall Study|Lack of Efficacy|35|||
124535207|NCT00545740|447911756|FG002|Overall Study|Lack of Efficacy|47|||
124535208|NCT00545740|447911757|FG003|Overall Study|Lack of Efficacy|36|||
124535209|NCT00545740|447911754|FG000|Overall Study|Withdrawal by Subject|17|||
124535210|NCT00545740|447911755|FG001|Overall Study|Withdrawal by Subject|15|||
124535211|NCT00545740|447911756|FG002|Overall Study|Withdrawal by Subject|16|||
124535212|NCT00545740|447911757|FG003|Overall Study|Withdrawal by Subject|18|||
124535213|NCT00545740|447911754|FG000|Overall Study|Adverse Event|10|||
124535214|NCT00545740|447911755|FG001|Overall Study|Adverse Event|18|||
124535215|NCT00545740|447911756|FG002|Overall Study|Adverse Event|19|||
124535216|NCT00545740|447911757|FG003|Overall Study|Adverse Event|9|||
124535217|NCT00545740|447911754|FG000|Overall Study|Lost to Follow-up|7|||
124535218|NCT00545740|447911755|FG001|Overall Study|Lost to Follow-up|5|||
124535219|NCT00545740|447911756|FG002|Overall Study|Lost to Follow-up|5|||
124535220|NCT00545740|447911757|FG003|Overall Study|Lost to Follow-up|6|||
124535221|NCT00545740|447911754|FG000|Overall Study|Protocol Violation|1|||
124535222|NCT00545740|447911755|FG001|Overall Study|Protocol Violation|3|||
124535223|NCT00545740|447911756|FG002|Overall Study|Protocol Violation|1|||
124535224|NCT00545740|447911757|FG003|Overall Study|Protocol Violation|0|||
124535225|NCT00545740|447911754|FG000|Overall Study|Non-compliance|0|||
124535226|NCT00545740|447911755|FG001|Overall Study|Non-compliance|2|||
124535227|NCT00545740|447911756|FG002|Overall Study|Non-compliance|1|||
124535228|NCT00545740|447911757|FG003|Overall Study|Non-compliance|0|||
124535229|NCT00545740|447911754|FG000|Overall Study|Moved|2|||
124535230|NCT00545740|447911755|FG001|Overall Study|Moved|0|||
124535231|NCT00545740|447911756|FG002|Overall Study|Moved|1|||
124535232|NCT00545740|447911757|FG003|Overall Study|Moved|0|||
124535233|NCT00545740|447911754|FG000|Overall Study|Diverticulitis attack|0|||
124535234|NCT00545740|447911755|FG001|Overall Study|Diverticulitis attack|0|||
124535235|NCT00545740|447911756|FG002|Overall Study|Diverticulitis attack|1|||
124535236|NCT00545740|447911757|FG003|Overall Study|Diverticulitis attack|1|||
124535237|NCT00545740|447911754|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
124535238|NCT00545740|447911755|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
124535239|NCT00545740|447911756|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
124535240|NCT00545740|447911757|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
124535241|NCT00545740|447911754|FG000|Overall Study|Site closure|1|||
124535242|NCT00545740|447911755|FG001|Overall Study|Site closure|0|||
124535243|NCT00545740|447911756|FG002|Overall Study|Site closure|0|||
124535244|NCT00545740|447911757|FG003|Overall Study|Site closure|0|||
124535245|NCT00545740|447911754|FG000|Overall Study|Missed visit|1|||
124535246|NCT00545740|447911755|FG001|Overall Study|Missed visit|0|||
124535247|NCT00545740|447911756|FG002|Overall Study|Missed visit|0|||
124535248|NCT00545740|447911757|FG003|Overall Study|Missed visit|0|||
124535249|NCT00545740|447911754|FG000|Overall Study|Physician Decision|0|||
124535250|NCT00545740|447911755|FG001|Overall Study|Physician Decision|0|||
124535251|NCT00545740|447911756|FG002|Overall Study|Physician Decision|3|||
124535252|NCT00545740|447911757|FG003|Overall Study|Physician Decision|0|||
124535253|NCT00545740|447911754|FG000|Overall Study|Accepted only monthly telephone calls|1|||
124535254|NCT00545740|447911755|FG001|Overall Study|Accepted only monthly telephone calls|0|||
124535255|NCT00545740|447911756|FG002|Overall Study|Accepted only monthly telephone calls|0|||
124535256|NCT00545740|447911757|FG003|Overall Study|Accepted only monthly telephone calls|0|||
124535257|NCT00545740|447911754|FG000|Overall Study|Sponsor decision|0|||
124535258|NCT00545740|447911755|FG001|Overall Study|Sponsor decision|1|||
124535259|NCT00545740|447911756|FG002|Overall Study|Sponsor decision|0|||
124535260|NCT00545740|447911757|FG003|Overall Study|Sponsor decision|0|||
124535261|NCT00545740|447911754|FG000|Overall Study|Lack of time|0|||
124535262|NCT00545740|447911755|FG001|Overall Study|Lack of time|1|||
124535263|NCT00545740|447911756|FG002|Overall Study|Lack of time|0|||
124535264|NCT00545740|447911757|FG003|Overall Study|Lack of time|0|||
124535265|NCT00545740|447911754|FG000|Overall Study|Non-adherence to visits|0|||
124535266|NCT00545740|447911755|FG001|Overall Study|Non-adherence to visits|1|||
124535267|NCT00545740|447911756|FG002|Overall Study|Non-adherence to visits|0|||
124535268|NCT00545740|447911757|FG003|Overall Study|Non-adherence to visits|0|||
124535269|NCT00545740|447911754|FG000|Overall Study|Patient difficulties|0|||
124535270|NCT00545740|447911755|FG001|Overall Study|Patient difficulties|1|||
124535271|NCT00545740|447911756|FG002|Overall Study|Patient difficulties|0|||
124535272|NCT00545740|447911757|FG003|Overall Study|Patient difficulties|0|||
124535273|NCT00545740|447911754|FG000|Overall Study|Husband against study|0|||
124535274|NCT00545740|447911755|FG001|Overall Study|Husband against study|0|||
124535275|NCT00545740|447911756|FG002|Overall Study|Husband against study|1|||
124535276|NCT00545740|447911757|FG003|Overall Study|Husband against study|0|||
124535277|NCT00082628|447911760|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
124535278|NCT00082628|447911761|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
124535279|NCT00082628|447911762|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
124535280|NCT00082628|447911763|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
124535281|NCT00082628|447911764|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
124535282|NCT00082628|447911760|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
124535283|NCT00082628|447911761|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
124535284|NCT00082628|447911762|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
124535285|NCT00082628|447911763|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
124535286|NCT00082628|447911764|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
124535287|NCT00082628|447911760|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
124535288|NCT00082628|447911761|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
124535289|NCT00082628|447911762|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
124535290|NCT00082628|447911763|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
124535291|NCT00082628|447911764|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
124535292|NCT00082628|447911760|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
124535293|NCT00082628|447911761|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
124535294|NCT00082628|447911762|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
124535295|NCT00082628|447911763|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
124535296|NCT00082628|447911764|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
124535297|NCT00082628|447911760|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
124535298|NCT00082628|447911761|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
124535299|NCT00082628|447911762|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
124535300|NCT00082628|447911763|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
124535301|NCT00082628|447911764|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
124535302|NCT00082628|447911760|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
124535303|NCT00082628|447911761|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
124535304|NCT00082628|447911762|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
124535305|NCT00082628|447911763|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
124535306|NCT00082628|447911764|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
124535307|NCT00082628|447911760|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
124535308|NCT00082628|447911761|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
124535309|NCT00082628|447911762|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
124535310|NCT00082628|447911763|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
124535311|NCT00082628|447911764|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
124535312|NCT02177942|447911769|FG000|Overall Study|Adverse Event|1|||
124535313|NCT02177942|447911770|FG001|Overall Study|Adverse Event|0|||
124535314|NCT02177942|447911769|FG000|Overall Study|Lost to Follow-up|1|||
124535315|NCT02177942|447911770|FG001|Overall Study|Lost to Follow-up|1|||
124535316|NCT02177942|447911769|FG000|Overall Study|Protocol Violation|4|||
124535317|NCT02177942|447911770|FG001|Overall Study|Protocol Violation|6|||
124535318|NCT02177942|447911769|FG000|Overall Study|Withdrawal by Subject|71|||
124535319|NCT02177942|447911770|FG001|Overall Study|Withdrawal by Subject|81|||
124535320|NCT01351415|447911771|FG000|Overall Study|Withdrawal by Subject|15|||
124535321|NCT01351415|447911772|FG001|Overall Study|Withdrawal by Subject|17|||
124535322|NCT01351415|447911771|FG000|Overall Study|Trial termination by the Sponsor|28|||
124535323|NCT01351415|447911772|FG001|Overall Study|Trial termination by the Sponsor|19|||
124535324|NCT01351415|447911771|FG000|Overall Study|Lost to Follow-up|5|||
124535325|NCT01351415|447911772|FG001|Overall Study|Lost to Follow-up|7|||
124535326|NCT01351415|447911771|FG000|Overall Study|Death|190|||
124535327|NCT01351415|447911772|FG001|Overall Study|Death|187|||
124535328|NCT01351415|447911771|FG000|Overall Study|Physician Decision|2|||
124535329|NCT01351415|447911772|FG001|Overall Study|Physician Decision|3|||
124535330|NCT01351415|447911771|FG000|Overall Study|Reason unknown|0|||
124535331|NCT01351415|447911772|FG001|Overall Study|Reason unknown|2|||
124535332|NCT01351415|447911771|FG000|Overall Study|Never Started|5|||
124535333|NCT01351415|447911772|FG001|Overall Study|Never Started|5|||
124535334|NCT01234337|447911773|FG000|Overall Study|Adverse Event|58|||
124535335|NCT01234337|447911774|FG001|Overall Study|Adverse Event|21|||
124535336|NCT01234337|447911773|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
124535337|NCT01234337|447911774|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
124535338|NCT01234337|447911773|FG000|Overall Study|Investi. decision not protocol driven|5|||
124535339|NCT01234337|447911774|FG001|Overall Study|Investi. decision not protocol driven|6|||
124535340|NCT01234337|447911773|FG000|Overall Study|Non-compliant with study medication|3|||
124535341|NCT01234337|447911774|FG001|Overall Study|Non-compliant with study medication|2|||
124535342|NCT01234337|447911773|FG000|Overall Study|Randomized but not treated|6|||
124535343|NCT01234337|447911774|FG001|Overall Study|Randomized but not treated|4|||
124535344|NCT01234337|447911773|FG000|Overall Study|Lost to Follow-up|0|||
124535345|NCT01234337|447911774|FG001|Overall Study|Lost to Follow-up|1|||
124535346|NCT01234337|447911773|FG000|Overall Study|Protocol Violation|2|||
124535347|NCT01234337|447911774|FG001|Overall Study|Protocol Violation|3|||
124535348|NCT01234337|447911773|FG000|Overall Study|Withdrawal by Subject|11|||
124535349|NCT01234337|447911774|FG001|Overall Study|Withdrawal by Subject|9|||
124535350|NCT01234337|447911773|FG000|Overall Study|Death|0|||
124535351|NCT01234337|447911774|FG001|Overall Study|Death|1|||
124535352|NCT01234337|447911773|FG000|Overall Study|Switch to commercial drug|0|||
124535353|NCT01234337|447911774|FG001|Overall Study|Switch to commercial drug|1|||
124535354|NCT04118127|447911775|FG000|Overall Study|Trial terminated by sponsor|0|||
124535355|NCT04118127|447911776|FG001|Overall Study|Trial terminated by sponsor|12|||
124535356|NCT04118127|447911775|FG000|Overall Study|Adverse Event|1|||
124535357|NCT04118127|447911776|FG001|Overall Study|Adverse Event|2|||
124535358|NCT04118127|447911775|FG000|Overall Study|Physician Decision|0|||
124535359|NCT04118127|447911776|FG001|Overall Study|Physician Decision|1|||
124535360|NCT04118127|447911775|FG000|Overall Study|Withdrawal by Subject|2|||
124535361|NCT04118127|447911776|FG001|Overall Study|Withdrawal by Subject|1|||
124535362|NCT03480360|447911777|FG000|Overall Study|Death|2|||
124535363|NCT01646255|447911780|FG000|Overall Study|Adverse Event|7|||
124535364|NCT01646255|447911781|FG001|Overall Study|Adverse Event|8|||
124535365|NCT01646255|447911780|FG000|Overall Study|Lack of Efficacy|2|||
124535366|NCT01646255|447911781|FG001|Overall Study|Lack of Efficacy|0|||
124535367|NCT01646255|447911780|FG000|Overall Study|Withdrawal by Subject|10|||
124535368|NCT01646255|447911781|FG001|Overall Study|Withdrawal by Subject|6|||
124535369|NCT01646255|447911780|FG000|Overall Study|Compliance is not well|1|||
124535370|NCT01646255|447911781|FG001|Overall Study|Compliance is not well|0|||
124535371|NCT01646255|447911780|FG000|Overall Study|Inclusion Criteria Deviation|1|||
124535372|NCT01646255|447911781|FG001|Overall Study|Inclusion Criteria Deviation|0|||
124535373|NCT02380703|447911782|FG000|Overall Study|Withdrawal by Subject|12|||
124535374|NCT02380703|447911783|FG001|Overall Study|Withdrawal by Subject|9|||
124535375|NCT02380703|447911782|FG000|Overall Study|Lost to Follow-up|12|||
124535376|NCT02380703|447911783|FG001|Overall Study|Lost to Follow-up|12|||
124535377|NCT02380703|447911782|FG000|Overall Study|Caregiver death|1|||
124535378|NCT02380703|447911783|FG001|Overall Study|Caregiver death|0|||
124535379|NCT02380703|447911782|FG000|Overall Study|Person with dementia (PWD) death|7|||
124535380|NCT02380703|447911783|FG001|Overall Study|Person with dementia (PWD) death|8|||
124535381|NCT02380703|447911782|FG000|Overall Study|Entered Long-term Care|4|||
124535382|NCT02380703|447911783|FG001|Overall Study|Entered Long-term Care|7|||
124535383|NCT03480841|447911784|FG000|Overall Study|Lost to Follow-up|2|||
124535384|NCT01362049|447911785|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
124535385|NCT01362049|447911786|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
124535386|NCT01362049|447911787|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
124535387|NCT01362049|447911788|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
124535388|NCT01362049|447911785|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
124535389|NCT01362049|447911786|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
124535390|NCT01362049|447911787|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
124535391|NCT01362049|447911788|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
124535392|NCT02269709|447911796|FG000|Time of Enrollment|Withdrawal by Subject|3|||
124535393|NCT02269709|447911796|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
124535394|NCT02269709|447911796|FG000|Six Month Follow-up|Lost to Follow-up|12|||
124535395|NCT00426842|447911797|FG000|Overall Study|Lost to Follow-up|1|||
124535396|NCT01156012|447911800|FG000|Overall Study|Adverse Event|3|||
124535397|NCT01156012|447911801|FG001|Overall Study|Adverse Event|1|||
124535398|NCT01156012|447911800|FG000|Overall Study|Lost to Follow-up|1|||
124535399|NCT01156012|447911801|FG001|Overall Study|Lost to Follow-up|0|||
124535400|NCT01156012|447911800|FG000|Overall Study|Withdrawal by Subject|1|||
124535401|NCT01156012|447911801|FG001|Overall Study|Withdrawal by Subject|0|||
124535402|NCT01156012|447911800|FG000|Overall Study|use of commercial drug instead of study|0|||
124535403|NCT01156012|447911801|FG001|Overall Study|use of commercial drug instead of study|1|||
124535404|NCT01156012|447911800|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
124535405|NCT01156012|447911801|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
124535406|NCT02475564|447911802|FG000|Overall Study|Withdrawal by Subject|1|||
124535407|NCT02475564|447911803|FG001|Overall Study|Withdrawal by Subject|0|||
124535408|NCT02475564|447911802|FG000|Overall Study|Lost to Follow-up|2|||
124535409|NCT02475564|447911803|FG001|Overall Study|Lost to Follow-up|1|||
124535410|NCT02475564|447911802|FG000|Overall Study|Intense Menstrual bleeding|1|||
124535411|NCT02475564|447911803|FG001|Overall Study|Intense Menstrual bleeding|0|||
124535412|NCT00939094|447911805|FG000|Overall Study|Adverse Event|9|||
124535413|NCT00939094|447911806|FG001|Overall Study|Adverse Event|0|||
124535414|NCT00939094|447911805|FG000|Overall Study|Withdrawal by Subject|1|||
124535415|NCT00939094|447911806|FG001|Overall Study|Withdrawal by Subject|6|||
124535416|NCT00939094|447911805|FG000|Overall Study|Lost to Follow-up|1|||
124535417|NCT00939094|447911806|FG001|Overall Study|Lost to Follow-up|1|||
124535418|NCT00939094|447911805|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
124535419|NCT00939094|447911806|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124535420|NCT00939094|447911805|FG000|Overall Study|Severe non-compliance to protocol|0|||
124535421|NCT00939094|447911806|FG001|Overall Study|Severe non-compliance to protocol|1|||
124535422|NCT00939094|447911805|FG000|Overall Study|Study stopped by sponsor|0|||
124535423|NCT00939094|447911806|FG001|Overall Study|Study stopped by sponsor|2|||
124535424|NCT00939094|447911805|FG000|Overall Study|Abnormal ECG findings|1|||
124535425|NCT00939094|447911806|FG001|Overall Study|Abnormal ECG findings|0|||
124535426|NCT01906489|447911807|FG000|Overall Study|Adverse Event|10|||
124535427|NCT01906489|447911808|FG001|Overall Study|Adverse Event|3|||
124535428|NCT01906489|447911807|FG000|Overall Study|Worsening of CKD|6|||
124535429|NCT01906489|447911808|FG001|Overall Study|Worsening of CKD|4|||
124535430|NCT01906489|447911807|FG000|Overall Study|Withdrawal by Subject|5|||
124535431|NCT01906489|447911808|FG001|Overall Study|Withdrawal by Subject|0|||
124535432|NCT01906489|447911807|FG000|Overall Study|Worsening of Anemia|1|||
124535433|NCT01906489|447911808|FG001|Overall Study|Worsening of Anemia|0|||
124535434|NCT01906489|447911807|FG000|Overall Study|Protocol Violation|0|||
124535435|NCT01906489|447911808|FG001|Overall Study|Protocol Violation|1|||
124535436|NCT01906489|447911807|FG000|Overall Study|Non- Compliance|1|||
124535437|NCT01906489|447911808|FG001|Overall Study|Non- Compliance|0|||
124535438|NCT01906489|447911807|FG000|Overall Study|Sponsor Decision|1|||
124535439|NCT01906489|447911808|FG001|Overall Study|Sponsor Decision|0|||
124535440|NCT01906489|447911807|FG000|Overall Study|Lost to Follow-up|1|||
124535441|NCT01906489|447911808|FG001|Overall Study|Lost to Follow-up|1|||
124535442|NCT01906489|447911807|FG000|Overall Study|Other|1|||
124535443|NCT01906489|447911808|FG001|Overall Study|Other|0|||
124535444|NCT01524900|447913533|FG000|Overall Study|Lost to Follow-up|3|||
124535445|NCT01524900|447913534|FG001|Overall Study|Lost to Follow-up|12|||
124535446|NCT01524900|447913535|FG002|Overall Study|Lost to Follow-up|1|||
124535447|NCT01524900|447913536|FG003|Overall Study|Lost to Follow-up|0|||
124535448|NCT01524900|447913537|FG004|Overall Study|Lost to Follow-up|0|||
124535449|NCT01524900|447913533|FG000|Overall Study|Other reason than stated above|1|||
124535450|NCT01524900|447913534|FG001|Overall Study|Other reason than stated above|1|||
124535451|NCT01524900|447913535|FG002|Overall Study|Other reason than stated above|0|||
124535452|NCT01524900|447913536|FG003|Overall Study|Other reason than stated above|0|||
124535453|NCT01524900|447913537|FG004|Overall Study|Other reason than stated above|0|||
124535454|NCT01524900|447913533|FG000|Overall Study|No reason documented|2|||
124535455|NCT01524900|447913534|FG001|Overall Study|No reason documented|1|||
124535456|NCT01524900|447913535|FG002|Overall Study|No reason documented|0|||
124535457|NCT01524900|447913536|FG003|Overall Study|No reason documented|1|||
124535458|NCT01524900|447913537|FG004|Overall Study|No reason documented|0|||
124535459|NCT03824704|447913538|FG000|Overall Study|Study Terminated by Sponsor|1|||
124535460|NCT00298766|447913539|FG000|Overall Study|Adverse Event|18|||
124535461|NCT00298766|447913539|FG000|Overall Study|Death|2|||
124535462|NCT00298766|447913539|FG000|Overall Study|Withdrawal by Subject|9|||
124535463|NCT00298766|447913539|FG000|Overall Study|Treatment ongoing|4|||
124535464|NCT00298766|447913539|FG000|Overall Study|Progression of amyloid markers|4|||
124535465|NCT00298766|447913539|FG000|Overall Study|Deterioration in KPS and organ function|1|||
124535466|NCT00298766|447913539|FG000|Overall Study|Subjects overall condition deterioration|4|||
124535467|NCT00298766|447913539|FG000|Overall Study|Other|4|||
124535468|NCT02988115|447913541|FG000|Overall Study|Adverse Event|6|||
124535469|NCT02988115|447913542|FG001|Overall Study|Adverse Event|1|||
124535470|NCT02988115|447913541|FG000|Overall Study|Sponsor Decision|5|||
124535471|NCT02988115|447913542|FG001|Overall Study|Sponsor Decision|2|||
124535472|NCT02988115|447913541|FG000|Overall Study|Withdrawal by Subject|1|||
124535473|NCT02988115|447913542|FG001|Overall Study|Withdrawal by Subject|1|||
124535474|NCT02988115|447913541|FG000|Overall Study|Withdrawn by Mistake|1|||
124535475|NCT02988115|447913542|FG001|Overall Study|Withdrawn by Mistake|0|||
124535476|NCT02988115|447913541|FG000|Overall Study|Lost to Follow-up|1|||
124535477|NCT02988115|447913542|FG001|Overall Study|Lost to Follow-up|0|||
124535478|NCT01731951|447913543|FG000|Overall Study|Documented Disease Progression|1|||
124535479|NCT01731951|447913544|FG001|Overall Study|Documented Disease Progression|0|||
124535480|NCT01731951|447913545|FG002|Overall Study|Documented Disease Progression|0|||
124535481|NCT01731951|447913546|FG003|Overall Study|Documented Disease Progression|0|||
124535482|NCT01731951|447913547|FG004|Overall Study|Documented Disease Progression|0|||
124535483|NCT01731951|447913548|FG005|Overall Study|Documented Disease Progression|0|||
124535484|NCT01731951|447913543|FG000|Overall Study|Lost to Follow-up|2|||
124535485|NCT01731951|447913544|FG001|Overall Study|Lost to Follow-up|0|||
124535486|NCT01731951|447913545|FG002|Overall Study|Lost to Follow-up|0|||
124535487|NCT01731951|447913546|FG003|Overall Study|Lost to Follow-up|1|||
124535488|NCT01731951|447913547|FG004|Overall Study|Lost to Follow-up|3|||
124535489|NCT01731951|447913548|FG005|Overall Study|Lost to Follow-up|1|||
124535490|NCT01731951|447913543|FG000|Overall Study|Withdrawal of Consent|1|||
124535491|NCT01731951|447913544|FG001|Overall Study|Withdrawal of Consent|0|||
124535492|NCT01731951|447913545|FG002|Overall Study|Withdrawal of Consent|0|||
124535493|NCT01731951|447913546|FG003|Overall Study|Withdrawal of Consent|0|||
124535494|NCT01731951|447913547|FG004|Overall Study|Withdrawal of Consent|0|||
124535495|NCT01731951|447913548|FG005|Overall Study|Withdrawal of Consent|2|||
124535496|NCT01731951|447913543|FG000|Overall Study|Death|13|||
124535497|NCT01731951|447913544|FG001|Overall Study|Death|15|||
124535498|NCT01731951|447913545|FG002|Overall Study|Death|9|||
124535499|NCT01731951|447913546|FG003|Overall Study|Death|8|||
124535500|NCT01731951|447913547|FG004|Overall Study|Death|9|||
124535501|NCT01731951|447913548|FG005|Overall Study|Death|6|||
124535502|NCT03287089|447913549|FG000|Overall Study|Lost to Follow-up|0|||
124535503|NCT03287089|447913550|FG001|Overall Study|Lost to Follow-up|2|||
124535504|NCT03287089|447913549|FG000|Overall Study|Physician Decision|0|||
124535505|NCT03287089|447913550|FG001|Overall Study|Physician Decision|2|||
124535506|NCT03287089|447913549|FG000|Overall Study|Withdrawal by Subject|0|||
124535507|NCT03287089|447913550|FG001|Overall Study|Withdrawal by Subject|2|||
124535508|NCT00661362|447913551|FG000|Overall Study|Adverse Event|5|||
124535509|NCT00661362|447913552|FG001|Overall Study|Adverse Event|4|||
124535510|NCT00661362|447913551|FG000|Overall Study|Incorrect enrollment|2|||
124535511|NCT00661362|447913552|FG001|Overall Study|Incorrect enrollment|0|||
124535512|NCT00661362|447913551|FG000|Overall Study|Study specific discontinuation criteria|4|||
124535513|NCT00661362|447913552|FG001|Overall Study|Study specific discontinuation criteria|11|||
124535514|NCT00661362|447913551|FG000|Overall Study|Withdrawal by Subject|13|||
124535515|NCT00661362|447913552|FG001|Overall Study|Withdrawal by Subject|23|||
124535516|NCT00661362|447913551|FG000|Overall Study|Lost to Follow-up|3|||
124535517|NCT00661362|447913552|FG001|Overall Study|Lost to Follow-up|1|||
124535518|NCT00661362|447913551|FG000|Overall Study|Severe non-compliance to protocol|0|||
124535519|NCT00661362|447913552|FG001|Overall Study|Severe non-compliance to protocol|1|||
124535520|NCT00661362|447913551|FG000|Overall Study|Safety reasons|1|||
124535521|NCT00661362|447913552|FG001|Overall Study|Safety reasons|0|||
124535522|NCT00661362|447913551|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
124535523|NCT00661362|447913552|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
124535524|NCT00775138|447913553|FG000|Overall Study|Withdrawal by Subject|0|||
124535525|NCT00775138|447913554|FG001|Overall Study|Withdrawal by Subject|0|||
124535526|NCT00775138|447913555|FG002|Overall Study|Withdrawal by Subject|2|||
124535527|NCT00775138|447913556|FG003|Overall Study|Withdrawal by Subject|2|||
124535528|NCT00775138|447913553|FG000|Overall Study|Adverse Event|0|||
124535529|NCT00775138|447913554|FG001|Overall Study|Adverse Event|0|||
124535530|NCT00775138|447913555|FG002|Overall Study|Adverse Event|1|||
124535531|NCT00775138|447913556|FG003|Overall Study|Adverse Event|0|||
124535532|NCT04880642|447913557|FG000|Randomization|Withdrawal by Subject|2|||
124535533|NCT04880642|447913558|FG001|Randomization|Withdrawal by Subject|3|||
124535534|NCT04880642|447913557|FG000|Treatment Period|Adverse Event|0|||
124535535|NCT04880642|447913558|FG001|Treatment Period|Adverse Event|1|||
124535536|NCT04880642|447913557|FG000|Treatment Period|Death|6|||
124535537|NCT04880642|447913558|FG001|Treatment Period|Death|6|||
124535538|NCT04880642|447913557|FG000|Treatment Period|Lost to Follow-up|1|||
124535539|NCT04880642|447913558|FG001|Treatment Period|Lost to Follow-up|0|||
124535540|NCT04880642|447913557|FG000|Treatment Period|Protocol Violation|0|||
124535541|NCT04880642|447913558|FG001|Treatment Period|Protocol Violation|1|||
124535542|NCT04880642|447913557|FG000|Treatment Period|Withdrawal by Subject|5|||
124535543|NCT04880642|447913558|FG001|Treatment Period|Withdrawal by Subject|3|||
124535544|NCT04880642|447913557|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
124535545|NCT04880642|447913558|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
124535546|NCT04880642|447913557|FG000|Follow-up|Death|4|||
124535547|NCT04880642|447913558|FG001|Follow-up|Death|3|||
124535548|NCT04880642|447913557|FG000|Follow-up|Withdrawal by Subject|1|||
124535549|NCT04880642|447913558|FG001|Follow-up|Withdrawal by Subject|0|||
124535550|NCT02906644|447913559|FG000|First 2 Weeks|Withdrawal by Subject|0|||
124535551|NCT02906644|447913560|FG001|First 2 Weeks|Withdrawal by Subject|2|||
124535552|NCT02906644|447913559|FG000|First 2 Weeks|Physician Decision|1|||
124535553|NCT02906644|447913560|FG001|First 2 Weeks|Physician Decision|1|||
124535554|NCT02906644|447913559|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
124535555|NCT02906644|447913560|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
124535556|NCT02906644|447913559|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
124535557|NCT02906644|447913560|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
124535558|NCT02452034|447913561|FG000|Overall Study|Adverse Event|0|||
124535559|NCT02452034|447913562|FG001|Overall Study|Adverse Event|0|||
124535560|NCT02452034|447913563|FG002|Overall Study|Adverse Event|0|||
124535561|NCT02452034|447913564|FG003|Overall Study|Adverse Event|0|||
124535562|NCT02452034|447913565|FG004|Overall Study|Adverse Event|0|||
124535563|NCT02452034|447913566|FG005|Overall Study|Adverse Event|1|||
124535564|NCT02452034|447913561|FG000|Overall Study|Death|0|||
124535565|NCT02452034|447913562|FG001|Overall Study|Death|0|||
124535566|NCT02452034|447913563|FG002|Overall Study|Death|0|||
124535567|NCT02452034|447913564|FG003|Overall Study|Death|0|||
124535568|NCT02452034|447913565|FG004|Overall Study|Death|1|||
124535569|NCT02452034|447913566|FG005|Overall Study|Death|1|||
124535570|NCT02452034|447913561|FG000|Overall Study|Physician Decision|0|||
124535571|NCT02452034|447913562|FG001|Overall Study|Physician Decision|1|||
124535572|NCT02452034|447913563|FG002|Overall Study|Physician Decision|1|||
124535573|NCT02452034|447913564|FG003|Overall Study|Physician Decision|0|||
124535574|NCT02452034|447913565|FG004|Overall Study|Physician Decision|0|||
124535575|NCT02452034|447913566|FG005|Overall Study|Physician Decision|0|||
124535576|NCT02452034|447913561|FG000|Overall Study|Protocol Violation|0|||
124535577|NCT02452034|447913562|FG001|Overall Study|Protocol Violation|0|||
124535578|NCT02452034|447913563|FG002|Overall Study|Protocol Violation|0|||
124535579|NCT02452034|447913564|FG003|Overall Study|Protocol Violation|0|||
124535580|NCT02452034|447913565|FG004|Overall Study|Protocol Violation|0|||
124535581|NCT02452034|447913566|FG005|Overall Study|Protocol Violation|1|||
124535582|NCT02452034|447913561|FG000|Overall Study|Screen Failure|1|||
124535583|NCT02452034|447913562|FG001|Overall Study|Screen Failure|0|||
124535584|NCT02452034|447913563|FG002|Overall Study|Screen Failure|0|||
124535585|NCT02452034|447913564|FG003|Overall Study|Screen Failure|1|||
124535586|NCT02452034|447913565|FG004|Overall Study|Screen Failure|0|||
124535587|NCT02452034|447913566|FG005|Overall Study|Screen Failure|0|||
124535588|NCT02452034|447913561|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
124535589|NCT02452034|447913562|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
124535590|NCT02452034|447913563|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
124535591|NCT02452034|447913564|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
124535592|NCT02452034|447913565|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
124535593|NCT02452034|447913566|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
124535594|NCT00561795|447913567|FG000|Overall Study|Adverse Event|3|||
124535595|NCT00561795|447913568|FG001|Overall Study|Adverse Event|3|||
124535596|NCT00561795|447913569|FG002|Overall Study|Adverse Event|0|||
124535597|NCT00561795|447913570|FG003|Overall Study|Adverse Event|0|||
124535598|NCT00561795|447913567|FG000|Overall Study|Study Closed/Terminated|0|||
124535599|NCT00561795|447913568|FG001|Overall Study|Study Closed/Terminated|3|||
124535600|NCT00561795|447913569|FG002|Overall Study|Study Closed/Terminated|0|||
124535601|NCT00561795|447913570|FG003|Overall Study|Study Closed/Terminated|0|||
124535602|NCT00561795|447913567|FG000|Overall Study|Physician Decision|1|||
124535603|NCT00561795|447913568|FG001|Overall Study|Physician Decision|0|||
124535604|NCT00561795|447913569|FG002|Overall Study|Physician Decision|0|||
124535605|NCT00561795|447913570|FG003|Overall Study|Physician Decision|0|||
124535606|NCT04235959|447913572|FG000|Overall Study|Protocol Violation|0|||
124535607|NCT04235959|447913573|FG001|Overall Study|Protocol Violation|1|||
124535608|NCT04235959|447913574|FG002|Overall Study|Protocol Violation|0|||
124535609|NCT04235959|447913572|FG000|Overall Study|Adverse Event|1|||
124535610|NCT04235959|447913573|FG001|Overall Study|Adverse Event|0|||
124535611|NCT04235959|447913574|FG002|Overall Study|Adverse Event|0|||
124535612|NCT02135848|447913577|FG000|Overall Study|Adverse Event|2|||
124535613|NCT02135848|447913578|FG001|Overall Study|Adverse Event|0|||
124535614|NCT02135848|447913577|FG000|Overall Study|Withdrawal by Subject|1|||
124535615|NCT02135848|447913578|FG001|Overall Study|Withdrawal by Subject|1|||
124535616|NCT04212221|447913582|FG000|Overall Study|Remained on Treatment|0|||
124535617|NCT04212221|447913583|FG001|Overall Study|Remained on Treatment|0|||
124535618|NCT04212221|447913584|FG002|Overall Study|Remained on Treatment|0|||
124535619|NCT04212221|447913585|FG003|Overall Study|Remained on Treatment|1|||
124535620|NCT04212221|447913586|FG004|Overall Study|Remained on Treatment|0|||
124535621|NCT04212221|447913587|FG005|Overall Study|Remained on Treatment|0|||
124535622|NCT04212221|447913588|FG006|Overall Study|Remained on Treatment|3|||
124535623|NCT04212221|447913589|FG007|Overall Study|Remained on Treatment|9|||
124535624|NCT04212221|447913582|FG000|Overall Study|Adverse Event|0|||
124535625|NCT04212221|447913583|FG001|Overall Study|Adverse Event|0|||
124535626|NCT04212221|447913584|FG002|Overall Study|Adverse Event|0|||
124535627|NCT04212221|447913585|FG003|Overall Study|Adverse Event|0|||
124535628|NCT04212221|447913586|FG004|Overall Study|Adverse Event|0|||
124535629|NCT04212221|447913587|FG005|Overall Study|Adverse Event|0|||
124535630|NCT04212221|447913588|FG006|Overall Study|Adverse Event|2|||
124535631|NCT04212221|447913589|FG007|Overall Study|Adverse Event|3|||
124535632|NCT04212221|447913582|FG000|Overall Study|Death|0|||
124535633|NCT04212221|447913583|FG001|Overall Study|Death|0|||
124535634|NCT04212221|447913584|FG002|Overall Study|Death|0|||
124535635|NCT04212221|447913585|FG003|Overall Study|Death|0|||
124535636|NCT04212221|447913586|FG004|Overall Study|Death|0|||
124535637|NCT04212221|447913587|FG005|Overall Study|Death|0|||
124535638|NCT04212221|447913588|FG006|Overall Study|Death|0|||
124535639|NCT04212221|447913589|FG007|Overall Study|Death|2|||
124535640|NCT04212221|447913582|FG000|Overall Study|Disease progression according to irRECIST|1|||
124535641|NCT04212221|447913583|FG001|Overall Study|Disease progression according to irRECIST|2|||
124535642|NCT04212221|447913584|FG002|Overall Study|Disease progression according to irRECIST|3|||
124535643|NCT04212221|447913585|FG003|Overall Study|Disease progression according to irRECIST|3|||
124535644|NCT04212221|447913586|FG004|Overall Study|Disease progression according to irRECIST|2|||
124535645|NCT04212221|447913587|FG005|Overall Study|Disease progression according to irRECIST|2|||
124535646|NCT04212221|447913588|FG006|Overall Study|Disease progression according to irRECIST|21|||
124535647|NCT04212221|447913589|FG007|Overall Study|Disease progression according to irRECIST|17|||
124535648|NCT04212221|447913582|FG000|Overall Study|Global Deterioration of Health Status|0|||
124535649|NCT04212221|447913583|FG001|Overall Study|Global Deterioration of Health Status|0|||
124535650|NCT04212221|447913584|FG002|Overall Study|Global Deterioration of Health Status|0|||
124535651|NCT04212221|447913585|FG003|Overall Study|Global Deterioration of Health Status|0|||
124535652|NCT04212221|447913586|FG004|Overall Study|Global Deterioration of Health Status|0|||
124535653|NCT04212221|447913587|FG005|Overall Study|Global Deterioration of Health Status|0|||
124535654|NCT04212221|447913588|FG006|Overall Study|Global Deterioration of Health Status|0|||
124535655|NCT04212221|447913589|FG007|Overall Study|Global Deterioration of Health Status|2|||
124535656|NCT04212221|447913582|FG000|Overall Study|Investigator's Decision|0|||
124535657|NCT04212221|447913583|FG001|Overall Study|Investigator's Decision|0|||
124535658|NCT04212221|447913584|FG002|Overall Study|Investigator's Decision|0|||
124535659|NCT04212221|447913585|FG003|Overall Study|Investigator's Decision|1|||
124535660|NCT04212221|447913586|FG004|Overall Study|Investigator's Decision|0|||
124535661|NCT04212221|447913587|FG005|Overall Study|Investigator's Decision|0|||
124535662|NCT04212221|447913588|FG006|Overall Study|Investigator's Decision|3|||
124535663|NCT04212221|447913589|FG007|Overall Study|Investigator's Decision|0|||
124535664|NCT04212221|447913582|FG000|Overall Study|Participant refused to continue treatment|0|||
124535665|NCT04212221|447913583|FG001|Overall Study|Participant refused to continue treatment|1|||
124535666|NCT04212221|447913584|FG002|Overall Study|Participant refused to continue treatment|0|||
124535667|NCT04212221|447913585|FG003|Overall Study|Participant refused to continue treatment|1|||
124535668|NCT04212221|447913586|FG004|Overall Study|Participant refused to continue treatment|1|||
124535669|NCT04212221|447913587|FG005|Overall Study|Participant refused to continue treatment|2|||
124535670|NCT04212221|447913588|FG006|Overall Study|Participant refused to continue treatment|4|||
124535671|NCT04212221|447913589|FG007|Overall Study|Participant refused to continue treatment|2|||
124535672|NCT04212221|447913582|FG000|Overall Study|Protocol Violation|0|||
124535673|NCT04212221|447913583|FG001|Overall Study|Protocol Violation|0|||
124535674|NCT04212221|447913584|FG002|Overall Study|Protocol Violation|0|||
124535675|NCT04212221|447913585|FG003|Overall Study|Protocol Violation|0|||
124535676|NCT04212221|447913586|FG004|Overall Study|Protocol Violation|0|||
124535677|NCT04212221|447913587|FG005|Overall Study|Protocol Violation|0|||
124535678|NCT04212221|447913588|FG006|Overall Study|Protocol Violation|0|||
124535679|NCT04212221|447913589|FG007|Overall Study|Protocol Violation|1|||
124535680|NCT00636506|447913594|FG000|Overall Study|Lost to Follow-up|8|||
124535681|NCT00636506|447913594|FG000|Overall Study|Explanted|1|||
124535682|NCT00636506|447913594|FG000|Overall Study|Withdrawal by Subject|6|||
124535683|NCT00636506|447913594|FG000|Overall Study|Procedure aborted|1|||
124535684|NCT03742271|447913595|FG000|Overall Study|Unsatisfactory Visual Response|1|||
124535685|NCT03742271|447913595|FG000|Overall Study|Withdrawal by Subject|3|||
124535686|NCT03742271|447913595|FG000|Overall Study|Lost to Follow-up|4|||
124535687|NCT03742271|447913595|FG000|Overall Study|Failed Insertion & removal|3|||
124535688|NCT03742271|447913595|FG000|Overall Study|Protocol Violation|1|||
124535689|NCT01624974|447913597|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
124535690|NCT01624974|447913598|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
124535691|NCT01624974|447913597|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
124535692|NCT01624974|447913598|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
124535693|NCT01624974|447913597|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
124535694|NCT01624974|447913598|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
124535695|NCT01624974|447913597|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
124535696|NCT01624974|447913598|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
124535697|NCT01624974|447913597|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
124535698|NCT01624974|447913598|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
124535699|NCT01624974|447913597|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
124535700|NCT01624974|447913598|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
124535701|NCT01624974|447913597|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
124535702|NCT01624974|447913598|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
124535703|NCT01624974|447913597|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
124535704|NCT01624974|447913598|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
124535705|NCT01624974|447913597|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
124535706|NCT01624974|447913598|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
124535707|NCT01624974|447913597|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
124535708|NCT01624974|447913598|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
124535709|NCT01624974|447913597|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
124535710|NCT01624974|447913598|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
124535711|NCT01624974|447913597|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
124535712|NCT01624974|447913598|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
124535713|NCT01376908|447913599|FG000|Overall Study|Protocol Violation|1|||
124535714|NCT01376908|447913600|FG001|Overall Study|Protocol Violation|1|||
124535715|NCT01376908|447913599|FG000|Overall Study|Withdrawal by Subject|1|||
124535716|NCT01376908|447913600|FG001|Overall Study|Withdrawal by Subject|2|||
124535717|NCT01468844|447913603|FG000|Overall Study|Adverse Event|1|||
124535718|NCT01468844|447913604|FG001|Overall Study|Adverse Event|0|||
124535719|NCT01468844|447913603|FG000|Overall Study|Withdrawal by Subject|1|||
124535720|NCT01468844|447913604|FG001|Overall Study|Withdrawal by Subject|0|||
124535721|NCT00266695|447913607|FG000|Overall Study|Adverse Event|1|||
124535722|NCT00266695|447913607|FG000|Overall Study|Death|9|||
124535723|NCT00266695|447913607|FG000|Overall Study|Physician Decision|1|||
124535724|NCT00266695|447913607|FG000|Overall Study|Lost to Follow-up|3|||
124535725|NCT00266695|447913607|FG000|Overall Study|Withdrawal by Subject|15|||
124535726|NCT03607994|447913608|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
124535727|NCT03607994|447913609|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
124535728|NCT02417935|447913610|FG000|Treatment Period|Adverse Event|12|||
124535729|NCT02417935|447913611|FG001|Treatment Period|Adverse Event|10|||
124535730|NCT02417935|447913610|FG000|Treatment Period|Lost to Follow-up|1|||
124535731|NCT02417935|447913611|FG001|Treatment Period|Lost to Follow-up|0|||
124535732|NCT02417935|447913610|FG000|Treatment Period|Entry Criteria not met|0|||
124535733|NCT02417935|447913611|FG001|Treatment Period|Entry Criteria not met|1|||
124535734|NCT02417935|447913610|FG000|Treatment Period|Protocol Violation|2|||
124535735|NCT02417935|447913611|FG001|Treatment Period|Protocol Violation|1|||
124535736|NCT02417935|447913610|FG000|Treatment Period|Withdrawal by Subject|3|||
124535737|NCT02417935|447913611|FG001|Treatment Period|Withdrawal by Subject|3|||
124535738|NCT02417935|447913610|FG000|Treatment Period|Physician Decision|3|||
124535739|NCT02417935|447913611|FG001|Treatment Period|Physician Decision|1|||
124535740|NCT02850276|447913612|FG000|Overall Study|screen failure|43|||
124535741|NCT02850276|447913612|FG000|Overall Study|Withdrawal by Subject|14|||
124535742|NCT02850276|447913612|FG000|Overall Study|Physician Decision|2|||
124535743|NCT02850276|447913612|FG000|Overall Study|Lost to Follow-up|2|||
124535744|NCT01899729|447913613|FG000|Overall Study|Adverse Event|1|||
124535745|NCT01899729|447913614|FG001|Overall Study|Adverse Event|0|||
124535746|NCT01899729|447913615|FG002|Overall Study|Adverse Event|0|||
124535747|NCT01899729|447913616|FG003|Overall Study|Adverse Event|0|||
124535748|NCT01899729|447913617|FG004|Overall Study|Adverse Event|1|||
124535749|NCT01899729|447913613|FG000|Overall Study|Withdrawal by Subject|1|||
124535750|NCT01899729|447913614|FG001|Overall Study|Withdrawal by Subject|2|||
124535751|NCT01899729|447913615|FG002|Overall Study|Withdrawal by Subject|0|||
124535752|NCT01899729|447913616|FG003|Overall Study|Withdrawal by Subject|0|||
124535753|NCT01899729|447913617|FG004|Overall Study|Withdrawal by Subject|0|||
124535754|NCT01899729|447913613|FG000|Overall Study|Lack of Efficacy|0|||
124535755|NCT01899729|447913614|FG001|Overall Study|Lack of Efficacy|0|||
124535756|NCT01899729|447913615|FG002|Overall Study|Lack of Efficacy|2|||
124535757|NCT01899729|447913616|FG003|Overall Study|Lack of Efficacy|0|||
124535758|NCT01899729|447913617|FG004|Overall Study|Lack of Efficacy|1|||
124535759|NCT01454531|447913618|FG000|Overall Study|Adverse Event|14|||
124535760|NCT01454531|447913618|FG000|Overall Study|Withdrawal by Subject|5|||
124535761|NCT01454531|447913618|FG000|Overall Study|Lost to Follow-up|1|||
124535762|NCT01454531|447913618|FG000|Overall Study|Physician Decision|1|||
124535763|NCT01454531|447913618|FG000|Overall Study|Delay in IMP administration|1|||
124535764|NCT01454531|447913618|FG000|Overall Study|Other|1|||
124535765|NCT02646332|447913624|FG000|Overall Study|Lost to Follow-up|0|||
124535766|NCT02646332|447913625|FG001|Overall Study|Lost to Follow-up|3|||
124535767|NCT00252499|447913631|FG000|Overall Study|Lost to Follow-up|1|||
124535768|NCT00252499|447913632|FG001|Overall Study|Lost to Follow-up|0|||
124535769|NCT00252499|447913633|FG002|Overall Study|Lost to Follow-up|0|||
124535770|NCT04490499|447913634|FG000|Overall Study|Withdrawal by Subject|2|||
124535771|NCT01882439|447913635|FG000|Overall Study|Adverse event related to study drug|3|||
124535772|NCT01882439|447913636|FG001|Overall Study|Adverse event related to study drug|8|||
124535773|NCT01882439|447913637|FG002|Overall Study|Adverse event related to study drug|1|||
124535774|NCT01882439|447913638|FG003|Overall Study|Adverse event related to study drug|2|||
124535775|NCT01882439|447913635|FG000|Overall Study|Pregnancy|0|||
124535776|NCT01882439|447913636|FG001|Overall Study|Pregnancy|1|||
124535777|NCT01882439|447913637|FG002|Overall Study|Pregnancy|0|||
124535778|NCT01882439|447913638|FG003|Overall Study|Pregnancy|0|||
124535779|NCT01882439|447913635|FG000|Overall Study|Protocol Violation|2|||
124535780|NCT01882439|447913636|FG001|Overall Study|Protocol Violation|2|||
124535781|NCT01882439|447913637|FG002|Overall Study|Protocol Violation|0|||
124535782|NCT01882439|447913638|FG003|Overall Study|Protocol Violation|1|||
124535783|NCT01882439|447913635|FG000|Overall Study|No longer willing to participate|1|||
124535784|NCT01882439|447913636|FG001|Overall Study|No longer willing to participate|4|||
124535785|NCT01882439|447913637|FG002|Overall Study|No longer willing to participate|2|||
124535786|NCT01882439|447913638|FG003|Overall Study|No longer willing to participate|3|||
124535787|NCT01882439|447913635|FG000|Overall Study|Medication error with no associated AE|0|||
124535788|NCT01882439|447913636|FG001|Overall Study|Medication error with no associated AE|0|||
124535789|NCT01882439|447913637|FG002|Overall Study|Medication error with no associated AE|2|||
124535790|NCT01882439|447913638|FG003|Overall Study|Medication error with no associated AE|0|||
124535791|NCT01882439|447913635|FG000|Overall Study|Insufficient clinical response|1|||
124535792|NCT01882439|447913636|FG001|Overall Study|Insufficient clinical response|4|||
124535793|NCT01882439|447913637|FG002|Overall Study|Insufficient clinical response|4|||
124535794|NCT01882439|447913638|FG003|Overall Study|Insufficient clinical response|2|||
124535795|NCT01882439|447913635|FG000|Overall Study|Adverse event unrelated to study drug|2|||
124535796|NCT01882439|447913636|FG001|Overall Study|Adverse event unrelated to study drug|2|||
124535797|NCT01882439|447913637|FG002|Overall Study|Adverse event unrelated to study drug|1|||
124535798|NCT01882439|447913638|FG003|Overall Study|Adverse event unrelated to study drug|1|||
124535799|NCT03125902|447913643|FG000|Overall Study|Adverse Event|0|||
124535800|NCT03125902|447913644|FG001|Overall Study|Adverse Event|1|||
124535801|NCT03125902|447913643|FG000|Overall Study|Death|119|||
124535802|NCT03125902|447913644|FG001|Overall Study|Death|229|||
124535803|NCT03125902|447913643|FG000|Overall Study|Lost to Follow-up|4|||
124535804|NCT03125902|447913644|FG001|Overall Study|Lost to Follow-up|13|||
124535805|NCT03125902|447913643|FG000|Overall Study|Other|0|||
124535806|NCT03125902|447913644|FG001|Overall Study|Other|4|||
124535807|NCT03125902|447913643|FG000|Overall Study|Physician Decision|2|||
124535808|NCT03125902|447913644|FG001|Overall Study|Physician Decision|1|||
124535809|NCT03125902|447913643|FG000|Overall Study|Progressive Disease|0|||
124535810|NCT03125902|447913644|FG001|Overall Study|Progressive Disease|3|||
124535811|NCT03125902|447913643|FG000|Overall Study|Study Terminated By Sponsor|74|||
124535812|NCT03125902|447913644|FG001|Overall Study|Study Terminated By Sponsor|143|||
124535813|NCT03125902|447913643|FG000|Overall Study|Withdrawal by Subject|21|||
124535814|NCT03125902|447913644|FG001|Overall Study|Withdrawal by Subject|37|||
124535815|NCT02504424|447913647|FG000|Overall Study|Withdrawal by Subject|2|||
124535816|NCT00440232|447913648|FG000|Overall Study|Lost to Follow-up|1|||
124535817|NCT00440232|447913649|FG001|Overall Study|Lost to Follow-up|1|||
124535818|NCT00440232|447913648|FG000|Overall Study|Unable to treat within allowed time|0|||
124535819|NCT00440232|447913649|FG001|Overall Study|Unable to treat within allowed time|1|||
124535820|NCT00440232|447913648|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
124535821|NCT00440232|447913649|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
124535822|NCT00362297|447913650|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
124535823|NCT00362297|447913651|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
124535824|NCT01070381|447913652|FG000|Period 2, 1 Week of Wear|Handling|0|||
124535825|NCT01070381|447913653|FG001|Period 2, 1 Week of Wear|Handling|1|||
124535826|NCT01070381|447913652|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
124535827|NCT01070381|447913653|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
124535828|NCT01259388|447913657|FG000|Overall Study|Adverse Event|3|||
124535829|NCT01259388|447913658|FG001|Overall Study|Adverse Event|0|||
124535830|NCT01259388|447913657|FG000|Overall Study|Withdrawal by Subject|1|||
124535831|NCT01259388|447913658|FG001|Overall Study|Withdrawal by Subject|1|||
124535832|NCT01259388|447913657|FG000|Overall Study|Physician Decision|1|||
124535833|NCT01259388|447913658|FG001|Overall Study|Physician Decision|0|||
124535834|NCT03512028|447913659|FG000|Overall Study|Withdrawal by Subject|2|||
124535835|NCT03512028|447913660|FG001|Overall Study|Withdrawal by Subject|0|||
124535836|NCT03512028|447913659|FG000|Overall Study|Protocol Violation|2|||
124535837|NCT03512028|447913660|FG001|Overall Study|Protocol Violation|0|||
124535838|NCT02743494|447913661|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
124535839|NCT02743494|447913662|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
124535840|NCT02743494|447913661|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
124535841|NCT02743494|447913662|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
124535842|NCT02743494|447913661|FG000|Treatment Period|Completed treatment|229|||
124535843|NCT02743494|447913662|FG001|Treatment Period|Completed treatment|99|||
124535844|NCT02743494|447913661|FG000|Treatment Period|Disease recurrence|149|||
124535845|NCT02743494|447913662|FG001|Treatment Period|Disease recurrence|113|||
124535846|NCT02743494|447913661|FG000|Treatment Period|Study drug toxicity|57|||
124535847|NCT02743494|447913662|FG001|Treatment Period|Study drug toxicity|8|||
124535848|NCT02743494|447913661|FG000|Treatment Period|Death|1|||
124535849|NCT02743494|447913662|FG001|Treatment Period|Death|0|||
124535850|NCT02743494|447913661|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
124535851|NCT02743494|447913662|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
124535852|NCT02743494|447913661|FG000|Treatment Period|Participant request to discontinue treatment|30|||
124535853|NCT02743494|447913662|FG001|Treatment Period|Participant request to discontinue treatment|5|||
124535854|NCT02743494|447913661|FG000|Treatment Period|Participant withdrew consent|12|||
124535855|NCT02743494|447913662|FG001|Treatment Period|Participant withdrew consent|4|||
124535856|NCT02743494|447913661|FG000|Treatment Period|Lost to Follow-up|0|||
124535857|NCT02743494|447913662|FG001|Treatment Period|Lost to Follow-up|1|||
124535858|NCT02743494|447913661|FG000|Treatment Period|Poor/Non-compliance|1|||
124535859|NCT02743494|447913662|FG001|Treatment Period|Poor/Non-compliance|0|||
124535860|NCT02743494|447913661|FG000|Treatment Period|Other reasons|7|||
124535861|NCT02743494|447913662|FG001|Treatment Period|Other reasons|2|||
124535862|NCT03529162|447913663|FG000|Overall Study|Lost to Follow-up|2|||
124535863|NCT03529162|447913664|FG001|Overall Study|Lost to Follow-up|2|||
124535864|NCT00983827|447913665|FG000|Overall Study|Withdrawal by Subject|1|||
124535865|NCT01521494|447913666|FG000|Overall Study|Adverse Event|1|||
124535866|NCT01521494|447913667|FG001|Overall Study|Adverse Event|2|||
124535867|NCT01521494|447913668|FG002|Overall Study|Adverse Event|9|||
124535868|NCT01521494|447913669|FG003|Overall Study|Adverse Event|6|||
124535869|NCT01521494|447913670|FG004|Overall Study|Adverse Event|2|||
124535870|NCT01521494|447913666|FG000|Overall Study|Lack of Efficacy|0|||
124535871|NCT01521494|447913667|FG001|Overall Study|Lack of Efficacy|0|||
124535872|NCT01521494|447913668|FG002|Overall Study|Lack of Efficacy|0|||
124535873|NCT01521494|447913669|FG003|Overall Study|Lack of Efficacy|0|||
124535874|NCT01521494|447913670|FG004|Overall Study|Lack of Efficacy|2|||
124535875|NCT01521494|447913666|FG000|Overall Study|Withdrawal by Subject|1|||
124535876|NCT01521494|447913667|FG001|Overall Study|Withdrawal by Subject|1|||
124535877|NCT01521494|447913668|FG002|Overall Study|Withdrawal by Subject|0|||
124535878|NCT01521494|447913669|FG003|Overall Study|Withdrawal by Subject|2|||
124535879|NCT01521494|447913670|FG004|Overall Study|Withdrawal by Subject|0|||
124535880|NCT01521494|447913666|FG000|Overall Study|Decrease in serum phosphate|0|||
124535881|NCT01521494|447913667|FG001|Overall Study|Decrease in serum phosphate|2|||
124535882|NCT01521494|447913668|FG002|Overall Study|Decrease in serum phosphate|3|||
124535883|NCT01521494|447913669|FG003|Overall Study|Decrease in serum phosphate|12|||
124535884|NCT01521494|447913670|FG004|Overall Study|Decrease in serum phosphate|0|||
124535885|NCT01521494|447913666|FG000|Overall Study|Decrease in serum calcium|0|||
124535886|NCT01521494|447913667|FG001|Overall Study|Decrease in serum calcium|0|||
124535887|NCT01521494|447913668|FG002|Overall Study|Decrease in serum calcium|0|||
124535888|NCT01521494|447913669|FG003|Overall Study|Decrease in serum calcium|1|||
124535889|NCT01521494|447913670|FG004|Overall Study|Decrease in serum calcium|1|||
124535890|NCT01521494|447913666|FG000|Overall Study|Physician Decision|0|||
124535891|NCT01521494|447913667|FG001|Overall Study|Physician Decision|0|||
124535892|NCT01521494|447913668|FG002|Overall Study|Physician Decision|0|||
124535893|NCT01521494|447913669|FG003|Overall Study|Physician Decision|0|||
124535894|NCT01521494|447913670|FG004|Overall Study|Physician Decision|2|||
124535895|NCT02728804|447913676|FG000|Overall Study|Ineligible|3|||
124535896|NCT02728804|447913676|FG000|Overall Study|Did not complete baseline questionnaire|9|||
124535897|NCT02728804|447913676|FG000|Overall Study|Death|99|||
124535898|NCT01854918|447913677|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
124535899|NCT01854918|447913678|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
124535900|NCT01854918|447913677|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
124535901|NCT01854918|447913678|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
124535902|NCT01854918|447913677|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
124535903|NCT01854918|447913678|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
124535904|NCT01854918|447913677|FG000|SOC-controlled Period (Year 1)|Death|5|||
124535905|NCT01854918|447913678|FG001|SOC-controlled Period (Year 1)|Death|5|||
124535906|NCT01854918|447913677|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
124535907|NCT01854918|447913678|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
124535908|NCT01854918|447913677|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
124535909|NCT01854918|447913678|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
124535910|NCT01854918|447913677|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
124535911|NCT01854918|447913678|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
124535912|NCT01854918|447913677|FG000|All-IP Period (Years 2 and 3)|Death|5|||
124535913|NCT01854918|447913678|FG001|All-IP Period (Years 2 and 3)|Death|16|||
124535914|NCT02146352|447913683|FG000|Overall Study|Death|1|||
124535915|NCT02146352|447913683|FG000|Overall Study|Patient entered hospice care|1|||
124535916|NCT02918006|447913684|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
124535917|NCT02918006|447913685|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
124535918|NCT02918006|447913686|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
124535919|NCT02918006|447913684|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
124535920|NCT02918006|447913685|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
124535921|NCT02918006|447913686|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
124535922|NCT02918006|447913684|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
124535923|NCT02918006|447913685|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
124535924|NCT02918006|447913686|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
124535925|NCT02918006|447913684|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
124535926|NCT02918006|447913685|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
124535927|NCT02918006|447913686|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
124535928|NCT02918006|447913684|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
124535929|NCT02918006|447913685|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
124535930|NCT02918006|447913686|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
124535931|NCT02918006|447913684|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
124535932|NCT02918006|447913685|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
124535933|NCT02918006|447913686|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
124535934|NCT02918006|447913684|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
124535935|NCT02918006|447913685|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
124535936|NCT02918006|447913686|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
124535937|NCT02918006|447913684|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
124535938|NCT02918006|447913685|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
124535939|NCT02918006|447913686|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
124535940|NCT02918006|447913684|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
124535941|NCT02918006|447913685|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
124535942|NCT02918006|447913686|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
124535943|NCT03091920|447913688|FG000|Overall Study|Adverse Event|0|||
124535944|NCT03091920|447913689|FG001|Overall Study|Adverse Event|1|||
124535945|NCT03091920|447913690|FG002|Overall Study|Adverse Event|0|||
124535946|NCT00453349|447913692|FG000|Randomized|Adverse Event|12|||
124535947|NCT00453349|447913693|FG001|Randomized|Adverse Event|11|||
124535948|NCT00453349|447913692|FG000|Randomized|Lack of Efficacy|2|||
124535949|NCT00453349|447913693|FG001|Randomized|Lack of Efficacy|1|||
124535950|NCT00453349|447913692|FG000|Randomized|Lost to Follow-up|7|||
124535951|NCT00453349|447913693|FG001|Randomized|Lost to Follow-up|5|||
124535952|NCT00453349|447913692|FG000|Randomized|Protocol Violation|1|||
124535953|NCT00453349|447913693|FG001|Randomized|Protocol Violation|1|||
124535954|NCT00453349|447913692|FG000|Randomized|Withdrawal by Subject|3|||
124535955|NCT00453349|447913693|FG001|Randomized|Withdrawal by Subject|5|||
124535956|NCT00453349|447913692|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
124535957|NCT00453349|447913693|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
124535958|NCT00453349|447913692|FG000|Completed Study|Adverse Event|12|||
124535959|NCT00453349|447913693|FG001|Completed Study|Adverse Event|11|||
124535960|NCT00453349|447913692|FG000|Completed Study|Lack of Efficacy|2|||
124535961|NCT00453349|447913693|FG001|Completed Study|Lack of Efficacy|1|||
124535962|NCT00453349|447913692|FG000|Completed Study|Lost to Follow-up|7|||
124535963|NCT00453349|447913693|FG001|Completed Study|Lost to Follow-up|5|||
124535964|NCT00453349|447913692|FG000|Completed Study|Protocol Violation|1|||
124535965|NCT00453349|447913693|FG001|Completed Study|Protocol Violation|1|||
124535966|NCT00453349|447913692|FG000|Completed Study|Withdrawal by Subject|3|||
124535967|NCT00453349|447913693|FG001|Completed Study|Withdrawal by Subject|5|||
124535968|NCT00453349|447913692|FG000|Completed Study|Lost to follow up after study treatment|2|||
124535969|NCT00453349|447913693|FG001|Completed Study|Lost to follow up after study treatment|11|||
124535970|NCT04369742|447913694|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
124535971|NCT04369742|447913695|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
124535972|NCT04369742|447913694|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
124535973|NCT04369742|447913695|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
124535974|NCT02098733|447913700|FG000|Overall Study|Data Not Available|5|||
124535975|NCT02098733|447913700|FG000|Overall Study|Lost to Follow-up|5|||
124535976|NCT00695318|447913701|FG000|Overall Study|Lost to Follow-up|1|||
124535977|NCT00695318|447913702|FG001|Overall Study|Lost to Follow-up|0|||
124535978|NCT00695318|447913701|FG000|Overall Study|Withdrawal by Subject|2|||
124758605|NCT02452424|448739816|FG007|Overall Study|Other|3|||
124535979|NCT00695318|447913702|FG001|Overall Study|Withdrawal by Subject|0|||
124535980|NCT00695318|447913701|FG000|Overall Study|Death|1|||
124535981|NCT00695318|447913702|FG001|Overall Study|Death|1|||
124535982|NCT00695318|447913701|FG000|Overall Study|Study Terminated|1|||
124535983|NCT00695318|447913702|FG001|Overall Study|Study Terminated|0|||
124535984|NCT00434876|447913703|FG000|Overall Study|Lost to Follow-up|1|||
124535985|NCT00434876|447913704|FG001|Overall Study|Lost to Follow-up|1|||
124535986|NCT01503229|447915608|FG000|Overall Study|Withdrew consent|1|||
124535987|NCT00240331|447915609|FG000|Overall Study|Withdrawal by Subject|125|||
124535988|NCT00240331|447915610|FG001|Overall Study|Withdrawal by Subject|132|||
124535989|NCT00240331|447915609|FG000|Overall Study|Option selected by investigator|1|||
124535990|NCT00240331|447915610|FG001|Overall Study|Option selected by investigator|2|||
124535991|NCT02551874|447915611|FG000|Overall Study|Lost to Follow-up|0|||
124535992|NCT02551874|447915612|FG001|Overall Study|Lost to Follow-up|2|||
124535993|NCT02551874|447915611|FG000|Overall Study|Pregnancy|0|||
124535994|NCT02551874|447915612|FG001|Overall Study|Pregnancy|1|||
124535995|NCT02551874|447915611|FG000|Overall Study|Reason not reported|10|||
124535996|NCT02551874|447915612|FG001|Overall Study|Reason not reported|4|||
124535997|NCT02551874|447915611|FG000|Overall Study|Did not receive randomized treatment|0|||
124535998|NCT02551874|447915612|FG001|Overall Study|Did not receive randomized treatment|7|||
124535999|NCT02551874|447915611|FG000|Overall Study|Did not enter long-term study|18|||
124536000|NCT02551874|447915612|FG001|Overall Study|Did not enter long-term study|25|||
124536001|NCT02491463|447915613|FG000|Overall Study|Withdrawal by Subject|1|||
124536002|NCT02491463|447915614|FG001|Overall Study|Withdrawal by Subject|2|||
124536003|NCT02491463|447915615|FG002|Overall Study|Withdrawal by Subject|0|||
124536004|NCT02491463|447915616|FG003|Overall Study|Withdrawal by Subject|0|||
124536005|NCT02491463|447915613|FG000|Overall Study|Migrated/moved from study area|1|||
124536006|NCT02491463|447915614|FG001|Overall Study|Migrated/moved from study area|5|||
124536007|NCT02491463|447915615|FG002|Overall Study|Migrated/moved from study area|1|||
124536008|NCT02491463|447915616|FG003|Overall Study|Migrated/moved from study area|1|||
124536009|NCT02491463|447915613|FG000|Overall Study|Lost to Follow-up|0|||
124536010|NCT02491463|447915614|FG001|Overall Study|Lost to Follow-up|3|||
124536011|NCT02491463|447915615|FG002|Overall Study|Lost to Follow-up|3|||
124536012|NCT02491463|447915616|FG003|Overall Study|Lost to Follow-up|0|||
124536013|NCT01491802|447915617|FG000|Overall Study|Adverse Event|1|||
124536014|NCT01491802|447915618|FG001|Overall Study|Adverse Event|1|||
124536015|NCT01491802|447915617|FG000|Overall Study|Withdrawal by Subject|0|||
124536016|NCT01491802|447915618|FG001|Overall Study|Withdrawal by Subject|1|||
124536017|NCT00386152|447915623|FG000|Overall Study|Adverse Event|6|||
124536018|NCT00386152|447915624|FG001|Overall Study|Adverse Event|5|||
124536019|NCT00386152|447915625|FG002|Overall Study|Adverse Event|4|||
124536020|NCT00386152|447915623|FG000|Overall Study|Chang from original chemo stratification|4|||
124536021|NCT00386152|447915624|FG001|Overall Study|Chang from original chemo stratification|5|||
124536022|NCT00386152|447915625|FG002|Overall Study|Chang from original chemo stratification|6|||
124536023|NCT00386152|447915623|FG000|Overall Study|Death|3|||
124536024|NCT00386152|447915624|FG001|Overall Study|Death|0|||
124536025|NCT00386152|447915625|FG002|Overall Study|Death|1|||
124536026|NCT00386152|447915623|FG000|Overall Study|Disease progression|7|||
124536027|NCT00386152|447915624|FG001|Overall Study|Disease progression|4|||
124536028|NCT00386152|447915625|FG002|Overall Study|Disease progression|5|||
124536029|NCT00386152|447915623|FG000|Overall Study|Physician Decision|13|||
124536030|NCT00386152|447915624|FG001|Overall Study|Physician Decision|10|||
124536031|NCT00386152|447915625|FG002|Overall Study|Physician Decision|4|||
124536032|NCT00386152|447915623|FG000|Overall Study|Lost to Follow-up|1|||
124536033|NCT00386152|447915624|FG001|Overall Study|Lost to Follow-up|0|||
124536034|NCT00386152|447915625|FG002|Overall Study|Lost to Follow-up|0|||
124536035|NCT00386152|447915623|FG000|Overall Study|Completed chemotherapy|4|||
124536036|NCT00386152|447915624|FG001|Overall Study|Completed chemotherapy|5|||
124536037|NCT00386152|447915625|FG002|Overall Study|Completed chemotherapy|1|||
124536038|NCT00386152|447915623|FG000|Overall Study|Protocol Violation|3|||
124536039|NCT00386152|447915624|FG001|Overall Study|Protocol Violation|5|||
124536040|NCT00386152|447915625|FG002|Overall Study|Protocol Violation|2|||
124536041|NCT00386152|447915623|FG000|Overall Study|Withdrawal by Subject|3|||
124536042|NCT00386152|447915624|FG001|Overall Study|Withdrawal by Subject|6|||
124536043|NCT00386152|447915625|FG002|Overall Study|Withdrawal by Subject|10|||
124536044|NCT00508872|447915629|FG000|Overall Study|Lost to Follow-up|1|||
124536045|NCT00508872|447915629|FG000|Overall Study|Physician Decision|1|||
124536046|NCT03007472|447915630|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
124536047|NCT03007472|447915630|FG000|Overall Study|Death|2|||
124536048|NCT03007472|447915630|FG000|Overall Study|Loss to Follow Up|1|||
124536049|NCT01977651|447915633|FG000|4 Month Treatment Period|Adverse Event|34|||
124536050|NCT01977651|447915633|FG000|4 Month Treatment Period|Death|3|||
124536051|NCT01977651|447915633|FG000|4 Month Treatment Period|Progressive Disease|43|||
124536052|NCT01977651|447915633|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
124536053|NCT01977651|447915633|FG000|4 Month Treatment Period|Physician Decision|4|||
124536054|NCT01977651|447915633|FG000|1 Year Extension Period|Adverse Event|14|||
124536055|NCT01977651|447915633|FG000|1 Year Extension Period|Death|10|||
124536056|NCT01977651|447915633|FG000|1 Year Extension Period|Lost to Follow-up|2|||
124536057|NCT01977651|447915633|FG000|1 Year Extension Period|Progressive Disease|86|||
124536058|NCT01977651|447915633|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
124536059|NCT01977651|447915633|FG000|1 Year Extension Period|Physician Decision|6|||
124536060|NCT01977651|447915633|FG000|1 Year Extension Period|Miscellaneous|1|||
124536061|NCT01977651|447915633|FG000|Post 1 Year Extension Period|Adverse Event|5|||
124536062|NCT01977651|447915633|FG000|Post 1 Year Extension Period|Death|13|||
124536063|NCT01977651|447915633|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
124536064|NCT01977651|447915633|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
124536065|NCT01977651|447915633|FG000|Post 1 Year Extension Period|Physician Decision|4|||
124536066|NCT01977651|447915633|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
124536067|NCT00253747|447915634|FG000|Overall Study|Lost to Follow-up|13|||
124536068|NCT00253747|447915635|FG001|Overall Study|Lost to Follow-up|14|||
124536069|NCT00253747|447915634|FG000|Overall Study|Withdrawal by Subject|10|||
124536070|NCT00253747|447915635|FG001|Overall Study|Withdrawal by Subject|11|||
124536071|NCT00253747|447915634|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
124536072|NCT00253747|447915635|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
124536073|NCT00104299|447915636|FG000|Overall Study|Adverse Event|3|||
124536074|NCT00104299|447915637|FG001|Overall Study|Adverse Event|1|||
124536075|NCT00104299|447915636|FG000|Overall Study|Death|2|||
124536076|NCT00104299|447915637|FG001|Overall Study|Death|2|||
124536077|NCT00104299|447915636|FG000|Overall Study|Withdrawal by Subject|2|||
124536078|NCT00104299|447915637|FG001|Overall Study|Withdrawal by Subject|6|||
124536079|NCT00104299|447915636|FG000|Overall Study|Physician Decision|1|||
124536080|NCT00104299|447915637|FG001|Overall Study|Physician Decision|1|||
124536081|NCT00104299|447915636|FG000|Overall Study|To have renal transplant|1|||
124536082|NCT00104299|447915637|FG001|Overall Study|To have renal transplant|0|||
124536083|NCT03672006|447915639|FG000|Overall Study|exclusion criteria met|0|||
124536084|NCT03672006|447915640|FG001|Overall Study|exclusion criteria met|1|||
124536085|NCT00608426|447915641|FG000|Overall Study|Death|32|||
124536086|NCT00608426|447915642|FG001|Overall Study|Death|36|||
124536087|NCT00608426|447915641|FG000|Overall Study|Lost to Follow-up|485|||
124536088|NCT00608426|447915642|FG001|Overall Study|Lost to Follow-up|521|||
124536089|NCT00608426|447915641|FG000|Overall Study|refused, health issues, wrong address|319|||
124536090|NCT00608426|447915642|FG001|Overall Study|refused, health issues, wrong address|348|||
124536091|NCT02630459|447915646|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
124536092|NCT02630459|447915647|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
124536093|NCT02630459|447915648|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
124536094|NCT02630459|447915649|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
124536095|NCT02630459|447915650|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
124536096|NCT02630459|447915651|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
124536097|NCT02630459|447915652|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
124536098|NCT02630459|447915653|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
124536099|NCT02630459|447915646|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
124536100|NCT02630459|447915647|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
124536101|NCT02630459|447915648|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
124536102|NCT02630459|447915649|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
124536103|NCT02630459|447915650|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
124536104|NCT02630459|447915651|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
124536105|NCT02630459|447915652|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
124536106|NCT02630459|447915653|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
124536107|NCT02630459|447915646|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
124536108|NCT02630459|447915647|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
124536109|NCT02630459|447915648|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
124536110|NCT02630459|447915649|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
124536111|NCT02630459|447915650|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
124536112|NCT02630459|447915651|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
124536113|NCT02630459|447915652|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
124536114|NCT02630459|447915653|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
124536115|NCT02630459|447915646|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
124536116|NCT02630459|447915647|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
124536117|NCT02630459|447915648|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
124536118|NCT02630459|447915649|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
124536119|NCT02630459|447915650|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
124536120|NCT02630459|447915651|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
124536121|NCT02630459|447915652|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
124536122|NCT02630459|447915653|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
124536123|NCT02630459|447915646|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
124536124|NCT02630459|447915647|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
124536125|NCT02630459|447915648|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
124536126|NCT02630459|447915649|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
124536127|NCT02630459|447915650|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
124536128|NCT02630459|447915651|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
124536129|NCT02630459|447915652|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
124536130|NCT02630459|447915653|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
124536131|NCT02630459|447915646|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
124536132|NCT02630459|447915647|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
124536133|NCT02630459|447915648|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
124536134|NCT02630459|447915649|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
124536135|NCT02630459|447915650|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
124536136|NCT02630459|447915651|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
124536137|NCT02630459|447915652|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
124536138|NCT02630459|447915653|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
124536139|NCT02630459|447915646|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
124536140|NCT02630459|447915647|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
124536141|NCT02630459|447915648|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
124536142|NCT02630459|447915649|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
124536143|NCT02630459|447915650|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
124536144|NCT02630459|447915651|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
124536145|NCT02630459|447915652|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
124536146|NCT02630459|447915653|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
124536147|NCT01453439|447915654|FG000|Treatment Phase|Withdrawal by Subject|13|||
124536148|NCT01453439|447915655|FG001|Treatment Phase|Withdrawal by Subject|10|||
124536149|NCT01453439|447915654|FG000|Treatment Phase|Suicidal Ideation|2|||
124536150|NCT01453439|447915655|FG001|Treatment Phase|Suicidal Ideation|0|||
124536151|NCT01453439|447915654|FG000|Treatment Phase|Need for higher level of care|1|||
124536152|NCT01453439|447915655|FG001|Treatment Phase|Need for higher level of care|1|||
124536153|NCT01453439|447915654|FG000|Treatment Phase|Therapist conflict of interest|1|||
124536154|NCT01453439|447915655|FG001|Treatment Phase|Therapist conflict of interest|0|||
124536155|NCT01453439|447915654|FG000|Follow-up|Withdrawal by Subject|0|||
124536156|NCT01453439|447915655|FG001|Follow-up|Withdrawal by Subject|1|||
124536157|NCT01453439|447915654|FG000|Follow-up|Lost to Follow-up|5|||
124536158|NCT01453439|447915655|FG001|Follow-up|Lost to Follow-up|10|||
124536159|NCT01014442|447915656|FG000|Overall Study|Adverse Event|0|||
124536160|NCT01014442|447915657|FG001|Overall Study|Adverse Event|8|||
124536161|NCT01014442|447915656|FG000|Overall Study|Withdrawal by Subject|4|||
124536162|NCT01014442|447915657|FG001|Overall Study|Withdrawal by Subject|4|||
124536163|NCT01014442|447915656|FG000|Overall Study|Protocol Violation|2|||
124536164|NCT01014442|447915657|FG001|Overall Study|Protocol Violation|5|||
124536165|NCT01014442|447915656|FG000|Overall Study|Lack of Compliance|0|||
124536166|NCT01014442|447915657|FG001|Overall Study|Lack of Compliance|1|||
124536167|NCT01014442|447915656|FG000|Overall Study|Unspecified Reason|1|||
124536168|NCT01014442|447915657|FG001|Overall Study|Unspecified Reason|1|||
124536169|NCT01220024|447915668|FG000|Overall Study|Lost to Follow-up|1|||
124536170|NCT01220024|447915669|FG001|Overall Study|Lost to Follow-up|1|||
124536171|NCT00174460|447915672|FG000|Overall Study|Withdrawal by Subject|0|||
124536172|NCT00174460|447915673|FG001|Overall Study|Withdrawal by Subject|1|||
124536173|NCT00490815|447915674|FG000|Overall Study|Adverse Event|2|||
124536174|NCT00490815|447915675|FG001|Overall Study|Adverse Event|3|||
124536175|NCT00490815|447915674|FG000|Overall Study|Withdrawal by Subject|4|||
124536176|NCT00490815|447915675|FG001|Overall Study|Withdrawal by Subject|0|||
124536177|NCT00490815|447915674|FG000|Overall Study|Lost to Follow-up|1|||
124536178|NCT00490815|447915675|FG001|Overall Study|Lost to Follow-up|3|||
124536179|NCT00490815|447915674|FG000|Overall Study|Death|1|||
124536180|NCT00490815|447915675|FG001|Overall Study|Death|3|||
124536181|NCT00579059|447915677|FG000|Overall Study|Study Canceled at 1 Year|21|||
124536182|NCT00579059|447915678|FG001|Overall Study|Study Canceled at 1 Year|10|||
124536183|NCT04047472|447915679|FG000|Overall Study|Adverse Event|3|||
124536184|NCT04047472|447915680|FG001|Overall Study|Adverse Event|3|||
124536185|NCT04047472|447915679|FG000|Overall Study|Death|0|||
124536186|NCT04047472|447915680|FG001|Overall Study|Death|1|||
124536187|NCT04047472|447915679|FG000|Overall Study|Lost to Follow-up|1|||
124536188|NCT04047472|447915680|FG001|Overall Study|Lost to Follow-up|0|||
124536189|NCT04047472|447915679|FG000|Overall Study|Physician Decision|1|||
124536190|NCT04047472|447915680|FG001|Overall Study|Physician Decision|2|||
124536191|NCT04047472|447915679|FG000|Overall Study|Protocol Violation|1|||
124536192|NCT04047472|447915680|FG001|Overall Study|Protocol Violation|0|||
124536193|NCT04047472|447915679|FG000|Overall Study|Withdrawal by Subject|10|||
124536194|NCT04047472|447915680|FG001|Overall Study|Withdrawal by Subject|10|||
124536195|NCT02030067|447915681|FG000|Overall Study|Disease Progression|1|||
124536196|NCT02030067|447915682|FG001|Overall Study|Disease Progression|1|||
124536197|NCT02030067|447915683|FG002|Overall Study|Disease Progression|2|||
124536198|NCT02030067|447915684|FG003|Overall Study|Disease Progression|2|||
124536199|NCT02030067|447915685|FG004|Overall Study|Disease Progression|3|||
124536200|NCT02030067|447915686|FG005|Overall Study|Disease Progression|2|||
124536201|NCT02030067|447915687|FG006|Overall Study|Disease Progression|3|||
124536202|NCT02030067|447915688|FG007|Overall Study|Disease Progression|3|||
124536203|NCT02030067|447915689|FG008|Overall Study|Disease Progression|4|||
124536204|NCT02030067|447915690|FG009|Overall Study|Disease Progression|3|||
124536205|NCT02030067|447915691|FG010|Overall Study|Disease Progression|7|||
124536206|NCT02030067|447915692|FG011|Overall Study|Disease Progression|2|||
124536207|NCT02030067|447915693|FG012|Overall Study|Disease Progression|59|||
124536208|NCT02030067|447915681|FG000|Overall Study|Withdrawal by Subject|0|||
124536209|NCT02030067|447915682|FG001|Overall Study|Withdrawal by Subject|0|||
124536210|NCT02030067|447915683|FG002|Overall Study|Withdrawal by Subject|0|||
124536211|NCT02030067|447915684|FG003|Overall Study|Withdrawal by Subject|1|||
124536212|NCT02030067|447915685|FG004|Overall Study|Withdrawal by Subject|0|||
124536213|NCT02030067|447915686|FG005|Overall Study|Withdrawal by Subject|0|||
124536214|NCT02030067|447915687|FG006|Overall Study|Withdrawal by Subject|0|||
124536215|NCT02030067|447915688|FG007|Overall Study|Withdrawal by Subject|1|||
124536216|NCT02030067|447915689|FG008|Overall Study|Withdrawal by Subject|0|||
124536217|NCT02030067|447915690|FG009|Overall Study|Withdrawal by Subject|0|||
124536218|NCT02030067|447915691|FG010|Overall Study|Withdrawal by Subject|3|||
124536219|NCT02030067|447915692|FG011|Overall Study|Withdrawal by Subject|0|||
124536220|NCT02030067|447915693|FG012|Overall Study|Withdrawal by Subject|6|||
124536221|NCT02030067|447915681|FG000|Overall Study|Physician Decision|0|||
124536222|NCT02030067|447915682|FG001|Overall Study|Physician Decision|0|||
124536223|NCT02030067|447915683|FG002|Overall Study|Physician Decision|0|||
124536224|NCT02030067|447915684|FG003|Overall Study|Physician Decision|0|||
124536225|NCT02030067|447915685|FG004|Overall Study|Physician Decision|0|||
124536226|NCT02030067|447915686|FG005|Overall Study|Physician Decision|0|||
124536227|NCT02030067|447915687|FG006|Overall Study|Physician Decision|0|||
124536228|NCT02030067|447915688|FG007|Overall Study|Physician Decision|0|||
124536229|NCT02030067|447915689|FG008|Overall Study|Physician Decision|0|||
124536230|NCT02030067|447915690|FG009|Overall Study|Physician Decision|0|||
124536231|NCT02030067|447915691|FG010|Overall Study|Physician Decision|1|||
124536232|NCT02030067|447915692|FG011|Overall Study|Physician Decision|0|||
124536233|NCT02030067|447915693|FG012|Overall Study|Physician Decision|3|||
124536234|NCT02030067|447915681|FG000|Overall Study|other reasons|0|||
124536235|NCT02030067|447915682|FG001|Overall Study|other reasons|0|||
124536236|NCT02030067|447915683|FG002|Overall Study|other reasons|0|||
124536237|NCT02030067|447915684|FG003|Overall Study|other reasons|0|||
124536238|NCT02030067|447915685|FG004|Overall Study|other reasons|0|||
124536239|NCT02030067|447915686|FG005|Overall Study|other reasons|1|||
124536240|NCT02030067|447915687|FG006|Overall Study|other reasons|0|||
124536241|NCT02030067|447915688|FG007|Overall Study|other reasons|0|||
124536242|NCT02030067|447915689|FG008|Overall Study|other reasons|2|||
124536243|NCT02030067|447915690|FG009|Overall Study|other reasons|0|||
124536244|NCT02030067|447915691|FG010|Overall Study|other reasons|0|||
124536245|NCT02030067|447915692|FG011|Overall Study|other reasons|0|||
124536246|NCT02030067|447915693|FG012|Overall Study|other reasons|4|||
124536247|NCT02030067|447915681|FG000|Overall Study|Adverse Event|0|||
124536248|NCT02030067|447915682|FG001|Overall Study|Adverse Event|0|||
124536249|NCT02030067|447915683|FG002|Overall Study|Adverse Event|0|||
124536250|NCT02030067|447915684|FG003|Overall Study|Adverse Event|0|||
124536251|NCT02030067|447915685|FG004|Overall Study|Adverse Event|0|||
124536252|NCT02030067|447915686|FG005|Overall Study|Adverse Event|0|||
124536253|NCT02030067|447915687|FG006|Overall Study|Adverse Event|0|||
124536254|NCT02030067|447915688|FG007|Overall Study|Adverse Event|0|||
124536255|NCT02030067|447915689|FG008|Overall Study|Adverse Event|0|||
124536256|NCT02030067|447915690|FG009|Overall Study|Adverse Event|0|||
124536257|NCT02030067|447915691|FG010|Overall Study|Adverse Event|0|||
124536258|NCT02030067|447915692|FG011|Overall Study|Adverse Event|1|||
124536259|NCT02030067|447915693|FG012|Overall Study|Adverse Event|8|||
124536260|NCT01756846|447915694|FG000|Overall Study|Lost to Follow-up|5|||
124536261|NCT01756846|447915695|FG001|Overall Study|Lost to Follow-up|10|||
124536262|NCT01756846|447915694|FG000|Overall Study|Withdrawal by Subject|1|||
124536263|NCT01756846|447915695|FG001|Overall Study|Withdrawal by Subject|2|||
124536264|NCT01284127|447915696|FG000|Overall Study|Adverse Event|2|||
124536265|NCT01284127|447915696|FG000|Overall Study|Withdrawal by Subject|4|||
124536266|NCT01284127|447915696|FG000|Overall Study|Physician Decision|1|||
124536267|NCT00699582|447915699|FG000|Overall Study|Adverse Event|4|||
124536268|NCT00699582|447915700|FG001|Overall Study|Adverse Event|11|||
124536269|NCT00699582|447915701|FG002|Overall Study|Adverse Event|23|||
124536270|NCT00699582|447915699|FG000|Overall Study|Withdrawal by Subject|6|||
124536271|NCT00699582|447915700|FG001|Overall Study|Withdrawal by Subject|7|||
124536272|NCT00699582|447915701|FG002|Overall Study|Withdrawal by Subject|4|||
124536273|NCT00699582|447915699|FG000|Overall Study|Lack of Efficacy|1|||
124536274|NCT00699582|447915700|FG001|Overall Study|Lack of Efficacy|0|||
124536275|NCT00699582|447915701|FG002|Overall Study|Lack of Efficacy|1|||
124536276|NCT00699582|447915699|FG000|Overall Study|Progressive Disease|1|||
124536277|NCT00699582|447915700|FG001|Overall Study|Progressive Disease|0|||
124536278|NCT00699582|447915701|FG002|Overall Study|Progressive Disease|0|||
124536279|NCT00699582|447915699|FG000|Overall Study|Administrative/Other|4|||
124536280|NCT00699582|447915700|FG001|Overall Study|Administrative/Other|3|||
124536281|NCT00699582|447915701|FG002|Overall Study|Administrative/Other|0|||
124536282|NCT00699582|447915699|FG000|Overall Study|Randomized, Not Treated|2|||
124536283|NCT00699582|447915700|FG001|Overall Study|Randomized, Not Treated|1|||
124536284|NCT00699582|447915701|FG002|Overall Study|Randomized, Not Treated|0|||
124536285|NCT02853318|447915707|FG000|Overall Study|Withdrawal by Subject|1|||
124536286|NCT01997333|447915708|FG000|Randomization and Treatment|Disease Progression|70|||
124536287|NCT01997333|447915709|FG001|Randomization and Treatment|Disease Progression|159|||
124536288|NCT01997333|447915708|FG000|Randomization and Treatment|Adverse Event|10|||
124536289|NCT01997333|447915709|FG001|Randomization and Treatment|Adverse Event|32|||
124536290|NCT01997333|447915708|FG000|Randomization and Treatment|Physician Decision|0|||
124536291|NCT01997333|447915709|FG001|Randomization and Treatment|Physician Decision|4|||
124536292|NCT01997333|447915708|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
124536293|NCT01997333|447915709|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
124536294|NCT01997333|447915708|FG000|Randomization and Treatment|Did not receive treatment|17|||
124536295|NCT01997333|447915709|FG001|Randomization and Treatment|Did not receive treatment|5|||
124536296|NCT01997333|447915708|FG000|Survival Follow up|Withdrawal by Subject|15|||
124536297|NCT01997333|447915709|FG001|Survival Follow up|Withdrawal by Subject|6|||
124536298|NCT01997333|447915708|FG000|Survival Follow up|Lost to Follow-up|0|||
124536299|NCT01997333|447915709|FG001|Survival Follow up|Lost to Follow-up|6|||
124536300|NCT01997333|447915708|FG000|Survival Follow up|Various|1|||
124536301|NCT01997333|447915709|FG001|Survival Follow up|Various|2|||
124536302|NCT01843933|447915710|FG000|Overall Study|Data lost|6|||
124536303|NCT01843933|447915711|FG001|Overall Study|Data lost|4|||
124536304|NCT02909504|447915712|FG000|Overall Study|Adverse Event|2|||
124536305|NCT02909504|447915712|FG000|Overall Study|Lack of Efficacy|3|||
124536306|NCT02909504|447915712|FG000|Overall Study|Withdrawal by Subject|4|||
124536307|NCT02909504|447915712|FG000|Overall Study|Pregnancy|1|||
124536308|NCT02909504|447915712|FG000|Overall Study|Subject moved|1|||
124536309|NCT02909504|447915712|FG000|Overall Study|Lost to Follow-up|1|||
124536310|NCT04411472|447915713|FG000|Overall Study|Adverse Event|5|||
124536311|NCT04411472|447915714|FG001|Overall Study|Adverse Event|10|||
124536312|NCT04411472|447915715|FG002|Overall Study|Adverse Event|1|||
124536313|NCT04411472|447915716|FG003|Overall Study|Adverse Event|0|||
124536314|NCT04411472|447915717|FG004|Overall Study|Adverse Event|0|||
124536315|NCT04411472|447915718|FG005|Overall Study|Adverse Event|0|||
124536316|NCT04411472|447915713|FG000|Overall Study|Protocol Violation|1|||
124536317|NCT04411472|447915714|FG001|Overall Study|Protocol Violation|0|||
124536318|NCT04411472|447915715|FG002|Overall Study|Protocol Violation|0|||
124536319|NCT04411472|447915716|FG003|Overall Study|Protocol Violation|0|||
124536320|NCT04411472|447915717|FG004|Overall Study|Protocol Violation|0|||
124536321|NCT04411472|447915718|FG005|Overall Study|Protocol Violation|0|||
124536322|NCT04411472|447915713|FG000|Overall Study|Withdrawal by Subject|0|||
124536323|NCT04411472|447915714|FG001|Overall Study|Withdrawal by Subject|1|||
124536324|NCT04411472|447915715|FG002|Overall Study|Withdrawal by Subject|0|||
124536325|NCT04411472|447915716|FG003|Overall Study|Withdrawal by Subject|1|||
124536326|NCT04411472|447915717|FG004|Overall Study|Withdrawal by Subject|0|||
124536327|NCT04411472|447915718|FG005|Overall Study|Withdrawal by Subject|0|||
124536328|NCT04411472|447915713|FG000|Overall Study|Physician Decision|1|||
124536329|NCT04411472|447915714|FG001|Overall Study|Physician Decision|0|||
124536330|NCT04411472|447915715|FG002|Overall Study|Physician Decision|0|||
124536331|NCT04411472|447915716|FG003|Overall Study|Physician Decision|0|||
124536332|NCT04411472|447915717|FG004|Overall Study|Physician Decision|0|||
124536333|NCT04411472|447915718|FG005|Overall Study|Physician Decision|0|||
124536334|NCT04411472|447915713|FG000|Overall Study|Study terminated by sponsor|17|||
124536335|NCT04411472|447915714|FG001|Overall Study|Study terminated by sponsor|20|||
124536336|NCT04411472|447915715|FG002|Overall Study|Study terminated by sponsor|3|||
124536337|NCT04411472|447915716|FG003|Overall Study|Study terminated by sponsor|0|||
124536338|NCT04411472|447915717|FG004|Overall Study|Study terminated by sponsor|0|||
124536339|NCT04411472|447915718|FG005|Overall Study|Study terminated by sponsor|0|||
124536340|NCT01747655|447915720|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
124536341|NCT01747655|447915721|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
124536342|NCT01747655|447915720|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
124536343|NCT01747655|447915721|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
124536344|NCT01747655|447915720|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
124536345|NCT01747655|447915721|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
124536346|NCT00982111|447915722|FG000|Overall Study|Adverse Event|1|||
124536347|NCT00982111|447915723|FG001|Overall Study|Adverse Event|1|||
124536348|NCT00982111|447915722|FG000|Overall Study|Progressive Disease|46|||
124536349|NCT00982111|447915723|FG001|Overall Study|Progressive Disease|39|||
124536350|NCT00982111|447915722|FG000|Overall Study|Lost to Follow-up|9|||
124536351|NCT00982111|447915723|FG001|Overall Study|Lost to Follow-up|6|||
124536352|NCT00982111|447915722|FG000|Overall Study|New Anti-Cancer Therapy|5|||
124536353|NCT00982111|447915723|FG001|Overall Study|New Anti-Cancer Therapy|5|||
124536354|NCT00982111|447915722|FG000|Overall Study|Medical Decision|1|||
124536355|NCT00982111|447915723|FG001|Overall Study|Medical Decision|0|||
124536356|NCT00982111|447915722|FG000|Overall Study|Withdrawal by Subject|17|||
124536357|NCT00982111|447915723|FG001|Overall Study|Withdrawal by Subject|19|||
124536358|NCT00982111|447915722|FG000|Overall Study|Global Study End|0|||
124536359|NCT00982111|447915723|FG001|Overall Study|Global Study End|1|||
124536360|NCT00982111|447915722|FG000|Overall Study|Sponsor's Decision|0|||
124536361|NCT00982111|447915723|FG001|Overall Study|Sponsor's Decision|1|||
124536362|NCT03769753|447915724|FG000|Overall Study|Not Treated|6|||
124536363|NCT03769753|447915724|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
124536364|NCT01482598|447915725|FG000|Overall Study|Death|7|||
124536365|NCT01482598|447915726|FG001|Overall Study|Death|10|||
124536366|NCT01482598|447915725|FG000|Overall Study|Physician Decision|0|||
124536367|NCT01482598|447915726|FG001|Overall Study|Physician Decision|3|||
124536368|NCT01482598|447915725|FG000|Overall Study|Withdrawal by Subject|4|||
124536369|NCT01482598|447915726|FG001|Overall Study|Withdrawal by Subject|5|||
124536370|NCT01482598|447915725|FG000|Overall Study|Lost to Follow-up|5|||
124536371|NCT01482598|447915726|FG001|Overall Study|Lost to Follow-up|4|||
124536372|NCT01373294|447915727|FG000|Overall Study|Adverse Event|1|||
124536373|NCT01373294|447915728|FG001|Overall Study|Adverse Event|0|||
124536374|NCT01657903|447915730|FG000|Overall Study|Lost to Follow-up|1|||
124536375|NCT01657903|447915730|FG000|Overall Study|Withdrawal by Subject|1|||
124536376|NCT00620815|447915733|FG000|Overall Study|Adverse Event|1|||
124536377|NCT00620815|447915734|FG001|Overall Study|Adverse Event|1|||
124536378|NCT00620815|447915735|FG002|Overall Study|Adverse Event|2|||
124536379|NCT00620815|447915733|FG000|Overall Study|Withdrawal by Subject|1|||
124536380|NCT00620815|447915734|FG001|Overall Study|Withdrawal by Subject|2|||
124536381|NCT00620815|447915735|FG002|Overall Study|Withdrawal by Subject|0|||
124536382|NCT00620815|447915733|FG000|Overall Study|Lost to Follow-up|1|||
124536383|NCT00620815|447915734|FG001|Overall Study|Lost to Follow-up|6|||
124536384|NCT00620815|447915735|FG002|Overall Study|Lost to Follow-up|3|||
124536385|NCT00620815|447915733|FG000|Overall Study|Inappropriate enrolment|0|||
124536386|NCT00620815|447915734|FG001|Overall Study|Inappropriate enrolment|0|||
124536387|NCT00620815|447915735|FG002|Overall Study|Inappropriate enrolment|1|||
124536388|NCT00620815|447915733|FG000|Overall Study|Protocol Violation|1|||
124536389|NCT00620815|447915734|FG001|Overall Study|Protocol Violation|2|||
124536390|NCT00620815|447915735|FG002|Overall Study|Protocol Violation|1|||
124536391|NCT01920061|447915738|FG000|Overall Study|Death|1|||
124536392|NCT01920061|447915739|FG001|Overall Study|Death|1|||
124536393|NCT01920061|447915740|FG002|Overall Study|Death|0|||
124536394|NCT01920061|447915741|FG003|Overall Study|Death|1|||
124536395|NCT01920061|447915742|FG004|Overall Study|Death|1|||
124536396|NCT01920061|447915743|FG005|Overall Study|Death|0|||
124536397|NCT01920061|447915744|FG006|Overall Study|Death|0|||
124536398|NCT01920061|447915745|FG007|Overall Study|Death|1|||
124536399|NCT01920061|447915746|FG008|Overall Study|Death|0|||
124536400|NCT01920061|447915747|FG009|Overall Study|Death|1|||
124536401|NCT01920061|447915748|FG010|Overall Study|Death|0|||
124536402|NCT01920061|447915749|FG011|Overall Study|Death|1|||
124536403|NCT01920061|447915750|FG012|Overall Study|Death|0|||
124536404|NCT01920061|447915751|FG013|Overall Study|Death|2|||
124536405|NCT01920061|447915752|FG014|Overall Study|Death|0|||
124536406|NCT01920061|447915753|FG015|Overall Study|Death|0|||
124536407|NCT01920061|447915754|FG016|Overall Study|Death|0|||
124536408|NCT01920061|447915755|FG017|Overall Study|Death|0|||
124536409|NCT01920061|447915756|FG018|Overall Study|Death|1|||
124536410|NCT01920061|447915757|FG019|Overall Study|Death|0|||
124536411|NCT01920061|447915738|FG000|Overall Study|Lost to Follow-up|0|||
124536412|NCT01920061|447915739|FG001|Overall Study|Lost to Follow-up|2|||
124536413|NCT01920061|447915740|FG002|Overall Study|Lost to Follow-up|0|||
124536414|NCT01920061|447915741|FG003|Overall Study|Lost to Follow-up|0|||
124536415|NCT01920061|447915742|FG004|Overall Study|Lost to Follow-up|0|||
124536416|NCT01920061|447915743|FG005|Overall Study|Lost to Follow-up|0|||
124536417|NCT01920061|447915744|FG006|Overall Study|Lost to Follow-up|1|||
124536418|NCT01920061|447915745|FG007|Overall Study|Lost to Follow-up|0|||
124536419|NCT01920061|447915746|FG008|Overall Study|Lost to Follow-up|0|||
124536420|NCT01920061|447915747|FG009|Overall Study|Lost to Follow-up|0|||
124536421|NCT01920061|447915748|FG010|Overall Study|Lost to Follow-up|3|||
124536422|NCT01920061|447915749|FG011|Overall Study|Lost to Follow-up|0|||
124536423|NCT01920061|447915750|FG012|Overall Study|Lost to Follow-up|0|||
124536424|NCT01920061|447915751|FG013|Overall Study|Lost to Follow-up|0|||
124536425|NCT01920061|447915752|FG014|Overall Study|Lost to Follow-up|0|||
124536426|NCT01920061|447915753|FG015|Overall Study|Lost to Follow-up|0|||
124536427|NCT01920061|447915754|FG016|Overall Study|Lost to Follow-up|0|||
124536428|NCT01920061|447915755|FG017|Overall Study|Lost to Follow-up|1|||
124536429|NCT01920061|447915756|FG018|Overall Study|Lost to Follow-up|4|||
124536430|NCT01920061|447915757|FG019|Overall Study|Lost to Follow-up|3|||
124536431|NCT01920061|447915738|FG000|Overall Study|Other|1|||
124536432|NCT01920061|447915739|FG001|Overall Study|Other|1|||
124536433|NCT01920061|447915740|FG002|Overall Study|Other|2|||
124536434|NCT01920061|447915741|FG003|Overall Study|Other|1|||
124536435|NCT01920061|447915742|FG004|Overall Study|Other|0|||
124536436|NCT01920061|447915743|FG005|Overall Study|Other|1|||
124536437|NCT01920061|447915744|FG006|Overall Study|Other|0|||
124536438|NCT01920061|447915745|FG007|Overall Study|Other|0|||
124536439|NCT01920061|447915746|FG008|Overall Study|Other|0|||
124536440|NCT01920061|447915747|FG009|Overall Study|Other|1|||
124536441|NCT01920061|447915748|FG010|Overall Study|Other|1|||
124536442|NCT01920061|447915749|FG011|Overall Study|Other|2|||
124536443|NCT01920061|447915750|FG012|Overall Study|Other|1|||
124536444|NCT01920061|447915751|FG013|Overall Study|Other|4|||
124536445|NCT01920061|447915752|FG014|Overall Study|Other|0|||
124536446|NCT01920061|447915753|FG015|Overall Study|Other|1|||
124536447|NCT01920061|447915754|FG016|Overall Study|Other|1|||
124536448|NCT01920061|447915755|FG017|Overall Study|Other|0|||
124536449|NCT01920061|447915756|FG018|Overall Study|Other|1|||
124536450|NCT01920061|447915757|FG019|Overall Study|Other|1|||
124536451|NCT01920061|447915738|FG000|Overall Study|Participant refused further follow-up|0|||
124536452|NCT01920061|447915739|FG001|Overall Study|Participant refused further follow-up|0|||
124536453|NCT01920061|447915740|FG002|Overall Study|Participant refused further follow-up|0|||
124536454|NCT01920061|447915741|FG003|Overall Study|Participant refused further follow-up|0|||
124536455|NCT01920061|447915742|FG004|Overall Study|Participant refused further follow-up|1|||
124536456|NCT01920061|447915743|FG005|Overall Study|Participant refused further follow-up|1|||
124536457|NCT01920061|447915744|FG006|Overall Study|Participant refused further follow-up|0|||
124536458|NCT01920061|447915745|FG007|Overall Study|Participant refused further follow-up|0|||
124758606|NCT02452424|448739817|FG008|Overall Study|Other|0|||
124536459|NCT01920061|447915746|FG008|Overall Study|Participant refused further follow-up|1|||
124536460|NCT01920061|447915747|FG009|Overall Study|Participant refused further follow-up|0|||
124644691|NCT03614078|448316489|FG001|Overall Study|Adverse Event|2|||
124536461|NCT01920061|447915748|FG010|Overall Study|Participant refused further follow-up|1|||
124536462|NCT01920061|447915749|FG011|Overall Study|Participant refused further follow-up|0|||
124536463|NCT01920061|447915750|FG012|Overall Study|Participant refused further follow-up|1|||
124536464|NCT01920061|447915751|FG013|Overall Study|Participant refused further follow-up|0|||
124536465|NCT01920061|447915752|FG014|Overall Study|Participant refused further follow-up|1|||
124536466|NCT01920061|447915753|FG015|Overall Study|Participant refused further follow-up|2|||
124536467|NCT01920061|447915754|FG016|Overall Study|Participant refused further follow-up|1|||
124536468|NCT01920061|447915755|FG017|Overall Study|Participant refused further follow-up|1|||
124536469|NCT01920061|447915756|FG018|Overall Study|Participant refused further follow-up|0|||
124536470|NCT01920061|447915757|FG019|Overall Study|Participant refused further follow-up|0|||
124536471|NCT00842829|447915760|FG000|Dose Titration Period|Adverse Event|11|||
124536472|NCT00842829|447915761|FG001|Dose Titration Period|Adverse Event|10|||
124536473|NCT00842829|447915762|FG002|Dose Titration Period|Adverse Event|0|||
124536474|NCT00842829|447915760|FG000|Dose Titration Period|Lack of Efficacy|4|||
124536475|NCT00842829|447915761|FG001|Dose Titration Period|Lack of Efficacy|1|||
124536476|NCT00842829|447915762|FG002|Dose Titration Period|Lack of Efficacy|0|||
124536477|NCT00842829|447915760|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
124536478|NCT00842829|447915761|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
124536479|NCT00842829|447915762|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
124536480|NCT00842829|447915760|FG000|Dose Titration Period|Withdrawal by Subject|2|||
124536481|NCT00842829|447915761|FG001|Dose Titration Period|Withdrawal by Subject|6|||
124536482|NCT00842829|447915762|FG002|Dose Titration Period|Withdrawal by Subject|0|||
124536483|NCT00842829|447915760|FG000|Dose Titration Period|Other|5|||
124536484|NCT00842829|447915761|FG001|Dose Titration Period|Other|4|||
124536485|NCT00842829|447915762|FG002|Dose Titration Period|Other|0|||
124536486|NCT00842829|447915760|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
124536487|NCT00842829|447915761|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
124536488|NCT00842829|447915762|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
124536489|NCT00842829|447915760|FG000|Dose Titration Period|Non-compliance to study drug|2|||
124536490|NCT00842829|447915761|FG001|Dose Titration Period|Non-compliance to study drug|1|||
124536491|NCT00842829|447915762|FG002|Dose Titration Period|Non-compliance to study drug|0|||
124536492|NCT00842829|447915760|FG000|Treatment Period|Adverse Event|0|||
124536493|NCT00842829|447915761|FG001|Treatment Period|Adverse Event|0|||
124536494|NCT00842829|447915762|FG002|Treatment Period|Adverse Event|15|||
124536495|NCT00842829|447915760|FG000|Treatment Period|Lack of Efficacy|0|||
124536496|NCT00842829|447915761|FG001|Treatment Period|Lack of Efficacy|0|||
124536497|NCT00842829|447915762|FG002|Treatment Period|Lack of Efficacy|6|||
124536498|NCT00842829|447915760|FG000|Treatment Period|Unstable persistent cancer pain|0|||
124536499|NCT00842829|447915761|FG001|Treatment Period|Unstable persistent cancer pain|0|||
124536500|NCT00842829|447915762|FG002|Treatment Period|Unstable persistent cancer pain|5|||
124536501|NCT00842829|447915760|FG000|Treatment Period|Withdrawal by Subject|0|||
124536502|NCT00842829|447915761|FG001|Treatment Period|Withdrawal by Subject|0|||
124536503|NCT00842829|447915762|FG002|Treatment Period|Withdrawal by Subject|11|||
124536504|NCT00842829|447915760|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
124536505|NCT00842829|447915761|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
124536506|NCT00842829|447915762|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
124536507|NCT00842829|447915760|FG000|Treatment Period|Protocol Violation|0|||
124536508|NCT00842829|447915761|FG001|Treatment Period|Protocol Violation|0|||
124536509|NCT00842829|447915762|FG002|Treatment Period|Protocol Violation|2|||
124536510|NCT00842829|447915760|FG000|Treatment Period|Other|0|||
124536511|NCT00842829|447915761|FG001|Treatment Period|Other|0|||
124536512|NCT00842829|447915762|FG002|Treatment Period|Other|18|||
124536513|NCT00842829|447915760|FG000|Treatment Period|Non-compliance to study procedures|0|||
124536514|NCT00842829|447915761|FG001|Treatment Period|Non-compliance to study procedures|0|||
124536515|NCT00842829|447915762|FG002|Treatment Period|Non-compliance to study procedures|4|||
124536516|NCT00842829|447915760|FG000|Treatment Period|Unclear completion status|0|||
124536517|NCT00842829|447915761|FG001|Treatment Period|Unclear completion status|0|||
124536518|NCT00842829|447915762|FG002|Treatment Period|Unclear completion status|1|||
124536519|NCT00842829|447915760|FG000|Continuation Period|Adverse Event|0|||
124536520|NCT00842829|447915761|FG001|Continuation Period|Adverse Event|0|||
124536521|NCT00842829|447915762|FG002|Continuation Period|Adverse Event|32|||
124536522|NCT00842829|447915760|FG000|Continuation Period|Lack of Efficacy|0|||
124536523|NCT00842829|447915761|FG001|Continuation Period|Lack of Efficacy|0|||
124536524|NCT00842829|447915762|FG002|Continuation Period|Lack of Efficacy|6|||
124536525|NCT00842829|447915760|FG000|Continuation Period|Unstable persistent cancer pain|0|||
124536526|NCT00842829|447915761|FG001|Continuation Period|Unstable persistent cancer pain|0|||
124536527|NCT00842829|447915762|FG002|Continuation Period|Unstable persistent cancer pain|3|||
124536528|NCT00842829|447915760|FG000|Continuation Period|Withdrawal by Subject|0|||
124536529|NCT00842829|447915761|FG001|Continuation Period|Withdrawal by Subject|0|||
124536530|NCT00842829|447915762|FG002|Continuation Period|Withdrawal by Subject|10|||
124536531|NCT00842829|447915760|FG000|Continuation Period|Other|0|||
124536532|NCT00842829|447915761|FG001|Continuation Period|Other|0|||
124536533|NCT00842829|447915762|FG002|Continuation Period|Other|7|||
124536534|NCT00842829|447915760|FG000|Continuation Period|Non-compliance to study procedures|0|||
124536535|NCT00842829|447915761|FG001|Continuation Period|Non-compliance to study procedures|0|||
124536536|NCT00842829|447915762|FG002|Continuation Period|Non-compliance to study procedures|2|||
124536537|NCT00842829|447915760|FG000|Continuation Period|Non-compliance to study drug|0|||
124536538|NCT00842829|447915761|FG001|Continuation Period|Non-compliance to study drug|0|||
124536539|NCT00842829|447915762|FG002|Continuation Period|Non-compliance to study drug|1|||
124536540|NCT00517634|447915763|FG000|Second Treatment Period|Withdrawal by Subject|0|||
124536541|NCT00517634|447915764|FG001|Second Treatment Period|Withdrawal by Subject|0|||
124536542|NCT00517634|447915765|FG002|Second Treatment Period|Withdrawal by Subject|0|||
124536543|NCT00517634|447915766|FG003|Second Treatment Period|Withdrawal by Subject|0|||
124536544|NCT00517634|447915767|FG004|Second Treatment Period|Withdrawal by Subject|1|||
124536545|NCT00517634|447915768|FG005|Second Treatment Period|Withdrawal by Subject|0|||
124536546|NCT03143855|447915771|FG000|Overall Study|Withdrawal by Subject|4|||
124536547|NCT03143855|447915772|FG001|Overall Study|Withdrawal by Subject|3|||
124536548|NCT03143855|447915771|FG000|Overall Study|Protocol Violation|1|||
124536549|NCT03143855|447915772|FG001|Overall Study|Protocol Violation|0|||
124536550|NCT03143855|447915771|FG000|Overall Study|Participant experienced withdrawal|0|||
124536551|NCT03143855|447915772|FG001|Overall Study|Participant experienced withdrawal|1|||
124536552|NCT01078389|447917687|FG000|Overall Study|Adverse Event|10|||
124536553|NCT01078389|447917688|FG001|Overall Study|Adverse Event|6|||
124536554|NCT01078389|447917687|FG000|Overall Study|Major Protocol Deviation|2|||
124536555|NCT01078389|447917688|FG001|Overall Study|Major Protocol Deviation|0|||
124536556|NCT01078389|447917687|FG000|Overall Study|Lost to Follow-up|23|||
124536557|NCT01078389|447917688|FG001|Overall Study|Lost to Follow-up|23|||
124536558|NCT01078389|447917687|FG000|Overall Study|Voluntary Withdrawal|20|||
124536559|NCT01078389|447917688|FG001|Overall Study|Voluntary Withdrawal|36|||
124536560|NCT01078389|447917687|FG000|Overall Study|Other|9|||
124536561|NCT01078389|447917688|FG001|Overall Study|Other|2|||
124536562|NCT01002573|447917689|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
124536563|NCT01002573|447917690|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
124536564|NCT02028182|447917691|FG000|Overall Study|Protocol Violation|2|||
124536565|NCT02198040|447917694|FG000|Overall Study|Work reasons|0|||
124536566|NCT02198040|447917695|FG001|Overall Study|Work reasons|1|||
124536567|NCT02198040|447917696|FG002|Overall Study|Work reasons|0|||
124536568|NCT02198040|447917694|FG000|Overall Study|Withdrawal by Subject|0|||
124536569|NCT02198040|447917695|FG001|Overall Study|Withdrawal by Subject|0|||
124536570|NCT02198040|447917696|FG002|Overall Study|Withdrawal by Subject|1|||
124536571|NCT04524663|447917697|FG000|Overall Study|Withdrawal by Subject|0|||
124536572|NCT04524663|447917698|FG001|Overall Study|Withdrawal by Subject|2|||
124536573|NCT00337935|447917699|FG000|Overall Study|Adverse Event|2|||
124536574|NCT00337935|447917700|FG001|Overall Study|Adverse Event|5|||
124536575|NCT00337935|447917699|FG000|Overall Study|Death|2|||
124536576|NCT00337935|447917700|FG001|Overall Study|Death|8|||
124536577|NCT00337935|447917699|FG000|Overall Study|Physician Decision|1|||
124536578|NCT00337935|447917700|FG001|Overall Study|Physician Decision|1|||
124536579|NCT00337935|447917699|FG000|Overall Study|Lost to Follow-up|0|||
124536580|NCT00337935|447917700|FG001|Overall Study|Lost to Follow-up|1|||
124536581|NCT00337935|447917699|FG000|Overall Study|Protocol Violation|4|||
124536582|NCT00337935|447917700|FG001|Overall Study|Protocol Violation|3|||
124536583|NCT00337935|447917699|FG000|Overall Study|Withdrawal by Subject|1|||
124536584|NCT00337935|447917700|FG001|Overall Study|Withdrawal by Subject|7|||
124536585|NCT00337935|447917699|FG000|Overall Study|Other|0|||
124536586|NCT00337935|447917700|FG001|Overall Study|Other|1|||
124536587|NCT00337935|447917699|FG000|Overall Study|Lack of Efficacy|0|||
124536588|NCT00337935|447917700|FG001|Overall Study|Lack of Efficacy|1|||
124536589|NCT01884675|447917701|FG000|Overall Study|Study closed/terminated|3|||
124536590|NCT01884675|447917702|FG001|Overall Study|Study closed/terminated|2|||
124536591|NCT02361307|447917703|FG000|Overall Study|Unstable medical condition.|0|||
124536592|NCT02361307|447917704|FG001|Overall Study|Unstable medical condition.|1|||
124536593|NCT00711009|447917705|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
124536594|NCT00711009|447917706|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
124536595|NCT00711009|447917705|FG000|Overall Study|Withdrawal by Subject|4|||
124536596|NCT00711009|447917706|FG001|Overall Study|Withdrawal by Subject|2|||
124536597|NCT00711009|447917705|FG000|Overall Study|Lost to Follow-up|3|||
124536598|NCT00711009|447917706|FG001|Overall Study|Lost to Follow-up|9|||
124536599|NCT00711009|447917705|FG000|Overall Study|Participant Noncompliant|0|||
124536600|NCT00711009|447917706|FG001|Overall Study|Participant Noncompliant|1|||
124536601|NCT00711009|447917705|FG000|Overall Study|Virologic Failure|2|||
124536602|NCT00711009|447917706|FG001|Overall Study|Virologic Failure|1|||
124536603|NCT00711009|447917705|FG000|Overall Study|Pregnancy|1|||
124536604|NCT00711009|447917706|FG001|Overall Study|Pregnancy|0|||
124536605|NCT00711009|447917705|FG000|Overall Study|Site closing|0|||
124536606|NCT00711009|447917706|FG001|Overall Study|Site closing|1|||
124536607|NCT00711009|447917705|FG000|Overall Study|Dose adjustment|1|||
124536608|NCT00711009|447917706|FG001|Overall Study|Dose adjustment|0|||
124536609|NCT03359811|447917707|FG000|Overall Study|Protocol Violation|2|||
124536610|NCT03359811|447917708|FG001|Overall Study|Protocol Violation|0|||
124536611|NCT01682876|447917709|FG000|Overall Study|Administrative reason|4|||
124536612|NCT01682876|447917710|FG001|Overall Study|Administrative reason|4|||
124536613|NCT01682876|447917711|FG002|Overall Study|Administrative reason|0|||
124536614|NCT01682876|447917712|FG003|Overall Study|Administrative reason|3|||
124536615|NCT01682876|447917709|FG000|Overall Study|Adverse Event|0|||
124536616|NCT01682876|447917710|FG001|Overall Study|Adverse Event|0|||
124536617|NCT01682876|447917711|FG002|Overall Study|Adverse Event|0|||
124536618|NCT01682876|447917712|FG003|Overall Study|Adverse Event|1|||
124536619|NCT01682876|447917709|FG000|Overall Study|Lost to Follow-up|11|||
124536620|NCT01682876|447917710|FG001|Overall Study|Lost to Follow-up|15|||
124536621|NCT01682876|447917711|FG002|Overall Study|Lost to Follow-up|9|||
124536622|NCT01682876|447917712|FG003|Overall Study|Lost to Follow-up|11|||
124536623|NCT01682876|447917709|FG000|Overall Study|Protocol Violation|1|||
124536624|NCT01682876|447917710|FG001|Overall Study|Protocol Violation|1|||
124536625|NCT01682876|447917711|FG002|Overall Study|Protocol Violation|1|||
124536626|NCT01682876|447917712|FG003|Overall Study|Protocol Violation|1|||
124536627|NCT01682876|447917709|FG000|Overall Study|Withdrawal by Subject|4|||
124536628|NCT01682876|447917710|FG001|Overall Study|Withdrawal by Subject|0|||
124536629|NCT01682876|447917711|FG002|Overall Study|Withdrawal by Subject|0|||
124536630|NCT01682876|447917712|FG003|Overall Study|Withdrawal by Subject|2|||
124536631|NCT01682876|447917709|FG000|Overall Study|Other|1|||
124536632|NCT01682876|447917710|FG001|Overall Study|Other|0|||
124536633|NCT01682876|447917711|FG002|Overall Study|Other|1|||
124536634|NCT01682876|447917712|FG003|Overall Study|Other|1|||
124536635|NCT02534324|447917714|FG000|Overall Study|Protocol Violation|4|||
124536636|NCT02534324|447917715|FG001|Overall Study|Protocol Violation|1|||
124536637|NCT02534324|447917714|FG000|Overall Study|Lost to Follow-up|20|||
124536638|NCT02534324|447917715|FG001|Overall Study|Lost to Follow-up|7|||
124536639|NCT02534324|447917714|FG000|Overall Study|Adverse Event|1|||
124536640|NCT02534324|447917715|FG001|Overall Study|Adverse Event|0|||
124536641|NCT01459016|447917718|FG000|Overall Study|Withdrawal by Subject|11|||
124536642|NCT01459016|447917718|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
124536643|NCT00303602|447917722|FG000|Overall Study|Adverse Event|2|||
124536644|NCT00303602|447917723|FG001|Overall Study|Adverse Event|2|||
124536645|NCT00303602|447917722|FG000|Overall Study|Withdrawal by Subject|5|||
124536646|NCT00303602|447917723|FG001|Overall Study|Withdrawal by Subject|6|||
124536647|NCT00303602|447917722|FG000|Overall Study|Lost to Follow-up|5|||
124536648|NCT00303602|447917723|FG001|Overall Study|Lost to Follow-up|2|||
124536649|NCT00303602|447917722|FG000|Overall Study|Protocol entry criteria not met|2|||
124536650|NCT00303602|447917723|FG001|Overall Study|Protocol entry criteria not met|2|||
124536651|NCT00303602|447917722|FG000|Overall Study|Physician Decision|2|||
124536652|NCT00303602|447917723|FG001|Overall Study|Physician Decision|1|||
124536653|NCT00303602|447917722|FG000|Overall Study|Noncompliance|2|||
124536654|NCT00303602|447917723|FG001|Overall Study|Noncompliance|2|||
124536655|NCT00303602|447917722|FG000|Overall Study|Protocol Violation|1|||
124536656|NCT00303602|447917723|FG001|Overall Study|Protocol Violation|0|||
124536657|NCT00663208|447917728|FG000|Treatment Period|Lost to Follow-up|0|||
124536658|NCT00663208|447917729|FG001|Treatment Period|Lost to Follow-up|1|||
124536659|NCT00663208|447917730|FG002|Treatment Period|Lost to Follow-up|0|||
124536660|NCT00663208|447917731|FG003|Treatment Period|Lost to Follow-up|0|||
124536661|NCT00663208|447917732|FG004|Treatment Period|Lost to Follow-up|0|||
124536662|NCT00663208|447917733|FG005|Treatment Period|Lost to Follow-up|0|||
124536663|NCT00663208|447917734|FG006|Treatment Period|Lost to Follow-up|0|||
124536664|NCT00663208|447917728|FG000|Follow-up Period|Lost to Follow-up|2|||
124536665|NCT00663208|447917729|FG001|Follow-up Period|Lost to Follow-up|0|||
124536666|NCT00663208|447917730|FG002|Follow-up Period|Lost to Follow-up|3|||
124536667|NCT00663208|447917731|FG003|Follow-up Period|Lost to Follow-up|2|||
124536668|NCT00663208|447917732|FG004|Follow-up Period|Lost to Follow-up|0|||
124536669|NCT00663208|447917733|FG005|Follow-up Period|Lost to Follow-up|0|||
124536670|NCT00663208|447917734|FG006|Follow-up Period|Lost to Follow-up|0|||
124536671|NCT00663208|447917728|FG000|Follow-up Period|Other reason|1|||
124536672|NCT00663208|447917729|FG001|Follow-up Period|Other reason|0|||
124536673|NCT00663208|447917730|FG002|Follow-up Period|Other reason|0|||
124536674|NCT00663208|447917731|FG003|Follow-up Period|Other reason|0|||
124536675|NCT00663208|447917732|FG004|Follow-up Period|Other reason|0|||
124536676|NCT00663208|447917733|FG005|Follow-up Period|Other reason|0|||
124536677|NCT00663208|447917734|FG006|Follow-up Period|Other reason|1|||
124536678|NCT04067310|447917739|FG000|Overall Study|Physician Decision|2|||
124536679|NCT04067310|447917740|FG001|Overall Study|Physician Decision|6|||
124536680|NCT04067310|447917739|FG000|Overall Study|Lost to Follow-up|0|||
124536681|NCT04067310|447917740|FG001|Overall Study|Lost to Follow-up|1|||
124536682|NCT04067310|447917739|FG000|Overall Study|Withdrawal by Subject|3|||
124536683|NCT04067310|447917740|FG001|Overall Study|Withdrawal by Subject|0|||
124536684|NCT01249404|447917741|FG000|Overall Study|Study treatment not received|0|||
124758607|NCT02452424|448739818|FG009|Overall Study|Other|0|||
124536685|NCT01249404|447917742|FG001|Overall Study|Study treatment not received|1|||
124758608|NCT02452424|448739819|FG010|Overall Study|Other|1|||
124758609|NCT02452424|448739809|FG000|Overall Study|Progressive disease (per RECIST)|0|||
124536686|NCT01249404|447917743|FG002|Overall Study|Study treatment not received|2|||
124536687|NCT01249404|447917741|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
124536688|NCT01249404|447917742|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
124536689|NCT01249404|447917743|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
124536690|NCT01249404|447917741|FG000|Overall Study|Adverse Event|2|||
124536691|NCT01249404|447917742|FG001|Overall Study|Adverse Event|2|||
124536692|NCT01249404|447917743|FG002|Overall Study|Adverse Event|2|||
124536693|NCT01249404|447917741|FG000|Overall Study|Withdrawal by Subject|2|||
124536694|NCT01249404|447917742|FG001|Overall Study|Withdrawal by Subject|2|||
124536695|NCT01249404|447917743|FG002|Overall Study|Withdrawal by Subject|0|||
124536696|NCT01249404|447917741|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
124536697|NCT01249404|447917742|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
124536698|NCT01249404|447917743|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
124536699|NCT01249404|447917741|FG000|Overall Study|Non compliance to visit schedule|0|||
124536700|NCT01249404|447917742|FG001|Overall Study|Non compliance to visit schedule|1|||
124536701|NCT01249404|447917743|FG002|Overall Study|Non compliance to visit schedule|0|||
124536702|NCT04563845|447917744|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
124536703|NCT04563845|447917745|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
124536704|NCT04563845|447917746|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
124536705|NCT04563845|447917747|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
124536706|NCT04563845|447917748|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
124536707|NCT04563845|447917749|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
124536708|NCT04563845|447917750|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
124536709|NCT04563845|447917751|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
124536710|NCT04563845|447917752|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
124536711|NCT04563845|447917753|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
124536712|NCT04563845|447917754|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
124536713|NCT04563845|447917755|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
124536714|NCT04563845|447917756|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
124536715|NCT04563845|447917757|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
124869908|NCT00863655|449143572|FG000|Overall Study|Treatment completed as per protocol|5|||
124869909|NCT00863655|449143573|FG001|Overall Study|Treatment completed as per protocol|1|||
124869910|NCT02157779|449143574|FG000|Overall Study|Logistical|9|||
124869911|NCT02157779|449143575|FG001|Overall Study|Logistical|3|||
124869912|NCT02157779|449143574|FG000|Overall Study|Stopped attending, reason unknown|11|||
124869913|NCT02157779|449143575|FG001|Overall Study|Stopped attending, reason unknown|7|||
124869914|NCT02157779|449143574|FG000|Overall Study|No response to outreach after Baseline|1|||
124869915|NCT02157779|449143575|FG001|Overall Study|No response to outreach after Baseline|1|||
124869916|NCT02157779|449143574|FG000|Overall Study|Moved|1|||
124869917|NCT02157779|449143575|FG001|Overall Study|Moved|0|||
124869918|NCT02157779|449143574|FG000|Overall Study|Medical|1|||
124869919|NCT02157779|449143575|FG001|Overall Study|Medical|0|||
124869920|NCT02157779|449143574|FG000|Overall Study|Legal issue|1|||
124869921|NCT02157779|449143575|FG001|Overall Study|Legal issue|0|||
124869922|NCT00430248|449143578|FG000|Overall Study|Adverse Event|49|||
124869923|NCT00430248|449143579|FG001|Overall Study|Adverse Event|61|||
124869924|NCT00430248|449143580|FG002|Overall Study|Adverse Event|64|||
124869925|NCT00430248|449143578|FG000|Overall Study|Protocol Violation|10|||
124869926|NCT00430248|449143579|FG001|Overall Study|Protocol Violation|2|||
124869927|NCT00430248|449143580|FG002|Overall Study|Protocol Violation|4|||
124536716|NCT04563845|447917744|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
124536717|NCT04563845|447917745|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
124536718|NCT04563845|447917746|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
124536719|NCT04563845|447917747|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
124536720|NCT04563845|447917748|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
124536721|NCT04563845|447917749|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
124758610|NCT02452424|448739810|FG001|Overall Study|Progressive disease (per RECIST)|0|||
124758611|NCT02452424|448739811|FG002|Overall Study|Progressive disease (per RECIST)|0|||
124758612|NCT02452424|448739812|FG003|Overall Study|Progressive disease (per RECIST)|0|||
124758613|NCT02452424|448739813|FG004|Overall Study|Progressive disease (per RECIST)|0|||
124758614|NCT02452424|448739814|FG005|Overall Study|Progressive disease (per RECIST)|0|||
124758615|NCT02452424|448739815|FG006|Overall Study|Progressive disease (per RECIST)|0|||
124758616|NCT02452424|448739816|FG007|Overall Study|Progressive disease (per RECIST)|0|||
124758617|NCT02452424|448739817|FG008|Overall Study|Progressive disease (per RECIST)|2|||
124758618|NCT02452424|448739818|FG009|Overall Study|Progressive disease (per RECIST)|0|||
124758619|NCT02452424|448739819|FG010|Overall Study|Progressive disease (per RECIST)|0|||
124758620|NCT02452424|448739809|FG000|Overall Study|Adverse Event|0|||
124758621|NCT02452424|448739810|FG001|Overall Study|Adverse Event|0|||
124758622|NCT02452424|448739811|FG002|Overall Study|Adverse Event|0|||
124758623|NCT02452424|448739812|FG003|Overall Study|Adverse Event|0|||
124758624|NCT02452424|448739813|FG004|Overall Study|Adverse Event|0|||
124869928|NCT00430248|449143578|FG000|Overall Study|Personal Reasons|12|||
124869929|NCT00430248|449143579|FG001|Overall Study|Personal Reasons|24|||
124869930|NCT00430248|449143580|FG002|Overall Study|Personal Reasons|9|||
124869931|NCT00430248|449143578|FG000|Overall Study|Lost to Follow-up|28|||
124869932|NCT00430248|449143579|FG001|Overall Study|Lost to Follow-up|33|||
124869933|NCT00430248|449143580|FG002|Overall Study|Lost to Follow-up|28|||
124869934|NCT00430248|449143578|FG000|Overall Study|Therapeutic Failure|1|||
124869935|NCT00430248|449143579|FG001|Overall Study|Therapeutic Failure|1|||
124869936|NCT00430248|449143580|FG002|Overall Study|Therapeutic Failure|1|||
124869937|NCT00430248|449143578|FG000|Overall Study|Withdrawal by Subject|14|||
124869938|NCT00430248|449143579|FG001|Overall Study|Withdrawal by Subject|20|||
124869939|NCT00430248|449143580|FG002|Overall Study|Withdrawal by Subject|16|||
124869940|NCT00430248|449143578|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124869941|NCT00430248|449143579|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
124869942|NCT00430248|449143580|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124869943|NCT00430248|449143578|FG000|Overall Study|Gout Flare|3|||
124869944|NCT00430248|449143579|FG001|Overall Study|Gout Flare|7|||
124869945|NCT00430248|449143580|FG002|Overall Study|Gout Flare|2|||
124869946|NCT00430248|449143578|FG000|Overall Study|Reason Not Specified|8|||
124869947|NCT00430248|449143579|FG001|Overall Study|Reason Not Specified|8|||
124869948|NCT00430248|449143580|FG002|Overall Study|Reason Not Specified|11|||
124869949|NCT00002558|449143583|FG000|Overall Study|Withdrawal by Subject|0|||
124869950|NCT00002558|449143584|FG001|Overall Study|Withdrawal by Subject|1|||
124869951|NCT01754467|449143585|FG000|Overall Study|Lost to Follow-up|1|||
124869952|NCT02065336|449143586|FG000|Extension Phase|Study Terminated by Sponsor|0|||
124869953|NCT02065336|449143587|FG001|Extension Phase|Study Terminated by Sponsor|0|||
124869954|NCT02065336|449143588|FG002|Extension Phase|Study Terminated by Sponsor|0|||
124869955|NCT02065336|449143589|FG003|Extension Phase|Study Terminated by Sponsor|0|||
124869956|NCT02065336|449143590|FG004|Extension Phase|Study Terminated by Sponsor|0|||
124869957|NCT02065336|449143591|FG005|Extension Phase|Study Terminated by Sponsor|0|||
124869958|NCT02065336|449143592|FG006|Extension Phase|Study Terminated by Sponsor|0|||
124869959|NCT02065336|449143593|FG007|Extension Phase|Study Terminated by Sponsor|0|||
124869960|NCT02065336|449143594|FG008|Extension Phase|Study Terminated by Sponsor|2|||
124869961|NCT02065336|449143595|FG009|Extension Phase|Study Terminated by Sponsor|8|||
124869962|NCT01970462|449143596|FG000|Overall Study|Lost to Follow-up|0|||
124869963|NCT01970462|449143597|FG001|Overall Study|Lost to Follow-up|2|||
124869964|NCT02316769|449143600|FG000|Overall Study|Physician Decision|1|||
124869965|NCT02316769|449143601|FG001|Overall Study|Physician Decision|0|||
124869966|NCT02316769|449143600|FG000|Overall Study|Withdrawal by Subject|1|||
124869967|NCT02316769|449143601|FG001|Overall Study|Withdrawal by Subject|0|||
124869968|NCT00677235|449143602|FG000|Overall Study|Withdrawal by Subject|1|||
124869969|NCT00677235|449143603|FG001|Overall Study|Withdrawal by Subject|1|||
124869970|NCT00677235|449143602|FG000|Overall Study|Lost to Follow-up|2|||
124869971|NCT00677235|449143603|FG001|Overall Study|Lost to Follow-up|1|||
124869972|NCT00677235|449143602|FG000|Overall Study|Death|37|||
124869973|NCT00677235|449143603|FG001|Overall Study|Death|36|||
124869974|NCT00677235|449143602|FG000|Overall Study|Adverse Experience|1|||
124869975|NCT00677235|449143603|FG001|Overall Study|Adverse Experience|0|||
124869976|NCT01040260|449143604|FG000|Overall Study|Withdrawal by Subject|12|||
124869977|NCT01040260|449143605|FG001|Overall Study|Withdrawal by Subject|6|||
124869978|NCT01040260|449143604|FG000|Overall Study|Lost to Follow-up|3|||
124869979|NCT01040260|449143605|FG001|Overall Study|Lost to Follow-up|5|||
124869980|NCT04570436|449143606|FG000|Overall Study|Adverse Event|0|||
124869981|NCT04570436|449143607|FG001|Overall Study|Adverse Event|0|||
124869982|NCT04570436|449143608|FG002|Overall Study|Adverse Event|1|||
124869983|NCT04570436|449143609|FG003|Overall Study|Adverse Event|0|||
124869984|NCT04570436|449143610|FG004|Overall Study|Adverse Event|0|||
124869985|NCT04570436|449143611|FG005|Overall Study|Adverse Event|0|||
124869986|NCT04570436|449143612|FG006|Overall Study|Adverse Event|0|||
124869987|NCT04570436|449143613|FG007|Overall Study|Adverse Event|0|||
124869988|NCT04570436|449143614|FG008|Overall Study|Adverse Event|0|||
124536722|NCT04563845|447917750|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
124536723|NCT04563845|447917751|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
124536724|NCT04563845|447917752|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
124869989|NCT04570436|449143615|FG009|Overall Study|Adverse Event|0|||
124869990|NCT04570436|449143606|FG000|Overall Study|Physician Decision|1|||
124869991|NCT04570436|449143607|FG001|Overall Study|Physician Decision|0|||
124869992|NCT04570436|449143608|FG002|Overall Study|Physician Decision|0|||
124869993|NCT04570436|449143609|FG003|Overall Study|Physician Decision|0|||
124869994|NCT04570436|449143610|FG004|Overall Study|Physician Decision|0|||
124869995|NCT04570436|449143611|FG005|Overall Study|Physician Decision|0|||
124869996|NCT04570436|449143612|FG006|Overall Study|Physician Decision|0|||
124869997|NCT04570436|449143613|FG007|Overall Study|Physician Decision|0|||
124869998|NCT04570436|449143614|FG008|Overall Study|Physician Decision|0|||
124536725|NCT04563845|447917753|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
124869999|NCT04570436|449143615|FG009|Overall Study|Physician Decision|0|||
124870000|NCT00929162|449143617|FG000|Overall Study|Adverse Event|8|||
124870001|NCT00929162|449143618|FG001|Overall Study|Adverse Event|5|||
124870002|NCT00929162|449143617|FG000|Overall Study|Withdrawal by Subject|3|||
124870003|NCT00929162|449143618|FG001|Overall Study|Withdrawal by Subject|1|||
124870004|NCT00929162|449143617|FG000|Overall Study|Protocol Violation|32|||
124870005|NCT00929162|449143618|FG001|Overall Study|Protocol Violation|30|||
124870006|NCT00929162|449143617|FG000|Overall Study|Other termination reason|5|||
124870007|NCT00929162|449143618|FG001|Overall Study|Other termination reason|6|||
124870008|NCT01274182|449143620|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
124870009|NCT01274182|449143621|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
124870010|NCT01274182|449143622|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
124870011|NCT01274182|449143620|FG000|Overall Study|Adverse Event|4|||
124870012|NCT01274182|449143621|FG001|Overall Study|Adverse Event|5|||
124870013|NCT01274182|449143622|FG002|Overall Study|Adverse Event|3|||
124870014|NCT01274182|449143620|FG000|Overall Study|Withdrawal by Subject|5|||
124870015|NCT01274182|449143621|FG001|Overall Study|Withdrawal by Subject|5|||
124870016|NCT01274182|449143622|FG002|Overall Study|Withdrawal by Subject|3|||
124870017|NCT01274182|449143620|FG000|Overall Study|Lost to Follow-up|2|||
124870018|NCT01274182|449143621|FG001|Overall Study|Lost to Follow-up|3|||
124870019|NCT01274182|449143622|FG002|Overall Study|Lost to Follow-up|1|||
124870020|NCT01274182|449143620|FG000|Overall Study|Protocol Violation|3|||
124870021|NCT01274182|449143621|FG001|Overall Study|Protocol Violation|2|||
124870022|NCT01274182|449143622|FG002|Overall Study|Protocol Violation|0|||
124870023|NCT01274182|449143620|FG000|Overall Study|Death|1|||
124870024|NCT01274182|449143621|FG001|Overall Study|Death|0|||
124870025|NCT01274182|449143622|FG002|Overall Study|Death|1|||
124870026|NCT02355002|449143623|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
124870027|NCT02355002|449143624|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
124870028|NCT02355002|449143623|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
124870029|NCT02355002|449143624|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
124870030|NCT02355002|449143623|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
124870031|NCT02355002|449143624|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
124870032|NCT02355002|449143623|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
124870033|NCT02355002|449143624|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
124870034|NCT02355002|449143623|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
124870035|NCT02355002|449143624|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
124870036|NCT02355002|449143623|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
124870037|NCT02355002|449143624|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
124870038|NCT02355002|449143623|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
124870039|NCT02355002|449143624|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
124870040|NCT03205371|449143627|FG000|Overall Study|Withdrawal by Subject|4|||
124870041|NCT03205371|449143628|FG001|Overall Study|Withdrawal by Subject|1|||
124870042|NCT03205371|449143629|FG002|Overall Study|Withdrawal by Subject|0|||
124870043|NCT03205371|449143630|FG003|Overall Study|Withdrawal by Subject|0|||
124870044|NCT03205371|449143631|FG004|Overall Study|Withdrawal by Subject|0|||
124870045|NCT03205371|449143632|FG005|Overall Study|Withdrawal by Subject|0|||
124870046|NCT03205371|449143633|FG006|Overall Study|Withdrawal by Subject|4|||
124870047|NCT03205371|449143634|FG007|Overall Study|Withdrawal by Subject|0|||
124870048|NCT03205371|449143635|FG008|Overall Study|Withdrawal by Subject|2|||
124870049|NCT03205371|449143636|FG009|Overall Study|Withdrawal by Subject|0|||
124870050|NCT03205371|449143637|FG010|Overall Study|Withdrawal by Subject|0|||
124870051|NCT03205371|449143638|FG011|Overall Study|Withdrawal by Subject|1|||
124870052|NCT03205371|449143627|FG000|Overall Study|Lost to Follow-up|0|||
124870053|NCT03205371|449143628|FG001|Overall Study|Lost to Follow-up|0|||
124870054|NCT03205371|449143629|FG002|Overall Study|Lost to Follow-up|0|||
124870055|NCT03205371|449143630|FG003|Overall Study|Lost to Follow-up|0|||
124870056|NCT03205371|449143631|FG004|Overall Study|Lost to Follow-up|0|||
124870057|NCT03205371|449143632|FG005|Overall Study|Lost to Follow-up|0|||
124870058|NCT03205371|449143633|FG006|Overall Study|Lost to Follow-up|5|||
124870059|NCT03205371|449143634|FG007|Overall Study|Lost to Follow-up|2|||
124870060|NCT03205371|449143635|FG008|Overall Study|Lost to Follow-up|3|||
124870061|NCT03205371|449143636|FG009|Overall Study|Lost to Follow-up|0|||
124870062|NCT03205371|449143637|FG010|Overall Study|Lost to Follow-up|0|||
124870063|NCT03205371|449143638|FG011|Overall Study|Lost to Follow-up|0|||
124870064|NCT03205371|449143627|FG000|Overall Study|Protocol Violation|0|||
124870065|NCT03205371|449143628|FG001|Overall Study|Protocol Violation|0|||
124870066|NCT03205371|449143629|FG002|Overall Study|Protocol Violation|0|||
124870067|NCT03205371|449143630|FG003|Overall Study|Protocol Violation|0|||
124870068|NCT03205371|449143631|FG004|Overall Study|Protocol Violation|0|||
124870069|NCT03205371|449143632|FG005|Overall Study|Protocol Violation|0|||
124870070|NCT03205371|449143633|FG006|Overall Study|Protocol Violation|1|||
124870071|NCT03205371|449143634|FG007|Overall Study|Protocol Violation|0|||
124870072|NCT03205371|449143635|FG008|Overall Study|Protocol Violation|0|||
124870073|NCT03205371|449143636|FG009|Overall Study|Protocol Violation|0|||
124870074|NCT03205371|449143637|FG010|Overall Study|Protocol Violation|0|||
124870075|NCT03205371|449143638|FG011|Overall Study|Protocol Violation|0|||
124870076|NCT03205371|449143627|FG000|Overall Study|Adverse Event|0|||
124870077|NCT03205371|449143628|FG001|Overall Study|Adverse Event|0|||
124870078|NCT03205371|449143629|FG002|Overall Study|Adverse Event|0|||
124870079|NCT03205371|449143630|FG003|Overall Study|Adverse Event|0|||
124870080|NCT03205371|449143631|FG004|Overall Study|Adverse Event|0|||
124870081|NCT03205371|449143632|FG005|Overall Study|Adverse Event|0|||
124870082|NCT03205371|449143633|FG006|Overall Study|Adverse Event|0|||
124870083|NCT03205371|449143634|FG007|Overall Study|Adverse Event|1|||
124870084|NCT03205371|449143635|FG008|Overall Study|Adverse Event|0|||
124870085|NCT03205371|449143636|FG009|Overall Study|Adverse Event|0|||
124870086|NCT03205371|449143637|FG010|Overall Study|Adverse Event|0|||
124870087|NCT03205371|449143638|FG011|Overall Study|Adverse Event|0|||
124870088|NCT02835339|449143640|FG000|Overall Study|Did not receive allocated intervention|13|||
124870089|NCT02835339|449143641|FG001|Overall Study|Did not receive allocated intervention|16|||
124870090|NCT01077544|449143642|FG000|Overall Study|New Cancer Therapy|3|||
124870091|NCT01077544|449143643|FG001|Overall Study|New Cancer Therapy|3|||
124870092|NCT01077544|449143642|FG000|Overall Study|Adverse Event|0|||
124870093|NCT01077544|449143643|FG001|Overall Study|Adverse Event|1|||
124870094|NCT01077544|449143642|FG000|Overall Study|Disease Progression|0|||
124870095|NCT01077544|449143643|FG001|Overall Study|Disease Progression|1|||
124870096|NCT03923959|449143644|FG000|Overall Study|Death|16|||
124870097|NCT03923959|449143645|FG001|Overall Study|Death|12|||
124870098|NCT03923959|449143644|FG000|Overall Study|Lost to Follow-up|56|||
124870099|NCT03923959|449143645|FG001|Overall Study|Lost to Follow-up|56|||
124870100|NCT03923959|449143644|FG000|Overall Study|Withdrawal by Subject|1|||
124870101|NCT03923959|449143645|FG001|Overall Study|Withdrawal by Subject|1|||
124870102|NCT03923959|449143644|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
124870103|NCT03923959|449143645|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
124870104|NCT04918147|449143646|FG000|Overall Study|Disease flare as defined in protocol|0|||
124870105|NCT04918147|449143647|FG001|Overall Study|Disease flare as defined in protocol|2|||
124870106|NCT01375114|449143649|FG000|Overall Study|Lost to Follow-up|1|||
124870107|NCT01375114|449143650|FG001|Overall Study|Lost to Follow-up|0|||
124870108|NCT01375114|449143651|FG002|Overall Study|Lost to Follow-up|1|||
124870109|NCT01375114|449143649|FG000|Overall Study|Disease Progression|3|||
124870110|NCT01375114|449143650|FG001|Overall Study|Disease Progression|2|||
124870111|NCT01375114|449143651|FG002|Overall Study|Disease Progression|2|||
124870112|NCT01375114|449143649|FG000|Overall Study|Patient Changed Mind|0|||
124870113|NCT01375114|449143650|FG001|Overall Study|Patient Changed Mind|0|||
124870114|NCT01375114|449143651|FG002|Overall Study|Patient Changed Mind|2|||
124870115|NCT01375114|449143649|FG000|Overall Study|Pruritus|0|||
124870116|NCT01375114|449143650|FG001|Overall Study|Pruritus|0|||
124870117|NCT01375114|449143651|FG002|Overall Study|Pruritus|1|||
124870118|NCT01375114|449143649|FG000|Overall Study|Restlessness|0|||
124870119|NCT01375114|449143650|FG001|Overall Study|Restlessness|0|||
124870120|NCT01375114|449143651|FG002|Overall Study|Restlessness|1|||
124870121|NCT01375114|449143649|FG000|Overall Study|Diarrhea|0|||
124870122|NCT01375114|449143650|FG001|Overall Study|Diarrhea|0|||
124870123|NCT01375114|449143651|FG002|Overall Study|Diarrhea|1|||
124870124|NCT01375114|449143649|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
124870125|NCT01375114|449143650|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
124870126|NCT01375114|449143651|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
124870127|NCT01375114|449143649|FG000|Overall Study|Nausea|0|||
124870128|NCT01375114|449143650|FG001|Overall Study|Nausea|1|||
124870129|NCT01375114|449143651|FG002|Overall Study|Nausea|0|||
124870130|NCT01375114|449143649|FG000|Overall Study|Increased AST/ALT|0|||
124870131|NCT01375114|449143650|FG001|Overall Study|Increased AST/ALT|1|||
124870132|NCT01375114|449143651|FG002|Overall Study|Increased AST/ALT|0|||
124870133|NCT01375114|449143649|FG000|Overall Study|Vaginal Hemorrhage|0|||
124870134|NCT01375114|449143650|FG001|Overall Study|Vaginal Hemorrhage|1|||
124870135|NCT01375114|449143651|FG002|Overall Study|Vaginal Hemorrhage|0|||
124870136|NCT01375114|449143649|FG000|Overall Study|Family problem|0|||
124870137|NCT01375114|449143650|FG001|Overall Study|Family problem|1|||
124870138|NCT01375114|449143651|FG002|Overall Study|Family problem|0|||
124870139|NCT01375114|449143649|FG000|Overall Study|Protocol Violation|2|||
124870140|NCT01375114|449143650|FG001|Overall Study|Protocol Violation|0|||
124536726|NCT04563845|447917754|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
124536727|NCT04563845|447917755|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
124644692|NCT03614078|448316490|FG002|Overall Study|Adverse Event|0|||
124870141|NCT01375114|449143651|FG002|Overall Study|Protocol Violation|0|||
124870142|NCT03338829|449143652|FG000|Overall Study|Lost to Follow-up|4|||
124870143|NCT03338829|449143653|FG001|Overall Study|Lost to Follow-up|2|||
124870144|NCT03338829|449143654|FG002|Overall Study|Lost to Follow-up|4|||
124870145|NCT03338829|449143652|FG000|Overall Study|Pregnancy loss|1|||
124870146|NCT03338829|449143653|FG001|Overall Study|Pregnancy loss|1|||
124870147|NCT03338829|449143654|FG002|Overall Study|Pregnancy loss|0|||
124870148|NCT03338829|449143652|FG000|Overall Study|Protocol Violation|0|||
124870149|NCT03338829|449143653|FG001|Overall Study|Protocol Violation|1|||
124870150|NCT03338829|449143654|FG002|Overall Study|Protocol Violation|0|||
124870151|NCT03575325|449143658|FG000|Overall Study|Death|1|||
124870152|NCT02612311|449143659|FG000|Overall Study|Adverse Event|16|||
124870153|NCT02612311|449143660|FG001|Overall Study|Adverse Event|12|||
124870154|NCT02612311|449143661|FG002|Overall Study|Adverse Event|7|||
124870155|NCT02612311|449143662|FG003|Overall Study|Adverse Event|13|||
124870156|NCT02612311|449143659|FG000|Overall Study|Death|29|||
124870157|NCT02612311|449143660|FG001|Overall Study|Death|10|||
124870158|NCT02612311|449143661|FG002|Overall Study|Death|11|||
124870159|NCT02612311|449143662|FG003|Overall Study|Death|11|||
124870160|NCT02612311|449143659|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
124870161|NCT02612311|449143660|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
124870162|NCT02612311|449143661|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
124870163|NCT02612311|449143662|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
124870164|NCT02612311|449143659|FG000|Overall Study|Investigator's Decision|11|||
124870165|NCT02612311|449143660|FG001|Overall Study|Investigator's Decision|15|||
124870166|NCT02612311|449143661|FG002|Overall Study|Investigator's Decision|6|||
124870167|NCT02612311|449143662|FG003|Overall Study|Investigator's Decision|6|||
124870168|NCT02612311|449143659|FG000|Overall Study|Lack of Efficacy|0|||
124870169|NCT02612311|449143660|FG001|Overall Study|Lack of Efficacy|0|||
124870170|NCT02612311|449143661|FG002|Overall Study|Lack of Efficacy|1|||
124870171|NCT02612311|449143662|FG003|Overall Study|Lack of Efficacy|1|||
124870172|NCT02612311|449143659|FG000|Overall Study|Lost to Follow-up|2|||
124870173|NCT02612311|449143660|FG001|Overall Study|Lost to Follow-up|2|||
124870174|NCT02612311|449143661|FG002|Overall Study|Lost to Follow-up|1|||
124870175|NCT02612311|449143662|FG003|Overall Study|Lost to Follow-up|2|||
124870176|NCT02612311|449143659|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
124870177|NCT02612311|449143660|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
124870178|NCT02612311|449143661|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
124870179|NCT02612311|449143662|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
124870180|NCT02612311|449143659|FG000|Overall Study|Site Terminated by Sponsor|29|||
124870181|NCT02612311|449143660|FG001|Overall Study|Site Terminated by Sponsor|12|||
124870182|NCT02612311|449143661|FG002|Overall Study|Site Terminated by Sponsor|13|||
124870183|NCT02612311|449143662|FG003|Overall Study|Site Terminated by Sponsor|5|||
124870184|NCT02612311|449143659|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
124870185|NCT02612311|449143660|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
124870186|NCT02612311|449143661|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
124870187|NCT02612311|449143662|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
124870188|NCT02612311|449143659|FG000|Overall Study|Reason Not Specified|3|||
124870189|NCT02612311|449143660|FG001|Overall Study|Reason Not Specified|7|||
124870190|NCT02612311|449143661|FG002|Overall Study|Reason Not Specified|4|||
124870191|NCT02612311|449143662|FG003|Overall Study|Reason Not Specified|5|||
124870192|NCT02612311|449143659|FG000|Overall Study|Unknown/Missing|10|||
124870193|NCT02612311|449143660|FG001|Overall Study|Unknown/Missing|13|||
124870194|NCT02612311|449143661|FG002|Overall Study|Unknown/Missing|4|||
124870195|NCT02612311|449143662|FG003|Overall Study|Unknown/Missing|0|||
124870196|NCT02612311|449143659|FG000|Overall Study|Non-Compliance with Study|1|||
124870197|NCT02612311|449143660|FG001|Overall Study|Non-Compliance with Study|0|||
124870198|NCT02612311|449143661|FG002|Overall Study|Non-Compliance with Study|0|||
124870199|NCT02612311|449143662|FG003|Overall Study|Non-Compliance with Study|0|||
124870200|NCT00715429|449143663|FG000|Overall Study|Did not complete the study diary|0|||
124870201|NCT00715429|449143664|FG001|Overall Study|Did not complete the study diary|1|||
124870202|NCT04085328|449143665|FG000|Overall Study|Witihdrew Consent|16|||
124870203|NCT04085328|449143666|FG001|Overall Study|Witihdrew Consent|16|||
124870204|NCT04085328|449143665|FG000|Overall Study|Adverse Event|8|||
124870205|NCT04085328|449143666|FG001|Overall Study|Adverse Event|7|||
124870206|NCT04085328|449143665|FG000|Overall Study|Lost to Follow-up|7|||
124870207|NCT04085328|449143666|FG001|Overall Study|Lost to Follow-up|2|||
124870208|NCT04085328|449143665|FG000|Overall Study|Physician Decision|0|||
124870209|NCT04085328|449143666|FG001|Overall Study|Physician Decision|1|||
124870210|NCT04085328|449143665|FG000|Overall Study|Pregnancy|0|||
124870211|NCT04085328|449143666|FG001|Overall Study|Pregnancy|1|||
124870212|NCT04085328|449143665|FG000|Overall Study|Reasons Related to COVID-19|5|||
124870213|NCT04085328|449143666|FG001|Overall Study|Reasons Related to COVID-19|8|||
124870214|NCT04085328|449143665|FG000|Overall Study|Did not meet inclusion criteria|1|||
124870215|NCT04085328|449143666|FG001|Overall Study|Did not meet inclusion criteria|1|||
124870216|NCT04085328|449143665|FG000|Overall Study|Early termination|1|||
124870217|NCT04085328|449143666|FG001|Overall Study|Early termination|0|||
124870218|NCT00514735|449143667|FG000|Overall Study|Withdrawal by Subject|13|||
124870219|NCT00514735|449143668|FG001|Overall Study|Withdrawal by Subject|5|||
124870220|NCT00514735|449143667|FG000|Overall Study|Death|1|||
124870221|NCT00514735|449143668|FG001|Overall Study|Death|0|||
124870222|NCT00514735|449143667|FG000|Overall Study|Lost to Follow-up|0|||
124870223|NCT00514735|449143668|FG001|Overall Study|Lost to Follow-up|1|||
124870224|NCT04393441|449143669|FG000|Overall Study|Adverse Event|0|||
124870225|NCT04393441|449143670|FG001|Overall Study|Adverse Event|3|||
124870226|NCT04393441|449143669|FG000|Overall Study|Withdrawal by Subject|5|||
124870227|NCT04393441|449143670|FG001|Overall Study|Withdrawal by Subject|7|||
124870228|NCT04393441|449143669|FG000|Overall Study|Lost to Follow-up|0|||
124870229|NCT04393441|449143670|FG001|Overall Study|Lost to Follow-up|2|||
124870230|NCT04393441|449143669|FG000|Overall Study|Protocol Deviation|2|||
124870231|NCT04393441|449143670|FG001|Overall Study|Protocol Deviation|1|||
124870232|NCT04393441|449143669|FG000|Overall Study|Reason not Specified|1|||
124870233|NCT04393441|449143670|FG001|Overall Study|Reason not Specified|1|||
124870234|NCT00689221|449143671|FG000|Overall Study|Ongoing at cut-off date|39|||
124870235|NCT00689221|449143672|FG001|Overall Study|Ongoing at cut-off date|36|||
124870236|NCT01749982|449143673|FG000|Overall Study|Physician Decision|0|||
124870237|NCT01749982|449143674|FG001|Overall Study|Physician Decision|0|||
124870238|NCT01749982|449143675|FG002|Overall Study|Physician Decision|0|||
124870239|NCT01749982|449143676|FG003|Overall Study|Physician Decision|1|||
124870240|NCT01749982|449143673|FG000|Overall Study|Lost to Follow-up|0|||
124870241|NCT01749982|449143674|FG001|Overall Study|Lost to Follow-up|0|||
124870242|NCT01749982|449143675|FG002|Overall Study|Lost to Follow-up|0|||
124870243|NCT01749982|449143676|FG003|Overall Study|Lost to Follow-up|1|||
124870244|NCT01749982|449143673|FG000|Overall Study|Withdrawal by Subject|0|||
124870245|NCT01749982|449143674|FG001|Overall Study|Withdrawal by Subject|0|||
124870246|NCT01749982|449143675|FG002|Overall Study|Withdrawal by Subject|0|||
124870247|NCT01749982|449143676|FG003|Overall Study|Withdrawal by Subject|1|||
124870248|NCT01596582|449143678|FG000|Overall Study|Deemed ineligible after study visit|3|||
124870249|NCT01596582|449143679|FG001|Overall Study|Deemed ineligible after study visit|6|||
124870250|NCT01596582|449143678|FG000|Overall Study|Missing all outcome data|1|||
124870251|NCT01596582|449143679|FG001|Overall Study|Missing all outcome data|1|||
124870252|NCT04435665|449143680|FG000|Overall Study|Lost to Follow-up|0|||
124870253|NCT04435665|449143681|FG001|Overall Study|Lost to Follow-up|0|||
124870254|NCT04435665|449143682|FG002|Overall Study|Lost to Follow-up|0|||
124870255|NCT04435665|449143683|FG003|Overall Study|Lost to Follow-up|1|||
124870256|NCT03923933|449143684|FG000|Overall Study|Lost to Follow-up|1|||
124870257|NCT03923933|449143685|FG001|Overall Study|Lost to Follow-up|0|||
124870258|NCT03923933|449143684|FG000|Overall Study|Withdrawal by Subject|0|||
124870259|NCT03923933|449143685|FG001|Overall Study|Withdrawal by Subject|1|||
124870260|NCT02454101|449143686|FG000|Overall Study|Adverse Event|2|||
124870261|NCT02454101|449143687|FG001|Overall Study|Adverse Event|3|||
124870262|NCT02454101|449143686|FG000|Overall Study|Lost to Follow-up|3|||
124870263|NCT02454101|449143687|FG001|Overall Study|Lost to Follow-up|4|||
124870264|NCT00419263|449143688|FG000|Overall Study|Lost to Follow-up|2|||
124870265|NCT00419263|449143689|FG001|Overall Study|Lost to Follow-up|1|||
124870266|NCT00419263|449143690|FG002|Overall Study|Lost to Follow-up|1|||
124870267|NCT00419263|449143688|FG000|Overall Study|Randomized in Error, Not Treated|1|||
124870268|NCT00419263|449143689|FG001|Overall Study|Randomized in Error, Not Treated|1|||
124870269|NCT00419263|449143690|FG002|Overall Study|Randomized in Error, Not Treated|0|||
124870270|NCT00419263|449143688|FG000|Overall Study|Adverse Event|0|||
124870271|NCT00419263|449143689|FG001|Overall Study|Adverse Event|0|||
124870272|NCT00419263|449143690|FG002|Overall Study|Adverse Event|1|||
124870273|NCT00419263|449143688|FG000|Overall Study|Withdrawal by Subject|0|||
124870274|NCT00419263|449143689|FG001|Overall Study|Withdrawal by Subject|0|||
124870275|NCT00419263|449143690|FG002|Overall Study|Withdrawal by Subject|1|||
124870276|NCT03311373|449143691|FG000|Overall Study|Adverse Event|1|||
124870277|NCT03311373|449143691|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
124870278|NCT03311373|449143691|FG000|Overall Study|Lost to Follow-up|1|||
124870279|NCT03311373|449143691|FG000|Overall Study|Physician Decision|1|||
124870280|NCT03311373|449143691|FG000|Overall Study|Withdrawal by Subject|3|||
124870281|NCT01563536|449143698|FG000|Overall Study|Withdrawal by Subject|0|||
124870282|NCT01563536|449143699|FG001|Overall Study|Withdrawal by Subject|2|||
124870283|NCT01563536|449143698|FG000|Overall Study|Lost to Follow-up|1|||
124870284|NCT01563536|449143699|FG001|Overall Study|Lost to Follow-up|0|||
124870285|NCT00538590|449143705|FG000|Overall Study|Death|1|||
124870286|NCT00538590|449143706|FG001|Overall Study|Death|0|||
124870287|NCT01256567|449143707|FG000|Overall Study|Withdrawal by Subject|1|||
124870288|NCT00686881|449143722|FG000|Overall Study|Withdrawal by Subject|11|||
124870289|NCT00686881|449143723|FG001|Overall Study|Withdrawal by Subject|18|||
124870290|NCT00686881|449143722|FG000|Overall Study|Lost to Follow-up|0|||
124870291|NCT00686881|449143723|FG001|Overall Study|Lost to Follow-up|1|||
124870292|NCT00686881|449143722|FG000|Overall Study|Treatment-related adverse event|10|||
124870293|NCT00686881|449143723|FG001|Overall Study|Treatment-related adverse event|9|||
124870294|NCT00686881|449143722|FG000|Overall Study|Met discontinuation criteria|5|||
124870295|NCT00686881|449143723|FG001|Overall Study|Met discontinuation criteria|0|||
124870296|NCT00686881|449143722|FG000|Overall Study|Onset of malignant tumor|11|||
124870297|NCT00686881|449143723|FG001|Overall Study|Onset of malignant tumor|11|||
124870298|NCT00686881|449143722|FG000|Overall Study|Lack of Efficacy|4|||
124870299|NCT00686881|449143723|FG001|Overall Study|Lack of Efficacy|3|||
124870300|NCT00686881|449143722|FG000|Overall Study|Physician Decision|1|||
124870301|NCT00686881|449143723|FG001|Overall Study|Physician Decision|0|||
124870302|NCT00686881|449143722|FG000|Overall Study|Circumstances of site|1|||
124870303|NCT00686881|449143723|FG001|Overall Study|Circumstances of site|1|||
124870304|NCT00686881|449143722|FG000|Overall Study|Did not meet protocol eligibility|1|||
124870305|NCT00686881|449143723|FG001|Overall Study|Did not meet protocol eligibility|0|||
124870306|NCT00686881|449143722|FG000|Overall Study|Irregular visits|1|||
124870307|NCT00686881|449143723|FG001|Overall Study|Irregular visits|0|||
124870308|NCT00686881|449143722|FG000|Overall Study|Study discontinuation|35|||
124870309|NCT00686881|449143723|FG001|Overall Study|Study discontinuation|32|||
124870310|NCT00686881|449143722|FG000|Overall Study|Never received study drug|2|||
124870311|NCT00686881|449143723|FG001|Overall Study|Never received study drug|6|||
124870312|NCT00671931|449143724|FG000|Overall Study|Physician Decision|1|||
124870313|NCT00671931|449143725|FG001|Overall Study|Physician Decision|0|||
124870314|NCT00671931|449143726|FG002|Overall Study|Physician Decision|0|||
124870315|NCT00671931|449143727|FG003|Overall Study|Physician Decision|2|||
124870316|NCT00671931|449143728|FG004|Overall Study|Physician Decision|1|||
124870317|NCT03260868|449143732|FG000|Overall Study|Poor Compliance to Protocol|0|||
124870318|NCT03260868|449143733|FG001|Overall Study|Poor Compliance to Protocol|2|||
124870319|NCT03260868|449143732|FG000|Overall Study|Study Terminated By Sponsor|2|||
124870320|NCT03260868|449143733|FG001|Overall Study|Study Terminated By Sponsor|1|||
124870321|NCT03260868|449143732|FG000|Overall Study|Other than specified above|1|||
124870322|NCT03260868|449143733|FG001|Overall Study|Other than specified above|0|||
124870323|NCT01298999|449143734|FG000|Overall Study|Physician Decision|0|||
124870324|NCT01298999|449143735|FG001|Overall Study|Physician Decision|1|||
124870325|NCT01298999|449143734|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
124870326|NCT01298999|449143735|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
124870327|NCT00541450|449143736|FG000|Phase A|Adverse Event|3|||
124870328|NCT00541450|449143737|FG001|Phase A|Adverse Event|0|||
124870329|NCT00541450|449143736|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
124870330|NCT00541450|449143737|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
124870331|NCT00541450|449143736|FG000|Phase A|Hyperglycemia|0|||
124870332|NCT00541450|449143737|FG001|Phase A|Hyperglycemia|1|||
124870333|NCT00541450|449143736|FG000|Phase A|Lost to Follow-up|6|||
124870334|NCT00541450|449143737|FG001|Phase A|Lost to Follow-up|4|||
124870335|NCT00541450|449143736|FG000|Phase A|Physician Decision|2|||
124870336|NCT00541450|449143737|FG001|Phase A|Physician Decision|0|||
124870337|NCT00541450|449143736|FG000|Phase A|Protocol Violation|2|||
124870338|NCT00541450|449143737|FG001|Phase A|Protocol Violation|3|||
124870339|NCT00541450|449143736|FG000|Phase A|Withdrawal by Subject|7|||
124870340|NCT00541450|449143737|FG001|Phase A|Withdrawal by Subject|7|||
124870341|NCT00541450|449143736|FG000|Phase B|Adverse Event|6|||
124870342|NCT00541450|449143737|FG001|Phase B|Adverse Event|6|||
124870343|NCT00541450|449143736|FG000|Phase B|Hyperglycemia|10|||
124870344|NCT00541450|449143737|FG001|Phase B|Hyperglycemia|9|||
124870345|NCT00541450|449143736|FG000|Phase B|Lost to Follow-up|6|||
124870346|NCT00541450|449143737|FG001|Phase B|Lost to Follow-up|4|||
124870347|NCT00541450|449143736|FG000|Phase B|Physician Decision|4|||
124870348|NCT00541450|449143737|FG001|Phase B|Physician Decision|2|||
124870349|NCT00541450|449143736|FG000|Phase B|Pregnancy|0|||
124870350|NCT00541450|449143737|FG001|Phase B|Pregnancy|1|||
124870351|NCT00541450|449143736|FG000|Phase B|Protocol Violation|3|||
124870352|NCT00541450|449143737|FG001|Phase B|Protocol Violation|3|||
124870353|NCT00541450|449143736|FG000|Phase B|Withdrawal by Subject|8|||
124870354|NCT00541450|449143737|FG001|Phase B|Withdrawal by Subject|6|||
124870355|NCT00803452|449143738|FG000|Overall Study|Adverse Event|0|||
124870356|NCT00803452|449143739|FG001|Overall Study|Adverse Event|2|||
124870357|NCT00803452|449143738|FG000|Overall Study|Lost to Follow-up|0|||
124870358|NCT00803452|449143739|FG001|Overall Study|Lost to Follow-up|3|||
124870359|NCT04839965|449143740|FG000|Overall Study|Death|6|||
124870360|NCT04839965|449143741|FG001|Overall Study|Death|6|||
124870361|NCT04839965|449143740|FG000|Overall Study|Lost to Follow-up|1|||
124870362|NCT04839965|449143741|FG001|Overall Study|Lost to Follow-up|0|||
124870363|NCT02816138|449143742|FG000|Overall Study|Adverse Event|1|||
124870364|NCT00981084|449143743|FG000|Post Intervention (Data Analysis)|poor effort|1|||
124870365|NCT00981084|449143744|FG001|Post Intervention (Data Analysis)|poor effort|1|||
124870366|NCT00981084|449143743|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
124870367|NCT00981084|449143744|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
124870368|NCT00289887|449145459|FG000|Overall Study|Adverse Event|3|||
124870369|NCT00289887|449145460|FG001|Overall Study|Adverse Event|3|||
124870370|NCT00289887|449145459|FG000|Overall Study|Lack of Efficacy|3|||
124870371|NCT00289887|449145460|FG001|Overall Study|Lack of Efficacy|11|||
124870372|NCT00289887|449145459|FG000|Overall Study|Lost to Follow-up|3|||
124870373|NCT00289887|449145460|FG001|Overall Study|Lost to Follow-up|3|||
124870374|NCT00289887|449145459|FG000|Overall Study|Protocol Violation|3|||
124870375|NCT00289887|449145460|FG001|Overall Study|Protocol Violation|1|||
124870376|NCT00289887|449145459|FG000|Overall Study|Withdrawal by Subject|3|||
124870377|NCT00289887|449145460|FG001|Overall Study|Withdrawal by Subject|8|||
124870378|NCT00289887|449145459|FG000|Overall Study|Other|7|||
124870379|NCT00289887|449145460|FG001|Overall Study|Other|3|||
124870380|NCT01266850|449145461|FG000|Overall Study|Lost to Follow-up|19|||
124870381|NCT01266850|449145462|FG001|Overall Study|Lost to Follow-up|19|||
124870382|NCT01266850|449145463|FG002|Overall Study|Lost to Follow-up|13|||
124870383|NCT01266850|449145464|FG003|Overall Study|Lost to Follow-up|13|||
124870384|NCT01266850|449145465|FG004|Overall Study|Lost to Follow-up|12|||
124870385|NCT01266850|449145461|FG000|Overall Study|Withdrawal by Subject|8|||
124870386|NCT01266850|449145462|FG001|Overall Study|Withdrawal by Subject|9|||
124870387|NCT01266850|449145463|FG002|Overall Study|Withdrawal by Subject|6|||
124870388|NCT01266850|449145464|FG003|Overall Study|Withdrawal by Subject|9|||
124870389|NCT01266850|449145465|FG004|Overall Study|Withdrawal by Subject|12|||
124870390|NCT01266850|449145461|FG000|Overall Study|Physician Decision|3|||
124870391|NCT01266850|449145462|FG001|Overall Study|Physician Decision|6|||
124870392|NCT01266850|449145463|FG002|Overall Study|Physician Decision|4|||
124870393|NCT01266850|449145464|FG003|Overall Study|Physician Decision|4|||
124870394|NCT01266850|449145465|FG004|Overall Study|Physician Decision|3|||
124870395|NCT01266850|449145461|FG000|Overall Study|Protocol Violation|0|||
124870396|NCT01266850|449145462|FG001|Overall Study|Protocol Violation|1|||
124870397|NCT01266850|449145463|FG002|Overall Study|Protocol Violation|0|||
124870398|NCT01266850|449145464|FG003|Overall Study|Protocol Violation|1|||
124870399|NCT01266850|449145465|FG004|Overall Study|Protocol Violation|2|||
124870400|NCT01266850|449145461|FG000|Overall Study|Adverse Event|0|||
124870401|NCT01266850|449145462|FG001|Overall Study|Adverse Event|0|||
124870402|NCT01266850|449145463|FG002|Overall Study|Adverse Event|0|||
124870403|NCT01266850|449145464|FG003|Overall Study|Adverse Event|0|||
124870404|NCT01266850|449145465|FG004|Overall Study|Adverse Event|1|||
124870405|NCT01266850|449145461|FG000|Overall Study|Site Closure|0|||
124870406|NCT01266850|449145462|FG001|Overall Study|Site Closure|1|||
124870407|NCT01266850|449145463|FG002|Overall Study|Site Closure|1|||
124870408|NCT01266850|449145464|FG003|Overall Study|Site Closure|1|||
124870409|NCT01266850|449145465|FG004|Overall Study|Site Closure|0|||
124870410|NCT04128293|449145469|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
124870411|NCT04128293|449145470|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
124870412|NCT04128293|449145471|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
124870413|NCT04128293|449145472|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
124870414|NCT00437645|449145473|FG000|Overall Study|Adverse Event|15|||
124870415|NCT00437645|449145474|FG001|Overall Study|Adverse Event|84|||
124870416|NCT00437645|449145473|FG000|Overall Study|Withdrawal by Subject|10|||
124870417|NCT00437645|449145474|FG001|Overall Study|Withdrawal by Subject|22|||
124870418|NCT00437645|449145473|FG000|Overall Study|Protocol Violation|3|||
124870419|NCT00437645|449145474|FG001|Overall Study|Protocol Violation|3|||
124870420|NCT00437645|449145473|FG000|Overall Study|Lost to Follow-up|2|||
124870421|NCT00437645|449145474|FG001|Overall Study|Lost to Follow-up|3|||
124870422|NCT00437645|449145473|FG000|Overall Study|Administrative problems|2|||
124870423|NCT00437645|449145474|FG001|Overall Study|Administrative problems|1|||
124870424|NCT00437645|449145473|FG000|Overall Study|Lack of Efficacy|2|||
124870425|NCT00437645|449145474|FG001|Overall Study|Lack of Efficacy|1|||
124870426|NCT00437645|449145473|FG000|Overall Study|Condition no longer requires study drug|1|||
124870427|NCT00437645|449145474|FG001|Overall Study|Condition no longer requires study drug|1|||
124870428|NCT03597568|449145475|FG000|Overall Study|Withdrawal by Subject|1|||
124870429|NCT03597568|449145476|FG001|Overall Study|Withdrawal by Subject|1|||
124870430|NCT03597568|449145475|FG000|Overall Study|Unable to analyze vascular data|1|||
124870431|NCT03597568|449145476|FG001|Overall Study|Unable to analyze vascular data|1|||
124870432|NCT03382782|449145477|FG000|Cohort 1|Withdrawal by Subject|11|||
124870433|NCT03382782|449145478|FG001|Cohort 1|Withdrawal by Subject|5|||
124870434|NCT03382782|449145479|FG002|Cohort 1|Withdrawal by Subject|0|||
124870435|NCT03382782|449145477|FG000|Cohort 2|Withdrawal by Subject|1|||
124870436|NCT03382782|449145478|FG001|Cohort 2|Withdrawal by Subject|1|||
124870437|NCT03382782|449145479|FG002|Cohort 2|Withdrawal by Subject|0|||
124870438|NCT03382782|449145477|FG000|Cohort 3|Withdrawal by Subject|1|||
124870439|NCT03382782|449145478|FG001|Cohort 3|Withdrawal by Subject|2|||
124870440|NCT03382782|449145479|FG002|Cohort 3|Withdrawal by Subject|0|||
124870441|NCT00337272|449145484|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
124870442|NCT00337272|449145485|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
124870443|NCT00337272|449145484|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
124870444|NCT00337272|449145485|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
124870445|NCT00337272|449145484|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
124870446|NCT00337272|449145485|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
124870447|NCT00337272|449145484|FG000|Treatment Period|Non-compliance|1|||
124870448|NCT00337272|449145485|FG001|Treatment Period|Non-compliance|1|||
124870449|NCT00337272|449145484|FG000|Treatment Period|Withdrawal by Subject|0|||
124536728|NCT04563845|447917756|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
124870450|NCT00337272|449145485|FG001|Treatment Period|Withdrawal by Subject|1|||
124536729|NCT04563845|447917757|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
124870451|NCT00337272|449145484|FG000|Withdrawal Period|Non-compliance|0|||
124870452|NCT00337272|449145485|FG001|Withdrawal Period|Non-compliance|1|||
124870453|NCT01699022|449145488|FG000|Overall Study|Early discontinuation from the study|3|||
124870454|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
124870455|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
124978556|NCT03829501|449548505|FG017|Overall Study|Death|1|||
124536730|NCT02146274|447917758|FG000|Overall Study|Protocol Violation|73|||
124870456|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
124870457|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
124870458|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
124870459|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
124870460|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
124870461|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
124870462|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Other|18|||
124870463|NCT02565914|449145493|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
124870464|NCT02565914|449145493|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
124870465|NCT02565914|449145493|FG000|Part B (Up to 96 Weeks)|Other|1|||
124870466|NCT02565914|449145493|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
124870467|NCT02565914|449145493|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
124870468|NCT02565914|449145493|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
124870469|NCT02565914|449145493|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
124870470|NCT02565914|449145493|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
124870471|NCT02565914|449145493|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
124870472|NCT02565914|449145493|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
124870473|NCT02565914|449145493|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
124870474|NCT02565914|449145493|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
124870475|NCT02565914|449145493|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
124870476|NCT02565914|449145493|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
124870477|NCT02565914|449145493|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
124870478|NCT01197508|449145502|FG000|Overall Study|Withdrawal by Subject|8|||
124870479|NCT01197508|449145503|FG001|Overall Study|Withdrawal by Subject|7|||
124870480|NCT01197508|449145504|FG002|Overall Study|Withdrawal by Subject|15|||
124870481|NCT01197508|449145505|FG003|Overall Study|Withdrawal by Subject|4|||
124870482|NCT01197508|449145502|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
124870483|NCT01197508|449145503|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
124870484|NCT01197508|449145504|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
124870485|NCT01197508|449145505|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
124870486|NCT01197508|449145502|FG000|Overall Study|Adverse Event|10|||
124870487|NCT01197508|449145503|FG001|Overall Study|Adverse Event|13|||
124870488|NCT01197508|449145504|FG002|Overall Study|Adverse Event|23|||
124870489|NCT01197508|449145505|FG003|Overall Study|Adverse Event|3|||
124870490|NCT01197508|449145502|FG000|Overall Study|Severe non-compliance to protocol|0|||
124870491|NCT01197508|449145503|FG001|Overall Study|Severe non-compliance to protocol|3|||
124870492|NCT01197508|449145504|FG002|Overall Study|Severe non-compliance to protocol|1|||
124870493|NCT01197508|449145505|FG003|Overall Study|Severe non-compliance to protocol|3|||
124870494|NCT01197508|449145502|FG000|Overall Study|Condition under investigation worsened|1|||
124870495|NCT01197508|449145503|FG001|Overall Study|Condition under investigation worsened|1|||
124870496|NCT01197508|449145504|FG002|Overall Study|Condition under investigation worsened|1|||
124870497|NCT01197508|449145505|FG003|Overall Study|Condition under investigation worsened|1|||
124870498|NCT01197508|449145502|FG000|Overall Study|Lack of Efficacy|1|||
124870499|NCT01197508|449145503|FG001|Overall Study|Lack of Efficacy|2|||
124870500|NCT01197508|449145504|FG002|Overall Study|Lack of Efficacy|2|||
124870501|NCT01197508|449145505|FG003|Overall Study|Lack of Efficacy|1|||
124870502|NCT01197508|449145502|FG000|Overall Study|Study-specific withdrawal criteria|0|||
124870503|NCT01197508|449145503|FG001|Overall Study|Study-specific withdrawal criteria|0|||
124870504|NCT01197508|449145504|FG002|Overall Study|Study-specific withdrawal criteria|1|||
124870505|NCT01197508|449145505|FG003|Overall Study|Study-specific withdrawal criteria|2|||
124870506|NCT01197508|449145502|FG000|Overall Study|Lost to Follow-up|1|||
124870507|NCT01197508|449145503|FG001|Overall Study|Lost to Follow-up|1|||
124870508|NCT01197508|449145504|FG002|Overall Study|Lost to Follow-up|2|||
124870509|NCT01197508|449145505|FG003|Overall Study|Lost to Follow-up|0|||
124870510|NCT01197508|449145502|FG000|Overall Study|Other|2|||
124870511|NCT01197508|449145503|FG001|Overall Study|Other|3|||
124870512|NCT01197508|449145504|FG002|Overall Study|Other|2|||
124870513|NCT01197508|449145505|FG003|Overall Study|Other|2|||
124870514|NCT01301391|449145506|FG000|Overall Study|Death|13|||
124870515|NCT01301391|449145506|FG000|Overall Study|Lost to Follow-up|3|||
124870516|NCT01301391|449145506|FG000|Overall Study|Physician Decision|2|||
124870517|NCT01301391|449145506|FG000|Overall Study|Sponsor's decision|8|||
124870518|NCT02799784|449145509|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
124870519|NCT02799784|449145510|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
124870520|NCT02799784|449145509|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
124870521|NCT02799784|449145510|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
124870522|NCT02799784|449145509|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
124870523|NCT02799784|449145510|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
124870524|NCT02799784|449145509|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
124870525|NCT02799784|449145510|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
124536731|NCT02719028|447917765|FG000|Overall Study|Adverse Event|2|||
124536732|NCT02719028|447917766|FG001|Overall Study|Adverse Event|1|||
124536733|NCT02719028|447917767|FG002|Overall Study|Adverse Event|4|||
124536734|NCT02719028|447917768|FG003|Overall Study|Adverse Event|8|||
124536735|NCT02719028|447917765|FG000|Overall Study|Physician Decision|0|||
124536736|NCT02719028|447917766|FG001|Overall Study|Physician Decision|1|||
124536737|NCT02719028|447917767|FG002|Overall Study|Physician Decision|1|||
124536738|NCT02719028|447917768|FG003|Overall Study|Physician Decision|1|||
124536739|NCT02719028|447917765|FG000|Overall Study|Use of prohibited medication|0|||
124536740|NCT02719028|447917766|FG001|Overall Study|Use of prohibited medication|0|||
124536741|NCT02719028|447917767|FG002|Overall Study|Use of prohibited medication|1|||
124536742|NCT02719028|447917768|FG003|Overall Study|Use of prohibited medication|0|||
124536743|NCT02719028|447917765|FG000|Overall Study|Protocol Violation|0|||
124536744|NCT02719028|447917766|FG001|Overall Study|Protocol Violation|0|||
124536745|NCT02719028|447917767|FG002|Overall Study|Protocol Violation|0|||
124536746|NCT02719028|447917768|FG003|Overall Study|Protocol Violation|1|||
124536747|NCT01539720|447917769|FG000|Overall Study|Screen Fail|15|||
124536748|NCT01539720|447917770|FG001|Overall Study|Screen Fail|3|||
124536749|NCT01539720|447917769|FG000|Overall Study|Lost to Follow-up|14|||
124536750|NCT01539720|447917770|FG001|Overall Study|Lost to Follow-up|7|||
124536751|NCT03287960|447917771|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
124536752|NCT03287960|447917771|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
124536753|NCT03730987|447917772|FG000|Overall Study|Lost to Follow-up|2|||
124536754|NCT03730987|447917773|FG001|Overall Study|Lost to Follow-up|0|||
124536755|NCT03730987|447917774|FG002|Overall Study|Lost to Follow-up|2|||
124536756|NCT03730987|447917775|FG003|Overall Study|Lost to Follow-up|0|||
124536757|NCT03938857|447917780|FG000|Overall Study|Physician Decision|1|||
124536758|NCT03938857|447917781|FG001|Overall Study|Physician Decision|0|||
124536759|NCT03938857|447917782|FG002|Overall Study|Physician Decision|0|||
124536760|NCT03938857|447917783|FG003|Overall Study|Physician Decision|0|||
124536761|NCT02516605|447917784|FG000|Overall Study|Protocol Violation|0|||
124536762|NCT02516605|447917785|FG001|Overall Study|Protocol Violation|0|||
124536763|NCT02516605|447917786|FG002|Overall Study|Protocol Violation|0|||
124536764|NCT02516605|447917787|FG003|Overall Study|Protocol Violation|0|||
124536765|NCT02516605|447917788|FG004|Overall Study|Protocol Violation|1|||
124536766|NCT02516605|447917784|FG000|Overall Study|Withdrawal by Subject|0|||
124536767|NCT02516605|447917785|FG001|Overall Study|Withdrawal by Subject|0|||
124536768|NCT02516605|447917786|FG002|Overall Study|Withdrawal by Subject|0|||
124536769|NCT02516605|447917787|FG003|Overall Study|Withdrawal by Subject|1|||
124536770|NCT02516605|447917788|FG004|Overall Study|Withdrawal by Subject|0|||
124536771|NCT02577107|447917789|FG000|Overall Study|Protocol deviation|0|||
124536772|NCT02577107|447917790|FG001|Overall Study|Protocol deviation|1|||
124536773|NCT00577382|447917791|FG000|Overall Study|Adverse Event|0|||
124536774|NCT00577382|447917792|FG001|Overall Study|Adverse Event|6|||
124536775|NCT00577382|447917791|FG000|Overall Study|Withdrawal by Subject|0|||
124536776|NCT00577382|447917792|FG001|Overall Study|Withdrawal by Subject|1|||
124536777|NCT00577382|447917791|FG000|Overall Study|Progressive Disease|17|||
124536778|NCT00577382|447917792|FG001|Overall Study|Progressive Disease|19|||
124536779|NCT00577382|447917791|FG000|Overall Study|Intercurrent Illness|1|||
124536780|NCT00577382|447917792|FG001|Overall Study|Intercurrent Illness|2|||
124536781|NCT00577382|447917791|FG000|Overall Study|Death|1|||
124536782|NCT00577382|447917792|FG001|Overall Study|Death|1|||
124536783|NCT00577382|447917791|FG000|Overall Study|Lost to Follow-up|2|||
124536784|NCT00577382|447917792|FG001|Overall Study|Lost to Follow-up|2|||
124536785|NCT02839330|447917793|FG000|Overall Study|Adverse Event|0|||
124536786|NCT02839330|447917794|FG001|Overall Study|Adverse Event|1|||
124536787|NCT02839330|447917795|FG002|Overall Study|Adverse Event|2|||
124536788|NCT02839330|447917796|FG003|Overall Study|Adverse Event|2|||
124536789|NCT02839330|447917793|FG000|Overall Study|Death|4|||
124536790|NCT02839330|447917794|FG001|Overall Study|Death|6|||
124536791|NCT02839330|447917795|FG002|Overall Study|Death|1|||
124536792|NCT02839330|447917796|FG003|Overall Study|Death|1|||
124536793|NCT02839330|447917793|FG000|Overall Study|Withdrawal by Subject|27|||
124536794|NCT02839330|447917794|FG001|Overall Study|Withdrawal by Subject|19|||
124536795|NCT02839330|447917795|FG002|Overall Study|Withdrawal by Subject|11|||
124536796|NCT02839330|447917796|FG003|Overall Study|Withdrawal by Subject|13|||
124536797|NCT02839330|447917793|FG000|Overall Study|Lost to Follow-up|22|||
124536798|NCT02839330|447917794|FG001|Overall Study|Lost to Follow-up|27|||
124536799|NCT02839330|447917795|FG002|Overall Study|Lost to Follow-up|29|||
124536800|NCT02839330|447917796|FG003|Overall Study|Lost to Follow-up|25|||
124536801|NCT02839330|447917793|FG000|Overall Study|Administrative Reason|0|||
124536802|NCT02839330|447917794|FG001|Overall Study|Administrative Reason|0|||
124536803|NCT02839330|447917795|FG002|Overall Study|Administrative Reason|0|||
124536804|NCT02839330|447917796|FG003|Overall Study|Administrative Reason|1|||
124536805|NCT02839330|447917793|FG000|Overall Study|Protocol Violation|1|||
124536806|NCT02839330|447917794|FG001|Overall Study|Protocol Violation|2|||
124536807|NCT02839330|447917795|FG002|Overall Study|Protocol Violation|2|||
124536808|NCT02839330|447917796|FG003|Overall Study|Protocol Violation|3|||
124536809|NCT02839330|447917793|FG000|Overall Study|Other reason, not specified|4|||
124536810|NCT02839330|447917794|FG001|Overall Study|Other reason, not specified|3|||
124870526|NCT02799784|449145509|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
124870527|NCT02799784|449145510|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
124870528|NCT02799784|449145509|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
124870529|NCT02799784|449145510|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
124870530|NCT01949870|449145513|FG000|Overall Study|Lack of Efficacy|2|||
124870531|NCT01949870|449145513|FG000|Overall Study|Adverse Event|1|||
124870532|NCT01949870|449145513|FG000|Overall Study|Study termination|1|||
124870533|NCT01949870|449145513|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
124870534|NCT02570126|449145514|FG000|Overall Study|Lost to Follow-up|2|||
124870535|NCT02570126|449145515|FG001|Overall Study|Lost to Follow-up|0|||
124870536|NCT02570126|449145514|FG000|Overall Study|Unable To Arrange Visit 3|1|||
124870537|NCT02570126|449145515|FG001|Overall Study|Unable To Arrange Visit 3|0|||
124870538|NCT02570126|449145514|FG000|Overall Study|Violation Of Procedures GSK|0|||
124870539|NCT02570126|449145515|FG001|Overall Study|Violation Of Procedures GSK|1|||
124870540|NCT02570126|449145514|FG000|Overall Study|Protocol Violation|0|||
124870541|NCT02570126|449145515|FG001|Overall Study|Protocol Violation|1|||
124870542|NCT02570126|449145514|FG000|Overall Study|Withdrawal by Subject|3|||
124870543|NCT02570126|449145515|FG001|Overall Study|Withdrawal by Subject|7|||
124870544|NCT00917579|449145516|FG000|Washout >= 2 Weeks|Adverse Event|1|||
124870545|NCT00917579|449145517|FG001|Washout >= 2 Weeks|Adverse Event|0|||
124870546|NCT00917579|449145516|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
124870547|NCT00917579|449145517|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
124870548|NCT00754338|449145518|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
124870549|NCT00754338|449145519|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
124870550|NCT00754338|449145520|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
124870551|NCT00754338|449145521|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
124870552|NCT00754338|449145518|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
124870553|NCT00754338|449145519|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
124870554|NCT00754338|449145520|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
124870555|NCT00754338|449145521|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
124870556|NCT04683926|449145522|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
124870557|NCT04683926|449145523|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
124870558|NCT04683926|449145524|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
124870559|NCT04683926|449145525|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
124870560|NCT04385368|449145527|FG000|Overall Study|Death|5|||
124870561|NCT04385368|449145528|FG001|Overall Study|Death|5|||
124870562|NCT04385368|449145527|FG000|Overall Study|Physician Decision|3|||
124870563|NCT04385368|449145528|FG001|Overall Study|Physician Decision|0|||
124870564|NCT04385368|449145527|FG000|Overall Study|Withdrawal by Subject|4|||
124870565|NCT04385368|449145528|FG001|Overall Study|Withdrawal by Subject|3|||
124870566|NCT02740049|449145529|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
124870567|NCT01256411|449145530|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
124870568|NCT01256411|449145531|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
124870569|NCT01256411|449145532|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
124870570|NCT01256411|449145533|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
124870571|NCT01256411|449145534|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
124870572|NCT01256411|449145535|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
124870573|NCT01256411|449145530|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
124870574|NCT01256411|449145531|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
124870575|NCT01256411|449145532|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
124870576|NCT01256411|449145533|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
124870577|NCT01256411|449145534|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
124870578|NCT01256411|449145535|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
124870579|NCT01256411|449145530|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
124870580|NCT01256411|449145531|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
124870581|NCT01256411|449145532|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
124870582|NCT01256411|449145533|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
124870583|NCT01256411|449145534|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
124870584|NCT01256411|449145535|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
124870585|NCT01256411|449145530|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
124870586|NCT01256411|449145531|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
124870587|NCT01256411|449145532|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
124870588|NCT01256411|449145533|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
124870589|NCT01256411|449145534|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
124870590|NCT01256411|449145535|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
124870591|NCT01256411|449145530|FG000|Extension by Maximum Treatment|Adverse Event|4|||
124870592|NCT01256411|449145531|FG001|Extension by Maximum Treatment|Adverse Event|2|||
124870593|NCT01256411|449145532|FG002|Extension by Maximum Treatment|Adverse Event|1|||
124870594|NCT01256411|449145533|FG003|Extension by Maximum Treatment|Adverse Event|0|||
124536811|NCT02839330|447917795|FG002|Overall Study|Other reason, not specified|3|||
124536812|NCT02839330|447917796|FG003|Overall Study|Other reason, not specified|6|||
124870595|NCT01256411|449145534|FG004|Extension by Maximum Treatment|Adverse Event|0|||
124870596|NCT01256411|449145535|FG005|Extension by Maximum Treatment|Adverse Event|0|||
124870597|NCT01256411|449145530|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
124870598|NCT01256411|449145531|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
124870599|NCT01256411|449145532|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
124870600|NCT01256411|449145533|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
124870601|NCT01256411|449145534|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
124870602|NCT01256411|449145535|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
124870603|NCT01256411|449145530|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
124870604|NCT01256411|449145531|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
124870605|NCT01256411|449145532|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
124870606|NCT01256411|449145533|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
124870607|NCT01256411|449145534|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
124870608|NCT01256411|449145535|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
124870609|NCT01256411|449145530|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
124870610|NCT01256411|449145531|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
124870611|NCT01256411|449145532|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
124870612|NCT01256411|449145533|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
124870613|NCT01256411|449145534|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
124870614|NCT01256411|449145535|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
124870615|NCT01256411|449145530|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
124870616|NCT01256411|449145531|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
124870617|NCT01256411|449145532|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
124870618|NCT01256411|449145533|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
124870619|NCT01256411|449145534|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
124870620|NCT01256411|449145535|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
124870621|NCT01256411|449145530|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
124870622|NCT01256411|449145531|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
124870623|NCT01256411|449145532|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
124870624|NCT01256411|449145533|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
124870625|NCT01256411|449145534|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
124870626|NCT01256411|449145535|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
124870627|NCT02123108|449145536|FG000|Overall Study|Death|2|||
124870628|NCT02123108|449145537|FG001|Overall Study|Death|3|||
124870629|NCT04721925|449145538|FG000|2-Month Assessment|Lost to Follow-up|5|||
124870630|NCT04721925|449145539|FG001|2-Month Assessment|Lost to Follow-up|3|||
124870631|NCT04721925|449145538|FG000|4-Month Assessment|Lost to Follow-up|3|||
124870632|NCT04721925|449145539|FG001|4-Month Assessment|Lost to Follow-up|6|||
124870633|NCT01132326|449145540|FG000|Overall Study|Lack of Efficacy|25|||
124870634|NCT01132326|449145540|FG000|Overall Study|Adverse Event|37|||
124870635|NCT01132326|449145540|FG000|Overall Study|Protocol Violation|1|||
124870636|NCT01132326|449145540|FG000|Overall Study|Lost to Follow-up|16|||
124870637|NCT01132326|449145540|FG000|Overall Study|Withdrawal by Subject|40|||
124870638|NCT01132326|449145540|FG000|Overall Study|Physician Decision|10|||
124536813|NCT03802331|447917798|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
124536814|NCT03802331|447917799|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
124536815|NCT02074059|447917800|FG000|Overall Study|Death|0|||
124536816|NCT02074059|447917801|FG001|Overall Study|Death|0|||
124536817|NCT02074059|447917802|FG002|Overall Study|Death|0|||
124536818|NCT02074059|447917803|FG003|Overall Study|Death|0|||
124870639|NCT01132326|449145540|FG000|Overall Study|Study Termination|80|||
124870640|NCT01132326|449145540|FG000|Overall Study|Declining Health|1|||
124870641|NCT01132326|449145540|FG000|Overall Study|Pregnancy|1|||
124870642|NCT01132326|449145540|FG000|Overall Study|Caregiver Withdrew Consent|1|||
124870643|NCT01132326|449145540|FG000|Overall Study|Death|5|||
124870644|NCT01132326|449145540|FG000|Overall Study|Subject Unable to Come To Visits|1|||
124870645|NCT00952367|449145541|FG000|Overall Study|Withdrawal by Subject|2|||
124870646|NCT00952367|449145541|FG000|Overall Study|Noncoordination|1|||
124870647|NCT00952367|449145541|FG000|Overall Study|Protocol Violation|3|||
124536819|NCT02074059|447917804|FG004|Overall Study|Death|1|||
124536820|NCT02074059|447917805|FG005|Overall Study|Death|1|||
124536821|NCT00779506|447917807|FG000|Overall Study|Screening Failed|2|||
124536822|NCT00779506|447917807|FG000|Overall Study|Adverse Event|4|||
124536823|NCT00779506|447917807|FG000|Overall Study|Lack of Efficacy|11|||
124536824|NCT00779506|447917807|FG000|Overall Study|Protocol Violation|5|||
124536825|NCT00779506|447917807|FG000|Overall Study|Withdrawal by Subject|6|||
124536826|NCT00779506|447917807|FG000|Overall Study|Lost to Follow-up|1|||
124870648|NCT00708916|449145546|FG000|Overall Study|Subject Noncompliance|2|||
124870649|NCT00708916|449145546|FG000|Overall Study|Adverse Event|2|||
124870650|NCT02954354|449145550|FG000|Overall Study|Adverse Event|2|||
124870651|NCT02954354|449145551|FG001|Overall Study|Adverse Event|2|||
124870652|NCT02954354|449145552|FG002|Overall Study|Adverse Event|4|||
124870653|NCT02954354|449145550|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
124870654|NCT02954354|449145551|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
124870655|NCT02954354|449145552|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
124870656|NCT02954354|449145550|FG000|Overall Study|Lack of Efficacy|0|||
124870657|NCT02954354|449145551|FG001|Overall Study|Lack of Efficacy|2|||
124870658|NCT02954354|449145552|FG002|Overall Study|Lack of Efficacy|0|||
124870659|NCT02954354|449145550|FG000|Overall Study|Withdrawal by Subject|17|||
124870660|NCT02954354|449145551|FG001|Overall Study|Withdrawal by Subject|9|||
124870661|NCT02954354|449145552|FG002|Overall Study|Withdrawal by Subject|11|||
124870662|NCT02954354|449145550|FG000|Overall Study|Lost to Follow-up|12|||
124870663|NCT02954354|449145551|FG001|Overall Study|Lost to Follow-up|5|||
124870664|NCT02954354|449145552|FG002|Overall Study|Lost to Follow-up|0|||
124870665|NCT02954354|449145550|FG000|Overall Study|Miscellaneous|2|||
124870666|NCT02954354|449145551|FG001|Overall Study|Miscellaneous|2|||
124870667|NCT02954354|449145552|FG002|Overall Study|Miscellaneous|1|||
124870668|NCT04495179|449145553|FG000|Overall Study|Lost to Follow-up|0|||
124870669|NCT04495179|449145554|FG001|Overall Study|Lost to Follow-up|1|||
124870670|NCT04495179|449145553|FG000|Overall Study|Withdrawal by Subject|2|||
124870671|NCT04495179|449145554|FG001|Overall Study|Withdrawal by Subject|4|||
124870672|NCT04495179|449145553|FG000|Overall Study|Study terminated by sponsor|0|||
124870673|NCT04495179|449145554|FG001|Overall Study|Study terminated by sponsor|18|||
124870674|NCT04495179|449145553|FG000|Overall Study|Death|0|||
124870675|NCT04495179|449145554|FG001|Overall Study|Death|4|||
124870676|NCT04495179|449145553|FG000|Overall Study|Adverse Event|0|||
124870677|NCT04495179|449145554|FG001|Overall Study|Adverse Event|1|||
124870678|NCT02355743|449145568|FG000|Overall Study|Withdrawal by Subject|1|||
124870679|NCT02355743|449145568|FG000|Overall Study|Lost to Follow-up|1|||
124870680|NCT04212091|449145569|FG000|Overall Study|Lost to Follow-up|0|||
124870681|NCT04212091|449145570|FG001|Overall Study|Lost to Follow-up|0|||
124870682|NCT04212091|449145571|FG002|Overall Study|Lost to Follow-up|0|||
124870683|NCT04212091|449145572|FG003|Overall Study|Lost to Follow-up|0|||
124870684|NCT04212091|449145573|FG004|Overall Study|Lost to Follow-up|1|||
124870685|NCT04212091|449145574|FG005|Overall Study|Lost to Follow-up|1|||
124870686|NCT04212091|449145569|FG000|Overall Study|Participant unable to adhere to visit|0|||
124870687|NCT04212091|449145570|FG001|Overall Study|Participant unable to adhere to visit|0|||
124870688|NCT04212091|449145571|FG002|Overall Study|Participant unable to adhere to visit|0|||
124870689|NCT04212091|449145572|FG003|Overall Study|Participant unable to adhere to visit|0|||
124870690|NCT04212091|449145573|FG004|Overall Study|Participant unable to adhere to visit|1|||
124870691|NCT04212091|449145574|FG005|Overall Study|Participant unable to adhere to visit|0|||
124870692|NCT01812655|449145575|FG000|Overall Study|Protocol Violation|1|||
124870693|NCT01812655|449145576|FG001|Overall Study|Protocol Violation|1|||
124870694|NCT01812655|449145577|FG002|Overall Study|Protocol Violation|0|||
124870695|NCT00344461|449145595|FG000|Overall Study|Adverse Event|6|||
124870696|NCT00344461|449145595|FG000|Overall Study|Death|1|||
124870697|NCT00344461|449145595|FG000|Overall Study|Lack of Efficacy|2|||
124870698|NCT00344461|449145595|FG000|Overall Study|Lost to Follow-up|2|||
124870699|NCT00344461|449145595|FG000|Overall Study|Physician Decision|2|||
124870700|NCT00344461|449145595|FG000|Overall Study|Protocol Violation|6|||
124870701|NCT00344461|449145595|FG000|Overall Study|Withdrawal by Subject|2|||
124870702|NCT00636610|449145598|FG000|Overall Study|Adverse Event|4|||
124870703|NCT00636610|449145599|FG001|Overall Study|Adverse Event|4|||
124870704|NCT00636610|449145598|FG000|Overall Study|Death|6|||
124870705|NCT00636610|449145599|FG001|Overall Study|Death|3|||
124870706|NCT00636610|449145598|FG000|Overall Study|Physician decision to withdraw patient|15|||
124870707|NCT00636610|449145599|FG001|Overall Study|Physician decision to withdraw patient|9|||
124870708|NCT00636610|449145598|FG000|Overall Study|Subject decision to withdraw|15|||
124870709|NCT00636610|449145599|FG001|Overall Study|Subject decision to withdraw|11|||
124870710|NCT00636610|449145598|FG000|Overall Study|Disease progression - radiographic|41|||
124870711|NCT00636610|449145599|FG001|Overall Study|Disease progression - radiographic|51|||
124870712|NCT00636610|449145598|FG000|Overall Study|Disease progression - clinical|8|||
124870713|NCT00636610|449145599|FG001|Overall Study|Disease progression - clinical|3|||
124870714|NCT00636610|449145598|FG000|Overall Study|Reason for discontinuation not available|3|||
124870715|NCT00636610|449145599|FG001|Overall Study|Reason for discontinuation not available|2|||
124536827|NCT01632345|447917810|FG000|Treatment: Part I|Adverse Event|1|||
124536828|NCT01632345|447917811|FG001|Treatment: Part I|Adverse Event|4|||
124870716|NCT02355028|449145600|FG000|Overall Study|Adverse Event|2|||
124870717|NCT02355028|449145601|FG001|Overall Study|Adverse Event|0|||
124870718|NCT02355028|449145600|FG000|Overall Study|Withdrawal by Subject|1|||
124870719|NCT02355028|449145601|FG001|Overall Study|Withdrawal by Subject|1|||
124870720|NCT02355028|449145600|FG000|Overall Study|Deemed ineligible after randomization|8|||
124870721|NCT02355028|449145601|FG001|Overall Study|Deemed ineligible after randomization|4|||
124536829|NCT01632345|447917812|FG002|Treatment: Part I|Adverse Event|2|||
124870722|NCT01971723|449145602|FG000|Overall Study|Withdrawal by Subject|1|||
124870723|NCT01971723|449145603|FG001|Overall Study|Withdrawal by Subject|1|||
124870724|NCT01971723|449145602|FG000|Overall Study|Protocol Violation|1|||
124870725|NCT01971723|449145603|FG001|Overall Study|Protocol Violation|2|||
124870726|NCT05899686|449145604|FG000|Overall Study|Protocol Violation|1|||
124870727|NCT01592370|449145614|FG000|Overall Study|Disease Progression|62|||
124870728|NCT01592370|449145615|FG001|Overall Study|Disease Progression|16|||
124870729|NCT01592370|449145616|FG002|Overall Study|Disease Progression|52|||
124870730|NCT01592370|449145617|FG003|Overall Study|Disease Progression|3|||
124870731|NCT01592370|449145618|FG004|Overall Study|Disease Progression|3|||
124870732|NCT01592370|449145619|FG005|Overall Study|Disease Progression|31|||
124870733|NCT01592370|449145620|FG006|Overall Study|Disease Progression|14|||
124870734|NCT01592370|449145614|FG000|Overall Study|Study Drug Toxicity|14|||
124870735|NCT01592370|449145615|FG001|Overall Study|Study Drug Toxicity|3|||
124870736|NCT01592370|449145616|FG002|Overall Study|Study Drug Toxicity|0|||
124870737|NCT01592370|449145617|FG003|Overall Study|Study Drug Toxicity|0|||
124870738|NCT01592370|449145618|FG004|Overall Study|Study Drug Toxicity|0|||
124870739|NCT01592370|449145619|FG005|Overall Study|Study Drug Toxicity|0|||
124870740|NCT01592370|449145620|FG006|Overall Study|Study Drug Toxicity|1|||
124870741|NCT01592370|449145614|FG000|Overall Study|AE unrelated to study drug|4|||
124870742|NCT01592370|449145615|FG001|Overall Study|AE unrelated to study drug|3|||
124870743|NCT01592370|449145616|FG002|Overall Study|AE unrelated to study drug|0|||
124870744|NCT01592370|449145617|FG003|Overall Study|AE unrelated to study drug|0|||
124870745|NCT01592370|449145618|FG004|Overall Study|AE unrelated to study drug|0|||
124870746|NCT01592370|449145619|FG005|Overall Study|AE unrelated to study drug|0|||
124870747|NCT01592370|449145620|FG006|Overall Study|AE unrelated to study drug|1|||
124870748|NCT01592370|449145614|FG000|Overall Study|Request to discontinue study treatment|5|||
124870749|NCT01592370|449145615|FG001|Overall Study|Request to discontinue study treatment|0|||
124870750|NCT01592370|449145616|FG002|Overall Study|Request to discontinue study treatment|2|||
124870751|NCT01592370|449145617|FG003|Overall Study|Request to discontinue study treatment|0|||
124870752|NCT01592370|449145618|FG004|Overall Study|Request to discontinue study treatment|1|||
124870753|NCT01592370|449145619|FG005|Overall Study|Request to discontinue study treatment|2|||
124870754|NCT01592370|449145620|FG006|Overall Study|Request to discontinue study treatment|0|||
124870755|NCT01592370|449145614|FG000|Overall Study|Withdrew consent|1|||
124870756|NCT01592370|449145615|FG001|Overall Study|Withdrew consent|2|||
124870757|NCT01592370|449145616|FG002|Overall Study|Withdrew consent|1|||
124870758|NCT01592370|449145617|FG003|Overall Study|Withdrew consent|1|||
124870759|NCT01592370|449145618|FG004|Overall Study|Withdrew consent|0|||
124870760|NCT01592370|449145619|FG005|Overall Study|Withdrew consent|0|||
124870761|NCT01592370|449145620|FG006|Overall Study|Withdrew consent|0|||
124870762|NCT01592370|449145614|FG000|Overall Study|Maximum clinical benefit|11|||
124870763|NCT01592370|449145615|FG001|Overall Study|Maximum clinical benefit|1|||
124870764|NCT01592370|449145616|FG002|Overall Study|Maximum clinical benefit|7|||
124870765|NCT01592370|449145617|FG003|Overall Study|Maximum clinical benefit|1|||
124870766|NCT01592370|449145618|FG004|Overall Study|Maximum clinical benefit|0|||
124870767|NCT01592370|449145619|FG005|Overall Study|Maximum clinical benefit|0|||
124870768|NCT01592370|449145620|FG006|Overall Study|Maximum clinical benefit|0|||
124870769|NCT01592370|449145614|FG000|Overall Study|No longer meets study criteria|1|||
124870770|NCT01592370|449145615|FG001|Overall Study|No longer meets study criteria|0|||
124870771|NCT01592370|449145616|FG002|Overall Study|No longer meets study criteria|0|||
124870772|NCT01592370|449145617|FG003|Overall Study|No longer meets study criteria|0|||
124870773|NCT01592370|449145618|FG004|Overall Study|No longer meets study criteria|0|||
124870774|NCT01592370|449145619|FG005|Overall Study|No longer meets study criteria|0|||
124870775|NCT01592370|449145620|FG006|Overall Study|No longer meets study criteria|0|||
124870776|NCT01592370|449145614|FG000|Overall Study|Other Reasons|6|||
124870777|NCT01592370|449145615|FG001|Overall Study|Other Reasons|0|||
124870778|NCT01592370|449145616|FG002|Overall Study|Other Reasons|10|||
124870779|NCT01592370|449145617|FG003|Overall Study|Other Reasons|0|||
124870780|NCT01592370|449145618|FG004|Overall Study|Other Reasons|0|||
124870781|NCT01592370|449145619|FG005|Overall Study|Other Reasons|1|||
124870782|NCT01592370|449145620|FG006|Overall Study|Other Reasons|0|||
124870783|NCT01323530|449147152|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
124870784|NCT01323530|449147153|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124870785|NCT01323530|449147154|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124870786|NCT01323530|449147155|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124870787|NCT01323530|449147156|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124870788|NCT01323530|449147157|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
124870789|NCT01323530|449147158|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124870790|NCT01323530|449147152|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
124870791|NCT01323530|449147153|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
124870792|NCT01323530|449147154|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
124870793|NCT01323530|449147155|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
124870794|NCT01323530|449147156|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
124870795|NCT01323530|449147157|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
124870796|NCT01323530|449147158|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
124870797|NCT01323530|449147152|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
124870798|NCT01323530|449147153|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
124870799|NCT01323530|449147154|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
124870800|NCT01323530|449147155|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
124870801|NCT01323530|449147156|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
124870802|NCT01323530|449147157|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
124870803|NCT01323530|449147158|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
124870804|NCT01323530|449147152|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
124870805|NCT01323530|449147153|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
124870806|NCT01323530|449147154|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
124870807|NCT01323530|449147155|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
124870808|NCT01323530|449147156|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
124870809|NCT01323530|449147157|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
124870810|NCT01323530|449147158|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
124870811|NCT01323530|449147152|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
124870812|NCT01323530|449147153|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
124870813|NCT01323530|449147154|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
124870814|NCT01323530|449147155|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
124870815|NCT01323530|449147156|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
124870816|NCT01323530|449147157|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
124870817|NCT01323530|449147158|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
124870818|NCT01323530|449147152|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
124870819|NCT01323530|449147153|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
124870820|NCT01323530|449147154|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
124870821|NCT01323530|449147155|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
124870822|NCT01323530|449147156|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
124870823|NCT01323530|449147157|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
124870824|NCT01323530|449147158|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
124870825|NCT01323530|449147152|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
124870826|NCT01323530|449147153|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
124870827|NCT01323530|449147154|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
124870828|NCT01323530|449147155|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
124870829|NCT01323530|449147156|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
124870830|NCT01323530|449147157|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
124870831|NCT01323530|449147158|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
124870832|NCT01323530|449147152|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
124870833|NCT01323530|449147153|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
124870834|NCT01323530|449147154|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
124870835|NCT01323530|449147155|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
124870836|NCT01323530|449147156|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
124870837|NCT01323530|449147157|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
124870838|NCT01323530|449147158|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
124870839|NCT01111123|449147159|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
124870840|NCT01111123|449147160|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
124870841|NCT01111123|449147159|FG000|Maintenance Phase|Lost to Follow-up|0|||
124870842|NCT01111123|449147160|FG001|Maintenance Phase|Lost to Follow-up|2|||
124870843|NCT00119405|449147161|FG000|Overall Study|Withdrawal by Subject|1|||
124870844|NCT01735201|449147163|FG000|Overall Study|Adverse Event|1|||
124870845|NCT01735201|449147164|FG001|Overall Study|Adverse Event|1|||
124870846|NCT01735201|449147165|FG002|Overall Study|Adverse Event|0|||
124870847|NCT01735201|449147166|FG003|Overall Study|Adverse Event|1|||
124870848|NCT01735201|449147167|FG004|Overall Study|Adverse Event|1|||
124870849|NCT01735201|449147168|FG005|Overall Study|Adverse Event|3|||
124870850|NCT01735201|449147169|FG006|Overall Study|Adverse Event|2|||
124870851|NCT01735201|449147170|FG007|Overall Study|Adverse Event|1|||
124870852|NCT01735201|449147163|FG000|Overall Study|Personal Reasons|1|||
124870853|NCT01735201|449147164|FG001|Overall Study|Personal Reasons|0|||
124870854|NCT01735201|449147165|FG002|Overall Study|Personal Reasons|0|||
124870855|NCT01735201|449147166|FG003|Overall Study|Personal Reasons|0|||
124870856|NCT01735201|449147167|FG004|Overall Study|Personal Reasons|0|||
124870857|NCT01735201|449147168|FG005|Overall Study|Personal Reasons|0|||
124870858|NCT01735201|449147169|FG006|Overall Study|Personal Reasons|0|||
124870859|NCT01735201|449147170|FG007|Overall Study|Personal Reasons|0|||
124870860|NCT01735201|449147163|FG000|Overall Study|Protocol Violation|1|||
124870861|NCT01735201|449147164|FG001|Overall Study|Protocol Violation|0|||
124870862|NCT01735201|449147165|FG002|Overall Study|Protocol Violation|0|||
124870863|NCT01735201|449147166|FG003|Overall Study|Protocol Violation|0|||
124870864|NCT01735201|449147167|FG004|Overall Study|Protocol Violation|0|||
124870865|NCT01735201|449147168|FG005|Overall Study|Protocol Violation|0|||
124870866|NCT01735201|449147169|FG006|Overall Study|Protocol Violation|0|||
124870867|NCT01735201|449147170|FG007|Overall Study|Protocol Violation|0|||
124870868|NCT01735201|449147163|FG000|Overall Study|Other Miscellaneous Reasons|0|||
124870869|NCT01735201|449147164|FG001|Overall Study|Other Miscellaneous Reasons|0|||
124870870|NCT01735201|449147165|FG002|Overall Study|Other Miscellaneous Reasons|0|||
124870871|NCT01735201|449147166|FG003|Overall Study|Other Miscellaneous Reasons|1|||
124870872|NCT01735201|449147167|FG004|Overall Study|Other Miscellaneous Reasons|0|||
124870873|NCT01735201|449147168|FG005|Overall Study|Other Miscellaneous Reasons|2|||
124870874|NCT01735201|449147169|FG006|Overall Study|Other Miscellaneous Reasons|1|||
124870875|NCT01735201|449147170|FG007|Overall Study|Other Miscellaneous Reasons|1|||
124870876|NCT01553318|449147171|FG000|Overall Study|Protocol Violation|3|||
124870877|NCT01553318|449147172|FG001|Overall Study|Protocol Violation|2|||
124870878|NCT02127372|449147178|FG000|Overall Study|Withdrawal by Subject|1|||
124870879|NCT02127372|449147179|FG001|Overall Study|Withdrawal by Subject|0|||
124870880|NCT01357616|449147183|FG000|Overall Study|Adverse Event|1|||
124870881|NCT01357616|449147184|FG001|Overall Study|Adverse Event|1|||
124870882|NCT01357616|449147183|FG000|Overall Study|Lost to Follow-up|4|||
124870883|NCT01357616|449147184|FG001|Overall Study|Lost to Follow-up|3|||
124870884|NCT01357616|449147183|FG000|Overall Study|Protocol Violation|0|||
124870885|NCT01357616|449147184|FG001|Overall Study|Protocol Violation|2|||
124870886|NCT01357616|449147183|FG000|Overall Study|Inadequate Control of IOP|1|||
124870887|NCT01357616|449147184|FG001|Overall Study|Inadequate Control of IOP|2|||
124870888|NCT01357616|449147183|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
124870889|NCT01357616|449147184|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
124870890|NCT01357616|449147183|FG000|Overall Study|Withdrawal by Subject|1|||
124870891|NCT01357616|449147184|FG001|Overall Study|Withdrawal by Subject|0|||
124870892|NCT02052310|449147188|FG000|Overall Study|Death|64|||
124870893|NCT02052310|449147189|FG001|Overall Study|Death|54|||
124870894|NCT02052310|449147188|FG000|Overall Study|Withdrawal by Subject|37|||
124870895|NCT02052310|449147189|FG001|Overall Study|Withdrawal by Subject|49|||
124870896|NCT02052310|449147188|FG000|Overall Study|Other than specified|32|||
124870897|NCT02052310|449147189|FG001|Overall Study|Other than specified|29|||
124870898|NCT02052310|449147188|FG000|Overall Study|Adverse Event|29|||
124870899|NCT02052310|449147189|FG001|Overall Study|Adverse Event|22|||
124870900|NCT02052310|449147188|FG000|Overall Study|Kidney Transplant|23|||
124870901|NCT02052310|449147189|FG001|Overall Study|Kidney Transplant|29|||
124870902|NCT02052310|449147188|FG000|Overall Study|Physician Decision|14|||
124870903|NCT02052310|449147189|FG001|Overall Study|Physician Decision|7|||
124870904|NCT02052310|449147188|FG000|Overall Study|Lack of Efficacy|6|||
124870905|NCT02052310|449147189|FG001|Overall Study|Lack of Efficacy|1|||
124870906|NCT02052310|449147188|FG000|Overall Study|Site Terminated by Sponsor|5|||
124870907|NCT02052310|449147189|FG001|Overall Study|Site Terminated by Sponsor|13|||
124870908|NCT02052310|449147188|FG000|Overall Study|Lost to Follow-up|4|||
124870909|NCT02052310|449147189|FG001|Overall Study|Lost to Follow-up|2|||
124870910|NCT02052310|449147188|FG000|Overall Study|Protocol Violation|1|||
124870911|NCT02052310|449147189|FG001|Overall Study|Protocol Violation|6|||
124870912|NCT01505387|449147192|FG000|Overall Study|Protocol Violation|1|||
124870913|NCT01505387|449147193|FG001|Overall Study|Protocol Violation|0|||
124870914|NCT01505387|449147192|FG000|Overall Study|Withdrawal by Subject|1|||
124870915|NCT01505387|449147193|FG001|Overall Study|Withdrawal by Subject|1|||
124870916|NCT00420199|449147195|FG000|Overall Study|Participant no longer met study criteria|1|||
124870917|NCT00420199|449147196|FG001|Overall Study|Participant no longer met study criteria|0|||
124870918|NCT03466086|449147200|FG000|Period 1|Sponsor decision due to study timeline|1|||
124870919|NCT03466086|449147201|FG001|Period 1|Sponsor decision due to study timeline|0|||
124870920|NCT03466086|449147200|FG000|Period 1|Withdrawal by Subject|1|||
124870921|NCT03466086|449147201|FG001|Period 1|Withdrawal by Subject|0|||
124870922|NCT04020341|449147204|FG000|Overall Study|Adverse Event|8|||
124870923|NCT04020341|449147205|FG001|Overall Study|Adverse Event|6|||
124870924|NCT04020341|449147204|FG000|Overall Study|Lost to Follow-up|8|||
124870925|NCT04020341|449147205|FG001|Overall Study|Lost to Follow-up|2|||
124870926|NCT04020341|449147204|FG000|Overall Study|Withdrawal by Subject|16|||
124870927|NCT04020341|449147205|FG001|Overall Study|Withdrawal by Subject|16|||
124870928|NCT04020341|449147204|FG000|Overall Study|Participant not able to swallow the tablet|1|||
124870929|NCT04020341|449147205|FG001|Overall Study|Participant not able to swallow the tablet|0|||
124870930|NCT04020341|449147204|FG000|Overall Study|Physician Decision|0|||
124870931|NCT04020341|449147205|FG001|Overall Study|Physician Decision|2|||
124870932|NCT04020341|449147204|FG000|Overall Study|Protocol Deviation|0|||
124870933|NCT04020341|449147205|FG001|Overall Study|Protocol Deviation|2|||
124870934|NCT00677352|449147206|FG000|Treatment Phase|Adverse Event|14|||
124870935|NCT00677352|449147207|FG001|Treatment Phase|Adverse Event|22|||
124870936|NCT00677352|449147206|FG000|Treatment Phase|Lack of Efficacy|2|||
124870937|NCT00677352|449147207|FG001|Treatment Phase|Lack of Efficacy|3|||
124870938|NCT00677352|449147206|FG000|Treatment Phase|Lost to Follow-up|0|||
124870939|NCT00677352|449147207|FG001|Treatment Phase|Lost to Follow-up|1|||
124870940|NCT00677352|449147206|FG000|Treatment Phase|Withdrawal by Subject|7|||
124870941|NCT00677352|449147207|FG001|Treatment Phase|Withdrawal by Subject|7|||
124870942|NCT00677352|449147206|FG000|Treatment Phase|Physician Decision|1|||
124870943|NCT00677352|449147207|FG001|Treatment Phase|Physician Decision|0|||
124870944|NCT00677352|449147206|FG000|Treatment Phase|Pregnancy|0|||
124870945|NCT00677352|449147207|FG001|Treatment Phase|Pregnancy|1|||
124870946|NCT00677352|449147206|FG000|Treatment Phase|Protocol Violation|1|||
124870947|NCT00677352|449147207|FG001|Treatment Phase|Protocol Violation|1|||
124870948|NCT00677352|449147206|FG000|Treatment Phase|Transference or work related matter|0|||
124870949|NCT00677352|449147207|FG001|Treatment Phase|Transference or work related matter|5|||
124870950|NCT00677352|449147206|FG000|Treatment Phase|Not treated|0|||
124870951|NCT00677352|449147207|FG001|Treatment Phase|Not treated|2|||
124870952|NCT00677352|449147206|FG000|Tapering Phase|Adverse Event|1|||
124870953|NCT00677352|449147207|FG001|Tapering Phase|Adverse Event|5|||
124870954|NCT00677352|449147206|FG000|Tapering Phase|Withdrawal by Subject|5|||
124870955|NCT00677352|449147207|FG001|Tapering Phase|Withdrawal by Subject|3|||
124870956|NCT00677352|449147206|FG000|Tapering Phase|Pregnancy|0|||
124870957|NCT00677352|449147207|FG001|Tapering Phase|Pregnancy|1|||
124870958|NCT00677352|449147206|FG000|Tapering Phase|Job transfer|0|||
124870959|NCT00677352|449147207|FG001|Tapering Phase|Job transfer|1|||
124870960|NCT05763628|449147208|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
124870961|NCT05763628|449147209|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
124870962|NCT05763628|449147208|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
124870963|NCT05763628|449147209|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
124870964|NCT05763628|449147208|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
124870965|NCT05763628|449147209|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
124870966|NCT00716092|449147210|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
124870967|NCT00716092|449147211|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
124870968|NCT00716092|449147212|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
124870969|NCT00781391|449147215|FG000|Overall Study|never received study drug|24|||
124870970|NCT00781391|449147216|FG001|Overall Study|never received study drug|23|||
124870971|NCT00781391|449147217|FG002|Overall Study|never received study drug|32|||
124870972|NCT00781391|449147215|FG000|Overall Study|Protocol Violation|19|||
124870973|NCT00781391|449147216|FG001|Overall Study|Protocol Violation|17|||
124870974|NCT00781391|449147217|FG002|Overall Study|Protocol Violation|20|||
124870975|NCT00781391|449147215|FG000|Overall Study|Death|789|||
124870976|NCT00781391|449147216|FG001|Overall Study|Death|730|||
124870977|NCT00781391|449147217|FG002|Overall Study|Death|706|||
124870978|NCT00781391|449147215|FG000|Overall Study|Withdrawal by Subject|47|||
124870979|NCT00781391|449147216|FG001|Overall Study|Withdrawal by Subject|37|||
124870980|NCT00781391|449147217|FG002|Overall Study|Withdrawal by Subject|25|||
124870981|NCT00781391|449147215|FG000|Overall Study|Lost to Follow-up|0|||
124870982|NCT00781391|449147216|FG001|Overall Study|Lost to Follow-up|0|||
124870983|NCT00781391|449147217|FG002|Overall Study|Lost to Follow-up|1|||
124870984|NCT04535947|449147218|FG000|Overall Study|Adverse Event|1|||
124870985|NCT04535947|449147219|FG001|Overall Study|Adverse Event|4|||
124870986|NCT04535947|449147218|FG000|Overall Study|Other reasons not specified|2|||
124870987|NCT04535947|449147219|FG001|Overall Study|Other reasons not specified|0|||
124870988|NCT04535947|449147218|FG000|Overall Study|Withdrawal by Subject|1|||
124870989|NCT04535947|449147219|FG001|Overall Study|Withdrawal by Subject|1|||
124870990|NCT03802123|449147221|FG000|Overall Study|Withdrawal by Subject|3|||
124870991|NCT03802123|449147221|FG000|Overall Study|Physician Decision|1|||
124870992|NCT03802123|449147221|FG000|Overall Study|Subject moved to hospice care|1|||
124870993|NCT03802123|449147221|FG000|Overall Study|technician error|1|||
124870994|NCT03802123|449147221|FG000|Overall Study|Death|3|||
124870995|NCT01822587|449147222|FG000|Overall Study|Lost to Follow-up|7|||
124870996|NCT01822587|449147223|FG001|Overall Study|Lost to Follow-up|9|||
124870997|NCT01822587|449147224|FG002|Overall Study|Lost to Follow-up|12|||
124870998|NCT01822587|449147222|FG000|Overall Study|Physician Decision|9|||
124870999|NCT01822587|449147223|FG001|Overall Study|Physician Decision|6|||
124871000|NCT01822587|449147224|FG002|Overall Study|Physician Decision|6|||
124871001|NCT00658567|449147227|FG000|Overall Study|Adverse Event|5|||
124871002|NCT00658567|449147228|FG001|Overall Study|Adverse Event|2|||
124871003|NCT00658567|449147229|FG002|Overall Study|Adverse Event|3|||
124871004|NCT00658567|449147227|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
124871005|NCT00658567|449147228|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
124871006|NCT00658567|449147229|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
124871007|NCT00658567|449147227|FG000|Overall Study|Physician Decision|0|||
124871008|NCT00658567|449147228|FG001|Overall Study|Physician Decision|1|||
124871009|NCT00658567|449147229|FG002|Overall Study|Physician Decision|0|||
124871010|NCT00658567|449147227|FG000|Overall Study|At Discretion of Sponsor|1|||
124871011|NCT00658567|449147228|FG001|Overall Study|At Discretion of Sponsor|1|||
124871012|NCT00658567|449147229|FG002|Overall Study|At Discretion of Sponsor|1|||
124871013|NCT01058304|449147240|FG000|Overall Study|Withdrawal by Subject|8|||
124871014|NCT01058304|449147241|FG001|Overall Study|Withdrawal by Subject|5|||
124871015|NCT01058304|449147240|FG000|Overall Study|Lost to Follow-up|13|||
124871016|NCT01058304|449147241|FG001|Overall Study|Lost to Follow-up|16|||
124871017|NCT01058304|449147240|FG000|Overall Study|Developed exclusion criterion|6|||
124871018|NCT01058304|449147241|FG001|Overall Study|Developed exclusion criterion|12|||
124871019|NCT01820559|449147242|FG000|Overall Study|Adverse Event|4|||
124871020|NCT01820559|449147243|FG001|Overall Study|Adverse Event|6|||
124871021|NCT01820559|449147244|FG002|Overall Study|Adverse Event|13|||
124871022|NCT01820559|449147242|FG000|Overall Study|Withdrawal by Subject|1|||
124871023|NCT01820559|449147243|FG001|Overall Study|Withdrawal by Subject|2|||
124871024|NCT01820559|449147244|FG002|Overall Study|Withdrawal by Subject|5|||
124871025|NCT01820559|449147242|FG000|Overall Study|Protocol Violation|2|||
124871026|NCT01820559|449147243|FG001|Overall Study|Protocol Violation|1|||
124871027|NCT01820559|449147244|FG002|Overall Study|Protocol Violation|3|||
124871028|NCT01820559|449147242|FG000|Overall Study|Subject's non-compliance|1|||
124871029|NCT01820559|449147243|FG001|Overall Study|Subject's non-compliance|0|||
124871030|NCT01820559|449147244|FG002|Overall Study|Subject's non-compliance|2|||
124871031|NCT01820559|449147242|FG000|Overall Study|Lost to Follow-up|3|||
124871032|NCT01820559|449147243|FG001|Overall Study|Lost to Follow-up|2|||
124871033|NCT01820559|449147244|FG002|Overall Study|Lost to Follow-up|2|||
124871034|NCT01820559|449147242|FG000|Overall Study|At sponsor request|0|||
124871035|NCT01820559|449147243|FG001|Overall Study|At sponsor request|0|||
124871036|NCT01820559|449147244|FG002|Overall Study|At sponsor request|1|||
124871037|NCT01820559|449147242|FG000|Overall Study|Lack of Efficacy|3|||
124871038|NCT01820559|449147243|FG001|Overall Study|Lack of Efficacy|2|||
124871039|NCT01820559|449147244|FG002|Overall Study|Lack of Efficacy|3|||
124871040|NCT02618967|449147245|FG000|Overall Study|Lost to Follow-up|0|||
124871041|NCT02618967|449147246|FG001|Overall Study|Lost to Follow-up|0|||
124871042|NCT02618967|449147247|FG002|Overall Study|Lost to Follow-up|1|||
124871043|NCT02618967|449147248|FG003|Overall Study|Lost to Follow-up|0|||
124871044|NCT02618967|449147249|FG004|Overall Study|Lost to Follow-up|2|||
124871045|NCT02618967|449147250|FG005|Overall Study|Lost to Follow-up|0|||
124871046|NCT02618967|449147251|FG006|Overall Study|Lost to Follow-up|0|||
124871047|NCT02618967|449147252|FG007|Overall Study|Lost to Follow-up|0|||
124871048|NCT02618967|449147245|FG000|Overall Study|Withdrawal by Subject|1|||
124871049|NCT02618967|449147246|FG001|Overall Study|Withdrawal by Subject|0|||
124871050|NCT02618967|449147247|FG002|Overall Study|Withdrawal by Subject|0|||
124871051|NCT02618967|449147248|FG003|Overall Study|Withdrawal by Subject|0|||
124871052|NCT02618967|449147249|FG004|Overall Study|Withdrawal by Subject|0|||
124871053|NCT02618967|449147250|FG005|Overall Study|Withdrawal by Subject|0|||
124871054|NCT02618967|449147251|FG006|Overall Study|Withdrawal by Subject|0|||
124871055|NCT02618967|449147252|FG007|Overall Study|Withdrawal by Subject|0|||
124871056|NCT01368965|449147253|FG000|Overall Study|Lost to Follow-up|12|||
124871057|NCT01936857|449147262|FG000|Overall Study|Sent to prison or 06 center|11|||
124871058|NCT01936857|449147263|FG001|Overall Study|Sent to prison or 06 center|12|||
124871059|NCT01936857|449147262|FG000|Overall Study|Lost to Follow-up|10|||
124871060|NCT01936857|449147263|FG001|Overall Study|Lost to Follow-up|7|||
124871061|NCT01936857|449147262|FG000|Overall Study|Death|7|||
124871062|NCT01936857|449147263|FG001|Overall Study|Death|3|||
124871063|NCT01936857|449147262|FG000|Overall Study|Moved|2|||
124871064|NCT01936857|449147263|FG001|Overall Study|Moved|1|||
124871065|NCT01936857|449147262|FG000|Overall Study|Withdrawal by Subject|1|||
124871066|NCT01936857|449147263|FG001|Overall Study|Withdrawal by Subject|0|||
124871067|NCT01936857|449147262|FG000|Overall Study|Side effect of medication|1|||
124871068|NCT01936857|449147263|FG001|Overall Study|Side effect of medication|0|||
124871069|NCT01936857|449147262|FG000|Overall Study|Other|2|||
124871070|NCT01936857|449147263|FG001|Overall Study|Other|2|||
124871071|NCT01939548|449147264|FG000|Overall Study|Non compliance|0|||
124871072|NCT01939548|449147265|FG001|Overall Study|Non compliance|2|||
124871073|NCT01939548|449147266|FG002|Overall Study|Non compliance|0|||
124871074|NCT01939548|449147264|FG000|Overall Study|Study Terminated by Sponsor|17|||
124871075|NCT01939548|449147265|FG001|Overall Study|Study Terminated by Sponsor|19|||
124871076|NCT01939548|449147266|FG002|Overall Study|Study Terminated by Sponsor|12|||
124871077|NCT01939548|449147264|FG000|Overall Study|Insufficient Clinical Response|1|||
124871078|NCT01939548|449147265|FG001|Overall Study|Insufficient Clinical Response|0|||
124871079|NCT01939548|449147266|FG002|Overall Study|Insufficient Clinical Response|0|||
124871080|NCT01939548|449147264|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
124871081|NCT01939548|449147265|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
124871082|NCT01939548|449147266|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
124871083|NCT01939548|449147264|FG000|Overall Study|Withdrawal by Subject|4|||
124871084|NCT01939548|449147265|FG001|Overall Study|Withdrawal by Subject|4|||
124871085|NCT01939548|449147266|FG002|Overall Study|Withdrawal by Subject|1|||
124871086|NCT01939548|449147264|FG000|Overall Study|Protocol Violation|7|||
124871087|NCT01939548|449147265|FG001|Overall Study|Protocol Violation|6|||
124871088|NCT01939548|449147266|FG002|Overall Study|Protocol Violation|5|||
124871089|NCT01939548|449147264|FG000|Overall Study|Lost to Follow-up|5|||
124871090|NCT01939548|449147265|FG001|Overall Study|Lost to Follow-up|5|||
124871091|NCT01939548|449147266|FG002|Overall Study|Lost to Follow-up|3|||
124871092|NCT01939548|449147264|FG000|Overall Study|Adverse Event|2|||
124871093|NCT01939548|449147265|FG001|Overall Study|Adverse Event|9|||
124871094|NCT01939548|449147266|FG002|Overall Study|Adverse Event|7|||
124536830|NCT01632345|447917813|FG003|Treatment: Part I|Adverse Event|1|||
124536831|NCT01632345|447917814|FG004|Treatment: Part I|Adverse Event|3|||
124871095|NCT01939548|449147264|FG000|Overall Study|Death|0|||
124871096|NCT01939548|449147265|FG001|Overall Study|Death|0|||
124871097|NCT01939548|449147266|FG002|Overall Study|Death|1|||
124871098|NCT01939548|449147264|FG000|Overall Study|Participant dropped|0|||
124871099|NCT01939548|449147265|FG001|Overall Study|Participant dropped|0|||
124536832|NCT01632345|447917815|FG005|Treatment: Part I|Adverse Event|0|||
124536833|NCT01632345|447917816|FG006|Treatment: Part I|Adverse Event|0|||
124871100|NCT01939548|449147266|FG002|Overall Study|Participant dropped|1|||
124871101|NCT01939548|449147264|FG000|Overall Study|Participant unwilling to continue|0|||
124871102|NCT01939548|449147265|FG001|Overall Study|Participant unwilling to continue|1|||
124871103|NCT01939548|449147266|FG002|Overall Study|Participant unwilling to continue|0|||
124871104|NCT01939548|449147264|FG000|Overall Study|Participant withdrew consent|0|||
124871105|NCT01939548|449147265|FG001|Overall Study|Participant withdrew consent|2|||
124871106|NCT01939548|449147266|FG002|Overall Study|Participant withdrew consent|0|||
124871107|NCT01939548|449147264|FG000|Overall Study|Did not complete follow-up|0|||
124871108|NCT01939548|449147265|FG001|Overall Study|Did not complete follow-up|1|||
124871109|NCT01939548|449147266|FG002|Overall Study|Did not complete follow-up|0|||
124871110|NCT00490282|449147267|FG000|Overall Study|Withdrawal by Subject|3|||
124871111|NCT04198805|449147268|FG000|Overall Study|Death|0|||
124871112|NCT04198805|449147269|FG001|Overall Study|Death|0|||
124871113|NCT04198805|449147270|FG002|Overall Study|Death|0|||
124871114|NCT04198805|449147271|FG003|Overall Study|Death|1|||
124871115|NCT04198805|449147268|FG000|Overall Study|Early Termination|8|||
124871116|NCT04198805|449147269|FG001|Overall Study|Early Termination|4|||
124871117|NCT04198805|449147270|FG002|Overall Study|Early Termination|6|||
124871118|NCT04198805|449147271|FG003|Overall Study|Early Termination|9|||
124871119|NCT03599349|449147272|FG000|Overall Study|Lost to Follow-up|1|||
124871120|NCT03221387|449147276|FG000|Overall Study|Lost to Follow-up|1|||
124871121|NCT03221387|449147276|FG000|Overall Study|Lung transplant|1|||
124871122|NCT00553696|449147277|FG000|Overall Study|Adverse Event|2|||
124871123|NCT00553696|449147278|FG001|Overall Study|Adverse Event|4|||
124871124|NCT00553696|449147279|FG002|Overall Study|Adverse Event|0|||
124871125|NCT00553696|449147280|FG003|Overall Study|Adverse Event|1|||
124871126|NCT00553696|449147277|FG000|Overall Study|Global deterioration of health status|0|||
124871127|NCT00553696|449147278|FG001|Overall Study|Global deterioration of health status|2|||
124871128|NCT00553696|449147279|FG002|Overall Study|Global deterioration of health status|0|||
124871129|NCT00553696|449147280|FG003|Overall Study|Global deterioration of health status|0|||
124871130|NCT00553696|449147277|FG000|Overall Study|Objective progression or relapse|2|||
124871131|NCT00553696|449147278|FG001|Overall Study|Objective progression or relapse|9|||
124871132|NCT00553696|449147279|FG002|Overall Study|Objective progression or relapse|6|||
124871133|NCT00553696|449147280|FG003|Overall Study|Objective progression or relapse|0|||
124871134|NCT00553696|449147277|FG000|Overall Study|Withdrawal by Subject|0|||
124871135|NCT00553696|449147278|FG001|Overall Study|Withdrawal by Subject|1|||
124871136|NCT00553696|449147279|FG002|Overall Study|Withdrawal by Subject|0|||
124871137|NCT00553696|449147280|FG003|Overall Study|Withdrawal by Subject|0|||
124871138|NCT02276222|449147283|FG000|Overall Study|Adverse Event|62|||
124871139|NCT02276222|449147284|FG001|Overall Study|Adverse Event|11|||
124871140|NCT02276222|449147283|FG000|Overall Study|Death|3|||
124871141|NCT02276222|449147284|FG001|Overall Study|Death|4|||
124871142|NCT02276222|449147283|FG000|Overall Study|Lack of Efficacy|13|||
124871143|NCT02276222|449147284|FG001|Overall Study|Lack of Efficacy|3|||
124871144|NCT02276222|449147283|FG000|Overall Study|Protocol Violation|3|||
124871145|NCT02276222|449147284|FG001|Overall Study|Protocol Violation|2|||
124871146|NCT02276222|449147283|FG000|Overall Study|Withdrawal by Subject|79|||
124871147|NCT02276222|449147284|FG001|Overall Study|Withdrawal by Subject|33|||
124871148|NCT02276222|449147283|FG000|Overall Study|non compliance with study medication|6|||
124871149|NCT02276222|449147284|FG001|Overall Study|non compliance with study medication|2|||
124871150|NCT02276222|449147283|FG000|Overall Study|sponsor decision|0|||
124871151|NCT02276222|449147284|FG001|Overall Study|sponsor decision|3|||
124871152|NCT02276222|449147283|FG000|Overall Study|Lost to Follow-up|15|||
124871153|NCT02276222|449147284|FG001|Overall Study|Lost to Follow-up|5|||
124871154|NCT02276222|449147283|FG000|Overall Study|Physician Decision|2|||
124871155|NCT02276222|449147284|FG001|Overall Study|Physician Decision|1|||
124871156|NCT02276222|449147283|FG000|Overall Study|sheduling conflict|1|||
124871157|NCT02276222|449147284|FG001|Overall Study|sheduling conflict|0|||
124871158|NCT02276222|449147283|FG000|Overall Study|subject withdrew after randomization|1|||
124871159|NCT02276222|449147284|FG001|Overall Study|subject withdrew after randomization|0|||
124871160|NCT03645759|449147285|FG000|Overall Study|Lost to Follow-up|3|||
124871161|NCT03645759|449147286|FG001|Overall Study|Lost to Follow-up|2|||
124871162|NCT01648270|449147287|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
124871163|NCT02170025|449147288|FG000|Overall Study|Adverse Event|2|||
124871164|NCT02170025|449147289|FG001|Overall Study|Adverse Event|0|||
124871165|NCT00572195|449147290|FG000|Overall Study|Withdrawal by Subject|50|||
124871166|NCT00572195|449147290|FG000|Overall Study|Death|9|||
124871167|NCT00572195|449147290|FG000|Overall Study|Adverse Event|4|||
124871168|NCT00572195|449147290|FG000|Overall Study|Lost to Follow-up|5|||
124871169|NCT00902694|449147291|FG000|Overall Study|Death|1|||
124871170|NCT00902694|449147292|FG001|Overall Study|Death|3|||
124871171|NCT00902694|449147291|FG000|Overall Study|Lost to Follow-up|1|||
124871172|NCT00902694|449147292|FG001|Overall Study|Lost to Follow-up|0|||
124871173|NCT00902694|449147291|FG000|Overall Study|Censored per protocol|3|||
124871174|NCT00902694|449147292|FG001|Overall Study|Censored per protocol|1|||
124871175|NCT00902694|449147291|FG000|Overall Study|Pregnancy|1|||
124871176|NCT00902694|449147292|FG001|Overall Study|Pregnancy|1|||
124871177|NCT00902694|449147291|FG000|Overall Study|Incarceration|1|||
124871178|NCT00902694|449147292|FG001|Overall Study|Incarceration|0|||
124871179|NCT04969263|449147293|FG000|Overall Study|Death|1|||
124871180|NCT04969263|449147293|FG000|Overall Study|Lost to Follow-up|2|||
124871181|NCT04969263|449147293|FG000|Overall Study|Withdrawal by Subject|5|||
124871182|NCT04969263|449147293|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
124871183|NCT02693743|449147294|FG000|Overall Study|Physician Decision|1|||
124871184|NCT02693743|449147295|FG001|Overall Study|Physician Decision|0|||
124871185|NCT01024608|449147296|FG000|Overall Study|Adverse Event|1|||
124871186|NCT01024608|449147297|FG001|Overall Study|Adverse Event|0|||
124871187|NCT01024608|449147296|FG000|Overall Study|Withdrawal by Subject|1|||
124871188|NCT01024608|449147297|FG001|Overall Study|Withdrawal by Subject|0|||
124871189|NCT01024608|449147296|FG000|Overall Study|Lost to Follow-up|0|||
124871190|NCT01024608|449147297|FG001|Overall Study|Lost to Follow-up|1|||
124871191|NCT01024608|449147296|FG000|Overall Study|Protocol Violation|0|||
124871192|NCT01024608|449147297|FG001|Overall Study|Protocol Violation|3|||
124871193|NCT01024608|449147296|FG000|Overall Study|Never received study treatment|2|||
124871194|NCT01024608|449147297|FG001|Overall Study|Never received study treatment|0|||
124871195|NCT02412137|449147298|FG000|Overall Study|Withdrawal by Subject|2|||
124871196|NCT02412137|449147299|FG001|Overall Study|Withdrawal by Subject|0|||
124871197|NCT02412137|449147298|FG000|Overall Study|Lost to Follow-up|21|||
124871198|NCT02412137|449147299|FG001|Overall Study|Lost to Follow-up|14|||
124871199|NCT02412137|449147298|FG000|Overall Study|Physician Decision|28|||
124871200|NCT02412137|449147299|FG001|Overall Study|Physician Decision|9|||
124871201|NCT04981678|449147306|FG000|Overall Study|Lost to Follow-up|0|||
124871202|NCT04981678|449147307|FG001|Overall Study|Lost to Follow-up|1|||
124871203|NCT04922554|449147308|FG000|Overall Study|Adverse Event|4|||
124871204|NCT04922554|449147309|FG001|Overall Study|Adverse Event|0|||
124871205|NCT04922554|449147308|FG000|Overall Study|Withdrawal by Subject|1|||
124871206|NCT04922554|449147309|FG001|Overall Study|Withdrawal by Subject|0|||
124871207|NCT01332227|449149220|FG000|Overall Study|Adverse Event|4|||
124871208|NCT01332227|449149221|FG001|Overall Study|Adverse Event|1|||
124871209|NCT01332227|449149220|FG000|Overall Study|Withdrawal by Subject|5|||
124871210|NCT01332227|449149221|FG001|Overall Study|Withdrawal by Subject|1|||
124871211|NCT01332227|449149220|FG000|Overall Study|Lost to Follow-up|2|||
124871212|NCT01332227|449149221|FG001|Overall Study|Lost to Follow-up|0|||
124871213|NCT01332227|449149220|FG000|Overall Study|Lack of Efficacy|3|||
124871214|NCT01332227|449149221|FG001|Overall Study|Lack of Efficacy|1|||
124871215|NCT01332227|449149220|FG000|Overall Study|Poor compliance/noncompliance|1|||
124871216|NCT01332227|449149221|FG001|Overall Study|Poor compliance/noncompliance|1|||
124871217|NCT01332227|449149220|FG000|Overall Study|Patient moved from area|1|||
124871218|NCT01332227|449149221|FG001|Overall Study|Patient moved from area|0|||
124871219|NCT01332227|449149220|FG000|Overall Study|Patient began prohibited medication|0|||
124871220|NCT01332227|449149221|FG001|Overall Study|Patient began prohibited medication|1|||
124871221|NCT00514943|449149222|FG000|Stage 1|Progressive disease|4|||
124871222|NCT00514943|449149223|FG001|Stage 1|Progressive disease|8|||
124871223|NCT00514943|449149222|FG000|Stage 1|Other Adverse Event|16|||
124871224|NCT00514943|449149223|FG001|Stage 1|Other Adverse Event|6|||
124871225|NCT00514943|449149222|FG000|Stage 1|Not treated|1|||
124871226|NCT00514943|449149223|FG001|Stage 1|Not treated|2|||
124871227|NCT00514943|449149222|FG000|Stage 1|Patient refused to continue study meds|8|||
124871228|NCT00514943|449149223|FG001|Stage 1|Patient refused to continue study meds|3|||
124871229|NCT00514943|449149222|FG000|Stage 1|Other than stated above|1|||
124871230|NCT00514943|449149223|FG001|Stage 1|Other than stated above|7|||
124871231|NCT00514943|449149222|FG000|Stage 2|Progressive disease|27|||
124871232|NCT00514943|449149223|FG001|Stage 2|Progressive disease|24|||
124871233|NCT00514943|449149222|FG000|Stage 2|Other Adverse Event|3|||
124871234|NCT00514943|449149223|FG001|Stage 2|Other Adverse Event|10|||
124871235|NCT00514943|449149222|FG000|Stage 2|Patient refused to continue study meds|2|||
124871236|NCT00514943|449149223|FG001|Stage 2|Patient refused to continue study meds|0|||
124871237|NCT00514943|449149222|FG000|Stage 2|Other than stated above|0|||
124871238|NCT00514943|449149223|FG001|Stage 2|Other than stated above|2|||
124871239|NCT02173548|449149228|FG000|Overall Study|Lost to Follow-up|0|||
124871240|NCT02173548|449149229|FG001|Overall Study|Lost to Follow-up|2|||
124871241|NCT02173548|449149228|FG000|Overall Study|Withdrawal by Subject|1|||
124871242|NCT02173548|449149229|FG001|Overall Study|Withdrawal by Subject|0|||
124871243|NCT02066402|449149232|FG000|Overall Study|Adverse Event|1|||
124871244|NCT02066402|449149233|FG001|Overall Study|Adverse Event|2|||
124871245|NCT02066402|449149232|FG000|Overall Study|Lost to Follow-up|11|||
124871246|NCT02066402|449149233|FG001|Overall Study|Lost to Follow-up|8|||
124871247|NCT02066402|449149232|FG000|Overall Study|Withdrawal by Subject|14|||
124871248|NCT02066402|449149233|FG001|Overall Study|Withdrawal by Subject|11|||
124871249|NCT02066402|449149232|FG000|Overall Study|Progressive disease-clinical progression|0|||
124871250|NCT02066402|449149233|FG001|Overall Study|Progressive disease-clinical progression|1|||
124871251|NCT02066402|449149232|FG000|Overall Study|Protocol driven decision point|0|||
124871252|NCT02066402|449149233|FG001|Overall Study|Protocol driven decision point|1|||
124871253|NCT04493931|449149234|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
124871254|NCT04493931|449149235|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
124871255|NCT04493931|449149236|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
124871256|NCT04493931|449149237|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
124871257|NCT04493931|449149238|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
124871258|NCT04493931|449149239|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
124871259|NCT04493931|449149240|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
124871260|NCT04493931|449149234|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
124871261|NCT04493931|449149235|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
124871262|NCT04493931|449149236|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
124871263|NCT04493931|449149237|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
124871264|NCT04493931|449149238|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
124871265|NCT04493931|449149239|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
124871266|NCT04493931|449149240|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
124871267|NCT04493931|449149234|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
124871268|NCT04493931|449149235|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
124871269|NCT04493931|449149236|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
124871270|NCT04493931|449149237|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
124871271|NCT04493931|449149238|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
124871272|NCT04493931|449149239|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
124871273|NCT04493931|449149240|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
124871274|NCT04493931|449149234|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
124871275|NCT04493931|449149235|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
124871276|NCT04493931|449149236|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
124871277|NCT04493931|449149237|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
124871278|NCT04493931|449149238|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
124871279|NCT04493931|449149239|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
124871280|NCT04493931|449149240|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
124871281|NCT00266825|449149241|FG000|Completed Follow-Up|Lost to Follow-up|14|||
124871282|NCT00266825|449149242|FG001|Completed Follow-Up|Lost to Follow-up|19|||
124871283|NCT00266825|449149241|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
124871284|NCT00266825|449149242|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
124871285|NCT00595504|449149246|FG000|Overall Study|Withdrawal by Subject|1|||
124871286|NCT00595504|449149247|FG001|Overall Study|Withdrawal by Subject|3|||
124871287|NCT00595504|449149246|FG000|Overall Study|Physician Decision|1|||
124871288|NCT00595504|449149247|FG001|Overall Study|Physician Decision|0|||
124871289|NCT02182973|449149259|FG000|Overall Study|Withdrawal by Subject|3|||
124871290|NCT02182973|449149260|FG001|Overall Study|Withdrawal by Subject|0|||
124871291|NCT01235546|449149261|FG000|Overall Study|Staff error, medication not administered|1|||
124871292|NCT01235546|449149262|FG001|Overall Study|Staff error, medication not administered|0|||
124871293|NCT01235546|449149261|FG000|Overall Study|Protocol Violation|1|||
124871294|NCT01235546|449149262|FG001|Overall Study|Protocol Violation|1|||
124871295|NCT01123382|449149263|FG000|Overall Study|Withdrawal by Subject|1|||
124871296|NCT01123382|449149264|FG001|Overall Study|Withdrawal by Subject|4|||
124871297|NCT01123382|449149263|FG000|Overall Study|Lost to Follow-up|1|||
124871298|NCT01123382|449149264|FG001|Overall Study|Lost to Follow-up|2|||
124871299|NCT02054806|449149265|FG000|Overall Study|Sponsor Decision|31|||
124871300|NCT02054806|449149265|FG000|Overall Study|Withdrawal by Subject|43|||
124871301|NCT02054806|449149265|FG000|Overall Study|Protocol Violation|2|||
124871302|NCT02054806|449149265|FG000|Overall Study|Lost to Follow-up|10|||
124871303|NCT02054806|449149265|FG000|Overall Study|Death|391|||
124871304|NCT00645164|449149270|FG000|Overall Study|Lost to Follow-up|2|||
124871305|NCT00645164|449149270|FG000|Overall Study|Withdrawal by Subject|4|||
124871306|NCT00645164|449149270|FG000|Overall Study|Protocol Violation|1|||
124871307|NCT01362439|449149271|FG000|Overall Study|Adverse Event|1|||
124871308|NCT01362439|449149271|FG000|Overall Study|Lack of Efficacy|3|||
124871309|NCT01362439|449149271|FG000|Overall Study|Lost to Follow-up|2|||
124871310|NCT01362439|449149271|FG000|Overall Study|Study medication non-compliant|1|||
124871311|NCT01362439|449149271|FG000|Overall Study|Participant who withdrew consent|8|||
124871312|NCT01281644|449149273|FG000|Overall Study|Lost to Follow-up|3|||
124871313|NCT01281644|449149273|FG000|Overall Study|Withdrawal by Subject|2|||
124871314|NCT01755702|449149274|FG000|Wash Out Period I|Other Reason|3|||
124871315|NCT01755702|449149274|FG000|Washout Period II|Other Reason|5|||
124871316|NCT00691938|449149275|FG000|Overall Study|QTc prolongation|1|||
124871317|NCT00691938|449149276|FG001|Overall Study|QTc prolongation|0|||
124536834|NCT01632345|447917810|FG000|Treatment: Part I|Lack of Efficacy|0|||
124871318|NCT00691938|449149277|FG002|Overall Study|QTc prolongation|0|||
124871319|NCT00691938|449149278|FG003|Overall Study|QTc prolongation|0|||
124871320|NCT00691938|449149279|FG004|Overall Study|QTc prolongation|0|||
124871321|NCT00691938|449149280|FG005|Overall Study|QTc prolongation|0|||
124871322|NCT00691938|449149281|FG006|Overall Study|QTc prolongation|0|||
124871323|NCT04860518|449149282|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
124536835|NCT01632345|447917811|FG001|Treatment: Part I|Lack of Efficacy|1|||
124871324|NCT04860518|449149283|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
124871325|NCT02755597|449149285|FG000|Overall Study|Withdrew consent|27|||
124871326|NCT02755597|449149286|FG001|Overall Study|Withdrew consent|11|||
124871327|NCT02755597|449149285|FG000|Overall Study|Lost to Follow-up|1|||
124871328|NCT02755597|449149286|FG001|Overall Study|Lost to Follow-up|0|||
124871329|NCT02755597|449149285|FG000|Overall Study|Death|78|||
124871330|NCT02755597|449149286|FG001|Overall Study|Death|36|||
124871331|NCT02755597|449149285|FG000|Overall Study|Study terminated by Sponsor|67|||
124871332|NCT02755597|449149286|FG001|Overall Study|Study terminated by Sponsor|47|||
124871333|NCT02755597|449149285|FG000|Overall Study|Other, not specified|20|||
124871334|NCT02755597|449149286|FG001|Overall Study|Other, not specified|3|||
124871335|NCT02755597|449149285|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
124871336|NCT02755597|449149286|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
124871337|NCT00594854|449149288|FG000|Overall Study|Study terminated|7|||
124871338|NCT00594854|449149289|FG001|Overall Study|Study terminated|10|||
124871339|NCT02684006|449149290|FG000|Overall Study|Other|18|||
124871340|NCT02684006|449149291|FG001|Overall Study|Other|6|||
124871341|NCT02684006|449149290|FG000|Overall Study|Protocol Violation|2|||
124871342|NCT02684006|449149291|FG001|Overall Study|Protocol Violation|1|||
124871343|NCT02684006|449149290|FG000|Overall Study|Non-compliance with study drug|1|||
124871344|NCT02684006|449149291|FG001|Overall Study|Non-compliance with study drug|1|||
124871345|NCT02684006|449149290|FG000|Overall Study|No longer met eligibility criteria|6|||
124871346|NCT02684006|449149291|FG001|Overall Study|No longer met eligibility criteria|2|||
124871347|NCT02684006|449149290|FG000|Overall Study|Lost to Follow-up|0|||
124871348|NCT02684006|449149291|FG001|Overall Study|Lost to Follow-up|1|||
124871349|NCT02684006|449149290|FG000|Overall Study|Death|25|||
124871350|NCT02684006|449149291|FG001|Overall Study|Death|22|||
124871351|NCT02684006|449149290|FG000|Overall Study|Global deterioration of health status|18|||
124871352|NCT02684006|449149291|FG001|Overall Study|Global deterioration of health status|20|||
124871353|NCT02684006|449149290|FG000|Overall Study|Physician Decision|15|||
124871354|NCT02684006|449149291|FG001|Overall Study|Physician Decision|8|||
124871355|NCT02684006|449149290|FG000|Overall Study|Adverse Event|86|||
124871356|NCT02684006|449149291|FG001|Overall Study|Adverse Event|65|||
124871357|NCT02684006|449149290|FG000|Overall Study|Withdrawal by Subject|29|||
124871358|NCT02684006|449149291|FG001|Overall Study|Withdrawal by Subject|43|||
124871359|NCT02684006|449149290|FG000|Overall Study|Progressive disease|236|||
124871360|NCT02684006|449149291|FG001|Overall Study|Progressive disease|266|||
124871361|NCT02684006|449149290|FG000|Overall Study|Participation terminated by sponsor|6|||
124871362|NCT02684006|449149291|FG001|Overall Study|Participation terminated by sponsor|9|||
124871363|NCT03804710|449149293|FG000|Overall Study|Adverse Event|0|||
124871364|NCT03804710|449149294|FG001|Overall Study|Adverse Event|3|||
124871365|NCT03804710|449149293|FG000|Overall Study|Withdrawal by Subject|2|||
124871366|NCT03804710|449149294|FG001|Overall Study|Withdrawal by Subject|1|||
124871367|NCT03804710|449149293|FG000|Overall Study|Other|0|||
124871368|NCT03804710|449149294|FG001|Overall Study|Other|1|||
124871369|NCT02660827|449149295|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
124871370|NCT02660827|449149295|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
124871371|NCT02660827|449149295|FG000|From Study to End of Continued Access|Adverse Event|3|||
124871372|NCT02660827|449149295|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
124871373|NCT02660827|449149295|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
124871374|NCT02660827|449149295|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
124871375|NCT02660827|449149295|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
124871376|NCT02660827|449149295|FG000|Period 2: Continued Access Period|Adverse Event|3|||
124871377|NCT01428076|449149296|FG000|Overall Study|Adverse Event|0|||
124871378|NCT01428076|449149297|FG001|Overall Study|Adverse Event|1|||
124871379|NCT00045305|449149301|FG000|Overall Study|Lack of Efficacy|6|||
124871380|NCT00045305|449149301|FG000|Overall Study|Adverse Event|3|||
124871381|NCT00045305|449149301|FG000|Overall Study|Death|3|||
124871382|NCT00045305|449149301|FG000|Overall Study|site error|2|||
124871383|NCT02216773|449149307|FG000|Overall Study|Disease progression|4|||
124871384|NCT02216773|449149308|FG001|Overall Study|Disease progression|2|||
124871385|NCT02216773|449149307|FG000|Overall Study|Insufficient FLRV|4|||
124871386|NCT02216773|449149308|FG001|Overall Study|Insufficient FLRV|0|||
124871387|NCT02216773|449149307|FG000|Overall Study|Abandoned|4|||
124871388|NCT02216773|449149308|FG001|Overall Study|Abandoned|3|||
124871389|NCT04274894|449149309|FG000|Overall Study|Adverse Event|7|||
124644693|NCT03614078|448316488|FG000|Overall Study|Dizziness and Rash|0|||
124871390|NCT04274894|449149309|FG000|Overall Study|Withdrew consent|5|||
124871391|NCT04274894|449149309|FG000|Overall Study|Lost to Follow-up|9|||
124871392|NCT04274894|449149309|FG000|Overall Study|COVID-19 infection|1|||
124871393|NCT04274894|449149309|FG000|Overall Study|Other, not specified|20|||
124871394|NCT02279043|449149310|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
124871395|NCT02279043|449149311|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
124871396|NCT02279043|449149312|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
124871397|NCT02279043|449149310|FG000|Overall Study|Lost to Follow-up|46|||
124871398|NCT02279043|449149311|FG001|Overall Study|Lost to Follow-up|88|||
124871399|NCT02279043|449149312|FG002|Overall Study|Lost to Follow-up|0|||
124871400|NCT03848403|449149313|FG000|Period 2 (Day 8)|Adverse Event|1|||
124871401|NCT03848403|449149314|FG001|Period 2 (Day 8)|Adverse Event|2|||
124871402|NCT03848403|449149315|FG002|Period 2 (Day 8)|Adverse Event|2|||
124871403|NCT03848403|449149313|FG000|Period 2 (Day 8)|Physician Decision|0|||
124871404|NCT03848403|449149314|FG001|Period 2 (Day 8)|Physician Decision|1|||
124871405|NCT03848403|449149315|FG002|Period 2 (Day 8)|Physician Decision|0|||
124871406|NCT03848403|449149313|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
124871407|NCT03848403|449149314|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
124871408|NCT03848403|449149315|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
124871409|NCT02124265|449149316|FG000|Overall Study|Adverse Event|1|||
124871410|NCT04510675|449149318|FG000|Overall Study|Withdrawal by Subject|5|||
124871411|NCT01330433|449149323|FG000|Overall Study|Death|1|||
124871412|NCT01330433|449149324|FG001|Overall Study|Death|3|||
124536836|NCT01632345|447917812|FG002|Treatment: Part I|Lack of Efficacy|0|||
124536837|NCT01632345|447917813|FG003|Treatment: Part I|Lack of Efficacy|1|||
124536838|NCT01632345|447917814|FG004|Treatment: Part I|Lack of Efficacy|1|||
124536839|NCT01632345|447917815|FG005|Treatment: Part I|Lack of Efficacy|0|||
124536840|NCT01632345|447917816|FG006|Treatment: Part I|Lack of Efficacy|0|||
124536841|NCT01632345|447917810|FG000|Treatment: Part I|Lost to Follow-up|3|||
124536842|NCT01632345|447917811|FG001|Treatment: Part I|Lost to Follow-up|2|||
124536843|NCT01632345|447917812|FG002|Treatment: Part I|Lost to Follow-up|1|||
124536844|NCT01632345|447917813|FG003|Treatment: Part I|Lost to Follow-up|3|||
124536845|NCT01632345|447917814|FG004|Treatment: Part I|Lost to Follow-up|4|||
124536846|NCT01632345|447917815|FG005|Treatment: Part I|Lost to Follow-up|0|||
124871413|NCT01330433|449149323|FG000|Overall Study|Lost to Follow-up|1|||
124871414|NCT01330433|449149324|FG001|Overall Study|Lost to Follow-up|0|||
124871415|NCT02114151|449149325|FG000|Overall Study|Death|1|||
124871416|NCT02114151|449149325|FG000|Overall Study|Lost to Follow-up|1|||
124871417|NCT02114151|449149325|FG000|Overall Study|Withdrawal by Subject|5|||
124871418|NCT01494584|449149326|FG000|Overall Study|Study Closed/Terminated|1|||
124871419|NCT01666808|449149327|FG000|Overall Study|Lost to Follow-up|9|||
124871420|NCT01666808|449149328|FG001|Overall Study|Lost to Follow-up|15|||
124871421|NCT01666808|449149327|FG000|Overall Study|Withdrawal by Subject|3|||
124871422|NCT01666808|449149328|FG001|Overall Study|Withdrawal by Subject|1|||
124871423|NCT01666808|449149327|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
124871424|NCT01666808|449149328|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
124871425|NCT01499082|449149329|FG000|Overall Study|Randomized but not Treated|0|||
124871426|NCT01499082|449149330|FG001|Overall Study|Randomized but not Treated|1|||
124871427|NCT01499082|449149329|FG000|Overall Study|Adverse Event|12|||
124871428|NCT01499082|449149330|FG001|Overall Study|Adverse Event|16|||
124871429|NCT01499082|449149329|FG000|Overall Study|Lack of Efficacy|1|||
124871430|NCT01499082|449149330|FG001|Overall Study|Lack of Efficacy|1|||
124871431|NCT01499082|449149329|FG000|Overall Study|Protocol Violation|6|||
124871432|NCT01499082|449149330|FG001|Overall Study|Protocol Violation|8|||
124871433|NCT01499082|449149329|FG000|Overall Study|Diverse Reasons|18|||
124871434|NCT01499082|449149330|FG001|Overall Study|Diverse Reasons|14|||
124871435|NCT01499082|449149329|FG000|Overall Study|Site Closure for Noncompliance|5|||
124871436|NCT01499082|449149330|FG001|Overall Study|Site Closure for Noncompliance|2|||
124871437|NCT01499082|449149329|FG000|Overall Study|Hypoglycemia|2|||
124871438|NCT01499082|449149330|FG001|Overall Study|Hypoglycemia|3|||
124871439|NCT01499082|449149329|FG000|Overall Study|Lost to Follow-up|1|||
124871440|NCT01499082|449149330|FG001|Overall Study|Lost to Follow-up|3|||
124871441|NCT02638948|449149331|FG000|Overall Study|Withdrawal by Subject|4|||
124871442|NCT02638948|449149332|FG001|Overall Study|Withdrawal by Subject|5|||
124871443|NCT02638948|449149333|FG002|Overall Study|Withdrawal by Subject|3|||
124871444|NCT02638948|449149334|FG003|Overall Study|Withdrawal by Subject|1|||
124871445|NCT02638948|449149331|FG000|Overall Study|Administrative Reason by Sponsor|0|||
124871446|NCT02638948|449149332|FG001|Overall Study|Administrative Reason by Sponsor|1|||
124871447|NCT02638948|449149333|FG002|Overall Study|Administrative Reason by Sponsor|0|||
124871448|NCT02638948|449149334|FG003|Overall Study|Administrative Reason by Sponsor|4|||
124871449|NCT02638948|449149331|FG000|Overall Study|Adverse Event|0|||
124871450|NCT02638948|449149332|FG001|Overall Study|Adverse Event|0|||
124871451|NCT02638948|449149333|FG002|Overall Study|Adverse Event|1|||
124536847|NCT01632345|447917816|FG006|Treatment: Part I|Lost to Follow-up|0|||
124536848|NCT01632345|447917810|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
124536849|NCT01632345|447917811|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
124871452|NCT02638948|449149334|FG003|Overall Study|Adverse Event|1|||
124871453|NCT02638948|449149331|FG000|Overall Study|Lack of Efficacy|1|||
124871454|NCT02638948|449149332|FG001|Overall Study|Lack of Efficacy|1|||
124871455|NCT02638948|449149333|FG002|Overall Study|Lack of Efficacy|0|||
124871456|NCT02638948|449149334|FG003|Overall Study|Lack of Efficacy|0|||
124871457|NCT02638948|449149331|FG000|Overall Study|Lost to Follow-up|0|||
124871458|NCT02638948|449149332|FG001|Overall Study|Lost to Follow-up|0|||
124871459|NCT02638948|449149333|FG002|Overall Study|Lost to Follow-up|1|||
124871460|NCT02638948|449149334|FG003|Overall Study|Lost to Follow-up|1|||
124871461|NCT02638948|449149331|FG000|Overall Study|Poor/Non-Compliance|0|||
124871462|NCT02638948|449149332|FG001|Overall Study|Poor/Non-Compliance|2|||
124871463|NCT02638948|449149333|FG002|Overall Study|Poor/Non-Compliance|1|||
124871464|NCT02638948|449149334|FG003|Overall Study|Poor/Non-Compliance|0|||
124871465|NCT02638948|449149331|FG000|Overall Study|Participant no longer met study criteria|0|||
124871466|NCT02638948|449149332|FG001|Overall Study|Participant no longer met study criteria|1|||
124871467|NCT02638948|449149333|FG002|Overall Study|Participant no longer met study criteria|0|||
124871468|NCT02638948|449149334|FG003|Overall Study|Participant no longer met study criteria|0|||
124871469|NCT02638948|449149331|FG000|Overall Study|Other than specified above|4|||
124871470|NCT02638948|449149332|FG001|Overall Study|Other than specified above|1|||
124871471|NCT02638948|449149333|FG002|Overall Study|Other than specified above|1|||
124871472|NCT02638948|449149334|FG003|Overall Study|Other than specified above|1|||
124871473|NCT00810264|449149338|FG000|Overall Study|Lost to Follow-up|191|||
124871474|NCT00810264|449149338|FG000|Overall Study|Withdrawal by subject or physician|721|||
124871475|NCT00810264|449149338|FG000|Overall Study|Death|641|||
124871476|NCT01830127|449149339|FG000|Overall Study|Adverse Event|1|||
124871477|NCT01830127|449149340|FG001|Overall Study|Adverse Event|6|||
124871478|NCT01830127|449149339|FG000|Overall Study|Lack of Efficacy|3|||
124871479|NCT01830127|449149340|FG001|Overall Study|Lack of Efficacy|0|||
124871480|NCT01830127|449149339|FG000|Overall Study|Withdrawal by Subject|1|||
124871481|NCT01830127|449149340|FG001|Overall Study|Withdrawal by Subject|1|||
124871482|NCT01830127|449149339|FG000|Overall Study|Other reason not defined above|0|||
124871483|NCT01830127|449149340|FG001|Overall Study|Other reason not defined above|2|||
124871484|NCT06213701|449149341|FG000|Overall Study|Withdrawal by Subject|2|||
124871485|NCT06213701|449149342|FG001|Overall Study|Withdrawal by Subject|1|||
124871486|NCT06213701|449149343|FG002|Overall Study|Withdrawal by Subject|0|||
124871487|NCT00567190|449149344|FG000|Overall Study|Death|235|||
124871488|NCT00567190|449149345|FG001|Overall Study|Death|280|||
124871489|NCT00567190|449149344|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
124871490|NCT00567190|449149345|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
124871491|NCT02495025|449149346|FG000|Overall Study|Lost to Follow-up|21|||
124871492|NCT02495025|449149347|FG001|Overall Study|Lost to Follow-up|14|||
124871493|NCT02495025|449149346|FG000|Overall Study|Withdrawal by Subject|5|||
124871494|NCT02495025|449149347|FG001|Overall Study|Withdrawal by Subject|0|||
124871495|NCT00313820|449149348|FG000|Assigned to Treatment|Other|1|||
124871496|NCT00313820|449149349|FG001|Assigned to Treatment|Other|0|||
124871497|NCT00313820|449149348|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
124871498|NCT00313820|449149349|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
124871499|NCT00313820|449149348|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
124871500|NCT00313820|449149349|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
124871501|NCT00313820|449149348|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
124871502|NCT00313820|449149349|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
124871503|NCT00313820|449149348|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
124871504|NCT00313820|449149349|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
124871505|NCT00313820|449149348|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
124871506|NCT00313820|449149349|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
124871507|NCT01515748|449149353|FG000|Overall Study|Withdrawal by Subject|32|||
124871508|NCT01515748|449149354|FG001|Overall Study|Withdrawal by Subject|41|||
124871509|NCT01515748|449149353|FG000|Overall Study|Lost to Follow-up|2|||
124871510|NCT01515748|449149354|FG001|Overall Study|Lost to Follow-up|4|||
124871511|NCT01515748|449149353|FG000|Overall Study|Other than specified above|5|||
124871512|NCT01515748|449149354|FG001|Overall Study|Other than specified above|10|||
124871513|NCT04102579|449149358|FG000|Overall Study|Withdrawal by Subject|3|||
124871514|NCT04102579|449149359|FG001|Overall Study|Withdrawal by Subject|4|||
124871515|NCT04102579|449149358|FG000|Overall Study|Lost to Follow-up|0|||
124871516|NCT04102579|449149359|FG001|Overall Study|Lost to Follow-up|1|||
124871517|NCT04102579|449149358|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
124871518|NCT04102579|449149359|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
124871519|NCT04102579|449149358|FG000|Overall Study|Other than Specified|1|||
124871520|NCT04102579|449149359|FG001|Overall Study|Other than Specified|0|||
124871521|NCT04102579|449149358|FG000|Overall Study|Not Dosed with Study Drug|0|||
124871522|NCT04102579|449149359|FG001|Overall Study|Not Dosed with Study Drug|1|||
124871523|NCT03419364|449149360|FG000|Overall Study|Delivery due to maternal condition|2|||
124871524|NCT03419364|449149361|FG001|Overall Study|Delivery due to maternal condition|0|||
124871525|NCT03419364|449149362|FG002|Overall Study|Delivery due to maternal condition|0|||
124871526|NCT02543658|449150770|FG000|Overall Study|Lack of Efficacy|0|||
124871527|NCT02543658|449150771|FG001|Overall Study|Lack of Efficacy|4|||
124871528|NCT00662857|449150772|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
124871529|NCT00662857|449150773|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
124871530|NCT00662857|449150772|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
124871531|NCT00662857|449150773|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
124871532|NCT00662857|449150772|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
124871533|NCT00662857|449150773|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
124871534|NCT00989092|449150774|FG000|Overall Study|Physician Decision|9|||
124871535|NCT00989092|449150775|FG001|Overall Study|Physician Decision|6|||
124871536|NCT00989092|449150774|FG000|Overall Study|Adverse Event|20|||
124871537|NCT00989092|449150775|FG001|Overall Study|Adverse Event|1|||
124871538|NCT00989092|449150774|FG000|Overall Study|Chemotherapy initiated|12|||
124871539|NCT00989092|449150775|FG001|Overall Study|Chemotherapy initiated|4|||
124871540|NCT00989092|449150774|FG000|Overall Study|Withdrawal by Subject|17|||
124871541|NCT00989092|449150775|FG001|Overall Study|Withdrawal by Subject|9|||
124871542|NCT00989092|449150774|FG000|Overall Study|Death|14|||
124871543|NCT00989092|449150775|FG001|Overall Study|Death|2|||
124871544|NCT00989092|449150774|FG000|Overall Study|Ineligibility determined|3|||
124871545|NCT00989092|449150775|FG001|Overall Study|Ineligibility determined|3|||
124871546|NCT00989092|449150774|FG000|Overall Study|Lost to Follow-up|6|||
124871547|NCT00989092|449150775|FG001|Overall Study|Lost to Follow-up|2|||
124871548|NCT00989092|449150774|FG000|Overall Study|Other|3|||
124871549|NCT00989092|449150775|FG001|Overall Study|Other|1|||
124871550|NCT00989092|449150774|FG000|Overall Study|Protocol deviation|2|||
124871551|NCT00989092|449150775|FG001|Overall Study|Protocol deviation|0|||
124871552|NCT00989092|449150774|FG000|Overall Study|Erythropoietin therapy initiated|2|||
124871553|NCT00989092|449150775|FG001|Overall Study|Erythropoietin therapy initiated|0|||
124871554|NCT00989092|449150774|FG000|Overall Study|Did not receive study drug|2|||
124871555|NCT00989092|449150775|FG001|Overall Study|Did not receive study drug|0|||
124871556|NCT03040713|449150776|FG000|Overall Study|Positive amyloid scan|3|||
124871557|NCT04539821|449150777|FG000|Overall Study|Withdrawal by Subject|2|||
124871558|NCT04539821|449150777|FG000|Overall Study|continued care with their physician|20|||
124871559|NCT04539821|449150777|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
124871560|NCT02691182|449150778|FG000|Overall Study|Withdrawal by Subject|4|||
124871561|NCT02691182|449150779|FG001|Overall Study|Withdrawal by Subject|7|||
124871562|NCT02691182|449150780|FG002|Overall Study|Withdrawal by Subject|6|||
124871563|NCT02691182|449150781|FG003|Overall Study|Withdrawal by Subject|8|||
124871564|NCT02691182|449150778|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
124871565|NCT02691182|449150779|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
124871566|NCT02691182|449150780|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
124871567|NCT02691182|449150781|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
124871568|NCT02691182|449150778|FG000|Overall Study|Lost to Follow-up|8|||
124871569|NCT02691182|449150779|FG001|Overall Study|Lost to Follow-up|33|||
124871570|NCT02691182|449150780|FG002|Overall Study|Lost to Follow-up|19|||
124871571|NCT02691182|449150781|FG003|Overall Study|Lost to Follow-up|22|||
124871572|NCT02691182|449150778|FG000|Overall Study|Adverse Event|3|||
124871573|NCT02691182|449150779|FG001|Overall Study|Adverse Event|10|||
124871574|NCT02691182|449150780|FG002|Overall Study|Adverse Event|10|||
124871575|NCT02691182|449150781|FG003|Overall Study|Adverse Event|11|||
124871576|NCT02691182|449150778|FG000|Overall Study|Physician Decision|3|||
124871577|NCT02691182|449150779|FG001|Overall Study|Physician Decision|7|||
124871578|NCT02691182|449150780|FG002|Overall Study|Physician Decision|14|||
124871579|NCT02691182|449150781|FG003|Overall Study|Physician Decision|8|||
124871580|NCT02691182|449150778|FG000|Overall Study|Lack of Efficacy|0|||
124871581|NCT02691182|449150779|FG001|Overall Study|Lack of Efficacy|0|||
124871582|NCT02691182|449150780|FG002|Overall Study|Lack of Efficacy|0|||
124871583|NCT02691182|449150781|FG003|Overall Study|Lack of Efficacy|4|||
124871584|NCT02691182|449150778|FG000|Overall Study|Protocol Violation|2|||
124871585|NCT02691182|449150779|FG001|Overall Study|Protocol Violation|6|||
124871586|NCT02691182|449150780|FG002|Overall Study|Protocol Violation|6|||
124871587|NCT02691182|449150781|FG003|Overall Study|Protocol Violation|8|||
124871588|NCT02691182|449150778|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
124871589|NCT02691182|449150779|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
124871590|NCT02691182|449150780|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
124871591|NCT02691182|449150781|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
124871592|NCT02691182|449150778|FG000|Overall Study|Missing|0|||
124871593|NCT02691182|449150779|FG001|Overall Study|Missing|5|||
124871594|NCT02691182|449150780|FG002|Overall Study|Missing|1|||
124871595|NCT02691182|449150781|FG003|Overall Study|Missing|5|||
124536850|NCT01632345|447917812|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
124536851|NCT01632345|447917813|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
124536852|NCT01632345|447917814|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
124536853|NCT01632345|447917815|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
124871596|NCT02563002|449150782|FG000|Overall Study|Death|72|||
124871597|NCT02563002|449150783|FG001|Overall Study|Death|87|||
124871598|NCT02563002|449150782|FG000|Overall Study|Lost to Follow-up|5|||
124871599|NCT02563002|449150783|FG001|Overall Study|Lost to Follow-up|0|||
124871600|NCT02563002|449150782|FG000|Overall Study|Physician Decision|0|||
124871601|NCT02563002|449150783|FG001|Overall Study|Physician Decision|2|||
124871602|NCT02563002|449150782|FG000|Overall Study|Withdrawal by Subject|2|||
124871603|NCT02563002|449150783|FG001|Overall Study|Withdrawal by Subject|10|||
124871604|NCT02563002|449150782|FG000|Overall Study|Sponsor decision|74|||
124871605|NCT02563002|449150783|FG001|Overall Study|Sponsor decision|55|||
124871606|NCT01844284|449150784|FG000|Overall Study|Lost to Follow-up|12|||
124871607|NCT01844284|449150785|FG001|Overall Study|Lost to Follow-up|7|||
124871608|NCT00611858|449150786|FG000|Overall Study|Adverse Event|2|||
124871609|NCT00611858|449150786|FG000|Overall Study|Withdrawal by Subject|2|||
124871610|NCT03172702|449150787|FG000|Overall Study|Adverse Event|9|||
124871611|NCT03172702|449150787|FG000|Overall Study|Death|2|||
124871612|NCT03172702|449150787|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
124871613|NCT03172702|449150787|FG000|Overall Study|Withdrawal by Subject|5|||
124871614|NCT03172702|449150787|FG000|Overall Study|Other|2|||
124871615|NCT06134180|449150788|FG000|Overall Study|Lost to Follow-up|4|||
124871616|NCT02152982|449150789|FG000|Overall Study|Ineligible|4|||
124871617|NCT02152982|449150790|FG001|Overall Study|Ineligible|4|||
124871618|NCT02152982|449150789|FG000|Overall Study|Did not start treatment|12|||
124871619|NCT02152982|449150790|FG001|Overall Study|Did not start treatment|6|||
124871620|NCT03641313|449150791|FG000|Overall Study|Death|1|||
124871621|NCT03641313|449150791|FG000|Overall Study|Withdrawal by Subject|2|||
124978557|NCT03829501|449548506|FG018|Overall Study|Death|1|||
124978558|NCT03829501|449548507|FG019|Overall Study|Death|1|||
124978559|NCT03829501|449548508|FG020|Overall Study|Death|1|||
124978560|NCT03829501|449548509|FG021|Overall Study|Death|2|||
124978561|NCT03829501|449548510|FG022|Overall Study|Death|3|||
124978562|NCT03829501|449548488|FG000|Overall Study|Miscellaneous|0|||
124978563|NCT03829501|449548489|FG001|Overall Study|Miscellaneous|0|||
124978564|NCT03829501|449548490|FG002|Overall Study|Miscellaneous|1|||
124978565|NCT03829501|449548491|FG003|Overall Study|Miscellaneous|0|||
124978566|NCT03829501|449548492|FG004|Overall Study|Miscellaneous|0|||
124978567|NCT03829501|449548493|FG005|Overall Study|Miscellaneous|0|||
124978568|NCT03829501|449548494|FG006|Overall Study|Miscellaneous|0|||
124978569|NCT03829501|449548495|FG007|Overall Study|Miscellaneous|1|||
124978570|NCT03829501|449548496|FG008|Overall Study|Miscellaneous|0|||
124978571|NCT03829501|449548497|FG009|Overall Study|Miscellaneous|0|||
124978572|NCT03829501|449548498|FG010|Overall Study|Miscellaneous|0|||
124978573|NCT03829501|449548499|FG011|Overall Study|Miscellaneous|0|||
124978574|NCT03829501|449548500|FG012|Overall Study|Miscellaneous|0|||
124978575|NCT03829501|449548501|FG013|Overall Study|Miscellaneous|0|||
124978576|NCT03829501|449548502|FG014|Overall Study|Miscellaneous|0|||
124978577|NCT03829501|449548503|FG015|Overall Study|Miscellaneous|0|||
124978578|NCT03829501|449548504|FG016|Overall Study|Miscellaneous|0|||
124978579|NCT03829501|449548505|FG017|Overall Study|Miscellaneous|0|||
124978580|NCT03829501|449548506|FG018|Overall Study|Miscellaneous|0|||
124978581|NCT03829501|449548507|FG019|Overall Study|Miscellaneous|0|||
124978582|NCT03829501|449548508|FG020|Overall Study|Miscellaneous|0|||
124978583|NCT03829501|449548509|FG021|Overall Study|Miscellaneous|0|||
124978584|NCT03829501|449548510|FG022|Overall Study|Miscellaneous|1|||
124978585|NCT01123070|449548511|FG000|Part B Double Blind Period|Protocol Violation|0|||
124978586|NCT01123070|449548512|FG001|Part B Double Blind Period|Protocol Violation|0|||
124978587|NCT01123070|449548513|FG002|Part B Double Blind Period|Protocol Violation|0|||
124978588|NCT01123070|449548514|FG003|Part B Double Blind Period|Protocol Violation|1|||
124978589|NCT01123070|449548511|FG000|Part B Double Blind Period|Adverse Event|0|||
124978590|NCT01123070|449548512|FG001|Part B Double Blind Period|Adverse Event|0|||
124978591|NCT01123070|449548513|FG002|Part B Double Blind Period|Adverse Event|2|||
124978592|NCT01123070|449548514|FG003|Part B Double Blind Period|Adverse Event|0|||
124871622|NCT03641313|449150791|FG000|Overall Study|Declining health|1|||
124871623|NCT03641313|449150791|FG000|Overall Study|Adverse Event|1|||
124871624|NCT04642898|449150792|FG000|Overall Study|Withdrawal by Subject|2|||
124871625|NCT04642898|449150793|FG001|Overall Study|Withdrawal by Subject|4|||
124871626|NCT04642898|449150794|FG002|Overall Study|Withdrawal by Subject|4|||
124871627|NCT04642898|449150795|FG003|Overall Study|Withdrawal by Subject|6|||
124871628|NCT04642898|449150796|FG004|Overall Study|Withdrawal by Subject|2|||
124871629|NCT04642898|449150797|FG005|Overall Study|Withdrawal by Subject|6|||
124871630|NCT04642898|449150792|FG000|Overall Study|Lost to Follow-up|0|||
124871631|NCT04642898|449150793|FG001|Overall Study|Lost to Follow-up|0|||
124871632|NCT04642898|449150794|FG002|Overall Study|Lost to Follow-up|0|||
124536854|NCT01632345|447917816|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
124871633|NCT04642898|449150795|FG003|Overall Study|Lost to Follow-up|2|||
124871634|NCT04642898|449150796|FG004|Overall Study|Lost to Follow-up|0|||
124871635|NCT04642898|449150797|FG005|Overall Study|Lost to Follow-up|1|||
124871636|NCT04642898|449150792|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
124871637|NCT04642898|449150793|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
124871638|NCT04642898|449150794|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
124871639|NCT04642898|449150795|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
124871640|NCT04642898|449150796|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
124871641|NCT04642898|449150797|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
124871642|NCT04642898|449150792|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
124871643|NCT04642898|449150793|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
124978593|NCT01123070|449548511|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
124978594|NCT01123070|449548512|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
124871644|NCT04642898|449150794|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
124871645|NCT04642898|449150795|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
124871646|NCT04642898|449150796|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
124871647|NCT04642898|449150797|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
124871648|NCT03574597|449150798|FG000|Overall Study|Withdrawal by Subject|67|||
124871649|NCT03574597|449150799|FG001|Overall Study|Withdrawal by Subject|96|||
124871650|NCT03574597|449150798|FG000|Overall Study|Lost to Follow-up|192|||
124871651|NCT03574597|449150799|FG001|Overall Study|Lost to Follow-up|188|||
124871652|NCT03434678|449150800|FG000|Overall Study|Withdrawal by Subject|13|||
124871653|NCT03434678|449150801|FG001|Overall Study|Withdrawal by Subject|13|||
124871654|NCT03434678|449150800|FG000|Overall Study|Found to be ineligible post randomization|2|||
124871655|NCT03434678|449150801|FG001|Overall Study|Found to be ineligible post randomization|1|||
124871656|NCT06060457|449150804|FG000|Overall Study|Adverse Event|1|||
124871657|NCT06060457|449150805|FG001|Overall Study|Adverse Event|1|||
124871658|NCT06060457|449150804|FG000|Overall Study|Death|2|||
124871659|NCT06060457|449150805|FG001|Overall Study|Death|2|||
124871660|NCT06060457|449150804|FG000|Overall Study|Lost to Follow-up|17|||
124871661|NCT06060457|449150805|FG001|Overall Study|Lost to Follow-up|19|||
124871662|NCT06060457|449150804|FG000|Overall Study|Physician Decision|0|||
124871663|NCT06060457|449150805|FG001|Overall Study|Physician Decision|1|||
124871664|NCT06060457|449150804|FG000|Overall Study|Protocol Violation|1|||
124871665|NCT06060457|449150805|FG001|Overall Study|Protocol Violation|1|||
124871666|NCT06060457|449150804|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
124871667|NCT06060457|449150805|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
124871668|NCT06060457|449150804|FG000|Overall Study|Withdrawal by Subject|12|||
124871669|NCT06060457|449150805|FG001|Overall Study|Withdrawal by Subject|15|||
124871670|NCT06060457|449150804|FG000|Overall Study|Other Than Specified|2|||
124871671|NCT06060457|449150805|FG001|Overall Study|Other Than Specified|1|||
124871672|NCT02061202|449150806|FG000|Overall Study|Lost to Follow-up|1|||
124871673|NCT02061202|449150807|FG001|Overall Study|Lost to Follow-up|1|||
124871674|NCT00569582|449150811|FG000|Overall Study|Withdrawal by Subject|5|||
124871675|NCT00569582|449150811|FG000|Overall Study|Death|2|||
124871676|NCT00569582|449150811|FG000|Overall Study|Adverse Event|7|||
124871677|NCT00569582|449150811|FG000|Overall Study|Subject was too ill to travel.|1|||
124871678|NCT00569582|449150811|FG000|Overall Study|Subject was non-compliant.|1|||
124871679|NCT01533493|449150812|FG000|Overall Study|Adverse Event|2|||
124871680|NCT01533493|449150813|FG001|Overall Study|Adverse Event|1|||
124871681|NCT01533493|449150812|FG000|Overall Study|Withdrawal by Subject|1|||
124871682|NCT01533493|449150813|FG001|Overall Study|Withdrawal by Subject|2|||
124871683|NCT01533493|449150812|FG000|Overall Study|Lost to Follow-up|2|||
124871684|NCT01533493|449150813|FG001|Overall Study|Lost to Follow-up|0|||
124871685|NCT05163522|449150816|FG000|Overall Study|Withdrawal by Subject|0|||
124871686|NCT05163522|449150817|FG001|Overall Study|Withdrawal by Subject|0|||
124871687|NCT05163522|449150818|FG002|Overall Study|Withdrawal by Subject|1|||
124871688|NCT05163522|449150819|FG003|Overall Study|Withdrawal by Subject|0|||
124871689|NCT05163522|449150820|FG004|Overall Study|Withdrawal by Subject|0|||
124871690|NCT05163522|449150821|FG005|Overall Study|Withdrawal by Subject|0|||
124871691|NCT05163522|449150822|FG006|Overall Study|Withdrawal by Subject|0|||
124871692|NCT05163522|449150823|FG007|Overall Study|Withdrawal by Subject|0|||
124871693|NCT05163522|449150824|FG008|Overall Study|Withdrawal by Subject|0|||
124871694|NCT05163522|449150825|FG009|Overall Study|Withdrawal by Subject|0|||
124871695|NCT05163522|449150826|FG010|Overall Study|Withdrawal by Subject|0|||
124871696|NCT03412396|449150827|FG000|Overall Study|Withdrawal by Subject|2|||
124871697|NCT03412396|449150827|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
124871698|NCT03412396|449150827|FG000|Overall Study|Did not undergo RP|2|||
124871699|NCT02753595|449150835|FG000|Overall Study|Sponsor termination|2|||
124871700|NCT02753595|449150836|FG001|Overall Study|Sponsor termination|2|||
124871701|NCT01570868|449150837|FG000|Overall Study|Adverse Event|8|||
124871702|NCT01570868|449150838|FG001|Overall Study|Adverse Event|1|||
124871703|NCT01570868|449150837|FG000|Overall Study|FDA Recommendation|23|||
124871704|NCT01570868|449150838|FG001|Overall Study|FDA Recommendation|3|||
124871705|NCT01570868|449150837|FG000|Overall Study|Physician Decision|10|||
124871706|NCT01570868|449150838|FG001|Overall Study|Physician Decision|4|||
124871707|NCT01570868|449150837|FG000|Overall Study|Lost to Follow-up|1|||
124871708|NCT01570868|449150838|FG001|Overall Study|Lost to Follow-up|0|||
124871709|NCT01570868|449150837|FG000|Overall Study|Withdrawal by Subject|1|||
124871710|NCT01570868|449150838|FG001|Overall Study|Withdrawal by Subject|0|||
124871711|NCT02782169|449150847|FG000|Overall Study|Lost to Follow-up|1|||
124871712|NCT02782169|449150848|FG001|Overall Study|Lost to Follow-up|2|||
124871713|NCT02975973|449150849|FG000|Overall Study|Adverse Event|1|||
124871714|NCT02975973|449150850|FG001|Overall Study|Adverse Event|1|||
124871715|NCT02975973|449150851|FG002|Overall Study|Adverse Event|1|||
124871716|NCT02975973|449150852|FG003|Overall Study|Adverse Event|0|||
124871717|NCT00771810|449150853|FG000|Overall Study|Adverse Event|3|||
124871718|NCT00771810|449150854|FG001|Overall Study|Adverse Event|0|||
124871719|NCT00771810|449150855|FG002|Overall Study|Adverse Event|2|||
124871720|NCT00771810|449150853|FG000|Overall Study|Lost to Follow-up|0|||
124871721|NCT00771810|449150854|FG001|Overall Study|Lost to Follow-up|0|||
124871722|NCT00771810|449150855|FG002|Overall Study|Lost to Follow-up|1|||
124871723|NCT00771810|449150853|FG000|Overall Study|Physician Decision|1|||
124871724|NCT00771810|449150854|FG001|Overall Study|Physician Decision|2|||
124871725|NCT00771810|449150855|FG002|Overall Study|Physician Decision|2|||
124871726|NCT00771810|449150853|FG000|Overall Study|Protocol Violation|0|||
124871727|NCT00771810|449150854|FG001|Overall Study|Protocol Violation|1|||
124871728|NCT00771810|449150855|FG002|Overall Study|Protocol Violation|1|||
124978595|NCT01123070|449548513|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
124978596|NCT01123070|449548514|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
124978597|NCT03284229|449548515|FG000|Overall Study|Lost to Follow-up|3|||
124978598|NCT01977677|449548520|FG000|Overall Study|Unrelated Adverse Event|0|||
124978599|NCT01977677|449548521|FG001|Overall Study|Unrelated Adverse Event|0|||
124978600|NCT01977677|449548522|FG002|Overall Study|Unrelated Adverse Event|1|||
124978601|NCT00626197|449548525|FG000|Overall Study|Did not cooperate|2|||
124978602|NCT00626197|449548526|FG001|Overall Study|Did not cooperate|6|||
124978603|NCT00626197|449548527|FG002|Overall Study|Did not cooperate|1|||
124978604|NCT00626197|449548525|FG000|Overall Study|Failure to return|6|||
124978605|NCT00626197|449548526|FG001|Overall Study|Failure to return|5|||
124978606|NCT00626197|449548527|FG002|Overall Study|Failure to return|6|||
124978607|NCT00626197|449548525|FG000|Overall Study|Adverse event, serious fatal|3|||
124978608|NCT00626197|449548526|FG001|Overall Study|Adverse event, serious fatal|6|||
124871729|NCT00771810|449150853|FG000|Overall Study|Withdrawal by Subject|1|||
124871730|NCT00771810|449150854|FG001|Overall Study|Withdrawal by Subject|2|||
124871731|NCT00771810|449150855|FG002|Overall Study|Withdrawal by Subject|0|||
124871732|NCT00771810|449150853|FG000|Overall Study|Other|0|||
124871733|NCT00771810|449150854|FG001|Overall Study|Other|0|||
124871734|NCT00771810|449150855|FG002|Overall Study|Other|1|||
124871735|NCT04542018|449150858|FG000|Overall Study|Withdrawal by Subject|0|||
124871736|NCT04542018|449150859|FG001|Overall Study|Withdrawal by Subject|0|||
124871737|NCT04542018|449150860|FG002|Overall Study|Withdrawal by Subject|4|||
124871738|NCT04542018|449150858|FG000|Overall Study|Protocol Violation|0|||
124871739|NCT04542018|449150859|FG001|Overall Study|Protocol Violation|0|||
124871740|NCT04542018|449150860|FG002|Overall Study|Protocol Violation|2|||
124978609|NCT00626197|449548527|FG002|Overall Study|Adverse event, serious fatal|6|||
124978610|NCT00626197|449548525|FG000|Overall Study|Adverse Event|1|||
124978611|NCT00626197|449548526|FG001|Overall Study|Adverse Event|1|||
124978612|NCT00626197|449548527|FG002|Overall Study|Adverse Event|2|||
124978613|NCT00626197|449548525|FG000|Overall Study|Withdrawal by Subject|17|||
124978614|NCT00626197|449548526|FG001|Overall Study|Withdrawal by Subject|17|||
124978615|NCT00626197|449548527|FG002|Overall Study|Withdrawal by Subject|7|||
124978616|NCT00626197|449548525|FG000|Overall Study|Administrative reasons|15|||
124978617|NCT00626197|449548526|FG001|Overall Study|Administrative reasons|19|||
124871741|NCT02953938|449150861|FG000|Overall Study|Adverse Event|0|||
124871742|NCT02953938|449150862|FG001|Overall Study|Adverse Event|1|||
124871743|NCT02953938|449150861|FG000|Overall Study|Withdrawal by Subject|1|||
124871744|NCT02953938|449150862|FG001|Overall Study|Withdrawal by Subject|1|||
124871745|NCT02657031|449150868|FG000|Overall Study|Adverse Event|1|||
124871746|NCT02657031|449150869|FG001|Overall Study|Adverse Event|2|||
124871747|NCT03078816|449150870|FG000|Overall Study|Withdrawal by Subject|1|||
124871748|NCT01218126|449150873|FG000|Overall Study|Adverse Event|8|||
124871749|NCT01218126|449150874|FG001|Overall Study|Adverse Event|10|||
124871750|NCT01218126|449150875|FG002|Overall Study|Adverse Event|12|||
124871751|NCT01218126|449150876|FG003|Overall Study|Adverse Event|16|||
124871752|NCT01218126|449150873|FG000|Overall Study|Lack of Efficacy|7|||
124871753|NCT01218126|449150874|FG001|Overall Study|Lack of Efficacy|2|||
124871754|NCT01218126|449150875|FG002|Overall Study|Lack of Efficacy|2|||
124871755|NCT01218126|449150876|FG003|Overall Study|Lack of Efficacy|6|||
124871756|NCT01218126|449150873|FG000|Overall Study|Protocol Violation|5|||
124871757|NCT01218126|449150874|FG001|Overall Study|Protocol Violation|2|||
124536855|NCT01632345|447917810|FG000|Treatment: Part I|Physician Decision|2|||
124536856|NCT01632345|447917811|FG001|Treatment: Part I|Physician Decision|1|||
124536857|NCT01632345|447917812|FG002|Treatment: Part I|Physician Decision|0|||
124871758|NCT01218126|449150875|FG002|Overall Study|Protocol Violation|2|||
124871759|NCT01218126|449150876|FG003|Overall Study|Protocol Violation|3|||
124871760|NCT01218126|449150873|FG000|Overall Study|Protocol-defined stopping criteria|1|||
124871761|NCT01218126|449150874|FG001|Overall Study|Protocol-defined stopping criteria|1|||
124871762|NCT01218126|449150875|FG002|Overall Study|Protocol-defined stopping criteria|0|||
124871763|NCT01218126|449150876|FG003|Overall Study|Protocol-defined stopping criteria|0|||
124871764|NCT01218126|449150873|FG000|Overall Study|Lost to Follow-up|0|||
124871765|NCT01218126|449150874|FG001|Overall Study|Lost to Follow-up|0|||
124871766|NCT01218126|449150875|FG002|Overall Study|Lost to Follow-up|0|||
124871767|NCT01218126|449150876|FG003|Overall Study|Lost to Follow-up|2|||
124871768|NCT01218126|449150873|FG000|Overall Study|Physician Decision|1|||
124871769|NCT01218126|449150874|FG001|Overall Study|Physician Decision|2|||
124871770|NCT01218126|449150875|FG002|Overall Study|Physician Decision|4|||
124978618|NCT00626197|449548527|FG002|Overall Study|Administrative reasons|55|||
124871771|NCT01218126|449150876|FG003|Overall Study|Physician Decision|2|||
124871772|NCT01218126|449150873|FG000|Overall Study|Withdrawal by Subject|2|||
124871773|NCT01218126|449150874|FG001|Overall Study|Withdrawal by Subject|5|||
124871774|NCT01218126|449150875|FG002|Overall Study|Withdrawal by Subject|4|||
124871775|NCT01218126|449150876|FG003|Overall Study|Withdrawal by Subject|6|||
124871776|NCT01860703|449150878|FG000|Overall Study|Adverse Event|1|||
124871777|NCT01860703|449150879|FG001|Overall Study|Adverse Event|4|||
124871778|NCT01860703|449150880|FG002|Overall Study|Adverse Event|0|||
124871779|NCT01860703|449150881|FG003|Overall Study|Adverse Event|2|||
124871780|NCT01860703|449150878|FG000|Overall Study|Withdrawal by Subject|0|||
124871781|NCT01860703|449150879|FG001|Overall Study|Withdrawal by Subject|1|||
124871782|NCT01860703|449150880|FG002|Overall Study|Withdrawal by Subject|0|||
124871783|NCT01860703|449150881|FG003|Overall Study|Withdrawal by Subject|0|||
124871784|NCT01860703|449150878|FG000|Overall Study|Personal reason|1|||
124871785|NCT01860703|449150879|FG001|Overall Study|Personal reason|0|||
124871786|NCT01860703|449150880|FG002|Overall Study|Personal reason|1|||
124871787|NCT01860703|449150881|FG003|Overall Study|Personal reason|0|||
124871788|NCT02134587|449150892|FG000|Overall Study|Did not completed all meetings|30|||
124871789|NCT00265889|449150893|FG000|Overall Study|Physician Decision|1|||
124871790|NCT00265889|449150893|FG000|Overall Study|Protocol Violation|1|||
124871791|NCT00265889|449150893|FG000|Overall Study|Insurance denied the request|3|||
124871792|NCT01525602|449150896|FG000|Overall Study|Adverse Event|1|||
124871793|NCT01525602|449150897|FG001|Overall Study|Adverse Event|0|||
124871794|NCT01525602|449150898|FG002|Overall Study|Adverse Event|1|||
124871795|NCT01525602|449150899|FG003|Overall Study|Adverse Event|1|||
124871796|NCT01525602|449150900|FG004|Overall Study|Adverse Event|3|||
124871797|NCT01525602|449150901|FG005|Overall Study|Adverse Event|3|||
124871798|NCT01525602|449150902|FG006|Overall Study|Adverse Event|0|||
124871799|NCT01525602|449150903|FG007|Overall Study|Adverse Event|1|||
124871800|NCT01525602|449150896|FG000|Overall Study|Disease progression|6|||
124871801|NCT01525602|449150897|FG001|Overall Study|Disease progression|3|||
124871802|NCT01525602|449150898|FG002|Overall Study|Disease progression|2|||
124871803|NCT01525602|449150899|FG003|Overall Study|Disease progression|5|||
124871804|NCT01525602|449150900|FG004|Overall Study|Disease progression|22|||
124871805|NCT01525602|449150901|FG005|Overall Study|Disease progression|2|||
124871806|NCT01525602|449150902|FG006|Overall Study|Disease progression|3|||
124871807|NCT01525602|449150903|FG007|Overall Study|Disease progression|3|||
124871808|NCT01525602|449150896|FG000|Overall Study|Clinical progression|2|||
124871809|NCT01525602|449150897|FG001|Overall Study|Clinical progression|0|||
124871810|NCT01525602|449150898|FG002|Overall Study|Clinical progression|0|||
124871811|NCT01525602|449150899|FG003|Overall Study|Clinical progression|0|||
124871812|NCT01525602|449150900|FG004|Overall Study|Clinical progression|0|||
124871813|NCT01525602|449150901|FG005|Overall Study|Clinical progression|0|||
124871814|NCT01525602|449150902|FG006|Overall Study|Clinical progression|1|||
124871815|NCT01525602|449150903|FG007|Overall Study|Clinical progression|1|||
124871816|NCT01525602|449150896|FG000|Overall Study|Non-compliance|0|||
124871817|NCT01525602|449150897|FG001|Overall Study|Non-compliance|0|||
124871818|NCT01525602|449150898|FG002|Overall Study|Non-compliance|0|||
124871819|NCT01525602|449150899|FG003|Overall Study|Non-compliance|0|||
124871820|NCT01525602|449150900|FG004|Overall Study|Non-compliance|1|||
124978619|NCT00461981|449548528|FG000|Overall Study|Lost to Follow-up|9|||
124978620|NCT00461981|449548529|FG001|Overall Study|Lost to Follow-up|6|||
124978621|NCT00461981|449548528|FG000|Overall Study|Withdrawal by Subject|2|||
124978622|NCT00461981|449548529|FG001|Overall Study|Withdrawal by Subject|3|||
124978623|NCT02383940|449548530|FG000|Overall Study|Adverse Event|1|||
124978624|NCT02383940|449548531|FG001|Overall Study|Adverse Event|0|||
124978625|NCT02383940|449548530|FG000|Overall Study|Lost to Follow-up|2|||
124978626|NCT02383940|449548531|FG001|Overall Study|Lost to Follow-up|2|||
124978627|NCT02383940|449548530|FG000|Overall Study|Physician Decision|2|||
124978628|NCT02383940|449548531|FG001|Overall Study|Physician Decision|0|||
124978629|NCT02383940|449548530|FG000|Overall Study|Withdrawal by Subject|1|||
124978630|NCT02383940|449548531|FG001|Overall Study|Withdrawal by Subject|1|||
124978631|NCT02383940|449548530|FG000|Overall Study|Randomized but not treated|2|||
124978632|NCT02383940|449548531|FG001|Overall Study|Randomized but not treated|0|||
124978633|NCT02383940|449548530|FG000|Overall Study|Other than specified above|1|||
124978634|NCT02383940|449548531|FG001|Overall Study|Other than specified above|0|||
124978635|NCT02672852|449548533|FG000|Part A1|Disease Worsening|1|||
124978636|NCT02672852|449548534|FG001|Part A1|Disease Worsening|0|||
124978637|NCT02672852|449548535|FG002|Part A1|Disease Worsening|0|||
124978638|NCT02672852|449548536|FG003|Part A1|Disease Worsening|0|||
124978639|NCT02672852|449548537|FG004|Part A1|Disease Worsening|0|||
124871821|NCT01525602|449150901|FG005|Overall Study|Non-compliance|0|||
124871822|NCT01525602|449150902|FG006|Overall Study|Non-compliance|0|||
124871823|NCT01525602|449150903|FG007|Overall Study|Non-compliance|0|||
124871824|NCT01525602|449150896|FG000|Overall Study|Withdrawal by Subject|0|||
124871825|NCT01525602|449150897|FG001|Overall Study|Withdrawal by Subject|0|||
124871826|NCT01525602|449150898|FG002|Overall Study|Withdrawal by Subject|0|||
124978640|NCT02672852|449548538|FG005|Part A1|Disease Worsening|0|||
124644694|NCT03614078|448316489|FG001|Overall Study|Dizziness and Rash|1|||
124871827|NCT01525602|449150899|FG003|Overall Study|Withdrawal by Subject|0|||
124871828|NCT01525602|449150900|FG004|Overall Study|Withdrawal by Subject|3|||
124871829|NCT01525602|449150901|FG005|Overall Study|Withdrawal by Subject|1|||
124871830|NCT01525602|449150902|FG006|Overall Study|Withdrawal by Subject|0|||
124871831|NCT01525602|449150903|FG007|Overall Study|Withdrawal by Subject|1|||
124871832|NCT01525602|449150896|FG000|Overall Study|Physician Decision|0|||
124871833|NCT01525602|449150897|FG001|Overall Study|Physician Decision|0|||
124871834|NCT01525602|449150898|FG002|Overall Study|Physician Decision|0|||
124871835|NCT01525602|449150899|FG003|Overall Study|Physician Decision|0|||
124871836|NCT01525602|449150900|FG004|Overall Study|Physician Decision|3|||
124871837|NCT01525602|449150901|FG005|Overall Study|Physician Decision|0|||
124871838|NCT01525602|449150902|FG006|Overall Study|Physician Decision|1|||
124871839|NCT01525602|449150903|FG007|Overall Study|Physician Decision|0|||
124871840|NCT01525602|449150896|FG000|Overall Study|Death|0|||
124871841|NCT01525602|449150897|FG001|Overall Study|Death|0|||
124871842|NCT01525602|449150898|FG002|Overall Study|Death|0|||
124871843|NCT01525602|449150899|FG003|Overall Study|Death|0|||
124871844|NCT01525602|449150900|FG004|Overall Study|Death|1|||
124871845|NCT01525602|449150901|FG005|Overall Study|Death|1|||
124871846|NCT01525602|449150902|FG006|Overall Study|Death|0|||
124871847|NCT01525602|449150903|FG007|Overall Study|Death|0|||
124871848|NCT01525602|449150896|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
124871849|NCT01525602|449150897|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
124871850|NCT01525602|449150898|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
124871851|NCT01525602|449150899|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
124871852|NCT01525602|449150900|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
124871853|NCT01525602|449150901|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
124871854|NCT01525602|449150902|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
124871855|NCT01525602|449150903|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
124978641|NCT02672852|449548539|FG006|Part A1|Disease Worsening|0|||
124978642|NCT02672852|449548533|FG000|Part A1|Adverse Event|0|||
124978643|NCT02672852|449548534|FG001|Part A1|Adverse Event|1|||
124978644|NCT02672852|449548535|FG002|Part A1|Adverse Event|0|||
124978645|NCT02672852|449548536|FG003|Part A1|Adverse Event|0|||
124978646|NCT02672852|449548537|FG004|Part A1|Adverse Event|0|||
124978647|NCT02672852|449548538|FG005|Part A1|Adverse Event|0|||
124978648|NCT02672852|449548539|FG006|Part A1|Adverse Event|0|||
124978649|NCT02672852|449548533|FG000|Part A1|Lost to Follow-up|1|||
124978650|NCT02672852|449548534|FG001|Part A1|Lost to Follow-up|2|||
124978651|NCT02672852|449548535|FG002|Part A1|Lost to Follow-up|0|||
124978652|NCT02672852|449548536|FG003|Part A1|Lost to Follow-up|0|||
124978653|NCT02672852|449548537|FG004|Part A1|Lost to Follow-up|0|||
124978654|NCT02672852|449548538|FG005|Part A1|Lost to Follow-up|0|||
124978655|NCT02672852|449548539|FG006|Part A1|Lost to Follow-up|0|||
124978656|NCT02672852|449548533|FG000|Part A1|Withdrawal by Subject|1|||
124978657|NCT02672852|449548534|FG001|Part A1|Withdrawal by Subject|1|||
124978658|NCT02672852|449548535|FG002|Part A1|Withdrawal by Subject|0|||
124978659|NCT02672852|449548536|FG003|Part A1|Withdrawal by Subject|0|||
124978660|NCT02672852|449548537|FG004|Part A1|Withdrawal by Subject|0|||
124978661|NCT02672852|449548538|FG005|Part A1|Withdrawal by Subject|0|||
124978662|NCT02672852|449548539|FG006|Part A1|Withdrawal by Subject|0|||
124978663|NCT02672852|449548533|FG000|Part A2|Disease worsening|0|||
124978664|NCT02672852|449548534|FG001|Part A2|Disease worsening|0|||
124978665|NCT02672852|449548535|FG002|Part A2|Disease worsening|1|||
124978666|NCT02672852|449548536|FG003|Part A2|Disease worsening|0|||
124978667|NCT02672852|449548537|FG004|Part A2|Disease worsening|0|||
124978668|NCT02672852|449548538|FG005|Part A2|Disease worsening|0|||
124978669|NCT02672852|449548539|FG006|Part A2|Disease worsening|0|||
124978670|NCT02672852|449548533|FG000|Part A2|Adverse Event|0|||
124978671|NCT02672852|449548534|FG001|Part A2|Adverse Event|0|||
124978672|NCT02672852|449548535|FG002|Part A2|Adverse Event|3|||
124978673|NCT02672852|449548536|FG003|Part A2|Adverse Event|0|||
124978674|NCT02672852|449548537|FG004|Part A2|Adverse Event|0|||
124978675|NCT02672852|449548538|FG005|Part A2|Adverse Event|0|||
124978676|NCT02672852|449548539|FG006|Part A2|Adverse Event|0|||
124978677|NCT02672852|449548533|FG000|Part A2|Lost to Follow-up|0|||
124978678|NCT02672852|449548534|FG001|Part A2|Lost to Follow-up|0|||
124978679|NCT02672852|449548535|FG002|Part A2|Lost to Follow-up|2|||
124978680|NCT02672852|449548536|FG003|Part A2|Lost to Follow-up|0|||
124978681|NCT02672852|449548537|FG004|Part A2|Lost to Follow-up|0|||
124978682|NCT02672852|449548538|FG005|Part A2|Lost to Follow-up|0|||
124978683|NCT02672852|449548539|FG006|Part A2|Lost to Follow-up|0|||
124978684|NCT02672852|449548533|FG000|Part A2|Withdrawal by Subject|0|||
124978685|NCT02672852|449548534|FG001|Part A2|Withdrawal by Subject|0|||
124871856|NCT04349280|449150907|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
124871857|NCT04349280|449150908|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
124978686|NCT02672852|449548535|FG002|Part A2|Withdrawal by Subject|1|||
124978687|NCT02672852|449548536|FG003|Part A2|Withdrawal by Subject|0|||
124978688|NCT02672852|449548537|FG004|Part A2|Withdrawal by Subject|0|||
124978689|NCT02672852|449548538|FG005|Part A2|Withdrawal by Subject|0|||
124978690|NCT02672852|449548539|FG006|Part A2|Withdrawal by Subject|0|||
124978691|NCT02672852|449548533|FG000|Part A2|Other|0|||
124978692|NCT02672852|449548534|FG001|Part A2|Other|0|||
124978693|NCT02672852|449548535|FG002|Part A2|Other|3|||
124978694|NCT02672852|449548536|FG003|Part A2|Other|0|||
124978695|NCT02672852|449548537|FG004|Part A2|Other|0|||
124978696|NCT02672852|449548538|FG005|Part A2|Other|0|||
124978697|NCT02672852|449548539|FG006|Part A2|Other|0|||
124978698|NCT02672852|449548533|FG000|Part A2|Not entered in Part B|0|||
124978699|NCT02672852|449548534|FG001|Part A2|Not entered in Part B|0|||
124978700|NCT02672852|449548535|FG002|Part A2|Not entered in Part B|0|||
124978701|NCT02672852|449548536|FG003|Part A2|Not entered in Part B|4|||
124978702|NCT02672852|449548537|FG004|Part A2|Not entered in Part B|0|||
124978703|NCT02672852|449548538|FG005|Part A2|Not entered in Part B|0|||
124978704|NCT02672852|449548539|FG006|Part A2|Not entered in Part B|0|||
124978705|NCT02672852|449548533|FG000|Part B|Disease worsening|0|||
124871858|NCT04349280|449150907|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
124871859|NCT04349280|449150908|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
124871860|NCT04349280|449150907|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
124871861|NCT04349280|449150908|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
124871862|NCT02532179|449152688|FG000|Overall Study|Lost to Follow-up|1|||
124871863|NCT02532179|449152688|FG000|Overall Study|Pregnancy|1|||
124871864|NCT02532179|449152688|FG000|Overall Study|Subject received depot steroid injection|1|||
124871865|NCT03076970|449152692|FG000|Washout Period 2|Adverse Event|0|||
124871866|NCT03076970|449152693|FG001|Washout Period 2|Adverse Event|0|||
124871867|NCT03076970|449152694|FG002|Washout Period 2|Adverse Event|0|||
124871868|NCT03076970|449152695|FG003|Washout Period 2|Adverse Event|0|||
124978706|NCT02672852|449548534|FG001|Part B|Disease worsening|0|||
124978707|NCT02672852|449548535|FG002|Part B|Disease worsening|0|||
124978708|NCT02672852|449548536|FG003|Part B|Disease worsening|0|||
124978709|NCT02672852|449548537|FG004|Part B|Disease worsening|1|||
124978710|NCT02672852|449548538|FG005|Part B|Disease worsening|0|||
124978711|NCT02672852|449548539|FG006|Part B|Disease worsening|1|||
124978712|NCT02672852|449548533|FG000|Part B|Worsening pre-existing condition|0|||
124978713|NCT02672852|449548534|FG001|Part B|Worsening pre-existing condition|0|||
124978714|NCT02672852|449548535|FG002|Part B|Worsening pre-existing condition|0|||
124978715|NCT02672852|449548536|FG003|Part B|Worsening pre-existing condition|0|||
124978716|NCT02672852|449548537|FG004|Part B|Worsening pre-existing condition|0|||
124978717|NCT02672852|449548538|FG005|Part B|Worsening pre-existing condition|1|||
124978718|NCT02672852|449548539|FG006|Part B|Worsening pre-existing condition|0|||
124978719|NCT02672852|449548533|FG000|Part B|Other adverse event|0|||
124978720|NCT02672852|449548534|FG001|Part B|Other adverse event|0|||
124978721|NCT02672852|449548535|FG002|Part B|Other adverse event|0|||
124978722|NCT02672852|449548536|FG003|Part B|Other adverse event|0|||
124978723|NCT02672852|449548537|FG004|Part B|Other adverse event|3|||
124978724|NCT02672852|449548538|FG005|Part B|Other adverse event|5|||
124978725|NCT02672852|449548539|FG006|Part B|Other adverse event|1|||
124978726|NCT02672852|449548533|FG000|Part B|Lost to Follow-up|0|||
124978727|NCT02672852|449548534|FG001|Part B|Lost to Follow-up|0|||
124978728|NCT02672852|449548535|FG002|Part B|Lost to Follow-up|0|||
124978729|NCT02672852|449548536|FG003|Part B|Lost to Follow-up|0|||
124978730|NCT02672852|449548537|FG004|Part B|Lost to Follow-up|3|||
124978731|NCT02672852|449548538|FG005|Part B|Lost to Follow-up|4|||
124978732|NCT02672852|449548539|FG006|Part B|Lost to Follow-up|1|||
124978733|NCT02672852|449548533|FG000|Part B|Withdrawal by Subject|0|||
124978734|NCT02672852|449548534|FG001|Part B|Withdrawal by Subject|0|||
124978735|NCT02672852|449548535|FG002|Part B|Withdrawal by Subject|0|||
124978736|NCT02672852|449548536|FG003|Part B|Withdrawal by Subject|0|||
124978737|NCT02672852|449548537|FG004|Part B|Withdrawal by Subject|5|||
124978738|NCT02672852|449548538|FG005|Part B|Withdrawal by Subject|0|||
124978739|NCT02672852|449548539|FG006|Part B|Withdrawal by Subject|7|||
124978740|NCT02672852|449548533|FG000|Part B|Other|0|||
124978741|NCT02672852|449548534|FG001|Part B|Other|0|||
124978742|NCT02672852|449548535|FG002|Part B|Other|0|||
124978743|NCT02672852|449548536|FG003|Part B|Other|0|||
124978744|NCT02672852|449548537|FG004|Part B|Other|4|||
124978745|NCT02672852|449548538|FG005|Part B|Other|1|||
124978746|NCT02672852|449548539|FG006|Part B|Other|2|||
124978747|NCT04958642|449548540|FG000|Overall Study|Transferred to OLEX program|3|||
124978748|NCT04958642|449548541|FG001|Overall Study|Transferred to OLEX program|0|||
124978749|NCT04958642|449548542|FG002|Overall Study|Transferred to OLEX program|5|||
124978750|NCT04958642|449548540|FG000|Overall Study|Death|0|||
124978751|NCT04958642|449548541|FG001|Overall Study|Death|0|||
124978752|NCT04958642|449548542|FG002|Overall Study|Death|1|||
124978753|NCT04958642|449548540|FG000|Overall Study|Withdrawal by Subject|4|||
124978754|NCT04958642|449548541|FG001|Overall Study|Withdrawal by Subject|9|||
124978755|NCT04958642|449548542|FG002|Overall Study|Withdrawal by Subject|13|||
124871869|NCT03076970|449152696|FG004|Washout Period 2|Adverse Event|1|||
124978756|NCT04958642|449548540|FG000|Overall Study|Investigator's Decision|0|||
124978757|NCT04958642|449548541|FG001|Overall Study|Investigator's Decision|0|||
124978758|NCT04958642|449548542|FG002|Overall Study|Investigator's Decision|1|||
124978759|NCT04958642|449548540|FG000|Overall Study|Adverse Event|1|||
124978760|NCT04958642|449548541|FG001|Overall Study|Adverse Event|0|||
124978761|NCT04958642|449548542|FG002|Overall Study|Adverse Event|1|||
124536858|NCT01632345|447917813|FG003|Treatment: Part I|Physician Decision|0|||
124536859|NCT01632345|447917814|FG004|Treatment: Part I|Physician Decision|1|||
124536860|NCT01632345|447917815|FG005|Treatment: Part I|Physician Decision|0|||
124536861|NCT01632345|447917816|FG006|Treatment: Part I|Physician Decision|0|||
124536862|NCT01632345|447917810|FG000|Treatment: Part I|Pregnancy|0|||
124536863|NCT01632345|447917811|FG001|Treatment: Part I|Pregnancy|1|||
124536864|NCT01632345|447917812|FG002|Treatment: Part I|Pregnancy|0|||
124536865|NCT01632345|447917813|FG003|Treatment: Part I|Pregnancy|0|||
124536866|NCT01632345|447917814|FG004|Treatment: Part I|Pregnancy|0|||
124536867|NCT01632345|447917815|FG005|Treatment: Part I|Pregnancy|0|||
124536868|NCT01632345|447917816|FG006|Treatment: Part I|Pregnancy|0|||
124536869|NCT01632345|447917810|FG000|Treatment: Part I|Protocol Deviation|0|||
124536870|NCT01632345|447917811|FG001|Treatment: Part I|Protocol Deviation|0|||
124536871|NCT01632345|447917812|FG002|Treatment: Part I|Protocol Deviation|1|||
124536872|NCT01632345|447917813|FG003|Treatment: Part I|Protocol Deviation|1|||
124536873|NCT01632345|447917814|FG004|Treatment: Part I|Protocol Deviation|0|||
124536874|NCT01632345|447917815|FG005|Treatment: Part I|Protocol Deviation|0|||
124536875|NCT01632345|447917816|FG006|Treatment: Part I|Protocol Deviation|0|||
124536876|NCT01632345|447917810|FG000|Treatment: Part I|Withdrawal by Subject|3|||
124536877|NCT01632345|447917811|FG001|Treatment: Part I|Withdrawal by Subject|4|||
124536878|NCT01632345|447917812|FG002|Treatment: Part I|Withdrawal by Subject|4|||
124536879|NCT01632345|447917813|FG003|Treatment: Part I|Withdrawal by Subject|1|||
124536880|NCT01632345|447917814|FG004|Treatment: Part I|Withdrawal by Subject|4|||
124536881|NCT01632345|447917815|FG005|Treatment: Part I|Withdrawal by Subject|0|||
124536882|NCT01632345|447917816|FG006|Treatment: Part I|Withdrawal by Subject|0|||
124536883|NCT01632345|447917810|FG000|Treatment: Part II|Adverse Event|0|||
124536884|NCT01632345|447917811|FG001|Treatment: Part II|Adverse Event|0|||
124536885|NCT01632345|447917812|FG002|Treatment: Part II|Adverse Event|0|||
124536886|NCT01632345|447917813|FG003|Treatment: Part II|Adverse Event|0|||
124536887|NCT01632345|447917814|FG004|Treatment: Part II|Adverse Event|0|||
124536888|NCT01632345|447917815|FG005|Treatment: Part II|Adverse Event|3|||
124536889|NCT01632345|447917816|FG006|Treatment: Part II|Adverse Event|8|||
124536890|NCT01632345|447917810|FG000|Treatment: Part II|Lost to Follow-up|0|||
124536891|NCT01632345|447917811|FG001|Treatment: Part II|Lost to Follow-up|0|||
124536892|NCT01632345|447917812|FG002|Treatment: Part II|Lost to Follow-up|0|||
124536893|NCT01632345|447917813|FG003|Treatment: Part II|Lost to Follow-up|0|||
124536894|NCT01632345|447917814|FG004|Treatment: Part II|Lost to Follow-up|0|||
124536895|NCT01632345|447917815|FG005|Treatment: Part II|Lost to Follow-up|3|||
124536896|NCT01632345|447917816|FG006|Treatment: Part II|Lost to Follow-up|1|||
124536897|NCT01632345|447917810|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
124536898|NCT01632345|447917811|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
124536899|NCT01632345|447917812|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
124536900|NCT01632345|447917813|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
124536901|NCT01632345|447917814|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
124536902|NCT01632345|447917815|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
124536903|NCT01632345|447917816|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
124536904|NCT01632345|447917810|FG000|Treatment: Part II|Withdrawal by Subject|0|||
124536905|NCT01632345|447917811|FG001|Treatment: Part II|Withdrawal by Subject|0|||
124536906|NCT01632345|447917812|FG002|Treatment: Part II|Withdrawal by Subject|0|||
124536907|NCT01632345|447917813|FG003|Treatment: Part II|Withdrawal by Subject|0|||
124536908|NCT01632345|447917814|FG004|Treatment: Part II|Withdrawal by Subject|0|||
124536909|NCT01632345|447917815|FG005|Treatment: Part II|Withdrawal by Subject|2|||
124536910|NCT01632345|447917816|FG006|Treatment: Part II|Withdrawal by Subject|2|||
124536911|NCT01535638|447917820|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
124536912|NCT01535638|447917821|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
124871870|NCT03076970|449152697|FG005|Washout Period 2|Adverse Event|0|||
124871871|NCT03076970|449152692|FG000|Period 3|Withdrawal by Subject|0|||
124871872|NCT03076970|449152693|FG001|Period 3|Withdrawal by Subject|0|||
124871873|NCT03076970|449152694|FG002|Period 3|Withdrawal by Subject|0|||
124871874|NCT03076970|449152695|FG003|Period 3|Withdrawal by Subject|0|||
124871875|NCT03076970|449152696|FG004|Period 3|Withdrawal by Subject|0|||
124871876|NCT03076970|449152697|FG005|Period 3|Withdrawal by Subject|1|||
124871877|NCT03076970|449152692|FG000|Period 3|Failure to meet I/E criteria|0|||
124871878|NCT03076970|449152693|FG001|Period 3|Failure to meet I/E criteria|0|||
124871879|NCT03076970|449152694|FG002|Period 3|Failure to meet I/E criteria|0|||
124871880|NCT03076970|449152695|FG003|Period 3|Failure to meet I/E criteria|0|||
124871881|NCT03076970|449152696|FG004|Period 3|Failure to meet I/E criteria|1|||
124871882|NCT03076970|449152697|FG005|Period 3|Failure to meet I/E criteria|0|||
124871883|NCT00789815|449152698|FG000|Overall Study|Protocol Violation|6|||
124871884|NCT00789815|449152699|FG001|Overall Study|Protocol Violation|1|||
124871885|NCT00789815|449152698|FG000|Overall Study|Intubation due to massive bleeding|1|||
124871886|NCT00789815|449152699|FG001|Overall Study|Intubation due to massive bleeding|0|||
124871887|NCT01203930|449152711|FG000|Overall Study|Disease Progression|0|||
124871888|NCT01203930|449152712|FG001|Overall Study|Disease Progression|4|||
124871889|NCT01203930|449152711|FG000|Overall Study|Death|3|||
124871890|NCT01203930|449152712|FG001|Overall Study|Death|1|||
124871891|NCT01203930|449152711|FG000|Overall Study|Withdrew Consent|1|||
124536913|NCT01535638|447917822|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
124536914|NCT01535638|447917823|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
124536915|NCT01535638|447917824|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
124536916|NCT01535638|447917825|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
124536917|NCT01535638|447917820|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
124536918|NCT01535638|447917821|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
124536919|NCT01535638|447917822|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
124536920|NCT01535638|447917823|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
124536921|NCT01535638|447917824|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
124536922|NCT01535638|447917825|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
124536923|NCT05060003|447917826|FG000|Overall Study|ctDNA negative|7|||
124536924|NCT00819052|447917827|FG000|Overall Study|Adverse Event|0|||
124536925|NCT00819052|447917828|FG001|Overall Study|Adverse Event|5|||
124536926|NCT00819052|447917827|FG000|Overall Study|Protocol Violation|1|||
124536927|NCT00819052|447917828|FG001|Overall Study|Protocol Violation|2|||
124536928|NCT00819052|447917827|FG000|Overall Study|Lost to Follow-up|1|||
124536929|NCT00819052|447917828|FG001|Overall Study|Lost to Follow-up|2|||
124536930|NCT00819052|447917827|FG000|Overall Study|Withdrawal by Subject|1|||
124536931|NCT00819052|447917828|FG001|Overall Study|Withdrawal by Subject|2|||
124536932|NCT00819052|447917827|FG000|Overall Study|Lack of Efficacy|1|||
124536933|NCT00819052|447917828|FG001|Overall Study|Lack of Efficacy|1|||
124536934|NCT00819052|447917827|FG000|Overall Study|Pregnancy|1|||
124536935|NCT00819052|447917828|FG001|Overall Study|Pregnancy|2|||
124536936|NCT00819052|447917827|FG000|Overall Study|Death or events leading to death|1|||
124536937|NCT00819052|447917828|FG001|Overall Study|Death or events leading to death|0|||
124536938|NCT01277666|447917833|FG000|Overall Study|Adverse Event|26|||
124536939|NCT01277666|447917834|FG001|Overall Study|Adverse Event|25|||
124536940|NCT01277666|447917835|FG002|Overall Study|Adverse Event|20|||
124536941|NCT01277666|447917833|FG000|Overall Study|Lack of Efficacy|8|||
124536942|NCT01277666|447917834|FG001|Overall Study|Lack of Efficacy|20|||
124536943|NCT01277666|447917835|FG002|Overall Study|Lack of Efficacy|12|||
124536944|NCT01277666|447917833|FG000|Overall Study|Protocol Violation|2|||
124536945|NCT01277666|447917834|FG001|Overall Study|Protocol Violation|3|||
124536946|NCT01277666|447917835|FG002|Overall Study|Protocol Violation|2|||
124536947|NCT01277666|447917833|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
124536948|NCT01277666|447917834|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
124536949|NCT01277666|447917835|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
124536950|NCT01277666|447917833|FG000|Overall Study|Lost to Follow-up|1|||
124536951|NCT01277666|447917834|FG001|Overall Study|Lost to Follow-up|1|||
124536952|NCT01277666|447917835|FG002|Overall Study|Lost to Follow-up|2|||
124536953|NCT01277666|447917833|FG000|Overall Study|Withdrawal by Subject|7|||
124536954|NCT01277666|447917834|FG001|Overall Study|Withdrawal by Subject|8|||
124536955|NCT01277666|447917835|FG002|Overall Study|Withdrawal by Subject|6|||
124536956|NCT01277666|447917833|FG000|Overall Study|Death|0|||
124536957|NCT01277666|447917834|FG001|Overall Study|Death|0|||
124536958|NCT01277666|447917835|FG002|Overall Study|Death|1|||
124536959|NCT03702166|447917836|FG000|Overall Study|Lost to Follow-up|1|||
124536960|NCT03702166|447917836|FG000|Overall Study|Withdrawal by Subject|1|||
124536961|NCT01888367|447917837|FG000|Overall Study|Physician Decision|3|||
124536962|NCT01888367|447917838|FG001|Overall Study|Physician Decision|4|||
124536963|NCT01888367|447917839|FG002|Overall Study|Physician Decision|2|||
124536964|NCT01888367|447917837|FG000|Overall Study|Death|2|||
124536965|NCT01888367|447917838|FG001|Overall Study|Death|0|||
124536966|NCT01888367|447917839|FG002|Overall Study|Death|1|||
124536967|NCT01888367|447917837|FG000|Overall Study|Withdrawal by Subject|1|||
124536968|NCT01888367|447917838|FG001|Overall Study|Withdrawal by Subject|0|||
124536969|NCT01888367|447917839|FG002|Overall Study|Withdrawal by Subject|1|||
124536970|NCT01888367|447917837|FG000|Overall Study|Lost to Follow-up|1|||
124536971|NCT01888367|447917838|FG001|Overall Study|Lost to Follow-up|1|||
124536972|NCT01888367|447917839|FG002|Overall Study|Lost to Follow-up|0|||
124536973|NCT01888367|447917837|FG000|Overall Study|Protocol Violation|0|||
124536974|NCT01888367|447917838|FG001|Overall Study|Protocol Violation|0|||
124536975|NCT01888367|447917839|FG002|Overall Study|Protocol Violation|1|||
124536976|NCT01888367|447917837|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
124536977|NCT01888367|447917838|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
124536978|NCT01888367|447917839|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
124536979|NCT03969589|447917841|FG000|Overall Study|Lost to Follow-up|3|||
124536980|NCT03969589|447917842|FG001|Overall Study|Lost to Follow-up|2|||
124536981|NCT03969589|447917841|FG000|Overall Study|Declined Follow-Up|0|||
124536982|NCT03969589|447917842|FG001|Overall Study|Declined Follow-Up|1|||
124536983|NCT03417999|447917843|FG000|Overall Study|Withdrawal by Subject|1|||
124536984|NCT03417999|447917844|FG001|Overall Study|Withdrawal by Subject|0|||
124536985|NCT03417999|447917845|FG002|Overall Study|Withdrawal by Subject|0|||
124536986|NCT03417999|447917843|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
124536987|NCT03417999|447917844|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
124536988|NCT03417999|447917845|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
124536989|NCT03417999|447917843|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
124536990|NCT03417999|447917844|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
124536991|NCT03417999|447917845|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
124536992|NCT03417999|447917843|FG000|Overall Study|Inadequate study staff available to process samples|0|||
124536993|NCT03417999|447917844|FG001|Overall Study|Inadequate study staff available to process samples|0|||
124536994|NCT03417999|447917845|FG002|Overall Study|Inadequate study staff available to process samples|1|||
124536995|NCT00039377|447919475|FG000|Initial Registration|Adverse Event|2|||
124536996|NCT00039377|447919476|FG001|Initial Registration|Adverse Event|0|||
124536997|NCT00039377|447919477|FG002|Initial Registration|Adverse Event|0|||
124536998|NCT00039377|447919478|FG003|Initial Registration|Adverse Event|0|||
124536999|NCT00039377|447919475|FG000|Initial Registration|Relapsed|6|||
124537000|NCT00039377|447919476|FG001|Initial Registration|Relapsed|0|||
124537001|NCT00039377|447919477|FG002|Initial Registration|Relapsed|0|||
124537002|NCT00039377|447919478|FG003|Initial Registration|Relapsed|0|||
124537003|NCT00039377|447919475|FG000|Initial Registration|Received non-protocol therapy|11|||
124537004|NCT00039377|447919476|FG001|Initial Registration|Received non-protocol therapy|0|||
124537005|NCT00039377|447919477|FG002|Initial Registration|Received non-protocol therapy|0|||
124537006|NCT00039377|447919478|FG003|Initial Registration|Received non-protocol therapy|0|||
124537007|NCT00039377|447919475|FG000|Initial Registration|Withdrawal by Subject|3|||
124537008|NCT00039377|447919476|FG001|Initial Registration|Withdrawal by Subject|0|||
124537009|NCT00039377|447919477|FG002|Initial Registration|Withdrawal by Subject|0|||
124537010|NCT00039377|447919478|FG003|Initial Registration|Withdrawal by Subject|0|||
124537011|NCT01020812|447919479|FG000|Overall Study|Physician Decision|1|||
124537012|NCT01020812|447919479|FG000|Overall Study|Withdrawal by Subject|1|||
124537013|NCT01020812|447919479|FG000|Overall Study|Protocol Violation|1|||
124537014|NCT02927990|447919480|FG000|Overall Study|Protocol Violation|4|||
124537015|NCT02927990|447919480|FG000|Overall Study|Physician Decision|9|||
124537016|NCT02927990|447919480|FG000|Overall Study|Room switched and therefore no study device available|15|||
124537017|NCT02927990|447919480|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
124537018|NCT00960323|447919481|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
124537019|NCT01667731|447919482|FG000|Overall Study|Enrolled but not treated|0|||
124537020|NCT01667731|447919483|FG001|Overall Study|Enrolled but not treated|0|||
124537021|NCT01667731|447919484|FG002|Overall Study|Enrolled but not treated|0|||
124537022|NCT01667731|447919485|FG003|Overall Study|Enrolled but not treated|0|||
124537023|NCT01667731|447919486|FG004|Overall Study|Enrolled but not treated|1|||
124537024|NCT01667731|447919482|FG000|Overall Study|Efficacy Failure|1|||
124537025|NCT01667731|447919483|FG001|Overall Study|Efficacy Failure|12|||
124537026|NCT01667731|447919484|FG002|Overall Study|Efficacy Failure|0|||
124537027|NCT01667731|447919485|FG003|Overall Study|Efficacy Failure|1|||
124537028|NCT01667731|447919486|FG004|Overall Study|Efficacy Failure|24|||
124537029|NCT01667731|447919482|FG000|Overall Study|Lost to Follow-up|2|||
124537030|NCT01667731|447919483|FG001|Overall Study|Lost to Follow-up|3|||
124537031|NCT01667731|447919484|FG002|Overall Study|Lost to Follow-up|1|||
124537032|NCT01667731|447919485|FG003|Overall Study|Lost to Follow-up|1|||
124537033|NCT01667731|447919486|FG004|Overall Study|Lost to Follow-up|2|||
124537034|NCT01667731|447919482|FG000|Overall Study|Subject Withdrew Consent|2|||
124537035|NCT01667731|447919483|FG001|Overall Study|Subject Withdrew Consent|0|||
124537036|NCT01667731|447919484|FG002|Overall Study|Subject Withdrew Consent|1|||
124537037|NCT01667731|447919485|FG003|Overall Study|Subject Withdrew Consent|0|||
124537038|NCT01667731|447919486|FG004|Overall Study|Subject Withdrew Consent|1|||
124537039|NCT01667731|447919482|FG000|Overall Study|Death|0|||
124537040|NCT01667731|447919483|FG001|Overall Study|Death|1|||
124978762|NCT04958642|449548540|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
124978763|NCT04958642|449548541|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
124978764|NCT04958642|449548542|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
124978765|NCT04958642|449548540|FG000|Overall Study|Lost to Follow-up|1|||
124978766|NCT04958642|449548541|FG001|Overall Study|Lost to Follow-up|0|||
124978767|NCT04958642|449548542|FG002|Overall Study|Lost to Follow-up|0|||
124978768|NCT04958642|449548540|FG000|Overall Study|Transferred to EAP following study termination|0|||
124978769|NCT04958642|449548541|FG001|Overall Study|Transferred to EAP following study termination|0|||
124978770|NCT04958642|449548542|FG002|Overall Study|Transferred to EAP following study termination|1|||
124978771|NCT04958642|449548540|FG000|Overall Study|Transferred to Expanded Access Program|1|||
124978772|NCT04958642|449548541|FG001|Overall Study|Transferred to Expanded Access Program|0|||
124978773|NCT04958642|449548542|FG002|Overall Study|Transferred to Expanded Access Program|0|||
124978774|NCT04308590|449548543|FG000|Overall Study|Adverse Event|12|||
124537041|NCT01667731|447919484|FG002|Overall Study|Death|0|||
124537042|NCT01667731|447919485|FG003|Overall Study|Death|0|||
124537043|NCT01667731|447919486|FG004|Overall Study|Death|0|||
124537044|NCT01425268|447919491|FG000|Overall Study|Withdrawal by Subject|2|||
124537045|NCT01425268|447919492|FG001|Overall Study|Withdrawal by Subject|0|||
124537046|NCT01425268|447919491|FG000|Overall Study|Sponsor Decision|5|||
124537047|NCT01425268|447919492|FG001|Overall Study|Sponsor Decision|0|||
124537048|NCT01425268|447919491|FG000|Overall Study|Physician Decision|1|||
124978775|NCT04308590|449548544|FG001|Overall Study|Adverse Event|2|||
124978776|NCT04308590|449548543|FG000|Overall Study|Withdrawal by Subject|10|||
124978777|NCT04308590|449548544|FG001|Overall Study|Withdrawal by Subject|4|||
124537049|NCT01425268|447919492|FG001|Overall Study|Physician Decision|0|||
124537050|NCT03633461|447919493|FG000|Overall Study|Lost to Follow-up|0|||
124537051|NCT03633461|447919494|FG001|Overall Study|Lost to Follow-up|1|||
124537052|NCT01345162|447919499|FG000|Overall Study|Protocol Violation|2|||
124537053|NCT01345162|447919500|FG001|Overall Study|Protocol Violation|4|||
124537054|NCT01871870|447919501|FG000|Overall Study|Hardware issues|7|||
124537055|NCT01871870|447919501|FG000|Overall Study|hyperglycemia|2|||
124537056|NCT01716585|447919517|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
124537057|NCT01716585|447919518|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
124537058|NCT01716585|447919517|FG000|Double-blind Treatment|Adverse Event|2|||
124537059|NCT01716585|447919518|FG001|Double-blind Treatment|Adverse Event|1|||
124537060|NCT01716585|447919517|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
124537061|NCT01716585|447919518|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
124537062|NCT01716585|447919517|FG000|Double-blind Treatment|Lost to Follow-up|2|||
124537063|NCT01716585|447919518|FG001|Double-blind Treatment|Lost to Follow-up|0|||
124537064|NCT01716585|447919517|FG000|Double-blind Treatment|Subject Noncompliant|1|||
124537065|NCT01716585|447919518|FG001|Double-blind Treatment|Subject Noncompliant|0|||
124537066|NCT01716585|447919517|FG000|Double-blind Treatment|Other|1|||
124537067|NCT01716585|447919518|FG001|Double-blind Treatment|Other|0|||
124537068|NCT01716585|447919517|FG000|Open-label Treatment|Adverse Event|0|||
124537069|NCT01716585|447919518|FG001|Open-label Treatment|Adverse Event|2|||
124537070|NCT01716585|447919517|FG000|Open-label Treatment|Virologic Failure|0|||
124537071|NCT01716585|447919518|FG001|Open-label Treatment|Virologic Failure|2|||
124537072|NCT01716585|447919517|FG000|Open-label Treatment|Withdrawal by Subject|0|||
124537073|NCT01716585|447919518|FG001|Open-label Treatment|Withdrawal by Subject|3|||
124537074|NCT00504595|447919519|FG000|Overall Study|Lack of Efficacy|1|||
124537075|NCT00504595|447919520|FG001|Overall Study|Lack of Efficacy|0|||
124537076|NCT00504595|447919521|FG002|Overall Study|Lack of Efficacy|0|||
124537077|NCT00504595|447919522|FG003|Overall Study|Lack of Efficacy|0|||
124537078|NCT00504595|447919519|FG000|Overall Study|Other|0|||
124537079|NCT00504595|447919520|FG001|Overall Study|Other|0|||
124537080|NCT00504595|447919521|FG002|Overall Study|Other|2|||
124537081|NCT00504595|447919522|FG003|Overall Study|Other|0|||
124537082|NCT02764229|447919523|FG000|Overall Study|Withdrawal by Subject|15|||
124537083|NCT02764229|447919523|FG000|Overall Study|Adverse Event|9|||
124537084|NCT02764229|447919523|FG000|Overall Study|Physician Decision|5|||
124537085|NCT02764229|447919523|FG000|Overall Study|Lost to Follow-up|3|||
124537086|NCT02764229|447919523|FG000|Overall Study|Lack of Efficacy|1|||
124537087|NCT02764229|447919523|FG000|Overall Study|Study Stopped by Sponsor|69|||
124537088|NCT00672490|447919524|FG000|Overall Study|Withdrawal by Subject|8|||
124537089|NCT00672490|447919525|FG001|Overall Study|Withdrawal by Subject|8|||
124537090|NCT00672490|447919524|FG000|Overall Study|Lack of Compliance|2|||
124978778|NCT04308590|449548543|FG000|Overall Study|Death|1|||
124978779|NCT04308590|449548544|FG001|Overall Study|Death|0|||
124978780|NCT04308590|449548543|FG000|Overall Study|Lost to Follow-up|1|||
124978781|NCT04308590|449548544|FG001|Overall Study|Lost to Follow-up|1|||
124978782|NCT04308590|449548543|FG000|Overall Study|Physician Decision|1|||
124978783|NCT04308590|449548544|FG001|Overall Study|Physician Decision|0|||
124978784|NCT04308590|449548543|FG000|Overall Study|Subject does not want to continue with Pi|0|||
124978785|NCT04308590|449548544|FG001|Overall Study|Subject does not want to continue with Pi|1|||
124978786|NCT05487586|449548548|FG000|Overall Study|Death|22|||
124978787|NCT05487586|449548548|FG000|Overall Study|Physician Decision|1|||
124978788|NCT05487586|449548548|FG000|Overall Study|Transfer to another hospital|4|||
124978789|NCT05487586|449548548|FG000|Overall Study|Other|1|||
124978790|NCT04798781|449548549|FG000|Overall Study|Withdrawal by Subject|1|||
124978791|NCT03853551|449548550|FG000|Overall Study|Death|2|||
124978792|NCT03853551|449548550|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
124978793|NCT02476175|449548551|FG000|Overall Study|Adverse Event|2|||
124978794|NCT02175641|449548553|FG000|Overall Study|Death|3|||
124978795|NCT02175641|449548554|FG001|Overall Study|Death|4|||
124537091|NCT00672490|447919525|FG001|Overall Study|Lack of Compliance|7|||
124537092|NCT00672490|447919524|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
124537093|NCT00672490|447919525|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
124978796|NCT02175641|449548553|FG000|Overall Study|Lost to Follow-up|4|||
124978797|NCT02175641|449548554|FG001|Overall Study|Lost to Follow-up|4|||
124978798|NCT02175641|449548553|FG000|Overall Study|Withdrawal by Subject|7|||
124537094|NCT00672490|447919524|FG000|Overall Study|Adverse Event|5|||
124537095|NCT00672490|447919525|FG001|Overall Study|Adverse Event|8|||
124537096|NCT00672490|447919524|FG000|Overall Study|Violation of Concomitant Medicine|1|||
124537097|NCT00672490|447919525|FG001|Overall Study|Violation of Concomitant Medicine|0|||
124537098|NCT00672490|447919524|FG000|Overall Study|Intolerance|0|||
124537099|NCT00672490|447919525|FG001|Overall Study|Intolerance|2|||
124537100|NCT00672490|447919524|FG000|Overall Study|Lost to Follow-up|1|||
124537101|NCT00672490|447919525|FG001|Overall Study|Lost to Follow-up|5|||
124978799|NCT02175641|449548554|FG001|Overall Study|Withdrawal by Subject|4|||
124537102|NCT00672490|447919524|FG000|Overall Study|No reason was provided|6|||
124537103|NCT00672490|447919525|FG001|Overall Study|No reason was provided|2|||
124537104|NCT00851721|447919527|FG000|Overall Study|planned surgery|1|||
124537105|NCT00851721|447919528|FG001|Overall Study|planned surgery|0|||
124537106|NCT00851721|447919527|FG000|Overall Study|Death|1|||
124537107|NCT00851721|447919528|FG001|Overall Study|Death|0|||
124537108|NCT00851721|447919527|FG000|Overall Study|Adverse Event|0|||
124537109|NCT00851721|447919528|FG001|Overall Study|Adverse Event|1|||
124537110|NCT03451630|447919533|FG000|Overall Study|Death|15|||
124537111|NCT03451630|447919534|FG001|Overall Study|Death|16|||
124537112|NCT03451630|447919535|FG002|Overall Study|Death|11|||
124978800|NCT02175641|449548553|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
124978801|NCT02175641|449548554|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
124978802|NCT02175641|449548553|FG000|Overall Study|Developed Contraindicated Condition|8|||
124978803|NCT02175641|449548554|FG001|Overall Study|Developed Contraindicated Condition|0|||
124978804|NCT03921723|449548556|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
124978805|NCT03921723|449548556|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
124978806|NCT01876901|449548557|FG000|Overall Study|Protocol Violation|10|||
124978807|NCT01876901|449548558|FG001|Overall Study|Protocol Violation|2|||
124978808|NCT01876901|449548557|FG000|Overall Study|No or other surgical intervention|7|||
124978809|NCT01876901|449548558|FG001|Overall Study|No or other surgical intervention|5|||
124978810|NCT02683785|449548559|FG000|Overall Study|Withdrawal by Subject|1|||
124978811|NCT02683785|449548560|FG001|Overall Study|Withdrawal by Subject|1|||
124978812|NCT02683785|449548559|FG000|Overall Study|Lost to Follow-up|0|||
124978813|NCT02683785|449548560|FG001|Overall Study|Lost to Follow-up|1|||
124978814|NCT02683785|449548559|FG000|Overall Study|Adverse Event|0|||
124978815|NCT02683785|449548560|FG001|Overall Study|Adverse Event|2|||
124978816|NCT00534495|449548561|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
124978817|NCT00534495|449548562|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
124978818|NCT00534495|449548563|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
124978819|NCT00534495|449548561|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
124978820|NCT00534495|449548562|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
124978821|NCT00534495|449548563|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
124978822|NCT00534495|449548561|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
124978823|NCT00534495|449548562|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
124978824|NCT00534495|449548563|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
124978825|NCT00534495|449548561|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
124978826|NCT00534495|449548562|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
124978827|NCT00534495|449548563|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
124978828|NCT00534495|449548561|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
124978829|NCT00534495|449548562|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
124978830|NCT00534495|449548563|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
124978831|NCT00534495|449548561|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
124978832|NCT00534495|449548562|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
124978833|NCT00534495|449548563|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
124978834|NCT00534495|449548561|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
124978835|NCT00534495|449548562|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
124978836|NCT00534495|449548563|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
124978837|NCT00534495|449548561|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
124978838|NCT00534495|449548562|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
124978839|NCT00534495|449548563|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
124978840|NCT00534495|449548561|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
124978841|NCT00534495|449548562|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
124978842|NCT00534495|449548563|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
124978843|NCT02233803|449548568|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
124978844|NCT02233803|449548569|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
124978845|NCT02233803|449548568|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
124978846|NCT02233803|449548569|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
124978847|NCT02233803|449548568|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
124978848|NCT02233803|449548569|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
124978849|NCT02233803|449548568|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
124978850|NCT02233803|449548569|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
124978851|NCT02233803|449548568|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
124978852|NCT02233803|449548569|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
124978853|NCT02233803|449548568|FG000|Washout Period (4-Wks)|Physician Decision|1|||
124978854|NCT02233803|449548569|FG001|Washout Period (4-Wks)|Physician Decision|0|||
124978855|NCT02233803|449548568|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
124978856|NCT02233803|449548569|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
124978857|NCT02233803|449548568|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
124537113|NCT03451630|447919533|FG000|Overall Study|Lost to Follow-up|9|||
124537114|NCT03451630|447919534|FG001|Overall Study|Lost to Follow-up|0|||
124537115|NCT03451630|447919535|FG002|Overall Study|Lost to Follow-up|4|||
124537116|NCT03451630|447919533|FG000|Overall Study|Withdrawal by Subject|0|||
124537117|NCT03451630|447919534|FG001|Overall Study|Withdrawal by Subject|3|||
124537118|NCT03451630|447919535|FG002|Overall Study|Withdrawal by Subject|0|||
124537119|NCT03451630|447919533|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
124537120|NCT03451630|447919534|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
124537121|NCT03451630|447919535|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
124537122|NCT02041533|447919536|FG000|Pre-Treatment Period|Disease Progression|1|||
124537123|NCT02041533|447919537|FG001|Pre-Treatment Period|Disease Progression|1|||
124537124|NCT02041533|447919536|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
124537125|NCT02041533|447919537|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
124537126|NCT02041533|447919536|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
124537127|NCT02041533|447919537|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
124537128|NCT02041533|447919536|FG000|Treatment Period|Disease progression|189|||
124537129|NCT02041533|447919537|FG001|Treatment Period|Disease progression|146|||
124537130|NCT02041533|447919536|FG000|Treatment Period|Study drug toxicity|30|||
124537131|NCT02041533|447919537|FG001|Treatment Period|Study drug toxicity|34|||
124537132|NCT02041533|447919536|FG000|Treatment Period|Death|1|||
124537133|NCT02041533|447919537|FG001|Treatment Period|Death|0|||
124537134|NCT02041533|447919536|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
124537135|NCT02041533|447919537|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
124537136|NCT02041533|447919536|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
124537137|NCT02041533|447919537|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
124537138|NCT02041533|447919536|FG000|Treatment Period|Participant withdrew consent|2|||
124537139|NCT02041533|447919537|FG001|Treatment Period|Participant withdrew consent|2|||
124537140|NCT02041533|447919536|FG000|Treatment Period|Maximum clinical benefit|0|||
124537141|NCT02041533|447919537|FG001|Treatment Period|Maximum clinical benefit|18|||
124537142|NCT02041533|447919536|FG000|Treatment Period|Poor/Non-compliance|1|||
124537143|NCT02041533|447919537|FG001|Treatment Period|Poor/Non-compliance|0|||
124537144|NCT02041533|447919536|FG000|Treatment Period|Administrative reason by sponsor|1|||
124537145|NCT02041533|447919537|FG001|Treatment Period|Administrative reason by sponsor|0|||
124537146|NCT02041533|447919536|FG000|Treatment Period|Other reasons|9|||
124537147|NCT02041533|447919537|FG001|Treatment Period|Other reasons|2|||
124537148|NCT02041533|447919536|FG000|Treatment Period|Not Reported|0|||
124537149|NCT02041533|447919537|FG001|Treatment Period|Not Reported|1|||
124537150|NCT02813681|447919538|FG000|Overall Study|Physician Decision|5|||
124537151|NCT02813681|447919539|FG001|Overall Study|Physician Decision|5|||
124537152|NCT02813681|447919540|FG002|Overall Study|Physician Decision|0|||
124537153|NCT02813681|447919538|FG000|Overall Study|Lost to Follow-up|0|||
124537154|NCT02813681|447919539|FG001|Overall Study|Lost to Follow-up|1|||
124537155|NCT02813681|447919540|FG002|Overall Study|Lost to Follow-up|0|||
124537156|NCT01874288|447919549|FG000|Overall Study|Withdrawal by Subject|1|||
124537157|NCT01874288|447919550|FG001|Overall Study|Withdrawal by Subject|0|||
124978858|NCT02233803|449548569|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
124978859|NCT02233803|449548568|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
124978860|NCT02233803|449548569|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
124978861|NCT03635099|449548570|FG000|Period 1|Adverse Event|1|||
124978862|NCT03635099|449548571|FG001|Period 1|Adverse Event|0|||
124978863|NCT03635099|449548572|FG002|Period 1|Adverse Event|0|||
124978864|NCT03635099|449548573|FG003|Period 1|Adverse Event|1|||
124978865|NCT03635099|449548574|FG004|Period 1|Adverse Event|0|||
124978866|NCT03635099|449548575|FG005|Period 1|Adverse Event|0|||
124978867|NCT03635099|449548576|FG006|Period 1|Adverse Event|0|||
124978868|NCT03635099|449548577|FG007|Period 1|Adverse Event|0|||
124978869|NCT03635099|449548570|FG000|Period 1|Protocol Violation|0|||
124978870|NCT03635099|449548571|FG001|Period 1|Protocol Violation|0|||
124978871|NCT03635099|449548572|FG002|Period 1|Protocol Violation|1|||
124978872|NCT03635099|449548573|FG003|Period 1|Protocol Violation|0|||
124978873|NCT03635099|449548574|FG004|Period 1|Protocol Violation|0|||
124978874|NCT03635099|449548575|FG005|Period 1|Protocol Violation|0|||
124978875|NCT03635099|449548576|FG006|Period 1|Protocol Violation|0|||
124978876|NCT03635099|449548577|FG007|Period 1|Protocol Violation|0|||
124978877|NCT03635099|449548570|FG000|Period 1|Lost to Follow-up|0|||
124978878|NCT03635099|449548571|FG001|Period 1|Lost to Follow-up|0|||
124978879|NCT03635099|449548572|FG002|Period 1|Lost to Follow-up|1|||
124537158|NCT01874288|447919551|FG002|Overall Study|Withdrawal by Subject|2|||
124537159|NCT01874288|447919552|FG003|Overall Study|Withdrawal by Subject|1|||
124537160|NCT01874288|447919553|FG004|Overall Study|Withdrawal by Subject|1|||
124537161|NCT01874288|447919549|FG000|Overall Study|Physician Decision|0|||
124978880|NCT03635099|449548573|FG003|Period 1|Lost to Follow-up|2|||
124978881|NCT03635099|449548574|FG004|Period 1|Lost to Follow-up|1|||
124978882|NCT03635099|449548575|FG005|Period 1|Lost to Follow-up|0|||
124978883|NCT03635099|449548576|FG006|Period 1|Lost to Follow-up|1|||
124978884|NCT03635099|449548577|FG007|Period 1|Lost to Follow-up|2|||
124978885|NCT03635099|449548570|FG000|Period 1|Withdrawal by Subject|3|||
124537162|NCT01874288|447919550|FG001|Overall Study|Physician Decision|0|||
124537163|NCT01874288|447919551|FG002|Overall Study|Physician Decision|0|||
124537164|NCT01874288|447919552|FG003|Overall Study|Physician Decision|1|||
124537165|NCT01874288|447919553|FG004|Overall Study|Physician Decision|0|||
124537166|NCT01874288|447919549|FG000|Overall Study|Progressive disease|2|||
124537167|NCT01874288|447919550|FG001|Overall Study|Progressive disease|0|||
124537168|NCT01874288|447919551|FG002|Overall Study|Progressive disease|3|||
124537169|NCT01874288|447919552|FG003|Overall Study|Progressive disease|5|||
124537170|NCT01874288|447919553|FG004|Overall Study|Progressive disease|1|||
124537171|NCT03370133|447919554|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
124537172|NCT03370133|447919555|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
124537173|NCT03370133|447919556|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
124537174|NCT03370133|447919557|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
124537175|NCT03370133|447919558|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
124537176|NCT03370133|447919559|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
124537177|NCT03370133|447919554|FG000|Initial Treatment Period (WK 16)|Death|1|||
124537178|NCT03370133|447919555|FG001|Initial Treatment Period (WK 16)|Death|1|||
124537179|NCT03370133|447919556|FG002|Initial Treatment Period (WK 16)|Death|1|||
124537180|NCT03370133|447919557|FG003|Initial Treatment Period (WK 16)|Death|0|||
124537181|NCT03370133|447919558|FG004|Initial Treatment Period (WK 16)|Death|0|||
124537182|NCT03370133|447919559|FG005|Initial Treatment Period (WK 16)|Death|0|||
124537183|NCT03370133|447919554|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
124537184|NCT03370133|447919555|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
124537185|NCT03370133|447919556|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
124537186|NCT03370133|447919557|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
124537187|NCT03370133|447919558|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
124537188|NCT03370133|447919559|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
124537189|NCT03370133|447919554|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
124537190|NCT03370133|447919555|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
124537191|NCT03370133|447919556|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
124537192|NCT03370133|447919557|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
124537193|NCT03370133|447919558|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
124537194|NCT03370133|447919559|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
124537195|NCT03370133|447919554|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
124537196|NCT03370133|447919555|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
124537197|NCT03370133|447919556|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
124537198|NCT03370133|447919557|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
124537199|NCT03370133|447919558|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
124537200|NCT03370133|447919559|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
124537201|NCT03370133|447919554|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
124537202|NCT03370133|447919555|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
124537203|NCT03370133|447919556|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
124537204|NCT03370133|447919557|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
124537205|NCT03370133|447919558|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
124537206|NCT03370133|447919559|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
124537207|NCT03370133|447919554|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
124537208|NCT03370133|447919555|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
124537209|NCT03370133|447919556|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
124537210|NCT03370133|447919557|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
124537211|NCT03370133|447919558|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
124537212|NCT03370133|447919559|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
124537213|NCT03370133|447919554|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
124537214|NCT03370133|447919555|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
124537215|NCT03370133|447919556|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
124537216|NCT03370133|447919557|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
124537217|NCT03370133|447919558|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
124537218|NCT03370133|447919559|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
124537219|NCT03370133|447919554|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
124537220|NCT03370133|447919555|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
124537221|NCT03370133|447919556|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
124537222|NCT03370133|447919557|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
124537223|NCT03370133|447919558|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
124537224|NCT03370133|447919559|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
124537225|NCT03370133|447919554|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
124537226|NCT03370133|447919555|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
124537227|NCT03370133|447919556|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
124537228|NCT03370133|447919557|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
124537229|NCT03370133|447919558|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
124537230|NCT03370133|447919559|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
124644695|NCT03614078|448316490|FG002|Overall Study|Dizziness and Rash|0|||
124537231|NCT03370133|447919554|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
124537232|NCT03370133|447919555|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
124537233|NCT03370133|447919556|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
124537234|NCT03370133|447919557|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
124537235|NCT03370133|447919558|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
124537236|NCT03370133|447919559|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
124537237|NCT03370133|447919554|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
124537238|NCT03370133|447919555|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
124537239|NCT03370133|447919556|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
124537240|NCT03370133|447919557|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
124537241|NCT03370133|447919558|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
124537242|NCT03370133|447919559|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
124537243|NCT03370133|447919554|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
124537244|NCT03370133|447919555|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
124537245|NCT03370133|447919556|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
124537246|NCT03370133|447919557|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
124537247|NCT03370133|447919558|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
124537248|NCT03370133|447919559|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
124537249|NCT03370133|447919554|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
124537250|NCT03370133|447919555|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
124537251|NCT03370133|447919556|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
124537252|NCT03370133|447919557|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
124537253|NCT03370133|447919558|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
124537254|NCT03370133|447919559|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
124537255|NCT03370133|447919554|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
124537256|NCT03370133|447919555|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
124537257|NCT03370133|447919556|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
124537258|NCT03370133|447919557|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
124537259|NCT03370133|447919558|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
124537260|NCT03370133|447919559|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
124537261|NCT01365468|447919560|FG000|Overall Study|Physician Decision|1|||
124537262|NCT01365468|447919561|FG001|Overall Study|Physician Decision|0|||
124537263|NCT01365468|447919560|FG000|Overall Study|Disease progression|1|||
124537264|NCT01365468|447919561|FG001|Overall Study|Disease progression|0|||
124537265|NCT01365468|447919560|FG000|Overall Study|Lost to Follow-up|2|||
124537266|NCT01365468|447919561|FG001|Overall Study|Lost to Follow-up|0|||
124537267|NCT03524664|447919562|FG000|Overall Study|Withdrawal by Subject|1|||
124537268|NCT03524664|447919563|FG001|Overall Study|Withdrawal by Subject|2|||
124537269|NCT03524664|447919562|FG000|Overall Study|Lost to Follow-up|4|||
124537270|NCT03524664|447919563|FG001|Overall Study|Lost to Follow-up|13|||
124537271|NCT02694562|447919564|FG000|Overall Study|Death|8|||
124537272|NCT02694562|447919564|FG000|Overall Study|Protocol Violation|4|||
124537273|NCT02694562|447919564|FG000|Overall Study|Lost to Follow-up|3|||
124537274|NCT02694562|447919564|FG000|Overall Study|Screen Failure|2|||
124537275|NCT02694562|447919564|FG000|Overall Study|Physician Decision|1|||
124537276|NCT00423267|447919565|FG000|Period A|Withdrawal by Subject|0|||
124537277|NCT00423267|447919566|FG001|Period A|Withdrawal by Subject|1|||
124537278|NCT00423267|447919565|FG000|Period A|Non-compliance with protocol|1|||
124537279|NCT00423267|447919566|FG001|Period A|Non-compliance with protocol|0|||
124537280|NCT00423267|447919565|FG000|Period A|Administrative|1|||
124537281|NCT00423267|447919566|FG001|Period A|Administrative|0|||
124537282|NCT01333865|447919567|FG000|Overall Study|Adverse Event|2|||
124537283|NCT00684073|447919568|FG000|Selection|Selection/non-selection criteria|3|||
124537284|NCT00684073|447919568|FG000|Selection|Death|1|||
124537285|NCT00684073|447919568|FG000|Selection|noncompliance|1|||
124537286|NCT00684073|447919568|FG000|Selection|Lost to Follow-up|1|||
124537287|NCT00684073|447919568|FG000|Selection|request of the sponsor|1|||
124537288|NCT00684073|447919568|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
124537289|NCT00591786|447919571|FG000|Overall Study|Withdrawal of Informed Consent|0|||
124978886|NCT03635099|449548571|FG001|Period 1|Withdrawal by Subject|3|||
124978887|NCT03635099|449548572|FG002|Period 1|Withdrawal by Subject|5|||
124978888|NCT03635099|449548573|FG003|Period 1|Withdrawal by Subject|2|||
124537290|NCT00591786|447919572|FG001|Overall Study|Withdrawal of Informed Consent|0|||
124537291|NCT00591786|447919573|FG002|Overall Study|Withdrawal of Informed Consent|1|||
124537292|NCT00591786|447919574|FG003|Overall Study|Withdrawal of Informed Consent|0|||
124537293|NCT00591786|447919575|FG004|Overall Study|Withdrawal of Informed Consent|0|||
124537294|NCT00591786|447919576|FG005|Overall Study|Withdrawal of Informed Consent|0|||
124537295|NCT00591786|447919577|FG006|Overall Study|Withdrawal of Informed Consent|0|||
124537296|NCT00591786|447919578|FG007|Overall Study|Withdrawal of Informed Consent|0|||
124537297|NCT00591786|447919579|FG008|Overall Study|Withdrawal of Informed Consent|0|||
124978889|NCT03635099|449548574|FG004|Period 1|Withdrawal by Subject|2|||
124978890|NCT03635099|449548575|FG005|Period 1|Withdrawal by Subject|0|||
124978891|NCT03635099|449548576|FG006|Period 1|Withdrawal by Subject|3|||
124978892|NCT03635099|449548577|FG007|Period 1|Withdrawal by Subject|0|||
124978893|NCT03635099|449548570|FG000|Period 1|History of suicidal ideation|0|||
124978894|NCT03635099|449548571|FG001|Period 1|History of suicidal ideation|0|||
124978895|NCT03635099|449548572|FG002|Period 1|History of suicidal ideation|1|||
124978896|NCT03635099|449548573|FG003|Period 1|History of suicidal ideation|0|||
124978897|NCT03635099|449548574|FG004|Period 1|History of suicidal ideation|0|||
124978898|NCT03635099|449548575|FG005|Period 1|History of suicidal ideation|0|||
124978899|NCT03635099|449548576|FG006|Period 1|History of suicidal ideation|0|||
124978900|NCT03635099|449548577|FG007|Period 1|History of suicidal ideation|0|||
124978901|NCT03635099|449548570|FG000|Period 1|pursue other treatment options|0|||
124978902|NCT03635099|449548571|FG001|Period 1|pursue other treatment options|0|||
124978903|NCT03635099|449548572|FG002|Period 1|pursue other treatment options|0|||
124978904|NCT03635099|449548573|FG003|Period 1|pursue other treatment options|0|||
124978905|NCT03635099|449548574|FG004|Period 1|pursue other treatment options|0|||
124978906|NCT03635099|449548575|FG005|Period 1|pursue other treatment options|1|||
124978907|NCT03635099|449548576|FG006|Period 1|pursue other treatment options|0|||
124978908|NCT03635099|449548577|FG007|Period 1|pursue other treatment options|0|||
124978909|NCT03635099|449548570|FG000|Not Eligible for Period 2|Pregnancy|0|||
124978910|NCT03635099|449548571|FG001|Not Eligible for Period 2|Pregnancy|0|||
124978911|NCT03635099|449548572|FG002|Not Eligible for Period 2|Pregnancy|0|||
124978912|NCT03635099|449548573|FG003|Not Eligible for Period 2|Pregnancy|1|||
124978913|NCT03635099|449548574|FG004|Not Eligible for Period 2|Pregnancy|0|||
124978914|NCT03635099|449548575|FG005|Not Eligible for Period 2|Pregnancy|0|||
124978915|NCT03635099|449548576|FG006|Not Eligible for Period 2|Pregnancy|0|||
124978916|NCT03635099|449548577|FG007|Not Eligible for Period 2|Pregnancy|0|||
124978917|NCT03635099|449548570|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
124978918|NCT03635099|449548571|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
124978919|NCT03635099|449548572|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
124978920|NCT03635099|449548573|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
124978921|NCT03635099|449548574|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
124978922|NCT03635099|449548575|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
124978923|NCT03635099|449548576|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
124978924|NCT03635099|449548577|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
124978925|NCT03635099|449548570|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
124978926|NCT03635099|449548571|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
124978927|NCT03635099|449548572|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
124978928|NCT03635099|449548573|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
124978929|NCT03635099|449548574|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
124978930|NCT03635099|449548575|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
124978931|NCT03635099|449548576|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
124978932|NCT03635099|449548577|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
124978933|NCT03635099|449548570|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
124978934|NCT03635099|449548571|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
124978935|NCT03635099|449548572|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
124978936|NCT03635099|449548573|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
124978937|NCT03635099|449548574|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
124978938|NCT03635099|449548575|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
124978939|NCT03635099|449548576|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
124978940|NCT03635099|449548577|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
124978941|NCT03635099|449548570|FG000|Period 2|Adverse Event|0|||
124978942|NCT03635099|449548571|FG001|Period 2|Adverse Event|0|||
124978943|NCT03635099|449548572|FG002|Period 2|Adverse Event|1|||
124978944|NCT03635099|449548573|FG003|Period 2|Adverse Event|0|||
124978945|NCT03635099|449548574|FG004|Period 2|Adverse Event|1|||
124978946|NCT03635099|449548575|FG005|Period 2|Adverse Event|0|||
124978947|NCT03635099|449548576|FG006|Period 2|Adverse Event|0|||
124978948|NCT03635099|449548577|FG007|Period 2|Adverse Event|0|||
124978949|NCT03635099|449548570|FG000|Period 2|Lost to Follow-up|0|||
124978950|NCT03635099|449548571|FG001|Period 2|Lost to Follow-up|0|||
124978951|NCT03635099|449548572|FG002|Period 2|Lost to Follow-up|1|||
124978952|NCT03635099|449548573|FG003|Period 2|Lost to Follow-up|0|||
124978953|NCT03635099|449548574|FG004|Period 2|Lost to Follow-up|4|||
124978954|NCT03635099|449548575|FG005|Period 2|Lost to Follow-up|0|||
124978955|NCT03635099|449548576|FG006|Period 2|Lost to Follow-up|0|||
124978956|NCT03635099|449548577|FG007|Period 2|Lost to Follow-up|0|||
124978957|NCT03635099|449548570|FG000|Period 2|Withdrawal by Subject|0|||
124978958|NCT03635099|449548571|FG001|Period 2|Withdrawal by Subject|0|||
124978959|NCT03635099|449548572|FG002|Period 2|Withdrawal by Subject|7|||
124978960|NCT03635099|449548573|FG003|Period 2|Withdrawal by Subject|4|||
124978961|NCT03635099|449548574|FG004|Period 2|Withdrawal by Subject|7|||
124537298|NCT00591786|447919580|FG009|Overall Study|Withdrawal of Informed Consent|0|||
124537299|NCT00554229|447919581|FG000|Overall Study|Lost to Follow-up|3|||
124537300|NCT00554229|447919582|FG001|Overall Study|Lost to Follow-up|6|||
124537301|NCT00554229|447919581|FG000|Overall Study|Withdrawal by Subject|29|||
124537302|NCT00554229|447919582|FG001|Overall Study|Withdrawal by Subject|37|||
124537303|NCT00554229|447919581|FG000|Overall Study|Adverse Event|71|||
124537304|NCT00554229|447919582|FG001|Overall Study|Adverse Event|39|||
124537305|NCT00554229|447919581|FG000|Overall Study|Protocol Violation|3|||
124537306|NCT00554229|447919582|FG001|Overall Study|Protocol Violation|3|||
124537307|NCT00554229|447919581|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
124537308|NCT00554229|447919582|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
124537309|NCT00554229|447919581|FG000|Overall Study|Randomised but no treatment received|1|||
124537310|NCT00554229|447919582|FG001|Overall Study|Randomised but no treatment received|0|||
124537311|NCT01140646|447919583|FG000|Overall Study|Adverse Event|4|||
124537312|NCT01140646|447919583|FG000|Overall Study|Refused Further Treatment|5|||
124537313|NCT00689728|447919585|FG000|Double-Blind Treatment|Adverse Event|1|||
124537314|NCT00689728|447919586|FG001|Double-Blind Treatment|Adverse Event|0|||
124537315|NCT00689728|447919587|FG002|Double-Blind Treatment|Adverse Event|0|||
124537316|NCT00689728|447919585|FG000|Double-Blind Treatment|Protocol Violation|0|||
124537317|NCT00689728|447919586|FG001|Double-Blind Treatment|Protocol Violation|0|||
124537318|NCT00689728|447919587|FG002|Double-Blind Treatment|Protocol Violation|1|||
124537319|NCT00689728|447919585|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
124537320|NCT00689728|447919586|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
124537321|NCT00689728|447919587|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
124537322|NCT00689728|447919585|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
124537323|NCT00689728|447919586|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
124537324|NCT00689728|447919587|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
124537325|NCT00689728|447919585|FG000|Rescue|Adverse Event|0|||
124537326|NCT00689728|447919586|FG001|Rescue|Adverse Event|1|||
124537327|NCT00689728|447919587|FG002|Rescue|Adverse Event|0|||
124537328|NCT00689728|447919585|FG000|Rescue|Withdrawal by Subject|1|||
124537329|NCT00689728|447919586|FG001|Rescue|Withdrawal by Subject|1|||
124537330|NCT00689728|447919587|FG002|Rescue|Withdrawal by Subject|1|||
124537331|NCT00689728|447919585|FG000|Optional Follow-Up|Adverse Event|1|||
124537332|NCT00689728|447919586|FG001|Optional Follow-Up|Adverse Event|0|||
124537333|NCT00689728|447919587|FG002|Optional Follow-Up|Adverse Event|0|||
124537334|NCT00689728|447919585|FG000|Optional Follow-Up|Lack of Efficacy|0|||
124537335|NCT00689728|447919586|FG001|Optional Follow-Up|Lack of Efficacy|1|||
124537336|NCT00689728|447919587|FG002|Optional Follow-Up|Lack of Efficacy|1|||
124537337|NCT00689728|447919585|FG000|Optional Follow-Up|Lost to Follow-up|0|||
124537338|NCT00689728|447919586|FG001|Optional Follow-Up|Lost to Follow-up|1|||
124537339|NCT00689728|447919587|FG002|Optional Follow-Up|Lost to Follow-up|1|||
124537340|NCT00689728|447919585|FG000|Optional Follow-Up|Protocol Violation|0|||
124537341|NCT00689728|447919586|FG001|Optional Follow-Up|Protocol Violation|0|||
124537342|NCT00689728|447919587|FG002|Optional Follow-Up|Protocol Violation|1|||
124537343|NCT00689728|447919585|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
124537344|NCT00689728|447919586|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
124537345|NCT00689728|447919587|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
124537346|NCT00784836|447919592|FG000|Overall Study|Early Study Termination|3|||
124537347|NCT00660829|447919594|FG000|Overall Study|Adverse Event|3|||
124537348|NCT00660829|447919595|FG001|Overall Study|Adverse Event|4|||
124537349|NCT00660829|447919594|FG000|Overall Study|Lack of Efficacy|2|||
124537350|NCT00660829|447919595|FG001|Overall Study|Lack of Efficacy|3|||
124537351|NCT00660829|447919594|FG000|Overall Study|Non-Compliance|0|||
124537352|NCT00660829|447919595|FG001|Overall Study|Non-Compliance|4|||
124537353|NCT00660829|447919594|FG000|Overall Study|Withdrawal by Subject|1|||
124537354|NCT00660829|447919595|FG001|Overall Study|Withdrawal by Subject|2|||
124537355|NCT00660829|447919594|FG000|Overall Study|Lost to Follow-up|3|||
124537356|NCT00660829|447919595|FG001|Overall Study|Lost to Follow-up|2|||
124537357|NCT00660829|447919594|FG000|Overall Study|Other|9|||
124537358|NCT00660829|447919595|FG001|Overall Study|Other|4|||
124537359|NCT03590613|447919596|FG000|Period 2, 4 Days|Physician Decision|0|||
124537360|NCT03590613|447919597|FG001|Period 2, 4 Days|Physician Decision|0|||
124537361|NCT03590613|447919598|FG002|Period 2, 4 Days|Physician Decision|0|||
124537362|NCT03590613|447919599|FG003|Period 2, 4 Days|Physician Decision|1|||
124537363|NCT00280059|447919600|FG000|Efficacy Assessment Phase|Death|2|||
124537364|NCT00280059|447919601|FG001|Efficacy Assessment Phase|Death|0|||
124537365|NCT00280059|447919600|FG000|Efficacy Assessment Phase|Adverse Event|33|||
124537366|NCT00280059|447919601|FG001|Efficacy Assessment Phase|Adverse Event|31|||
124537367|NCT00280059|447919600|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
124537368|NCT00280059|447919601|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
124537369|NCT00280059|447919600|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
124537370|NCT00280059|447919601|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
124537371|NCT00280059|447919600|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
124537372|NCT00280059|447919601|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
124537373|NCT00280059|447919600|FG000|Efficacy Assessment Phase|Other|7|||
124537374|NCT00280059|447919601|FG001|Efficacy Assessment Phase|Other|8|||
124537375|NCT00280059|447919600|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
124537376|NCT00280059|447919601|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
124537377|NCT01130831|447919604|FG000|Overall Study|Withdrawal by Subject|7|||
124537378|NCT01130831|447919604|FG000|Overall Study|Death|4|||
124537379|NCT01130831|447919604|FG000|Overall Study|Information was missing|3|||
124537380|NCT00951912|447919605|FG000|Overall Study|Lack of Efficacy|1|||
124537381|NCT00951912|447919606|FG001|Overall Study|Lack of Efficacy|0|||
124537382|NCT00951912|447919607|FG002|Overall Study|Lack of Efficacy|0|||
124537383|NCT00951912|447919605|FG000|Overall Study|Adverse Event|0|||
124537384|NCT00951912|447919606|FG001|Overall Study|Adverse Event|1|||
124537385|NCT00951912|447919607|FG002|Overall Study|Adverse Event|1|||
124537386|NCT00951912|447919605|FG000|Overall Study|Lost to Follow-up|2|||
124537387|NCT00951912|447919606|FG001|Overall Study|Lost to Follow-up|2|||
124537388|NCT00951912|447919607|FG002|Overall Study|Lost to Follow-up|0|||
124537389|NCT00951912|447919605|FG000|Overall Study|Physician Decision|1|||
124537390|NCT00951912|447919606|FG001|Overall Study|Physician Decision|0|||
124537391|NCT00951912|447919607|FG002|Overall Study|Physician Decision|1|||
124537392|NCT00951912|447919605|FG000|Overall Study|Withdrawal by Subject|1|||
124537393|NCT00951912|447919606|FG001|Overall Study|Withdrawal by Subject|1|||
124537394|NCT00951912|447919607|FG002|Overall Study|Withdrawal by Subject|0|||
124537395|NCT00951912|447919605|FG000|Overall Study|Other:Depression|1|||
124537396|NCT00951912|447919606|FG001|Overall Study|Other:Depression|0|||
124537397|NCT00951912|447919607|FG002|Overall Study|Other:Depression|0|||
124537398|NCT00951912|447919605|FG000|Overall Study|Other: Colon cancer|1|||
124537399|NCT00951912|447919606|FG001|Overall Study|Other: Colon cancer|0|||
124537400|NCT00951912|447919607|FG002|Overall Study|Other: Colon cancer|0|||
124537401|NCT00951912|447919605|FG000|Overall Study|Other: Stroke|0|||
124537402|NCT00951912|447919606|FG001|Overall Study|Other: Stroke|1|||
124537403|NCT00951912|447919607|FG002|Overall Study|Other: Stroke|0|||
124537404|NCT01513460|447919608|FG000|Overall Study|Death|0|||
124537405|NCT01513460|447919609|FG001|Overall Study|Death|0|||
124537406|NCT01513460|447919610|FG002|Overall Study|Death|1|||
124537407|NCT01513460|447919608|FG000|Overall Study|Lost to Follow-up|0|||
124537408|NCT01513460|447919609|FG001|Overall Study|Lost to Follow-up|0|||
124537409|NCT01513460|447919610|FG002|Overall Study|Lost to Follow-up|2|||
124537410|NCT01513460|447919608|FG000|Overall Study|Abnormal laboratory value|1|||
124537411|NCT01513460|447919609|FG001|Overall Study|Abnormal laboratory value|0|||
124537412|NCT01513460|447919610|FG002|Overall Study|Abnormal laboratory value|1|||
124537413|NCT01513460|447919608|FG000|Overall Study|Lack of Efficacy|1|||
124537414|NCT01513460|447919609|FG001|Overall Study|Lack of Efficacy|2|||
124537415|NCT01513460|447919610|FG002|Overall Study|Lack of Efficacy|5|||
124537416|NCT01513460|447919608|FG000|Overall Study|Protocol deviations|3|||
124537417|NCT01513460|447919609|FG001|Overall Study|Protocol deviations|4|||
124537418|NCT01513460|447919610|FG002|Overall Study|Protocol deviations|3|||
124537419|NCT01513460|447919608|FG000|Overall Study|Withdrawal by Subject|7|||
124537420|NCT01513460|447919609|FG001|Overall Study|Withdrawal by Subject|8|||
124537421|NCT01513460|447919610|FG002|Overall Study|Withdrawal by Subject|21|||
124537422|NCT01513460|447919608|FG000|Overall Study|Adverse Event|16|||
124537423|NCT01513460|447919609|FG001|Overall Study|Adverse Event|18|||
124537424|NCT01513460|447919610|FG002|Overall Study|Adverse Event|23|||
124537425|NCT01513460|447919608|FG000|Overall Study|Abnormal test procedure|1|||
124537426|NCT01513460|447919609|FG001|Overall Study|Abnormal test procedure|0|||
124537427|NCT01513460|447919610|FG002|Overall Study|Abnormal test procedure|0|||
124537428|NCT00489216|447919614|FG000|Overall Study|Adverse Event|1|||
124537429|NCT02612194|447919619|FG000|Overall Study|Death|5|||
124537430|NCT02612194|447919620|FG001|Overall Study|Death|0|||
124537431|NCT02612194|447919621|FG002|Overall Study|Death|2|||
124537432|NCT02612194|447919619|FG000|Overall Study|Early Study Termination|1|||
124537433|NCT02612194|447919620|FG001|Overall Study|Early Study Termination|0|||
124537434|NCT02612194|447919621|FG002|Overall Study|Early Study Termination|0|||
124537435|NCT02539160|447919622|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
124537436|NCT02539160|447919623|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
124537437|NCT02539160|447919624|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
124537438|NCT02539160|447919625|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
124537439|NCT02539160|447919622|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
124537440|NCT02539160|447919623|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
124537441|NCT02539160|447919624|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
124537442|NCT02539160|447919625|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
124537443|NCT02539160|447919622|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
124537444|NCT02539160|447919623|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
124537445|NCT02539160|447919624|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
124537446|NCT02539160|447919625|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
124537447|NCT01681004|447919626|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
124537448|NCT01681004|447919627|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
124537449|NCT01681004|447919626|FG000|Study Completion|Lost to Follow-up|8|||
124537450|NCT01681004|447919627|FG001|Study Completion|Lost to Follow-up|3|||
124537451|NCT01681004|447919626|FG000|Study Completion|Physician Decision|1|||
124978962|NCT03635099|449548575|FG005|Period 2|Withdrawal by Subject|0|||
124978963|NCT03635099|449548576|FG006|Period 2|Withdrawal by Subject|0|||
124978964|NCT03635099|449548577|FG007|Period 2|Withdrawal by Subject|0|||
124978965|NCT01068665|449548578|FG000|Overall Study|Adverse Event|5|||
124978966|NCT01068665|449548579|FG001|Overall Study|Adverse Event|4|||
124978967|NCT01068665|449548578|FG000|Overall Study|Lack of Efficacy|0|||
124978968|NCT01068665|449548579|FG001|Overall Study|Lack of Efficacy|2|||
124978969|NCT01068665|449548578|FG000|Overall Study|Protocol Violation|5|||
124978970|NCT01068665|449548579|FG001|Overall Study|Protocol Violation|2|||
124978971|NCT01068665|449548578|FG000|Overall Study|Withdrawal Criteria|3|||
124978972|NCT01068665|449548579|FG001|Overall Study|Withdrawal Criteria|9|||
124978973|NCT01068665|449548578|FG000|Overall Study|Other|17|||
124978974|NCT01068665|449548579|FG001|Overall Study|Other|12|||
124978975|NCT04191616|449548581|FG000|Pre-assignment Period|Did not receive study treatment|2|||
124978976|NCT04191616|449548581|FG000|Treatment Period|Death|37|||
124978977|NCT04191616|449548581|FG000|Treatment Period|Sponsor decision|11|||
124978978|NCT04191616|449548581|FG000|Treatment Period|Withdrawal by Subject|4|||
124978979|NCT04230122|449548582|FG000|Overall Study|Lost to Follow-up|1|||
124978980|NCT04230122|449548583|FG001|Overall Study|Lost to Follow-up|0|||
124978981|NCT01840410|449548586|FG000|Overall Study|Physician Decision|1|||
124978982|NCT01840410|449548587|FG001|Overall Study|Physician Decision|2|||
124978983|NCT01840410|449548586|FG000|Overall Study|Pregnancy|1|||
124978984|NCT01840410|449548587|FG001|Overall Study|Pregnancy|0|||
124978985|NCT01840410|449548586|FG000|Overall Study|Protocol deviation|1|||
124978986|NCT01840410|449548587|FG001|Overall Study|Protocol deviation|0|||
124978987|NCT01840410|449548586|FG000|Overall Study|Lost to Follow-up|1|||
124978988|NCT01840410|449548587|FG001|Overall Study|Lost to Follow-up|0|||
124978989|NCT01840410|449548586|FG000|Overall Study|Withdrawal by Subject|2|||
124978990|NCT01840410|449548587|FG001|Overall Study|Withdrawal by Subject|1|||
124978991|NCT01840410|449548586|FG000|Overall Study|Adverse Event|1|||
124978992|NCT01840410|449548587|FG001|Overall Study|Adverse Event|1|||
124978993|NCT02671500|449548601|FG000|Overall Study|Lack of Efficacy|12|||
124978994|NCT02671500|449548601|FG000|Overall Study|Lost to Follow-up|2|||
124978995|NCT05235269|449548608|FG000|Overall Study|Adverse Event|1|||
124978996|NCT05235269|449548608|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
124978997|NCT05235269|449548608|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
124978998|NCT00798434|449548609|FG000|Double-Blind|Adverse Event|22|||
124978999|NCT00798434|449548610|FG001|Double-Blind|Adverse Event|46|||
124979000|NCT00798434|449548609|FG000|Double-Blind|Death|0|||
124979001|NCT00798434|449548610|FG001|Double-Blind|Death|1|||
124979002|NCT00798434|449548609|FG000|Double-Blind|Lost to Follow-up|1|||
124979003|NCT00798434|449548610|FG001|Double-Blind|Lost to Follow-up|0|||
124979004|NCT00798434|449548609|FG000|Double-Blind|Lack of Efficacy|8|||
124979005|NCT00798434|449548610|FG001|Double-Blind|Lack of Efficacy|12|||
124979006|NCT00798434|449548609|FG000|Double-Blind|Withdrawal by Subject|17|||
124979007|NCT00798434|449548610|FG001|Double-Blind|Withdrawal by Subject|14|||
124979008|NCT00798434|449548609|FG000|Double-Blind|Protocol Violation|1|||
124979009|NCT00798434|449548610|FG001|Double-Blind|Protocol Violation|4|||
124979010|NCT00798434|449548609|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
124979011|NCT00798434|449548610|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
124979012|NCT00798434|449548609|FG000|Double-Blind|Other|1|||
124979013|NCT00798434|449548610|FG001|Double-Blind|Other|0|||
124979014|NCT00798434|449548609|FG000|Double-Blind|Not Treated|3|||
124979015|NCT00798434|449548610|FG001|Double-Blind|Not Treated|6|||
124979016|NCT00798434|449548609|FG000|Open-Label|Adverse Event|33|||
124979017|NCT00798434|449548610|FG001|Open-Label|Adverse Event|11|||
124979018|NCT00798434|449548609|FG000|Open-Label|Lack of Efficacy|5|||
124979019|NCT00798434|449548610|FG001|Open-Label|Lack of Efficacy|11|||
124979020|NCT00798434|449548609|FG000|Open-Label|Withdrawal by Subject|2|||
124979021|NCT00798434|449548610|FG001|Open-Label|Withdrawal by Subject|7|||
124979022|NCT00798434|449548609|FG000|Open-Label|Protocol Violation|1|||
124979023|NCT00798434|449548610|FG001|Open-Label|Protocol Violation|0|||
124979024|NCT00798434|449548609|FG000|Open-Label|Other|1|||
124979025|NCT00798434|449548610|FG001|Open-Label|Other|2|||
124979026|NCT00798434|449548609|FG000|Open-Label|Not Treated|0|||
124979027|NCT00798434|449548610|FG001|Open-Label|Not Treated|1|||
124979028|NCT05292586|449548611|FG000|Overall Study|Withdrawal by Subject|3|||
124979029|NCT05292586|449548612|FG001|Overall Study|Withdrawal by Subject|10|||
124979030|NCT05292586|449548611|FG000|Overall Study|Randomization error|3|||
124979031|NCT05292586|449548612|FG001|Overall Study|Randomization error|7|||
124979032|NCT05292586|449548611|FG000|Overall Study|Adverse Event|3|||
124979033|NCT05292586|449548612|FG001|Overall Study|Adverse Event|0|||
124979034|NCT05292586|449548611|FG000|Overall Study|Lost to Follow-up|0|||
124979035|NCT05292586|449548612|FG001|Overall Study|Lost to Follow-up|1|||
124979036|NCT05292586|449548611|FG000|Overall Study|Patient refused treatment|1|||
124979037|NCT05292586|449548612|FG001|Overall Study|Patient refused treatment|0|||
124979038|NCT05292586|449548611|FG000|Overall Study|Patient could not travel to the study site|1|||
124979039|NCT05292586|449548612|FG001|Overall Study|Patient could not travel to the study site|0|||
124979040|NCT05292586|449548611|FG000|Overall Study|Technical issues with the masterscope|0|||
124537452|NCT01681004|447919627|FG001|Study Completion|Physician Decision|3|||
124537453|NCT01681004|447919626|FG000|Study Completion|Site Termination|2|||
124537454|NCT01681004|447919627|FG001|Study Completion|Site Termination|1|||
124537455|NCT01681004|447919626|FG000|Study Completion|Death|1|||
124537456|NCT01681004|447919627|FG001|Study Completion|Death|1|||
124537457|NCT00372905|447919628|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
124537458|NCT00372905|447919629|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
124537459|NCT00372905|447919630|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
124537460|NCT00372905|447919631|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
124537461|NCT00372905|447919628|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
124537462|NCT00372905|447919629|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
124537463|NCT00372905|447919630|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
124537464|NCT00372905|447919631|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
124537465|NCT00372905|447919628|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
124537466|NCT00372905|447919629|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
124537467|NCT00372905|447919630|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
124537468|NCT00372905|447919631|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
124537469|NCT00372905|447919628|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
124537470|NCT00372905|447919629|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
124537471|NCT00372905|447919630|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
124537472|NCT00372905|447919631|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
124537473|NCT00372905|447919628|FG000|Follow up Until Relapse or Progression|Study closed|0|||
124537474|NCT00372905|447919629|FG001|Follow up Until Relapse or Progression|Study closed|0|||
124537475|NCT00372905|447919630|FG002|Follow up Until Relapse or Progression|Study closed|0|||
124537476|NCT00372905|447919631|FG003|Follow up Until Relapse or Progression|Study closed|3|||
124537477|NCT00372905|447919628|FG000|Follow up Until Relapse or Progression|Other|0|||
124537478|NCT00372905|447919629|FG001|Follow up Until Relapse or Progression|Other|1|||
124537479|NCT00372905|447919630|FG002|Follow up Until Relapse or Progression|Other|0|||
124537480|NCT00372905|447919631|FG003|Follow up Until Relapse or Progression|Other|0|||
124537481|NCT02312934|447919632|FG000|Overall Study|Lost to Follow-up|1|||
124537482|NCT02312934|447919633|FG001|Overall Study|Lost to Follow-up|0|||
124537483|NCT02312934|447919632|FG000|Overall Study|Physician Decision|1|||
124537484|NCT02312934|447919633|FG001|Overall Study|Physician Decision|0|||
124537485|NCT00701064|447919635|FG000|Overall Study|Protocol Violation|1|||
124537486|NCT00701064|447919636|FG001|Overall Study|Protocol Violation|1|||
124537487|NCT00701064|447919635|FG000|Overall Study|Withdrawal by Subject|1|||
124537488|NCT00701064|447919636|FG001|Overall Study|Withdrawal by Subject|1|||
124537489|NCT00701064|447919635|FG000|Overall Study|initiated other PTSD treatment|2|||
124537490|NCT00701064|447919636|FG001|Overall Study|initiated other PTSD treatment|2|||
124537491|NCT00689299|447919637|FG000|Overall Study|Adverse Event|2|||
124537492|NCT00689299|447919638|FG001|Overall Study|Adverse Event|1|||
124537493|NCT00689299|447919639|FG002|Overall Study|Adverse Event|1|||
124537494|NCT00689299|447919637|FG000|Overall Study|Lost to Follow-up|0|||
124537495|NCT00689299|447919638|FG001|Overall Study|Lost to Follow-up|1|||
124537496|NCT00689299|447919639|FG002|Overall Study|Lost to Follow-up|1|||
124537497|NCT00689299|447919637|FG000|Overall Study|Withdrawal by Subject|4|||
124537498|NCT00689299|447919638|FG001|Overall Study|Withdrawal by Subject|1|||
124537499|NCT00689299|447919639|FG002|Overall Study|Withdrawal by Subject|3|||
124537500|NCT00689299|447919637|FG000|Overall Study|Protocol Violation|1|||
124537501|NCT00689299|447919638|FG001|Overall Study|Protocol Violation|0|||
124537502|NCT00689299|447919639|FG002|Overall Study|Protocol Violation|0|||
124537503|NCT02613910|447919642|FG000|Overall Study|Termination of study|1|||
124537504|NCT03395704|447919643|FG000|Overall Study|Adverse Event|2|||
124537505|NCT03395704|447919644|FG001|Overall Study|Adverse Event|1|||
124537506|NCT03395704|447919643|FG000|Overall Study|Withdrawal by Subject|2|||
124537507|NCT03395704|447919644|FG001|Overall Study|Withdrawal by Subject|1|||
124537508|NCT03395704|447919643|FG000|Overall Study|Physician Decision|0|||
124537509|NCT03395704|447919644|FG001|Overall Study|Physician Decision|1|||
124537510|NCT00758394|447919645|FG000|2nd Intervention Order|Lost to Follow-up|0|||
124537511|NCT00758394|447919646|FG001|2nd Intervention Order|Lost to Follow-up|1|||
124537512|NCT00758394|447919647|FG002|2nd Intervention Order|Lost to Follow-up|0|||
124537513|NCT00758394|447919648|FG003|2nd Intervention Order|Lost to Follow-up|0|||
124537514|NCT00758394|447919645|FG000|3rd Intervention|Lost to Follow-up|1|||
124537515|NCT00758394|447919646|FG001|3rd Intervention|Lost to Follow-up|0|||
124537516|NCT00758394|447919647|FG002|3rd Intervention|Lost to Follow-up|0|||
124537517|NCT00758394|447919648|FG003|3rd Intervention|Lost to Follow-up|1|||
124537518|NCT04823494|447921431|FG000|Overall Study|Programming software malfunction.|1|||
124537519|NCT04823494|447921432|FG001|Overall Study|Programming software malfunction.|0|||
124537520|NCT04823494|447921431|FG000|Overall Study|Withdrawal by Subject|1|||
124537521|NCT04823494|447921432|FG001|Overall Study|Withdrawal by Subject|0|||
124537522|NCT04823494|447921431|FG000|Overall Study|Devices lost|0|||
124537523|NCT04823494|447921432|FG001|Overall Study|Devices lost|1|||
124537524|NCT03726320|447921433|FG000|Overall Study|Lost to Follow-up|2|||
124537525|NCT03726320|447921434|FG001|Overall Study|Lost to Follow-up|4|||
124537526|NCT03726320|447921435|FG002|Overall Study|Lost to Follow-up|0|||
124537527|NCT03726320|447921433|FG000|Overall Study|Time Constraints|4|||
124537528|NCT03726320|447921434|FG001|Overall Study|Time Constraints|1|||
124537529|NCT03726320|447921435|FG002|Overall Study|Time Constraints|0|||
124537530|NCT03726320|447921433|FG000|Overall Study|Ineligible after enrollment|3|||
124537531|NCT03726320|447921434|FG001|Overall Study|Ineligible after enrollment|3|||
124537532|NCT03726320|447921435|FG002|Overall Study|Ineligible after enrollment|0|||
124537533|NCT03726320|447921433|FG000|Overall Study|Clinic / insurance issue|2|||
124537534|NCT03726320|447921434|FG001|Overall Study|Clinic / insurance issue|0|||
124537535|NCT03726320|447921435|FG002|Overall Study|Clinic / insurance issue|0|||
124537536|NCT03726320|447921433|FG000|Overall Study|Language barrier|1|||
124537537|NCT03726320|447921434|FG001|Overall Study|Language barrier|0|||
124537538|NCT03726320|447921435|FG002|Overall Study|Language barrier|0|||
124537539|NCT03726320|447921433|FG000|Overall Study|Provider left the clinic|0|||
124537540|NCT03726320|447921434|FG001|Overall Study|Provider left the clinic|0|||
124537541|NCT03726320|447921435|FG002|Overall Study|Provider left the clinic|1|||
124537542|NCT01684930|447921438|FG000|Overall Study|Withdrawal by Subject|3|||
124537543|NCT01684930|447921439|FG001|Overall Study|Withdrawal by Subject|1|||
124537544|NCT00313716|447921449|FG000|Overall Study|Death|3|||
124537545|NCT00313716|447921450|FG001|Overall Study|Death|2|||
124537546|NCT00313716|447921451|FG002|Overall Study|Death|9|||
124537547|NCT00313716|447921452|FG003|Overall Study|Death|3|||
124537548|NCT00313716|447921453|FG004|Overall Study|Death|5|||
124537549|NCT00313716|447921454|FG005|Overall Study|Death|9|||
124537550|NCT00313716|447921449|FG000|Overall Study|Lost to Follow-up|2|||
124537551|NCT00313716|447921450|FG001|Overall Study|Lost to Follow-up|5|||
124537552|NCT00313716|447921451|FG002|Overall Study|Lost to Follow-up|2|||
124537553|NCT00313716|447921452|FG003|Overall Study|Lost to Follow-up|1|||
124537554|NCT00313716|447921453|FG004|Overall Study|Lost to Follow-up|0|||
124537555|NCT00313716|447921454|FG005|Overall Study|Lost to Follow-up|4|||
124537556|NCT00313716|447921449|FG000|Overall Study|Withdrawal by Subject|0|||
124537557|NCT00313716|447921450|FG001|Overall Study|Withdrawal by Subject|1|||
124537558|NCT00313716|447921451|FG002|Overall Study|Withdrawal by Subject|1|||
124537559|NCT00313716|447921452|FG003|Overall Study|Withdrawal by Subject|0|||
124537560|NCT00313716|447921453|FG004|Overall Study|Withdrawal by Subject|1|||
124537561|NCT00313716|447921454|FG005|Overall Study|Withdrawal by Subject|0|||
124537562|NCT01041027|447921456|FG000|Overall Study|Withdrawal by Subject|2|||
124537563|NCT01041027|447921456|FG000|Overall Study|Protocol Violation|1|||
124537564|NCT01041027|447921456|FG000|Overall Study|Delayed Radiation Therapy|1|||
124537565|NCT01041027|447921456|FG000|Overall Study|Adverse Event|4|||
124537566|NCT01347931|447921457|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
124537567|NCT02493712|447921458|FG000|Overall Study|Withdrawal by Subject|1|||
124537568|NCT02493712|447921459|FG001|Overall Study|Withdrawal by Subject|0|||
124537569|NCT02493712|447921460|FG002|Overall Study|Withdrawal by Subject|2|||
124537570|NCT02493712|447921458|FG000|Overall Study|Protocol Violation|0|||
124537571|NCT02493712|447921459|FG001|Overall Study|Protocol Violation|0|||
124537572|NCT02493712|447921460|FG002|Overall Study|Protocol Violation|1|||
124537573|NCT02493712|447921458|FG000|Overall Study|Lost to Follow-up|1|||
124537574|NCT02493712|447921459|FG001|Overall Study|Lost to Follow-up|0|||
124537575|NCT02493712|447921460|FG002|Overall Study|Lost to Follow-up|0|||
124537576|NCT02493712|447921458|FG000|Overall Study|Physician Decision|0|||
124537577|NCT02493712|447921459|FG001|Overall Study|Physician Decision|1|||
124537578|NCT02493712|447921460|FG002|Overall Study|Physician Decision|0|||
124537579|NCT02493712|447921458|FG000|Overall Study|Lack of Efficacy|0|||
124537580|NCT02493712|447921459|FG001|Overall Study|Lack of Efficacy|5|||
124537581|NCT02493712|447921460|FG002|Overall Study|Lack of Efficacy|3|||
124537582|NCT02528643|447921461|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
124537583|NCT02528643|447921462|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
124537584|NCT02528643|447921461|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
124537585|NCT02528643|447921462|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
124537586|NCT02528643|447921461|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
124537587|NCT02528643|447921462|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
124537588|NCT02528643|447921461|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
124537589|NCT02528643|447921462|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
124537590|NCT02528643|447921461|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
124537591|NCT02528643|447921462|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
124537592|NCT02528643|447921461|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
124537593|NCT02528643|447921462|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
124537594|NCT02528643|447921461|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
124537595|NCT02528643|447921462|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
124537596|NCT04120116|447921463|FG000|Overall Study|Lost to Follow-up|0|||
124537597|NCT04120116|447921464|FG001|Overall Study|Lost to Follow-up|1|||
124537598|NCT04120116|447921465|FG002|Overall Study|Lost to Follow-up|0|||
124537599|NCT04120116|447921466|FG003|Overall Study|Lost to Follow-up|2|||
124537600|NCT04120116|447921463|FG000|Overall Study|Withdrawal by Subject|1|||
124537601|NCT04120116|447921464|FG001|Overall Study|Withdrawal by Subject|0|||
124537602|NCT04120116|447921465|FG002|Overall Study|Withdrawal by Subject|1|||
124537603|NCT04120116|447921466|FG003|Overall Study|Withdrawal by Subject|1|||
124537604|NCT04120116|447921463|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
124537605|NCT04120116|447921464|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
124537606|NCT04120116|447921465|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
124537607|NCT04120116|447921466|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
124537608|NCT02087085|447921467|FG000|Overall Study|Adverse Event|10|||
124537609|NCT02087085|447921468|FG001|Overall Study|Adverse Event|14|||
124537610|NCT02087085|447921467|FG000|Overall Study|Lack of Efficacy|4|||
124537611|NCT02087085|447921468|FG001|Overall Study|Lack of Efficacy|3|||
124537612|NCT02087085|447921467|FG000|Overall Study|Lost to Follow-up|6|||
124537613|NCT02087085|447921468|FG001|Overall Study|Lost to Follow-up|4|||
124537614|NCT02087085|447921467|FG000|Overall Study|Withdrawal by Subject|9|||
124537615|NCT02087085|447921468|FG001|Overall Study|Withdrawal by Subject|11|||
124537616|NCT02087085|447921467|FG000|Overall Study|Protocol Violation|1|||
124537617|NCT02087085|447921468|FG001|Overall Study|Protocol Violation|0|||
124537618|NCT02087085|447921467|FG000|Overall Study|Study Terminated by Sponsor|87|||
124537619|NCT02087085|447921468|FG001|Overall Study|Study Terminated by Sponsor|80|||
124537620|NCT02087085|447921467|FG000|Overall Study|Other Miscellaneous Reasons|3|||
124537621|NCT02087085|447921468|FG001|Overall Study|Other Miscellaneous Reasons|4|||
124537622|NCT01191190|447921469|FG000|Overall Study|Withdrawal by Subject|1|||
124537623|NCT00883896|447921477|FG000|Overall Study|Lost to Follow-up|0|||
124537624|NCT00883896|447921478|FG001|Overall Study|Lost to Follow-up|0|||
124537625|NCT00883896|447921479|FG002|Overall Study|Lost to Follow-up|0|||
124537626|NCT00883896|447921480|FG003|Overall Study|Lost to Follow-up|2|||
124537627|NCT00883896|447921477|FG000|Overall Study|Withdrawal by Subject|5|||
124537628|NCT00883896|447921478|FG001|Overall Study|Withdrawal by Subject|0|||
124537629|NCT00883896|447921479|FG002|Overall Study|Withdrawal by Subject|1|||
124537630|NCT00883896|447921480|FG003|Overall Study|Withdrawal by Subject|3|||
124537631|NCT00883896|447921477|FG000|Overall Study|Lack of Efficacy|0|||
124537632|NCT00883896|447921478|FG001|Overall Study|Lack of Efficacy|0|||
124537633|NCT00883896|447921479|FG002|Overall Study|Lack of Efficacy|0|||
124537634|NCT00883896|447921480|FG003|Overall Study|Lack of Efficacy|2|||
124537635|NCT00883896|447921477|FG000|Overall Study|Other|1|||
124537636|NCT00883896|447921478|FG001|Overall Study|Other|0|||
124537637|NCT00883896|447921479|FG002|Overall Study|Other|0|||
124537638|NCT00883896|447921480|FG003|Overall Study|Other|0|||
124537639|NCT01856920|447921481|FG000|Overall Study|Disease Progression On Study|3|||
124537640|NCT01856920|447921482|FG001|Overall Study|Disease Progression On Study|4|||
124537641|NCT01856920|447921481|FG000|Overall Study|Disease Progression before Treatment|1|||
124537642|NCT01856920|447921482|FG001|Overall Study|Disease Progression before Treatment|0|||
124537643|NCT01856920|447921481|FG000|Overall Study|Ineligible|0|||
124537644|NCT01856920|447921482|FG001|Overall Study|Ineligible|1|||
124537645|NCT01856920|447921481|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
124537646|NCT01856920|447921482|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
124537647|NCT01856920|447921481|FG000|Overall Study|Refused further Treatment|5|||
124537648|NCT01856920|447921482|FG001|Overall Study|Refused further Treatment|1|||
124537649|NCT01856920|447921481|FG000|Overall Study|Other Reasons|0|||
124537650|NCT01856920|447921482|FG001|Overall Study|Other Reasons|1|||
124537651|NCT01856920|447921481|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
124537652|NCT01856920|447921482|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
124979041|NCT05292586|449548612|FG001|Overall Study|Technical issues with the masterscope|3|||
124537653|NCT02545270|447921483|FG000|Overall Study|technical difficulties|0|||
124537654|NCT02545270|447921484|FG001|Overall Study|technical difficulties|1|||
124537655|NCT02545270|447921485|FG002|Overall Study|technical difficulties|0|||
124537656|NCT02545270|447921483|FG000|Overall Study|Videos being too similar to other|0|||
124537657|NCT02545270|447921484|FG001|Overall Study|Videos being too similar to other|0|||
124537658|NCT02545270|447921485|FG002|Overall Study|Videos being too similar to other|2|||
124537659|NCT03380091|447921488|FG000|Overall Study|Withdrawal by Subject|2|||
124537660|NCT03380091|447921489|FG001|Overall Study|Withdrawal by Subject|1|||
124537661|NCT00761891|447921490|FG000|Overall Study|Withdrawal by Subject|10|||
124537662|NCT01707667|447921491|FG000|Period 1|expulsion of colonic sensor catheter|1|||
124537663|NCT01707667|447921492|FG001|Period 1|expulsion of colonic sensor catheter|0|||
124537664|NCT04382066|447921500|FG000|Overall Study|Adverse Event|1|||
124537665|NCT04382066|447921501|FG001|Overall Study|Adverse Event|0|||
124537666|NCT04382066|447921502|FG002|Overall Study|Adverse Event|0|||
124537667|NCT04382066|447921500|FG000|Overall Study|Death|1|||
124979042|NCT05292586|449548611|FG000|Overall Study|Patient moved to a different state|0|||
124537668|NCT04382066|447921501|FG001|Overall Study|Death|0|||
124537669|NCT04382066|447921502|FG002|Overall Study|Death|1|||
124537670|NCT03326323|447921505|FG000|Overall Study|Unable to receive ANH protocol|3|||
124537671|NCT04225026|447921507|FG000|Overall Study|Withdrawal by Subject|4|||
124537672|NCT04225026|447921507|FG000|Overall Study|Adverse Event|1|||
124979043|NCT05292586|449548612|FG001|Overall Study|Patient moved to a different state|1|||
124537673|NCT04225026|447921507|FG000|Overall Study|Other|1|||
124537674|NCT04225026|447921507|FG000|Overall Study|Death|11|||
124537675|NCT04225026|447921507|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
124537676|NCT00779142|447921510|FG000|Overall Study|Screen Failures|3|||
124537677|NCT04533204|447921513|FG000|Overall Study|Unable to understand training instructions|1|||
124537678|NCT04533204|447921514|FG001|Overall Study|Unable to understand training instructions|1|||
124537679|NCT03982069|447921515|FG000|Overall Study|Lost to Follow-up|5|||
124537680|NCT03982069|447921516|FG001|Overall Study|Lost to Follow-up|5|||
124537681|NCT03982069|447921517|FG002|Overall Study|Lost to Follow-up|3|||
124537682|NCT03982069|447921518|FG003|Overall Study|Lost to Follow-up|5|||
124537683|NCT03982069|447921515|FG000|Overall Study|Physician Decision|0|||
124537684|NCT03982069|447921516|FG001|Overall Study|Physician Decision|1|||
124537685|NCT03982069|447921517|FG002|Overall Study|Physician Decision|0|||
124537686|NCT03982069|447921518|FG003|Overall Study|Physician Decision|0|||
124537687|NCT03982069|447921515|FG000|Overall Study|Withdrawal by Subject|2|||
124537688|NCT03982069|447921516|FG001|Overall Study|Withdrawal by Subject|1|||
124537689|NCT03982069|447921517|FG002|Overall Study|Withdrawal by Subject|5|||
124537690|NCT03982069|447921518|FG003|Overall Study|Withdrawal by Subject|2|||
124537691|NCT03982069|447921515|FG000|Overall Study|Specimen loss|3|||
124537692|NCT03982069|447921516|FG001|Overall Study|Specimen loss|3|||
124537693|NCT03982069|447921517|FG002|Overall Study|Specimen loss|1|||
124537694|NCT03982069|447921518|FG003|Overall Study|Specimen loss|1|||
124537695|NCT01218477|447921519|FG000|Overall Study|Disease progression|2|||
124537696|NCT01218477|447921520|FG001|Overall Study|Disease progression|3|||
124537697|NCT01218477|447921521|FG002|Overall Study|Disease progression|6|||
124537698|NCT01218477|447921522|FG003|Overall Study|Disease progression|2|||
124537699|NCT01218477|447921519|FG000|Overall Study|Study drug toxicity|0|||
124537700|NCT01218477|447921520|FG001|Overall Study|Study drug toxicity|2|||
124537701|NCT01218477|447921521|FG002|Overall Study|Study drug toxicity|5|||
124537702|NCT01218477|447921522|FG003|Overall Study|Study drug toxicity|0|||
124537703|NCT01218477|447921519|FG000|Overall Study|No longer meets study criteria|1|||
124537704|NCT01218477|447921520|FG001|Overall Study|No longer meets study criteria|0|||
124537705|NCT01218477|447921521|FG002|Overall Study|No longer meets study criteria|0|||
124537706|NCT01218477|447921522|FG003|Overall Study|No longer meets study criteria|0|||
124537707|NCT01218477|447921519|FG000|Overall Study|Withdrawal by Subject|0|||
124537708|NCT01218477|447921520|FG001|Overall Study|Withdrawal by Subject|0|||
124537709|NCT01218477|447921521|FG002|Overall Study|Withdrawal by Subject|1|||
124537710|NCT01218477|447921522|FG003|Overall Study|Withdrawal by Subject|0|||
124537711|NCT01218477|447921519|FG000|Overall Study|Prepared for cell transplantation|0|||
124537712|NCT01218477|447921520|FG001|Overall Study|Prepared for cell transplantation|1|||
124537713|NCT01218477|447921521|FG002|Overall Study|Prepared for cell transplantation|1|||
124537714|NCT01218477|447921522|FG003|Overall Study|Prepared for cell transplantation|0|||
124537715|NCT01218477|447921519|FG000|Overall Study|Administrative reason by sponsor|0|||
124537716|NCT01218477|447921520|FG001|Overall Study|Administrative reason by sponsor|0|||
124537717|NCT01218477|447921521|FG002|Overall Study|Administrative reason by sponsor|1|||
124537718|NCT01218477|447921522|FG003|Overall Study|Administrative reason by sponsor|0|||
124537719|NCT01218477|447921519|FG000|Overall Study|Maximum clinical benefit|0|||
124537720|NCT01218477|447921520|FG001|Overall Study|Maximum clinical benefit|2|||
124537721|NCT01218477|447921521|FG002|Overall Study|Maximum clinical benefit|0|||
124537722|NCT01218477|447921522|FG003|Overall Study|Maximum clinical benefit|0|||
124537723|NCT03137433|447921523|FG000|Overall Study|Withdrawal by Subject|11|||
124537724|NCT03137433|447921524|FG001|Overall Study|Withdrawal by Subject|11|||
124537725|NCT03137433|447921523|FG000|Overall Study|Lost to Follow-up|5|||
124537726|NCT03137433|447921524|FG001|Overall Study|Lost to Follow-up|6|||
124537727|NCT03137433|447921523|FG000|Overall Study|Physician Decision|2|||
124537728|NCT03137433|447921524|FG001|Overall Study|Physician Decision|0|||
124537729|NCT03137433|447921523|FG000|Overall Study|Moved out of study area|1|||
124537730|NCT03137433|447921524|FG001|Overall Study|Moved out of study area|0|||
124537731|NCT03137433|447921523|FG000|Overall Study|Too far out of window due to COVID|0|||
124537732|NCT03137433|447921524|FG001|Overall Study|Too far out of window due to COVID|1|||
124537733|NCT00083616|447921525|FG000|Overall Study|Disease Progression|16|||
124537734|NCT00083616|447921525|FG000|Overall Study|Lost to Follow-up|1|||
124537735|NCT00083616|447921525|FG000|Overall Study|Physician Decision|2|||
124537736|NCT00083616|447921525|FG000|Overall Study|Withdrawal by Subject|3|||
124537737|NCT00083616|447921525|FG000|Overall Study|Ineligibility determined|2|||
124537738|NCT00083616|447921525|FG000|Overall Study|Non-compliance|1|||
124537739|NCT00083616|447921525|FG000|Overall Study|Other|6|||
124537740|NCT00265382|447921526|FG000|Overall Study|Adverse Event|21|||
124537741|NCT00265382|447921526|FG000|Overall Study|Laboratory Abnormality|1|||
124537742|NCT00265382|447921526|FG000|Overall Study|Lost to Follow-up|3|||
124537743|NCT00265382|447921526|FG000|Overall Study|Lack of Efficacy|6|||
124537744|NCT00265382|447921526|FG000|Overall Study|Miscellaneous|6|||
124537745|NCT00265382|447921526|FG000|Overall Study|Withdrawal by Subject|13|||
124537746|NCT00265382|447921526|FG000|Overall Study|Study terminated by sponsor|94|||
124537747|NCT00265382|447921526|FG000|Overall Study|Death|1|||
124537748|NCT01474993|447921527|FG000|Overall Study|Lost to Follow-up|1|||
124537749|NCT01474993|447921528|FG001|Overall Study|Lost to Follow-up|2|||
124537750|NCT01474993|447921527|FG000|Overall Study|Adverse Event|0|||
124537751|NCT01474993|447921528|FG001|Overall Study|Adverse Event|1|||
124537752|NCT00760994|447921529|FG000|Overall Study|Lost to Follow-up|4|||
124537753|NCT00760994|447921530|FG001|Overall Study|Lost to Follow-up|4|||
124537754|NCT00760994|447921531|FG002|Overall Study|Lost to Follow-up|3|||
124537755|NCT01853397|447921532|FG000|Overall Study|Withdrawal by Subject|0|||
124537756|NCT01853397|447921533|FG001|Overall Study|Withdrawal by Subject|0|||
124537757|NCT01853397|447921534|FG002|Overall Study|Withdrawal by Subject|0|||
124537758|NCT01853397|447921535|FG003|Overall Study|Withdrawal by Subject|1|||
124537759|NCT01853397|447921532|FG000|Overall Study|Subject Noncompliance|0|||
124537760|NCT01853397|447921533|FG001|Overall Study|Subject Noncompliance|0|||
124537761|NCT01853397|447921534|FG002|Overall Study|Subject Noncompliance|0|||
124537762|NCT01853397|447921535|FG003|Overall Study|Subject Noncompliance|1|||
124537763|NCT02132312|447921536|FG000|Overall Study|Adverse Event|2|||
124537764|NCT02132312|447921537|FG001|Overall Study|Adverse Event|0|||
124537765|NCT02132312|447921536|FG000|Overall Study|Physician Decision|1|||
124537766|NCT02132312|447921537|FG001|Overall Study|Physician Decision|1|||
124537767|NCT02132312|447921536|FG000|Overall Study|Protocol Violation|0|||
124537768|NCT02132312|447921537|FG001|Overall Study|Protocol Violation|1|||
124537769|NCT02132312|447921536|FG000|Overall Study|Withdrawal by Subject|1|||
124537770|NCT02132312|447921537|FG001|Overall Study|Withdrawal by Subject|0|||
124537771|NCT02132312|447921536|FG000|Overall Study|Lost to Follow-up|2|||
124537772|NCT02132312|447921537|FG001|Overall Study|Lost to Follow-up|1|||
124537773|NCT01724021|447921540|FG000|Overall Study|Adverse Event|11|||
124537774|NCT01724021|447921541|FG001|Overall Study|Adverse Event|6|||
124537775|NCT01724021|447921540|FG000|Overall Study|Death|46|||
124537776|NCT01724021|447921541|FG001|Overall Study|Death|58|||
124537777|NCT01724021|447921540|FG000|Overall Study|Participant request/ Withdrew consent|18|||
124537778|NCT01724021|447921541|FG001|Overall Study|Participant request/ Withdrew consent|14|||
124537779|NCT01724021|447921540|FG000|Overall Study|Lost to Follow-up|15|||
124537780|NCT01724021|447921541|FG001|Overall Study|Lost to Follow-up|15|||
124537781|NCT01724021|447921540|FG000|Overall Study|Reason Not Specified|36|||
124537782|NCT01724021|447921541|FG001|Overall Study|Reason Not Specified|39|||
124537783|NCT01724021|447921540|FG000|Overall Study|Missing|1|||
124537784|NCT01724021|447921541|FG001|Overall Study|Missing|1|||
124537785|NCT02452892|447921544|FG000|Week 1 Initial Randommization|Adverse Event|1|||
124537786|NCT02452892|447921545|FG001|Week 1 Initial Randommization|Adverse Event|0|||
124537787|NCT02452892|447921546|FG002|Week 1 Initial Randommization|Adverse Event|0|||
124537788|NCT02452892|447921547|FG003|Week 1 Initial Randommization|Adverse Event|0|||
124537789|NCT02452892|447921544|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
124537790|NCT02452892|447921545|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
124537791|NCT02452892|447921546|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
124537792|NCT02452892|447921547|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
124537793|NCT02452892|447921544|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
124537794|NCT02452892|447921545|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
124537795|NCT02452892|447921546|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
124537796|NCT02452892|447921547|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
124537797|NCT02452892|447921544|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
124537798|NCT02452892|447921545|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
124537799|NCT02452892|447921546|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
124537800|NCT02452892|447921547|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
124537801|NCT02452892|447921544|FG000|Follow-up|Withdrawal by Subject|0|||
124537802|NCT02452892|447921545|FG001|Follow-up|Withdrawal by Subject|0|||
124537803|NCT02452892|447921546|FG002|Follow-up|Withdrawal by Subject|0|||
124537804|NCT02452892|447921547|FG003|Follow-up|Withdrawal by Subject|1|||
124537805|NCT02452892|447921544|FG000|Follow-up|Subject left town on Day 42|1|||
124537806|NCT02452892|447921545|FG001|Follow-up|Subject left town on Day 42|0|||
124537807|NCT02452892|447921546|FG002|Follow-up|Subject left town on Day 42|0|||
124537808|NCT02452892|447921547|FG003|Follow-up|Subject left town on Day 42|0|||
124537809|NCT00486720|447921548|FG000|Overall Study|Adverse Event|1|||
124537810|NCT00486720|447921549|FG001|Overall Study|Adverse Event|2|||
124537811|NCT00486720|447921548|FG000|Overall Study|Lack of Efficacy|4|||
124537812|NCT00486720|447921549|FG001|Overall Study|Lack of Efficacy|6|||
124537813|NCT00486720|447921548|FG000|Overall Study|Physician Decision|1|||
124537814|NCT00486720|447921549|FG001|Overall Study|Physician Decision|2|||
124537815|NCT00486720|447921548|FG000|Overall Study|Protocol Violation|1|||
124537816|NCT00486720|447921549|FG001|Overall Study|Protocol Violation|0|||
124537817|NCT00486720|447921548|FG000|Overall Study|Withdrawal by Subject|3|||
124537818|NCT00486720|447921549|FG001|Overall Study|Withdrawal by Subject|1|||
124537819|NCT00486720|447921548|FG000|Overall Study|Progressive Disease|0|||
124537820|NCT00486720|447921549|FG001|Overall Study|Progressive Disease|1|||
124537821|NCT00955682|447921551|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
124537822|NCT00955682|447921552|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
124537823|NCT02117024|447921553|FG000|Overall Study|Progressive Disease|26|||
124537824|NCT02117024|447921554|FG001|Overall Study|Progressive Disease|9|||
124537825|NCT02117024|447921553|FG000|Overall Study|Significant Clinical Progression|7|||
124537826|NCT02117024|447921554|FG001|Overall Study|Significant Clinical Progression|4|||
124537827|NCT02117024|447921553|FG000|Overall Study|Death|5|||
124537828|NCT02117024|447921554|FG001|Overall Study|Death|0|||
124537829|NCT02117024|447921553|FG000|Overall Study|Withdrawal by Subject|3|||
124537830|NCT02117024|447921554|FG001|Overall Study|Withdrawal by Subject|1|||
124537831|NCT02117024|447921553|FG000|Overall Study|Protocol Violation|1|||
124537832|NCT02117024|447921554|FG001|Overall Study|Protocol Violation|0|||
124537833|NCT02117024|447921553|FG000|Overall Study|Adverse Event|1|||
124537834|NCT02117024|447921554|FG001|Overall Study|Adverse Event|2|||
124537835|NCT02117024|447921553|FG000|Overall Study|Randomized in Error|1|||
124537836|NCT02117024|447921554|FG001|Overall Study|Randomized in Error|0|||
124537837|NCT02117024|447921553|FG000|Overall Study|Patient returned to primary oncologist|0|||
124537838|NCT02117024|447921554|FG001|Overall Study|Patient returned to primary oncologist|1|||
124537839|NCT02117024|447921553|FG000|Overall Study|Patient took treatment break|0|||
124537840|NCT02117024|447921554|FG001|Overall Study|Patient took treatment break|1|||
124537841|NCT02117024|447921553|FG000|Overall Study|Physician Decision|0|||
124537842|NCT02117024|447921554|FG001|Overall Study|Physician Decision|2|||
124537843|NCT00565721|447921557|FG000|Overall Study|Screen Failure|2|||
124537844|NCT00565721|447921557|FG000|Overall Study|Lost to Follow-up|6|||
124537845|NCT00565721|447921557|FG000|Overall Study|Technical Problems|1|||
124537846|NCT00565721|447921557|FG000|Overall Study|Physician Decision|2|||
124537847|NCT00565721|447921557|FG000|Overall Study|Other reasons|6|||
124537848|NCT02500706|447921560|FG000|Overall Study|Adverse Event|0|||
124537849|NCT02500706|447921561|FG001|Overall Study|Adverse Event|0|||
124537850|NCT02500706|447921562|FG002|Overall Study|Adverse Event|1|||
124537851|NCT02500706|447921560|FG000|Overall Study|Lost to Follow-up|0|||
124537852|NCT02500706|447921561|FG001|Overall Study|Lost to Follow-up|1|||
124537853|NCT02500706|447921562|FG002|Overall Study|Lost to Follow-up|1|||
124537854|NCT02500706|447921560|FG000|Overall Study|Withdrawal by Subject|4|||
124537855|NCT02500706|447921561|FG001|Overall Study|Withdrawal by Subject|6|||
124537856|NCT02500706|447921562|FG002|Overall Study|Withdrawal by Subject|4|||
124537857|NCT02500706|447921560|FG000|Overall Study|Unclassified|0|||
124537858|NCT02500706|447921561|FG001|Overall Study|Unclassified|0|||
124537859|NCT02500706|447921562|FG002|Overall Study|Unclassified|1|||
124537860|NCT00529152|447921563|FG000|Overall Study|Adverse Event|2|||
124537861|NCT00529152|447921563|FG000|Overall Study|Withdrawal by Subject|2|||
124537862|NCT00529152|447921563|FG000|Overall Study|Lost to Follow-up|1|||
124537863|NCT01497899|447921568|FG000|Double-Blind Phase|Randomized but not Treated|1|||
124537864|NCT01497899|447921569|FG001|Double-Blind Phase|Randomized but not Treated|0|||
124537865|NCT01497899|447921570|FG002|Double-Blind Phase|Randomized but not Treated|0|||
124537866|NCT01497899|447921571|FG003|Double-Blind Phase|Randomized but not Treated|0|||
124537867|NCT01497899|447921568|FG000|Double-Blind Phase|Adverse Event|1|||
124537868|NCT01497899|447921569|FG001|Double-Blind Phase|Adverse Event|0|||
124537869|NCT01497899|447921570|FG002|Double-Blind Phase|Adverse Event|0|||
124537870|NCT01497899|447921571|FG003|Double-Blind Phase|Adverse Event|0|||
124537871|NCT01497899|447921568|FG000|Double-Blind Phase|Lack of Efficacy|0|||
124537872|NCT01497899|447921569|FG001|Double-Blind Phase|Lack of Efficacy|1|||
124537873|NCT01497899|447921570|FG002|Double-Blind Phase|Lack of Efficacy|0|||
124537874|NCT01497899|447921571|FG003|Double-Blind Phase|Lack of Efficacy|0|||
124537875|NCT01497899|447921568|FG000|Double-Blind Phase|Investigator's Discretion|1|||
124537876|NCT01497899|447921569|FG001|Double-Blind Phase|Investigator's Discretion|0|||
124537877|NCT01497899|447921570|FG002|Double-Blind Phase|Investigator's Discretion|0|||
124537878|NCT01497899|447921571|FG003|Double-Blind Phase|Investigator's Discretion|0|||
124537879|NCT01497899|447921568|FG000|Double-Blind Phase|Withdrew Consent|0|||
124537880|NCT01497899|447921569|FG001|Double-Blind Phase|Withdrew Consent|1|||
124537881|NCT01497899|447921570|FG002|Double-Blind Phase|Withdrew Consent|0|||
124537882|NCT01497899|447921571|FG003|Double-Blind Phase|Withdrew Consent|0|||
124537883|NCT01497899|447921568|FG000|Double-Blind Phase|Lost to Follow-up|3|||
124537884|NCT01497899|447921569|FG001|Double-Blind Phase|Lost to Follow-up|2|||
124537885|NCT01497899|447921570|FG002|Double-Blind Phase|Lost to Follow-up|0|||
124537886|NCT01497899|447921571|FG003|Double-Blind Phase|Lost to Follow-up|0|||
124537887|NCT01497899|447921568|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
124537888|NCT01497899|447921569|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
124537889|NCT01497899|447921570|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
124537890|NCT01497899|447921571|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
124537891|NCT01497899|447921568|FG000|Open-Label Extension Phase|Adverse Event|1|||
124537892|NCT01497899|447921569|FG001|Open-Label Extension Phase|Adverse Event|0|||
124537893|NCT01497899|447921570|FG002|Open-Label Extension Phase|Adverse Event|0|||
124537894|NCT01497899|447921571|FG003|Open-Label Extension Phase|Adverse Event|0|||
124537895|NCT01497899|447921568|FG000|Open-Label Extension Phase|Death|1|||
124537896|NCT01497899|447921569|FG001|Open-Label Extension Phase|Death|0|||
124537897|NCT01497899|447921570|FG002|Open-Label Extension Phase|Death|0|||
124537898|NCT01497899|447921571|FG003|Open-Label Extension Phase|Death|0|||
124537899|NCT01497899|447921568|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
124537900|NCT01497899|447921569|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
124758625|NCT02452424|448739814|FG005|Overall Study|Adverse Event|0|||
124537901|NCT01497899|447921570|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
124537902|NCT01497899|447921571|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
124537903|NCT01497899|447921568|FG000|Open-Label Extension Phase|Pregnancy|0|||
124537904|NCT01497899|447921569|FG001|Open-Label Extension Phase|Pregnancy|1|||
124537905|NCT01497899|447921570|FG002|Open-Label Extension Phase|Pregnancy|1|||
124537906|NCT01497899|447921571|FG003|Open-Label Extension Phase|Pregnancy|0|||
124537907|NCT01497899|447921568|FG000|Open-Label Extension Phase|Protocol Violation|0|||
124537908|NCT01497899|447921569|FG001|Open-Label Extension Phase|Protocol Violation|0|||
124537909|NCT01497899|447921570|FG002|Open-Label Extension Phase|Protocol Violation|1|||
124537910|NCT01497899|447921571|FG003|Open-Label Extension Phase|Protocol Violation|0|||
124537911|NCT01497899|447921568|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
124537912|NCT01497899|447921569|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
124537913|NCT01497899|447921570|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
124537914|NCT01497899|447921571|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
124537915|NCT05047601|447921572|FG000|Overall Study|Lost to Follow-up|9|||
124537916|NCT05047601|447921573|FG001|Overall Study|Lost to Follow-up|11|||
124537917|NCT05047601|447921574|FG002|Overall Study|Lost to Follow-up|7|||
124537918|NCT05047601|447921572|FG000|Overall Study|Withdrawal by Subject|25|||
124537919|NCT05047601|447921573|FG001|Overall Study|Withdrawal by Subject|36|||
124537920|NCT05047601|447921574|FG002|Overall Study|Withdrawal by Subject|23|||
124537921|NCT05047601|447921572|FG000|Overall Study|Other|10|||
124537922|NCT05047601|447921573|FG001|Overall Study|Other|6|||
124537923|NCT05047601|447921574|FG002|Overall Study|Other|5|||
124537924|NCT00286234|447921575|FG000|Overall Study|Protocol Violation|1|||
124537925|NCT00286234|447921576|FG001|Overall Study|Protocol Violation|2|||
124537926|NCT00286234|447921577|FG002|Overall Study|Protocol Violation|0|||
124537927|NCT00286234|447921578|FG003|Overall Study|Protocol Violation|1|||
124537928|NCT00286234|447921575|FG000|Overall Study|Physician Decision|1|||
124537929|NCT00286234|447921576|FG001|Overall Study|Physician Decision|0|||
124537930|NCT00286234|447921577|FG002|Overall Study|Physician Decision|0|||
124537931|NCT00286234|447921578|FG003|Overall Study|Physician Decision|1|||
124537932|NCT00286234|447921575|FG000|Overall Study|Adverse Event|0|||
124537933|NCT00286234|447921576|FG001|Overall Study|Adverse Event|0|||
124537934|NCT00286234|447921577|FG002|Overall Study|Adverse Event|0|||
124537935|NCT00286234|447921578|FG003|Overall Study|Adverse Event|1|||
124537936|NCT00286234|447921575|FG000|Overall Study|Adverse Event|0|||
124537937|NCT00286234|447921576|FG001|Overall Study|Adverse Event|0|||
124537938|NCT00286234|447921577|FG002|Overall Study|Adverse Event|0|||
124537939|NCT00286234|447921578|FG003|Overall Study|Adverse Event|1|||
124537940|NCT00283062|447921583|FG000|Overall Study|Did not receive any study medication|5|||
124537941|NCT00283062|447921584|FG001|Overall Study|Did not receive any study medication|4|||
124537942|NCT00283062|447921585|FG002|Overall Study|Did not receive any study medication|36|||
124537943|NCT00283062|447921586|FG003|Overall Study|Did not receive any study medication|45|||
124537944|NCT00283062|447921583|FG000|Overall Study|Adverse Event|2|||
124537945|NCT00283062|447921584|FG001|Overall Study|Adverse Event|0|||
124537946|NCT00283062|447921585|FG002|Overall Study|Adverse Event|1|||
124537947|NCT00283062|447921586|FG003|Overall Study|Adverse Event|0|||
124537948|NCT00283062|447921583|FG000|Overall Study|Lost to Follow-up|1|||
124537949|NCT00283062|447921584|FG001|Overall Study|Lost to Follow-up|0|||
124537950|NCT00283062|447921585|FG002|Overall Study|Lost to Follow-up|1|||
124537951|NCT00283062|447921586|FG003|Overall Study|Lost to Follow-up|0|||
124537952|NCT00283062|447921583|FG000|Overall Study|Progressive disease|0|||
124537953|NCT00283062|447921584|FG001|Overall Study|Progressive disease|0|||
124537954|NCT00283062|447921585|FG002|Overall Study|Progressive disease|1|||
124537955|NCT00283062|447921586|FG003|Overall Study|Progressive disease|0|||
124537956|NCT00283062|447921583|FG000|Overall Study|Participant did not wish to continue|3|||
124537957|NCT00283062|447921584|FG001|Overall Study|Participant did not wish to continue|2|||
124537958|NCT00283062|447921585|FG002|Overall Study|Participant did not wish to continue|1|||
124537959|NCT00283062|447921586|FG003|Overall Study|Participant did not wish to continue|0|||
124537960|NCT00283062|447921583|FG000|Overall Study|Undefined|0|||
124537961|NCT00283062|447921584|FG001|Overall Study|Undefined|1|||
124537962|NCT00283062|447921585|FG002|Overall Study|Undefined|1|||
124537963|NCT00283062|447921586|FG003|Overall Study|Undefined|4|||
124537964|NCT00283062|447921583|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
124537965|NCT00283062|447921584|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
124537966|NCT00283062|447921585|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
124537967|NCT00283062|447921586|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
124537968|NCT00827112|447921589|FG000|Overall Study|Adverse Event|2|||
124537969|NCT00827112|447921590|FG001|Overall Study|Adverse Event|0|||
124537970|NCT00827112|447921589|FG000|Overall Study|Lack of Efficacy|2|||
124537971|NCT00827112|447921590|FG001|Overall Study|Lack of Efficacy|0|||
124537972|NCT00827112|447921589|FG000|Overall Study|Lost to Follow-up|3|||
124537973|NCT00827112|447921590|FG001|Overall Study|Lost to Follow-up|2|||
124537974|NCT00827112|447921589|FG000|Overall Study|Pregnancy|0|||
124537975|NCT00827112|447921590|FG001|Overall Study|Pregnancy|1|||
124537976|NCT00827112|447921589|FG000|Overall Study|Protocol Violation|0|||
124537977|NCT00827112|447921590|FG001|Overall Study|Protocol Violation|2|||
124979044|NCT01099215|449549872|FG000|Overall Study|Withdrawal by Subject|1|||
124979045|NCT01099215|449549873|FG001|Overall Study|Withdrawal by Subject|0|||
124979046|NCT01099215|449549872|FG000|Overall Study|Adverse Event|0|||
124979047|NCT01099215|449549873|FG001|Overall Study|Adverse Event|1|||
124979048|NCT00747227|449549875|FG000|Overall Study|Death|3|||
124979049|NCT00747227|449549876|FG001|Overall Study|Death|1|||
124979050|NCT00747227|449549875|FG000|Overall Study|Withdrawal by Subject|1|||
124979051|NCT00747227|449549876|FG001|Overall Study|Withdrawal by Subject|0|||
124979052|NCT00747227|449549875|FG000|Overall Study|Lost to Follow-up|1|||
124979053|NCT00747227|449549876|FG001|Overall Study|Lost to Follow-up|2|||
124979054|NCT00747227|449549875|FG000|Overall Study|Illness|1|||
124979055|NCT00747227|449549876|FG001|Overall Study|Illness|1|||
124979056|NCT03554629|449549877|FG000|Overall Study|Inadequate data|6|||
124979057|NCT00515671|449549886|FG000|Overall Study|Lost to Follow-up|13|||
124979058|NCT00515671|449549887|FG001|Overall Study|Lost to Follow-up|10|||
124979059|NCT00515671|449549886|FG000|Overall Study|Withdrawal by Subject|3|||
124979060|NCT00515671|449549887|FG001|Overall Study|Withdrawal by Subject|5|||
124979061|NCT00515671|449549886|FG000|Overall Study|incarcerated|1|||
124979062|NCT00515671|449549887|FG001|Overall Study|incarcerated|2|||
124979063|NCT00288639|449549890|FG000|Overall Study|Adverse Event|5|||
124979064|NCT00288639|449549890|FG000|Overall Study|Lack of Efficacy|4|||
124979065|NCT00288639|449549890|FG000|Overall Study|Withdrawal by Subject|2|||
124979066|NCT00288639|449549890|FG000|Overall Study|Other|1|||
124979067|NCT01014208|449549899|FG000|Overall Study|Lost to Follow-up|2|||
124979068|NCT01014208|449549900|FG001|Overall Study|Lost to Follow-up|5|||
124979069|NCT01014208|449549899|FG000|Overall Study|Participant Withdrew Consent|12|||
124979070|NCT01014208|449549900|FG001|Overall Study|Participant Withdrew Consent|12|||
124979071|NCT01014208|449549899|FG000|Overall Study|Did Not Receive Study Drug|2|||
124979072|NCT01014208|449549900|FG001|Overall Study|Did Not Receive Study Drug|0|||
124979073|NCT01014208|449549899|FG000|Overall Study|Study Closed/terminated|78|||
124979074|NCT01014208|449549900|FG001|Overall Study|Study Closed/terminated|83|||
124979075|NCT04165031|449549901|FG000|Overall Study|Adverse Event|1|||
124979076|NCT04165031|449549902|FG001|Overall Study|Adverse Event|1|||
124979077|NCT04165031|449549903|FG002|Overall Study|Adverse Event|0|||
124979078|NCT04165031|449549904|FG003|Overall Study|Adverse Event|0|||
124979079|NCT04165031|449549905|FG004|Overall Study|Adverse Event|0|||
124979080|NCT04165031|449549906|FG005|Overall Study|Adverse Event|0|||
124979081|NCT04165031|449549901|FG000|Overall Study|Withdrawal by Subject|0|||
124979082|NCT04165031|449549902|FG001|Overall Study|Withdrawal by Subject|0|||
124979083|NCT04165031|449549903|FG002|Overall Study|Withdrawal by Subject|1|||
124979084|NCT04165031|449549904|FG003|Overall Study|Withdrawal by Subject|0|||
124537978|NCT00827112|447921589|FG000|Overall Study|Withdrawal by Subject|2|||
124537979|NCT00827112|447921590|FG001|Overall Study|Withdrawal by Subject|1|||
124537980|NCT00827112|447921589|FG000|Overall Study|Randomized but not treated|5|||
124537981|NCT00827112|447921590|FG001|Overall Study|Randomized but not treated|3|||
124979085|NCT04165031|449549905|FG004|Overall Study|Withdrawal by Subject|0|||
124979086|NCT04165031|449549906|FG005|Overall Study|Withdrawal by Subject|0|||
124979087|NCT01332630|449549909|FG000|Overall Study|Withdrawal by Subject|3|||
124979088|NCT03140280|449549910|FG000|Overall Study|Physician Decision|5|||
124979089|NCT00663702|449549919|FG000|Overall Study|Adverse Event|8|||
124979090|NCT00663702|449549920|FG001|Overall Study|Adverse Event|4|||
124979091|NCT00663702|449549919|FG000|Overall Study|Withdrawal by Subject|3|||
124979092|NCT00663702|449549920|FG001|Overall Study|Withdrawal by Subject|1|||
124979093|NCT00663702|449549919|FG000|Overall Study|Pregnancy|0|||
124979094|NCT00663702|449549920|FG001|Overall Study|Pregnancy|1|||
124979095|NCT00663702|449549919|FG000|Overall Study|Lost to Follow-up|3|||
124979096|NCT00663702|449549920|FG001|Overall Study|Lost to Follow-up|0|||
124979097|NCT00663702|449549919|FG000|Overall Study|Death|1|||
124979098|NCT00663702|449549920|FG001|Overall Study|Death|1|||
124979099|NCT00663702|449549919|FG000|Overall Study|Lack of Efficacy|3|||
124979100|NCT00663702|449549920|FG001|Overall Study|Lack of Efficacy|3|||
124979101|NCT01498887|449549921|FG000|Overall Study|Administrative problems|1|||
124979102|NCT01498887|449549922|FG001|Overall Study|Administrative problems|0|||
124979103|NCT01498887|449549921|FG000|Overall Study|Lost to Follow-up|1|||
124979104|NCT01498887|449549922|FG001|Overall Study|Lost to Follow-up|1|||
124537982|NCT00827112|447921589|FG000|Overall Study|Other|1|||
124537983|NCT00827112|447921590|FG001|Overall Study|Other|3|||
124537984|NCT01475214|447921591|FG000|Overall Study|Lost to Follow-up|1|||
124537985|NCT01475214|447921592|FG001|Overall Study|Lost to Follow-up|0|||
124979105|NCT01498887|449549921|FG000|Overall Study|Withdrawal by Subject|1|||
124979106|NCT01498887|449549922|FG001|Overall Study|Withdrawal by Subject|0|||
124537986|NCT01475214|447921593|FG002|Overall Study|Lost to Follow-up|1|||
124979107|NCT01498887|449549921|FG000|Overall Study|Protocol Violation|1|||
124979108|NCT01498887|449549922|FG001|Overall Study|Protocol Violation|3|||
124979109|NCT01498887|449549921|FG000|Overall Study|Lack of Efficacy|5|||
124979110|NCT01498887|449549922|FG001|Overall Study|Lack of Efficacy|3|||
124979111|NCT01498887|449549921|FG000|Overall Study|Abnormal result from test procedure|1|||
124979112|NCT01498887|449549922|FG001|Overall Study|Abnormal result from test procedure|1|||
124979113|NCT01498887|449549921|FG000|Overall Study|Abnormal laboratory value|2|||
124537987|NCT01475214|447921591|FG000|Overall Study|Physician Decision|2|||
124537988|NCT01475214|447921592|FG001|Overall Study|Physician Decision|0|||
124537989|NCT01475214|447921593|FG002|Overall Study|Physician Decision|0|||
124537990|NCT01475214|447921591|FG000|Overall Study|Withdrawal by Subject|2|||
124537991|NCT01475214|447921592|FG001|Overall Study|Withdrawal by Subject|4|||
124537992|NCT01475214|447921593|FG002|Overall Study|Withdrawal by Subject|1|||
124537993|NCT00877929|447921596|FG000|Overall Study|Adverse Event|11|||
124537994|NCT00877929|447921597|FG001|Overall Study|Adverse Event|20|||
124537995|NCT00877929|447921596|FG000|Overall Study|Protocol Violation|3|||
124537996|NCT00877929|447921597|FG001|Overall Study|Protocol Violation|3|||
124537997|NCT00877929|447921596|FG000|Overall Study|Lost to Follow-up|0|||
124537998|NCT00877929|447921597|FG001|Overall Study|Lost to Follow-up|1|||
124537999|NCT00877929|447921596|FG000|Overall Study|Withdrawal by Subject|4|||
124538000|NCT00877929|447921597|FG001|Overall Study|Withdrawal by Subject|4|||
124538001|NCT00877929|447921596|FG000|Overall Study|Lack of Efficacy|0|||
124538002|NCT00877929|447921597|FG001|Overall Study|Lack of Efficacy|1|||
124538003|NCT00877929|447921596|FG000|Overall Study|Other reason (not specified)|2|||
124538004|NCT00877929|447921597|FG001|Overall Study|Other reason (not specified)|6|||
124538005|NCT02127931|447921600|FG000|Overall Study|Glitch in Game|1|||
124538006|NCT00422942|447921601|FG000|Overall Study|Study terminated by Sponsor|3|||
124538007|NCT02828982|447921602|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
124538008|NCT02828982|447921603|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
124538009|NCT03691831|447923057|FG000|Overall Study|Lost to Follow-up|16|||
124538010|NCT03691831|447923058|FG001|Overall Study|Lost to Follow-up|12|||
124538011|NCT03691831|447923057|FG000|Overall Study|Withdrawal by Subject|9|||
124538012|NCT03691831|447923058|FG001|Overall Study|Withdrawal by Subject|17|||
124538013|NCT03691831|447923057|FG000|Overall Study|Investigator Decision|2|||
124538014|NCT03691831|447923058|FG001|Overall Study|Investigator Decision|2|||
124538015|NCT03922945|447923059|FG000|Overall Study|Adverse Event|1|||
124538016|NCT03922945|447923060|FG001|Overall Study|Adverse Event|1|||
124538017|NCT03922945|447923061|FG002|Overall Study|Adverse Event|2|||
124538018|NCT03922945|447923059|FG000|Overall Study|Lost to Follow-up|13|||
124538019|NCT03922945|447923060|FG001|Overall Study|Lost to Follow-up|9|||
124538020|NCT03922945|447923061|FG002|Overall Study|Lost to Follow-up|20|||
124538021|NCT03922945|447923059|FG000|Overall Study|Lack of Efficacy|2|||
124538022|NCT03922945|447923060|FG001|Overall Study|Lack of Efficacy|0|||
124538023|NCT03922945|447923061|FG002|Overall Study|Lack of Efficacy|1|||
124538024|NCT03922945|447923059|FG000|Overall Study|Protocol Non-Compliance|0|||
124538025|NCT03922945|447923060|FG001|Overall Study|Protocol Non-Compliance|0|||
124538026|NCT03922945|447923061|FG002|Overall Study|Protocol Non-Compliance|1|||
124538027|NCT03922945|447923059|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
124538028|NCT03922945|447923060|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
124538029|NCT03922945|447923061|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
124538030|NCT03922945|447923059|FG000|Overall Study|All Other Personal Reasons|1|||
124538031|NCT03922945|447923060|FG001|Overall Study|All Other Personal Reasons|1|||
124538032|NCT03922945|447923061|FG002|Overall Study|All Other Personal Reasons|2|||
124538033|NCT00911508|447923062|FG000|Overall Study|Lost to Follow-up|27|||
124538034|NCT00911508|447923063|FG001|Overall Study|Lost to Follow-up|18|||
124538035|NCT00911508|447923062|FG000|Overall Study|Withdrawal by Subject|79|||
124538036|NCT00911508|447923063|FG001|Overall Study|Withdrawal by Subject|112|||
124538037|NCT02079077|447923069|FG000|Overall Study|Lost to Follow-up|5|||
124538038|NCT02079077|447923070|FG001|Overall Study|Lost to Follow-up|7|||
124538039|NCT02079077|447923069|FG000|Overall Study|Became STIs Positive|1|||
124538040|NCT02079077|447923070|FG001|Overall Study|Became STIs Positive|2|||
124538041|NCT00772031|447923071|FG000|Overall Study|Early termination of trial|12|||
124538042|NCT00772031|447923072|FG001|Overall Study|Early termination of trial|10|||
124538043|NCT00772031|447923071|FG000|Overall Study|Lost to Follow-up|20|||
124538044|NCT00772031|447923072|FG001|Overall Study|Lost to Follow-up|33|||
124538045|NCT00656136|447923073|FG000|Overall Study|Progressive disease|177|||
124538046|NCT00656136|447923074|FG001|Overall Study|Progressive disease|322|||
124538047|NCT00656136|447923073|FG000|Overall Study|Other Adverse Event|5|||
124538048|NCT00656136|447923074|FG001|Overall Study|Other Adverse Event|51|||
124538049|NCT00656136|447923073|FG000|Overall Study|Protocol Violation|2|||
124538050|NCT00656136|447923074|FG001|Overall Study|Protocol Violation|3|||
124538051|NCT00656136|447923073|FG000|Overall Study|Patient refused to take study medication|7|||
124538052|NCT00656136|447923074|FG001|Overall Study|Patient refused to take study medication|10|||
124538053|NCT00656136|447923073|FG000|Overall Study|Unknown and others|4|||
124538054|NCT00656136|447923074|FG001|Overall Study|Unknown and others|4|||
124538055|NCT00635804|447923075|FG000|Overall Study|Adverse Event|0|||
124538056|NCT00635804|447923076|FG001|Overall Study|Adverse Event|0|||
124538057|NCT00635804|447923077|FG002|Overall Study|Adverse Event|0|||
124538058|NCT00635804|447923078|FG003|Overall Study|Adverse Event|0|||
124538059|NCT00635804|447923079|FG004|Overall Study|Adverse Event|0|||
124538060|NCT00635804|447923080|FG005|Overall Study|Adverse Event|1|||
124538061|NCT00635804|447923081|FG006|Overall Study|Adverse Event|0|||
124538062|NCT00635804|447923082|FG007|Overall Study|Adverse Event|0|||
124538063|NCT00635804|447923075|FG000|Overall Study|Withdrawal by Subject|1|||
124538064|NCT00635804|447923076|FG001|Overall Study|Withdrawal by Subject|0|||
124538065|NCT00635804|447923077|FG002|Overall Study|Withdrawal by Subject|0|||
124538066|NCT00635804|447923078|FG003|Overall Study|Withdrawal by Subject|0|||
124538067|NCT00635804|447923079|FG004|Overall Study|Withdrawal by Subject|0|||
124538068|NCT00635804|447923080|FG005|Overall Study|Withdrawal by Subject|0|||
124538069|NCT00635804|447923081|FG006|Overall Study|Withdrawal by Subject|0|||
124538070|NCT00635804|447923082|FG007|Overall Study|Withdrawal by Subject|0|||
124538071|NCT01097057|447923083|FG000|Overall Study|Physician Decision|3|||
124538072|NCT01101321|447923084|FG000|Period 1|Withdrawal by Subject|1|||
124538073|NCT01101321|447923085|FG001|Period 1|Withdrawal by Subject|1|||
124538074|NCT01101321|447923084|FG000|Period 1|Adverse Event|3|||
124538075|NCT01101321|447923085|FG001|Period 1|Adverse Event|3|||
124538076|NCT02681094|447923086|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
124538077|NCT02681094|447923087|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
124538078|NCT02681094|447923088|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
124538079|NCT02681094|447923086|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
124538080|NCT02681094|447923087|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
124538081|NCT02681094|447923088|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
124538082|NCT02681094|447923086|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
124538083|NCT02681094|447923087|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
124538084|NCT02681094|447923088|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
124538085|NCT02681094|447923086|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
124538086|NCT02681094|447923087|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
124538087|NCT02681094|447923088|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
124538088|NCT02681094|447923086|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
124538089|NCT02681094|447923087|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
124538090|NCT02681094|447923088|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
124538091|NCT02681094|447923086|FG000|1 -Modified Enrolled Participants Set|Other|6|||
124538092|NCT02681094|447923087|FG001|1 -Modified Enrolled Participants Set|Other|6|||
124538093|NCT02681094|447923088|FG002|1 -Modified Enrolled Participants Set|Other|7|||
124538094|NCT02681094|447923086|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
124538095|NCT02681094|447923087|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
124538096|NCT02681094|447923088|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
124538097|NCT02681094|447923086|FG000|2 - Enrolled Participants Set|Participant decision|7|||
124538098|NCT02681094|447923087|FG001|2 - Enrolled Participants Set|Participant decision|10|||
124538099|NCT02681094|447923088|FG002|2 - Enrolled Participants Set|Participant decision|9|||
124538100|NCT02681094|447923086|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
124538101|NCT02681094|447923087|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
124538102|NCT02681094|447923088|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
124538103|NCT02681094|447923086|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
124538104|NCT02681094|447923087|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
124538105|NCT02681094|447923088|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
124538106|NCT02681094|447923086|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
124538107|NCT02681094|447923087|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
124538108|NCT02681094|447923088|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
124538109|NCT02681094|447923086|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
124538110|NCT02681094|447923087|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
124538111|NCT02681094|447923088|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
124538112|NCT02681094|447923086|FG000|2 - Enrolled Participants Set|Other|6|||
124538113|NCT02681094|447923087|FG001|2 - Enrolled Participants Set|Other|6|||
124538114|NCT02681094|447923088|FG002|2 - Enrolled Participants Set|Other|7|||
124538115|NCT02681094|447923086|FG000|2 - Enrolled Participants Set|No treatment given|0|||
124538116|NCT02681094|447923087|FG001|2 - Enrolled Participants Set|No treatment given|1|||
124538117|NCT02681094|447923088|FG002|2 - Enrolled Participants Set|No treatment given|1|||
124538118|NCT02210559|447923089|FG000|Overall Study|Progressive Disease|3|||
124538119|NCT02210559|447923090|FG001|Overall Study|Progressive Disease|2|||
124538120|NCT02210559|447923089|FG000|Overall Study|Adverse Event|2|||
124538121|NCT02210559|447923090|FG001|Overall Study|Adverse Event|2|||
124538122|NCT02210559|447923089|FG000|Overall Study|Physician Decision|1|||
124538123|NCT02210559|447923090|FG001|Overall Study|Physician Decision|0|||
124538124|NCT02210559|447923089|FG000|Overall Study|Withdrawal by Subject|0|||
124538125|NCT02210559|447923090|FG001|Overall Study|Withdrawal by Subject|1|||
124538126|NCT02210559|447923089|FG000|Overall Study|Other than specified|0|||
124538127|NCT02210559|447923090|FG001|Overall Study|Other than specified|1|||
124538128|NCT00310440|447923091|FG000|Overall Study|Lost to Follow-up|17|||
124538129|NCT00310440|447923092|FG001|Overall Study|Lost to Follow-up|8|||
124538130|NCT00310440|447923091|FG000|Overall Study|Withdrawal by Subject|2|||
124538131|NCT00310440|447923092|FG001|Overall Study|Withdrawal by Subject|1|||
124758626|NCT02452424|448739815|FG006|Overall Study|Adverse Event|0|||
124538132|NCT00310440|447923091|FG000|Overall Study|Missed 12 Month Visit|7|||
124538133|NCT00310440|447923092|FG001|Overall Study|Missed 12 Month Visit|4|||
124538134|NCT01098266|447923093|FG000|Overall Study|Physician Decision|1|||
124538135|NCT01098266|447923094|FG001|Overall Study|Physician Decision|0|||
124538136|NCT01098266|447923093|FG000|Overall Study|Death|3|||
124538137|NCT01098266|447923094|FG001|Overall Study|Death|2|||
124538138|NCT01098266|447923093|FG000|Overall Study|Withdrawal by Subject|3|||
124538139|NCT01098266|447923094|FG001|Overall Study|Withdrawal by Subject|5|||
124538140|NCT00525499|447923095|FG000|Overall Study|Lost to Follow-up|2|||
124538141|NCT00525499|447923096|FG001|Overall Study|Lost to Follow-up|4|||
124538142|NCT00525499|447923097|FG002|Overall Study|Lost to Follow-up|1|||
124538143|NCT00525499|447923098|FG003|Overall Study|Lost to Follow-up|4|||
124538144|NCT00525499|447923095|FG000|Overall Study|Adverse Event|0|||
124538145|NCT00525499|447923096|FG001|Overall Study|Adverse Event|1|||
124538146|NCT00525499|447923097|FG002|Overall Study|Adverse Event|0|||
124538147|NCT00525499|447923098|FG003|Overall Study|Adverse Event|1|||
124538148|NCT00525499|447923095|FG000|Overall Study|Withdrawal by Subject|5|||
124538149|NCT00525499|447923096|FG001|Overall Study|Withdrawal by Subject|1|||
124538150|NCT00525499|447923097|FG002|Overall Study|Withdrawal by Subject|5|||
124538151|NCT00525499|447923098|FG003|Overall Study|Withdrawal by Subject|2|||
124538152|NCT00525499|447923095|FG000|Overall Study|Protocol Violation|0|||
124538153|NCT00525499|447923096|FG001|Overall Study|Protocol Violation|1|||
124538154|NCT00525499|447923097|FG002|Overall Study|Protocol Violation|1|||
124538155|NCT00525499|447923098|FG003|Overall Study|Protocol Violation|0|||
124538156|NCT03339999|447923099|FG000|Overall Study|Adverse Event|1|||
124538157|NCT03339999|447923100|FG001|Overall Study|Adverse Event|2|||
124538158|NCT03339999|447923101|FG002|Overall Study|Adverse Event|2|||
124538159|NCT03339999|447923102|FG003|Overall Study|Adverse Event|1|||
124538160|NCT03339999|447923099|FG000|Overall Study|Lack of Efficacy|0|||
124538161|NCT03339999|447923100|FG001|Overall Study|Lack of Efficacy|1|||
124538162|NCT03339999|447923101|FG002|Overall Study|Lack of Efficacy|0|||
124538163|NCT03339999|447923102|FG003|Overall Study|Lack of Efficacy|0|||
124538164|NCT03339999|447923099|FG000|Overall Study|Lost to Follow-up|0|||
124538165|NCT03339999|447923100|FG001|Overall Study|Lost to Follow-up|0|||
124538166|NCT03339999|447923101|FG002|Overall Study|Lost to Follow-up|0|||
124538167|NCT03339999|447923102|FG003|Overall Study|Lost to Follow-up|1|||
124538168|NCT03339999|447923099|FG000|Overall Study|Study Terminated by Sponsor|6|||
124538169|NCT03339999|447923100|FG001|Overall Study|Study Terminated by Sponsor|3|||
124538170|NCT03339999|447923101|FG002|Overall Study|Study Terminated by Sponsor|4|||
124538171|NCT03339999|447923102|FG003|Overall Study|Study Terminated by Sponsor|3|||
124538172|NCT01733758|447923105|FG000|Overall Study|Adverse Event|5|||
124538173|NCT01733758|447923106|FG001|Overall Study|Adverse Event|7|||
124538174|NCT01733758|447923107|FG002|Overall Study|Adverse Event|8|||
124538175|NCT01733758|447923108|FG003|Overall Study|Adverse Event|1|||
124538176|NCT01733758|447923105|FG000|Overall Study|Withdrawal by Subject|1|||
124538177|NCT01733758|447923106|FG001|Overall Study|Withdrawal by Subject|1|||
124538178|NCT01733758|447923107|FG002|Overall Study|Withdrawal by Subject|5|||
124538179|NCT01733758|447923108|FG003|Overall Study|Withdrawal by Subject|3|||
124538180|NCT01733758|447923105|FG000|Overall Study|Persistent Hyperglycemia|3|||
124538181|NCT01733758|447923106|FG001|Overall Study|Persistent Hyperglycemia|2|||
124538182|NCT01733758|447923107|FG002|Overall Study|Persistent Hyperglycemia|0|||
124538183|NCT01733758|447923108|FG003|Overall Study|Persistent Hyperglycemia|0|||
124538184|NCT01733758|447923105|FG000|Overall Study|Protocol Violation|0|||
124538185|NCT01733758|447923106|FG001|Overall Study|Protocol Violation|1|||
124538186|NCT01733758|447923107|FG002|Overall Study|Protocol Violation|2|||
124538187|NCT01733758|447923108|FG003|Overall Study|Protocol Violation|2|||
124538188|NCT01733758|447923105|FG000|Overall Study|Non-compliance|1|||
124538189|NCT01733758|447923106|FG001|Overall Study|Non-compliance|0|||
124538190|NCT01733758|447923107|FG002|Overall Study|Non-compliance|0|||
124538191|NCT01733758|447923108|FG003|Overall Study|Non-compliance|0|||
124538192|NCT01733758|447923105|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
124538193|NCT01733758|447923106|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
124538194|NCT01733758|447923107|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
124538195|NCT01733758|447923108|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
124538196|NCT01733758|447923105|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
124538197|NCT01733758|447923106|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
124538198|NCT01733758|447923107|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
124538199|NCT01733758|447923108|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
124538200|NCT05602818|447923109|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
124538201|NCT05602818|447923110|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
124538202|NCT05602818|447923111|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
124538203|NCT05602818|447923112|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
124538204|NCT05602818|447923113|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
124538205|NCT05602818|447923114|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
124538206|NCT05602818|447923115|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
124538207|NCT05602818|447923116|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
124538208|NCT05602818|447923117|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
124538209|NCT05602818|447923118|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
124538210|NCT05602818|447923119|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
124538211|NCT05602818|447923120|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
124538212|NCT05602818|447923109|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
124538213|NCT05602818|447923110|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
124538214|NCT05602818|447923111|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
124538215|NCT05602818|447923112|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
124538216|NCT05602818|447923113|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
124538217|NCT05602818|447923114|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
124538218|NCT05602818|447923115|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
124538219|NCT05602818|447923116|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
124538220|NCT05602818|447923117|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
124538221|NCT05602818|447923118|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
124538222|NCT05602818|447923119|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
124538223|NCT05602818|447923120|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
124538224|NCT05602818|447923109|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
124538225|NCT05602818|447923110|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
124538226|NCT05602818|447923111|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
124538227|NCT05602818|447923112|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
124538228|NCT05602818|447923113|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
124538229|NCT05602818|447923114|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
124538230|NCT05602818|447923115|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
124538231|NCT05602818|447923116|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
124538232|NCT05602818|447923117|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
124538233|NCT05602818|447923118|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
124538234|NCT05602818|447923119|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
124538235|NCT05602818|447923120|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
124538236|NCT05602818|447923109|FG000|Qualification Phase (3 Days)|Other|1|||
124538237|NCT05602818|447923110|FG001|Qualification Phase (3 Days)|Other|0|||
124538238|NCT05602818|447923111|FG002|Qualification Phase (3 Days)|Other|0|||
124538239|NCT05602818|447923112|FG003|Qualification Phase (3 Days)|Other|0|||
124538240|NCT05602818|447923113|FG004|Qualification Phase (3 Days)|Other|0|||
124538241|NCT05602818|447923114|FG005|Qualification Phase (3 Days)|Other|0|||
124538242|NCT05602818|447923115|FG006|Qualification Phase (3 Days)|Other|0|||
124538243|NCT05602818|447923116|FG007|Qualification Phase (3 Days)|Other|0|||
124538244|NCT05602818|447923117|FG008|Qualification Phase (3 Days)|Other|0|||
124538245|NCT05602818|447923118|FG009|Qualification Phase (3 Days)|Other|0|||
124538246|NCT05602818|447923119|FG010|Qualification Phase (3 Days)|Other|0|||
124538247|NCT05602818|447923120|FG011|Qualification Phase (3 Days)|Other|0|||
124538248|NCT05602818|447923109|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
124538249|NCT05602818|447923110|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
124538250|NCT05602818|447923111|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
124538251|NCT05602818|447923112|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
124538252|NCT05602818|447923113|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
124538253|NCT05602818|447923114|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
124538254|NCT05602818|447923115|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
124979114|NCT01498887|449549922|FG001|Overall Study|Abnormal laboratory value|2|||
124538255|NCT05602818|447923116|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
124538256|NCT05602818|447923117|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
124538257|NCT05602818|447923118|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
124538258|NCT05602818|447923119|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
124538259|NCT05602818|447923120|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
124538260|NCT05602818|447923109|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
124538261|NCT05602818|447923110|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
124538262|NCT05602818|447923111|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
124538263|NCT05602818|447923112|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
124538264|NCT05602818|447923113|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
124538265|NCT05602818|447923114|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
124538266|NCT05602818|447923115|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
124538267|NCT05602818|447923116|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
124538268|NCT05602818|447923117|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
124538269|NCT05602818|447923118|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
124979115|NCT01498887|449549921|FG000|Overall Study|Adverse Event|4|||
124979116|NCT01498887|449549922|FG001|Overall Study|Adverse Event|1|||
124538270|NCT05602818|447923119|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
124979117|NCT00667225|449549925|FG000|Overall Study|Subject had no more lesions to treat.|1|||
124538271|NCT05602818|447923120|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
124538272|NCT05602818|447923109|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
124538273|NCT05602818|447923110|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
124538274|NCT05602818|447923111|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
124538275|NCT05602818|447923112|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
124538276|NCT05602818|447923113|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
124538277|NCT05602818|447923114|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
124538278|NCT05602818|447923115|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
124538279|NCT05602818|447923116|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
124538280|NCT05602818|447923117|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
124538281|NCT05602818|447923118|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
124538282|NCT05602818|447923119|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
124538283|NCT05602818|447923120|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
124538284|NCT05602818|447923109|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
124538285|NCT05602818|447923110|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
124538286|NCT05602818|447923111|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
124538287|NCT05602818|447923112|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
124538288|NCT05602818|447923113|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
124538289|NCT05602818|447923114|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
124538290|NCT05602818|447923115|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
124538291|NCT05602818|447923116|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
124538292|NCT05602818|447923117|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
124538293|NCT05602818|447923118|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
124538294|NCT05602818|447923119|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
124538295|NCT05602818|447923120|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
124538296|NCT04594213|447923125|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
124538297|NCT04594213|447923126|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
124538298|NCT04594213|447923127|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
124538299|NCT04594213|447923128|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
124538300|NCT04594213|447923129|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
124538301|NCT04594213|447923130|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
124538302|NCT04594213|447923125|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
124538303|NCT04594213|447923126|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
124538304|NCT04594213|447923127|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
124538305|NCT04594213|447923128|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
124538306|NCT04594213|447923129|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
124538307|NCT04594213|447923130|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
124538308|NCT04594213|447923125|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
124538309|NCT04594213|447923126|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
124538310|NCT04594213|447923127|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
124538311|NCT04594213|447923128|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
124538312|NCT04594213|447923129|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
124538313|NCT04594213|447923130|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
124538314|NCT04594213|447923125|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
124538315|NCT04594213|447923126|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
124538316|NCT04594213|447923127|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
124538317|NCT04594213|447923128|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
124538318|NCT04594213|447923129|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
124538319|NCT04594213|447923130|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
124538320|NCT04594213|447923125|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
124538321|NCT04594213|447923126|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
124538322|NCT04594213|447923127|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
124538323|NCT04594213|447923128|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
124538324|NCT04594213|447923129|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
124538325|NCT04594213|447923130|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
124538326|NCT04594213|447923125|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
124538327|NCT04594213|447923126|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
124538328|NCT04594213|447923127|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
124538329|NCT04594213|447923128|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
124538330|NCT04594213|447923129|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
124538331|NCT04594213|447923130|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
124538332|NCT04594213|447923125|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
124538333|NCT04594213|447923126|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
124538334|NCT04594213|447923127|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
124538335|NCT04594213|447923128|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
124538336|NCT04594213|447923129|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
124538337|NCT04594213|447923130|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
124758627|NCT02452424|448739816|FG007|Overall Study|Adverse Event|0|||
124538338|NCT04594213|447923125|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
124538339|NCT04594213|447923126|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
124538340|NCT04594213|447923127|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
124538341|NCT04594213|447923128|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
124538342|NCT04594213|447923129|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
124538343|NCT04594213|447923130|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
124538344|NCT04594213|447923125|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
124538345|NCT04594213|447923126|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
124538346|NCT04594213|447923127|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
124538347|NCT04594213|447923128|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
124538348|NCT04594213|447923129|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
124538349|NCT04594213|447923130|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
124538350|NCT04594213|447923125|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
124538351|NCT04594213|447923126|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
124538352|NCT04594213|447923127|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
124538353|NCT04594213|447923128|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
124538354|NCT04594213|447923129|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
124538355|NCT04594213|447923130|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
124538356|NCT04594213|447923125|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
124538357|NCT04594213|447923126|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
124538358|NCT04594213|447923127|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
124538359|NCT04594213|447923128|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
124538360|NCT04594213|447923129|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
124538361|NCT04594213|447923130|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
124538362|NCT03814499|447923132|FG000|Overall Study|Lost to Follow-up|3|||
124538363|NCT01589185|447923133|FG000|Overall Study|Death|1|||
124538364|NCT01589185|447923134|FG001|Overall Study|Death|2|||
124538365|NCT01589185|447923135|FG002|Overall Study|Death|2|||
124538366|NCT01589185|447923136|FG003|Overall Study|Death|0|||
124538367|NCT01589185|447923137|FG004|Overall Study|Death|1|||
124538368|NCT01589185|447923133|FG000|Overall Study|Lost to Follow-up|1|||
124538369|NCT01589185|447923134|FG001|Overall Study|Lost to Follow-up|0|||
124538370|NCT01589185|447923135|FG002|Overall Study|Lost to Follow-up|2|||
124538371|NCT01589185|447923136|FG003|Overall Study|Lost to Follow-up|3|||
124538372|NCT01589185|447923137|FG004|Overall Study|Lost to Follow-up|0|||
124538373|NCT02046993|447923138|FG000|Overall Study|Withdrawal by Subject|2|||
124538374|NCT02046993|447923139|FG001|Overall Study|Withdrawal by Subject|10|||
124538375|NCT02046993|447923138|FG000|Overall Study|Lost to Follow-up|1|||
124538376|NCT02046993|447923139|FG001|Overall Study|Lost to Follow-up|1|||
124538377|NCT00598442|447923142|FG000|Overall Study|Adverse Event|3|||
124538378|NCT00598442|447923143|FG001|Overall Study|Adverse Event|0|||
124538379|NCT00598442|447923144|FG002|Overall Study|Adverse Event|0|||
124538380|NCT00598442|447923142|FG000|Overall Study|Death|19|||
124538381|NCT00598442|447923143|FG001|Overall Study|Death|11|||
124538382|NCT00598442|447923144|FG002|Overall Study|Death|11|||
124538383|NCT00598442|447923142|FG000|Overall Study|Lost to Follow-up|4|||
124538384|NCT00598442|447923143|FG001|Overall Study|Lost to Follow-up|3|||
124538385|NCT00598442|447923144|FG002|Overall Study|Lost to Follow-up|3|||
124538386|NCT00598442|447923142|FG000|Overall Study|Physician Decision|2|||
124538387|NCT00598442|447923143|FG001|Overall Study|Physician Decision|1|||
124538388|NCT00598442|447923144|FG002|Overall Study|Physician Decision|1|||
124538389|NCT00598442|447923142|FG000|Overall Study|Withdrawal by Subject|8|||
124538390|NCT00598442|447923143|FG001|Overall Study|Withdrawal by Subject|16|||
124538391|NCT00598442|447923144|FG002|Overall Study|Withdrawal by Subject|6|||
124538392|NCT00598442|447923142|FG000|Overall Study|Noncompliance|0|||
124538393|NCT00598442|447923143|FG001|Overall Study|Noncompliance|2|||
124538394|NCT00598442|447923144|FG002|Overall Study|Noncompliance|1|||
124538395|NCT00598442|447923142|FG000|Overall Study|Relocation|1|||
124538396|NCT00598442|447923143|FG001|Overall Study|Relocation|4|||
124538397|NCT00598442|447923144|FG002|Overall Study|Relocation|0|||
124538398|NCT00598442|447923142|FG000|Overall Study|Renal transplant|0|||
124538399|NCT00598442|447923143|FG001|Overall Study|Renal transplant|0|||
124538400|NCT00598442|447923144|FG002|Overall Study|Renal transplant|1|||
124538401|NCT00598442|447923142|FG000|Overall Study|Site closed by sponsor|5|||
124538402|NCT00598442|447923143|FG001|Overall Study|Site closed by sponsor|2|||
124538403|NCT00598442|447923144|FG002|Overall Study|Site closed by sponsor|1|||
124538404|NCT00598442|447923142|FG000|Overall Study|Started dialysis|1|||
124538405|NCT00598442|447923143|FG001|Overall Study|Started dialysis|0|||
124538406|NCT00598442|447923144|FG002|Overall Study|Started dialysis|0|||
124538407|NCT01729559|447923150|FG000|Overall Study|Protocol Violation|31|||
124538408|NCT01729559|447923151|FG001|Overall Study|Protocol Violation|28|||
124538409|NCT03764813|447923156|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
124538410|NCT03764813|447923157|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
124538411|NCT03764813|447923158|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
124538412|NCT03764813|447923159|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
124538413|NCT01654666|447923164|FG000|Overall Study|Protocol Violation|7|||
124538414|NCT01654666|447923165|FG001|Overall Study|Protocol Violation|4|||
124538415|NCT01654666|447923166|FG002|Overall Study|Protocol Violation|8|||
124538416|NCT01654666|447923164|FG000|Overall Study|Lost to Follow-up|4|||
124538417|NCT01654666|447923165|FG001|Overall Study|Lost to Follow-up|5|||
124538418|NCT01654666|447923166|FG002|Overall Study|Lost to Follow-up|5|||
124538419|NCT01654666|447923164|FG000|Overall Study|Withdrawal by Subject|4|||
124538420|NCT01654666|447923165|FG001|Overall Study|Withdrawal by Subject|4|||
124538421|NCT01654666|447923166|FG002|Overall Study|Withdrawal by Subject|1|||
124538422|NCT00535262|447923169|FG000|Overall Study|No funding|3|||
124538423|NCT02898662|447923170|FG000|Overall Study|Adverse Event|1|||
124538424|NCT02898662|447923171|FG001|Overall Study|Adverse Event|0|||
124538425|NCT02898662|447923170|FG000|Overall Study|Loss of asthma control|23|||
124538426|NCT02898662|447923171|FG001|Overall Study|Loss of asthma control|24|||
124538427|NCT02898662|447923170|FG000|Overall Study|Withdrawal by Subject|4|||
124538428|NCT02898662|447923171|FG001|Overall Study|Withdrawal by Subject|1|||
124538429|NCT02898662|447923170|FG000|Overall Study|Technical issue|0|||
124538430|NCT02898662|447923171|FG001|Overall Study|Technical issue|1|||
124538431|NCT02898662|447923170|FG000|Overall Study|Randomized in error|0|||
124538432|NCT02898662|447923171|FG001|Overall Study|Randomized in error|1|||
124538433|NCT02898662|447923170|FG000|Overall Study|Subject decision|1|||
124538434|NCT02898662|447923171|FG001|Overall Study|Subject decision|0|||
124538435|NCT02898662|447923170|FG000|Overall Study|Other|0|||
124538436|NCT02898662|447923171|FG001|Overall Study|Other|1|||
124538437|NCT00917553|447923172|FG000|Overall Study|Lost to Follow-up|2|||
124538438|NCT00917553|447923173|FG001|Overall Study|Lost to Follow-up|1|||
124538439|NCT01616173|447923174|FG000|Overall Study|Lost to Follow-up|0|||
124538440|NCT01616173|447923175|FG001|Overall Study|Lost to Follow-up|2|||
124538441|NCT01616173|447923176|FG002|Overall Study|Lost to Follow-up|0|||
124538442|NCT03432819|447923179|FG000|Overall Study|Lost to Follow-up|2|||
124538443|NCT03432819|447923180|FG001|Overall Study|Lost to Follow-up|2|||
124538444|NCT03432819|447923179|FG000|Overall Study|Withdrawal by Subject|5|||
124538445|NCT03432819|447923180|FG001|Overall Study|Withdrawal by Subject|3|||
124538446|NCT04738123|447923181|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
124538447|NCT04738123|447923182|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
124538448|NCT04738123|447923181|FG000|Overall Study|Progressive Disease|0|||
124538449|NCT04738123|447923182|FG001|Overall Study|Progressive Disease|4|||
124538450|NCT04738123|447923181|FG000|Overall Study|Adverse Event|8|||
124538451|NCT04738123|447923182|FG001|Overall Study|Adverse Event|7|||
124538452|NCT04738123|447923181|FG000|Overall Study|Other Reasons|0|||
124538453|NCT04738123|447923182|FG001|Overall Study|Other Reasons|1|||
124538454|NCT04738123|447923181|FG000|Overall Study|Suicidal or assaultive behavior|0|||
124538455|NCT04738123|447923182|FG001|Overall Study|Suicidal or assaultive behavior|2|||
124538456|NCT04738123|447923181|FG000|Overall Study|Protocol Violation|2|||
124538457|NCT04738123|447923182|FG001|Overall Study|Protocol Violation|2|||
124538458|NCT04738123|447923181|FG000|Overall Study|Consent Withdrawn|35|||
124538459|NCT04738123|447923182|FG001|Overall Study|Consent Withdrawn|22|||
124538460|NCT00665002|447923183|FG000|Overall Study|Progression/relapse during treatment|11|||
124538461|NCT00665002|447923183|FG000|Overall Study|Cytogenetic resistance|1|||
124538462|NCT03604159|447923184|FG000|Overall Study|Lost to Follow-up|6|||
124538463|NCT03604159|447923185|FG001|Overall Study|Lost to Follow-up|7|||
124538464|NCT00787527|447923190|FG000|Overall Study|Toxicity|3|||
124538465|NCT02243306|447923191|FG000|Overall Study|Adverse Event|0|||
124538466|NCT02243306|447923192|FG001|Overall Study|Adverse Event|1|||
124538467|NCT02243306|447923191|FG000|Overall Study|Other: Reached stopping criteria|0|||
124538468|NCT02243306|447923192|FG001|Overall Study|Other: Reached stopping criteria|1|||
124538469|NCT02243306|447923191|FG000|Overall Study|Physician Decision|0|||
124538470|NCT02243306|447923192|FG001|Overall Study|Physician Decision|1|||
124538471|NCT03258710|447923198|FG000|Overall Study|Adverse Event|1|||
124538472|NCT03258710|447923198|FG000|Overall Study|Protocol-defined stopping criteria|1|||
124538473|NCT03258710|447923198|FG000|Overall Study|Physician Decision|1|||
124538474|NCT03137173|447923199|FG000|Overall Study|Withdrawal by Subject|8|||
124538475|NCT03137173|447923200|FG001|Overall Study|Withdrawal by Subject|13|||
124538476|NCT03137173|447923199|FG000|Overall Study|Death|1|||
124538477|NCT03137173|447923200|FG001|Overall Study|Death|3|||
124538478|NCT03137173|447923199|FG000|Overall Study|Physician Decision|1|||
124538479|NCT03137173|447923200|FG001|Overall Study|Physician Decision|0|||
124538480|NCT03137173|447923199|FG000|Overall Study|Lost to Follow-up|13|||
124538481|NCT03137173|447923200|FG001|Overall Study|Lost to Follow-up|18|||
124538482|NCT03137173|447923199|FG000|Overall Study|Other reasons|3|||
124538483|NCT03137173|447923200|FG001|Overall Study|Other reasons|2|||
124538484|NCT03044730|447923211|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
124538485|NCT03044730|447923211|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
124538486|NCT03044730|447923211|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
124538487|NCT03044730|447923211|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
124538488|NCT03044730|447923211|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
124538489|NCT03044730|447923211|FG000|Cycles 4 and Beyond|Adverse Event|1|||
124758628|NCT02452424|448739817|FG008|Overall Study|Adverse Event|0|||
124538490|NCT03044730|447923211|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
124538491|NCT03044730|447923211|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
124538492|NCT03044730|447923211|FG000|On Follow-up for 2 Years|Death|17|||
124538493|NCT00690612|447924951|FG000|Overall Study|Adverse Event|1|||
124538494|NCT00690612|447924951|FG000|Overall Study|Withdrawal by Subject|2|||
124538495|NCT01409382|447924952|FG000|Overall Study|Lost to Follow-up|1|||
124538496|NCT01409382|447924953|FG001|Overall Study|Lost to Follow-up|1|||
124538497|NCT01409382|447924952|FG000|Overall Study|Protocol Violation|0|||
124538498|NCT01409382|447924953|FG001|Overall Study|Protocol Violation|3|||
124538499|NCT01409382|447924952|FG000|Overall Study|Multiple pregnancy|2|||
124538500|NCT01409382|447924953|FG001|Overall Study|Multiple pregnancy|4|||
124538501|NCT01409382|447924952|FG000|Overall Study|Still pregnant when study ended|13|||
124538502|NCT01409382|447924953|FG001|Overall Study|Still pregnant when study ended|2|||
124538503|NCT01409382|447924952|FG000|Overall Study|Did not manage to get pregnant|64|||
124538504|NCT01409382|447924953|FG001|Overall Study|Did not manage to get pregnant|70|||
124538505|NCT01409382|447924952|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
124538506|NCT01409382|447924953|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
124538507|NCT01233076|447924954|FG000|Period 2, One Week|Lost to Follow-up|1|||
124538508|NCT01233076|447924955|FG001|Period 2, One Week|Lost to Follow-up|0|||
124538509|NCT01786707|447924957|FG000|Overall Study|Lost to Follow-up|1|||
124538510|NCT01786707|447924958|FG001|Overall Study|Lost to Follow-up|1|||
124538511|NCT02058940|447924960|FG000|Overall Study|Discharged from Critical Care Unit|1|||
124538512|NCT01519700|447924961|FG000|Overall Study|Death|1|||
124538513|NCT01519700|447924962|FG001|Overall Study|Death|0|||
124538514|NCT01519700|447924963|FG002|Overall Study|Death|0|||
124538515|NCT01519700|447924964|FG003|Overall Study|Death|0|||
124538516|NCT01519700|447924961|FG000|Overall Study|Lost to Follow-up|0|||
124538517|NCT01519700|447924962|FG001|Overall Study|Lost to Follow-up|0|||
124538518|NCT01519700|447924963|FG002|Overall Study|Lost to Follow-up|1|||
124538519|NCT01519700|447924964|FG003|Overall Study|Lost to Follow-up|1|||
124538520|NCT01519700|447924961|FG000|Overall Study|Physician Decision|1|||
124538521|NCT01519700|447924962|FG001|Overall Study|Physician Decision|1|||
124538522|NCT01519700|447924963|FG002|Overall Study|Physician Decision|3|||
124538523|NCT01519700|447924964|FG003|Overall Study|Physician Decision|0|||
124538524|NCT01519700|447924961|FG000|Overall Study|Withdrawal by Subject|5|||
124538525|NCT01519700|447924962|FG001|Overall Study|Withdrawal by Subject|3|||
124538526|NCT01519700|447924963|FG002|Overall Study|Withdrawal by Subject|3|||
124538527|NCT01519700|447924964|FG003|Overall Study|Withdrawal by Subject|2|||
124538528|NCT01519700|447924961|FG000|Overall Study|Other Reason|2|||
124538529|NCT01519700|447924962|FG001|Overall Study|Other Reason|2|||
124538530|NCT01519700|447924963|FG002|Overall Study|Other Reason|0|||
124538531|NCT01519700|447924964|FG003|Overall Study|Other Reason|4|||
124538532|NCT01789476|447924970|FG000|Overall Study|Lack of Efficacy|6|||
124538533|NCT01789476|447924971|FG001|Overall Study|Lack of Efficacy|2|||
124538534|NCT01789476|447924970|FG000|Overall Study|Adverse Event|1|||
124538535|NCT01789476|447924971|FG001|Overall Study|Adverse Event|0|||
124538536|NCT01789476|447924970|FG000|Overall Study|Unable to get IV access|1|||
124538537|NCT01789476|447924971|FG001|Overall Study|Unable to get IV access|0|||
124538538|NCT00965458|447924972|FG000|Overall Study|Adverse Event|1|||
124538539|NCT00965458|447924973|FG001|Overall Study|Adverse Event|0|||
124538540|NCT00965458|447924972|FG000|Overall Study|Lost to Follow-up|1|||
124538541|NCT00965458|447924973|FG001|Overall Study|Lost to Follow-up|3|||
124538542|NCT00965458|447924972|FG000|Overall Study|Withdrawal by Subject|0|||
124538543|NCT00965458|447924973|FG001|Overall Study|Withdrawal by Subject|1|||
124538544|NCT04177862|447924980|FG000|Overall Study|Protocol Violation|2|||
124979118|NCT00667225|449549926|FG001|Overall Study|Subject had no more lesions to treat.|0|||
124538545|NCT04177862|447924981|FG001|Overall Study|Protocol Violation|7|||
124979119|NCT00667225|449549925|FG000|Overall Study|Lost to Follow-up|0|||
124979120|NCT00667225|449549926|FG001|Overall Study|Lost to Follow-up|1|||
124979121|NCT02993406|449549927|FG000|Overall Study|Withdrawal by Subject|170|||
124979122|NCT02993406|449549928|FG001|Overall Study|Withdrawal by Subject|196|||
124538546|NCT05111548|447924982|FG000|Overall Study|Withdrawal by Subject|2|||
124979123|NCT02993406|449549927|FG000|Overall Study|Physician Decision|3|||
124979124|NCT02993406|449549928|FG001|Overall Study|Physician Decision|5|||
124538547|NCT05111548|447924983|FG001|Overall Study|Withdrawal by Subject|1|||
124538548|NCT05111548|447924982|FG000|Overall Study|Adverse Event|1|||
124538549|NCT05111548|447924983|FG001|Overall Study|Adverse Event|0|||
124538550|NCT00379639|447924984|FG000|Overall Study|Disease Progression|3|||
124979125|NCT02993406|449549927|FG000|Overall Study|Lost to Follow-up|12|||
124538551|NCT00379639|447924985|FG001|Overall Study|Disease Progression|3|||
124538552|NCT00379639|447924986|FG002|Overall Study|Disease Progression|3|||
124538553|NCT00379639|447924987|FG003|Overall Study|Disease Progression|4|||
124538554|NCT00379639|447924988|FG004|Overall Study|Disease Progression|4|||
124538555|NCT00379639|447924984|FG000|Overall Study|Physician Decision|0|||
124538556|NCT00379639|447924985|FG001|Overall Study|Physician Decision|2|||
124538557|NCT00379639|447924986|FG002|Overall Study|Physician Decision|1|||
124538558|NCT00379639|447924987|FG003|Overall Study|Physician Decision|1|||
124538559|NCT00379639|447924988|FG004|Overall Study|Physician Decision|0|||
124538560|NCT00379639|447924984|FG000|Overall Study|Symptomatic Deterioration|0|||
124538561|NCT00379639|447924985|FG001|Overall Study|Symptomatic Deterioration|0|||
124538562|NCT00379639|447924986|FG002|Overall Study|Symptomatic Deterioration|1|||
124979126|NCT02993406|449549928|FG001|Overall Study|Lost to Follow-up|13|||
124979127|NCT02993406|449549927|FG000|Overall Study|Unclassifiable Response|105|||
124979128|NCT02993406|449549928|FG001|Overall Study|Unclassifiable Response|139|||
124979129|NCT02993406|449549927|FG000|Overall Study|Administrative decision|1|||
124979130|NCT02993406|449549928|FG001|Overall Study|Administrative decision|0|||
124979131|NCT02993406|449549927|FG000|Overall Study|Sponsor decision|4|||
124979132|NCT02993406|449549928|FG001|Overall Study|Sponsor decision|5|||
124979133|NCT02248818|449549929|FG000|Screening|Protocol Violation|0|||
124979134|NCT02248818|449549930|FG001|Screening|Protocol Violation|0|||
124979135|NCT02248818|449549931|FG002|Screening|Protocol Violation|0|||
124979136|NCT02248818|449549932|FG003|Screening|Protocol Violation|0|||
124979137|NCT02248818|449549933|FG004|Screening|Protocol Violation|0|||
124979138|NCT02248818|449549934|FG005|Screening|Protocol Violation|0|||
124979139|NCT02248818|449549935|FG006|Screening|Protocol Violation|0|||
124979140|NCT02248818|449549936|FG007|Screening|Protocol Violation|0|||
124979141|NCT02248818|449549937|FG008|Screening|Protocol Violation|7|||
124979142|NCT02248818|449549929|FG000|Screening|Study fully enrolled|0|||
124979143|NCT02248818|449549930|FG001|Screening|Study fully enrolled|0|||
124979144|NCT02248818|449549931|FG002|Screening|Study fully enrolled|0|||
124979145|NCT02248818|449549932|FG003|Screening|Study fully enrolled|0|||
124979146|NCT02248818|449549933|FG004|Screening|Study fully enrolled|0|||
124979147|NCT02248818|449549934|FG005|Screening|Study fully enrolled|0|||
124979148|NCT02248818|449549935|FG006|Screening|Study fully enrolled|0|||
124979149|NCT02248818|449549936|FG007|Screening|Study fully enrolled|0|||
124979150|NCT02248818|449549937|FG008|Screening|Study fully enrolled|14|||
124979151|NCT02248818|449549929|FG000|Screening|Physician Decision|0|||
124979152|NCT02248818|449549930|FG001|Screening|Physician Decision|0|||
124979153|NCT02248818|449549931|FG002|Screening|Physician Decision|0|||
124979154|NCT02248818|449549932|FG003|Screening|Physician Decision|0|||
124979155|NCT02248818|449549933|FG004|Screening|Physician Decision|0|||
124979156|NCT02248818|449549934|FG005|Screening|Physician Decision|0|||
124538563|NCT00379639|447924987|FG003|Overall Study|Symptomatic Deterioration|0|||
124538564|NCT00379639|447924988|FG004|Overall Study|Symptomatic Deterioration|1|||
124538565|NCT00379639|447924984|FG000|Overall Study|Adverse Event|0|||
124538566|NCT00379639|447924985|FG001|Overall Study|Adverse Event|0|||
124538567|NCT00379639|447924986|FG002|Overall Study|Adverse Event|1|||
124538568|NCT00379639|447924987|FG003|Overall Study|Adverse Event|0|||
124538569|NCT00379639|447924988|FG004|Overall Study|Adverse Event|1|||
124538570|NCT00379639|447924984|FG000|Overall Study|Lost to Follow-up|0|||
124538571|NCT00379639|447924985|FG001|Overall Study|Lost to Follow-up|0|||
124979157|NCT02248818|449549935|FG006|Screening|Physician Decision|0|||
124979158|NCT02248818|449549936|FG007|Screening|Physician Decision|0|||
124979159|NCT02248818|449549937|FG008|Screening|Physician Decision|73|||
124979160|NCT02248818|449549929|FG000|Screening|Withdrawal by Subject|0|||
124979161|NCT02248818|449549930|FG001|Screening|Withdrawal by Subject|0|||
124979162|NCT02248818|449549931|FG002|Screening|Withdrawal by Subject|0|||
124979163|NCT02248818|449549932|FG003|Screening|Withdrawal by Subject|0|||
124979164|NCT02248818|449549933|FG004|Screening|Withdrawal by Subject|0|||
124979165|NCT02248818|449549934|FG005|Screening|Withdrawal by Subject|0|||
124979166|NCT02248818|449549935|FG006|Screening|Withdrawal by Subject|0|||
124979167|NCT02248818|449549936|FG007|Screening|Withdrawal by Subject|0|||
124979168|NCT02248818|449549937|FG008|Screening|Withdrawal by Subject|6|||
124979169|NCT02248818|449549929|FG000|Screening|Lost to Follow-up|0|||
124979170|NCT02248818|449549930|FG001|Screening|Lost to Follow-up|0|||
124979171|NCT02248818|449549931|FG002|Screening|Lost to Follow-up|0|||
124979172|NCT02248818|449549932|FG003|Screening|Lost to Follow-up|0|||
124979173|NCT02248818|449549933|FG004|Screening|Lost to Follow-up|0|||
124979174|NCT02248818|449549934|FG005|Screening|Lost to Follow-up|0|||
124979175|NCT02248818|449549935|FG006|Screening|Lost to Follow-up|0|||
124979176|NCT02248818|449549936|FG007|Screening|Lost to Follow-up|0|||
124979177|NCT02248818|449549937|FG008|Screening|Lost to Follow-up|7|||
124979178|NCT02248818|449549929|FG000|Randomised Study|Administrative - randomization error|0|||
124979179|NCT02248818|449549930|FG001|Randomised Study|Administrative - randomization error|0|||
124979180|NCT02248818|449549931|FG002|Randomised Study|Administrative - randomization error|0|||
124979181|NCT02248818|449549932|FG003|Randomised Study|Administrative - randomization error|0|||
124979182|NCT02248818|449549933|FG004|Randomised Study|Administrative - randomization error|0|||
124979183|NCT02248818|449549934|FG005|Randomised Study|Administrative - randomization error|8|||
124979184|NCT02248818|449549935|FG006|Randomised Study|Administrative - randomization error|0|||
124979185|NCT02248818|449549936|FG007|Randomised Study|Administrative - randomization error|0|||
124979186|NCT02248818|449549937|FG008|Randomised Study|Administrative - randomization error|0|||
124979187|NCT05262517|449549938|FG000|Overall Study|Randomized but not treated|5|||
124538572|NCT00379639|447924986|FG002|Overall Study|Lost to Follow-up|0|||
124538573|NCT00379639|447924987|FG003|Overall Study|Lost to Follow-up|1|||
124538574|NCT00379639|447924988|FG004|Overall Study|Lost to Follow-up|0|||
124538575|NCT00379639|447924984|FG000|Overall Study|Other|0|||
124979188|NCT05262517|449549939|FG001|Overall Study|Randomized but not treated|11|||
124979189|NCT04325282|449549940|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
124979190|NCT04325282|449549941|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
124979191|NCT04325282|449549940|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
124979192|NCT04325282|449549941|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
124979193|NCT00527787|449549943|FG000|Overall Study|Adverse Event|14|||
124979194|NCT00527787|449549944|FG001|Overall Study|Adverse Event|24|||
124979195|NCT00527787|449549943|FG000|Overall Study|Withdrawal by Subject|13|||
124979196|NCT00527787|449549944|FG001|Overall Study|Withdrawal by Subject|25|||
124979197|NCT00527787|449549943|FG000|Overall Study|Lost to Follow-up|5|||
124979198|NCT00527787|449549944|FG001|Overall Study|Lost to Follow-up|2|||
124979199|NCT00527787|449549943|FG000|Overall Study|Duodenal Ulcer|1|||
124979200|NCT00527787|449549944|FG001|Overall Study|Duodenal Ulcer|10|||
124979201|NCT00527787|449549943|FG000|Overall Study|misc|5|||
124979202|NCT00527787|449549944|FG001|Overall Study|misc|2|||
124979203|NCT03330405|449549945|FG000|Overall Study|Other|1|||
124979204|NCT03330405|449549946|FG001|Overall Study|Other|3|||
124979205|NCT03330405|449549947|FG002|Overall Study|Other|1|||
124979206|NCT03330405|449549948|FG003|Overall Study|Other|0|||
124979207|NCT03330405|449549949|FG004|Overall Study|Other|2|||
124979208|NCT03330405|449549950|FG005|Overall Study|Other|0|||
124979209|NCT03330405|449549951|FG006|Overall Study|Other|1|||
124979210|NCT03330405|449549952|FG007|Overall Study|Other|0|||
124979211|NCT03330405|449549953|FG008|Overall Study|Other|0|||
124979212|NCT03330405|449549954|FG009|Overall Study|Other|0|||
124979213|NCT03330405|449549955|FG010|Overall Study|Other|0|||
124979214|NCT03330405|449549945|FG000|Overall Study|Progressive disease|8|||
124979215|NCT03330405|449549946|FG001|Overall Study|Progressive disease|27|||
124979216|NCT03330405|449549947|FG002|Overall Study|Progressive disease|4|||
124979217|NCT03330405|449549948|FG003|Overall Study|Progressive disease|18|||
124979218|NCT03330405|449549949|FG004|Overall Study|Progressive disease|16|||
124979219|NCT03330405|449549950|FG005|Overall Study|Progressive disease|14|||
124979220|NCT03330405|449549951|FG006|Overall Study|Progressive disease|7|||
124979221|NCT03330405|449549952|FG007|Overall Study|Progressive disease|29|||
124979222|NCT03330405|449549953|FG008|Overall Study|Progressive disease|9|||
124979223|NCT03330405|449549954|FG009|Overall Study|Progressive disease|11|||
124979224|NCT03330405|449549955|FG010|Overall Study|Progressive disease|5|||
124979225|NCT03330405|449549945|FG000|Overall Study|Withdrawal by Subject|1|||
124979226|NCT03330405|449549946|FG001|Overall Study|Withdrawal by Subject|4|||
124979227|NCT03330405|449549947|FG002|Overall Study|Withdrawal by Subject|0|||
124979228|NCT03330405|449549948|FG003|Overall Study|Withdrawal by Subject|1|||
124979229|NCT03330405|449549949|FG004|Overall Study|Withdrawal by Subject|1|||
124979230|NCT03330405|449549950|FG005|Overall Study|Withdrawal by Subject|1|||
124979231|NCT03330405|449549951|FG006|Overall Study|Withdrawal by Subject|0|||
124979232|NCT03330405|449549952|FG007|Overall Study|Withdrawal by Subject|2|||
124979233|NCT03330405|449549953|FG008|Overall Study|Withdrawal by Subject|2|||
124979234|NCT03330405|449549954|FG009|Overall Study|Withdrawal by Subject|1|||
124979235|NCT03330405|449549955|FG010|Overall Study|Withdrawal by Subject|1|||
124979236|NCT03330405|449549945|FG000|Overall Study|Global deterioration of health status|2|||
124979237|NCT03330405|449549946|FG001|Overall Study|Global deterioration of health status|3|||
124979238|NCT03330405|449549947|FG002|Overall Study|Global deterioration of health status|0|||
124979239|NCT03330405|449549948|FG003|Overall Study|Global deterioration of health status|2|||
124979240|NCT03330405|449549949|FG004|Overall Study|Global deterioration of health status|3|||
124979241|NCT03330405|449549950|FG005|Overall Study|Global deterioration of health status|3|||
124979242|NCT03330405|449549951|FG006|Overall Study|Global deterioration of health status|0|||
124979243|NCT03330405|449549952|FG007|Overall Study|Global deterioration of health status|2|||
124979244|NCT03330405|449549953|FG008|Overall Study|Global deterioration of health status|8|||
124979245|NCT03330405|449549954|FG009|Overall Study|Global deterioration of health status|4|||
124979246|NCT03330405|449549955|FG010|Overall Study|Global deterioration of health status|1|||
124979247|NCT03330405|449549945|FG000|Overall Study|Adverse Event|0|||
124979248|NCT03330405|449549946|FG001|Overall Study|Adverse Event|1|||
124979249|NCT03330405|449549947|FG002|Overall Study|Adverse Event|0|||
124538576|NCT00379639|447924985|FG001|Overall Study|Other|0|||
124979250|NCT03330405|449549948|FG003|Overall Study|Adverse Event|1|||
124538577|NCT00379639|447924986|FG002|Overall Study|Other|3|||
124979251|NCT03330405|449549949|FG004|Overall Study|Adverse Event|1|||
124979252|NCT03330405|449549950|FG005|Overall Study|Adverse Event|1|||
124979253|NCT03330405|449549951|FG006|Overall Study|Adverse Event|3|||
124979254|NCT03330405|449549952|FG007|Overall Study|Adverse Event|4|||
124979255|NCT03330405|449549953|FG008|Overall Study|Adverse Event|2|||
124979256|NCT03330405|449549954|FG009|Overall Study|Adverse Event|2|||
124979257|NCT03330405|449549955|FG010|Overall Study|Adverse Event|2|||
124979258|NCT03330405|449549945|FG000|Overall Study|Death|0|||
124979259|NCT03330405|449549946|FG001|Overall Study|Death|4|||
124979260|NCT03330405|449549947|FG002|Overall Study|Death|0|||
124979261|NCT03330405|449549948|FG003|Overall Study|Death|0|||
124538578|NCT00379639|447924987|FG003|Overall Study|Other|0|||
124538579|NCT00379639|447924988|FG004|Overall Study|Other|0|||
124979262|NCT03330405|449549949|FG004|Overall Study|Death|0|||
124979263|NCT03330405|449549950|FG005|Overall Study|Death|1|||
124979264|NCT03330405|449549951|FG006|Overall Study|Death|0|||
124979265|NCT03330405|449549952|FG007|Overall Study|Death|2|||
124979266|NCT03330405|449549953|FG008|Overall Study|Death|0|||
124979267|NCT03330405|449549954|FG009|Overall Study|Death|0|||
124979268|NCT03330405|449549955|FG010|Overall Study|Death|0|||
124979269|NCT03330405|449549945|FG000|Overall Study|Physician Decision|0|||
124979270|NCT03330405|449549946|FG001|Overall Study|Physician Decision|0|||
124979271|NCT03330405|449549947|FG002|Overall Study|Physician Decision|0|||
124979272|NCT03330405|449549948|FG003|Overall Study|Physician Decision|0|||
124979273|NCT03330405|449549949|FG004|Overall Study|Physician Decision|0|||
124979274|NCT03330405|449549950|FG005|Overall Study|Physician Decision|0|||
124979275|NCT03330405|449549951|FG006|Overall Study|Physician Decision|0|||
124979276|NCT03330405|449549952|FG007|Overall Study|Physician Decision|1|||
124979277|NCT03330405|449549953|FG008|Overall Study|Physician Decision|0|||
124979278|NCT03330405|449549954|FG009|Overall Study|Physician Decision|0|||
124979279|NCT03330405|449549955|FG010|Overall Study|Physician Decision|0|||
124979280|NCT02643303|449549956|FG000|Overall Study|Progressive Disease|4|||
124979281|NCT02643303|449549957|FG001|Overall Study|Progressive Disease|4|||
124979282|NCT02643303|449549958|FG002|Overall Study|Progressive Disease|1|||
124979283|NCT02643303|449549959|FG003|Overall Study|Progressive Disease|12|||
124979284|NCT02643303|449549960|FG004|Overall Study|Progressive Disease|6|||
124979285|NCT02643303|449549961|FG005|Overall Study|Progressive Disease|4|||
124979286|NCT02643303|449549962|FG006|Overall Study|Progressive Disease|8|||
124979287|NCT02643303|449549963|FG007|Overall Study|Progressive Disease|2|||
124979288|NCT02643303|449549964|FG008|Overall Study|Progressive Disease|6|||
124979289|NCT02643303|449549956|FG000|Overall Study|Adverse Event|0|||
124979290|NCT02643303|449549957|FG001|Overall Study|Adverse Event|1|||
124979291|NCT02643303|449549958|FG002|Overall Study|Adverse Event|0|||
124979292|NCT02643303|449549959|FG003|Overall Study|Adverse Event|0|||
124979293|NCT02643303|449549960|FG004|Overall Study|Adverse Event|1|||
124979294|NCT02643303|449549961|FG005|Overall Study|Adverse Event|0|||
124979295|NCT02643303|449549962|FG006|Overall Study|Adverse Event|0|||
124979296|NCT02643303|449549963|FG007|Overall Study|Adverse Event|0|||
124979297|NCT02643303|449549964|FG008|Overall Study|Adverse Event|0|||
124979298|NCT02643303|449549956|FG000|Overall Study|Withdrawal by Subject|0|||
124979299|NCT02643303|449549957|FG001|Overall Study|Withdrawal by Subject|0|||
124979300|NCT02643303|449549958|FG002|Overall Study|Withdrawal by Subject|0|||
124979301|NCT02643303|449549959|FG003|Overall Study|Withdrawal by Subject|1|||
124979302|NCT02643303|449549960|FG004|Overall Study|Withdrawal by Subject|0|||
124979303|NCT02643303|449549961|FG005|Overall Study|Withdrawal by Subject|0|||
124979304|NCT02643303|449549962|FG006|Overall Study|Withdrawal by Subject|1|||
124979305|NCT02643303|449549963|FG007|Overall Study|Withdrawal by Subject|1|||
124979306|NCT02643303|449549964|FG008|Overall Study|Withdrawal by Subject|1|||
124979307|NCT01598662|449549967|FG000|Overall Study|Lost to Follow-up|10|||
124979308|NCT01598662|449549968|FG001|Overall Study|Lost to Follow-up|17|||
124979309|NCT01598662|449549967|FG000|Overall Study|Physician Decision|1|||
124979310|NCT01598662|449549968|FG001|Overall Study|Physician Decision|2|||
124979311|NCT01598662|449549967|FG000|Overall Study|IUD expelled before month 6|0|||
124979312|NCT01598662|449549968|FG001|Overall Study|IUD expelled before month 6|2|||
124979313|NCT03898167|449549969|FG000|Overall Study|Terminated phone call early|7|||
124979314|NCT03898167|449549970|FG001|Overall Study|Terminated phone call early|0|||
124979315|NCT03898167|449549971|FG002|Overall Study|Terminated phone call early|0|||
124979316|NCT03898167|449549969|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
124979317|NCT03898167|449549970|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
124979318|NCT03898167|449549971|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
124979319|NCT05177354|449549972|FG000|Implant to 30-day Visit|Physician Decision|1|||
124979320|NCT05177354|449549972|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
124979321|NCT05177354|449549972|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
124979322|NCT05177354|449549972|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
124979323|NCT03548220|449549974|FG000|Overall Study|Lost to Follow-up|1|||
124979324|NCT03548220|449549975|FG001|Overall Study|Lost to Follow-up|0|||
124979325|NCT03548220|449549976|FG002|Overall Study|Lost to Follow-up|0|||
124979326|NCT03548220|449549977|FG003|Overall Study|Lost to Follow-up|0|||
124979327|NCT02906007|449549978|FG000|Overall Study|Physician Decision|0|||
124979328|NCT02906007|449549979|FG001|Overall Study|Physician Decision|0|||
124979329|NCT02906007|449549980|FG002|Overall Study|Physician Decision|1|||
124979330|NCT02906007|449549978|FG000|Overall Study|Died|1|||
124979331|NCT02906007|449549979|FG001|Overall Study|Died|0|||
124979332|NCT02906007|449549980|FG002|Overall Study|Died|0|||
124979333|NCT01946529|449549983|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
124979334|NCT01946529|449549984|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
124979335|NCT01946529|449549985|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
124979336|NCT01946529|449549983|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
124538580|NCT00594958|447924989|FG000|Overall Study|Withdrawal by Subject|1|||
124979337|NCT01946529|449549984|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
124979338|NCT01946529|449549985|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
124979339|NCT06655558|449549989|FG000|Overall Study|Protocol Violation|1|||
124979340|NCT06748729|449549998|FG000|Overall Study|Withdrawal by Subject|1|||
124979341|NCT01253135|449551514|FG000|Original Protocol|Protocol Amendment|15|||
124979342|NCT01253135|449551514|FG000|Amended Protocol|Non-compliance|1|||
124979343|NCT01901432|449551519|FG000|Overall Study|Adverse Event|0|||
124979344|NCT01901432|449551520|FG001|Overall Study|Adverse Event|1|||
124979345|NCT01901432|449551521|FG002|Overall Study|Adverse Event|1|||
124979346|NCT01901432|449551522|FG003|Overall Study|Adverse Event|0|||
124979347|NCT01901432|449551523|FG004|Overall Study|Adverse Event|1|||
124979348|NCT01901432|449551519|FG000|Overall Study|Withdrawal by Subject|0|||
124979349|NCT01901432|449551520|FG001|Overall Study|Withdrawal by Subject|0|||
124979350|NCT01901432|449551521|FG002|Overall Study|Withdrawal by Subject|1|||
124979351|NCT01901432|449551522|FG003|Overall Study|Withdrawal by Subject|0|||
124979352|NCT01901432|449551523|FG004|Overall Study|Withdrawal by Subject|5|||
124979353|NCT01901432|449551519|FG000|Overall Study|Physician Decision|0|||
124979354|NCT01901432|449551520|FG001|Overall Study|Physician Decision|0|||
124979355|NCT01901432|449551521|FG002|Overall Study|Physician Decision|0|||
124979356|NCT01901432|449551522|FG003|Overall Study|Physician Decision|0|||
124979357|NCT01901432|449551523|FG004|Overall Study|Physician Decision|2|||
124979358|NCT01901432|449551519|FG000|Overall Study|Patient decision to stop study drug|0|||
124979359|NCT01901432|449551520|FG001|Overall Study|Patient decision to stop study drug|0|||
124979360|NCT01901432|449551521|FG002|Overall Study|Patient decision to stop study drug|0|||
124979361|NCT01901432|449551522|FG003|Overall Study|Patient decision to stop study drug|0|||
124979362|NCT01901432|449551523|FG004|Overall Study|Patient decision to stop study drug|1|||
124979363|NCT00379288|449551526|FG000|Overall Study|Adverse Event|5|||
124979364|NCT00379288|449551527|FG001|Overall Study|Adverse Event|6|||
124979365|NCT00379288|449551528|FG002|Overall Study|Adverse Event|2|||
124979366|NCT00379288|449551529|FG003|Overall Study|Adverse Event|0|||
124979367|NCT00379288|449551526|FG000|Overall Study|Treatment Failure|0|||
124979368|NCT00379288|449551527|FG001|Overall Study|Treatment Failure|1|||
124979369|NCT00379288|449551528|FG002|Overall Study|Treatment Failure|0|||
124979370|NCT00379288|449551529|FG003|Overall Study|Treatment Failure|1|||
124979371|NCT00379288|449551526|FG000|Overall Study|Lost to Follow-up|3|||
124979372|NCT00379288|449551527|FG001|Overall Study|Lost to Follow-up|3|||
124979373|NCT00379288|449551528|FG002|Overall Study|Lost to Follow-up|2|||
124979374|NCT00379288|449551529|FG003|Overall Study|Lost to Follow-up|0|||
124979375|NCT00379288|449551526|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
124979376|NCT00379288|449551527|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
124979377|NCT00379288|449551528|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
124979378|NCT00379288|449551529|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
124979379|NCT00379288|449551526|FG000|Overall Study|Subject withdrew-related to study drug|1|||
124979380|NCT00379288|449551527|FG001|Overall Study|Subject withdrew-related to study drug|0|||
124979381|NCT00379288|449551528|FG002|Overall Study|Subject withdrew-related to study drug|0|||
124979382|NCT00379288|449551529|FG003|Overall Study|Subject withdrew-related to study drug|1|||
124979383|NCT00379288|449551526|FG000|Overall Study|Noncompliance with protocol|8|||
124979384|NCT00379288|449551527|FG001|Overall Study|Noncompliance with protocol|6|||
124979385|NCT00379288|449551528|FG002|Overall Study|Noncompliance with protocol|2|||
124979386|NCT00379288|449551529|FG003|Overall Study|Noncompliance with protocol|1|||
124979387|NCT00379288|449551526|FG000|Overall Study|Did not meet protocol eligibility|0|||
124979388|NCT00379288|449551527|FG001|Overall Study|Did not meet protocol eligibility|1|||
124979389|NCT00379288|449551528|FG002|Overall Study|Did not meet protocol eligibility|0|||
124979390|NCT00379288|449551529|FG003|Overall Study|Did not meet protocol eligibility|2|||
124979391|NCT00379288|449551526|FG000|Overall Study|Administrative|2|||
124979392|NCT00379288|449551527|FG001|Overall Study|Administrative|2|||
124979393|NCT00379288|449551528|FG002|Overall Study|Administrative|0|||
124979394|NCT00379288|449551529|FG003|Overall Study|Administrative|1|||
124979395|NCT00918879|449551530|FG000|Overall Study|Withdrawal by Subject|4|||
124979396|NCT00918879|449551531|FG001|Overall Study|Withdrawal by Subject|4|||
124979397|NCT00918879|449551530|FG000|Overall Study|Lost to Follow-up|1|||
124979398|NCT00918879|449551531|FG001|Overall Study|Lost to Follow-up|1|||
124979399|NCT00918879|449551530|FG000|Overall Study|Severe non-compliance to protocol|1|||
124538581|NCT00594958|447924990|FG001|Overall Study|Withdrawal by Subject|0|||
124538582|NCT00594958|447924991|FG002|Overall Study|Withdrawal by Subject|1|||
124979400|NCT00918879|449551531|FG001|Overall Study|Severe non-compliance to protocol|1|||
124979401|NCT00833261|449551534|FG000|Overall Study|Withdrawal by Subject|4|||
124979402|NCT00357110|449551535|FG000|Overall Study|Early study termination|5|||
124979403|NCT00357110|449551536|FG001|Overall Study|Early study termination|5|||
124979404|NCT05602727|449551539|FG000|Overall Study|Physician Decision|0|||
124979405|NCT05602727|449551540|FG001|Overall Study|Physician Decision|1|||
124979406|NCT05602727|449551541|FG002|Overall Study|Physician Decision|0|||
124979407|NCT05602727|449551539|FG000|Overall Study|Randomized by mistake without study medication|1|||
124979408|NCT05602727|449551540|FG001|Overall Study|Randomized by mistake without study medication|0|||
124979409|NCT05602727|449551541|FG002|Overall Study|Randomized by mistake without study medication|0|||
124538583|NCT00594958|447924989|FG000|Overall Study|Adverse Event|4|||
124979410|NCT05602727|449551539|FG000|Overall Study|Study termination by Sponsor|18|||
124979411|NCT05602727|449551540|FG001|Overall Study|Study termination by Sponsor|15|||
124979412|NCT05602727|449551541|FG002|Overall Study|Study termination by Sponsor|19|||
124979413|NCT05602727|449551539|FG000|Overall Study|Withdrawal by Subject|2|||
124979414|NCT05602727|449551540|FG001|Overall Study|Withdrawal by Subject|1|||
124979415|NCT05602727|449551541|FG002|Overall Study|Withdrawal by Subject|1|||
124979416|NCT05602727|449551539|FG000|Overall Study|Various reasons|1|||
124979417|NCT05602727|449551540|FG001|Overall Study|Various reasons|6|||
124979418|NCT05602727|449551541|FG002|Overall Study|Various reasons|1|||
124979419|NCT01283152|449551544|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
124979420|NCT01283152|449551545|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
124979421|NCT01283152|449551544|FG000|Overall Study|Refused HESA|1|||
124979422|NCT01283152|449551545|FG001|Overall Study|Refused HESA|0|||
124979423|NCT04020185|449551550|FG000|Overall Study|Death|0|||
124979424|NCT04020185|449551551|FG001|Overall Study|Death|0|||
124979425|NCT04020185|449551552|FG002|Overall Study|Death|1|||
124979426|NCT04020185|449551553|FG003|Overall Study|Death|2|||
124979427|NCT04020185|449551554|FG004|Overall Study|Death|1|||
124979428|NCT04020185|449551555|FG005|Overall Study|Death|0|||
124979429|NCT04020185|449551556|FG006|Overall Study|Death|1|||
124979430|NCT04020185|449551557|FG007|Overall Study|Death|0|||
124979431|NCT04020185|449551550|FG000|Overall Study|Consent withdrawn|1|||
124979432|NCT04020185|449551551|FG001|Overall Study|Consent withdrawn|0|||
124979433|NCT04020185|449551552|FG002|Overall Study|Consent withdrawn|0|||
124979434|NCT04020185|449551553|FG003|Overall Study|Consent withdrawn|0|||
124979435|NCT04020185|449551554|FG004|Overall Study|Consent withdrawn|2|||
124979436|NCT04020185|449551555|FG005|Overall Study|Consent withdrawn|0|||
124979437|NCT04020185|449551556|FG006|Overall Study|Consent withdrawn|1|||
124979438|NCT04020185|449551557|FG007|Overall Study|Consent withdrawn|1|||
124979439|NCT04020185|449551550|FG000|Overall Study|Patient in hospice|0|||
124979440|NCT04020185|449551551|FG001|Overall Study|Patient in hospice|1|||
124979441|NCT04020185|449551552|FG002|Overall Study|Patient in hospice|0|||
124979442|NCT04020185|449551553|FG003|Overall Study|Patient in hospice|0|||
124979443|NCT04020185|449551554|FG004|Overall Study|Patient in hospice|0|||
124979444|NCT04020185|449551555|FG005|Overall Study|Patient in hospice|0|||
124979445|NCT04020185|449551556|FG006|Overall Study|Patient in hospice|0|||
124979446|NCT04020185|449551557|FG007|Overall Study|Patient in hospice|0|||
124979447|NCT04020185|449551550|FG000|Overall Study|Continuing on expanded access|0|||
124979448|NCT04020185|449551551|FG001|Overall Study|Continuing on expanded access|0|||
124979449|NCT04020185|449551552|FG002|Overall Study|Continuing on expanded access|0|||
124979450|NCT04020185|449551553|FG003|Overall Study|Continuing on expanded access|0|||
124979451|NCT04020185|449551554|FG004|Overall Study|Continuing on expanded access|0|||
124979452|NCT04020185|449551555|FG005|Overall Study|Continuing on expanded access|0|||
124979453|NCT04020185|449551556|FG006|Overall Study|Continuing on expanded access|1|||
124979454|NCT04020185|449551557|FG007|Overall Study|Continuing on expanded access|1|||
124979455|NCT03433677|449551559|FG000|Period 1|Protocol Violation|1|||
124979456|NCT03433677|449551560|FG001|Period 1|Protocol Violation|0|||
124979457|NCT03433677|449551559|FG000|Period 2|Withdrawal by Subject|1|||
124979458|NCT03433677|449551560|FG001|Period 2|Withdrawal by Subject|1|||
124979459|NCT01499303|449551565|FG000|Overall Study|Ongoing|2|||
124979460|NCT01499303|449551566|FG001|Overall Study|Ongoing|1|||
124979461|NCT01499303|449551565|FG000|Overall Study|Withdrawal by Subject|0|||
124979462|NCT01499303|449551566|FG001|Overall Study|Withdrawal by Subject|1|||
124979463|NCT01499303|449551565|FG000|Overall Study|Adverse Event|1|||
124979464|NCT01499303|449551566|FG001|Overall Study|Adverse Event|4|||
124979465|NCT01499303|449551565|FG000|Overall Study|Other|0|||
124979466|NCT01499303|449551566|FG001|Overall Study|Other|1|||
124979467|NCT04939701|449551569|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
124979468|NCT04939701|449551570|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
124979469|NCT04939701|449551571|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
124979470|NCT04939701|449551569|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
124979471|NCT04939701|449551570|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
124979472|NCT04939701|449551571|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
124979473|NCT04939701|449551569|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
124979474|NCT04939701|449551570|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
124979475|NCT04939701|449551571|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
124979476|NCT04939701|449551569|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
124979477|NCT04939701|449551570|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
124979478|NCT04939701|449551571|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
124979479|NCT04939701|449551569|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
124979480|NCT04939701|449551570|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
124979481|NCT04939701|449551571|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
124979482|NCT04939701|449551569|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
124979483|NCT04939701|449551570|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
124979484|NCT04939701|449551571|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
124979485|NCT04939701|449551569|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
124979486|NCT04939701|449551570|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
124979487|NCT04939701|449551571|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
124979488|NCT00565773|449551572|FG000|Overall Study|Withdrawal by Subject|1|||
124979489|NCT00565773|449551572|FG000|Overall Study|Physician Decision|1|||
124979490|NCT00702962|449551573|FG000|Overall Study|Progressive disease|0|||
124979491|NCT00702962|449551574|FG001|Overall Study|Progressive disease|1|||
124979492|NCT00702962|449551573|FG000|Overall Study|Hospitalized for other health disorder|1|||
124979493|NCT00702962|449551574|FG001|Overall Study|Hospitalized for other health disorder|0|||
124979494|NCT01923467|449551576|FG000|Overall Study|Lost to Follow-up|62|||
124979495|NCT01923467|449551576|FG000|Overall Study|Subject non-interest|479|||
124979496|NCT03015129|449551577|FG000|Overall Study|Death|2|||
124979497|NCT03015129|449551578|FG001|Overall Study|Death|2|||
124979498|NCT03015129|449551577|FG000|Overall Study|Lost to Follow-up|0|||
124979499|NCT03015129|449551578|FG001|Overall Study|Lost to Follow-up|1|||
124979500|NCT03015129|449551577|FG000|Overall Study|Progression of disease|38|||
124979501|NCT03015129|449551578|FG001|Overall Study|Progression of disease|33|||
124979502|NCT03015129|449551577|FG000|Overall Study|Adverse Event|0|||
124979503|NCT03015129|449551578|FG001|Overall Study|Adverse Event|4|||
124979504|NCT02242097|449551579|FG000|Ibrutinib Treatment|Adverse Event|16|||
124979505|NCT02242097|449551579|FG000|Ibrutinib Treatment|Physician Decision|1|||
124979506|NCT02242097|449551579|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
124979507|NCT02242097|449551579|FG000|Ibrutinib Treatment|Death|1|||
124979508|NCT02242097|449551579|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
124979509|NCT02242097|449551579|FG000|Post Therapy Follow Up|Death|3|||
124979510|NCT02242097|449551579|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
124979511|NCT01075958|449551580|FG000|Overall Study|Blood sample could not be obtained|44|||
124979512|NCT03733314|449551582|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
124979513|NCT03733314|449551583|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
124979514|NCT03733314|449551582|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
124979515|NCT03733314|449551583|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
124979516|NCT03733314|449551582|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
124979517|NCT03733314|449551583|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
124979518|NCT03733314|449551582|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
124979519|NCT03733314|449551583|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
124979520|NCT03733314|449551582|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
124979521|NCT03733314|449551583|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
124979522|NCT03733314|449551582|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
124979523|NCT03733314|449551583|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
124979524|NCT01240915|449551584|FG000|Overall Study|Adverse Event|0|||
124979525|NCT01240915|449551585|FG001|Overall Study|Adverse Event|0|||
124979526|NCT01240915|449551586|FG002|Overall Study|Adverse Event|0|||
124979527|NCT01240915|449551587|FG003|Overall Study|Adverse Event|1|||
124979528|NCT01240915|449551588|FG004|Overall Study|Adverse Event|0|||
124979529|NCT01240915|449551589|FG005|Overall Study|Adverse Event|2|||
124979530|NCT01240915|449551590|FG006|Overall Study|Adverse Event|0|||
124979531|NCT01240915|449551591|FG007|Overall Study|Adverse Event|0|||
124979532|NCT01240915|449551592|FG008|Overall Study|Adverse Event|1|||
124979533|NCT01240915|449551584|FG000|Overall Study|Lost to Follow-up|0|||
124979534|NCT01240915|449551585|FG001|Overall Study|Lost to Follow-up|0|||
124979535|NCT01240915|449551586|FG002|Overall Study|Lost to Follow-up|0|||
124979536|NCT01240915|449551587|FG003|Overall Study|Lost to Follow-up|0|||
124979537|NCT01240915|449551588|FG004|Overall Study|Lost to Follow-up|1|||
124979538|NCT01240915|449551589|FG005|Overall Study|Lost to Follow-up|1|||
124979539|NCT01240915|449551590|FG006|Overall Study|Lost to Follow-up|0|||
124979540|NCT01240915|449551591|FG007|Overall Study|Lost to Follow-up|1|||
124979541|NCT01240915|449551592|FG008|Overall Study|Lost to Follow-up|1|||
124979542|NCT01240915|449551584|FG000|Overall Study|Withdrawal by Subject|2|||
124979543|NCT01240915|449551585|FG001|Overall Study|Withdrawal by Subject|1|||
124979544|NCT01240915|449551586|FG002|Overall Study|Withdrawal by Subject|0|||
124979545|NCT01240915|449551587|FG003|Overall Study|Withdrawal by Subject|2|||
124979546|NCT01240915|449551588|FG004|Overall Study|Withdrawal by Subject|0|||
124979547|NCT01240915|449551589|FG005|Overall Study|Withdrawal by Subject|4|||
124979548|NCT01240915|449551590|FG006|Overall Study|Withdrawal by Subject|2|||
124979549|NCT01240915|449551591|FG007|Overall Study|Withdrawal by Subject|3|||
124979550|NCT01240915|449551592|FG008|Overall Study|Withdrawal by Subject|3|||
124979551|NCT01240915|449551584|FG000|Overall Study|Other|0|||
124979552|NCT01240915|449551585|FG001|Overall Study|Other|0|||
124979553|NCT01240915|449551586|FG002|Overall Study|Other|0|||
124979554|NCT01240915|449551587|FG003|Overall Study|Other|0|||
124538584|NCT00594958|447924990|FG001|Overall Study|Adverse Event|1|||
124979555|NCT01240915|449551588|FG004|Overall Study|Other|2|||
124979556|NCT01240915|449551589|FG005|Overall Study|Other|0|||
124979557|NCT01240915|449551590|FG006|Overall Study|Other|0|||
124979558|NCT01240915|449551591|FG007|Overall Study|Other|0|||
124979559|NCT01240915|449551592|FG008|Overall Study|Other|0|||
124979560|NCT01240915|449551584|FG000|Overall Study|Insufficient Clinical Response|0|||
124979561|NCT01240915|449551585|FG001|Overall Study|Insufficient Clinical Response|0|||
124979562|NCT01240915|449551586|FG002|Overall Study|Insufficient Clinical Response|0|||
124979563|NCT01240915|449551587|FG003|Overall Study|Insufficient Clinical Response|0|||
124979564|NCT01240915|449551588|FG004|Overall Study|Insufficient Clinical Response|1|||
124979565|NCT01240915|449551589|FG005|Overall Study|Insufficient Clinical Response|3|||
124979566|NCT01240915|449551590|FG006|Overall Study|Insufficient Clinical Response|6|||
124979567|NCT01240915|449551591|FG007|Overall Study|Insufficient Clinical Response|0|||
124979568|NCT01240915|449551592|FG008|Overall Study|Insufficient Clinical Response|3|||
124979569|NCT02574845|449551594|FG000|Overall Study|Consent withdrawn further participation|0|||
124979570|NCT02574845|449551595|FG001|Overall Study|Consent withdrawn further participation|0|||
124979571|NCT02574845|449551596|FG002|Overall Study|Consent withdrawn further participation|0|||
124979572|NCT02574845|449551597|FG003|Overall Study|Consent withdrawn further participation|0|||
124979573|NCT02574845|449551598|FG004|Overall Study|Consent withdrawn further participation|1|||
124979574|NCT02574845|449551599|FG005|Overall Study|Consent withdrawn further participation|0|||
124979575|NCT02574845|449551594|FG000|Overall Study|Adverse Event|0|||
124979576|NCT02574845|449551595|FG001|Overall Study|Adverse Event|1|||
124979577|NCT02574845|449551596|FG002|Overall Study|Adverse Event|0|||
124979578|NCT02574845|449551597|FG003|Overall Study|Adverse Event|0|||
124979579|NCT02574845|449551598|FG004|Overall Study|Adverse Event|0|||
124979580|NCT02574845|449551599|FG005|Overall Study|Adverse Event|1|||
124979581|NCT03435692|449551601|FG000|Overall Study|Lack of Efficacy|2|||
124979582|NCT03435692|449551602|FG001|Overall Study|Lack of Efficacy|2|||
124979583|NCT03435692|449551603|FG002|Overall Study|Lack of Efficacy|0|||
124979584|NCT00821587|449551608|FG000|Overall Study|Physician Decision|0|||
124979585|NCT00821587|449551609|FG001|Overall Study|Physician Decision|1|||
124979586|NCT01712061|449551612|FG000|Overall Study|Adverse Event|4|||
124979587|NCT01712061|449551613|FG001|Overall Study|Adverse Event|9|||
124979588|NCT01712061|449551614|FG002|Overall Study|Adverse Event|5|||
124979589|NCT01712061|449551612|FG000|Overall Study|Death|0|||
124979590|NCT01712061|449551613|FG001|Overall Study|Death|0|||
124979591|NCT01712061|449551614|FG002|Overall Study|Death|1|||
124979592|NCT01712061|449551612|FG000|Overall Study|Lost to Follow-up|1|||
124979593|NCT01712061|449551613|FG001|Overall Study|Lost to Follow-up|0|||
124979594|NCT01712061|449551614|FG002|Overall Study|Lost to Follow-up|1|||
124979595|NCT01712061|449551612|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
124979596|NCT01712061|449551613|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
124979597|NCT01712061|449551614|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
124979598|NCT01712061|449551612|FG000|Overall Study|Medication Error Without Associated AE|0|||
124979599|NCT01712061|449551613|FG001|Overall Study|Medication Error Without Associated AE|1|||
124979600|NCT01712061|449551614|FG002|Overall Study|Medication Error Without Associated AE|0|||
124979601|NCT01712061|449551612|FG000|Overall Study|Withdrawal by Subject|1|||
124979602|NCT01712061|449551613|FG001|Overall Study|Withdrawal by Subject|7|||
124979603|NCT01712061|449551614|FG002|Overall Study|Withdrawal by Subject|1|||
124979604|NCT01712061|449551612|FG000|Overall Study|Other|0|||
124979605|NCT01712061|449551613|FG001|Overall Study|Other|3|||
124979606|NCT01712061|449551614|FG002|Overall Study|Other|0|||
124979607|NCT00879775|449551617|FG000|Overall Study|Lost to Follow-up|2|||
124979608|NCT00879775|449551618|FG001|Overall Study|Lost to Follow-up|1|||
124979609|NCT01195623|449551619|FG000|Overall Study|Lost to Follow-up|35|||
124979610|NCT01195623|449551620|FG001|Overall Study|Lost to Follow-up|37|||
124979611|NCT01677767|449551621|FG000|Overall Study|Adverse Event|1|||
124979612|NCT01677767|449551621|FG000|Overall Study|Death|4|||
124979613|NCT01677767|449551621|FG000|Overall Study|Protocol Violation|4|||
124979614|NCT01677767|449551621|FG000|Overall Study|Withdrawal by Subject|10|||
124979615|NCT01677767|449551621|FG000|Overall Study|Non-compliance by the participants|3|||
124979616|NCT03846453|449551622|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
124538585|NCT00594958|447924991|FG002|Overall Study|Adverse Event|2|||
124538586|NCT00594958|447924989|FG000|Overall Study|Pregnancy|0|||
124538587|NCT00594958|447924990|FG001|Overall Study|Pregnancy|2|||
124538588|NCT00594958|447924991|FG002|Overall Study|Pregnancy|0|||
124538589|NCT00594958|447924989|FG000|Overall Study|Protocol Violation|1|||
124538590|NCT00594958|447924990|FG001|Overall Study|Protocol Violation|0|||
124538591|NCT00594958|447924991|FG002|Overall Study|Protocol Violation|2|||
124538592|NCT00594958|447924989|FG000|Overall Study|Lost to Follow-up|5|||
124538593|NCT00594958|447924990|FG001|Overall Study|Lost to Follow-up|0|||
124538594|NCT00594958|447924991|FG002|Overall Study|Lost to Follow-up|3|||
124538595|NCT00594958|447924989|FG000|Overall Study|administrative|3|||
124538596|NCT00594958|447924990|FG001|Overall Study|administrative|0|||
124979617|NCT03846453|449551623|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
124979618|NCT03846453|449551624|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
124979619|NCT03846453|449551622|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
124979620|NCT03846453|449551623|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
124979621|NCT03846453|449551624|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
124979622|NCT03846453|449551622|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
124979623|NCT03846453|449551623|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
124979624|NCT03846453|449551624|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
124538597|NCT00594958|447924991|FG002|Overall Study|administrative|2|||
124538598|NCT05637515|447924992|FG000|Overall Study|Withdrawal by Subject|17|||
124538599|NCT05637515|447924993|FG001|Overall Study|Withdrawal by Subject|17|||
124538600|NCT03233009|447924994|FG000|Overall Study|Lost to Follow-up|1|||
124538601|NCT00278473|447924996|FG000|Overall Study|drop out|4|||
124538602|NCT00278473|447924997|FG001|Overall Study|drop out|3|||
124538603|NCT04516291|447924998|FG000|Treatment Period (24 Weeks)|Other|1|||
124538604|NCT04516291|447924999|FG001|Treatment Period (24 Weeks)|Other|0|||
124979625|NCT03846453|449551622|FG000|Placebo Run-in (14 Days)|Other|2|||
124979626|NCT03846453|449551623|FG001|Placebo Run-in (14 Days)|Other|0|||
124979627|NCT03846453|449551624|FG002|Placebo Run-in (14 Days)|Other|0|||
124979628|NCT03846453|449551622|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
124979629|NCT03846453|449551623|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
124979630|NCT03846453|449551624|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
124979631|NCT03846453|449551622|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
124979632|NCT03846453|449551623|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
124979633|NCT03846453|449551624|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
124538605|NCT04516291|447925000|FG002|Treatment Period (24 Weeks)|Other|0|||
124538606|NCT04516291|447925001|FG003|Treatment Period (24 Weeks)|Other|2|||
124538607|NCT04516291|447925002|FG004|Treatment Period (24 Weeks)|Other|2|||
124538608|NCT04516291|447925003|FG005|Treatment Period (24 Weeks)|Other|4|||
124979634|NCT03846453|449551622|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
124979635|NCT03846453|449551623|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
124979636|NCT03846453|449551624|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
124979637|NCT03846453|449551622|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
124979638|NCT03846453|449551623|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
124979639|NCT03846453|449551624|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
124979640|NCT03846453|449551622|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
124979641|NCT03846453|449551623|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
124979642|NCT03846453|449551624|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
124979643|NCT00468143|449551625|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
124979644|NCT00468143|449551626|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
124979645|NCT00468143|449551625|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
124979646|NCT00468143|449551626|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
124979647|NCT01606670|449551629|FG000|Overall Study|Adverse Event|6|||
124979648|NCT01606670|449551629|FG000|Overall Study|Lack of Efficacy|2|||
124979649|NCT01606670|449551629|FG000|Overall Study|Lost to Follow-up|3|||
124979650|NCT01606670|449551629|FG000|Overall Study|Withdrawal by Subject|3|||
124979651|NCT01606670|449551629|FG000|Overall Study|Other Reason|2|||
124979652|NCT02636725|449551631|FG000|Overall Study|Adverse Event|1|||
124979653|NCT02145468|449551632|FG000|Overall Study|Withdrawal by Subject|5|||
124979654|NCT02145468|449551633|FG001|Overall Study|Withdrawal by Subject|8|||
124979655|NCT00623805|449551634|FG000|Overall Study|Adverse Event|9|||
124979656|NCT00623805|449551635|FG001|Overall Study|Adverse Event|6|||
124979657|NCT00623805|449551634|FG000|Overall Study|Death|2|||
124979658|NCT00623805|449551635|FG001|Overall Study|Death|0|||
124979659|NCT00623805|449551634|FG000|Overall Study|Lack of Efficacy|3|||
124979660|NCT00623805|449551635|FG001|Overall Study|Lack of Efficacy|7|||
124979661|NCT00623805|449551634|FG000|Overall Study|Lost to Follow-up|2|||
124979662|NCT00623805|449551635|FG001|Overall Study|Lost to Follow-up|2|||
124979663|NCT00623805|449551634|FG000|Overall Study|Protocol Violation|1|||
124979664|NCT00623805|449551635|FG001|Overall Study|Protocol Violation|1|||
124979665|NCT00623805|449551634|FG000|Overall Study|Reason not Specified|3|||
124979666|NCT00623805|449551635|FG001|Overall Study|Reason not Specified|6|||
124979667|NCT04655027|449551639|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
124979668|NCT04655027|449551640|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
124979669|NCT03519997|449551643|FG000|Overall Study|Adverse Event|4|||
124979670|NCT03519997|449551643|FG000|Overall Study|Withdrawal by Subject|2|||
124979671|NCT03519997|449551643|FG000|Overall Study|Protocol Violation|1|||
124979672|NCT03820947|449551644|FG000|Overall Study|Physician Decision|0|||
124979673|NCT03820947|449551645|FG001|Overall Study|Physician Decision|1|||
124979674|NCT03820947|449551646|FG002|Overall Study|Physician Decision|1|||
124538609|NCT04516291|447925004|FG006|Treatment Period (24 Weeks)|Other|2|||
124538610|NCT04516291|447925005|FG007|Treatment Period (24 Weeks)|Other|0|||
124538611|NCT04516291|447924998|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124979675|NCT03820947|449551647|FG003|Overall Study|Physician Decision|0|||
124979676|NCT03820947|449551648|FG004|Overall Study|Physician Decision|3|||
124979677|NCT03820947|449551644|FG000|Overall Study|Withdrawal by Subject|6|||
124979678|NCT03820947|449551645|FG001|Overall Study|Withdrawal by Subject|10|||
124538612|NCT04516291|447924999|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
124538613|NCT04516291|447925000|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
124979679|NCT03820947|449551646|FG002|Overall Study|Withdrawal by Subject|3|||
124979680|NCT03820947|449551647|FG003|Overall Study|Withdrawal by Subject|8|||
124758629|NCT02452424|448739818|FG009|Overall Study|Adverse Event|0|||
124979681|NCT03820947|449551648|FG004|Overall Study|Withdrawal by Subject|5|||
124979682|NCT03820947|449551644|FG000|Overall Study|Procedure Not Attempted|0|||
124979683|NCT03820947|449551645|FG001|Overall Study|Procedure Not Attempted|2|||
124979684|NCT03820947|449551646|FG002|Overall Study|Procedure Not Attempted|1|||
124979685|NCT03820947|449551647|FG003|Overall Study|Procedure Not Attempted|0|||
124979686|NCT03820947|449551648|FG004|Overall Study|Procedure Not Attempted|0|||
124979687|NCT03820947|449551644|FG000|Overall Study|Other Exit|1|||
124979688|NCT03820947|449551645|FG001|Overall Study|Other Exit|3|||
124979689|NCT03820947|449551646|FG002|Overall Study|Other Exit|3|||
124979690|NCT03820947|449551647|FG003|Overall Study|Other Exit|3|||
124979691|NCT03820947|449551648|FG004|Overall Study|Other Exit|0|||
124979692|NCT03820947|449551644|FG000|Overall Study|Follow-up Not Done|10|||
124979693|NCT03820947|449551645|FG001|Overall Study|Follow-up Not Done|13|||
124979694|NCT03820947|449551646|FG002|Overall Study|Follow-up Not Done|2|||
124979695|NCT03820947|449551647|FG003|Overall Study|Follow-up Not Done|3|||
124979696|NCT03820947|449551648|FG004|Overall Study|Follow-up Not Done|12|||
124979697|NCT03820947|449551644|FG000|Overall Study|Death|0|||
124979698|NCT03820947|449551645|FG001|Overall Study|Death|0|||
124979699|NCT03820947|449551646|FG002|Overall Study|Death|0|||
124979700|NCT03820947|449551647|FG003|Overall Study|Death|0|||
124979701|NCT03820947|449551648|FG004|Overall Study|Death|9|||
124979702|NCT03820947|449551644|FG000|Overall Study|Lost to Follow-up|4|||
124979703|NCT03820947|449551645|FG001|Overall Study|Lost to Follow-up|6|||
124979704|NCT03820947|449551646|FG002|Overall Study|Lost to Follow-up|0|||
124979705|NCT03820947|449551647|FG003|Overall Study|Lost to Follow-up|0|||
124979706|NCT03820947|449551648|FG004|Overall Study|Lost to Follow-up|9|||
124979707|NCT03578887|449551649|FG000|Overall Study|Withdrawal by Subject|7|||
124979708|NCT03578887|449551650|FG001|Overall Study|Withdrawal by Subject|2|||
124979709|NCT03578887|449551651|FG002|Overall Study|Withdrawal by Subject|1|||
124979710|NCT03578887|449551649|FG000|Overall Study|Lost to Follow-up|13|||
124979711|NCT03578887|449551650|FG001|Overall Study|Lost to Follow-up|1|||
124979712|NCT03578887|449551651|FG002|Overall Study|Lost to Follow-up|4|||
124979713|NCT03578887|449551649|FG000|Overall Study|Physician Decision|0|||
124979714|NCT03578887|449551650|FG001|Overall Study|Physician Decision|1|||
124979715|NCT03578887|449551651|FG002|Overall Study|Physician Decision|1|||
124979716|NCT00387426|449553429|FG000|Overall Study|Lack of Response|7|||
124979717|NCT00387426|449553429|FG000|Overall Study|Toxicities|4|||
124979718|NCT00387426|449553429|FG000|Overall Study|Disease Progression|3|||
124979719|NCT02218606|449553430|FG000|Overall Study|Adverse Event|1|||
124979720|NCT02218606|449553431|FG001|Overall Study|Adverse Event|1|||
124979721|NCT02218606|449553430|FG000|Overall Study|Death|15|||
124979722|NCT02218606|449553431|FG001|Overall Study|Death|28|||
124979723|NCT02218606|449553430|FG000|Overall Study|Physician Decision|0|||
124979724|NCT02218606|449553431|FG001|Overall Study|Physician Decision|1|||
124979725|NCT02218606|449553430|FG000|Overall Study|Withdrawal by Subject|4|||
124979726|NCT02218606|449553431|FG001|Overall Study|Withdrawal by Subject|0|||
124979727|NCT02218606|449553430|FG000|Overall Study|Noncompliance|1|||
124979728|NCT02218606|449553431|FG001|Overall Study|Noncompliance|0|||
124979729|NCT02218606|449553430|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
124979730|NCT02218606|449553431|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
124979731|NCT02218606|449553430|FG000|Overall Study|Other|2|||
124979732|NCT02218606|449553431|FG001|Overall Study|Other|1|||
124979733|NCT02218606|449553430|FG000|Overall Study|Never started treatment|0|||
124979734|NCT02218606|449553431|FG001|Overall Study|Never started treatment|1|||
124979735|NCT00890695|449553432|FG000|Overall Study|Protocol Violation|1|||
124979736|NCT00890695|449553433|FG001|Overall Study|Protocol Violation|0|||
124979737|NCT01531673|449553434|FG000|Overall Study|Non-Compliance|0|||
124979738|NCT01531673|449553435|FG001|Overall Study|Non-Compliance|0|||
124979739|NCT01531673|449553436|FG002|Overall Study|Non-Compliance|0|||
124979740|NCT01531673|449553437|FG003|Overall Study|Non-Compliance|0|||
124979741|NCT01531673|449553438|FG004|Overall Study|Non-Compliance|0|||
124979742|NCT01531673|449553439|FG005|Overall Study|Non-Compliance|1|||
124979743|NCT01531673|449553440|FG006|Overall Study|Non-Compliance|0|||
124979744|NCT01531673|449553441|FG007|Overall Study|Non-Compliance|0|||
124979745|NCT01531673|449553442|FG008|Overall Study|Non-Compliance|0|||
124979746|NCT01531673|449553443|FG009|Overall Study|Non-Compliance|0|||
124979747|NCT01531673|449553444|FG010|Overall Study|Non-Compliance|0|||
124979748|NCT01531673|449553445|FG011|Overall Study|Non-Compliance|0|||
124979749|NCT01531673|449553446|FG012|Overall Study|Non-Compliance|0|||
124979750|NCT01531673|449553434|FG000|Overall Study|Adverse Event|0|||
124979751|NCT01531673|449553435|FG001|Overall Study|Adverse Event|1|||
124979752|NCT01531673|449553436|FG002|Overall Study|Adverse Event|0|||
124979753|NCT01531673|449553437|FG003|Overall Study|Adverse Event|0|||
124979754|NCT01531673|449553438|FG004|Overall Study|Adverse Event|0|||
124979755|NCT01531673|449553439|FG005|Overall Study|Adverse Event|0|||
124979756|NCT01531673|449553440|FG006|Overall Study|Adverse Event|0|||
124979757|NCT01531673|449553441|FG007|Overall Study|Adverse Event|0|||
124979758|NCT01531673|449553442|FG008|Overall Study|Adverse Event|0|||
124979759|NCT01531673|449553443|FG009|Overall Study|Adverse Event|0|||
124979760|NCT01531673|449553444|FG010|Overall Study|Adverse Event|0|||
124979761|NCT01531673|449553445|FG011|Overall Study|Adverse Event|0|||
124979762|NCT01531673|449553446|FG012|Overall Study|Adverse Event|0|||
124979763|NCT01531673|449553434|FG000|Overall Study|Lost to Follow-up|0|||
124979764|NCT01531673|449553435|FG001|Overall Study|Lost to Follow-up|0|||
124979765|NCT01531673|449553436|FG002|Overall Study|Lost to Follow-up|0|||
124979766|NCT01531673|449553437|FG003|Overall Study|Lost to Follow-up|0|||
124979767|NCT01531673|449553438|FG004|Overall Study|Lost to Follow-up|1|||
124979768|NCT01531673|449553439|FG005|Overall Study|Lost to Follow-up|0|||
124979769|NCT01531673|449553440|FG006|Overall Study|Lost to Follow-up|0|||
124979770|NCT01531673|449553441|FG007|Overall Study|Lost to Follow-up|0|||
124979771|NCT01531673|449553442|FG008|Overall Study|Lost to Follow-up|0|||
124979772|NCT01531673|449553443|FG009|Overall Study|Lost to Follow-up|0|||
124979773|NCT01531673|449553444|FG010|Overall Study|Lost to Follow-up|0|||
124979774|NCT01531673|449553445|FG011|Overall Study|Lost to Follow-up|0|||
124979775|NCT01531673|449553446|FG012|Overall Study|Lost to Follow-up|0|||
124979776|NCT01531673|449553434|FG000|Overall Study|Other|0|||
124979777|NCT01531673|449553435|FG001|Overall Study|Other|0|||
124979778|NCT01531673|449553436|FG002|Overall Study|Other|0|||
124979779|NCT01531673|449553437|FG003|Overall Study|Other|1|||
124979780|NCT01531673|449553438|FG004|Overall Study|Other|0|||
124979781|NCT01531673|449553439|FG005|Overall Study|Other|0|||
124979782|NCT01531673|449553440|FG006|Overall Study|Other|0|||
124979783|NCT01531673|449553441|FG007|Overall Study|Other|0|||
124979784|NCT01531673|449553442|FG008|Overall Study|Other|0|||
124979785|NCT01531673|449553443|FG009|Overall Study|Other|1|||
124979786|NCT01531673|449553444|FG010|Overall Study|Other|0|||
124979787|NCT01531673|449553445|FG011|Overall Study|Other|0|||
124979788|NCT01531673|449553446|FG012|Overall Study|Other|0|||
124979789|NCT02187159|449553447|FG000|Overall Study|Protocol Violation|4|||
124979790|NCT02187159|449553448|FG001|Overall Study|Protocol Violation|6|||
124979791|NCT02187159|449553449|FG002|Overall Study|Protocol Violation|3|||
124979792|NCT02187159|449553450|FG003|Overall Study|Protocol Violation|4|||
124979793|NCT02187159|449553447|FG000|Overall Study|Lack of Efficacy|10|||
124979794|NCT02187159|449553448|FG001|Overall Study|Lack of Efficacy|5|||
124979795|NCT02187159|449553449|FG002|Overall Study|Lack of Efficacy|4|||
124979796|NCT02187159|449553450|FG003|Overall Study|Lack of Efficacy|7|||
124979797|NCT02187159|449553447|FG000|Overall Study|Adverse Event|28|||
124979798|NCT02187159|449553448|FG001|Overall Study|Adverse Event|33|||
124979799|NCT02187159|449553449|FG002|Overall Study|Adverse Event|42|||
124979800|NCT02187159|449553450|FG003|Overall Study|Adverse Event|50|||
124979801|NCT02187159|449553447|FG000|Overall Study|Withdrawal by Subject|24|||
124979802|NCT02187159|449553448|FG001|Overall Study|Withdrawal by Subject|28|||
124979803|NCT02187159|449553449|FG002|Overall Study|Withdrawal by Subject|25|||
124979804|NCT02187159|449553450|FG003|Overall Study|Withdrawal by Subject|26|||
124979805|NCT02187159|449553447|FG000|Overall Study|Other|3|||
124979806|NCT02187159|449553448|FG001|Overall Study|Other|7|||
124979807|NCT02187159|449553449|FG002|Overall Study|Other|3|||
124979808|NCT02187159|449553450|FG003|Overall Study|Other|9|||
124979809|NCT00567567|449553451|FG000|Overall Study|Adverse Event|0|||
124979810|NCT00567567|449553452|FG001|Overall Study|Adverse Event|2|||
124979811|NCT00567567|449553453|FG002|Overall Study|Adverse Event|5|||
124979812|NCT00567567|449553451|FG000|Overall Study|Death|8|||
124979813|NCT00567567|449553452|FG001|Overall Study|Death|1|||
124979814|NCT00567567|449553453|FG002|Overall Study|Death|5|||
124979815|NCT00567567|449553451|FG000|Overall Study|Lack of Efficacy|16|||
124979816|NCT00567567|449553452|FG001|Overall Study|Lack of Efficacy|17|||
124979817|NCT00567567|449553453|FG002|Overall Study|Lack of Efficacy|48|||
124979818|NCT00567567|449553451|FG000|Overall Study|Lost to Follow-up|0|||
124979819|NCT00567567|449553452|FG001|Overall Study|Lost to Follow-up|0|||
124979820|NCT00567567|449553453|FG002|Overall Study|Lost to Follow-up|1|||
124979821|NCT00567567|449553451|FG000|Overall Study|Physician Decision|16|||
124979822|NCT00567567|449553452|FG001|Overall Study|Physician Decision|18|||
124979823|NCT00567567|449553453|FG002|Overall Study|Physician Decision|84|||
124979824|NCT00567567|449553451|FG000|Overall Study|Withdrawal by Subject|0|||
124979825|NCT00567567|449553452|FG001|Overall Study|Withdrawal by Subject|0|||
124979826|NCT00567567|449553453|FG002|Overall Study|Withdrawal by Subject|2|||
124979827|NCT00567567|449553451|FG000|Overall Study|Ineligible|4|||
124979828|NCT00567567|449553452|FG001|Overall Study|Ineligible|0|||
124979829|NCT00567567|449553453|FG002|Overall Study|Ineligible|9|||
124979830|NCT00567567|449553451|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
124979831|NCT00567567|449553452|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
124979832|NCT00567567|449553453|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
124979833|NCT00567567|449553451|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
124979834|NCT00567567|449553452|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
124979835|NCT00567567|449553453|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
124979836|NCT00567567|449553451|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
124979837|NCT00567567|449553452|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
124979838|NCT00567567|449553453|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
124979839|NCT03889704|449553454|FG000|Overall Study|Study terminated due to pandemic|1|||
124979840|NCT03482466|449553455|FG000|Overall Study|Protocol Violation|2|||
124979841|NCT02060370|449553456|FG000|Overall Study|Physician Decision|1|||
124979842|NCT01493427|449553457|FG000|Overall Study|Adverse Event|10|||
124979843|NCT01493427|449553457|FG000|Overall Study|Personal Reasons|4|||
124979844|NCT01493427|449553457|FG000|Overall Study|Lost to Follow-up|2|||
124979845|NCT01493427|449553457|FG000|Overall Study|Inability to Follow Instructions|2|||
124979846|NCT01493427|449553457|FG000|Overall Study|Other|2|||
124979847|NCT01461811|449553458|FG000|Overall Study|Adverse Event|2|||
124979848|NCT01461811|449553459|FG001|Overall Study|Adverse Event|1|||
124979849|NCT01461811|449553458|FG000|Overall Study|Subject decision unrelated to an AE|1|||
124979850|NCT01461811|449553459|FG001|Overall Study|Subject decision unrelated to an AE|1|||
124979851|NCT01461811|449553458|FG000|Overall Study|Noncompliance|1|||
124979852|NCT01461811|449553459|FG001|Overall Study|Noncompliance|1|||
124979853|NCT02781090|449553460|FG000|3-Month Follow-Up|Missed Visit|20|||
124979854|NCT02781090|449553461|FG001|3-Month Follow-Up|Missed Visit|20|||
124979855|NCT02781090|449553460|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
124979856|NCT02781090|449553461|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
124979857|NCT02781090|449553460|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
124979858|NCT02781090|449553461|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
124979859|NCT02781090|449553460|FG000|3-Month Follow-Up|Death|1|||
124979860|NCT02781090|449553461|FG001|3-Month Follow-Up|Death|0|||
124979861|NCT02781090|449553460|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
124979862|NCT02781090|449553461|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
124979863|NCT02781090|449553460|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
124979864|NCT02781090|449553461|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
124979865|NCT02781090|449553460|FG000|6-Month Follow-Up|Death|0|||
124979866|NCT02781090|449553461|FG001|6-Month Follow-Up|Death|1|||
124979867|NCT01401153|449553463|FG000|First Test Day|Learning disabilities; illness|1|||
124979868|NCT01401153|449553464|FG001|First Test Day|Learning disabilities; illness|10|||
124979869|NCT01401153|449553463|FG000|Second Test Day|illness|0|||
124979870|NCT01401153|449553464|FG001|Second Test Day|illness|5|||
124979871|NCT00757627|449553465|FG000|Overall Study|Adverse Event|15|||
124979872|NCT00757627|449553465|FG000|Overall Study|Lack of Efficacy|10|||
124979873|NCT00757627|449553465|FG000|Overall Study|Lost to Follow-up|28|||
124979874|NCT00757627|449553465|FG000|Overall Study|Withdrawal by Subject|27|||
124979875|NCT00757627|449553465|FG000|Overall Study|Other|1|||
124979876|NCT00403767|449553466|FG000|Overall Study|Adverse Event|993|||
124979877|NCT00403767|449553467|FG001|Overall Study|Adverse Event|919|||
124979878|NCT00403767|449553466|FG000|Overall Study|Non-compliant with study medication|134|||
124979879|NCT00403767|449553467|FG001|Overall Study|Non-compliant with study medication|164|||
124979880|NCT00403767|449553466|FG000|Overall Study|Consent withdrawn|671|||
124979881|NCT00403767|449553467|FG001|Overall Study|Consent withdrawn|673|||
124979882|NCT00403767|449553466|FG000|Overall Study|Investigator dec./not protocol-related|191|||
124979883|NCT00403767|449553467|FG001|Overall Study|Investigator dec./not protocol-related|178|||
124979884|NCT00403767|449553466|FG000|Overall Study|Lost to Follow-up|6|||
124979885|NCT00403767|449553467|FG001|Overall Study|Lost to Follow-up|8|||
124979886|NCT00403767|449553466|FG000|Overall Study|Protocol Violation|142|||
124979887|NCT00403767|449553467|FG001|Overall Study|Protocol Violation|124|||
124979888|NCT00403767|449553466|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
124979889|NCT00403767|449553467|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
124979890|NCT00403767|449553466|FG000|Overall Study|Study terminated by sponsor|82|||
124979891|NCT00403767|449553467|FG001|Overall Study|Study terminated by sponsor|69|||
124979892|NCT00403767|449553466|FG000|Overall Study|Missing/incomplete data|1|||
124979893|NCT00403767|449553467|FG001|Overall Study|Missing/incomplete data|1|||
124979894|NCT05330676|449553468|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
124979895|NCT05330676|449553469|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
124979896|NCT00436605|449553470|FG000|Overall Study|Protocol Violation|3|||
124979897|NCT01559129|449553474|FG000|Treatment Phase|Adverse Event|0|||
124979898|NCT01559129|449553475|FG001|Treatment Phase|Adverse Event|2|||
124979899|NCT01559129|449553474|FG000|Treatment Phase|Progressive Disease|1|||
124979900|NCT01559129|449553475|FG001|Treatment Phase|Progressive Disease|1|||
124979901|NCT01559129|449553474|FG000|Treatment Phase|Lack of Efficacy|0|||
124979902|NCT01559129|449553475|FG001|Treatment Phase|Lack of Efficacy|1|||
124979903|NCT01559129|449553474|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
124979904|NCT01559129|449553475|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
124979905|NCT01559129|449553474|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
124979906|NCT01559129|449553475|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
124979907|NCT01559129|449553474|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
124979908|NCT01559129|449553475|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
124979909|NCT01559129|449553474|FG000|Open-label Extension Period|Adverse Event|1|||
124979910|NCT01559129|449553475|FG001|Open-label Extension Period|Adverse Event|0|||
124979911|NCT01559129|449553474|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
124979912|NCT01559129|449553475|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
124979913|NCT00368927|449553476|FG000|Overall Study|Lost to Follow-up|2|||
124979914|NCT00368927|449553477|FG001|Overall Study|Lost to Follow-up|0|||
124979915|NCT00368927|449553476|FG000|Overall Study|Adverse Event|1|||
124979916|NCT00368927|449553477|FG001|Overall Study|Adverse Event|1|||
124979917|NCT00368927|449553476|FG000|Overall Study|Withdrawal by Subject|1|||
124979918|NCT00368927|449553477|FG001|Overall Study|Withdrawal by Subject|2|||
124979919|NCT00368927|449553476|FG000|Overall Study|Physician Decision|1|||
124979920|NCT00368927|449553477|FG001|Overall Study|Physician Decision|0|||
124979921|NCT03525392|449553478|FG000|Overall Study|Adverse Event|1|||
124979922|NCT03525392|449553479|FG001|Overall Study|Adverse Event|0|||
124979923|NCT03525392|449553480|FG002|Overall Study|Adverse Event|2|||
124979924|NCT03525392|449553481|FG003|Overall Study|Adverse Event|0|||
124979925|NCT03525392|449553482|FG004|Overall Study|Adverse Event|0|||
124979926|NCT03525392|449553478|FG000|Overall Study|Progressive disease|0|||
124979927|NCT03525392|449553479|FG001|Overall Study|Progressive disease|1|||
124979928|NCT03525392|449553480|FG002|Overall Study|Progressive disease|1|||
124979929|NCT03525392|449553481|FG003|Overall Study|Progressive disease|3|||
124979930|NCT03525392|449553482|FG004|Overall Study|Progressive disease|1|||
124979931|NCT03284203|449553485|FG000|Overall Study|Lost to Follow-up|3|||
124979932|NCT02229851|449553486|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
124979933|NCT02229851|449553487|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
124979934|NCT02229851|449553488|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
124979935|NCT02229851|449553489|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
124979936|NCT02229851|449553490|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
124979937|NCT02229851|449553491|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
124979938|NCT02229851|449553492|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
124979939|NCT02229851|449553486|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
124979940|NCT02229851|449553487|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
124979941|NCT02229851|449553488|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
124979942|NCT02229851|449553489|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
124979943|NCT02229851|449553490|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
124979944|NCT02229851|449553491|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
124979945|NCT02229851|449553492|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
124979946|NCT02229851|449553486|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
124979947|NCT02229851|449553487|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
124979948|NCT02229851|449553488|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
124979949|NCT02229851|449553489|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
124979950|NCT02229851|449553490|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
124979951|NCT02229851|449553491|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
124979952|NCT02229851|449553492|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
124979953|NCT02229851|449553486|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
124979954|NCT02229851|449553487|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
124979955|NCT02229851|449553488|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
124979956|NCT02229851|449553489|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
124979957|NCT02229851|449553490|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
124979958|NCT02229851|449553491|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
124979959|NCT02229851|449553492|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
124979960|NCT02229851|449553486|FG000|Main Phase (Double-blind Phase)|Death|1|||
124979961|NCT02229851|449553487|FG001|Main Phase (Double-blind Phase)|Death|1|||
124979962|NCT02229851|449553488|FG002|Main Phase (Double-blind Phase)|Death|0|||
124979963|NCT02229851|449553489|FG003|Main Phase (Double-blind Phase)|Death|0|||
124979964|NCT02229851|449553490|FG004|Main Phase (Double-blind Phase)|Death|0|||
124979965|NCT02229851|449553491|FG005|Main Phase (Double-blind Phase)|Death|0|||
124979966|NCT02229851|449553492|FG006|Main Phase (Double-blind Phase)|Death|0|||
124979967|NCT02229851|449553486|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
124979968|NCT02229851|449553487|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
124979969|NCT02229851|449553488|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
124979970|NCT02229851|449553489|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
124979971|NCT02229851|449553490|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
124979972|NCT02229851|449553491|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
124979973|NCT02229851|449553492|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
124979974|NCT02229851|449553486|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
124979975|NCT02229851|449553487|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
124979976|NCT02229851|449553488|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
124979977|NCT02229851|449553489|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
124979978|NCT02229851|449553490|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
124979979|NCT02229851|449553491|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
124979980|NCT02229851|449553492|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
124979981|NCT02229851|449553486|FG000|Extension Phase (Open-label Phase)|Death|0|||
124979982|NCT02229851|449553487|FG001|Extension Phase (Open-label Phase)|Death|0|||
124979983|NCT02229851|449553488|FG002|Extension Phase (Open-label Phase)|Death|0|||
124979984|NCT02229851|449553489|FG003|Extension Phase (Open-label Phase)|Death|1|||
124979985|NCT02229851|449553490|FG004|Extension Phase (Open-label Phase)|Death|0|||
124538614|NCT04516291|447925001|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124538615|NCT04516291|447925002|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
124979986|NCT02229851|449553491|FG005|Extension Phase (Open-label Phase)|Death|1|||
124979987|NCT02229851|449553492|FG006|Extension Phase (Open-label Phase)|Death|1|||
124979988|NCT01111240|449553493|FG000|Overall Study|Adverse Event|190|||
124979989|NCT01111240|449553493|FG000|Overall Study|Lack of Efficacy|545|||
124979990|NCT01111240|449553493|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
124979991|NCT01111240|449553493|FG000|Overall Study|Other|312|||
124979992|NCT02206061|449553494|FG000|Overall Study|Withdrawal by Subject|4|||
124979993|NCT02206061|449553495|FG001|Overall Study|Withdrawal by Subject|7|||
124979994|NCT02206061|449553496|FG002|Overall Study|Withdrawal by Subject|1|||
124979995|NCT02206061|449553494|FG000|Overall Study|Lost to Follow-up|14|||
124979996|NCT02206061|449553495|FG001|Overall Study|Lost to Follow-up|7|||
124979997|NCT02206061|449553496|FG002|Overall Study|Lost to Follow-up|20|||
124979998|NCT04187326|449553497|FG000|Overall Study|Lost to Follow-up|2|||
124979999|NCT04187326|449553498|FG001|Overall Study|Lost to Follow-up|1|||
124980000|NCT04187326|449553497|FG000|Overall Study|Computer error- task was only partially completed.|0|||
124980001|NCT04187326|449553498|FG001|Overall Study|Computer error- task was only partially completed.|1|||
124980002|NCT01607476|449553499|FG000|Overall Study|Withdrawal by Subject|1|||
124980003|NCT01607476|449553500|FG001|Overall Study|Withdrawal by Subject|0|||
124980004|NCT01607476|449553501|FG002|Overall Study|Withdrawal by Subject|1|||
124980005|NCT01607476|449553499|FG000|Overall Study|Lost to Follow-up|0|||
124980006|NCT01607476|449553500|FG001|Overall Study|Lost to Follow-up|0|||
124980007|NCT01607476|449553501|FG002|Overall Study|Lost to Follow-up|2|||
124980008|NCT04958200|449553508|FG000|Overall Study|Withdrawal by Subject|0|||
124980009|NCT04958200|449553509|FG001|Overall Study|Withdrawal by Subject|2|||
124980010|NCT04958200|449553508|FG000|Overall Study|Lost to Follow-up|3|||
124980011|NCT04958200|449553509|FG001|Overall Study|Lost to Follow-up|2|||
124980012|NCT04531098|449553515|FG000|Stage I|Adverse Event|0|||
124980013|NCT04531098|449553516|FG001|Stage I|Adverse Event|0|||
124980014|NCT04531098|449553517|FG002|Stage I|Adverse Event|3|||
124980015|NCT04531098|449553515|FG000|Stage I|Protocol Violation|0|||
124980016|NCT04531098|449553516|FG001|Stage I|Protocol Violation|0|||
124980017|NCT04531098|449553517|FG002|Stage I|Protocol Violation|5|||
124980018|NCT04531098|449553515|FG000|Stage I|Withdrawal by Subject|0|||
124980019|NCT04531098|449553516|FG001|Stage I|Withdrawal by Subject|5|||
124980020|NCT04531098|449553517|FG002|Stage I|Withdrawal by Subject|10|||
124980021|NCT04531098|449553515|FG000|Stage II|Adverse Event|1|||
124980022|NCT04531098|449553516|FG001|Stage II|Adverse Event|2|||
124980023|NCT04531098|449553517|FG002|Stage II|Adverse Event|0|||
124980024|NCT04531098|449553515|FG000|Stage II|Protocol Violation|1|||
124980025|NCT04531098|449553516|FG001|Stage II|Protocol Violation|2|||
124980026|NCT04531098|449553517|FG002|Stage II|Protocol Violation|0|||
124980027|NCT04531098|449553515|FG000|Stage II|Withdrawal by Subject|3|||
124980028|NCT04531098|449553516|FG001|Stage II|Withdrawal by Subject|1|||
124980029|NCT04531098|449553517|FG002|Stage II|Withdrawal by Subject|0|||
124980030|NCT04531098|449553515|FG000|Stage II|Moved from study area|8|||
124980031|NCT04531098|449553516|FG001|Stage II|Moved from study area|5|||
124980032|NCT04531098|449553517|FG002|Stage II|Moved from study area|0|||
124980033|NCT02628028|449553518|FG000|Dosing Period|Withdrawal by Subject|0|||
124980034|NCT02628028|449553519|FG001|Dosing Period|Withdrawal by Subject|0|||
124980035|NCT02628028|449553520|FG002|Dosing Period|Withdrawal by Subject|1|||
124980036|NCT02628028|449553521|FG003|Dosing Period|Withdrawal by Subject|0|||
124980037|NCT02628028|449553522|FG004|Dosing Period|Withdrawal by Subject|2|||
124980038|NCT02628028|449553523|FG005|Dosing Period|Withdrawal by Subject|4|||
124980039|NCT02628028|449553524|FG006|Dosing Period|Withdrawal by Subject|1|||
124980040|NCT02628028|449553525|FG007|Dosing Period|Withdrawal by Subject|1|||
124980041|NCT02628028|449553518|FG000|Dosing Period|Adverse Event|0|||
124980042|NCT02628028|449553519|FG001|Dosing Period|Adverse Event|0|||
124980043|NCT02628028|449553520|FG002|Dosing Period|Adverse Event|0|||
124980044|NCT02628028|449553521|FG003|Dosing Period|Adverse Event|0|||
124980045|NCT02628028|449553522|FG004|Dosing Period|Adverse Event|2|||
124980046|NCT02628028|449553523|FG005|Dosing Period|Adverse Event|1|||
124980047|NCT02628028|449553524|FG006|Dosing Period|Adverse Event|3|||
124980048|NCT02628028|449553525|FG007|Dosing Period|Adverse Event|2|||
124980049|NCT02628028|449553518|FG000|Dosing Period|Death|0|||
124980050|NCT02628028|449553519|FG001|Dosing Period|Death|0|||
124980051|NCT02628028|449553520|FG002|Dosing Period|Death|0|||
124538616|NCT04516291|447925003|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124538617|NCT04516291|447925004|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124980052|NCT02628028|449553521|FG003|Dosing Period|Death|0|||
124980053|NCT02628028|449553522|FG004|Dosing Period|Death|0|||
124980054|NCT02628028|449553523|FG005|Dosing Period|Death|0|||
124980055|NCT02628028|449553524|FG006|Dosing Period|Death|0|||
124980056|NCT02628028|449553525|FG007|Dosing Period|Death|1|||
124980057|NCT02628028|449553518|FG000|Dosing Period|Lack of Efficacy|0|||
124980058|NCT02628028|449553519|FG001|Dosing Period|Lack of Efficacy|0|||
124980059|NCT02628028|449553520|FG002|Dosing Period|Lack of Efficacy|0|||
124980060|NCT02628028|449553521|FG003|Dosing Period|Lack of Efficacy|0|||
124980061|NCT02628028|449553522|FG004|Dosing Period|Lack of Efficacy|3|||
124980062|NCT02628028|449553523|FG005|Dosing Period|Lack of Efficacy|0|||
124980063|NCT02628028|449553524|FG006|Dosing Period|Lack of Efficacy|1|||
124980064|NCT02628028|449553525|FG007|Dosing Period|Lack of Efficacy|0|||
124980065|NCT02628028|449553518|FG000|Dosing Period|Study Terminated by Sponsor|0|||
124980066|NCT02628028|449553519|FG001|Dosing Period|Study Terminated by Sponsor|0|||
124980067|NCT02628028|449553520|FG002|Dosing Period|Study Terminated by Sponsor|0|||
124980068|NCT02628028|449553521|FG003|Dosing Period|Study Terminated by Sponsor|0|||
124980069|NCT02628028|449553522|FG004|Dosing Period|Study Terminated by Sponsor|7|||
124980070|NCT02628028|449553523|FG005|Dosing Period|Study Terminated by Sponsor|6|||
124980071|NCT02628028|449553524|FG006|Dosing Period|Study Terminated by Sponsor|7|||
124980072|NCT02628028|449553525|FG007|Dosing Period|Study Terminated by Sponsor|7|||
124980073|NCT02628028|449553518|FG000|Dosing Period|Physician Decision|0|||
124980074|NCT02628028|449553519|FG001|Dosing Period|Physician Decision|0|||
124980075|NCT02628028|449553520|FG002|Dosing Period|Physician Decision|0|||
124980076|NCT02628028|449553521|FG003|Dosing Period|Physician Decision|0|||
124980077|NCT02628028|449553522|FG004|Dosing Period|Physician Decision|0|||
124980078|NCT02628028|449553523|FG005|Dosing Period|Physician Decision|1|||
124980079|NCT02628028|449553524|FG006|Dosing Period|Physician Decision|0|||
124980080|NCT02628028|449553525|FG007|Dosing Period|Physician Decision|0|||
124980081|NCT02628028|449553518|FG000|Dosing Period|Site Terminated by Sponsor|0|||
124980082|NCT02628028|449553519|FG001|Dosing Period|Site Terminated by Sponsor|0|||
124980083|NCT02628028|449553520|FG002|Dosing Period|Site Terminated by Sponsor|0|||
124980084|NCT02628028|449553521|FG003|Dosing Period|Site Terminated by Sponsor|0|||
124980085|NCT02628028|449553522|FG004|Dosing Period|Site Terminated by Sponsor|0|||
124980086|NCT02628028|449553523|FG005|Dosing Period|Site Terminated by Sponsor|1|||
124980087|NCT02628028|449553524|FG006|Dosing Period|Site Terminated by Sponsor|1|||
124980088|NCT02628028|449553525|FG007|Dosing Period|Site Terminated by Sponsor|0|||
124980089|NCT02628028|449553518|FG000|Dosing Period|Lost to Follow-up|0|||
124980090|NCT02628028|449553519|FG001|Dosing Period|Lost to Follow-up|0|||
124980091|NCT02628028|449553520|FG002|Dosing Period|Lost to Follow-up|0|||
124980092|NCT02628028|449553521|FG003|Dosing Period|Lost to Follow-up|0|||
124980093|NCT02628028|449553522|FG004|Dosing Period|Lost to Follow-up|0|||
124980094|NCT02628028|449553523|FG005|Dosing Period|Lost to Follow-up|0|||
124980095|NCT02628028|449553524|FG006|Dosing Period|Lost to Follow-up|1|||
124980096|NCT02628028|449553525|FG007|Dosing Period|Lost to Follow-up|0|||
124980097|NCT02628028|449553518|FG000|Dosing Period|Other|0|||
124980098|NCT02628028|449553519|FG001|Dosing Period|Other|0|||
124980099|NCT02628028|449553520|FG002|Dosing Period|Other|0|||
124980100|NCT02628028|449553521|FG003|Dosing Period|Other|0|||
124980101|NCT02628028|449553522|FG004|Dosing Period|Other|2|||
124980102|NCT02628028|449553523|FG005|Dosing Period|Other|1|||
124980103|NCT02628028|449553524|FG006|Dosing Period|Other|2|||
124980104|NCT02628028|449553525|FG007|Dosing Period|Other|4|||
124980105|NCT02628028|449553518|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
124980106|NCT02628028|449553519|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
124980107|NCT02628028|449553520|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
124980108|NCT02628028|449553521|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
124980109|NCT02628028|449553522|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
124980110|NCT02628028|449553523|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
124980111|NCT02628028|449553524|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
124980112|NCT02628028|449553525|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
124980113|NCT02628028|449553518|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
124980114|NCT02628028|449553519|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
124980115|NCT02628028|449553520|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
124980116|NCT02628028|449553521|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
124980117|NCT02628028|449553522|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
124980118|NCT02628028|449553523|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
124980119|NCT02628028|449553524|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
124980120|NCT02628028|449553525|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
124980121|NCT02628028|449553518|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
124980122|NCT02628028|449553519|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
124980123|NCT02628028|449553520|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
124980124|NCT02628028|449553521|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
124980125|NCT02628028|449553522|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
124980126|NCT02628028|449553523|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
124980127|NCT02628028|449553524|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
124980128|NCT02628028|449553525|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
124980129|NCT02628028|449553518|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
124980130|NCT02628028|449553519|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
124980131|NCT02628028|449553520|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
124980132|NCT02628028|449553521|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
124980133|NCT02628028|449553522|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
124980134|NCT02628028|449553523|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
124980135|NCT02628028|449553524|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
124980136|NCT02628028|449553525|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
124538618|NCT04516291|447925005|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124980137|NCT02628028|449553518|FG000|Long-term Extension (LTE) Period|Other|0|||
124980138|NCT02628028|449553519|FG001|Long-term Extension (LTE) Period|Other|0|||
124980139|NCT02628028|449553520|FG002|Long-term Extension (LTE) Period|Other|0|||
124980140|NCT02628028|449553521|FG003|Long-term Extension (LTE) Period|Other|0|||
124980141|NCT02628028|449553522|FG004|Long-term Extension (LTE) Period|Other|0|||
124980142|NCT02628028|449553523|FG005|Long-term Extension (LTE) Period|Other|3|||
124980143|NCT02628028|449553524|FG006|Long-term Extension (LTE) Period|Other|4|||
124980144|NCT02628028|449553525|FG007|Long-term Extension (LTE) Period|Other|3|||
124980145|NCT04157400|449553526|FG000|Overall Study|Withdrawal by Subject|1|||
124980146|NCT04157400|449553526|FG000|Overall Study|Lost to Follow-up|3|||
124980147|NCT00186888|449553528|FG000|Overall Study|Toxicity|0|||
124980148|NCT00186888|449553529|FG001|Overall Study|Toxicity|1|||
124980149|NCT00186888|449553530|FG002|Overall Study|Toxicity|0|||
124980150|NCT00186888|449553528|FG000|Overall Study|Relapse or progression of disease|4|||
124980151|NCT00186888|449553529|FG001|Overall Study|Relapse or progression of disease|2|||
124980152|NCT00186888|449553530|FG002|Overall Study|Relapse or progression of disease|0|||
124980153|NCT02108964|449553531|FG000|Overall Study|Progressive disease|15|||
124980154|NCT02108964|449553532|FG001|Overall Study|Progressive disease|31|||
124980155|NCT02108964|449553533|FG002|Overall Study|Progressive disease|54|||
124980156|NCT02108964|449553534|FG003|Overall Study|Progressive disease|7|||
124980157|NCT02108964|449553535|FG004|Overall Study|Progressive disease|20|||
124980158|NCT02108964|449553536|FG005|Overall Study|Progressive disease|4|||
124980159|NCT02108964|449553537|FG006|Overall Study|Progressive disease|6|||
124980160|NCT02108964|449553538|FG007|Overall Study|Progressive disease|33|||
124980161|NCT02108964|449553531|FG000|Overall Study|Physician Decision|1|||
124980162|NCT02108964|449553532|FG001|Overall Study|Physician Decision|5|||
124980163|NCT02108964|449553533|FG002|Overall Study|Physician Decision|7|||
124980164|NCT02108964|449553534|FG003|Overall Study|Physician Decision|1|||
124980165|NCT02108964|449553535|FG004|Overall Study|Physician Decision|2|||
124980166|NCT02108964|449553536|FG005|Overall Study|Physician Decision|1|||
124980167|NCT02108964|449553537|FG006|Overall Study|Physician Decision|1|||
124980168|NCT02108964|449553538|FG007|Overall Study|Physician Decision|3|||
124980169|NCT02108964|449553531|FG000|Overall Study|Adverse Event|0|||
124980170|NCT02108964|449553532|FG001|Overall Study|Adverse Event|0|||
124980171|NCT02108964|449553533|FG002|Overall Study|Adverse Event|4|||
124980172|NCT02108964|449553534|FG003|Overall Study|Adverse Event|0|||
124980173|NCT02108964|449553535|FG004|Overall Study|Adverse Event|1|||
124980174|NCT02108964|449553536|FG005|Overall Study|Adverse Event|0|||
124980175|NCT02108964|449553537|FG006|Overall Study|Adverse Event|3|||
124980176|NCT02108964|449553538|FG007|Overall Study|Adverse Event|2|||
124980177|NCT02108964|449553531|FG000|Overall Study|Death|1|||
124980178|NCT02108964|449553532|FG001|Overall Study|Death|1|||
124980179|NCT02108964|449553533|FG002|Overall Study|Death|4|||
124980180|NCT02108964|449553534|FG003|Overall Study|Death|0|||
124980181|NCT02108964|449553535|FG004|Overall Study|Death|3|||
124980182|NCT02108964|449553536|FG005|Overall Study|Death|0|||
124980183|NCT02108964|449553537|FG006|Overall Study|Death|0|||
124980184|NCT02108964|449553538|FG007|Overall Study|Death|2|||
124980185|NCT02108964|449553531|FG000|Overall Study|Subject/Guardian decision|0|||
124980186|NCT02108964|449553532|FG001|Overall Study|Subject/Guardian decision|1|||
124980187|NCT02108964|449553533|FG002|Overall Study|Subject/Guardian decision|4|||
124980188|NCT02108964|449553534|FG003|Overall Study|Subject/Guardian decision|0|||
124980189|NCT02108964|449553535|FG004|Overall Study|Subject/Guardian decision|2|||
124980190|NCT02108964|449553536|FG005|Overall Study|Subject/Guardian decision|0|||
124980191|NCT02108964|449553537|FG006|Overall Study|Subject/Guardian decision|1|||
124980192|NCT02108964|449553538|FG007|Overall Study|Subject/Guardian decision|2|||
124980193|NCT02108964|449553531|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
124980194|NCT02108964|449553532|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
124980195|NCT02108964|449553533|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
124980196|NCT02108964|449553534|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
124980197|NCT02108964|449553535|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
124980198|NCT02108964|449553536|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
124980199|NCT02108964|449553537|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
124980200|NCT02108964|449553538|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
124980201|NCT02344290|449553545|FG000|Overall Study|Withdrawal by Subject|315|||
124980202|NCT02344290|449553546|FG001|Overall Study|Withdrawal by Subject|324|||
124980203|NCT02344290|449553545|FG000|Overall Study|Lost to Follow-up|258|||
124980204|NCT02344290|449553546|FG001|Overall Study|Lost to Follow-up|249|||
124980205|NCT02344290|449553545|FG000|Overall Study|Unable to get to clinic|69|||
124980206|NCT02344290|449553546|FG001|Overall Study|Unable to get to clinic|60|||
124980207|NCT02344290|449553545|FG000|Overall Study|Physician Decision|25|||
124980208|NCT02344290|449553546|FG001|Overall Study|Physician Decision|25|||
124980209|NCT02344290|449553545|FG000|Overall Study|Site Closure|15|||
124980210|NCT02344290|449553546|FG001|Overall Study|Site Closure|19|||
124980211|NCT02344290|449553545|FG000|Overall Study|Other|5|||
124980212|NCT02344290|449553546|FG001|Overall Study|Other|3|||
124980213|NCT04998812|449553547|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
124980214|NCT04998812|449553548|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
124980215|NCT04998812|449553547|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
124980216|NCT04998812|449553548|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
124980217|NCT04998812|449553547|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
124980218|NCT04998812|449553548|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
124980219|NCT04998812|449553547|FG000|Vaccination Period|Ongoing in study|23|||
124980220|NCT04998812|449553548|FG001|Vaccination Period|Ongoing in study|23|||
124980221|NCT03826030|449553549|FG000|Overall Study|Withdrawal by Subject|2|||
124980222|NCT03826030|449553550|FG001|Overall Study|Withdrawal by Subject|0|||
124980223|NCT03826030|449553551|FG002|Overall Study|Withdrawal by Subject|1|||
124980224|NCT03826030|449553549|FG000|Overall Study|Lost to Follow-up|1|||
124980225|NCT03826030|449553550|FG001|Overall Study|Lost to Follow-up|1|||
124980226|NCT03826030|449553551|FG002|Overall Study|Lost to Follow-up|1|||
124980227|NCT03826030|449553549|FG000|Overall Study|Too busy to return for visits|1|||
124980228|NCT03826030|449553550|FG001|Overall Study|Too busy to return for visits|0|||
124980229|NCT03826030|449553551|FG002|Overall Study|Too busy to return for visits|0|||
124980230|NCT04893460|449553556|FG000|Overall Study|Lost to Follow-up|18|||
124980231|NCT05718466|449555064|FG000|Overall Study|Withdrawal by Subject|1|||
124980232|NCT05718466|449555065|FG001|Overall Study|Withdrawal by Subject|2|||
124980233|NCT05718466|449555064|FG000|Overall Study|Death|0|||
124980234|NCT05718466|449555065|FG001|Overall Study|Death|1|||
124980235|NCT03203473|449555066|FG000|Induction Phase|Never started primary treatment|2|||
124980236|NCT03203473|449555067|FG001|Induction Phase|Never started primary treatment|0|||
124980237|NCT03203473|449555068|FG002|Induction Phase|Never started primary treatment|0|||
124980238|NCT03203473|449555066|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
124980239|NCT03203473|449555067|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
124538619|NCT04516291|447924998|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
124538620|NCT04516291|447924999|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
124538621|NCT04516291|447925000|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
124538622|NCT04516291|447925001|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
124538623|NCT04516291|447925002|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
124538624|NCT04516291|447925003|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
124538625|NCT04516291|447925004|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
124538626|NCT04516291|447925005|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
124538627|NCT04516291|447924998|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124538628|NCT04516291|447924999|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
124538629|NCT04516291|447925000|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124538630|NCT04516291|447925001|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124538631|NCT04516291|447925002|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124538632|NCT04516291|447925003|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124871892|NCT01203930|449152712|FG001|Overall Study|Withdrew Consent|10|||
124871893|NCT01203930|449152711|FG000|Overall Study|Investigator Request|0|||
124871894|NCT01203930|449152712|FG001|Overall Study|Investigator Request|8|||
124871895|NCT01203930|449152711|FG000|Overall Study|Study Terminated by Sponsor|0|||
124871896|NCT01203930|449152712|FG001|Overall Study|Study Terminated by Sponsor|12|||
124871897|NCT01203930|449152711|FG000|Overall Study|Poor tolerance of study drug|0|||
124871898|NCT01203930|449152712|FG001|Overall Study|Poor tolerance of study drug|1|||
124871899|NCT01203930|449152711|FG000|Overall Study|Adverse Event|17|||
124871900|NCT01203930|449152712|FG001|Overall Study|Adverse Event|5|||
124871901|NCT03966053|449152713|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
124871902|NCT04098406|449152716|FG000|Overall Study|Adverse Event|2|||
124871903|NCT04098406|449152717|FG001|Overall Study|Adverse Event|1|||
124871904|NCT04098406|449152716|FG000|Overall Study|Withdrawal by Subject|1|||
124871905|NCT04098406|449152717|FG001|Overall Study|Withdrawal by Subject|0|||
124871906|NCT01783418|449152721|FG000|Overall Study|Withdrawal by Subject|1|||
124871907|NCT01783418|449152722|FG001|Overall Study|Withdrawal by Subject|0|||
124871908|NCT04791761|449152723|FG000|Overall Study|Lost to Follow-up|8|||
124871909|NCT04791761|449152724|FG001|Overall Study|Lost to Follow-up|6|||
124871910|NCT04791761|449152725|FG002|Overall Study|Lost to Follow-up|10|||
124871911|NCT04791761|449152723|FG000|Overall Study|Withdrawal by Subject|0|||
124871912|NCT04791761|449152724|FG001|Overall Study|Withdrawal by Subject|1|||
124871913|NCT04791761|449152725|FG002|Overall Study|Withdrawal by Subject|1|||
124871914|NCT04791761|449152723|FG000|Overall Study|Protocol Violation|0|||
124871915|NCT04791761|449152724|FG001|Overall Study|Protocol Violation|1|||
124871916|NCT04791761|449152725|FG002|Overall Study|Protocol Violation|1|||
124871917|NCT03548207|449152726|FG000|Overall Study|Death|10|||
124871918|NCT03548207|449152727|FG001|Overall Study|Death|23|||
124871919|NCT03548207|449152728|FG002|Overall Study|Death|3|||
124871920|NCT03548207|449152726|FG000|Overall Study|Lost to Follow-up|0|||
124871921|NCT03548207|449152727|FG001|Overall Study|Lost to Follow-up|2|||
124871922|NCT03548207|449152728|FG002|Overall Study|Lost to Follow-up|0|||
124980240|NCT03203473|449555068|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
124980241|NCT03203473|449555066|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
124980242|NCT03203473|449555067|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
124980243|NCT03203473|449555068|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
124980244|NCT03203473|449555066|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
124980245|NCT03203473|449555067|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
124980246|NCT03203473|449555068|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
124980247|NCT03203473|449555066|FG000|Arm Allocation Phase|started salvage therapy|0|||
124980248|NCT03203473|449555067|FG001|Arm Allocation Phase|started salvage therapy|5|||
124980249|NCT03203473|449555068|FG002|Arm Allocation Phase|started salvage therapy|0|||
124980250|NCT03203473|449555066|FG000|Arm Allocation Phase|Disease progression|0|||
124980251|NCT03203473|449555067|FG001|Arm Allocation Phase|Disease progression|0|||
124980252|NCT03203473|449555068|FG002|Arm Allocation Phase|Disease progression|37|||
124980253|NCT03203473|449555066|FG000|Arm Allocation Phase|Adverse Event|0|||
124980254|NCT03203473|449555067|FG001|Arm Allocation Phase|Adverse Event|0|||
124980255|NCT03203473|449555068|FG002|Arm Allocation Phase|Adverse Event|11|||
124980256|NCT03203473|449555066|FG000|Arm Allocation Phase|Physician Decision|0|||
124980257|NCT03203473|449555067|FG001|Arm Allocation Phase|Physician Decision|0|||
124980258|NCT03203473|449555068|FG002|Arm Allocation Phase|Physician Decision|3|||
124980259|NCT03203473|449555066|FG000|Arm Allocation Phase|Death|0|||
124980260|NCT03203473|449555067|FG001|Arm Allocation Phase|Death|0|||
124980261|NCT03203473|449555068|FG002|Arm Allocation Phase|Death|1|||
124980262|NCT03203473|449555066|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
124980263|NCT03203473|449555067|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
124980264|NCT03203473|449555068|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
124980265|NCT03203473|449555066|FG000|Arm Allocation Phase|Intercurrent illness|0|||
124980266|NCT03203473|449555067|FG001|Arm Allocation Phase|Intercurrent illness|0|||
124980267|NCT03203473|449555068|FG002|Arm Allocation Phase|Intercurrent illness|1|||
124980268|NCT03203473|449555066|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
124980269|NCT03203473|449555067|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
124980270|NCT03203473|449555068|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
124980271|NCT00568178|449555073|FG000|Double Blind Base Study|Adverse Event|0|||
124980272|NCT00568178|449555074|FG001|Double Blind Base Study|Adverse Event|2|||
124980273|NCT00568178|449555075|FG002|Double Blind Base Study|Adverse Event|1|||
124980274|NCT00568178|449555076|FG003|Double Blind Base Study|Adverse Event|2|||
124980275|NCT00568178|449555077|FG004|Double Blind Base Study|Adverse Event|0|||
124980276|NCT00568178|449555078|FG005|Double Blind Base Study|Adverse Event|0|||
124980277|NCT00568178|449555073|FG000|Double Blind Base Study|Lost to Follow-up|1|||
124980278|NCT00568178|449555074|FG001|Double Blind Base Study|Lost to Follow-up|0|||
124980279|NCT00568178|449555075|FG002|Double Blind Base Study|Lost to Follow-up|0|||
124980280|NCT00568178|449555076|FG003|Double Blind Base Study|Lost to Follow-up|1|||
124980281|NCT00568178|449555077|FG004|Double Blind Base Study|Lost to Follow-up|0|||
124980282|NCT00568178|449555078|FG005|Double Blind Base Study|Lost to Follow-up|0|||
124980283|NCT00568178|449555073|FG000|Double Blind Base Study|Physician Decision|1|||
124980284|NCT00568178|449555074|FG001|Double Blind Base Study|Physician Decision|1|||
124980285|NCT00568178|449555075|FG002|Double Blind Base Study|Physician Decision|0|||
124980286|NCT00568178|449555076|FG003|Double Blind Base Study|Physician Decision|1|||
124980287|NCT00568178|449555077|FG004|Double Blind Base Study|Physician Decision|0|||
124980288|NCT00568178|449555078|FG005|Double Blind Base Study|Physician Decision|0|||
124980289|NCT00568178|449555073|FG000|Double Blind Base Study|Protocol Violation|3|||
124980290|NCT00568178|449555074|FG001|Double Blind Base Study|Protocol Violation|2|||
124980291|NCT00568178|449555075|FG002|Double Blind Base Study|Protocol Violation|0|||
124980292|NCT00568178|449555076|FG003|Double Blind Base Study|Protocol Violation|0|||
124980293|NCT00568178|449555077|FG004|Double Blind Base Study|Protocol Violation|0|||
124980294|NCT00568178|449555078|FG005|Double Blind Base Study|Protocol Violation|0|||
124980295|NCT00568178|449555073|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
124980296|NCT00568178|449555074|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
124980297|NCT00568178|449555075|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
124980298|NCT00568178|449555076|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
124980299|NCT00568178|449555077|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
124538633|NCT04516291|447925004|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124538634|NCT04516291|447925005|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124980300|NCT00568178|449555078|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
124980301|NCT00568178|449555073|FG000|Double Blind Base Study|Progressive Disease|0|||
124980302|NCT00568178|449555074|FG001|Double Blind Base Study|Progressive Disease|0|||
124980303|NCT00568178|449555075|FG002|Double Blind Base Study|Progressive Disease|0|||
124980304|NCT00568178|449555076|FG003|Double Blind Base Study|Progressive Disease|1|||
124980305|NCT00568178|449555077|FG004|Double Blind Base Study|Progressive Disease|0|||
124980306|NCT00568178|449555078|FG005|Double Blind Base Study|Progressive Disease|0|||
124538635|NCT04516291|447924998|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
124980307|NCT00568178|449555073|FG000|Open Label Extension|Adverse Event|0|||
124538636|NCT04516291|447924999|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
124980308|NCT00568178|449555074|FG001|Open Label Extension|Adverse Event|0|||
124980309|NCT00568178|449555075|FG002|Open Label Extension|Adverse Event|0|||
124980310|NCT00568178|449555076|FG003|Open Label Extension|Adverse Event|0|||
124980311|NCT00568178|449555077|FG004|Open Label Extension|Adverse Event|11|||
124980312|NCT00568178|449555078|FG005|Open Label Extension|Adverse Event|8|||
124980313|NCT00568178|449555073|FG000|Open Label Extension|Protocol Violation|0|||
124980314|NCT00568178|449555074|FG001|Open Label Extension|Protocol Violation|0|||
124980315|NCT00568178|449555075|FG002|Open Label Extension|Protocol Violation|0|||
124980316|NCT00568178|449555076|FG003|Open Label Extension|Protocol Violation|0|||
124980317|NCT00568178|449555077|FG004|Open Label Extension|Protocol Violation|1|||
124980318|NCT00568178|449555078|FG005|Open Label Extension|Protocol Violation|0|||
124980319|NCT00568178|449555073|FG000|Open Label Extension|Lost to Follow-up|0|||
124980320|NCT00568178|449555074|FG001|Open Label Extension|Lost to Follow-up|0|||
124980321|NCT00568178|449555075|FG002|Open Label Extension|Lost to Follow-up|0|||
124980322|NCT00568178|449555076|FG003|Open Label Extension|Lost to Follow-up|0|||
124980323|NCT00568178|449555077|FG004|Open Label Extension|Lost to Follow-up|6|||
124980324|NCT00568178|449555078|FG005|Open Label Extension|Lost to Follow-up|11|||
124980325|NCT00568178|449555073|FG000|Open Label Extension|Physician Decision|0|||
124980326|NCT00568178|449555074|FG001|Open Label Extension|Physician Decision|0|||
124980327|NCT00568178|449555075|FG002|Open Label Extension|Physician Decision|0|||
124980328|NCT00568178|449555076|FG003|Open Label Extension|Physician Decision|0|||
124980329|NCT00568178|449555077|FG004|Open Label Extension|Physician Decision|9|||
124980330|NCT00568178|449555078|FG005|Open Label Extension|Physician Decision|8|||
124980331|NCT00568178|449555073|FG000|Open Label Extension|Pregnancy|0|||
124980332|NCT00568178|449555074|FG001|Open Label Extension|Pregnancy|0|||
124538637|NCT04516291|447925000|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
124538638|NCT04516291|447925001|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
124538639|NCT04516291|447925002|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
124538640|NCT04516291|447925003|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
124538641|NCT04516291|447925004|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
124538642|NCT04516291|447925005|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
124538643|NCT04516291|447924998|FG000|Follow-up Period (12 Weeks)|Other|0|||
124538644|NCT04516291|447924999|FG001|Follow-up Period (12 Weeks)|Other|1|||
124538645|NCT04516291|447925000|FG002|Follow-up Period (12 Weeks)|Other|0|||
124538646|NCT04516291|447925001|FG003|Follow-up Period (12 Weeks)|Other|2|||
124538647|NCT04516291|447925002|FG004|Follow-up Period (12 Weeks)|Other|0|||
124538648|NCT04516291|447925003|FG005|Follow-up Period (12 Weeks)|Other|0|||
124538649|NCT04516291|447925004|FG006|Follow-up Period (12 Weeks)|Other|0|||
124538650|NCT04516291|447925005|FG007|Follow-up Period (12 Weeks)|Other|0|||
124538651|NCT04516291|447924998|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
124538652|NCT04516291|447924999|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
124538653|NCT04516291|447925000|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
124538654|NCT04516291|447925001|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
124871923|NCT03548207|449152726|FG000|Overall Study|Withdrawal by Subject|0|||
124871924|NCT03548207|449152727|FG001|Overall Study|Withdrawal by Subject|3|||
124871925|NCT03548207|449152728|FG002|Overall Study|Withdrawal by Subject|0|||
124871926|NCT03548207|449152726|FG000|Overall Study|Sponsor decision|19|||
124871927|NCT03548207|449152727|FG001|Overall Study|Sponsor decision|40|||
124871928|NCT03548207|449152728|FG002|Overall Study|Sponsor decision|6|||
124871929|NCT03548207|449152726|FG000|Overall Study|Randomized but not treated|6|||
124871930|NCT03548207|449152727|FG001|Overall Study|Randomized but not treated|10|||
124871931|NCT03548207|449152728|FG002|Overall Study|Randomized but not treated|4|||
124871932|NCT01756352|449152729|FG000|Overall Study|moved away and lost to followup|1|||
124871933|NCT00415610|449152730|FG000|Overall Study|Death|3|||
124871934|NCT00415610|449152731|FG001|Overall Study|Death|2|||
124871935|NCT00415610|449152732|FG002|Overall Study|Death|5|||
124871936|NCT00999466|449152735|FG000|Main Part|Withdrawal by Subject|0|||
124871937|NCT00999466|449152736|FG001|Main Part|Withdrawal by Subject|0|||
124871938|NCT00999466|449152737|FG002|Main Part|Withdrawal by Subject|2|||
124871939|NCT00999466|449152735|FG000|Main Part|Adverse Event|0|||
124871940|NCT00999466|449152736|FG001|Main Part|Adverse Event|4|||
124871941|NCT00999466|449152737|FG002|Main Part|Adverse Event|2|||
124871942|NCT01113502|449152739|FG000|Overall Study|Withdrawal by Subject|1|||
124871943|NCT01113502|449152740|FG001|Overall Study|Withdrawal by Subject|0|||
124871944|NCT01113502|449152741|FG002|Overall Study|Withdrawal by Subject|1|||
124871945|NCT01113502|449152742|FG003|Overall Study|Withdrawal by Subject|1|||
124871946|NCT01113502|449152743|FG004|Overall Study|Withdrawal by Subject|0|||
124871947|NCT01113502|449152739|FG000|Overall Study|Adverse Event|0|||
124871948|NCT01113502|449152740|FG001|Overall Study|Adverse Event|0|||
124871949|NCT01113502|449152741|FG002|Overall Study|Adverse Event|3|||
124871950|NCT01113502|449152742|FG003|Overall Study|Adverse Event|2|||
124871951|NCT01113502|449152743|FG004|Overall Study|Adverse Event|0|||
124871952|NCT03002610|449152752|FG000|Overall Study|Withdrawal by Subject|6|||
124538655|NCT04516291|447925002|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
124980333|NCT00568178|449555075|FG002|Open Label Extension|Pregnancy|0|||
124538656|NCT04516291|447925003|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
124871953|NCT03002610|449152753|FG001|Overall Study|Withdrawal by Subject|25|||
124980334|NCT00568178|449555076|FG003|Open Label Extension|Pregnancy|0|||
124980335|NCT00568178|449555077|FG004|Open Label Extension|Pregnancy|0|||
124980336|NCT00568178|449555078|FG005|Open Label Extension|Pregnancy|1|||
124980337|NCT00568178|449555073|FG000|Open Label Extension|Progressive Disease|0|||
124980338|NCT00568178|449555074|FG001|Open Label Extension|Progressive Disease|0|||
124980339|NCT00568178|449555075|FG002|Open Label Extension|Progressive Disease|0|||
124980340|NCT00568178|449555076|FG003|Open Label Extension|Progressive Disease|0|||
124980341|NCT00568178|449555077|FG004|Open Label Extension|Progressive Disease|3|||
124980342|NCT00568178|449555078|FG005|Open Label Extension|Progressive Disease|1|||
124980343|NCT00568178|449555073|FG000|Open Label Extension|Termination of Trial|0|||
124980344|NCT00568178|449555074|FG001|Open Label Extension|Termination of Trial|0|||
124538657|NCT04516291|447925004|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
124538658|NCT04516291|447925005|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
124538659|NCT04516291|447924998|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
124538660|NCT04516291|447924999|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
124538661|NCT04516291|447925000|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
124538662|NCT04516291|447925001|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
124538663|NCT04516291|447925002|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
124538664|NCT04516291|447925003|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
124538665|NCT04516291|447925004|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
124538666|NCT04516291|447925005|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
124538667|NCT03039686|447925006|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
124538668|NCT03039686|447925007|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
124538669|NCT03039686|447925008|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
124538670|NCT03039686|447925006|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
124538671|NCT03039686|447925007|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
124538672|NCT03039686|447925008|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
124538673|NCT03039686|447925006|FG000|Double-blind Period|Withdrawal by Subject|2|||
124538674|NCT03039686|447925007|FG001|Double-blind Period|Withdrawal by Subject|2|||
124538675|NCT03039686|447925008|FG002|Double-blind Period|Withdrawal by Subject|1|||
124538676|NCT03039686|447925006|FG000|Double-blind Period|Death|0|||
124538677|NCT03039686|447925007|FG001|Double-blind Period|Death|0|||
124538678|NCT03039686|447925008|FG002|Double-blind Period|Death|1|||
124538679|NCT03039686|447925006|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
124538680|NCT03039686|447925007|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
124538681|NCT03039686|447925008|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
124538682|NCT03039686|447925006|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
124538683|NCT03039686|447925007|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
124538684|NCT03039686|447925008|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
124538685|NCT03039686|447925006|FG000|Open Label Period|Withdrawal by Subject|0|||
124538686|NCT03039686|447925007|FG001|Open Label Period|Withdrawal by Subject|3|||
124538687|NCT03039686|447925008|FG002|Open Label Period|Withdrawal by Subject|1|||
124538688|NCT02158949|447925009|FG000|Overall Study|Withdrawal by Subject|1|||
124538689|NCT02158949|447925010|FG001|Overall Study|Withdrawal by Subject|0|||
124538690|NCT02158949|447925009|FG000|Overall Study|Lost to Follow-up|5|||
124538691|NCT02158949|447925010|FG001|Overall Study|Lost to Follow-up|11|||
124538692|NCT02322866|447925012|FG000|Overall Study|Adverse Event|6|||
124538693|NCT02322866|447925013|FG001|Overall Study|Adverse Event|11|||
124538694|NCT02322866|447925012|FG000|Overall Study|Withdrawal of Consent|16|||
124538695|NCT02322866|447925013|FG001|Overall Study|Withdrawal of Consent|25|||
124538696|NCT02322866|447925012|FG000|Overall Study|Lost to Follow-up|36|||
124538697|NCT02322866|447925013|FG001|Overall Study|Lost to Follow-up|39|||
124538698|NCT02322866|447925012|FG000|Overall Study|Protocol Violation|1|||
124538699|NCT02322866|447925013|FG001|Overall Study|Protocol Violation|0|||
124538700|NCT02322866|447925012|FG000|Overall Study|Noncompliance with Treatment|3|||
124538701|NCT02322866|447925013|FG001|Overall Study|Noncompliance with Treatment|4|||
124538702|NCT02322866|447925012|FG000|Overall Study|Lack of Efficacy|3|||
124538703|NCT02322866|447925013|FG001|Overall Study|Lack of Efficacy|1|||
124538704|NCT02322866|447925012|FG000|Overall Study|Other Miscellaneous Reasons|6|||
124538705|NCT02322866|447925013|FG001|Overall Study|Other Miscellaneous Reasons|6|||
124538706|NCT02505945|447925022|FG000|Overall Study|Withdrawal by Subject|13|||
124538707|NCT02505945|447925023|FG001|Overall Study|Withdrawal by Subject|2|||
124538708|NCT02505945|447925022|FG000|Overall Study|Adverse Event|1|||
124538709|NCT02505945|447925023|FG001|Overall Study|Adverse Event|0|||
124538710|NCT02505945|447925022|FG000|Overall Study|Physician Decision|2|||
124538711|NCT02505945|447925023|FG001|Overall Study|Physician Decision|1|||
124538712|NCT02505945|447925022|FG000|Overall Study|Lost to Follow-up|6|||
124980345|NCT00568178|449555075|FG002|Open Label Extension|Termination of Trial|0|||
124538713|NCT02505945|447925023|FG001|Overall Study|Lost to Follow-up|1|||
124538714|NCT01270139|447925024|FG000|Overall Study|Adverse Event|8|||
124980346|NCT00568178|449555076|FG003|Open Label Extension|Termination of Trial|0|||
124980347|NCT00568178|449555077|FG004|Open Label Extension|Termination of Trial|45|||
124538715|NCT01270139|447925025|FG001|Overall Study|Adverse Event|17|||
124980348|NCT00568178|449555078|FG005|Open Label Extension|Termination of Trial|47|||
124538716|NCT01270139|447925026|FG002|Overall Study|Adverse Event|18|||
124538717|NCT01270139|447925024|FG000|Overall Study|Lost to Follow-up|10|||
124538718|NCT01270139|447925025|FG001|Overall Study|Lost to Follow-up|9|||
124538719|NCT01270139|447925026|FG002|Overall Study|Lost to Follow-up|2|||
124538720|NCT00134563|447925027|FG000|Overall Study|Not treated due to protocol violation|0|||
124538721|NCT00134563|447925028|FG001|Overall Study|Not treated due to protocol violation|1|||
124538722|NCT00134563|447925029|FG002|Overall Study|Not treated due to protocol violation|1|||
124538723|NCT00134563|447925027|FG000|Overall Study|Adverse Event|29|||
124980349|NCT00568178|449555073|FG000|Open Label Extension|Withdrawal by Subject|0|||
124980350|NCT00568178|449555074|FG001|Open Label Extension|Withdrawal by Subject|0|||
124980351|NCT00568178|449555075|FG002|Open Label Extension|Withdrawal by Subject|0|||
124980352|NCT00568178|449555076|FG003|Open Label Extension|Withdrawal by Subject|0|||
124980353|NCT00568178|449555077|FG004|Open Label Extension|Withdrawal by Subject|4|||
124980354|NCT00568178|449555078|FG005|Open Label Extension|Withdrawal by Subject|4|||
124980355|NCT01008553|449555079|FG000|Period 1 (Titration Period)|Physician Decision|2|||
124980356|NCT01008553|449555080|FG001|Period 1 (Titration Period)|Physician Decision|0|||
124980357|NCT01008553|449555081|FG002|Period 1 (Titration Period)|Physician Decision|0|||
124980358|NCT01008553|449555079|FG000|Period 1 (Titration Period)|Adverse Event|33|||
124980359|NCT01008553|449555080|FG001|Period 1 (Titration Period)|Adverse Event|0|||
124980360|NCT01008553|449555081|FG002|Period 1 (Titration Period)|Adverse Event|0|||
124980361|NCT01008553|449555079|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
124980362|NCT01008553|449555080|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
124980363|NCT01008553|449555081|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
124980364|NCT01008553|449555079|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
124980365|NCT01008553|449555080|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
124980366|NCT01008553|449555081|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
124980367|NCT01008553|449555079|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
124980368|NCT01008553|449555080|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
124980369|NCT01008553|449555081|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
124980370|NCT01008553|449555079|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
124980371|NCT01008553|449555080|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
124980372|NCT01008553|449555081|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
124980373|NCT01008553|449555079|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
124980374|NCT01008553|449555080|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
124980375|NCT01008553|449555081|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
124980376|NCT01008553|449555079|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
124980377|NCT01008553|449555080|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
124980378|NCT01008553|449555081|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
124980379|NCT01008553|449555079|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
124980380|NCT01008553|449555080|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
124980381|NCT01008553|449555081|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
124980382|NCT01008553|449555079|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
124980383|NCT01008553|449555080|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
124980384|NCT01008553|449555081|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
124980385|NCT01008553|449555079|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
124980386|NCT01008553|449555080|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
124980387|NCT01008553|449555081|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
124980388|NCT01008553|449555079|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
124980389|NCT01008553|449555080|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
124980390|NCT01008553|449555081|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
124980391|NCT01008553|449555079|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
124980392|NCT01008553|449555080|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
124980393|NCT01008553|449555081|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
124980394|NCT01008553|449555079|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
124980395|NCT01008553|449555080|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
124980396|NCT01008553|449555081|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
124980397|NCT04138576|449555082|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
124980398|NCT03563157|449555089|FG000|Overall Study|Progressive Disease|2|||
124980399|NCT04335591|449555090|FG000|Overall Study|Adverse Event|5|||
124980400|NCT04335591|449555091|FG001|Overall Study|Adverse Event|2|||
124980401|NCT04335591|449555092|FG002|Overall Study|Adverse Event|3|||
124980402|NCT04335591|449555093|FG003|Overall Study|Adverse Event|2|||
124980403|NCT04335591|449555090|FG000|Overall Study|Protocol Violation|1|||
124980404|NCT04335591|449555091|FG001|Overall Study|Protocol Violation|0|||
124980405|NCT04335591|449555092|FG002|Overall Study|Protocol Violation|0|||
124538724|NCT00134563|447925028|FG001|Overall Study|Adverse Event|37|||
124538725|NCT00134563|447925029|FG002|Overall Study|Adverse Event|38|||
124980406|NCT04335591|449555093|FG003|Overall Study|Protocol Violation|0|||
124980407|NCT04335591|449555090|FG000|Overall Study|Withdrawal by Subject|8|||
124980408|NCT04335591|449555091|FG001|Overall Study|Withdrawal by Subject|4|||
124980409|NCT04335591|449555092|FG002|Overall Study|Withdrawal by Subject|4|||
124980410|NCT04335591|449555093|FG003|Overall Study|Withdrawal by Subject|5|||
124980411|NCT04335591|449555090|FG000|Overall Study|Subject planning pregnancy|0|||
124980412|NCT04335591|449555091|FG001|Overall Study|Subject planning pregnancy|1|||
124980413|NCT04335591|449555092|FG002|Overall Study|Subject planning pregnancy|0|||
124980414|NCT04335591|449555093|FG003|Overall Study|Subject planning pregnancy|0|||
124980415|NCT04335591|449555090|FG000|Overall Study|Ukrainian Russian war conflict|4|||
124980416|NCT04335591|449555091|FG001|Overall Study|Ukrainian Russian war conflict|5|||
124980417|NCT04335591|449555092|FG002|Overall Study|Ukrainian Russian war conflict|2|||
124980418|NCT04335591|449555093|FG003|Overall Study|Ukrainian Russian war conflict|0|||
124980419|NCT03268603|449555094|FG000|Overall Study|Withdrawal by Subject|6|||
124980420|NCT03268603|449555094|FG000|Overall Study|Physician Decision|1|||
124980421|NCT03268603|449555094|FG000|Overall Study|Withdrawn due to disease progression|2|||
124980422|NCT00356408|449555095|FG000|Overall Study|Adverse Event|9|||
124980423|NCT00356408|449555095|FG000|Overall Study|Lack of Efficacy|36|||
124980424|NCT00356408|449555095|FG000|Overall Study|Lost to Follow-up|2|||
124980425|NCT00356408|449555095|FG000|Overall Study|Withdrawal by Subject|6|||
124980426|NCT00356408|449555095|FG000|Overall Study|Other: Principal investigator discretion|3|||
124980427|NCT00356408|449555095|FG000|Overall Study|Other: Sponsor request|1|||
124980428|NCT00356408|449555095|FG000|Overall Study|Other: Azathioprine stopped|1|||
124980429|NCT00356408|449555095|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
124980430|NCT00356408|449555095|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
124980431|NCT05775991|449555097|FG000|Overall Study|Withdrawal by Subject|0|||
124980432|NCT05775991|449555098|FG001|Overall Study|Withdrawal by Subject|0|||
124980433|NCT05775991|449555099|FG002|Overall Study|Withdrawal by Subject|2|||
124980434|NCT04514510|449555100|FG000|Overall Study|Lost to Follow-up|0|||
124980435|NCT04514510|449555101|FG001|Overall Study|Lost to Follow-up|1|||
124980436|NCT04514510|449555100|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
124980437|NCT04514510|449555101|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
124980438|NCT00406692|449555102|FG000|Overall Study|Withdrawal by Subject|4|||
124980439|NCT00406692|449555102|FG000|Overall Study|Physician Decision|1|||
124980440|NCT00406692|449555102|FG000|Overall Study|Adverse Event|1|||
124980441|NCT00406692|449555102|FG000|Overall Study|Lack of Efficacy|1|||
124980442|NCT03174431|449555103|FG000|Overall Study|Withdrawal by Subject|14|||
124980443|NCT03174431|449555104|FG001|Overall Study|Withdrawal by Subject|11|||
124980444|NCT03174431|449555103|FG000|Overall Study|alternative treatment|2|||
124980445|NCT03174431|449555104|FG001|Overall Study|alternative treatment|0|||
124980446|NCT03174431|449555103|FG000|Overall Study|Lost to Follow-up|1|||
124980447|NCT03174431|449555104|FG001|Overall Study|Lost to Follow-up|5|||
124980448|NCT01867333|449555105|FG000|Overall Study|Withdrawal by Subject|1|||
124980449|NCT01867333|449555106|FG001|Overall Study|Withdrawal by Subject|0|||
124538726|NCT00134563|447925027|FG000|Overall Study|Lack of Efficacy|24|||
124538727|NCT00134563|447925028|FG001|Overall Study|Lack of Efficacy|14|||
124538728|NCT00134563|447925029|FG002|Overall Study|Lack of Efficacy|17|||
124538729|NCT00134563|447925027|FG000|Overall Study|Protocol Violation|3|||
124538730|NCT00134563|447925028|FG001|Overall Study|Protocol Violation|2|||
124538731|NCT00134563|447925029|FG002|Overall Study|Protocol Violation|5|||
124538732|NCT00134563|447925027|FG000|Overall Study|Lost to Follow-up|4|||
124538733|NCT00134563|447925028|FG001|Overall Study|Lost to Follow-up|0|||
124538734|NCT00134563|447925029|FG002|Overall Study|Lost to Follow-up|2|||
124538735|NCT00134563|447925027|FG000|Overall Study|progressive disease|11|||
124538736|NCT00134563|447925028|FG001|Overall Study|progressive disease|4|||
124538737|NCT00134563|447925029|FG002|Overall Study|progressive disease|2|||
124538738|NCT00134563|447925027|FG000|Overall Study|did not wish to continue|33|||
124538739|NCT00134563|447925028|FG001|Overall Study|did not wish to continue|32|||
124980450|NCT01867333|449555105|FG000|Overall Study|Adverse Event|1|||
124980451|NCT01867333|449555106|FG001|Overall Study|Adverse Event|0|||
124980452|NCT01867333|449555105|FG000|Overall Study|Participant choice|1|||
124980453|NCT01867333|449555106|FG001|Overall Study|Participant choice|2|||
124538740|NCT00134563|447925029|FG002|Overall Study|did not wish to continue|26|||
124538741|NCT00134563|447925027|FG000|Overall Study|Reason other than above|0|||
124980454|NCT01867333|449555105|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
124980455|NCT01867333|449555106|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
124980456|NCT01867333|449555105|FG000|Overall Study|Death|0|||
124980457|NCT01867333|449555106|FG001|Overall Study|Death|1|||
124538742|NCT00134563|447925028|FG001|Overall Study|Reason other than above|2|||
124538743|NCT00134563|447925029|FG002|Overall Study|Reason other than above|5|||
124538744|NCT02452320|447925030|FG000|Overall Study|Adverse Event|0|||
124538745|NCT02452320|447925031|FG001|Overall Study|Adverse Event|1|||
124538746|NCT03382639|447925032|FG000|Overall Study|Adverse Event|2|||
124980458|NCT01867333|449555105|FG000|Overall Study|Physician Decision|3|||
124538747|NCT03382639|447925033|FG001|Overall Study|Adverse Event|0|||
124980459|NCT01867333|449555106|FG001|Overall Study|Physician Decision|2|||
124980460|NCT01867333|449555105|FG000|Overall Study|Switched to alternative treatment|1|||
124980461|NCT01867333|449555106|FG001|Overall Study|Switched to alternative treatment|0|||
124980462|NCT01145898|449555107|FG000|3-year Treatment|medication change by treating physician|3|||
124980463|NCT01145898|449555108|FG001|3-year Treatment|medication change by treating physician|16|||
124538748|NCT03382639|447925034|FG002|Overall Study|Adverse Event|1|||
124538749|NCT03382639|447925035|FG003|Overall Study|Adverse Event|1|||
124538750|NCT03382639|447925032|FG000|Overall Study|Lost to Follow-up|1|||
124538751|NCT03382639|447925033|FG001|Overall Study|Lost to Follow-up|0|||
124980464|NCT00951015|449555111|FG000|Randomization Phase 96 Week|Adverse Event|1|||
124980465|NCT00951015|449555112|FG001|Randomization Phase 96 Week|Adverse Event|1|||
124980466|NCT00951015|449555113|FG002|Randomization Phase 96 Week|Adverse Event|2|||
124980467|NCT00951015|449555114|FG003|Randomization Phase 96 Week|Adverse Event|5|||
124980468|NCT00951015|449555115|FG004|Randomization Phase 96 Week|Adverse Event|0|||
124980469|NCT00951015|449555111|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
124980470|NCT00951015|449555112|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
124980471|NCT00951015|449555113|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
124980472|NCT00951015|449555114|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
124980473|NCT00951015|449555115|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
124980474|NCT00951015|449555111|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
124980475|NCT00951015|449555112|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
124980476|NCT00951015|449555113|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
124980477|NCT00951015|449555114|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
124980478|NCT00951015|449555115|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
124980479|NCT00951015|449555111|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
124980480|NCT00951015|449555112|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
124980481|NCT00951015|449555113|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
124538752|NCT03382639|447925034|FG002|Overall Study|Lost to Follow-up|0|||
124538753|NCT03382639|447925035|FG003|Overall Study|Lost to Follow-up|0|||
124538754|NCT03382639|447925032|FG000|Overall Study|Withdrawal by Subject|4|||
124538755|NCT03382639|447925033|FG001|Overall Study|Withdrawal by Subject|3|||
124538756|NCT03382639|447925034|FG002|Overall Study|Withdrawal by Subject|2|||
124538757|NCT03382639|447925035|FG003|Overall Study|Withdrawal by Subject|3|||
124538758|NCT03382639|447925032|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
124538759|NCT03382639|447925033|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
124538760|NCT03382639|447925034|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
124538761|NCT03382639|447925035|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
124538762|NCT03382639|447925032|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
124538763|NCT03382639|447925033|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
124538764|NCT03382639|447925034|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
124538765|NCT03382639|447925035|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
124538766|NCT03382639|447925032|FG000|Overall Study|Other|2|||
124538767|NCT03382639|447925033|FG001|Overall Study|Other|0|||
124538768|NCT03382639|447925034|FG002|Overall Study|Other|0|||
124538769|NCT03382639|447925035|FG003|Overall Study|Other|3|||
124538770|NCT02406586|447925036|FG000|Overall Study|Lost to Follow-up|0|||
124538771|NCT02406586|447925037|FG001|Overall Study|Lost to Follow-up|4|||
124538772|NCT02406586|447925038|FG002|Overall Study|Lost to Follow-up|2|||
124538773|NCT02406586|447925036|FG000|Overall Study|Withdrawal by Subject|1|||
124538774|NCT02406586|447925037|FG001|Overall Study|Withdrawal by Subject|0|||
124538775|NCT02406586|447925038|FG002|Overall Study|Withdrawal by Subject|0|||
124538776|NCT03198559|447925039|FG000|Overall Study|Adverse Event|2|||
124538777|NCT01072175|447925040|FG000|Part A (Drug-Drug Interaction)|Death|1|||
124538778|NCT01072175|447925041|FG001|Part A (Drug-Drug Interaction)|Death|0|||
124538779|NCT01072175|447925042|FG002|Part A (Drug-Drug Interaction)|Death|0|||
124538780|NCT01072175|447925043|FG003|Part A (Drug-Drug Interaction)|Death|0|||
124538781|NCT01072175|447925044|FG004|Part A (Drug-Drug Interaction)|Death|0|||
124538782|NCT01072175|447925045|FG005|Part A (Drug-Drug Interaction)|Death|0|||
124538783|NCT01072175|447925046|FG006|Part A (Drug-Drug Interaction)|Death|0|||
124538784|NCT01072175|447925047|FG007|Part A (Drug-Drug Interaction)|Death|0|||
124538785|NCT01072175|447925048|FG008|Part A (Drug-Drug Interaction)|Death|0|||
124538786|NCT01072175|447925049|FG009|Part A (Drug-Drug Interaction)|Death|0|||
124538787|NCT01072175|447925050|FG010|Part A (Drug-Drug Interaction)|Death|0|||
124538788|NCT01072175|447925051|FG011|Part A (Drug-Drug Interaction)|Death|0|||
124538789|NCT01072175|447925052|FG012|Part A (Drug-Drug Interaction)|Death|0|||
124980482|NCT00951015|449555114|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
124538790|NCT01072175|447925040|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
124538791|NCT01072175|447925041|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
124538792|NCT01072175|447925042|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
124538793|NCT01072175|447925043|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
124538794|NCT01072175|447925044|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
124538795|NCT01072175|447925045|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
124538796|NCT01072175|447925046|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
124538797|NCT01072175|447925047|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
124538798|NCT01072175|447925048|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
124538799|NCT01072175|447925049|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
124538800|NCT01072175|447925050|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
124538801|NCT01072175|447925051|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
124538802|NCT01072175|447925052|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
124538803|NCT01072175|447925040|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
124538804|NCT01072175|447925041|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
124538805|NCT01072175|447925042|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
124538806|NCT01072175|447925043|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
124538807|NCT01072175|447925044|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
124538808|NCT01072175|447925045|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
124980483|NCT00951015|449555115|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
124980484|NCT00951015|449555111|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
124980485|NCT00951015|449555112|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
124980486|NCT00951015|449555113|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
124980487|NCT00951015|449555114|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
124980488|NCT00951015|449555115|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
124980489|NCT00951015|449555111|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
124980490|NCT00951015|449555112|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
124980491|NCT00951015|449555113|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
124538809|NCT01072175|447925046|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
124538810|NCT01072175|447925047|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
124980492|NCT00951015|449555114|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
124538811|NCT01072175|447925048|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
124538812|NCT01072175|447925049|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
124980493|NCT00951015|449555115|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
124980494|NCT00951015|449555111|FG000|Open-label Phase|Adverse Event|0|||
124980495|NCT00951015|449555112|FG001|Open-label Phase|Adverse Event|0|||
124980496|NCT00951015|449555113|FG002|Open-label Phase|Adverse Event|0|||
124980497|NCT00951015|449555114|FG003|Open-label Phase|Adverse Event|0|||
124980498|NCT00951015|449555115|FG004|Open-label Phase|Adverse Event|3|||
124980499|NCT00951015|449555111|FG000|Open-label Phase|Lack of Efficacy|0|||
124980500|NCT00951015|449555112|FG001|Open-label Phase|Lack of Efficacy|0|||
124980501|NCT00951015|449555113|FG002|Open-label Phase|Lack of Efficacy|0|||
124980502|NCT00951015|449555114|FG003|Open-label Phase|Lack of Efficacy|0|||
124980503|NCT00951015|449555115|FG004|Open-label Phase|Lack of Efficacy|1|||
124980504|NCT00951015|449555111|FG000|Open-label Phase|Protocol Violation|0|||
124980505|NCT00951015|449555112|FG001|Open-label Phase|Protocol Violation|0|||
124980506|NCT00951015|449555113|FG002|Open-label Phase|Protocol Violation|0|||
124980507|NCT00951015|449555114|FG003|Open-label Phase|Protocol Violation|0|||
124980508|NCT00951015|449555115|FG004|Open-label Phase|Protocol Violation|12|||
124538813|NCT01072175|447925050|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
124538814|NCT01072175|447925051|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
124538815|NCT01072175|447925052|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
124538816|NCT01072175|447925040|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
124980509|NCT00951015|449555111|FG000|Open-label Phase|Lost to Follow-up|0|||
124980510|NCT00951015|449555112|FG001|Open-label Phase|Lost to Follow-up|0|||
124980511|NCT00951015|449555113|FG002|Open-label Phase|Lost to Follow-up|0|||
124980512|NCT00951015|449555114|FG003|Open-label Phase|Lost to Follow-up|0|||
124980513|NCT00951015|449555115|FG004|Open-label Phase|Lost to Follow-up|12|||
124980514|NCT00951015|449555111|FG000|Open-label Phase|Withdrawal by Subject|0|||
124538817|NCT01072175|447925041|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
124538818|NCT01072175|447925042|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
124538819|NCT01072175|447925043|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
124538820|NCT01072175|447925044|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
124538821|NCT01072175|447925045|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
124538822|NCT01072175|447925046|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
124538823|NCT01072175|447925047|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
124538824|NCT01072175|447925048|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
124538825|NCT01072175|447925049|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
124538826|NCT01072175|447925050|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
124538827|NCT01072175|447925051|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
124538828|NCT01072175|447925052|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
124538829|NCT01072175|447925040|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
124538830|NCT01072175|447925041|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
124980515|NCT00951015|449555112|FG001|Open-label Phase|Withdrawal by Subject|0|||
124980516|NCT00951015|449555113|FG002|Open-label Phase|Withdrawal by Subject|0|||
124980517|NCT00951015|449555114|FG003|Open-label Phase|Withdrawal by Subject|0|||
124980518|NCT00951015|449555115|FG004|Open-label Phase|Withdrawal by Subject|14|||
124980519|NCT00951015|449555111|FG000|Open-label Phase|Physician Decision|0|||
124538831|NCT01072175|447925042|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
124538832|NCT01072175|447925043|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
124538833|NCT01072175|447925044|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
124538834|NCT01072175|447925045|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
124538835|NCT01072175|447925046|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
124538836|NCT01072175|447925047|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
124980520|NCT00951015|449555112|FG001|Open-label Phase|Physician Decision|0|||
124980521|NCT00951015|449555113|FG002|Open-label Phase|Physician Decision|0|||
124538837|NCT01072175|447925048|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
124538838|NCT01072175|447925049|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
124538839|NCT01072175|447925050|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
124538840|NCT01072175|447925051|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
124980522|NCT00951015|449555114|FG003|Open-label Phase|Physician Decision|0|||
124980523|NCT00951015|449555115|FG004|Open-label Phase|Physician Decision|8|||
124980524|NCT03819634|449555117|FG000|Overall Study|Physician Decision|2|||
124980525|NCT01208103|449555118|FG000|Overall Study|Adverse Event|1|||
124980526|NCT01208103|449555118|FG000|Overall Study|Withdrawal by Subject|1|||
124980527|NCT00299494|449555119|FG000|Overall Study|Withdrawal by Subject|0|||
124980528|NCT00299494|449555120|FG001|Overall Study|Withdrawal by Subject|0|||
124980529|NCT00299494|449555121|FG002|Overall Study|Withdrawal by Subject|0|||
124980530|NCT00299494|449555122|FG003|Overall Study|Withdrawal by Subject|3|||
124980531|NCT00299494|449555123|FG004|Overall Study|Withdrawal by Subject|1|||
124980532|NCT00299494|449555124|FG005|Overall Study|Withdrawal by Subject|4|||
124980533|NCT00299494|449555119|FG000|Overall Study|Physician Decision|0|||
124980534|NCT00299494|449555120|FG001|Overall Study|Physician Decision|0|||
124980535|NCT00299494|449555121|FG002|Overall Study|Physician Decision|0|||
124980536|NCT00299494|449555122|FG003|Overall Study|Physician Decision|0|||
124980537|NCT00299494|449555123|FG004|Overall Study|Physician Decision|1|||
124980538|NCT00299494|449555124|FG005|Overall Study|Physician Decision|0|||
124980539|NCT00299494|449555119|FG000|Overall Study|Death|3|||
124980540|NCT00299494|449555120|FG001|Overall Study|Death|1|||
124980541|NCT00299494|449555121|FG002|Overall Study|Death|4|||
124980542|NCT00299494|449555122|FG003|Overall Study|Death|6|||
124980543|NCT00299494|449555123|FG004|Overall Study|Death|18|||
124980544|NCT00299494|449555124|FG005|Overall Study|Death|19|||
124538841|NCT01072175|447925052|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
124538842|NCT01072175|447925040|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
124538843|NCT01072175|447925041|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
124538844|NCT01072175|447925042|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
124538845|NCT01072175|447925043|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
124538846|NCT01072175|447925044|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
124538847|NCT01072175|447925045|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
124538848|NCT01072175|447925046|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
124538849|NCT01072175|447925047|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
124538850|NCT01072175|447925048|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
124538851|NCT01072175|447925049|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
124538852|NCT01072175|447925050|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
124538853|NCT01072175|447925051|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
124538854|NCT01072175|447925052|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
124538855|NCT01072175|447925040|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
124538856|NCT01072175|447925041|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
124538857|NCT01072175|447925042|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
124538858|NCT01072175|447925043|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
124538859|NCT01072175|447925044|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
124538860|NCT01072175|447925045|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
124980545|NCT00299494|449555119|FG000|Overall Study|Lost to Follow-up|0|||
124980546|NCT00299494|449555120|FG001|Overall Study|Lost to Follow-up|0|||
124980547|NCT00299494|449555121|FG002|Overall Study|Lost to Follow-up|0|||
124980548|NCT00299494|449555122|FG003|Overall Study|Lost to Follow-up|0|||
124980549|NCT00299494|449555123|FG004|Overall Study|Lost to Follow-up|3|||
124980550|NCT00299494|449555124|FG005|Overall Study|Lost to Follow-up|1|||
124538861|NCT01072175|447925046|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
124538862|NCT01072175|447925047|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
124538863|NCT01072175|447925048|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
124980551|NCT00299494|449555119|FG000|Overall Study|Other - Unspecified|0|||
124980552|NCT00299494|449555120|FG001|Overall Study|Other - Unspecified|0|||
124980553|NCT00299494|449555121|FG002|Overall Study|Other - Unspecified|0|||
124980554|NCT00299494|449555122|FG003|Overall Study|Other - Unspecified|0|||
124980555|NCT00299494|449555123|FG004|Overall Study|Other - Unspecified|3|||
124980556|NCT00299494|449555124|FG005|Overall Study|Other - Unspecified|1|||
124980557|NCT00299494|449555119|FG000|Overall Study|Other - site closure|0|||
124980558|NCT00299494|449555120|FG001|Overall Study|Other - site closure|0|||
124980559|NCT00299494|449555121|FG002|Overall Study|Other - site closure|0|||
124980560|NCT00299494|449555122|FG003|Overall Study|Other - site closure|1|||
124980561|NCT00299494|449555123|FG004|Overall Study|Other - site closure|1|||
124980562|NCT00299494|449555124|FG005|Overall Study|Other - site closure|1|||
124980563|NCT00416195|449555125|FG000|Overall Study|Adverse Event|1|||
124980564|NCT00416195|449555126|FG001|Overall Study|Adverse Event|2|||
124980565|NCT00416195|449555125|FG000|Overall Study|Protocol Violation|1|||
124980566|NCT00416195|449555126|FG001|Overall Study|Protocol Violation|1|||
124980567|NCT00416195|449555125|FG000|Overall Study|Other|0|||
124980568|NCT00416195|449555126|FG001|Overall Study|Other|1|||
124980569|NCT01417104|449555131|FG000|Overall Study|Withdrawal by Subject|5|||
124980570|NCT01417104|449555132|FG001|Overall Study|Withdrawal by Subject|1|||
124980571|NCT01417104|449555131|FG000|Overall Study|Failure to make contact|0|||
124980572|NCT01417104|449555132|FG001|Overall Study|Failure to make contact|1|||
124980573|NCT01417104|449555131|FG000|Overall Study|Adverse Event|1|||
124980574|NCT01417104|449555132|FG001|Overall Study|Adverse Event|0|||
124980575|NCT03101462|449555133|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
124980576|NCT03101462|449555134|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
124980577|NCT00214019|449555137|FG000|Overall Study|Lost to Follow-up|11|||
124980578|NCT00214019|449555137|FG000|Overall Study|Withdrawal by Subject|2|||
124980579|NCT00214019|449555137|FG000|Overall Study|Screen Failed prior to randomization|17|||
124980580|NCT00842244|449555138|FG000|Overall Study|Death|3|||
124980581|NCT00842244|449555138|FG000|Overall Study|Withdrawal by Subject|1|||
124980582|NCT00842244|449555138|FG000|Overall Study|Other|17|||
124980583|NCT00635661|449555144|FG000|Overall Study|Withdrawal by Subject|4|||
124980584|NCT01696955|449555147|FG000|Main Study|Protocol Violation|1|||
124980585|NCT01696955|449555148|FG001|Main Study|Protocol Violation|0|||
124980586|NCT01696955|449555147|FG000|Main Study|Withdrawal by Subject|1|||
124980587|NCT01696955|449555148|FG001|Main Study|Withdrawal by Subject|1|||
124980588|NCT03192475|449555149|FG000|Overall Study|Death|0|||
124980589|NCT03192475|449555150|FG001|Overall Study|Death|1|||
124980590|NCT03192475|449555149|FG000|Overall Study|Lost to Follow-up|13|||
124980591|NCT03192475|449555150|FG001|Overall Study|Lost to Follow-up|8|||
124980592|NCT01696045|449555153|FG000|Overall Study|Study drug toxicity|1|||
124980593|NCT01696045|449555154|FG001|Overall Study|Study drug toxicity|5|||
124980594|NCT01696045|449555153|FG000|Overall Study|Disease progression|2|||
124980595|NCT01696045|449555154|FG001|Overall Study|Disease progression|2|||
124980596|NCT00573859|449555155|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
124980597|NCT00573859|449555155|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
124980598|NCT03541200|449555162|FG000|Overall Study|Adverse Event|19|||
124980599|NCT03541200|449555162|FG000|Overall Study|Death|1|||
124980600|NCT03541200|449555162|FG000|Overall Study|Lost to Follow-up|10|||
124980601|NCT03541200|449555162|FG000|Overall Study|Physician Decision|1|||
124980602|NCT03541200|449555162|FG000|Overall Study|Protocol Violation|51|||
124980603|NCT03541200|449555162|FG000|Overall Study|Withdrawal by Subject|23|||
124980604|NCT03541200|449555162|FG000|Overall Study|other|8|||
124980605|NCT01276379|449555166|FG000|Overall Study|Screening failure|40|||
124980606|NCT00864253|449555167|FG000|Overall Study|Adverse Event|56|||
124980607|NCT00864253|449555168|FG001|Overall Study|Adverse Event|11|||
124980608|NCT00864253|449555167|FG000|Overall Study|Unrelated Adverse Event|3|||
124980609|NCT00864253|449555168|FG001|Overall Study|Unrelated Adverse Event|1|||
124980610|NCT00864253|449555167|FG000|Overall Study|Physician Decision|11|||
124980611|NCT00864253|449555168|FG001|Overall Study|Physician Decision|15|||
124980612|NCT00864253|449555167|FG000|Overall Study|Protocol Violation|0|||
124980613|NCT00864253|449555168|FG001|Overall Study|Protocol Violation|2|||
124980614|NCT00864253|449555167|FG000|Overall Study|Lost to Follow-up|1|||
124980615|NCT00864253|449555168|FG001|Overall Study|Lost to Follow-up|1|||
124980616|NCT00864253|449555167|FG000|Overall Study|Withdrawal by Subject|18|||
124980617|NCT00864253|449555168|FG001|Overall Study|Withdrawal by Subject|18|||
124980618|NCT00864253|449555167|FG000|Overall Study|Death|1|||
124980619|NCT00864253|449555168|FG001|Overall Study|Death|0|||
124980620|NCT00864253|449555167|FG000|Overall Study|Ongoing|2|||
124980621|NCT00864253|449555168|FG001|Overall Study|Ongoing|3|||
124980622|NCT00864253|449555167|FG000|Overall Study|Untreated|7|||
124980623|NCT00864253|449555168|FG001|Overall Study|Untreated|7|||
124980624|NCT01896726|449555169|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
124980625|NCT01896726|449555169|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
124980626|NCT01128114|449555170|FG000|Overall Study|Treatment Withdrawn|6|||
124980627|NCT01128114|449555170|FG000|Overall Study|Screening Failed|2|||
124980628|NCT00208325|449555171|FG000|Overall Study|Death|18|||
124980629|NCT00208325|449555172|FG001|Overall Study|Death|19|||
124980630|NCT00208325|449555173|FG002|Overall Study|Death|7|||
124980631|NCT00208325|449555174|FG003|Overall Study|Death|5|||
124980632|NCT00208325|449555171|FG000|Overall Study|Withdrawal by Subject|0|||
124980633|NCT00208325|449555172|FG001|Overall Study|Withdrawal by Subject|1|||
124980634|NCT00208325|449555173|FG002|Overall Study|Withdrawal by Subject|0|||
124980635|NCT00208325|449555174|FG003|Overall Study|Withdrawal by Subject|0|||
124980636|NCT00208325|449555171|FG000|Overall Study|Revision|4|||
124980637|NCT00208325|449555172|FG001|Overall Study|Revision|1|||
124980638|NCT00208325|449555173|FG002|Overall Study|Revision|0|||
124980639|NCT00208325|449555174|FG003|Overall Study|Revision|4|||
124980640|NCT00208325|449555171|FG000|Overall Study|Lost to Follow-up|1|||
124980641|NCT00208325|449555172|FG001|Overall Study|Lost to Follow-up|0|||
124980642|NCT00208325|449555173|FG002|Overall Study|Lost to Follow-up|2|||
124980643|NCT00208325|449555174|FG003|Overall Study|Lost to Follow-up|0|||
124980644|NCT00208325|449555171|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
124980645|NCT00208325|449555172|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
124980646|NCT00208325|449555173|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
124980647|NCT00208325|449555174|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
124980648|NCT00208325|449555171|FG000|Overall Study|Does not wish to Continue in Study|5|||
124980649|NCT00208325|449555172|FG001|Overall Study|Does not wish to Continue in Study|8|||
124980650|NCT00208325|449555173|FG002|Overall Study|Does not wish to Continue in Study|3|||
124980651|NCT00208325|449555174|FG003|Overall Study|Does not wish to Continue in Study|2|||
124980652|NCT00208325|449555171|FG000|Overall Study|Other|2|||
124980653|NCT00208325|449555172|FG001|Overall Study|Other|1|||
124980654|NCT00208325|449555173|FG002|Overall Study|Other|1|||
124980655|NCT00208325|449555174|FG003|Overall Study|Other|0|||
124980656|NCT00208325|449555171|FG000|Overall Study|Mis-Randomized|17|||
124980657|NCT00208325|449555172|FG001|Overall Study|Mis-Randomized|20|||
124980658|NCT00208325|449555173|FG002|Overall Study|Mis-Randomized|0|||
124980659|NCT00208325|449555174|FG003|Overall Study|Mis-Randomized|0|||
124980660|NCT04445987|449555175|FG000|Overall Study|Adverse Event|0|||
124980661|NCT04445987|449555176|FG001|Overall Study|Adverse Event|0|||
124980662|NCT04445987|449555177|FG002|Overall Study|Adverse Event|1|||
124980663|NCT04445987|449555178|FG003|Overall Study|Adverse Event|0|||
124980664|NCT04445987|449555179|FG004|Overall Study|Adverse Event|4|||
124980665|NCT04445987|449555180|FG005|Overall Study|Adverse Event|0|||
124980666|NCT04445987|449555175|FG000|Overall Study|Lost to Follow-up|4|||
124980667|NCT04445987|449555176|FG001|Overall Study|Lost to Follow-up|3|||
124980668|NCT04445987|449555177|FG002|Overall Study|Lost to Follow-up|1|||
124980669|NCT04445987|449555178|FG003|Overall Study|Lost to Follow-up|1|||
124980670|NCT04445987|449555179|FG004|Overall Study|Lost to Follow-up|29|||
124980671|NCT04445987|449555180|FG005|Overall Study|Lost to Follow-up|0|||
124980672|NCT04445987|449555175|FG000|Overall Study|Physician Decision|0|||
124980673|NCT04445987|449555176|FG001|Overall Study|Physician Decision|0|||
124980674|NCT04445987|449555177|FG002|Overall Study|Physician Decision|0|||
124980675|NCT04445987|449555178|FG003|Overall Study|Physician Decision|0|||
124980676|NCT04445987|449555179|FG004|Overall Study|Physician Decision|1|||
124980677|NCT04445987|449555180|FG005|Overall Study|Physician Decision|0|||
124980678|NCT04445987|449555175|FG000|Overall Study|Protocol Violation|1|||
124980679|NCT04445987|449555176|FG001|Overall Study|Protocol Violation|0|||
124980680|NCT04445987|449555177|FG002|Overall Study|Protocol Violation|0|||
124980681|NCT04445987|449555178|FG003|Overall Study|Protocol Violation|0|||
124980682|NCT04445987|449555179|FG004|Overall Study|Protocol Violation|2|||
124980683|NCT04445987|449555180|FG005|Overall Study|Protocol Violation|0|||
124980684|NCT04445987|449555175|FG000|Overall Study|Withdrawal by Subject|4|||
124980685|NCT04445987|449555176|FG001|Overall Study|Withdrawal by Subject|0|||
124980686|NCT04445987|449555177|FG002|Overall Study|Withdrawal by Subject|1|||
124980687|NCT04445987|449555178|FG003|Overall Study|Withdrawal by Subject|0|||
124980688|NCT04445987|449555179|FG004|Overall Study|Withdrawal by Subject|18|||
124980689|NCT04445987|449555180|FG005|Overall Study|Withdrawal by Subject|1|||
124980690|NCT04445987|449555175|FG000|Overall Study|Other reason|0|||
124980691|NCT04445987|449555176|FG001|Overall Study|Other reason|0|||
124980692|NCT04445987|449555177|FG002|Overall Study|Other reason|1|||
124980693|NCT04445987|449555178|FG003|Overall Study|Other reason|0|||
124980694|NCT04445987|449555179|FG004|Overall Study|Other reason|2|||
124980695|NCT04445987|449555180|FG005|Overall Study|Other reason|0|||
124980696|NCT01803282|449555181|FG000|Overall Study|Progressive Disease|4|||
124980697|NCT01803282|449555182|FG001|Overall Study|Progressive Disease|3|||
124980698|NCT01803282|449555183|FG002|Overall Study|Progressive Disease|6|||
124980699|NCT01803282|449555184|FG003|Overall Study|Progressive Disease|22|||
124980700|NCT01803282|449555185|FG004|Overall Study|Progressive Disease|5|||
124980701|NCT01803282|449555186|FG005|Overall Study|Progressive Disease|8|||
124980702|NCT01803282|449555187|FG006|Overall Study|Progressive Disease|23|||
124980703|NCT01803282|449555188|FG007|Overall Study|Progressive Disease|24|||
124980704|NCT01803282|449555189|FG008|Overall Study|Progressive Disease|3|||
124980705|NCT01803282|449555190|FG009|Overall Study|Progressive Disease|29|||
124538864|NCT01072175|447925049|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
124980706|NCT01803282|449555191|FG010|Overall Study|Progressive Disease|6|||
124980707|NCT01803282|449555192|FG011|Overall Study|Progressive Disease|11|||
124980708|NCT01803282|449555181|FG000|Overall Study|Death|0|||
124980709|NCT01803282|449555182|FG001|Overall Study|Death|0|||
124980710|NCT01803282|449555183|FG002|Overall Study|Death|0|||
124980711|NCT01803282|449555184|FG003|Overall Study|Death|0|||
124980712|NCT01803282|449555185|FG004|Overall Study|Death|2|||
124980713|NCT01803282|449555186|FG005|Overall Study|Death|1|||
124980714|NCT01803282|449555187|FG006|Overall Study|Death|1|||
124980715|NCT01803282|449555188|FG007|Overall Study|Death|5|||
124980716|NCT01803282|449555189|FG008|Overall Study|Death|1|||
124980717|NCT01803282|449555190|FG009|Overall Study|Death|1|||
124980718|NCT01803282|449555191|FG010|Overall Study|Death|0|||
124980719|NCT01803282|449555192|FG011|Overall Study|Death|0|||
124980720|NCT01803282|449555181|FG000|Overall Study|Withdrew Consent|0|||
124980721|NCT01803282|449555182|FG001|Overall Study|Withdrew Consent|0|||
124980722|NCT01803282|449555183|FG002|Overall Study|Withdrew Consent|0|||
124980723|NCT01803282|449555184|FG003|Overall Study|Withdrew Consent|6|||
124980724|NCT01803282|449555185|FG004|Overall Study|Withdrew Consent|1|||
124980725|NCT01803282|449555186|FG005|Overall Study|Withdrew Consent|0|||
124980726|NCT01803282|449555187|FG006|Overall Study|Withdrew Consent|8|||
124980727|NCT01803282|449555188|FG007|Overall Study|Withdrew Consent|3|||
124980728|NCT01803282|449555189|FG008|Overall Study|Withdrew Consent|1|||
124980729|NCT01803282|449555190|FG009|Overall Study|Withdrew Consent|5|||
124980730|NCT01803282|449555191|FG010|Overall Study|Withdrew Consent|0|||
124980731|NCT01803282|449555192|FG011|Overall Study|Withdrew Consent|1|||
124980732|NCT01803282|449555181|FG000|Overall Study|Investigator's Discretion|0|||
124980733|NCT01803282|449555182|FG001|Overall Study|Investigator's Discretion|0|||
124980734|NCT01803282|449555183|FG002|Overall Study|Investigator's Discretion|0|||
124980735|NCT01803282|449555184|FG003|Overall Study|Investigator's Discretion|7|||
124980736|NCT01803282|449555185|FG004|Overall Study|Investigator's Discretion|2|||
124980737|NCT01803282|449555186|FG005|Overall Study|Investigator's Discretion|1|||
124980738|NCT01803282|449555187|FG006|Overall Study|Investigator's Discretion|7|||
124980739|NCT01803282|449555188|FG007|Overall Study|Investigator's Discretion|10|||
124980740|NCT01803282|449555189|FG008|Overall Study|Investigator's Discretion|6|||
124980741|NCT01803282|449555190|FG009|Overall Study|Investigator's Discretion|7|||
124980742|NCT01803282|449555191|FG010|Overall Study|Investigator's Discretion|1|||
124980743|NCT01803282|449555192|FG011|Overall Study|Investigator's Discretion|0|||
124980744|NCT01803282|449555181|FG000|Overall Study|Adverse Event|0|||
124980745|NCT01803282|449555182|FG001|Overall Study|Adverse Event|0|||
124980746|NCT01803282|449555183|FG002|Overall Study|Adverse Event|0|||
124980747|NCT01803282|449555184|FG003|Overall Study|Adverse Event|0|||
124980748|NCT01803282|449555185|FG004|Overall Study|Adverse Event|0|||
124980749|NCT01803282|449555186|FG005|Overall Study|Adverse Event|0|||
124980750|NCT01803282|449555187|FG006|Overall Study|Adverse Event|1|||
124980751|NCT01803282|449555188|FG007|Overall Study|Adverse Event|2|||
124980752|NCT01803282|449555189|FG008|Overall Study|Adverse Event|0|||
124980753|NCT01803282|449555190|FG009|Overall Study|Adverse Event|1|||
124980754|NCT01803282|449555191|FG010|Overall Study|Adverse Event|0|||
124980755|NCT01803282|449555192|FG011|Overall Study|Adverse Event|3|||
124980756|NCT01803282|449555181|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124980757|NCT01803282|449555182|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124980758|NCT01803282|449555183|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124980759|NCT01803282|449555184|FG003|Overall Study|Non-Compliance with Study Drug|1|||
124980760|NCT01803282|449555185|FG004|Overall Study|Non-Compliance with Study Drug|0|||
124980761|NCT01803282|449555186|FG005|Overall Study|Non-Compliance with Study Drug|0|||
124980762|NCT01803282|449555187|FG006|Overall Study|Non-Compliance with Study Drug|0|||
124980763|NCT01803282|449555188|FG007|Overall Study|Non-Compliance with Study Drug|0|||
124980764|NCT01803282|449555189|FG008|Overall Study|Non-Compliance with Study Drug|0|||
124980765|NCT01803282|449555190|FG009|Overall Study|Non-Compliance with Study Drug|0|||
124980766|NCT01803282|449555191|FG010|Overall Study|Non-Compliance with Study Drug|0|||
124980767|NCT01803282|449555192|FG011|Overall Study|Non-Compliance with Study Drug|0|||
124980768|NCT01803282|449555181|FG000|Overall Study|Unknown Reason|0|||
124980769|NCT01803282|449555182|FG001|Overall Study|Unknown Reason|0|||
124980770|NCT01803282|449555183|FG002|Overall Study|Unknown Reason|0|||
124980771|NCT01803282|449555184|FG003|Overall Study|Unknown Reason|0|||
124980772|NCT01803282|449555185|FG004|Overall Study|Unknown Reason|0|||
124980773|NCT01803282|449555186|FG005|Overall Study|Unknown Reason|0|||
124980774|NCT01803282|449555187|FG006|Overall Study|Unknown Reason|0|||
124980775|NCT01803282|449555188|FG007|Overall Study|Unknown Reason|1|||
124980776|NCT01803282|449555189|FG008|Overall Study|Unknown Reason|0|||
124980777|NCT01803282|449555190|FG009|Overall Study|Unknown Reason|0|||
124980778|NCT01803282|449555191|FG010|Overall Study|Unknown Reason|0|||
124980779|NCT01803282|449555192|FG011|Overall Study|Unknown Reason|0|||
124980780|NCT01803282|449555181|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
124980781|NCT01803282|449555182|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
124538865|NCT01072175|447925050|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
124758630|NCT02452424|448739819|FG010|Overall Study|Adverse Event|1|||
124980782|NCT01803282|449555183|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
124980783|NCT01803282|449555184|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
124980784|NCT01803282|449555185|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
124980785|NCT01803282|449555186|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
124980786|NCT01803282|449555187|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
124980787|NCT01803282|449555188|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
124980788|NCT01803282|449555189|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
124980789|NCT01803282|449555190|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
124980790|NCT01803282|449555191|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
124980791|NCT01803282|449555192|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
124980792|NCT01803282|449555181|FG000|Overall Study|Enrolled but Never Treated|0|||
124980793|NCT01803282|449555182|FG001|Overall Study|Enrolled but Never Treated|0|||
124538866|NCT01072175|447925051|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
124538867|NCT01072175|447925052|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
124538868|NCT01072175|447925040|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
124538869|NCT01072175|447925041|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
124538870|NCT01072175|447925042|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
124538871|NCT01072175|447925043|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
124538872|NCT01072175|447925044|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
124538873|NCT01072175|447925045|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
124538874|NCT01072175|447925046|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
124538875|NCT01072175|447925047|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
124538876|NCT01072175|447925048|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
124538877|NCT01072175|447925049|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
124538878|NCT01072175|447925050|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
124538879|NCT01072175|447925051|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
124980794|NCT01803282|449555183|FG002|Overall Study|Enrolled but Never Treated|0|||
124980795|NCT01803282|449555184|FG003|Overall Study|Enrolled but Never Treated|0|||
124980796|NCT01803282|449555185|FG004|Overall Study|Enrolled but Never Treated|1|||
124980797|NCT01803282|449555186|FG005|Overall Study|Enrolled but Never Treated|0|||
124980798|NCT01803282|449555187|FG006|Overall Study|Enrolled but Never Treated|1|||
124980799|NCT01803282|449555188|FG007|Overall Study|Enrolled but Never Treated|1|||
124980800|NCT01803282|449555189|FG008|Overall Study|Enrolled but Never Treated|0|||
124980801|NCT01803282|449555190|FG009|Overall Study|Enrolled but Never Treated|1|||
124980802|NCT01803282|449555191|FG010|Overall Study|Enrolled but Never Treated|0|||
124980803|NCT01803282|449555192|FG011|Overall Study|Enrolled but Never Treated|0|||
124980804|NCT01743989|449555193|FG000|Treatment Phase|Unstable MR4.0|0|||
124980805|NCT01743989|449555194|FG001|Treatment Phase|Unstable MR4.0|6|||
124980806|NCT01743989|449555195|FG002|Treatment Phase|Unstable MR4.0|263|||
124980807|NCT01743989|449555193|FG000|Treatment Phase|Adverse Event|0|||
124980808|NCT01743989|449555194|FG001|Treatment Phase|Adverse Event|4|||
124980809|NCT01743989|449555195|FG002|Treatment Phase|Adverse Event|67|||
124980810|NCT01743989|449555193|FG000|Treatment Phase|Withdrawal by Subject|1|||
124980811|NCT01743989|449555194|FG001|Treatment Phase|Withdrawal by Subject|3|||
124980812|NCT01743989|449555195|FG002|Treatment Phase|Withdrawal by Subject|28|||
124980813|NCT01743989|449555193|FG000|Treatment Phase|Death|0|||
124980814|NCT01743989|449555194|FG001|Treatment Phase|Death|1|||
124980815|NCT01743989|449555195|FG002|Treatment Phase|Death|3|||
124980816|NCT01743989|449555193|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
124980817|NCT01743989|449555194|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
124980818|NCT01743989|449555195|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
124980819|NCT01743989|449555193|FG000|Treatment Phase|Protocol deviation|0|||
124980820|NCT01743989|449555194|FG001|Treatment Phase|Protocol deviation|0|||
124980821|NCT01743989|449555195|FG002|Treatment Phase|Protocol deviation|3|||
124980822|NCT01743989|449555193|FG000|Treatment Phase|Pregnancy|0|||
124980823|NCT01743989|449555194|FG001|Treatment Phase|Pregnancy|0|||
124980824|NCT01743989|449555195|FG002|Treatment Phase|Pregnancy|2|||
124980825|NCT01743989|449555193|FG000|Treatment Phase|Lost to Follow-up|0|||
124980826|NCT01743989|449555194|FG001|Treatment Phase|Lost to Follow-up|0|||
124980827|NCT01743989|449555195|FG002|Treatment Phase|Lost to Follow-up|2|||
124980828|NCT01743989|449555193|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
124980829|NCT01743989|449555194|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
124980830|NCT01743989|449555195|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
124538880|NCT01072175|447925052|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
124538881|NCT01072175|447925040|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
124538882|NCT01072175|447925041|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
124538883|NCT01072175|447925042|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
124538884|NCT01072175|447925043|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
124538885|NCT01072175|447925044|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
124538886|NCT01072175|447925045|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
124538887|NCT01072175|447925046|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
124538888|NCT01072175|447925047|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
124538889|NCT01072175|447925048|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
124538890|NCT01072175|447925049|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
124538891|NCT01072175|447925050|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
124538892|NCT01072175|447925051|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
124538893|NCT01072175|447925052|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
124980831|NCT01743989|449555193|FG000|Treatment Phase|Administrative problems|0|||
124980832|NCT01743989|449555194|FG001|Treatment Phase|Administrative problems|0|||
124980833|NCT01743989|449555195|FG002|Treatment Phase|Administrative problems|1|||
124980834|NCT01743989|449555193|FG000|Treatment Phase|New cancer (CML) therapy|0|||
124980835|NCT01743989|449555194|FG001|Treatment Phase|New cancer (CML) therapy|1|||
124980836|NCT01743989|449555195|FG002|Treatment Phase|New cancer (CML) therapy|0|||
124980837|NCT01743989|449555193|FG000|Treatment Phase|Physician Decision|0|||
124980838|NCT01743989|449555194|FG001|Treatment Phase|Physician Decision|0|||
124980839|NCT01743989|449555195|FG002|Treatment Phase|Physician Decision|3|||
124980840|NCT01743989|449555193|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
124980841|NCT01743989|449555194|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
124980842|NCT01743989|449555195|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
124980843|NCT01743989|449555193|FG000|Treatment Phase|Not randomized by mistake|0|||
124980844|NCT01743989|449555194|FG001|Treatment Phase|Not randomized by mistake|0|||
124980845|NCT01743989|449555195|FG002|Treatment Phase|Not randomized by mistake|1|||
124980846|NCT01743989|449555193|FG000|Treatment Phase|Included by mistake|0|||
124980847|NCT01743989|449555194|FG001|Treatment Phase|Included by mistake|0|||
124980848|NCT01743989|449555195|FG002|Treatment Phase|Included by mistake|1|||
124980849|NCT01743989|449555193|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
124980850|NCT01743989|449555194|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
124980851|NCT01743989|449555195|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
124980852|NCT01743989|449555193|FG000|TFR Phase|Adverse Event|0|||
124980853|NCT01743989|449555194|FG001|TFR Phase|Adverse Event|1|||
124980854|NCT01743989|449555195|FG002|TFR Phase|Adverse Event|0|||
124980855|NCT01743989|449555193|FG000|TFR Phase|Lost to Follow-up|0|||
124980856|NCT01743989|449555194|FG001|TFR Phase|Lost to Follow-up|2|||
124980857|NCT01743989|449555195|FG002|TFR Phase|Lost to Follow-up|0|||
124980858|NCT01743989|449555193|FG000|TFR Phase|Physician Decision|0|||
124980859|NCT01743989|449555194|FG001|TFR Phase|Physician Decision|1|||
124980860|NCT01743989|449555195|FG002|TFR Phase|Physician Decision|0|||
124980861|NCT01743989|449555193|FG000|TFR Phase|Logistical problems|0|||
124980862|NCT01743989|449555194|FG001|TFR Phase|Logistical problems|2|||
124980863|NCT01743989|449555195|FG002|TFR Phase|Logistical problems|0|||
124980864|NCT01743989|449555193|FG000|TFR Phase|Protocol deviation|0|||
124980865|NCT01743989|449555194|FG001|TFR Phase|Protocol deviation|1|||
124980866|NCT01743989|449555195|FG002|TFR Phase|Protocol deviation|0|||
124980867|NCT01743989|449555193|FG000|TFR Phase|Withdrawal by Subject|0|||
124980868|NCT01743989|449555194|FG001|TFR Phase|Withdrawal by Subject|2|||
124980869|NCT01743989|449555195|FG002|TFR Phase|Withdrawal by Subject|0|||
124980870|NCT01743989|449555193|FG000|Re-treatment Phase|Adverse Event|8|||
124980871|NCT01743989|449555194|FG001|Re-treatment Phase|Adverse Event|4|||
124980872|NCT01743989|449555195|FG002|Re-treatment Phase|Adverse Event|0|||
124980873|NCT01743989|449555193|FG000|Re-treatment Phase|Death|1|||
124980874|NCT01743989|449555194|FG001|Re-treatment Phase|Death|1|||
124980875|NCT01743989|449555195|FG002|Re-treatment Phase|Death|0|||
124980876|NCT01743989|449555193|FG000|Re-treatment Phase|Administrative problems|1|||
124980877|NCT01743989|449555194|FG001|Re-treatment Phase|Administrative problems|1|||
124980878|NCT01743989|449555195|FG002|Re-treatment Phase|Administrative problems|0|||
124980879|NCT01743989|449555193|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
124980880|NCT01743989|449555194|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
124980881|NCT01743989|449555195|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
124980882|NCT01743989|449555193|FG000|Re-treatment Phase|Unstable MR|1|||
124980883|NCT01743989|449555194|FG001|Re-treatment Phase|Unstable MR|0|||
124980884|NCT01743989|449555195|FG002|Re-treatment Phase|Unstable MR|0|||
124980885|NCT01743989|449555193|FG000|Re-treatment Phase|Physician Decision|0|||
124980886|NCT01743989|449555194|FG001|Re-treatment Phase|Physician Decision|1|||
124980887|NCT01743989|449555195|FG002|Re-treatment Phase|Physician Decision|0|||
124980888|NCT01743989|449555193|FG000|Re-treatment Phase|Lost to Follow-up|0|||
124980889|NCT01743989|449555194|FG001|Re-treatment Phase|Lost to Follow-up|1|||
124980890|NCT01743989|449555195|FG002|Re-treatment Phase|Lost to Follow-up|0|||
124980891|NCT02235311|449555198|FG000|Overall Study|Lost to Follow-up|0|||
124980892|NCT02235311|449555199|FG001|Overall Study|Lost to Follow-up|1|||
124980893|NCT02235311|449555198|FG000|Overall Study|Protocol Violation|0|||
124980894|NCT02235311|449555199|FG001|Overall Study|Protocol Violation|1|||
124980895|NCT05543707|449555200|FG000|Overall Study|Study drug non-compliance/|5|||
124980896|NCT05543707|449555201|FG001|Overall Study|Study drug non-compliance/|0|||
124980897|NCT05543707|449555200|FG000|Overall Study|Withdrawal by Subject|1|||
124980898|NCT05543707|449555201|FG001|Overall Study|Withdrawal by Subject|1|||
124980899|NCT05543707|449555200|FG000|Overall Study|Adverse Event|1|||
124980900|NCT05543707|449555201|FG001|Overall Study|Adverse Event|0|||
124538894|NCT01072175|447925040|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
124980901|NCT05543707|449555200|FG000|Overall Study|concurrent illness|0|||
124980902|NCT05543707|449555201|FG001|Overall Study|concurrent illness|1|||
124980903|NCT05543707|449555200|FG000|Overall Study|Pregnancy|1|||
124980904|NCT05543707|449555201|FG001|Overall Study|Pregnancy|1|||
124980905|NCT03006848|449555202|FG000|Overall Study|Adverse Event|1|||
124980906|NCT03006848|449555202|FG000|Overall Study|Physician Decision|1|||
124980907|NCT03006848|449555202|FG000|Overall Study|Lack of Efficacy|16|||
124980908|NCT00384397|449555204|FG000|Overall Study|Adverse Event|0|||
124980909|NCT00384397|449555205|FG001|Overall Study|Adverse Event|1|||
124980910|NCT00384397|449555206|FG002|Overall Study|Adverse Event|2|||
124980911|NCT00384397|449555204|FG000|Overall Study|Protocol Violation|7|||
124980912|NCT00384397|449555205|FG001|Overall Study|Protocol Violation|15|||
124980913|NCT00384397|449555206|FG002|Overall Study|Protocol Violation|13|||
124980914|NCT00384397|449555204|FG000|Overall Study|Lost to Follow-up|11|||
124980915|NCT00384397|449555205|FG001|Overall Study|Lost to Follow-up|13|||
124980916|NCT00384397|449555206|FG002|Overall Study|Lost to Follow-up|3|||
124980917|NCT00384397|449555204|FG000|Overall Study|Withdrawal by Subject|14|||
124980918|NCT00384397|449555205|FG001|Overall Study|Withdrawal by Subject|17|||
124980919|NCT00384397|449555206|FG002|Overall Study|Withdrawal by Subject|15|||
124980920|NCT02336451|449555207|FG000|Overall Study|Adverse Event|1|||
124980921|NCT02336451|449555208|FG001|Overall Study|Adverse Event|2|||
124980922|NCT02336451|449555209|FG002|Overall Study|Adverse Event|0|||
124980923|NCT02336451|449555210|FG003|Overall Study|Adverse Event|6|||
124980924|NCT02336451|449555211|FG004|Overall Study|Adverse Event|4|||
124980925|NCT02336451|449555207|FG000|Overall Study|Death|6|||
124980926|NCT02336451|449555208|FG001|Overall Study|Death|2|||
124980927|NCT02336451|449555209|FG002|Overall Study|Death|3|||
124980928|NCT02336451|449555210|FG003|Overall Study|Death|6|||
124980929|NCT02336451|449555211|FG004|Overall Study|Death|6|||
124980930|NCT02336451|449555207|FG000|Overall Study|Physician Decision|9|||
124980931|NCT02336451|449555208|FG001|Overall Study|Physician Decision|6|||
124980932|NCT02336451|449555209|FG002|Overall Study|Physician Decision|7|||
124980933|NCT02336451|449555210|FG003|Overall Study|Physician Decision|16|||
124980934|NCT02336451|449555211|FG004|Overall Study|Physician Decision|3|||
124980935|NCT02336451|449555207|FG000|Overall Study|Progressive disease|23|||
124980936|NCT02336451|449555208|FG001|Overall Study|Progressive disease|26|||
124980937|NCT02336451|449555209|FG002|Overall Study|Progressive disease|2|||
124980938|NCT02336451|449555210|FG003|Overall Study|Progressive disease|14|||
124980939|NCT02336451|449555211|FG004|Overall Study|Progressive disease|4|||
124980940|NCT02336451|449555207|FG000|Overall Study|Protocol Violation|1|||
124980941|NCT02336451|449555208|FG001|Overall Study|Protocol Violation|0|||
124980942|NCT02336451|449555209|FG002|Overall Study|Protocol Violation|0|||
124980943|NCT02336451|449555210|FG003|Overall Study|Protocol Violation|0|||
124980944|NCT02336451|449555211|FG004|Overall Study|Protocol Violation|0|||
124980945|NCT02336451|449555207|FG000|Overall Study|Patient/guardian decision|2|||
124980946|NCT02336451|449555208|FG001|Overall Study|Patient/guardian decision|4|||
124980947|NCT02336451|449555209|FG002|Overall Study|Patient/guardian decision|0|||
124980948|NCT02336451|449555210|FG003|Overall Study|Patient/guardian decision|2|||
124980949|NCT02336451|449555211|FG004|Overall Study|Patient/guardian decision|1|||
124980950|NCT01214642|449555212|FG000|Overall Study|Progressive Disease|3|||
124980951|NCT01214642|449555213|FG001|Overall Study|Progressive Disease|2|||
124980952|NCT01214642|449555214|FG002|Overall Study|Progressive Disease|3|||
124980953|NCT01214642|449555215|FG003|Overall Study|Progressive Disease|5|||
124980954|NCT01214642|449555216|FG004|Overall Study|Progressive Disease|5|||
124980955|NCT01214642|449555217|FG005|Overall Study|Progressive Disease|3|||
124980956|NCT01214642|449555218|FG006|Overall Study|Progressive Disease|5|||
124980957|NCT01214642|449555219|FG007|Overall Study|Progressive Disease|3|||
124980958|NCT01214642|449555220|FG008|Overall Study|Progressive Disease|10|||
124980959|NCT01214642|449555221|FG009|Overall Study|Progressive Disease|2|||
124980960|NCT01214642|449555222|FG010|Overall Study|Progressive Disease|1|||
124980961|NCT01214642|449555223|FG011|Overall Study|Progressive Disease|4|||
124980962|NCT01214642|449555212|FG000|Overall Study|Adverse Event|0|||
124980963|NCT01214642|449555213|FG001|Overall Study|Adverse Event|1|||
124980964|NCT01214642|449555214|FG002|Overall Study|Adverse Event|0|||
124980965|NCT01214642|449555215|FG003|Overall Study|Adverse Event|0|||
124980966|NCT01214642|449555216|FG004|Overall Study|Adverse Event|0|||
124980967|NCT01214642|449555217|FG005|Overall Study|Adverse Event|0|||
124980968|NCT01214642|449555218|FG006|Overall Study|Adverse Event|1|||
124980969|NCT01214642|449555219|FG007|Overall Study|Adverse Event|0|||
124980970|NCT01214642|449555220|FG008|Overall Study|Adverse Event|0|||
124980971|NCT01214642|449555221|FG009|Overall Study|Adverse Event|1|||
124980972|NCT01214642|449555222|FG010|Overall Study|Adverse Event|1|||
124980973|NCT01214642|449555223|FG011|Overall Study|Adverse Event|0|||
124980974|NCT01214642|449555212|FG000|Overall Study|Death|0|||
124980975|NCT01214642|449555213|FG001|Overall Study|Death|0|||
124980976|NCT01214642|449555214|FG002|Overall Study|Death|1|||
124980977|NCT01214642|449555215|FG003|Overall Study|Death|0|||
124980978|NCT01214642|449555216|FG004|Overall Study|Death|0|||
124980979|NCT01214642|449555217|FG005|Overall Study|Death|0|||
124980980|NCT01214642|449555218|FG006|Overall Study|Death|0|||
124980981|NCT01214642|449555219|FG007|Overall Study|Death|0|||
124980982|NCT01214642|449555220|FG008|Overall Study|Death|0|||
124980983|NCT01214642|449555221|FG009|Overall Study|Death|0|||
124980984|NCT01214642|449555222|FG010|Overall Study|Death|1|||
124980985|NCT01214642|449555223|FG011|Overall Study|Death|0|||
124980986|NCT01214642|449555212|FG000|Overall Study|Withdrawal by Subject|0|||
124980987|NCT01214642|449555213|FG001|Overall Study|Withdrawal by Subject|0|||
124980988|NCT01214642|449555214|FG002|Overall Study|Withdrawal by Subject|1|||
124980989|NCT01214642|449555215|FG003|Overall Study|Withdrawal by Subject|0|||
124980990|NCT01214642|449555216|FG004|Overall Study|Withdrawal by Subject|0|||
124980991|NCT01214642|449555217|FG005|Overall Study|Withdrawal by Subject|0|||
124980992|NCT01214642|449555218|FG006|Overall Study|Withdrawal by Subject|0|||
124980993|NCT01214642|449555219|FG007|Overall Study|Withdrawal by Subject|0|||
124980994|NCT01214642|449555220|FG008|Overall Study|Withdrawal by Subject|3|||
124980995|NCT01214642|449555221|FG009|Overall Study|Withdrawal by Subject|1|||
124980996|NCT01214642|449555222|FG010|Overall Study|Withdrawal by Subject|1|||
124980997|NCT01214642|449555223|FG011|Overall Study|Withdrawal by Subject|0|||
124980998|NCT01214642|449555212|FG000|Overall Study|Physician Decision|0|||
124538895|NCT01072175|447925041|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
124538896|NCT01072175|447925042|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
124538897|NCT01072175|447925043|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
124538898|NCT01072175|447925044|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
124538899|NCT01072175|447925045|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
124538900|NCT01072175|447925046|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
124538901|NCT01072175|447925047|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
124538902|NCT01072175|447925048|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
124538903|NCT01072175|447925049|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
124538904|NCT01072175|447925050|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
124538905|NCT01072175|447925051|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
124538906|NCT01072175|447925052|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
124980999|NCT01214642|449555213|FG001|Overall Study|Physician Decision|0|||
124981000|NCT01214642|449555214|FG002|Overall Study|Physician Decision|1|||
124981001|NCT01214642|449555215|FG003|Overall Study|Physician Decision|1|||
124981002|NCT01214642|449555216|FG004|Overall Study|Physician Decision|1|||
124981003|NCT01214642|449555217|FG005|Overall Study|Physician Decision|0|||
124981004|NCT01214642|449555218|FG006|Overall Study|Physician Decision|0|||
124981005|NCT01214642|449555219|FG007|Overall Study|Physician Decision|0|||
124981006|NCT01214642|449555220|FG008|Overall Study|Physician Decision|0|||
124981007|NCT01214642|449555221|FG009|Overall Study|Physician Decision|0|||
124981008|NCT01214642|449555222|FG010|Overall Study|Physician Decision|0|||
124981009|NCT01214642|449555223|FG011|Overall Study|Physician Decision|2|||
124981010|NCT04372121|449555228|FG000|Overall Study|Lost to Follow-up|0|||
124981011|NCT04372121|449555229|FG001|Overall Study|Lost to Follow-up|0|||
124981012|NCT04372121|449555230|FG002|Overall Study|Lost to Follow-up|0|||
124981013|NCT04372121|449555231|FG003|Overall Study|Lost to Follow-up|1|||
124981014|NCT04372121|449555228|FG000|Overall Study|Protocol Violation|0|||
124981015|NCT04372121|449555229|FG001|Overall Study|Protocol Violation|0|||
124981016|NCT04372121|449555230|FG002|Overall Study|Protocol Violation|1|||
124981017|NCT04372121|449555231|FG003|Overall Study|Protocol Violation|0|||
124981018|NCT04372121|449555228|FG000|Overall Study|Withdrawal by Subject|3|||
124981019|NCT04372121|449555229|FG001|Overall Study|Withdrawal by Subject|1|||
124981020|NCT04372121|449555230|FG002|Overall Study|Withdrawal by Subject|0|||
124981021|NCT04372121|449555231|FG003|Overall Study|Withdrawal by Subject|0|||
124981022|NCT04372121|449555228|FG000|Overall Study|Study termination|6|||
124981023|NCT04372121|449555229|FG001|Overall Study|Study termination|5|||
124981024|NCT04372121|449555230|FG002|Overall Study|Study termination|1|||
124981025|NCT04372121|449555231|FG003|Overall Study|Study termination|1|||
124981026|NCT04372121|449555228|FG000|Overall Study|Hysterectomy planned|1|||
124981027|NCT04372121|449555229|FG001|Overall Study|Hysterectomy planned|0|||
124981028|NCT04372121|449555230|FG002|Overall Study|Hysterectomy planned|0|||
124981029|NCT04372121|449555231|FG003|Overall Study|Hysterectomy planned|0|||
124981030|NCT03345576|449555232|FG000|Overall Study|Withdrawal by Subject|2|||
124981031|NCT03345576|449555233|FG001|Overall Study|Withdrawal by Subject|2|||
124981032|NCT03345576|449555232|FG000|Overall Study|Adverse Event|1|||
124981033|NCT03345576|449555233|FG001|Overall Study|Adverse Event|0|||
124981034|NCT01732822|449557317|FG000|Overall Study|Withdrawal by Subject|123|||
124981035|NCT01732822|449557318|FG001|Overall Study|Withdrawal by Subject|113|||
124981036|NCT02314780|449557319|FG000|Overall Study|organizational reasons|0|||
124981037|NCT02314780|449557320|FG001|Overall Study|organizational reasons|2|||
124981038|NCT02314780|449557321|FG002|Overall Study|organizational reasons|0|||
124981039|NCT02314780|449557319|FG000|Overall Study|Adverse Event|0|||
124981040|NCT02314780|449557320|FG001|Overall Study|Adverse Event|1|||
124981041|NCT02314780|449557321|FG002|Overall Study|Adverse Event|0|||
124538907|NCT01072175|447925040|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
124981042|NCT00215137|449557325|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
124981043|NCT00215137|449557326|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
124981044|NCT00215137|449557327|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
124981045|NCT00215137|449557325|FG000|Randomization Period|Lost to Follow-up|0|||
124981046|NCT00215137|449557326|FG001|Randomization Period|Lost to Follow-up|1|||
124981047|NCT00215137|449557327|FG002|Randomization Period|Lost to Follow-up|0|||
124981048|NCT00215137|449557325|FG000|Randomization Period|Withdrawal by Subject|0|||
124981049|NCT00215137|449557326|FG001|Randomization Period|Withdrawal by Subject|1|||
124981050|NCT00215137|449557327|FG002|Randomization Period|Withdrawal by Subject|0|||
124981051|NCT01183260|449557329|FG000|Overall Study|Intraop screen failure|2|||
124981052|NCT01183260|449557330|FG001|Overall Study|Intraop screen failure|0|||
124981053|NCT01183260|449557329|FG000|Overall Study|Withdrawal by Subject|1|||
124981054|NCT01183260|449557330|FG001|Overall Study|Withdrawal by Subject|1|||
124981055|NCT01183260|449557329|FG000|Overall Study|Revised within 30 days|0|||
124981056|NCT01183260|449557330|FG001|Overall Study|Revised within 30 days|1|||
124981057|NCT01183260|449557329|FG000|Overall Study|Death|1|||
124981058|NCT01183260|449557330|FG001|Overall Study|Death|0|||
124981059|NCT01255631|449557331|FG000|Overall Study|poor enrollment, no data analyzed|9|||
124981060|NCT01255631|449557332|FG001|Overall Study|poor enrollment, no data analyzed|6|||
124981061|NCT00264303|449557342|FG000|Overall Study|Adverse Event|4|||
124981062|NCT00264303|449557343|FG001|Overall Study|Adverse Event|3|||
124981063|NCT00264303|449557342|FG000|Overall Study|Lack of Efficacy|10|||
124981064|NCT00264303|449557343|FG001|Overall Study|Lack of Efficacy|13|||
124981065|NCT00264303|449557342|FG000|Overall Study|Lost to Follow-up|3|||
124981066|NCT00264303|449557343|FG001|Overall Study|Lost to Follow-up|3|||
124981067|NCT00264303|449557342|FG000|Overall Study|Withdrawal by Subject|2|||
124981068|NCT00264303|449557343|FG001|Overall Study|Withdrawal by Subject|3|||
124981069|NCT00264303|449557342|FG000|Overall Study|Various reasons listed in study report|6|||
124981070|NCT00264303|449557343|FG001|Overall Study|Various reasons listed in study report|7|||
124981071|NCT02815579|449557344|FG000|Overall Study|Non-payment of loan down-payment|16|||
124981072|NCT02815579|449557345|FG001|Overall Study|Non-payment of loan down-payment|0|||
124981073|NCT02815579|449557344|FG000|Overall Study|Withdrawal by Subject|7|||
124981074|NCT02815579|449557345|FG001|Overall Study|Withdrawal by Subject|1|||
124981075|NCT02815579|449557344|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
124981076|NCT02815579|449557345|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
124981077|NCT02815579|449557344|FG000|Overall Study|Lost to Follow-up|7|||
124981078|NCT02815579|449557345|FG001|Overall Study|Lost to Follow-up|4|||
124981079|NCT02815579|449557344|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
124981080|NCT02815579|449557345|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
124981081|NCT02815579|449557344|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
124981082|NCT02815579|449557345|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
124981083|NCT02815579|449557344|FG000|Overall Study|Death|5|||
124981084|NCT02815579|449557345|FG001|Overall Study|Death|4|||
124981085|NCT02815579|449557344|FG000|Overall Study|Imprisoned|0|||
124981086|NCT02815579|449557345|FG001|Overall Study|Imprisoned|2|||
124981087|NCT02815579|449557344|FG000|Overall Study|Did not meet enrollment criteria|0|||
124981088|NCT02815579|449557345|FG001|Overall Study|Did not meet enrollment criteria|1|||
124981089|NCT02389452|449557346|FG000|Overall Study|Lost to Follow-up|13|||
124981090|NCT02389452|449557346|FG000|Overall Study|Adverse Event|1|||
124981091|NCT02389452|449557346|FG000|Overall Study|Withdrawal by Subject|5|||
124981092|NCT02389452|449557346|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
124981093|NCT02311673|449557347|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
124981094|NCT02311673|449557348|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
124981095|NCT02311673|449557349|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
124981096|NCT02311673|449557350|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
124981097|NCT00414908|449557356|FG000|Overall Study|Protocol Violation|1|||
124981098|NCT00414908|449557357|FG001|Overall Study|Protocol Violation|1|||
124981099|NCT00818168|449557358|FG000|Overall Study|Lack of Efficacy|18|||
124981100|NCT00818168|449557358|FG000|Overall Study|Pregnancy|2|||
124981101|NCT00818168|449557358|FG000|Overall Study|Withdrawal by Subject|16|||
124981102|NCT00818168|449557358|FG000|Overall Study|Lost to Follow-up|7|||
124981103|NCT00818168|449557358|FG000|Overall Study|Adverse Event|19|||
124981104|NCT00818168|449557358|FG000|Overall Study|Reason for Non-completion Not reported|6|||
124981105|NCT00818168|449557358|FG000|Overall Study|Participant Moved|2|||
124981106|NCT02040259|449557359|FG000|Overall Study|Death|280|||
124981107|NCT02040259|449557359|FG000|Overall Study|Lost to Follow-up|76|||
124981108|NCT02040259|449557359|FG000|Overall Study|Assessment not completed|3|||
124981109|NCT02040259|449557359|FG000|Overall Study|Withdrawal by Subject|4|||
124981110|NCT04476251|449557360|FG000|Overall Study|Not treated|1|||
124981111|NCT00316602|449557370|FG000|Overall Study|Withdrawal by Subject|3|||
124538908|NCT01072175|447925041|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
124538909|NCT01072175|447925042|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
124538910|NCT01072175|447925043|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
124981112|NCT00316602|449557371|FG001|Overall Study|Withdrawal by Subject|2|||
124981113|NCT00316602|449557370|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
124981114|NCT00316602|449557371|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
124981115|NCT00316602|449557370|FG000|Overall Study|Adverse Event|1|||
124981116|NCT00316602|449557371|FG001|Overall Study|Adverse Event|0|||
124981117|NCT00316602|449557370|FG000|Overall Study|Other|3|||
124981118|NCT00316602|449557371|FG001|Overall Study|Other|6|||
124981119|NCT00626990|449557372|FG000|Overall Study|Lack of Efficacy|6|||
124981120|NCT00626990|449557373|FG001|Overall Study|Lack of Efficacy|7|||
124981121|NCT00626990|449557374|FG002|Overall Study|Lack of Efficacy|49|||
124981122|NCT00626990|449557375|FG003|Overall Study|Lack of Efficacy|40|||
124981123|NCT00626990|449557372|FG000|Overall Study|Adverse Event|1|||
124981124|NCT00626990|449557373|FG001|Overall Study|Adverse Event|7|||
124981125|NCT00626990|449557374|FG002|Overall Study|Adverse Event|14|||
124981126|NCT00626990|449557375|FG003|Overall Study|Adverse Event|28|||
124981127|NCT00626990|449557372|FG000|Overall Study|Death|0|||
124981128|NCT00626990|449557373|FG001|Overall Study|Death|1|||
124981129|NCT00626990|449557374|FG002|Overall Study|Death|0|||
124981130|NCT00626990|449557375|FG003|Overall Study|Death|0|||
124981131|NCT00626990|449557372|FG000|Overall Study|Withdrawal by Subject|3|||
124981132|NCT00626990|449557373|FG001|Overall Study|Withdrawal by Subject|1|||
124981133|NCT00626990|449557374|FG002|Overall Study|Withdrawal by Subject|5|||
124981134|NCT00626990|449557375|FG003|Overall Study|Withdrawal by Subject|11|||
124981135|NCT00626990|449557372|FG000|Overall Study|Protocol Violation|0|||
124981136|NCT00626990|449557373|FG001|Overall Study|Protocol Violation|1|||
124981137|NCT00626990|449557374|FG002|Overall Study|Protocol Violation|1|||
124981138|NCT00626990|449557375|FG003|Overall Study|Protocol Violation|0|||
124981139|NCT00626990|449557372|FG000|Overall Study|Various different reasons/missing|4|||
124981140|NCT00626990|449557373|FG001|Overall Study|Various different reasons/missing|8|||
124981141|NCT00626990|449557374|FG002|Overall Study|Various different reasons/missing|8|||
124981142|NCT00626990|449557375|FG003|Overall Study|Various different reasons/missing|16|||
124981143|NCT01008410|449557381|FG000|Overall Study|Adverse Event|13|||
124981144|NCT01008410|449557382|FG001|Overall Study|Adverse Event|7|||
124981145|NCT01008410|449557381|FG000|Overall Study|Withdrawal by Subject|6|||
124981146|NCT01008410|449557382|FG001|Overall Study|Withdrawal by Subject|2|||
124981147|NCT01008410|449557381|FG000|Overall Study|Lost to Follow-up|1|||
124981148|NCT01008410|449557382|FG001|Overall Study|Lost to Follow-up|0|||
124981149|NCT01008410|449557381|FG000|Overall Study|Noncompliance|1|||
124981150|NCT01008410|449557382|FG001|Overall Study|Noncompliance|0|||
124981151|NCT01008410|449557381|FG000|Overall Study|Low Cortisol|2|||
124981152|NCT01008410|449557382|FG001|Overall Study|Low Cortisol|0|||
124981153|NCT01008410|449557381|FG000|Overall Study|Lack of Efficacy|2|||
124981154|NCT01008410|449557382|FG001|Overall Study|Lack of Efficacy|6|||
124981155|NCT01008410|449557381|FG000|Overall Study|Met Exclusion Criterion|0|||
124981156|NCT01008410|449557382|FG001|Overall Study|Met Exclusion Criterion|1|||
124981157|NCT00297427|449557385|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
124981158|NCT00297427|449557386|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
124981159|NCT00297427|449557385|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
124981160|NCT00297427|449557386|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
124981161|NCT00297427|449557385|FG000|Phase 1: Initial Intervention|Death|0|||
124981162|NCT00297427|449557386|FG001|Phase 1: Initial Intervention|Death|1|||
124981163|NCT00297427|449557385|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
124981164|NCT00297427|449557386|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
124981165|NCT00297427|449557385|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
124981166|NCT00297427|449557386|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
124981167|NCT00297427|449557385|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
124981168|NCT00297427|449557386|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
124538911|NCT01072175|447925044|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
124538912|NCT01072175|447925045|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
124538913|NCT01072175|447925046|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
124538914|NCT01072175|447925047|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
124538915|NCT01072175|447925048|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
124538916|NCT01072175|447925049|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
124538917|NCT01072175|447925050|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
124538918|NCT01072175|447925051|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
124538919|NCT01072175|447925052|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
124538920|NCT01072175|447925040|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
124538921|NCT01072175|447925041|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
124538922|NCT01072175|447925042|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
124538923|NCT01072175|447925043|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
124538924|NCT01072175|447925044|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
124538925|NCT01072175|447925045|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
124538926|NCT01072175|447925046|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
124538927|NCT01072175|447925047|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
124538928|NCT01072175|447925048|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
124538929|NCT01072175|447925049|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
124538930|NCT01072175|447925050|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
124538931|NCT01072175|447925051|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
124538932|NCT01072175|447925052|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
124538933|NCT01072175|447925040|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
124538934|NCT01072175|447925041|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
124538935|NCT01072175|447925042|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
124981169|NCT00297427|449557385|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
124981170|NCT00297427|449557386|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
124981171|NCT00297427|449557385|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
124538936|NCT01072175|447925043|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
124538937|NCT01072175|447925044|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
124538938|NCT01072175|447925045|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
124538939|NCT01072175|447925046|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
124538940|NCT01072175|447925047|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
124538941|NCT01072175|447925048|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
124538942|NCT01072175|447925049|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
124538943|NCT01072175|447925050|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
124538944|NCT01072175|447925051|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
124538945|NCT01072175|447925052|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
124538946|NCT01072175|447925040|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
124538947|NCT01072175|447925041|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
124538948|NCT01072175|447925042|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
124538949|NCT01072175|447925043|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
124538950|NCT01072175|447925044|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
124538951|NCT01072175|447925045|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
124538952|NCT01072175|447925046|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
124538953|NCT01072175|447925047|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
124538954|NCT01072175|447925048|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
124538955|NCT01072175|447925049|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
124538956|NCT01072175|447925050|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
124538957|NCT01072175|447925051|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
124538958|NCT01072175|447925052|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
124538959|NCT01072175|447925040|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
124538960|NCT01072175|447925041|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
124538961|NCT01072175|447925042|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
124538962|NCT01072175|447925043|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
124538963|NCT01072175|447925044|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
124538964|NCT01072175|447925045|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
124538965|NCT01072175|447925046|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
124538966|NCT01072175|447925047|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
124538967|NCT01072175|447925048|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
124538968|NCT01072175|447925049|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
124538969|NCT01072175|447925050|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
124538970|NCT01072175|447925051|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
124538971|NCT01072175|447925052|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
124538972|NCT01072175|447925040|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
124538973|NCT01072175|447925041|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
124981172|NCT00297427|449557386|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
124981173|NCT03056300|449557388|FG000|Overall Study|Surgical reason per study protocol|3|||
124981174|NCT03248882|449557389|FG000|Overall Study|Adverse Event|3|||
124981175|NCT03248882|449557390|FG001|Overall Study|Adverse Event|3|||
124981176|NCT03248882|449557391|FG002|Overall Study|Adverse Event|2|||
124981177|NCT03248882|449557392|FG003|Overall Study|Adverse Event|6|||
124981178|NCT03248882|449557393|FG004|Overall Study|Adverse Event|9|||
124981179|NCT03248882|449557389|FG000|Overall Study|Lost to Follow-up|0|||
124981180|NCT03248882|449557390|FG001|Overall Study|Lost to Follow-up|0|||
124981181|NCT03248882|449557391|FG002|Overall Study|Lost to Follow-up|0|||
124981182|NCT03248882|449557392|FG003|Overall Study|Lost to Follow-up|0|||
124981183|NCT03248882|449557393|FG004|Overall Study|Lost to Follow-up|1|||
124981184|NCT03248882|449557389|FG000|Overall Study|Protocol Violation|2|||
124981185|NCT03248882|449557390|FG001|Overall Study|Protocol Violation|0|||
124981186|NCT03248882|449557391|FG002|Overall Study|Protocol Violation|2|||
124981187|NCT03248882|449557392|FG003|Overall Study|Protocol Violation|0|||
124981188|NCT03248882|449557393|FG004|Overall Study|Protocol Violation|1|||
124981189|NCT03248882|449557389|FG000|Overall Study|Withdrawal by Subject|2|||
124981190|NCT03248882|449557390|FG001|Overall Study|Withdrawal by Subject|2|||
124981191|NCT03248882|449557391|FG002|Overall Study|Withdrawal by Subject|3|||
124981192|NCT03248882|449557392|FG003|Overall Study|Withdrawal by Subject|4|||
124981193|NCT03248882|449557393|FG004|Overall Study|Withdrawal by Subject|2|||
124981194|NCT01656200|449557394|FG000|Overall Study|Withdrawal by Subject|1|||
124981195|NCT01156376|449557396|FG000|Overall Study|Adverse Event|1|||
124981196|NCT01156376|449557397|FG001|Overall Study|Adverse Event|0|||
124981197|NCT01156376|449557398|FG002|Overall Study|Adverse Event|1|||
124981198|NCT01156376|449557396|FG000|Overall Study|Withdrawal by Subject|0|||
124758631|NCT01463306|448739820|FG000|Overall Study|Adverse Event|6|||
124981199|NCT01156376|449557397|FG001|Overall Study|Withdrawal by Subject|0|||
124981200|NCT01156376|449557398|FG002|Overall Study|Withdrawal by Subject|3|||
124981201|NCT02797080|449557400|FG000|Overall Study|Lost to Follow-up|1|||
124981202|NCT02797080|449557400|FG000|Overall Study|Withdrawal by Subject|1|||
124981203|NCT01305408|449557401|FG000|Overall Study|Adverse Event|10|||
124981204|NCT01305408|449557402|FG001|Overall Study|Adverse Event|7|||
124981205|NCT01305408|449557401|FG000|Overall Study|Lack of Efficacy|3|||
124981206|NCT01305408|449557402|FG001|Overall Study|Lack of Efficacy|4|||
124981207|NCT01305408|449557401|FG000|Overall Study|Withdrawal by Subject|9|||
124981208|NCT01305408|449557402|FG001|Overall Study|Withdrawal by Subject|9|||
124981209|NCT01305408|449557401|FG000|Overall Study|Protocol Violation|4|||
124981210|NCT01305408|449557402|FG001|Overall Study|Protocol Violation|6|||
124981211|NCT01305408|449557401|FG000|Overall Study|Lost to Follow-up|5|||
124981212|NCT01305408|449557402|FG001|Overall Study|Lost to Follow-up|3|||
124981213|NCT01305408|449557401|FG000|Overall Study|Noncompliance with study medication|0|||
124981214|NCT01305408|449557402|FG001|Overall Study|Noncompliance with study medication|1|||
124981215|NCT01305408|449557401|FG000|Overall Study|Noncompliance with study procedures|0|||
124981216|NCT01305408|449557402|FG001|Overall Study|Noncompliance with study procedures|1|||
124981217|NCT01305408|449557401|FG000|Overall Study|Other|1|||
124981218|NCT01305408|449557402|FG001|Overall Study|Other|0|||
124981219|NCT02530970|449557403|FG000|Overall Study|Adverse Event|8|||
124981220|NCT02530970|449557403|FG000|Overall Study|Lost to Follow-up|88|||
124981221|NCT02530970|449557403|FG000|Overall Study|Physician Decision|5|||
124981222|NCT02530970|449557403|FG000|Overall Study|Withdrawal by Subject|14|||
124981223|NCT02530970|449557403|FG000|Overall Study|Death|6|||
124981224|NCT02530970|449557403|FG000|Overall Study|Hospitalization|1|||
124981225|NCT02530970|449557403|FG000|Overall Study|Insurance|2|||
124981226|NCT02530970|449557403|FG000|Overall Study|Explant|2|||
124981227|NCT02530970|449557403|FG000|Overall Study|Change in Provider|5|||
124981228|NCT02530970|449557403|FG000|Overall Study|Relocation|3|||
124981229|NCT01365481|449557410|FG000|Overall Study|Adverse Event|6|||
124981230|NCT01365481|449557411|FG001|Overall Study|Adverse Event|9|||
124981231|NCT01365481|449557412|FG002|Overall Study|Adverse Event|0|||
124981232|NCT01365481|449557413|FG003|Overall Study|Adverse Event|2|||
124981233|NCT01365481|449557410|FG000|Overall Study|Withdrawal by Subject|0|||
124981234|NCT01365481|449557411|FG001|Overall Study|Withdrawal by Subject|2|||
124981235|NCT01365481|449557412|FG002|Overall Study|Withdrawal by Subject|1|||
124981236|NCT01365481|449557413|FG003|Overall Study|Withdrawal by Subject|1|||
124981237|NCT01365481|449557410|FG000|Overall Study|Lost to Follow-up|1|||
124981238|NCT01365481|449557411|FG001|Overall Study|Lost to Follow-up|1|||
124981239|NCT01365481|449557412|FG002|Overall Study|Lost to Follow-up|2|||
124981240|NCT01365481|449557413|FG003|Overall Study|Lost to Follow-up|3|||
124981241|NCT01365481|449557410|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124981242|NCT01365481|449557411|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124981243|NCT01365481|449557412|FG002|Overall Study|Abnormal laboratory value(s)|0|||
124981244|NCT01365481|449557413|FG003|Overall Study|Abnormal laboratory value(s)|0|||
124981245|NCT01365481|449557410|FG000|Overall Study|Administrative problems|0|||
124981246|NCT01365481|449557411|FG001|Overall Study|Administrative problems|1|||
124981247|NCT01365481|449557412|FG002|Overall Study|Administrative problems|0|||
124981248|NCT01365481|449557413|FG003|Overall Study|Administrative problems|0|||
124981249|NCT01365481|449557410|FG000|Overall Study|Protocol deviation|0|||
124981250|NCT01365481|449557411|FG001|Overall Study|Protocol deviation|1|||
124981251|NCT01365481|449557412|FG002|Overall Study|Protocol deviation|0|||
124981252|NCT01365481|449557413|FG003|Overall Study|Protocol deviation|1|||
124981253|NCT01365481|449557410|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124981254|NCT01365481|449557411|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124981255|NCT01365481|449557412|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
124981256|NCT01365481|449557413|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
124981257|NCT01641159|449557424|FG000|Overall Study|Lost to Follow-up|2|||
124981258|NCT01641159|449557425|FG001|Overall Study|Lost to Follow-up|1|||
124981259|NCT01641159|449557424|FG000|Overall Study|Withdrawal by Subject|0|||
124981260|NCT01641159|449557425|FG001|Overall Study|Withdrawal by Subject|1|||
124981261|NCT03653208|449557429|FG000|Overall Study|Withdrawal by Subject|0|||
124981262|NCT03653208|449557430|FG001|Overall Study|Withdrawal by Subject|0|||
124981263|NCT03653208|449557431|FG002|Overall Study|Withdrawal by Subject|0|||
124981264|NCT03653208|449557432|FG003|Overall Study|Withdrawal by Subject|0|||
124981265|NCT03653208|449557433|FG004|Overall Study|Withdrawal by Subject|1|||
124981266|NCT03653208|449557434|FG005|Overall Study|Withdrawal by Subject|0|||
124981267|NCT03653208|449557435|FG006|Overall Study|Withdrawal by Subject|0|||
124981268|NCT03653208|449557436|FG007|Overall Study|Withdrawal by Subject|1|||
124981269|NCT03653208|449557437|FG008|Overall Study|Withdrawal by Subject|1|||
124981270|NCT03752970|449557439|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
124981271|NCT03752970|449557440|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
124981272|NCT03752970|449557441|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
124981273|NCT03752970|449557439|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
124981274|NCT03752970|449557440|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
124981275|NCT03752970|449557441|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
124981276|NCT03752970|449557439|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
124981277|NCT03752970|449557440|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
124981278|NCT03752970|449557441|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
124981279|NCT03752970|449557439|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
124981280|NCT03752970|449557440|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
124981281|NCT03752970|449557441|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
124981282|NCT03752970|449557439|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
124981283|NCT03752970|449557440|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
124871954|NCT03002610|449152754|FG002|Overall Study|Withdrawal by Subject|13|||
124871955|NCT02227875|449152757|FG000|Overall Study|Protocol Violation|10|||
124871956|NCT02227875|449152758|FG001|Overall Study|Protocol Violation|7|||
124871957|NCT02227875|449152757|FG000|Overall Study|Other|1|||
124871958|NCT02227875|449152758|FG001|Overall Study|Other|3|||
124871959|NCT02227875|449152757|FG000|Overall Study|Physician Decision|1|||
124871960|NCT02227875|449152758|FG001|Overall Study|Physician Decision|0|||
124871961|NCT02227875|449152757|FG000|Overall Study|Adverse Event|3|||
124871962|NCT02227875|449152758|FG001|Overall Study|Adverse Event|0|||
124871963|NCT02227875|449152757|FG000|Overall Study|Withdrawal by Subject|12|||
124871964|NCT02227875|449152758|FG001|Overall Study|Withdrawal by Subject|13|||
124871965|NCT02227875|449152757|FG000|Overall Study|Lost to Follow-up|10|||
124871966|NCT02227875|449152758|FG001|Overall Study|Lost to Follow-up|10|||
124871967|NCT04209725|449152759|FG000|Overall Study|Adverse Event|1|||
124871968|NCT02657317|449152760|FG000|Overall Study|Withdrawal by Subject|2|||
124871969|NCT02657317|449152761|FG001|Overall Study|Withdrawal by Subject|0|||
124871970|NCT02657317|449152760|FG000|Overall Study|Lost to Follow-up|3|||
124871971|NCT02657317|449152761|FG001|Overall Study|Lost to Follow-up|3|||
124871972|NCT03033225|449152772|FG000|Overall Study|Withdrawal by Subject|5|||
124871973|NCT02515279|449152773|FG000|Overall Study|Adverse Event|7|||
124871974|NCT02515279|449152773|FG000|Overall Study|Lack of Efficacy|31|||
124871975|NCT02515279|449152773|FG000|Overall Study|Lost to Follow-up|9|||
124871976|NCT02515279|449152773|FG000|Overall Study|Withdrawal by Subject|18|||
124871977|NCT02515279|449152773|FG000|Overall Study|End-of-treatment visit not attended|17|||
124871978|NCT02515279|449152773|FG000|Overall Study|Other|22|||
124871979|NCT01800968|449152775|FG000|Overall Study|Death|23|||
124871980|NCT01800968|449152776|FG001|Overall Study|Death|16|||
124871981|NCT01800968|449152775|FG000|Overall Study|Lost to Follow-up|5|||
124871982|NCT01800968|449152776|FG001|Overall Study|Lost to Follow-up|7|||
124871983|NCT01800968|449152775|FG000|Overall Study|Withdrawal by Subject|7|||
124871984|NCT01800968|449152776|FG001|Overall Study|Withdrawal by Subject|9|||
124871985|NCT01800968|449152775|FG000|Overall Study|Physician Decision|1|||
124871986|NCT01800968|449152776|FG001|Overall Study|Physician Decision|0|||
124871987|NCT03266770|449152779|FG000|Overall Study|Physician Decision|3|||
124871988|NCT03266770|449152779|FG000|Overall Study|Insufficient study supplies|1|||
124871989|NCT03266770|449152779|FG000|Overall Study|Adverse Event|1|||
124871990|NCT02220894|449152780|FG000|Overall Study|Adverse Event|127|||
124871991|NCT02220894|449152781|FG001|Overall Study|Adverse Event|74|||
124871992|NCT02220894|449152780|FG000|Overall Study|Death|418|||
124871993|NCT02220894|449152781|FG001|Overall Study|Death|508|||
124871994|NCT02220894|449152780|FG000|Overall Study|Lost to Follow-up|0|||
124871995|NCT02220894|449152781|FG001|Overall Study|Lost to Follow-up|4|||
124871996|NCT02220894|449152780|FG000|Overall Study|Site Terminated by Sponsor|2|||
124871997|NCT02220894|449152781|FG001|Overall Study|Site Terminated by Sponsor|0|||
124871998|NCT02220894|449152780|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
124871999|NCT02220894|449152781|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
124872000|NCT02220894|449152780|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124872001|NCT02220894|449152781|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
124872002|NCT02220894|449152780|FG000|Overall Study|Withdrawal by Subject|10|||
124872003|NCT02220894|449152781|FG001|Overall Study|Withdrawal by Subject|9|||
124872004|NCT05007392|449152782|FG000|Overall Study|Randomized but not treated|1|||
124872005|NCT05007392|449152783|FG001|Overall Study|Randomized but not treated|2|||
124872006|NCT05007392|449152782|FG000|Overall Study|Other|5|||
124872007|NCT05007392|449152783|FG001|Overall Study|Other|4|||
124872008|NCT05007392|449152782|FG000|Overall Study|Lost to Follow-up|1|||
124872009|NCT05007392|449152783|FG001|Overall Study|Lost to Follow-up|2|||
124872010|NCT05007392|449152782|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
124872011|NCT05007392|449152783|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
124872012|NCT05007392|449152782|FG000|Overall Study|Use of prohibited concomitant drug|1|||
124872013|NCT05007392|449152783|FG001|Overall Study|Use of prohibited concomitant drug|1|||
124872014|NCT05007392|449152782|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
124872015|NCT05007392|449152783|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
124872016|NCT05007392|449152782|FG000|Overall Study|Adverse Event|10|||
124872017|NCT05007392|449152783|FG001|Overall Study|Adverse Event|6|||
124872018|NCT05007392|449152782|FG000|Overall Study|Participant choice|5|||
124872019|NCT05007392|449152783|FG001|Overall Study|Participant choice|10|||
124872020|NCT05007392|449152782|FG000|Overall Study|Withdrawal of consent|5|||
124872021|NCT05007392|449152783|FG001|Overall Study|Withdrawal of consent|4|||
124872022|NCT02453685|449152784|FG000|Overall Study|Adverse Event|0|||
124872023|NCT02453685|449152785|FG001|Overall Study|Adverse Event|1|||
124981284|NCT03752970|449557441|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
124981285|NCT01152814|449557443|FG000|Overall Study|Lost to Follow-up|2|||
124981286|NCT01669577|449557447|FG000|Overall Study|Death|22|||
124981287|NCT01669577|449557447|FG000|Overall Study|Lost to Follow-up|78|||
124981288|NCT01669577|449557447|FG000|Overall Study|Physician Decision|34|||
124981289|NCT01283516|449557448|FG000|Overall Study|Adverse Event|0|||
124981290|NCT01283516|449557449|FG001|Overall Study|Adverse Event|0|||
124538974|NCT01072175|447925042|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
124538975|NCT01072175|447925043|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
124538976|NCT01072175|447925044|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
124538977|NCT01072175|447925045|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
124538978|NCT01072175|447925046|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
124538979|NCT01072175|447925047|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
124538980|NCT01072175|447925048|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
124538981|NCT01072175|447925049|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
124538982|NCT01072175|447925050|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
124538983|NCT01072175|447925051|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
124538984|NCT01072175|447925052|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
124538985|NCT01072175|447925040|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
124538986|NCT01072175|447925041|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
124538987|NCT01072175|447925042|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
124538988|NCT01072175|447925043|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
124538989|NCT01072175|447925044|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
124538990|NCT01072175|447925045|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
124538991|NCT01072175|447925046|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
124538992|NCT01072175|447925047|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
124538993|NCT01072175|447925048|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
124538994|NCT01072175|447925049|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
124538995|NCT01072175|447925050|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
124538996|NCT01072175|447925051|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
124538997|NCT01072175|447925052|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
124538998|NCT01072175|447925040|FG000|Part D (HPMC Capsules)|Death|0|||
124538999|NCT01072175|447925041|FG001|Part D (HPMC Capsules)|Death|0|||
124539000|NCT01072175|447925042|FG002|Part D (HPMC Capsules)|Death|0|||
124539001|NCT01072175|447925043|FG003|Part D (HPMC Capsules)|Death|0|||
124539002|NCT01072175|447925044|FG004|Part D (HPMC Capsules)|Death|0|||
124539003|NCT01072175|447925045|FG005|Part D (HPMC Capsules)|Death|0|||
124539004|NCT01072175|447925046|FG006|Part D (HPMC Capsules)|Death|0|||
124539005|NCT01072175|447925047|FG007|Part D (HPMC Capsules)|Death|0|||
124539006|NCT01072175|447925048|FG008|Part D (HPMC Capsules)|Death|0|||
124539007|NCT01072175|447925049|FG009|Part D (HPMC Capsules)|Death|10|||
124539008|NCT01072175|447925050|FG010|Part D (HPMC Capsules)|Death|12|||
124539009|NCT01072175|447925051|FG011|Part D (HPMC Capsules)|Death|28|||
124539010|NCT01072175|447925052|FG012|Part D (HPMC Capsules)|Death|26|||
124539011|NCT01072175|447925040|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
124539012|NCT01072175|447925041|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
124539013|NCT01072175|447925042|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
124539014|NCT01072175|447925043|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
124539015|NCT01072175|447925044|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
124539016|NCT01072175|447925045|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
124539017|NCT01072175|447925046|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
124539018|NCT01072175|447925047|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
124539019|NCT01072175|447925048|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
124539020|NCT01072175|447925049|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
124539021|NCT01072175|447925050|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
124539022|NCT01072175|447925051|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
124981291|NCT01283516|449557450|FG002|Overall Study|Adverse Event|0|||
124981292|NCT01283516|449557451|FG003|Overall Study|Adverse Event|0|||
124981293|NCT01283516|449557452|FG004|Overall Study|Adverse Event|0|||
124981294|NCT01283516|449557453|FG005|Overall Study|Adverse Event|0|||
124981295|NCT01283516|449557454|FG006|Overall Study|Adverse Event|2|||
124981296|NCT01283516|449557455|FG007|Overall Study|Adverse Event|0|||
124981297|NCT01283516|449557456|FG008|Overall Study|Adverse Event|28|||
124981298|NCT01283516|449557448|FG000|Overall Study|Death|0|||
124981299|NCT01283516|449557449|FG001|Overall Study|Death|0|||
124539023|NCT01072175|447925052|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
124539024|NCT01072175|447925040|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
124981300|NCT01283516|449557450|FG002|Overall Study|Death|0|||
124981301|NCT01283516|449557451|FG003|Overall Study|Death|0|||
124981302|NCT01283516|449557452|FG004|Overall Study|Death|0|||
124981303|NCT01283516|449557453|FG005|Overall Study|Death|1|||
124981304|NCT01283516|449557454|FG006|Overall Study|Death|0|||
124981305|NCT01283516|449557455|FG007|Overall Study|Death|1|||
124539025|NCT01072175|447925041|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
124539026|NCT01072175|447925042|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
124539027|NCT01072175|447925043|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
124539028|NCT01072175|447925044|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
124539029|NCT01072175|447925045|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
124539030|NCT01072175|447925046|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
124539031|NCT01072175|447925047|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
124539032|NCT01072175|447925048|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
124539033|NCT01072175|447925049|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
124539034|NCT01072175|447925050|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
124539035|NCT01072175|447925051|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
124539036|NCT01072175|447925052|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
124539037|NCT01072175|447925040|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
124539038|NCT01072175|447925041|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
124539039|NCT01072175|447925042|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
124539040|NCT01072175|447925043|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
124539041|NCT01072175|447925044|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
124539042|NCT01072175|447925045|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
124539043|NCT01072175|447925046|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
124539044|NCT01072175|447925047|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
124539045|NCT01072175|447925048|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
124539046|NCT01072175|447925049|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
124539047|NCT01072175|447925050|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
124539048|NCT01072175|447925051|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
124539049|NCT01072175|447925052|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
124539050|NCT01072175|447925040|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
124539051|NCT01072175|447925041|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
124539052|NCT01072175|447925042|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
124539053|NCT01072175|447925043|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
124539054|NCT01072175|447925044|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
124539055|NCT01072175|447925045|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
124539056|NCT01072175|447925046|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
124539057|NCT01072175|447925047|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
124539058|NCT01072175|447925048|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
124539059|NCT01072175|447925049|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
124539060|NCT01072175|447925050|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
124539061|NCT01072175|447925051|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
124539062|NCT01072175|447925052|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
124539063|NCT02477215|447925055|FG000|Dose Escalation Phase|Physician Decision|1|||
124539064|NCT02477215|447925056|FG001|Dose Escalation Phase|Physician Decision|2|||
124539065|NCT02477215|447925057|FG002|Dose Escalation Phase|Physician Decision|0|||
124539066|NCT02477215|447925055|FG000|Fixed Dose Phase|Physician Decision|0|||
124539067|NCT02477215|447925056|FG001|Fixed Dose Phase|Physician Decision|7|||
124539068|NCT02477215|447925057|FG002|Fixed Dose Phase|Physician Decision|0|||
124539069|NCT01474291|447925058|FG000|Overall Study|Not Evaluable for Efficacy|26|||
124539070|NCT01474291|447925058|FG000|Overall Study|Lack of Treatment Efficacy|88|||
124539071|NCT01474291|447925058|FG000|Overall Study|Adverse Event|53|||
124539072|NCT01474291|447925058|FG000|Overall Study|Lost to Follow-up|29|||
124539073|NCT01474291|447925058|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
124539074|NCT01474291|447925058|FG000|Overall Study|No Reason Reported|10|||
124539075|NCT01474291|447925058|FG000|Overall Study|Death|2|||
124539076|NCT00438815|447925062|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
124539077|NCT00438815|447925062|FG000|Overall Study|3-month follow-up no longer required|12|||
124539078|NCT00438815|447925062|FG000|Overall Study|Noncompliance with protocol requirements|9|||
124539079|NCT00438815|447925062|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
124539080|NCT00438815|447925062|FG000|Overall Study|Lost to Follow-up|6|||
124539081|NCT00438815|447925062|FG000|Overall Study|Withdrawal by Subject|6|||
124539082|NCT00438815|447925062|FG000|Overall Study|Death|1|||
124539083|NCT00679354|447925067|FG000|Overall Study|Death|3|||
124539084|NCT00679354|447925067|FG000|Overall Study|Lack of Efficacy|22|||
124539085|NCT00679354|447925067|FG000|Overall Study|Physician Decision|4|||
124539086|NCT00679354|447925067|FG000|Overall Study|Ineligible|1|||
124539087|NCT00697255|447925072|FG000|Stage 1a|Insufficient ovarian response|1|||
124539088|NCT00697255|447925073|FG001|Stage 1a|Insufficient ovarian response|0|||
124539089|NCT00697255|447925072|FG000|Stage 1a|Multifollicular growth|1|||
124539090|NCT00697255|447925073|FG001|Stage 1a|Multifollicular growth|0|||
124539091|NCT00697255|447925072|FG000|Stage 1a|Not growing of dominant follicle|1|||
124539092|NCT00697255|447925073|FG001|Stage 1a|Not growing of dominant follicle|0|||
124539093|NCT00697255|447925072|FG000|Stage 1b|Not growing of dominant follicle|0|||
124539094|NCT00697255|447925073|FG001|Stage 1b|Not growing of dominant follicle|1|||
124539095|NCT00697255|447925072|FG000|Stage 1b|Insufficient ovarian response|0|||
124872024|NCT02453685|449152784|FG000|Overall Study|Protocol Violation|7|||
124539096|NCT00697255|447925073|FG001|Stage 1b|Insufficient ovarian response|1|||
124539097|NCT01303159|447925081|FG000|Overall Study|Death|16|||
124539098|NCT01303159|447925081|FG000|Overall Study|Study Termination|7|||
124539099|NCT00496782|447925082|FG000|Overall Study|Protocol Violation|1|||
124539100|NCT00496782|447925083|FG001|Overall Study|Protocol Violation|2|||
124539101|NCT02242305|447925088|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
124539102|NCT02242305|447925089|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
124539103|NCT02242305|447925088|FG000|Overall Study|Adverse Event|1|||
124539104|NCT02242305|447925089|FG001|Overall Study|Adverse Event|0|||
124539105|NCT02242305|447925088|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
124539106|NCT02242305|447925089|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
124539107|NCT02242305|447925088|FG000|Overall Study|Subject withdraws inform consent|0|||
124539108|NCT02242305|447925089|FG001|Overall Study|Subject withdraws inform consent|4|||
124539109|NCT02242305|447925088|FG000|Overall Study|Lost to Follow-up|2|||
124539110|NCT02242305|447925089|FG001|Overall Study|Lost to Follow-up|0|||
124539111|NCT01005875|447925097|FG000|Overall Study|Death|3|||
124539112|NCT00242658|447925100|FG000|Overall Study|Lost to Follow-up|22|||
124539113|NCT00242658|447925101|FG001|Overall Study|Lost to Follow-up|19|||
124539114|NCT01815099|447925102|FG000|Overall Study|Lack of Efficacy|1|||
124539115|NCT01815099|447925102|FG000|Overall Study|unable to attend study visits|1|||
124539116|NCT00643851|447925103|FG000|Overall Study|Death|0|||
124539117|NCT00643851|447925104|FG001|Overall Study|Death|1|||
124539118|NCT00643851|447925105|FG002|Overall Study|Death|0|||
124539119|NCT00643851|447925103|FG000|Overall Study|Lack of Efficacy|0|||
124539120|NCT00643851|447925104|FG001|Overall Study|Lack of Efficacy|1|||
124539121|NCT00643851|447925105|FG002|Overall Study|Lack of Efficacy|0|||
124539122|NCT00643851|447925103|FG000|Overall Study|Adverse Event|2|||
124539123|NCT00643851|447925104|FG001|Overall Study|Adverse Event|6|||
124539124|NCT00643851|447925105|FG002|Overall Study|Adverse Event|6|||
124539125|NCT00643851|447925103|FG000|Overall Study|Lost to Follow-up|4|||
124539126|NCT00643851|447925104|FG001|Overall Study|Lost to Follow-up|6|||
124539127|NCT00643851|447925105|FG002|Overall Study|Lost to Follow-up|9|||
124539128|NCT00643851|447925103|FG000|Overall Study|Withdrawal by Subject|8|||
124539129|NCT00643851|447925104|FG001|Overall Study|Withdrawal by Subject|15|||
124539130|NCT00643851|447925105|FG002|Overall Study|Withdrawal by Subject|9|||
124539131|NCT00643851|447925103|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
124539132|NCT00643851|447925104|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
124539133|NCT00643851|447925105|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
124539134|NCT04557189|447925108|FG000|Overall Study|Adverse Event|0|||
124539135|NCT04557189|447925109|FG001|Overall Study|Adverse Event|1|||
124539136|NCT04557189|447925108|FG000|Overall Study|Lost to Follow-up|1|||
124539137|NCT04557189|447925109|FG001|Overall Study|Lost to Follow-up|1|||
124539138|NCT04557189|447925108|FG000|Overall Study|Withdrawal by Subject|2|||
124539139|NCT04557189|447925109|FG001|Overall Study|Withdrawal by Subject|1|||
124539140|NCT04557189|447925108|FG000|Overall Study|Reason not Specified|3|||
124539141|NCT04557189|447925109|FG001|Overall Study|Reason not Specified|6|||
124539142|NCT01728454|447925110|FG000|Stage 1 and 2|Pregnancy|1|||
124539143|NCT01728454|447925111|FG001|Stage 1 and 2|Pregnancy|0|||
124539144|NCT01728454|447925112|FG002|Stage 1 and 2|Pregnancy|0|||
124539145|NCT01728454|447925110|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
124539146|NCT01728454|447925111|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
124539147|NCT01728454|447925112|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
124539148|NCT01728454|447925110|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
124539149|NCT01728454|447925111|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
124539150|NCT01728454|447925112|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
124539151|NCT01728454|447925110|FG000|Stage 1 and 2|Lost to Follow-up|1|||
124539152|NCT01728454|447925111|FG001|Stage 1 and 2|Lost to Follow-up|1|||
124539153|NCT01728454|447925112|FG002|Stage 1 and 2|Lost to Follow-up|0|||
124539154|NCT01728454|447925110|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
124539155|NCT01728454|447925111|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
124539156|NCT01728454|447925112|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
124539157|NCT01728454|447925110|FG000|Stage 3|Reason Missing|0|||
124539158|NCT01728454|447925111|FG001|Stage 3|Reason Missing|0|||
124539159|NCT01728454|447925112|FG002|Stage 3|Reason Missing|1|||
124539160|NCT01728454|447925110|FG000|Stage 3|Subject Required Other Treatment|0|||
124539161|NCT01728454|447925111|FG001|Stage 3|Subject Required Other Treatment|1|||
124539162|NCT01728454|447925112|FG002|Stage 3|Subject Required Other Treatment|0|||
124539163|NCT01728454|447925110|FG000|Stage 3|Pregnancy|1|||
124539164|NCT01728454|447925111|FG001|Stage 3|Pregnancy|0|||
124539165|NCT01728454|447925112|FG002|Stage 3|Pregnancy|0|||
124539166|NCT01728454|447925110|FG000|Stage 3|Withdrew Consent|1|||
124539167|NCT01728454|447925111|FG001|Stage 3|Withdrew Consent|0|||
124539168|NCT01728454|447925112|FG002|Stage 3|Withdrew Consent|1|||
124539169|NCT01728454|447925110|FG000|Stage 3|Non-compliance with Protocol|0|||
124539170|NCT01728454|447925111|FG001|Stage 3|Non-compliance with Protocol|0|||
124539171|NCT01728454|447925112|FG002|Stage 3|Non-compliance with Protocol|1|||
124539172|NCT01728454|447925110|FG000|Stage 3|Lost to Follow-up|0|||
124539173|NCT01728454|447925111|FG001|Stage 3|Lost to Follow-up|3|||
124539174|NCT01728454|447925112|FG002|Stage 3|Lost to Follow-up|1|||
124539175|NCT01728454|447925110|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
124539176|NCT01728454|447925111|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
124539177|NCT01728454|447925112|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
124539178|NCT01190839|447925113|FG000|Overall Study|Adverse Event|32|||
124539179|NCT01190839|447925114|FG001|Overall Study|Adverse Event|41|||
124539180|NCT01190839|447925113|FG000|Overall Study|Protocol Violation|2|||
124539181|NCT01190839|447925114|FG001|Overall Study|Protocol Violation|2|||
124539182|NCT01190839|447925113|FG000|Overall Study|Lost to Follow-up|7|||
124539183|NCT01190839|447925114|FG001|Overall Study|Lost to Follow-up|1|||
124539184|NCT01190839|447925113|FG000|Overall Study|Death|1|||
124539185|NCT01190839|447925114|FG001|Overall Study|Death|0|||
124539186|NCT01190839|447925113|FG000|Overall Study|Trial stopped by Sponsor|71|||
124539187|NCT01190839|447925114|FG001|Overall Study|Trial stopped by Sponsor|68|||
124539188|NCT01190839|447925113|FG000|Overall Study|Undefined|35|||
124539189|NCT01190839|447925114|FG001|Overall Study|Undefined|31|||
124539190|NCT01190839|447925113|FG000|Overall Study|Randomized but not treated|2|||
124539191|NCT01190839|447925114|FG001|Overall Study|Randomized but not treated|4|||
124539192|NCT03077646|447925118|FG000|Overall Study|Lost to Follow-up|29|||
124539193|NCT03077646|447925119|FG001|Overall Study|Lost to Follow-up|30|||
124539194|NCT03077646|447925120|FG002|Overall Study|Lost to Follow-up|31|||
124539195|NCT02058966|447925121|FG000|Open-Label Methamphetamine|Adverse Event|1|||
124539196|NCT02058966|447925121|FG000|First Intervention|Withdrawal by Subject|1|||
124539197|NCT02545504|447925123|FG000|Overall Study|Death|174|||
124539198|NCT02545504|447925124|FG001|Overall Study|Death|168|||
124539199|NCT02545504|447925123|FG000|Overall Study|Unknown reason|30|||
124539200|NCT02545504|447925124|FG001|Overall Study|Unknown reason|32|||
124539201|NCT02545504|447925123|FG000|Overall Study|Withdrew consent|9|||
124539202|NCT02545504|447925124|FG001|Overall Study|Withdrew consent|11|||
124539203|NCT02545504|447925123|FG000|Overall Study|Investigator's discretion|3|||
124539204|NCT02545504|447925124|FG001|Overall Study|Investigator's discretion|1|||
124539205|NCT02545504|447925123|FG000|Overall Study|Lost to Follow-up|2|||
124539206|NCT02545504|447925124|FG001|Overall Study|Lost to Follow-up|2|||
124539207|NCT01336647|447927109|FG000|Overall Study|Lost to Follow-up|4|||
124539208|NCT01336647|447927110|FG001|Overall Study|Lost to Follow-up|1|||
124539209|NCT01336647|447927111|FG002|Overall Study|Lost to Follow-up|3|||
124539210|NCT03808298|447927112|FG000|Overall Study|Adverse Event|3|||
124539211|NCT03808298|447927112|FG000|Overall Study|Physician Decision|1|||
124539212|NCT03808298|447927112|FG000|Overall Study|Withdrawal by Subject|1|||
124539213|NCT03808298|447927112|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
124539214|NCT01858701|447927113|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
124539215|NCT01858701|447927114|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
124539216|NCT01858701|447927113|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
124539217|NCT01858701|447927114|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
124539218|NCT01858701|447927113|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
124539219|NCT01858701|447927114|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
124539220|NCT01858701|447927113|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
124539221|NCT01858701|447927114|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
124539222|NCT05056311|447927117|FG000|Overall Study|Lost to Follow-up|14|||
124539223|NCT05056311|447927117|FG000|Overall Study|Withdrawal by Subject|1|||
124539224|NCT05056311|447927117|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
124539225|NCT02713490|447927118|FG000|Overall Study|Withdrawal by Subject|2|||
124539226|NCT02713490|447927119|FG001|Overall Study|Withdrawal by Subject|1|||
124539227|NCT02713490|447927118|FG000|Overall Study|Did not receive study drug|1|||
124539228|NCT02713490|447927119|FG001|Overall Study|Did not receive study drug|0|||
124539229|NCT02713490|447927118|FG000|Overall Study|Met exclusion criteria|0|||
124539230|NCT02713490|447927119|FG001|Overall Study|Met exclusion criteria|1|||
124539231|NCT03799198|447927120|FG000|Overall Study|Lost to Follow-up|4|||
124539232|NCT03799198|447927121|FG001|Overall Study|Lost to Follow-up|8|||
124539233|NCT03799198|447927120|FG000|Overall Study|Death|0|||
124539234|NCT03799198|447927121|FG001|Overall Study|Death|1|||
124539235|NCT00151775|447927134|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
124539236|NCT00151775|447927135|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
124539237|NCT00151775|447927136|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
124539238|NCT00151775|447927137|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
124539239|NCT00151775|447927138|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
124539240|NCT00151775|447927139|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
124539241|NCT00151775|447927140|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
124539242|NCT00151775|447927141|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
124539243|NCT00151775|447927142|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
124539244|NCT00151775|447927143|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
124539245|NCT00151775|447927144|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
124539246|NCT00151775|447927145|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
124539247|NCT00151775|447927134|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
124539248|NCT00151775|447927135|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
124539249|NCT00151775|447927136|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
124758632|NCT01463306|448739821|FG001|Overall Study|Adverse Event|9|||
124539250|NCT00151775|447927137|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
124539251|NCT00151775|447927138|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
124539252|NCT00151775|447927139|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
124539253|NCT00151775|447927140|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
124539254|NCT00151775|447927141|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
124539255|NCT00151775|447927142|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
124539256|NCT00151775|447927143|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
124539257|NCT00151775|447927144|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
124539258|NCT00151775|447927145|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
124539259|NCT00151775|447927134|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
124539260|NCT00151775|447927135|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
124539261|NCT00151775|447927136|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
124539262|NCT00151775|447927137|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
124539263|NCT00151775|447927138|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
124539264|NCT00151775|447927139|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
124539265|NCT00151775|447927140|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
124539266|NCT00151775|447927141|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
124539267|NCT00151775|447927142|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
124539268|NCT00151775|447927143|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
124539269|NCT00151775|447927144|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
124539270|NCT00151775|447927145|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
124539271|NCT00151775|447927134|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
124539272|NCT00151775|447927135|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
124539273|NCT00151775|447927136|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
124539274|NCT00151775|447927137|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
124539275|NCT00151775|447927138|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
124539276|NCT00151775|447927139|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
124539277|NCT00151775|447927140|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
124539278|NCT00151775|447927141|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
124539279|NCT00151775|447927142|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
124539280|NCT00151775|447927143|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
124539281|NCT00151775|447927144|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
124539282|NCT00151775|447927145|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
124539283|NCT00151775|447927134|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
124539284|NCT00151775|447927135|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
124539285|NCT00151775|447927136|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
124539286|NCT00151775|447927137|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
124539287|NCT00151775|447927138|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
124539288|NCT00151775|447927139|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
124539289|NCT00151775|447927140|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
124539290|NCT00151775|447927141|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
124539291|NCT00151775|447927142|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
124539292|NCT00151775|447927143|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
124539293|NCT00151775|447927144|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
124539294|NCT00151775|447927145|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
124539295|NCT00151775|447927134|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
124539296|NCT00151775|447927135|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
124539297|NCT00151775|447927136|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
124539298|NCT00151775|447927137|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
124539299|NCT00151775|447927138|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
124539300|NCT00151775|447927139|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
124539301|NCT00151775|447927140|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
124539302|NCT00151775|447927141|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
124539303|NCT00151775|447927142|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
124539304|NCT00151775|447927143|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
124539305|NCT00151775|447927144|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
124539306|NCT00151775|447927145|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
124539307|NCT00151775|447927134|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
124539308|NCT00151775|447927135|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
124872025|NCT02453685|449152785|FG001|Overall Study|Protocol Violation|4|||
124872026|NCT02453685|449152784|FG000|Overall Study|Lost to Follow-up|0|||
124872027|NCT02453685|449152785|FG001|Overall Study|Lost to Follow-up|1|||
124872028|NCT02453685|449152784|FG000|Overall Study|Withdrawal by Subject|8|||
124872029|NCT02453685|449152785|FG001|Overall Study|Withdrawal by Subject|4|||
124872030|NCT02453685|449152784|FG000|Overall Study|Unclassified|4|||
124872031|NCT02453685|449152785|FG001|Overall Study|Unclassified|2|||
124872032|NCT00453986|449152788|FG000|Overall Study|Lost to Follow-up|6|||
124872033|NCT00453986|449152789|FG001|Overall Study|Lost to Follow-up|5|||
124539309|NCT00151775|447927136|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
124539310|NCT00151775|447927137|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
124539311|NCT00151775|447927138|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
124539312|NCT00151775|447927139|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
124539313|NCT00151775|447927140|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
124539314|NCT00151775|447927141|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
124539315|NCT00151775|447927142|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
124539316|NCT00151775|447927143|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
124539317|NCT00151775|447927144|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
124539318|NCT00151775|447927145|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
124539319|NCT00151775|447927134|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
124539320|NCT00151775|447927135|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
124539321|NCT00151775|447927136|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
124539322|NCT00151775|447927137|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
124539323|NCT00151775|447927138|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
124539324|NCT00151775|447927139|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
124539325|NCT00151775|447927140|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
124539326|NCT00151775|447927141|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
124539327|NCT00151775|447927142|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
124539328|NCT00151775|447927143|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
124539329|NCT00151775|447927144|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
124539330|NCT00151775|447927145|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
124539331|NCT00151775|447927134|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
124539332|NCT00151775|447927135|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
124539333|NCT00151775|447927136|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
124539334|NCT00151775|447927137|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
124539335|NCT00151775|447927138|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
124539336|NCT00151775|447927139|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
124539337|NCT00151775|447927140|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
124539338|NCT00151775|447927141|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
124539339|NCT00151775|447927142|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
124539340|NCT00151775|447927143|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
124539341|NCT00151775|447927144|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
124539342|NCT00151775|447927145|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
124539343|NCT00151775|447927134|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
124539344|NCT00151775|447927135|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
124539345|NCT00151775|447927136|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
124539346|NCT00151775|447927137|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
124539347|NCT00151775|447927138|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
124539348|NCT00151775|447927139|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
124539349|NCT00151775|447927140|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
124539350|NCT00151775|447927141|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
124539351|NCT00151775|447927142|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
124539352|NCT00151775|447927143|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
124539353|NCT00151775|447927144|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
124539354|NCT00151775|447927145|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
124539355|NCT00151775|447927134|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
124539356|NCT00151775|447927135|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
124539357|NCT00151775|447927136|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
124539358|NCT00151775|447927137|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
124539359|NCT00151775|447927138|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
124539360|NCT00151775|447927139|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
124539361|NCT00151775|447927140|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
124539362|NCT00151775|447927141|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
124539363|NCT00151775|447927142|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
124539364|NCT00151775|447927143|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
124539365|NCT00151775|447927144|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
124539366|NCT00151775|447927145|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
124539367|NCT00151775|447927134|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
124539368|NCT00151775|447927135|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
124539369|NCT00151775|447927136|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
124539370|NCT00151775|447927137|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
124539371|NCT00151775|447927138|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
124539372|NCT00151775|447927139|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
124539373|NCT00151775|447927140|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
124539374|NCT00151775|447927141|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
124539375|NCT00151775|447927142|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
124539376|NCT00151775|447927143|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
124539377|NCT00151775|447927144|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
124539378|NCT00151775|447927145|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
124539379|NCT00151775|447927134|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
124539380|NCT00151775|447927135|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
124539381|NCT00151775|447927136|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
124539382|NCT00151775|447927137|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
124539383|NCT00151775|447927138|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
124539384|NCT00151775|447927139|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
124539385|NCT00151775|447927140|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
124539386|NCT00151775|447927141|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
124539387|NCT00151775|447927142|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
124539388|NCT00151775|447927143|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
124539389|NCT00151775|447927144|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
124539390|NCT00151775|447927145|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
124539391|NCT00151775|447927134|FG000|Period 4: Open Label|Increased blood pressure|0|||
124539392|NCT00151775|447927135|FG001|Period 4: Open Label|Increased blood pressure|0|||
124539393|NCT00151775|447927136|FG002|Period 4: Open Label|Increased blood pressure|0|||
124539394|NCT00151775|447927137|FG003|Period 4: Open Label|Increased blood pressure|0|||
124539395|NCT00151775|447927138|FG004|Period 4: Open Label|Increased blood pressure|1|||
124539396|NCT00151775|447927139|FG005|Period 4: Open Label|Increased blood pressure|0|||
124539397|NCT00151775|447927140|FG006|Period 4: Open Label|Increased blood pressure|0|||
124539398|NCT00151775|447927141|FG007|Period 4: Open Label|Increased blood pressure|0|||
124539399|NCT00151775|447927142|FG008|Period 4: Open Label|Increased blood pressure|0|||
124539400|NCT00151775|447927143|FG009|Period 4: Open Label|Increased blood pressure|1|||
124539401|NCT00151775|447927144|FG010|Period 4: Open Label|Increased blood pressure|0|||
124539402|NCT00151775|447927145|FG011|Period 4: Open Label|Increased blood pressure|0|||
124539403|NCT00151775|447927134|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
124539404|NCT00151775|447927135|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
124539405|NCT00151775|447927136|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
124539406|NCT00151775|447927137|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
124539407|NCT00151775|447927138|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
124539408|NCT00151775|447927139|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
124539409|NCT00151775|447927140|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
124539410|NCT00151775|447927141|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
124539411|NCT00151775|447927142|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
124539412|NCT00151775|447927143|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
124539413|NCT00151775|447927144|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
124539414|NCT00151775|447927145|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
124539415|NCT00151775|447927134|FG000|Period 4: Open Label|Adverse Event|0|||
124539416|NCT00151775|447927135|FG001|Period 4: Open Label|Adverse Event|0|||
124539417|NCT00151775|447927136|FG002|Period 4: Open Label|Adverse Event|0|||
124539418|NCT00151775|447927137|FG003|Period 4: Open Label|Adverse Event|0|||
124539419|NCT00151775|447927138|FG004|Period 4: Open Label|Adverse Event|1|||
124539420|NCT00151775|447927139|FG005|Period 4: Open Label|Adverse Event|0|||
124539421|NCT00151775|447927140|FG006|Period 4: Open Label|Adverse Event|0|||
124539422|NCT00151775|447927141|FG007|Period 4: Open Label|Adverse Event|0|||
124539423|NCT00151775|447927142|FG008|Period 4: Open Label|Adverse Event|0|||
124539424|NCT00151775|447927143|FG009|Period 4: Open Label|Adverse Event|2|||
124539425|NCT00151775|447927144|FG010|Period 4: Open Label|Adverse Event|0|||
124539426|NCT00151775|447927145|FG011|Period 4: Open Label|Adverse Event|0|||
124539427|NCT00151775|447927134|FG000|Period 4: Open Label|Lost to Follow-up|0|||
124539428|NCT00151775|447927135|FG001|Period 4: Open Label|Lost to Follow-up|0|||
124539429|NCT00151775|447927136|FG002|Period 4: Open Label|Lost to Follow-up|0|||
124539430|NCT00151775|447927137|FG003|Period 4: Open Label|Lost to Follow-up|0|||
124539431|NCT00151775|447927138|FG004|Period 4: Open Label|Lost to Follow-up|17|||
124539432|NCT00151775|447927139|FG005|Period 4: Open Label|Lost to Follow-up|0|||
124539433|NCT00151775|447927140|FG006|Period 4: Open Label|Lost to Follow-up|0|||
124539434|NCT00151775|447927141|FG007|Period 4: Open Label|Lost to Follow-up|0|||
124539435|NCT00151775|447927142|FG008|Period 4: Open Label|Lost to Follow-up|0|||
124539436|NCT00151775|447927143|FG009|Period 4: Open Label|Lost to Follow-up|7|||
124539437|NCT00151775|447927144|FG010|Period 4: Open Label|Lost to Follow-up|0|||
124539438|NCT00151775|447927145|FG011|Period 4: Open Label|Lost to Follow-up|0|||
124539439|NCT00151775|447927134|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
124539440|NCT00151775|447927135|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
124539441|NCT00151775|447927136|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
124981306|NCT01283516|449557456|FG008|Overall Study|Death|12|||
124539442|NCT00151775|447927137|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
124539443|NCT00151775|447927138|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
124981307|NCT01283516|449557448|FG000|Overall Study|Disease Progression|2|||
124539444|NCT00151775|447927139|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
124539445|NCT00151775|447927140|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
124539446|NCT00151775|447927141|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
124539447|NCT00151775|447927142|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
124539448|NCT00151775|447927143|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
124539449|NCT00151775|447927144|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
124539450|NCT00151775|447927145|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
124539451|NCT00151775|447927134|FG000|Period 4: Open Label|Other|0|||
124539452|NCT00151775|447927135|FG001|Period 4: Open Label|Other|0|||
124539453|NCT00151775|447927136|FG002|Period 4: Open Label|Other|0|||
124539454|NCT00151775|447927137|FG003|Period 4: Open Label|Other|0|||
124539455|NCT00151775|447927138|FG004|Period 4: Open Label|Other|1|||
124539456|NCT00151775|447927139|FG005|Period 4: Open Label|Other|0|||
124539457|NCT00151775|447927140|FG006|Period 4: Open Label|Other|0|||
124539458|NCT00151775|447927141|FG007|Period 4: Open Label|Other|0|||
124539459|NCT00151775|447927142|FG008|Period 4: Open Label|Other|0|||
124539460|NCT00151775|447927143|FG009|Period 4: Open Label|Other|3|||
124539461|NCT00151775|447927144|FG010|Period 4: Open Label|Other|0|||
124539462|NCT00151775|447927145|FG011|Period 4: Open Label|Other|0|||
124539463|NCT00151775|447927134|FG000|Period 4: Open Label|Physician Decision|0|||
124539464|NCT00151775|447927135|FG001|Period 4: Open Label|Physician Decision|0|||
124539465|NCT00151775|447927136|FG002|Period 4: Open Label|Physician Decision|0|||
124539466|NCT00151775|447927137|FG003|Period 4: Open Label|Physician Decision|0|||
124539467|NCT00151775|447927138|FG004|Period 4: Open Label|Physician Decision|0|||
124539468|NCT00151775|447927139|FG005|Period 4: Open Label|Physician Decision|0|||
124539469|NCT00151775|447927140|FG006|Period 4: Open Label|Physician Decision|0|||
124539470|NCT00151775|447927141|FG007|Period 4: Open Label|Physician Decision|0|||
124539471|NCT00151775|447927142|FG008|Period 4: Open Label|Physician Decision|0|||
124539472|NCT00151775|447927143|FG009|Period 4: Open Label|Physician Decision|2|||
124539473|NCT00151775|447927144|FG010|Period 4: Open Label|Physician Decision|0|||
124539474|NCT00151775|447927145|FG011|Period 4: Open Label|Physician Decision|0|||
124539475|NCT00151775|447927134|FG000|Period 4: Open Label|Protocol Violation|0|||
124539476|NCT00151775|447927135|FG001|Period 4: Open Label|Protocol Violation|0|||
124539477|NCT00151775|447927136|FG002|Period 4: Open Label|Protocol Violation|0|||
124539478|NCT00151775|447927137|FG003|Period 4: Open Label|Protocol Violation|0|||
124539479|NCT00151775|447927138|FG004|Period 4: Open Label|Protocol Violation|1|||
124539480|NCT00151775|447927139|FG005|Period 4: Open Label|Protocol Violation|0|||
124539481|NCT00151775|447927140|FG006|Period 4: Open Label|Protocol Violation|0|||
124539482|NCT00151775|447927141|FG007|Period 4: Open Label|Protocol Violation|0|||
124539483|NCT00151775|447927142|FG008|Period 4: Open Label|Protocol Violation|0|||
124539484|NCT00151775|447927143|FG009|Period 4: Open Label|Protocol Violation|0|||
124539485|NCT00151775|447927144|FG010|Period 4: Open Label|Protocol Violation|0|||
124539486|NCT00151775|447927145|FG011|Period 4: Open Label|Protocol Violation|0|||
124539487|NCT00474994|447927154|FG000|Overall Study|Patient Not treated|1|||
124539488|NCT00474994|447927154|FG000|Overall Study|Patient evaluable for toxicity only|3|||
124539489|NCT00474994|447927154|FG000|Overall Study|Patient found to be ineligible|1|||
124539490|NCT02181634|447927157|FG000|Overall Study|Lack of Efficacy|33|||
124539491|NCT02181634|447927157|FG000|Overall Study|Adverse Event|17|||
124539492|NCT02181634|447927157|FG000|Overall Study|Physician Decision|8|||
124539493|NCT02181634|447927157|FG000|Overall Study|Withdrawal by Subject|5|||
124539494|NCT02181634|447927157|FG000|Overall Study|Death|2|||
124539495|NCT02181634|447927157|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
124539496|NCT02181634|447927157|FG000|Overall Study|Ineligible|1|||
124539497|NCT02181634|447927157|FG000|Overall Study|Max number of dose reduction|1|||
124539498|NCT02181634|447927157|FG000|Overall Study|Symptomatic progression|1|||
124539499|NCT02181634|447927157|FG000|Overall Study|Patient opted to proceed to surgery|1|||
124539500|NCT01928758|447927165|FG000|Overall Study|Lost to Follow-up|14|||
124539501|NCT01928758|447927166|FG001|Overall Study|Lost to Follow-up|9|||
124539502|NCT01928758|447927165|FG000|Overall Study|Withdrawal by Subject|5|||
124539503|NCT01928758|447927166|FG001|Overall Study|Withdrawal by Subject|2|||
124539504|NCT01928758|447927165|FG000|Overall Study|Adverse Event|3|||
124539505|NCT01928758|447927166|FG001|Overall Study|Adverse Event|5|||
124539506|NCT01928758|447927165|FG000|Overall Study|Protocol Violation|3|||
124539507|NCT01928758|447927166|FG001|Overall Study|Protocol Violation|4|||
124539508|NCT02718131|447927167|FG000|Overall Study|Withdrawal by Subject|1|||
124539509|NCT02718131|447927168|FG001|Overall Study|Withdrawal by Subject|0|||
124539510|NCT02718131|447927167|FG000|Overall Study|Adverse Event|1|||
124539511|NCT02718131|447927168|FG001|Overall Study|Adverse Event|0|||
124539512|NCT02718131|447927167|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
124539513|NCT02718131|447927168|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
124539514|NCT00719706|447927169|FG000|Overall Study|Adverse Event|5|||
124539515|NCT00719706|447927170|FG001|Overall Study|Adverse Event|4|||
124539516|NCT00719706|447927169|FG000|Overall Study|Withdrawal by Subject|1|||
124539517|NCT00719706|447927170|FG001|Overall Study|Withdrawal by Subject|2|||
124539518|NCT00719706|447927169|FG000|Overall Study|Protocol Violation|3|||
124539519|NCT00719706|447927170|FG001|Overall Study|Protocol Violation|0|||
124539520|NCT00682539|447927178|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
124539521|NCT00682539|447927179|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
124539522|NCT00682539|447927180|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
124539523|NCT00682539|447927178|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
124539524|NCT00682539|447927179|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
124539525|NCT00682539|447927180|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
124539526|NCT01911546|447927183|FG000|Overall Study|Lost to Follow-up|1|||
124539527|NCT01911546|447927183|FG000|Overall Study|Everolimus was discontinued|5|||
124539528|NCT02546193|447927184|FG000|Overall Study|Withdrawal by Subject|2|||
124539529|NCT02546193|447927185|FG001|Overall Study|Withdrawal by Subject|0|||
124539530|NCT02546193|447927186|FG002|Overall Study|Withdrawal by Subject|1|||
124539531|NCT02546193|447927187|FG003|Overall Study|Withdrawal by Subject|0|||
124539532|NCT02546193|447927184|FG000|Overall Study|Not eligible at time of induction|4|||
124539533|NCT02546193|447927185|FG001|Overall Study|Not eligible at time of induction|6|||
124539534|NCT02546193|447927186|FG002|Overall Study|Not eligible at time of induction|1|||
124539535|NCT02546193|447927187|FG003|Overall Study|Not eligible at time of induction|0|||
124539536|NCT01287403|447927188|FG000|1st Intervention (1 Day)|Adverse Event|1|||
124539537|NCT00148109|447927189|FG000|Overall Study|Lack of Efficacy|10|||
124539538|NCT00148109|447927190|FG001|Overall Study|Lack of Efficacy|18|||
124539539|NCT00148109|447927189|FG000|Overall Study|Adverse Event|0|||
124539540|NCT00148109|447927190|FG001|Overall Study|Adverse Event|2|||
124539541|NCT00148109|447927189|FG000|Overall Study|Withdrawal by Subject|2|||
124539542|NCT00148109|447927190|FG001|Overall Study|Withdrawal by Subject|0|||
124539543|NCT00649220|447927191|FG000|Overall Study|Adverse Event|2|||
124539544|NCT00649220|447927191|FG000|Overall Study|Withdrawal by Subject|1|||
124539545|NCT01399619|447927192|FG000|Overall Study|Adverse Event|10|||
124539546|NCT01399619|447927193|FG001|Overall Study|Adverse Event|0|||
124539547|NCT01399619|447927194|FG002|Overall Study|Adverse Event|4|||
124539548|NCT01399619|447927195|FG003|Overall Study|Adverse Event|10|||
124539549|NCT01399619|447927192|FG000|Overall Study|Lack of Efficacy|9|||
124539550|NCT01399619|447927193|FG001|Overall Study|Lack of Efficacy|0|||
124539551|NCT01399619|447927194|FG002|Overall Study|Lack of Efficacy|5|||
124539552|NCT01399619|447927195|FG003|Overall Study|Lack of Efficacy|0|||
124539553|NCT01399619|447927192|FG000|Overall Study|Withdrawal by Subject|6|||
124539554|NCT01399619|447927193|FG001|Overall Study|Withdrawal by Subject|0|||
124539555|NCT01399619|447927194|FG002|Overall Study|Withdrawal by Subject|3|||
124539556|NCT01399619|447927195|FG003|Overall Study|Withdrawal by Subject|4|||
124539557|NCT01399619|447927192|FG000|Overall Study|Protocol Violation|0|||
124539558|NCT01399619|447927193|FG001|Overall Study|Protocol Violation|0|||
124539559|NCT01399619|447927194|FG002|Overall Study|Protocol Violation|0|||
124539560|NCT01399619|447927195|FG003|Overall Study|Protocol Violation|1|||
124539561|NCT01399619|447927192|FG000|Overall Study|Not treated|0|||
124539562|NCT01399619|447927193|FG001|Overall Study|Not treated|0|||
124539563|NCT01399619|447927194|FG002|Overall Study|Not treated|0|||
124539564|NCT01399619|447927195|FG003|Overall Study|Not treated|2|||
124539565|NCT02557308|447927196|FG000|Overall Study|Withdrawal by Subject|11|||
124539566|NCT02557308|447927197|FG001|Overall Study|Withdrawal by Subject|3|||
124539567|NCT02557308|447927198|FG002|Overall Study|Withdrawal by Subject|2|||
124539568|NCT02557308|447927199|FG003|Overall Study|Withdrawal by Subject|0|||
124539569|NCT02557308|447927200|FG004|Overall Study|Withdrawal by Subject|1|||
124539570|NCT02557308|447927201|FG005|Overall Study|Withdrawal by Subject|0|||
124539571|NCT02557308|447927202|FG006|Overall Study|Withdrawal by Subject|10|||
124539572|NCT02557308|447927203|FG007|Overall Study|Withdrawal by Subject|1|||
124539573|NCT02557308|447927196|FG000|Overall Study|Disease Progression|0|||
124539574|NCT02557308|447927197|FG001|Overall Study|Disease Progression|1|||
124539575|NCT02557308|447927198|FG002|Overall Study|Disease Progression|0|||
124539576|NCT02557308|447927199|FG003|Overall Study|Disease Progression|0|||
124539577|NCT02557308|447927200|FG004|Overall Study|Disease Progression|0|||
124539578|NCT02557308|447927201|FG005|Overall Study|Disease Progression|0|||
124539579|NCT02557308|447927202|FG006|Overall Study|Disease Progression|0|||
124539580|NCT02557308|447927203|FG007|Overall Study|Disease Progression|0|||
124539581|NCT02557308|447927196|FG000|Overall Study|Lack of Efficacy|3|||
124539582|NCT02557308|447927197|FG001|Overall Study|Lack of Efficacy|0|||
124539583|NCT02557308|447927198|FG002|Overall Study|Lack of Efficacy|0|||
124539584|NCT02557308|447927199|FG003|Overall Study|Lack of Efficacy|0|||
124539585|NCT02557308|447927200|FG004|Overall Study|Lack of Efficacy|0|||
124539586|NCT02557308|447927201|FG005|Overall Study|Lack of Efficacy|0|||
124539587|NCT02557308|447927202|FG006|Overall Study|Lack of Efficacy|1|||
124539588|NCT02557308|447927203|FG007|Overall Study|Lack of Efficacy|0|||
124539589|NCT02557308|447927196|FG000|Overall Study|Adverse Event|4|||
124539590|NCT02557308|447927197|FG001|Overall Study|Adverse Event|1|||
124539591|NCT02557308|447927198|FG002|Overall Study|Adverse Event|2|||
124539592|NCT02557308|447927199|FG003|Overall Study|Adverse Event|0|||
124539593|NCT02557308|447927200|FG004|Overall Study|Adverse Event|0|||
124539594|NCT02557308|447927201|FG005|Overall Study|Adverse Event|0|||
124539595|NCT02557308|447927202|FG006|Overall Study|Adverse Event|4|||
124539596|NCT02557308|447927203|FG007|Overall Study|Adverse Event|1|||
124539597|NCT02557308|447927196|FG000|Overall Study|Lost to Follow-up|2|||
124539598|NCT02557308|447927197|FG001|Overall Study|Lost to Follow-up|0|||
124539599|NCT02557308|447927198|FG002|Overall Study|Lost to Follow-up|1|||
124539600|NCT02557308|447927199|FG003|Overall Study|Lost to Follow-up|0|||
124539601|NCT02557308|447927200|FG004|Overall Study|Lost to Follow-up|0|||
124539602|NCT02557308|447927201|FG005|Overall Study|Lost to Follow-up|0|||
124539603|NCT02557308|447927202|FG006|Overall Study|Lost to Follow-up|2|||
124539604|NCT02557308|447927203|FG007|Overall Study|Lost to Follow-up|0|||
124539605|NCT02557308|447927196|FG000|Overall Study|Death|1|||
124539606|NCT02557308|447927197|FG001|Overall Study|Death|0|||
124539607|NCT02557308|447927198|FG002|Overall Study|Death|0|||
124539608|NCT02557308|447927199|FG003|Overall Study|Death|0|||
124539609|NCT02557308|447927200|FG004|Overall Study|Death|0|||
124539610|NCT02557308|447927201|FG005|Overall Study|Death|0|||
124539611|NCT02557308|447927202|FG006|Overall Study|Death|0|||
124539612|NCT02557308|447927203|FG007|Overall Study|Death|0|||
124539613|NCT02557308|447927196|FG000|Overall Study|Study Close|98|||
124539614|NCT02557308|447927197|FG001|Overall Study|Study Close|18|||
124539615|NCT02557308|447927198|FG002|Overall Study|Study Close|5|||
124539616|NCT02557308|447927199|FG003|Overall Study|Study Close|3|||
124539617|NCT02557308|447927200|FG004|Overall Study|Study Close|1|||
124539618|NCT02557308|447927201|FG005|Overall Study|Study Close|0|||
124539619|NCT02557308|447927202|FG006|Overall Study|Study Close|123|||
124539620|NCT02557308|447927203|FG007|Overall Study|Study Close|5|||
124539621|NCT02557308|447927196|FG000|Overall Study|Except for study close|5|||
124539622|NCT02557308|447927197|FG001|Overall Study|Except for study close|0|||
124539623|NCT02557308|447927198|FG002|Overall Study|Except for study close|0|||
124539624|NCT02557308|447927199|FG003|Overall Study|Except for study close|0|||
124539625|NCT02557308|447927200|FG004|Overall Study|Except for study close|3|||
124539626|NCT02557308|447927201|FG005|Overall Study|Except for study close|0|||
124539627|NCT02557308|447927202|FG006|Overall Study|Except for study close|6|||
124539628|NCT02557308|447927203|FG007|Overall Study|Except for study close|10|||
124539629|NCT00351611|447927206|FG000|Overall Study|Adverse Event|11|||
124539630|NCT00351611|447927207|FG001|Overall Study|Adverse Event|3|||
124539631|NCT00351611|447927206|FG000|Overall Study|Death|1|||
124539632|NCT00351611|447927207|FG001|Overall Study|Death|0|||
124539633|NCT00351611|447927206|FG000|Overall Study|Lost to Follow-up|1|||
124539634|NCT00351611|447927207|FG001|Overall Study|Lost to Follow-up|0|||
124539635|NCT00351611|447927206|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
124539636|NCT00351611|447927207|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
124539637|NCT00351611|447927206|FG000|Overall Study|Other|1|||
124539638|NCT00351611|447927207|FG001|Overall Study|Other|0|||
124539639|NCT00351611|447927206|FG000|Overall Study|Protocol Violation|0|||
124539640|NCT00351611|447927207|FG001|Overall Study|Protocol Violation|2|||
124539641|NCT00267202|447927208|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
124539642|NCT00267202|447927209|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
124539643|NCT00267202|447927208|FG000|Overall Study|Withdrawal by Subject|12|||
124539644|NCT00267202|447927209|FG001|Overall Study|Withdrawal by Subject|15|||
124539645|NCT00267202|447927208|FG000|Overall Study|Adverse Event|13|||
124539646|NCT00267202|447927209|FG001|Overall Study|Adverse Event|7|||
124539647|NCT00267202|447927208|FG000|Overall Study|Protocol Violation|2|||
124539648|NCT00267202|447927209|FG001|Overall Study|Protocol Violation|3|||
124539649|NCT00267202|447927208|FG000|Overall Study|Administrative problems|2|||
124539650|NCT00267202|447927209|FG001|Overall Study|Administrative problems|1|||
124539651|NCT00267202|447927208|FG000|Overall Study|Lost to Follow-up|3|||
124539652|NCT00267202|447927209|FG001|Overall Study|Lost to Follow-up|0|||
124539653|NCT00368069|447927210|FG000|Overall Study|Adverse Event|5|||
124539654|NCT00368069|447927211|FG001|Overall Study|Adverse Event|2|||
124539655|NCT00368069|447927210|FG000|Overall Study|Lack of Efficacy|0|||
124539656|NCT00368069|447927211|FG001|Overall Study|Lack of Efficacy|1|||
124539657|NCT00368069|447927210|FG000|Overall Study|Lost to Follow-up|1|||
124539658|NCT00368069|447927211|FG001|Overall Study|Lost to Follow-up|0|||
124539659|NCT00368069|447927210|FG000|Overall Study|Protocol Violation|0|||
124539660|NCT00368069|447927211|FG001|Overall Study|Protocol Violation|2|||
124539661|NCT00368069|447927210|FG000|Overall Study|Withdrawal of Consent|2|||
124539662|NCT00368069|447927211|FG001|Overall Study|Withdrawal of Consent|1|||
124539663|NCT00368069|447927210|FG000|Overall Study|no blood sampling possible|0|||
124539664|NCT00368069|447927211|FG001|Overall Study|no blood sampling possible|1|||
124539665|NCT03907072|447927215|FG000|Overall Study|Study Terminated by Sponsor|2|||
124539666|NCT03907072|447927216|FG001|Overall Study|Study Terminated by Sponsor|2|||
124539667|NCT03907072|447927217|FG002|Overall Study|Study Terminated by Sponsor|2|||
124539668|NCT01430559|447927220|FG000|Overall Study|Adverse Event|7|||
124539669|NCT01430559|447927221|FG001|Overall Study|Adverse Event|3|||
124539670|NCT01430559|447927220|FG000|Overall Study|Entry criteria not met|1|||
124539671|NCT01430559|447927221|FG001|Overall Study|Entry criteria not met|1|||
124539672|NCT01430559|447927220|FG000|Overall Study|Lost to Follow-up|1|||
124539673|NCT01430559|447927221|FG001|Overall Study|Lost to Follow-up|0|||
124539674|NCT01430559|447927220|FG000|Overall Study|Medication error|1|||
124539675|NCT01430559|447927221|FG001|Overall Study|Medication error|0|||
124539676|NCT01430559|447927220|FG000|Overall Study|Withdrawal by Subject|3|||
124539677|NCT01430559|447927221|FG001|Overall Study|Withdrawal by Subject|2|||
124539678|NCT01430559|447927220|FG000|Overall Study|Protocol Violation|1|||
124539679|NCT01430559|447927221|FG001|Overall Study|Protocol Violation|0|||
124539680|NCT01430559|447927220|FG000|Overall Study|Other|3|||
124539681|NCT01430559|447927221|FG001|Overall Study|Other|3|||
124539682|NCT01430559|447927220|FG000|Overall Study|Randomized, Not Treated|3|||
124539683|NCT01430559|447927221|FG001|Overall Study|Randomized, Not Treated|3|||
124539684|NCT01177943|447927223|FG000|First Intervention|Withdrawal by Subject|2|||
124539685|NCT01177943|447927224|FG001|First Intervention|Withdrawal by Subject|0|||
124539686|NCT00808665|447927225|FG000|Overall Study|Withdrawal by Subject|1|||
124539687|NCT00808665|447927226|FG001|Overall Study|Withdrawal by Subject|0|||
124539688|NCT00808665|447927225|FG000|Overall Study|only required minimally invasive surgery|1|||
124539689|NCT00808665|447927226|FG001|Overall Study|only required minimally invasive surgery|0|||
124539690|NCT00808665|447927225|FG000|Overall Study|surgery cancelled|1|||
124539691|NCT00808665|447927226|FG001|Overall Study|surgery cancelled|0|||
124539692|NCT00808665|447927225|FG000|Overall Study|required an additional procedure|0|||
124539693|NCT00808665|447927226|FG001|Overall Study|required an additional procedure|1|||
124539694|NCT00808665|447927225|FG000|Overall Study|Physician Decision|3|||
124539695|NCT00808665|447927226|FG001|Overall Study|Physician Decision|1|||
124539696|NCT00808665|447927225|FG000|Overall Study|Medication stopped by resident|0|||
124539697|NCT00808665|447927226|FG001|Overall Study|Medication stopped by resident|1|||
124539698|NCT03319160|447927227|FG000|Overall Study|Data not available.|7|||
124539699|NCT02431559|447927228|FG000|Overall Study|Adverse Event|0|||
124539700|NCT02431559|447927229|FG001|Overall Study|Adverse Event|1|||
124539701|NCT02431559|447927230|FG002|Overall Study|Adverse Event|0|||
124539702|NCT02431559|447927231|FG003|Overall Study|Adverse Event|4|||
124539703|NCT02431559|447927228|FG000|Overall Study|Progressive disease|2|||
124539704|NCT02431559|447927229|FG001|Overall Study|Progressive disease|1|||
124539705|NCT02431559|447927230|FG002|Overall Study|Progressive disease|4|||
124539706|NCT02431559|447927231|FG003|Overall Study|Progressive disease|22|||
124539707|NCT02431559|447927228|FG000|Overall Study|Withdrawal by Subject|0|||
124539708|NCT02431559|447927229|FG001|Overall Study|Withdrawal by Subject|1|||
124539709|NCT02431559|447927230|FG002|Overall Study|Withdrawal by Subject|0|||
124539710|NCT02431559|447927231|FG003|Overall Study|Withdrawal by Subject|4|||
124539711|NCT02431559|447927228|FG000|Overall Study|Physician Decision|0|||
124539712|NCT02431559|447927229|FG001|Overall Study|Physician Decision|0|||
124539713|NCT02431559|447927230|FG002|Overall Study|Physician Decision|0|||
124539714|NCT02431559|447927231|FG003|Overall Study|Physician Decision|1|||
124539715|NCT02543918|447927232|FG000|Overall Study|Never treated|0|||
124539716|NCT02543918|447927233|FG001|Overall Study|Never treated|1|||
124539717|NCT02543918|447927232|FG000|Overall Study|Lost to Follow-up|1|||
124539718|NCT02543918|447927233|FG001|Overall Study|Lost to Follow-up|1|||
124539719|NCT02543918|447927232|FG000|Overall Study|Withdrawal by Subject|1|||
124539720|NCT02543918|447927233|FG001|Overall Study|Withdrawal by Subject|1|||
124539721|NCT02543918|447927232|FG000|Overall Study|Adverse Event|1|||
124539722|NCT02543918|447927233|FG001|Overall Study|Adverse Event|1|||
124539723|NCT01411917|447927235|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
124539724|NCT01411917|447927236|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
124539725|NCT04806334|447927243|FG000|Overall Study|Withdrawal by Subject|1|||
124539726|NCT01731600|447927246|FG000|Overall Study|Adverse Event|2|||
124539727|NCT01731600|447927247|FG001|Overall Study|Adverse Event|0|||
124539728|NCT01731600|447927246|FG000|Overall Study|Withdrawal criteria|1|||
124539729|NCT01731600|447927247|FG001|Overall Study|Withdrawal criteria|0|||
124539730|NCT01731600|447927246|FG000|Overall Study|Other reasons|3|||
124539731|NCT01731600|447927247|FG001|Overall Study|Other reasons|0|||
124539732|NCT00465894|447927248|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
124539733|NCT00465894|447927249|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
124872034|NCT00453986|449152790|FG002|Overall Study|Lost to Follow-up|6|||
124872035|NCT00453986|449152791|FG003|Overall Study|Lost to Follow-up|2|||
124872036|NCT00453986|449152792|FG004|Overall Study|Lost to Follow-up|0|||
124872037|NCT02778100|449152794|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
124872038|NCT02778100|449152795|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
124872039|NCT00522626|449152800|FG000|Overall Study|Lost to Follow-up|7|||
124872040|NCT00552084|449152803|FG000|Overall Study|Adverse Event|2|||
124872041|NCT00552084|449152804|FG001|Overall Study|Adverse Event|3|||
124872042|NCT00552084|449152803|FG000|Overall Study|Withdrawal by Subject|4|||
124872043|NCT00552084|449152804|FG001|Overall Study|Withdrawal by Subject|5|||
124872044|NCT00552084|449152803|FG000|Overall Study|Protocol Violation|1|||
124872045|NCT00552084|449152804|FG001|Overall Study|Protocol Violation|0|||
124872046|NCT00552084|449152803|FG000|Overall Study|change in anti-arrythmic drug|1|||
124872047|NCT00552084|449152804|FG001|Overall Study|change in anti-arrythmic drug|1|||
124872048|NCT01338025|449152805|FG000|Overall Study|Unexpected closure of study|10|||
124872049|NCT01338025|449152806|FG001|Overall Study|Unexpected closure of study|9|||
124872050|NCT01338025|449152805|FG000|Overall Study|Withdrawal by Subject|0|||
124872051|NCT01338025|449152806|FG001|Overall Study|Withdrawal by Subject|2|||
124539734|NCT00465894|447927248|FG000|Treatment For 12 Weeks|Family Issues|1|||
124539735|NCT00465894|447927249|FG001|Treatment For 12 Weeks|Family Issues|1|||
124539736|NCT00465894|447927248|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
124539737|NCT00465894|447927249|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
124539738|NCT01636076|447927250|FG000|Overall Study|Terminated by sponsor|1|||
124539739|NCT01636076|447927251|FG001|Overall Study|Terminated by sponsor|1|||
124539740|NCT01636076|447927250|FG000|Overall Study|Lack of Efficacy|0|||
124539741|NCT01636076|447927251|FG001|Overall Study|Lack of Efficacy|1|||
124539742|NCT01636076|447927250|FG000|Overall Study|Lost to Follow-up|1|||
124539743|NCT01636076|447927251|FG001|Overall Study|Lost to Follow-up|0|||
124539744|NCT01636076|447927250|FG000|Overall Study|Physician Decision|1|||
124539745|NCT01636076|447927251|FG001|Overall Study|Physician Decision|1|||
124539746|NCT01636076|447927250|FG000|Overall Study|Non-compliance with study treatment|1|||
124539747|NCT01636076|447927251|FG001|Overall Study|Non-compliance with study treatment|1|||
124539748|NCT01636076|447927250|FG000|Overall Study|Adverse Event|6|||
124539749|NCT01636076|447927251|FG001|Overall Study|Adverse Event|11|||
124539750|NCT01636076|447927250|FG000|Overall Study|Withdrawal by Subject|7|||
124539751|NCT01636076|447927251|FG001|Overall Study|Withdrawal by Subject|10|||
124539752|NCT00540228|447927252|FG000|Overall Study|Adverse Event|2|||
124539753|NCT00540228|447927253|FG001|Overall Study|Adverse Event|0|||
124539754|NCT00540228|447927254|FG002|Overall Study|Adverse Event|0|||
124539755|NCT00540228|447927255|FG003|Overall Study|Adverse Event|0|||
124539756|NCT00540228|447927256|FG004|Overall Study|Adverse Event|0|||
124981308|NCT01283516|449557449|FG001|Overall Study|Disease Progression|2|||
124981309|NCT01283516|449557450|FG002|Overall Study|Disease Progression|3|||
124539757|NCT00540228|447927252|FG000|Overall Study|Lost to Follow-up|1|||
124539758|NCT00540228|447927253|FG001|Overall Study|Lost to Follow-up|1|||
124539759|NCT00540228|447927254|FG002|Overall Study|Lost to Follow-up|0|||
124539760|NCT00540228|447927255|FG003|Overall Study|Lost to Follow-up|0|||
124539761|NCT00540228|447927256|FG004|Overall Study|Lost to Follow-up|0|||
124539762|NCT02173158|447927258|FG000|Efficacy Phase|Adverse Event|1|||
124539763|NCT00765726|447927270|FG000|Overall Study|Withdrawal by Subject|1|||
124539764|NCT00765726|447927270|FG000|Overall Study|Discontinuation of study by sponsor|8|||
124539765|NCT01265511|447927271|FG000|Overall Study|Lack of Efficacy|2|||
124539766|NCT01265511|447927272|FG001|Overall Study|Lack of Efficacy|1|||
124539767|NCT01265511|447927271|FG000|Overall Study|Met stopping rules|0|||
124539768|NCT01265511|447927272|FG001|Overall Study|Met stopping rules|2|||
124539769|NCT00323479|447927273|FG000|Overall Study|Adverse Event|2|||
124539770|NCT00323479|447927273|FG000|Overall Study|Withdrawal by Subject|2|||
124539771|NCT00323479|447927273|FG000|Overall Study|Protocol Violation|3|||
124539772|NCT00323479|447927273|FG000|Overall Study|house moving|1|||
124539773|NCT01362062|447927275|FG000|Overall Study|Adverse Event|1|||
124539774|NCT01362062|447927276|FG001|Overall Study|Adverse Event|0|||
124539775|NCT01362062|447927275|FG000|Overall Study|Lost to Follow-up|11|||
124539776|NCT01362062|447927276|FG001|Overall Study|Lost to Follow-up|0|||
124539777|NCT01362062|447927275|FG000|Overall Study|Withdrawal by Subject|2|||
124539778|NCT01362062|447927276|FG001|Overall Study|Withdrawal by Subject|0|||
124539779|NCT01362062|447927275|FG000|Overall Study|Non-compliant participant|2|||
124539780|NCT01362062|447927276|FG001|Overall Study|Non-compliant participant|0|||
124539781|NCT01362062|447927275|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
124539782|NCT01362062|447927276|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
124539783|NCT01362062|447927275|FG000|Overall Study|Had significant improvement|9|||
124539784|NCT01362062|447927276|FG001|Overall Study|Had significant improvement|0|||
124539785|NCT00967343|447927277|FG000|Overall Study|Study termination by sponsor|12|||
124539786|NCT00967343|447927277|FG000|Overall Study|Death|24|||
124539787|NCT00967343|447927277|FG000|Overall Study|Relapse|1|||
124539788|NCT00967343|447927277|FG000|Overall Study|Lost to Follow-up|1|||
124539789|NCT00950755|447927278|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
124539790|NCT00950755|447927278|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
124539791|NCT00950755|447927278|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
124539792|NCT00950755|447927278|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
124539793|NCT00950755|447927278|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
124539794|NCT00950755|447927278|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
124539795|NCT00950755|447927278|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
124539796|NCT00950755|447927278|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
124539797|NCT00950755|447927278|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
124539798|NCT00950755|447927278|FG000|Long-Term Follow-Up|Death|8|||
124539799|NCT00508820|447927280|FG000|Overall Study|Adverse Event|6|||
124539800|NCT00508820|447927281|FG001|Overall Study|Adverse Event|10|||
124539801|NCT00508820|447927280|FG000|Overall Study|Death|6|||
124539802|NCT00508820|447927281|FG001|Overall Study|Death|8|||
124539803|NCT00508820|447927280|FG000|Overall Study|Lost to Follow-up|1|||
124539804|NCT00508820|447927281|FG001|Overall Study|Lost to Follow-up|1|||
124539805|NCT00508820|447927280|FG000|Overall Study|Physician Decision|8|||
124539806|NCT00508820|447927281|FG001|Overall Study|Physician Decision|2|||
124539807|NCT00508820|447927280|FG000|Overall Study|Pregnancy|0|||
124539808|NCT00508820|447927281|FG001|Overall Study|Pregnancy|2|||
124539809|NCT00508820|447927280|FG000|Overall Study|Protocol Violation|2|||
124539810|NCT00508820|447927281|FG001|Overall Study|Protocol Violation|0|||
124981310|NCT01283516|449557451|FG003|Overall Study|Disease Progression|3|||
124539811|NCT00508820|447927280|FG000|Overall Study|Withdrawal by Subject|10|||
124539812|NCT00508820|447927281|FG001|Overall Study|Withdrawal by Subject|12|||
124539813|NCT00508820|447927280|FG000|Overall Study|Other|11|||
124539814|NCT00508820|447927281|FG001|Overall Study|Other|2|||
124539815|NCT00508820|447927280|FG000|Overall Study|Noncompliance|1|||
124539816|NCT00508820|447927281|FG001|Overall Study|Noncompliance|0|||
124539817|NCT00508820|447927280|FG000|Overall Study|Requirement for alternative therapy|7|||
124539818|NCT00508820|447927281|FG001|Overall Study|Requirement for alternative therapy|15|||
124539819|NCT00508820|447927280|FG000|Overall Study|Protocol-specified Criteria|3|||
124539820|NCT00508820|447927281|FG001|Overall Study|Protocol-specified Criteria|12|||
124539821|NCT02926833|447928783|FG000|Overall Study|Death|1|||
124539822|NCT02926833|447928784|FG001|Overall Study|Death|1|||
124539823|NCT02926833|447928785|FG002|Overall Study|Death|2|||
124539824|NCT02926833|447928786|FG003|Overall Study|Death|13|||
124539825|NCT02926833|447928783|FG000|Overall Study|Lost to Follow-up|1|||
124539826|NCT02926833|447928784|FG001|Overall Study|Lost to Follow-up|2|||
124539827|NCT02926833|447928785|FG002|Overall Study|Lost to Follow-up|0|||
124539828|NCT02926833|447928786|FG003|Overall Study|Lost to Follow-up|3|||
124539829|NCT02926833|447928783|FG000|Overall Study|Full Consent Withdrawal|0|||
124539830|NCT02926833|447928784|FG001|Overall Study|Full Consent Withdrawal|0|||
124539831|NCT02926833|447928785|FG002|Overall Study|Full Consent Withdrawal|0|||
124539832|NCT02926833|447928786|FG003|Overall Study|Full Consent Withdrawal|2|||
124539833|NCT02926833|447928783|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
124539834|NCT02926833|447928784|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
124539835|NCT02926833|447928785|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
124539836|NCT02926833|447928786|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
124539837|NCT02926833|447928783|FG000|Overall Study|Investigator Decision|0|||
124539838|NCT02926833|447928784|FG001|Overall Study|Investigator Decision|1|||
124539839|NCT02926833|447928785|FG002|Overall Study|Investigator Decision|0|||
124539840|NCT02926833|447928786|FG003|Overall Study|Investigator Decision|0|||
124539841|NCT02926833|447928783|FG000|Overall Study|Adverse Event|0|||
124539842|NCT02926833|447928784|FG001|Overall Study|Adverse Event|0|||
124539843|NCT02926833|447928785|FG002|Overall Study|Adverse Event|1|||
124539844|NCT02926833|447928786|FG003|Overall Study|Adverse Event|0|||
124539845|NCT02926833|447928783|FG000|Overall Study|Partial Withdrawal of Consent|0|||
124539846|NCT02926833|447928784|FG001|Overall Study|Partial Withdrawal of Consent|0|||
124539847|NCT02926833|447928785|FG002|Overall Study|Partial Withdrawal of Consent|0|||
124539848|NCT02926833|447928786|FG003|Overall Study|Partial Withdrawal of Consent|1|||
124539849|NCT01189201|447928787|FG000|Overall Study|Adverse Event|1|||
124539850|NCT01277757|447928788|FG000|Overall Study|Disease Progression|1|||
124539851|NCT01277757|447928788|FG000|Overall Study|Withdrawal by Subject|1|||
124539852|NCT04308668|447928789|FG000|Overall Study|Lost to Follow-up|32|||
124539853|NCT04308668|447928790|FG001|Overall Study|Lost to Follow-up|38|||
124539854|NCT04308668|447928789|FG000|Overall Study|Withdrawal by Subject|4|||
124539855|NCT04308668|447928790|FG001|Overall Study|Withdrawal by Subject|4|||
124539856|NCT01266967|447928791|FG000|Overall Study|Death|69|||
124539857|NCT01266967|447928792|FG001|Overall Study|Death|61|||
124539858|NCT01266967|447928791|FG000|Overall Study|Study Closed/Terminated|15|||
124539859|NCT01266967|447928792|FG001|Overall Study|Study Closed/Terminated|17|||
124539860|NCT01266967|447928791|FG000|Overall Study|Lost to Follow-up|2|||
124539861|NCT01266967|447928792|FG001|Overall Study|Lost to Follow-up|1|||
124539862|NCT01266967|447928791|FG000|Overall Study|Physician Decision|0|||
124539863|NCT01266967|447928792|FG001|Overall Study|Physician Decision|1|||
124539864|NCT01266967|447928791|FG000|Overall Study|Withdrawal by Subject|3|||
124539865|NCT01266967|447928792|FG001|Overall Study|Withdrawal by Subject|3|||
124539866|NCT01945866|447928793|FG000|Overall Study|Eyes did not complete or were dropped|2|||
124539867|NCT01945866|447928794|FG001|Overall Study|Eyes did not complete or were dropped|0|||
124539868|NCT01004822|447928795|FG000|Overall Study|Objective progression or relapse|3|||
124539869|NCT01004822|447928796|FG001|Overall Study|Objective progression or relapse|3|||
124539870|NCT01004822|447928797|FG002|Overall Study|Objective progression or relapse|0|||
124539871|NCT01004822|447928798|FG003|Overall Study|Objective progression or relapse|1|||
124539872|NCT01004822|447928799|FG004|Overall Study|Objective progression or relapse|2|||
124539873|NCT01004822|447928800|FG005|Overall Study|Objective progression or relapse|2|||
124539874|NCT01004822|447928801|FG006|Overall Study|Objective progression or relapse|1|||
124539875|NCT01004822|447928802|FG007|Overall Study|Objective progression or relapse|4|||
124539876|NCT01004822|447928795|FG000|Overall Study|Global deterioration of health status|0|||
124539877|NCT01004822|447928796|FG001|Overall Study|Global deterioration of health status|0|||
124539878|NCT01004822|447928797|FG002|Overall Study|Global deterioration of health status|0|||
124539879|NCT01004822|447928798|FG003|Overall Study|Global deterioration of health status|1|||
124539880|NCT01004822|447928799|FG004|Overall Study|Global deterioration of health status|0|||
124539881|NCT01004822|447928800|FG005|Overall Study|Global deterioration of health status|0|||
124539882|NCT01004822|447928801|FG006|Overall Study|Global deterioration of health status|1|||
124539883|NCT01004822|447928802|FG007|Overall Study|Global deterioration of health status|0|||
124539884|NCT01004822|447928795|FG000|Overall Study|No longer willing to continue|0|||
124758633|NCT01463306|448739822|FG002|Overall Study|Adverse Event|3|||
124539885|NCT01004822|447928796|FG001|Overall Study|No longer willing to continue|0|||
124539886|NCT01004822|447928797|FG002|Overall Study|No longer willing to continue|0|||
124539887|NCT01004822|447928798|FG003|Overall Study|No longer willing to continue|1|||
124539888|NCT01004822|447928799|FG004|Overall Study|No longer willing to continue|2|||
124539889|NCT01004822|447928800|FG005|Overall Study|No longer willing to continue|1|||
124539890|NCT01004822|447928801|FG006|Overall Study|No longer willing to continue|1|||
124539891|NCT01004822|447928802|FG007|Overall Study|No longer willing to continue|0|||
124539892|NCT01004822|447928795|FG000|Overall Study|Adverse Event|0|||
124539893|NCT01004822|447928796|FG001|Overall Study|Adverse Event|0|||
124539894|NCT01004822|447928797|FG002|Overall Study|Adverse Event|0|||
124539895|NCT01004822|447928798|FG003|Overall Study|Adverse Event|0|||
124539896|NCT01004822|447928799|FG004|Overall Study|Adverse Event|0|||
124981311|NCT01283516|449557452|FG004|Overall Study|Disease Progression|13|||
124539897|NCT01004822|447928800|FG005|Overall Study|Adverse Event|0|||
124539898|NCT01004822|447928801|FG006|Overall Study|Adverse Event|1|||
124539899|NCT01004822|447928802|FG007|Overall Study|Adverse Event|1|||
124539900|NCT01004822|447928795|FG000|Overall Study|Other|0|||
124539901|NCT01004822|447928796|FG001|Overall Study|Other|0|||
124539902|NCT01004822|447928797|FG002|Overall Study|Other|4|||
124539903|NCT01004822|447928798|FG003|Overall Study|Other|1|||
124539904|NCT01004822|447928799|FG004|Overall Study|Other|0|||
124539905|NCT01004822|447928800|FG005|Overall Study|Other|1|||
124539906|NCT01004822|447928801|FG006|Overall Study|Other|0|||
124539907|NCT01004822|447928802|FG007|Overall Study|Other|0|||
124539908|NCT01674010|447928803|FG000|Open Treatment Phase 1|Adverse Event|10|||
124539909|NCT01674010|447928804|FG001|Open Treatment Phase 1|Adverse Event|0|||
124539910|NCT01674010|447928805|FG002|Open Treatment Phase 1|Adverse Event|0|||
124539911|NCT01674010|447928803|FG000|Open Treatment Phase 1|Death|1|||
124539912|NCT01674010|447928804|FG001|Open Treatment Phase 1|Death|0|||
124539913|NCT01674010|447928805|FG002|Open Treatment Phase 1|Death|0|||
124539914|NCT01674010|447928803|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
124539915|NCT01674010|447928804|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
124539916|NCT01674010|447928805|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
124539917|NCT01674010|447928803|FG000|Open Treatment Phase 1|Physician Decision|9|||
124539918|NCT01674010|447928804|FG001|Open Treatment Phase 1|Physician Decision|0|||
124539919|NCT01674010|447928805|FG002|Open Treatment Phase 1|Physician Decision|0|||
124539920|NCT01674010|447928803|FG000|Open Treatment Phase 1|Protocol Violation|7|||
124539921|NCT01674010|447928804|FG001|Open Treatment Phase 1|Protocol Violation|0|||
124539922|NCT01674010|447928805|FG002|Open Treatment Phase 1|Protocol Violation|0|||
124539923|NCT01674010|447928803|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
124539924|NCT01674010|447928804|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
124539925|NCT01674010|447928805|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
124539926|NCT01674010|447928803|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
124539927|NCT01674010|447928804|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
124539928|NCT01674010|447928805|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
124539929|NCT01674010|447928803|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
124539930|NCT01674010|447928804|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
124539931|NCT01674010|447928805|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
124539932|NCT01674010|447928803|FG000|Randomization Phase 2|Adverse Event|0|||
124539933|NCT01674010|447928804|FG001|Randomization Phase 2|Adverse Event|1|||
124539934|NCT01674010|447928805|FG002|Randomization Phase 2|Adverse Event|1|||
124539935|NCT01674010|447928803|FG000|Randomization Phase 2|Lost to Follow-up|0|||
124539936|NCT01674010|447928804|FG001|Randomization Phase 2|Lost to Follow-up|1|||
124539937|NCT01674010|447928805|FG002|Randomization Phase 2|Lost to Follow-up|2|||
124539938|NCT01674010|447928803|FG000|Randomization Phase 2|Mood episode recurrence|0|||
124539939|NCT01674010|447928804|FG001|Randomization Phase 2|Mood episode recurrence|8|||
124539940|NCT01674010|447928805|FG002|Randomization Phase 2|Mood episode recurrence|2|||
124539941|NCT01674010|447928803|FG000|Randomization Phase 2|Physician Decision|0|||
124539942|NCT01674010|447928804|FG001|Randomization Phase 2|Physician Decision|0|||
124539943|NCT01674010|447928805|FG002|Randomization Phase 2|Physician Decision|2|||
124539944|NCT01674010|447928803|FG000|Randomization Phase 2|Pregnancy|0|||
124539945|NCT01674010|447928804|FG001|Randomization Phase 2|Pregnancy|1|||
124539946|NCT01674010|447928805|FG002|Randomization Phase 2|Pregnancy|1|||
124539947|NCT01674010|447928803|FG000|Randomization Phase 2|Protocol Violation|0|||
124539948|NCT01674010|447928804|FG001|Randomization Phase 2|Protocol Violation|1|||
124539949|NCT01674010|447928805|FG002|Randomization Phase 2|Protocol Violation|1|||
124539950|NCT01674010|447928803|FG000|Randomization Phase 2|Sponsor Decision|0|||
124539951|NCT01674010|447928804|FG001|Randomization Phase 2|Sponsor Decision|42|||
124539952|NCT01674010|447928805|FG002|Randomization Phase 2|Sponsor Decision|45|||
124539953|NCT01674010|447928803|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
124539954|NCT01674010|447928804|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
124539955|NCT01674010|447928805|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
124539956|NCT03159455|447928808|FG000|Overall Study|Adverse Event|0|||
124539957|NCT03159455|447928809|FG001|Overall Study|Adverse Event|0|||
124539958|NCT03159455|447928810|FG002|Overall Study|Adverse Event|0|||
124539959|NCT03159455|447928811|FG003|Overall Study|Adverse Event|0|||
124539960|NCT03159455|447928812|FG004|Overall Study|Adverse Event|0|||
124539961|NCT03159455|447928813|FG005|Overall Study|Adverse Event|1|||
124539962|NCT01801475|447928821|FG000|Overall Study|Withdrawal by Subject|0|||
124539963|NCT01801475|447928822|FG001|Overall Study|Withdrawal by Subject|0|||
124539964|NCT01801475|447928823|FG002|Overall Study|Withdrawal by Subject|0|||
124539965|NCT01801475|447928824|FG003|Overall Study|Withdrawal by Subject|0|||
124539966|NCT01801475|447928825|FG004|Overall Study|Withdrawal by Subject|1|||
124539967|NCT00421928|447928826|FG000|Overall Study|Adverse Event|61|||
124539968|NCT00421928|447928827|FG001|Overall Study|Adverse Event|140|||
124539969|NCT00421928|447928828|FG002|Overall Study|Adverse Event|22|||
124539970|NCT00421928|447928826|FG000|Overall Study|Lost to Follow-up|5|||
124539971|NCT00421928|447928827|FG001|Overall Study|Lost to Follow-up|0|||
124539972|NCT00421928|447928828|FG002|Overall Study|Lost to Follow-up|3|||
124539973|NCT00421928|447928826|FG000|Overall Study|Withdrawal by Subject|50|||
124539974|NCT00421928|447928827|FG001|Overall Study|Withdrawal by Subject|48|||
124539975|NCT00421928|447928828|FG002|Overall Study|Withdrawal by Subject|43|||
124539976|NCT00421928|447928826|FG000|Overall Study|Lack of Efficacy|15|||
124539977|NCT00421928|447928827|FG001|Overall Study|Lack of Efficacy|7|||
124539978|NCT00421928|447928828|FG002|Overall Study|Lack of Efficacy|35|||
124539979|NCT00421928|447928826|FG000|Overall Study|Study drug non-compliant|6|||
124539980|NCT00421928|447928827|FG001|Overall Study|Study drug non-compliant|7|||
124539981|NCT00421928|447928828|FG002|Overall Study|Study drug non-compliant|4|||
124539982|NCT00421928|447928826|FG000|Overall Study|All other|26|||
124539983|NCT00421928|447928827|FG001|Overall Study|All other|21|||
124539984|NCT00421928|447928828|FG002|Overall Study|All other|27|||
124539985|NCT00421928|447928826|FG000|Overall Study|Death|0|||
124539986|NCT00421928|447928827|FG001|Overall Study|Death|1|||
124539987|NCT00421928|447928828|FG002|Overall Study|Death|0|||
124539988|NCT00346775|447928837|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
124539989|NCT00346775|447928838|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
124539990|NCT00346775|447928837|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
124539991|NCT00346775|447928838|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
124539992|NCT00346775|447928837|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
124539993|NCT00346775|447928838|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
124539994|NCT00960869|447928839|FG000|Overall Study|Adverse Event|17|||
124539995|NCT00960869|447928840|FG001|Overall Study|Adverse Event|26|||
124539996|NCT00960869|447928839|FG000|Overall Study|Withdrawal by Subject|16|||
124539997|NCT00960869|447928840|FG001|Overall Study|Withdrawal by Subject|14|||
124539998|NCT00960869|447928839|FG000|Overall Study|Lost to Follow-up|1|||
124539999|NCT00960869|447928840|FG001|Overall Study|Lost to Follow-up|4|||
124540000|NCT00960869|447928839|FG000|Overall Study|Misc|19|||
124540001|NCT00960869|447928840|FG001|Overall Study|Misc|18|||
124540002|NCT01714726|447928841|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
124540003|NCT01714726|447928842|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
124540004|NCT01714726|447928843|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
124540005|NCT01714726|447928844|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
124540006|NCT01714726|447928841|FG000|Double-Blinded Induction Period|Adverse Event|0|||
124540007|NCT01714726|447928842|FG001|Double-Blinded Induction Period|Adverse Event|1|||
124540008|NCT01714726|447928843|FG002|Double-Blinded Induction Period|Adverse Event|0|||
124540009|NCT01714726|447928844|FG003|Double-Blinded Induction Period|Adverse Event|0|||
124540010|NCT01714726|447928841|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
124540011|NCT01714726|447928842|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
124540012|NCT01714726|447928843|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
124540013|NCT01714726|447928844|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
124540014|NCT01714726|447928841|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
124540015|NCT01714726|447928842|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
124540016|NCT01714726|447928843|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
124540017|NCT01714726|447928844|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
124540018|NCT01714726|447928841|FG000|Open-Label Period|Other|0|||
124540019|NCT01714726|447928842|FG001|Open-Label Period|Other|0|||
124540020|NCT01714726|447928843|FG002|Open-Label Period|Other|1|||
124540021|NCT01714726|447928844|FG003|Open-Label Period|Other|3|||
124540022|NCT01714726|447928841|FG000|Open-Label Period|Adverse Event|0|||
124540023|NCT01714726|447928842|FG001|Open-Label Period|Adverse Event|0|||
124540024|NCT01714726|447928843|FG002|Open-Label Period|Adverse Event|1|||
124540025|NCT01714726|447928844|FG003|Open-Label Period|Adverse Event|0|||
124540026|NCT01714726|447928841|FG000|Open-Label Period|Withdrawal by Subject|0|||
124540027|NCT01714726|447928842|FG001|Open-Label Period|Withdrawal by Subject|0|||
124540028|NCT01714726|447928843|FG002|Open-Label Period|Withdrawal by Subject|9|||
124540029|NCT01714726|447928844|FG003|Open-Label Period|Withdrawal by Subject|19|||
124540030|NCT01714726|447928841|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
124540031|NCT01714726|447928842|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
124981312|NCT01283516|449557453|FG005|Overall Study|Disease Progression|8|||
124540032|NCT01714726|447928843|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
124540033|NCT01714726|447928844|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
124981313|NCT01283516|449557454|FG006|Overall Study|Disease Progression|6|||
124981314|NCT01283516|449557455|FG007|Overall Study|Disease Progression|3|||
124981315|NCT01283516|449557456|FG008|Overall Study|Disease Progression|139|||
124981316|NCT01283516|449557448|FG000|Overall Study|Withdrawal by Subject|0|||
124981317|NCT01283516|449557449|FG001|Overall Study|Withdrawal by Subject|0|||
124981318|NCT01283516|449557450|FG002|Overall Study|Withdrawal by Subject|0|||
124981319|NCT01283516|449557451|FG003|Overall Study|Withdrawal by Subject|0|||
124981320|NCT01283516|449557452|FG004|Overall Study|Withdrawal by Subject|1|||
124981321|NCT01283516|449557453|FG005|Overall Study|Withdrawal by Subject|0|||
124981322|NCT01283516|449557454|FG006|Overall Study|Withdrawal by Subject|1|||
124981323|NCT01283516|449557455|FG007|Overall Study|Withdrawal by Subject|0|||
124981324|NCT01283516|449557456|FG008|Overall Study|Withdrawal by Subject|36|||
124981325|NCT01283516|449557448|FG000|Overall Study|Administrative problems|0|||
124981326|NCT01283516|449557449|FG001|Overall Study|Administrative problems|0|||
124981327|NCT01283516|449557450|FG002|Overall Study|Administrative problems|0|||
124981328|NCT01283516|449557451|FG003|Overall Study|Administrative problems|0|||
124981329|NCT01283516|449557452|FG004|Overall Study|Administrative problems|0|||
124981330|NCT01283516|449557453|FG005|Overall Study|Administrative problems|1|||
124981331|NCT01283516|449557454|FG006|Overall Study|Administrative problems|1|||
124981332|NCT01283516|449557455|FG007|Overall Study|Administrative problems|1|||
124981333|NCT01283516|449557456|FG008|Overall Study|Administrative problems|39|||
124981334|NCT01283516|449557448|FG000|Overall Study|Lost to Follow-up|0|||
124981335|NCT01283516|449557449|FG001|Overall Study|Lost to Follow-up|0|||
124981336|NCT01283516|449557450|FG002|Overall Study|Lost to Follow-up|0|||
124981337|NCT01283516|449557451|FG003|Overall Study|Lost to Follow-up|0|||
124981338|NCT01283516|449557452|FG004|Overall Study|Lost to Follow-up|0|||
124981339|NCT01283516|449557453|FG005|Overall Study|Lost to Follow-up|0|||
124981340|NCT01283516|449557454|FG006|Overall Study|Lost to Follow-up|0|||
124981341|NCT01283516|449557455|FG007|Overall Study|Lost to Follow-up|0|||
124981342|NCT01283516|449557456|FG008|Overall Study|Lost to Follow-up|1|||
124981343|NCT00132873|449557460|FG000|Overall Study|Adverse Event|3|||
124981344|NCT00132873|449557460|FG000|Overall Study|Lost to Follow-up|1|||
124981345|NCT00132873|449557460|FG000|Overall Study|Lack of Efficacy|1|||
124981346|NCT00132873|449557460|FG000|Overall Study|Withdrawal by Subject|3|||
124981347|NCT00132873|449557460|FG000|Overall Study|Planned Pregnancy|1|||
124981348|NCT02045875|449557461|FG000|Overall Study|Lost to Follow-up|3|||
124981349|NCT02045875|449557462|FG001|Overall Study|Lost to Follow-up|0|||
124981350|NCT02045875|449557461|FG000|Overall Study|Withdrawal by Subject|4|||
124981351|NCT02045875|449557462|FG001|Overall Study|Withdrawal by Subject|3|||
124981352|NCT00444275|449557463|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
124981353|NCT00444275|449557464|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
124981354|NCT00444275|449557465|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
124981355|NCT00444275|449557466|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
124981356|NCT00444275|449557467|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
124981357|NCT00444275|449557463|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
124981358|NCT00444275|449557464|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
124981359|NCT00444275|449557465|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
124981360|NCT00444275|449557466|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
124981361|NCT00444275|449557467|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
124981362|NCT00444275|449557463|FG000|Maintenance Treatment Phase|Adverse Event|0|||
124981363|NCT00444275|449557464|FG001|Maintenance Treatment Phase|Adverse Event|0|||
124981364|NCT00444275|449557465|FG002|Maintenance Treatment Phase|Adverse Event|3|||
124981365|NCT00444275|449557466|FG003|Maintenance Treatment Phase|Adverse Event|2|||
124981366|NCT00444275|449557467|FG004|Maintenance Treatment Phase|Adverse Event|13|||
124981367|NCT00444275|449557463|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
124981368|NCT00444275|449557464|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
124981369|NCT00444275|449557465|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
124981370|NCT00444275|449557466|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
124981371|NCT00444275|449557467|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
124981372|NCT00444275|449557463|FG000|Maintenance Treatment Phase|Patient's wish|0|||
124981373|NCT00444275|449557464|FG001|Maintenance Treatment Phase|Patient's wish|0|||
124981374|NCT00444275|449557465|FG002|Maintenance Treatment Phase|Patient's wish|19|||
124981375|NCT00444275|449557466|FG003|Maintenance Treatment Phase|Patient's wish|9|||
124981376|NCT00444275|449557467|FG004|Maintenance Treatment Phase|Patient's wish|20|||
124981377|NCT00444275|449557463|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
124981378|NCT00444275|449557464|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
124981379|NCT00444275|449557465|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
124981380|NCT00444275|449557466|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
124981381|NCT00444275|449557467|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
124981382|NCT00444275|449557463|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
124981383|NCT00444275|449557464|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
124981384|NCT00444275|449557465|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
124981385|NCT00444275|449557466|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
124540034|NCT01714726|447928841|FG000|Open-Label Period|Lost to Follow-up|0|||
124540035|NCT01714726|447928842|FG001|Open-Label Period|Lost to Follow-up|0|||
124540036|NCT01714726|447928843|FG002|Open-Label Period|Lost to Follow-up|3|||
124540037|NCT01714726|447928844|FG003|Open-Label Period|Lost to Follow-up|4|||
124540038|NCT00548340|447928845|FG000|Overall Study|Protocol Violation|2|||
124540039|NCT00548340|447928846|FG001|Overall Study|Protocol Violation|3|||
124540040|NCT00548340|447928847|FG002|Overall Study|Protocol Violation|3|||
124540041|NCT00548340|447928845|FG000|Overall Study|Adverse Event|2|||
124540042|NCT00548340|447928846|FG001|Overall Study|Adverse Event|2|||
124540043|NCT00548340|447928847|FG002|Overall Study|Adverse Event|2|||
124540044|NCT00548340|447928845|FG000|Overall Study|Lost to Follow-up|1|||
124540045|NCT00548340|447928846|FG001|Overall Study|Lost to Follow-up|1|||
124540046|NCT00548340|447928847|FG002|Overall Study|Lost to Follow-up|0|||
124540047|NCT00548340|447928845|FG000|Overall Study|Withdrawal by Subject|2|||
124540048|NCT00548340|447928846|FG001|Overall Study|Withdrawal by Subject|4|||
124540049|NCT00548340|447928847|FG002|Overall Study|Withdrawal by Subject|3|||
124540050|NCT00548340|447928845|FG000|Overall Study|Other|1|||
124540051|NCT00548340|447928846|FG001|Overall Study|Other|1|||
124540052|NCT00548340|447928847|FG002|Overall Study|Other|1|||
124540053|NCT01096017|447928848|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
124540054|NCT01096017|447928849|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
124540055|NCT02600559|447928853|FG000|Overall Study|Withdrawal by Subject|3|||
124540056|NCT02600559|447928853|FG000|Overall Study|Lost to Follow-up|20|||
124540057|NCT00501969|447928854|FG000|Overall Study|Major Protocol Violation|4|||
124540058|NCT00501969|447928854|FG000|Overall Study|Lack of Efficacy|29|||
124540059|NCT00501969|447928854|FG000|Overall Study|Adverse Event|76|||
124540060|NCT00501969|447928854|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
124540061|NCT00501969|447928854|FG000|Overall Study|Subject withdrew consent|51|||
124540062|NCT00501969|447928854|FG000|Overall Study|Lost to Follow-up|4|||
124540063|NCT00501969|447928854|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
124540064|NCT00501969|447928854|FG000|Overall Study|Other: Sponsors Request|10|||
124540065|NCT00501969|447928854|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
124540066|NCT00501969|447928854|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
124540067|NCT00501969|447928854|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
124540068|NCT00501969|447928854|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
124540069|NCT00501969|447928854|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
124540070|NCT00501969|447928854|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
124540071|NCT00501969|447928854|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
124540072|NCT00501969|447928854|FG000|Overall Study|Other: As Required by Local EC|2|||
124540073|NCT00501969|447928854|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
124540074|NCT00501969|447928854|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
124540075|NCT00665366|447928855|FG000|Overall Study|Lack of Efficacy|11|||
124540076|NCT00665366|447928856|FG001|Overall Study|Lack of Efficacy|10|||
124540077|NCT00665366|447928855|FG000|Overall Study|Adverse Event|25|||
124540078|NCT00665366|447928856|FG001|Overall Study|Adverse Event|23|||
124540079|NCT00665366|447928855|FG000|Overall Study|Withdrawal by Subject|11|||
124540080|NCT00665366|447928856|FG001|Overall Study|Withdrawal by Subject|14|||
124540081|NCT00665366|447928855|FG000|Overall Study|Lost to Follow-up|3|||
124540082|NCT00665366|447928856|FG001|Overall Study|Lost to Follow-up|5|||
124540083|NCT00665366|447928855|FG000|Overall Study|Poor compliance/noncompliance|3|||
124540084|NCT00665366|447928856|FG001|Overall Study|Poor compliance/noncompliance|5|||
124540085|NCT00665366|447928855|FG000|Overall Study|Pregnancy|1|||
124540086|NCT00665366|447928856|FG001|Overall Study|Pregnancy|0|||
124540087|NCT00665366|447928855|FG000|Overall Study|No longer meets study criteria|0|||
124540088|NCT00665366|447928856|FG001|Overall Study|No longer meets study criteria|1|||
124540089|NCT00665366|447928855|FG000|Overall Study|Other reasons|4|||
124540090|NCT00665366|447928856|FG001|Overall Study|Other reasons|1|||
124540091|NCT01545375|447928857|FG000|Overall Study|Adverse Event|2|||
124540092|NCT01545375|447928858|FG001|Overall Study|Adverse Event|1|||
124540093|NCT01545375|447928857|FG000|Overall Study|Lost to Follow-up|34|||
124540094|NCT01545375|447928858|FG001|Overall Study|Lost to Follow-up|31|||
124540095|NCT01545375|447928857|FG000|Overall Study|Protocol Violation|3|||
124540096|NCT01545375|447928858|FG001|Overall Study|Protocol Violation|3|||
124540097|NCT01545375|447928857|FG000|Overall Study|Withdrawal by Subject|58|||
124540098|NCT01545375|447928858|FG001|Overall Study|Withdrawal by Subject|55|||
124540099|NCT01846039|447928859|FG000|Overall Study|Protocol Violation|1|||
124540100|NCT01846039|447928859|FG000|Overall Study|Subject Withdrew Consent|1|||
124540101|NCT04854421|447928862|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
124540102|NCT04854421|447928863|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
124540103|NCT01980056|447928864|FG000|Overall Study|Death|1|||
124540104|NCT01980056|447928865|FG001|Overall Study|Death|1|||
124540105|NCT01980056|447928866|FG002|Overall Study|Death|0|||
124540106|NCT00408408|447928867|FG000|Overall Study|No follow up data|2|||
124540107|NCT00408408|447928868|FG001|Overall Study|No follow up data|3|||
124540108|NCT00408408|447928869|FG002|Overall Study|No follow up data|0|||
124540109|NCT00408408|447928870|FG003|Overall Study|No follow up data|7|||
124540110|NCT00408408|447928871|FG004|Overall Study|No follow up data|5|||
124540111|NCT00408408|447928872|FG005|Overall Study|No follow up data|3|||
124540112|NCT00399542|447928877|FG000|Overall Study|Adverse Event|18|||
124540113|NCT00399542|447928878|FG001|Overall Study|Adverse Event|15|||
124540114|NCT00399542|447928877|FG000|Overall Study|Protocol Violation|13|||
124540115|NCT00399542|447928878|FG001|Overall Study|Protocol Violation|3|||
124540116|NCT00399542|447928877|FG000|Overall Study|Withdrawal by Subject|28|||
124540117|NCT00399542|447928878|FG001|Overall Study|Withdrawal by Subject|10|||
124540118|NCT00399542|447928877|FG000|Overall Study|Lack of Efficacy|18|||
124540119|NCT00399542|447928878|FG001|Overall Study|Lack of Efficacy|8|||
124540120|NCT00399542|447928877|FG000|Overall Study|Lost to Follow-up|6|||
124540121|NCT00399542|447928878|FG001|Overall Study|Lost to Follow-up|6|||
124540122|NCT00399542|447928877|FG000|Overall Study|Other|1|||
124540123|NCT00399542|447928878|FG001|Overall Study|Other|0|||
124540124|NCT00399542|447928877|FG000|Overall Study|Physician Decision|0|||
124540125|NCT00399542|447928878|FG001|Overall Study|Physician Decision|1|||
124540126|NCT03172026|447928879|FG000|Overall Study|Withdrawal by Subject|1|||
124540127|NCT03172026|447928880|FG001|Overall Study|Withdrawal by Subject|0|||
124540128|NCT03172026|447928879|FG000|Overall Study|COVID restrictions|1|||
124540129|NCT03172026|447928880|FG001|Overall Study|COVID restrictions|0|||
124540130|NCT00265109|447928881|FG000|Overall Study|Withdrawal by Subject|5|||
124540131|NCT00265109|447928881|FG000|Overall Study|Adverse Event|1|||
124540132|NCT02463097|447928882|FG000|Overall Study|Withdrawal by Subject|1|||
124540133|NCT01757821|447928883|FG000|Overall Study|Adverse Event|1|||
124540134|NCT00334893|447928884|FG000|Overall Study|Not Treated|1|||
124540135|NCT00334893|447928885|FG001|Overall Study|Not Treated|0|||
124540136|NCT01552408|447928889|FG000|Overall Study|Lost to Follow-up|2|||
124540137|NCT01552408|447928890|FG001|Overall Study|Lost to Follow-up|0|||
124540138|NCT01552408|447928889|FG000|Overall Study|Relocation|0|||
124540139|NCT01552408|447928890|FG001|Overall Study|Relocation|1|||
124540140|NCT01552408|447928889|FG000|Overall Study|Withdrawal by Subject|2|||
124540141|NCT01552408|447928890|FG001|Overall Study|Withdrawal by Subject|1|||
124540142|NCT03457701|447928897|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
124540143|NCT03457701|447928898|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
124540144|NCT03457701|447928897|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
124540145|NCT03457701|447928898|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
124540146|NCT01288911|447928899|FG000|Double-blind Period|Death|11|||
124540147|NCT01288911|447928900|FG001|Double-blind Period|Death|7|||
124540148|NCT01288911|447928899|FG000|Double-blind Period|Lost to Follow-up|0|||
124540149|NCT01288911|447928900|FG001|Double-blind Period|Lost to Follow-up|2|||
124540150|NCT01288911|447928899|FG000|Double-blind Period|Progressive Disease|75|||
124540151|NCT01288911|447928900|FG001|Double-blind Period|Progressive Disease|103|||
124540152|NCT01288911|447928899|FG000|Double-blind Period|Protocol Violation|1|||
124540153|NCT01288911|447928900|FG001|Double-blind Period|Protocol Violation|0|||
124540154|NCT01288911|447928899|FG000|Double-blind Period|Withdrawal by Subject|25|||
124540155|NCT01288911|447928900|FG001|Double-blind Period|Withdrawal by Subject|26|||
124540156|NCT01288911|447928899|FG000|Double-blind Period|Miscellaneous Reason|29|||
124540157|NCT01288911|447928900|FG001|Double-blind Period|Miscellaneous Reason|42|||
124540158|NCT01288911|447928899|FG000|Double-blind Period|Randomized but never received study drug|1|||
124540159|NCT01288911|447928900|FG001|Double-blind Period|Randomized but never received study drug|2|||
124540160|NCT01288911|447928899|FG000|Open-label Period (All Enzalutamide)|Death|0|||
124540161|NCT01288911|447928900|FG001|Open-label Period (All Enzalutamide)|Death|1|||
124540162|NCT01288911|447928899|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
124540163|NCT01288911|447928900|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
124540164|NCT01288911|447928899|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
124540165|NCT01288911|447928900|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
124540166|NCT01288911|447928899|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
124540167|NCT01288911|447928900|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
124540168|NCT01288911|447928899|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
124540169|NCT01288911|447928900|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
124540170|NCT01288911|447928899|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
124540171|NCT01288911|447928900|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
124540172|NCT02451137|447928910|FG000|Overall Study|Randomized but not treated|19|||
124540173|NCT02451137|447928911|FG001|Overall Study|Randomized but not treated|27|||
124540174|NCT02451137|447928910|FG000|Overall Study|Adverse Event|43|||
124540175|NCT02451137|447928911|FG001|Overall Study|Adverse Event|42|||
124540176|NCT02451137|447928910|FG000|Overall Study|Lack of Efficacy|4|||
124540177|NCT02451137|447928911|FG001|Overall Study|Lack of Efficacy|9|||
124540178|NCT02451137|447928910|FG000|Overall Study|Participant decision:discontinue insulin|41|||
124540179|NCT02451137|447928911|FG001|Overall Study|Participant decision:discontinue insulin|43|||
124540180|NCT02451137|447928910|FG000|Overall Study|Hypoglycemia|2|||
124540181|NCT02451137|447928911|FG001|Overall Study|Hypoglycemia|1|||
124540182|NCT02451137|447928910|FG000|Overall Study|Investigator's decision|23|||
124540183|NCT02451137|447928911|FG001|Overall Study|Investigator's decision|19|||
124540184|NCT02451137|447928910|FG000|Overall Study|Lost to Follow-up|53|||
124540185|NCT02451137|447928911|FG001|Overall Study|Lost to Follow-up|61|||
124540186|NCT02451137|447928910|FG000|Overall Study|Physician Decision|6|||
124540187|NCT02451137|447928911|FG001|Overall Study|Physician Decision|5|||
124540188|NCT02451137|447928910|FG000|Overall Study|Sponsor decision|13|||
124540189|NCT02451137|447928911|FG001|Overall Study|Sponsor decision|25|||
124540190|NCT02451137|447928910|FG000|Overall Study|Withdrawal by Subject|40|||
124540191|NCT02451137|447928911|FG001|Overall Study|Withdrawal by Subject|63|||
124981386|NCT00444275|449557467|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
124981387|NCT01204710|449557471|FG000|Randomization Treatment|Lost to Follow-up|1|||
124981388|NCT01204710|449557472|FG001|Randomization Treatment|Lost to Follow-up|0|||
124981389|NCT01204710|449557471|FG000|Randomization Treatment|Withdrawal by Subject|6|||
124981390|NCT01204710|449557472|FG001|Randomization Treatment|Withdrawal by Subject|5|||
124981391|NCT01204710|449557471|FG000|Randomization Treatment|Physician Decision|3|||
124981392|NCT01204710|449557472|FG001|Randomization Treatment|Physician Decision|2|||
124981393|NCT01204710|449557471|FG000|Randomization Treatment|Entry criteria not met|0|||
124981394|NCT01204710|449557472|FG001|Randomization Treatment|Entry criteria not met|1|||
124540192|NCT02451137|447928910|FG000|Overall Study|Other than specified above|2|||
124540193|NCT02451137|447928911|FG001|Overall Study|Other than specified above|3|||
124540194|NCT01977573|447928914|FG000|Overall Study|Adverse Event|7|||
124540195|NCT01977573|447928915|FG001|Overall Study|Adverse Event|0|||
124540196|NCT01977573|447928916|FG002|Overall Study|Adverse Event|2|||
124540197|NCT01977573|447928917|FG003|Overall Study|Adverse Event|1|||
124540198|NCT01977573|447928914|FG000|Overall Study|Lost to Follow-up|1|||
124540199|NCT01977573|447928915|FG001|Overall Study|Lost to Follow-up|0|||
124540200|NCT01977573|447928916|FG002|Overall Study|Lost to Follow-up|0|||
124540201|NCT01977573|447928917|FG003|Overall Study|Lost to Follow-up|1|||
124540202|NCT01977573|447928914|FG000|Overall Study|Physician Decision|1|||
124540203|NCT01977573|447928915|FG001|Overall Study|Physician Decision|0|||
124540204|NCT01977573|447928916|FG002|Overall Study|Physician Decision|0|||
124540205|NCT01977573|447928917|FG003|Overall Study|Physician Decision|0|||
124540206|NCT01977573|447928914|FG000|Overall Study|Protocol Violation|3|||
124540207|NCT01977573|447928915|FG001|Overall Study|Protocol Violation|1|||
124540208|NCT01977573|447928916|FG002|Overall Study|Protocol Violation|0|||
124540209|NCT01977573|447928917|FG003|Overall Study|Protocol Violation|0|||
124540210|NCT01977573|447928914|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
124540211|NCT01977573|447928915|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
124540212|NCT01977573|447928916|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
124540213|NCT01977573|447928917|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
124540214|NCT01977573|447928914|FG000|Overall Study|Withdrawal by Subject|6|||
124540215|NCT01977573|447928915|FG001|Overall Study|Withdrawal by Subject|1|||
124540216|NCT01977573|447928916|FG002|Overall Study|Withdrawal by Subject|1|||
124540217|NCT01977573|447928917|FG003|Overall Study|Withdrawal by Subject|1|||
124540218|NCT02993731|447928918|FG000|Overall Study|Study Termination|101|||
124540219|NCT02993731|447928919|FG001|Overall Study|Study Termination|105|||
124540220|NCT04398030|447931050|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
124540221|NCT04398030|447931051|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
124540222|NCT04398030|447931050|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
124540223|NCT04398030|447931051|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
124540224|NCT02946515|447931052|FG000|Overall Study|Lost to Follow-up|2|||
124540225|NCT02946515|447931053|FG001|Overall Study|Lost to Follow-up|1|||
124540226|NCT02501642|447931054|FG000|Overall Study|Lost to Follow-up|7|||
124540227|NCT02501642|447931055|FG001|Overall Study|Lost to Follow-up|11|||
124540228|NCT01153971|447931066|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
124540229|NCT01153971|447931066|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
124540230|NCT01153971|447931066|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
124540231|NCT01153971|447931066|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
124540232|NCT01153971|447931066|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
124540233|NCT01153971|447931066|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
124540234|NCT01153971|447931066|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
124540235|NCT03410693|447931067|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
124540236|NCT03410693|447931068|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
124540237|NCT03410693|447931067|FG000|Overall Study|Disc trt: Lost to follow up|0|||
124540238|NCT03410693|447931068|FG001|Overall Study|Disc trt: Lost to follow up|1|||
124540239|NCT03410693|447931067|FG000|Overall Study|Disc trt: radiological progression|58|||
124540240|NCT03410693|447931068|FG001|Overall Study|Disc trt: radiological progression|50|||
124540241|NCT03410693|447931067|FG000|Overall Study|Disc trt: Other|1|||
124540242|NCT03410693|447931068|FG001|Overall Study|Disc trt: Other|0|||
124540243|NCT03410693|447931067|FG000|Overall Study|Study drug never administered|1|||
124540244|NCT03410693|447931068|FG001|Overall Study|Study drug never administered|6|||
124540245|NCT03410693|447931067|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
124540246|NCT03410693|447931068|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
124540247|NCT03410693|447931067|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
124540248|NCT03410693|447931068|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
124540249|NCT03410693|447931067|FG000|Overall Study|Disc trt: Physician decision|0|||
124540250|NCT03410693|447931068|FG001|Overall Study|Disc trt: Physician decision|5|||
124540251|NCT03410693|447931067|FG000|Overall Study|Disc trt: clinical progression|1|||
124540252|NCT03410693|447931068|FG001|Overall Study|Disc trt: clinical progression|5|||
124540253|NCT03410693|447931067|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
124540254|NCT03410693|447931068|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
124540255|NCT00953576|447931069|FG000|Overall Study|Adverse Event|0|||
124540256|NCT00953576|447931070|FG001|Overall Study|Adverse Event|1|||
124540257|NCT00953576|447931069|FG000|Overall Study|Ineligible after Consent|2|||
124540258|NCT00953576|447931070|FG001|Overall Study|Ineligible after Consent|0|||
124540259|NCT03628781|447931077|FG000|Overall Study|Lost to Follow-up|16|||
124540260|NCT03628781|447931078|FG001|Overall Study|Lost to Follow-up|8|||
124540261|NCT03628781|447931077|FG000|Overall Study|Withdrawal by Subject|16|||
124540262|NCT03628781|447931078|FG001|Overall Study|Withdrawal by Subject|1|||
124540263|NCT00656669|447931079|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
124540264|NCT00656669|447931079|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
124540265|NCT00656669|447931079|FG000|AC (Cycles 6-9)|Adverse Event|1|||
124540266|NCT00656669|447931079|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
124540267|NCT03778021|447931082|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
124540268|NCT03778021|447931083|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
124540269|NCT00679042|447931084|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
124540270|NCT00679042|447931084|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
124540271|NCT00679042|447931084|FG000|5-Year Follow Up|Death|1|||
124540272|NCT00679042|447931084|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
124540273|NCT00679042|447931084|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
124540274|NCT02687815|447931085|FG000|Overall Study|Lost to Follow-up|2|||
124540275|NCT02687815|447931086|FG001|Overall Study|Lost to Follow-up|4|||
124540276|NCT02687815|447931085|FG000|Overall Study|Withdrawal by Subject|2|||
124540277|NCT02687815|447931086|FG001|Overall Study|Withdrawal by Subject|4|||
124540278|NCT03472586|447931094|FG000|Overall Study|Physician Decision|6|||
124540279|NCT03472586|447931094|FG000|Overall Study|Death|6|||
124540280|NCT03472586|447931094|FG000|Overall Study|Adverse Event|1|||
124540281|NCT02528331|447931095|FG000|Overall Study|Withdrawal by Subject|2|||
124540282|NCT06045026|447931101|FG000|Overall Study|Lost to Follow-up|60|||
124540283|NCT06045026|447931101|FG000|Overall Study|Adverse Event|12|||
124540284|NCT06045026|447931101|FG000|Overall Study|Withdrawal by Subject|3|||
124540285|NCT06045026|447931101|FG000|Overall Study|Enrollment closed|1|||
124540286|NCT00612456|447931102|FG000|Overall Study|Adverse Event|1|||
124540287|NCT00612456|447931103|FG001|Overall Study|Adverse Event|0|||
124540288|NCT00612456|447931104|FG002|Overall Study|Adverse Event|0|||
124540289|NCT00612456|447931102|FG000|Overall Study|Lack of Efficacy|1|||
124540290|NCT00612456|447931103|FG001|Overall Study|Lack of Efficacy|1|||
124540291|NCT00612456|447931104|FG002|Overall Study|Lack of Efficacy|0|||
124540292|NCT00612456|447931102|FG000|Overall Study|Withdrawal by Subject|0|||
124540293|NCT00612456|447931103|FG001|Overall Study|Withdrawal by Subject|1|||
124540294|NCT00612456|447931104|FG002|Overall Study|Withdrawal by Subject|0|||
124540295|NCT01258803|447931105|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
124540296|NCT01258803|447931106|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
124540297|NCT01258803|447931107|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
124540298|NCT01258803|447931108|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
124540299|NCT01258803|447931109|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
124540300|NCT01258803|447931110|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
124540301|NCT01258803|447931105|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
124540302|NCT01258803|447931106|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
124540303|NCT01258803|447931107|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
124540304|NCT01258803|447931108|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
124540305|NCT01258803|447931109|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
124540306|NCT01258803|447931110|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
124540307|NCT01258803|447931105|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
124540308|NCT01258803|447931106|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
124540309|NCT01258803|447931107|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
124540310|NCT01258803|447931108|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
124540311|NCT01258803|447931109|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
124540312|NCT01258803|447931110|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
124540313|NCT00920582|447931111|FG000|Overall Study|Lost to Follow-up|5|||
124540314|NCT00920582|447931112|FG001|Overall Study|Lost to Follow-up|1|||
124540315|NCT00920582|447931113|FG002|Overall Study|Lost to Follow-up|2|||
124540316|NCT00920582|447931114|FG003|Overall Study|Lost to Follow-up|0|||
124540317|NCT00920582|447931111|FG000|Overall Study|Withdrawal by Subject|5|||
124540318|NCT00920582|447931112|FG001|Overall Study|Withdrawal by Subject|4|||
124540319|NCT00920582|447931113|FG002|Overall Study|Withdrawal by Subject|6|||
124540320|NCT00920582|447931114|FG003|Overall Study|Withdrawal by Subject|3|||
124540321|NCT00920582|447931111|FG000|Overall Study|Protocol Violation|1|||
124540322|NCT00920582|447931112|FG001|Overall Study|Protocol Violation|0|||
124540323|NCT00920582|447931113|FG002|Overall Study|Protocol Violation|0|||
124540324|NCT00920582|447931114|FG003|Overall Study|Protocol Violation|0|||
124540325|NCT00920582|447931111|FG000|Overall Study|Other|2|||
124540326|NCT00920582|447931112|FG001|Overall Study|Other|1|||
124540327|NCT00920582|447931113|FG002|Overall Study|Other|3|||
124540328|NCT00920582|447931114|FG003|Overall Study|Other|2|||
124540329|NCT04419558|447931119|FG000|DB Period (48 Weeks)|Adverse Event|6|||
124540330|NCT04419558|447931120|FG001|DB Period (48 Weeks)|Adverse Event|6|||
124540331|NCT04419558|447931119|FG000|DB Period (48 Weeks)|Death|14|||
124540332|NCT04419558|447931120|FG001|DB Period (48 Weeks)|Death|11|||
124540333|NCT04419558|447931119|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
124540334|NCT04419558|447931120|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
124540335|NCT04419558|447931119|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
124540336|NCT04419558|447931120|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
124540337|NCT04419558|447931119|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
124540338|NCT04419558|447931120|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
124540339|NCT04419558|447931119|FG000|DB Period (48 Weeks)|Disease Progression|1|||
124540340|NCT04419558|447931120|FG001|DB Period (48 Weeks)|Disease Progression|0|||
124540341|NCT04419558|447931119|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
124540342|NCT04419558|447931120|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
124540343|NCT04419558|447931119|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
124540344|NCT04419558|447931120|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
124540345|NCT04419558|447931119|FG000|DB Period (48 Weeks)|Participant Decision|4|||
124540346|NCT04419558|447931120|FG001|DB Period (48 Weeks)|Participant Decision|3|||
124540347|NCT04419558|447931119|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
124540348|NCT04419558|447931120|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
124540349|NCT04419558|447931119|FG000|OLE Period (48 Weeks)|Death|4|||
124540350|NCT04419558|447931120|FG001|OLE Period (48 Weeks)|Death|6|||
124540351|NCT04419558|447931119|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
124540352|NCT04419558|447931120|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
124540353|NCT04419558|447931119|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
124540354|NCT04419558|447931120|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
124540355|NCT00903357|447931121|FG000|First Intervention|Withdrawal by Subject|5|||
124540356|NCT00903357|447931122|FG001|First Intervention|Withdrawal by Subject|3|||
124540357|NCT00903357|447931121|FG000|First Intervention|Flu|0|||
124540358|NCT00903357|447931122|FG001|First Intervention|Flu|1|||
124540359|NCT00903357|447931121|FG000|Wash Out Period of 2 Weeks|Flu|0|||
124540360|NCT00903357|447931122|FG001|Wash Out Period of 2 Weeks|Flu|1|||
124540361|NCT00903357|447931121|FG000|Second Intervention|Lost to Follow-up|1|||
124540362|NCT00903357|447931122|FG001|Second Intervention|Lost to Follow-up|0|||
124540363|NCT05146999|447931124|FG000|Overall Study|Withdrew consent|6|||
124540364|NCT05146999|447931125|FG001|Overall Study|Withdrew consent|1|||
124540365|NCT05146999|447931124|FG000|Overall Study|Lost to Follow-up|3|||
124540366|NCT05146999|447931125|FG001|Overall Study|Lost to Follow-up|2|||
124540367|NCT05146999|447931124|FG000|Overall Study|Other|1|||
124540368|NCT05146999|447931125|FG001|Overall Study|Other|3|||
124540369|NCT04668157|447931126|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
124540370|NCT04668157|447931127|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
124540371|NCT04668157|447931126|FG000|Treatment Period (52 Weeks)|Other|0|||
124540372|NCT04668157|447931127|FG001|Treatment Period (52 Weeks)|Other|2|||
124540373|NCT00383292|447931128|FG000|Overall Study|Adverse Event|4|||
124540374|NCT00383292|447931129|FG001|Overall Study|Adverse Event|1|||
124540375|NCT00383292|447931130|FG002|Overall Study|Adverse Event|2|||
124540376|NCT00383292|447931128|FG000|Overall Study|Death|3|||
124540377|NCT00383292|447931129|FG001|Overall Study|Death|3|||
124540378|NCT00383292|447931130|FG002|Overall Study|Death|3|||
124540379|NCT00383292|447931128|FG000|Overall Study|Physician Decision|4|||
124540380|NCT00383292|447931129|FG001|Overall Study|Physician Decision|0|||
124540381|NCT00383292|447931130|FG002|Overall Study|Physician Decision|1|||
124540382|NCT00383292|447931128|FG000|Overall Study|Withdrawal by Subject|3|||
124540383|NCT00383292|447931129|FG001|Overall Study|Withdrawal by Subject|2|||
124540384|NCT00383292|447931130|FG002|Overall Study|Withdrawal by Subject|2|||
124540385|NCT00383292|447931128|FG000|Overall Study|Other|1|||
124540386|NCT00383292|447931129|FG001|Overall Study|Other|0|||
124540387|NCT00383292|447931130|FG002|Overall Study|Other|0|||
124540388|NCT03329404|447931131|FG000|Overall Study|The study was suspended.|1|||
124540389|NCT03329404|447931132|FG001|Overall Study|The study was suspended.|4|||
124540390|NCT01016912|447931133|FG000|End of Treatment Period|Lack of Efficacy|0|||
124540391|NCT01016912|447931134|FG001|End of Treatment Period|Lack of Efficacy|1|||
124540392|NCT01016912|447931135|FG002|End of Treatment Period|Lack of Efficacy|0|||
124540393|NCT01016912|447931136|FG003|End of Treatment Period|Lack of Efficacy|4|||
124981395|NCT01204710|449557471|FG000|Randomization Treatment|Adverse Event|4|||
124540394|NCT01016912|447931137|FG004|End of Treatment Period|Lack of Efficacy|4|||
124540395|NCT01016912|447931133|FG000|End of Treatment Period|Adverse Event|0|||
124540396|NCT01016912|447931134|FG001|End of Treatment Period|Adverse Event|1|||
124540397|NCT01016912|447931135|FG002|End of Treatment Period|Adverse Event|1|||
124540398|NCT01016912|447931136|FG003|End of Treatment Period|Adverse Event|0|||
124540399|NCT01016912|447931137|FG004|End of Treatment Period|Adverse Event|0|||
124540400|NCT01016912|447931133|FG000|End of Treatment Period|Completed double-blind period only|0|||
124540401|NCT01016912|447931134|FG001|End of Treatment Period|Completed double-blind period only|1|||
124540402|NCT01016912|447931135|FG002|End of Treatment Period|Completed double-blind period only|0|||
124540403|NCT01016912|447931136|FG003|End of Treatment Period|Completed double-blind period only|0|||
124540404|NCT01016912|447931137|FG004|End of Treatment Period|Completed double-blind period only|0|||
124540405|NCT01016912|447931133|FG000|Follow-up Period|Other reason|0|||
124540406|NCT01016912|447931134|FG001|Follow-up Period|Other reason|0|||
124540407|NCT01016912|447931135|FG002|Follow-up Period|Other reason|1|||
124540408|NCT01016912|447931136|FG003|Follow-up Period|Other reason|1|||
124540409|NCT01016912|447931137|FG004|Follow-up Period|Other reason|0|||
124540410|NCT02221882|447931138|FG000|Overall Study|Withdrawal by Subject|0|||
124540411|NCT02221882|447931139|FG001|Overall Study|Withdrawal by Subject|0|||
124540412|NCT02221882|447931140|FG002|Overall Study|Withdrawal by Subject|4|||
124540413|NCT02221882|447931141|FG003|Overall Study|Withdrawal by Subject|2|||
124540414|NCT02221882|447931142|FG004|Overall Study|Withdrawal by Subject|2|||
124540415|NCT02221882|447931143|FG005|Overall Study|Withdrawal by Subject|2|||
124540416|NCT02221882|447931138|FG000|Overall Study|Death|0|||
124540417|NCT02221882|447931139|FG001|Overall Study|Death|1|||
124540418|NCT02221882|447931140|FG002|Overall Study|Death|0|||
124540419|NCT02221882|447931141|FG003|Overall Study|Death|0|||
124540420|NCT02221882|447931142|FG004|Overall Study|Death|0|||
124540421|NCT02221882|447931143|FG005|Overall Study|Death|0|||
124540422|NCT00796367|447931144|FG000|Overall Study|Adverse Event|6|||
124540423|NCT00796367|447931145|FG001|Overall Study|Adverse Event|4|||
124540424|NCT00796367|447931146|FG002|Overall Study|Adverse Event|7|||
124540425|NCT00796367|447931144|FG000|Overall Study|Lost to Follow-up|5|||
124540426|NCT00796367|447931145|FG001|Overall Study|Lost to Follow-up|4|||
124540427|NCT00796367|447931146|FG002|Overall Study|Lost to Follow-up|21|||
124540428|NCT00796367|447931144|FG000|Overall Study|Withdrawal by Subject|9|||
124540429|NCT00796367|447931145|FG001|Overall Study|Withdrawal by Subject|11|||
124540430|NCT00796367|447931146|FG002|Overall Study|Withdrawal by Subject|12|||
124540431|NCT00796367|447931144|FG000|Overall Study|Lack of Efficacy|2|||
124540432|NCT00796367|447931145|FG001|Overall Study|Lack of Efficacy|1|||
124540433|NCT00796367|447931146|FG002|Overall Study|Lack of Efficacy|0|||
124540434|NCT00796367|447931144|FG000|Overall Study|non compliance|3|||
124540435|NCT00796367|447931145|FG001|Overall Study|non compliance|1|||
124540436|NCT00796367|447931146|FG002|Overall Study|non compliance|1|||
124540437|NCT00796367|447931144|FG000|Overall Study|Pregnancy|1|||
124540438|NCT00796367|447931145|FG001|Overall Study|Pregnancy|0|||
124540439|NCT00796367|447931146|FG002|Overall Study|Pregnancy|1|||
124540440|NCT00796367|447931144|FG000|Overall Study|Requirement for restricted medication|2|||
124540441|NCT00796367|447931145|FG001|Overall Study|Requirement for restricted medication|0|||
124540442|NCT00796367|447931146|FG002|Overall Study|Requirement for restricted medication|2|||
124540443|NCT00796367|447931144|FG000|Overall Study|other|2|||
124540444|NCT00796367|447931145|FG001|Overall Study|other|4|||
124540445|NCT00796367|447931146|FG002|Overall Study|other|3|||
124540446|NCT05664672|447931147|FG000|Overall Study|Adverse Event|0|||
124540447|NCT05664672|447931148|FG001|Overall Study|Adverse Event|0|||
124540448|NCT05664672|447931149|FG002|Overall Study|Adverse Event|0|||
124540449|NCT05664672|447931150|FG003|Overall Study|Adverse Event|0|||
124540450|NCT05664672|447931151|FG004|Overall Study|Adverse Event|0|||
124540451|NCT05664672|447931152|FG005|Overall Study|Adverse Event|1|||
124540452|NCT05664672|447931147|FG000|Overall Study|Withdrawal by Subject|0|||
124540453|NCT05664672|447931148|FG001|Overall Study|Withdrawal by Subject|1|||
124540454|NCT05664672|447931149|FG002|Overall Study|Withdrawal by Subject|3|||
124540455|NCT05664672|447931150|FG003|Overall Study|Withdrawal by Subject|0|||
124540456|NCT05664672|447931151|FG004|Overall Study|Withdrawal by Subject|5|||
124540457|NCT05664672|447931152|FG005|Overall Study|Withdrawal by Subject|6|||
124540458|NCT05664672|447931147|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
124540459|NCT05664672|447931148|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
124540460|NCT05664672|447931149|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
124540461|NCT05664672|447931150|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
124540462|NCT05664672|447931151|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
124540463|NCT05664672|447931152|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
124540464|NCT05664672|447931147|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
124540465|NCT05664672|447931148|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
124540466|NCT05664672|447931149|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
124540467|NCT05664672|447931150|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
124540468|NCT05664672|447931151|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
124540469|NCT05664672|447931152|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
124540470|NCT04236986|447931161|FG000|Overall Study|Withdrawal by Subject|3|||
124540471|NCT04236986|447931162|FG001|Overall Study|Withdrawal by Subject|1|||
124540472|NCT04034225|447931163|FG000|Overall Study|Death|3|||
124540473|NCT04034225|447931163|FG000|Overall Study|Withdrawal by Subject|2|||
124758634|NCT01463306|448739820|FG000|Overall Study|Death|3|||
124540474|NCT04034225|447931163|FG000|Overall Study|Study termination by Sponsor|18|||
124540475|NCT04034225|447931163|FG000|Overall Study|Physician Decision|1|||
124540476|NCT04034225|447931163|FG000|Overall Study|Lack of Efficacy|1|||
124540477|NCT01326481|447931169|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
124540478|NCT00307736|447931170|FG000|Overall Study|Adverse Event|0|||
124540479|NCT00307736|447931171|FG001|Overall Study|Adverse Event|0|||
124540480|NCT00307736|447931172|FG002|Overall Study|Adverse Event|1|||
124540481|NCT00307736|447931173|FG003|Overall Study|Adverse Event|3|||
124540482|NCT00307736|447931170|FG000|Overall Study|Withdrawal by Subject|0|||
124540483|NCT00307736|447931171|FG001|Overall Study|Withdrawal by Subject|0|||
124540484|NCT00307736|447931172|FG002|Overall Study|Withdrawal by Subject|2|||
124540485|NCT00307736|447931173|FG003|Overall Study|Withdrawal by Subject|0|||
124540486|NCT02260791|447931176|FG000|Overall Study|Lost to Follow-up|4|||
124540487|NCT02260791|447931177|FG001|Overall Study|Lost to Follow-up|4|||
124981396|NCT01204710|449557472|FG001|Randomization Treatment|Adverse Event|2|||
124981397|NCT01204710|449557471|FG000|Randomization Treatment|Sponsor Decision|0|||
124981398|NCT01204710|449557472|FG001|Randomization Treatment|Sponsor Decision|1|||
124981399|NCT01204710|449557471|FG000|Randomization Treatment|Worsening of General condition|0|||
124981400|NCT01204710|449557472|FG001|Randomization Treatment|Worsening of General condition|1|||
124981401|NCT01204710|449557471|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
124981402|NCT01204710|449557472|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
124540488|NCT02260791|447931176|FG000|Overall Study|Lack of Efficacy|2|||
124540489|NCT02260791|447931177|FG001|Overall Study|Lack of Efficacy|1|||
124540490|NCT02260791|447931176|FG000|Overall Study|Adverse Event|13|||
124540491|NCT02260791|447931177|FG001|Overall Study|Adverse Event|9|||
124540492|NCT02260791|447931176|FG000|Overall Study|Death|1|||
124540493|NCT02260791|447931177|FG001|Overall Study|Death|0|||
124540494|NCT02260791|447931176|FG000|Overall Study|Withdrawal by Subject|11|||
124540495|NCT02260791|447931177|FG001|Overall Study|Withdrawal by Subject|16|||
124540496|NCT02260791|447931176|FG000|Overall Study|Screen failure|0|||
124540497|NCT02260791|447931177|FG001|Overall Study|Screen failure|1|||
124540498|NCT02260791|447931176|FG000|Overall Study|Protocol deviation|2|||
124540499|NCT02260791|447931177|FG001|Overall Study|Protocol deviation|3|||
124540500|NCT00606931|447931178|FG000|Overall Study|Withdrawal by Subject|3|||
124540501|NCT02924129|447931192|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
124540502|NCT02924129|447931193|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
124540503|NCT02924129|447931192|FG000|Overall Study|Withdrawal by Subject|2|||
124540504|NCT02924129|447931193|FG001|Overall Study|Withdrawal by Subject|2|||
124540505|NCT02924129|447931192|FG000|Overall Study|Physician Decision|1|||
124540506|NCT02924129|447931193|FG001|Overall Study|Physician Decision|0|||
124540507|NCT02924129|447931192|FG000|Overall Study|Missed Visit|0|||
124540508|NCT02924129|447931193|FG001|Overall Study|Missed Visit|1|||
124540509|NCT01348828|447931195|FG000|Overall Study|Death|20|||
124540510|NCT01348828|447931195|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
124540511|NCT01348828|447931195|FG000|Overall Study|Conversion|2|||
124540512|NCT01348828|447931195|FG000|Overall Study|missed visit|1|||
124540513|NCT00302731|447931196|FG000|Overall Study|Lost to Follow-up|1|||
124540514|NCT00302731|447931197|FG001|Overall Study|Lost to Follow-up|2|||
124540515|NCT00302731|447931198|FG002|Overall Study|Lost to Follow-up|0|||
124540516|NCT00302731|447931199|FG003|Overall Study|Lost to Follow-up|0|||
124540517|NCT00302731|447931196|FG000|Overall Study|Adverse Event|0|||
124540518|NCT00302731|447931197|FG001|Overall Study|Adverse Event|2|||
124540519|NCT00302731|447931198|FG002|Overall Study|Adverse Event|2|||
124540520|NCT00302731|447931199|FG003|Overall Study|Adverse Event|0|||
124540521|NCT00302731|447931196|FG000|Overall Study|Withdrawal by Subject|1|||
124540522|NCT00302731|447931197|FG001|Overall Study|Withdrawal by Subject|1|||
124540523|NCT00302731|447931198|FG002|Overall Study|Withdrawal by Subject|0|||
124540524|NCT00302731|447931199|FG003|Overall Study|Withdrawal by Subject|0|||
124540525|NCT00302731|447931196|FG000|Overall Study|Protocol Violation|1|||
124540526|NCT00302731|447931197|FG001|Overall Study|Protocol Violation|0|||
124540527|NCT00302731|447931198|FG002|Overall Study|Protocol Violation|0|||
124540528|NCT00302731|447931199|FG003|Overall Study|Protocol Violation|0|||
124540529|NCT00302731|447931196|FG000|Overall Study|cancer unrelated to study discovered|1|||
124540530|NCT00302731|447931197|FG001|Overall Study|cancer unrelated to study discovered|0|||
124540531|NCT00302731|447931198|FG002|Overall Study|cancer unrelated to study discovered|1|||
124540532|NCT00302731|447931199|FG003|Overall Study|cancer unrelated to study discovered|0|||
124981403|NCT01204710|449557471|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
124981404|NCT01204710|449557472|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
124540533|NCT01000311|447931200|FG000|Overall Study|Adverse Event|2|||
124540534|NCT01000311|447931201|FG001|Overall Study|Adverse Event|5|||
124540535|NCT01000311|447931200|FG000|Overall Study|Withdrawal by Subject|16|||
124540536|NCT01000311|447931201|FG001|Overall Study|Withdrawal by Subject|24|||
124540537|NCT01000311|447931200|FG000|Overall Study|Lost to Follow-up|15|||
124540538|NCT01000311|447931201|FG001|Overall Study|Lost to Follow-up|24|||
124540539|NCT01000311|447931200|FG000|Overall Study|Protocol Violation|1|||
124540540|NCT01000311|447931201|FG001|Overall Study|Protocol Violation|2|||
124540541|NCT01000311|447931200|FG000|Overall Study|Inappropriate enrollment|2|||
124540542|NCT01000311|447931201|FG001|Overall Study|Inappropriate enrollment|0|||
124540543|NCT01000311|447931200|FG000|Overall Study|Administrative reason|9|||
124540544|NCT01000311|447931201|FG001|Overall Study|Administrative reason|15|||
124540545|NCT01610752|447931204|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
124540546|NCT01610752|447931205|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
124540547|NCT01610752|447931206|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
124540548|NCT02815670|447931207|FG000|Overall Study|Prematurely discontinued of the trial|1|||
124540549|NCT02354599|447931211|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
124540550|NCT02354599|447931212|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
124540551|NCT02354599|447931213|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
124540552|NCT02354599|447931214|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
124540553|NCT02354599|447931215|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
124540554|NCT02354599|447931216|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
124540555|NCT02354599|447931211|FG000|Overall Study|Withdrawal by Subject|1|||
124540556|NCT02354599|447931212|FG001|Overall Study|Withdrawal by Subject|1|||
124540557|NCT02354599|447931213|FG002|Overall Study|Withdrawal by Subject|0|||
124540558|NCT02354599|447931214|FG003|Overall Study|Withdrawal by Subject|0|||
124540559|NCT02354599|447931215|FG004|Overall Study|Withdrawal by Subject|0|||
124540560|NCT02354599|447931216|FG005|Overall Study|Withdrawal by Subject|0|||
124540561|NCT01087944|447931229|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
124540562|NCT01087944|447931230|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
124540563|NCT01087944|447931229|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
124540564|NCT01087944|447931230|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
124540565|NCT01159665|447931231|FG000|Overall Study|Withdrawal by Subject|0|||
124540566|NCT01159665|447931232|FG001|Overall Study|Withdrawal by Subject|1|||
124540567|NCT01159665|447931233|FG002|Overall Study|Withdrawal by Subject|0|||
124540568|NCT01159665|447931234|FG003|Overall Study|Withdrawal by Subject|0|||
124540569|NCT01159665|447931235|FG004|Overall Study|Withdrawal by Subject|0|||
124540570|NCT01159665|447931236|FG005|Overall Study|Withdrawal by Subject|0|||
124540571|NCT01377194|447931238|FG000|Overall Study|Adverse Event|3|||
124540572|NCT01377194|447931239|FG001|Overall Study|Adverse Event|12|||
124540573|NCT01377194|447931240|FG002|Overall Study|Adverse Event|19|||
124540574|NCT01377194|447931238|FG000|Overall Study|Lack of Efficacy|3|||
124540575|NCT01377194|447931239|FG001|Overall Study|Lack of Efficacy|3|||
124540576|NCT01377194|447931240|FG002|Overall Study|Lack of Efficacy|3|||
124540577|NCT01377194|447931238|FG000|Overall Study|Protocol Violation|4|||
124540578|NCT01377194|447931239|FG001|Overall Study|Protocol Violation|10|||
124540579|NCT01377194|447931240|FG002|Overall Study|Protocol Violation|6|||
124540580|NCT01377194|447931238|FG000|Overall Study|Withdrawal by Subject|8|||
124540581|NCT01377194|447931239|FG001|Overall Study|Withdrawal by Subject|10|||
124540582|NCT01377194|447931240|FG002|Overall Study|Withdrawal by Subject|7|||
124540583|NCT01377194|447931238|FG000|Overall Study|Lost to Follow-up|14|||
124540584|NCT01377194|447931239|FG001|Overall Study|Lost to Follow-up|8|||
124540585|NCT01377194|447931240|FG002|Overall Study|Lost to Follow-up|11|||
124540586|NCT01230489|447931241|FG000|Overall Study|Death|2|||
124540587|NCT01230489|447931241|FG000|Overall Study|Adverse Event|2|||
124540588|NCT01230489|447931241|FG000|Overall Study|Treatment modality changed|1|||
124540589|NCT01791543|447931242|FG000|Overall Study|Lost to Follow-up|1|||
124540590|NCT01791543|447931242|FG000|Overall Study|Adverse Event|1|||
124540591|NCT02985541|447932427|FG000|Overall Study|Withdrawal by Subject|33|||
124540592|NCT02985541|447932427|FG000|Overall Study|Lost to Follow-up|26|||
124540593|NCT02985541|447932427|FG000|Overall Study|Adverse Event|27|||
124540594|NCT02985541|447932427|FG000|Overall Study|Physician Decision|2|||
124540595|NCT02985541|447932427|FG000|Overall Study|Pregnancy|2|||
124540596|NCT02985541|447932427|FG000|Overall Study|Wish for pregnancy|44|||
124540597|NCT02985541|447932427|FG000|Overall Study|Other reason|5|||
124540598|NCT02985541|447932427|FG000|Overall Study|Not valid for analysis|2|||
124540599|NCT01846442|447932428|FG000|Overall Study|Adverse Event|2|||
124540600|NCT01846442|447932429|FG001|Overall Study|Adverse Event|4|||
124981405|NCT01204710|449557471|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
124981406|NCT01204710|449557472|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
124981407|NCT01204710|449557471|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
124981408|NCT01204710|449557472|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
124540601|NCT01846442|447932430|FG002|Overall Study|Adverse Event|2|||
124540602|NCT01846442|447932431|FG003|Overall Study|Adverse Event|1|||
124540603|NCT01846442|447932428|FG000|Overall Study|Lost to Follow-up|0|||
124540604|NCT01846442|447932429|FG001|Overall Study|Lost to Follow-up|0|||
124540605|NCT01846442|447932430|FG002|Overall Study|Lost to Follow-up|1|||
124540606|NCT01846442|447932431|FG003|Overall Study|Lost to Follow-up|0|||
124540607|NCT01846442|447932428|FG000|Overall Study|Withdrawal by Subject|3|||
124540608|NCT01846442|447932429|FG001|Overall Study|Withdrawal by Subject|2|||
124540609|NCT01846442|447932430|FG002|Overall Study|Withdrawal by Subject|0|||
124540610|NCT01846442|447932431|FG003|Overall Study|Withdrawal by Subject|1|||
124540611|NCT01846442|447932428|FG000|Overall Study|Left the city/Lost medication|1|||
124540612|NCT01846442|447932429|FG001|Overall Study|Left the city/Lost medication|0|||
124758635|NCT01463306|448739821|FG001|Overall Study|Death|3|||
124540613|NCT01846442|447932430|FG002|Overall Study|Left the city/Lost medication|1|||
124540614|NCT01846442|447932431|FG003|Overall Study|Left the city/Lost medication|1|||
124540615|NCT00761761|447932439|FG000|Overall Study|Lost to Follow-up|3|||
124540616|NCT00761761|447932440|FG001|Overall Study|Lost to Follow-up|1|||
124540617|NCT00761761|447932439|FG000|Overall Study|Withdrawal by Subject|3|||
124540618|NCT00761761|447932440|FG001|Overall Study|Withdrawal by Subject|0|||
124540619|NCT01982942|447932441|FG000|Overall Study|Adverse Event|10|||
124540620|NCT01982942|447932442|FG001|Overall Study|Adverse Event|5|||
124540621|NCT01982942|447932441|FG000|Overall Study|Lost to Follow-up|4|||
124540622|NCT01982942|447932442|FG001|Overall Study|Lost to Follow-up|3|||
124540623|NCT01982942|447932441|FG000|Overall Study|Multiple sclerosis progression|3|||
124540624|NCT01982942|447932442|FG001|Overall Study|Multiple sclerosis progression|2|||
124540625|NCT01982942|447932441|FG000|Overall Study|Wanted to try therapy not permitted|1|||
124540626|NCT01982942|447932442|FG001|Overall Study|Wanted to try therapy not permitted|0|||
124540627|NCT01982942|447932441|FG000|Overall Study|Subject declined future visits|0|||
124540628|NCT01982942|447932442|FG001|Overall Study|Subject declined future visits|1|||
124540629|NCT01982942|447932441|FG000|Overall Study|Left geographical area|2|||
124540630|NCT01982942|447932442|FG001|Overall Study|Left geographical area|0|||
124540631|NCT01982942|447932441|FG000|Overall Study|Too many pills|1|||
124540632|NCT01982942|447932442|FG001|Overall Study|Too many pills|0|||
124540633|NCT01982942|447932441|FG000|Overall Study|MS Relapse|0|||
124540634|NCT01982942|447932442|FG001|Overall Study|MS Relapse|1|||
124540635|NCT01982942|447932441|FG000|Overall Study|Chose to join a stem cell trial|0|||
124540636|NCT01982942|447932442|FG001|Overall Study|Chose to join a stem cell trial|1|||
124540637|NCT01982942|447932441|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
124540638|NCT01982942|447932442|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
124540639|NCT01224171|447932443|FG000|Overall Study|Adverse Event|8|||
124540640|NCT01224171|447932444|FG001|Overall Study|Adverse Event|4|||
124540641|NCT01224171|447932443|FG000|Overall Study|Protocol Violation|0|||
124540642|NCT01224171|447932444|FG001|Overall Study|Protocol Violation|1|||
124540643|NCT01224171|447932443|FG000|Overall Study|Lack of Efficacy|5|||
124540644|NCT01224171|447932444|FG001|Overall Study|Lack of Efficacy|1|||
124540645|NCT01224171|447932443|FG000|Overall Study|Withdrawal of Consent|2|||
124540646|NCT01224171|447932444|FG001|Overall Study|Withdrawal of Consent|4|||
124540647|NCT01224171|447932443|FG000|Overall Study|Lost to Follow-up|0|||
124540648|NCT01224171|447932444|FG001|Overall Study|Lost to Follow-up|3|||
124540649|NCT03737812|447932445|FG000|Overall Study|Withdrawal by Subject|1|||
124540650|NCT03737812|447932446|FG001|Overall Study|Withdrawal by Subject|2|||
124540651|NCT03737812|447932447|FG002|Overall Study|Withdrawal by Subject|1|||
124540652|NCT03737812|447932445|FG000|Overall Study|Sponsor Discontinued the Study|4|||
124540653|NCT03737812|447932446|FG001|Overall Study|Sponsor Discontinued the Study|3|||
124540654|NCT03737812|447932447|FG002|Overall Study|Sponsor Discontinued the Study|2|||
124540655|NCT03737812|447932445|FG000|Overall Study|Adverse Event|0|||
124540656|NCT03737812|447932446|FG001|Overall Study|Adverse Event|1|||
124540657|NCT03737812|447932447|FG002|Overall Study|Adverse Event|0|||
124540658|NCT03737812|447932445|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
124540659|NCT03737812|447932446|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
124540660|NCT03737812|447932447|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
124540661|NCT02624713|447932448|FG000|Overall Study|Lost to Follow-up|14|||
124540662|NCT02624713|447932449|FG001|Overall Study|Lost to Follow-up|0|||
124540663|NCT00285857|447932453|FG000|Overall Study|Withdrawal by Subject|2|||
124540664|NCT00285857|447932453|FG000|Overall Study|Inadequate initial breast cytology|1|||
124540665|NCT00285857|447932453|FG000|Overall Study|Adverse Event|1|||
124540666|NCT01161173|447932459|FG000|Overall Study|Protocol Violation|13|||
124540667|NCT01161173|447932459|FG000|Overall Study|Lost to Follow-up|7|||
124540668|NCT01161173|447932459|FG000|Overall Study|Progressive Disease|82|||
124540669|NCT01161173|447932459|FG000|Overall Study|Withdrawal of Consent|5|||
124540670|NCT01161173|447932459|FG000|Overall Study|Unacceptable Toxicity|21|||
124540671|NCT01161173|447932459|FG000|Overall Study|Death|194|||
124540672|NCT01161173|447932459|FG000|Overall Study|End of Study|2|||
124540673|NCT01161173|447932459|FG000|Overall Study|Reasons Not Specified|23|||
124540674|NCT00792467|447932462|FG000|Overall Study|progression of disease|17|||
124540675|NCT00792467|447932462|FG000|Overall Study|Adverse Event|1|||
124540676|NCT00792467|447932462|FG000|Overall Study|patient request|1|||
124540677|NCT00792467|447932462|FG000|Overall Study|Lost to Follow-up|1|||
124540678|NCT00792467|447932462|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
124540679|NCT00792467|447932462|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
124540680|NCT03911401|447932463|FG000|Overall Study|Adverse Event|1|||
124540681|NCT03911401|447932464|FG001|Overall Study|Adverse Event|2|||
124540682|NCT03911401|447932465|FG002|Overall Study|Adverse Event|5|||
124540683|NCT03911401|447932463|FG000|Overall Study|Lack of Efficacy|1|||
124540684|NCT03911401|447932464|FG001|Overall Study|Lack of Efficacy|1|||
124540685|NCT03911401|447932465|FG002|Overall Study|Lack of Efficacy|8|||
124540686|NCT03911401|447932463|FG000|Overall Study|Physician Decision|0|||
124540687|NCT03911401|447932464|FG001|Overall Study|Physician Decision|0|||
124540688|NCT03911401|447932465|FG002|Overall Study|Physician Decision|1|||
124540689|NCT03911401|447932463|FG000|Overall Study|Withdrawal by Subject|1|||
124540690|NCT03911401|447932464|FG001|Overall Study|Withdrawal by Subject|2|||
124540691|NCT03911401|447932465|FG002|Overall Study|Withdrawal by Subject|0|||
124540692|NCT03911401|447932463|FG000|Overall Study|Withdrawal by parent/guardian|4|||
124540693|NCT03911401|447932464|FG001|Overall Study|Withdrawal by parent/guardian|4|||
124540694|NCT03911401|447932465|FG002|Overall Study|Withdrawal by parent/guardian|11|||
124540695|NCT00462501|447932466|FG000|Overall Study|Not treated|3|||
124540696|NCT00462501|447932466|FG000|Overall Study|Adverse Event|2|||
124540697|NCT00933543|447932469|FG000|Overall Study|Adverse Event|2|||
124540698|NCT00933543|447932470|FG001|Overall Study|Adverse Event|1|||
124540699|NCT00933543|447932469|FG000|Overall Study|Lost to Follow-up|0|||
124540700|NCT00933543|447932470|FG001|Overall Study|Lost to Follow-up|1|||
124540701|NCT00933543|447932469|FG000|Overall Study|Withdrawal by Subject|0|||
124540702|NCT00933543|447932470|FG001|Overall Study|Withdrawal by Subject|1|||
124540703|NCT00933543|447932469|FG000|Overall Study|Lack of Efficacy|0|||
124540704|NCT00933543|447932470|FG001|Overall Study|Lack of Efficacy|3|||
124540705|NCT00933543|447932469|FG000|Overall Study|Other|1|||
124540706|NCT00933543|447932470|FG001|Overall Study|Other|1|||
124540707|NCT04837807|447932471|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
124540708|NCT04837807|447932472|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
124540709|NCT04652245|447932478|FG000|Wash-Out Period|Adverse Event|0|||
124540710|NCT04652245|447932479|FG001|Wash-Out Period|Adverse Event|2|||
124540711|NCT04652245|447932478|FG000|Wash-Out Period|Withdrawal by Subject|0|||
124540712|NCT04652245|447932479|FG001|Wash-Out Period|Withdrawal by Subject|2|||
124540713|NCT04246996|447932486|FG000|Overall Study|Physician Decision|1|||
124540714|NCT04246996|447932487|FG001|Overall Study|Physician Decision|1|||
124540715|NCT04246996|447932486|FG000|Overall Study|Did not meet eligibility criteria|1|||
124540716|NCT04246996|447932487|FG001|Overall Study|Did not meet eligibility criteria|4|||
124540717|NCT02442284|447932488|FG000|Overall Study|Adverse Event|1|||
124540718|NCT02442284|447932488|FG000|Overall Study|Withdrew Consent|2|||
124540719|NCT02442284|447932488|FG000|Overall Study|Lost to Follow-up|3|||
124540720|NCT02442284|447932488|FG000|Overall Study|Other|1|||
124540721|NCT01365182|447932489|FG000|Overall Study|Withdrawal by Subject|10|||
124540722|NCT01365182|447932490|FG001|Overall Study|Withdrawal by Subject|13|||
124540723|NCT01365182|447932491|FG002|Overall Study|Withdrawal by Subject|12|||
124540724|NCT02309372|447932494|FG000|Overall Study|Lost to Follow-up|3|||
124540725|NCT02309372|447932495|FG001|Overall Study|Lost to Follow-up|2|||
124540726|NCT01590810|447932497|FG000|Overall Study|Physician Decision|0|||
124540727|NCT01590810|447932498|FG001|Overall Study|Physician Decision|1|||
124540728|NCT01590810|447932499|FG002|Overall Study|Physician Decision|1|||
124540729|NCT01590810|447932500|FG003|Overall Study|Physician Decision|0|||
124540730|NCT01590810|447932501|FG004|Overall Study|Physician Decision|0|||
124540731|NCT02129192|447932502|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
124540732|NCT02129192|447932503|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
124540733|NCT01231620|447932505|FG000|Overall Study|Physician Decision|3|||
124540734|NCT01231620|447932506|FG001|Overall Study|Physician Decision|5|||
124540735|NCT01231620|447932507|FG002|Overall Study|Physician Decision|10|||
124540736|NCT01231620|447932505|FG000|Overall Study|Death|12|||
124540737|NCT01231620|447932506|FG001|Overall Study|Death|14|||
124540738|NCT01231620|447932507|FG002|Overall Study|Death|11|||
124540739|NCT01231620|447932505|FG000|Overall Study|Adverse Event|2|||
124540740|NCT01231620|447932506|FG001|Overall Study|Adverse Event|2|||
124540741|NCT01231620|447932507|FG002|Overall Study|Adverse Event|1|||
124540742|NCT01231620|447932505|FG000|Overall Study|Withdrawal by Subject|6|||
124540743|NCT01231620|447932506|FG001|Overall Study|Withdrawal by Subject|6|||
124540744|NCT01231620|447932507|FG002|Overall Study|Withdrawal by Subject|8|||
124540745|NCT01231620|447932505|FG000|Overall Study|Lost to Follow-up|3|||
124540746|NCT01231620|447932506|FG001|Overall Study|Lost to Follow-up|4|||
124540747|NCT01231620|447932507|FG002|Overall Study|Lost to Follow-up|9|||
124540748|NCT02400281|447932508|FG000|Overall Study|Adverse Event|0|||
124540749|NCT02400281|447932509|FG001|Overall Study|Adverse Event|0|||
124540750|NCT02400281|447932510|FG002|Overall Study|Adverse Event|1|||
124540751|NCT02400281|447932511|FG003|Overall Study|Adverse Event|0|||
124540752|NCT02400281|447932512|FG004|Overall Study|Adverse Event|1|||
124540753|NCT02400281|447932513|FG005|Overall Study|Adverse Event|0|||
124540754|NCT02400281|447932508|FG000|Overall Study|Physician Decision|0|||
124540755|NCT02400281|447932509|FG001|Overall Study|Physician Decision|0|||
124540756|NCT02400281|447932510|FG002|Overall Study|Physician Decision|1|||
124540757|NCT02400281|447932511|FG003|Overall Study|Physician Decision|0|||
124540758|NCT02400281|447932512|FG004|Overall Study|Physician Decision|0|||
124540759|NCT02400281|447932513|FG005|Overall Study|Physician Decision|0|||
124540760|NCT00412360|447932514|FG000|Overall Study|Lost to Follow-up|0|||
124540761|NCT00412360|447932515|FG001|Overall Study|Lost to Follow-up|1|||
124540762|NCT00412360|447932514|FG000|Overall Study|Not Transplanted|1|||
124540763|NCT00412360|447932515|FG001|Overall Study|Not Transplanted|2|||
124540764|NCT02576652|447932517|FG000|Overall Study|Withdrawal by Subject|2|||
124540765|NCT00553319|447932526|FG000|Overall Study|Lost to Follow-up|10|||
124540766|NCT00553319|447932527|FG001|Overall Study|Lost to Follow-up|9|||
124540767|NCT00553319|447932528|FG002|Overall Study|Lost to Follow-up|5|||
124540768|NCT00553319|447932526|FG000|Overall Study|wanted treatment elsewhere|2|||
124540769|NCT00553319|447932527|FG001|Overall Study|wanted treatment elsewhere|1|||
124540770|NCT00553319|447932528|FG002|Overall Study|wanted treatment elsewhere|1|||
124540771|NCT00553319|447932526|FG000|Overall Study|non-compliance|0|||
124540772|NCT00553319|447932527|FG001|Overall Study|non-compliance|0|||
124540773|NCT00553319|447932528|FG002|Overall Study|non-compliance|2|||
124540774|NCT00553319|447932526|FG000|Overall Study|incarceration|1|||
124540775|NCT00553319|447932527|FG001|Overall Study|incarceration|0|||
124540776|NCT00553319|447932528|FG002|Overall Study|incarceration|0|||
124540777|NCT00553319|447932526|FG000|Overall Study|moved|1|||
124540778|NCT00553319|447932527|FG001|Overall Study|moved|0|||
124540779|NCT00553319|447932528|FG002|Overall Study|moved|1|||
124540780|NCT01078974|447932529|FG000|Overall Study|Adverse Event|3|||
124540781|NCT00495794|447932536|FG000|Overall Study|Pharmacist did not activate patient|522|||
124540782|NCT00495794|447932537|FG001|Overall Study|Pharmacist did not activate patient|0|||
124540783|NCT03039699|447932538|FG000|Overall Study|Incorrect inclusion|5|||
124540784|NCT03039699|447932539|FG001|Overall Study|Incorrect inclusion|4|||
124540785|NCT03039699|447932538|FG000|Overall Study|Lack of data to assess study endpoint|5|||
124540786|NCT03039699|447932539|FG001|Overall Study|Lack of data to assess study endpoint|3|||
124540787|NCT03039699|447932538|FG000|Overall Study|Bacterial infection|12|||
124540788|NCT03039699|447932539|FG001|Overall Study|Bacterial infection|28|||
124540789|NCT04511533|447934085|FG000|Treatment|Other|2|||
124540790|NCT04511533|447934085|FG000|Treatment|Withdrawal by Subject|11|||
124540791|NCT04511533|447934085|FG000|Treatment|Death|5|||
124540792|NCT04511533|447934085|FG000|Treatment|Physician Decision|1|||
124540793|NCT04511533|447934085|FG000|Treatment|Progressive Disease|61|||
124540794|NCT04511533|447934085|FG000|Follow-Up|Other|7|||
124540795|NCT04511533|447934085|FG000|Follow-Up|Withdrawal by Subject|5|||
124540796|NCT04511533|447934085|FG000|Follow-Up|Lost to Follow-up|2|||
124540797|NCT04511533|447934085|FG000|Follow-Up|Death|4|||
124540798|NCT02918968|447934088|FG000|1st Line AAT|Progressive disease|9|||
124540799|NCT02918968|447934089|FG001|1st Line AAT|Progressive disease|4|||
124540800|NCT02918968|447934088|FG000|1st Line AAT|Adverse Event|12|||
124540801|NCT02918968|447934089|FG001|1st Line AAT|Adverse Event|3|||
124540802|NCT02918968|447934088|FG000|1st Line AAT|Physician Decision|4|||
124540803|NCT02918968|447934089|FG001|1st Line AAT|Physician Decision|2|||
124540804|NCT02918968|447934088|FG000|1st Line AAT|Withdrawal by Subject|2|||
124540805|NCT02918968|447934089|FG001|1st Line AAT|Withdrawal by Subject|1|||
124540806|NCT02918968|447934088|FG000|1st Line AAT|Lost to Follow-up|0|||
124540807|NCT02918968|447934089|FG001|1st Line AAT|Lost to Follow-up|1|||
124540808|NCT02918968|447934088|FG000|1st Line AAT|Death|1|||
124540809|NCT02918968|447934089|FG001|1st Line AAT|Death|0|||
124540810|NCT02918968|447934088|FG000|1st Line AAT|Miscellaneous|1|||
124540811|NCT02918968|447934089|FG001|1st Line AAT|Miscellaneous|0|||
124540812|NCT02918968|447934088|FG000|2nd Line AAT|Progressive disease|21|||
124540813|NCT02918968|447934089|FG001|2nd Line AAT|Progressive disease|3|||
124540814|NCT02918968|447934088|FG000|2nd Line AAT|Adverse Event|2|||
124540815|NCT02918968|447934089|FG001|2nd Line AAT|Adverse Event|5|||
124540816|NCT02918968|447934088|FG000|2nd Line AAT|Physician Decision|0|||
124540817|NCT02918968|447934089|FG001|2nd Line AAT|Physician Decision|1|||
124540818|NCT02918968|447934088|FG000|2nd Line AAT|Withdrawal by Subject|2|||
124540819|NCT02918968|447934089|FG001|2nd Line AAT|Withdrawal by Subject|2|||
124540820|NCT02918968|447934088|FG000|2nd Line AAT|Death|0|||
124540821|NCT02918968|447934089|FG001|2nd Line AAT|Death|1|||
124540822|NCT00727246|447934094|FG000|Overall Study|could not complete MRI|0|||
124540823|NCT00727246|447934095|FG001|Overall Study|could not complete MRI|1|||
124540824|NCT00727246|447934096|FG002|Overall Study|could not complete MRI|0|||
124540825|NCT00727246|447934097|FG003|Overall Study|could not complete MRI|1|||
124540826|NCT00727246|447934094|FG000|Overall Study|incidental finding|0|||
124540827|NCT00727246|447934095|FG001|Overall Study|incidental finding|0|||
124540828|NCT00727246|447934096|FG002|Overall Study|incidental finding|0|||
124540829|NCT00727246|447934097|FG003|Overall Study|incidental finding|1|||
124540830|NCT00727246|447934094|FG000|Overall Study|withdrawn|0|||
124540831|NCT00727246|447934095|FG001|Overall Study|withdrawn|0|||
124540832|NCT00727246|447934096|FG002|Overall Study|withdrawn|1|||
124540833|NCT00727246|447934097|FG003|Overall Study|withdrawn|0|||
124540834|NCT02696382|447934098|FG000|Overall Study|Death|7|||
124540835|NCT02696382|447934099|FG001|Overall Study|Death|2|||
124540836|NCT02696382|447934098|FG000|Overall Study|Withdrawal by Subject|5|||
124540837|NCT02696382|447934099|FG001|Overall Study|Withdrawal by Subject|12|||
124540838|NCT02696382|447934098|FG000|Overall Study|Lost to Follow-up|4|||
124540839|NCT02696382|447934099|FG001|Overall Study|Lost to Follow-up|7|||
124540840|NCT00483574|447934101|FG000|Overall Study|Adverse Event|6|||
124540841|NCT00483574|447934102|FG001|Overall Study|Adverse Event|0|||
124540842|NCT00483574|447934101|FG000|Overall Study|Protocol Violation|28|||
124540843|NCT00483574|447934102|FG001|Overall Study|Protocol Violation|9|||
124540844|NCT00483574|447934101|FG000|Overall Study|Lost to Follow-up|16|||
124540845|NCT00483574|447934102|FG001|Overall Study|Lost to Follow-up|4|||
124540846|NCT00483574|447934101|FG000|Overall Study|Withdrawal by Subject|52|||
124540847|NCT00483574|447934102|FG001|Overall Study|Withdrawal by Subject|0|||
124540848|NCT00998166|447934103|FG000|Overall Study|Early Study Termination|8|||
124540849|NCT04988035|447934116|FG000|Overall Study|Death|19|||
124540850|NCT04988035|447934117|FG001|Overall Study|Death|13|||
124540851|NCT04988035|447934116|FG000|Overall Study|Lost to Follow-up|12|||
124540852|NCT04988035|447934117|FG001|Overall Study|Lost to Follow-up|6|||
124540853|NCT04988035|447934116|FG000|Overall Study|Protocol Violation|0|||
124540854|NCT04988035|447934117|FG001|Overall Study|Protocol Violation|1|||
124540855|NCT04988035|447934116|FG000|Overall Study|Withdrawal by Subject|2|||
124540856|NCT04988035|447934117|FG001|Overall Study|Withdrawal by Subject|4|||
124540857|NCT04988035|447934116|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
124540858|NCT04988035|447934117|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
124540859|NCT03602976|447934118|FG000|Overall Study|Withdrawal by Subject|1|||
124540860|NCT04626947|447934119|FG000|Overall Study|Study terminated|14|||
124540861|NCT01428882|447934120|FG000|Overall Study|Lack of Efficacy|2|||
124540862|NCT01428882|447934121|FG001|Overall Study|Lack of Efficacy|7|||
124540863|NCT01428882|447934120|FG000|Overall Study|Protocol Violation|4|||
124540864|NCT01428882|447934121|FG001|Overall Study|Protocol Violation|3|||
124540865|NCT00429026|447934124|FG000|Overall Study|Inevaluable for response.|40|||
124540866|NCT03831282|447934125|FG000|Overall Study|Could not place sensor|1|||
124540867|NCT04338685|447934130|FG000|Overall Study|Death|3|||
124540868|NCT04338685|447934131|FG001|Overall Study|Death|4|||
124540869|NCT04338685|447934132|FG002|Overall Study|Death|2|||
124540870|NCT04338685|447934133|FG003|Overall Study|Death|4|||
124540871|NCT04338685|447934134|FG004|Overall Study|Death|4|||
124540872|NCT04338685|447934135|FG005|Overall Study|Death|8|||
124540873|NCT04338685|447934136|FG006|Overall Study|Death|1|||
124540874|NCT04338685|447934137|FG007|Overall Study|Death|0|||
124540875|NCT04338685|447934138|FG008|Overall Study|Death|0|||
124540876|NCT04338685|447934130|FG000|Overall Study|Study terminated by Sponsor|0|||
124540877|NCT04338685|447934131|FG001|Overall Study|Study terminated by Sponsor|0|||
124540878|NCT04338685|447934132|FG002|Overall Study|Study terminated by Sponsor|1|||
124540879|NCT04338685|447934133|FG003|Overall Study|Study terminated by Sponsor|4|||
124540880|NCT04338685|447934134|FG004|Overall Study|Study terminated by Sponsor|0|||
124540881|NCT04338685|447934135|FG005|Overall Study|Study terminated by Sponsor|5|||
124540882|NCT04338685|447934136|FG006|Overall Study|Study terminated by Sponsor|2|||
124540883|NCT04338685|447934137|FG007|Overall Study|Study terminated by Sponsor|4|||
124540884|NCT04338685|447934138|FG008|Overall Study|Study terminated by Sponsor|1|||
124540885|NCT04338685|447934130|FG000|Overall Study|Withdrawal by Subject|1|||
124540886|NCT04338685|447934131|FG001|Overall Study|Withdrawal by Subject|2|||
124540887|NCT04338685|447934132|FG002|Overall Study|Withdrawal by Subject|0|||
124540888|NCT04338685|447934133|FG003|Overall Study|Withdrawal by Subject|2|||
124540889|NCT04338685|447934134|FG004|Overall Study|Withdrawal by Subject|0|||
124540890|NCT04338685|447934135|FG005|Overall Study|Withdrawal by Subject|5|||
124540891|NCT04338685|447934136|FG006|Overall Study|Withdrawal by Subject|1|||
124540892|NCT04338685|447934137|FG007|Overall Study|Withdrawal by Subject|1|||
124540893|NCT04338685|447934138|FG008|Overall Study|Withdrawal by Subject|0|||
124540894|NCT03556202|447934139|FG000|Extension Treatment Period|Adverse Event|18|||
124540895|NCT03556202|447934140|FG001|Extension Treatment Period|Adverse Event|14|||
124540896|NCT03556202|447934141|FG002|Extension Treatment Period|Adverse Event|9|||
124540897|NCT03556202|447934139|FG000|Extension Treatment Period|Death|2|||
124540898|NCT03556202|447934140|FG001|Extension Treatment Period|Death|6|||
124540899|NCT03556202|447934141|FG002|Extension Treatment Period|Death|0|||
124540900|NCT03556202|447934139|FG000|Extension Treatment Period|Lack of Efficacy|5|||
124540901|NCT03556202|447934140|FG001|Extension Treatment Period|Lack of Efficacy|12|||
124540902|NCT03556202|447934141|FG002|Extension Treatment Period|Lack of Efficacy|18|||
124540903|NCT03556202|447934139|FG000|Extension Treatment Period|Lost to Follow-up|9|||
124540904|NCT03556202|447934140|FG001|Extension Treatment Period|Lost to Follow-up|20|||
124540905|NCT03556202|447934141|FG002|Extension Treatment Period|Lost to Follow-up|2|||
124540906|NCT03556202|447934139|FG000|Extension Treatment Period|Pregnancy|2|||
124540907|NCT03556202|447934140|FG001|Extension Treatment Period|Pregnancy|4|||
124540908|NCT03556202|447934141|FG002|Extension Treatment Period|Pregnancy|3|||
124540909|NCT03556202|447934139|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
124540910|NCT03556202|447934140|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
124540911|NCT03556202|447934141|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
124540912|NCT03556202|447934139|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
124540913|NCT03556202|447934140|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
124540914|NCT03556202|447934141|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
124540915|NCT03556202|447934139|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
124540916|NCT03556202|447934140|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
124540917|NCT03556202|447934141|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
124540918|NCT03556202|447934139|FG000|Extension Treatment Period|Physician Decision|0|||
124540919|NCT03556202|447934140|FG001|Extension Treatment Period|Physician Decision|8|||
124540920|NCT03556202|447934141|FG002|Extension Treatment Period|Physician Decision|2|||
124540921|NCT03556202|447934139|FG000|Extension Treatment Period|Protocol Violation|0|||
124540922|NCT03556202|447934140|FG001|Extension Treatment Period|Protocol Violation|1|||
124540923|NCT03556202|447934141|FG002|Extension Treatment Period|Protocol Violation|1|||
124540924|NCT03556202|447934139|FG000|Extension Treatment Period|Sponsor Decision|0|||
124540925|NCT03556202|447934140|FG001|Extension Treatment Period|Sponsor Decision|1|||
124540926|NCT03556202|447934141|FG002|Extension Treatment Period|Sponsor Decision|0|||
124540927|NCT03556202|447934139|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
124540928|NCT03556202|447934140|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
124540929|NCT03556202|447934141|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
124540930|NCT03556202|447934139|FG000|Follow-Up Period (12 Weeks)|Death|1|||
124540931|NCT03556202|447934140|FG001|Follow-Up Period (12 Weeks)|Death|0|||
124540932|NCT03556202|447934141|FG002|Follow-Up Period (12 Weeks)|Death|0|||
124540933|NCT03556202|447934139|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
124540934|NCT03556202|447934140|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
124540935|NCT03556202|447934141|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
124540936|NCT03556202|447934139|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
124540937|NCT03556202|447934140|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
124540938|NCT03556202|447934141|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
124540939|NCT03556202|447934139|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
124540940|NCT03556202|447934140|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
124540941|NCT03556202|447934141|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
124540942|NCT03556202|447934139|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
124540943|NCT03556202|447934140|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
124540944|NCT03556202|447934141|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
124540945|NCT03556202|447934139|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
124540946|NCT03556202|447934140|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
124540947|NCT03556202|447934141|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
124540948|NCT03556202|447934139|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
124540949|NCT03556202|447934140|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
124540950|NCT03556202|447934141|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
124540951|NCT03556202|447934139|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
124540952|NCT03556202|447934140|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
124540953|NCT03556202|447934141|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
124540954|NCT03556202|447934139|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
124540955|NCT03556202|447934140|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
124540956|NCT03556202|447934141|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
124540957|NCT03556202|447934139|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
124540958|NCT03556202|447934140|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
124540959|NCT03556202|447934141|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
124540960|NCT03556202|447934139|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
124540961|NCT03556202|447934140|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
124540962|NCT03556202|447934141|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
124540963|NCT03556202|447934139|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
124540964|NCT03556202|447934140|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
124540965|NCT03556202|447934141|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
124540966|NCT03556202|447934139|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
124540967|NCT03556202|447934140|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
124540968|NCT03556202|447934141|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
124540969|NCT01539512|447934142|FG000|Overall Study|Adverse Event|9|||
124540970|NCT01539512|447934143|FG001|Overall Study|Adverse Event|7|||
124540971|NCT01539512|447934142|FG000|Overall Study|Physician Decision|1|||
124540972|NCT01539512|447934143|FG001|Overall Study|Physician Decision|1|||
124540973|NCT01539512|447934142|FG000|Overall Study|Withdrawal by Subject|12|||
124540974|NCT01539512|447934143|FG001|Overall Study|Withdrawal by Subject|5|||
124540975|NCT01539512|447934142|FG000|Overall Study|Richter's Transformation|1|||
124540976|NCT01539512|447934143|FG001|Overall Study|Richter's Transformation|0|||
124540977|NCT04479358|447934150|FG000|Overall Study|Withdrawal by Subject|0|||
124540978|NCT04479358|447934151|FG001|Overall Study|Withdrawal by Subject|0|||
124540979|NCT04479358|447934152|FG002|Overall Study|Withdrawal by Subject|1|||
124540980|NCT04479358|447934153|FG003|Overall Study|Withdrawal by Subject|0|||
124540981|NCT04479358|447934154|FG004|Overall Study|Withdrawal by Subject|0|||
124540982|NCT04479358|447934155|FG005|Overall Study|Withdrawal by Subject|1|||
124540983|NCT00764465|447934156|FG000|Overall Study|Adverse Event|2|||
124540984|NCT00764465|447934157|FG001|Overall Study|Adverse Event|0|||
124540985|NCT00764465|447934158|FG002|Overall Study|Adverse Event|0|||
124540986|NCT00764465|447934159|FG003|Overall Study|Adverse Event|1|||
124540987|NCT00764465|447934160|FG004|Overall Study|Adverse Event|1|||
124540988|NCT00764465|447934161|FG005|Overall Study|Adverse Event|1|||
124540989|NCT00764465|447934156|FG000|Overall Study|Withdrawal by Subject|0|||
124540990|NCT00764465|447934157|FG001|Overall Study|Withdrawal by Subject|1|||
124540991|NCT00764465|447934158|FG002|Overall Study|Withdrawal by Subject|1|||
124540992|NCT00764465|447934159|FG003|Overall Study|Withdrawal by Subject|0|||
124540993|NCT00764465|447934160|FG004|Overall Study|Withdrawal by Subject|0|||
124540994|NCT00764465|447934161|FG005|Overall Study|Withdrawal by Subject|0|||
124540995|NCT01333501|447934162|FG000|Overall Study|Adverse Event|3|||
124540996|NCT01333501|447934163|FG001|Overall Study|Adverse Event|1|||
124540997|NCT01333501|447934162|FG000|Overall Study|Abnormal laboratory value|2|||
124540998|NCT01333501|447934163|FG001|Overall Study|Abnormal laboratory value|1|||
124540999|NCT01333501|447934162|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124541000|NCT01333501|447934163|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
124541001|NCT01333501|447934162|FG000|Overall Study|Withdrawn consent|3|||
124541002|NCT01333501|447934163|FG001|Overall Study|Withdrawn consent|12|||
124541003|NCT00674440|447934164|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
124541004|NCT00674440|447934164|FG000|Overall Study|did not have surgery, so unevaluable|7|||
124541005|NCT00674440|447934164|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
124541006|NCT00914940|447934165|FG000|D0 to D100 Post-transplant|Death|2|||
124541007|NCT00914940|447934165|FG000|D101 to 2 Years Post-transplant|Death|8|||
124541008|NCT00914940|447934165|FG000|2 Years to 5 Years Post-transplant|Death|3|||
124541009|NCT04095039|447934167|FG000|Overall Study|Withdrawal by Subject|2|||
124541010|NCT04095039|447934168|FG001|Overall Study|Withdrawal by Subject|16|||
124541011|NCT04095039|447934167|FG000|Overall Study|Transplanted|21|||
124541012|NCT04095039|447934168|FG001|Overall Study|Transplanted|24|||
124541013|NCT04095039|447934167|FG000|Overall Study|Transferred to Non-study Facility|47|||
124541014|NCT04095039|447934168|FG001|Overall Study|Transferred to Non-study Facility|44|||
124541015|NCT04095039|447934167|FG000|Overall Study|Withdrawal from internvention target|0|||
124541016|NCT04095039|447934168|FG001|Overall Study|Withdrawal from internvention target|2|||
124541017|NCT04095039|447934167|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
124541018|NCT04095039|447934168|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
124541019|NCT04095039|447934167|FG000|Overall Study|Cacliphylaxis|0|||
124541020|NCT04095039|447934168|FG001|Overall Study|Cacliphylaxis|1|||
124541021|NCT04095039|447934167|FG000|Overall Study|Pregnancy|1|||
124541022|NCT04095039|447934168|FG001|Overall Study|Pregnancy|0|||
124541023|NCT02370173|447934169|FG000|Overall Study|Protocol Violation|1|||
124541024|NCT02370173|447934170|FG001|Overall Study|Protocol Violation|1|||
124541025|NCT02370173|447934169|FG000|Overall Study|Withdrawal by Subject|2|||
124541026|NCT02370173|447934170|FG001|Overall Study|Withdrawal by Subject|2|||
124541027|NCT03205605|447934171|FG000|Overall Study|Withdrawal by Subject|1|||
124541028|NCT00945815|447934174|FG000|Overall Study|Death|3|||
124541029|NCT00945815|447934174|FG000|Overall Study|Not protocol specified|1|||
124541030|NCT00945815|447934174|FG000|Overall Study|Ineligible|3|||
124541031|NCT00945815|447934174|FG000|Overall Study|Did not begin protocol therapy|1|||
124541032|NCT01990339|447934177|FG000|Overall Study|Data Not Available|49|||
124541033|NCT01990339|447934177|FG000|Overall Study|Voluntary Withdrawal|1402|||
124541034|NCT01990339|447934177|FG000|Overall Study|Lost to Follow-up|861|||
124541035|NCT01038609|447934178|FG000|Overall Study|Adverse Event|0|||
124541036|NCT01038609|447934179|FG001|Overall Study|Adverse Event|0|||
124541037|NCT01038609|447934180|FG002|Overall Study|Adverse Event|1|||
124541038|NCT01038609|447934181|FG003|Overall Study|Adverse Event|0|||
124541039|NCT01038609|447934182|FG004|Overall Study|Adverse Event|0|||
124541040|NCT01038609|447934178|FG000|Overall Study|Dosing Error|0|||
124541041|NCT01038609|447934179|FG001|Overall Study|Dosing Error|0|||
124541042|NCT01038609|447934180|FG002|Overall Study|Dosing Error|0|||
124541043|NCT01038609|447934181|FG003|Overall Study|Dosing Error|1|||
124541044|NCT01038609|447934182|FG004|Overall Study|Dosing Error|1|||
124541045|NCT01038609|447934178|FG000|Overall Study|Death in the Family|1|||
124541046|NCT01038609|447934179|FG001|Overall Study|Death in the Family|0|||
124541047|NCT01038609|447934180|FG002|Overall Study|Death in the Family|0|||
124541048|NCT01038609|447934181|FG003|Overall Study|Death in the Family|0|||
124541049|NCT01038609|447934182|FG004|Overall Study|Death in the Family|0|||
124541050|NCT01038609|447934178|FG000|Overall Study|Refusal of Blood Draws|0|||
124541051|NCT01038609|447934179|FG001|Overall Study|Refusal of Blood Draws|1|||
124541052|NCT01038609|447934180|FG002|Overall Study|Refusal of Blood Draws|0|||
124541053|NCT01038609|447934181|FG003|Overall Study|Refusal of Blood Draws|0|||
124541054|NCT01038609|447934182|FG004|Overall Study|Refusal of Blood Draws|0|||
124541055|NCT01728194|447934183|FG000|Overall Study|Lost to Follow-up|4|||
124541056|NCT01728194|447934184|FG001|Overall Study|Lost to Follow-up|3|||
124541057|NCT01728194|447934183|FG000|Overall Study|Physician Decision|4|||
124981409|NCT00586612|449557473|FG000|Primary Phase|Protocol Violation|1|||
124981410|NCT00586612|449557474|FG001|Primary Phase|Protocol Violation|0|||
124981411|NCT00586612|449557473|FG000|Primary Phase|Lost to Follow-up|0|||
124541058|NCT01728194|447934184|FG001|Overall Study|Physician Decision|0|||
124541059|NCT01728194|447934183|FG000|Overall Study|Withdrawal by Subject|7|||
124541060|NCT01728194|447934184|FG001|Overall Study|Withdrawal by Subject|3|||
124541061|NCT01728194|447934183|FG000|Overall Study|Perceived Medication Side Effects|4|||
124541062|NCT01728194|447934184|FG001|Overall Study|Perceived Medication Side Effects|0|||
124541063|NCT01728194|447934183|FG000|Overall Study|Family Member Request|1|||
124541064|NCT01728194|447934184|FG001|Overall Study|Family Member Request|0|||
124541065|NCT04604015|447934186|FG000|Overall Study|Incomplete Data Collection|33|||
124541066|NCT01314261|447934187|FG000|Overall Study|Adverse Event|1|||
124541067|NCT01314261|447934188|FG001|Overall Study|Adverse Event|0|||
124541068|NCT01314261|447934189|FG002|Overall Study|Adverse Event|0|||
124541069|NCT01314261|447934190|FG003|Overall Study|Adverse Event|0|||
124541070|NCT01314261|447934187|FG000|Overall Study|Withdrawal by Subject|0|||
124541071|NCT01314261|447934188|FG001|Overall Study|Withdrawal by Subject|3|||
124541072|NCT01314261|447934189|FG002|Overall Study|Withdrawal by Subject|1|||
124541073|NCT01314261|447934190|FG003|Overall Study|Withdrawal by Subject|0|||
124541074|NCT01314261|447934187|FG000|Overall Study|Lost to Follow-up|1|||
124541075|NCT01314261|447934188|FG001|Overall Study|Lost to Follow-up|0|||
124541076|NCT01314261|447934189|FG002|Overall Study|Lost to Follow-up|2|||
124541077|NCT01314261|447934190|FG003|Overall Study|Lost to Follow-up|2|||
124541078|NCT01314261|447934187|FG000|Overall Study|Virologic Failure|0|||
124541079|NCT01314261|447934188|FG001|Overall Study|Virologic Failure|1|||
124541080|NCT01314261|447934189|FG002|Overall Study|Virologic Failure|0|||
124541081|NCT01314261|447934190|FG003|Overall Study|Virologic Failure|1|||
124541082|NCT04524507|447934191|FG000|Overall Study|Lost to Follow-up|2|||
124541083|NCT04524507|447934192|FG001|Overall Study|Lost to Follow-up|4|||
124541084|NCT04524507|447934191|FG000|Overall Study|Withdrawal by Subject|2|||
124541085|NCT04524507|447934192|FG001|Overall Study|Withdrawal by Subject|9|||
124541086|NCT04524507|447934191|FG000|Overall Study|Death|2|||
124541087|NCT04524507|447934192|FG001|Overall Study|Death|10|||
124541088|NCT02711306|447934194|FG000|Overall Study|Withdrawal by Subject|2|||
124541089|NCT02711306|447934195|FG001|Overall Study|Withdrawal by Subject|2|||
124541090|NCT03655951|447934196|FG000|Overall Study|Lost to Follow-up|39|||
124541091|NCT03655951|447934197|FG001|Overall Study|Lost to Follow-up|20|||
124541092|NCT03655951|447934196|FG000|Overall Study|Withdrawal by Subject|0|||
124541093|NCT03655951|447934197|FG001|Overall Study|Withdrawal by Subject|1|||
124541094|NCT02811640|447934198|FG000|Overall Study|Technology malfunction|2|||
124541095|NCT03575975|447934200|FG000|Overall Study|Lost to Follow-up|1|||
124541096|NCT03575975|447934201|FG001|Overall Study|Lost to Follow-up|0|||
124541097|NCT03575975|447934202|FG002|Overall Study|Lost to Follow-up|0|||
124541098|NCT02441517|447934203|FG000|Overall Study|Lost to Follow-up|1|||
124541099|NCT02441517|447934203|FG000|Overall Study|Withdrawal by Subject|2|||
124541100|NCT02441517|447934203|FG000|Overall Study|Study Terminated by Sponsor|1|||
124541101|NCT01393444|447934204|FG000|Overall Study|Withdrawal by Subject|1|||
124541102|NCT01393444|447934204|FG000|Overall Study|Determined ineligible during screening.|2|||
124541103|NCT00129220|447934206|FG000|Study Period II|Adverse Event|9|||
124541104|NCT00129220|447934207|FG001|Study Period II|Adverse Event|5|||
124541105|NCT00129220|447934208|FG002|Study Period II|Adverse Event|7|||
124541106|NCT00129220|447934206|FG000|Study Period II|Lack of Efficacy|15|||
124541107|NCT00129220|447934207|FG001|Study Period II|Lack of Efficacy|1|||
124541108|NCT00129220|447934208|FG002|Study Period II|Lack of Efficacy|28|||
124541109|NCT00129220|447934206|FG000|Study Period II|Entry Criteria Not Met|2|||
124541110|NCT00129220|447934207|FG001|Study Period II|Entry Criteria Not Met|0|||
124541111|NCT00129220|447934208|FG002|Study Period II|Entry Criteria Not Met|2|||
124541112|NCT00129220|447934206|FG000|Study Period II|Protocol Violation|4|||
124541113|NCT00129220|447934207|FG001|Study Period II|Protocol Violation|2|||
124541114|NCT00129220|447934208|FG002|Study Period II|Protocol Violation|1|||
124541115|NCT00129220|447934206|FG000|Study Period II|Physician Decision|0|||
124541116|NCT00129220|447934207|FG001|Study Period II|Physician Decision|1|||
124541117|NCT00129220|447934208|FG002|Study Period II|Physician Decision|0|||
124541118|NCT00129220|447934206|FG000|Study Period II|Withdrawal by Subject|1|||
124541119|NCT00129220|447934207|FG001|Study Period II|Withdrawal by Subject|3|||
124541120|NCT00129220|447934208|FG002|Study Period II|Withdrawal by Subject|4|||
124541121|NCT00129220|447934206|FG000|Study Period II|Reason Not Specified|2|||
124541122|NCT00129220|447934207|FG001|Study Period II|Reason Not Specified|0|||
124541123|NCT00129220|447934208|FG002|Study Period II|Reason Not Specified|5|||
124541124|NCT00129220|447934206|FG000|Study Period III|Adverse Event|1|||
124541125|NCT00129220|447934207|FG001|Study Period III|Adverse Event|0|||
124541126|NCT00129220|447934208|FG002|Study Period III|Adverse Event|3|||
124541127|NCT00129220|447934206|FG000|Study Period III|Protocol Violation|1|||
124541128|NCT00129220|447934207|FG001|Study Period III|Protocol Violation|1|||
124541129|NCT00129220|447934208|FG002|Study Period III|Protocol Violation|2|||
124541130|NCT00129220|447934206|FG000|Study Period III|Withdrawal by Subject|1|||
124541131|NCT00129220|447934207|FG001|Study Period III|Withdrawal by Subject|0|||
124541132|NCT00129220|447934208|FG002|Study Period III|Withdrawal by Subject|3|||
124541133|NCT00129220|447934206|FG000|Study Period III|Sponsor Decision|1|||
124541134|NCT00129220|447934207|FG001|Study Period III|Sponsor Decision|0|||
124541135|NCT00129220|447934208|FG002|Study Period III|Sponsor Decision|0|||
124541136|NCT00129220|447934206|FG000|Study Period III|Reason Not Specified|9|||
124541137|NCT00129220|447934207|FG001|Study Period III|Reason Not Specified|0|||
124541138|NCT00129220|447934208|FG002|Study Period III|Reason Not Specified|2|||
124541139|NCT01883362|447934209|FG000|Treatment|Adverse Event|1|||
124541140|NCT01883362|447934210|FG001|Treatment|Adverse Event|8|||
124541141|NCT01883362|447934209|FG000|Treatment|Withdrawal by Subject|6|||
124541142|NCT01883362|447934210|FG001|Treatment|Withdrawal by Subject|2|||
124541143|NCT01883362|447934209|FG000|Treatment|Administrative problems|4|||
124541144|NCT01883362|447934210|FG001|Treatment|Administrative problems|1|||
124541145|NCT01883362|447934209|FG000|Treatment|Relapse|4|||
124541146|NCT01883362|447934210|FG001|Treatment|Relapse|2|||
124541147|NCT01883362|447934209|FG000|Treatment|Randomized, not treated|1|||
124541148|NCT01883362|447934210|FG001|Treatment|Randomized, not treated|1|||
124541149|NCT01883362|447934209|FG000|Post Treatment Follow-up|Protocol Violation|0|||
124541150|NCT01883362|447934210|FG001|Post Treatment Follow-up|Protocol Violation|1|||
124541151|NCT01883362|447934209|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
124541152|NCT01883362|447934210|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
124541153|NCT01883362|447934209|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
124541154|NCT01883362|447934210|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
124541155|NCT01883362|447934209|FG000|Post Treatment Follow-up|Administrative problems|2|||
124541156|NCT01883362|447934210|FG001|Post Treatment Follow-up|Administrative problems|0|||
124541157|NCT01883362|447934209|FG000|Post Treatment Follow-up|Death|8|||
124541158|NCT01883362|447934210|FG001|Post Treatment Follow-up|Death|4|||
124541159|NCT01883362|447934209|FG000|Post Treatment Follow-up|Relapse|1|||
124541160|NCT01883362|447934210|FG001|Post Treatment Follow-up|Relapse|2|||
124541161|NCT01383317|447934211|FG000|Overall Study|Lost to Follow-up|2|||
124541162|NCT01383317|447934212|FG001|Overall Study|Lost to Follow-up|1|||
124541163|NCT01383317|447934211|FG000|Overall Study|Death|1|||
124541164|NCT01383317|447934212|FG001|Overall Study|Death|0|||
124541165|NCT01383317|447934211|FG000|Overall Study|Adverse Event|0|||
124541166|NCT01383317|447934212|FG001|Overall Study|Adverse Event|1|||
124541167|NCT02569996|447934215|FG000|Overall Study|Adverse Event|6|||
124541168|NCT02569996|447934215|FG000|Overall Study|Physician Decision|3|||
124541169|NCT02569996|447934215|FG000|Overall Study|Progression of the disease|18|||
124541170|NCT02569996|447934215|FG000|Overall Study|New anti-lymphoma treatment|1|||
124541171|NCT02569996|447934215|FG000|Overall Study|Non-compliance|9|||
124541172|NCT02569996|447934215|FG000|Overall Study|Withdrawal by Subject|5|||
124541173|NCT02569996|447934215|FG000|Overall Study|Lost to Follow-up|5|||
124541174|NCT02569996|447934215|FG000|Overall Study|Complete remission|7|||
124541175|NCT02569996|447934215|FG000|Overall Study|Unknown reason|1|||
124541176|NCT01349816|447934216|FG000|Overall Study|Withdrawal by Subject|4|||
124541177|NCT01349816|447934216|FG000|Overall Study|Physician Decision|1|||
124541178|NCT01349816|447934216|FG000|Overall Study|Adverse Event|14|||
124541179|NCT01349816|447934216|FG000|Overall Study|Lost to Follow-up|2|||
124541180|NCT01349816|447934216|FG000|Overall Study|Protocol Violation|1|||
124541181|NCT01349816|447934216|FG000|Overall Study|Protocol-specified criteria|8|||
124541182|NCT01397409|447934219|FG000|Stage 2|Adverse Event|0|||
124541183|NCT01397409|447934220|FG001|Stage 2|Adverse Event|0|||
124541184|NCT01397409|447934221|FG002|Stage 2|Adverse Event|0|||
124541185|NCT01397409|447934222|FG003|Stage 2|Adverse Event|0|||
124541186|NCT01397409|447934223|FG004|Stage 2|Adverse Event|6|||
124541187|NCT01397409|447934224|FG005|Stage 2|Adverse Event|3|||
124541188|NCT01397409|447934225|FG006|Stage 2|Adverse Event|0|||
124541189|NCT01397409|447934226|FG007|Stage 2|Adverse Event|0|||
124541190|NCT01397409|447934227|FG008|Stage 2|Adverse Event|0|||
124541191|NCT01397409|447934228|FG009|Stage 2|Adverse Event|0|||
124541192|NCT01397409|447934219|FG000|Stage 2|Personal Reasons|0|||
124541193|NCT01397409|447934220|FG001|Stage 2|Personal Reasons|0|||
124541194|NCT01397409|447934221|FG002|Stage 2|Personal Reasons|0|||
124541195|NCT01397409|447934222|FG003|Stage 2|Personal Reasons|0|||
124541196|NCT01397409|447934223|FG004|Stage 2|Personal Reasons|1|||
124541197|NCT01397409|447934224|FG005|Stage 2|Personal Reasons|0|||
124541198|NCT01397409|447934225|FG006|Stage 2|Personal Reasons|0|||
124541199|NCT01397409|447934226|FG007|Stage 2|Personal Reasons|0|||
124541200|NCT01397409|447934227|FG008|Stage 2|Personal Reasons|0|||
124541201|NCT01397409|447934228|FG009|Stage 2|Personal Reasons|0|||
124541202|NCT01397409|447934219|FG000|Stage 2|Other Miscellaneous Reasons|0|||
124541203|NCT01397409|447934220|FG001|Stage 2|Other Miscellaneous Reasons|0|||
124541204|NCT01397409|447934221|FG002|Stage 2|Other Miscellaneous Reasons|0|||
124541205|NCT01397409|447934222|FG003|Stage 2|Other Miscellaneous Reasons|0|||
124541206|NCT01397409|447934223|FG004|Stage 2|Other Miscellaneous Reasons|1|||
124541207|NCT01397409|447934224|FG005|Stage 2|Other Miscellaneous Reasons|1|||
124541208|NCT01397409|447934225|FG006|Stage 2|Other Miscellaneous Reasons|0|||
124541209|NCT01397409|447934226|FG007|Stage 2|Other Miscellaneous Reasons|0|||
124541210|NCT01397409|447934227|FG008|Stage 2|Other Miscellaneous Reasons|0|||
124541211|NCT01397409|447934228|FG009|Stage 2|Other Miscellaneous Reasons|0|||
124541212|NCT01397409|447934219|FG000|Stage 3|Adverse Event|0|||
124541213|NCT01397409|447934220|FG001|Stage 3|Adverse Event|0|||
124541214|NCT01397409|447934221|FG002|Stage 3|Adverse Event|0|||
124541215|NCT01397409|447934222|FG003|Stage 3|Adverse Event|0|||
124541216|NCT01397409|447934223|FG004|Stage 3|Adverse Event|0|||
124541217|NCT01397409|447934224|FG005|Stage 3|Adverse Event|0|||
124541218|NCT01397409|447934225|FG006|Stage 3|Adverse Event|0|||
124541219|NCT01397409|447934226|FG007|Stage 3|Adverse Event|1|||
124541220|NCT01397409|447934227|FG008|Stage 3|Adverse Event|0|||
124541221|NCT01397409|447934228|FG009|Stage 3|Adverse Event|0|||
124541222|NCT01397409|447934219|FG000|Stage 3|Other Miscellaneous Reasons|0|||
124541223|NCT01397409|447934220|FG001|Stage 3|Other Miscellaneous Reasons|0|||
124541224|NCT01397409|447934221|FG002|Stage 3|Other Miscellaneous Reasons|0|||
124541225|NCT01397409|447934222|FG003|Stage 3|Other Miscellaneous Reasons|0|||
124541226|NCT01397409|447934223|FG004|Stage 3|Other Miscellaneous Reasons|0|||
124541227|NCT01397409|447934224|FG005|Stage 3|Other Miscellaneous Reasons|0|||
124541228|NCT01397409|447934225|FG006|Stage 3|Other Miscellaneous Reasons|0|||
124541229|NCT01397409|447934226|FG007|Stage 3|Other Miscellaneous Reasons|1|||
124541230|NCT01397409|447934227|FG008|Stage 3|Other Miscellaneous Reasons|0|||
124541231|NCT01397409|447934228|FG009|Stage 3|Other Miscellaneous Reasons|0|||
124541232|NCT02911285|447934229|FG000|Overall Study|Lost to Follow-up|8|||
124541233|NCT02911285|447934230|FG001|Overall Study|Lost to Follow-up|5|||
124541234|NCT02911285|447934229|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
124541235|NCT02911285|447934230|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
124541236|NCT01207427|447934231|FG000|Double-blind Treatment Period|Adverse Event|0|||
124541237|NCT01207427|447934232|FG001|Double-blind Treatment Period|Adverse Event|1|||
124541238|NCT01207427|447934233|FG002|Double-blind Treatment Period|Adverse Event|0|||
124541239|NCT01207427|447934231|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
124541240|NCT01207427|447934232|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
124541241|NCT01207427|447934233|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
124541242|NCT01207427|447934231|FG000|Double-blind Treatment Period|Protocol Violation|2|||
124541243|NCT01207427|447934232|FG001|Double-blind Treatment Period|Protocol Violation|1|||
124541244|NCT01207427|447934233|FG002|Double-blind Treatment Period|Protocol Violation|1|||
124541245|NCT01207427|447934231|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
124541246|NCT01207427|447934232|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
124541247|NCT01207427|447934233|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
124541248|NCT01790633|447934234|FG000|Overall Study|Protocol Violation|1|||
124541249|NCT01790633|447934235|FG001|Overall Study|Protocol Violation|2|||
124541250|NCT01790633|447934234|FG000|Overall Study|Did not have serology performed|47|||
124541251|NCT01790633|447934235|FG001|Overall Study|Did not have serology performed|0|||
124541252|NCT01790633|447934234|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
124541253|NCT01790633|447934235|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
124541254|NCT02930889|447935917|FG000|Overall Study|Lost to Follow-up|2|||
124541255|NCT02930889|447935917|FG000|Overall Study|Withdrawal by Subject|6|||
124541256|NCT02930889|447935917|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
124541257|NCT00198107|447935921|FG000|Double-Blind Period|Adverse Event|1|||
124541258|NCT00198107|447935922|FG001|Double-Blind Period|Adverse Event|1|||
124541259|NCT00198107|447935923|FG002|Double-Blind Period|Adverse Event|0|||
124541260|NCT00198107|447935921|FG000|Double-Blind Period|Lack of Efficacy|2|||
124541261|NCT00198107|447935922|FG001|Double-Blind Period|Lack of Efficacy|0|||
124541262|NCT00198107|447935923|FG002|Double-Blind Period|Lack of Efficacy|0|||
124541263|NCT00198107|447935921|FG000|Double-Blind Period|Lost to Follow-up|2|||
124541264|NCT00198107|447935922|FG001|Double-Blind Period|Lost to Follow-up|1|||
124541265|NCT00198107|447935923|FG002|Double-Blind Period|Lost to Follow-up|0|||
124541266|NCT00198107|447935921|FG000|Double-Blind Period|Physician Decision|1|||
124541267|NCT00198107|447935922|FG001|Double-Blind Period|Physician Decision|0|||
124541268|NCT00198107|447935923|FG002|Double-Blind Period|Physician Decision|0|||
124541269|NCT00198107|447935921|FG000|Double-Blind Period|Withdrawal by Subject|0|||
124541270|NCT00198107|447935922|FG001|Double-Blind Period|Withdrawal by Subject|1|||
124541271|NCT00198107|447935923|FG002|Double-Blind Period|Withdrawal by Subject|0|||
124541272|NCT00198107|447935921|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
124541273|NCT00198107|447935922|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
124541274|NCT00198107|447935923|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
124541275|NCT03996694|447935932|FG000|First Washout (7 Days)|positive urine drug screen|0|||
124541276|NCT03996694|447935933|FG001|First Washout (7 Days)|positive urine drug screen|0|||
124541277|NCT03996694|447935934|FG002|First Washout (7 Days)|positive urine drug screen|1|||
124541278|NCT03996694|447935935|FG003|First Washout (7 Days)|positive urine drug screen|0|||
124541279|NCT03996694|447935936|FG004|First Washout (7 Days)|positive urine drug screen|0|||
124541280|NCT03996694|447935937|FG005|First Washout (7 Days)|positive urine drug screen|0|||
124541281|NCT03996694|447935932|FG000|First Washout (7 Days)|Adverse Event|0|||
124541282|NCT03996694|447935933|FG001|First Washout (7 Days)|Adverse Event|1|||
124541283|NCT03996694|447935934|FG002|First Washout (7 Days)|Adverse Event|0|||
124981412|NCT00586612|449557474|FG001|Primary Phase|Lost to Follow-up|1|||
124981413|NCT00586612|449557473|FG000|Primary Phase|Withdrawal by Subject|0|||
124541284|NCT03996694|447935935|FG003|First Washout (7 Days)|Adverse Event|0|||
124541285|NCT03996694|447935936|FG004|First Washout (7 Days)|Adverse Event|0|||
124541286|NCT03996694|447935937|FG005|First Washout (7 Days)|Adverse Event|0|||
124541287|NCT03996694|447935932|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
124541288|NCT03996694|447935933|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
124541289|NCT03996694|447935934|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
124541290|NCT03996694|447935935|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
124541291|NCT03996694|447935936|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
124541292|NCT03996694|447935937|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
124541293|NCT03996694|447935932|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
124541294|NCT03996694|447935933|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
124541295|NCT03996694|447935934|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
124541296|NCT03996694|447935935|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
124541297|NCT03996694|447935936|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
124541298|NCT03996694|447935937|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
124541299|NCT00451191|447935942|FG000|Overall Study|withdrawal or received alternate tx|15|||
124541300|NCT00451191|447935943|FG001|Overall Study|withdrawal or received alternate tx|11|||
124541301|NCT01269346|447935945|FG000|Treatment Phase|Disease progression|3|||
124541302|NCT01269346|447935945|FG000|Treatment Phase|Adverse Event|3|||
124541303|NCT01269346|447935945|FG000|Treatment Phase|Withdrawal by Subject|1|||
124541304|NCT01269346|447935945|FG000|Treatment Phase|Other|2|||
124541305|NCT01269346|447935945|FG000|Extension Phase|Adverse Event|6|||
124541306|NCT01269346|447935945|FG000|Extension Phase|Withdrawal by Subject|4|||
124541307|NCT01269346|447935945|FG000|Extension Phase|Disease progression|22|||
124541308|NCT01269346|447935945|FG000|Extension Phase|Physician decision or participant choice|9|||
124541309|NCT01269346|447935945|FG000|Extension Phase|Clinical progression|1|||
124541310|NCT01269346|447935945|FG000|Extension Phase|Started a prohibited con med|1|||
124541311|NCT00247416|447935946|FG000|Overall Study|3 patients were found to be ineligible|1|||
124541312|NCT00247416|447935947|FG001|Overall Study|3 patients were found to be ineligible|2|||
124541313|NCT00798161|447935948|FG000|Overall Study|Adverse Event|3|||
124541314|NCT00798161|447935949|FG001|Overall Study|Adverse Event|4|||
124541315|NCT00798161|447935950|FG002|Overall Study|Adverse Event|6|||
124541316|NCT00798161|447935951|FG003|Overall Study|Adverse Event|6|||
124541317|NCT00798161|447935952|FG004|Overall Study|Adverse Event|5|||
124541318|NCT00798161|447935953|FG005|Overall Study|Adverse Event|2|||
124541319|NCT00798161|447935954|FG006|Overall Study|Adverse Event|4|||
124541320|NCT00798161|447935948|FG000|Overall Study|Protocol Violation|2|||
124541321|NCT00798161|447935949|FG001|Overall Study|Protocol Violation|1|||
124541322|NCT00798161|447935950|FG002|Overall Study|Protocol Violation|3|||
124541323|NCT00798161|447935951|FG003|Overall Study|Protocol Violation|3|||
124541324|NCT00798161|447935952|FG004|Overall Study|Protocol Violation|3|||
124541325|NCT00798161|447935953|FG005|Overall Study|Protocol Violation|2|||
124541326|NCT00798161|447935954|FG006|Overall Study|Protocol Violation|0|||
124541327|NCT00798161|447935948|FG000|Overall Study|Lost to Follow-up|1|||
124541328|NCT00798161|447935949|FG001|Overall Study|Lost to Follow-up|3|||
124541329|NCT00798161|447935950|FG002|Overall Study|Lost to Follow-up|4|||
124541330|NCT00798161|447935951|FG003|Overall Study|Lost to Follow-up|3|||
124541331|NCT00798161|447935952|FG004|Overall Study|Lost to Follow-up|4|||
124541332|NCT00798161|447935953|FG005|Overall Study|Lost to Follow-up|0|||
124541333|NCT00798161|447935954|FG006|Overall Study|Lost to Follow-up|0|||
124541334|NCT00798161|447935948|FG000|Overall Study|Withdrawal by Subject|5|||
124541335|NCT00798161|447935949|FG001|Overall Study|Withdrawal by Subject|4|||
124541336|NCT00798161|447935950|FG002|Overall Study|Withdrawal by Subject|5|||
124541337|NCT00798161|447935951|FG003|Overall Study|Withdrawal by Subject|4|||
124541338|NCT00798161|447935952|FG004|Overall Study|Withdrawal by Subject|2|||
124541339|NCT00798161|447935953|FG005|Overall Study|Withdrawal by Subject|3|||
124541340|NCT00798161|447935954|FG006|Overall Study|Withdrawal by Subject|1|||
124541341|NCT00798161|447935948|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
124541342|NCT00798161|447935949|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
124541343|NCT00798161|447935950|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
124541344|NCT00798161|447935951|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
124541345|NCT00798161|447935952|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
124541346|NCT00798161|447935953|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
124541347|NCT00798161|447935954|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
124541348|NCT02706327|447935955|FG000|Overall Study|Lost to Follow-up|1|||
124541349|NCT02706327|447935956|FG001|Overall Study|Lost to Follow-up|1|||
124541350|NCT02706327|447935957|FG002|Overall Study|Lost to Follow-up|2|||
124541357|NCT02213666|447935966|FG000|Overall Study|Withdrawal by Subject|1|||
124541358|NCT01319422|447935967|FG000|Overall Study|Withdrawal by Subject|1|||
124541359|NCT01319422|447935968|FG001|Overall Study|Withdrawal by Subject|0|||
124541360|NCT03417245|447935970|FG000|Overall Study|Adverse Event|1|||
124541361|NCT03417245|447935971|FG001|Overall Study|Adverse Event|0|||
124541362|NCT03417245|447935970|FG000|Overall Study|Protocol Violation|1|||
124541363|NCT03417245|447935971|FG001|Overall Study|Protocol Violation|0|||
124541364|NCT03417245|447935970|FG000|Overall Study|Withdrawal by Subject|1|||
124541365|NCT03417245|447935971|FG001|Overall Study|Withdrawal by Subject|1|||
124541366|NCT02708524|447935979|FG000|Overall Study|Adverse Event|0|||
124541367|NCT02708524|447935980|FG001|Overall Study|Adverse Event|1|||
124541368|NCT02708524|447935981|FG002|Overall Study|Adverse Event|0|||
124541369|NCT02708524|447935982|FG003|Overall Study|Adverse Event|0|||
124541370|NCT02708524|447935979|FG000|Overall Study|Lens Discomfort|1|||
124541371|NCT02708524|447935980|FG001|Overall Study|Lens Discomfort|0|||
124541372|NCT02708524|447935981|FG002|Overall Study|Lens Discomfort|1|||
124541373|NCT02708524|447935982|FG003|Overall Study|Lens Discomfort|0|||
124541374|NCT02708524|447935979|FG000|Overall Study|Lost to Follow-up|1|||
124541375|NCT02708524|447935980|FG001|Overall Study|Lost to Follow-up|1|||
124541376|NCT02708524|447935981|FG002|Overall Study|Lost to Follow-up|1|||
124541377|NCT02708524|447935982|FG003|Overall Study|Lost to Follow-up|0|||
124541378|NCT02708524|447935979|FG000|Overall Study|Protocol Violation|0|||
124541379|NCT02708524|447935980|FG001|Overall Study|Protocol Violation|1|||
124541380|NCT02708524|447935981|FG002|Overall Study|Protocol Violation|0|||
124541381|NCT02708524|447935982|FG003|Overall Study|Protocol Violation|0|||
124541382|NCT02708524|447935979|FG000|Overall Study|Withdrawal by Subject|1|||
124541383|NCT02708524|447935980|FG001|Overall Study|Withdrawal by Subject|1|||
124541384|NCT02708524|447935981|FG002|Overall Study|Withdrawal by Subject|0|||
124541385|NCT02708524|447935982|FG003|Overall Study|Withdrawal by Subject|0|||
124541386|NCT02708524|447935979|FG000|Overall Study|Dispensed incorrect study lens|0|||
124541387|NCT02708524|447935980|FG001|Overall Study|Dispensed incorrect study lens|1|||
124541388|NCT02708524|447935981|FG002|Overall Study|Dispensed incorrect study lens|1|||
124541389|NCT02708524|447935982|FG003|Overall Study|Dispensed incorrect study lens|0|||
124541390|NCT02708524|447935979|FG000|Overall Study|Did not wear lens at final visit|0|||
124541391|NCT02708524|447935980|FG001|Overall Study|Did not wear lens at final visit|1|||
124541392|NCT02708524|447935981|FG002|Overall Study|Did not wear lens at final visit|0|||
124541393|NCT02708524|447935982|FG003|Overall Study|Did not wear lens at final visit|0|||
124541394|NCT02708524|447935979|FG000|Overall Study|Subject lost study lens|1|||
124541395|NCT02708524|447935980|FG001|Overall Study|Subject lost study lens|0|||
124541396|NCT02708524|447935981|FG002|Overall Study|Subject lost study lens|0|||
124541397|NCT02708524|447935982|FG003|Overall Study|Subject lost study lens|0|||
124541398|NCT03781167|447935988|FG000|Overall Study|Adverse Event|23|||
124541399|NCT03781167|447935989|FG001|Overall Study|Adverse Event|25|||
124541400|NCT03781167|447935988|FG000|Overall Study|Withdrew consent|16|||
124541401|NCT03781167|447935989|FG001|Overall Study|Withdrew consent|12|||
124541402|NCT03781167|447935988|FG000|Overall Study|Lost to Follow-up|0|||
124541403|NCT03781167|447935989|FG001|Overall Study|Lost to Follow-up|1|||
124541404|NCT03781167|447935988|FG000|Overall Study|Lack of Efficacy|4|||
124541405|NCT03781167|447935989|FG001|Overall Study|Lack of Efficacy|5|||
124541406|NCT03781167|447935988|FG000|Overall Study|Difficulty with drug delivery system|2|||
124541407|NCT03781167|447935989|FG001|Overall Study|Difficulty with drug delivery system|3|||
124541408|NCT03781167|447935988|FG000|Overall Study|Other, not specified|2|||
124541409|NCT03781167|447935989|FG001|Overall Study|Other, not specified|2|||
124541410|NCT01590628|447935997|FG000|Overall Study|Death|2|||
124541411|NCT01590628|447935998|FG001|Overall Study|Death|0|||
124541412|NCT00475657|447935999|FG000|Overall Study|Death|1|||
124541413|NCT00475657|447935999|FG000|Overall Study|Sponsor's Decision|3|||
124541414|NCT02992743|447936000|FG000|Overall Study|Withdrawal by Subject|1|||
124541415|NCT02992743|447936001|FG001|Overall Study|Withdrawal by Subject|1|||
124541416|NCT02992743|447936000|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
124541417|NCT02992743|447936001|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
124541418|NCT02992743|447936000|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
124541419|NCT02992743|447936001|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
124541420|NCT02992743|447936000|FG000|Overall Study|No measurable disease|1|||
124541421|NCT02992743|447936001|FG001|Overall Study|No measurable disease|0|||
124541422|NCT02992743|447936000|FG000|Overall Study|Lost to Follow-up|0|||
124541423|NCT02992743|447936001|FG001|Overall Study|Lost to Follow-up|1|||
124541424|NCT00761735|447936002|FG000|Overall Study|Lost to Follow-up|6|||
124541425|NCT00761735|447936002|FG000|Overall Study|Withdrawal by Subject|6|||
124541426|NCT00761735|447936002|FG000|Overall Study|Non-compliance with protocol|1|||
124541427|NCT00761735|447936002|FG000|Overall Study|Administrative|1|||
124541428|NCT00381680|447936003|FG000|Overall Study|Adverse Event|9|||
124541429|NCT00381680|447936004|FG001|Overall Study|Adverse Event|3|||
124541430|NCT00381680|447936003|FG000|Overall Study|Death|10|||
124541431|NCT00381680|447936004|FG001|Overall Study|Death|7|||
124541432|NCT00381680|447936003|FG000|Overall Study|Lost to Follow-up|3|||
124541433|NCT00381680|447936004|FG001|Overall Study|Lost to Follow-up|2|||
124981414|NCT00586612|449557474|FG001|Primary Phase|Withdrawal by Subject|2|||
124541434|NCT00381680|447936003|FG000|Overall Study|Physician Decision|25|||
124541435|NCT00381680|447936004|FG001|Overall Study|Physician Decision|6|||
124541436|NCT00381680|447936003|FG000|Overall Study|Withdrawal by Subject|3|||
124541437|NCT00381680|447936004|FG001|Overall Study|Withdrawal by Subject|1|||
124541438|NCT00381680|447936003|FG000|Overall Study|Entry onto another COG Trial|1|||
124541439|NCT00381680|447936004|FG001|Overall Study|Entry onto another COG Trial|2|||
124541440|NCT00381680|447936003|FG000|Overall Study|Alternative Therapy|11|||
124541441|NCT00381680|447936004|FG001|Overall Study|Alternative Therapy|5|||
124541442|NCT00381680|447936003|FG000|Overall Study|Secondary Malignancy|3|||
124541443|NCT00381680|447936004|FG001|Overall Study|Secondary Malignancy|0|||
124541444|NCT00381680|447936003|FG000|Overall Study|Delay initiation|1|||
124541445|NCT00381680|447936004|FG001|Overall Study|Delay initiation|0|||
124541446|NCT00381680|447936003|FG000|Overall Study|Stem Cell Transplant|26|||
124541447|NCT00381680|447936004|FG001|Overall Study|Stem Cell Transplant|10|||
124541448|NCT00381680|447936003|FG000|Overall Study|Relapse|18|||
124541449|NCT00381680|447936004|FG001|Overall Study|Relapse|9|||
124541450|NCT00381680|447936003|FG000|Overall Study|Induction Failure|4|||
124541451|NCT00381680|447936004|FG001|Overall Study|Induction Failure|1|||
124541452|NCT00381680|447936003|FG000|Overall Study|Progression|1|||
124541453|NCT00381680|447936004|FG001|Overall Study|Progression|1|||
124541454|NCT00381680|447936003|FG000|Overall Study|Other not otherwise specified|7|||
124541455|NCT00381680|447936004|FG001|Overall Study|Other not otherwise specified|2|||
124541456|NCT00381680|447936003|FG000|Overall Study|Ineligible|3|||
124541457|NCT00381680|447936004|FG001|Overall Study|Ineligible|1|||
124541458|NCT03290131|447936007|FG000|Overall Study|Adverse Event|22|||
124541459|NCT03290131|447936008|FG001|Overall Study|Adverse Event|57|||
124541460|NCT03290131|447936009|FG002|Overall Study|Adverse Event|11|||
124541461|NCT03290131|447936007|FG000|Overall Study|Withdrawal by Subject|18|||
124541462|NCT03290131|447936008|FG001|Overall Study|Withdrawal by Subject|13|||
124541463|NCT03290131|447936009|FG002|Overall Study|Withdrawal by Subject|8|||
124541464|NCT03290131|447936007|FG000|Overall Study|MS Relapse|2|||
124541465|NCT03290131|447936008|FG001|Overall Study|MS Relapse|1|||
124541466|NCT03290131|447936009|FG002|Overall Study|MS Relapse|0|||
124541467|NCT03290131|447936007|FG000|Overall Study|Unknown reason|0|||
124541468|NCT03290131|447936008|FG001|Overall Study|Unknown reason|1|||
124541469|NCT03290131|447936009|FG002|Overall Study|Unknown reason|0|||
124541470|NCT03099096|447936012|FG000|Overall Study|Adverse Event|1|||
124541471|NCT03099096|447936012|FG000|Overall Study|Physician Decision|1|||
124541472|NCT00450814|447936020|FG000|Overall Study|Failed to complete the initial therapy|0|||
124541473|NCT00450814|447936021|FG001|Overall Study|Failed to complete the initial therapy|0|||
124541474|NCT00450814|447936022|FG002|Overall Study|Failed to complete the initial therapy|0|||
124541475|NCT00450814|447936023|FG003|Overall Study|Failed to complete the initial therapy|1|||
124541476|NCT00450814|447936024|FG004|Overall Study|Failed to complete the initial therapy|1|||
124541477|NCT00450814|447936025|FG005|Overall Study|Failed to complete the initial therapy|1|||
124541478|NCT00450814|447936026|FG006|Overall Study|Failed to complete the initial therapy|0|||
124541479|NCT00450814|447936027|FG007|Overall Study|Failed to complete the initial therapy|0|||
124541480|NCT00450814|447936028|FG008|Overall Study|Failed to complete the initial therapy|0|||
124541481|NCT00450814|447936029|FG009|Overall Study|Failed to complete the initial therapy|0|||
124541482|NCT00450814|447936030|FG010|Overall Study|Failed to complete the initial therapy|0|||
124541483|NCT00450814|447936020|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
124541484|NCT00450814|447936021|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
124541485|NCT00450814|447936022|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
124541486|NCT00450814|447936023|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
124541487|NCT00450814|447936024|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
124541488|NCT00450814|447936025|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
124541489|NCT00450814|447936026|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
124541490|NCT00450814|447936027|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
124541491|NCT00450814|447936028|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
124541492|NCT00450814|447936029|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
124541493|NCT00450814|447936030|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
124541494|NCT04629534|447936031|FG000|Overall Study|Physician Decision|1|||
124541495|NCT04629534|447936032|FG001|Overall Study|Physician Decision|0|||
124541496|NCT04629534|447936031|FG000|Overall Study|Protocol Violation|0|||
124541497|NCT04629534|447936032|FG001|Overall Study|Protocol Violation|2|||
124541498|NCT03732534|447936033|FG000|Overall Study|Study terminated by Sponsor|6|||
124541499|NCT02190604|447936034|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541500|NCT02190604|447936035|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541501|NCT02190604|447936036|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541502|NCT02190604|447936037|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541503|NCT02190604|447936038|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541504|NCT02190604|447936039|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541505|NCT02190604|447936040|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541506|NCT02190604|447936041|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541507|NCT02190604|447936042|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541508|NCT02190604|447936043|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541509|NCT02190604|447936044|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541510|NCT02190604|447936045|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541511|NCT02190604|447936046|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541512|NCT02190604|447936047|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541513|NCT02190604|447936048|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
124541514|NCT02190604|447936049|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541515|NCT02190604|447936050|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541516|NCT02190604|447936051|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541517|NCT02190604|447936052|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
124541518|NCT02190604|447936034|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541519|NCT02190604|447936035|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541520|NCT02190604|447936036|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541521|NCT02190604|447936037|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541522|NCT02190604|447936038|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541523|NCT02190604|447936039|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541524|NCT02190604|447936040|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541525|NCT02190604|447936041|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541526|NCT02190604|447936042|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541527|NCT02190604|447936043|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541528|NCT02190604|447936044|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541529|NCT02190604|447936045|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541530|NCT02190604|447936046|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541531|NCT02190604|447936047|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
124541532|NCT02190604|447936048|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541533|NCT02190604|447936049|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541534|NCT02190604|447936050|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541535|NCT02190604|447936051|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541536|NCT02190604|447936052|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
124541537|NCT02797951|447936053|FG000|Overall Study|Adverse Event|4|||
124541538|NCT02797951|447936053|FG000|Overall Study|Death|1|||
124541539|NCT02797951|447936053|FG000|Overall Study|Lack of Efficacy|19|||
124541540|NCT02797951|447936053|FG000|Overall Study|Lost to Follow-up|4|||
124541541|NCT02797951|447936053|FG000|Overall Study|Physician Decision|6|||
124541542|NCT02797951|447936053|FG000|Overall Study|Withdrawal by Subject|15|||
124541543|NCT03735849|447936056|FG000|Overall Study|Lost to Follow-up|1|||
124541544|NCT03735849|447936057|FG001|Overall Study|Lost to Follow-up|0|||
124541545|NCT03735849|447936058|FG002|Overall Study|Lost to Follow-up|0|||
124541546|NCT03735849|447936056|FG000|Overall Study|Participant unable to adhere to visit|1|||
124541547|NCT03735849|447936057|FG001|Overall Study|Participant unable to adhere to visit|0|||
124541548|NCT03735849|447936058|FG002|Overall Study|Participant unable to adhere to visit|0|||
124981415|NCT00586612|449557473|FG000|Booster Phase|Lost to Follow-up|3|||
124541549|NCT03735849|447936056|FG000|Overall Study|Not Randomized|0|||
124541550|NCT03735849|447936057|FG001|Overall Study|Not Randomized|0|||
124541551|NCT03735849|447936058|FG002|Overall Study|Not Randomized|4|||
124541552|NCT02369874|447936062|FG000|Overall Study|Lost to Follow-up|2|||
124541553|NCT02369874|447936063|FG001|Overall Study|Lost to Follow-up|2|||
124541554|NCT02369874|447936064|FG002|Overall Study|Lost to Follow-up|2|||
124541555|NCT02369874|447936062|FG000|Overall Study|Withdrawal by Subject|7|||
124541556|NCT02369874|447936063|FG001|Overall Study|Withdrawal by Subject|9|||
124541557|NCT02369874|447936064|FG002|Overall Study|Withdrawal by Subject|27|||
124541558|NCT02369874|447936062|FG000|Overall Study|Miscellaneous|1|||
124541559|NCT02369874|447936063|FG001|Overall Study|Miscellaneous|1|||
124541560|NCT02369874|447936064|FG002|Overall Study|Miscellaneous|0|||
124541561|NCT02369874|447936062|FG000|Overall Study|On Treatment/Off Study|34|||
124541562|NCT02369874|447936063|FG001|Overall Study|On Treatment/Off Study|45|||
124541563|NCT02369874|447936064|FG002|Overall Study|On Treatment/Off Study|32|||
124541564|NCT01012765|447936065|FG000|Treatment Period 1|Adverse Event|1|||
124541565|NCT01012765|447936066|FG001|Treatment Period 1|Adverse Event|0|||
124541566|NCT01012765|447936067|FG002|Treatment Period 1|Adverse Event|1|||
124541567|NCT01012765|447936068|FG003|Treatment Period 1|Adverse Event|0|||
124541568|NCT01012765|447936069|FG004|Treatment Period 1|Adverse Event|0|||
124541569|NCT01012765|447936070|FG005|Treatment Period 1|Adverse Event|0|||
124541570|NCT01012765|447936065|FG000|Treatment Period 1|Withdrawal by Subject|2|||
124541571|NCT01012765|447936066|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124541572|NCT01012765|447936067|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124541573|NCT01012765|447936068|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124541574|NCT01012765|447936069|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124541575|NCT01012765|447936070|FG005|Treatment Period 1|Withdrawal by Subject|0|||
124541576|NCT01012765|447936065|FG000|Treatment Period 1|Administrative problems|0|||
124541577|NCT01012765|447936066|FG001|Treatment Period 1|Administrative problems|0|||
124541578|NCT01012765|447936067|FG002|Treatment Period 1|Administrative problems|1|||
124541579|NCT01012765|447936068|FG003|Treatment Period 1|Administrative problems|1|||
124541580|NCT01012765|447936069|FG004|Treatment Period 1|Administrative problems|1|||
124541581|NCT01012765|447936070|FG005|Treatment Period 1|Administrative problems|0|||
124541582|NCT01012765|447936065|FG000|Treatment Period 1|Protocol Violation|0|||
124541583|NCT01012765|447936066|FG001|Treatment Period 1|Protocol Violation|0|||
124541584|NCT01012765|447936067|FG002|Treatment Period 1|Protocol Violation|0|||
124541585|NCT01012765|447936068|FG003|Treatment Period 1|Protocol Violation|2|||
124541586|NCT01012765|447936069|FG004|Treatment Period 1|Protocol Violation|1|||
124541587|NCT01012765|447936070|FG005|Treatment Period 1|Protocol Violation|0|||
124541588|NCT01012765|447936065|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
124541589|NCT01012765|447936066|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
124541590|NCT01012765|447936067|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
124541591|NCT01012765|447936068|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
124541592|NCT01012765|447936069|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
124541593|NCT01012765|447936070|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
124541594|NCT01012765|447936065|FG000|Treatment Period 2|Withdrawal by Subject|1|||
124541595|NCT01012765|447936066|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124541596|NCT01012765|447936067|FG002|Treatment Period 2|Withdrawal by Subject|1|||
124541597|NCT01012765|447936068|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124541598|NCT01012765|447936069|FG004|Treatment Period 2|Withdrawal by Subject|1|||
124541599|NCT01012765|447936070|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124541600|NCT01012765|447936065|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
124541601|NCT01012765|447936066|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
124541602|NCT01012765|447936067|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
124541603|NCT01012765|447936068|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
124541604|NCT01012765|447936069|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
124541605|NCT01012765|447936070|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
124541606|NCT01012765|447936065|FG000|Treatment Period 2|Adverse Event|0|||
124541607|NCT01012765|447936066|FG001|Treatment Period 2|Adverse Event|1|||
124541608|NCT01012765|447936067|FG002|Treatment Period 2|Adverse Event|1|||
124541609|NCT01012765|447936068|FG003|Treatment Period 2|Adverse Event|0|||
124541610|NCT01012765|447936069|FG004|Treatment Period 2|Adverse Event|0|||
124541611|NCT01012765|447936070|FG005|Treatment Period 2|Adverse Event|0|||
124541612|NCT01012765|447936065|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
124541613|NCT01012765|447936066|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
124541614|NCT01012765|447936067|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
124541615|NCT01012765|447936068|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
124541616|NCT01012765|447936069|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
124541617|NCT01012765|447936070|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
124541618|NCT01326312|447936071|FG000|Overall Study|Adverse Event|11|||
124541619|NCT01326312|447936072|FG001|Overall Study|Adverse Event|11|||
124541620|NCT01326312|447936073|FG002|Overall Study|Adverse Event|1|||
124541621|NCT01326312|447936071|FG000|Overall Study|Withdrawal by Subject|1|||
124541622|NCT01326312|447936072|FG001|Overall Study|Withdrawal by Subject|2|||
124541623|NCT01326312|447936073|FG002|Overall Study|Withdrawal by Subject|1|||
124541624|NCT01326312|447936071|FG000|Overall Study|Protocol Violation|0|||
124541625|NCT01326312|447936072|FG001|Overall Study|Protocol Violation|1|||
124541626|NCT01326312|447936073|FG002|Overall Study|Protocol Violation|0|||
124541627|NCT01326312|447936071|FG000|Overall Study|Lack of Efficacy|13|||
124541628|NCT01326312|447936072|FG001|Overall Study|Lack of Efficacy|7|||
124541629|NCT01326312|447936073|FG002|Overall Study|Lack of Efficacy|1|||
124541630|NCT01326312|447936071|FG000|Overall Study|Death|1|||
124541631|NCT01326312|447936072|FG001|Overall Study|Death|0|||
124541632|NCT01326312|447936073|FG002|Overall Study|Death|1|||
124541633|NCT01326312|447936071|FG000|Overall Study|progressive disease|0|||
124541634|NCT01326312|447936072|FG001|Overall Study|progressive disease|1|||
124541635|NCT01326312|447936073|FG002|Overall Study|progressive disease|1|||
124541636|NCT01326312|447936071|FG000|Overall Study|Study terminated by Sponsor|8|||
124541637|NCT01326312|447936072|FG001|Overall Study|Study terminated by Sponsor|32|||
124541638|NCT01326312|447936073|FG002|Overall Study|Study terminated by Sponsor|46|||
124541639|NCT01326312|447936071|FG000|Overall Study|Treatment arm terminated|19|||
124541640|NCT01326312|447936072|FG001|Overall Study|Treatment arm terminated|0|||
124541641|NCT01326312|447936073|FG002|Overall Study|Treatment arm terminated|0|||
124541642|NCT01326312|447936071|FG000|Overall Study|QTc > 500|0|||
124541643|NCT01326312|447936072|FG001|Overall Study|QTc > 500|1|||
124541644|NCT01326312|447936073|FG002|Overall Study|QTc > 500|0|||
124541645|NCT02219477|447936074|FG000|Overall Study|Adverse Event|0|||
124541646|NCT02219477|447936075|FG001|Overall Study|Adverse Event|1|||
124541647|NCT02219477|447936076|FG002|Overall Study|Adverse Event|1|||
124541648|NCT02219477|447936074|FG000|Overall Study|Withdrawal by Subject|0|||
124541649|NCT02219477|447936075|FG001|Overall Study|Withdrawal by Subject|1|||
124541650|NCT02219477|447936076|FG002|Overall Study|Withdrawal by Subject|0|||
124541651|NCT00499694|447936081|FG000|Overall Study|Patient never received treatment.|1|||
124541652|NCT00234533|447936082|FG000|Overall Study|Withdrawal by Subject|6|||
124541653|NCT00234533|447936082|FG000|Overall Study|Adverse Event|2|||
124541654|NCT00234533|447936082|FG000|Overall Study|Enrolled but not treated|3|||
124541655|NCT01484691|447936084|FG000|Overall Study|Withdrawal by Subject|1|||
124541656|NCT01484691|447936085|FG001|Overall Study|Withdrawal by Subject|1|||
124541657|NCT01484691|447936086|FG002|Overall Study|Withdrawal by Subject|1|||
124541658|NCT01484691|447936084|FG000|Overall Study|Physician Decision|0|||
124541659|NCT01484691|447936085|FG001|Overall Study|Physician Decision|2|||
124541660|NCT01484691|447936086|FG002|Overall Study|Physician Decision|1|||
124541661|NCT03958045|447936089|FG000|Overall Study|Withdrawal by Subject|1|||
124981416|NCT00586612|449557474|FG001|Booster Phase|Lost to Follow-up|1|||
124541662|NCT00422227|447936092|FG000|Overall Study|Adverse Event|3|||
124541663|NCT00422227|447936093|FG001|Overall Study|Adverse Event|8|||
124541664|NCT00422227|447936092|FG000|Overall Study|Lost to Follow-up|1|||
124541665|NCT00422227|447936093|FG001|Overall Study|Lost to Follow-up|3|||
124541666|NCT00422227|447936092|FG000|Overall Study|Withdrawal by Subject|0|||
124541667|NCT00422227|447936093|FG001|Overall Study|Withdrawal by Subject|4|||
124541668|NCT03575806|447937554|FG000|Overall Study|Withdrawal by Subject|0|||
124541669|NCT03575806|447937555|FG001|Overall Study|Withdrawal by Subject|2|||
124541670|NCT03575806|447937554|FG000|Overall Study|Protocol Violation|0|||
124541671|NCT03575806|447937555|FG001|Overall Study|Protocol Violation|2|||
124541672|NCT01458535|447937556|FG000|Overall Study|Other|0|||
124541673|NCT01458535|447937557|FG001|Overall Study|Other|0|||
124541674|NCT01458535|447937558|FG002|Overall Study|Other|0|||
124541675|NCT01458535|447937559|FG003|Overall Study|Other|0|||
124541676|NCT01458535|447937560|FG004|Overall Study|Other|1|||
124541677|NCT01458535|447937561|FG005|Overall Study|Other|1|||
124541678|NCT01458535|447937556|FG000|Overall Study|Withdrawal by Subject|0|||
124541679|NCT01458535|447937557|FG001|Overall Study|Withdrawal by Subject|0|||
124541680|NCT01458535|447937558|FG002|Overall Study|Withdrawal by Subject|2|||
124541681|NCT01458535|447937559|FG003|Overall Study|Withdrawal by Subject|0|||
124541682|NCT01458535|447937560|FG004|Overall Study|Withdrawal by Subject|1|||
124541683|NCT01458535|447937561|FG005|Overall Study|Withdrawal by Subject|1|||
124541684|NCT01458535|447937556|FG000|Overall Study|Lost to Follow-up|0|||
124541685|NCT01458535|447937557|FG001|Overall Study|Lost to Follow-up|2|||
124541686|NCT01458535|447937558|FG002|Overall Study|Lost to Follow-up|0|||
124541687|NCT01458535|447937559|FG003|Overall Study|Lost to Follow-up|3|||
124541688|NCT01458535|447937560|FG004|Overall Study|Lost to Follow-up|2|||
124541689|NCT01458535|447937561|FG005|Overall Study|Lost to Follow-up|2|||
124541690|NCT01458535|447937556|FG000|Overall Study|Adverse Event|0|||
124541691|NCT01458535|447937557|FG001|Overall Study|Adverse Event|0|||
124541692|NCT01458535|447937558|FG002|Overall Study|Adverse Event|0|||
124541693|NCT01458535|447937559|FG003|Overall Study|Adverse Event|1|||
124541694|NCT01458535|447937560|FG004|Overall Study|Adverse Event|0|||
124541695|NCT01458535|447937561|FG005|Overall Study|Adverse Event|0|||
124541696|NCT01238861|447937562|FG000|Overall Study|Lost to Follow-up|4|||
124541697|NCT01238861|447937563|FG001|Overall Study|Lost to Follow-up|2|||
124541698|NCT01238861|447937564|FG002|Overall Study|Lost to Follow-up|3|||
124541699|NCT01238861|447937565|FG003|Overall Study|Lost to Follow-up|1|||
124541700|NCT01238861|447937566|FG004|Overall Study|Lost to Follow-up|1|||
124541701|NCT01238861|447937567|FG005|Overall Study|Lost to Follow-up|2|||
124541702|NCT01238861|447937562|FG000|Overall Study|Unplanned surgery|1|||
124541703|NCT01238861|447937563|FG001|Overall Study|Unplanned surgery|0|||
124541704|NCT01238861|447937564|FG002|Overall Study|Unplanned surgery|0|||
124541705|NCT01238861|447937565|FG003|Overall Study|Unplanned surgery|0|||
124541706|NCT01238861|447937566|FG004|Overall Study|Unplanned surgery|0|||
124541707|NCT01238861|447937567|FG005|Overall Study|Unplanned surgery|0|||
124541708|NCT01238861|447937562|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
124541709|NCT01238861|447937563|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
124541710|NCT01238861|447937564|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
124541711|NCT01238861|447937565|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
124541712|NCT01238861|447937566|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
124541713|NCT01238861|447937567|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
124541714|NCT01238861|447937562|FG000|Overall Study|Incorrect enrollment/randomization|0|||
124541715|NCT01238861|447937563|FG001|Overall Study|Incorrect enrollment/randomization|0|||
124541716|NCT01238861|447937564|FG002|Overall Study|Incorrect enrollment/randomization|1|||
124541717|NCT01238861|447937565|FG003|Overall Study|Incorrect enrollment/randomization|0|||
124541718|NCT01238861|447937566|FG004|Overall Study|Incorrect enrollment/randomization|1|||
124541719|NCT01238861|447937567|FG005|Overall Study|Incorrect enrollment/randomization|0|||
124541720|NCT01238861|447937562|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
124541721|NCT01238861|447937563|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
124541722|NCT01238861|447937564|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
124541723|NCT01238861|447937565|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
124541724|NCT01238861|447937566|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
124541725|NCT01238861|447937567|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
124541726|NCT01238861|447937562|FG000|Overall Study|Subject moved out of state/area|0|||
124541727|NCT01238861|447937563|FG001|Overall Study|Subject moved out of state/area|0|||
124541728|NCT01238861|447937564|FG002|Overall Study|Subject moved out of state/area|1|||
124541729|NCT01238861|447937565|FG003|Overall Study|Subject moved out of state/area|1|||
124541730|NCT01238861|447937566|FG004|Overall Study|Subject moved out of state/area|0|||
124541731|NCT01238861|447937567|FG005|Overall Study|Subject moved out of state/area|0|||
124541732|NCT01238861|447937562|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
124541733|NCT01238861|447937563|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
124541734|NCT01238861|447937564|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
124541735|NCT01238861|447937565|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
124541736|NCT01238861|447937566|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
124541737|NCT01238861|447937567|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
124541738|NCT01238861|447937562|FG000|Overall Study|Personal problems|0|||
124541739|NCT01238861|447937563|FG001|Overall Study|Personal problems|0|||
124541740|NCT01238861|447937564|FG002|Overall Study|Personal problems|0|||
124541741|NCT01238861|447937565|FG003|Overall Study|Personal problems|1|||
124541742|NCT01238861|447937566|FG004|Overall Study|Personal problems|0|||
124541743|NCT01238861|447937567|FG005|Overall Study|Personal problems|0|||
124541744|NCT01238861|447937562|FG000|Overall Study|Unable to continue visits|0|||
124541745|NCT01238861|447937563|FG001|Overall Study|Unable to continue visits|0|||
124541746|NCT01238861|447937564|FG002|Overall Study|Unable to continue visits|0|||
124541747|NCT01238861|447937565|FG003|Overall Study|Unable to continue visits|1|||
124541748|NCT01238861|447937566|FG004|Overall Study|Unable to continue visits|0|||
124541749|NCT01238861|447937567|FG005|Overall Study|Unable to continue visits|1|||
124541750|NCT01238861|447937562|FG000|Overall Study|Serious adverse event|0|||
124541751|NCT01238861|447937563|FG001|Overall Study|Serious adverse event|0|||
124541752|NCT01238861|447937564|FG002|Overall Study|Serious adverse event|0|||
124541753|NCT01238861|447937565|FG003|Overall Study|Serious adverse event|0|||
124541754|NCT01238861|447937566|FG004|Overall Study|Serious adverse event|0|||
124541755|NCT01238861|447937567|FG005|Overall Study|Serious adverse event|1|||
124541756|NCT01238861|447937562|FG000|Overall Study|Lack of compliance|0|||
124541757|NCT01238861|447937563|FG001|Overall Study|Lack of compliance|0|||
124541758|NCT01238861|447937564|FG002|Overall Study|Lack of compliance|0|||
124541759|NCT01238861|447937565|FG003|Overall Study|Lack of compliance|0|||
124541760|NCT01238861|447937566|FG004|Overall Study|Lack of compliance|0|||
124541761|NCT01238861|447937567|FG005|Overall Study|Lack of compliance|1|||
124541762|NCT01238861|447937562|FG000|Overall Study|Adverse Event|0|||
124541763|NCT01238861|447937563|FG001|Overall Study|Adverse Event|1|||
124541764|NCT01238861|447937564|FG002|Overall Study|Adverse Event|0|||
124541765|NCT01238861|447937565|FG003|Overall Study|Adverse Event|0|||
124541766|NCT01238861|447937566|FG004|Overall Study|Adverse Event|0|||
124541767|NCT01238861|447937567|FG005|Overall Study|Adverse Event|0|||
124541768|NCT01238861|447937562|FG000|Overall Study|Withdrawal by Subject|6|||
124541769|NCT01238861|447937563|FG001|Overall Study|Withdrawal by Subject|5|||
124541770|NCT01238861|447937564|FG002|Overall Study|Withdrawal by Subject|4|||
124541771|NCT01238861|447937565|FG003|Overall Study|Withdrawal by Subject|8|||
124541772|NCT01238861|447937566|FG004|Overall Study|Withdrawal by Subject|10|||
124541773|NCT01238861|447937567|FG005|Overall Study|Withdrawal by Subject|9|||
124541774|NCT01855607|447937568|FG000|Overall Study|Withdrawal by Subject|1|||
124541775|NCT01855607|447937568|FG000|Overall Study|Study was terminated|11|||
124541776|NCT04001790|447937573|FG000|Overall Study|Withdrawal by Subject|1|||
124541777|NCT04001790|447937574|FG001|Overall Study|Withdrawal by Subject|2|||
124541778|NCT04963231|447937579|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
124541779|NCT04963231|447937580|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
124541780|NCT04963231|447937581|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
124541781|NCT04963231|447937579|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
124541782|NCT04963231|447937580|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
124541783|NCT04963231|447937581|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
124541784|NCT04963231|447937579|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
124541785|NCT04963231|447937580|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
124541786|NCT04963231|447937581|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
124541787|NCT04963231|447937579|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
124541788|NCT04963231|447937580|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
124541789|NCT04963231|447937581|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
124541790|NCT04963231|447937579|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
124541791|NCT04963231|447937580|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
124541792|NCT04963231|447937581|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
124541793|NCT04963231|447937579|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
124541794|NCT04963231|447937580|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
124541795|NCT04963231|447937581|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
124541796|NCT04963231|447937579|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
124541797|NCT04963231|447937580|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
124541798|NCT04963231|447937581|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
124541799|NCT04576702|447937582|FG000|Overall Study|Death|1|||
124541800|NCT04576702|447937583|FG001|Overall Study|Death|0|||
124981417|NCT02001064|449557477|FG000|Overall Study|Withdrawal by Subject|2|||
124981418|NCT02001064|449557478|FG001|Overall Study|Withdrawal by Subject|1|||
124541801|NCT04576702|447937584|FG002|Overall Study|Death|0|||
124541802|NCT04576702|447937585|FG003|Overall Study|Death|0|||
124541803|NCT04576702|447937582|FG000|Overall Study|Withdrawal by Subject|0|||
124541804|NCT04576702|447937583|FG001|Overall Study|Withdrawal by Subject|2|||
124541805|NCT04576702|447937584|FG002|Overall Study|Withdrawal by Subject|1|||
124541806|NCT04576702|447937585|FG003|Overall Study|Withdrawal by Subject|0|||
124541807|NCT04576702|447937582|FG000|Overall Study|Lost to Follow-up|3|||
124541808|NCT04576702|447937583|FG001|Overall Study|Lost to Follow-up|3|||
124541809|NCT04576702|447937584|FG002|Overall Study|Lost to Follow-up|3|||
124541810|NCT04576702|447937585|FG003|Overall Study|Lost to Follow-up|4|||
124541811|NCT00229931|447937590|FG000|Overall Study|Death|1|||
124541812|NCT00229931|447937591|FG001|Overall Study|Death|0|||
124541813|NCT00229931|447937590|FG000|Overall Study|Lost to Follow-up|3|||
124541814|NCT00229931|447937591|FG001|Overall Study|Lost to Follow-up|2|||
124541815|NCT00465101|447937592|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
124541816|NCT00465101|447937592|FG000|Overall Study|Change in health precluded follow up|4|||
124541817|NCT00465101|447937592|FG000|Overall Study|Did not meet study criteria|4|||
124541818|NCT00465101|447937592|FG000|Overall Study|Lost to Follow-up|5|||
124541819|NCT00465101|447937592|FG000|Overall Study|Other|6|||
124541820|NCT00465101|447937592|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
124541821|NCT00465101|447937592|FG000|Overall Study|Patient postponed procedure|1|||
124541822|NCT00465101|447937592|FG000|Overall Study|Site closed due to IRB expiration|1|||
124541823|NCT00465101|447937592|FG000|Overall Study|Unable to obtain IRB approval|1|||
124541824|NCT00465101|447937592|FG000|Overall Study|Death|3|||
124541825|NCT00465101|447937592|FG000|Overall Study|Withdrawal by Subject|25|||
124541826|NCT00465101|447937592|FG000|Overall Study|Physician Decision|1|||
124541827|NCT00465101|447937592|FG000|Overall Study|Withdrew consent prior to procedure|3|||
124541828|NCT00361504|447937593|FG000|Overall Study|Withdrawal by Subject|94|||
124541829|NCT00361504|447937594|FG001|Overall Study|Withdrawal by Subject|31|||
124541830|NCT00361504|447937593|FG000|Overall Study|Lost to Follow-up|40|||
124541831|NCT00361504|447937594|FG001|Overall Study|Lost to Follow-up|7|||
124541832|NCT00361504|447937593|FG000|Overall Study|Adverse Event|203|||
124541833|NCT00361504|447937594|FG001|Overall Study|Adverse Event|82|||
124541834|NCT00361504|447937593|FG000|Overall Study|Lack of Efficacy|72|||
124541835|NCT00361504|447937594|FG001|Overall Study|Lack of Efficacy|7|||
124541836|NCT00361504|447937593|FG000|Overall Study|Resolution of Pain|2|||
124541837|NCT00361504|447937594|FG001|Overall Study|Resolution of Pain|0|||
124541838|NCT00361504|447937593|FG000|Overall Study|Study medication non compliant|42|||
124541839|NCT00361504|447937594|FG001|Overall Study|Study medication non compliant|15|||
124541840|NCT00361504|447937593|FG000|Overall Study|All other|28|||
124541841|NCT00361504|447937594|FG001|Overall Study|All other|3|||
124541842|NCT01374516|447937596|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
124541843|NCT01374516|447937597|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
124541844|NCT01374516|447937596|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
124541845|NCT01374516|447937597|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
124541846|NCT01374516|447937596|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
124541847|NCT01374516|447937597|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
124541848|NCT01374516|447937596|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
124541849|NCT01374516|447937597|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
124541850|NCT01374516|447937596|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
124541851|NCT01374516|447937597|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
124541852|NCT01374516|447937596|FG000|Surveillance Expansion Period|Protocol Violation|386|||
124541853|NCT01374516|447937597|FG001|Surveillance Expansion Period|Protocol Violation|217|||
124541854|NCT01374516|447937596|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
124541855|NCT01374516|447937597|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
124541856|NCT01374516|447937596|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
124541857|NCT01374516|447937597|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
124541858|NCT01374516|447937596|FG000|Surveillance Expansion Period|Serious adverse event|20|||
124541859|NCT01374516|447937597|FG001|Surveillance Expansion Period|Serious adverse event|5|||
124541860|NCT03219372|447937598|FG000|Overall Study|Withdrawal by Subject|1|||
124541861|NCT03219372|447937599|FG001|Overall Study|Withdrawal by Subject|0|||
124541862|NCT00401726|447937600|FG000|Overall Study|Adverse Event|34|||
124541863|NCT00401726|447937601|FG001|Overall Study|Adverse Event|45|||
124541864|NCT00401726|447937600|FG000|Overall Study|Death|0|||
124541865|NCT00401726|447937601|FG001|Overall Study|Death|3|||
124541866|NCT00401726|447937600|FG000|Overall Study|Sponsor Request|0|||
124541867|NCT00401726|447937601|FG001|Overall Study|Sponsor Request|1|||
124541868|NCT00401726|447937600|FG000|Overall Study|Physician Decision|3|||
124541869|NCT00401726|447937601|FG001|Overall Study|Physician Decision|6|||
124541870|NCT00401726|447937600|FG000|Overall Study|Lost to Follow-up|23|||
124541871|NCT00401726|447937601|FG001|Overall Study|Lost to Follow-up|20|||
124541872|NCT00401726|447937600|FG000|Overall Study|Protocol Violation|6|||
124541873|NCT00401726|447937601|FG001|Overall Study|Protocol Violation|3|||
124541874|NCT00401726|447937600|FG000|Overall Study|Withdrawal by Subject|18|||
124541875|NCT00401726|447937601|FG001|Overall Study|Withdrawal by Subject|24|||
124541876|NCT00401726|447937600|FG000|Overall Study|Lack of Efficacy|4|||
124541877|NCT00401726|447937601|FG001|Overall Study|Lack of Efficacy|6|||
124541878|NCT00401726|447937600|FG000|Overall Study|Protocol Deviation|9|||
124541879|NCT00401726|447937601|FG001|Overall Study|Protocol Deviation|4|||
124541880|NCT02067728|447937602|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
124541881|NCT02067728|447937603|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
124541882|NCT02067728|447937602|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
124541883|NCT02067728|447937603|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
124541884|NCT02067728|447937602|FG000|6 Month Measurements|Unable to attend|114|||
124541885|NCT02067728|447937603|FG001|6 Month Measurements|Unable to attend|97|||
124541886|NCT00814502|447937607|FG000|Overall Study|Adverse Event|1|||
124541887|NCT00814502|447937608|FG001|Overall Study|Adverse Event|0|||
124541888|NCT00814502|447937607|FG000|Overall Study|Withdrawal by Subject|0|||
124541889|NCT00814502|447937608|FG001|Overall Study|Withdrawal by Subject|2|||
124541890|NCT01050998|447937612|FG000|Overall Study|Adverse Event|1|||
124541891|NCT01050998|447937613|FG001|Overall Study|Adverse Event|0|||
124541892|NCT01050998|447937614|FG002|Overall Study|Adverse Event|1|||
124541893|NCT01050998|447937615|FG003|Overall Study|Adverse Event|0|||
124541894|NCT01050998|447937616|FG004|Overall Study|Adverse Event|2|||
124541895|NCT01050998|447937612|FG000|Overall Study|Withdrawal by Subject|0|||
124541896|NCT01050998|447937613|FG001|Overall Study|Withdrawal by Subject|0|||
124541897|NCT01050998|447937614|FG002|Overall Study|Withdrawal by Subject|0|||
124541898|NCT01050998|447937615|FG003|Overall Study|Withdrawal by Subject|1|||
124541899|NCT01050998|447937616|FG004|Overall Study|Withdrawal by Subject|3|||
124541900|NCT01050998|447937612|FG000|Overall Study|Other|3|||
124541901|NCT01050998|447937613|FG001|Overall Study|Other|2|||
124541902|NCT01050998|447937614|FG002|Overall Study|Other|1|||
124541903|NCT01050998|447937615|FG003|Overall Study|Other|1|||
124541904|NCT01050998|447937616|FG004|Overall Study|Other|5|||
124541905|NCT01050998|447937612|FG000|Overall Study|Data integrity issues|0|||
124541906|NCT01050998|447937613|FG001|Overall Study|Data integrity issues|0|||
124541907|NCT01050998|447937614|FG002|Overall Study|Data integrity issues|1|||
124541908|NCT01050998|447937615|FG003|Overall Study|Data integrity issues|1|||
124541909|NCT01050998|447937616|FG004|Overall Study|Data integrity issues|4|||
124541910|NCT02304484|447937624|FG000|Overall Study|Death|9|||
124541911|NCT02304484|447937624|FG000|Overall Study|Withdrawal by Subject|14|||
124541912|NCT02304484|447937624|FG000|Overall Study|Lost to Follow-up|2|||
124541913|NCT00145795|447937625|FG000|Overall Study|Adverse Event|1|||
124541914|NCT00145795|447937626|FG001|Overall Study|Adverse Event|0|||
124541915|NCT02967055|447937627|FG000|Overall Study|Excluded|40|||
124541916|NCT02967055|447937627|FG000|Overall Study|Screen fail|3|||
124541917|NCT02967055|447937627|FG000|Overall Study|Lost to Follow-up|2|||
124541918|NCT02967055|447937627|FG000|Overall Study|Stopped due to side effects|3|||
124541919|NCT02967055|447937627|FG000|Overall Study|Stopped due to drug cost|1|||
124541920|NCT00976989|447937628|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
124541921|NCT00976989|447937629|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
124541922|NCT00976989|447937630|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
124541923|NCT00976989|447937628|FG000|Overall Study|Death|5|||
124541924|NCT00976989|447937629|FG001|Overall Study|Death|7|||
124541925|NCT00976989|447937630|FG002|Overall Study|Death|10|||
124541926|NCT00976989|447937628|FG000|Overall Study|Refused Treatment|4|||
124541927|NCT00976989|447937629|FG001|Overall Study|Refused Treatment|3|||
124541928|NCT00976989|447937630|FG002|Overall Study|Refused Treatment|5|||
124541929|NCT00976989|447937628|FG000|Overall Study|Failure to Return|2|||
124541930|NCT00976989|447937629|FG001|Overall Study|Failure to Return|1|||
124541931|NCT00976989|447937630|FG002|Overall Study|Failure to Return|0|||
124541932|NCT00976989|447937628|FG000|Overall Study|Recurrence of Disease|0|||
124541933|NCT00976989|447937629|FG001|Overall Study|Recurrence of Disease|1|||
124541934|NCT00976989|447937630|FG002|Overall Study|Recurrence of Disease|0|||
124541935|NCT00976989|447937628|FG000|Overall Study|Other|1|||
124541936|NCT00976989|447937629|FG001|Overall Study|Other|0|||
124541937|NCT00976989|447937630|FG002|Overall Study|Other|1|||
124541938|NCT00570492|447937631|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
124541939|NCT00570492|447937632|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
124541940|NCT00570492|447937633|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
124541941|NCT00570492|447937631|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
124541942|NCT00570492|447937632|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
124541943|NCT00570492|447937633|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
124541944|NCT00570492|447937631|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
124541945|NCT00570492|447937632|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
124541946|NCT00570492|447937633|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
124541947|NCT00570492|447937631|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
124541948|NCT00570492|447937632|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
124541949|NCT00570492|447937633|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
124541950|NCT00570492|447937631|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
124541951|NCT00570492|447937632|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
124541952|NCT00570492|447937633|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
124541953|NCT00570492|447937631|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
124541954|NCT00570492|447937632|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
124541955|NCT00570492|447937633|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
124541956|NCT00570492|447937631|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
124541957|NCT00570492|447937632|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
124541958|NCT00570492|447937633|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
124541959|NCT00570492|447937631|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
124541960|NCT00570492|447937632|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
124541961|NCT00570492|447937633|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
124541962|NCT00570492|447937631|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
124541963|NCT00570492|447937632|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
124541964|NCT00570492|447937633|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
124541965|NCT00570492|447937631|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
124541966|NCT00570492|447937632|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
124541967|NCT00570492|447937633|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
124541968|NCT00570492|447937631|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
124541969|NCT00570492|447937632|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
124541970|NCT00570492|447937633|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
124541971|NCT00570492|447937631|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
124541972|NCT00570492|447937632|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
124541973|NCT00570492|447937633|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
124541974|NCT00570492|447937631|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
124541975|NCT00570492|447937632|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
124541976|NCT00570492|447937633|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
124541977|NCT00570492|447937631|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
124541978|NCT00570492|447937632|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
124541979|NCT00570492|447937633|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
124541980|NCT02283411|447937634|FG000|Overall Study|Withdrawal by Subject|3|||
124541981|NCT02283411|447937634|FG000|Overall Study|Screen Failed|28|||
124541982|NCT02500732|447937636|FG000|Overall Study|Physician Decision|0|||
124541983|NCT02500732|447937637|FG001|Overall Study|Physician Decision|1|||
124541984|NCT04409262|447937638|FG000|Overall Study|Adverse Event|0|||
124981419|NCT01609062|449557479|FG000|Extension Phase|Terminated by Sponsor|14|||
124981420|NCT01609062|449557480|FG001|Extension Phase|Terminated by Sponsor|9|||
124981421|NCT01609062|449557479|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
124981422|NCT01609062|449557480|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
124981423|NCT01609062|449557479|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
124981424|NCT01609062|449557480|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
124541985|NCT04409262|447937639|FG001|Overall Study|Adverse Event|2|||
124541986|NCT04409262|447937638|FG000|Overall Study|Death|55|||
124541987|NCT04409262|447937639|FG001|Overall Study|Death|97|||
124541988|NCT04409262|447937638|FG000|Overall Study|Lost to Follow-up|12|||
124541989|NCT04409262|447937639|FG001|Overall Study|Lost to Follow-up|23|||
124541990|NCT04409262|447937638|FG000|Overall Study|Lack of Staff|0|||
124541991|NCT04409262|447937639|FG001|Overall Study|Lack of Staff|1|||
124541992|NCT04409262|447937638|FG000|Overall Study|Protocol Violation|3|||
124541993|NCT04409262|447937639|FG001|Overall Study|Protocol Violation|1|||
124541994|NCT04409262|447937638|FG000|Overall Study|Withdrawal by Subject|5|||
124541995|NCT04409262|447937639|FG001|Overall Study|Withdrawal by Subject|10|||
124541996|NCT03328325|447937640|FG000|Overall Study|Lost to Follow-up|4|||
124541997|NCT03328325|447937640|FG000|Overall Study|Physician Decision|1|||
124541998|NCT03328325|447937640|FG000|Overall Study|Withdrawal by Subject|3|||
124541999|NCT03328325|447937640|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
124542000|NCT03759340|447937642|FG000|Overall Study|Adverse Event|2|||
124542001|NCT03759340|447937642|FG000|Overall Study|Lost to Follow-up|1|||
124542002|NCT03759340|447937642|FG000|Overall Study|Withdrawal by Subject|15|||
124542003|NCT03759340|447937642|FG000|Overall Study|Study Terminated by Sponsor|38|||
124542004|NCT00736840|447937643|FG000|Overall Study|Lost to Follow-up|13|||
124542005|NCT03289676|447937646|FG000|Overall Study|Withdrawal by Subject|2|||
124542006|NCT03289676|447937647|FG001|Overall Study|Withdrawal by Subject|0|||
124542007|NCT03289676|447937646|FG000|Overall Study|Protocol Violation|2|||
124542008|NCT03289676|447937647|FG001|Overall Study|Protocol Violation|0|||
124542009|NCT03289676|447937646|FG000|Overall Study|Lost to Follow-up|0|||
124542010|NCT03289676|447937647|FG001|Overall Study|Lost to Follow-up|1|||
124542011|NCT01396434|447937648|FG000|Overall Study|Lost to Follow-up|1|||
124542012|NCT01396434|447937649|FG001|Overall Study|Lost to Follow-up|0|||
124542013|NCT01396434|447937650|FG002|Overall Study|Lost to Follow-up|0|||
124542014|NCT01396434|447937648|FG000|Overall Study|Other|10|||
124542015|NCT01396434|447937649|FG001|Overall Study|Other|0|||
124542016|NCT01396434|447937650|FG002|Overall Study|Other|0|||
124542017|NCT00157157|447937651|FG000|Overall Study|Withdrawal by Subject|6|||
124542018|NCT00157157|447937651|FG000|Overall Study|Physician Decision|1|||
124542019|NCT00157157|447937651|FG000|Overall Study|Lost to Follow-up|1|||
124542020|NCT00157157|447937651|FG000|Overall Study|Enrolled in another study|1|||
124981425|NCT02738853|449557481|FG000|Enrollment|Inclusion/Exclusion not met|21|||
124981426|NCT02738853|449557481|FG000|Enrollment|Withdrawal by Subject|3|||
124981427|NCT02738853|449557481|FG000|Enrollment|Subject treated with commercially available device|6|||
124981428|NCT02738853|449557481|FG000|Enrollment|Study Enrollment Closed|3|||
124981429|NCT02738853|449557481|FG000|Procedure|Death|1|||
124542021|NCT00157157|447937651|FG000|Overall Study|Met exclusion criteria|1|||
124542022|NCT00157157|447937651|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
124542023|NCT02260804|447937658|FG000|Induction Study Period|Protocol Violation|2|||
124542024|NCT02260804|447937659|FG001|Induction Study Period|Protocol Violation|0|||
124542025|NCT02260804|447937658|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
124542026|NCT02260804|447937659|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
124542027|NCT02260804|447937658|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
124542028|NCT02260804|447937659|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
124542029|NCT02260804|447937658|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
124542030|NCT02260804|447937659|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
124542031|NCT02260804|447937658|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
124542032|NCT02260804|447937659|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
124542033|NCT02260804|447937658|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
124542034|NCT02260804|447937659|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
124542035|NCT02260804|447937658|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
124542036|NCT02260804|447937659|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
124542037|NCT02260804|447937658|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
124542038|NCT02260804|447937659|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
124542039|NCT02260804|447937658|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
124542040|NCT02260804|447937659|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
124542041|NCT02260804|447937658|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
124542042|NCT02260804|447937659|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
124542043|NCT02260804|447937658|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
124542044|NCT02260804|447937659|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
124542045|NCT02207413|447937660|FG000|Overall Study|Withdrawal by Subject|1|||
124542046|NCT02207413|447937661|FG001|Overall Study|Withdrawal by Subject|0|||
124542047|NCT02207413|447937662|FG002|Overall Study|Withdrawal by Subject|0|||
124542048|NCT02207413|447937663|FG003|Overall Study|Withdrawal by Subject|0|||
124542049|NCT02207413|447937664|FG004|Overall Study|Withdrawal by Subject|3|||
124542050|NCT02207413|447937665|FG005|Overall Study|Withdrawal by Subject|7|||
124542051|NCT02207413|447937660|FG000|Overall Study|Lost to Follow-up|0|||
124542052|NCT02207413|447937661|FG001|Overall Study|Lost to Follow-up|0|||
124542053|NCT02207413|447937662|FG002|Overall Study|Lost to Follow-up|0|||
124542054|NCT02207413|447937663|FG003|Overall Study|Lost to Follow-up|1|||
124542055|NCT02207413|447937664|FG004|Overall Study|Lost to Follow-up|1|||
124542056|NCT02207413|447937665|FG005|Overall Study|Lost to Follow-up|5|||
124542057|NCT02207413|447937660|FG000|Overall Study|Adverse Event|0|||
124542058|NCT02207413|447937661|FG001|Overall Study|Adverse Event|0|||
124542059|NCT02207413|447937662|FG002|Overall Study|Adverse Event|0|||
124542060|NCT02207413|447937663|FG003|Overall Study|Adverse Event|0|||
124542061|NCT02207413|447937664|FG004|Overall Study|Adverse Event|2|||
124542062|NCT02207413|447937665|FG005|Overall Study|Adverse Event|1|||
124542063|NCT02207413|447937660|FG000|Overall Study|Migrated/moved from study area|0|||
124542064|NCT02207413|447937661|FG001|Overall Study|Migrated/moved from study area|0|||
124542065|NCT02207413|447937662|FG002|Overall Study|Migrated/moved from study area|0|||
124542066|NCT02207413|447937663|FG003|Overall Study|Migrated/moved from study area|0|||
124542067|NCT02207413|447937664|FG004|Overall Study|Migrated/moved from study area|1|||
124542068|NCT02207413|447937665|FG005|Overall Study|Migrated/moved from study area|0|||
124542069|NCT01018680|447939600|FG000|Overall Study|Adverse Event|23|||
124542070|NCT01018680|447939601|FG001|Overall Study|Adverse Event|40|||
124542071|NCT01018680|447939600|FG000|Overall Study|Withdrawal by Subject|10|||
124542072|NCT01018680|447939601|FG001|Overall Study|Withdrawal by Subject|10|||
124542073|NCT01018680|447939600|FG000|Overall Study|Protocol Violation|5|||
124542074|NCT01018680|447939601|FG001|Overall Study|Protocol Violation|8|||
124542075|NCT01018680|447939600|FG000|Overall Study|Sponsor Decision|6|||
124542076|NCT01018680|447939601|FG001|Overall Study|Sponsor Decision|7|||
124542077|NCT01018680|447939600|FG000|Overall Study|Lack of Efficacy|8|||
124542078|NCT01018680|447939601|FG001|Overall Study|Lack of Efficacy|2|||
124542079|NCT01018680|447939600|FG000|Overall Study|Lost to Follow-up|5|||
124542080|NCT01018680|447939601|FG001|Overall Study|Lost to Follow-up|3|||
124542081|NCT01018680|447939600|FG000|Overall Study|Entry Criteria Not Met|1|||
124542082|NCT01018680|447939601|FG001|Overall Study|Entry Criteria Not Met|4|||
124542083|NCT01018680|447939600|FG000|Overall Study|Physician Decision|3|||
124542084|NCT01018680|447939601|FG001|Overall Study|Physician Decision|1|||
124542085|NCT02383966|447939605|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
124542086|NCT02383966|447939606|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
124542087|NCT02383966|447939605|FG000|Overall Study|Randomized, but not treated|1|||
124542088|NCT02383966|447939606|FG001|Overall Study|Randomized, but not treated|3|||
124542089|NCT02163759|447939607|FG000|Overall Study|Withdrawal by Subject|1|||
124542090|NCT02163759|447939608|FG001|Overall Study|Withdrawal by Subject|5|||
124542091|NCT02163759|447939609|FG002|Overall Study|Withdrawal by Subject|1|||
124542092|NCT02163759|447939607|FG000|Overall Study|Adverse Event|0|||
124542093|NCT02163759|447939608|FG001|Overall Study|Adverse Event|0|||
124542094|NCT02163759|447939609|FG002|Overall Study|Adverse Event|1|||
124542095|NCT02163759|447939607|FG000|Overall Study|Death|0|||
124542096|NCT02163759|447939608|FG001|Overall Study|Death|0|||
124542097|NCT02163759|447939609|FG002|Overall Study|Death|1|||
124542098|NCT00219349|447939621|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
124542099|NCT00219349|447939621|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
124542100|NCT00219349|447939621|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
124542101|NCT00219349|447939621|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
124542102|NCT02777554|447939623|FG000|Overall Study|Adverse Event|4|||
124542103|NCT02777554|447939624|FG001|Overall Study|Adverse Event|4|||
124542104|NCT02777554|447939625|FG002|Overall Study|Adverse Event|0|||
124542105|NCT02777554|447939626|FG003|Overall Study|Adverse Event|1|||
124542106|NCT02777554|447939627|FG004|Overall Study|Adverse Event|0|||
124542107|NCT02777554|447939628|FG005|Overall Study|Adverse Event|0|||
124542108|NCT02777554|447939623|FG000|Overall Study|Withdrawal by Subject|3|||
124542109|NCT02777554|447939624|FG001|Overall Study|Withdrawal by Subject|1|||
124542110|NCT02777554|447939625|FG002|Overall Study|Withdrawal by Subject|1|||
124542111|NCT02777554|447939626|FG003|Overall Study|Withdrawal by Subject|0|||
124542112|NCT02777554|447939627|FG004|Overall Study|Withdrawal by Subject|0|||
124542113|NCT02777554|447939628|FG005|Overall Study|Withdrawal by Subject|0|||
124542114|NCT02777554|447939623|FG000|Overall Study|Discharged early due to hurricane|22|||
124542115|NCT02777554|447939624|FG001|Overall Study|Discharged early due to hurricane|20|||
124542116|NCT02777554|447939625|FG002|Overall Study|Discharged early due to hurricane|0|||
124542117|NCT02777554|447939626|FG003|Overall Study|Discharged early due to hurricane|0|||
124542118|NCT02777554|447939627|FG004|Overall Study|Discharged early due to hurricane|0|||
124542119|NCT02777554|447939628|FG005|Overall Study|Discharged early due to hurricane|0|||
124542120|NCT02777554|447939623|FG000|Overall Study|Other - Miscellaneous|1|||
124542121|NCT02777554|447939624|FG001|Overall Study|Other - Miscellaneous|0|||
124542122|NCT02777554|447939625|FG002|Overall Study|Other - Miscellaneous|0|||
124542123|NCT02777554|447939626|FG003|Overall Study|Other - Miscellaneous|0|||
124542124|NCT02777554|447939627|FG004|Overall Study|Other - Miscellaneous|0|||
124542125|NCT02777554|447939628|FG005|Overall Study|Other - Miscellaneous|0|||
124542126|NCT00270205|447939629|FG000|Overall Study|Lost to Follow-up|1|||
124542127|NCT00270205|447939630|FG001|Overall Study|Lost to Follow-up|0|||
124542128|NCT00270205|447939631|FG002|Overall Study|Lost to Follow-up|0|||
124542129|NCT00270205|447939632|FG003|Overall Study|Lost to Follow-up|1|||
124542130|NCT00066573|447939633|FG000|Overall Study|Did not received protocol treatment|28|||
124542131|NCT00066573|447939634|FG001|Overall Study|Did not received protocol treatment|28|||
124542132|NCT00869362|447939635|FG000|Overall Study|Death|0|||
124542133|NCT00869362|447939636|FG001|Overall Study|Death|2|||
124542134|NCT00869362|447939635|FG000|Overall Study|Lost to Follow-up|1|||
124542135|NCT00869362|447939636|FG001|Overall Study|Lost to Follow-up|3|||
124542136|NCT01241591|447939637|FG000|Overall Study|Lack of Efficacy|5|||
124542137|NCT01241591|447939638|FG001|Overall Study|Lack of Efficacy|2|||
124542138|NCT01241591|447939639|FG002|Overall Study|Lack of Efficacy|2|||
124542139|NCT01241591|447939640|FG003|Overall Study|Lack of Efficacy|3|||
124542140|NCT01241591|447939637|FG000|Overall Study|Protocol Violation|5|||
124542141|NCT01241591|447939638|FG001|Overall Study|Protocol Violation|2|||
124542142|NCT01241591|447939639|FG002|Overall Study|Protocol Violation|3|||
124542143|NCT01241591|447939640|FG003|Overall Study|Protocol Violation|0|||
124542144|NCT01241591|447939637|FG000|Overall Study|Lost to Follow-up|1|||
124542145|NCT01241591|447939638|FG001|Overall Study|Lost to Follow-up|2|||
124542146|NCT01241591|447939639|FG002|Overall Study|Lost to Follow-up|2|||
124542147|NCT01241591|447939640|FG003|Overall Study|Lost to Follow-up|2|||
124542148|NCT01241591|447939637|FG000|Overall Study|Screen Failure|3|||
124542149|NCT01241591|447939638|FG001|Overall Study|Screen Failure|2|||
124542150|NCT01241591|447939639|FG002|Overall Study|Screen Failure|1|||
124542151|NCT01241591|447939640|FG003|Overall Study|Screen Failure|0|||
124542152|NCT01241591|447939637|FG000|Overall Study|Withdrawal by Subject|6|||
124542153|NCT01241591|447939638|FG001|Overall Study|Withdrawal by Subject|4|||
124542154|NCT01241591|447939639|FG002|Overall Study|Withdrawal by Subject|2|||
124542155|NCT01241591|447939640|FG003|Overall Study|Withdrawal by Subject|2|||
124542156|NCT01241591|447939637|FG000|Overall Study|Other|0|||
124542157|NCT01241591|447939638|FG001|Overall Study|Other|1|||
124542158|NCT01241591|447939639|FG002|Overall Study|Other|0|||
124542159|NCT01241591|447939640|FG003|Overall Study|Other|1|||
124542160|NCT01241591|447939637|FG000|Overall Study|Adverse Event|3|||
124542161|NCT01241591|447939638|FG001|Overall Study|Adverse Event|11|||
124542162|NCT01241591|447939639|FG002|Overall Study|Adverse Event|12|||
124542163|NCT01241591|447939640|FG003|Overall Study|Adverse Event|4|||
124542164|NCT01945034|447939641|FG000|Overall Study|Medication Error|0|||
124542165|NCT01945034|447939642|FG001|Overall Study|Medication Error|1|||
124542166|NCT01945034|447939643|FG002|Overall Study|Medication Error|0|||
124542167|NCT01945034|447939641|FG000|Overall Study|Withdrawal by Subject|0|||
124542168|NCT01945034|447939642|FG001|Overall Study|Withdrawal by Subject|3|||
124542169|NCT01945034|447939643|FG002|Overall Study|Withdrawal by Subject|1|||
124542170|NCT01945034|447939641|FG000|Overall Study|Other|0|||
124542171|NCT01945034|447939642|FG001|Overall Study|Other|1|||
124542172|NCT01945034|447939643|FG002|Overall Study|Other|3|||
124542173|NCT01945034|447939641|FG000|Overall Study|Lost to Follow-up|0|||
124542174|NCT01945034|447939642|FG001|Overall Study|Lost to Follow-up|0|||
124542175|NCT01945034|447939643|FG002|Overall Study|Lost to Follow-up|2|||
124542176|NCT01945034|447939641|FG000|Overall Study|Protocol Violation|1|||
124542177|NCT01945034|447939642|FG001|Overall Study|Protocol Violation|0|||
124542178|NCT01945034|447939643|FG002|Overall Study|Protocol Violation|1|||
124542179|NCT03053102|447939644|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
124542180|NCT03053102|447939644|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
124542181|NCT01798056|447939645|FG000|Overall Study|Serious Adverse Event|13|||
124542182|NCT01798056|447939646|FG001|Overall Study|Serious Adverse Event|12|||
124542183|NCT01798056|447939645|FG000|Overall Study|Withdrawal by Subject|12|||
124542184|NCT01798056|447939646|FG001|Overall Study|Withdrawal by Subject|9|||
124542185|NCT01798056|447939645|FG000|Overall Study|Migrated/moved from study area|1|||
124542186|NCT01798056|447939646|FG001|Overall Study|Migrated/moved from study area|1|||
124542187|NCT01798056|447939645|FG000|Overall Study|Lost to Follow-up|1|||
124542188|NCT01798056|447939646|FG001|Overall Study|Lost to Follow-up|1|||
124542189|NCT01798056|447939645|FG000|Overall Study|Other|0|||
124542190|NCT01798056|447939646|FG001|Overall Study|Other|2|||
124542191|NCT02842736|447939649|FG000|Overall Study|Lost to Follow-up|13|||
124542192|NCT02842736|447939649|FG000|Overall Study|Intervention for menstrual bleeding|17|||
124542193|NCT02842736|447939649|FG000|Overall Study|Withdrawal by Subject|4|||
124542194|NCT02842736|447939649|FG000|Overall Study|Pregnancy|3|||
124542195|NCT02842736|447939649|FG000|Overall Study|Hysterectomy for fibroids|2|||
124542196|NCT02842736|447939649|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
124542197|NCT02842736|447939649|FG000|Overall Study|IUD: Mirena|1|||
124542198|NCT03323034|447939651|FG000|Overall Study|Lack of Efficacy|5|||
124542199|NCT03323034|447939652|FG001|Overall Study|Lack of Efficacy|5|||
124542200|NCT03323034|447939653|FG002|Overall Study|Lack of Efficacy|6|||
124542201|NCT03323034|447939654|FG003|Overall Study|Lack of Efficacy|5|||
124542202|NCT03323034|447939655|FG004|Overall Study|Lack of Efficacy|5|||
124542203|NCT03323034|447939651|FG000|Overall Study|Physician Decision|0|||
124542204|NCT03323034|447939652|FG001|Overall Study|Physician Decision|0|||
124542205|NCT03323034|447939653|FG002|Overall Study|Physician Decision|0|||
124542206|NCT03323034|447939654|FG003|Overall Study|Physician Decision|0|||
124542207|NCT03323034|447939655|FG004|Overall Study|Physician Decision|1|||
124542208|NCT03323034|447939651|FG000|Overall Study|Withdrawal by Subject|1|||
124542209|NCT03323034|447939652|FG001|Overall Study|Withdrawal by Subject|1|||
124542210|NCT03323034|447939653|FG002|Overall Study|Withdrawal by Subject|0|||
124542211|NCT03323034|447939654|FG003|Overall Study|Withdrawal by Subject|1|||
124542212|NCT03323034|447939655|FG004|Overall Study|Withdrawal by Subject|0|||
124542213|NCT02646566|447939656|FG000|Overall Study|Lost to Follow-up|5|||
124542214|NCT02646566|447939657|FG001|Overall Study|Lost to Follow-up|4|||
124542215|NCT02646566|447939658|FG002|Overall Study|Lost to Follow-up|5|||
124542216|NCT02646566|447939656|FG000|Overall Study|Treatment failure|1|||
124542217|NCT02646566|447939657|FG001|Overall Study|Treatment failure|0|||
124542218|NCT02646566|447939658|FG002|Overall Study|Treatment failure|0|||
124542219|NCT02815540|447939659|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
124542220|NCT02660489|447939660|FG000|Overall Study|Lost to Follow-up|1|||
124542221|NCT02660489|447939661|FG001|Overall Study|Lost to Follow-up|1|||
124542222|NCT02660489|447939660|FG000|Overall Study|Adverse Event|1|||
124542223|NCT02660489|447939661|FG001|Overall Study|Adverse Event|3|||
124542224|NCT02660489|447939660|FG000|Overall Study|no rhinovirus infection|4|||
124542225|NCT02660489|447939661|FG001|Overall Study|no rhinovirus infection|4|||
124542226|NCT04887922|447939662|FG000|1st Randomization|Decided not to have surgery|0|||
124542227|NCT04887922|447939663|FG001|1st Randomization|Decided not to have surgery|1|||
124542228|NCT04887922|447939664|FG002|1st Randomization|Decided not to have surgery|0|||
124542229|NCT04887922|447939665|FG003|1st Randomization|Decided not to have surgery|0|||
124542230|NCT04887922|447939666|FG004|1st Randomization|Decided not to have surgery|0|||
124542231|NCT00718809|447939667|FG000|Overall Study|Disease progression|9|||
124542232|NCT00718809|447939668|FG001|Overall Study|Disease progression|7|||
124542233|NCT00718809|447939667|FG000|Overall Study|Adverse Event|1|||
124542234|NCT00718809|447939668|FG001|Overall Study|Adverse Event|1|||
124542235|NCT00718809|447939667|FG000|Overall Study|Withdrawal by Subject|0|||
124542236|NCT00718809|447939668|FG001|Overall Study|Withdrawal by Subject|1|||
124542237|NCT00718809|447939667|FG000|Overall Study|Lost to Follow-up|1|||
124542238|NCT00718809|447939668|FG001|Overall Study|Lost to Follow-up|0|||
124542239|NCT00718809|447939667|FG000|Overall Study|Noncompliance|1|||
124542240|NCT00718809|447939668|FG001|Overall Study|Noncompliance|0|||
124542241|NCT00463385|447939669|FG000|Overall Study|Other|4|||
124542242|NCT00463385|447939670|FG001|Overall Study|Other|3|||
124542243|NCT00463385|447939671|FG002|Overall Study|Other|6|||
124542244|NCT00463385|447939672|FG003|Overall Study|Other|4|||
124542245|NCT00463385|447939669|FG000|Overall Study|Adverse Event|5|||
124542246|NCT00463385|447939670|FG001|Overall Study|Adverse Event|8|||
124542247|NCT00463385|447939671|FG002|Overall Study|Adverse Event|4|||
124542248|NCT00463385|447939672|FG003|Overall Study|Adverse Event|2|||
124542249|NCT00463385|447939669|FG000|Overall Study|Lack of Efficacy|6|||
124542250|NCT00463385|447939670|FG001|Overall Study|Lack of Efficacy|6|||
124542251|NCT00463385|447939671|FG002|Overall Study|Lack of Efficacy|7|||
124542252|NCT00463385|447939672|FG003|Overall Study|Lack of Efficacy|9|||
124542253|NCT00463385|447939669|FG000|Overall Study|Withdrawal by Subject|3|||
124542254|NCT00463385|447939670|FG001|Overall Study|Withdrawal by Subject|3|||
124542255|NCT00463385|447939671|FG002|Overall Study|Withdrawal by Subject|3|||
124542256|NCT00463385|447939672|FG003|Overall Study|Withdrawal by Subject|4|||
124542257|NCT00463385|447939669|FG000|Overall Study|Lost to Follow-up|0|||
124542258|NCT00463385|447939670|FG001|Overall Study|Lost to Follow-up|0|||
124542259|NCT00463385|447939671|FG002|Overall Study|Lost to Follow-up|0|||
124542260|NCT00463385|447939672|FG003|Overall Study|Lost to Follow-up|1|||
124542261|NCT00463385|447939669|FG000|Overall Study|Death|2|||
124542262|NCT00463385|447939670|FG001|Overall Study|Death|1|||
124542263|NCT00463385|447939671|FG002|Overall Study|Death|2|||
124542264|NCT00463385|447939672|FG003|Overall Study|Death|0|||
124542265|NCT00463385|447939669|FG000|Overall Study|Missing|2|||
124542266|NCT00463385|447939670|FG001|Overall Study|Missing|0|||
124542267|NCT00463385|447939671|FG002|Overall Study|Missing|0|||
124542268|NCT00463385|447939672|FG003|Overall Study|Missing|2|||
124542269|NCT00463385|447939669|FG000|Overall Study|1 participant received commercial drug|0|||
124542270|NCT00463385|447939670|FG001|Overall Study|1 participant received commercial drug|1|||
124542271|NCT00463385|447939671|FG002|Overall Study|1 participant received commercial drug|0|||
124542272|NCT00463385|447939672|FG003|Overall Study|1 participant received commercial drug|0|||
124542273|NCT00536991|447939675|FG000|Overall Study|Withdrawal by Subject|10|||
124542274|NCT00536991|447939675|FG000|Overall Study|Physician Decision|1|||
124542275|NCT00536991|447939675|FG000|Overall Study|patient ineligible|2|||
124542276|NCT01600755|447939676|FG000|Overall Study|Withdrawal by Subject|6|||
124542277|NCT00447265|447939681|FG000|Overall Study|Physician Decision|1|||
124542278|NCT00447265|447939682|FG001|Overall Study|Physician Decision|0|||
124542279|NCT02204449|447939683|FG000|Overall Study|Lost to Follow-up|7|||
124542280|NCT02204449|447939684|FG001|Overall Study|Lost to Follow-up|9|||
124542281|NCT02204449|447939683|FG000|Overall Study|Death|0|||
124542282|NCT02204449|447939684|FG001|Overall Study|Death|1|||
124542283|NCT02204449|447939683|FG000|Overall Study|Withdrawal by Subject|0|||
124542284|NCT02204449|447939684|FG001|Overall Study|Withdrawal by Subject|1|||
124542285|NCT00503035|447939685|FG000|Overall Study|Lost to Follow-up|2|||
124542286|NCT00503035|447939685|FG000|Overall Study|Physician Decision|3|||
124542287|NCT00503035|447939685|FG000|Overall Study|Ineligible|15|||
124542288|NCT03868410|447939686|FG000|Overall Study|Physician Decision|0|||
124542289|NCT03868410|447939687|FG001|Overall Study|Physician Decision|1|||
124542290|NCT01059175|447939688|FG000|Overall Study|Death|17|||
124542291|NCT01059175|447939689|FG001|Overall Study|Death|17|||
124542292|NCT01059175|447939688|FG000|Overall Study|Adverse Event|4|||
124542293|NCT01059175|447939689|FG001|Overall Study|Adverse Event|2|||
124542294|NCT01059175|447939688|FG000|Overall Study|Lost to Follow-up|0|||
124542295|NCT01059175|447939689|FG001|Overall Study|Lost to Follow-up|1|||
124542296|NCT00643006|447939691|FG000|Overall Study|Lost to Follow-up|5|||
124542297|NCT00643006|447939692|FG001|Overall Study|Lost to Follow-up|4|||
124542298|NCT03471507|447939693|FG000|Overall Study|Lost to Follow-up|1|||
124542299|NCT03471507|447939694|FG001|Overall Study|Lost to Follow-up|3|||
124542300|NCT03471507|447939693|FG000|Overall Study|Physician Decision|0|||
124542301|NCT03471507|447939694|FG001|Overall Study|Physician Decision|1|||
124542302|NCT03471507|447939693|FG000|Overall Study|Withdrawal by Subject|2|||
124542303|NCT03471507|447939694|FG001|Overall Study|Withdrawal by Subject|1|||
124542304|NCT01151085|447939695|FG000|Overall Study|Lost to Follow-up|31|||
124542305|NCT01151085|447939695|FG000|Overall Study|Protocol Violation|25|||
124542306|NCT01308476|447939697|FG000|Overall Study|Lost to Follow-up|2|||
124542307|NCT01308476|447939698|FG001|Overall Study|Lost to Follow-up|2|||
124542308|NCT01308476|447939697|FG000|Overall Study|Other|1|||
124542309|NCT01308476|447939698|FG001|Overall Study|Other|0|||
124542310|NCT06104423|447939701|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
124542311|NCT06104423|447939702|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
124542312|NCT06104423|447939703|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
124542313|NCT06104423|447939701|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
124542314|NCT06104423|447939702|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
124981430|NCT02738853|449557481|FG000|1 Month|Death|2|||
124542315|NCT06104423|447939703|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
124542316|NCT00750061|447939704|FG000|Overall Study|Adverse Event|2|||
124542317|NCT00750061|447939705|FG001|Overall Study|Adverse Event|0|||
124542318|NCT00750061|447939704|FG000|Overall Study|Withdrawal by Subject|0|||
124542319|NCT00750061|447939705|FG001|Overall Study|Withdrawal by Subject|1|||
124542320|NCT00750061|447939704|FG000|Overall Study|Physician Decision|0|||
124542321|NCT00750061|447939705|FG001|Overall Study|Physician Decision|1|||
124542322|NCT00812968|447939706|FG000|Overall Study|Relapse after erythroid response|6|||
124542323|NCT00812968|447939706|FG000|Overall Study|Disease progression|1|||
124542324|NCT00812968|447939706|FG000|Overall Study|No further treatment required|1|||
124542325|NCT00812968|447939706|FG000|Overall Study|Study closed due to marketing approval|3|||
124542326|NCT03246152|447939708|FG000|Overall Study|Lost to Follow-up|2|||
124981431|NCT02738853|449557481|FG000|6 Month|Death|4|||
124542327|NCT03246152|447939708|FG000|Overall Study|Protocol Violation|1|||
124542328|NCT01243762|447939713|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
124542329|NCT01243762|447939714|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
124542330|NCT01243762|447939715|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
124542331|NCT01243762|447939716|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
124542332|NCT01243762|447939717|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
124542333|NCT01243762|447939718|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
124542334|NCT01243762|447939719|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
124542335|NCT01243762|447939713|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
124542336|NCT01243762|447939714|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
124542337|NCT01243762|447939715|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
124542338|NCT01243762|447939716|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
124542339|NCT01243762|447939717|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
124542340|NCT01243762|447939718|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
124542341|NCT01243762|447939719|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
124542342|NCT01243762|447939713|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
124542343|NCT01243762|447939714|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
124542344|NCT01243762|447939715|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
124542345|NCT01243762|447939716|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
124542346|NCT01243762|447939717|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
124542347|NCT01243762|447939718|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
124542348|NCT01243762|447939719|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
124542349|NCT01243762|447939713|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
124542350|NCT01243762|447939714|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
124542351|NCT01243762|447939715|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
124542352|NCT01243762|447939716|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
124542353|NCT01243762|447939717|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
124542354|NCT01243762|447939718|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
124542355|NCT01243762|447939719|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
124542356|NCT01243762|447939713|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
124542357|NCT01243762|447939714|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
124542358|NCT01243762|447939715|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
124542359|NCT01243762|447939716|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
124542360|NCT01243762|447939717|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
124542361|NCT01243762|447939718|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
124542362|NCT01243762|447939719|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
124542363|NCT01243762|447939713|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
124542364|NCT01243762|447939714|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
124542365|NCT01243762|447939715|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
124542366|NCT01243762|447939716|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
124542367|NCT01243762|447939717|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
124542368|NCT01243762|447939718|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
124542369|NCT01243762|447939719|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
124542370|NCT01243762|447939713|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
124542371|NCT01243762|447939714|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
124542372|NCT01243762|447939715|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
124542373|NCT01243762|447939716|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
124542374|NCT01243762|447939717|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
124542375|NCT01243762|447939718|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
124542376|NCT01243762|447939719|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
124542377|NCT01243762|447939713|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
124542378|NCT01243762|447939714|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
124542379|NCT01243762|447939715|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
124542380|NCT01243762|447939716|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
124542381|NCT01243762|447939717|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
124542382|NCT01243762|447939718|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
124542383|NCT01243762|447939719|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
124542384|NCT02059265|447939720|FG000|Overall Study|Ineligible|4|||
124542385|NCT04753606|447939725|FG000|Overall Study|Adverse Event|1|||
124542386|NCT04753606|447939726|FG001|Overall Study|Adverse Event|0|||
124542387|NCT04753606|447939727|FG002|Overall Study|Adverse Event|0|||
124542388|NCT03841331|447939730|FG000|Overall Study|Withdrawal by Subject|4|||
124542389|NCT03841331|447939731|FG001|Overall Study|Withdrawal by Subject|9|||
124542390|NCT03841331|447939730|FG000|Overall Study|Lost to Follow-up|5|||
124542391|NCT03841331|447939731|FG001|Overall Study|Lost to Follow-up|1|||
124542392|NCT04145531|447939735|FG000|Part A|Adverse Event|2|||
124542393|NCT04145531|447939736|FG001|Part A|Adverse Event|12|||
124542394|NCT04145531|447939737|FG002|Part A|Adverse Event|6|||
124542395|NCT04145531|447939738|FG003|Part A|Adverse Event|0|||
124542396|NCT04145531|447939735|FG000|Part A|Death|1|||
124542397|NCT04145531|447939736|FG001|Part A|Death|2|||
124981432|NCT02738853|449557481|FG000|6 Month|Withdrawal by Subject|2|||
124981433|NCT02738853|449557481|FG000|1 Year|Death|6|||
124981434|NCT02738853|449557481|FG000|1 Year|Withdrawal by Subject|1|||
124981435|NCT02738853|449557481|FG000|2 Year|Death|2|||
124981436|NCT02738853|449557481|FG000|2 Year|Lost to Follow-up|1|||
124981437|NCT02738853|449557481|FG000|3 Year|Death|2|||
124981438|NCT02738853|449557481|FG000|3 Year|Withdrawal by Subject|1|||
124981439|NCT02738853|449557481|FG000|4 Year|Death|9|||
124981440|NCT02738853|449557481|FG000|5 Year|Lost to Follow-up|4|||
124981441|NCT02626455|449557486|FG000|Overall Study|Other|1|||
124542398|NCT04145531|447939737|FG002|Part A|Death|0|||
124981442|NCT02626455|449557487|FG001|Overall Study|Other|1|||
124981443|NCT02626455|449557488|FG002|Overall Study|Other|0|||
124981444|NCT02626455|449557489|FG003|Overall Study|Other|0|||
124981445|NCT02626455|449557490|FG004|Overall Study|Other|0|||
124981446|NCT02626455|449557491|FG005|Overall Study|Other|17|||
124981447|NCT02626455|449557492|FG006|Overall Study|Other|23|||
124981448|NCT02626455|449557486|FG000|Overall Study|Withdrawal by Subject|1|||
124981449|NCT02626455|449557487|FG001|Overall Study|Withdrawal by Subject|0|||
124981450|NCT02626455|449557488|FG002|Overall Study|Withdrawal by Subject|0|||
124981451|NCT02626455|449557489|FG003|Overall Study|Withdrawal by Subject|0|||
124981452|NCT02626455|449557490|FG004|Overall Study|Withdrawal by Subject|0|||
124981453|NCT02626455|449557491|FG005|Overall Study|Withdrawal by Subject|10|||
124981454|NCT02626455|449557492|FG006|Overall Study|Withdrawal by Subject|6|||
124981455|NCT02626455|449557486|FG000|Overall Study|Physician Decision|0|||
124981456|NCT02626455|449557487|FG001|Overall Study|Physician Decision|2|||
124981457|NCT02626455|449557488|FG002|Overall Study|Physician Decision|2|||
124981458|NCT02626455|449557489|FG003|Overall Study|Physician Decision|2|||
124981459|NCT02626455|449557490|FG004|Overall Study|Physician Decision|1|||
124981460|NCT02626455|449557491|FG005|Overall Study|Physician Decision|10|||
124981461|NCT02626455|449557492|FG006|Overall Study|Physician Decision|3|||
124981462|NCT02626455|449557486|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
124981463|NCT02626455|449557487|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
124981464|NCT02626455|449557488|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
124981465|NCT02626455|449557489|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
124981466|NCT02626455|449557490|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
124981467|NCT02626455|449557491|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
124981468|NCT02626455|449557492|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
124981469|NCT02626455|449557486|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
124981470|NCT02626455|449557487|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
124981471|NCT02626455|449557488|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
124981472|NCT02626455|449557489|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
124981473|NCT02626455|449557490|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
124981474|NCT02626455|449557491|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
124981475|NCT02626455|449557492|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
124981476|NCT02626455|449557486|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
124981477|NCT02626455|449557487|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
124981478|NCT02626455|449557488|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
124981479|NCT02626455|449557489|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
124981480|NCT02626455|449557490|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
124981481|NCT02626455|449557491|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
124981482|NCT02626455|449557492|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
124981483|NCT02626455|449557486|FG000|Overall Study|Patient decision|0|||
124981484|NCT02626455|449557487|FG001|Overall Study|Patient decision|1|||
124981485|NCT02626455|449557488|FG002|Overall Study|Patient decision|0|||
124981486|NCT02626455|449557489|FG003|Overall Study|Patient decision|0|||
124542399|NCT04145531|447939738|FG003|Part A|Death|0|||
124542400|NCT04145531|447939735|FG000|Part A|Physician Decision|2|||
124542401|NCT04145531|447939736|FG001|Part A|Physician Decision|5|||
124542402|NCT04145531|447939737|FG002|Part A|Physician Decision|2|||
124542403|NCT04145531|447939738|FG003|Part A|Physician Decision|0|||
124542404|NCT04145531|447939735|FG000|Part A|Progressive disease|0|||
124542405|NCT04145531|447939736|FG001|Part A|Progressive disease|2|||
124542406|NCT04145531|447939737|FG002|Part A|Progressive disease|1|||
124542407|NCT04145531|447939738|FG003|Part A|Progressive disease|0|||
124542408|NCT04145531|447939735|FG000|Part A|Protocol deviation|0|||
124542409|NCT04145531|447939736|FG001|Part A|Protocol deviation|0|||
124981487|NCT02626455|449557490|FG004|Overall Study|Patient decision|1|||
124981488|NCT02626455|449557491|FG005|Overall Study|Patient decision|36|||
124981489|NCT02626455|449557492|FG006|Overall Study|Patient decision|22|||
124981490|NCT02626455|449557486|FG000|Overall Study|Protocol Violation|0|||
124981491|NCT02626455|449557487|FG001|Overall Study|Protocol Violation|0|||
124542410|NCT04145531|447939737|FG002|Part A|Protocol deviation|1|||
124542411|NCT04145531|447939738|FG003|Part A|Protocol deviation|0|||
124542412|NCT04145531|447939735|FG000|Part A|Withdrawal by parent or guardian|1|||
124542413|NCT04145531|447939736|FG001|Part A|Withdrawal by parent or guardian|0|||
124542414|NCT04145531|447939737|FG002|Part A|Withdrawal by parent or guardian|0|||
124542415|NCT04145531|447939738|FG003|Part A|Withdrawal by parent or guardian|0|||
124542416|NCT04145531|447939735|FG000|Part A|Withdrawal by participant|0|||
124542417|NCT04145531|447939736|FG001|Part A|Withdrawal by participant|0|||
124542418|NCT04145531|447939737|FG002|Part A|Withdrawal by participant|1|||
124542419|NCT04145531|447939738|FG003|Part A|Withdrawal by participant|0|||
124542420|NCT04145531|447939735|FG000|Part A|Other|0|||
124542421|NCT04145531|447939736|FG001|Part A|Other|0|||
124542422|NCT04145531|447939737|FG002|Part A|Other|1|||
124542423|NCT04145531|447939738|FG003|Part A|Other|0|||
124542424|NCT04145531|447939735|FG000|Part B|Adverse Event|0|||
124542425|NCT04145531|447939736|FG001|Part B|Adverse Event|0|||
124542426|NCT04145531|447939737|FG002|Part B|Adverse Event|0|||
124542427|NCT04145531|447939738|FG003|Part B|Adverse Event|21|||
124542428|NCT04145531|447939735|FG000|Part B|Physician Decision|0|||
124542429|NCT04145531|447939736|FG001|Part B|Physician Decision|0|||
124542430|NCT04145531|447939737|FG002|Part B|Physician Decision|0|||
124542431|NCT04145531|447939738|FG003|Part B|Physician Decision|7|||
124542432|NCT04145531|447939735|FG000|Part B|Progressive disease|0|||
124542433|NCT04145531|447939736|FG001|Part B|Progressive disease|0|||
124542434|NCT04145531|447939737|FG002|Part B|Progressive disease|0|||
124542435|NCT04145531|447939738|FG003|Part B|Progressive disease|1|||
124542436|NCT04145531|447939735|FG000|Part B|Recurrent disease|0|||
124542437|NCT04145531|447939736|FG001|Part B|Recurrent disease|0|||
124542438|NCT04145531|447939737|FG002|Part B|Recurrent disease|0|||
124542439|NCT04145531|447939738|FG003|Part B|Recurrent disease|1|||
124542440|NCT04145531|447939735|FG000|Part B|Withdrawal by parent or guardian|0|||
124542441|NCT04145531|447939736|FG001|Part B|Withdrawal by parent or guardian|0|||
124542442|NCT04145531|447939737|FG002|Part B|Withdrawal by parent or guardian|0|||
124542443|NCT04145531|447939738|FG003|Part B|Withdrawal by parent or guardian|3|||
124542444|NCT04145531|447939735|FG000|Part B|Withdrawal by participant|0|||
124542445|NCT04145531|447939736|FG001|Part B|Withdrawal by participant|0|||
124542446|NCT04145531|447939737|FG002|Part B|Withdrawal by participant|0|||
124542447|NCT04145531|447939738|FG003|Part B|Withdrawal by participant|1|||
124542448|NCT04145531|447939735|FG000|Part B|Other|0|||
124542449|NCT04145531|447939736|FG001|Part B|Other|0|||
124542450|NCT04145531|447939737|FG002|Part B|Other|0|||
124542451|NCT04145531|447939738|FG003|Part B|Other|1|||
124542452|NCT02985996|447939739|FG000|Overall Study|Withdrawal by Subject|0|||
124542453|NCT02985996|447939740|FG001|Overall Study|Withdrawal by Subject|0|||
124542454|NCT02985996|447939741|FG002|Overall Study|Withdrawal by Subject|1|||
124542455|NCT02985996|447939742|FG003|Overall Study|Withdrawal by Subject|0|||
124542456|NCT02985996|447939743|FG004|Overall Study|Withdrawal by Subject|0|||
124542457|NCT02985996|447939739|FG000|Overall Study|Protocol Violation|0|||
124542458|NCT02985996|447939740|FG001|Overall Study|Protocol Violation|1|||
124542459|NCT02985996|447939741|FG002|Overall Study|Protocol Violation|0|||
124542460|NCT02985996|447939742|FG003|Overall Study|Protocol Violation|0|||
124542461|NCT02985996|447939743|FG004|Overall Study|Protocol Violation|0|||
124542462|NCT01207219|447939744|FG000|Overall Study|changed diagnosis during study period|5|||
124542463|NCT01207219|447939745|FG001|Overall Study|changed diagnosis during study period|3|||
124542464|NCT01207219|447939746|FG002|Overall Study|changed diagnosis during study period|1|||
124542465|NCT01207219|447939744|FG000|Overall Study|Lost to Follow-up|6|||
124542466|NCT01207219|447939745|FG001|Overall Study|Lost to Follow-up|8|||
124542467|NCT01207219|447939746|FG002|Overall Study|Lost to Follow-up|6|||
124542468|NCT00442572|447939747|FG000|Overall Study|Relapse|8|||
124542469|NCT00442572|447939748|FG001|Overall Study|Relapse|1|||
124542470|NCT00442572|447939747|FG000|Overall Study|Lost to Follow-up|0|||
124542471|NCT00442572|447939748|FG001|Overall Study|Lost to Follow-up|1|||
124542472|NCT00442572|447939747|FG000|Overall Study|Withdrawal by Subject|0|||
124542473|NCT00442572|447939748|FG001|Overall Study|Withdrawal by Subject|1|||
124542474|NCT04246593|447939752|FG000|Overall Study|Withdrawal by Subject|14|||
124542475|NCT04246593|447939753|FG001|Overall Study|Withdrawal by Subject|13|||
124542476|NCT04246593|447939752|FG000|Overall Study|Lost to Follow-up|124|||
124542477|NCT04246593|447939753|FG001|Overall Study|Lost to Follow-up|71|||
124542478|NCT04246593|447939752|FG000|Overall Study|Moved out of area/became ineligible|3|||
124542479|NCT04246593|447939753|FG001|Overall Study|Moved out of area/became ineligible|1|||
124542480|NCT04246593|447939752|FG000|Overall Study|Reason unknown|4|||
124542481|NCT04246593|447939753|FG001|Overall Study|Reason unknown|2|||
124542482|NCT00634933|447939760|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
124542483|NCT00634933|447939761|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
124542484|NCT00634933|447939762|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
124542485|NCT00634933|447939763|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
124542486|NCT00634933|447939764|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
124542487|NCT00634933|447939760|FG000|Part A: Baseline to Week 24|Death|1|||
124542488|NCT00634933|447939761|FG001|Part A: Baseline to Week 24|Death|0|||
124542489|NCT00634933|447939762|FG002|Part A: Baseline to Week 24|Death|0|||
124542490|NCT00634933|447939763|FG003|Part A: Baseline to Week 24|Death|0|||
124542491|NCT00634933|447939764|FG004|Part A: Baseline to Week 24|Death|0|||
124542492|NCT00634933|447939760|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
124542493|NCT00634933|447939761|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
124758636|NCT01463306|448739822|FG002|Overall Study|Death|0|||
124542494|NCT00634933|447939762|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
124542495|NCT00634933|447939763|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
124542496|NCT00634933|447939764|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
124542497|NCT00634933|447939760|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
124542498|NCT00634933|447939761|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
124542499|NCT00634933|447939762|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
124542500|NCT00634933|447939763|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
124542501|NCT00634933|447939764|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
124981492|NCT02626455|449557488|FG002|Overall Study|Protocol Violation|0|||
124981493|NCT02626455|449557489|FG003|Overall Study|Protocol Violation|0|||
124981494|NCT02626455|449557490|FG004|Overall Study|Protocol Violation|0|||
124981495|NCT02626455|449557491|FG005|Overall Study|Protocol Violation|0|||
124981496|NCT02626455|449557492|FG006|Overall Study|Protocol Violation|1|||
124981497|NCT02626455|449557486|FG000|Overall Study|Progressive disease - radiological progression|0|||
124981498|NCT02626455|449557487|FG001|Overall Study|Progressive disease - radiological progression|0|||
124981499|NCT02626455|449557488|FG002|Overall Study|Progressive disease - radiological progression|0|||
124981500|NCT02626455|449557489|FG003|Overall Study|Progressive disease - radiological progression|0|||
124981501|NCT02626455|449557490|FG004|Overall Study|Progressive disease - radiological progression|0|||
124981502|NCT02626455|449557491|FG005|Overall Study|Progressive disease - radiological progression|11|||
124981503|NCT02626455|449557492|FG006|Overall Study|Progressive disease - radiological progression|22|||
124981504|NCT02626455|449557486|FG000|Overall Study|Progressive disease - clinical progression|0|||
124981505|NCT02626455|449557487|FG001|Overall Study|Progressive disease - clinical progression|0|||
124981506|NCT02626455|449557488|FG002|Overall Study|Progressive disease - clinical progression|0|||
124981507|NCT02626455|449557489|FG003|Overall Study|Progressive disease - clinical progression|0|||
124981508|NCT02626455|449557490|FG004|Overall Study|Progressive disease - clinical progression|0|||
124981509|NCT02626455|449557491|FG005|Overall Study|Progressive disease - clinical progression|1|||
124981510|NCT02626455|449557492|FG006|Overall Study|Progressive disease - clinical progression|2|||
124981511|NCT02626455|449557486|FG000|Overall Study|Lost to Follow-up|0|||
124981512|NCT02626455|449557487|FG001|Overall Study|Lost to Follow-up|0|||
124981513|NCT02626455|449557488|FG002|Overall Study|Lost to Follow-up|0|||
124981514|NCT02626455|449557489|FG003|Overall Study|Lost to Follow-up|0|||
124981515|NCT02626455|449557490|FG004|Overall Study|Lost to Follow-up|0|||
124981516|NCT02626455|449557491|FG005|Overall Study|Lost to Follow-up|1|||
124981517|NCT02626455|449557492|FG006|Overall Study|Lost to Follow-up|0|||
124981518|NCT02626455|449557486|FG000|Overall Study|AE not associated with clinical disease progression|1|||
124981519|NCT02626455|449557487|FG001|Overall Study|AE not associated with clinical disease progression|1|||
124981520|NCT02626455|449557488|FG002|Overall Study|AE not associated with clinical disease progression|0|||
124981521|NCT02626455|449557489|FG003|Overall Study|AE not associated with clinical disease progression|2|||
124981522|NCT02626455|449557490|FG004|Overall Study|AE not associated with clinical disease progression|1|||
124981523|NCT02626455|449557491|FG005|Overall Study|AE not associated with clinical disease progression|65|||
124981524|NCT02626455|449557492|FG006|Overall Study|AE not associated with clinical disease progression|21|||
124981525|NCT02626455|449557486|FG000|Overall Study|AE associated with clinical disease progression|0|||
124981526|NCT02626455|449557487|FG001|Overall Study|AE associated with clinical disease progression|0|||
124981527|NCT02626455|449557488|FG002|Overall Study|AE associated with clinical disease progression|0|||
124981528|NCT02626455|449557489|FG003|Overall Study|AE associated with clinical disease progression|0|||
124981529|NCT02626455|449557490|FG004|Overall Study|AE associated with clinical disease progression|0|||
124981530|NCT02626455|449557491|FG005|Overall Study|AE associated with clinical disease progression|1|||
124981531|NCT02626455|449557492|FG006|Overall Study|AE associated with clinical disease progression|2|||
124981532|NCT02626455|449557486|FG000|Overall Study|Study intervention never administered|0|||
124981533|NCT02626455|449557487|FG001|Overall Study|Study intervention never administered|0|||
124981534|NCT02626455|449557488|FG002|Overall Study|Study intervention never administered|0|||
124981535|NCT02626455|449557489|FG003|Overall Study|Study intervention never administered|0|||
124981536|NCT02626455|449557490|FG004|Overall Study|Study intervention never administered|0|||
124981537|NCT02626455|449557491|FG005|Overall Study|Study intervention never administered|1|||
124981538|NCT02626455|449557492|FG006|Overall Study|Study intervention never administered|3|||
124542502|NCT00634933|447939760|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
124542503|NCT00634933|447939761|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
124542504|NCT00634933|447939762|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
124542505|NCT00634933|447939763|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
124542506|NCT00634933|447939764|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
124542507|NCT00634933|447939760|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
124542508|NCT00634933|447939761|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
124542509|NCT00634933|447939762|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
124542510|NCT00634933|447939763|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
124542511|NCT00634933|447939764|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
124542512|NCT00634933|447939760|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
124542513|NCT00634933|447939761|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
124542514|NCT00634933|447939762|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
124542515|NCT00634933|447939763|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
124542516|NCT00634933|447939764|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
124542517|NCT00634933|447939760|FG000|Part A: Baseline to Week 24|Other|1|||
124542518|NCT00634933|447939761|FG001|Part A: Baseline to Week 24|Other|8|||
124542519|NCT00634933|447939762|FG002|Part A: Baseline to Week 24|Other|5|||
124542520|NCT00634933|447939763|FG003|Part A: Baseline to Week 24|Other|0|||
124542521|NCT00634933|447939764|FG004|Part A: Baseline to Week 24|Other|0|||
124542522|NCT00634933|447939760|FG000|Between Part A and Part B|Physician Decision|0|||
124542523|NCT00634933|447939761|FG001|Between Part A and Part B|Physician Decision|1|||
124542524|NCT00634933|447939762|FG002|Between Part A and Part B|Physician Decision|0|||
124542525|NCT00634933|447939763|FG003|Between Part A and Part B|Physician Decision|0|||
124542526|NCT00634933|447939764|FG004|Between Part A and Part B|Physician Decision|0|||
124542527|NCT00634933|447939760|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
124542528|NCT00634933|447939761|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
124542529|NCT00634933|447939762|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
124542530|NCT00634933|447939763|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
124542531|NCT00634933|447939764|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
124542532|NCT00634933|447939760|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
124542533|NCT00634933|447939761|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
124542534|NCT00634933|447939762|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
124542535|NCT00634933|447939763|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
124542536|NCT00634933|447939764|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
124542537|NCT00634933|447939760|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
124542538|NCT00634933|447939761|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
124542539|NCT00634933|447939762|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
124542540|NCT00634933|447939763|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
124542541|NCT00634933|447939764|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
124542542|NCT00634933|447939760|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
124542543|NCT00634933|447939761|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
124542544|NCT00634933|447939762|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
124542545|NCT00634933|447939763|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
124542546|NCT00634933|447939764|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
124542547|NCT00634933|447939760|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
124542548|NCT00634933|447939761|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
124542549|NCT00634933|447939762|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
124542550|NCT00634933|447939763|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
124542551|NCT00634933|447939764|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
124542552|NCT00634933|447939760|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
124542553|NCT00634933|447939761|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
124542554|NCT00634933|447939762|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
124542555|NCT00634933|447939763|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
124542556|NCT00634933|447939764|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
124542557|NCT00634933|447939760|FG000|Part B: Week 24 to Week 52|Other|0|||
124542558|NCT00634933|447939761|FG001|Part B: Week 24 to Week 52|Other|0|||
124542559|NCT00634933|447939762|FG002|Part B: Week 24 to Week 52|Other|5|||
124542560|NCT00634933|447939763|FG003|Part B: Week 24 to Week 52|Other|0|||
124542561|NCT00634933|447939764|FG004|Part B: Week 24 to Week 52|Other|1|||
124542562|NCT01049360|447939765|FG000|Period 1|Adverse Event|0|||
124542563|NCT01049360|447939766|FG001|Period 1|Adverse Event|1|||
124542564|NCT01049360|447939767|FG002|Period 1|Adverse Event|0|||
124542565|NCT01049360|447939768|FG003|Period 1|Adverse Event|1|||
124542566|NCT01049360|447939769|FG004|Period 1|Adverse Event|0|||
124542567|NCT01049360|447939770|FG005|Period 1|Adverse Event|0|||
124542568|NCT01049360|447939771|FG006|Period 1|Adverse Event|0|||
124542569|NCT01049360|447939772|FG007|Period 1|Adverse Event|1|||
124542570|NCT01049360|447939773|FG008|Period 1|Adverse Event|0|||
124542571|NCT01049360|447939774|FG009|Period 1|Adverse Event|0|||
124542572|NCT01049360|447939775|FG010|Period 1|Adverse Event|0|||
124542573|NCT01049360|447939776|FG011|Period 1|Adverse Event|0|||
124542574|NCT01049360|447939777|FG012|Period 1|Adverse Event|1|||
124542575|NCT01049360|447939778|FG013|Period 1|Adverse Event|1|||
124542576|NCT01049360|447939779|FG014|Period 1|Adverse Event|0|||
124542577|NCT01049360|447939780|FG015|Period 1|Adverse Event|0|||
124542578|NCT01049360|447939781|FG016|Period 1|Adverse Event|1|||
124542579|NCT01049360|447939782|FG017|Period 1|Adverse Event|0|||
124542580|NCT01049360|447939783|FG018|Period 1|Adverse Event|1|||
124542581|NCT01049360|447939784|FG019|Period 1|Adverse Event|0|||
124542582|NCT01049360|447939765|FG000|Period 1|Did not meet inc/exc criteria|0|||
124542583|NCT01049360|447939766|FG001|Period 1|Did not meet inc/exc criteria|0|||
124542584|NCT01049360|447939767|FG002|Period 1|Did not meet inc/exc criteria|0|||
124542585|NCT01049360|447939768|FG003|Period 1|Did not meet inc/exc criteria|0|||
124542586|NCT01049360|447939769|FG004|Period 1|Did not meet inc/exc criteria|0|||
124542587|NCT01049360|447939770|FG005|Period 1|Did not meet inc/exc criteria|0|||
124542588|NCT01049360|447939771|FG006|Period 1|Did not meet inc/exc criteria|0|||
124542589|NCT01049360|447939772|FG007|Period 1|Did not meet inc/exc criteria|1|||
124542590|NCT01049360|447939773|FG008|Period 1|Did not meet inc/exc criteria|1|||
124542591|NCT01049360|447939774|FG009|Period 1|Did not meet inc/exc criteria|0|||
124542592|NCT01049360|447939775|FG010|Period 1|Did not meet inc/exc criteria|0|||
124542593|NCT01049360|447939776|FG011|Period 1|Did not meet inc/exc criteria|0|||
124542594|NCT01049360|447939777|FG012|Period 1|Did not meet inc/exc criteria|0|||
124542595|NCT01049360|447939778|FG013|Period 1|Did not meet inc/exc criteria|0|||
124542596|NCT01049360|447939779|FG014|Period 1|Did not meet inc/exc criteria|0|||
124542597|NCT01049360|447939780|FG015|Period 1|Did not meet inc/exc criteria|0|||
124542598|NCT01049360|447939781|FG016|Period 1|Did not meet inc/exc criteria|0|||
124542599|NCT01049360|447939782|FG017|Period 1|Did not meet inc/exc criteria|0|||
124542600|NCT01049360|447939783|FG018|Period 1|Did not meet inc/exc criteria|0|||
124542601|NCT01049360|447939784|FG019|Period 1|Did not meet inc/exc criteria|0|||
124542602|NCT01049360|447939765|FG000|Period 1|Withdrawal by Subject|0|||
124542603|NCT01049360|447939766|FG001|Period 1|Withdrawal by Subject|0|||
124542604|NCT01049360|447939767|FG002|Period 1|Withdrawal by Subject|0|||
124542605|NCT01049360|447939768|FG003|Period 1|Withdrawal by Subject|0|||
124542606|NCT01049360|447939769|FG004|Period 1|Withdrawal by Subject|0|||
124542607|NCT01049360|447939770|FG005|Period 1|Withdrawal by Subject|0|||
124542608|NCT01049360|447939771|FG006|Period 1|Withdrawal by Subject|0|||
124542609|NCT01049360|447939772|FG007|Period 1|Withdrawal by Subject|0|||
124542610|NCT01049360|447939773|FG008|Period 1|Withdrawal by Subject|1|||
124542611|NCT01049360|447939774|FG009|Period 1|Withdrawal by Subject|0|||
124542612|NCT01049360|447939775|FG010|Period 1|Withdrawal by Subject|1|||
124542613|NCT01049360|447939776|FG011|Period 1|Withdrawal by Subject|0|||
124542614|NCT01049360|447939777|FG012|Period 1|Withdrawal by Subject|1|||
124542615|NCT01049360|447939778|FG013|Period 1|Withdrawal by Subject|0|||
124542616|NCT01049360|447939779|FG014|Period 1|Withdrawal by Subject|0|||
124542617|NCT01049360|447939780|FG015|Period 1|Withdrawal by Subject|0|||
124542618|NCT01049360|447939781|FG016|Period 1|Withdrawal by Subject|0|||
124542619|NCT01049360|447939782|FG017|Period 1|Withdrawal by Subject|0|||
124542620|NCT01049360|447939783|FG018|Period 1|Withdrawal by Subject|0|||
124542621|NCT01049360|447939784|FG019|Period 1|Withdrawal by Subject|0|||
124542622|NCT01049360|447939765|FG000|Period 2|Protocol Violation|0|||
124542623|NCT01049360|447939766|FG001|Period 2|Protocol Violation|0|||
124542624|NCT01049360|447939767|FG002|Period 2|Protocol Violation|0|||
124542625|NCT01049360|447939768|FG003|Period 2|Protocol Violation|1|||
124542626|NCT01049360|447939769|FG004|Period 2|Protocol Violation|0|||
124542627|NCT01049360|447939770|FG005|Period 2|Protocol Violation|0|||
124542628|NCT01049360|447939771|FG006|Period 2|Protocol Violation|0|||
124542629|NCT01049360|447939772|FG007|Period 2|Protocol Violation|0|||
124542630|NCT01049360|447939773|FG008|Period 2|Protocol Violation|0|||
124542631|NCT01049360|447939774|FG009|Period 2|Protocol Violation|0|||
124542632|NCT01049360|447939775|FG010|Period 2|Protocol Violation|0|||
124542633|NCT01049360|447939776|FG011|Period 2|Protocol Violation|0|||
124542634|NCT01049360|447939777|FG012|Period 2|Protocol Violation|0|||
124542635|NCT01049360|447939778|FG013|Period 2|Protocol Violation|0|||
124542636|NCT01049360|447939779|FG014|Period 2|Protocol Violation|1|||
124542637|NCT01049360|447939780|FG015|Period 2|Protocol Violation|1|||
124542638|NCT01049360|447939781|FG016|Period 2|Protocol Violation|0|||
124542639|NCT01049360|447939782|FG017|Period 2|Protocol Violation|0|||
124542640|NCT01049360|447939783|FG018|Period 2|Protocol Violation|0|||
124542641|NCT01049360|447939784|FG019|Period 2|Protocol Violation|0|||
124542642|NCT01049360|447939765|FG000|Period 2|Adverse Event|0|||
124542643|NCT01049360|447939766|FG001|Period 2|Adverse Event|1|||
124542644|NCT01049360|447939767|FG002|Period 2|Adverse Event|0|||
124542645|NCT01049360|447939768|FG003|Period 2|Adverse Event|0|||
124542646|NCT01049360|447939769|FG004|Period 2|Adverse Event|0|||
124542647|NCT01049360|447939770|FG005|Period 2|Adverse Event|0|||
124542648|NCT01049360|447939771|FG006|Period 2|Adverse Event|0|||
124542649|NCT01049360|447939772|FG007|Period 2|Adverse Event|0|||
124542650|NCT01049360|447939773|FG008|Period 2|Adverse Event|1|||
124542651|NCT01049360|447939774|FG009|Period 2|Adverse Event|0|||
124542652|NCT01049360|447939775|FG010|Period 2|Adverse Event|0|||
124542653|NCT01049360|447939776|FG011|Period 2|Adverse Event|0|||
124542654|NCT01049360|447939777|FG012|Period 2|Adverse Event|0|||
124542655|NCT01049360|447939778|FG013|Period 2|Adverse Event|0|||
124542656|NCT01049360|447939779|FG014|Period 2|Adverse Event|0|||
124542657|NCT01049360|447939780|FG015|Period 2|Adverse Event|0|||
124542658|NCT01049360|447939781|FG016|Period 2|Adverse Event|0|||
124542659|NCT01049360|447939782|FG017|Period 2|Adverse Event|0|||
124542660|NCT01049360|447939783|FG018|Period 2|Adverse Event|0|||
124542661|NCT01049360|447939784|FG019|Period 2|Adverse Event|1|||
124872052|NCT01338025|449152805|FG000|Overall Study|Found ineligible after starting|1|||
124872053|NCT01338025|449152806|FG001|Overall Study|Found ineligible after starting|0|||
124542662|NCT01049360|447939765|FG000|Period 2|Withdrawal by Subject|0|||
124542663|NCT01049360|447939766|FG001|Period 2|Withdrawal by Subject|0|||
124542664|NCT01049360|447939767|FG002|Period 2|Withdrawal by Subject|0|||
124542665|NCT01049360|447939768|FG003|Period 2|Withdrawal by Subject|1|||
124542666|NCT01049360|447939769|FG004|Period 2|Withdrawal by Subject|0|||
124542667|NCT01049360|447939770|FG005|Period 2|Withdrawal by Subject|0|||
124542668|NCT01049360|447939771|FG006|Period 2|Withdrawal by Subject|0|||
124542669|NCT01049360|447939772|FG007|Period 2|Withdrawal by Subject|0|||
124542670|NCT01049360|447939773|FG008|Period 2|Withdrawal by Subject|0|||
124542671|NCT01049360|447939774|FG009|Period 2|Withdrawal by Subject|0|||
124542672|NCT01049360|447939775|FG010|Period 2|Withdrawal by Subject|0|||
124542673|NCT01049360|447939776|FG011|Period 2|Withdrawal by Subject|0|||
124542674|NCT01049360|447939777|FG012|Period 2|Withdrawal by Subject|0|||
124542675|NCT01049360|447939778|FG013|Period 2|Withdrawal by Subject|0|||
124542676|NCT01049360|447939779|FG014|Period 2|Withdrawal by Subject|1|||
124542677|NCT01049360|447939780|FG015|Period 2|Withdrawal by Subject|0|||
124542678|NCT01049360|447939781|FG016|Period 2|Withdrawal by Subject|0|||
124542679|NCT01049360|447939782|FG017|Period 2|Withdrawal by Subject|0|||
124542680|NCT01049360|447939783|FG018|Period 2|Withdrawal by Subject|0|||
124542681|NCT01049360|447939784|FG019|Period 2|Withdrawal by Subject|1|||
124542682|NCT01049360|447939765|FG000|Period 2|Lack of Efficacy|0|||
124542683|NCT01049360|447939766|FG001|Period 2|Lack of Efficacy|0|||
124542684|NCT01049360|447939767|FG002|Period 2|Lack of Efficacy|0|||
124542685|NCT01049360|447939768|FG003|Period 2|Lack of Efficacy|0|||
124542686|NCT01049360|447939769|FG004|Period 2|Lack of Efficacy|0|||
124542687|NCT01049360|447939770|FG005|Period 2|Lack of Efficacy|1|||
124542688|NCT01049360|447939771|FG006|Period 2|Lack of Efficacy|0|||
124542689|NCT01049360|447939772|FG007|Period 2|Lack of Efficacy|0|||
124542690|NCT01049360|447939773|FG008|Period 2|Lack of Efficacy|0|||
124542691|NCT01049360|447939774|FG009|Period 2|Lack of Efficacy|0|||
124542692|NCT01049360|447939775|FG010|Period 2|Lack of Efficacy|0|||
124542693|NCT01049360|447939776|FG011|Period 2|Lack of Efficacy|0|||
124542694|NCT01049360|447939777|FG012|Period 2|Lack of Efficacy|0|||
124542695|NCT01049360|447939778|FG013|Period 2|Lack of Efficacy|0|||
124542696|NCT01049360|447939779|FG014|Period 2|Lack of Efficacy|0|||
124542697|NCT01049360|447939780|FG015|Period 2|Lack of Efficacy|0|||
124542698|NCT01049360|447939781|FG016|Period 2|Lack of Efficacy|0|||
124542699|NCT01049360|447939782|FG017|Period 2|Lack of Efficacy|0|||
124542700|NCT01049360|447939783|FG018|Period 2|Lack of Efficacy|0|||
124542701|NCT01049360|447939784|FG019|Period 2|Lack of Efficacy|0|||
124542702|NCT01049360|447939765|FG000|Period 4|Protocol Violation|0|||
124542703|NCT01049360|447939766|FG001|Period 4|Protocol Violation|0|||
124542704|NCT01049360|447939767|FG002|Period 4|Protocol Violation|0|||
124542705|NCT01049360|447939768|FG003|Period 4|Protocol Violation|0|||
124542706|NCT01049360|447939769|FG004|Period 4|Protocol Violation|0|||
124542707|NCT01049360|447939770|FG005|Period 4|Protocol Violation|0|||
124542708|NCT01049360|447939771|FG006|Period 4|Protocol Violation|0|||
124542709|NCT01049360|447939772|FG007|Period 4|Protocol Violation|0|||
124542710|NCT01049360|447939773|FG008|Period 4|Protocol Violation|0|||
124542711|NCT01049360|447939774|FG009|Period 4|Protocol Violation|0|||
124542712|NCT01049360|447939775|FG010|Period 4|Protocol Violation|0|||
124542713|NCT01049360|447939776|FG011|Period 4|Protocol Violation|0|||
124542714|NCT01049360|447939777|FG012|Period 4|Protocol Violation|0|||
124542715|NCT01049360|447939778|FG013|Period 4|Protocol Violation|0|||
124542716|NCT01049360|447939779|FG014|Period 4|Protocol Violation|0|||
124542717|NCT01049360|447939780|FG015|Period 4|Protocol Violation|0|||
124542718|NCT01049360|447939781|FG016|Period 4|Protocol Violation|0|||
124542719|NCT01049360|447939782|FG017|Period 4|Protocol Violation|1|||
124542720|NCT01049360|447939783|FG018|Period 4|Protocol Violation|0|||
124542721|NCT01049360|447939784|FG019|Period 4|Protocol Violation|0|||
124542722|NCT01049360|447939765|FG000|Period 4|Withdrawal by Subject|0|||
124542723|NCT01049360|447939766|FG001|Period 4|Withdrawal by Subject|0|||
124542724|NCT01049360|447939767|FG002|Period 4|Withdrawal by Subject|0|||
124542725|NCT01049360|447939768|FG003|Period 4|Withdrawal by Subject|1|||
124542726|NCT01049360|447939769|FG004|Period 4|Withdrawal by Subject|0|||
124542727|NCT01049360|447939770|FG005|Period 4|Withdrawal by Subject|0|||
124542728|NCT01049360|447939771|FG006|Period 4|Withdrawal by Subject|0|||
124542729|NCT01049360|447939772|FG007|Period 4|Withdrawal by Subject|0|||
124542730|NCT01049360|447939773|FG008|Period 4|Withdrawal by Subject|0|||
124542731|NCT01049360|447939774|FG009|Period 4|Withdrawal by Subject|0|||
124542732|NCT01049360|447939775|FG010|Period 4|Withdrawal by Subject|0|||
124542733|NCT01049360|447939776|FG011|Period 4|Withdrawal by Subject|0|||
124542734|NCT01049360|447939777|FG012|Period 4|Withdrawal by Subject|0|||
124542735|NCT01049360|447939778|FG013|Period 4|Withdrawal by Subject|0|||
124542736|NCT01049360|447939779|FG014|Period 4|Withdrawal by Subject|0|||
124542737|NCT01049360|447939780|FG015|Period 4|Withdrawal by Subject|0|||
124542738|NCT01049360|447939781|FG016|Period 4|Withdrawal by Subject|0|||
124542739|NCT01049360|447939782|FG017|Period 4|Withdrawal by Subject|0|||
124542740|NCT01049360|447939783|FG018|Period 4|Withdrawal by Subject|0|||
124542741|NCT01049360|447939784|FG019|Period 4|Withdrawal by Subject|0|||
124542742|NCT02058849|447939785|FG000|Overall Study|Hospitalization|1|||
124542743|NCT02058849|447939786|FG001|Overall Study|Hospitalization|1|||
124542744|NCT02058849|447939785|FG000|Overall Study|Death|1|||
124542745|NCT02058849|447939786|FG001|Overall Study|Death|0|||
124542746|NCT02058849|447939785|FG000|Overall Study|Lost to Follow-up|1|||
124542747|NCT02058849|447939786|FG001|Overall Study|Lost to Follow-up|0|||
124542748|NCT02058849|447939785|FG000|Overall Study|Withdrawal by Subject|4|||
124542749|NCT02058849|447939786|FG001|Overall Study|Withdrawal by Subject|0|||
124542750|NCT00686894|447939787|FG000|Overall Study|Relapse|2|||
124542751|NCT00686894|447939787|FG000|Overall Study|Protocol Violation|4|||
124542752|NCT02147132|447941177|FG000|Overall Study|Lost to Follow-up|1|||
124542753|NCT02147132|447941178|FG001|Overall Study|Lost to Follow-up|0|||
124542754|NCT02147132|447941179|FG002|Overall Study|Lost to Follow-up|0|||
124542755|NCT02147132|447941180|FG003|Overall Study|Lost to Follow-up|0|||
124872054|NCT03017079|449152807|FG000|Overall Study|Physician Decision|1|||
124872055|NCT03017079|449152808|FG001|Overall Study|Physician Decision|1|||
124872056|NCT03017079|449152807|FG000|Overall Study|Death|3|||
124872057|NCT03017079|449152808|FG001|Overall Study|Death|2|||
124872058|NCT03017079|449152807|FG000|Overall Study|Lack of Efficacy|2|||
124872059|NCT03017079|449152808|FG001|Overall Study|Lack of Efficacy|2|||
124872060|NCT03017079|449152807|FG000|Overall Study|Protocol Violation|0|||
124872061|NCT03017079|449152808|FG001|Overall Study|Protocol Violation|1|||
124872062|NCT03538951|449152809|FG000|Overall Study|Withdrawal by Subject|1|||
124872063|NCT03538951|449152810|FG001|Overall Study|Withdrawal by Subject|2|||
124872064|NCT04120233|449152815|FG000|Overall Study|Adverse Event|0|||
124872065|NCT04120233|449152816|FG001|Overall Study|Adverse Event|0|||
124872066|NCT04120233|449152817|FG002|Overall Study|Adverse Event|0|||
124872067|NCT04120233|449152818|FG003|Overall Study|Adverse Event|0|||
124872068|NCT04120233|449152819|FG004|Overall Study|Adverse Event|1|||
124872069|NCT04120233|449152820|FG005|Overall Study|Adverse Event|0|||
124872070|NCT03779906|449152822|FG000|Overall Study|Lost to Follow-up|7|||
124872071|NCT03779906|449152822|FG000|Overall Study|COVID pandemic|1|||
124872072|NCT02553460|449152825|FG000|Overall Study|Death|3|||
124872073|NCT02553460|449152825|FG000|Overall Study|Withdrawal by Subject|1|||
124872074|NCT02553460|449152825|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
124872075|NCT02553460|449152825|FG000|Overall Study|Relapse or Transplant|14|||
124872076|NCT02553460|449152825|FG000|Overall Study|No response to treatment|2|||
124872077|NCT02553460|449152825|FG000|Overall Study|CAR T cells|2|||
124872078|NCT04814368|449152826|FG000|Overall Study|Study Terminated by Sponsor|0|||
124758637|NCT01463306|448739820|FG000|Overall Study|Lack of Efficacy|22|||
124981539|NCT03002220|449559682|FG000|Overall Study|Lack of Efficacy|2|||
124981540|NCT03002220|449559682|FG000|Overall Study|Withdrawal by Subject|3|||
124981541|NCT03002220|449559682|FG000|Overall Study|Adverse Event|2|||
124981542|NCT03002220|449559682|FG000|Overall Study|Disease progression|13|||
124981543|NCT03002220|449559682|FG000|Overall Study|Physician Decision|1|||
124981544|NCT01015560|449559683|FG000|Overall Study|Adverse Event|1|||
124981545|NCT01015560|449559683|FG000|Overall Study|Not protocol specified|1|||
124981546|NCT01015560|449559683|FG000|Overall Study|Withdrawal by Subject|1|||
124981547|NCT00640133|449559686|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
124981548|NCT00640133|449559687|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
124981549|NCT00640133|449559686|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
124981550|NCT00640133|449559687|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
124981551|NCT00640133|449559686|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
124981552|NCT00640133|449559687|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
124981553|NCT00128102|449559688|FG000|Overall Study|Site Discontinued|3|||
124981554|NCT00128102|449559689|FG001|Overall Study|Site Discontinued|6|||
124981555|NCT00128102|449559688|FG000|Overall Study|Other|0|||
124981556|NCT00128102|449559689|FG001|Overall Study|Other|1|||
124981557|NCT00128102|449559688|FG000|Overall Study|Progressive Disease|255|||
124981558|NCT00128102|449559689|FG001|Overall Study|Progressive Disease|285|||
124981559|NCT00128102|449559688|FG000|Overall Study|Adverse Event|34|||
124981560|NCT00128102|449559689|FG001|Overall Study|Adverse Event|11|||
124981561|NCT00128102|449559688|FG000|Overall Study|Death|12|||
124981562|NCT00128102|449559689|FG001|Overall Study|Death|13|||
124981563|NCT00128102|449559688|FG000|Overall Study|Physician Decision|3|||
124981564|NCT00128102|449559689|FG001|Overall Study|Physician Decision|3|||
124981565|NCT00128102|449559688|FG000|Overall Study|Withdrawal by Subject|19|||
124981566|NCT00128102|449559689|FG001|Overall Study|Withdrawal by Subject|11|||
124981567|NCT00128102|449559688|FG000|Overall Study|Protocol Violation|2|||
124981568|NCT00128102|449559689|FG001|Overall Study|Protocol Violation|2|||
124981569|NCT01202903|449559691|FG000|Overall Study|Administrative Probelms|1|||
124981570|NCT01202903|449559692|FG001|Overall Study|Administrative Probelms|4|||
124981571|NCT01202903|449559691|FG000|Overall Study|Protocol Violation|0|||
124981572|NCT01202903|449559692|FG001|Overall Study|Protocol Violation|1|||
124981573|NCT01202903|449559691|FG000|Overall Study|Death|1|||
124981574|NCT01202903|449559692|FG001|Overall Study|Death|0|||
124981575|NCT01202903|449559691|FG000|Overall Study|Lost to Follow-up|1|||
124981576|NCT01202903|449559692|FG001|Overall Study|Lost to Follow-up|1|||
124981577|NCT01202903|449559691|FG000|Overall Study|Lack of Efficacy|1|||
124981578|NCT01202903|449559692|FG001|Overall Study|Lack of Efficacy|3|||
124981579|NCT01202903|449559691|FG000|Overall Study|Adverse Event|3|||
124981580|NCT01202903|449559692|FG001|Overall Study|Adverse Event|3|||
124981581|NCT01202903|449559691|FG000|Overall Study|Withdrawal by Subject|4|||
124981582|NCT01202903|449559692|FG001|Overall Study|Withdrawal by Subject|4|||
124981583|NCT01302080|449559693|FG000|Overall Study|Withdrew Consent|92|||
124981584|NCT01302080|449559694|FG001|Overall Study|Withdrew Consent|39|||
124981585|NCT01302080|449559693|FG000|Overall Study|Patient/Family Moved|28|||
124981586|NCT01302080|449559694|FG001|Overall Study|Patient/Family Moved|3|||
124981587|NCT01302080|449559693|FG000|Overall Study|Lost to Follow-up|192|||
124981588|NCT01302080|449559694|FG001|Overall Study|Lost to Follow-up|93|||
124981589|NCT01302080|449559693|FG000|Overall Study|Death|1|||
124981590|NCT01302080|449559694|FG001|Overall Study|Death|0|||
124981591|NCT01302080|449559693|FG000|Overall Study|Other|52|||
124981592|NCT01302080|449559694|FG001|Overall Study|Other|8|||
124981593|NCT01302080|449559693|FG000|Overall Study|Reason Missing For Discontinuation|1|||
124981594|NCT01302080|449559694|FG001|Overall Study|Reason Missing For Discontinuation|0|||
124981595|NCT01076153|449559702|FG000|Overall Study|Symptoms improved/resolved|10|||
124981596|NCT01076153|449559702|FG000|Overall Study|Adverse Event|1|||
124981597|NCT01142232|449559706|FG000|Overall Study|Adverse Event|1|||
124981598|NCT01142232|449559707|FG001|Overall Study|Adverse Event|2|||
124981599|NCT01142232|449559708|FG002|Overall Study|Adverse Event|1|||
124981600|NCT01142232|449559709|FG003|Overall Study|Adverse Event|0|||
124981601|NCT01142232|449559710|FG004|Overall Study|Adverse Event|4|||
124981602|NCT01142232|449559706|FG000|Overall Study|Death|0|||
124981603|NCT01142232|449559707|FG001|Overall Study|Death|0|||
124981604|NCT01142232|449559708|FG002|Overall Study|Death|0|||
124981605|NCT01142232|449559709|FG003|Overall Study|Death|0|||
124981606|NCT01142232|449559710|FG004|Overall Study|Death|1|||
124981607|NCT01142232|449559706|FG000|Overall Study|Disease Progression|2|||
124981608|NCT01142232|449559707|FG001|Overall Study|Disease Progression|0|||
124981609|NCT01142232|449559708|FG002|Overall Study|Disease Progression|1|||
124981610|NCT01142232|449559709|FG003|Overall Study|Disease Progression|2|||
124981611|NCT01142232|449559710|FG004|Overall Study|Disease Progression|12|||
124981612|NCT01142232|449559706|FG000|Overall Study|Withdrawal by Subject|0|||
124981613|NCT01142232|449559707|FG001|Overall Study|Withdrawal by Subject|0|||
124981614|NCT01142232|449559708|FG002|Overall Study|Withdrawal by Subject|0|||
124981615|NCT01142232|449559709|FG003|Overall Study|Withdrawal by Subject|1|||
124981616|NCT01142232|449559710|FG004|Overall Study|Withdrawal by Subject|3|||
124981617|NCT01142232|449559706|FG000|Overall Study|Physician Decision|0|||
124981618|NCT01142232|449559707|FG001|Overall Study|Physician Decision|1|||
124981619|NCT01142232|449559708|FG002|Overall Study|Physician Decision|0|||
124981620|NCT01142232|449559709|FG003|Overall Study|Physician Decision|2|||
124981621|NCT01142232|449559710|FG004|Overall Study|Physician Decision|10|||
124981622|NCT01142232|449559706|FG000|Overall Study|Alternative Therapy|0|||
124981623|NCT01142232|449559707|FG001|Overall Study|Alternative Therapy|1|||
124981624|NCT01142232|449559708|FG002|Overall Study|Alternative Therapy|1|||
124981625|NCT01142232|449559709|FG003|Overall Study|Alternative Therapy|0|||
124981626|NCT01142232|449559710|FG004|Overall Study|Alternative Therapy|1|||
124981627|NCT01142232|449559706|FG000|Overall Study|Off Trt for other complicating disease|0|||
124981628|NCT01142232|449559707|FG001|Overall Study|Off Trt for other complicating disease|0|||
124981629|NCT01142232|449559708|FG002|Overall Study|Off Trt for other complicating disease|0|||
124981630|NCT01142232|449559709|FG003|Overall Study|Off Trt for other complicating disease|0|||
124981631|NCT01142232|449559710|FG004|Overall Study|Off Trt for other complicating disease|1|||
124981632|NCT01142232|449559706|FG000|Overall Study|Noncompliance|0|||
124981633|NCT01142232|449559707|FG001|Overall Study|Noncompliance|0|||
124981634|NCT01142232|449559708|FG002|Overall Study|Noncompliance|0|||
124981635|NCT01142232|449559709|FG003|Overall Study|Noncompliance|0|||
124981636|NCT01142232|449559710|FG004|Overall Study|Noncompliance|2|||
124981637|NCT00574873|449559713|FG000|Overall Study|Withdrawal by Subject|18|||
124981638|NCT00574873|449559714|FG001|Overall Study|Withdrawal by Subject|19|||
124981639|NCT00574873|449559713|FG000|Overall Study|Investigator request|18|||
124981640|NCT00574873|449559714|FG001|Overall Study|Investigator request|8|||
124981641|NCT00574873|449559713|FG000|Overall Study|Death|15|||
124981642|NCT00574873|449559714|FG001|Overall Study|Death|14|||
124981643|NCT00574873|449559713|FG000|Overall Study|Lost to Follow-up|14|||
124981644|NCT00574873|449559714|FG001|Overall Study|Lost to Follow-up|5|||
124542821|NCT02222246|447941196|FG000|Overall Study|No Emergency Department Visits|27|||
124542822|NCT02222246|447941197|FG001|Overall Study|No Emergency Department Visits|26|||
124542823|NCT02222246|447941196|FG000|Overall Study|Physician Decision|0|||
124542824|NCT02222246|447941197|FG001|Overall Study|Physician Decision|1|||
124542825|NCT02064231|447941198|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
124542826|NCT02064231|447941199|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
124542827|NCT02064231|447941200|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
124542828|NCT02064231|447941201|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
124542829|NCT02064231|447941198|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
124542830|NCT02064231|447941199|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
124542831|NCT02064231|447941200|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
124542832|NCT02064231|447941201|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
124542833|NCT02064231|447941198|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
124542834|NCT02064231|447941199|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
124542835|NCT02064231|447941200|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
124542836|NCT02064231|447941201|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
124542837|NCT02064231|447941198|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
124542838|NCT02064231|447941199|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
124542839|NCT02064231|447941200|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
124542840|NCT02064231|447941201|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
124981645|NCT00574873|449559713|FG000|Overall Study|Other|40|||
124981646|NCT00574873|449559714|FG001|Overall Study|Other|4|||
124981647|NCT00574873|449559713|FG000|Overall Study|Discontinuation of study by sponsor|5|||
124981648|NCT00574873|449559714|FG001|Overall Study|Discontinuation of study by sponsor|199|||
124981649|NCT00574873|449559713|FG000|Overall Study|Blank, site closed per local regulations|2|||
124981650|NCT00574873|449559714|FG001|Overall Study|Blank, site closed per local regulations|2|||
124981651|NCT00574873|449559713|FG000|Overall Study|Extension Study|126|||
124981652|NCT00574873|449559714|FG001|Overall Study|Extension Study|0|||
124981653|NCT00201643|449559716|FG000|Overall Study|Withdrawal by Subject|5|||
124981654|NCT00201643|449559717|FG001|Overall Study|Withdrawal by Subject|4|||
124981655|NCT02787044|449559724|FG000|Overall Study|Lost to Follow-up|15|||
124981656|NCT02787044|449559725|FG001|Overall Study|Lost to Follow-up|19|||
124981657|NCT00490490|449559728|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
124981658|NCT00490490|449559728|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
124981659|NCT03207451|449559730|FG000|Overall Study|scheduling conflict|1|||
124981660|NCT03207451|449559731|FG001|Overall Study|scheduling conflict|0|||
124981661|NCT03207451|449559732|FG002|Overall Study|scheduling conflict|2|||
124981662|NCT03207451|449559733|FG003|Overall Study|scheduling conflict|2|||
124981663|NCT03207451|449559730|FG000|Overall Study|Adverse Event|0|||
124981664|NCT03207451|449559731|FG001|Overall Study|Adverse Event|0|||
124981665|NCT03207451|449559732|FG002|Overall Study|Adverse Event|0|||
124981666|NCT03207451|449559733|FG003|Overall Study|Adverse Event|1|||
124981667|NCT02040584|449559734|FG000|Overall Study|Adverse Event|13|||
124981668|NCT02040584|449559735|FG001|Overall Study|Adverse Event|6|||
124981669|NCT02040584|449559734|FG000|Overall Study|Protocol Violation|9|||
124981670|NCT02040584|449559735|FG001|Overall Study|Protocol Violation|11|||
124981671|NCT02040584|449559734|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124981672|NCT02040584|449559735|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124981673|NCT02040584|449559734|FG000|Overall Study|Death|6|||
124981674|NCT02040584|449559735|FG001|Overall Study|Death|3|||
124981675|NCT02040584|449559734|FG000|Overall Study|Transplant rejection/retransplant|0|||
124981676|NCT02040584|449559735|FG001|Overall Study|Transplant rejection/retransplant|1|||
124981677|NCT02040584|449559734|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
124981678|NCT02040584|449559735|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
124981679|NCT05540717|449559736|FG000|Overall Study|Lost to Follow-up|2|||
124981680|NCT05540717|449559737|FG001|Overall Study|Lost to Follow-up|5|||
124981681|NCT05540717|449559736|FG000|Overall Study|Withdrawal by Subject|6|||
124981682|NCT05540717|449559737|FG001|Overall Study|Withdrawal by Subject|6|||
124981683|NCT05540717|449559736|FG000|Overall Study|Sponsor request|1|||
124981684|NCT05540717|449559737|FG001|Overall Study|Sponsor request|0|||
124981685|NCT05540717|449559736|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
124981686|NCT05540717|449559737|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
124542841|NCT04621227|447941202|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
124542842|NCT04621227|447941202|FG000|Period 3 (29 Days)|Adverse Event|1|||
124542843|NCT04621227|447941202|FG000|Period 8 (2 Days)|Adverse Event|1|||
124542844|NCT01548573|447941203|FG000|Overall Study|Death|3|||
124542845|NCT01548573|447941203|FG000|Overall Study|Withdrawal by Subject|2|||
124542846|NCT01366846|447941206|FG000|Overall Study|Withdrawal by Subject|2|||
124542847|NCT01366846|447941207|FG001|Overall Study|Withdrawal by Subject|0|||
124542848|NCT01366846|447941208|FG002|Overall Study|Withdrawal by Subject|0|||
124542849|NCT01366846|447941209|FG003|Overall Study|Withdrawal by Subject|0|||
124542850|NCT01366846|447941206|FG000|Overall Study|Communication Difficulties|1|||
124542851|NCT01366846|447941207|FG001|Overall Study|Communication Difficulties|4|||
124542852|NCT01366846|447941208|FG002|Overall Study|Communication Difficulties|0|||
124542853|NCT01366846|447941209|FG003|Overall Study|Communication Difficulties|1|||
124542854|NCT01366846|447941206|FG000|Overall Study|Scheduling Conflicts|0|||
124542855|NCT01366846|447941207|FG001|Overall Study|Scheduling Conflicts|0|||
124542856|NCT01366846|447941208|FG002|Overall Study|Scheduling Conflicts|1|||
124542857|NCT01366846|447941209|FG003|Overall Study|Scheduling Conflicts|0|||
124542858|NCT00558831|447941210|FG000|Overall Study|Lost to Follow-up|1|||
124542859|NCT01342445|447941211|FG000|Overall Study|Experienced side effects|0|||
124542860|NCT01342445|447941212|FG001|Overall Study|Experienced side effects|2|||
124542861|NCT05299359|447941213|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
124542862|NCT05299359|447941214|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
124542863|NCT05299359|447941213|FG000|Main Part: Day 1 up to Day 366|Other|2|||
124981687|NCT05540717|449559736|FG000|Overall Study|Other|0|||
124981688|NCT05540717|449559737|FG001|Overall Study|Other|1|||
124981689|NCT01940939|449559738|FG000|Overall Study|Withdrawal by Subject|2|||
124981690|NCT01940939|449559739|FG001|Overall Study|Withdrawal by Subject|8|||
124981691|NCT01470001|449559740|FG000|Overall Study|Lost to Follow-up|1|||
124981692|NCT01470001|449559741|FG001|Overall Study|Lost to Follow-up|1|||
124981693|NCT01470001|449559740|FG000|Overall Study|Physician Decision|2|||
124981694|NCT01470001|449559741|FG001|Overall Study|Physician Decision|0|||
124981695|NCT01470001|449559740|FG000|Overall Study|Withdrawal by Subject|2|||
124981696|NCT01470001|449559741|FG001|Overall Study|Withdrawal by Subject|1|||
124981697|NCT02591953|449559744|FG000|Overall Study|Lost to Follow-up|6|||
124542864|NCT05299359|447941214|FG001|Main Part: Day 1 up to Day 366|Other|0|||
124542865|NCT05299359|447941213|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
124542866|NCT05299359|447941214|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
124981698|NCT02591953|449559745|FG001|Overall Study|Lost to Follow-up|6|||
124981699|NCT03167359|449559748|FG000|Overall Study|Physician Decision|1|||
124981700|NCT03167359|449559748|FG000|Overall Study|Lost to Follow-up|1|||
124981701|NCT01896557|449559749|FG000|Clopidogrel Alone|Adverse Event|1|||
124981702|NCT01896557|449559750|FG001|Clopidogrel Alone|Adverse Event|0|||
124981703|NCT01896557|449559749|FG000|Clopidogrel + GI Protector|low adherence|1|||
124981704|NCT01896557|449559750|FG001|Clopidogrel + GI Protector|low adherence|1|||
124981705|NCT01896557|449559749|FG000|Clopidogrel + GI Protector|Reading error|1|||
124981706|NCT01896557|449559750|FG001|Clopidogrel + GI Protector|Reading error|3|||
124981707|NCT01517295|449559751|FG000|Overall Study|Physician Decision|1|||
124981708|NCT01517295|449559752|FG001|Overall Study|Physician Decision|0|||
124981709|NCT02182947|449559753|FG000|Overall Study|Withdrawal by Subject|7|||
124981710|NCT02182947|449559753|FG000|Overall Study|Lost to Follow-up|3|||
124981711|NCT02182947|449559753|FG000|Overall Study|Failed screening activities|8|||
124981712|NCT02236988|449559756|FG000|Overall Study|Lost to Follow-up|0|||
124981713|NCT02236988|449559757|FG001|Overall Study|Lost to Follow-up|0|||
124981714|NCT02236988|449559758|FG002|Overall Study|Lost to Follow-up|0|||
124981715|NCT02236988|449559759|FG003|Overall Study|Lost to Follow-up|1|||
124981716|NCT02236988|449559756|FG000|Overall Study|Unable to Comply with Study Visits|0|||
124981717|NCT02236988|449559757|FG001|Overall Study|Unable to Comply with Study Visits|0|||
124981718|NCT02236988|449559758|FG002|Overall Study|Unable to Comply with Study Visits|0|||
124981719|NCT02236988|449559759|FG003|Overall Study|Unable to Comply with Study Visits|2|||
124981720|NCT00730275|449559760|FG000|Overall Study|Withdrawal by Subject|0|||
124981721|NCT00730275|449559761|FG001|Overall Study|Withdrawal by Subject|0|||
124981722|NCT00730275|449559762|FG002|Overall Study|Withdrawal by Subject|0|||
124981723|NCT00730275|449559763|FG003|Overall Study|Withdrawal by Subject|1|||
124981724|NCT04032613|449559764|FG000|Overall Study|Did not complete post-program assessment|5|||
124981725|NCT04032613|449559765|FG001|Overall Study|Did not complete post-program assessment|2|||
124981726|NCT03053518|449559770|FG000|Overall Study|Withdrawal by Subject|3|||
124981727|NCT03053518|449559770|FG000|Overall Study|Lost to Follow-up|2|||
124981728|NCT03053518|449559770|FG000|Overall Study|Ineligible|5|||
124981729|NCT02071290|449559771|FG000|Overall Study|Death|1|||
124981730|NCT02071290|449559772|FG001|Overall Study|Death|0|||
124981731|NCT02071290|449559771|FG000|Overall Study|Withdrawal by Subject|0|||
124981732|NCT02071290|449559772|FG001|Overall Study|Withdrawal by Subject|1|||
124981733|NCT02071290|449559771|FG000|Overall Study|Protocol Violation|3|||
124981734|NCT02071290|449559772|FG001|Overall Study|Protocol Violation|5|||
124981735|NCT02071290|449559771|FG000|Overall Study|Physician Decision|0|||
124981736|NCT02071290|449559772|FG001|Overall Study|Physician Decision|1|||
124981737|NCT04488770|449559775|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981738|NCT04488770|449559776|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981739|NCT04488770|449559777|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981740|NCT04488770|449559778|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
124981741|NCT04488770|449559779|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981742|NCT04488770|449559780|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981743|NCT04488770|449559781|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981744|NCT04488770|449559782|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981745|NCT04488770|449559783|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981746|NCT04488770|449559784|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981747|NCT04488770|449559785|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981748|NCT04488770|449559786|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981749|NCT04488770|449559787|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
124981750|NCT04488770|449559775|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
124981751|NCT04488770|449559776|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981752|NCT04488770|449559777|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981753|NCT04488770|449559778|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981754|NCT04488770|449559779|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981755|NCT04488770|449559780|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981756|NCT04488770|449559781|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981757|NCT04488770|449559782|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981758|NCT04488770|449559783|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981759|NCT04488770|449559784|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981760|NCT04488770|449559785|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981761|NCT04488770|449559786|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981762|NCT04488770|449559787|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
124981763|NCT04488770|449559775|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981764|NCT04488770|449559776|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981765|NCT04488770|449559777|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981766|NCT04488770|449559778|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981767|NCT04488770|449559779|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981768|NCT04488770|449559780|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
124981769|NCT04488770|449559781|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
124981770|NCT04488770|449559782|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981771|NCT04488770|449559783|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981772|NCT04488770|449559784|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981773|NCT04488770|449559785|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981774|NCT04488770|449559786|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981775|NCT04488770|449559787|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124981776|NCT04488770|449559775|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981777|NCT04488770|449559776|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981778|NCT04488770|449559777|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981779|NCT04488770|449559778|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981780|NCT04488770|449559779|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
124981781|NCT04488770|449559780|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981782|NCT04488770|449559781|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981783|NCT04488770|449559782|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981784|NCT04488770|449559783|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981785|NCT04488770|449559784|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981786|NCT04488770|449559785|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981787|NCT04488770|449559786|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981788|NCT04488770|449559787|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
124981789|NCT02075073|449559788|FG000|Overall Study|Withdrawal by Subject|0|||
124981790|NCT02075073|449559789|FG001|Overall Study|Withdrawal by Subject|1|||
124981791|NCT02075073|449559790|FG002|Overall Study|Withdrawal by Subject|0|||
124981792|NCT03361605|449559798|FG000|Overall Study|Analyzable data not available|3|||
124981793|NCT02770612|449559799|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
124981794|NCT00958841|449559802|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124981795|NCT00958841|449559802|FG000|Overall Study|Abnormal test procedure result(s)|3|||
124981796|NCT00958841|449559802|FG000|Overall Study|Administrative problems|1|||
124981797|NCT00958841|449559802|FG000|Overall Study|Adverse Event|8|||
124981798|NCT00958841|449559802|FG000|Overall Study|New cancer therapy|5|||
124981799|NCT00958841|449559802|FG000|Overall Study|Withdrawal by Subject|1|||
124981800|NCT00958841|449559802|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
124981801|NCT00958841|449559802|FG000|Overall Study|Completed M6/did not enter extension|27|||
124981802|NCT00958841|449559802|FG000|Overall Study|Discontinued prior to M*|28|||
124981803|NCT03014011|449559804|FG000|First Intervention|Withdrawal by Subject|1|||
124981804|NCT03014011|449559805|FG001|First Intervention|Withdrawal by Subject|0|||
124981805|NCT03014011|449559804|FG000|Washout|Withdrawal by Subject|1|||
124981806|NCT03014011|449559805|FG001|Washout|Withdrawal by Subject|0|||
124981807|NCT02416453|449559806|FG000|Overall Study|Adverse Event|0|||
124981808|NCT02416453|449559807|FG001|Overall Study|Adverse Event|0|||
124981809|NCT02416453|449559808|FG002|Overall Study|Adverse Event|0|||
124981810|NCT02416453|449559809|FG003|Overall Study|Adverse Event|2|||
124981811|NCT02416453|449559810|FG004|Overall Study|Adverse Event|0|||
124981812|NCT02416453|449559811|FG005|Overall Study|Adverse Event|1|||
124981813|NCT02416453|449559812|FG006|Overall Study|Adverse Event|0|||
124981814|NCT02416453|449559813|FG007|Overall Study|Adverse Event|0|||
124981815|NCT02416453|449559814|FG008|Overall Study|Adverse Event|0|||
124981816|NCT02416453|449559815|FG009|Overall Study|Adverse Event|0|||
124981817|NCT02416453|449559816|FG010|Overall Study|Adverse Event|0|||
124981818|NCT02416453|449559806|FG000|Overall Study|Lost to Follow-up|1|||
124981819|NCT02416453|449559807|FG001|Overall Study|Lost to Follow-up|3|||
124981820|NCT02416453|449559808|FG002|Overall Study|Lost to Follow-up|0|||
124981821|NCT02416453|449559809|FG003|Overall Study|Lost to Follow-up|8|||
124981822|NCT02416453|449559810|FG004|Overall Study|Lost to Follow-up|0|||
124981823|NCT02416453|449559811|FG005|Overall Study|Lost to Follow-up|5|||
124981824|NCT02416453|449559812|FG006|Overall Study|Lost to Follow-up|1|||
124981825|NCT02416453|449559813|FG007|Overall Study|Lost to Follow-up|3|||
124981826|NCT02416453|449559814|FG008|Overall Study|Lost to Follow-up|1|||
124981827|NCT02416453|449559815|FG009|Overall Study|Lost to Follow-up|0|||
124981828|NCT02416453|449559816|FG010|Overall Study|Lost to Follow-up|0|||
124981829|NCT02416453|449559806|FG000|Overall Study|Physician Decision|0|||
124981830|NCT02416453|449559807|FG001|Overall Study|Physician Decision|0|||
124981831|NCT02416453|449559808|FG002|Overall Study|Physician Decision|0|||
124981832|NCT02416453|449559809|FG003|Overall Study|Physician Decision|0|||
124981833|NCT02416453|449559810|FG004|Overall Study|Physician Decision|0|||
124981834|NCT02416453|449559811|FG005|Overall Study|Physician Decision|1|||
124981835|NCT02416453|449559812|FG006|Overall Study|Physician Decision|1|||
124542867|NCT05299359|447941213|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
124542868|NCT05299359|447941214|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
124542869|NCT05299359|447941213|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
124981836|NCT02416453|449559813|FG007|Overall Study|Physician Decision|1|||
124981837|NCT02416453|449559814|FG008|Overall Study|Physician Decision|0|||
124981838|NCT02416453|449559815|FG009|Overall Study|Physician Decision|0|||
124981839|NCT02416453|449559816|FG010|Overall Study|Physician Decision|0|||
124981840|NCT02416453|449559806|FG000|Overall Study|Withdrawal by Subject|2|||
124981841|NCT02416453|449559807|FG001|Overall Study|Withdrawal by Subject|0|||
124981842|NCT02416453|449559808|FG002|Overall Study|Withdrawal by Subject|0|||
124981843|NCT02416453|449559809|FG003|Overall Study|Withdrawal by Subject|5|||
124981844|NCT02416453|449559810|FG004|Overall Study|Withdrawal by Subject|1|||
124981845|NCT02416453|449559811|FG005|Overall Study|Withdrawal by Subject|8|||
124981846|NCT02416453|449559812|FG006|Overall Study|Withdrawal by Subject|0|||
124981847|NCT02416453|449559813|FG007|Overall Study|Withdrawal by Subject|8|||
124981848|NCT02416453|449559814|FG008|Overall Study|Withdrawal by Subject|4|||
124981849|NCT02416453|449559815|FG009|Overall Study|Withdrawal by Subject|0|||
124981850|NCT02416453|449559816|FG010|Overall Study|Withdrawal by Subject|0|||
124981851|NCT02416453|449559806|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981852|NCT02416453|449559807|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981853|NCT02416453|449559808|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
124981854|NCT02416453|449559809|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981855|NCT02416453|449559810|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981856|NCT02416453|449559811|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981857|NCT02416453|449559812|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981858|NCT02416453|449559813|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981859|NCT02416453|449559814|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981860|NCT02416453|449559815|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981861|NCT02416453|449559816|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
124981862|NCT02416453|449559806|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981863|NCT02416453|449559807|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981864|NCT02416453|449559808|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981865|NCT02416453|449559809|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981866|NCT02416453|449559810|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981867|NCT02416453|449559811|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
124981868|NCT02416453|449559812|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981869|NCT02416453|449559813|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981870|NCT02416453|449559814|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981871|NCT02416453|449559815|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981872|NCT02416453|449559816|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
124981873|NCT00831129|449559824|FG000|Overall Study|Adverse Event|0|||
124981874|NCT00831129|449559825|FG001|Overall Study|Adverse Event|1|||
124981875|NCT00831129|449559824|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
124981876|NCT00831129|449559825|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
124981877|NCT01877239|449559826|FG000|Overall Study|Adverse Event|4|||
124981878|NCT01877239|449559826|FG000|Overall Study|Disease Remission|1|||
124981879|NCT01877239|449559826|FG000|Overall Study|Withdrawal by Subject|4|||
124981880|NCT01877239|449559826|FG000|Overall Study|Other|2|||
124981881|NCT01877239|449559826|FG000|Overall Study|Lack of Efficacy|4|||
124981882|NCT01877239|449559826|FG000|Overall Study|Data not available|35|||
124981883|NCT00743431|449559830|FG000|Overall Study|Toxicity|6|||
124981884|NCT00743431|449559830|FG000|Overall Study|Tumor progression|56|||
124981885|NCT00743431|449559830|FG000|Overall Study|Withdrawal by Subject|13|||
124981886|NCT00743431|449559830|FG000|Overall Study|Death|9|||
124981887|NCT00743431|449559830|FG000|Overall Study|Reason for discontinuation not specified|29|||
124981888|NCT00743431|449559830|FG000|Overall Study|No documentation available|13|||
124981889|NCT03291288|449559831|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
124981890|NCT03291288|449559832|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
124981891|NCT03291288|449559831|FG000|Drug-drug Interaction Phase|Disease progression|1|||
124981892|NCT03291288|449559832|FG001|Drug-drug Interaction Phase|Disease progression|0|||
124981893|NCT03291288|449559831|FG000|Drug-drug Interaction Phase|Other|3|||
124981894|NCT03291288|449559832|FG001|Drug-drug Interaction Phase|Other|0|||
124542870|NCT05299359|447941214|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
124542871|NCT05299359|447941213|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
124981895|NCT03291288|449559831|FG000|Pexidartinib Only|Ongoing|0|||
124981896|NCT03291288|449559832|FG001|Pexidartinib Only|Ongoing|2|||
124542872|NCT05299359|447941214|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
124981897|NCT04276415|449559833|FG000|Overall Study|Adverse Event|0|||
124981898|NCT04276415|449559834|FG001|Overall Study|Adverse Event|0|||
124542873|NCT05299359|447941213|FG000|Extension Part: Day 1 to Day 366|Other|0|||
124542874|NCT05299359|447941214|FG001|Extension Part: Day 1 to Day 366|Other|1|||
124542875|NCT02392078|447941215|FG000|Overall Study|Did not have procedure|32|||
124981899|NCT04276415|449559835|FG002|Overall Study|Adverse Event|0|||
124981900|NCT04276415|449559836|FG003|Overall Study|Adverse Event|3|||
124981901|NCT04276415|449559837|FG004|Overall Study|Adverse Event|0|||
124981902|NCT04276415|449559838|FG005|Overall Study|Adverse Event|0|||
124542876|NCT02392078|447941216|FG001|Overall Study|Did not have procedure|43|||
124981903|NCT04276415|449559833|FG000|Overall Study|Clinical progression|1|||
124981904|NCT04276415|449559834|FG001|Overall Study|Clinical progression|1|||
124542877|NCT02392078|447941217|FG002|Overall Study|Did not have procedure|20|||
124542878|NCT02392078|447941218|FG003|Overall Study|Did not have procedure|1|||
124542879|NCT02652793|447941221|FG000|Overall Study|Adverse Event|1|||
124542880|NCT02652793|447941221|FG000|Overall Study|Lost to Follow-up|2|||
124542881|NCT02652793|447941221|FG000|Overall Study|Withdrawal by Subject|1|||
124542882|NCT02957149|447941222|FG000|Overall Study|Withdrawal by Subject|5|||
124542883|NCT04579666|447941223|FG000|RTP (Up to Week 52)|Adverse Event|4|||
124542884|NCT04579666|447941224|FG001|RTP (Up to Week 52)|Adverse Event|3|||
124542885|NCT04579666|447941225|FG002|RTP (Up to Week 52)|Adverse Event|0|||
124542886|NCT04579666|447941226|FG003|RTP (Up to Week 52)|Adverse Event|0|||
124542887|NCT04579666|447941223|FG000|RTP (Up to Week 52)|Death|24|||
124542888|NCT04579666|447941224|FG001|RTP (Up to Week 52)|Death|9|||
124542889|NCT04579666|447941225|FG002|RTP (Up to Week 52)|Death|0|||
124542890|NCT04579666|447941226|FG003|RTP (Up to Week 52)|Death|0|||
124542891|NCT04579666|447941223|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
124542892|NCT04579666|447941224|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
124542893|NCT04579666|447941225|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
124542894|NCT04579666|447941226|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
124542895|NCT04579666|447941223|FG000|RTP (Up to Week 52)|Physician Decision|4|||
124542896|NCT04579666|447941224|FG001|RTP (Up to Week 52)|Physician Decision|1|||
124542897|NCT04579666|447941225|FG002|RTP (Up to Week 52)|Physician Decision|0|||
124542898|NCT04579666|447941226|FG003|RTP (Up to Week 52)|Physician Decision|0|||
124542899|NCT04579666|447941223|FG000|RTP (Up to Week 52)|Progressive disease|1|||
124542900|NCT04579666|447941224|FG001|RTP (Up to Week 52)|Progressive disease|0|||
124542901|NCT04579666|447941225|FG002|RTP (Up to Week 52)|Progressive disease|0|||
124542902|NCT04579666|447941226|FG003|RTP (Up to Week 52)|Progressive disease|0|||
124542903|NCT04579666|447941223|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
124542904|NCT04579666|447941224|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
124542905|NCT04579666|447941225|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
124542906|NCT04579666|447941226|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
124542907|NCT04579666|447941223|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
124542908|NCT04579666|447941224|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
124542909|NCT04579666|447941225|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
124542910|NCT04579666|447941226|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
124542911|NCT04579666|447941223|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
124542912|NCT04579666|447941224|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
124542913|NCT04579666|447941225|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
124542914|NCT04579666|447941226|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
124542915|NCT04579666|447941223|FG000|RTP (Up to Week 52)|Other|2|||
124542916|NCT04579666|447941224|FG001|RTP (Up to Week 52)|Other|0|||
124542917|NCT04579666|447941225|FG002|RTP (Up to Week 52)|Other|0|||
124542918|NCT04579666|447941226|FG003|RTP (Up to Week 52)|Other|0|||
124542919|NCT04579666|447941223|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
124542920|NCT04579666|447941224|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
124872079|NCT04814368|449152827|FG001|Overall Study|Study Terminated by Sponsor|3|||
124872080|NCT04814368|449152828|FG002|Overall Study|Study Terminated by Sponsor|0|||
124542921|NCT04579666|447941225|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
124542922|NCT04579666|447941226|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
124542923|NCT04579666|447941223|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
124542924|NCT04579666|447941224|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
124542925|NCT04579666|447941225|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
124542926|NCT04579666|447941226|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
124542927|NCT04579666|447941223|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
124542928|NCT04579666|447941224|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
124542929|NCT04579666|447941225|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
124542930|NCT04579666|447941226|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
124542931|NCT04579666|447941223|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
124542932|NCT04579666|447941224|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
124542933|NCT04579666|447941225|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
124542934|NCT04579666|447941226|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
124542935|NCT04579666|447941223|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
124542936|NCT04579666|447941224|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
124542937|NCT04579666|447941225|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
124542938|NCT04579666|447941226|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
124542939|NCT05450198|447941227|FG000|Overall Study|Withdrawal by Subject|1|||
124542940|NCT05450198|447941228|FG001|Overall Study|Withdrawal by Subject|1|||
124542941|NCT05450198|447941229|FG002|Overall Study|Withdrawal by Subject|2|||
124542942|NCT05450198|447941230|FG003|Overall Study|Withdrawal by Subject|0|||
124542943|NCT05450198|447941227|FG000|Overall Study|Lost to Follow-up|1|||
124542944|NCT05450198|447941228|FG001|Overall Study|Lost to Follow-up|0|||
124872081|NCT04814368|449152829|FG003|Overall Study|Study Terminated by Sponsor|2|||
124542945|NCT05450198|447941229|FG002|Overall Study|Lost to Follow-up|2|||
124542946|NCT05450198|447941230|FG003|Overall Study|Lost to Follow-up|1|||
124542947|NCT04359758|447941234|FG000|Overall Study|Protocol Violation|3|||
124542948|NCT04359758|447941235|FG001|Overall Study|Protocol Violation|2|||
124542949|NCT01748162|447941236|FG000|Overall Study|no additional croup episodes to evaluate|2|||
124542950|NCT01748162|447941237|FG001|Overall Study|no additional croup episodes to evaluate|2|||
124542951|NCT01748162|447941236|FG000|Overall Study|participant consented but did not begin|0|||
124542952|NCT01748162|447941237|FG001|Overall Study|participant consented but did not begin|1|||
124542953|NCT01748162|447941236|FG000|Overall Study|reasons not available|3|||
124542954|NCT01748162|447941237|FG001|Overall Study|reasons not available|2|||
124542955|NCT00505765|447941238|FG000|Overall Study|Withdrawal by Subject|1|||
124542956|NCT00505765|447941239|FG001|Overall Study|Withdrawal by Subject|0|||
124542957|NCT00505765|447941240|FG002|Overall Study|Withdrawal by Subject|0|||
124542958|NCT00505765|447941238|FG000|Overall Study|Adverse Event|1|||
124542959|NCT00505765|447941239|FG001|Overall Study|Adverse Event|2|||
124542960|NCT00505765|447941240|FG002|Overall Study|Adverse Event|0|||
124542961|NCT00505765|447941238|FG000|Overall Study|Noncompliance|0|||
124542962|NCT00505765|447941239|FG001|Overall Study|Noncompliance|1|||
124542963|NCT00505765|447941240|FG002|Overall Study|Noncompliance|3|||
124542964|NCT02743117|447941241|FG000|Overall Study|Lost to Follow-up|0|||
124542965|NCT02743117|447941242|FG001|Overall Study|Lost to Follow-up|1|||
124542966|NCT02743117|447941241|FG000|Overall Study|Other|1|||
124542967|NCT02743117|447941242|FG001|Overall Study|Other|0|||
124542968|NCT03532048|447941244|FG000|Overall Study|Lost to Follow-up|12|||
124542969|NCT03532048|447941245|FG001|Overall Study|Lost to Follow-up|17|||
124542970|NCT03532048|447941244|FG000|Overall Study|Withdrawal by Subject|7|||
124542971|NCT03532048|447941245|FG001|Overall Study|Withdrawal by Subject|0|||
124542972|NCT01901393|447941248|FG000|Overall Study|Adverse Event|1|||
124542973|NCT01901393|447941249|FG001|Overall Study|Adverse Event|0|||
124542974|NCT04585906|447941250|FG000|Overall Study|Lost to Follow-up|8|||
124542975|NCT04585906|447941251|FG001|Overall Study|Lost to Follow-up|5|||
124542976|NCT01694849|447941252|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
124542977|NCT01694849|447941253|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
124542978|NCT01694849|447941254|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
124542979|NCT01694849|447941252|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
124542980|NCT01694849|447941253|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
124542981|NCT01694849|447941254|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
124542982|NCT01694849|447941252|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
124542983|NCT01694849|447941253|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
124542984|NCT01694849|447941254|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
124542985|NCT01694849|447941252|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
124542986|NCT01694849|447941253|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
124542987|NCT01694849|447941254|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
124542988|NCT01694849|447941252|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
124542989|NCT01694849|447941253|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
124542990|NCT01694849|447941254|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
124542991|NCT01694849|447941252|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
124542992|NCT01694849|447941253|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
124542993|NCT01694849|447941254|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
124542994|NCT01694849|447941252|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
124542995|NCT01694849|447941253|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
124542996|NCT01694849|447941254|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
124542997|NCT01694849|447941252|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
124542998|NCT01694849|447941253|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
124542999|NCT01694849|447941254|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
124543000|NCT00596466|447941257|FG000|Overall Study|Lack of Efficacy|5|||
124543001|NCT00596466|447941257|FG000|Overall Study|Adverse Event|4|||
124543002|NCT00596466|447941257|FG000|Overall Study|Withdrawal by Subject|2|||
124543003|NCT00596466|447941257|FG000|Overall Study|Protocol Violation|2|||
124543004|NCT00596466|447941257|FG000|Overall Study|Unpecified|2|||
124543005|NCT00596466|447941257|FG000|Overall Study|Enrolled, not treated|2|||
124543006|NCT00908375|447941258|FG000|Overall Study|Withdrawal by Subject|2|||
124543007|NCT00908375|447941259|FG001|Overall Study|Withdrawal by Subject|4|||
124543008|NCT00908375|447941258|FG000|Overall Study|Lost to Follow-up|8|||
124543009|NCT00908375|447941259|FG001|Overall Study|Lost to Follow-up|6|||
124543010|NCT00752206|447941260|FG000|Overall Study|Disease progression|8|||
124543011|NCT00752206|447941261|FG001|Overall Study|Disease progression|11|||
124543012|NCT00752206|447941260|FG000|Overall Study|Pregnancy|1|||
124543013|NCT00752206|447941261|FG001|Overall Study|Pregnancy|0|||
124543014|NCT00678652|447941262|FG000|Overall Study|Protocol Violation|2|||
124543015|NCT00678652|447941263|FG001|Overall Study|Protocol Violation|0|||
124543016|NCT00678652|447941264|FG002|Overall Study|Protocol Violation|0|||
124543017|NCT00678652|447941265|FG003|Overall Study|Protocol Violation|0|||
124872082|NCT04814368|449152826|FG000|Overall Study|Subject Decision|1|||
124543018|NCT00678652|447941262|FG000|Overall Study|Pregnancy|0|||
124543019|NCT00678652|447941263|FG001|Overall Study|Pregnancy|0|||
124543020|NCT00678652|447941264|FG002|Overall Study|Pregnancy|1|||
124543021|NCT00678652|447941265|FG003|Overall Study|Pregnancy|0|||
124981905|NCT04276415|449559835|FG002|Overall Study|Clinical progression|0|||
124981906|NCT04276415|449559836|FG003|Overall Study|Clinical progression|0|||
124981907|NCT04276415|449559837|FG004|Overall Study|Clinical progression|1|||
124981908|NCT04276415|449559838|FG005|Overall Study|Clinical progression|0|||
124981909|NCT04276415|449559833|FG000|Overall Study|Other|0|||
124981910|NCT04276415|449559834|FG001|Overall Study|Other|0|||
124543022|NCT00678652|447941262|FG000|Overall Study|Relocation|1|||
124543023|NCT00678652|447941263|FG001|Overall Study|Relocation|0|||
124543024|NCT00678652|447941264|FG002|Overall Study|Relocation|0|||
124543025|NCT00678652|447941265|FG003|Overall Study|Relocation|0|||
124543026|NCT05770401|447941268|FG000|Overall Study|Lost to Follow-up|5|||
124543027|NCT05770401|447941269|FG001|Overall Study|Lost to Follow-up|4|||
124543028|NCT00402298|447941270|FG000|Overall Study|Withdrawal by Subject|1|||
124543029|NCT00402298|447941271|FG001|Overall Study|Withdrawal by Subject|0|||
124543030|NCT00480077|447941272|FG000|Overall Study|Death|19|||
124543031|NCT00480077|447941273|FG001|Overall Study|Death|15|||
124543032|NCT00480077|447941272|FG000|Overall Study|early exit|12|||
124543033|NCT00480077|447941273|FG001|Overall Study|early exit|11|||
124543034|NCT04784455|447941274|FG000|Overall Study|Death|4|||
124543035|NCT04298229|447941279|FG000|Overall Study|Physician Decision|1|||
124543036|NCT04298229|447941280|FG001|Overall Study|Physician Decision|1|||
124543037|NCT04298229|447941279|FG000|Overall Study|Withdrawal by Subject|1|||
124543038|NCT04298229|447941280|FG001|Overall Study|Withdrawal by Subject|1|||
124543039|NCT04298229|447941279|FG000|Overall Study|Did not receive IV loop diuretics|2|||
124543040|NCT04298229|447941280|FG001|Overall Study|Did not receive IV loop diuretics|0|||
124543041|NCT00262119|447941282|FG000|Overall Study|Lost to Follow-up|38|||
124543042|NCT00262119|447941283|FG001|Overall Study|Lost to Follow-up|51|||
124543043|NCT00262119|447941284|FG002|Overall Study|Lost to Follow-up|42|||
124543044|NCT00262119|447941282|FG000|Overall Study|Death|20|||
124543045|NCT00262119|447941283|FG001|Overall Study|Death|19|||
124543046|NCT00262119|447941284|FG002|Overall Study|Death|16|||
124543047|NCT01683565|447941285|FG000|Overall Study|Lost to Follow-up|2|||
124543048|NCT01683565|447941286|FG001|Overall Study|Lost to Follow-up|0|||
124543049|NCT01683565|447941285|FG000|Overall Study|Discontinued Intervention|1|||
124543050|NCT01683565|447941286|FG001|Overall Study|Discontinued Intervention|1|||
124543051|NCT00071006|447941287|FG000|Overall Study|Lack of Efficacy|7|||
124543052|NCT00071006|447941287|FG000|Overall Study|Adverse Event|1|||
124543053|NCT00071006|447941287|FG000|Overall Study|Withdrawal by Subject|1|||
124543054|NCT00071006|447941287|FG000|Overall Study|Other|3|||
124543055|NCT00859313|447941288|FG000|Overall Study|Lack of Efficacy|2|||
124543056|NCT00859313|447941288|FG000|Overall Study|Adverse Event|1|||
124543057|NCT00859313|447941288|FG000|Overall Study|staff error|1|||
124543058|NCT05261126|447941289|FG000|Overall Study|Death|0|||
124543059|NCT05261126|447941290|FG001|Overall Study|Death|0|||
124543060|NCT05261126|447941291|FG002|Overall Study|Death|1|||
124543061|NCT05261126|447941292|FG003|Overall Study|Death|0|||
124543062|NCT05261126|447941293|FG004|Overall Study|Death|0|||
124543063|NCT05261126|447941289|FG000|Overall Study|Lost to Follow-up|0|||
124543064|NCT05261126|447941290|FG001|Overall Study|Lost to Follow-up|0|||
124543065|NCT05261126|447941291|FG002|Overall Study|Lost to Follow-up|0|||
124543066|NCT05261126|447941292|FG003|Overall Study|Lost to Follow-up|0|||
124543067|NCT05261126|447941293|FG004|Overall Study|Lost to Follow-up|1|||
124543068|NCT05261126|447941289|FG000|Overall Study|Physician Decision|1|||
124543069|NCT05261126|447941290|FG001|Overall Study|Physician Decision|0|||
124543070|NCT05261126|447941291|FG002|Overall Study|Physician Decision|0|||
124543071|NCT05261126|447941292|FG003|Overall Study|Physician Decision|0|||
124543072|NCT05261126|447941293|FG004|Overall Study|Physician Decision|0|||
124543073|NCT05261126|447941289|FG000|Overall Study|Screen Failure|0|||
124543074|NCT05261126|447941290|FG001|Overall Study|Screen Failure|0|||
124543075|NCT05261126|447941291|FG002|Overall Study|Screen Failure|0|||
124543076|NCT05261126|447941292|FG003|Overall Study|Screen Failure|0|||
124543077|NCT05261126|447941293|FG004|Overall Study|Screen Failure|1|||
124543078|NCT05261126|447941289|FG000|Overall Study|Withdrawal by Subject|1|||
124543079|NCT05261126|447941290|FG001|Overall Study|Withdrawal by Subject|0|||
124543080|NCT05261126|447941291|FG002|Overall Study|Withdrawal by Subject|1|||
124543081|NCT05261126|447941292|FG003|Overall Study|Withdrawal by Subject|1|||
124543082|NCT05261126|447941293|FG004|Overall Study|Withdrawal by Subject|0|||
124543083|NCT05261126|447941289|FG000|Overall Study|Not Recorded|0|||
124981911|NCT04276415|449559835|FG002|Overall Study|Other|0|||
124543084|NCT05261126|447941290|FG001|Overall Study|Not Recorded|0|||
124543085|NCT05261126|447941291|FG002|Overall Study|Not Recorded|0|||
124543086|NCT05261126|447941292|FG003|Overall Study|Not Recorded|1|||
124543087|NCT05261126|447941293|FG004|Overall Study|Not Recorded|0|||
124543088|NCT03901274|447941294|FG000|Overall Study|Lost to Follow-up|120|||
124543089|NCT03901274|447941295|FG001|Overall Study|Lost to Follow-up|124|||
124543090|NCT03901274|447941294|FG000|Overall Study|Withdrawal by Subject|0|||
124981912|NCT04276415|449559836|FG003|Overall Study|Other|1|||
124543091|NCT03901274|447941295|FG001|Overall Study|Withdrawal by Subject|6|||
124543092|NCT05570604|447941296|FG000|Overall Study|Lost to Follow-up|1|||
124543093|NCT05570604|447941297|FG001|Overall Study|Lost to Follow-up|5|||
124543094|NCT05570604|447941296|FG000|Overall Study|Illness|2|||
124543095|NCT05570604|447941297|FG001|Overall Study|Illness|2|||
124543096|NCT00145119|447941300|FG000|Overall Study|Death|45|||
124543097|NCT04527380|447941301|FG000|Overall Study|Lack of Efficacy|0|||
124543098|NCT04527380|447941302|FG001|Overall Study|Lack of Efficacy|1|||
124543099|NCT04527380|447941301|FG000|Overall Study|Withdrawal by Subject|1|||
124543100|NCT04527380|447941302|FG001|Overall Study|Withdrawal by Subject|0|||
124543101|NCT05437211|447941309|FG000|Overall Study|Patient's decision|1|||
124543102|NCT05437211|447941310|FG001|Overall Study|Patient's decision|1|||
124543103|NCT00931515|447941320|FG000|Overall Study|Lost to Follow-up|2|||
124543104|NCT00931515|447941321|FG001|Overall Study|Lost to Follow-up|5|||
124543105|NCT02950831|447941322|FG000|Overall Study|Lost to Follow-up|1|||
124543106|NCT02950831|447941322|FG000|Overall Study|Withdrawal by Subject|3|||
124543107|NCT02950831|447941322|FG000|Overall Study|stimulation trail failure|5|||
124543108|NCT01875731|447941328|FG000|Overall Study|Fail to obtain lab sample|1|||
124543109|NCT01875731|447941329|FG001|Overall Study|Fail to obtain lab sample|0|||
124543110|NCT01013207|447943216|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
124543111|NCT04196023|447943223|FG000|Overall Study|Withdrawal by Subject|0|||
124543112|NCT04196023|447943224|FG001|Overall Study|Withdrawal by Subject|1|||
124543113|NCT04196023|447943223|FG000|Overall Study|Adverse Event|3|||
124543114|NCT04196023|447943224|FG001|Overall Study|Adverse Event|1|||
124543115|NCT04196023|447943223|FG000|Overall Study|Lost to Follow-up|0|||
124543116|NCT04196023|447943224|FG001|Overall Study|Lost to Follow-up|1|||
124543117|NCT03358407|447943225|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
124543118|NCT03358407|447943226|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
124543119|NCT03358407|447943227|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
124543120|NCT03358407|447943228|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
124543121|NCT03358407|447943229|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
124543122|NCT03358407|447943230|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
124543123|NCT03358407|447943231|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
124543124|NCT03358407|447943232|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
124543125|NCT03358407|447943233|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
124543126|NCT03358407|447943234|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
124543127|NCT03358407|447943225|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
124543128|NCT03358407|447943226|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
124543129|NCT03358407|447943227|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
124543130|NCT03358407|447943228|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
124543131|NCT03358407|447943229|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
124543132|NCT03358407|447943230|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
124981913|NCT04276415|449559837|FG004|Overall Study|Other|0|||
124981914|NCT04276415|449559838|FG005|Overall Study|Other|0|||
124981915|NCT04276415|449559833|FG000|Overall Study|Physician Decision|0|||
124543133|NCT03358407|447943231|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
124543134|NCT03358407|447943232|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
124981916|NCT04276415|449559834|FG001|Overall Study|Physician Decision|0|||
124981917|NCT04276415|449559835|FG002|Overall Study|Physician Decision|1|||
124543135|NCT03358407|447943233|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
124543136|NCT03358407|447943234|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
124543137|NCT03358407|447943225|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
124543138|NCT03358407|447943226|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
124543139|NCT03358407|447943227|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
124543140|NCT03358407|447943228|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
124543141|NCT03358407|447943229|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
124543142|NCT03358407|447943230|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
124543143|NCT03358407|447943231|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
124543144|NCT03358407|447943232|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
124543145|NCT03358407|447943233|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
124981918|NCT04276415|449559836|FG003|Overall Study|Physician Decision|3|||
124981919|NCT04276415|449559837|FG004|Overall Study|Physician Decision|2|||
124981920|NCT04276415|449559838|FG005|Overall Study|Physician Decision|0|||
124981921|NCT04276415|449559833|FG000|Overall Study|Progressive disease|3|||
124981922|NCT04276415|449559834|FG001|Overall Study|Progressive disease|3|||
124981923|NCT04276415|449559835|FG002|Overall Study|Progressive disease|4|||
124543146|NCT03358407|447943234|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
124543147|NCT03358407|447943225|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
124543148|NCT03358407|447943226|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
124543149|NCT03358407|447943227|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
124543150|NCT03358407|447943228|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
124543151|NCT03358407|447943229|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
124758638|NCT01463306|448739821|FG001|Overall Study|Lack of Efficacy|16|||
124981924|NCT04276415|449559836|FG003|Overall Study|Progressive disease|5|||
124981925|NCT04276415|449559837|FG004|Overall Study|Progressive disease|1|||
124543152|NCT03358407|447943230|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
124543153|NCT03358407|447943231|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
124543154|NCT03358407|447943232|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
124543155|NCT03358407|447943233|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
124543156|NCT03358407|447943234|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
124543157|NCT03358407|447943225|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
124543158|NCT03358407|447943226|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
124543159|NCT03358407|447943227|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
124543160|NCT03358407|447943228|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
124543161|NCT03358407|447943229|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
124543162|NCT03358407|447943230|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
124543163|NCT03358407|447943231|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
124543164|NCT03358407|447943232|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
124543165|NCT03358407|447943233|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
124543166|NCT03358407|447943234|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
124543167|NCT03358407|447943225|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
124543168|NCT03358407|447943226|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
124543169|NCT03358407|447943227|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
124543170|NCT03358407|447943228|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
124543171|NCT03358407|447943229|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
124543172|NCT03358407|447943230|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
124543173|NCT03358407|447943231|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
124543174|NCT03358407|447943232|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
124543175|NCT03358407|447943233|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
124543176|NCT03358407|447943234|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
124543177|NCT03605758|447943235|FG000|Overall Study|Lost to Follow-up|2|||
124543178|NCT03605758|447943236|FG001|Overall Study|Lost to Follow-up|1|||
124543179|NCT03605758|447943235|FG000|Overall Study|Illness|0|||
124543180|NCT03605758|447943236|FG001|Overall Study|Illness|1|||
124872083|NCT04814368|449152827|FG001|Overall Study|Subject Decision|2|||
124872084|NCT04814368|449152828|FG002|Overall Study|Subject Decision|0|||
124872085|NCT04814368|449152829|FG003|Overall Study|Subject Decision|0|||
124872086|NCT01194570|449154007|FG000|Overall Study|Adverse Event|22|||
124872087|NCT01194570|449154008|FG001|Overall Study|Adverse Event|40|||
124872088|NCT01194570|449154007|FG000|Overall Study|Death|6|||
124872089|NCT01194570|449154008|FG001|Overall Study|Death|20|||
124872090|NCT01194570|449154007|FG000|Overall Study|Lack of Efficacy|32|||
124872091|NCT01194570|449154008|FG001|Overall Study|Lack of Efficacy|33|||
124872092|NCT01194570|449154007|FG000|Overall Study|Lost to Follow-up|4|||
124872093|NCT01194570|449154008|FG001|Overall Study|Lost to Follow-up|15|||
124872094|NCT01194570|449154007|FG000|Overall Study|Non-Compliance|2|||
124872095|NCT01194570|449154008|FG001|Overall Study|Non-Compliance|2|||
124872096|NCT01194570|449154007|FG000|Overall Study|Non-Compliance With Study Drug|2|||
124872097|NCT01194570|449154008|FG001|Overall Study|Non-Compliance With Study Drug|2|||
124872098|NCT01194570|449154007|FG000|Overall Study|Other|18|||
124872099|NCT01194570|449154008|FG001|Overall Study|Other|47|||
124872100|NCT01194570|449154007|FG000|Overall Study|Physician Decision|10|||
124872101|NCT01194570|449154008|FG001|Overall Study|Physician Decision|25|||
124872102|NCT01194570|449154007|FG000|Overall Study|Protocol Violation|1|||
124872103|NCT01194570|449154008|FG001|Overall Study|Protocol Violation|2|||
124872104|NCT01194570|449154007|FG000|Overall Study|Study Terminated By Sponsor|0|||
124872105|NCT01194570|449154008|FG001|Overall Study|Study Terminated By Sponsor|1|||
124872106|NCT01194570|449154007|FG000|Overall Study|Withdrawal by Subject|57|||
124872107|NCT01194570|449154008|FG001|Overall Study|Withdrawal by Subject|82|||
124872108|NCT01194570|449154007|FG000|Overall Study|Pregnancy|1|||
124872109|NCT01194570|449154008|FG001|Overall Study|Pregnancy|1|||
124872110|NCT01337674|449154009|FG000|Treatment Period 1|Adverse Event|0|||
124872111|NCT01337674|449154010|FG001|Treatment Period 1|Adverse Event|1|||
124872112|NCT01337674|449154011|FG002|Treatment Period 1|Adverse Event|0|||
124872113|NCT01337674|449154012|FG003|Treatment Period 1|Adverse Event|0|||
124872114|NCT01337674|449154009|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
124872115|NCT01337674|449154010|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
124872116|NCT01337674|449154011|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
124872117|NCT01337674|449154012|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
124872118|NCT01337674|449154009|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124872119|NCT01337674|449154010|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124872120|NCT01337674|449154011|FG002|Treatment Period 2|Withdrawal by Subject|1|||
124872121|NCT01337674|449154012|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124872122|NCT00939484|449154016|FG000|Overall Study|Progression/Relapse|8|||
124872123|NCT00939484|449154017|FG001|Overall Study|Progression/Relapse|20|||
124872124|NCT00939484|449154018|FG002|Overall Study|Progression/Relapse|3|||
124872125|NCT01224925|449154019|FG000|Overall Study|Lost to Follow-up|3|||
124543181|NCT03605758|447943235|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
124543182|NCT03605758|447943236|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
124543183|NCT00489411|447943237|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
124543184|NCT00489411|447943238|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
124543185|NCT00489411|447943237|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
124543186|NCT00489411|447943238|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
124543187|NCT00489411|447943237|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
124543188|NCT00489411|447943238|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
124543189|NCT00489411|447943237|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
124543190|NCT00489411|447943238|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
124543191|NCT00489411|447943237|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
124543192|NCT00489411|447943238|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
124543193|NCT01283009|447943239|FG000|Overall Study|Death|83|||
124543194|NCT01283009|447943240|FG001|Overall Study|Death|78|||
124543195|NCT01283009|447943239|FG000|Overall Study|Study ended early|23|||
124543196|NCT01283009|447943240|FG001|Overall Study|Study ended early|26|||
124543197|NCT01283009|447943239|FG000|Overall Study|Withdrawal by Subject|10|||
124543198|NCT01283009|447943240|FG001|Overall Study|Withdrawal by Subject|8|||
124543199|NCT01283009|447943239|FG000|Overall Study|Physician Decision|1|||
124543200|NCT01283009|447943240|FG001|Overall Study|Physician Decision|1|||
124543201|NCT01283009|447943239|FG000|Overall Study|Lost to Follow-up|1|||
124543202|NCT01283009|447943240|FG001|Overall Study|Lost to Follow-up|0|||
124543203|NCT01283009|447943239|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
124543204|NCT01283009|447943240|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
124543205|NCT04640168|447943244|FG000|Overall Study|Withdrawal by Subject|8|||
124543206|NCT04640168|447943245|FG001|Overall Study|Withdrawal by Subject|7|||
124543207|NCT04640168|447943244|FG000|Overall Study|Lost to Follow-up|1|||
124543208|NCT04640168|447943245|FG001|Overall Study|Lost to Follow-up|0|||
124543209|NCT04640168|447943244|FG000|Overall Study|Enrolled but not treated|12|||
124543210|NCT04640168|447943245|FG001|Overall Study|Enrolled but not treated|12|||
124543211|NCT04366258|447943249|FG000|Baseline Assessments|Screen Failure|21|||
124543212|NCT04366258|447943249|FG000|Baseline Assessments|Early Termination|3|||
124543213|NCT00308555|447943250|FG000|Overall Study|Withdrawal by Subject|1|||
124543214|NCT00308555|447943251|FG001|Overall Study|Withdrawal by Subject|0|||
124543215|NCT00308555|447943250|FG000|Overall Study|Physician Decision|2|||
124543216|NCT00308555|447943251|FG001|Overall Study|Physician Decision|0|||
124543217|NCT00276458|447943252|FG000|Overall Study|Adverse Event|0|||
124543218|NCT00276458|447943253|FG001|Overall Study|Adverse Event|2|||
124543219|NCT00276458|447943252|FG000|Overall Study|Lost to Follow-up|2|||
124543220|NCT00276458|447943253|FG001|Overall Study|Lost to Follow-up|2|||
124543221|NCT00276458|447943252|FG000|Overall Study|Protocol Violation|4|||
124543222|NCT00276458|447943253|FG001|Overall Study|Protocol Violation|3|||
124543223|NCT02940392|447943256|FG000|Overall Study|Lost to Follow-up|3|||
124543224|NCT02940392|447943256|FG000|Overall Study|Retreatment|3|||
124543225|NCT02940392|447943256|FG000|Overall Study|Death|2|||
124543226|NCT00910000|447943260|FG000|Overall Study|Adverse Event|0|||
124543227|NCT00910000|447943261|FG001|Overall Study|Adverse Event|3|||
124543228|NCT00910000|447943262|FG002|Overall Study|Adverse Event|2|||
124543229|NCT00910000|447943263|FG003|Overall Study|Adverse Event|2|||
124543230|NCT00910000|447943264|FG004|Overall Study|Adverse Event|0|||
124543231|NCT00910000|447943265|FG005|Overall Study|Adverse Event|1|||
124543232|NCT00910000|447943260|FG000|Overall Study|Withdrawal by Subject|0|||
124543233|NCT00910000|447943261|FG001|Overall Study|Withdrawal by Subject|0|||
124543234|NCT00910000|447943262|FG002|Overall Study|Withdrawal by Subject|1|||
124543235|NCT00910000|447943263|FG003|Overall Study|Withdrawal by Subject|0|||
124543236|NCT00910000|447943264|FG004|Overall Study|Withdrawal by Subject|1|||
124543237|NCT00910000|447943265|FG005|Overall Study|Withdrawal by Subject|0|||
124543238|NCT03125382|447943266|FG000|Randomization|screening failure|1|||
124543239|NCT03125382|447943267|FG001|Randomization|screening failure|4|||
124543240|NCT03125382|447943268|FG002|Randomization|screening failure|2|||
124543241|NCT03125382|447943269|FG003|Randomization|screening failure|0|||
124543242|NCT03125382|447943266|FG000|Follow-up|Death|1|||
124543243|NCT03125382|447943267|FG001|Follow-up|Death|2|||
124543244|NCT03125382|447943268|FG002|Follow-up|Death|1|||
124543245|NCT03125382|447943269|FG003|Follow-up|Death|2|||
124543246|NCT03125382|447943266|FG000|Follow-up|Lost to Follow-up|1|||
124543247|NCT03125382|447943267|FG001|Follow-up|Lost to Follow-up|4|||
124543248|NCT03125382|447943268|FG002|Follow-up|Lost to Follow-up|3|||
124543249|NCT03125382|447943269|FG003|Follow-up|Lost to Follow-up|1|||
124543250|NCT02686749|447943270|FG000|Overall Study|terminated for poor enrollment|2|||
124543251|NCT02686749|447943271|FG001|Overall Study|terminated for poor enrollment|2|||
124543252|NCT05147311|447943274|FG000|Overall Study|Did not complete survey|2|||
124543253|NCT05147311|447943275|FG001|Overall Study|Did not complete survey|1|||
124543254|NCT05147311|447943274|FG000|Overall Study|Patient too sick|1|||
124543255|NCT05147311|447943275|FG001|Overall Study|Patient too sick|2|||
124543256|NCT05147311|447943274|FG000|Overall Study|Death|0|||
124543257|NCT05147311|447943275|FG001|Overall Study|Death|1|||
124543258|NCT05147311|447943274|FG000|Overall Study|Declined survey|1|||
124543259|NCT05147311|447943275|FG001|Overall Study|Declined survey|0|||
124543260|NCT04505592|447943277|FG000|Overall Study|Death|2|||
124543261|NCT04505592|447943278|FG001|Overall Study|Death|1|||
124543262|NCT01015118|447943283|FG000|Overall Study|Protocol Violation|5|||
124543263|NCT01015118|447943284|FG001|Overall Study|Protocol Violation|6|||
124543264|NCT01015118|447943283|FG000|Overall Study|Withdrawal by Subject|103|||
124543265|NCT01015118|447943284|FG001|Overall Study|Withdrawal by Subject|27|||
124543266|NCT01015118|447943283|FG000|Overall Study|Other Adverse Event (AE)|141|||
124543267|NCT01015118|447943284|FG001|Overall Study|Other Adverse Event (AE)|33|||
124543268|NCT01015118|447943283|FG000|Overall Study|Worsening or AE of underlying disease|5|||
124543269|NCT01015118|447943284|FG001|Overall Study|Worsening or AE of underlying disease|4|||
124543270|NCT01015118|447943283|FG000|Overall Study|Progressive disease|364|||
124543271|NCT01015118|447943284|FG001|Overall Study|Progressive disease|229|||
124543272|NCT01015118|447943283|FG000|Overall Study|Not treated|9|||
124543273|NCT01015118|447943284|FG001|Overall Study|Not treated|5|||
124543274|NCT01015118|447943283|FG000|Overall Study|Other than stated above|42|||
124543275|NCT01015118|447943284|FG001|Overall Study|Other than stated above|23|||
124543276|NCT03522506|447943285|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124543277|NCT03522506|447943286|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124543278|NCT03522506|447943287|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124543279|NCT03522506|447943288|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
124543280|NCT03522506|447943285|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
124543281|NCT03522506|447943286|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
124543282|NCT03522506|447943287|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
124543283|NCT03522506|447943288|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
124543284|NCT03480243|447943289|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
124543285|NCT03480243|447943289|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
124543286|NCT02388906|447943291|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
124543287|NCT02388906|447943292|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
124543288|NCT02388906|447943291|FG000|Treatment Period|Disease progression|121|||
124543289|NCT02388906|447943292|FG001|Treatment Period|Disease progression|100|||
124543290|NCT02388906|447943291|FG000|Treatment Period|Study drug toxicity|41|||
124543291|NCT02388906|447943292|FG001|Treatment Period|Study drug toxicity|208|||
124543292|NCT02388906|447943291|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
124543293|NCT02388906|447943292|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
124543294|NCT02388906|447943291|FG000|Treatment Period|Participant request to stop treatment|5|||
124543295|NCT02388906|447943292|FG001|Treatment Period|Participant request to stop treatment|9|||
124543296|NCT02388906|447943291|FG000|Treatment Period|Participant withdrew consent|2|||
124543297|NCT02388906|447943292|FG001|Treatment Period|Participant withdrew consent|3|||
124543298|NCT02388906|447943291|FG000|Treatment Period|Poor/non-compliance|0|||
124543299|NCT02388906|447943292|FG001|Treatment Period|Poor/non-compliance|1|||
124543300|NCT02388906|447943291|FG000|Treatment Period|Participant no longer meets study criteria|0|||
124543301|NCT02388906|447943292|FG001|Treatment Period|Participant no longer meets study criteria|1|||
124543302|NCT02388906|447943291|FG000|Treatment Period|Other reasons|3|||
124543303|NCT02388906|447943292|FG001|Treatment Period|Other reasons|3|||
124543304|NCT04365387|447943293|FG000|Overall Study|Adverse Event|4|||
124543305|NCT04365387|447943294|FG001|Overall Study|Adverse Event|2|||
124543306|NCT04365387|447943293|FG000|Overall Study|Participants request|14|||
124543307|NCT04365387|447943294|FG001|Overall Study|Participants request|14|||
124543308|NCT04365387|447943293|FG000|Overall Study|Lost to Follow-up|8|||
124543309|NCT04365387|447943294|FG001|Overall Study|Lost to Follow-up|5|||
124543310|NCT04365387|447943293|FG000|Overall Study|Protocol deviation|3|||
124543311|NCT04365387|447943294|FG001|Overall Study|Protocol deviation|4|||
124543312|NCT04365387|447943293|FG000|Overall Study|Participant compliance with visit schedule|1|||
124543313|NCT04365387|447943294|FG001|Overall Study|Participant compliance with visit schedule|0|||
124543314|NCT04365387|447943293|FG000|Overall Study|Participant incarcerated|1|||
124543315|NCT04365387|447943294|FG001|Overall Study|Participant incarcerated|0|||
124543316|NCT04365387|447943293|FG000|Overall Study|Participant moved out of town (relocated)|0|||
124543317|NCT04365387|447943294|FG001|Overall Study|Participant moved out of town (relocated)|1|||
124543318|NCT04365387|447943293|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
124543319|NCT04365387|447943294|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
124543320|NCT04365387|447943293|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
124543321|NCT04365387|447943294|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
124543322|NCT04410991|447943303|FG000|Overall Study|Poor compliance to protocol|5|||
124543323|NCT04410991|447943304|FG001|Overall Study|Poor compliance to protocol|4|||
124543324|NCT04410991|447943303|FG000|Overall Study|Withdrawal by Subject|59|||
124543325|NCT04410991|447943304|FG001|Overall Study|Withdrawal by Subject|55|||
124543326|NCT04410991|447943303|FG000|Overall Study|Other|10|||
124543327|NCT04410991|447943304|FG001|Overall Study|Other|4|||
124543328|NCT03282123|447943305|FG000|Overall Study|Withdrawal by Subject|5|||
124543329|NCT00938366|447943306|FG000|Overall Study|Withdrawal by Subject|1|||
124981926|NCT04276415|449559838|FG005|Overall Study|Progressive disease|2|||
124543330|NCT00938366|447943307|FG001|Overall Study|Withdrawal by Subject|0|||
124543331|NCT01463631|447943314|FG000|Overall Study|Withdrawal by Subject|0|||
124543332|NCT01463631|447943315|FG001|Overall Study|Withdrawal by Subject|0|||
124543333|NCT01463631|447943316|FG002|Overall Study|Withdrawal by Subject|0|||
124543334|NCT01463631|447943317|FG003|Overall Study|Withdrawal by Subject|1|||
124543335|NCT01463631|447943314|FG000|Overall Study|Death|0|||
124543336|NCT01463631|447943315|FG001|Overall Study|Death|0|||
124543337|NCT01463631|447943316|FG002|Overall Study|Death|1|||
124644696|NCT02691936|448316491|FG000|Overall Study|Withdrawal by Subject|2|||
124644697|NCT02691936|448316492|FG001|Overall Study|Withdrawal by Subject|5|||
124644698|NCT03382834|448316494|FG000|Step 1|Lost to Follow-up|0|||
124644699|NCT03382834|448316495|FG001|Step 1|Lost to Follow-up|1|||
124644700|NCT03382834|448316494|FG000|Step 2|Death|1|||
124644701|NCT03382834|448316495|FG001|Step 2|Death|0|||
124644702|NCT03382834|448316494|FG000|Step 2|Lost to Follow-up|2|||
124644703|NCT03382834|448316495|FG001|Step 2|Lost to Follow-up|2|||
124644704|NCT03382834|448316494|FG000|Step 2|Site Terminated by Sponsor|1|||
124644705|NCT03382834|448316495|FG001|Step 2|Site Terminated by Sponsor|0|||
124644706|NCT02387957|448316496|FG000|Overall Study|The study was discontinued|21|||
124644707|NCT02387957|448316497|FG001|Overall Study|The study was discontinued|21|||
124644708|NCT02387957|448316498|FG002|Overall Study|The study was discontinued|20|||
124644709|NCT01992653|448316507|FG000|Overall Study|Death|0|||
124644710|NCT01992653|448316508|FG001|Overall Study|Death|0|||
124644711|NCT01992653|448316509|FG002|Overall Study|Death|1|||
124644712|NCT01992653|448316510|FG003|Overall Study|Death|0|||
124644713|NCT01992653|448316511|FG004|Overall Study|Death|1|||
124644714|NCT01992653|448316512|FG005|Overall Study|Death|0|||
124644715|NCT01992653|448316513|FG006|Overall Study|Death|4|||
124644716|NCT01992653|448316514|FG007|Overall Study|Death|2|||
124644717|NCT01992653|448316507|FG000|Overall Study|Lost to Follow-up|0|||
124644718|NCT01992653|448316508|FG001|Overall Study|Lost to Follow-up|0|||
124644719|NCT01992653|448316509|FG002|Overall Study|Lost to Follow-up|0|||
124644720|NCT01992653|448316510|FG003|Overall Study|Lost to Follow-up|0|||
124644721|NCT01992653|448316511|FG004|Overall Study|Lost to Follow-up|0|||
124644722|NCT01992653|448316512|FG005|Overall Study|Lost to Follow-up|0|||
124644723|NCT01992653|448316513|FG006|Overall Study|Lost to Follow-up|0|||
124644724|NCT01992653|448316514|FG007|Overall Study|Lost to Follow-up|1|||
124644725|NCT01992653|448316507|FG000|Overall Study|Study Completed|0|||
124644726|NCT01992653|448316508|FG001|Overall Study|Study Completed|0|||
124644727|NCT01992653|448316509|FG002|Overall Study|Study Completed|0|||
124644728|NCT01992653|448316510|FG003|Overall Study|Study Completed|0|||
124644729|NCT01992653|448316511|FG004|Overall Study|Study Completed|0|||
124644730|NCT01992653|448316512|FG005|Overall Study|Study Completed|0|||
124543338|NCT01463631|447943317|FG003|Overall Study|Death|0|||
124543339|NCT01463631|447943314|FG000|Overall Study|Progressive Disease|0|||
124543340|NCT01463631|447943315|FG001|Overall Study|Progressive Disease|0|||
124543341|NCT01463631|447943316|FG002|Overall Study|Progressive Disease|0|||
124543342|NCT01463631|447943317|FG003|Overall Study|Progressive Disease|5|||
124543343|NCT05966129|447943320|FG000|Overall Study|Death|1|||
124543344|NCT05966129|447943321|FG001|Overall Study|Death|2|||
124543345|NCT05966129|447943320|FG000|Overall Study|Lost to Follow-up|63|||
124644731|NCT01992653|448316513|FG006|Overall Study|Study Completed|0|||
124644732|NCT01992653|448316514|FG007|Overall Study|Study Completed|1|||
124644733|NCT01992653|448316507|FG000|Overall Study|Disease Progression|0|||
124644734|NCT01992653|448316508|FG001|Overall Study|Disease Progression|0|||
124644735|NCT01992653|448316509|FG002|Overall Study|Disease Progression|0|||
124644736|NCT01992653|448316510|FG003|Overall Study|Disease Progression|0|||
124644737|NCT01992653|448316511|FG004|Overall Study|Disease Progression|0|||
124981927|NCT04276415|449559833|FG000|Overall Study|Withdrawal by patient|0|||
124981928|NCT04276415|449559834|FG001|Overall Study|Withdrawal by patient|0|||
124981929|NCT04276415|449559835|FG002|Overall Study|Withdrawal by patient|0|||
124644738|NCT01992653|448316512|FG005|Overall Study|Disease Progression|0|||
124981930|NCT04276415|449559836|FG003|Overall Study|Withdrawal by patient|1|||
124981931|NCT04276415|449559837|FG004|Overall Study|Withdrawal by patient|2|||
124644739|NCT01992653|448316513|FG006|Overall Study|Disease Progression|4|||
124644740|NCT01992653|448316514|FG007|Overall Study|Disease Progression|0|||
124644741|NCT00977314|448316515|FG000|Overall Study|Withdrawal by Subject|1|||
124644742|NCT00977314|448316516|FG001|Overall Study|Withdrawal by Subject|0|||
124644743|NCT00977314|448316515|FG000|Overall Study|Physician Decision|1|||
124981932|NCT04276415|449559838|FG005|Overall Study|Withdrawal by patient|0|||
124644744|NCT00977314|448316516|FG001|Overall Study|Physician Decision|0|||
124644745|NCT01343277|448316520|FG000|Overall Study|Other|3|||
124644746|NCT01343277|448316521|FG001|Overall Study|Other|3|||
124644747|NCT01343277|448316520|FG000|Overall Study|Withdrawal by Subject|18|||
124644748|NCT01343277|448316521|FG001|Overall Study|Withdrawal by Subject|13|||
124644749|NCT01343277|448316520|FG000|Overall Study|Physician Decision|1|||
124543346|NCT05966129|447943321|FG001|Overall Study|Lost to Follow-up|66|||
124543347|NCT05966129|447943320|FG000|Overall Study|Protocol Violation|1|||
124644750|NCT01343277|448316521|FG001|Overall Study|Physician Decision|2|||
124644751|NCT01343277|448316520|FG000|Overall Study|Death|10|||
124644752|NCT01343277|448316521|FG001|Overall Study|Death|1|||
124543348|NCT05966129|447943321|FG001|Overall Study|Protocol Violation|0|||
124543349|NCT05966129|447943320|FG000|Overall Study|Withdrawal by Subject|26|||
124543350|NCT05966129|447943321|FG001|Overall Study|Withdrawal by Subject|25|||
124543351|NCT05966129|447943320|FG000|Overall Study|Surgery not completed|63|||
124543352|NCT05966129|447943321|FG001|Overall Study|Surgery not completed|69|||
124543353|NCT05966129|447943320|FG000|Overall Study|Surgery logistics issue|2|||
124543354|NCT05966129|447943321|FG001|Overall Study|Surgery logistics issue|1|||
124543355|NCT01298323|447943322|FG000|Overall Study|Adverse Event|2|||
124543356|NCT01298323|447943323|FG001|Overall Study|Adverse Event|4|||
124543357|NCT01298323|447943322|FG000|Overall Study|Death|11|||
124543358|NCT01298323|447943323|FG001|Overall Study|Death|16|||
124543359|NCT01298323|447943322|FG000|Overall Study|Lost to Follow-up|1|||
124543360|NCT01298323|447943323|FG001|Overall Study|Lost to Follow-up|0|||
124543361|NCT01298323|447943322|FG000|Overall Study|Withdrawal by Subject|6|||
124543362|NCT01298323|447943323|FG001|Overall Study|Withdrawal by Subject|3|||
124543363|NCT01298323|447943322|FG000|Overall Study|Protocol Violation|1|||
124543364|NCT01298323|447943323|FG001|Overall Study|Protocol Violation|0|||
124543365|NCT01298323|447943322|FG000|Overall Study|Other|10|||
124543366|NCT01298323|447943323|FG001|Overall Study|Other|9|||
124543367|NCT01298323|447943322|FG000|Overall Study|Ongoing|55|||
124543368|NCT01298323|447943323|FG001|Overall Study|Ongoing|55|||
124543369|NCT01298323|447943322|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124543370|NCT01298323|447943323|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
124543371|NCT04089566|447943326|FG000|Overall Study|Death|0|||
124543372|NCT04089566|447943327|FG001|Overall Study|Death|6|||
124543373|NCT04089566|447943328|FG002|Overall Study|Death|10|||
124543374|NCT04089566|447943329|FG003|Overall Study|Death|0|||
124543375|NCT04089566|447943330|FG004|Overall Study|Death|0|||
124543376|NCT04089566|447943331|FG005|Overall Study|Death|0|||
124543377|NCT04089566|447943326|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
124543378|NCT04089566|447943327|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
124543379|NCT04089566|447943328|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
124543380|NCT04089566|447943329|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
124543381|NCT04089566|447943330|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
124543382|NCT04089566|447943331|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
124543383|NCT04089566|447943326|FG000|Overall Study|Reason not Specified|0|||
124543384|NCT04089566|447943327|FG001|Overall Study|Reason not Specified|4|||
124543385|NCT04089566|447943328|FG002|Overall Study|Reason not Specified|4|||
124543386|NCT04089566|447943329|FG003|Overall Study|Reason not Specified|1|||
124543387|NCT04089566|447943330|FG004|Overall Study|Reason not Specified|0|||
124543388|NCT04089566|447943331|FG005|Overall Study|Reason not Specified|0|||
124543389|NCT01083121|447943332|FG000|Overall Study|Use of Humira outside the approved label|81|||
124543390|NCT01958619|447943337|FG000|Overall Study|Protocol Violation|2|||
124543391|NCT01958619|447943338|FG001|Overall Study|Protocol Violation|0|||
124543392|NCT01958619|447943339|FG002|Overall Study|Protocol Violation|1|||
124543393|NCT01958619|447943340|FG003|Overall Study|Protocol Violation|0|||
124543394|NCT02396849|447943342|FG000|Overall Study|Lost to Follow-up|1|||
124543395|NCT02396849|447943343|FG001|Overall Study|Lost to Follow-up|1|||
124543396|NCT02396849|447943342|FG000|Overall Study|Did not tolerate intervention|1|||
124543397|NCT02396849|447943343|FG001|Overall Study|Did not tolerate intervention|1|||
124543398|NCT04794491|447943352|FG000|Overall Study|Adverse Event|1|||
124543399|NCT04794491|447943352|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
124543400|NCT04794491|447943352|FG000|Overall Study|Noncompliance With Study Intervention|1|||
124543401|NCT04794491|447943352|FG000|Overall Study|Withdrawal by Subject|2|||
124543402|NCT00985114|447943353|FG000|Overall Study|Adverse Event|1|||
124543403|NCT00985114|447943354|FG001|Overall Study|Adverse Event|0|||
124543404|NCT00985114|447943353|FG000|Overall Study|Withdrawal by Subject|0|||
124543405|NCT00985114|447943354|FG001|Overall Study|Withdrawal by Subject|2|||
124543406|NCT01965600|447943357|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
124543407|NCT01965600|447943358|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
124543408|NCT01965600|447943359|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
124543409|NCT01965600|447943360|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
124543410|NCT01965600|447943357|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
124543411|NCT01965600|447943358|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
124543412|NCT01965600|447943359|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
124543413|NCT01965600|447943360|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
124543414|NCT01965600|447943357|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
124543415|NCT01965600|447943358|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
124543416|NCT01965600|447943359|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
124543417|NCT01965600|447943360|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
124543418|NCT01965600|447943357|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
124543419|NCT01965600|447943358|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
124644753|NCT01343277|448316520|FG000|Overall Study|Adverse Event|67|||
124644754|NCT01343277|448316521|FG001|Overall Study|Adverse Event|13|||
124644755|NCT01343277|448316520|FG000|Overall Study|Disease progression|270|||
124644756|NCT01343277|448316521|FG001|Overall Study|Disease progression|138|||
124644757|NCT01343277|448316520|FG000|Overall Study|Randomized not treated|6|||
124644758|NCT01343277|448316521|FG001|Overall Study|Randomized not treated|21|||
124644759|NCT01343277|448316520|FG000|Overall Study|Treatment ongoing|8|||
124644760|NCT01343277|448316521|FG001|Overall Study|Treatment ongoing|2|||
124644761|NCT01343277|448316520|FG000|Overall Study|Subsequent anticancer therapy|1|||
124644762|NCT01343277|448316521|FG001|Overall Study|Subsequent anticancer therapy|0|||
124644763|NCT01582178|448316529|FG000|Overall Study|Physician Decision|6|||
124644764|NCT01582178|448316530|FG001|Overall Study|Physician Decision|5|||
124644765|NCT03852628|448316531|FG000|Overall Study|Lost to Follow-up|7|||
124644766|NCT03852628|448316532|FG001|Overall Study|Lost to Follow-up|6|||
124644767|NCT03852628|448316531|FG000|Overall Study|Lack of Efficacy|6|||
124644768|NCT03852628|448316532|FG001|Overall Study|Lack of Efficacy|6|||
124644769|NCT02964208|448316533|FG000|Overall Study|Death|103|||
124644770|NCT02964208|448316533|FG000|Overall Study|Withdrawal by Subject|6|||
124543420|NCT01965600|447943359|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
124644771|NCT02964208|448316533|FG000|Overall Study|Lost to Follow-up|6|||
124644772|NCT02964208|448316533|FG000|Overall Study|Unsuccessful Procedure|5|||
124644773|NCT02964208|448316533|FG000|Overall Study|Device Explant|1|||
124644774|NCT02964208|448316533|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
124644775|NCT00556933|448316534|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
124872126|NCT01224925|449154020|FG001|Overall Study|Lost to Follow-up|2|||
124543421|NCT01965600|447943360|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
124543422|NCT01965600|447943357|FG000|Second Intervention|Study terminated by Sponsor|0|||
124543423|NCT01965600|447943358|FG001|Second Intervention|Study terminated by Sponsor|0|||
124543424|NCT01965600|447943359|FG002|Second Intervention|Study terminated by Sponsor|2|||
124543425|NCT01965600|447943360|FG003|Second Intervention|Study terminated by Sponsor|2|||
124543426|NCT03418727|447943362|FG000|Overall Study|Adverse Event|1|||
124543427|NCT03418727|447943363|FG001|Overall Study|Adverse Event|2|||
124543428|NCT03418727|447943364|FG002|Overall Study|Adverse Event|0|||
124543429|NCT03418727|447943362|FG000|Overall Study|Withdrawal by Subject|0|||
124543430|NCT03418727|447943363|FG001|Overall Study|Withdrawal by Subject|0|||
124543431|NCT03418727|447943364|FG002|Overall Study|Withdrawal by Subject|2|||
124543432|NCT03145207|447943365|FG000|Overall Study|volunteer started taking allergy shots|1|||
124543433|NCT03145207|447943365|FG000|Overall Study|baseline blood pressure high|1|||
124543434|NCT04678557|447943368|FG000|Overall Study|Withdrawal by Subject|1|||
124543435|NCT04678557|447943369|FG001|Overall Study|Withdrawal by Subject|0|||
124543436|NCT04678557|447943368|FG000|Overall Study|Lack of Efficacy|0|||
124543437|NCT04678557|447943369|FG001|Overall Study|Lack of Efficacy|13|||
124543438|NCT04678557|447943368|FG000|Overall Study|Safety Evaluation|0|||
124543439|NCT04678557|447943369|FG001|Overall Study|Safety Evaluation|1|||
124543440|NCT00223990|447943370|FG000|Overall Study|Moved from area|2|||
124543441|NCT00223990|447943371|FG001|Overall Study|Moved from area|1|||
124543442|NCT00223990|447943370|FG000|Overall Study|Withdrawal by Subject|4|||
124543443|NCT00223990|447943371|FG001|Overall Study|Withdrawal by Subject|8|||
124543444|NCT00223990|447943370|FG000|Overall Study|Lost to Follow-up|1|||
124543445|NCT00223990|447943371|FG001|Overall Study|Lost to Follow-up|0|||
124543446|NCT01302366|447944972|FG000|Overall Study|patient choice or noncompliance|5|||
124543447|NCT00509223|447944975|FG000|Overall Study|Lost to Follow-up|1|||
124543448|NCT00509223|447944976|FG001|Overall Study|Lost to Follow-up|1|||
124543449|NCT00509223|447944975|FG000|Overall Study|Adverse Event|1|||
124543450|NCT00509223|447944976|FG001|Overall Study|Adverse Event|1|||
124543451|NCT00509223|447944975|FG000|Overall Study|Withdrawal by Subject|25|||
124543452|NCT00509223|447944976|FG001|Overall Study|Withdrawal by Subject|6|||
124543453|NCT00509223|447944975|FG000|Overall Study|Including: subject change of address|5|||
124543454|NCT00509223|447944976|FG001|Overall Study|Including: subject change of address|2|||
124543455|NCT00509223|447944975|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
124543456|NCT00509223|447944976|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
124543457|NCT02513732|447944977|FG000|Overall Study|Lost to Follow-up|11|||
124543458|NCT02513732|447944977|FG000|Overall Study|Death|9|||
124543459|NCT02513732|447944977|FG000|Overall Study|Changing hospital|2|||
124543460|NCT00467051|447944978|FG000|Overall Study|Adverse Event|2|||
124543461|NCT00934661|447944979|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
124543462|NCT00934661|447944980|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
124543463|NCT01740297|447944981|FG000|Overall Study|Withdrawal by Subject|4|||
124543464|NCT01740297|447944982|FG001|Overall Study|Withdrawal by Subject|16|||
124543465|NCT01740297|447944983|FG002|Overall Study|Withdrawal by Subject|17|||
124543466|NCT01740297|447944981|FG000|Overall Study|Death|8|||
124543467|NCT01740297|447944982|FG001|Overall Study|Death|46|||
124543468|NCT01740297|447944983|FG002|Overall Study|Death|40|||
124543469|NCT01740297|447944981|FG000|Overall Study|Lost to Follow-up|1|||
124543470|NCT01740297|447944982|FG001|Overall Study|Lost to Follow-up|2|||
124644776|NCT00556933|448316535|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
124644777|NCT00556933|448316536|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
124543471|NCT01740297|447944983|FG002|Overall Study|Lost to Follow-up|4|||
124543472|NCT00761462|447944988|FG000|Treatment|Subjects never received study medication|23|||
124543473|NCT00761462|447944989|FG001|Treatment|Subjects never received study medication|12|||
124543474|NCT00761462|447944988|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
124543475|NCT00761462|447944989|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
124543476|NCT00761462|447944988|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
124543477|NCT00761462|447944989|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
124543478|NCT00761462|447944988|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
124543479|NCT00761462|447944989|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
124543480|NCT01479777|447944990|FG000|Overall Study|Physician Decision|2|||
124543481|NCT01541644|447944994|FG000|Overall Study|Withdrawal by Subject|3|||
124543482|NCT02389621|447944997|FG000|Treatment Period|Withdrawal by Subject|1|||
124543483|NCT02389621|447944998|FG001|Treatment Period|Withdrawal by Subject|1|||
124543484|NCT02389621|447944997|FG000|Posttreatment Period|Adverse Event|3|||
124543485|NCT02389621|447944998|FG001|Posttreatment Period|Adverse Event|1|||
124543486|NCT02389621|447944997|FG000|Posttreatment Period|Withdrawal by Subject|3|||
124543487|NCT02389621|447944998|FG001|Posttreatment Period|Withdrawal by Subject|2|||
124543488|NCT02389621|447944997|FG000|Posttreatment Period|Lost to Follow-up|1|||
124543489|NCT02389621|447944998|FG001|Posttreatment Period|Lost to Follow-up|1|||
124543490|NCT02389621|447944997|FG000|Posttreatment Period|Other - Miscellaneous|2|||
124543491|NCT02389621|447944998|FG001|Posttreatment Period|Other - Miscellaneous|0|||
124543492|NCT00437294|447945001|FG000|Overall Study|Adverse Event|5|||
124543493|NCT00437294|447945002|FG001|Overall Study|Adverse Event|4|||
124543494|NCT00437294|447945001|FG000|Overall Study|Death|5|||
124543495|NCT00437294|447945002|FG001|Overall Study|Death|2|||
124543496|NCT00437294|447945001|FG000|Overall Study|Physician Decision|0|||
124543497|NCT00437294|447945002|FG001|Overall Study|Physician Decision|3|||
124543498|NCT00437294|447945001|FG000|Overall Study|Withdrawal by Subject|5|||
124543499|NCT00437294|447945002|FG001|Overall Study|Withdrawal by Subject|0|||
124543500|NCT00437294|447945001|FG000|Overall Study|Progressive Disease|19|||
124543501|NCT00437294|447945002|FG001|Overall Study|Progressive Disease|23|||
124543502|NCT00437294|447945001|FG000|Overall Study|Sponsor Decision|8|||
124543503|NCT00437294|447945002|FG001|Overall Study|Sponsor Decision|9|||
124543504|NCT00437294|447945001|FG000|Overall Study|Protocol Violation|0|||
124543505|NCT00437294|447945002|FG001|Overall Study|Protocol Violation|1|||
124543506|NCT00437294|447945001|FG000|Overall Study|Entry criteria not met|1|||
124543507|NCT00437294|447945002|FG001|Overall Study|Entry criteria not met|1|||
124543508|NCT00953017|447945022|FG000|Overall Study|DId not show up for colonoscopy|4|||
124543509|NCT00953017|447945023|FG001|Overall Study|DId not show up for colonoscopy|4|||
124543510|NCT00953017|447945024|FG002|Overall Study|DId not show up for colonoscopy|5|||
124543511|NCT00953017|447945025|FG003|Overall Study|DId not show up for colonoscopy|4|||
124543512|NCT00953017|447945022|FG000|Overall Study|Incomplete data|1|||
124543513|NCT00953017|447945023|FG001|Overall Study|Incomplete data|1|||
124543514|NCT00953017|447945024|FG002|Overall Study|Incomplete data|0|||
124543515|NCT00953017|447945025|FG003|Overall Study|Incomplete data|0|||
124543516|NCT00953017|447945022|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
124543517|NCT00953017|447945023|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
124543518|NCT00953017|447945024|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
124543519|NCT00953017|447945025|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
124543520|NCT00953017|447945022|FG000|Overall Study|Brown stool prior to procedure|0|||
124543521|NCT00953017|447945023|FG001|Overall Study|Brown stool prior to procedure|0|||
124543522|NCT00953017|447945024|FG002|Overall Study|Brown stool prior to procedure|1|||
124543523|NCT00953017|447945025|FG003|Overall Study|Brown stool prior to procedure|0|||
124543524|NCT01473602|447945027|FG000|Overall Study|Adverse Event|1|||
124543525|NCT01473602|447945028|FG001|Overall Study|Adverse Event|2|||
124543526|NCT01473602|447945027|FG000|Overall Study|Death|0|||
124543527|NCT01473602|447945028|FG001|Overall Study|Death|1|||
124543528|NCT01473602|447945027|FG000|Overall Study|Lost to Follow-up|1|||
124543529|NCT01473602|447945028|FG001|Overall Study|Lost to Follow-up|1|||
124543530|NCT01473602|447945027|FG000|Overall Study|Withdrawal by Subject|5|||
124543531|NCT01473602|447945028|FG001|Overall Study|Withdrawal by Subject|4|||
124543532|NCT01473602|447945027|FG000|Overall Study|Physician Decision|1|||
124543533|NCT01473602|447945028|FG001|Overall Study|Physician Decision|0|||
124543534|NCT00449761|447945030|FG000|Overall Study|Disease progression|12|||
124543535|NCT00449761|447945030|FG000|Overall Study|Death|5|||
124872127|NCT02178059|449154021|FG000|Washout|Physician Decision|1|||
124543536|NCT00449761|447945030|FG000|Overall Study|New cancer therapy|1|||
124543537|NCT00344968|447945033|FG000|Overall Study|Adverse Event|5|||
124543538|NCT00344968|447945034|FG001|Overall Study|Adverse Event|4|||
124543539|NCT00344968|447945035|FG002|Overall Study|Adverse Event|15|||
124543540|NCT00344968|447945033|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
124543541|NCT00344968|447945034|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124543542|NCT00344968|447945035|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
124543543|NCT00344968|447945033|FG000|Overall Study|Protocol Violation|2|||
124543544|NCT00344968|447945034|FG001|Overall Study|Protocol Violation|2|||
124981933|NCT01989169|449559841|FG000|Period 2|Adverse Event|0|||
124981934|NCT01989169|449559842|FG001|Period 2|Adverse Event|1|||
124981935|NCT02406677|449559843|FG000|Overall Study|Death|16|||
124981936|NCT02406677|449559844|FG001|Overall Study|Death|8|||
124981937|NCT02406677|449559843|FG000|Overall Study|Discharged without P2Y12|1|||
124981938|NCT02406677|449559844|FG001|Overall Study|Discharged without P2Y12|3|||
124981939|NCT02406677|449559843|FG000|Overall Study|Discharged on prasugrel|283|||
124981940|NCT02406677|449559844|FG001|Overall Study|Discharged on prasugrel|587|||
124981941|NCT02406677|449559843|FG000|Overall Study|Withdrawal by Subject|1|||
124981942|NCT02406677|449559844|FG001|Overall Study|Withdrawal by Subject|0|||
124981943|NCT01114880|449559845|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
124981944|NCT01114880|449559846|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
124981945|NCT01114880|449559845|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
124981946|NCT01114880|449559846|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
124981947|NCT01114880|449559845|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
124981948|NCT01114880|449559846|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
124981949|NCT01114880|449559845|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
124981950|NCT01114880|449559846|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
124981951|NCT01114880|449559845|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
124981952|NCT01114880|449559846|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
124981953|NCT01114880|449559845|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
124981954|NCT01114880|449559846|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
124981955|NCT04531904|449559847|FG000|Overall Study|Lost to Follow-up|1|||
124981956|NCT04531904|449559847|FG000|Overall Study|Death|14|||
124981957|NCT00283244|449559848|FG000|Overall Study|Adverse Event|0|||
124981958|NCT00283244|449559849|FG001|Overall Study|Adverse Event|8|||
124981959|NCT00283244|449559850|FG002|Overall Study|Adverse Event|11|||
124981960|NCT00283244|449559848|FG000|Overall Study|Death|4|||
124981961|NCT00283244|449559849|FG001|Overall Study|Death|3|||
124981962|NCT00283244|449559850|FG002|Overall Study|Death|2|||
124981963|NCT00283244|449559848|FG000|Overall Study|Lack of Efficacy|8|||
124981964|NCT00283244|449559849|FG001|Overall Study|Lack of Efficacy|32|||
124981965|NCT00283244|449559850|FG002|Overall Study|Lack of Efficacy|26|||
124981966|NCT00283244|449559848|FG000|Overall Study|Withdrawal by Subject|1|||
124981967|NCT00283244|449559849|FG001|Overall Study|Withdrawal by Subject|2|||
124981968|NCT00283244|449559850|FG002|Overall Study|Withdrawal by Subject|2|||
124981969|NCT00283244|449559848|FG000|Overall Study|Physician Decision|0|||
124981970|NCT00283244|449559849|FG001|Overall Study|Physician Decision|0|||
124981971|NCT00283244|449559850|FG002|Overall Study|Physician Decision|1|||
124981972|NCT00283244|449559848|FG000|Overall Study|Medical illness (other complicating dz)|4|||
124981973|NCT00283244|449559849|FG001|Overall Study|Medical illness (other complicating dz)|3|||
124981974|NCT00283244|449559850|FG002|Overall Study|Medical illness (other complicating dz)|6|||
124981975|NCT00283244|449559848|FG000|Overall Study|Clinical deterioration|1|||
124981976|NCT00283244|449559849|FG001|Overall Study|Clinical deterioration|3|||
124981977|NCT00283244|449559850|FG002|Overall Study|Clinical deterioration|3|||
124981978|NCT04500769|449561218|FG000|Overall Study|Withdrawal by Subject|5|||
124981979|NCT01967147|449561219|FG000|Overall Study|Adverse Event|5|||
124543545|NCT00344968|447945035|FG002|Overall Study|Protocol Violation|5|||
124543546|NCT00344968|447945033|FG000|Overall Study|Withdrawal by Subject|14|||
124543547|NCT00344968|447945034|FG001|Overall Study|Withdrawal by Subject|31|||
124543548|NCT00344968|447945035|FG002|Overall Study|Withdrawal by Subject|27|||
124543549|NCT00344968|447945033|FG000|Overall Study|Lost to Follow-up|24|||
124543550|NCT00344968|447945034|FG001|Overall Study|Lost to Follow-up|37|||
124543551|NCT00344968|447945035|FG002|Overall Study|Lost to Follow-up|37|||
124543552|NCT00344968|447945033|FG000|Overall Study|Death|11|||
124543553|NCT00344968|447945034|FG001|Overall Study|Death|27|||
124543554|NCT00344968|447945035|FG002|Overall Study|Death|31|||
124543555|NCT00344968|447945033|FG000|Overall Study|Other|0|||
124543556|NCT00344968|447945034|FG001|Overall Study|Other|1|||
124543557|NCT00344968|447945035|FG002|Overall Study|Other|0|||
124543558|NCT03735680|447945036|FG000|Overall Study|Withdrawal by Subject|0|||
124543559|NCT03735680|447945037|FG001|Overall Study|Withdrawal by Subject|1|||
124543560|NCT03735680|447945038|FG002|Overall Study|Withdrawal by Subject|0|||
124543561|NCT03735680|447945039|FG003|Overall Study|Withdrawal by Subject|0|||
124543562|NCT03735680|447945040|FG004|Overall Study|Withdrawal by Subject|0|||
124543563|NCT03735680|447945041|FG005|Overall Study|Withdrawal by Subject|1|||
124543564|NCT03735680|447945036|FG000|Overall Study|Patient unable or unwilling to continue|0|||
124543565|NCT03735680|447945037|FG001|Overall Study|Patient unable or unwilling to continue|0|||
124543566|NCT03735680|447945038|FG002|Overall Study|Patient unable or unwilling to continue|1|||
124543567|NCT03735680|447945039|FG003|Overall Study|Patient unable or unwilling to continue|0|||
124543568|NCT03735680|447945040|FG004|Overall Study|Patient unable or unwilling to continue|0|||
124981980|NCT01967147|449561220|FG001|Overall Study|Adverse Event|2|||
124981981|NCT01967147|449561219|FG000|Overall Study|Lack of Efficacy|1|||
124543569|NCT03735680|447945041|FG005|Overall Study|Patient unable or unwilling to continue|0|||
124543570|NCT01422876|447945043|FG000|Week 24|Lost to Follow-up|1|||
124543571|NCT01422876|447945044|FG001|Week 24|Lost to Follow-up|1|||
124543572|NCT01422876|447945045|FG002|Week 24|Lost to Follow-up|2|||
124543573|NCT01422876|447945046|FG003|Week 24|Lost to Follow-up|4|||
124543574|NCT01422876|447945047|FG004|Week 24|Lost to Follow-up|2|||
124543575|NCT01422876|447945048|FG005|Week 24|Lost to Follow-up|0|||
124543576|NCT01422876|447945049|FG006|Week 24|Lost to Follow-up|1|||
124543577|NCT01422876|447945050|FG007|Week 24|Lost to Follow-up|3|||
124543578|NCT01422876|447945051|FG008|Week 24|Lost to Follow-up|3|||
124543579|NCT01422876|447945052|FG009|Week 24|Lost to Follow-up|4|||
124543580|NCT01422876|447945043|FG000|Week 24|Consent withdrawn|5|||
124543581|NCT01422876|447945044|FG001|Week 24|Consent withdrawn|1|||
124543582|NCT01422876|447945045|FG002|Week 24|Consent withdrawn|3|||
124543583|NCT01422876|447945046|FG003|Week 24|Consent withdrawn|4|||
124543584|NCT01422876|447945047|FG004|Week 24|Consent withdrawn|5|||
124543585|NCT01422876|447945048|FG005|Week 24|Consent withdrawn|6|||
124543586|NCT01422876|447945049|FG006|Week 24|Consent withdrawn|5|||
124543587|NCT01422876|447945050|FG007|Week 24|Consent withdrawn|4|||
124543588|NCT01422876|447945051|FG008|Week 24|Consent withdrawn|3|||
124543589|NCT01422876|447945052|FG009|Week 24|Consent withdrawn|6|||
124543590|NCT01422876|447945043|FG000|Week 24|Death|0|||
124543591|NCT01422876|447945044|FG001|Week 24|Death|1|||
124543592|NCT01422876|447945045|FG002|Week 24|Death|0|||
124543593|NCT01422876|447945046|FG003|Week 24|Death|0|||
124543594|NCT01422876|447945047|FG004|Week 24|Death|0|||
124543595|NCT01422876|447945048|FG005|Week 24|Death|0|||
124543596|NCT01422876|447945049|FG006|Week 24|Death|0|||
124543597|NCT01422876|447945050|FG007|Week 24|Death|0|||
124543598|NCT01422876|447945051|FG008|Week 24|Death|0|||
124543599|NCT01422876|447945052|FG009|Week 24|Death|0|||
124543600|NCT01422876|447945043|FG000|Week 52|Lost to Follow-up|3|||
124543601|NCT01422876|447945044|FG001|Week 52|Lost to Follow-up|5|||
124543602|NCT01422876|447945045|FG002|Week 52|Lost to Follow-up|7|||
124543603|NCT01422876|447945046|FG003|Week 52|Lost to Follow-up|5|||
124543604|NCT01422876|447945047|FG004|Week 52|Lost to Follow-up|8|||
124543605|NCT01422876|447945048|FG005|Week 52|Lost to Follow-up|5|||
124543606|NCT01422876|447945049|FG006|Week 52|Lost to Follow-up|5|||
124543607|NCT01422876|447945050|FG007|Week 52|Lost to Follow-up|8|||
124872128|NCT02178059|449154022|FG001|Washout|Physician Decision|0|||
124872129|NCT05178121|449154023|FG000|Overall Study|Other|4|||
124872130|NCT05178121|449154023|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
124872131|NCT00245102|449154024|FG000|Overall Study|Not Treated|1|||
124872132|NCT00245102|449154025|FG001|Overall Study|Not Treated|0|||
124872133|NCT00245102|449154026|FG002|Overall Study|Not Treated|1|||
124872134|NCT00245102|449154027|FG003|Overall Study|Not Treated|0|||
124872135|NCT00245102|449154028|FG004|Overall Study|Not Treated|0|||
124872136|NCT00245102|449154029|FG005|Overall Study|Not Treated|0|||
124872137|NCT00245102|449154024|FG000|Overall Study|Protocol Violation|1|||
124872138|NCT00245102|449154025|FG001|Overall Study|Protocol Violation|0|||
124872139|NCT00245102|449154026|FG002|Overall Study|Protocol Violation|0|||
124872140|NCT00245102|449154027|FG003|Overall Study|Protocol Violation|0|||
124872141|NCT00245102|449154028|FG004|Overall Study|Protocol Violation|0|||
124872142|NCT00245102|449154029|FG005|Overall Study|Protocol Violation|0|||
124872143|NCT00245102|449154024|FG000|Overall Study|Death|0|||
124872144|NCT00245102|449154025|FG001|Overall Study|Death|0|||
124872145|NCT00245102|449154026|FG002|Overall Study|Death|0|||
124872146|NCT00245102|449154027|FG003|Overall Study|Death|1|||
124872147|NCT00245102|449154028|FG004|Overall Study|Death|0|||
124872148|NCT00245102|449154029|FG005|Overall Study|Death|0|||
124872149|NCT00245102|449154024|FG000|Overall Study|Adverse Event|4|||
124872150|NCT00245102|449154025|FG001|Overall Study|Adverse Event|2|||
124872151|NCT00245102|449154026|FG002|Overall Study|Adverse Event|5|||
124872152|NCT00245102|449154027|FG003|Overall Study|Adverse Event|1|||
124872153|NCT00245102|449154028|FG004|Overall Study|Adverse Event|0|||
124872154|NCT00245102|449154029|FG005|Overall Study|Adverse Event|2|||
124872155|NCT00245102|449154024|FG000|Overall Study|Decline in performance|0|||
124872156|NCT00245102|449154025|FG001|Overall Study|Decline in performance|2|||
124872157|NCT00245102|449154026|FG002|Overall Study|Decline in performance|0|||
124872158|NCT00245102|449154027|FG003|Overall Study|Decline in performance|1|||
124872159|NCT00245102|449154028|FG004|Overall Study|Decline in performance|0|||
124872160|NCT00245102|449154029|FG005|Overall Study|Decline in performance|2|||
124872161|NCT00245102|449154024|FG000|Overall Study|Participant needed surgery|0|||
124872162|NCT00245102|449154025|FG001|Overall Study|Participant needed surgery|0|||
124543608|NCT01422876|447945051|FG008|Week 52|Lost to Follow-up|7|||
124543609|NCT01422876|447945052|FG009|Week 52|Lost to Follow-up|8|||
124543610|NCT01422876|447945043|FG000|Week 52|Consent withdrawn|9|||
124543611|NCT01422876|447945044|FG001|Week 52|Consent withdrawn|4|||
124543612|NCT01422876|447945045|FG002|Week 52|Consent withdrawn|6|||
124543613|NCT01422876|447945046|FG003|Week 52|Consent withdrawn|12|||
124543614|NCT01422876|447945047|FG004|Week 52|Consent withdrawn|7|||
124543615|NCT01422876|447945048|FG005|Week 52|Consent withdrawn|12|||
124543616|NCT01422876|447945049|FG006|Week 52|Consent withdrawn|10|||
124543617|NCT01422876|447945050|FG007|Week 52|Consent withdrawn|12|||
124543618|NCT01422876|447945051|FG008|Week 52|Consent withdrawn|13|||
124543619|NCT01422876|447945052|FG009|Week 52|Consent withdrawn|9|||
124543620|NCT01422876|447945043|FG000|Week 52|Death|0|||
124543621|NCT01422876|447945044|FG001|Week 52|Death|1|||
124872163|NCT00245102|449154026|FG002|Overall Study|Participant needed surgery|1|||
124543622|NCT01422876|447945045|FG002|Week 52|Death|0|||
124543623|NCT01422876|447945046|FG003|Week 52|Death|1|||
124543624|NCT01422876|447945047|FG004|Week 52|Death|0|||
124543625|NCT01422876|447945048|FG005|Week 52|Death|0|||
124543626|NCT01422876|447945049|FG006|Week 52|Death|1|||
124543627|NCT01422876|447945050|FG007|Week 52|Death|3|||
124543628|NCT01422876|447945051|FG008|Week 52|Death|1|||
124543629|NCT01422876|447945052|FG009|Week 52|Death|0|||
124543630|NCT00054639|447945062|FG000|Overall Study|Lack of Efficacy|1|||
124543631|NCT00054639|447945062|FG000|Overall Study|Physician Decision|1|||
124543632|NCT05028816|447945074|FG000|Overall Study|Lost to Follow-up|5|||
124543633|NCT05028816|447945075|FG001|Overall Study|Lost to Follow-up|3|||
124543634|NCT05028816|447945074|FG000|Overall Study|Withdrawal by Subject|4|||
124543635|NCT05028816|447945075|FG001|Overall Study|Withdrawal by Subject|1|||
124543636|NCT05028816|447945074|FG000|Overall Study|Physician Decision|1|||
124543637|NCT05028816|447945075|FG001|Overall Study|Physician Decision|0|||
124543638|NCT05064436|447945076|FG000|Overall Study|Other Reasons|1|||
124543639|NCT05064436|447945077|FG001|Overall Study|Other Reasons|0|||
124543640|NCT01711736|447945079|FG000|Overall Study|Lost to Follow-up|4|||
124543641|NCT01711736|447945080|FG001|Overall Study|Lost to Follow-up|1|||
124543642|NCT01711736|447945079|FG000|Overall Study|Withdrawal by Subject|6|||
124543643|NCT01711736|447945080|FG001|Overall Study|Withdrawal by Subject|6|||
124543644|NCT01711736|447945079|FG000|Overall Study|Migrated/moved from study area|2|||
124543645|NCT01711736|447945080|FG001|Overall Study|Migrated/moved from study area|1|||
124543646|NCT03113760|447945081|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
124543647|NCT03113760|447945082|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
124543648|NCT03113760|447945083|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
124543649|NCT03113760|447945084|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
124543650|NCT03113760|447945081|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
124543651|NCT03113760|447945082|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
124543652|NCT03113760|447945083|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
124543653|NCT03113760|447945084|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
124543654|NCT03113760|447945081|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
124543655|NCT03113760|447945082|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
124543656|NCT03113760|447945083|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
124543657|NCT03113760|447945084|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
124543658|NCT02506101|447945085|FG000|Overall Study|Transportation issues|1|||
124543659|NCT02506101|447945086|FG001|Overall Study|Transportation issues|0|||
124543660|NCT02506101|447945085|FG000|Overall Study|No enrollment and staff unavailability|1|||
124543661|NCT02506101|447945086|FG001|Overall Study|No enrollment and staff unavailability|0|||
124543662|NCT00003526|447945087|FG000|Overall Study|Not evaluable|6|||
124543663|NCT00779857|447945088|FG000|Overall Study|Death|1|||
124543664|NCT00779857|447945088|FG000|Overall Study|Withdrawal by Subject|3|||
124543665|NCT00779857|447945088|FG000|Overall Study|Missed Visit|2|||
124543666|NCT00620776|447945093|FG000|Overall Study|Did not receive treatment|3|||
124543667|NCT00620776|447945094|FG001|Overall Study|Did not receive treatment|5|||
124543668|NCT00620776|447945093|FG000|Overall Study|Adverse Event|2|||
124543669|NCT00620776|447945094|FG001|Overall Study|Adverse Event|3|||
124543670|NCT00620776|447945093|FG000|Overall Study|Lack of Efficacy|2|||
124543671|NCT00620776|447945094|FG001|Overall Study|Lack of Efficacy|1|||
124543672|NCT00620776|447945093|FG000|Overall Study|Lost to Follow-up|2|||
124543673|NCT00620776|447945094|FG001|Overall Study|Lost to Follow-up|5|||
124543674|NCT00620776|447945093|FG000|Overall Study|Withdrawal by Subject|3|||
124543675|NCT00620776|447945094|FG001|Overall Study|Withdrawal by Subject|2|||
124543676|NCT01725217|447945095|FG000|Overall Study|Withdrawal by Subject|1|||
124543677|NCT01725217|447945096|FG001|Overall Study|Withdrawal by Subject|0|||
124543678|NCT01725217|447945097|FG002|Overall Study|Withdrawal by Subject|0|||
124543679|NCT03992456|447945098|FG000|Overall Study|Withdrawal by Subject|1|||
124543680|NCT03992456|447945099|FG001|Overall Study|Withdrawal by Subject|0|||
124543681|NCT03992456|447945098|FG000|Overall Study|Disease progression|4|||
124543682|NCT03992456|447945099|FG001|Overall Study|Disease progression|5|||
124543683|NCT03992456|447945098|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
124543684|NCT03992456|447945099|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
124543685|NCT01977625|447945100|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
124981982|NCT01967147|449561220|FG001|Overall Study|Lack of Efficacy|4|||
124543686|NCT01977625|447945101|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
124543687|NCT01977625|447945100|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
124543688|NCT01977625|447945101|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
124543689|NCT04113746|447945102|FG000|Overall Study|Lost to Follow-up|4|||
124543690|NCT04113746|447945103|FG001|Overall Study|Lost to Follow-up|4|||
124543691|NCT02594384|447945104|FG000|Overall Study|Disease Progression|3|||
124543692|NCT02594384|447945105|FG001|Overall Study|Disease Progression|7|||
124543693|NCT02594384|447945106|FG002|Overall Study|Disease Progression|0|||
124543694|NCT02594384|447945107|FG003|Overall Study|Disease Progression|2|||
124543695|NCT02594384|447945108|FG004|Overall Study|Disease Progression|2|||
124543696|NCT02594384|447945109|FG005|Overall Study|Disease Progression|12|||
124543697|NCT02594384|447945110|FG006|Overall Study|Disease Progression|5|||
124543698|NCT02594384|447945111|FG007|Overall Study|Disease Progression|5|||
124543699|NCT02594384|447945104|FG000|Overall Study|Adverse Event|0|||
124543700|NCT02594384|447945105|FG001|Overall Study|Adverse Event|1|||
124543701|NCT02594384|447945106|FG002|Overall Study|Adverse Event|4|||
124543702|NCT02594384|447945107|FG003|Overall Study|Adverse Event|1|||
124543703|NCT02594384|447945108|FG004|Overall Study|Adverse Event|0|||
124543704|NCT02594384|447945109|FG005|Overall Study|Adverse Event|6|||
124543705|NCT02594384|447945110|FG006|Overall Study|Adverse Event|1|||
124543706|NCT02594384|447945111|FG007|Overall Study|Adverse Event|1|||
124543707|NCT02594384|447945104|FG000|Overall Study|Withdrawal by Subject|0|||
124543708|NCT02594384|447945105|FG001|Overall Study|Withdrawal by Subject|0|||
124543709|NCT02594384|447945106|FG002|Overall Study|Withdrawal by Subject|0|||
124543710|NCT02594384|447945107|FG003|Overall Study|Withdrawal by Subject|1|||
124543711|NCT02594384|447945108|FG004|Overall Study|Withdrawal by Subject|0|||
124543712|NCT02594384|447945109|FG005|Overall Study|Withdrawal by Subject|0|||
124543713|NCT02594384|447945110|FG006|Overall Study|Withdrawal by Subject|0|||
124543714|NCT02594384|447945111|FG007|Overall Study|Withdrawal by Subject|1|||
124981983|NCT01967147|449561219|FG000|Overall Study|Lost to Follow-up|1|||
124543715|NCT02594384|447945104|FG000|Overall Study|Physician Decision|0|||
124543716|NCT02594384|447945105|FG001|Overall Study|Physician Decision|0|||
124543717|NCT02594384|447945106|FG002|Overall Study|Physician Decision|0|||
124543718|NCT02594384|447945107|FG003|Overall Study|Physician Decision|0|||
124543719|NCT02594384|447945108|FG004|Overall Study|Physician Decision|0|||
124543720|NCT02594384|447945109|FG005|Overall Study|Physician Decision|1|||
124543721|NCT02594384|447945110|FG006|Overall Study|Physician Decision|2|||
124543722|NCT02594384|447945111|FG007|Overall Study|Physician Decision|0|||
124543723|NCT02594384|447945104|FG000|Overall Study|Progressive Leukocytosis|0|||
124543724|NCT02594384|447945105|FG001|Overall Study|Progressive Leukocytosis|0|||
124543725|NCT02594384|447945106|FG002|Overall Study|Progressive Leukocytosis|1|||
124543726|NCT02594384|447945107|FG003|Overall Study|Progressive Leukocytosis|0|||
124543727|NCT02594384|447945108|FG004|Overall Study|Progressive Leukocytosis|0|||
124543728|NCT02594384|447945109|FG005|Overall Study|Progressive Leukocytosis|0|||
124543729|NCT02594384|447945110|FG006|Overall Study|Progressive Leukocytosis|0|||
124543730|NCT02594384|447945111|FG007|Overall Study|Progressive Leukocytosis|0|||
124543731|NCT02594384|447945104|FG000|Overall Study|Lack of Efficacy|0|||
124543732|NCT02594384|447945105|FG001|Overall Study|Lack of Efficacy|0|||
124543733|NCT02594384|447945106|FG002|Overall Study|Lack of Efficacy|0|||
124543734|NCT02594384|447945107|FG003|Overall Study|Lack of Efficacy|0|||
124543735|NCT02594384|447945108|FG004|Overall Study|Lack of Efficacy|1|||
124543736|NCT02594384|447945109|FG005|Overall Study|Lack of Efficacy|0|||
124543737|NCT02594384|447945110|FG006|Overall Study|Lack of Efficacy|0|||
124543738|NCT02594384|447945111|FG007|Overall Study|Lack of Efficacy|0|||
124543739|NCT02594384|447945104|FG000|Overall Study|Substantial noncompliance|0|||
124543740|NCT02594384|447945105|FG001|Overall Study|Substantial noncompliance|0|||
124543741|NCT02594384|447945106|FG002|Overall Study|Substantial noncompliance|0|||
124543742|NCT02594384|447945107|FG003|Overall Study|Substantial noncompliance|0|||
124543743|NCT02594384|447945108|FG004|Overall Study|Substantial noncompliance|0|||
124543744|NCT02594384|447945109|FG005|Overall Study|Substantial noncompliance|0|||
124543745|NCT02594384|447945110|FG006|Overall Study|Substantial noncompliance|1|||
124981984|NCT01967147|449561220|FG001|Overall Study|Lost to Follow-up|2|||
124981985|NCT01967147|449561219|FG000|Overall Study|Withdrawal by Subject|2|||
124981986|NCT01967147|449561220|FG001|Overall Study|Withdrawal by Subject|4|||
124981987|NCT01967147|449561219|FG000|Overall Study|Non-compliance with Study Drug|0|||
124981988|NCT01967147|449561220|FG001|Overall Study|Non-compliance with Study Drug|3|||
124981989|NCT01967147|449561219|FG000|Overall Study|Other|4|||
124981990|NCT01967147|449561220|FG001|Overall Study|Other|5|||
124981991|NCT00166712|449561222|FG000|Overall Study|Death|0|||
124981992|NCT00166712|449561223|FG001|Overall Study|Death|1|||
124981993|NCT00166712|449561222|FG000|Overall Study|Adverse Event|1|||
124981994|NCT00166712|449561223|FG001|Overall Study|Adverse Event|0|||
124981995|NCT00166712|449561222|FG000|Overall Study|Withdrawal by Subject|1|||
124981996|NCT00166712|449561223|FG001|Overall Study|Withdrawal by Subject|2|||
124981997|NCT00166712|449561222|FG000|Overall Study|Physician Decision|0|||
124981998|NCT00166712|449561223|FG001|Overall Study|Physician Decision|2|||
124981999|NCT03986944|449561224|FG000|Overall Study|Adverse Event|1|||
124543746|NCT02594384|447945111|FG007|Overall Study|Substantial noncompliance|0|||
124543747|NCT04964960|447945114|FG000|Overall Study|Withdrawal by Subject|1|||
124543748|NCT00483119|447945115|FG000|Overall Study|Adverse Event|0|||
124543749|NCT00483119|447945116|FG001|Overall Study|Adverse Event|1|||
124543750|NCT00483119|447945115|FG000|Overall Study|Physician Decision|1|||
124543751|NCT00483119|447945116|FG001|Overall Study|Physician Decision|0|||
124543752|NCT04668066|447945117|FG000|Part 1: Treatment Phase|Adverse Event|0|||
124543753|NCT04668066|447945118|FG001|Part 1: Treatment Phase|Adverse Event|0|||
124543754|NCT04668066|447945119|FG002|Part 1: Treatment Phase|Adverse Event|0|||
124543755|NCT04668066|447945120|FG003|Part 1: Treatment Phase|Adverse Event|0|||
124543756|NCT04668066|447945121|FG004|Part 1: Treatment Phase|Adverse Event|0|||
124543757|NCT04668066|447945122|FG005|Part 1: Treatment Phase|Adverse Event|0|||
124543758|NCT04668066|447945123|FG006|Part 1: Treatment Phase|Adverse Event|0|||
124543759|NCT04668066|447945124|FG007|Part 1: Treatment Phase|Adverse Event|0|||
124543760|NCT04668066|447945125|FG008|Part 1: Treatment Phase|Adverse Event|0|||
124543761|NCT04668066|447945126|FG009|Part 1: Treatment Phase|Adverse Event|0|||
124543762|NCT04668066|447945127|FG010|Part 1: Treatment Phase|Adverse Event|0|||
124543763|NCT04668066|447945128|FG011|Part 1: Treatment Phase|Adverse Event|1|||
124543764|NCT04668066|447945129|FG012|Part 1: Treatment Phase|Adverse Event|1|||
124543765|NCT04668066|447945130|FG013|Part 1: Treatment Phase|Adverse Event|0|||
124543766|NCT04668066|447945131|FG014|Part 1: Treatment Phase|Adverse Event|0|||
124543767|NCT04668066|447945132|FG015|Part 1: Treatment Phase|Adverse Event|0|||
124543768|NCT04668066|447945133|FG016|Part 1: Treatment Phase|Adverse Event|0|||
124543769|NCT04668066|447945134|FG017|Part 1: Treatment Phase|Adverse Event|0|||
124543770|NCT04668066|447945135|FG018|Part 1: Treatment Phase|Adverse Event|0|||
124543771|NCT04668066|447945117|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
124543772|NCT04668066|447945118|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
124543773|NCT04668066|447945119|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
124543774|NCT04668066|447945120|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
124543775|NCT04668066|447945121|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
124543776|NCT04668066|447945122|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
124543777|NCT04668066|447945123|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
124543778|NCT04668066|447945124|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
124543779|NCT04668066|447945125|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
124543780|NCT04668066|447945126|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
124543781|NCT04668066|447945127|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
124543782|NCT04668066|447945128|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
124543783|NCT04668066|447945129|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
124543784|NCT04668066|447945130|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
124543785|NCT04668066|447945131|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
124982000|NCT03986944|449561225|FG001|Overall Study|Adverse Event|2|||
124982001|NCT03986944|449561226|FG002|Overall Study|Adverse Event|3|||
124982002|NCT03986944|449561224|FG000|Overall Study|Protocol Violation|0|||
124982003|NCT03986944|449561225|FG001|Overall Study|Protocol Violation|1|||
124982004|NCT03986944|449561226|FG002|Overall Study|Protocol Violation|1|||
124982005|NCT03986944|449561224|FG000|Overall Study|Withdrawal by Subject|3|||
124982006|NCT03986944|449561225|FG001|Overall Study|Withdrawal by Subject|5|||
124982007|NCT03986944|449561226|FG002|Overall Study|Withdrawal by Subject|5|||
124982008|NCT03986944|449561224|FG000|Overall Study|Study termination|10|||
124982009|NCT03986944|449561225|FG001|Overall Study|Study termination|10|||
124543786|NCT04668066|447945132|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
124543787|NCT04668066|447945133|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
124543788|NCT04668066|447945134|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
124543789|NCT04668066|447945135|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
124543790|NCT04668066|447945117|FG000|Part 1: Treatment Phase|Other|0|||
124543791|NCT04668066|447945118|FG001|Part 1: Treatment Phase|Other|0|||
124543792|NCT04668066|447945119|FG002|Part 1: Treatment Phase|Other|0|||
124543793|NCT04668066|447945120|FG003|Part 1: Treatment Phase|Other|0|||
124543794|NCT04668066|447945121|FG004|Part 1: Treatment Phase|Other|0|||
124543795|NCT04668066|447945122|FG005|Part 1: Treatment Phase|Other|0|||
124543796|NCT04668066|447945123|FG006|Part 1: Treatment Phase|Other|0|||
124543797|NCT04668066|447945124|FG007|Part 1: Treatment Phase|Other|0|||
124543798|NCT04668066|447945125|FG008|Part 1: Treatment Phase|Other|0|||
124543799|NCT04668066|447945126|FG009|Part 1: Treatment Phase|Other|0|||
124543800|NCT04668066|447945127|FG010|Part 1: Treatment Phase|Other|0|||
124543801|NCT04668066|447945128|FG011|Part 1: Treatment Phase|Other|1|||
124543802|NCT04668066|447945129|FG012|Part 1: Treatment Phase|Other|0|||
124543803|NCT04668066|447945130|FG013|Part 1: Treatment Phase|Other|0|||
124543804|NCT04668066|447945131|FG014|Part 1: Treatment Phase|Other|0|||
124543805|NCT04668066|447945132|FG015|Part 1: Treatment Phase|Other|0|||
124543806|NCT04668066|447945133|FG016|Part 1: Treatment Phase|Other|0|||
124543807|NCT04668066|447945134|FG017|Part 1: Treatment Phase|Other|0|||
124543808|NCT04668066|447945135|FG018|Part 1: Treatment Phase|Other|0|||
124543809|NCT04668066|447945117|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124982010|NCT03986944|449561226|FG002|Overall Study|Study termination|10|||
124982011|NCT03986944|449561224|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
124543810|NCT04668066|447945118|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124543811|NCT04668066|447945119|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124543812|NCT04668066|447945120|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124543813|NCT04668066|447945121|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124543814|NCT04668066|447945122|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124543815|NCT04668066|447945123|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124543816|NCT04668066|447945124|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124543817|NCT04668066|447945125|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124543818|NCT04668066|447945126|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124543819|NCT04668066|447945127|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124543820|NCT04668066|447945128|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124758639|NCT01463306|448739822|FG002|Overall Study|Lack of Efficacy|1|||
124982012|NCT03986944|449561225|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
124982013|NCT03986944|449561226|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
124982014|NCT03986944|449561224|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
124982015|NCT03986944|449561225|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
124982016|NCT03986944|449561226|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
124982017|NCT03339245|449561230|FG000|Overall Study|Adverse Event|1|||
124982018|NCT03339245|449561231|FG001|Overall Study|Adverse Event|1|||
124982019|NCT03339245|449561230|FG000|Overall Study|Withdrawal by Subject|1|||
124982020|NCT03339245|449561231|FG001|Overall Study|Withdrawal by Subject|0|||
124982021|NCT00837694|449561232|FG000|Overall Study|Lost to Follow-up|2|||
124982022|NCT00837694|449561233|FG001|Overall Study|Lost to Follow-up|0|||
124982023|NCT00837694|449561234|FG002|Overall Study|Lost to Follow-up|2|||
124982024|NCT00837694|449561235|FG003|Overall Study|Lost to Follow-up|1|||
124982025|NCT00837694|449561236|FG004|Overall Study|Lost to Follow-up|1|||
124982026|NCT00837694|449561237|FG005|Overall Study|Lost to Follow-up|1|||
124982027|NCT00306670|449561244|FG000|Overall Study|patients recruited; Genentech, the st|0|||
124982028|NCT00306670|449561245|FG001|Overall Study|patients recruited; Genentech, the st|2|||
124982029|NCT00503139|449561246|FG000|Overall Study|Case Report Forms were not collected|4|||
124982030|NCT00503139|449561246|FG000|Overall Study|Protocol Violation|4|||
124982031|NCT02735577|449561247|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
124982032|NCT02735577|449561247|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
124982033|NCT02731690|449561248|FG000|Overall Study|Adverse Event|1|||
124543821|NCT04668066|447945129|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
124543822|NCT04668066|447945130|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124543823|NCT04668066|447945131|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124543824|NCT04668066|447945132|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
124543825|NCT04668066|447945133|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124543826|NCT04668066|447945134|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124543827|NCT04668066|447945135|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
124543828|NCT04668066|447945117|FG000|Part 1: Follow-Up|Adverse Event|0|||
124543829|NCT04668066|447945118|FG001|Part 1: Follow-Up|Adverse Event|0|||
124543830|NCT04668066|447945119|FG002|Part 1: Follow-Up|Adverse Event|0|||
124543831|NCT04668066|447945120|FG003|Part 1: Follow-Up|Adverse Event|0|||
124543832|NCT04668066|447945121|FG004|Part 1: Follow-Up|Adverse Event|0|||
124543833|NCT04668066|447945122|FG005|Part 1: Follow-Up|Adverse Event|0|||
124543834|NCT04668066|447945123|FG006|Part 1: Follow-Up|Adverse Event|0|||
124543835|NCT04668066|447945124|FG007|Part 1: Follow-Up|Adverse Event|0|||
124543836|NCT04668066|447945125|FG008|Part 1: Follow-Up|Adverse Event|0|||
124543837|NCT04668066|447945126|FG009|Part 1: Follow-Up|Adverse Event|0|||
124543838|NCT04668066|447945127|FG010|Part 1: Follow-Up|Adverse Event|0|||
124543839|NCT04668066|447945128|FG011|Part 1: Follow-Up|Adverse Event|1|||
124543840|NCT04668066|447945129|FG012|Part 1: Follow-Up|Adverse Event|0|||
124543841|NCT04668066|447945130|FG013|Part 1: Follow-Up|Adverse Event|0|||
124543842|NCT04668066|447945131|FG014|Part 1: Follow-Up|Adverse Event|0|||
124543843|NCT04668066|447945132|FG015|Part 1: Follow-Up|Adverse Event|0|||
124543844|NCT04668066|447945133|FG016|Part 1: Follow-Up|Adverse Event|0|||
124543845|NCT04668066|447945134|FG017|Part 1: Follow-Up|Adverse Event|0|||
124543846|NCT04668066|447945135|FG018|Part 1: Follow-Up|Adverse Event|0|||
124543847|NCT04668066|447945117|FG000|Part 1: Follow-Up|Other|0|||
124543848|NCT04668066|447945118|FG001|Part 1: Follow-Up|Other|0|||
124543849|NCT04668066|447945119|FG002|Part 1: Follow-Up|Other|0|||
124543850|NCT04668066|447945120|FG003|Part 1: Follow-Up|Other|0|||
124543851|NCT04668066|447945121|FG004|Part 1: Follow-Up|Other|0|||
124543852|NCT04668066|447945122|FG005|Part 1: Follow-Up|Other|0|||
124543853|NCT04668066|447945123|FG006|Part 1: Follow-Up|Other|0|||
124543854|NCT04668066|447945124|FG007|Part 1: Follow-Up|Other|0|||
124543855|NCT04668066|447945125|FG008|Part 1: Follow-Up|Other|0|||
124543856|NCT04668066|447945126|FG009|Part 1: Follow-Up|Other|0|||
124543857|NCT04668066|447945127|FG010|Part 1: Follow-Up|Other|0|||
124543858|NCT04668066|447945128|FG011|Part 1: Follow-Up|Other|1|||
124543859|NCT04668066|447945129|FG012|Part 1: Follow-Up|Other|1|||
124543860|NCT04668066|447945130|FG013|Part 1: Follow-Up|Other|0|||
124543861|NCT04668066|447945131|FG014|Part 1: Follow-Up|Other|0|||
124543862|NCT04668066|447945132|FG015|Part 1: Follow-Up|Other|0|||
124543863|NCT04668066|447945133|FG016|Part 1: Follow-Up|Other|0|||
124543864|NCT04668066|447945134|FG017|Part 1: Follow-Up|Other|0|||
124543865|NCT04668066|447945135|FG018|Part 1: Follow-Up|Other|0|||
124543866|NCT04668066|447945117|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
124543867|NCT04668066|447945118|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
124543868|NCT04668066|447945119|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
124543869|NCT04668066|447945120|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
124543870|NCT04668066|447945121|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
124543871|NCT04668066|447945122|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
124543872|NCT04668066|447945123|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
124543873|NCT04668066|447945124|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
124543874|NCT04668066|447945125|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
124982034|NCT02731690|449561248|FG000|Overall Study|Withdrawal by Subject|3|||
124982035|NCT02731690|449561248|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
124982036|NCT00833833|449561249|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
124982037|NCT00833833|449561250|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
124982038|NCT00833833|449561251|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
124982039|NCT00833833|449561252|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
124982040|NCT00833833|449561253|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
124982041|NCT00833833|449561254|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
124982042|NCT00833833|449561249|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
124982043|NCT00833833|449561250|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
124982044|NCT00833833|449561251|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
124982045|NCT00833833|449561252|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
124982046|NCT00833833|449561253|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
124982047|NCT00833833|449561254|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
124982048|NCT00833833|449561249|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
124982049|NCT00833833|449561250|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
124982050|NCT00833833|449561251|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
124982051|NCT00833833|449561252|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
124982052|NCT00833833|449561253|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
124982053|NCT00833833|449561254|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
124982054|NCT00833833|449561249|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
124982055|NCT00833833|449561250|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
124982056|NCT00833833|449561251|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
124982057|NCT00833833|449561252|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
124982058|NCT00833833|449561253|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
124982059|NCT00833833|449561254|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
124982060|NCT00833833|449561249|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
124982061|NCT00833833|449561250|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
124982062|NCT00833833|449561251|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
124982063|NCT00833833|449561252|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
124982064|NCT00833833|449561253|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
124982065|NCT00833833|449561254|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
124982066|NCT00833833|449561249|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
124982067|NCT00833833|449561250|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
124982068|NCT00833833|449561251|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
124982069|NCT00833833|449561252|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
124982070|NCT00833833|449561253|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
124982071|NCT00833833|449561254|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
124982072|NCT00833833|449561249|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
124982073|NCT00833833|449561250|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
124982074|NCT00833833|449561251|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
124982075|NCT00833833|449561252|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
124982076|NCT00833833|449561253|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
124982077|NCT00833833|449561254|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
124982078|NCT00833833|449561249|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
124982079|NCT00833833|449561250|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
124982080|NCT00833833|449561251|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
124982081|NCT00833833|449561252|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
124982082|NCT00833833|449561253|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
124982083|NCT00833833|449561254|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
124982084|NCT00833833|449561249|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
124982085|NCT00833833|449561250|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
124982086|NCT00833833|449561251|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
124982087|NCT00833833|449561252|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
124982088|NCT00833833|449561253|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
124982089|NCT00833833|449561254|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
124982090|NCT00833833|449561249|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
124982091|NCT00833833|449561250|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
124982092|NCT00833833|449561251|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
124982093|NCT00833833|449561252|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
124982094|NCT00833833|449561253|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
124982095|NCT00833833|449561254|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
124982096|NCT00833833|449561249|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
124982097|NCT00833833|449561250|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
124982098|NCT00833833|449561251|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
124982099|NCT00833833|449561252|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
124982100|NCT00833833|449561253|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
124982101|NCT00833833|449561254|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
124543875|NCT04668066|447945126|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
124543876|NCT04668066|447945127|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
124543877|NCT04668066|447945128|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
124543878|NCT04668066|447945129|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
124543879|NCT04668066|447945130|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
124543880|NCT04668066|447945131|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
124543881|NCT04668066|447945132|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
124543882|NCT04668066|447945133|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
124543883|NCT04668066|447945134|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
124543884|NCT04668066|447945135|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
124543885|NCT04668066|447945117|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543886|NCT04668066|447945118|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543887|NCT04668066|447945119|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543888|NCT04668066|447945120|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543889|NCT04668066|447945121|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543890|NCT04668066|447945122|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543891|NCT04668066|447945123|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543892|NCT04668066|447945124|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543893|NCT04668066|447945125|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543894|NCT04668066|447945126|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543895|NCT04668066|447945127|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543896|NCT04668066|447945128|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543897|NCT04668066|447945129|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543898|NCT04668066|447945130|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543899|NCT04668066|447945131|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543900|NCT04668066|447945132|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543901|NCT04668066|447945133|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543902|NCT04668066|447945134|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
124543903|NCT04668066|447945135|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
124543904|NCT04668066|447945117|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
124543905|NCT04668066|447945118|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
124543906|NCT04668066|447945119|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
124543907|NCT04668066|447945120|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
124543908|NCT04668066|447945121|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
124543909|NCT04668066|447945122|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
124543910|NCT04668066|447945123|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
124543911|NCT04668066|447945124|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
124543912|NCT04668066|447945125|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
124543913|NCT04668066|447945126|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
124543914|NCT04668066|447945127|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
124543915|NCT04668066|447945128|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
124543916|NCT04668066|447945129|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
124543917|NCT04668066|447945130|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
124543918|NCT04668066|447945131|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
124543919|NCT04668066|447945132|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
124872164|NCT00245102|449154027|FG003|Overall Study|Participant needed surgery|0|||
124872165|NCT00245102|449154028|FG004|Overall Study|Participant needed surgery|0|||
124872166|NCT00245102|449154029|FG005|Overall Study|Participant needed surgery|0|||
124872167|NCT00245102|449154024|FG000|Overall Study|Clinical progression|1|||
124872168|NCT00245102|449154025|FG001|Overall Study|Clinical progression|0|||
124872169|NCT00245102|449154026|FG002|Overall Study|Clinical progression|0|||
124872170|NCT00245102|449154027|FG003|Overall Study|Clinical progression|0|||
124872171|NCT00245102|449154028|FG004|Overall Study|Clinical progression|0|||
124872172|NCT00245102|449154029|FG005|Overall Study|Clinical progression|0|||
124872173|NCT01953003|449154030|FG000|Overall Study|Not treated|0|||
124872174|NCT01953003|449154031|FG001|Overall Study|Not treated|1|||
124872175|NCT01953003|449154030|FG000|Overall Study|Progressive disease|35|||
124872176|NCT01953003|449154031|FG001|Overall Study|Progressive disease|45|||
124872177|NCT01953003|449154030|FG000|Overall Study|Related Adverse events|7|||
124872178|NCT01953003|449154031|FG001|Overall Study|Related Adverse events|2|||
124872179|NCT01953003|449154030|FG000|Overall Study|Non-related adverse events|0|||
124872180|NCT01953003|449154031|FG001|Overall Study|Non-related adverse events|2|||
124872181|NCT01953003|449154030|FG000|Overall Study|Protocol Violation|0|||
124872182|NCT01953003|449154031|FG001|Overall Study|Protocol Violation|1|||
124872183|NCT01953003|449154030|FG000|Overall Study|Withdrawal by Subject|14|||
124872184|NCT01953003|449154031|FG001|Overall Study|Withdrawal by Subject|4|||
124872185|NCT03092375|449154034|FG000|Overall Study|Lack of Efficacy|0|||
124543920|NCT04668066|447945133|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
124543921|NCT04668066|447945134|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
124543922|NCT04668066|447945135|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
124543923|NCT04668066|447945117|FG000|Part 2: Treatment Phase|Other|0|||
124543924|NCT04668066|447945118|FG001|Part 2: Treatment Phase|Other|0|||
124543925|NCT04668066|447945119|FG002|Part 2: Treatment Phase|Other|0|||
124543926|NCT04668066|447945120|FG003|Part 2: Treatment Phase|Other|0|||
124543927|NCT04668066|447945121|FG004|Part 2: Treatment Phase|Other|0|||
124543928|NCT04668066|447945122|FG005|Part 2: Treatment Phase|Other|0|||
124982102|NCT00833833|449561249|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
124982103|NCT00833833|449561250|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
124982104|NCT00833833|449561251|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
124982105|NCT00833833|449561252|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
124543929|NCT04668066|447945123|FG006|Part 2: Treatment Phase|Other|0|||
124543930|NCT04668066|447945124|FG007|Part 2: Treatment Phase|Other|0|||
124543931|NCT04668066|447945125|FG008|Part 2: Treatment Phase|Other|0|||
124543932|NCT04668066|447945126|FG009|Part 2: Treatment Phase|Other|0|||
124543933|NCT04668066|447945127|FG010|Part 2: Treatment Phase|Other|0|||
124543934|NCT04668066|447945128|FG011|Part 2: Treatment Phase|Other|0|||
124543935|NCT04668066|447945129|FG012|Part 2: Treatment Phase|Other|0|||
124543936|NCT04668066|447945130|FG013|Part 2: Treatment Phase|Other|0|||
124543937|NCT04668066|447945131|FG014|Part 2: Treatment Phase|Other|0|||
124543938|NCT04668066|447945132|FG015|Part 2: Treatment Phase|Other|0|||
124543939|NCT04668066|447945133|FG016|Part 2: Treatment Phase|Other|0|||
124543940|NCT04668066|447945134|FG017|Part 2: Treatment Phase|Other|0|||
124543941|NCT04668066|447945135|FG018|Part 2: Treatment Phase|Other|1|||
124543942|NCT04668066|447945117|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543943|NCT04668066|447945118|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543944|NCT04668066|447945119|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543945|NCT04668066|447945120|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543946|NCT04668066|447945121|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543947|NCT04668066|447945122|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543948|NCT04668066|447945123|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543949|NCT04668066|447945124|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543950|NCT04668066|447945125|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543951|NCT04668066|447945126|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543952|NCT04668066|447945127|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543953|NCT04668066|447945128|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543954|NCT04668066|447945129|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543955|NCT04668066|447945130|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543956|NCT04668066|447945131|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543957|NCT04668066|447945132|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543958|NCT04668066|447945133|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543959|NCT04668066|447945134|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
124543960|NCT04668066|447945135|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
124543961|NCT01195662|447945140|FG000|Double Blind Treatment Period|Adverse Event|4|||
124543962|NCT01195662|447945141|FG001|Double Blind Treatment Period|Adverse Event|1|||
124543963|NCT01195662|447945142|FG002|Double Blind Treatment Period|Adverse Event|2|||
124543964|NCT01195662|447945140|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
124543965|NCT01195662|447945141|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
124543966|NCT01195662|447945142|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
124543967|NCT01195662|447945140|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
124543968|NCT01195662|447945141|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
124543969|NCT01195662|447945142|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
124543970|NCT01195662|447945140|FG000|Double Blind Treatment Period|Administrative reason|2|||
124543971|NCT01195662|447945141|FG001|Double Blind Treatment Period|Administrative reason|1|||
124543972|NCT01195662|447945142|FG002|Double Blind Treatment Period|Administrative reason|1|||
124543973|NCT01195662|447945140|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
124543974|NCT01195662|447945141|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
124543975|NCT01195662|447945142|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
124982106|NCT00833833|449561253|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
124982107|NCT00833833|449561254|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
124982108|NCT00833833|449561249|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
124982109|NCT00833833|449561250|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
124982110|NCT00833833|449561251|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
124982111|NCT00833833|449561252|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
124982112|NCT00833833|449561253|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
124982113|NCT00833833|449561254|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
124982114|NCT01994837|449561255|FG000|Overall Study|Progressive disease per protocol|23|||
124982115|NCT01994837|449561255|FG000|Overall Study|Adv event related to progressive disease|3|||
124982116|NCT01994837|449561255|FG000|Overall Study|Fatal progressive disease|2|||
124982117|NCT01994837|449561255|FG000|Overall Study|Adverse event not related to progression|1|||
124982118|NCT01994837|449561255|FG000|Overall Study|Chose palliative care|1|||
124982119|NCT01994837|449561255|FG000|Overall Study|Proceeded to transplant|1|||
124982120|NCT01994837|449561255|FG000|Overall Study|Removed from study due to no response|1|||
124982121|NCT01127893|449561256|FG000|Overall Study|Study Termination by the Sponsor|1|||
124543976|NCT01195662|447945140|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
124543977|NCT01195662|447945141|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
124543978|NCT01195662|447945142|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
124543979|NCT01195662|447945140|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
124543980|NCT01195662|447945141|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
124982122|NCT01262677|449561257|FG000|Overall Study|Does not meet entrance criteria|0|||
124982123|NCT01262677|449561258|FG001|Overall Study|Does not meet entrance criteria|2|||
124982124|NCT01262677|449561259|FG002|Overall Study|Does not meet entrance criteria|0|||
124982125|NCT01262677|449561257|FG000|Overall Study|Insufficient clinical response|0|||
124982126|NCT01262677|449561258|FG001|Overall Study|Insufficient clinical response|0|||
124982127|NCT01262677|449561259|FG002|Overall Study|Insufficient clinical response|1|||
124982128|NCT01262677|449561257|FG000|Overall Study|Lost to Follow-up|1|||
124982129|NCT01262677|449561258|FG001|Overall Study|Lost to Follow-up|0|||
124982130|NCT01262677|449561259|FG002|Overall Study|Lost to Follow-up|2|||
124982131|NCT01262677|449561257|FG000|Overall Study|No longer willing to participate|3|||
124982132|NCT01262677|449561258|FG001|Overall Study|No longer willing to participate|3|||
124982133|NCT01262677|449561259|FG002|Overall Study|No longer willing to participate|2|||
124982134|NCT01262677|449561257|FG000|Overall Study|Reason not provided|2|||
124982135|NCT01262677|449561258|FG001|Overall Study|Reason not provided|1|||
124982136|NCT01262677|449561259|FG002|Overall Study|Reason not provided|3|||
124982137|NCT01262677|449561257|FG000|Overall Study|Protocol Violation|0|||
124982138|NCT01262677|449561258|FG001|Overall Study|Protocol Violation|1|||
124982139|NCT01262677|449561259|FG002|Overall Study|Protocol Violation|1|||
124982140|NCT01262677|449561257|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
124982141|NCT01262677|449561258|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
124982142|NCT01262677|449561259|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
124982143|NCT03446781|449561265|FG000|Overall Study|Lost to Follow-up|11|||
124982144|NCT03446781|449561266|FG001|Overall Study|Lost to Follow-up|5|||
124982145|NCT03446781|449561265|FG000|Overall Study|Withdrawal by Subject|9|||
124982146|NCT03446781|449561266|FG001|Overall Study|Withdrawal by Subject|7|||
124982147|NCT03446781|449561265|FG000|Overall Study|Adverse Event|8|||
124982148|NCT03446781|449561266|FG001|Overall Study|Adverse Event|2|||
124982149|NCT03446781|449561265|FG000|Overall Study|Protocol Violation|0|||
124982150|NCT03446781|449561266|FG001|Overall Study|Protocol Violation|3|||
124982151|NCT01638429|449561273|FG000|Overall Study|Withdrawal by Subject|1|||
124982152|NCT00996476|449561275|FG000|Overall Study|Withdrawal by Subject|1|||
124982153|NCT00996476|449561276|FG001|Overall Study|Withdrawal by Subject|2|||
124982154|NCT00996476|449561277|FG002|Overall Study|Withdrawal by Subject|1|||
124982155|NCT00996476|449561278|FG003|Overall Study|Withdrawal by Subject|0|||
124982156|NCT00996476|449561279|FG004|Overall Study|Withdrawal by Subject|1|||
124982157|NCT00996476|449561275|FG000|Overall Study|Adverse Event|0|||
124982158|NCT00996476|449561276|FG001|Overall Study|Adverse Event|1|||
124982159|NCT00996476|449561277|FG002|Overall Study|Adverse Event|0|||
124982160|NCT00996476|449561278|FG003|Overall Study|Adverse Event|0|||
124982161|NCT00996476|449561279|FG004|Overall Study|Adverse Event|1|||
124982162|NCT00473265|449561280|FG000|Overall Study|Unrelated adverse event|5|||
124982163|NCT00473265|449561280|FG000|Overall Study|Off treatment early|15|||
124982164|NCT01802567|449561281|FG000|Overall Study|Withdrawal by Subject|2|||
124982165|NCT01802567|449561281|FG000|Overall Study|Physician Decision|1|||
124982166|NCT01802567|449561281|FG000|Overall Study|Lack of Efficacy|7|||
124543981|NCT01195662|447945142|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
124543982|NCT01195662|447945140|FG000|Double Blind Treatment Period|Non-specified|3|||
124543983|NCT01195662|447945141|FG001|Double Blind Treatment Period|Non-specified|0|||
124543984|NCT01195662|447945142|FG002|Double Blind Treatment Period|Non-specified|0|||
124543985|NCT01195662|447945140|FG000|Double Blind Treatment Period|Missing disposition information|0|||
124543986|NCT01195662|447945141|FG001|Double Blind Treatment Period|Missing disposition information|1|||
124543987|NCT01195662|447945142|FG002|Double Blind Treatment Period|Missing disposition information|1|||
124543988|NCT01195662|447945140|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
124543989|NCT01195662|447945141|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
124543990|NCT01195662|447945142|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
124543991|NCT01195662|447945140|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
124543992|NCT01195662|447945141|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
124543993|NCT01195662|447945142|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
124543994|NCT01215968|447945143|FG000|Overall Study|Adverse Event|0|||
124543995|NCT01215968|447945144|FG001|Overall Study|Adverse Event|2|||
124543996|NCT01215968|447945143|FG000|Overall Study|Protocol Violation|2|||
124543997|NCT01215968|447945144|FG001|Overall Study|Protocol Violation|4|||
124543998|NCT01215968|447945143|FG000|Overall Study|Not received study drug|0|||
124543999|NCT01215968|447945144|FG001|Overall Study|Not received study drug|1|||
124544000|NCT05643573|447945148|FG000|Overall Study|Adverse Event|117|||
124544001|NCT05643573|447945149|FG001|Overall Study|Adverse Event|90|||
124544002|NCT05643573|447945148|FG000|Overall Study|Death|53|||
124544003|NCT05643573|447945149|FG001|Overall Study|Death|57|||
124544004|NCT05643573|447945148|FG000|Overall Study|Lost to Follow-up|6|||
124544005|NCT05643573|447945149|FG001|Overall Study|Lost to Follow-up|3|||
124544006|NCT05643573|447945148|FG000|Overall Study|Other|18|||
124544007|NCT05643573|447945149|FG001|Overall Study|Other|15|||
124982167|NCT01802567|449561281|FG000|Overall Study|Consented but did not start therapy|7|||
124982168|NCT01802567|449561281|FG000|Overall Study|Protocol Violation|1|||
124982169|NCT01895101|449561286|FG000|Overall Study|OPCAB procedure|1|||
124544008|NCT05643573|447945148|FG000|Overall Study|Outcome event|64|||
124544009|NCT05643573|447945149|FG001|Overall Study|Outcome event|36|||
124544010|NCT05643573|447945148|FG000|Overall Study|Physician Decision|33|||
124544011|NCT05643573|447945149|FG001|Overall Study|Physician Decision|19|||
124544012|NCT05643573|447945148|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
124544013|NCT05643573|447945149|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
124544014|NCT05643573|447945148|FG000|Overall Study|Site terminated by sponsor|10|||
124544015|NCT05643573|447945149|FG001|Overall Study|Site terminated by sponsor|10|||
124544016|NCT05643573|447945148|FG000|Overall Study|Study terminated by sponsor|1|||
124544017|NCT05643573|447945149|FG001|Overall Study|Study terminated by sponsor|0|||
124544018|NCT05643573|447945148|FG000|Overall Study|Withdrawal by Subject|178|||
124544019|NCT05643573|447945149|FG001|Overall Study|Withdrawal by Subject|130|||
124544020|NCT04768881|447945150|FG000|Overall Study|Completed Study Follow-up|0|||
124544021|NCT04768881|447945151|FG001|Overall Study|Completed Study Follow-up|2|||
124544022|NCT04768881|447945150|FG000|Overall Study|Death|3|||
124544023|NCT04768881|447945151|FG001|Overall Study|Death|2|||
124544024|NCT04768881|447945150|FG000|Overall Study|Study Terminated by Sponsor|2|||
124544025|NCT04768881|447945151|FG001|Overall Study|Study Terminated by Sponsor|2|||
124544026|NCT04768881|447945150|FG000|Overall Study|Withdrawal by Subject|2|||
124544027|NCT04768881|447945151|FG001|Overall Study|Withdrawal by Subject|0|||
124544028|NCT04768881|447945150|FG000|Overall Study|Other|2|||
124544029|NCT04768881|447945151|FG001|Overall Study|Other|0|||
124544030|NCT01119118|447945153|FG000|Overall Study|Adverse Event|1|||
124544031|NCT01593761|447945154|FG000|Overall Study|Lost to Follow-up|1|||
124544032|NCT01593761|447945154|FG000|Overall Study|culture negative for MRSA at baseline|5|||
124544033|NCT01593761|447945154|FG000|Overall Study|positive for hepatitis C virus|1|||
124544034|NCT01593761|447945154|FG000|Overall Study|secondary cellulitis|1|||
124544035|NCT01012609|447946679|FG000|Overall Study|Withdrawal by Subject|1|||
124544036|NCT01012609|447946680|FG001|Overall Study|Withdrawal by Subject|1|||
124544037|NCT01453296|447946681|FG000|Treatment Period 1|Adverse Event|0|||
124544038|NCT01453296|447946682|FG001|Treatment Period 1|Adverse Event|1|||
124544039|NCT01453296|447946681|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
124544040|NCT01453296|447946682|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
124544041|NCT01453296|447946681|FG000|Treatment Period 2|Adverse Event|1|||
124544042|NCT01453296|447946682|FG001|Treatment Period 2|Adverse Event|0|||
124544043|NCT01453296|447946681|FG000|Treatment Period 2|Withdrawal by Subject|1|||
124544044|NCT01453296|447946682|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124544045|NCT03557775|447946685|FG000|Overall Study|Withdrawal by Subject|1|||
124544046|NCT03557775|447946686|FG001|Overall Study|Withdrawal by Subject|2|||
124544047|NCT03557775|447946687|FG002|Overall Study|Withdrawal by Subject|4|||
124544048|NCT03557775|447946685|FG000|Overall Study|Physician Decision|0|||
124544049|NCT03557775|447946686|FG001|Overall Study|Physician Decision|1|||
124544050|NCT03557775|447946687|FG002|Overall Study|Physician Decision|0|||
124544051|NCT03205046|447946695|FG000|Overall Study|Death|10|||
124544052|NCT03205046|447946696|FG001|Overall Study|Death|6|||
124544053|NCT03205046|447946695|FG000|Overall Study|Withdrawal by Subject|1|||
124544054|NCT03205046|447946696|FG001|Overall Study|Withdrawal by Subject|2|||
124544055|NCT03205046|447946695|FG000|Overall Study|Lost to Follow-up|0|||
124544056|NCT03205046|447946696|FG001|Overall Study|Lost to Follow-up|1|||
124544057|NCT03205046|447946695|FG000|Overall Study|Study terminated by sponsor|2|||
124544058|NCT03205046|447946696|FG001|Overall Study|Study terminated by sponsor|1|||
124544059|NCT01023815|447946697|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
124544060|NCT01023815|447946698|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
124544061|NCT01023815|447946699|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
124544062|NCT01023815|447946700|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
124544063|NCT01023815|447946697|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
124544064|NCT01023815|447946698|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
124544065|NCT01023815|447946699|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
124544066|NCT01023815|447946700|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
124544067|NCT01023815|447946697|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
124544068|NCT01023815|447946698|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
124544069|NCT01023815|447946699|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
124544070|NCT01023815|447946700|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
124644778|NCT00556933|448316537|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
124644779|NCT00556933|448316534|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
124644780|NCT00556933|448316535|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
124544071|NCT01023815|447946697|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
124544072|NCT01023815|447946698|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
124544073|NCT01023815|447946699|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
124544074|NCT01023815|447946700|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
124544075|NCT01023815|447946697|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
124544076|NCT01023815|447946698|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
124644781|NCT00556933|448316536|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
124644782|NCT00556933|448316537|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
124644783|NCT00556933|448316534|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
124644784|NCT00556933|448316535|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
124644785|NCT00556933|448316536|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
124644786|NCT00556933|448316537|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
124644787|NCT00556933|448316534|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
124644788|NCT00556933|448316535|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
124982170|NCT01895101|449561287|FG001|Overall Study|OPCAB procedure|1|||
124982171|NCT01895101|449561288|FG002|Overall Study|OPCAB procedure|3|||
124982172|NCT01895101|449561286|FG000|Overall Study|Withdrawal by Subject|0|||
124982173|NCT01895101|449561287|FG001|Overall Study|Withdrawal by Subject|1|||
124982174|NCT01895101|449561288|FG002|Overall Study|Withdrawal by Subject|2|||
124982175|NCT01895101|449561286|FG000|Overall Study|another study, enrolled in other study|0|||
124982176|NCT01895101|449561287|FG001|Overall Study|another study, enrolled in other study|1|||
124982177|NCT01895101|449561288|FG002|Overall Study|another study, enrolled in other study|0|||
124982178|NCT01895101|449561286|FG000|Overall Study|Death|0|||
124982179|NCT01895101|449561287|FG001|Overall Study|Death|1|||
124982180|NCT01895101|449561288|FG002|Overall Study|Death|0|||
124982181|NCT01895101|449561286|FG000|Overall Study|coagulation disorder|0|||
124982182|NCT01895101|449561287|FG001|Overall Study|coagulation disorder|1|||
124982183|NCT01895101|449561288|FG002|Overall Study|coagulation disorder|0|||
124982184|NCT03339583|449561289|FG000|First Intervention (14 Days)|Adverse Event|1|||
124982185|NCT03339583|449561290|FG001|First Intervention (14 Days)|Adverse Event|0|||
124982186|NCT03339583|449561289|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
124982187|NCT03339583|449561290|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
124982188|NCT03339583|449561289|FG000|Second Intervention (14 Days)|Adverse Event|0|||
124982189|NCT03339583|449561290|FG001|Second Intervention (14 Days)|Adverse Event|1|||
124982190|NCT03339583|449561289|FG000|Follow-up (14 Days)|Physician Decision|6|||
124982191|NCT03339583|449561290|FG001|Follow-up (14 Days)|Physician Decision|3|||
124982192|NCT00734591|449561291|FG000|Screening for Prospective Period|Site did not participate|1604|||
124982193|NCT00734591|449561292|FG001|Screening for Prospective Period|Site did not participate|1488|||
124982194|NCT00734591|449561291|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
124982195|NCT00734591|449561292|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
124982196|NCT00734591|449561291|FG000|Prospective Period|Withdrawal by Subject|11|||
124982197|NCT00734591|449561292|FG001|Prospective Period|Withdrawal by Subject|9|||
124982198|NCT00734591|449561291|FG000|Prospective Period|Lost to Follow-up|37|||
124982199|NCT00734591|449561292|FG001|Prospective Period|Lost to Follow-up|33|||
124982200|NCT00734591|449561291|FG000|Prospective Period|Study Terminated|1|||
124982201|NCT00734591|449561292|FG001|Prospective Period|Study Terminated|0|||
124982202|NCT00734591|449561291|FG000|Prospective Period|Other|2|||
124982203|NCT00734591|449561292|FG001|Prospective Period|Other|2|||
124982204|NCT01659853|449561293|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
124982205|NCT01659853|449561294|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
124982206|NCT01659853|449561293|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
124982207|NCT01659853|449561294|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
124982208|NCT05560243|449561298|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
124982209|NCT00939822|449561303|FG000|Overall Study|Lost to Follow-up|1|||
124982210|NCT00939822|449561304|FG001|Overall Study|Lost to Follow-up|0|||
124982211|NCT00939822|449561303|FG000|Overall Study|withdrew from study due to busy schedule|1|||
124982212|NCT00939822|449561304|FG001|Overall Study|withdrew from study due to busy schedule|1|||
124982213|NCT00939822|449561303|FG000|Overall Study|Mental health issues|0|||
124982214|NCT00939822|449561304|FG001|Overall Study|Mental health issues|2|||
124982215|NCT01072630|449561307|FG000|Overall Study|Adverse Event|11|||
124982216|NCT01072630|449561308|FG001|Overall Study|Adverse Event|19|||
124982217|NCT01072630|449561309|FG002|Overall Study|Adverse Event|2|||
124982218|NCT01072630|449561307|FG000|Overall Study|Lack of Efficacy|10|||
124982219|NCT01072630|449561308|FG001|Overall Study|Lack of Efficacy|10|||
124982220|NCT01072630|449561309|FG002|Overall Study|Lack of Efficacy|1|||
124982221|NCT01072630|449561307|FG000|Overall Study|Withdrawal by Subject|8|||
124982222|NCT01072630|449561308|FG001|Overall Study|Withdrawal by Subject|7|||
124644789|NCT00556933|448316536|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
124644790|NCT00556933|448316537|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
124982223|NCT01072630|449561309|FG002|Overall Study|Withdrawal by Subject|2|||
124982224|NCT01072630|449561307|FG000|Overall Study|Protocol Violation|10|||
124982225|NCT01072630|449561308|FG001|Overall Study|Protocol Violation|8|||
124982226|NCT01072630|449561309|FG002|Overall Study|Protocol Violation|4|||
124982227|NCT01072630|449561307|FG000|Overall Study|Lost to Follow-up|11|||
124982228|NCT01072630|449561308|FG001|Overall Study|Lost to Follow-up|11|||
124982229|NCT01072630|449561309|FG002|Overall Study|Lost to Follow-up|1|||
124982230|NCT01072630|449561307|FG000|Overall Study|Noncompliance with study medication|1|||
124982231|NCT01072630|449561308|FG001|Overall Study|Noncompliance with study medication|1|||
124644791|NCT00556933|448316534|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
124644792|NCT00556933|448316535|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
124644793|NCT00556933|448316536|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
124644794|NCT00556933|448316537|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
124644795|NCT00556933|448316534|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
124644796|NCT00556933|448316535|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
124644797|NCT00556933|448316536|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
124644798|NCT00556933|448316537|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
124644799|NCT00556933|448316534|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
124644800|NCT00556933|448316535|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
124644801|NCT00556933|448316536|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
124644802|NCT00556933|448316537|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
124644803|NCT00556933|448316534|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
124644804|NCT00556933|448316535|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
124644805|NCT00556933|448316536|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
124644806|NCT00556933|448316537|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
124644807|NCT00556933|448316534|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
124644808|NCT00556933|448316535|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
124644809|NCT00556933|448316536|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
124644810|NCT00556933|448316537|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
124644811|NCT00556933|448316534|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
124644812|NCT00556933|448316535|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
124644813|NCT00556933|448316536|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
124644814|NCT00556933|448316537|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
124644815|NCT00556933|448316534|FG000|CNI Withdrawal vs. Minimization|Death|0|||
124644816|NCT00556933|448316535|FG001|CNI Withdrawal vs. Minimization|Death|0|||
124644817|NCT00556933|448316536|FG002|CNI Withdrawal vs. Minimization|Death|0|||
124644818|NCT00556933|448316537|FG003|CNI Withdrawal vs. Minimization|Death|1|||
124644819|NCT01743560|448316538|FG000|Overall Study|Disease progression|26|||
124644820|NCT01743560|448316538|FG000|Overall Study|Adverse Event|8|||
124644821|NCT01743560|448316538|FG000|Overall Study|Death|3|||
124644822|NCT01743560|448316538|FG000|Overall Study|Withdrawal by Subject|2|||
124644823|NCT01743560|448316538|FG000|Overall Study|Protocol Violation|1|||
124644824|NCT01743560|448316538|FG000|Overall Study|>1 dose of study drug|3|||
124644825|NCT00940823|448316541|FG000|Overall Study|Death|8|||
124644826|NCT00940823|448316542|FG001|Overall Study|Death|12|||
124644827|NCT00940823|448316541|FG000|Overall Study|Lost to Follow-up|27|||
124644828|NCT00940823|448316542|FG001|Overall Study|Lost to Follow-up|20|||
124644829|NCT02572076|448316543|FG000|Overall Study|Protocol Violation|1|||
124644830|NCT03395184|448316548|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
124644831|NCT03395184|448316549|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
124644832|NCT03395184|448316550|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
124644833|NCT03395184|448316551|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
124644834|NCT03395184|448316552|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
124644835|NCT03395184|448316553|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
124644836|NCT03395184|448316554|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
124644837|NCT03395184|448316548|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
124711967|NCT01127633|448570697|FG000|Overall Study|Withdrawal by Subject|57|||
124982232|NCT01072630|449561309|FG002|Overall Study|Noncompliance with study medication|1|||
124982233|NCT01072630|449561307|FG000|Overall Study|Noncompliance with study procedures|1|||
124982234|NCT01072630|449561308|FG001|Overall Study|Noncompliance with study procedures|2|||
124982235|NCT01072630|449561309|FG002|Overall Study|Noncompliance with study procedures|1|||
124982236|NCT01072630|449561307|FG000|Overall Study|Other|3|||
124982237|NCT01072630|449561308|FG001|Overall Study|Other|2|||
124982238|NCT01072630|449561309|FG002|Overall Study|Other|1|||
124982239|NCT01232738|449561310|FG000|Overall Study|Death|3|||
124982240|NCT01232738|449561310|FG000|Overall Study|Physician Decision|2|||
124982241|NCT01232738|449561310|FG000|Overall Study|Lost to Follow-up|1|||
124982242|NCT01232738|449561310|FG000|Overall Study|Withdrawal by Subject|2|||
124982243|NCT01232738|449561310|FG000|Overall Study|Adverse Event|5|||
124982244|NCT00338962|449561311|FG000|Overall Study|Lost to Follow-up|3|||
124982245|NCT00338962|449561312|FG001|Overall Study|Lost to Follow-up|3|||
124982246|NCT00338962|449561313|FG002|Overall Study|Lost to Follow-up|2|||
124982247|NCT00338962|449561314|FG003|Overall Study|Lost to Follow-up|3|||
124982248|NCT00338962|449561311|FG000|Overall Study|Withdrawal by Subject|1|||
124982249|NCT00338962|449561312|FG001|Overall Study|Withdrawal by Subject|0|||
124982250|NCT00338962|449561313|FG002|Overall Study|Withdrawal by Subject|0|||
124982251|NCT00338962|449561314|FG003|Overall Study|Withdrawal by Subject|0|||
124982252|NCT00338962|449561311|FG000|Overall Study|No Transportation|2|||
124982253|NCT00338962|449561312|FG001|Overall Study|No Transportation|0|||
124982254|NCT00338962|449561313|FG002|Overall Study|No Transportation|0|||
124982255|NCT00338962|449561314|FG003|Overall Study|No Transportation|0|||
124982256|NCT00338962|449561311|FG000|Overall Study|Time Constraint|2|||
124644838|NCT03395184|448316549|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
124644839|NCT03395184|448316550|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
124644840|NCT03395184|448316551|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
124644841|NCT03395184|448316552|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
124644842|NCT03395184|448316553|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
124644843|NCT03395184|448316554|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
124644844|NCT03395184|448316548|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
124644845|NCT03395184|448316549|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
124644846|NCT03395184|448316550|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
124644847|NCT03395184|448316551|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
124644848|NCT03395184|448316552|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
124644849|NCT03395184|448316553|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
124644850|NCT03395184|448316554|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
124644851|NCT03395184|448316548|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
124644852|NCT03395184|448316549|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
124644853|NCT03395184|448316550|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
124644854|NCT03395184|448316551|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
124644855|NCT03395184|448316552|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
124982257|NCT00338962|449561312|FG001|Overall Study|Time Constraint|0|||
124982258|NCT00338962|449561313|FG002|Overall Study|Time Constraint|0|||
124982259|NCT00338962|449561314|FG003|Overall Study|Time Constraint|0|||
124982260|NCT00338962|449561311|FG000|Overall Study|Moved|0|||
124982261|NCT00338962|449561312|FG001|Overall Study|Moved|1|||
124982262|NCT00338962|449561313|FG002|Overall Study|Moved|0|||
124982263|NCT00338962|449561314|FG003|Overall Study|Moved|0|||
124982264|NCT00338962|449561311|FG000|Overall Study|Adverse Event|0|||
124982265|NCT00338962|449561312|FG001|Overall Study|Adverse Event|0|||
124982266|NCT00338962|449561313|FG002|Overall Study|Adverse Event|2|||
124982267|NCT00338962|449561314|FG003|Overall Study|Adverse Event|0|||
124982268|NCT00338962|449561311|FG000|Overall Study|Poor Compliance|0|||
124982269|NCT00338962|449561312|FG001|Overall Study|Poor Compliance|0|||
124982270|NCT00338962|449561313|FG002|Overall Study|Poor Compliance|2|||
124982271|NCT00338962|449561314|FG003|Overall Study|Poor Compliance|0|||
124982272|NCT03046121|449561315|FG000|Overall Study|Death|32|||
124982273|NCT03046121|449561316|FG001|Overall Study|Death|60|||
124982274|NCT03046121|449561315|FG000|Overall Study|Withdrawal by Subject|14|||
124982275|NCT03046121|449561316|FG001|Overall Study|Withdrawal by Subject|12|||
124982276|NCT03214640|449561317|FG000|Overall Study|Protocol Violation|1|||
124982277|NCT03214640|449561318|FG001|Overall Study|Protocol Violation|2|||
124982278|NCT03214640|449561319|FG002|Overall Study|Protocol Violation|1|||
124982279|NCT03214640|449561320|FG003|Overall Study|Protocol Violation|4|||
124982280|NCT00910039|449561321|FG000|Overall Study|Physician Decision|1|||
124982281|NCT04155047|449561327|FG000|Overall Study|Adverse Event|1|||
124982282|NCT04155047|449561328|FG001|Overall Study|Adverse Event|0|||
124982283|NCT04155047|449561327|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
124982284|NCT04155047|449561328|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
124982285|NCT01280357|449561336|FG000|Overall Study|Excluded no internal monitoring|14|||
124982286|NCT01280357|449561336|FG000|Overall Study|IInsufficient data/No data supplied|12|||
124982287|NCT00886795|449561337|FG000|Overall Study|Lack of Efficacy|1|||
124982288|NCT01259089|449561342|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
124982289|NCT01259089|449561343|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
124982290|NCT01259089|449561344|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
124982291|NCT01259089|449561345|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
124982292|NCT01259089|449561346|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
124982293|NCT01259089|449561347|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
124982294|NCT01259089|449561342|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
124982295|NCT01259089|449561343|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
124982296|NCT01259089|449561344|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
124982297|NCT01259089|449561345|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
124982298|NCT01259089|449561346|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
124982299|NCT01259089|449561347|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
124982300|NCT01259089|449561342|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
124982301|NCT01259089|449561343|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
124982302|NCT01259089|449561344|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
124982303|NCT01259089|449561345|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
124982304|NCT01259089|449561346|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
124982305|NCT01259089|449561347|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
124982306|NCT01259089|449561342|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
124982307|NCT01259089|449561343|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
124982308|NCT01259089|449561344|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
124644856|NCT03395184|448316553|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
124644857|NCT03395184|448316554|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
124644858|NCT03395184|448316548|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
124644859|NCT03395184|448316549|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
124644860|NCT03395184|448316550|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
124644861|NCT03395184|448316551|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
124644862|NCT03395184|448316552|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
124644863|NCT03395184|448316553|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
124644864|NCT03395184|448316554|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
124644865|NCT03395184|448316548|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
124644866|NCT03395184|448316549|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
124644867|NCT03395184|448316550|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
124644868|NCT03395184|448316551|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
124644869|NCT03395184|448316552|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
124644870|NCT03395184|448316553|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
124644871|NCT03395184|448316554|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
124644872|NCT03395184|448316548|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
124644873|NCT03395184|448316549|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
124644874|NCT03395184|448316550|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
124644875|NCT03395184|448316551|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
124644876|NCT03395184|448316552|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
124644877|NCT03395184|448316553|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
124644878|NCT03395184|448316554|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
124644879|NCT03395184|448316548|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
124644880|NCT03395184|448316549|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
124644881|NCT03395184|448316550|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
124644882|NCT03395184|448316551|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
124644883|NCT03395184|448316552|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
124644884|NCT03395184|448316553|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
124644885|NCT03395184|448316554|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
124644886|NCT03395184|448316548|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
124644887|NCT03395184|448316549|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
124644888|NCT03395184|448316550|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
124644889|NCT03395184|448316551|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
124644890|NCT03395184|448316552|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
124644891|NCT03395184|448316553|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
124644892|NCT03395184|448316554|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
124644893|NCT03395184|448316548|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
124644894|NCT03395184|448316549|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
124644895|NCT03395184|448316550|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
124644896|NCT03395184|448316551|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
124644897|NCT03395184|448316552|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
124644898|NCT03395184|448316553|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
124644899|NCT03395184|448316554|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
124644900|NCT03395184|448316548|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
124644901|NCT03395184|448316549|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
124644902|NCT03395184|448316550|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
124644903|NCT03395184|448316551|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
124644904|NCT03395184|448316552|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
124644905|NCT03395184|448316553|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
124644906|NCT03395184|448316554|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
124644907|NCT03395184|448316548|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
124644908|NCT03395184|448316549|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
124644909|NCT03395184|448316550|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
124644910|NCT03395184|448316551|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
124644911|NCT03395184|448316552|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
124644912|NCT03395184|448316553|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
124644913|NCT03395184|448316554|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
124711968|NCT01127633|448570698|FG001|Overall Study|Withdrawal by Subject|72|||
124711969|NCT01127633|448570697|FG000|Overall Study|Sponsor Decision|163|||
124711970|NCT01127633|448570698|FG001|Overall Study|Sponsor Decision|195|||
124711971|NCT01127633|448570697|FG000|Overall Study|Protocol Violation|8|||
124711972|NCT01127633|448570698|FG001|Overall Study|Protocol Violation|16|||
124711973|NCT01127633|448570697|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
124711974|NCT01127633|448570698|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
124711975|NCT01127633|448570697|FG000|Overall Study|Not treated|1|||
124711976|NCT01127633|448570698|FG001|Overall Study|Not treated|0|||
124711977|NCT00688467|448570699|FG000|Treatment Period 1|Adverse Event|2|||
124711978|NCT00688467|448570700|FG001|Treatment Period 1|Adverse Event|1|||
124872186|NCT03092375|449154035|FG001|Overall Study|Lack of Efficacy|1|||
124872187|NCT03092375|449154036|FG002|Overall Study|Lack of Efficacy|1|||
124872188|NCT03092375|449154037|FG003|Overall Study|Lack of Efficacy|0|||
124982309|NCT01259089|449561345|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
124644914|NCT00199797|448319222|FG000|Overall Study|Progressive Disease|1|||
124644915|NCT00199797|448319222|FG000|Overall Study|Adverse Event|1|||
124872189|NCT00553501|449154042|FG000|Overall Study|Adverse Event|2|||
124872190|NCT00553501|449154042|FG000|Overall Study|Death|1|||
124872191|NCT00553501|449154042|FG000|Overall Study|Progression|1|||
124872192|NCT02293395|449154043|FG000|Overall Study|Lost to Follow-up|1|||
124872193|NCT02293395|449154044|FG001|Overall Study|Lost to Follow-up|0|||
124872194|NCT02293395|449154043|FG000|Overall Study|Withdrawal by Subject|8|||
124872195|NCT02293395|449154044|FG001|Overall Study|Withdrawal by Subject|7|||
124872196|NCT00224770|449154048|FG000|Overall Study|Lost to Follow-up|4|||
124872197|NCT00224770|449154049|FG001|Overall Study|Lost to Follow-up|2|||
124872198|NCT00224770|449154050|FG002|Overall Study|Lost to Follow-up|0|||
124872199|NCT00861614|449154051|FG000|Overall Study|Disease Progression|182|||
124872200|NCT00861614|449154052|FG001|Overall Study|Disease Progression|263|||
124872201|NCT00861614|449154051|FG000|Overall Study|Study Drug Toxicity|79|||
124872202|NCT00861614|449154052|FG001|Overall Study|Study Drug Toxicity|6|||
124872203|NCT00861614|449154051|FG000|Overall Study|Death|32|||
124872204|NCT00861614|449154052|FG001|Overall Study|Death|19|||
124872205|NCT00861614|449154051|FG000|Overall Study|Adverse Event|27|||
124872206|NCT00861614|449154052|FG001|Overall Study|Adverse Event|23|||
124872207|NCT00861614|449154051|FG000|Overall Study|Withdrawal by Subject|34|||
124872208|NCT00861614|449154052|FG001|Overall Study|Withdrawal by Subject|35|||
124872209|NCT00861614|449154051|FG000|Overall Study|Other|17|||
124872210|NCT00861614|449154052|FG001|Overall Study|Other|22|||
124872211|NCT03391765|449154053|FG000|Overall Study|Adverse Event|2|||
124872212|NCT03391765|449154054|FG001|Overall Study|Adverse Event|0|||
124872213|NCT03391765|449154055|FG002|Overall Study|Adverse Event|0|||
124872214|NCT03391765|449154056|FG003|Overall Study|Adverse Event|2|||
124872215|NCT03391765|449154053|FG000|Overall Study|Withdrew consent|5|||
124872216|NCT03391765|449154054|FG001|Overall Study|Withdrew consent|7|||
124872217|NCT03391765|449154055|FG002|Overall Study|Withdrew consent|2|||
124872218|NCT03391765|449154056|FG003|Overall Study|Withdrew consent|5|||
124872219|NCT03391765|449154053|FG000|Overall Study|Other, not specified|44|||
124872220|NCT03391765|449154054|FG001|Overall Study|Other, not specified|38|||
124872221|NCT03391765|449154055|FG002|Overall Study|Other, not specified|21|||
124872222|NCT03391765|449154056|FG003|Overall Study|Other, not specified|16|||
124872223|NCT01255592|449154057|FG000|Overall Study|Adverse Event|5|||
124872224|NCT01255592|449154058|FG001|Overall Study|Adverse Event|0|||
124872225|NCT01255592|449154057|FG000|Overall Study|Withdrawal by Subject|1|||
124872226|NCT01255592|449154058|FG001|Overall Study|Withdrawal by Subject|0|||
124872227|NCT01255592|449154057|FG000|Overall Study|Other|0|||
124872228|NCT01255592|449154058|FG001|Overall Study|Other|1|||
124872229|NCT02035332|449154059|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
124872230|NCT00838682|449154061|FG000|Overall Study|Lost to Follow-up|21|||
124872231|NCT00838682|449154062|FG001|Overall Study|Lost to Follow-up|14|||
124872232|NCT00838682|449154061|FG000|Overall Study|detection of exclusion criteria|4|||
124872233|NCT00838682|449154062|FG001|Overall Study|detection of exclusion criteria|3|||
124872234|NCT00838682|449154061|FG000|Overall Study|Protocol Violation|0|||
124872235|NCT00838682|449154062|FG001|Overall Study|Protocol Violation|1|||
124872236|NCT00838682|449154061|FG000|Overall Study|Withdrawal by Subject|0|||
124872237|NCT00838682|449154062|FG001|Overall Study|Withdrawal by Subject|1|||
124872238|NCT03315143|449154068|FG000|Overall Study|Death|240|||
124872239|NCT03315143|449154069|FG001|Overall Study|Death|246|||
124872240|NCT03315143|449154068|FG000|Overall Study|Withdrawal by Subject|57|||
124872241|NCT03315143|449154069|FG001|Overall Study|Withdrawal by Subject|68|||
124872242|NCT03315143|449154068|FG000|Overall Study|Site Terminated by Sponsor|256|||
124872243|NCT03315143|449154069|FG001|Overall Study|Site Terminated by Sponsor|282|||
124872244|NCT03315143|449154068|FG000|Overall Study|Study Terminated by Sponsor|4723|||
124872245|NCT03315143|449154069|FG001|Overall Study|Study Terminated by Sponsor|4664|||
124872246|NCT03315143|449154068|FG000|Overall Study|Reason not Specified|16|||
124872247|NCT03315143|449154069|FG001|Overall Study|Reason not Specified|32|||
124872248|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
124872249|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
124872250|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
124872251|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
124872252|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
124872253|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
124872254|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
124872255|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
124872256|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
124872257|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
124872258|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
124872259|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
124872260|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
124982310|NCT01259089|449561346|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
124982311|NCT01259089|449561347|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
124982312|NCT01259089|449561342|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
124982313|NCT01259089|449561343|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
124982314|NCT01259089|449561344|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
124982315|NCT01259089|449561345|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
124982316|NCT01259089|449561346|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
124982317|NCT01259089|449561347|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
124982318|NCT01259089|449561342|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
124982319|NCT01259089|449561343|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
124982320|NCT01259089|449561344|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
124982321|NCT01259089|449561345|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
124982322|NCT01259089|449561346|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
124982323|NCT01259089|449561347|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
124982324|NCT01259089|449561342|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
124982325|NCT01259089|449561343|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
124982326|NCT01259089|449561344|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
124982327|NCT01259089|449561345|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
124982328|NCT01259089|449561346|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
124982329|NCT01259089|449561347|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
124982330|NCT01259089|449561342|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
124982331|NCT01259089|449561343|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
124982332|NCT01259089|449561344|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
124982333|NCT01259089|449561345|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
124982334|NCT01259089|449561346|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
124982335|NCT01259089|449561347|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
124982336|NCT01259089|449561342|FG000|Survival Follow up for Two Years|Death|3|||
124982337|NCT01259089|449561343|FG001|Survival Follow up for Two Years|Death|2|||
124982338|NCT01259089|449561344|FG002|Survival Follow up for Two Years|Death|2|||
124982339|NCT01259089|449561345|FG003|Survival Follow up for Two Years|Death|3|||
124982340|NCT01259089|449561346|FG004|Survival Follow up for Two Years|Death|6|||
124982341|NCT01259089|449561347|FG005|Survival Follow up for Two Years|Death|13|||
124982342|NCT01259089|449561342|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
124982343|NCT01259089|449561343|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
124982344|NCT01259089|449561344|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
124982345|NCT01259089|449561345|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
124982346|NCT01259089|449561346|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
124982347|NCT01259089|449561347|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
124982348|NCT01259089|449561342|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
124982349|NCT01259089|449561343|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
124982350|NCT01259089|449561344|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
124982351|NCT01259089|449561345|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
124982352|NCT01259089|449561346|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
124982353|NCT01259089|449561347|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
124982354|NCT02310100|449561348|FG000|Overall Study|Physician Decision|3|||
124982355|NCT02310100|449561348|FG000|Overall Study|Withdrawal by Subject|10|||
124982356|NCT02310100|449561348|FG000|Overall Study|Enrollment closure|1|||
124982357|NCT02310100|449561348|FG000|Overall Study|Unapproved ablation operator|1|||
124982358|NCT02310100|449561348|FG000|Overall Study|Visit compliance|1|||
124982359|NCT02310100|449561348|FG000|Overall Study|Lost to Follow-up|2|||
124982360|NCT00688870|449561349|FG000|Infant Series|Parent or legal guardian request|4|||
124982361|NCT00688870|449561350|FG001|Infant Series|Parent or legal guardian request|0|||
124982362|NCT01253018|449561361|FG000|Overall Study|Lost to Follow-up|1|||
124982363|NCT01253018|449561362|FG001|Overall Study|Lost to Follow-up|1|||
124982364|NCT01253018|449561361|FG000|Overall Study|Robot Repair Issues|2|||
124982365|NCT01253018|449561362|FG001|Overall Study|Robot Repair Issues|0|||
124982366|NCT01253018|449561361|FG000|Overall Study|Withdrawal by Subject|1|||
124982367|NCT01253018|449561362|FG001|Overall Study|Withdrawal by Subject|1|||
124982368|NCT03449901|449561363|FG000|Overall Study|Progression|57|||
124982369|NCT03449901|449561364|FG001|Overall Study|Progression|12|||
124982370|NCT03449901|449561363|FG000|Overall Study|Adverse Event|3|||
124982371|NCT03449901|449561364|FG001|Overall Study|Adverse Event|0|||
124982372|NCT03449901|449561363|FG000|Overall Study|Death|6|||
124644916|NCT00199797|448319222|FG000|Overall Study|Physician Decision|1|||
124644917|NCT01106677|448319225|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
124982373|NCT03449901|449561364|FG001|Overall Study|Death|2|||
124982374|NCT03449901|449561363|FG000|Overall Study|Withdrawal by Subject|12|||
124982375|NCT03449901|449561364|FG001|Overall Study|Withdrawal by Subject|1|||
124982376|NCT03449901|449561363|FG000|Overall Study|Physician Decision|1|||
124644918|NCT01106677|448319226|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
124758640|NCT01463306|448739820|FG000|Overall Study|Lost to Follow-up|5|||
124644919|NCT01106677|448319227|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
124644920|NCT01106677|448319228|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
124644921|NCT01106677|448319225|FG000|Core Period: Baseline to Week 26|Death|0|||
124644922|NCT01106677|448319226|FG001|Core Period: Baseline to Week 26|Death|0|||
124644923|NCT01106677|448319227|FG002|Core Period: Baseline to Week 26|Death|1|||
124644924|NCT01106677|448319228|FG003|Core Period: Baseline to Week 26|Death|0|||
124644925|NCT01106677|448319225|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
124644926|NCT01106677|448319226|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
124644927|NCT01106677|448319227|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
124644928|NCT01106677|448319228|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
124644929|NCT01106677|448319225|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
124644930|NCT01106677|448319226|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
124644931|NCT01106677|448319227|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
124644932|NCT01106677|448319228|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
124644933|NCT01106677|448319225|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
124982377|NCT03449901|449561364|FG001|Overall Study|Physician Decision|0|||
124982378|NCT03449901|449561363|FG000|Overall Study|Patient elected for surgical intervention|1|||
124982379|NCT03449901|449561364|FG001|Overall Study|Patient elected for surgical intervention|0|||
124644934|NCT01106677|448319226|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
124644935|NCT01106677|448319227|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
124644936|NCT01106677|448319228|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
124644937|NCT01106677|448319225|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
124644938|NCT01106677|448319226|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
124644939|NCT01106677|448319227|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
124644940|NCT01106677|448319228|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
124644941|NCT01106677|448319225|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
124644942|NCT01106677|448319226|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
124644943|NCT01106677|448319227|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
124644944|NCT01106677|448319228|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
124644945|NCT01106677|448319225|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
124644946|NCT01106677|448319226|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
124644947|NCT01106677|448319227|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
124644948|NCT01106677|448319228|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
124644949|NCT01106677|448319225|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
124644950|NCT01106677|448319226|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
124644951|NCT01106677|448319227|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
124644952|NCT01106677|448319228|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
124644953|NCT01106677|448319225|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
124644954|NCT01106677|448319226|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
124644955|NCT01106677|448319227|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
124644956|NCT01106677|448319228|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
124644957|NCT01106677|448319225|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
124644958|NCT01106677|448319226|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
124644959|NCT01106677|448319227|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
124644960|NCT01106677|448319228|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
124644961|NCT01106677|448319225|FG000|Core Period: Baseline to Week 26|Other|8|||
124644962|NCT01106677|448319226|FG001|Core Period: Baseline to Week 26|Other|14|||
124644963|NCT01106677|448319227|FG002|Core Period: Baseline to Week 26|Other|8|||
124644964|NCT01106677|448319228|FG003|Core Period: Baseline to Week 26|Other|23|||
124644965|NCT01106677|448319225|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
124644966|NCT01106677|448319226|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
124644967|NCT01106677|448319227|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
124982380|NCT03449901|449561363|FG000|Overall Study|Patient off for other complicating disease|1|||
124982381|NCT03449901|449561364|FG001|Overall Study|Patient off for other complicating disease|0|||
124982382|NCT03466073|449561365|FG000|Overall Study|Death|1|||
124982383|NCT03466073|449561366|FG001|Overall Study|Death|0|||
124982384|NCT03466073|449561367|FG002|Overall Study|Death|0|||
124982385|NCT03466073|449561368|FG003|Overall Study|Death|0|||
124982386|NCT03466073|449561369|FG004|Overall Study|Death|0|||
124982387|NCT03466073|449561370|FG005|Overall Study|Death|1|||
124982388|NCT00744757|449561371|FG000|Overall Study|Objective disease progression|7|||
124982389|NCT00744757|449561371|FG000|Overall Study|Physician Decision|5|||
124982390|NCT00744757|449561371|FG000|Overall Study|Withdrawal by Subject|1|||
124982391|NCT00744757|449561371|FG000|Overall Study|Death|6|||
124644968|NCT01106677|448319228|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
124982392|NCT00744757|449561371|FG000|Overall Study|Adverse Event|2|||
124982393|NCT03682302|449561372|FG000|Overall Study|Lost to Follow-up|1|||
124982394|NCT03682302|449561373|FG001|Overall Study|Lost to Follow-up|2|||
124982395|NCT03682302|449561374|FG002|Overall Study|Lost to Follow-up|0|||
124644969|NCT01106677|448319225|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
124644970|NCT01106677|448319226|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
124644971|NCT01106677|448319227|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
124644972|NCT01106677|448319228|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
124644973|NCT01106677|448319225|FG000|Extension Period: Week 26 to Week 52|Death|0|||
124644974|NCT01106677|448319226|FG001|Extension Period: Week 26 to Week 52|Death|0|||
124644975|NCT01106677|448319227|FG002|Extension Period: Week 26 to Week 52|Death|0|||
124644976|NCT01106677|448319228|FG003|Extension Period: Week 26 to Week 52|Death|1|||
124644977|NCT01106677|448319225|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
124644978|NCT01106677|448319226|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
124644979|NCT01106677|448319227|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
124644980|NCT01106677|448319228|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
124644981|NCT01106677|448319225|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
124644982|NCT01106677|448319226|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
124644983|NCT01106677|448319227|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
124644984|NCT01106677|448319228|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
124644985|NCT01106677|448319225|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
124644986|NCT01106677|448319226|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
124644987|NCT01106677|448319227|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
124644988|NCT01106677|448319228|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
124644989|NCT01106677|448319225|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
124644990|NCT01106677|448319226|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
124644991|NCT01106677|448319227|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
124644992|NCT01106677|448319228|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
124644993|NCT01106677|448319225|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
124644994|NCT01106677|448319226|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
124644995|NCT01106677|448319227|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
124644996|NCT01106677|448319228|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
124644997|NCT01106677|448319225|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
124644998|NCT01106677|448319226|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
124644999|NCT01106677|448319227|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
124645000|NCT01106677|448319228|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
124645001|NCT01106677|448319225|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
124645002|NCT01106677|448319226|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
124645003|NCT01106677|448319227|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
124645004|NCT01106677|448319228|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
124645005|NCT01106677|448319225|FG000|Extension Period: Week 26 to Week 52|Other|6|||
124645006|NCT01106677|448319226|FG001|Extension Period: Week 26 to Week 52|Other|5|||
124645007|NCT01106677|448319227|FG002|Extension Period: Week 26 to Week 52|Other|8|||
124645008|NCT01106677|448319228|FG003|Extension Period: Week 26 to Week 52|Other|5|||
124645009|NCT03937908|448319229|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
124645010|NCT03937908|448319230|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
124645011|NCT03205761|448319231|FG000|Overall Study|Withdrawal by Subject|1|||
124645012|NCT03205761|448319231|FG000|Overall Study|Progressive Disease|10|||
124645013|NCT02163226|448319232|FG000|Overall Study|Death|2|||
124645014|NCT02163226|448319233|FG001|Overall Study|Death|1|||
124645015|NCT02163226|448319232|FG000|Overall Study|Withdrawal by Subject|5|||
124645016|NCT02163226|448319233|FG001|Overall Study|Withdrawal by Subject|2|||
124645017|NCT02163226|448319232|FG000|Overall Study|Returned home, local radiotherapy|3|||
124645018|NCT02163226|448319233|FG001|Overall Study|Returned home, local radiotherapy|0|||
124645019|NCT02163226|448319232|FG000|Overall Study|Repeat imaging showed no disease|2|||
124645020|NCT02163226|448319233|FG001|Overall Study|Repeat imaging showed no disease|0|||
124645021|NCT02163226|448319232|FG000|Overall Study|Incomplete radiotherapy|3|||
124645022|NCT02163226|448319233|FG001|Overall Study|Incomplete radiotherapy|0|||
124645023|NCT02163226|448319232|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
124645024|NCT02163226|448319233|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
124645025|NCT02163226|448319232|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
124645026|NCT02163226|448319233|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
124645027|NCT02163226|448319232|FG000|Overall Study|ineligible|0|||
124645028|NCT02163226|448319233|FG001|Overall Study|ineligible|3|||
124645029|NCT00477750|448319234|FG000|Overall Study|Currently Receiving Treatment|11|||
124645030|NCT00601172|448319238|FG000|Overall Study|Adverse Event|43|||
124645031|NCT00601172|448319239|FG001|Overall Study|Adverse Event|32|||
124645032|NCT00601172|448319238|FG000|Overall Study|Lack of Efficacy|11|||
124645033|NCT00601172|448319239|FG001|Overall Study|Lack of Efficacy|12|||
124645034|NCT00601172|448319238|FG000|Overall Study|Protocol Violation|2|||
124645035|NCT00601172|448319239|FG001|Overall Study|Protocol Violation|5|||
124645036|NCT00601172|448319238|FG000|Overall Study|Lost to Follow-up|4|||
124982396|NCT03682302|449561375|FG003|Overall Study|Lost to Follow-up|1|||
124982397|NCT03682302|449561372|FG000|Overall Study|Study drug was not administered|0|||
124982398|NCT03682302|449561373|FG001|Overall Study|Study drug was not administered|0|||
124982399|NCT03682302|449561374|FG002|Overall Study|Study drug was not administered|1|||
124982400|NCT03682302|449561375|FG003|Overall Study|Study drug was not administered|1|||
124982401|NCT03309813|449561378|FG000|Main Randomized Study|Withdrawal by Subject|1|||
124982402|NCT03309813|449561379|FG001|Main Randomized Study|Withdrawal by Subject|0|||
124982403|NCT00658788|449561380|FG000|Overall Study|Adverse Event|11|||
124982404|NCT00658788|449561380|FG000|Overall Study|Withdrawal by Subject|13|||
124982405|NCT00658788|449561380|FG000|Overall Study|Lost to Follow-up|18|||
124982406|NCT00658788|449561380|FG000|Overall Study|Treatment Discontinuation|32|||
124982407|NCT00653523|449561381|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
124982408|NCT00653523|449561381|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
124982409|NCT00653523|449561381|FG000|Overall Study|Adverse Event|7|||
124982410|NCT00653523|449561381|FG000|Overall Study|Withdrawal by Subject|6|||
124982411|NCT00653523|449561381|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
124982412|NCT00653523|449561381|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
124982413|NCT05384938|449561382|FG000|Overall Study|Withdrawal by Subject|8|||
124982414|NCT05384938|449561382|FG000|Overall Study|Lost to Follow-up|6|||
124982415|NCT05384938|449561382|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
124982416|NCT02079740|449563198|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
124982417|NCT02079740|449563199|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
124982418|NCT02079740|449563200|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
124982419|NCT02079740|449563201|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
124982420|NCT02079740|449563202|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
124982421|NCT02079740|449563203|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
124982422|NCT02079740|449563204|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
124982423|NCT02079740|449563205|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
124982424|NCT02079740|449563206|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
124982425|NCT02079740|449563207|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
124645037|NCT00601172|448319239|FG001|Overall Study|Lost to Follow-up|3|||
124645038|NCT00601172|448319238|FG000|Overall Study|Physician Decision|27|||
124645039|NCT00601172|448319239|FG001|Overall Study|Physician Decision|28|||
124645040|NCT00601172|448319238|FG000|Overall Study|Withdrawal by Subject|35|||
124645041|NCT00601172|448319239|FG001|Overall Study|Withdrawal by Subject|27|||
124645042|NCT00601172|448319238|FG000|Overall Study|Did not meet continuation criteria|19|||
124645043|NCT00601172|448319239|FG001|Overall Study|Did not meet continuation criteria|20|||
124645044|NCT05318092|448319240|FG000|Overall Study|Lost to Follow-up|3|||
124982426|NCT02079740|449563208|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
124982427|NCT02079740|449563209|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
124982428|NCT02079740|449563210|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
124982429|NCT02079740|449563198|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
124982430|NCT02079740|449563199|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
124982431|NCT02079740|449563200|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
124982432|NCT02079740|449563201|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
124982433|NCT02079740|449563202|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
124982434|NCT02079740|449563203|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
124982435|NCT02079740|449563204|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
124982436|NCT02079740|449563205|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
124982437|NCT02079740|449563206|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
124982438|NCT02079740|449563207|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
124982439|NCT02079740|449563208|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
124982440|NCT02079740|449563209|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
124982441|NCT02079740|449563210|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
124982442|NCT02079740|449563198|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
124982443|NCT02079740|449563199|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
124982444|NCT02079740|449563200|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
124982445|NCT02079740|449563201|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
124982446|NCT02079740|449563202|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
124982447|NCT02079740|449563203|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
124982448|NCT02079740|449563204|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
124982449|NCT02079740|449563205|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
124982450|NCT02079740|449563206|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
124982451|NCT02079740|449563207|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
124645045|NCT05318092|448319240|FG000|Overall Study|Withdrawal by Subject|1|||
124982452|NCT02079740|449563208|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
124982453|NCT02079740|449563209|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
124982454|NCT02079740|449563210|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
124645046|NCT03030989|448319244|FG000|Overall Study|Fever|2|||
124982455|NCT02079740|449563198|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
124645047|NCT03030989|448319245|FG001|Overall Study|Fever|2|||
124645048|NCT03030989|448319244|FG000|Overall Study|Rash|2|||
124982456|NCT02079740|449563199|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
124982457|NCT02079740|449563200|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
124982458|NCT02079740|449563201|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
124645049|NCT03030989|448319245|FG001|Overall Study|Rash|1|||
124645050|NCT03030989|448319244|FG000|Overall Study|Fatigue/Overwhelmed|1|||
124645051|NCT03030989|448319245|FG001|Overall Study|Fatigue/Overwhelmed|5|||
124645052|NCT03030989|448319244|FG000|Overall Study|Positive Blood Cultures|2|||
124645053|NCT03030989|448319245|FG001|Overall Study|Positive Blood Cultures|1|||
124645054|NCT03030989|448319244|FG000|Overall Study|Line Removed|0|||
124645055|NCT03030989|448319245|FG001|Overall Study|Line Removed|2|||
124645056|NCT03030989|448319244|FG000|Overall Study|No longer interested|5|||
124645057|NCT03030989|448319245|FG001|Overall Study|No longer interested|3|||
124645058|NCT02706886|448319246|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
124645059|NCT02706886|448319247|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
124982459|NCT02079740|449563202|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
124982460|NCT02079740|449563203|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
124645060|NCT02706886|448319248|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
124645061|NCT02706886|448319249|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
124645062|NCT02706886|448319250|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
124645063|NCT02706886|448319251|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
124645064|NCT02706886|448319252|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
124645065|NCT02706886|448319253|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
124645066|NCT02706886|448319254|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
124645067|NCT03917472|448319255|FG000|Overall Study|Physician Decision|4|||
124645068|NCT03917472|448319256|FG001|Overall Study|Physician Decision|0|||
124645069|NCT03917472|448319255|FG000|Overall Study|Adverse Event|3|||
124645070|NCT03917472|448319256|FG001|Overall Study|Adverse Event|1|||
124645071|NCT03917472|448319255|FG000|Overall Study|Death|7|||
124645072|NCT03917472|448319256|FG001|Overall Study|Death|5|||
124645073|NCT03917472|448319255|FG000|Overall Study|Withdrawal by Subject|11|||
124645074|NCT03917472|448319256|FG001|Overall Study|Withdrawal by Subject|4|||
124645075|NCT03917472|448319255|FG000|Overall Study|Lost to Follow-up|10|||
124645076|NCT03917472|448319256|FG001|Overall Study|Lost to Follow-up|5|||
124645077|NCT04434469|448319263|FG000|Overall Study|Death|2|||
124645078|NCT04434469|448319264|FG001|Overall Study|Death|3|||
124645079|NCT04434469|448319265|FG002|Overall Study|Death|2|||
124645080|NCT04434469|448319266|FG003|Overall Study|Death|2|||
124645081|NCT04434469|448319267|FG004|Overall Study|Death|2|||
124645082|NCT04434469|448319268|FG005|Overall Study|Death|0|||
124645083|NCT04434469|448319263|FG000|Overall Study|Lost to Follow-up|0|||
124645084|NCT04434469|448319264|FG001|Overall Study|Lost to Follow-up|0|||
124645085|NCT04434469|448319265|FG002|Overall Study|Lost to Follow-up|0|||
124645086|NCT04434469|448319266|FG003|Overall Study|Lost to Follow-up|1|||
124645087|NCT04434469|448319267|FG004|Overall Study|Lost to Follow-up|1|||
124645088|NCT04434469|448319268|FG005|Overall Study|Lost to Follow-up|0|||
124645089|NCT04434469|448319263|FG000|Overall Study|Study terminated by sponsor|1|||
124645090|NCT04434469|448319264|FG001|Overall Study|Study terminated by sponsor|1|||
124645091|NCT04434469|448319265|FG002|Overall Study|Study terminated by sponsor|1|||
124645092|NCT04434469|448319266|FG003|Overall Study|Study terminated by sponsor|2|||
124645093|NCT04434469|448319267|FG004|Overall Study|Study terminated by sponsor|3|||
124645094|NCT04434469|448319268|FG005|Overall Study|Study terminated by sponsor|3|||
124645095|NCT04434469|448319263|FG000|Overall Study|Withdrawal by Subject|0|||
124645096|NCT04434469|448319264|FG001|Overall Study|Withdrawal by Subject|0|||
124645097|NCT04434469|448319265|FG002|Overall Study|Withdrawal by Subject|1|||
124645098|NCT04434469|448319266|FG003|Overall Study|Withdrawal by Subject|0|||
124645099|NCT04434469|448319267|FG004|Overall Study|Withdrawal by Subject|0|||
124645100|NCT04434469|448319268|FG005|Overall Study|Withdrawal by Subject|0|||
124645101|NCT01669174|448319269|FG000|Overall Study|Subject withdrew consent|2|||
124645102|NCT01669174|448319270|FG001|Overall Study|Subject withdrew consent|2|||
124645103|NCT01669174|448319269|FG000|Overall Study|Lost to Follow-up|1|||
124645104|NCT01669174|448319270|FG001|Overall Study|Lost to Follow-up|0|||
124645105|NCT01669174|448319269|FG000|Overall Study|Adverse Event|2|||
124645106|NCT01669174|448319270|FG001|Overall Study|Adverse Event|2|||
124645107|NCT01669174|448319269|FG000|Overall Study|Administrative problems|1|||
124645108|NCT01669174|448319270|FG001|Overall Study|Administrative problems|2|||
124645109|NCT01953601|448319274|FG000|Part 1 (Base Study)|Adverse Event|24|||
124872261|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
124872262|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
124872263|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
124872264|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
124872265|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
124872266|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
124872267|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
124872268|NCT00549757|449154070|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
124872269|NCT00549757|449154071|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
124982461|NCT02079740|449563204|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
124645110|NCT01953601|448319275|FG001|Part 1 (Base Study)|Adverse Event|37|||
124645111|NCT01953601|448319276|FG002|Part 1 (Base Study)|Adverse Event|15|||
124645112|NCT01953601|448319274|FG000|Part 1 (Base Study)|Death|2|||
124645113|NCT01953601|448319275|FG001|Part 1 (Base Study)|Death|0|||
124645114|NCT01953601|448319276|FG002|Part 1 (Base Study)|Death|3|||
124645115|NCT01953601|448319274|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
124645116|NCT01953601|448319275|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
124645117|NCT01953601|448319276|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
124645118|NCT01953601|448319274|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
124645119|NCT01953601|448319275|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
124645120|NCT01953601|448319276|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
124645121|NCT01953601|448319274|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
124645122|NCT01953601|448319275|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
124645123|NCT01953601|448319276|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
124645124|NCT01953601|448319274|FG000|Part 1 (Base Study)|Physician Decision|3|||
124645125|NCT01953601|448319275|FG001|Part 1 (Base Study)|Physician Decision|7|||
124645126|NCT01953601|448319276|FG002|Part 1 (Base Study)|Physician Decision|4|||
124645127|NCT01953601|448319274|FG000|Part 1 (Base Study)|Screen failure|1|||
124645128|NCT01953601|448319275|FG001|Part 1 (Base Study)|Screen failure|0|||
124645129|NCT01953601|448319276|FG002|Part 1 (Base Study)|Screen failure|1|||
124645130|NCT01953601|448319274|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
124645131|NCT01953601|448319275|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
124645132|NCT01953601|448319276|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
124645133|NCT01953601|448319274|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
124645134|NCT01953601|448319275|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
124645135|NCT01953601|448319276|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
124645136|NCT01953601|448319274|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
124645137|NCT01953601|448319275|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
124645138|NCT01953601|448319276|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
124645139|NCT01953601|448319274|FG000|Part 1 (Base Study)|Subject moved|2|||
124645140|NCT01953601|448319275|FG001|Part 1 (Base Study)|Subject moved|2|||
124645141|NCT01953601|448319276|FG002|Part 1 (Base Study)|Subject moved|1|||
124645142|NCT01953601|448319274|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
124645143|NCT01953601|448319275|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
124645144|NCT01953601|448319276|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
124645145|NCT01953601|448319274|FG000|Part 2 (Extension Study)|Adverse Event|1|||
124645146|NCT01953601|448319275|FG001|Part 2 (Extension Study)|Adverse Event|1|||
124645147|NCT01953601|448319276|FG002|Part 2 (Extension Study)|Adverse Event|10|||
124645148|NCT01953601|448319274|FG000|Part 2 (Extension Study)|Death|0|||
124645149|NCT01953601|448319275|FG001|Part 2 (Extension Study)|Death|3|||
124645150|NCT01953601|448319276|FG002|Part 2 (Extension Study)|Death|0|||
124645151|NCT01953601|448319274|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
124982462|NCT02079740|449563205|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
124982463|NCT02079740|449563206|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
124982464|NCT02079740|449563207|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
124982465|NCT02079740|449563208|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
124982466|NCT02079740|449563209|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
124982467|NCT02079740|449563210|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
124982468|NCT02079740|449563198|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
124982469|NCT02079740|449563199|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
124982470|NCT02079740|449563200|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
124982471|NCT02079740|449563201|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
124982472|NCT02079740|449563202|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
124982473|NCT02079740|449563203|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
124982474|NCT02079740|449563204|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
124982475|NCT02079740|449563205|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
124982476|NCT02079740|449563206|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
124982477|NCT02079740|449563207|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
124982478|NCT02079740|449563208|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
124982479|NCT02079740|449563209|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
124982480|NCT02079740|449563210|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
124982481|NCT02328014|449563211|FG000|Overall Study|Adverse Event|1|||
124982482|NCT02328014|449563212|FG001|Overall Study|Adverse Event|0|||
124982483|NCT02328014|449563213|FG002|Overall Study|Adverse Event|0|||
124982484|NCT02328014|449563214|FG003|Overall Study|Adverse Event|1|||
124982485|NCT02328014|449563211|FG000|Overall Study|Death|0|||
124982486|NCT02328014|449563212|FG001|Overall Study|Death|0|||
124645152|NCT01953601|448319275|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
124645153|NCT01953601|448319276|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
124645154|NCT01953601|448319274|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
124645155|NCT01953601|448319275|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
124645156|NCT01953601|448319276|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
124645157|NCT01953601|448319274|FG000|Part 2 (Extension Study)|Physician Decision|2|||
124645158|NCT01953601|448319275|FG001|Part 2 (Extension Study)|Physician Decision|0|||
124645159|NCT01953601|448319276|FG002|Part 2 (Extension Study)|Physician Decision|2|||
124645160|NCT01953601|448319274|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
124645161|NCT01953601|448319275|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
124645162|NCT01953601|448319276|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
124645163|NCT01953601|448319274|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
124645164|NCT01953601|448319275|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
124645165|NCT01953601|448319276|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
124645166|NCT01953601|448319274|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
124645167|NCT01953601|448319275|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
124645168|NCT01953601|448319276|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
124645169|NCT01953601|448319274|FG000|Part 2 (Extension Study)|Subject moved|0|||
124645170|NCT01953601|448319275|FG001|Part 2 (Extension Study)|Subject moved|0|||
124645171|NCT01953601|448319276|FG002|Part 2 (Extension Study)|Subject moved|1|||
124645172|NCT01953601|448319274|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
124645173|NCT01953601|448319275|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
124645174|NCT01953601|448319276|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
124645175|NCT01154296|448319277|FG000|Randomization and Intervention|Decided to decline|1|||
124645176|NCT01154296|448319278|FG001|Randomization and Intervention|Decided to decline|1|||
124645177|NCT01154296|448319277|FG000|Randomization and Intervention|Declined by staff|1|||
124645178|NCT01154296|448319278|FG001|Randomization and Intervention|Declined by staff|0|||
124645179|NCT01154296|448319277|FG000|Randomization and Intervention|Did not return|1|||
124645180|NCT01154296|448319278|FG001|Randomization and Intervention|Did not return|0|||
124645181|NCT01154296|448319277|FG000|Randomization and Intervention|Left before test|0|||
124645182|NCT01154296|448319278|FG001|Randomization and Intervention|Left before test|1|||
124645183|NCT01154296|448319277|FG000|Randomization and Intervention|Left clinic early|2|||
124645184|NCT01154296|448319278|FG001|Randomization and Intervention|Left clinic early|0|||
124645185|NCT01154296|448319277|FG000|6-month Follow-up|Lost contact|269|||
124645186|NCT01154296|448319278|FG001|6-month Follow-up|Lost contact|275|||
124645187|NCT01154296|448319277|FG000|6-month Follow-up|Incarcerated|37|||
124645188|NCT01154296|448319278|FG001|6-month Follow-up|Incarcerated|32|||
124645189|NCT01154296|448319277|FG000|6-month Follow-up|Withdrew consent|14|||
124645190|NCT01154296|448319278|FG001|6-month Follow-up|Withdrew consent|15|||
124645191|NCT01154296|448319277|FG000|6-month Follow-up|Death|3|||
124645192|NCT01154296|448319278|FG001|6-month Follow-up|Death|2|||
124645193|NCT01154296|448319277|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
124645194|NCT01154296|448319278|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
124645195|NCT00664859|448319298|FG000|Overall Study|Adverse Event|2|||
124645196|NCT00664859|448319299|FG001|Overall Study|Adverse Event|1|||
124645197|NCT00664859|448319300|FG002|Overall Study|Adverse Event|3|||
124645198|NCT00664859|448319298|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
124645199|NCT00664859|448319299|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
124645200|NCT00664859|448319300|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
124645201|NCT00664859|448319298|FG000|Overall Study|Noncompliance with protocol|1|||
124645202|NCT00664859|448319299|FG001|Overall Study|Noncompliance with protocol|0|||
124645203|NCT00664859|448319300|FG002|Overall Study|Noncompliance with protocol|4|||
124645204|NCT00664859|448319298|FG000|Overall Study|Laboratory abnormality|2|||
124645205|NCT00664859|448319299|FG001|Overall Study|Laboratory abnormality|1|||
124645206|NCT00664859|448319300|FG002|Overall Study|Laboratory abnormality|4|||
124645207|NCT00664859|448319298|FG000|Overall Study|Withdrawal by Subject|4|||
124645208|NCT00664859|448319299|FG001|Overall Study|Withdrawal by Subject|1|||
124645209|NCT00664859|448319300|FG002|Overall Study|Withdrawal by Subject|3|||
124645210|NCT00664859|448319298|FG000|Overall Study|Lost to Follow-up|2|||
124645211|NCT00664859|448319299|FG001|Overall Study|Lost to Follow-up|2|||
124645212|NCT00664859|448319300|FG002|Overall Study|Lost to Follow-up|1|||
124645213|NCT00664859|448319298|FG000|Overall Study|Other|0|||
124645214|NCT00664859|448319299|FG001|Overall Study|Other|1|||
124645215|NCT00664859|448319300|FG002|Overall Study|Other|2|||
124645216|NCT01943851|448319301|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
124645217|NCT01943851|448319302|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
124645218|NCT01943851|448319303|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
124645219|NCT01943851|448319304|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
124645220|NCT01943851|448319305|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
124645221|NCT01943851|448319306|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
124645222|NCT01943851|448319307|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
124645223|NCT01943851|448319308|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
124645224|NCT01943851|448319309|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
124645225|NCT01943851|448319310|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
124645226|NCT01943851|448319311|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
124645227|NCT01943851|448319312|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
124645228|NCT01943851|448319313|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
124645229|NCT01943851|448319314|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
124645230|NCT01943851|448319315|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
124645231|NCT01943851|448319316|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
124645232|NCT01943851|448319317|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
124645233|NCT01943851|448319318|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
124645234|NCT01943851|448319301|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
124645235|NCT01943851|448319302|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
124645236|NCT01943851|448319303|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
124645237|NCT01943851|448319304|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
124645238|NCT01943851|448319305|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
124645239|NCT01943851|448319306|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
124645240|NCT01943851|448319307|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
124645241|NCT01943851|448319308|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
124645242|NCT01943851|448319309|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
124645243|NCT01943851|448319310|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
124645244|NCT01943851|448319311|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
124645245|NCT01943851|448319312|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
124645246|NCT01943851|448319313|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
124645247|NCT01943851|448319314|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
124645248|NCT01943851|448319315|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
124645249|NCT01943851|448319316|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
124645250|NCT01943851|448319317|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
124645251|NCT01943851|448319318|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
124645252|NCT01943851|448319301|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
124645253|NCT01943851|448319302|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
124645254|NCT01943851|448319303|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
124645255|NCT01943851|448319304|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
124645256|NCT01943851|448319305|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
124645257|NCT01943851|448319306|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
124645258|NCT01943851|448319307|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
124645259|NCT01943851|448319308|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
124645260|NCT01943851|448319309|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
124645261|NCT01943851|448319310|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
124645262|NCT01943851|448319311|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
124645263|NCT01943851|448319312|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
124645264|NCT01943851|448319313|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
124645265|NCT01943851|448319314|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
124645266|NCT01943851|448319315|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
124645267|NCT01943851|448319316|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
124645268|NCT01943851|448319317|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
124645269|NCT01943851|448319318|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
124645270|NCT01943851|448319301|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
124645271|NCT01943851|448319302|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
124645272|NCT01943851|448319303|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
124645273|NCT01943851|448319304|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
124645274|NCT01943851|448319305|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
124645275|NCT01943851|448319306|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
124645276|NCT01943851|448319307|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
124645277|NCT01943851|448319308|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
124645278|NCT01943851|448319309|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
124645279|NCT01943851|448319310|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
124645280|NCT01943851|448319311|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
124645281|NCT01943851|448319312|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
124645282|NCT01943851|448319313|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
124645283|NCT01943851|448319314|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
124645284|NCT01943851|448319315|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
124645285|NCT01943851|448319316|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
124645286|NCT01943851|448319317|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
124645287|NCT01943851|448319318|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
124645288|NCT01943851|448319301|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
124645289|NCT01943851|448319302|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
124645290|NCT01943851|448319303|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
124645291|NCT01943851|448319304|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
124645292|NCT01943851|448319305|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
124645293|NCT01943851|448319306|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
124645294|NCT01943851|448319307|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
124645295|NCT01943851|448319308|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
124645296|NCT01943851|448319309|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
124645297|NCT01943851|448319310|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
124982487|NCT02328014|449563213|FG002|Overall Study|Death|0|||
124645298|NCT01943851|448319311|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
124645299|NCT01943851|448319312|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
124645300|NCT01943851|448319313|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
124645301|NCT01943851|448319314|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
124645302|NCT01943851|448319315|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
124645303|NCT01943851|448319316|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
124645304|NCT01943851|448319317|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
124645305|NCT01943851|448319318|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
124645306|NCT00900757|448319319|FG000|Overall Study|screen failure|19|||
124645307|NCT03320850|448319320|FG000|Overall Study|Lost to Follow-up|0|||
124645308|NCT03320850|448319321|FG001|Overall Study|Lost to Follow-up|0|||
124645309|NCT03320850|448319322|FG002|Overall Study|Lost to Follow-up|0|||
124645310|NCT03320850|448319323|FG003|Overall Study|Lost to Follow-up|0|||
124645311|NCT03320850|448319324|FG004|Overall Study|Lost to Follow-up|1|||
124645312|NCT03320850|448319325|FG005|Overall Study|Lost to Follow-up|2|||
124645313|NCT03320850|448319326|FG006|Overall Study|Lost to Follow-up|2|||
124645314|NCT03320850|448319327|FG007|Overall Study|Lost to Follow-up|0|||
124645315|NCT03320850|448319328|FG008|Overall Study|Lost to Follow-up|6|||
124645316|NCT03320850|448319329|FG009|Overall Study|Lost to Follow-up|4|||
124645317|NCT03320850|448319320|FG000|Overall Study|Withdrawal by Subject|0|||
124645318|NCT03320850|448319321|FG001|Overall Study|Withdrawal by Subject|0|||
124645319|NCT03320850|448319322|FG002|Overall Study|Withdrawal by Subject|0|||
124645320|NCT03320850|448319323|FG003|Overall Study|Withdrawal by Subject|0|||
124645321|NCT03320850|448319324|FG004|Overall Study|Withdrawal by Subject|1|||
124645322|NCT03320850|448319325|FG005|Overall Study|Withdrawal by Subject|2|||
124645323|NCT03320850|448319326|FG006|Overall Study|Withdrawal by Subject|4|||
124645324|NCT03320850|448319327|FG007|Overall Study|Withdrawal by Subject|5|||
124645325|NCT03320850|448319328|FG008|Overall Study|Withdrawal by Subject|2|||
124645326|NCT03320850|448319329|FG009|Overall Study|Withdrawal by Subject|1|||
124645327|NCT03320850|448319320|FG000|Overall Study|Lack of Efficacy|0|||
124645328|NCT03320850|448319321|FG001|Overall Study|Lack of Efficacy|0|||
124645329|NCT03320850|448319322|FG002|Overall Study|Lack of Efficacy|0|||
124645330|NCT03320850|448319323|FG003|Overall Study|Lack of Efficacy|1|||
124645331|NCT03320850|448319324|FG004|Overall Study|Lack of Efficacy|0|||
124645332|NCT03320850|448319325|FG005|Overall Study|Lack of Efficacy|1|||
124645333|NCT03320850|448319326|FG006|Overall Study|Lack of Efficacy|0|||
124645334|NCT03320850|448319327|FG007|Overall Study|Lack of Efficacy|2|||
124645335|NCT03320850|448319328|FG008|Overall Study|Lack of Efficacy|0|||
124645336|NCT03320850|448319329|FG009|Overall Study|Lack of Efficacy|3|||
124645337|NCT03320850|448319320|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
124872270|NCT00549757|449154070|FG000|Extension Period (in Average 9 Months)|Death|143|||
124872271|NCT00549757|449154071|FG001|Extension Period (in Average 9 Months)|Death|136|||
124872272|NCT00549757|449154070|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
124872273|NCT00549757|449154071|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
124872274|NCT00549757|449154070|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
124872275|NCT00549757|449154071|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
124872276|NCT00549757|449154070|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
124872277|NCT00549757|449154071|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
124872278|NCT02641392|449154072|FG000|Overall Study|Lost to Follow-up|0|||
124872279|NCT02641392|449154073|FG001|Overall Study|Lost to Follow-up|0|||
124872280|NCT02641392|449154074|FG002|Overall Study|Lost to Follow-up|2|||
124872281|NCT02641392|449154072|FG000|Overall Study|Withdrawal by Subject|0|||
124872282|NCT02641392|449154073|FG001|Overall Study|Withdrawal by Subject|0|||
124872283|NCT02641392|449154074|FG002|Overall Study|Withdrawal by Subject|17|||
124872284|NCT02641392|449154072|FG000|Overall Study|Adverse Event|0|||
124872285|NCT02641392|449154073|FG001|Overall Study|Adverse Event|1|||
124872286|NCT02641392|449154074|FG002|Overall Study|Adverse Event|25|||
124872287|NCT02641392|449154072|FG000|Overall Study|Study Terminated by Sponsor|4|||
124872288|NCT02641392|449154073|FG001|Overall Study|Study Terminated by Sponsor|12|||
124872289|NCT02641392|449154074|FG002|Overall Study|Study Terminated by Sponsor|144|||
124872290|NCT02641392|449154072|FG000|Overall Study|Lack of Efficacy|0|||
124872291|NCT02641392|449154073|FG001|Overall Study|Lack of Efficacy|0|||
124872292|NCT02641392|449154074|FG002|Overall Study|Lack of Efficacy|101|||
124872293|NCT02641392|449154072|FG000|Overall Study|Miscellaneous|0|||
124872294|NCT02641392|449154073|FG001|Overall Study|Miscellaneous|0|||
124872295|NCT02641392|449154074|FG002|Overall Study|Miscellaneous|3|||
124872296|NCT02641392|449154072|FG000|Overall Study|Death|0|||
124872297|NCT02641392|449154073|FG001|Overall Study|Death|0|||
124872298|NCT02641392|449154074|FG002|Overall Study|Death|1|||
124872299|NCT04067401|449154075|FG000|Overall Study|Withdrawal by Subject|7|||
124872300|NCT04067401|449154076|FG001|Overall Study|Withdrawal by Subject|0|||
124872301|NCT04067401|449154075|FG000|Overall Study|no data provided|1|||
124872302|NCT04067401|449154076|FG001|Overall Study|no data provided|0|||
124872303|NCT01477853|449154077|FG000|Phase A|Adverse Event|1|||
124872304|NCT01477853|449154078|FG001|Phase A|Adverse Event|2|||
124872305|NCT01477853|449154079|FG002|Phase A|Adverse Event|2|||
124645338|NCT03320850|448319321|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
124645339|NCT03320850|448319322|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
124645340|NCT03320850|448319323|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
124645341|NCT03320850|448319324|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
124645342|NCT03320850|448319325|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
124645343|NCT03320850|448319326|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
124645344|NCT03320850|448319327|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
124645345|NCT03320850|448319328|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
124645346|NCT03320850|448319329|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
124645347|NCT03320850|448319320|FG000|Overall Study|Adverse Event|0|||
124645348|NCT03320850|448319321|FG001|Overall Study|Adverse Event|0|||
124645349|NCT03320850|448319322|FG002|Overall Study|Adverse Event|0|||
124645350|NCT03320850|448319323|FG003|Overall Study|Adverse Event|0|||
124645351|NCT03320850|448319324|FG004|Overall Study|Adverse Event|0|||
124645352|NCT03320850|448319325|FG005|Overall Study|Adverse Event|2|||
124645353|NCT03320850|448319326|FG006|Overall Study|Adverse Event|1|||
124645354|NCT03320850|448319327|FG007|Overall Study|Adverse Event|0|||
124645355|NCT03320850|448319328|FG008|Overall Study|Adverse Event|2|||
124645356|NCT03320850|448319329|FG009|Overall Study|Adverse Event|0|||
124645357|NCT03320850|448319320|FG000|Overall Study|Reason Not Specified|0|||
124645358|NCT03320850|448319321|FG001|Overall Study|Reason Not Specified|0|||
124645359|NCT03320850|448319322|FG002|Overall Study|Reason Not Specified|0|||
124645360|NCT03320850|448319323|FG003|Overall Study|Reason Not Specified|0|||
124645361|NCT03320850|448319324|FG004|Overall Study|Reason Not Specified|0|||
124645362|NCT03320850|448319325|FG005|Overall Study|Reason Not Specified|1|||
124645363|NCT03320850|448319326|FG006|Overall Study|Reason Not Specified|0|||
124645364|NCT03320850|448319327|FG007|Overall Study|Reason Not Specified|0|||
124645365|NCT03320850|448319328|FG008|Overall Study|Reason Not Specified|0|||
124645366|NCT03320850|448319329|FG009|Overall Study|Reason Not Specified|1|||
124645367|NCT00546117|448319330|FG000|Overall Study|Withdrawal by Subject|3|||
124645368|NCT00546117|448319331|FG001|Overall Study|Withdrawal by Subject|0|||
124645369|NCT00546117|448319330|FG000|Overall Study|Inability to schedule follow-up visit|1|||
124645370|NCT00546117|448319331|FG001|Overall Study|Inability to schedule follow-up visit|0|||
124645371|NCT01609543|448319347|FG000|Overall Study|Disease Progression|28|||
124645372|NCT01609543|448319347|FG000|Overall Study|Adverse Event|5|||
124645373|NCT01609543|448319347|FG000|Overall Study|Withdrawal by Subject|1|||
124645374|NCT01609543|448319347|FG000|Overall Study|Protocol Violation|1|||
124645375|NCT01609543|448319347|FG000|Overall Study|Death|7|||
124645376|NCT00507819|448319348|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
124645377|NCT00507819|448319349|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
124645378|NCT03452488|448319350|FG000|Overall Study|Adverse Event|4|||
124645379|NCT03452488|448319351|FG001|Overall Study|Adverse Event|6|||
124645380|NCT03452488|448319352|FG002|Overall Study|Adverse Event|1|||
124645381|NCT03452488|448319350|FG000|Overall Study|Death|0|||
124645382|NCT03452488|448319351|FG001|Overall Study|Death|0|||
124645383|NCT03452488|448319352|FG002|Overall Study|Death|1|||
124645384|NCT03452488|448319350|FG000|Overall Study|Lost to Follow-up|1|||
124645385|NCT03452488|448319351|FG001|Overall Study|Lost to Follow-up|2|||
124645386|NCT03452488|448319352|FG002|Overall Study|Lost to Follow-up|0|||
124645387|NCT03452488|448319350|FG000|Overall Study|PI Decision|1|||
124645388|NCT03452488|448319351|FG001|Overall Study|PI Decision|0|||
124645389|NCT03452488|448319352|FG002|Overall Study|PI Decision|0|||
124645390|NCT03452488|448319350|FG000|Overall Study|Withdrew consent|4|||
124645391|NCT03452488|448319351|FG001|Overall Study|Withdrew consent|2|||
124645392|NCT03452488|448319352|FG002|Overall Study|Withdrew consent|2|||
124645393|NCT03452488|448319350|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
124645394|NCT03452488|448319351|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
124645395|NCT03452488|448319352|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
124645396|NCT03452488|448319350|FG000|Overall Study|Other|0|||
124645397|NCT03452488|448319351|FG001|Overall Study|Other|2|||
124645398|NCT03452488|448319352|FG002|Overall Study|Other|2|||
124645399|NCT01254318|448319353|FG000|Overall Study|Lost to Follow-up|5|||
124645400|NCT01254318|448319353|FG000|Overall Study|Death|47|||
124645401|NCT00782184|448319360|FG000|Overall Study|Adverse Event|1|||
124645402|NCT00782184|448319361|FG001|Overall Study|Adverse Event|2|||
124645403|NCT00782184|448319360|FG000|Overall Study|Protocol Violation|0|||
124645404|NCT00782184|448319361|FG001|Overall Study|Protocol Violation|1|||
124645405|NCT00782184|448319360|FG000|Overall Study|Withdrawal by Subject|3|||
124645406|NCT00782184|448319361|FG001|Overall Study|Withdrawal by Subject|2|||
124645407|NCT00749684|448319363|FG000|Overall Study|Death|1|||
124645408|NCT00749684|448319363|FG000|Overall Study|Adverse Event|27|||
124645409|NCT00749684|448319363|FG000|Overall Study|Participant's Wish|10|||
124645410|NCT00749684|448319363|FG000|Overall Study|Not Documented|1|||
124645411|NCT00749684|448319363|FG000|Overall Study|Progressive Desease|31|||
124645412|NCT00749684|448319363|FG000|Overall Study|Therapy according to protocol + AE|2|||
124645413|NCT00749684|448319363|FG000|Overall Study|AE+discontinuation on participants wish|1|||
124645414|NCT00749684|448319363|FG000|Overall Study|Missing|9|||
124645415|NCT01878084|448319364|FG000|Overall Study|Physician Decision|2|||
124645416|NCT02892422|448319366|FG000|Overall Study|Enrolled not treated|4|||
124645417|NCT02892422|448319366|FG000|Overall Study|Adverse Event|38|||
124645418|NCT02892422|448319366|FG000|Overall Study|Lack of Efficacy|32|||
124645419|NCT02892422|448319366|FG000|Overall Study|Non-compliance with study drug|11|||
124645420|NCT02892422|448319366|FG000|Overall Study|Protocol Violation|4|||
124645421|NCT02892422|448319366|FG000|Overall Study|Withdrawal by Subject|56|||
124645422|NCT02892422|448319366|FG000|Overall Study|Lost to Follow-up|5|||
124645423|NCT02892422|448319366|FG000|Overall Study|sponsor information 16159A results|21|||
124645424|NCT02892422|448319366|FG000|Overall Study|withdrawal of consent|13|||
124645425|NCT02892422|448319366|FG000|Overall Study|exclusion criteria met|3|||
124645426|NCT02892422|448319366|FG000|Overall Study|moving elsewhere|4|||
124645427|NCT02892422|448319366|FG000|Overall Study|non-compliance|10|||
124645428|NCT02892422|448319366|FG000|Overall Study|patient legally incapable|1|||
124645429|NCT02892422|448319366|FG000|Overall Study|patient decision|7|||
124645430|NCT02892422|448319366|FG000|Overall Study|Investigator decision|1|||
124645431|NCT01023256|448319367|FG000|Overall Study|Protocol Violation|2|||
124645432|NCT01023256|448319368|FG001|Overall Study|Protocol Violation|3|||
124645433|NCT01023256|448319369|FG002|Overall Study|Protocol Violation|0|||
124645434|NCT01023256|448319370|FG003|Overall Study|Protocol Violation|0|||
124645435|NCT01023256|448319367|FG000|Overall Study|Randomized but not treated|1|||
124645436|NCT01023256|448319368|FG001|Overall Study|Randomized but not treated|0|||
124645437|NCT01023256|448319369|FG002|Overall Study|Randomized but not treated|1|||
124645438|NCT01023256|448319370|FG003|Overall Study|Randomized but not treated|0|||
124645439|NCT01023256|448319367|FG000|Overall Study|Other|1|||
124982488|NCT02328014|449563214|FG003|Overall Study|Death|4|||
124982489|NCT02328014|449563211|FG000|Overall Study|Physician Decision|0|||
124982490|NCT02328014|449563212|FG001|Overall Study|Physician Decision|0|||
124982491|NCT02328014|449563213|FG002|Overall Study|Physician Decision|0|||
124982492|NCT02328014|449563214|FG003|Overall Study|Physician Decision|1|||
124645440|NCT01023256|448319368|FG001|Overall Study|Other|0|||
124982493|NCT02328014|449563211|FG000|Overall Study|Disease Progression|1|||
124982494|NCT02328014|449563212|FG001|Overall Study|Disease Progression|0|||
124982495|NCT02328014|449563213|FG002|Overall Study|Disease Progression|1|||
124982496|NCT02328014|449563214|FG003|Overall Study|Disease Progression|3|||
124982497|NCT02328014|449563211|FG000|Overall Study|Study Terminated by Sponsor|4|||
124982498|NCT02328014|449563212|FG001|Overall Study|Study Terminated by Sponsor|1|||
124982499|NCT02328014|449563213|FG002|Overall Study|Study Terminated by Sponsor|1|||
124982500|NCT02328014|449563214|FG003|Overall Study|Study Terminated by Sponsor|0|||
124982501|NCT02328014|449563211|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
124982502|NCT02328014|449563212|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
124982503|NCT02328014|449563213|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
124982504|NCT02328014|449563214|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
124982505|NCT02328014|449563211|FG000|Overall Study|Withdrawal by Subject|0|||
124982506|NCT02328014|449563212|FG001|Overall Study|Withdrawal by Subject|0|||
124982507|NCT02328014|449563213|FG002|Overall Study|Withdrawal by Subject|0|||
124982508|NCT02328014|449563214|FG003|Overall Study|Withdrawal by Subject|1|||
124982509|NCT01274338|449563215|FG000|Overall Study|Lack of Efficacy|72|||
124982510|NCT01274338|449563216|FG001|Overall Study|Lack of Efficacy|108|||
124982511|NCT01274338|449563217|FG002|Overall Study|Lack of Efficacy|116|||
124982512|NCT01274338|449563218|FG003|Overall Study|Lack of Efficacy|0|||
124982513|NCT01274338|449563219|FG004|Overall Study|Lack of Efficacy|0|||
124982514|NCT01274338|449563220|FG005|Overall Study|Lack of Efficacy|0|||
124982515|NCT01274338|449563215|FG000|Overall Study|Adverse Event|272|||
124982516|NCT01274338|449563216|FG001|Overall Study|Adverse Event|105|||
124982517|NCT01274338|449563217|FG002|Overall Study|Adverse Event|180|||
124982518|NCT01274338|449563218|FG003|Overall Study|Adverse Event|1|||
124982519|NCT01274338|449563219|FG004|Overall Study|Adverse Event|0|||
124982520|NCT01274338|449563220|FG005|Overall Study|Adverse Event|0|||
124982521|NCT01274338|449563215|FG000|Overall Study|Death|8|||
124982522|NCT01274338|449563216|FG001|Overall Study|Death|1|||
124982523|NCT01274338|449563217|FG002|Overall Study|Death|0|||
124982524|NCT01274338|449563218|FG003|Overall Study|Death|0|||
124982525|NCT01274338|449563219|FG004|Overall Study|Death|0|||
124982526|NCT01274338|449563220|FG005|Overall Study|Death|0|||
124982527|NCT01274338|449563215|FG000|Overall Study|Withdrawal by Subject|27|||
124645441|NCT01023256|448319369|FG002|Overall Study|Other|0|||
124645442|NCT01023256|448319370|FG003|Overall Study|Other|2|||
124982528|NCT01274338|449563216|FG001|Overall Study|Withdrawal by Subject|99|||
124982529|NCT01274338|449563217|FG002|Overall Study|Withdrawal by Subject|17|||
124982530|NCT01274338|449563218|FG003|Overall Study|Withdrawal by Subject|0|||
124645443|NCT01023256|448319367|FG000|Overall Study|Adverse Event|0|||
124645444|NCT01023256|448319368|FG001|Overall Study|Adverse Event|0|||
124645445|NCT01023256|448319369|FG002|Overall Study|Adverse Event|0|||
124645446|NCT01023256|448319370|FG003|Overall Study|Adverse Event|1|||
124645447|NCT01023256|448319367|FG000|Overall Study|Withdrawal by Subject|0|||
124645448|NCT01023256|448319368|FG001|Overall Study|Withdrawal by Subject|0|||
124645449|NCT01023256|448319369|FG002|Overall Study|Withdrawal by Subject|0|||
124982531|NCT01274338|449563219|FG004|Overall Study|Withdrawal by Subject|0|||
124982532|NCT01274338|449563220|FG005|Overall Study|Withdrawal by Subject|0|||
124982533|NCT01274338|449563215|FG000|Overall Study|Did not start treatment|8|||
124982534|NCT01274338|449563216|FG001|Overall Study|Did not start treatment|116|||
124982535|NCT01274338|449563217|FG002|Overall Study|Did not start treatment|7|||
124982536|NCT01274338|449563218|FG003|Overall Study|Did not start treatment|0|||
124645450|NCT01023256|448319370|FG003|Overall Study|Withdrawal by Subject|2|||
124872306|NCT01477853|449154077|FG000|Phase A|Lost to Follow-up|4|||
124872307|NCT01477853|449154078|FG001|Phase A|Lost to Follow-up|3|||
124872308|NCT01477853|449154079|FG002|Phase A|Lost to Follow-up|2|||
124872309|NCT01477853|449154077|FG000|Phase A|Physician Decision|1|||
124872310|NCT01477853|449154078|FG001|Phase A|Physician Decision|0|||
124872311|NCT01477853|449154079|FG002|Phase A|Physician Decision|1|||
124872312|NCT01477853|449154077|FG000|Phase A|Study terminated by sponsor|37|||
124872313|NCT01477853|449154078|FG001|Phase A|Study terminated by sponsor|40|||
124872314|NCT01477853|449154079|FG002|Phase A|Study terminated by sponsor|39|||
124872315|NCT01477853|449154077|FG000|Phase B|Lost to Follow-up|0|||
124872316|NCT01477853|449154078|FG001|Phase B|Lost to Follow-up|1|||
124872317|NCT01477853|449154079|FG002|Phase B|Lost to Follow-up|0|||
124872318|NCT01477853|449154077|FG000|Phase B|Study terminated by sponsor|12|||
124872319|NCT01477853|449154078|FG001|Phase B|Study terminated by sponsor|10|||
124872320|NCT01477853|449154079|FG002|Phase B|Study terminated by sponsor|11|||
124872321|NCT01050816|449154080|FG000|Overall Study|Lost to Follow-up|2|||
124872322|NCT01050816|449154080|FG000|Overall Study|patient's refusal|2|||
124872323|NCT00948974|449154086|FG000|Overall Study|Lost to Follow-up|23|||
124872324|NCT00948974|449154087|FG001|Overall Study|Lost to Follow-up|20|||
124872325|NCT00238433|449154089|FG000|Overall Study|Screen failure|1|||
124872326|NCT00238433|449154089|FG000|Overall Study|Lost to Follow-up|1|||
124872327|NCT00238433|449154089|FG000|Overall Study|Death|1|||
124872328|NCT01814748|449154092|FG000|Overall Study|Lost to Follow-up|1|||
124872329|NCT01814748|449154093|FG001|Overall Study|Lost to Follow-up|2|||
124872330|NCT01814748|449154092|FG000|Overall Study|Study site terminated by sponsor|1|||
124872331|NCT01814748|449154093|FG001|Overall Study|Study site terminated by sponsor|1|||
124872332|NCT01814748|449154092|FG000|Overall Study|Withdrawal by Subject|6|||
124872333|NCT01814748|449154093|FG001|Overall Study|Withdrawal by Subject|4|||
124872334|NCT04044456|449154094|FG000|Overall Study|Lost to Follow-up|4|||
124872335|NCT04044456|449154095|FG001|Overall Study|Lost to Follow-up|1|||
124872336|NCT04044456|449154094|FG000|Overall Study|Withdrawal by Subject|1|||
124872337|NCT04044456|449154095|FG001|Overall Study|Withdrawal by Subject|0|||
124872338|NCT01972529|449154096|FG000|Overall Study|Adverse Event|0|||
124872339|NCT01972529|449154097|FG001|Overall Study|Adverse Event|1|||
124872340|NCT01972529|449154098|FG002|Overall Study|Adverse Event|0|||
124872341|NCT01972529|449154099|FG003|Overall Study|Adverse Event|0|||
124872342|NCT01972529|449154096|FG000|Overall Study|Lost to Follow-up|1|||
124872343|NCT01972529|449154097|FG001|Overall Study|Lost to Follow-up|0|||
124872344|NCT01972529|449154098|FG002|Overall Study|Lost to Follow-up|0|||
124872345|NCT01972529|449154099|FG003|Overall Study|Lost to Follow-up|0|||
124872346|NCT01972529|449154096|FG000|Overall Study|Participant Choice|0|||
124872347|NCT01972529|449154097|FG001|Overall Study|Participant Choice|1|||
124872348|NCT01972529|449154098|FG002|Overall Study|Participant Choice|0|||
124872349|NCT01972529|449154099|FG003|Overall Study|Participant Choice|0|||
124872350|NCT01972529|449154096|FG000|Overall Study|Withdrawl of Consent|1|||
124872351|NCT01972529|449154097|FG001|Overall Study|Withdrawl of Consent|2|||
124872352|NCT01972529|449154098|FG002|Overall Study|Withdrawl of Consent|0|||
124872353|NCT01972529|449154099|FG003|Overall Study|Withdrawl of Consent|1|||
124872354|NCT01972529|449154096|FG000|Overall Study|Other|0|||
124872355|NCT01972529|449154097|FG001|Overall Study|Other|0|||
124872356|NCT01972529|449154098|FG002|Overall Study|Other|0|||
124872357|NCT01972529|449154099|FG003|Overall Study|Other|2|||
124872358|NCT01972529|449154096|FG000|Overall Study|Not treated|0|||
124872359|NCT01972529|449154097|FG001|Overall Study|Not treated|1|||
124872360|NCT01972529|449154098|FG002|Overall Study|Not treated|2|||
124872361|NCT01972529|449154099|FG003|Overall Study|Not treated|1|||
124872362|NCT02274857|449154100|FG000|Overall Study|Adverse Event|1|||
124872363|NCT02274857|449154101|FG001|Overall Study|Adverse Event|0|||
124872364|NCT02274857|449154100|FG000|Overall Study|Death|1|||
124872365|NCT02274857|449154101|FG001|Overall Study|Death|2|||
124872366|NCT02274857|449154100|FG000|Overall Study|Lost to Follow-up|3|||
124872367|NCT02274857|449154101|FG001|Overall Study|Lost to Follow-up|0|||
124872368|NCT02274857|449154100|FG000|Overall Study|Physician Decision|2|||
124872369|NCT02274857|449154101|FG001|Overall Study|Physician Decision|0|||
124872370|NCT02274857|449154100|FG000|Overall Study|Trial screen failure|0|||
124872371|NCT02274857|449154101|FG001|Overall Study|Trial screen failure|2|||
124872372|NCT02274857|449154100|FG000|Overall Study|Withdrawal by Subject|11|||
124872373|NCT02274857|449154101|FG001|Overall Study|Withdrawal by Subject|2|||
124872374|NCT02274857|449154100|FG000|Overall Study|Other|2|||
124872375|NCT02274857|449154101|FG001|Overall Study|Other|0|||
124872376|NCT00330174|449154105|FG000|Overall Study|Withdrawal by Subject|7|||
124872377|NCT00330174|449154106|FG001|Overall Study|Withdrawal by Subject|7|||
124872378|NCT00330174|449154105|FG000|Overall Study|Lost to Follow-up|4|||
124982537|NCT01274338|449563219|FG004|Overall Study|Did not start treatment|0|||
124645451|NCT03155178|448319371|FG000|Overall Study|Did not meet treatment day baseline|7|||
124645452|NCT03155178|448319372|FG001|Overall Study|Did not meet treatment day baseline|7|||
124645453|NCT03155178|448319373|FG002|Overall Study|Did not meet treatment day baseline|7|||
124645454|NCT03155178|448319374|FG003|Overall Study|Did not meet treatment day baseline|7|||
124645455|NCT03089697|448319375|FG000|Overall Study|Adverse Event|1|||
124645456|NCT03089697|448319376|FG001|Overall Study|Adverse Event|2|||
124645457|NCT03089697|448319375|FG000|Overall Study|Withdrawal by Subject|1|||
124645458|NCT03089697|448319376|FG001|Overall Study|Withdrawal by Subject|0|||
124645459|NCT03613649|448319377|FG000|Second Treatment|Lost to Follow-up|0|||
124645460|NCT03613649|448319378|FG001|Second Treatment|Lost to Follow-up|0|||
124645461|NCT03613649|448319379|FG002|Second Treatment|Lost to Follow-up|1|||
124645462|NCT03613649|448319380|FG003|Second Treatment|Lost to Follow-up|0|||
124645463|NCT03613649|448319381|FG004|Second Treatment|Lost to Follow-up|0|||
124645464|NCT03613649|448319382|FG005|Second Treatment|Lost to Follow-up|0|||
124645465|NCT03613649|448319383|FG006|Second Treatment|Lost to Follow-up|0|||
124645466|NCT03613649|448319384|FG007|Second Treatment|Lost to Follow-up|0|||
124645467|NCT03613649|448319385|FG008|Second Treatment|Lost to Follow-up|0|||
124645468|NCT03613649|448319386|FG009|Second Treatment|Lost to Follow-up|0|||
124645469|NCT03613649|448319387|FG010|Second Treatment|Lost to Follow-up|0|||
124645470|NCT03613649|448319388|FG011|Second Treatment|Lost to Follow-up|0|||
124645471|NCT03613649|448319377|FG000|Second Treatment|Withdrawal by Subject|0|||
124645472|NCT03613649|448319378|FG001|Second Treatment|Withdrawal by Subject|0|||
124645473|NCT03613649|448319379|FG002|Second Treatment|Withdrawal by Subject|0|||
124645474|NCT03613649|448319380|FG003|Second Treatment|Withdrawal by Subject|0|||
124645475|NCT03613649|448319381|FG004|Second Treatment|Withdrawal by Subject|1|||
124645476|NCT03613649|448319382|FG005|Second Treatment|Withdrawal by Subject|0|||
124645477|NCT03613649|448319383|FG006|Second Treatment|Withdrawal by Subject|0|||
124645478|NCT03613649|448319384|FG007|Second Treatment|Withdrawal by Subject|0|||
124872379|NCT00330174|449154106|FG001|Overall Study|Lost to Follow-up|1|||
124872380|NCT00330174|449154105|FG000|Overall Study|Clinical deterioration|1|||
124872381|NCT00330174|449154106|FG001|Overall Study|Clinical deterioration|2|||
124872382|NCT00330174|449154105|FG000|Overall Study|Excessive missed visits|3|||
124872383|NCT00330174|449154106|FG001|Overall Study|Excessive missed visits|8|||
124872384|NCT00330174|449154105|FG000|Overall Study|Miscellaneous reasons|7|||
124872385|NCT00330174|449154106|FG001|Overall Study|Miscellaneous reasons|1|||
124872386|NCT02403180|449154107|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
124872387|NCT02403180|449154108|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
124872388|NCT02403180|449154107|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
124872389|NCT02403180|449154108|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
124872390|NCT00118716|449154111|FG000|Overall Study|Adverse Event|2|||
124872391|NCT00118716|449154112|FG001|Overall Study|Adverse Event|7|||
124872392|NCT00118716|449154111|FG000|Overall Study|Protocol Violation|5|||
124872393|NCT00118716|449154112|FG001|Overall Study|Protocol Violation|4|||
124872394|NCT00118716|449154111|FG000|Overall Study|Withdrawal by Subject|0|||
124872395|NCT00118716|449154112|FG001|Overall Study|Withdrawal by Subject|1|||
124872396|NCT00118716|449154111|FG000|Overall Study|Exacerbation|2|||
124872397|NCT00118716|449154112|FG001|Overall Study|Exacerbation|2|||
124872398|NCT00118716|449154111|FG000|Overall Study|Discontinued by sponsor|1|||
124872399|NCT00118716|449154112|FG001|Overall Study|Discontinued by sponsor|1|||
124872400|NCT00118716|449154111|FG000|Overall Study|Non-compliance|1|||
124872401|NCT00118716|449154112|FG001|Overall Study|Non-compliance|3|||
124872402|NCT00118716|449154111|FG000|Overall Study|misrandomized|1|||
124872403|NCT00118716|449154112|FG001|Overall Study|misrandomized|1|||
124872404|NCT00118716|449154111|FG000|Overall Study|Expired drug use|1|||
124872405|NCT00118716|449154112|FG001|Overall Study|Expired drug use|2|||
124872406|NCT00118716|449154111|FG000|Overall Study|Investigator discretion|0|||
124872407|NCT00118716|449154112|FG001|Overall Study|Investigator discretion|1|||
124872408|NCT01445652|449154114|FG000|Overall Study|Not comfortable in lenses|5|||
124872409|NCT01445652|449154115|FG001|Overall Study|Not comfortable in lenses|0|||
124872410|NCT01445652|449154114|FG000|Overall Study|Failed to attend scheduled visit|2|||
124872411|NCT01445652|449154115|FG001|Overall Study|Failed to attend scheduled visit|3|||
124872412|NCT01445652|449154114|FG000|Overall Study|Failed teach session|2|||
124872413|NCT01445652|449154115|FG001|Overall Study|Failed teach session|0|||
124872414|NCT01445652|449154114|FG000|Overall Study|Adverse Event|1|||
124872415|NCT01445652|449154115|FG001|Overall Study|Adverse Event|0|||
124872416|NCT00454571|449154116|FG000|Overall Study|Adverse Event|2|||
124872417|NCT00454571|449154117|FG001|Overall Study|Adverse Event|0|||
124872418|NCT00454571|449154116|FG000|Overall Study|Physician Decision|0|||
124872419|NCT00454571|449154117|FG001|Overall Study|Physician Decision|1|||
124872420|NCT00454571|449154116|FG000|Overall Study|Protocol Violation|1|||
124872421|NCT00454571|449154117|FG001|Overall Study|Protocol Violation|0|||
124872422|NCT00454571|449154116|FG000|Overall Study|Withdrawal by Subject|10|||
124872423|NCT00454571|449154117|FG001|Overall Study|Withdrawal by Subject|5|||
124872424|NCT02436811|449154118|FG000|Overall Study|Lost to Follow-up|2|||
124645479|NCT03613649|448319385|FG008|Second Treatment|Withdrawal by Subject|0|||
124872425|NCT02436811|449154119|FG001|Overall Study|Lost to Follow-up|9|||
124982538|NCT01274338|449563220|FG005|Overall Study|Did not start treatment|0|||
124982539|NCT01274338|449563215|FG000|Overall Study|Alternative therapy|0|||
124982540|NCT01274338|449563216|FG001|Overall Study|Alternative therapy|1|||
124982541|NCT01274338|449563217|FG002|Overall Study|Alternative therapy|0|||
124982542|NCT01274338|449563218|FG003|Overall Study|Alternative therapy|0|||
124982543|NCT01274338|449563219|FG004|Overall Study|Alternative therapy|0|||
124982544|NCT01274338|449563220|FG005|Overall Study|Alternative therapy|0|||
124982545|NCT01274338|449563215|FG000|Overall Study|Other complicating diseases|0|||
124982546|NCT01274338|449563216|FG001|Overall Study|Other complicating diseases|3|||
124982547|NCT01274338|449563217|FG002|Overall Study|Other complicating diseases|1|||
124982548|NCT01274338|449563218|FG003|Overall Study|Other complicating diseases|0|||
124982549|NCT01274338|449563219|FG004|Overall Study|Other complicating diseases|0|||
124982550|NCT01274338|449563220|FG005|Overall Study|Other complicating diseases|0|||
124982551|NCT01274338|449563215|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
124982552|NCT01274338|449563216|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
124982553|NCT01274338|449563217|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
124982554|NCT01274338|449563218|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
124982555|NCT01274338|449563219|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
124982556|NCT01274338|449563220|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
124982557|NCT01274338|449563215|FG000|Overall Study|Pregnancy|0|||
124982558|NCT01274338|449563216|FG001|Overall Study|Pregnancy|0|||
124982559|NCT01274338|449563217|FG002|Overall Study|Pregnancy|1|||
124982560|NCT01274338|449563218|FG003|Overall Study|Pregnancy|0|||
124982561|NCT01274338|449563219|FG004|Overall Study|Pregnancy|0|||
124982562|NCT01274338|449563220|FG005|Overall Study|Pregnancy|0|||
124982563|NCT01274338|449563215|FG000|Overall Study|Reason not reported|12|||
124982564|NCT01274338|449563216|FG001|Overall Study|Reason not reported|21|||
124982565|NCT01274338|449563217|FG002|Overall Study|Reason not reported|3|||
124982566|NCT01274338|449563218|FG003|Overall Study|Reason not reported|0|||
124982567|NCT01274338|449563219|FG004|Overall Study|Reason not reported|1|||
124982568|NCT01274338|449563220|FG005|Overall Study|Reason not reported|0|||
124982569|NCT03493945|449563221|FG000|Phase I Dose Escalation|Ineligible|0|||
124982570|NCT03493945|449563222|FG001|Phase I Dose Escalation|Ineligible|0|||
124982571|NCT03493945|449563223|FG002|Phase I Dose Escalation|Ineligible|1|||
124982572|NCT03493945|449563224|FG003|Phase I Dose Escalation|Ineligible|0|||
124982573|NCT03493945|449563225|FG004|Phase I Dose Escalation|Ineligible|0|||
124982574|NCT03493945|449563226|FG005|Phase I Dose Escalation|Ineligible|0|||
124982575|NCT03493945|449563227|FG006|Phase I Dose Escalation|Ineligible|0|||
124982576|NCT03493945|449563221|FG000|Phase I Dose Escalation|New therapy|0|||
124982577|NCT03493945|449563222|FG001|Phase I Dose Escalation|New therapy|1|||
124982578|NCT03493945|449563223|FG002|Phase I Dose Escalation|New therapy|0|||
124982579|NCT03493945|449563224|FG003|Phase I Dose Escalation|New therapy|0|||
124982580|NCT03493945|449563225|FG004|Phase I Dose Escalation|New therapy|0|||
124982581|NCT03493945|449563226|FG005|Phase I Dose Escalation|New therapy|0|||
124982582|NCT03493945|449563227|FG006|Phase I Dose Escalation|New therapy|0|||
124982583|NCT03493945|449563221|FG000|Phase II Dose Expansion|Refused further treatment|0|||
124982584|NCT03493945|449563222|FG001|Phase II Dose Expansion|Refused further treatment|0|||
124982585|NCT03493945|449563223|FG002|Phase II Dose Expansion|Refused further treatment|0|||
124982586|NCT03493945|449563224|FG003|Phase II Dose Expansion|Refused further treatment|0|||
124982587|NCT03493945|449563225|FG004|Phase II Dose Expansion|Refused further treatment|1|||
124982588|NCT03493945|449563226|FG005|Phase II Dose Expansion|Refused further treatment|1|||
124982589|NCT03493945|449563227|FG006|Phase II Dose Expansion|Refused further treatment|0|||
124982590|NCT03493945|449563221|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
124982591|NCT03493945|449563222|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
124982592|NCT03493945|449563223|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
124982593|NCT03493945|449563224|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
124645480|NCT03613649|448319386|FG009|Second Treatment|Withdrawal by Subject|0|||
124645481|NCT03613649|448319387|FG010|Second Treatment|Withdrawal by Subject|0|||
124645482|NCT03613649|448319388|FG011|Second Treatment|Withdrawal by Subject|0|||
124645483|NCT03613649|448319377|FG000|Third Treatment|Lost to Follow-up|0|||
124645484|NCT03613649|448319378|FG001|Third Treatment|Lost to Follow-up|0|||
124645485|NCT03613649|448319379|FG002|Third Treatment|Lost to Follow-up|0|||
124645486|NCT03613649|448319380|FG003|Third Treatment|Lost to Follow-up|0|||
124645487|NCT03613649|448319381|FG004|Third Treatment|Lost to Follow-up|1|||
124645488|NCT03613649|448319382|FG005|Third Treatment|Lost to Follow-up|0|||
124982594|NCT03493945|449563225|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
124982595|NCT03493945|449563226|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
124982596|NCT03493945|449563227|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
124982597|NCT05422339|449563228|FG000|Overall Study|Withdrawal by Subject|17|||
124982598|NCT05422339|449563229|FG001|Overall Study|Withdrawal by Subject|15|||
124982599|NCT04319198|449563230|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
124982600|NCT04319198|449563231|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
124645489|NCT03613649|448319383|FG006|Third Treatment|Lost to Follow-up|0|||
124645490|NCT03613649|448319384|FG007|Third Treatment|Lost to Follow-up|0|||
124982601|NCT04319198|449563232|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
124982602|NCT04319198|449563230|FG000|Overall Study|Death|0|||
124982603|NCT04319198|449563231|FG001|Overall Study|Death|3|||
124982604|NCT04319198|449563232|FG002|Overall Study|Death|3|||
124982605|NCT04319198|449563230|FG000|Overall Study|Reason Not Specified|0|||
124982606|NCT04319198|449563231|FG001|Overall Study|Reason Not Specified|2|||
124982607|NCT04319198|449563232|FG002|Overall Study|Reason Not Specified|4|||
124982608|NCT04319198|449563230|FG000|Overall Study|Withdrawal of Consent|0|||
124982609|NCT04319198|449563231|FG001|Overall Study|Withdrawal of Consent|0|||
124982610|NCT04319198|449563232|FG002|Overall Study|Withdrawal of Consent|5|||
124982611|NCT04319198|449563230|FG000|Overall Study|Site Terminated by Sponsor|0|||
124982612|NCT04319198|449563231|FG001|Overall Study|Site Terminated by Sponsor|1|||
124982613|NCT04319198|449563232|FG002|Overall Study|Site Terminated by Sponsor|0|||
124982614|NCT03843554|449563233|FG000|Overall Study|Physician Decision|0|||
124982615|NCT03843554|449563234|FG001|Overall Study|Physician Decision|2|||
124982616|NCT04396366|449563235|FG000|Overall Study|Adverse Event|1|||
124982617|NCT04396366|449563236|FG001|Overall Study|Adverse Event|0|||
124982618|NCT06056310|449563237|FG000|Overall Study|Other Reasons|2|||
124982619|NCT06056310|449563237|FG000|Overall Study|Sponsor Request|16|||
124982620|NCT06039579|449563250|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
124982621|NCT06039579|449563251|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
124982622|NCT06039579|449563252|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
124982623|NCT06039579|449563253|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
124982624|NCT06039579|449563254|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
124982625|NCT06039579|449563255|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
124982626|NCT06039579|449563256|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
124982627|NCT06039579|449563257|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
124982628|NCT02356159|449563266|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
124982629|NCT02356159|449563267|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
124982630|NCT02356159|449563268|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
124982631|NCT02356159|449563269|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
124982632|NCT02356159|449563270|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
124982633|NCT02356159|449563271|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
124982634|NCT00861705|449563272|FG000|Overall Study|Never Began Treatment|7|||
124982635|NCT00861705|449563273|FG001|Overall Study|Never Began Treatment|3|||
124982636|NCT00861705|449563274|FG002|Overall Study|Never Began Treatment|0|||
124982637|NCT00861705|449563275|FG003|Overall Study|Never Began Treatment|1|||
124982638|NCT06418152|449563276|FG000|Overall Study|Frequent DBS setting changes|1|||
124982639|NCT06418152|449563276|FG000|Overall Study|Withdrawal by Subject|2|||
124982640|NCT05250115|449563277|FG000|Overall Study|Premature study end|40|||
124982641|NCT05250115|449563277|FG000|Overall Study|Adverse Event|8|||
124982642|NCT05250115|449563277|FG000|Overall Study|Lost to Follow-up|7|||
124982643|NCT05250115|449563277|FG000|Overall Study|Withdrawal by Subject|6|||
124982644|NCT05250115|449563277|FG000|Overall Study|Withdrawal of informed consent|1|||
124982645|NCT05250115|449563277|FG000|Overall Study|Other|7|||
124645491|NCT03613649|448319385|FG008|Third Treatment|Lost to Follow-up|0|||
124645492|NCT03613649|448319386|FG009|Third Treatment|Lost to Follow-up|0|||
124645493|NCT03613649|448319387|FG010|Third Treatment|Lost to Follow-up|0|||
124645494|NCT03613649|448319388|FG011|Third Treatment|Lost to Follow-up|1|||
124645495|NCT03613649|448319377|FG000|Third Treatment|Protocol Violation|0|||
124645496|NCT03613649|448319378|FG001|Third Treatment|Protocol Violation|0|||
124645497|NCT03613649|448319379|FG002|Third Treatment|Protocol Violation|0|||
124645498|NCT03613649|448319380|FG003|Third Treatment|Protocol Violation|0|||
124645499|NCT03613649|448319381|FG004|Third Treatment|Protocol Violation|0|||
124645500|NCT03613649|448319382|FG005|Third Treatment|Protocol Violation|0|||
124645501|NCT03613649|448319383|FG006|Third Treatment|Protocol Violation|1|||
124645502|NCT03613649|448319384|FG007|Third Treatment|Protocol Violation|0|||
124645503|NCT03613649|448319385|FG008|Third Treatment|Protocol Violation|0|||
124645504|NCT03613649|448319386|FG009|Third Treatment|Protocol Violation|0|||
124645505|NCT03613649|448319387|FG010|Third Treatment|Protocol Violation|0|||
124645506|NCT03613649|448319388|FG011|Third Treatment|Protocol Violation|1|||
124645507|NCT03613649|448319377|FG000|Fourth Treatment|Protocol Violation|1|||
124645508|NCT03613649|448319378|FG001|Fourth Treatment|Protocol Violation|0|||
124645509|NCT03613649|448319379|FG002|Fourth Treatment|Protocol Violation|0|||
124982646|NCT04401267|449563278|FG000|Overall Study|Death|0|||
124982647|NCT04401267|449563279|FG001|Overall Study|Death|1|||
124982648|NCT04401267|449563278|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
124982649|NCT04401267|449563279|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
124645510|NCT03613649|448319380|FG003|Fourth Treatment|Protocol Violation|0|||
124982650|NCT04401267|449563278|FG000|Overall Study|Found to be Ineligible|1|||
124982651|NCT04401267|449563279|FG001|Overall Study|Found to be Ineligible|0|||
124645511|NCT03613649|448319381|FG004|Fourth Treatment|Protocol Violation|1|||
124645512|NCT03613649|448319382|FG005|Fourth Treatment|Protocol Violation|0|||
124645513|NCT03613649|448319383|FG006|Fourth Treatment|Protocol Violation|0|||
124645514|NCT03613649|448319384|FG007|Fourth Treatment|Protocol Violation|0|||
124645515|NCT03613649|448319385|FG008|Fourth Treatment|Protocol Violation|0|||
124645516|NCT03613649|448319386|FG009|Fourth Treatment|Protocol Violation|0|||
124645517|NCT03613649|448319387|FG010|Fourth Treatment|Protocol Violation|0|||
124645518|NCT03613649|448319388|FG011|Fourth Treatment|Protocol Violation|0|||
124645519|NCT03613649|448319377|FG000|Fourth Treatment|Physician Decision|0|||
124645520|NCT03613649|448319378|FG001|Fourth Treatment|Physician Decision|0|||
124645521|NCT03613649|448319379|FG002|Fourth Treatment|Physician Decision|0|||
124645522|NCT03613649|448319380|FG003|Fourth Treatment|Physician Decision|0|||
124645523|NCT03613649|448319381|FG004|Fourth Treatment|Physician Decision|0|||
124645524|NCT03613649|448319382|FG005|Fourth Treatment|Physician Decision|0|||
124645525|NCT03613649|448319383|FG006|Fourth Treatment|Physician Decision|1|||
124645526|NCT03613649|448319384|FG007|Fourth Treatment|Physician Decision|0|||
124645527|NCT03613649|448319385|FG008|Fourth Treatment|Physician Decision|0|||
124645528|NCT03613649|448319386|FG009|Fourth Treatment|Physician Decision|0|||
124645529|NCT03613649|448319387|FG010|Fourth Treatment|Physician Decision|0|||
124645530|NCT03613649|448319388|FG011|Fourth Treatment|Physician Decision|0|||
124645531|NCT00675428|448319389|FG000|Overall Study|Disease Progression|2|||
124645532|NCT00675428|448319390|FG001|Overall Study|Disease Progression|2|||
124645533|NCT00675428|448319389|FG000|Overall Study|No Disease Response After Cycle 6|0|||
124645534|NCT00675428|448319390|FG001|Overall Study|No Disease Response After Cycle 6|1|||
124645535|NCT00675428|448319389|FG000|Overall Study|Physician Decision|1|||
124645536|NCT00675428|448319390|FG001|Overall Study|Physician Decision|0|||
124645537|NCT00319592|448319391|FG000|Overall Study|Protocol Violation|1|||
124645538|NCT00319592|448319392|FG001|Overall Study|Protocol Violation|0|||
124645539|NCT00319592|448319391|FG000|Overall Study|Physician Decision|0|||
124645540|NCT00319592|448319392|FG001|Overall Study|Physician Decision|1|||
124645541|NCT01500187|448319395|FG000|Overall Study|Lost to Follow-up|6|||
124645542|NCT01500187|448319396|FG001|Overall Study|Lost to Follow-up|0|||
124645543|NCT02537431|448319397|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
124645544|NCT02727777|448319398|FG000|Overall Study|Screen Failure|2|||
124645545|NCT02727777|448319399|FG001|Overall Study|Screen Failure|0|||
124645546|NCT02727777|448319400|FG002|Overall Study|Screen Failure|0|||
124645547|NCT02727777|448319398|FG000|Overall Study|Progressive disease|2|||
124645548|NCT02727777|448319399|FG001|Overall Study|Progressive disease|0|||
124645549|NCT02727777|448319400|FG002|Overall Study|Progressive disease|0|||
124645550|NCT01758731|448319402|FG000|Overall Study|Physician Decision|1|||
124645551|NCT01340027|448319403|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
124645552|NCT01340027|448319404|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
124645553|NCT01340027|448319405|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
124645554|NCT01340027|448319406|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
124645555|NCT01340027|448319407|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
124645556|NCT01340027|448319408|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
124645557|NCT01340027|448319409|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
124645558|NCT01340027|448319410|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
124645559|NCT01340027|448319411|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
124645560|NCT01340027|448319412|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
124645561|NCT01340027|448319413|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
124645562|NCT01340027|448319414|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
124645563|NCT01340027|448319403|FG000|Overall Study|Adverse Event|0|||
124645564|NCT01340027|448319404|FG001|Overall Study|Adverse Event|1|||
124645565|NCT01340027|448319405|FG002|Overall Study|Adverse Event|2|||
124645566|NCT01340027|448319406|FG003|Overall Study|Adverse Event|0|||
124645567|NCT01340027|448319407|FG004|Overall Study|Adverse Event|1|||
124645568|NCT01340027|448319408|FG005|Overall Study|Adverse Event|2|||
124645569|NCT01340027|448319409|FG006|Overall Study|Adverse Event|2|||
124645570|NCT01340027|448319410|FG007|Overall Study|Adverse Event|1|||
124645571|NCT01340027|448319411|FG008|Overall Study|Adverse Event|4|||
124645572|NCT01340027|448319412|FG009|Overall Study|Adverse Event|1|||
124645573|NCT01340027|448319413|FG010|Overall Study|Adverse Event|1|||
124645574|NCT01340027|448319414|FG011|Overall Study|Adverse Event|3|||
124645575|NCT01340027|448319403|FG000|Overall Study|Lack of Efficacy|0|||
124645576|NCT01340027|448319404|FG001|Overall Study|Lack of Efficacy|0|||
124645577|NCT01340027|448319405|FG002|Overall Study|Lack of Efficacy|0|||
124645578|NCT01340027|448319406|FG003|Overall Study|Lack of Efficacy|0|||
124645579|NCT01340027|448319407|FG004|Overall Study|Lack of Efficacy|0|||
124645580|NCT01340027|448319408|FG005|Overall Study|Lack of Efficacy|0|||
124645581|NCT01340027|448319409|FG006|Overall Study|Lack of Efficacy|1|||
124645582|NCT01340027|448319410|FG007|Overall Study|Lack of Efficacy|1|||
124645583|NCT01340027|448319411|FG008|Overall Study|Lack of Efficacy|1|||
124645584|NCT01340027|448319412|FG009|Overall Study|Lack of Efficacy|0|||
124645585|NCT01340027|448319413|FG010|Overall Study|Lack of Efficacy|0|||
124645586|NCT01340027|448319414|FG011|Overall Study|Lack of Efficacy|0|||
124645587|NCT01340027|448319403|FG000|Overall Study|Lost to Follow-up|0|||
124645588|NCT01340027|448319404|FG001|Overall Study|Lost to Follow-up|1|||
124645589|NCT01340027|448319405|FG002|Overall Study|Lost to Follow-up|0|||
124982652|NCT03568318|449563280|FG000|Overall Study|Adverse Event|3|||
124982653|NCT03568318|449563281|FG001|Overall Study|Adverse Event|1|||
124982654|NCT03568318|449563282|FG002|Overall Study|Adverse Event|1|||
124982655|NCT03568318|449563283|FG003|Overall Study|Adverse Event|0|||
124645590|NCT01340027|448319406|FG003|Overall Study|Lost to Follow-up|0|||
124645591|NCT01340027|448319407|FG004|Overall Study|Lost to Follow-up|0|||
124645592|NCT01340027|448319408|FG005|Overall Study|Lost to Follow-up|0|||
124645593|NCT01340027|448319409|FG006|Overall Study|Lost to Follow-up|1|||
124982656|NCT03568318|449563284|FG004|Overall Study|Adverse Event|1|||
124982657|NCT03568318|449563285|FG005|Overall Study|Adverse Event|0|||
124982658|NCT03568318|449563280|FG000|Overall Study|Withdrawal by Subject|6|||
124982659|NCT03568318|449563281|FG001|Overall Study|Withdrawal by Subject|5|||
124982660|NCT03568318|449563282|FG002|Overall Study|Withdrawal by Subject|2|||
124982661|NCT03568318|449563283|FG003|Overall Study|Withdrawal by Subject|1|||
124982662|NCT03568318|449563284|FG004|Overall Study|Withdrawal by Subject|0|||
124982663|NCT03568318|449563285|FG005|Overall Study|Withdrawal by Subject|0|||
124982664|NCT03568318|449563280|FG000|Overall Study|Lost to Follow-up|3|||
124982665|NCT03568318|449563281|FG001|Overall Study|Lost to Follow-up|2|||
124982666|NCT03568318|449563282|FG002|Overall Study|Lost to Follow-up|2|||
124982667|NCT03568318|449563283|FG003|Overall Study|Lost to Follow-up|2|||
124982668|NCT03568318|449563284|FG004|Overall Study|Lost to Follow-up|1|||
124982669|NCT03568318|449563285|FG005|Overall Study|Lost to Follow-up|0|||
124982670|NCT03568318|449563280|FG000|Overall Study|Other|3|||
124982671|NCT03568318|449563281|FG001|Overall Study|Other|1|||
124982672|NCT03568318|449563282|FG002|Overall Study|Other|3|||
124982673|NCT03568318|449563283|FG003|Overall Study|Other|0|||
124645594|NCT01340027|448319410|FG007|Overall Study|Lost to Follow-up|0|||
124645595|NCT01340027|448319411|FG008|Overall Study|Lost to Follow-up|0|||
124645596|NCT01340027|448319412|FG009|Overall Study|Lost to Follow-up|1|||
124645597|NCT01340027|448319413|FG010|Overall Study|Lost to Follow-up|0|||
124645598|NCT01340027|448319414|FG011|Overall Study|Lost to Follow-up|0|||
124645599|NCT01340027|448319403|FG000|Overall Study|Protocol Violation|1|||
124645600|NCT01340027|448319404|FG001|Overall Study|Protocol Violation|2|||
124645601|NCT01340027|448319405|FG002|Overall Study|Protocol Violation|0|||
124645602|NCT01340027|448319406|FG003|Overall Study|Protocol Violation|0|||
124645603|NCT01340027|448319407|FG004|Overall Study|Protocol Violation|6|||
124982674|NCT03568318|449563284|FG004|Overall Study|Other|0|||
124982675|NCT03568318|449563285|FG005|Overall Study|Other|0|||
124982676|NCT03568318|449563280|FG000|Overall Study|Ongoing at Time of Analysis|5|||
124982677|NCT03568318|449563281|FG001|Overall Study|Ongoing at Time of Analysis|3|||
124982678|NCT03568318|449563282|FG002|Overall Study|Ongoing at Time of Analysis|2|||
124982679|NCT03568318|449563283|FG003|Overall Study|Ongoing at Time of Analysis|1|||
124982680|NCT03568318|449563284|FG004|Overall Study|Ongoing at Time of Analysis|0|||
124982681|NCT03568318|449563285|FG005|Overall Study|Ongoing at Time of Analysis|0|||
124982682|NCT03360682|449563286|FG000|Overall Study|Adverse Event|3|||
124982683|NCT05815342|449563289|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
124982684|NCT05815342|449563289|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
124982685|NCT05815342|449563289|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
124982686|NCT05815342|449563289|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
124982687|NCT05815342|449563289|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
124982688|NCT05767021|449563290|FG000|Overall Study|Adverse Event|2|||
124982689|NCT05767021|449563290|FG000|Overall Study|Protocol Deviation|1|||
124982690|NCT05767021|449563290|FG000|Overall Study|Withdrawal by Subject|1|||
124982691|NCT05767021|449563290|FG000|Overall Study|Physician Decision|1|||
124982692|NCT05767021|449563290|FG000|Overall Study|Lack of Efficacy|11|||
124982693|NCT05767021|449563290|FG000|Overall Study|Assigned Treatment by Mistake|1|||
124982694|NCT04885998|449563298|FG000|Overall Study|Withdrawal by Subject|0|||
124982695|NCT04885998|449563299|FG001|Overall Study|Withdrawal by Subject|2|||
124982696|NCT04885998|449563300|FG002|Overall Study|Withdrawal by Subject|0|||
124982697|NCT04885998|449563301|FG003|Overall Study|Withdrawal by Subject|3|||
124982698|NCT04885998|449563298|FG000|Overall Study|Lost to Follow-up|1|||
124645604|NCT01340027|448319408|FG005|Overall Study|Protocol Violation|0|||
124645605|NCT01340027|448319409|FG006|Overall Study|Protocol Violation|0|||
124645606|NCT01340027|448319410|FG007|Overall Study|Protocol Violation|1|||
124645607|NCT01340027|448319411|FG008|Overall Study|Protocol Violation|2|||
124645608|NCT01340027|448319412|FG009|Overall Study|Protocol Violation|2|||
124645609|NCT01340027|448319413|FG010|Overall Study|Protocol Violation|0|||
124645610|NCT01340027|448319414|FG011|Overall Study|Protocol Violation|0|||
124982699|NCT04885998|449563299|FG001|Overall Study|Lost to Follow-up|1|||
124982700|NCT04885998|449563300|FG002|Overall Study|Lost to Follow-up|0|||
124982701|NCT04885998|449563301|FG003|Overall Study|Lost to Follow-up|0|||
124982702|NCT04885998|449563298|FG000|Overall Study|Death|2|||
124982703|NCT04885998|449563299|FG001|Overall Study|Death|1|||
124982704|NCT04885998|449563300|FG002|Overall Study|Death|2|||
124982705|NCT04885998|449563301|FG003|Overall Study|Death|2|||
124982706|NCT04885998|449563298|FG000|Overall Study|Decision by sponsor|1|||
124645611|NCT01340027|448319403|FG000|Overall Study|Withdrawal by Subject|4|||
124645612|NCT01340027|448319404|FG001|Overall Study|Withdrawal by Subject|3|||
124645613|NCT01340027|448319405|FG002|Overall Study|Withdrawal by Subject|1|||
124645614|NCT01340027|448319406|FG003|Overall Study|Withdrawal by Subject|3|||
124645615|NCT01340027|448319407|FG004|Overall Study|Withdrawal by Subject|3|||
124645616|NCT01340027|448319408|FG005|Overall Study|Withdrawal by Subject|2|||
124645617|NCT01340027|448319409|FG006|Overall Study|Withdrawal by Subject|3|||
124645618|NCT01340027|448319410|FG007|Overall Study|Withdrawal by Subject|4|||
124645619|NCT01340027|448319411|FG008|Overall Study|Withdrawal by Subject|1|||
124645620|NCT01340027|448319412|FG009|Overall Study|Withdrawal by Subject|2|||
124645621|NCT01340027|448319413|FG010|Overall Study|Withdrawal by Subject|0|||
124645622|NCT01340027|448319414|FG011|Overall Study|Withdrawal by Subject|1|||
124645623|NCT01340027|448319403|FG000|Overall Study|Miscellaneous|0|||
124645624|NCT01340027|448319404|FG001|Overall Study|Miscellaneous|0|||
124645625|NCT01340027|448319405|FG002|Overall Study|Miscellaneous|0|||
124645626|NCT01340027|448319406|FG003|Overall Study|Miscellaneous|1|||
124645627|NCT01340027|448319407|FG004|Overall Study|Miscellaneous|0|||
124645628|NCT01340027|448319408|FG005|Overall Study|Miscellaneous|0|||
124645629|NCT01340027|448319409|FG006|Overall Study|Miscellaneous|0|||
124645630|NCT01340027|448319410|FG007|Overall Study|Miscellaneous|0|||
124645631|NCT01340027|448319411|FG008|Overall Study|Miscellaneous|0|||
124645632|NCT01340027|448319412|FG009|Overall Study|Miscellaneous|0|||
124645633|NCT01340027|448319413|FG010|Overall Study|Miscellaneous|1|||
124645634|NCT01340027|448319414|FG011|Overall Study|Miscellaneous|0|||
124645635|NCT04687072|448319415|FG000|Overall Study|Adverse Event|2|||
124645636|NCT04687072|448319416|FG001|Overall Study|Adverse Event|0|||
124645637|NCT04687072|448319415|FG000|Overall Study|Death|1|||
124645638|NCT04687072|448319416|FG001|Overall Study|Death|0|||
124645639|NCT04687072|448319415|FG000|Overall Study|Lack of Efficacy|2|||
124645640|NCT04687072|448319416|FG001|Overall Study|Lack of Efficacy|1|||
124645641|NCT04687072|448319415|FG000|Overall Study|Physician Decision|1|||
124645642|NCT04687072|448319416|FG001|Overall Study|Physician Decision|0|||
124645643|NCT04687072|448319415|FG000|Overall Study|Pregnancy|1|||
124645644|NCT04687072|448319416|FG001|Overall Study|Pregnancy|0|||
124645645|NCT04687072|448319415|FG000|Overall Study|Requires Prohibited Medication|2|||
124645646|NCT04687072|448319416|FG001|Overall Study|Requires Prohibited Medication|0|||
124645647|NCT04687072|448319415|FG000|Overall Study|Withdrawal of Consent|11|||
124645648|NCT04687072|448319416|FG001|Overall Study|Withdrawal of Consent|6|||
124645649|NCT04687072|448319415|FG000|Overall Study|Miscellaneous|4|||
124645650|NCT04687072|448319416|FG001|Overall Study|Miscellaneous|1|||
124645651|NCT00915876|448319417|FG000|Overall Study|Adverse Event|0|||
124645652|NCT00915876|448319418|FG001|Overall Study|Adverse Event|1|||
124645653|NCT01397786|448320953|FG000|Phase A|Lost to Follow-up|0|||
124645654|NCT01397786|448320954|FG001|Phase A|Lost to Follow-up|0|||
124645655|NCT01397786|448320955|FG002|Phase A|Lost to Follow-up|6|||
124645656|NCT01397786|448320953|FG000|Phase A|Adverse Event|0|||
124645657|NCT01397786|448320954|FG001|Phase A|Adverse Event|0|||
124645658|NCT01397786|448320955|FG002|Phase A|Adverse Event|8|||
124645659|NCT01397786|448320953|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
124645660|NCT01397786|448320954|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
124645661|NCT01397786|448320955|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
124645662|NCT01397786|448320953|FG000|Phase A|Physician Decision|0|||
124645663|NCT01397786|448320954|FG001|Phase A|Physician Decision|0|||
124645664|NCT01397786|448320955|FG002|Phase A|Physician Decision|1|||
124645665|NCT01397786|448320953|FG000|Phase A|Withdrawal by Subject|0|||
124645666|NCT01397786|448320954|FG001|Phase A|Withdrawal by Subject|0|||
124645667|NCT01397786|448320955|FG002|Phase A|Withdrawal by Subject|5|||
124645668|NCT01397786|448320953|FG000|Phase A|Lack of Efficacy|0|||
124645669|NCT01397786|448320954|FG001|Phase A|Lack of Efficacy|0|||
124645670|NCT01397786|448320955|FG002|Phase A|Lack of Efficacy|1|||
124645671|NCT01397786|448320953|FG000|Phase B|Lost to Follow-up|22|||
124645672|NCT01397786|448320954|FG001|Phase B|Lost to Follow-up|12|||
124645673|NCT01397786|448320955|FG002|Phase B|Lost to Follow-up|22|||
124645674|NCT01397786|448320953|FG000|Phase B|Adverse Event|109|||
124645675|NCT01397786|448320954|FG001|Phase B|Adverse Event|23|||
124645676|NCT01397786|448320955|FG002|Phase B|Adverse Event|27|||
124645677|NCT01397786|448320953|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
124645678|NCT01397786|448320954|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
124645679|NCT01397786|448320955|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
124645680|NCT01397786|448320953|FG000|Phase B|Physician Decision|9|||
124645681|NCT01397786|448320954|FG001|Phase B|Physician Decision|1|||
124645682|NCT01397786|448320955|FG002|Phase B|Physician Decision|3|||
124645683|NCT01397786|448320953|FG000|Phase B|Withdrawal by Subject|102|||
124645684|NCT01397786|448320954|FG001|Phase B|Withdrawal by Subject|45|||
124982707|NCT04885998|449563299|FG001|Overall Study|Decision by sponsor|1|||
124645685|NCT01397786|448320955|FG002|Phase B|Withdrawal by Subject|30|||
124645686|NCT01397786|448320953|FG000|Phase B|Protocol Deviation|1|||
124645687|NCT01397786|448320954|FG001|Phase B|Protocol Deviation|2|||
124645688|NCT01397786|448320955|FG002|Phase B|Protocol Deviation|4|||
124645689|NCT01397786|448320953|FG000|Phase B|Lack of Efficacy|22|||
124645690|NCT01397786|448320954|FG001|Phase B|Lack of Efficacy|7|||
124645691|NCT01397786|448320955|FG002|Phase B|Lack of Efficacy|14|||
124645692|NCT00784550|448320956|FG000|Overall Study|Adverse Event|12|||
124645693|NCT00784550|448320957|FG001|Overall Study|Adverse Event|10|||
124982708|NCT04885998|449563300|FG002|Overall Study|Decision by sponsor|0|||
124982709|NCT04885998|449563301|FG003|Overall Study|Decision by sponsor|0|||
124982710|NCT04154943|449563307|FG000|Overall Study|Study Ongoing|68|||
124982711|NCT04154943|449563307|FG000|Overall Study|Lost to Follow-up|1|||
124982712|NCT04154943|449563307|FG000|Overall Study|Decision by the Investigator|1|||
124982713|NCT04154943|449563307|FG000|Overall Study|Death|5|||
124982714|NCT04154943|449563307|FG000|Overall Study|Withdrawal by Subject|4|||
124982715|NCT02362035|449563310|FG000|Overall Study|Death|67|||
124982716|NCT02362035|449563310|FG000|Overall Study|Lost to Follow-up|3|||
124982717|NCT02362035|449563310|FG000|Overall Study|Adverse Event|1|||
124982718|NCT02362035|449563310|FG000|Overall Study|Physician Decision|1|||
124982719|NCT02362035|449563310|FG000|Overall Study|Subject started another cancer therapy|10|||
124982720|NCT02362035|449563310|FG000|Overall Study|Study terminated by sponsor|45|||
124982721|NCT02362035|449563310|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
124982722|NCT02362035|449563310|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
124982723|NCT02362035|449563310|FG000|Overall Study|Disease progression|11|||
124982724|NCT02362035|449563310|FG000|Overall Study|Withdrawal by Subject|20|||
124982725|NCT04250194|449563313|FG000|Overall Study|Declined to schedule biopsy|6|||
124982726|NCT04250194|449563314|FG001|Overall Study|Declined to schedule biopsy|10|||
124982727|NCT04250194|449563313|FG000|Overall Study|Medically Unfit for Biopsy|2|||
124982728|NCT04250194|449563314|FG001|Overall Study|Medically Unfit for Biopsy|1|||
124982729|NCT04250194|449563313|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
124982730|NCT04250194|449563314|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
124982731|NCT04250194|449563313|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
124982732|NCT04250194|449563314|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
124982733|NCT04250194|449563313|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
124982734|NCT04250194|449563314|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
124982735|NCT01239381|449563315|FG000|Overall Study|Protocol Violation|1|||
124982736|NCT01239381|449563315|FG000|Overall Study|Withdrawal by Subject|1|||
124982737|NCT06237049|449563316|FG000|Overall Study|Death|0|||
124982738|NCT06237049|449563317|FG001|Overall Study|Death|0|||
124982739|NCT06237049|449563318|FG002|Overall Study|Death|0|||
124982740|NCT06237049|449563319|FG003|Overall Study|Death|1|||
124982741|NCT06237049|449563316|FG000|Overall Study|Lost to Follow-up|11|||
124982742|NCT06237049|449563317|FG001|Overall Study|Lost to Follow-up|5|||
124982743|NCT06237049|449563318|FG002|Overall Study|Lost to Follow-up|8|||
124982744|NCT06237049|449563319|FG003|Overall Study|Lost to Follow-up|8|||
124982745|NCT06237049|449563316|FG000|Overall Study|Protocol Violation|0|||
124982746|NCT06237049|449563317|FG001|Overall Study|Protocol Violation|1|||
124982747|NCT06237049|449563318|FG002|Overall Study|Protocol Violation|0|||
124982748|NCT06237049|449563319|FG003|Overall Study|Protocol Violation|1|||
124982749|NCT06237049|449563316|FG000|Overall Study|Withdrawal by Subject|4|||
124982750|NCT06237049|449563317|FG001|Overall Study|Withdrawal by Subject|2|||
124982751|NCT06237049|449563318|FG002|Overall Study|Withdrawal by Subject|1|||
124982752|NCT06237049|449563319|FG003|Overall Study|Withdrawal by Subject|0|||
124982753|NCT05870228|449563320|FG000|Overall Study|Lost to Follow-up|2|||
124982754|NCT05870228|449563321|FG001|Overall Study|Lost to Follow-up|0|||
124982755|NCT05870228|449563320|FG000|Overall Study|Withdrawal by Subject|1|||
124982756|NCT05870228|449563321|FG001|Overall Study|Withdrawal by Subject|0|||
124982757|NCT05014412|449563322|FG000|Overall Study|Death|11|||
124982758|NCT05014412|449563323|FG001|Overall Study|Death|7|||
124982759|NCT05014412|449563324|FG002|Overall Study|Death|4|||
124872426|NCT02436811|449154120|FG002|Overall Study|Lost to Follow-up|7|||
124872427|NCT03595332|449154121|FG000|Overall Study|Lost to Follow-up|16|||
124872428|NCT03595332|449154122|FG001|Overall Study|Lost to Follow-up|22|||
124872429|NCT03595332|449154121|FG000|Overall Study|Unable to retrieve ID from school|0|||
124872430|NCT03595332|449154122|FG001|Overall Study|Unable to retrieve ID from school|2|||
124872431|NCT01201811|449154125|FG000|Overall Study|Adverse Event|6|||
124872432|NCT01201811|449154125|FG000|Overall Study|Disease progression|3|||
124872433|NCT01201811|449154125|FG000|Overall Study|Withdrawal by Subject|3|||
124872434|NCT01201811|449154125|FG000|Overall Study|Death|4|||
124872435|NCT01201811|449154125|FG000|Overall Study|Treatment Failure|2|||
124872436|NCT01201811|449154125|FG000|Overall Study|Physician Decision|1|||
124872437|NCT00117676|449154126|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
124872438|NCT00117676|449154127|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
124872439|NCT00117676|449154126|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
124872440|NCT00117676|449154127|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
124872441|NCT00117676|449154126|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
124982760|NCT05014412|449563325|FG003|Overall Study|Death|7|||
124982761|NCT05014412|449563322|FG000|Overall Study|Withdrawal by Subject|1|||
124982762|NCT05014412|449563323|FG001|Overall Study|Withdrawal by Subject|1|||
124982763|NCT05014412|449563324|FG002|Overall Study|Withdrawal by Subject|1|||
124982764|NCT05014412|449563325|FG003|Overall Study|Withdrawal by Subject|2|||
124982765|NCT05014412|449563322|FG000|Overall Study|Ongoing|21|||
124982766|NCT05014412|449563323|FG001|Overall Study|Ongoing|4|||
124982767|NCT05014412|449563324|FG002|Overall Study|Ongoing|6|||
124982768|NCT05014412|449563325|FG003|Overall Study|Ongoing|20|||
124982769|NCT03547739|449563326|FG000|Overall Study|Death|0|||
124982770|NCT03547739|449563327|FG001|Overall Study|Death|1|||
124982771|NCT03547739|449563328|FG002|Overall Study|Death|5|||
124982772|NCT03547739|449563326|FG000|Overall Study|Adverse Event|24|||
124982773|NCT03547739|449563327|FG001|Overall Study|Adverse Event|11|||
124982774|NCT03547739|449563328|FG002|Overall Study|Adverse Event|13|||
124982775|NCT03547739|449563326|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
124982776|NCT03547739|449563327|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
124982777|NCT03547739|449563328|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
124982778|NCT03547739|449563326|FG000|Overall Study|Lost to Follow-up|80|||
124982779|NCT03547739|449563327|FG001|Overall Study|Lost to Follow-up|84|||
124982780|NCT03547739|449563328|FG002|Overall Study|Lost to Follow-up|116|||
124982781|NCT02101775|449563329|FG000|Overall Study|Adverse Event|4|||
124982782|NCT02101775|449563330|FG001|Overall Study|Adverse Event|0|||
124982783|NCT02101775|449563331|FG002|Overall Study|Adverse Event|0|||
124982784|NCT02101775|449563329|FG000|Overall Study|Admission to Hospital|0|||
124982785|NCT02101775|449563330|FG001|Overall Study|Admission to Hospital|1|||
124982786|NCT02101775|449563331|FG002|Overall Study|Admission to Hospital|0|||
124982787|NCT04035499|449563336|FG000|Overall Study|Death|2|||
124982788|NCT04035499|449563336|FG000|Overall Study|Withdrawal by Subject|1|||
124982789|NCT02003222|449563337|FG000|Induction|Never started treatment|0|||
124982790|NCT02003222|449563338|FG001|Induction|Never started treatment|0|||
124982791|NCT02003222|449563339|FG002|Induction|Never started treatment|0|||
124982792|NCT02003222|449563340|FG003|Induction|Never started treatment|0|||
124982793|NCT02003222|449563341|FG004|Induction|Never started treatment|8|||
124982794|NCT02003222|449563337|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
124982795|NCT02003222|449563338|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
124982796|NCT02003222|449563339|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
124982797|NCT02003222|449563340|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
124982798|NCT02003222|449563341|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
124982799|NCT02003222|449563337|FG000|Induction|Adverse Event|0|||
124982800|NCT02003222|449563338|FG001|Induction|Adverse Event|0|||
124982801|NCT02003222|449563339|FG002|Induction|Adverse Event|0|||
124982802|NCT02003222|449563340|FG003|Induction|Adverse Event|0|||
124982803|NCT02003222|449563341|FG004|Induction|Adverse Event|13|||
124982804|NCT02003222|449563337|FG000|Induction|Alternative therapy|0|||
124982805|NCT02003222|449563338|FG001|Induction|Alternative therapy|0|||
124982806|NCT02003222|449563339|FG002|Induction|Alternative therapy|0|||
124982807|NCT02003222|449563340|FG003|Induction|Alternative therapy|0|||
124982808|NCT02003222|449563341|FG004|Induction|Alternative therapy|12|||
124982809|NCT02003222|449563337|FG000|Induction|Disease progression|0|||
124982810|NCT02003222|449563338|FG001|Induction|Disease progression|0|||
124982811|NCT02003222|449563339|FG002|Induction|Disease progression|0|||
124982812|NCT02003222|449563340|FG003|Induction|Disease progression|0|||
124982813|NCT02003222|449563341|FG004|Induction|Disease progression|22|||
124982814|NCT02003222|449563337|FG000|Induction|Death|0|||
124982815|NCT02003222|449563338|FG001|Induction|Death|0|||
124982816|NCT02003222|449563339|FG002|Induction|Death|0|||
124982817|NCT02003222|449563340|FG003|Induction|Death|0|||
124982818|NCT02003222|449563341|FG004|Induction|Death|3|||
124982819|NCT02003222|449563337|FG000|Induction|Withdrawal by Subject|0|||
124645694|NCT00784550|448320956|FG000|Overall Study|Lack of Efficacy|0|||
124645695|NCT00784550|448320957|FG001|Overall Study|Lack of Efficacy|1|||
124982820|NCT02003222|449563338|FG001|Induction|Withdrawal by Subject|0|||
124982821|NCT02003222|449563339|FG002|Induction|Withdrawal by Subject|0|||
124982822|NCT02003222|449563340|FG003|Induction|Withdrawal by Subject|0|||
124982823|NCT02003222|449563341|FG004|Induction|Withdrawal by Subject|8|||
124982824|NCT02003222|449563337|FG000|Induction|Other reasons|0|||
124982825|NCT02003222|449563338|FG001|Induction|Other reasons|0|||
124982826|NCT02003222|449563339|FG002|Induction|Other reasons|0|||
124982827|NCT02003222|449563340|FG003|Induction|Other reasons|0|||
124982828|NCT02003222|449563341|FG004|Induction|Other reasons|22|||
124982829|NCT02003222|449563337|FG000|Intensification|Never started treatment|0|||
124645696|NCT00784550|448320956|FG000|Overall Study|Protocol Violation|10|||
124982830|NCT02003222|449563338|FG001|Intensification|Never started treatment|0|||
124982831|NCT02003222|449563339|FG002|Intensification|Never started treatment|0|||
124982832|NCT02003222|449563340|FG003|Intensification|Never started treatment|0|||
124982833|NCT02003222|449563341|FG004|Intensification|Never started treatment|2|||
124645697|NCT00784550|448320957|FG001|Overall Study|Protocol Violation|10|||
124982834|NCT02003222|449563337|FG000|Intensification|Adverse Event|0|||
124982835|NCT02003222|449563338|FG001|Intensification|Adverse Event|0|||
124982836|NCT02003222|449563339|FG002|Intensification|Adverse Event|0|||
124982837|NCT02003222|449563340|FG003|Intensification|Adverse Event|0|||
124982838|NCT02003222|449563341|FG004|Intensification|Adverse Event|6|||
124982839|NCT02003222|449563337|FG000|Intensification|Alternative therapy|0|||
124982840|NCT02003222|449563338|FG001|Intensification|Alternative therapy|0|||
124982841|NCT02003222|449563339|FG002|Intensification|Alternative therapy|0|||
124982842|NCT02003222|449563340|FG003|Intensification|Alternative therapy|0|||
124982843|NCT02003222|449563341|FG004|Intensification|Alternative therapy|8|||
124982844|NCT02003222|449563337|FG000|Intensification|Disease progression|0|||
124982845|NCT02003222|449563338|FG001|Intensification|Disease progression|0|||
124982846|NCT02003222|449563339|FG002|Intensification|Disease progression|0|||
124982847|NCT02003222|449563340|FG003|Intensification|Disease progression|0|||
124982848|NCT02003222|449563341|FG004|Intensification|Disease progression|18|||
124982849|NCT02003222|449563337|FG000|Intensification|Withdrawal by Subject|0|||
124982850|NCT02003222|449563338|FG001|Intensification|Withdrawal by Subject|0|||
124982851|NCT02003222|449563339|FG002|Intensification|Withdrawal by Subject|0|||
124982852|NCT02003222|449563340|FG003|Intensification|Withdrawal by Subject|0|||
124982853|NCT02003222|449563341|FG004|Intensification|Withdrawal by Subject|5|||
124982854|NCT02003222|449563337|FG000|Intensification|Other reasons|0|||
124982855|NCT02003222|449563338|FG001|Intensification|Other reasons|0|||
124982856|NCT02003222|449563339|FG002|Intensification|Other reasons|0|||
124982857|NCT02003222|449563340|FG003|Intensification|Other reasons|0|||
124982858|NCT02003222|449563341|FG004|Intensification|Other reasons|8|||
124982859|NCT01886872|449563344|FG000|Overall Study|Ineligible|7|||
124982860|NCT01886872|449563345|FG001|Overall Study|Ineligible|4|||
124982861|NCT01886872|449563346|FG002|Overall Study|Ineligible|12|||
124982862|NCT04908397|449563347|FG000|Overall Study|Withdrawal by Subject|2|||
124982863|NCT04264442|449563348|FG000|Overall Study|Lack of Efficacy|6|||
124982864|NCT04264442|449563348|FG000|Overall Study|Lost to Follow-up|2|||
124982865|NCT04264442|449563348|FG000|Overall Study|Sponsor Decision|23|||
124982866|NCT04264442|449563348|FG000|Overall Study|Withdrawal by Subject|11|||
124982867|NCT04264442|449563348|FG000|Overall Study|Study Termination|5|||
124982868|NCT04941482|449563349|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
124982869|NCT04941482|449563350|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
124982870|NCT04662931|449563351|FG000|Overall Study|Withdrawal by Subject|17|||
124982871|NCT04662931|449563351|FG000|Overall Study|Death|3|||
124982872|NCT04662931|449563351|FG000|Overall Study|Lost to Follow-up|3|||
124982873|NCT04662931|449563351|FG000|Overall Study|Guardian Decision|1|||
124982874|NCT05051462|449563355|FG000|Overall Study|Lost to Follow-up|1|||
124982875|NCT05051462|449563356|FG001|Overall Study|Lost to Follow-up|8|||
124982876|NCT05051462|449563355|FG000|Overall Study|Withdrawal by Subject|1|||
124982877|NCT05051462|449563356|FG001|Overall Study|Withdrawal by Subject|0|||
124982878|NCT05051462|449563355|FG000|Overall Study|Protocol Violation|0|||
124982879|NCT05051462|449563356|FG001|Overall Study|Protocol Violation|2|||
124982880|NCT02425904|449563357|FG000|Overall Study|Lost to Follow-up|1|||
124982881|NCT02425904|449563358|FG001|Overall Study|Lost to Follow-up|0|||
124982882|NCT02425904|449563357|FG000|Overall Study|Withdrawal by Subject|2|||
124982883|NCT02425904|449563358|FG001|Overall Study|Withdrawal by Subject|0|||
124982884|NCT02425904|449563357|FG000|Overall Study|Death|0|||
124982885|NCT02425904|449563358|FG001|Overall Study|Death|3|||
124982886|NCT05260021|449563364|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
124982887|NCT05260021|449563365|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
124982888|NCT05260021|449563366|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
124982889|NCT05260021|449563364|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
124982890|NCT05260021|449563365|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
124982891|NCT05260021|449563366|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
124982892|NCT05260021|449563364|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
124982893|NCT05260021|449563365|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
124982894|NCT05260021|449563366|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
124982895|NCT05260021|449563364|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
124982896|NCT05260021|449563365|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
124982897|NCT05260021|449563366|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
124982898|NCT05260021|449563364|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
124982899|NCT05260021|449563365|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
124982900|NCT05260021|449563366|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
124982901|NCT03842358|449564798|FG000|Overall Study|Poor DOT probe contact with breast|2|||
124982902|NCT03842358|449564798|FG000|Overall Study|DOT system problem|1|||
124982903|NCT03842358|449564798|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
124982904|NCT03842358|449564798|FG000|Overall Study|No biopsy after physician review|4|||
124982905|NCT03842358|449564798|FG000|Overall Study|Patient withdrew|2|||
124982906|NCT03745313|449564799|FG000|At 30 Days Follow-up|Death|2|||
124982907|NCT03745313|449564799|FG000|At 6 Months Follow-up|Death|1|||
124982908|NCT03745313|449564799|FG000|At 6 Months Follow-up|Missed Visit|1|||
124982909|NCT03745313|449564799|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
124982910|NCT03745313|449564799|FG000|At 1 Year Follow-up|Death|2|||
124982911|NCT03745313|449564799|FG000|At 1 Year Follow-up|Missed Visit|2|||
124982912|NCT03745313|449564799|FG000|At 2 Year Follow-up|Missed Visit|1|||
124982913|NCT04879628|449564800|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
124982914|NCT04879628|449564801|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
124982915|NCT04879628|449564802|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
124982916|NCT04879628|449564803|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
124982917|NCT04879628|449564800|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
124982918|NCT04879628|449564801|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
124982919|NCT04879628|449564802|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
124982920|NCT04879628|449564803|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
124982921|NCT04879628|449564800|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
124982922|NCT04879628|449564801|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
124982923|NCT04879628|449564802|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
124982924|NCT04879628|449564803|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
124982925|NCT04879628|449564800|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
124982926|NCT04879628|449564801|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
124982927|NCT04879628|449564802|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
124982928|NCT04879628|449564803|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
124982929|NCT03516812|449564804|FG000|Overall Study|Adverse Event|4|||
124982930|NCT03516812|449564804|FG000|Overall Study|Lack of Efficacy|2|||
124982931|NCT04875195|449564806|FG000|Overall Study|Death|9|||
124982932|NCT04875195|449564807|FG001|Overall Study|Death|3|||
124645698|NCT00784550|448320956|FG000|Overall Study|Lost to Follow-up|8|||
124645699|NCT00784550|448320957|FG001|Overall Study|Lost to Follow-up|5|||
124645700|NCT00784550|448320956|FG000|Overall Study|Physician Decision|2|||
124645701|NCT00784550|448320957|FG001|Overall Study|Physician Decision|3|||
124645702|NCT00784550|448320956|FG000|Overall Study|Withdrawal by Subject|4|||
124645703|NCT00784550|448320957|FG001|Overall Study|Withdrawal by Subject|13|||
124645704|NCT00688701|448320958|FG000|Overall Study|Adverse Event|1|||
124645705|NCT00688701|448320959|FG001|Overall Study|Adverse Event|0|||
124645706|NCT00688701|448320960|FG002|Overall Study|Adverse Event|5|||
124645707|NCT00688701|448320961|FG003|Overall Study|Adverse Event|3|||
124645708|NCT00688701|448320958|FG000|Overall Study|Lack of Efficacy|0|||
124645709|NCT00688701|448320959|FG001|Overall Study|Lack of Efficacy|1|||
124645710|NCT00688701|448320960|FG002|Overall Study|Lack of Efficacy|0|||
124645711|NCT00688701|448320961|FG003|Overall Study|Lack of Efficacy|0|||
124645712|NCT00688701|448320958|FG000|Overall Study|Withdrawal by Subject|3|||
124645713|NCT00688701|448320959|FG001|Overall Study|Withdrawal by Subject|3|||
124645714|NCT00688701|448320960|FG002|Overall Study|Withdrawal by Subject|4|||
124645715|NCT00688701|448320961|FG003|Overall Study|Withdrawal by Subject|8|||
124645716|NCT00688701|448320958|FG000|Overall Study|Poor compliance to protocol|0|||
124645717|NCT00688701|448320959|FG001|Overall Study|Poor compliance to protocol|1|||
124645718|NCT00688701|448320960|FG002|Overall Study|Poor compliance to protocol|1|||
124645719|NCT00688701|448320961|FG003|Overall Study|Poor compliance to protocol|0|||
124645720|NCT03875092|448320967|FG000|Overall Study|Adverse Event|2|||
124645721|NCT03875092|448320968|FG001|Overall Study|Adverse Event|5|||
124645722|NCT03875092|448320967|FG000|Overall Study|Death|44|||
124645723|NCT03875092|448320968|FG001|Overall Study|Death|51|||
124645724|NCT03875092|448320967|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
124645725|NCT03875092|448320968|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
124645726|NCT00784238|448320969|FG000|Overall Study|Adverse Event|14|||
124645727|NCT00784238|448320969|FG000|Overall Study|Death|2|||
124645728|NCT00784238|448320969|FG000|Overall Study|Lack of Efficacy|33|||
124645729|NCT00784238|448320969|FG000|Overall Study|Lost to Follow-up|29|||
124645730|NCT00784238|448320969|FG000|Overall Study|Pregnancy|1|||
124645731|NCT00784238|448320969|FG000|Overall Study|Withdrawal by Subject|26|||
124645732|NCT00784238|448320969|FG000|Overall Study|Other|14|||
124982933|NCT04875195|449564806|FG000|Overall Study|Withdrawal by Subject|2|||
124982934|NCT04875195|449564807|FG001|Overall Study|Withdrawal by Subject|1|||
124982935|NCT04875195|449564806|FG000|Overall Study|Ongoing in study|49|||
124982936|NCT04875195|449564807|FG001|Overall Study|Ongoing in study|2|||
124982937|NCT03389802|449564808|FG000|Overall Study|Lack of Efficacy|3|||
124982938|NCT03389802|449564809|FG001|Overall Study|Lack of Efficacy|3|||
124982939|NCT03389802|449564810|FG002|Overall Study|Lack of Efficacy|13|||
124982940|NCT03389802|449564811|FG003|Overall Study|Lack of Efficacy|6|||
124645733|NCT02759055|448320970|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
124645734|NCT02759055|448320971|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
124645735|NCT00723255|448320972|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
124645736|NCT00723255|448320972|FG000|Overall Study|Ineligible: Second primary|1|||
124645737|NCT00723255|448320972|FG000|Overall Study|Ineligible: Wrong Primary|2|||
124645738|NCT00614523|448320973|FG000|Overall Study|Adverse Event|4|||
124645739|NCT00614523|448320974|FG001|Overall Study|Adverse Event|20|||
124645740|NCT00614523|448320973|FG000|Overall Study|Death|5|||
124982941|NCT03389802|449564812|FG004|Overall Study|Lack of Efficacy|1|||
124982942|NCT03389802|449564808|FG000|Overall Study|Adverse Event|0|||
124645741|NCT00614523|448320974|FG001|Overall Study|Death|8|||
124645742|NCT00614523|448320973|FG000|Overall Study|Lack of Efficacy|9|||
124645743|NCT00614523|448320974|FG001|Overall Study|Lack of Efficacy|11|||
124645744|NCT00614523|448320973|FG000|Overall Study|Lost to Follow-up|0|||
124645745|NCT00614523|448320974|FG001|Overall Study|Lost to Follow-up|1|||
124645746|NCT00614523|448320973|FG000|Overall Study|Protocol Violation|3|||
124645747|NCT00614523|448320974|FG001|Overall Study|Protocol Violation|2|||
124645748|NCT00614523|448320973|FG000|Overall Study|Withdrawal by Subject|12|||
124645749|NCT00614523|448320974|FG001|Overall Study|Withdrawal by Subject|22|||
124645750|NCT00614523|448320973|FG000|Overall Study|Other|6|||
124645751|NCT00614523|448320974|FG001|Overall Study|Other|11|||
124645752|NCT00614523|448320973|FG000|Overall Study|Ineligibility Determined|1|||
124645753|NCT00614523|448320974|FG001|Overall Study|Ineligibility Determined|2|||
124645754|NCT00614523|448320973|FG000|Overall Study|Disease Progression|0|||
124645755|NCT00614523|448320974|FG001|Overall Study|Disease Progression|8|||
124645756|NCT00614523|448320973|FG000|Overall Study|Administrative Decision|23|||
124645757|NCT00614523|448320974|FG001|Overall Study|Administrative Decision|46|||
124645758|NCT03692325|448320975|FG000|Overall Study|Adverse Event|2|||
124645759|NCT03692325|448320975|FG000|Overall Study|Progression/Recurrence|2|||
124645760|NCT02461524|448320976|FG000|Overall Study|Death|16|||
124645761|NCT02461524|448320976|FG000|Overall Study|Withdrawal by Subject|4|||
124645762|NCT02461524|448320976|FG000|Overall Study|Device Explanted|5|||
124645763|NCT02461524|448320976|FG000|Overall Study|Missed Visit|6|||
124645764|NCT04481191|448320987|FG000|Overall Study|Withdrawn by parent/guardian|15|||
124645765|NCT04481191|448320988|FG001|Overall Study|Withdrawn by parent/guardian|10|||
124645766|NCT02487771|448320989|FG000|Overall Study|Lost to Follow-up|2|||
124645767|NCT02487771|448320990|FG001|Overall Study|Lost to Follow-up|3|||
124645768|NCT02487771|448320989|FG000|Overall Study|Moved out of area|5|||
124645769|NCT02487771|448320990|FG001|Overall Study|Moved out of area|6|||
124645770|NCT02487771|448320989|FG000|Overall Study|Withdrawal by Subject|3|||
124645771|NCT02487771|448320990|FG001|Overall Study|Withdrawal by Subject|5|||
124645772|NCT02002533|448320991|FG000|Overall Study|Withdrawal by Subject|6|||
124645773|NCT02002533|448320992|FG001|Overall Study|Withdrawal by Subject|13|||
124645774|NCT02002533|448320991|FG000|Overall Study|Protocol Violation|0|||
124645775|NCT02002533|448320992|FG001|Overall Study|Protocol Violation|1|||
124982943|NCT03389802|449564809|FG001|Overall Study|Adverse Event|0|||
124982944|NCT03389802|449564810|FG002|Overall Study|Adverse Event|1|||
124982945|NCT03389802|449564811|FG003|Overall Study|Adverse Event|0|||
124982946|NCT03389802|449564812|FG004|Overall Study|Adverse Event|4|||
124982947|NCT03389802|449564808|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
124982948|NCT03389802|449564809|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
124982949|NCT03389802|449564810|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
124982950|NCT03389802|449564811|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
124982951|NCT03389802|449564812|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
124982952|NCT05190120|449564813|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
124982953|NCT05190120|449564814|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
124982954|NCT05190120|449564815|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
124982955|NCT05190120|449564816|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
124982956|NCT05190120|449564813|FG000|Overall Study|Lost to Follow-up|5|||
124982957|NCT05190120|449564814|FG001|Overall Study|Lost to Follow-up|0|||
124982958|NCT05190120|449564815|FG002|Overall Study|Lost to Follow-up|2|||
124982959|NCT05190120|449564816|FG003|Overall Study|Lost to Follow-up|3|||
124982960|NCT03069352|449564817|FG000|Overall Study|Ongoing|12|||
124982961|NCT03069352|449564818|FG001|Overall Study|Ongoing|40|||
124982962|NCT02621424|449564819|FG000|Overall Study|Withdrawal by Subject|1|||
124982963|NCT02621424|449564820|FG001|Overall Study|Withdrawal by Subject|2|||
124982964|NCT06665919|449564823|FG000|Overall Study|Withdrawal by Subject|4|||
124982965|NCT06665919|449564824|FG001|Overall Study|Withdrawal by Subject|4|||
124645776|NCT02002533|448320991|FG000|Overall Study|Adverse Event|0|||
124645777|NCT02002533|448320992|FG001|Overall Study|Adverse Event|3|||
124645778|NCT02002533|448320991|FG000|Overall Study|Lost to Follow-up|0|||
124645779|NCT02002533|448320992|FG001|Overall Study|Lost to Follow-up|1|||
124645780|NCT04984278|448320997|FG000|Period 1|Withdrawal by Subject|1|||
124645781|NCT04984278|448320998|FG001|Period 1|Withdrawal by Subject|0|||
124645782|NCT04984278|448320997|FG000|Period 1|Other|0|||
124982966|NCT06665919|449564825|FG002|Overall Study|Withdrawal by Subject|4|||
124982967|NCT06665919|449564823|FG000|Overall Study|Non-compliance to Treatment|4|||
124982968|NCT06665919|449564824|FG001|Overall Study|Non-compliance to Treatment|1|||
124982969|NCT06665919|449564825|FG002|Overall Study|Non-compliance to Treatment|6|||
124982970|NCT06665919|449564823|FG000|Overall Study|Lost to Follow-up|3|||
124982971|NCT06665919|449564824|FG001|Overall Study|Lost to Follow-up|0|||
124982972|NCT06665919|449564825|FG002|Overall Study|Lost to Follow-up|2|||
124982973|NCT06665919|449564823|FG000|Overall Study|Physician Decision|4|||
124982974|NCT06665919|449564824|FG001|Overall Study|Physician Decision|0|||
124645783|NCT04984278|448320998|FG001|Period 1|Other|1|||
124982975|NCT06665919|449564825|FG002|Overall Study|Physician Decision|1|||
124982976|NCT05148234|449564826|FG000|Phase I|Ineligible|0|||
124982977|NCT05148234|449564827|FG001|Phase I|Ineligible|0|||
124982978|NCT05148234|449564828|FG002|Phase I|Ineligible|0|||
124982979|NCT05148234|449564829|FG003|Phase I|Ineligible|0|||
124982980|NCT05148234|449564830|FG004|Phase I|Ineligible|0|||
124982981|NCT05148234|449564831|FG005|Phase I|Ineligible|0|||
124982982|NCT05148234|449564832|FG006|Phase I|Ineligible|0|||
124982983|NCT05148234|449564833|FG007|Phase I|Ineligible|1|||
124982984|NCT05148234|449564826|FG000|Phase I|Company closed the trial.|0|||
124982985|NCT05148234|449564827|FG001|Phase I|Company closed the trial.|1|||
124982986|NCT05148234|449564828|FG002|Phase I|Company closed the trial.|0|||
124982987|NCT05148234|449564829|FG003|Phase I|Company closed the trial.|0|||
124982988|NCT05148234|449564830|FG004|Phase I|Company closed the trial.|0|||
124982989|NCT05148234|449564831|FG005|Phase I|Company closed the trial.|0|||
124982990|NCT05148234|449564832|FG006|Phase I|Company closed the trial.|0|||
124982991|NCT05148234|449564833|FG007|Phase I|Company closed the trial.|0|||
124982992|NCT03061201|449564834|FG000|Overall Study|Participants Terminated at Month 36|0|||
124982993|NCT03061201|449564835|FG001|Overall Study|Participants Terminated at Month 36|1|||
124982994|NCT03061201|449564836|FG002|Overall Study|Participants Terminated at Month 36|0|||
124982995|NCT03061201|449564837|FG003|Overall Study|Participants Terminated at Month 36|1|||
124982996|NCT03061201|449564834|FG000|Overall Study|Lost to Follow-up|1|||
124982997|NCT03061201|449564835|FG001|Overall Study|Lost to Follow-up|0|||
124982998|NCT03061201|449564836|FG002|Overall Study|Lost to Follow-up|0|||
124982999|NCT03061201|449564837|FG003|Overall Study|Lost to Follow-up|0|||
124983000|NCT03062358|449564838|FG000|Overall Study|Death|269|||
124983001|NCT03062358|449564839|FG001|Overall Study|Death|145|||
124983002|NCT03062358|449564838|FG000|Overall Study|Withdrawal by Subject|2|||
124983003|NCT03062358|449564839|FG001|Overall Study|Withdrawal by Subject|1|||
124983004|NCT03062358|449564838|FG000|Overall Study|Sponsor Decision|29|||
124983005|NCT03062358|449564839|FG001|Overall Study|Sponsor Decision|7|||
124983006|NCT04745676|449564840|FG000|Overall Study|Death|1|||
124983007|NCT04745676|449564841|FG001|Overall Study|Death|0|||
124983008|NCT04745676|449564842|FG002|Overall Study|Death|0|||
124983009|NCT04150068|449564843|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
124983010|NCT04150068|449564844|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
124983011|NCT04150068|449564845|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
124983012|NCT04150068|449564843|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
124983013|NCT04150068|449564844|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
124983014|NCT04150068|449564845|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
124983015|NCT05316701|449564846|FG000|Overall Study|Adverse Event|0|||
124983016|NCT05316701|449564847|FG001|Overall Study|Adverse Event|1|||
124983017|NCT05316701|449564846|FG000|Overall Study|Death|3|||
124983018|NCT05316701|449564847|FG001|Overall Study|Death|9|||
124983019|NCT05316701|449564846|FG000|Overall Study|Lost to Follow-up|1|||
124983020|NCT05316701|449564847|FG001|Overall Study|Lost to Follow-up|0|||
124983021|NCT05316701|449564846|FG000|Overall Study|Physician Decision|1|||
124983022|NCT05316701|449564847|FG001|Overall Study|Physician Decision|4|||
124983023|NCT05316701|449564846|FG000|Overall Study|Withdrawal by Subject|3|||
124983024|NCT05316701|449564847|FG001|Overall Study|Withdrawal by Subject|5|||
124983025|NCT05316701|449564846|FG000|Overall Study|Progression/Relapse|14|||
124983026|NCT05316701|449564847|FG001|Overall Study|Progression/Relapse|9|||
124983027|NCT05316701|449564846|FG000|Overall Study|Received Standard of Care|1|||
124983028|NCT05316701|449564847|FG001|Overall Study|Received Standard of Care|0|||
124983029|NCT05316701|449564846|FG000|Overall Study|Ongoing|70|||
124983030|NCT05316701|449564847|FG001|Overall Study|Ongoing|64|||
124983031|NCT04696653|449564848|FG000|Overall Study|left organization|18|||
124983032|NCT04696653|449564848|FG000|Overall Study|Lost to Follow-up|3|||
124983033|NCT03861273|449564849|FG000|Screening Phase (3 Weeks)|Other|1|||
124983034|NCT03861273|449564849|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
124983035|NCT03861273|449564849|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
124983036|NCT03861273|449564849|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
124983037|NCT03861273|449564849|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
124983038|NCT04625413|449564850|FG000|Overall Study|Hospice|2|||
124983039|NCT04625413|449564850|FG000|Overall Study|Distress|1|||
124983040|NCT04625413|449564850|FG000|Overall Study|Not feeling well|1|||
124983041|NCT03799341|449564851|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
124983042|NCT03799341|449564852|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
124983043|NCT03799341|449564853|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
124983044|NCT03799341|449564851|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
124983045|NCT03799341|449564852|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
124983046|NCT03799341|449564853|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
124983047|NCT03799341|449564851|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
124983048|NCT03799341|449564852|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
124983049|NCT03799341|449564853|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
124983050|NCT03799341|449564851|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
124645784|NCT04984278|448320997|FG000|Period 2|Adverse Event|1|||
124983051|NCT03799341|449564852|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
124645785|NCT04984278|448320998|FG001|Period 2|Adverse Event|0|||
124645786|NCT04984278|448320997|FG000|Period 2|Other|0|||
124645787|NCT04984278|448320998|FG001|Period 2|Other|1|||
124872442|NCT00117676|449154127|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
124872443|NCT00117676|449154126|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
124872444|NCT00117676|449154127|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
124872445|NCT00117676|449154126|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
124872446|NCT00117676|449154127|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
124872447|NCT00117676|449154126|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
124872448|NCT00117676|449154127|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
124872449|NCT00117676|449154126|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
124872450|NCT00117676|449154127|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
124872451|NCT00117676|449154126|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
124872452|NCT00117676|449154127|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
124872453|NCT00117676|449154126|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
124872454|NCT00117676|449154127|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
124872455|NCT00117676|449154126|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
124872456|NCT00117676|449154127|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
124872457|NCT00117676|449154126|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
124872458|NCT00117676|449154127|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
124872459|NCT00117676|449154126|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
124872460|NCT00117676|449154127|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
124872461|NCT00117676|449154126|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
124872462|NCT00117676|449154127|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
124872463|NCT00117676|449154126|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
124872464|NCT00117676|449154127|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
124872465|NCT00117676|449154126|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
124872466|NCT00117676|449154127|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
124872467|NCT00117676|449154126|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
124872468|NCT00117676|449154127|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
124872469|NCT00117676|449154126|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
124872470|NCT00117676|449154127|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
124872471|NCT00117676|449154126|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
124872472|NCT00117676|449154127|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
124872473|NCT00117676|449154126|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
124872474|NCT00117676|449154127|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
124872475|NCT00117676|449154126|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
124872476|NCT00117676|449154127|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
124872477|NCT00117676|449154126|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
124872478|NCT00117676|449154127|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
124872479|NCT00117676|449154126|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
124872480|NCT00117676|449154127|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
124872481|NCT00117676|449154126|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
124872482|NCT00117676|449154127|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
124872483|NCT00117676|449154126|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
124872484|NCT00117676|449154127|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
124872485|NCT00117676|449154126|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
124872486|NCT00117676|449154127|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
124872487|NCT00117676|449154126|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
124872488|NCT00117676|449154127|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
124872489|NCT00117676|449154126|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
124872490|NCT00117676|449154127|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
124872491|NCT00117676|449154126|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
124872492|NCT00117676|449154127|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
124872493|NCT00117676|449154126|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
124872494|NCT00117676|449154127|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
124872495|NCT00117676|449154126|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
124872496|NCT00117676|449154127|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
124872497|NCT00117676|449154126|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
124872498|NCT00117676|449154127|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
124872499|NCT00117676|449154126|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
124872500|NCT00117676|449154127|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
124645788|NCT01482065|448320999|FG000|Overall Study|Withdrawal by Subject|0|||
124983052|NCT03799341|449564853|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
124983053|NCT03799341|449564851|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
124983054|NCT03799341|449564852|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
124983055|NCT03799341|449564853|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
124983056|NCT03799341|449564851|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
124983057|NCT03799341|449564852|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
124983058|NCT03799341|449564853|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
124983059|NCT04679935|449564854|FG000|Overall Study|Death|0|||
124983060|NCT04679935|449564855|FG001|Overall Study|Death|1|||
124983061|NCT01116648|449564856|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
124983062|NCT01116648|449564857|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
124983063|NCT01116648|449564858|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
124983064|NCT01116648|449564859|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
124645789|NCT01482065|448321000|FG001|Overall Study|Withdrawal by Subject|1|||
124645790|NCT00425061|448321001|FG000|Overall Study|Adverse Event|1|||
124645791|NCT00425061|448321002|FG001|Overall Study|Adverse Event|0|||
124645792|NCT00425061|448321003|FG002|Overall Study|Adverse Event|0|||
124645793|NCT00425061|448321004|FG003|Overall Study|Adverse Event|2|||
124645794|NCT00425061|448321005|FG004|Overall Study|Adverse Event|2|||
124645795|NCT00425061|448321006|FG005|Overall Study|Adverse Event|0|||
124645796|NCT00425061|448321007|FG006|Overall Study|Adverse Event|0|||
124645797|NCT00425061|448321001|FG000|Overall Study|Lost to Follow-up|0|||
124645798|NCT00425061|448321002|FG001|Overall Study|Lost to Follow-up|1|||
124645799|NCT00425061|448321003|FG002|Overall Study|Lost to Follow-up|0|||
124645800|NCT00425061|448321004|FG003|Overall Study|Lost to Follow-up|0|||
124645801|NCT00425061|448321005|FG004|Overall Study|Lost to Follow-up|0|||
124645802|NCT00425061|448321006|FG005|Overall Study|Lost to Follow-up|0|||
124645803|NCT00425061|448321007|FG006|Overall Study|Lost to Follow-up|0|||
124645804|NCT00425061|448321001|FG000|Overall Study|Protocol Violation|1|||
124645805|NCT00425061|448321002|FG001|Overall Study|Protocol Violation|0|||
124645806|NCT00425061|448321003|FG002|Overall Study|Protocol Violation|0|||
124645807|NCT00425061|448321004|FG003|Overall Study|Protocol Violation|0|||
124645808|NCT00425061|448321005|FG004|Overall Study|Protocol Violation|0|||
124645809|NCT00425061|448321006|FG005|Overall Study|Protocol Violation|0|||
124645810|NCT00425061|448321007|FG006|Overall Study|Protocol Violation|0|||
124645811|NCT00425061|448321001|FG000|Overall Study|Withdrawal by Subject|0|||
124645812|NCT00425061|448321002|FG001|Overall Study|Withdrawal by Subject|1|||
124645813|NCT00425061|448321003|FG002|Overall Study|Withdrawal by Subject|0|||
124645814|NCT00425061|448321004|FG003|Overall Study|Withdrawal by Subject|0|||
124645815|NCT00425061|448321005|FG004|Overall Study|Withdrawal by Subject|1|||
124645816|NCT00425061|448321006|FG005|Overall Study|Withdrawal by Subject|0|||
124645817|NCT00425061|448321007|FG006|Overall Study|Withdrawal by Subject|3|||
124645818|NCT00425061|448321001|FG000|Overall Study|Sponsor's request|0|||
124645819|NCT00425061|448321002|FG001|Overall Study|Sponsor's request|0|||
124645820|NCT00425061|448321003|FG002|Overall Study|Sponsor's request|0|||
124645821|NCT00425061|448321004|FG003|Overall Study|Sponsor's request|0|||
124645822|NCT00425061|448321005|FG004|Overall Study|Sponsor's request|19|||
124983065|NCT01116648|449564860|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
124983066|NCT01116648|449564861|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
124983067|NCT01116648|449564862|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
124983068|NCT01116648|449564863|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
124983069|NCT01116648|449564864|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
124983070|NCT01116648|449564865|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
124983071|NCT01116648|449564866|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
124983072|NCT01116648|449564867|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
124983073|NCT01116648|449564868|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
124983074|NCT01116648|449564869|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
124983075|NCT01116648|449564870|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
124983076|NCT04539938|449564871|FG000|Overall Study|Death|30|||
124983077|NCT04539938|449564871|FG000|Overall Study|Withdrawal by Subject|4|||
124983078|NCT02993146|449564872|FG000|Overall Study|Withdrawal by Subject|0|||
124983079|NCT02993146|449564873|FG001|Overall Study|Withdrawal by Subject|0|||
124983080|NCT02993146|449564874|FG002|Overall Study|Withdrawal by Subject|1|||
124983081|NCT02993146|449564875|FG003|Overall Study|Withdrawal by Subject|1|||
124983082|NCT04362189|449564876|FG000|Overall Study|Lost to Follow-up|0|||
124983083|NCT04362189|449564877|FG001|Overall Study|Lost to Follow-up|1|||
124983084|NCT04362189|449564876|FG000|Overall Study|Withdrawal by Subject|1|||
124645823|NCT00425061|448321006|FG005|Overall Study|Sponsor's request|4|||
124645824|NCT00425061|448321007|FG006|Overall Study|Sponsor's request|15|||
124645825|NCT00425061|448321001|FG000|Overall Study|Physician Decision|0|||
124983085|NCT04362189|449564877|FG001|Overall Study|Withdrawal by Subject|0|||
124983086|NCT04362189|449564876|FG000|Overall Study|FDA Clinical Hold|7|||
124983087|NCT04362189|449564877|FG001|Overall Study|FDA Clinical Hold|2|||
124645826|NCT00425061|448321002|FG001|Overall Study|Physician Decision|0|||
124645827|NCT00425061|448321003|FG002|Overall Study|Physician Decision|0|||
124645828|NCT00425061|448321004|FG003|Overall Study|Physician Decision|0|||
124645829|NCT00425061|448321005|FG004|Overall Study|Physician Decision|1|||
124983088|NCT04362189|449564876|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
124983089|NCT04362189|449564877|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
124983090|NCT04362189|449564876|FG000|Overall Study|Adverse Event|0|||
124983091|NCT04362189|449564877|FG001|Overall Study|Adverse Event|2|||
124983092|NCT04362189|449564876|FG000|Overall Study|Death|4|||
124983093|NCT04362189|449564877|FG001|Overall Study|Death|1|||
124983094|NCT02111681|449564878|FG000|Overall Study|Death|5|||
124983095|NCT02111681|449564878|FG000|Overall Study|Lack of Efficacy|2|||
124983096|NCT02111681|449564878|FG000|Overall Study|Progression of disease|4|||
124983097|NCT03100149|449564882|FG000|Overall Study|Adverse Event|0|||
124983098|NCT03100149|449564883|FG001|Overall Study|Adverse Event|1|||
124983099|NCT03100149|449564884|FG002|Overall Study|Adverse Event|0|||
124983100|NCT03100149|449564882|FG000|Overall Study|Participant Moved out of Country|0|||
124983101|NCT03100149|449564883|FG001|Overall Study|Participant Moved out of Country|0|||
124983102|NCT03100149|449564884|FG002|Overall Study|Participant Moved out of Country|1|||
124983103|NCT03100149|449564882|FG000|Overall Study|Withdrawal by Subject|0|||
124983104|NCT03100149|449564883|FG001|Overall Study|Withdrawal by Subject|3|||
124983105|NCT03100149|449564884|FG002|Overall Study|Withdrawal by Subject|1|||
124983106|NCT04827732|449564888|FG000|Overall Study|Did not start treatment|0|||
124983107|NCT04827732|449564889|FG001|Overall Study|Did not start treatment|1|||
124983108|NCT04827732|449564890|FG002|Overall Study|Did not start treatment|0|||
124983109|NCT04827732|449564891|FG003|Overall Study|Did not start treatment|1|||
124983110|NCT03414684|449564899|FG000|First-course Treatment|Complete response|0|||
124983111|NCT03414684|449564900|FG001|First-course Treatment|Complete response|1|||
124983112|NCT03414684|449564899|FG000|First-course Treatment|Intercurrent illness|1|||
124983113|NCT03414684|449564900|FG001|First-course Treatment|Intercurrent illness|0|||
124983114|NCT03414684|449564899|FG000|First-course Treatment|Progressive Disease|31|||
124983115|NCT03414684|449564900|FG001|First-course Treatment|Progressive Disease|32|||
124983116|NCT03414684|449564899|FG000|First-course Treatment|Adverse Event|1|||
124983117|NCT03414684|449564900|FG001|First-course Treatment|Adverse Event|2|||
124983118|NCT03414684|449564899|FG000|First-course Treatment|Physician Decision|0|||
124983119|NCT03414684|449564900|FG001|First-course Treatment|Physician Decision|1|||
124983120|NCT03414684|449564899|FG000|First-course Treatment|Withdrawal by Subject|0|||
124983121|NCT03414684|449564900|FG001|First-course Treatment|Withdrawal by Subject|1|||
124983122|NCT03414684|449564899|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
124983123|NCT03414684|449564900|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
124983124|NCT03414684|449564899|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
124983125|NCT03414684|449564900|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
124983126|NCT03414684|449564899|FG000|First-course Treatment|Still on treatment|3|||
124983127|NCT03414684|449564900|FG001|First-course Treatment|Still on treatment|0|||
124983128|NCT03414684|449564899|FG000|First-course Treatment|Never started protocol therapy|2|||
124983129|NCT03414684|449564900|FG001|First-course Treatment|Never started protocol therapy|1|||
124983130|NCT03414684|449564899|FG000|Crossover Treatment|Progressive disease|0|||
124983131|NCT03414684|449564900|FG001|Crossover Treatment|Progressive disease|12|||
124983132|NCT03414684|449564899|FG000|Crossover Treatment|Adverse Event|0|||
124983133|NCT03414684|449564900|FG001|Crossover Treatment|Adverse Event|3|||
124983134|NCT03414684|449564899|FG000|Crossover Treatment|Physician Decision|0|||
124983135|NCT03414684|449564900|FG001|Crossover Treatment|Physician Decision|1|||
124983136|NCT03414684|449564899|FG000|Crossover Treatment|Still on treatment|0|||
124983137|NCT03414684|449564900|FG001|Crossover Treatment|Still on treatment|2|||
124983138|NCT04038580|449564901|FG000|Washout 1|Death|0|||
124983139|NCT04038580|449564902|FG001|Washout 1|Death|0|||
124983140|NCT04038580|449564903|FG002|Washout 1|Death|0|||
124983141|NCT04038580|449564904|FG003|Washout 1|Death|1|||
124983142|NCT04038580|449564905|FG004|Washout 1|Death|0|||
124983143|NCT04038580|449564906|FG005|Washout 1|Death|0|||
124983144|NCT04038580|449564901|FG000|Washout 1|Withdrawal by Subject|0|||
124983145|NCT04038580|449564902|FG001|Washout 1|Withdrawal by Subject|0|||
124983146|NCT04038580|449564903|FG002|Washout 1|Withdrawal by Subject|0|||
124983147|NCT04038580|449564904|FG003|Washout 1|Withdrawal by Subject|0|||
124983148|NCT04038580|449564905|FG004|Washout 1|Withdrawal by Subject|1|||
124983149|NCT04038580|449564906|FG005|Washout 1|Withdrawal by Subject|0|||
124983150|NCT04038580|449564901|FG000|Wash-out 2|Withdrawal by Subject|1|||
124983151|NCT04038580|449564902|FG001|Wash-out 2|Withdrawal by Subject|0|||
124983152|NCT04038580|449564903|FG002|Wash-out 2|Withdrawal by Subject|0|||
124983153|NCT04038580|449564904|FG003|Wash-out 2|Withdrawal by Subject|2|||
124983154|NCT04038580|449564905|FG004|Wash-out 2|Withdrawal by Subject|0|||
124983155|NCT04038580|449564906|FG005|Wash-out 2|Withdrawal by Subject|1|||
124983156|NCT04038580|449564901|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
124983157|NCT04038580|449564902|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
124645830|NCT00425061|448321006|FG005|Overall Study|Physician Decision|0|||
124983158|NCT04038580|449564903|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
124983159|NCT04038580|449564904|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
124983160|NCT04038580|449564905|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
124983161|NCT04038580|449564906|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
124645831|NCT00425061|448321007|FG006|Overall Study|Physician Decision|0|||
124645832|NCT00425061|448321001|FG000|Overall Study|Other|0|||
124645833|NCT00425061|448321002|FG001|Overall Study|Other|0|||
124645834|NCT00425061|448321003|FG002|Overall Study|Other|0|||
124645835|NCT00425061|448321004|FG003|Overall Study|Other|0|||
124645836|NCT00425061|448321005|FG004|Overall Study|Other|3|||
124645837|NCT00425061|448321006|FG005|Overall Study|Other|0|||
124645838|NCT00425061|448321007|FG006|Overall Study|Other|1|||
124645839|NCT02137850|448321010|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
124983162|NCT04038580|449564901|FG000|Wash-out 3|Withdrawal by Subject|1|||
124645840|NCT02137850|448321011|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
124645841|NCT02137850|448321012|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
124645842|NCT02137850|448321010|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
124645843|NCT02137850|448321011|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
124645844|NCT02137850|448321012|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
124645845|NCT02137850|448321010|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
124645846|NCT02137850|448321011|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
124645847|NCT02137850|448321012|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
124645848|NCT02137850|448321010|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
124645849|NCT02137850|448321011|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
124645850|NCT02137850|448321012|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
124645851|NCT02137850|448321010|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
124645852|NCT02137850|448321011|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
124645853|NCT02137850|448321012|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
124645854|NCT02137850|448321010|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
124983163|NCT04038580|449564902|FG001|Wash-out 3|Withdrawal by Subject|0|||
124983164|NCT04038580|449564903|FG002|Wash-out 3|Withdrawal by Subject|2|||
124983165|NCT04038580|449564904|FG003|Wash-out 3|Withdrawal by Subject|0|||
124983166|NCT04038580|449564905|FG004|Wash-out 3|Withdrawal by Subject|0|||
124983167|NCT04038580|449564906|FG005|Wash-out 3|Withdrawal by Subject|0|||
124983168|NCT04972162|449565174|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
124983169|NCT04972162|449565175|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
124983170|NCT00336024|449565176|FG000|Overall Study|Death|2|||
124983171|NCT00336024|449565177|FG001|Overall Study|Death|1|||
124983172|NCT00336024|449565176|FG000|Overall Study|Physician Decision|4|||
124983173|NCT00336024|449565177|FG001|Overall Study|Physician Decision|1|||
124983174|NCT00336024|449565176|FG000|Overall Study|Protocol Violation|1|||
124983175|NCT00336024|449565177|FG001|Overall Study|Protocol Violation|0|||
124983176|NCT00336024|449565176|FG000|Overall Study|Withdrawal by Subject|1|||
124983177|NCT00336024|449565177|FG001|Overall Study|Withdrawal by Subject|2|||
124983178|NCT00336024|449565176|FG000|Overall Study|Failure to fulfill consolidation|1|||
124983179|NCT00336024|449565177|FG001|Overall Study|Failure to fulfill consolidation|1|||
124983180|NCT00336024|449565176|FG000|Overall Study|Progressive Disease|4|||
124983181|NCT00336024|449565177|FG001|Overall Study|Progressive Disease|7|||
124983182|NCT00336024|449565176|FG000|Overall Study|Ineligible|7|||
124983183|NCT00336024|449565177|FG001|Overall Study|Ineligible|7|||
124983184|NCT04349631|449565182|FG000|Overall Study|Lost to Follow-up|3|||
124983185|NCT04349631|449565182|FG000|Overall Study|Withdrawal by Subject|7|||
124983186|NCT03147287|449565183|FG000|Overall Study|Randomized Not Treated|1|||
124983187|NCT03147287|449565184|FG001|Overall Study|Randomized Not Treated|2|||
124983188|NCT03147287|449565185|FG002|Overall Study|Randomized Not Treated|1|||
124983189|NCT03147287|449565183|FG000|Overall Study|Progressive Disease RECIST|72|||
124983190|NCT03147287|449565184|FG001|Overall Study|Progressive Disease RECIST|31|||
124983191|NCT03147287|449565185|FG002|Overall Study|Progressive Disease RECIST|32|||
124983192|NCT03147287|449565183|FG000|Overall Study|Progressive Disease not RECIST|21|||
124983193|NCT03147287|449565184|FG001|Overall Study|Progressive Disease not RECIST|13|||
124983194|NCT03147287|449565185|FG002|Overall Study|Progressive Disease not RECIST|13|||
124983195|NCT03147287|449565183|FG000|Overall Study|Physician Decision|2|||
124983196|NCT03147287|449565184|FG001|Overall Study|Physician Decision|1|||
124983197|NCT03147287|449565185|FG002|Overall Study|Physician Decision|1|||
124983198|NCT03147287|449565183|FG000|Overall Study|Intercurrent illness|1|||
124983199|NCT03147287|449565184|FG001|Overall Study|Intercurrent illness|0|||
124983200|NCT03147287|449565185|FG002|Overall Study|Intercurrent illness|0|||
124983201|NCT03147287|449565183|FG000|Overall Study|Withdrawal by Subject|3|||
124983202|NCT03147287|449565184|FG001|Overall Study|Withdrawal by Subject|2|||
124983203|NCT03147287|449565185|FG002|Overall Study|Withdrawal by Subject|2|||
124983204|NCT03147287|449565183|FG000|Overall Study|Patient Non-Compliance|2|||
124645855|NCT02137850|448321011|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
124645856|NCT02137850|448321012|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
124645857|NCT02137850|448321010|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
124758641|NCT01463306|448739821|FG001|Overall Study|Lost to Follow-up|2|||
124983205|NCT03147287|449565184|FG001|Overall Study|Patient Non-Compliance|0|||
124983206|NCT03147287|449565185|FG002|Overall Study|Patient Non-Compliance|0|||
124983207|NCT03147287|449565183|FG000|Overall Study|Patient moved|0|||
124983208|NCT03147287|449565184|FG001|Overall Study|Patient moved|1|||
124983209|NCT03147287|449565185|FG002|Overall Study|Patient moved|0|||
124983210|NCT03147287|449565183|FG000|Overall Study|Arm A crossover without PD|1|||
124983211|NCT03147287|449565184|FG001|Overall Study|Arm A crossover without PD|0|||
124983212|NCT03147287|449565185|FG002|Overall Study|Arm A crossover without PD|0|||
124983213|NCT03147287|449565183|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
124983214|NCT03147287|449565184|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
124983215|NCT03147287|449565185|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
124983216|NCT01982448|449565186|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
124983217|NCT01982448|449565187|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
124983218|NCT01982448|449565186|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
124983219|NCT01982448|449565187|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
124983220|NCT01982448|449565186|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
124983221|NCT01982448|449565187|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
124983222|NCT01982448|449565186|FG000|Preoperative Chemotherapy|Lost to Follow-up|1|||
124983223|NCT01982448|449565187|FG001|Preoperative Chemotherapy|Lost to Follow-up|0|||
124645858|NCT02137850|448321011|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
124645859|NCT02137850|448321012|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
124645860|NCT02137850|448321010|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
124645861|NCT02137850|448321011|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
124645862|NCT02137850|448321012|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
124645863|NCT02137850|448321010|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
124645864|NCT02137850|448321011|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
124645865|NCT02137850|448321012|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
124645866|NCT02137850|448321010|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
124645867|NCT02137850|448321011|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
124645868|NCT02137850|448321012|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
124645869|NCT02137850|448321010|FG000|Main Phase: Prophylaxis|Other|0|||
124645870|NCT02137850|448321011|FG001|Main Phase: Prophylaxis|Other|1|||
124645871|NCT02137850|448321012|FG002|Main Phase: Prophylaxis|Other|0|||
124645872|NCT02137850|448321010|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
124645873|NCT02137850|448321011|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
124645874|NCT02137850|448321012|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
124645875|NCT02137850|448321010|FG000|Main Phase: Prophylaxis|Early site closure|0|||
124645876|NCT02137850|448321011|FG001|Main Phase: Prophylaxis|Early site closure|2|||
124645877|NCT02137850|448321012|FG002|Main Phase: Prophylaxis|Early site closure|0|||
124645878|NCT02137850|448321010|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
124645879|NCT02137850|448321011|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
124645880|NCT02137850|448321012|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
124645881|NCT02137850|448321010|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
124645882|NCT02137850|448321011|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
124645883|NCT02137850|448321012|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
124645884|NCT02137850|448321010|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
124645885|NCT02137850|448321011|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
124645886|NCT02137850|448321012|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
124645887|NCT02137850|448321010|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
124645888|NCT02137850|448321011|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
124645889|NCT02137850|448321012|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
124645890|NCT02137850|448321010|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
124645891|NCT02137850|448321011|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
124645892|NCT02137850|448321012|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
124645893|NCT02137850|448321010|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
124645894|NCT02137850|448321011|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
124645895|NCT02137850|448321012|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
124645896|NCT02137850|448321010|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
124645897|NCT02137850|448321011|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
124645898|NCT02137850|448321012|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
124645899|NCT02137850|448321010|FG000|Extension Phase: Prophylaxis|Other|0|||
124645900|NCT02137850|448321011|FG001|Extension Phase: Prophylaxis|Other|1|||
124645901|NCT02137850|448321012|FG002|Extension Phase: Prophylaxis|Other|0|||
124645902|NCT02137850|448321010|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
124645903|NCT02137850|448321011|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
124645904|NCT02137850|448321012|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
124645905|NCT02651155|448321013|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
124645906|NCT02651155|448321014|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
124645907|NCT02651155|448321013|FG000|Overall Study|Voluntary Withdrawal|5|||
124645908|NCT02651155|448321014|FG001|Overall Study|Voluntary Withdrawal|0|||
124645909|NCT04533412|448321018|FG000|Overall Study|Withdrawal by Subject|1|||
124645910|NCT04533412|448321019|FG001|Overall Study|Withdrawal by Subject|1|||
124645911|NCT04533412|448321018|FG000|Overall Study|Lost to Follow-up|1|||
124645912|NCT04533412|448321019|FG001|Overall Study|Lost to Follow-up|4|||
124645913|NCT00968981|448321022|FG000|Overall Study|Adverse Event|2|||
124645914|NCT00968981|448321023|FG001|Overall Study|Adverse Event|0|||
124645915|NCT00968981|448321024|FG002|Overall Study|Adverse Event|0|||
124645916|NCT00968981|448321022|FG000|Overall Study|Disease Progression|14|||
124645917|NCT00968981|448321023|FG001|Overall Study|Disease Progression|16|||
124645918|NCT00968981|448321024|FG002|Overall Study|Disease Progression|13|||
124645919|NCT00968981|448321022|FG000|Overall Study|Lost to Follow-up|0|||
124645920|NCT00968981|448321023|FG001|Overall Study|Lost to Follow-up|0|||
124645921|NCT00968981|448321024|FG002|Overall Study|Lost to Follow-up|1|||
124645922|NCT00968981|448321022|FG000|Overall Study|Physician Decision|5|||
124645923|NCT00968981|448321023|FG001|Overall Study|Physician Decision|3|||
124645924|NCT00968981|448321024|FG002|Overall Study|Physician Decision|5|||
124645925|NCT00968981|448321022|FG000|Overall Study|Withdrawal by Subject|1|||
124645926|NCT00968981|448321023|FG001|Overall Study|Withdrawal by Subject|3|||
124645927|NCT00968981|448321024|FG002|Overall Study|Withdrawal by Subject|3|||
124645928|NCT01489254|448321027|FG000|Double-blind Part|Adverse Event|7|||
124645929|NCT01489254|448321028|FG001|Double-blind Part|Adverse Event|2|||
124645930|NCT01489254|448321029|FG002|Double-blind Part|Adverse Event|2|||
124645931|NCT01489254|448321030|FG003|Double-blind Part|Adverse Event|0|||
124645932|NCT01489254|448321027|FG000|Double-blind Part|Pregnancy|1|||
124645933|NCT01489254|448321028|FG001|Double-blind Part|Pregnancy|3|||
124645934|NCT01489254|448321029|FG002|Double-blind Part|Pregnancy|0|||
124645935|NCT01489254|448321030|FG003|Double-blind Part|Pregnancy|0|||
124645936|NCT01489254|448321027|FG000|Double-blind Part|Withdrawal by Subject|12|||
124645937|NCT01489254|448321028|FG001|Double-blind Part|Withdrawal by Subject|20|||
124645938|NCT01489254|448321029|FG002|Double-blind Part|Withdrawal by Subject|1|||
124645939|NCT01489254|448321030|FG003|Double-blind Part|Withdrawal by Subject|0|||
124645940|NCT01489254|448321027|FG000|Double-blind Part|Lost to Follow-up|1|||
124645941|NCT01489254|448321028|FG001|Double-blind Part|Lost to Follow-up|2|||
124645942|NCT01489254|448321029|FG002|Double-blind Part|Lost to Follow-up|0|||
124645943|NCT01489254|448321030|FG003|Double-blind Part|Lost to Follow-up|0|||
124645944|NCT01489254|448321027|FG000|Double-blind Part|Other reasons for not completing study|4|||
124645945|NCT01489254|448321028|FG001|Double-blind Part|Other reasons for not completing study|6|||
124645946|NCT01489254|448321029|FG002|Double-blind Part|Other reasons for not completing study|0|||
124645947|NCT01489254|448321030|FG003|Double-blind Part|Other reasons for not completing study|0|||
124645948|NCT01489254|448321027|FG000|Open-label Extension Part|Adverse Event|0|||
124645949|NCT01489254|448321028|FG001|Open-label Extension Part|Adverse Event|0|||
124645950|NCT01489254|448321029|FG002|Open-label Extension Part|Adverse Event|0|||
124645951|NCT01489254|448321030|FG003|Open-label Extension Part|Adverse Event|10|||
124645952|NCT01489254|448321027|FG000|Open-label Extension Part|Pregnancy|0|||
124645953|NCT01489254|448321028|FG001|Open-label Extension Part|Pregnancy|0|||
124645954|NCT01489254|448321029|FG002|Open-label Extension Part|Pregnancy|0|||
124645955|NCT01489254|448321030|FG003|Open-label Extension Part|Pregnancy|3|||
124645956|NCT01489254|448321027|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
124645957|NCT01489254|448321028|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
124645958|NCT01489254|448321029|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
124645959|NCT01489254|448321030|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
124645960|NCT01489254|448321027|FG000|Open-label Extension Part|Protocol Violation|0|||
124645961|NCT01489254|448321028|FG001|Open-label Extension Part|Protocol Violation|0|||
124645962|NCT01489254|448321029|FG002|Open-label Extension Part|Protocol Violation|0|||
124645963|NCT01489254|448321030|FG003|Open-label Extension Part|Protocol Violation|1|||
124645964|NCT01489254|448321027|FG000|Open-label Extension Part|Lost to Follow-up|0|||
124645965|NCT01489254|448321028|FG001|Open-label Extension Part|Lost to Follow-up|0|||
124645966|NCT01489254|448321029|FG002|Open-label Extension Part|Lost to Follow-up|0|||
124645967|NCT01489254|448321030|FG003|Open-label Extension Part|Lost to Follow-up|9|||
124645968|NCT01489254|448321027|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
124645969|NCT01489254|448321028|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
124645970|NCT01489254|448321029|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
124645971|NCT01489254|448321030|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
124645972|NCT02833844|448321034|FG000|Double-Blind Period|Withdrawal by Subject|2|||
124645973|NCT02833844|448321035|FG001|Double-Blind Period|Withdrawal by Subject|3|||
124645974|NCT02833844|448321034|FG000|Double-Blind Period|Protocol Violation|0|||
124645975|NCT02833844|448321035|FG001|Double-Blind Period|Protocol Violation|4|||
124645976|NCT02833844|448321034|FG000|Open-Label Period|Death|0|||
124645977|NCT02833844|448321035|FG001|Open-Label Period|Death|2|||
124645978|NCT02833844|448321034|FG000|Open-Label Period|Lost to Follow-up|1|||
124645979|NCT02833844|448321035|FG001|Open-Label Period|Lost to Follow-up|0|||
124645980|NCT02833844|448321034|FG000|Open-Label Period|Withdrawal by Subject|1|||
124645981|NCT02833844|448321035|FG001|Open-Label Period|Withdrawal by Subject|0|||
124645982|NCT01154088|448321036|FG000|Overall Study|Lost to Follow-up|4|||
124645983|NCT01154088|448321037|FG001|Overall Study|Lost to Follow-up|6|||
124645984|NCT01154088|448321038|FG002|Overall Study|Lost to Follow-up|7|||
124645985|NCT01475851|448321039|FG000|Overall Study|Protocol defined stopping criteria|1|||
124645986|NCT01475851|448321040|FG001|Overall Study|Protocol defined stopping criteria|0|||
124645987|NCT02017912|448321043|FG000|Overall Study|Withdrawal by Subject|2|||
124645988|NCT02017912|448321044|FG001|Overall Study|Withdrawal by Subject|1|||
124645989|NCT02017912|448321043|FG000|Overall Study|miscellaneous|1|||
124645990|NCT02017912|448321044|FG001|Overall Study|miscellaneous|1|||
124645991|NCT01508130|448321048|FG000|Overall Study|Adverse Event|81|||
124645992|NCT01508130|448321049|FG001|Overall Study|Adverse Event|28|||
124645993|NCT01508130|448321048|FG000|Overall Study|Death|3|||
124645994|NCT01508130|448321049|FG001|Overall Study|Death|1|||
124645995|NCT01508130|448321048|FG000|Overall Study|Protocol Violation|2|||
124645996|NCT01508130|448321049|FG001|Overall Study|Protocol Violation|0|||
124645997|NCT01508130|448321048|FG000|Overall Study|Lost to Follow-up|25|||
124645998|NCT01508130|448321049|FG001|Overall Study|Lost to Follow-up|2|||
124645999|NCT01508130|448321048|FG000|Overall Study|Withdrawal by Subject|3|||
124646000|NCT01508130|448321049|FG001|Overall Study|Withdrawal by Subject|3|||
124646001|NCT01508130|448321048|FG000|Overall Study|Subject's substantial non-compliance|25|||
124646002|NCT01508130|448321049|FG001|Overall Study|Subject's substantial non-compliance|9|||
124646003|NCT01508130|448321048|FG000|Overall Study|Insufficient therapeutic response|74|||
124646004|NCT01508130|448321049|FG001|Overall Study|Insufficient therapeutic response|23|||
124646005|NCT01508130|448321048|FG000|Overall Study|Administrative|14|||
124646006|NCT01508130|448321049|FG001|Overall Study|Administrative|3|||
124646007|NCT01680159|448321050|FG000|Screening Period|Not meet criteria for dose-up period|7|||
124646008|NCT01680159|448321050|FG000|Increased Dose Period|Adverse Event|6|||
124646009|NCT01680159|448321050|FG000|Increased Dose Period|Withdrawal by Subject|2|||
124646010|NCT03429244|448321055|FG000|Overall Study|Withdrawal by Subject|2|||
124646011|NCT03429244|448321056|FG001|Overall Study|Withdrawal by Subject|1|||
124646012|NCT03429244|448321057|FG002|Overall Study|Withdrawal by Subject|1|||
124646013|NCT03403751|448321058|FG000|Overall Study|Death|5|||
124646014|NCT03403751|448321059|FG001|Overall Study|Death|6|||
124646015|NCT03403751|448321058|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
124646016|NCT03403751|448321059|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
124646017|NCT00750139|448321060|FG000|Overall Study|Adverse Event|1|||
124646018|NCT00750139|448321061|FG001|Overall Study|Adverse Event|2|||
124646019|NCT00750139|448321062|FG002|Overall Study|Adverse Event|0|||
124646020|NCT00750139|448321063|FG003|Overall Study|Adverse Event|1|||
124646021|NCT00750139|448321060|FG000|Overall Study|Lost to Follow-up|17|||
124646022|NCT00750139|448321061|FG001|Overall Study|Lost to Follow-up|12|||
124646023|NCT00750139|448321062|FG002|Overall Study|Lost to Follow-up|15|||
124646024|NCT00750139|448321063|FG003|Overall Study|Lost to Follow-up|6|||
124646025|NCT00750139|448321060|FG000|Overall Study|Withdrawal by Subject|3|||
124646026|NCT00750139|448321061|FG001|Overall Study|Withdrawal by Subject|2|||
124646027|NCT00750139|448321062|FG002|Overall Study|Withdrawal by Subject|6|||
124646028|NCT00750139|448321063|FG003|Overall Study|Withdrawal by Subject|2|||
124646029|NCT00750139|448321060|FG000|Overall Study|Physician Decision|1|||
124646030|NCT00750139|448321061|FG001|Overall Study|Physician Decision|1|||
124646031|NCT00750139|448321062|FG002|Overall Study|Physician Decision|0|||
124646032|NCT00750139|448321063|FG003|Overall Study|Physician Decision|0|||
124646033|NCT00750139|448321060|FG000|Overall Study|Non-compliance|1|||
124646034|NCT00750139|448321061|FG001|Overall Study|Non-compliance|0|||
124646035|NCT00750139|448321062|FG002|Overall Study|Non-compliance|1|||
124646036|NCT00750139|448321063|FG003|Overall Study|Non-compliance|3|||
124646037|NCT00750139|448321060|FG000|Overall Study|Termination by sponsor|4|||
124646038|NCT00750139|448321061|FG001|Overall Study|Termination by sponsor|0|||
124646039|NCT00750139|448321062|FG002|Overall Study|Termination by sponsor|0|||
124646040|NCT00750139|448321063|FG003|Overall Study|Termination by sponsor|1|||
124646041|NCT00750139|448321060|FG000|Overall Study|Non-specific|62|||
124646042|NCT00750139|448321061|FG001|Overall Study|Non-specific|42|||
124646043|NCT00750139|448321062|FG002|Overall Study|Non-specific|79|||
124646044|NCT00750139|448321063|FG003|Overall Study|Non-specific|33|||
124646045|NCT00658775|448321066|FG000|Overall Study|Adverse Event|4|||
124646046|NCT00658775|448321067|FG001|Overall Study|Adverse Event|6|||
124646047|NCT00658775|448321066|FG000|Overall Study|Lost to Follow-up|17|||
124646048|NCT00658775|448321067|FG001|Overall Study|Lost to Follow-up|18|||
124646049|NCT00658775|448321066|FG000|Overall Study|Withdrawal by Subject|6|||
124646050|NCT00658775|448321067|FG001|Overall Study|Withdrawal by Subject|4|||
124646051|NCT00658775|448321066|FG000|Overall Study|Withdrawal of consent|8|||
124646052|NCT00658775|448321067|FG001|Overall Study|Withdrawal of consent|7|||
124646053|NCT00658775|448321066|FG000|Overall Study|Other|7|||
124646054|NCT00658775|448321067|FG001|Overall Study|Other|8|||
124646055|NCT05033262|448321068|FG000|Overall Study|Lost to Follow-up|1|||
124646056|NCT05033262|448321069|FG001|Overall Study|Lost to Follow-up|0|||
124646057|NCT05033262|448321070|FG002|Overall Study|Lost to Follow-up|0|||
124646058|NCT05033262|448321071|FG003|Overall Study|Lost to Follow-up|1|||
124646059|NCT04413552|448321073|FG000|Overall Study|Adverse Event|0|||
124646060|NCT04413552|448321074|FG001|Overall Study|Adverse Event|0|||
124646061|NCT04413552|448321075|FG002|Overall Study|Adverse Event|0|||
124646062|NCT04413552|448321076|FG003|Overall Study|Adverse Event|0|||
124646063|NCT04413552|448321077|FG004|Overall Study|Adverse Event|0|||
124646064|NCT04413552|448321078|FG005|Overall Study|Adverse Event|0|||
124646065|NCT04413552|448321079|FG006|Overall Study|Adverse Event|1|||
124646066|NCT04413552|448321080|FG007|Overall Study|Adverse Event|0|||
124646067|NCT04413552|448321081|FG008|Overall Study|Adverse Event|0|||
124646068|NCT04413552|448321082|FG009|Overall Study|Adverse Event|0|||
124646069|NCT01300338|448323573|FG000|Overall Study|Lost to Follow-up|5|||
124646070|NCT01300338|448323574|FG001|Overall Study|Lost to Follow-up|0|||
124646071|NCT01895270|448323575|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
124646072|NCT01895270|448323576|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
124646073|NCT01895270|448323575|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
124646074|NCT01895270|448323576|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
124646075|NCT01895270|448323575|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
124646076|NCT01895270|448323576|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
124646077|NCT01895270|448323575|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
124646078|NCT01895270|448323576|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
124646079|NCT01895270|448323575|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
124646080|NCT01895270|448323576|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
124646081|NCT01895270|448323575|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
124646082|NCT01895270|448323576|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
124646083|NCT01895270|448323575|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
124646084|NCT01895270|448323576|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
124646085|NCT00976820|448323577|FG000|Overall Study|Lost to Follow-up|5|||
124646086|NCT00976820|448323578|FG001|Overall Study|Lost to Follow-up|16|||
124646087|NCT00976820|448323579|FG002|Overall Study|Lost to Follow-up|2|||
124646088|NCT00976820|448323580|FG003|Overall Study|Lost to Follow-up|3|||
124646089|NCT00976820|448323577|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
124646090|NCT00976820|448323578|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
124646091|NCT00976820|448323579|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
124646092|NCT00976820|448323580|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
124646093|NCT00976820|448323577|FG000|Overall Study|Withdrawal by Subject|2|||
124646094|NCT00976820|448323578|FG001|Overall Study|Withdrawal by Subject|4|||
124646095|NCT00976820|448323579|FG002|Overall Study|Withdrawal by Subject|1|||
124646096|NCT00976820|448323580|FG003|Overall Study|Withdrawal by Subject|4|||
124646097|NCT03261674|448323583|FG000|Overall Study|Lost to Follow-up|6|||
124646098|NCT03261674|448323584|FG001|Overall Study|Lost to Follow-up|7|||
124646099|NCT03261674|448323583|FG000|Overall Study|Protocol Violation|1|||
124646100|NCT03261674|448323584|FG001|Overall Study|Protocol Violation|4|||
124646101|NCT03261674|448323583|FG000|Overall Study|Withdrawal by Subject|1|||
124646102|NCT03261674|448323584|FG001|Overall Study|Withdrawal by Subject|4|||
124646103|NCT03261674|448323583|FG000|Overall Study|Physician Decision|1|||
124646104|NCT03261674|448323584|FG001|Overall Study|Physician Decision|0|||
124646105|NCT00623935|448323587|FG000|Overall Study|Death|1|||
124646106|NCT00623935|448323587|FG000|Overall Study|Patient Declined Transplant|1|||
124646107|NCT00747474|448323592|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
124646108|NCT00747474|448323593|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
124646109|NCT00747474|448323594|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
124646110|NCT00747474|448323595|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
124646111|NCT00747474|448323596|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
124646112|NCT00747474|448323597|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
124646113|NCT00747474|448323598|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
124646114|NCT00747474|448323599|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
124646115|NCT00747474|448323600|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
124646116|NCT00747474|448323601|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
124646117|NCT00747474|448323602|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
124646118|NCT00747474|448323603|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
124646119|NCT04507256|448323604|FG000|Overall Study|Withdrawal by Subject|1|||
124646120|NCT04507256|448323605|FG001|Overall Study|Withdrawal by Subject|0|||
124646121|NCT04507256|448323606|FG002|Overall Study|Withdrawal by Subject|0|||
124646122|NCT04507256|448323607|FG003|Overall Study|Withdrawal by Subject|1|||
124646123|NCT04507256|448323608|FG004|Overall Study|Withdrawal by Subject|0|||
124646124|NCT04507256|448323609|FG005|Overall Study|Withdrawal by Subject|0|||
124646125|NCT00631410|448323610|FG000|Overall Study|Adverse Event|1|||
124646126|NCT00631410|448323611|FG001|Overall Study|Adverse Event|3|||
124646127|NCT00631410|448323610|FG000|Overall Study|Objective Progression or Relapse|4|||
124646128|NCT00631410|448323611|FG001|Overall Study|Objective Progression or Relapse|3|||
124646129|NCT00631410|448323610|FG000|Overall Study|Surgery|1|||
124646130|NCT00631410|448323611|FG001|Overall Study|Surgery|0|||
124646131|NCT00890084|448323612|FG000|Overall Study|Adverse Event|16|||
124646132|NCT00890084|448323612|FG000|Overall Study|Lost to Follow-up|126|||
124646133|NCT01647516|448323617|FG000|Induction Period (IP)|Physician Decision|2|||
124646134|NCT01647516|448323618|FG001|Induction Period (IP)|Physician Decision|0|||
124646135|NCT01647516|448323619|FG002|Induction Period (IP)|Physician Decision|0|||
124646136|NCT01647516|448323620|FG003|Induction Period (IP)|Physician Decision|0|||
124646137|NCT01647516|448323621|FG004|Induction Period (IP)|Physician Decision|0|||
124646138|NCT01647516|448323622|FG005|Induction Period (IP)|Physician Decision|0|||
124646139|NCT01647516|448323617|FG000|Induction Period (IP)|Adverse Event|1|||
124646140|NCT01647516|448323618|FG001|Induction Period (IP)|Adverse Event|2|||
124646141|NCT01647516|448323619|FG002|Induction Period (IP)|Adverse Event|0|||
124646142|NCT01647516|448323620|FG003|Induction Period (IP)|Adverse Event|0|||
124646143|NCT01647516|448323621|FG004|Induction Period (IP)|Adverse Event|0|||
124646144|NCT01647516|448323622|FG005|Induction Period (IP)|Adverse Event|0|||
124646145|NCT01647516|448323617|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
124646146|NCT01647516|448323618|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
124646147|NCT01647516|448323619|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
124646148|NCT01647516|448323620|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
124646149|NCT01647516|448323621|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
124646150|NCT01647516|448323622|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
124646151|NCT01647516|448323617|FG000|Induction Period (IP)|Participant Choice|0|||
124646152|NCT01647516|448323618|FG001|Induction Period (IP)|Participant Choice|0|||
124646153|NCT01647516|448323619|FG002|Induction Period (IP)|Participant Choice|1|||
124646154|NCT01647516|448323620|FG003|Induction Period (IP)|Participant Choice|0|||
124646155|NCT01647516|448323621|FG004|Induction Period (IP)|Participant Choice|0|||
124646156|NCT01647516|448323622|FG005|Induction Period (IP)|Participant Choice|0|||
124646157|NCT01647516|448323617|FG000|Induction Period (IP)|Lack of Efficacy|1|||
124646158|NCT01647516|448323618|FG001|Induction Period (IP)|Lack of Efficacy|0|||
124646159|NCT01647516|448323619|FG002|Induction Period (IP)|Lack of Efficacy|0|||
124646160|NCT01647516|448323620|FG003|Induction Period (IP)|Lack of Efficacy|0|||
124646161|NCT01647516|448323621|FG004|Induction Period (IP)|Lack of Efficacy|0|||
124646162|NCT01647516|448323622|FG005|Induction Period (IP)|Lack of Efficacy|0|||
124646163|NCT01647516|448323617|FG000|Induction Period (IP)|No study drug received|1|||
124646164|NCT01647516|448323618|FG001|Induction Period (IP)|No study drug received|1|||
124646165|NCT01647516|448323619|FG002|Induction Period (IP)|No study drug received|0|||
124646166|NCT01647516|448323620|FG003|Induction Period (IP)|No study drug received|0|||
124646167|NCT01647516|448323621|FG004|Induction Period (IP)|No study drug received|0|||
124646168|NCT01647516|448323622|FG005|Induction Period (IP)|No study drug received|0|||
124646169|NCT01647516|448323617|FG000|Maintenance Period (MP)|Adverse Event|2|||
124646170|NCT01647516|448323618|FG001|Maintenance Period (MP)|Adverse Event|1|||
124646171|NCT01647516|448323619|FG002|Maintenance Period (MP)|Adverse Event|0|||
124646172|NCT01647516|448323620|FG003|Maintenance Period (MP)|Adverse Event|0|||
124646173|NCT01647516|448323621|FG004|Maintenance Period (MP)|Adverse Event|0|||
124646174|NCT01647516|448323622|FG005|Maintenance Period (MP)|Adverse Event|0|||
124646175|NCT01647516|448323617|FG000|Maintenance Period (MP)|Non-compliance|1|||
124646176|NCT01647516|448323618|FG001|Maintenance Period (MP)|Non-compliance|0|||
124646177|NCT01647516|448323619|FG002|Maintenance Period (MP)|Non-compliance|0|||
124646178|NCT01647516|448323620|FG003|Maintenance Period (MP)|Non-compliance|0|||
124646179|NCT01647516|448323621|FG004|Maintenance Period (MP)|Non-compliance|0|||
124646180|NCT01647516|448323622|FG005|Maintenance Period (MP)|Non-compliance|0|||
124646181|NCT01647516|448323617|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
124646182|NCT01647516|448323618|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
124646183|NCT01647516|448323619|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
124646184|NCT01647516|448323620|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
124646185|NCT01647516|448323621|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
124646186|NCT01647516|448323622|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
124646187|NCT01647516|448323617|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
124646188|NCT01647516|448323618|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
124646189|NCT01647516|448323619|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
124646190|NCT01647516|448323620|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
124646191|NCT01647516|448323621|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
124646192|NCT01647516|448323622|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
124646193|NCT01647516|448323617|FG000|Open-Label Period|Adverse Event|0|||
124646194|NCT01647516|448323618|FG001|Open-Label Period|Adverse Event|0|||
124646195|NCT01647516|448323619|FG002|Open-Label Period|Adverse Event|0|||
124646196|NCT01647516|448323620|FG003|Open-Label Period|Adverse Event|5|||
124646197|NCT01647516|448323621|FG004|Open-Label Period|Adverse Event|6|||
124646198|NCT01647516|448323622|FG005|Open-Label Period|Adverse Event|3|||
124646199|NCT01647516|448323617|FG000|Open-Label Period|Pregnancy|0|||
124646200|NCT01647516|448323618|FG001|Open-Label Period|Pregnancy|0|||
124646201|NCT01647516|448323619|FG002|Open-Label Period|Pregnancy|0|||
124646202|NCT01647516|448323620|FG003|Open-Label Period|Pregnancy|0|||
124646203|NCT01647516|448323621|FG004|Open-Label Period|Pregnancy|0|||
124646204|NCT01647516|448323622|FG005|Open-Label Period|Pregnancy|1|||
124646205|NCT01647516|448323617|FG000|Open-Label Period|Non-compliance|0|||
124646206|NCT01647516|448323618|FG001|Open-Label Period|Non-compliance|0|||
124646207|NCT01647516|448323619|FG002|Open-Label Period|Non-compliance|0|||
124646208|NCT01647516|448323620|FG003|Open-Label Period|Non-compliance|1|||
124646209|NCT01647516|448323621|FG004|Open-Label Period|Non-compliance|0|||
124646210|NCT01647516|448323622|FG005|Open-Label Period|Non-compliance|1|||
124646211|NCT01647516|448323617|FG000|Open-Label Period|Physician Decision|0|||
124646212|NCT01647516|448323618|FG001|Open-Label Period|Physician Decision|0|||
124646213|NCT01647516|448323619|FG002|Open-Label Period|Physician Decision|0|||
124646214|NCT01647516|448323620|FG003|Open-Label Period|Physician Decision|1|||
124646215|NCT01647516|448323621|FG004|Open-Label Period|Physician Decision|1|||
124646216|NCT01647516|448323622|FG005|Open-Label Period|Physician Decision|0|||
124646217|NCT01647516|448323617|FG000|Open-Label Period|Withdrawal by Subject|0|||
124646218|NCT01647516|448323618|FG001|Open-Label Period|Withdrawal by Subject|0|||
124646219|NCT01647516|448323619|FG002|Open-Label Period|Withdrawal by Subject|0|||
124646220|NCT01647516|448323620|FG003|Open-Label Period|Withdrawal by Subject|9|||
124646221|NCT01647516|448323621|FG004|Open-Label Period|Withdrawal by Subject|11|||
124646222|NCT01647516|448323622|FG005|Open-Label Period|Withdrawal by Subject|6|||
124646223|NCT01647516|448323617|FG000|Open-Label Period|Lost to Follow-up|0|||
124646224|NCT01647516|448323618|FG001|Open-Label Period|Lost to Follow-up|0|||
124646225|NCT01647516|448323619|FG002|Open-Label Period|Lost to Follow-up|0|||
124646226|NCT01647516|448323620|FG003|Open-Label Period|Lost to Follow-up|1|||
124646227|NCT01647516|448323621|FG004|Open-Label Period|Lost to Follow-up|0|||
124646228|NCT01647516|448323622|FG005|Open-Label Period|Lost to Follow-up|1|||
124646229|NCT01647516|448323617|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
124646230|NCT01647516|448323618|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
124646231|NCT01647516|448323619|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
124646232|NCT01647516|448323620|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
124646233|NCT01647516|448323621|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
124646234|NCT01647516|448323622|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
124646235|NCT01647516|448323617|FG000|Open-Label Period|Lack of Efficacy|0|||
124646236|NCT01647516|448323618|FG001|Open-Label Period|Lack of Efficacy|0|||
124646237|NCT01647516|448323619|FG002|Open-Label Period|Lack of Efficacy|0|||
124646238|NCT01647516|448323620|FG003|Open-Label Period|Lack of Efficacy|7|||
124646239|NCT01647516|448323621|FG004|Open-Label Period|Lack of Efficacy|9|||
124646240|NCT01647516|448323622|FG005|Open-Label Period|Lack of Efficacy|10|||
124646241|NCT01647516|448323617|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
124646242|NCT01647516|448323618|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
124646243|NCT01647516|448323619|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
124646244|NCT01647516|448323620|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
124646245|NCT01647516|448323621|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
124646246|NCT01647516|448323622|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
124646247|NCT01647516|448323617|FG000|Open-Label Period|No completion / discontinuation visit|0|||
124646248|NCT01647516|448323618|FG001|Open-Label Period|No completion / discontinuation visit|0|||
124646249|NCT01647516|448323619|FG002|Open-Label Period|No completion / discontinuation visit|0|||
124646250|NCT01647516|448323620|FG003|Open-Label Period|No completion / discontinuation visit|0|||
124646251|NCT01647516|448323621|FG004|Open-Label Period|No completion / discontinuation visit|2|||
124646252|NCT01647516|448323622|FG005|Open-Label Period|No completion / discontinuation visit|1|||
124646253|NCT02980341|448323623|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
124646254|NCT02980341|448323624|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
124646255|NCT02980341|448323625|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
124646256|NCT02980341|448323626|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
124646257|NCT02980341|448323627|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
124646258|NCT02980341|448323628|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
124646259|NCT02980341|448323629|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
124646260|NCT02980341|448323630|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
124646261|NCT02980341|448323631|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
124646262|NCT02980341|448323632|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
124646263|NCT02980341|448323633|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
124646264|NCT02980341|448323623|FG000|Dose Escalation|Clinical progression|0|||
124646265|NCT02980341|448323624|FG001|Dose Escalation|Clinical progression|0|||
124646266|NCT02980341|448323625|FG002|Dose Escalation|Clinical progression|2|||
124646267|NCT02980341|448323626|FG003|Dose Escalation|Clinical progression|1|||
124646268|NCT02980341|448323627|FG004|Dose Escalation|Clinical progression|0|||
124646269|NCT02980341|448323628|FG005|Dose Escalation|Clinical progression|0|||
124646270|NCT02980341|448323629|FG006|Dose Escalation|Clinical progression|0|||
124646271|NCT02980341|448323630|FG007|Dose Escalation|Clinical progression|0|||
124646272|NCT02980341|448323631|FG008|Dose Escalation|Clinical progression|0|||
124646273|NCT02980341|448323632|FG009|Dose Escalation|Clinical progression|0|||
124646274|NCT02980341|448323633|FG010|Dose Escalation|Clinical progression|0|||
124646275|NCT02980341|448323623|FG000|Dose Escalation|Adverse Event|0|||
124646276|NCT02980341|448323624|FG001|Dose Escalation|Adverse Event|0|||
124646277|NCT02980341|448323625|FG002|Dose Escalation|Adverse Event|1|||
124646278|NCT02980341|448323626|FG003|Dose Escalation|Adverse Event|2|||
124646279|NCT02980341|448323627|FG004|Dose Escalation|Adverse Event|2|||
124646280|NCT02980341|448323628|FG005|Dose Escalation|Adverse Event|0|||
124646281|NCT02980341|448323629|FG006|Dose Escalation|Adverse Event|0|||
124646282|NCT02980341|448323630|FG007|Dose Escalation|Adverse Event|0|||
124646283|NCT02980341|448323631|FG008|Dose Escalation|Adverse Event|0|||
124646284|NCT02980341|448323632|FG009|Dose Escalation|Adverse Event|0|||
124646285|NCT02980341|448323633|FG010|Dose Escalation|Adverse Event|0|||
124646286|NCT02980341|448323623|FG000|Dose Escalation|Withdrawal by Subject|0|||
124646287|NCT02980341|448323624|FG001|Dose Escalation|Withdrawal by Subject|0|||
124646288|NCT02980341|448323625|FG002|Dose Escalation|Withdrawal by Subject|1|||
124646289|NCT02980341|448323626|FG003|Dose Escalation|Withdrawal by Subject|0|||
124646290|NCT02980341|448323627|FG004|Dose Escalation|Withdrawal by Subject|0|||
124646291|NCT02980341|448323628|FG005|Dose Escalation|Withdrawal by Subject|0|||
124646292|NCT02980341|448323629|FG006|Dose Escalation|Withdrawal by Subject|0|||
124646293|NCT02980341|448323630|FG007|Dose Escalation|Withdrawal by Subject|0|||
124646294|NCT02980341|448323631|FG008|Dose Escalation|Withdrawal by Subject|0|||
124646295|NCT02980341|448323632|FG009|Dose Escalation|Withdrawal by Subject|0|||
124646296|NCT02980341|448323633|FG010|Dose Escalation|Withdrawal by Subject|0|||
124646297|NCT02980341|448323623|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
124646298|NCT02980341|448323624|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
124646299|NCT02980341|448323625|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
124646300|NCT02980341|448323626|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
124646301|NCT02980341|448323627|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
124646302|NCT02980341|448323628|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
124544077|NCT01023815|447946699|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
124544078|NCT01023815|447946700|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
124544079|NCT03253809|447946703|FG000|Overall Study|Unable to obtain study related data|14|||
124544080|NCT03919669|447946704|FG000|Overall Study|Withdrawal by Subject|1|||
124544081|NCT03919669|447946705|FG001|Overall Study|Withdrawal by Subject|0|||
124544082|NCT03919669|447946706|FG002|Overall Study|Withdrawal by Subject|0|||
124544083|NCT02319642|447946707|FG000|Overall Study|Adverse Event|2|||
124544084|NCT02319642|447946708|FG001|Overall Study|Adverse Event|4|||
124544085|NCT02319642|447946707|FG000|Overall Study|Lack of Efficacy|1|||
124646303|NCT02980341|448323629|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
124544086|NCT02319642|447946708|FG001|Overall Study|Lack of Efficacy|1|||
124646304|NCT02980341|448323630|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
124646305|NCT02980341|448323631|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
124646306|NCT02980341|448323632|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
124646307|NCT02980341|448323633|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
124646308|NCT02980341|448323623|FG000|Dose Escalation|Due to investigator's decision|0|||
124646309|NCT02980341|448323624|FG001|Dose Escalation|Due to investigator's decision|0|||
124646310|NCT02980341|448323625|FG002|Dose Escalation|Due to investigator's decision|0|||
124646311|NCT02980341|448323626|FG003|Dose Escalation|Due to investigator's decision|0|||
124646312|NCT02980341|448323627|FG004|Dose Escalation|Due to investigator's decision|1|||
124646313|NCT02980341|448323628|FG005|Dose Escalation|Due to investigator's decision|0|||
124646314|NCT02980341|448323629|FG006|Dose Escalation|Due to investigator's decision|0|||
124646315|NCT02980341|448323630|FG007|Dose Escalation|Due to investigator's decision|0|||
124646316|NCT02980341|448323631|FG008|Dose Escalation|Due to investigator's decision|0|||
124646317|NCT02980341|448323632|FG009|Dose Escalation|Due to investigator's decision|0|||
124646318|NCT02980341|448323633|FG010|Dose Escalation|Due to investigator's decision|0|||
124646319|NCT02980341|448323623|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
124646320|NCT02980341|448323624|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
124646321|NCT02980341|448323625|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
124646322|NCT02980341|448323626|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
124646323|NCT02980341|448323627|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
124646324|NCT02980341|448323628|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
124646325|NCT02980341|448323629|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
124646326|NCT02980341|448323630|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
124646327|NCT02980341|448323631|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
124646328|NCT02980341|448323632|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
124646329|NCT02980341|448323633|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
124646330|NCT02980341|448323623|FG000|Dose Finding|Adverse Event|0|||
124646331|NCT02980341|448323624|FG001|Dose Finding|Adverse Event|0|||
124646332|NCT02980341|448323625|FG002|Dose Finding|Adverse Event|0|||
124646333|NCT02980341|448323626|FG003|Dose Finding|Adverse Event|0|||
124646334|NCT02980341|448323627|FG004|Dose Finding|Adverse Event|0|||
124646335|NCT02980341|448323628|FG005|Dose Finding|Adverse Event|3|||
124646336|NCT02980341|448323629|FG006|Dose Finding|Adverse Event|0|||
124646337|NCT02980341|448323630|FG007|Dose Finding|Adverse Event|0|||
124646338|NCT02980341|448323631|FG008|Dose Finding|Adverse Event|0|||
124646339|NCT02980341|448323632|FG009|Dose Finding|Adverse Event|0|||
124646340|NCT02980341|448323633|FG010|Dose Finding|Adverse Event|0|||
124646341|NCT02980341|448323623|FG000|Dose Finding|Withdrawal by Subject|0|||
124646342|NCT02980341|448323624|FG001|Dose Finding|Withdrawal by Subject|0|||
124646343|NCT02980341|448323625|FG002|Dose Finding|Withdrawal by Subject|0|||
124646344|NCT02980341|448323626|FG003|Dose Finding|Withdrawal by Subject|0|||
124646345|NCT02980341|448323627|FG004|Dose Finding|Withdrawal by Subject|0|||
124646346|NCT02980341|448323628|FG005|Dose Finding|Withdrawal by Subject|1|||
124646347|NCT02980341|448323629|FG006|Dose Finding|Withdrawal by Subject|1|||
124646348|NCT02980341|448323630|FG007|Dose Finding|Withdrawal by Subject|0|||
124646349|NCT02980341|448323631|FG008|Dose Finding|Withdrawal by Subject|0|||
124646350|NCT02980341|448323632|FG009|Dose Finding|Withdrawal by Subject|0|||
124646351|NCT02980341|448323633|FG010|Dose Finding|Withdrawal by Subject|0|||
124646352|NCT02980341|448323623|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
124646353|NCT02980341|448323624|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
124646354|NCT02980341|448323625|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
124646355|NCT02980341|448323626|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
124646356|NCT02980341|448323627|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
124646357|NCT02980341|448323628|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
124646358|NCT02980341|448323629|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
124646359|NCT02980341|448323630|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
124646360|NCT02980341|448323631|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
124646361|NCT02980341|448323632|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
124646362|NCT02980341|448323633|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
124646363|NCT02980341|448323623|FG000|Dose Expansion|Clinical progression|0|||
124646364|NCT02980341|448323624|FG001|Dose Expansion|Clinical progression|0|||
124646365|NCT02980341|448323625|FG002|Dose Expansion|Clinical progression|0|||
124646366|NCT02980341|448323626|FG003|Dose Expansion|Clinical progression|0|||
124646367|NCT02980341|448323627|FG004|Dose Expansion|Clinical progression|0|||
124646368|NCT02980341|448323628|FG005|Dose Expansion|Clinical progression|0|||
124646369|NCT02980341|448323629|FG006|Dose Expansion|Clinical progression|0|||
124646370|NCT02980341|448323630|FG007|Dose Expansion|Clinical progression|4|||
124646371|NCT02980341|448323631|FG008|Dose Expansion|Clinical progression|3|||
124646372|NCT02980341|448323632|FG009|Dose Expansion|Clinical progression|1|||
124646373|NCT02980341|448323633|FG010|Dose Expansion|Clinical progression|4|||
124646374|NCT02980341|448323623|FG000|Dose Expansion|Adverse Event|0|||
124646375|NCT02980341|448323624|FG001|Dose Expansion|Adverse Event|0|||
124646376|NCT02980341|448323625|FG002|Dose Expansion|Adverse Event|0|||
124646377|NCT02980341|448323626|FG003|Dose Expansion|Adverse Event|0|||
124646378|NCT02980341|448323627|FG004|Dose Expansion|Adverse Event|0|||
124646379|NCT02980341|448323628|FG005|Dose Expansion|Adverse Event|0|||
124646380|NCT02980341|448323629|FG006|Dose Expansion|Adverse Event|0|||
124646381|NCT02980341|448323630|FG007|Dose Expansion|Adverse Event|3|||
124646382|NCT02980341|448323631|FG008|Dose Expansion|Adverse Event|0|||
124646383|NCT02980341|448323632|FG009|Dose Expansion|Adverse Event|1|||
124646384|NCT02980341|448323633|FG010|Dose Expansion|Adverse Event|3|||
124646385|NCT02980341|448323623|FG000|Dose Expansion|Death|0|||
124646386|NCT02980341|448323624|FG001|Dose Expansion|Death|0|||
124646387|NCT02980341|448323625|FG002|Dose Expansion|Death|0|||
124646388|NCT02980341|448323626|FG003|Dose Expansion|Death|0|||
124646389|NCT02980341|448323627|FG004|Dose Expansion|Death|0|||
124646390|NCT02980341|448323628|FG005|Dose Expansion|Death|0|||
124646391|NCT02980341|448323629|FG006|Dose Expansion|Death|0|||
124646392|NCT02980341|448323630|FG007|Dose Expansion|Death|0|||
124646393|NCT02980341|448323631|FG008|Dose Expansion|Death|2|||
124646394|NCT02980341|448323632|FG009|Dose Expansion|Death|1|||
124646395|NCT02980341|448323633|FG010|Dose Expansion|Death|0|||
124646396|NCT02980341|448323623|FG000|Dose Expansion|Withdrawal by Subject|0|||
124646397|NCT02980341|448323624|FG001|Dose Expansion|Withdrawal by Subject|0|||
124646398|NCT02980341|448323625|FG002|Dose Expansion|Withdrawal by Subject|0|||
124646399|NCT02980341|448323626|FG003|Dose Expansion|Withdrawal by Subject|0|||
124646400|NCT02980341|448323627|FG004|Dose Expansion|Withdrawal by Subject|0|||
124646401|NCT02980341|448323628|FG005|Dose Expansion|Withdrawal by Subject|0|||
124646402|NCT02980341|448323629|FG006|Dose Expansion|Withdrawal by Subject|0|||
124646403|NCT02980341|448323630|FG007|Dose Expansion|Withdrawal by Subject|2|||
124646404|NCT02980341|448323631|FG008|Dose Expansion|Withdrawal by Subject|0|||
124646405|NCT02980341|448323632|FG009|Dose Expansion|Withdrawal by Subject|1|||
124646406|NCT02980341|448323633|FG010|Dose Expansion|Withdrawal by Subject|0|||
124646407|NCT02980341|448323623|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
124646408|NCT02980341|448323624|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
124646409|NCT02980341|448323625|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
124646410|NCT02980341|448323626|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
124646411|NCT02980341|448323627|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
124646412|NCT02980341|448323628|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
124646413|NCT02980341|448323629|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
124646414|NCT02980341|448323630|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
124646415|NCT02980341|448323631|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
124646416|NCT02980341|448323632|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
124646417|NCT02980341|448323633|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
124646418|NCT02980341|448323623|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
124646419|NCT02980341|448323624|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
124646420|NCT02980341|448323625|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
124646421|NCT02980341|448323626|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
124646422|NCT02980341|448323627|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
124646423|NCT02980341|448323628|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
124646424|NCT02980341|448323629|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
124646425|NCT02980341|448323630|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
124646426|NCT02980341|448323631|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
124646427|NCT02980341|448323632|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
124646428|NCT02980341|448323633|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
124646429|NCT02980341|448323623|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
124646430|NCT02980341|448323624|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
124646431|NCT02980341|448323625|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
124646432|NCT02980341|448323626|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
124646433|NCT02980341|448323627|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
124646434|NCT02980341|448323628|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
124646435|NCT02980341|448323629|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
124646436|NCT02980341|448323630|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
124646437|NCT02980341|448323631|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
124646438|NCT02980341|448323632|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
124646439|NCT02980341|448323633|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
124646440|NCT02980341|448323623|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
124646441|NCT02980341|448323624|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
124646442|NCT02980341|448323625|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
124646443|NCT02980341|448323626|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
124646444|NCT02980341|448323627|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
124646445|NCT02980341|448323628|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
124646446|NCT02980341|448323629|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
124646447|NCT02980341|448323630|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
124646448|NCT02980341|448323631|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
124646449|NCT02980341|448323632|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
124646450|NCT02980341|448323633|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
124646451|NCT03193801|448323638|FG000|Overall Study|Physician Decision|2|||
124646452|NCT03193801|448323638|FG000|Overall Study|Withdrawal by Subject|1|||
124646453|NCT04964544|448323639|FG000|Overall Study|Screen failure or other uncategorised|10|||
124646454|NCT04964544|448323639|FG000|Overall Study|Physician Decision|4|||
124646455|NCT04964544|448323639|FG000|Overall Study|Lost to Follow-up|9|||
124646456|NCT04964544|448323639|FG000|Overall Study|Withdrawal by Subject|18|||
124646457|NCT04964544|448323639|FG000|Overall Study|Death|1|||
124646458|NCT01613222|448323642|FG000|Overall Study|Physician Decision|1|||
124646459|NCT01613222|448323642|FG000|Overall Study|Unable to place arterial line|1|||
124646460|NCT01613222|448323642|FG000|Overall Study|Reused disposable sensors|10|||
124646461|NCT03696108|448323643|FG000|Overall Study|Physician Decision|1|||
124646462|NCT03696108|448323644|FG001|Overall Study|Physician Decision|0|||
124646463|NCT03696108|448323643|FG000|Overall Study|Withdrawal by Subject|3|||
124646464|NCT03696108|448323644|FG001|Overall Study|Withdrawal by Subject|6|||
124646465|NCT01899742|448323648|FG000|Overall Study|Adverse Event|5|||
124646466|NCT01899742|448323649|FG001|Overall Study|Adverse Event|4|||
124646467|NCT01899742|448323648|FG000|Overall Study|Lack of Efficacy|1|||
124646468|NCT01899742|448323649|FG001|Overall Study|Lack of Efficacy|5|||
124646469|NCT01899742|448323648|FG000|Overall Study|Protocol Violation|2|||
124646470|NCT01899742|448323649|FG001|Overall Study|Protocol Violation|2|||
124646471|NCT01899742|448323648|FG000|Overall Study|Withdrawal by Subject|9|||
124646472|NCT01899742|448323649|FG001|Overall Study|Withdrawal by Subject|5|||
124646473|NCT02662764|448323650|FG000|Overall Study|Adverse Event|6|||
124646474|NCT02662764|448323650|FG000|Overall Study|Lack of Efficacy|8|||
124646475|NCT02662764|448323650|FG000|Overall Study|Protocol Violation|1|||
124646476|NCT02662764|448323650|FG000|Overall Study|Withdrawal by Subject|5|||
124646477|NCT02662764|448323650|FG000|Overall Study|Device failure|4|||
124646478|NCT02662764|448323650|FG000|Overall Study|Patient changed treatment|1|||
124646479|NCT02662764|448323650|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
124646480|NCT04323306|448323651|FG000|Overall Study|Physician Decision|1|||
124646481|NCT04323306|448323652|FG001|Overall Study|Physician Decision|0|||
124646482|NCT04323306|448323653|FG002|Overall Study|Physician Decision|0|||
124646483|NCT04323306|448323654|FG003|Overall Study|Physician Decision|0|||
124646484|NCT04323306|448323655|FG004|Overall Study|Physician Decision|0|||
124646485|NCT04323306|448323656|FG005|Overall Study|Physician Decision|0|||
124646486|NCT04323306|448323657|FG006|Overall Study|Physician Decision|0|||
124646487|NCT04323306|448323658|FG007|Overall Study|Physician Decision|0|||
124646488|NCT04323306|448323659|FG008|Overall Study|Physician Decision|0|||
124646489|NCT04323306|448323651|FG000|Overall Study|Withdrawal by Subject|0|||
124646490|NCT04323306|448323652|FG001|Overall Study|Withdrawal by Subject|0|||
124646491|NCT04323306|448323653|FG002|Overall Study|Withdrawal by Subject|0|||
124646492|NCT04323306|448323654|FG003|Overall Study|Withdrawal by Subject|0|||
124646493|NCT04323306|448323655|FG004|Overall Study|Withdrawal by Subject|0|||
124646494|NCT04323306|448323656|FG005|Overall Study|Withdrawal by Subject|1|||
124646495|NCT04323306|448323657|FG006|Overall Study|Withdrawal by Subject|3|||
124646496|NCT04323306|448323658|FG007|Overall Study|Withdrawal by Subject|0|||
124646497|NCT04323306|448323659|FG008|Overall Study|Withdrawal by Subject|1|||
124646498|NCT00089778|448323660|FG000|Overall Study|Protocol Violation|0|||
124646499|NCT00089778|448323661|FG001|Overall Study|Protocol Violation|0|||
124646500|NCT00089778|448323662|FG002|Overall Study|Protocol Violation|1|||
124646501|NCT05129137|448323665|FG000|Second Period|Adverse Event|1|||
124646502|NCT05129137|448323666|FG001|Second Period|Adverse Event|0|||
124646503|NCT05129137|448323667|FG002|Second Period|Adverse Event|0|||
124646504|NCT05129137|448323668|FG003|Second Period|Adverse Event|0|||
124646505|NCT05129137|448323665|FG000|Second Period|Protocol Violation|0|||
124646506|NCT05129137|448323666|FG001|Second Period|Protocol Violation|0|||
124646507|NCT05129137|448323667|FG002|Second Period|Protocol Violation|0|||
124646508|NCT05129137|448323668|FG003|Second Period|Protocol Violation|1|||
124646509|NCT05129137|448323665|FG000|Third Period|Protocol Violation|0|||
124646510|NCT05129137|448323666|FG001|Third Period|Protocol Violation|0|||
124646511|NCT05129137|448323667|FG002|Third Period|Protocol Violation|0|||
124646512|NCT05129137|448323668|FG003|Third Period|Protocol Violation|1|||
124646513|NCT05129137|448323665|FG000|Forth Period|Protocol Violation|0|||
124646514|NCT05129137|448323666|FG001|Forth Period|Protocol Violation|1|||
124646515|NCT05129137|448323667|FG002|Forth Period|Protocol Violation|0|||
124646516|NCT05129137|448323668|FG003|Forth Period|Protocol Violation|0|||
124646517|NCT05129137|448323665|FG000|Forth Period|Withdrawal by Subject|0|||
124646518|NCT05129137|448323666|FG001|Forth Period|Withdrawal by Subject|0|||
124646519|NCT05129137|448323667|FG002|Forth Period|Withdrawal by Subject|1|||
124646520|NCT05129137|448323668|FG003|Forth Period|Withdrawal by Subject|0|||
124646521|NCT01104246|448323669|FG000|Overall Study|Withdrawal by Subject|1|||
124646522|NCT01104246|448323669|FG000|Overall Study|did not meet inclusion criteria|4|||
124646523|NCT05178641|448323680|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
124646524|NCT05178641|448323681|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
124646525|NCT05178641|448323680|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
124646526|NCT05178641|448323681|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
124646527|NCT01869699|448323682|FG000|Overall Study|Withdrawal by Subject|1|||
124646528|NCT01869699|448323683|FG001|Overall Study|Withdrawal by Subject|0|||
124646529|NCT01867294|448323684|FG000|Overall Study|Withdrawal by Subject|1|||
124646530|NCT01867294|448323685|FG001|Overall Study|Withdrawal by Subject|1|||
124646531|NCT01867294|448323686|FG002|Overall Study|Withdrawal by Subject|0|||
124646532|NCT01867294|448323687|FG003|Overall Study|Withdrawal by Subject|0|||
124646533|NCT02658734|448323688|FG000|Overall Study|Adverse Event|2|||
124646534|NCT02658734|448323688|FG000|Overall Study|Death|4|||
124646535|NCT02658734|448323688|FG000|Overall Study|Lost to Follow-up|7|||
124646536|NCT02658734|448323688|FG000|Overall Study|Withdrawal of Consent|16|||
124646537|NCT02658734|448323688|FG000|Overall Study|Disease Progression|28|||
124646538|NCT00459706|448323689|FG000|Overall Study|Adverse Event|19|||
124646539|NCT00459706|448323690|FG001|Overall Study|Adverse Event|13|||
124646540|NCT00459706|448323689|FG000|Overall Study|Withdrawal by Subject|1|||
124646541|NCT00459706|448323690|FG001|Overall Study|Withdrawal by Subject|6|||
124646542|NCT00459706|448323689|FG000|Overall Study|Physician Decision|2|||
124646543|NCT00459706|448323690|FG001|Overall Study|Physician Decision|0|||
124646544|NCT00459706|448323689|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
124646545|NCT00459706|448323690|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
124646546|NCT00459706|448323689|FG000|Overall Study|Protocol Violation|2|||
124646547|NCT00459706|448323690|FG001|Overall Study|Protocol Violation|1|||
124646548|NCT00459706|448323689|FG000|Overall Study|Failed to Return|1|||
124646549|NCT00459706|448323690|FG001|Overall Study|Failed to Return|0|||
124646550|NCT00459706|448323689|FG000|Overall Study|Other|0|||
124646551|NCT00459706|448323690|FG001|Overall Study|Other|1|||
124646552|NCT01252563|448323692|FG000|Overall Study|Contract Deviation|41|||
124646553|NCT01252563|448323692|FG000|Overall Study|Centralized Registration Deviation|30|||
124646554|NCT01252563|448323692|FG000|Overall Study|Lost to Follow-up|161|||
124646555|NCT01252563|448323692|FG000|Overall Study|No visit after first day of treatment|194|||
124646556|NCT01252563|448323692|FG000|Overall Study|No drug administration|6|||
124646557|NCT01880086|448323693|FG000|Overall Study|Lost to Follow-up|1|||
124646558|NCT01880086|448323694|FG001|Overall Study|Lost to Follow-up|1|||
124646559|NCT03843632|448323697|FG000|Overall Study|Withdrawal by Subject|1|||
124646560|NCT03843632|448323698|FG001|Overall Study|Withdrawal by Subject|0|||
124646561|NCT03843632|448323699|FG002|Overall Study|Withdrawal by Subject|0|||
124646562|NCT03843632|448323700|FG003|Overall Study|Withdrawal by Subject|0|||
124646563|NCT01820572|448323701|FG000|Randomization|Not Treated|2|||
124646564|NCT01820572|448323702|FG001|Randomization|Not Treated|1|||
124646565|NCT01820572|448323701|FG000|Treatment Period|Adverse Event|12|||
124646566|NCT01820572|448323702|FG001|Treatment Period|Adverse Event|7|||
124646567|NCT01820572|448323701|FG000|Treatment Period|Death|3|||
124646568|NCT01820572|448323702|FG001|Treatment Period|Death|3|||
124646569|NCT01820572|448323701|FG000|Treatment Period|Lack of Efficacy|1|||
124646570|NCT01820572|448323702|FG001|Treatment Period|Lack of Efficacy|0|||
124646571|NCT01820572|448323701|FG000|Treatment Period|poor/non compliance|0|||
124646572|NCT01820572|448323702|FG001|Treatment Period|poor/non compliance|3|||
124646573|NCT01820572|448323701|FG000|Treatment Period|request to discontinue|6|||
124646574|NCT01820572|448323702|FG001|Treatment Period|request to discontinue|11|||
124646575|NCT01820572|448323701|FG000|Treatment Period|No longer meets study criteria|3|||
124646576|NCT01820572|448323702|FG001|Treatment Period|No longer meets study criteria|10|||
124646577|NCT01820572|448323701|FG000|Treatment Period|withdrew consent|1|||
124646578|NCT01820572|448323702|FG001|Treatment Period|withdrew consent|2|||
124646579|NCT00387010|448323704|FG000|Dose Titration Period|Adverse Event|12|||
124646580|NCT00387010|448323704|FG000|Dose Titration Period|Lack of Efficacy|5|||
124646581|NCT00387010|448323704|FG000|Dose Titration Period|Withdrawal by Subject|3|||
124646582|NCT00387010|448323704|FG000|Dose Titration Period|Protocol Violation|1|||
124646583|NCT00387010|448323704|FG000|Dose Titration Period|Lost to Follow-up|2|||
124646584|NCT00387010|448323704|FG000|Dose Titration Period|Noncompliance with study medication|8|||
124646585|NCT00387010|448323704|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
124646586|NCT00387010|448323704|FG000|Treatment Period|Adverse Event|4|||
124646587|NCT00387010|448323704|FG000|Treatment Period|Withdrawal by Subject|1|||
124646588|NCT00387010|448323704|FG000|Treatment Period|Noncompliance with study medication|2|||
124646589|NCT00387010|448323704|FG000|Treatment Period|Noncompliance with study procedures|3|||
124646590|NCT00387010|448323704|FG000|Treatment Period|Participant reported study drug stolen|1|||
124646591|NCT00520481|448323705|FG000|Overall Study|Adverse Event|4|||
124646592|NCT00520481|448323706|FG001|Overall Study|Adverse Event|1|||
124646593|NCT00520481|448323705|FG000|Overall Study|Withdrawal by Subject|3|||
124646594|NCT00520481|448323706|FG001|Overall Study|Withdrawal by Subject|0|||
124646595|NCT01931956|448323711|FG000|Overall Study|Death|42|||
124646596|NCT01931956|448323712|FG001|Overall Study|Death|7|||
124646597|NCT01931956|448323713|FG002|Overall Study|Death|379|||
124646598|NCT01931956|448323714|FG003|Overall Study|Death|96|||
124646599|NCT01931956|448323711|FG000|Overall Study|Withdrawal by Subject|5|||
124646600|NCT01931956|448323712|FG001|Overall Study|Withdrawal by Subject|0|||
124646601|NCT01931956|448323713|FG002|Overall Study|Withdrawal by Subject|70|||
124646602|NCT01931956|448323714|FG003|Overall Study|Withdrawal by Subject|30|||
124646603|NCT01931956|448323711|FG000|Overall Study|Lost to Follow-up|2|||
124646604|NCT01931956|448323712|FG001|Overall Study|Lost to Follow-up|0|||
124646605|NCT01931956|448323713|FG002|Overall Study|Lost to Follow-up|11|||
124646606|NCT01931956|448323714|FG003|Overall Study|Lost to Follow-up|7|||
124646607|NCT01931956|448323711|FG000|Overall Study|Expected|2|||
124646608|NCT01931956|448323712|FG001|Overall Study|Expected|0|||
124646609|NCT01931956|448323713|FG002|Overall Study|Expected|6|||
124646610|NCT01931956|448323714|FG003|Overall Study|Expected|0|||
124646611|NCT01931956|448323711|FG000|Overall Study|Not due|0|||
124646612|NCT01931956|448323712|FG001|Overall Study|Not due|0|||
124646613|NCT01931956|448323713|FG002|Overall Study|Not due|21|||
124646614|NCT01931956|448323714|FG003|Overall Study|Not due|0|||
124646615|NCT02847494|448323715|FG000|Overall Study|Lost to Follow-up|8|||
124646616|NCT02847494|448323716|FG001|Overall Study|Lost to Follow-up|5|||
124646617|NCT02841280|448323717|FG000|Overall Study|Adverse Event|2|||
124646618|NCT02841280|448323718|FG001|Overall Study|Adverse Event|1|||
124646619|NCT02841280|448323717|FG000|Overall Study|Death|1|||
124646620|NCT02841280|448323718|FG001|Overall Study|Death|0|||
124646621|NCT02841280|448323717|FG000|Overall Study|Lost to Follow-up|2|||
124646622|NCT02841280|448323718|FG001|Overall Study|Lost to Follow-up|2|||
124646623|NCT02841280|448323717|FG000|Overall Study|Withdrawal by Subject|7|||
124646624|NCT02841280|448323718|FG001|Overall Study|Withdrawal by Subject|3|||
124646625|NCT02841280|448323717|FG000|Overall Study|Stop Point: BP above threshold|2|||
124646626|NCT02841280|448323718|FG001|Overall Study|Stop Point: BP above threshold|0|||
124646627|NCT01738503|448323719|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
124646628|NCT01738503|448323720|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
124646629|NCT01738503|448323721|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
124646630|NCT01738503|448323722|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
124646631|NCT01738503|448323723|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
124646632|NCT01738503|448323724|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
124646633|NCT01738503|448323725|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
124646634|NCT01738503|448323719|FG000|Treatment Period|Adverse Event|0|||
124646635|NCT01738503|448323720|FG001|Treatment Period|Adverse Event|1|||
124646636|NCT01738503|448323721|FG002|Treatment Period|Adverse Event|0|||
124646637|NCT01738503|448323722|FG003|Treatment Period|Adverse Event|1|||
124646638|NCT01738503|448323723|FG004|Treatment Period|Adverse Event|2|||
124646639|NCT01738503|448323724|FG005|Treatment Period|Adverse Event|2|||
124646640|NCT01738503|448323725|FG006|Treatment Period|Adverse Event|2|||
124646641|NCT01738503|448323719|FG000|Treatment Period|Lost to Follow-up|0|||
124646642|NCT01738503|448323720|FG001|Treatment Period|Lost to Follow-up|0|||
124646643|NCT01738503|448323721|FG002|Treatment Period|Lost to Follow-up|3|||
124646644|NCT01738503|448323722|FG003|Treatment Period|Lost to Follow-up|4|||
124646645|NCT01738503|448323723|FG004|Treatment Period|Lost to Follow-up|1|||
124646646|NCT01738503|448323724|FG005|Treatment Period|Lost to Follow-up|1|||
124646647|NCT01738503|448323725|FG006|Treatment Period|Lost to Follow-up|5|||
124646648|NCT01738503|448323719|FG000|Treatment Period|Withdrawal by Subject|0|||
124646649|NCT01738503|448323720|FG001|Treatment Period|Withdrawal by Subject|1|||
124646650|NCT01738503|448323721|FG002|Treatment Period|Withdrawal by Subject|0|||
124646651|NCT01738503|448323722|FG003|Treatment Period|Withdrawal by Subject|1|||
124646652|NCT01738503|448323723|FG004|Treatment Period|Withdrawal by Subject|1|||
124646653|NCT01738503|448323724|FG005|Treatment Period|Withdrawal by Subject|1|||
124646654|NCT01738503|448323725|FG006|Treatment Period|Withdrawal by Subject|1|||
124646655|NCT01738503|448323719|FG000|Treatment Period|Protocol Violation|0|||
124646656|NCT01738503|448323720|FG001|Treatment Period|Protocol Violation|3|||
124646657|NCT01738503|448323721|FG002|Treatment Period|Protocol Violation|1|||
124646658|NCT01738503|448323722|FG003|Treatment Period|Protocol Violation|0|||
124646659|NCT01738503|448323723|FG004|Treatment Period|Protocol Violation|4|||
124646660|NCT01738503|448323724|FG005|Treatment Period|Protocol Violation|2|||
124646661|NCT01738503|448323725|FG006|Treatment Period|Protocol Violation|0|||
124646662|NCT01738503|448323719|FG000|Treatment Period|Other|0|||
124646663|NCT01738503|448323720|FG001|Treatment Period|Other|0|||
124646664|NCT01738503|448323721|FG002|Treatment Period|Other|1|||
124646665|NCT01738503|448323722|FG003|Treatment Period|Other|0|||
124646666|NCT01738503|448323723|FG004|Treatment Period|Other|0|||
124646667|NCT01738503|448323724|FG005|Treatment Period|Other|0|||
124646668|NCT01738503|448323725|FG006|Treatment Period|Other|0|||
124646669|NCT01738503|448323719|FG000|PET Imaging Sub-study|Adverse Event|0|||
124646670|NCT01738503|448323720|FG001|PET Imaging Sub-study|Adverse Event|0|||
124646671|NCT01738503|448323721|FG002|PET Imaging Sub-study|Adverse Event|0|||
124646672|NCT01738503|448323722|FG003|PET Imaging Sub-study|Adverse Event|0|||
124646673|NCT01738503|448323723|FG004|PET Imaging Sub-study|Adverse Event|0|||
124646674|NCT01738503|448323724|FG005|PET Imaging Sub-study|Adverse Event|1|||
124646675|NCT01738503|448323725|FG006|PET Imaging Sub-study|Adverse Event|0|||
124646676|NCT01738503|448323719|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
124646677|NCT01738503|448323720|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
124646678|NCT01738503|448323721|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
124646679|NCT01738503|448323722|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
124646680|NCT01738503|448323723|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
124646681|NCT01738503|448323724|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
124646682|NCT01738503|448323725|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
124646683|NCT03005327|448323726|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
124646684|NCT03005327|448323727|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
124646685|NCT03005327|448323728|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
124646686|NCT03005327|448323729|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
124646687|NCT03005327|448323726|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124646688|NCT03005327|448323727|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
124646689|NCT03005327|448323728|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124646690|NCT03005327|448323729|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124646691|NCT02496091|448323733|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
124646692|NCT02272842|448323734|FG000|Overall Study|Lost to Follow-up|8|||
124646693|NCT02272842|448323735|FG001|Overall Study|Lost to Follow-up|8|||
124646694|NCT02272842|448323734|FG000|Overall Study|Withdrawal by Subject|8|||
124646695|NCT02272842|448323735|FG001|Overall Study|Withdrawal by Subject|2|||
124646696|NCT01493284|448323737|FG000|Overall Study|Death|29|||
124646697|NCT01493284|448323737|FG000|Overall Study|Withdrawal by Subject|32|||
124646698|NCT03626363|448323740|FG000|Overall Study|Protocol Violation|4|||
124646699|NCT03626363|448323741|FG001|Overall Study|Protocol Violation|0|||
124646700|NCT03626363|448323740|FG000|Overall Study|Lost to Follow-up|5|||
124646701|NCT03626363|448323741|FG001|Overall Study|Lost to Follow-up|7|||
124646702|NCT00533702|448323742|FG000|Overall Study|Withdrawal by Subject|3|||
124646703|NCT00533702|448323743|FG001|Overall Study|Withdrawal by Subject|1|||
124646704|NCT00533702|448323742|FG000|Overall Study|Found ineligible after randomization|2|||
124646705|NCT00533702|448323743|FG001|Overall Study|Found ineligible after randomization|1|||
124646706|NCT02100670|448323747|FG000|Overall Study|Adverse Event|10|||
124646707|NCT02100670|448323748|FG001|Overall Study|Adverse Event|3|||
124646708|NCT02100670|448323749|FG002|Overall Study|Adverse Event|3|||
124646709|NCT02100670|448323750|FG003|Overall Study|Adverse Event|0|||
124646710|NCT02100670|448323747|FG000|Overall Study|Lost to Follow-up|1|||
124646711|NCT02100670|448323748|FG001|Overall Study|Lost to Follow-up|0|||
124646712|NCT02100670|448323749|FG002|Overall Study|Lost to Follow-up|0|||
124646713|NCT02100670|448323750|FG003|Overall Study|Lost to Follow-up|0|||
124646714|NCT02100670|448323747|FG000|Overall Study|Protocol Violation|0|||
124646715|NCT02100670|448323748|FG001|Overall Study|Protocol Violation|1|||
124646716|NCT02100670|448323749|FG002|Overall Study|Protocol Violation|0|||
124646717|NCT02100670|448323750|FG003|Overall Study|Protocol Violation|1|||
124646718|NCT02100670|448323747|FG000|Overall Study|Withdrawal of Consent|0|||
124646719|NCT02100670|448323748|FG001|Overall Study|Withdrawal of Consent|1|||
124646720|NCT02100670|448323749|FG002|Overall Study|Withdrawal of Consent|1|||
124646721|NCT02100670|448323750|FG003|Overall Study|Withdrawal of Consent|0|||
124646722|NCT02100670|448323747|FG000|Overall Study|No swelling no pain|1|||
124646723|NCT02100670|448323748|FG001|Overall Study|No swelling no pain|0|||
124646724|NCT02100670|448323749|FG002|Overall Study|No swelling no pain|0|||
124646725|NCT02100670|448323750|FG003|Overall Study|No swelling no pain|0|||
124646726|NCT02100670|448323747|FG000|Overall Study|Poor Efficacy|0|||
124646727|NCT02100670|448323748|FG001|Overall Study|Poor Efficacy|1|||
124646728|NCT02100670|448323749|FG002|Overall Study|Poor Efficacy|0|||
124646729|NCT02100670|448323750|FG003|Overall Study|Poor Efficacy|0|||
124646730|NCT02100670|448323747|FG000|Overall Study|Physician Decision|0|||
124646731|NCT02100670|448323748|FG001|Overall Study|Physician Decision|1|||
124646732|NCT02100670|448323749|FG002|Overall Study|Physician Decision|0|||
124646733|NCT02100670|448323750|FG003|Overall Study|Physician Decision|0|||
124646734|NCT02100670|448323747|FG000|Overall Study|Withdrawal by Subject|1|||
124646735|NCT02100670|448323748|FG001|Overall Study|Withdrawal by Subject|0|||
124646736|NCT02100670|448323749|FG002|Overall Study|Withdrawal by Subject|0|||
124646737|NCT02100670|448323750|FG003|Overall Study|Withdrawal by Subject|0|||
124646738|NCT04852679|448323751|FG000|Main Intervention Period|Withdrawal by Subject|3|||
124646739|NCT04852679|448323751|FG000|Main Intervention Period|Adverse Event|1|||
124646740|NCT04852679|448323751|FG000|Main Intervention Period|Progressive Disease|16|||
124646741|NCT04852679|448323751|FG000|Main Intervention Period|Refused study visit|1|||
124646742|NCT04852679|448323751|FG000|Independent Injection Period|Missed study visit|1|||
124646743|NCT01294696|448323752|FG000|Overall Study|Screening failures|7|||
124646744|NCT01294696|448323752|FG000|Overall Study|Protocol Violation|8|||
124646745|NCT01294696|448323752|FG000|Overall Study|Missing BPI Response|7|||
124646746|NCT01294696|448323752|FG000|Overall Study|Site closure|52|||
124646747|NCT03339726|448325546|FG000|Overall Study|Withdrawal by Subject|1|||
124646748|NCT03339726|448325547|FG001|Overall Study|Withdrawal by Subject|0|||
124646749|NCT03339726|448325548|FG002|Overall Study|Withdrawal by Subject|0|||
124646750|NCT03339726|448325546|FG000|Overall Study|Lost to Follow-up|0|||
124646751|NCT03339726|448325547|FG001|Overall Study|Lost to Follow-up|1|||
124646752|NCT03339726|448325548|FG002|Overall Study|Lost to Follow-up|0|||
124646753|NCT01275755|448325549|FG000|Double-blind Treatment Period|Adverse Event|0|||
124646754|NCT01275755|448325550|FG001|Double-blind Treatment Period|Adverse Event|2|||
124646755|NCT01275755|448325549|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
124646756|NCT01275755|448325550|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
124646757|NCT01275755|448325549|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
124646758|NCT01275755|448325550|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
124646759|NCT01275755|448325549|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
124646760|NCT01275755|448325550|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
124646761|NCT00636194|448325556|FG000|Overall Study|Study related symptoms and complaints|1|||
124646762|NCT00636194|448325557|FG001|Overall Study|Study related symptoms and complaints|0|||
124646763|NCT00636194|448325556|FG000|Overall Study|Protocol Violation|2|||
124646764|NCT00636194|448325557|FG001|Overall Study|Protocol Violation|0|||
124646765|NCT04934189|448325562|FG000|Overall Study|Lost to Follow-up|4|||
124646766|NCT04934189|448325562|FG000|Overall Study|Withdrawal by Subject|17|||
124646767|NCT03962790|448325563|FG000|Period 1|Adverse Event|0|||
124646768|NCT03962790|448325564|FG001|Period 1|Adverse Event|1|||
124646769|NCT03962790|448325563|FG000|Period 1|Failed to meet all eligibility criteria|1|||
124646770|NCT03962790|448325564|FG001|Period 1|Failed to meet all eligibility criteria|1|||
124646771|NCT03962790|448325563|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
124646772|NCT03962790|448325564|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
124646773|NCT03962790|448325563|FG000|Period 1|Withdrawal by Subject|1|||
124646774|NCT03962790|448325564|FG001|Period 1|Withdrawal by Subject|0|||
124646775|NCT01286168|448325566|FG000|Overall Study|Withdrawal by Subject|1|||
124646776|NCT01286168|448325566|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
124646777|NCT04598451|448325569|FG000|Overall Study|Adverse Event|3|||
124646778|NCT04598451|448325570|FG001|Overall Study|Adverse Event|2|||
124646779|NCT04598451|448325569|FG000|Overall Study|Withdrawal by Subject|3|||
124646780|NCT04598451|448325570|FG001|Overall Study|Withdrawal by Subject|7|||
124646781|NCT04598451|448325569|FG000|Overall Study|Lost to Follow-up|2|||
124646782|NCT04598451|448325570|FG001|Overall Study|Lost to Follow-up|0|||
124646783|NCT04598451|448325569|FG000|Overall Study|Physician Decision|4|||
124646784|NCT04598451|448325570|FG001|Overall Study|Physician Decision|1|||
124646785|NCT04598451|448325569|FG000|Overall Study|Requires Prohibited Medication|1|||
124646786|NCT04598451|448325570|FG001|Overall Study|Requires Prohibited Medication|0|||
124646787|NCT04598451|448325569|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
124646788|NCT04598451|448325570|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
124646789|NCT04594941|448325574|FG000|Overall Study|Other|0|||
124646790|NCT04594941|448325575|FG001|Overall Study|Other|3|||
124646791|NCT04594941|448325576|FG002|Overall Study|Other|1|||
124646792|NCT04594941|448325577|FG003|Overall Study|Other|0|||
124646793|NCT02091960|448325578|FG000|Overall Study|Death|7|||
124646794|NCT02091960|448325578|FG000|Overall Study|Withdrawal by Subject|1|||
124646795|NCT02091960|448325578|FG000|Overall Study|Miscellaneous Reasons|37|||
124646796|NCT02424630|448325591|FG000|Overall Study|No rotator cuff tear|1|||
124646797|NCT02424630|448325592|FG001|Overall Study|No rotator cuff tear|2|||
124646798|NCT02424630|448325591|FG000|Overall Study|Open procedure|0|||
124646799|NCT02424630|448325592|FG001|Overall Study|Open procedure|1|||
124646800|NCT02703272|448325593|FG000|Overall Study|Death|4|||
124646801|NCT02703272|448325594|FG001|Overall Study|Death|9|||
124646802|NCT02703272|448325595|FG002|Overall Study|Death|19|||
124646803|NCT02703272|448325596|FG003|Overall Study|Death|10|||
124646804|NCT02703272|448325593|FG000|Overall Study|Withdrawal by Subject|0|||
124646805|NCT02703272|448325594|FG001|Overall Study|Withdrawal by Subject|0|||
124646806|NCT02703272|448325595|FG002|Overall Study|Withdrawal by Subject|4|||
124646807|NCT02703272|448325596|FG003|Overall Study|Withdrawal by Subject|2|||
124646808|NCT02703272|448325593|FG000|Overall Study|Study Terminated by Sponsor|6|||
124646809|NCT02703272|448325594|FG001|Overall Study|Study Terminated by Sponsor|1|||
124646810|NCT02703272|448325595|FG002|Overall Study|Study Terminated by Sponsor|12|||
124646811|NCT02703272|448325596|FG003|Overall Study|Study Terminated by Sponsor|4|||
124646812|NCT02703272|448325593|FG000|Overall Study|Other|1|||
124646813|NCT02703272|448325594|FG001|Overall Study|Other|0|||
124646814|NCT02703272|448325595|FG002|Overall Study|Other|0|||
124646815|NCT02703272|448325596|FG003|Overall Study|Other|0|||
124646816|NCT02637895|448325599|FG000|Overall Study|Lost to Follow-up|4|||
124646817|NCT02637895|448325600|FG001|Overall Study|Lost to Follow-up|0|||
124646818|NCT02637895|448325599|FG000|Overall Study|Protocol Violation|0|||
124646819|NCT02637895|448325600|FG001|Overall Study|Protocol Violation|1|||
124646820|NCT02637895|448325599|FG000|Overall Study|Lack of Efficacy|1|||
124646821|NCT02637895|448325600|FG001|Overall Study|Lack of Efficacy|0|||
124646822|NCT02637895|448325599|FG000|Overall Study|Withdrawal by Subject|1|||
124646823|NCT02637895|448325600|FG001|Overall Study|Withdrawal by Subject|1|||
124646824|NCT02637895|448325599|FG000|Overall Study|Abnormal baseline lab|0|||
124646825|NCT02637895|448325600|FG001|Overall Study|Abnormal baseline lab|1|||
124646826|NCT02005692|448325601|FG000|Overall Study|Protocol Violation|1|||
124646827|NCT02005692|448325601|FG000|Overall Study|Withdrawal by Subject|1|||
124646828|NCT02005692|448325601|FG000|Overall Study|Discharged earlier than anticipated|5|||
124646829|NCT02091375|448325603|FG000|Overall Study|Adverse Event|8|||
124646830|NCT02091375|448325604|FG001|Overall Study|Adverse Event|1|||
124646831|NCT02091375|448325603|FG000|Overall Study|Lost to Follow-up|0|||
124646832|NCT02091375|448325604|FG001|Overall Study|Lost to Follow-up|1|||
124646833|NCT02091375|448325603|FG000|Overall Study|Withdrawal by Subject|0|||
124646834|NCT02091375|448325604|FG001|Overall Study|Withdrawal by Subject|1|||
124646835|NCT02091375|448325603|FG000|Overall Study|Withdrawn by the investigator|1|||
124646836|NCT02091375|448325604|FG001|Overall Study|Withdrawn by the investigator|0|||
124646837|NCT02682823|448325605|FG000|Overall Study|Withdrawal by Subject|0|||
124646838|NCT02682823|448325606|FG001|Overall Study|Withdrawal by Subject|0|||
124646839|NCT02682823|448325607|FG002|Overall Study|Withdrawal by Subject|1|||
124646840|NCT02682823|448325608|FG003|Overall Study|Withdrawal by Subject|0|||
124646841|NCT02682823|448325609|FG004|Overall Study|Withdrawal by Subject|1|||
124646842|NCT02682823|448325605|FG000|Overall Study|Protocol Deviation|0|||
124646843|NCT02682823|448325606|FG001|Overall Study|Protocol Deviation|1|||
124646844|NCT02682823|448325607|FG002|Overall Study|Protocol Deviation|0|||
124646845|NCT02682823|448325608|FG003|Overall Study|Protocol Deviation|0|||
124646846|NCT02682823|448325609|FG004|Overall Study|Protocol Deviation|0|||
124646847|NCT02682823|448325605|FG000|Overall Study|Adverse Event|0|||
124646848|NCT02682823|448325606|FG001|Overall Study|Adverse Event|0|||
124646849|NCT02682823|448325607|FG002|Overall Study|Adverse Event|0|||
124646850|NCT02682823|448325608|FG003|Overall Study|Adverse Event|1|||
124646851|NCT02682823|448325609|FG004|Overall Study|Adverse Event|0|||
124646852|NCT01741792|448325610|FG000|Overall Study|Death|6|||
124646853|NCT01741792|448325611|FG001|Overall Study|Death|1|||
124646854|NCT01741792|448325612|FG002|Overall Study|Death|12|||
124646855|NCT02222545|448325613|FG000|Overall Study|Adverse Event|1|||
124646856|NCT02222545|448325614|FG001|Overall Study|Adverse Event|0|||
124646857|NCT02222545|448325615|FG002|Overall Study|Adverse Event|2|||
124646858|NCT02222545|448325613|FG000|Overall Study|Death|0|||
124646859|NCT02222545|448325614|FG001|Overall Study|Death|0|||
124646860|NCT02222545|448325615|FG002|Overall Study|Death|9|||
124646861|NCT02222545|448325613|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
124646862|NCT02222545|448325614|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
124646863|NCT02222545|448325615|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
124646864|NCT02222545|448325613|FG000|Overall Study|Withdrawal by Subject|0|||
124646865|NCT02222545|448325614|FG001|Overall Study|Withdrawal by Subject|0|||
124646866|NCT02222545|448325615|FG002|Overall Study|Withdrawal by Subject|3|||
124646867|NCT02222545|448325613|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
124646868|NCT02222545|448325614|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
124646869|NCT02222545|448325615|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
124646870|NCT00761280|448325616|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
124646871|NCT00761280|448325617|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
124646872|NCT00761280|448325616|FG000|Randomization to First Dose|Sponsor decision|1|||
124646873|NCT00761280|448325617|FG001|Randomization to First Dose|Sponsor decision|0|||
124646874|NCT00761280|448325616|FG000|Randomization to First Dose|Other|1|||
124646875|NCT00761280|448325617|FG001|Randomization to First Dose|Other|0|||
124646876|NCT00761280|448325616|FG000|First Dose to End of Study|End of trial|5|||
124646877|NCT00761280|448325617|FG001|First Dose to End of Study|End of trial|5|||
124646878|NCT00761280|448325616|FG000|First Dose to End of Study|Progressive disease|5|||
124646879|NCT00761280|448325617|FG001|First Dose to End of Study|Progressive disease|3|||
124646880|NCT00761280|448325616|FG000|First Dose to End of Study|Sponsor decision|1|||
124646881|NCT00761280|448325617|FG001|First Dose to End of Study|Sponsor decision|2|||
124646882|NCT00761280|448325616|FG000|First Dose to End of Study|Death|1|||
124646883|NCT00761280|448325617|FG001|First Dose to End of Study|Death|0|||
124646884|NCT00761280|448325616|FG000|First Dose to End of Study|Lost to Follow-up|0|||
124646885|NCT00761280|448325617|FG001|First Dose to End of Study|Lost to Follow-up|1|||
124646886|NCT01938430|448325618|FG000|Overall Study|Randomized but Not Treated|0|||
124646887|NCT01938430|448325619|FG001|Overall Study|Randomized but Not Treated|0|||
124646888|NCT01938430|448325620|FG002|Overall Study|Randomized but Not Treated|0|||
124646889|NCT01938430|448325621|FG003|Overall Study|Randomized but Not Treated|0|||
124646890|NCT01938430|448325622|FG004|Overall Study|Randomized but Not Treated|0|||
124646891|NCT01938430|448325623|FG005|Overall Study|Randomized but Not Treated|0|||
124646892|NCT01938430|448325624|FG006|Overall Study|Randomized but Not Treated|0|||
124646893|NCT01938430|448325625|FG007|Overall Study|Randomized but Not Treated|0|||
124646894|NCT01938430|448325626|FG008|Overall Study|Randomized but Not Treated|0|||
124646895|NCT01938430|448325627|FG009|Overall Study|Randomized but Not Treated|0|||
124646896|NCT01938430|448325628|FG010|Overall Study|Randomized but Not Treated|1|||
124646897|NCT01938430|448325629|FG011|Overall Study|Randomized but Not Treated|0|||
124646898|NCT01938430|448325630|FG012|Overall Study|Randomized but Not Treated|0|||
124646899|NCT01938430|448325631|FG013|Overall Study|Randomized but Not Treated|1|||
124646900|NCT01938430|448325618|FG000|Overall Study|Adverse Event|0|||
124646901|NCT01938430|448325619|FG001|Overall Study|Adverse Event|0|||
124646902|NCT01938430|448325620|FG002|Overall Study|Adverse Event|0|||
124646903|NCT01938430|448325621|FG003|Overall Study|Adverse Event|0|||
124646904|NCT01938430|448325622|FG004|Overall Study|Adverse Event|0|||
124646905|NCT01938430|448325623|FG005|Overall Study|Adverse Event|0|||
124646906|NCT01938430|448325624|FG006|Overall Study|Adverse Event|1|||
124646907|NCT01938430|448325625|FG007|Overall Study|Adverse Event|0|||
124646908|NCT01938430|448325626|FG008|Overall Study|Adverse Event|0|||
124646909|NCT01938430|448325627|FG009|Overall Study|Adverse Event|0|||
124646910|NCT01938430|448325628|FG010|Overall Study|Adverse Event|0|||
124646911|NCT01938430|448325629|FG011|Overall Study|Adverse Event|0|||
124646912|NCT01938430|448325630|FG012|Overall Study|Adverse Event|0|||
124646913|NCT01938430|448325631|FG013|Overall Study|Adverse Event|0|||
124646914|NCT01938430|448325618|FG000|Overall Study|Death|1|||
124646915|NCT01938430|448325619|FG001|Overall Study|Death|2|||
124646916|NCT01938430|448325620|FG002|Overall Study|Death|2|||
124646917|NCT01938430|448325621|FG003|Overall Study|Death|1|||
124646918|NCT01938430|448325622|FG004|Overall Study|Death|0|||
124646919|NCT01938430|448325623|FG005|Overall Study|Death|0|||
124646920|NCT01938430|448325624|FG006|Overall Study|Death|1|||
124646921|NCT01938430|448325625|FG007|Overall Study|Death|1|||
124646922|NCT01938430|448325626|FG008|Overall Study|Death|2|||
124646923|NCT01938430|448325627|FG009|Overall Study|Death|3|||
124646924|NCT01938430|448325628|FG010|Overall Study|Death|0|||
124646925|NCT01938430|448325629|FG011|Overall Study|Death|0|||
124646926|NCT01938430|448325630|FG012|Overall Study|Death|0|||
124646927|NCT01938430|448325631|FG013|Overall Study|Death|0|||
124646928|NCT01938430|448325618|FG000|Overall Study|Investigator's Discretion|0|||
124646929|NCT01938430|448325619|FG001|Overall Study|Investigator's Discretion|0|||
124646930|NCT01938430|448325620|FG002|Overall Study|Investigator's Discretion|1|||
124646931|NCT01938430|448325621|FG003|Overall Study|Investigator's Discretion|0|||
124646932|NCT01938430|448325622|FG004|Overall Study|Investigator's Discretion|0|||
124646933|NCT01938430|448325623|FG005|Overall Study|Investigator's Discretion|0|||
124646934|NCT01938430|448325624|FG006|Overall Study|Investigator's Discretion|0|||
124646935|NCT01938430|448325625|FG007|Overall Study|Investigator's Discretion|0|||
124646936|NCT01938430|448325626|FG008|Overall Study|Investigator's Discretion|0|||
124646937|NCT01938430|448325627|FG009|Overall Study|Investigator's Discretion|0|||
124646938|NCT01938430|448325628|FG010|Overall Study|Investigator's Discretion|0|||
124646939|NCT01938430|448325629|FG011|Overall Study|Investigator's Discretion|0|||
124646940|NCT01938430|448325630|FG012|Overall Study|Investigator's Discretion|0|||
124646941|NCT01938430|448325631|FG013|Overall Study|Investigator's Discretion|0|||
124646942|NCT01938430|448325618|FG000|Overall Study|Lack of Efficacy|3|||
124646943|NCT01938430|448325619|FG001|Overall Study|Lack of Efficacy|1|||
124646944|NCT01938430|448325620|FG002|Overall Study|Lack of Efficacy|1|||
124646945|NCT01938430|448325621|FG003|Overall Study|Lack of Efficacy|1|||
124646946|NCT01938430|448325622|FG004|Overall Study|Lack of Efficacy|0|||
124646947|NCT01938430|448325623|FG005|Overall Study|Lack of Efficacy|0|||
124646948|NCT01938430|448325624|FG006|Overall Study|Lack of Efficacy|0|||
124646949|NCT01938430|448325625|FG007|Overall Study|Lack of Efficacy|0|||
124646950|NCT01938430|448325626|FG008|Overall Study|Lack of Efficacy|1|||
124646951|NCT01938430|448325627|FG009|Overall Study|Lack of Efficacy|0|||
124646952|NCT01938430|448325628|FG010|Overall Study|Lack of Efficacy|2|||
124646953|NCT01938430|448325629|FG011|Overall Study|Lack of Efficacy|1|||
124646954|NCT01938430|448325630|FG012|Overall Study|Lack of Efficacy|0|||
124646955|NCT01938430|448325631|FG013|Overall Study|Lack of Efficacy|0|||
124646956|NCT01938430|448325618|FG000|Overall Study|Lost to Follow-up|0|||
124646957|NCT01938430|448325619|FG001|Overall Study|Lost to Follow-up|0|||
124646958|NCT01938430|448325620|FG002|Overall Study|Lost to Follow-up|1|||
124646959|NCT01938430|448325621|FG003|Overall Study|Lost to Follow-up|0|||
124646960|NCT01938430|448325622|FG004|Overall Study|Lost to Follow-up|0|||
124646961|NCT01938430|448325623|FG005|Overall Study|Lost to Follow-up|1|||
124646962|NCT01938430|448325624|FG006|Overall Study|Lost to Follow-up|0|||
124646963|NCT01938430|448325625|FG007|Overall Study|Lost to Follow-up|0|||
124646964|NCT01938430|448325626|FG008|Overall Study|Lost to Follow-up|0|||
124646965|NCT01938430|448325627|FG009|Overall Study|Lost to Follow-up|0|||
124646966|NCT01938430|448325628|FG010|Overall Study|Lost to Follow-up|0|||
124646967|NCT01938430|448325629|FG011|Overall Study|Lost to Follow-up|0|||
124646968|NCT01938430|448325630|FG012|Overall Study|Lost to Follow-up|0|||
124646969|NCT01938430|448325631|FG013|Overall Study|Lost to Follow-up|0|||
124646970|NCT01938430|448325618|FG000|Overall Study|Withdrew Consent|0|||
124646971|NCT01938430|448325619|FG001|Overall Study|Withdrew Consent|0|||
124646972|NCT01938430|448325620|FG002|Overall Study|Withdrew Consent|0|||
124646973|NCT01938430|448325621|FG003|Overall Study|Withdrew Consent|0|||
124646974|NCT01938430|448325622|FG004|Overall Study|Withdrew Consent|0|||
124646975|NCT01938430|448325623|FG005|Overall Study|Withdrew Consent|0|||
124646976|NCT01938430|448325624|FG006|Overall Study|Withdrew Consent|0|||
124646977|NCT01938430|448325625|FG007|Overall Study|Withdrew Consent|0|||
124646978|NCT01938430|448325626|FG008|Overall Study|Withdrew Consent|1|||
124646979|NCT01938430|448325627|FG009|Overall Study|Withdrew Consent|0|||
124646980|NCT01938430|448325628|FG010|Overall Study|Withdrew Consent|0|||
124646981|NCT01938430|448325629|FG011|Overall Study|Withdrew Consent|0|||
124646982|NCT01938430|448325630|FG012|Overall Study|Withdrew Consent|0|||
124646983|NCT01938430|448325631|FG013|Overall Study|Withdrew Consent|0|||
124646984|NCT03875482|448325632|FG000|Overall Study|Adverse Event|0|||
124646985|NCT03875482|448325633|FG001|Overall Study|Adverse Event|1|||
124646986|NCT03875482|448325632|FG000|Overall Study|Withdrew consent|5|||
124646987|NCT03875482|448325633|FG001|Overall Study|Withdrew consent|6|||
124646988|NCT03875482|448325632|FG000|Overall Study|Lost to Follow-up|8|||
124646989|NCT03875482|448325633|FG001|Overall Study|Lost to Follow-up|2|||
124646990|NCT03875482|448325632|FG000|Overall Study|Lack of Efficacy|0|||
124646991|NCT03875482|448325633|FG001|Overall Study|Lack of Efficacy|11|||
124646992|NCT02111785|448325635|FG000|Overall Study|Death|0|||
124646993|NCT02111785|448325636|FG001|Overall Study|Death|1|||
124646994|NCT02111785|448325637|FG002|Overall Study|Death|0|||
124646995|NCT02111785|448325638|FG003|Overall Study|Death|0|||
124646996|NCT02738879|448325645|FG000|Overall Study|Adverse Event|1|||
124646997|NCT02738879|448325646|FG001|Overall Study|Adverse Event|1|||
124646998|NCT02738879|448325645|FG000|Overall Study|Death|0|||
124646999|NCT02738879|448325646|FG001|Overall Study|Death|2|||
124647000|NCT02738879|448325645|FG000|Overall Study|Lost to Follow-up|1|||
124647001|NCT02738879|448325646|FG001|Overall Study|Lost to Follow-up|5|||
124647002|NCT02738879|448325645|FG000|Overall Study|Protocol Violation|1|||
124647003|NCT02738879|448325646|FG001|Overall Study|Protocol Violation|3|||
124647004|NCT02738879|448325645|FG000|Overall Study|Physician Decision|3|||
124647005|NCT02738879|448325646|FG001|Overall Study|Physician Decision|4|||
124647006|NCT02738879|448325645|FG000|Overall Study|Pregnancy|0|||
124647007|NCT02738879|448325646|FG001|Overall Study|Pregnancy|1|||
124647008|NCT02738879|448325645|FG000|Overall Study|Screen Failure|1|||
124647009|NCT02738879|448325646|FG001|Overall Study|Screen Failure|2|||
124647010|NCT02738879|448325645|FG000|Overall Study|Site Discontinued Study Participation|1|||
124647011|NCT02738879|448325646|FG001|Overall Study|Site Discontinued Study Participation|0|||
124647012|NCT02738879|448325645|FG000|Overall Study|Withdrawal by Subject|5|||
124647013|NCT02738879|448325646|FG001|Overall Study|Withdrawal by Subject|7|||
124647014|NCT01438294|448325647|FG000|Overall Study|Lost to Follow-up|3|||
124647015|NCT01438294|448325648|FG001|Overall Study|Lost to Follow-up|7|||
124647016|NCT01346189|448325651|FG000|Overall Study|Withdrawal by Subject|7|||
124647017|NCT01346189|448325652|FG001|Overall Study|Withdrawal by Subject|5|||
124647018|NCT01346189|448325653|FG002|Overall Study|Withdrawal by Subject|3|||
124647019|NCT01346189|448325654|FG003|Overall Study|Withdrawal by Subject|5|||
124647020|NCT01346189|448325651|FG000|Overall Study|Physician Decision|4|||
124647021|NCT01346189|448325652|FG001|Overall Study|Physician Decision|0|||
124647022|NCT01346189|448325653|FG002|Overall Study|Physician Decision|0|||
124647023|NCT01346189|448325654|FG003|Overall Study|Physician Decision|0|||
124647024|NCT01346189|448325651|FG000|Overall Study|Moved|3|||
124647025|NCT01346189|448325652|FG001|Overall Study|Moved|0|||
124647026|NCT01346189|448325653|FG002|Overall Study|Moved|4|||
124647027|NCT01346189|448325654|FG003|Overall Study|Moved|0|||
124647028|NCT01346189|448325651|FG000|Overall Study|Other|2|||
124647029|NCT01346189|448325652|FG001|Overall Study|Other|4|||
124647030|NCT01346189|448325653|FG002|Overall Study|Other|7|||
124647031|NCT01346189|448325654|FG003|Overall Study|Other|3|||
124647032|NCT01346189|448325651|FG000|Overall Study|Death|0|||
124647033|NCT01346189|448325652|FG001|Overall Study|Death|3|||
124647034|NCT01346189|448325653|FG002|Overall Study|Death|0|||
124647035|NCT01346189|448325654|FG003|Overall Study|Death|0|||
124647036|NCT01346189|448325651|FG000|Overall Study|Non-health system primary care physician|0|||
124647037|NCT01346189|448325652|FG001|Overall Study|Non-health system primary care physician|5|||
124647038|NCT01346189|448325653|FG002|Overall Study|Non-health system primary care physician|0|||
124647039|NCT01346189|448325654|FG003|Overall Study|Non-health system primary care physician|0|||
124647040|NCT01346189|448325651|FG000|Overall Study|Travel|0|||
124647041|NCT01346189|448325652|FG001|Overall Study|Travel|0|||
124647042|NCT01346189|448325653|FG002|Overall Study|Travel|0|||
124647043|NCT01346189|448325654|FG003|Overall Study|Travel|3|||
124647044|NCT01730534|448325658|FG000|Overall Study|Withdrawal by Subject|97|||
124647045|NCT01730534|448325659|FG001|Overall Study|Withdrawal by Subject|127|||
124647046|NCT01730534|448325658|FG000|Overall Study|Lost to Follow-up|12|||
124647047|NCT01730534|448325659|FG001|Overall Study|Lost to Follow-up|18|||
124647048|NCT01676896|448325663|FG000|Overall Study|Withdrawal by Subject|12|||
124647049|NCT01676896|448325664|FG001|Overall Study|Withdrawal by Subject|7|||
124647050|NCT01676896|448325665|FG002|Overall Study|Withdrawal by Subject|19|||
124647051|NCT02256982|448325666|FG000|Overall Study|Disease Progression|0|||
124647052|NCT02256982|448325667|FG001|Overall Study|Disease Progression|1|||
124647053|NCT00655733|448325671|FG000|Overall Study|Lost to Follow-up|2|||
124647054|NCT00655733|448325672|FG001|Overall Study|Lost to Follow-up|2|||
124647055|NCT00655733|448325671|FG000|Overall Study|Adverse Event|2|||
124647056|NCT00655733|448325672|FG001|Overall Study|Adverse Event|2|||
124647057|NCT00655733|448325671|FG000|Overall Study|Withdrawal by Subject|3|||
124647058|NCT00655733|448325672|FG001|Overall Study|Withdrawal by Subject|3|||
124647059|NCT00655733|448325671|FG000|Overall Study|Physician Decision|0|||
124647060|NCT00655733|448325672|FG001|Overall Study|Physician Decision|1|||
124647061|NCT02447497|448325673|FG000|Overall Study|Did not meet treatment day baseline.|6|||
124647062|NCT02447497|448325674|FG001|Overall Study|Did not meet treatment day baseline.|5|||
124647063|NCT02447497|448325675|FG002|Overall Study|Did not meet treatment day baseline.|2|||
124647064|NCT02447497|448325676|FG003|Overall Study|Did not meet treatment day baseline.|2|||
124647065|NCT02447497|448325673|FG000|Overall Study|Dressing was compromised|0|||
124647066|NCT02447497|448325674|FG001|Overall Study|Dressing was compromised|1|||
124647067|NCT02447497|448325675|FG002|Overall Study|Dressing was compromised|0|||
124647068|NCT02447497|448325676|FG003|Overall Study|Dressing was compromised|0|||
124647069|NCT01322035|448325677|FG000|Overall Study|Lost to Follow-up|8|||
124647070|NCT01322035|448325678|FG001|Overall Study|Lost to Follow-up|3|||
124647071|NCT00732758|448325679|FG000|Overall Study|Lost to Follow-up|8|||
124647072|NCT00732758|448325680|FG001|Overall Study|Lost to Follow-up|16|||
124647073|NCT04240457|448325683|FG000|Overall Study|Lost to Follow-up|5|||
124647074|NCT04240457|448325684|FG001|Overall Study|Lost to Follow-up|1|||
124647075|NCT05036668|448325691|FG000|Overall Study|lost to follow Up|0|||
124647076|NCT05036668|448325692|FG001|Overall Study|lost to follow Up|0|||
124647077|NCT05036668|448325693|FG002|Overall Study|lost to follow Up|1|||
124647078|NCT01190267|448325694|FG000|Overall Study|Adverse Event|10|||
124647079|NCT01190267|448325695|FG001|Overall Study|Adverse Event|0|||
124647080|NCT01190267|448325694|FG000|Overall Study|Treatment Failure|8|||
124647081|NCT01190267|448325695|FG001|Overall Study|Treatment Failure|2|||
124647082|NCT01190267|448325694|FG000|Overall Study|Lost to Follow-up|2|||
124647083|NCT01190267|448325695|FG001|Overall Study|Lost to Follow-up|0|||
124647084|NCT01190267|448325694|FG000|Overall Study|Withdrawal by Subject|13|||
124647085|NCT01190267|448325695|FG001|Overall Study|Withdrawal by Subject|1|||
124647086|NCT01190267|448325694|FG000|Overall Study|Protocol Violation|8|||
124647087|NCT01190267|448325695|FG001|Overall Study|Protocol Violation|1|||
124647088|NCT00325156|448325698|FG000|Overall Study|Protocol Violation|8|||
124647089|NCT00325156|448325698|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
124647090|NCT00325156|448325698|FG000|Overall Study|Migrated/moved from study area|12|||
124647091|NCT00325156|448325698|FG000|Overall Study|Adverse event, non-fatal|3|||
124647092|NCT00325156|448325698|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
124647093|NCT00325156|448325698|FG000|Overall Study|Other|1|||
124647094|NCT00325156|448325698|FG000|Overall Study|Withdrawal by Subject|31|||
124647095|NCT00519428|448325699|FG000|Overall Study|Adverse Event|5|||
124647096|NCT00519428|448325700|FG001|Overall Study|Adverse Event|2|||
124647097|NCT00519428|448325701|FG002|Overall Study|Adverse Event|10|||
124647098|NCT00519428|448325699|FG000|Overall Study|Lost to Follow-up|7|||
124647099|NCT00519428|448325700|FG001|Overall Study|Lost to Follow-up|7|||
124647100|NCT00519428|448325701|FG002|Overall Study|Lost to Follow-up|6|||
124647101|NCT00519428|448325699|FG000|Overall Study|Withdrawal by Subject|8|||
124647102|NCT00519428|448325700|FG001|Overall Study|Withdrawal by Subject|3|||
124647103|NCT00519428|448325701|FG002|Overall Study|Withdrawal by Subject|7|||
124647104|NCT00519428|448325699|FG000|Overall Study|unstated|1|||
124647105|NCT00519428|448325700|FG001|Overall Study|unstated|3|||
124647106|NCT00519428|448325701|FG002|Overall Study|unstated|2|||
124647107|NCT03053063|448325702|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
124647108|NCT03053063|448325703|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
124647109|NCT03053063|448325704|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
124647110|NCT03053063|448325705|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
124647111|NCT03053063|448325702|FG000|Randomized Phase|Withdrew consent|8|||
124647112|NCT03053063|448325703|FG001|Randomized Phase|Withdrew consent|11|||
124647113|NCT03053063|448325704|FG002|Randomized Phase|Withdrew consent|5|||
124647114|NCT03053063|448325705|FG003|Randomized Phase|Withdrew consent|0|||
124647115|NCT03053063|448325702|FG000|Randomized Phase|Investigator's Discretion|8|||
124647116|NCT03053063|448325703|FG001|Randomized Phase|Investigator's Discretion|6|||
124647117|NCT03053063|448325704|FG002|Randomized Phase|Investigator's Discretion|2|||
124647118|NCT03053063|448325705|FG003|Randomized Phase|Investigator's Discretion|0|||
124647119|NCT03053063|448325702|FG000|Randomized Phase|Lost to Follow-up|3|||
124647120|NCT03053063|448325703|FG001|Randomized Phase|Lost to Follow-up|5|||
124647121|NCT03053063|448325704|FG002|Randomized Phase|Lost to Follow-up|1|||
124647122|NCT03053063|448325705|FG003|Randomized Phase|Lost to Follow-up|0|||
124647123|NCT03053063|448325702|FG000|Randomized Phase|Adverse Event|0|||
124647124|NCT03053063|448325703|FG001|Randomized Phase|Adverse Event|1|||
124647125|NCT03053063|448325704|FG002|Randomized Phase|Adverse Event|0|||
124647126|NCT03053063|448325705|FG003|Randomized Phase|Adverse Event|0|||
124647127|NCT03053063|448325702|FG000|Randomized Phase|Randomized but Never Treated|1|||
124647128|NCT03053063|448325703|FG001|Randomized Phase|Randomized but Never Treated|3|||
124647129|NCT03053063|448325704|FG002|Randomized Phase|Randomized but Never Treated|2|||
124647130|NCT03053063|448325705|FG003|Randomized Phase|Randomized but Never Treated|0|||
124647131|NCT03053063|448325702|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
124647132|NCT03053063|448325703|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
124647133|NCT03053063|448325704|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
124647134|NCT03053063|448325705|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
124647135|NCT03053063|448325702|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
124647136|NCT03053063|448325703|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
124647137|NCT03053063|448325704|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
124647138|NCT03053063|448325705|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
124647139|NCT03053063|448325702|FG000|Open-Label Phase|Death|0|||
124647140|NCT03053063|448325703|FG001|Open-Label Phase|Death|0|||
124647141|NCT03053063|448325704|FG002|Open-Label Phase|Death|0|||
124647142|NCT03053063|448325705|FG003|Open-Label Phase|Death|2|||
124647143|NCT03053063|448325702|FG000|Open-Label Phase|Investigator's discretion|0|||
124647144|NCT03053063|448325703|FG001|Open-Label Phase|Investigator's discretion|0|||
124647145|NCT03053063|448325704|FG002|Open-Label Phase|Investigator's discretion|0|||
124647146|NCT03053063|448325705|FG003|Open-Label Phase|Investigator's discretion|2|||
124647147|NCT02600845|448325706|FG000|Overall Study|Reason Not Specified|3|||
124647148|NCT02600845|448325706|FG000|Overall Study|Non-compliance with Study Procedures|10|||
124647149|NCT02600845|448325706|FG000|Overall Study|Consent Withdrawal|5|||
124647150|NCT00381238|448327790|FG000|Overall Study|Adverse Event|3|||
124647151|NCT00381238|448327790|FG000|Overall Study|Protocol Violation|1|||
124647152|NCT00381238|448327790|FG000|Overall Study|Withdrawal by Subject|4|||
124647153|NCT00381238|448327790|FG000|Overall Study|Lack of Efficacy|2|||
124647154|NCT00381238|448327790|FG000|Overall Study|Withdrew by physician|1|||
124647155|NCT00381238|448327790|FG000|Overall Study|Disease progression|1|||
124647156|NCT02086448|448327792|FG000|Overall Study|Withdrawal by Subject|1|||
124647157|NCT02086448|448327793|FG001|Overall Study|Withdrawal by Subject|0|||
124647158|NCT02086448|448327794|FG002|Overall Study|Withdrawal by Subject|0|||
124647159|NCT02086448|448327795|FG003|Overall Study|Withdrawal by Subject|2|||
124647160|NCT00843037|448327798|FG000|Overall Study|Lost to Follow-up|1|||
124647161|NCT03535194|448327801|FG000|Induction Period|Adverse Event|2|||
124647162|NCT03535194|448327802|FG001|Induction Period|Adverse Event|2|||
124647163|NCT03535194|448327803|FG002|Induction Period|Adverse Event|1|||
124647164|NCT03535194|448327804|FG003|Induction Period|Adverse Event|3|||
124647165|NCT03535194|448327805|FG004|Induction Period|Adverse Event|0|||
124647166|NCT03535194|448327801|FG000|Induction Period|Death|0|||
124647167|NCT03535194|448327802|FG001|Induction Period|Death|1|||
124647168|NCT03535194|448327803|FG002|Induction Period|Death|0|||
124647169|NCT03535194|448327804|FG003|Induction Period|Death|0|||
124647170|NCT03535194|448327805|FG004|Induction Period|Death|0|||
124647171|NCT03535194|448327801|FG000|Induction Period|Lack of Efficacy|1|||
124647172|NCT03535194|448327802|FG001|Induction Period|Lack of Efficacy|3|||
124647173|NCT03535194|448327803|FG002|Induction Period|Lack of Efficacy|2|||
124647174|NCT03535194|448327804|FG003|Induction Period|Lack of Efficacy|2|||
124647175|NCT03535194|448327805|FG004|Induction Period|Lack of Efficacy|0|||
124647176|NCT03535194|448327801|FG000|Induction Period|Lost to Follow-up|3|||
124647177|NCT03535194|448327802|FG001|Induction Period|Lost to Follow-up|5|||
124647178|NCT03535194|448327803|FG002|Induction Period|Lost to Follow-up|2|||
124647179|NCT03535194|448327804|FG003|Induction Period|Lost to Follow-up|3|||
124647180|NCT03535194|448327805|FG004|Induction Period|Lost to Follow-up|0|||
124647181|NCT03535194|448327801|FG000|Induction Period|Physician Decision|1|||
124647182|NCT03535194|448327802|FG001|Induction Period|Physician Decision|1|||
124647183|NCT03535194|448327803|FG002|Induction Period|Physician Decision|0|||
124647184|NCT03535194|448327804|FG003|Induction Period|Physician Decision|0|||
124647185|NCT03535194|448327805|FG004|Induction Period|Physician Decision|0|||
124647186|NCT03535194|448327801|FG000|Induction Period|Protocol Violation|1|||
124647187|NCT03535194|448327802|FG001|Induction Period|Protocol Violation|0|||
124647188|NCT03535194|448327803|FG002|Induction Period|Protocol Violation|0|||
124647189|NCT03535194|448327804|FG003|Induction Period|Protocol Violation|1|||
124647190|NCT03535194|448327805|FG004|Induction Period|Protocol Violation|0|||
124647191|NCT03535194|448327801|FG000|Induction Period|Screen Failure|0|||
124647192|NCT03535194|448327802|FG001|Induction Period|Screen Failure|1|||
124647193|NCT03535194|448327803|FG002|Induction Period|Screen Failure|0|||
124647194|NCT03535194|448327804|FG003|Induction Period|Screen Failure|0|||
124647195|NCT03535194|448327805|FG004|Induction Period|Screen Failure|0|||
124647196|NCT03535194|448327801|FG000|Induction Period|Withdrawal by Subject|3|||
124647197|NCT03535194|448327802|FG001|Induction Period|Withdrawal by Subject|4|||
124647198|NCT03535194|448327803|FG002|Induction Period|Withdrawal by Subject|3|||
124647199|NCT03535194|448327804|FG003|Induction Period|Withdrawal by Subject|2|||
124647200|NCT03535194|448327805|FG004|Induction Period|Withdrawal by Subject|0|||
124647201|NCT03535194|448327801|FG000|Maintenance Period|Adverse Event|6|||
124647202|NCT03535194|448327802|FG001|Maintenance Period|Adverse Event|5|||
124647203|NCT03535194|448327803|FG002|Maintenance Period|Adverse Event|1|||
124647204|NCT03535194|448327804|FG003|Maintenance Period|Adverse Event|11|||
124647205|NCT03535194|448327805|FG004|Maintenance Period|Adverse Event|4|||
124647206|NCT03535194|448327801|FG000|Maintenance Period|Lack of Efficacy|3|||
124647207|NCT03535194|448327802|FG001|Maintenance Period|Lack of Efficacy|2|||
124647208|NCT03535194|448327803|FG002|Maintenance Period|Lack of Efficacy|5|||
124647209|NCT03535194|448327804|FG003|Maintenance Period|Lack of Efficacy|9|||
124647210|NCT03535194|448327805|FG004|Maintenance Period|Lack of Efficacy|0|||
124647211|NCT03535194|448327801|FG000|Maintenance Period|Lost to Follow-up|4|||
124647212|NCT03535194|448327802|FG001|Maintenance Period|Lost to Follow-up|2|||
124647213|NCT03535194|448327803|FG002|Maintenance Period|Lost to Follow-up|1|||
124647214|NCT03535194|448327804|FG003|Maintenance Period|Lost to Follow-up|5|||
124647215|NCT03535194|448327805|FG004|Maintenance Period|Lost to Follow-up|2|||
124647216|NCT03535194|448327801|FG000|Maintenance Period|Other|1|||
124647217|NCT03535194|448327802|FG001|Maintenance Period|Other|2|||
124647218|NCT03535194|448327803|FG002|Maintenance Period|Other|0|||
124647219|NCT03535194|448327804|FG003|Maintenance Period|Other|0|||
124647220|NCT03535194|448327805|FG004|Maintenance Period|Other|0|||
124647221|NCT03535194|448327801|FG000|Maintenance Period|Physician Decision|1|||
124647222|NCT03535194|448327802|FG001|Maintenance Period|Physician Decision|2|||
124647223|NCT03535194|448327803|FG002|Maintenance Period|Physician Decision|0|||
124647224|NCT03535194|448327804|FG003|Maintenance Period|Physician Decision|2|||
124647225|NCT03535194|448327805|FG004|Maintenance Period|Physician Decision|0|||
124647226|NCT03535194|448327801|FG000|Maintenance Period|Pregnancy|0|||
124647227|NCT03535194|448327802|FG001|Maintenance Period|Pregnancy|0|||
124647228|NCT03535194|448327803|FG002|Maintenance Period|Pregnancy|0|||
124647229|NCT03535194|448327804|FG003|Maintenance Period|Pregnancy|2|||
124647230|NCT03535194|448327805|FG004|Maintenance Period|Pregnancy|0|||
124647231|NCT03535194|448327801|FG000|Maintenance Period|Protocol Violation|0|||
124647232|NCT03535194|448327802|FG001|Maintenance Period|Protocol Violation|1|||
124647233|NCT03535194|448327803|FG002|Maintenance Period|Protocol Violation|0|||
124647234|NCT03535194|448327804|FG003|Maintenance Period|Protocol Violation|0|||
124647235|NCT03535194|448327805|FG004|Maintenance Period|Protocol Violation|0|||
124647236|NCT03535194|448327801|FG000|Maintenance Period|Withdrawal by Subject|7|||
124647237|NCT03535194|448327802|FG001|Maintenance Period|Withdrawal by Subject|2|||
124647238|NCT03535194|448327803|FG002|Maintenance Period|Withdrawal by Subject|1|||
124647239|NCT03535194|448327804|FG003|Maintenance Period|Withdrawal by Subject|8|||
124647240|NCT03535194|448327805|FG004|Maintenance Period|Withdrawal by Subject|0|||
124647241|NCT03535194|448327801|FG000|Post-Treatment Followup Period|Adverse Event|4|||
124647242|NCT03535194|448327802|FG001|Post-Treatment Followup Period|Adverse Event|5|||
124647243|NCT03535194|448327803|FG002|Post-Treatment Followup Period|Adverse Event|1|||
124647244|NCT03535194|448327804|FG003|Post-Treatment Followup Period|Adverse Event|8|||
124647245|NCT03535194|448327805|FG004|Post-Treatment Followup Period|Adverse Event|0|||
124647246|NCT03535194|448327801|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
124647247|NCT03535194|448327802|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
124647248|NCT03535194|448327803|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
124647249|NCT03535194|448327804|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
124647250|NCT03535194|448327805|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
124647251|NCT03535194|448327801|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
124647252|NCT03535194|448327802|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
124647253|NCT03535194|448327803|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
124647254|NCT03535194|448327804|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
124647255|NCT03535194|448327805|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
124647256|NCT03535194|448327801|FG000|Post-Treatment Followup Period|Other|1|||
124647257|NCT03535194|448327802|FG001|Post-Treatment Followup Period|Other|0|||
124647258|NCT03535194|448327803|FG002|Post-Treatment Followup Period|Other|0|||
124647259|NCT03535194|448327804|FG003|Post-Treatment Followup Period|Other|5|||
124647260|NCT03535194|448327805|FG004|Post-Treatment Followup Period|Other|0|||
124647261|NCT03535194|448327801|FG000|Post-Treatment Followup Period|Physician Decision|0|||
124647262|NCT03535194|448327802|FG001|Post-Treatment Followup Period|Physician Decision|2|||
124647263|NCT03535194|448327803|FG002|Post-Treatment Followup Period|Physician Decision|1|||
124647264|NCT03535194|448327804|FG003|Post-Treatment Followup Period|Physician Decision|1|||
124647265|NCT03535194|448327805|FG004|Post-Treatment Followup Period|Physician Decision|0|||
124647266|NCT03535194|448327801|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
124544087|NCT02319642|447946707|FG000|Overall Study|Withdrawal by Subject|1|||
124544088|NCT02319642|447946708|FG001|Overall Study|Withdrawal by Subject|1|||
124544089|NCT05048875|447946714|FG000|Overall Study|Withdrawal by Subject|1|||
124544090|NCT05048875|447946715|FG001|Overall Study|Withdrawal by Subject|0|||
124544091|NCT05048875|447946716|FG002|Overall Study|Withdrawal by Subject|0|||
124544092|NCT05048875|447946717|FG003|Overall Study|Withdrawal by Subject|0|||
124544093|NCT05048875|447946718|FG004|Overall Study|Withdrawal by Subject|0|||
124544094|NCT05048875|447946719|FG005|Overall Study|Withdrawal by Subject|0|||
124544095|NCT05048875|447946720|FG006|Overall Study|Withdrawal by Subject|0|||
124544096|NCT05048875|447946721|FG007|Overall Study|Withdrawal by Subject|0|||
124544097|NCT05048875|447946714|FG000|Overall Study|Adverse Event|0|||
124544098|NCT05048875|447946715|FG001|Overall Study|Adverse Event|0|||
124544099|NCT05048875|447946716|FG002|Overall Study|Adverse Event|0|||
124544100|NCT05048875|447946717|FG003|Overall Study|Adverse Event|1|||
124544101|NCT05048875|447946718|FG004|Overall Study|Adverse Event|0|||
124544102|NCT05048875|447946719|FG005|Overall Study|Adverse Event|0|||
124544103|NCT05048875|447946720|FG006|Overall Study|Adverse Event|0|||
124647267|NCT03535194|448327802|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
124647268|NCT03535194|448327803|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
124647269|NCT03535194|448327804|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
124544104|NCT05048875|447946721|FG007|Overall Study|Adverse Event|0|||
124544105|NCT02255422|447946726|FG000|Overall Study|Withdrawal by Subject|0|||
124544106|NCT02255422|447946727|FG001|Overall Study|Withdrawal by Subject|0|||
124544107|NCT02255422|447946728|FG002|Overall Study|Withdrawal by Subject|0|||
124647270|NCT03535194|448327805|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
124647271|NCT01279070|448327806|FG000|Overall Study|Withdrawal by Subject|2|||
124647272|NCT01279070|448327807|FG001|Overall Study|Withdrawal by Subject|3|||
124647273|NCT01279070|448327806|FG000|Overall Study|Acute exacerbation|3|||
124647274|NCT01279070|448327807|FG001|Overall Study|Acute exacerbation|1|||
124647275|NCT03781583|448327808|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
124647276|NCT03781583|448327809|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
124647277|NCT03781583|448327810|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
124647278|NCT03781583|448327811|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
124647279|NCT03781583|448327808|FG000|Overall Study|Technology did not work for that person in that environment|1|||
124647280|NCT03781583|448327809|FG001|Overall Study|Technology did not work for that person in that environment|0|||
124647281|NCT03781583|448327810|FG002|Overall Study|Technology did not work for that person in that environment|0|||
124647282|NCT03781583|448327811|FG003|Overall Study|Technology did not work for that person in that environment|0|||
124647283|NCT03781583|448327808|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
124647284|NCT03781583|448327809|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
124647285|NCT03781583|448327810|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
124647286|NCT03781583|448327811|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
124647287|NCT03781583|448327808|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
124647288|NCT03781583|448327809|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
124647289|NCT03781583|448327810|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
124647290|NCT03781583|448327811|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
124647291|NCT02045862|448327812|FG000|Overall Study|Death|0|||
124647292|NCT02045862|448327813|FG001|Overall Study|Death|0|||
124647293|NCT02045862|448327814|FG002|Overall Study|Death|1|||
124647294|NCT02045862|448327812|FG000|Overall Study|Miscellaneous|5|||
124647295|NCT02045862|448327813|FG001|Overall Study|Miscellaneous|0|||
124647296|NCT02045862|448327814|FG002|Overall Study|Miscellaneous|8|||
124647297|NCT02045862|448327812|FG000|Overall Study|Withdrawal by Patient|18|||
124647298|NCT02045862|448327813|FG001|Overall Study|Withdrawal by Patient|27|||
124647299|NCT02045862|448327814|FG002|Overall Study|Withdrawal by Patient|57|||
124647300|NCT02045862|448327812|FG000|Overall Study|Protocol Violation|0|||
124647301|NCT02045862|448327813|FG001|Overall Study|Protocol Violation|0|||
124647302|NCT02045862|448327814|FG002|Overall Study|Protocol Violation|6|||
124647303|NCT02045862|448327812|FG000|Overall Study|Lack of Efficacy|8|||
124647304|NCT02045862|448327813|FG001|Overall Study|Lack of Efficacy|4|||
124647305|NCT02045862|448327814|FG002|Overall Study|Lack of Efficacy|13|||
124647306|NCT02045862|448327812|FG000|Overall Study|Randomized but not Received Study Drug|0|||
124647307|NCT02045862|448327813|FG001|Overall Study|Randomized but not Received Study Drug|2|||
124647308|NCT02045862|448327814|FG002|Overall Study|Randomized but not Received Study Drug|8|||
124647309|NCT02045862|448327812|FG000|Overall Study|Adverse Event|7|||
124647310|NCT02045862|448327813|FG001|Overall Study|Adverse Event|5|||
124647311|NCT02045862|448327814|FG002|Overall Study|Adverse Event|27|||
124647312|NCT02045862|448327812|FG000|Overall Study|Lost to Follow-up|1|||
124647313|NCT02045862|448327813|FG001|Overall Study|Lost to Follow-up|2|||
124647314|NCT02045862|448327814|FG002|Overall Study|Lost to Follow-up|6|||
124647315|NCT03164564|448327815|FG000|Overall Study|Death|3|||
124647316|NCT03164564|448327816|FG001|Overall Study|Death|0|||
124647317|NCT03164564|448327815|FG000|Overall Study|Withdrawal by Subject|20|||
124647318|NCT03164564|448327816|FG001|Overall Study|Withdrawal by Subject|15|||
124647319|NCT03164564|448327815|FG000|Overall Study|Lost to Follow-up|2|||
124647320|NCT03164564|448327816|FG001|Overall Study|Lost to Follow-up|0|||
124647321|NCT03164564|448327815|FG000|Overall Study|Physician Decision|0|||
124647322|NCT03164564|448327816|FG001|Overall Study|Physician Decision|1|||
124647323|NCT03164564|448327815|FG000|Overall Study|Adverse Event|0|||
124647324|NCT03164564|448327816|FG001|Overall Study|Adverse Event|1|||
124647325|NCT03164564|448327815|FG000|Overall Study|Ongoing|1586|||
124647326|NCT03164564|448327816|FG001|Overall Study|Ongoing|1586|||
124647327|NCT02691013|448327817|FG000|Overall Study|Withdrawal by Subject|3|||
124647328|NCT02691013|448327818|FG001|Overall Study|Withdrawal by Subject|0|||
124647329|NCT01075646|448327823|FG000|Overall Study|Lost to Follow-up|4|||
124647330|NCT01075646|448327824|FG001|Overall Study|Lost to Follow-up|3|||
124647331|NCT01075646|448327825|FG002|Overall Study|Lost to Follow-up|1|||
124647332|NCT01075646|448327826|FG003|Overall Study|Lost to Follow-up|2|||
124647333|NCT01895608|448327827|FG000|Overall Study|change in health status|0|||
124647334|NCT01895608|448327828|FG001|Overall Study|change in health status|1|||
124647335|NCT01895608|448327829|FG002|Overall Study|change in health status|1|||
124647336|NCT01895608|448327830|FG003|Overall Study|change in health status|0|||
124647337|NCT01895608|448327827|FG000|Overall Study|Withdrawal by Subject|0|||
124647338|NCT01895608|448327828|FG001|Overall Study|Withdrawal by Subject|0|||
124647339|NCT01895608|448327829|FG002|Overall Study|Withdrawal by Subject|2|||
124647340|NCT01895608|448327830|FG003|Overall Study|Withdrawal by Subject|0|||
124647341|NCT03505593|448327834|FG000|Overall Study|Withdrawal by Subject|1|||
124647342|NCT03505593|448327834|FG000|Overall Study|Died before procedure|1|||
124647343|NCT03505593|448327834|FG000|Overall Study|Anatomical abnormality|1|||
124647344|NCT03505593|448327834|FG000|Overall Study|Unable to pass through esophagus|1|||
124647345|NCT03505593|448327834|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
124647346|NCT02275780|448327835|FG000|Base Study: 96 Weeks|Adverse Event|6|||
124647347|NCT02275780|448327836|FG001|Base Study: 96 Weeks|Adverse Event|14|||
124647348|NCT02275780|448327835|FG000|Base Study: 96 Weeks|Death|3|||
124647349|NCT02275780|448327836|FG001|Base Study: 96 Weeks|Death|1|||
124647350|NCT02275780|448327835|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
124647351|NCT02275780|448327836|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
124647352|NCT02275780|448327835|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
124647353|NCT02275780|448327836|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
124647354|NCT02275780|448327835|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
124647355|NCT02275780|448327836|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
124647356|NCT02275780|448327835|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
124647357|NCT02275780|448327836|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
124647358|NCT02275780|448327835|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
124647359|NCT02275780|448327836|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
124647360|NCT02275780|448327835|FG000|Base Study: 96 Weeks|Physician Decision|2|||
124647361|NCT02275780|448327836|FG001|Base Study: 96 Weeks|Physician Decision|4|||
124647362|NCT02275780|448327835|FG000|Base Study: 96 Weeks|Pregnancy|2|||
124647363|NCT02275780|448327836|FG001|Base Study: 96 Weeks|Pregnancy|1|||
124647364|NCT02275780|448327835|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
124647365|NCT02275780|448327836|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
124647366|NCT02275780|448327835|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
124647367|NCT02275780|448327836|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
124647368|NCT02275780|448327835|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
124647369|NCT02275780|448327836|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
124647370|NCT02275780|448327835|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
124647371|NCT02275780|448327836|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
124647372|NCT02275780|448327835|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
124647373|NCT02275780|448327836|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
124647374|NCT02275780|448327835|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
124647375|NCT02275780|448327836|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
124647376|NCT02275780|448327835|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
124647377|NCT02275780|448327836|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
124647378|NCT02275780|448327835|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
124647379|NCT02275780|448327836|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
124647380|NCT02275780|448327835|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
124647381|NCT02275780|448327836|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
124647382|NCT02275780|448327835|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
124647383|NCT02275780|448327836|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
124647384|NCT02275780|448327835|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
124647385|NCT02275780|448327836|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
124647386|NCT02275780|448327835|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
124647387|NCT02275780|448327836|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
124647388|NCT02275780|448327835|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
124647389|NCT02275780|448327836|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
124647390|NCT02275780|448327835|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
124647391|NCT02275780|448327836|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
124647392|NCT02275780|448327835|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
124647393|NCT02275780|448327836|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
124647394|NCT02275780|448327835|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
124647395|NCT02275780|448327836|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
124647396|NCT02275780|448327835|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
124647397|NCT02275780|448327836|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
124647398|NCT02275780|448327835|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
124647399|NCT02275780|448327836|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
124647400|NCT02275780|448327835|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
124647401|NCT02275780|448327836|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
124647402|NCT02275780|448327835|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
124647403|NCT02275780|448327836|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
124647404|NCT02275780|448327835|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
124647405|NCT02275780|448327836|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
124647406|NCT02275780|448327835|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
124647407|NCT02275780|448327836|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
124647408|NCT02855359|448327841|FG000|Overall Study|Death|2|||
124647409|NCT02855359|448327842|FG001|Overall Study|Death|2|||
124647410|NCT02855359|448327843|FG002|Overall Study|Death|0|||
124647411|NCT02855359|448327844|FG003|Overall Study|Death|0|||
124647412|NCT02855359|448327841|FG000|Overall Study|Study Termination by Sponsor|9|||
124647413|NCT02855359|448327842|FG001|Overall Study|Study Termination by Sponsor|11|||
124647414|NCT02855359|448327843|FG002|Overall Study|Study Termination by Sponsor|0|||
124647415|NCT02855359|448327844|FG003|Overall Study|Study Termination by Sponsor|0|||
124647416|NCT00348790|448327847|FG000|Completed Treatment|Withdrawal by Subject|4|||
124647417|NCT00348790|448327847|FG000|Completed Treatment|Disease progression|14|||
124647418|NCT00348790|448327847|FG000|Completed Treatment|Adverse Event|4|||
124647419|NCT00348790|448327847|FG000|Completed Treatment|Required surgery|2|||
124647420|NCT00348790|448327847|FG000|Completed Treatment|Unable to travel to study site|1|||
124647421|NCT01044290|448327848|FG000|Follow-up 1|Death|3|||
124647422|NCT01044290|448327849|FG001|Follow-up 1|Death|3|||
124647423|NCT01044290|448327850|FG002|Follow-up 1|Death|1|||
124647424|NCT01044290|448327848|FG000|Follow-up 1|Withdrawal by Subject|2|||
124647425|NCT01044290|448327849|FG001|Follow-up 1|Withdrawal by Subject|2|||
124647426|NCT01044290|448327850|FG002|Follow-up 1|Withdrawal by Subject|0|||
124647427|NCT01044290|448327848|FG000|Follow-Up 2|Death|0|||
124647428|NCT01044290|448327849|FG001|Follow-Up 2|Death|1|||
124647429|NCT01044290|448327850|FG002|Follow-Up 2|Death|1|||
124647430|NCT01044290|448327848|FG000|Follow-Up 2|Withdrawal by Subject|0|||
124647431|NCT01044290|448327849|FG001|Follow-Up 2|Withdrawal by Subject|1|||
124647432|NCT01044290|448327850|FG002|Follow-Up 2|Withdrawal by Subject|1|||
124647433|NCT01084668|448327857|FG000|Overall Study|Lack of Efficacy|5|||
124647434|NCT01084668|448327857|FG000|Overall Study|Withdrawal by Subject|2|||
124647435|NCT01084668|448327857|FG000|Overall Study|Pregnancy|1|||
124647436|NCT01084668|448327857|FG000|Overall Study|Non-compliance|1|||
124647437|NCT01083186|448327859|FG000|Overall Study|Lost to Follow-up|48|||
124647438|NCT01083186|448327859|FG000|Overall Study|Consent Withdrawal|7|||
124647439|NCT01083186|448327859|FG000|Overall Study|Death|3|||
124647440|NCT01083186|448327859|FG000|Overall Study|Adverse Event|3|||
124647441|NCT01083186|448327859|FG000|Overall Study|Lack of Efficacy|2|||
124647442|NCT01083186|448327859|FG000|Overall Study|Hemodialysis Initiation|28|||
124647443|NCT01083186|448327859|FG000|Overall Study|Administrative Reasons|2|||
124647444|NCT01083186|448327859|FG000|Overall Study|Non-compliance to Study Treatment|1|||
124647445|NCT02122770|448327863|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
124647446|NCT02122770|448327864|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
124647447|NCT02122770|448327865|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
124647448|NCT02122770|448327866|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
124647449|NCT02122770|448327867|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
124647450|NCT02122770|448327868|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
124647451|NCT02122770|448327863|FG000|Part A: Drug-drug Interaction 2|Other|0|||
124647452|NCT02122770|448327864|FG001|Part A: Drug-drug Interaction 2|Other|0|||
124647453|NCT02122770|448327865|FG002|Part A: Drug-drug Interaction 2|Other|1|||
124647454|NCT02122770|448327866|FG003|Part A: Drug-drug Interaction 2|Other|0|||
124647455|NCT02122770|448327867|FG004|Part A: Drug-drug Interaction 2|Other|0|||
124647456|NCT02122770|448327868|FG005|Part A: Drug-drug Interaction 2|Other|0|||
124647457|NCT02122770|448327863|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
124647458|NCT02122770|448327864|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
124647459|NCT02122770|448327865|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
124647460|NCT02122770|448327866|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
124647461|NCT02122770|448327867|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
124647462|NCT02122770|448327868|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
124647463|NCT02122770|448327863|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
124647464|NCT02122770|448327864|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
124647465|NCT02122770|448327865|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
124647466|NCT02122770|448327866|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
124647467|NCT02122770|448327867|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
124647468|NCT02122770|448327868|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
124647469|NCT02122770|448327863|FG000|Part B: Standard of Care|Adverse Event|0|||
124647470|NCT02122770|448327864|FG001|Part B: Standard of Care|Adverse Event|0|||
124647471|NCT02122770|448327865|FG002|Part B: Standard of Care|Adverse Event|0|||
124647472|NCT02122770|448327866|FG003|Part B: Standard of Care|Adverse Event|0|||
124647473|NCT02122770|448327867|FG004|Part B: Standard of Care|Adverse Event|4|||
124647474|NCT02122770|448327868|FG005|Part B: Standard of Care|Adverse Event|1|||
124647475|NCT02122770|448327863|FG000|Part B: Standard of Care|Other|0|||
124647476|NCT02122770|448327864|FG001|Part B: Standard of Care|Other|0|||
124647477|NCT02122770|448327865|FG002|Part B: Standard of Care|Other|0|||
124647478|NCT02122770|448327866|FG003|Part B: Standard of Care|Other|0|||
124647479|NCT02122770|448327867|FG004|Part B: Standard of Care|Other|0|||
124647480|NCT02122770|448327868|FG005|Part B: Standard of Care|Other|2|||
124647481|NCT02122770|448327863|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
124647482|NCT02122770|448327864|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
124647483|NCT02122770|448327865|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
124647484|NCT02122770|448327866|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
124647485|NCT02122770|448327867|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
124647486|NCT02122770|448327868|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
124647487|NCT02122770|448327863|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
124647488|NCT02122770|448327864|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
124647489|NCT02122770|448327865|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
124647490|NCT02122770|448327866|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
124647491|NCT02122770|448327867|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
124647492|NCT02122770|448327868|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
124647493|NCT02122770|448327863|FG000|Part B: Standard of Care|Progressive Disease|0|||
124647494|NCT02122770|448327864|FG001|Part B: Standard of Care|Progressive Disease|0|||
124647495|NCT02122770|448327865|FG002|Part B: Standard of Care|Progressive Disease|0|||
124647496|NCT02122770|448327866|FG003|Part B: Standard of Care|Progressive Disease|0|||
124647497|NCT02122770|448327867|FG004|Part B: Standard of Care|Progressive Disease|10|||
124647498|NCT02122770|448327868|FG005|Part B: Standard of Care|Progressive Disease|8|||
124647499|NCT00189306|448327870|FG000|Treatment Period|Withdrawal by Subject|2|||
124647500|NCT00189306|448327870|FG000|Treatment Period|Adverse Event|2|||
124647501|NCT00189306|448327870|FG000|Treatment Period|Protocol Violation|1|||
124647502|NCT00189306|448327870|FG000|Posttreatment Period|Death|1|||
124647503|NCT00189306|448327870|FG000|Posttreatment Period|Withdrawal by Subject|2|||
124647504|NCT00189306|448327870|FG000|Posttreatment Period|Noncompliance|1|||
124647505|NCT00189306|448327870|FG000|Posttreatment Period|Target lesion excised|1|||
124647506|NCT00189306|448327870|FG000|Posttreatment Period|Protocol Violation|1|||
124647507|NCT00189306|448327870|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
124647508|NCT00189306|448327870|FG000|Posttreatment Period|Local skin reaction/sign|1|||
124647509|NCT00189306|448327870|FG000|Long-Term Follow-up|Adverse Event|2|||
124647510|NCT00189306|448327870|FG000|Long-Term Follow-up|Death|4|||
124647511|NCT00189306|448327870|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
124647512|NCT00189306|448327870|FG000|Long-Term Follow-up|Intercurrent disease|2|||
124647513|NCT00189306|448327870|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
124647514|NCT00189306|448327870|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
124647515|NCT03640481|448327871|FG000|Overall Study|Death|14|||
124647516|NCT03640481|448327872|FG001|Overall Study|Death|14|||
124647517|NCT03640481|448327873|FG002|Overall Study|Death|0|||
124647518|NCT03640481|448327874|FG003|Overall Study|Death|0|||
124647519|NCT03640481|448327871|FG000|Overall Study|Lost to Follow-up|2|||
124647520|NCT03640481|448327872|FG001|Overall Study|Lost to Follow-up|0|||
124647521|NCT03640481|448327873|FG002|Overall Study|Lost to Follow-up|0|||
124647522|NCT03640481|448327874|FG003|Overall Study|Lost to Follow-up|0|||
124647523|NCT03640481|448327871|FG000|Overall Study|Site terminated by sponsor|1|||
124647524|NCT03640481|448327872|FG001|Overall Study|Site terminated by sponsor|3|||
124647525|NCT03640481|448327873|FG002|Overall Study|Site terminated by sponsor|0|||
124647526|NCT03640481|448327874|FG003|Overall Study|Site terminated by sponsor|0|||
124647527|NCT03640481|448327871|FG000|Overall Study|Study terminated by sponsor|29|||
124647528|NCT03640481|448327872|FG001|Overall Study|Study terminated by sponsor|42|||
124647529|NCT03640481|448327873|FG002|Overall Study|Study terminated by sponsor|1|||
124647530|NCT03640481|448327874|FG003|Overall Study|Study terminated by sponsor|0|||
124647531|NCT03640481|448327871|FG000|Overall Study|Withdrawal by Subject|5|||
124647532|NCT03640481|448327872|FG001|Overall Study|Withdrawal by Subject|4|||
124647533|NCT03640481|448327873|FG002|Overall Study|Withdrawal by Subject|0|||
124647534|NCT03640481|448327874|FG003|Overall Study|Withdrawal by Subject|1|||
124647535|NCT03640481|448327871|FG000|Overall Study|Other|26|||
124647536|NCT03640481|448327872|FG001|Overall Study|Other|12|||
124647537|NCT03640481|448327873|FG002|Overall Study|Other|1|||
124647538|NCT03640481|448327874|FG003|Overall Study|Other|0|||
124647539|NCT03640481|448327871|FG000|Overall Study|Randomized, but not treated|1|||
124647540|NCT03640481|448327872|FG001|Overall Study|Randomized, but not treated|3|||
124647541|NCT03640481|448327873|FG002|Overall Study|Randomized, but not treated|0|||
124647542|NCT03640481|448327874|FG003|Overall Study|Randomized, but not treated|0|||
124647543|NCT00535847|448327875|FG000|Overall Study|Adverse Event|5|||
124647544|NCT00535847|448327876|FG001|Overall Study|Adverse Event|3|||
124647545|NCT00535847|448327877|FG002|Overall Study|Adverse Event|2|||
124647546|NCT00535847|448327875|FG000|Overall Study|Non compliance|1|||
124647547|NCT00535847|448327876|FG001|Overall Study|Non compliance|1|||
124647548|NCT00535847|448327877|FG002|Overall Study|Non compliance|0|||
124647549|NCT00535847|448327875|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
124647550|NCT00535847|448327876|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
124647551|NCT00535847|448327877|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
124647552|NCT04569968|448327878|FG000|Overall Study|Lost to Follow-up|2|||
124647553|NCT04569968|448327879|FG001|Overall Study|Lost to Follow-up|5|||
124647554|NCT04569968|448327878|FG000|Overall Study|Story of head and/or neck surgery|2|||
124647555|NCT04569968|448327879|FG001|Overall Study|Story of head and/or neck surgery|2|||
124647556|NCT04569968|448327878|FG000|Overall Study|Time of stroke onset|8|||
124647557|NCT04569968|448327879|FG001|Overall Study|Time of stroke onset|7|||
124647558|NCT04569968|448327878|FG000|Overall Study|Type of strokr|12|||
124647559|NCT04569968|448327879|FG001|Overall Study|Type of strokr|8|||
124647560|NCT04569968|448327878|FG000|Overall Study|Cooperation|8|||
124647561|NCT04569968|448327879|FG001|Overall Study|Cooperation|8|||
124647562|NCT04569968|448327878|FG000|Overall Study|Age interval|17|||
124647563|NCT04569968|448327879|FG001|Overall Study|Age interval|6|||
124647564|NCT04569968|448327878|FG000|Overall Study|Denial of participation to the study|0|||
124647565|NCT04569968|448327879|FG001|Overall Study|Denial of participation to the study|3|||
124647566|NCT04569968|448327878|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
124647567|NCT04569968|448327879|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
124647568|NCT04569968|448327878|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
124647569|NCT04569968|448327879|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
124647570|NCT04569968|448327878|FG000|Overall Study|Quarantine|1|||
124647571|NCT04569968|448327879|FG001|Overall Study|Quarantine|0|||
124647572|NCT04569968|448327878|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
124647573|NCT04569968|448327879|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
124647574|NCT04569968|448327878|FG000|Overall Study|Repetitive stroke|8|||
124647575|NCT04569968|448327879|FG001|Overall Study|Repetitive stroke|0|||
124647576|NCT04569968|448327878|FG000|Overall Study|Insufficient mastication|1|||
124544108|NCT02255422|447946729|FG003|Overall Study|Withdrawal by Subject|0|||
124544109|NCT02255422|447946730|FG004|Overall Study|Withdrawal by Subject|0|||
124544110|NCT02255422|447946731|FG005|Overall Study|Withdrawal by Subject|0|||
124544111|NCT02255422|447946732|FG006|Overall Study|Withdrawal by Subject|2|||
124544112|NCT02255422|447946726|FG000|Overall Study|Lost to Follow-up|0|||
124544113|NCT02255422|447946727|FG001|Overall Study|Lost to Follow-up|0|||
124544114|NCT02255422|447946728|FG002|Overall Study|Lost to Follow-up|1|||
124544115|NCT02255422|447946729|FG003|Overall Study|Lost to Follow-up|0|||
124544116|NCT02255422|447946730|FG004|Overall Study|Lost to Follow-up|0|||
124544117|NCT02255422|447946731|FG005|Overall Study|Lost to Follow-up|0|||
124544118|NCT02255422|447946732|FG006|Overall Study|Lost to Follow-up|0|||
124544119|NCT04411641|447946733|FG000|DB Period|Other|7|||
124544120|NCT04411641|447946734|FG001|DB Period|Other|27|||
124544121|NCT04411641|447946735|FG002|DB Period|Other|0|||
124544122|NCT04411641|447946736|FG003|DB Period|Other|0|||
124544123|NCT04411641|447946733|FG000|DB Period|Withdrawal by Subject|67|||
124544124|NCT04411641|447946734|FG001|DB Period|Withdrawal by Subject|122|||
124544125|NCT04411641|447946735|FG002|DB Period|Withdrawal by Subject|0|||
124544126|NCT04411641|447946736|FG003|DB Period|Withdrawal by Subject|0|||
124544127|NCT04411641|447946733|FG000|DB Period|Progressive disease|76|||
124544128|NCT04411641|447946734|FG001|DB Period|Progressive disease|116|||
124544129|NCT04411641|447946735|FG002|DB Period|Progressive disease|0|||
124544130|NCT04411641|447946736|FG003|DB Period|Progressive disease|0|||
124544131|NCT04411641|447946733|FG000|DB Period|Poor compliance to protocol|1|||
124544132|NCT04411641|447946734|FG001|DB Period|Poor compliance to protocol|5|||
124544133|NCT04411641|447946735|FG002|DB Period|Poor compliance to protocol|0|||
124544134|NCT04411641|447946736|FG003|DB Period|Poor compliance to protocol|0|||
124544135|NCT04411641|447946733|FG000|DB Period|Lack of Efficacy|19|||
124544136|NCT04411641|447946734|FG001|DB Period|Lack of Efficacy|19|||
124544137|NCT04411641|447946735|FG002|DB Period|Lack of Efficacy|0|||
124544138|NCT04411641|447946736|FG003|DB Period|Lack of Efficacy|0|||
124544139|NCT04411641|447946733|FG000|DB Period|Adverse Event|13|||
124544140|NCT04411641|447946734|FG001|DB Period|Adverse Event|29|||
124544141|NCT04411641|447946735|FG002|DB Period|Adverse Event|0|||
124544142|NCT04411641|447946736|FG003|DB Period|Adverse Event|0|||
124544143|NCT04411641|447946733|FG000|DB Period|Randomized and not treated|2|||
124544144|NCT04411641|447946734|FG001|DB Period|Randomized and not treated|2|||
124544145|NCT04411641|447946735|FG002|DB Period|Randomized and not treated|0|||
124544146|NCT04411641|447946736|FG003|DB Period|Randomized and not treated|0|||
124544147|NCT04411641|447946733|FG000|OL|Withdrawal by Subject|0|||
124544148|NCT04411641|447946734|FG001|OL|Withdrawal by Subject|0|||
124544149|NCT04411641|447946735|FG002|OL|Withdrawal by Subject|6|||
124544150|NCT04411641|447946736|FG003|OL|Withdrawal by Subject|17|||
124544151|NCT04411641|447946733|FG000|OL|Progressive disease|0|||
124544152|NCT04411641|447946734|FG001|OL|Progressive disease|0|||
124544153|NCT04411641|447946735|FG002|OL|Progressive disease|1|||
124544154|NCT04411641|447946736|FG003|OL|Progressive disease|2|||
124544155|NCT04411641|447946733|FG000|OL|Poor compliance to protocol|0|||
124544156|NCT04411641|447946734|FG001|OL|Poor compliance to protocol|0|||
124544157|NCT04411641|447946735|FG002|OL|Poor compliance to protocol|1|||
124544158|NCT04411641|447946736|FG003|OL|Poor compliance to protocol|0|||
124544159|NCT04411641|447946733|FG000|OL|Adverse Event|0|||
124544160|NCT04411641|447946734|FG001|OL|Adverse Event|0|||
124544161|NCT04411641|447946735|FG002|OL|Adverse Event|1|||
124544162|NCT04411641|447946736|FG003|OL|Adverse Event|0|||
124544163|NCT04411641|447946733|FG000|OL|Other|0|||
124544164|NCT04411641|447946734|FG001|OL|Other|0|||
124544165|NCT04411641|447946735|FG002|OL|Other|0|||
124544166|NCT04411641|447946736|FG003|OL|Other|6|||
124544167|NCT01250418|447946744|FG000|Overall Study|monitor data failure|1|||
124544168|NCT01250418|447946745|FG001|Overall Study|monitor data failure|1|||
124544169|NCT01761565|447946746|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
124544170|NCT05182840|447946748|FG000|Run-in Period|Not treated|0|||
124544171|NCT05182840|447946749|FG001|Run-in Period|Not treated|1|||
124544172|NCT05182840|447946750|FG002|Run-in Period|Not treated|0|||
124544173|NCT05182840|447946751|FG003|Run-in Period|Not treated|0|||
124544174|NCT05182840|447946752|FG004|Run-in Period|Not treated|0|||
124758642|NCT01463306|448739822|FG002|Overall Study|Lost to Follow-up|0|||
124544175|NCT05182840|447946753|FG005|Run-in Period|Not treated|0|||
124544176|NCT05182840|447946754|FG006|Run-in Period|Not treated|0|||
124647577|NCT04569968|448327879|FG001|Overall Study|Insufficient mastication|0|||
124647578|NCT04569968|448327878|FG000|Overall Study|Infection|1|||
124647579|NCT04569968|448327879|FG001|Overall Study|Infection|0|||
124647580|NCT00727844|448327880|FG000|Initial Randomization|Physician Decision|2|||
124647581|NCT00727844|448327881|FG001|Initial Randomization|Physician Decision|0|||
124544177|NCT05182840|447946755|FG007|Run-in Period|Not treated|0|||
124544178|NCT05182840|447946756|FG008|Run-in Period|Not treated|0|||
124544179|NCT05182840|447946757|FG009|Run-in Period|Not treated|0|||
124544180|NCT05182840|447946748|FG000|Run-in Period|Other reason but not sponsor termination|14|||
124544181|NCT05182840|447946749|FG001|Run-in Period|Other reason but not sponsor termination|18|||
124544182|NCT05182840|447946750|FG002|Run-in Period|Other reason but not sponsor termination|0|||
124544183|NCT05182840|447946751|FG003|Run-in Period|Other reason but not sponsor termination|0|||
124544184|NCT05182840|447946752|FG004|Run-in Period|Other reason but not sponsor termination|0|||
124544185|NCT05182840|447946753|FG005|Run-in Period|Other reason but not sponsor termination|0|||
124647582|NCT00727844|448327882|FG002|Initial Randomization|Physician Decision|0|||
124544186|NCT05182840|447946754|FG006|Run-in Period|Other reason but not sponsor termination|0|||
124544187|NCT05182840|447946755|FG007|Run-in Period|Other reason but not sponsor termination|0|||
124544188|NCT05182840|447946756|FG008|Run-in Period|Other reason but not sponsor termination|0|||
124544189|NCT05182840|447946757|FG009|Run-in Period|Other reason but not sponsor termination|0|||
124544190|NCT05182840|447946748|FG000|Run-in Period|No reason available|2|||
124544191|NCT05182840|447946749|FG001|Run-in Period|No reason available|2|||
124544192|NCT05182840|447946750|FG002|Run-in Period|No reason available|0|||
124544193|NCT05182840|447946751|FG003|Run-in Period|No reason available|0|||
124647583|NCT00727844|448327883|FG003|Initial Randomization|Physician Decision|0|||
124544194|NCT05182840|447946752|FG004|Run-in Period|No reason available|0|||
124544195|NCT05182840|447946753|FG005|Run-in Period|No reason available|0|||
124872501|NCT00117676|449154126|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
124872502|NCT00117676|449154127|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
124544196|NCT05182840|447946754|FG006|Run-in Period|No reason available|0|||
124647584|NCT00373958|448327884|FG000|Infant Series|Withdrawal by Subject|13|||
124647585|NCT00373958|448327885|FG001|Infant Series|Withdrawal by Subject|15|||
124647586|NCT00373958|448327884|FG000|Infant Series|Failed to return|8|||
124647587|NCT00373958|448327885|FG001|Infant Series|Failed to return|13|||
124647588|NCT00373958|448327884|FG000|Infant Series|Lost to Follow-up|6|||
124647589|NCT00373958|448327885|FG001|Infant Series|Lost to Follow-up|5|||
124647590|NCT00373958|448327884|FG000|Infant Series|Protocol Violation|3|||
124647591|NCT00373958|448327885|FG001|Infant Series|Protocol Violation|7|||
124647592|NCT00373958|448327884|FG000|Infant Series|Lost Kaiser coverage|4|||
124647593|NCT00373958|448327885|FG001|Infant Series|Lost Kaiser coverage|0|||
124647594|NCT00373958|448327884|FG000|Infant Series|Child relocated|1|||
124647595|NCT00373958|448327885|FG001|Infant Series|Child relocated|0|||
124647596|NCT00373958|448327884|FG000|Infant Series|Consent was not received|1|||
124647597|NCT00373958|448327885|FG001|Infant Series|Consent was not received|0|||
124647598|NCT00373958|448327884|FG000|Infant Series|Adverse Event|3|||
124647599|NCT00373958|448327885|FG001|Infant Series|Adverse Event|1|||
124647600|NCT00373958|448327884|FG000|Infant Series|Physician Decision|1|||
124647601|NCT00373958|448327885|FG001|Infant Series|Physician Decision|1|||
124647602|NCT00373958|448327884|FG000|Toddler Dose|Lost to Follow-up|5|||
124647603|NCT00373958|448327885|FG001|Toddler Dose|Lost to Follow-up|8|||
124647604|NCT00373958|448327884|FG000|Toddler Dose|Withdrawal by Subject|2|||
124647605|NCT00373958|448327885|FG001|Toddler Dose|Withdrawal by Subject|2|||
124647606|NCT00373958|448327884|FG000|Toddler Dose|Failed to return|1|||
124647607|NCT00373958|448327885|FG001|Toddler Dose|Failed to return|2|||
124647608|NCT00373958|448327884|FG000|Toddler Dose|Protocol Violation|0|||
124647609|NCT00373958|448327885|FG001|Toddler Dose|Protocol Violation|1|||
124647610|NCT00373958|448327884|FG000|Toddler Dose|Withdrawn after infant series|22|||
124647611|NCT00373958|448327885|FG001|Toddler Dose|Withdrawn after infant series|25|||
124758643|NCT01463306|448739820|FG000|Overall Study|Protocol Violation|4|||
124647612|NCT05007041|448327886|FG000|Overall Study|Missing Diary Entries|0|||
124647613|NCT05007041|448327887|FG001|Overall Study|Missing Diary Entries|1|||
124647614|NCT01552915|448327888|FG000|Overall Study|Adverse Event|3|||
124647615|NCT01552915|448327889|FG001|Overall Study|Adverse Event|14|||
124647616|NCT01552915|448327890|FG002|Overall Study|Adverse Event|3|||
124647617|NCT01552915|448327888|FG000|Overall Study|Lost to Follow-up|4|||
124647618|NCT01552915|448327889|FG001|Overall Study|Lost to Follow-up|6|||
124544197|NCT05182840|447946755|FG007|Run-in Period|No reason available|0|||
124647619|NCT01552915|448327890|FG002|Overall Study|Lost to Follow-up|5|||
124647620|NCT01552915|448327888|FG000|Overall Study|Withdrawal by Subject|6|||
124647621|NCT01552915|448327889|FG001|Overall Study|Withdrawal by Subject|4|||
124647622|NCT01552915|448327890|FG002|Overall Study|Withdrawal by Subject|5|||
124647623|NCT01552915|448327888|FG000|Overall Study|Protocol Violation|0|||
124647624|NCT01552915|448327889|FG001|Overall Study|Protocol Violation|4|||
124647625|NCT01552915|448327890|FG002|Overall Study|Protocol Violation|4|||
124647626|NCT01552915|448327888|FG000|Overall Study|Lack of Efficacy|8|||
124647627|NCT01552915|448327889|FG001|Overall Study|Lack of Efficacy|1|||
124647628|NCT01552915|448327890|FG002|Overall Study|Lack of Efficacy|4|||
124647629|NCT01552915|448327888|FG000|Overall Study|Other|2|||
124647630|NCT01552915|448327889|FG001|Overall Study|Other|0|||
124647631|NCT01552915|448327890|FG002|Overall Study|Other|6|||
124647632|NCT02850016|448327893|FG000|Overall Study|Withdrawal by Subject|1|||
124647633|NCT02850016|448327894|FG001|Overall Study|Withdrawal by Subject|2|||
124647634|NCT02457832|448327895|FG000|Training|Lost to Follow-up|10|||
124647635|NCT02457832|448327896|FG001|Training|Lost to Follow-up|6|||
124647636|NCT02457832|448327897|FG002|Training|Lost to Follow-up|3|||
124647637|NCT02457832|448327895|FG000|One Month Washout|Lost to Follow-up|0|||
124647638|NCT02457832|448327896|FG001|One Month Washout|Lost to Follow-up|1|||
124647639|NCT02457832|448327897|FG002|One Month Washout|Lost to Follow-up|1|||
124647640|NCT00423189|448327898|FG000|Overall Study|Death|0|||
124647641|NCT00423189|448327899|FG001|Overall Study|Death|1|||
124647642|NCT00423189|448327900|FG002|Overall Study|Death|0|||
124647643|NCT03973918|448327905|FG000|Overall Study|Adverse Event|0|||
124647644|NCT03973918|448327906|FG001|Overall Study|Adverse Event|0|||
124647645|NCT03973918|448327907|FG002|Overall Study|Adverse Event|0|||
124647646|NCT03973918|448327908|FG003|Overall Study|Adverse Event|1|||
124647647|NCT03973918|448327905|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
124647648|NCT03973918|448327906|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
124647649|NCT03973918|448327907|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
124647650|NCT03973918|448327908|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
124647651|NCT02951533|448327912|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
124647652|NCT02951533|448327913|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
124647653|NCT02951533|448327914|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
124647654|NCT02951533|448327912|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
124647655|NCT02951533|448327913|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
124647656|NCT02951533|448327914|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
124647657|NCT02951533|448327912|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
124647658|NCT02951533|448327913|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
124647659|NCT02951533|448327914|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
124647660|NCT02951533|448327912|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
124647661|NCT02951533|448327913|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
124647662|NCT02951533|448327914|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
124647663|NCT02951533|448327912|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
124647664|NCT02951533|448327913|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
124647665|NCT02951533|448327914|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
124647666|NCT02951533|448327912|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
124647667|NCT02951533|448327913|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
124647668|NCT02951533|448327914|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
124647669|NCT02951533|448327912|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
124647670|NCT02951533|448327913|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
124647671|NCT02951533|448327914|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
124647672|NCT02951533|448327912|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
124647673|NCT02951533|448327913|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
124647674|NCT02951533|448327914|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
124647675|NCT02951533|448327912|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
124647676|NCT02951533|448327913|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
124647677|NCT02951533|448327914|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
124647678|NCT02951533|448327912|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
124647679|NCT02951533|448327913|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
124647680|NCT02951533|448327914|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
124647681|NCT02951533|448327912|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
124647682|NCT02951533|448327913|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
124647683|NCT02951533|448327914|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
124647684|NCT01446237|448327923|FG000|Overall Study|Adverse Event|1|||
124647685|NCT01446237|448327923|FG000|Overall Study|Lost to Follow-up|2|||
124647686|NCT01446237|448327923|FG000|Overall Study|Withdrawal by Subject|7|||
124647687|NCT00742508|448327926|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
124647688|NCT00742508|448327927|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
124647689|NCT00742508|448327926|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
124647690|NCT00742508|448327927|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
124711979|NCT00688467|448570699|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
124544198|NCT05182840|447946756|FG008|Run-in Period|No reason available|0|||
124544199|NCT05182840|447946757|FG009|Run-in Period|No reason available|0|||
124758644|NCT01463306|448739821|FG001|Overall Study|Protocol Violation|0|||
124647691|NCT00742508|448327926|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
124647692|NCT00742508|448327927|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
124647693|NCT00742508|448327926|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
124647694|NCT00742508|448327927|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
124647695|NCT00742508|448327926|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
124758645|NCT01463306|448739822|FG002|Overall Study|Protocol Violation|0|||
124647696|NCT00742508|448327927|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
124647697|NCT04017832|448327928|FG000|Overall Study|Withdrawal by Subject|13|||
124647698|NCT04017832|448327929|FG001|Overall Study|Withdrawal by Subject|12|||
124647699|NCT04017832|448327930|FG002|Overall Study|Withdrawal by Subject|21|||
124647700|NCT04017832|448327931|FG003|Overall Study|Withdrawal by Subject|7|||
124647701|NCT04017832|448327928|FG000|Overall Study|Lost to Follow-up|0|||
124647702|NCT04017832|448327929|FG001|Overall Study|Lost to Follow-up|3|||
124647703|NCT04017832|448327930|FG002|Overall Study|Lost to Follow-up|3|||
124647704|NCT04017832|448327931|FG003|Overall Study|Lost to Follow-up|1|||
124647705|NCT04017832|448327928|FG000|Overall Study|Physician Decision|1|||
124647706|NCT04017832|448327929|FG001|Overall Study|Physician Decision|1|||
124647707|NCT04017832|448327930|FG002|Overall Study|Physician Decision|1|||
124647708|NCT04017832|448327931|FG003|Overall Study|Physician Decision|1|||
124647709|NCT04017832|448327928|FG000|Overall Study|Death|2|||
124647710|NCT04017832|448327929|FG001|Overall Study|Death|2|||
124647711|NCT04017832|448327930|FG002|Overall Study|Death|1|||
124647712|NCT04017832|448327931|FG003|Overall Study|Death|0|||
124647713|NCT01901653|448327937|FG000|Overall Study|Death|2|||
124647714|NCT01901653|448327938|FG001|Overall Study|Death|1|||
124647715|NCT01901653|448327939|FG002|Overall Study|Death|8|||
124647716|NCT01901653|448327940|FG003|Overall Study|Death|3|||
124647717|NCT01901653|448327941|FG004|Overall Study|Death|2|||
124647718|NCT01901653|448327942|FG005|Overall Study|Death|2|||
124647719|NCT01901653|448327943|FG006|Overall Study|Death|6|||
124647720|NCT01901653|448327944|FG007|Overall Study|Death|9|||
124647721|NCT01901653|448327945|FG008|Overall Study|Death|1|||
124647722|NCT01901653|448327946|FG009|Overall Study|Death|16|||
124647723|NCT01901653|448327947|FG010|Overall Study|Death|2|||
124647724|NCT01901653|448327948|FG011|Overall Study|Death|15|||
124647725|NCT01901653|448327949|FG012|Overall Study|Death|4|||
124647726|NCT01901653|448327937|FG000|Overall Study|Lost to Follow-up|1|||
124647727|NCT01901653|448327938|FG001|Overall Study|Lost to Follow-up|0|||
124647728|NCT01901653|448327939|FG002|Overall Study|Lost to Follow-up|2|||
124647729|NCT01901653|448327940|FG003|Overall Study|Lost to Follow-up|0|||
124647730|NCT01901653|448327941|FG004|Overall Study|Lost to Follow-up|0|||
124647731|NCT01901653|448327942|FG005|Overall Study|Lost to Follow-up|1|||
124647732|NCT01901653|448327943|FG006|Overall Study|Lost to Follow-up|0|||
124872503|NCT00117676|449154126|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
124872504|NCT00117676|449154127|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
124872505|NCT00117676|449154126|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
124872506|NCT00117676|449154127|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
124872507|NCT00952822|449154128|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
124872508|NCT00952822|449154129|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
124872509|NCT00952822|449154130|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
124872510|NCT00952822|449154131|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
124872511|NCT00952822|449154128|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
124872512|NCT00952822|449154129|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
124872513|NCT00952822|449154130|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
124872514|NCT00952822|449154131|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
124872515|NCT04555096|449154135|FG000|Overall Study|Death|4|||
124872516|NCT04555096|449154136|FG001|Overall Study|Death|4|||
124872517|NCT04555096|449154135|FG000|Overall Study|Withdrawal by Subject|1|||
124872518|NCT04555096|449154136|FG001|Overall Study|Withdrawal by Subject|0|||
124872519|NCT04555096|449154135|FG000|Overall Study|Other|0|||
124872520|NCT04555096|449154136|FG001|Overall Study|Other|1|||
124872521|NCT01464021|449155651|FG000|Overall Study|Withdrawal by Subject|13|||
124872522|NCT01464021|449155651|FG000|Overall Study|Lost to Follow-up|1|||
124872523|NCT01464021|449155651|FG000|Overall Study|Lack of Efficacy|1|||
124872524|NCT01464021|449155651|FG000|Overall Study|various|11|||
124872525|NCT01106430|449155654|FG000|Overall Study|Adverse Event|8|||
124872526|NCT01106430|449155655|FG001|Overall Study|Adverse Event|10|||
124872527|NCT01106430|449155654|FG000|Overall Study|Lack of Efficacy|2|||
124872528|NCT01106430|449155655|FG001|Overall Study|Lack of Efficacy|13|||
124872529|NCT01106430|449155654|FG000|Overall Study|Lost to Follow-up|5|||
124872530|NCT01106430|449155655|FG001|Overall Study|Lost to Follow-up|1|||
124872531|NCT01106430|449155654|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
124872532|NCT01106430|449155655|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
124872533|NCT01106430|449155654|FG000|Overall Study|Moved Out Of State|0|||
124872534|NCT01106430|449155655|FG001|Overall Study|Moved Out Of State|1|||
124872535|NCT01106430|449155654|FG000|Overall Study|Refused To Take Medication|0|||
124872536|NCT01106430|449155655|FG001|Overall Study|Refused To Take Medication|1|||
124872537|NCT01106430|449155654|FG000|Overall Study|Noncompliance|0|||
124872538|NCT01106430|449155655|FG001|Overall Study|Noncompliance|1|||
124872539|NCT01106430|449155654|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
124872540|NCT01106430|449155655|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
124872541|NCT01106430|449155654|FG000|Overall Study|Previous Use Of Marijuana|1|||
124872542|NCT01106430|449155655|FG001|Overall Study|Previous Use Of Marijuana|0|||
124872543|NCT01106430|449155654|FG000|Overall Study|Protocol Violation|7|||
124872544|NCT01106430|449155655|FG001|Overall Study|Protocol Violation|2|||
124872545|NCT01106430|449155654|FG000|Overall Study|Withdrawal by Subject|8|||
124872546|NCT01106430|449155655|FG001|Overall Study|Withdrawal by Subject|4|||
124872547|NCT01424930|449155660|FG000|Overall Study|Adverse Event|0|||
124872548|NCT01424930|449155661|FG001|Overall Study|Adverse Event|1|||
124872549|NCT01424930|449155660|FG000|Overall Study|Death|1|||
124872550|NCT01424930|449155661|FG001|Overall Study|Death|0|||
124872551|NCT01424930|449155660|FG000|Overall Study|Progressive Disease|3|||
124872552|NCT01424930|449155661|FG001|Overall Study|Progressive Disease|6|||
124872553|NCT01424930|449155660|FG000|Overall Study|Screen Failure|0|||
124872554|NCT01424930|449155661|FG001|Overall Study|Screen Failure|1|||
124872555|NCT01424930|449155660|FG000|Overall Study|Reason not specified|0|||
124872556|NCT01424930|449155661|FG001|Overall Study|Reason not specified|6|||
124872557|NCT01078155|449155662|FG000|Overall Study|Adverse Event|7|||
124872558|NCT01078155|449155662|FG000|Overall Study|Lack of Efficacy|16|||
124872559|NCT01078155|449155662|FG000|Overall Study|Participant's Decision|6|||
124872560|NCT01078155|449155662|FG000|Overall Study|Lost to Follow-up|15|||
124872561|NCT03286751|449155663|FG000|Washout Period 1|Withdrawal by Subject|0|||
124872562|NCT03286751|449155664|FG001|Washout Period 1|Withdrawal by Subject|0|||
124872563|NCT03286751|449155665|FG002|Washout Period 1|Withdrawal by Subject|0|||
124872564|NCT03286751|449155666|FG003|Washout Period 1|Withdrawal by Subject|0|||
124647733|NCT01901653|448327944|FG007|Overall Study|Lost to Follow-up|1|||
124647734|NCT01901653|448327945|FG008|Overall Study|Lost to Follow-up|0|||
124872565|NCT03286751|449155667|FG004|Washout Period 1|Withdrawal by Subject|1|||
124872566|NCT03286751|449155668|FG005|Washout Period 1|Withdrawal by Subject|0|||
124872567|NCT03286751|449155663|FG000|Washout Period 2|Personal Reasons|0|||
124872568|NCT03286751|449155664|FG001|Washout Period 2|Personal Reasons|1|||
124647735|NCT01901653|448327946|FG009|Overall Study|Lost to Follow-up|0|||
124647736|NCT01901653|448327947|FG010|Overall Study|Lost to Follow-up|0|||
124647737|NCT01901653|448327948|FG011|Overall Study|Lost to Follow-up|0|||
124647738|NCT01901653|448327949|FG012|Overall Study|Lost to Follow-up|0|||
124647739|NCT01901653|448327937|FG000|Overall Study|Withdrawal by Subject|0|||
124647740|NCT01901653|448327938|FG001|Overall Study|Withdrawal by Subject|0|||
124647741|NCT01901653|448327939|FG002|Overall Study|Withdrawal by Subject|0|||
124647742|NCT01901653|448327940|FG003|Overall Study|Withdrawal by Subject|0|||
124647743|NCT01901653|448327941|FG004|Overall Study|Withdrawal by Subject|0|||
124647744|NCT01901653|448327942|FG005|Overall Study|Withdrawal by Subject|0|||
124647745|NCT01901653|448327943|FG006|Overall Study|Withdrawal by Subject|1|||
124647746|NCT01901653|448327944|FG007|Overall Study|Withdrawal by Subject|0|||
124647747|NCT01901653|448327945|FG008|Overall Study|Withdrawal by Subject|0|||
124647748|NCT01901653|448327946|FG009|Overall Study|Withdrawal by Subject|0|||
124647749|NCT01901653|448327947|FG010|Overall Study|Withdrawal by Subject|0|||
124647750|NCT01901653|448327948|FG011|Overall Study|Withdrawal by Subject|0|||
124647751|NCT01901653|448327949|FG012|Overall Study|Withdrawal by Subject|0|||
124647752|NCT01901653|448327937|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
124647753|NCT01901653|448327938|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
124647754|NCT01901653|448327939|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
124647755|NCT01901653|448327940|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
124647756|NCT01901653|448327941|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
124647757|NCT01901653|448327942|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
124647758|NCT01901653|448327943|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
124647759|NCT01901653|448327944|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
124647760|NCT01901653|448327945|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
124647761|NCT01901653|448327946|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
124647762|NCT01901653|448327947|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
124647763|NCT01901653|448327948|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
124647764|NCT01901653|448327949|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
124647765|NCT02091986|448327950|FG000|Overall Study|7 rand in error 1 patient decision|2|||
124647766|NCT02091986|448327951|FG001|Overall Study|7 rand in error 1 patient decision|3|||
124647767|NCT02091986|448327952|FG002|Overall Study|7 rand in error 1 patient decision|3|||
124647768|NCT02091986|448327950|FG000|Overall Study|Lost to Follow-up|1|||
124647769|NCT02091986|448327951|FG001|Overall Study|Lost to Follow-up|0|||
124647770|NCT02091986|448327952|FG002|Overall Study|Lost to Follow-up|0|||
124647771|NCT02091986|448327950|FG000|Overall Study|Withdrawal by Subject|4|||
124647772|NCT02091986|448327951|FG001|Overall Study|Withdrawal by Subject|8|||
124647773|NCT02091986|448327952|FG002|Overall Study|Withdrawal by Subject|3|||
124647774|NCT02091986|448327950|FG000|Overall Study|Adverse Event|0|||
124647775|NCT02091986|448327951|FG001|Overall Study|Adverse Event|0|||
124647776|NCT02091986|448327952|FG002|Overall Study|Adverse Event|2|||
124647777|NCT00957268|448327956|FG000|Overall Study|Voluntary Withdrawal|0|||
124647778|NCT00957268|448327957|FG001|Overall Study|Voluntary Withdrawal|0|||
124647779|NCT00957268|448327958|FG002|Overall Study|Voluntary Withdrawal|1|||
124647780|NCT00957268|448327959|FG003|Overall Study|Voluntary Withdrawal|0|||
124647781|NCT00957268|448327960|FG004|Overall Study|Voluntary Withdrawal|0|||
124647782|NCT00794040|448327961|FG000|Overall Study|Withdrawal by Subject|3|||
124647783|NCT00794040|448327962|FG001|Overall Study|Withdrawal by Subject|4|||
124647784|NCT00794040|448327961|FG000|Overall Study|Physician Decision|0|||
124647785|NCT00794040|448327962|FG001|Overall Study|Physician Decision|1|||
124647786|NCT02396420|448327963|FG000|Overall Study|Death|1|||
124647787|NCT01273623|448327964|FG000|Overall Study|did not meet IVUS criteria|29|||
124647788|NCT04064411|448327965|FG000|Overall Study|Adverse Event|29|||
124647789|NCT04064411|448327966|FG001|Overall Study|Adverse Event|19|||
124647790|NCT04064411|448327965|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
124647791|NCT04064411|448327966|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
124647792|NCT04064411|448327965|FG000|Overall Study|Protocol Deviation|0|||
124647793|NCT04064411|448327966|FG001|Overall Study|Protocol Deviation|2|||
124647794|NCT04064411|448327965|FG000|Overall Study|Withdrawal by Subject|25|||
124647795|NCT04064411|448327966|FG001|Overall Study|Withdrawal by Subject|29|||
124647796|NCT04064411|448327965|FG000|Overall Study|Lost to Follow-up|5|||
124647797|NCT04064411|448327966|FG001|Overall Study|Lost to Follow-up|2|||
124647798|NCT04064411|448327965|FG000|Overall Study|Other than Specified|4|||
124647799|NCT04064411|448327966|FG001|Overall Study|Other than Specified|1|||
124647800|NCT04064411|448327965|FG000|Overall Study|Death|1|||
124647801|NCT04064411|448327966|FG001|Overall Study|Death|0|||
124647802|NCT01970475|448327975|FG000|Overall Study|Withdrawal by Subject|11|||
124647803|NCT01970475|448327976|FG001|Overall Study|Withdrawal by Subject|6|||
124647804|NCT01970475|448327975|FG000|Overall Study|Adverse Event|7|||
124647805|NCT01970475|448327976|FG001|Overall Study|Adverse Event|3|||
124647806|NCT01970475|448327975|FG000|Overall Study|Lost to Follow-up|2|||
124647807|NCT01970475|448327976|FG001|Overall Study|Lost to Follow-up|2|||
124647808|NCT01970475|448327975|FG000|Overall Study|Protocol Violation|1|||
124647809|NCT01970475|448327976|FG001|Overall Study|Protocol Violation|0|||
124647810|NCT00860249|448329402|FG000|Overall Study|trial was terminated prior to completion|21|||
124647811|NCT00860249|448329403|FG001|Overall Study|trial was terminated prior to completion|18|||
124647812|NCT00860249|448329404|FG002|Overall Study|trial was terminated prior to completion|21|||
124647813|NCT01871402|448329406|FG000|Overall Study|Lost to Follow-up|1|||
124647814|NCT01871402|448329407|FG001|Overall Study|Lost to Follow-up|0|||
124647815|NCT01871402|448329406|FG000|Overall Study|Withdrawal by Subject|0|||
124647816|NCT01871402|448329407|FG001|Overall Study|Withdrawal by Subject|2|||
124647817|NCT01871402|448329406|FG000|Overall Study|Non-compliance|0|||
124647818|NCT01871402|448329407|FG001|Overall Study|Non-compliance|1|||
124647819|NCT05896527|448329410|FG000|Overall Study|Withdrawal by Subject|11|||
124647820|NCT05896527|448329411|FG001|Overall Study|Withdrawal by Subject|10|||
124647821|NCT05896527|448329412|FG002|Overall Study|Withdrawal by Subject|4|||
124647822|NCT05896527|448329413|FG003|Overall Study|Withdrawal by Subject|3|||
124647823|NCT05896527|448329414|FG004|Overall Study|Withdrawal by Subject|2|||
124647824|NCT05896527|448329410|FG000|Overall Study|Lost to Follow-up|0|||
124647825|NCT05896527|448329411|FG001|Overall Study|Lost to Follow-up|2|||
124647826|NCT05896527|448329412|FG002|Overall Study|Lost to Follow-up|2|||
124647827|NCT05896527|448329413|FG003|Overall Study|Lost to Follow-up|2|||
124647828|NCT05896527|448329414|FG004|Overall Study|Lost to Follow-up|1|||
124647829|NCT05896527|448329410|FG000|Overall Study|Significant protocol noncompliance|0|||
124647830|NCT05896527|448329411|FG001|Overall Study|Significant protocol noncompliance|1|||
124647831|NCT05896527|448329412|FG002|Overall Study|Significant protocol noncompliance|0|||
124647832|NCT05896527|448329413|FG003|Overall Study|Significant protocol noncompliance|0|||
124647833|NCT05896527|448329414|FG004|Overall Study|Significant protocol noncompliance|0|||
124647834|NCT05896527|448329410|FG000|Overall Study|Eligibility criteria not met|1|||
124647835|NCT05896527|448329411|FG001|Overall Study|Eligibility criteria not met|0|||
124647836|NCT05896527|448329412|FG002|Overall Study|Eligibility criteria not met|0|||
124647837|NCT05896527|448329413|FG003|Overall Study|Eligibility criteria not met|0|||
124647838|NCT05896527|448329414|FG004|Overall Study|Eligibility criteria not met|0|||
124647839|NCT05896527|448329410|FG000|Overall Study|Sponsor's decision|0|||
124647840|NCT05896527|448329411|FG001|Overall Study|Sponsor's decision|0|||
124647841|NCT05896527|448329412|FG002|Overall Study|Sponsor's decision|0|||
124647842|NCT05896527|448329413|FG003|Overall Study|Sponsor's decision|1|||
124647843|NCT05896527|448329414|FG004|Overall Study|Sponsor's decision|0|||
124647844|NCT05896527|448329410|FG000|Overall Study|Investigator's decision|0|||
124647845|NCT05896527|448329411|FG001|Overall Study|Investigator's decision|1|||
124647846|NCT05896527|448329412|FG002|Overall Study|Investigator's decision|0|||
124647847|NCT05896527|448329413|FG003|Overall Study|Investigator's decision|0|||
124647848|NCT05896527|448329414|FG004|Overall Study|Investigator's decision|0|||
124647849|NCT05896527|448329410|FG000|Overall Study|Pregnancy of his partner|0|||
124647850|NCT05896527|448329411|FG001|Overall Study|Pregnancy of his partner|0|||
124647851|NCT05896527|448329412|FG002|Overall Study|Pregnancy of his partner|0|||
124647852|NCT05896527|448329413|FG003|Overall Study|Pregnancy of his partner|1|||
124647853|NCT05896527|448329414|FG004|Overall Study|Pregnancy of his partner|0|||
124647854|NCT05139303|448329415|FG000|Overall Study|Lost to Follow-up|3|||
124647855|NCT05139303|448329416|FG001|Overall Study|Lost to Follow-up|0|||
124647856|NCT05139303|448329415|FG000|Overall Study|Adverse Event|1|||
124647857|NCT05139303|448329416|FG001|Overall Study|Adverse Event|0|||
124647858|NCT00738881|448329419|FG000|Overall Study|Withdrawal by Subject|0|||
124647859|NCT00738881|448329420|FG001|Overall Study|Withdrawal by Subject|2|||
124647860|NCT00759785|448329426|FG000|Overall Study|Participant sample not evaluable|11|||
124647861|NCT00759785|448329427|FG001|Overall Study|Participant sample not evaluable|2|||
124647862|NCT00759785|448329426|FG000|Overall Study|Participant sample lost|0|||
124647863|NCT00759785|448329427|FG001|Overall Study|Participant sample lost|1|||
124647864|NCT00759785|448329426|FG000|Overall Study|Protocol Violation|1|||
124647865|NCT00759785|448329427|FG001|Overall Study|Protocol Violation|0|||
124647866|NCT00759785|448329426|FG000|Overall Study|Physician Decision|0|||
124647867|NCT00759785|448329427|FG001|Overall Study|Physician Decision|1|||
124647868|NCT00759785|448329426|FG000|Overall Study|Withdrawal by Subject|0|||
124647869|NCT00759785|448329427|FG001|Overall Study|Withdrawal by Subject|1|||
124647870|NCT01646021|448329428|FG000|Overall Study|Death|77|||
124647871|NCT01646021|448329429|FG001|Overall Study|Death|83|||
124647872|NCT01646021|448329428|FG000|Overall Study|Study Terminated by Sponsor|50|||
124647873|NCT01646021|448329429|FG001|Overall Study|Study Terminated by Sponsor|41|||
124647874|NCT01646021|448329428|FG000|Overall Study|Lost to Follow-up|2|||
124647875|NCT01646021|448329429|FG001|Overall Study|Lost to Follow-up|2|||
124647876|NCT01646021|448329428|FG000|Overall Study|Withdrawal by Subject|10|||
124647877|NCT01646021|448329429|FG001|Overall Study|Withdrawal by Subject|15|||
124647878|NCT04712019|448329430|FG000|Overall Study|Withdrawal by Subject|2|||
124647879|NCT04712019|448329431|FG001|Overall Study|Withdrawal by Subject|2|||
124647880|NCT04712019|448329430|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
124647881|NCT04712019|448329431|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
124647882|NCT04521621|448329432|FG000|Overall Study|Death|17|||
124647883|NCT04521621|448329433|FG001|Overall Study|Death|8|||
124647884|NCT04521621|448329434|FG002|Overall Study|Death|8|||
124647885|NCT04521621|448329435|FG003|Overall Study|Death|5|||
124647886|NCT04521621|448329436|FG004|Overall Study|Death|2|||
124647887|NCT04521621|448329437|FG005|Overall Study|Death|7|||
124647888|NCT04521621|448329438|FG006|Overall Study|Death|0|||
124647889|NCT04521621|448329439|FG007|Overall Study|Death|0|||
124647890|NCT04521621|448329432|FG000|Overall Study|Study Terminated by Sponsor|4|||
124647891|NCT04521621|448329433|FG001|Overall Study|Study Terminated by Sponsor|6|||
124647892|NCT04521621|448329434|FG002|Overall Study|Study Terminated by Sponsor|8|||
124647893|NCT04521621|448329435|FG003|Overall Study|Study Terminated by Sponsor|0|||
124647894|NCT04521621|448329436|FG004|Overall Study|Study Terminated by Sponsor|1|||
124647895|NCT04521621|448329437|FG005|Overall Study|Study Terminated by Sponsor|7|||
124647896|NCT04521621|448329438|FG006|Overall Study|Study Terminated by Sponsor|0|||
124647897|NCT04521621|448329439|FG007|Overall Study|Study Terminated by Sponsor|0|||
124647898|NCT04521621|448329432|FG000|Overall Study|Withdrawal by Subject|0|||
124872569|NCT03286751|449155665|FG002|Washout Period 2|Personal Reasons|0|||
124647899|NCT04521621|448329433|FG001|Overall Study|Withdrawal by Subject|0|||
124647900|NCT04521621|448329434|FG002|Overall Study|Withdrawal by Subject|1|||
124647901|NCT04521621|448329435|FG003|Overall Study|Withdrawal by Subject|1|||
124647902|NCT04521621|448329436|FG004|Overall Study|Withdrawal by Subject|0|||
124647903|NCT04521621|448329437|FG005|Overall Study|Withdrawal by Subject|0|||
124647904|NCT04521621|448329438|FG006|Overall Study|Withdrawal by Subject|0|||
124647905|NCT04521621|448329439|FG007|Overall Study|Withdrawal by Subject|0|||
124647906|NCT04521621|448329432|FG000|Overall Study|Allocated in error without study intervention|1|||
124647907|NCT04521621|448329433|FG001|Overall Study|Allocated in error without study intervention|0|||
124647908|NCT04521621|448329434|FG002|Overall Study|Allocated in error without study intervention|0|||
124647909|NCT04521621|448329435|FG003|Overall Study|Allocated in error without study intervention|0|||
124647910|NCT04521621|448329436|FG004|Overall Study|Allocated in error without study intervention|0|||
124647911|NCT04521621|448329437|FG005|Overall Study|Allocated in error without study intervention|0|||
124647912|NCT04521621|448329438|FG006|Overall Study|Allocated in error without study intervention|0|||
124647913|NCT04521621|448329439|FG007|Overall Study|Allocated in error without study intervention|0|||
124647914|NCT01282164|448329445|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
124647915|NCT01282164|448329446|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
124647916|NCT01967706|448329454|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
124647917|NCT01967706|448329455|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
124647918|NCT01967706|448329456|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
124647919|NCT01967706|448329457|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
124647920|NCT02777970|448329460|FG000|Overall Study|Lost to Follow-up|0|||
124647921|NCT02777970|448329461|FG001|Overall Study|Lost to Follow-up|1|||
124647922|NCT02777970|448329462|FG002|Overall Study|Lost to Follow-up|0|||
124647923|NCT02777970|448329460|FG000|Overall Study|Protocol Violation|1|||
124647924|NCT02777970|448329461|FG001|Overall Study|Protocol Violation|0|||
124647925|NCT02777970|448329462|FG002|Overall Study|Protocol Violation|0|||
124647926|NCT05845567|448329463|FG000|Overall Study|Withdrawal by Subject|1|||
124647927|NCT02347891|448329464|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
124647928|NCT02347891|448329465|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
124647929|NCT02347891|448329464|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
124647930|NCT02347891|448329465|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
124647931|NCT02541669|448329466|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
124647932|NCT02541669|448329467|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
124647933|NCT02541669|448329468|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
124647934|NCT02541669|448329469|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
124647935|NCT02541669|448329470|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
124647936|NCT00725608|448329471|FG000|Overall Study|Lost to Follow-up|60|||
124647937|NCT00725608|448329471|FG000|Overall Study|Adverse Event|14|||
124647938|NCT00725608|448329471|FG000|Overall Study|Individual reasons|86|||
124647939|NCT00725608|448329471|FG000|Overall Study|Other|7|||
124647940|NCT03409107|448329472|FG000|Overall Study|Withdrawal by Subject|4|||
124544200|NCT05182840|447946748|FG000|Run-in Period|Burden of study procedures|2|||
124544201|NCT05182840|447946749|FG001|Run-in Period|Burden of study procedures|2|||
124544202|NCT05182840|447946750|FG002|Run-in Period|Burden of study procedures|0|||
124544203|NCT05182840|447946751|FG003|Run-in Period|Burden of study procedures|0|||
124544204|NCT05182840|447946752|FG004|Run-in Period|Burden of study procedures|0|||
124544205|NCT05182840|447946753|FG005|Run-in Period|Burden of study procedures|0|||
124544206|NCT05182840|447946754|FG006|Run-in Period|Burden of study procedures|0|||
124544207|NCT05182840|447946755|FG007|Run-in Period|Burden of study procedures|0|||
124544208|NCT05182840|447946756|FG008|Run-in Period|Burden of study procedures|0|||
124544209|NCT05182840|447946757|FG009|Run-in Period|Burden of study procedures|0|||
124647941|NCT03409107|448329473|FG001|Overall Study|Withdrawal by Subject|2|||
124647942|NCT03409107|448329472|FG000|Overall Study|Physician Decision|1|||
124647943|NCT03409107|448329473|FG001|Overall Study|Physician Decision|0|||
124647944|NCT03409107|448329472|FG000|Overall Study|Lost to Follow-up|7|||
124647945|NCT03409107|448329473|FG001|Overall Study|Lost to Follow-up|2|||
124647946|NCT03409107|448329472|FG000|Overall Study|Adverse Event|5|||
124647947|NCT03409107|448329473|FG001|Overall Study|Adverse Event|3|||
124647948|NCT01258075|448329491|FG000|Overall Study|Adverse Event|8|||
124647949|NCT01258075|448329492|FG001|Overall Study|Adverse Event|3|||
124647950|NCT01258075|448329491|FG000|Overall Study|Lost to Follow-up|11|||
124647951|NCT01258075|448329492|FG001|Overall Study|Lost to Follow-up|6|||
124647952|NCT01258075|448329491|FG000|Overall Study|Withdrawal by Subject|10|||
124647953|NCT01258075|448329492|FG001|Overall Study|Withdrawal by Subject|7|||
124647954|NCT01258075|448329491|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
124647955|NCT01258075|448329492|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
124647956|NCT01258075|448329491|FG000|Overall Study|Other|12|||
124647957|NCT01258075|448329492|FG001|Overall Study|Other|5|||
124647958|NCT01500213|448329493|FG000|Overall Study|Adverse Event|35|||
124647959|NCT01500213|448329494|FG001|Overall Study|Adverse Event|35|||
124647960|NCT01500213|448329493|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
124647961|NCT01500213|448329494|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
124647962|NCT01500213|448329493|FG000|Overall Study|Withdrawal by Subject|28|||
124647963|NCT01500213|448329494|FG001|Overall Study|Withdrawal by Subject|37|||
124647964|NCT01500213|448329493|FG000|Overall Study|Death|7|||
124647965|NCT01500213|448329494|FG001|Overall Study|Death|3|||
124647966|NCT01500213|448329493|FG000|Overall Study|Disease Progression|13|||
124647967|NCT01500213|448329494|FG001|Overall Study|Disease Progression|21|||
124647968|NCT01500213|448329493|FG000|Overall Study|Protocol Violation|19|||
124647969|NCT01500213|448329494|FG001|Overall Study|Protocol Violation|19|||
124647970|NCT01500213|448329493|FG000|Overall Study|Physician Decision|12|||
124647971|NCT01500213|448329494|FG001|Overall Study|Physician Decision|10|||
124647972|NCT01500213|448329493|FG000|Overall Study|Lack of Efficacy|9|||
124647973|NCT01500213|448329494|FG001|Overall Study|Lack of Efficacy|7|||
124647974|NCT01500213|448329493|FG000|Overall Study|Lost to Follow-up|3|||
124647975|NCT01500213|448329494|FG001|Overall Study|Lost to Follow-up|6|||
124647976|NCT01500213|448329493|FG000|Overall Study|Other Reasons|7|||
124647977|NCT01500213|448329494|FG001|Overall Study|Other Reasons|5|||
124647978|NCT03197870|448329499|FG000|Overall Study|Adverse Event|9|||
124647979|NCT03197870|448329500|FG001|Overall Study|Adverse Event|4|||
124647980|NCT03197870|448329501|FG002|Overall Study|Adverse Event|6|||
124647981|NCT03197870|448329499|FG000|Overall Study|Withdrawal by Subject|2|||
124647982|NCT03197870|448329500|FG001|Overall Study|Withdrawal by Subject|3|||
124647983|NCT03197870|448329501|FG002|Overall Study|Withdrawal by Subject|0|||
124647984|NCT03197870|448329499|FG000|Overall Study|Lost to Follow-up|2|||
124647985|NCT03197870|448329500|FG001|Overall Study|Lost to Follow-up|2|||
124647986|NCT03197870|448329501|FG002|Overall Study|Lost to Follow-up|0|||
124647987|NCT03197870|448329499|FG000|Overall Study|data not available|1|||
124647988|NCT03197870|448329500|FG001|Overall Study|data not available|1|||
124647989|NCT03197870|448329501|FG002|Overall Study|data not available|0|||
124647990|NCT01618019|448329503|FG000|Overall Study|Withdrawal by Subject|14|||
124647991|NCT01618019|448329504|FG001|Overall Study|Withdrawal by Subject|14|||
124647992|NCT05174949|448329505|FG000|Overall Study|Physician Decision|1|||
124647993|NCT05174949|448329506|FG001|Overall Study|Physician Decision|2|||
124647994|NCT05174949|448329507|FG002|Overall Study|Physician Decision|0|||
124647995|NCT05174949|448329508|FG003|Overall Study|Physician Decision|1|||
124647996|NCT05174949|448329509|FG004|Overall Study|Physician Decision|0|||
124647997|NCT05174949|448329510|FG005|Overall Study|Physician Decision|0|||
124647998|NCT05174949|448329505|FG000|Overall Study|Withdrawal by Subject|0|||
124647999|NCT05174949|448329506|FG001|Overall Study|Withdrawal by Subject|1|||
124648000|NCT05174949|448329507|FG002|Overall Study|Withdrawal by Subject|0|||
124648001|NCT05174949|448329508|FG003|Overall Study|Withdrawal by Subject|0|||
124648002|NCT05174949|448329509|FG004|Overall Study|Withdrawal by Subject|0|||
124648003|NCT05174949|448329510|FG005|Overall Study|Withdrawal by Subject|0|||
124648004|NCT05174949|448329505|FG000|Overall Study|Lost to Follow-up|0|||
124648005|NCT05174949|448329506|FG001|Overall Study|Lost to Follow-up|0|||
124648006|NCT05174949|448329507|FG002|Overall Study|Lost to Follow-up|0|||
124648007|NCT05174949|448329508|FG003|Overall Study|Lost to Follow-up|1|||
124648008|NCT05174949|448329509|FG004|Overall Study|Lost to Follow-up|0|||
124648009|NCT05174949|448329510|FG005|Overall Study|Lost to Follow-up|0|||
124648010|NCT02880865|448329511|FG000|Overall Study|Adverse Event|1|||
124648011|NCT02880865|448329512|FG001|Overall Study|Adverse Event|0|||
124648012|NCT02880865|448329511|FG000|Overall Study|Withdrawal by Subject|0|||
124648013|NCT02880865|448329512|FG001|Overall Study|Withdrawal by Subject|2|||
124648014|NCT02880865|448329511|FG000|Overall Study|Physician Decision|0|||
124648015|NCT02880865|448329512|FG001|Overall Study|Physician Decision|1|||
124648016|NCT01597375|448329515|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
124648017|NCT01597375|448329516|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
124648018|NCT01597375|448329515|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
124648019|NCT01597375|448329516|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
124648020|NCT01597375|448329515|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
124648021|NCT01597375|448329516|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
124648022|NCT01597375|448329515|FG000|Washout (2 Weeks)|Adverse Event|1|||
124648023|NCT01597375|448329516|FG001|Washout (2 Weeks)|Adverse Event|0|||
124648024|NCT01597375|448329515|FG000|Second Intervention|Failed to react at both Aspirin|1|||
124648025|NCT01597375|448329516|FG001|Second Intervention|Failed to react at both Aspirin|1|||
124648026|NCT04696354|448329517|FG000|Overall Study|Study termination|6|||
124648027|NCT04696354|448329518|FG001|Overall Study|Study termination|6|||
124648028|NCT05238025|448329519|FG000|Overall Study|Adverse Event|2|||
124648029|NCT05238025|448329520|FG001|Overall Study|Adverse Event|2|||
124648030|NCT05238025|448329519|FG000|Overall Study|Lost to Follow-up|334|||
124648031|NCT05238025|448329520|FG001|Overall Study|Lost to Follow-up|339|||
124648032|NCT05238025|448329519|FG000|Overall Study|Withdrawal by Subject|203|||
124648033|NCT05238025|448329520|FG001|Overall Study|Withdrawal by Subject|222|||
124648034|NCT05238025|448329519|FG000|Overall Study|Physician Decision|20|||
124648035|NCT05238025|448329520|FG001|Overall Study|Physician Decision|8|||
124648036|NCT05238025|448329519|FG000|Overall Study|Protocol Violation|6|||
124648037|NCT05238025|448329520|FG001|Overall Study|Protocol Violation|2|||
124648038|NCT05238025|448329519|FG000|Overall Study|Death|38|||
124648039|NCT05238025|448329520|FG001|Overall Study|Death|32|||
124648040|NCT05238025|448329519|FG000|Overall Study|Study terminated by Sponsor|6358|||
124648041|NCT05238025|448329520|FG001|Overall Study|Study terminated by Sponsor|6358|||
124648042|NCT05238025|448329519|FG000|Overall Study|Other Reason|669|||
124648043|NCT05238025|448329520|FG001|Overall Study|Other Reason|690|||
124648044|NCT03814720|448329522|FG000|Overall Study|Lost to Follow-up|0|||
124648045|NCT03814720|448329523|FG001|Overall Study|Lost to Follow-up|1|||
124648046|NCT03814720|448329524|FG002|Overall Study|Lost to Follow-up|0|||
124648047|NCT03814720|448329525|FG003|Overall Study|Lost to Follow-up|0|||
124648048|NCT03814720|448329526|FG004|Overall Study|Lost to Follow-up|0|||
124648049|NCT03197324|448329527|FG000|Overall Study|Adverse Event|0|||
124648050|NCT03197324|448329528|FG001|Overall Study|Adverse Event|1|||
124648051|NCT00965341|448329529|FG000|Overall Study|Withdrew consent|1|||
124648052|NCT00965341|448329530|FG001|Overall Study|Withdrew consent|5|||
124648053|NCT00965341|448329529|FG000|Overall Study|Lost to Follow-up|1|||
124648054|NCT00965341|448329530|FG001|Overall Study|Lost to Follow-up|0|||
124648055|NCT00965341|448329529|FG000|Overall Study|Transportation issues|4|||
124648056|NCT00965341|448329530|FG001|Overall Study|Transportation issues|3|||
124648057|NCT03057054|448329536|FG000|Overall Study|Death|4|||
124648058|NCT03057054|448329537|FG001|Overall Study|Death|4|||
124648059|NCT03057054|448329536|FG000|Overall Study|Withdrawal by Subject|6|||
124648060|NCT03057054|448329537|FG001|Overall Study|Withdrawal by Subject|3|||
124648061|NCT03057054|448329536|FG000|Overall Study|Ineligible|1|||
124648062|NCT03057054|448329537|FG001|Overall Study|Ineligible|1|||
124648063|NCT00960986|448329538|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
124648064|NCT00960986|448329539|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
124648065|NCT00960986|448329540|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
124648066|NCT00960986|448329541|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
124648067|NCT00960986|448329538|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
124648068|NCT00960986|448329539|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
124648069|NCT00960986|448329540|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
124648070|NCT00960986|448329541|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
124648071|NCT00960986|448329538|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
124648072|NCT00960986|448329539|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
124648073|NCT00960986|448329540|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
124648074|NCT00960986|448329541|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
124648075|NCT00960986|448329538|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
124648076|NCT00960986|448329539|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
124648077|NCT00960986|448329540|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
124648078|NCT00960986|448329541|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
124648079|NCT00960986|448329538|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
124648080|NCT00960986|448329539|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
124648081|NCT00960986|448329540|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
124648082|NCT00960986|448329541|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
124648083|NCT00960986|448329538|FG000|Period 3 (7-week Therapy Period)|Death|0|||
124648084|NCT00960986|448329539|FG001|Period 3 (7-week Therapy Period)|Death|0|||
124648085|NCT00960986|448329540|FG002|Period 3 (7-week Therapy Period)|Death|1|||
124648086|NCT00960986|448329541|FG003|Period 3 (7-week Therapy Period)|Death|0|||
124648087|NCT00960986|448329538|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
124648088|NCT00960986|448329539|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
124648089|NCT00960986|448329540|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
124648090|NCT00960986|448329541|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
124648091|NCT00960986|448329538|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
124648092|NCT00960986|448329539|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
124648093|NCT00960986|448329540|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
124648094|NCT00960986|448329541|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
124648095|NCT00960986|448329538|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
124648096|NCT00960986|448329539|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
124648097|NCT00960986|448329540|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
124648098|NCT00960986|448329541|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
124648099|NCT00960986|448329538|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
124648100|NCT00960986|448329539|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
124648101|NCT00960986|448329540|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
124648102|NCT00960986|448329541|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
124544210|NCT05182840|447946748|FG000|Run-in Period|Change of residence|1|||
124544211|NCT05182840|447946749|FG001|Run-in Period|Change of residence|0|||
124544212|NCT05182840|447946750|FG002|Run-in Period|Change of residence|0|||
124544213|NCT05182840|447946751|FG003|Run-in Period|Change of residence|0|||
124544214|NCT05182840|447946752|FG004|Run-in Period|Change of residence|0|||
124544215|NCT05182840|447946753|FG005|Run-in Period|Change of residence|0|||
124544216|NCT05182840|447946754|FG006|Run-in Period|Change of residence|0|||
124544217|NCT05182840|447946755|FG007|Run-in Period|Change of residence|0|||
124544218|NCT05182840|447946756|FG008|Run-in Period|Change of residence|0|||
124544219|NCT05182840|447946757|FG009|Run-in Period|Change of residence|0|||
124544220|NCT05182840|447946748|FG000|Run-in Period|Adverse Event|5|||
124544221|NCT05182840|447946749|FG001|Run-in Period|Adverse Event|5|||
124544222|NCT05182840|447946750|FG002|Run-in Period|Adverse Event|0|||
124544223|NCT05182840|447946751|FG003|Run-in Period|Adverse Event|0|||
124544224|NCT05182840|447946752|FG004|Run-in Period|Adverse Event|0|||
124544225|NCT05182840|447946753|FG005|Run-in Period|Adverse Event|0|||
124544226|NCT05182840|447946754|FG006|Run-in Period|Adverse Event|0|||
124544227|NCT05182840|447946755|FG007|Run-in Period|Adverse Event|0|||
124544228|NCT05182840|447946756|FG008|Run-in Period|Adverse Event|0|||
124544229|NCT05182840|447946757|FG009|Run-in Period|Adverse Event|0|||
124648103|NCT01077739|448329542|FG000|Overall Study|Premature withdrawal|1|||
124648104|NCT01077739|448329543|FG001|Overall Study|Premature withdrawal|3|||
124648105|NCT01077739|448329542|FG000|Overall Study|Withdrawal by Subject|1|||
124648106|NCT01077739|448329543|FG001|Overall Study|Withdrawal by Subject|0|||
124648107|NCT01077739|448329542|FG000|Overall Study|Death|0|||
124648108|NCT01077739|448329543|FG001|Overall Study|Death|3|||
124648109|NCT01077739|448329542|FG000|Overall Study|Unacceptable toxicity|1|||
124648110|NCT01077739|448329543|FG001|Overall Study|Unacceptable toxicity|2|||
124648111|NCT01077739|448329542|FG000|Overall Study|Other|2|||
124648112|NCT01077739|448329543|FG001|Overall Study|Other|2|||
124648113|NCT00877071|448329544|FG000|Overall Study|disease progression|2|||
124648114|NCT01984892|448329545|FG000|Overall Study|Progressive disease|7|||
124648115|NCT04464720|448329546|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
124648116|NCT05723328|448329552|FG000|Overall Study|Investigator's Decision|5|||
124648117|NCT05723328|448329553|FG001|Overall Study|Investigator's Decision|2|||
124648118|NCT00954512|448329556|FG000|Overall Study|Withdrawal by Subject|0|||
124648119|NCT00954512|448329557|FG001|Overall Study|Withdrawal by Subject|0|||
124648120|NCT00954512|448329558|FG002|Overall Study|Withdrawal by Subject|0|||
124648121|NCT00954512|448329559|FG003|Overall Study|Withdrawal by Subject|0|||
124648122|NCT00954512|448329560|FG004|Overall Study|Withdrawal by Subject|0|||
124648123|NCT00954512|448329561|FG005|Overall Study|Withdrawal by Subject|1|||
124648124|NCT00954512|448329556|FG000|Overall Study|Adverse Event|0|||
124648125|NCT00954512|448329557|FG001|Overall Study|Adverse Event|0|||
124648126|NCT00954512|448329558|FG002|Overall Study|Adverse Event|0|||
124648127|NCT00954512|448329559|FG003|Overall Study|Adverse Event|0|||
124648128|NCT00954512|448329560|FG004|Overall Study|Adverse Event|1|||
124648129|NCT00954512|448329561|FG005|Overall Study|Adverse Event|2|||
124648130|NCT00954512|448329556|FG000|Overall Study|Physician Decision|0|||
124648131|NCT00954512|448329557|FG001|Overall Study|Physician Decision|1|||
124648132|NCT00954512|448329558|FG002|Overall Study|Physician Decision|0|||
124648133|NCT00954512|448329559|FG003|Overall Study|Physician Decision|1|||
124648134|NCT00954512|448329560|FG004|Overall Study|Physician Decision|0|||
124648135|NCT00954512|448329561|FG005|Overall Study|Physician Decision|0|||
124648136|NCT00954512|448329556|FG000|Overall Study|Symptomatic Deterioration|0|||
124648137|NCT00954512|448329557|FG001|Overall Study|Symptomatic Deterioration|1|||
124648138|NCT00954512|448329558|FG002|Overall Study|Symptomatic Deterioration|0|||
124648139|NCT00954512|448329559|FG003|Overall Study|Symptomatic Deterioration|0|||
124648140|NCT00954512|448329560|FG004|Overall Study|Symptomatic Deterioration|2|||
124648141|NCT00954512|448329561|FG005|Overall Study|Symptomatic Deterioration|0|||
124648142|NCT00954512|448329556|FG000|Overall Study|Progression of Disease|2|||
124648143|NCT00954512|448329557|FG001|Overall Study|Progression of Disease|1|||
124648144|NCT00954512|448329558|FG002|Overall Study|Progression of Disease|0|||
124648145|NCT00954512|448329559|FG003|Overall Study|Progression of Disease|1|||
124648146|NCT00954512|448329560|FG004|Overall Study|Progression of Disease|1|||
124648147|NCT00954512|448329561|FG005|Overall Study|Progression of Disease|1|||
124648148|NCT01794793|448329563|FG000|Treatment Period|Withdrawal by Subject|24|||
124648149|NCT01794793|448329563|FG000|Treatment Period|Lack of Efficacy|22|||
124648150|NCT01794793|448329563|FG000|Treatment Period|Adverse Event|17|||
124648151|NCT01794793|448329563|FG000|Treatment Period|Physician Decision|14|||
124648152|NCT01794793|448329563|FG000|Treatment Period|Lost to Follow-up|7|||
124648153|NCT01794793|448329563|FG000|Treatment Period|Death|6|||
124648154|NCT01794793|448329563|FG000|Treatment Period|Protocol Violation|5|||
124648155|NCT01794793|448329563|FG000|Treatment Period|administrative problem|3|||
124648156|NCT01794793|448329563|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
124648157|NCT01794793|448329563|FG000|Post-treatment Follow-up|Adverse Event|8|||
124648158|NCT01794793|448329563|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
124648159|NCT01794793|448329563|FG000|Post-treatment Follow-up|administrative problem|5|||
124648160|NCT01794793|448329563|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
124648161|NCT01794793|448329563|FG000|Post-treatment Follow-up|Protocol Violation|3|||
124648162|NCT03495154|448329564|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
124648163|NCT03495154|448329564|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
124648164|NCT03495154|448329564|FG000|Overall Study|Screen Failures During Surgery|6|||
124648165|NCT03495154|448329564|FG000|Overall Study|Death|2|||
124648166|NCT03495154|448329564|FG000|Overall Study|Lost to Follow-up|16|||
124648167|NCT03495154|448329564|FG000|Overall Study|Withdrawal by Subject|2|||
124648168|NCT03495154|448329564|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
124648169|NCT05685732|448329565|FG000|Overall Study|Withdrawal by Subject|2|||
124648170|NCT05685732|448329566|FG001|Overall Study|Withdrawal by Subject|0|||
124648171|NCT05685732|448329567|FG002|Overall Study|Withdrawal by Subject|2|||
124648172|NCT05685732|448329568|FG003|Overall Study|Withdrawal by Subject|3|||
124648173|NCT05685732|448329565|FG000|Overall Study|Protocol Violation|1|||
124648174|NCT05685732|448329566|FG001|Overall Study|Protocol Violation|2|||
124648175|NCT05685732|448329567|FG002|Overall Study|Protocol Violation|4|||
124648176|NCT05685732|448329568|FG003|Overall Study|Protocol Violation|1|||
124648177|NCT05685732|448329565|FG000|Overall Study|Lost to Follow-up|5|||
124648178|NCT05685732|448329566|FG001|Overall Study|Lost to Follow-up|1|||
124648179|NCT05685732|448329567|FG002|Overall Study|Lost to Follow-up|3|||
124648180|NCT05685732|448329568|FG003|Overall Study|Lost to Follow-up|1|||
124648181|NCT05685732|448329565|FG000|Overall Study|Adverse Event|2|||
124648182|NCT05685732|448329566|FG001|Overall Study|Adverse Event|1|||
124648183|NCT05685732|448329567|FG002|Overall Study|Adverse Event|0|||
124648184|NCT05685732|448329568|FG003|Overall Study|Adverse Event|0|||
124648185|NCT05685732|448329565|FG000|Overall Study|Physician Decision|1|||
124648186|NCT05685732|448329566|FG001|Overall Study|Physician Decision|0|||
124648187|NCT05685732|448329567|FG002|Overall Study|Physician Decision|0|||
124648188|NCT05685732|448329568|FG003|Overall Study|Physician Decision|0|||
124648189|NCT02640404|448329569|FG000|Overall Study|Protocol Violation|1|||
124648190|NCT02640404|448329570|FG001|Overall Study|Protocol Violation|0|||
124648191|NCT02640404|448329569|FG000|Overall Study|Withdrawal by Subject|1|||
124648192|NCT02640404|448329570|FG001|Overall Study|Withdrawal by Subject|0|||
124648193|NCT05397171|448329571|FG000|Overall Study|Death|2|||
124648194|NCT05397171|448329572|FG001|Overall Study|Death|3|||
124648195|NCT05397171|448329573|FG002|Overall Study|Death|3|||
124648196|NCT05397171|448329571|FG000|Overall Study|Study Terminated By Sponsor|1|||
124648197|NCT05397171|448329572|FG001|Overall Study|Study Terminated By Sponsor|2|||
124648198|NCT05397171|448329573|FG002|Overall Study|Study Terminated By Sponsor|3|||
124648199|NCT05397171|448329571|FG000|Overall Study|Withdrawal by Subject|0|||
124648200|NCT05397171|448329572|FG001|Overall Study|Withdrawal by Subject|1|||
124648201|NCT05397171|448329573|FG002|Overall Study|Withdrawal by Subject|1|||
124648202|NCT02234596|448329574|FG000|Overall Study|Participant not treated|2|||
124648203|NCT06366087|448331437|FG000|Overall Study|Withdrawal by Subject|0|||
124648204|NCT06366087|448331438|FG001|Overall Study|Withdrawal by Subject|1|||
124648205|NCT01944670|448331440|FG000|Overall Study|Lost to Follow-up|2|||
124648206|NCT00743288|448331441|FG000|Overall Study|Adverse Event|1|||
124648207|NCT00743288|448331442|FG001|Overall Study|Adverse Event|1|||
124648208|NCT00743288|448331443|FG002|Overall Study|Adverse Event|2|||
124648209|NCT00743288|448331444|FG003|Overall Study|Adverse Event|2|||
124648210|NCT00743288|448331445|FG004|Overall Study|Adverse Event|1|||
124648211|NCT00743288|448331446|FG005|Overall Study|Adverse Event|1|||
124648212|NCT00743288|448331447|FG006|Overall Study|Adverse Event|2|||
124648213|NCT00743288|448331441|FG000|Overall Study|Withdrawal by Subject|0|||
124648214|NCT00743288|448331442|FG001|Overall Study|Withdrawal by Subject|0|||
124648215|NCT00743288|448331443|FG002|Overall Study|Withdrawal by Subject|1|||
124648216|NCT00743288|448331444|FG003|Overall Study|Withdrawal by Subject|0|||
124648217|NCT00743288|448331445|FG004|Overall Study|Withdrawal by Subject|0|||
124648218|NCT00743288|448331446|FG005|Overall Study|Withdrawal by Subject|1|||
124648219|NCT00743288|448331447|FG006|Overall Study|Withdrawal by Subject|1|||
124648220|NCT00743288|448331441|FG000|Overall Study|Progressive disease (PD)|2|||
124648221|NCT00743288|448331442|FG001|Overall Study|Progressive disease (PD)|0|||
124648222|NCT00743288|448331443|FG002|Overall Study|Progressive disease (PD)|1|||
124648223|NCT00743288|448331444|FG003|Overall Study|Progressive disease (PD)|4|||
124648224|NCT00743288|448331445|FG004|Overall Study|Progressive disease (PD)|5|||
124648225|NCT00743288|448331446|FG005|Overall Study|Progressive disease (PD)|3|||
124648226|NCT00743288|448331447|FG006|Overall Study|Progressive disease (PD)|6|||
124648227|NCT00743288|448331441|FG000|Overall Study|Worsening of condition (Not PD)|0|||
124648228|NCT00743288|448331442|FG001|Overall Study|Worsening of condition (Not PD)|2|||
124648229|NCT00743288|448331443|FG002|Overall Study|Worsening of condition (Not PD)|1|||
124648230|NCT00743288|448331444|FG003|Overall Study|Worsening of condition (Not PD)|1|||
124648231|NCT00743288|448331445|FG004|Overall Study|Worsening of condition (Not PD)|0|||
124648232|NCT00743288|448331446|FG005|Overall Study|Worsening of condition (Not PD)|0|||
124648233|NCT00743288|448331447|FG006|Overall Study|Worsening of condition (Not PD)|0|||
124648234|NCT05903924|448331448|FG000|Overall Study|Lost to Follow-up|1|||
124648235|NCT05903924|448331449|FG001|Overall Study|Lost to Follow-up|0|||
124648236|NCT05903924|448331450|FG002|Overall Study|Lost to Follow-up|0|||
124648237|NCT04338269|448331451|FG000|Overall Study|Death|86|||
124648238|NCT04338269|448331452|FG001|Overall Study|Death|89|||
124648239|NCT04338269|448331451|FG000|Overall Study|Lost to Follow-up|1|||
124648240|NCT04338269|448331452|FG001|Overall Study|Lost to Follow-up|2|||
124648241|NCT04338269|448331451|FG000|Overall Study|Physician Decision|1|||
124648242|NCT04338269|448331452|FG001|Overall Study|Physician Decision|0|||
124648243|NCT04338269|448331451|FG000|Overall Study|Withdrawal by Subject|14|||
124648244|NCT04338269|448331452|FG001|Overall Study|Withdrawal by Subject|11|||
124648245|NCT00174967|448331453|FG000|Overall Study|Adverse Event|1|||
124648246|NCT00174967|448331454|FG001|Overall Study|Adverse Event|2|||
124648247|NCT00174967|448331455|FG002|Overall Study|Adverse Event|2|||
124648248|NCT00174967|448331456|FG003|Overall Study|Adverse Event|1|||
124648249|NCT00174967|448331453|FG000|Overall Study|Gout Flare|0|||
124648250|NCT00174967|448331454|FG001|Overall Study|Gout Flare|0|||
124648251|NCT00174967|448331455|FG002|Overall Study|Gout Flare|0|||
124648252|NCT00174967|448331456|FG003|Overall Study|Gout Flare|1|||
124648253|NCT00174967|448331453|FG000|Overall Study|Other|0|||
124648254|NCT00174967|448331454|FG001|Overall Study|Other|1|||
124648255|NCT00174967|448331455|FG002|Overall Study|Other|0|||
124648256|NCT00174967|448331456|FG003|Overall Study|Other|0|||
124648257|NCT02031640|448331457|FG000|Screening Period|Adverse Event|1|||
124648258|NCT02031640|448331458|FG001|Screening Period|Adverse Event|0|||
124648259|NCT02031640|448331459|FG002|Screening Period|Adverse Event|0|||
124648260|NCT02031640|448331460|FG003|Screening Period|Adverse Event|0|||
124648261|NCT02031640|448331461|FG004|Screening Period|Adverse Event|0|||
124648262|NCT02031640|448331462|FG005|Screening Period|Adverse Event|0|||
124648263|NCT02031640|448331457|FG000|Screening Period|Withdrawal by Subject|29|||
124648264|NCT02031640|448331458|FG001|Screening Period|Withdrawal by Subject|0|||
124648265|NCT02031640|448331459|FG002|Screening Period|Withdrawal by Subject|0|||
124648266|NCT02031640|448331460|FG003|Screening Period|Withdrawal by Subject|0|||
124648267|NCT02031640|448331461|FG004|Screening Period|Withdrawal by Subject|0|||
124648268|NCT02031640|448331462|FG005|Screening Period|Withdrawal by Subject|0|||
124648269|NCT02031640|448331457|FG000|Screening Period|Inclusion criteria not met|312|||
124648270|NCT02031640|448331458|FG001|Screening Period|Inclusion criteria not met|0|||
124648271|NCT02031640|448331459|FG002|Screening Period|Inclusion criteria not met|0|||
124648272|NCT02031640|448331460|FG003|Screening Period|Inclusion criteria not met|0|||
124648273|NCT02031640|448331461|FG004|Screening Period|Inclusion criteria not met|0|||
124648274|NCT02031640|448331462|FG005|Screening Period|Inclusion criteria not met|0|||
124648275|NCT02031640|448331457|FG000|Screening Period|Exclusion criteria met|30|||
124648276|NCT02031640|448331458|FG001|Screening Period|Exclusion criteria met|0|||
124648277|NCT02031640|448331459|FG002|Screening Period|Exclusion criteria met|0|||
124648278|NCT02031640|448331460|FG003|Screening Period|Exclusion criteria met|0|||
124648279|NCT02031640|448331461|FG004|Screening Period|Exclusion criteria met|0|||
124648280|NCT02031640|448331462|FG005|Screening Period|Exclusion criteria met|0|||
124648281|NCT02031640|448331457|FG000|Screening Period|Lost to Follow-up|14|||
124648282|NCT02031640|448331458|FG001|Screening Period|Lost to Follow-up|0|||
124648283|NCT02031640|448331459|FG002|Screening Period|Lost to Follow-up|0|||
124648284|NCT02031640|448331460|FG003|Screening Period|Lost to Follow-up|0|||
124648285|NCT02031640|448331461|FG004|Screening Period|Lost to Follow-up|0|||
124648286|NCT02031640|448331462|FG005|Screening Period|Lost to Follow-up|0|||
124648287|NCT02031640|448331457|FG000|Screening Period|Enrollment closed|26|||
124648288|NCT02031640|448331458|FG001|Screening Period|Enrollment closed|0|||
124648289|NCT02031640|448331459|FG002|Screening Period|Enrollment closed|0|||
124648290|NCT02031640|448331460|FG003|Screening Period|Enrollment closed|0|||
124648291|NCT02031640|448331461|FG004|Screening Period|Enrollment closed|0|||
124648292|NCT02031640|448331462|FG005|Screening Period|Enrollment closed|0|||
124648293|NCT02031640|448331457|FG000|Run-In Period|Adverse Event|4|||
124648294|NCT02031640|448331458|FG001|Run-In Period|Adverse Event|0|||
124648295|NCT02031640|448331459|FG002|Run-In Period|Adverse Event|0|||
124648296|NCT02031640|448331460|FG003|Run-In Period|Adverse Event|0|||
124648297|NCT02031640|448331461|FG004|Run-In Period|Adverse Event|0|||
124648298|NCT02031640|448331462|FG005|Run-In Period|Adverse Event|0|||
124648299|NCT02031640|448331457|FG000|Run-In Period|Withdrawal by Subject|17|||
124648300|NCT02031640|448331458|FG001|Run-In Period|Withdrawal by Subject|0|||
124648301|NCT02031640|448331459|FG002|Run-In Period|Withdrawal by Subject|0|||
124648302|NCT02031640|448331460|FG003|Run-In Period|Withdrawal by Subject|0|||
124648303|NCT02031640|448331461|FG004|Run-In Period|Withdrawal by Subject|0|||
124648304|NCT02031640|448331462|FG005|Run-In Period|Withdrawal by Subject|0|||
124648305|NCT02031640|448331457|FG000|Run-In Period|Inclusion criteria not met|38|||
124648306|NCT02031640|448331458|FG001|Run-In Period|Inclusion criteria not met|0|||
124648307|NCT02031640|448331459|FG002|Run-In Period|Inclusion criteria not met|0|||
124648308|NCT02031640|448331460|FG003|Run-In Period|Inclusion criteria not met|0|||
124648309|NCT02031640|448331461|FG004|Run-In Period|Inclusion criteria not met|0|||
124648310|NCT02031640|448331462|FG005|Run-In Period|Inclusion criteria not met|0|||
124648311|NCT02031640|448331457|FG000|Run-In Period|Exclusion criteria met|8|||
124648312|NCT02031640|448331458|FG001|Run-In Period|Exclusion criteria met|0|||
124648313|NCT02031640|448331459|FG002|Run-In Period|Exclusion criteria met|0|||
124648314|NCT02031640|448331460|FG003|Run-In Period|Exclusion criteria met|0|||
124648315|NCT02031640|448331461|FG004|Run-In Period|Exclusion criteria met|0|||
124648316|NCT02031640|448331462|FG005|Run-In Period|Exclusion criteria met|0|||
124648317|NCT02031640|448331457|FG000|Run-In Period|Randomization criteria not met|85|||
124648318|NCT02031640|448331458|FG001|Run-In Period|Randomization criteria not met|0|||
124648319|NCT02031640|448331459|FG002|Run-In Period|Randomization criteria not met|0|||
124648320|NCT02031640|448331460|FG003|Run-In Period|Randomization criteria not met|0|||
124648321|NCT02031640|448331461|FG004|Run-In Period|Randomization criteria not met|0|||
124648322|NCT02031640|448331462|FG005|Run-In Period|Randomization criteria not met|0|||
124648323|NCT02031640|448331457|FG000|Run-In Period|Various administrative reasons|17|||
124648324|NCT02031640|448331458|FG001|Run-In Period|Various administrative reasons|0|||
124648325|NCT02031640|448331459|FG002|Run-In Period|Various administrative reasons|0|||
124769814|NCT01502293|448785204|FG000|Overall Study|Adverse Event|0|||
124648326|NCT02031640|448331460|FG003|Run-In Period|Various administrative reasons|0|||
124648327|NCT02031640|448331461|FG004|Run-In Period|Various administrative reasons|0|||
124648328|NCT02031640|448331462|FG005|Run-In Period|Various administrative reasons|0|||
124648329|NCT02031640|448331457|FG000|Double-blind Treatment Period|Protocol deviation|0|||
124648330|NCT02031640|448331458|FG001|Double-blind Treatment Period|Protocol deviation|2|||
124648331|NCT02031640|448331459|FG002|Double-blind Treatment Period|Protocol deviation|0|||
124648332|NCT02031640|448331460|FG003|Double-blind Treatment Period|Protocol deviation|1|||
124648333|NCT02031640|448331461|FG004|Double-blind Treatment Period|Protocol deviation|3|||
124648334|NCT02031640|448331462|FG005|Double-blind Treatment Period|Protocol deviation|1|||
124648335|NCT02031640|448331457|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
124648336|NCT02031640|448331458|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
124648337|NCT02031640|448331459|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
124648338|NCT02031640|448331460|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
124648339|NCT02031640|448331461|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
124648340|NCT02031640|448331462|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
124648341|NCT02031640|448331457|FG000|Double-blind Treatment Period|Non-compliance|0|||
124648342|NCT02031640|448331458|FG001|Double-blind Treatment Period|Non-compliance|1|||
124648343|NCT02031640|448331459|FG002|Double-blind Treatment Period|Non-compliance|0|||
124648344|NCT02031640|448331460|FG003|Double-blind Treatment Period|Non-compliance|1|||
124648345|NCT02031640|448331461|FG004|Double-blind Treatment Period|Non-compliance|1|||
124648346|NCT02031640|448331462|FG005|Double-blind Treatment Period|Non-compliance|0|||
124648347|NCT02031640|448331457|FG000|Double-blind Treatment Period|Adverse Event|0|||
124648348|NCT02031640|448331458|FG001|Double-blind Treatment Period|Adverse Event|0|||
124648349|NCT02031640|448331459|FG002|Double-blind Treatment Period|Adverse Event|0|||
124648350|NCT02031640|448331460|FG003|Double-blind Treatment Period|Adverse Event|2|||
124648351|NCT02031640|448331461|FG004|Double-blind Treatment Period|Adverse Event|0|||
124648352|NCT02031640|448331462|FG005|Double-blind Treatment Period|Adverse Event|0|||
124648353|NCT02031640|448331457|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
124648354|NCT02031640|448331458|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
124648355|NCT02031640|448331459|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
124648356|NCT02031640|448331460|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
124648357|NCT02031640|448331461|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
124648358|NCT02031640|448331462|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
124648359|NCT02031640|448331457|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
124648360|NCT02031640|448331458|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
124648361|NCT02031640|448331459|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
124648362|NCT02031640|448331460|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
124648363|NCT02031640|448331461|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
124648364|NCT02031640|448331462|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
124648365|NCT03085238|448331465|FG000|Overall Study|Adverse Event|2|||
124648366|NCT03085238|448331465|FG000|Overall Study|Death|2|||
124648367|NCT02822573|448331474|FG000|Overall Study|Lost to Follow-up|5|||
124648368|NCT02822573|448331475|FG001|Overall Study|Lost to Follow-up|3|||
124648369|NCT02822573|448331474|FG000|Overall Study|Physician Decision|1|||
124648370|NCT02822573|448331475|FG001|Overall Study|Physician Decision|1|||
124648371|NCT02822573|448331474|FG000|Overall Study|Withdrawal by Subject|9|||
124648372|NCT02822573|448331475|FG001|Overall Study|Withdrawal by Subject|5|||
124648373|NCT02822573|448331474|FG000|Overall Study|Protocol Violation|6|||
124648374|NCT02822573|448331475|FG001|Overall Study|Protocol Violation|4|||
124648375|NCT02822573|448331474|FG000|Overall Study|Too sick or ill|2|||
124648376|NCT02822573|448331475|FG001|Overall Study|Too sick or ill|1|||
124648377|NCT02822573|448331474|FG000|Overall Study|Disease Progression|1|||
124648378|NCT02822573|448331475|FG001|Overall Study|Disease Progression|1|||
124648379|NCT02822573|448331474|FG000|Overall Study|No reason given|6|||
124648380|NCT02822573|448331475|FG001|Overall Study|No reason given|4|||
124648381|NCT01054300|448331476|FG000|Period 1|Adverse Event|1|||
124648382|NCT01054300|448331477|FG001|Period 1|Adverse Event|0|||
124648383|NCT01054300|448331478|FG002|Period 1|Adverse Event|0|||
124648384|NCT01054300|448331479|FG003|Period 1|Adverse Event|0|||
124648385|NCT01054300|448331476|FG000|Period 2|Withdrawal by Subject|0|||
124648386|NCT01054300|448331477|FG001|Period 2|Withdrawal by Subject|0|||
124648387|NCT01054300|448331478|FG002|Period 2|Withdrawal by Subject|1|||
124648388|NCT01054300|448331479|FG003|Period 2|Withdrawal by Subject|0|||
124648389|NCT00308087|448331480|FG000|Overall Study|Progressive Disease|19|||
124648390|NCT00308087|448331481|FG001|Overall Study|Progressive Disease|21|||
124648391|NCT00308087|448331480|FG000|Overall Study|Study Closure|11|||
124648392|NCT00308087|448331481|FG001|Overall Study|Study Closure|12|||
124648393|NCT00308087|448331480|FG000|Overall Study|Withdrawal by Subject|2|||
124648394|NCT00308087|448331481|FG001|Overall Study|Withdrawal by Subject|1|||
124648395|NCT00308087|448331480|FG000|Overall Study|Other|4|||
124648396|NCT00308087|448331481|FG001|Overall Study|Other|3|||
124648397|NCT04186806|448331485|FG000|Period 1: 7 Days|Adverse Event|1|||
124648398|NCT04186806|448331486|FG001|Period 1: 7 Days|Adverse Event|0|||
124648399|NCT00177307|448331490|FG000|Overall Study|Withdrawal by Subject|1|||
124648400|NCT02677038|448331494|FG000|Overall Study|Physician Decision|1|||
124648401|NCT02677038|448331494|FG000|Overall Study|Withdrawal by Subject|1|||
124648402|NCT03671564|448331495|FG000|Overall Study|Progressive Disease|3|||
124648403|NCT03671564|448331496|FG001|Overall Study|Progressive Disease|5|||
124648404|NCT03671564|448331497|FG002|Overall Study|Progressive Disease|3|||
124648405|NCT03671564|448331495|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
124648406|NCT03671564|448331496|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
124648407|NCT03671564|448331497|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
124648408|NCT03671564|448331495|FG000|Overall Study|Withdrawal by Subject|1|||
124648409|NCT03671564|448331496|FG001|Overall Study|Withdrawal by Subject|1|||
124648410|NCT03671564|448331497|FG002|Overall Study|Withdrawal by Subject|0|||
124648411|NCT04739722|448331500|FG000|Overall Study|Lost to Follow-up|5301|||
124648412|NCT04739722|448331500|FG000|Overall Study|Withdrawal by Subject|42|||
124648413|NCT04739722|448331500|FG000|Overall Study|Non Average-risk|1157|||
124648414|NCT01185509|448331504|FG000|Overall Study|Progression/Relapse|9|||
124648415|NCT01185509|448331505|FG001|Overall Study|Progression/Relapse|15|||
124648416|NCT01185509|448331504|FG000|Overall Study|Physician Decision|2|||
124648417|NCT01185509|448331505|FG001|Overall Study|Physician Decision|2|||
124648418|NCT01185509|448331504|FG000|Overall Study|Withdrawal by Subject|0|||
124648419|NCT01185509|448331505|FG001|Overall Study|Withdrawal by Subject|1|||
124648420|NCT01185509|448331504|FG000|Overall Study|Death|0|||
124648421|NCT01185509|448331505|FG001|Overall Study|Death|1|||
124648422|NCT01185509|448331504|FG000|Overall Study|Intercurrent Illness|0|||
124648423|NCT01185509|448331505|FG001|Overall Study|Intercurrent Illness|1|||
124648424|NCT03687372|448331506|FG000|Overall Study|Lost to Follow-up|12|||
124648425|NCT03687372|448331507|FG001|Overall Study|Lost to Follow-up|21|||
124648426|NCT03687372|448331506|FG000|Overall Study|Withdrawal by Subject|4|||
124648427|NCT03687372|448331507|FG001|Overall Study|Withdrawal by Subject|17|||
124648428|NCT03687372|448331506|FG000|Overall Study|Investigator Decision|1|||
124648429|NCT03687372|448331507|FG001|Overall Study|Investigator Decision|1|||
124648430|NCT00878969|448331513|FG000|Overall Study|Physician Decision|5|||
124648431|NCT00878969|448331514|FG001|Overall Study|Physician Decision|3|||
124648432|NCT00878969|448331515|FG002|Overall Study|Physician Decision|2|||
124648433|NCT00878969|448331513|FG000|Overall Study|Withdrawal by Subject|1|||
124648434|NCT00878969|448331514|FG001|Overall Study|Withdrawal by Subject|6|||
124648435|NCT00878969|448331515|FG002|Overall Study|Withdrawal by Subject|3|||
124648436|NCT00878969|448331513|FG000|Overall Study|kidney transplant|2|||
124648437|NCT00878969|448331514|FG001|Overall Study|kidney transplant|3|||
124648438|NCT00878969|448331515|FG002|Overall Study|kidney transplant|2|||
124648439|NCT00878969|448331513|FG000|Overall Study|Adverse Event|3|||
124648440|NCT00878969|448331514|FG001|Overall Study|Adverse Event|1|||
124872570|NCT03286751|449155666|FG003|Washout Period 2|Personal Reasons|0|||
124648441|NCT00878969|448331515|FG002|Overall Study|Adverse Event|2|||
124648442|NCT00878969|448331513|FG000|Overall Study|Lost to Follow-up|2|||
124648443|NCT00878969|448331514|FG001|Overall Study|Lost to Follow-up|1|||
124648444|NCT00878969|448331515|FG002|Overall Study|Lost to Follow-up|0|||
124648445|NCT00878969|448331513|FG000|Overall Study|Protocol Violation|2|||
124648446|NCT00878969|448331514|FG001|Overall Study|Protocol Violation|0|||
124648447|NCT00878969|448331515|FG002|Overall Study|Protocol Violation|0|||
124648448|NCT00878969|448331513|FG000|Overall Study|Death|0|||
124648449|NCT00878969|448331514|FG001|Overall Study|Death|0|||
124648450|NCT00878969|448331515|FG002|Overall Study|Death|2|||
124648451|NCT00878969|448331513|FG000|Overall Study|Pregnancy|0|||
124648452|NCT00878969|448331514|FG001|Overall Study|Pregnancy|1|||
124648453|NCT00878969|448331515|FG002|Overall Study|Pregnancy|0|||
124648454|NCT00380081|448331518|FG000|Overall Study|Withdrawal by Subject|0|||
124648455|NCT00380081|448331519|FG001|Overall Study|Withdrawal by Subject|0|||
124648456|NCT00380081|448331520|FG002|Overall Study|Withdrawal by Subject|0|||
124648457|NCT00380081|448331521|FG003|Overall Study|Withdrawal by Subject|0|||
124648458|NCT00380081|448331522|FG004|Overall Study|Withdrawal by Subject|1|||
124648459|NCT00380081|448331523|FG005|Overall Study|Withdrawal by Subject|0|||
124648460|NCT00380081|448331518|FG000|Overall Study|Family Emergency|0|||
124648461|NCT00380081|448331519|FG001|Overall Study|Family Emergency|0|||
124648462|NCT00380081|448331520|FG002|Overall Study|Family Emergency|0|||
124648463|NCT00380081|448331521|FG003|Overall Study|Family Emergency|0|||
124648464|NCT00380081|448331522|FG004|Overall Study|Family Emergency|0|||
124648465|NCT00380081|448331523|FG005|Overall Study|Family Emergency|1|||
124648466|NCT01546168|448331524|FG000|Overall Study|Lost to Follow-up|1|||
124648467|NCT01546168|448331525|FG001|Overall Study|Lost to Follow-up|0|||
124648468|NCT01546168|448331524|FG000|Overall Study|Withdrawal by Subject|1|||
124648469|NCT01546168|448331525|FG001|Overall Study|Withdrawal by Subject|0|||
124648470|NCT01546168|448331524|FG000|Overall Study|ineligible after signing consent|2|||
124648471|NCT01546168|448331525|FG001|Overall Study|ineligible after signing consent|0|||
124648472|NCT03787303|448331526|FG000|Overall Study|Death|1|||
124648473|NCT03787303|448331526|FG000|Overall Study|Premature Termination of Study|1|||
124648474|NCT01459718|448331527|FG000|Overall Study|Physician Decision|1|||
124648475|NCT01459718|448331527|FG000|Overall Study|Lost to Follow-up|1|||
124648476|NCT01459718|448331527|FG000|Overall Study|Adverse Event|1|||
124648477|NCT01542034|448331530|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
124648478|NCT01542034|448331531|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
124648479|NCT01542034|448331530|FG000|Overall Study|Administrative decision|0|||
124648480|NCT01542034|448331531|FG001|Overall Study|Administrative decision|3|||
124648481|NCT01542034|448331530|FG000|Overall Study|Subject Noncompliance|1|||
124648482|NCT01542034|448331531|FG001|Overall Study|Subject Noncompliance|0|||
124648483|NCT01542034|448331530|FG000|Overall Study|Adverse Event|2|||
124648484|NCT01542034|448331531|FG001|Overall Study|Adverse Event|2|||
124648485|NCT01542034|448331530|FG000|Overall Study|Lost to Follow-up|7|||
124648486|NCT01542034|448331531|FG001|Overall Study|Lost to Follow-up|6|||
124872571|NCT03286751|449155667|FG004|Washout Period 2|Personal Reasons|0|||
124872572|NCT03286751|449155668|FG005|Washout Period 2|Personal Reasons|0|||
124648487|NCT02612610|448331532|FG000|Overall Study|Withdrawal by Subject|1|||
124648488|NCT02612610|448331533|FG001|Overall Study|Withdrawal by Subject|1|||
124648489|NCT02612610|448331534|FG002|Overall Study|Withdrawal by Subject|0|||
124648490|NCT02612610|448331535|FG003|Overall Study|Withdrawal by Subject|2|||
124648491|NCT02612610|448331532|FG000|Overall Study|Adverse Event|2|||
124648492|NCT02612610|448331533|FG001|Overall Study|Adverse Event|2|||
124648493|NCT02612610|448331534|FG002|Overall Study|Adverse Event|3|||
124648494|NCT02612610|448331535|FG003|Overall Study|Adverse Event|10|||
124648495|NCT02612610|448331532|FG000|Overall Study|Lost to Follow-up|0|||
124648496|NCT02612610|448331533|FG001|Overall Study|Lost to Follow-up|1|||
124648497|NCT02612610|448331534|FG002|Overall Study|Lost to Follow-up|0|||
124648498|NCT02612610|448331535|FG003|Overall Study|Lost to Follow-up|0|||
124648499|NCT02612610|448331532|FG000|Overall Study|Protocol Violation|0|||
124648500|NCT02612610|448331533|FG001|Overall Study|Protocol Violation|1|||
124648501|NCT02612610|448331534|FG002|Overall Study|Protocol Violation|1|||
124648502|NCT02612610|448331535|FG003|Overall Study|Protocol Violation|0|||
124648503|NCT02612610|448331532|FG000|Overall Study|Lack of Efficacy|1|||
124648504|NCT02612610|448331533|FG001|Overall Study|Lack of Efficacy|2|||
124648505|NCT02612610|448331534|FG002|Overall Study|Lack of Efficacy|0|||
124648506|NCT02612610|448331535|FG003|Overall Study|Lack of Efficacy|1|||
124648507|NCT02612610|448331532|FG000|Overall Study|Physician Decision|0|||
124648508|NCT02612610|448331533|FG001|Overall Study|Physician Decision|1|||
124648509|NCT02612610|448331534|FG002|Overall Study|Physician Decision|0|||
124648510|NCT02612610|448331535|FG003|Overall Study|Physician Decision|0|||
124648511|NCT02612610|448331532|FG000|Overall Study|Noncompliance|1|||
124648512|NCT02612610|448331533|FG001|Overall Study|Noncompliance|0|||
124648513|NCT02612610|448331534|FG002|Overall Study|Noncompliance|0|||
124648514|NCT02612610|448331535|FG003|Overall Study|Noncompliance|0|||
124648515|NCT02612610|448331532|FG000|Overall Study|Cough Improvement|0|||
124648516|NCT02612610|448331533|FG001|Overall Study|Cough Improvement|0|||
124648517|NCT02612610|448331534|FG002|Overall Study|Cough Improvement|1|||
124648518|NCT02612610|448331535|FG003|Overall Study|Cough Improvement|0|||
124648519|NCT00176644|448331536|FG000|Overall Study|Withdrawal by Subject|1|||
124648520|NCT01801280|448331537|FG000|Period 1|Withdrawal by Subject|0|||
124648521|NCT01801280|448331538|FG001|Period 1|Withdrawal by Subject|1|||
124648522|NCT01801280|448331539|FG002|Period 1|Withdrawal by Subject|0|||
124648523|NCT01801280|448331540|FG003|Period 1|Withdrawal by Subject|0|||
124648524|NCT01801280|448331537|FG000|Period 2|Withdrawal by Subject|1|||
124648525|NCT01801280|448331538|FG001|Period 2|Withdrawal by Subject|0|||
124648526|NCT01801280|448331539|FG002|Period 2|Withdrawal by Subject|0|||
124648527|NCT01801280|448331540|FG003|Period 2|Withdrawal by Subject|0|||
124648528|NCT01801280|448331537|FG000|Period 4|Protocol Violation|0|||
124648529|NCT01801280|448331538|FG001|Period 4|Protocol Violation|0|||
124648530|NCT01801280|448331539|FG002|Period 4|Protocol Violation|1|||
124648531|NCT01801280|448331540|FG003|Period 4|Protocol Violation|0|||
124648532|NCT02783729|448331541|FG000|Overall Study|Lack of Efficacy|1|||
124648533|NCT02783729|448331542|FG001|Overall Study|Lack of Efficacy|0|||
124648534|NCT02783729|448331543|FG002|Overall Study|Lack of Efficacy|0|||
124648535|NCT02783729|448331544|FG003|Overall Study|Lack of Efficacy|0|||
124648536|NCT02783729|448331541|FG000|Overall Study|Adverse Event|2|||
124648537|NCT02783729|448331542|FG001|Overall Study|Adverse Event|6|||
124648538|NCT02783729|448331543|FG002|Overall Study|Adverse Event|2|||
124648539|NCT02783729|448331544|FG003|Overall Study|Adverse Event|3|||
124648540|NCT02783729|448331541|FG000|Overall Study|Other|1|||
124648541|NCT02783729|448331542|FG001|Overall Study|Other|6|||
124648542|NCT02783729|448331543|FG002|Overall Study|Other|2|||
124648543|NCT02783729|448331544|FG003|Overall Study|Other|3|||
124648544|NCT02783729|448331541|FG000|Overall Study|Withdrawal by Subject|2|||
124648545|NCT02783729|448331542|FG001|Overall Study|Withdrawal by Subject|3|||
124648546|NCT02783729|448331543|FG002|Overall Study|Withdrawal by Subject|1|||
124648547|NCT02783729|448331544|FG003|Overall Study|Withdrawal by Subject|2|||
124648548|NCT02783729|448331541|FG000|Overall Study|Participant's choice|2|||
124872573|NCT03286751|449155663|FG000|Washout Period 5|Adverse Event|0|||
124872574|NCT03286751|449155664|FG001|Washout Period 5|Adverse Event|0|||
124872575|NCT03286751|449155665|FG002|Washout Period 5|Adverse Event|0|||
124872576|NCT03286751|449155666|FG003|Washout Period 5|Adverse Event|0|||
124872577|NCT03286751|449155667|FG004|Washout Period 5|Adverse Event|1|||
124872578|NCT03286751|449155668|FG005|Washout Period 5|Adverse Event|0|||
124872579|NCT01621880|449155669|FG000|Overall Study|Adverse Event|5|||
124872580|NCT01621880|449155670|FG001|Overall Study|Adverse Event|1|||
124648549|NCT02783729|448331542|FG001|Overall Study|Participant's choice|1|||
124648550|NCT02783729|448331543|FG002|Overall Study|Participant's choice|2|||
124648551|NCT02783729|448331544|FG003|Overall Study|Participant's choice|1|||
124648552|NCT02783729|448331541|FG000|Overall Study|Lost to Follow-up|2|||
124648553|NCT02783729|448331542|FG001|Overall Study|Lost to Follow-up|1|||
124648554|NCT02783729|448331543|FG002|Overall Study|Lost to Follow-up|1|||
124648555|NCT02783729|448331544|FG003|Overall Study|Lost to Follow-up|0|||
124648556|NCT02693171|448331545|FG000|Overall Study|Adverse Event|1|||
124648557|NCT02693171|448331545|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
124648558|NCT01866657|448331548|FG000|Overall Study|Surgery canceled|2|||
124648559|NCT01866657|448331549|FG001|Overall Study|Surgery canceled|0|||
124648560|NCT04021121|448331562|FG000|Overall Study|Death|3|||
124648561|NCT04021121|448331563|FG001|Overall Study|Death|3|||
124648562|NCT04021121|448331564|FG002|Overall Study|Death|5|||
124648563|NCT04021121|448331565|FG003|Overall Study|Death|4|||
124648564|NCT02288091|448331566|FG000|Overall Study|Lost to Follow-up|1|||
124648565|NCT02288091|448331566|FG000|Overall Study|Screen fail|7|||
124648566|NCT00978250|448331568|FG000|Overall Study|Late determination of ineligibility|0|||
124648567|NCT00978250|448331569|FG001|Overall Study|Late determination of ineligibility|1|||
124648568|NCT00978250|448331570|FG002|Overall Study|Late determination of ineligibility|0|||
124648569|NCT00978250|448331571|FG003|Overall Study|Late determination of ineligibility|1|||
124648570|NCT02029989|448331576|FG000|Overall Study|Withdrawal by Subject|1|||
124648571|NCT02029989|448331577|FG001|Overall Study|Withdrawal by Subject|0|||
124648572|NCT02029989|448331576|FG000|Overall Study|Withdrawal: Fear of needles|1|||
124648573|NCT02029989|448331577|FG001|Overall Study|Withdrawal: Fear of needles|0|||
124648574|NCT02029989|448331576|FG000|Overall Study|Change of location|2|||
124648575|NCT02029989|448331577|FG001|Overall Study|Change of location|3|||
124648576|NCT02029989|448331576|FG000|Overall Study|Physician Decision|2|||
124648577|NCT02029989|448331577|FG001|Overall Study|Physician Decision|0|||
124648578|NCT02029989|448331576|FG000|Overall Study|Lost to Follow-up|9|||
124648579|NCT02029989|448331577|FG001|Overall Study|Lost to Follow-up|7|||
124648580|NCT02029989|448331576|FG000|Overall Study|Death|0|||
124648581|NCT02029989|448331577|FG001|Overall Study|Death|1|||
124648582|NCT02029989|448331576|FG000|Overall Study|Protocol Violation|1|||
124648583|NCT02029989|448331577|FG001|Overall Study|Protocol Violation|0|||
124648584|NCT04351373|448331578|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
124648585|NCT00471718|448331590|FG000|Overall Study|Adverse Event|3|||
124648586|NCT00471718|448331590|FG000|Overall Study|other complicating disease|1|||
124648587|NCT00471718|448331590|FG000|Overall Study|disease progression|22|||
124648588|NCT00471718|448331590|FG000|Overall Study|Withdrawal by Subject|1|||
124648589|NCT04713592|448331593|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
124648590|NCT04713592|448331594|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
124648591|NCT04713592|448331595|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
124648592|NCT04713592|448331596|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
124648593|NCT04713592|448331593|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
124648594|NCT04713592|448331594|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
124648595|NCT04713592|448331595|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
124648596|NCT04713592|448331596|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
124648597|NCT04713592|448331593|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
124648598|NCT04713592|448331594|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
124648599|NCT04713592|448331595|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
124648600|NCT04713592|448331596|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
124648601|NCT04713592|448331593|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124648602|NCT04713592|448331594|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124648603|NCT04713592|448331595|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
124648604|NCT04713592|448331596|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
124648605|NCT04713592|448331593|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
124648606|NCT04713592|448331594|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
124648607|NCT04713592|448331595|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
124648608|NCT04713592|448331596|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
124648609|NCT04713592|448331593|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124648610|NCT04713592|448331594|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124648611|NCT04713592|448331595|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
124648612|NCT04713592|448331596|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
124648613|NCT04713592|448331593|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
124648614|NCT04713592|448331594|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
124648615|NCT04713592|448331595|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
124648616|NCT04713592|448331596|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
124648617|NCT02294175|448331603|FG000|Overall Study|Withdrawal by Subject|1|||
124648618|NCT02294175|448331604|FG001|Overall Study|Withdrawal by Subject|2|||
124648619|NCT02294175|448331603|FG000|Overall Study|pt taking excluded medication|3|||
124648620|NCT02294175|448331604|FG001|Overall Study|pt taking excluded medication|1|||
124648621|NCT02294175|448331603|FG000|Overall Study|Protocol Violation|1|||
124648622|NCT02294175|448331604|FG001|Overall Study|Protocol Violation|0|||
124648623|NCT02294175|448331603|FG000|Overall Study|Lost to Follow-up|0|||
124648624|NCT02294175|448331604|FG001|Overall Study|Lost to Follow-up|1|||
124648625|NCT02294175|448331603|FG000|Overall Study|wound healed|0|||
124648626|NCT02294175|448331604|FG001|Overall Study|wound healed|2|||
124648627|NCT01664949|448331608|FG000|Overall Study|Adverse Event|11|||
124648628|NCT01664949|448331609|FG001|Overall Study|Adverse Event|12|||
124648629|NCT01664949|448331608|FG000|Overall Study|Lack of Efficacy|1|||
124648630|NCT01664949|448331609|FG001|Overall Study|Lack of Efficacy|1|||
124648631|NCT01664949|448331608|FG000|Overall Study|Lost to Follow-up|1|||
124648632|NCT01664949|448331609|FG001|Overall Study|Lost to Follow-up|2|||
124648633|NCT01664949|448331608|FG000|Overall Study|Personal Reasons|3|||
124648634|NCT01664949|448331609|FG001|Overall Study|Personal Reasons|4|||
124648635|NCT01664949|448331608|FG000|Overall Study|Protocol Violation|5|||
124648636|NCT01664949|448331609|FG001|Overall Study|Protocol Violation|5|||
124648637|NCT01664949|448331608|FG000|Overall Study|Other Miscellaneous Reasons|3|||
124648638|NCT01664949|448331609|FG001|Overall Study|Other Miscellaneous Reasons|1|||
124648639|NCT03003494|448331610|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
124648640|NCT03634033|448333247|FG000|Overall Study|Did not have a post-assessment|384|||
124648641|NCT03634033|448333248|FG001|Overall Study|Did not have a post-assessment|291|||
124648642|NCT03634033|448333249|FG002|Overall Study|Did not have a post-assessment|114|||
124648643|NCT03634033|448333250|FG003|Overall Study|Did not have a post-assessment|161|||
124648644|NCT03634033|448333251|FG004|Overall Study|Did not have a post-assessment|5|||
124648645|NCT03634033|448333252|FG005|Overall Study|Did not have a post-assessment|0|||
124648646|NCT03634033|448333253|FG006|Overall Study|Did not have a post-assessment|0|||
124648647|NCT03634033|448333247|FG000|Overall Study|Death|0|||
124648648|NCT03634033|448333248|FG001|Overall Study|Death|0|||
124648649|NCT03634033|448333249|FG002|Overall Study|Death|0|||
124648650|NCT03634033|448333250|FG003|Overall Study|Death|0|||
124648651|NCT03634033|448333251|FG004|Overall Study|Death|0|||
124648652|NCT03634033|448333252|FG005|Overall Study|Death|7|||
124648653|NCT03634033|448333253|FG006|Overall Study|Death|7|||
124648654|NCT03634033|448333247|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
124648655|NCT03634033|448333248|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
124648656|NCT03634033|448333249|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
124648657|NCT03634033|448333250|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
124648658|NCT03634033|448333251|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
124648659|NCT03634033|448333252|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
124648660|NCT03634033|448333253|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
124648661|NCT03634033|448333247|FG000|Overall Study|Lost to Follow-up|0|||
124648662|NCT03634033|448333248|FG001|Overall Study|Lost to Follow-up|0|||
124648663|NCT03634033|448333249|FG002|Overall Study|Lost to Follow-up|0|||
124648664|NCT03634033|448333250|FG003|Overall Study|Lost to Follow-up|0|||
124648665|NCT03634033|448333251|FG004|Overall Study|Lost to Follow-up|0|||
124648666|NCT03634033|448333252|FG005|Overall Study|Lost to Follow-up|1|||
124648667|NCT03634033|448333253|FG006|Overall Study|Lost to Follow-up|2|||
124648668|NCT03634033|448333247|FG000|Overall Study|Withdrawal by Subject|0|||
124648669|NCT03634033|448333248|FG001|Overall Study|Withdrawal by Subject|0|||
124648670|NCT03634033|448333249|FG002|Overall Study|Withdrawal by Subject|0|||
124648671|NCT03634033|448333250|FG003|Overall Study|Withdrawal by Subject|0|||
124648672|NCT03634033|448333251|FG004|Overall Study|Withdrawal by Subject|0|||
124648673|NCT03634033|448333252|FG005|Overall Study|Withdrawal by Subject|0|||
124648674|NCT03634033|448333253|FG006|Overall Study|Withdrawal by Subject|1|||
124648675|NCT04166591|448333260|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
124648676|NCT04166591|448333261|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
124648677|NCT04166591|448333262|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
124648678|NCT04166591|448333263|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
124648679|NCT04166591|448333260|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
124648680|NCT04166591|448333261|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
124648681|NCT04166591|448333262|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
124648682|NCT04166591|448333263|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
124648683|NCT02730377|448333264|FG000|Overall Study|Other|5|||
124648684|NCT02730377|448333265|FG001|Overall Study|Other|4|||
124648685|NCT02730377|448333264|FG000|Overall Study|Death|1|||
124648686|NCT02730377|448333265|FG001|Overall Study|Death|8|||
124648687|NCT02730377|448333264|FG000|Overall Study|Inadequate glycaemic control|368|||
124648688|NCT02730377|448333265|FG001|Overall Study|Inadequate glycaemic control|473|||
124648689|NCT02730377|448333264|FG000|Overall Study|Adverse Event|79|||
124648690|NCT02730377|448333265|FG001|Overall Study|Adverse Event|41|||
124648691|NCT02730377|448333264|FG000|Overall Study|Protocol Violation|23|||
124648692|NCT02730377|448333265|FG001|Overall Study|Protocol Violation|30|||
124648693|NCT02730377|448333264|FG000|Overall Study|Lack of Efficacy|4|||
124648694|NCT02730377|448333265|FG001|Overall Study|Lack of Efficacy|13|||
124648695|NCT02730377|448333264|FG000|Overall Study|Pregnancy|0|||
124648696|NCT02730377|448333265|FG001|Overall Study|Pregnancy|1|||
124648697|NCT02730377|448333264|FG000|Overall Study|Withdrawal by Subject|45|||
124648698|NCT02730377|448333265|FG001|Overall Study|Withdrawal by Subject|42|||
124648699|NCT02730377|448333264|FG000|Overall Study|Lost to Follow-up|25|||
124648700|NCT02730377|448333265|FG001|Overall Study|Lost to Follow-up|21|||
124648701|NCT02203851|448333268|FG000|Overall Study|Lost to Follow-up|4|||
124648702|NCT02203851|448333268|FG000|Overall Study|Withdrawal by Subject|6|||
124648703|NCT02203851|448333268|FG000|Overall Study|Other|1|||
124648704|NCT04045132|448333271|FG000|Overall Study|Lost to Follow-up|3|||
124648705|NCT04045132|448333272|FG001|Overall Study|Lost to Follow-up|6|||
124648706|NCT01632150|448333276|FG000|Overall Study|Disease progression|27|||
124648707|NCT01632150|448333276|FG000|Overall Study|Study drug toxicity|1|||
124648708|NCT01632150|448333276|FG000|Overall Study|Unrelated adverse event|7|||
124648709|NCT01632150|448333276|FG000|Overall Study|Withdrawal by Subject|2|||
124648710|NCT01632150|448333276|FG000|Overall Study|Patient underwent autologous transplant|1|||
124648711|NCT01632150|448333276|FG000|Overall Study|Moved to compassionate program|2|||
124648712|NCT02143791|448333277|FG000|Enrolled|Withdrawal by Subject|4|||
124648713|NCT02143791|448333277|FG000|Trial Stimulation|Lack of Efficacy|21|||
124648714|NCT02143791|448333277|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
124648715|NCT02143791|448333277|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
124648716|NCT02143791|448333277|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
124648717|NCT02143791|448333277|FG000|Any Programming (3-6 Months)|Missing Data|1|||
124648718|NCT02143791|448333277|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
124648719|NCT00401544|448333280|FG000|Overall Study|Adverse Event|5|||
124648720|NCT00401544|448333281|FG001|Overall Study|Adverse Event|1|||
124648721|NCT00401544|448333282|FG002|Overall Study|Adverse Event|1|||
124648722|NCT00401544|448333283|FG003|Overall Study|Adverse Event|1|||
124648723|NCT00401544|448333280|FG000|Overall Study|Death|3|||
124648724|NCT00401544|448333281|FG001|Overall Study|Death|6|||
124648725|NCT00401544|448333282|FG002|Overall Study|Death|2|||
124648726|NCT00401544|448333283|FG003|Overall Study|Death|5|||
124648727|NCT00401544|448333280|FG000|Overall Study|Lost to Follow-up|2|||
124648728|NCT00401544|448333281|FG001|Overall Study|Lost to Follow-up|0|||
124648729|NCT00401544|448333282|FG002|Overall Study|Lost to Follow-up|1|||
124648730|NCT00401544|448333283|FG003|Overall Study|Lost to Follow-up|1|||
124648731|NCT00401544|448333280|FG000|Overall Study|Withdrawal by Subject|7|||
124648732|NCT00401544|448333281|FG001|Overall Study|Withdrawal by Subject|6|||
124648733|NCT00401544|448333282|FG002|Overall Study|Withdrawal by Subject|6|||
124648734|NCT00401544|448333283|FG003|Overall Study|Withdrawal by Subject|5|||
124648735|NCT00401544|448333280|FG000|Overall Study|Physician Decision|1|||
124648736|NCT00401544|448333281|FG001|Overall Study|Physician Decision|3|||
124648737|NCT00401544|448333282|FG002|Overall Study|Physician Decision|0|||
124648738|NCT00401544|448333283|FG003|Overall Study|Physician Decision|0|||
124648739|NCT00401544|448333280|FG000|Overall Study|Ineligibility determined|0|||
124648740|NCT00401544|448333281|FG001|Overall Study|Ineligibility determined|1|||
124648741|NCT00401544|448333282|FG002|Overall Study|Ineligibility determined|0|||
124648742|NCT00401544|448333283|FG003|Overall Study|Ineligibility determined|2|||
124648743|NCT00401544|448333280|FG000|Overall Study|Disease progression|0|||
124648744|NCT00401544|448333281|FG001|Overall Study|Disease progression|1|||
124648745|NCT00401544|448333282|FG002|Overall Study|Disease progression|0|||
124648746|NCT00401544|448333283|FG003|Overall Study|Disease progression|0|||
124648747|NCT00401544|448333280|FG000|Overall Study|Other|0|||
124648748|NCT00401544|448333281|FG001|Overall Study|Other|0|||
124648749|NCT00401544|448333282|FG002|Overall Study|Other|2|||
124648750|NCT00401544|448333283|FG003|Overall Study|Other|2|||
124648751|NCT02339155|448333291|FG000|Overall Study|Adverse Event|0|||
124648752|NCT02339155|448333292|FG001|Overall Study|Adverse Event|6|||
124648753|NCT02339155|448333291|FG000|Overall Study|Death|1|||
124648754|NCT02339155|448333292|FG001|Overall Study|Death|1|||
124648755|NCT02339155|448333291|FG000|Overall Study|Lost to Follow-up|8|||
124648756|NCT02339155|448333292|FG001|Overall Study|Lost to Follow-up|9|||
124648757|NCT02339155|448333291|FG000|Overall Study|Physician Decision|2|||
124648758|NCT02339155|448333292|FG001|Overall Study|Physician Decision|1|||
124648759|NCT02339155|448333291|FG000|Overall Study|Withdrawal by Subject|4|||
124648760|NCT02339155|448333292|FG001|Overall Study|Withdrawal by Subject|4|||
124648761|NCT01214252|448333293|FG000|Overall Study|Not eligible per protocol|82|||
124648762|NCT04327661|448333296|FG000|Overall Study|Withdrawal by Subject|1|||
124648763|NCT04327661|448333297|FG001|Overall Study|Withdrawal by Subject|0|||
124648764|NCT04327661|448333298|FG002|Overall Study|Withdrawal by Subject|0|||
124648765|NCT01877551|448333301|FG000|Overall Study|Physician Decision|0|||
124648766|NCT01877551|448333302|FG001|Overall Study|Physician Decision|1|||
124648767|NCT01968707|448333310|FG000|Overall Study|Did not meet treatment day baseline|49|||
124648768|NCT01968707|448333311|FG001|Overall Study|Did not meet treatment day baseline|12|||
124648769|NCT01968707|448333312|FG002|Overall Study|Did not meet treatment day baseline|41|||
124648770|NCT01968707|448333313|FG003|Overall Study|Did not meet treatment day baseline|44|||
124648771|NCT01968707|448333314|FG004|Overall Study|Did not meet treatment day baseline|36|||
124648772|NCT01968707|448333315|FG005|Overall Study|Did not meet treatment day baseline|11|||
124648773|NCT01968707|448333316|FG006|Overall Study|Did not meet treatment day baseline|34|||
124648774|NCT01968707|448333317|FG007|Overall Study|Did not meet treatment day baseline|35|||
124648775|NCT00916344|448333318|FG000|Overall Study|Death|2|||
124648776|NCT00916344|448333318|FG000|Overall Study|ICD upgrade|1|||
124648777|NCT00916344|448333318|FG000|Overall Study|Drop-out|5|||
124648778|NCT00108485|448333322|FG000|Overall Study|Withdrawal by Subject|3|||
124648779|NCT00108485|448333323|FG001|Overall Study|Withdrawal by Subject|0|||
124648780|NCT00108485|448333322|FG000|Overall Study|Lost to Follow-up|0|||
124648781|NCT00108485|448333323|FG001|Overall Study|Lost to Follow-up|2|||
124648782|NCT01097421|448333324|FG000|Overall Study|Adverse Event|8|||
124648783|NCT01097421|448333324|FG000|Overall Study|Protocol Violation|2|||
124648784|NCT01097421|448333324|FG000|Overall Study|Lost to Follow-up|1|||
124648785|NCT01097421|448333324|FG000|Overall Study|Withdrawal by Subject|3|||
124648786|NCT01701193|448333329|FG000|Overall Study|Withdrawal by Subject|2|||
124648787|NCT01701193|448333330|FG001|Overall Study|Withdrawal by Subject|2|||
124648788|NCT01701193|448333331|FG002|Overall Study|Withdrawal by Subject|1|||
124648789|NCT01701193|448333332|FG003|Overall Study|Withdrawal by Subject|2|||
124648790|NCT01701193|448333329|FG000|Overall Study|Adverse Event|1|||
124648791|NCT01701193|448333330|FG001|Overall Study|Adverse Event|0|||
124648792|NCT01701193|448333331|FG002|Overall Study|Adverse Event|0|||
124648793|NCT01701193|448333332|FG003|Overall Study|Adverse Event|0|||
124648794|NCT02062944|448333333|FG000|Overall Study|Lost to Follow-up|1|||
124648795|NCT02062944|448333333|FG000|Overall Study|New hemotological disorder identified|1|||
124648796|NCT02062944|448333333|FG000|Overall Study|Uncontrolled Hypertension|1|||
124648797|NCT02062944|448333333|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
124648798|NCT00278148|448333334|FG000|Phase II - Expansion Phase|Disease progression|0|||
124648799|NCT00278148|448333335|FG001|Phase II - Expansion Phase|Disease progression|0|||
124769815|NCT01502293|448785205|FG001|Overall Study|Adverse Event|2|||
124648800|NCT00278148|448333336|FG002|Phase II - Expansion Phase|Disease progression|4|||
124648801|NCT00278148|448333334|FG000|Phase II - Expansion Phase|Adverse Event|0|||
124648802|NCT00278148|448333335|FG001|Phase II - Expansion Phase|Adverse Event|0|||
124648803|NCT00278148|448333336|FG002|Phase II - Expansion Phase|Adverse Event|2|||
124648804|NCT02035748|448333337|FG000|Overall Study|Adverse Event|5|||
124648805|NCT02035748|448333337|FG000|Overall Study|Death|3|||
124648806|NCT02035748|448333337|FG000|Overall Study|Lost to Follow-up|2|||
124648807|NCT02035748|448333337|FG000|Overall Study|Physician Decision|3|||
124648808|NCT02035748|448333337|FG000|Overall Study|Withdrawal by Subject|6|||
124648809|NCT02035748|448333337|FG000|Overall Study|Progressive Disease|1|||
124648810|NCT01088243|448333339|FG000|Overall Study|Adverse Event|1|||
124648811|NCT01088243|448333340|FG001|Overall Study|Adverse Event|0|||
124648812|NCT02083185|448333341|FG000|Overall Study|Lost to Follow-up|0|||
124648813|NCT02083185|448333342|FG001|Overall Study|Lost to Follow-up|3|||
124648814|NCT02083185|448333343|FG002|Overall Study|Lost to Follow-up|0|||
124648815|NCT02083185|448333341|FG000|Overall Study|Withdrawal by Subject|9|||
124648816|NCT02083185|448333342|FG001|Overall Study|Withdrawal by Subject|15|||
124648817|NCT02083185|448333343|FG002|Overall Study|Withdrawal by Subject|1|||
124648818|NCT02083185|448333341|FG000|Overall Study|Death|2|||
124648819|NCT02083185|448333342|FG001|Overall Study|Death|2|||
124648820|NCT02083185|448333343|FG002|Overall Study|Death|1|||
124648821|NCT02083185|448333341|FG000|Overall Study|Reason not Specified|9|||
124648822|NCT02083185|448333342|FG001|Overall Study|Reason not Specified|6|||
124648823|NCT02083185|448333343|FG002|Overall Study|Reason not Specified|5|||
124648824|NCT02083185|448333341|FG000|Overall Study|Study Terminated by Sponsor|0|||
124648825|NCT02083185|448333342|FG001|Overall Study|Study Terminated by Sponsor|1|||
124648826|NCT02083185|448333343|FG002|Overall Study|Study Terminated by Sponsor|0|||
124648827|NCT02083185|448333341|FG000|Overall Study|Did not Receive Study Drug|0|||
124648828|NCT02083185|448333342|FG001|Overall Study|Did not Receive Study Drug|2|||
124648829|NCT02083185|448333343|FG002|Overall Study|Did not Receive Study Drug|0|||
124648830|NCT03419598|448333344|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
124648831|NCT01740128|448333345|FG000|Overall Study|Pregnancy|0|||
124648832|NCT01740128|448333346|FG001|Overall Study|Pregnancy|1|||
124648833|NCT01740128|448333345|FG000|Overall Study|Protocol Violation|1|||
124648834|NCT01740128|448333346|FG001|Overall Study|Protocol Violation|2|||
124648835|NCT01740128|448333345|FG000|Overall Study|Lost to Follow-up|2|||
124648836|NCT01740128|448333346|FG001|Overall Study|Lost to Follow-up|2|||
124648837|NCT01740128|448333345|FG000|Overall Study|Withdrawal by Subject|1|||
124648838|NCT01740128|448333346|FG001|Overall Study|Withdrawal by Subject|0|||
124648839|NCT01740128|448333345|FG000|Overall Study|Insufficient protocol compliance|2|||
124648840|NCT01740128|448333346|FG001|Overall Study|Insufficient protocol compliance|2|||
124648841|NCT02474589|448333347|FG000|Overall Study|Adverse Event|6|||
124648842|NCT02474589|448333348|FG001|Overall Study|Adverse Event|2|||
124648843|NCT02474589|448333347|FG000|Overall Study|Lost to Follow-up|6|||
124648844|NCT02474589|448333348|FG001|Overall Study|Lost to Follow-up|1|||
124648845|NCT02474589|448333347|FG000|Overall Study|Protocol Violation|4|||
124648846|NCT02474589|448333348|FG001|Overall Study|Protocol Violation|1|||
124648847|NCT02474589|448333347|FG000|Overall Study|Withdrawal by Subject|4|||
124648848|NCT02474589|448333348|FG001|Overall Study|Withdrawal by Subject|0|||
124648849|NCT02474589|448333347|FG000|Overall Study|Inability to complete study procedures|5|||
124648850|NCT02474589|448333348|FG001|Overall Study|Inability to complete study procedures|1|||
124648851|NCT01041976|448333349|FG000|Overall Study|Withdrawal by Subject|3|||
124648852|NCT01041976|448333350|FG001|Overall Study|Withdrawal by Subject|0|||
124648853|NCT01041976|448333349|FG000|Overall Study|Incarceration|2|||
124648854|NCT01041976|448333350|FG001|Overall Study|Incarceration|0|||
124648855|NCT01041976|448333349|FG000|Overall Study|Death|0|||
124648856|NCT01041976|448333350|FG001|Overall Study|Death|4|||
124648857|NCT02231879|448333351|FG000|Overall Study|Adverse Event|2|||
124648858|NCT02231879|448333352|FG001|Overall Study|Adverse Event|1|||
124648859|NCT02231879|448333351|FG000|Overall Study|Lack of Efficacy|0|||
124648860|NCT02231879|448333352|FG001|Overall Study|Lack of Efficacy|1|||
124648861|NCT02370667|448333355|FG000|Overall Study|Lost to Follow-up|0|||
124648862|NCT02370667|448333356|FG001|Overall Study|Lost to Follow-up|1|||
124648863|NCT02370667|448333357|FG002|Overall Study|Lost to Follow-up|0|||
124648864|NCT02954653|448333358|FG000|Overall Study|Death|3|||
124648865|NCT02954653|448333359|FG001|Overall Study|Death|1|||
124648866|NCT02954653|448333360|FG002|Overall Study|Death|0|||
124648867|NCT02954653|448333361|FG003|Overall Study|Death|0|||
124648868|NCT02954653|448333362|FG004|Overall Study|Death|0|||
124648869|NCT02954653|448333363|FG005|Overall Study|Death|0|||
124648870|NCT02954653|448333364|FG006|Overall Study|Death|0|||
124648871|NCT02954653|448333365|FG007|Overall Study|Death|0|||
124648872|NCT02954653|448333366|FG008|Overall Study|Death|0|||
124648873|NCT02954653|448333358|FG000|Overall Study|Randomized but did not receive treatment|1|||
124648874|NCT02954653|448333359|FG001|Overall Study|Randomized but did not receive treatment|0|||
124648875|NCT02954653|448333360|FG002|Overall Study|Randomized but did not receive treatment|0|||
124648876|NCT02954653|448333361|FG003|Overall Study|Randomized but did not receive treatment|0|||
124648877|NCT02954653|448333362|FG004|Overall Study|Randomized but did not receive treatment|0|||
124648878|NCT02954653|448333363|FG005|Overall Study|Randomized but did not receive treatment|0|||
124648879|NCT02954653|448333364|FG006|Overall Study|Randomized but did not receive treatment|0|||
124648880|NCT02954653|448333365|FG007|Overall Study|Randomized but did not receive treatment|0|||
124648881|NCT02954653|448333366|FG008|Overall Study|Randomized but did not receive treatment|0|||
124648882|NCT02954653|448333358|FG000|Overall Study|Started another anti-cancer therapy|0|||
124648883|NCT02954653|448333359|FG001|Overall Study|Started another anti-cancer therapy|1|||
124648884|NCT02954653|448333360|FG002|Overall Study|Started another anti-cancer therapy|0|||
124648885|NCT02954653|448333361|FG003|Overall Study|Started another anti-cancer therapy|0|||
124648886|NCT02954653|448333362|FG004|Overall Study|Started another anti-cancer therapy|0|||
124648887|NCT02954653|448333363|FG005|Overall Study|Started another anti-cancer therapy|0|||
124648888|NCT02954653|448333364|FG006|Overall Study|Started another anti-cancer therapy|0|||
124648889|NCT02954653|448333365|FG007|Overall Study|Started another anti-cancer therapy|0|||
124648890|NCT02954653|448333366|FG008|Overall Study|Started another anti-cancer therapy|0|||
124648891|NCT02954653|448333358|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
124648892|NCT02954653|448333359|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
124648893|NCT02954653|448333360|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
124648894|NCT02954653|448333361|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
124648895|NCT02954653|448333362|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
124648896|NCT02954653|448333363|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
124648897|NCT02954653|448333364|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
124648898|NCT02954653|448333365|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
124648899|NCT02954653|448333366|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
124648900|NCT03054064|448333367|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
124648901|NCT03054064|448333367|FG000|Overall Study|Investigator Decision|2|||
124648902|NCT03054064|448333367|FG000|Overall Study|Bladder Issue|1|||
124648903|NCT03054064|448333367|FG000|Overall Study|High Blood Pressure|1|||
124648904|NCT03054064|448333367|FG000|Overall Study|Change in Status|1|||
124648905|NCT01210495|448333369|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
124648906|NCT01210495|448333370|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
124648907|NCT01210495|448333371|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
124648908|NCT01210495|448333372|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
124648909|NCT01210495|448333369|FG000|Overall Study|Death|14|||
124648910|NCT01210495|448333370|FG001|Overall Study|Death|7|||
124648911|NCT01210495|448333371|FG002|Overall Study|Death|112|||
124648912|NCT01210495|448333372|FG003|Overall Study|Death|54|||
124648913|NCT01210495|448333369|FG000|Overall Study|Study Terminated by Sponsor|0|||
124648914|NCT01210495|448333370|FG001|Overall Study|Study Terminated by Sponsor|0|||
124648915|NCT01210495|448333371|FG002|Overall Study|Study Terminated by Sponsor|4|||
124648916|NCT01210495|448333372|FG003|Overall Study|Study Terminated by Sponsor|11|||
124648917|NCT01210495|448333369|FG000|Overall Study|Lost to Follow-up|0|||
124648918|NCT01210495|448333370|FG001|Overall Study|Lost to Follow-up|0|||
124648919|NCT01210495|448333371|FG002|Overall Study|Lost to Follow-up|1|||
124648920|NCT01210495|448333372|FG003|Overall Study|Lost to Follow-up|1|||
124648921|NCT01210495|448333369|FG000|Overall Study|Other unspecified|0|||
124648922|NCT01210495|448333370|FG001|Overall Study|Other unspecified|0|||
124648923|NCT01210495|448333371|FG002|Overall Study|Other unspecified|6|||
124648924|NCT01210495|448333372|FG003|Overall Study|Other unspecified|0|||
124648925|NCT00985959|448333382|FG000|Overall Study|Adverse Event|0|||
124648926|NCT00985959|448333383|FG001|Overall Study|Adverse Event|0|||
124648927|NCT00985959|448333384|FG002|Overall Study|Adverse Event|19|||
124648928|NCT00985959|448333382|FG000|Overall Study|Withdrawal by Subject|0|||
124648929|NCT00985959|448333383|FG001|Overall Study|Withdrawal by Subject|0|||
124648930|NCT00985959|448333384|FG002|Overall Study|Withdrawal by Subject|8|||
124648931|NCT00985959|448333382|FG000|Overall Study|Progressive disease|1|||
124648932|NCT00985959|448333383|FG001|Overall Study|Progressive disease|2|||
124648933|NCT00985959|448333384|FG002|Overall Study|Progressive disease|8|||
124648934|NCT00985959|448333382|FG000|Overall Study|Unrecovered toxicity|0|||
124648935|NCT00985959|448333383|FG001|Overall Study|Unrecovered toxicity|0|||
124648936|NCT00985959|448333384|FG002|Overall Study|Unrecovered toxicity|7|||
124648937|NCT00985959|448333382|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
124648938|NCT00985959|448333383|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
124648939|NCT00985959|448333384|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
124648940|NCT00985959|448333382|FG000|Overall Study|Complete response observed over 2 cycles|0|||
124648941|NCT00985959|448333383|FG001|Overall Study|Complete response observed over 2 cycles|1|||
124648942|NCT00985959|448333384|FG002|Overall Study|Complete response observed over 2 cycles|4|||
124648943|NCT00985959|448333382|FG000|Overall Study|Other|0|||
124648944|NCT00985959|448333383|FG001|Overall Study|Other|0|||
124648945|NCT00985959|448333384|FG002|Overall Study|Other|11|||
124648946|NCT00976209|448333385|FG000|Treatment Period 1|Protocol Violation|1|||
124648947|NCT00976209|448333386|FG001|Treatment Period 1|Protocol Violation|0|||
124648948|NCT00976209|448333385|FG000|Treatment Period 1|Lost to Follow-up|2|||
124648949|NCT00976209|448333386|FG001|Treatment Period 1|Lost to Follow-up|0|||
124648950|NCT00976209|448333385|FG000|Treatment Period 1|Other|0|||
124648951|NCT00976209|448333386|FG001|Treatment Period 1|Other|1|||
124648952|NCT00976209|448333385|FG000|Wash-out Period|Adverse Event|1|||
124648953|NCT00976209|448333386|FG001|Wash-out Period|Adverse Event|2|||
124648954|NCT00976209|448333385|FG000|Wash-out Period|Lost to Follow-up|1|||
124648955|NCT00976209|448333386|FG001|Wash-out Period|Lost to Follow-up|0|||
124648956|NCT00976209|448333385|FG000|Wash-out Period|Protocol Violation|1|||
124648957|NCT00976209|448333386|FG001|Wash-out Period|Protocol Violation|0|||
124648958|NCT00976209|448333385|FG000|Wash-out Period|Other|1|||
124648959|NCT00976209|448333386|FG001|Wash-out Period|Other|0|||
124648960|NCT00976209|448333385|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124648961|NCT00976209|448333386|FG001|Treatment Period 2|Withdrawal by Subject|1|||
124648962|NCT00976209|448333385|FG000|Treatment Period 2|Lost to Follow-up|0|||
124648963|NCT00976209|448333386|FG001|Treatment Period 2|Lost to Follow-up|1|||
124648964|NCT00979420|448333387|FG000|Overall Study|Adverse Event|1|||
124648965|NCT00979420|448333388|FG001|Overall Study|Adverse Event|0|||
124648966|NCT00979420|448333389|FG002|Overall Study|Adverse Event|0|||
124648967|NCT00979420|448333390|FG003|Overall Study|Adverse Event|0|||
124648968|NCT00979420|448333387|FG000|Overall Study|Lack of Efficacy|3|||
124648969|NCT00979420|448333388|FG001|Overall Study|Lack of Efficacy|0|||
124648970|NCT00979420|448333389|FG002|Overall Study|Lack of Efficacy|1|||
124648971|NCT00979420|448333390|FG003|Overall Study|Lack of Efficacy|1|||
124648972|NCT00979420|448333387|FG000|Overall Study|Other reasons not related to Viramune|3|||
124648973|NCT00979420|448333388|FG001|Overall Study|Other reasons not related to Viramune|0|||
124648974|NCT00979420|448333389|FG002|Overall Study|Other reasons not related to Viramune|0|||
124648975|NCT00979420|448333390|FG003|Overall Study|Other reasons not related to Viramune|1|||
124648976|NCT00574249|448333391|FG000|Overall Study|Adverse Event|6|||
124648977|NCT00574249|448333392|FG001|Overall Study|Adverse Event|18|||
124648978|NCT00574249|448333391|FG000|Overall Study|Lack of Efficacy|5|||
124648979|NCT00574249|448333392|FG001|Overall Study|Lack of Efficacy|3|||
124648980|NCT00574249|448333391|FG000|Overall Study|Lost to Follow-up|4|||
124648981|NCT00574249|448333392|FG001|Overall Study|Lost to Follow-up|3|||
124648982|NCT00574249|448333391|FG000|Overall Study|Protocol Violation|5|||
124648983|NCT00574249|448333392|FG001|Overall Study|Protocol Violation|2|||
124648984|NCT00574249|448333391|FG000|Overall Study|History of carcinoma|1|||
124648985|NCT00574249|448333392|FG001|Overall Study|History of carcinoma|0|||
124648986|NCT00574249|448333391|FG000|Overall Study|Withdrawal by Subject|3|||
124648987|NCT00574249|448333392|FG001|Overall Study|Withdrawal by Subject|0|||
124648988|NCT00574249|448333391|FG000|Overall Study|Physician Decision|1|||
124648989|NCT00574249|448333392|FG001|Overall Study|Physician Decision|0|||
124648990|NCT00574249|448333391|FG000|Overall Study|Pregnancy|1|||
124648991|NCT00574249|448333392|FG001|Overall Study|Pregnancy|0|||
124648992|NCT00574249|448333391|FG000|Overall Study|Excluded by company|0|||
124648993|NCT00574249|448333392|FG001|Overall Study|Excluded by company|1|||
124648994|NCT00574249|448333391|FG000|Overall Study|PPD test taken twice|0|||
124648995|NCT00574249|448333392|FG001|Overall Study|PPD test taken twice|1|||
124648996|NCT01259375|448333393|FG000|Overall Study|Adverse Event|1|||
124648997|NCT00478699|448333398|FG000|Overall Study|Inclusion Error|1|||
124648998|NCT00478699|448333399|FG001|Overall Study|Inclusion Error|7|||
124648999|NCT00478699|448333398|FG000|Overall Study|Not receive study treatment|6|||
124649000|NCT00478699|448333399|FG001|Overall Study|Not receive study treatment|30|||
124649001|NCT00656851|448333401|FG000|Overall Study|Withdrawal by Subject|0|||
124649002|NCT00656851|448333402|FG001|Overall Study|Withdrawal by Subject|4|||
124649003|NCT01123941|448333403|FG000|Overall Study|Lost to Follow-up|2|||
124649004|NCT01123941|448333404|FG001|Overall Study|Lost to Follow-up|1|||
124649005|NCT04601103|448333405|FG000|Overall Study|Needed crown & cleaning|0|||
124649006|NCT04601103|448333406|FG001|Overall Study|Needed crown & cleaning|0|||
124649007|NCT04601103|448333407|FG002|Overall Study|Needed crown & cleaning|1|||
124649008|NCT04601103|448333405|FG000|Overall Study|study was terminated|18|||
124649009|NCT04601103|448333406|FG001|Overall Study|study was terminated|18|||
124649010|NCT04601103|448333407|FG002|Overall Study|study was terminated|16|||
124649011|NCT06011161|448333410|FG000|Overall Study|Withdrawal by Subject|2|||
124649012|NCT06011161|448333410|FG000|Overall Study|Lost to Follow-up|5|||
124649013|NCT02548351|448333414|FG000|Overall Study|Withdrawal by Subject|149|||
124649014|NCT02548351|448333415|FG001|Overall Study|Withdrawal by Subject|154|||
124649015|NCT02548351|448333416|FG002|Overall Study|Withdrawal by Subject|152|||
124649016|NCT02548351|448333414|FG000|Overall Study|Death|11|||
124649017|NCT02548351|448333415|FG001|Overall Study|Death|15|||
124649018|NCT02548351|448333416|FG002|Overall Study|Death|12|||
124649019|NCT02548351|448333414|FG000|Overall Study|Adverse Event|22|||
124649020|NCT02548351|448333415|FG001|Overall Study|Adverse Event|56|||
124649021|NCT02548351|448333416|FG002|Overall Study|Adverse Event|36|||
124649022|NCT02548351|448333414|FG000|Overall Study|Study Terminated by Sponsor|549|||
124649023|NCT02548351|448333415|FG001|Overall Study|Study Terminated by Sponsor|509|||
124649024|NCT02548351|448333416|FG002|Overall Study|Study Terminated by Sponsor|528|||
124649025|NCT02548351|448333414|FG000|Overall Study|Site Closure|14|||
124649026|NCT02548351|448333415|FG001|Overall Study|Site Closure|5|||
124649027|NCT02548351|448333416|FG002|Overall Study|Site Closure|7|||
124649028|NCT02548351|448333414|FG000|Overall Study|Non-compliance with Study Drug|4|||
124649029|NCT02548351|448333415|FG001|Overall Study|Non-compliance with Study Drug|2|||
124649030|NCT02548351|448333416|FG002|Overall Study|Non-compliance with Study Drug|0|||
124649031|NCT02548351|448333414|FG000|Overall Study|Protocol Violation|2|||
124649032|NCT02548351|448333415|FG001|Overall Study|Protocol Violation|1|||
124649033|NCT02548351|448333416|FG002|Overall Study|Protocol Violation|2|||
124649034|NCT02548351|448333414|FG000|Overall Study|Physician Decision|11|||
124649035|NCT02548351|448333415|FG001|Overall Study|Physician Decision|18|||
124649036|NCT02548351|448333416|FG002|Overall Study|Physician Decision|11|||
124649037|NCT02548351|448333414|FG000|Overall Study|Lost to Follow-up|43|||
124649038|NCT02548351|448333415|FG001|Overall Study|Lost to Follow-up|50|||
124649039|NCT02548351|448333416|FG002|Overall Study|Lost to Follow-up|57|||
124649040|NCT02548351|448333414|FG000|Overall Study|Other|19|||
124649041|NCT02548351|448333415|FG001|Overall Study|Other|16|||
124649042|NCT02548351|448333416|FG002|Overall Study|Other|20|||
124649043|NCT02548351|448333414|FG000|Overall Study|Missing|1|||
124649044|NCT02548351|448333415|FG001|Overall Study|Missing|1|||
124649045|NCT02548351|448333416|FG002|Overall Study|Missing|0|||
124649046|NCT00125242|448333417|FG000|Overall Study|did not qualify|7|||
124649047|NCT00125242|448333418|FG001|Overall Study|did not qualify|2|||
124649048|NCT02659514|448334752|FG000|Overall Study|Adverse Event|3|||
124649049|NCT02659514|448334753|FG001|Overall Study|Adverse Event|12|||
124649050|NCT02659514|448334752|FG000|Overall Study|Disease Progression|23|||
124649051|NCT02659514|448334753|FG001|Overall Study|Disease Progression|13|||
124649052|NCT02659514|448334752|FG000|Overall Study|Withdrawal by Subject|0|||
124649053|NCT02659514|448334753|FG001|Overall Study|Withdrawal by Subject|4|||
124649054|NCT02659514|448334752|FG000|Overall Study|Lost to Follow-up|0|||
124649055|NCT02659514|448334753|FG001|Overall Study|Lost to Follow-up|1|||
124649056|NCT02659514|448334752|FG000|Overall Study|Death|6|||
124649057|NCT02659514|448334753|FG001|Overall Study|Death|1|||
124649058|NCT02659514|448334752|FG000|Overall Study|Reason Unspecified|0|||
124649059|NCT02659514|448334753|FG001|Overall Study|Reason Unspecified|3|||
124649060|NCT00454818|448334756|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
124649061|NCT00454818|448334757|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
124649062|NCT00454818|448334758|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
124649063|NCT00454818|448334759|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
124649064|NCT00454818|448334760|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
124649065|NCT00454818|448334756|FG000|Phase I: Open-label Dose-escalation|Death|0|||
124649066|NCT00454818|448334757|FG001|Phase I: Open-label Dose-escalation|Death|1|||
124649067|NCT00454818|448334758|FG002|Phase I: Open-label Dose-escalation|Death|0|||
124649068|NCT00454818|448334759|FG003|Phase I: Open-label Dose-escalation|Death|0|||
124649069|NCT00454818|448334760|FG004|Phase I: Open-label Dose-escalation|Death|0|||
124649070|NCT00454818|448334756|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
124649071|NCT00454818|448334757|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
124649072|NCT00454818|448334758|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
124649073|NCT00454818|448334759|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
124649074|NCT00454818|448334760|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
124649075|NCT00454818|448334756|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
124649076|NCT00454818|448334757|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
124649077|NCT00454818|448334758|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
124649078|NCT00454818|448334759|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
124649079|NCT00454818|448334760|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
124649080|NCT00454818|448334756|FG000|Phase 2: Randomized Double-blind|Death|0|||
124649081|NCT00454818|448334757|FG001|Phase 2: Randomized Double-blind|Death|1|||
124649082|NCT00454818|448334758|FG002|Phase 2: Randomized Double-blind|Death|0|||
124649083|NCT00454818|448334759|FG003|Phase 2: Randomized Double-blind|Death|0|||
124649084|NCT00454818|448334760|FG004|Phase 2: Randomized Double-blind|Death|1|||
124649085|NCT00454818|448334756|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
124649086|NCT00454818|448334757|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
124649087|NCT00454818|448334758|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
124649088|NCT00454818|448334759|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
124649089|NCT00454818|448334760|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
124649090|NCT00454818|448334756|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
124649091|NCT00454818|448334757|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
124649092|NCT00454818|448334758|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
124649093|NCT00454818|448334759|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
124649094|NCT00454818|448334760|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
124649095|NCT01384019|448334761|FG000|Overall Study|Withdrawal by Subject|3|||
124649096|NCT01384019|448334762|FG001|Overall Study|Withdrawal by Subject|0|||
124649097|NCT01384019|448334761|FG000|Overall Study|Death|1|||
124649098|NCT01384019|448334762|FG001|Overall Study|Death|0|||
124649099|NCT01384019|448334761|FG000|Overall Study|MRI refusal|6|||
124649100|NCT01384019|448334762|FG001|Overall Study|MRI refusal|6|||
124649101|NCT00767039|448334763|FG000|Overall Study|Death|5|||
124649102|NCT00767039|448334764|FG001|Overall Study|Death|2|||
124649103|NCT01826370|448334765|FG000|Overall Study|Protocol Violation|6|||
124649104|NCT01826370|448334765|FG000|Overall Study|Lost to Follow-up|12|||
124649105|NCT01826370|448334765|FG000|Overall Study|Other reason not defined above|2|||
124649106|NCT04416737|448334767|FG000|Week 1 (First Injection)|Physician Decision|0|||
124649107|NCT04416737|448334768|FG001|Week 1 (First Injection)|Physician Decision|1|||
124649108|NCT03332628|448334769|FG000|Overall Study|Physician Decision|2|||
124649109|NCT01472757|448334770|FG000|Overall Study|Withdrawal by Subject|1|||
124649110|NCT01472757|448334771|FG001|Overall Study|Withdrawal by Subject|2|||
124649111|NCT01472757|448334772|FG002|Overall Study|Withdrawal by Subject|2|||
124649112|NCT01472757|448334773|FG003|Overall Study|Withdrawal by Subject|0|||
124649113|NCT01472757|448334770|FG000|Overall Study|Asthma exacerbation|4|||
124649114|NCT01472757|448334771|FG001|Overall Study|Asthma exacerbation|1|||
124649115|NCT01472757|448334772|FG002|Overall Study|Asthma exacerbation|2|||
124649116|NCT01472757|448334773|FG003|Overall Study|Asthma exacerbation|1|||
124649117|NCT01472757|448334770|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
124649118|NCT01472757|448334771|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
124649119|NCT01472757|448334772|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
124649120|NCT01472757|448334773|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
124649121|NCT01472757|448334770|FG000|Overall Study|Protocol Violation|3|||
124649122|NCT01472757|448334771|FG001|Overall Study|Protocol Violation|2|||
124649123|NCT01472757|448334772|FG002|Overall Study|Protocol Violation|4|||
124649124|NCT01472757|448334773|FG003|Overall Study|Protocol Violation|4|||
124649125|NCT01472757|448334770|FG000|Overall Study|Other reasons|1|||
124649126|NCT01472757|448334771|FG001|Overall Study|Other reasons|0|||
124649127|NCT01472757|448334772|FG002|Overall Study|Other reasons|2|||
124649128|NCT01472757|448334773|FG003|Overall Study|Other reasons|2|||
124649129|NCT04489381|448334774|FG000|Overall Study|Lost to Follow-up|2|||
124649130|NCT04489381|448334775|FG001|Overall Study|Lost to Follow-up|3|||
124649131|NCT04489381|448334774|FG000|Overall Study|Withdrawal by Subject|1|||
124649132|NCT04489381|448334775|FG001|Overall Study|Withdrawal by Subject|0|||
124649133|NCT00070018|448334778|FG000|Overall Study|Adverse Event|2|||
124649134|NCT00070018|448334778|FG000|Overall Study|Lack of Efficacy|1|||
124649135|NCT00070018|448334778|FG000|Overall Study|Withdrawal by Subject|1|||
124649136|NCT02939716|448334782|FG000|Overall Study|scanner failure|0|||
124649137|NCT02939716|448334783|FG001|Overall Study|scanner failure|0|||
124649138|NCT02939716|448334784|FG002|Overall Study|scanner failure|0|||
124649139|NCT02939716|448334785|FG003|Overall Study|scanner failure|1|||
124649140|NCT02939716|448334786|FG004|Overall Study|scanner failure|1|||
124649141|NCT02939716|448334787|FG005|Overall Study|scanner failure|1|||
124649142|NCT02543892|448334790|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
124649143|NCT02543892|448334791|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
124649144|NCT02543892|448334792|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
124649145|NCT02543892|448334793|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
124649146|NCT02543892|448334794|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
124649147|NCT02543892|448334795|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
124649148|NCT02543892|448334796|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
124649149|NCT02543892|448334797|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
124649150|NCT02543892|448334790|FG000|Received Vaccination 2|Physician Decision|0|||
124649151|NCT02543892|448334791|FG001|Received Vaccination 2|Physician Decision|0|||
124649152|NCT02543892|448334792|FG002|Received Vaccination 2|Physician Decision|0|||
124649153|NCT02543892|448334793|FG003|Received Vaccination 2|Physician Decision|0|||
124649154|NCT02543892|448334794|FG004|Received Vaccination 2|Physician Decision|0|||
124649155|NCT02543892|448334795|FG005|Received Vaccination 2|Physician Decision|1|||
124649156|NCT02543892|448334796|FG006|Received Vaccination 2|Physician Decision|0|||
124649157|NCT02543892|448334797|FG007|Received Vaccination 2|Physician Decision|0|||
124649158|NCT02543892|448334790|FG000|Received Vaccination 2|Adverse Event|0|||
124649159|NCT02543892|448334791|FG001|Received Vaccination 2|Adverse Event|1|||
124649160|NCT02543892|448334792|FG002|Received Vaccination 2|Adverse Event|0|||
124649161|NCT02543892|448334793|FG003|Received Vaccination 2|Adverse Event|0|||
124649162|NCT02543892|448334794|FG004|Received Vaccination 2|Adverse Event|0|||
124649163|NCT02543892|448334795|FG005|Received Vaccination 2|Adverse Event|0|||
124649164|NCT02543892|448334796|FG006|Received Vaccination 2|Adverse Event|0|||
124649165|NCT02543892|448334797|FG007|Received Vaccination 2|Adverse Event|0|||
124649166|NCT02543892|448334790|FG000|Had Immunology Data|Withdrawal by Subject|0|||
124649167|NCT02543892|448334791|FG001|Had Immunology Data|Withdrawal by Subject|0|||
124649168|NCT02543892|448334792|FG002|Had Immunology Data|Withdrawal by Subject|0|||
124649169|NCT02543892|448334793|FG003|Had Immunology Data|Withdrawal by Subject|0|||
124649170|NCT02543892|448334794|FG004|Had Immunology Data|Withdrawal by Subject|0|||
124649171|NCT02543892|448334795|FG005|Had Immunology Data|Withdrawal by Subject|0|||
124649172|NCT02543892|448334796|FG006|Had Immunology Data|Withdrawal by Subject|1|||
124649173|NCT02543892|448334797|FG007|Had Immunology Data|Withdrawal by Subject|0|||
124649174|NCT00785213|448334798|FG000|Quinine Sulfate Alone|Adverse Event|4|||
124649175|NCT00785213|448334798|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
124649176|NCT00525902|448334799|FG000|Overall Study|Lack of Efficacy|1|||
124649177|NCT02858180|448334806|FG000|Overall Study|Lost to Follow-up|0|||
124649178|NCT02858180|448334807|FG001|Overall Study|Lost to Follow-up|2|||
124649179|NCT00844480|448334808|FG000|Overall Study|Withdrawal by Subject|2|||
124649180|NCT00844480|448334809|FG001|Overall Study|Withdrawal by Subject|3|||
124649181|NCT00526331|448334810|FG000|Overall Study|Sponsor Termination|55|||
124649182|NCT01043705|448334813|FG000|Overall Study|Death|28|||
124649183|NCT01043705|448334814|FG001|Overall Study|Death|60|||
124649184|NCT01043705|448334815|FG002|Overall Study|Death|26|||
124649185|NCT01043705|448334813|FG000|Overall Study|Lost to Follow-up|27|||
124649186|NCT01043705|448334814|FG001|Overall Study|Lost to Follow-up|12|||
124649187|NCT01043705|448334815|FG002|Overall Study|Lost to Follow-up|0|||
124649188|NCT01043705|448334813|FG000|Overall Study|Multiple Reasons|4|||
124649189|NCT01043705|448334814|FG001|Overall Study|Multiple Reasons|7|||
124649190|NCT01043705|448334815|FG002|Overall Study|Multiple Reasons|0|||
124649191|NCT01043705|448334813|FG000|Overall Study|Protocol Violation|2|||
124649192|NCT01043705|448334814|FG001|Overall Study|Protocol Violation|1|||
124649193|NCT01043705|448334815|FG002|Overall Study|Protocol Violation|0|||
124649194|NCT01043705|448334813|FG000|Overall Study|Withdrawal by Subject|8|||
124649195|NCT01043705|448334814|FG001|Overall Study|Withdrawal by Subject|6|||
124649196|NCT01043705|448334815|FG002|Overall Study|Withdrawal by Subject|0|||
124649197|NCT01043705|448334813|FG000|Overall Study|Site Closure|8|||
124649198|NCT01043705|448334814|FG001|Overall Study|Site Closure|0|||
124649199|NCT01043705|448334815|FG002|Overall Study|Site Closure|0|||
124649200|NCT01043705|448334813|FG000|Overall Study|Subsequent Procedure|9|||
124649201|NCT01043705|448334814|FG001|Overall Study|Subsequent Procedure|24|||
124649202|NCT01043705|448334815|FG002|Overall Study|Subsequent Procedure|29|||
124649203|NCT01043705|448334813|FG000|Overall Study|Adverse Event|0|||
124649204|NCT01043705|448334814|FG001|Overall Study|Adverse Event|2|||
124649205|NCT01043705|448334815|FG002|Overall Study|Adverse Event|0|||
124649206|NCT01043705|448334813|FG000|Overall Study|Screen Fail|21|||
124649207|NCT01043705|448334814|FG001|Overall Study|Screen Fail|0|||
124649208|NCT01043705|448334815|FG002|Overall Study|Screen Fail|0|||
124649209|NCT01043705|448334813|FG000|Overall Study|Other|0|||
124649210|NCT01043705|448334814|FG001|Overall Study|Other|19|||
124649211|NCT01043705|448334815|FG002|Overall Study|Other|25|||
124649212|NCT00581542|448334817|FG000|Overall Study|they met an exclusion criteria|2|||
124649213|NCT00581542|448334818|FG001|Overall Study|they met an exclusion criteria|2|||
124649214|NCT00581542|448334817|FG000|Overall Study|Lost to Follow-up|9|||
124649215|NCT00581542|448334818|FG001|Overall Study|Lost to Follow-up|21|||
124649216|NCT03099694|448334820|FG000|Overall Study|Withdrawal by Subject|11|||
124649217|NCT03099694|448334821|FG001|Overall Study|Withdrawal by Subject|13|||
124649218|NCT03099694|448334820|FG000|Overall Study|Lost to Follow-up|9|||
124649219|NCT03099694|448334821|FG001|Overall Study|Lost to Follow-up|5|||
124649220|NCT02291601|448334822|FG000|Abdomen|Did not qualify|333|||
124649221|NCT02291601|448334823|FG001|Abdomen|Did not qualify|54|||
124649222|NCT02291601|448334824|FG002|Abdomen|Did not qualify|339|||
124649223|NCT02291601|448334822|FG000|Groin|Did not qualify|183|||
124649224|NCT02291601|448334823|FG001|Groin|Did not qualify|30|||
124649225|NCT02291601|448334824|FG002|Groin|Did not qualify|177|||
124649226|NCT00381043|448334825|FG000|Overall Study|Lost to Follow-up|8|||
124649227|NCT00381043|448334826|FG001|Overall Study|Lost to Follow-up|6|||
124649228|NCT00381043|448334825|FG000|Overall Study|Withdrawal by Subject|3|||
124649229|NCT00381043|448334826|FG001|Overall Study|Withdrawal by Subject|1|||
124649230|NCT00381043|448334825|FG000|Overall Study|wanted more care|0|||
124649231|NCT00381043|448334826|FG001|Overall Study|wanted more care|1|||
124649232|NCT00381043|448334825|FG000|Overall Study|incarcerated|1|||
124649233|NCT00381043|448334826|FG001|Overall Study|incarcerated|0|||
124649234|NCT03045276|448334827|FG000|Intervention Phase|Withdrawal by Subject|7|||
124649235|NCT03045276|448334828|FG001|Intervention Phase|Withdrawal by Subject|2|||
124649236|NCT03045276|448334829|FG002|Intervention Phase|Withdrawal by Subject|3|||
124649237|NCT03045276|448334830|FG003|Intervention Phase|Withdrawal by Subject|7|||
124649238|NCT03045276|448334827|FG000|Intervention Phase|Developed exclusionary criteria|3|||
124649239|NCT03045276|448334828|FG001|Intervention Phase|Developed exclusionary criteria|3|||
124649240|NCT03045276|448334829|FG002|Intervention Phase|Developed exclusionary criteria|0|||
124649241|NCT03045276|448334830|FG003|Intervention Phase|Developed exclusionary criteria|0|||
124649242|NCT03045276|448334827|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
124649243|NCT03045276|448334828|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
124649244|NCT03045276|448334829|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
124649245|NCT03045276|448334830|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
124649246|NCT03045276|448334827|FG000|Follow-Up Phase|Lost to Follow-up|0|||
124649247|NCT03045276|448334828|FG001|Follow-Up Phase|Lost to Follow-up|1|||
124649248|NCT03045276|448334829|FG002|Follow-Up Phase|Lost to Follow-up|0|||
124649249|NCT03045276|448334830|FG003|Follow-Up Phase|Lost to Follow-up|1|||
124649250|NCT03045276|448334827|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
124649251|NCT03045276|448334828|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
124649252|NCT03045276|448334829|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
124649253|NCT03045276|448334830|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
124649254|NCT03379753|448334831|FG000|Overall Study|Withdrawal by Subject|2|||
124649255|NCT03379753|448334832|FG001|Overall Study|Withdrawal by Subject|1|||
124649256|NCT03379753|448334831|FG000|Overall Study|not having correct procedure|1|||
124649257|NCT03379753|448334832|FG001|Overall Study|not having correct procedure|2|||
124649258|NCT03379753|448334831|FG000|Overall Study|No primary outcome|12|||
124649259|NCT03379753|448334832|FG001|Overall Study|No primary outcome|22|||
124649260|NCT00347919|448334833|FG000|Overall Study|Lost to Follow-up|11|||
124649261|NCT00347919|448334834|FG001|Overall Study|Lost to Follow-up|13|||
124649262|NCT00347919|448334835|FG002|Overall Study|Lost to Follow-up|0|||
124649263|NCT00347919|448334833|FG000|Overall Study|Withdrawal by Subject|6|||
124649264|NCT00347919|448334834|FG001|Overall Study|Withdrawal by Subject|8|||
124649265|NCT00347919|448334835|FG002|Overall Study|Withdrawal by Subject|0|||
124649266|NCT00347919|448334833|FG000|Overall Study|Physician Decision|1|||
124649267|NCT00347919|448334834|FG001|Overall Study|Physician Decision|1|||
124649268|NCT00347919|448334835|FG002|Overall Study|Physician Decision|0|||
124649269|NCT00347919|448334833|FG000|Overall Study|Sponsor terminated study|15|||
124649270|NCT00347919|448334834|FG001|Overall Study|Sponsor terminated study|10|||
124649271|NCT00347919|448334835|FG002|Overall Study|Sponsor terminated study|16|||
124649272|NCT00347919|448334833|FG000|Overall Study|Death|35|||
124649273|NCT00347919|448334834|FG001|Overall Study|Death|42|||
124649274|NCT00347919|448334835|FG002|Overall Study|Death|19|||
124649275|NCT00347919|448334833|FG000|Overall Study|Par. Started Other Treatment|1|||
124649276|NCT00347919|448334834|FG001|Overall Study|Par. Started Other Treatment|1|||
124649277|NCT00347919|448334835|FG002|Overall Study|Par. Started Other Treatment|1|||
124649278|NCT00347919|448334833|FG000|Overall Study|Missing|2|||
124649279|NCT00347919|448334834|FG001|Overall Study|Missing|1|||
124649280|NCT00347919|448334835|FG002|Overall Study|Missing|2|||
124649281|NCT01032239|448334836|FG000|Overall Study|Lost to Follow-up|3|||
124649282|NCT01032239|448334837|FG001|Overall Study|Lost to Follow-up|2|||
124649283|NCT01032239|448334836|FG000|Overall Study|Withdrawal by Subject|2|||
124649284|NCT01032239|448334837|FG001|Overall Study|Withdrawal by Subject|3|||
124649285|NCT01032239|448334836|FG000|Overall Study|Death|1|||
124649286|NCT01032239|448334837|FG001|Overall Study|Death|0|||
124649287|NCT01032239|448334836|FG000|Overall Study|Protocol Violation|1|||
124649288|NCT01032239|448334837|FG001|Overall Study|Protocol Violation|0|||
124649289|NCT01940900|448334844|FG000|Overall Study|Physician Decision|4|||
124649290|NCT01940900|448334845|FG001|Overall Study|Physician Decision|0|||
124649291|NCT01940900|448334844|FG000|Overall Study|Adverse Event|10|||
124649292|NCT01940900|448334845|FG001|Overall Study|Adverse Event|15|||
124649293|NCT01940900|448334844|FG000|Overall Study|Withdrawal by Subject|11|||
124649294|NCT01940900|448334845|FG001|Overall Study|Withdrawal by Subject|15|||
124649295|NCT01940900|448334844|FG000|Overall Study|Lost to Follow-up|1|||
124649296|NCT01940900|448334845|FG001|Overall Study|Lost to Follow-up|0|||
124649297|NCT01940900|448334844|FG000|Overall Study|Sponsor Decision|1|||
124649298|NCT01940900|448334845|FG001|Overall Study|Sponsor Decision|0|||
124649299|NCT01940900|448334844|FG000|Overall Study|subject non-compliance|1|||
124649300|NCT01940900|448334845|FG001|Overall Study|subject non-compliance|1|||
124649301|NCT01940900|448334844|FG000|Overall Study|other|1|||
124649302|NCT01940900|448334845|FG001|Overall Study|other|0|||
124649303|NCT02225366|448334848|FG000|Overall Study|Lack of Efficacy|1|||
124649304|NCT02225366|448334849|FG001|Overall Study|Lack of Efficacy|0|||
124649305|NCT03782298|448334850|FG000|Overall Study|Protocol Deviation|4|||
124649306|NCT01382225|448334860|FG000|Overall Study|Adverse Event|3|||
124649307|NCT01382225|448334861|FG001|Overall Study|Adverse Event|2|||
124649308|NCT01382225|448334860|FG000|Overall Study|Protocol Violation|2|||
124649309|NCT01382225|448334861|FG001|Overall Study|Protocol Violation|1|||
124649310|NCT01382225|448334860|FG000|Overall Study|Subject Withdrew Consent|5|||
124649311|NCT01382225|448334861|FG001|Overall Study|Subject Withdrew Consent|2|||
124649312|NCT01382225|448334860|FG000|Overall Study|Other|4|||
124649313|NCT01382225|448334861|FG001|Overall Study|Other|2|||
124649314|NCT01797081|448334862|FG000|Overall Study|Adverse Event|1|||
124649315|NCT01797081|448334863|FG001|Overall Study|Adverse Event|0|||
124649316|NCT01797081|448334864|FG002|Overall Study|Adverse Event|1|||
124649317|NCT01797081|448334865|FG003|Overall Study|Adverse Event|0|||
124649318|NCT01797081|448334862|FG000|Overall Study|Pregnancy|1|||
124649319|NCT01797081|448334863|FG001|Overall Study|Pregnancy|0|||
124649320|NCT01797081|448334864|FG002|Overall Study|Pregnancy|0|||
124649321|NCT01797081|448334865|FG003|Overall Study|Pregnancy|0|||
124649322|NCT01797081|448334862|FG000|Overall Study|Personal Reasons|12|||
124649323|NCT01797081|448334863|FG001|Overall Study|Personal Reasons|4|||
124649324|NCT01797081|448334864|FG002|Overall Study|Personal Reasons|4|||
124649325|NCT01797081|448334865|FG003|Overall Study|Personal Reasons|8|||
124649326|NCT01797081|448334862|FG000|Overall Study|Protocol Violation|0|||
124649327|NCT01797081|448334863|FG001|Overall Study|Protocol Violation|0|||
124649328|NCT01797081|448334864|FG002|Overall Study|Protocol Violation|0|||
124649329|NCT01797081|448334865|FG003|Overall Study|Protocol Violation|1|||
124649330|NCT00819780|448334873|FG000|Overall Study|Did not receive study drug|3|||
124649331|NCT00819780|448334874|FG001|Overall Study|Did not receive study drug|4|||
124649332|NCT00819780|448334873|FG000|Overall Study|Still in treatment|25|||
124649333|NCT00819780|448334874|FG001|Overall Study|Still in treatment|17|||
124649334|NCT01793688|448334875|FG000|Overall Study|Protocol Violation|2|||
124649335|NCT02484651|448334878|FG000|Overall Study|Patients' data files were corrupted.|1|||
124649336|NCT02484651|448334879|FG001|Overall Study|Patients' data files were corrupted.|1|||
124649337|NCT02484651|448334878|FG000|Overall Study|BIS monitoring failed.|1|||
124649338|NCT02484651|448334879|FG001|Overall Study|BIS monitoring failed.|1|||
124649339|NCT02484651|448334878|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
124649340|NCT02484651|448334879|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
124649341|NCT04972968|448334880|FG000|Overall Study|Adverse Event|3|||
124649342|NCT04972968|448334881|FG001|Overall Study|Adverse Event|1|||
124649343|NCT04972968|448334882|FG002|Overall Study|Adverse Event|1|||
124649344|NCT04972968|448334883|FG003|Overall Study|Adverse Event|7|||
124649345|NCT04972968|448334880|FG000|Overall Study|Lack of Efficacy|2|||
124649346|NCT04972968|448334881|FG001|Overall Study|Lack of Efficacy|1|||
124649347|NCT04972968|448334882|FG002|Overall Study|Lack of Efficacy|0|||
124649348|NCT04972968|448334883|FG003|Overall Study|Lack of Efficacy|0|||
124649349|NCT04972968|448334880|FG000|Overall Study|Withdrawal by Subject|7|||
124649350|NCT04972968|448334881|FG001|Overall Study|Withdrawal by Subject|4|||
124649351|NCT04972968|448334882|FG002|Overall Study|Withdrawal by Subject|3|||
124649352|NCT04972968|448334883|FG003|Overall Study|Withdrawal by Subject|2|||
124649353|NCT04972968|448334880|FG000|Overall Study|Study Terminated by Sponsor|25|||
124649354|NCT04972968|448334881|FG001|Overall Study|Study Terminated by Sponsor|28|||
124649355|NCT04972968|448334882|FG002|Overall Study|Study Terminated by Sponsor|32|||
124649356|NCT04972968|448334883|FG003|Overall Study|Study Terminated by Sponsor|27|||
124649357|NCT04972968|448334880|FG000|Overall Study|Other|1|||
124649358|NCT04972968|448334881|FG001|Overall Study|Other|0|||
124649359|NCT04972968|448334882|FG002|Overall Study|Other|1|||
124649360|NCT04972968|448334883|FG003|Overall Study|Other|1|||
124649361|NCT00150800|448334884|FG000|Overall Study|Adverse Event|89|||
124649362|NCT00150800|448334884|FG000|Overall Study|Death|18|||
124649363|NCT00150800|448334884|FG000|Overall Study|Lack of Efficacy|166|||
124649364|NCT00150800|448334884|FG000|Overall Study|Lost to Follow-up|58|||
124649365|NCT00150800|448334884|FG000|Overall Study|Subject's choice|90|||
124649366|NCT00150800|448334884|FG000|Overall Study|No compliance|18|||
124649367|NCT00150800|448334884|FG000|Overall Study|IP misshandling|1|||
124649368|NCT00150800|448334884|FG000|Overall Study|Site closure|24|||
124649369|NCT00150800|448334884|FG000|Overall Study|Protocol non-adherence|2|||
124649370|NCT00150800|448334884|FG000|Overall Study|Nobody to accompany patient|1|||
124649371|NCT00150800|448334884|FG000|Overall Study|Distance too long for patient|1|||
124649372|NCT00150800|448334884|FG000|Overall Study|Neurosurgery|2|||
124649373|NCT00150800|448334884|FG000|Overall Study|BRV monotherapy|1|||
124649374|NCT00150800|448334884|FG000|Overall Study|Visit refusal|3|||
124649375|NCT00150800|448334884|FG000|Overall Study|Sponsor's request|2|||
124649376|NCT00150800|448334884|FG000|Overall Study|Generalized Epilepsy|1|||
124649377|NCT00150800|448334884|FG000|Overall Study|Moved from area/country|8|||
124649378|NCT00150800|448334884|FG000|Overall Study|PI retiring|2|||
124649379|NCT00150800|448334884|FG000|Overall Study|PI leaving site|2|||
124649380|NCT00150800|448334884|FG000|Overall Study|Patient insurance|1|||
124649381|NCT00150800|448334884|FG000|Overall Study|Surgical intervention|4|||
124649382|NCT00150800|448334884|FG000|Overall Study|Pregnancy planned|1|||
124649383|NCT00150800|448334884|FG000|Overall Study|PI discontinuation request|1|||
124649384|NCT01698879|448334885|FG000|Overall Study|Withdrawal by Subject|1|||
124649385|NCT01698879|448334886|FG001|Overall Study|Withdrawal by Subject|0|||
124649386|NCT01698879|448334887|FG002|Overall Study|Withdrawal by Subject|0|||
124649387|NCT02375555|448334895|FG000|Induction Period|Adverse Event|7|||
124649388|NCT02375555|448334895|FG000|Induction Period|Withdrawal by Subject|2|||
124649389|NCT02375555|448334895|FG000|Induction Period|Other|1|||
124649390|NCT02375555|448334895|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
124649391|NCT02375555|448334895|FG000|Maintenance Period|Adverse Event|2|||
124649392|NCT02375555|448334895|FG000|Maintenance Period|Withdrawal by Subject|4|||
124649393|NCT02375555|448334895|FG000|Maintenance Period|Death|1|||
124649394|NCT02375555|448334895|FG000|Maintenance Period|Disease Progression|5|||
124649395|NCT02375555|448334895|FG000|Maintenance Period|Patient Non-compliance|1|||
124649396|NCT02375555|448334895|FG000|Maintenance Period|Still on maintenance|16|||
124649397|NCT01744184|448334907|FG000|Overall Study|Adverse Event|1|||
124649398|NCT01744184|448334908|FG001|Overall Study|Adverse Event|0|||
124649399|NCT01744184|448334907|FG000|Overall Study|Withdrawal by Subject|0|||
124649400|NCT01744184|448334908|FG001|Overall Study|Withdrawal by Subject|1|||
124649401|NCT01263782|448334916|FG000|Overall Study|Death|0|||
124649402|NCT01263782|448334917|FG001|Overall Study|Death|0|||
124649403|NCT01263782|448334918|FG002|Overall Study|Death|1|||
124649404|NCT01263782|448334919|FG003|Overall Study|Death|0|||
124649405|NCT01263782|448334916|FG000|Overall Study|Progressive disease|0|||
124649406|NCT01263782|448334917|FG001|Overall Study|Progressive disease|0|||
124649407|NCT01263782|448334918|FG002|Overall Study|Progressive disease|0|||
124649408|NCT01263782|448334919|FG003|Overall Study|Progressive disease|1|||
124649409|NCT01263782|448334916|FG000|Overall Study|Too early|0|||
124649410|NCT01263782|448334917|FG001|Overall Study|Too early|0|||
124649411|NCT01263782|448334918|FG002|Overall Study|Too early|1|||
124649412|NCT01263782|448334919|FG003|Overall Study|Too early|0|||
124649413|NCT01263782|448334916|FG000|Overall Study|Inevaluable|0|||
124649414|NCT01263782|448334917|FG001|Overall Study|Inevaluable|0|||
124649415|NCT01263782|448334918|FG002|Overall Study|Inevaluable|1|||
124649416|NCT01263782|448334919|FG003|Overall Study|Inevaluable|0|||
124649417|NCT04545567|448334921|FG000|Overall Study|tested positive for SARS-co-V2|1|||
124649418|NCT04545567|448334922|FG001|Overall Study|tested positive for SARS-co-V2|1|||
124649419|NCT04545567|448334921|FG000|Overall Study|Withdrawal by Subject|0|||
124649420|NCT04545567|448334922|FG001|Overall Study|Withdrawal by Subject|1|||
124649421|NCT03026530|448334933|FG000|Overall Study|Lost to Follow-up|19|||
124649422|NCT03026530|448334934|FG001|Overall Study|Lost to Follow-up|24|||
124649423|NCT03026530|448334933|FG000|Overall Study|Protocol Violation|2|||
124649424|NCT03026530|448334934|FG001|Overall Study|Protocol Violation|5|||
124649425|NCT03721835|448334935|FG000|Overall Study|Participant not able to return|1|||
124649426|NCT03721835|448334935|FG000|Overall Study|Lost to Follow-up|1|||
124649427|NCT03721835|448334935|FG000|Overall Study|Revision of the components of the study device|2|||
124649428|NCT03721835|448334935|FG000|Overall Study|Sponsor terminated study|6|||
124649429|NCT03721835|448334935|FG000|Overall Study|Death|1|||
124649430|NCT03721835|448334935|FG000|Overall Study|Sponsor decision|1|||
124649431|NCT05079750|448336680|FG000|Overall Study|Lost to Follow-up|0|||
124649432|NCT05079750|448336681|FG001|Overall Study|Lost to Follow-up|0|||
124649433|NCT05079750|448336682|FG002|Overall Study|Lost to Follow-up|1|||
124649434|NCT05897827|448336683|FG000|Overall Study|Lost to Follow-up|33|||
124649435|NCT05897827|448336684|FG001|Overall Study|Lost to Follow-up|14|||
124649436|NCT05897827|448336683|FG000|Overall Study|Withdrawal by Subject|1|||
124649437|NCT05897827|448336684|FG001|Overall Study|Withdrawal by Subject|1|||
124649438|NCT02017717|448336685|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
124649439|NCT02017717|448336686|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
124649440|NCT02017717|448336687|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
124649441|NCT02017717|448336688|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
124649442|NCT02017717|448336689|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
124649443|NCT02017717|448336690|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
124872581|NCT01621880|449155669|FG000|Overall Study|Withdrawal by Subject|5|||
124649444|NCT02017717|448336691|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
124649445|NCT02017717|448336692|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
124649446|NCT02017717|448336693|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
124649447|NCT02017717|448336685|FG000|Before Treatment Period|Participant request to stop therapy|0|||
124649448|NCT02017717|448336686|FG001|Before Treatment Period|Participant request to stop therapy|0|||
124649449|NCT02017717|448336687|FG002|Before Treatment Period|Participant request to stop therapy|0|||
124649450|NCT02017717|448336688|FG003|Before Treatment Period|Participant request to stop therapy|0|||
124649451|NCT02017717|448336689|FG004|Before Treatment Period|Participant request to stop therapy|0|||
124649452|NCT02017717|448336690|FG005|Before Treatment Period|Participant request to stop therapy|0|||
124649453|NCT02017717|448336691|FG006|Before Treatment Period|Participant request to stop therapy|0|||
124649454|NCT02017717|448336692|FG007|Before Treatment Period|Participant request to stop therapy|0|||
124649455|NCT02017717|448336693|FG008|Before Treatment Period|Participant request to stop therapy|5|||
124649456|NCT02017717|448336685|FG000|Before Treatment Period|Participant withdrew consent|0|||
124649457|NCT02017717|448336686|FG001|Before Treatment Period|Participant withdrew consent|0|||
124649458|NCT02017717|448336687|FG002|Before Treatment Period|Participant withdrew consent|0|||
124649459|NCT02017717|448336688|FG003|Before Treatment Period|Participant withdrew consent|0|||
124649460|NCT02017717|448336689|FG004|Before Treatment Period|Participant withdrew consent|0|||
124649461|NCT02017717|448336690|FG005|Before Treatment Period|Participant withdrew consent|0|||
124649462|NCT02017717|448336691|FG006|Before Treatment Period|Participant withdrew consent|2|||
124649463|NCT02017717|448336692|FG007|Before Treatment Period|Participant withdrew consent|0|||
124649464|NCT02017717|448336693|FG008|Before Treatment Period|Participant withdrew consent|11|||
124649465|NCT02017717|448336685|FG000|Before Treatment Period|Lost to Follow-up|0|||
124649466|NCT02017717|448336686|FG001|Before Treatment Period|Lost to Follow-up|0|||
124649467|NCT02017717|448336687|FG002|Before Treatment Period|Lost to Follow-up|0|||
124649468|NCT02017717|448336688|FG003|Before Treatment Period|Lost to Follow-up|0|||
124649469|NCT02017717|448336689|FG004|Before Treatment Period|Lost to Follow-up|0|||
124872582|NCT01621880|449155670|FG001|Overall Study|Withdrawal by Subject|4|||
124649470|NCT02017717|448336690|FG005|Before Treatment Period|Lost to Follow-up|0|||
124649471|NCT02017717|448336691|FG006|Before Treatment Period|Lost to Follow-up|0|||
124649472|NCT02017717|448336692|FG007|Before Treatment Period|Lost to Follow-up|0|||
124649473|NCT02017717|448336693|FG008|Before Treatment Period|Lost to Follow-up|1|||
124649474|NCT02017717|448336685|FG000|Before Treatment Period|Participant no longer met criteria|0|||
124649475|NCT02017717|448336686|FG001|Before Treatment Period|Participant no longer met criteria|0|||
124649476|NCT02017717|448336687|FG002|Before Treatment Period|Participant no longer met criteria|0|||
124649477|NCT02017717|448336688|FG003|Before Treatment Period|Participant no longer met criteria|0|||
124649478|NCT02017717|448336689|FG004|Before Treatment Period|Participant no longer met criteria|0|||
124649479|NCT02017717|448336690|FG005|Before Treatment Period|Participant no longer met criteria|1|||
124649480|NCT02017717|448336691|FG006|Before Treatment Period|Participant no longer met criteria|0|||
124649481|NCT02017717|448336692|FG007|Before Treatment Period|Participant no longer met criteria|1|||
124649482|NCT02017717|448336693|FG008|Before Treatment Period|Participant no longer met criteria|2|||
124649483|NCT02017717|448336685|FG000|Before Treatment Period|other reason|0|||
124649484|NCT02017717|448336686|FG001|Before Treatment Period|other reason|0|||
124649485|NCT02017717|448336687|FG002|Before Treatment Period|other reason|0|||
124649486|NCT02017717|448336688|FG003|Before Treatment Period|other reason|0|||
124649487|NCT02017717|448336689|FG004|Before Treatment Period|other reason|0|||
124649488|NCT02017717|448336690|FG005|Before Treatment Period|other reason|0|||
124649489|NCT02017717|448336691|FG006|Before Treatment Period|other reason|0|||
124649490|NCT02017717|448336692|FG007|Before Treatment Period|other reason|0|||
124649491|NCT02017717|448336693|FG008|Before Treatment Period|other reason|1|||
124649492|NCT02017717|448336685|FG000|Treatment Period|Disease progression|7|||
124649493|NCT02017717|448336686|FG001|Treatment Period|Disease progression|9|||
124649494|NCT02017717|448336687|FG002|Treatment Period|Disease progression|12|||
124649495|NCT02017717|448336688|FG003|Treatment Period|Disease progression|20|||
124649496|NCT02017717|448336689|FG004|Treatment Period|Disease progression|26|||
124649497|NCT02017717|448336690|FG005|Treatment Period|Disease progression|16|||
124649498|NCT02017717|448336691|FG006|Treatment Period|Disease progression|22|||
124649499|NCT02017717|448336692|FG007|Treatment Period|Disease progression|165|||
124649500|NCT02017717|448336693|FG008|Treatment Period|Disease progression|135|||
124649501|NCT02017717|448336685|FG000|Treatment Period|Study drug toxicity|3|||
124649502|NCT02017717|448336686|FG001|Treatment Period|Study drug toxicity|0|||
124649503|NCT02017717|448336687|FG002|Treatment Period|Study drug toxicity|1|||
124649504|NCT02017717|448336688|FG003|Treatment Period|Study drug toxicity|4|||
124649505|NCT02017717|448336689|FG004|Treatment Period|Study drug toxicity|4|||
124649506|NCT02017717|448336690|FG005|Treatment Period|Study drug toxicity|5|||
124649507|NCT02017717|448336691|FG006|Treatment Period|Study drug toxicity|3|||
124649508|NCT02017717|448336692|FG007|Treatment Period|Study drug toxicity|7|||
124649509|NCT02017717|448336693|FG008|Treatment Period|Study drug toxicity|11|||
124649510|NCT02017717|448336685|FG000|Treatment Period|Death|0|||
124649511|NCT02017717|448336686|FG001|Treatment Period|Death|0|||
124649512|NCT02017717|448336687|FG002|Treatment Period|Death|1|||
124649513|NCT02017717|448336688|FG003|Treatment Period|Death|0|||
124649514|NCT02017717|448336689|FG004|Treatment Period|Death|0|||
124649515|NCT02017717|448336690|FG005|Treatment Period|Death|2|||
124649516|NCT02017717|448336691|FG006|Treatment Period|Death|0|||
124649517|NCT02017717|448336692|FG007|Treatment Period|Death|0|||
124649518|NCT02017717|448336693|FG008|Treatment Period|Death|0|||
124649519|NCT02017717|448336685|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
124649520|NCT02017717|448336686|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
124649521|NCT02017717|448336687|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
124769816|NCT01502293|448785206|FG002|Overall Study|Adverse Event|0|||
124649522|NCT02017717|448336688|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
124649523|NCT02017717|448336689|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
124649524|NCT02017717|448336690|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
124649525|NCT02017717|448336691|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
124649526|NCT02017717|448336692|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
124649527|NCT02017717|448336693|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
124649528|NCT02017717|448336685|FG000|Treatment Period|Participant request to stop therapy|0|||
124649529|NCT02017717|448336686|FG001|Treatment Period|Participant request to stop therapy|0|||
124649530|NCT02017717|448336687|FG002|Treatment Period|Participant request to stop therapy|3|||
124649531|NCT02017717|448336688|FG003|Treatment Period|Participant request to stop therapy|6|||
124649532|NCT02017717|448336689|FG004|Treatment Period|Participant request to stop therapy|0|||
124649533|NCT02017717|448336690|FG005|Treatment Period|Participant request to stop therapy|2|||
124649534|NCT02017717|448336691|FG006|Treatment Period|Participant request to stop therapy|1|||
124649535|NCT02017717|448336692|FG007|Treatment Period|Participant request to stop therapy|4|||
124649536|NCT02017717|448336693|FG008|Treatment Period|Participant request to stop therapy|7|||
124649537|NCT02017717|448336685|FG000|Treatment Period|Participant withdrew consent|0|||
124649538|NCT02017717|448336686|FG001|Treatment Period|Participant withdrew consent|0|||
124649539|NCT02017717|448336687|FG002|Treatment Period|Participant withdrew consent|1|||
124649540|NCT02017717|448336688|FG003|Treatment Period|Participant withdrew consent|0|||
124649541|NCT02017717|448336689|FG004|Treatment Period|Participant withdrew consent|0|||
124649542|NCT02017717|448336690|FG005|Treatment Period|Participant withdrew consent|2|||
124649543|NCT02017717|448336691|FG006|Treatment Period|Participant withdrew consent|0|||
124649544|NCT02017717|448336692|FG007|Treatment Period|Participant withdrew consent|1|||
124649545|NCT02017717|448336693|FG008|Treatment Period|Participant withdrew consent|4|||
124649546|NCT02017717|448336685|FG000|Treatment Period|Participant no longer met criteria|0|||
124649547|NCT02017717|448336686|FG001|Treatment Period|Participant no longer met criteria|0|||
124649548|NCT02017717|448336687|FG002|Treatment Period|Participant no longer met criteria|0|||
124649549|NCT02017717|448336688|FG003|Treatment Period|Participant no longer met criteria|0|||
124649550|NCT02017717|448336689|FG004|Treatment Period|Participant no longer met criteria|0|||
124872583|NCT01127646|449155671|FG000|Overall Study|Entry Criteria Not Met|1|||
124649551|NCT02017717|448336690|FG005|Treatment Period|Participant no longer met criteria|0|||
124872584|NCT01127646|449155672|FG001|Overall Study|Entry Criteria Not Met|0|||
124649552|NCT02017717|448336691|FG006|Treatment Period|Participant no longer met criteria|0|||
124649553|NCT02017717|448336692|FG007|Treatment Period|Participant no longer met criteria|0|||
124649554|NCT02017717|448336693|FG008|Treatment Period|Participant no longer met criteria|1|||
124649555|NCT02017717|448336685|FG000|Treatment Period|Other reasons|0|||
124649556|NCT02017717|448336686|FG001|Treatment Period|Other reasons|0|||
124649557|NCT02017717|448336687|FG002|Treatment Period|Other reasons|0|||
124649558|NCT02017717|448336688|FG003|Treatment Period|Other reasons|1|||
124649559|NCT02017717|448336689|FG004|Treatment Period|Other reasons|0|||
124649560|NCT02017717|448336690|FG005|Treatment Period|Other reasons|1|||
124649561|NCT02017717|448336691|FG006|Treatment Period|Other reasons|1|||
124649562|NCT02017717|448336692|FG007|Treatment Period|Other reasons|1|||
124649563|NCT02017717|448336693|FG008|Treatment Period|Other reasons|1|||
124649564|NCT02017717|448336685|FG000|Treatment Period|Maximum clinical benefit|0|||
124649565|NCT02017717|448336686|FG001|Treatment Period|Maximum clinical benefit|0|||
124649566|NCT02017717|448336687|FG002|Treatment Period|Maximum clinical benefit|0|||
124649567|NCT02017717|448336688|FG003|Treatment Period|Maximum clinical benefit|0|||
124649568|NCT02017717|448336689|FG004|Treatment Period|Maximum clinical benefit|0|||
124649569|NCT02017717|448336690|FG005|Treatment Period|Maximum clinical benefit|0|||
124649570|NCT02017717|448336691|FG006|Treatment Period|Maximum clinical benefit|0|||
124649571|NCT02017717|448336692|FG007|Treatment Period|Maximum clinical benefit|0|||
124649572|NCT02017717|448336693|FG008|Treatment Period|Maximum clinical benefit|1|||
124649573|NCT02017717|448336685|FG000|Treatment Period|Not reported|0|||
124649574|NCT02017717|448336686|FG001|Treatment Period|Not reported|1|||
124649575|NCT02017717|448336687|FG002|Treatment Period|Not reported|0|||
124649576|NCT02017717|448336688|FG003|Treatment Period|Not reported|0|||
124649577|NCT02017717|448336689|FG004|Treatment Period|Not reported|0|||
124649578|NCT02017717|448336690|FG005|Treatment Period|Not reported|0|||
124649579|NCT02017717|448336691|FG006|Treatment Period|Not reported|0|||
124649580|NCT02017717|448336692|FG007|Treatment Period|Not reported|0|||
124649581|NCT02017717|448336693|FG008|Treatment Period|Not reported|0|||
124649582|NCT04161079|448336694|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
124649583|NCT03617861|448336697|FG000|Second Intervention (1 Day)|Adverse Event|0|||
124649584|NCT03617861|448336698|FG001|Second Intervention (1 Day)|Adverse Event|0|||
124649585|NCT03617861|448336699|FG002|Second Intervention (1 Day)|Adverse Event|1|||
124649586|NCT03617861|448336700|FG003|Second Intervention (1 Day)|Adverse Event|0|||
124649587|NCT00623597|448336701|FG000|Overall Study|Failed to return|1|||
124649588|NCT00623597|448336702|FG001|Overall Study|Failed to return|0|||
124649589|NCT02515994|448336703|FG000|Overall Study|Protocol Violation|3|||
124649590|NCT02515994|448336704|FG001|Overall Study|Protocol Violation|5|||
124649591|NCT02515994|448336703|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
124649592|NCT02515994|448336704|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
124649593|NCT02515994|448336703|FG000|Overall Study|Adverse Event|3|||
124649594|NCT02515994|448336704|FG001|Overall Study|Adverse Event|1|||
124649595|NCT02515994|448336703|FG000|Overall Study|Withdrawal by Subject|2|||
124649596|NCT02515994|448336704|FG001|Overall Study|Withdrawal by Subject|0|||
124649597|NCT01668966|448336714|FG000|Overall Study|Withdrawal by Subject|1|||
124649598|NCT01668966|448336714|FG000|Overall Study|Death|1|||
124649599|NCT01668966|448336714|FG000|Overall Study|Not treated|2|||
124649600|NCT00345878|448336719|FG000|Overall Study|Adverse Event|1|||
124649601|NCT00345878|448336720|FG001|Overall Study|Adverse Event|0|||
124649602|NCT00345878|448336719|FG000|Overall Study|Lost to Follow-up|2|||
124649603|NCT00345878|448336720|FG001|Overall Study|Lost to Follow-up|1|||
124649604|NCT00345878|448336719|FG000|Overall Study|Other|1|||
124649605|NCT00345878|448336720|FG001|Overall Study|Other|0|||
124649606|NCT00552032|448336721|FG000|Overall Study|Withdrawal by Subject|2|||
124649607|NCT00552032|448336722|FG001|Overall Study|Withdrawal by Subject|2|||
124649608|NCT00552032|448336721|FG000|Overall Study|Protocol Violation|7|||
124649609|NCT00552032|448336722|FG001|Overall Study|Protocol Violation|12|||
124649610|NCT00552032|448336721|FG000|Overall Study|Lost to Follow-up|8|||
124649611|NCT00552032|448336722|FG001|Overall Study|Lost to Follow-up|5|||
124649612|NCT01643798|448336723|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
124649613|NCT01643798|448336724|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
124649614|NCT00984061|448336730|FG000|Clarithromycin Alone|Protocol Violation|1|||
124649615|NCT00614120|448336732|FG000|Overall Study|Adverse Event|9|||
124649616|NCT00614120|448336733|FG001|Overall Study|Adverse Event|22|||
124649617|NCT00614120|448336734|FG002|Overall Study|Adverse Event|30|||
124649618|NCT00614120|448336735|FG003|Overall Study|Adverse Event|3|||
124649619|NCT00614120|448336732|FG000|Overall Study|Lack of Efficacy|3|||
124649620|NCT00614120|448336733|FG001|Overall Study|Lack of Efficacy|3|||
124649621|NCT00614120|448336734|FG002|Overall Study|Lack of Efficacy|2|||
124649622|NCT00614120|448336735|FG003|Overall Study|Lack of Efficacy|2|||
124649623|NCT00614120|448336732|FG000|Overall Study|Protocol Violation|2|||
124649624|NCT00614120|448336733|FG001|Overall Study|Protocol Violation|5|||
124649625|NCT00614120|448336734|FG002|Overall Study|Protocol Violation|3|||
124649626|NCT00614120|448336735|FG003|Overall Study|Protocol Violation|1|||
124649627|NCT00614120|448336732|FG000|Overall Study|Withdrawal criteria|1|||
124649628|NCT00614120|448336733|FG001|Overall Study|Withdrawal criteria|0|||
124649629|NCT00614120|448336734|FG002|Overall Study|Withdrawal criteria|0|||
124649630|NCT00614120|448336735|FG003|Overall Study|Withdrawal criteria|0|||
124649631|NCT00614120|448336732|FG000|Overall Study|Withdrawal by Subject|9|||
124649632|NCT00614120|448336733|FG001|Overall Study|Withdrawal by Subject|10|||
124649633|NCT00614120|448336734|FG002|Overall Study|Withdrawal by Subject|16|||
124649634|NCT00614120|448336735|FG003|Overall Study|Withdrawal by Subject|3|||
124649635|NCT00614120|448336732|FG000|Overall Study|Did not meet trial criteria|0|||
124649636|NCT00614120|448336733|FG001|Overall Study|Did not meet trial criteria|1|||
124649637|NCT00614120|448336734|FG002|Overall Study|Did not meet trial criteria|1|||
124649638|NCT00614120|448336735|FG003|Overall Study|Did not meet trial criteria|1|||
124649639|NCT00614120|448336732|FG000|Overall Study|hCG positive (not pregnant)|0|||
124649640|NCT00614120|448336733|FG001|Overall Study|hCG positive (not pregnant)|0|||
124649641|NCT00614120|448336734|FG002|Overall Study|hCG positive (not pregnant)|1|||
124649642|NCT00614120|448336735|FG003|Overall Study|hCG positive (not pregnant)|0|||
124649643|NCT00614120|448336732|FG000|Overall Study|Hypoglycaemia|0|||
124649644|NCT00614120|448336733|FG001|Overall Study|Hypoglycaemia|0|||
124649645|NCT00614120|448336734|FG002|Overall Study|Hypoglycaemia|0|||
124649646|NCT00614120|448336735|FG003|Overall Study|Hypoglycaemia|1|||
124649647|NCT00614120|448336732|FG000|Overall Study|Lack of trial product|3|||
124649648|NCT00614120|448336733|FG001|Overall Study|Lack of trial product|3|||
124649649|NCT00614120|448336734|FG002|Overall Study|Lack of trial product|2|||
124649650|NCT00614120|448336735|FG003|Overall Study|Lack of trial product|0|||
124649651|NCT00614120|448336732|FG000|Overall Study|Late syphilis, latent|1|||
124649652|NCT00614120|448336733|FG001|Overall Study|Late syphilis, latent|0|||
124649653|NCT00614120|448336734|FG002|Overall Study|Late syphilis, latent|0|||
124649654|NCT00614120|448336735|FG003|Overall Study|Late syphilis, latent|0|||
124649655|NCT00614120|448336732|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
124649656|NCT00614120|448336733|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
124649657|NCT00614120|448336734|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
124649658|NCT00614120|448336735|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
124649659|NCT00614120|448336732|FG000|Overall Study|Lost to Follow-up|1|||
124649660|NCT00614120|448336733|FG001|Overall Study|Lost to Follow-up|2|||
124649661|NCT00614120|448336734|FG002|Overall Study|Lost to Follow-up|3|||
124649662|NCT00614120|448336735|FG003|Overall Study|Lost to Follow-up|4|||
124649663|NCT03047720|448336736|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
124649664|NCT03047720|448336737|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
124649665|NCT03602391|448336744|FG000|Overall Study|COVID-19|7|||
124649666|NCT03602391|448336745|FG001|Overall Study|COVID-19|6|||
124649667|NCT01527487|448336756|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
124649668|NCT01527487|448336757|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
124649669|NCT01527487|448336756|FG000|Overall Study|Disease Progression|4|||
124649670|NCT01527487|448336757|FG001|Overall Study|Disease Progression|1|||
124649671|NCT01527487|448336756|FG000|Overall Study|Adverse Event|1|||
124649672|NCT01527487|448336757|FG001|Overall Study|Adverse Event|1|||
124649673|NCT01527487|448336756|FG000|Overall Study|Death|0|||
124649674|NCT01527487|448336757|FG001|Overall Study|Death|1|||
124649675|NCT02258542|448336762|FG000|Overall Study|eg. not made to the visit|7|||
124649676|NCT02258542|448336763|FG001|Overall Study|eg. not made to the visit|4|||
124649677|NCT02258542|448336764|FG002|Overall Study|eg. not made to the visit|0|||
124649678|NCT02258542|448336765|FG003|Overall Study|eg. not made to the visit|1|||
124649679|NCT02258542|448336762|FG000|Overall Study|study specific discount. criteria|1|||
124649680|NCT02258542|448336763|FG001|Overall Study|study specific discount. criteria|1|||
124649681|NCT02258542|448336764|FG002|Overall Study|study specific discount. criteria|0|||
124649682|NCT02258542|448336765|FG003|Overall Study|study specific discount. criteria|0|||
124649683|NCT02258542|448336762|FG000|Overall Study|Withdrawal by Subject|20|||
124649684|NCT02258542|448336763|FG001|Overall Study|Withdrawal by Subject|20|||
124649685|NCT02258542|448336764|FG002|Overall Study|Withdrawal by Subject|7|||
124649686|NCT02258542|448336765|FG003|Overall Study|Withdrawal by Subject|1|||
124649687|NCT02258542|448336762|FG000|Overall Study|Lost to Follow-up|5|||
124649688|NCT02258542|448336763|FG001|Overall Study|Lost to Follow-up|12|||
124649689|NCT02258542|448336764|FG002|Overall Study|Lost to Follow-up|1|||
124649690|NCT02258542|448336765|FG003|Overall Study|Lost to Follow-up|2|||
124649691|NCT02258542|448336762|FG000|Overall Study|Death|5|||
124649692|NCT02258542|448336763|FG001|Overall Study|Death|4|||
124872585|NCT01127646|449155671|FG000|Overall Study|Protocol Violation|0|||
124649693|NCT02258542|448336764|FG002|Overall Study|Death|0|||
124649694|NCT02258542|448336765|FG003|Overall Study|Death|1|||
124872586|NCT01127646|449155672|FG001|Overall Study|Protocol Violation|1|||
124649695|NCT02258542|448336762|FG000|Overall Study|Adverse Event|3|||
124649696|NCT02258542|448336763|FG001|Overall Study|Adverse Event|4|||
124649697|NCT02258542|448336764|FG002|Overall Study|Adverse Event|0|||
124649698|NCT02258542|448336765|FG003|Overall Study|Adverse Event|0|||
124649699|NCT02258542|448336762|FG000|Overall Study|Protocol Violation|1|||
124649700|NCT02258542|448336763|FG001|Overall Study|Protocol Violation|2|||
124649701|NCT02258542|448336764|FG002|Overall Study|Protocol Violation|0|||
124649702|NCT02258542|448336765|FG003|Overall Study|Protocol Violation|0|||
124649703|NCT02258542|448336762|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124649704|NCT02258542|448336763|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
124649705|NCT02258542|448336764|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
124649706|NCT02258542|448336765|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
124649707|NCT00986986|448336766|FG000|Overall Study|Lost to Follow-up|0|||
124649708|NCT00986986|448336767|FG001|Overall Study|Lost to Follow-up|1|||
124649709|NCT02419612|448336769|FG000|Short-term Treatment Period|Adverse Event|1|||
124649710|NCT02419612|448336770|FG001|Short-term Treatment Period|Adverse Event|1|||
124649711|NCT02419612|448336769|FG000|Short-term Treatment Period|Death|0|||
124649712|NCT02419612|448336770|FG001|Short-term Treatment Period|Death|2|||
124649713|NCT02419612|448336769|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
124649714|NCT02419612|448336770|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
124649715|NCT02419612|448336769|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
124649716|NCT02419612|448336770|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
124649717|NCT02419612|448336769|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
124649718|NCT02419612|448336770|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
124649719|NCT02419612|448336769|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
124649720|NCT02419612|448336770|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
124649721|NCT02419612|448336769|FG000|Short-term Treatment Period|Worsening of liver function|0|||
124649722|NCT02419612|448336770|FG001|Short-term Treatment Period|Worsening of liver function|1|||
124649723|NCT02419612|448336769|FG000|Short-term Treatment Period|Subject moved out of state|0|||
124649724|NCT02419612|448336770|FG001|Short-term Treatment Period|Subject moved out of state|1|||
124649725|NCT02419612|448336769|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
124649726|NCT02419612|448336770|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
124649727|NCT02419612|448336769|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
124649728|NCT02419612|448336770|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
124649729|NCT02419612|448336769|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
124649730|NCT02419612|448336770|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
124649731|NCT02419612|448336769|FG000|Long-term Treatment Period|Death|0|||
124649732|NCT02419612|448336770|FG001|Long-term Treatment Period|Death|1|||
124649733|NCT02419612|448336769|FG000|Long-term Treatment Period|Adverse Event|0|||
124649734|NCT02419612|448336770|FG001|Long-term Treatment Period|Adverse Event|5|||
124649735|NCT02419612|448336769|FG000|Long-term Treatment Period|Other|4|||
124649736|NCT02419612|448336770|FG001|Long-term Treatment Period|Other|4|||
124649737|NCT02419612|448336769|FG000|Long-term Treatment Period|Subject Decision|2|||
124649738|NCT02419612|448336770|FG001|Long-term Treatment Period|Subject Decision|4|||
124649739|NCT02419612|448336769|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
124649740|NCT02419612|448336770|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
124649741|NCT01095978|448336777|FG000|Overall Study|Did not take Klacid SR|2|||
124649742|NCT01095978|448336777|FG000|Overall Study|Adverse Event|1|||
124649743|NCT02135107|448336778|FG000|Treatment Period|Withdrawal by Subject|11|||
124649744|NCT02135107|448336779|FG001|Treatment Period|Withdrawal by Subject|0|||
124649745|NCT02135107|448336780|FG002|Treatment Period|Withdrawal by Subject|0|||
124649746|NCT02135107|448336781|FG003|Treatment Period|Withdrawal by Subject|0|||
124649747|NCT02135107|448336778|FG000|Treatment Period|Adverse Event|5|||
124649748|NCT02135107|448336779|FG001|Treatment Period|Adverse Event|2|||
124649749|NCT02135107|448336780|FG002|Treatment Period|Adverse Event|0|||
124649750|NCT02135107|448336781|FG003|Treatment Period|Adverse Event|0|||
124649751|NCT02135107|448336778|FG000|Treatment Period|Pregnancy|1|||
124649752|NCT02135107|448336779|FG001|Treatment Period|Pregnancy|0|||
124649753|NCT02135107|448336780|FG002|Treatment Period|Pregnancy|0|||
124649754|NCT02135107|448336781|FG003|Treatment Period|Pregnancy|0|||
124649755|NCT02135107|448336778|FG000|Treatment Period|Other|115|||
124649756|NCT02135107|448336779|FG001|Treatment Period|Other|24|||
124649757|NCT02135107|448336780|FG002|Treatment Period|Other|0|||
124649758|NCT02135107|448336781|FG003|Treatment Period|Other|0|||
124649759|NCT02135107|448336778|FG000|Maintenance Therapy Period|Adverse Event|0|||
124649760|NCT02135107|448336779|FG001|Maintenance Therapy Period|Adverse Event|0|||
124649761|NCT02135107|448336780|FG002|Maintenance Therapy Period|Adverse Event|3|||
124649762|NCT02135107|448336781|FG003|Maintenance Therapy Period|Adverse Event|7|||
124649763|NCT02135107|448336778|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
124649764|NCT02135107|448336779|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
124649765|NCT02135107|448336780|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
124649766|NCT02135107|448336781|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
124649767|NCT02135107|448336778|FG000|Maintenance Therapy Period|Pregnancy|0|||
124649768|NCT02135107|448336779|FG001|Maintenance Therapy Period|Pregnancy|0|||
124649769|NCT02135107|448336780|FG002|Maintenance Therapy Period|Pregnancy|0|||
124649770|NCT02135107|448336781|FG003|Maintenance Therapy Period|Pregnancy|1|||
124649771|NCT02135107|448336778|FG000|Maintenance Therapy Period|Other|0|||
124649772|NCT02135107|448336779|FG001|Maintenance Therapy Period|Other|0|||
124649773|NCT02135107|448336780|FG002|Maintenance Therapy Period|Other|7|||
124649774|NCT02135107|448336781|FG003|Maintenance Therapy Period|Other|8|||
124649775|NCT00474045|448336782|FG000|Overall Study|Adverse Event|18|||
124649776|NCT00474045|448336783|FG001|Overall Study|Adverse Event|8|||
124649777|NCT00474045|448336782|FG000|Overall Study|Unclassified|1|||
124649778|NCT00474045|448336783|FG001|Overall Study|Unclassified|3|||
124649779|NCT00474045|448336782|FG000|Overall Study|Lack of Efficacy|0|||
124649780|NCT00474045|448336783|FG001|Overall Study|Lack of Efficacy|9|||
124649781|NCT00474045|448336782|FG000|Overall Study|Lost to Follow-up|1|||
124649782|NCT00474045|448336783|FG001|Overall Study|Lost to Follow-up|1|||
124649783|NCT00474045|448336782|FG000|Overall Study|Protocol Violation|10|||
124649784|NCT00474045|448336783|FG001|Overall Study|Protocol Violation|12|||
124649785|NCT00474045|448336782|FG000|Overall Study|Withdrawal by Subject|16|||
124649786|NCT00474045|448336783|FG001|Overall Study|Withdrawal by Subject|18|||
124649787|NCT00474045|448336782|FG000|Overall Study|Withdrawal criteria|60|||
124649788|NCT00474045|448336783|FG001|Overall Study|Withdrawal criteria|50|||
124649789|NCT02009397|448336786|FG000|Overall Study|Protocol Violation|6|||
124649790|NCT02009397|448336786|FG000|Overall Study|Death|8|||
124649791|NCT02009397|448336786|FG000|Overall Study|Lost to Follow-up|6|||
124649792|NCT02278120|448336789|FG000|Treatment Period|Progressive disease|234|||
124649793|NCT02278120|448336790|FG001|Treatment Period|Progressive disease|260|||
124649794|NCT02278120|448336789|FG000|Treatment Period|Subject/guardian decision|23|||
124649795|NCT02278120|448336790|FG001|Treatment Period|Subject/guardian decision|20|||
124649796|NCT02278120|448336789|FG000|Treatment Period|Adverse Event|16|||
124649797|NCT02278120|448336790|FG001|Treatment Period|Adverse Event|14|||
124649798|NCT02278120|448336789|FG000|Treatment Period|Physician Decision|14|||
124649799|NCT02278120|448336790|FG001|Treatment Period|Physician Decision|27|||
124649800|NCT02278120|448336789|FG000|Treatment Period|Death|3|||
124649801|NCT02278120|448336790|FG001|Treatment Period|Death|3|||
124649802|NCT02278120|448336789|FG000|Treatment Period|Lost to Follow-up|2|||
124649803|NCT02278120|448336790|FG001|Treatment Period|Lost to Follow-up|0|||
124649804|NCT02278120|448336789|FG000|Treatment Period|Protocol deviation|0|||
124649805|NCT02278120|448336790|FG001|Treatment Period|Protocol deviation|2|||
124649806|NCT02278120|448336789|FG000|Treatment Period|Study terminated as per protocol|43|||
124649807|NCT02278120|448336790|FG001|Treatment Period|Study terminated as per protocol|11|||
124649808|NCT02278120|448336789|FG000|Post-treatment Efficacy Follow-up|Death|0|||
124649809|NCT02278120|448336790|FG001|Post-treatment Efficacy Follow-up|Death|1|||
124649810|NCT02278120|448336789|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
124649811|NCT02278120|448336790|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
124649812|NCT02278120|448336789|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
124649813|NCT02278120|448336790|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
124649814|NCT02278120|448336789|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
124649815|NCT02278120|448336790|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
124649816|NCT02278120|448336789|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
124649817|NCT02278120|448336790|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
124649818|NCT01966068|448336796|FG000|Overall Study|Withdrawal by Subject|57|||
124649819|NCT01966068|448336796|FG000|Overall Study|Lost to Follow-up|81|||
124649820|NCT00808639|448336797|FG000|Overall Study|Disease progression before surgery.|1|||
124649821|NCT00191282|448336802|FG000|Overall Study|Adverse Event|5|||
124649822|NCT00191282|448336803|FG001|Overall Study|Adverse Event|6|||
124649823|NCT00191282|448336802|FG000|Overall Study|Death|51|||
124649824|NCT00191282|448336803|FG001|Overall Study|Death|51|||
124649825|NCT00191282|448336802|FG000|Overall Study|Lack of Efficacy|11|||
124649826|NCT00191282|448336803|FG001|Overall Study|Lack of Efficacy|6|||
124649827|NCT00191282|448336802|FG000|Overall Study|Noncompliance|14|||
124649828|NCT00191282|448336803|FG001|Overall Study|Noncompliance|17|||
124649829|NCT00191282|448336802|FG000|Overall Study|Patient moved|11|||
124649830|NCT00191282|448336803|FG001|Overall Study|Patient moved|14|||
124649831|NCT00191282|448336802|FG000|Overall Study|Withdrawal by Subject|59|||
124649832|NCT00191282|448336803|FG001|Overall Study|Withdrawal by Subject|44|||
124649833|NCT00191282|448336802|FG000|Overall Study|Physician Decision|18|||
124649834|NCT00191282|448336803|FG001|Overall Study|Physician Decision|15|||
124649835|NCT00191282|448336802|FG000|Overall Study|Protocol entry criteria not met|14|||
124649836|NCT00191282|448336803|FG001|Overall Study|Protocol entry criteria not met|9|||
124649837|NCT00191282|448336802|FG000|Overall Study|Protocol Violation|9|||
124649838|NCT00191282|448336803|FG001|Overall Study|Protocol Violation|12|||
124649839|NCT00191282|448336802|FG000|Overall Study|Severity of outcome|2|||
124649840|NCT00191282|448336803|FG001|Overall Study|Severity of outcome|5|||
124649841|NCT00191282|448336802|FG000|Overall Study|Sponsor's decision|2|||
124649842|NCT00191282|448336803|FG001|Overall Study|Sponsor's decision|2|||
124649843|NCT00191282|448336802|FG000|Overall Study|Lost to Follow-up|24|||
124649844|NCT00191282|448336803|FG001|Overall Study|Lost to Follow-up|31|||
124649845|NCT00102531|448336804|FG000|Overall Study|Adverse Event|0|||
124649846|NCT00102531|448336805|FG001|Overall Study|Adverse Event|1|||
124649847|NCT00102531|448336804|FG000|Overall Study|Disease Progression|5|||
124649848|NCT00102531|448336805|FG001|Overall Study|Disease Progression|9|||
124649849|NCT00102531|448336804|FG000|Overall Study|Physician Decision|0|||
124649850|NCT00102531|448336805|FG001|Overall Study|Physician Decision|1|||
124649851|NCT04756154|448336807|FG000|Overall Study|Did not meet treatment day baseline|30|||
124649852|NCT04756154|448336808|FG001|Overall Study|Did not meet treatment day baseline|28|||
124649853|NCT04756154|448336809|FG002|Overall Study|Did not meet treatment day baseline|7|||
124649854|NCT04756154|448336807|FG000|Overall Study|Did not return for final sample collection|1|||
124649855|NCT04756154|448336808|FG001|Overall Study|Did not return for final sample collection|1|||
124649856|NCT04756154|448336809|FG002|Overall Study|Did not return for final sample collection|0|||
124649857|NCT01790828|448336811|FG000|Overall Study|Other|34|||
124649858|NCT05072964|448336816|FG000|Overall Study|Withdrawal by Subject|4|||
124649859|NCT05072964|448336816|FG000|Overall Study|Death|1|||
124649860|NCT01047332|448336819|FG000|Overall Study|SEMS Obstruction|11|||
124649861|NCT01047332|448336820|FG001|Overall Study|SEMS Obstruction|20|||
124649862|NCT01047332|448336819|FG000|Overall Study|Died Unobstructed|38|||
124649863|NCT01047332|448336820|FG001|Overall Study|Died Unobstructed|41|||
124649864|NCT01047332|448336819|FG000|Overall Study|Lost to Follow-up|8|||
124649865|NCT01047332|448336820|FG001|Overall Study|Lost to Follow-up|3|||
124649866|NCT03521817|448336825|FG000|Overall Study|Protocol Violation|0|||
124649867|NCT03521817|448336826|FG001|Overall Study|Protocol Violation|1|||
124649868|NCT03055494|448338384|FG000|Overall Study|Lost to Follow-up|6|||
124649869|NCT03055494|448338385|FG001|Overall Study|Lost to Follow-up|0|||
124649870|NCT03055494|448338384|FG000|Overall Study|Physician Decision|2|||
124649871|NCT03055494|448338385|FG001|Overall Study|Physician Decision|0|||
124649872|NCT03055494|448338384|FG000|Overall Study|Withdrawal by Subject|1|||
124649873|NCT03055494|448338385|FG001|Overall Study|Withdrawal by Subject|0|||
124649874|NCT03055494|448338384|FG000|Overall Study|Adverse Event|0|||
124649875|NCT03055494|448338385|FG001|Overall Study|Adverse Event|1|||
124649876|NCT03055494|448338384|FG000|Overall Study|Non-compliance with study treatment|1|||
124649877|NCT03055494|448338385|FG001|Overall Study|Non-compliance with study treatment|0|||
124649878|NCT00197002|448338386|FG000|Overall Study|Adverse Event|0|||
124649879|NCT00197002|448338387|FG001|Overall Study|Adverse Event|1|||
124649880|NCT00197002|448338388|FG002|Overall Study|Adverse Event|0|||
124649881|NCT00197002|448338386|FG000|Overall Study|Protocol Violation|1|||
124649882|NCT00197002|448338387|FG001|Overall Study|Protocol Violation|0|||
124649883|NCT00197002|448338388|FG002|Overall Study|Protocol Violation|2|||
124649884|NCT00197002|448338386|FG000|Overall Study|Withdrawal by Subject|9|||
124649885|NCT00197002|448338387|FG001|Overall Study|Withdrawal by Subject|5|||
124649886|NCT00197002|448338388|FG002|Overall Study|Withdrawal by Subject|7|||
124649887|NCT00197002|448338386|FG000|Overall Study|Migrated/moved from study area|3|||
124649888|NCT00197002|448338387|FG001|Overall Study|Migrated/moved from study area|5|||
124649889|NCT00197002|448338388|FG002|Overall Study|Migrated/moved from study area|1|||
124649890|NCT00197002|448338386|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
124649891|NCT00197002|448338387|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
124649892|NCT00197002|448338388|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
124649893|NCT00197002|448338386|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
124649894|NCT00197002|448338387|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
124649895|NCT00197002|448338388|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
124649896|NCT00197002|448338386|FG000|Overall Study|Others|3|||
124649897|NCT00197002|448338387|FG001|Overall Study|Others|1|||
124649898|NCT00197002|448338388|FG002|Overall Study|Others|1|||
124649899|NCT04488419|448338393|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
124649900|NCT04488419|448338394|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
124649901|NCT04488419|448338395|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
124649902|NCT04488419|448338393|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
124649903|NCT04488419|448338394|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
124649904|NCT04488419|448338395|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
124649905|NCT04488419|448338393|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
124649906|NCT04488419|448338394|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
124649907|NCT04488419|448338395|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
124649908|NCT04488419|448338393|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
124649909|NCT04488419|448338394|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
124649910|NCT04488419|448338395|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
124649911|NCT04488419|448338393|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
124649912|NCT04488419|448338394|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
124649913|NCT04488419|448338395|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
124649914|NCT04488419|448338393|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
124649915|NCT04488419|448338394|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
124649916|NCT04488419|448338395|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
124649917|NCT04488419|448338393|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
124649918|NCT04488419|448338394|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
124649919|NCT04488419|448338395|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
124649920|NCT04488419|448338393|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
124649921|NCT04488419|448338394|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
124649922|NCT04488419|448338395|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
124649923|NCT04488419|448338393|FG000|Primary Analysis Population|Adverse Event|6|||
124649924|NCT04488419|448338394|FG001|Primary Analysis Population|Adverse Event|9|||
124649925|NCT04488419|448338395|FG002|Primary Analysis Population|Adverse Event|0|||
124649926|NCT04488419|448338393|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
124649927|NCT04488419|448338394|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
124649928|NCT04488419|448338395|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
124649929|NCT04488419|448338393|FG000|Primary Analysis Population|Protocol Violation|1|||
124649930|NCT04488419|448338394|FG001|Primary Analysis Population|Protocol Violation|1|||
124649931|NCT04488419|448338395|FG002|Primary Analysis Population|Protocol Violation|0|||
124649932|NCT04488419|448338393|FG000|Primary Analysis Population|Undetermined|7|||
124649933|NCT04488419|448338394|FG001|Primary Analysis Population|Undetermined|3|||
124649934|NCT04488419|448338395|FG002|Primary Analysis Population|Undetermined|0|||
124649935|NCT04488419|448338393|FG000|Primary Analysis Population|>1 Reason|2|||
124649936|NCT04488419|448338394|FG001|Primary Analysis Population|>1 Reason|4|||
124649937|NCT04488419|448338395|FG002|Primary Analysis Population|>1 Reason|0|||
124649938|NCT02276053|448338398|FG000|Overall Study|Death|2|||
124649939|NCT02276053|448338398|FG000|Overall Study|Adverse Event|5|||
124649940|NCT02276053|448338398|FG000|Overall Study|Lack of Efficacy|2|||
124649941|NCT02276053|448338398|FG000|Overall Study|Withdrawal by Subject|1|||
124649942|NCT02276053|448338398|FG000|Overall Study|Patient does not meet selection criteria|3|||
124649943|NCT02276053|448338398|FG000|Overall Study|Patient needs to increase baseline AED|1|||
124649944|NCT04542499|448338401|FG000|Overall Study|Adverse Event|23|||
124649945|NCT04542499|448338402|FG001|Overall Study|Adverse Event|43|||
124649946|NCT04542499|448338401|FG000|Overall Study|Lack of Efficacy|5|||
124649947|NCT04542499|448338402|FG001|Overall Study|Lack of Efficacy|2|||
124649948|NCT04542499|448338401|FG000|Overall Study|Lost to Follow-up|3|||
124649949|NCT04542499|448338402|FG001|Overall Study|Lost to Follow-up|4|||
124649950|NCT04542499|448338401|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
124649951|NCT04542499|448338402|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
124649952|NCT04542499|448338401|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
124649953|NCT04542499|448338402|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
124649954|NCT04542499|448338401|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124649955|NCT04542499|448338402|FG001|Overall Study|Non-Compliance with Study Drug|2|||
124649956|NCT04542499|448338401|FG000|Overall Study|Physician Decision|0|||
124649957|NCT04542499|448338402|FG001|Overall Study|Physician Decision|1|||
124649958|NCT04542499|448338401|FG000|Overall Study|Site Terminated by Sponsor|3|||
124649959|NCT04542499|448338402|FG001|Overall Study|Site Terminated by Sponsor|5|||
124649960|NCT04542499|448338401|FG000|Overall Study|Withdrawal by Subject|12|||
124649961|NCT04542499|448338402|FG001|Overall Study|Withdrawal by Subject|33|||
124649962|NCT04542499|448338401|FG000|Overall Study|Other|2|||
124649963|NCT04542499|448338402|FG001|Overall Study|Other|2|||
124649964|NCT03427268|448338407|FG000|Overall Study|Progressive disease|25|||
124649965|NCT03427268|448338407|FG000|Overall Study|Never treated|2|||
124649966|NCT03427268|448338407|FG000|Overall Study|Compassionate use|1|||
124649967|NCT03427268|448338407|FG000|Overall Study|Withdrawal by Subject|1|||
124649968|NCT03427268|448338407|FG000|Overall Study|Adverse Event|3|||
124649969|NCT03391232|448338408|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
124649970|NCT03391232|448338409|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
124649971|NCT03391232|448338408|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
124649972|NCT03391232|448338409|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
124649973|NCT01995175|448338410|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
124649974|NCT01995175|448338410|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
124649975|NCT01995175|448338410|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
124649976|NCT01995175|448338410|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
124649977|NCT01995175|448338410|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
124649978|NCT01995175|448338410|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
124649979|NCT01995175|448338410|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
124649980|NCT01995175|448338410|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
124649981|NCT01995175|448338410|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
124649982|NCT03729570|448338414|FG000|Overall Study|Lost to Follow-up|16|||
124649983|NCT03729570|448338415|FG001|Overall Study|Lost to Follow-up|20|||
124649984|NCT03729570|448338414|FG000|Overall Study|Seroconversion|5|||
124649985|NCT03729570|448338415|FG001|Overall Study|Seroconversion|0|||
124649986|NCT03729570|448338414|FG000|Overall Study|Moved out of the city|1|||
124649987|NCT03729570|448338415|FG001|Overall Study|Moved out of the city|0|||
124649988|NCT03729570|448338414|FG000|Overall Study|Time Conflict|1|||
124649989|NCT03729570|448338415|FG001|Overall Study|Time Conflict|0|||
124649990|NCT03729570|448338414|FG000|Overall Study|Time Commitment|2|||
124649991|NCT03729570|448338415|FG001|Overall Study|Time Commitment|0|||
124649992|NCT03729570|448338414|FG000|Overall Study|Bad Experience|0|||
124649993|NCT03729570|448338415|FG001|Overall Study|Bad Experience|1|||
124649994|NCT03729570|448338414|FG000|Overall Study|No reason provided|2|||
124649995|NCT03729570|448338415|FG001|Overall Study|No reason provided|1|||
124649996|NCT03729570|448338414|FG000|Overall Study|Family Conflict|0|||
124649997|NCT03729570|448338415|FG001|Overall Study|Family Conflict|1|||
124649998|NCT03729570|448338414|FG000|Overall Study|Did not want to continue taking medications|0|||
124649999|NCT03729570|448338415|FG001|Overall Study|Did not want to continue taking medications|1|||
124650000|NCT03729570|448338414|FG000|Overall Study|Found another PrEP provider|1|||
124650001|NCT03729570|448338415|FG001|Overall Study|Found another PrEP provider|0|||
124650002|NCT03729570|448338414|FG000|Overall Study|Did not enjoy being in the control group|0|||
124650003|NCT03729570|448338415|FG001|Overall Study|Did not enjoy being in the control group|1|||
124650004|NCT01482962|448338419|FG000|Overall Study|Progressive Disease|65|||
124650005|NCT01482962|448338420|FG001|Overall Study|Progressive Disease|53|||
124650006|NCT01482962|448338419|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
124650007|NCT01482962|448338420|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
124650008|NCT01482962|448338419|FG000|Overall Study|Adverse Event|18|||
124650009|NCT01482962|448338420|FG001|Overall Study|Adverse Event|22|||
124650010|NCT01482962|448338419|FG000|Overall Study|Withdrawal by Participant|8|||
124650011|NCT01482962|448338420|FG001|Overall Study|Withdrawal by Participant|13|||
124650012|NCT01482962|448338419|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
124650013|NCT01482962|448338420|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
124650014|NCT01482962|448338419|FG000|Overall Study|Other Reason|1|||
124650015|NCT01482962|448338420|FG001|Overall Study|Other Reason|5|||
124650016|NCT01482962|448338419|FG000|Overall Study|Study Terminated by Sponsor|5|||
124650017|NCT01482962|448338420|FG001|Overall Study|Study Terminated by Sponsor|2|||
124650018|NCT01482962|448338419|FG000|Overall Study|Did not Receive Study Drug|1|||
124650019|NCT01482962|448338420|FG001|Overall Study|Did not Receive Study Drug|6|||
124650020|NCT02407457|448338421|FG000|1 Month|Death|3|||
124650021|NCT02407457|448338422|FG001|1 Month|Death|0|||
124650022|NCT02407457|448338421|FG000|1 Month|Lost to Follow-up|1|||
124650023|NCT02407457|448338422|FG001|1 Month|Lost to Follow-up|1|||
124650024|NCT02407457|448338421|FG000|1 Month|missed visit|2|||
124650025|NCT02407457|448338422|FG001|1 Month|missed visit|5|||
124650026|NCT02407457|448338421|FG000|6-Month|Death|2|||
124650027|NCT02407457|448338422|FG001|6-Month|Death|8|||
124650028|NCT02407457|448338421|FG000|6-Month|Lost to Follow-up|2|||
124650029|NCT02407457|448338422|FG001|6-Month|Lost to Follow-up|2|||
124650030|NCT02407457|448338421|FG000|6-Month|missed visit|16|||
124650031|NCT02407457|448338422|FG001|6-Month|missed visit|14|||
124650032|NCT02407457|448338421|FG000|6-Month|Open Repair|0|||
124650033|NCT02407457|448338422|FG001|6-Month|Open Repair|1|||
124650034|NCT02407457|448338421|FG000|1 Year|Death|6|||
124650035|NCT02407457|448338422|FG001|1 Year|Death|11|||
124650036|NCT02407457|448338421|FG000|1 Year|Lost to Follow-up|3|||
124650037|NCT02407457|448338422|FG001|1 Year|Lost to Follow-up|2|||
124650038|NCT02407457|448338421|FG000|1 Year|Missed Visit|24|||
124650039|NCT02407457|448338422|FG001|1 Year|Missed Visit|14|||
124650040|NCT02407457|448338421|FG000|1 Year|Open Repair|0|||
124650041|NCT02407457|448338422|FG001|1 Year|Open Repair|1|||
124650042|NCT02407457|448338421|FG000|2-year|Death|14|||
124650043|NCT02407457|448338422|FG001|2-year|Death|8|||
124650044|NCT02407457|448338421|FG000|2-year|Lost to Follow-up|7|||
124650045|NCT02407457|448338422|FG001|2-year|Lost to Follow-up|10|||
124650046|NCT02407457|448338421|FG000|2-year|Missed Visit|13|||
124650047|NCT02407457|448338422|FG001|2-year|Missed Visit|15|||
124650048|NCT02407457|448338421|FG000|2-year|Open Repair|0|||
124650049|NCT02407457|448338422|FG001|2-year|Open Repair|2|||
124650050|NCT02407457|448338421|FG000|3-year|Death|11|||
124650051|NCT02407457|448338422|FG001|3-year|Death|10|||
124650052|NCT02407457|448338421|FG000|3-year|Lost to Follow-up|9|||
124650053|NCT02407457|448338422|FG001|3-year|Lost to Follow-up|10|||
124650054|NCT02407457|448338421|FG000|3-year|Missed Visit|19|||
124650055|NCT02407457|448338422|FG001|3-year|Missed Visit|16|||
124650056|NCT02407457|448338421|FG000|4-year|Death|18|||
124650057|NCT02407457|448338422|FG001|4-year|Death|10|||
124650058|NCT02407457|448338421|FG000|4-year|Lost to Follow-up|10|||
124650059|NCT02407457|448338422|FG001|4-year|Lost to Follow-up|12|||
124650060|NCT02407457|448338421|FG000|4-year|Missed Visit|18|||
124650061|NCT02407457|448338422|FG001|4-year|Missed Visit|16|||
124650062|NCT02407457|448338421|FG000|5-year|Death|10|||
124650063|NCT02407457|448338422|FG001|5-year|Death|3|||
124650064|NCT02407457|448338421|FG000|5-year|Lost to Follow-up|22|||
124650065|NCT02407457|448338422|FG001|5-year|Lost to Follow-up|13|||
124650066|NCT02407457|448338421|FG000|5-year|Missed Visit|9|||
124650067|NCT02407457|448338422|FG001|5-year|Missed Visit|1|||
124650068|NCT04495816|448338423|FG000|Overall Study|Lost to Follow-up|10|||
124650069|NCT04495816|448338424|FG001|Overall Study|Lost to Follow-up|4|||
124650070|NCT04495816|448338423|FG000|Overall Study|Withdrawal by Subject|3|||
124650071|NCT04495816|448338424|FG001|Overall Study|Withdrawal by Subject|5|||
124650072|NCT00558896|448338425|FG000|Overall Study|Adverse Event|1|||
124650073|NCT00558896|448338426|FG001|Overall Study|Adverse Event|1|||
124650074|NCT00558896|448338427|FG002|Overall Study|Adverse Event|1|||
124650075|NCT00558896|448338428|FG003|Overall Study|Adverse Event|3|||
124650076|NCT00558896|448338429|FG004|Overall Study|Adverse Event|4|||
124650077|NCT00558896|448338430|FG005|Overall Study|Adverse Event|10|||
124650078|NCT00558896|448338431|FG006|Overall Study|Adverse Event|3|||
124650079|NCT00558896|448338425|FG000|Overall Study|Death|3|||
124650080|NCT00558896|448338426|FG001|Overall Study|Death|0|||
124650081|NCT00558896|448338427|FG002|Overall Study|Death|2|||
124650082|NCT00558896|448338428|FG003|Overall Study|Death|3|||
124650083|NCT00558896|448338429|FG004|Overall Study|Death|2|||
124650084|NCT00558896|448338430|FG005|Overall Study|Death|2|||
124650085|NCT00558896|448338431|FG006|Overall Study|Death|6|||
124650086|NCT00558896|448338425|FG000|Overall Study|Withdrawal by Subject|2|||
124650087|NCT00558896|448338426|FG001|Overall Study|Withdrawal by Subject|1|||
124650088|NCT00558896|448338427|FG002|Overall Study|Withdrawal by Subject|1|||
124650089|NCT00558896|448338428|FG003|Overall Study|Withdrawal by Subject|1|||
124650090|NCT00558896|448338429|FG004|Overall Study|Withdrawal by Subject|1|||
124650091|NCT00558896|448338430|FG005|Overall Study|Withdrawal by Subject|5|||
124650092|NCT00558896|448338431|FG006|Overall Study|Withdrawal by Subject|5|||
124650093|NCT00558896|448338425|FG000|Overall Study|Alternative Treatment|2|||
124650094|NCT00558896|448338426|FG001|Overall Study|Alternative Treatment|2|||
124650095|NCT00558896|448338427|FG002|Overall Study|Alternative Treatment|0|||
124650096|NCT00558896|448338428|FG003|Overall Study|Alternative Treatment|2|||
124650097|NCT00558896|448338429|FG004|Overall Study|Alternative Treatment|6|||
124650098|NCT00558896|448338430|FG005|Overall Study|Alternative Treatment|7|||
124650099|NCT00558896|448338431|FG006|Overall Study|Alternative Treatment|1|||
124650100|NCT00558896|448338425|FG000|Overall Study|Physician discretion|3|||
124650101|NCT00558896|448338426|FG001|Overall Study|Physician discretion|2|||
124650102|NCT00558896|448338427|FG002|Overall Study|Physician discretion|1|||
124650103|NCT00558896|448338428|FG003|Overall Study|Physician discretion|2|||
124650104|NCT00558896|448338429|FG004|Overall Study|Physician discretion|1|||
124650105|NCT00558896|448338430|FG005|Overall Study|Physician discretion|3|||
124650106|NCT00558896|448338431|FG006|Overall Study|Physician discretion|3|||
124650107|NCT00558896|448338425|FG000|Overall Study|Continues on treatment|10|||
124650108|NCT00558896|448338426|FG001|Overall Study|Continues on treatment|1|||
124650109|NCT00558896|448338427|FG002|Overall Study|Continues on treatment|0|||
124650110|NCT00558896|448338428|FG003|Overall Study|Continues on treatment|1|||
124650111|NCT00558896|448338429|FG004|Overall Study|Continues on treatment|9|||
124650112|NCT00558896|448338430|FG005|Overall Study|Continues on treatment|25|||
124650113|NCT00558896|448338431|FG006|Overall Study|Continues on treatment|6|||
124650114|NCT04329091|448338434|FG000|Overall Study|Physician Decision|5|||
124650115|NCT01801358|448338435|FG000|Overall Study|Adverse Event|0|||
124650116|NCT01801358|448338436|FG001|Overall Study|Adverse Event|2|||
124650117|NCT01801358|448338437|FG002|Overall Study|Adverse Event|1|||
124650118|NCT01801358|448338438|FG003|Overall Study|Adverse Event|0|||
124650119|NCT01801358|448338439|FG004|Overall Study|Adverse Event|0|||
124650120|NCT01801358|448338440|FG005|Overall Study|Adverse Event|1|||
124650121|NCT01801358|448338435|FG000|Overall Study|Physician Decision|0|||
124650122|NCT01801358|448338436|FG001|Overall Study|Physician Decision|0|||
124650123|NCT01801358|448338437|FG002|Overall Study|Physician Decision|1|||
124650124|NCT01801358|448338438|FG003|Overall Study|Physician Decision|0|||
124650125|NCT01801358|448338439|FG004|Overall Study|Physician Decision|0|||
124650126|NCT01801358|448338440|FG005|Overall Study|Physician Decision|0|||
124650127|NCT01801358|448338435|FG000|Overall Study|Progressive Disease|6|||
124650128|NCT01801358|448338436|FG001|Overall Study|Progressive Disease|4|||
124650129|NCT01801358|448338437|FG002|Overall Study|Progressive Disease|4|||
124650130|NCT01801358|448338438|FG003|Overall Study|Progressive Disease|5|||
124650131|NCT01801358|448338439|FG004|Overall Study|Progressive Disease|6|||
124650132|NCT01801358|448338440|FG005|Overall Study|Progressive Disease|5|||
124650133|NCT01801358|448338435|FG000|Overall Study|Withdrawal by Subject|0|||
124650134|NCT01801358|448338436|FG001|Overall Study|Withdrawal by Subject|0|||
124650135|NCT01801358|448338437|FG002|Overall Study|Withdrawal by Subject|0|||
124650136|NCT01801358|448338438|FG003|Overall Study|Withdrawal by Subject|1|||
124650137|NCT01801358|448338439|FG004|Overall Study|Withdrawal by Subject|0|||
124650138|NCT01801358|448338440|FG005|Overall Study|Withdrawal by Subject|2|||
124650139|NCT00723190|448338441|FG000|Overall Study|Withdrawal by Subject|45|||
124650140|NCT00723190|448338441|FG000|Overall Study|Lost to Follow-up|37|||
124650141|NCT00723190|448338441|FG000|Overall Study|Adverse Event|18|||
124650142|NCT00723190|448338441|FG000|Overall Study|Lack of Efficacy|16|||
124650143|NCT00723190|448338441|FG000|Overall Study|Protocol Violation|15|||
124650144|NCT00723190|448338441|FG000|Overall Study|Other-Premature Discontinuation|9|||
124650145|NCT00723190|448338441|FG000|Overall Study|Other-Not included in safety population|2|||
124650146|NCT03181503|448338442|FG000|Overall Study|Adverse Event|2|||
124650147|NCT03181503|448338443|FG001|Overall Study|Adverse Event|2|||
124650148|NCT03181503|448338442|FG000|Overall Study|Protocol Violation|1|||
124650149|NCT03181503|448338443|FG001|Overall Study|Protocol Violation|0|||
124650150|NCT03181503|448338442|FG000|Overall Study|Withdrawal by Subject|3|||
124650151|NCT03181503|448338443|FG001|Overall Study|Withdrawal by Subject|0|||
124650152|NCT03181503|448338442|FG000|Overall Study|Lost to Follow-up|1|||
124650153|NCT03181503|448338443|FG001|Overall Study|Lost to Follow-up|1|||
124650154|NCT04450407|448338454|FG000|Overall Study|Withdrawal by Subject|10|||
124650155|NCT04450407|448338455|FG001|Overall Study|Withdrawal by Subject|1|||
124650156|NCT04450407|448338456|FG002|Overall Study|Withdrawal by Subject|4|||
124650157|NCT04450407|448338454|FG000|Overall Study|Adverse Event|0|||
124650158|NCT04450407|448338455|FG001|Overall Study|Adverse Event|0|||
124650159|NCT04450407|448338456|FG002|Overall Study|Adverse Event|1|||
124650160|NCT04450407|448338454|FG000|Overall Study|Lost to Follow-up|1|||
124650161|NCT04450407|448338455|FG001|Overall Study|Lost to Follow-up|0|||
124650162|NCT04450407|448338456|FG002|Overall Study|Lost to Follow-up|0|||
124650163|NCT04450407|448338454|FG000|Overall Study|Physician Decision|0|||
124650164|NCT04450407|448338455|FG001|Overall Study|Physician Decision|0|||
124650165|NCT04450407|448338456|FG002|Overall Study|Physician Decision|1|||
124650166|NCT04450407|448338454|FG000|Overall Study|Pregnancy|1|||
124650167|NCT04450407|448338455|FG001|Overall Study|Pregnancy|0|||
124650168|NCT04450407|448338456|FG002|Overall Study|Pregnancy|0|||
124650169|NCT04450407|448338454|FG000|Overall Study|Protocol Violation|2|||
124650170|NCT04450407|448338455|FG001|Overall Study|Protocol Violation|0|||
124650171|NCT04450407|448338456|FG002|Overall Study|Protocol Violation|0|||
124650172|NCT04450407|448338454|FG000|Overall Study|Investigational site terminated by sponsor|3|||
124650173|NCT04450407|448338455|FG001|Overall Study|Investigational site terminated by sponsor|0|||
124650174|NCT04450407|448338456|FG002|Overall Study|Investigational site terminated by sponsor|2|||
124650175|NCT03589976|448338460|FG000|Overall Study|Death|5|||
124650176|NCT03589976|448338461|FG001|Overall Study|Death|1|||
124650177|NCT03589976|448338460|FG000|Overall Study|Adverse Event|5|||
124650178|NCT03589976|448338461|FG001|Overall Study|Adverse Event|1|||
124650179|NCT03589976|448338460|FG000|Overall Study|Withdrawal by Subject|4|||
124650180|NCT03589976|448338461|FG001|Overall Study|Withdrawal by Subject|1|||
124650181|NCT03589976|448338460|FG000|Overall Study|Lost to Follow-up|1|||
124650182|NCT03589976|448338461|FG001|Overall Study|Lost to Follow-up|0|||
124650183|NCT03589976|448338460|FG000|Overall Study|Other|4|||
124650184|NCT03589976|448338461|FG001|Overall Study|Other|3|||
124650185|NCT02089334|448338462|FG000|Overall Study|Withdrawal by Subject|0|||
124650186|NCT02089334|448338463|FG001|Overall Study|Withdrawal by Subject|0|||
124650187|NCT02089334|448338464|FG002|Overall Study|Withdrawal by Subject|0|||
124650188|NCT02089334|448338465|FG003|Overall Study|Withdrawal by Subject|2|||
124650189|NCT02089334|448338462|FG000|Overall Study|Adverse Event|0|||
124650190|NCT02089334|448338463|FG001|Overall Study|Adverse Event|0|||
124650191|NCT02089334|448338464|FG002|Overall Study|Adverse Event|0|||
124650192|NCT02089334|448338465|FG003|Overall Study|Adverse Event|2|||
124650193|NCT02089334|448338462|FG000|Overall Study|Progressive disease|0|||
124650194|NCT02089334|448338463|FG001|Overall Study|Progressive disease|0|||
124650195|NCT02089334|448338464|FG002|Overall Study|Progressive disease|0|||
124650196|NCT02089334|448338465|FG003|Overall Study|Progressive disease|2|||
124650197|NCT02089334|448338462|FG000|Overall Study|Physician Decision|0|||
124650198|NCT02089334|448338463|FG001|Overall Study|Physician Decision|0|||
124650199|NCT02089334|448338464|FG002|Overall Study|Physician Decision|1|||
124650200|NCT02089334|448338465|FG003|Overall Study|Physician Decision|1|||
124650201|NCT02832375|448338466|FG000|Overall Study|Lost to Follow-up|1|||
124650202|NCT02832375|448338467|FG001|Overall Study|Lost to Follow-up|0|||
124650203|NCT02832375|448338466|FG000|Overall Study|Withdrawal of Consent|1|||
124650204|NCT02832375|448338467|FG001|Overall Study|Withdrawal of Consent|0|||
124650205|NCT00514904|448338470|FG000|Overall Study|Withdrawal by Subject|3|||
124650206|NCT00514904|448338471|FG001|Overall Study|Withdrawal by Subject|2|||
124650207|NCT00514904|448338470|FG000|Overall Study|Lost to Follow-up|21|||
124650208|NCT00514904|448338471|FG001|Overall Study|Lost to Follow-up|3|||
124650223|NCT03430895|448338474|FG000|Overall Study|Not Treated|2|||
124650224|NCT00084318|448338476|FG000|Overall Study|Withdrawal by Subject|5|||
124650225|NCT00084318|448338477|FG001|Overall Study|Withdrawal by Subject|2|||
124650226|NCT00084318|448338476|FG000|Overall Study|Protocol Violation|15|||
124650227|NCT00084318|448338477|FG001|Overall Study|Protocol Violation|11|||
124650228|NCT00084318|448338476|FG000|Overall Study|No protocol treatment|2|||
124650229|NCT00084318|448338477|FG001|Overall Study|No protocol treatment|0|||
124650230|NCT01317797|448338479|FG000|Overall Study|Other|0|||
124650231|NCT01317797|448338480|FG001|Overall Study|Other|1|||
124650232|NCT01317797|448338481|FG002|Overall Study|Other|0|||
124650233|NCT01317797|448338479|FG000|Overall Study|Withdrawal of Patient|0|||
124650234|NCT01317797|448338480|FG001|Overall Study|Withdrawal of Patient|0|||
124650235|NCT01317797|448338481|FG002|Overall Study|Withdrawal of Patient|1|||
124650236|NCT01645891|448338488|FG000|Overall Study|Adverse Event|6|||
124650237|NCT01645891|448338489|FG001|Overall Study|Adverse Event|10|||
124650238|NCT01645891|448338488|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
124650239|NCT01645891|448338489|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
124650240|NCT01645891|448338488|FG000|Overall Study|Withdrawal by Subject|3|||
124650241|NCT01645891|448338489|FG001|Overall Study|Withdrawal by Subject|3|||
124650242|NCT01645891|448338488|FG000|Overall Study|Protocol Violation|4|||
124650243|NCT01645891|448338489|FG001|Overall Study|Protocol Violation|0|||
124650244|NCT01645891|448338488|FG000|Overall Study|Lost to Follow-up|4|||
124650245|NCT01645891|448338489|FG001|Overall Study|Lost to Follow-up|1|||
124650246|NCT01645891|448338488|FG000|Overall Study|Death|0|||
124650247|NCT01645891|448338489|FG001|Overall Study|Death|2|||
124650248|NCT00138073|448338490|FG000|Overall Study|lack of resources|55|||
124650249|NCT03301740|448338491|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
124650250|NCT03301740|448338492|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
124650251|NCT03301740|448338491|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
124650252|NCT03301740|448338492|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
124650253|NCT01173055|448338497|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
124650254|NCT01173055|448338498|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
124650255|NCT01173055|448338497|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
124650256|NCT01173055|448338498|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
124650257|NCT04325698|448338500|FG000|Overall Study|Study Terminated By Sponsor|1|||
124650258|NCT04325698|448338501|FG001|Overall Study|Study Terminated By Sponsor|1|||
124650259|NCT04325698|448338500|FG000|Overall Study|Withdrawal by Subject|0|||
124650260|NCT04325698|448338501|FG001|Overall Study|Withdrawal by Subject|2|||
124650261|NCT00962091|448338502|FG000|Overall Study|Withdrawal by Subject|1|||
124650262|NCT00962091|448338503|FG001|Overall Study|Withdrawal by Subject|2|||
124650263|NCT00962091|448338504|FG002|Overall Study|Withdrawal by Subject|1|||
124650264|NCT00962091|448338505|FG003|Overall Study|Withdrawal by Subject|1|||
124650265|NCT00962091|448338506|FG004|Overall Study|Withdrawal by Subject|0|||
124650266|NCT00962091|448338507|FG005|Overall Study|Withdrawal by Subject|1|||
124650267|NCT00962091|448338508|FG006|Overall Study|Withdrawal by Subject|0|||
124650268|NCT00962091|448338502|FG000|Overall Study|Adverse Event|0|||
124650269|NCT00962091|448338503|FG001|Overall Study|Adverse Event|0|||
124650270|NCT00962091|448338504|FG002|Overall Study|Adverse Event|0|||
124650271|NCT00962091|448338505|FG003|Overall Study|Adverse Event|0|||
124650272|NCT00962091|448338506|FG004|Overall Study|Adverse Event|0|||
124650273|NCT00962091|448338507|FG005|Overall Study|Adverse Event|0|||
124650274|NCT00962091|448338508|FG006|Overall Study|Adverse Event|1|||
124650275|NCT04253782|448338509|FG000|Overall Study|Death|2|||
124650276|NCT04253782|448338510|FG001|Overall Study|Death|0|||
124650277|NCT04216589|448338511|FG000|Overall Study|Withdrawal by Subject|2|||
124650278|NCT04216589|448338511|FG000|Overall Study|Protocol Violation|1|||
124650279|NCT04216589|448338511|FG000|Overall Study|Incarceration|1|||
124650280|NCT03191864|448338518|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
124650281|NCT03191864|448338519|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
124650282|NCT03191864|448338520|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
124650283|NCT03191864|448338521|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
124650284|NCT03191864|448338522|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
124650285|NCT03191864|448338523|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
124650286|NCT03191864|448338518|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
124650287|NCT03191864|448338519|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
124650288|NCT03191864|448338520|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
124650289|NCT03191864|448338521|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
124650290|NCT03191864|448338522|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
124650291|NCT03191864|448338523|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
124650292|NCT03191864|448338518|FG000|Baseline Symptom Assessment|Adverse Event|0|||
124650293|NCT03191864|448338519|FG001|Baseline Symptom Assessment|Adverse Event|0|||
124650294|NCT03191864|448338520|FG002|Baseline Symptom Assessment|Adverse Event|0|||
124650295|NCT03191864|448338521|FG003|Baseline Symptom Assessment|Adverse Event|0|||
124650296|NCT03191864|448338522|FG004|Baseline Symptom Assessment|Adverse Event|0|||
124650297|NCT03191864|448338523|FG005|Baseline Symptom Assessment|Adverse Event|2|||
124650298|NCT03191864|448338518|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
124650299|NCT03191864|448338519|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
124650300|NCT03191864|448338520|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
124650301|NCT03191864|448338521|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
124650302|NCT03191864|448338522|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
124650303|NCT03191864|448338523|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
124650304|NCT03191864|448338518|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
124650305|NCT03191864|448338519|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
124650306|NCT03191864|448338520|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
124650307|NCT03191864|448338521|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
124650308|NCT03191864|448338522|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
124650309|NCT03191864|448338523|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
124650310|NCT03191864|448338518|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
124650311|NCT03191864|448338519|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
124650312|NCT03191864|448338520|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
124650313|NCT03191864|448338521|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
124650314|NCT03191864|448338522|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
124650315|NCT03191864|448338523|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
124650316|NCT03191864|448338518|FG000|Part 1 - Induction|Adverse Event|0|||
124650317|NCT03191864|448338519|FG001|Part 1 - Induction|Adverse Event|2|||
124650318|NCT03191864|448338520|FG002|Part 1 - Induction|Adverse Event|0|||
124650319|NCT03191864|448338521|FG003|Part 1 - Induction|Adverse Event|1|||
124650320|NCT03191864|448338522|FG004|Part 1 - Induction|Adverse Event|0|||
124650321|NCT03191864|448338523|FG005|Part 1 - Induction|Adverse Event|2|||
124650322|NCT03191864|448338518|FG000|Part 1 - Induction|Randomized but never dosed|0|||
124650323|NCT03191864|448338519|FG001|Part 1 - Induction|Randomized but never dosed|0|||
124650324|NCT03191864|448338520|FG002|Part 1 - Induction|Randomized but never dosed|1|||
124650325|NCT03191864|448338521|FG003|Part 1 - Induction|Randomized but never dosed|0|||
124650326|NCT03191864|448338522|FG004|Part 1 - Induction|Randomized but never dosed|0|||
124650327|NCT03191864|448338523|FG005|Part 1 - Induction|Randomized but never dosed|0|||
124650328|NCT03191864|448338518|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
124650329|NCT03191864|448338519|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
124650330|NCT03191864|448338520|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
124650331|NCT03191864|448338521|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
124650332|NCT03191864|448338522|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
124650333|NCT03191864|448338523|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
124650334|NCT03191864|448338518|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
124650335|NCT03191864|448338519|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
124650336|NCT03191864|448338520|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
124650337|NCT03191864|448338521|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
124650338|NCT03191864|448338522|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
124650339|NCT03191864|448338523|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
124650340|NCT03191864|448338518|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
124650341|NCT03191864|448338519|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
124650342|NCT03191864|448338520|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
124650343|NCT03191864|448338521|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
124650344|NCT03191864|448338522|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
124650345|NCT03191864|448338523|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
124650346|NCT03191864|448338518|FG000|Part 2 - Maintenance|Physician Decision|1|||
124650347|NCT03191864|448338519|FG001|Part 2 - Maintenance|Physician Decision|0|||
124650348|NCT03191864|448338520|FG002|Part 2 - Maintenance|Physician Decision|0|||
124650349|NCT03191864|448338521|FG003|Part 2 - Maintenance|Physician Decision|0|||
124650350|NCT03191864|448338522|FG004|Part 2 - Maintenance|Physician Decision|0|||
124650351|NCT03191864|448338523|FG005|Part 2 - Maintenance|Physician Decision|0|||
124650352|NCT03191864|448338518|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
124650353|NCT03191864|448338519|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
124650354|NCT03191864|448338520|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
124650355|NCT03191864|448338521|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
124650356|NCT03191864|448338522|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
124650357|NCT03191864|448338523|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
124650358|NCT03191864|448338518|FG000|Part 2 - Maintenance|Adverse Event|0|||
124650359|NCT03191864|448338519|FG001|Part 2 - Maintenance|Adverse Event|0|||
124650360|NCT03191864|448338520|FG002|Part 2 - Maintenance|Adverse Event|0|||
124650361|NCT03191864|448338521|FG003|Part 2 - Maintenance|Adverse Event|0|||
124650362|NCT03191864|448338522|FG004|Part 2 - Maintenance|Adverse Event|1|||
124650363|NCT03191864|448338523|FG005|Part 2 - Maintenance|Adverse Event|0|||
124650364|NCT03191864|448338518|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
124650365|NCT03191864|448338519|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
124650366|NCT03191864|448338520|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
124650367|NCT03191864|448338521|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
124650368|NCT03191864|448338522|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
124650369|NCT03191864|448338523|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
124650370|NCT03191864|448338518|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
124650371|NCT03191864|448338519|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
124650372|NCT03191864|448338520|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
124650373|NCT03191864|448338521|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
124650374|NCT03191864|448338522|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
124650375|NCT03191864|448338523|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
124650376|NCT02342548|448338526|FG000|Overall Study|Adverse Event|12|||
124650377|NCT02342548|448338527|FG001|Overall Study|Adverse Event|17|||
124650378|NCT02342548|448338528|FG002|Overall Study|Adverse Event|13|||
124650379|NCT02342548|448338526|FG000|Overall Study|Lost to Follow-up|0|||
124650380|NCT02342548|448338527|FG001|Overall Study|Lost to Follow-up|1|||
124650381|NCT02342548|448338528|FG002|Overall Study|Lost to Follow-up|0|||
124650382|NCT02342548|448338526|FG000|Overall Study|Study terminated by sponsor|20|||
124650383|NCT02342548|448338527|FG001|Overall Study|Study terminated by sponsor|39|||
124650384|NCT02342548|448338528|FG002|Overall Study|Study terminated by sponsor|25|||
124650385|NCT02342548|448338526|FG000|Overall Study|Protocol Violation|0|||
124650386|NCT02342548|448338527|FG001|Overall Study|Protocol Violation|1|||
124650387|NCT02342548|448338528|FG002|Overall Study|Protocol Violation|0|||
124650388|NCT02342548|448338526|FG000|Overall Study|Withdrawal by Subject|1|||
124650389|NCT02342548|448338527|FG001|Overall Study|Withdrawal by Subject|3|||
124650390|NCT02342548|448338528|FG002|Overall Study|Withdrawal by Subject|4|||
124650391|NCT02342548|448338526|FG000|Overall Study|Other|1|||
124650392|NCT02342548|448338527|FG001|Overall Study|Other|1|||
124650393|NCT02342548|448338528|FG002|Overall Study|Other|1|||
124650394|NCT00073983|448338530|FG000|Overall Study|not evaluable|1|||
124650395|NCT03800836|448338531|FG000|Overall Study|Other|2|||
124650396|NCT03800836|448338532|FG001|Overall Study|Other|1|||
124650397|NCT03800836|448338533|FG002|Overall Study|Other|0|||
124650398|NCT03800836|448338534|FG003|Overall Study|Other|2|||
124650399|NCT03800836|448338535|FG004|Overall Study|Other|0|||
124650400|NCT03800836|448338536|FG005|Overall Study|Other|1|||
124650401|NCT03800836|448338531|FG000|Overall Study|Lost to Follow-up|2|||
124650402|NCT03800836|448338532|FG001|Overall Study|Lost to Follow-up|0|||
124650403|NCT03800836|448338533|FG002|Overall Study|Lost to Follow-up|1|||
124650404|NCT03800836|448338534|FG003|Overall Study|Lost to Follow-up|1|||
124650405|NCT03800836|448338535|FG004|Overall Study|Lost to Follow-up|3|||
124650406|NCT03800836|448338536|FG005|Overall Study|Lost to Follow-up|0|||
124650407|NCT03800836|448338531|FG000|Overall Study|Withdrawal by Subject|1|||
124650408|NCT03800836|448338532|FG001|Overall Study|Withdrawal by Subject|0|||
124650409|NCT03800836|448338533|FG002|Overall Study|Withdrawal by Subject|0|||
124650410|NCT03800836|448338534|FG003|Overall Study|Withdrawal by Subject|0|||
124650411|NCT03800836|448338535|FG004|Overall Study|Withdrawal by Subject|0|||
124650412|NCT03800836|448338536|FG005|Overall Study|Withdrawal by Subject|0|||
124650413|NCT03800836|448338531|FG000|Overall Study|Physician Decision|31|||
124650414|NCT03800836|448338532|FG001|Overall Study|Physician Decision|3|||
124650415|NCT03800836|448338533|FG002|Overall Study|Physician Decision|6|||
124650416|NCT03800836|448338534|FG003|Overall Study|Physician Decision|4|||
124650417|NCT03800836|448338535|FG004|Overall Study|Physician Decision|4|||
124650418|NCT03800836|448338536|FG005|Overall Study|Physician Decision|5|||
124650419|NCT03800836|448338531|FG000|Overall Study|Death|34|||
124650420|NCT03800836|448338532|FG001|Overall Study|Death|16|||
124650421|NCT03800836|448338533|FG002|Overall Study|Death|5|||
124650422|NCT03800836|448338534|FG003|Overall Study|Death|5|||
124650423|NCT03800836|448338535|FG004|Overall Study|Death|10|||
124650424|NCT03800836|448338536|FG005|Overall Study|Death|0|||
124650425|NCT03800836|448338531|FG000|Overall Study|Symptomatic Deterioration|1|||
124650426|NCT03800836|448338532|FG001|Overall Study|Symptomatic Deterioration|0|||
124650427|NCT03800836|448338533|FG002|Overall Study|Symptomatic Deterioration|1|||
124650428|NCT03800836|448338534|FG003|Overall Study|Symptomatic Deterioration|0|||
124650429|NCT03800836|448338535|FG004|Overall Study|Symptomatic Deterioration|0|||
124650430|NCT03800836|448338536|FG005|Overall Study|Symptomatic Deterioration|0|||
124650431|NCT01390428|448339842|FG000|Overall Study|Elective Surgery|0|||
124650432|NCT01390428|448339843|FG001|Overall Study|Elective Surgery|0|||
124650433|NCT01390428|448339844|FG002|Overall Study|Elective Surgery|0|||
124650434|NCT01390428|448339845|FG003|Overall Study|Elective Surgery|0|||
124650435|NCT01390428|448339846|FG004|Overall Study|Elective Surgery|1|||
124650436|NCT01390428|448339847|FG005|Overall Study|Elective Surgery|0|||
124650437|NCT01390428|448339842|FG000|Overall Study|Withdrawal by Subject|0|||
124650438|NCT01390428|448339843|FG001|Overall Study|Withdrawal by Subject|0|||
124650439|NCT01390428|448339844|FG002|Overall Study|Withdrawal by Subject|1|||
124650440|NCT01390428|448339845|FG003|Overall Study|Withdrawal by Subject|0|||
124650441|NCT01390428|448339846|FG004|Overall Study|Withdrawal by Subject|0|||
124650442|NCT01390428|448339847|FG005|Overall Study|Withdrawal by Subject|0|||
124650443|NCT04322539|448339856|FG000|Overall Study|Adverse Event|2|||
124650444|NCT04322539|448339857|FG001|Overall Study|Adverse Event|0|||
124650445|NCT04322539|448339856|FG000|Overall Study|Death|411|||
124650446|NCT04322539|448339857|FG001|Overall Study|Death|203|||
124650447|NCT04322539|448339856|FG000|Overall Study|Lost to Follow-up|3|||
124650448|NCT04322539|448339857|FG001|Overall Study|Lost to Follow-up|1|||
124650449|NCT04322539|448339856|FG000|Overall Study|Withdrawal of consent|14|||
124650450|NCT04322539|448339857|FG001|Overall Study|Withdrawal of consent|8|||
124650451|NCT04322539|448339856|FG000|Overall Study|Radiological Disease Progression|6|||
124650452|NCT04322539|448339857|FG001|Overall Study|Radiological Disease Progression|0|||
124650453|NCT04322539|448339856|FG000|Overall Study|Sponsor Decision|19|||
124650454|NCT04322539|448339857|FG001|Overall Study|Sponsor Decision|14|||
124650455|NCT04322539|448339856|FG000|Overall Study|Other|6|||
124650456|NCT04322539|448339857|FG001|Overall Study|Other|4|||
124650457|NCT01702532|448339858|FG000|Overall Study|Adverse Event|0|||
124650458|NCT01702532|448339859|FG001|Overall Study|Adverse Event|1|||
124650459|NCT01451164|448339860|FG000|Overall Study|Adverse Event|19|||
124650460|NCT01451164|448339861|FG001|Overall Study|Adverse Event|12|||
124650461|NCT01451164|448339862|FG002|Overall Study|Adverse Event|18|||
124650462|NCT01451164|448339863|FG003|Overall Study|Adverse Event|21|||
124650463|NCT01451164|448339860|FG000|Overall Study|Withdrawal Criteria|1|||
124650464|NCT01451164|448339861|FG001|Overall Study|Withdrawal Criteria|1|||
124650465|NCT01451164|448339862|FG002|Overall Study|Withdrawal Criteria|1|||
124650466|NCT01451164|448339863|FG003|Overall Study|Withdrawal Criteria|1|||
124650467|NCT01451164|448339860|FG000|Overall Study|Physician Decision|2|||
124650468|NCT01451164|448339861|FG001|Overall Study|Physician Decision|0|||
124650469|NCT01451164|448339862|FG002|Overall Study|Physician Decision|1|||
124650470|NCT01451164|448339863|FG003|Overall Study|Physician Decision|0|||
124650471|NCT01451164|448339860|FG000|Overall Study|Withdrawal by Subject|14|||
124650472|NCT01451164|448339861|FG001|Overall Study|Withdrawal by Subject|11|||
124650473|NCT01451164|448339862|FG002|Overall Study|Withdrawal by Subject|16|||
124650474|NCT01451164|448339863|FG003|Overall Study|Withdrawal by Subject|17|||
124650475|NCT01451164|448339860|FG000|Overall Study|Protocol Violation|0|||
124650476|NCT01451164|448339861|FG001|Overall Study|Protocol Violation|1|||
124650477|NCT01451164|448339862|FG002|Overall Study|Protocol Violation|0|||
124650478|NCT01451164|448339863|FG003|Overall Study|Protocol Violation|0|||
124650479|NCT01451164|448339860|FG000|Overall Study|Lack of Efficacy|7|||
124650480|NCT01451164|448339861|FG001|Overall Study|Lack of Efficacy|9|||
124650481|NCT01451164|448339862|FG002|Overall Study|Lack of Efficacy|9|||
124650482|NCT01451164|448339863|FG003|Overall Study|Lack of Efficacy|7|||
124650483|NCT01846221|448339864|FG000|Overall Study|Catheter Failure|2|||
124650484|NCT01846221|448339865|FG001|Overall Study|Catheter Failure|0|||
124650485|NCT01846221|448339864|FG000|Overall Study|Age Exclusion|1|||
124650486|NCT01846221|448339865|FG001|Overall Study|Age Exclusion|0|||
124650487|NCT04599933|448339866|FG000|Overall Study|Adverse Event|4|||
124650488|NCT04599933|448339867|FG001|Overall Study|Adverse Event|1|||
124650489|NCT04599933|448339866|FG000|Overall Study|Withdrawal by Subject|4|||
124650490|NCT04599933|448339867|FG001|Overall Study|Withdrawal by Subject|2|||
124650491|NCT04599933|448339866|FG000|Overall Study|Lost to Follow-up|0|||
124650492|NCT04599933|448339867|FG001|Overall Study|Lost to Follow-up|1|||
124650493|NCT04599933|448339866|FG000|Overall Study|Physician Decision|0|||
124650494|NCT04599933|448339867|FG001|Overall Study|Physician Decision|1|||
124650495|NCT04599933|448339866|FG000|Overall Study|Screen Failure|1|||
124650496|NCT04599933|448339867|FG001|Overall Study|Screen Failure|2|||
124650497|NCT04392167|448339875|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
124650498|NCT02879994|448339876|FG000|Overall Study|off treatment early|7|||
124650499|NCT02879994|448339876|FG000|Overall Study|Adverse Event|2|||
124650500|NCT02879994|448339876|FG000|Overall Study|Death|2|||
124650501|NCT04063657|448339877|FG000|Overall Study|Lost to Follow-up|1|||
124650502|NCT04063657|448339878|FG001|Overall Study|Lost to Follow-up|0|||
124650503|NCT03408444|448339879|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
124650504|NCT03408444|448339880|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
124650505|NCT03408444|448339881|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
124650506|NCT03408444|448339882|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
124650507|NCT03408444|448339879|FG000|Overall Study|Lens Discomfort|0|||
124650508|NCT03408444|448339880|FG001|Overall Study|Lens Discomfort|1|||
124650509|NCT03408444|448339881|FG002|Overall Study|Lens Discomfort|0|||
124650510|NCT03408444|448339882|FG003|Overall Study|Lens Discomfort|0|||
124650511|NCT03408444|448339879|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
124650512|NCT03408444|448339880|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
124650513|NCT03408444|448339881|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
124650514|NCT03408444|448339882|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
124650515|NCT03408444|448339879|FG000|Overall Study|Withdrawal by Subject|0|||
124650516|NCT03408444|448339880|FG001|Overall Study|Withdrawal by Subject|2|||
124650517|NCT03408444|448339881|FG002|Overall Study|Withdrawal by Subject|3|||
124650518|NCT03408444|448339882|FG003|Overall Study|Withdrawal by Subject|0|||
124650519|NCT03408444|448339879|FG000|Overall Study|Lost to Follow-up|0|||
124650520|NCT03408444|448339880|FG001|Overall Study|Lost to Follow-up|0|||
124650521|NCT03408444|448339881|FG002|Overall Study|Lost to Follow-up|1|||
124650522|NCT03408444|448339882|FG003|Overall Study|Lost to Follow-up|0|||
124650523|NCT03408444|448339879|FG000|Overall Study|Adverse Event|0|||
124650524|NCT03408444|448339880|FG001|Overall Study|Adverse Event|0|||
124650525|NCT03408444|448339881|FG002|Overall Study|Adverse Event|0|||
124650526|NCT03408444|448339882|FG003|Overall Study|Adverse Event|1|||
124650527|NCT03408444|448339879|FG000|Overall Study|Lens Handling Difficulties|0|||
124650528|NCT03408444|448339880|FG001|Overall Study|Lens Handling Difficulties|0|||
124650529|NCT03408444|448339881|FG002|Overall Study|Lens Handling Difficulties|1|||
124650530|NCT03408444|448339882|FG003|Overall Study|Lens Handling Difficulties|0|||
124650531|NCT03408444|448339879|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
124650532|NCT03408444|448339880|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
124650533|NCT03408444|448339881|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
124650534|NCT03408444|448339882|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
124650535|NCT04984681|448339883|FG000|Overall Study|Lost to Follow-up|3|||
124650536|NCT04984681|448339884|FG001|Overall Study|Lost to Follow-up|1|||
124650537|NCT01447446|448339885|FG000|Overall Study|Death|6|||
124650538|NCT01447446|448339886|FG001|Overall Study|Death|3|||
124650539|NCT01447446|448339887|FG002|Overall Study|Death|2|||
124650540|NCT01447446|448339888|FG003|Overall Study|Death|1|||
124650541|NCT01447446|448339889|FG004|Overall Study|Death|7|||
124650542|NCT01447446|448339890|FG005|Overall Study|Death|0|||
124650543|NCT01447446|448339885|FG000|Overall Study|Adverse Event|3|||
124650544|NCT01447446|448339886|FG001|Overall Study|Adverse Event|0|||
124650545|NCT01447446|448339887|FG002|Overall Study|Adverse Event|1|||
124650546|NCT01447446|448339888|FG003|Overall Study|Adverse Event|0|||
124650547|NCT01447446|448339889|FG004|Overall Study|Adverse Event|2|||
124650548|NCT01447446|448339890|FG005|Overall Study|Adverse Event|0|||
124650549|NCT01447446|448339885|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
124650550|NCT01447446|448339886|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
124650551|NCT01447446|448339887|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
124650552|NCT01447446|448339888|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
124650553|NCT01447446|448339889|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
124650554|NCT01447446|448339890|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
124650555|NCT01447446|448339885|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
124650556|NCT01447446|448339886|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
124650557|NCT01447446|448339887|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
124650558|NCT01447446|448339888|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
124650559|NCT01447446|448339889|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
124650560|NCT01447446|448339890|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
124650561|NCT01447446|448339885|FG000|Overall Study|Administrative/Other|34|||
124650562|NCT01447446|448339886|FG001|Overall Study|Administrative/Other|9|||
124650563|NCT01447446|448339887|FG002|Overall Study|Administrative/Other|10|||
124650564|NCT01447446|448339888|FG003|Overall Study|Administrative/Other|2|||
124650565|NCT01447446|448339889|FG004|Overall Study|Administrative/Other|33|||
124650566|NCT01447446|448339890|FG005|Overall Study|Administrative/Other|4|||
124650567|NCT01447446|448339885|FG000|Overall Study|SVR12 Assessment|13|||
124650568|NCT01447446|448339886|FG001|Overall Study|SVR12 Assessment|1|||
124650569|NCT01447446|448339887|FG002|Overall Study|SVR12 Assessment|2|||
124650570|NCT01447446|448339888|FG003|Overall Study|SVR12 Assessment|1|||
124650571|NCT01447446|448339889|FG004|Overall Study|SVR12 Assessment|5|||
124650572|NCT01447446|448339890|FG005|Overall Study|SVR12 Assessment|5|||
124650573|NCT01447446|448339885|FG000|Overall Study|New Treatment Started|8|||
124650574|NCT01447446|448339886|FG001|Overall Study|New Treatment Started|2|||
124650575|NCT01447446|448339887|FG002|Overall Study|New Treatment Started|1|||
124650576|NCT01447446|448339888|FG003|Overall Study|New Treatment Started|0|||
124650577|NCT01447446|448339889|FG004|Overall Study|New Treatment Started|2|||
124650578|NCT01447446|448339890|FG005|Overall Study|New Treatment Started|0|||
124650579|NCT01447446|448339885|FG000|Overall Study|Reason not Specified|1|||
124650580|NCT01447446|448339886|FG001|Overall Study|Reason not Specified|1|||
124650581|NCT01447446|448339887|FG002|Overall Study|Reason not Specified|1|||
124650582|NCT01447446|448339888|FG003|Overall Study|Reason not Specified|1|||
124650583|NCT01447446|448339889|FG004|Overall Study|Reason not Specified|1|||
124650584|NCT01447446|448339890|FG005|Overall Study|Reason not Specified|0|||
124650585|NCT02052596|448339899|FG000|Active Phase|Adverse Event|3|||
124650586|NCT02052596|448339900|FG001|Active Phase|Adverse Event|2|||
124650587|NCT02052596|448339899|FG000|Active Phase|Lost to Follow-up|8|||
124650588|NCT02052596|448339900|FG001|Active Phase|Lost to Follow-up|11|||
124650589|NCT02052596|448339899|FG000|Active Phase|Protocol Violation|1|||
124650590|NCT02052596|448339900|FG001|Active Phase|Protocol Violation|2|||
124650591|NCT02052596|448339899|FG000|Active Phase|Withdrawal by Subject|3|||
124650592|NCT02052596|448339900|FG001|Active Phase|Withdrawal by Subject|4|||
124650593|NCT02052596|448339899|FG000|Active Phase|Enrolled in error|1|||
124650594|NCT02052596|448339900|FG001|Active Phase|Enrolled in error|0|||
124650595|NCT02052596|448339899|FG000|Active Phase|Lost due to Crohn's disease|0|||
124650596|NCT02052596|448339900|FG001|Active Phase|Lost due to Crohn's disease|1|||
124650597|NCT02052596|448339899|FG000|Safety Phase|Adverse Event|6|||
124650598|NCT02052596|448339900|FG001|Safety Phase|Adverse Event|3|||
124650599|NCT02052596|448339899|FG000|Safety Phase|Lost to Follow-up|11|||
124650600|NCT02052596|448339900|FG001|Safety Phase|Lost to Follow-up|18|||
124650601|NCT02052596|448339899|FG000|Safety Phase|Protocol Violation|1|||
124650602|NCT02052596|448339900|FG001|Safety Phase|Protocol Violation|2|||
124650603|NCT02052596|448339899|FG000|Safety Phase|Withdrawal by Subject|8|||
124650604|NCT02052596|448339900|FG001|Safety Phase|Withdrawal by Subject|11|||
124650605|NCT02052596|448339899|FG000|Safety Phase|Enrolled in error|1|||
124650606|NCT02052596|448339900|FG001|Safety Phase|Enrolled in error|0|||
124650607|NCT02052596|448339899|FG000|Safety Phase|Lost due to Crohn's disease|0|||
124650608|NCT02052596|448339900|FG001|Safety Phase|Lost due to Crohn's disease|1|||
124650609|NCT03536949|448339901|FG000|Overall Study|Adverse Event|4|||
124650610|NCT03536949|448339902|FG001|Overall Study|Adverse Event|0|||
124650611|NCT03536949|448339901|FG000|Overall Study|Lost to Follow-up|2|||
124650612|NCT03536949|448339902|FG001|Overall Study|Lost to Follow-up|1|||
124650613|NCT03536949|448339901|FG000|Overall Study|Withdrawal by Subject|6|||
124650614|NCT03536949|448339902|FG001|Overall Study|Withdrawal by Subject|0|||
124650615|NCT03536949|448339901|FG000|Overall Study|Non-compliance|2|||
124650616|NCT03536949|448339902|FG001|Overall Study|Non-compliance|1|||
124650617|NCT00705718|448339903|FG000|Overall Study|Death|6|||
124650618|NCT00705718|448339904|FG001|Overall Study|Death|6|||
124650619|NCT00705718|448339903|FG000|Overall Study|Not due for Visit|0|||
124650620|NCT00705718|448339904|FG001|Overall Study|Not due for Visit|12|||
124650621|NCT00705718|448339903|FG000|Overall Study|Follow up not done|1|||
124650622|NCT00705718|448339904|FG001|Overall Study|Follow up not done|4|||
124650623|NCT00250458|448339911|FG000|Overall Study|Lost to Follow-up|4|||
124650624|NCT00250458|448339912|FG001|Overall Study|Lost to Follow-up|2|||
124650625|NCT00250458|448339911|FG000|Overall Study|Protocol Violation|0|||
124650626|NCT00250458|448339912|FG001|Overall Study|Protocol Violation|1|||
124650627|NCT00250458|448339911|FG000|Overall Study|Withdrawal by Subject|4|||
124650628|NCT00250458|448339912|FG001|Overall Study|Withdrawal by Subject|2|||
124650629|NCT00250458|448339911|FG000|Overall Study|Lack of Migraine Attack|20|||
124650630|NCT00250458|448339912|FG001|Overall Study|Lack of Migraine Attack|9|||
124650631|NCT00250458|448339911|FG000|Overall Study|Qualifying migraine but did not treat|3|||
124650632|NCT00250458|448339912|FG001|Overall Study|Qualifying migraine but did not treat|3|||
124650633|NCT00250458|448339911|FG000|Overall Study|Other|1|||
124650634|NCT00250458|448339912|FG001|Overall Study|Other|0|||
124650635|NCT06137703|448339913|FG000|Overall Study|Other|0|||
124650636|NCT06137703|448339914|FG001|Overall Study|Other|1|||
124650637|NCT06137703|448339915|FG002|Overall Study|Other|0|||
124650638|NCT06137703|448339916|FG003|Overall Study|Other|0|||
124650639|NCT06137703|448339913|FG000|Overall Study|Adverse Event|0|||
124650640|NCT06137703|448339914|FG001|Overall Study|Adverse Event|0|||
124650641|NCT06137703|448339915|FG002|Overall Study|Adverse Event|1|||
124650642|NCT06137703|448339916|FG003|Overall Study|Adverse Event|0|||
124650643|NCT00741091|448339919|FG000|Overall Study|Death|13|||
124650644|NCT00741091|448339919|FG000|Overall Study|Lost to Follow-up|16|||
124650645|NCT00741091|448339919|FG000|Overall Study|Withdrawal by Subject|6|||
124650646|NCT00741091|448339919|FG000|Overall Study|Missed Visit|22|||
124650647|NCT01892085|448339923|FG000|Overall Study|Death|4|||
124650648|NCT01892085|448339924|FG001|Overall Study|Death|1|||
124650649|NCT01892085|448339925|FG002|Overall Study|Death|3|||
124650650|NCT01892085|448339923|FG000|Overall Study|Withdrawal by Subject|2|||
124650651|NCT01892085|448339924|FG001|Overall Study|Withdrawal by Subject|0|||
124650652|NCT01892085|448339925|FG002|Overall Study|Withdrawal by Subject|2|||
124650653|NCT02505334|448339926|FG000|Main Treatment Period|Adverse Event|3|||
124650654|NCT02505334|448339927|FG001|Main Treatment Period|Adverse Event|3|||
124650655|NCT02505334|448339926|FG000|Main Treatment Period|Lack of Efficacy|7|||
124650656|NCT02505334|448339927|FG001|Main Treatment Period|Lack of Efficacy|17|||
124650657|NCT02505334|448339926|FG000|Main Treatment Period|Protocol Violation|0|||
124650658|NCT02505334|448339927|FG001|Main Treatment Period|Protocol Violation|1|||
124650659|NCT02505334|448339926|FG000|Main Treatment Period|Withdrawal by Subject|1|||
124650660|NCT02505334|448339927|FG001|Main Treatment Period|Withdrawal by Subject|8|||
124650661|NCT02505334|448339926|FG000|Main Treatment Period|Unclassified|4|||
124650662|NCT02505334|448339927|FG001|Main Treatment Period|Unclassified|10|||
124650663|NCT02505334|448339926|FG000|Extension Treatment Period|Adverse Event|5|||
124650664|NCT02505334|448339927|FG001|Extension Treatment Period|Adverse Event|0|||
124650665|NCT02505334|448339926|FG000|Extension Treatment Period|Lack of Efficacy|4|||
124650666|NCT02505334|448339927|FG001|Extension Treatment Period|Lack of Efficacy|0|||
124650667|NCT02505334|448339926|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
124650668|NCT02505334|448339927|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
124650669|NCT02505334|448339926|FG000|Extension Treatment Period|Unclassified|3|||
124650670|NCT02505334|448339927|FG001|Extension Treatment Period|Unclassified|0|||
124650671|NCT01549041|448339928|FG000|Overall Study|Lack of Efficacy|2|||
124650672|NCT01549041|448339929|FG001|Overall Study|Lack of Efficacy|4|||
124650673|NCT01549041|448339928|FG000|Overall Study|Adverse Event|0|||
124650674|NCT01549041|448339929|FG001|Overall Study|Adverse Event|4|||
124650675|NCT00597506|448339930|FG000|Overall Study|Subject is being followed for survival|1|||
124650676|NCT03199612|448339931|FG000|Overall Study|Adverse Event|1|||
124650677|NCT03199612|448339932|FG001|Overall Study|Adverse Event|0|||
124650678|NCT00081731|448339938|FG000|Overall Study|scientific integrity issue|8|||
124650679|NCT00081731|448339939|FG001|Overall Study|scientific integrity issue|8|||
124650680|NCT02386345|448339943|FG000|Overall Study|Not treated|14|||
124650681|NCT02386345|448339943|FG000|Overall Study|Lost to Follow-up|1|||
124650682|NCT02386345|448339943|FG000|Overall Study|Adverse Event|5|||
124650683|NCT02386345|448339943|FG000|Overall Study|Repeat Procedure|10|||
124650684|NCT02386345|448339943|FG000|Overall Study|Did not complete 12-month follow-up|72|||
124650685|NCT04050124|448339944|FG000|Overall Study|Death|1|||
124650686|NCT04050124|448339945|FG001|Overall Study|Death|0|||
124650687|NCT01537068|448339956|FG000|Overall Study|Lost to Follow-up|2|||
124650688|NCT01537068|448339957|FG001|Overall Study|Lost to Follow-up|1|||
124650689|NCT01537068|448339956|FG000|Overall Study|Adverse Event|0|||
124650690|NCT01537068|448339957|FG001|Overall Study|Adverse Event|1|||
124650691|NCT01537068|448339956|FG000|Overall Study|Withdrawal by Subject|1|||
124650692|NCT01537068|448339957|FG001|Overall Study|Withdrawal by Subject|1|||
124650693|NCT01537068|448339956|FG000|Overall Study|Lack of Efficacy|1|||
124650694|NCT01537068|448339957|FG001|Overall Study|Lack of Efficacy|0|||
124650695|NCT00483704|448339958|FG000|Randomization|Withdrawal by Subject|19|||
124650696|NCT00483704|448339959|FG001|Randomization|Withdrawal by Subject|28|||
124650697|NCT00483704|448339960|FG002|Randomization|Withdrawal by Subject|18|||
124650698|NCT00483704|448339958|FG000|Randomization|Protocol Violation|14|||
124650699|NCT00483704|448339959|FG001|Randomization|Protocol Violation|25|||
124650700|NCT00483704|448339960|FG002|Randomization|Protocol Violation|22|||
124650701|NCT00483704|448339958|FG000|Randomization|Lost to Follow-up|14|||
124650702|NCT00483704|448339959|FG001|Randomization|Lost to Follow-up|14|||
124650703|NCT00483704|448339960|FG002|Randomization|Lost to Follow-up|19|||
124650704|NCT00483704|448339958|FG000|Randomization|Pregnancy|1|||
124650705|NCT00483704|448339959|FG001|Randomization|Pregnancy|0|||
124650706|NCT00483704|448339960|FG002|Randomization|Pregnancy|0|||
124650707|NCT00483704|448339958|FG000|Randomization|Physician Decision|2|||
124650708|NCT00483704|448339959|FG001|Randomization|Physician Decision|4|||
124650709|NCT00483704|448339960|FG002|Randomization|Physician Decision|0|||
124650710|NCT00483704|448339958|FG000|Randomization|Progressive disease|0|||
124650711|NCT00483704|448339959|FG001|Randomization|Progressive disease|0|||
124650712|NCT00483704|448339960|FG002|Randomization|Progressive disease|1|||
124650713|NCT00483704|448339958|FG000|Randomization|Lack of qualifying migraines|21|||
124650714|NCT00483704|448339959|FG001|Randomization|Lack of qualifying migraines|25|||
124650715|NCT00483704|448339960|FG002|Randomization|Lack of qualifying migraines|31|||
124650716|NCT00483704|448339958|FG000|Treatment|Lack of qualifying migraines|101|||
124650717|NCT00483704|448339959|FG001|Treatment|Lack of qualifying migraines|99|||
124650718|NCT00483704|448339960|FG002|Treatment|Lack of qualifying migraines|116|||
124650719|NCT00483704|448339958|FG000|Treatment|Adverse Event|3|||
124650720|NCT00483704|448339959|FG001|Treatment|Adverse Event|5|||
124650721|NCT00483704|448339960|FG002|Treatment|Adverse Event|4|||
124650722|NCT00483704|448339958|FG000|Treatment|Withdrawal by Subject|16|||
124650723|NCT00483704|448339959|FG001|Treatment|Withdrawal by Subject|12|||
124650724|NCT00483704|448339960|FG002|Treatment|Withdrawal by Subject|21|||
124650725|NCT00483704|448339958|FG000|Treatment|Protocol Violation|6|||
124650726|NCT00483704|448339959|FG001|Treatment|Protocol Violation|3|||
124650727|NCT00483704|448339960|FG002|Treatment|Protocol Violation|5|||
124650728|NCT00483704|448339958|FG000|Treatment|Lost to Follow-up|2|||
124650729|NCT00483704|448339959|FG001|Treatment|Lost to Follow-up|7|||
124650730|NCT00483704|448339960|FG002|Treatment|Lost to Follow-up|5|||
124650731|NCT00483704|448339958|FG000|Treatment|Lack of Efficacy|1|||
124650732|NCT00483704|448339959|FG001|Treatment|Lack of Efficacy|1|||
124650733|NCT00483704|448339960|FG002|Treatment|Lack of Efficacy|1|||
124650734|NCT00483704|448339958|FG000|Treatment|Pregnancy|0|||
124650735|NCT00483704|448339959|FG001|Treatment|Pregnancy|1|||
124650736|NCT00483704|448339960|FG002|Treatment|Pregnancy|0|||
124650737|NCT00483704|448339958|FG000|Treatment|Physician Decision|0|||
124650738|NCT00483704|448339959|FG001|Treatment|Physician Decision|1|||
124650739|NCT00483704|448339960|FG002|Treatment|Physician Decision|4|||
124650740|NCT04442269|448339961|FG000|Overall Study|Adverse Event|1|||
124650741|NCT04442269|448339962|FG001|Overall Study|Adverse Event|0|||
124650742|NCT04442269|448339961|FG000|Overall Study|Death|0|||
124650743|NCT04442269|448339962|FG001|Overall Study|Death|1|||
124650744|NCT04442269|448339961|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
124650745|NCT04442269|448339962|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
124650746|NCT04442269|448339961|FG000|Overall Study|Lost to Follow-up|1|||
124650747|NCT04442269|448339962|FG001|Overall Study|Lost to Follow-up|0|||
124650748|NCT04442269|448339961|FG000|Overall Study|Withdrawal by Subject|3|||
124650749|NCT04442269|448339962|FG001|Overall Study|Withdrawal by Subject|2|||
124650750|NCT04442269|448339961|FG000|Overall Study|Protocol Deviation|0|||
124650751|NCT04442269|448339962|FG001|Overall Study|Protocol Deviation|1|||
124650752|NCT04442269|448339961|FG000|Overall Study|Travel Limitations|1|||
124650753|NCT04442269|448339962|FG001|Overall Study|Travel Limitations|1|||
124650754|NCT02326298|448339963|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124650755|NCT02326298|448339964|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124650756|NCT02326298|448339965|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
124650757|NCT02326298|448339966|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124650758|NCT02326298|448339967|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124650759|NCT02326298|448339968|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124650760|NCT02326298|448339969|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124650761|NCT02326298|448339970|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124650762|NCT02326298|448339971|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124650763|NCT02326298|448339972|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124650764|NCT02326298|448339973|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124650765|NCT02326298|448339974|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124650766|NCT02326298|448339975|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124650767|NCT02326298|448339976|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124650768|NCT02326298|448339963|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
124650769|NCT02326298|448339964|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
124650770|NCT02326298|448339965|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
124650771|NCT02326298|448339966|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
124650772|NCT02326298|448339967|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
124650773|NCT02326298|448339968|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
124650774|NCT02326298|448339969|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
124650775|NCT02326298|448339970|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
124650776|NCT02326298|448339971|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
124650777|NCT02326298|448339972|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
124650778|NCT02326298|448339973|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
124650779|NCT02326298|448339974|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
124650780|NCT02326298|448339975|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
124650781|NCT02326298|448339976|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
124650782|NCT02326298|448339963|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
124650783|NCT02326298|448339964|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
124650784|NCT02326298|448339965|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124650785|NCT02326298|448339966|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124650786|NCT02326298|448339967|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124650787|NCT02326298|448339968|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124650788|NCT02326298|448339969|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124650789|NCT02326298|448339970|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124650790|NCT02326298|448339971|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124650791|NCT02326298|448339972|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124650792|NCT02326298|448339973|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124650793|NCT02326298|448339974|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124650794|NCT02326298|448339975|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124650795|NCT02326298|448339976|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124650796|NCT02326298|448339963|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
124650797|NCT02326298|448339964|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
124650798|NCT02326298|448339965|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124650799|NCT02326298|448339966|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124650800|NCT02326298|448339967|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124650801|NCT02326298|448339968|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124650802|NCT02326298|448339969|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124650803|NCT02326298|448339970|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124650804|NCT02326298|448339971|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124650805|NCT02326298|448339972|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124650806|NCT02326298|448339973|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124650807|NCT02326298|448339974|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124650808|NCT02326298|448339975|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124650809|NCT02326298|448339976|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124650810|NCT02326298|448339963|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
124650811|NCT02326298|448339964|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
124650812|NCT02326298|448339965|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
124650813|NCT02326298|448339966|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
124650814|NCT02326298|448339967|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
124650815|NCT02326298|448339968|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
124650816|NCT02326298|448339969|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
124650817|NCT02326298|448339970|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
124650818|NCT02326298|448339971|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
124650819|NCT02326298|448339972|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
124650820|NCT02326298|448339973|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
124650821|NCT02326298|448339974|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
124650822|NCT02326298|448339975|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
124650823|NCT02326298|448339976|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
124650824|NCT02326298|448339963|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124650825|NCT02326298|448339964|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124650826|NCT02326298|448339965|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124650827|NCT02326298|448339966|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124650828|NCT02326298|448339967|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124650829|NCT02326298|448339968|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124650830|NCT02326298|448339969|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
124650831|NCT02326298|448339970|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124650832|NCT02326298|448339971|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124650833|NCT02326298|448339972|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124650834|NCT02326298|448339973|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124650835|NCT02326298|448339974|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124650836|NCT02326298|448339975|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124650837|NCT02326298|448339976|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124650838|NCT02326298|448339963|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
124650839|NCT02326298|448339964|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
124650840|NCT02326298|448339965|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
124650841|NCT02326298|448339966|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
124650842|NCT02326298|448339967|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
124650843|NCT02326298|448339968|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
124650844|NCT02326298|448339969|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
124650845|NCT02326298|448339970|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
124650846|NCT02326298|448339971|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
124650847|NCT02326298|448339972|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
124650848|NCT02326298|448339973|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
124650849|NCT02326298|448339974|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
124650850|NCT02326298|448339975|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
124650851|NCT02326298|448339976|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
124650852|NCT02326298|448339963|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
124650853|NCT02326298|448339964|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
124650854|NCT02326298|448339965|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
124650855|NCT02326298|448339966|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
124650856|NCT02326298|448339967|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
124650857|NCT02326298|448339968|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
124650858|NCT02326298|448339969|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
124650859|NCT02326298|448339970|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
124650860|NCT02326298|448339971|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
124650861|NCT02326298|448339972|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
124650862|NCT02326298|448339973|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
124650863|NCT02326298|448339974|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
124650864|NCT02326298|448339975|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
124650865|NCT02326298|448339976|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
124650866|NCT02326298|448339963|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124650867|NCT02326298|448339964|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124650868|NCT02326298|448339965|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124650869|NCT02326298|448339966|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124650870|NCT02326298|448339967|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124650871|NCT02326298|448339968|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124650872|NCT02326298|448339969|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
124650873|NCT02326298|448339970|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124650874|NCT02326298|448339971|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124650875|NCT02326298|448339972|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124650876|NCT02326298|448339973|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124650877|NCT02326298|448339974|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124650878|NCT02326298|448339975|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124650879|NCT02326298|448339976|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124650880|NCT02326298|448339963|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
124650881|NCT02326298|448339964|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
124650882|NCT02326298|448339965|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
124650883|NCT02326298|448339966|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
124650884|NCT02326298|448339967|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
124650885|NCT02326298|448339968|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
124650886|NCT02326298|448339969|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
124650887|NCT02326298|448339970|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
124650888|NCT02326298|448339971|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
124650889|NCT02326298|448339972|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
124650890|NCT02326298|448339973|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
124650891|NCT02326298|448339974|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
124650892|NCT02326298|448339975|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
124650893|NCT02326298|448339976|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
124650894|NCT02326298|448339963|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124650895|NCT02326298|448339964|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124650896|NCT02326298|448339965|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124650897|NCT02326298|448339966|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124650898|NCT02326298|448339967|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124650899|NCT02326298|448339968|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124650900|NCT02326298|448339969|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
124650901|NCT02326298|448339970|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
124650902|NCT02326298|448339971|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124650903|NCT02326298|448339972|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124650904|NCT02326298|448339973|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124650905|NCT02326298|448339974|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124650906|NCT02326298|448339975|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124650907|NCT02326298|448339976|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124650908|NCT02326298|448339963|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124650909|NCT02326298|448339964|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124650910|NCT02326298|448339965|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124650911|NCT02326298|448339966|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124650912|NCT02326298|448339967|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124650913|NCT02326298|448339968|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124650914|NCT02326298|448339969|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124650915|NCT02326298|448339970|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
124650916|NCT02326298|448339971|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124650917|NCT02326298|448339972|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124650918|NCT02326298|448339973|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124650919|NCT02326298|448339974|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124650920|NCT02326298|448339975|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124650921|NCT02326298|448339976|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124650922|NCT02326298|448339963|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
124650923|NCT02326298|448339964|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
124650924|NCT02326298|448339965|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
124650925|NCT02326298|448339966|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
124650926|NCT02326298|448339967|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
124650927|NCT02326298|448339968|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
124650928|NCT02326298|448339969|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
124650929|NCT02326298|448339970|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
124650930|NCT02326298|448339971|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
124650931|NCT02326298|448339972|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
124650932|NCT02326298|448339973|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
124650933|NCT02326298|448339974|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
124650934|NCT02326298|448339975|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
124650935|NCT02326298|448339976|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
124650936|NCT02326298|448339963|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
124650937|NCT02326298|448339964|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
124650938|NCT02326298|448339965|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
124650939|NCT02326298|448339966|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
124650940|NCT02326298|448339967|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
124650941|NCT02326298|448339968|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
124650942|NCT02326298|448339969|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
124650943|NCT02326298|448339970|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
124650944|NCT02326298|448339971|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
124650945|NCT02326298|448339972|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
124650946|NCT02326298|448339973|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
124650947|NCT02326298|448339974|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
124650948|NCT02326298|448339975|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
124650949|NCT02326298|448339976|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
124650950|NCT02326298|448339963|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124872587|NCT01662063|449155673|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
124872588|NCT01662063|449155674|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
124872589|NCT01662063|449155675|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
124872590|NCT01662063|449155673|FG000|Overall Study|Lack of Efficacy|1|||
124872591|NCT01662063|449155674|FG001|Overall Study|Lack of Efficacy|6|||
124872592|NCT01662063|449155675|FG002|Overall Study|Lack of Efficacy|0|||
124872593|NCT01662063|449155673|FG000|Overall Study|Lost to Follow-up|0|||
124650951|NCT02326298|448339964|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124872594|NCT01662063|449155674|FG001|Overall Study|Lost to Follow-up|4|||
124872595|NCT01662063|449155675|FG002|Overall Study|Lost to Follow-up|0|||
124650952|NCT02326298|448339965|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124650953|NCT02326298|448339966|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124650954|NCT02326298|448339967|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124650955|NCT02326298|448339968|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124650956|NCT02326298|448339969|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124650957|NCT02326298|448339970|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124650958|NCT02326298|448339971|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124650959|NCT02326298|448339972|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124650960|NCT02326298|448339973|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124650961|NCT02326298|448339974|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
124650962|NCT02326298|448339975|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
124650963|NCT02326298|448339976|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124650964|NCT02326298|448339963|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124650965|NCT02326298|448339964|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124650966|NCT02326298|448339965|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124650967|NCT02326298|448339966|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124650968|NCT02326298|448339967|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124650969|NCT02326298|448339968|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124650970|NCT02326298|448339969|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124650971|NCT02326298|448339970|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124650972|NCT02326298|448339971|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124650973|NCT02326298|448339972|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124650974|NCT02326298|448339973|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124650975|NCT02326298|448339974|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
124650976|NCT02326298|448339975|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
124650977|NCT02326298|448339976|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124650978|NCT02326298|448339963|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124650979|NCT02326298|448339964|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124650980|NCT02326298|448339965|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124650981|NCT02326298|448339966|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124650982|NCT02326298|448339967|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124650983|NCT02326298|448339968|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124650984|NCT02326298|448339969|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124650985|NCT02326298|448339970|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124650986|NCT02326298|448339971|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124650987|NCT02326298|448339972|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124650988|NCT02326298|448339973|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124650989|NCT02326298|448339974|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124650990|NCT02326298|448339975|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124650991|NCT02326298|448339976|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
124650992|NCT02326298|448339963|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124650993|NCT02326298|448339964|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124650994|NCT02326298|448339965|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124650995|NCT02326298|448339966|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124650996|NCT02326298|448339967|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124650997|NCT02326298|448339968|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124650998|NCT02326298|448339969|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124650999|NCT02326298|448339970|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124651000|NCT02326298|448339971|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124651001|NCT02326298|448339972|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124651002|NCT02326298|448339973|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124651003|NCT02326298|448339974|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
124651004|NCT02326298|448339975|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
124651005|NCT02326298|448339976|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
124651006|NCT02326298|448339963|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124651007|NCT02326298|448339964|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124651008|NCT02326298|448339965|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124651009|NCT02326298|448339966|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124651010|NCT02326298|448339967|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124651011|NCT02326298|448339968|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124651012|NCT02326298|448339969|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124651013|NCT02326298|448339970|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124651014|NCT02326298|448339971|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124651015|NCT02326298|448339972|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124651016|NCT02326298|448339973|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124651017|NCT02326298|448339974|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
124651018|NCT02326298|448339975|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
124651019|NCT02326298|448339976|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
124651020|NCT02326298|448339963|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124651021|NCT02326298|448339964|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124651022|NCT02326298|448339965|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124651023|NCT02326298|448339966|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124651024|NCT02326298|448339967|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124651025|NCT02326298|448339968|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124651026|NCT02326298|448339969|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124651027|NCT02326298|448339970|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124651028|NCT02326298|448339971|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124651029|NCT02326298|448339972|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124651030|NCT02326298|448339973|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124651031|NCT02326298|448339974|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
124651032|NCT02326298|448339975|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
124651033|NCT02326298|448339976|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
124651034|NCT00787917|448339977|FG000|Blinded Treatment|Adverse Event|1|||
124651035|NCT00787917|448339978|FG001|Blinded Treatment|Adverse Event|0|||
124651036|NCT00787917|448339977|FG000|Blinded Treatment|Lack of Efficacy|1|||
124651037|NCT00787917|448339978|FG001|Blinded Treatment|Lack of Efficacy|0|||
124651038|NCT00787917|448339977|FG000|Blinded Treatment|Administrative problems|3|||
124651039|NCT00787917|448339978|FG001|Blinded Treatment|Administrative problems|2|||
124651040|NCT00787917|448339977|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
124651041|NCT00787917|448339978|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
124651042|NCT00787917|448339977|FG000|Open Label|Administrative problems|3|||
124651043|NCT00787917|448339978|FG001|Open Label|Administrative problems|0|||
124651044|NCT00778102|448339979|FG000|Overall Study|Adverse Event|8|||
124651045|NCT00778102|448339980|FG001|Overall Study|Adverse Event|5|||
124651046|NCT00778102|448339979|FG000|Overall Study|Death|1|||
124651047|NCT00778102|448339980|FG001|Overall Study|Death|1|||
124651048|NCT00778102|448339979|FG000|Overall Study|Lost to Follow-up|1|||
124651049|NCT00778102|448339980|FG001|Overall Study|Lost to Follow-up|0|||
124651050|NCT00778102|448339979|FG000|Overall Study|Violation of Selection Criteria|1|||
124651051|NCT00778102|448339980|FG001|Overall Study|Violation of Selection Criteria|1|||
124651052|NCT00778102|448339979|FG000|Overall Study|Protocol Violation|0|||
124651053|NCT00778102|448339980|FG001|Overall Study|Protocol Violation|1|||
124651054|NCT00778102|448339979|FG000|Overall Study|Refused Treatment|2|||
124651055|NCT00778102|448339980|FG001|Overall Study|Refused Treatment|3|||
124651056|NCT00778102|448339979|FG000|Overall Study|Withdrawal by Subject|1|||
124651057|NCT00778102|448339980|FG001|Overall Study|Withdrawal by Subject|1|||
124651058|NCT00778102|448339979|FG000|Overall Study|Administrative Reason|7|||
124651059|NCT00778102|448339980|FG001|Overall Study|Administrative Reason|10|||
124651060|NCT01328548|448339981|FG000|Overall Study|Death|3|||
124651061|NCT01328548|448339982|FG001|Overall Study|Death|0|||
124651062|NCT01328548|448339981|FG000|Overall Study|Protocol Violation|1|||
124651063|NCT01328548|448339982|FG001|Overall Study|Protocol Violation|0|||
124651064|NCT02417961|448341189|FG000|Overall Study|Adverse Event|1|||
124651065|NCT02417961|448341189|FG000|Overall Study|Lost to Follow-up|1|||
124651066|NCT02417961|448341189|FG000|Overall Study|Withdrawal by Subject|2|||
124651067|NCT03197467|448341192|FG000|Overall Study|Withdrawal by Subject|1|||
124651068|NCT03666533|448341194|FG000|Overall Study|Lost to Follow-up|2|||
124651069|NCT03666533|448341195|FG001|Overall Study|Lost to Follow-up|2|||
124651070|NCT04240886|448341200|FG000|Treatment Phase|Death|4|||
124651071|NCT04240886|448341200|FG000|Treatment Phase|Discontinuation by Subject|1|||
124651072|NCT04240886|448341200|FG000|Treatment Phase|Adverse Event|5|||
124651073|NCT04240886|448341200|FG000|Follow-up Phase|Withdrawal by Subject|1|||
124651074|NCT04240886|448341200|FG000|Follow-up Phase|Discontinuation by Subject|1|||
124651075|NCT04240886|448341200|FG000|Follow-up Phase|Death|2|||
124651076|NCT04743804|448341201|FG000|Overall Study|Other|1|||
124651077|NCT04743804|448341202|FG001|Overall Study|Other|0|||
124651078|NCT04743804|448341201|FG000|Overall Study|Withdrawal by Subject|0|||
124651079|NCT04743804|448341202|FG001|Overall Study|Withdrawal by Subject|1|||
124651080|NCT04743804|448341201|FG000|Overall Study|Study Terminated by Sponsor|1|||
124651081|NCT04743804|448341202|FG001|Overall Study|Study Terminated by Sponsor|4|||
124651082|NCT04743804|448341201|FG000|Overall Study|Physician Decision|0|||
124651083|NCT04743804|448341202|FG001|Overall Study|Physician Decision|1|||
124651084|NCT04743804|448341201|FG000|Overall Study|Death|3|||
124651085|NCT04743804|448341202|FG001|Overall Study|Death|0|||
124651086|NCT01632904|448341203|FG000|Overall Study|Adverse Event|4|||
124651087|NCT01632904|448341204|FG001|Overall Study|Adverse Event|1|||
124651088|NCT01632904|448341203|FG000|Overall Study|Physician Decision|0|||
124651089|NCT01632904|448341204|FG001|Overall Study|Physician Decision|1|||
124651090|NCT01632904|448341203|FG000|Overall Study|Subject decision|3|||
124651091|NCT01632904|448341204|FG001|Overall Study|Subject decision|2|||
124651092|NCT01632904|448341203|FG000|Overall Study|Disease Progression|0|||
124651093|NCT01632904|448341204|FG001|Overall Study|Disease Progression|1|||
124651094|NCT01632904|448341203|FG000|Overall Study|Reason for discontinuation not available|0|||
124651095|NCT01632904|448341204|FG001|Overall Study|Reason for discontinuation not available|1|||
124651096|NCT01473394|448341208|FG000|Overall Study|Adverse Event|13|||
124651097|NCT01473394|448341209|FG001|Overall Study|Adverse Event|16|||
124651098|NCT01473394|448341208|FG000|Overall Study|Insufficient Therapeutic Response|4|||
124651099|NCT01473394|448341209|FG001|Overall Study|Insufficient Therapeutic Response|1|||
124651100|NCT01473394|448341208|FG000|Overall Study|Protocol Violation|7|||
124651101|NCT01473394|448341209|FG001|Overall Study|Protocol Violation|5|||
124651102|NCT01473394|448341208|FG000|Overall Study|Withdrew Consent|12|||
124651103|NCT01473394|448341209|FG001|Overall Study|Withdrew Consent|10|||
124651104|NCT01473394|448341208|FG000|Overall Study|Lost to Follow-up|9|||
124651105|NCT01473394|448341209|FG001|Overall Study|Lost to Follow-up|11|||
124651106|NCT03117881|448341210|FG000|Baseline|Withdrawal by Subject|21|||
124651107|NCT03117881|448341211|FG001|Baseline|Withdrawal by Subject|10|||
124651108|NCT03117881|448341212|FG002|Baseline|Withdrawal by Subject|0|||
124651109|NCT03117881|448341210|FG000|Baseline|Lost to Follow-up|22|||
124651110|NCT03117881|448341211|FG001|Baseline|Lost to Follow-up|25|||
124651111|NCT03117881|448341212|FG002|Baseline|Lost to Follow-up|0|||
124651112|NCT03117881|448341210|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
124651113|NCT03117881|448341211|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
124651114|NCT03117881|448341212|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
124651115|NCT03117881|448341210|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
124651116|NCT03117881|448341211|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
124651117|NCT03117881|448341212|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
124651118|NCT03117881|448341210|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
124651119|NCT03117881|448341211|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
124651120|NCT03117881|448341212|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
124651121|NCT03117881|448341210|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
124651122|NCT03117881|448341211|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
124651123|NCT03117881|448341212|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
124651124|NCT03117881|448341210|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
124651125|NCT03117881|448341211|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
124651126|NCT03117881|448341212|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
124651127|NCT03117881|448341210|FG000|6-Month Follow-Up|Did not complete test|53|||
124651128|NCT03117881|448341211|FG001|6-Month Follow-Up|Did not complete test|25|||
124651129|NCT03117881|448341212|FG002|6-Month Follow-Up|Did not complete test|7|||
124651130|NCT03117881|448341210|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
124651131|NCT03117881|448341211|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
124651132|NCT03117881|448341212|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
124651133|NCT03117881|448341210|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
124651134|NCT03117881|448341211|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
124651135|NCT03117881|448341212|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
124651136|NCT03117881|448341210|FG000|12-Month Follow-Up|Did not complete test|40|||
124651137|NCT03117881|448341211|FG001|12-Month Follow-Up|Did not complete test|0|||
124651138|NCT03117881|448341212|FG002|12-Month Follow-Up|Did not complete test|0|||
124651139|NCT01027897|448341215|FG000|Overall Study|Protocol Violation|1|||
124651140|NCT01027897|448341215|FG000|Overall Study|Withdrawal by Subject|1|||
124651141|NCT00473824|448341218|FG000|Overall Study|Virologic Breakthrough|1|||
124651142|NCT00473824|448341219|FG001|Overall Study|Virologic Breakthrough|0|||
124651143|NCT00473824|448341218|FG000|Overall Study|Adverse Event|1|||
124651144|NCT00473824|448341219|FG001|Overall Study|Adverse Event|0|||
124651145|NCT00473824|448341218|FG000|Overall Study|Death|1|||
124651146|NCT00473824|448341219|FG001|Overall Study|Death|0|||
124651147|NCT00473824|448341218|FG000|Overall Study|Lost to Follow-up|1|||
124651148|NCT00473824|448341219|FG001|Overall Study|Lost to Follow-up|0|||
124651149|NCT00473824|448341218|FG000|Overall Study|Withdrawal by physician|1|||
124651150|NCT00473824|448341219|FG001|Overall Study|Withdrawal by physician|0|||
124651151|NCT02560623|448341220|FG000|Overall Study|Unable to swallow sponge|0|||
124651152|NCT02560623|448341221|FG001|Overall Study|Unable to swallow sponge|1|||
124651153|NCT02560623|448341222|FG002|Overall Study|Unable to swallow sponge|0|||
124651154|NCT02560623|448341223|FG003|Overall Study|Unable to swallow sponge|0|||
124651155|NCT02560623|448341220|FG000|Overall Study|Intervention prior to sponge administration|0|||
124651156|NCT02560623|448341221|FG001|Overall Study|Intervention prior to sponge administration|1|||
124651157|NCT02560623|448341222|FG002|Overall Study|Intervention prior to sponge administration|0|||
124651158|NCT02560623|448341223|FG003|Overall Study|Intervention prior to sponge administration|0|||
124651159|NCT01661933|448341227|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
124651160|NCT01661933|448341227|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
124651161|NCT02720744|448341228|FG000|Overall Study|Protocol Violation|0|||
124651162|NCT02720744|448341229|FG001|Overall Study|Protocol Violation|2|||
124651163|NCT02720744|448341228|FG000|Overall Study|Pregnancy|2|||
124651164|NCT02720744|448341229|FG001|Overall Study|Pregnancy|0|||
124651165|NCT02720744|448341228|FG000|Overall Study|Lack of Efficacy|2|||
124651166|NCT02720744|448341229|FG001|Overall Study|Lack of Efficacy|8|||
124651167|NCT02720744|448341228|FG000|Overall Study|Adverse Event|21|||
124651168|NCT02720744|448341229|FG001|Overall Study|Adverse Event|3|||
124651169|NCT02720744|448341228|FG000|Overall Study|Withdrawal by Subject|11|||
124651170|NCT02720744|448341229|FG001|Overall Study|Withdrawal by Subject|11|||
124651171|NCT02720744|448341228|FG000|Overall Study|Lost to follow up|2|||
124651172|NCT02720744|448341229|FG001|Overall Study|Lost to follow up|0|||
124651173|NCT02720744|448341228|FG000|Overall Study|Non Compliance with Investigational Product|0|||
124651174|NCT02720744|448341229|FG001|Overall Study|Non Compliance with Investigational Product|1|||
124651175|NCT02720744|448341228|FG000|Overall Study|Excluded Concomitant Medication|0|||
124651176|NCT02720744|448341229|FG001|Overall Study|Excluded Concomitant Medication|1|||
124651177|NCT02609724|448341234|FG000|Overall Study|Death|2|||
124651178|NCT02609724|448341235|FG001|Overall Study|Death|0|||
124651179|NCT02609724|448341236|FG002|Overall Study|Death|1|||
124651180|NCT02609724|448341234|FG000|Overall Study|Withdrawal by Subject|1|||
124651181|NCT02609724|448341235|FG001|Overall Study|Withdrawal by Subject|2|||
124651182|NCT02609724|448341236|FG002|Overall Study|Withdrawal by Subject|3|||
124651183|NCT02609724|448341234|FG000|Overall Study|Illness|2|||
124651184|NCT02609724|448341235|FG001|Overall Study|Illness|1|||
124651185|NCT02609724|448341236|FG002|Overall Study|Illness|0|||
124651186|NCT03077659|448341237|FG000|Overall Study|Withdrawal by Subject|0|||
124651187|NCT03077659|448341238|FG001|Overall Study|Withdrawal by Subject|0|||
124651188|NCT03077659|448341239|FG002|Overall Study|Withdrawal by Subject|1|||
124651189|NCT02844907|448341240|FG000|With Dexamethasone|No IV access|1|||
124872596|NCT01662063|449155673|FG000|Overall Study|Protocol Violation|1|||
124872597|NCT01662063|449155674|FG001|Overall Study|Protocol Violation|0|||
124872598|NCT01662063|449155675|FG002|Overall Study|Protocol Violation|0|||
124872599|NCT01662063|449155673|FG000|Overall Study|Withdrawal by Subject|2|||
124872600|NCT01662063|449155674|FG001|Overall Study|Withdrawal by Subject|4|||
124872601|NCT01662063|449155675|FG002|Overall Study|Withdrawal by Subject|1|||
124651190|NCT00426660|448341241|FG000|Overall Study|Death|14|||
124651191|NCT00426660|448341241|FG000|Overall Study|Adverse Event|23|||
124651192|NCT00426660|448341241|FG000|Overall Study|Insufficient Clinical Response|22|||
124651193|NCT00426660|448341241|FG000|Overall Study|Lost to Follow-up|15|||
124651194|NCT00426660|448341241|FG000|Overall Study|Other|23|||
124651195|NCT00426660|448341241|FG000|Overall Study|Withdrawal by Subject|18|||
124651196|NCT00426660|448341241|FG000|Overall Study|Protocol Violation|1|||
124651197|NCT00426660|448341241|FG000|Overall Study|Enrolled Not Treated|15|||
124651198|NCT00738062|448341242|FG000|Open Label Treatment|Lack of Efficacy|5|||
124651199|NCT00738062|448341243|FG001|Open Label Treatment|Lack of Efficacy|0|||
124651200|NCT00738062|448341244|FG002|Open Label Treatment|Lack of Efficacy|0|||
124651201|NCT00738062|448341242|FG000|Open Label Treatment|Adverse Event|11|||
124651202|NCT00738062|448341243|FG001|Open Label Treatment|Adverse Event|0|||
124651203|NCT00738062|448341244|FG002|Open Label Treatment|Adverse Event|0|||
124651204|NCT00738062|448341242|FG000|Open Label Treatment|Protocol Violation|2|||
124651205|NCT00738062|448341243|FG001|Open Label Treatment|Protocol Violation|0|||
124651206|NCT00738062|448341244|FG002|Open Label Treatment|Protocol Violation|0|||
124651207|NCT00738062|448341242|FG000|Open Label Treatment|Withdrawal by Subject|9|||
124651208|NCT00738062|448341243|FG001|Open Label Treatment|Withdrawal by Subject|0|||
124651209|NCT00738062|448341244|FG002|Open Label Treatment|Withdrawal by Subject|0|||
124651210|NCT00738062|448341242|FG000|Open Label Treatment|Investigator Decision|1|||
124651211|NCT00738062|448341243|FG001|Open Label Treatment|Investigator Decision|0|||
124651212|NCT00738062|448341244|FG002|Open Label Treatment|Investigator Decision|0|||
124651213|NCT00738062|448341242|FG000|Open-Label Extension|Adverse Event|5|||
124872602|NCT01662063|449155673|FG000|Overall Study|Physician Decision|0|||
124872603|NCT01662063|449155674|FG001|Overall Study|Physician Decision|2|||
124872604|NCT01662063|449155675|FG002|Overall Study|Physician Decision|0|||
124651214|NCT00738062|448341243|FG001|Open-Label Extension|Adverse Event|0|||
124651215|NCT00738062|448341244|FG002|Open-Label Extension|Adverse Event|0|||
124651216|NCT00738062|448341242|FG000|Open-Label Extension|Physician Decision|1|||
124651217|NCT00738062|448341243|FG001|Open-Label Extension|Physician Decision|0|||
124651218|NCT00738062|448341244|FG002|Open-Label Extension|Physician Decision|0|||
124651219|NCT00738062|448341242|FG000|Open-Label Extension|Lack of Efficacy|2|||
124651220|NCT00738062|448341243|FG001|Open-Label Extension|Lack of Efficacy|0|||
124651221|NCT00738062|448341244|FG002|Open-Label Extension|Lack of Efficacy|0|||
124651222|NCT00738062|448341242|FG000|Open-Label Extension|Withdrawal by Subject|6|||
124651223|NCT00738062|448341243|FG001|Open-Label Extension|Withdrawal by Subject|0|||
124651224|NCT00738062|448341244|FG002|Open-Label Extension|Withdrawal by Subject|0|||
124651225|NCT00738062|448341242|FG000|Open-Label Extension|Protocol Violation|1|||
124651226|NCT00738062|448341243|FG001|Open-Label Extension|Protocol Violation|0|||
124651227|NCT00738062|448341244|FG002|Open-Label Extension|Protocol Violation|0|||
124651228|NCT00738062|448341242|FG000|Open-Label Extension|Study Terminated|2|||
124651229|NCT00738062|448341243|FG001|Open-Label Extension|Study Terminated|0|||
124651230|NCT00738062|448341244|FG002|Open-Label Extension|Study Terminated|0|||
124651231|NCT00550862|448341245|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
124651232|NCT00550862|448341246|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
124651233|NCT00550862|448341247|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
124651234|NCT00550862|448341248|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
124651235|NCT00550862|448341249|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
124651236|NCT00550862|448341245|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
124651237|NCT00550862|448341246|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
124651238|NCT00550862|448341247|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
124651239|NCT00550862|448341248|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
124651240|NCT00550862|448341249|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
124651241|NCT00550862|448341245|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
124651242|NCT00550862|448341246|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
124651243|NCT00550862|448341247|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
124651244|NCT00550862|448341248|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
124651245|NCT00550862|448341249|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
124651246|NCT00550862|448341245|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
124651247|NCT00550862|448341246|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
124651248|NCT00550862|448341247|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
124651249|NCT00550862|448341248|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
124651250|NCT00550862|448341249|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
124651251|NCT00550862|448341245|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
124651252|NCT00550862|448341246|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
124651253|NCT00550862|448341247|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
124651254|NCT00550862|448341248|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
124651255|NCT00550862|448341249|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
124651256|NCT00550862|448341245|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
124651257|NCT00550862|448341246|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
124651258|NCT00550862|448341247|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
124651259|NCT00550862|448341248|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
124651260|NCT00550862|448341249|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
124651261|NCT00550862|448341245|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
124651262|NCT00550862|448341246|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
124651263|NCT00550862|448341247|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
124651264|NCT00550862|448341248|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
124651265|NCT00550862|448341249|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
124651266|NCT00550862|448341245|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
124651267|NCT00550862|448341246|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
124651268|NCT00550862|448341247|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
124651269|NCT00550862|448341248|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
124651270|NCT00550862|448341249|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
124651271|NCT00550862|448341245|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
124651272|NCT00550862|448341246|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
124651273|NCT00550862|448341247|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
124651274|NCT00550862|448341248|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
124651275|NCT00550862|448341249|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
124651276|NCT00550862|448341245|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
124651277|NCT00550862|448341246|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
124651278|NCT00550862|448341247|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
124651279|NCT00550862|448341248|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
124651280|NCT00550862|448341249|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
124651281|NCT00980174|448341251|FG000|Overall Study|Withdrawal by Subject|1|||
124651282|NCT00980174|448341252|FG001|Overall Study|Withdrawal by Subject|4|||
124651283|NCT00980174|448341251|FG000|Overall Study|Adverse Event|0|||
124651284|NCT00980174|448341252|FG001|Overall Study|Adverse Event|3|||
124651285|NCT00980174|448341251|FG000|Overall Study|Ineligibility determined|2|||
124651286|NCT00980174|448341252|FG001|Overall Study|Ineligibility determined|1|||
124651287|NCT00980174|448341251|FG000|Overall Study|Death|1|||
124651288|NCT00980174|448341252|FG001|Overall Study|Death|1|||
124651289|NCT00980174|448341251|FG000|Overall Study|Other|0|||
124651290|NCT00980174|448341252|FG001|Overall Study|Other|1|||
124651291|NCT04631107|448341257|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
124651292|NCT04631107|448341257|FG000|Second Intervention (1 Night)|Adverse Event|1|||
124651293|NCT04631107|448341257|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
124651294|NCT04631107|448341257|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
124651295|NCT02003963|448341258|FG000|Overall Study|Lost to Follow-up|2|||
124651296|NCT02003963|448341259|FG001|Overall Study|Lost to Follow-up|1|||
124651297|NCT01935128|448341261|FG000|Overall Study|Death|1|||
124651298|NCT01935128|448341261|FG000|Overall Study|Adverse Event|6|||
124651299|NCT01440569|448341262|FG000|Main Study|Enrolled but not treated|1|||
124651300|NCT01440569|448341263|FG001|Main Study|Enrolled but not treated|0|||
124651301|NCT01440569|448341262|FG000|Main Study|Adverse Event|9|||
124651302|NCT01440569|448341263|FG001|Main Study|Adverse Event|0|||
124651303|NCT01440569|448341262|FG000|Main Study|Pregnancy|1|||
124651304|NCT01440569|448341263|FG001|Main Study|Pregnancy|0|||
124651305|NCT01440569|448341262|FG000|Main Study|Investigator's Discretion|1|||
124651306|NCT01440569|448341263|FG001|Main Study|Investigator's Discretion|1|||
124651307|NCT01440569|448341262|FG000|Main Study|Withdrew Consent|7|||
124651308|NCT01440569|448341263|FG001|Main Study|Withdrew Consent|1|||
124651309|NCT01440569|448341262|FG000|Main Study|Lost to Follow-up|13|||
124651310|NCT01440569|448341263|FG001|Main Study|Lost to Follow-up|2|||
124651311|NCT01440569|448341262|FG000|Main Study|Subject Non-Compliance|3|||
124651312|NCT01440569|448341263|FG001|Main Study|Subject Non-Compliance|0|||
124651313|NCT01440569|448341262|FG000|Main Study|Protocol Violation|1|||
124651314|NCT01440569|448341263|FG001|Main Study|Protocol Violation|0|||
124651315|NCT01440569|448341262|FG000|Open-Label Rollover Phase|Adverse Event|3|||
124651316|NCT01440569|448341263|FG001|Open-Label Rollover Phase|Adverse Event|0|||
124651317|NCT01440569|448341262|FG000|Open-Label Rollover Phase|Pregnancy|1|||
124651318|NCT01440569|448341263|FG001|Open-Label Rollover Phase|Pregnancy|0|||
124651319|NCT01440569|448341262|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
124651320|NCT01440569|448341263|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
124651321|NCT01440569|448341262|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
124651322|NCT01440569|448341263|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
124651323|NCT01440569|448341262|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
124651324|NCT01440569|448341263|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
124651325|NCT01440569|448341262|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
124651326|NCT01440569|448341263|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
124651327|NCT01440569|448341262|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
124651328|NCT01440569|448341263|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
124651329|NCT03589326|448341268|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
124651330|NCT03589326|448341269|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
124651331|NCT03589326|448341268|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
124651332|NCT03589326|448341269|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
124651333|NCT03589326|448341268|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
124651334|NCT03589326|448341269|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
124651335|NCT03589326|448341268|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
124651336|NCT03589326|448341269|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
124651337|NCT03589326|448341268|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
124651338|NCT03589326|448341269|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
124651339|NCT05087966|448341270|FG000|Overall Study|Lost to Follow-up|1|||
124651340|NCT05087966|448341270|FG000|Overall Study|Withdrawal by Subject|5|||
124651341|NCT00501059|448341271|FG000|Overall Study|Protocol Violation|80|||
124651342|NCT00501059|448341272|FG001|Overall Study|Protocol Violation|69|||
124651343|NCT00501059|448341271|FG000|Overall Study|Death|140|||
124651344|NCT00501059|448341272|FG001|Overall Study|Death|137|||
124651345|NCT00501059|448341271|FG000|Overall Study|Other|236|||
124651346|NCT00501059|448341272|FG001|Overall Study|Other|239|||
124651347|NCT00501059|448341271|FG000|Overall Study|Missing end-of-study page|91|||
124651348|NCT00501059|448341272|FG001|Overall Study|Missing end-of-study page|92|||
124651349|NCT00501059|448341271|FG000|Overall Study|Clinical endpoint reached|110|||
124651350|NCT00501059|448341272|FG001|Overall Study|Clinical endpoint reached|123|||
124651351|NCT00501059|448341271|FG000|Overall Study|Insufficient therapeutic effect|4|||
124651352|NCT00501059|448341272|FG001|Overall Study|Insufficient therapeutic effect|5|||
124651353|NCT00501059|448341271|FG000|Overall Study|Consent withdrawn by subject|817|||
124651354|NCT00501059|448341272|FG001|Overall Study|Consent withdrawn by subject|873|||
124651355|NCT00501059|448341271|FG000|Overall Study|Non-compliant with study treatment|23|||
124651356|NCT00501059|448341272|FG001|Overall Study|Non-compliant with study treatment|16|||
124651357|NCT00501059|448341271|FG000|Overall Study|Reason not given|3|||
124651358|NCT00501059|448341272|FG001|Overall Study|Reason not given|1|||
124651359|NCT00501059|448341271|FG000|Overall Study|Adverse Event|129|||
124651360|NCT00501059|448341272|FG001|Overall Study|Adverse Event|122|||
124651361|NCT00501059|448341271|FG000|Overall Study|Lost to Follow-up|210|||
124651362|NCT00501059|448341272|FG001|Overall Study|Lost to Follow-up|198|||
124651363|NCT00501059|448341271|FG000|Overall Study|Not treated|25|||
124651364|NCT00501059|448341272|FG001|Overall Study|Not treated|17|||
124651365|NCT00430352|448341276|FG000|Overall Study|Disease progression|58|||
124651366|NCT00430352|448341276|FG000|Overall Study|Withdrawal by Subject|11|||
124651367|NCT00430352|448341276|FG000|Overall Study|Adverse Event|16|||
124651368|NCT00430352|448341276|FG000|Overall Study|Death|5|||
124651369|NCT00430352|448341276|FG000|Overall Study|Other|48|||
124651370|NCT04326439|448341277|FG000|Overall Study|Withdrawal by Subject|1|||
124651371|NCT04326439|448341278|FG001|Overall Study|Withdrawal by Subject|0|||
124651372|NCT04326439|448341277|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
124651373|NCT04326439|448341278|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
124651374|NCT04326439|448341277|FG000|Overall Study|Relapse after Induction 2|0|||
124651375|NCT04326439|448341278|FG001|Overall Study|Relapse after Induction 2|1|||
124651376|NCT04326439|448341277|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
124651377|NCT04326439|448341278|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
124651378|NCT01785849|448341285|FG000|Overall Study|Death|7|||
124651379|NCT01785849|448341286|FG001|Overall Study|Death|9|||
124651380|NCT01785849|448341285|FG000|Overall Study|Protocol Specified Criteria|29|||
124651381|NCT01785849|448341286|FG001|Overall Study|Protocol Specified Criteria|1|||
124651382|NCT01785849|448341285|FG000|Overall Study|Withdrawal by Subject|15|||
124651383|NCT01785849|448341286|FG001|Overall Study|Withdrawal by Subject|12|||
124651384|NCT01785849|448341285|FG000|Overall Study|Sponsor Decision|0|||
124651385|NCT01785849|448341286|FG001|Overall Study|Sponsor Decision|1|||
124651386|NCT01785849|448341285|FG000|Overall Study|Lost to Follow-up|10|||
124651387|NCT01785849|448341286|FG001|Overall Study|Lost to Follow-up|11|||
124651388|NCT00204477|448341287|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
124651389|NCT00204477|448341288|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
124651390|NCT00204477|448341287|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
124651391|NCT00204477|448341288|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
124651392|NCT04272606|448341291|FG000|Overall Study|Protocol Violation|1|||
124651393|NCT04272606|448341292|FG001|Overall Study|Protocol Violation|1|||
124651394|NCT04272606|448341291|FG000|Overall Study|Physician Decision|0|||
124651395|NCT04272606|448341292|FG001|Overall Study|Physician Decision|1|||
124651396|NCT01037127|448341293|FG000|Overall Study|Lost to Follow-up|2|||
124651397|NCT01037127|448341294|FG001|Overall Study|Lost to Follow-up|4|||
124651398|NCT01037127|448341293|FG000|Overall Study|Physician Decision|1|||
124651399|NCT01037127|448341294|FG001|Overall Study|Physician Decision|0|||
124651400|NCT01037127|448341293|FG000|Overall Study|Study Closed Terminated|2|||
124651401|NCT01037127|448341294|FG001|Overall Study|Study Closed Terminated|17|||
124651402|NCT02637713|448341298|FG000|Overall Study|Screen Failure|2|||
124651403|NCT02847182|448341299|FG000|Overall Study|Withdrawal by Subject|0|||
124651404|NCT02847182|448341300|FG001|Overall Study|Withdrawal by Subject|1|||
124651405|NCT02345889|448341301|FG000|Overall Study|Inadequate Bowel Prep|17|||
124651406|NCT02345889|448341302|FG001|Overall Study|Inadequate Bowel Prep|16|||
124651407|NCT02345889|448341303|FG002|Overall Study|Inadequate Bowel Prep|18|||
124651408|NCT02345889|448341304|FG003|Overall Study|Inadequate Bowel Prep|14|||
124651409|NCT02345889|448341301|FG000|Overall Study|Polyposis identified during procedure|1|||
124651410|NCT02345889|448341302|FG001|Overall Study|Polyposis identified during procedure|1|||
124651411|NCT02345889|448341303|FG002|Overall Study|Polyposis identified during procedure|0|||
124651412|NCT02345889|448341304|FG003|Overall Study|Polyposis identified during procedure|1|||
124651413|NCT02345889|448341301|FG000|Overall Study|Recognized ineligible post-randomization|1|||
124651414|NCT02345889|448341302|FG001|Overall Study|Recognized ineligible post-randomization|0|||
124651415|NCT02345889|448341303|FG002|Overall Study|Recognized ineligible post-randomization|2|||
124651416|NCT02345889|448341304|FG003|Overall Study|Recognized ineligible post-randomization|1|||
124651417|NCT02345889|448341301|FG000|Overall Study|Ulcerative Colitis identified|1|||
124651418|NCT02345889|448341302|FG001|Overall Study|Ulcerative Colitis identified|0|||
124872605|NCT01662063|449155673|FG000|Overall Study|Other|0|||
124651419|NCT02345889|448341303|FG002|Overall Study|Ulcerative Colitis identified|0|||
124651420|NCT02345889|448341304|FG003|Overall Study|Ulcerative Colitis identified|0|||
124651421|NCT02345889|448341301|FG000|Overall Study|Cecum not intubated|1|||
124651422|NCT02345889|448341302|FG001|Overall Study|Cecum not intubated|0|||
124651423|NCT02345889|448341303|FG002|Overall Study|Cecum not intubated|0|||
124651424|NCT02345889|448341304|FG003|Overall Study|Cecum not intubated|0|||
124651425|NCT02059434|448343512|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
124651426|NCT02059434|448343513|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
124651427|NCT02059434|448343514|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
124651428|NCT02059434|448343515|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
124651429|NCT02059434|448343516|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
124651430|NCT02059434|448343517|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
124651431|NCT02059434|448343518|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
124651432|NCT02059434|448343519|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
124651433|NCT02059434|448343520|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
124651434|NCT02059434|448343512|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
124651435|NCT02059434|448343513|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
124651436|NCT02059434|448343514|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
124651437|NCT02059434|448343515|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
124651438|NCT02059434|448343516|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
124651439|NCT02059434|448343517|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
124651440|NCT02059434|448343518|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
124651441|NCT02059434|448343519|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
124651442|NCT02059434|448343520|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
124651443|NCT02059434|448343512|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
124651444|NCT02059434|448343513|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
124651445|NCT02059434|448343514|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
124651446|NCT02059434|448343515|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
124651447|NCT02059434|448343516|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
124651448|NCT02059434|448343517|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
124651449|NCT02059434|448343518|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
124651450|NCT02059434|448343519|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
124651451|NCT02059434|448343520|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
124651452|NCT02059434|448343512|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
124651453|NCT02059434|448343513|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
124651454|NCT02059434|448343514|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
124651455|NCT02059434|448343515|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
124651456|NCT02059434|448343516|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
124651457|NCT02059434|448343517|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
124651458|NCT02059434|448343518|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
124651459|NCT02059434|448343519|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
124651460|NCT02059434|448343520|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
124651461|NCT02059434|448343512|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
124651462|NCT02059434|448343513|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
124651463|NCT02059434|448343514|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
124651464|NCT02059434|448343515|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
124651465|NCT02059434|448343516|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
124651466|NCT02059434|448343517|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
124651467|NCT02059434|448343518|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
124651468|NCT02059434|448343519|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
124651469|NCT02059434|448343520|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
124651470|NCT01004406|448343525|FG000|Overall Study|Withdrawal by Subject|2|||
124651471|NCT01004406|448343526|FG001|Overall Study|Withdrawal by Subject|0|||
124651472|NCT01004406|448343525|FG000|Overall Study|Lost to Follow-up|1|||
124651473|NCT01004406|448343526|FG001|Overall Study|Lost to Follow-up|0|||
124651474|NCT02928770|448343527|FG000|Overall Study|Withdrawal by Subject|2|||
124651475|NCT03201874|448343530|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
124651476|NCT03201874|448343531|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
124651477|NCT03201874|448343530|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
124651478|NCT03201874|448343531|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
124651479|NCT02907593|448343532|FG000|Overall Study|Withdrawal by Subject|0|||
124651480|NCT02907593|448343533|FG001|Overall Study|Withdrawal by Subject|0|||
124651481|NCT02907593|448343534|FG002|Overall Study|Withdrawal by Subject|1|||
124651482|NCT02907593|448343535|FG003|Overall Study|Withdrawal by Subject|0|||
124651483|NCT04618471|448343536|FG000|Overall Study|Screen Failure|62|||
124651484|NCT04618471|448343536|FG000|Overall Study|Withdrawal by Subject|6|||
124651485|NCT04618471|448343536|FG000|Overall Study|Physician Decision|2|||
124651486|NCT04618471|448343536|FG000|Overall Study|Lost to Follow-up|1|||
124651487|NCT04618471|448343536|FG000|Overall Study|Various other reasons|2|||
124651488|NCT04618471|448343536|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
124651489|NCT01752634|448343537|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
124651490|NCT01752634|448343538|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
124651491|NCT01752634|448343539|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
124651492|NCT01752634|448343540|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
124651493|NCT01752634|448343541|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
124651494|NCT01752634|448343542|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
124651495|NCT01752634|448343537|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
124651496|NCT01752634|448343538|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
124651497|NCT01752634|448343539|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
124651498|NCT01752634|448343540|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
124651499|NCT01752634|448343541|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
124651500|NCT01752634|448343542|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
124651501|NCT01752634|448343537|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
124651502|NCT01752634|448343538|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
124651503|NCT01752634|448343539|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
124651504|NCT01752634|448343540|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
124651505|NCT01752634|448343541|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
124651506|NCT01752634|448343542|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
124651507|NCT01752634|448343537|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
124651508|NCT01752634|448343538|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
124651509|NCT01752634|448343539|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
124651510|NCT01752634|448343540|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
124651511|NCT01752634|448343541|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
124651512|NCT01752634|448343542|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
124651513|NCT01752634|448343537|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
124651514|NCT01752634|448343538|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
124651515|NCT01752634|448343539|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
124651516|NCT01752634|448343540|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
124651517|NCT01752634|448343541|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
124651518|NCT01752634|448343542|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
124651519|NCT01752634|448343537|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
124651520|NCT01752634|448343538|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
124651521|NCT01752634|448343539|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
124651522|NCT01752634|448343540|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
124651523|NCT01752634|448343541|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
124651524|NCT01752634|448343542|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
124651525|NCT01752634|448343537|FG000|Week 24 to Week 260|Physician Decision|1|||
124651526|NCT01752634|448343538|FG001|Week 24 to Week 260|Physician Decision|2|||
124651527|NCT01752634|448343539|FG002|Week 24 to Week 260|Physician Decision|4|||
124651528|NCT01752634|448343540|FG003|Week 24 to Week 260|Physician Decision|2|||
124651529|NCT01752634|448343541|FG004|Week 24 to Week 260|Physician Decision|1|||
124651530|NCT01752634|448343542|FG005|Week 24 to Week 260|Physician Decision|0|||
124651531|NCT01752634|448343537|FG000|Week 24 to Week 260|Death|0|||
124651532|NCT01752634|448343538|FG001|Week 24 to Week 260|Death|1|||
124651533|NCT01752634|448343539|FG002|Week 24 to Week 260|Death|0|||
124651534|NCT01752634|448343540|FG003|Week 24 to Week 260|Death|0|||
124651535|NCT01752634|448343541|FG004|Week 24 to Week 260|Death|0|||
124651536|NCT01752634|448343542|FG005|Week 24 to Week 260|Death|0|||
124651537|NCT01752634|448343537|FG000|Week 24 to Week 260|Pregnancy|0|||
124651538|NCT01752634|448343538|FG001|Week 24 to Week 260|Pregnancy|0|||
124651539|NCT01752634|448343539|FG002|Week 24 to Week 260|Pregnancy|1|||
124651540|NCT01752634|448343540|FG003|Week 24 to Week 260|Pregnancy|0|||
124651541|NCT01752634|448343541|FG004|Week 24 to Week 260|Pregnancy|0|||
124651542|NCT01752634|448343542|FG005|Week 24 to Week 260|Pregnancy|0|||
124651543|NCT01752634|448343537|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
124651544|NCT01752634|448343538|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
124651545|NCT01752634|448343539|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
124651546|NCT01752634|448343540|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
124651547|NCT01752634|448343541|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
124651548|NCT01752634|448343542|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
124651549|NCT01752634|448343537|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
124651550|NCT01752634|448343538|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
124651551|NCT01752634|448343539|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
124651552|NCT01752634|448343540|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
124651553|NCT01752634|448343541|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
124651554|NCT01752634|448343542|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
124651555|NCT01752634|448343537|FG000|Week 24 to Week 260|Adverse Event|4|||
124651556|NCT01752634|448343538|FG001|Week 24 to Week 260|Adverse Event|8|||
124651557|NCT01752634|448343539|FG002|Week 24 to Week 260|Adverse Event|8|||
124651558|NCT01752634|448343540|FG003|Week 24 to Week 260|Adverse Event|4|||
124651559|NCT01752634|448343541|FG004|Week 24 to Week 260|Adverse Event|2|||
124651560|NCT01752634|448343542|FG005|Week 24 to Week 260|Adverse Event|0|||
124651561|NCT01250171|448343543|FG000|Overall Study|Administrative reasons|1|||
124651562|NCT01250171|448343544|FG001|Overall Study|Administrative reasons|0|||
124651563|NCT01250171|448343545|FG002|Overall Study|Administrative reasons|0|||
124651564|NCT04557124|448343553|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
124651565|NCT04557124|448343554|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
124651566|NCT04557124|448343553|FG000|Mid-point (1 Month)|Missed testing|5|||
124651567|NCT04557124|448343554|FG001|Mid-point (1 Month)|Missed testing|4|||
124651568|NCT04557124|448343553|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
124651569|NCT04557124|448343554|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
124651570|NCT04557124|448343553|FG000|Post-testing (2 Months)|Missed testing|1|||
124651571|NCT04557124|448343554|FG001|Post-testing (2 Months)|Missed testing|5|||
124651572|NCT04557124|448343553|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
124651573|NCT04557124|448343554|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
124651574|NCT04557124|448343553|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
124651575|NCT04557124|448343554|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
124651576|NCT03226678|448343561|FG000|Part A (Core Study Phase)|Adverse Event|0|||
124651577|NCT03226678|448343562|FG001|Part A (Core Study Phase)|Adverse Event|1|||
124651578|NCT03226678|448343563|FG002|Part A (Core Study Phase)|Adverse Event|0|||
124651579|NCT03226678|448343564|FG003|Part A (Core Study Phase)|Adverse Event|0|||
124651580|NCT03226678|448343565|FG004|Part A (Core Study Phase)|Adverse Event|0|||
124651581|NCT03226678|448343566|FG005|Part A (Core Study Phase)|Adverse Event|0|||
124651582|NCT03226678|448343561|FG000|Part A (Core Study Phase)|Death|0|||
124651583|NCT03226678|448343562|FG001|Part A (Core Study Phase)|Death|0|||
124651584|NCT03226678|448343563|FG002|Part A (Core Study Phase)|Death|1|||
124651585|NCT03226678|448343564|FG003|Part A (Core Study Phase)|Death|0|||
124651586|NCT03226678|448343565|FG004|Part A (Core Study Phase)|Death|0|||
124651587|NCT03226678|448343566|FG005|Part A (Core Study Phase)|Death|0|||
124651588|NCT03226678|448343561|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
124651589|NCT03226678|448343562|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
124651590|NCT03226678|448343563|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
124651591|NCT03226678|448343564|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
124651592|NCT03226678|448343565|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
124651593|NCT03226678|448343566|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
124651594|NCT03226678|448343561|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
124651595|NCT03226678|448343562|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
124651596|NCT03226678|448343563|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
124651597|NCT03226678|448343564|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
124651598|NCT03226678|448343565|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
124651599|NCT03226678|448343566|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
124651600|NCT03226678|448343561|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
124651601|NCT03226678|448343562|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
124651602|NCT03226678|448343563|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
124651603|NCT03226678|448343564|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
124651604|NCT03226678|448343565|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
124651605|NCT03226678|448343566|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
124651606|NCT03226678|448343561|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
124651607|NCT03226678|448343562|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
124651608|NCT03226678|448343563|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
124651609|NCT03226678|448343564|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
124651610|NCT03226678|448343565|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
124651611|NCT03226678|448343566|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
124651612|NCT03226678|448343561|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
124651613|NCT03226678|448343562|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
124651614|NCT03226678|448343563|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
124651615|NCT03226678|448343564|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
124651616|NCT03226678|448343565|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
124651617|NCT03226678|448343566|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
124651618|NCT03226678|448343561|FG000|Part B (Long-Term Extension Phase)|Death|0|||
124651619|NCT03226678|448343562|FG001|Part B (Long-Term Extension Phase)|Death|0|||
124651620|NCT03226678|448343563|FG002|Part B (Long-Term Extension Phase)|Death|0|||
124651621|NCT03226678|448343564|FG003|Part B (Long-Term Extension Phase)|Death|0|||
124651622|NCT03226678|448343565|FG004|Part B (Long-Term Extension Phase)|Death|0|||
124651623|NCT03226678|448343566|FG005|Part B (Long-Term Extension Phase)|Death|1|||
124651624|NCT03226678|448343561|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
124651625|NCT03226678|448343562|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
124651626|NCT03226678|448343563|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
124651627|NCT03226678|448343564|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
124651628|NCT03226678|448343565|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
124651629|NCT03226678|448343566|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
124651630|NCT03226678|448343561|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
124651631|NCT03226678|448343562|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
124651632|NCT03226678|448343563|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
124651633|NCT03226678|448343564|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
124651634|NCT03226678|448343565|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
124651635|NCT03226678|448343566|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
124651636|NCT03226678|448343561|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
124651637|NCT03226678|448343562|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
124651638|NCT03226678|448343563|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
124651639|NCT03226678|448343564|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
124651640|NCT03226678|448343565|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
124651641|NCT03226678|448343566|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
124651642|NCT01911780|448343569|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
124651643|NCT01911780|448343570|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
124651644|NCT01911780|448343569|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
124651645|NCT01911780|448343570|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
124651646|NCT01911780|448343569|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
124651647|NCT01911780|448343570|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
124651648|NCT01911780|448343569|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
124651649|NCT01911780|448343570|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
124651650|NCT01911780|448343569|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
124651651|NCT01911780|448343570|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
124651652|NCT01911780|448343569|FG000|Extension Period (52 Weeks)|Personal reason|1|||
124651653|NCT01911780|448343570|FG001|Extension Period (52 Weeks)|Personal reason|1|||
124651654|NCT02045732|448343571|FG000|Overall Study|At the discretion of the investigator|1|||
124651655|NCT02045732|448343572|FG001|Overall Study|At the discretion of the investigator|1|||
124651656|NCT05014815|448343573|FG000|Overall Study|Death|63|||
124651657|NCT05014815|448343574|FG001|Overall Study|Death|70|||
124651658|NCT05014815|448343573|FG000|Overall Study|Withdrawal by Subject|10|||
124651659|NCT05014815|448343574|FG001|Overall Study|Withdrawal by Subject|10|||
124651660|NCT05014815|448343573|FG000|Overall Study|Lost to Follow-up|4|||
124651661|NCT05014815|448343574|FG001|Overall Study|Lost to Follow-up|2|||
124651662|NCT05014815|448343573|FG000|Overall Study|Physician Decision|2|||
124651663|NCT05014815|448343574|FG001|Overall Study|Physician Decision|4|||
124651664|NCT04247880|448343575|FG000|Overall Study|Lost to Follow-up|24|||
124651665|NCT04247880|448343576|FG001|Overall Study|Lost to Follow-up|17|||
124651666|NCT04247880|448343575|FG000|Overall Study|Withdrawal by Subject|3|||
124651667|NCT04247880|448343576|FG001|Overall Study|Withdrawal by Subject|0|||
124651668|NCT06303167|448343577|FG000|Overall Study|Ineligible|1|||
124651669|NCT06303167|448343577|FG000|Overall Study|Never start protocol therapy|2|||
124651670|NCT06303167|448343577|FG000|Overall Study|Disease progression|16|||
124651671|NCT02453282|448343578|FG000|Overall Study|Death|275|||
124651672|NCT02453282|448343579|FG001|Overall Study|Death|277|||
124651673|NCT02453282|448343580|FG002|Overall Study|Death|296|||
124651674|NCT02453282|448343578|FG000|Overall Study|Lost to Follow-up|1|||
124651675|NCT02453282|448343579|FG001|Overall Study|Lost to Follow-up|0|||
124651676|NCT02453282|448343580|FG002|Overall Study|Lost to Follow-up|2|||
124651677|NCT02453282|448343578|FG000|Overall Study|Withdrawal by Subject|12|||
124651678|NCT02453282|448343579|FG001|Overall Study|Withdrawal by Subject|10|||
124651679|NCT02453282|448343580|FG002|Overall Study|Withdrawal by Subject|11|||
124651680|NCT02453282|448343578|FG000|Overall Study|Participants ongoing at data cut-off|85|||
124651681|NCT02453282|448343579|FG001|Overall Study|Participants ongoing at data cut-off|84|||
124651682|NCT02453282|448343580|FG002|Overall Study|Participants ongoing at data cut-off|62|||
124651683|NCT02453282|448343578|FG000|Overall Study|Other|1|||
124651684|NCT02453282|448343579|FG001|Overall Study|Other|1|||
124651685|NCT02453282|448343580|FG002|Overall Study|Other|1|||
124651686|NCT03385304|448343582|FG000|Overall Study|Death|19|||
124651687|NCT03385304|448343583|FG001|Overall Study|Death|7|||
124651688|NCT03385304|448343582|FG000|Overall Study|Lost to Follow-up|17|||
124651689|NCT03385304|448343583|FG001|Overall Study|Lost to Follow-up|14|||
124651690|NCT03385304|448343582|FG000|Overall Study|Withdrawal by Subject|3|||
124651691|NCT03385304|448343583|FG001|Overall Study|Withdrawal by Subject|2|||
124651692|NCT03385304|448343582|FG000|Overall Study|Incarceration|2|||
124651693|NCT03385304|448343583|FG001|Overall Study|Incarceration|3|||
124651694|NCT01120249|448343584|FG000|Overall Study|No protocol treatment received|21|||
124651695|NCT01120249|448343585|FG001|Overall Study|No protocol treatment received|15|||
124651696|NCT01120249|448343584|FG000|Overall Study|Disease recurrence|107|||
124651697|NCT01120249|448343585|FG001|Overall Study|Disease recurrence|57|||
124651698|NCT01120249|448343584|FG000|Overall Study|Death|1|||
124651699|NCT01120249|448343585|FG001|Overall Study|Death|0|||
124651700|NCT01120249|448343584|FG000|Overall Study|Adverse Event|40|||
124651701|NCT01120249|448343585|FG001|Overall Study|Adverse Event|276|||
124651702|NCT01120249|448343584|FG000|Overall Study|Participant refusal|34|||
124651703|NCT01120249|448343585|FG001|Overall Study|Participant refusal|42|||
124651704|NCT01120249|448343584|FG000|Overall Study|Other reasons, not protocol specified|29|||
124651705|NCT01120249|448343585|FG001|Overall Study|Other reasons, not protocol specified|22|||
124651706|NCT01629823|448343591|FG000|Trial Period|Missed visit|11|||
124651707|NCT01629823|448343592|FG001|Trial Period|Missed visit|9|||
124651708|NCT01629823|448343593|FG002|Trial Period|Missed visit|8|||
124651709|NCT01629823|448343591|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
124651710|NCT01629823|448343592|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
124651711|NCT01629823|448343593|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
124651712|NCT01629823|448343591|FG000|Trial Period|Pregnancy|1|||
124651713|NCT01629823|448343592|FG001|Trial Period|Pregnancy|0|||
124651714|NCT01629823|448343593|FG002|Trial Period|Pregnancy|0|||
124651715|NCT01629823|448343591|FG000|Trial Period|Adverse Event|0|||
124651716|NCT01629823|448343592|FG001|Trial Period|Adverse Event|1|||
124651717|NCT01629823|448343593|FG002|Trial Period|Adverse Event|0|||
124651718|NCT01629823|448343591|FG000|Trial Period|Out-of-window visit|0|||
124651719|NCT01629823|448343592|FG001|Trial Period|Out-of-window visit|2|||
124651720|NCT01629823|448343593|FG002|Trial Period|Out-of-window visit|0|||
124651721|NCT01629823|448343591|FG000|Trial Period|Failed to hold medication|0|||
124651722|NCT01629823|448343592|FG001|Trial Period|Failed to hold medication|0|||
124651723|NCT01629823|448343593|FG002|Trial Period|Failed to hold medication|1|||
124651724|NCT01629823|448343591|FG000|Washout Period|Safety|2|||
124651725|NCT01629823|448343592|FG001|Washout Period|Safety|5|||
124651726|NCT01629823|448343593|FG002|Washout Period|Safety|0|||
124651727|NCT01629823|448343591|FG000|Washout Period|Pregnancy|1|||
124651728|NCT01629823|448343592|FG001|Washout Period|Pregnancy|0|||
124651729|NCT01629823|448343593|FG002|Washout Period|Pregnancy|0|||
124651730|NCT01629823|448343591|FG000|Washout Period|Protocol Violation|0|||
124651731|NCT01629823|448343592|FG001|Washout Period|Protocol Violation|1|||
124651732|NCT01629823|448343593|FG002|Washout Period|Protocol Violation|0|||
124651733|NCT00480493|448343594|FG000|Overall Study|moved|2|||
124651734|NCT00480493|448343595|FG001|Overall Study|moved|7|||
124651735|NCT01032070|448343596|FG000|Overall Study|Disease progression|13|||
124651736|NCT01032070|448343597|FG001|Overall Study|Disease progression|8|||
124651737|NCT01032070|448343596|FG000|Overall Study|Medical or ethical reasons|0|||
124651738|NCT01032070|448343597|FG001|Overall Study|Medical or ethical reasons|2|||
124651739|NCT01032070|448343596|FG000|Overall Study|Withdrawal by Subject|0|||
124651740|NCT01032070|448343597|FG001|Overall Study|Withdrawal by Subject|2|||
124651741|NCT00894790|448343598|FG000|Overall Study|Protocol Violation|0|||
124651742|NCT00894790|448343599|FG001|Overall Study|Protocol Violation|1|||
124651743|NCT00894790|448343598|FG000|Overall Study|Lost to Follow-up|0|||
124651744|NCT00894790|448343599|FG001|Overall Study|Lost to Follow-up|1|||
124651745|NCT00894790|448343598|FG000|Overall Study|Did not meet entrance criteria|1|||
124651746|NCT00894790|448343599|FG001|Overall Study|Did not meet entrance criteria|0|||
124651747|NCT04093492|448343600|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
124872606|NCT01662063|449155674|FG001|Overall Study|Other|1|||
124651748|NCT04093492|448343601|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
124651749|NCT04093492|448343602|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
124651750|NCT04093492|448343603|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
124651751|NCT04093492|448343600|FG000|25 Weeks Gestational Age (GA)|No response|5|||
124651752|NCT04093492|448343601|FG001|25 Weeks Gestational Age (GA)|No response|5|||
124651753|NCT04093492|448343602|FG002|25 Weeks Gestational Age (GA)|No response|5|||
124651754|NCT04093492|448343603|FG003|25 Weeks Gestational Age (GA)|No response|2|||
124651755|NCT04093492|448343600|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
124651756|NCT04093492|448343601|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
124651757|NCT04093492|448343602|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
124651758|NCT04093492|448343603|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
124651759|NCT04093492|448343600|FG000|30 Weeks GA|Delivered before assessment|1|||
124651760|NCT04093492|448343601|FG001|30 Weeks GA|Delivered before assessment|2|||
124651761|NCT04093492|448343602|FG002|30 Weeks GA|Delivered before assessment|0|||
124651762|NCT04093492|448343603|FG003|30 Weeks GA|Delivered before assessment|0|||
124651763|NCT04093492|448343600|FG000|30 Weeks GA|No response|7|||
124651764|NCT04093492|448343601|FG001|30 Weeks GA|No response|5|||
124651765|NCT04093492|448343602|FG002|30 Weeks GA|No response|5|||
124651766|NCT04093492|448343603|FG003|30 Weeks GA|No response|2|||
124651767|NCT04093492|448343600|FG000|30 Weeks GA|Lost to Follow-up|0|||
124651768|NCT04093492|448343601|FG001|30 Weeks GA|Lost to Follow-up|1|||
124651769|NCT04093492|448343602|FG002|30 Weeks GA|Lost to Follow-up|0|||
124651770|NCT04093492|448343603|FG003|30 Weeks GA|Lost to Follow-up|0|||
124651771|NCT04093492|448343600|FG000|34 Weeks GA|Delivered before assessment|6|||
124651772|NCT04093492|448343601|FG001|34 Weeks GA|Delivered before assessment|3|||
124651773|NCT04093492|448343602|FG002|34 Weeks GA|Delivered before assessment|0|||
124651774|NCT04093492|448343603|FG003|34 Weeks GA|Delivered before assessment|0|||
124651775|NCT04093492|448343600|FG000|34 Weeks GA|No response|0|||
124651776|NCT04093492|448343601|FG001|34 Weeks GA|No response|7|||
124651777|NCT04093492|448343602|FG002|34 Weeks GA|No response|5|||
124651778|NCT04093492|448343603|FG003|34 Weeks GA|No response|3|||
124651779|NCT04093492|448343600|FG000|34 Weeks GA|Lost to Follow-up|0|||
124651780|NCT04093492|448343601|FG001|34 Weeks GA|Lost to Follow-up|1|||
124651781|NCT04093492|448343602|FG002|34 Weeks GA|Lost to Follow-up|0|||
124651782|NCT04093492|448343603|FG003|34 Weeks GA|Lost to Follow-up|0|||
124651783|NCT00551161|448343604|FG000|Overall Study|Withdrawal by Subject|1|||
124651784|NCT00096993|448343605|FG000|Overall Study|Death|1|||
124651785|NCT00096993|448343606|FG001|Overall Study|Death|0|||
124651786|NCT00096993|448343605|FG000|Overall Study|Disease progression|56|||
124651787|NCT00096993|448343606|FG001|Overall Study|Disease progression|53|||
124651788|NCT00096993|448343605|FG000|Overall Study|Adverse Event|2|||
124651789|NCT00096993|448343606|FG001|Overall Study|Adverse Event|8|||
124651790|NCT00096993|448343605|FG000|Overall Study|Subject's decision|3|||
124651791|NCT00096993|448343606|FG001|Overall Study|Subject's decision|1|||
124651792|NCT00096993|448343605|FG000|Overall Study|Physician Decision|2|||
124651793|NCT00096993|448343606|FG001|Overall Study|Physician Decision|1|||
124651794|NCT00096993|448343605|FG000|Overall Study|Non-compliance|0|||
124651795|NCT00096993|448343606|FG001|Overall Study|Non-compliance|1|||
124651796|NCT00096993|448343605|FG000|Overall Study|Other unspecified|1|||
124651797|NCT00096993|448343606|FG001|Overall Study|Other unspecified|1|||
124651798|NCT00772005|448343608|FG000|Overall Study|Adverse Event|9|||
124651799|NCT00772005|448343609|FG001|Overall Study|Adverse Event|14|||
124651800|NCT00772005|448343610|FG002|Overall Study|Adverse Event|10|||
124651801|NCT00772005|448343611|FG003|Overall Study|Adverse Event|13|||
124651802|NCT00772005|448343608|FG000|Overall Study|Lack of Efficacy|0|||
124651803|NCT00772005|448343609|FG001|Overall Study|Lack of Efficacy|1|||
124651804|NCT00772005|448343610|FG002|Overall Study|Lack of Efficacy|0|||
124651805|NCT00772005|448343611|FG003|Overall Study|Lack of Efficacy|0|||
124651806|NCT00772005|448343608|FG000|Overall Study|Withdrawal by Subject|3|||
124651807|NCT00772005|448343609|FG001|Overall Study|Withdrawal by Subject|7|||
124651808|NCT00772005|448343610|FG002|Overall Study|Withdrawal by Subject|10|||
124651809|NCT00772005|448343611|FG003|Overall Study|Withdrawal by Subject|2|||
124651810|NCT00772005|448343608|FG000|Overall Study|Protocol Violation|2|||
124651811|NCT00772005|448343609|FG001|Overall Study|Protocol Violation|4|||
124651812|NCT00772005|448343610|FG002|Overall Study|Protocol Violation|1|||
124651813|NCT00772005|448343611|FG003|Overall Study|Protocol Violation|6|||
124651814|NCT00772005|448343608|FG000|Overall Study|Lost to Follow-up|7|||
124651815|NCT00772005|448343609|FG001|Overall Study|Lost to Follow-up|3|||
124651816|NCT00772005|448343610|FG002|Overall Study|Lost to Follow-up|6|||
124651817|NCT00772005|448343611|FG003|Overall Study|Lost to Follow-up|3|||
124651818|NCT00772005|448343608|FG000|Overall Study|Non-compliance with study procedures|1|||
124872607|NCT01662063|449155675|FG002|Overall Study|Other|0|||
124872608|NCT02313909|449155677|FG000|Overall Study|Consent withdrawn by participant|33|||
124872609|NCT02313909|449155678|FG001|Overall Study|Consent withdrawn by participant|33|||
124872610|NCT02313909|449155677|FG000|Overall Study|Lost to Follow-up|24|||
124872611|NCT02313909|449155678|FG001|Overall Study|Lost to Follow-up|17|||
124872612|NCT00293267|449155684|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
124872613|NCT00293267|449155685|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
124872614|NCT00293267|449155684|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
124872615|NCT00293267|449155685|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
124872616|NCT00293267|449155684|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
124872617|NCT00293267|449155685|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
124872618|NCT00293267|449155684|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
124872619|NCT00293267|449155685|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
124872620|NCT00293267|449155684|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
124872621|NCT00293267|449155685|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
124872622|NCT00293267|449155684|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
124872623|NCT00293267|449155685|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
124872624|NCT00293267|449155684|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
124872625|NCT00293267|449155685|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
124872626|NCT00293267|449155684|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
124872627|NCT00293267|449155685|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
124872628|NCT00293267|449155684|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
124872629|NCT00293267|449155685|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
124872630|NCT00293267|449155684|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
124872631|NCT00293267|449155685|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
124872632|NCT00293267|449155684|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
124872633|NCT00293267|449155685|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
124872634|NCT00293267|449155684|FG000|Extension - Double-Blind Week 49-156|Death|3|||
124872635|NCT00293267|449155685|FG001|Extension - Double-Blind Week 49-156|Death|0|||
124872636|NCT00293267|449155684|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
124872637|NCT00293267|449155685|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
124872638|NCT00293267|449155684|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
124872639|NCT00293267|449155685|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
124872640|NCT00293267|449155684|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
124872641|NCT00293267|449155685|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
124872642|NCT00293267|449155684|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
124872643|NCT00293267|449155685|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
124872644|NCT00293267|449155684|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
124872645|NCT00293267|449155685|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
124872646|NCT00293267|449155684|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
124872647|NCT00293267|449155685|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
124872648|NCT00293267|449155684|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
124872649|NCT00293267|449155685|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
124872650|NCT00293267|449155684|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
124872651|NCT00293267|449155685|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
124872652|NCT00293267|449155684|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
124872653|NCT00293267|449155685|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
124872654|NCT00293267|449155684|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
124872655|NCT00293267|449155685|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
124872656|NCT00293267|449155684|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
124872657|NCT00293267|449155685|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
124872658|NCT00293267|449155684|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
124872659|NCT00293267|449155685|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
124872660|NCT00293267|449155684|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
124872661|NCT00293267|449155685|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
124872662|NCT00293267|449155684|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
124872663|NCT00293267|449155685|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
124872664|NCT00293267|449155684|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
124872665|NCT00293267|449155685|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
124872666|NCT00293267|449155684|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
124872667|NCT00293267|449155685|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
124872668|NCT03086330|449155686|FG000|Overall Study|Withdrawal by Subject|3|||
124872669|NCT03086330|449155687|FG001|Overall Study|Withdrawal by Subject|2|||
124872670|NCT03086330|449155686|FG000|Overall Study|Lost to Follow-up|1|||
124872671|NCT03086330|449155687|FG001|Overall Study|Lost to Follow-up|2|||
124872672|NCT04899245|449155707|FG000|Overall Study|Withdrawal by Subject|3|||
124872673|NCT04899245|449155708|FG001|Overall Study|Withdrawal by Subject|5|||
124872674|NCT04899245|449155709|FG002|Overall Study|Withdrawal by Subject|2|||
124872675|NCT04899245|449155707|FG000|Overall Study|No longer eligible - Left staff position|0|||
124872676|NCT04899245|449155708|FG001|Overall Study|No longer eligible - Left staff position|0|||
124872677|NCT04899245|449155709|FG002|Overall Study|No longer eligible - Left staff position|1|||
124872678|NCT04899245|449155707|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
124872679|NCT04899245|449155708|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
124872680|NCT04899245|449155709|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
124872681|NCT04899245|449155707|FG000|Overall Study|No longer eligible - Moved away from area|2|||
124872682|NCT04899245|449155708|FG001|Overall Study|No longer eligible - Moved away from area|2|||
124872683|NCT04899245|449155709|FG002|Overall Study|No longer eligible - Moved away from area|0|||
124872684|NCT03371940|449155721|FG000|Overall Study|Withdrawal by Subject|8|||
124872685|NCT03371940|449155722|FG001|Overall Study|Withdrawal by Subject|1|||
124872686|NCT03371940|449155723|FG002|Overall Study|Withdrawal by Subject|3|||
124872687|NCT03371940|449155724|FG003|Overall Study|Withdrawal by Subject|4|||
124872688|NCT05099926|449155730|FG000|Overall Study|Lost to Follow-up|1|||
124872689|NCT00724152|449155733|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
124872690|NCT00724152|449155734|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
124872691|NCT00724152|449155735|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
124872692|NCT00724152|449155733|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
124872693|NCT00724152|449155734|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
124872694|NCT00724152|449155735|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
124872695|NCT00031486|449155741|FG000|Overall Study|Adverse Event|1|||
124872696|NCT00031486|449155742|FG001|Overall Study|Adverse Event|0|||
124872697|NCT00031486|449155741|FG000|Overall Study|Lost to Follow-up|0|||
124872698|NCT00031486|449155742|FG001|Overall Study|Lost to Follow-up|1|||
124872699|NCT00031486|449155741|FG000|Overall Study|Withdrawal by Subject|3|||
124872700|NCT00031486|449155742|FG001|Overall Study|Withdrawal by Subject|2|||
124872701|NCT00031486|449155741|FG000|Overall Study|Death|0|||
124872702|NCT00031486|449155742|FG001|Overall Study|Death|3|||
124872703|NCT00031486|449155741|FG000|Overall Study|Non-compliant|0|||
124872704|NCT00031486|449155742|FG001|Overall Study|Non-compliant|4|||
124872705|NCT00031486|449155741|FG000|Overall Study|Did not meet eligibility requirement|2|||
124872706|NCT00031486|449155742|FG001|Overall Study|Did not meet eligibility requirement|1|||
124872707|NCT00031486|449155741|FG000|Overall Study|Other|1|||
124872708|NCT00031486|449155742|FG001|Overall Study|Other|1|||
124872709|NCT03685591|449155743|FG000|Overall Study|Global Deterioration of Health Status|0|||
124872710|NCT03685591|449155744|FG001|Overall Study|Global Deterioration of Health Status|0|||
124872711|NCT03685591|449155745|FG002|Overall Study|Global Deterioration of Health Status|0|||
124872712|NCT03685591|449155746|FG003|Overall Study|Global Deterioration of Health Status|1|||
124872713|NCT03685591|449155747|FG004|Overall Study|Global Deterioration of Health Status|2|||
124872714|NCT03685591|449155748|FG005|Overall Study|Global Deterioration of Health Status|4|||
124872715|NCT03685591|449155749|FG006|Overall Study|Global Deterioration of Health Status|1|||
124872716|NCT03685591|449155750|FG007|Overall Study|Global Deterioration of Health Status|1|||
124872717|NCT03685591|449155751|FG008|Overall Study|Global Deterioration of Health Status|0|||
124872718|NCT03685591|449155743|FG000|Overall Study|Progressive Disease|1|||
124872719|NCT03685591|449155744|FG001|Overall Study|Progressive Disease|1|||
124872720|NCT03685591|449155745|FG002|Overall Study|Progressive Disease|0|||
124872721|NCT03685591|449155746|FG003|Overall Study|Progressive Disease|3|||
124872722|NCT03685591|449155747|FG004|Overall Study|Progressive Disease|5|||
124872723|NCT03685591|449155748|FG005|Overall Study|Progressive Disease|4|||
124872724|NCT03685591|449155749|FG006|Overall Study|Progressive Disease|3|||
124872725|NCT03685591|449155750|FG007|Overall Study|Progressive Disease|2|||
124872726|NCT03685591|449155751|FG008|Overall Study|Progressive Disease|1|||
124872727|NCT03685591|449155743|FG000|Overall Study|Other|0|||
124872728|NCT03685591|449155744|FG001|Overall Study|Other|0|||
124872729|NCT03685591|449155745|FG002|Overall Study|Other|1|||
124872730|NCT03685591|449155746|FG003|Overall Study|Other|0|||
124872731|NCT03685591|449155747|FG004|Overall Study|Other|2|||
124872732|NCT03685591|449155748|FG005|Overall Study|Other|3|||
124872733|NCT03685591|449155749|FG006|Overall Study|Other|0|||
124872734|NCT03685591|449155750|FG007|Overall Study|Other|0|||
124872735|NCT03685591|449155751|FG008|Overall Study|Other|0|||
124872736|NCT03685591|449155743|FG000|Overall Study|Withdrawal by Subject|0|||
124872737|NCT03685591|449155744|FG001|Overall Study|Withdrawal by Subject|0|||
124872738|NCT03685591|449155745|FG002|Overall Study|Withdrawal by Subject|0|||
124872739|NCT03685591|449155746|FG003|Overall Study|Withdrawal by Subject|0|||
124872740|NCT03685591|449155747|FG004|Overall Study|Withdrawal by Subject|3|||
124872741|NCT03685591|449155748|FG005|Overall Study|Withdrawal by Subject|2|||
124872742|NCT03685591|449155749|FG006|Overall Study|Withdrawal by Subject|0|||
124872743|NCT03685591|449155750|FG007|Overall Study|Withdrawal by Subject|0|||
124872744|NCT03685591|449155751|FG008|Overall Study|Withdrawal by Subject|1|||
124872745|NCT03685591|449155743|FG000|Overall Study|Adverse Event|0|||
124872746|NCT03685591|449155744|FG001|Overall Study|Adverse Event|0|||
124872747|NCT03685591|449155745|FG002|Overall Study|Adverse Event|0|||
124872748|NCT03685591|449155746|FG003|Overall Study|Adverse Event|1|||
124872749|NCT03685591|449155747|FG004|Overall Study|Adverse Event|1|||
124872750|NCT03685591|449155748|FG005|Overall Study|Adverse Event|4|||
124872751|NCT03685591|449155749|FG006|Overall Study|Adverse Event|0|||
124872752|NCT03685591|449155750|FG007|Overall Study|Adverse Event|1|||
124872753|NCT03685591|449155751|FG008|Overall Study|Adverse Event|1|||
124872754|NCT01685138|449155754|FG000|Overall Study|Lost to Follow-up|1|||
124872755|NCT01685138|449155754|FG000|Overall Study|Protocol Violation|1|||
124872756|NCT01685138|449155754|FG000|Overall Study|No longer requires treatment|1|||
124872757|NCT01685138|449155754|FG000|Overall Study|Subject/guardian decision|2|||
124872758|NCT01685138|449155754|FG000|Overall Study|Physician Decision|6|||
124872759|NCT01685138|449155754|FG000|Overall Study|Death|10|||
124872760|NCT01685138|449155754|FG000|Overall Study|Adverse Event|18|||
124872761|NCT01685138|449155754|FG000|Overall Study|Progressive disease|53|||
124872762|NCT02068495|449155757|FG000|Overall Study|Case Report Forms Uncollected|60|||
124872763|NCT02068495|449155757|FG000|Overall Study|Protocol Deviation|49|||
124872764|NCT00689026|449155758|FG000|Overall Study|Withdrawal by Subject|13|||
124872765|NCT00689026|449155759|FG001|Overall Study|Withdrawal by Subject|6|||
124872766|NCT02703922|449155762|FG000|Overall Study|Death|5|||
124872767|NCT02703922|449155763|FG001|Overall Study|Death|8|||
124872768|NCT02703922|449155762|FG000|Overall Study|Lost to Follow-up|10|||
124872769|NCT02703922|449155763|FG001|Overall Study|Lost to Follow-up|10|||
124872770|NCT00394355|449155765|FG000|Overall Study|Adverse Event|10|||
124872771|NCT00394355|449155766|FG001|Overall Study|Adverse Event|6|||
124872772|NCT00394355|449155767|FG002|Overall Study|Adverse Event|7|||
124872773|NCT00394355|449155768|FG003|Overall Study|Adverse Event|8|||
124872774|NCT00394355|449155765|FG000|Overall Study|Did not meet protocol eligibility|1|||
124872775|NCT00394355|449155766|FG001|Overall Study|Did not meet protocol eligibility|5|||
124872776|NCT00394355|449155767|FG002|Overall Study|Did not meet protocol eligibility|4|||
124872777|NCT00394355|449155768|FG003|Overall Study|Did not meet protocol eligibility|2|||
124872778|NCT00394355|449155765|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
124872779|NCT00394355|449155766|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
124872780|NCT00394355|449155767|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
124872781|NCT00394355|449155768|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
124872782|NCT00394355|449155765|FG000|Overall Study|Subject withdrawal - related to drug|1|||
124872783|NCT00394355|449155766|FG001|Overall Study|Subject withdrawal - related to drug|0|||
124872784|NCT00394355|449155767|FG002|Overall Study|Subject withdrawal - related to drug|0|||
124872785|NCT00394355|449155768|FG003|Overall Study|Subject withdrawal - related to drug|0|||
124872786|NCT00394355|449155765|FG000|Overall Study|Lost to Follow-up|7|||
124872787|NCT00394355|449155766|FG001|Overall Study|Lost to Follow-up|5|||
124872788|NCT00394355|449155767|FG002|Overall Study|Lost to Follow-up|4|||
124872789|NCT00394355|449155768|FG003|Overall Study|Lost to Follow-up|3|||
124872790|NCT00394355|449155765|FG000|Overall Study|Noncompliance with protocol|4|||
124872791|NCT00394355|449155766|FG001|Overall Study|Noncompliance with protocol|3|||
124651819|NCT00772005|448343609|FG001|Overall Study|Non-compliance with study procedures|1|||
124651820|NCT00772005|448343610|FG002|Overall Study|Non-compliance with study procedures|0|||
124651821|NCT00772005|448343611|FG003|Overall Study|Non-compliance with study procedures|1|||
124651822|NCT00772005|448343608|FG000|Overall Study|Non-compliance with drug administration|3|||
124651823|NCT00772005|448343609|FG001|Overall Study|Non-compliance with drug administration|0|||
124651824|NCT00772005|448343610|FG002|Overall Study|Non-compliance with drug administration|1|||
124651825|NCT00772005|448343611|FG003|Overall Study|Non-compliance with drug administration|1|||
124651826|NCT01606202|448343615|FG000|Overall Study|Adverse Event|5|||
124651827|NCT01606202|448343616|FG001|Overall Study|Adverse Event|0|||
124651828|NCT01606202|448343615|FG000|Overall Study|Withdrawal by Subject|2|||
124651829|NCT01606202|448343616|FG001|Overall Study|Withdrawal by Subject|1|||
124651830|NCT01606202|448343615|FG000|Overall Study|Personal problems|0|||
124651831|NCT01606202|448343616|FG001|Overall Study|Personal problems|1|||
124651832|NCT01606202|448343615|FG000|Overall Study|Problems with administration|0|||
124651833|NCT01606202|448343616|FG001|Overall Study|Problems with administration|1|||
124651834|NCT05020366|448343617|FG000|Overall Study|Lost to Follow-up|2|||
124651835|NCT05020366|448343618|FG001|Overall Study|Lost to Follow-up|0|||
124651836|NCT05020366|448343617|FG000|Overall Study|Withdrawal by Subject|2|||
124651837|NCT05020366|448343618|FG001|Overall Study|Withdrawal by Subject|0|||
124651838|NCT00435487|448343630|FG000|Overall Study|Death|3|||
124651839|NCT00435487|448343631|FG001|Overall Study|Death|4|||
124651840|NCT00435487|448343630|FG000|Overall Study|Adverse Event|0|||
124651841|NCT00435487|448343631|FG001|Overall Study|Adverse Event|3|||
124651842|NCT00435487|448343630|FG000|Overall Study|Lost to Follow-up|2|||
124651843|NCT00435487|448343631|FG001|Overall Study|Lost to Follow-up|2|||
124651844|NCT00435487|448343630|FG000|Overall Study|Other|5|||
124651845|NCT00435487|448343631|FG001|Overall Study|Other|2|||
124651846|NCT00435487|448343630|FG000|Overall Study|Withdrawal by Subject|2|||
124651847|NCT00435487|448343631|FG001|Overall Study|Withdrawal by Subject|1|||
124651848|NCT00435487|448343630|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
124651849|NCT00435487|448343631|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
124651850|NCT00435487|448343630|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
124651851|NCT00435487|448343631|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
124651852|NCT03301844|448343632|FG000|Overall Study|suspected colon cancer|1|||
124651853|NCT03301844|448343633|FG001|Overall Study|suspected colon cancer|1|||
124651854|NCT01267201|448343634|FG000|First Intervention Period|Withdrawal by Subject|1|||
124651855|NCT01267201|448343635|FG001|First Intervention Period|Withdrawal by Subject|0|||
124651856|NCT01267201|448343636|FG002|First Intervention Period|Withdrawal by Subject|0|||
124651857|NCT01267201|448343637|FG003|First Intervention Period|Withdrawal by Subject|0|||
124651858|NCT01267201|448343638|FG004|First Intervention Period|Withdrawal by Subject|0|||
124651859|NCT01267201|448343639|FG005|First Intervention Period|Withdrawal by Subject|0|||
124651860|NCT01267201|448343634|FG000|Second Intervention Period|Withdrawal by Subject|0|||
124651861|NCT01267201|448343635|FG001|Second Intervention Period|Withdrawal by Subject|1|||
124651862|NCT01267201|448343636|FG002|Second Intervention Period|Withdrawal by Subject|0|||
124651863|NCT01267201|448343637|FG003|Second Intervention Period|Withdrawal by Subject|0|||
124651864|NCT01267201|448343638|FG004|Second Intervention Period|Withdrawal by Subject|0|||
124651865|NCT01267201|448343639|FG005|Second Intervention Period|Withdrawal by Subject|0|||
124651866|NCT00955968|448343643|FG000|Overall Study|Death|2|||
124651867|NCT00955968|448343644|FG001|Overall Study|Death|4|||
124651868|NCT00955968|448343643|FG000|Overall Study|Withdrawal by Subject|35|||
124651869|NCT00955968|448343644|FG001|Overall Study|Withdrawal by Subject|31|||
124651870|NCT00955968|448343643|FG000|Overall Study|Lost to Follow-up|45|||
124651871|NCT00955968|448343644|FG001|Overall Study|Lost to Follow-up|39|||
124651872|NCT00955968|448343643|FG000|Overall Study|Site closed|55|||
124651873|NCT00955968|448343644|FG001|Overall Study|Site closed|52|||
124651874|NCT05020899|448343646|FG000|8 Week Follow-up|Lost to Follow-up|3|||
124651875|NCT05020899|448343647|FG001|8 Week Follow-up|Lost to Follow-up|6|||
124651876|NCT05020899|448343646|FG000|12 Week Follow-up|Lost to Follow-up|1|||
124651877|NCT05020899|448343647|FG001|12 Week Follow-up|Lost to Follow-up|0|||
124651878|NCT05020899|448343646|FG000|12 Week Follow-up|Death|0|||
124651879|NCT05020899|448343647|FG001|12 Week Follow-up|Death|1|||
124651880|NCT05619536|448343648|FG000|Overall Study|Withdrawal by Subject|0|||
124651881|NCT05619536|448343649|FG001|Overall Study|Withdrawal by Subject|1|||
124651882|NCT05619536|448343650|FG002|Overall Study|Withdrawal by Subject|0|||
124651883|NCT05619536|448343651|FG003|Overall Study|Withdrawal by Subject|1|||
124651884|NCT05619536|448343648|FG000|Overall Study|Lost to Follow-up|0|||
124651885|NCT05619536|448343649|FG001|Overall Study|Lost to Follow-up|1|||
124651886|NCT05619536|448343650|FG002|Overall Study|Lost to Follow-up|1|||
124651887|NCT05619536|448343651|FG003|Overall Study|Lost to Follow-up|0|||
124651888|NCT02923245|448343652|FG000|Overall Study|ultrasound order was cancelled|2|||
124651889|NCT02923245|448343653|FG001|Overall Study|ultrasound order was cancelled|1|||
124651890|NCT00793624|448343654|FG000|Overall Study|Adverse Event|18|||
124651891|NCT00793624|448343655|FG001|Overall Study|Adverse Event|16|||
124651892|NCT00793624|448343656|FG002|Overall Study|Adverse Event|15|||
124651893|NCT00793624|448343657|FG003|Overall Study|Adverse Event|20|||
124651894|NCT00793624|448343654|FG000|Overall Study|Lost to Follow-up|2|||
124651895|NCT00793624|448343655|FG001|Overall Study|Lost to Follow-up|2|||
124651896|NCT00793624|448343656|FG002|Overall Study|Lost to Follow-up|4|||
124651897|NCT00793624|448343657|FG003|Overall Study|Lost to Follow-up|0|||
124651898|NCT00793624|448343654|FG000|Overall Study|Withdrawal by Subject|20|||
124651899|NCT00793624|448343655|FG001|Overall Study|Withdrawal by Subject|9|||
124651900|NCT00793624|448343656|FG002|Overall Study|Withdrawal by Subject|11|||
124651901|NCT00793624|448343657|FG003|Overall Study|Withdrawal by Subject|14|||
124651902|NCT00793624|448343654|FG000|Overall Study|Lack of Efficacy|9|||
124651903|NCT00793624|448343655|FG001|Overall Study|Lack of Efficacy|2|||
124651904|NCT00793624|448343656|FG002|Overall Study|Lack of Efficacy|1|||
124651905|NCT00793624|448343657|FG003|Overall Study|Lack of Efficacy|3|||
124651906|NCT00793624|448343654|FG000|Overall Study|Non compliance with protocol|2|||
124651907|NCT00793624|448343655|FG001|Overall Study|Non compliance with protocol|3|||
124651908|NCT00793624|448343656|FG002|Overall Study|Non compliance with protocol|2|||
124651909|NCT00793624|448343657|FG003|Overall Study|Non compliance with protocol|3|||
124651910|NCT00793624|448343654|FG000|Overall Study|Other reason not described above|6|||
124651911|NCT00793624|448343655|FG001|Overall Study|Other reason not described above|4|||
124651912|NCT00793624|448343656|FG002|Overall Study|Other reason not described above|6|||
124651913|NCT00793624|448343657|FG003|Overall Study|Other reason not described above|3|||
124651914|NCT00710684|448343658|FG000|Overall Study|Adverse Event|11|||
124651915|NCT00710684|448343659|FG001|Overall Study|Adverse Event|19|||
124651916|NCT00710684|448343660|FG002|Overall Study|Adverse Event|16|||
124651917|NCT00710684|448343658|FG000|Overall Study|Lack of Efficacy|4|||
124651918|NCT00710684|448343659|FG001|Overall Study|Lack of Efficacy|3|||
124651919|NCT00710684|448343660|FG002|Overall Study|Lack of Efficacy|5|||
124651920|NCT00710684|448343658|FG000|Overall Study|Protocol Violation|5|||
124651921|NCT00710684|448343659|FG001|Overall Study|Protocol Violation|5|||
124651922|NCT00710684|448343660|FG002|Overall Study|Protocol Violation|5|||
124651923|NCT00710684|448343658|FG000|Overall Study|Lost to Follow-up|4|||
124651924|NCT00710684|448343659|FG001|Overall Study|Lost to Follow-up|6|||
124651925|NCT00710684|448343660|FG002|Overall Study|Lost to Follow-up|7|||
124651926|NCT00710684|448343658|FG000|Overall Study|Physician Decision|0|||
124651927|NCT00710684|448343659|FG001|Overall Study|Physician Decision|2|||
124651928|NCT00710684|448343660|FG002|Overall Study|Physician Decision|4|||
124651929|NCT00710684|448343658|FG000|Overall Study|Withdrawal by Subject|24|||
124651930|NCT00710684|448343659|FG001|Overall Study|Withdrawal by Subject|18|||
124651931|NCT00710684|448343660|FG002|Overall Study|Withdrawal by Subject|11|||
124651932|NCT00710684|448343658|FG000|Overall Study|Missing|1|||
124651933|NCT00710684|448343659|FG001|Overall Study|Missing|0|||
124651934|NCT00710684|448343660|FG002|Overall Study|Missing|0|||
124651935|NCT00710684|448343658|FG000|Overall Study|Did not continue after week 24|25|||
124651936|NCT00710684|448343659|FG001|Overall Study|Did not continue after week 24|21|||
124651937|NCT00710684|448343660|FG002|Overall Study|Did not continue after week 24|16|||
124651938|NCT04676412|448344916|FG000|Overall Study|Death|28|||
124651939|NCT04676412|448344917|FG001|Overall Study|Death|31|||
124651940|NCT04676412|448344916|FG000|Overall Study|Lost to Follow-up|1|||
124651941|NCT04676412|448344917|FG001|Overall Study|Lost to Follow-up|2|||
124651942|NCT04676412|448344916|FG000|Overall Study|Sponsor Decision|20|||
124651943|NCT04676412|448344917|FG001|Overall Study|Sponsor Decision|23|||
124651944|NCT04676412|448344916|FG000|Overall Study|Withdrawal by Subject|0|||
124651945|NCT04676412|448344917|FG001|Overall Study|Withdrawal by Subject|2|||
124651946|NCT04697056|448344918|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
124651947|NCT04697056|448344919|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
124651948|NCT04550832|448344920|FG000|Overall Study|Adverse Event|0|||
124651949|NCT04550832|448344921|FG001|Overall Study|Adverse Event|0|||
124651950|NCT04550832|448344922|FG002|Overall Study|Adverse Event|2|||
124651951|NCT04550832|448344923|FG003|Overall Study|Adverse Event|0|||
124651952|NCT04550832|448344924|FG004|Overall Study|Adverse Event|1|||
124651953|NCT04823130|448344925|FG000|Overall Study|Withdrawal by Subject|2|||
124651954|NCT04823130|448344926|FG001|Overall Study|Withdrawal by Subject|3|||
124651955|NCT04823130|448344925|FG000|Overall Study|Failure to meet inclusion criteria|6|||
124651956|NCT04823130|448344926|FG001|Overall Study|Failure to meet inclusion criteria|4|||
124651957|NCT04823130|448344925|FG000|Overall Study|Other-unspecified|1|||
124651958|NCT04823130|448344926|FG001|Overall Study|Other-unspecified|0|||
124651959|NCT03315455|448344928|FG000|Overall Study|Ongoing in the Study|13|||
124651960|NCT03315455|448344929|FG001|Overall Study|Ongoing in the Study|24|||
124651961|NCT03315455|448344930|FG002|Overall Study|Ongoing in the Study|17|||
124651962|NCT03315455|448344931|FG003|Overall Study|Ongoing in the Study|15|||
124651963|NCT03315455|448344928|FG000|Overall Study|Withdrawal by Subject|0|||
124651964|NCT03315455|448344929|FG001|Overall Study|Withdrawal by Subject|1|||
124651965|NCT03315455|448344930|FG002|Overall Study|Withdrawal by Subject|0|||
124651966|NCT03315455|448344931|FG003|Overall Study|Withdrawal by Subject|0|||
124651967|NCT04439357|448344935|FG000|Overall Study|Disease Progression|4|||
124651968|NCT05906836|448344941|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
124651969|NCT05906836|448344941|FG000|Overall Study|Lost to Follow-up|1|||
124651970|NCT02542293|448344942|FG000|Overall Study|Death|367|||
124651971|NCT02542293|448344943|FG001|Overall Study|Death|377|||
124651972|NCT02542293|448344942|FG000|Overall Study|Withdrawal by Subject|8|||
124651973|NCT02542293|448344943|FG001|Overall Study|Withdrawal by Subject|19|||
124651974|NCT03030118|448344944|FG000|Overall Study|Achieved SLE Diagnosis|11|||
124651975|NCT03030118|448344945|FG001|Overall Study|Achieved SLE Diagnosis|10|||
124651976|NCT03030118|448344944|FG000|Overall Study|Adverse Event|1|||
124651977|NCT03030118|448344945|FG001|Overall Study|Adverse Event|1|||
124651978|NCT03030118|448344944|FG000|Overall Study|Pregnancy|2|||
124651979|NCT03030118|448344945|FG001|Overall Study|Pregnancy|2|||
124651980|NCT03030118|448344944|FG000|Overall Study|Lost to Follow-up|5|||
124651981|NCT03030118|448344945|FG001|Overall Study|Lost to Follow-up|6|||
124651982|NCT03030118|448344944|FG000|Overall Study|Concomitant Medications|1|||
124651983|NCT03030118|448344945|FG001|Overall Study|Concomitant Medications|1|||
124651984|NCT03030118|448344944|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
124651985|NCT03030118|448344945|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
124651986|NCT03030118|448344944|FG000|Overall Study|Other|2|||
124651987|NCT03030118|448344945|FG001|Overall Study|Other|0|||
124651988|NCT03030118|448344944|FG000|Overall Study|Withdrawal by Subject|26|||
124651989|NCT03030118|448344945|FG001|Overall Study|Withdrawal by Subject|21|||
124651990|NCT03030118|448344944|FG000|Overall Study|Protocol Violation|1|||
124651991|NCT03030118|448344945|FG001|Overall Study|Protocol Violation|6|||
124651992|NCT03488225|448344948|FG000|Overall Study|Off Protocol Therapy|2|||
124651993|NCT03488225|448344948|FG000|Overall Study|Stem Cell Transplant|2|||
124651994|NCT00503997|448344953|FG000|Overall Study|disease progression|1|||
124651995|NCT00503997|448344953|FG000|Overall Study|Adverse Event|5|||
124651996|NCT00503997|448344953|FG000|Overall Study|Death|1|||
124651997|NCT00503997|448344953|FG000|Overall Study|Withdrawal by Subject|1|||
124651998|NCT01195844|448344954|FG000|Overall Study|Fecal sample not collected|40|||
124651999|NCT05385224|448344955|FG000|Overall Study|Unable to swallow capsule|2|||
124652000|NCT05385224|448344955|FG000|Overall Study|Withdrawal by Subject|2|||
124652001|NCT05385224|448344955|FG000|Overall Study|Did not meet study criteria|1|||
124652002|NCT01935700|448344956|FG000|Overall Study|Withdrawal by Subject|1|||
124652003|NCT01935700|448344957|FG001|Overall Study|Withdrawal by Subject|0|||
124652004|NCT01935700|448344956|FG000|Overall Study|Physician Decision|4|||
124652005|NCT01935700|448344957|FG001|Overall Study|Physician Decision|0|||
124652006|NCT01294371|448344960|FG000|Overall Study|Adverse Event|1|||
124652007|NCT01294371|448344960|FG000|Overall Study|Withdrawal by Subject|12|||
124652008|NCT01294371|448344960|FG000|Overall Study|Lost to Follow-up|6|||
124652009|NCT01294371|448344960|FG000|Overall Study|Administrative Reason|1|||
124652010|NCT01294371|448344960|FG000|Overall Study|Other|14|||
124652011|NCT02520427|448344961|FG000|Overall Study|Decision by sponsor|0|||
124652012|NCT02520427|448344962|FG001|Overall Study|Decision by sponsor|0|||
124652013|NCT02520427|448344963|FG002|Overall Study|Decision by sponsor|0|||
124652014|NCT02520427|448344964|FG003|Overall Study|Decision by sponsor|0|||
124652015|NCT02520427|448344965|FG004|Overall Study|Decision by sponsor|0|||
124652016|NCT02520427|448344966|FG005|Overall Study|Decision by sponsor|0|||
124652017|NCT02520427|448344967|FG006|Overall Study|Decision by sponsor|0|||
124652018|NCT02520427|448344968|FG007|Overall Study|Decision by sponsor|0|||
124652019|NCT02520427|448344969|FG008|Overall Study|Decision by sponsor|1|||
124652020|NCT02520427|448344970|FG009|Overall Study|Decision by sponsor|1|||
124652021|NCT02520427|448344971|FG010|Overall Study|Decision by sponsor|0|||
124652022|NCT02520427|448344972|FG011|Overall Study|Decision by sponsor|0|||
124652023|NCT02520427|448344973|FG012|Overall Study|Decision by sponsor|0|||
124652024|NCT02520427|448344974|FG013|Overall Study|Decision by sponsor|0|||
124652025|NCT02520427|448344975|FG014|Overall Study|Decision by sponsor|0|||
124652026|NCT02520427|448344976|FG015|Overall Study|Decision by sponsor|0|||
124652027|NCT02520427|448344977|FG016|Overall Study|Decision by sponsor|0|||
124652028|NCT02520427|448344978|FG017|Overall Study|Decision by sponsor|0|||
124652029|NCT02520427|448344979|FG018|Overall Study|Decision by sponsor|0|||
124652030|NCT02520427|448344980|FG019|Overall Study|Decision by sponsor|0|||
124652031|NCT02520427|448344981|FG020|Overall Study|Decision by sponsor|0|||
124652032|NCT02520427|448344982|FG021|Overall Study|Decision by sponsor|0|||
124652033|NCT02520427|448344983|FG022|Overall Study|Decision by sponsor|0|||
124652034|NCT02520427|448344984|FG023|Overall Study|Decision by sponsor|0|||
124652035|NCT02520427|448344985|FG024|Overall Study|Decision by sponsor|0|||
124652036|NCT02520427|448344986|FG025|Overall Study|Decision by sponsor|0|||
124652037|NCT02520427|448344961|FG000|Overall Study|Withdrawal by Subject|0|||
124652038|NCT02520427|448344962|FG001|Overall Study|Withdrawal by Subject|0|||
124652039|NCT02520427|448344963|FG002|Overall Study|Withdrawal by Subject|1|||
124652040|NCT02520427|448344964|FG003|Overall Study|Withdrawal by Subject|0|||
124652041|NCT02520427|448344965|FG004|Overall Study|Withdrawal by Subject|0|||
124652042|NCT02520427|448344966|FG005|Overall Study|Withdrawal by Subject|0|||
124652043|NCT02520427|448344967|FG006|Overall Study|Withdrawal by Subject|0|||
124652044|NCT02520427|448344968|FG007|Overall Study|Withdrawal by Subject|0|||
124652045|NCT02520427|448344969|FG008|Overall Study|Withdrawal by Subject|0|||
124652046|NCT02520427|448344970|FG009|Overall Study|Withdrawal by Subject|0|||
124652047|NCT02520427|448344971|FG010|Overall Study|Withdrawal by Subject|0|||
124652048|NCT02520427|448344972|FG011|Overall Study|Withdrawal by Subject|0|||
124652049|NCT02520427|448344973|FG012|Overall Study|Withdrawal by Subject|1|||
124652050|NCT02520427|448344974|FG013|Overall Study|Withdrawal by Subject|1|||
124652051|NCT02520427|448344975|FG014|Overall Study|Withdrawal by Subject|1|||
124652052|NCT02520427|448344976|FG015|Overall Study|Withdrawal by Subject|0|||
124652053|NCT02520427|448344977|FG016|Overall Study|Withdrawal by Subject|1|||
124652054|NCT02520427|448344978|FG017|Overall Study|Withdrawal by Subject|0|||
124652055|NCT02520427|448344979|FG018|Overall Study|Withdrawal by Subject|0|||
124652056|NCT02520427|448344980|FG019|Overall Study|Withdrawal by Subject|3|||
124652057|NCT02520427|448344981|FG020|Overall Study|Withdrawal by Subject|2|||
124652058|NCT02520427|448344982|FG021|Overall Study|Withdrawal by Subject|0|||
124652059|NCT02520427|448344983|FG022|Overall Study|Withdrawal by Subject|0|||
124652060|NCT02520427|448344984|FG023|Overall Study|Withdrawal by Subject|0|||
124652061|NCT02520427|448344985|FG024|Overall Study|Withdrawal by Subject|0|||
124652062|NCT02520427|448344986|FG025|Overall Study|Withdrawal by Subject|0|||
124652063|NCT02520427|448344961|FG000|Overall Study|Death|1|||
124652064|NCT02520427|448344962|FG001|Overall Study|Death|0|||
124652065|NCT02520427|448344963|FG002|Overall Study|Death|0|||
124652066|NCT02520427|448344964|FG003|Overall Study|Death|0|||
124652067|NCT02520427|448344965|FG004|Overall Study|Death|0|||
124652068|NCT02520427|448344966|FG005|Overall Study|Death|0|||
124652069|NCT02520427|448344967|FG006|Overall Study|Death|0|||
124652070|NCT02520427|448344968|FG007|Overall Study|Death|0|||
124652071|NCT02520427|448344969|FG008|Overall Study|Death|0|||
124652072|NCT02520427|448344970|FG009|Overall Study|Death|0|||
124652073|NCT02520427|448344971|FG010|Overall Study|Death|0|||
124652074|NCT02520427|448344972|FG011|Overall Study|Death|0|||
124652075|NCT02520427|448344973|FG012|Overall Study|Death|0|||
124652076|NCT02520427|448344974|FG013|Overall Study|Death|0|||
124652077|NCT02520427|448344975|FG014|Overall Study|Death|0|||
124652078|NCT02520427|448344976|FG015|Overall Study|Death|0|||
124652079|NCT02520427|448344977|FG016|Overall Study|Death|2|||
124652080|NCT02520427|448344978|FG017|Overall Study|Death|1|||
124652081|NCT02520427|448344979|FG018|Overall Study|Death|3|||
124652082|NCT02520427|448344980|FG019|Overall Study|Death|2|||
124652083|NCT02520427|448344981|FG020|Overall Study|Death|0|||
124652084|NCT02520427|448344982|FG021|Overall Study|Death|0|||
124652085|NCT02520427|448344983|FG022|Overall Study|Death|1|||
124652086|NCT02520427|448344984|FG023|Overall Study|Death|0|||
124652087|NCT02520427|448344985|FG024|Overall Study|Death|1|||
124652088|NCT02520427|448344986|FG025|Overall Study|Death|0|||
124652089|NCT04778059|448344989|FG000|Overall Study|Death|2|||
124652090|NCT04778059|448344990|FG001|Overall Study|Death|2|||
124652091|NCT04778059|448344991|FG002|Overall Study|Death|1|||
124652092|NCT04778059|448344992|FG003|Overall Study|Death|1|||
124652093|NCT04778059|448344993|FG004|Overall Study|Death|1|||
124652094|NCT04778059|448344989|FG000|Overall Study|Lost to Follow-up|0|||
124652095|NCT04778059|448344990|FG001|Overall Study|Lost to Follow-up|0|||
124652096|NCT04778059|448344991|FG002|Overall Study|Lost to Follow-up|0|||
124652097|NCT04778059|448344992|FG003|Overall Study|Lost to Follow-up|0|||
124652098|NCT04778059|448344993|FG004|Overall Study|Lost to Follow-up|1|||
124652099|NCT04778059|448344989|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
124652100|NCT04778059|448344990|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
124652101|NCT04778059|448344991|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
124652102|NCT04778059|448344992|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
124652103|NCT04778059|448344993|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
124652104|NCT00157248|448344995|FG000|Overall Study|Adverse Event|36|||
124652105|NCT00157248|448344996|FG001|Overall Study|Adverse Event|25|||
124652106|NCT00157248|448344997|FG002|Overall Study|Adverse Event|13|||
124652107|NCT00157248|448344998|FG003|Overall Study|Adverse Event|33|||
124652108|NCT00157248|448344995|FG000|Overall Study|Protocol Violation|4|||
124652109|NCT00157248|448344996|FG001|Overall Study|Protocol Violation|0|||
124652110|NCT00157248|448344997|FG002|Overall Study|Protocol Violation|2|||
124652111|NCT00157248|448344998|FG003|Overall Study|Protocol Violation|2|||
124652112|NCT00157248|448344995|FG000|Overall Study|Lost to Follow-up|0|||
124652113|NCT00157248|448344996|FG001|Overall Study|Lost to Follow-up|1|||
124652114|NCT00157248|448344997|FG002|Overall Study|Lost to Follow-up|0|||
124652115|NCT00157248|448344998|FG003|Overall Study|Lost to Follow-up|0|||
124652116|NCT00157248|448344995|FG000|Overall Study|Withdrawal by Subject|1|||
124652117|NCT00157248|448344996|FG001|Overall Study|Withdrawal by Subject|4|||
124652118|NCT00157248|448344997|FG002|Overall Study|Withdrawal by Subject|3|||
124652119|NCT00157248|448344998|FG003|Overall Study|Withdrawal by Subject|3|||
124652120|NCT00157248|448344995|FG000|Overall Study|site closures, subject moving|7|||
124652121|NCT00157248|448344996|FG001|Overall Study|site closures, subject moving|7|||
124652122|NCT00157248|448344997|FG002|Overall Study|site closures, subject moving|3|||
124652123|NCT00157248|448344998|FG003|Overall Study|site closures, subject moving|9|||
124652124|NCT01306045|448345003|FG000|Met General Eligibility Criteria|Screen failures|193|||
124652125|NCT01306045|448345004|FG001|Met General Eligibility Criteria|Screen failures|11|||
124652126|NCT01306045|448345005|FG002|Met General Eligibility Criteria|Screen failures|8|||
124652127|NCT02987972|448345006|FG000|Overall Study|Adverse Event|1|||
124652128|NCT02987972|448345007|FG001|Overall Study|Adverse Event|1|||
124652129|NCT02987972|448345008|FG002|Overall Study|Adverse Event|0|||
124652130|NCT02987972|448345006|FG000|Overall Study|Death|1|||
124652131|NCT02987972|448345007|FG001|Overall Study|Death|0|||
124652132|NCT02987972|448345008|FG002|Overall Study|Death|0|||
124652133|NCT02987972|448345006|FG000|Overall Study|Lack of Efficacy|9|||
124652134|NCT02987972|448345007|FG001|Overall Study|Lack of Efficacy|12|||
124652135|NCT02987972|448345008|FG002|Overall Study|Lack of Efficacy|12|||
124652136|NCT02987972|448345006|FG000|Overall Study|Lost to Follow-up|7|||
124652137|NCT02987972|448345007|FG001|Overall Study|Lost to Follow-up|8|||
124652138|NCT02987972|448345008|FG002|Overall Study|Lost to Follow-up|4|||
124652139|NCT02987972|448345006|FG000|Overall Study|Physician Decision|1|||
124652140|NCT02987972|448345007|FG001|Overall Study|Physician Decision|6|||
124652141|NCT02987972|448345008|FG002|Overall Study|Physician Decision|0|||
124652142|NCT02987972|448345006|FG000|Overall Study|Protocol Violation|2|||
124652143|NCT02987972|448345007|FG001|Overall Study|Protocol Violation|1|||
124652144|NCT02987972|448345008|FG002|Overall Study|Protocol Violation|5|||
124652145|NCT02987972|448345006|FG000|Overall Study|Withdrawal by Subject|22|||
124652146|NCT02987972|448345007|FG001|Overall Study|Withdrawal by Subject|17|||
124652147|NCT02987972|448345008|FG002|Overall Study|Withdrawal by Subject|21|||
124652148|NCT04506905|448345011|FG000|Overall Study|Lost to Follow-up|1|||
124652149|NCT04506905|448345012|FG001|Overall Study|Lost to Follow-up|0|||
124652150|NCT04506905|448345013|FG002|Overall Study|Lost to Follow-up|0|||
124652151|NCT04506905|448345014|FG003|Overall Study|Lost to Follow-up|1|||
124652152|NCT04506905|448345015|FG004|Overall Study|Lost to Follow-up|0|||
124652153|NCT04506905|448345016|FG005|Overall Study|Lost to Follow-up|0|||
124652154|NCT04506905|448345017|FG006|Overall Study|Lost to Follow-up|0|||
124652155|NCT04506905|448345018|FG007|Overall Study|Lost to Follow-up|0|||
124652156|NCT04506905|448345019|FG008|Overall Study|Lost to Follow-up|0|||
124652157|NCT04506905|448345011|FG000|Overall Study|Withdrawal by Subject|0|||
124652158|NCT04506905|448345012|FG001|Overall Study|Withdrawal by Subject|0|||
124652159|NCT04506905|448345013|FG002|Overall Study|Withdrawal by Subject|0|||
124652160|NCT04506905|448345014|FG003|Overall Study|Withdrawal by Subject|2|||
124652161|NCT04506905|448345015|FG004|Overall Study|Withdrawal by Subject|0|||
124652162|NCT04506905|448345016|FG005|Overall Study|Withdrawal by Subject|0|||
124652163|NCT04506905|448345017|FG006|Overall Study|Withdrawal by Subject|0|||
124652164|NCT04506905|448345018|FG007|Overall Study|Withdrawal by Subject|0|||
124652165|NCT04506905|448345019|FG008|Overall Study|Withdrawal by Subject|0|||
124652166|NCT05072106|448346127|FG000|Overall Study|Progressive disease|3|||
124652167|NCT05072106|448346128|FG001|Overall Study|Progressive disease|3|||
124652168|NCT05072106|448346127|FG000|Overall Study|Compassionate use|3|||
124652169|NCT05072106|448346128|FG001|Overall Study|Compassionate use|1|||
124652170|NCT05072106|448346127|FG000|Overall Study|Withdrawal by Subject|1|||
124652171|NCT05072106|448346128|FG001|Overall Study|Withdrawal by Subject|0|||
124652172|NCT03839459|448346129|FG000|Overall Study|Withdrawal by Subject|2|||
124652173|NCT03839459|448346129|FG000|Overall Study|progression of disease|3|||
124652174|NCT05128773|448346137|FG000|Overall Study|Sponsor decision to terminate study|3|||
124652175|NCT04250714|448346139|FG000|Overall Study|Treatment - withdrawal by subject|14|||
124652176|NCT04250714|448346139|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
124652177|NCT04250714|448346139|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
124652178|NCT04250714|448346139|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
124652179|NCT04250714|448346139|FG000|Overall Study|Treatment - Death|1|||
124652180|NCT04250714|448346139|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
124652181|NCT04250714|448346139|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
124652182|NCT04250714|448346139|FG000|Overall Study|Attempt|2|||
124652183|NCT04250714|448346139|FG000|Overall Study|Intent|7|||
124652184|NCT04529850|448346140|FG000|Overall Study|Death|2|||
124652185|NCT04529850|448346140|FG000|Overall Study|Physician Decision|1|||
124652186|NCT04529850|448346140|FG000|Overall Study|Withdrawal by Subject|2|||
124652187|NCT01458951|448346143|FG000|Overall Study|Other|1|||
124652188|NCT01458951|448346144|FG001|Overall Study|Other|0|||
124652189|NCT01458951|448346145|FG002|Overall Study|Other|0|||
124652190|NCT01458951|448346143|FG000|Overall Study|Protocol Violation|5|||
124652191|NCT01458951|448346144|FG001|Overall Study|Protocol Violation|1|||
124652192|NCT01458951|448346145|FG002|Overall Study|Protocol Violation|0|||
124652193|NCT01458951|448346143|FG000|Overall Study|Withdrawal by Subject|2|||
124652194|NCT01458951|448346144|FG001|Overall Study|Withdrawal by Subject|0|||
124652195|NCT01458951|448346145|FG002|Overall Study|Withdrawal by Subject|2|||
124652196|NCT01458951|448346143|FG000|Overall Study|Adverse Event|7|||
124652197|NCT01458951|448346144|FG001|Overall Study|Adverse Event|0|||
124652198|NCT01458951|448346145|FG002|Overall Study|Adverse Event|2|||
124652199|NCT01458951|448346143|FG000|Overall Study|Insufficient Clinical Response|17|||
124652200|NCT01458951|448346144|FG001|Overall Study|Insufficient Clinical Response|0|||
124652201|NCT01458951|448346145|FG002|Overall Study|Insufficient Clinical Response|11|||
124652202|NCT02963558|448346148|FG000|Overall Study|Withdrawn by investigator|1|||
124652203|NCT02963558|448346149|FG001|Overall Study|Withdrawn by investigator|0|||
124652204|NCT02963558|448346148|FG000|Overall Study|Withdrawal by Subject|0|||
124652205|NCT02963558|448346149|FG001|Overall Study|Withdrawal by Subject|1|||
124652206|NCT03309696|448346150|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
124652207|NCT03309696|448346151|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
124652208|NCT03309696|448346152|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
124652209|NCT03309696|448346153|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
124652210|NCT01573767|448346154|FG000|Overall Study|Adverse Event|0|||
124652211|NCT01573767|448346155|FG001|Overall Study|Adverse Event|1|||
124652212|NCT01573767|448346156|FG002|Overall Study|Adverse Event|0|||
124652213|NCT01573767|448346157|FG003|Overall Study|Adverse Event|1|||
124652214|NCT01573767|448346154|FG000|Overall Study|Lack of Efficacy|18|||
124652215|NCT01573767|448346155|FG001|Overall Study|Lack of Efficacy|15|||
124652216|NCT01573767|448346156|FG002|Overall Study|Lack of Efficacy|12|||
124652217|NCT01573767|448346157|FG003|Overall Study|Lack of Efficacy|17|||
124652218|NCT01573767|448346154|FG000|Overall Study|Protocol Violation|3|||
124652219|NCT01573767|448346155|FG001|Overall Study|Protocol Violation|1|||
124652220|NCT01573767|448346156|FG002|Overall Study|Protocol Violation|1|||
124652221|NCT01573767|448346157|FG003|Overall Study|Protocol Violation|3|||
124652222|NCT01573767|448346154|FG000|Overall Study|Lost to Follow-up|0|||
124652223|NCT01573767|448346155|FG001|Overall Study|Lost to Follow-up|1|||
124652224|NCT01573767|448346156|FG002|Overall Study|Lost to Follow-up|1|||
124652225|NCT01573767|448346157|FG003|Overall Study|Lost to Follow-up|1|||
124652226|NCT01573767|448346154|FG000|Overall Study|Physician Decision|1|||
124652227|NCT01573767|448346155|FG001|Overall Study|Physician Decision|2|||
124652228|NCT01573767|448346156|FG002|Overall Study|Physician Decision|0|||
124872792|NCT00394355|449155767|FG002|Overall Study|Noncompliance with protocol|10|||
124872793|NCT00394355|449155768|FG003|Overall Study|Noncompliance with protocol|8|||
124872794|NCT00394355|449155765|FG000|Overall Study|Administrative|0|||
124872795|NCT00394355|449155766|FG001|Overall Study|Administrative|1|||
124872796|NCT00394355|449155767|FG002|Overall Study|Administrative|1|||
124872797|NCT00394355|449155768|FG003|Overall Study|Administrative|1|||
124652229|NCT01573767|448346157|FG003|Overall Study|Physician Decision|2|||
124872798|NCT00394355|449155765|FG000|Overall Study|Lack of Efficacy|0|||
124872799|NCT00394355|449155766|FG001|Overall Study|Lack of Efficacy|0|||
124872800|NCT00394355|449155767|FG002|Overall Study|Lack of Efficacy|2|||
124872801|NCT00394355|449155768|FG003|Overall Study|Lack of Efficacy|3|||
124872802|NCT00500903|449155769|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
124872803|NCT00500903|449155770|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
124872804|NCT00500903|449155771|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
124872805|NCT00500903|449155769|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
124872806|NCT00500903|449155770|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
124872807|NCT00500903|449155771|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
124872808|NCT00500903|449155769|FG000|Overall Study|Progressive Disease|41|||
124872809|NCT00500903|449155770|FG001|Overall Study|Progressive Disease|2|||
124872810|NCT00500903|449155771|FG002|Overall Study|Progressive Disease|15|||
124872811|NCT00500903|449155769|FG000|Overall Study|Patient Declined Further Treatment|0|||
124652230|NCT01573767|448346154|FG000|Overall Study|Withdrawal by Subject|0|||
124652231|NCT01573767|448346155|FG001|Overall Study|Withdrawal by Subject|1|||
124652232|NCT01573767|448346156|FG002|Overall Study|Withdrawal by Subject|0|||
124652233|NCT01573767|448346157|FG003|Overall Study|Withdrawal by Subject|0|||
124652234|NCT01371877|448346160|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
124652235|NCT01371877|448346161|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
124652236|NCT00869557|448346162|FG000|Randomized Phase|Lost to Follow-up|2|||
124652237|NCT00869557|448346163|FG001|Randomized Phase|Lost to Follow-up|1|||
124652238|NCT00869557|448346162|FG000|Randomized Phase|Investigator's Discretion|1|||
124652239|NCT00869557|448346163|FG001|Randomized Phase|Investigator's Discretion|0|||
124652240|NCT00869557|448346162|FG000|Randomized Phase|Withdrew Consent|0|||
124652241|NCT00869557|448346163|FG001|Randomized Phase|Withdrew Consent|1|||
124652242|NCT00869557|448346162|FG000|Extension Phase|Adverse Event|2|||
124652243|NCT00869557|448346163|FG001|Extension Phase|Adverse Event|2|||
124652244|NCT00869557|448346162|FG000|Extension Phase|Lack of Efficacy|1|||
124652245|NCT00869557|448346163|FG001|Extension Phase|Lack of Efficacy|0|||
124652246|NCT00869557|448346162|FG000|Extension Phase|Lost to Follow-up|3|||
124652247|NCT00869557|448346163|FG001|Extension Phase|Lost to Follow-up|1|||
124652248|NCT00869557|448346162|FG000|Extension Phase|Investigator's Discretion|2|||
124652249|NCT00869557|448346163|FG001|Extension Phase|Investigator's Discretion|0|||
124652250|NCT00869557|448346162|FG000|Extension Phase|Withdrew Consent|2|||
124652251|NCT00869557|448346163|FG001|Extension Phase|Withdrew Consent|0|||
124652252|NCT05940077|448346164|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
124652253|NCT02304380|448346165|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
124652254|NCT02304380|448346166|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
124652255|NCT02304380|448346167|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
124652256|NCT02304380|448346168|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
124652257|NCT02304380|448346169|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
124652258|NCT02304380|448346170|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
124652259|NCT02368210|448346171|FG000|Overall Study|Withdrawal by Subject|1|||
124652260|NCT02368210|448346172|FG001|Overall Study|Withdrawal by Subject|0|||
124652261|NCT02368210|448346171|FG000|Overall Study|Adverse Event|0|||
124652262|NCT02368210|448346172|FG001|Overall Study|Adverse Event|1|||
124652263|NCT00078949|448346173|FG000|Overall Study|No treated|4|||
124652264|NCT00078949|448346174|FG001|Overall Study|No treated|5|||
124652265|NCT00078949|448346175|FG002|Overall Study|No treated|3|||
124652266|NCT00078949|448346176|FG003|Overall Study|No treated|3|||
124652267|NCT01143064|448346177|FG000|Overall Study|Death|109|||
124652268|NCT01143064|448346178|FG001|Overall Study|Death|91|||
124652269|NCT01143064|448346177|FG000|Overall Study|Adverse Event|0|||
124652270|NCT01143064|448346178|FG001|Overall Study|Adverse Event|1|||
124652271|NCT01143064|448346177|FG000|Overall Study|Withdrawal by Subject|7|||
124652272|NCT01143064|448346178|FG001|Overall Study|Withdrawal by Subject|5|||
124652273|NCT01143064|448346177|FG000|Overall Study|Lost to Follow-up|17|||
124652274|NCT01143064|448346178|FG001|Overall Study|Lost to Follow-up|14|||
124652275|NCT01143064|448346177|FG000|Overall Study|Physician Decision|0|||
124652276|NCT01143064|448346178|FG001|Overall Study|Physician Decision|4|||
124652277|NCT01199822|448346184|FG000|Overall Study|Investigator discontinued therapy|0|||
124652278|NCT01199822|448346185|FG001|Overall Study|Investigator discontinued therapy|1|||
124652279|NCT01199822|448346186|FG002|Overall Study|Investigator discontinued therapy|0|||
124652280|NCT03747302|448346187|FG000|Overall Study|Withdrawal by Subject|1|||
124652281|NCT03747302|448346188|FG001|Overall Study|Withdrawal by Subject|2|||
124652282|NCT03769675|448346189|FG000|Overall Study|Lost to Follow-up|1|||
124652283|NCT04027075|448346192|FG000|Overall Study|Lost to Follow-up|41|||
124652284|NCT04027075|448346193|FG001|Overall Study|Lost to Follow-up|22|||
124652285|NCT01472965|448346194|FG000|Overall Study|Withdrawal by Subject|1|||
124872812|NCT00500903|449155770|FG001|Overall Study|Patient Declined Further Treatment|0|||
124652286|NCT01472965|448346195|FG001|Overall Study|Withdrawal by Subject|0|||
124652287|NCT01432275|448346200|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
124652288|NCT01432275|448346201|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
124652289|NCT01432275|448346200|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
124652290|NCT01432275|448346201|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
124652291|NCT01432275|448346200|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
124652292|NCT01432275|448346201|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
124652293|NCT01432275|448346200|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
124652294|NCT01432275|448346201|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
124652295|NCT01432275|448346200|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
124652296|NCT01432275|448346201|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
124652297|NCT01432275|448346200|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
124652298|NCT01432275|448346201|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
124652299|NCT01432275|448346200|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
124652300|NCT01432275|448346201|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
124652301|NCT01432275|448346200|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
124652302|NCT01432275|448346201|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
124652303|NCT01432275|448346200|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
124652304|NCT01432275|448346201|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
124652305|NCT02565706|448346202|FG000|Overall Study|Withdrawal by Subject|5|||
124652306|NCT02565706|448346203|FG001|Overall Study|Withdrawal by Subject|7|||
124652307|NCT02565706|448346204|FG002|Overall Study|Withdrawal by Subject|7|||
124652308|NCT02565706|448346205|FG003|Overall Study|Withdrawal by Subject|11|||
124652309|NCT02565706|448346202|FG000|Overall Study|Lost to Follow-up|72|||
124652310|NCT02565706|448346203|FG001|Overall Study|Lost to Follow-up|75|||
124652311|NCT02565706|448346204|FG002|Overall Study|Lost to Follow-up|82|||
124652312|NCT02565706|448346205|FG003|Overall Study|Lost to Follow-up|74|||
124652313|NCT02584959|448346206|FG000|Period 1|Withdrawn from study|3|||
124652314|NCT02584959|448346207|FG001|Period 1|Withdrawn from study|4|||
124652315|NCT02584959|448346208|FG002|Period 1|Withdrawn from study|0|||
124652316|NCT02584959|448346206|FG000|Period 2|Withdrawn from study|6|||
124652317|NCT02584959|448346207|FG001|Period 2|Withdrawn from study|1|||
124652318|NCT02584959|448346208|FG002|Period 2|Withdrawn from study|2|||
124652319|NCT03008278|448346211|FG000|Overall Study|Progressive Disease|0|||
124652320|NCT03008278|448346212|FG001|Overall Study|Progressive Disease|0|||
124652321|NCT03008278|448346213|FG002|Overall Study|Progressive Disease|32|||
124652322|NCT03008278|448346211|FG000|Overall Study|Adverse Event|0|||
124652323|NCT03008278|448346212|FG001|Overall Study|Adverse Event|0|||
124652324|NCT03008278|448346213|FG002|Overall Study|Adverse Event|4|||
124652325|NCT03008278|448346211|FG000|Overall Study|Withdrawal by Subject|0|||
124652326|NCT03008278|448346212|FG001|Overall Study|Withdrawal by Subject|0|||
124652327|NCT03008278|448346213|FG002|Overall Study|Withdrawal by Subject|3|||
124652328|NCT03008278|448346211|FG000|Overall Study|Physician Decision|0|||
124652329|NCT03008278|448346212|FG001|Overall Study|Physician Decision|2|||
124652330|NCT03008278|448346213|FG002|Overall Study|Physician Decision|0|||
124652336|NCT03802565|448346218|FG000|Overall Study|Adverse Event|0|||
124652337|NCT03802565|448346219|FG001|Overall Study|Adverse Event|1|||
124652338|NCT03802565|448346220|FG002|Overall Study|Adverse Event|2|||
124652339|NCT03802565|448346221|FG003|Overall Study|Adverse Event|1|||
124652340|NCT03802565|448346222|FG004|Overall Study|Adverse Event|1|||
124652341|NCT03802565|448346218|FG000|Overall Study|Withdrawal by Subject|2|||
124652342|NCT03802565|448346219|FG001|Overall Study|Withdrawal by Subject|2|||
124652343|NCT03802565|448346220|FG002|Overall Study|Withdrawal by Subject|2|||
124652344|NCT03802565|448346221|FG003|Overall Study|Withdrawal by Subject|0|||
124652345|NCT03802565|448346222|FG004|Overall Study|Withdrawal by Subject|1|||
124652346|NCT03802565|448346218|FG000|Overall Study|Protocol Violation|2|||
124652347|NCT03802565|448346219|FG001|Overall Study|Protocol Violation|1|||
124652348|NCT03802565|448346220|FG002|Overall Study|Protocol Violation|4|||
124652349|NCT03802565|448346221|FG003|Overall Study|Protocol Violation|5|||
124652350|NCT03802565|448346222|FG004|Overall Study|Protocol Violation|1|||
124652351|NCT03802565|448346218|FG000|Overall Study|Lost to Follow-up|0|||
124652352|NCT03802565|448346219|FG001|Overall Study|Lost to Follow-up|0|||
124652353|NCT03802565|448346220|FG002|Overall Study|Lost to Follow-up|1|||
124652354|NCT03802565|448346221|FG003|Overall Study|Lost to Follow-up|0|||
124652355|NCT03802565|448346222|FG004|Overall Study|Lost to Follow-up|0|||
124652356|NCT03802565|448346218|FG000|Overall Study|Subjects Related to Each Other|1|||
124652357|NCT03802565|448346219|FG001|Overall Study|Subjects Related to Each Other|0|||
124652358|NCT03802565|448346220|FG002|Overall Study|Subjects Related to Each Other|0|||
124652359|NCT03802565|448346221|FG003|Overall Study|Subjects Related to Each Other|2|||
124652360|NCT03802565|448346222|FG004|Overall Study|Subjects Related to Each Other|1|||
124652361|NCT03802565|448346218|FG000|Overall Study|Elevated Enzymes|0|||
124652362|NCT03802565|448346219|FG001|Overall Study|Elevated Enzymes|0|||
124652363|NCT03802565|448346220|FG002|Overall Study|Elevated Enzymes|0|||
124652364|NCT03802565|448346221|FG003|Overall Study|Elevated Enzymes|0|||
124652365|NCT03802565|448346222|FG004|Overall Study|Elevated Enzymes|2|||
124652366|NCT02124759|448346223|FG000|Overall Study|Withdrawal by Subject|3|||
124652367|NCT02124759|448346224|FG001|Overall Study|Withdrawal by Subject|1|||
124652368|NCT02124759|448346225|FG002|Overall Study|Withdrawal by Subject|1|||
124652369|NCT02124759|448346223|FG000|Overall Study|Screen Fail|2|||
124652370|NCT02124759|448346224|FG001|Overall Study|Screen Fail|2|||
124652371|NCT02124759|448346225|FG002|Overall Study|Screen Fail|3|||
124652372|NCT01068626|448346226|FG000|Overall Study|Adverse Event|3|||
124652373|NCT01068626|448346227|FG001|Overall Study|Adverse Event|0|||
124652374|NCT01068626|448346226|FG000|Overall Study|Withdrawal by Subject|0|||
124652375|NCT01068626|448346227|FG001|Overall Study|Withdrawal by Subject|2|||
124652376|NCT04340843|448346228|FG000|Overall Study|Adverse Event|0|||
124652377|NCT04340843|448346229|FG001|Overall Study|Adverse Event|2|||
124652378|NCT04340843|448346228|FG000|Overall Study|Withdrawal by Subject|0|||
124652379|NCT04340843|448346229|FG001|Overall Study|Withdrawal by Subject|2|||
124652380|NCT04249622|448346230|FG000|Overall Study|Withdrawal by Subject|1|||
124652381|NCT04249622|448346231|FG001|Overall Study|Withdrawal by Subject|1|||
124652382|NCT04249622|448346230|FG000|Overall Study|Alternative therapy|1|||
124652383|NCT04249622|448346231|FG001|Overall Study|Alternative therapy|0|||
124652384|NCT04249622|448346230|FG000|Overall Study|Discontinuation of pertuzumab|1|||
124652385|NCT04249622|448346231|FG001|Overall Study|Discontinuation of pertuzumab|0|||
124652386|NCT03689543|448346235|FG000|Overall Study|Adverse Event|0|||
124652387|NCT03689543|448346236|FG001|Overall Study|Adverse Event|0|||
124652388|NCT03689543|448346237|FG002|Overall Study|Adverse Event|1|||
124652389|NCT01634659|448346238|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
124652390|NCT01634659|448346239|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
124652391|NCT01634659|448346238|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
124652392|NCT01634659|448346239|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
124652393|NCT03627416|448346240|FG000|Overall Study|Adverse Event|0|||
124652394|NCT03627416|448346241|FG001|Overall Study|Adverse Event|1|||
124652395|NCT03619902|448346243|FG000|Overall Study|Termination of Study by Investigator|1|||
124652396|NCT03619902|448346243|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
124652397|NCT05625477|448347953|FG000|Overall Study|Lost to Follow-up|2|||
124652398|NCT05625477|448347954|FG001|Overall Study|Lost to Follow-up|2|||
124652399|NCT05625477|448347955|FG002|Overall Study|Lost to Follow-up|1|||
124652400|NCT05625477|448347956|FG003|Overall Study|Lost to Follow-up|1|||
124652401|NCT05625477|448347957|FG004|Overall Study|Lost to Follow-up|0|||
124652402|NCT05625477|448347953|FG000|Overall Study|Covid quarantine|1|||
124652403|NCT05625477|448347954|FG001|Overall Study|Covid quarantine|0|||
124652404|NCT05625477|448347955|FG002|Overall Study|Covid quarantine|0|||
124652405|NCT05625477|448347956|FG003|Overall Study|Covid quarantine|0|||
124652406|NCT05625477|448347957|FG004|Overall Study|Covid quarantine|0|||
124652407|NCT02502266|448347958|FG000|Overall Study|Adverse Event|0|||
124652408|NCT02502266|448347959|FG001|Overall Study|Adverse Event|0|||
124652409|NCT02502266|448347960|FG002|Overall Study|Adverse Event|0|||
124652410|NCT02502266|448347961|FG003|Overall Study|Adverse Event|0|||
124652411|NCT02502266|448347962|FG004|Overall Study|Adverse Event|1|||
124652412|NCT02502266|448347963|FG005|Overall Study|Adverse Event|1|||
124652413|NCT02502266|448347964|FG006|Overall Study|Adverse Event|1|||
124652414|NCT02502266|448347958|FG000|Overall Study|Withdrawal by Subject|30|||
124652415|NCT02502266|448347959|FG001|Overall Study|Withdrawal by Subject|15|||
124652416|NCT02502266|448347960|FG002|Overall Study|Withdrawal by Subject|16|||
124652417|NCT02502266|448347961|FG003|Overall Study|Withdrawal by Subject|0|||
124652418|NCT02502266|448347962|FG004|Overall Study|Withdrawal by Subject|0|||
124652419|NCT02502266|448347963|FG005|Overall Study|Withdrawal by Subject|0|||
124652420|NCT02502266|448347964|FG006|Overall Study|Withdrawal by Subject|0|||
124652421|NCT02502266|448347958|FG000|Overall Study|Still on Treatment|0|||
124652422|NCT02502266|448347959|FG001|Overall Study|Still on Treatment|0|||
124652423|NCT02502266|448347960|FG002|Overall Study|Still on Treatment|1|||
124652424|NCT02502266|448347961|FG003|Overall Study|Still on Treatment|0|||
124652425|NCT02502266|448347962|FG004|Overall Study|Still on Treatment|0|||
124652426|NCT02502266|448347963|FG005|Overall Study|Still on Treatment|0|||
124652427|NCT02502266|448347964|FG006|Overall Study|Still on Treatment|0|||
124652428|NCT02502266|448347958|FG000|Overall Study|Other Reasons|19|||
124652429|NCT02502266|448347959|FG001|Overall Study|Other Reasons|6|||
124652430|NCT02502266|448347960|FG002|Overall Study|Other Reasons|14|||
124652431|NCT02502266|448347961|FG003|Overall Study|Other Reasons|0|||
124652432|NCT02502266|448347962|FG004|Overall Study|Other Reasons|1|||
124652433|NCT02502266|448347963|FG005|Overall Study|Other Reasons|1|||
124652434|NCT02502266|448347964|FG006|Overall Study|Other Reasons|0|||
124652435|NCT02502266|448347958|FG000|Overall Study|Arm 4 Discontinued|0|||
124652436|NCT02502266|448347959|FG001|Overall Study|Arm 4 Discontinued|0|||
124652437|NCT02502266|448347960|FG002|Overall Study|Arm 4 Discontinued|0|||
124652438|NCT02502266|448347961|FG003|Overall Study|Arm 4 Discontinued|52|||
124652439|NCT02502266|448347962|FG004|Overall Study|Arm 4 Discontinued|0|||
124652440|NCT02502266|448347963|FG005|Overall Study|Arm 4 Discontinued|0|||
124652441|NCT02502266|448347964|FG006|Overall Study|Arm 4 Discontinued|0|||
124652442|NCT02502266|448347958|FG000|Overall Study|Never treated|0|||
124652443|NCT02502266|448347959|FG001|Overall Study|Never treated|0|||
124652444|NCT02502266|448347960|FG002|Overall Study|Never treated|0|||
124652445|NCT02502266|448347961|FG003|Overall Study|Never treated|0|||
124652446|NCT02502266|448347962|FG004|Overall Study|Never treated|0|||
124652447|NCT02502266|448347963|FG005|Overall Study|Never treated|1|||
124652448|NCT02502266|448347964|FG006|Overall Study|Never treated|0|||
124652449|NCT02327013|448347965|FG000|Overall Study|Adverse Event|4|||
124652450|NCT02327013|448347966|FG001|Overall Study|Adverse Event|4|||
124652451|NCT02327013|448347967|FG002|Overall Study|Adverse Event|3|||
124652452|NCT02327013|448347968|FG003|Overall Study|Adverse Event|0|||
124652453|NCT02327013|448347969|FG004|Overall Study|Adverse Event|1|||
124652454|NCT02327013|448347965|FG000|Overall Study|Lack of Efficacy|2|||
124652455|NCT02327013|448347966|FG001|Overall Study|Lack of Efficacy|0|||
124652456|NCT02327013|448347967|FG002|Overall Study|Lack of Efficacy|5|||
124652457|NCT02327013|448347968|FG003|Overall Study|Lack of Efficacy|0|||
124652458|NCT02327013|448347969|FG004|Overall Study|Lack of Efficacy|1|||
124652459|NCT02327013|448347965|FG000|Overall Study|Non-compliance with IMP|1|||
124652460|NCT02327013|448347966|FG001|Overall Study|Non-compliance with IMP|2|||
124652461|NCT02327013|448347967|FG002|Overall Study|Non-compliance with IMP|7|||
124652462|NCT02327013|448347968|FG003|Overall Study|Non-compliance with IMP|0|||
124652463|NCT02327013|448347969|FG004|Overall Study|Non-compliance with IMP|0|||
124652464|NCT02327013|448347965|FG000|Overall Study|Withdrawal of Consent|1|||
124652465|NCT02327013|448347966|FG001|Overall Study|Withdrawal of Consent|0|||
124652466|NCT02327013|448347967|FG002|Overall Study|Withdrawal of Consent|3|||
124652467|NCT02327013|448347968|FG003|Overall Study|Withdrawal of Consent|0|||
124652468|NCT02327013|448347969|FG004|Overall Study|Withdrawal of Consent|0|||
124652469|NCT02327013|448347965|FG000|Overall Study|Lost to Follow-up|2|||
124652470|NCT02327013|448347966|FG001|Overall Study|Lost to Follow-up|4|||
124652471|NCT02327013|448347967|FG002|Overall Study|Lost to Follow-up|5|||
124652472|NCT02327013|448347968|FG003|Overall Study|Lost to Follow-up|0|||
124652473|NCT02327013|448347969|FG004|Overall Study|Lost to Follow-up|0|||
124652474|NCT02327013|448347965|FG000|Overall Study|Administrative or other reason(s)|1|||
124652475|NCT02327013|448347966|FG001|Overall Study|Administrative or other reason(s)|5|||
124652476|NCT02327013|448347967|FG002|Overall Study|Administrative or other reason(s)|11|||
124652477|NCT02327013|448347968|FG003|Overall Study|Administrative or other reason(s)|1|||
124652478|NCT02327013|448347969|FG004|Overall Study|Administrative or other reason(s)|1|||
124652479|NCT02327013|448347965|FG000|Overall Study|Protocol Violation|0|||
124652480|NCT02327013|448347966|FG001|Overall Study|Protocol Violation|0|||
124652481|NCT02327013|448347967|FG002|Overall Study|Protocol Violation|3|||
124652482|NCT02327013|448347968|FG003|Overall Study|Protocol Violation|0|||
124652483|NCT02327013|448347969|FG004|Overall Study|Protocol Violation|1|||
124652484|NCT02327013|448347965|FG000|Overall Study|Withdrawal before treatment|2|||
124652485|NCT02327013|448347966|FG001|Overall Study|Withdrawal before treatment|1|||
124652486|NCT02327013|448347967|FG002|Overall Study|Withdrawal before treatment|5|||
124652487|NCT02327013|448347968|FG003|Overall Study|Withdrawal before treatment|0|||
124652488|NCT02327013|448347969|FG004|Overall Study|Withdrawal before treatment|0|||
124652489|NCT04829331|448347970|FG000|Overall Study|Lost to Follow-up|1|||
124652490|NCT04829331|448347971|FG001|Overall Study|Lost to Follow-up|0|||
124652491|NCT03435224|448347972|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
124652492|NCT00367484|448347975|FG000|Overall Study|Adverse Event|7|||
124652493|NCT00367484|448347975|FG000|Overall Study|Withdrew informed consent|5|||
124652494|NCT00367484|448347975|FG000|Overall Study|Travel to USA|1|||
124652495|NCT00367484|448347975|FG000|Overall Study|Lost to Follow-up|1|||
124652496|NCT00367484|448347975|FG000|Overall Study|Protocol Violation|1|||
124652497|NCT00367484|448347975|FG000|Overall Study|The choice of the patient|1|||
124652498|NCT00367484|448347975|FG000|Overall Study|Lack of Efficacy|1|||
124652499|NCT01404208|448347976|FG000|Overall Study|Discontinued|3|||
124652500|NCT01404208|448347977|FG001|Overall Study|Discontinued|0|||
124652501|NCT04007107|448347980|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
124652502|NCT04007107|448347981|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
124652503|NCT04007107|448347982|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
124652504|NCT04007107|448347983|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
124652505|NCT04068688|448347984|FG000|Overall Study|Lost to Follow-up|1|||
124652506|NCT04068688|448347985|FG001|Overall Study|Lost to Follow-up|1|||
124652507|NCT04068688|448347986|FG002|Overall Study|Lost to Follow-up|0|||
124652508|NCT04068688|448347987|FG003|Overall Study|Lost to Follow-up|0|||
124652509|NCT04068688|448347988|FG004|Overall Study|Lost to Follow-up|5|||
124652510|NCT04068688|448347989|FG005|Overall Study|Lost to Follow-up|5|||
124652511|NCT04068688|448347990|FG006|Overall Study|Lost to Follow-up|0|||
124652512|NCT04068688|448347991|FG007|Overall Study|Lost to Follow-up|0|||
124652513|NCT04068688|448347992|FG008|Overall Study|Lost to Follow-up|1|||
124652514|NCT04068688|448347993|FG009|Overall Study|Lost to Follow-up|0|||
124652515|NCT04068688|448347984|FG000|Overall Study|Withdrawal by Subject|1|||
124652516|NCT04068688|448347985|FG001|Overall Study|Withdrawal by Subject|1|||
124652517|NCT04068688|448347986|FG002|Overall Study|Withdrawal by Subject|0|||
124652518|NCT04068688|448347987|FG003|Overall Study|Withdrawal by Subject|0|||
124652519|NCT04068688|448347988|FG004|Overall Study|Withdrawal by Subject|0|||
124652520|NCT04068688|448347989|FG005|Overall Study|Withdrawal by Subject|0|||
124652521|NCT04068688|448347990|FG006|Overall Study|Withdrawal by Subject|0|||
124652522|NCT04068688|448347991|FG007|Overall Study|Withdrawal by Subject|0|||
124652523|NCT04068688|448347992|FG008|Overall Study|Withdrawal by Subject|0|||
124652524|NCT04068688|448347993|FG009|Overall Study|Withdrawal by Subject|0|||
124652525|NCT04068688|448347984|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
124652526|NCT04068688|448347985|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
124652527|NCT04068688|448347986|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
124652528|NCT04068688|448347987|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
124652529|NCT04068688|448347988|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
124652530|NCT04068688|448347989|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
124652531|NCT04068688|448347990|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
124652532|NCT04068688|448347991|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
124652533|NCT04068688|448347992|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
124652534|NCT04068688|448347993|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
124652535|NCT04679051|448347994|FG000|Overall Study|felt tired after restricted time in bed|3|||
124652536|NCT04679051|448347995|FG001|Overall Study|felt tired after restricted time in bed|0|||
124652537|NCT04679051|448347994|FG000|Overall Study|discomfort with blood pressure cuff|2|||
124652538|NCT04679051|448347995|FG001|Overall Study|discomfort with blood pressure cuff|0|||
124652539|NCT04679051|448347994|FG000|Overall Study|scheduling conflict|1|||
124652540|NCT04679051|448347995|FG001|Overall Study|scheduling conflict|1|||
124652541|NCT04679051|448347994|FG000|Overall Study|Protocol Violation|0|||
124652542|NCT04679051|448347995|FG001|Overall Study|Protocol Violation|4|||
124652543|NCT02772276|448347997|FG000|Overall Study|Lost to Follow-up|0|||
124652544|NCT02772276|448347998|FG001|Overall Study|Lost to Follow-up|0|||
124652545|NCT02772276|448347999|FG002|Overall Study|Lost to Follow-up|0|||
124652546|NCT02772276|448348000|FG003|Overall Study|Lost to Follow-up|0|||
124652547|NCT02772276|448348001|FG004|Overall Study|Lost to Follow-up|0|||
124652548|NCT02772276|448348002|FG005|Overall Study|Lost to Follow-up|0|||
124652549|NCT02772276|448348003|FG006|Overall Study|Lost to Follow-up|1|||
124652550|NCT02772276|448348004|FG007|Overall Study|Lost to Follow-up|0|||
124652551|NCT02772276|448348005|FG008|Overall Study|Lost to Follow-up|0|||
124652552|NCT02772276|448348006|FG009|Overall Study|Lost to Follow-up|0|||
124652553|NCT02772276|448348007|FG010|Overall Study|Lost to Follow-up|0|||
124652554|NCT02772276|448348008|FG011|Overall Study|Lost to Follow-up|0|||
124652555|NCT02772276|448348009|FG012|Overall Study|Lost to Follow-up|0|||
124652556|NCT02772276|448347997|FG000|Overall Study|Withdrew consent|0|||
124652557|NCT02772276|448347998|FG001|Overall Study|Withdrew consent|0|||
124652558|NCT02772276|448347999|FG002|Overall Study|Withdrew consent|0|||
124652559|NCT02772276|448348000|FG003|Overall Study|Withdrew consent|0|||
124652560|NCT02772276|448348001|FG004|Overall Study|Withdrew consent|0|||
124652561|NCT02772276|448348002|FG005|Overall Study|Withdrew consent|0|||
124652562|NCT02772276|448348003|FG006|Overall Study|Withdrew consent|0|||
124652563|NCT02772276|448348004|FG007|Overall Study|Withdrew consent|1|||
124652564|NCT02772276|448348005|FG008|Overall Study|Withdrew consent|0|||
124652565|NCT02772276|448348006|FG009|Overall Study|Withdrew consent|0|||
124652566|NCT02772276|448348007|FG010|Overall Study|Withdrew consent|0|||
124652567|NCT02772276|448348008|FG011|Overall Study|Withdrew consent|0|||
124652568|NCT02772276|448348009|FG012|Overall Study|Withdrew consent|0|||
124652569|NCT00455520|448348010|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
124652570|NCT00455520|448348011|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
124652571|NCT00455520|448348010|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
124652572|NCT00455520|448348011|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
124652573|NCT00455520|448348010|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
124652574|NCT00455520|448348011|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
124652575|NCT00455520|448348010|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
124652576|NCT00455520|448348011|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
124652577|NCT00455520|448348010|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
124652578|NCT00455520|448348011|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
124652579|NCT00455520|448348010|FG000|Open Label Tapentadol Extended Release|All other|33|||
124652580|NCT00455520|448348011|FG001|Open Label Tapentadol Extended Release|All other|0|||
124652581|NCT00455520|448348010|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
124652582|NCT00455520|448348011|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
124652583|NCT00455520|448348010|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
124652584|NCT00455520|448348011|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
124652585|NCT00455520|448348010|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
124652586|NCT00455520|448348011|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
124652587|NCT00455520|448348010|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
124652588|NCT00455520|448348011|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
124652589|NCT00455520|448348010|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
124652590|NCT00455520|448348011|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
124652591|NCT00455520|448348010|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
124652592|NCT00455520|448348011|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
124652593|NCT02248974|448348013|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
124652594|NCT02248974|448348014|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
124652595|NCT02248974|448348013|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
124652596|NCT02248974|448348014|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
124652597|NCT02248974|448348013|FG000|1-Day Follow-Up|Enrolled in another study|1|||
124652598|NCT02248974|448348014|FG001|1-Day Follow-Up|Enrolled in another study|0|||
124652599|NCT02248974|448348013|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
124652600|NCT02248974|448348014|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
124652601|NCT02248974|448348013|FG000|1-Week Follow-Up|Enrolled in another study|1|||
124652602|NCT02248974|448348014|FG001|1-Week Follow-Up|Enrolled in another study|1|||
124652603|NCT02248974|448348013|FG000|1-Week Follow-Up|Transferred to another facility|1|||
124652604|NCT02248974|448348014|FG001|1-Week Follow-Up|Transferred to another facility|0|||
124652605|NCT02248974|448348013|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
124652606|NCT02248974|448348014|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
124652607|NCT02248974|448348013|FG000|1-Week Follow-Up|Death|1|||
124652608|NCT02248974|448348014|FG001|1-Week Follow-Up|Death|1|||
124652609|NCT02248974|448348013|FG000|1-Week Follow-Up|Excluded because of age|0|||
124652610|NCT02248974|448348014|FG001|1-Week Follow-Up|Excluded because of age|1|||
124652611|NCT02248974|448348013|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
124652612|NCT02248974|448348014|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
124652613|NCT02248974|448348013|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
124652614|NCT02248974|448348014|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
124652615|NCT02248974|448348013|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
124652616|NCT02248974|448348014|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
124652617|NCT02248974|448348013|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
124652618|NCT02248974|448348014|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
124652619|NCT02248974|448348013|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
124652620|NCT02248974|448348014|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
124652621|NCT02332239|448348015|FG000|Overall Study|Lost to Follow-up|4|||
124652622|NCT02332239|448348016|FG001|Overall Study|Lost to Follow-up|6|||
124652623|NCT03448939|448348017|FG000|Overall Study|Adverse Event|5|||
124872813|NCT00500903|449155771|FG002|Overall Study|Patient Declined Further Treatment|3|||
124872814|NCT00500903|449155769|FG000|Overall Study|Symptomatic Deterioration|2|||
124652624|NCT03448939|448348018|FG001|Overall Study|Adverse Event|1|||
124652625|NCT03448939|448348017|FG000|Overall Study|Lost to Follow-up|6|||
124652626|NCT03448939|448348018|FG001|Overall Study|Lost to Follow-up|6|||
124652627|NCT03448939|448348017|FG000|Overall Study|Pregnancy|1|||
124652628|NCT03448939|448348018|FG001|Overall Study|Pregnancy|1|||
124652629|NCT03448939|448348017|FG000|Overall Study|Withdrawal by Subject|9|||
124652630|NCT03448939|448348018|FG001|Overall Study|Withdrawal by Subject|3|||
124652631|NCT00628095|448348019|FG000|Overall Study|Adverse Event|5|||
124652632|NCT00628095|448348020|FG001|Overall Study|Adverse Event|3|||
124652633|NCT00628095|448348019|FG000|Overall Study|Lack of Efficacy|0|||
124652634|NCT00628095|448348020|FG001|Overall Study|Lack of Efficacy|3|||
124652635|NCT00628095|448348019|FG000|Overall Study|Withdrawal by Subject|2|||
124652636|NCT00628095|448348020|FG001|Overall Study|Withdrawal by Subject|0|||
124652637|NCT00628095|448348019|FG000|Overall Study|Other|0|||
124652638|NCT00628095|448348020|FG001|Overall Study|Other|1|||
124652639|NCT03235115|448348024|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
124652640|NCT03235115|448348025|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
124652641|NCT03235115|448348026|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
124652642|NCT03235115|448348027|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
124652643|NCT03235115|448348028|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
124652644|NCT03235115|448348029|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
124652645|NCT00006305|448348030|FG000|Overall Study|Withdrawal by Subject|17|||
124652646|NCT00006305|448348031|FG001|Overall Study|Withdrawal by Subject|10|||
124652647|NCT00006305|448348032|FG002|Overall Study|Withdrawal by Subject|15|||
124652648|NCT00006305|448348033|FG003|Overall Study|Withdrawal by Subject|14|||
124652649|NCT00662558|448348034|FG000|Overall Study|Adverse Event|21|||
124652650|NCT00662558|448348035|FG001|Overall Study|Adverse Event|59|||
124652651|NCT00662558|448348034|FG000|Overall Study|Lack of Efficacy|4|||
124652652|NCT00662558|448348035|FG001|Overall Study|Lack of Efficacy|7|||
124652653|NCT00662558|448348034|FG000|Overall Study|Lost to Follow-up|13|||
124652654|NCT00662558|448348035|FG001|Overall Study|Lost to Follow-up|10|||
124652655|NCT00662558|448348034|FG000|Overall Study|Other|9|||
124652656|NCT00662558|448348035|FG001|Overall Study|Other|14|||
124652657|NCT00662558|448348034|FG000|Overall Study|Withdrawal by Subject|7|||
124652658|NCT00662558|448348035|FG001|Overall Study|Withdrawal by Subject|12|||
124652659|NCT00662558|448348034|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
124652660|NCT00662558|448348035|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
124652661|NCT00329641|448348036|FG000|Overall Study|Did not start treatment|1|||
124652662|NCT00329641|448348036|FG000|Overall Study|Not eligible|1|||
124652663|NCT00329641|448348036|FG000|Overall Study|Adverse Event|3|||
124652664|NCT00329641|448348036|FG000|Overall Study|Other reason, not protocol specified|1|||
124652665|NCT00115037|448348037|FG000|Phase1|Lost to Follow-up|16|||
124652666|NCT00115037|448348038|FG001|Phase1|Lost to Follow-up|23|||
124652667|NCT00115037|448348039|FG002|Phase1|Lost to Follow-up|0|||
124652668|NCT00115037|448348040|FG003|Phase1|Lost to Follow-up|0|||
124652669|NCT00115037|448348041|FG004|Phase1|Lost to Follow-up|0|||
124652670|NCT00115037|448348042|FG005|Phase1|Lost to Follow-up|0|||
124652671|NCT00115037|448348037|FG000|Phase1|Withdrawal by Subject|9|||
124652672|NCT00115037|448348038|FG001|Phase1|Withdrawal by Subject|4|||
124652673|NCT00115037|448348039|FG002|Phase1|Withdrawal by Subject|0|||
124652674|NCT00115037|448348040|FG003|Phase1|Withdrawal by Subject|0|||
124652675|NCT00115037|448348041|FG004|Phase1|Withdrawal by Subject|0|||
124652676|NCT00115037|448348042|FG005|Phase1|Withdrawal by Subject|0|||
124652677|NCT00115037|448348037|FG000|Phase2|Death|0|||
124652678|NCT00115037|448348038|FG001|Phase2|Death|0|||
124652679|NCT00115037|448348039|FG002|Phase2|Death|1|||
124652680|NCT00115037|448348040|FG003|Phase2|Death|0|||
124652681|NCT00115037|448348041|FG004|Phase2|Death|0|||
124652682|NCT00115037|448348042|FG005|Phase2|Death|1|||
124652683|NCT00115037|448348037|FG000|Phase2|Withdrawal by Subject|0|||
124652684|NCT00115037|448348038|FG001|Phase2|Withdrawal by Subject|0|||
124652685|NCT00115037|448348039|FG002|Phase2|Withdrawal by Subject|2|||
124652686|NCT00115037|448348040|FG003|Phase2|Withdrawal by Subject|1|||
124652687|NCT00115037|448348041|FG004|Phase2|Withdrawal by Subject|2|||
124652688|NCT00115037|448348042|FG005|Phase2|Withdrawal by Subject|1|||
124652689|NCT00115037|448348037|FG000|Phase2|Lost to Follow-up|0|||
124652690|NCT00115037|448348038|FG001|Phase2|Lost to Follow-up|0|||
124652691|NCT00115037|448348039|FG002|Phase2|Lost to Follow-up|12|||
124652692|NCT00115037|448348040|FG003|Phase2|Lost to Follow-up|14|||
124652693|NCT00115037|448348041|FG004|Phase2|Lost to Follow-up|4|||
124652694|NCT00115037|448348042|FG005|Phase2|Lost to Follow-up|10|||
124652695|NCT00396877|448348043|FG000|Overall Study|Lost to Follow-up|2|||
124652696|NCT00396877|448348044|FG001|Overall Study|Lost to Follow-up|1|||
124652697|NCT00396877|448348043|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
124652698|NCT00396877|448348044|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
124652699|NCT00783224|448348047|FG000|Overall Study|Adverse Event|0|||
124652700|NCT00783224|448348048|FG001|Overall Study|Adverse Event|0|||
124652701|NCT00783224|448348049|FG002|Overall Study|Adverse Event|1|||
124652702|NCT00783224|448348050|FG003|Overall Study|Adverse Event|0|||
124652703|NCT00783224|448348047|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
124652704|NCT00783224|448348048|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
124652705|NCT00783224|448348049|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
124652706|NCT00783224|448348050|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
124652707|NCT00783224|448348047|FG000|Overall Study|Inappropriate as a study subject|0|||
124652708|NCT00783224|448348048|FG001|Overall Study|Inappropriate as a study subject|0|||
124652709|NCT00783224|448348049|FG002|Overall Study|Inappropriate as a study subject|0|||
124652710|NCT00783224|448348050|FG003|Overall Study|Inappropriate as a study subject|1|||
124652711|NCT01711619|448348051|FG000|Overall Study|Early study termination|10|||
124652712|NCT01711619|448348052|FG001|Overall Study|Early study termination|14|||
124652713|NCT01711619|448348051|FG000|Overall Study|Withdrawal by Subject|3|||
124652714|NCT01711619|448348052|FG001|Overall Study|Withdrawal by Subject|7|||
124652715|NCT01711619|448348051|FG000|Overall Study|Protocol Violation|2|||
124652716|NCT01711619|448348052|FG001|Overall Study|Protocol Violation|3|||
124652717|NCT01711619|448348051|FG000|Overall Study|Adverse Event|2|||
124652718|NCT01711619|448348052|FG001|Overall Study|Adverse Event|0|||
124652719|NCT01711619|448348051|FG000|Overall Study|Lost to Follow-up|1|||
124652720|NCT01711619|448348052|FG001|Overall Study|Lost to Follow-up|0|||
124652721|NCT03422159|448348053|FG000|Overall Study|Exclusion due to terminal disease|2|||
124652722|NCT03422159|448348054|FG001|Overall Study|Exclusion due to terminal disease|1|||
124652723|NCT02631070|448348055|FG000|Overall Study|Withdrawal by Subject|35|||
124652724|NCT02631070|448348056|FG001|Overall Study|Withdrawal by Subject|13|||
124652725|NCT02631070|448348055|FG000|Overall Study|Death|45|||
124652726|NCT02631070|448348056|FG001|Overall Study|Death|24|||
124652727|NCT02631070|448348055|FG000|Overall Study|Lost to Follow-up|5|||
124652728|NCT02631070|448348056|FG001|Overall Study|Lost to Follow-up|1|||
124652729|NCT02631070|448348055|FG000|Overall Study|Transition to rollover protocol|52|||
124652730|NCT02631070|448348056|FG001|Overall Study|Transition to rollover protocol|21|||
124652731|NCT02631070|448348055|FG000|Overall Study|Other reasons|12|||
124652732|NCT02631070|448348056|FG001|Overall Study|Other reasons|5|||
124652733|NCT00087126|448348060|FG000|Overall Study|Ineligible - second primary|1|||
124652734|NCT00087126|448348060|FG000|Overall Study|Never treated|1|||
124652735|NCT00934856|448348063|FG000|Feasibility Part|Progressive disease|4|||
124652736|NCT00934856|448348064|FG001|Feasibility Part|Progressive disease|4|||
124652737|NCT00934856|448348065|FG002|Feasibility Part|Progressive disease|2|||
124652738|NCT00934856|448348066|FG003|Feasibility Part|Progressive disease|3|||
124652739|NCT00934856|448348067|FG004|Feasibility Part|Progressive disease|0|||
124652740|NCT00934856|448348068|FG005|Feasibility Part|Progressive disease|0|||
124652741|NCT00934856|448348063|FG000|Feasibility Part|Physician Decision|0|||
124652742|NCT00934856|448348064|FG001|Feasibility Part|Physician Decision|0|||
124652743|NCT00934856|448348065|FG002|Feasibility Part|Physician Decision|1|||
124652744|NCT00934856|448348066|FG003|Feasibility Part|Physician Decision|0|||
124652745|NCT00934856|448348067|FG004|Feasibility Part|Physician Decision|0|||
124652746|NCT00934856|448348068|FG005|Feasibility Part|Physician Decision|0|||
124652747|NCT00934856|448348063|FG000|Feasibility Part|Adverse Event|1|||
124652748|NCT00934856|448348064|FG001|Feasibility Part|Adverse Event|1|||
124652749|NCT00934856|448348065|FG002|Feasibility Part|Adverse Event|0|||
124652750|NCT00934856|448348066|FG003|Feasibility Part|Adverse Event|1|||
124652751|NCT00934856|448348067|FG004|Feasibility Part|Adverse Event|0|||
124652752|NCT00934856|448348068|FG005|Feasibility Part|Adverse Event|2|||
124652753|NCT00934856|448348063|FG000|Feasibility Part|Withdrawal by Subject|0|||
124652754|NCT00934856|448348064|FG001|Feasibility Part|Withdrawal by Subject|0|||
124652755|NCT00934856|448348065|FG002|Feasibility Part|Withdrawal by Subject|0|||
124652756|NCT00934856|448348066|FG003|Feasibility Part|Withdrawal by Subject|1|||
124652757|NCT00934856|448348067|FG004|Feasibility Part|Withdrawal by Subject|0|||
124652758|NCT00934856|448348068|FG005|Feasibility Part|Withdrawal by Subject|1|||
124652759|NCT00934856|448348063|FG000|Extension Part|Adverse Event|0|||
124652760|NCT00934856|448348064|FG001|Extension Part|Adverse Event|0|||
124652761|NCT00934856|448348065|FG002|Extension Part|Adverse Event|0|||
124652762|NCT00934856|448348066|FG003|Extension Part|Adverse Event|1|||
124652763|NCT00934856|448348067|FG004|Extension Part|Adverse Event|4|||
124652764|NCT00934856|448348068|FG005|Extension Part|Adverse Event|4|||
124652765|NCT00934856|448348063|FG000|Extension Part|Progressive disease|0|||
124652766|NCT00934856|448348064|FG001|Extension Part|Progressive disease|0|||
124652767|NCT00934856|448348065|FG002|Extension Part|Progressive disease|0|||
124652768|NCT00934856|448348066|FG003|Extension Part|Progressive disease|1|||
124652769|NCT00934856|448348067|FG004|Extension Part|Progressive disease|0|||
124652770|NCT00934856|448348068|FG005|Extension Part|Progressive disease|0|||
124652771|NCT00934856|448348063|FG000|Extension Part|Non-compliance with drug|0|||
124652772|NCT00934856|448348064|FG001|Extension Part|Non-compliance with drug|0|||
124652773|NCT00934856|448348065|FG002|Extension Part|Non-compliance with drug|0|||
124652774|NCT00934856|448348066|FG003|Extension Part|Non-compliance with drug|0|||
124652775|NCT00934856|448348067|FG004|Extension Part|Non-compliance with drug|0|||
124652776|NCT00934856|448348068|FG005|Extension Part|Non-compliance with drug|1|||
124652777|NCT01273155|448348076|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
124652778|NCT01273155|448348077|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
124652779|NCT01273155|448348078|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
124652780|NCT01273155|448348079|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
124652781|NCT01273155|448348080|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
124652782|NCT01273155|448348081|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
124652783|NCT01273155|448348082|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
124652784|NCT01273155|448348076|FG000|Overall Study|Change in liver function/no longer eval.|0|||
124652785|NCT01273155|448348077|FG001|Overall Study|Change in liver function/no longer eval.|1|||
124652786|NCT01273155|448348078|FG002|Overall Study|Change in liver function/no longer eval.|0|||
124652787|NCT01273155|448348079|FG003|Overall Study|Change in liver function/no longer eval.|0|||
124652788|NCT01273155|448348080|FG004|Overall Study|Change in liver function/no longer eval.|1|||
124652789|NCT01273155|448348081|FG005|Overall Study|Change in liver function/no longer eval.|0|||
124652790|NCT01273155|448348082|FG006|Overall Study|Change in liver function/no longer eval.|0|||
124652791|NCT01273155|448348076|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
124652792|NCT01273155|448348077|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
124652793|NCT01273155|448348078|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
124652794|NCT01273155|448348079|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
124652795|NCT01273155|448348080|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
124652796|NCT01273155|448348081|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
124652797|NCT01273155|448348082|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
124652798|NCT01273155|448348076|FG000|Overall Study|Died during Cycle 1|0|||
124652799|NCT01273155|448348077|FG001|Overall Study|Died during Cycle 1|0|||
124652800|NCT01273155|448348078|FG002|Overall Study|Died during Cycle 1|1|||
124652801|NCT01273155|448348079|FG003|Overall Study|Died during Cycle 1|1|||
124652802|NCT01273155|448348080|FG004|Overall Study|Died during Cycle 1|0|||
124652803|NCT01273155|448348081|FG005|Overall Study|Died during Cycle 1|2|||
124652804|NCT01273155|448348082|FG006|Overall Study|Died during Cycle 1|2|||
124652805|NCT01273155|448348076|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
124652806|NCT01273155|448348077|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
124652807|NCT01273155|448348078|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
124652808|NCT01273155|448348079|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
124652809|NCT01273155|448348080|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
124652810|NCT01273155|448348081|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
124652811|NCT01273155|448348082|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
124652812|NCT00401960|448348083|FG000|Overall Study|Lost to Follow-up|3|||
124652813|NCT00401960|448348084|FG001|Overall Study|Lost to Follow-up|0|||
124652814|NCT00401960|448348083|FG000|Overall Study|Death|2|||
124652815|NCT00401960|448348084|FG001|Overall Study|Death|0|||
124652816|NCT02649426|448348085|FG000|Overall Study|Follow-up on going|1|||
124652817|NCT02649426|448348086|FG001|Overall Study|Follow-up on going|26|||
124652818|NCT02649426|448348087|FG002|Overall Study|Follow-up on going|28|||
124652819|NCT02649426|448348088|FG003|Overall Study|Follow-up on going|31|||
124652820|NCT00195494|448348089|FG000|Year 1|Adverse Event|0|||
124652821|NCT00195494|448348090|FG001|Year 1|Adverse Event|0|||
124652822|NCT00195494|448348091|FG002|Year 1|Adverse Event|0|||
124652823|NCT00195494|448348092|FG003|Year 1|Adverse Event|0|||
124652824|NCT00195494|448348093|FG004|Year 1|Adverse Event|34|||
124652825|NCT00195494|448348094|FG005|Year 1|Adverse Event|27|||
124652826|NCT00195494|448348089|FG000|Year 1|System Toxicity|0|||
124652827|NCT00195494|448348090|FG001|Year 1|System Toxicity|0|||
124652828|NCT00195494|448348091|FG002|Year 1|System Toxicity|0|||
124652829|NCT00195494|448348092|FG003|Year 1|System Toxicity|0|||
124652830|NCT00195494|448348093|FG004|Year 1|System Toxicity|0|||
124652831|NCT00195494|448348094|FG005|Year 1|System Toxicity|1|||
124652832|NCT00195494|448348089|FG000|Year 1|Lack of Efficacy|0|||
124652833|NCT00195494|448348090|FG001|Year 1|Lack of Efficacy|0|||
124652834|NCT00195494|448348091|FG002|Year 1|Lack of Efficacy|0|||
124652835|NCT00195494|448348092|FG003|Year 1|Lack of Efficacy|0|||
124652836|NCT00195494|448348093|FG004|Year 1|Lack of Efficacy|24|||
124652837|NCT00195494|448348094|FG005|Year 1|Lack of Efficacy|9|||
124652838|NCT00195494|448348089|FG000|Year 1|Compliance|0|||
124652839|NCT00195494|448348090|FG001|Year 1|Compliance|0|||
124652840|NCT00195494|448348091|FG002|Year 1|Compliance|0|||
124652841|NCT00195494|448348092|FG003|Year 1|Compliance|0|||
124652842|NCT00195494|448348093|FG004|Year 1|Compliance|5|||
124652843|NCT00195494|448348094|FG005|Year 1|Compliance|1|||
124652844|NCT00195494|448348089|FG000|Year 1|Lost to Follow-up|0|||
124652845|NCT00195494|448348090|FG001|Year 1|Lost to Follow-up|0|||
124652846|NCT00195494|448348091|FG002|Year 1|Lost to Follow-up|0|||
124652847|NCT00195494|448348092|FG003|Year 1|Lost to Follow-up|0|||
124652848|NCT00195494|448348093|FG004|Year 1|Lost to Follow-up|1|||
124652849|NCT00195494|448348094|FG005|Year 1|Lost to Follow-up|0|||
124652850|NCT00195494|448348089|FG000|Year 1|Missed >4 consecutive doses|0|||
124652851|NCT00195494|448348090|FG001|Year 1|Missed >4 consecutive doses|0|||
124652852|NCT00195494|448348091|FG002|Year 1|Missed >4 consecutive doses|0|||
124652853|NCT00195494|448348092|FG003|Year 1|Missed >4 consecutive doses|0|||
124652854|NCT00195494|448348093|FG004|Year 1|Missed >4 consecutive doses|3|||
124652855|NCT00195494|448348094|FG005|Year 1|Missed >4 consecutive doses|2|||
124652856|NCT00195494|448348089|FG000|Year 1|Protocol deviation|0|||
124652857|NCT00195494|448348090|FG001|Year 1|Protocol deviation|0|||
124652858|NCT00195494|448348091|FG002|Year 1|Protocol deviation|0|||
124652859|NCT00195494|448348092|FG003|Year 1|Protocol deviation|0|||
124652860|NCT00195494|448348093|FG004|Year 1|Protocol deviation|2|||
124652861|NCT00195494|448348094|FG005|Year 1|Protocol deviation|3|||
124652862|NCT00195494|448348089|FG000|Year 1|Physician Decision|0|||
124652863|NCT00195494|448348090|FG001|Year 1|Physician Decision|0|||
124652864|NCT00195494|448348091|FG002|Year 1|Physician Decision|0|||
124652865|NCT00195494|448348092|FG003|Year 1|Physician Decision|0|||
124652866|NCT00195494|448348093|FG004|Year 1|Physician Decision|1|||
124652867|NCT00195494|448348094|FG005|Year 1|Physician Decision|0|||
124652868|NCT00195494|448348089|FG000|Year 1|Withdrawal by Subject|0|||
124652869|NCT00195494|448348090|FG001|Year 1|Withdrawal by Subject|0|||
124652870|NCT00195494|448348091|FG002|Year 1|Withdrawal by Subject|0|||
124652871|NCT00195494|448348092|FG003|Year 1|Withdrawal by Subject|0|||
124652872|NCT00195494|448348093|FG004|Year 1|Withdrawal by Subject|8|||
124652873|NCT00195494|448348094|FG005|Year 1|Withdrawal by Subject|9|||
124652874|NCT00195494|448348089|FG000|Year 1|Protocol Violation|0|||
124652875|NCT00195494|448348090|FG001|Year 1|Protocol Violation|0|||
124652876|NCT00195494|448348091|FG002|Year 1|Protocol Violation|0|||
124652877|NCT00195494|448348092|FG003|Year 1|Protocol Violation|0|||
124652878|NCT00195494|448348093|FG004|Year 1|Protocol Violation|1|||
124652879|NCT00195494|448348094|FG005|Year 1|Protocol Violation|1|||
124652880|NCT00195494|448348089|FG000|Year 2|Adverse Event|3|||
124652881|NCT00195494|448348090|FG001|Year 2|Adverse Event|7|||
124652882|NCT00195494|448348091|FG002|Year 2|Adverse Event|5|||
124652883|NCT00195494|448348092|FG003|Year 2|Adverse Event|9|||
124652884|NCT00195494|448348093|FG004|Year 2|Adverse Event|0|||
124652885|NCT00195494|448348094|FG005|Year 2|Adverse Event|0|||
124652886|NCT00195494|448348089|FG000|Year 2|Lack of Efficacy|0|||
124652887|NCT00195494|448348090|FG001|Year 2|Lack of Efficacy|1|||
124652888|NCT00195494|448348091|FG002|Year 2|Lack of Efficacy|7|||
124652889|NCT00195494|448348092|FG003|Year 2|Lack of Efficacy|7|||
124652890|NCT00195494|448348093|FG004|Year 2|Lack of Efficacy|0|||
124652891|NCT00195494|448348094|FG005|Year 2|Lack of Efficacy|0|||
124652892|NCT00195494|448348089|FG000|Year 2|Compliance|1|||
124652893|NCT00195494|448348090|FG001|Year 2|Compliance|0|||
124652894|NCT00195494|448348091|FG002|Year 2|Compliance|0|||
124652895|NCT00195494|448348092|FG003|Year 2|Compliance|2|||
124652896|NCT00195494|448348093|FG004|Year 2|Compliance|0|||
124652897|NCT00195494|448348094|FG005|Year 2|Compliance|0|||
124652898|NCT00195494|448348089|FG000|Year 2|Lost to Follow-up|0|||
124652899|NCT00195494|448348090|FG001|Year 2|Lost to Follow-up|0|||
124652900|NCT00195494|448348091|FG002|Year 2|Lost to Follow-up|1|||
124652901|NCT00195494|448348092|FG003|Year 2|Lost to Follow-up|1|||
124652902|NCT00195494|448348093|FG004|Year 2|Lost to Follow-up|0|||
124652903|NCT00195494|448348094|FG005|Year 2|Lost to Follow-up|0|||
124652904|NCT00195494|448348089|FG000|Year 2|Missed >4 consecutive doses|1|||
124652905|NCT00195494|448348090|FG001|Year 2|Missed >4 consecutive doses|1|||
124652906|NCT00195494|448348091|FG002|Year 2|Missed >4 consecutive doses|1|||
124652907|NCT00195494|448348092|FG003|Year 2|Missed >4 consecutive doses|0|||
124652908|NCT00195494|448348093|FG004|Year 2|Missed >4 consecutive doses|0|||
124652909|NCT00195494|448348094|FG005|Year 2|Missed >4 consecutive doses|0|||
124652910|NCT00195494|448348089|FG000|Year 2|Protocol deviation|0|||
124652911|NCT00195494|448348090|FG001|Year 2|Protocol deviation|1|||
124652912|NCT00195494|448348091|FG002|Year 2|Protocol deviation|0|||
124652913|NCT00195494|448348092|FG003|Year 2|Protocol deviation|0|||
124652914|NCT00195494|448348093|FG004|Year 2|Protocol deviation|0|||
124652915|NCT00195494|448348094|FG005|Year 2|Protocol deviation|0|||
124652916|NCT00195494|448348089|FG000|Year 2|Physician Decision|1|||
124652917|NCT00195494|448348090|FG001|Year 2|Physician Decision|1|||
124652918|NCT00195494|448348091|FG002|Year 2|Physician Decision|0|||
124652919|NCT00195494|448348092|FG003|Year 2|Physician Decision|0|||
124652920|NCT00195494|448348093|FG004|Year 2|Physician Decision|0|||
124652921|NCT00195494|448348094|FG005|Year 2|Physician Decision|0|||
124652922|NCT00195494|448348089|FG000|Year 2|Withdrawal by Subject|1|||
124652923|NCT00195494|448348090|FG001|Year 2|Withdrawal by Subject|5|||
124652924|NCT00195494|448348091|FG002|Year 2|Withdrawal by Subject|4|||
124652925|NCT00195494|448348092|FG003|Year 2|Withdrawal by Subject|3|||
124652926|NCT00195494|448348093|FG004|Year 2|Withdrawal by Subject|0|||
124652927|NCT00195494|448348094|FG005|Year 2|Withdrawal by Subject|0|||
124652928|NCT00195494|448348089|FG000|Year 2|System toxicity|0|||
124652929|NCT00195494|448348090|FG001|Year 2|System toxicity|0|||
124652930|NCT00195494|448348091|FG002|Year 2|System toxicity|0|||
124652931|NCT00195494|448348092|FG003|Year 2|System toxicity|1|||
124652932|NCT00195494|448348093|FG004|Year 2|System toxicity|0|||
124652933|NCT00195494|448348094|FG005|Year 2|System toxicity|0|||
124652934|NCT00513357|448348095|FG000|Overall Study|did not receive allocated placebo|2|||
124652935|NCT00513357|448348096|FG001|Overall Study|did not receive allocated placebo|3|||
124652936|NCT00513357|448348095|FG000|Overall Study|Adverse Event|4|||
124652937|NCT00513357|448348096|FG001|Overall Study|Adverse Event|2|||
124652938|NCT00513357|448348095|FG000|Overall Study|Death|2|||
124652939|NCT00513357|448348096|FG001|Overall Study|Death|0|||
124652940|NCT00513357|448348095|FG000|Overall Study|Withdrawal by Subject|5|||
124652941|NCT00513357|448348096|FG001|Overall Study|Withdrawal by Subject|4|||
124652942|NCT00513357|448348095|FG000|Overall Study|Disease Progression|2|||
124652943|NCT00513357|448348096|FG001|Overall Study|Disease Progression|1|||
124652944|NCT01217385|448348101|FG000|Overall Study|Withdrawal by Subject|3|||
124652945|NCT01217385|448348101|FG000|Overall Study|DOSI not performed/not eval|12|||
124652946|NCT01217385|448348101|FG000|Overall Study|Central Path not Available|1|||
124652947|NCT01217385|448348101|FG000|Overall Study|Normal Breast TOI not available|10|||
124652948|NCT00090987|448348102|FG000|Overall Study|Adverse Event|5|||
124652949|NCT00090987|448348102|FG000|Overall Study|Lack of Efficacy|7|||
124652950|NCT00090987|448348102|FG000|Overall Study|Withdrawal by Subject|3|||
124652951|NCT00090987|448348102|FG000|Overall Study|alternative therapy|1|||
124652952|NCT00090987|448348102|FG000|Overall Study|Non-compliance|4|||
124652953|NCT00090987|448348102|FG000|Overall Study|Incarcerated|1|||
124652954|NCT00835679|448348104|FG000|Overall Study|Withdrawal by Subject|1|||
124652955|NCT00835679|448348105|FG001|Overall Study|Withdrawal by Subject|0|||
124652956|NCT00835679|448348106|FG002|Overall Study|Withdrawal by Subject|0|||
124652957|NCT00835679|448348107|FG003|Overall Study|Withdrawal by Subject|0|||
124652958|NCT04769739|448348109|FG000|Overall Study|Colorectal cancer obstruction|2|||
124652959|NCT04769739|448348110|FG001|Overall Study|Colorectal cancer obstruction|0|||
124652960|NCT04769739|448348111|FG002|Overall Study|Colorectal cancer obstruction|0|||
124652961|NCT04769739|448348112|FG003|Overall Study|Colorectal cancer obstruction|0|||
124652962|NCT04769739|448348109|FG000|Overall Study|Failed cecal intubation|1|||
124652963|NCT04769739|448348110|FG001|Overall Study|Failed cecal intubation|0|||
124652964|NCT04769739|448348111|FG002|Overall Study|Failed cecal intubation|0|||
124652965|NCT04769739|448348112|FG003|Overall Study|Failed cecal intubation|1|||
124652966|NCT04769739|448348109|FG000|Overall Study|Poor bowel preparation|0|||
124652967|NCT04769739|448348110|FG001|Overall Study|Poor bowel preparation|0|||
124652968|NCT04769739|448348111|FG002|Overall Study|Poor bowel preparation|0|||
124652969|NCT04769739|448348112|FG003|Overall Study|Poor bowel preparation|1|||
124652970|NCT02431806|448348130|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
124652971|NCT02431806|448348131|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
124652972|NCT02431806|448348132|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
124652973|NCT02431806|448348133|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
124652974|NCT02431806|448348130|FG000|Double-blind Treatment Period|Adverse Event|4|||
124652975|NCT02431806|448348131|FG001|Double-blind Treatment Period|Adverse Event|7|||
124652976|NCT02431806|448348132|FG002|Double-blind Treatment Period|Adverse Event|11|||
124652977|NCT02431806|448348133|FG003|Double-blind Treatment Period|Adverse Event|7|||
124544230|NCT05182840|447946748|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
124544231|NCT05182840|447946749|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
124544232|NCT05182840|447946750|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
124544233|NCT05182840|447946751|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
124544234|NCT05182840|447946752|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
124544235|NCT05182840|447946753|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
124551163|NCT04071366|447974674|FG000|Part 1: Open-label (29 Days)|Death|4|||
124551164|NCT04071366|447974675|FG001|Part 1: Open-label (29 Days)|Death|2|||
124551165|NCT04071366|447974676|FG002|Part 1: Open-label (29 Days)|Death|8|||
124551166|NCT04071366|447974677|FG003|Part 1: Open-label (29 Days)|Death|0|||
124551167|NCT04071366|447974678|FG004|Part 1: Open-label (29 Days)|Death|0|||
124551168|NCT04071366|447974674|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
124551169|NCT04071366|447974675|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
124551170|NCT04071366|447974676|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
124551171|NCT04071366|447974677|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
124551172|NCT04071366|447974678|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
124551173|NCT04071366|447974674|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
124551174|NCT04071366|447974675|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
124551175|NCT04071366|447974676|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
124551176|NCT04071366|447974677|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
124551177|NCT04071366|447974678|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
124551178|NCT04071366|447974674|FG000|Part 2: Randomized (29 Days)|Death|0|||
124551179|NCT04071366|447974675|FG001|Part 2: Randomized (29 Days)|Death|0|||
124551180|NCT04071366|447974676|FG002|Part 2: Randomized (29 Days)|Death|0|||
124551181|NCT04071366|447974677|FG003|Part 2: Randomized (29 Days)|Death|2|||
124551182|NCT04071366|447974678|FG004|Part 2: Randomized (29 Days)|Death|2|||
124551183|NCT04071366|447974674|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
124551184|NCT04071366|447974675|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
124551185|NCT04071366|447974676|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
124551186|NCT04071366|447974677|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
124551187|NCT04071366|447974678|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
124551188|NCT04071366|447974674|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
124551189|NCT04071366|447974675|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
124551190|NCT04071366|447974676|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
124551191|NCT04071366|447974677|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
124551192|NCT04071366|447974678|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
124551193|NCT04071366|447974674|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
124551194|NCT04071366|447974675|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
124551195|NCT04071366|447974676|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
124551196|NCT04071366|447974677|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
124551197|NCT04071366|447974678|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
124551198|NCT04071366|447974674|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
124551199|NCT04071366|447974675|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
124551200|NCT04071366|447974676|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
124551201|NCT04071366|447974677|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
124551202|NCT04071366|447974678|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
124551203|NCT04071366|447974674|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
124551204|NCT04071366|447974675|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
124551205|NCT04071366|447974676|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
124551206|NCT04071366|447974677|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
124551207|NCT04071366|447974678|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
124551208|NCT04071366|447974674|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
124551209|NCT04071366|447974675|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
124551210|NCT04071366|447974676|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
124551211|NCT04071366|447974677|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
124652978|NCT02431806|448348130|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
124652979|NCT02431806|448348131|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
124652980|NCT02431806|448348132|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
124652981|NCT02431806|448348133|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
124652982|NCT02431806|448348130|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
124652983|NCT02431806|448348131|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
124652984|NCT02431806|448348132|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
124652985|NCT02431806|448348133|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
124652986|NCT02431806|448348130|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
124652987|NCT02431806|448348131|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
124652988|NCT02431806|448348132|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
124652989|NCT02431806|448348133|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
124652990|NCT02431806|448348130|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
124652991|NCT02431806|448348131|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
124652992|NCT02431806|448348132|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
124652993|NCT02431806|448348133|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
124652994|NCT02431806|448348130|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
124652995|NCT02431806|448348131|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
124652996|NCT02431806|448348132|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
124652997|NCT02431806|448348133|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
124652998|NCT02968433|448348134|FG000|Overall Study|Withdrawal by Subject|1|||
124652999|NCT02079636|448348135|FG000|Overall Study|Death|2|||
124653000|NCT02079636|448348136|FG001|Overall Study|Death|1|||
124653001|NCT02079636|448348137|FG002|Overall Study|Death|0|||
124653002|NCT02079636|448348138|FG003|Overall Study|Death|5|||
124653003|NCT02079636|448348139|FG004|Overall Study|Death|1|||
124653004|NCT02079636|448348140|FG005|Overall Study|Death|2|||
124653005|NCT02079636|448348141|FG006|Overall Study|Death|1|||
124653006|NCT02079636|448348142|FG007|Overall Study|Death|0|||
124653007|NCT02079636|448348143|FG008|Overall Study|Death|0|||
124653008|NCT02079636|448348144|FG009|Overall Study|Death|0|||
124653009|NCT02079636|448348145|FG010|Overall Study|Death|0|||
124653010|NCT02079636|448348146|FG011|Overall Study|Death|1|||
124653011|NCT02079636|448348147|FG012|Overall Study|Death|1|||
124653012|NCT02079636|448348148|FG013|Overall Study|Death|0|||
124653013|NCT02079636|448348149|FG014|Overall Study|Death|2|||
124653014|NCT02079636|448348135|FG000|Overall Study|Adverse Event|1|||
124653015|NCT02079636|448348136|FG001|Overall Study|Adverse Event|1|||
124653016|NCT02079636|448348137|FG002|Overall Study|Adverse Event|0|||
124653017|NCT02079636|448348138|FG003|Overall Study|Adverse Event|1|||
124653018|NCT02079636|448348139|FG004|Overall Study|Adverse Event|1|||
124653019|NCT02079636|448348140|FG005|Overall Study|Adverse Event|2|||
124653020|NCT02079636|448348141|FG006|Overall Study|Adverse Event|0|||
124653021|NCT02079636|448348142|FG007|Overall Study|Adverse Event|0|||
124653022|NCT02079636|448348143|FG008|Overall Study|Adverse Event|0|||
124653023|NCT02079636|448348144|FG009|Overall Study|Adverse Event|0|||
124653024|NCT02079636|448348145|FG010|Overall Study|Adverse Event|0|||
124653025|NCT02079636|448348146|FG011|Overall Study|Adverse Event|0|||
124653026|NCT02079636|448348147|FG012|Overall Study|Adverse Event|0|||
124653027|NCT02079636|448348148|FG013|Overall Study|Adverse Event|0|||
124653028|NCT02079636|448348149|FG014|Overall Study|Adverse Event|0|||
124653029|NCT02079636|448348135|FG000|Overall Study|Progressive disease|0|||
124653030|NCT02079636|448348136|FG001|Overall Study|Progressive disease|0|||
124653031|NCT02079636|448348137|FG002|Overall Study|Progressive disease|0|||
124653032|NCT02079636|448348138|FG003|Overall Study|Progressive disease|2|||
124653033|NCT02079636|448348139|FG004|Overall Study|Progressive disease|0|||
124653034|NCT02079636|448348140|FG005|Overall Study|Progressive disease|0|||
124653035|NCT02079636|448348141|FG006|Overall Study|Progressive disease|0|||
124653036|NCT02079636|448348142|FG007|Overall Study|Progressive disease|0|||
124653037|NCT02079636|448348143|FG008|Overall Study|Progressive disease|0|||
124653038|NCT02079636|448348144|FG009|Overall Study|Progressive disease|0|||
124653039|NCT02079636|448348145|FG010|Overall Study|Progressive disease|0|||
124653040|NCT02079636|448348146|FG011|Overall Study|Progressive disease|0|||
124653041|NCT02079636|448348147|FG012|Overall Study|Progressive disease|1|||
124653042|NCT02079636|448348148|FG013|Overall Study|Progressive disease|0|||
124653043|NCT02079636|448348149|FG014|Overall Study|Progressive disease|0|||
124653044|NCT02079636|448348135|FG000|Overall Study|Withdrawal by Subject|0|||
124653045|NCT02079636|448348136|FG001|Overall Study|Withdrawal by Subject|0|||
124653046|NCT02079636|448348137|FG002|Overall Study|Withdrawal by Subject|0|||
124653047|NCT02079636|448348138|FG003|Overall Study|Withdrawal by Subject|4|||
124653048|NCT02079636|448348139|FG004|Overall Study|Withdrawal by Subject|0|||
124653049|NCT02079636|448348140|FG005|Overall Study|Withdrawal by Subject|1|||
124653050|NCT02079636|448348141|FG006|Overall Study|Withdrawal by Subject|0|||
124653051|NCT02079636|448348142|FG007|Overall Study|Withdrawal by Subject|0|||
124653052|NCT02079636|448348143|FG008|Overall Study|Withdrawal by Subject|0|||
124653053|NCT02079636|448348144|FG009|Overall Study|Withdrawal by Subject|2|||
124653054|NCT02079636|448348145|FG010|Overall Study|Withdrawal by Subject|1|||
124653055|NCT02079636|448348146|FG011|Overall Study|Withdrawal by Subject|1|||
124653056|NCT02079636|448348147|FG012|Overall Study|Withdrawal by Subject|1|||
124653057|NCT02079636|448348148|FG013|Overall Study|Withdrawal by Subject|0|||
124653058|NCT02079636|448348149|FG014|Overall Study|Withdrawal by Subject|2|||
124653059|NCT02079636|448348135|FG000|Overall Study|Physician Decision|0|||
124653060|NCT02079636|448348136|FG001|Overall Study|Physician Decision|0|||
124653061|NCT02079636|448348137|FG002|Overall Study|Physician Decision|0|||
124653062|NCT02079636|448348138|FG003|Overall Study|Physician Decision|0|||
124653063|NCT02079636|448348139|FG004|Overall Study|Physician Decision|0|||
124653064|NCT02079636|448348140|FG005|Overall Study|Physician Decision|1|||
124653065|NCT02079636|448348141|FG006|Overall Study|Physician Decision|0|||
124653066|NCT02079636|448348142|FG007|Overall Study|Physician Decision|0|||
124653067|NCT02079636|448348143|FG008|Overall Study|Physician Decision|0|||
124653068|NCT02079636|448348144|FG009|Overall Study|Physician Decision|1|||
124653069|NCT02079636|448348145|FG010|Overall Study|Physician Decision|1|||
124653070|NCT02079636|448348146|FG011|Overall Study|Physician Decision|0|||
124653071|NCT02079636|448348147|FG012|Overall Study|Physician Decision|0|||
124653072|NCT02079636|448348148|FG013|Overall Study|Physician Decision|0|||
124653073|NCT02079636|448348149|FG014|Overall Study|Physician Decision|1|||
124653074|NCT02079636|448348135|FG000|Overall Study|Lost to Follow-up|0|||
124653075|NCT02079636|448348136|FG001|Overall Study|Lost to Follow-up|0|||
124653076|NCT02079636|448348137|FG002|Overall Study|Lost to Follow-up|0|||
124653077|NCT02079636|448348138|FG003|Overall Study|Lost to Follow-up|0|||
124653078|NCT02079636|448348139|FG004|Overall Study|Lost to Follow-up|0|||
124653079|NCT02079636|448348140|FG005|Overall Study|Lost to Follow-up|0|||
124653080|NCT02079636|448348141|FG006|Overall Study|Lost to Follow-up|0|||
124653081|NCT02079636|448348142|FG007|Overall Study|Lost to Follow-up|1|||
124653082|NCT02079636|448348143|FG008|Overall Study|Lost to Follow-up|0|||
124653083|NCT02079636|448348144|FG009|Overall Study|Lost to Follow-up|0|||
124653084|NCT02079636|448348145|FG010|Overall Study|Lost to Follow-up|0|||
124653085|NCT02079636|448348146|FG011|Overall Study|Lost to Follow-up|0|||
124653086|NCT02079636|448348147|FG012|Overall Study|Lost to Follow-up|0|||
124653087|NCT02079636|448348148|FG013|Overall Study|Lost to Follow-up|0|||
124653088|NCT02079636|448348149|FG014|Overall Study|Lost to Follow-up|0|||
124653089|NCT00875433|448348150|FG000|Overall Study|Progressive disease|41|||
124653090|NCT00875433|448348150|FG000|Overall Study|Other Adverse Event|14|||
124653091|NCT00875433|448348150|FG000|Overall Study|Withdrawal by Subject|2|||
124653092|NCT00875433|448348150|FG000|Overall Study|Other|3|||
124653093|NCT00622336|448348151|FG000|Treatment Phase|Progression of Disease|181|||
124653094|NCT00622336|448348151|FG000|Treatment Phase|Adverse Event|46|||
124653095|NCT00622336|448348151|FG000|Treatment Phase|Other|40|||
124653096|NCT00622336|448348151|FG000|Treatment Phase|Death|14|||
124653097|NCT00622336|448348151|FG000|Treatment Phase|Lack of therapeutic effect|13|||
124653098|NCT00622336|448348151|FG000|Treatment Phase|Withdrawal by Subject|13|||
124653099|NCT00622336|448348151|FG000|Treatment Phase|Lost to Follow-up|2|||
124653100|NCT00622336|448348151|FG000|Extension Phase|Adverse Event|2|||
124653101|NCT00622336|448348151|FG000|Extension Phase|Progressive Disease|6|||
124653102|NCT00622336|448348151|FG000|Extension Phase|Lack of therapeutic effect|2|||
124653103|NCT00622336|448348151|FG000|Extension Phase|Withdrawal by Subject|1|||
124653104|NCT00622336|448348151|FG000|Extension Phase|Lost to Follow-up|1|||
124653105|NCT00622336|448348151|FG000|Extension Phase|Other|9|||
124653106|NCT04148287|448348152|FG000|Overall Study|Death|2|||
124653107|NCT03164265|448348153|FG000|Overall Study|Physician Decision|3|||
124653108|NCT03912428|448348154|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
124653109|NCT03912428|448348155|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
124653110|NCT03912428|448348156|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
124653111|NCT03912428|448348157|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
124653112|NCT03912428|448348154|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
124653113|NCT03912428|448348155|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
124653114|NCT03912428|448348156|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
124653115|NCT03912428|448348157|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
124653116|NCT03912428|448348154|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
124653117|NCT03912428|448348155|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
124653118|NCT03912428|448348156|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
124653119|NCT03912428|448348157|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
124653120|NCT03233204|448348158|FG000|Overall Study|Adverse Event|1|||
124653121|NCT03233204|448348158|FG000|Overall Study|Death|1|||
124653122|NCT03233204|448348158|FG000|Overall Study|Withdrawal by Subject|1|||
124653123|NCT03233204|448348158|FG000|Overall Study|Progressive Disease|3|||
124653124|NCT01777139|448349670|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
124653125|NCT01777139|448349671|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
124653126|NCT01777139|448349670|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
124653127|NCT01777139|448349671|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
124872815|NCT00500903|449155770|FG001|Overall Study|Symptomatic Deterioration|0|||
124653128|NCT01777139|448349670|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
124653129|NCT01777139|448349671|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
124544236|NCT05182840|447946754|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
124544237|NCT05182840|447946755|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
124544238|NCT05182840|447946756|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
124544239|NCT05182840|447946757|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
124544240|NCT05182840|447946748|FG000|Treatment Period|Reason missing|0|||
124544241|NCT05182840|447946749|FG001|Treatment Period|Reason missing|0|||
124544242|NCT05182840|447946750|FG002|Treatment Period|Reason missing|1|||
124544243|NCT05182840|447946751|FG003|Treatment Period|Reason missing|0|||
124544244|NCT05182840|447946752|FG004|Treatment Period|Reason missing|0|||
124653130|NCT01777139|448349670|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
124653131|NCT01777139|448349671|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
124653132|NCT01777139|448349670|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
124653133|NCT01777139|448349671|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
124653134|NCT01777139|448349670|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
124653135|NCT01777139|448349671|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
124653136|NCT01777139|448349670|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
124653137|NCT01777139|448349671|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
124653138|NCT01777139|448349670|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
124653139|NCT01777139|448349671|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
124653140|NCT02921750|448349672|FG000|Overall Study|Adverse Event|1|||
124653141|NCT02921750|448349673|FG001|Overall Study|Adverse Event|2|||
124653142|NCT02921750|448349672|FG000|Overall Study|Withdrawal by Subject|1|||
124653143|NCT02921750|448349673|FG001|Overall Study|Withdrawal by Subject|1|||
124653144|NCT02921750|448349672|FG000|Overall Study|Lost to Follow-up|3|||
124653145|NCT02921750|448349673|FG001|Overall Study|Lost to Follow-up|3|||
124653146|NCT02921750|448349672|FG000|Overall Study|Wound healed|3|||
124653147|NCT02921750|448349673|FG001|Overall Study|Wound healed|3|||
124653148|NCT02921750|448349672|FG000|Overall Study|Serious Adverse Event|1|||
124653149|NCT02921750|448349673|FG001|Overall Study|Serious Adverse Event|2|||
124653150|NCT03605849|448349674|FG000|Overall Study|Adverse Event|20|||
124653151|NCT03605849|448349675|FG001|Overall Study|Adverse Event|21|||
124653152|NCT03605849|448349676|FG002|Overall Study|Adverse Event|29|||
124653153|NCT03605849|448349677|FG003|Overall Study|Adverse Event|11|||
124653154|NCT03605849|448349674|FG000|Overall Study|Lack of Efficacy|4|||
124653155|NCT03605849|448349675|FG001|Overall Study|Lack of Efficacy|7|||
124653156|NCT03605849|448349676|FG002|Overall Study|Lack of Efficacy|9|||
124653157|NCT03605849|448349677|FG003|Overall Study|Lack of Efficacy|2|||
124653158|NCT03605849|448349674|FG000|Overall Study|Lost to Follow-up|8|||
124653159|NCT03605849|448349675|FG001|Overall Study|Lost to Follow-up|8|||
124653160|NCT03605849|448349676|FG002|Overall Study|Lost to Follow-up|14|||
124653161|NCT03605849|448349677|FG003|Overall Study|Lost to Follow-up|11|||
124653162|NCT03605849|448349674|FG000|Overall Study|Non-compliance With IMP|6|||
124653163|NCT03605849|448349675|FG001|Overall Study|Non-compliance With IMP|5|||
124653164|NCT03605849|448349676|FG002|Overall Study|Non-compliance With IMP|2|||
124653165|NCT03605849|448349677|FG003|Overall Study|Non-compliance With IMP|1|||
124653166|NCT03605849|448349674|FG000|Overall Study|Protocol Deviation|1|||
124653167|NCT03605849|448349675|FG001|Overall Study|Protocol Deviation|2|||
124653168|NCT03605849|448349676|FG002|Overall Study|Protocol Deviation|1|||
124653169|NCT03605849|448349677|FG003|Overall Study|Protocol Deviation|3|||
124653170|NCT03605849|448349674|FG000|Overall Study|Withdrawal by Subject|33|||
124653171|NCT03605849|448349675|FG001|Overall Study|Withdrawal by Subject|28|||
124653172|NCT03605849|448349676|FG002|Overall Study|Withdrawal by Subject|30|||
124653173|NCT03605849|448349677|FG003|Overall Study|Withdrawal by Subject|28|||
124653174|NCT03605849|448349674|FG000|Overall Study|Site Terminated by Sponsor|0|||
124653175|NCT03605849|448349675|FG001|Overall Study|Site Terminated by Sponsor|0|||
124653176|NCT03605849|448349676|FG002|Overall Study|Site Terminated by Sponsor|0|||
124653177|NCT03605849|448349677|FG003|Overall Study|Site Terminated by Sponsor|1|||
124653178|NCT03605849|448349674|FG000|Overall Study|Physician Decision|2|||
124653179|NCT03605849|448349675|FG001|Overall Study|Physician Decision|1|||
124653180|NCT03605849|448349676|FG002|Overall Study|Physician Decision|2|||
124653181|NCT03605849|448349677|FG003|Overall Study|Physician Decision|1|||
124653182|NCT03605849|448349674|FG000|Overall Study|Enrolled, but not Treated|2|||
124653183|NCT03605849|448349675|FG001|Overall Study|Enrolled, but not Treated|2|||
124653184|NCT03605849|448349676|FG002|Overall Study|Enrolled, but not Treated|3|||
124653185|NCT03605849|448349677|FG003|Overall Study|Enrolled, but not Treated|2|||
124653186|NCT03605849|448349674|FG000|Overall Study|Other (COVID-19 Related)|0|||
124653187|NCT03605849|448349675|FG001|Overall Study|Other (COVID-19 Related)|1|||
124653188|NCT03605849|448349676|FG002|Overall Study|Other (COVID-19 Related)|1|||
124653189|NCT03605849|448349677|FG003|Overall Study|Other (COVID-19 Related)|0|||
124653190|NCT03605849|448349674|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
124653191|NCT03605849|448349675|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
124653192|NCT03605849|448349676|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
124653193|NCT03605849|448349677|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
124653194|NCT00328094|448349680|FG000|Overall Study|Physician Decision|3|||
124653195|NCT00328094|448349681|FG001|Overall Study|Physician Decision|3|||
124653196|NCT00590538|448349682|FG000|Overall Study|Study terminated before completed|2|||
124653197|NCT02309723|448349683|FG000|Overall Study|Withdrawal by Subject|24|||
124653198|NCT02309723|448349684|FG001|Overall Study|Withdrawal by Subject|23|||
124653199|NCT02309723|448349685|FG002|Overall Study|Withdrawal by Subject|24|||
124653200|NCT01125813|448349686|FG000|Overall Study|Death|1|||
124653201|NCT01125813|448349686|FG000|Overall Study|Withdrawal by Subject|1|||
124653202|NCT01125813|448349686|FG000|Overall Study|Screen Failures|4|||
124653203|NCT00985426|448349687|FG000|Overall Study|Adverse Event|0|||
124653204|NCT00985426|448349688|FG001|Overall Study|Adverse Event|1|||
124653205|NCT00985426|448349687|FG000|Overall Study|Subject Non-Compliance|3|||
124653206|NCT00985426|448349688|FG001|Overall Study|Subject Non-Compliance|3|||
124653207|NCT00985426|448349687|FG000|Overall Study|Withdrawal by Subject|12|||
124653208|NCT00985426|448349688|FG001|Overall Study|Withdrawal by Subject|16|||
124653209|NCT00985426|448349687|FG000|Overall Study|Lost to Follow-up|8|||
124653210|NCT00985426|448349688|FG001|Overall Study|Lost to Follow-up|10|||
124653211|NCT00985426|448349687|FG000|Overall Study|Death|7|||
124653212|NCT00985426|448349688|FG001|Overall Study|Death|3|||
124653213|NCT00985426|448349687|FG000|Overall Study|Protocol Violation|2|||
124653214|NCT00985426|448349688|FG001|Overall Study|Protocol Violation|0|||
124653215|NCT00985426|448349687|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
124653216|NCT00985426|448349688|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
124653217|NCT01565668|448349689|FG000|Overall Study|Death|2|||
124653218|NCT01565668|448349690|FG001|Overall Study|Death|1|||
124653219|NCT01565668|448349689|FG000|Overall Study|Lack of Efficacy|4|||
124653220|NCT01565668|448349690|FG001|Overall Study|Lack of Efficacy|2|||
124653221|NCT01565668|448349689|FG000|Overall Study|Participant went on Hospice Care|1|||
124653222|NCT01565668|448349690|FG001|Overall Study|Participant went on Hospice Care|0|||
124653223|NCT01565668|448349689|FG000|Overall Study|Adverse Event|6|||
124653224|NCT01565668|448349690|FG001|Overall Study|Adverse Event|1|||
124653225|NCT01565668|448349689|FG000|Overall Study|Randomized, but never received drug|0|||
124653226|NCT01565668|448349690|FG001|Overall Study|Randomized, but never received drug|2|||
124653227|NCT01565668|448349689|FG000|Overall Study|Progressive disease|13|||
124653228|NCT01565668|448349690|FG001|Overall Study|Progressive disease|14|||
124653229|NCT01565668|448349689|FG000|Overall Study|Withdrawal by Subject|1|||
124653230|NCT01565668|448349690|FG001|Overall Study|Withdrawal by Subject|3|||
124653231|NCT01565668|448349689|FG000|Overall Study|HSCT Transplant|11|||
124653232|NCT01565668|448349690|FG001|Overall Study|HSCT Transplant|15|||
124653233|NCT04258254|448349691|FG000|Overall Study|Withdrawal by Subject|0|||
124653234|NCT04258254|448349692|FG001|Overall Study|Withdrawal by Subject|1|||
124653235|NCT04258254|448349693|FG002|Overall Study|Withdrawal by Subject|0|||
124653236|NCT02255552|448349694|FG000|Overall Study|Participants enrolled into another study|0|||
124653237|NCT02255552|448349695|FG001|Overall Study|Participants enrolled into another study|11|||
124653238|NCT02255552|448349694|FG000|Overall Study|Withdrawal by Subject|1|||
124653239|NCT02255552|448349695|FG001|Overall Study|Withdrawal by Subject|4|||
124653240|NCT03570554|448349697|FG000|Overall Study|Non-compliance with study drug|0|||
124653241|NCT03570554|448349698|FG001|Overall Study|Non-compliance with study drug|0|||
124653242|NCT03570554|448349699|FG002|Overall Study|Non-compliance with study drug|1|||
124653243|NCT03570554|448349700|FG003|Overall Study|Non-compliance with study drug|0|||
124653244|NCT03570554|448349697|FG000|Overall Study|Adverse Event|0|||
124653245|NCT03570554|448349698|FG001|Overall Study|Adverse Event|0|||
124653246|NCT03570554|448349699|FG002|Overall Study|Adverse Event|0|||
124653247|NCT03570554|448349700|FG003|Overall Study|Adverse Event|1|||
124653248|NCT02223819|448349715|FG000|Overall Study|Lost to Follow-up|2|||
124653249|NCT02956057|448349717|FG000|Overall Study|Discontinued intervention|14|||
124653250|NCT02956057|448349718|FG001|Overall Study|Discontinued intervention|10|||
124653251|NCT02956057|448349719|FG002|Overall Study|Discontinued intervention|7|||
124653252|NCT02956057|448349720|FG003|Overall Study|Discontinued intervention|14|||
124653253|NCT02956057|448349721|FG004|Overall Study|Discontinued intervention|4|||
124653254|NCT02956057|448349722|FG005|Overall Study|Discontinued intervention|17|||
124653255|NCT02956057|448349717|FG000|Overall Study|Lost to Follow-up|0|||
124653256|NCT02956057|448349718|FG001|Overall Study|Lost to Follow-up|2|||
124653257|NCT02956057|448349719|FG002|Overall Study|Lost to Follow-up|1|||
124653258|NCT02956057|448349720|FG003|Overall Study|Lost to Follow-up|1|||
124653259|NCT02956057|448349721|FG004|Overall Study|Lost to Follow-up|1|||
124653260|NCT02956057|448349722|FG005|Overall Study|Lost to Follow-up|0|||
124653261|NCT01420679|448349725|FG000|Overall Study|Disease Progression|3|||
124653262|NCT01420679|448349726|FG001|Overall Study|Disease Progression|2|||
124653263|NCT01420679|448349725|FG000|Overall Study|Adverse Event|4|||
124653264|NCT01420679|448349726|FG001|Overall Study|Adverse Event|0|||
124653265|NCT01420679|448349725|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
124653266|NCT01420679|448349726|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
124653267|NCT01420679|448349725|FG000|Overall Study|Patient Decision|1|||
124653268|NCT01420679|448349726|FG001|Overall Study|Patient Decision|0|||
124653269|NCT01420679|448349725|FG000|Overall Study|Investigator Decision|1|||
124653270|NCT01420679|448349726|FG001|Overall Study|Investigator Decision|2|||
124653271|NCT01420679|448349725|FG000|Overall Study|Sponsor Decision|3|||
124653272|NCT01420679|448349726|FG001|Overall Study|Sponsor Decision|3|||
124653273|NCT01420679|448349725|FG000|Overall Study|Other|1|||
124653274|NCT01420679|448349726|FG001|Overall Study|Other|0|||
124653275|NCT02604550|448349729|FG000|Overall Study|Lost to Follow-up|7|||
124653276|NCT02604550|448349730|FG001|Overall Study|Lost to Follow-up|6|||
124653277|NCT02604550|448349729|FG000|Overall Study|Withdrawal by Subject|0|||
124653278|NCT02604550|448349730|FG001|Overall Study|Withdrawal by Subject|1|||
124653279|NCT02604550|448349729|FG000|Overall Study|Incomplete data using paper journal|18|||
124653280|NCT02604550|448349730|FG001|Overall Study|Incomplete data using paper journal|19|||
124653281|NCT04472026|448349731|FG000|Overall Study|Lost to Follow-up|5|||
124653282|NCT03769194|448349738|FG000|Overall Study|Withdrawal by Subject|0|||
124653283|NCT03769194|448349739|FG001|Overall Study|Withdrawal by Subject|7|||
124653284|NCT03769194|448349740|FG002|Overall Study|Withdrawal by Subject|4|||
124653285|NCT03769194|448349741|FG003|Overall Study|Withdrawal by Subject|1|||
124653286|NCT03769194|448349738|FG000|Overall Study|moved from study area|0|||
124653287|NCT03769194|448349739|FG001|Overall Study|moved from study area|2|||
124653288|NCT03769194|448349740|FG002|Overall Study|moved from study area|1|||
124653289|NCT03769194|448349741|FG003|Overall Study|moved from study area|1|||
124653290|NCT03769194|448349738|FG000|Overall Study|Lost to Follow-up|3|||
124653291|NCT03769194|448349739|FG001|Overall Study|Lost to Follow-up|6|||
124653292|NCT03769194|448349740|FG002|Overall Study|Lost to Follow-up|3|||
124653293|NCT03769194|448349741|FG003|Overall Study|Lost to Follow-up|6|||
124653294|NCT03769194|448349738|FG000|Overall Study|other|1|||
124653295|NCT03769194|448349739|FG001|Overall Study|other|3|||
124653296|NCT03769194|448349740|FG002|Overall Study|other|0|||
124653297|NCT03769194|448349741|FG003|Overall Study|other|1|||
124653298|NCT01832818|448349743|FG000|Overall Study|Lost to Follow-up|6|||
124653299|NCT01256385|448349744|FG000|Overall Study|Physician Decision|1|||
124653300|NCT01256385|448349745|FG001|Overall Study|Physician Decision|1|||
124653301|NCT01256385|448349744|FG000|Overall Study|Withdrawal by Subject|2|||
124653302|NCT01256385|448349745|FG001|Overall Study|Withdrawal by Subject|2|||
124653303|NCT01080391|448349746|FG000|Overall Study|Randomized but not treated|7|||
124653304|NCT01080391|448349747|FG001|Overall Study|Randomized but not treated|4|||
124653305|NCT01904903|448349748|FG000|Overall Study|Withdrawal by Subject|1|||
124653306|NCT00672841|448349749|FG000|Overall Study|Comfort care|1|||
124653307|NCT00672841|448349750|FG001|Overall Study|Comfort care|4|||
124653308|NCT00672841|448349749|FG000|Overall Study|icteric specimens|0|||
124653309|NCT00672841|448349750|FG001|Overall Study|icteric specimens|3|||
124653310|NCT00672841|448349749|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
124653311|NCT00672841|448349750|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
124653312|NCT00672841|448349749|FG000|Overall Study|Adverse Event|0|||
124653313|NCT00672841|448349750|FG001|Overall Study|Adverse Event|3|||
124653314|NCT00672841|448349749|FG000|Overall Study|Pregnancy|0|||
124653315|NCT00672841|448349750|FG001|Overall Study|Pregnancy|1|||
124653316|NCT03578146|448349751|FG000|Overall Study|Did Not Receive Treatment|1|||
124653317|NCT03578146|448349752|FG001|Overall Study|Did Not Receive Treatment|0|||
124653318|NCT03578146|448349753|FG002|Overall Study|Did Not Receive Treatment|0|||
124653319|NCT03578146|448349754|FG003|Overall Study|Did Not Receive Treatment|0|||
124653320|NCT03578146|448349755|FG004|Overall Study|Did Not Receive Treatment|0|||
124653321|NCT03578146|448349756|FG005|Overall Study|Did Not Receive Treatment|2|||
124653322|NCT03578146|448349751|FG000|Overall Study|Lost to Follow-up|0|||
124653323|NCT03578146|448349752|FG001|Overall Study|Lost to Follow-up|1|||
124653324|NCT03578146|448349753|FG002|Overall Study|Lost to Follow-up|1|||
124653325|NCT03578146|448349754|FG003|Overall Study|Lost to Follow-up|0|||
124653326|NCT03578146|448349755|FG004|Overall Study|Lost to Follow-up|0|||
124653327|NCT03578146|448349756|FG005|Overall Study|Lost to Follow-up|1|||
124653328|NCT03677934|448349757|FG000|Overall Study|Adverse Event|1|||
124653329|NCT03677934|448349758|FG001|Overall Study|Adverse Event|1|||
124653330|NCT03677934|448349757|FG000|Overall Study|Death|8|||
124653331|NCT03677934|448349758|FG001|Overall Study|Death|4|||
124653332|NCT03677934|448349757|FG000|Overall Study|Lost to Follow-up|3|||
124653333|NCT03677934|448349758|FG001|Overall Study|Lost to Follow-up|0|||
124653334|NCT03677934|448349757|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124653335|NCT03677934|448349758|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124653336|NCT03677934|448349757|FG000|Overall Study|Physician Decision|0|||
124653337|NCT03677934|448349758|FG001|Overall Study|Physician Decision|1|||
124653338|NCT03677934|448349757|FG000|Overall Study|Withdrawal by Subject|1|||
124653339|NCT03677934|448349758|FG001|Overall Study|Withdrawal by Subject|7|||
124653340|NCT01260584|448349759|FG000|Period 1|Protocol Violation|0|||
124653341|NCT01260584|448349760|FG001|Period 1|Protocol Violation|0|||
124653342|NCT01260584|448349761|FG002|Period 1|Protocol Violation|1|||
124653343|NCT01260584|448349762|FG003|Period 1|Protocol Violation|1|||
124653344|NCT01260584|448349759|FG000|Period 1|Adverse Event|0|||
124653345|NCT01260584|448349760|FG001|Period 1|Adverse Event|0|||
124653346|NCT01260584|448349761|FG002|Period 1|Adverse Event|1|||
124653347|NCT01260584|448349762|FG003|Period 1|Adverse Event|0|||
124653348|NCT01260584|448349759|FG000|Period 2|Protocol Violation|0|||
124653349|NCT01260584|448349760|FG001|Period 2|Protocol Violation|2|||
124653350|NCT01260584|448349761|FG002|Period 2|Protocol Violation|3|||
124653351|NCT01260584|448349762|FG003|Period 2|Protocol Violation|1|||
124653352|NCT01260584|448349759|FG000|Period 2|Adverse Event|1|||
124653353|NCT01260584|448349760|FG001|Period 2|Adverse Event|0|||
124653354|NCT01260584|448349761|FG002|Period 2|Adverse Event|2|||
124653355|NCT01260584|448349762|FG003|Period 2|Adverse Event|0|||
124653356|NCT01260584|448349759|FG000|Period 2|Withdrawal by Subject|0|||
124653357|NCT01260584|448349760|FG001|Period 2|Withdrawal by Subject|1|||
124653358|NCT01260584|448349761|FG002|Period 2|Withdrawal by Subject|0|||
124653359|NCT01260584|448349762|FG003|Period 2|Withdrawal by Subject|0|||
124653360|NCT00932451|448349763|FG000|Overall Study|Withdrawal by Subject|69|||
124653361|NCT00932451|448349763|FG000|Overall Study|Lost to Follow-up|22|||
124653362|NCT00932451|448349763|FG000|Overall Study|Death|726|||
124653363|NCT00932451|448349763|FG000|Overall Study|Other reasons|5|||
124653364|NCT00637806|448349767|FG000|Double-blind Phase|Study Discontinued|2|||
124653365|NCT00637806|448349768|FG001|Double-blind Phase|Study Discontinued|0|||
124653366|NCT00637806|448349769|FG002|Double-blind Phase|Study Discontinued|1|||
124653367|NCT00637806|448349770|FG003|Double-blind Phase|Study Discontinued|0|||
124653368|NCT00637806|448349767|FG000|Extension Phase|Study Discontinued|0|||
124653369|NCT00637806|448349768|FG001|Extension Phase|Study Discontinued|0|||
124653370|NCT00637806|448349769|FG002|Extension Phase|Study Discontinued|0|||
124653371|NCT00637806|448349770|FG003|Extension Phase|Study Discontinued|1|||
124653372|NCT00561470|448349771|FG000|Overall Study|Adverse Event|74|||
124653373|NCT00561470|448349772|FG001|Overall Study|Adverse Event|163|||
124653374|NCT00561470|448349771|FG000|Overall Study|Disease progression|437|||
124653375|NCT00561470|448349772|FG001|Overall Study|Disease progression|305|||
124653376|NCT00561470|448349771|FG000|Overall Study|poor compliance to protocol|4|||
124653377|NCT00561470|448349772|FG001|Overall Study|poor compliance to protocol|4|||
124653378|NCT00561470|448349771|FG000|Overall Study|Lost to Follow-up|2|||
124653379|NCT00561470|448349772|FG001|Overall Study|Lost to Follow-up|0|||
124653380|NCT00561470|448349771|FG000|Overall Study|Physician Decision|21|||
124653381|NCT00561470|448349772|FG001|Overall Study|Physician Decision|20|||
124653382|NCT00561470|448349771|FG000|Overall Study|Consent Withdrawn|2|||
124653383|NCT00561470|448349772|FG001|Overall Study|Consent Withdrawn|6|||
124653384|NCT00561470|448349771|FG000|Overall Study|Subject request|43|||
124653385|NCT00561470|448349772|FG001|Overall Study|Subject request|77|||
124653386|NCT00561470|448349771|FG000|Overall Study|Metastatic surgery|10|||
124653387|NCT00561470|448349772|FG001|Overall Study|Metastatic surgery|12|||
124653388|NCT00561470|448349771|FG000|Overall Study|Unauthorized procedure|3|||
124653389|NCT00561470|448349772|FG001|Overall Study|Unauthorized procedure|1|||
124653390|NCT00561470|448349771|FG000|Overall Study|Randomized but not treated|5|||
124653391|NCT00561470|448349772|FG001|Overall Study|Randomized but not treated|5|||
124653392|NCT00561470|448349771|FG000|Overall Study|Missed visit window|1|||
124653393|NCT00561470|448349772|FG001|Overall Study|Missed visit window|4|||
124653394|NCT00561470|448349771|FG000|Overall Study|Planning surgery|1|||
124653395|NCT00561470|448349772|FG001|Overall Study|Planning surgery|1|||
124653396|NCT00561470|448349771|FG000|Overall Study|Ongoing Treatment|11|||
124653397|NCT00561470|448349772|FG001|Overall Study|Ongoing Treatment|14|||
124653398|NCT03434249|448349773|FG000|Overall Study|Adverse Event|1|||
124653399|NCT03434249|448349774|FG001|Overall Study|Adverse Event|0|||
124653400|NCT03434249|448349773|FG000|Overall Study|Lost to Follow-up|0|||
124653401|NCT03434249|448349774|FG001|Overall Study|Lost to Follow-up|1|||
124653402|NCT03434249|448349773|FG000|Overall Study|Non-compliance of family|2|||
124653403|NCT03434249|448349774|FG001|Overall Study|Non-compliance of family|1|||
124653404|NCT03434249|448349773|FG000|Overall Study|Difficulties in completing daily diary|2|||
124653405|NCT03434249|448349774|FG001|Overall Study|Difficulties in completing daily diary|1|||
124653406|NCT00725101|448349775|FG000|Overall Study|Death|3|||
124653407|NCT00725101|448349775|FG000|Overall Study|Lost to Follow-up|353|||
124653408|NCT00725101|448349775|FG000|Overall Study|Protocol Violation|1|||
124653409|NCT00725101|448349775|FG000|Overall Study|Withdrawal by Subject|127|||
124653410|NCT00725101|448349775|FG000|Overall Study|not specified/no reason given|11|||
124653411|NCT03325894|448349776|FG000|Overall Study|Adverse Event|2|||
124653412|NCT03325894|448349777|FG001|Overall Study|Adverse Event|3|||
124653413|NCT03325894|448349776|FG000|Overall Study|Protocol Violation|1|||
124653414|NCT03325894|448349777|FG001|Overall Study|Protocol Violation|2|||
124653415|NCT03325894|448349776|FG000|Overall Study|Withdrawal by Subject|10|||
124653416|NCT03325894|448349777|FG001|Overall Study|Withdrawal by Subject|6|||
124653417|NCT03325894|448349776|FG000|Overall Study|Lost to Follow-up|4|||
124653418|NCT03325894|448349777|FG001|Overall Study|Lost to Follow-up|9|||
124653419|NCT03325894|448349776|FG000|Overall Study|Lack of Efficacy|8|||
124653420|NCT03325894|448349777|FG001|Overall Study|Lack of Efficacy|14|||
124653421|NCT03325894|448349776|FG000|Overall Study|Study Terminated by Sponsor|38|||
124653422|NCT03325894|448349777|FG001|Overall Study|Study Terminated by Sponsor|43|||
124653423|NCT03325894|448349776|FG000|Overall Study|Other (Not received Treatment)|1|||
124653424|NCT03325894|448349777|FG001|Overall Study|Other (Not received Treatment)|0|||
124653425|NCT01592292|448349778|FG000|Overall Study|Follow-up loss|3|||
124653426|NCT01592292|448349779|FG001|Overall Study|Follow-up loss|3|||
124653427|NCT01592292|448349780|FG002|Overall Study|Follow-up loss|1|||
124653428|NCT01592292|448349781|FG003|Overall Study|Follow-up loss|0|||
124653429|NCT01592292|448349778|FG000|Overall Study|Withdrew consent|2|||
124653430|NCT01592292|448349779|FG001|Overall Study|Withdrew consent|1|||
124653431|NCT01592292|448349780|FG002|Overall Study|Withdrew consent|0|||
124653432|NCT01592292|448349781|FG003|Overall Study|Withdrew consent|0|||
124653433|NCT01592292|448349778|FG000|Overall Study|Other|1|||
124653434|NCT01592292|448349779|FG001|Overall Study|Other|1|||
124653435|NCT01592292|448349780|FG002|Overall Study|Other|2|||
124653436|NCT01592292|448349781|FG003|Overall Study|Other|1|||
124653437|NCT00948506|448349785|FG000|Overall Study|Withdrawal by Subject|3|||
124653438|NCT00948506|448349786|FG001|Overall Study|Withdrawal by Subject|1|||
124653439|NCT00824382|448349788|FG000|Overall Study|Adverse Event|4|||
124653440|NCT00824382|448349789|FG001|Overall Study|Adverse Event|1|||
124653441|NCT00824382|448349790|FG002|Overall Study|Adverse Event|1|||
124653442|NCT00824382|448349791|FG003|Overall Study|Adverse Event|4|||
124653443|NCT00824382|448349788|FG000|Overall Study|Protocol Violation|1|||
124653444|NCT00824382|448349789|FG001|Overall Study|Protocol Violation|0|||
124653445|NCT00824382|448349790|FG002|Overall Study|Protocol Violation|0|||
124653446|NCT00824382|448349791|FG003|Overall Study|Protocol Violation|1|||
124653447|NCT00824382|448349788|FG000|Overall Study|Investigator's decision|0|||
124653448|NCT00824382|448349789|FG001|Overall Study|Investigator's decision|1|||
124653449|NCT00824382|448349790|FG002|Overall Study|Investigator's decision|2|||
124653450|NCT00824382|448349791|FG003|Overall Study|Investigator's decision|0|||
124653451|NCT00721279|448349792|FG000|Overall Study|Lack of Efficacy|6|||
124653452|NCT00721279|448349793|FG001|Overall Study|Lack of Efficacy|3|||
124653453|NCT00721279|448349792|FG000|Overall Study|Tolerability insufficient|5|||
124653454|NCT00721279|448349793|FG001|Overall Study|Tolerability insufficient|2|||
124653455|NCT00721279|448349792|FG000|Overall Study|Withdrawal by Subject|13|||
124653456|NCT00721279|448349793|FG001|Overall Study|Withdrawal by Subject|3|||
124653457|NCT00721279|448349792|FG000|Overall Study|Other|12|||
124653458|NCT00721279|448349793|FG001|Overall Study|Other|16|||
124653459|NCT02680834|448349794|FG000|Overall Study|Physician Decision|5|||
124653460|NCT02680834|448349795|FG001|Overall Study|Physician Decision|2|||
124653461|NCT02680834|448349794|FG000|Overall Study|Withdrawal by Subject|6|||
124653462|NCT02680834|448349795|FG001|Overall Study|Withdrawal by Subject|0|||
124653463|NCT02680834|448349794|FG000|Overall Study|Lost to Follow-up|0|||
124653464|NCT02680834|448349795|FG001|Overall Study|Lost to Follow-up|1|||
124653465|NCT01732471|448349796|FG000|Overall Study|Withdrawal by Subject|1|||
124653466|NCT00232596|448349797|FG000|6-Week Titration Phase|Adverse Event|6|||
124653467|NCT00232596|448349798|FG001|6-Week Titration Phase|Adverse Event|19|||
124653468|NCT00232596|448349797|FG000|6-Week Titration Phase|Failed to Return|2|||
124653469|NCT00232596|448349798|FG001|6-Week Titration Phase|Failed to Return|1|||
124653470|NCT00232596|448349797|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
124653471|NCT00232596|448349798|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
124653472|NCT00232596|448349797|FG000|6-Week Titration Phase|Protocol Violation|1|||
124653473|NCT00232596|448349798|FG001|6-Week Titration Phase|Protocol Violation|3|||
124653474|NCT00232596|448349797|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
124653475|NCT00232596|448349798|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
124653476|NCT00232596|448349797|FG000|6-Week Titration Phase|Other|3|||
124653477|NCT00232596|448349798|FG001|6-Week Titration Phase|Other|3|||
124653478|NCT00232596|448349797|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
124653479|NCT00232596|448349798|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
124653480|NCT00232596|448349797|FG000|12-Week Maintenance Phase|Adverse Event|7|||
124653481|NCT00232596|448349798|FG001|12-Week Maintenance Phase|Adverse Event|22|||
124653482|NCT00232596|448349797|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
124653483|NCT00232596|448349798|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
124653484|NCT00232596|448349797|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
124653485|NCT00232596|448349798|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
124653486|NCT00232596|448349797|FG000|12-Week Maintenance Phase|Other|1|||
124653487|NCT00232596|448349798|FG001|12-Week Maintenance Phase|Other|3|||
124653488|NCT01253174|448349799|FG000|Period 1|Randomized but not treated|0|||
124653489|NCT01253174|448349800|FG001|Period 1|Randomized but not treated|1|||
124653490|NCT01253174|448349801|FG002|Period 1|Randomized but not treated|1|||
124653491|NCT01253174|448349802|FG003|Period 1|Randomized but not treated|0|||
124653492|NCT01253174|448349803|FG004|Period 1|Randomized but not treated|1|||
124653493|NCT01253174|448349804|FG005|Period 1|Randomized but not treated|0|||
124653494|NCT01253174|448349799|FG000|Period 2|Adverse Event|0|||
124653495|NCT01253174|448349800|FG001|Period 2|Adverse Event|0|||
124653496|NCT01253174|448349801|FG002|Period 2|Adverse Event|1|||
124653497|NCT01253174|448349802|FG003|Period 2|Adverse Event|0|||
124653498|NCT01253174|448349803|FG004|Period 2|Adverse Event|0|||
124653499|NCT01253174|448349804|FG005|Period 2|Adverse Event|0|||
124653500|NCT01253174|448349799|FG000|Period 3|Withdrawal by Subject|0|||
124653501|NCT01253174|448349800|FG001|Period 3|Withdrawal by Subject|1|||
124653502|NCT01253174|448349801|FG002|Period 3|Withdrawal by Subject|0|||
124653503|NCT01253174|448349802|FG003|Period 3|Withdrawal by Subject|0|||
124653504|NCT01253174|448349803|FG004|Period 3|Withdrawal by Subject|1|||
124653505|NCT01253174|448349804|FG005|Period 3|Withdrawal by Subject|0|||
124653506|NCT01253174|448349799|FG000|Period 3|Pregnancy|0|||
124653507|NCT01253174|448349800|FG001|Period 3|Pregnancy|0|||
124653508|NCT01253174|448349801|FG002|Period 3|Pregnancy|1|||
124653509|NCT01253174|448349802|FG003|Period 3|Pregnancy|0|||
124653510|NCT01253174|448349803|FG004|Period 3|Pregnancy|0|||
124653511|NCT01253174|448349804|FG005|Period 3|Pregnancy|0|||
124653512|NCT03467763|448349805|FG000|Overall Study|Lost to Follow-up|1|||
124653513|NCT03467763|448349805|FG000|Overall Study|Protocol Violation|2|||
124653514|NCT02889835|448349806|FG000|Overall Study|Lost to Follow-up|13|||
124653515|NCT02889835|448349807|FG001|Overall Study|Lost to Follow-up|13|||
124653516|NCT02889835|448349808|FG002|Overall Study|Lost to Follow-up|13|||
124653517|NCT02889835|448349806|FG000|Overall Study|Withdrawal by Subject|2|||
124653518|NCT02889835|448349807|FG001|Overall Study|Withdrawal by Subject|2|||
124653519|NCT02889835|448349808|FG002|Overall Study|Withdrawal by Subject|2|||
124653520|NCT02889835|448349806|FG000|Overall Study|Protocol Violation|1|||
124653521|NCT02889835|448349807|FG001|Overall Study|Protocol Violation|1|||
124653522|NCT02889835|448349808|FG002|Overall Study|Protocol Violation|1|||
124653523|NCT02889835|448349806|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
124653524|NCT02889835|448349807|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
124653525|NCT02889835|448349808|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
124653526|NCT02889835|448349806|FG000|Overall Study|Death|1|||
124653527|NCT02889835|448349807|FG001|Overall Study|Death|1|||
124653528|NCT02889835|448349808|FG002|Overall Study|Death|1|||
124653529|NCT04438499|448349809|FG000|Overall Study|Lack of Efficacy|3|||
124653530|NCT04918355|448349810|FG000|Overall Study|no qualifying health encounter|497|||
124653531|NCT04918355|448349811|FG001|Overall Study|no qualifying health encounter|192|||
124653532|NCT04918355|448349812|FG002|Overall Study|no qualifying health encounter|438|||
124653533|NCT04918355|448349813|FG003|Overall Study|no qualifying health encounter|424|||
124653534|NCT00224406|448351519|FG000|Overall Study|Re-transplant|0|||
124653535|NCT00224406|448351520|FG001|Overall Study|Re-transplant|2|||
124653536|NCT00224406|448351519|FG000|Overall Study|Death|0|||
124653537|NCT00224406|448351520|FG001|Overall Study|Death|1|||
124653538|NCT00224406|448351519|FG000|Overall Study|Transplant cancelled|0|||
124653539|NCT00224406|448351520|FG001|Overall Study|Transplant cancelled|4|||
124653540|NCT00224406|448351519|FG000|Overall Study|Drug not delivered|2|||
124653541|NCT00224406|448351520|FG001|Overall Study|Drug not delivered|0|||
124653542|NCT00224406|448351519|FG000|Overall Study|Other|4|||
124653543|NCT00224406|448351520|FG001|Overall Study|Other|0|||
124653544|NCT00224406|448351519|FG000|Overall Study|Transplant cancelled|3|||
124653545|NCT00224406|448351520|FG001|Overall Study|Transplant cancelled|0|||
124653546|NCT01556997|448351521|FG000|Overall Study|Adverse Event|10|||
124653547|NCT01556997|448351522|FG001|Overall Study|Adverse Event|12|||
124653548|NCT01556997|448351523|FG002|Overall Study|Adverse Event|12|||
124653549|NCT01556997|448351521|FG000|Overall Study|Lost to Follow-up|6|||
124653550|NCT01556997|448351522|FG001|Overall Study|Lost to Follow-up|6|||
124653551|NCT01556997|448351523|FG002|Overall Study|Lost to Follow-up|4|||
124653552|NCT01556997|448351521|FG000|Overall Study|Physician Decision|1|||
124653553|NCT01556997|448351522|FG001|Overall Study|Physician Decision|1|||
124653554|NCT01556997|448351523|FG002|Overall Study|Physician Decision|1|||
124653555|NCT01556997|448351521|FG000|Overall Study|Withdrawal by Subject|7|||
124653556|NCT01556997|448351522|FG001|Overall Study|Withdrawal by Subject|6|||
124653557|NCT01556997|448351523|FG002|Overall Study|Withdrawal by Subject|8|||
124653558|NCT01556997|448351521|FG000|Overall Study|Other|2|||
124653559|NCT01556997|448351522|FG001|Overall Study|Other|3|||
124653560|NCT01556997|448351523|FG002|Overall Study|Other|7|||
124653561|NCT01172808|448351524|FG000|Overall Study|Adverse Event|8|||
124653562|NCT01172808|448351525|FG001|Overall Study|Adverse Event|4|||
124653563|NCT01172808|448351526|FG002|Overall Study|Adverse Event|8|||
124653564|NCT01172808|448351527|FG003|Overall Study|Adverse Event|3|||
124653565|NCT01172808|448351524|FG000|Overall Study|Lack of Efficacy|1|||
124653566|NCT01172808|448351525|FG001|Overall Study|Lack of Efficacy|0|||
124653567|NCT01172808|448351526|FG002|Overall Study|Lack of Efficacy|0|||
124653568|NCT01172808|448351527|FG003|Overall Study|Lack of Efficacy|0|||
124653569|NCT01172808|448351524|FG000|Overall Study|Protocol Violation|2|||
124653570|NCT01172808|448351525|FG001|Overall Study|Protocol Violation|2|||
124653571|NCT01172808|448351526|FG002|Overall Study|Protocol Violation|2|||
124653572|NCT01172808|448351527|FG003|Overall Study|Protocol Violation|0|||
124653573|NCT01172808|448351524|FG000|Overall Study|Lost to Follow-up|0|||
124653574|NCT01172808|448351525|FG001|Overall Study|Lost to Follow-up|1|||
124653575|NCT01172808|448351526|FG002|Overall Study|Lost to Follow-up|1|||
124653576|NCT01172808|448351527|FG003|Overall Study|Lost to Follow-up|3|||
124653577|NCT01172808|448351524|FG000|Overall Study|Withdrawal by Subject|4|||
124653578|NCT01172808|448351525|FG001|Overall Study|Withdrawal by Subject|1|||
124653579|NCT01172808|448351526|FG002|Overall Study|Withdrawal by Subject|3|||
124653580|NCT01172808|448351527|FG003|Overall Study|Withdrawal by Subject|2|||
124653581|NCT01172808|448351524|FG000|Overall Study|Other|6|||
124653582|NCT01172808|448351525|FG001|Overall Study|Other|5|||
124653583|NCT01172808|448351526|FG002|Overall Study|Other|9|||
124653584|NCT01172808|448351527|FG003|Overall Study|Other|7|||
124653585|NCT01092637|448351535|FG000|Overall Study|Death|47|||
124653586|NCT01092637|448351536|FG001|Overall Study|Death|49|||
124653587|NCT00577005|448351537|FG000|Overall Study|Lost to Follow-up|3|||
124653588|NCT00577005|448351538|FG001|Overall Study|Lost to Follow-up|2|||
124653589|NCT00577005|448351537|FG000|Overall Study|Withdrawal by Subject|2|||
124653590|NCT00577005|448351538|FG001|Overall Study|Withdrawal by Subject|1|||
124653591|NCT01004432|448351539|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
124653592|NCT01004432|448351540|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
124653593|NCT01004432|448351541|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
124653594|NCT01004432|448351542|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
124653595|NCT01004432|448351543|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
124653596|NCT01004432|448351539|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
124653597|NCT01004432|448351540|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
124653598|NCT01004432|448351541|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
124653599|NCT01004432|448351542|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
124653600|NCT01004432|448351543|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
124653601|NCT01004432|448351539|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
124653602|NCT01004432|448351540|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
124653603|NCT01004432|448351541|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
124653604|NCT01004432|448351542|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
124653605|NCT01004432|448351543|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
124653606|NCT01004432|448351539|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
124653607|NCT01004432|448351540|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
124653608|NCT01004432|448351541|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
124653609|NCT01004432|448351542|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
124653610|NCT01004432|448351543|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
124653611|NCT01004432|448351539|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
124653612|NCT01004432|448351540|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
124653613|NCT01004432|448351541|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
124653614|NCT01004432|448351542|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
124653615|NCT01004432|448351543|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
124653616|NCT01004432|448351539|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
124653617|NCT01004432|448351540|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
124653618|NCT01004432|448351541|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
124653619|NCT01004432|448351542|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
124653620|NCT01004432|448351543|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
124653621|NCT01004432|448351539|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
124653622|NCT01004432|448351540|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
124872816|NCT00500903|449155771|FG002|Overall Study|Symptomatic Deterioration|0|||
124653623|NCT01004432|448351541|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
124653624|NCT01004432|448351542|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
124653625|NCT01004432|448351543|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
124653626|NCT01004432|448351539|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
124653627|NCT01004432|448351540|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
124653628|NCT01004432|448351541|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
124653629|NCT01004432|448351542|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
124653630|NCT01004432|448351543|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
124653631|NCT01004432|448351539|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
124653632|NCT01004432|448351540|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
124653633|NCT01004432|448351541|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
124653634|NCT01004432|448351542|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
124653635|NCT01004432|448351543|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
124653636|NCT01004432|448351539|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
124653637|NCT01004432|448351540|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
124653638|NCT01004432|448351541|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
124653639|NCT01004432|448351542|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
124653640|NCT01004432|448351543|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
124653641|NCT01004432|448351539|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
124653642|NCT01004432|448351540|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
124653643|NCT01004432|448351541|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
124653644|NCT01004432|448351542|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
124653645|NCT01004432|448351543|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
124653646|NCT01004432|448351539|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
124653647|NCT01004432|448351540|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
124653648|NCT01004432|448351541|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
124653649|NCT01004432|448351542|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
124653650|NCT01004432|448351543|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
124653651|NCT01004432|448351539|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
124653652|NCT01004432|448351540|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
124653653|NCT01004432|448351541|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
124653654|NCT01004432|448351542|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
124653655|NCT01004432|448351543|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
124653656|NCT01004432|448351539|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
124653657|NCT01004432|448351540|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
124653658|NCT01004432|448351541|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
124653659|NCT01004432|448351542|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
124653660|NCT01004432|448351543|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
124653661|NCT01004432|448351539|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
124653662|NCT01004432|448351540|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
124653663|NCT01004432|448351541|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
124653664|NCT01004432|448351542|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
124653665|NCT01004432|448351543|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
124653666|NCT02667626|448351544|FG000|Overall Study|Withdrawal by Subject|0|||
124653667|NCT02667626|448351545|FG001|Overall Study|Withdrawal by Subject|1|||
124653668|NCT02696434|448351547|FG000|Overall Study|Adverse Event|3|||
124653669|NCT02696434|448351548|FG001|Overall Study|Adverse Event|1|||
124653670|NCT02696434|448351547|FG000|Overall Study|Lost to Follow-up|5|||
124653671|NCT02696434|448351548|FG001|Overall Study|Lost to Follow-up|4|||
124653672|NCT02696434|448351547|FG000|Overall Study|Withdrawal by Subject|14|||
124653673|NCT02696434|448351548|FG001|Overall Study|Withdrawal by Subject|12|||
124653674|NCT02696434|448351547|FG000|Overall Study|Physician Decision|0|||
124653675|NCT02696434|448351548|FG001|Overall Study|Physician Decision|1|||
124653676|NCT01149421|448351550|FG000|Overall Study|Adverse Event|22|||
124653677|NCT01149421|448351551|FG001|Overall Study|Adverse Event|6|||
124653678|NCT01149421|448351552|FG002|Overall Study|Adverse Event|11|||
124653679|NCT01149421|448351550|FG000|Overall Study|Withdrawal by Subject|20|||
124653680|NCT01149421|448351551|FG001|Overall Study|Withdrawal by Subject|12|||
124653681|NCT01149421|448351552|FG002|Overall Study|Withdrawal by Subject|13|||
124653682|NCT01149421|448351550|FG000|Overall Study|Sponsor Decision|0|||
124653683|NCT01149421|448351551|FG001|Overall Study|Sponsor Decision|1|||
124653684|NCT01149421|448351552|FG002|Overall Study|Sponsor Decision|1|||
124653685|NCT01149421|448351550|FG000|Overall Study|Lost to Follow-up|2|||
124653686|NCT01149421|448351551|FG001|Overall Study|Lost to Follow-up|4|||
124653687|NCT01149421|448351552|FG002|Overall Study|Lost to Follow-up|5|||
124653688|NCT01149421|448351550|FG000|Overall Study|Physician Decision|5|||
124653689|NCT01149421|448351551|FG001|Overall Study|Physician Decision|3|||
124653690|NCT01149421|448351552|FG002|Overall Study|Physician Decision|6|||
124653691|NCT01149421|448351550|FG000|Overall Study|Entry Criteria Not Met|1|||
124653692|NCT01149421|448351551|FG001|Overall Study|Entry Criteria Not Met|1|||
124653693|NCT01149421|448351552|FG002|Overall Study|Entry Criteria Not Met|2|||
124653694|NCT01149421|448351550|FG000|Overall Study|Protocol Violation|2|||
124653695|NCT01149421|448351551|FG001|Overall Study|Protocol Violation|2|||
124653696|NCT01149421|448351552|FG002|Overall Study|Protocol Violation|6|||
124653697|NCT00616603|448351553|FG000|Overall Study|Physician Decision|2|||
124653698|NCT00616603|448351554|FG001|Overall Study|Physician Decision|0|||
124653699|NCT00616603|448351555|FG002|Overall Study|Physician Decision|2|||
124653700|NCT03738800|448351558|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
124653701|NCT03738800|448351559|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
124653702|NCT03738800|448351560|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
124653703|NCT03738800|448351558|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
124653704|NCT03738800|448351559|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
124653705|NCT03738800|448351560|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
124653706|NCT03738800|448351558|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
124653707|NCT03738800|448351559|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
124653708|NCT03738800|448351560|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
124653709|NCT00943670|448351561|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
124653710|NCT00943670|448351561|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
124653711|NCT00943670|448351561|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
124653712|NCT00943670|448351561|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
124653713|NCT00943670|448351561|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
124653714|NCT00943670|448351561|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
124653715|NCT00943670|448351561|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
124653716|NCT00943670|448351561|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
124653717|NCT00943670|448351561|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
124653718|NCT00943670|448351561|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
124653719|NCT03956615|448351562|FG000|Overall Study|No multiple myeloma confirmed|2|||
124653720|NCT03956615|448351562|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
124653721|NCT03956615|448351562|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
124653722|NCT03956615|448351562|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
124653723|NCT01777295|448351563|FG000|Overall Study|Withdrawal by Subject|2|||
124653724|NCT01777295|448351564|FG001|Overall Study|Withdrawal by Subject|2|||
124653725|NCT01777295|448351563|FG000|Overall Study|Pregnancy|0|||
124653726|NCT01777295|448351564|FG001|Overall Study|Pregnancy|1|||
124653727|NCT01777295|448351563|FG000|Overall Study|Personal problem|1|||
124653728|NCT01777295|448351564|FG001|Overall Study|Personal problem|0|||
124653729|NCT01777295|448351563|FG000|Overall Study|Investigator call for AEs check|1|||
124653730|NCT01777295|448351564|FG001|Overall Study|Investigator call for AEs check|0|||
124653731|NCT02554318|448351565|FG000|Overall Study|Withdrawal by Subject|10|||
124653732|NCT02554318|448351566|FG001|Overall Study|Withdrawal by Subject|8|||
124653733|NCT00033657|448351567|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
124653734|NCT00033657|448351568|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
124653735|NCT00033657|448351567|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
124653736|NCT00033657|448351568|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
124653737|NCT00033657|448351567|FG000|Neoadjuvant Chemotherapy|Death|1|||
124653738|NCT00033657|448351568|FG001|Neoadjuvant Chemotherapy|Death|1|||
124653739|NCT00033657|448351567|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
124653740|NCT00033657|448351568|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
124653741|NCT00033657|448351567|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
124653742|NCT00033657|448351568|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
124653743|NCT00033657|448351567|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
124653744|NCT00033657|448351568|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
124653745|NCT00033657|448351567|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
124653746|NCT00033657|448351568|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
124653747|NCT00033657|448351567|FG000|Surgical Resection|not complete resection|0|||
124653748|NCT00033657|448351568|FG001|Surgical Resection|not complete resection|3|||
124653749|NCT00033657|448351567|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
124653750|NCT00033657|448351568|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
124653751|NCT00033657|448351567|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
124653752|NCT00033657|448351568|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
124653753|NCT00033657|448351567|FG000|Adjuvant Chemotherapy|Death|2|||
124653754|NCT00033657|448351568|FG001|Adjuvant Chemotherapy|Death|1|||
124653755|NCT00033657|448351567|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
124653756|NCT00033657|448351568|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
124653757|NCT00033657|448351567|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
124653758|NCT00033657|448351568|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
124653759|NCT00033657|448351567|FG000|Adjuvant Chemotherapy|Other|0|||
124653760|NCT00033657|448351568|FG001|Adjuvant Chemotherapy|Other|2|||
124653761|NCT02945254|448351569|FG000|Overall Study|Lost to Follow-up|1|||
124653762|NCT02945254|448351570|FG001|Overall Study|Lost to Follow-up|0|||
124653763|NCT02945254|448351569|FG000|Overall Study|Withdrawal by Subject|1|||
124653764|NCT02945254|448351570|FG001|Overall Study|Withdrawal by Subject|0|||
124653765|NCT03436199|448351575|FG000|Overall Study|Adverse Event|15|||
124653766|NCT03436199|448351576|FG001|Overall Study|Adverse Event|40|||
124653767|NCT03436199|448351577|FG002|Overall Study|Adverse Event|7|||
124653768|NCT03436199|448351575|FG000|Overall Study|Withdrawal by Subject|4|||
124653769|NCT03436199|448351576|FG001|Overall Study|Withdrawal by Subject|10|||
124653770|NCT03436199|448351577|FG002|Overall Study|Withdrawal by Subject|3|||
124653771|NCT03436199|448351575|FG000|Overall Study|Lost to Follow-up|1|||
124653772|NCT03436199|448351576|FG001|Overall Study|Lost to Follow-up|0|||
124653773|NCT03436199|448351577|FG002|Overall Study|Lost to Follow-up|2|||
124653774|NCT03436199|448351575|FG000|Overall Study|Protocol Violation|1|||
124653775|NCT03436199|448351576|FG001|Overall Study|Protocol Violation|1|||
124653776|NCT03436199|448351577|FG002|Overall Study|Protocol Violation|0|||
124653777|NCT03436199|448351575|FG000|Overall Study|Physician Decision|0|||
124653778|NCT03436199|448351576|FG001|Overall Study|Physician Decision|1|||
124653779|NCT03436199|448351577|FG002|Overall Study|Physician Decision|0|||
124653780|NCT03436199|448351575|FG000|Overall Study|Could not return to clinic|1|||
124653781|NCT03436199|448351576|FG001|Overall Study|Could not return to clinic|0|||
124653782|NCT03436199|448351577|FG002|Overall Study|Could not return to clinic|0|||
124653783|NCT03436199|448351575|FG000|Overall Study|Withdrawn per physician|0|||
124653784|NCT03436199|448351576|FG001|Overall Study|Withdrawn per physician|1|||
124653785|NCT03436199|448351577|FG002|Overall Study|Withdrawn per physician|0|||
124653786|NCT00085098|448351578|FG000|Overall Study|Withdrawal by Subject|0|||
124653787|NCT00085098|448351579|FG001|Overall Study|Withdrawal by Subject|1|||
124653788|NCT00085098|448351578|FG000|Overall Study|Ineligible|1|||
124653789|NCT00085098|448351579|FG001|Overall Study|Ineligible|1|||
124653790|NCT03515629|448351580|FG000|Overall Study|Death|0|||
124653791|NCT03515629|448351581|FG001|Overall Study|Death|1|||
124653792|NCT03515629|448351582|FG002|Overall Study|Death|1|||
124653793|NCT03515629|448351580|FG000|Overall Study|Progressive disease|0|||
124653794|NCT03515629|448351581|FG001|Overall Study|Progressive disease|1|||
124653795|NCT03515629|448351582|FG002|Overall Study|Progressive disease|0|||
124653796|NCT01886781|448351583|FG000|Overall Study|Protocol Violation|5|||
124653797|NCT01886781|448351584|FG001|Overall Study|Protocol Violation|0|||
124653798|NCT01886781|448351583|FG000|Overall Study|Adverse Event|1|||
124653799|NCT01886781|448351584|FG001|Overall Study|Adverse Event|0|||
124653800|NCT01886781|448351583|FG000|Overall Study|Lost to Follow-up|5|||
124653801|NCT01886781|448351584|FG001|Overall Study|Lost to Follow-up|0|||
124653802|NCT01886781|448351583|FG000|Overall Study|Withdrawal by Subject|2|||
124653803|NCT01886781|448351584|FG001|Overall Study|Withdrawal by Subject|1|||
124653804|NCT01886781|448351583|FG000|Overall Study|Worsening of symptoms|1|||
124653805|NCT01886781|448351584|FG001|Overall Study|Worsening of symptoms|1|||
124653806|NCT00980018|448351585|FG000|Overall Study|Adverse Event|8|||
124653807|NCT00980018|448351585|FG000|Overall Study|Patient withdrew consent|3|||
124653808|NCT00980018|448351585|FG000|Overall Study|Lost to Follow-up|1|||
124653809|NCT01522235|448351586|FG000|Overall Study|Physician Decision|1|||
124653810|NCT01522235|448351587|FG001|Overall Study|Physician Decision|1|||
124653811|NCT01672294|448351590|FG000|Overall Study|Withdrawal by Subject|4|||
124653812|NCT01672294|448351591|FG001|Overall Study|Withdrawal by Subject|4|||
124653813|NCT01672294|448351592|FG002|Overall Study|Withdrawal by Subject|4|||
124653814|NCT01672294|448351593|FG003|Overall Study|Withdrawal by Subject|4|||
124653815|NCT01672294|448351590|FG000|Overall Study|Excluded by study|1|||
124653816|NCT01672294|448351591|FG001|Overall Study|Excluded by study|1|||
124653817|NCT01672294|448351592|FG002|Overall Study|Excluded by study|0|||
124653818|NCT01672294|448351593|FG003|Overall Study|Excluded by study|0|||
124653819|NCT01672294|448351590|FG000|Overall Study|Lost to Follow-up|1|||
124653820|NCT01672294|448351591|FG001|Overall Study|Lost to Follow-up|16|||
124653821|NCT01672294|448351592|FG002|Overall Study|Lost to Follow-up|7|||
124653822|NCT01672294|448351593|FG003|Overall Study|Lost to Follow-up|9|||
124653823|NCT01438814|448351599|FG000|Overall Study|Adverse Event|3|||
124653824|NCT01438814|448351600|FG001|Overall Study|Adverse Event|3|||
124653825|NCT01438814|448351599|FG000|Overall Study|Protocol Violation|1|||
124653826|NCT01438814|448351600|FG001|Overall Study|Protocol Violation|2|||
124653827|NCT01438814|448351599|FG000|Overall Study|Lost to Follow-up|4|||
124653828|NCT01438814|448351600|FG001|Overall Study|Lost to Follow-up|3|||
124653829|NCT01438814|448351599|FG000|Overall Study|Withdrawal by Subject|4|||
124653830|NCT01438814|448351600|FG001|Overall Study|Withdrawal by Subject|2|||
124653831|NCT01438814|448351599|FG000|Overall Study|Other|2|||
124653832|NCT01438814|448351600|FG001|Overall Study|Other|4|||
124653833|NCT01870297|448351605|FG000|Overall Study|Adverse Event|0|||
124653834|NCT01870297|448351606|FG001|Overall Study|Adverse Event|0|||
124653835|NCT01870297|448351607|FG002|Overall Study|Adverse Event|0|||
124653836|NCT01870297|448351608|FG003|Overall Study|Adverse Event|0|||
124653837|NCT01870297|448351609|FG004|Overall Study|Adverse Event|2|||
124653838|NCT01870297|448351610|FG005|Overall Study|Adverse Event|0|||
124653839|NCT01870297|448351611|FG006|Overall Study|Adverse Event|0|||
124653840|NCT01870297|448351605|FG000|Overall Study|Lost to Follow-up|0|||
124653841|NCT01870297|448351606|FG001|Overall Study|Lost to Follow-up|1|||
124653842|NCT01870297|448351607|FG002|Overall Study|Lost to Follow-up|1|||
124653843|NCT01870297|448351608|FG003|Overall Study|Lost to Follow-up|0|||
124653844|NCT01870297|448351609|FG004|Overall Study|Lost to Follow-up|0|||
124653845|NCT01870297|448351610|FG005|Overall Study|Lost to Follow-up|0|||
124653846|NCT01870297|448351611|FG006|Overall Study|Lost to Follow-up|0|||
124653847|NCT01870297|448351605|FG000|Overall Study|Withdrawal by Subject|0|||
124653848|NCT01870297|448351606|FG001|Overall Study|Withdrawal by Subject|0|||
124653849|NCT01870297|448351607|FG002|Overall Study|Withdrawal by Subject|0|||
124653850|NCT01870297|448351608|FG003|Overall Study|Withdrawal by Subject|0|||
124653851|NCT01870297|448351609|FG004|Overall Study|Withdrawal by Subject|1|||
124653852|NCT01870297|448351610|FG005|Overall Study|Withdrawal by Subject|1|||
124653853|NCT01870297|448351611|FG006|Overall Study|Withdrawal by Subject|1|||
124653854|NCT01870297|448351605|FG000|Overall Study|Sponsor Decision|0|||
124653855|NCT01870297|448351606|FG001|Overall Study|Sponsor Decision|6|||
124653856|NCT01870297|448351607|FG002|Overall Study|Sponsor Decision|0|||
124653857|NCT01870297|448351608|FG003|Overall Study|Sponsor Decision|0|||
124653858|NCT01870297|448351609|FG004|Overall Study|Sponsor Decision|0|||
124653859|NCT01870297|448351610|FG005|Overall Study|Sponsor Decision|0|||
124653860|NCT01870297|448351611|FG006|Overall Study|Sponsor Decision|1|||
124653861|NCT00337779|448351612|FG000|Overall Study|Withdrawal by Subject|10|||
124653862|NCT00337779|448351613|FG001|Overall Study|Withdrawal by Subject|12|||
124653863|NCT00337779|448351612|FG000|Overall Study|Sponsor decision|1|||
124653864|NCT00337779|448351613|FG001|Overall Study|Sponsor decision|1|||
124653865|NCT00337779|448351612|FG000|Overall Study|Physician Decision|3|||
124653866|NCT00337779|448351613|FG001|Overall Study|Physician Decision|6|||
124653867|NCT00337779|448351612|FG000|Overall Study|Protocol Violation|1|||
124653868|NCT00337779|448351613|FG001|Overall Study|Protocol Violation|1|||
124653869|NCT00337779|448351612|FG000|Overall Study|Lost to Follow-up|6|||
124653870|NCT00337779|448351613|FG001|Overall Study|Lost to Follow-up|5|||
124653871|NCT00337779|448351612|FG000|Overall Study|Adverse Event|28|||
124653872|NCT00337779|448351613|FG001|Overall Study|Adverse Event|51|||
124653873|NCT00337779|448351612|FG000|Overall Study|Pregnancy|3|||
124653874|NCT00337779|448351613|FG001|Overall Study|Pregnancy|2|||
124653875|NCT00337779|448351612|FG000|Overall Study|Death|0|||
124653876|NCT00337779|448351613|FG001|Overall Study|Death|1|||
124653877|NCT01162122|448351614|FG000|Overall Study|Withdrawal by Subject|52|||
124653878|NCT01162122|448351615|FG001|Overall Study|Withdrawal by Subject|43|||
124653879|NCT01162122|448351614|FG000|Overall Study|Lost to Follow-up|73|||
124653880|NCT01162122|448351615|FG001|Overall Study|Lost to Follow-up|91|||
124653881|NCT01162122|448351614|FG000|Overall Study|Adverse Event|3|||
124653882|NCT01162122|448351615|FG001|Overall Study|Adverse Event|2|||
124653883|NCT01162122|448351614|FG000|Overall Study|Death|51|||
124653884|NCT01162122|448351615|FG001|Overall Study|Death|46|||
124653885|NCT01162122|448351614|FG000|Overall Study|Protocol Violation|2|||
124653886|NCT01162122|448351615|FG001|Overall Study|Protocol Violation|2|||
124653887|NCT01162122|448351614|FG000|Overall Study|Inappropriate enrollment|5|||
124653888|NCT01162122|448351615|FG001|Overall Study|Inappropriate enrollment|4|||
124653889|NCT01162122|448351614|FG000|Overall Study|Administrative reason|1|||
124653890|NCT01162122|448351615|FG001|Overall Study|Administrative reason|1|||
124653891|NCT01162122|448351614|FG000|Overall Study|Unable to classify|3|||
124653892|NCT01162122|448351615|FG001|Overall Study|Unable to classify|7|||
124653893|NCT01162122|448351614|FG000|Overall Study|Missing primary reason|1|||
124653894|NCT01162122|448351615|FG001|Overall Study|Missing primary reason|0|||
124653895|NCT02020512|448351616|FG000|Overall Study|Adverse Event|1|||
124653896|NCT02020512|448351616|FG000|Overall Study|Lost to Follow-up|3|||
124653897|NCT02020512|448351616|FG000|Overall Study|Protocol Violation|4|||
124653898|NCT00422422|448351620|FG000|Overall Study|Lack of Efficacy|1|||
124653899|NCT00422422|448351620|FG000|Overall Study|Protocol Violation|1|||
124653900|NCT00422422|448351620|FG000|Overall Study|Withdrawal by Subject|2|||
124653901|NCT00422422|448351620|FG000|Overall Study|SAE, non-fatal|1|||
124653902|NCT00422422|448351620|FG000|Overall Study|AE, non-serious non-fatal|5|||
124653903|NCT03313310|448351621|FG000|Phase 2|Lost to Follow-up|4|||
124653904|NCT03313310|448351622|FG001|Phase 2|Lost to Follow-up|0|||
124653905|NCT03313310|448351621|FG000|Phase 3|Lost to Follow-up|0|||
124653906|NCT03313310|448351622|FG001|Phase 3|Lost to Follow-up|1|||
124653907|NCT00926536|448351623|FG000|Overall Study|Physician Decision|1|||
124653908|NCT00926536|448351624|FG001|Overall Study|Physician Decision|2|||
124653909|NCT00990665|448351625|FG000|Overall Study|Unsuccessful Implant|8|||
124653910|NCT00990665|448351625|FG000|Overall Study|Death|29|||
124653911|NCT00990665|448351625|FG000|Overall Study|Heart Transplant|1|||
124653912|NCT00990665|448351625|FG000|Overall Study|Withdrawal by Subject|6|||
124653913|NCT00990665|448351625|FG000|Overall Study|Lost to Follow-up|1|||
124653914|NCT00990665|448351625|FG000|Overall Study|System Explant|3|||
124653915|NCT01717391|448351628|FG000|Overall Study|Withdrawal by Subject|5|||
124653916|NCT01717391|448351628|FG000|Overall Study|Physician Decision|1|||
124653917|NCT01717391|448351628|FG000|Overall Study|FLT technical failure|3|||
124653918|NCT02918552|448351630|FG000|Overall Study|Failed Pharmacokinetics|1|||
124653919|NCT02918552|448351631|FG001|Overall Study|Failed Pharmacokinetics|0|||
124653920|NCT02918552|448351630|FG000|Overall Study|Withdrawal by Subject|0|||
124653921|NCT02918552|448351631|FG001|Overall Study|Withdrawal by Subject|1|||
124653922|NCT02918552|448351630|FG000|Overall Study|Lost to Follow-up|0|||
124653923|NCT02918552|448351631|FG001|Overall Study|Lost to Follow-up|1|||
124653924|NCT01731470|448351632|FG000|Overall Study|Withdrawal by Subject|1|||
124653925|NCT01731470|448351632|FG000|Overall Study|Did not meet study criteria|1|||
124653926|NCT04395274|448351633|FG000|Overall Study|Lost to Follow-up|20|||
124653927|NCT04395274|448351634|FG001|Overall Study|Lost to Follow-up|11|||
124653928|NCT04395274|448351633|FG000|Overall Study|Withdrawal by Subject|13|||
124653929|NCT04395274|448351634|FG001|Overall Study|Withdrawal by Subject|10|||
124653930|NCT04395274|448351633|FG000|Overall Study|Moved Abroad|0|||
124653931|NCT04395274|448351634|FG001|Overall Study|Moved Abroad|1|||
124653932|NCT00335959|448351637|FG000|Overall Study|Adverse Event|2|||
124653933|NCT00335959|448351637|FG000|Overall Study|Ineligible|1|||
124653934|NCT03482167|448351640|FG000|Allocated to Intervention|Physician Decision|1|||
124653935|NCT03482167|448351641|FG001|Allocated to Intervention|Physician Decision|2|||
124653936|NCT03482167|448351640|FG000|Received Intervention|Adverse Event|3|||
124653937|NCT03482167|448351641|FG001|Received Intervention|Adverse Event|1|||
124653938|NCT03482167|448351640|FG000|Received Intervention|Physician Decision|1|||
124653939|NCT03482167|448351641|FG001|Received Intervention|Physician Decision|1|||
124653940|NCT03482167|448351640|FG000|Received Intervention|Withdrawal by Subject|1|||
124653941|NCT03482167|448351641|FG001|Received Intervention|Withdrawal by Subject|0|||
124653942|NCT02450552|448351645|FG000|Overall Study|Withdrawal by Subject|4|||
124653943|NCT02450552|448351646|FG001|Overall Study|Withdrawal by Subject|0|||
124653944|NCT02450552|448351647|FG002|Overall Study|Withdrawal by Subject|4|||
124653945|NCT02450552|448351645|FG000|Overall Study|Physician Decision|1|||
124653946|NCT02450552|448351646|FG001|Overall Study|Physician Decision|0|||
124653947|NCT02450552|448351647|FG002|Overall Study|Physician Decision|1|||
124653948|NCT05079230|448351656|FG000|Overall Study|Study Terminated by Sponsor|101|||
124653949|NCT05079230|448351657|FG001|Overall Study|Study Terminated by Sponsor|102|||
124653950|NCT05079230|448351656|FG000|Overall Study|Death|72|||
124653951|NCT05079230|448351657|FG001|Overall Study|Death|66|||
124653952|NCT05079230|448351656|FG000|Overall Study|Withdrew Consent|16|||
124653953|NCT05079230|448351657|FG001|Overall Study|Withdrew Consent|18|||
124653954|NCT05079230|448351656|FG000|Overall Study|Lost to Follow-up|0|||
124653955|NCT05079230|448351657|FG001|Overall Study|Lost to Follow-up|3|||
124653956|NCT02920177|448351658|FG000|Overall Study|Withdrawal by Subject|1|||
124653957|NCT02920177|448351659|FG001|Overall Study|Withdrawal by Subject|1|||
124653958|NCT02920177|448351658|FG000|Overall Study|Physician Decision|1|||
124653959|NCT02920177|448351659|FG001|Overall Study|Physician Decision|0|||
124653960|NCT02920177|448351658|FG000|Overall Study|Lost to Follow-up|0|||
124653961|NCT02920177|448351659|FG001|Overall Study|Lost to Follow-up|1|||
124653962|NCT01876979|448351660|FG000|Overall Study|Physician Decision|2|||
124653963|NCT01876979|448351661|FG001|Overall Study|Physician Decision|3|||
124653964|NCT05153148|448351663|FG000|Overall Study|Adverse Event|1|||
124653965|NCT05153148|448351664|FG001|Overall Study|Adverse Event|0|||
124653966|NCT05153148|448351665|FG002|Overall Study|Adverse Event|3|||
124653967|NCT05153148|448351666|FG003|Overall Study|Adverse Event|5|||
124653968|NCT05153148|448351663|FG000|Overall Study|Lost to Follow-up|1|||
124653969|NCT05153148|448351664|FG001|Overall Study|Lost to Follow-up|1|||
124653970|NCT05153148|448351665|FG002|Overall Study|Lost to Follow-up|2|||
124653971|NCT05153148|448351666|FG003|Overall Study|Lost to Follow-up|0|||
124653972|NCT05153148|448351663|FG000|Overall Study|Withdrawal by Subject|6|||
124653973|NCT05153148|448351664|FG001|Overall Study|Withdrawal by Subject|8|||
124653974|NCT05153148|448351665|FG002|Overall Study|Withdrawal by Subject|6|||
124653975|NCT05153148|448351666|FG003|Overall Study|Withdrawal by Subject|8|||
124653976|NCT05153148|448351663|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
124653977|NCT05153148|448351664|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
124653978|NCT05153148|448351665|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
124653979|NCT05153148|448351666|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
124653980|NCT05153148|448351663|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
124653981|NCT05153148|448351664|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
124653982|NCT05153148|448351665|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
124653983|NCT05153148|448351666|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
124653984|NCT05153148|448351663|FG000|Overall Study|Reason not Specified|1|||
124653985|NCT05153148|448351664|FG001|Overall Study|Reason not Specified|1|||
124653986|NCT05153148|448351665|FG002|Overall Study|Reason not Specified|1|||
124653987|NCT05153148|448351666|FG003|Overall Study|Reason not Specified|1|||
124653988|NCT01712334|448351669|FG000|Treatment Period 1|Randomized in Error|0|||
124653989|NCT01712334|448351670|FG001|Treatment Period 1|Randomized in Error|2|||
124653990|NCT02892513|448351671|FG000|Overall Study|Withdrawal by Subject|0|||
124653991|NCT02892513|448351672|FG001|Overall Study|Withdrawal by Subject|1|||
124653992|NCT03426436|448351673|FG000|Overall Study|Incorrect lead placement|12|||
124653993|NCT03426436|448351673|FG000|Overall Study|Withdrawal by Subject|2|||
124653994|NCT03426436|448351673|FG000|Overall Study|Consent issue|1|||
124653995|NCT03426436|448351673|FG000|Overall Study|ECGs not saved|4|||
124653996|NCT02044874|448351674|FG000|Overall Study|Adverse Event|5|||
124653997|NCT02044874|448351675|FG001|Overall Study|Adverse Event|6|||
124653998|NCT02044874|448351676|FG002|Overall Study|Adverse Event|6|||
124653999|NCT02044874|448351674|FG000|Overall Study|Withdrawal by Subject|8|||
124654000|NCT02044874|448351675|FG001|Overall Study|Withdrawal by Subject|16|||
124654001|NCT02044874|448351676|FG002|Overall Study|Withdrawal by Subject|23|||
124654002|NCT02044874|448351674|FG000|Overall Study|Physician Decision|0|||
124654003|NCT02044874|448351675|FG001|Overall Study|Physician Decision|2|||
124654004|NCT02044874|448351676|FG002|Overall Study|Physician Decision|1|||
124654005|NCT02044874|448351674|FG000|Overall Study|Lost to Follow-up|10|||
124654006|NCT02044874|448351675|FG001|Overall Study|Lost to Follow-up|27|||
124654007|NCT02044874|448351676|FG002|Overall Study|Lost to Follow-up|21|||
124654008|NCT02044874|448351674|FG000|Overall Study|Sponsor Decision|0|||
124654009|NCT02044874|448351675|FG001|Overall Study|Sponsor Decision|1|||
124654010|NCT02044874|448351676|FG002|Overall Study|Sponsor Decision|1|||
124654011|NCT02044874|448351674|FG000|Overall Study|Other|7|||
124654012|NCT02044874|448351675|FG001|Overall Study|Other|3|||
124654013|NCT02044874|448351676|FG002|Overall Study|Other|8|||
124654014|NCT02278367|448353398|FG000|Overall Study|Physician Decision|5|||
124654015|NCT02278367|448353399|FG001|Overall Study|Physician Decision|0|||
124654016|NCT02278367|448353398|FG000|Overall Study|Withdrawal by Subject|5|||
124654017|NCT02278367|448353399|FG001|Overall Study|Withdrawal by Subject|0|||
124654018|NCT05932225|448353401|FG000|Overall Study|Lost to Follow-up|0|||
124654019|NCT05932225|448353402|FG001|Overall Study|Lost to Follow-up|1|||
124654020|NCT05932225|448353403|FG002|Overall Study|Lost to Follow-up|0|||
124654021|NCT05932225|448353401|FG000|Overall Study|Withdrawal by Subject|1|||
124654022|NCT05932225|448353402|FG001|Overall Study|Withdrawal by Subject|0|||
124654023|NCT05932225|448353403|FG002|Overall Study|Withdrawal by Subject|0|||
124654024|NCT05932225|448353401|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
124654025|NCT05932225|448353402|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
124654026|NCT05932225|448353403|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
124654027|NCT02638129|448353404|FG000|Overall Study|Study terminated|28|||
124654028|NCT02638129|448353405|FG001|Overall Study|Study terminated|30|||
124654029|NCT02949908|448353408|FG000|Overall Study|Study termination|2|||
124654030|NCT02607280|448353413|FG000|Overall Study|Adverse Event|4|||
124654031|NCT02607280|448353414|FG001|Overall Study|Adverse Event|0|||
124654032|NCT02607280|448353413|FG000|Overall Study|Decrease in CrCl <15|0|||
124654033|NCT02607280|448353414|FG001|Overall Study|Decrease in CrCl <15|1|||
124654034|NCT02539134|448353415|FG000|Overall Study|Lost to Follow-up|1|||
124654035|NCT02539134|448353416|FG001|Overall Study|Lost to Follow-up|0|||
124654036|NCT02539134|448353417|FG002|Overall Study|Lost to Follow-up|0|||
124654037|NCT02539134|448353418|FG003|Overall Study|Lost to Follow-up|0|||
124654038|NCT02539134|448353419|FG004|Overall Study|Lost to Follow-up|0|||
124654039|NCT02539134|448353420|FG005|Overall Study|Lost to Follow-up|0|||
124654040|NCT00766467|448353422|FG000|Overall Study|Withdrawal by Subject|7|||
124654041|NCT00766467|448353423|FG001|Overall Study|Withdrawal by Subject|2|||
124654042|NCT00766467|448353422|FG000|Overall Study|Adverse Event|1|||
124654043|NCT00766467|448353423|FG001|Overall Study|Adverse Event|1|||
124654044|NCT00766467|448353422|FG000|Overall Study|Protocol Violation|2|||
124654045|NCT00766467|448353423|FG001|Overall Study|Protocol Violation|4|||
124654046|NCT00766467|448353422|FG000|Overall Study|Tumor Progression on Study|0|||
124654047|NCT00766467|448353423|FG001|Overall Study|Tumor Progression on Study|1|||
124654048|NCT00766467|448353422|FG000|Overall Study|Physician Decision|1|||
124654049|NCT00766467|448353423|FG001|Overall Study|Physician Decision|0|||
124654050|NCT01069419|448353433|FG000|Overall Study|Adverse Event|233|||
124654051|NCT01069419|448353433|FG000|Overall Study|Lack of Efficacy|332|||
124654052|NCT01069419|448353433|FG000|Overall Study|Lost to Follow-up|49|||
124654053|NCT01069419|448353433|FG000|Overall Study|Remission of disease|11|||
124654054|NCT01069419|448353433|FG000|Overall Study|Withdrawal by Subject|34|||
124654055|NCT01069419|448353433|FG000|Overall Study|Other Reason|43|||
124654056|NCT01069419|448353433|FG000|Overall Study|Missing termination information|13|||
124654057|NCT00908076|448353434|FG000|Overall Study|Lack of Efficacy|1|||
124654058|NCT00908076|448353435|FG001|Overall Study|Lack of Efficacy|1|||
124654059|NCT02382796|448353436|FG000|Overall Study|Global deterioration of health status|1|||
124654060|NCT02382796|448353436|FG000|Overall Study|Objective progression or relapse|3|||
124654061|NCT02382796|448353436|FG000|Overall Study|Commercial dacomitinib became available|3|||
124654062|NCT00334802|448353443|FG000|Overall Study|Progressive Disease|2|||
124654063|NCT00334802|448353444|FG001|Overall Study|Progressive Disease|24|||
124654064|NCT00334802|448353443|FG000|Overall Study|Toxicity|1|||
124654065|NCT00334802|448353444|FG001|Overall Study|Toxicity|5|||
124654066|NCT00334802|448353443|FG000|Overall Study|Lack of Efficacy|1|||
124654067|NCT00334802|448353444|FG001|Overall Study|Lack of Efficacy|3|||
124654068|NCT00334802|448353443|FG000|Overall Study|Patient Condition Aggrevated|1|||
124654069|NCT00334802|448353444|FG001|Overall Study|Patient Condition Aggrevated|0|||
124654070|NCT00334802|448353443|FG000|Overall Study|Physician Decision|1|||
124654071|NCT00334802|448353444|FG001|Overall Study|Physician Decision|0|||
124654072|NCT00334802|448353443|FG000|Overall Study|Withdrawal by Subject|0|||
124654073|NCT00334802|448353444|FG001|Overall Study|Withdrawal by Subject|4|||
124654074|NCT00334802|448353443|FG000|Overall Study|Adverse Event|0|||
124654075|NCT00334802|448353444|FG001|Overall Study|Adverse Event|3|||
124654076|NCT00334802|448353443|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
124654077|NCT00334802|448353444|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
124654078|NCT03887117|448353445|FG000|Overall Study|Discontinued prematurely|0|||
124654079|NCT03887117|448353446|FG001|Overall Study|Discontinued prematurely|1|||
124654080|NCT03887117|448353447|FG002|Overall Study|Discontinued prematurely|1|||
124654081|NCT03887117|448353448|FG003|Overall Study|Discontinued prematurely|2|||
124654082|NCT01739764|448353449|FG000|Overall Study|Adverse Event|0|||
124654083|NCT01739764|448353450|FG001|Overall Study|Adverse Event|3|||
124654084|NCT01739764|448353451|FG002|Overall Study|Adverse Event|4|||
124654085|NCT01739764|448353449|FG000|Overall Study|Death|4|||
124654086|NCT01739764|448353450|FG001|Overall Study|Death|6|||
124654087|NCT01739764|448353451|FG002|Overall Study|Death|38|||
124654088|NCT01739764|448353449|FG000|Overall Study|Lost to Follow-up|0|||
124654089|NCT01739764|448353450|FG001|Overall Study|Lost to Follow-up|0|||
124654090|NCT01739764|448353451|FG002|Overall Study|Lost to Follow-up|5|||
124654091|NCT01739764|448353449|FG000|Overall Study|Non-Compliance|0|||
124654092|NCT01739764|448353450|FG001|Overall Study|Non-Compliance|0|||
124654093|NCT01739764|448353451|FG002|Overall Study|Non-Compliance|1|||
124654094|NCT01739764|448353449|FG000|Overall Study|Multiple Reasons|3|||
124654095|NCT01739764|448353450|FG001|Overall Study|Multiple Reasons|2|||
124654096|NCT01739764|448353451|FG002|Overall Study|Multiple Reasons|3|||
124654097|NCT01739764|448353449|FG000|Overall Study|Physician Decision|2|||
124654098|NCT01739764|448353450|FG001|Overall Study|Physician Decision|2|||
124654099|NCT01739764|448353451|FG002|Overall Study|Physician Decision|4|||
124654100|NCT01739764|448353449|FG000|Overall Study|Progressive Disease|3|||
124654101|NCT01739764|448353450|FG001|Overall Study|Progressive Disease|5|||
124654102|NCT01739764|448353451|FG002|Overall Study|Progressive Disease|16|||
124654103|NCT01739764|448353449|FG000|Overall Study|Protocol Violation|0|||
124654104|NCT01739764|448353450|FG001|Overall Study|Protocol Violation|0|||
124654105|NCT01739764|448353451|FG002|Overall Study|Protocol Violation|2|||
124654106|NCT01739764|448353449|FG000|Overall Study|Study Terminated by Sponsor|8|||
124654107|NCT01739764|448353450|FG001|Overall Study|Study Terminated by Sponsor|13|||
124654108|NCT01739764|448353451|FG002|Overall Study|Study Terminated by Sponsor|26|||
124654109|NCT01739764|448353449|FG000|Overall Study|Withdrawal by Subject|6|||
124654110|NCT01739764|448353450|FG001|Overall Study|Withdrawal by Subject|5|||
124654111|NCT01739764|448353451|FG002|Overall Study|Withdrawal by Subject|27|||
124654112|NCT01389258|448353452|FG000|Overall Study|Lost to Follow-up|5|||
124654113|NCT01534208|448353453|FG000|Overall Study|Lost to Follow-up|19|||
124654114|NCT01534208|448353454|FG001|Overall Study|Lost to Follow-up|14|||
124654115|NCT01534208|448353453|FG000|Overall Study|Withdrawal by Subject|6|||
124654116|NCT01534208|448353454|FG001|Overall Study|Withdrawal by Subject|20|||
124654117|NCT01534208|448353453|FG000|Overall Study|Adverse Event|15|||
124654118|NCT01534208|448353454|FG001|Overall Study|Adverse Event|8|||
124654119|NCT01534208|448353453|FG000|Overall Study|Physician Decision|2|||
124654120|NCT01534208|448353454|FG001|Overall Study|Physician Decision|0|||
124654121|NCT01534208|448353453|FG000|Overall Study|Lack of Efficacy|0|||
124654122|NCT01534208|448353454|FG001|Overall Study|Lack of Efficacy|3|||
124654123|NCT01534208|448353453|FG000|Overall Study|Protocol Violation|2|||
124654124|NCT01534208|448353454|FG001|Overall Study|Protocol Violation|2|||
124654125|NCT01534208|448353453|FG000|Overall Study|Sponsor decision|4|||
124654126|NCT01534208|448353454|FG001|Overall Study|Sponsor decision|1|||
124654127|NCT01534208|448353453|FG000|Overall Study|Subject relocation|2|||
124654128|NCT01534208|448353454|FG001|Overall Study|Subject relocation|0|||
124654129|NCT01534208|448353453|FG000|Overall Study|Lab assessment|2|||
124654130|NCT01534208|448353454|FG001|Overall Study|Lab assessment|1|||
124654131|NCT01534208|448353453|FG000|Overall Study|Eligibility error|3|||
124654132|NCT01534208|448353454|FG001|Overall Study|Eligibility error|0|||
124654133|NCT01534208|448353453|FG000|Overall Study|PCP decision|1|||
124654134|NCT01534208|448353454|FG001|Overall Study|PCP decision|0|||
124654135|NCT01534208|448353453|FG000|Overall Study|Needed prohibited meds|1|||
124654136|NCT01534208|448353454|FG001|Overall Study|Needed prohibited meds|0|||
124654137|NCT00045734|448353455|FG000|Overall Study|Protocol Violation|1|||
124654138|NCT01001598|448353457|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
124654139|NCT01001598|448353457|FG000|Overall Study|Adverse Event|1|||
124654140|NCT01524783|448353464|FG000|Blinded Period|Adverse Event|64|||
124654141|NCT01524783|448353465|FG001|Blinded Period|Adverse Event|7|||
124654142|NCT01524783|448353466|FG002|Blinded Period|Adverse Event|0|||
124654143|NCT01524783|448353464|FG000|Blinded Period|Disease Progression|89|||
124654144|NCT01524783|448353465|FG001|Blinded Period|Disease Progression|75|||
124654145|NCT01524783|448353466|FG002|Blinded Period|Disease Progression|0|||
124654146|NCT01524783|448353464|FG000|Blinded Period|Withdrawal by Subject|19|||
124654147|NCT01524783|448353465|FG001|Blinded Period|Withdrawal by Subject|6|||
124654148|NCT01524783|448353466|FG002|Blinded Period|Withdrawal by Subject|0|||
124654149|NCT01524783|448353464|FG000|Blinded Period|Protocol deviation|2|||
124654150|NCT01524783|448353465|FG001|Blinded Period|Protocol deviation|1|||
124654151|NCT01524783|448353466|FG002|Blinded Period|Protocol deviation|0|||
124654152|NCT01524783|448353464|FG000|Blinded Period|Death|5|||
124654153|NCT01524783|448353465|FG001|Blinded Period|Death|2|||
124654154|NCT01524783|448353466|FG002|Blinded Period|Death|0|||
124654155|NCT01524783|448353464|FG000|Open-label Period|Disease progression|13|||
124654156|NCT01524783|448353465|FG001|Open-label Period|Disease progression|0|||
124654157|NCT01524783|448353466|FG002|Open-label Period|Disease progression|2|||
124654158|NCT01524783|448353464|FG000|Open-label Period|Administrative problems|5|||
124654159|NCT01524783|448353465|FG001|Open-label Period|Administrative problems|0|||
124654160|NCT01524783|448353466|FG002|Open-label Period|Administrative problems|2|||
124654161|NCT01524783|448353464|FG000|Open-label Period|Adverse Event|5|||
124654162|NCT01524783|448353465|FG001|Open-label Period|Adverse Event|0|||
124654163|NCT01524783|448353466|FG002|Open-label Period|Adverse Event|1|||
124654164|NCT01524783|448353464|FG000|Open-label Period|Withdrawal by Subject|2|||
124654165|NCT01524783|448353465|FG001|Open-label Period|Withdrawal by Subject|0|||
124654166|NCT01524783|448353466|FG002|Open-label Period|Withdrawal by Subject|1|||
124654167|NCT01524783|448353464|FG000|Open-label Period|Protocol deviation|1|||
124654168|NCT01524783|448353465|FG001|Open-label Period|Protocol deviation|0|||
124654169|NCT01524783|448353466|FG002|Open-label Period|Protocol deviation|0|||
124654170|NCT02054910|448353468|FG000|Overall Study|Lost to Follow-up|4|||
124654171|NCT02054910|448353469|FG001|Overall Study|Lost to Follow-up|1|||
124654172|NCT01096589|448353475|FG000|Overall Study|Adverse Event|2|||
124654173|NCT01096589|448353476|FG001|Overall Study|Adverse Event|1|||
124654174|NCT01096589|448353477|FG002|Overall Study|Adverse Event|2|||
124654175|NCT01096589|448353478|FG003|Overall Study|Adverse Event|1|||
124654176|NCT01096589|448353475|FG000|Overall Study|Withdrawal by Subject|2|||
124654177|NCT01096589|448353476|FG001|Overall Study|Withdrawal by Subject|1|||
124654178|NCT01096589|448353477|FG002|Overall Study|Withdrawal by Subject|1|||
124654179|NCT01096589|448353478|FG003|Overall Study|Withdrawal by Subject|1|||
124654180|NCT01096589|448353475|FG000|Overall Study|Compliance with protocol|0|||
124654181|NCT01096589|448353476|FG001|Overall Study|Compliance with protocol|0|||
124654182|NCT01096589|448353477|FG002|Overall Study|Compliance with protocol|1|||
124654183|NCT01096589|448353478|FG003|Overall Study|Compliance with protocol|0|||
124654184|NCT01096589|448353475|FG000|Overall Study|found treatment exhausting|0|||
124654185|NCT01096589|448353476|FG001|Overall Study|found treatment exhausting|0|||
124654186|NCT01096589|448353477|FG002|Overall Study|found treatment exhausting|0|||
124654187|NCT01096589|448353478|FG003|Overall Study|found treatment exhausting|1|||
124654188|NCT03673345|448353479|FG000|Overall Study|Lost to Follow-up|1|||
124654189|NCT03673345|448353480|FG001|Overall Study|Lost to Follow-up|0|||
124654190|NCT03673345|448353481|FG002|Overall Study|Lost to Follow-up|3|||
124654191|NCT03673345|448353482|FG003|Overall Study|Lost to Follow-up|3|||
124654192|NCT03673345|448353483|FG004|Overall Study|Lost to Follow-up|2|||
124654193|NCT03673345|448353484|FG005|Overall Study|Lost to Follow-up|1|||
124654194|NCT03673345|448353485|FG006|Overall Study|Lost to Follow-up|0|||
124654195|NCT03673345|448353486|FG007|Overall Study|Lost to Follow-up|0|||
124654196|NCT03673345|448353479|FG000|Overall Study|Withdrawal by Subject|1|||
124654197|NCT03673345|448353480|FG001|Overall Study|Withdrawal by Subject|0|||
124654198|NCT03673345|448353481|FG002|Overall Study|Withdrawal by Subject|4|||
124654199|NCT03673345|448353482|FG003|Overall Study|Withdrawal by Subject|2|||
124654200|NCT03673345|448353483|FG004|Overall Study|Withdrawal by Subject|0|||
124654201|NCT03673345|448353484|FG005|Overall Study|Withdrawal by Subject|0|||
124654202|NCT03673345|448353485|FG006|Overall Study|Withdrawal by Subject|0|||
124654203|NCT03673345|448353486|FG007|Overall Study|Withdrawal by Subject|0|||
124654204|NCT03673345|448353479|FG000|Overall Study|Physician Decision|0|||
124654205|NCT03673345|448353480|FG001|Overall Study|Physician Decision|0|||
124654206|NCT03673345|448353481|FG002|Overall Study|Physician Decision|2|||
124654207|NCT03673345|448353482|FG003|Overall Study|Physician Decision|0|||
124654208|NCT03673345|448353483|FG004|Overall Study|Physician Decision|0|||
124654209|NCT03673345|448353484|FG005|Overall Study|Physician Decision|0|||
124654210|NCT03673345|448353485|FG006|Overall Study|Physician Decision|0|||
124654211|NCT03673345|448353486|FG007|Overall Study|Physician Decision|0|||
124654212|NCT01362244|448353487|FG000|Overall Study|Adverse Event|3|||
124654213|NCT01362244|448353488|FG001|Overall Study|Adverse Event|5|||
124654214|NCT01362244|448353487|FG000|Overall Study|Lack of Efficacy|5|||
124654215|NCT01362244|448353488|FG001|Overall Study|Lack of Efficacy|11|||
124654216|NCT01362244|448353487|FG000|Overall Study|Lost to Follow-up|0|||
124654217|NCT01362244|448353488|FG001|Overall Study|Lost to Follow-up|2|||
124654218|NCT01362244|448353487|FG000|Overall Study|Protocol Violation|5|||
124654219|NCT01362244|448353488|FG001|Overall Study|Protocol Violation|1|||
124654220|NCT01362244|448353487|FG000|Overall Study|Withdrawal by Subject|2|||
124654221|NCT01362244|448353488|FG001|Overall Study|Withdrawal by Subject|1|||
124654222|NCT01362244|448353487|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
124654223|NCT01362244|448353488|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
124654224|NCT01362244|448353487|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
124654225|NCT01362244|448353488|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
124654226|NCT02267135|448353489|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
124654227|NCT02267135|448353490|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
124654228|NCT02267135|448353489|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
124654229|NCT02267135|448353490|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
124654230|NCT02267135|448353489|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
124654231|NCT02267135|448353490|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
124654232|NCT02267135|448353489|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
124654233|NCT02267135|448353490|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
124654234|NCT02267135|448353489|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
124654235|NCT02267135|448353490|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
124654236|NCT03806231|448353491|FG000|Overall Study|Physician Decision|1|||
124654237|NCT03806231|448353492|FG001|Overall Study|Physician Decision|0|||
124654238|NCT03806231|448353491|FG000|Overall Study|Withdrawal by Subject|1|||
124654239|NCT03806231|448353492|FG001|Overall Study|Withdrawal by Subject|0|||
124654240|NCT00900731|448353493|FG000|Overall Study|Adverse Event|31|||
124654241|NCT00900731|448353494|FG001|Overall Study|Adverse Event|27|||
124654242|NCT00900731|448353493|FG000|Overall Study|Withdrawal by Subject|8|||
124654243|NCT00900731|448353494|FG001|Overall Study|Withdrawal by Subject|7|||
124654244|NCT00900731|448353493|FG000|Overall Study|Protocol Deviation|8|||
124654245|NCT00900731|448353494|FG001|Overall Study|Protocol Deviation|11|||
124654246|NCT00900731|448353493|FG000|Overall Study|Administrative Problems|5|||
124654247|NCT00900731|448353494|FG001|Overall Study|Administrative Problems|4|||
124654248|NCT00900731|448353493|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
124654249|NCT00900731|448353494|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
124654250|NCT00900731|448353493|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
124654251|NCT00900731|448353494|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
124654252|NCT00900731|448353493|FG000|Overall Study|Lost to Follow-up|2|||
124654253|NCT00900731|448353494|FG001|Overall Study|Lost to Follow-up|3|||
124654254|NCT00900731|448353493|FG000|Overall Study|Lack of Efficacy|1|||
124654255|NCT00900731|448353494|FG001|Overall Study|Lack of Efficacy|3|||
124654256|NCT00900731|448353493|FG000|Overall Study|Death|0|||
124654257|NCT00900731|448353494|FG001|Overall Study|Death|2|||
124654258|NCT02919267|448353495|FG000|Overall Study|Protocol Violation|0|||
124654259|NCT02919267|448353496|FG001|Overall Study|Protocol Violation|3|||
124654260|NCT02919267|448353497|FG002|Overall Study|Protocol Violation|3|||
124654261|NCT02919267|448353498|FG003|Overall Study|Protocol Violation|4|||
124654262|NCT02407054|448353499|FG000|Overall Study|Adverse Event|1|||
124654263|NCT02407054|448353500|FG001|Overall Study|Adverse Event|4|||
124654264|NCT02407054|448353501|FG002|Overall Study|Adverse Event|1|||
124654265|NCT02407054|448353499|FG000|Overall Study|Non-compliance with Study|0|||
124654266|NCT02407054|448353500|FG001|Overall Study|Non-compliance with Study|2|||
124654267|NCT02407054|448353501|FG002|Overall Study|Non-compliance with Study|1|||
124654268|NCT02407054|448353499|FG000|Overall Study|Physician Decision|1|||
124654269|NCT02407054|448353500|FG001|Overall Study|Physician Decision|3|||
124654270|NCT02407054|448353501|FG002|Overall Study|Physician Decision|3|||
124654271|NCT02407054|448353499|FG000|Overall Study|Withdrawal by Subject|5|||
124654272|NCT02407054|448353500|FG001|Overall Study|Withdrawal by Subject|9|||
124654273|NCT02407054|448353501|FG002|Overall Study|Withdrawal by Subject|2|||
124654274|NCT00932698|448353502|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
124654275|NCT00932698|448353503|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
124654276|NCT00932698|448353504|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
124654277|NCT00932698|448353505|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
124654278|NCT00932698|448353506|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
124654279|NCT00932698|448353507|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
124654280|NCT00932698|448353508|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
124654281|NCT00932698|448353509|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
124654282|NCT00932698|448353510|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
124654283|NCT00932698|448353511|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
124654284|NCT00932698|448353512|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
124654285|NCT00932698|448353502|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
124654286|NCT00932698|448353503|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
124654287|NCT00932698|448353504|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
124654288|NCT00932698|448353505|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
124654289|NCT00932698|448353506|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
124654290|NCT00932698|448353507|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
124654291|NCT00932698|448353508|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
124654292|NCT00932698|448353509|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
124654293|NCT00932698|448353510|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
124654294|NCT00932698|448353511|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
124654295|NCT00932698|448353512|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
124654296|NCT00932698|448353502|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
124654297|NCT00932698|448353503|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
124654298|NCT00932698|448353504|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
124654299|NCT00932698|448353505|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
124654300|NCT00932698|448353506|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
124654301|NCT00932698|448353507|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
124654302|NCT00932698|448353508|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
124654303|NCT00932698|448353509|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
124654304|NCT00932698|448353510|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
124654305|NCT00932698|448353511|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
124654306|NCT00932698|448353512|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
124654307|NCT00932698|448353502|FG000|Part 1 (Dose Escalation)|Other|0|||
124654308|NCT00932698|448353503|FG001|Part 1 (Dose Escalation)|Other|0|||
124654309|NCT00932698|448353504|FG002|Part 1 (Dose Escalation)|Other|1|||
124654310|NCT00932698|448353505|FG003|Part 1 (Dose Escalation)|Other|0|||
124654311|NCT00932698|448353506|FG004|Part 1 (Dose Escalation)|Other|0|||
124654312|NCT00932698|448353507|FG005|Part 1 (Dose Escalation)|Other|0|||
124654313|NCT00932698|448353508|FG006|Part 1 (Dose Escalation)|Other|1|||
124654314|NCT00932698|448353509|FG007|Part 1 (Dose Escalation)|Other|0|||
124654315|NCT00932698|448353510|FG008|Part 1 (Dose Escalation)|Other|0|||
124654316|NCT00932698|448353511|FG009|Part 1 (Dose Escalation)|Other|0|||
124654317|NCT00932698|448353512|FG010|Part 1 (Dose Escalation)|Other|0|||
124654318|NCT00932698|448353502|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
124654319|NCT00932698|448353503|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
124654320|NCT00932698|448353504|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
124654321|NCT00932698|448353505|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
124654322|NCT00932698|448353506|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
124654323|NCT00932698|448353507|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
124654324|NCT00932698|448353508|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
124654325|NCT00932698|448353509|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
124654326|NCT00932698|448353510|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
124654327|NCT00932698|448353511|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
124654328|NCT00932698|448353512|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
124654329|NCT00932698|448353502|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
124654330|NCT00932698|448353503|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
124654331|NCT00932698|448353504|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
124654332|NCT00932698|448353505|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
124654333|NCT00932698|448353506|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
124654334|NCT00932698|448353507|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
124654335|NCT00932698|448353508|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
124654336|NCT00932698|448353509|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
124654337|NCT00932698|448353510|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
124654338|NCT00932698|448353511|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
124654339|NCT00932698|448353512|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
124654340|NCT00932698|448353502|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
124654341|NCT00932698|448353503|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
124654342|NCT00932698|448353504|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
124654343|NCT00932698|448353505|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
124654344|NCT00932698|448353506|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
124654345|NCT00932698|448353507|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
124654346|NCT00932698|448353508|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
124654347|NCT00932698|448353509|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
124654348|NCT00932698|448353510|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
124654349|NCT00932698|448353511|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
124654350|NCT00932698|448353512|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
124654351|NCT04608344|448353513|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
124654352|NCT04608344|448353514|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
124654353|NCT04608344|448353513|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
124654354|NCT04608344|448353514|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
124654355|NCT00131365|448353515|FG000|Overall Study|Withdrawal by Subject|1|||
124654356|NCT00131365|448353515|FG000|Overall Study|Alternative treatment|3|||
124654357|NCT00655681|448353516|FG000|Overall Study|Lost to Follow-up|1|||
124654358|NCT00655681|448353517|FG001|Overall Study|Lost to Follow-up|1|||
124654359|NCT00415597|448353518|FG000|Enrollment|Withdrawal by Subject|1|||
124654360|NCT00415597|448353518|FG000|Enrollment|Protocol Violation|1|||
124654361|NCT00415597|448353518|FG000|Treatment|Adverse Event|110|||
124654362|NCT00415597|448353518|FG000|Treatment|Lack of Efficacy|39|||
124654363|NCT00415597|448353518|FG000|Treatment|Protocol Violation|67|||
124654364|NCT00415597|448353518|FG000|Treatment|Physician Decision|3|||
124654365|NCT00415597|448353518|FG000|Treatment|Withdrawal by Subject|51|||
124654366|NCT00415597|448353518|FG000|Treatment|Lost to Follow-up|28|||
124654367|NCT00415597|448353518|FG000|Treatment|Drug Screen|2|||
124654368|NCT00415597|448353518|FG000|Treatment|Administrative|3|||
124654369|NCT00415597|448353518|FG000|Treatment|Sponsor Decision|1|||
124654370|NCT00415597|448353518|FG000|Treatment|Multiple Reasons|1|||
124654371|NCT01447927|448353519|FG000|Overall Study|Adverse Event|4|||
124654372|NCT01447927|448353520|FG001|Overall Study|Adverse Event|3|||
124654373|NCT01447927|448353519|FG000|Overall Study|Withdrawal by Subject|1|||
124654374|NCT01447927|448353520|FG001|Overall Study|Withdrawal by Subject|0|||
124654375|NCT04102865|448353521|FG000|Overall Study|Adverse Event|4|||
124654376|NCT04102865|448353522|FG001|Overall Study|Adverse Event|0|||
124654377|NCT04102865|448353521|FG000|Overall Study|Lost to Follow-up|1|||
124654378|NCT04102865|448353522|FG001|Overall Study|Lost to Follow-up|0|||
124654379|NCT04102865|448353521|FG000|Overall Study|Withdrawal by Subject|2|||
124654380|NCT04102865|448353522|FG001|Overall Study|Withdrawal by Subject|0|||
124654381|NCT02429310|448353523|FG000|Overall Study|Lost to Follow-up|1|||
124654382|NCT02429310|448353524|FG001|Overall Study|Lost to Follow-up|2|||
124654383|NCT02429310|448353523|FG000|Overall Study|Protocol Violation|1|||
124654384|NCT02429310|448353524|FG001|Overall Study|Protocol Violation|1|||
124654385|NCT00394433|448353525|FG000|Overall Study|Adverse Event|2|||
124654386|NCT00394433|448353525|FG000|Overall Study|Alternative Therapy|1|||
124654387|NCT01764997|448353526|FG000|Run-in Period|Adverse Event|15|||
124654388|NCT01764997|448353527|FG001|Run-in Period|Adverse Event|0|||
124654389|NCT01764997|448353528|FG002|Run-in Period|Adverse Event|0|||
124654390|NCT01764997|448353529|FG003|Run-in Period|Adverse Event|0|||
124654391|NCT01764997|448353530|FG004|Run-in Period|Adverse Event|0|||
124654392|NCT01764997|448353526|FG000|Run-in Period|Lack of Efficacy|5|||
124654393|NCT01764997|448353527|FG001|Run-in Period|Lack of Efficacy|0|||
124654394|NCT01764997|448353528|FG002|Run-in Period|Lack of Efficacy|0|||
124654395|NCT01764997|448353529|FG003|Run-in Period|Lack of Efficacy|0|||
124654396|NCT01764997|448353530|FG004|Run-in Period|Lack of Efficacy|0|||
124654397|NCT01764997|448353526|FG000|Run-in Period|Poor compliance to protocol|1|||
124654398|NCT01764997|448353527|FG001|Run-in Period|Poor compliance to protocol|0|||
124654399|NCT01764997|448353528|FG002|Run-in Period|Poor compliance to protocol|0|||
124654400|NCT01764997|448353529|FG003|Run-in Period|Poor compliance to protocol|0|||
124654401|NCT01764997|448353530|FG004|Run-in Period|Poor compliance to protocol|0|||
124654402|NCT01764997|448353526|FG000|Run-in Period|Other than specified above|17|||
124654403|NCT01764997|448353527|FG001|Run-in Period|Other than specified above|0|||
124654404|NCT01764997|448353528|FG002|Run-in Period|Other than specified above|0|||
124654405|NCT01764997|448353529|FG003|Run-in Period|Other than specified above|0|||
124654406|NCT01764997|448353530|FG004|Run-in Period|Other than specified above|0|||
124654407|NCT01764997|448353526|FG000|Study Drug Treatment Period|Adverse Event|0|||
124654408|NCT01764997|448353527|FG001|Study Drug Treatment Period|Adverse Event|1|||
124654409|NCT01764997|448353528|FG002|Study Drug Treatment Period|Adverse Event|0|||
124654410|NCT01764997|448353529|FG003|Study Drug Treatment Period|Adverse Event|0|||
124654411|NCT01764997|448353530|FG004|Study Drug Treatment Period|Adverse Event|24|||
124654412|NCT01764997|448353526|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
124654413|NCT01764997|448353527|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
124654414|NCT01764997|448353528|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
124654415|NCT01764997|448353529|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
124654416|NCT01764997|448353530|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
124654417|NCT01764997|448353526|FG000|Study Drug Treatment Period|Other than specified above|0|||
124654418|NCT01764997|448353527|FG001|Study Drug Treatment Period|Other than specified above|0|||
124654419|NCT01764997|448353528|FG002|Study Drug Treatment Period|Other than specified above|0|||
124654420|NCT01764997|448353529|FG003|Study Drug Treatment Period|Other than specified above|0|||
124654421|NCT01764997|448353530|FG004|Study Drug Treatment Period|Other than specified above|10|||
124654422|NCT01554176|448353531|FG000|Treatment Phase|Protocol Violation|1|||
124654423|NCT01554176|448353532|FG001|Treatment Phase|Protocol Violation|2|||
124654424|NCT01554176|448353533|FG002|Treatment Phase|Protocol Violation|0|||
124654425|NCT01554176|448353534|FG003|Treatment Phase|Protocol Violation|0|||
124654426|NCT01554176|448353535|FG004|Treatment Phase|Protocol Violation|0|||
124654427|NCT01554176|448353531|FG000|Treatment Phase|Physician Decision|1|||
124654428|NCT01554176|448353532|FG001|Treatment Phase|Physician Decision|1|||
124654429|NCT01554176|448353533|FG002|Treatment Phase|Physician Decision|0|||
124654430|NCT01554176|448353534|FG003|Treatment Phase|Physician Decision|0|||
124654431|NCT01554176|448353535|FG004|Treatment Phase|Physician Decision|0|||
124654432|NCT01554176|448353531|FG000|Treatment Phase|Lack of Efficacy|0|||
124654433|NCT01554176|448353532|FG001|Treatment Phase|Lack of Efficacy|1|||
124654434|NCT01554176|448353533|FG002|Treatment Phase|Lack of Efficacy|0|||
124654435|NCT01554176|448353534|FG003|Treatment Phase|Lack of Efficacy|0|||
124654436|NCT01554176|448353535|FG004|Treatment Phase|Lack of Efficacy|0|||
124654437|NCT01554176|448353531|FG000|Treatment Phase|Adverse event, non-fatal|1|||
124654438|NCT01554176|448353532|FG001|Treatment Phase|Adverse event, non-fatal|1|||
124654439|NCT01554176|448353533|FG002|Treatment Phase|Adverse event, non-fatal|0|||
124654440|NCT01554176|448353534|FG003|Treatment Phase|Adverse event, non-fatal|0|||
124654441|NCT01554176|448353535|FG004|Treatment Phase|Adverse event, non-fatal|0|||
124654442|NCT01554176|448353531|FG000|Treatment Phase|Non-compliance with study drug|1|||
124654443|NCT01554176|448353532|FG001|Treatment Phase|Non-compliance with study drug|0|||
124654444|NCT01554176|448353533|FG002|Treatment Phase|Non-compliance with study drug|0|||
124654445|NCT01554176|448353534|FG003|Treatment Phase|Non-compliance with study drug|0|||
124654446|NCT01554176|448353535|FG004|Treatment Phase|Non-compliance with study drug|0|||
124654447|NCT01554176|448353531|FG000|Treatment Phase|Withdrawal by Subject|1|||
124654448|NCT01554176|448353532|FG001|Treatment Phase|Withdrawal by Subject|0|||
124654449|NCT01554176|448353533|FG002|Treatment Phase|Withdrawal by Subject|0|||
124654450|NCT01554176|448353534|FG003|Treatment Phase|Withdrawal by Subject|0|||
124654451|NCT01554176|448353535|FG004|Treatment Phase|Withdrawal by Subject|0|||
124654452|NCT01554176|448353531|FG000|Treatment Phase|Lost to Follow-up|3|||
124654453|NCT01554176|448353532|FG001|Treatment Phase|Lost to Follow-up|0|||
124654454|NCT01554176|448353533|FG002|Treatment Phase|Lost to Follow-up|0|||
124654455|NCT01554176|448353534|FG003|Treatment Phase|Lost to Follow-up|0|||
124654456|NCT01554176|448353535|FG004|Treatment Phase|Lost to Follow-up|0|||
124654457|NCT01554176|448353531|FG000|Run-out Phase|Protocol Violation|0|||
124654458|NCT01554176|448353532|FG001|Run-out Phase|Protocol Violation|0|||
124654459|NCT01554176|448353533|FG002|Run-out Phase|Protocol Violation|0|||
124654460|NCT01554176|448353534|FG003|Run-out Phase|Protocol Violation|1|||
124654461|NCT01554176|448353535|FG004|Run-out Phase|Protocol Violation|0|||
124654462|NCT01085136|448353536|FG000|Part A|Other Adverse event|223|||
124654463|NCT01085136|448353537|FG001|Part A|Other Adverse event|0|||
124654464|NCT01085136|448353538|FG002|Part A|Other Adverse event|0|||
124654465|NCT01085136|448353536|FG000|Part A|Protocol Violation|3|||
124654466|NCT01085136|448353537|FG001|Part A|Protocol Violation|0|||
124654467|NCT01085136|448353538|FG002|Part A|Protocol Violation|0|||
124654468|NCT01085136|448353536|FG000|Part A|Lost to Follow-up|3|||
124654469|NCT01085136|448353537|FG001|Part A|Lost to Follow-up|0|||
124654470|NCT01085136|448353538|FG002|Part A|Lost to Follow-up|0|||
124654471|NCT01085136|448353536|FG000|Part A|Refusal to continue trial medication|64|||
124654472|NCT01085136|448353537|FG001|Part A|Refusal to continue trial medication|0|||
124654473|NCT01085136|448353538|FG002|Part A|Refusal to continue trial medication|0|||
124654474|NCT01085136|448353536|FG000|Part A|Other reason not defined above|30|||
124654475|NCT01085136|448353537|FG001|Part A|Other reason not defined above|0|||
124654476|NCT01085136|448353538|FG002|Part A|Other reason not defined above|0|||
124654477|NCT01085136|448353536|FG000|Part B|Other AE|0|||
124654478|NCT01085136|448353537|FG001|Part B|Other AE|29|||
124654479|NCT01085136|448353538|FG002|Part B|Other AE|8|||
124654480|NCT01085136|448353536|FG000|Part B|Refusal to continue trial medication|0|||
124654481|NCT01085136|448353537|FG001|Part B|Refusal to continue trial medication|12|||
124654482|NCT01085136|448353538|FG002|Part B|Refusal to continue trial medication|7|||
124654483|NCT01085136|448353536|FG000|Part B|Not treated|0|||
124654484|NCT01085136|448353537|FG001|Part B|Not treated|4|||
124654485|NCT01085136|448353538|FG002|Part B|Not treated|8|||
124654486|NCT01085136|448353536|FG000|Part B|Other reason not defined above|0|||
124654487|NCT01085136|448353537|FG001|Part B|Other reason not defined above|6|||
124654488|NCT01085136|448353538|FG002|Part B|Other reason not defined above|3|||
124654489|NCT02678000|448353540|FG000|PART 2|Adverse Event|0|||
124654490|NCT02678000|448353541|FG001|PART 2|Adverse Event|0|||
124654491|NCT02678000|448353542|FG002|PART 2|Adverse Event|2|||
124654492|NCT02678000|448353543|FG003|PART 2|Adverse Event|1|||
124654493|NCT02678000|448353544|FG004|PART 2|Adverse Event|0|||
124654494|NCT02678000|448353540|FG000|PART 2|Withdrawal by Subject|0|||
124654495|NCT02678000|448353541|FG001|PART 2|Withdrawal by Subject|0|||
124654496|NCT02678000|448353542|FG002|PART 2|Withdrawal by Subject|1|||
124654497|NCT02678000|448353543|FG003|PART 2|Withdrawal by Subject|0|||
124654498|NCT02678000|448353544|FG004|PART 2|Withdrawal by Subject|0|||
124654499|NCT01210352|448353553|FG000|Overall Study|Adverse Event|0|||
124654500|NCT01210352|448353554|FG001|Overall Study|Adverse Event|0|||
124654501|NCT01210352|448353555|FG002|Overall Study|Adverse Event|0|||
124654502|NCT01210352|448353556|FG003|Overall Study|Adverse Event|0|||
124654503|NCT01210352|448353557|FG004|Overall Study|Adverse Event|0|||
124654504|NCT01210352|448353558|FG005|Overall Study|Adverse Event|0|||
124654505|NCT01210352|448353559|FG006|Overall Study|Adverse Event|0|||
124654506|NCT01210352|448353560|FG007|Overall Study|Adverse Event|2|||
124654507|NCT01210352|448353561|FG008|Overall Study|Adverse Event|1|||
124654508|NCT01210352|448353553|FG000|Overall Study|Lack of Efficacy|0|||
124654509|NCT01210352|448353554|FG001|Overall Study|Lack of Efficacy|0|||
124654510|NCT01210352|448353555|FG002|Overall Study|Lack of Efficacy|0|||
124654511|NCT01210352|448353556|FG003|Overall Study|Lack of Efficacy|0|||
124654512|NCT01210352|448353557|FG004|Overall Study|Lack of Efficacy|0|||
124654513|NCT01210352|448353558|FG005|Overall Study|Lack of Efficacy|0|||
124654514|NCT01210352|448353559|FG006|Overall Study|Lack of Efficacy|1|||
124654515|NCT01210352|448353560|FG007|Overall Study|Lack of Efficacy|0|||
124654516|NCT01210352|448353561|FG008|Overall Study|Lack of Efficacy|0|||
124654517|NCT01210352|448353553|FG000|Overall Study|Physician Decision|0|||
124654518|NCT01210352|448353554|FG001|Overall Study|Physician Decision|0|||
124654519|NCT01210352|448353555|FG002|Overall Study|Physician Decision|0|||
124654520|NCT01210352|448353556|FG003|Overall Study|Physician Decision|0|||
124544245|NCT05182840|447946753|FG005|Treatment Period|Reason missing|0|||
124544246|NCT05182840|447946754|FG006|Treatment Period|Reason missing|0|||
124544247|NCT05182840|447946755|FG007|Treatment Period|Reason missing|0|||
124544248|NCT05182840|447946756|FG008|Treatment Period|Reason missing|0|||
124544249|NCT05182840|447946757|FG009|Treatment Period|Reason missing|0|||
124544250|NCT05182840|447946748|FG000|Treatment Period|Other but not sponsor termination|0|||
124544251|NCT05182840|447946749|FG001|Treatment Period|Other but not sponsor termination|0|||
124544252|NCT05182840|447946750|FG002|Treatment Period|Other but not sponsor termination|8|||
124544253|NCT05182840|447946751|FG003|Treatment Period|Other but not sponsor termination|6|||
124544254|NCT05182840|447946752|FG004|Treatment Period|Other but not sponsor termination|6|||
124544255|NCT05182840|447946753|FG005|Treatment Period|Other but not sponsor termination|7|||
124544256|NCT05182840|447946754|FG006|Treatment Period|Other but not sponsor termination|5|||
124544257|NCT05182840|447946755|FG007|Treatment Period|Other but not sponsor termination|8|||
124544258|NCT05182840|447946756|FG008|Treatment Period|Other but not sponsor termination|7|||
124544259|NCT05182840|447946757|FG009|Treatment Period|Other but not sponsor termination|2|||
124544260|NCT05182840|447946748|FG000|Treatment Period|Protocol deviation|0|||
124544261|NCT05182840|447946749|FG001|Treatment Period|Protocol deviation|0|||
124544262|NCT05182840|447946750|FG002|Treatment Period|Protocol deviation|0|||
124544263|NCT05182840|447946751|FG003|Treatment Period|Protocol deviation|0|||
124544264|NCT05182840|447946752|FG004|Treatment Period|Protocol deviation|0|||
124544265|NCT05182840|447946753|FG005|Treatment Period|Protocol deviation|0|||
124544266|NCT05182840|447946754|FG006|Treatment Period|Protocol deviation|0|||
124544267|NCT05182840|447946755|FG007|Treatment Period|Protocol deviation|0|||
124544268|NCT05182840|447946756|FG008|Treatment Period|Protocol deviation|1|||
124544269|NCT05182840|447946757|FG009|Treatment Period|Protocol deviation|0|||
124544270|NCT05182840|447946748|FG000|Treatment Period|No reason available|0|||
124544271|NCT05182840|447946749|FG001|Treatment Period|No reason available|0|||
124544272|NCT05182840|447946750|FG002|Treatment Period|No reason available|0|||
124544273|NCT05182840|447946751|FG003|Treatment Period|No reason available|1|||
124544274|NCT05182840|447946752|FG004|Treatment Period|No reason available|0|||
124544275|NCT05182840|447946753|FG005|Treatment Period|No reason available|2|||
124544276|NCT05182840|447946754|FG006|Treatment Period|No reason available|0|||
124544277|NCT05182840|447946755|FG007|Treatment Period|No reason available|1|||
124544278|NCT05182840|447946756|FG008|Treatment Period|No reason available|0|||
124544279|NCT05182840|447946757|FG009|Treatment Period|No reason available|0|||
124544280|NCT05182840|447946748|FG000|Treatment Period|Burden of study procedures|0|||
124544281|NCT05182840|447946749|FG001|Treatment Period|Burden of study procedures|0|||
124544282|NCT05182840|447946750|FG002|Treatment Period|Burden of study procedures|0|||
124544283|NCT05182840|447946751|FG003|Treatment Period|Burden of study procedures|0|||
124544284|NCT05182840|447946752|FG004|Treatment Period|Burden of study procedures|1|||
124544285|NCT05182840|447946753|FG005|Treatment Period|Burden of study procedures|0|||
124544286|NCT05182840|447946754|FG006|Treatment Period|Burden of study procedures|0|||
124544287|NCT05182840|447946755|FG007|Treatment Period|Burden of study procedures|0|||
124544288|NCT05182840|447946756|FG008|Treatment Period|Burden of study procedures|0|||
124544289|NCT05182840|447946757|FG009|Treatment Period|Burden of study procedures|0|||
124544290|NCT05182840|447946748|FG000|Treatment Period|Change of residence|0|||
124544291|NCT05182840|447946749|FG001|Treatment Period|Change of residence|0|||
124544292|NCT05182840|447946750|FG002|Treatment Period|Change of residence|0|||
124544293|NCT05182840|447946751|FG003|Treatment Period|Change of residence|0|||
124544294|NCT05182840|447946752|FG004|Treatment Period|Change of residence|0|||
124544295|NCT05182840|447946753|FG005|Treatment Period|Change of residence|1|||
124544296|NCT05182840|447946754|FG006|Treatment Period|Change of residence|0|||
124544297|NCT05182840|447946755|FG007|Treatment Period|Change of residence|0|||
124544298|NCT05182840|447946756|FG008|Treatment Period|Change of residence|0|||
124544299|NCT05182840|447946757|FG009|Treatment Period|Change of residence|0|||
124544300|NCT05182840|447946748|FG000|Treatment Period|Adverse Event|0|||
124544301|NCT05182840|447946749|FG001|Treatment Period|Adverse Event|0|||
124654521|NCT01210352|448353557|FG004|Overall Study|Physician Decision|0|||
124654522|NCT01210352|448353558|FG005|Overall Study|Physician Decision|0|||
124654523|NCT01210352|448353559|FG006|Overall Study|Physician Decision|0|||
124654524|NCT01210352|448353560|FG007|Overall Study|Physician Decision|1|||
124654525|NCT01210352|448353561|FG008|Overall Study|Physician Decision|2|||
124654526|NCT01210352|448353553|FG000|Overall Study|Withdrawal by Subject|0|||
124654527|NCT01210352|448353554|FG001|Overall Study|Withdrawal by Subject|0|||
124654528|NCT01210352|448353555|FG002|Overall Study|Withdrawal by Subject|1|||
124654529|NCT01210352|448353556|FG003|Overall Study|Withdrawal by Subject|0|||
124654530|NCT01210352|448353557|FG004|Overall Study|Withdrawal by Subject|0|||
124654531|NCT01210352|448353558|FG005|Overall Study|Withdrawal by Subject|0|||
124654532|NCT01210352|448353559|FG006|Overall Study|Withdrawal by Subject|1|||
124654533|NCT01210352|448353560|FG007|Overall Study|Withdrawal by Subject|0|||
124654534|NCT01210352|448353561|FG008|Overall Study|Withdrawal by Subject|1|||
124654535|NCT01210352|448353553|FG000|Overall Study|Patient Discharged Early|0|||
124654536|NCT01210352|448353554|FG001|Overall Study|Patient Discharged Early|0|||
124654537|NCT01210352|448353555|FG002|Overall Study|Patient Discharged Early|1|||
124654538|NCT01210352|448353556|FG003|Overall Study|Patient Discharged Early|0|||
124654539|NCT01210352|448353557|FG004|Overall Study|Patient Discharged Early|0|||
124654540|NCT01210352|448353558|FG005|Overall Study|Patient Discharged Early|0|||
124654541|NCT01210352|448353559|FG006|Overall Study|Patient Discharged Early|0|||
124654542|NCT01210352|448353560|FG007|Overall Study|Patient Discharged Early|0|||
124654543|NCT01210352|448353561|FG008|Overall Study|Patient Discharged Early|0|||
124654544|NCT01298141|448353562|FG000|Overall Study|Adverse Event|3|||
124654545|NCT01298141|448353562|FG000|Overall Study|Refusal of Required Study Procedures|1|||
124654546|NCT01298141|448353562|FG000|Overall Study|Withdrawal by Subject|6|||
124654547|NCT01298141|448353562|FG000|Overall Study|Termination of Study by the Investigator|5|||
124654548|NCT01298141|448353562|FG000|Overall Study|Other|5|||
124654549|NCT01298141|448353562|FG000|Overall Study|Lost to Follow-up|1|||
124654550|NCT01298141|448353562|FG000|Overall Study|Death|6|||
124654551|NCT01298141|448353562|FG000|Overall Study|Not treated|4|||
124654552|NCT02093390|448353563|FG000|Overall Study|Withdrawal by Subject|0|||
124654553|NCT02093390|448353564|FG001|Overall Study|Withdrawal by Subject|1|||
124654554|NCT01854879|448353565|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
124654555|NCT01854879|448353565|FG000|Overall Study|screen fail|3|||
124654556|NCT01854879|448353565|FG000|Overall Study|incomplete data set|1|||
124654557|NCT04683939|448353569|FG000|Overall Study|Study termination by the sponsor|0|||
124654558|NCT04683939|448353570|FG001|Overall Study|Study termination by the sponsor|1|||
124654559|NCT04683939|448353571|FG002|Overall Study|Study termination by the sponsor|2|||
124654560|NCT04683939|448353572|FG003|Overall Study|Study termination by the sponsor|2|||
124654561|NCT04683939|448353569|FG000|Overall Study|Death|1|||
124654562|NCT04683939|448353570|FG001|Overall Study|Death|1|||
124654563|NCT04683939|448353571|FG002|Overall Study|Death|2|||
124654564|NCT04683939|448353572|FG003|Overall Study|Death|1|||
124654565|NCT04683939|448353569|FG000|Overall Study|Withdrawal by Subject|1|||
124654566|NCT04683939|448353570|FG001|Overall Study|Withdrawal by Subject|0|||
124654567|NCT04683939|448353571|FG002|Overall Study|Withdrawal by Subject|0|||
124654568|NCT04683939|448353572|FG003|Overall Study|Withdrawal by Subject|0|||
124654569|NCT04683939|448353569|FG000|Overall Study|Physician Decision|1|||
124654570|NCT04683939|448353570|FG001|Overall Study|Physician Decision|0|||
124654571|NCT04683939|448353571|FG002|Overall Study|Physician Decision|0|||
124654572|NCT04683939|448353572|FG003|Overall Study|Physician Decision|0|||
124654573|NCT04683939|448353569|FG000|Overall Study|Lost to Follow-up|0|||
124654574|NCT04683939|448353570|FG001|Overall Study|Lost to Follow-up|1|||
124654575|NCT04683939|448353571|FG002|Overall Study|Lost to Follow-up|0|||
124654576|NCT04683939|448353572|FG003|Overall Study|Lost to Follow-up|0|||
124654577|NCT02000882|448355670|FG000|Overall Study|Adverse Event|3|||
124654578|NCT02000882|448355670|FG000|Overall Study|Physician Decision|2|||
124654579|NCT02000882|448355670|FG000|Overall Study|Withdrawal by Subject|1|||
124654580|NCT00549601|448355671|FG000|Randomized|Protocol Violation|0|||
124654581|NCT00549601|448355672|FG001|Randomized|Protocol Violation|0|||
124654582|NCT00549601|448355673|FG002|Randomized|Protocol Violation|1|||
124654583|NCT00549601|448355671|FG000|Randomized|Withdrawal by Subject|0|||
124654584|NCT00549601|448355672|FG001|Randomized|Withdrawal by Subject|1|||
124654585|NCT00549601|448355673|FG002|Randomized|Withdrawal by Subject|1|||
124654586|NCT00549601|448355671|FG000|Received Study Drug|Adverse Event|2|||
124654587|NCT00549601|448355672|FG001|Received Study Drug|Adverse Event|5|||
124654588|NCT00549601|448355673|FG002|Received Study Drug|Adverse Event|1|||
124654589|NCT00549601|448355671|FG000|Received Study Drug|Death|0|||
124654590|NCT00549601|448355672|FG001|Received Study Drug|Death|1|||
124654591|NCT00549601|448355673|FG002|Received Study Drug|Death|0|||
124654592|NCT00549601|448355671|FG000|Received Study Drug|Lost to Follow-up|0|||
124654593|NCT00549601|448355672|FG001|Received Study Drug|Lost to Follow-up|1|||
124654594|NCT00549601|448355673|FG002|Received Study Drug|Lost to Follow-up|1|||
124654595|NCT00549601|448355671|FG000|Received Study Drug|Protocol Violation|3|||
124654596|NCT00549601|448355672|FG001|Received Study Drug|Protocol Violation|4|||
124654597|NCT00549601|448355673|FG002|Received Study Drug|Protocol Violation|1|||
124654598|NCT00549601|448355671|FG000|Received Study Drug|Withdrawal by Subject|2|||
124654599|NCT00549601|448355672|FG001|Received Study Drug|Withdrawal by Subject|0|||
124654600|NCT00549601|448355673|FG002|Received Study Drug|Withdrawal by Subject|1|||
124654601|NCT00908596|448355677|FG000|Overall Study|Other reasons|46|||
124654602|NCT00908596|448355678|FG001|Overall Study|Other reasons|6|||
124654603|NCT00908596|448355679|FG002|Overall Study|Other reasons|2|||
124654604|NCT00908596|448355680|FG003|Overall Study|Other reasons|0|||
124654605|NCT00908596|448355677|FG000|Overall Study|Lost to Follow-up|0|||
124654606|NCT00908596|448355678|FG001|Overall Study|Lost to Follow-up|1|||
124654607|NCT00908596|448355679|FG002|Overall Study|Lost to Follow-up|12|||
124654608|NCT00908596|448355680|FG003|Overall Study|Lost to Follow-up|4|||
124654609|NCT00908596|448355677|FG000|Overall Study|Death|0|||
124654610|NCT00908596|448355678|FG001|Overall Study|Death|5|||
124654611|NCT00908596|448355679|FG002|Overall Study|Death|57|||
124654612|NCT00908596|448355680|FG003|Overall Study|Death|32|||
124654613|NCT00908596|448355677|FG000|Overall Study|Protocol Violation|1|||
124654614|NCT00908596|448355678|FG001|Overall Study|Protocol Violation|0|||
124654615|NCT00908596|448355679|FG002|Overall Study|Protocol Violation|0|||
124654616|NCT00908596|448355680|FG003|Overall Study|Protocol Violation|0|||
124654617|NCT00908596|448355677|FG000|Overall Study|Withdrawal by Subject|0|||
124654618|NCT00908596|448355678|FG001|Overall Study|Withdrawal by Subject|1|||
124654619|NCT00908596|448355679|FG002|Overall Study|Withdrawal by Subject|3|||
124654620|NCT00908596|448355680|FG003|Overall Study|Withdrawal by Subject|1|||
124654621|NCT02437188|448355683|FG000|Overall Study|Randomized but did not receive surgery|4|||
124654622|NCT02437188|448355684|FG001|Overall Study|Randomized but did not receive surgery|8|||
124654623|NCT02437188|448355683|FG000|Overall Study|Adverse Event|0|||
124654624|NCT02437188|448355684|FG001|Overall Study|Adverse Event|1|||
124654625|NCT02661061|448355687|FG000|Overall Study|Lack of Efficacy|1|||
124654626|NCT02661061|448355688|FG001|Overall Study|Lack of Efficacy|1|||
124654627|NCT02661061|448355687|FG000|Overall Study|Withdrawal by Subject|1|||
124654628|NCT02661061|448355688|FG001|Overall Study|Withdrawal by Subject|1|||
124654629|NCT03246061|448355689|FG000|Overall Study|Still in follow-up|15|||
124654630|NCT03246061|448355690|FG001|Overall Study|Still in follow-up|21|||
124654631|NCT01937715|448355695|FG000|Overall Study|Death|0|||
124654632|NCT01937715|448355696|FG001|Overall Study|Death|0|||
124654633|NCT01937715|448355697|FG002|Overall Study|Death|0|||
124654634|NCT01937715|448355698|FG003|Overall Study|Death|1|||
124654635|NCT01937715|448355699|FG004|Overall Study|Death|0|||
124654636|NCT01937715|448355695|FG000|Overall Study|Withdrawal by Subject|0|||
124654637|NCT01937715|448355696|FG001|Overall Study|Withdrawal by Subject|1|||
124654638|NCT01937715|448355697|FG002|Overall Study|Withdrawal by Subject|0|||
124654639|NCT01937715|448355698|FG003|Overall Study|Withdrawal by Subject|0|||
124654640|NCT01937715|448355699|FG004|Overall Study|Withdrawal by Subject|2|||
124654641|NCT01937715|448355695|FG000|Overall Study|Other|0|||
124654642|NCT01937715|448355696|FG001|Overall Study|Other|0|||
124654643|NCT01937715|448355697|FG002|Overall Study|Other|0|||
124654644|NCT01937715|448355698|FG003|Overall Study|Other|3|||
124654645|NCT01937715|448355699|FG004|Overall Study|Other|0|||
124654646|NCT05459558|448355700|FG000|Overall Study|Adverse Event|1|||
124654647|NCT05459558|448355701|FG001|Overall Study|Adverse Event|0|||
124654648|NCT05459558|448355702|FG002|Overall Study|Adverse Event|0|||
124654649|NCT05459558|448355700|FG000|Overall Study|Scheduling issue|0|||
124654650|NCT05459558|448355701|FG001|Overall Study|Scheduling issue|1|||
124654651|NCT05459558|448355702|FG002|Overall Study|Scheduling issue|3|||
124654652|NCT05459558|448355700|FG000|Overall Study|Withdrawal by Subject|0|||
124654653|NCT05459558|448355701|FG001|Overall Study|Withdrawal by Subject|0|||
124654654|NCT05459558|448355702|FG002|Overall Study|Withdrawal by Subject|2|||
124654655|NCT03292458|448355705|FG000|Period 1|Adverse Event|2|||
124654656|NCT03292458|448355706|FG001|Period 1|Adverse Event|0|||
124654657|NCT00593606|448355707|FG000|Overall Study|Adverse Event|13|||
124654658|NCT00593606|448355707|FG000|Overall Study|Withdrawal by Subject|1|||
124654659|NCT00593606|448355707|FG000|Overall Study|Protocol Violation|3|||
124654660|NCT00593606|448355707|FG000|Overall Study|Lost to Follow-up|2|||
124654661|NCT00593606|448355707|FG000|Overall Study|Run-In Failure|5|||
124654662|NCT00593606|448355707|FG000|Overall Study|Screen Failure|3|||
124654663|NCT04643964|448355708|FG000|Overall Study|Lost to Follow-up|55|||
124654664|NCT04643964|448355709|FG001|Overall Study|Lost to Follow-up|59|||
124654665|NCT04643964|448355710|FG002|Overall Study|Lost to Follow-up|54|||
124654666|NCT04643964|448355711|FG003|Overall Study|Lost to Follow-up|129|||
124654667|NCT04643964|448355712|FG004|Overall Study|Lost to Follow-up|48|||
124654668|NCT04643964|448355708|FG000|Overall Study|Failed attention check|1|||
124654669|NCT04643964|448355709|FG001|Overall Study|Failed attention check|8|||
124654670|NCT04643964|448355710|FG002|Overall Study|Failed attention check|2|||
124654671|NCT04643964|448355711|FG003|Overall Study|Failed attention check|14|||
124654672|NCT04643964|448355712|FG004|Overall Study|Failed attention check|11|||
124654673|NCT01472939|448355713|FG000|Overall Study|Adverse Event|3|||
124654674|NCT01472939|448355714|FG001|Overall Study|Adverse Event|7|||
124654675|NCT01472939|448355715|FG002|Overall Study|Adverse Event|7|||
124654676|NCT01472939|448355716|FG003|Overall Study|Adverse Event|14|||
124654677|NCT01472939|448355713|FG000|Overall Study|Lack of Efficacy|1|||
124654678|NCT01472939|448355714|FG001|Overall Study|Lack of Efficacy|0|||
124654679|NCT01472939|448355715|FG002|Overall Study|Lack of Efficacy|0|||
124654680|NCT01472939|448355716|FG003|Overall Study|Lack of Efficacy|1|||
124654681|NCT01472939|448355713|FG000|Overall Study|Lost to Follow-up|3|||
124654682|NCT01472939|448355714|FG001|Overall Study|Lost to Follow-up|0|||
124654683|NCT01472939|448355715|FG002|Overall Study|Lost to Follow-up|2|||
124654684|NCT01472939|448355716|FG003|Overall Study|Lost to Follow-up|0|||
124654685|NCT01472939|448355713|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
124654686|NCT01472939|448355714|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
124654687|NCT01472939|448355715|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
124654688|NCT01472939|448355716|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
124654689|NCT01472939|448355713|FG000|Overall Study|Prohibited Medication|0|||
124654690|NCT01472939|448355714|FG001|Overall Study|Prohibited Medication|1|||
124654691|NCT01472939|448355715|FG002|Overall Study|Prohibited Medication|0|||
124654692|NCT01472939|448355716|FG003|Overall Study|Prohibited Medication|0|||
124654693|NCT01472939|448355713|FG000|Overall Study|Withdrawal By PI|1|||
124654694|NCT01472939|448355714|FG001|Overall Study|Withdrawal By PI|0|||
124654695|NCT01472939|448355715|FG002|Overall Study|Withdrawal By PI|0|||
124654696|NCT01472939|448355716|FG003|Overall Study|Withdrawal By PI|0|||
124654697|NCT01472939|448355713|FG000|Overall Study|Protocol Violation|3|||
124654698|NCT01472939|448355714|FG001|Overall Study|Protocol Violation|3|||
124654699|NCT01472939|448355715|FG002|Overall Study|Protocol Violation|0|||
124654700|NCT01472939|448355716|FG003|Overall Study|Protocol Violation|1|||
124654701|NCT01472939|448355713|FG000|Overall Study|Withdrawal by Subject|9|||
124654702|NCT01472939|448355714|FG001|Overall Study|Withdrawal by Subject|3|||
124654703|NCT01472939|448355715|FG002|Overall Study|Withdrawal by Subject|1|||
124654704|NCT01472939|448355716|FG003|Overall Study|Withdrawal by Subject|4|||
124654705|NCT00114738|448355717|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
124654706|NCT00114738|448355718|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
124654707|NCT00114738|448355719|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
124654708|NCT00114738|448355717|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
124654709|NCT00114738|448355718|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
124654710|NCT00114738|448355719|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
124654711|NCT00114738|448355717|FG000|Screening for Randomization|Neuropathy|17|||
124654712|NCT00114738|448355718|FG001|Screening for Randomization|Neuropathy|0|||
124654713|NCT00114738|448355719|FG002|Screening for Randomization|Neuropathy|0|||
124654714|NCT00114738|448355717|FG000|Screening for Randomization|Progressive disease|2|||
124654715|NCT00114738|448355718|FG001|Screening for Randomization|Progressive disease|0|||
124654716|NCT00114738|448355719|FG002|Screening for Randomization|Progressive disease|0|||
124654717|NCT00114738|448355717|FG000|Screening for Randomization|CNS Hemorrhage|1|||
124654718|NCT00114738|448355718|FG001|Screening for Randomization|CNS Hemorrhage|0|||
124654719|NCT00114738|448355719|FG002|Screening for Randomization|CNS Hemorrhage|0|||
124654720|NCT00114738|448355717|FG000|Screening for Randomization|Other|1|||
124654721|NCT00114738|448355718|FG001|Screening for Randomization|Other|0|||
124654722|NCT00114738|448355719|FG002|Screening for Randomization|Other|0|||
124654723|NCT00308750|448355720|FG000|Overall Study|Adverse Event|9|||
124654724|NCT00308750|448355721|FG001|Overall Study|Adverse Event|9|||
124654725|NCT00308750|448355722|FG002|Overall Study|Adverse Event|13|||
124654726|NCT00308750|448355720|FG000|Overall Study|Withdrawal by Subject|6|||
124654727|NCT00308750|448355721|FG001|Overall Study|Withdrawal by Subject|2|||
124654728|NCT00308750|448355722|FG002|Overall Study|Withdrawal by Subject|3|||
124654729|NCT00308750|448355720|FG000|Overall Study|Physician Decision|3|||
124654730|NCT00308750|448355721|FG001|Overall Study|Physician Decision|4|||
124654731|NCT00308750|448355722|FG002|Overall Study|Physician Decision|3|||
124654732|NCT00308750|448355720|FG000|Overall Study|Sponsor Decision|1|||
124654733|NCT00308750|448355721|FG001|Overall Study|Sponsor Decision|0|||
124654734|NCT00308750|448355722|FG002|Overall Study|Sponsor Decision|0|||
124654735|NCT00308750|448355720|FG000|Overall Study|Disease Progression|47|||
124654736|NCT00308750|448355721|FG001|Overall Study|Disease Progression|24|||
124654737|NCT00308750|448355722|FG002|Overall Study|Disease Progression|28|||
124654738|NCT00308750|448355720|FG000|Overall Study|Unrelated Complication|3|||
124654739|NCT00308750|448355721|FG001|Overall Study|Unrelated Complication|0|||
124654740|NCT00308750|448355722|FG002|Overall Study|Unrelated Complication|1|||
124654741|NCT00308750|448355720|FG000|Overall Study|Death|1|||
124654742|NCT00308750|448355721|FG001|Overall Study|Death|0|||
124654743|NCT00308750|448355722|FG002|Overall Study|Death|1|||
124654744|NCT00308750|448355720|FG000|Overall Study|Protocol Violation|1|||
124654745|NCT00308750|448355721|FG001|Overall Study|Protocol Violation|0|||
124654746|NCT00308750|448355722|FG002|Overall Study|Protocol Violation|0|||
124654747|NCT00308750|448355720|FG000|Overall Study|New Primary Disease Identified|1|||
124654748|NCT00308750|448355721|FG001|Overall Study|New Primary Disease Identified|1|||
124654749|NCT00308750|448355722|FG002|Overall Study|New Primary Disease Identified|0|||
124654750|NCT01358578|448355723|FG000|Induction Period|Adverse Event|2|||
124654751|NCT01358578|448355724|FG001|Induction Period|Adverse Event|4|||
124654752|NCT01358578|448355725|FG002|Induction Period|Adverse Event|2|||
124654753|NCT01358578|448355726|FG003|Induction Period|Adverse Event|6|||
124654754|NCT01358578|448355727|FG004|Induction Period|Adverse Event|0|||
124654755|NCT01358578|448355728|FG005|Induction Period|Adverse Event|0|||
124654756|NCT01358578|448355723|FG000|Induction Period|Lack of Efficacy|0|||
124654757|NCT01358578|448355724|FG001|Induction Period|Lack of Efficacy|0|||
124654758|NCT01358578|448355725|FG002|Induction Period|Lack of Efficacy|9|||
124654759|NCT01358578|448355726|FG003|Induction Period|Lack of Efficacy|1|||
124654760|NCT01358578|448355727|FG004|Induction Period|Lack of Efficacy|0|||
124654761|NCT01358578|448355728|FG005|Induction Period|Lack of Efficacy|0|||
124654762|NCT01358578|448355723|FG000|Induction Period|Lost to Follow-up|0|||
124654763|NCT01358578|448355724|FG001|Induction Period|Lost to Follow-up|0|||
124654764|NCT01358578|448355725|FG002|Induction Period|Lost to Follow-up|1|||
124654765|NCT01358578|448355726|FG003|Induction Period|Lost to Follow-up|4|||
124654766|NCT01358578|448355727|FG004|Induction Period|Lost to Follow-up|0|||
124654767|NCT01358578|448355728|FG005|Induction Period|Lost to Follow-up|0|||
124654768|NCT01358578|448355723|FG000|Induction Period|Physician Decision|2|||
124654769|NCT01358578|448355724|FG001|Induction Period|Physician Decision|1|||
124654770|NCT01358578|448355725|FG002|Induction Period|Physician Decision|2|||
124654771|NCT01358578|448355726|FG003|Induction Period|Physician Decision|0|||
124654772|NCT01358578|448355727|FG004|Induction Period|Physician Decision|0|||
124654773|NCT01358578|448355728|FG005|Induction Period|Physician Decision|0|||
124654774|NCT01358578|448355723|FG000|Induction Period|Protocol Deviation|3|||
124654775|NCT01358578|448355724|FG001|Induction Period|Protocol Deviation|5|||
124654776|NCT01358578|448355725|FG002|Induction Period|Protocol Deviation|0|||
124654777|NCT01358578|448355726|FG003|Induction Period|Protocol Deviation|3|||
124654778|NCT01358578|448355727|FG004|Induction Period|Protocol Deviation|0|||
124654779|NCT01358578|448355728|FG005|Induction Period|Protocol Deviation|0|||
124654780|NCT01358578|448355723|FG000|Induction Period|technical problems|0|||
124654781|NCT01358578|448355724|FG001|Induction Period|technical problems|0|||
124654782|NCT01358578|448355725|FG002|Induction Period|technical problems|1|||
124654783|NCT01358578|448355726|FG003|Induction Period|technical problems|1|||
124654784|NCT01358578|448355727|FG004|Induction Period|technical problems|0|||
124654785|NCT01358578|448355728|FG005|Induction Period|technical problems|0|||
124654786|NCT01358578|448355723|FG000|Induction Period|Withdrawal by Subject|5|||
124654787|NCT01358578|448355724|FG001|Induction Period|Withdrawal by Subject|5|||
124654788|NCT01358578|448355725|FG002|Induction Period|Withdrawal by Subject|10|||
124654789|NCT01358578|448355726|FG003|Induction Period|Withdrawal by Subject|6|||
124654790|NCT01358578|448355727|FG004|Induction Period|Withdrawal by Subject|0|||
124654791|NCT01358578|448355728|FG005|Induction Period|Withdrawal by Subject|0|||
124654792|NCT01358578|448355723|FG000|Maintenance Period|Adverse Event|2|||
124654793|NCT01358578|448355724|FG001|Maintenance Period|Adverse Event|7|||
124654794|NCT01358578|448355725|FG002|Maintenance Period|Adverse Event|0|||
124654795|NCT01358578|448355726|FG003|Maintenance Period|Adverse Event|6|||
124654796|NCT01358578|448355727|FG004|Maintenance Period|Adverse Event|4|||
124654797|NCT01358578|448355728|FG005|Maintenance Period|Adverse Event|3|||
124654798|NCT01358578|448355723|FG000|Maintenance Period|Lack of Efficacy|10|||
124654799|NCT01358578|448355724|FG001|Maintenance Period|Lack of Efficacy|2|||
124654800|NCT01358578|448355725|FG002|Maintenance Period|Lack of Efficacy|0|||
124654801|NCT01358578|448355726|FG003|Maintenance Period|Lack of Efficacy|11|||
124654802|NCT01358578|448355727|FG004|Maintenance Period|Lack of Efficacy|3|||
124654803|NCT01358578|448355728|FG005|Maintenance Period|Lack of Efficacy|0|||
124654804|NCT01358578|448355723|FG000|Maintenance Period|Lost to Follow-up|4|||
124654805|NCT01358578|448355724|FG001|Maintenance Period|Lost to Follow-up|0|||
124654806|NCT01358578|448355725|FG002|Maintenance Period|Lost to Follow-up|0|||
124654807|NCT01358578|448355726|FG003|Maintenance Period|Lost to Follow-up|5|||
124654808|NCT01358578|448355727|FG004|Maintenance Period|Lost to Follow-up|1|||
124654809|NCT01358578|448355728|FG005|Maintenance Period|Lost to Follow-up|1|||
124654810|NCT01358578|448355723|FG000|Maintenance Period|Non-compliance with study treatment|3|||
124654811|NCT01358578|448355724|FG001|Maintenance Period|Non-compliance with study treatment|1|||
124654812|NCT01358578|448355725|FG002|Maintenance Period|Non-compliance with study treatment|0|||
124654813|NCT01358578|448355726|FG003|Maintenance Period|Non-compliance with study treatment|2|||
124654814|NCT01358578|448355727|FG004|Maintenance Period|Non-compliance with study treatment|1|||
124654815|NCT01358578|448355728|FG005|Maintenance Period|Non-compliance with study treatment|2|||
124654816|NCT01358578|448355723|FG000|Maintenance Period|Physician Decision|0|||
124654817|NCT01358578|448355724|FG001|Maintenance Period|Physician Decision|1|||
124654818|NCT01358578|448355725|FG002|Maintenance Period|Physician Decision|0|||
124654819|NCT01358578|448355726|FG003|Maintenance Period|Physician Decision|1|||
124654820|NCT01358578|448355727|FG004|Maintenance Period|Physician Decision|0|||
124654821|NCT01358578|448355728|FG005|Maintenance Period|Physician Decision|0|||
124654822|NCT01358578|448355723|FG000|Maintenance Period|Pregnancy|1|||
124654823|NCT01358578|448355724|FG001|Maintenance Period|Pregnancy|0|||
124654824|NCT01358578|448355725|FG002|Maintenance Period|Pregnancy|0|||
124654825|NCT01358578|448355726|FG003|Maintenance Period|Pregnancy|0|||
124654826|NCT01358578|448355727|FG004|Maintenance Period|Pregnancy|0|||
124654827|NCT01358578|448355728|FG005|Maintenance Period|Pregnancy|0|||
124654828|NCT01358578|448355723|FG000|Maintenance Period|Protocol deviation|7|||
124654829|NCT01358578|448355724|FG001|Maintenance Period|Protocol deviation|4|||
124654830|NCT01358578|448355725|FG002|Maintenance Period|Protocol deviation|0|||
124654831|NCT01358578|448355726|FG003|Maintenance Period|Protocol deviation|2|||
124654832|NCT01358578|448355727|FG004|Maintenance Period|Protocol deviation|2|||
124654833|NCT01358578|448355728|FG005|Maintenance Period|Protocol deviation|2|||
124654834|NCT01358578|448355723|FG000|Maintenance Period|Withdrawal by Subject|12|||
124654835|NCT01358578|448355724|FG001|Maintenance Period|Withdrawal by Subject|7|||
124654836|NCT01358578|448355725|FG002|Maintenance Period|Withdrawal by Subject|2|||
124654837|NCT01358578|448355726|FG003|Maintenance Period|Withdrawal by Subject|15|||
124654838|NCT01358578|448355727|FG004|Maintenance Period|Withdrawal by Subject|6|||
124654839|NCT01358578|448355728|FG005|Maintenance Period|Withdrawal by Subject|3|||
124654840|NCT01358578|448355723|FG000|Follow-up Period|Adverse Event|1|||
124654841|NCT01358578|448355724|FG001|Follow-up Period|Adverse Event|1|||
124654842|NCT01358578|448355725|FG002|Follow-up Period|Adverse Event|0|||
124654843|NCT01358578|448355726|FG003|Follow-up Period|Adverse Event|0|||
124654844|NCT01358578|448355727|FG004|Follow-up Period|Adverse Event|0|||
124654845|NCT01358578|448355728|FG005|Follow-up Period|Adverse Event|0|||
124654846|NCT01358578|448355723|FG000|Follow-up Period|Lack of Efficacy|3|||
124654847|NCT01358578|448355724|FG001|Follow-up Period|Lack of Efficacy|0|||
124654848|NCT01358578|448355725|FG002|Follow-up Period|Lack of Efficacy|4|||
124654849|NCT01358578|448355726|FG003|Follow-up Period|Lack of Efficacy|1|||
124654850|NCT01358578|448355727|FG004|Follow-up Period|Lack of Efficacy|0|||
124654851|NCT01358578|448355728|FG005|Follow-up Period|Lack of Efficacy|0|||
124654852|NCT01358578|448355723|FG000|Follow-up Period|Lost to Follow-up|0|||
124654853|NCT01358578|448355724|FG001|Follow-up Period|Lost to Follow-up|1|||
124654854|NCT01358578|448355725|FG002|Follow-up Period|Lost to Follow-up|0|||
124654855|NCT01358578|448355726|FG003|Follow-up Period|Lost to Follow-up|4|||
124654856|NCT01358578|448355727|FG004|Follow-up Period|Lost to Follow-up|0|||
124654857|NCT01358578|448355728|FG005|Follow-up Period|Lost to Follow-up|0|||
124654858|NCT01358578|448355723|FG000|Follow-up Period|non- compliance with study treatment|1|||
124654859|NCT01358578|448355724|FG001|Follow-up Period|non- compliance with study treatment|0|||
124654860|NCT01358578|448355725|FG002|Follow-up Period|non- compliance with study treatment|0|||
124654861|NCT01358578|448355726|FG003|Follow-up Period|non- compliance with study treatment|0|||
124654862|NCT01358578|448355727|FG004|Follow-up Period|non- compliance with study treatment|0|||
124654863|NCT01358578|448355728|FG005|Follow-up Period|non- compliance with study treatment|0|||
124654864|NCT01358578|448355723|FG000|Follow-up Period|Pregnancy|1|||
124654865|NCT01358578|448355724|FG001|Follow-up Period|Pregnancy|0|||
124654866|NCT01358578|448355725|FG002|Follow-up Period|Pregnancy|0|||
124654867|NCT01358578|448355726|FG003|Follow-up Period|Pregnancy|0|||
124654868|NCT01358578|448355727|FG004|Follow-up Period|Pregnancy|0|||
124654869|NCT01358578|448355728|FG005|Follow-up Period|Pregnancy|0|||
124654870|NCT01358578|448355723|FG000|Follow-up Period|Withdrawal by Subject|3|||
124654871|NCT01358578|448355724|FG001|Follow-up Period|Withdrawal by Subject|3|||
124654872|NCT01358578|448355725|FG002|Follow-up Period|Withdrawal by Subject|1|||
124654873|NCT01358578|448355726|FG003|Follow-up Period|Withdrawal by Subject|12|||
124654874|NCT01358578|448355727|FG004|Follow-up Period|Withdrawal by Subject|0|||
124654875|NCT01358578|448355728|FG005|Follow-up Period|Withdrawal by Subject|0|||
124654876|NCT01358578|448355723|FG000|Follow-up Period|Physician Decision|1|||
124654877|NCT01358578|448355724|FG001|Follow-up Period|Physician Decision|1|||
124654878|NCT01358578|448355725|FG002|Follow-up Period|Physician Decision|0|||
124654879|NCT01358578|448355726|FG003|Follow-up Period|Physician Decision|2|||
124654880|NCT01358578|448355727|FG004|Follow-up Period|Physician Decision|0|||
124654881|NCT01358578|448355728|FG005|Follow-up Period|Physician Decision|0|||
124654882|NCT00388297|448355729|FG000|Overall Study|Lost to Follow-up|16|||
124654883|NCT00388297|448355730|FG001|Overall Study|Lost to Follow-up|12|||
124654884|NCT00388297|448355731|FG002|Overall Study|Lost to Follow-up|11|||
124654885|NCT00388297|448355732|FG003|Overall Study|Lost to Follow-up|8|||
124654886|NCT01492101|448355734|FG000|Overall Study|Death|323|||
124654887|NCT01492101|448355735|FG001|Overall Study|Death|322|||
124654888|NCT01492101|448355734|FG000|Overall Study|Withdrawal by Subject|14|||
124654889|NCT01492101|448355735|FG001|Overall Study|Withdrawal by Subject|18|||
124654890|NCT01492101|448355734|FG000|Overall Study|Lost to Follow-up|0|||
124654891|NCT01492101|448355735|FG001|Overall Study|Lost to Follow-up|2|||
124654892|NCT01675154|448355736|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
124654893|NCT01675154|448355737|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
124654894|NCT01675154|448355738|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
124654895|NCT01675154|448355739|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
124654896|NCT02971800|448355742|FG000|Overall Study|Protocol Violation|1|||
124654897|NCT02971800|448355742|FG000|Overall Study|Withdrawal by Subject|1|||
124654898|NCT02971800|448355742|FG000|Overall Study|Exclusion criteria prior intervention|1|||
124654899|NCT02971800|448355742|FG000|Overall Study|Number evaluable participant already reached|4|||
124654900|NCT00460265|448355743|FG000|Overall Study|Lost to Follow-up|14|||
124654901|NCT00460265|448355744|FG001|Overall Study|Lost to Follow-up|15|||
124654902|NCT00460265|448355743|FG000|Overall Study|Physician Decision|1|||
124654903|NCT00460265|448355744|FG001|Overall Study|Physician Decision|2|||
124654904|NCT00460265|448355743|FG000|Overall Study|Withdrawal by Subject|10|||
124654905|NCT00460265|448355744|FG001|Overall Study|Withdrawal by Subject|25|||
124654906|NCT00460265|448355743|FG000|Overall Study|Ongoing|60|||
124654907|NCT00460265|448355744|FG001|Overall Study|Ongoing|47|||
124654908|NCT05323994|448355745|FG000|Overall Study|Protocol Violation|1|||
124654909|NCT02719353|448355747|FG000|First Intervention|Physician Decision|0|||
124654910|NCT02719353|448355748|FG001|First Intervention|Physician Decision|1|||
124654911|NCT01917344|448355752|FG000|Overall Study|Withdrawal by Subject|1|||
124654912|NCT04526574|448355757|FG000|Overall Study|Protocol Violation|3|||
124654913|NCT04526574|448355758|FG001|Overall Study|Protocol Violation|1|||
124654914|NCT04526574|448355757|FG000|Overall Study|Withdrawal by Subject|12|||
124654915|NCT04526574|448355758|FG001|Overall Study|Withdrawal by Subject|9|||
124654916|NCT04526574|448355757|FG000|Overall Study|Other|1|||
124654917|NCT04526574|448355758|FG001|Overall Study|Other|2|||
124654918|NCT04526574|448355757|FG000|Overall Study|Adverse Event|1|||
124654919|NCT04526574|448355758|FG001|Overall Study|Adverse Event|1|||
124654920|NCT04526574|448355757|FG000|Overall Study|Death|2|||
124654921|NCT04526574|448355758|FG001|Overall Study|Death|3|||
124654922|NCT04526574|448355757|FG000|Overall Study|Lost to Follow-up|9|||
124654923|NCT04526574|448355758|FG001|Overall Study|Lost to Follow-up|9|||
124654924|NCT04526574|448355757|FG000|Overall Study|No longer meets eligibility criteria|8|||
124654925|NCT04526574|448355758|FG001|Overall Study|No longer meets eligibility criteria|8|||
124654926|NCT00717275|448355766|FG000|Overall Study|Premature study termination.|3|||
124654927|NCT00424021|448355767|FG000|NCT00046319 Study Period|Adverse Event|1|||
124654928|NCT00424021|448355768|FG001|NCT00046319 Study Period|Adverse Event|0|||
124654929|NCT00424021|448355769|FG002|NCT00046319 Study Period|Adverse Event|1|||
124654930|NCT00424021|448355770|FG003|NCT00046319 Study Period|Adverse Event|1|||
124654931|NCT00424021|448355767|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
124654932|NCT00424021|448355768|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
124654933|NCT00424021|448355769|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
124654934|NCT00424021|448355770|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
124654935|NCT00424021|448355767|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
124654936|NCT00424021|448355768|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
124654937|NCT00424021|448355769|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
124654938|NCT00424021|448355770|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
124654939|NCT00424021|448355767|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
124654940|NCT00424021|448355768|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
124654941|NCT00424021|448355769|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
124654942|NCT00424021|448355770|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
124654943|NCT00424021|448355767|FG000|AMB-220-E Study Period|Adverse Event|1|||
124654944|NCT00424021|448355768|FG001|AMB-220-E Study Period|Adverse Event|1|||
124654945|NCT00424021|448355769|FG002|AMB-220-E Study Period|Adverse Event|3|||
124654946|NCT00424021|448355770|FG003|AMB-220-E Study Period|Adverse Event|7|||
124654947|NCT00424021|448355767|FG000|AMB-220-E Study Period|Death|0|||
124654948|NCT00424021|448355768|FG001|AMB-220-E Study Period|Death|0|||
124654949|NCT00424021|448355769|FG002|AMB-220-E Study Period|Death|1|||
124654950|NCT00424021|448355770|FG003|AMB-220-E Study Period|Death|1|||
124654951|NCT00424021|448355767|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
124654952|NCT00424021|448355768|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
124654953|NCT00424021|448355769|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
124654954|NCT00424021|448355770|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
124654955|NCT00424021|448355767|FG000|AMB-220-E Study Period|Physician Decision|0|||
124654956|NCT00424021|448355768|FG001|AMB-220-E Study Period|Physician Decision|0|||
124654957|NCT00424021|448355769|FG002|AMB-220-E Study Period|Physician Decision|0|||
124654958|NCT00424021|448355770|FG003|AMB-220-E Study Period|Physician Decision|1|||
124654959|NCT03000530|448355771|FG000|Overall Study|Adverse Event|0|||
124654960|NCT03000530|448355772|FG001|Overall Study|Adverse Event|0|||
124654961|NCT03000530|448355773|FG002|Overall Study|Adverse Event|2|||
124654962|NCT03000530|448355771|FG000|Overall Study|Lost to Follow-up|0|||
124654963|NCT03000530|448355772|FG001|Overall Study|Lost to Follow-up|3|||
124654964|NCT03000530|448355773|FG002|Overall Study|Lost to Follow-up|1|||
124654965|NCT03000530|448355771|FG000|Overall Study|Withdrawal by Subject|0|||
124654966|NCT03000530|448355772|FG001|Overall Study|Withdrawal by Subject|2|||
124654967|NCT03000530|448355773|FG002|Overall Study|Withdrawal by Subject|1|||
124654968|NCT00312572|448355774|FG000|Overall Study|Adverse Event|10|||
124654969|NCT00312572|448355775|FG001|Overall Study|Adverse Event|16|||
124654970|NCT00312572|448355774|FG000|Overall Study|Lost to Follow-up|1|||
124654971|NCT00312572|448355775|FG001|Overall Study|Lost to Follow-up|1|||
124654972|NCT00312572|448355774|FG000|Overall Study|Administrative|4|||
124654973|NCT00312572|448355775|FG001|Overall Study|Administrative|2|||
124654974|NCT00312572|448355774|FG000|Overall Study|Lack of Efficacy|1|||
124654975|NCT00312572|448355775|FG001|Overall Study|Lack of Efficacy|2|||
124654976|NCT01285492|448355776|FG000|Overall Study|Adverse Event|11|||
124654977|NCT01285492|448355777|FG001|Overall Study|Adverse Event|0|||
124654978|NCT01285492|448355776|FG000|Overall Study|Protocol Violation|3|||
124654979|NCT01285492|448355777|FG001|Overall Study|Protocol Violation|0|||
124654980|NCT01285492|448355776|FG000|Overall Study|Withdrawal by Subject|2|||
124654981|NCT01285492|448355777|FG001|Overall Study|Withdrawal by Subject|1|||
124654982|NCT01285492|448355776|FG000|Overall Study|Death|1|||
124654983|NCT01285492|448355777|FG001|Overall Study|Death|0|||
124654984|NCT00634049|448355783|FG000|Overall Study|Never received study drug|1|||
124654985|NCT00634049|448355783|FG000|Overall Study|Died prior to receiving study drug|1|||
124654986|NCT00634049|448355783|FG000|Overall Study|Screening failure|1|||
124654987|NCT00314132|448355784|FG000|Overall Study|Lost to Follow-up|3|||
124654988|NCT00314132|448355785|FG001|Overall Study|Lost to Follow-up|13|||
124654989|NCT00314132|448355784|FG000|Overall Study|Withdrawal by Subject|3|||
124654990|NCT00314132|448355785|FG001|Overall Study|Withdrawal by Subject|5|||
124654991|NCT00314132|448355784|FG000|Overall Study|Adverse Event|1|||
124654992|NCT00314132|448355785|FG001|Overall Study|Adverse Event|0|||
124654993|NCT00314132|448355784|FG000|Overall Study|Physician Decision|1|||
124654994|NCT00314132|448355785|FG001|Overall Study|Physician Decision|0|||
124654995|NCT01380691|448355787|FG000|Washout (7 Days)|Protocol Violation|0|||
124654996|NCT01380691|448355788|FG001|Washout (7 Days)|Protocol Violation|0|||
124654997|NCT01380691|448355789|FG002|Washout (7 Days)|Protocol Violation|0|||
124654998|NCT01380691|448355790|FG003|Washout (7 Days)|Protocol Violation|1|||
124654999|NCT01380691|448355787|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
124655000|NCT01380691|448355788|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
124655001|NCT01380691|448355789|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
124655002|NCT01380691|448355790|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
124655003|NCT01987232|448355793|FG000|Overall Study|Ongoing in Study|0|||
124655004|NCT01987232|448355794|FG001|Overall Study|Ongoing in Study|0|||
124655005|NCT01987232|448355795|FG002|Overall Study|Ongoing in Study|0|||
124655006|NCT01987232|448355796|FG003|Overall Study|Ongoing in Study|1|||
124655007|NCT01987232|448355797|FG004|Overall Study|Ongoing in Study|0|||
124655008|NCT03564795|448355798|FG000|Overall Study|Withdrawal by Subject|3|||
124655009|NCT03564795|448355798|FG000|Overall Study|Lost to Follow-up|6|||
124655010|NCT03564795|448355798|FG000|Overall Study|Physician Decision|2|||
124655011|NCT02906033|448355799|FG000|Baseline|Protocol Violation|37|||
124655012|NCT02906033|448355800|FG001|Baseline|Protocol Violation|33|||
124655013|NCT02906033|448355799|FG000|Follow-up|Lost to Follow-up|46|||
124655014|NCT02906033|448355800|FG001|Follow-up|Lost to Follow-up|62|||
124655015|NCT01333956|448355809|FG000|Overall Study|Lost to Follow-up|1|||
124655016|NCT01333956|448355810|FG001|Overall Study|Lost to Follow-up|2|||
124655017|NCT01333956|448355811|FG002|Overall Study|Lost to Follow-up|0|||
124655018|NCT01333956|448355812|FG003|Overall Study|Lost to Follow-up|1|||
124655019|NCT01333956|448355809|FG000|Overall Study|Unable to complete study procedure|1|||
124655020|NCT01333956|448355810|FG001|Overall Study|Unable to complete study procedure|0|||
124655021|NCT01333956|448355811|FG002|Overall Study|Unable to complete study procedure|0|||
124655022|NCT01333956|448355812|FG003|Overall Study|Unable to complete study procedure|1|||
124655023|NCT01333956|448355809|FG000|Overall Study|Withdrawal by Subject|0|||
124655024|NCT01333956|448355810|FG001|Overall Study|Withdrawal by Subject|2|||
124655025|NCT01333956|448355811|FG002|Overall Study|Withdrawal by Subject|1|||
124655026|NCT01333956|448355812|FG003|Overall Study|Withdrawal by Subject|0|||
124655027|NCT00432276|448355813|FG000|Overall Study|Hyperglycemic Rescue|44|||
124655028|NCT00432276|448355814|FG001|Overall Study|Hyperglycemic Rescue|87|||
124655029|NCT00432276|448355813|FG000|Overall Study|Adverse Event|13|||
124655030|NCT00432276|448355814|FG001|Overall Study|Adverse Event|16|||
124655031|NCT00432276|448355813|FG000|Overall Study|Protocol Violation|25|||
124655032|NCT00432276|448355814|FG001|Overall Study|Protocol Violation|20|||
124655033|NCT00432276|448355813|FG000|Overall Study|Lost to Follow-up|6|||
124655034|NCT00432276|448355814|FG001|Overall Study|Lost to Follow-up|2|||
124655035|NCT00432276|448355813|FG000|Overall Study|Withdrawal by Subject|25|||
124655036|NCT00432276|448355814|FG001|Overall Study|Withdrawal by Subject|20|||
124655037|NCT00432276|448355813|FG000|Overall Study|Physician Decision|6|||
124655038|NCT00432276|448355814|FG001|Overall Study|Physician Decision|8|||
124655039|NCT00432276|448355813|FG000|Overall Study|Other|2|||
124655040|NCT00432276|448355814|FG001|Overall Study|Other|3|||
124655041|NCT02360475|448355822|FG000|Overall Study|Lost to Follow-up|4|||
124655042|NCT02360475|448355823|FG001|Overall Study|Lost to Follow-up|12|||
124655043|NCT02360475|448355824|FG002|Overall Study|Lost to Follow-up|6|||
124655044|NCT02360475|448355825|FG003|Overall Study|Lost to Follow-up|4|||
124655045|NCT02360475|448355822|FG000|Overall Study|Withdrawal by Subject|0|||
124655046|NCT02360475|448355823|FG001|Overall Study|Withdrawal by Subject|1|||
124655047|NCT02360475|448355824|FG002|Overall Study|Withdrawal by Subject|2|||
124655048|NCT02360475|448355825|FG003|Overall Study|Withdrawal by Subject|0|||
124655049|NCT02360475|448355822|FG000|Overall Study|Migrated/moved from study area|0|||
124655050|NCT02360475|448355823|FG001|Overall Study|Migrated/moved from study area|0|||
124655051|NCT02360475|448355824|FG002|Overall Study|Migrated/moved from study area|0|||
124655052|NCT02360475|448355825|FG003|Overall Study|Migrated/moved from study area|1|||
124655053|NCT01764659|448355829|FG000|Overall Study|Death|1|||
124655054|NCT01764659|448355829|FG000|Overall Study|Physician Decision|1|||
124655055|NCT00628927|448355830|FG000|Overall Study|Problems performing blood draw|6|||
124655056|NCT00628927|448355831|FG001|Overall Study|Problems performing blood draw|0|||
124655057|NCT00628927|448355830|FG000|Overall Study|Lost to Follow-up|1|||
124655058|NCT00628927|448355831|FG001|Overall Study|Lost to Follow-up|0|||
124655059|NCT00628927|448355830|FG000|Overall Study|Equipment failure|1|||
124655060|NCT00628927|448355831|FG001|Overall Study|Equipment failure|0|||
124655061|NCT02440854|448355832|FG000|Overall Study|Relocation of patient|1|||
124655062|NCT02440854|448355832|FG000|Overall Study|Death|6|||
124655063|NCT02440854|448355832|FG000|Overall Study|Lost to Follow-up|10|||
124655064|NCT02440854|448355832|FG000|Overall Study|Afatinib discontinuation|46|||
124655065|NCT02440854|448355832|FG000|Overall Study|stopped study at earlier timepoint|14|||
124655066|NCT02440854|448355832|FG000|Overall Study|Study medication not received|1|||
124655067|NCT02440854|448355832|FG000|Overall Study|Violation of inclusion criteria|2|||
124655068|NCT02669082|448355833|FG000|Overall Study|Adverse Event|1|||
124655069|NCT04852276|448355834|FG000|Overall Study|Death|2|||
124655070|NCT04852276|448355835|FG001|Overall Study|Death|0|||
124655071|NCT04852276|448355834|FG000|Overall Study|Lost to Follow-up|15|||
124655072|NCT04852276|448355835|FG001|Overall Study|Lost to Follow-up|9|||
124655073|NCT04852276|448355834|FG000|Overall Study|Withdrawal by Subject|26|||
124655074|NCT04852276|448355835|FG001|Overall Study|Withdrawal by Subject|6|||
124655075|NCT00316914|448357408|FG000|Overall Study|Withdrawal by Subject|5|||
124655076|NCT00316914|448357409|FG001|Overall Study|Withdrawal by Subject|3|||
124655077|NCT00316914|448357408|FG000|Overall Study|Adverse Event|8|||
124655078|NCT00316914|448357409|FG001|Overall Study|Adverse Event|7|||
124655079|NCT00316914|448357408|FG000|Overall Study|Other Problems|6|||
124655080|NCT00316914|448357409|FG001|Overall Study|Other Problems|11|||
124655081|NCT00316914|448357408|FG000|Overall Study|Missing end of treatment documentation|14|||
124655082|NCT00316914|448357409|FG001|Overall Study|Missing end of treatment documentation|15|||
124655083|NCT04105010|448357410|FG000|Overall Study|Death|3|||
124655084|NCT04105010|448357411|FG001|Overall Study|Death|1|||
124655085|NCT04105010|448357412|FG002|Overall Study|Death|1|||
124655086|NCT04105010|448357413|FG003|Overall Study|Death|54|||
124655087|NCT04105010|448357410|FG000|Overall Study|Lost to Follow-up|0|||
124655088|NCT04105010|448357411|FG001|Overall Study|Lost to Follow-up|0|||
124655089|NCT04105010|448357412|FG002|Overall Study|Lost to Follow-up|0|||
124655090|NCT04105010|448357413|FG003|Overall Study|Lost to Follow-up|4|||
124655091|NCT04105010|448357410|FG000|Overall Study|Withdrawal by Subject|8|||
124655092|NCT04105010|448357411|FG001|Overall Study|Withdrawal by Subject|1|||
124655093|NCT04105010|448357412|FG002|Overall Study|Withdrawal by Subject|1|||
124655094|NCT04105010|448357413|FG003|Overall Study|Withdrawal by Subject|4|||
124655095|NCT04105010|448357410|FG000|Overall Study|Other reason|4|||
124655096|NCT04105010|448357411|FG001|Overall Study|Other reason|7|||
124655097|NCT04105010|448357412|FG002|Overall Study|Other reason|0|||
124655098|NCT04105010|448357413|FG003|Overall Study|Other reason|19|||
124655099|NCT01179737|448357416|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
124655100|NCT01179737|448357417|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
124655101|NCT01179737|448357418|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
124655102|NCT01179737|448357419|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
124655103|NCT01179737|448357416|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
124655104|NCT01179737|448357417|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
124655105|NCT01179737|448357418|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
124655106|NCT01179737|448357419|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
124655107|NCT01179737|448357416|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
124655108|NCT01179737|448357417|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
124655109|NCT01179737|448357418|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
124655110|NCT01179737|448357419|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
124655111|NCT01179737|448357416|FG000|Cohort 1 & Cohort 2|Death|0|||
124655112|NCT01179737|448357417|FG001|Cohort 1 & Cohort 2|Death|0|||
124655113|NCT01179737|448357418|FG002|Cohort 1 & Cohort 2|Death|1|||
124655114|NCT01179737|448357419|FG003|Cohort 1 & Cohort 2|Death|0|||
124655115|NCT01179737|448357416|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
124655116|NCT01179737|448357417|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
124655117|NCT01179737|448357418|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
124655118|NCT01179737|448357419|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
124655119|NCT01179737|448357416|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
124655120|NCT01179737|448357417|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
124655121|NCT01179737|448357418|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
124655122|NCT01179737|448357419|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
124655123|NCT01179737|448357416|FG000|Extension|The study was terminated|3|||
124655124|NCT01179737|448357417|FG001|Extension|The study was terminated|0|||
124655125|NCT01179737|448357418|FG002|Extension|The study was terminated|0|||
124655126|NCT01179737|448357419|FG003|Extension|The study was terminated|0|||
124655127|NCT03329248|448357423|FG000|Overall Study|Progressive Disease|6|||
124655128|NCT00987402|448357424|FG000|Overall Study|Insufficient data entry|86|||
124655129|NCT00987402|448357425|FG001|Overall Study|Insufficient data entry|98|||
124655130|NCT01254721|448357426|FG000|Overall Study|Lost to Follow-up|0|||
124655131|NCT01254721|448357427|FG001|Overall Study|Lost to Follow-up|4|||
124655132|NCT01254721|448357426|FG000|Overall Study|Lack of Efficacy|4|||
124655133|NCT01254721|448357427|FG001|Overall Study|Lack of Efficacy|2|||
124655134|NCT01254721|448357426|FG000|Overall Study|Death|0|||
124655135|NCT01254721|448357427|FG001|Overall Study|Death|1|||
124655136|NCT01254721|448357426|FG000|Overall Study|technical problum|1|||
124655137|NCT01254721|448357427|FG001|Overall Study|technical problum|0|||
124655138|NCT01254721|448357426|FG000|Overall Study|Adverse Event|2|||
124655139|NCT01254721|448357427|FG001|Overall Study|Adverse Event|3|||
124655140|NCT01254721|448357426|FG000|Overall Study|Withdrawal by Subject|8|||
124655141|NCT01254721|448357427|FG001|Overall Study|Withdrawal by Subject|11|||
124655142|NCT01254721|448357426|FG000|Overall Study|Wrongly randomization|0|||
124655143|NCT01254721|448357427|FG001|Overall Study|Wrongly randomization|1|||
124655144|NCT03597022|448357431|FG000|Overall Study|Premature termination of the study|7|||
124655145|NCT03597022|448357432|FG001|Overall Study|Premature termination of the study|7|||
124655146|NCT03597022|448357433|FG002|Overall Study|Premature termination of the study|8|||
124655147|NCT03597022|448357431|FG000|Overall Study|Serious adverse event|1|||
124655148|NCT03597022|448357432|FG001|Overall Study|Serious adverse event|1|||
124655149|NCT03597022|448357433|FG002|Overall Study|Serious adverse event|0|||
124655150|NCT02614131|448357436|FG000|Overall Study|Withdrawal by Subject|1|||
124655151|NCT02614131|448357437|FG001|Overall Study|Withdrawal by Subject|0|||
124655152|NCT02614131|448357438|FG002|Overall Study|Withdrawal by Subject|0|||
124655153|NCT02614131|448357439|FG003|Overall Study|Withdrawal by Subject|0|||
124655154|NCT02614131|448357440|FG004|Overall Study|Withdrawal by Subject|0|||
124655155|NCT02614131|448357441|FG005|Overall Study|Withdrawal by Subject|0|||
124655156|NCT02614131|448357442|FG006|Overall Study|Withdrawal by Subject|0|||
124655157|NCT02614131|448357436|FG000|Overall Study|Adverse Event|0|||
124655158|NCT02614131|448357437|FG001|Overall Study|Adverse Event|0|||
124655159|NCT02614131|448357438|FG002|Overall Study|Adverse Event|0|||
124655160|NCT02614131|448357439|FG003|Overall Study|Adverse Event|0|||
124655161|NCT02614131|448357440|FG004|Overall Study|Adverse Event|0|||
124655162|NCT02614131|448357441|FG005|Overall Study|Adverse Event|0|||
124655163|NCT02614131|448357442|FG006|Overall Study|Adverse Event|1|||
124655164|NCT03209518|448357443|FG000|Overall Study|Case Report Forms Uncollected|1|||
124655165|NCT03209518|448357443|FG000|Overall Study|Protocol Deviation|1|||
124655166|NCT00236899|448357444|FG000|Overall Study|Adverse Event (Study Related)|1|||
124655167|NCT00236899|448357445|FG001|Overall Study|Adverse Event (Study Related)|1|||
124655168|NCT00236899|448357446|FG002|Overall Study|Adverse Event (Study Related)|2|||
124655169|NCT00236899|448357447|FG003|Overall Study|Adverse Event (Study Related)|1|||
124655170|NCT00236899|448357444|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
124655171|NCT00236899|448357445|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
124655172|NCT00236899|448357446|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
124655173|NCT00236899|448357447|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
124655174|NCT00236899|448357444|FG000|Overall Study|Death (Study Disease)|1|||
124655175|NCT00236899|448357445|FG001|Overall Study|Death (Study Disease)|4|||
124655176|NCT00236899|448357446|FG002|Overall Study|Death (Study Disease)|0|||
124655177|NCT00236899|448357447|FG003|Overall Study|Death (Study Disease)|0|||
124655178|NCT00236899|448357444|FG000|Overall Study|Death (Not Study Related)|2|||
124655179|NCT00236899|448357445|FG001|Overall Study|Death (Not Study Related)|0|||
124655180|NCT00236899|448357446|FG002|Overall Study|Death (Not Study Related)|0|||
124655181|NCT00236899|448357447|FG003|Overall Study|Death (Not Study Related)|0|||
124655182|NCT00236899|448357444|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
124655183|NCT00236899|448357445|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
124655184|NCT00236899|448357446|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
124655185|NCT00236899|448357447|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
124655186|NCT00236899|448357444|FG000|Overall Study|Lost to Follow-up|0|||
124655187|NCT00236899|448357445|FG001|Overall Study|Lost to Follow-up|1|||
124655188|NCT00236899|448357446|FG002|Overall Study|Lost to Follow-up|0|||
124655189|NCT00236899|448357447|FG003|Overall Study|Lost to Follow-up|0|||
124655190|NCT00236899|448357444|FG000|Overall Study|Entry Criteria Exclusion|0|||
124655191|NCT00236899|448357445|FG001|Overall Study|Entry Criteria Exclusion|1|||
124655192|NCT00236899|448357446|FG002|Overall Study|Entry Criteria Exclusion|1|||
124655193|NCT00236899|448357447|FG003|Overall Study|Entry Criteria Exclusion|0|||
124655194|NCT00236899|448357444|FG000|Overall Study|Protocol Violation|1|||
124655195|NCT00236899|448357445|FG001|Overall Study|Protocol Violation|0|||
124655196|NCT00236899|448357446|FG002|Overall Study|Protocol Violation|0|||
124655197|NCT00236899|448357447|FG003|Overall Study|Protocol Violation|0|||
124655198|NCT00236899|448357444|FG000|Overall Study|Withdrawal by Subject|6|||
124655199|NCT00236899|448357445|FG001|Overall Study|Withdrawal by Subject|4|||
124655200|NCT00236899|448357446|FG002|Overall Study|Withdrawal by Subject|5|||
124655201|NCT00236899|448357447|FG003|Overall Study|Withdrawal by Subject|2|||
124655202|NCT00236899|448357444|FG000|Overall Study|Physician Decision|7|||
124655203|NCT00236899|448357445|FG001|Overall Study|Physician Decision|8|||
124655204|NCT00236899|448357446|FG002|Overall Study|Physician Decision|7|||
124655205|NCT00236899|448357447|FG003|Overall Study|Physician Decision|6|||
124655206|NCT00236899|448357444|FG000|Overall Study|Satisfactory Response|2|||
124655207|NCT00236899|448357445|FG001|Overall Study|Satisfactory Response|0|||
124655208|NCT00236899|448357446|FG002|Overall Study|Satisfactory Response|0|||
124655209|NCT00236899|448357447|FG003|Overall Study|Satisfactory Response|1|||
124655210|NCT00236899|448357444|FG000|Overall Study|Lack of Efficacy|18|||
124655211|NCT00236899|448357445|FG001|Overall Study|Lack of Efficacy|18|||
124655212|NCT00236899|448357446|FG002|Overall Study|Lack of Efficacy|25|||
124655213|NCT00236899|448357447|FG003|Overall Study|Lack of Efficacy|23|||
124655214|NCT00568334|448357454|FG000|Overall Study|Withdrawal by Subject|0|||
124655215|NCT00568334|448357455|FG001|Overall Study|Withdrawal by Subject|1|||
124655216|NCT00568334|448357454|FG000|Overall Study|Lost to Follow-up|1|||
124655217|NCT00568334|448357455|FG001|Overall Study|Lost to Follow-up|0|||
124655218|NCT01897571|448357456|FG000|Overall Study|Lost to Follow-up|3|||
124655219|NCT01897571|448357457|FG001|Overall Study|Lost to Follow-up|0|||
124655220|NCT01897571|448357458|FG002|Overall Study|Lost to Follow-up|0|||
124655221|NCT01897571|448357459|FG003|Overall Study|Lost to Follow-up|0|||
124655222|NCT01897571|448357460|FG004|Overall Study|Lost to Follow-up|2|||
124655223|NCT01897571|448357461|FG005|Overall Study|Lost to Follow-up|0|||
124655224|NCT01897571|448357462|FG006|Overall Study|Lost to Follow-up|0|||
124655225|NCT01897571|448357463|FG007|Overall Study|Lost to Follow-up|0|||
124655226|NCT01897571|448357464|FG008|Overall Study|Lost to Follow-up|1|||
124655227|NCT01897571|448357465|FG009|Overall Study|Lost to Follow-up|2|||
124655228|NCT01897571|448357466|FG010|Overall Study|Lost to Follow-up|4|||
124655229|NCT01897571|448357456|FG000|Overall Study|Withdrawal by Subject|0|||
124655230|NCT01897571|448357457|FG001|Overall Study|Withdrawal by Subject|0|||
124655231|NCT01897571|448357458|FG002|Overall Study|Withdrawal by Subject|0|||
124655232|NCT01897571|448357459|FG003|Overall Study|Withdrawal by Subject|0|||
124655233|NCT01897571|448357460|FG004|Overall Study|Withdrawal by Subject|0|||
124655234|NCT01897571|448357461|FG005|Overall Study|Withdrawal by Subject|0|||
124655235|NCT01897571|448357462|FG006|Overall Study|Withdrawal by Subject|0|||
124655236|NCT01897571|448357463|FG007|Overall Study|Withdrawal by Subject|1|||
124655237|NCT01897571|448357464|FG008|Overall Study|Withdrawal by Subject|4|||
124655238|NCT01897571|448357465|FG009|Overall Study|Withdrawal by Subject|3|||
124655239|NCT01897571|448357466|FG010|Overall Study|Withdrawal by Subject|1|||
124655240|NCT01897571|448357456|FG000|Overall Study|Other|1|||
124655241|NCT01897571|448357457|FG001|Overall Study|Other|0|||
124655242|NCT01897571|448357458|FG002|Overall Study|Other|0|||
124655243|NCT01897571|448357459|FG003|Overall Study|Other|3|||
124655244|NCT01897571|448357460|FG004|Overall Study|Other|3|||
124655245|NCT01897571|448357461|FG005|Overall Study|Other|4|||
124655246|NCT01897571|448357462|FG006|Overall Study|Other|7|||
124655247|NCT01897571|448357463|FG007|Overall Study|Other|0|||
124655248|NCT01897571|448357464|FG008|Overall Study|Other|0|||
124655249|NCT01897571|448357465|FG009|Overall Study|Other|0|||
124655250|NCT01897571|448357466|FG010|Overall Study|Other|0|||
124655251|NCT01897571|448357456|FG000|Overall Study|Enrolled in rollover study|0|||
124655252|NCT01897571|448357457|FG001|Overall Study|Enrolled in rollover study|0|||
124655253|NCT01897571|448357458|FG002|Overall Study|Enrolled in rollover study|0|||
124655254|NCT01897571|448357459|FG003|Overall Study|Enrolled in rollover study|0|||
124655255|NCT01897571|448357460|FG004|Overall Study|Enrolled in rollover study|0|||
124655256|NCT01897571|448357461|FG005|Overall Study|Enrolled in rollover study|0|||
124655257|NCT01897571|448357462|FG006|Overall Study|Enrolled in rollover study|0|||
124655258|NCT01897571|448357463|FG007|Overall Study|Enrolled in rollover study|9|||
124655259|NCT01897571|448357464|FG008|Overall Study|Enrolled in rollover study|7|||
124655260|NCT01897571|448357465|FG009|Overall Study|Enrolled in rollover study|9|||
124655261|NCT01897571|448357466|FG010|Overall Study|Enrolled in rollover study|1|||
124655262|NCT01897571|448357456|FG000|Overall Study|Death|2|||
124655263|NCT01897571|448357457|FG001|Overall Study|Death|2|||
124655264|NCT01897571|448357458|FG002|Overall Study|Death|3|||
124655265|NCT01897571|448357459|FG003|Overall Study|Death|6|||
124655266|NCT01897571|448357460|FG004|Overall Study|Death|7|||
124655267|NCT01897571|448357461|FG005|Overall Study|Death|9|||
124655268|NCT01897571|448357462|FG006|Overall Study|Death|5|||
124655269|NCT01897571|448357463|FG007|Overall Study|Death|22|||
124655270|NCT01897571|448357464|FG008|Overall Study|Death|23|||
124655271|NCT01897571|448357465|FG009|Overall Study|Death|129|||
124655272|NCT01897571|448357466|FG010|Overall Study|Death|59|||
124655273|NCT01797094|448357468|FG000|Overall Study|Adverse Event|1|||
124655274|NCT01797094|448357469|FG001|Overall Study|Adverse Event|1|||
124655275|NCT01797094|448357468|FG000|Overall Study|Personal Reasons|4|||
124655276|NCT01797094|448357469|FG001|Overall Study|Personal Reasons|0|||
124655277|NCT01797094|448357468|FG000|Overall Study|Protocol Violation|0|||
124655278|NCT01797094|448357469|FG001|Overall Study|Protocol Violation|1|||
124655279|NCT01797094|448357468|FG000|Overall Study|Other Miscellaneous Reasons|1|||
124655280|NCT01797094|448357469|FG001|Overall Study|Other Miscellaneous Reasons|0|||
124655281|NCT03217968|448357473|FG000|Overall Study|Withdrawal by Subject|4|||
124655282|NCT03217968|448357473|FG000|Overall Study|Lost to Follow-up|1|||
124655283|NCT03217968|448357473|FG000|Overall Study|Protocol Violation|6|||
124655284|NCT00306787|448357475|FG000|Overall Study|Discontinued without taking study drug|208|||
124655285|NCT00306787|448357476|FG001|Overall Study|Discontinued without taking study drug|215|||
124655286|NCT00306787|448357475|FG000|Overall Study|Adverse Event|1|||
124655287|NCT00306787|448357476|FG001|Overall Study|Adverse Event|1|||
124655288|NCT00306787|448357475|FG000|Overall Study|Lack of Efficacy|1|||
124655289|NCT00306787|448357476|FG001|Overall Study|Lack of Efficacy|0|||
124655290|NCT00306787|448357475|FG000|Overall Study|Protocol Violation|8|||
124655291|NCT00306787|448357476|FG001|Overall Study|Protocol Violation|10|||
124655292|NCT00306787|448357475|FG000|Overall Study|Withdrawal by Subject|2|||
124655293|NCT00306787|448357476|FG001|Overall Study|Withdrawal by Subject|9|||
124655294|NCT00306787|448357475|FG000|Overall Study|Lost to Follow-up|9|||
124655295|NCT00306787|448357476|FG001|Overall Study|Lost to Follow-up|6|||
124655296|NCT00306787|448357475|FG000|Overall Study|Administrative problems|4|||
124655297|NCT00306787|448357476|FG001|Overall Study|Administrative problems|0|||
124655298|NCT00306787|448357475|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124655299|NCT00306787|448357476|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124655300|NCT03913104|448357477|FG000|Overall Study|Lost to Follow-up|20|||
124655301|NCT03913104|448357477|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
124655302|NCT03913104|448357477|FG000|Overall Study|Withdrawal by Subject|2|||
124655303|NCT01593254|448357483|FG000|Overall Study|Disease progression|2|||
124655304|NCT01593254|448357484|FG001|Overall Study|Disease progression|7|||
124655305|NCT01593254|448357483|FG000|Overall Study|Study drug toxicity|6|||
124655306|NCT01593254|448357484|FG001|Overall Study|Study drug toxicity|20|||
124655307|NCT01593254|448357483|FG000|Overall Study|Death|3|||
124655308|NCT01593254|448357484|FG001|Overall Study|Death|3|||
124655309|NCT01593254|448357483|FG000|Overall Study|AE unrelated to study drug|0|||
124655310|NCT01593254|448357484|FG001|Overall Study|AE unrelated to study drug|1|||
124655311|NCT01593254|448357483|FG000|Overall Study|participant request to discontinue study treatment|1|||
124655312|NCT01593254|448357484|FG001|Overall Study|participant request to discontinue study treatment|3|||
124655313|NCT01593254|448357483|FG000|Overall Study|participant withdrew consent|0|||
124655314|NCT01593254|448357484|FG001|Overall Study|participant withdrew consent|9|||
124655315|NCT01593254|448357483|FG000|Overall Study|lost to follow up|1|||
124655316|NCT01593254|448357484|FG001|Overall Study|lost to follow up|6|||
124655317|NCT01593254|448357483|FG000|Overall Study|maximum clinical benefit|1|||
124655318|NCT01593254|448357484|FG001|Overall Study|maximum clinical benefit|2|||
124655319|NCT01593254|448357483|FG000|Overall Study|Poor/non compliance|1|||
124655320|NCT01593254|448357484|FG001|Overall Study|Poor/non compliance|1|||
124655321|NCT01593254|448357483|FG000|Overall Study|Pregnancy|0|||
124655322|NCT01593254|448357484|FG001|Overall Study|Pregnancy|3|||
124655323|NCT01593254|448357483|FG000|Overall Study|participant no longer meets study criteria|1|||
124655324|NCT01593254|448357484|FG001|Overall Study|participant no longer meets study criteria|1|||
124655325|NCT01593254|448357483|FG000|Overall Study|Admin reason by sponsor|7|||
124655326|NCT01593254|448357484|FG001|Overall Study|Admin reason by sponsor|3|||
124655327|NCT01593254|448357483|FG000|Overall Study|Imatinib treatment failure|2|||
124655328|NCT01593254|448357484|FG001|Overall Study|Imatinib treatment failure|0|||
124655329|NCT01593254|448357483|FG000|Overall Study|Other Reasons|61|||
124655330|NCT01593254|448357484|FG001|Overall Study|Other Reasons|115|||
124655331|NCT03013985|448357487|FG000|Overall Study|Protocol Violation|2|||
124655332|NCT03013985|448357488|FG001|Overall Study|Protocol Violation|2|||
124655333|NCT03013985|448357487|FG000|Overall Study|Withdrawal by Subject|14|||
124655334|NCT03013985|448357488|FG001|Overall Study|Withdrawal by Subject|17|||
124655335|NCT01887678|448357489|FG000|Overall Study|Adverse Event|4|||
124655336|NCT01887678|448357490|FG001|Overall Study|Adverse Event|6|||
124655337|NCT01887678|448357489|FG000|Overall Study|Exceeded rescue medication dosage|4|||
124655338|NCT01887678|448357490|FG001|Overall Study|Exceeded rescue medication dosage|5|||
124655339|NCT01887678|448357489|FG000|Overall Study|Withdrawal of consent|3|||
124655340|NCT01887678|448357490|FG001|Overall Study|Withdrawal of consent|4|||
124655341|NCT01887678|448357489|FG000|Overall Study|Lost to Follow-up|4|||
124655342|NCT01887678|448357490|FG001|Overall Study|Lost to Follow-up|2|||
124655343|NCT01887678|448357489|FG000|Overall Study|Deterioration of clinical condition|0|||
124655344|NCT01887678|448357490|FG001|Overall Study|Deterioration of clinical condition|4|||
124655345|NCT01887678|448357489|FG000|Overall Study|Lack of Efficacy|1|||
124655346|NCT01887678|448357490|FG001|Overall Study|Lack of Efficacy|2|||
124655347|NCT01887678|448357489|FG000|Overall Study|Non-compliance|0|||
124655348|NCT01887678|448357490|FG001|Overall Study|Non-compliance|3|||
124655349|NCT01887678|448357489|FG000|Overall Study|Specified|1|||
124655350|NCT01887678|448357490|FG001|Overall Study|Specified|2|||
124655351|NCT00791492|448357493|FG000|Overall Study|Withdrawal by Subject|1|||
124655352|NCT00791492|448357494|FG001|Overall Study|Withdrawal by Subject|2|||
124655353|NCT00791492|448357493|FG000|Overall Study|Liver transplantation|5|||
124655354|NCT00791492|448357494|FG001|Overall Study|Liver transplantation|1|||
124655355|NCT00076999|448357499|FG000|Overall Study|Adverse Event|2|||
124655356|NCT00076999|448357500|FG001|Overall Study|Adverse Event|8|||
124655357|NCT00076999|448357501|FG002|Overall Study|Adverse Event|6|||
124655358|NCT00076999|448357502|FG003|Overall Study|Adverse Event|0|||
124655359|NCT00076999|448357503|FG004|Overall Study|Adverse Event|2|||
124655360|NCT00076999|448357499|FG000|Overall Study|Protocol Violation|0|||
124655361|NCT00076999|448357500|FG001|Overall Study|Protocol Violation|3|||
124655362|NCT00076999|448357501|FG002|Overall Study|Protocol Violation|4|||
124655363|NCT00076999|448357502|FG003|Overall Study|Protocol Violation|0|||
124655364|NCT00076999|448357503|FG004|Overall Study|Protocol Violation|9|||
124655365|NCT00076999|448357499|FG000|Overall Study|Lost to Follow-up|2|||
124655366|NCT00076999|448357500|FG001|Overall Study|Lost to Follow-up|1|||
124655367|NCT00076999|448357501|FG002|Overall Study|Lost to Follow-up|0|||
124655368|NCT00076999|448357502|FG003|Overall Study|Lost to Follow-up|0|||
124655369|NCT00076999|448357503|FG004|Overall Study|Lost to Follow-up|0|||
124655370|NCT00076999|448357499|FG000|Overall Study|Withdrawal by Subject|0|||
124655371|NCT00076999|448357500|FG001|Overall Study|Withdrawal by Subject|4|||
124655372|NCT00076999|448357501|FG002|Overall Study|Withdrawal by Subject|3|||
124655373|NCT00076999|448357502|FG003|Overall Study|Withdrawal by Subject|0|||
124655374|NCT00076999|448357503|FG004|Overall Study|Withdrawal by Subject|1|||
124655375|NCT00076999|448357499|FG000|Overall Study|Other reason (not specified)|8|||
124655376|NCT00076999|448357500|FG001|Overall Study|Other reason (not specified)|8|||
124655377|NCT00076999|448357501|FG002|Overall Study|Other reason (not specified)|4|||
124655378|NCT00076999|448357502|FG003|Overall Study|Other reason (not specified)|1|||
124655379|NCT00076999|448357503|FG004|Overall Study|Other reason (not specified)|13|||
124655380|NCT02603562|448357515|FG000|Overall Study|Lost to Follow-up|1|||
124655381|NCT02117713|448357521|FG000|Week 48|Adverse Event|4|||
124655382|NCT02117713|448357521|FG000|Week 48|Withdrawal by caregiver|2|||
124655383|NCT02117713|448357521|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
124655384|NCT02117713|448357521|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
124655385|NCT02117713|448357521|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
124655386|NCT02117713|448357521|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
124655387|NCT00574795|448357522|FG000|Infant Series|Withdrawal by Subject|2|||
124655388|NCT00574795|448357522|FG000|Infant Series|Protocol Violation|2|||
124655389|NCT00574795|448357522|FG000|Infant Series|Adverse Event|1|||
124655390|NCT00574795|448357522|FG000|After Infant Series|Withdrawal by Subject|1|||
124655391|NCT00574795|448357522|FG000|After Infant Series|Adverse Event|2|||
124655392|NCT00574795|448357522|FG000|Toddler Dose|Withdrawal by Subject|1|||
124655393|NCT00586508|448357524|FG000|Overall Study|Progressive disease|52|||
124655394|NCT00586508|448357525|FG001|Overall Study|Progressive disease|8|||
124655395|NCT00586508|448357524|FG000|Overall Study|Death|0|||
124655396|NCT00586508|448357525|FG001|Overall Study|Death|1|||
124655397|NCT00586508|448357524|FG000|Overall Study|Adverse Event|12|||
124655398|NCT00586508|448357525|FG001|Overall Study|Adverse Event|4|||
124655399|NCT00586508|448357524|FG000|Overall Study|Withdrawal by Subject|4|||
124655400|NCT00586508|448357525|FG001|Overall Study|Withdrawal by Subject|0|||
124655401|NCT05249127|448357530|FG000|Overall Study|Protocol Violation|13|||
124655402|NCT05249127|448357530|FG000|Overall Study|Physician Decision|4|||
124655403|NCT05249127|448357530|FG000|Overall Study|Withdrawal by Subject|2|||
124655404|NCT05249127|448357530|FG000|Overall Study|Participant Non-compliance|1|||
124655405|NCT02073565|448357531|FG000|Cohort A|Withdrawal by Subject|1|||
124655406|NCT02073565|448357532|FG001|Cohort A|Withdrawal by Subject|0|||
124655407|NCT02073565|448357531|FG000|Cohort B|Withdrawal by Subject|1|||
124655408|NCT02073565|448357532|FG001|Cohort B|Withdrawal by Subject|2|||
124655409|NCT02073565|448357531|FG000|Cohort C|Withdrawal by Subject|0|||
124655410|NCT02073565|448357532|FG001|Cohort C|Withdrawal by Subject|2|||
124655411|NCT02073565|448357531|FG000|Cohort C|Lost to Follow-up|0|||
124655412|NCT02073565|448357532|FG001|Cohort C|Lost to Follow-up|2|||
124655413|NCT03646305|448357533|FG000|Overall Study|Lost to Follow-up|4|||
124655414|NCT03646305|448357534|FG001|Overall Study|Lost to Follow-up|2|||
124655415|NCT03646305|448357535|FG002|Overall Study|Lost to Follow-up|2|||
124655416|NCT03646305|448357536|FG003|Overall Study|Lost to Follow-up|1|||
124655417|NCT03646305|448357533|FG000|Overall Study|Withdrawal by Subject|1|||
124655418|NCT03646305|448357534|FG001|Overall Study|Withdrawal by Subject|0|||
124655419|NCT03646305|448357535|FG002|Overall Study|Withdrawal by Subject|0|||
124655420|NCT03646305|448357536|FG003|Overall Study|Withdrawal by Subject|1|||
124655421|NCT03417024|448357537|FG000|Overall Study|Study Termination prior to follow-up|11|||
124655422|NCT03417024|448357537|FG000|Overall Study|Physician Decision|2|||
124655423|NCT03168919|448357538|FG000|Overall Study|Withdrawal by Subject|2|||
124655424|NCT04015518|448357539|FG000|Overall Study|Adverse Event|6|||
124655425|NCT04015518|448357540|FG001|Overall Study|Adverse Event|1|||
124655426|NCT04015518|448357541|FG002|Overall Study|Adverse Event|1|||
124655427|NCT04015518|448357542|FG003|Overall Study|Adverse Event|3|||
124655428|NCT04015518|448357543|FG004|Overall Study|Adverse Event|3|||
124655429|NCT04015518|448357539|FG000|Overall Study|Lack of Efficacy|1|||
124655430|NCT04015518|448357540|FG001|Overall Study|Lack of Efficacy|0|||
124655431|NCT04015518|448357541|FG002|Overall Study|Lack of Efficacy|1|||
124655432|NCT04015518|448357542|FG003|Overall Study|Lack of Efficacy|0|||
124655433|NCT04015518|448357543|FG004|Overall Study|Lack of Efficacy|4|||
124655434|NCT04015518|448357539|FG000|Overall Study|Lost to Follow-up|0|||
124655435|NCT04015518|448357540|FG001|Overall Study|Lost to Follow-up|0|||
124655436|NCT04015518|448357541|FG002|Overall Study|Lost to Follow-up|0|||
124655437|NCT04015518|448357542|FG003|Overall Study|Lost to Follow-up|0|||
124655438|NCT04015518|448357543|FG004|Overall Study|Lost to Follow-up|1|||
124655439|NCT04015518|448357539|FG000|Overall Study|Withdrawal by Subject|0|||
124655440|NCT04015518|448357540|FG001|Overall Study|Withdrawal by Subject|1|||
124655441|NCT04015518|448357541|FG002|Overall Study|Withdrawal by Subject|0|||
124655442|NCT04015518|448357542|FG003|Overall Study|Withdrawal by Subject|1|||
124655443|NCT04015518|448357543|FG004|Overall Study|Withdrawal by Subject|1|||
124655444|NCT04015518|448357539|FG000|Overall Study|Patient did not come for consecutive visits|0|||
124655445|NCT04015518|448357540|FG001|Overall Study|Patient did not come for consecutive visits|1|||
124655446|NCT04015518|448357541|FG002|Overall Study|Patient did not come for consecutive visits|0|||
124655447|NCT04015518|448357542|FG003|Overall Study|Patient did not come for consecutive visits|0|||
124655448|NCT04015518|448357543|FG004|Overall Study|Patient did not come for consecutive visits|0|||
124655449|NCT04015518|448357539|FG000|Overall Study|not willing to travel due to Covid-19|0|||
124655450|NCT04015518|448357540|FG001|Overall Study|not willing to travel due to Covid-19|0|||
124655451|NCT04015518|448357541|FG002|Overall Study|not willing to travel due to Covid-19|1|||
124655452|NCT04015518|448357542|FG003|Overall Study|not willing to travel due to Covid-19|0|||
124655453|NCT04015518|448357543|FG004|Overall Study|not willing to travel due to Covid-19|0|||
124655454|NCT04015518|448357539|FG000|Overall Study|Patient wants to discontinue treatment|0|||
124655455|NCT04015518|448357540|FG001|Overall Study|Patient wants to discontinue treatment|0|||
124655456|NCT04015518|448357541|FG002|Overall Study|Patient wants to discontinue treatment|0|||
124655457|NCT04015518|448357542|FG003|Overall Study|Patient wants to discontinue treatment|1|||
124655458|NCT04015518|448357543|FG004|Overall Study|Patient wants to discontinue treatment|0|||
124655459|NCT04015518|448357539|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
124655460|NCT04015518|448357540|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
124655461|NCT04015518|448357541|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
124655462|NCT04015518|448357542|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
124655463|NCT04015518|448357543|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
124655464|NCT04015518|448357539|FG000|Overall Study|Pregnancy|0|||
124655465|NCT04015518|448357540|FG001|Overall Study|Pregnancy|0|||
124655466|NCT04015518|448357541|FG002|Overall Study|Pregnancy|0|||
124655467|NCT04015518|448357542|FG003|Overall Study|Pregnancy|0|||
124655468|NCT04015518|448357543|FG004|Overall Study|Pregnancy|1|||
124655469|NCT04015518|448357539|FG000|Overall Study|Personal reasons|1|||
124655470|NCT04015518|448357540|FG001|Overall Study|Personal reasons|0|||
124655471|NCT04015518|448357541|FG002|Overall Study|Personal reasons|0|||
124655472|NCT04015518|448357542|FG003|Overall Study|Personal reasons|0|||
124655473|NCT04015518|448357543|FG004|Overall Study|Personal reasons|1|||
124655474|NCT04015518|448357539|FG000|Overall Study|Withdrew consent|1|||
124655475|NCT04015518|448357540|FG001|Overall Study|Withdrew consent|0|||
124655476|NCT04015518|448357541|FG002|Overall Study|Withdrew consent|0|||
124655477|NCT04015518|448357542|FG003|Overall Study|Withdrew consent|0|||
124655478|NCT04015518|448357543|FG004|Overall Study|Withdrew consent|0|||
124655479|NCT04015518|448357539|FG000|Overall Study|Prostate carcinoma|1|||
124655480|NCT04015518|448357540|FG001|Overall Study|Prostate carcinoma|0|||
124655481|NCT04015518|448357541|FG002|Overall Study|Prostate carcinoma|0|||
124655482|NCT04015518|448357542|FG003|Overall Study|Prostate carcinoma|0|||
124655483|NCT04015518|448357543|FG004|Overall Study|Prostate carcinoma|0|||
124655484|NCT04015518|448357539|FG000|Overall Study|Could not keep appointments due to work|1|||
124655485|NCT04015518|448357540|FG001|Overall Study|Could not keep appointments due to work|0|||
124655486|NCT04015518|448357541|FG002|Overall Study|Could not keep appointments due to work|0|||
124655487|NCT04015518|448357542|FG003|Overall Study|Could not keep appointments due to work|0|||
124655488|NCT04015518|448357543|FG004|Overall Study|Could not keep appointments due to work|0|||
124655489|NCT02195427|448357544|FG000|Overall Study|Did not consent to study extension|13|||
124655490|NCT02195427|448357545|FG001|Overall Study|Did not consent to study extension|9|||
124655491|NCT02195427|448357544|FG000|Overall Study|Withdrawal by Subject|4|||
124655492|NCT02195427|448357545|FG001|Overall Study|Withdrawal by Subject|2|||
124655493|NCT02195427|448357544|FG000|Overall Study|Lost to Follow-up|0|||
124655494|NCT02195427|448357545|FG001|Overall Study|Lost to Follow-up|1|||
124655495|NCT02195427|448357544|FG000|Overall Study|Protocol Violation|7|||
124655496|NCT02195427|448357545|FG001|Overall Study|Protocol Violation|14|||
124655497|NCT02195427|448357544|FG000|Overall Study|Conditional re-treatment at W52|2|||
124655498|NCT02195427|448357545|FG001|Overall Study|Conditional re-treatment at W52|1|||
124655499|NCT00386425|448357546|FG000|Overall Study|Physician Decision|3|||
124655500|NCT00386425|448357547|FG001|Overall Study|Physician Decision|0|||
124655501|NCT00386425|448357548|FG002|Overall Study|Physician Decision|0|||
124655502|NCT00386425|448357546|FG000|Overall Study|Withdrawal by Subject|0|||
124655503|NCT00386425|448357547|FG001|Overall Study|Withdrawal by Subject|1|||
124655504|NCT00386425|448357548|FG002|Overall Study|Withdrawal by Subject|0|||
124655505|NCT01324570|448357552|FG000|Overall Study|Adverse Event|4|||
124655506|NCT01324570|448357553|FG001|Overall Study|Adverse Event|7|||
124655507|NCT01324570|448357552|FG000|Overall Study|Withdrawal by Subject|0|||
124655508|NCT01324570|448357553|FG001|Overall Study|Withdrawal by Subject|3|||
124655509|NCT01324570|448357552|FG000|Overall Study|Lack of Efficacy|0|||
124655510|NCT01324570|448357553|FG001|Overall Study|Lack of Efficacy|1|||
124655511|NCT01324570|448357552|FG000|Overall Study|Confirmed or suspected diversion|0|||
124655512|NCT01324570|448357553|FG001|Overall Study|Confirmed or suspected diversion|1|||
124655513|NCT01324570|448357552|FG000|Overall Study|Administrative|0|||
124655514|NCT01324570|448357553|FG001|Overall Study|Administrative|2|||
124655515|NCT00207727|448357554|FG000|Overall Study|Withdrawal by Subject|0|||
124655516|NCT00207727|448357555|FG001|Overall Study|Withdrawal by Subject|0|||
124655517|NCT00207727|448357556|FG002|Overall Study|Withdrawal by Subject|0|||
124655518|NCT00207727|448357557|FG003|Overall Study|Withdrawal by Subject|0|||
124655519|NCT00207727|448357558|FG004|Overall Study|Withdrawal by Subject|1|||
124655520|NCT00207727|448357554|FG000|Overall Study|Lost to Follow-up|0|||
124655521|NCT00207727|448357555|FG001|Overall Study|Lost to Follow-up|1|||
124655522|NCT00207727|448357556|FG002|Overall Study|Lost to Follow-up|0|||
124655523|NCT00207727|448357557|FG003|Overall Study|Lost to Follow-up|0|||
124655524|NCT00207727|448357558|FG004|Overall Study|Lost to Follow-up|0|||
124655525|NCT00207727|448357554|FG000|Overall Study|Other|38|||
124655526|NCT00207727|448357555|FG001|Overall Study|Other|41|||
124655527|NCT00207727|448357556|FG002|Overall Study|Other|41|||
124655528|NCT00207727|448357557|FG003|Overall Study|Other|37|||
124655529|NCT00207727|448357558|FG004|Overall Study|Other|33|||
124655530|NCT00539032|448357562|FG000|Overall Study|Withdrawal by Subject|2|||
124655531|NCT00539032|448357563|FG001|Overall Study|Withdrawal by Subject|1|||
124655532|NCT00435019|448357564|FG000|Overall Study|Adverse Event|1|||
124655533|NCT00435019|448357565|FG001|Overall Study|Adverse Event|0|||
124655534|NCT00435019|448357564|FG000|Overall Study|Lack of Efficacy|1|||
124655535|NCT00435019|448357565|FG001|Overall Study|Lack of Efficacy|2|||
124655536|NCT00435019|448357564|FG000|Overall Study|Protocol Violation|3|||
124655537|NCT00435019|448357565|FG001|Overall Study|Protocol Violation|1|||
124655538|NCT00435019|448357564|FG000|Overall Study|Personal reasons for withdrawal|8|||
124655539|NCT00435019|448357565|FG001|Overall Study|Personal reasons for withdrawal|7|||
124655540|NCT00422292|448357569|FG000|Overall Study|Serious adverse events|1|||
124655541|NCT00422292|448357570|FG001|Overall Study|Serious adverse events|4|||
124655542|NCT00422292|448357571|FG002|Overall Study|Serious adverse events|0|||
124655543|NCT00422292|448357572|FG003|Overall Study|Serious adverse events|0|||
124655544|NCT00422292|448357569|FG000|Overall Study|Adverse Event|1|||
124655545|NCT00422292|448357570|FG001|Overall Study|Adverse Event|0|||
124655546|NCT00422292|448357571|FG002|Overall Study|Adverse Event|1|||
124655547|NCT00422292|448357572|FG003|Overall Study|Adverse Event|0|||
124655548|NCT00422292|448357569|FG000|Overall Study|Protocol Violation|4|||
124655549|NCT00422292|448357570|FG001|Overall Study|Protocol Violation|25|||
124655550|NCT00422292|448357571|FG002|Overall Study|Protocol Violation|8|||
124655551|NCT00422292|448357572|FG003|Overall Study|Protocol Violation|5|||
124655552|NCT00422292|448357569|FG000|Overall Study|Lost to Follow-up|6|||
124655553|NCT00422292|448357570|FG001|Overall Study|Lost to Follow-up|12|||
124655554|NCT00422292|448357571|FG002|Overall Study|Lost to Follow-up|6|||
124655555|NCT00422292|448357572|FG003|Overall Study|Lost to Follow-up|6|||
124655556|NCT00422292|448357569|FG000|Overall Study|Withdrawal by Subject|6|||
124655557|NCT00422292|448357570|FG001|Overall Study|Withdrawal by Subject|25|||
124655558|NCT00422292|448357571|FG002|Overall Study|Withdrawal by Subject|7|||
124655559|NCT00422292|448357572|FG003|Overall Study|Withdrawal by Subject|13|||
124655560|NCT04607980|448357573|FG000|Overall Study|Adverse Event|3|||
124655561|NCT04607980|448357574|FG001|Overall Study|Adverse Event|4|||
124655562|NCT04607980|448357573|FG000|Overall Study|Death|0|||
124655563|NCT04607980|448357574|FG001|Overall Study|Death|1|||
124655564|NCT04607980|448357573|FG000|Overall Study|Withdrawal by Subject|2|||
124655565|NCT04607980|448357574|FG001|Overall Study|Withdrawal by Subject|5|||
124655566|NCT04607980|448357573|FG000|Overall Study|Lost to Follow-up|4|||
124655567|NCT04607980|448357574|FG001|Overall Study|Lost to Follow-up|8|||
124655568|NCT04607980|448357573|FG000|Overall Study|Protocol Violation|0|||
124655569|NCT04607980|448357574|FG001|Overall Study|Protocol Violation|3|||
124655570|NCT04607980|448357573|FG000|Overall Study|Other|3|||
124655571|NCT04607980|448357574|FG001|Overall Study|Other|0|||
124655572|NCT02824562|448359405|FG000|Overall Study|Lost to Follow-up|3|||
124655573|NCT02824562|448359406|FG001|Overall Study|Lost to Follow-up|4|||
124655574|NCT02824562|448359405|FG000|Overall Study|Death|0|||
124655575|NCT02824562|448359406|FG001|Overall Study|Death|1|||
124655576|NCT01709864|448359407|FG000|Overall Study|Physician Decision|0|||
124655577|NCT01709864|448359408|FG001|Overall Study|Physician Decision|1|||
124655578|NCT01709864|448359407|FG000|Overall Study|subject/guardian decision|5|||
124655579|NCT01709864|448359408|FG001|Overall Study|subject/guardian decision|6|||
124655580|NCT01709864|448359407|FG000|Overall Study|Lost to Follow-up|1|||
124655581|NCT01709864|448359408|FG001|Overall Study|Lost to Follow-up|0|||
124655582|NCT01709864|448359407|FG000|Overall Study|non-compliance with study treatment|1|||
124655583|NCT01709864|448359408|FG001|Overall Study|non-compliance with study treatment|1|||
124655584|NCT01709864|448359407|FG000|Overall Study|Adverse Event|0|||
124655585|NCT01709864|448359408|FG001|Overall Study|Adverse Event|2|||
124655586|NCT01709864|448359407|FG000|Overall Study|Death|0|||
124655587|NCT01709864|448359408|FG001|Overall Study|Death|1|||
124655588|NCT01313221|448359412|FG000|Overall Study|Protocol Violation|0|||
124655589|NCT01313221|448359413|FG001|Overall Study|Protocol Violation|1|||
124655590|NCT01313221|448359414|FG002|Overall Study|Protocol Violation|1|||
124655591|NCT01313221|448359412|FG000|Overall Study|Non-compliance|3|||
124655592|NCT01313221|448359413|FG001|Overall Study|Non-compliance|0|||
124655593|NCT01313221|448359414|FG002|Overall Study|Non-compliance|2|||
124655594|NCT01313221|448359412|FG000|Overall Study|Withdrawal by Subject|2|||
124655595|NCT01313221|448359413|FG001|Overall Study|Withdrawal by Subject|3|||
124655596|NCT01313221|448359414|FG002|Overall Study|Withdrawal by Subject|5|||
124655597|NCT01313221|448359412|FG000|Overall Study|Requirement for alternative therapy|0|||
124655598|NCT01313221|448359413|FG001|Overall Study|Requirement for alternative therapy|1|||
124655599|NCT01313221|448359414|FG002|Overall Study|Requirement for alternative therapy|1|||
124655600|NCT01313221|448359412|FG000|Overall Study|Lost to Follow-up|6|||
124655601|NCT01313221|448359413|FG001|Overall Study|Lost to Follow-up|3|||
124655602|NCT01313221|448359414|FG002|Overall Study|Lost to Follow-up|1|||
124655603|NCT01313221|448359412|FG000|Overall Study|Other|1|||
124655604|NCT01313221|448359413|FG001|Overall Study|Other|0|||
124655605|NCT01313221|448359414|FG002|Overall Study|Other|0|||
124655606|NCT01313221|448359412|FG000|Overall Study|Adverse Event|0|||
124655607|NCT01313221|448359413|FG001|Overall Study|Adverse Event|0|||
124655608|NCT01313221|448359414|FG002|Overall Study|Adverse Event|7|||
124655609|NCT01313221|448359412|FG000|Overall Study|Disease progression|0|||
124655610|NCT01313221|448359413|FG001|Overall Study|Disease progression|0|||
124655611|NCT01313221|448359414|FG002|Overall Study|Disease progression|2|||
124655612|NCT01313221|448359412|FG000|Overall Study|Physician Decision|0|||
124655613|NCT01313221|448359413|FG001|Overall Study|Physician Decision|0|||
124655614|NCT01313221|448359414|FG002|Overall Study|Physician Decision|2|||
124655615|NCT01313221|448359412|FG000|Overall Study|Pregnancy|0|||
124655616|NCT01313221|448359413|FG001|Overall Study|Pregnancy|0|||
124655617|NCT01313221|448359414|FG002|Overall Study|Pregnancy|2|||
124655618|NCT00994214|448359415|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
124655619|NCT00994214|448359416|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
124655620|NCT00994214|448359417|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
124655621|NCT00994214|448359418|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
124655622|NCT00994214|448359415|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
124655623|NCT00994214|448359416|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
124655624|NCT00994214|448359417|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
124655625|NCT00994214|448359418|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
124655626|NCT00994214|448359415|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
124655627|NCT00994214|448359416|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
124655628|NCT00994214|448359417|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
124655629|NCT00994214|448359418|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
124655630|NCT00994214|448359415|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
124655631|NCT00994214|448359416|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
124655632|NCT00994214|448359417|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
124655633|NCT00994214|448359418|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
124655634|NCT00994214|448359415|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
124655635|NCT00994214|448359416|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
124655636|NCT00994214|448359417|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
124655637|NCT00994214|448359418|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
124655638|NCT00994214|448359415|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
124655639|NCT00994214|448359416|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
124655640|NCT00994214|448359417|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
124655641|NCT00994214|448359418|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
124655642|NCT01698268|448359422|FG000|Overall Study|Physician Decision|2|||
124655643|NCT01698268|448359423|FG001|Overall Study|Physician Decision|1|||
124655644|NCT00298363|448359424|FG000|Overall Study|Lost to Follow-up|0|||
124655645|NCT00298363|448359425|FG001|Overall Study|Lost to Follow-up|0|||
124655646|NCT00298363|448359426|FG002|Overall Study|Lost to Follow-up|1|||
124655647|NCT00298363|448359424|FG000|Overall Study|Physician Decision|4|||
124655648|NCT00298363|448359425|FG001|Overall Study|Physician Decision|1|||
124655649|NCT00298363|448359426|FG002|Overall Study|Physician Decision|0|||
124655650|NCT00298363|448359424|FG000|Overall Study|Protocol Violation|1|||
124655651|NCT00298363|448359425|FG001|Overall Study|Protocol Violation|1|||
124655652|NCT00298363|448359426|FG002|Overall Study|Protocol Violation|0|||
124655653|NCT00298363|448359424|FG000|Overall Study|Withdrawal by Subject|5|||
124655654|NCT00298363|448359425|FG001|Overall Study|Withdrawal by Subject|1|||
124655655|NCT00298363|448359426|FG002|Overall Study|Withdrawal by Subject|3|||
124655656|NCT00298363|448359424|FG000|Overall Study|Adverse Event|5|||
124655657|NCT00298363|448359425|FG001|Overall Study|Adverse Event|2|||
124655658|NCT00298363|448359426|FG002|Overall Study|Adverse Event|2|||
124655659|NCT00298363|448359424|FG000|Overall Study|Lack of Efficacy|2|||
124655660|NCT00298363|448359425|FG001|Overall Study|Lack of Efficacy|3|||
124655661|NCT00298363|448359426|FG002|Overall Study|Lack of Efficacy|0|||
124655662|NCT00153816|448359427|FG000|Overall Study|Death|6|||
124655663|NCT00153816|448359428|FG001|Overall Study|Death|5|||
124655664|NCT00153816|448359429|FG002|Overall Study|Death|4|||
124655665|NCT00153816|448359430|FG003|Overall Study|Death|6|||
124655666|NCT00153816|448359431|FG004|Overall Study|Death|0|||
124655667|NCT00153816|448359432|FG005|Overall Study|Death|2|||
124655668|NCT00153816|448359427|FG000|Overall Study|Lost to Follow-up|7|||
124655669|NCT00153816|448359428|FG001|Overall Study|Lost to Follow-up|8|||
124655670|NCT00153816|448359429|FG002|Overall Study|Lost to Follow-up|5|||
124655671|NCT00153816|448359430|FG003|Overall Study|Lost to Follow-up|8|||
124655672|NCT00153816|448359431|FG004|Overall Study|Lost to Follow-up|7|||
124655673|NCT00153816|448359432|FG005|Overall Study|Lost to Follow-up|9|||
124655674|NCT00153816|448359427|FG000|Overall Study|Withdrawal by Subject|9|||
124655675|NCT00153816|448359428|FG001|Overall Study|Withdrawal by Subject|9|||
124655676|NCT00153816|448359429|FG002|Overall Study|Withdrawal by Subject|9|||
124655677|NCT00153816|448359430|FG003|Overall Study|Withdrawal by Subject|4|||
124655678|NCT00153816|448359431|FG004|Overall Study|Withdrawal by Subject|1|||
124655679|NCT00153816|448359432|FG005|Overall Study|Withdrawal by Subject|5|||
124655680|NCT00153816|448359427|FG000|Overall Study|Follow-up exam not done|8|||
124655681|NCT00153816|448359428|FG001|Overall Study|Follow-up exam not done|7|||
124655682|NCT00153816|448359429|FG002|Overall Study|Follow-up exam not done|11|||
124655683|NCT00153816|448359430|FG003|Overall Study|Follow-up exam not done|10|||
124655684|NCT00153816|448359431|FG004|Overall Study|Follow-up exam not done|8|||
124655685|NCT00153816|448359432|FG005|Overall Study|Follow-up exam not done|9|||
124655686|NCT00153816|448359427|FG000|Overall Study|Follow-up exam done, histology missing|2|||
124655687|NCT00153816|448359428|FG001|Overall Study|Follow-up exam done, histology missing|3|||
124872817|NCT00500903|449155769|FG000|Overall Study|Reason Not Specified|10|||
124655688|NCT00153816|448359429|FG002|Overall Study|Follow-up exam done, histology missing|3|||
124655689|NCT00153816|448359430|FG003|Overall Study|Follow-up exam done, histology missing|3|||
124655690|NCT00153816|448359431|FG004|Overall Study|Follow-up exam done, histology missing|1|||
124655691|NCT00153816|448359432|FG005|Overall Study|Follow-up exam done, histology missing|2|||
124655692|NCT05916131|448359437|FG000|Overall Study|Lost to Follow-up|0|||
124655693|NCT05916131|448359438|FG001|Overall Study|Lost to Follow-up|0|||
124655694|NCT05916131|448359439|FG002|Overall Study|Lost to Follow-up|1|||
124655695|NCT05916131|448359440|FG003|Overall Study|Lost to Follow-up|0|||
124655696|NCT01211483|448359450|FG000|Phase 1b|Death|6|||
124655697|NCT01211483|448359451|FG001|Phase 1b|Death|0|||
124655698|NCT01211483|448359452|FG002|Phase 1b|Death|0|||
124655699|NCT01211483|448359453|FG003|Phase 1b|Death|0|||
124655700|NCT01211483|448359450|FG000|Phase 1b|Withdrawal by Subject|1|||
124655701|NCT01211483|448359451|FG001|Phase 1b|Withdrawal by Subject|0|||
124655702|NCT01211483|448359452|FG002|Phase 1b|Withdrawal by Subject|0|||
124655703|NCT01211483|448359453|FG003|Phase 1b|Withdrawal by Subject|0|||
124655704|NCT01211483|448359450|FG000|Phase 2|Lost to Follow-up|0|||
124655705|NCT01211483|448359451|FG001|Phase 2|Lost to Follow-up|1|||
124655706|NCT01211483|448359452|FG002|Phase 2|Lost to Follow-up|1|||
124655707|NCT01211483|448359453|FG003|Phase 2|Lost to Follow-up|2|||
124655708|NCT01211483|448359450|FG000|Phase 2|Death|0|||
124655709|NCT01211483|448359451|FG001|Phase 2|Death|64|||
124655710|NCT01211483|448359452|FG002|Phase 2|Death|53|||
124655711|NCT01211483|448359453|FG003|Phase 2|Death|53|||
124655712|NCT01211483|448359450|FG000|Phase 2|Withdrawal by Subject|0|||
124655713|NCT01211483|448359451|FG001|Phase 2|Withdrawal by Subject|1|||
124655714|NCT01211483|448359452|FG002|Phase 2|Withdrawal by Subject|10|||
124655715|NCT01211483|448359453|FG003|Phase 2|Withdrawal by Subject|5|||
124655716|NCT01211483|448359450|FG000|Phase 2|Study terminated by Sponsor|0|||
124655717|NCT01211483|448359451|FG001|Phase 2|Study terminated by Sponsor|6|||
124655718|NCT01211483|448359452|FG002|Phase 2|Study terminated by Sponsor|8|||
124655719|NCT01211483|448359453|FG003|Phase 2|Study terminated by Sponsor|11|||
124655720|NCT00427999|448359454|FG000|Overall Study|Adverse Event|6|||
124655721|NCT00427999|448359454|FG000|Overall Study|Abnormal laboratory values|1|||
124655722|NCT00427999|448359454|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
124655723|NCT00427999|448359454|FG000|Overall Study|Protocol Violation|2|||
124655724|NCT00427999|448359454|FG000|Overall Study|Withdrawal by Subject|9|||
124655725|NCT00427999|448359454|FG000|Overall Study|Death|1|||
124655726|NCT02380859|448359455|FG000|Overall Study|Withdrawal by Subject|2|||
124655727|NCT02380859|448359456|FG001|Overall Study|Withdrawal by Subject|0|||
124655728|NCT02284568|448359457|FG000|Overall Study|Adverse Event|2|||
124655729|NCT02284568|448359458|FG001|Overall Study|Adverse Event|9|||
124655730|NCT02284568|448359459|FG002|Overall Study|Adverse Event|4|||
124655731|NCT02284568|448359457|FG000|Overall Study|Withdrawal by Subject|22|||
124655732|NCT02284568|448359458|FG001|Overall Study|Withdrawal by Subject|21|||
124655733|NCT02284568|448359459|FG002|Overall Study|Withdrawal by Subject|1|||
124655734|NCT02284568|448359457|FG000|Overall Study|Noncompliance with study drug admin|1|||
124655735|NCT02284568|448359458|FG001|Overall Study|Noncompliance with study drug admin|2|||
124655736|NCT02284568|448359459|FG002|Overall Study|Noncompliance with study drug admin|0|||
124655737|NCT02284568|448359457|FG000|Overall Study|Noncompliance|1|||
124655738|NCT02284568|448359458|FG001|Overall Study|Noncompliance|0|||
124655739|NCT02284568|448359459|FG002|Overall Study|Noncompliance|0|||
124655740|NCT02284568|448359457|FG000|Overall Study|Protocol Violation|0|||
124655741|NCT02284568|448359458|FG001|Overall Study|Protocol Violation|1|||
124655742|NCT02284568|448359459|FG002|Overall Study|Protocol Violation|0|||
124655743|NCT02284568|448359457|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
124655744|NCT02284568|448359458|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
124655745|NCT02284568|448359459|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
124655746|NCT02284568|448359457|FG000|Overall Study|Lost to Follow-up|0|||
124655747|NCT02284568|448359458|FG001|Overall Study|Lost to Follow-up|3|||
124655748|NCT02284568|448359459|FG002|Overall Study|Lost to Follow-up|0|||
124655749|NCT02284568|448359457|FG000|Overall Study|Lack of Efficacy|4|||
124655750|NCT02284568|448359458|FG001|Overall Study|Lack of Efficacy|7|||
124655751|NCT02284568|448359459|FG002|Overall Study|Lack of Efficacy|0|||
124655752|NCT02284568|448359457|FG000|Overall Study|Other|1|||
124655753|NCT02284568|448359458|FG001|Overall Study|Other|2|||
124655754|NCT02284568|448359459|FG002|Overall Study|Other|0|||
124655755|NCT02284568|448359457|FG000|Overall Study|Withdrew before taking study drug|0|||
124655756|NCT02284568|448359458|FG001|Overall Study|Withdrew before taking study drug|1|||
124655757|NCT02284568|448359459|FG002|Overall Study|Withdrew before taking study drug|0|||
124655758|NCT00412217|448359460|FG000|Overall Study|Insufficient Data Available|8|||
124655759|NCT00412217|448359461|FG001|Overall Study|Insufficient Data Available|3|||
124655760|NCT00412217|448359460|FG000|Overall Study|Death|5|||
124655761|NCT00412217|448359461|FG001|Overall Study|Death|4|||
124655762|NCT00412217|448359460|FG000|Overall Study|Disease Progression|2|||
124655763|NCT00412217|448359461|FG001|Overall Study|Disease Progression|3|||
124655764|NCT00412217|448359460|FG000|Overall Study|Investigator Decision|1|||
124655765|NCT00412217|448359461|FG001|Overall Study|Investigator Decision|0|||
124655766|NCT00412217|448359460|FG000|Overall Study|Withdrawal by Subject|2|||
124655767|NCT00412217|448359461|FG001|Overall Study|Withdrawal by Subject|0|||
124655768|NCT00412217|448359460|FG000|Overall Study|Lost to Follow-up|1|||
124655769|NCT00412217|448359461|FG001|Overall Study|Lost to Follow-up|4|||
124655770|NCT00412217|448359460|FG000|Overall Study|Study Terminated by Sponsor|26|||
124655771|NCT00412217|448359461|FG001|Overall Study|Study Terminated by Sponsor|33|||
124655772|NCT00412217|448359460|FG000|Overall Study|Other|1|||
124655773|NCT00412217|448359461|FG001|Overall Study|Other|1|||
124655774|NCT03114657|448359463|FG000|Overall Study|Adverse Event|9|||
124655775|NCT03114657|448359464|FG001|Overall Study|Adverse Event|6|||
124655776|NCT03114657|448359463|FG000|Overall Study|Death|4|||
124655777|NCT03114657|448359464|FG001|Overall Study|Death|0|||
124655778|NCT03114657|448359463|FG000|Overall Study|Multiple Reasons|1|||
124655779|NCT03114657|448359464|FG001|Overall Study|Multiple Reasons|2|||
124655780|NCT03114657|448359463|FG000|Overall Study|Physician Decision|2|||
124655781|NCT03114657|448359464|FG001|Overall Study|Physician Decision|2|||
124655782|NCT03114657|448359463|FG000|Overall Study|Study Terminated By Sponsor|355|||
124655783|NCT03114657|448359464|FG001|Overall Study|Study Terminated By Sponsor|374|||
124655784|NCT03114657|448359463|FG000|Overall Study|Symptomatic Deterioration|0|||
124655785|NCT03114657|448359464|FG001|Overall Study|Symptomatic Deterioration|1|||
124655786|NCT03114657|448359463|FG000|Overall Study|Withdrawal by Subject|28|||
124655787|NCT03114657|448359464|FG001|Overall Study|Withdrawal by Subject|22|||
124655788|NCT01546038|448359465|FG000|Overall Study|Death|15|||
124655789|NCT01546038|448359466|FG001|Overall Study|Death|6|||
124655790|NCT01546038|448359467|FG002|Overall Study|Death|4|||
124655791|NCT01546038|448359468|FG003|Overall Study|Death|2|||
124655792|NCT01546038|448359469|FG004|Overall Study|Death|9|||
124655793|NCT01546038|448359470|FG005|Overall Study|Death|3|||
124655794|NCT01546038|448359471|FG006|Overall Study|Death|46|||
124655795|NCT01546038|448359472|FG007|Overall Study|Death|76|||
124655796|NCT01546038|448359473|FG008|Overall Study|Death|39|||
124655797|NCT01546038|448359465|FG000|Overall Study|Lost to Follow-up|0|||
124655798|NCT01546038|448359466|FG001|Overall Study|Lost to Follow-up|0|||
124655799|NCT01546038|448359467|FG002|Overall Study|Lost to Follow-up|0|||
124655800|NCT01546038|448359468|FG003|Overall Study|Lost to Follow-up|0|||
124655801|NCT01546038|448359469|FG004|Overall Study|Lost to Follow-up|1|||
124655802|NCT01546038|448359470|FG005|Overall Study|Lost to Follow-up|0|||
124655803|NCT01546038|448359471|FG006|Overall Study|Lost to Follow-up|2|||
124655804|NCT01546038|448359472|FG007|Overall Study|Lost to Follow-up|1|||
124655805|NCT01546038|448359473|FG008|Overall Study|Lost to Follow-up|0|||
124655806|NCT01546038|448359465|FG000|Overall Study|Withdrawal by Subject|1|||
124655807|NCT01546038|448359466|FG001|Overall Study|Withdrawal by Subject|0|||
124655808|NCT01546038|448359467|FG002|Overall Study|Withdrawal by Subject|0|||
124655809|NCT01546038|448359468|FG003|Overall Study|Withdrawal by Subject|1|||
124655810|NCT01546038|448359469|FG004|Overall Study|Withdrawal by Subject|0|||
124655811|NCT01546038|448359470|FG005|Overall Study|Withdrawal by Subject|1|||
124655812|NCT01546038|448359471|FG006|Overall Study|Withdrawal by Subject|3|||
124655813|NCT01546038|448359472|FG007|Overall Study|Withdrawal by Subject|3|||
124655814|NCT01546038|448359473|FG008|Overall Study|Withdrawal by Subject|1|||
124655815|NCT01546038|448359465|FG000|Overall Study|: Randomized, not treated|0|||
124655816|NCT01546038|448359466|FG001|Overall Study|: Randomized, not treated|0|||
124655817|NCT01546038|448359467|FG002|Overall Study|: Randomized, not treated|0|||
124655818|NCT01546038|448359468|FG003|Overall Study|: Randomized, not treated|0|||
124655819|NCT01546038|448359469|FG004|Overall Study|: Randomized, not treated|0|||
124655820|NCT01546038|448359470|FG005|Overall Study|: Randomized, not treated|0|||
124655821|NCT01546038|448359471|FG006|Overall Study|: Randomized, not treated|2|||
124655822|NCT01546038|448359472|FG007|Overall Study|: Randomized, not treated|4|||
124655823|NCT01546038|448359473|FG008|Overall Study|: Randomized, not treated|3|||
124655824|NCT01398410|448359474|FG000|Overall Study|Adverse Event|12|||
124655825|NCT01398410|448359475|FG001|Overall Study|Adverse Event|16|||
124655826|NCT01398410|448359474|FG000|Overall Study|Participants Choice|8|||
124655827|NCT01398410|448359475|FG001|Overall Study|Participants Choice|11|||
124655828|NCT01398410|448359474|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
124655829|NCT01398410|448359475|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
124655830|NCT01398410|448359474|FG000|Overall Study|Other|36|||
124655831|NCT01398410|448359475|FG001|Overall Study|Other|29|||
124655832|NCT04245202|448359476|FG000|Overall Study|Lack of Efficacy|10|||
124655833|NCT04245202|448359477|FG001|Overall Study|Lack of Efficacy|1|||
124655834|NCT01362517|448359486|FG000|Overall Study|Protocol Violation|1|||
124655835|NCT01362517|448359486|FG000|Overall Study|Lost to Follow-up|1|||
124655836|NCT03379792|448359488|FG000|Overall Study|Physician Decision|0|||
124655837|NCT03379792|448359489|FG001|Overall Study|Physician Decision|0|||
124655838|NCT03379792|448359490|FG002|Overall Study|Physician Decision|0|||
124655839|NCT03379792|448359491|FG003|Overall Study|Physician Decision|1|||
124655840|NCT03379792|448359492|FG004|Overall Study|Physician Decision|0|||
124655841|NCT03379792|448359493|FG005|Overall Study|Physician Decision|0|||
124655842|NCT03379792|448359488|FG000|Overall Study|Withdrawal by Subject|0|||
124655843|NCT03379792|448359489|FG001|Overall Study|Withdrawal by Subject|0|||
124655844|NCT03379792|448359490|FG002|Overall Study|Withdrawal by Subject|0|||
124655845|NCT03379792|448359491|FG003|Overall Study|Withdrawal by Subject|0|||
124655846|NCT03379792|448359492|FG004|Overall Study|Withdrawal by Subject|1|||
124655847|NCT03379792|448359493|FG005|Overall Study|Withdrawal by Subject|1|||
124655848|NCT01121536|448359494|FG000|Overall Study|Adverse Event|63|||
124655849|NCT01121536|448359494|FG000|Overall Study|Lack of Efficacy|35|||
124655850|NCT01121536|448359494|FG000|Overall Study|Withdrawal by Subject|65|||
124655851|NCT01121536|448359494|FG000|Overall Study|Protocol Violation|20|||
124655852|NCT01121536|448359494|FG000|Overall Study|Noncompliance with study medication|12|||
124655853|NCT01121536|448359494|FG000|Overall Study|Noncompliance with study procedures|9|||
124655854|NCT01121536|448359494|FG000|Overall Study|Lost to Follow-up|39|||
124655855|NCT01121536|448359494|FG000|Overall Study|Other|118|||
124655856|NCT02854605|448359497|FG000|Overall Study|Adverse Event|1|||
124655857|NCT02854605|448359498|FG001|Overall Study|Adverse Event|5|||
124655858|NCT02854605|448359499|FG002|Overall Study|Adverse Event|2|||
124655859|NCT02854605|448359497|FG000|Overall Study|Lost to Follow-up|0|||
124655860|NCT02854605|448359498|FG001|Overall Study|Lost to Follow-up|2|||
124655861|NCT02854605|448359499|FG002|Overall Study|Lost to Follow-up|0|||
124655862|NCT02854605|448359497|FG000|Overall Study|Withdrew Consent|1|||
124655863|NCT02854605|448359498|FG001|Overall Study|Withdrew Consent|0|||
124655864|NCT02854605|448359499|FG002|Overall Study|Withdrew Consent|1|||
124655865|NCT02854605|448359497|FG000|Overall Study|Investigator's Discretion|1|||
124655866|NCT02854605|448359498|FG001|Overall Study|Investigator's Discretion|0|||
124655867|NCT02854605|448359499|FG002|Overall Study|Investigator's Discretion|0|||
124655868|NCT02854605|448359497|FG000|Overall Study|Protocol Violation|0|||
124655869|NCT02854605|448359498|FG001|Overall Study|Protocol Violation|0|||
124655870|NCT02854605|448359499|FG002|Overall Study|Protocol Violation|1|||
124655871|NCT05268016|448359501|FG000|Overall Study|Unacceptable toxicity or AE|2|||
124655872|NCT05268016|448359502|FG001|Overall Study|Unacceptable toxicity or AE|2|||
124655873|NCT05268016|448359503|FG002|Overall Study|Unacceptable toxicity or AE|4|||
124655874|NCT05268016|448359504|FG003|Overall Study|Unacceptable toxicity or AE|3|||
124655875|NCT05268016|448359505|FG004|Overall Study|Unacceptable toxicity or AE|1|||
124655876|NCT05268016|448359501|FG000|Overall Study|Withdrawal by Subject|1|||
124655877|NCT05268016|448359502|FG001|Overall Study|Withdrawal by Subject|3|||
124655878|NCT05268016|448359503|FG002|Overall Study|Withdrawal by Subject|2|||
124655879|NCT05268016|448359504|FG003|Overall Study|Withdrawal by Subject|2|||
124655880|NCT05268016|448359505|FG004|Overall Study|Withdrawal by Subject|1|||
124655881|NCT05268016|448359501|FG000|Overall Study|Lost to Follow-up|4|||
124655882|NCT05268016|448359502|FG001|Overall Study|Lost to Follow-up|7|||
124655883|NCT05268016|448359503|FG002|Overall Study|Lost to Follow-up|1|||
124655884|NCT05268016|448359504|FG003|Overall Study|Lost to Follow-up|3|||
124655885|NCT05268016|448359505|FG004|Overall Study|Lost to Follow-up|5|||
124655886|NCT05268016|448359501|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
124655887|NCT05268016|448359502|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
124655888|NCT05268016|448359503|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
124655889|NCT05268016|448359504|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
124655890|NCT05268016|448359505|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
124655891|NCT05268016|448359501|FG000|Overall Study|Lack of Efficacy|0|||
124655892|NCT05268016|448359502|FG001|Overall Study|Lack of Efficacy|0|||
124655893|NCT05268016|448359503|FG002|Overall Study|Lack of Efficacy|0|||
124655894|NCT05268016|448359504|FG003|Overall Study|Lack of Efficacy|0|||
124655895|NCT05268016|448359505|FG004|Overall Study|Lack of Efficacy|4|||
124655896|NCT05268016|448359501|FG000|Overall Study|Physician Decision|0|||
124655897|NCT05268016|448359502|FG001|Overall Study|Physician Decision|0|||
124655898|NCT05268016|448359503|FG002|Overall Study|Physician Decision|0|||
124655899|NCT05268016|448359504|FG003|Overall Study|Physician Decision|1|||
124655900|NCT05268016|448359505|FG004|Overall Study|Physician Decision|0|||
124655901|NCT05268016|448359501|FG000|Overall Study|Other|1|||
124655902|NCT05268016|448359502|FG001|Overall Study|Other|0|||
124655903|NCT05268016|448359503|FG002|Overall Study|Other|1|||
124655904|NCT05268016|448359504|FG003|Overall Study|Other|2|||
124655905|NCT05268016|448359505|FG004|Overall Study|Other|0|||
124655906|NCT02273908|448359506|FG000|Overall Study|Adverse Event|16|||
124655907|NCT02273908|448359507|FG001|Overall Study|Adverse Event|0|||
124655908|NCT02273908|448359506|FG000|Overall Study|Lost to Follow-up|10|||
124655909|NCT02273908|448359507|FG001|Overall Study|Lost to Follow-up|1|||
124655910|NCT02273908|448359506|FG000|Overall Study|Did not meet entrance criteria|3|||
124655911|NCT02273908|448359507|FG001|Overall Study|Did not meet entrance criteria|2|||
124655912|NCT02273908|448359506|FG000|Overall Study|Withdrawal by Subject|4|||
124655913|NCT02273908|448359507|FG001|Overall Study|Withdrawal by Subject|2|||
124655914|NCT04908475|448359508|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
124655915|NCT04908475|448359509|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
124655916|NCT04908475|448359510|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
124655917|NCT04908475|448359511|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
124655918|NCT04908475|448359512|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
124655919|NCT04908475|448359513|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
124655920|NCT04908475|448359508|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
124655921|NCT04908475|448359509|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
124655922|NCT04908475|448359510|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
124655923|NCT04908475|448359511|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
124655924|NCT04908475|448359512|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
124655925|NCT04908475|448359513|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
124655926|NCT04908475|448359508|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
124655927|NCT04908475|448359509|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
124655928|NCT04908475|448359510|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
124655929|NCT04908475|448359511|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
124655930|NCT04908475|448359512|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
124655931|NCT04908475|448359513|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
124655932|NCT04908475|448359508|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
124655933|NCT04908475|448359509|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
124655934|NCT04908475|448359510|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
124655935|NCT04908475|448359511|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
124655936|NCT04908475|448359512|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
124655937|NCT04908475|448359513|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
124655938|NCT04908475|448359508|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
124655939|NCT04908475|448359509|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
124655940|NCT04908475|448359510|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
124655941|NCT04908475|448359511|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
124655942|NCT04908475|448359512|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
124655943|NCT04908475|448359513|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
124655944|NCT04908475|448359508|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
124655945|NCT04908475|448359509|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
124655946|NCT04908475|448359510|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
124655947|NCT04908475|448359511|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
124655948|NCT04908475|448359512|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
124655949|NCT04908475|448359513|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
124655950|NCT00404924|448359514|FG000|Overall Study|Adverse Event|75|||
124655951|NCT00404924|448359515|FG001|Overall Study|Adverse Event|16|||
124655952|NCT00404924|448359514|FG000|Overall Study|Condition under investigation worsened|475|||
124655953|NCT00404924|448359515|FG001|Overall Study|Condition under investigation worsened|264|||
124655954|NCT00404924|448359514|FG000|Overall Study|Lost to Follow-up|1|||
124655955|NCT00404924|448359515|FG001|Overall Study|Lost to Follow-up|1|||
124655956|NCT00404924|448359514|FG000|Overall Study|Withdrawal by Subject|26|||
124655957|NCT00404924|448359515|FG001|Overall Study|Withdrawal by Subject|13|||
124655958|NCT00404924|448359514|FG000|Overall Study|Other|25|||
124655959|NCT00404924|448359515|FG001|Overall Study|Other|11|||
124655960|NCT00404924|448359514|FG000|Overall Study|Randomised but not received treatment|1|||
124655961|NCT00404924|448359515|FG001|Overall Study|Randomised but not received treatment|1|||
124655962|NCT00089635|448359518|FG000|Overall Study|Adverse Event|2|||
124655963|NCT00089635|448359518|FG000|Overall Study|Death|17|||
124655964|NCT00089635|448359518|FG000|Overall Study|Disease Progression|12|||
124655965|NCT00089635|448359518|FG000|Overall Study|Lost to Follow-up|3|||
124655966|NCT00089635|448359518|FG000|Overall Study|Withdrawal by Subject|6|||
124655967|NCT00089635|448359518|FG000|Overall Study|Ineligibility determined|1|||
124655968|NCT00089635|448359518|FG000|Overall Study|Other|2|||
124655969|NCT00821015|448359520|FG000|Overall Study|Lost to Follow-up|12|||
124655970|NCT01857102|448359528|FG000|Period 1|No longer meets Eligibility Criteria|0|||
124655971|NCT01857102|448359529|FG001|Period 1|No longer meets Eligibility Criteria|2|||
124655972|NCT01857102|448359528|FG000|Period 1|Lost to Follow-up|0|||
124655973|NCT01857102|448359529|FG001|Period 1|Lost to Follow-up|3|||
124655974|NCT01857102|448359528|FG000|Period 1|Unsatisfactory Lens Fit|1|||
124655975|NCT01857102|448359529|FG001|Period 1|Unsatisfactory Lens Fit|0|||
124655976|NCT01857102|448359528|FG000|Period 1|Unsatisfactory Visual Response|1|||
124655977|NCT01857102|448359529|FG001|Period 1|Unsatisfactory Visual Response|0|||
124655978|NCT01857102|448359528|FG000|Period 1|Physician Decision|1|||
124655979|NCT01857102|448359529|FG001|Period 1|Physician Decision|0|||
124655980|NCT01857102|448359528|FG000|Period 2|Lens Discomfort|1|||
124655981|NCT01857102|448359529|FG001|Period 2|Lens Discomfort|0|||
124655982|NCT01857102|448359528|FG000|Period 2|Unsatisfactory Lens Fit|1|||
124655983|NCT01857102|448359529|FG001|Period 2|Unsatisfactory Lens Fit|0|||
124655984|NCT01490697|448359530|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
124655985|NCT01490697|448359531|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
124655986|NCT00090584|448359533|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
124655987|NCT00090584|448359534|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
124655988|NCT00090584|448359533|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
124655989|NCT00090584|448359534|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
124655990|NCT00270231|448359535|FG000|First Intervention|Lost to Follow-up|1|||
124655991|NCT00270231|448359536|FG001|First Intervention|Lost to Follow-up|1|||
124655992|NCT00270231|448359535|FG000|Washout Period|Lost to Follow-up|1|||
124655993|NCT00270231|448359536|FG001|Washout Period|Lost to Follow-up|0|||
124655994|NCT00270231|448359535|FG000|Second Intervention|Lost to Follow-up|0|||
124655995|NCT00270231|448359536|FG001|Second Intervention|Lost to Follow-up|1|||
124655996|NCT00467961|448359553|FG000|Overall Study|Technical Failures|5|||
124655997|NCT00467961|448359553|FG000|Overall Study|Disease Progression|2|||
124655998|NCT03759366|448359554|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
124655999|NCT03759366|448359554|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
124656000|NCT03759366|448359554|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
124656001|NCT03759366|448359554|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
124656002|NCT03759366|448359554|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
124656003|NCT03759366|448359554|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
124656004|NCT03759366|448359554|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
124656005|NCT00597012|448359555|FG000|Overall Study|Death|1|||
124656006|NCT00597012|448359556|FG001|Overall Study|Death|1|||
124656007|NCT00597012|448359555|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
124656008|NCT00597012|448359556|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
124656009|NCT00597012|448359555|FG000|Overall Study|Withdrawal by Subject|7|||
124656010|NCT00597012|448359556|FG001|Overall Study|Withdrawal by Subject|4|||
124656011|NCT00597012|448359555|FG000|Overall Study|Ineligible|2|||
124656012|NCT00597012|448359556|FG001|Overall Study|Ineligible|0|||
124656013|NCT00597012|448359555|FG000|Overall Study|Lost to Follow-up|0|||
124656014|NCT00597012|448359556|FG001|Overall Study|Lost to Follow-up|2|||
124656015|NCT04226495|448359557|FG000|Overall Study|Withdrawal by Subject|3|||
124656016|NCT04226495|448359558|FG001|Overall Study|Withdrawal by Subject|3|||
124656017|NCT04226495|448359557|FG000|Overall Study|PI discretion|3|||
124656018|NCT04226495|448359558|FG001|Overall Study|PI discretion|4|||
124656019|NCT03403621|448359559|FG000|Overall Study|Withdrawal by Subject|2|||
124656020|NCT03403621|448359560|FG001|Overall Study|Withdrawal by Subject|2|||
124656021|NCT00583102|448359561|FG000|Overall Study|Adverse Event|3|||
124656022|NCT02168777|448361774|FG000|Overall Study|Withdrawal by Subject|1|||
124656023|NCT02168777|448361775|FG001|Overall Study|Withdrawal by Subject|0|||
124656024|NCT02168777|448361776|FG002|Overall Study|Withdrawal by Subject|2|||
124656025|NCT02168777|448361774|FG000|Overall Study|Adverse Event|1|||
124656026|NCT02168777|448361775|FG001|Overall Study|Adverse Event|0|||
124656027|NCT02168777|448361776|FG002|Overall Study|Adverse Event|1|||
124656028|NCT02168777|448361774|FG000|Overall Study|Disease recurrence|0|||
124656029|NCT02168777|448361775|FG001|Overall Study|Disease recurrence|0|||
124656030|NCT02168777|448361776|FG002|Overall Study|Disease recurrence|1|||
124656031|NCT02168777|448361774|FG000|Overall Study|Radiological disease progression|0|||
124656032|NCT02168777|448361775|FG001|Overall Study|Radiological disease progression|5|||
124656033|NCT02168777|448361776|FG002|Overall Study|Radiological disease progression|5|||
124656034|NCT02168777|448361774|FG000|Overall Study|Clinical disease progression|0|||
124656035|NCT02168777|448361775|FG001|Overall Study|Clinical disease progression|1|||
124656036|NCT02168777|448361776|FG002|Overall Study|Clinical disease progression|2|||
124656037|NCT02168777|448361774|FG000|Overall Study|Other reason|0|||
124656038|NCT02168777|448361775|FG001|Overall Study|Other reason|1|||
124656039|NCT02168777|448361776|FG002|Overall Study|Other reason|0|||
124656040|NCT05243563|448361777|FG000|Overall Study|Withdrawal by Subject|1|||
124656041|NCT05243563|448361778|FG001|Overall Study|Withdrawal by Subject|0|||
124656042|NCT05243563|448361777|FG000|Overall Study|Physician Decision|1|||
124656043|NCT05243563|448361778|FG001|Overall Study|Physician Decision|0|||
124656044|NCT02697916|448361779|FG000|Overall Study|Death|357|||
124656045|NCT02697916|448361780|FG001|Overall Study|Death|315|||
124656046|NCT02697916|448361779|FG000|Overall Study|Withdrawal by Subject|221|||
124656047|NCT02697916|448361780|FG001|Overall Study|Withdrawal by Subject|393|||
124656048|NCT03774394|448361781|FG000|Overall Study|Withdrawal by Subject|2|||
124656049|NCT03774394|448361782|FG001|Overall Study|Withdrawal by Subject|0|||
124656050|NCT03334422|448361783|FG000|Overall Study|Adverse Event|1|||
124656051|NCT03334422|448361784|FG001|Overall Study|Adverse Event|3|||
124656052|NCT03334422|448361785|FG002|Overall Study|Adverse Event|2|||
124656053|NCT03334422|448361786|FG003|Overall Study|Adverse Event|2|||
124656054|NCT03334422|448361783|FG000|Overall Study|Lack of Efficacy|10|||
124656055|NCT03334422|448361784|FG001|Overall Study|Lack of Efficacy|2|||
124656056|NCT03334422|448361785|FG002|Overall Study|Lack of Efficacy|7|||
124656057|NCT03334422|448361786|FG003|Overall Study|Lack of Efficacy|3|||
124656058|NCT03334422|448361783|FG000|Overall Study|Withdrawal by Subject|8|||
124656059|NCT03334422|448361784|FG001|Overall Study|Withdrawal by Subject|3|||
124656060|NCT03334422|448361785|FG002|Overall Study|Withdrawal by Subject|1|||
124656061|NCT03334422|448361786|FG003|Overall Study|Withdrawal by Subject|0|||
124656062|NCT03334422|448361783|FG000|Overall Study|Lost to Follow-up|0|||
124656063|NCT03334422|448361784|FG001|Overall Study|Lost to Follow-up|0|||
124656064|NCT03334422|448361785|FG002|Overall Study|Lost to Follow-up|0|||
124656065|NCT03334422|448361786|FG003|Overall Study|Lost to Follow-up|1|||
124656066|NCT03334422|448361783|FG000|Overall Study|Inability to obtain laboratory samples|0|||
124656067|NCT03334422|448361784|FG001|Overall Study|Inability to obtain laboratory samples|1|||
124656068|NCT03334422|448361785|FG002|Overall Study|Inability to obtain laboratory samples|0|||
124656069|NCT03334422|448361786|FG003|Overall Study|Inability to obtain laboratory samples|0|||
124656070|NCT03334422|448361783|FG000|Overall Study|Pregnancy|0|||
124656071|NCT03334422|448361784|FG001|Overall Study|Pregnancy|1|||
124656072|NCT03334422|448361785|FG002|Overall Study|Pregnancy|0|||
124656073|NCT03334422|448361786|FG003|Overall Study|Pregnancy|0|||
124656074|NCT02864316|448361787|FG000|Overall Study|Progressive Disease|2|||
124872818|NCT00500903|449155770|FG001|Overall Study|Reason Not Specified|0|||
124656075|NCT02864316|448361788|FG001|Overall Study|Progressive Disease|1|||
124656076|NCT02864316|448361787|FG000|Overall Study|Adverse Event|0|||
124656077|NCT02864316|448361788|FG001|Overall Study|Adverse Event|1|||
124656078|NCT04710368|448361789|FG000|Overall Study|Withdrawal by Subject|9|||
124656079|NCT04710368|448361789|FG000|Overall Study|Lost to Follow-up|4|||
124656080|NCT04710368|448361789|FG000|Overall Study|Death|2|||
124656081|NCT04710368|448361789|FG000|Overall Study|Patient preference|11|||
124656082|NCT04710368|448361789|FG000|Overall Study|Treatment discontinuation|1|||
124656083|NCT00135356|448361790|FG000|Overall Study|Adverse Event|6|||
124656084|NCT00135356|448361791|FG001|Overall Study|Adverse Event|2|||
124656085|NCT00135356|448361790|FG000|Overall Study|Lack of Efficacy|2|||
124656086|NCT00135356|448361791|FG001|Overall Study|Lack of Efficacy|0|||
124656087|NCT00135356|448361790|FG000|Overall Study|Lost to Follow-up|3|||
124656088|NCT00135356|448361791|FG001|Overall Study|Lost to Follow-up|1|||
124656089|NCT00135356|448361790|FG000|Overall Study|Surgery for abdominal fat|1|||
124656090|NCT00135356|448361791|FG001|Overall Study|Surgery for abdominal fat|0|||
124656091|NCT00135356|448361790|FG000|Overall Study|Change in antiviral regimen|0|||
124656092|NCT00135356|448361791|FG001|Overall Study|Change in antiviral regimen|1|||
124656093|NCT00135356|448361790|FG000|Overall Study|Poor/noncompliance|1|||
124656094|NCT00135356|448361791|FG001|Overall Study|Poor/noncompliance|1|||
124656095|NCT00135356|448361790|FG000|Overall Study|No longer meets study criteria|2|||
124656096|NCT00135356|448361791|FG001|Overall Study|No longer meets study criteria|0|||
124656097|NCT00135356|448361790|FG000|Overall Study|Withdrawal by Subject|2|||
124656098|NCT00135356|448361791|FG001|Overall Study|Withdrawal by Subject|4|||
124656099|NCT01887288|448361792|FG000|Overall Study|The study was terminated and the PI has|16|||
124656100|NCT00253370|448361795|FG000|Overall Study|Adverse Event|18|||
124656101|NCT00253370|448361795|FG000|Overall Study|Disease progression|13|||
124656102|NCT00253370|448361795|FG000|Overall Study|Death|2|||
124656103|NCT00253370|448361795|FG000|Overall Study|Withdrawal by Subject|6|||
124656104|NCT00253370|448361795|FG000|Overall Study|Non-protocol therapy|1|||
124656105|NCT00253370|448361795|FG000|Overall Study|Physician Decision|1|||
124656106|NCT00253370|448361795|FG000|Overall Study|Protocol Violation|1|||
124656107|NCT00253370|448361795|FG000|Overall Study|Abdominal pain due to disease|1|||
124656108|NCT02470403|448361796|FG000|Overall Study|Adverse Event|1|||
124656109|NCT02470403|448361797|FG001|Overall Study|Adverse Event|0|||
124656110|NCT02470403|448361798|FG002|Overall Study|Adverse Event|0|||
124656111|NCT02470403|448361799|FG003|Overall Study|Adverse Event|0|||
124656112|NCT02470403|448361800|FG004|Overall Study|Adverse Event|0|||
124656113|NCT02470403|448361796|FG000|Overall Study|Lost to Follow-up|0|||
124656114|NCT02470403|448361797|FG001|Overall Study|Lost to Follow-up|1|||
124656115|NCT02470403|448361798|FG002|Overall Study|Lost to Follow-up|0|||
124656116|NCT02470403|448361799|FG003|Overall Study|Lost to Follow-up|0|||
124656117|NCT02470403|448361800|FG004|Overall Study|Lost to Follow-up|0|||
124656118|NCT02470403|448361796|FG000|Overall Study|Subject/guardian decision|1|||
124656119|NCT02470403|448361797|FG001|Overall Study|Subject/guardian decision|0|||
124656120|NCT02470403|448361798|FG002|Overall Study|Subject/guardian decision|0|||
124656121|NCT02470403|448361799|FG003|Overall Study|Subject/guardian decision|4|||
124656122|NCT02470403|448361800|FG004|Overall Study|Subject/guardian decision|0|||
124656123|NCT00904839|448361805|FG000|Overall Study|Adverse Event|0|||
124656124|NCT00904839|448361806|FG001|Overall Study|Adverse Event|5|||
124656125|NCT00904839|448361807|FG002|Overall Study|Adverse Event|4|||
124656126|NCT00904839|448361805|FG000|Overall Study|Protocol Violation|0|||
124656127|NCT00904839|448361806|FG001|Overall Study|Protocol Violation|1|||
124656128|NCT00904839|448361807|FG002|Overall Study|Protocol Violation|1|||
124656129|NCT00904839|448361805|FG000|Overall Study|Lost to Follow-up|0|||
124656130|NCT00904839|448361806|FG001|Overall Study|Lost to Follow-up|1|||
124656131|NCT00904839|448361807|FG002|Overall Study|Lost to Follow-up|2|||
124656132|NCT00904839|448361805|FG000|Overall Study|Withdrawal by Subject|0|||
124656133|NCT00904839|448361806|FG001|Overall Study|Withdrawal by Subject|2|||
124656134|NCT00904839|448361807|FG002|Overall Study|Withdrawal by Subject|0|||
124656135|NCT00904839|448361805|FG000|Overall Study|Not treated|1|||
124656136|NCT00904839|448361806|FG001|Overall Study|Not treated|0|||
124656137|NCT00904839|448361807|FG002|Overall Study|Not treated|1|||
124656138|NCT00904839|448361805|FG000|Overall Study|Other than above|0|||
124656139|NCT00904839|448361806|FG001|Overall Study|Other than above|9|||
124656140|NCT00904839|448361807|FG002|Overall Study|Other than above|7|||
124656141|NCT01430624|448361808|FG000|Overall Study|Lost to Follow-up|23|||
124656142|NCT01430624|448361809|FG001|Overall Study|Lost to Follow-up|29|||
124656143|NCT01430624|448361810|FG002|Overall Study|Lost to Follow-up|27|||
124656144|NCT01430624|448361808|FG000|Overall Study|technical or eligibility|5|||
124656145|NCT01430624|448361809|FG001|Overall Study|technical or eligibility|5|||
124656146|NCT01430624|448361810|FG002|Overall Study|technical or eligibility|2|||
124656147|NCT01167634|448361813|FG000|Overall Study|Lost to Follow-up|1|||
124656148|NCT01167634|448361814|FG001|Overall Study|Lost to Follow-up|3|||
124656149|NCT01167634|448361815|FG002|Overall Study|Lost to Follow-up|3|||
124656150|NCT01167634|448361816|FG003|Overall Study|Lost to Follow-up|4|||
124656151|NCT01167634|448361813|FG000|Overall Study|Withdrawal by Subject|1|||
124656152|NCT01167634|448361814|FG001|Overall Study|Withdrawal by Subject|1|||
124656153|NCT01167634|448361815|FG002|Overall Study|Withdrawal by Subject|0|||
124656154|NCT01167634|448361816|FG003|Overall Study|Withdrawal by Subject|0|||
124656155|NCT00553358|448361817|FG000|Overall Study|Randomized but did not receive treatment|3|||
124656156|NCT00553358|448361818|FG001|Overall Study|Randomized but did not receive treatment|3|||
124656157|NCT00553358|448361819|FG002|Overall Study|Randomized but did not receive treatment|1|||
124656158|NCT00553358|448361817|FG000|Overall Study|Lost to Follow-up|22|||
124656159|NCT00553358|448361818|FG001|Overall Study|Lost to Follow-up|26|||
124656160|NCT00553358|448361819|FG002|Overall Study|Lost to Follow-up|18|||
124656161|NCT00553358|448361817|FG000|Overall Study|Withdrew completely|23|||
124656162|NCT00553358|448361818|FG001|Overall Study|Withdrew completely|33|||
124656163|NCT00553358|448361819|FG002|Overall Study|Withdrew completely|34|||
124656164|NCT00553358|448361817|FG000|Overall Study|Died during clinical follow-up|25|||
124656165|NCT00553358|448361818|FG001|Overall Study|Died during clinical follow-up|29|||
124656166|NCT00553358|448361819|FG002|Overall Study|Died during clinical follow-up|32|||
124656167|NCT00553358|448361817|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
124656168|NCT00553358|448361818|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
124656169|NCT00553358|448361819|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
124656170|NCT00553358|448361817|FG000|Overall Study|Died after clinical follow-up ended|1|||
124656171|NCT00553358|448361818|FG001|Overall Study|Died after clinical follow-up ended|2|||
124656172|NCT00553358|448361819|FG002|Overall Study|Died after clinical follow-up ended|0|||
124656173|NCT00553358|448361817|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
124656174|NCT00553358|448361818|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
124656175|NCT00553358|448361819|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
124656176|NCT02147067|448361824|FG000|Overall Study|Withdrawal by Subject|2|||
124656177|NCT02147067|448361825|FG001|Overall Study|Withdrawal by Subject|2|||
124656178|NCT01074255|448361826|FG000|Overall Study|Did not receive EMEND|2|||
124656179|NCT02943785|448361827|FG000|Overall Study|Adverse Event|112|||
124656180|NCT02943785|448361828|FG001|Overall Study|Adverse Event|97|||
124656181|NCT02943785|448361827|FG000|Overall Study|Withdrawal by Subject|63|||
124656182|NCT02943785|448361828|FG001|Overall Study|Withdrawal by Subject|126|||
124656183|NCT02943785|448361827|FG000|Overall Study|Physician Decision|23|||
124656184|NCT02943785|448361828|FG001|Overall Study|Physician Decision|47|||
124656185|NCT02943785|448361827|FG000|Overall Study|Death|46|||
124656186|NCT02943785|448361828|FG001|Overall Study|Death|46|||
124656187|NCT02943785|448361827|FG000|Overall Study|Lost to Follow-up|1|||
124656188|NCT02943785|448361828|FG001|Overall Study|Lost to Follow-up|0|||
124656189|NCT02943785|448361827|FG000|Overall Study|Other|16|||
124656190|NCT02943785|448361828|FG001|Overall Study|Other|19|||
124656191|NCT02943785|448361827|FG000|Overall Study|Did not receive any study medication|21|||
124656192|NCT02943785|448361828|FG001|Overall Study|Did not receive any study medication|28|||
124656193|NCT02603107|448361829|FG000|Randomized Phase|Withdrew consent|8|||
124656194|NCT02603107|448361830|FG001|Randomized Phase|Withdrew consent|15|||
124656195|NCT02603107|448361829|FG000|Randomized Phase|Lost to Follow-up|1|||
124656196|NCT02603107|448361830|FG001|Randomized Phase|Lost to Follow-up|3|||
124656197|NCT02603107|448361829|FG000|Randomized Phase|Adverse Event|2|||
124656198|NCT02603107|448361830|FG001|Randomized Phase|Adverse Event|0|||
124656199|NCT02603107|448361829|FG000|Randomized Phase|Death|1|||
124656200|NCT02603107|448361830|FG001|Randomized Phase|Death|1|||
124656201|NCT02603107|448361829|FG000|Randomized Phase|Non-compliance with study drug|1|||
124656202|NCT02603107|448361830|FG001|Randomized Phase|Non-compliance with study drug|1|||
124656203|NCT02603107|448361829|FG000|Randomized Phase|Investigator's discretion|0|||
124656204|NCT02603107|448361830|FG001|Randomized Phase|Investigator's discretion|1|||
124656205|NCT02603107|448361829|FG000|Randomized Phase|Lack of Efficacy|1|||
124656206|NCT02603107|448361830|FG001|Randomized Phase|Lack of Efficacy|0|||
124656207|NCT02603107|448361829|FG000|Randomized Phase|Protocol Violation|1|||
124656208|NCT02603107|448361830|FG001|Randomized Phase|Protocol Violation|0|||
124656209|NCT02603107|448361829|FG000|Optional Extension Phase|Lost to Follow-up|3|||
124656210|NCT02603107|448361830|FG001|Optional Extension Phase|Lost to Follow-up|3|||
124656211|NCT02603107|448361829|FG000|Optional Extension Phase|Withdrew consent|3|||
124656212|NCT02603107|448361830|FG001|Optional Extension Phase|Withdrew consent|2|||
124656213|NCT02603107|448361829|FG000|Optional Extension Phase|Investigator's discretion|2|||
124656214|NCT02603107|448361830|FG001|Optional Extension Phase|Investigator's discretion|2|||
124656215|NCT02603107|448361829|FG000|Optional Extension Phase|Pregnancy|0|||
124656216|NCT02603107|448361830|FG001|Optional Extension Phase|Pregnancy|3|||
124656217|NCT02603107|448361829|FG000|Optional Extension Phase|Adverse Event|0|||
124656218|NCT02603107|448361830|FG001|Optional Extension Phase|Adverse Event|2|||
124656219|NCT02603107|448361829|FG000|Optional Extension Phase|Not treated in extension phase|0|||
124656220|NCT02603107|448361830|FG001|Optional Extension Phase|Not treated in extension phase|1|||
124656221|NCT02603107|448361829|FG000|Optional Extension Phase|Protocol Violation|1|||
124656222|NCT02603107|448361830|FG001|Optional Extension Phase|Protocol Violation|0|||
124656223|NCT03170609|448361833|FG000|Overall Study|Death|0|||
124656224|NCT03170609|448361834|FG001|Overall Study|Death|0|||
124656225|NCT03170609|448361835|FG002|Overall Study|Death|1|||
124656226|NCT03170609|448361836|FG003|Overall Study|Death|0|||
124656227|NCT03170609|448361837|FG004|Overall Study|Death|0|||
124656228|NCT03170609|448361838|FG005|Overall Study|Death|0|||
124656229|NCT03170609|448361839|FG006|Overall Study|Death|0|||
124656230|NCT03170609|448361833|FG000|Overall Study|Withdrawal by Subject|1|||
124656231|NCT03170609|448361834|FG001|Overall Study|Withdrawal by Subject|2|||
124656232|NCT03170609|448361835|FG002|Overall Study|Withdrawal by Subject|0|||
124656233|NCT03170609|448361836|FG003|Overall Study|Withdrawal by Subject|0|||
124656234|NCT03170609|448361837|FG004|Overall Study|Withdrawal by Subject|0|||
124656235|NCT03170609|448361838|FG005|Overall Study|Withdrawal by Subject|0|||
124656236|NCT03170609|448361839|FG006|Overall Study|Withdrawal by Subject|1|||
124656237|NCT03170609|448361833|FG000|Overall Study|Lost to Follow-up|1|||
124656238|NCT03170609|448361834|FG001|Overall Study|Lost to Follow-up|0|||
124656239|NCT03170609|448361835|FG002|Overall Study|Lost to Follow-up|5|||
124656240|NCT03170609|448361836|FG003|Overall Study|Lost to Follow-up|2|||
124656241|NCT03170609|448361837|FG004|Overall Study|Lost to Follow-up|1|||
124656242|NCT03170609|448361838|FG005|Overall Study|Lost to Follow-up|1|||
124656243|NCT03170609|448361839|FG006|Overall Study|Lost to Follow-up|0|||
124656244|NCT03170609|448361833|FG000|Overall Study|Other|1|||
124656245|NCT03170609|448361834|FG001|Overall Study|Other|0|||
124656246|NCT03170609|448361835|FG002|Overall Study|Other|0|||
124656247|NCT03170609|448361836|FG003|Overall Study|Other|0|||
124656248|NCT03170609|448361837|FG004|Overall Study|Other|0|||
124656249|NCT03170609|448361838|FG005|Overall Study|Other|1|||
124656250|NCT03170609|448361839|FG006|Overall Study|Other|0|||
124656251|NCT01281956|448361840|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
124656252|NCT01281956|448361841|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
124656253|NCT00419159|448361843|FG000|Overall Study|Adverse Event|7|||
124656254|NCT00419159|448361844|FG001|Overall Study|Adverse Event|15|||
124656255|NCT00419159|448361843|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124656256|NCT00419159|448361844|FG001|Overall Study|Abnormal laboratory value(s)|2|||
124656257|NCT00419159|448361843|FG000|Overall Study|Subject's no longer requires study drug|0|||
124656258|NCT00419159|448361844|FG001|Overall Study|Subject's no longer requires study drug|1|||
124656259|NCT00419159|448361843|FG000|Overall Study|Protocol Violation|1|||
124656260|NCT00419159|448361844|FG001|Overall Study|Protocol Violation|0|||
124656261|NCT00419159|448361843|FG000|Overall Study|Withdrawal by Subject|10|||
124656262|NCT00419159|448361844|FG001|Overall Study|Withdrawal by Subject|3|||
124656263|NCT00419159|448361843|FG000|Overall Study|Lost to Follow-up|0|||
124656264|NCT00419159|448361844|FG001|Overall Study|Lost to Follow-up|1|||
124656265|NCT00419159|448361843|FG000|Overall Study|Death|2|||
124656266|NCT00419159|448361844|FG001|Overall Study|Death|2|||
124656267|NCT00419159|448361843|FG000|Overall Study|Disease progression|79|||
124656268|NCT00419159|448361844|FG001|Overall Study|Disease progression|76|||
124656269|NCT00187278|448361849|FG000|Overall Study|Protocol Violation|10|||
124656270|NCT00187278|448361850|FG001|Overall Study|Protocol Violation|13|||
124656271|NCT02735096|448361851|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
124656272|NCT02638259|448361854|FG000|Treatment Period 1|Adverse Event|1|||
124656273|NCT02638259|448361855|FG001|Treatment Period 1|Adverse Event|5|||
124656274|NCT02638259|448361854|FG000|Treatment Period 1|Death|0|||
124656275|NCT02638259|448361855|FG001|Treatment Period 1|Death|1|||
124656276|NCT02638259|448361854|FG000|Treatment Period 1|Lack of Efficacy|0|||
124656277|NCT02638259|448361855|FG001|Treatment Period 1|Lack of Efficacy|1|||
124656278|NCT02638259|448361854|FG000|Treatment Period 1|Protocol Violation|0|||
124656279|NCT02638259|448361855|FG001|Treatment Period 1|Protocol Violation|3|||
124656280|NCT02638259|448361854|FG000|Treatment Period 1|Withdrawal by Subject|4|||
124656281|NCT02638259|448361855|FG001|Treatment Period 1|Withdrawal by Subject|6|||
124656282|NCT02638259|448361854|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
124656283|NCT02638259|448361855|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
124656284|NCT02638259|448361854|FG000|Treatment Period 2|Adverse Event|5|||
124656285|NCT02638259|448361855|FG001|Treatment Period 2|Adverse Event|4|||
124656286|NCT02638259|448361854|FG000|Treatment Period 2|Withdrawal by Subject|1|||
124656287|NCT02638259|448361855|FG001|Treatment Period 2|Withdrawal by Subject|7|||
124656288|NCT04299048|448361857|FG000|Overall Study|Death|1|||
124656289|NCT04299048|448361857|FG000|Overall Study|Global deterioration of health status|2|||
124656290|NCT04299048|448361857|FG000|Overall Study|Enrolled and not treated|1|||
124656291|NCT01706575|448361858|FG000|Overall Study|Participant Withdrew Consent|4|||
124656292|NCT01706575|448361858|FG000|Overall Study|Lost to Follow-up|2|||
124656293|NCT01706575|448361858|FG000|Overall Study|Started but not Treated|6|||
124656294|NCT02536781|448361875|FG000|Overall Study|Lost to Follow-up|2|||
124656295|NCT02536781|448361876|FG001|Overall Study|Lost to Follow-up|0|||
124656296|NCT03423147|448361877|FG000|Overall Study|Lost to Follow-up|5|||
124656297|NCT03423147|448361878|FG001|Overall Study|Lost to Follow-up|8|||
124656298|NCT03423147|448361877|FG000|Overall Study|Withdrawal by Subject|1|||
124656299|NCT03423147|448361878|FG001|Overall Study|Withdrawal by Subject|0|||
124656300|NCT03423147|448361877|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
124656301|NCT03423147|448361878|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
124656302|NCT03423147|448361877|FG000|Overall Study|Age < 18|1|||
124656303|NCT03423147|448361878|FG001|Overall Study|Age < 18|0|||
124656304|NCT03423147|448361877|FG000|Overall Study|No Trial of Labor|0|||
124656305|NCT03423147|448361878|FG001|Overall Study|No Trial of Labor|1|||
124656306|NCT02069093|448361879|FG000|Overall Study|Disease progression|14|||
124656307|NCT02069093|448361879|FG000|Overall Study|New cancer therapy|1|||
124656308|NCT02069093|448361879|FG000|Overall Study|Death|1|||
124656309|NCT02069093|448361879|FG000|Overall Study|Administrative problems|1|||
124656310|NCT02069093|448361879|FG000|Overall Study|Withdrawal by Subject|2|||
124656311|NCT02069093|448361879|FG000|Overall Study|Abnormal laboratory values|1|||
124656312|NCT02069093|448361879|FG000|Overall Study|Adverse Event|10|||
124656313|NCT02028169|448361880|FG000|Overall Study|Lost to Follow-up|21|||
124656314|NCT02028169|448361880|FG000|Overall Study|Lack of Efficacy|2|||
124656315|NCT02028169|448361880|FG000|Overall Study|Withdrawal by Subject|2|||
124656316|NCT02028169|448361880|FG000|Overall Study|Adverse Event|1|||
124656317|NCT02028169|448361880|FG000|Overall Study|Cessation of Drug|1|||
124656318|NCT02028169|448361880|FG000|Overall Study|Concomitant Medication Usage|1|||
124656319|NCT02258334|448361881|FG000|Overall Study|Adverse Event|1|||
124656320|NCT02258334|448361882|FG001|Overall Study|Adverse Event|0|||
124656321|NCT02258334|448361883|FG002|Overall Study|Adverse Event|0|||
124656322|NCT02258334|448361884|FG003|Overall Study|Adverse Event|0|||
124656323|NCT01969084|448361885|FG000|Overall Study|Adverse Event|0|||
124656324|NCT01969084|448361886|FG001|Overall Study|Adverse Event|1|||
124656325|NCT00862459|448361887|FG000|Overall Study|Lost to Follow-up|1|||
124656326|NCT00862459|448361888|FG001|Overall Study|Lost to Follow-up|2|||
124656327|NCT00862459|448361889|FG002|Overall Study|Lost to Follow-up|2|||
124656328|NCT00862459|448361887|FG000|Overall Study|Protocol Violation|1|||
124656329|NCT00862459|448361888|FG001|Overall Study|Protocol Violation|0|||
124656330|NCT00862459|448361889|FG002|Overall Study|Protocol Violation|0|||
124656331|NCT00862459|448361887|FG000|Overall Study|Withdrawal by Subject|1|||
124656332|NCT00862459|448361888|FG001|Overall Study|Withdrawal by Subject|1|||
124656333|NCT00862459|448361889|FG002|Overall Study|Withdrawal by Subject|3|||
124656334|NCT00862459|448361887|FG000|Overall Study|Adverse Event|0|||
124656335|NCT00862459|448361888|FG001|Overall Study|Adverse Event|1|||
124656336|NCT00862459|448361889|FG002|Overall Study|Adverse Event|0|||
124656337|NCT00862459|448361887|FG000|Overall Study|Personal reasons|1|||
124656338|NCT00862459|448361888|FG001|Overall Study|Personal reasons|0|||
124656339|NCT00862459|448361889|FG002|Overall Study|Personal reasons|0|||
124656340|NCT00862459|448361887|FG000|Overall Study|Operation|1|||
124656341|NCT00862459|448361888|FG001|Overall Study|Operation|1|||
124656342|NCT00862459|448361889|FG002|Overall Study|Operation|0|||
124656343|NCT00862459|448361887|FG000|Overall Study|Intravenous (IV) site problems|1|||
124656344|NCT00862459|448361888|FG001|Overall Study|Intravenous (IV) site problems|0|||
124656345|NCT00862459|448361889|FG002|Overall Study|Intravenous (IV) site problems|1|||
124656346|NCT00862459|448361887|FG000|Overall Study|Unable to hold still for imaging|0|||
124656347|NCT00862459|448361888|FG001|Overall Study|Unable to hold still for imaging|1|||
124656348|NCT00862459|448361889|FG002|Overall Study|Unable to hold still for imaging|0|||
124656349|NCT00862459|448361887|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
124656350|NCT00862459|448361888|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
124656351|NCT00862459|448361889|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
124656352|NCT00862459|448361887|FG000|Overall Study|Administrative problems|0|||
124656353|NCT00862459|448361888|FG001|Overall Study|Administrative problems|1|||
124656354|NCT00862459|448361889|FG002|Overall Study|Administrative problems|0|||
124656355|NCT04776018|448361892|FG000|Overall Study|Death|0|||
124656356|NCT04776018|448361893|FG001|Overall Study|Death|1|||
124656357|NCT04776018|448361894|FG002|Overall Study|Death|4|||
124656358|NCT04776018|448361895|FG003|Overall Study|Death|1|||
124656359|NCT04776018|448361896|FG004|Overall Study|Death|4|||
124656360|NCT04776018|448361897|FG005|Overall Study|Death|0|||
124656361|NCT04776018|448361898|FG006|Overall Study|Death|0|||
124656362|NCT04776018|448361892|FG000|Overall Study|Study terminated by sponsor|2|||
124656363|NCT04776018|448361893|FG001|Overall Study|Study terminated by sponsor|1|||
124656364|NCT04776018|448361894|FG002|Overall Study|Study terminated by sponsor|4|||
124656365|NCT04776018|448361895|FG003|Overall Study|Study terminated by sponsor|0|||
124656366|NCT04776018|448361896|FG004|Overall Study|Study terminated by sponsor|3|||
124656367|NCT04776018|448361897|FG005|Overall Study|Study terminated by sponsor|0|||
124656368|NCT04776018|448361898|FG006|Overall Study|Study terminated by sponsor|0|||
124656369|NCT04776018|448361892|FG000|Overall Study|Withdrawal by Subject|1|||
124656370|NCT04776018|448361893|FG001|Overall Study|Withdrawal by Subject|0|||
124656371|NCT04776018|448361894|FG002|Overall Study|Withdrawal by Subject|0|||
124656372|NCT04776018|448361895|FG003|Overall Study|Withdrawal by Subject|2|||
124656373|NCT04776018|448361896|FG004|Overall Study|Withdrawal by Subject|1|||
124656374|NCT04776018|448361897|FG005|Overall Study|Withdrawal by Subject|0|||
124656375|NCT04776018|448361898|FG006|Overall Study|Withdrawal by Subject|0|||
124656376|NCT04776018|448361892|FG000|Overall Study|Other|0|||
124656377|NCT04776018|448361893|FG001|Overall Study|Other|1|||
124656378|NCT04776018|448361894|FG002|Overall Study|Other|1|||
124656379|NCT04776018|448361895|FG003|Overall Study|Other|0|||
124656380|NCT04776018|448361896|FG004|Overall Study|Other|0|||
124656381|NCT04776018|448361897|FG005|Overall Study|Other|0|||
124656382|NCT04776018|448361898|FG006|Overall Study|Other|0|||
124656383|NCT04776018|448361892|FG000|Overall Study|Lost to Follow-up|0|||
124656384|NCT04776018|448361893|FG001|Overall Study|Lost to Follow-up|0|||
124656385|NCT04776018|448361894|FG002|Overall Study|Lost to Follow-up|1|||
124656386|NCT04776018|448361895|FG003|Overall Study|Lost to Follow-up|0|||
124656387|NCT04776018|448361896|FG004|Overall Study|Lost to Follow-up|0|||
124656388|NCT04776018|448361897|FG005|Overall Study|Lost to Follow-up|0|||
124656389|NCT04776018|448361898|FG006|Overall Study|Lost to Follow-up|0|||
124656390|NCT02908074|448361900|FG000|Overall Study|sponsor/ICON decision|0|||
124656391|NCT02908074|448361901|FG001|Overall Study|sponsor/ICON decision|0|||
124656392|NCT02908074|448361902|FG002|Overall Study|sponsor/ICON decision|1|||
124656393|NCT02908074|448361903|FG003|Overall Study|sponsor/ICON decision|0|||
124656394|NCT02908074|448361904|FG004|Overall Study|sponsor/ICON decision|0|||
124656395|NCT02908074|448361905|FG005|Overall Study|sponsor/ICON decision|0|||
124656396|NCT02908074|448361900|FG000|Overall Study|Protocol Violation|0|||
124656397|NCT02908074|448361901|FG001|Overall Study|Protocol Violation|1|||
124656398|NCT02908074|448361902|FG002|Overall Study|Protocol Violation|0|||
124656399|NCT02908074|448361903|FG003|Overall Study|Protocol Violation|0|||
124656400|NCT02908074|448361904|FG004|Overall Study|Protocol Violation|0|||
124656401|NCT02908074|448361905|FG005|Overall Study|Protocol Violation|0|||
124656402|NCT02908074|448361900|FG000|Overall Study|Adverse Event|5|||
124656403|NCT02908074|448361901|FG001|Overall Study|Adverse Event|2|||
124656404|NCT02908074|448361902|FG002|Overall Study|Adverse Event|0|||
124656405|NCT02908074|448361903|FG003|Overall Study|Adverse Event|0|||
124656406|NCT02908074|448361904|FG004|Overall Study|Adverse Event|1|||
124656407|NCT02908074|448361905|FG005|Overall Study|Adverse Event|0|||
124656408|NCT02908074|448361900|FG000|Overall Study|AESI|1|||
124656409|NCT02908074|448361901|FG001|Overall Study|AESI|0|||
124656410|NCT02908074|448361902|FG002|Overall Study|AESI|1|||
124656411|NCT02908074|448361903|FG003|Overall Study|AESI|0|||
124656412|NCT02908074|448361904|FG004|Overall Study|AESI|1|||
124656413|NCT02908074|448361905|FG005|Overall Study|AESI|0|||
124656414|NCT02908074|448361900|FG000|Overall Study|Discontinuation criteria per protocol|0|||
124656415|NCT02908074|448361901|FG001|Overall Study|Discontinuation criteria per protocol|0|||
124656416|NCT02908074|448361902|FG002|Overall Study|Discontinuation criteria per protocol|1|||
124656417|NCT02908074|448361903|FG003|Overall Study|Discontinuation criteria per protocol|0|||
124656418|NCT02908074|448361904|FG004|Overall Study|Discontinuation criteria per protocol|0|||
124656419|NCT02908074|448361905|FG005|Overall Study|Discontinuation criteria per protocol|1|||
124656420|NCT02908074|448361900|FG000|Overall Study|Withdrawal by Subject|3|||
124656421|NCT02908074|448361901|FG001|Overall Study|Withdrawal by Subject|2|||
124656422|NCT02908074|448361902|FG002|Overall Study|Withdrawal by Subject|2|||
124656423|NCT02908074|448361903|FG003|Overall Study|Withdrawal by Subject|2|||
124656424|NCT02908074|448361904|FG004|Overall Study|Withdrawal by Subject|2|||
124656425|NCT02908074|448361905|FG005|Overall Study|Withdrawal by Subject|2|||
124656426|NCT02908074|448361900|FG000|Overall Study|Lost to Follow-up|0|||
124656427|NCT02908074|448361901|FG001|Overall Study|Lost to Follow-up|1|||
124656428|NCT02908074|448361902|FG002|Overall Study|Lost to Follow-up|1|||
124656429|NCT02908074|448361903|FG003|Overall Study|Lost to Follow-up|1|||
124656430|NCT02908074|448361904|FG004|Overall Study|Lost to Follow-up|0|||
124656431|NCT02908074|448361905|FG005|Overall Study|Lost to Follow-up|1|||
124656432|NCT02655419|448361910|FG000|Overall Study|Enrolled but not treated|1|||
124656433|NCT02655419|448361911|FG001|Overall Study|Enrolled but not treated|5|||
124656434|NCT02655419|448361910|FG000|Overall Study|Withdrawal by Subject|4|||
124656435|NCT02655419|448361911|FG001|Overall Study|Withdrawal by Subject|1|||
124656436|NCT02655419|448361910|FG000|Overall Study|Other|0|||
124656437|NCT02655419|448361911|FG001|Overall Study|Other|1|||
124656438|NCT03053427|448361912|FG000|Overall Study|Adverse Event|4|||
124656439|NCT03053427|448361913|FG001|Overall Study|Adverse Event|4|||
124656440|NCT03053427|448361912|FG000|Overall Study|Lack of Efficacy|1|||
124656441|NCT03053427|448361913|FG001|Overall Study|Lack of Efficacy|3|||
124656442|NCT03053427|448361912|FG000|Overall Study|Lost to Follow-up|2|||
124656443|NCT03053427|448361913|FG001|Overall Study|Lost to Follow-up|2|||
124656444|NCT03053427|448361912|FG000|Overall Study|Worsening of the target disease|0|||
124656445|NCT03053427|448361913|FG001|Overall Study|Worsening of the target disease|1|||
124656446|NCT03053427|448361912|FG000|Overall Study|Protocol Deviation|3|||
124656447|NCT03053427|448361913|FG001|Overall Study|Protocol Deviation|3|||
124656448|NCT03053427|448361912|FG000|Overall Study|Withdrawal by Subject|3|||
124656449|NCT03053427|448361913|FG001|Overall Study|Withdrawal by Subject|2|||
124656450|NCT03053427|448361912|FG000|Overall Study|Miscellaneous|0|||
124656451|NCT03053427|448361913|FG001|Overall Study|Miscellaneous|1|||
124656452|NCT02172040|448361916|FG000|Overall Study|Adverse Event|0|||
124656453|NCT02172040|448361917|FG001|Overall Study|Adverse Event|2|||
124656454|NCT02172040|448361918|FG002|Overall Study|Adverse Event|0|||
124656455|NCT02172040|448361919|FG003|Overall Study|Adverse Event|0|||
124656456|NCT02172040|448361916|FG000|Overall Study|Protocol Violation|0|||
124656457|NCT02172040|448361917|FG001|Overall Study|Protocol Violation|1|||
124656458|NCT02172040|448361918|FG002|Overall Study|Protocol Violation|0|||
124656459|NCT02172040|448361919|FG003|Overall Study|Protocol Violation|0|||
124656460|NCT02172040|448361916|FG000|Overall Study|Withdrawal by Subject|0|||
124656461|NCT02172040|448361917|FG001|Overall Study|Withdrawal by Subject|0|||
124656462|NCT02172040|448361918|FG002|Overall Study|Withdrawal by Subject|1|||
124656463|NCT02172040|448361919|FG003|Overall Study|Withdrawal by Subject|0|||
124656464|NCT02172040|448361916|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
124656465|NCT02172040|448361917|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
124656466|NCT02172040|448361918|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
124656467|NCT02172040|448361919|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
124656468|NCT02172040|448361916|FG000|Overall Study|Family emergency abroad|0|||
124656469|NCT02172040|448361917|FG001|Overall Study|Family emergency abroad|0|||
124656470|NCT02172040|448361918|FG002|Overall Study|Family emergency abroad|0|||
124656471|NCT02172040|448361919|FG003|Overall Study|Family emergency abroad|1|||
124656472|NCT02607306|448361920|FG000|Overall Study|Adverse Event|8|||
124656473|NCT02607306|448361921|FG001|Overall Study|Adverse Event|6|||
124656474|NCT02607306|448361922|FG002|Overall Study|Adverse Event|6|||
124656475|NCT02607306|448361920|FG000|Overall Study|Unclassified|1|||
124656476|NCT02607306|448361921|FG001|Overall Study|Unclassified|4|||
124656477|NCT02607306|448361922|FG002|Overall Study|Unclassified|0|||
124656478|NCT02607306|448361920|FG000|Overall Study|Withdrawal by Subject|8|||
124656479|NCT02607306|448361921|FG001|Overall Study|Withdrawal by Subject|10|||
124656480|NCT02607306|448361922|FG002|Overall Study|Withdrawal by Subject|2|||
124656481|NCT02607306|448361920|FG000|Overall Study|Lack of Efficacy|0|||
124656482|NCT02607306|448361921|FG001|Overall Study|Lack of Efficacy|1|||
124656483|NCT02607306|448361922|FG002|Overall Study|Lack of Efficacy|1|||
124656484|NCT02607306|448361920|FG000|Overall Study|Protocol Violation|4|||
124656485|NCT02607306|448361921|FG001|Overall Study|Protocol Violation|2|||
124656486|NCT02607306|448361922|FG002|Overall Study|Protocol Violation|1|||
124656487|NCT00505661|448361923|FG000|Overall Study|Not Eligible|4|||
124656488|NCT03611582|448361926|FG000|Overall Study|Adverse Event|26|||
124656489|NCT03611582|448361927|FG001|Overall Study|Adverse Event|6|||
124656490|NCT03611582|448361926|FG000|Overall Study|Protocol Violation|0|||
124656491|NCT03611582|448361927|FG001|Overall Study|Protocol Violation|1|||
124656492|NCT03611582|448361926|FG000|Overall Study|Pregnancy|1|||
124656493|NCT03611582|448361927|FG001|Overall Study|Pregnancy|2|||
124656494|NCT03611582|448361926|FG000|Overall Study|Lack of Efficacy|0|||
124656495|NCT03611582|448361927|FG001|Overall Study|Lack of Efficacy|1|||
124656496|NCT03611582|448361926|FG000|Overall Study|At the discretion of the investigator|1|||
124656497|NCT03611582|448361927|FG001|Overall Study|At the discretion of the investigator|0|||
124656498|NCT03611582|448361926|FG000|Overall Study|Safety concern as judged by the investigator|1|||
124656499|NCT03611582|448361927|FG001|Overall Study|Safety concern as judged by the investigator|2|||
124656500|NCT03611582|448361926|FG000|Overall Study|Withdrawal by Subject|4|||
124656501|NCT03611582|448361927|FG001|Overall Study|Withdrawal by Subject|3|||
124656502|NCT03611582|448361926|FG000|Overall Study|Lost to Follow-up|18|||
124656503|NCT03611582|448361927|FG001|Overall Study|Lost to Follow-up|7|||
124656504|NCT03611582|448361926|FG000|Overall Study|other|17|||
124656505|NCT03611582|448361927|FG001|Overall Study|other|16|||
124656506|NCT04459598|448361928|FG000|Overall Study|Adverse Event|1|||
124656507|NCT04459598|448361929|FG001|Overall Study|Adverse Event|1|||
124656508|NCT01078298|448361930|FG000|Overall Study|Lost to Follow-up|12|||
124656509|NCT01078298|448361931|FG001|Overall Study|Lost to Follow-up|13|||
124656510|NCT01078298|448361930|FG000|Overall Study|Withdrawal by Subject|31|||
124656511|NCT01078298|448361931|FG001|Overall Study|Withdrawal by Subject|33|||
124656512|NCT01078298|448361930|FG000|Overall Study|Protocol Violation|6|||
124656513|NCT01078298|448361931|FG001|Overall Study|Protocol Violation|6|||
124656514|NCT01078298|448361930|FG000|Overall Study|Adverse Event|6|||
124656515|NCT01078298|448361931|FG001|Overall Study|Adverse Event|5|||
124656516|NCT01078298|448361930|FG000|Overall Study|Death|2|||
124656517|NCT01078298|448361931|FG001|Overall Study|Death|0|||
124656518|NCT01078298|448361930|FG000|Overall Study|Did not meet entrance criteria|0|||
124656519|NCT01078298|448361931|FG001|Overall Study|Did not meet entrance criteria|1|||
124656520|NCT01078298|448361930|FG000|Overall Study|Other|24|||
124656521|NCT01078298|448361931|FG001|Overall Study|Other|32|||
124656522|NCT00463840|448361932|FG000|Overall Study|Disease progression|7|||
124656523|NCT00463840|448361932|FG000|Overall Study|Withdrawal by Subject|2|||
124656524|NCT00463840|448361932|FG000|Overall Study|Adverse Event|3|||
124656525|NCT00866333|448361933|FG000|Overall Study|Withdrawal of consent|0|||
124656526|NCT00866333|448361934|FG001|Overall Study|Withdrawal of consent|1|||
124656527|NCT00866333|448361935|FG002|Overall Study|Withdrawal of consent|2|||
124656528|NCT00866333|448361933|FG000|Overall Study|Reason not Specified|3|||
124656529|NCT00866333|448361934|FG001|Overall Study|Reason not Specified|1|||
124656530|NCT00866333|448361935|FG002|Overall Study|Reason not Specified|1|||
124656531|NCT00866333|448361933|FG000|Overall Study|Study Terminated by Sponsor|2|||
124656532|NCT00866333|448361934|FG001|Overall Study|Study Terminated by Sponsor|5|||
124656533|NCT00866333|448361935|FG002|Overall Study|Study Terminated by Sponsor|9|||
124656534|NCT01653327|448361936|FG000|Overall Study|Withdrawal by Subject|1|||
124656535|NCT01738191|448361937|FG000|Overall Study|Withdrawal by Subject|4|||
124656536|NCT01738191|448361938|FG001|Overall Study|Withdrawal by Subject|1|||
124656537|NCT02243046|448361939|FG000|Overall Study|Lost to Follow-up|1|||
124656538|NCT02243046|448361940|FG001|Overall Study|Lost to Follow-up|1|||
124656539|NCT02243046|448361941|FG002|Overall Study|Lost to Follow-up|4|||
124656540|NCT03338569|448361942|FG000|Overall Study|Physician Decision|8|||
124656541|NCT03338569|448361943|FG001|Overall Study|Physician Decision|3|||
124656542|NCT03338569|448361942|FG000|Overall Study|Withdrawal by Subject|0|||
124656543|NCT03338569|448361943|FG001|Overall Study|Withdrawal by Subject|1|||
124656544|NCT03338569|448361942|FG000|Overall Study|Lost to Follow-up|0|||
124656545|NCT03338569|448361943|FG001|Overall Study|Lost to Follow-up|1|||
124656546|NCT02109445|448361946|FG000|Overall Study|Symptomatic deterioration|2|||
124656547|NCT02109445|448361946|FG000|Overall Study|Adverse Event|1|||
124656548|NCT00441363|448363426|FG000|Overall Study|Adverse Event|4|||
124656549|NCT00441363|448363427|FG001|Overall Study|Adverse Event|2|||
124656550|NCT00441363|448363426|FG000|Overall Study|Withdrawal by Subject|3|||
124656551|NCT00441363|448363427|FG001|Overall Study|Withdrawal by Subject|4|||
124656552|NCT00441363|448363426|FG000|Overall Study|Physician Decision|6|||
124656553|NCT00441363|448363427|FG001|Overall Study|Physician Decision|7|||
124656554|NCT00441363|448363426|FG000|Overall Study|Lost to Follow-up|2|||
124656555|NCT00441363|448363427|FG001|Overall Study|Lost to Follow-up|2|||
124656556|NCT00441363|448363426|FG000|Overall Study|Other|2|||
124656557|NCT00441363|448363427|FG001|Overall Study|Other|0|||
124656558|NCT02474355|448363430|FG000|Overall Study|Other|43|||
124656559|NCT02474355|448363430|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
124656560|NCT02474355|448363430|FG000|Overall Study|Lost to Follow-up|98|||
124656561|NCT02474355|448363430|FG000|Overall Study|Withdrawal by Subject|124|||
124656562|NCT02474355|448363430|FG000|Overall Study|Death|1361|||
124656563|NCT01066793|448363431|FG000|Overall Study|Death|4|||
124656564|NCT01066793|448363432|FG001|Overall Study|Death|1|||
124656565|NCT01066793|448363433|FG002|Overall Study|Death|1|||
124656566|NCT01066793|448363434|FG003|Overall Study|Death|0|||
124656567|NCT01066793|448363435|FG004|Overall Study|Death|0|||
124656568|NCT01066793|448363436|FG005|Overall Study|Death|0|||
124656569|NCT01066793|448363431|FG000|Overall Study|Lack of Efficacy|2|||
124656570|NCT01066793|448363432|FG001|Overall Study|Lack of Efficacy|1|||
124656571|NCT01066793|448363433|FG002|Overall Study|Lack of Efficacy|0|||
124656572|NCT01066793|448363434|FG003|Overall Study|Lack of Efficacy|0|||
124656573|NCT01066793|448363435|FG004|Overall Study|Lack of Efficacy|0|||
124656574|NCT01066793|448363436|FG005|Overall Study|Lack of Efficacy|0|||
124656575|NCT01066793|448363431|FG000|Overall Study|Lost to Follow-up|180|||
124656576|NCT01066793|448363432|FG001|Overall Study|Lost to Follow-up|39|||
124656577|NCT01066793|448363433|FG002|Overall Study|Lost to Follow-up|82|||
124656578|NCT01066793|448363434|FG003|Overall Study|Lost to Follow-up|16|||
124656579|NCT01066793|448363435|FG004|Overall Study|Lost to Follow-up|0|||
124656580|NCT01066793|448363436|FG005|Overall Study|Lost to Follow-up|1|||
124656581|NCT01066793|448363431|FG000|Overall Study|Physician Decision|3|||
124656582|NCT01066793|448363432|FG001|Overall Study|Physician Decision|0|||
124656583|NCT01066793|448363433|FG002|Overall Study|Physician Decision|0|||
124656584|NCT01066793|448363434|FG003|Overall Study|Physician Decision|0|||
124656585|NCT01066793|448363435|FG004|Overall Study|Physician Decision|0|||
124656586|NCT01066793|448363436|FG005|Overall Study|Physician Decision|0|||
124656587|NCT01066793|448363431|FG000|Overall Study|Protocol Violation|3|||
124656588|NCT01066793|448363432|FG001|Overall Study|Protocol Violation|2|||
124656589|NCT01066793|448363433|FG002|Overall Study|Protocol Violation|2|||
124656590|NCT01066793|448363434|FG003|Overall Study|Protocol Violation|0|||
124656591|NCT01066793|448363435|FG004|Overall Study|Protocol Violation|0|||
124656592|NCT01066793|448363436|FG005|Overall Study|Protocol Violation|0|||
124656593|NCT01066793|448363431|FG000|Overall Study|Withdrawal by Subject|7|||
124656594|NCT01066793|448363432|FG001|Overall Study|Withdrawal by Subject|4|||
124656595|NCT01066793|448363433|FG002|Overall Study|Withdrawal by Subject|1|||
124656596|NCT01066793|448363434|FG003|Overall Study|Withdrawal by Subject|0|||
124656597|NCT01066793|448363435|FG004|Overall Study|Withdrawal by Subject|0|||
124656598|NCT01066793|448363436|FG005|Overall Study|Withdrawal by Subject|0|||
124656599|NCT01066793|448363431|FG000|Overall Study|Early Termination|3|||
124656600|NCT01066793|448363432|FG001|Overall Study|Early Termination|0|||
124656601|NCT01066793|448363433|FG002|Overall Study|Early Termination|0|||
124656602|NCT01066793|448363434|FG003|Overall Study|Early Termination|0|||
124656603|NCT01066793|448363435|FG004|Overall Study|Early Termination|0|||
124656604|NCT01066793|448363436|FG005|Overall Study|Early Termination|0|||
124656605|NCT01066793|448363431|FG000|Overall Study|Lab test not done|7|||
124656606|NCT01066793|448363432|FG001|Overall Study|Lab test not done|0|||
124656607|NCT01066793|448363433|FG002|Overall Study|Lab test not done|0|||
124656608|NCT01066793|448363434|FG003|Overall Study|Lab test not done|1|||
124656609|NCT01066793|448363435|FG004|Overall Study|Lab test not done|0|||
124656610|NCT01066793|448363436|FG005|Overall Study|Lab test not done|0|||
124656611|NCT01066793|448363431|FG000|Overall Study|Miscellaneous|4|||
124656612|NCT01066793|448363432|FG001|Overall Study|Miscellaneous|5|||
124656613|NCT01066793|448363433|FG002|Overall Study|Miscellaneous|6|||
124656614|NCT01066793|448363434|FG003|Overall Study|Miscellaneous|0|||
124656615|NCT01066793|448363435|FG004|Overall Study|Miscellaneous|0|||
124656616|NCT01066793|448363436|FG005|Overall Study|Miscellaneous|0|||
124656617|NCT01066793|448363431|FG000|Overall Study|Non-responders|104|||
124656618|NCT01066793|448363432|FG001|Overall Study|Non-responders|5|||
124656619|NCT01066793|448363433|FG002|Overall Study|Non-responders|11|||
124656620|NCT01066793|448363434|FG003|Overall Study|Non-responders|25|||
124656621|NCT01066793|448363435|FG004|Overall Study|Non-responders|0|||
124656622|NCT01066793|448363436|FG005|Overall Study|Non-responders|0|||
124656623|NCT01066793|448363431|FG000|Overall Study|Other|15|||
124656624|NCT01066793|448363432|FG001|Overall Study|Other|5|||
124656625|NCT01066793|448363433|FG002|Overall Study|Other|6|||
124656626|NCT01066793|448363434|FG003|Overall Study|Other|2|||
124656627|NCT01066793|448363435|FG004|Overall Study|Other|0|||
124656628|NCT01066793|448363436|FG005|Overall Study|Other|0|||
124656629|NCT01066793|448363431|FG000|Overall Study|Relapse|20|||
124656630|NCT01066793|448363432|FG001|Overall Study|Relapse|8|||
124656631|NCT01066793|448363433|FG002|Overall Study|Relapse|2|||
124656632|NCT01066793|448363434|FG003|Overall Study|Relapse|3|||
124656633|NCT01066793|448363435|FG004|Overall Study|Relapse|0|||
124656634|NCT01066793|448363436|FG005|Overall Study|Relapse|0|||
124656635|NCT01066793|448363431|FG000|Overall Study|Result Not Available|1|||
124656636|NCT01066793|448363432|FG001|Overall Study|Result Not Available|0|||
124656637|NCT01066793|448363433|FG002|Overall Study|Result Not Available|0|||
124656638|NCT01066793|448363434|FG003|Overall Study|Result Not Available|0|||
124656639|NCT01066793|448363435|FG004|Overall Study|Result Not Available|0|||
124656640|NCT01066793|448363436|FG005|Overall Study|Result Not Available|0|||
124656641|NCT01066793|448363431|FG000|Overall Study|Treatment Interrupted|1|||
124656642|NCT01066793|448363432|FG001|Overall Study|Treatment Interrupted|1|||
124656643|NCT01066793|448363433|FG002|Overall Study|Treatment Interrupted|0|||
124656644|NCT01066793|448363434|FG003|Overall Study|Treatment Interrupted|0|||
124656645|NCT01066793|448363435|FG004|Overall Study|Treatment Interrupted|0|||
124656646|NCT01066793|448363436|FG005|Overall Study|Treatment Interrupted|0|||
124656647|NCT01066793|448363431|FG000|Overall Study|Treatment Never Started|18|||
124656648|NCT01066793|448363432|FG001|Overall Study|Treatment Never Started|5|||
124656649|NCT01066793|448363433|FG002|Overall Study|Treatment Never Started|4|||
124656650|NCT01066793|448363434|FG003|Overall Study|Treatment Never Started|1|||
124656651|NCT01066793|448363435|FG004|Overall Study|Treatment Never Started|0|||
124656652|NCT01066793|448363436|FG005|Overall Study|Treatment Never Started|0|||
124656653|NCT01066793|448363431|FG000|Overall Study|Treatment Stopped|2|||
124656654|NCT01066793|448363432|FG001|Overall Study|Treatment Stopped|1|||
124656655|NCT01066793|448363433|FG002|Overall Study|Treatment Stopped|0|||
124656656|NCT01066793|448363434|FG003|Overall Study|Treatment Stopped|1|||
124656657|NCT01066793|448363435|FG004|Overall Study|Treatment Stopped|0|||
124656658|NCT01066793|448363436|FG005|Overall Study|Treatment Stopped|0|||
124656659|NCT01911793|448363437|FG000|Overall Study|Physician Decision|1|||
124656660|NCT01911793|448363438|FG001|Overall Study|Physician Decision|5|||
124656661|NCT01533688|448363439|FG000|Overall Study|Withdrawal by Subject|5|||
124656662|NCT01533688|448363440|FG001|Overall Study|Withdrawal by Subject|4|||
124656663|NCT01533688|448363441|FG002|Overall Study|Withdrawal by Subject|3|||
124656664|NCT01533688|448363439|FG000|Overall Study|Medically unstable|1|||
124656665|NCT01533688|448363440|FG001|Overall Study|Medically unstable|3|||
124656666|NCT01533688|448363441|FG002|Overall Study|Medically unstable|3|||
124656667|NCT01533688|448363439|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
124656668|NCT01533688|448363440|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
124656669|NCT01533688|448363441|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
124656670|NCT04591015|448363442|FG000|Overall Study|Death|6|||
124656671|NCT04591015|448363443|FG001|Overall Study|Death|4|||
124656672|NCT04591015|448363442|FG000|Overall Study|Withdrawal by Subject|6|||
124656673|NCT04591015|448363443|FG001|Overall Study|Withdrawal by Subject|3|||
124656674|NCT04591015|448363442|FG000|Overall Study|Lost to Follow-up|16|||
124656675|NCT04591015|448363443|FG001|Overall Study|Lost to Follow-up|11|||
124656676|NCT02509078|448363444|FG000|Overall Study|Protocol Violation|1|||
124656677|NCT02509078|448363445|FG001|Overall Study|Protocol Violation|1|||
124656678|NCT02686814|448363446|FG000|Overall Study|Physician Decision|14|||
124656679|NCT02686814|448363446|FG000|Overall Study|Withdrawal by Subject|4|||
124656680|NCT02686814|448363446|FG000|Overall Study|Death|1|||
124656681|NCT00290693|448363447|FG000|Overall Study|Withdrawal by Subject|2|||
124656682|NCT02907619|448363448|FG000|Overall Study|Study terminated by sponsor|18|||
124656683|NCT02907619|448363449|FG001|Overall Study|Study terminated by sponsor|18|||
124656684|NCT02907619|448363450|FG002|Overall Study|Study terminated by sponsor|19|||
124656685|NCT02907619|448363448|FG000|Overall Study|Death|0|||
124656686|NCT02907619|448363449|FG001|Overall Study|Death|0|||
124656687|NCT02907619|448363450|FG002|Overall Study|Death|1|||
124656688|NCT02907619|448363448|FG000|Overall Study|Withdrawal by Subject|1|||
124656689|NCT02907619|448363449|FG001|Overall Study|Withdrawal by Subject|1|||
124656690|NCT02907619|448363450|FG002|Overall Study|Withdrawal by Subject|0|||
124656691|NCT02907619|448363448|FG000|Overall Study|Other|0|||
124656692|NCT02907619|448363449|FG001|Overall Study|Other|1|||
124656693|NCT02907619|448363450|FG002|Overall Study|Other|0|||
124656694|NCT04942210|448363456|FG000|Overall Study|Adverse Event|0|||
124656695|NCT04942210|448363457|FG001|Overall Study|Adverse Event|1|||
124656696|NCT04942210|448363456|FG000|Overall Study|Protocol Deviation|4|||
124656697|NCT04942210|448363457|FG001|Overall Study|Protocol Deviation|1|||
124656698|NCT04942210|448363456|FG000|Overall Study|Withdrawal by Subject|5|||
124656699|NCT04942210|448363457|FG001|Overall Study|Withdrawal by Subject|2|||
124656700|NCT04942210|448363456|FG000|Overall Study|Lost to Follow-up|16|||
124656701|NCT04942210|448363457|FG001|Overall Study|Lost to Follow-up|7|||
124656702|NCT04942210|448363456|FG000|Overall Study|Ongoing at the time of DBL date|60|||
124656703|NCT04942210|448363457|FG001|Overall Study|Ongoing at the time of DBL date|25|||
124656704|NCT04942210|448363456|FG000|Overall Study|Randomized but did not receive vaccination|3|||
124656705|NCT04942210|448363457|FG001|Overall Study|Randomized but did not receive vaccination|0|||
124656706|NCT05697627|448363462|FG000|Overall Study|Adverse Event|1|||
124656707|NCT02570750|448363463|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
124656708|NCT02570750|448363464|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
124656709|NCT02570750|448363463|FG000|Overall Study|Protocol deviation|4|||
124656710|NCT02570750|448363464|FG001|Overall Study|Protocol deviation|2|||
124656711|NCT02570750|448363463|FG000|Overall Study|Withdrawal by Subject|5|||
124656712|NCT02570750|448363464|FG001|Overall Study|Withdrawal by Subject|0|||
124656713|NCT02570750|448363463|FG000|Overall Study|Lost to Follow-up|2|||
124656714|NCT02570750|448363464|FG001|Overall Study|Lost to Follow-up|2|||
124656715|NCT02570750|448363463|FG000|Overall Study|Adverse Event|2|||
124656716|NCT02570750|448363464|FG001|Overall Study|Adverse Event|1|||
124656717|NCT01410240|448363465|FG000|Overall Study|Physician Decision|0|||
124656718|NCT01410240|448363466|FG001|Overall Study|Physician Decision|0|||
124656719|NCT01410240|448363467|FG002|Overall Study|Physician Decision|1|||
124656720|NCT01410240|448363465|FG000|Overall Study|Missed week 6 assessments|1|||
124656721|NCT01410240|448363466|FG001|Overall Study|Missed week 6 assessments|1|||
124656722|NCT01410240|448363467|FG002|Overall Study|Missed week 6 assessments|1|||
124656723|NCT02722746|448363472|FG000|Overall Study|Withdrawal by Subject|0|||
124656724|NCT02722746|448363473|FG001|Overall Study|Withdrawal by Subject|1|||
124656725|NCT02722746|448363474|FG002|Overall Study|Withdrawal by Subject|0|||
124656726|NCT02722746|448363472|FG000|Overall Study|Protocol Violation|8|||
124656727|NCT02722746|448363473|FG001|Overall Study|Protocol Violation|4|||
124656728|NCT02722746|448363474|FG002|Overall Study|Protocol Violation|6|||
124656729|NCT02636699|448363481|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
124656730|NCT02636699|448363482|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
124656731|NCT02636699|448363483|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
124656732|NCT02636699|448363481|FG000|Screening Period|Withdrawal by Subject|0|||
124656733|NCT02636699|448363482|FG001|Screening Period|Withdrawal by Subject|0|||
124656734|NCT02636699|448363483|FG002|Screening Period|Withdrawal by Subject|23|||
124656735|NCT02636699|448363481|FG000|Screening Period|Adverse Event|0|||
124656736|NCT02636699|448363482|FG001|Screening Period|Adverse Event|0|||
124656737|NCT02636699|448363483|FG002|Screening Period|Adverse Event|1|||
124656738|NCT02636699|448363481|FG000|Screening Period|Other not specified|0|||
124656739|NCT02636699|448363482|FG001|Screening Period|Other not specified|0|||
124656740|NCT02636699|448363483|FG002|Screening Period|Other not specified|3|||
124656741|NCT02636699|448363481|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
124656742|NCT02636699|448363482|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
124656743|NCT02636699|448363483|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
124656744|NCT02636699|448363481|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
124656745|NCT02636699|448363482|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
124656746|NCT02636699|448363483|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
124656747|NCT02636699|448363481|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
124656748|NCT02636699|448363482|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
124656749|NCT02636699|448363483|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
124656750|NCT02636699|448363481|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
124656751|NCT02636699|448363482|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
124656752|NCT02636699|448363483|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
124656753|NCT02636699|448363481|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
124656754|NCT02636699|448363482|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
124656755|NCT02636699|448363483|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
124656756|NCT02636699|448363481|FG000|Treatment and Follow-up Periods|Other|3|||
124656757|NCT02636699|448363482|FG001|Treatment and Follow-up Periods|Other|1|||
124656758|NCT02636699|448363483|FG002|Treatment and Follow-up Periods|Other|0|||
124656759|NCT01134263|448363486|FG000|Overall Study|Serious adverse event|2|||
124656760|NCT01134263|448363487|FG001|Overall Study|Serious adverse event|1|||
124656761|NCT01134263|448363488|FG002|Overall Study|Serious adverse event|1|||
124656762|NCT01134263|448363489|FG003|Overall Study|Serious adverse event|1|||
124656763|NCT01134263|448363490|FG004|Overall Study|Serious adverse event|1|||
124656764|NCT01134263|448363486|FG000|Overall Study|Other adverse event|1|||
124656765|NCT01134263|448363487|FG001|Overall Study|Other adverse event|2|||
124656766|NCT01134263|448363488|FG002|Overall Study|Other adverse event|5|||
124656767|NCT01134263|448363489|FG003|Overall Study|Other adverse event|3|||
124656768|NCT01134263|448363490|FG004|Overall Study|Other adverse event|0|||
124656769|NCT01134263|448363486|FG000|Overall Study|Protocol Violation|8|||
124656770|NCT01134263|448363487|FG001|Overall Study|Protocol Violation|7|||
124656771|NCT01134263|448363488|FG002|Overall Study|Protocol Violation|2|||
124656772|NCT01134263|448363489|FG003|Overall Study|Protocol Violation|4|||
124656773|NCT01134263|448363490|FG004|Overall Study|Protocol Violation|2|||
124656774|NCT01134263|448363486|FG000|Overall Study|Lost to Follow-up|4|||
124656775|NCT01134263|448363487|FG001|Overall Study|Lost to Follow-up|3|||
124656776|NCT01134263|448363488|FG002|Overall Study|Lost to Follow-up|5|||
124656777|NCT01134263|448363489|FG003|Overall Study|Lost to Follow-up|3|||
124656778|NCT01134263|448363490|FG004|Overall Study|Lost to Follow-up|1|||
124656779|NCT01134263|448363486|FG000|Overall Study|Withdrawal by Subject|8|||
124656780|NCT01134263|448363487|FG001|Overall Study|Withdrawal by Subject|6|||
124656781|NCT01134263|448363488|FG002|Overall Study|Withdrawal by Subject|16|||
124656782|NCT01134263|448363489|FG003|Overall Study|Withdrawal by Subject|7|||
124656783|NCT01134263|448363490|FG004|Overall Study|Withdrawal by Subject|5|||
124656784|NCT01134263|448363486|FG000|Overall Study|Enrolled, but not treated|1|||
124656785|NCT01134263|448363487|FG001|Overall Study|Enrolled, but not treated|1|||
124656786|NCT01134263|448363488|FG002|Overall Study|Enrolled, but not treated|0|||
124656787|NCT01134263|448363489|FG003|Overall Study|Enrolled, but not treated|1|||
124656788|NCT01134263|448363490|FG004|Overall Study|Enrolled, but not treated|0|||
124656789|NCT02305446|448363497|FG000|Overall Study|Adverse Event|1|||
124656790|NCT01636947|448363498|FG000|Overall Study|Not Treated|2|||
124656791|NCT01636947|448363499|FG001|Overall Study|Not Treated|2|||
124656792|NCT01636947|448363498|FG000|Overall Study|Lost to Follow-up|4|||
124656793|NCT01636947|448363499|FG001|Overall Study|Lost to Follow-up|0|||
124656794|NCT01636947|448363498|FG000|Overall Study|Protocol Violation|1|||
124656795|NCT01636947|448363499|FG001|Overall Study|Protocol Violation|1|||
124656796|NCT01636947|448363498|FG000|Overall Study|Withdrawal by Subject|3|||
124656797|NCT01636947|448363499|FG001|Overall Study|Withdrawal by Subject|3|||
124656798|NCT01636947|448363498|FG000|Overall Study|Adverse Event|1|||
124656799|NCT01636947|448363499|FG001|Overall Study|Adverse Event|1|||
124656800|NCT01636947|448363498|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
124656801|NCT01636947|448363499|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
124656802|NCT00957424|448363500|FG000|Overall Study|Lost to Follow-up|19|||
124656803|NCT00957424|448363500|FG000|Overall Study|Protocol Violation|3|||
124656804|NCT00957424|448363500|FG000|Overall Study|Withdrawal by Subject|1|||
124656805|NCT00369161|448363504|FG000|Overall Study|Adverse Event|15|||
124656806|NCT00369161|448363505|FG001|Overall Study|Adverse Event|13|||
124656807|NCT00369161|448363504|FG000|Overall Study|Abnormal laboratory value|0|||
124656808|NCT00369161|448363505|FG001|Overall Study|Abnormal laboratory value|1|||
124656809|NCT00369161|448363504|FG000|Overall Study|Lack of Efficacy|3|||
124656810|NCT00369161|448363505|FG001|Overall Study|Lack of Efficacy|1|||
124656811|NCT00369161|448363504|FG000|Overall Study|Protocol Violation|0|||
124656812|NCT00369161|448363505|FG001|Overall Study|Protocol Violation|2|||
124656813|NCT00369161|448363504|FG000|Overall Study|Withdrawal by Subject|2|||
124656814|NCT00369161|448363505|FG001|Overall Study|Withdrawal by Subject|3|||
124656815|NCT00369161|448363504|FG000|Overall Study|Death|1|||
124656816|NCT00369161|448363505|FG001|Overall Study|Death|2|||
124656817|NCT00369161|448363504|FG000|Overall Study|Graft loss|4|||
124656818|NCT00369161|448363505|FG001|Overall Study|Graft loss|0|||
124656819|NCT00369161|448363504|FG000|Overall Study|Administrative Problem|2|||
124656820|NCT00369161|448363505|FG001|Overall Study|Administrative Problem|2|||
124656821|NCT00750919|448363506|FG000|Overall Study|Adverse Event|9|||
124656822|NCT00750919|448363506|FG000|Overall Study|Withdrawal by Subject|1|||
124656823|NCT00750919|448363506|FG000|Overall Study|Lack of Efficacy|8|||
124656824|NCT00750919|448363506|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
124656825|NCT00750919|448363506|FG000|Overall Study|Other|36|||
124656826|NCT01404949|448363512|FG000|Overall Study|Not Treated|1|||
124656827|NCT03411902|448363515|FG000|Overall Study|Lost to Follow-up|3|||
124656828|NCT03411902|448363516|FG001|Overall Study|Lost to Follow-up|0|||
124656829|NCT01017601|448363517|FG000|Overall Study|Disease Progression|12|||
124656830|NCT01017601|448363518|FG001|Overall Study|Disease Progression|12|||
124656831|NCT01017601|448363517|FG000|Overall Study|Withdrawal by Subject|0|||
124656832|NCT01017601|448363518|FG001|Overall Study|Withdrawal by Subject|1|||
124656833|NCT00803205|448363519|FG000|Overall Study|Adverse Event|7|||
124656834|NCT00803205|448363520|FG001|Overall Study|Adverse Event|2|||
124656835|NCT00803205|448363519|FG000|Overall Study|Lost to Follow-up|1|||
124656836|NCT00803205|448363520|FG001|Overall Study|Lost to Follow-up|0|||
124656837|NCT00803205|448363519|FG000|Overall Study|Withdrawal by Subject|9|||
124656838|NCT00803205|448363520|FG001|Overall Study|Withdrawal by Subject|9|||
124656839|NCT00803205|448363519|FG000|Overall Study|Physician Decision|1|||
124656840|NCT00803205|448363520|FG001|Overall Study|Physician Decision|0|||
124656841|NCT00803205|448363519|FG000|Overall Study|Protocol Violation|1|||
124656842|NCT00803205|448363520|FG001|Overall Study|Protocol Violation|1|||
124656843|NCT00803205|448363519|FG000|Overall Study|Medical Monitor Decision|1|||
124656844|NCT00803205|448363520|FG001|Overall Study|Medical Monitor Decision|0|||
124656845|NCT00803205|448363519|FG000|Overall Study|Acquired a Lung Infection|0|||
124656846|NCT00803205|448363520|FG001|Overall Study|Acquired a Lung Infection|1|||
124656847|NCT00803205|448363519|FG000|Overall Study|Sponsor Decision|0|||
124656848|NCT00803205|448363520|FG001|Overall Study|Sponsor Decision|1|||
124656849|NCT00379808|448363521|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
124656850|NCT00379808|448363522|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
124656851|NCT04907227|448363528|FG000|Overall Study|Death|12|||
124656852|NCT04907227|448363529|FG001|Overall Study|Death|8|||
124656853|NCT04907227|448363528|FG000|Overall Study|Withdrawal by Subject|2|||
124656854|NCT04907227|448363529|FG001|Overall Study|Withdrawal by Subject|2|||
124656855|NCT04907227|448363528|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
124656856|NCT04907227|448363529|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
124656857|NCT04907227|448363528|FG000|Overall Study|Sponsor Decision|25|||
124656858|NCT04907227|448363529|FG001|Overall Study|Sponsor Decision|30|||
124656859|NCT04907227|448363528|FG000|Overall Study|Physician Decision|1|||
124656860|NCT04907227|448363529|FG001|Overall Study|Physician Decision|0|||
124656861|NCT02240069|448363530|FG000|Overall Study|Withdrawal by Subject|5|||
124656862|NCT02240069|448363531|FG001|Overall Study|Withdrawal by Subject|5|||
124656863|NCT02240069|448363532|FG002|Overall Study|Withdrawal by Subject|2|||
124656864|NCT03723070|448363533|FG000|Overall Study|Lost to Follow-up|2|||
124656865|NCT03723070|448363533|FG000|Overall Study|Physician Decision|1|||
124656866|NCT03723070|448363533|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
124656867|NCT01810783|448363534|FG000|Overall Study|Adverse Event|32|||
124656868|NCT01810783|448363534|FG000|Overall Study|Withdrawal by Subject|22|||
124656869|NCT01810783|448363534|FG000|Overall Study|Lack of Efficacy|12|||
124656870|NCT01810783|448363534|FG000|Overall Study|Lost to Follow-up|10|||
124656871|NCT01810783|448363534|FG000|Overall Study|Protocol Violation|5|||
124656872|NCT01810783|448363534|FG000|Overall Study|Non-compliance with IMP|4|||
124656873|NCT01810783|448363534|FG000|Overall Study|Adminstrative or other reason(s)|23|||
124656874|NCT01810783|448363534|FG000|Overall Study|Enrolled, not treated|1|||
124656875|NCT02208050|448363537|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
124656876|NCT02208050|448363538|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
124656877|NCT02134353|448363539|FG000|Overall Study|Adverse Event|10|||
124656878|NCT02134353|448363540|FG001|Overall Study|Adverse Event|6|||
124656879|NCT02134353|448363539|FG000|Overall Study|Lost to Follow-up|1|||
124656880|NCT02134353|448363540|FG001|Overall Study|Lost to Follow-up|1|||
124656881|NCT02134353|448363539|FG000|Overall Study|Lack of Efficacy|2|||
124656882|NCT02134353|448363540|FG001|Overall Study|Lack of Efficacy|1|||
124656883|NCT02134353|448363539|FG000|Overall Study|Withdrawal by Subject|12|||
124656884|NCT02134353|448363540|FG001|Overall Study|Withdrawal by Subject|13|||
124656885|NCT02134353|448363539|FG000|Overall Study|Death|0|||
124656886|NCT02134353|448363540|FG001|Overall Study|Death|1|||
124656887|NCT02134353|448363539|FG000|Overall Study|Pregnancy|0|||
124656888|NCT02134353|448363540|FG001|Overall Study|Pregnancy|1|||
124656889|NCT02134353|448363539|FG000|Overall Study|Relocation|1|||
124656890|NCT02134353|448363540|FG001|Overall Study|Relocation|0|||
124656891|NCT02134353|448363539|FG000|Overall Study|Other - Patient's Choice|0|||
124656892|NCT02134353|448363540|FG001|Overall Study|Other - Patient's Choice|1|||
124656893|NCT00477607|448363542|FG000|Overall Study|Lost to Follow-up|7|||
124656894|NCT00477607|448363543|FG001|Overall Study|Lost to Follow-up|7|||
124656895|NCT00474786|448363544|FG000|Overall Study|Not Meeting Study Criteria|0|||
124656896|NCT00474786|448363545|FG001|Overall Study|Not Meeting Study Criteria|1|||
124656897|NCT00474786|448363544|FG000|Overall Study|Investigator Request|2|||
124656898|NCT00474786|448363545|FG001|Overall Study|Investigator Request|1|||
124656899|NCT00474786|448363544|FG000|Overall Study|Death|189|||
124656900|NCT00474786|448363545|FG001|Overall Study|Death|170|||
124656901|NCT00474786|448363544|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
124656902|NCT00474786|448363545|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
124656903|NCT00474786|448363544|FG000|Overall Study|Lost to Follow-up|4|||
124656904|NCT00474786|448363545|FG001|Overall Study|Lost to Follow-up|7|||
124656905|NCT00474786|448363544|FG000|Overall Study|Protocol Violation|2|||
124656906|NCT00474786|448363545|FG001|Overall Study|Protocol Violation|0|||
124656907|NCT00474786|448363544|FG000|Overall Study|Withdrawal by Subject|15|||
124656908|NCT00474786|448363545|FG001|Overall Study|Withdrawal by Subject|15|||
124656909|NCT00474786|448363544|FG000|Overall Study|Other|5|||
124656910|NCT00474786|448363545|FG001|Overall Study|Other|0|||
124656911|NCT00358956|448363546|FG000|Overall Study|Adverse Event|3|||
124656912|NCT00358956|448363546|FG000|Overall Study|condition under investigation worsened|4|||
124656913|NCT00358956|448363546|FG000|Overall Study|Withdrawal by Subject|1|||
124656914|NCT02578940|448364683|FG000|Overall Study|Screening failure|5|||
124656915|NCT02578940|448364683|FG000|Overall Study|Lost to Follow-up|1|||
124656916|NCT05182606|448364690|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
124656917|NCT01955109|448364693|FG000|Overall Study|Adverse Event|2|||
124656918|NCT01955109|448364694|FG001|Overall Study|Adverse Event|0|||
124656919|NCT01955109|448364693|FG000|Overall Study|Participant unwilling to continue|35|||
124656920|NCT01955109|448364694|FG001|Overall Study|Participant unwilling to continue|7|||
124656921|NCT01955109|448364693|FG000|Overall Study|Physician Decision|2|||
124656922|NCT01955109|448364694|FG001|Overall Study|Physician Decision|0|||
124656923|NCT01955109|448364693|FG000|Overall Study|Lost to Follow-up|3|||
124656924|NCT01955109|448364694|FG001|Overall Study|Lost to Follow-up|1|||
124656925|NCT01955109|448364693|FG000|Overall Study|Non-compliance|3|||
124656926|NCT01955109|448364694|FG001|Overall Study|Non-compliance|1|||
124656927|NCT01618916|448364696|FG000|Overall Study|Adverse Event|1|||
124656928|NCT01618916|448364697|FG001|Overall Study|Adverse Event|0|||
124656929|NCT01618916|448364698|FG002|Overall Study|Adverse Event|0|||
124656930|NCT01618916|448364699|FG003|Overall Study|Adverse Event|0|||
124656931|NCT01618916|448364700|FG004|Overall Study|Adverse Event|0|||
124656932|NCT01618916|448364701|FG005|Overall Study|Adverse Event|0|||
124656933|NCT01618916|448364696|FG000|Overall Study|Withdrawal by Subject|0|||
124656934|NCT01618916|448364697|FG001|Overall Study|Withdrawal by Subject|1|||
124656935|NCT01618916|448364698|FG002|Overall Study|Withdrawal by Subject|1|||
124656936|NCT01618916|448364699|FG003|Overall Study|Withdrawal by Subject|0|||
124656937|NCT01618916|448364700|FG004|Overall Study|Withdrawal by Subject|1|||
124656938|NCT01618916|448364701|FG005|Overall Study|Withdrawal by Subject|0|||
124656939|NCT01618916|448364696|FG000|Overall Study|Lost to Follow-up|1|||
124656940|NCT01618916|448364697|FG001|Overall Study|Lost to Follow-up|0|||
124656941|NCT01618916|448364698|FG002|Overall Study|Lost to Follow-up|0|||
124656942|NCT01618916|448364699|FG003|Overall Study|Lost to Follow-up|2|||
124656943|NCT01618916|448364700|FG004|Overall Study|Lost to Follow-up|0|||
124656944|NCT01618916|448364701|FG005|Overall Study|Lost to Follow-up|0|||
124656945|NCT04521114|448364702|FG000|Overall Study|Lost to Follow-up|1|||
124656946|NCT04521114|448364703|FG001|Overall Study|Lost to Follow-up|2|||
124656947|NCT04521114|448364704|FG002|Overall Study|Lost to Follow-up|0|||
124656948|NCT04521114|448364702|FG000|Overall Study|Withdrawal by Subject|1|||
124656949|NCT04521114|448364703|FG001|Overall Study|Withdrawal by Subject|2|||
124656950|NCT04521114|448364704|FG002|Overall Study|Withdrawal by Subject|2|||
124656951|NCT04521114|448364702|FG000|Overall Study|Adverse Event|1|||
124656952|NCT04521114|448364703|FG001|Overall Study|Adverse Event|0|||
124656953|NCT04521114|448364704|FG002|Overall Study|Adverse Event|0|||
124656954|NCT04521114|448364702|FG000|Overall Study|Sponsor Wish|1|||
124656955|NCT04521114|448364703|FG001|Overall Study|Sponsor Wish|0|||
124656956|NCT04521114|448364704|FG002|Overall Study|Sponsor Wish|0|||
124656957|NCT04521114|448364702|FG000|Overall Study|Withdrawal of Consent|2|||
124656958|NCT04521114|448364703|FG001|Overall Study|Withdrawal of Consent|2|||
124656959|NCT04521114|448364704|FG002|Overall Study|Withdrawal of Consent|0|||
124656960|NCT00438256|448364707|FG000|Overall Study|Ineligible for Resection|2|||
124656961|NCT00438256|448364708|FG001|Overall Study|Ineligible for Resection|1|||
124544302|NCT05182840|447946750|FG002|Treatment Period|Adverse Event|4|||
124656962|NCT00438256|448364709|FG002|Overall Study|Ineligible for Resection|1|||
124656963|NCT00438256|448364710|FG003|Overall Study|Ineligible for Resection|7|||
124656964|NCT00438256|448364707|FG000|Overall Study|Excluded final Diagnosis|0|||
124656965|NCT00438256|448364708|FG001|Overall Study|Excluded final Diagnosis|0|||
124656966|NCT00438256|448364709|FG002|Overall Study|Excluded final Diagnosis|0|||
124656967|NCT00438256|448364710|FG003|Overall Study|Excluded final Diagnosis|2|||
124656968|NCT01133288|448364711|FG000|Eligibility Assessment|met exclusion criteria|5|||
124656969|NCT01133288|448364711|FG000|Intervention Allocation|study terminated|2|||
124656970|NCT00380718|448364720|FG000|Overall Study|Adverse Event|1|||
124656971|NCT00380718|448364720|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
124656972|NCT01094782|448364721|FG000|Overall Study|Withdrawal by Subject|5|||
124656973|NCT01094782|448364722|FG001|Overall Study|Withdrawal by Subject|5|||
124656974|NCT01094782|448364723|FG002|Overall Study|Withdrawal by Subject|1|||
124656975|NCT01094782|448364724|FG003|Overall Study|Withdrawal by Subject|5|||
124656976|NCT01094782|448364725|FG004|Overall Study|Withdrawal by Subject|5|||
124656977|NCT01094782|448364726|FG005|Overall Study|Withdrawal by Subject|0|||
124656978|NCT01094782|448364721|FG000|Overall Study|Lost to Follow-up|1|||
124656979|NCT01094782|448364722|FG001|Overall Study|Lost to Follow-up|0|||
124656980|NCT01094782|448364723|FG002|Overall Study|Lost to Follow-up|0|||
124656981|NCT01094782|448364724|FG003|Overall Study|Lost to Follow-up|2|||
124656982|NCT01094782|448364725|FG004|Overall Study|Lost to Follow-up|1|||
124656983|NCT01094782|448364726|FG005|Overall Study|Lost to Follow-up|4|||
124656984|NCT01094782|448364721|FG000|Overall Study|Positive Drug Screen|2|||
124656985|NCT01094782|448364722|FG001|Overall Study|Positive Drug Screen|2|||
124656986|NCT01094782|448364723|FG002|Overall Study|Positive Drug Screen|1|||
124656987|NCT01094782|448364724|FG003|Overall Study|Positive Drug Screen|1|||
124656988|NCT01094782|448364725|FG004|Overall Study|Positive Drug Screen|3|||
124656989|NCT01094782|448364726|FG005|Overall Study|Positive Drug Screen|2|||
124656990|NCT01094782|448364721|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
124656991|NCT01094782|448364722|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
124656992|NCT01094782|448364723|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
124656993|NCT01094782|448364724|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
124656994|NCT01094782|448364725|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
124656995|NCT01094782|448364726|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
124656996|NCT01094782|448364721|FG000|Overall Study|Unable to Complete Questionnaires|0|||
124656997|NCT01094782|448364722|FG001|Overall Study|Unable to Complete Questionnaires|1|||
124656998|NCT01094782|448364723|FG002|Overall Study|Unable to Complete Questionnaires|0|||
124656999|NCT01094782|448364724|FG003|Overall Study|Unable to Complete Questionnaires|0|||
124657000|NCT01094782|448364725|FG004|Overall Study|Unable to Complete Questionnaires|0|||
124657001|NCT01094782|448364726|FG005|Overall Study|Unable to Complete Questionnaires|0|||
124657002|NCT01094782|448364721|FG000|Overall Study|Healthy Subject Had Pain|0|||
124657003|NCT01094782|448364722|FG001|Overall Study|Healthy Subject Had Pain|1|||
124657004|NCT01094782|448364723|FG002|Overall Study|Healthy Subject Had Pain|0|||
124657005|NCT01094782|448364724|FG003|Overall Study|Healthy Subject Had Pain|0|||
124657006|NCT01094782|448364725|FG004|Overall Study|Healthy Subject Had Pain|0|||
124657007|NCT01094782|448364726|FG005|Overall Study|Healthy Subject Had Pain|0|||
124657008|NCT01094782|448364721|FG000|Overall Study|Hypertension|0|||
124657009|NCT01094782|448364722|FG001|Overall Study|Hypertension|0|||
124657010|NCT01094782|448364723|FG002|Overall Study|Hypertension|1|||
124657011|NCT01094782|448364724|FG003|Overall Study|Hypertension|0|||
124657012|NCT01094782|448364725|FG004|Overall Study|Hypertension|0|||
124657013|NCT01094782|448364726|FG005|Overall Study|Hypertension|0|||
124657014|NCT01094782|448364721|FG000|Overall Study|Wrong Pain Condition|0|||
124657015|NCT01094782|448364722|FG001|Overall Study|Wrong Pain Condition|0|||
124657016|NCT01094782|448364723|FG002|Overall Study|Wrong Pain Condition|0|||
124657017|NCT01094782|448364724|FG003|Overall Study|Wrong Pain Condition|2|||
124657018|NCT01094782|448364725|FG004|Overall Study|Wrong Pain Condition|1|||
124657019|NCT01094782|448364726|FG005|Overall Study|Wrong Pain Condition|1|||
124657020|NCT01094782|448364721|FG000|Overall Study|Recent Interventional Injection|0|||
124657021|NCT01094782|448364722|FG001|Overall Study|Recent Interventional Injection|0|||
124657022|NCT01094782|448364723|FG002|Overall Study|Recent Interventional Injection|0|||
124657023|NCT01094782|448364724|FG003|Overall Study|Recent Interventional Injection|0|||
124657024|NCT01094782|448364725|FG004|Overall Study|Recent Interventional Injection|0|||
124657025|NCT01094782|448364726|FG005|Overall Study|Recent Interventional Injection|1|||
124657026|NCT01094782|448364721|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
124657027|NCT01094782|448364722|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
124657028|NCT01094782|448364723|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
124657029|NCT01094782|448364724|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
124657030|NCT01094782|448364725|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
124657031|NCT01094782|448364726|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
124657032|NCT01094782|448364721|FG000|Overall Study|Noncompliance With Study Schedule|0|||
124657033|NCT01094782|448364722|FG001|Overall Study|Noncompliance With Study Schedule|0|||
124657034|NCT01094782|448364723|FG002|Overall Study|Noncompliance With Study Schedule|0|||
124657035|NCT01094782|448364724|FG003|Overall Study|Noncompliance With Study Schedule|1|||
124657036|NCT01094782|448364725|FG004|Overall Study|Noncompliance With Study Schedule|0|||
124657037|NCT01094782|448364726|FG005|Overall Study|Noncompliance With Study Schedule|0|||
124657038|NCT02912455|448364727|FG000|Overall Study|Withdrawal by Subject|0|||
124657039|NCT02912455|448364728|FG001|Overall Study|Withdrawal by Subject|1|||
124657040|NCT02912455|448364727|FG000|Overall Study|Lack of Efficacy|0|||
124657041|NCT02912455|448364728|FG001|Overall Study|Lack of Efficacy|1|||
124657042|NCT02912455|448364727|FG000|Overall Study|Lost to Follow-up|2|||
124657043|NCT02912455|448364728|FG001|Overall Study|Lost to Follow-up|1|||
124657044|NCT00957905|448364735|FG000|Part B|Not Treated|0|||
124657045|NCT00957905|448364736|FG001|Part B|Not Treated|1|||
124657046|NCT00957905|448364735|FG000|Part B|Physician Decision|0|||
124657047|NCT00957905|448364736|FG001|Part B|Physician Decision|1|||
124657048|NCT00957905|448364735|FG000|Part B|Death|0|||
124657049|NCT00957905|448364736|FG001|Part B|Death|1|||
124657050|NCT00957905|448364735|FG000|Part B|Protocol Violation|0|||
124657051|NCT00957905|448364736|FG001|Part B|Protocol Violation|1|||
124657052|NCT02073656|448364737|FG000|Primary Study|Lost to Follow-up|6|||
124657053|NCT02073656|448364737|FG000|Primary Study|Death|1|||
124657054|NCT02073656|448364737|FG000|Primary Study|Withdrew Consent|1|||
124657055|NCT01048099|448364743|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
124657056|NCT01048099|448364743|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
124657057|NCT00508157|448364744|FG000|Overall Study|Adverse Event|0|||
124657058|NCT00508157|448364745|FG001|Overall Study|Adverse Event|1|||
124657059|NCT00508157|448364744|FG000|Overall Study|Subject Withdrew Consent|1|||
124657060|NCT00508157|448364745|FG001|Overall Study|Subject Withdrew Consent|0|||
124657061|NCT00508157|448364744|FG000|Overall Study|Lost to Follow-up|1|||
124657062|NCT00508157|448364745|FG001|Overall Study|Lost to Follow-up|0|||
124657063|NCT00508157|448364744|FG000|Overall Study|Subject no longer met study criteria|0|||
124657064|NCT00508157|448364745|FG001|Overall Study|Subject no longer met study criteria|1|||
124657065|NCT00508157|448364744|FG000|Overall Study|Other known cause|0|||
124657066|NCT00508157|448364745|FG001|Overall Study|Other known cause|1|||
124657067|NCT01625689|448364748|FG000|Overall Study|Migration|2|||
124657068|NCT01625689|448364749|FG001|Overall Study|Migration|1|||
124657069|NCT00106639|448364750|FG000|Overall Study|Adverse Event|3|||
124657070|NCT00106639|448364751|FG001|Overall Study|Adverse Event|4|||
124657071|NCT00106639|448364752|FG002|Overall Study|Adverse Event|1|||
124657072|NCT00106639|448364750|FG000|Overall Study|Protocol Violation|0|||
124657073|NCT00106639|448364751|FG001|Overall Study|Protocol Violation|1|||
124657074|NCT00106639|448364752|FG002|Overall Study|Protocol Violation|0|||
124657075|NCT00106639|448364750|FG000|Overall Study|Withdrawal by Subject|0|||
124657076|NCT00106639|448364751|FG001|Overall Study|Withdrawal by Subject|1|||
124657077|NCT00106639|448364752|FG002|Overall Study|Withdrawal by Subject|0|||
124657078|NCT00106639|448364750|FG000|Overall Study|Participant defaulted|0|||
124657079|NCT00106639|448364751|FG001|Overall Study|Participant defaulted|1|||
124657080|NCT00106639|448364752|FG002|Overall Study|Participant defaulted|1|||
124657081|NCT00594386|448364754|FG000|Overall Study|Major protocol violation|2|||
124657082|NCT00594386|448364754|FG000|Overall Study|Lack of Efficacy|12|||
124657083|NCT00594386|448364754|FG000|Overall Study|Adverse Event|68|||
124657084|NCT00594386|448364754|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
124657085|NCT00594386|448364754|FG000|Overall Study|Subject withdrew consent|35|||
124657086|NCT00594386|448364754|FG000|Overall Study|Study ended per sponsor|115|||
124657087|NCT00594386|448364754|FG000|Overall Study|Lost to Follow-up|6|||
124657088|NCT00594386|448364754|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
124657089|NCT00594386|448364754|FG000|Overall Study|Other: Subject moved to Seattle|1|||
124657090|NCT00594386|448364754|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
124657091|NCT00594386|448364754|FG000|Overall Study|Other: Study terminated per investigator|2|||
124657092|NCT00594386|448364754|FG000|Overall Study|Other: Sponsor closure of study|1|||
124657093|NCT00594386|448364754|FG000|Overall Study|Other: Site terminated participation|1|||
124657094|NCT00594386|448364754|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
124544303|NCT05182840|447946751|FG003|Treatment Period|Adverse Event|16|||
124657095|NCT00594386|448364754|FG000|Overall Study|Other: Loss of drivers license|1|||
124657096|NCT01210144|448364757|FG000|Overall Study|Lack of ovarian response|1|||
124657097|NCT01210144|448364758|FG001|Overall Study|Lack of ovarian response|0|||
124657098|NCT01210144|448364757|FG000|Overall Study|No fertilization|1|||
124657099|NCT01210144|448364758|FG001|Overall Study|No fertilization|0|||
124657100|NCT01210144|448364757|FG000|Overall Study|No transfer|1|||
124657101|NCT01210144|448364758|FG001|Overall Study|No transfer|0|||
124657102|NCT00094536|448364763|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
124657103|NCT00094536|448364763|FG000|Treatment and Follow-up|Adverse Event|4|||
124657104|NCT00094536|448364763|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
124657105|NCT00094536|448364763|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
124657106|NCT00094536|448364763|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
124657107|NCT00094536|448364763|FG000|Treatment and Follow-up|Subject non-compliance|9|||
124657108|NCT00094536|448364763|FG000|Treatment and Follow-up|Unable to attend visits|1|||
124657109|NCT00494221|448364764|FG000|Overall Study|Death|15|||
124657110|NCT00494221|448364765|FG001|Overall Study|Death|9|||
124657111|NCT00494221|448364766|FG002|Overall Study|Death|14|||
124657112|NCT00494221|448364764|FG000|Overall Study|Withdrawal by Subject|1|||
124657113|NCT00494221|448364765|FG001|Overall Study|Withdrawal by Subject|2|||
124657114|NCT00494221|448364766|FG002|Overall Study|Withdrawal by Subject|0|||
124657115|NCT01900431|448364771|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
124657116|NCT01900431|448364772|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
124657117|NCT01900431|448364773|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
124657118|NCT01900431|448364771|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
124657119|NCT01900431|448364772|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
124657120|NCT01900431|448364773|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
124657121|NCT01900431|448364771|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
124657122|NCT01900431|448364772|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
124657123|NCT01900431|448364773|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
124657124|NCT01900431|448364771|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
124657125|NCT01900431|448364772|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
124657126|NCT01900431|448364773|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
124657127|NCT01900431|448364771|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
124657128|NCT01900431|448364772|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
124657129|NCT01900431|448364773|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
124657130|NCT01900431|448364771|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
124657131|NCT01900431|448364772|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
124657132|NCT01900431|448364773|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
124657133|NCT01900431|448364771|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
124657134|NCT01900431|448364772|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
124657135|NCT01900431|448364773|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
124657136|NCT01900431|448364771|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
124657137|NCT01900431|448364772|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
124657138|NCT01900431|448364773|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
124657139|NCT01900431|448364771|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
124657140|NCT01900431|448364772|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
124657141|NCT01900431|448364773|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
124657142|NCT03755518|448364774|FG000|Overall Study|Lack of Efficacy|10|||
124657143|NCT03755518|448364774|FG000|Overall Study|Adverse Event|7|||
124657144|NCT03755518|448364774|FG000|Overall Study|Study Terminated by Sponsor|5|||
124657145|NCT03755518|448364774|FG000|Overall Study|Death|1|||
124657146|NCT03755518|448364774|FG000|Overall Study|Withdrawal by Subject|3|||
124657147|NCT03755518|448364774|FG000|Overall Study|Progressive Disease|4|||
124657148|NCT03755518|448364774|FG000|Overall Study|Bone Marrow Transplant|4|||
124657149|NCT03755518|448364774|FG000|Overall Study|Physicians Decision|1|||
124657150|NCT03755518|448364774|FG000|Overall Study|Relapse|1|||
124657151|NCT03755518|448364774|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
124657152|NCT03755518|448364774|FG000|Overall Study|Withdrawal by PI|1|||
124657153|NCT03172364|448364775|FG000|Overall Study|Adverse Event|1|||
124657154|NCT03172364|448364776|FG001|Overall Study|Adverse Event|1|||
124657155|NCT03172364|448364775|FG000|Overall Study|Protocol Violation|1|||
124657156|NCT03172364|448364776|FG001|Overall Study|Protocol Violation|0|||
124657157|NCT01714609|448364777|FG000|Overall Study|Protocol Violation|1|||
124657158|NCT01714609|448364778|FG001|Overall Study|Protocol Violation|0|||
124657159|NCT00630747|448364779|FG000|Overall Study|Death|1|||
124657160|NCT00630747|448364779|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
124657161|NCT00630747|448364779|FG000|Overall Study|Returned to country of origin|1|||
124657162|NCT02306694|448364782|FG000|Overall Study|Withdrawal by Subject|3|||
124657163|NCT02306694|448364782|FG000|Overall Study|Lost to Follow-up|1|||
124657164|NCT00603382|448364783|FG000|Overall Study|Adverse Event|0|||
124657165|NCT00603382|448364784|FG001|Overall Study|Adverse Event|1|||
124657166|NCT00603382|448364785|FG002|Overall Study|Adverse Event|1|||
124657167|NCT00603382|448364786|FG003|Overall Study|Adverse Event|2|||
124657168|NCT00603382|448364787|FG004|Overall Study|Adverse Event|1|||
124657169|NCT00603382|448364788|FG005|Overall Study|Adverse Event|2|||
124657170|NCT00603382|448364783|FG000|Overall Study|Lack of Efficacy|14|||
124657171|NCT00603382|448364784|FG001|Overall Study|Lack of Efficacy|9|||
124657172|NCT00603382|448364785|FG002|Overall Study|Lack of Efficacy|3|||
124657173|NCT00603382|448364786|FG003|Overall Study|Lack of Efficacy|6|||
124657174|NCT00603382|448364787|FG004|Overall Study|Lack of Efficacy|6|||
124657175|NCT00603382|448364788|FG005|Overall Study|Lack of Efficacy|11|||
124657176|NCT00603382|448364783|FG000|Overall Study|Protocol Violation|1|||
124657177|NCT00603382|448364784|FG001|Overall Study|Protocol Violation|0|||
124657178|NCT00603382|448364785|FG002|Overall Study|Protocol Violation|1|||
124657179|NCT00603382|448364786|FG003|Overall Study|Protocol Violation|2|||
124657180|NCT00603382|448364787|FG004|Overall Study|Protocol Violation|1|||
124657181|NCT00603382|448364788|FG005|Overall Study|Protocol Violation|0|||
124657182|NCT00603382|448364783|FG000|Overall Study|Lost to Follow-up|0|||
124657183|NCT00603382|448364784|FG001|Overall Study|Lost to Follow-up|1|||
124657184|NCT00603382|448364785|FG002|Overall Study|Lost to Follow-up|1|||
124657185|NCT00603382|448364786|FG003|Overall Study|Lost to Follow-up|1|||
124657186|NCT00603382|448364787|FG004|Overall Study|Lost to Follow-up|0|||
124657187|NCT00603382|448364788|FG005|Overall Study|Lost to Follow-up|1|||
124657188|NCT00603382|448364783|FG000|Overall Study|Physician Decision|0|||
124657189|NCT00603382|448364784|FG001|Overall Study|Physician Decision|0|||
124657190|NCT00603382|448364785|FG002|Overall Study|Physician Decision|2|||
124657191|NCT00603382|448364786|FG003|Overall Study|Physician Decision|0|||
124657192|NCT00603382|448364787|FG004|Overall Study|Physician Decision|1|||
124657193|NCT00603382|448364788|FG005|Overall Study|Physician Decision|3|||
124657194|NCT00603382|448364783|FG000|Overall Study|Withdrawal by Subject|3|||
124657195|NCT00603382|448364784|FG001|Overall Study|Withdrawal by Subject|3|||
124657196|NCT00603382|448364785|FG002|Overall Study|Withdrawal by Subject|1|||
124657197|NCT00603382|448364786|FG003|Overall Study|Withdrawal by Subject|1|||
124657198|NCT00603382|448364787|FG004|Overall Study|Withdrawal by Subject|0|||
124657199|NCT00603382|448364788|FG005|Overall Study|Withdrawal by Subject|1|||
124657200|NCT00395642|448364789|FG000|Overall Study|Death|4|||
124657201|NCT00395642|448364789|FG000|Overall Study|Lost to Follow-up|1|||
124657202|NCT00395642|448364789|FG000|Overall Study|Physician Decision|7|||
124657203|NCT00395642|448364789|FG000|Overall Study|Withdrawal by Subject|1|||
124657204|NCT02012959|448364790|FG000|Treatment Phase A|Adverse Event|2|||
124657205|NCT02012959|448364791|FG001|Treatment Phase A|Adverse Event|0|||
124657206|NCT02012959|448364792|FG002|Treatment Phase A|Adverse Event|0|||
124657207|NCT02012959|448364793|FG003|Treatment Phase A|Adverse Event|0|||
124657208|NCT02012959|448364794|FG004|Treatment Phase A|Adverse Event|0|||
124657209|NCT02333383|448364797|FG000|Overall Study|Adalimumab discontinuation|21|||
124657210|NCT02333383|448364797|FG000|Overall Study|Lost to Follow-up|15|||
124657211|NCT02333383|448364797|FG000|Overall Study|Withdrawal by Subject|3|||
124657212|NCT02333383|448364797|FG000|Overall Study|Transfer to another hospital|2|||
124657213|NCT01905592|448364810|FG000|Overall Study|Disease Progression|51|||
124657214|NCT01905592|448364811|FG001|Overall Study|Disease Progression|110|||
124657215|NCT01905592|448364810|FG000|Overall Study|Toxicity|1|||
124657216|NCT01905592|448364811|FG001|Overall Study|Toxicity|16|||
124657217|NCT01905592|448364810|FG000|Overall Study|Physician Decision|0|||
124657218|NCT01905592|448364811|FG001|Overall Study|Physician Decision|2|||
124657219|NCT01905592|448364810|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
124657220|NCT01905592|448364811|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
124657221|NCT01905592|448364810|FG000|Overall Study|Protocol Violation|0|||
124657222|NCT01905592|448364811|FG001|Overall Study|Protocol Violation|1|||
124657223|NCT01905592|448364810|FG000|Overall Study|Sponsor's decision|1|||
124657224|NCT01905592|448364811|FG001|Overall Study|Sponsor's decision|1|||
124657225|NCT01905592|448364810|FG000|Overall Study|Not treated|7|||
124657226|NCT01905592|448364811|FG001|Overall Study|Not treated|3|||
124657227|NCT01905592|448364810|FG000|Overall Study|Withdrawal by Subject|10|||
124657228|NCT01905592|448364811|FG001|Overall Study|Withdrawal by Subject|2|||
124657229|NCT03089853|448366224|FG000|Overall Study|Lost to Follow-up|2|||
124657230|NCT03089853|448366225|FG001|Overall Study|Lost to Follow-up|1|||
124657231|NCT04114656|448366226|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
124657232|NCT04114656|448366227|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
124657233|NCT04114656|448366226|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
124657234|NCT04114656|448366227|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
124657235|NCT04114656|448366226|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
124657236|NCT04114656|448366227|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
124657237|NCT04114656|448366226|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
124657238|NCT04114656|448366227|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
124657239|NCT04114656|448366226|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
124657240|NCT04114656|448366227|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
124657241|NCT03326518|448366233|FG000|Overall Study|Protocol Violation|1|||
124657242|NCT03326518|448366234|FG001|Overall Study|Protocol Violation|0|||
124657243|NCT03326518|448366235|FG002|Overall Study|Protocol Violation|0|||
124657244|NCT03326518|448366233|FG000|Overall Study|Withdrawal by Subject|1|||
124657245|NCT03326518|448366234|FG001|Overall Study|Withdrawal by Subject|0|||
124657246|NCT03326518|448366235|FG002|Overall Study|Withdrawal by Subject|0|||
124657247|NCT03326518|448366233|FG000|Overall Study|Lost to Follow-up|1|||
124657248|NCT03326518|448366234|FG001|Overall Study|Lost to Follow-up|0|||
124657249|NCT03326518|448366235|FG002|Overall Study|Lost to Follow-up|1|||
124657250|NCT01375374|448366238|FG000|Overall Study|Adverse Event|1|||
124657251|NCT01908582|448366239|FG000|Period 2|Physician Decision|1|||
124657252|NCT01908582|448366239|FG000|Period 2|Withdrawal by Subject|1|||
124657253|NCT01108237|448366241|FG000|Overall Study|No alignment data|2|||
124657254|NCT01108237|448366242|FG001|Overall Study|No alignment data|15|||
124657255|NCT01108237|448366241|FG000|Overall Study|Did not meet criteria for analysis|7|||
124657256|NCT01108237|448366242|FG001|Overall Study|Did not meet criteria for analysis|0|||
124657257|NCT02065518|448366244|FG000|Overall Study|Lost to Follow-up|3|||
124657258|NCT02065518|448366245|FG001|Overall Study|Lost to Follow-up|4|||
124657259|NCT02065518|448366246|FG002|Overall Study|Lost to Follow-up|0|||
124657260|NCT02065518|448366247|FG003|Overall Study|Lost to Follow-up|3|||
124657261|NCT02065518|448366244|FG000|Overall Study|Withdrawal by Subject|3|||
124657262|NCT02065518|448366245|FG001|Overall Study|Withdrawal by Subject|4|||
124657263|NCT02065518|448366246|FG002|Overall Study|Withdrawal by Subject|9|||
124657264|NCT02065518|448366247|FG003|Overall Study|Withdrawal by Subject|2|||
124657265|NCT03484403|448366250|FG000|Overall Study|Withdrawal by Subject|6|||
124657266|NCT03484403|448366251|FG001|Overall Study|Withdrawal by Subject|4|||
124657267|NCT02131636|448366252|FG000|Overall Study|Personal Reasons|4|||
124657268|NCT02131636|448366253|FG001|Overall Study|Personal Reasons|4|||
124657269|NCT02131636|448366252|FG000|Overall Study|Lost to Follow-up|4|||
124657270|NCT02131636|448366253|FG001|Overall Study|Lost to Follow-up|0|||
124657271|NCT02131636|448366252|FG000|Overall Study|Adverse Event|4|||
124657272|NCT02131636|448366253|FG001|Overall Study|Adverse Event|1|||
124657273|NCT02173379|448366254|FG000|Overall Study|Lost to Follow-up|89|||
124657274|NCT02173379|448366255|FG001|Overall Study|Lost to Follow-up|81|||
124657275|NCT02173379|448366254|FG000|Overall Study|Withdrawal by Subject|24|||
124657276|NCT02173379|448366255|FG001|Overall Study|Withdrawal by Subject|29|||
124657277|NCT02173379|448366254|FG000|Overall Study|Physician Decision|8|||
124657278|NCT02173379|448366255|FG001|Overall Study|Physician Decision|8|||
124657279|NCT02173379|448366254|FG000|Overall Study|Death|75|||
124657280|NCT02173379|448366255|FG001|Overall Study|Death|72|||
124657281|NCT02173379|448366254|FG000|Overall Study|Other Reason|1|||
124657282|NCT02173379|448366255|FG001|Overall Study|Other Reason|0|||
124657283|NCT06226649|448366259|FG000|Overall Study|Withdrawal by Subject|4|||
124657284|NCT06226649|448366260|FG001|Overall Study|Withdrawal by Subject|1|||
124657285|NCT04767529|448366265|FG000|Overall Study|Adverse Event|0|||
124657286|NCT04767529|448366266|FG001|Overall Study|Adverse Event|4|||
124657287|NCT04767529|448366267|FG002|Overall Study|Adverse Event|3|||
124657288|NCT04767529|448366265|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
124657289|NCT04767529|448366266|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
124657290|NCT04767529|448366267|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
124657291|NCT04767529|448366265|FG000|Overall Study|Required use of a prohibited medication|0|||
124657292|NCT04767529|448366266|FG001|Overall Study|Required use of a prohibited medication|1|||
124657293|NCT04767529|448366267|FG002|Overall Study|Required use of a prohibited medication|0|||
124657294|NCT04767529|448366265|FG000|Overall Study|Withdrawal by Subject|7|||
124657295|NCT04767529|448366266|FG001|Overall Study|Withdrawal by Subject|5|||
124657296|NCT04767529|448366267|FG002|Overall Study|Withdrawal by Subject|4|||
124657297|NCT04767529|448366265|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
124657298|NCT04767529|448366266|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
124657299|NCT04767529|448366267|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
124657300|NCT04767529|448366265|FG000|Overall Study|Lost to Follow-up|0|||
124657301|NCT04767529|448366266|FG001|Overall Study|Lost to Follow-up|2|||
124657302|NCT04767529|448366267|FG002|Overall Study|Lost to Follow-up|3|||
124657303|NCT04122625|448366272|FG000|Part A (up to 2.92 Years)|Death|2|||
124657304|NCT04122625|448366273|FG001|Part A (up to 2.92 Years)|Death|4|||
124657305|NCT04122625|448366274|FG002|Part A (up to 2.92 Years)|Death|0|||
124657306|NCT04122625|448366275|FG003|Part A (up to 2.92 Years)|Death|0|||
124657307|NCT04122625|448366276|FG004|Part A (up to 2.92 Years)|Death|0|||
124657308|NCT04122625|448366277|FG005|Part A (up to 2.92 Years)|Death|0|||
124657309|NCT04122625|448366272|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
124657310|NCT04122625|448366273|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
124657311|NCT04122625|448366274|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
124657312|NCT04122625|448366275|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
124657313|NCT04122625|448366276|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
124657314|NCT04122625|448366277|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
124657315|NCT04122625|448366272|FG000|Part B (up to 2.33 Years)|Death|0|||
124657316|NCT04122625|448366273|FG001|Part B (up to 2.33 Years)|Death|0|||
124657317|NCT04122625|448366274|FG002|Part B (up to 2.33 Years)|Death|5|||
124657318|NCT04122625|448366275|FG003|Part B (up to 2.33 Years)|Death|7|||
124657319|NCT04122625|448366276|FG004|Part B (up to 2.33 Years)|Death|6|||
124657320|NCT04122625|448366277|FG005|Part B (up to 2.33 Years)|Death|7|||
124657321|NCT04348500|448366278|FG000|Overall Study|Death|2|||
124657322|NCT04348500|448366279|FG001|Overall Study|Death|2|||
124657323|NCT04348500|448366278|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
124657324|NCT04348500|448366279|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
124657325|NCT02776670|448366280|FG000|Overall Study|Adverse Event|0|||
124657326|NCT02776670|448366281|FG001|Overall Study|Adverse Event|2|||
124657327|NCT02776670|448366280|FG000|Overall Study|Protocol Violation|0|||
124657328|NCT02776670|448366281|FG001|Overall Study|Protocol Violation|2|||
124657329|NCT02776670|448366280|FG000|Overall Study|Withdrawal by Subject|0|||
124657330|NCT02776670|448366281|FG001|Overall Study|Withdrawal by Subject|1|||
124657331|NCT02776670|448366280|FG000|Overall Study|Other - Reason not given|0|||
124657332|NCT02776670|448366281|FG001|Overall Study|Other - Reason not given|1|||
124657333|NCT01937884|448366282|FG000|Overall Study|Withdrawal by Subject|1|||
124657334|NCT01937884|448366283|FG001|Overall Study|Withdrawal by Subject|0|||
124657335|NCT00004088|448366284|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
124657336|NCT00004088|448366284|FG000|Overall Study|Withdrawal by Subject|1|||
124657337|NCT00004088|448366284|FG000|Overall Study|Protocol Violation|3|||
124657338|NCT00004088|448366284|FG000|Overall Study|Physician Decision|1|||
124657339|NCT00981058|448366285|FG000|Overall Study|Progressive Disease|38|||
124657340|NCT00981058|448366286|FG001|Overall Study|Progressive Disease|31|||
124657341|NCT00981058|448366285|FG000|Overall Study|Lost to Follow-up|3|||
124657342|NCT00981058|448366286|FG001|Overall Study|Lost to Follow-up|2|||
124657343|NCT00981058|448366285|FG000|Overall Study|Physician Decision|4|||
124657344|NCT00981058|448366286|FG001|Overall Study|Physician Decision|5|||
124657345|NCT00981058|448366285|FG000|Overall Study|Randomization Error|0|||
124657346|NCT00981058|448366286|FG001|Overall Study|Randomization Error|1|||
124657347|NCT00981058|448366285|FG000|Overall Study|Withdrawal by Subject|24|||
124657348|NCT00981058|448366286|FG001|Overall Study|Withdrawal by Subject|22|||
124657349|NCT02667587|448366287|FG000|Pre-Treatment|Not reported|1|||
124657350|NCT02667587|448366288|FG001|Pre-Treatment|Not reported|0|||
124657351|NCT02667587|448366287|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
124657352|NCT02667587|448366288|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
124657353|NCT02667587|448366287|FG000|Pre-Treatment|Participant withdrew consent|0|||
124657354|NCT02667587|448366288|FG001|Pre-Treatment|Participant withdrew consent|1|||
124657355|NCT02667587|448366287|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
124657356|NCT02667587|448366288|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
124657357|NCT02667587|448366287|FG000|End of Treatment|Disease Progression|193|||
124657358|NCT02667587|448366288|FG001|End of Treatment|Disease Progression|226|||
124657359|NCT02667587|448366287|FG000|End of Treatment|Study Drug Toxicity|75|||
124657360|NCT02667587|448366288|FG001|End of Treatment|Study Drug Toxicity|19|||
124657361|NCT02667587|448366287|FG000|End of Treatment|Death|2|||
124657362|NCT02667587|448366288|FG001|End of Treatment|Death|1|||
124657363|NCT02667587|448366287|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
124657364|NCT02667587|448366288|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
124657365|NCT02667587|448366287|FG000|End of Treatment|participant request to discontinue treatment|33|||
124657366|NCT02667587|448366288|FG001|End of Treatment|participant request to discontinue treatment|35|||
124657367|NCT02667587|448366287|FG000|End of Treatment|participant withdrew consent|5|||
124657368|NCT02667587|448366288|FG001|End of Treatment|participant withdrew consent|6|||
124657369|NCT02667587|448366287|FG000|End of Treatment|Lost to Follow-up|1|||
124657370|NCT02667587|448366288|FG001|End of Treatment|Lost to Follow-up|2|||
124657371|NCT02667587|448366287|FG000|End of Treatment|maximum clinical benefit|4|||
124657372|NCT02667587|448366288|FG001|End of Treatment|maximum clinical benefit|4|||
124657373|NCT02667587|448366287|FG000|End of Treatment|poor or non compliant|0|||
124657374|NCT02667587|448366288|FG001|End of Treatment|poor or non compliant|1|||
124657375|NCT02667587|448366287|FG000|End of Treatment|participant no longer meets study criteria|1|||
124657376|NCT02667587|448366288|FG001|End of Treatment|participant no longer meets study criteria|1|||
124657377|NCT02667587|448366287|FG000|End of Treatment|administrative reason by sponsor|1|||
124657378|NCT02667587|448366288|FG001|End of Treatment|administrative reason by sponsor|29|||
124657379|NCT02667587|448366287|FG000|End of Treatment|other reasonse|21|||
124657380|NCT02667587|448366288|FG001|End of Treatment|other reasonse|10|||
124657381|NCT04165135|448366289|FG000|Overall Study|Protocol Violation|10|||
124657382|NCT04165135|448366289|FG000|Overall Study|Participants withdrawal of consent|5|||
124657383|NCT02886884|448366295|FG000|Follow-up|Withdrawal by Subject|0|||
124657384|NCT02886884|448366296|FG001|Follow-up|Withdrawal by Subject|0|||
124657385|NCT02886884|448366297|FG002|Follow-up|Withdrawal by Subject|0|||
124657386|NCT02886884|448366298|FG003|Follow-up|Withdrawal by Subject|1|||
124657387|NCT00575510|448366301|FG000|Overall Study|Lost to Follow-up|4|||
124657388|NCT00575510|448366302|FG001|Overall Study|Lost to Follow-up|6|||
124657389|NCT00575510|448366303|FG002|Overall Study|Lost to Follow-up|9|||
124657390|NCT00575510|448366301|FG000|Overall Study|Withdrawal by Subject|1|||
124657391|NCT00575510|448366302|FG001|Overall Study|Withdrawal by Subject|0|||
124657392|NCT00575510|448366303|FG002|Overall Study|Withdrawal by Subject|0|||
124657393|NCT00575510|448366301|FG000|Overall Study|Clinic Called Patient|7|||
124657394|NCT00575510|448366302|FG001|Overall Study|Clinic Called Patient|7|||
124657395|NCT00575510|448366303|FG002|Overall Study|Clinic Called Patient|7|||
124657396|NCT00575510|448366301|FG000|Overall Study|Pregnancy|0|||
124657397|NCT00575510|448366302|FG001|Overall Study|Pregnancy|0|||
124657398|NCT00575510|448366303|FG002|Overall Study|Pregnancy|1|||
124657399|NCT01693185|448366307|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
124657400|NCT01693185|448366308|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
124657401|NCT01084538|448366309|FG000|Overall Study|Drug not available|30|||
124657402|NCT01084538|448366309|FG000|Overall Study|Adverse Event|9|||
124657403|NCT01084538|448366309|FG000|Overall Study|Kidney transplant|6|||
124657404|NCT01084538|448366309|FG000|Overall Study|Serious Adverse Event|3|||
124657405|NCT01084538|448366309|FG000|Overall Study|Lack of effectiveness|2|||
124657406|NCT01084538|448366309|FG000|Overall Study|Patient noncompliance|2|||
124657407|NCT01084538|448366309|FG000|Overall Study|Hyperphosphatemia|2|||
124657408|NCT01084538|448366309|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
124657409|NCT01084538|448366309|FG000|Overall Study|Change of residence|2|||
124657410|NCT01084538|448366309|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
124657411|NCT01084538|448366309|FG000|Overall Study|Reason unknown|8|||
124657412|NCT02279745|448366310|FG000|Overall Study|Adverse Event|7|||
124657413|NCT02279745|448366310|FG000|Overall Study|Death|6|||
124657414|NCT02279745|448366310|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
124657415|NCT02279745|448366310|FG000|Overall Study|Withdrawal by Subject|2|||
124657416|NCT02279745|448366310|FG000|Overall Study|Pregnancy|1|||
124657417|NCT02279745|448366310|FG000|Overall Study|Study Non-compliance|1|||
124657418|NCT02279745|448366310|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
124657419|NCT01606748|448366315|FG000|Overall Study|Adverse Event|1|||
124657420|NCT01606748|448366316|FG001|Overall Study|Adverse Event|0|||
124657421|NCT01606748|448366315|FG000|Overall Study|Progressive Disease|1|||
124657422|NCT01606748|448366316|FG001|Overall Study|Progressive Disease|0|||
124657423|NCT01606748|448366315|FG000|Overall Study|Withdrawal by Subject|1|||
124657424|NCT01606748|448366316|FG001|Overall Study|Withdrawal by Subject|0|||
124657425|NCT03084315|448366318|FG000|Overall Study|Lost to Follow-up|8|||
124657426|NCT03084315|448366319|FG001|Overall Study|Lost to Follow-up|7|||
124657427|NCT03084315|448366318|FG000|Overall Study|Withdrawal by Subject|2|||
124657428|NCT03084315|448366319|FG001|Overall Study|Withdrawal by Subject|2|||
124657429|NCT01952080|448366320|FG000|Overall Study|Withdrawal by Subject|0|||
124657430|NCT01952080|448366321|FG001|Overall Study|Withdrawal by Subject|0|||
124657431|NCT01952080|448366322|FG002|Overall Study|Withdrawal by Subject|0|||
124657432|NCT01952080|448366323|FG003|Overall Study|Withdrawal by Subject|1|||
124657433|NCT01952080|448366320|FG000|Overall Study|Protocol Non-compliance|0|||
124657434|NCT01952080|448366321|FG001|Overall Study|Protocol Non-compliance|1|||
124657435|NCT01952080|448366322|FG002|Overall Study|Protocol Non-compliance|0|||
124657436|NCT01952080|448366323|FG003|Overall Study|Protocol Non-compliance|0|||
124657437|NCT02732327|448366324|FG000|Overall Study|Protocol Violation|0|||
124657438|NCT02732327|448366325|FG001|Overall Study|Protocol Violation|1|||
124657439|NCT04503668|448366326|FG000|Overall Study|Incomplete data|4|||
124657440|NCT04503668|448366327|FG001|Overall Study|Incomplete data|3|||
124657441|NCT04503668|448366326|FG000|Overall Study|Withdrawal by Subject|1|||
124657442|NCT04503668|448366327|FG001|Overall Study|Withdrawal by Subject|1|||
124657443|NCT04503668|448366326|FG000|Overall Study|Adverse Event|2|||
124657444|NCT04503668|448366327|FG001|Overall Study|Adverse Event|0|||
124657445|NCT03782974|448366328|FG000|Overall Study|Withdrawal by Subject|7|||
124657446|NCT03782974|448366329|FG001|Overall Study|Withdrawal by Subject|7|||
124657447|NCT03782974|448366328|FG000|Overall Study|Pregnancy|1|||
124657448|NCT03782974|448366329|FG001|Overall Study|Pregnancy|0|||
124657449|NCT01687283|448367705|FG000|Overall Study|Adverse Event|11|||
124657450|NCT01687283|448367706|FG001|Overall Study|Adverse Event|4|||
124657451|NCT01687283|448367705|FG000|Overall Study|Lack of Efficacy|3|||
124657452|NCT01687283|448367706|FG001|Overall Study|Lack of Efficacy|1|||
124657453|NCT01687283|448367705|FG000|Overall Study|Protocol Violation|1|||
124657454|NCT01687283|448367706|FG001|Overall Study|Protocol Violation|3|||
124657455|NCT01687283|448367705|FG000|Overall Study|protocol defined stopping criteria|8|||
124657456|NCT01687283|448367706|FG001|Overall Study|protocol defined stopping criteria|10|||
124657457|NCT01687283|448367705|FG000|Overall Study|Lost to Follow-up|1|||
124657458|NCT01687283|448367706|FG001|Overall Study|Lost to Follow-up|1|||
124657459|NCT01687283|448367705|FG000|Overall Study|Investigator discretion|2|||
124657460|NCT01687283|448367706|FG001|Overall Study|Investigator discretion|0|||
124657461|NCT01687283|448367705|FG000|Overall Study|Withdrawal by Subject|9|||
124657462|NCT01687283|448367706|FG001|Overall Study|Withdrawal by Subject|8|||
124657463|NCT00642954|448367707|FG000|Overall Study|Progressive Disease|3|||
124657464|NCT00642954|448367708|FG001|Overall Study|Progressive Disease|3|||
124657465|NCT00642954|448367709|FG002|Overall Study|Progressive Disease|3|||
124657466|NCT00642954|448367710|FG003|Overall Study|Progressive Disease|3|||
124657467|NCT00642954|448367711|FG004|Overall Study|Progressive Disease|9|||
124657468|NCT00642954|448367707|FG000|Overall Study|Withdrawal by Subject|0|||
124657469|NCT00642954|448367708|FG001|Overall Study|Withdrawal by Subject|0|||
124657470|NCT00642954|448367709|FG002|Overall Study|Withdrawal by Subject|0|||
124657471|NCT00642954|448367710|FG003|Overall Study|Withdrawal by Subject|0|||
124657472|NCT00642954|448367711|FG004|Overall Study|Withdrawal by Subject|1|||
124657473|NCT00642954|448367707|FG000|Overall Study|Adverse Event|1|||
124657474|NCT00642954|448367708|FG001|Overall Study|Adverse Event|1|||
124657475|NCT00642954|448367709|FG002|Overall Study|Adverse Event|0|||
124657476|NCT00642954|448367710|FG003|Overall Study|Adverse Event|0|||
124657477|NCT00642954|448367711|FG004|Overall Study|Adverse Event|6|||
124657478|NCT01663857|448367712|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
124657479|NCT01663857|448367713|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
124657480|NCT01663857|448367714|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
124657481|NCT01663857|448367715|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
124657482|NCT01663857|448367712|FG000|Overall Study|Lost to Follow-up|0|||
124657483|NCT01663857|448367713|FG001|Overall Study|Lost to Follow-up|0|||
124657484|NCT01663857|448367714|FG002|Overall Study|Lost to Follow-up|3|||
124657485|NCT01663857|448367715|FG003|Overall Study|Lost to Follow-up|1|||
124657486|NCT03041467|448367716|FG000|Overall Study|Death|46|||
124657487|NCT03041467|448367717|FG001|Overall Study|Death|39|||
124657488|NCT03041467|448367716|FG000|Overall Study|Withdrawal by Subject|36|||
124657489|NCT03041467|448367717|FG001|Overall Study|Withdrawal by Subject|37|||
124657490|NCT03041467|448367716|FG000|Overall Study|Lost to Follow-up|6|||
124657491|NCT03041467|448367717|FG001|Overall Study|Lost to Follow-up|8|||
124657492|NCT03041467|448367716|FG000|Overall Study|Declined consent for study extension|21|||
124657493|NCT03041467|448367717|FG001|Overall Study|Declined consent for study extension|33|||
124657494|NCT03041467|448367716|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
124657495|NCT03041467|448367717|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
124657496|NCT02732015|448367718|FG000|Overall Study|Lost to Follow-up|0|||
124657497|NCT02732015|448367719|FG001|Overall Study|Lost to Follow-up|1|||
124657498|NCT03052920|448367720|FG000|Overall Study|Withdrawal by Subject|1|||
124657499|NCT01980628|448367721|FG000|Overall Study|Adverse Event|12|||
124657500|NCT01980628|448367721|FG000|Overall Study|Physician Decision|5|||
124657501|NCT01980628|448367721|FG000|Overall Study|Withdrawal by Subject|4|||
124657502|NCT01980628|448367721|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
124657503|NCT00564278|448367722|FG000|Overall Study|Lost to Follow-up|35|||
124657504|NCT00564278|448367723|FG001|Overall Study|Lost to Follow-up|33|||
124657505|NCT00564278|448367722|FG000|Overall Study|Physician Decision|1|||
124657506|NCT00564278|448367723|FG001|Overall Study|Physician Decision|2|||
124657507|NCT00564278|448367722|FG000|Overall Study|Withdrawal by Subject|11|||
124657508|NCT00564278|448367723|FG001|Overall Study|Withdrawal by Subject|7|||
124657509|NCT06439095|448367724|FG000|Overall Study|Lost to Follow-up|2|||
124657510|NCT03341936|448367725|FG000|Overall Study|Ineligible|1|||
124657511|NCT03341936|448367725|FG000|Overall Study|Disease Progression|2|||
124657512|NCT03341936|448367725|FG000|Overall Study|Withdrew Consent|4|||
124657513|NCT03341936|448367725|FG000|Overall Study|Non-Compliance|1|||
124657514|NCT03341936|448367725|FG000|Overall Study|Physician Decision|1|||
124657515|NCT03341936|448367725|FG000|Overall Study|Withdrawal by Subject|1|||
124657516|NCT03341936|448367725|FG000|Overall Study|Other|1|||
124657517|NCT02368886|448367726|FG000|Overall Study|Cancel|1|||
124657518|NCT02368886|448367727|FG001|Overall Study|Cancel|1|||
124657519|NCT02368886|448367728|FG002|Overall Study|Cancel|1|||
124657520|NCT02368886|448367729|FG003|Overall Study|Cancel|3|||
124657521|NCT02368886|448367726|FG000|Overall Study|Ineligible|0|||
124657522|NCT02368886|448367727|FG001|Overall Study|Ineligible|0|||
124657523|NCT02368886|448367728|FG002|Overall Study|Ineligible|0|||
124657524|NCT02368886|448367729|FG003|Overall Study|Ineligible|1|||
124657525|NCT04849416|448367731|FG000|Overall Study|Ongoing Treatment|12|||
124657526|NCT04849416|448367732|FG001|Overall Study|Ongoing Treatment|5|||
124657527|NCT04849416|448367733|FG002|Overall Study|Ongoing Treatment|3|||
124657528|NCT04849416|448367731|FG000|Overall Study|On Post-Treatment Follow-up|8|||
124657529|NCT04849416|448367732|FG001|Overall Study|On Post-Treatment Follow-up|9|||
124657530|NCT04849416|448367733|FG002|Overall Study|On Post-Treatment Follow-up|10|||
124657531|NCT04849416|448367731|FG000|Overall Study|Withdrawal by Subject|0|||
124544304|NCT05182840|447946752|FG004|Treatment Period|Adverse Event|12|||
124657532|NCT04849416|448367732|FG001|Overall Study|Withdrawal by Subject|0|||
124657533|NCT04849416|448367733|FG002|Overall Study|Withdrawal by Subject|1|||
124657534|NCT04849416|448367731|FG000|Overall Study|Lost to Follow-up|1|||
124657535|NCT04849416|448367732|FG001|Overall Study|Lost to Follow-up|0|||
124657536|NCT04849416|448367733|FG002|Overall Study|Lost to Follow-up|0|||
124657537|NCT04847232|448367740|FG000|Overall Study|Death|123|||
124657538|NCT04847232|448367741|FG001|Overall Study|Death|115|||
124657539|NCT04847232|448367740|FG000|Overall Study|Lost to Follow-up|3|||
124657540|NCT04847232|448367741|FG001|Overall Study|Lost to Follow-up|10|||
124657541|NCT04847232|448367740|FG000|Overall Study|Withdrawal by Subject|73|||
124657542|NCT04847232|448367741|FG001|Overall Study|Withdrawal by Subject|101|||
124657543|NCT04847232|448367740|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
124657544|NCT04847232|448367741|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
124657545|NCT02290925|448367747|FG000|First Period of Three Months|Lost to Follow-up|2|||
124657546|NCT02290925|448367748|FG001|First Period of Three Months|Lost to Follow-up|1|||
124657547|NCT02290925|448367747|FG000|First Period of Three Months|Death|1|||
124657548|NCT02290925|448367748|FG001|First Period of Three Months|Death|0|||
124657549|NCT02290925|448367747|FG000|First Period of Three Months|Insulin Started|1|||
124657550|NCT02290925|448367748|FG001|First Period of Three Months|Insulin Started|1|||
124657551|NCT02290925|448367747|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
124657552|NCT02290925|448367748|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
124657553|NCT02290925|448367747|FG000|Second Period of 3 Months|insulin started|0|||
124657554|NCT02290925|448367748|FG001|Second Period of 3 Months|insulin started|1|||
124657555|NCT01716520|448367749|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
124657556|NCT01716520|448367750|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
124657557|NCT01716520|448367751|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
124657558|NCT01716520|448367752|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
124657559|NCT01716520|448367753|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
124657560|NCT01716520|448367754|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
124657561|NCT01716520|448367749|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
124657562|NCT01716520|448367750|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
124657563|NCT01716520|448367751|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
124657564|NCT01716520|448367752|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
124657565|NCT01716520|448367753|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
124657566|NCT01716520|448367754|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
124657567|NCT01716520|448367749|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124657568|NCT01716520|448367750|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
124657569|NCT01716520|448367751|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124657570|NCT01716520|448367752|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124657571|NCT01716520|448367753|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124657572|NCT01716520|448367754|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124657573|NCT01716520|448367749|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
124657574|NCT01716520|448367750|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
124657575|NCT01716520|448367751|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
124657576|NCT01716520|448367752|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
124657577|NCT01716520|448367753|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
124657578|NCT01716520|448367754|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
124657579|NCT01716520|448367749|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
124657580|NCT01716520|448367750|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
124657581|NCT01716520|448367751|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
124657582|NCT01716520|448367752|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
124657583|NCT01716520|448367753|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
124657584|NCT01716520|448367754|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
124657585|NCT01716520|448367749|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
124657586|NCT01716520|448367750|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
124657587|NCT01716520|448367751|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
124657588|NCT01716520|448367752|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
124657589|NCT01716520|448367753|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
124657590|NCT01716520|448367754|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
124657591|NCT01716520|448367749|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
124657592|NCT01716520|448367750|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
124657593|NCT01716520|448367751|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
124657594|NCT01716520|448367752|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
124657595|NCT01716520|448367753|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
124657596|NCT01716520|448367754|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
124657597|NCT01716520|448367749|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
124657598|NCT01716520|448367750|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
124657599|NCT01716520|448367751|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
124657600|NCT01716520|448367752|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
124657601|NCT01716520|448367753|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
124657602|NCT01716520|448367754|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
124657603|NCT01716520|448367749|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
124657604|NCT01716520|448367750|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
124657605|NCT01716520|448367751|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
124657606|NCT01716520|448367752|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
124657607|NCT01716520|448367753|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
124657608|NCT01716520|448367754|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
124657609|NCT01716520|448367749|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
124657610|NCT01716520|448367750|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
124657611|NCT01716520|448367751|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
124657612|NCT01716520|448367752|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
124657613|NCT01716520|448367753|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
124657614|NCT01716520|448367754|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
124657615|NCT01716520|448367749|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
124657616|NCT01716520|448367750|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
124657617|NCT01716520|448367751|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
124657618|NCT01716520|448367752|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
124657619|NCT01716520|448367753|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
124657620|NCT01716520|448367754|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
124657621|NCT01716520|448367749|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
124657622|NCT01716520|448367750|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
124657623|NCT01716520|448367751|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
124657624|NCT01716520|448367752|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
124657625|NCT01716520|448367753|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
124657626|NCT01716520|448367754|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
124657627|NCT01716520|448367749|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
124657628|NCT01716520|448367750|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
124657629|NCT01716520|448367751|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
124657630|NCT01716520|448367752|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
124657631|NCT01716520|448367753|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
124657632|NCT01716520|448367754|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
124657633|NCT01716520|448367749|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
124657634|NCT01716520|448367750|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
124657635|NCT01716520|448367751|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
124657636|NCT01716520|448367752|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
124657637|NCT01716520|448367753|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
124657638|NCT01716520|448367754|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
124657639|NCT01716520|448367749|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
124657640|NCT01716520|448367750|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
124657641|NCT01716520|448367751|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
124657642|NCT01716520|448367752|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
124657643|NCT01716520|448367753|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
124657644|NCT01716520|448367754|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
124657645|NCT03699540|448367755|FG000|Overall Study|Lost to Follow-up|1|||
124657646|NCT02697591|448367760|FG000|Overall Study|Lost to Follow-up|0|||
124657647|NCT02697591|448367761|FG001|Overall Study|Lost to Follow-up|0|||
124657648|NCT02697591|448367762|FG002|Overall Study|Lost to Follow-up|0|||
124657649|NCT02697591|448367763|FG003|Overall Study|Lost to Follow-up|0|||
124657650|NCT02697591|448367764|FG004|Overall Study|Lost to Follow-up|0|||
124657651|NCT02697591|448367765|FG005|Overall Study|Lost to Follow-up|1|||
124657652|NCT02697591|448367766|FG006|Overall Study|Lost to Follow-up|1|||
124657653|NCT02697591|448367767|FG007|Overall Study|Lost to Follow-up|0|||
124657654|NCT02697591|448367768|FG008|Overall Study|Lost to Follow-up|0|||
124657655|NCT02697591|448367769|FG009|Overall Study|Lost to Follow-up|1|||
124657656|NCT02697591|448367760|FG000|Overall Study|Withdrawal by Subject|1|||
124657657|NCT02697591|448367761|FG001|Overall Study|Withdrawal by Subject|1|||
124657658|NCT02697591|448367762|FG002|Overall Study|Withdrawal by Subject|2|||
124657659|NCT02697591|448367763|FG003|Overall Study|Withdrawal by Subject|1|||
124657660|NCT02697591|448367764|FG004|Overall Study|Withdrawal by Subject|7|||
124657661|NCT02697591|448367765|FG005|Overall Study|Withdrawal by Subject|6|||
124657662|NCT02697591|448367766|FG006|Overall Study|Withdrawal by Subject|9|||
124657663|NCT02697591|448367767|FG007|Overall Study|Withdrawal by Subject|1|||
124657664|NCT02697591|448367768|FG008|Overall Study|Withdrawal by Subject|6|||
124657665|NCT02697591|448367769|FG009|Overall Study|Withdrawal by Subject|10|||
124657666|NCT02697591|448367760|FG000|Overall Study|Physician Decision|1|||
124657667|NCT02697591|448367761|FG001|Overall Study|Physician Decision|0|||
124657668|NCT02697591|448367762|FG002|Overall Study|Physician Decision|0|||
124657669|NCT02697591|448367763|FG003|Overall Study|Physician Decision|0|||
124657670|NCT02697591|448367764|FG004|Overall Study|Physician Decision|1|||
124657671|NCT02697591|448367765|FG005|Overall Study|Physician Decision|2|||
124657672|NCT02697591|448367766|FG006|Overall Study|Physician Decision|0|||
124657673|NCT02697591|448367767|FG007|Overall Study|Physician Decision|0|||
124657674|NCT02697591|448367768|FG008|Overall Study|Physician Decision|1|||
124657675|NCT02697591|448367769|FG009|Overall Study|Physician Decision|1|||
124657676|NCT02697591|448367760|FG000|Overall Study|Death|2|||
124657677|NCT02697591|448367761|FG001|Overall Study|Death|3|||
124657678|NCT02697591|448367762|FG002|Overall Study|Death|1|||
124657679|NCT02697591|448367763|FG003|Overall Study|Death|1|||
124657680|NCT02697591|448367764|FG004|Overall Study|Death|4|||
124657681|NCT02697591|448367765|FG005|Overall Study|Death|5|||
124657682|NCT02697591|448367766|FG006|Overall Study|Death|3|||
124657683|NCT02697591|448367767|FG007|Overall Study|Death|1|||
124657684|NCT02697591|448367768|FG008|Overall Study|Death|1|||
124657685|NCT02697591|448367769|FG009|Overall Study|Death|5|||
124657686|NCT02697591|448367760|FG000|Overall Study|Reason not Specified|0|||
124657687|NCT02697591|448367761|FG001|Overall Study|Reason not Specified|0|||
124657688|NCT02697591|448367762|FG002|Overall Study|Reason not Specified|0|||
124657689|NCT02697591|448367763|FG003|Overall Study|Reason not Specified|1|||
124657690|NCT02697591|448367764|FG004|Overall Study|Reason not Specified|1|||
124657691|NCT02697591|448367765|FG005|Overall Study|Reason not Specified|2|||
124657692|NCT02697591|448367766|FG006|Overall Study|Reason not Specified|3|||
124657693|NCT02697591|448367767|FG007|Overall Study|Reason not Specified|1|||
124657694|NCT02697591|448367768|FG008|Overall Study|Reason not Specified|1|||
124657695|NCT02697591|448367769|FG009|Overall Study|Reason not Specified|3|||
124657696|NCT00624832|448367770|FG000|Overall Study|Adverse Event|0|||
124657697|NCT00624832|448367771|FG001|Overall Study|Adverse Event|1|||
124657698|NCT00624832|448367772|FG002|Overall Study|Adverse Event|0|||
124657699|NCT00624832|448367773|FG003|Overall Study|Adverse Event|1|||
124657700|NCT00624832|448367770|FG000|Overall Study|Abnormal Laboratory Value|2|||
124657701|NCT00624832|448367771|FG001|Overall Study|Abnormal Laboratory Value|0|||
124657702|NCT00624832|448367772|FG002|Overall Study|Abnormal Laboratory Value|0|||
124657703|NCT00624832|448367773|FG003|Overall Study|Abnormal Laboratory Value|0|||
124657704|NCT04379700|448367774|FG000|Overall Study|Withdrawal by Subject|10|||
124657705|NCT04379700|448367774|FG000|Overall Study|Screen Fail|4|||
124657706|NCT04379700|448367774|FG000|Overall Study|Lost to Follow-up|3|||
124657707|NCT00592592|448367775|FG000|Overall Study|Patient found ineligible upon chart review|1|||
124657708|NCT01038752|448367777|FG000|Overall Study|Tumor Progression|2|||
124657709|NCT01038752|448367778|FG001|Overall Study|Tumor Progression|2|||
124657710|NCT01038752|448367777|FG000|Overall Study|Lost to Follow-up|3|||
124657711|NCT01038752|448367778|FG001|Overall Study|Lost to Follow-up|3|||
124657712|NCT00530790|448367779|FG000|Overall Study|Adverse Event|2|||
124657713|NCT00530790|448367779|FG000|Overall Study|Withdrawal by Subject|2|||
124657714|NCT00530790|448367779|FG000|Overall Study|Physician Decision|1|||
124657715|NCT02005627|448367784|FG000|Overall Study|Lost to Follow-up|1|||
124657716|NCT02005627|448367785|FG001|Overall Study|Lost to Follow-up|2|||
124657717|NCT02005627|448367784|FG000|Overall Study|Withdrawal by Subject|1|||
124657718|NCT02005627|448367785|FG001|Overall Study|Withdrawal by Subject|2|||
124657719|NCT03003000|448367789|FG000|Overall Study|Adverse Event|1|||
124657720|NCT03003000|448367790|FG001|Overall Study|Adverse Event|2|||
124657721|NCT03003000|448367791|FG002|Overall Study|Adverse Event|3|||
124657722|NCT03003000|448367789|FG000|Overall Study|Lack of Efficacy|1|||
124657723|NCT03003000|448367790|FG001|Overall Study|Lack of Efficacy|0|||
124657724|NCT03003000|448367791|FG002|Overall Study|Lack of Efficacy|0|||
124657725|NCT03003000|448367789|FG000|Overall Study|Non-compliant with protocol|0|||
124657726|NCT03003000|448367790|FG001|Overall Study|Non-compliant with protocol|1|||
124657727|NCT03003000|448367791|FG002|Overall Study|Non-compliant with protocol|1|||
124657728|NCT03003000|448367789|FG000|Overall Study|Refused to continue medication|2|||
124657729|NCT03003000|448367790|FG001|Overall Study|Refused to continue medication|0|||
124657730|NCT03003000|448367791|FG002|Overall Study|Refused to continue medication|0|||
124657731|NCT03003000|448367789|FG000|Overall Study|Other than listed|1|||
124657732|NCT03003000|448367790|FG001|Overall Study|Other than listed|1|||
124657733|NCT03003000|448367791|FG002|Overall Study|Other than listed|1|||
124657734|NCT04933617|448367793|FG000|Dose Escalation|Early closure of study|0|||
124657735|NCT04933617|448367794|FG001|Dose Escalation|Early closure of study|3|||
124657736|NCT04933617|448367795|FG002|Dose Escalation|Early closure of study|0|||
124657737|NCT04933617|448367796|FG003|Dose Escalation|Early closure of study|0|||
124657738|NCT04933617|448367797|FG004|Dose Escalation|Early closure of study|0|||
124657739|NCT02191046|448367800|FG000|Overall Study|low compliance|5|||
124657740|NCT02191046|448367801|FG001|Overall Study|low compliance|1|||
124657741|NCT03760458|448367802|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
124657742|NCT03760458|448367803|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
124657743|NCT03760458|448367804|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
124657744|NCT03760458|448367805|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
124657745|NCT03760458|448367806|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
124657746|NCT00048997|448367811|FG000|Overall Study|Protocol Violation|7|||
124657747|NCT00048997|448367812|FG001|Overall Study|Protocol Violation|2|||
124657748|NCT00048997|448367811|FG000|Overall Study|Withdrawal by Subject|6|||
124657749|NCT00048997|448367812|FG001|Overall Study|Withdrawal by Subject|1|||
124657750|NCT02819440|448367813|FG000|Overall Study|Adverse Event|3|||
124657751|NCT02819440|448367814|FG001|Overall Study|Adverse Event|1|||
124657752|NCT02819440|448367813|FG000|Overall Study|Lost to Follow-up|1|||
124657753|NCT02819440|448367814|FG001|Overall Study|Lost to Follow-up|3|||
124657754|NCT02819440|448367813|FG000|Overall Study|Withdrawal by Subject|9|||
124657755|NCT02819440|448367814|FG001|Overall Study|Withdrawal by Subject|8|||
124657756|NCT03970200|448367826|FG000|Overall Study|Death|2|||
124657757|NCT03970200|448367827|FG001|Overall Study|Death|2|||
124657758|NCT03970200|448367828|FG002|Overall Study|Death|1|||
124657759|NCT03970200|448367826|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
124657760|NCT03970200|448367827|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
124657761|NCT03970200|448367828|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
124657762|NCT03742258|448367829|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
124657763|NCT03742258|448367830|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
124657764|NCT03742258|448367831|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
124657765|NCT03742258|448367829|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
124657766|NCT03742258|448367830|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
124657767|NCT03742258|448367831|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
124657768|NCT03742258|448367829|FG000|Survival Follow-Up|Still in Follow-up|0|||
124657769|NCT03742258|448367830|FG001|Survival Follow-Up|Still in Follow-up|0|||
124657770|NCT03742258|448367831|FG002|Survival Follow-Up|Still in Follow-up|2|||
124657771|NCT01428115|448367832|FG000|Overall Study|Lack of Efficacy|3|||
124657772|NCT01428115|448367832|FG000|Overall Study|Lost to Follow-up|10|||
124657773|NCT01428115|448367832|FG000|Overall Study|Pregnancy|1|||
124657774|NCT01428115|448367832|FG000|Overall Study|Protocol Violation|3|||
124657775|NCT01428115|448367832|FG000|Overall Study|Withdrawal by Subject|4|||
124657776|NCT02101359|448367837|FG000|Overall Study|Not included|23|||
124657777|NCT02101359|448367838|FG001|Overall Study|Not included|13|||
124657778|NCT02101359|448367837|FG000|Overall Study|Withdrawal by Subject|5|||
124657779|NCT02101359|448367838|FG001|Overall Study|Withdrawal by Subject|4|||
124657780|NCT02101359|448367837|FG000|Overall Study|Lost to Follow-up|1|||
124657781|NCT02101359|448367838|FG001|Overall Study|Lost to Follow-up|0|||
124657782|NCT02101359|448367837|FG000|Overall Study|Protocol Violation|0|||
124657783|NCT02101359|448367838|FG001|Overall Study|Protocol Violation|2|||
124657784|NCT01783821|448367839|FG000|Overall Study|Screen Failure|1|||
124657785|NCT01783821|448367840|FG001|Overall Study|Screen Failure|1|||
124657786|NCT01907217|448367841|FG000|Overall Study|Withdrawal by Subject|0|||
124657787|NCT01907217|448367842|FG001|Overall Study|Withdrawal by Subject|2|||
124657788|NCT00659776|448367843|FG000|Overall Study|Withdrawal by Subject|12|||
124657789|NCT00659776|448367844|FG001|Overall Study|Withdrawal by Subject|2|||
124657790|NCT00659776|448367845|FG002|Overall Study|Withdrawal by Subject|0|||
124657791|NCT01180049|448367846|FG000|Overall Study|Other|9|||
124657792|NCT01180049|448367847|FG001|Overall Study|Other|7|||
124657793|NCT01180049|448367846|FG000|Overall Study|Lost to Follow-up|8|||
124657794|NCT01180049|448367847|FG001|Overall Study|Lost to Follow-up|6|||
124657795|NCT01180049|448367846|FG000|Overall Study|Death|36|||
124657796|NCT01180049|448367847|FG001|Overall Study|Death|35|||
124657797|NCT00350779|448367849|FG000|Overall Study|Adverse Event|4|||
124657798|NCT00350779|448367850|FG001|Overall Study|Adverse Event|2|||
124657799|NCT00350779|448367849|FG000|Overall Study|Lack of Efficacy|0|||
124657800|NCT00350779|448367850|FG001|Overall Study|Lack of Efficacy|4|||
124657801|NCT00350779|448367849|FG000|Overall Study|Lost to Follow-up|2|||
124657802|NCT00350779|448367850|FG001|Overall Study|Lost to Follow-up|0|||
124657803|NCT00350779|448367849|FG000|Overall Study|Physician Decision|2|||
124657804|NCT00350779|448367850|FG001|Overall Study|Physician Decision|4|||
124657805|NCT00350779|448367849|FG000|Overall Study|Protocol Violation|3|||
124657806|NCT00350779|448367850|FG001|Overall Study|Protocol Violation|1|||
124657807|NCT00350779|448367849|FG000|Overall Study|Withdrawal by Subject|9|||
124657808|NCT00350779|448367850|FG001|Overall Study|Withdrawal by Subject|8|||
124657809|NCT00350779|448367849|FG000|Overall Study|Patient Moved|2|||
124657810|NCT00350779|448367850|FG001|Overall Study|Patient Moved|1|||
124657811|NCT00350779|448367849|FG000|Overall Study|Non-compliance with study procedures|0|||
124657812|NCT00350779|448367850|FG001|Overall Study|Non-compliance with study procedures|1|||
124657813|NCT03015194|448369135|FG000|Overall Study|Death|10|||
124657814|NCT03015194|448369135|FG000|Overall Study|Withdrawal by Subject|2|||
124657815|NCT02469168|448369138|FG000|Overall Study|Trial closed|1|||
124657816|NCT02469168|448369139|FG001|Overall Study|Trial closed|0|||
124657817|NCT00433017|448369140|FG000|Overall Study|Adverse Event|5|||
124657818|NCT00433017|448369141|FG001|Overall Study|Adverse Event|3|||
124657819|NCT00433017|448369140|FG000|Overall Study|Withdrawal by Subject|4|||
124657820|NCT00433017|448369141|FG001|Overall Study|Withdrawal by Subject|5|||
124657821|NCT00433017|448369140|FG000|Overall Study|Lost to Follow-up|3|||
124657822|NCT00433017|448369141|FG001|Overall Study|Lost to Follow-up|4|||
124657823|NCT00433017|448369140|FG000|Overall Study|Administrative problems|80|||
124657824|NCT00433017|448369141|FG001|Overall Study|Administrative problems|86|||
124657825|NCT00433017|448369140|FG000|Overall Study|Protocol Violation|1|||
124657826|NCT00433017|448369141|FG001|Overall Study|Protocol Violation|0|||
124657827|NCT00433017|448369140|FG000|Overall Study|Death|2|||
124657828|NCT00433017|448369141|FG001|Overall Study|Death|2|||
124657829|NCT00433017|448369140|FG000|Overall Study|Subject no longer requires study drug|1|||
124657830|NCT00433017|448369141|FG001|Overall Study|Subject no longer requires study drug|1|||
124657831|NCT01709409|448369144|FG000|Overall Study|Protocol Violation|1|||
124657832|NCT01709409|448369145|FG001|Overall Study|Protocol Violation|0|||
124657833|NCT03594955|448369146|FG000|Overall Study|Adverse Event|1|||
124657834|NCT03594955|448369146|FG000|Overall Study|Progressive disease|5|||
124657835|NCT03594955|448369146|FG000|Overall Study|Sponsor's decision|1|||
124657836|NCT00255840|448369149|FG000|Overall Study|Lost to Follow-up|10|||
124657837|NCT00255840|448369150|FG001|Overall Study|Lost to Follow-up|14|||
124657838|NCT00255840|448369149|FG000|Overall Study|Discontinued intervention|53|||
124657839|NCT00255840|448369150|FG001|Overall Study|Discontinued intervention|56|||
124657840|NCT00715520|448369152|FG000|Overall Study|Screen failure|8|||
124657841|NCT00715520|448369153|FG001|Overall Study|Screen failure|1|||
124657842|NCT00715520|448369154|FG002|Overall Study|Screen failure|1|||
124657843|NCT00715520|448369152|FG000|Overall Study|Withdrawal by Subject|2|||
124657844|NCT00715520|448369153|FG001|Overall Study|Withdrawal by Subject|0|||
124657845|NCT00715520|448369154|FG002|Overall Study|Withdrawal by Subject|1|||
124657846|NCT01006590|448369155|FG000|Overall Study|Adverse Event|2|||
124657847|NCT01006590|448369156|FG001|Overall Study|Adverse Event|3|||
124657848|NCT01006590|448369155|FG000|Overall Study|Death|1|||
124657849|NCT01006590|448369156|FG001|Overall Study|Death|1|||
124657850|NCT01006590|448369155|FG000|Overall Study|Lost to Follow-up|1|||
124657851|NCT01006590|448369156|FG001|Overall Study|Lost to Follow-up|1|||
124657852|NCT01006590|448369155|FG000|Overall Study|Protocol Violation|1|||
124657853|NCT01006590|448369156|FG001|Overall Study|Protocol Violation|0|||
124657854|NCT01006590|448369155|FG000|Overall Study|Withdrawal by Subject|4|||
124657855|NCT01006590|448369156|FG001|Overall Study|Withdrawal by Subject|2|||
124657856|NCT01006590|448369155|FG000|Overall Study|Study specific discontinuation criteria|16|||
124657857|NCT01006590|448369156|FG001|Overall Study|Study specific discontinuation criteria|23|||
124657858|NCT01006590|448369155|FG000|Overall Study|Other|3|||
124657859|NCT01006590|448369156|FG001|Overall Study|Other|2|||
124657860|NCT03332095|448369157|FG000|Overall Study|Lost to Follow-up|1|||
124657861|NCT03332095|448369158|FG001|Overall Study|Lost to Follow-up|0|||
124657862|NCT03332095|448369157|FG000|Overall Study|Pregnancy|0|||
124657863|NCT03332095|448369158|FG001|Overall Study|Pregnancy|1|||
124657864|NCT00329745|448369159|FG000|Overall Study|Protocol Violation|1|||
124657865|NCT00329745|448369160|FG001|Overall Study|Protocol Violation|0|||
124657866|NCT00329745|448369159|FG000|Overall Study|Withdrawal by Subject|0|||
124657867|NCT00329745|448369160|FG001|Overall Study|Withdrawal by Subject|1|||
124657868|NCT00329745|448369159|FG000|Overall Study|Lost to Follow-up|86|||
124657869|NCT00329745|448369160|FG001|Overall Study|Lost to Follow-up|101|||
124657870|NCT02700698|448369168|FG000|Overall Study|Withdrawal by Subject|1|||
124657871|NCT02700698|448369169|FG001|Overall Study|Withdrawal by Subject|0|||
124657872|NCT00703118|448369170|FG000|Overall Study|Adverse Event|1|||
124657873|NCT00703118|448369171|FG001|Overall Study|Adverse Event|2|||
124657874|NCT00703118|448369172|FG002|Overall Study|Adverse Event|2|||
124657875|NCT00703118|448369170|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
124657876|NCT00703118|448369171|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
124657877|NCT00703118|448369172|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
124657878|NCT00703118|448369170|FG000|Overall Study|Lost to Follow-up|6|||
124657879|NCT00703118|448369171|FG001|Overall Study|Lost to Follow-up|4|||
124657880|NCT00703118|448369172|FG002|Overall Study|Lost to Follow-up|4|||
124657881|NCT00703118|448369170|FG000|Overall Study|Withdrawal by Subject|8|||
124657882|NCT00703118|448369171|FG001|Overall Study|Withdrawal by Subject|7|||
124657883|NCT00703118|448369172|FG002|Overall Study|Withdrawal by Subject|13|||
124657884|NCT00703118|448369170|FG000|Overall Study|Other|0|||
124657885|NCT00703118|448369171|FG001|Overall Study|Other|0|||
124657886|NCT00703118|448369172|FG002|Overall Study|Other|1|||
124657887|NCT05053035|448369173|FG000|Overall Study|Withdrawal by Subject|1|||
124657888|NCT05053035|448369174|FG001|Overall Study|Withdrawal by Subject|0|||
124657889|NCT02007278|448369179|FG000|Overall Study|Failure to comply with an eligibility|0|||
124657890|NCT02007278|448369180|FG001|Overall Study|Failure to comply with an eligibility|1|||
124657891|NCT02007278|448369179|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
124657892|NCT02007278|448369180|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
124657893|NCT02007278|448369179|FG000|Overall Study|Incorrect medication administration|1|||
124657894|NCT02007278|448369180|FG001|Overall Study|Incorrect medication administration|0|||
124657895|NCT02007278|448369179|FG000|Overall Study|Mis-randomization|1|||
124657896|NCT02007278|448369180|FG001|Overall Study|Mis-randomization|1|||
124657897|NCT00435188|448369182|FG000|Overall Study|Death|1|||
124657898|NCT00435188|448369183|FG001|Overall Study|Death|6|||
124657899|NCT00435188|448369182|FG000|Overall Study|Withdrawal by Subject|16|||
124657900|NCT00435188|448369183|FG001|Overall Study|Withdrawal by Subject|11|||
124657901|NCT00435188|448369182|FG000|Overall Study|Lost to Follow-up|5|||
124657902|NCT00435188|448369183|FG001|Overall Study|Lost to Follow-up|6|||
124657903|NCT00055497|448369186|FG000|Overall Study|Adverse Event|1|||
124657904|NCT00055497|448369187|FG001|Overall Study|Adverse Event|1|||
124657905|NCT00055497|448369188|FG002|Overall Study|Adverse Event|1|||
124657906|NCT00055497|448369189|FG003|Overall Study|Adverse Event|28|||
124657907|NCT00055497|448369186|FG000|Overall Study|Withdrawal by Subject|3|||
124657908|NCT00055497|448369187|FG001|Overall Study|Withdrawal by Subject|1|||
124657909|NCT00055497|448369188|FG002|Overall Study|Withdrawal by Subject|1|||
124657910|NCT00055497|448369189|FG003|Overall Study|Withdrawal by Subject|15|||
124657911|NCT00055497|448369186|FG000|Overall Study|Lost to Follow-up|0|||
124657912|NCT00055497|448369187|FG001|Overall Study|Lost to Follow-up|1|||
124657913|NCT00055497|448369188|FG002|Overall Study|Lost to Follow-up|0|||
124657914|NCT00055497|448369189|FG003|Overall Study|Lost to Follow-up|5|||
124657915|NCT00055497|448369186|FG000|Overall Study|Protocol Violation|0|||
124657916|NCT00055497|448369187|FG001|Overall Study|Protocol Violation|0|||
124657917|NCT00055497|448369188|FG002|Overall Study|Protocol Violation|0|||
124657918|NCT00055497|448369189|FG003|Overall Study|Protocol Violation|3|||
124657919|NCT00055497|448369186|FG000|Overall Study|Lack of Efficacy|1|||
124657920|NCT00055497|448369187|FG001|Overall Study|Lack of Efficacy|0|||
124657921|NCT00055497|448369188|FG002|Overall Study|Lack of Efficacy|0|||
124657922|NCT00055497|448369189|FG003|Overall Study|Lack of Efficacy|27|||
124657923|NCT00055497|448369186|FG000|Overall Study|Administrative Reasons|0|||
124657924|NCT00055497|448369187|FG001|Overall Study|Administrative Reasons|0|||
124657925|NCT00055497|448369188|FG002|Overall Study|Administrative Reasons|0|||
124657926|NCT00055497|448369189|FG003|Overall Study|Administrative Reasons|1|||
124657927|NCT00055497|448369186|FG000|Overall Study|Other|0|||
124657928|NCT00055497|448369187|FG001|Overall Study|Other|0|||
124657929|NCT00055497|448369188|FG002|Overall Study|Other|0|||
124657930|NCT00055497|448369189|FG003|Overall Study|Other|11|||
124657931|NCT00048165|448369190|FG000|Completed 6 Months Study|Administration/Other|8|||
124657932|NCT00048165|448369191|FG001|Completed 6 Months Study|Administration/Other|8|||
124657933|NCT00048165|448369190|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
124657934|NCT00048165|448369191|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
124657935|NCT00048165|448369190|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
124657936|NCT00048165|448369191|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
124657937|NCT00048165|448369190|FG000|Completed 6 Months Study|Death|12|||
124657938|NCT00048165|448369191|FG001|Completed 6 Months Study|Death|6|||
124657939|NCT00048165|448369190|FG000|Completed 6 Months Study|Insufficient therapy|1|||
124657940|NCT00048165|448369191|FG001|Completed 6 Months Study|Insufficient therapy|4|||
124657941|NCT00048165|448369190|FG000|Completed 6 Months Study|Other violation|4|||
124657942|NCT00048165|448369191|FG001|Completed 6 Months Study|Other violation|6|||
124657943|NCT00048165|448369190|FG000|Completed 6 Months Study|Refused treatment|5|||
124657944|NCT00048165|448369191|FG001|Completed 6 Months Study|Refused treatment|5|||
124657945|NCT00048165|448369190|FG000|Completed 6 Months Study|Violation criteria|0|||
124657946|NCT00048165|448369191|FG001|Completed 6 Months Study|Violation criteria|2|||
124657947|NCT00048165|448369190|FG000|Completed 6 Months Study|Did not receive study drug|6|||
124657948|NCT00048165|448369191|FG001|Completed 6 Months Study|Did not receive study drug|6|||
124657949|NCT00048165|448369190|FG000|Completed 12 Months Study|Administration/Other|0|||
124657950|NCT00048165|448369191|FG001|Completed 12 Months Study|Administration/Other|2|||
124657951|NCT00048165|448369190|FG000|Completed 12 Months Study|Death|2|||
124657952|NCT00048165|448369191|FG001|Completed 12 Months Study|Death|1|||
124657953|NCT00048165|448369190|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
124657954|NCT00048165|448369191|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
124657955|NCT00731731|448369192|FG000|Overall Study|Protocol Violation|0|||
124657956|NCT00731731|448369193|FG001|Overall Study|Protocol Violation|0|||
124657957|NCT00731731|448369194|FG002|Overall Study|Protocol Violation|1|||
124657958|NCT00731731|448369192|FG000|Overall Study|Cancel prior to treatment|0|||
124657959|NCT00731731|448369193|FG001|Overall Study|Cancel prior to treatment|0|||
124657960|NCT00731731|448369194|FG002|Overall Study|Cancel prior to treatment|2|||
124657961|NCT02112877|448369195|FG000|Overall Study|Withdrawal by Subject|1|||
124657962|NCT02112877|448369196|FG001|Overall Study|Withdrawal by Subject|7|||
124657963|NCT02112877|448369195|FG000|Overall Study|Visit Missed|1|||
124657964|NCT02112877|448369196|FG001|Overall Study|Visit Missed|6|||
124657965|NCT02083653|448369199|FG000|Overall Study|Randomized but not Treated|0|||
124657966|NCT02083653|448369200|FG001|Overall Study|Randomized but not Treated|2|||
124657967|NCT02083653|448369201|FG002|Overall Study|Randomized but not Treated|7|||
124657968|NCT02083653|448369199|FG000|Overall Study|Adverse Event|12|||
124657969|NCT02083653|448369200|FG001|Overall Study|Adverse Event|5|||
124657970|NCT02083653|448369201|FG002|Overall Study|Adverse Event|4|||
124657971|NCT02083653|448369199|FG000|Overall Study|Lost to Follow-up|1|||
124657972|NCT02083653|448369200|FG001|Overall Study|Lost to Follow-up|0|||
124657973|NCT02083653|448369201|FG002|Overall Study|Lost to Follow-up|0|||
124657974|NCT02083653|448369199|FG000|Overall Study|Death|2|||
124657975|NCT02083653|448369200|FG001|Overall Study|Death|2|||
124657976|NCT02083653|448369201|FG002|Overall Study|Death|2|||
124657977|NCT02083653|448369199|FG000|Overall Study|Progressive Disease|65|||
124657978|NCT02083653|448369200|FG001|Overall Study|Progressive Disease|73|||
124657979|NCT02083653|448369201|FG002|Overall Study|Progressive Disease|63|||
124657980|NCT02083653|448369199|FG000|Overall Study|Withdrawal by Subject|2|||
124657981|NCT02083653|448369200|FG001|Overall Study|Withdrawal by Subject|1|||
124657982|NCT02083653|448369201|FG002|Overall Study|Withdrawal by Subject|2|||
124657983|NCT02083653|448369199|FG000|Overall Study|Other Events|0|||
124657984|NCT02083653|448369200|FG001|Overall Study|Other Events|2|||
124657985|NCT02083653|448369201|FG002|Overall Study|Other Events|2|||
124657986|NCT02083653|448369199|FG000|Overall Study|Reason Missing|0|||
124657987|NCT02083653|448369200|FG001|Overall Study|Reason Missing|0|||
124657988|NCT02083653|448369201|FG002|Overall Study|Reason Missing|4|||
124657989|NCT00621517|448369202|FG000|Overall Study|Lost to Follow-up|3|||
124657990|NCT00621517|448369203|FG001|Overall Study|Lost to Follow-up|3|||
124657991|NCT00621517|448369202|FG000|Overall Study|Withdrawal by Subject|3|||
124657992|NCT00621517|448369203|FG001|Overall Study|Withdrawal by Subject|4|||
124657993|NCT00621517|448369202|FG000|Overall Study|Adverse Event|1|||
124657994|NCT00621517|448369203|FG001|Overall Study|Adverse Event|0|||
124657995|NCT02155322|448369205|FG000|Overall Study|Adverse Event|1|||
124657996|NCT02155322|448369205|FG000|Overall Study|Physician Decision|1|||
124657997|NCT02155322|448369205|FG000|Overall Study|Relapse/Recurrence|8|||
124657998|NCT02155322|448369205|FG000|Overall Study|Withdrawal by Subject|4|||
124657999|NCT00073008|448369206|FG000|Overall Study|Missing|6|||
124658000|NCT00073008|448369207|FG001|Overall Study|Missing|6|||
124658001|NCT00073008|448369206|FG000|Overall Study|Withdrawal by Subject|2|||
124658002|NCT00073008|448369207|FG001|Overall Study|Withdrawal by Subject|2|||
124658003|NCT00073008|448369206|FG000|Overall Study|Lost to Follow-up|1|||
124658004|NCT00073008|448369207|FG001|Overall Study|Lost to Follow-up|3|||
124658005|NCT00073008|448369206|FG000|Overall Study|Death|46|||
124658006|NCT00073008|448369207|FG001|Overall Study|Death|47|||
124658007|NCT00073008|448369206|FG000|Overall Study|"Other selected on Case Report Form"|7|||
124658008|NCT00073008|448369207|FG001|Overall Study|"Other selected on Case Report Form"|5|||
124658009|NCT00913770|448369208|FG000|Overall Study|Unable to contact|24|||
124658010|NCT00913770|448369209|FG001|Overall Study|Unable to contact|19|||
124658011|NCT00913770|448369210|FG002|Overall Study|Unable to contact|13|||
124658012|NCT00913770|448369208|FG000|Overall Study|Refused|11|||
124658013|NCT00913770|448369209|FG001|Overall Study|Refused|10|||
124658014|NCT00913770|448369210|FG002|Overall Study|Refused|8|||
124658015|NCT03337048|448369211|FG000|Overall Study|Withdrawal by Subject|2|||
124658016|NCT03337048|448369212|FG001|Overall Study|Withdrawal by Subject|0|||
124658017|NCT03337048|448369213|FG002|Overall Study|Withdrawal by Subject|0|||
124658018|NCT02791438|448369216|FG000|Treatment Period|Adverse Event|1|||
124658019|NCT02791438|448369217|FG001|Treatment Period|Adverse Event|0|||
124658020|NCT02791438|448369216|FG000|Treatment Period|Withdrawal by Subject|0|||
124658021|NCT02791438|448369217|FG001|Treatment Period|Withdrawal by Subject|1|||
124658022|NCT02791438|448369216|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
124658023|NCT02791438|448369217|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
124658024|NCT02669667|448369219|FG000|Overall Study|Lost to Follow-up|0|||
124658025|NCT02669667|448369220|FG001|Overall Study|Lost to Follow-up|0|||
124658026|NCT02669667|448369221|FG002|Overall Study|Lost to Follow-up|0|||
124658027|NCT02669667|448369222|FG003|Overall Study|Lost to Follow-up|0|||
124658028|NCT02669667|448369223|FG004|Overall Study|Lost to Follow-up|0|||
124658029|NCT02669667|448369224|FG005|Overall Study|Lost to Follow-up|1|||
124658030|NCT02669667|448369225|FG006|Overall Study|Lost to Follow-up|0|||
124658031|NCT02839876|448369230|FG000|Overall Study|Protocol Violation|10|||
124658032|NCT02839876|448369231|FG001|Overall Study|Protocol Violation|11|||
124658033|NCT01156051|448369234|FG000|Overall Study|Lost to Follow-up|1|||
124658034|NCT01156051|448369235|FG001|Overall Study|Lost to Follow-up|0|||
124658035|NCT01156051|448369234|FG000|Overall Study|patient not compliant with protocol|0|||
124658036|NCT01156051|448369235|FG001|Overall Study|patient not compliant with protocol|1|||
124658037|NCT01926197|448369239|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
124658038|NCT01926197|448369240|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
124658039|NCT01926197|448369239|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
124658040|NCT01926197|448369240|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
124658041|NCT00564395|448369242|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
124658042|NCT00564395|448369243|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
124658043|NCT00564395|448369242|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
124658044|NCT00564395|448369243|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
124658045|NCT02620384|448369244|FG000|Overall Study|Adverse Event|2|||
124658046|NCT02620384|448369245|FG001|Overall Study|Adverse Event|1|||
124658047|NCT02620384|448369244|FG000|Overall Study|Discharged prior to 2nd dose|2|||
124658048|NCT02620384|448369245|FG001|Overall Study|Discharged prior to 2nd dose|5|||
124658049|NCT02620384|448369244|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
124658050|NCT02620384|448369245|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
124658051|NCT02071082|448369246|FG000|Overall Study|Enrolled and Never Treated|1|||
124658052|NCT02071082|448369247|FG001|Overall Study|Enrolled and Never Treated|1|||
124658053|NCT02071082|448369246|FG000|Overall Study|Adverse Event|0|||
124658054|NCT02071082|448369247|FG001|Overall Study|Adverse Event|1|||
124658055|NCT02071082|448369246|FG000|Overall Study|Withdrew Consent|0|||
124658056|NCT02071082|448369247|FG001|Overall Study|Withdrew Consent|4|||
124658057|NCT02071082|448369246|FG000|Overall Study|Lost to Follow-up|1|||
124658058|NCT02071082|448369247|FG001|Overall Study|Lost to Follow-up|1|||
124658059|NCT02494401|448369252|FG000|Overall Study|Lost to Follow-up|22|||
124658060|NCT02494401|448369253|FG001|Overall Study|Lost to Follow-up|25|||
124658061|NCT02494401|448369252|FG000|Overall Study|Withdrawal by Subject|3|||
124658062|NCT02494401|448369253|FG001|Overall Study|Withdrawal by Subject|2|||
124658063|NCT00958412|448369254|FG000|Overall Study|Study prematurely terminated|18|||
124658064|NCT00966355|448369255|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
124658065|NCT00966355|448369256|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
124658066|NCT00966355|448369257|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
124658067|NCT00966355|448369255|FG000|Overall Study|newly diagnosed advanced HCC|11|||
124658068|NCT00966355|448369256|FG001|Overall Study|newly diagnosed advanced HCC|12|||
124658069|NCT00966355|448369257|FG002|Overall Study|newly diagnosed advanced HCC|10|||
124658070|NCT00966355|448369255|FG000|Overall Study|Lost to Follow-up|5|||
124658071|NCT00966355|448369256|FG001|Overall Study|Lost to Follow-up|4|||
124658072|NCT00966355|448369257|FG002|Overall Study|Lost to Follow-up|3|||
124658073|NCT02227368|448371173|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
124658074|NCT02227368|448371174|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
124658075|NCT02227368|448371173|FG000|Overall Study|Lost to Follow-up|1|||
124658076|NCT02227368|448371174|FG001|Overall Study|Lost to Follow-up|0|||
124658077|NCT02227368|448371173|FG000|Overall Study|Adverse Event|1|||
124658078|NCT02227368|448371174|FG001|Overall Study|Adverse Event|0|||
124658079|NCT04494425|448371176|FG000|Overall Study|Death|160|||
124658080|NCT04494425|448371177|FG001|Overall Study|Death|166|||
124658081|NCT04494425|448371176|FG000|Overall Study|Withdrawal by Subject|10|||
124658082|NCT04494425|448371177|FG001|Overall Study|Withdrawal by Subject|40|||
124658083|NCT04494425|448371176|FG000|Overall Study|Other|1|||
124658084|NCT04494425|448371177|FG001|Overall Study|Other|1|||
124658085|NCT04494425|448371176|FG000|Overall Study|Ongoing at the time of PCD|265|||
124658086|NCT04494425|448371177|FG001|Overall Study|Ongoing at the time of PCD|223|||
124658087|NCT01744483|448371179|FG000|Overall Study|Death|9|||
124658088|NCT01744483|448371180|FG001|Overall Study|Death|4|||
124658089|NCT01744483|448371181|FG002|Overall Study|Death|11|||
124658090|NCT01744483|448371179|FG000|Overall Study|Lost to Follow-up|8|||
124658091|NCT01744483|448371180|FG001|Overall Study|Lost to Follow-up|9|||
124658092|NCT01744483|448371181|FG002|Overall Study|Lost to Follow-up|11|||
124658093|NCT01744483|448371179|FG000|Overall Study|Protocol Violation|1|||
124658094|NCT01744483|448371180|FG001|Overall Study|Protocol Violation|2|||
124658095|NCT01744483|448371181|FG002|Overall Study|Protocol Violation|1|||
124658096|NCT01744483|448371179|FG000|Overall Study|Withdrawal by Subject|4|||
124658097|NCT01744483|448371180|FG001|Overall Study|Withdrawal by Subject|6|||
124658098|NCT01744483|448371181|FG002|Overall Study|Withdrawal by Subject|2|||
124658099|NCT01744483|448371179|FG000|Overall Study|No ICU Admit|5|||
124658100|NCT01744483|448371180|FG001|Overall Study|No ICU Admit|1|||
124658101|NCT01744483|448371181|FG002|Overall Study|No ICU Admit|2|||
124658102|NCT01744483|448371179|FG000|Overall Study|Routed to OSH|2|||
124658103|NCT01744483|448371180|FG001|Overall Study|Routed to OSH|0|||
124658104|NCT01744483|448371181|FG002|Overall Study|Routed to OSH|1|||
124658105|NCT01190189|448371182|FG000|Overall Study|Lost to Follow-up|4|||
124658106|NCT01190189|448371182|FG000|Overall Study|Withdrawal by Subject|1|||
124658107|NCT01190189|448371182|FG000|Overall Study|Migrated/moved from study area|1|||
124658108|NCT03214679|448371184|FG000|Overall Study|Lost to Follow-up|12|||
124658109|NCT03214679|448371185|FG001|Overall Study|Lost to Follow-up|14|||
124658110|NCT03214679|448371184|FG000|Overall Study|not eligible|2|||
124658111|NCT03214679|448371185|FG001|Overall Study|not eligible|0|||
124658112|NCT01754766|448371189|FG000|Overall Study|Personal reasons|1|||
124658113|NCT01754766|448371190|FG001|Overall Study|Personal reasons|1|||
124658114|NCT01754766|448371191|FG002|Overall Study|Personal reasons|0|||
124658115|NCT02412878|448371192|FG000|Overall Study|Withdrawal by Subject|19|||
124658116|NCT02412878|448371193|FG001|Overall Study|Withdrawal by Subject|10|||
124658117|NCT02412878|448371192|FG000|Overall Study|Lost to Follow-up|2|||
124658118|NCT02412878|448371193|FG001|Overall Study|Lost to Follow-up|3|||
124658119|NCT02190721|448371194|FG000|Overall Study|Patient was out of the city|0|||
124658120|NCT02190721|448371195|FG001|Overall Study|Patient was out of the city|1|||
124658121|NCT02190721|448371196|FG002|Overall Study|Patient was out of the city|0|||
124658122|NCT04571385|448371197|FG000|Overall Study|Participant non-compliance|1|||
124658123|NCT04571385|448371198|FG001|Overall Study|Participant non-compliance|0|||
124658124|NCT04571385|448371199|FG002|Overall Study|Participant non-compliance|0|||
124658125|NCT04571385|448371197|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
124658126|NCT04571385|448371198|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
124658127|NCT04571385|448371199|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
124658128|NCT04571385|448371197|FG000|Overall Study|Screen failure|0|||
124658129|NCT04571385|448371198|FG001|Overall Study|Screen failure|0|||
124658130|NCT04571385|448371199|FG002|Overall Study|Screen failure|1|||
124658131|NCT05025332|448371201|FG000|Screening|Screen failure|12|||
124658132|NCT05025332|448371201|FG000|Treatment & Follow Up|Protocol Violation|1|||
124658133|NCT05025332|448371201|FG000|Treatment & Follow Up|Adverse Event|4|||
124658134|NCT01212159|448371202|FG000|Overall Study|Withdrawal by Subject|12|||
124658135|NCT01212159|448371203|FG001|Overall Study|Withdrawal by Subject|12|||
124658136|NCT01306214|448371204|FG000|Overall Study|Death|0|||
124658137|NCT01306214|448371205|FG001|Overall Study|Death|0|||
124658138|NCT01306214|448371206|FG002|Overall Study|Death|1|||
124658139|NCT01306214|448371204|FG000|Overall Study|Lost to Follow-up|3|||
124658140|NCT01306214|448371205|FG001|Overall Study|Lost to Follow-up|5|||
124658141|NCT01306214|448371206|FG002|Overall Study|Lost to Follow-up|4|||
124658142|NCT01306214|448371204|FG000|Overall Study|Withdrawal by Subject|24|||
124658143|NCT01306214|448371205|FG001|Overall Study|Withdrawal by Subject|22|||
124658144|NCT01306214|448371206|FG002|Overall Study|Withdrawal by Subject|16|||
124658145|NCT01306214|448371204|FG000|Overall Study|Not treated|1|||
124658146|NCT01306214|448371205|FG001|Overall Study|Not treated|1|||
124658147|NCT01306214|448371206|FG002|Overall Study|Not treated|1|||
124658148|NCT01928199|448371209|FG000|Overall Study|Lost to Follow-up|2|||
124658149|NCT01928199|448371210|FG001|Overall Study|Lost to Follow-up|1|||
124658150|NCT01928199|448371209|FG000|Overall Study|Withdrawal by Subject|3|||
124658151|NCT01928199|448371210|FG001|Overall Study|Withdrawal by Subject|5|||
124658152|NCT01502956|448371218|FG000|Overall Study|Death|0|||
124658153|NCT01502956|448371219|FG001|Overall Study|Death|2|||
124658154|NCT01502956|448371218|FG000|Overall Study|Lost to Follow-up|14|||
124658155|NCT01502956|448371219|FG001|Overall Study|Lost to Follow-up|11|||
124658156|NCT01502956|448371218|FG000|Overall Study|Physician Decision|2|||
124658157|NCT01502956|448371219|FG001|Overall Study|Physician Decision|3|||
124658158|NCT01502956|448371218|FG000|Overall Study|Withdrawal by Subject|8|||
124658159|NCT01502956|448371219|FG001|Overall Study|Withdrawal by Subject|10|||
124658160|NCT03959488|448371220|FG000|Season 1|Other|6|||
124658161|NCT03959488|448371221|FG001|Season 1|Other|7|||
124658162|NCT03959488|448371222|FG002|Season 1|Other|0|||
124658163|NCT03959488|448371223|FG003|Season 1|Other|0|||
124658164|NCT03959488|448371224|FG004|Season 1|Other|0|||
124658165|NCT03959488|448371220|FG000|Season 1|Withdrawal by parent/guardian|43|||
124658166|NCT03959488|448371221|FG001|Season 1|Withdrawal by parent/guardian|28|||
124658167|NCT03959488|448371222|FG002|Season 1|Withdrawal by parent/guardian|0|||
124658168|NCT03959488|448371223|FG003|Season 1|Withdrawal by parent/guardian|0|||
124658169|NCT03959488|448371224|FG004|Season 1|Withdrawal by parent/guardian|0|||
124658170|NCT03959488|448371220|FG000|Season 1|Due to COVID-19 pandemic|2|||
124658171|NCT03959488|448371221|FG001|Season 1|Due to COVID-19 pandemic|3|||
124658172|NCT03959488|448371222|FG002|Season 1|Due to COVID-19 pandemic|0|||
124658173|NCT03959488|448371223|FG003|Season 1|Due to COVID-19 pandemic|0|||
124658174|NCT03959488|448371224|FG004|Season 1|Due to COVID-19 pandemic|0|||
124658175|NCT03959488|448371220|FG000|Season 1|Lost to Follow-up|17|||
124658176|NCT03959488|448371221|FG001|Season 1|Lost to Follow-up|7|||
124658177|NCT03959488|448371222|FG002|Season 1|Lost to Follow-up|0|||
124658178|NCT03959488|448371223|FG003|Season 1|Lost to Follow-up|0|||
124658179|NCT03959488|448371224|FG004|Season 1|Lost to Follow-up|0|||
124658180|NCT03959488|448371220|FG000|Season 1|Death|5|||
124658181|NCT03959488|448371221|FG001|Season 1|Death|1|||
124658182|NCT03959488|448371222|FG002|Season 1|Death|0|||
124658183|NCT03959488|448371223|FG003|Season 1|Death|0|||
124658184|NCT03959488|448371224|FG004|Season 1|Death|0|||
124658185|NCT03959488|448371220|FG000|Season 2|Other|0|||
124658186|NCT03959488|448371221|FG001|Season 2|Other|0|||
124658187|NCT03959488|448371222|FG002|Season 2|Other|2|||
124658188|NCT03959488|448371223|FG003|Season 2|Other|0|||
124658189|NCT03959488|448371224|FG004|Season 2|Other|0|||
124658190|NCT03959488|448371220|FG000|Season 2|Withdrawal by parent/guardian|0|||
124658191|NCT03959488|448371221|FG001|Season 2|Withdrawal by parent/guardian|0|||
124658192|NCT03959488|448371222|FG002|Season 2|Withdrawal by parent/guardian|3|||
124658193|NCT03959488|448371223|FG003|Season 2|Withdrawal by parent/guardian|1|||
124658194|NCT03959488|448371224|FG004|Season 2|Withdrawal by parent/guardian|1|||
124658195|NCT03959488|448371220|FG000|Season 2|Lost to Follow-up|0|||
124658196|NCT03959488|448371221|FG001|Season 2|Lost to Follow-up|0|||
124658197|NCT03959488|448371222|FG002|Season 2|Lost to Follow-up|1|||
124658198|NCT03959488|448371223|FG003|Season 2|Lost to Follow-up|0|||
124658199|NCT03959488|448371224|FG004|Season 2|Lost to Follow-up|1|||
124658200|NCT01026818|448371225|FG000|Screening Period|Entry Criteria Not Met|105|||
124658201|NCT01026818|448371226|FG001|Screening Period|Entry Criteria Not Met|0|||
124658202|NCT01026818|448371227|FG002|Screening Period|Entry Criteria Not Met|0|||
124658203|NCT01026818|448371228|FG003|Screening Period|Entry Criteria Not Met|0|||
124658204|NCT01026818|448371225|FG000|Screening Period|Withdrawal by Subject|49|||
124658205|NCT01026818|448371226|FG001|Screening Period|Withdrawal by Subject|0|||
124658206|NCT01026818|448371227|FG002|Screening Period|Withdrawal by Subject|0|||
124658207|NCT01026818|448371228|FG003|Screening Period|Withdrawal by Subject|0|||
124658208|NCT01026818|448371225|FG000|Screening Period|Protocol Deviation|3|||
124658209|NCT01026818|448371226|FG001|Screening Period|Protocol Deviation|0|||
124658210|NCT01026818|448371227|FG002|Screening Period|Protocol Deviation|0|||
124658211|NCT01026818|448371228|FG003|Screening Period|Protocol Deviation|0|||
124658212|NCT01026818|448371225|FG000|Screening Period|Adverse Event|2|||
124658213|NCT01026818|448371226|FG001|Screening Period|Adverse Event|0|||
124658214|NCT01026818|448371227|FG002|Screening Period|Adverse Event|0|||
124658215|NCT01026818|448371228|FG003|Screening Period|Adverse Event|0|||
124658216|NCT01026818|448371225|FG000|Screening Period|Physician Decision|1|||
124658217|NCT01026818|448371226|FG001|Screening Period|Physician Decision|0|||
124658218|NCT01026818|448371227|FG002|Screening Period|Physician Decision|0|||
124658219|NCT01026818|448371228|FG003|Screening Period|Physician Decision|0|||
124658220|NCT01026818|448371225|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
124658221|NCT01026818|448371226|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
124658222|NCT01026818|448371227|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
124658223|NCT01026818|448371228|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
124658224|NCT01026818|448371225|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
124658225|NCT01026818|448371226|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
124658226|NCT01026818|448371227|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
124658227|NCT01026818|448371228|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
124658228|NCT01026818|448371225|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
124658229|NCT01026818|448371226|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
124658230|NCT01026818|448371227|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
124658231|NCT01026818|448371228|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
124658232|NCT01026818|448371225|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
124658233|NCT01026818|448371226|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
124658234|NCT01026818|448371227|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
124658235|NCT01026818|448371228|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
124658236|NCT01026818|448371225|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
124658237|NCT01026818|448371226|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
124658238|NCT01026818|448371227|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
124658239|NCT01026818|448371228|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
124658240|NCT01026818|448371225|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
124658241|NCT01026818|448371226|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
124658242|NCT01026818|448371227|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
124658243|NCT01026818|448371228|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
124658244|NCT01026818|448371225|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
124658245|NCT01026818|448371226|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
124658246|NCT01026818|448371227|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
124658247|NCT01026818|448371228|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
124658248|NCT01026818|448371225|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
124658249|NCT01026818|448371226|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
124658250|NCT01026818|448371227|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
124658251|NCT01026818|448371228|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
124658252|NCT01026818|448371225|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
124658253|NCT01026818|448371226|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
124658254|NCT01026818|448371227|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
124658255|NCT01026818|448371228|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
124658256|NCT01026818|448371225|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
124658257|NCT01026818|448371226|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
124658258|NCT01026818|448371227|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
124658259|NCT01026818|448371228|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
124658260|NCT01026818|448371225|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
124658261|NCT01026818|448371226|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
124658262|NCT01026818|448371227|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
124658263|NCT01026818|448371228|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
124658264|NCT01026818|448371225|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
124658265|NCT01026818|448371226|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
124658266|NCT01026818|448371227|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
124658267|NCT01026818|448371228|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
124658268|NCT01026818|448371225|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
124658269|NCT01026818|448371226|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
124658270|NCT01026818|448371227|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
124658271|NCT01026818|448371228|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
124658272|NCT01026818|448371225|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
124658273|NCT01026818|448371226|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
124658274|NCT01026818|448371227|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
124658275|NCT01026818|448371228|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
124658276|NCT01026818|448371225|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
124658277|NCT01026818|448371226|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
124658278|NCT01026818|448371227|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
124658279|NCT01026818|448371228|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
124658280|NCT01026818|448371225|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
124658281|NCT01026818|448371226|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
124658282|NCT01026818|448371227|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
124658283|NCT01026818|448371228|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
124658284|NCT01026818|448371225|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
124658285|NCT01026818|448371226|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
124658286|NCT01026818|448371227|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
124658287|NCT01026818|448371228|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
124658288|NCT01026818|448371225|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
124658289|NCT01026818|448371226|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
124658290|NCT01026818|448371227|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
124658291|NCT01026818|448371228|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
124658292|NCT01026818|448371225|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
124658293|NCT01026818|448371226|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
124658294|NCT01026818|448371227|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
124658295|NCT01026818|448371228|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
124658296|NCT01760447|448371231|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
124658297|NCT01760447|448371232|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
124658298|NCT01760447|448371233|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
124658299|NCT01760447|448371234|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
124658300|NCT01760447|448371231|FG000|Weeks 0-20|Withdrawal by Subject|2|||
124658301|NCT01760447|448371232|FG001|Weeks 0-20|Withdrawal by Subject|0|||
124658302|NCT01760447|448371233|FG002|Weeks 0-20|Withdrawal by Subject|1|||
124658303|NCT01760447|448371234|FG003|Weeks 0-20|Withdrawal by Subject|0|||
124658304|NCT01760447|448371231|FG000|Weeks 0-20|Lost to Follow-up|1|||
124658305|NCT01760447|448371232|FG001|Weeks 0-20|Lost to Follow-up|0|||
124658306|NCT01760447|448371233|FG002|Weeks 0-20|Lost to Follow-up|1|||
124658307|NCT01760447|448371234|FG003|Weeks 0-20|Lost to Follow-up|1|||
124658308|NCT01760447|448371231|FG000|Weeks 0-20|Randomized but not treated|0|||
124658309|NCT01760447|448371232|FG001|Weeks 0-20|Randomized but not treated|0|||
124658310|NCT01760447|448371233|FG002|Weeks 0-20|Randomized but not treated|2|||
124658311|NCT01760447|448371234|FG003|Weeks 0-20|Randomized but not treated|0|||
124658312|NCT01760447|448371231|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
124658313|NCT01760447|448371232|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
124658314|NCT01760447|448371233|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
124658315|NCT01760447|448371234|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
124658316|NCT01760447|448371231|FG000|Weeks 20-54|Withdrawal by Subject|2|||
124658317|NCT01760447|448371232|FG001|Weeks 20-54|Withdrawal by Subject|1|||
124658318|NCT01760447|448371233|FG002|Weeks 20-54|Withdrawal by Subject|1|||
124658319|NCT01760447|448371234|FG003|Weeks 20-54|Withdrawal by Subject|2|||
124658320|NCT01760447|448371231|FG000|Weeks 20-54|Lost to Follow-up|0|||
124658321|NCT01760447|448371232|FG001|Weeks 20-54|Lost to Follow-up|0|||
124658322|NCT01760447|448371233|FG002|Weeks 20-54|Lost to Follow-up|1|||
124658323|NCT01760447|448371234|FG003|Weeks 20-54|Lost to Follow-up|2|||
124658324|NCT01641471|448371235|FG000|Overall Study|Withdrawal by Subject|19|||
124658325|NCT01641471|448371236|FG001|Overall Study|Withdrawal by Subject|19|||
124658326|NCT01641471|448371235|FG000|Overall Study|Lost to Follow-up|2|||
124658327|NCT01641471|448371236|FG001|Overall Study|Lost to Follow-up|4|||
124658328|NCT01641471|448371235|FG000|Overall Study|Protocol Violation|2|||
124658329|NCT01641471|448371236|FG001|Overall Study|Protocol Violation|4|||
124658330|NCT04575584|448371237|FG000|Overall Study|Death|6|||
124658331|NCT04575584|448371238|FG001|Overall Study|Death|4|||
124658332|NCT04575584|448371239|FG002|Overall Study|Death|6|||
124658333|NCT04575584|448371240|FG003|Overall Study|Death|2|||
124658334|NCT04575584|448371241|FG004|Overall Study|Death|0|||
124658335|NCT04575584|448371242|FG005|Overall Study|Death|0|||
124658336|NCT04575584|448371237|FG000|Overall Study|Lost to Follow-up|1|||
124658337|NCT04575584|448371238|FG001|Overall Study|Lost to Follow-up|1|||
124658338|NCT04575584|448371239|FG002|Overall Study|Lost to Follow-up|1|||
124658339|NCT04575584|448371240|FG003|Overall Study|Lost to Follow-up|1|||
124658340|NCT04575584|448371241|FG004|Overall Study|Lost to Follow-up|0|||
124658341|NCT04575584|448371242|FG005|Overall Study|Lost to Follow-up|0|||
124658342|NCT04575584|448371237|FG000|Overall Study|Physician Decision|0|||
124658343|NCT04575584|448371238|FG001|Overall Study|Physician Decision|1|||
124658344|NCT04575584|448371239|FG002|Overall Study|Physician Decision|1|||
124658345|NCT04575584|448371240|FG003|Overall Study|Physician Decision|1|||
124658346|NCT04575584|448371241|FG004|Overall Study|Physician Decision|0|||
124658347|NCT04575584|448371242|FG005|Overall Study|Physician Decision|0|||
124658348|NCT04575584|448371237|FG000|Overall Study|Withdrawal by Subject|7|||
124658349|NCT04575584|448371238|FG001|Overall Study|Withdrawal by Subject|9|||
124658350|NCT04575584|448371239|FG002|Overall Study|Withdrawal by Subject|5|||
124658351|NCT04575584|448371240|FG003|Overall Study|Withdrawal by Subject|3|||
124658352|NCT04575584|448371241|FG004|Overall Study|Withdrawal by Subject|0|||
124658353|NCT04575584|448371242|FG005|Overall Study|Withdrawal by Subject|0|||
124658354|NCT04575584|448371237|FG000|Overall Study|Not recorded|0|||
124658355|NCT04575584|448371238|FG001|Overall Study|Not recorded|0|||
124658356|NCT04575584|448371239|FG002|Overall Study|Not recorded|0|||
124658357|NCT04575584|448371240|FG003|Overall Study|Not recorded|1|||
124658358|NCT04575584|448371241|FG004|Overall Study|Not recorded|0|||
124658359|NCT04575584|448371242|FG005|Overall Study|Not recorded|0|||
124658360|NCT03488563|448371243|FG000|Overall Study|Lost to Follow-up|7|||
124658361|NCT03488563|448371244|FG001|Overall Study|Lost to Follow-up|6|||
124658362|NCT03488563|448371245|FG002|Overall Study|Lost to Follow-up|7|||
124658363|NCT03488563|448371243|FG000|Overall Study|Withdrawal by Subject|8|||
124658364|NCT03488563|448371244|FG001|Overall Study|Withdrawal by Subject|7|||
124658365|NCT03488563|448371245|FG002|Overall Study|Withdrawal by Subject|7|||
124658366|NCT03488563|448371243|FG000|Overall Study|Physician Decision|0|||
124658367|NCT03488563|448371244|FG001|Overall Study|Physician Decision|0|||
124658368|NCT03488563|448371245|FG002|Overall Study|Physician Decision|1|||
124658369|NCT03488563|448371243|FG000|Overall Study|Protocol Violation|3|||
124658370|NCT03488563|448371244|FG001|Overall Study|Protocol Violation|2|||
124658371|NCT03488563|448371245|FG002|Overall Study|Protocol Violation|6|||
124658372|NCT03488563|448371243|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
124658373|NCT03488563|448371244|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
124658374|NCT03488563|448371245|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
124658375|NCT03488563|448371243|FG000|Overall Study|Use of prohibited medication|2|||
124658376|NCT03488563|448371244|FG001|Overall Study|Use of prohibited medication|0|||
124658377|NCT03488563|448371245|FG002|Overall Study|Use of prohibited medication|0|||
124658378|NCT03488563|448371243|FG000|Overall Study|Adverse Event|1|||
124658379|NCT03488563|448371244|FG001|Overall Study|Adverse Event|0|||
124658380|NCT03488563|448371245|FG002|Overall Study|Adverse Event|1|||
124658381|NCT03488563|448371243|FG000|Overall Study|Subject returned for ET visit|0|||
124658382|NCT03488563|448371244|FG001|Overall Study|Subject returned for ET visit|1|||
124658383|NCT03488563|448371245|FG002|Overall Study|Subject returned for ET visit|0|||
124658384|NCT03488563|448371243|FG000|Overall Study|Sponsor's decision|0|||
124658385|NCT03488563|448371244|FG001|Overall Study|Sponsor's decision|0|||
124658386|NCT03488563|448371245|FG002|Overall Study|Sponsor's decision|1|||
124658387|NCT02815267|448371253|FG000|Double-Blind Phase|Adverse Event|0|||
124658388|NCT02815267|448371254|FG001|Double-Blind Phase|Adverse Event|3|||
124658389|NCT02815267|448371253|FG000|Double-Blind Phase|Lost to Follow-up|17|||
124658390|NCT02815267|448371254|FG001|Double-Blind Phase|Lost to Follow-up|9|||
124658391|NCT02815267|448371253|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
124658392|NCT02815267|448371254|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
124658393|NCT02815267|448371253|FG000|Double-Blind Phase|Protocol Violation|3|||
124658394|NCT02815267|448371254|FG001|Double-Blind Phase|Protocol Violation|2|||
124658395|NCT02815267|448371253|FG000|Double-Blind Phase|Site withdrawal|1|||
124658396|NCT02815267|448371254|FG001|Double-Blind Phase|Site withdrawal|6|||
124658397|NCT02815267|448371253|FG000|Double-Blind Phase|Received a disallowed medication|1|||
124658398|NCT02815267|448371254|FG001|Double-Blind Phase|Received a disallowed medication|1|||
124658399|NCT02815267|448371253|FG000|Open-Label Phase|Adverse Event|1|||
124658400|NCT02815267|448371254|FG001|Open-Label Phase|Adverse Event|1|||
124658401|NCT02815267|448371253|FG000|Open-Label Phase|Lost to Follow-up|23|||
124658402|NCT02815267|448371254|FG001|Open-Label Phase|Lost to Follow-up|9|||
124658403|NCT02815267|448371253|FG000|Open-Label Phase|Withdrawal by Subject|24|||
124658404|NCT02815267|448371254|FG001|Open-Label Phase|Withdrawal by Subject|13|||
124658405|NCT02815267|448371253|FG000|Open-Label Phase|Protocol Violation|0|||
124658406|NCT02815267|448371254|FG001|Open-Label Phase|Protocol Violation|1|||
124658407|NCT02815267|448371253|FG000|Open-Label Phase|Administrative|21|||
124658408|NCT02815267|448371254|FG001|Open-Label Phase|Administrative|12|||
124658409|NCT02815267|448371253|FG000|Open-Label Phase|Other|2|||
124658410|NCT02815267|448371254|FG001|Open-Label Phase|Other|5|||
124658411|NCT04278924|448371257|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
124658412|NCT04278924|448371258|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
124658413|NCT04278924|448371259|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
124658414|NCT04278924|448371260|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
124658415|NCT04278924|448371261|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
124658416|NCT04278924|448371262|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
124658417|NCT04278924|448371263|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
124658418|NCT04278924|448371257|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
124658419|NCT04278924|448371258|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
124658420|NCT04278924|448371259|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
124658421|NCT04278924|448371260|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
124658422|NCT04278924|448371261|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
124658423|NCT04278924|448371262|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
124658424|NCT04278924|448371263|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
124658425|NCT05600036|448371264|FG000|Overall Study|Adverse Event|0|||
124658426|NCT05600036|448371265|FG001|Overall Study|Adverse Event|2|||
124658427|NCT05600036|448371266|FG002|Overall Study|Adverse Event|1|||
124658428|NCT05600036|448371267|FG003|Overall Study|Adverse Event|0|||
124658429|NCT05600036|448371268|FG004|Overall Study|Adverse Event|1|||
124658430|NCT05600036|448371269|FG005|Overall Study|Adverse Event|0|||
124658431|NCT05600036|448371264|FG000|Overall Study|Lost to Follow-up|0|||
124658432|NCT05600036|448371265|FG001|Overall Study|Lost to Follow-up|2|||
124658433|NCT05600036|448371266|FG002|Overall Study|Lost to Follow-up|1|||
124658434|NCT05600036|448371267|FG003|Overall Study|Lost to Follow-up|1|||
124658435|NCT05600036|448371268|FG004|Overall Study|Lost to Follow-up|0|||
124658436|NCT05600036|448371269|FG005|Overall Study|Lost to Follow-up|0|||
124658437|NCT05600036|448371264|FG000|Overall Study|Protocol Violation|0|||
124658438|NCT05600036|448371265|FG001|Overall Study|Protocol Violation|0|||
124658439|NCT05600036|448371266|FG002|Overall Study|Protocol Violation|2|||
124658440|NCT05600036|448371267|FG003|Overall Study|Protocol Violation|0|||
124658441|NCT05600036|448371268|FG004|Overall Study|Protocol Violation|0|||
124658442|NCT05600036|448371269|FG005|Overall Study|Protocol Violation|0|||
124658443|NCT05600036|448371264|FG000|Overall Study|Withdrawal by Subject|0|||
124658444|NCT05600036|448371265|FG001|Overall Study|Withdrawal by Subject|1|||
124658445|NCT05600036|448371266|FG002|Overall Study|Withdrawal by Subject|2|||
124658446|NCT05600036|448371267|FG003|Overall Study|Withdrawal by Subject|0|||
124658447|NCT05600036|448371268|FG004|Overall Study|Withdrawal by Subject|3|||
124658448|NCT05600036|448371269|FG005|Overall Study|Withdrawal by Subject|5|||
124658449|NCT05600036|448371264|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
124658450|NCT05600036|448371265|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
124658451|NCT05600036|448371266|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
124658452|NCT05600036|448371267|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
124658453|NCT05600036|448371268|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
124658454|NCT05600036|448371269|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
124658455|NCT05600036|448371264|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
124658456|NCT05600036|448371265|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
124658457|NCT05600036|448371266|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
124658458|NCT05600036|448371267|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
124658459|NCT05600036|448371268|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
124658460|NCT05600036|448371269|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
124658461|NCT05600036|448371264|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
124658462|NCT05600036|448371265|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
124658463|NCT05600036|448371266|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
124658464|NCT05600036|448371267|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
124658465|NCT05600036|448371268|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
124658466|NCT05600036|448371269|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
124658467|NCT01204918|448371274|FG000|Overall Study|Withdrawal by Subject|4|||
124658468|NCT01204918|448371275|FG001|Overall Study|Withdrawal by Subject|10|||
124658469|NCT01204918|448371276|FG002|Overall Study|Withdrawal by Subject|5|||
124658470|NCT01853696|448371279|FG000|Overall Study|Withdrawal by Subject|1|||
124658471|NCT01853696|448371280|FG001|Overall Study|Withdrawal by Subject|1|||
124658472|NCT01853696|448371279|FG000|Overall Study|Lost to Follow-up|5|||
124658473|NCT01853696|448371280|FG001|Overall Study|Lost to Follow-up|4|||
124658474|NCT00431067|448371283|FG000|Overall Study|Other Adverse Event|9|||
124658475|NCT00431067|448371283|FG000|Overall Study|Progressive disease|30|||
124658476|NCT00431067|448371283|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
124658477|NCT00938587|448371284|FG000|Overall Study|Adverse Event|2|||
124658478|NCT00938587|448371285|FG001|Overall Study|Adverse Event|0|||
124658479|NCT00938587|448371286|FG002|Overall Study|Adverse Event|0|||
124658480|NCT00938587|448371287|FG003|Overall Study|Adverse Event|2|||
124658481|NCT00938587|448371284|FG000|Overall Study|Did not meet entrance criteria|0|||
124658482|NCT00938587|448371285|FG001|Overall Study|Did not meet entrance criteria|0|||
124658483|NCT00938587|448371286|FG002|Overall Study|Did not meet entrance criteria|1|||
124658484|NCT00938587|448371287|FG003|Overall Study|Did not meet entrance criteria|0|||
124658485|NCT00938587|448371284|FG000|Overall Study|Withdrawal by Subject|1|||
124658486|NCT00938587|448371285|FG001|Overall Study|Withdrawal by Subject|1|||
124658487|NCT00938587|448371286|FG002|Overall Study|Withdrawal by Subject|0|||
124658488|NCT00938587|448371287|FG003|Overall Study|Withdrawal by Subject|0|||
124658489|NCT00849290|448371288|FG000|Overall Study|Adverse Event|3|||
124658490|NCT00849290|448371288|FG000|Overall Study|Death|14|||
124658491|NCT00849290|448371288|FG000|Overall Study|Withdrawal by Subject|11|||
124658492|NCT00849290|448371288|FG000|Overall Study|Lost to Follow-up|2|||
124658493|NCT00849290|448371288|FG000|Overall Study|Protocol Violation|5|||
124658494|NCT00849290|448371288|FG000|Overall Study|Disease Progression|20|||
124658495|NCT00548249|448371289|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
124658496|NCT00548249|448371290|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
124658497|NCT00548249|448371291|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
124658498|NCT00548249|448371292|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
124658499|NCT00548249|448371293|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
124658500|NCT00548249|448371289|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
124658501|NCT00548249|448371290|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
124658502|NCT00548249|448371291|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
124658503|NCT00548249|448371292|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
124658504|NCT00548249|448371293|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
124658505|NCT00548249|448371289|FG000|Overall Study|Protocol Violation|1|||
124658506|NCT00548249|448371290|FG001|Overall Study|Protocol Violation|1|||
124658507|NCT00548249|448371291|FG002|Overall Study|Protocol Violation|4|||
124658508|NCT00548249|448371292|FG003|Overall Study|Protocol Violation|0|||
124658509|NCT00548249|448371293|FG004|Overall Study|Protocol Violation|3|||
124658510|NCT00548249|448371289|FG000|Overall Study|Miscellaneous|2|||
124658511|NCT00548249|448371290|FG001|Overall Study|Miscellaneous|3|||
124658512|NCT00548249|448371291|FG002|Overall Study|Miscellaneous|2|||
124658513|NCT00548249|448371292|FG003|Overall Study|Miscellaneous|0|||
124658514|NCT00548249|448371293|FG004|Overall Study|Miscellaneous|2|||
124658515|NCT00548249|448371289|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
124658516|NCT00548249|448371290|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
124658517|NCT00548249|448371291|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
124658518|NCT00548249|448371292|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
124658519|NCT00548249|448371293|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
124658520|NCT00548249|448371289|FG000|Overall Study|Adverse Event|2|||
124658521|NCT00548249|448371290|FG001|Overall Study|Adverse Event|2|||
124658522|NCT00548249|448371291|FG002|Overall Study|Adverse Event|0|||
124658523|NCT00548249|448371292|FG003|Overall Study|Adverse Event|1|||
124658524|NCT00548249|448371293|FG004|Overall Study|Adverse Event|1|||
124658525|NCT00548249|448371289|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
124658526|NCT00548249|448371290|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
124658527|NCT00548249|448371291|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
124658528|NCT00548249|448371292|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
124658529|NCT00548249|448371293|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
124658530|NCT00548249|448371289|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
124658531|NCT00548249|448371290|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
124658532|NCT00548249|448371291|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
124658533|NCT00548249|448371292|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
124658534|NCT00548249|448371293|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
124658535|NCT00548249|448371289|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
124658536|NCT00548249|448371290|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
124658537|NCT00548249|448371291|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
124658538|NCT00548249|448371292|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
124658539|NCT00548249|448371293|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
124658540|NCT00548249|448371289|FG000|Overall Study|Prolonged hospitalization|0|||
124658541|NCT00548249|448371290|FG001|Overall Study|Prolonged hospitalization|0|||
124658542|NCT00548249|448371291|FG002|Overall Study|Prolonged hospitalization|2|||
124658543|NCT00548249|448371292|FG003|Overall Study|Prolonged hospitalization|1|||
124658544|NCT00548249|448371293|FG004|Overall Study|Prolonged hospitalization|0|||
124658545|NCT00548249|448371289|FG000|Overall Study|Withdrawal by Subject|2|||
124658546|NCT00548249|448371290|FG001|Overall Study|Withdrawal by Subject|0|||
124658547|NCT00548249|448371291|FG002|Overall Study|Withdrawal by Subject|0|||
124658548|NCT00548249|448371292|FG003|Overall Study|Withdrawal by Subject|0|||
124658549|NCT00548249|448371293|FG004|Overall Study|Withdrawal by Subject|0|||
124658550|NCT00548249|448371289|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
124658551|NCT00548249|448371290|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
124658552|NCT00548249|448371291|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
124658553|NCT00548249|448371292|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
124658554|NCT00548249|448371293|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
124658555|NCT00548249|448371289|FG000|Overall Study|Sponsor's request|0|||
124658556|NCT00548249|448371290|FG001|Overall Study|Sponsor's request|0|||
124658557|NCT00548249|448371291|FG002|Overall Study|Sponsor's request|0|||
124658558|NCT00548249|448371292|FG003|Overall Study|Sponsor's request|1|||
124658559|NCT00548249|448371293|FG004|Overall Study|Sponsor's request|0|||
124658560|NCT00002525|448371298|FG000|Overall Study|Adverse Event|36|||
124658561|NCT00002525|448371299|FG001|Overall Study|Adverse Event|0|||
124658562|NCT00002525|448371298|FG000|Overall Study|Death|5|||
124658563|NCT00002525|448371299|FG001|Overall Study|Death|0|||
124658564|NCT00002525|448371298|FG000|Overall Study|Withdrawal by Subject|11|||
124658565|NCT00002525|448371299|FG001|Overall Study|Withdrawal by Subject|0|||
124658566|NCT00002525|448371298|FG000|Overall Study|Start non-protocol therapy|1|||
124658567|NCT00002525|448371299|FG001|Overall Study|Start non-protocol therapy|0|||
124658568|NCT00002525|448371298|FG000|Overall Study|Other complicating disease|1|||
124658569|NCT00002525|448371299|FG001|Overall Study|Other complicating disease|0|||
124658570|NCT00002525|448371298|FG000|Overall Study|Duke's A, B1, D disease|92|||
124658571|NCT00002525|448371299|FG001|Overall Study|Duke's A, B1, D disease|0|||
124658572|NCT00002525|448371298|FG000|Overall Study|Error|6|||
124658573|NCT00002525|448371299|FG001|Overall Study|Error|0|||
124658574|NCT00002525|448371298|FG000|Overall Study|Other|26|||
124658575|NCT00002525|448371299|FG001|Overall Study|Other|0|||
124658576|NCT00002525|448371298|FG000|Overall Study|Never start protocol therapy|8|||
124658577|NCT00002525|448371299|FG001|Overall Study|Never start protocol therapy|0|||
124658578|NCT03230838|448371300|FG000|Overall Study|Withdrawal by Subject|3|||
124658579|NCT03230838|448371301|FG001|Overall Study|Withdrawal by Subject|0|||
124658580|NCT03230838|448371300|FG000|Overall Study|Temperature excursion|1|||
124658581|NCT03230838|448371301|FG001|Overall Study|Temperature excursion|0|||
124658582|NCT03304184|448371302|FG000|Overall Study|Withdrawal by Subject|1|||
124658583|NCT03304184|448371303|FG001|Overall Study|Withdrawal by Subject|2|||
124658584|NCT01915771|448371306|FG000|Day 1|Withdrawal by Subject|1|||
124658585|NCT01915771|448371306|FG000|Day 15|Withdrawal by Subject|1|||
124658586|NCT03420222|448371312|FG000|Overall Study|Withdrawal by Subject|5|||
124658587|NCT03420222|448371313|FG001|Overall Study|Withdrawal by Subject|0|||
124658588|NCT03420222|448371312|FG000|Overall Study|Physician Decision|0|||
124658589|NCT03420222|448371313|FG001|Overall Study|Physician Decision|1|||
124658590|NCT02697734|448371314|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
124658591|NCT02697734|448371315|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
124658592|NCT02697734|448371314|FG000|Core Phase - up to Week 48|Adverse Event|1|||
124658593|NCT02697734|448371315|FG001|Core Phase - up to Week 48|Adverse Event|2|||
124658594|NCT02697734|448371314|FG000|Core Phase - up to Week 48|Physician Decision|1|||
124658595|NCT02697734|448371315|FG001|Core Phase - up to Week 48|Physician Decision|0|||
124658596|NCT02697734|448371314|FG000|Optional Extension Phase|Adverse Event|5|||
124658597|NCT02697734|448371315|FG001|Optional Extension Phase|Adverse Event|1|||
124658598|NCT02697734|448371314|FG000|Optional Extension Phase|Physician Decision|0|||
124658599|NCT02697734|448371315|FG001|Optional Extension Phase|Physician Decision|1|||
124658600|NCT02334384|448371317|FG000|Overall Study|Lost to Follow-up|1|||
124658601|NCT02334384|448371318|FG001|Overall Study|Lost to Follow-up|1|||
124658602|NCT02651688|448371319|FG000|Overall Study|Non-compliance|0|||
124658603|NCT02651688|448371320|FG001|Overall Study|Non-compliance|0|||
124658604|NCT02651688|448371321|FG002|Overall Study|Non-compliance|1|||
124658605|NCT02651688|448371319|FG000|Overall Study|Principal Investigator (PI) decision|0|||
124658606|NCT02651688|448371320|FG001|Overall Study|Principal Investigator (PI) decision|2|||
124658607|NCT02651688|448371321|FG002|Overall Study|Principal Investigator (PI) decision|0|||
124658608|NCT02651688|448371319|FG000|Overall Study|Lost to Follow-up|1|||
124658609|NCT02651688|448371320|FG001|Overall Study|Lost to Follow-up|3|||
124658610|NCT02651688|448371321|FG002|Overall Study|Lost to Follow-up|0|||
124658611|NCT02651688|448371319|FG000|Overall Study|Withdrawal by Subject|1|||
124658612|NCT02651688|448371320|FG001|Overall Study|Withdrawal by Subject|0|||
124658613|NCT02651688|448371321|FG002|Overall Study|Withdrawal by Subject|2|||
124658614|NCT04527978|448371322|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
124658615|NCT04527978|448371323|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
124658616|NCT01429441|448371324|FG000|Overall Study|Adverse Event|5|||
124658617|NCT01429441|448371325|FG001|Overall Study|Adverse Event|1|||
124658618|NCT01429441|448371324|FG000|Overall Study|Death|0|||
124658619|NCT01429441|448371325|FG001|Overall Study|Death|2|||
124658620|NCT01429441|448371324|FG000|Overall Study|Lost to Follow-up|5|||
124658621|NCT01429441|448371325|FG001|Overall Study|Lost to Follow-up|2|||
124658622|NCT01429441|448371324|FG000|Overall Study|Physician Decision|1|||
124658623|NCT01429441|448371325|FG001|Overall Study|Physician Decision|0|||
124658624|NCT01429441|448371324|FG000|Overall Study|Withdrawal by Subject|27|||
124658625|NCT01429441|448371325|FG001|Overall Study|Withdrawal by Subject|18|||
124658626|NCT01578499|448371331|FG000|Overall Study|Reason not Specified|0|||
124658627|NCT01578499|448371332|FG001|Overall Study|Reason not Specified|1|||
124658628|NCT01578499|448371331|FG000|Overall Study|Lost to Follow-up|2|||
124658629|NCT01578499|448371332|FG001|Overall Study|Lost to Follow-up|1|||
124658630|NCT01578499|448371331|FG000|Overall Study|Withdrawal by Subject|10|||
124658631|NCT01578499|448371332|FG001|Overall Study|Withdrawal by Subject|16|||
124658632|NCT01578499|448371331|FG000|Overall Study|Death|20|||
124658633|NCT01578499|448371332|FG001|Overall Study|Death|25|||
124658634|NCT01578499|448371331|FG000|Overall Study|Died and End of Study Page not Completed|2|||
124658635|NCT01578499|448371332|FG001|Overall Study|Died and End of Study Page not Completed|0|||
124658636|NCT00830518|448371333|FG000|Overall Study|Progressive Disease|18|||
124658637|NCT00830518|448371334|FG001|Overall Study|Progressive Disease|8|||
124658638|NCT00830518|448371333|FG000|Overall Study|Symptomatic Deterioration|4|||
124658639|NCT00830518|448371334|FG001|Overall Study|Symptomatic Deterioration|1|||
124658640|NCT00830518|448371333|FG000|Overall Study|Adverse Event|14|||
124658641|NCT00830518|448371334|FG001|Overall Study|Adverse Event|1|||
124658642|NCT00830518|448371333|FG000|Overall Study|Withdrawal by Patient|2|||
124658643|NCT00830518|448371334|FG001|Overall Study|Withdrawal by Patient|0|||
124658644|NCT00830518|448371333|FG000|Overall Study|Reason not Specified|8|||
124658645|NCT00830518|448371334|FG001|Overall Study|Reason not Specified|1|||
124658646|NCT00394771|448371341|FG000|Overall Study|Did not meet protocol requirements|1|||
124658647|NCT00394771|448371342|FG001|Overall Study|Did not meet protocol requirements|0|||
124658648|NCT00394771|448371343|FG002|Overall Study|Did not meet protocol requirements|2|||
124658649|NCT00394771|448371344|FG003|Overall Study|Did not meet protocol requirements|0|||
124658650|NCT00394771|448371341|FG000|Overall Study|Protocol Violation|2|||
124658651|NCT00394771|448371342|FG001|Overall Study|Protocol Violation|4|||
124658652|NCT00394771|448371343|FG002|Overall Study|Protocol Violation|9|||
124658653|NCT00394771|448371344|FG003|Overall Study|Protocol Violation|7|||
124658654|NCT00394771|448371341|FG000|Overall Study|Withdrawal by Subject|10|||
124658655|NCT00394771|448371342|FG001|Overall Study|Withdrawal by Subject|6|||
124658656|NCT00394771|448371343|FG002|Overall Study|Withdrawal by Subject|8|||
124658657|NCT00394771|448371344|FG003|Overall Study|Withdrawal by Subject|12|||
124658658|NCT00394771|448371341|FG000|Overall Study|Adverse Event|10|||
124658659|NCT00394771|448371342|FG001|Overall Study|Adverse Event|5|||
124658660|NCT00394771|448371343|FG002|Overall Study|Adverse Event|12|||
124658661|NCT00394771|448371344|FG003|Overall Study|Adverse Event|8|||
124658662|NCT00394771|448371341|FG000|Overall Study|Participant pregnant|0|||
124658663|NCT00394771|448371342|FG001|Overall Study|Participant pregnant|1|||
124658664|NCT00394771|448371343|FG002|Overall Study|Participant pregnant|2|||
124658665|NCT00394771|448371344|FG003|Overall Study|Participant pregnant|2|||
124658666|NCT00394771|448371341|FG000|Overall Study|Lost to Follow-up|15|||
124658667|NCT00394771|448371342|FG001|Overall Study|Lost to Follow-up|15|||
124658668|NCT00394771|448371343|FG002|Overall Study|Lost to Follow-up|13|||
124658669|NCT00394771|448371344|FG003|Overall Study|Lost to Follow-up|10|||
124658670|NCT00394771|448371341|FG000|Overall Study|Other|3|||
124658671|NCT00394771|448371342|FG001|Overall Study|Other|3|||
124658672|NCT00394771|448371343|FG002|Overall Study|Other|1|||
124658673|NCT00394771|448371344|FG003|Overall Study|Other|0|||
124658674|NCT00520767|448371345|FG000|Overall Study|Death|2|||
124658675|NCT03597139|448371347|FG000|Overall Study|Adverse Event|3|||
124658676|NCT03597139|448371348|FG001|Overall Study|Adverse Event|0|||
124658677|NCT03597139|448371347|FG000|Overall Study|Protocol Non-compliance|1|||
124658678|NCT03597139|448371348|FG001|Overall Study|Protocol Non-compliance|0|||
124658679|NCT00382109|448371349|FG000|Overall Study|Adverse Event|3|||
124658680|NCT00382109|448371350|FG001|Overall Study|Adverse Event|0|||
124658681|NCT00382109|448371349|FG000|Overall Study|Physician Decision|6|||
124658682|NCT00382109|448371350|FG001|Overall Study|Physician Decision|1|||
124658683|NCT00382109|448371349|FG000|Overall Study|Withdrawal by Subject|1|||
124658684|NCT00382109|448371350|FG001|Overall Study|Withdrawal by Subject|0|||
124658685|NCT00382109|448371349|FG000|Overall Study|ineligible|2|||
124658686|NCT00382109|448371350|FG001|Overall Study|ineligible|0|||
124658687|NCT00382109|448371349|FG000|Overall Study|Other|0|||
124658688|NCT00382109|448371350|FG001|Overall Study|Other|2|||
124658689|NCT00382109|448371349|FG000|Overall Study|consent withdrawal|0|||
124658690|NCT00382109|448371350|FG001|Overall Study|consent withdrawal|1|||
124658691|NCT00248833|448371351|FG000|Overall Study|Adverse Event|2|||
124658692|NCT00248833|448371352|FG001|Overall Study|Adverse Event|0|||
124658693|NCT00248833|448371353|FG002|Overall Study|Adverse Event|0|||
124658694|NCT00248833|448371351|FG000|Overall Study|Withdrawal by Subject|0|||
124658695|NCT00248833|448371352|FG001|Overall Study|Withdrawal by Subject|1|||
124658696|NCT00248833|448371353|FG002|Overall Study|Withdrawal by Subject|1|||
124658697|NCT00248833|448371351|FG000|Overall Study|Lost to Follow-up|1|||
124658698|NCT00248833|448371352|FG001|Overall Study|Lost to Follow-up|1|||
124658699|NCT00248833|448371353|FG002|Overall Study|Lost to Follow-up|1|||
124658700|NCT00248833|448371351|FG000|Overall Study|Other|0|||
124658701|NCT00248833|448371352|FG001|Overall Study|Other|1|||
124658702|NCT00248833|448371353|FG002|Overall Study|Other|0|||
124658703|NCT01900899|448371354|FG000|Overall Study|Withdrawal by Subject|7|||
124658704|NCT01900899|448371355|FG001|Overall Study|Withdrawal by Subject|1|||
124658705|NCT01900899|448371354|FG000|Overall Study|Migrated from study area|2|||
124658706|NCT01900899|448371355|FG001|Overall Study|Migrated from study area|0|||
124658707|NCT00723697|448371358|FG000|Overall Study|Physician questionnaires not received|2|||
124658708|NCT00723697|448371358|FG000|Overall Study|Missing Informed Consent Form|10|||
124658709|NCT00723697|448371358|FG000|Overall Study|Other exclusion criteria applied|6|||
124658710|NCT01483599|448371361|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
124658711|NCT01483599|448371362|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
124658712|NCT01483599|448371363|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
124658713|NCT01483599|448371364|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
124658714|NCT01483599|448371365|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
124658715|NCT01483599|448371366|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
124658716|NCT01483599|448371367|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
124658717|NCT01483599|448371368|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
124658718|NCT01483599|448371369|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
124658719|NCT01483599|448371370|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
124658720|NCT01483599|448371371|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
124658721|NCT01483599|448371372|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
124658722|NCT01483599|448371373|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
124658723|NCT01483599|448371374|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
124658724|NCT01483599|448371361|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
124658725|NCT01483599|448371362|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
124658726|NCT01483599|448371363|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
124658727|NCT01483599|448371364|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
124658728|NCT01483599|448371365|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
124658729|NCT01483599|448371366|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
124658730|NCT01483599|448371367|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
124658731|NCT01483599|448371368|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
124658732|NCT01483599|448371369|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
124658733|NCT01483599|448371370|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
124658734|NCT01483599|448371371|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
124658735|NCT01483599|448371372|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
124658736|NCT01483599|448371373|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
124658737|NCT01483599|448371374|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
124658738|NCT01483599|448371361|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
124658739|NCT01483599|448371362|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
124658740|NCT01483599|448371363|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
124658741|NCT01483599|448371364|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
124658742|NCT01483599|448371365|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
124658743|NCT01483599|448371366|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
124658744|NCT01483599|448371367|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
124658745|NCT01483599|448371368|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
124658746|NCT01483599|448371369|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
124658747|NCT01483599|448371370|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
124658748|NCT01483599|448371371|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
124658749|NCT01483599|448371372|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
124658750|NCT01483599|448371373|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
124658751|NCT01483599|448371374|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
124658752|NCT01483599|448371361|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
124658753|NCT01483599|448371362|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
124658754|NCT01483599|448371363|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
124658755|NCT01483599|448371364|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
124658756|NCT01483599|448371365|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
124658757|NCT01483599|448371366|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
124658758|NCT01483599|448371367|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
124658759|NCT01483599|448371368|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
124658760|NCT01483599|448371369|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
124658761|NCT01483599|448371370|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
124658762|NCT01483599|448371371|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
124658763|NCT01483599|448371372|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
124658764|NCT01483599|448371373|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
124658765|NCT01483599|448371374|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
124658766|NCT01483599|448371361|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
124658767|NCT01483599|448371362|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
124658768|NCT01483599|448371363|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
124658769|NCT01483599|448371364|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
124658770|NCT01483599|448371365|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
124658771|NCT01483599|448371366|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
124658772|NCT01483599|448371367|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
124658773|NCT01483599|448371368|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
124658774|NCT01483599|448371369|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
124658775|NCT01483599|448371370|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
124658776|NCT01483599|448371371|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
124658777|NCT01483599|448371372|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
124658778|NCT01483599|448371373|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
124658779|NCT01483599|448371374|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
124658780|NCT01483599|448371361|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
124658781|NCT01483599|448371362|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
124658782|NCT01483599|448371363|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
124658783|NCT01483599|448371364|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
124658784|NCT01483599|448371365|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
124658785|NCT01483599|448371366|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
124658786|NCT01483599|448371367|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
124658787|NCT01483599|448371368|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
124658788|NCT01483599|448371369|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
124658789|NCT01483599|448371370|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
124658790|NCT01483599|448371371|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
124658791|NCT01483599|448371372|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
124658792|NCT01483599|448371373|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
124658793|NCT01483599|448371374|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
124658794|NCT01483599|448371361|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
124658795|NCT01483599|448371362|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
124658796|NCT01483599|448371363|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
124658797|NCT01483599|448371364|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
124544305|NCT05182840|447946753|FG005|Treatment Period|Adverse Event|6|||
124658798|NCT01483599|448371365|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
124658799|NCT01483599|448371366|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
124658800|NCT01483599|448371367|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
124658801|NCT01483599|448371368|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
124658802|NCT01483599|448371369|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
124658803|NCT01483599|448371370|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
124658804|NCT01483599|448371371|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
124658805|NCT01483599|448371372|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
124658806|NCT01483599|448371373|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
124658807|NCT01483599|448371374|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
124658808|NCT01483599|448371361|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
124658809|NCT01483599|448371362|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
124658810|NCT01483599|448371363|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
124658811|NCT01483599|448371364|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
124658812|NCT01483599|448371365|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
124658813|NCT01483599|448371366|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
124658814|NCT01483599|448371367|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
124658815|NCT01483599|448371368|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
124658816|NCT01483599|448371369|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
124658817|NCT01483599|448371370|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
124658818|NCT01483599|448371371|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
124658819|NCT01483599|448371372|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
124658820|NCT01483599|448371373|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
124658821|NCT01483599|448371374|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
124658822|NCT01483599|448371361|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
124658823|NCT01483599|448371362|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
124658824|NCT01483599|448371363|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
124658825|NCT01483599|448371364|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
124658826|NCT01483599|448371365|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
124658827|NCT01483599|448371366|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
124658828|NCT01483599|448371367|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
124658829|NCT01483599|448371368|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
124658830|NCT01483599|448371369|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
124658831|NCT01483599|448371370|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
124658832|NCT01483599|448371371|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
124658833|NCT01483599|448371372|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
124658834|NCT01483599|448371373|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
124658835|NCT01483599|448371374|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
124658836|NCT01483599|448371361|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
124658837|NCT01483599|448371362|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
124658838|NCT01483599|448371363|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
124658839|NCT01483599|448371364|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
124658840|NCT01483599|448371365|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
124658841|NCT01483599|448371366|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
124658842|NCT01483599|448371367|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
124658843|NCT01483599|448371368|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
124658844|NCT01483599|448371369|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
124658845|NCT01483599|448371370|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
124658846|NCT01483599|448371371|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
124658847|NCT01483599|448371372|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
124658848|NCT01483599|448371373|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
124658849|NCT01483599|448371374|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
124658850|NCT02510820|448373499|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
124658851|NCT02510820|448373500|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
124658852|NCT02510820|448373499|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
124658853|NCT02510820|448373500|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
124658854|NCT03046056|448373501|FG000|Overall Study|Non-responder at Week 10|6|||
124658855|NCT03046056|448373502|FG001|Overall Study|Non-responder at Week 10|6|||
124658856|NCT03046056|448373503|FG002|Overall Study|Non-responder at Week 10|4|||
124658857|NCT03046056|448373501|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
124658858|NCT03046056|448373502|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
124658859|NCT03046056|448373503|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
124658860|NCT03046056|448373501|FG000|Overall Study|Adverse Event|1|||
124658861|NCT03046056|448373502|FG001|Overall Study|Adverse Event|5|||
124658862|NCT03046056|448373503|FG002|Overall Study|Adverse Event|0|||
124658863|NCT03046056|448373501|FG000|Overall Study|Non-compliance With Study Drug|0|||
124658864|NCT03046056|448373502|FG001|Overall Study|Non-compliance With Study Drug|0|||
124658865|NCT03046056|448373503|FG002|Overall Study|Non-compliance With Study Drug|2|||
124658866|NCT03046056|448373501|FG000|Overall Study|Protocol Violation|1|||
124658867|NCT03046056|448373502|FG001|Overall Study|Protocol Violation|1|||
124658868|NCT03046056|448373503|FG002|Overall Study|Protocol Violation|0|||
124658869|NCT03046056|448373501|FG000|Overall Study|Investigator's Discretion|0|||
124658870|NCT03046056|448373502|FG001|Overall Study|Investigator's Discretion|1|||
124658871|NCT03046056|448373503|FG002|Overall Study|Investigator's Discretion|0|||
124658872|NCT03046056|448373501|FG000|Overall Study|Withdrew Consent|1|||
124658873|NCT03046056|448373502|FG001|Overall Study|Withdrew Consent|0|||
124658874|NCT03046056|448373503|FG002|Overall Study|Withdrew Consent|0|||
124658875|NCT02913105|448373504|FG000|Overall Study|Adverse Event|11|||
124658876|NCT02913105|448373505|FG001|Overall Study|Adverse Event|0|||
124658877|NCT02913105|448373506|FG002|Overall Study|Adverse Event|4|||
124658878|NCT02913105|448373504|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124658879|NCT02913105|448373505|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124658880|NCT02913105|448373506|FG002|Overall Study|Non-Compliance With Study Drug|1|||
124658881|NCT02913105|448373504|FG000|Overall Study|Reason Not Specified|3|||
124658882|NCT02913105|448373505|FG001|Overall Study|Reason Not Specified|1|||
124658883|NCT02913105|448373506|FG002|Overall Study|Reason Not Specified|1|||
124658884|NCT02913105|448373504|FG000|Overall Study|Physician Decision|1|||
124658885|NCT02913105|448373505|FG001|Overall Study|Physician Decision|1|||
124658886|NCT02913105|448373506|FG002|Overall Study|Physician Decision|0|||
124658887|NCT02913105|448373504|FG000|Overall Study|Withdrawal by Subject|0|||
124658888|NCT02913105|448373505|FG001|Overall Study|Withdrawal by Subject|3|||
124658889|NCT02913105|448373506|FG002|Overall Study|Withdrawal by Subject|1|||
124658890|NCT01317004|448373507|FG000|Overall Study|Withdrawal by Subject|1|||
124658891|NCT01317004|448373508|FG001|Overall Study|Withdrawal by Subject|4|||
124658892|NCT01317004|448373507|FG000|Overall Study|Protocol Violation|0|||
124658893|NCT01317004|448373508|FG001|Overall Study|Protocol Violation|2|||
124658894|NCT01317004|448373507|FG000|Overall Study|Adverse Event|3|||
124658895|NCT01317004|448373508|FG001|Overall Study|Adverse Event|3|||
124658896|NCT01344759|448373512|FG000|Overall Study|Patients failed to reach sedation level|0|||
124658897|NCT01344759|448373513|FG001|Overall Study|Patients failed to reach sedation level|2|||
124658898|NCT01153009|448373514|FG000|Overall Study|Adverse Event|4|||
124658899|NCT01153009|448373515|FG001|Overall Study|Adverse Event|14|||
124658900|NCT01153009|448373516|FG002|Overall Study|Adverse Event|14|||
124658901|NCT01153009|448373517|FG003|Overall Study|Adverse Event|10|||
124658902|NCT01153009|448373514|FG000|Overall Study|Lack of Efficacy|9|||
124658903|NCT01153009|448373515|FG001|Overall Study|Lack of Efficacy|0|||
124658904|NCT01153009|448373516|FG002|Overall Study|Lack of Efficacy|2|||
124658905|NCT01153009|448373517|FG003|Overall Study|Lack of Efficacy|1|||
124658906|NCT01153009|448373514|FG000|Overall Study|Noncompliance with Study Medication|1|||
124658907|NCT01153009|448373515|FG001|Overall Study|Noncompliance with Study Medication|3|||
124658908|NCT01153009|448373516|FG002|Overall Study|Noncompliance with Study Medication|4|||
124658909|NCT01153009|448373517|FG003|Overall Study|Noncompliance with Study Medication|1|||
124658910|NCT01153009|448373514|FG000|Overall Study|Protocol Deviations|4|||
124658911|NCT01153009|448373515|FG001|Overall Study|Protocol Deviations|3|||
124658912|NCT01153009|448373516|FG002|Overall Study|Protocol Deviations|3|||
124658913|NCT01153009|448373517|FG003|Overall Study|Protocol Deviations|2|||
124658914|NCT01153009|448373514|FG000|Overall Study|Withdrawal of Consent|5|||
124658915|NCT01153009|448373515|FG001|Overall Study|Withdrawal of Consent|5|||
124658916|NCT01153009|448373516|FG002|Overall Study|Withdrawal of Consent|4|||
124658917|NCT01153009|448373517|FG003|Overall Study|Withdrawal of Consent|6|||
124658918|NCT01153009|448373514|FG000|Overall Study|Lost to Follow-up|8|||
124658919|NCT01153009|448373515|FG001|Overall Study|Lost to Follow-up|8|||
124658920|NCT01153009|448373516|FG002|Overall Study|Lost to Follow-up|11|||
124658921|NCT01153009|448373517|FG003|Overall Study|Lost to Follow-up|15|||
124658922|NCT01153009|448373514|FG000|Overall Study|Other|1|||
124658923|NCT01153009|448373515|FG001|Overall Study|Other|1|||
124658924|NCT01153009|448373516|FG002|Overall Study|Other|3|||
124658925|NCT01153009|448373517|FG003|Overall Study|Other|2|||
124658926|NCT04003623|448373521|FG000|Overall Study|Withdrawal by Subject|1|||
124658927|NCT04003623|448373522|FG001|Overall Study|Withdrawal by Subject|0|||
124658928|NCT00703326|448373524|FG000|Overall Study|Lost to Follow-up|47|||
124658929|NCT00703326|448373525|FG001|Overall Study|Lost to Follow-up|18|||
124658930|NCT00703326|448373524|FG000|Overall Study|Withdrawal by Subject|54|||
124658931|NCT00703326|448373525|FG001|Overall Study|Withdrawal by Subject|20|||
124658932|NCT00703326|448373524|FG000|Overall Study|Adverse Event|1|||
124658933|NCT00703326|448373525|FG001|Overall Study|Adverse Event|0|||
124658934|NCT01393106|448373530|FG000|Overall Study|Adverse Event|3|||
124658935|NCT01393106|448373530|FG000|Overall Study|Withdrawal by Subject|1|||
124658936|NCT01393106|448373530|FG000|Overall Study|Lack of Efficacy|1|||
124658937|NCT03307837|448373531|FG000|Overall Study|Withdrawal by Subject|0|||
124658938|NCT03307837|448373532|FG001|Overall Study|Withdrawal by Subject|0|||
124658939|NCT03307837|448373533|FG002|Overall Study|Withdrawal by Subject|1|||
124658940|NCT03307837|448373534|FG003|Overall Study|Withdrawal by Subject|0|||
124658941|NCT03307837|448373535|FG004|Overall Study|Withdrawal by Subject|0|||
124658942|NCT03307837|448373536|FG005|Overall Study|Withdrawal by Subject|1|||
124658943|NCT03307837|448373531|FG000|Overall Study|Lost to Follow-up|1|||
124658944|NCT03307837|448373532|FG001|Overall Study|Lost to Follow-up|1|||
124658945|NCT03307837|448373533|FG002|Overall Study|Lost to Follow-up|0|||
124658946|NCT03307837|448373534|FG003|Overall Study|Lost to Follow-up|0|||
124658947|NCT03307837|448373535|FG004|Overall Study|Lost to Follow-up|0|||
124658948|NCT03307837|448373536|FG005|Overall Study|Lost to Follow-up|1|||
124658949|NCT02263729|448373548|FG000|Overall Study|Lost to Follow-up|1|||
124658950|NCT02263729|448373549|FG001|Overall Study|Lost to Follow-up|1|||
124658951|NCT04676152|448373550|FG000|Overall Study|screen fail|9|||
124658952|NCT02626000|448373568|FG000|Overall Study|Decision by Sponsor|1|||
124658953|NCT02626000|448373568|FG000|Overall Study|Death|29|||
124658954|NCT02164318|448373569|FG000|Overall Study|Withdrawal by Subject|0|||
124658955|NCT02164318|448373570|FG001|Overall Study|Withdrawal by Subject|1|||
124658956|NCT02164318|448373571|FG002|Overall Study|Withdrawal by Subject|0|||
124658957|NCT02164318|448373572|FG003|Overall Study|Withdrawal by Subject|1|||
124658958|NCT02335346|448373593|FG000|Overall Study|Adverse Event|11|||
124658959|NCT02335346|448373593|FG000|Overall Study|Withdrawal by Subject|1|||
124658960|NCT03300050|448373597|FG000|Overall Study|Lost to Follow-up|2|||
124658961|NCT03300050|448373598|FG001|Overall Study|Lost to Follow-up|1|||
124658962|NCT03300050|448373599|FG002|Overall Study|Lost to Follow-up|0|||
124658963|NCT03300050|448373600|FG003|Overall Study|Lost to Follow-up|0|||
124658964|NCT03300050|448373601|FG004|Overall Study|Lost to Follow-up|1|||
124658965|NCT03300050|448373597|FG000|Overall Study|Withdrawal by Subject|1|||
124658966|NCT03300050|448373598|FG001|Overall Study|Withdrawal by Subject|1|||
124658967|NCT03300050|448373599|FG002|Overall Study|Withdrawal by Subject|1|||
124658968|NCT03300050|448373600|FG003|Overall Study|Withdrawal by Subject|0|||
124658969|NCT03300050|448373601|FG004|Overall Study|Withdrawal by Subject|0|||
124658970|NCT03300050|448373597|FG000|Overall Study|Death|0|||
124658971|NCT03300050|448373598|FG001|Overall Study|Death|0|||
124658972|NCT03300050|448373599|FG002|Overall Study|Death|1|||
124658973|NCT03300050|448373600|FG003|Overall Study|Death|0|||
124658974|NCT03300050|448373601|FG004|Overall Study|Death|0|||
124658975|NCT03300050|448373597|FG000|Overall Study|Not Eligible at Randomization|0|||
124658976|NCT03300050|448373598|FG001|Overall Study|Not Eligible at Randomization|0|||
124658977|NCT03300050|448373599|FG002|Overall Study|Not Eligible at Randomization|1|||
124658978|NCT03300050|448373600|FG003|Overall Study|Not Eligible at Randomization|1|||
124658979|NCT03300050|448373601|FG004|Overall Study|Not Eligible at Randomization|0|||
124658980|NCT02476916|448373604|FG000|Core Period|Adverse Event|2|||
124658981|NCT02476916|448373605|FG001|Core Period|Adverse Event|2|||
124658982|NCT02476916|448373604|FG000|Core Period|Investigator decision|1|||
124658983|NCT02476916|448373605|FG001|Core Period|Investigator decision|1|||
124658984|NCT02476916|448373604|FG000|Core Period|Withdrawal by Subject|3|||
124658985|NCT02476916|448373605|FG001|Core Period|Withdrawal by Subject|0|||
124658986|NCT02476916|448373604|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
124658987|NCT02476916|448373605|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
124658988|NCT02476916|448373604|FG000|Extension Period|On Treatment|12|||
124658989|NCT02476916|448373605|FG001|Extension Period|On Treatment|17|||
124658990|NCT06010732|448373606|FG000|Crossover Period 1|Protocol Violation|0|||
124658991|NCT06010732|448373607|FG001|Crossover Period 1|Protocol Violation|0|||
124658992|NCT06010732|448373608|FG002|Crossover Period 1|Protocol Violation|1|||
124658993|NCT06010732|448373609|FG003|Crossover Period 1|Protocol Violation|0|||
124658994|NCT06010732|448373610|FG004|Crossover Period 1|Protocol Violation|1|||
124658995|NCT06010732|448373611|FG005|Crossover Period 1|Protocol Violation|0|||
124658996|NCT06010732|448373606|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
124658997|NCT06010732|448373607|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
124658998|NCT06010732|448373608|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
124658999|NCT06010732|448373609|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
124659000|NCT06010732|448373610|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
124659001|NCT06010732|448373611|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
124659002|NCT06010732|448373606|FG000|Crossover Period 2|Adverse Event|0|||
124659003|NCT06010732|448373607|FG001|Crossover Period 2|Adverse Event|1|||
124659004|NCT06010732|448373608|FG002|Crossover Period 2|Adverse Event|0|||
124659005|NCT06010732|448373609|FG003|Crossover Period 2|Adverse Event|0|||
124659006|NCT06010732|448373610|FG004|Crossover Period 2|Adverse Event|0|||
124659007|NCT06010732|448373611|FG005|Crossover Period 2|Adverse Event|0|||
124659008|NCT06010732|448373606|FG000|Crossover Period 2|broken denture|0|||
124659009|NCT06010732|448373607|FG001|Crossover Period 2|broken denture|0|||
124659010|NCT06010732|448373608|FG002|Crossover Period 2|broken denture|1|||
124659011|NCT06010732|448373609|FG003|Crossover Period 2|broken denture|0|||
124659012|NCT06010732|448373610|FG004|Crossover Period 2|broken denture|0|||
124659013|NCT06010732|448373611|FG005|Crossover Period 2|broken denture|0|||
124659014|NCT04401202|448373612|FG000|Overall Study|Lost to Follow-up|2|||
124659015|NCT04401202|448373613|FG001|Overall Study|Lost to Follow-up|2|||
124659016|NCT04401202|448373612|FG000|Overall Study|Adverse Event|0|||
124659017|NCT04401202|448373613|FG001|Overall Study|Adverse Event|1|||
124659018|NCT04401202|448373612|FG000|Overall Study|Hospitalized|4|||
124659019|NCT04401202|448373613|FG001|Overall Study|Hospitalized|1|||
124659020|NCT00631163|448373615|FG000|Number of Participants in Year 1|Adverse Event|12|||
124659021|NCT00631163|448373615|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
124659022|NCT00631163|448373615|FG000|Number of Participants in Year 1|Death|6|||
124659023|NCT00631163|448373615|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
124659024|NCT00631163|448373615|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
124659025|NCT00631163|448373615|FG000|Number of Participants in Year 1|Administrative problems|6|||
124659026|NCT00631163|448373615|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
124659027|NCT00631163|448373615|FG000|Number of Participants in Year 2|Adverse Event|1|||
124659028|NCT00631163|448373615|FG000|Number of Participants in Year 2|Protocol Violation|1|||
124659029|NCT00631163|448373615|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
124659030|NCT02714036|448373618|FG000|Overall Study|Adverse Event|9|||
124659031|NCT02714036|448373619|FG001|Overall Study|Adverse Event|2|||
124659032|NCT02714036|448373618|FG000|Overall Study|Withdrawal by Subject|3|||
124659033|NCT02714036|448373619|FG001|Overall Study|Withdrawal by Subject|2|||
124659034|NCT01597492|448373620|FG000|Overall Study|Withdrawal by Subject|1|||
124659035|NCT01597492|448373621|FG001|Overall Study|Withdrawal by Subject|2|||
124659036|NCT01597492|448373620|FG000|Overall Study|Adverse Event|3|||
124659037|NCT01597492|448373621|FG001|Overall Study|Adverse Event|0|||
124659038|NCT01597492|448373620|FG000|Overall Study|Lost to Follow-up|0|||
124659039|NCT01597492|448373621|FG001|Overall Study|Lost to Follow-up|2|||
124659040|NCT01597492|448373620|FG000|Overall Study|Other Reason|2|||
124659041|NCT01597492|448373621|FG001|Overall Study|Other Reason|0|||
124659042|NCT03624569|448373622|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
124659043|NCT03624569|448373623|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
124659044|NCT03624569|448373622|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
124659045|NCT03624569|448373623|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
124659046|NCT03517449|448373634|FG000|Overall Study|Death|184|||
124659047|NCT03517449|448373635|FG001|Overall Study|Death|236|||
124659048|NCT03517449|448373634|FG000|Overall Study|Lost to Follow-up|0|||
124659049|NCT03517449|448373635|FG001|Overall Study|Lost to Follow-up|2|||
124659050|NCT03517449|448373634|FG000|Overall Study|Withdrawal by Subject|7|||
124659051|NCT03517449|448373635|FG001|Overall Study|Withdrawal by Subject|26|||
124659052|NCT03517449|448373634|FG000|Overall Study|Participants Ongoing|220|||
124659053|NCT03517449|448373635|FG001|Overall Study|Participants Ongoing|152|||
124659054|NCT01119846|448373636|FG000|Overall Study|Adverse Event|1|||
124659055|NCT01119846|448373637|FG001|Overall Study|Adverse Event|0|||
124659056|NCT01119846|448373638|FG002|Overall Study|Adverse Event|6|||
124659057|NCT01119846|448373636|FG000|Overall Study|Physician Decision|1|||
124659058|NCT01119846|448373637|FG001|Overall Study|Physician Decision|0|||
124659059|NCT01119846|448373638|FG002|Overall Study|Physician Decision|0|||
124659060|NCT01119846|448373636|FG000|Overall Study|Protocol Violation|0|||
124659061|NCT01119846|448373637|FG001|Overall Study|Protocol Violation|0|||
124659062|NCT01119846|448373638|FG002|Overall Study|Protocol Violation|1|||
124659063|NCT01119846|448373636|FG000|Overall Study|Withdrawal by Subject|0|||
124659064|NCT01119846|448373637|FG001|Overall Study|Withdrawal by Subject|0|||
124659065|NCT01119846|448373638|FG002|Overall Study|Withdrawal by Subject|4|||
124659066|NCT01370616|448373643|FG000|Overall Study|Adverse Event|11|||
124659067|NCT01370616|448373644|FG001|Overall Study|Adverse Event|16|||
124659068|NCT01370616|448373643|FG000|Overall Study|Death|1|||
124659069|NCT01370616|448373644|FG001|Overall Study|Death|0|||
124659070|NCT01370616|448373643|FG000|Overall Study|Lack of Efficacy|6|||
124659071|NCT01370616|448373644|FG001|Overall Study|Lack of Efficacy|2|||
124659072|NCT01370616|448373643|FG000|Overall Study|Lost to Follow-up|0|||
124659073|NCT01370616|448373644|FG001|Overall Study|Lost to Follow-up|3|||
124659074|NCT01370616|448373643|FG000|Overall Study|Physician Decision|6|||
124659075|NCT01370616|448373644|FG001|Overall Study|Physician Decision|6|||
124659076|NCT01370616|448373643|FG000|Overall Study|Progressive Disease|0|||
124659077|NCT01370616|448373644|FG001|Overall Study|Progressive Disease|1|||
124659078|NCT01370616|448373643|FG000|Overall Study|Recovery|1|||
124659079|NCT01370616|448373644|FG001|Overall Study|Recovery|0|||
124659080|NCT01370616|448373643|FG000|Overall Study|Technical Problems|3|||
124659081|NCT01370616|448373644|FG001|Overall Study|Technical Problems|5|||
124659082|NCT01370616|448373643|FG000|Overall Study|Withdrawal by Subject|34|||
124659083|NCT01370616|448373644|FG001|Overall Study|Withdrawal by Subject|34|||
124659084|NCT02324699|448373645|FG000|Overall Study|study terminated|1|||
124659085|NCT01605825|448373650|FG000|Overall Study|Adverse Event|4|||
124659086|NCT01605825|448373651|FG001|Overall Study|Adverse Event|2|||
124659087|NCT01605825|448373650|FG000|Overall Study|Withdrawal by Subject|0|||
124659088|NCT01605825|448373651|FG001|Overall Study|Withdrawal by Subject|1|||
124659089|NCT01605825|448373650|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
124659090|NCT01605825|448373651|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
124659091|NCT01605825|448373650|FG000|Overall Study|Non-Compliance with Protocol|3|||
124659092|NCT01605825|448373651|FG001|Overall Study|Non-Compliance with Protocol|0|||
124659093|NCT03469999|448373660|FG000|Overall Study|Lost to Follow-up|2|||
124659094|NCT01863732|448373661|FG000|Overall Study|Adverse Event|2|||
124659095|NCT01863732|448373662|FG001|Overall Study|Adverse Event|0|||
124659096|NCT01863732|448373663|FG002|Overall Study|Adverse Event|3|||
124659097|NCT01863732|448373664|FG003|Overall Study|Adverse Event|3|||
124659098|NCT01863732|448373661|FG000|Overall Study|Lack of Efficacy|1|||
124659099|NCT01863732|448373662|FG001|Overall Study|Lack of Efficacy|0|||
124659100|NCT01863732|448373663|FG002|Overall Study|Lack of Efficacy|2|||
124659101|NCT01863732|448373664|FG003|Overall Study|Lack of Efficacy|1|||
124659102|NCT01863732|448373661|FG000|Overall Study|Lost to Follow-up|2|||
124659103|NCT01863732|448373662|FG001|Overall Study|Lost to Follow-up|2|||
124659104|NCT01863732|448373663|FG002|Overall Study|Lost to Follow-up|1|||
124659105|NCT01863732|448373664|FG003|Overall Study|Lost to Follow-up|1|||
124659106|NCT01863732|448373661|FG000|Overall Study|Physician Decision|1|||
124659107|NCT01863732|448373662|FG001|Overall Study|Physician Decision|0|||
124659108|NCT01863732|448373663|FG002|Overall Study|Physician Decision|1|||
124659109|NCT01863732|448373664|FG003|Overall Study|Physician Decision|0|||
124659110|NCT01863732|448373661|FG000|Overall Study|Pregnancy|0|||
124659111|NCT01863732|448373662|FG001|Overall Study|Pregnancy|0|||
124659112|NCT01863732|448373663|FG002|Overall Study|Pregnancy|0|||
124659113|NCT01863732|448373664|FG003|Overall Study|Pregnancy|1|||
124659114|NCT01863732|448373661|FG000|Overall Study|Technical problems|0|||
124659115|NCT01863732|448373662|FG001|Overall Study|Technical problems|1|||
124659116|NCT01863732|448373663|FG002|Overall Study|Technical problems|1|||
124659117|NCT01863732|448373664|FG003|Overall Study|Technical problems|0|||
124659118|NCT01863732|448373661|FG000|Overall Study|Subject/guardian decision|6|||
124659119|NCT01863732|448373662|FG001|Overall Study|Subject/guardian decision|9|||
124659120|NCT01863732|448373663|FG002|Overall Study|Subject/guardian decision|3|||
124659121|NCT01863732|448373664|FG003|Overall Study|Subject/guardian decision|1|||
124659122|NCT01863732|448373661|FG000|Overall Study|Death|1|||
124659123|NCT01863732|448373662|FG001|Overall Study|Death|0|||
124659124|NCT01863732|448373663|FG002|Overall Study|Death|0|||
124659125|NCT01863732|448373664|FG003|Overall Study|Death|1|||
124659126|NCT01249833|448373665|FG000|Overall Study|Lost to Follow-up|0|||
124659127|NCT01249833|448373666|FG001|Overall Study|Lost to Follow-up|1|||
124659128|NCT03796676|448373667|FG000|Overall Study|Adverse Event|2|||
124659129|NCT03796676|448373668|FG001|Overall Study|Adverse Event|1|||
124659130|NCT03796676|448373669|FG002|Overall Study|Adverse Event|2|||
124659131|NCT03796676|448373667|FG000|Overall Study|Lost to Follow-up|2|||
124659132|NCT03796676|448373668|FG001|Overall Study|Lost to Follow-up|1|||
124659133|NCT03796676|448373669|FG002|Overall Study|Lost to Follow-up|0|||
124659134|NCT03796676|448373667|FG000|Overall Study|Protocol Violation|0|||
124659135|NCT03796676|448373668|FG001|Overall Study|Protocol Violation|0|||
124659136|NCT03796676|448373669|FG002|Overall Study|Protocol Violation|1|||
124659137|NCT03796676|448373667|FG000|Overall Study|Withdrawal by Subject|1|||
124659138|NCT03796676|448373668|FG001|Overall Study|Withdrawal by Subject|1|||
124659139|NCT03796676|448373669|FG002|Overall Study|Withdrawal by Subject|0|||
124659140|NCT03796676|448373667|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
124659141|NCT03796676|448373668|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
124659142|NCT03796676|448373669|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
124659143|NCT02432144|448373673|FG000|Overall Study|Participant Non-Compliance|1|||
124659144|NCT00448812|448373674|FG000|Year 2|Missed visit but remained in study|4|||
124659145|NCT00448812|448373675|FG001|Year 2|Missed visit but remained in study|1|||
124659146|NCT00448812|448373674|FG000|Year 3|Withdrawal by Subject|1|||
124659147|NCT00448812|448373675|FG001|Year 3|Withdrawal by Subject|3|||
124659148|NCT00448812|448373674|FG000|Year 3|Lost to Follow-up|1|||
124659149|NCT00448812|448373675|FG001|Year 3|Lost to Follow-up|0|||
124659150|NCT00448812|448373674|FG000|Year 3|Missed visit but remained in study|2|||
124659151|NCT00448812|448373675|FG001|Year 3|Missed visit but remained in study|0|||
124659152|NCT00448812|448373674|FG000|Year 5|Missed visit but remained in study|1|||
124659153|NCT00448812|448373675|FG001|Year 5|Missed visit but remained in study|0|||
124659154|NCT00385827|448375603|FG000|Part 1|Adverse Event|1|||
124659155|NCT00385827|448375604|FG001|Part 1|Adverse Event|0|||
124659156|NCT00385827|448375605|FG002|Part 1|Adverse Event|0|||
124659157|NCT00385827|448375603|FG000|Part 1|Death|2|||
124659158|NCT00385827|448375604|FG001|Part 1|Death|0|||
124659159|NCT00385827|448375605|FG002|Part 1|Death|0|||
124659160|NCT00385827|448375603|FG000|Part 1|Lack of Efficacy|5|||
124659161|NCT00385827|448375604|FG001|Part 1|Lack of Efficacy|0|||
124659162|NCT00385827|448375605|FG002|Part 1|Lack of Efficacy|0|||
124659163|NCT00385827|448375603|FG000|Part 1|Other|1|||
124659164|NCT00385827|448375604|FG001|Part 1|Other|0|||
124659165|NCT00385827|448375605|FG002|Part 1|Other|0|||
124659166|NCT00385827|448375603|FG000|Part 2|Adverse Event|0|||
124659167|NCT00385827|448375604|FG001|Part 2|Adverse Event|6|||
124659168|NCT00385827|448375605|FG002|Part 2|Adverse Event|10|||
124659169|NCT00385827|448375603|FG000|Part 2|Death|0|||
124659170|NCT00385827|448375604|FG001|Part 2|Death|0|||
124659171|NCT00385827|448375605|FG002|Part 2|Death|2|||
124659172|NCT00385827|448375603|FG000|Part 2|Lack of Efficacy|0|||
124659173|NCT00385827|448375604|FG001|Part 2|Lack of Efficacy|14|||
124659174|NCT00385827|448375605|FG002|Part 2|Lack of Efficacy|13|||
124659175|NCT00385827|448375603|FG000|Part 2|Randomized but not treated|0|||
124659176|NCT00385827|448375604|FG001|Part 2|Randomized but not treated|2|||
124659177|NCT00385827|448375605|FG002|Part 2|Randomized but not treated|2|||
124659178|NCT00385827|448375603|FG000|Part 2|Other|0|||
124659179|NCT00385827|448375604|FG001|Part 2|Other|11|||
124659180|NCT00385827|448375605|FG002|Part 2|Other|21|||
124659181|NCT00410072|448375606|FG000|Day 1 to Week 48|Adverse Event|1|||
124659182|NCT00410072|448375607|FG001|Day 1 to Week 48|Adverse Event|2|||
124659183|NCT00410072|448375606|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
124659184|NCT00410072|448375607|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
124659185|NCT00410072|448375606|FG000|Day 1 to Week 48|Other|0|||
124659186|NCT00410072|448375607|FG001|Day 1 to Week 48|Other|1|||
124659187|NCT00410072|448375606|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
124659188|NCT00410072|448375607|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
124659189|NCT00410072|448375606|FG000|Day 1 to Week 48|Pregnancy|0|||
124659190|NCT00410072|448375607|FG001|Day 1 to Week 48|Pregnancy|2|||
124659191|NCT00410072|448375606|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
124659192|NCT00410072|448375607|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
124659193|NCT00410072|448375606|FG000|After Week 48 to Week 96|Adverse Event|1|||
124659194|NCT00410072|448375607|FG001|After Week 48 to Week 96|Adverse Event|2|||
124659195|NCT00410072|448375606|FG000|After Week 48 to Week 96|Death|0|||
124659196|NCT00410072|448375607|FG001|After Week 48 to Week 96|Death|1|||
124659197|NCT00410072|448375606|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
124659198|NCT00410072|448375607|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
124659199|NCT00410072|448375606|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
124659200|NCT00410072|448375607|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
124659201|NCT00410072|448375606|FG000|After Week 48 to Week 96|Other|2|||
124659202|NCT00410072|448375607|FG001|After Week 48 to Week 96|Other|0|||
124659203|NCT00410072|448375606|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
124659204|NCT00410072|448375607|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
124659205|NCT00410072|448375606|FG000|After Week 48 to Week 96|Pregnancy|0|||
124659206|NCT00410072|448375607|FG001|After Week 48 to Week 96|Pregnancy|2|||
124659207|NCT00410072|448375606|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
124659208|NCT00410072|448375607|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
124659209|NCT01421147|448375612|FG000|Treatment Period|Adverse Event|2|||
124659210|NCT01421147|448375613|FG001|Treatment Period|Adverse Event|3|||
124659211|NCT01421147|448375612|FG000|Treatment Period|Lost to Follow-up|2|||
124659212|NCT01421147|448375613|FG001|Treatment Period|Lost to Follow-up|1|||
124659213|NCT01421147|448375612|FG000|Treatment Period|Physician Decision|2|||
124659214|NCT01421147|448375613|FG001|Treatment Period|Physician Decision|2|||
124659215|NCT01421147|448375612|FG000|Treatment Period|Withdrawal by Subject|10|||
124659216|NCT01421147|448375613|FG001|Treatment Period|Withdrawal by Subject|5|||
124659217|NCT01421147|448375612|FG000|Extension Period|Adverse Event|0|||
124659218|NCT01421147|448375613|FG001|Extension Period|Adverse Event|2|||
124659219|NCT01421147|448375612|FG000|Extension Period|Death|0|||
124659220|NCT01421147|448375613|FG001|Extension Period|Death|1|||
124659221|NCT01421147|448375612|FG000|Extension Period|Lost to Follow-up|2|||
124659222|NCT01421147|448375613|FG001|Extension Period|Lost to Follow-up|5|||
124659223|NCT01421147|448375612|FG000|Extension Period|Physician Decision|1|||
124659224|NCT01421147|448375613|FG001|Extension Period|Physician Decision|0|||
124659225|NCT01421147|448375612|FG000|Extension Period|Withdrawal by Subject|5|||
124659226|NCT01421147|448375613|FG001|Extension Period|Withdrawal by Subject|3|||
124659227|NCT01270321|448375614|FG000|Overall Study|Death|3|||
124659228|NCT01270321|448375615|FG001|Overall Study|Death|1|||
124659229|NCT01270321|448375616|FG002|Overall Study|Death|4|||
124659230|NCT01270321|448375614|FG000|Overall Study|Adverse Event|7|||
124659231|NCT01270321|448375615|FG001|Overall Study|Adverse Event|9|||
124659232|NCT01270321|448375616|FG002|Overall Study|Adverse Event|5|||
124659233|NCT03536663|448375618|FG000|Endexo|Protocol Violation|1|||
124659234|NCT05437640|448375619|FG000|Washout (1 Week)|Adverse Event|1|||
124659235|NCT05437640|448375620|FG001|Washout (1 Week)|Adverse Event|0|||
124659236|NCT00904917|448375621|FG000|Overall Study|Lost to Follow-up|2|||
124659237|NCT00904917|448375622|FG001|Overall Study|Lost to Follow-up|2|||
124659238|NCT00904917|448375623|FG002|Overall Study|Lost to Follow-up|2|||
124659239|NCT00904917|448375624|FG003|Overall Study|Lost to Follow-up|2|||
124659240|NCT04228965|448375627|FG000|Overall Study|Lost to Follow-up|26|||
124659241|NCT04228965|448375628|FG001|Overall Study|Lost to Follow-up|11|||
124659242|NCT04228965|448375627|FG000|Overall Study|Withdrawal by Subject|18|||
124659243|NCT04228965|448375628|FG001|Overall Study|Withdrawal by Subject|5|||
124659244|NCT00734656|448375631|FG000|Lab Session 1|Withdrawal by Subject|2|||
124659245|NCT00734656|448375632|FG001|Lab Session 1|Withdrawal by Subject|0|||
124659246|NCT00734656|448375633|FG002|Lab Session 1|Withdrawal by Subject|0|||
124659247|NCT00734656|448375634|FG003|Lab Session 1|Withdrawal by Subject|0|||
124659248|NCT00734656|448375631|FG000|Washout 1|Withdrawal by Subject|1|||
124659249|NCT00734656|448375632|FG001|Washout 1|Withdrawal by Subject|5|||
124659250|NCT00734656|448375633|FG002|Washout 1|Withdrawal by Subject|2|||
124659251|NCT00734656|448375634|FG003|Washout 1|Withdrawal by Subject|3|||
124659252|NCT00734656|448375631|FG000|Lab Session 2|Withdrawal by Subject|1|||
124659253|NCT00734656|448375632|FG001|Lab Session 2|Withdrawal by Subject|0|||
124659254|NCT00734656|448375633|FG002|Lab Session 2|Withdrawal by Subject|0|||
124659255|NCT00734656|448375634|FG003|Lab Session 2|Withdrawal by Subject|1|||
124659256|NCT00734656|448375631|FG000|Washout 2|Withdrawal by Subject|1|||
124659257|NCT00734656|448375632|FG001|Washout 2|Withdrawal by Subject|1|||
124659258|NCT00734656|448375633|FG002|Washout 2|Withdrawal by Subject|1|||
124659259|NCT00734656|448375634|FG003|Washout 2|Withdrawal by Subject|0|||
124659260|NCT00734656|448375631|FG000|Washout 3|Withdrawal by Subject|1|||
124659261|NCT00734656|448375632|FG001|Washout 3|Withdrawal by Subject|0|||
124659262|NCT00734656|448375633|FG002|Washout 3|Withdrawal by Subject|0|||
124659263|NCT00734656|448375634|FG003|Washout 3|Withdrawal by Subject|1|||
124544306|NCT05182840|447946754|FG006|Treatment Period|Adverse Event|4|||
124659264|NCT00734656|448375631|FG000|Lab Session 4|Withdrawal by Subject|0|||
124659265|NCT00734656|448375632|FG001|Lab Session 4|Withdrawal by Subject|0|||
124659266|NCT00734656|448375633|FG002|Lab Session 4|Withdrawal by Subject|0|||
124659267|NCT00734656|448375634|FG003|Lab Session 4|Withdrawal by Subject|1|||
124659268|NCT01471444|448375635|FG000|Overall Study|Physician Decision|3|||
124659269|NCT01471444|448375636|FG001|Overall Study|Physician Decision|2|||
124659270|NCT01471444|448375635|FG000|Overall Study|Withdrawal by Subject|0|||
124659271|NCT01471444|448375636|FG001|Overall Study|Withdrawal by Subject|1|||
124659272|NCT03915626|448375637|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
124659273|NCT02769312|448375638|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
124659274|NCT02769312|448375639|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
124659275|NCT02769312|448375638|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
124659276|NCT02769312|448375639|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
124659277|NCT02769312|448375638|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
124659278|NCT02769312|448375639|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
124659279|NCT02769312|448375638|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
124659280|NCT02769312|448375639|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
124659281|NCT02769312|448375638|FG000|Follow-up|Lost to Follow-up|1|||
124659282|NCT02769312|448375639|FG001|Follow-up|Lost to Follow-up|1|||
124659283|NCT02178358|448375640|FG000|Overall Study|Withdrawal by Subject|0|||
124659284|NCT02178358|448375641|FG001|Overall Study|Withdrawal by Subject|2|||
124659285|NCT02178358|448375642|FG002|Overall Study|Withdrawal by Subject|2|||
124659286|NCT02178358|448375640|FG000|Overall Study|Lost to Follow-up|1|||
124659287|NCT02178358|448375641|FG001|Overall Study|Lost to Follow-up|0|||
124659288|NCT02178358|448375642|FG002|Overall Study|Lost to Follow-up|0|||
124659289|NCT01066663|448375644|FG000|Overall Study|Adverse Event|0|||
124659290|NCT01066663|448375645|FG001|Overall Study|Adverse Event|0|||
124659291|NCT01066663|448375646|FG002|Overall Study|Adverse Event|1|||
124659292|NCT02985021|448375647|FG000|Overall Study|Inability to comply with study procedures|1|||
124659293|NCT02756819|448375648|FG000|Overall Study|Lost for observation|23|||
124659294|NCT02756819|448375648|FG000|Overall Study|Patient's unwillingness|16|||
124659295|NCT02756819|448375648|FG000|Overall Study|Insufficient efficacy|2|||
124659296|NCT02756819|448375648|FG000|Overall Study|Adverse Event|2|||
124659297|NCT02756819|448375648|FG000|Overall Study|Reason not Specified|9|||
124659298|NCT01090050|448375649|FG000|Overall Study|Lost to Follow-up|0|||
124659299|NCT01090050|448375650|FG001|Overall Study|Lost to Follow-up|1|||
124659300|NCT01090050|448375649|FG000|Overall Study|Lack of Efficacy|1|||
124659301|NCT01090050|448375650|FG001|Overall Study|Lack of Efficacy|5|||
124659302|NCT01090050|448375649|FG000|Overall Study|Physician Decision|0|||
124659303|NCT01090050|448375650|FG001|Overall Study|Physician Decision|1|||
124659304|NCT03539484|448375651|FG000|Overall Study|Death|1|||
124659305|NCT03539484|448375652|FG001|Overall Study|Death|0|||
124659306|NCT03539484|448375653|FG002|Overall Study|Death|0|||
124659307|NCT03539484|448375654|FG003|Overall Study|Death|2|||
124659308|NCT03539484|448375655|FG004|Overall Study|Death|8|||
124659309|NCT03539484|448375656|FG005|Overall Study|Death|3|||
124659310|NCT03539484|448375657|FG006|Overall Study|Death|0|||
124659311|NCT03539484|448375651|FG000|Overall Study|Lost to Follow-up|0|||
124659312|NCT03539484|448375652|FG001|Overall Study|Lost to Follow-up|1|||
124659313|NCT03539484|448375653|FG002|Overall Study|Lost to Follow-up|0|||
124659314|NCT03539484|448375654|FG003|Overall Study|Lost to Follow-up|0|||
124659315|NCT03539484|448375655|FG004|Overall Study|Lost to Follow-up|1|||
124659316|NCT03539484|448375656|FG005|Overall Study|Lost to Follow-up|0|||
124659317|NCT03539484|448375657|FG006|Overall Study|Lost to Follow-up|0|||
124659318|NCT03539484|448375651|FG000|Overall Study|Withdrawal by Subject|0|||
124659319|NCT03539484|448375652|FG001|Overall Study|Withdrawal by Subject|0|||
124659320|NCT03539484|448375653|FG002|Overall Study|Withdrawal by Subject|0|||
124659321|NCT03539484|448375654|FG003|Overall Study|Withdrawal by Subject|0|||
124659322|NCT03539484|448375655|FG004|Overall Study|Withdrawal by Subject|2|||
124659323|NCT03539484|448375656|FG005|Overall Study|Withdrawal by Subject|0|||
124659324|NCT03539484|448375657|FG006|Overall Study|Withdrawal by Subject|1|||
124659325|NCT03539484|448375651|FG000|Overall Study|Study Terminated by Sponsor|0|||
124659326|NCT03539484|448375652|FG001|Overall Study|Study Terminated by Sponsor|0|||
124659327|NCT03539484|448375653|FG002|Overall Study|Study Terminated by Sponsor|1|||
124659328|NCT03539484|448375654|FG003|Overall Study|Study Terminated by Sponsor|1|||
124659329|NCT03539484|448375655|FG004|Overall Study|Study Terminated by Sponsor|2|||
124659330|NCT03539484|448375656|FG005|Overall Study|Study Terminated by Sponsor|2|||
124659331|NCT03539484|448375657|FG006|Overall Study|Study Terminated by Sponsor|1|||
124659332|NCT02232061|448375658|FG000|Overall Study|Administrative problems|1|||
124659333|NCT02232061|448375658|FG000|Overall Study|Withdrawal by Subject|1|||
124659334|NCT00264290|448375659|FG000|Intervention (8 Weeks)|Adverse Event|1|||
124659335|NCT00264290|448375660|FG001|Intervention (8 Weeks)|Adverse Event|0|||
124659336|NCT00560703|448375662|FG000|Overall Study|Adverse Event|0|||
124659337|NCT00560703|448375663|FG001|Overall Study|Adverse Event|2|||
124659338|NCT00560703|448375662|FG000|Overall Study|Protocol Violation|0|||
124659339|NCT00560703|448375663|FG001|Overall Study|Protocol Violation|2|||
124659340|NCT00560703|448375662|FG000|Overall Study|Withdrawal by Subject|0|||
124659341|NCT00560703|448375663|FG001|Overall Study|Withdrawal by Subject|1|||
124659342|NCT00560703|448375662|FG000|Overall Study|non-compliance|0|||
124659343|NCT00560703|448375663|FG001|Overall Study|non-compliance|1|||
124659344|NCT00339833|448375673|FG000|Overall Study|Withdrawal by Subject|1|||
124659345|NCT00339833|448375674|FG001|Overall Study|Withdrawal by Subject|2|||
124659346|NCT00339833|448375673|FG000|Overall Study|toothache|0|||
124659347|NCT00339833|448375674|FG001|Overall Study|toothache|1|||
124659348|NCT00339833|448375673|FG000|Overall Study|indigestion|0|||
124659349|NCT00339833|448375674|FG001|Overall Study|indigestion|1|||
124659350|NCT00339833|448375673|FG000|Overall Study|Chest pain|0|||
124659351|NCT00339833|448375674|FG001|Overall Study|Chest pain|1|||
124659352|NCT00339833|448375673|FG000|Overall Study|minor infection|0|||
124659353|NCT00339833|448375674|FG001|Overall Study|minor infection|1|||
124544307|NCT05182840|447946755|FG007|Treatment Period|Adverse Event|8|||
124659354|NCT00339833|448375673|FG000|Overall Study|Poor venous access|2|||
124659355|NCT00339833|448375674|FG001|Overall Study|Poor venous access|2|||
124659356|NCT00339833|448375673|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
124659357|NCT00339833|448375674|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
124659358|NCT00339833|448375673|FG000|Overall Study|Error in data records|1|||
124659359|NCT00339833|448375674|FG001|Overall Study|Error in data records|0|||
124659360|NCT03077607|448375675|FG000|Period 1 (15 Days)|Adverse Event|1|||
124659361|NCT03077607|448375676|FG001|Period 1 (15 Days)|Adverse Event|0|||
124659362|NCT03077607|448375675|FG000|Period 1 (15 Days)|Death|1|||
124659363|NCT03077607|448375676|FG001|Period 1 (15 Days)|Death|0|||
124659364|NCT03077607|448375675|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
124659365|NCT03077607|448375676|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
124659366|NCT03077607|448375675|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
124659367|NCT03077607|448375676|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
124659368|NCT03004924|448375677|FG000|Overall Study|Adverse Event|6|||
124659369|NCT03004924|448375678|FG001|Overall Study|Adverse Event|5|||
124659370|NCT03004924|448375679|FG002|Overall Study|Adverse Event|10|||
124659371|NCT03004924|448375677|FG000|Overall Study|Protocol Violation|4|||
124659372|NCT03004924|448375678|FG001|Overall Study|Protocol Violation|0|||
124659373|NCT03004924|448375679|FG002|Overall Study|Protocol Violation|1|||
124659374|NCT03004924|448375677|FG000|Overall Study|Withdrawal by Subject|5|||
124659375|NCT03004924|448375678|FG001|Overall Study|Withdrawal by Subject|3|||
124659376|NCT03004924|448375679|FG002|Overall Study|Withdrawal by Subject|5|||
124659377|NCT03004924|448375677|FG000|Overall Study|Lost to Follow-up|6|||
124659378|NCT03004924|448375678|FG001|Overall Study|Lost to Follow-up|1|||
124659379|NCT03004924|448375679|FG002|Overall Study|Lost to Follow-up|4|||
124659380|NCT03004924|448375677|FG000|Overall Study|Lack of Efficacy|2|||
124659381|NCT03004924|448375678|FG001|Overall Study|Lack of Efficacy|4|||
124659382|NCT03004924|448375679|FG002|Overall Study|Lack of Efficacy|2|||
124659383|NCT03004924|448375677|FG000|Overall Study|Physician Decision|1|||
124659384|NCT03004924|448375678|FG001|Overall Study|Physician Decision|0|||
124659385|NCT03004924|448375679|FG002|Overall Study|Physician Decision|1|||
124659386|NCT03004924|448375677|FG000|Overall Study|Withdrawal by parent/guardian|1|||
124659387|NCT03004924|448375678|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124659388|NCT03004924|448375679|FG002|Overall Study|Withdrawal by parent/guardian|2|||
124659389|NCT03004924|448375677|FG000|Overall Study|Screen Failure|1|||
124659390|NCT03004924|448375678|FG001|Overall Study|Screen Failure|0|||
124659391|NCT03004924|448375679|FG002|Overall Study|Screen Failure|0|||
124659392|NCT03004924|448375677|FG000|Overall Study|Pregnancy|0|||
124659393|NCT03004924|448375678|FG001|Overall Study|Pregnancy|1|||
124659394|NCT03004924|448375679|FG002|Overall Study|Pregnancy|0|||
124659395|NCT03004924|448375677|FG000|Overall Study|Terminated by Sponsor|0|||
124659396|NCT03004924|448375678|FG001|Overall Study|Terminated by Sponsor|0|||
124659397|NCT03004924|448375679|FG002|Overall Study|Terminated by Sponsor|1|||
124659398|NCT03004924|448375677|FG000|Overall Study|Missed Study Visit|0|||
124659399|NCT03004924|448375678|FG001|Overall Study|Missed Study Visit|0|||
124659400|NCT03004924|448375679|FG002|Overall Study|Missed Study Visit|2|||
124659401|NCT03004924|448375677|FG000|Overall Study|HSV1 Positive|1|||
124659402|NCT03004924|448375678|FG001|Overall Study|HSV1 Positive|0|||
124659403|NCT03004924|448375679|FG002|Overall Study|HSV1 Positive|0|||
124659404|NCT00269477|448375680|FG000|Overall Study|Protocol Violation|5|||
124659405|NCT00269477|448375681|FG001|Overall Study|Protocol Violation|5|||
124659406|NCT00269477|448375682|FG002|Overall Study|Protocol Violation|1|||
124659407|NCT00269477|448375683|FG003|Overall Study|Protocol Violation|0|||
124659408|NCT00269477|448375680|FG000|Overall Study|Missed post-vaccination blood draw|0|||
124659409|NCT00269477|448375681|FG001|Overall Study|Missed post-vaccination blood draw|1|||
124659410|NCT00269477|448375682|FG002|Overall Study|Missed post-vaccination blood draw|0|||
124659411|NCT00269477|448375683|FG003|Overall Study|Missed post-vaccination blood draw|0|||
124659412|NCT02670382|448375684|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
124659413|NCT02670382|448375685|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
124659414|NCT03244618|448375686|FG000|Overall Study|Lost to Follow-up|3|||
124659415|NCT03244618|448375687|FG001|Overall Study|Lost to Follow-up|4|||
124659416|NCT03244618|448375686|FG000|Overall Study|Protocol Violation|4|||
124659417|NCT03244618|448375687|FG001|Overall Study|Protocol Violation|3|||
124659418|NCT03244618|448375686|FG000|Overall Study|Withdrawal by Subject|0|||
124659419|NCT03244618|448375687|FG001|Overall Study|Withdrawal by Subject|2|||
124659420|NCT01603394|448375692|FG000|Overall Study|Adverse Event|1|||
124659421|NCT01215435|448375694|FG000|Overall Study|Adverse Event|1|||
124659422|NCT01215435|448375695|FG001|Overall Study|Adverse Event|0|||
124659423|NCT01215435|448375694|FG000|Overall Study|Protocol Violation|2|||
124659424|NCT01215435|448375695|FG001|Overall Study|Protocol Violation|0|||
124659425|NCT01215435|448375694|FG000|Overall Study|Withdrawal Criteria|8|||
124659426|NCT01215435|448375695|FG001|Overall Study|Withdrawal Criteria|11|||
124659427|NCT01215435|448375694|FG000|Overall Study|Lost to Follow-up|3|||
124659428|NCT01215435|448375695|FG001|Overall Study|Lost to Follow-up|0|||
124659429|NCT01215435|448375694|FG000|Overall Study|Unclassified|5|||
124659430|NCT01215435|448375695|FG001|Overall Study|Unclassified|5|||
124659431|NCT00840034|448375696|FG000|Acute Treatment Phase|Adverse Event|6|||
124659432|NCT00840034|448375697|FG001|Acute Treatment Phase|Adverse Event|8|||
124659433|NCT00840034|448375696|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
124659434|NCT00840034|448375697|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
124659435|NCT00840034|448375696|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
124659436|NCT00840034|448375697|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
124659437|NCT00840034|448375696|FG000|Acute Treatment Phase|Physician Decision|0|||
124659438|NCT00840034|448375697|FG001|Acute Treatment Phase|Physician Decision|1|||
124659439|NCT00840034|448375696|FG000|Acute Treatment Phase|Protocol Violation|2|||
124659440|NCT00840034|448375697|FG001|Acute Treatment Phase|Protocol Violation|4|||
124659441|NCT00840034|448375696|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
124659442|NCT00840034|448375697|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
124659443|NCT00840034|448375696|FG000|Taper Phase|Adverse Event|1|||
124659444|NCT00840034|448375697|FG001|Taper Phase|Adverse Event|0|||
124659445|NCT00840034|448375696|FG000|Taper Phase|Lost to Follow-up|1|||
124659446|NCT00840034|448375697|FG001|Taper Phase|Lost to Follow-up|1|||
124659447|NCT00840034|448375696|FG000|Taper Phase|Withdrawal by Subject|1|||
124659448|NCT00840034|448375697|FG001|Taper Phase|Withdrawal by Subject|1|||
124659449|NCT00586898|448375706|FG000|Overall Study|Adverse Event|1|||
124659450|NCT00586898|448375706|FG000|Overall Study|Patiemt Non-compliance|1|||
124659451|NCT00586898|448375706|FG000|Overall Study|Evaluable for Toxicity Only|5|||
124659452|NCT03816007|448375707|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
124659453|NCT03816007|448375708|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
124659454|NCT03816007|448375707|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
124659455|NCT03816007|448375708|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
124659456|NCT03816007|448375707|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
124659457|NCT03816007|448375708|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
124659458|NCT02179749|448375709|FG000|Overall Study|Adverse Event|0|||
124659459|NCT02179749|448375710|FG001|Overall Study|Adverse Event|0|||
124659460|NCT02179749|448375711|FG002|Overall Study|Adverse Event|1|||
124659461|NCT02179749|448375709|FG000|Overall Study|Withdrawal by Subject|0|||
124659462|NCT02179749|448375710|FG001|Overall Study|Withdrawal by Subject|0|||
124659463|NCT02179749|448375711|FG002|Overall Study|Withdrawal by Subject|1|||
124659464|NCT00793546|448375713|FG000|Overall Study|Death|3|||
124659465|NCT00793546|448375714|FG001|Overall Study|Death|0|||
124659466|NCT00793546|448375713|FG000|Overall Study|Lost to Follow-up|1|||
124659467|NCT00793546|448375714|FG001|Overall Study|Lost to Follow-up|0|||
124659468|NCT00793546|448375713|FG000|Overall Study|Withdrawal by Subject|1|||
124659469|NCT00793546|448375714|FG001|Overall Study|Withdrawal by Subject|1|||
124659470|NCT00793546|448375713|FG000|Overall Study|Study Terminated by Sponsor|8|||
124659471|NCT00793546|448375714|FG001|Overall Study|Study Terminated by Sponsor|27|||
124659472|NCT00793546|448375713|FG000|Overall Study|Other|1|||
124659473|NCT00793546|448375714|FG001|Overall Study|Other|0|||
124659474|NCT01416155|448375715|FG000|Overall Study|Adverse Event|8|||
124659475|NCT01416155|448375715|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
124659476|NCT01416155|448375715|FG000|Overall Study|Withdrawal by Subject|33|||
124659477|NCT01416155|448375715|FG000|Overall Study|Investigator decision|8|||
124659478|NCT01416155|448375715|FG000|Overall Study|Other|7|||
124659479|NCT02634710|448375716|FG000|Overall Study|Death|4|||
124659480|NCT02772809|448375717|FG000|Overall Study|not completed some tasks|6|||
124659481|NCT02774005|448375723|FG000|Overall Study|Adverse Event|8|||
124659482|NCT02774005|448375723|FG000|Overall Study|Withdrawal by Subject|23|||
124659483|NCT02774005|448375723|FG000|Overall Study|Lost to Follow-up|7|||
124659484|NCT02774005|448375723|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
124659485|NCT02774005|448375723|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
124659486|NCT02774005|448375723|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
124659487|NCT02774005|448375723|FG000|Overall Study|Death|1|||
124659488|NCT02774005|448375723|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
124659489|NCT02774005|448375723|FG000|Overall Study|Lack of compliance with study medication|4|||
124659490|NCT02774005|448375723|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
124659491|NCT02774005|448375723|FG000|Overall Study|another study|1|||
124659492|NCT02774005|448375723|FG000|Overall Study|cardiologist imposed travel restriction|1|||
124659493|NCT00534105|448375724|FG000|Overall Study|Lost to Follow-up|23|||
124659494|NCT00534105|448375725|FG001|Overall Study|Lost to Follow-up|39|||
124659495|NCT03275389|448375729|FG000|Overall Study|Lost to Follow-up|10|||
124659496|NCT03275389|448375730|FG001|Overall Study|Lost to Follow-up|10|||
124659497|NCT03275389|448375731|FG002|Overall Study|Lost to Follow-up|19|||
124659498|NCT03275389|448375732|FG003|Overall Study|Lost to Follow-up|12|||
124659499|NCT03275389|448375733|FG004|Overall Study|Lost to Follow-up|11|||
124659500|NCT03275389|448375734|FG005|Overall Study|Lost to Follow-up|12|||
124659501|NCT03275389|448375735|FG006|Overall Study|Lost to Follow-up|21|||
124659502|NCT03275389|448375736|FG007|Overall Study|Lost to Follow-up|15|||
124659503|NCT03275389|448375737|FG008|Overall Study|Lost to Follow-up|12|||
124659504|NCT03275389|448375738|FG009|Overall Study|Lost to Follow-up|14|||
124659505|NCT03275389|448375729|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
124659506|NCT03275389|448375730|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
124659507|NCT03275389|448375731|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
124659508|NCT03275389|448375732|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
124659509|NCT03275389|448375733|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
124659510|NCT03275389|448375734|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
124659511|NCT03275389|448375735|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
124659512|NCT03275389|448375736|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
124659513|NCT03275389|448375737|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
124659514|NCT03275389|448375738|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
124659515|NCT03275389|448375729|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
124659516|NCT03275389|448375730|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
124659517|NCT03275389|448375731|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
124659518|NCT03275389|448375732|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
124659519|NCT03275389|448375733|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
124659520|NCT03275389|448375734|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
124659521|NCT03275389|448375735|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
124659522|NCT03275389|448375736|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
124659523|NCT03275389|448375737|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
124659524|NCT03275389|448375738|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
124659525|NCT03275389|448375729|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124659526|NCT03275389|448375730|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
124659527|NCT03275389|448375731|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124659528|NCT03275389|448375732|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
124659529|NCT03275389|448375733|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124659530|NCT03275389|448375734|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124659531|NCT03275389|448375735|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124659532|NCT03275389|448375736|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124659533|NCT03275389|448375737|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124659534|NCT03275389|448375738|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124659535|NCT03275389|448375729|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
124659536|NCT03275389|448375730|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
124659537|NCT03275389|448375731|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
124659538|NCT03275389|448375732|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
124659539|NCT03275389|448375733|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
124659540|NCT03275389|448375734|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
124659541|NCT03275389|448375735|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
124659542|NCT03275389|448375736|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
124659543|NCT03275389|448375737|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
124659544|NCT03275389|448375738|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
124659545|NCT03275389|448375729|FG000|Overall Study|Other|0|||
124659546|NCT03275389|448375730|FG001|Overall Study|Other|4|||
124659547|NCT03275389|448375731|FG002|Overall Study|Other|3|||
124659548|NCT03275389|448375732|FG003|Overall Study|Other|2|||
124659549|NCT03275389|448375733|FG004|Overall Study|Other|2|||
124659550|NCT03275389|448375734|FG005|Overall Study|Other|2|||
124659551|NCT03275389|448375735|FG006|Overall Study|Other|0|||
124659552|NCT03275389|448375736|FG007|Overall Study|Other|0|||
124659553|NCT03275389|448375737|FG008|Overall Study|Other|1|||
124659554|NCT03275389|448375738|FG009|Overall Study|Other|0|||
124659555|NCT00978341|448375739|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
124659556|NCT00978341|448375740|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
124659557|NCT03035916|448375741|FG000|Overall Study|Puncture failed|0|||
124659558|NCT03035916|448375742|FG001|Overall Study|Puncture failed|2|||
124659559|NCT03035916|448375743|FG002|Overall Study|Puncture failed|0|||
124659560|NCT03885999|448375744|FG000|Overall Study|Adverse Event|1|||
124659561|NCT02452554|448375745|FG000|Overall Study|Death|2|||
124659562|NCT02452554|448375746|FG001|Overall Study|Death|1|||
124659563|NCT02452554|448375747|FG002|Overall Study|Death|0|||
124659564|NCT02452554|448375748|FG003|Overall Study|Death|0|||
124659565|NCT02452554|448375749|FG004|Overall Study|Death|0|||
124659566|NCT02452554|448375750|FG005|Overall Study|Death|0|||
124659567|NCT02452554|448375745|FG000|Overall Study|Lack of Efficacy|13|||
124659568|NCT02452554|448375746|FG001|Overall Study|Lack of Efficacy|14|||
124659569|NCT02452554|448375747|FG002|Overall Study|Lack of Efficacy|9|||
124659570|NCT02452554|448375748|FG003|Overall Study|Lack of Efficacy|1|||
124659571|NCT02452554|448375749|FG004|Overall Study|Lack of Efficacy|5|||
124659572|NCT02452554|448375750|FG005|Overall Study|Lack of Efficacy|8|||
124659573|NCT02452554|448375745|FG000|Overall Study|Physician Decision|0|||
124659574|NCT02452554|448375746|FG001|Overall Study|Physician Decision|1|||
124659575|NCT02452554|448375747|FG002|Overall Study|Physician Decision|0|||
124659576|NCT02452554|448375748|FG003|Overall Study|Physician Decision|0|||
124659577|NCT02452554|448375749|FG004|Overall Study|Physician Decision|0|||
124659578|NCT02452554|448375750|FG005|Overall Study|Physician Decision|0|||
124659579|NCT02452554|448375745|FG000|Overall Study|Withdrawal by Subject|1|||
124659580|NCT02452554|448375746|FG001|Overall Study|Withdrawal by Subject|0|||
124659581|NCT02452554|448375747|FG002|Overall Study|Withdrawal by Subject|2|||
124659582|NCT02452554|448375748|FG003|Overall Study|Withdrawal by Subject|0|||
124659583|NCT02452554|448375749|FG004|Overall Study|Withdrawal by Subject|0|||
124659584|NCT02452554|448375750|FG005|Overall Study|Withdrawal by Subject|1|||
124659585|NCT02452554|448375745|FG000|Overall Study|Ineligible|0|||
124659586|NCT02452554|448375746|FG001|Overall Study|Ineligible|1|||
124659587|NCT02452554|448375747|FG002|Overall Study|Ineligible|0|||
124659588|NCT02452554|448375748|FG003|Overall Study|Ineligible|0|||
124659589|NCT02452554|448375749|FG004|Overall Study|Ineligible|0|||
124659590|NCT02452554|448375750|FG005|Overall Study|Ineligible|0|||
124659591|NCT02452554|448375745|FG000|Overall Study|Never Received Treatment|1|||
124659592|NCT02452554|448375746|FG001|Overall Study|Never Received Treatment|0|||
124659593|NCT02452554|448375747|FG002|Overall Study|Never Received Treatment|0|||
124659594|NCT02452554|448375748|FG003|Overall Study|Never Received Treatment|0|||
124659595|NCT02452554|448375749|FG004|Overall Study|Never Received Treatment|0|||
124659596|NCT02452554|448375750|FG005|Overall Study|Never Received Treatment|0|||
124659597|NCT05188729|448375753|FG000|Overall Study|Withdrawal by Subject|0|||
124659598|NCT05188729|448375754|FG001|Overall Study|Withdrawal by Subject|0|||
124659599|NCT05188729|448375755|FG002|Overall Study|Withdrawal by Subject|0|||
124659600|NCT05188729|448375756|FG003|Overall Study|Withdrawal by Subject|0|||
124659601|NCT05188729|448375757|FG004|Overall Study|Withdrawal by Subject|0|||
124659602|NCT05188729|448375758|FG005|Overall Study|Withdrawal by Subject|0|||
124659603|NCT05188729|448375759|FG006|Overall Study|Withdrawal by Subject|0|||
124659604|NCT05188729|448375760|FG007|Overall Study|Withdrawal by Subject|0|||
124659605|NCT05188729|448375761|FG008|Overall Study|Withdrawal by Subject|0|||
124659606|NCT05188729|448375762|FG009|Overall Study|Withdrawal by Subject|1|||
124659607|NCT05188729|448375763|FG010|Overall Study|Withdrawal by Subject|0|||
124659608|NCT05188729|448375764|FG011|Overall Study|Withdrawal by Subject|0|||
124659609|NCT05188729|448375765|FG012|Overall Study|Withdrawal by Subject|0|||
124659610|NCT05188729|448375753|FG000|Overall Study|Lost to Follow-up|0|||
124659611|NCT05188729|448375754|FG001|Overall Study|Lost to Follow-up|0|||
124659612|NCT05188729|448375755|FG002|Overall Study|Lost to Follow-up|0|||
124659613|NCT05188729|448375756|FG003|Overall Study|Lost to Follow-up|0|||
124659614|NCT05188729|448375757|FG004|Overall Study|Lost to Follow-up|0|||
124659615|NCT05188729|448375758|FG005|Overall Study|Lost to Follow-up|0|||
124659616|NCT05188729|448375759|FG006|Overall Study|Lost to Follow-up|0|||
124659617|NCT05188729|448375760|FG007|Overall Study|Lost to Follow-up|0|||
124659618|NCT05188729|448375761|FG008|Overall Study|Lost to Follow-up|0|||
124659619|NCT05188729|448375762|FG009|Overall Study|Lost to Follow-up|0|||
124659620|NCT05188729|448375763|FG010|Overall Study|Lost to Follow-up|1|||
124659621|NCT05188729|448375764|FG011|Overall Study|Lost to Follow-up|1|||
124659622|NCT05188729|448375765|FG012|Overall Study|Lost to Follow-up|0|||
124659623|NCT02552888|448375766|FG000|Overall Study|Lost to Follow-up|1|||
124659624|NCT02552888|448375767|FG001|Overall Study|Lost to Follow-up|1|||
124659625|NCT01859949|448377281|FG000|Overall Study|Family Matters|0|||
124659626|NCT01859949|448377282|FG001|Overall Study|Family Matters|1|||
124659627|NCT01859949|448377281|FG000|Overall Study|Physician Decision|2|||
124659628|NCT01859949|448377282|FG001|Overall Study|Physician Decision|4|||
124659629|NCT01859949|448377281|FG000|Overall Study|Withdrawal by Subject|11|||
124659630|NCT01859949|448377282|FG001|Overall Study|Withdrawal by Subject|10|||
124659631|NCT01859949|448377281|FG000|Overall Study|Protocol Violation|1|||
124659632|NCT01859949|448377282|FG001|Overall Study|Protocol Violation|1|||
124659633|NCT01859949|448377281|FG000|Overall Study|Adverse Event|0|||
124659634|NCT01859949|448377282|FG001|Overall Study|Adverse Event|1|||
124659635|NCT01890759|448377283|FG000|Overall Study|Protocol Violation|0|||
124659636|NCT01890759|448377284|FG001|Overall Study|Protocol Violation|2|||
124659637|NCT01890759|448377283|FG000|Overall Study|Lost to Follow-up|0|||
124659638|NCT01890759|448377284|FG001|Overall Study|Lost to Follow-up|2|||
124659639|NCT01890759|448377283|FG000|Overall Study|Withdrawal by Subject|2|||
124659640|NCT01890759|448377284|FG001|Overall Study|Withdrawal by Subject|8|||
124659641|NCT00171158|448377285|FG000|Core Study|Death|27|||
124659642|NCT00171158|448377285|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
124659643|NCT00171158|448377285|FG000|Core Study|Protocol Violation|4|||
124659644|NCT00171158|448377285|FG000|Core Study|Administrative problems|1|||
124659645|NCT00171158|448377285|FG000|Core Study|Adverse event, non-fatal|21|||
124659646|NCT00171158|448377285|FG000|Core Study|Consent withdrawn by subject|6|||
124659647|NCT00171158|448377285|FG000|Core Study|No longer required drug (BMT)|14|||
124659648|NCT00171158|448377285|FG000|Core Study|Abnormal Laboratory Values|2|||
124659649|NCT00171158|448377285|FG000|Core Study|Lost to Follow-up|1|||
124659650|NCT00171158|448377285|FG000|E2 Extension|Other|7|||
124659651|NCT01031004|448377292|FG000|Overall Study|Protocol Violation|0|||
124659652|NCT01031004|448377293|FG001|Overall Study|Protocol Violation|1|||
124659653|NCT01031004|448377292|FG000|Overall Study|Lost to Follow-up|1|||
124659654|NCT01031004|448377293|FG001|Overall Study|Lost to Follow-up|0|||
124659655|NCT02634801|448377294|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
124659656|NCT02634801|448377295|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
124659657|NCT02634801|448377296|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
124659658|NCT02634801|448377294|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
124659659|NCT02634801|448377295|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
124659660|NCT02634801|448377296|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
124659661|NCT02634801|448377294|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
124659662|NCT02634801|448377295|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
124659663|NCT02634801|448377296|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
124659664|NCT02634801|448377294|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
124659665|NCT02634801|448377295|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
124659666|NCT02634801|448377296|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
124659667|NCT02634801|448377294|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
124659668|NCT02634801|448377295|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
124659669|NCT02634801|448377296|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
124659670|NCT02634801|448377294|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
124659671|NCT02634801|448377295|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
124659672|NCT02634801|448377296|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
124659673|NCT02634801|448377294|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
124659674|NCT02634801|448377295|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
124659675|NCT02634801|448377296|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
124659676|NCT02634801|448377294|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
124659677|NCT02634801|448377295|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
124659678|NCT02634801|448377296|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
124659679|NCT02634801|448377294|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
124659680|NCT02634801|448377295|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
124659681|NCT02634801|448377296|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
124659682|NCT02634801|448377294|FG000|Follow-up Period|Lost to Follow-up|3|||
124659683|NCT02634801|448377295|FG001|Follow-up Period|Lost to Follow-up|1|||
124659684|NCT02634801|448377296|FG002|Follow-up Period|Lost to Follow-up|2|||
124659685|NCT02634801|448377294|FG000|Follow-up Period|Physician Decision|0|||
124659686|NCT02634801|448377295|FG001|Follow-up Period|Physician Decision|0|||
124659687|NCT02634801|448377296|FG002|Follow-up Period|Physician Decision|1|||
124659688|NCT02634801|448377294|FG000|Follow-up Period|Withdrawal by Subject|1|||
124659689|NCT02634801|448377295|FG001|Follow-up Period|Withdrawal by Subject|2|||
124659690|NCT02634801|448377296|FG002|Follow-up Period|Withdrawal by Subject|5|||
124659691|NCT02634801|448377294|FG000|Follow-up Period|Adverse Event|1|||
124659692|NCT02634801|448377295|FG001|Follow-up Period|Adverse Event|5|||
124659693|NCT02634801|448377296|FG002|Follow-up Period|Adverse Event|0|||
124659694|NCT00582426|448377297|FG000|Overall Study|Lost to Follow-up|0|||
124659695|NCT00582426|448377298|FG001|Overall Study|Lost to Follow-up|2|||
124659696|NCT00582426|448377297|FG000|Overall Study|Adverse Event|4|||
124659697|NCT00582426|448377298|FG001|Overall Study|Adverse Event|2|||
124659698|NCT00582426|448377297|FG000|Overall Study|Protocol Violation|6|||
124659699|NCT00582426|448377298|FG001|Overall Study|Protocol Violation|2|||
124659700|NCT00582426|448377297|FG000|Overall Study|Death|4|||
124659701|NCT00582426|448377298|FG001|Overall Study|Death|3|||
124659702|NCT00582426|448377297|FG000|Overall Study|Withdrawal by Subject|3|||
124659703|NCT00582426|448377298|FG001|Overall Study|Withdrawal by Subject|2|||
124659704|NCT00582426|448377297|FG000|Overall Study|Disease Progression|2|||
124659705|NCT00582426|448377298|FG001|Overall Study|Disease Progression|2|||
124659706|NCT00582426|448377297|FG000|Overall Study|Use of illicit drugs|1|||
124659707|NCT00582426|448377298|FG001|Overall Study|Use of illicit drugs|0|||
124659708|NCT00662311|448377299|FG000|Overall Study|Respiratory Infection|1|||
124659709|NCT00662311|448377300|FG001|Overall Study|Respiratory Infection|0|||
124659710|NCT00662311|448377301|FG002|Overall Study|Respiratory Infection|0|||
124659711|NCT01467271|448377304|FG000|Overall Study|Death|84|||
124659712|NCT01467271|448377304|FG000|Overall Study|Lost to Follow-up|83|||
124659713|NCT01467271|448377304|FG000|Overall Study|Retraction of patient's consent|21|||
124659714|NCT01467271|448377304|FG000|Overall Study|Other reason|14|||
124659715|NCT01548768|448377305|FG000|Overall Study|Withdrawal by Subject|0|||
124659716|NCT01548768|448377306|FG001|Overall Study|Withdrawal by Subject|2|||
124659717|NCT01548768|448377307|FG002|Overall Study|Withdrawal by Subject|1|||
124659718|NCT01548768|448377308|FG003|Overall Study|Withdrawal by Subject|0|||
124659719|NCT01548768|448377305|FG000|Overall Study|Physician Decision|1|||
124659720|NCT01548768|448377306|FG001|Overall Study|Physician Decision|0|||
124659721|NCT01548768|448377307|FG002|Overall Study|Physician Decision|0|||
124659722|NCT01548768|448377308|FG003|Overall Study|Physician Decision|0|||
124659723|NCT01548768|448377305|FG000|Overall Study|Adverse Event|0|||
124659724|NCT01548768|448377306|FG001|Overall Study|Adverse Event|0|||
124659725|NCT01548768|448377307|FG002|Overall Study|Adverse Event|0|||
124659726|NCT01548768|448377308|FG003|Overall Study|Adverse Event|1|||
124659727|NCT01548768|448377305|FG000|Overall Study|Non-Compliance|0|||
124659728|NCT01548768|448377306|FG001|Overall Study|Non-Compliance|0|||
124659729|NCT01548768|448377307|FG002|Overall Study|Non-Compliance|0|||
124659730|NCT01548768|448377308|FG003|Overall Study|Non-Compliance|3|||
124659731|NCT04126317|448377325|FG000|Overall Study|Adverse Event|0|||
124659732|NCT04126317|448377326|FG001|Overall Study|Adverse Event|1|||
124659733|NCT04126317|448377325|FG000|Overall Study|Withdrawal by Subject|4|||
124659734|NCT04126317|448377326|FG001|Overall Study|Withdrawal by Subject|1|||
124659735|NCT01796301|448377327|FG000|Overall Study|Withdrawal by Subject|15|||
124659736|NCT01796301|448377328|FG001|Overall Study|Withdrawal by Subject|15|||
124659737|NCT01796301|448377327|FG000|Overall Study|Lost to Follow-up|3|||
124659738|NCT01796301|448377328|FG001|Overall Study|Lost to Follow-up|3|||
124659739|NCT01796301|448377327|FG000|Overall Study|Death|0|||
124659740|NCT01796301|448377328|FG001|Overall Study|Death|1|||
124659741|NCT01796301|448377327|FG000|Overall Study|Decision by Sponsor|0|||
124659742|NCT01796301|448377328|FG001|Overall Study|Decision by Sponsor|1|||
124659743|NCT00667563|448377329|FG000|Overall Study|Protocol Violation|24|||
124659744|NCT01939223|448377330|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
124659745|NCT01939223|448377331|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
124659746|NCT01939223|448377330|FG000|Overall Study|Disease recurrence (radiological)|1|||
124659747|NCT01939223|448377331|FG001|Overall Study|Disease recurrence (radiological)|3|||
124659748|NCT01939223|448377330|FG000|Overall Study|Study stopped by Sponsor|5|||
124659749|NCT01939223|448377331|FG001|Overall Study|Study stopped by Sponsor|7|||
124659750|NCT01939223|448377330|FG000|Overall Study|Withdrawal by Subject|6|||
124659751|NCT01939223|448377331|FG001|Overall Study|Withdrawal by Subject|0|||
124659752|NCT01557517|448377332|FG000|Overall Study|Death|1|||
124659753|NCT01557517|448377333|FG001|Overall Study|Death|0|||
124659754|NCT01557517|448377332|FG000|Overall Study|Refused further treatment|0|||
124659755|NCT01557517|448377333|FG001|Overall Study|Refused further treatment|2|||
124659756|NCT01557517|448377332|FG000|Overall Study|Adverse Event|0|||
124659757|NCT01557517|448377333|FG001|Overall Study|Adverse Event|2|||
124659758|NCT01557517|448377332|FG000|Overall Study|Pt declined before treatment started|1|||
124659759|NCT01557517|448377333|FG001|Overall Study|Pt declined before treatment started|0|||
124659760|NCT00162097|448377334|FG000|Overall Study|Participant no longer met study criteria|0|||
124659761|NCT00162097|448377335|FG001|Overall Study|Participant no longer met study criteria|0|||
124659762|NCT00162097|448377336|FG002|Overall Study|Participant no longer met study criteria|0|||
124659763|NCT00162097|448377337|FG003|Overall Study|Participant no longer met study criteria|1|||
124659764|NCT03585712|448377342|FG000|Treatment Period 1|Protocol Violation|1|||
124659765|NCT03585712|448377343|FG001|Treatment Period 1|Protocol Violation|0|||
124659766|NCT03585712|448377344|FG002|Treatment Period 1|Protocol Violation|0|||
124659767|NCT03585712|448377342|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
124659768|NCT03585712|448377343|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
124659769|NCT03585712|448377344|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
124659770|NCT03585712|448377342|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
124659771|NCT03585712|448377343|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
124659772|NCT03585712|448377344|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
124659773|NCT03585712|448377342|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
124659774|NCT03585712|448377343|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
124659775|NCT03585712|448377344|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
124659776|NCT01280682|448377349|FG000|Overall Study|Lost to Follow-up|0|||
124659777|NCT01280682|448377350|FG001|Overall Study|Lost to Follow-up|6|||
124659778|NCT01280682|448377349|FG000|Overall Study|Withdrawal by Subject|0|||
124659779|NCT01280682|448377350|FG001|Overall Study|Withdrawal by Subject|7|||
124659780|NCT01964716|448377359|FG000|Overall Study|Withdrawal by Subject|2|||
124659781|NCT01964716|448377360|FG001|Overall Study|Withdrawal by Subject|3|||
124659782|NCT01964716|448377359|FG000|Overall Study|Lost to Follow-up|1|||
124659783|NCT01964716|448377360|FG001|Overall Study|Lost to Follow-up|2|||
124659784|NCT01964716|448377359|FG000|Overall Study|No longer met eligibility criteria|1|||
124659785|NCT01964716|448377360|FG001|Overall Study|No longer met eligibility criteria|1|||
124659786|NCT01964716|448377359|FG000|Overall Study|Death|1|||
124659787|NCT01964716|448377360|FG001|Overall Study|Death|0|||
124659788|NCT01464619|448377365|FG000|Overall Study|Lost to Follow-up|3|||
124659789|NCT01464619|448377366|FG001|Overall Study|Lost to Follow-up|4|||
124659790|NCT01658904|448377367|FG000|Overall Study|Principal Investigator discretion|2|||
124659791|NCT01658904|448377368|FG001|Overall Study|Principal Investigator discretion|0|||
124659792|NCT01658904|448377369|FG002|Overall Study|Principal Investigator discretion|0|||
124659793|NCT00080483|448377370|FG000|Overall Study|Lost to Follow-up|1|||
124659794|NCT00080483|448377371|FG001|Overall Study|Lost to Follow-up|1|||
124659795|NCT00080483|448377370|FG000|Overall Study|Physician Decision|1|||
124659796|NCT00080483|448377371|FG001|Overall Study|Physician Decision|1|||
124659797|NCT01808222|448377372|FG000|Overall Study|mpMR scan was not performed|1|||
124659798|NCT00460746|448377380|FG000|Overall Study|Adverse Event|1|||
124659799|NCT00460746|448377380|FG000|Overall Study|Lost to Follow-up|1|||
124659800|NCT04399538|448377385|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
124659801|NCT04399538|448377386|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
124659802|NCT04399538|448377387|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
124659803|NCT04399538|448377388|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
124659804|NCT04399538|448377389|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
124659805|NCT04399538|448377385|FG000|Double-Blind Treatment|Adverse Event|0|||
124659806|NCT04399538|448377386|FG001|Double-Blind Treatment|Adverse Event|0|||
124659807|NCT04399538|448377387|FG002|Double-Blind Treatment|Adverse Event|0|||
124659808|NCT04399538|448377388|FG003|Double-Blind Treatment|Adverse Event|0|||
124659809|NCT04399538|448377389|FG004|Double-Blind Treatment|Adverse Event|1|||
124659810|NCT04399538|448377385|FG000|Follow-Up|Adverse Event|0|||
124659811|NCT04399538|448377386|FG001|Follow-Up|Adverse Event|0|||
124659812|NCT04399538|448377387|FG002|Follow-Up|Adverse Event|0|||
124659813|NCT04399538|448377388|FG003|Follow-Up|Adverse Event|0|||
124659814|NCT04399538|448377389|FG004|Follow-Up|Adverse Event|1|||
124659815|NCT04399538|448377385|FG000|Follow-Up|Withdrawal by Subject|0|||
124659816|NCT04399538|448377386|FG001|Follow-Up|Withdrawal by Subject|0|||
124659817|NCT04399538|448377387|FG002|Follow-Up|Withdrawal by Subject|0|||
124659818|NCT04399538|448377388|FG003|Follow-Up|Withdrawal by Subject|2|||
124659819|NCT04399538|448377389|FG004|Follow-Up|Withdrawal by Subject|0|||
124659820|NCT00636961|448377396|FG000|Period 1|Administrative problems|1|||
124659821|NCT00636961|448377397|FG001|Period 1|Administrative problems|1|||
124659822|NCT00636961|448377396|FG000|Period 2|Adverse Event|1|||
124659823|NCT00636961|448377397|FG001|Period 2|Adverse Event|0|||
124659824|NCT02756364|448377399|FG000|Overall Study|Site Terminated by Sponsor|24|||
124659825|NCT02756364|448377400|FG001|Overall Study|Site Terminated by Sponsor|30|||
124659826|NCT02756364|448377401|FG002|Overall Study|Site Terminated by Sponsor|21|||
124659827|NCT02756364|448377399|FG000|Overall Study|Death|20|||
124659828|NCT02756364|448377400|FG001|Overall Study|Death|15|||
124659829|NCT02756364|448377401|FG002|Overall Study|Death|18|||
124659830|NCT02756364|448377399|FG000|Overall Study|Withdrawal by Patient|2|||
124659831|NCT02756364|448377400|FG001|Overall Study|Withdrawal by Patient|1|||
124659832|NCT02756364|448377401|FG002|Overall Study|Withdrawal by Patient|8|||
124659833|NCT02756364|448377399|FG000|Overall Study|Lost to Follow-up|0|||
124659834|NCT02756364|448377400|FG001|Overall Study|Lost to Follow-up|1|||
124659835|NCT02756364|448377401|FG002|Overall Study|Lost to Follow-up|1|||
124659836|NCT02655016|448377402|FG000|Overall Study|Disease progression|6|||
124659837|NCT02655016|448377403|FG001|Overall Study|Disease progression|4|||
124659838|NCT02655016|448377402|FG000|Overall Study|Site closed|0|||
124659839|NCT02655016|448377403|FG001|Overall Study|Site closed|1|||
124659840|NCT02655016|448377402|FG000|Overall Study|Death|30|||
124659841|NCT02655016|448377403|FG001|Overall Study|Death|48|||
124659842|NCT02655016|448377402|FG000|Overall Study|Lost to Follow-up|1|||
124659843|NCT02655016|448377403|FG001|Overall Study|Lost to Follow-up|1|||
124659844|NCT02655016|448377402|FG000|Overall Study|Withdrawal by Subject|18|||
124659845|NCT02655016|448377403|FG001|Overall Study|Withdrawal by Subject|36|||
124659846|NCT02223364|448377404|FG000|Overall Study|Protocol Violation|3|||
124659847|NCT02223364|448377405|FG001|Overall Study|Protocol Violation|0|||
124659848|NCT02223364|448377406|FG002|Overall Study|Protocol Violation|3|||
124659849|NCT02223364|448377404|FG000|Overall Study|subject expired before surgery|1|||
124659850|NCT02223364|448377405|FG001|Overall Study|subject expired before surgery|0|||
124659851|NCT02223364|448377406|FG002|Overall Study|subject expired before surgery|0|||
124659852|NCT02223364|448377404|FG000|Overall Study|Physician Decision|1|||
124659853|NCT02223364|448377405|FG001|Overall Study|Physician Decision|0|||
124659854|NCT02223364|448377406|FG002|Overall Study|Physician Decision|0|||
124659855|NCT01841567|448377407|FG000|Overall Study|Adverse Event|3|||
124659856|NCT01573754|448377412|FG000|Overall Study|Noncompliance or remission not achieved|3|||
124659857|NCT01573754|448377413|FG001|Overall Study|Noncompliance or remission not achieved|15|||
124659858|NCT00829829|448377415|FG000|Overall Study|Protocol Violation|0|||
124659859|NCT00829829|448377416|FG001|Overall Study|Protocol Violation|3|||
124659860|NCT00829829|448377417|FG002|Overall Study|Protocol Violation|0|||
124659861|NCT00829829|448377415|FG000|Overall Study|Adverse Event|4|||
124659862|NCT00829829|448377416|FG001|Overall Study|Adverse Event|4|||
124659863|NCT00829829|448377417|FG002|Overall Study|Adverse Event|3|||
124659864|NCT00829829|448377415|FG000|Overall Study|Withdrawal by Subject|8|||
124659865|NCT00829829|448377416|FG001|Overall Study|Withdrawal by Subject|4|||
124659866|NCT00829829|448377417|FG002|Overall Study|Withdrawal by Subject|2|||
124659867|NCT00829829|448377415|FG000|Overall Study|Decision by the Sponsor|1|||
124659868|NCT00829829|448377416|FG001|Overall Study|Decision by the Sponsor|0|||
124659869|NCT00829829|448377417|FG002|Overall Study|Decision by the Sponsor|2|||
124659870|NCT00829829|448377415|FG000|Overall Study|Lost to Follow-up|7|||
124659871|NCT00829829|448377416|FG001|Overall Study|Lost to Follow-up|3|||
124659872|NCT00829829|448377417|FG002|Overall Study|Lost to Follow-up|3|||
124659873|NCT00829829|448377415|FG000|Overall Study|Other than specified above|2|||
124659874|NCT00829829|448377416|FG001|Overall Study|Other than specified above|2|||
124659875|NCT00829829|448377417|FG002|Overall Study|Other than specified above|1|||
124659876|NCT02984267|448377418|FG000|Overall Study|Protocol Violation|1|||
124659877|NCT02984267|448377419|FG001|Overall Study|Protocol Violation|0|||
124659878|NCT02984267|448377418|FG000|Overall Study|Withdrawal by Subject|0|||
124659879|NCT02984267|448377419|FG001|Overall Study|Withdrawal by Subject|1|||
124659880|NCT02685072|448377420|FG000|Treatment Period|Lost to Follow-up|12|||
124659881|NCT02685072|448377421|FG001|Treatment Period|Lost to Follow-up|6|||
124659882|NCT02685072|448377420|FG000|Treatment Period|Withdrawal by Subject|1|||
124659883|NCT02685072|448377421|FG001|Treatment Period|Withdrawal by Subject|3|||
124659884|NCT02685072|448377420|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
124659885|NCT02685072|448377421|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
124659886|NCT00742027|448377422|FG000|Overall Study|Disease Progression|76|||
124659887|NCT00742027|448377422|FG000|Overall Study|New Cancer Therapy|19|||
124659888|NCT00742027|448377422|FG000|Overall Study|Withdrawal by Subject|18|||
124659889|NCT00742027|448377422|FG000|Overall Study|Death|7|||
124659890|NCT00742027|448377422|FG000|Overall Study|Lost to Follow-up|4|||
124659891|NCT00742027|448377422|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
124659892|NCT00742027|448377422|FG000|Overall Study|Missing|2|||
124659893|NCT00742027|448377422|FG000|Overall Study|Administrative Problems|1|||
124659894|NCT02717442|448377426|FG000|Overall Study|Study Terminated by Sponsor|31|||
124659895|NCT02717442|448377427|FG001|Overall Study|Study Terminated by Sponsor|29|||
124659896|NCT02717442|448377426|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
124659897|NCT02717442|448377427|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
124659898|NCT02717442|448377426|FG000|Overall Study|Other - Not Specified|2|||
124659899|NCT02717442|448377427|FG001|Overall Study|Other - Not Specified|0|||
124659900|NCT00528372|448377431|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
124659901|NCT00528372|448377432|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
124659902|NCT00528372|448377433|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
124659903|NCT00528372|448377434|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
124659904|NCT00528372|448377435|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
124659905|NCT00528372|448377436|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
124659906|NCT00528372|448377437|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
124659907|NCT00528372|448377438|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
124659908|NCT00528372|448377439|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
124659909|NCT00528372|448377431|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
124659910|NCT00528372|448377432|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
124659911|NCT00528372|448377433|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
124659912|NCT00528372|448377434|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
124659913|NCT00528372|448377435|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
124659914|NCT00528372|448377436|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
124659915|NCT00528372|448377437|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
124659916|NCT00528372|448377438|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
124659917|NCT00528372|448377439|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
124659918|NCT00528372|448377431|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
124659919|NCT00528372|448377432|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
124659920|NCT00528372|448377433|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
124659921|NCT00528372|448377434|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
124659922|NCT00528372|448377435|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
124659923|NCT00528372|448377436|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
124659924|NCT00528372|448377437|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
124659925|NCT00528372|448377438|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
124659926|NCT00528372|448377439|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
124659927|NCT00528372|448377431|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
124659928|NCT00528372|448377432|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
124659929|NCT00528372|448377433|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
124659930|NCT00528372|448377434|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
124659931|NCT00528372|448377435|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
124659932|NCT00528372|448377436|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
124659933|NCT00528372|448377437|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
124659934|NCT00528372|448377438|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
124659935|NCT00528372|448377439|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
124659936|NCT00528372|448377431|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
124659937|NCT00528372|448377432|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
124659938|NCT00528372|448377433|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
124659939|NCT00528372|448377434|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
124659940|NCT00528372|448377435|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
124659941|NCT00528372|448377436|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
124659942|NCT00528372|448377437|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
124659943|NCT00528372|448377438|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
124659944|NCT00528372|448377439|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
124659945|NCT00528372|448377431|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
124659946|NCT00528372|448377432|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
124659947|NCT00528372|448377433|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
124659948|NCT00528372|448377434|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
124659949|NCT00528372|448377435|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
124659950|NCT00528372|448377436|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
124659951|NCT00528372|448377437|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
124659952|NCT00528372|448377438|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
124659953|NCT00528372|448377439|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
124659954|NCT00528372|448377431|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
124659955|NCT00528372|448377432|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
124659956|NCT00528372|448377433|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
124659957|NCT00528372|448377434|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
124659958|NCT00528372|448377435|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
124659959|NCT00528372|448377436|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
124659960|NCT00528372|448377437|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
124659961|NCT00528372|448377438|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
124659962|NCT00528372|448377439|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
124659963|NCT00528372|448377431|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
124659964|NCT00528372|448377432|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
124659965|NCT00528372|448377433|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
124659966|NCT00528372|448377434|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
124659967|NCT00528372|448377435|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
124659968|NCT00528372|448377436|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
124659969|NCT00528372|448377437|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
124659970|NCT00528372|448377438|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
124659971|NCT00528372|448377439|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
124659972|NCT00528372|448377431|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
124659973|NCT00528372|448377432|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
124659974|NCT00528372|448377433|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
124659975|NCT00528372|448377434|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
124659976|NCT00528372|448377435|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
124659977|NCT00528372|448377436|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
124659978|NCT00528372|448377437|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
124659979|NCT00528372|448377438|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
124659980|NCT00528372|448377439|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
124659981|NCT00528372|448377431|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
124659982|NCT00528372|448377432|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
124659983|NCT00528372|448377433|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
124659984|NCT00528372|448377434|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
124659985|NCT00528372|448377435|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
124659986|NCT00528372|448377436|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
124659987|NCT00528372|448377437|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
124659988|NCT00528372|448377438|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
124659989|NCT00528372|448377439|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
124659990|NCT00528372|448377431|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
124659991|NCT00528372|448377432|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
124659992|NCT00528372|448377433|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
124659993|NCT00528372|448377434|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
124659994|NCT00528372|448377435|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
124659995|NCT00528372|448377436|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
124659996|NCT00528372|448377437|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
124659997|NCT00528372|448377438|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
124659998|NCT00528372|448377439|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
124659999|NCT00528372|448377431|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
124660000|NCT00528372|448377432|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
124660001|NCT00528372|448377433|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
124660002|NCT00528372|448377434|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
124660003|NCT00528372|448377435|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
124660004|NCT00528372|448377436|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
124660005|NCT00528372|448377437|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
124660006|NCT00528372|448377438|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
124660007|NCT00528372|448377439|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
124660008|NCT00528372|448377431|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
124660009|NCT00528372|448377432|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
124660010|NCT00528372|448377433|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
124660011|NCT00528372|448377434|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
124660012|NCT00528372|448377435|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
124660013|NCT00528372|448377436|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
124660014|NCT00528372|448377437|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
124660015|NCT00528372|448377438|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
124660016|NCT00528372|448377439|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
124660017|NCT00528372|448377431|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
124660018|NCT00528372|448377432|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
124660019|NCT00528372|448377433|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
124660020|NCT00528372|448377434|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
124660021|NCT00528372|448377435|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
124660022|NCT00528372|448377436|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
124660023|NCT00528372|448377437|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
124660024|NCT00528372|448377438|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
124660025|NCT00528372|448377439|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
124660026|NCT00528372|448377431|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
124660027|NCT00528372|448377432|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
124660028|NCT00528372|448377433|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
124660029|NCT00528372|448377434|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
124660030|NCT00528372|448377435|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
124660031|NCT00528372|448377436|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
124660032|NCT00528372|448377437|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
124660033|NCT00528372|448377438|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
124660034|NCT00528372|448377439|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
124660035|NCT00762034|448379287|FG000|Induction Period|Protocol Violation|1|||
124660036|NCT00762034|448379288|FG001|Induction Period|Protocol Violation|2|||
124660037|NCT00762034|448379287|FG000|Induction Period|Entry Criterion Not Met|12|||
124660038|NCT00762034|448379288|FG001|Induction Period|Entry Criterion Not Met|11|||
124660039|NCT00762034|448379287|FG000|Induction Period|Adverse Event|27|||
124660040|NCT00762034|448379288|FG001|Induction Period|Adverse Event|38|||
124660041|NCT00762034|448379287|FG000|Induction Period|Lost to Follow-up|1|||
124660042|NCT00762034|448379288|FG001|Induction Period|Lost to Follow-up|1|||
124660043|NCT00762034|448379287|FG000|Induction Period|Progressive Disease|73|||
124660044|NCT00762034|448379288|FG001|Induction Period|Progressive Disease|55|||
124660045|NCT00762034|448379287|FG000|Induction Period|Physician Decision|21|||
124660046|NCT00762034|448379288|FG001|Induction Period|Physician Decision|20|||
124660047|NCT00762034|448379287|FG000|Induction Period|Withdrawal by Subject|15|||
124660048|NCT00762034|448379288|FG001|Induction Period|Withdrawal by Subject|19|||
124660049|NCT00762034|448379287|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
124660050|NCT00762034|448379288|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
124660051|NCT00762034|448379287|FG000|Induction Period|Deaths Due to Study Disease|9|||
124660052|NCT00762034|448379288|FG001|Induction Period|Deaths Due to Study Disease|9|||
124660053|NCT00762034|448379287|FG000|Maintenance Period|Protocol Violation|1|||
124660054|NCT00762034|448379288|FG001|Maintenance Period|Protocol Violation|3|||
124660055|NCT00762034|448379287|FG000|Maintenance Period|Entry Criterion Not Met|0|||
124660056|NCT00762034|448379288|FG001|Maintenance Period|Entry Criterion Not Met|2|||
124660057|NCT00762034|448379287|FG000|Maintenance Period|Adverse Event|42|||
124660058|NCT00762034|448379288|FG001|Maintenance Period|Adverse Event|26|||
124660059|NCT00762034|448379287|FG000|Maintenance Period|Progressive Disease|186|||
124660060|NCT00762034|448379288|FG001|Maintenance Period|Progressive Disease|224|||
124660061|NCT00762034|448379287|FG000|Maintenance Period|Physician Decision|25|||
124660062|NCT00762034|448379288|FG001|Maintenance Period|Physician Decision|20|||
124660063|NCT00762034|448379287|FG000|Maintenance Period|Withdrawal by Subject|34|||
124660064|NCT00762034|448379288|FG001|Maintenance Period|Withdrawal by Subject|14|||
124660065|NCT00762034|448379287|FG000|Maintenance Period|Death not due to study disease|2|||
124660066|NCT00762034|448379288|FG001|Maintenance Period|Death not due to study disease|5|||
124660067|NCT00762034|448379287|FG000|Maintenance Period|Death due to study disease|3|||
124660068|NCT00762034|448379288|FG001|Maintenance Period|Death due to study disease|3|||
124660069|NCT00762034|448379287|FG000|Maintenance Period|Other|1|||
124660070|NCT00762034|448379288|FG001|Maintenance Period|Other|1|||
124660071|NCT02442206|448379289|FG000|Period 1|Adverse Event|1|||
124660072|NCT02442206|448379290|FG001|Period 1|Adverse Event|1|||
124660073|NCT02442206|448379289|FG000|Period 1|withdrew consent|0|||
124660074|NCT02442206|448379290|FG001|Period 1|withdrew consent|1|||
124660075|NCT02442206|448379289|FG000|Period 1|COPD exacerbation|0|||
124660076|NCT02442206|448379290|FG001|Period 1|COPD exacerbation|1|||
124660077|NCT02442206|448379289|FG000|Period 2|Adverse Event|1|||
124660078|NCT02442206|448379290|FG001|Period 2|Adverse Event|0|||
124660079|NCT00497146|448379291|FG000|Treatment Period|Adverse Event|6|||
124660080|NCT00497146|448379292|FG001|Treatment Period|Adverse Event|2|||
124660081|NCT00497146|448379291|FG000|Treatment Period|Withdrawal by Subject|5|||
124660082|NCT00497146|448379292|FG001|Treatment Period|Withdrawal by Subject|9|||
124660083|NCT00497146|448379291|FG000|Treatment Period|Lost to Follow-up|1|||
124660084|NCT00497146|448379292|FG001|Treatment Period|Lost to Follow-up|3|||
124660085|NCT00497146|448379291|FG000|Treatment Period|Required dialysis|4|||
124660086|NCT00497146|448379292|FG001|Treatment Period|Required dialysis|1|||
124660087|NCT00497146|448379291|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
124660088|NCT00497146|448379292|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
124660089|NCT00497146|448379291|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
124660090|NCT00497146|448379292|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
124660091|NCT00497146|448379291|FG000|Treatment Period|Other Reason|2|||
124660092|NCT00497146|448379292|FG001|Treatment Period|Other Reason|3|||
124660093|NCT00497146|448379291|FG000|Long-term Follow-up Period|Adverse Event|2|||
124660094|NCT00497146|448379292|FG001|Long-term Follow-up Period|Adverse Event|2|||
124660095|NCT00497146|448379291|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
124660096|NCT00497146|448379292|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
124660097|NCT00497146|448379291|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
124660098|NCT00497146|448379292|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
124660099|NCT00497146|448379291|FG000|Long-term Follow-up Period|Other|0|||
124660100|NCT00497146|448379292|FG001|Long-term Follow-up Period|Other|1|||
124660101|NCT02155309|448379295|FG000|Overall Study|Protocol Violation|0|||
124660102|NCT02155309|448379296|FG001|Overall Study|Protocol Violation|0|||
124660103|NCT02155309|448379297|FG002|Overall Study|Protocol Violation|1|||
124660104|NCT01299896|448379298|FG000|Overall Study|Withdrawal by Subject|1|||
124660105|NCT01299896|448379299|FG001|Overall Study|Withdrawal by Subject|7|||
124660106|NCT01299896|448379298|FG000|Overall Study|Lost to Follow-up|0|||
124660107|NCT01299896|448379299|FG001|Overall Study|Lost to Follow-up|11|||
124660108|NCT02107313|448379300|FG000|Overall Study|One participant did not do the FED cohor|0|||
124660109|NCT02107313|448379301|FG001|Overall Study|One participant did not do the FED cohor|1|||
124660110|NCT03084302|448379303|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
124660111|NCT03084302|448379303|FG000|Overall Study|No valid objective monitor data|6|||
124660112|NCT00929994|448379304|FG000|Overall Study|Withdrawal by Subject|1|||
124660113|NCT00929994|448379304|FG000|Overall Study|medical issue unrelated to intervention|4|||
124660114|NCT00929994|448379304|FG000|Overall Study|employment|1|||
124660115|NCT01411319|448379308|FG000|Overall Study|Lost to Follow-up|1|||
124660116|NCT01214668|448379309|FG000|Overall Study|Adverse Event|0|||
124660117|NCT01214668|448379310|FG001|Overall Study|Adverse Event|1|||
124660118|NCT01214668|448379311|FG002|Overall Study|Adverse Event|0|||
124660119|NCT01214668|448379312|FG003|Overall Study|Adverse Event|2|||
124660120|NCT01214668|448379313|FG004|Overall Study|Adverse Event|1|||
124660121|NCT01214668|448379314|FG005|Overall Study|Adverse Event|1|||
124660122|NCT01214668|448379309|FG000|Overall Study|Death|0|||
124660123|NCT01214668|448379310|FG001|Overall Study|Death|0|||
124660124|NCT01214668|448379311|FG002|Overall Study|Death|1|||
124660125|NCT01214668|448379312|FG003|Overall Study|Death|0|||
124660126|NCT01214668|448379313|FG004|Overall Study|Death|0|||
124660127|NCT01214668|448379314|FG005|Overall Study|Death|0|||
124660128|NCT01214668|448379309|FG000|Overall Study|Progressive Disease|4|||
124660129|NCT01214668|448379310|FG001|Overall Study|Progressive Disease|2|||
124660130|NCT01214668|448379311|FG002|Overall Study|Progressive Disease|5|||
124660131|NCT01214668|448379312|FG003|Overall Study|Progressive Disease|4|||
124660132|NCT01214668|448379313|FG004|Overall Study|Progressive Disease|4|||
124660133|NCT01214668|448379314|FG005|Overall Study|Progressive Disease|5|||
124660134|NCT01214668|448379309|FG000|Overall Study|Withdrawal by Subject|0|||
124660135|NCT01214668|448379310|FG001|Overall Study|Withdrawal by Subject|0|||
124660136|NCT01214668|448379311|FG002|Overall Study|Withdrawal by Subject|0|||
124660137|NCT01214668|448379312|FG003|Overall Study|Withdrawal by Subject|0|||
124660138|NCT01214668|448379313|FG004|Overall Study|Withdrawal by Subject|1|||
124660139|NCT01214668|448379314|FG005|Overall Study|Withdrawal by Subject|0|||
124660140|NCT01964989|448379315|FG000|Overall Study|Protocol Violation|3|||
124660141|NCT01964989|448379316|FG001|Overall Study|Protocol Violation|4|||
124660142|NCT01964989|448379315|FG000|Overall Study|Administrative Reason|103|||
124660143|NCT01964989|448379316|FG001|Overall Study|Administrative Reason|95|||
124660144|NCT01964989|448379315|FG000|Overall Study|Adverse Event|0|||
124660145|NCT01964989|448379316|FG001|Overall Study|Adverse Event|1|||
124660146|NCT01964989|448379315|FG000|Overall Study|Death|1|||
124660147|NCT01964989|448379316|FG001|Overall Study|Death|3|||
124660148|NCT01964989|448379315|FG000|Overall Study|Withdrawal by Subject|156|||
124660149|NCT01964989|448379316|FG001|Overall Study|Withdrawal by Subject|160|||
124660150|NCT01964989|448379315|FG000|Overall Study|Lost to Follow-up|254|||
124660151|NCT01964989|448379316|FG001|Overall Study|Lost to Follow-up|232|||
124660152|NCT01964989|448379315|FG000|Overall Study|Other|267|||
124660153|NCT01964989|448379316|FG001|Overall Study|Other|252|||
124660154|NCT00424593|448379317|FG000|Acute Double-Blind Period|Adverse Event|16|||
124660155|NCT00424593|448379318|FG001|Acute Double-Blind Period|Adverse Event|7|||
124660156|NCT00424593|448379317|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
124660157|NCT00424593|448379318|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
124660158|NCT00424593|448379317|FG000|Acute Double-Blind Period|Protocol Violation|2|||
124660159|NCT00424593|448379318|FG001|Acute Double-Blind Period|Protocol Violation|2|||
124660160|NCT00424593|448379317|FG000|Acute Double-Blind Period|Physician Decision|1|||
124660161|NCT00424593|448379318|FG001|Acute Double-Blind Period|Physician Decision|2|||
124660162|NCT00424593|448379317|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
124660163|NCT00424593|448379318|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
124660164|NCT00424593|448379317|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
124660165|NCT00424593|448379318|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
124660166|NCT00424593|448379317|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
124660167|NCT00424593|448379318|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
124660168|NCT00424593|448379317|FG000|Dose-Blind Extension Period|Adverse Event|18|||
124660169|NCT00424593|448379318|FG001|Dose-Blind Extension Period|Adverse Event|0|||
124660170|NCT00424593|448379317|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
124660171|NCT00424593|448379318|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
124660172|NCT00424593|448379317|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
124660173|NCT00424593|448379318|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
124660174|NCT00424593|448379317|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
124660175|NCT00424593|448379318|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
124660176|NCT00424593|448379317|FG000|Dose-Blind Extension Period|Physician Decision|3|||
124660177|NCT00424593|448379318|FG001|Dose-Blind Extension Period|Physician Decision|0|||
124660178|NCT03042910|448379324|FG000|Overall Study|Adverse Event|1|||
124660179|NCT03042910|448379324|FG000|Overall Study|Disease Progression|2|||
124660180|NCT03042910|448379324|FG000|Overall Study|Withdrawal by Subject|3|||
124660181|NCT03042910|448379324|FG000|Overall Study|Enrolled but not treated|1|||
124660182|NCT01491841|448379328|FG000|Overall Study|Screen Failure|10|||
124660183|NCT01491841|448379328|FG000|Overall Study|Withdrawal by Subject|1|||
124660184|NCT02933528|448379329|FG000|Overall Study|Lost to Follow-up|2|||
124660185|NCT01301079|448379330|FG000|Overall Study|Lost to Follow-up|2|||
124660186|NCT01301079|448379331|FG001|Overall Study|Lost to Follow-up|2|||
124660187|NCT00948922|448379333|FG000|Overall Study|Did not start study treatment|2|||
124660188|NCT00948922|448379334|FG001|Overall Study|Did not start study treatment|5|||
124660189|NCT00948922|448379335|FG002|Overall Study|Did not start study treatment|0|||
124660190|NCT00948922|448379333|FG000|Overall Study|Withdrawal by Subject|0|||
124660191|NCT00948922|448379334|FG001|Overall Study|Withdrawal by Subject|2|||
124660192|NCT00948922|448379335|FG002|Overall Study|Withdrawal by Subject|1|||
124660193|NCT00948922|448379333|FG000|Overall Study|Death|3|||
124660194|NCT00948922|448379334|FG001|Overall Study|Death|0|||
124660195|NCT00948922|448379335|FG002|Overall Study|Death|0|||
124660196|NCT00948922|448379333|FG000|Overall Study|Disease progression|0|||
124660197|NCT00948922|448379334|FG001|Overall Study|Disease progression|1|||
124660198|NCT00948922|448379335|FG002|Overall Study|Disease progression|0|||
124660199|NCT00948922|448379333|FG000|Overall Study|Insurance issues|1|||
124660200|NCT00948922|448379334|FG001|Overall Study|Insurance issues|0|||
124660201|NCT00948922|448379335|FG002|Overall Study|Insurance issues|0|||
124660202|NCT00948922|448379333|FG000|Overall Study|Transplant eligibility issues|2|||
124660203|NCT00948922|448379334|FG001|Overall Study|Transplant eligibility issues|3|||
124660204|NCT00948922|448379335|FG002|Overall Study|Transplant eligibility issues|0|||
124660205|NCT00948922|448379333|FG000|Overall Study|Not evaluable at time of analysis|0|||
124660206|NCT00948922|448379334|FG001|Overall Study|Not evaluable at time of analysis|3|||
124660207|NCT00948922|448379335|FG002|Overall Study|Not evaluable at time of analysis|0|||
124660208|NCT02784288|448379336|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
124660209|NCT02734862|448379337|FG000|Part A|Death|3|||
124660210|NCT02734862|448379338|FG001|Part A|Death|4|||
124660211|NCT02734862|448379339|FG002|Part A|Death|6|||
124660212|NCT02734862|448379337|FG000|Part A|Lost to Follow-up|2|||
124660213|NCT02734862|448379338|FG001|Part A|Lost to Follow-up|1|||
124660214|NCT02734862|448379339|FG002|Part A|Lost to Follow-up|1|||
124660215|NCT02734862|448379337|FG000|Part A|Withdrawal by Subject|1|||
124660216|NCT02734862|448379338|FG001|Part A|Withdrawal by Subject|1|||
124660217|NCT02734862|448379339|FG002|Part A|Withdrawal by Subject|2|||
124660218|NCT02734862|448379337|FG000|Part A|Physician Decision|2|||
124660219|NCT02734862|448379338|FG001|Part A|Physician Decision|0|||
124660220|NCT02734862|448379339|FG002|Part A|Physician Decision|1|||
124660221|NCT02734862|448379337|FG000|Part A|Adverse Event|2|||
124660222|NCT02734862|448379338|FG001|Part A|Adverse Event|0|||
124660223|NCT02734862|448379339|FG002|Part A|Adverse Event|1|||
124660224|NCT02734862|448379337|FG000|Part A|Noncompliance|1|||
124660225|NCT02734862|448379338|FG001|Part A|Noncompliance|1|||
124660226|NCT02734862|448379339|FG002|Part A|Noncompliance|0|||
124660227|NCT02734862|448379337|FG000|Part A|Other|1|||
124660228|NCT02734862|448379338|FG001|Part A|Other|1|||
124660229|NCT02734862|448379339|FG002|Part A|Other|3|||
124660230|NCT02734862|448379337|FG000|Part B|Death|8|||
124660231|NCT02734862|448379338|FG001|Part B|Death|3|||
124660232|NCT02734862|448379339|FG002|Part B|Death|5|||
124660233|NCT02734862|448379337|FG000|Part B|Lost to Follow-up|2|||
124660234|NCT02734862|448379338|FG001|Part B|Lost to Follow-up|2|||
124660235|NCT02734862|448379339|FG002|Part B|Lost to Follow-up|0|||
124660236|NCT02734862|448379337|FG000|Part B|Withdrawal by Subject|3|||
124660237|NCT02734862|448379338|FG001|Part B|Withdrawal by Subject|1|||
124660238|NCT02734862|448379339|FG002|Part B|Withdrawal by Subject|0|||
124660239|NCT02734862|448379337|FG000|Part B|Other|0|||
124660240|NCT02734862|448379338|FG001|Part B|Other|1|||
124660241|NCT02734862|448379339|FG002|Part B|Other|0|||
124660242|NCT02757625|448379340|FG000|Overall Study|Investigator's discretion|0|||
124660243|NCT02757625|448379341|FG001|Overall Study|Investigator's discretion|0|||
124660244|NCT02757625|448379342|FG002|Overall Study|Investigator's discretion|1|||
124660245|NCT02757625|448379343|FG003|Overall Study|Investigator's discretion|0|||
124660246|NCT02757625|448379340|FG000|Overall Study|Adverse Event|0|||
124660247|NCT02757625|448379341|FG001|Overall Study|Adverse Event|0|||
124660248|NCT02757625|448379342|FG002|Overall Study|Adverse Event|1|||
124660249|NCT02757625|448379343|FG003|Overall Study|Adverse Event|0|||
124660250|NCT04854057|448379344|FG000|Overall Study|Adverse Event|0|||
124660251|NCT04854057|448379345|FG001|Overall Study|Adverse Event|1|||
124660252|NCT02131233|448379346|FG000|Overall Study|Not Treated|2|||
124660253|NCT02131233|448379347|FG001|Overall Study|Not Treated|3|||
124660254|NCT02131233|448379346|FG000|Overall Study|Adverse Event|7|||
124660255|NCT02131233|448379347|FG001|Overall Study|Adverse Event|6|||
124660256|NCT02131233|448379346|FG000|Overall Study|Death|0|||
124660257|NCT02131233|448379347|FG001|Overall Study|Death|1|||
124660258|NCT02131233|448379346|FG000|Overall Study|Lack of Efficacy|6|||
124660259|NCT02131233|448379347|FG001|Overall Study|Lack of Efficacy|3|||
124660260|NCT02131233|448379346|FG000|Overall Study|Lost to Follow-up|14|||
124660261|NCT02131233|448379347|FG001|Overall Study|Lost to Follow-up|13|||
124660262|NCT02131233|448379346|FG000|Overall Study|Non-Compliance With Study Drug|8|||
124660263|NCT02131233|448379347|FG001|Overall Study|Non-Compliance With Study Drug|5|||
124660264|NCT02131233|448379346|FG000|Overall Study|Physician Decision|7|||
124660265|NCT02131233|448379347|FG001|Overall Study|Physician Decision|0|||
124660266|NCT02131233|448379346|FG000|Overall Study|Pregnancy|4|||
124660267|NCT02131233|448379347|FG001|Overall Study|Pregnancy|0|||
124660268|NCT02131233|448379346|FG000|Overall Study|Withdrawal by Subject|18|||
124660269|NCT02131233|448379347|FG001|Overall Study|Withdrawal by Subject|11|||
124660270|NCT03519919|448379348|FG000|Overall Study|Withdrawal by Subject|1|||
124660271|NCT03519919|448379348|FG000|Overall Study|Lack of Efficacy|1|||
124660272|NCT03519919|448379348|FG000|Overall Study|Screen Failure|1|||
124660273|NCT00645671|448379349|FG000|Overall Study|Protocol Violation|1|||
124660274|NCT00645671|448379350|FG001|Overall Study|Protocol Violation|0|||
124660275|NCT00645671|448379349|FG000|Overall Study|Withdrawal by Subject|0|||
124660276|NCT00645671|448379350|FG001|Overall Study|Withdrawal by Subject|4|||
124660277|NCT00645671|448379349|FG000|Overall Study|Adverse Event|0|||
124660278|NCT00645671|448379350|FG001|Overall Study|Adverse Event|1|||
124660279|NCT00645671|448379349|FG000|Overall Study|Physician Decision|0|||
124660280|NCT00645671|448379350|FG001|Overall Study|Physician Decision|1|||
124660281|NCT00790556|448379351|FG000|Treatment Period 1|Physician Decision|1|||
124660282|NCT00790556|448379352|FG001|Treatment Period 1|Physician Decision|0|||
124660283|NCT00790556|448379351|FG000|Treatment Period 1|Withdrawal by Subject|1|||
124660284|NCT00790556|448379352|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124660285|NCT01951573|448379355|FG000|Washout Period|Adverse Event|0|||
124660286|NCT01951573|448379356|FG001|Washout Period|Adverse Event|1|||
124660287|NCT00217581|448379357|FG000|Overall Study|Withdrawal by Subject|1|||
124660288|NCT04399889|448379358|FG000|Overall Study|Death|5|||
124660289|NCT04399889|448379359|FG001|Overall Study|Death|1|||
124660290|NCT04399889|448379360|FG002|Overall Study|Death|1|||
124660291|NCT02829047|448379364|FG000|Overall Study|Withdrawal by Subject|1|||
124660292|NCT01909973|448379366|FG000|Overall Study|Lost to Follow-up|1|||
124660293|NCT01909973|448379367|FG001|Overall Study|Lost to Follow-up|0|||
124660294|NCT00460239|448379368|FG000|Overall Study|Physician Decision|0|||
124660295|NCT00460239|448379369|FG001|Overall Study|Physician Decision|1|||
124660296|NCT00460239|448379370|FG002|Overall Study|Physician Decision|0|||
124660297|NCT00460239|448379371|FG003|Overall Study|Physician Decision|0|||
124660298|NCT00460239|448379372|FG004|Overall Study|Physician Decision|0|||
124660299|NCT00460239|448379373|FG005|Overall Study|Physician Decision|2|||
124660300|NCT00460239|448379374|FG006|Overall Study|Physician Decision|0|||
124660301|NCT00460239|448379375|FG007|Overall Study|Physician Decision|0|||
124660302|NCT00460239|448379376|FG008|Overall Study|Physician Decision|0|||
124660303|NCT00460239|448379368|FG000|Overall Study|Withdrawal by Subject|0|||
124660304|NCT00460239|448379369|FG001|Overall Study|Withdrawal by Subject|0|||
124660305|NCT00460239|448379370|FG002|Overall Study|Withdrawal by Subject|0|||
124660306|NCT00460239|448379371|FG003|Overall Study|Withdrawal by Subject|0|||
124660307|NCT00460239|448379372|FG004|Overall Study|Withdrawal by Subject|0|||
124660308|NCT00460239|448379373|FG005|Overall Study|Withdrawal by Subject|1|||
124660309|NCT00460239|448379374|FG006|Overall Study|Withdrawal by Subject|0|||
124660310|NCT00460239|448379375|FG007|Overall Study|Withdrawal by Subject|0|||
124660311|NCT00460239|448379376|FG008|Overall Study|Withdrawal by Subject|0|||
124660312|NCT02020889|448379401|FG000|Overall Study|Adverse Event|0|||
124660313|NCT02020889|448379402|FG001|Overall Study|Adverse Event|1|||
124660314|NCT02020889|448379401|FG000|Overall Study|Lack of Efficacy|1|||
124660315|NCT02020889|448379402|FG001|Overall Study|Lack of Efficacy|0|||
124660316|NCT02020889|448379401|FG000|Overall Study|Lost to Follow-up|1|||
124660317|NCT02020889|448379402|FG001|Overall Study|Lost to Follow-up|0|||
124660318|NCT02020889|448379401|FG000|Overall Study|Physician Decision|2|||
124660319|NCT02020889|448379402|FG001|Overall Study|Physician Decision|0|||
124660320|NCT02020889|448379401|FG000|Overall Study|Withdrawal by Subject|3|||
124660321|NCT02020889|448379402|FG001|Overall Study|Withdrawal by Subject|2|||
124660322|NCT01005901|448379403|FG000|Overall Study|Withdrawal by Subject|38|||
124660323|NCT01005901|448379404|FG001|Overall Study|Withdrawal by Subject|14|||
124660324|NCT01005901|448379403|FG000|Overall Study|Adverse Event|30|||
124660325|NCT01005901|448379404|FG001|Overall Study|Adverse Event|16|||
124660326|NCT01005901|448379403|FG000|Overall Study|Administrative problems|21|||
124660327|NCT01005901|448379404|FG001|Overall Study|Administrative problems|13|||
124660328|NCT01005901|448379403|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
124660329|NCT01005901|448379404|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
124660330|NCT01005901|448379403|FG000|Overall Study|Protocol Violation|4|||
124660331|NCT01005901|448379404|FG001|Overall Study|Protocol Violation|3|||
124660332|NCT01005901|448379403|FG000|Overall Study|Death|2|||
124660333|NCT01005901|448379404|FG001|Overall Study|Death|3|||
124660334|NCT01005901|448379403|FG000|Overall Study|Lost to Follow-up|1|||
124660335|NCT01005901|448379404|FG001|Overall Study|Lost to Follow-up|2|||
124660336|NCT01005901|448379403|FG000|Overall Study|Patient's inability to use the device|1|||
124660337|NCT01005901|448379404|FG001|Overall Study|Patient's inability to use the device|1|||
124660338|NCT01005901|448379403|FG000|Overall Study|No longer requires study drug|0|||
124660339|NCT01005901|448379404|FG001|Overall Study|No longer requires study drug|1|||
124660340|NCT00760487|448379405|FG000|Overall Study|Unilateral implantation|3|||
124660341|NCT06360588|448379408|FG000|Overall Study|Adverse Event|3|||
124660342|NCT06360588|448379408|FG000|Overall Study|Death|2|||
124660343|NCT06360588|448379408|FG000|Overall Study|Disease Progression|14|||
124660344|NCT06360588|448379408|FG000|Overall Study|Withdrawal by Subject|1|||
124660345|NCT06360588|448379408|FG000|Overall Study|Lack of Efficacy|1|||
124660346|NCT06360588|448379408|FG000|Overall Study|Ineligible|1|||
124660347|NCT02087943|448379411|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
124660348|NCT02087943|448379412|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
124660349|NCT02087943|448379413|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
124660350|NCT02087943|448379414|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
124660351|NCT02087943|448379415|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
124660352|NCT02087943|448379411|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
124660353|NCT02087943|448379412|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
124660354|NCT02087943|448379413|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
124660355|NCT02087943|448379414|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
124660356|NCT02087943|448379415|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
124660357|NCT02087943|448379411|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
124660358|NCT02087943|448379412|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
124660359|NCT02087943|448379413|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
124660360|NCT02087943|448379414|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
124660361|NCT02087943|448379415|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
124660362|NCT02087943|448379411|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
124660363|NCT02087943|448379412|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
124660364|NCT02087943|448379413|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
124660365|NCT02087943|448379414|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
124660366|NCT02087943|448379415|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
124660367|NCT02087943|448379411|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
124660368|NCT02087943|448379412|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
124660369|NCT02087943|448379413|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
124660370|NCT02087943|448379414|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
124660371|NCT02087943|448379415|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
124660372|NCT02087943|448379411|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
124660373|NCT02087943|448379412|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
124660374|NCT02087943|448379413|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
124660375|NCT02087943|448379414|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
124660376|NCT02087943|448379415|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
124660377|NCT02087943|448379411|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
124660378|NCT02087943|448379412|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
124660379|NCT02087943|448379413|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
124660380|NCT02087943|448379414|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
124660381|NCT02087943|448379415|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
124660382|NCT02087943|448379411|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
124660383|NCT02087943|448379412|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
124660384|NCT02087943|448379413|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
124660385|NCT02087943|448379414|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
124660386|NCT02087943|448379415|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
124660387|NCT02087943|448379411|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
124660388|NCT02087943|448379412|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
124660389|NCT02087943|448379413|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
124660390|NCT02087943|448379414|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
124660391|NCT02087943|448379415|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
124660392|NCT02087943|448379411|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
124660393|NCT02087943|448379412|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
124660394|NCT02087943|448379413|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
124660395|NCT02087943|448379414|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
124660396|NCT02087943|448379415|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
124660397|NCT01690299|448379417|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
124660398|NCT01690299|448379418|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
124660399|NCT01690299|448379419|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
124660400|NCT01690299|448379420|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
124660401|NCT01690299|448379421|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
124660402|NCT01690299|448379422|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
124660403|NCT01690299|448379417|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
124660404|NCT01690299|448379418|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
124660405|NCT01690299|448379419|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
124660406|NCT01690299|448379420|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
124660407|NCT01690299|448379421|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
124660408|NCT01690299|448379422|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
124660409|NCT01690299|448379417|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
124660410|NCT01690299|448379418|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
124660411|NCT01690299|448379419|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
124660412|NCT01690299|448379420|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
124660413|NCT01690299|448379421|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
124660414|NCT01690299|448379422|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
124660415|NCT01690299|448379417|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
124660416|NCT01690299|448379418|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
124660417|NCT01690299|448379419|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
124660418|NCT01690299|448379420|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
124660419|NCT01690299|448379421|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
124660420|NCT01690299|448379422|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
124660421|NCT01690299|448379417|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
124660422|NCT01690299|448379418|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
124660423|NCT01690299|448379419|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
124660424|NCT01690299|448379420|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
124660425|NCT01690299|448379421|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
124660426|NCT01690299|448379422|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
124660427|NCT01690299|448379417|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
124660428|NCT01690299|448379418|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
124660429|NCT01690299|448379419|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
124660430|NCT01690299|448379420|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
124660431|NCT01690299|448379421|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
124660432|NCT01690299|448379422|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
124660433|NCT01690299|448379417|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
124660434|NCT01690299|448379418|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
124660435|NCT01690299|448379419|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
124660436|NCT01690299|448379420|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
124660437|NCT01690299|448379421|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
124660438|NCT01690299|448379422|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
124660439|NCT01690299|448379417|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
124660440|NCT01690299|448379418|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
124660441|NCT01690299|448379419|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
124660442|NCT01690299|448379420|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
124660443|NCT01690299|448379421|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
124660444|NCT01690299|448379422|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
124660445|NCT01690299|448379417|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
124660446|NCT01690299|448379418|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
124660447|NCT01690299|448379419|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
124660448|NCT01690299|448379420|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
124660449|NCT01690299|448379421|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
124660450|NCT01690299|448379422|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
124660451|NCT01690299|448379417|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
124660452|NCT01690299|448379418|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
124660453|NCT01690299|448379419|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
124660454|NCT01690299|448379420|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
124660455|NCT01690299|448379421|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
124660456|NCT01690299|448379422|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
124660457|NCT03836209|448379423|FG000|Overall Study|Adverse Event|5|||
124660458|NCT03836209|448379424|FG001|Overall Study|Adverse Event|2|||
124660459|NCT03836209|448379423|FG000|Overall Study|Death|4|||
124660460|NCT03836209|448379424|FG001|Overall Study|Death|1|||
124660461|NCT03836209|448379423|FG000|Overall Study|Lack of Efficacy|7|||
124660462|NCT03836209|448379424|FG001|Overall Study|Lack of Efficacy|10|||
124660463|NCT03836209|448379423|FG000|Overall Study|Physician Decision|7|||
124660464|NCT03836209|448379424|FG001|Overall Study|Physician Decision|11|||
124660465|NCT03836209|448379423|FG000|Overall Study|Protocol Violation|0|||
124660466|NCT03836209|448379424|FG001|Overall Study|Protocol Violation|3|||
124660467|NCT03836209|448379423|FG000|Overall Study|Withdrawal by Subject|2|||
124660468|NCT03836209|448379424|FG001|Overall Study|Withdrawal by Subject|10|||
124660469|NCT03836209|448379423|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
124660470|NCT03836209|448379424|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
124660471|NCT03739710|448379425|FG000|Overall Study|Screen Failed|81|||
124660472|NCT01753115|448379426|FG000|Overall Study|Lost to Follow-up|3|||
124660473|NCT01753115|448379427|FG001|Overall Study|Lost to Follow-up|6|||
124660474|NCT01753115|448379428|FG002|Overall Study|Lost to Follow-up|8|||
124660475|NCT01753115|448379426|FG000|Overall Study|Withdrawal by Subject|6|||
124660476|NCT01753115|448379427|FG001|Overall Study|Withdrawal by Subject|5|||
124660477|NCT01753115|448379428|FG002|Overall Study|Withdrawal by Subject|6|||
124660478|NCT01753115|448379426|FG000|Overall Study|Subject non-compliant|3|||
124660479|NCT01753115|448379427|FG001|Overall Study|Subject non-compliant|3|||
124660480|NCT01753115|448379428|FG002|Overall Study|Subject non-compliant|0|||
124660481|NCT01753115|448379426|FG000|Overall Study|Used excluded drug|0|||
124660482|NCT01753115|448379427|FG001|Overall Study|Used excluded drug|1|||
124660483|NCT01753115|448379428|FG002|Overall Study|Used excluded drug|0|||
124660484|NCT01424241|448379432|FG000|Overall Study|Withdrawal by Subject|1|||
124660485|NCT01424241|448379432|FG000|Overall Study|Time constraints|2|||
124660486|NCT05259917|448379433|FG000|Overall Study|Protocol Violation|0|||
124660487|NCT05259917|448379434|FG001|Overall Study|Protocol Violation|0|||
124660488|NCT05259917|448379435|FG002|Overall Study|Protocol Violation|1|||
124660489|NCT05259917|448379436|FG003|Overall Study|Protocol Violation|0|||
124660490|NCT05259917|448379437|FG004|Overall Study|Protocol Violation|0|||
124660491|NCT05259917|448379438|FG005|Overall Study|Protocol Violation|0|||
124660492|NCT05259917|448379433|FG000|Overall Study|Lost to Follow-up|0|||
124660493|NCT05259917|448379434|FG001|Overall Study|Lost to Follow-up|0|||
124660494|NCT05259917|448379435|FG002|Overall Study|Lost to Follow-up|1|||
124660495|NCT05259917|448379436|FG003|Overall Study|Lost to Follow-up|0|||
124660496|NCT05259917|448379437|FG004|Overall Study|Lost to Follow-up|0|||
124660497|NCT05259917|448379438|FG005|Overall Study|Lost to Follow-up|1|||
124660498|NCT05259917|448379433|FG000|Overall Study|Physician Decision|0|||
124660499|NCT05259917|448379434|FG001|Overall Study|Physician Decision|1|||
124660500|NCT05259917|448379435|FG002|Overall Study|Physician Decision|0|||
124660501|NCT05259917|448379436|FG003|Overall Study|Physician Decision|0|||
124660502|NCT05259917|448379437|FG004|Overall Study|Physician Decision|0|||
124660503|NCT05259917|448379438|FG005|Overall Study|Physician Decision|0|||
124660504|NCT05259917|448379433|FG000|Overall Study|Withdrawal by Subject|0|||
124660505|NCT05259917|448379434|FG001|Overall Study|Withdrawal by Subject|1|||
124660506|NCT05259917|448379435|FG002|Overall Study|Withdrawal by Subject|0|||
124660507|NCT05259917|448379436|FG003|Overall Study|Withdrawal by Subject|0|||
124660508|NCT05259917|448379437|FG004|Overall Study|Withdrawal by Subject|1|||
124660509|NCT05259917|448379438|FG005|Overall Study|Withdrawal by Subject|1|||
124660510|NCT05259917|448379433|FG000|Overall Study|Trial Termination by Sponsor|7|||
124660511|NCT05259917|448379434|FG001|Overall Study|Trial Termination by Sponsor|2|||
124660512|NCT05259917|448379435|FG002|Overall Study|Trial Termination by Sponsor|3|||
124660513|NCT05259917|448379436|FG003|Overall Study|Trial Termination by Sponsor|5|||
124660514|NCT05259917|448379437|FG004|Overall Study|Trial Termination by Sponsor|11|||
124660515|NCT05259917|448379438|FG005|Overall Study|Trial Termination by Sponsor|4|||
124660516|NCT05259917|448379433|FG000|Overall Study|Other|1|||
124660517|NCT05259917|448379434|FG001|Overall Study|Other|0|||
124660518|NCT05259917|448379435|FG002|Overall Study|Other|2|||
124660519|NCT05259917|448379436|FG003|Overall Study|Other|0|||
124660520|NCT05259917|448379437|FG004|Overall Study|Other|0|||
124660521|NCT05259917|448379438|FG005|Overall Study|Other|0|||
124660522|NCT00482170|448379439|FG000|Overall Study|Adverse Event|5|||
124660523|NCT00482170|448379440|FG001|Overall Study|Adverse Event|14|||
124660524|NCT00482170|448379439|FG000|Overall Study|Withdrawal by Subject|6|||
124660525|NCT00482170|448379440|FG001|Overall Study|Withdrawal by Subject|1|||
124660526|NCT00482170|448379439|FG000|Overall Study|Protocol Violation|2|||
124660527|NCT00482170|448379440|FG001|Overall Study|Protocol Violation|3|||
124660528|NCT00482170|448379439|FG000|Overall Study|Lost to Follow-up|2|||
124660529|NCT00482170|448379440|FG001|Overall Study|Lost to Follow-up|0|||
124660530|NCT00482170|448379439|FG000|Overall Study|Unspecified reason|0|||
124660531|NCT00482170|448379440|FG001|Overall Study|Unspecified reason|2|||
124660532|NCT01994902|448379443|FG000|Test Period 1|Withdrawal by Subject|3|||
124660533|NCT01994902|448379444|FG001|Test Period 1|Withdrawal by Subject|0|||
124660534|NCT01994902|448379443|FG000|Test Period 1|device deficiency with adverse event|0|||
124660535|NCT01994902|448379444|FG001|Test Period 1|device deficiency with adverse event|1|||
124660536|NCT01994902|448379443|FG000|Test Period 1|Adverse Event|2|||
124660537|NCT01994902|448379444|FG001|Test Period 1|Adverse Event|1|||
124660538|NCT01994902|448379443|FG000|Test Period 1|Lack of Efficacy|0|||
124660539|NCT01994902|448379444|FG001|Test Period 1|Lack of Efficacy|1|||
124660540|NCT01994902|448379443|FG000|Test Period 1|bag too small|1|||
124660541|NCT01994902|448379444|FG001|Test Period 1|bag too small|0|||
124660542|NCT01994902|448379443|FG000|Test Period 2|Withdrawal by Subject|0|||
124660543|NCT01994902|448379444|FG001|Test Period 2|Withdrawal by Subject|2|||
124660544|NCT01994902|448379443|FG000|Test Period 2|Lack of Efficacy|0|||
124660545|NCT01994902|448379444|FG001|Test Period 2|Lack of Efficacy|1|||
124660546|NCT01994902|448379443|FG000|Test Period 2|Other|0|||
124660547|NCT01994902|448379444|FG001|Test Period 2|Other|3|||
124660548|NCT00467558|448379445|FG000|Overall Study|Lost to Follow-up|2|||
124660549|NCT00467558|448379446|FG001|Overall Study|Lost to Follow-up|0|||
124660550|NCT02636439|448379447|FG000|Overall Study|Adverse Event|2|||
124660551|NCT02636439|448379448|FG001|Overall Study|Adverse Event|2|||
124660552|NCT02636439|448379447|FG000|Overall Study|Lost to Follow-up|1|||
124660553|NCT02636439|448379448|FG001|Overall Study|Lost to Follow-up|0|||
124660554|NCT02636439|448379447|FG000|Overall Study|Non-compliance|1|||
124660555|NCT02636439|448379448|FG001|Overall Study|Non-compliance|1|||
124660556|NCT02636439|448379447|FG000|Overall Study|Personal reasons|2|||
124660557|NCT02636439|448379448|FG001|Overall Study|Personal reasons|0|||
124660558|NCT00376532|448380845|FG000|Overall Study|Lack sufficient blood sample|6|||
124660559|NCT00376532|448380846|FG001|Overall Study|Lack sufficient blood sample|6|||
124660560|NCT02213380|448380850|FG000|Underwent Randomization|Withdrawal by Subject|2|||
124660561|NCT02213380|448380851|FG001|Underwent Randomization|Withdrawal by Subject|0|||
124660562|NCT02213380|448380850|FG000|Underwent Randomization|Not treated|3|||
124660563|NCT02213380|448380851|FG001|Underwent Randomization|Not treated|3|||
124660564|NCT02213380|448380850|FG000|Per-protocol Analysis|Protocol Violation|32|||
124660565|NCT02213380|448380851|FG001|Per-protocol Analysis|Protocol Violation|36|||
124660566|NCT02090283|448380854|FG000|Overall Study|Withdrawal by Subject|6|||
124660567|NCT02090283|448380855|FG001|Overall Study|Withdrawal by Subject|6|||
124660568|NCT02090283|448380856|FG002|Overall Study|Withdrawal by Subject|6|||
124660569|NCT02090283|448380854|FG000|Overall Study|Sponsor Terminated Study|6|||
124660570|NCT02090283|448380855|FG001|Overall Study|Sponsor Terminated Study|6|||
124660571|NCT02090283|448380856|FG002|Overall Study|Sponsor Terminated Study|1|||
124660572|NCT02090283|448380854|FG000|Overall Study|Lost to Follow-up|2|||
124660573|NCT02090283|448380855|FG001|Overall Study|Lost to Follow-up|2|||
124660574|NCT02090283|448380856|FG002|Overall Study|Lost to Follow-up|3|||
124660575|NCT02090283|448380854|FG000|Overall Study|Adverse Event|1|||
124660576|NCT02090283|448380855|FG001|Overall Study|Adverse Event|1|||
124660577|NCT02090283|448380856|FG002|Overall Study|Adverse Event|0|||
124660578|NCT02090283|448380854|FG000|Overall Study|Protocol Violation|2|||
124660579|NCT02090283|448380855|FG001|Overall Study|Protocol Violation|0|||
124660580|NCT02090283|448380856|FG002|Overall Study|Protocol Violation|0|||
124660581|NCT03498313|448380859|FG000|Experimental Period 1|Adverse Event|1|||
124660582|NCT03498313|448380860|FG001|Experimental Period 1|Adverse Event|0|||
124660583|NCT03498313|448380861|FG002|Experimental Period 1|Adverse Event|0|||
124660584|NCT03498313|448380862|FG003|Experimental Period 1|Adverse Event|1|||
124660585|NCT03498313|448380863|FG004|Experimental Period 1|Adverse Event|0|||
124660586|NCT03498313|448380864|FG005|Experimental Period 1|Adverse Event|0|||
124660587|NCT03498313|448380859|FG000|Experimental Period 1|Withdrawal by Subject|0|||
124660588|NCT03498313|448380860|FG001|Experimental Period 1|Withdrawal by Subject|1|||
124660589|NCT03498313|448380861|FG002|Experimental Period 1|Withdrawal by Subject|0|||
124660590|NCT03498313|448380862|FG003|Experimental Period 1|Withdrawal by Subject|0|||
124660591|NCT03498313|448380863|FG004|Experimental Period 1|Withdrawal by Subject|0|||
124660592|NCT03498313|448380864|FG005|Experimental Period 1|Withdrawal by Subject|0|||
124660593|NCT03498313|448380859|FG000|Washout Period 1|Anovulation|1|||
124660594|NCT03498313|448380860|FG001|Washout Period 1|Anovulation|0|||
124660595|NCT03498313|448380861|FG002|Washout Period 1|Anovulation|0|||
124660596|NCT03498313|448380862|FG003|Washout Period 1|Anovulation|0|||
124660597|NCT03498313|448380863|FG004|Washout Period 1|Anovulation|0|||
124660598|NCT03498313|448380864|FG005|Washout Period 1|Anovulation|0|||
124660599|NCT03498313|448380859|FG000|Washout Period 1|Withdrawal by Subject|0|||
124660600|NCT03498313|448380860|FG001|Washout Period 1|Withdrawal by Subject|3|||
124660601|NCT03498313|448380861|FG002|Washout Period 1|Withdrawal by Subject|0|||
124660602|NCT03498313|448380862|FG003|Washout Period 1|Withdrawal by Subject|1|||
124660603|NCT03498313|448380863|FG004|Washout Period 1|Withdrawal by Subject|0|||
124660604|NCT03498313|448380864|FG005|Washout Period 1|Withdrawal by Subject|1|||
124660605|NCT03498313|448380859|FG000|Experimental Period 2|Adverse Event|0|||
124660606|NCT03498313|448380860|FG001|Experimental Period 2|Adverse Event|0|||
124660607|NCT03498313|448380861|FG002|Experimental Period 2|Adverse Event|0|||
124660608|NCT03498313|448380862|FG003|Experimental Period 2|Adverse Event|0|||
124660609|NCT03498313|448380863|FG004|Experimental Period 2|Adverse Event|1|||
124660610|NCT03498313|448380864|FG005|Experimental Period 2|Adverse Event|2|||
124660611|NCT03498313|448380859|FG000|Washout Period 2|Physician Decision|1|||
124660612|NCT03498313|448380860|FG001|Washout Period 2|Physician Decision|0|||
124660613|NCT03498313|448380861|FG002|Washout Period 2|Physician Decision|0|||
124660614|NCT03498313|448380862|FG003|Washout Period 2|Physician Decision|1|||
124660615|NCT03498313|448380863|FG004|Washout Period 2|Physician Decision|0|||
124660616|NCT03498313|448380864|FG005|Washout Period 2|Physician Decision|1|||
124660617|NCT03498313|448380859|FG000|Washout Period 2|Withdrawal by Subject|3|||
124660618|NCT03498313|448380860|FG001|Washout Period 2|Withdrawal by Subject|2|||
124660619|NCT03498313|448380861|FG002|Washout Period 2|Withdrawal by Subject|0|||
124660620|NCT03498313|448380862|FG003|Washout Period 2|Withdrawal by Subject|0|||
124660621|NCT03498313|448380863|FG004|Washout Period 2|Withdrawal by Subject|2|||
124660622|NCT03498313|448380864|FG005|Washout Period 2|Withdrawal by Subject|0|||
124660623|NCT03498313|448380859|FG000|Washout Period 2|Anovulation|0|||
124660624|NCT03498313|448380860|FG001|Washout Period 2|Anovulation|0|||
124660625|NCT03498313|448380861|FG002|Washout Period 2|Anovulation|0|||
124660626|NCT03498313|448380862|FG003|Washout Period 2|Anovulation|0|||
124660627|NCT03498313|448380863|FG004|Washout Period 2|Anovulation|0|||
124660628|NCT03498313|448380864|FG005|Washout Period 2|Anovulation|1|||
124660629|NCT00184002|448380865|FG000|Overall Study|Adverse Event|9|||
124660630|NCT00184002|448380865|FG000|Overall Study|Death|3|||
124660631|NCT00184002|448380865|FG000|Overall Study|Physician Decision|1|||
124660632|NCT00184002|448380865|FG000|Overall Study|Withdrawal by Subject|4|||
124660633|NCT02499263|448380866|FG000|Overall Study|Lost to Follow-up|9|||
124660634|NCT02499263|448380866|FG000|Overall Study|Participant's withdrawal of consent|4|||
124660635|NCT02499263|448380866|FG000|Overall Study|Lack of Efficacy|22|||
124660636|NCT02499263|448380866|FG000|Overall Study|investigator's judgment|12|||
124660637|NCT02499263|448380866|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
124660638|NCT02499263|448380866|FG000|Overall Study|Participant's decision|3|||
124660639|NCT02499263|448380866|FG000|Overall Study|Pregnancy|1|||
124660640|NCT02075008|448380873|FG000|Overall Study|Technical problems|1|||
124660641|NCT02075008|448380873|FG000|Overall Study|Pregnancy|1|||
124660642|NCT02075008|448380873|FG000|Overall Study|Physician Decision|1|||
124660643|NCT02075008|448380873|FG000|Overall Study|Lost to Follow-up|1|||
124660644|NCT02075008|448380873|FG000|Overall Study|Lack of Efficacy|1|||
124660645|NCT02075008|448380873|FG000|Overall Study|Death|1|||
124660646|NCT02075008|448380873|FG000|Overall Study|Adverse Event|5|||
124660647|NCT02075008|448380873|FG000|Overall Study|Withdrawal by Subject|6|||
124660648|NCT02075008|448380873|FG000|Overall Study|Study terminated by Sponsor|159|||
124660649|NCT00660595|448380874|FG000|Overall Study|Lost to Follow-up|0|||
124660650|NCT00660595|448380875|FG001|Overall Study|Lost to Follow-up|1|||
124660651|NCT00660595|448380874|FG000|Overall Study|Did not consent to participate in study|12|||
124660652|NCT00660595|448380875|FG001|Overall Study|Did not consent to participate in study|8|||
124660653|NCT00660595|448380874|FG000|Overall Study|Participant left hospital|1|||
124660654|NCT00660595|448380875|FG001|Overall Study|Participant left hospital|0|||
124660655|NCT00660595|448380874|FG000|Overall Study|Non Specified reasons|5|||
124660656|NCT00660595|448380875|FG001|Overall Study|Non Specified reasons|0|||
124660657|NCT05205005|448380890|FG000|Overall Study|Withdrawal by Subject|1|||
124660658|NCT05205005|448380891|FG001|Overall Study|Withdrawal by Subject|0|||
124660659|NCT05205005|448380890|FG000|Overall Study|Adverse Event|1|||
124660660|NCT05205005|448380891|FG001|Overall Study|Adverse Event|0|||
124660661|NCT01148459|448380894|FG000|Overall Study|Serious Adverse Event|5|||
124660662|NCT01148459|448380895|FG001|Overall Study|Serious Adverse Event|4|||
124660663|NCT01148459|448380894|FG000|Overall Study|Withdrawal by Subject|1|||
124660664|NCT01148459|448380895|FG001|Overall Study|Withdrawal by Subject|0|||
124660665|NCT01148459|448380894|FG000|Overall Study|Migrated/moved from study area|3|||
124660666|NCT01148459|448380895|FG001|Overall Study|Migrated/moved from study area|6|||
124660667|NCT01148459|448380894|FG000|Overall Study|Lost to Follow-up|2|||
124660668|NCT01148459|448380895|FG001|Overall Study|Lost to Follow-up|0|||
124660669|NCT01148459|448380894|FG000|Overall Study|Refusal|1|||
124660670|NCT01148459|448380895|FG001|Overall Study|Refusal|0|||
124660671|NCT01148459|448380894|FG000|Overall Study|Failure to comply with study procedures|0|||
124660672|NCT01148459|448380895|FG001|Overall Study|Failure to comply with study procedures|1|||
124660673|NCT02187029|448380896|FG000|Overall Study|Adverse Event|0|||
124660674|NCT02187029|448380897|FG001|Overall Study|Adverse Event|1|||
124660675|NCT02187029|448380898|FG002|Overall Study|Adverse Event|1|||
124660676|NCT02187029|448380899|FG003|Overall Study|Adverse Event|0|||
124660677|NCT02187029|448380896|FG000|Overall Study|Study Terminated by Sponsor|0|||
124660678|NCT02187029|448380897|FG001|Overall Study|Study Terminated by Sponsor|0|||
124660679|NCT02187029|448380898|FG002|Overall Study|Study Terminated by Sponsor|10|||
124660680|NCT02187029|448380899|FG003|Overall Study|Study Terminated by Sponsor|3|||
124660681|NCT02187029|448380896|FG000|Overall Study|Withdrawal by Subject|1|||
124660682|NCT02187029|448380897|FG001|Overall Study|Withdrawal by Subject|0|||
124660683|NCT02187029|448380898|FG002|Overall Study|Withdrawal by Subject|0|||
124660684|NCT02187029|448380899|FG003|Overall Study|Withdrawal by Subject|0|||
124660685|NCT00694356|448380900|FG000|Overall Study|Adverse Event|1|||
124660686|NCT00694356|448380901|FG001|Overall Study|Adverse Event|0|||
124660687|NCT00694356|448380902|FG002|Overall Study|Adverse Event|0|||
124660688|NCT00694356|448380900|FG000|Overall Study|Progressive Disease|2|||
124660689|NCT00694356|448380901|FG001|Overall Study|Progressive Disease|6|||
124660690|NCT00694356|448380902|FG002|Overall Study|Progressive Disease|6|||
124660691|NCT02496039|448380908|FG000|Overall Study|Adverse Event|3|||
124660692|NCT02496039|448380908|FG000|Overall Study|Protocol Violation|1|||
124660693|NCT04472494|448380909|FG000|Pre-treatment|Other reasons|2|||
124660694|NCT04472494|448380910|FG001|Pre-treatment|Other reasons|0|||
124660695|NCT04472494|448380909|FG000|Treatment|Death|5|||
124660696|NCT04472494|448380910|FG001|Treatment|Death|2|||
124660697|NCT04472494|448380909|FG000|Treatment|Hospital discharge|1|||
124660698|NCT04472494|448380910|FG001|Treatment|Hospital discharge|1|||
124660699|NCT00571103|448380911|FG000|Overall Study|Withdrawal by Subject|1|||
124660700|NCT00571103|448380911|FG000|Overall Study|Lost to Follow-up|1|||
124660701|NCT01308463|448380913|FG000|Overall Study|Study Discontinued|23|||
124660702|NCT01308463|448380913|FG000|Overall Study|Death|4|||
124660703|NCT01308463|448380913|FG000|Overall Study|Revision|2|||
124660704|NCT03297021|448380914|FG000|Overall Study|Incomplete/illegible data sheet|4|||
124660705|NCT03297021|448380915|FG001|Overall Study|Incomplete/illegible data sheet|2|||
124660706|NCT03297021|448380916|FG002|Overall Study|Incomplete/illegible data sheet|3|||
124660707|NCT03297021|448380914|FG000|Overall Study|Missing Post-Op Data|1|||
124660708|NCT03297021|448380915|FG001|Overall Study|Missing Post-Op Data|2|||
124660709|NCT03297021|448380916|FG002|Overall Study|Missing Post-Op Data|1|||
124660710|NCT02095197|448380918|FG000|Overall Study|Lost to Follow-up|0|||
124660711|NCT02095197|448380919|FG001|Overall Study|Lost to Follow-up|3|||
124660712|NCT05114564|448380920|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
124660713|NCT05114564|448380921|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
124660714|NCT05114564|448380920|FG000|First Intervention|Adverse Event|0|||
124660715|NCT05114564|448380921|FG001|First Intervention|Adverse Event|1|||
124660716|NCT04217317|448380922|FG000|Overall Study|Lack of Efficacy|4|||
124660717|NCT04217317|448380922|FG000|Overall Study|Physician Decision|1|||
124660718|NCT04313400|448380923|FG000|Overall Study|Withdrawal by Subject|0|||
124660719|NCT04313400|448380924|FG001|Overall Study|Withdrawal by Subject|0|||
124660720|NCT04313400|448380925|FG002|Overall Study|Withdrawal by Subject|0|||
124660721|NCT04313400|448380926|FG003|Overall Study|Withdrawal by Subject|0|||
124660722|NCT04313400|448380927|FG004|Overall Study|Withdrawal by Subject|0|||
124660723|NCT04313400|448380928|FG005|Overall Study|Withdrawal by Subject|4|||
124660724|NCT04313400|448380929|FG006|Overall Study|Withdrawal by Subject|1|||
124660725|NCT04313400|448380923|FG000|Overall Study|Adverse Event|0|||
124660726|NCT04313400|448380924|FG001|Overall Study|Adverse Event|0|||
124660727|NCT04313400|448380925|FG002|Overall Study|Adverse Event|0|||
124660728|NCT04313400|448380926|FG003|Overall Study|Adverse Event|0|||
124660729|NCT04313400|448380927|FG004|Overall Study|Adverse Event|0|||
124660730|NCT04313400|448380928|FG005|Overall Study|Adverse Event|1|||
124660731|NCT04313400|448380929|FG006|Overall Study|Adverse Event|0|||
124660732|NCT04313400|448380923|FG000|Overall Study|Lost to Follow-up|0|||
124660733|NCT04313400|448380924|FG001|Overall Study|Lost to Follow-up|0|||
124660734|NCT04313400|448380925|FG002|Overall Study|Lost to Follow-up|0|||
124660735|NCT04313400|448380926|FG003|Overall Study|Lost to Follow-up|0|||
124660736|NCT04313400|448380927|FG004|Overall Study|Lost to Follow-up|0|||
124660737|NCT04313400|448380928|FG005|Overall Study|Lost to Follow-up|1|||
124660738|NCT04313400|448380929|FG006|Overall Study|Lost to Follow-up|0|||
124660739|NCT00496587|448380934|FG000|Overall Study|Adverse Event|2|||
124660740|NCT00496587|448380934|FG000|Overall Study|Progressive Disease|24|||
124660741|NCT00496587|448380934|FG000|Overall Study|Withdrawal by Subject|2|||
124660742|NCT00496587|448380934|FG000|Overall Study|Death|1|||
124660743|NCT00496587|448380934|FG000|Overall Study|Complications unrelated|2|||
124660744|NCT02383355|448380935|FG000|Overall Study|Adverse Event|2|||
124660745|NCT02383355|448380936|FG001|Overall Study|Adverse Event|0|||
124660746|NCT01146561|448380938|FG000|Overall Study|Withdrawal by Subject|1|||
124660747|NCT01146561|448380938|FG000|Overall Study|Lost to Follow-up|1|||
124660748|NCT01778751|448380940|FG000|Overall Study|Lost to Follow-up|1|||
124660749|NCT01778751|448380941|FG001|Overall Study|Lost to Follow-up|0|||
124660750|NCT01778751|448380940|FG000|Overall Study|Withdrawal by Subject|0|||
124660751|NCT01778751|448380941|FG001|Overall Study|Withdrawal by Subject|2|||
124660752|NCT01778751|448380940|FG000|Overall Study|Transfered care|1|||
124660753|NCT01778751|448380941|FG001|Overall Study|Transfered care|0|||
124660754|NCT03628716|448380943|FG000|Overall Study|Adverse Event|1|||
124660755|NCT03628716|448380944|FG001|Overall Study|Adverse Event|1|||
124660756|NCT03628716|448380943|FG000|Overall Study|Death|1|||
124660757|NCT03628716|448380944|FG001|Overall Study|Death|0|||
124660758|NCT03628716|448380943|FG000|Overall Study|Lack of Efficacy|15|||
124660759|NCT03628716|448380944|FG001|Overall Study|Lack of Efficacy|20|||
124660760|NCT03628716|448380943|FG000|Overall Study|Withdrawal by Subject|1|||
124660761|NCT03628716|448380944|FG001|Overall Study|Withdrawal by Subject|2|||
124660762|NCT03628716|448380943|FG000|Overall Study|Study Terminated by Sponsor|1|||
124660763|NCT03628716|448380944|FG001|Overall Study|Study Terminated by Sponsor|0|||
124660764|NCT00856843|448380945|FG000|Overall Study|Withdrawal by Subject|1|||
124660765|NCT00856843|448380946|FG001|Overall Study|Withdrawal by Subject|5|||
124660766|NCT00856843|448380945|FG000|Overall Study|Lack of Efficacy|1|||
124660767|NCT00856843|448380946|FG001|Overall Study|Lack of Efficacy|0|||
124660768|NCT01366638|448380950|FG000|Overall Study|Withdrawal by Subject|0|||
124660769|NCT01366638|448380951|FG001|Overall Study|Withdrawal by Subject|0|||
124660770|NCT01366638|448380952|FG002|Overall Study|Withdrawal by Subject|6|||
124660771|NCT01366638|448380950|FG000|Overall Study|Other|1|||
124660772|NCT01366638|448380951|FG001|Overall Study|Other|0|||
124660773|NCT01366638|448380952|FG002|Overall Study|Other|0|||
124660774|NCT01451554|448380953|FG000|Overall Study|Withdrawal by Subject|14|||
124660775|NCT01451554|448380954|FG001|Overall Study|Withdrawal by Subject|9|||
124660776|NCT01402986|448380955|FG000|Overall Study|Withdrawal by Subject|7|||
124660777|NCT01402986|448380956|FG001|Overall Study|Withdrawal by Subject|10|||
124660778|NCT01402986|448380957|FG002|Overall Study|Withdrawal by Subject|7|||
124660779|NCT01402986|448380958|FG003|Overall Study|Withdrawal by Subject|13|||
124660780|NCT01402986|448380955|FG000|Overall Study|Death|0|||
124660781|NCT01402986|448380956|FG001|Overall Study|Death|0|||
124660782|NCT01402986|448380957|FG002|Overall Study|Death|0|||
124660783|NCT01402986|448380958|FG003|Overall Study|Death|2|||
124660784|NCT01402986|448380955|FG000|Overall Study|Lost to Follow-up|0|||
124660785|NCT01402986|448380956|FG001|Overall Study|Lost to Follow-up|0|||
124660786|NCT01402986|448380957|FG002|Overall Study|Lost to Follow-up|0|||
124660787|NCT01402986|448380958|FG003|Overall Study|Lost to Follow-up|1|||
124660788|NCT01402986|448380955|FG000|Overall Study|Other|2|||
124660789|NCT01402986|448380956|FG001|Overall Study|Other|5|||
124660790|NCT01402986|448380957|FG002|Overall Study|Other|1|||
124660791|NCT01402986|448380958|FG003|Overall Study|Other|6|||
124660792|NCT01085084|448380959|FG000|Overall Study|Withdrawal by Subject|1|||
124660793|NCT01085084|448380960|FG001|Overall Study|Withdrawal by Subject|0|||
124660794|NCT01085084|448380961|FG002|Overall Study|Withdrawal by Subject|0|||
124660795|NCT01085084|448380959|FG000|Overall Study|Lost to Follow-up|2|||
124660796|NCT01085084|448380960|FG001|Overall Study|Lost to Follow-up|1|||
124660797|NCT01085084|448380961|FG002|Overall Study|Lost to Follow-up|1|||
124660798|NCT01085084|448380959|FG000|Overall Study|Adverse Event|4|||
124660799|NCT01085084|448380960|FG001|Overall Study|Adverse Event|3|||
124660800|NCT01085084|448380961|FG002|Overall Study|Adverse Event|6|||
124660801|NCT01085084|448380959|FG000|Overall Study|Treatment Failure|0|||
124660802|NCT01085084|448380960|FG001|Overall Study|Treatment Failure|1|||
124660803|NCT01085084|448380961|FG002|Overall Study|Treatment Failure|2|||
124660804|NCT02427802|448380962|FG000|Overall Study|Adverse Event|11|||
124660805|NCT02427802|448380963|FG001|Overall Study|Adverse Event|3|||
124660806|NCT02427802|448380964|FG002|Overall Study|Adverse Event|7|||
124660807|NCT02427802|448380962|FG000|Overall Study|Death|0|||
124660808|NCT02427802|448380963|FG001|Overall Study|Death|4|||
124660809|NCT02427802|448380964|FG002|Overall Study|Death|1|||
124660810|NCT02427802|448380962|FG000|Overall Study|Lost to Follow-up|13|||
124660811|NCT02427802|448380963|FG001|Overall Study|Lost to Follow-up|8|||
124660812|NCT02427802|448380964|FG002|Overall Study|Lost to Follow-up|8|||
124660813|NCT02427802|448380962|FG000|Overall Study|Physician Decision|4|||
124660814|NCT02427802|448380963|FG001|Overall Study|Physician Decision|2|||
124660815|NCT02427802|448380964|FG002|Overall Study|Physician Decision|4|||
124660816|NCT02427802|448380962|FG000|Overall Study|Withdrawal by Subject|10|||
124660817|NCT02427802|448380963|FG001|Overall Study|Withdrawal by Subject|5|||
124660818|NCT02427802|448380964|FG002|Overall Study|Withdrawal by Subject|11|||
124660819|NCT02427802|448380962|FG000|Overall Study|Protocol Violation|3|||
124660820|NCT02427802|448380963|FG001|Overall Study|Protocol Violation|1|||
124660821|NCT02427802|448380964|FG002|Overall Study|Protocol Violation|1|||
124660822|NCT02427802|448380962|FG000|Overall Study|protocol specific treatment unrelated|18|||
124660823|NCT02427802|448380963|FG001|Overall Study|protocol specific treatment unrelated|11|||
124660824|NCT02427802|448380964|FG002|Overall Study|protocol specific treatment unrelated|11|||
124660825|NCT02749799|448380965|FG000|Overall Study|Adverse Event|2|||
124660826|NCT02749799|448380965|FG000|Overall Study|Lost to Follow-up|4|||
124660827|NCT02749799|448380965|FG000|Overall Study|Protocol Violation|1|||
124660828|NCT02749799|448380965|FG000|Overall Study|Withdrawal by Subject|1|||
124660829|NCT02634983|448380966|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
124660830|NCT02634983|448380967|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
124660831|NCT03749109|448380968|FG000|Overall Study|Adverse Event|2|||
124660832|NCT03749109|448380969|FG001|Overall Study|Adverse Event|0|||
124660833|NCT02070978|448380970|FG000|Overall Study|Adverse Event|6|||
124660834|NCT02070978|448380971|FG001|Overall Study|Adverse Event|2|||
124660835|NCT02070978|448380972|FG002|Overall Study|Adverse Event|0|||
124660836|NCT02070978|448380970|FG000|Overall Study|Lost to Follow-up|1|||
124660837|NCT02070978|448380971|FG001|Overall Study|Lost to Follow-up|3|||
124660838|NCT02070978|448380972|FG002|Overall Study|Lost to Follow-up|4|||
124660839|NCT02070978|448380970|FG000|Overall Study|Withdrawal by Subject|3|||
124660840|NCT02070978|448380971|FG001|Overall Study|Withdrawal by Subject|5|||
124660841|NCT02070978|448380972|FG002|Overall Study|Withdrawal by Subject|3|||
124660842|NCT02070978|448380970|FG000|Overall Study|Protocol Violation|1|||
124660843|NCT02070978|448380971|FG001|Overall Study|Protocol Violation|0|||
124660844|NCT02070978|448380972|FG002|Overall Study|Protocol Violation|3|||
124660845|NCT02070978|448380970|FG000|Overall Study|Lack of Efficacy|0|||
124660846|NCT02070978|448380971|FG001|Overall Study|Lack of Efficacy|1|||
124660847|NCT02070978|448380972|FG002|Overall Study|Lack of Efficacy|0|||
124660848|NCT02070978|448380970|FG000|Overall Study|Death|0|||
124660849|NCT02070978|448380971|FG001|Overall Study|Death|0|||
124660850|NCT02070978|448380972|FG002|Overall Study|Death|2|||
124660851|NCT02070978|448380970|FG000|Overall Study|Un-specified|3|||
124660852|NCT02070978|448380971|FG001|Overall Study|Un-specified|2|||
124660853|NCT02070978|448380972|FG002|Overall Study|Un-specified|2|||
124660854|NCT02070978|448380970|FG000|Overall Study|Terminated by Sponsor|33|||
124660855|NCT02070978|448380971|FG001|Overall Study|Terminated by Sponsor|40|||
124660856|NCT02070978|448380972|FG002|Overall Study|Terminated by Sponsor|39|||
124660857|NCT03951753|448380973|FG000|Overall Study|Adverse Event|1|||
124660858|NCT03951753|448380974|FG001|Overall Study|Adverse Event|0|||
124660859|NCT03951753|448380975|FG002|Overall Study|Adverse Event|3|||
124660860|NCT03951753|448380973|FG000|Overall Study|Withdrawal by Subject|3|||
124660861|NCT03951753|448380974|FG001|Overall Study|Withdrawal by Subject|1|||
124660862|NCT03951753|448380975|FG002|Overall Study|Withdrawal by Subject|0|||
124660863|NCT03951753|448380973|FG000|Overall Study|Lost to Follow-up|0|||
124660864|NCT03951753|448380974|FG001|Overall Study|Lost to Follow-up|0|||
124660865|NCT03951753|448380975|FG002|Overall Study|Lost to Follow-up|1|||
124660866|NCT03178851|448380976|FG000|Overall Study|Death|48|||
124660867|NCT03178851|448380977|FG001|Overall Study|Death|2|||
124660868|NCT03178851|448380978|FG002|Overall Study|Death|25|||
124660869|NCT03178851|448380976|FG000|Overall Study|Withdrawal by Subject|8|||
124660870|NCT03178851|448380977|FG001|Overall Study|Withdrawal by Subject|0|||
124660871|NCT03178851|448380978|FG002|Overall Study|Withdrawal by Subject|0|||
124660872|NCT03178851|448380976|FG000|Overall Study|Lost to Follow-up|5|||
124660873|NCT03178851|448380977|FG001|Overall Study|Lost to Follow-up|2|||
124660874|NCT03178851|448380978|FG002|Overall Study|Lost to Follow-up|0|||
124660875|NCT03178851|448380976|FG000|Overall Study|Adverse Event|0|||
124660876|NCT03178851|448380977|FG001|Overall Study|Adverse Event|0|||
124660877|NCT03178851|448380978|FG002|Overall Study|Adverse Event|1|||
124660878|NCT03178851|448380976|FG000|Overall Study|Study Termination by Sponsor|31|||
124660879|NCT03178851|448380977|FG001|Overall Study|Study Termination by Sponsor|7|||
124660880|NCT03178851|448380978|FG002|Overall Study|Study Termination by Sponsor|26|||
124660881|NCT02226120|448380981|FG000|Overall Study|Adverse Event|60|||
124660882|NCT02226120|448380981|FG000|Overall Study|Death|172|||
124660883|NCT02226120|448380981|FG000|Overall Study|Study terminated by sponsor|1|||
124660884|NCT02226120|448380981|FG000|Overall Study|Technical problems|4|||
124660885|NCT02226120|448380981|FG000|Overall Study|Lost to Follow-up|13|||
124660886|NCT02226120|448380981|FG000|Overall Study|Physician Decision|21|||
124660887|NCT02226120|448380981|FG000|Overall Study|Withdrawal by parent/guardian|36|||
124660888|NCT02226120|448380981|FG000|Overall Study|Non-compliance with study drug|10|||
124660889|NCT02226120|448380981|FG000|Overall Study|Protocol deviation|1|||
124660890|NCT02226120|448380981|FG000|Overall Study|missing treatment disposition pages|2|||
124660891|NCT02669043|448380984|FG000|Overall Study|Didn't meet I/E criteria|4|||
124660892|NCT00401193|448383430|FG000|Overall Study|Adverse Event|1|||
124660893|NCT00401193|448383431|FG001|Overall Study|Adverse Event|3|||
124660894|NCT00401193|448383432|FG002|Overall Study|Adverse Event|1|||
124660895|NCT00401193|448383430|FG000|Overall Study|Protocol Violation|3|||
124660896|NCT00401193|448383431|FG001|Overall Study|Protocol Violation|1|||
124660897|NCT00401193|448383432|FG002|Overall Study|Protocol Violation|1|||
124660898|NCT00401193|448383430|FG000|Overall Study|Lost to Follow-up|6|||
124660899|NCT00401193|448383431|FG001|Overall Study|Lost to Follow-up|5|||
124660900|NCT00401193|448383432|FG002|Overall Study|Lost to Follow-up|1|||
124660901|NCT00401193|448383430|FG000|Overall Study|Withdrawal by Subject|2|||
124660902|NCT00401193|448383431|FG001|Overall Study|Withdrawal by Subject|0|||
124660903|NCT00401193|448383432|FG002|Overall Study|Withdrawal by Subject|1|||
124660904|NCT00401193|448383430|FG000|Overall Study|Other Event|3|||
124660905|NCT00401193|448383431|FG001|Overall Study|Other Event|2|||
124660906|NCT00401193|448383432|FG002|Overall Study|Other Event|2|||
124660907|NCT00398216|448383433|FG000|Overall Study|Adverse Event|4|||
124660908|NCT00398216|448383434|FG001|Overall Study|Adverse Event|2|||
124660909|NCT00398216|448383435|FG002|Overall Study|Adverse Event|5|||
124660910|NCT00398216|448383436|FG003|Overall Study|Adverse Event|7|||
124660911|NCT00398216|448383437|FG004|Overall Study|Adverse Event|2|||
124660912|NCT00398216|448383433|FG000|Overall Study|Protocol Violation|2|||
124660913|NCT00398216|448383434|FG001|Overall Study|Protocol Violation|4|||
124660914|NCT00398216|448383435|FG002|Overall Study|Protocol Violation|5|||
124660915|NCT00398216|448383436|FG003|Overall Study|Protocol Violation|7|||
124660916|NCT00398216|448383437|FG004|Overall Study|Protocol Violation|5|||
124660917|NCT00398216|448383433|FG000|Overall Study|Lost to Follow-up|1|||
124660918|NCT00398216|448383434|FG001|Overall Study|Lost to Follow-up|6|||
124660919|NCT00398216|448383435|FG002|Overall Study|Lost to Follow-up|4|||
124660920|NCT00398216|448383436|FG003|Overall Study|Lost to Follow-up|4|||
124660921|NCT00398216|448383437|FG004|Overall Study|Lost to Follow-up|1|||
124660922|NCT00398216|448383433|FG000|Overall Study|Death|0|||
124660923|NCT00398216|448383434|FG001|Overall Study|Death|3|||
124660924|NCT00398216|448383435|FG002|Overall Study|Death|0|||
124660925|NCT00398216|448383436|FG003|Overall Study|Death|0|||
124660926|NCT00398216|448383437|FG004|Overall Study|Death|0|||
124660927|NCT00398216|448383433|FG000|Overall Study|Withdrawal by Subject|1|||
124660928|NCT00398216|448383434|FG001|Overall Study|Withdrawal by Subject|0|||
124660929|NCT00398216|448383435|FG002|Overall Study|Withdrawal by Subject|3|||
124660930|NCT00398216|448383436|FG003|Overall Study|Withdrawal by Subject|1|||
124660931|NCT00398216|448383437|FG004|Overall Study|Withdrawal by Subject|2|||
124660932|NCT00398216|448383433|FG000|Overall Study|administrative reasons|3|||
124660933|NCT00398216|448383434|FG001|Overall Study|administrative reasons|4|||
124660934|NCT00398216|448383435|FG002|Overall Study|administrative reasons|4|||
124660935|NCT00398216|448383436|FG003|Overall Study|administrative reasons|3|||
124660936|NCT00398216|448383437|FG004|Overall Study|administrative reasons|3|||
124660937|NCT00398216|448383433|FG000|Overall Study|entrance criteria|0|||
124660938|NCT00398216|448383434|FG001|Overall Study|entrance criteria|0|||
124660939|NCT00398216|448383435|FG002|Overall Study|entrance criteria|0|||
124660940|NCT00398216|448383436|FG003|Overall Study|entrance criteria|0|||
124660941|NCT00398216|448383437|FG004|Overall Study|entrance criteria|2|||
124660942|NCT01048944|448383440|FG000|Overall Study|Protocol Violation|8|||
124660943|NCT01048944|448383441|FG001|Overall Study|Protocol Violation|10|||
124660944|NCT01048944|448383442|FG002|Overall Study|Protocol Violation|10|||
124660945|NCT01048944|448383443|FG003|Overall Study|Protocol Violation|2|||
124660946|NCT01844817|448383444|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
124660947|NCT01844817|448383445|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
124660948|NCT01844817|448383444|FG000|Treatment|Progressive Disease|27|||
124660949|NCT01844817|448383445|FG001|Treatment|Progressive Disease|36|||
124660950|NCT01844817|448383444|FG000|Treatment|Adverse Event|17|||
124660951|NCT01844817|448383445|FG001|Treatment|Adverse Event|9|||
124660952|NCT01844817|448383444|FG000|Treatment|Withdrawal by Subject|10|||
124660953|NCT01844817|448383445|FG001|Treatment|Withdrawal by Subject|6|||
124660954|NCT01844817|448383444|FG000|Treatment|Death|10|||
124660955|NCT01844817|448383445|FG001|Treatment|Death|8|||
124660956|NCT01844817|448383444|FG000|Treatment|Lost to Follow-up|0|||
124660957|NCT01844817|448383445|FG001|Treatment|Lost to Follow-up|1|||
124660958|NCT01844817|448383444|FG000|Treatment|Other|0|||
124660959|NCT01844817|448383445|FG001|Treatment|Other|3|||
124660960|NCT04227405|448383446|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
124660961|NCT04227405|448383447|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
124660962|NCT04227405|448383446|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
124660963|NCT04227405|448383447|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
124660964|NCT04227405|448383446|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
124660965|NCT04227405|448383447|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
124660966|NCT02207400|448383448|FG000|Overall Study|Adverse Event|1|||
124660967|NCT02207400|448383449|FG001|Overall Study|Adverse Event|1|||
124660968|NCT02207400|448383448|FG000|Overall Study|Lost to Follow-up|6|||
124660969|NCT02207400|448383449|FG001|Overall Study|Lost to Follow-up|7|||
124660970|NCT02207400|448383448|FG000|Overall Study|Protocol Violation|1|||
124660971|NCT02207400|448383449|FG001|Overall Study|Protocol Violation|1|||
124660972|NCT02207400|448383448|FG000|Overall Study|Withdrawal by Subject|8|||
124660973|NCT02207400|448383449|FG001|Overall Study|Withdrawal by Subject|4|||
124660974|NCT02207400|448383448|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
124660975|NCT02207400|448383449|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
124660976|NCT03396822|448383450|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
124660977|NCT03396822|448383450|FG000|Overall Study|Physician Decision|1|||
124660978|NCT02757352|448383451|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
124660979|NCT02757352|448383452|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
124660980|NCT02757352|448383453|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
124660981|NCT02757352|448383454|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
124660982|NCT02757352|448383455|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
124660983|NCT02757352|448383456|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
124660984|NCT02757352|448383457|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
124660985|NCT02757352|448383458|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
124660986|NCT02757352|448383459|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
124660987|NCT02757352|448383460|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
124660988|NCT02757352|448383451|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
124660989|NCT02757352|448383452|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
124660990|NCT02757352|448383453|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
124660991|NCT02757352|448383454|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
124660992|NCT02757352|448383455|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
124660993|NCT02757352|448383456|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
124660994|NCT02757352|448383457|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
124660995|NCT02757352|448383458|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
124660996|NCT02757352|448383459|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
124660997|NCT02757352|448383460|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
124660998|NCT02757352|448383451|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
124660999|NCT02757352|448383452|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
124661000|NCT02757352|448383453|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
124661001|NCT02757352|448383454|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
124661002|NCT02757352|448383455|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
124661003|NCT02757352|448383456|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
124661004|NCT02757352|448383457|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
124661005|NCT02757352|448383458|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
124661006|NCT02757352|448383459|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
124661007|NCT02757352|448383460|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
124661008|NCT02757352|448383451|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
124661009|NCT02757352|448383452|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
124661010|NCT02757352|448383453|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
124661011|NCT02757352|448383454|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
124661012|NCT02757352|448383455|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
124661013|NCT02757352|448383456|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
124661014|NCT02757352|448383457|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
124661015|NCT02757352|448383458|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
124661016|NCT02757352|448383459|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
124661017|NCT02757352|448383460|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
124661018|NCT02757352|448383451|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124661019|NCT02757352|448383452|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
124661020|NCT02757352|448383453|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124661021|NCT02757352|448383454|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124661022|NCT02757352|448383455|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124661023|NCT02757352|448383456|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124661024|NCT02757352|448383457|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124661025|NCT02757352|448383458|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124661026|NCT02757352|448383459|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124661027|NCT02757352|448383460|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124661028|NCT02757352|448383451|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
124661029|NCT02757352|448383452|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
124661030|NCT02757352|448383453|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
124661031|NCT02757352|448383454|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124661032|NCT02757352|448383455|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124661033|NCT02757352|448383456|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124661034|NCT02757352|448383457|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124661035|NCT02757352|448383458|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124661036|NCT02757352|448383459|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124661037|NCT02757352|448383460|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124661038|NCT02757352|448383451|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
124661039|NCT02757352|448383452|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
124661040|NCT02757352|448383453|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
124661041|NCT02757352|448383454|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
124661042|NCT02757352|448383455|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
124661043|NCT02757352|448383456|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
124661044|NCT02757352|448383457|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
124661045|NCT02757352|448383458|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
124661046|NCT02757352|448383459|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
124661047|NCT02757352|448383460|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
124661048|NCT02757352|448383451|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
124661049|NCT02757352|448383452|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
124661050|NCT02757352|448383453|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
124661051|NCT02757352|448383454|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
124661052|NCT02757352|448383455|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
124661053|NCT02757352|448383456|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
124661054|NCT02757352|448383457|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
124661055|NCT02757352|448383458|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
124661056|NCT02757352|448383459|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
124661057|NCT02757352|448383460|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
124661058|NCT02757352|448383451|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124661059|NCT02757352|448383452|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124661060|NCT02757352|448383453|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124661061|NCT02757352|448383454|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
124661062|NCT02757352|448383455|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
124661063|NCT02757352|448383456|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
124661064|NCT02757352|448383457|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124661065|NCT02757352|448383458|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124661066|NCT02757352|448383459|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124661067|NCT02757352|448383460|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
124661068|NCT02757352|448383451|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
124661069|NCT02757352|448383452|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
124661070|NCT02757352|448383453|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
124661071|NCT02757352|448383454|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
124661072|NCT02757352|448383455|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
124661073|NCT02757352|448383456|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
124661074|NCT02757352|448383457|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
124661075|NCT02757352|448383458|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
124661076|NCT02757352|448383459|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
124661077|NCT02757352|448383460|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
124661078|NCT02757352|448383451|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
124661079|NCT02757352|448383452|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
124661080|NCT02757352|448383453|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
124661081|NCT02757352|448383454|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
124661082|NCT02757352|448383455|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
124661083|NCT02757352|448383456|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
124661084|NCT02757352|448383457|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
124661085|NCT02757352|448383458|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
124661086|NCT02757352|448383459|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
124661087|NCT02757352|448383460|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
124661088|NCT02757352|448383451|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124661089|NCT02757352|448383452|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124661090|NCT02757352|448383453|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124661091|NCT02757352|448383454|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
124661092|NCT02757352|448383455|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
124661093|NCT02757352|448383456|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
124661094|NCT02757352|448383457|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124661095|NCT02757352|448383458|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124661096|NCT02757352|448383459|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124661097|NCT02757352|448383460|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
124661098|NCT02757352|448383451|FG000|Follow-Up Period|Adverse Event|0|||
124661099|NCT02757352|448383452|FG001|Follow-Up Period|Adverse Event|0|||
124661100|NCT02757352|448383453|FG002|Follow-Up Period|Adverse Event|0|||
124661101|NCT02757352|448383454|FG003|Follow-Up Period|Adverse Event|0|||
124661102|NCT02757352|448383455|FG004|Follow-Up Period|Adverse Event|0|||
124661103|NCT02757352|448383456|FG005|Follow-Up Period|Adverse Event|0|||
124661104|NCT02757352|448383457|FG006|Follow-Up Period|Adverse Event|1|||
124661105|NCT02757352|448383458|FG007|Follow-Up Period|Adverse Event|0|||
124661106|NCT02757352|448383459|FG008|Follow-Up Period|Adverse Event|2|||
124661107|NCT02757352|448383460|FG009|Follow-Up Period|Adverse Event|0|||
124661108|NCT02757352|448383451|FG000|Follow-Up Period|Lost to Follow-up|0|||
124661109|NCT02757352|448383452|FG001|Follow-Up Period|Lost to Follow-up|0|||
124661110|NCT02757352|448383453|FG002|Follow-Up Period|Lost to Follow-up|0|||
124661111|NCT02757352|448383454|FG003|Follow-Up Period|Lost to Follow-up|0|||
124661112|NCT02757352|448383455|FG004|Follow-Up Period|Lost to Follow-up|0|||
124661113|NCT02757352|448383456|FG005|Follow-Up Period|Lost to Follow-up|0|||
124661114|NCT02757352|448383457|FG006|Follow-Up Period|Lost to Follow-up|0|||
124661115|NCT02757352|448383458|FG007|Follow-Up Period|Lost to Follow-up|0|||
124661116|NCT02757352|448383459|FG008|Follow-Up Period|Lost to Follow-up|1|||
124661117|NCT02757352|448383460|FG009|Follow-Up Period|Lost to Follow-up|0|||
124661118|NCT02757352|448383451|FG000|Follow-Up Period|Lack of Efficacy|0|||
124661119|NCT02757352|448383452|FG001|Follow-Up Period|Lack of Efficacy|0|||
124661120|NCT02757352|448383453|FG002|Follow-Up Period|Lack of Efficacy|0|||
124661121|NCT02757352|448383454|FG003|Follow-Up Period|Lack of Efficacy|0|||
124661122|NCT02757352|448383455|FG004|Follow-Up Period|Lack of Efficacy|0|||
124661123|NCT02757352|448383456|FG005|Follow-Up Period|Lack of Efficacy|0|||
124661124|NCT02757352|448383457|FG006|Follow-Up Period|Lack of Efficacy|0|||
124661125|NCT02757352|448383458|FG007|Follow-Up Period|Lack of Efficacy|0|||
124661126|NCT02757352|448383459|FG008|Follow-Up Period|Lack of Efficacy|1|||
124661127|NCT02757352|448383460|FG009|Follow-Up Period|Lack of Efficacy|1|||
124661128|NCT02757352|448383451|FG000|Follow-Up Period|Withdrawal by Subject|0|||
124661129|NCT02757352|448383452|FG001|Follow-Up Period|Withdrawal by Subject|0|||
124661130|NCT02757352|448383453|FG002|Follow-Up Period|Withdrawal by Subject|0|||
124661131|NCT02757352|448383454|FG003|Follow-Up Period|Withdrawal by Subject|0|||
124661132|NCT02757352|448383455|FG004|Follow-Up Period|Withdrawal by Subject|0|||
124661133|NCT02757352|448383456|FG005|Follow-Up Period|Withdrawal by Subject|0|||
124661134|NCT02757352|448383457|FG006|Follow-Up Period|Withdrawal by Subject|0|||
124661135|NCT02757352|448383458|FG007|Follow-Up Period|Withdrawal by Subject|1|||
124661136|NCT02757352|448383459|FG008|Follow-Up Period|Withdrawal by Subject|6|||
124661137|NCT02757352|448383460|FG009|Follow-Up Period|Withdrawal by Subject|2|||
124661138|NCT03638466|448383461|FG000|Overall Study|Early Termination|0|||
124661139|NCT03638466|448383462|FG001|Overall Study|Early Termination|1|||
124661140|NCT03251482|448383463|FG000|Overall Study|Withdrawal by Subject|0|||
124661141|NCT03251482|448383464|FG001|Overall Study|Withdrawal by Subject|1|||
124661142|NCT03251482|448383465|FG002|Overall Study|Withdrawal by Subject|0|||
124661143|NCT03251482|448383466|FG003|Overall Study|Withdrawal by Subject|0|||
124661144|NCT03251482|448383467|FG004|Overall Study|Withdrawal by Subject|0|||
124661145|NCT02447328|448383468|FG000|Overall Study|Withdrawal by Subject|1|||
124661146|NCT02362425|448383469|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
124661147|NCT02362425|448383470|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
124661148|NCT02362425|448383471|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
124661149|NCT02362425|448383472|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
124661150|NCT02362425|448383469|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
124661151|NCT02362425|448383470|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
124661152|NCT02362425|448383471|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
124661153|NCT02362425|448383472|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
124661154|NCT02362425|448383469|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
124661155|NCT02362425|448383470|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
124661156|NCT02362425|448383471|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
124661157|NCT02362425|448383472|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
124661158|NCT02362425|448383469|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
124661159|NCT02362425|448383470|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
124661160|NCT02362425|448383471|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
124661161|NCT02362425|448383472|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
124661162|NCT02362425|448383469|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
124661163|NCT02362425|448383470|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
124661164|NCT02362425|448383471|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
124661165|NCT02362425|448383472|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
124661166|NCT02362425|448383469|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
124661167|NCT02362425|448383470|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
124661168|NCT02362425|448383471|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
124661169|NCT02362425|448383472|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
124661170|NCT02362425|448383469|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
124661171|NCT02362425|448383470|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
124661172|NCT02362425|448383471|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
124661173|NCT02362425|448383472|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
124661174|NCT02362425|448383469|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
124661175|NCT02362425|448383470|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
124661176|NCT02362425|448383471|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
124661177|NCT02362425|448383472|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
124661178|NCT00802672|448383475|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
124661179|NCT00802672|448383476|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
124661180|NCT00802672|448383477|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
124661181|NCT00802672|448383475|FG000|Overall Study|Adverse Event|1|||
124661182|NCT00802672|448383476|FG001|Overall Study|Adverse Event|1|||
124661183|NCT00802672|448383477|FG002|Overall Study|Adverse Event|1|||
124661184|NCT00802672|448383475|FG000|Overall Study|Protocol Violation|2|||
124661185|NCT00802672|448383476|FG001|Overall Study|Protocol Violation|1|||
124661186|NCT00802672|448383477|FG002|Overall Study|Protocol Violation|1|||
124661187|NCT00802672|448383475|FG000|Overall Study|Lost to Follow-up|5|||
124661188|NCT00802672|448383476|FG001|Overall Study|Lost to Follow-up|5|||
124661189|NCT00802672|448383477|FG002|Overall Study|Lost to Follow-up|3|||
124661190|NCT00802672|448383475|FG000|Overall Study|Withdrawal by Subject|1|||
124661191|NCT00802672|448383476|FG001|Overall Study|Withdrawal by Subject|1|||
124661192|NCT00802672|448383477|FG002|Overall Study|Withdrawal by Subject|2|||
124661193|NCT00802672|448383475|FG000|Overall Study|other|3|||
124661194|NCT00802672|448383476|FG001|Overall Study|other|1|||
124661195|NCT00802672|448383477|FG002|Overall Study|other|2|||
124661196|NCT02579382|448383480|FG000|Main Study Phase|Lost to Follow-up|0|||
124661197|NCT02579382|448383481|FG001|Main Study Phase|Lost to Follow-up|0|||
124661198|NCT02579382|448383482|FG002|Main Study Phase|Lost to Follow-up|2|||
124661199|NCT02579382|448383483|FG003|Main Study Phase|Lost to Follow-up|0|||
124661200|NCT02579382|448383480|FG000|Main Study Phase|Withdrew Consent|0|||
124661201|NCT02579382|448383481|FG001|Main Study Phase|Withdrew Consent|0|||
124661202|NCT02579382|448383482|FG002|Main Study Phase|Withdrew Consent|0|||
124661203|NCT02579382|448383483|FG003|Main Study Phase|Withdrew Consent|2|||
124661204|NCT02579382|448383480|FG000|Main Study Phase|Lack of Efficacy|0|||
124661205|NCT02579382|448383481|FG001|Main Study Phase|Lack of Efficacy|0|||
124661206|NCT02579382|448383482|FG002|Main Study Phase|Lack of Efficacy|0|||
124661207|NCT02579382|448383483|FG003|Main Study Phase|Lack of Efficacy|1|||
124661208|NCT02579382|448383480|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
124661209|NCT02579382|448383481|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
124661210|NCT02579382|448383482|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
124661211|NCT02579382|448383483|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
124661212|NCT02579382|448383480|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
124661213|NCT02579382|448383481|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
124661214|NCT02579382|448383482|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
124661215|NCT02579382|448383483|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
124661216|NCT02579382|448383480|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
124661217|NCT02579382|448383481|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
124661218|NCT02579382|448383482|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
124661219|NCT02579382|448383483|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
124661220|NCT02579382|448383480|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
124661221|NCT02579382|448383481|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
124661222|NCT02579382|448383482|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
124661223|NCT02579382|448383483|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
124661224|NCT02579382|448383480|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
124661225|NCT02579382|448383481|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
124661226|NCT02579382|448383482|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
124661227|NCT02579382|448383483|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
124661228|NCT02579382|448383480|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
124661229|NCT02579382|448383481|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
124661230|NCT02579382|448383482|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
124661231|NCT02579382|448383483|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
124661232|NCT03026283|448383485|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
124661233|NCT03026283|448383486|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
124661234|NCT03026283|448383487|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
124661235|NCT03026283|448383488|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
124661236|NCT03026283|448383489|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
124661237|NCT03026283|448383490|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
124661238|NCT03026283|448383491|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
124661239|NCT03026283|448383492|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
124661240|NCT03026283|448383485|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
124661241|NCT03026283|448383486|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
124661242|NCT03026283|448383487|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
124661243|NCT03026283|448383488|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
124661244|NCT03026283|448383489|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
124661245|NCT03026283|448383490|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
124661246|NCT03026283|448383491|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
124661247|NCT03026283|448383492|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
124661248|NCT03026283|448383485|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
124661249|NCT03026283|448383486|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
124661250|NCT03026283|448383487|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
124661251|NCT03026283|448383488|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
124661252|NCT03026283|448383489|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
124661253|NCT03026283|448383490|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
124661254|NCT03026283|448383491|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
124661255|NCT03026283|448383492|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
124661256|NCT03026283|448383485|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
124661257|NCT03026283|448383486|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
124661258|NCT03026283|448383487|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
124661259|NCT03026283|448383488|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
124661260|NCT03026283|448383489|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
124661261|NCT03026283|448383490|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
124661262|NCT03026283|448383491|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
124661263|NCT03026283|448383492|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
124661264|NCT03026283|448383485|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
124661265|NCT03026283|448383486|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
124661266|NCT03026283|448383487|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
124661267|NCT03026283|448383488|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
124661268|NCT03026283|448383489|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
124661269|NCT03026283|448383490|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
124661270|NCT03026283|448383491|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
124661271|NCT03026283|448383492|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
124661272|NCT03026283|448383485|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
124661273|NCT03026283|448383486|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
124661274|NCT03026283|448383487|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
124661275|NCT03026283|448383488|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
124661276|NCT03026283|448383489|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
124661277|NCT03026283|448383490|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
124661278|NCT03026283|448383491|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
124661279|NCT03026283|448383492|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
124661280|NCT03026283|448383485|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
124661281|NCT03026283|448383486|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
124661282|NCT03026283|448383487|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
124661283|NCT03026283|448383488|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
124661284|NCT03026283|448383489|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
124661285|NCT03026283|448383490|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
124661286|NCT03026283|448383491|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
124661287|NCT03026283|448383492|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
124661288|NCT03026283|448383485|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
124661289|NCT03026283|448383486|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
124661290|NCT03026283|448383487|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
124661291|NCT03026283|448383488|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
124661292|NCT03026283|448383489|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
124661293|NCT03026283|448383490|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
124661294|NCT03026283|448383491|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
124661295|NCT03026283|448383492|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
124661296|NCT03026283|448383485|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
124661297|NCT03026283|448383486|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
124661298|NCT03026283|448383487|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
124661299|NCT03026283|448383488|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
124661300|NCT03026283|448383489|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
124661301|NCT03026283|448383490|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
124661302|NCT03026283|448383491|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
124661303|NCT03026283|448383492|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
124661304|NCT03782571|448383493|FG000|Period 1|Withdrawal by Subject|1|||
124661305|NCT03782571|448383494|FG001|Period 1|Withdrawal by Subject|0|||
124661306|NCT03782571|448383495|FG002|Period 1|Withdrawal by Subject|0|||
124661307|NCT03782571|448383496|FG003|Period 1|Withdrawal by Subject|0|||
124661308|NCT03782571|448383493|FG000|Period 3|Subject Unable to Attend V5|1|||
124661309|NCT03782571|448383494|FG001|Period 3|Subject Unable to Attend V5|0|||
124661310|NCT03782571|448383495|FG002|Period 3|Subject Unable to Attend V5|0|||
124661311|NCT03782571|448383496|FG003|Period 3|Subject Unable to Attend V5|0|||
124661312|NCT03782571|448383493|FG000|Period 3|Adverse Event|1|||
124661313|NCT03782571|448383494|FG001|Period 3|Adverse Event|0|||
124661314|NCT03782571|448383495|FG002|Period 3|Adverse Event|0|||
124661315|NCT03782571|448383496|FG003|Period 3|Adverse Event|0|||
124661316|NCT00493311|448383499|FG000|Overall Study|Need for rescue medication|2|||
124661317|NCT00493311|448383500|FG001|Overall Study|Need for rescue medication|2|||
124661318|NCT02779075|448383501|FG000|Overall Study|Withdrawal by Subject|1|||
124661319|NCT02779075|448383502|FG001|Overall Study|Withdrawal by Subject|3|||
124661320|NCT02779075|448383501|FG000|Overall Study|IV lost during 2nd study|1|||
124661321|NCT02779075|448383502|FG001|Overall Study|IV lost during 2nd study|0|||
124661322|NCT03959527|448383503|FG000|Overall Study|Withdrawal by Subject|8|||
124661323|NCT03959527|448383504|FG001|Overall Study|Withdrawal by Subject|3|||
124661324|NCT03959527|448383503|FG000|Overall Study|Lost to Follow-up|31|||
124661325|NCT03959527|448383504|FG001|Overall Study|Lost to Follow-up|15|||
124661326|NCT03959527|448383503|FG000|Overall Study|Did not meet eligibility criteria|1|||
124661327|NCT03959527|448383504|FG001|Overall Study|Did not meet eligibility criteria|1|||
124661328|NCT03959527|448383503|FG000|Overall Study|Protocol Violation|10|||
124661329|NCT03959527|448383504|FG001|Overall Study|Protocol Violation|5|||
124661330|NCT00707980|448383505|FG000|Overall Study|Adverse Event|49|||
124661331|NCT00707980|448383505|FG000|Overall Study|Lack of Efficacy|35|||
124661332|NCT00707980|448383505|FG000|Overall Study|Non-Compliance with Study Drug|28|||
124661333|NCT00707980|448383505|FG000|Overall Study|Protocol Deviations|19|||
124661334|NCT00707980|448383505|FG000|Overall Study|Withdrawal of Consent|81|||
124661335|NCT00707980|448383505|FG000|Overall Study|Lost to Follow-up|59|||
124661336|NCT00707980|448383505|FG000|Overall Study|Other|39|||
124661337|NCT01152996|448383506|FG000|Overall Study|Withdrawal by Subject|142|||
124661338|NCT01152996|448383506|FG000|Overall Study|Adverse Event|115|||
124661339|NCT01152996|448383506|FG000|Overall Study|Lost to Follow-up|112|||
124661340|NCT01152996|448383506|FG000|Overall Study|Lack of Efficacy|68|||
124661341|NCT01152996|448383506|FG000|Overall Study|Noncompliance|41|||
124661342|NCT01152996|448383506|FG000|Overall Study|Other|36|||
124661343|NCT01152996|448383506|FG000|Overall Study|Protocol Violation|22|||
124661344|NCT01152996|448383506|FG000|Overall Study|Elevated liver enzymes|1|||
124661345|NCT02072941|448383508|FG000|Overall Study|Withdrawal by Subject|29|||
124661346|NCT02072941|448383509|FG001|Overall Study|Withdrawal by Subject|21|||
124661347|NCT02072941|448383508|FG000|Overall Study|Lost to Follow-up|4|||
124661348|NCT02072941|448383509|FG001|Overall Study|Lost to Follow-up|4|||
124661349|NCT02072941|448383508|FG000|Overall Study|Death|3|||
124661350|NCT02072941|448383509|FG001|Overall Study|Death|2|||
124661351|NCT02072941|448383508|FG000|Overall Study|Removed by Study Staff|2|||
124661352|NCT02072941|448383509|FG001|Overall Study|Removed by Study Staff|2|||
124661353|NCT03146741|448383510|FG000|Overall Study|Txp with non-HCV+ heart|4|||
124661354|NCT03146741|448383510|FG000|Overall Study|Listeted for MOT|2|||
124661355|NCT03146741|448383510|FG000|Overall Study|Physician Decision|2|||
124661356|NCT03146741|448383510|FG000|Overall Study|Awaiting txp|2|||
124661357|NCT03224624|448383511|FG000|Overall Study|Lost to Follow-up|9|||
124661358|NCT03224624|448383512|FG001|Overall Study|Lost to Follow-up|4|||
124661359|NCT03224624|448383511|FG000|Overall Study|Death|1|||
124661360|NCT03224624|448383512|FG001|Overall Study|Death|0|||
124661361|NCT01884545|448383513|FG000|Overall Study|Lost to Follow-up|6|||
124661362|NCT01884545|448383514|FG001|Overall Study|Lost to Follow-up|4|||
124661363|NCT01884545|448383515|FG002|Overall Study|Lost to Follow-up|9|||
124661364|NCT01884545|448383516|FG003|Overall Study|Lost to Follow-up|4|||
124661365|NCT01884545|448383513|FG000|Overall Study|Patient withdrawn|7|||
124661366|NCT01884545|448383514|FG001|Overall Study|Patient withdrawn|12|||
124661367|NCT01884545|448383515|FG002|Overall Study|Patient withdrawn|5|||
124661368|NCT01884545|448383516|FG003|Overall Study|Patient withdrawn|5|||
124661369|NCT01884545|448383513|FG000|Overall Study|Non-adherence|0|||
124661370|NCT01884545|448383514|FG001|Overall Study|Non-adherence|2|||
124661371|NCT01884545|448383515|FG002|Overall Study|Non-adherence|0|||
124661372|NCT01884545|448383516|FG003|Overall Study|Non-adherence|0|||
124661373|NCT02521792|448383522|FG000|Overall Study|Study Terminated|6|||
124661374|NCT00398047|448383523|FG000|Overall Study|all patient progressed before completion|3|||
124661375|NCT00902746|448383524|FG000|Overall Study|Protocol Violation|7|||
124661376|NCT00902746|448383524|FG000|Overall Study|Withdrawal by Subject|16|||
124661377|NCT00902746|448383524|FG000|Overall Study|Adverse Event|8|||
124661378|NCT00902746|448383524|FG000|Overall Study|Lost to Follow-up|3|||
124661379|NCT00902746|448383524|FG000|Overall Study|Physician Decision|2|||
124661380|NCT02937636|448383526|FG000|Overall Study|Other (Not specified)|3|||
124661381|NCT02937636|448383527|FG001|Overall Study|Other (Not specified)|2|||
124661382|NCT00770913|448383532|FG000|Overall Study|Adverse Event|1|||
124661383|NCT00770913|448383533|FG001|Overall Study|Adverse Event|3|||
124661384|NCT00770913|448383534|FG002|Overall Study|Adverse Event|6|||
124661385|NCT00770913|448383532|FG000|Overall Study|Refusal to continue participation|6|||
124661386|NCT00770913|448383533|FG001|Overall Study|Refusal to continue participation|4|||
124661387|NCT00770913|448383534|FG002|Overall Study|Refusal to continue participation|5|||
124661388|NCT00770913|448383532|FG000|Overall Study|Physician Decision|0|||
124661389|NCT00770913|448383533|FG001|Overall Study|Physician Decision|1|||
124661390|NCT00770913|448383534|FG002|Overall Study|Physician Decision|1|||
124661391|NCT00770913|448383532|FG000|Overall Study|Protocol Violation|3|||
124661392|NCT00770913|448383533|FG001|Overall Study|Protocol Violation|0|||
124661393|NCT00770913|448383534|FG002|Overall Study|Protocol Violation|1|||
124661394|NCT00770913|448383532|FG000|Overall Study|Incorrect drug was allocated|1|||
124661395|NCT00770913|448383533|FG001|Overall Study|Incorrect drug was allocated|0|||
124661396|NCT00770913|448383534|FG002|Overall Study|Incorrect drug was allocated|0|||
124661397|NCT00359294|448383538|FG000|Overall Study|Progressive disease|1|||
124661398|NCT00359294|448383539|FG001|Overall Study|Progressive disease|1|||
124661399|NCT00359294|448383540|FG002|Overall Study|Progressive disease|2|||
124661400|NCT00359294|448383541|FG003|Overall Study|Progressive disease|3|||
124661401|NCT00359294|448383542|FG004|Overall Study|Progressive disease|2|||
124661402|NCT00359294|448383538|FG000|Overall Study|Withdrawal by Subject|0|||
124661403|NCT00359294|448383539|FG001|Overall Study|Withdrawal by Subject|0|||
124661404|NCT00359294|448383540|FG002|Overall Study|Withdrawal by Subject|0|||
124661405|NCT00359294|448383541|FG003|Overall Study|Withdrawal by Subject|0|||
124661406|NCT00359294|448383542|FG004|Overall Study|Withdrawal by Subject|1|||
124661407|NCT00359294|448383538|FG000|Overall Study|Not treated|0|||
124661408|NCT00359294|448383539|FG001|Overall Study|Not treated|0|||
124661409|NCT00359294|448383540|FG002|Overall Study|Not treated|0|||
124661410|NCT00359294|448383541|FG003|Overall Study|Not treated|1|||
124661411|NCT00359294|448383542|FG004|Overall Study|Not treated|0|||
124661412|NCT00359294|448383538|FG000|Overall Study|Physician Decision|0|||
124661413|NCT00359294|448383539|FG001|Overall Study|Physician Decision|0|||
124661414|NCT00359294|448383540|FG002|Overall Study|Physician Decision|1|||
124661415|NCT00359294|448383541|FG003|Overall Study|Physician Decision|0|||
124661416|NCT00359294|448383542|FG004|Overall Study|Physician Decision|0|||
124661417|NCT01398358|448383549|FG000|Overall Study|Lost to Follow-up|11|||
124661418|NCT01398358|448383550|FG001|Overall Study|Lost to Follow-up|21|||
124661419|NCT01398358|448383551|FG002|Overall Study|Lost to Follow-up|18|||
124661420|NCT01398358|448383549|FG000|Overall Study|Withdrawal by Subject|3|||
124661421|NCT01398358|448383550|FG001|Overall Study|Withdrawal by Subject|2|||
124661422|NCT01398358|448383551|FG002|Overall Study|Withdrawal by Subject|2|||
124661423|NCT01398358|448383549|FG000|Overall Study|no longer eligible|1|||
124661424|NCT01398358|448383550|FG001|Overall Study|no longer eligible|0|||
124661425|NCT01398358|448383551|FG002|Overall Study|no longer eligible|1|||
124661426|NCT03148067|448383553|FG000|Overall Study|Lost to Follow-up|3|||
124661427|NCT03148067|448383553|FG000|Overall Study|Death|1|||
124661428|NCT02559570|448383554|FG000|Overall Study|Adverse Event|0|||
124661429|NCT02559570|448383555|FG001|Overall Study|Adverse Event|2|||
124661430|NCT02559570|448383556|FG002|Overall Study|Adverse Event|0|||
124661431|NCT02559570|448383557|FG003|Overall Study|Adverse Event|1|||
124661432|NCT02559570|448383558|FG004|Overall Study|Adverse Event|0|||
124661433|NCT02559570|448383554|FG000|Overall Study|Withdrawal of Consent|0|||
124661434|NCT02559570|448383555|FG001|Overall Study|Withdrawal of Consent|0|||
124661435|NCT02559570|448383556|FG002|Overall Study|Withdrawal of Consent|1|||
124661436|NCT02559570|448383557|FG003|Overall Study|Withdrawal of Consent|2|||
124661437|NCT02559570|448383558|FG004|Overall Study|Withdrawal of Consent|1|||
124661438|NCT02559570|448383554|FG000|Overall Study|Lost to Follow-up|1|||
124661439|NCT02559570|448383555|FG001|Overall Study|Lost to Follow-up|0|||
124661440|NCT02559570|448383556|FG002|Overall Study|Lost to Follow-up|0|||
124661441|NCT02559570|448383557|FG003|Overall Study|Lost to Follow-up|0|||
124661442|NCT02559570|448383558|FG004|Overall Study|Lost to Follow-up|0|||
124661443|NCT02559570|448383554|FG000|Overall Study|Protocol Violation|1|||
124661444|NCT02559570|448383555|FG001|Overall Study|Protocol Violation|0|||
124661445|NCT02559570|448383556|FG002|Overall Study|Protocol Violation|0|||
124661446|NCT02559570|448383557|FG003|Overall Study|Protocol Violation|0|||
124661447|NCT02559570|448383558|FG004|Overall Study|Protocol Violation|1|||
124661448|NCT02559570|448383554|FG000|Overall Study|Other Miscellaneous Reasons|0|||
124661449|NCT02559570|448383555|FG001|Overall Study|Other Miscellaneous Reasons|0|||
124661450|NCT02559570|448383556|FG002|Overall Study|Other Miscellaneous Reasons|1|||
124661451|NCT02559570|448383557|FG003|Overall Study|Other Miscellaneous Reasons|0|||
124661452|NCT02559570|448383558|FG004|Overall Study|Other Miscellaneous Reasons|0|||
124661453|NCT00524680|448383564|FG000|Overall Study|progression|0|||
124661454|NCT00524680|448383565|FG001|Overall Study|progression|0|||
124661455|NCT00524680|448383566|FG002|Overall Study|progression|0|||
124661456|NCT00524680|448383567|FG003|Overall Study|progression|1|||
124661457|NCT00524680|448383564|FG000|Overall Study|Adverse Event|2|||
124661458|NCT00524680|448383565|FG001|Overall Study|Adverse Event|0|||
124661459|NCT00524680|448383566|FG002|Overall Study|Adverse Event|0|||
124661460|NCT00524680|448383567|FG003|Overall Study|Adverse Event|1|||
124661461|NCT00524680|448383564|FG000|Overall Study|Other|0|||
124661462|NCT00524680|448383565|FG001|Overall Study|Other|1|||
124661463|NCT00524680|448383566|FG002|Overall Study|Other|2|||
124661464|NCT00524680|448383567|FG003|Overall Study|Other|3|||
124661465|NCT00524680|448383564|FG000|Overall Study|Withdrawal by Subject|1|||
124661466|NCT00524680|448383565|FG001|Overall Study|Withdrawal by Subject|0|||
124661467|NCT00524680|448383566|FG002|Overall Study|Withdrawal by Subject|1|||
124661468|NCT00524680|448383567|FG003|Overall Study|Withdrawal by Subject|1|||
124661469|NCT01607346|448383568|FG000|Overall Study|Adverse Event|3|||
124661470|NCT01098162|448383569|FG000|Overall Study|Adverse Event|37|||
124661471|NCT01098162|448383569|FG000|Overall Study|Lack of Efficacy|4|||
124661472|NCT01098162|448383569|FG000|Overall Study|Wish of Patient|7|||
124661473|NCT01098162|448383569|FG000|Overall Study|Lost to Follow-up|9|||
124661474|NCT01098162|448383569|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
124661475|NCT01098162|448383569|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
124661476|NCT01098162|448383569|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
124661477|NCT01098162|448383569|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
124661478|NCT01098162|448383569|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
124661479|NCT01098162|448383569|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
124661480|NCT01098162|448383569|FG000|Overall Study|Other Reason|1|||
124661481|NCT01098162|448383569|FG000|Overall Study|Reason Unknown|26|||
124661482|NCT00625183|448383570|FG000|Overall Study|Disease Progression|1|||
124661483|NCT04424914|448383571|FG000|Overall Study|Other|0|||
124661484|NCT04424914|448383572|FG001|Overall Study|Other|0|||
124661485|NCT04424914|448383573|FG002|Overall Study|Other|28|||
124661486|NCT04424914|448383571|FG000|Overall Study|Withdrawal by Subject|3|||
124661487|NCT04424914|448383572|FG001|Overall Study|Withdrawal by Subject|0|||
124661488|NCT04424914|448383573|FG002|Overall Study|Withdrawal by Subject|0|||
124661489|NCT04424914|448383571|FG000|Overall Study|Study terminated by sponsor|23|||
124661490|NCT04424914|448383572|FG001|Overall Study|Study terminated by sponsor|7|||
124661491|NCT04424914|448383573|FG002|Overall Study|Study terminated by sponsor|0|||
124661492|NCT04424914|448383571|FG000|Overall Study|Lost to Follow-up|0|||
124661493|NCT04424914|448383572|FG001|Overall Study|Lost to Follow-up|0|||
124661494|NCT04424914|448383573|FG002|Overall Study|Lost to Follow-up|1|||
124661495|NCT04424914|448383571|FG000|Overall Study|Death|3|||
124661496|NCT04424914|448383572|FG001|Overall Study|Death|1|||
124661497|NCT04424914|448383573|FG002|Overall Study|Death|0|||
124661498|NCT00334295|448383578|FG000|Overall Study|Patients received fewer than 3 injection|5|||
124661499|NCT03383692|448383583|FG000|Overall Study|Progressive disease as per RECIST|3|||
124661500|NCT03383692|448383584|FG001|Overall Study|Progressive disease as per RECIST|3|||
124661501|NCT03383692|448383583|FG000|Overall Study|Clinical progression|0|||
124661502|NCT03383692|448383584|FG001|Overall Study|Clinical progression|1|||
124661503|NCT03383692|448383583|FG000|Overall Study|Adverse Event|3|||
124661504|NCT03383692|448383584|FG001|Overall Study|Adverse Event|0|||
124661505|NCT00492232|448383585|FG000|Placebo Run-in|Adverse Event|0|||
124661506|NCT00492232|448383586|FG001|Placebo Run-in|Adverse Event|2|||
124661507|NCT00492232|448383585|FG000|Placebo Run-in|Protocol Violation|0|||
124661508|NCT00492232|448383586|FG001|Placebo Run-in|Protocol Violation|3|||
124661509|NCT00492232|448383585|FG000|Placebo Run-in|Lost to Follow-up|0|||
124661510|NCT00492232|448383586|FG001|Placebo Run-in|Lost to Follow-up|3|||
124661511|NCT00492232|448383585|FG000|Placebo Run-in|Withdrawal by Subject|0|||
124661512|NCT00492232|448383586|FG001|Placebo Run-in|Withdrawal by Subject|8|||
124661513|NCT00492232|448383585|FG000|Placebo Run-in|Pregnancy|0|||
124661514|NCT00492232|448383586|FG001|Placebo Run-in|Pregnancy|1|||
124661515|NCT00492232|448383585|FG000|Placebo Run-in|Entrance criteria not met|0|||
124661516|NCT00492232|448383586|FG001|Placebo Run-in|Entrance criteria not met|45|||
124661517|NCT00492232|448383585|FG000|Placebo Run-in|Other|0|||
124661518|NCT00492232|448383586|FG001|Placebo Run-in|Other|6|||
124661519|NCT00492232|448383585|FG000|Placebo Run-in|Missing|0|||
124661520|NCT00492232|448383586|FG001|Placebo Run-in|Missing|2|||
124661521|NCT00492232|448383585|FG000|Double-Blind Treatment|Adverse Event|1|||
124661522|NCT00492232|448383586|FG001|Double-Blind Treatment|Adverse Event|2|||
124661523|NCT00492232|448383585|FG000|Double-Blind Treatment|Protocol Violation|3|||
124661524|NCT00492232|448383586|FG001|Double-Blind Treatment|Protocol Violation|7|||
124661525|NCT00492232|448383585|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
124661526|NCT00492232|448383586|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
124661527|NCT00492232|448383585|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
124661528|NCT00492232|448383586|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
124661529|NCT00492232|448383585|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
124661530|NCT00492232|448383586|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
124661531|NCT00492232|448383585|FG000|Double-Blind Treatment|Other|6|||
124661532|NCT00492232|448383586|FG001|Double-Blind Treatment|Other|5|||
124661533|NCT00492232|448383585|FG000|Double-Blind Treatment|Randomized not treated|1|||
124661534|NCT00492232|448383586|FG001|Double-Blind Treatment|Randomized not treated|0|||
124661535|NCT00492232|448383585|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
124661536|NCT00492232|448383586|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
124661537|NCT02453256|448383587|FG000|Double Blind Period|Death|1|||
124661538|NCT02453256|448383588|FG001|Double Blind Period|Death|1|||
124661539|NCT02453256|448383587|FG000|Double Blind Period|Adverse Event|3|||
124661540|NCT02453256|448383588|FG001|Double Blind Period|Adverse Event|2|||
124661541|NCT02453256|448383587|FG000|Double Blind Period|Withdrawal by Subject|9|||
124661542|NCT02453256|448383588|FG001|Double Blind Period|Withdrawal by Subject|5|||
124661543|NCT02453256|448383587|FG000|Double Blind Period|Other|0|||
124661544|NCT02453256|448383588|FG001|Double Blind Period|Other|1|||
124661545|NCT02453256|448383587|FG000|Open Label Period|Adverse Event|1|||
124661546|NCT02453256|448383588|FG001|Open Label Period|Adverse Event|3|||
124661547|NCT02453256|448383587|FG000|Open Label Period|Death|0|||
124661548|NCT02453256|448383588|FG001|Open Label Period|Death|1|||
124661549|NCT02453256|448383587|FG000|Open Label Period|Lost to Follow-up|1|||
124661550|NCT02453256|448383588|FG001|Open Label Period|Lost to Follow-up|0|||
124661551|NCT02453256|448383587|FG000|Open Label Period|Other|0|||
124661552|NCT02453256|448383588|FG001|Open Label Period|Other|2|||
124661553|NCT02453256|448383587|FG000|Open Label Period|Withdrawal by Subject|5|||
124661554|NCT02453256|448383588|FG001|Open Label Period|Withdrawal by Subject|1|||
124661555|NCT01216332|448383589|FG000|Overall Study|Withdrawal by Subject|4|||
124661556|NCT01216332|448383590|FG001|Overall Study|Withdrawal by Subject|0|||
124661557|NCT00636636|448383591|FG000|Overall Study|Other reason|4|||
124661558|NCT00636636|448383592|FG001|Overall Study|Other reason|6|||
124661559|NCT00636636|448383591|FG000|Overall Study|Adverse Event|19|||
124661560|NCT00636636|448383592|FG001|Overall Study|Adverse Event|8|||
124661561|NCT00636636|448383591|FG000|Overall Study|Lack of Efficacy|7|||
124661562|NCT00636636|448383592|FG001|Overall Study|Lack of Efficacy|12|||
124661563|NCT00636636|448383591|FG000|Overall Study|Protocol Violation|2|||
124661564|NCT00636636|448383592|FG001|Overall Study|Protocol Violation|2|||
124661565|NCT00636636|448383591|FG000|Overall Study|Lost to Follow-up|0|||
124661566|NCT00636636|448383592|FG001|Overall Study|Lost to Follow-up|1|||
124661567|NCT00636636|448383591|FG000|Overall Study|Death|0|||
124661568|NCT00636636|448383592|FG001|Overall Study|Death|1|||
124661569|NCT00636636|448383591|FG000|Overall Study|Withdrawal by Subject|4|||
124661570|NCT00636636|448383592|FG001|Overall Study|Withdrawal by Subject|9|||
124661571|NCT00524173|448383593|FG000|Overall Study|Lost to Follow-up|0|||
124661572|NCT00524173|448383594|FG001|Overall Study|Lost to Follow-up|1|||
124661573|NCT00524173|448383593|FG000|Overall Study|Death|1|||
124661574|NCT00524173|448383594|FG001|Overall Study|Death|0|||
124661575|NCT00524173|448383593|FG000|Overall Study|Had not reached endpoint at study close|4|||
124661576|NCT00524173|448383594|FG001|Overall Study|Had not reached endpoint at study close|1|||
124661577|NCT01237327|448383595|FG000|Overall Study|Protocol Violation: Core Study|1|||
124661578|NCT01237327|448383596|FG001|Overall Study|Protocol Violation: Core Study|0|||
124661579|NCT01237327|448383595|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
124661580|NCT01237327|448383596|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
124661581|NCT01237327|448383595|FG000|Overall Study|Progression of Disease: Core Study|18|||
124661582|NCT01237327|448383596|FG001|Overall Study|Progression of Disease: Core Study|22|||
124661583|NCT01237327|448383595|FG000|Overall Study|Progression of Disease: Extension Study|15|||
124661584|NCT01237327|448383596|FG001|Overall Study|Progression of Disease: Extension Study|13|||
124661585|NCT01237327|448383595|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
124661586|NCT01237327|448383596|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
124661587|NCT01237327|448383595|FG000|Overall Study|Withdrawal by Subject|1|||
124661588|NCT01237327|448383596|FG001|Overall Study|Withdrawal by Subject|3|||
124661589|NCT01237327|448383595|FG000|Overall Study|Lost to Follow-up|3|||
124661590|NCT01237327|448383596|FG001|Overall Study|Lost to Follow-up|0|||
124661591|NCT02483572|448383599|FG000|Overall Study|Withdrawal by Subject|1|||
124661592|NCT02483572|448383600|FG001|Overall Study|Withdrawal by Subject|0|||
124661593|NCT02483572|448383599|FG000|Overall Study|Lost to Follow-up|1|||
124661594|NCT02483572|448383600|FG001|Overall Study|Lost to Follow-up|0|||
124661595|NCT02483572|448383599|FG000|Overall Study|Physician Decision|0|||
124661596|NCT02483572|448383600|FG001|Overall Study|Physician Decision|1|||
124661597|NCT04811664|448383601|FG000|Overall Study|Lost to Follow-up|78|||
124661598|NCT04811664|448383602|FG001|Overall Study|Lost to Follow-up|125|||
124661599|NCT04811664|448383603|FG002|Overall Study|Lost to Follow-up|46|||
124661600|NCT04811664|448383601|FG000|Overall Study|Withdrawal by Subject|39|||
124661601|NCT04811664|448383602|FG001|Overall Study|Withdrawal by Subject|76|||
124661602|NCT04811664|448383603|FG002|Overall Study|Withdrawal by Subject|12|||
124661603|NCT04811664|448383601|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
124661604|NCT04811664|448383602|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
124661605|NCT04811664|448383603|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
124661606|NCT04811664|448383601|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
124661607|NCT04811664|448383602|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
124661608|NCT04811664|448383603|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
124661609|NCT04811664|448383601|FG000|Overall Study|Protocol Violation|0|||
124661610|NCT04811664|448383602|FG001|Overall Study|Protocol Violation|5|||
124661611|NCT04811664|448383603|FG002|Overall Study|Protocol Violation|11|||
124661612|NCT04811664|448383601|FG000|Overall Study|Study Terminated by Sponsor|4|||
124661613|NCT04811664|448383602|FG001|Overall Study|Study Terminated by Sponsor|3|||
124661614|NCT04811664|448383603|FG002|Overall Study|Study Terminated by Sponsor|34|||
124661615|NCT04811664|448383601|FG000|Overall Study|Early Study Closure|3|||
124661616|NCT04811664|448383602|FG001|Overall Study|Early Study Closure|7|||
124661617|NCT04811664|448383603|FG002|Overall Study|Early Study Closure|79|||
124661618|NCT04811664|448383601|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
124661619|NCT04811664|448383602|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
124661620|NCT04811664|448383603|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
124661621|NCT05052697|448383604|FG000|Substudy A|Lost to Follow-up|0|||
124661622|NCT05052697|448383605|FG001|Substudy A|Lost to Follow-up|0|||
124661623|NCT05052697|448383606|FG002|Substudy A|Lost to Follow-up|0|||
124661624|NCT05052697|448383607|FG003|Substudy A|Lost to Follow-up|0|||
124661625|NCT05052697|448383608|FG004|Substudy A|Lost to Follow-up|0|||
124661626|NCT05052697|448383609|FG005|Substudy A|Lost to Follow-up|1|||
124661627|NCT05052697|448383610|FG006|Substudy A|Lost to Follow-up|0|||
124661628|NCT05052697|448383611|FG007|Substudy A|Lost to Follow-up|0|||
124661629|NCT05052697|448383612|FG008|Substudy A|Lost to Follow-up|0|||
124661630|NCT05052697|448383613|FG009|Substudy A|Lost to Follow-up|0|||
124661631|NCT05052697|448383614|FG010|Substudy A|Lost to Follow-up|0|||
124661632|NCT05052697|448383615|FG011|Substudy A|Lost to Follow-up|0|||
124661633|NCT05052697|448383616|FG012|Substudy A|Lost to Follow-up|0|||
124661634|NCT05052697|448383617|FG013|Substudy A|Lost to Follow-up|0|||
124661635|NCT05052697|448383618|FG014|Substudy A|Lost to Follow-up|0|||
124661636|NCT05052697|448383619|FG015|Substudy A|Lost to Follow-up|2|||
124661637|NCT05052697|448383620|FG016|Substudy A|Lost to Follow-up|0|||
124661638|NCT05052697|448383621|FG017|Substudy A|Lost to Follow-up|0|||
124661639|NCT05052697|448383622|FG018|Substudy A|Lost to Follow-up|0|||
124661640|NCT05052697|448383623|FG019|Substudy A|Lost to Follow-up|0|||
124661641|NCT05052697|448383624|FG020|Substudy A|Lost to Follow-up|0|||
124661642|NCT05052697|448383625|FG021|Substudy A|Lost to Follow-up|0|||
124661643|NCT05052697|448383626|FG022|Substudy A|Lost to Follow-up|0|||
124661644|NCT05052697|448383627|FG023|Substudy A|Lost to Follow-up|0|||
124661645|NCT05052697|448383628|FG024|Substudy A|Lost to Follow-up|0|||
124661646|NCT05052697|448383629|FG025|Substudy A|Lost to Follow-up|0|||
124661647|NCT05052697|448383630|FG026|Substudy A|Lost to Follow-up|0|||
124661648|NCT05052697|448383631|FG027|Substudy A|Lost to Follow-up|0|||
124661649|NCT05052697|448383632|FG028|Substudy A|Lost to Follow-up|0|||
124661650|NCT05052697|448383633|FG029|Substudy A|Lost to Follow-up|0|||
124661651|NCT05052697|448383634|FG030|Substudy A|Lost to Follow-up|0|||
124661652|NCT05052697|448383635|FG031|Substudy A|Lost to Follow-up|0|||
124661653|NCT05052697|448383636|FG032|Substudy A|Lost to Follow-up|0|||
124661654|NCT05052697|448383637|FG033|Substudy A|Lost to Follow-up|0|||
124661655|NCT05052697|448383604|FG000|Substudy A|No longer met eligibility criteria|0|||
124661656|NCT05052697|448383605|FG001|Substudy A|No longer met eligibility criteria|0|||
124661657|NCT05052697|448383606|FG002|Substudy A|No longer met eligibility criteria|0|||
124661658|NCT05052697|448383607|FG003|Substudy A|No longer met eligibility criteria|0|||
124661659|NCT05052697|448383608|FG004|Substudy A|No longer met eligibility criteria|0|||
124661660|NCT05052697|448383609|FG005|Substudy A|No longer met eligibility criteria|0|||
124661661|NCT05052697|448383610|FG006|Substudy A|No longer met eligibility criteria|0|||
124661662|NCT05052697|448383611|FG007|Substudy A|No longer met eligibility criteria|0|||
124661663|NCT05052697|448383612|FG008|Substudy A|No longer met eligibility criteria|0|||
124661664|NCT05052697|448383613|FG009|Substudy A|No longer met eligibility criteria|0|||
124661665|NCT05052697|448383614|FG010|Substudy A|No longer met eligibility criteria|0|||
124661666|NCT05052697|448383615|FG011|Substudy A|No longer met eligibility criteria|0|||
124661667|NCT05052697|448383616|FG012|Substudy A|No longer met eligibility criteria|0|||
124661668|NCT05052697|448383617|FG013|Substudy A|No longer met eligibility criteria|1|||
124661669|NCT05052697|448383618|FG014|Substudy A|No longer met eligibility criteria|0|||
124661670|NCT05052697|448383619|FG015|Substudy A|No longer met eligibility criteria|0|||
124661671|NCT05052697|448383620|FG016|Substudy A|No longer met eligibility criteria|0|||
124661672|NCT05052697|448383621|FG017|Substudy A|No longer met eligibility criteria|0|||
124661673|NCT05052697|448383622|FG018|Substudy A|No longer met eligibility criteria|0|||
124661674|NCT05052697|448383623|FG019|Substudy A|No longer met eligibility criteria|0|||
124661675|NCT05052697|448383624|FG020|Substudy A|No longer met eligibility criteria|0|||
124661676|NCT05052697|448383625|FG021|Substudy A|No longer met eligibility criteria|0|||
124661677|NCT05052697|448383626|FG022|Substudy A|No longer met eligibility criteria|0|||
124661678|NCT05052697|448383627|FG023|Substudy A|No longer met eligibility criteria|0|||
124661679|NCT05052697|448383628|FG024|Substudy A|No longer met eligibility criteria|0|||
124661680|NCT05052697|448383629|FG025|Substudy A|No longer met eligibility criteria|0|||
124661681|NCT05052697|448383630|FG026|Substudy A|No longer met eligibility criteria|0|||
124661682|NCT05052697|448383631|FG027|Substudy A|No longer met eligibility criteria|0|||
124661683|NCT05052697|448383632|FG028|Substudy A|No longer met eligibility criteria|0|||
124661684|NCT05052697|448383633|FG029|Substudy A|No longer met eligibility criteria|0|||
124661685|NCT05052697|448383634|FG030|Substudy A|No longer met eligibility criteria|0|||
124661686|NCT05052697|448383635|FG031|Substudy A|No longer met eligibility criteria|0|||
124661687|NCT05052697|448383636|FG032|Substudy A|No longer met eligibility criteria|0|||
124661688|NCT05052697|448383637|FG033|Substudy A|No longer met eligibility criteria|0|||
124661689|NCT05052697|448383604|FG000|Substudy A|Not vaccinated|0|||
124661690|NCT05052697|448383605|FG001|Substudy A|Not vaccinated|0|||
124661691|NCT05052697|448383606|FG002|Substudy A|Not vaccinated|0|||
124661692|NCT05052697|448383607|FG003|Substudy A|Not vaccinated|1|||
124661693|NCT05052697|448383608|FG004|Substudy A|Not vaccinated|0|||
124661694|NCT05052697|448383609|FG005|Substudy A|Not vaccinated|0|||
124661695|NCT05052697|448383610|FG006|Substudy A|Not vaccinated|0|||
124661696|NCT05052697|448383611|FG007|Substudy A|Not vaccinated|0|||
124661697|NCT05052697|448383612|FG008|Substudy A|Not vaccinated|1|||
124661698|NCT05052697|448383613|FG009|Substudy A|Not vaccinated|0|||
124661699|NCT05052697|448383614|FG010|Substudy A|Not vaccinated|0|||
124661700|NCT05052697|448383615|FG011|Substudy A|Not vaccinated|0|||
124661701|NCT05052697|448383616|FG012|Substudy A|Not vaccinated|0|||
124661702|NCT05052697|448383617|FG013|Substudy A|Not vaccinated|0|||
124661703|NCT05052697|448383618|FG014|Substudy A|Not vaccinated|0|||
124661704|NCT05052697|448383619|FG015|Substudy A|Not vaccinated|0|||
124661705|NCT05052697|448383620|FG016|Substudy A|Not vaccinated|0|||
124661706|NCT05052697|448383621|FG017|Substudy A|Not vaccinated|0|||
124661707|NCT05052697|448383622|FG018|Substudy A|Not vaccinated|0|||
124661708|NCT05052697|448383623|FG019|Substudy A|Not vaccinated|0|||
124661709|NCT05052697|448383624|FG020|Substudy A|Not vaccinated|0|||
124661710|NCT05052697|448383625|FG021|Substudy A|Not vaccinated|0|||
124661711|NCT05052697|448383626|FG022|Substudy A|Not vaccinated|0|||
124661712|NCT05052697|448383627|FG023|Substudy A|Not vaccinated|0|||
124661713|NCT05052697|448383628|FG024|Substudy A|Not vaccinated|0|||
124661714|NCT05052697|448383629|FG025|Substudy A|Not vaccinated|0|||
124661715|NCT05052697|448383630|FG026|Substudy A|Not vaccinated|0|||
124661716|NCT05052697|448383631|FG027|Substudy A|Not vaccinated|0|||
124661717|NCT05052697|448383632|FG028|Substudy A|Not vaccinated|0|||
124661718|NCT05052697|448383633|FG029|Substudy A|Not vaccinated|0|||
124661719|NCT05052697|448383634|FG030|Substudy A|Not vaccinated|0|||
124661720|NCT05052697|448383635|FG031|Substudy A|Not vaccinated|0|||
124661721|NCT05052697|448383636|FG032|Substudy A|Not vaccinated|0|||
124661722|NCT05052697|448383637|FG033|Substudy A|Not vaccinated|0|||
124661723|NCT05052697|448383604|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661724|NCT05052697|448383605|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661725|NCT05052697|448383606|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661726|NCT05052697|448383607|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661727|NCT05052697|448383608|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661728|NCT05052697|448383609|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661729|NCT05052697|448383610|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661730|NCT05052697|448383611|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661731|NCT05052697|448383612|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661732|NCT05052697|448383613|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661733|NCT05052697|448383614|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661734|NCT05052697|448383615|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661735|NCT05052697|448383616|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661736|NCT05052697|448383617|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661737|NCT05052697|448383618|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661738|NCT05052697|448383619|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661739|NCT05052697|448383620|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661740|NCT05052697|448383621|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661741|NCT05052697|448383622|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
124661742|NCT05052697|448383623|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
124661743|NCT05052697|448383624|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661744|NCT05052697|448383625|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
124661745|NCT05052697|448383626|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
124661746|NCT05052697|448383627|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661747|NCT05052697|448383628|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661748|NCT05052697|448383629|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661749|NCT05052697|448383630|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661750|NCT05052697|448383631|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661751|NCT05052697|448383632|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661752|NCT05052697|448383633|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661753|NCT05052697|448383634|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661754|NCT05052697|448383635|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661755|NCT05052697|448383636|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661756|NCT05052697|448383637|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
124661757|NCT05052697|448383604|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661758|NCT05052697|448383605|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661759|NCT05052697|448383606|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661760|NCT05052697|448383607|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661761|NCT05052697|448383608|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661762|NCT05052697|448383609|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661763|NCT05052697|448383610|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661764|NCT05052697|448383611|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661765|NCT05052697|448383612|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661766|NCT05052697|448383613|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661767|NCT05052697|448383614|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661768|NCT05052697|448383615|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661769|NCT05052697|448383616|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661770|NCT05052697|448383617|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661771|NCT05052697|448383618|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661772|NCT05052697|448383619|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661773|NCT05052697|448383620|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661774|NCT05052697|448383621|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
124661775|NCT05052697|448383622|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661776|NCT05052697|448383623|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661777|NCT05052697|448383624|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661778|NCT05052697|448383625|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661779|NCT05052697|448383626|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661780|NCT05052697|448383627|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661781|NCT05052697|448383628|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661782|NCT05052697|448383629|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661783|NCT05052697|448383630|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661784|NCT05052697|448383631|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661785|NCT05052697|448383632|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661786|NCT05052697|448383633|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661787|NCT05052697|448383634|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661788|NCT05052697|448383635|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661789|NCT05052697|448383636|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661790|NCT05052697|448383637|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
124661791|NCT05052697|448383604|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661792|NCT05052697|448383605|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661793|NCT05052697|448383606|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661794|NCT05052697|448383607|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661795|NCT05052697|448383608|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661796|NCT05052697|448383609|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661797|NCT05052697|448383610|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661798|NCT05052697|448383611|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661799|NCT05052697|448383612|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661800|NCT05052697|448383613|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661801|NCT05052697|448383614|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661802|NCT05052697|448383615|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661803|NCT05052697|448383616|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661804|NCT05052697|448383617|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661805|NCT05052697|448383618|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661806|NCT05052697|448383619|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661807|NCT05052697|448383620|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661808|NCT05052697|448383621|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661809|NCT05052697|448383622|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661810|NCT05052697|448383623|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
124661811|NCT05052697|448383624|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661812|NCT05052697|448383625|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661813|NCT05052697|448383626|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661814|NCT05052697|448383627|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661815|NCT05052697|448383628|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661816|NCT05052697|448383629|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661817|NCT05052697|448383630|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661818|NCT05052697|448383631|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661819|NCT05052697|448383632|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661820|NCT05052697|448383633|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661821|NCT05052697|448383634|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661822|NCT05052697|448383635|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661823|NCT05052697|448383636|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661824|NCT05052697|448383637|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
124661825|NCT05052697|448383604|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661826|NCT05052697|448383605|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661827|NCT05052697|448383606|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661828|NCT05052697|448383607|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661829|NCT05052697|448383608|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661830|NCT05052697|448383609|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661831|NCT05052697|448383610|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661832|NCT05052697|448383611|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661833|NCT05052697|448383612|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661834|NCT05052697|448383613|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661835|NCT05052697|448383614|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661836|NCT05052697|448383615|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661837|NCT05052697|448383616|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661838|NCT05052697|448383617|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661839|NCT05052697|448383618|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661840|NCT05052697|448383619|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661841|NCT05052697|448383620|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661842|NCT05052697|448383621|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
124661843|NCT05052697|448383622|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661844|NCT05052697|448383623|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661845|NCT05052697|448383624|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661846|NCT05052697|448383625|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661847|NCT05052697|448383626|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661848|NCT05052697|448383627|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661849|NCT05052697|448383628|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661850|NCT05052697|448383629|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
124661851|NCT05052697|448383630|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661852|NCT05052697|448383631|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
124661853|NCT05052697|448383632|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661854|NCT05052697|448383633|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661855|NCT05052697|448383634|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661856|NCT05052697|448383635|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661857|NCT05052697|448383636|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661858|NCT05052697|448383637|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
124661859|NCT05052697|448383604|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661860|NCT05052697|448383605|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661861|NCT05052697|448383606|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661862|NCT05052697|448383607|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661863|NCT05052697|448383608|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661864|NCT05052697|448383609|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661865|NCT05052697|448383610|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661866|NCT05052697|448383611|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661867|NCT05052697|448383612|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661868|NCT05052697|448383613|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661869|NCT05052697|448383614|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661870|NCT05052697|448383615|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661871|NCT05052697|448383616|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661872|NCT05052697|448383617|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661873|NCT05052697|448383618|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661874|NCT05052697|448383619|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661875|NCT05052697|448383620|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661876|NCT05052697|448383621|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661877|NCT05052697|448383622|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661878|NCT05052697|448383623|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661879|NCT05052697|448383624|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661880|NCT05052697|448383625|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661881|NCT05052697|448383626|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661882|NCT05052697|448383627|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661883|NCT05052697|448383628|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661884|NCT05052697|448383629|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661885|NCT05052697|448383630|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661886|NCT05052697|448383631|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661887|NCT05052697|448383632|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
124661888|NCT05052697|448383633|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661889|NCT05052697|448383634|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
124661890|NCT05052697|448383635|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
124661891|NCT05052697|448383636|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
124661892|NCT05052697|448383637|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
124661893|NCT05052697|448383604|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661894|NCT05052697|448383605|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661895|NCT05052697|448383606|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661896|NCT05052697|448383607|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661897|NCT05052697|448383608|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661898|NCT05052697|448383609|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661899|NCT05052697|448383610|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661900|NCT05052697|448383611|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661901|NCT05052697|448383612|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661902|NCT05052697|448383613|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661903|NCT05052697|448383614|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661904|NCT05052697|448383615|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661905|NCT05052697|448383616|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661906|NCT05052697|448383617|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661907|NCT05052697|448383618|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661908|NCT05052697|448383619|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661909|NCT05052697|448383620|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661910|NCT05052697|448383621|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661911|NCT05052697|448383622|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661912|NCT05052697|448383623|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661913|NCT05052697|448383624|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661914|NCT05052697|448383625|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661915|NCT05052697|448383626|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661916|NCT05052697|448383627|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661917|NCT05052697|448383628|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661918|NCT05052697|448383629|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661919|NCT05052697|448383630|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661920|NCT05052697|448383631|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661921|NCT05052697|448383632|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
124661922|NCT05052697|448383633|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
124661923|NCT05052697|448383634|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
124661924|NCT05052697|448383635|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
124661925|NCT05052697|448383636|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
124661926|NCT05052697|448383637|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
124661927|NCT05052697|448383604|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661928|NCT05052697|448383605|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661929|NCT05052697|448383606|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661930|NCT05052697|448383607|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661931|NCT05052697|448383608|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661932|NCT05052697|448383609|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661933|NCT05052697|448383610|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661934|NCT05052697|448383611|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661935|NCT05052697|448383612|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661936|NCT05052697|448383613|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661937|NCT05052697|448383614|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661938|NCT05052697|448383615|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661939|NCT05052697|448383616|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661940|NCT05052697|448383617|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661941|NCT05052697|448383618|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661942|NCT05052697|448383619|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661943|NCT05052697|448383620|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661944|NCT05052697|448383621|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661945|NCT05052697|448383622|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661946|NCT05052697|448383623|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661947|NCT05052697|448383624|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661948|NCT05052697|448383625|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661949|NCT05052697|448383626|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661950|NCT05052697|448383627|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661951|NCT05052697|448383628|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661952|NCT05052697|448383629|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661953|NCT05052697|448383630|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661954|NCT05052697|448383631|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661955|NCT05052697|448383632|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661956|NCT05052697|448383633|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661957|NCT05052697|448383634|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661958|NCT05052697|448383635|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661959|NCT05052697|448383636|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
124661960|NCT05052697|448383637|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
124661961|NCT05052697|448383604|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661962|NCT05052697|448383605|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661963|NCT05052697|448383606|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661964|NCT05052697|448383607|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661965|NCT05052697|448383608|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661966|NCT05052697|448383609|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661967|NCT05052697|448383610|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661968|NCT05052697|448383611|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661969|NCT05052697|448383612|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661970|NCT05052697|448383613|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661971|NCT05052697|448383614|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661972|NCT05052697|448383615|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661973|NCT05052697|448383616|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661974|NCT05052697|448383617|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661975|NCT05052697|448383618|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661976|NCT05052697|448383619|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661977|NCT05052697|448383620|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661978|NCT05052697|448383621|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661979|NCT05052697|448383622|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661980|NCT05052697|448383623|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661981|NCT05052697|448383624|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661982|NCT05052697|448383625|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661983|NCT05052697|448383626|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661984|NCT05052697|448383627|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661985|NCT05052697|448383628|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661986|NCT05052697|448383629|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661987|NCT05052697|448383630|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661988|NCT05052697|448383631|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661989|NCT05052697|448383632|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
124661990|NCT05052697|448383633|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
124661991|NCT05052697|448383634|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
124661992|NCT05052697|448383635|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661993|NCT05052697|448383636|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661994|NCT05052697|448383637|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
124661995|NCT01289574|448383638|FG000|Overall Study|Lack of Efficacy|4|||
124661996|NCT01289574|448383639|FG001|Overall Study|Lack of Efficacy|0|||
124661997|NCT01289574|448383640|FG002|Overall Study|Lack of Efficacy|1|||
124661998|NCT01289574|448383638|FG000|Overall Study|Lost to Follow-up|2|||
124661999|NCT01289574|448383639|FG001|Overall Study|Lost to Follow-up|0|||
124662000|NCT01289574|448383640|FG002|Overall Study|Lost to Follow-up|1|||
124662001|NCT01289574|448383638|FG000|Overall Study|Withdrawal by Subject|1|||
124662002|NCT01289574|448383639|FG001|Overall Study|Withdrawal by Subject|1|||
124662003|NCT01289574|448383640|FG002|Overall Study|Withdrawal by Subject|1|||
124662004|NCT01289574|448383638|FG000|Overall Study|Adverse Event|0|||
124662005|NCT01289574|448383639|FG001|Overall Study|Adverse Event|1|||
124662006|NCT01289574|448383640|FG002|Overall Study|Adverse Event|0|||
124662007|NCT01289574|448383638|FG000|Overall Study|Subject wanted alternate treatment|0|||
124662008|NCT01289574|448383639|FG001|Overall Study|Subject wanted alternate treatment|1|||
124662009|NCT01289574|448383640|FG002|Overall Study|Subject wanted alternate treatment|0|||
124662010|NCT00262002|448383641|FG000|Overall Study|Adverse Event|2|||
124662011|NCT00262002|448383642|FG001|Overall Study|Adverse Event|1|||
124662012|NCT00262002|448383643|FG002|Overall Study|Adverse Event|0|||
124662013|NCT00262002|448383644|FG003|Overall Study|Adverse Event|0|||
124662014|NCT00262002|448383645|FG004|Overall Study|Adverse Event|0|||
124662015|NCT00262002|448383646|FG005|Overall Study|Adverse Event|1|||
124662016|NCT00262002|448383647|FG006|Overall Study|Adverse Event|0|||
124662017|NCT00262002|448383641|FG000|Overall Study|Withdrawal by Subject|4|||
124662018|NCT00262002|448383642|FG001|Overall Study|Withdrawal by Subject|2|||
124662019|NCT00262002|448383643|FG002|Overall Study|Withdrawal by Subject|0|||
124662020|NCT00262002|448383644|FG003|Overall Study|Withdrawal by Subject|1|||
124662021|NCT00262002|448383645|FG004|Overall Study|Withdrawal by Subject|2|||
124662022|NCT00262002|448383646|FG005|Overall Study|Withdrawal by Subject|2|||
124662023|NCT00262002|448383647|FG006|Overall Study|Withdrawal by Subject|2|||
124662024|NCT00262002|448383641|FG000|Overall Study|Lost to Follow-up|2|||
124662025|NCT00262002|448383642|FG001|Overall Study|Lost to Follow-up|0|||
124662026|NCT00262002|448383643|FG002|Overall Study|Lost to Follow-up|0|||
124662027|NCT00262002|448383644|FG003|Overall Study|Lost to Follow-up|2|||
124662028|NCT00262002|448383645|FG004|Overall Study|Lost to Follow-up|0|||
124662029|NCT00262002|448383646|FG005|Overall Study|Lost to Follow-up|1|||
124662030|NCT00262002|448383647|FG006|Overall Study|Lost to Follow-up|0|||
124662031|NCT00262002|448383641|FG000|Overall Study|Inapropriate enrollment|0|||
124662032|NCT00262002|448383642|FG001|Overall Study|Inapropriate enrollment|1|||
124662033|NCT00262002|448383643|FG002|Overall Study|Inapropriate enrollment|0|||
124662034|NCT00262002|448383644|FG003|Overall Study|Inapropriate enrollment|0|||
124662035|NCT00262002|448383645|FG004|Overall Study|Inapropriate enrollment|0|||
124662036|NCT00262002|448383646|FG005|Overall Study|Inapropriate enrollment|0|||
124662037|NCT00262002|448383647|FG006|Overall Study|Inapropriate enrollment|0|||
124662038|NCT00262002|448383641|FG000|Overall Study|Protocol Violation|3|||
124662039|NCT00262002|448383642|FG001|Overall Study|Protocol Violation|2|||
124662040|NCT00262002|448383643|FG002|Overall Study|Protocol Violation|0|||
124662041|NCT00262002|448383644|FG003|Overall Study|Protocol Violation|2|||
124662042|NCT00262002|448383645|FG004|Overall Study|Protocol Violation|5|||
124662043|NCT00262002|448383646|FG005|Overall Study|Protocol Violation|3|||
124662044|NCT00262002|448383647|FG006|Overall Study|Protocol Violation|2|||
124662045|NCT00262002|448383641|FG000|Overall Study|Unable to classify|0|||
124662046|NCT00262002|448383642|FG001|Overall Study|Unable to classify|0|||
124662047|NCT00262002|448383643|FG002|Overall Study|Unable to classify|0|||
124662048|NCT00262002|448383644|FG003|Overall Study|Unable to classify|0|||
124662049|NCT00262002|448383645|FG004|Overall Study|Unable to classify|0|||
124662050|NCT00262002|448383646|FG005|Overall Study|Unable to classify|0|||
124662051|NCT00262002|448383647|FG006|Overall Study|Unable to classify|2|||
124662052|NCT01790516|448383648|FG000|Overall Study|Physician Decision|1|||
124662053|NCT01790516|448383649|FG001|Overall Study|Physician Decision|0|||
124662054|NCT01554163|448383650|FG000|Overall Study|Adverse Event|3|||
124662055|NCT01554163|448383651|FG001|Overall Study|Adverse Event|0|||
124662056|NCT01554163|448383650|FG000|Overall Study|Lack of Efficacy|1|||
124662057|NCT01554163|448383651|FG001|Overall Study|Lack of Efficacy|0|||
124662058|NCT01554163|448383650|FG000|Overall Study|Lost to Follow-up|1|||
124662059|NCT01554163|448383651|FG001|Overall Study|Lost to Follow-up|0|||
124662060|NCT01554163|448383650|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124662061|NCT01554163|448383651|FG001|Overall Study|Non-Compliance With Study Drug|1|||
124662062|NCT01554163|448383650|FG000|Overall Study|Protocol Violation|0|||
124662063|NCT01554163|448383651|FG001|Overall Study|Protocol Violation|4|||
124662064|NCT01554163|448383650|FG000|Overall Study|Withdrawal by Subject|1|||
124662065|NCT01554163|448383651|FG001|Overall Study|Withdrawal by Subject|5|||
124662066|NCT01554163|448383650|FG000|Overall Study|Not Treated|1|||
124662067|NCT01554163|448383651|FG001|Overall Study|Not Treated|0|||
124662068|NCT03034135|448383652|FG000|Overall Study|Withdrawal by Subject|2|||
124662069|NCT01972464|448383653|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
124662070|NCT01972464|448383654|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
124662071|NCT01972464|448383653|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
124662072|NCT01972464|448383654|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
124662073|NCT01972464|448383653|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
124662074|NCT01972464|448383654|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
124662075|NCT01972464|448383653|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
124662076|NCT01972464|448383654|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
124662077|NCT01133704|448385363|FG000|Overall Study|Death|44|||
124662078|NCT01133704|448385364|FG001|Overall Study|Death|26|||
124662079|NCT01133704|448385363|FG000|Overall Study|Patient refused to continue|4|||
124662080|NCT01133704|448385364|FG001|Overall Study|Patient refused to continue|0|||
124662081|NCT01133704|448385363|FG000|Overall Study|Study Closure|1|||
124662082|NCT01133704|448385364|FG001|Overall Study|Study Closure|0|||
124662083|NCT04985942|448385367|FG000|Overall Study|Adverse Event|14|||
124662084|NCT04985942|448385368|FG001|Overall Study|Adverse Event|2|||
124662085|NCT04985942|448385367|FG000|Overall Study|Lack of Efficacy|0|||
124662086|NCT04985942|448385368|FG001|Overall Study|Lack of Efficacy|3|||
124662087|NCT04985942|448385367|FG000|Overall Study|Lost to Follow-up|1|||
124662088|NCT04985942|448385368|FG001|Overall Study|Lost to Follow-up|1|||
124662089|NCT04985942|448385367|FG000|Overall Study|Protocol Violation|1|||
124662090|NCT04985942|448385368|FG001|Overall Study|Protocol Violation|1|||
124662091|NCT04985942|448385367|FG000|Overall Study|Withdrawal by Subject|5|||
124662092|NCT04985942|448385368|FG001|Overall Study|Withdrawal by Subject|4|||
124662093|NCT02849704|448385370|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
124662094|NCT02849704|448385371|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
124662095|NCT02849704|448385370|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
124662096|NCT02849704|448385371|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
124662097|NCT02849704|448385370|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
124662098|NCT02849704|448385371|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
124662099|NCT02576977|448385374|FG000|Overall Study|Adverse Event|13|||
124662100|NCT02576977|448385375|FG001|Overall Study|Adverse Event|2|||
124662101|NCT02576977|448385374|FG000|Overall Study|Death|73|||
124662102|NCT02576977|448385375|FG001|Overall Study|Death|60|||
124662103|NCT02576977|448385374|FG000|Overall Study|Screen failure|1|||
124662104|NCT02576977|448385375|FG001|Overall Study|Screen failure|0|||
124662105|NCT02576977|448385374|FG000|Overall Study|Study Terminated at Selected Sites|27|||
124662106|NCT02576977|448385375|FG001|Overall Study|Study Terminated at Selected Sites|50|||
124662107|NCT02576977|448385374|FG000|Overall Study|Withdrawal by Subject|11|||
124662108|NCT02576977|448385375|FG001|Overall Study|Withdrawal by Subject|11|||
124662109|NCT02576977|448385374|FG000|Overall Study|Final Disposition Unknown|0|||
124662110|NCT02576977|448385375|FG001|Overall Study|Final Disposition Unknown|1|||
124662111|NCT02576977|448385374|FG000|Overall Study|Lost to Follow-up|1|||
124662112|NCT02576977|448385375|FG001|Overall Study|Lost to Follow-up|0|||
124662113|NCT02576977|448385374|FG000|Overall Study|Progressive Disease|0|||
124662114|NCT02576977|448385375|FG001|Overall Study|Progressive Disease|1|||
124662115|NCT01128400|448385378|FG000|Overall Study|Lost to Follow-up|1|||
124662116|NCT01128400|448385379|FG001|Overall Study|Lost to Follow-up|0|||
124662117|NCT01128400|448385380|FG002|Overall Study|Lost to Follow-up|1|||
124662118|NCT01128400|448385378|FG000|Overall Study|Screening failure|1|||
124662119|NCT01128400|448385379|FG001|Overall Study|Screening failure|0|||
124662120|NCT01128400|448385380|FG002|Overall Study|Screening failure|0|||
124662121|NCT01128400|448385378|FG000|Overall Study|were not invited to participate on taste|0|||
124662122|NCT01128400|448385379|FG001|Overall Study|were not invited to participate on taste|0|||
124662123|NCT01128400|448385380|FG002|Overall Study|were not invited to participate on taste|15|||
124662124|NCT01128400|448385378|FG000|Overall Study|Excluded due to sinus problems|0|||
124662125|NCT01128400|448385379|FG001|Overall Study|Excluded due to sinus problems|1|||
124662126|NCT01128400|448385380|FG002|Overall Study|Excluded due to sinus problems|0|||
124662127|NCT00885378|448385390|FG000|Overall Study|Lack of Efficacy|2|||
124662128|NCT00885378|448385391|FG001|Overall Study|Lack of Efficacy|2|||
124662129|NCT00885378|448385390|FG000|Overall Study|Withdrawal by Subject|1|||
124662130|NCT00885378|448385391|FG001|Overall Study|Withdrawal by Subject|2|||
124662131|NCT00885378|448385390|FG000|Overall Study|Lost to Follow-up|1|||
124662132|NCT00885378|448385391|FG001|Overall Study|Lost to Follow-up|2|||
124662133|NCT00885378|448385390|FG000|Overall Study|Poor/Noncompliance|2|||
124662134|NCT00885378|448385391|FG001|Overall Study|Poor/Noncompliance|2|||
124662135|NCT00885378|448385390|FG000|Overall Study|Protocol Violation|2|||
124662136|NCT00885378|448385391|FG001|Overall Study|Protocol Violation|0|||
124662137|NCT04750278|448385393|FG000|Overall Study|Death|9|||
124662138|NCT04750278|448385394|FG001|Overall Study|Death|10|||
124662139|NCT04750278|448385395|FG002|Overall Study|Death|10|||
124662140|NCT04750278|448385393|FG000|Overall Study|Withdrawal by Subject|4|||
124662141|NCT04750278|448385394|FG001|Overall Study|Withdrawal by Subject|1|||
124662142|NCT04750278|448385395|FG002|Overall Study|Withdrawal by Subject|2|||
124662143|NCT04750278|448385393|FG000|Overall Study|Lost to Follow-up|1|||
124662144|NCT04750278|448385394|FG001|Overall Study|Lost to Follow-up|1|||
124662145|NCT04750278|448385395|FG002|Overall Study|Lost to Follow-up|1|||
124662146|NCT04750278|448385393|FG000|Overall Study|Pregnancy|1|||
124662147|NCT04750278|448385394|FG001|Overall Study|Pregnancy|0|||
124662148|NCT04750278|448385395|FG002|Overall Study|Pregnancy|0|||
124662149|NCT04750278|448385393|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
124662150|NCT04750278|448385394|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
124662151|NCT04750278|448385395|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
124662152|NCT04750278|448385393|FG000|Overall Study|Non-compliance|0|||
124662153|NCT04750278|448385394|FG001|Overall Study|Non-compliance|0|||
124662154|NCT04750278|448385395|FG002|Overall Study|Non-compliance|1|||
124662155|NCT04750278|448385393|FG000|Overall Study|Transfer to Outside Facility|0|||
124662156|NCT04750278|448385394|FG001|Overall Study|Transfer to Outside Facility|2|||
124662157|NCT04750278|448385395|FG002|Overall Study|Transfer to Outside Facility|1|||
124662158|NCT04750278|448385393|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
124662159|NCT04750278|448385394|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
124662160|NCT04750278|448385395|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
124662161|NCT04750278|448385393|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
124662162|NCT04750278|448385394|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
124662163|NCT04750278|448385395|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
124662164|NCT01616758|448385397|FG000|Overall Study|Adverse Event|1|||
124662165|NCT01616758|448385397|FG000|Overall Study|Withdrawal by Subject|2|||
124662166|NCT01616758|448385397|FG000|Overall Study|Disease progression|18|||
124662167|NCT01616758|448385397|FG000|Overall Study|Study termination by Sponsor|1|||
124662168|NCT04076319|448385402|FG000|Overall Study|Withdrawal by Subject|2|||
124662169|NCT04076319|448385403|FG001|Overall Study|Withdrawal by Subject|0|||
124662170|NCT04076319|448385402|FG000|Overall Study|Death|1|||
124662171|NCT04076319|448385403|FG001|Overall Study|Death|0|||
124662172|NCT01054222|448385404|FG000|Overall Study|Lack of Efficacy|1|||
124662173|NCT01054222|448385404|FG000|Overall Study|Lost to Follow-up|4|||
124662174|NCT01054222|448385404|FG000|Overall Study|Withdrawal by Subject|6|||
124662175|NCT00824655|448385405|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
124662176|NCT00824655|448385406|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
124662177|NCT00824655|448385405|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
124662178|NCT00824655|448385406|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
124662179|NCT03504189|448385407|FG000|Overall Study|Withdrawal by Subject|1|||
124662180|NCT03504189|448385407|FG000|Overall Study|Screening Failure|1|||
124662181|NCT03504189|448385407|FG000|Overall Study|Device Failure|2|||
124662182|NCT04336475|448385408|FG000|Overall Study|pain|1|||
124662183|NCT04336475|448385409|FG001|Overall Study|pain|0|||
124662184|NCT04336475|448385408|FG000|Overall Study|upper respiratory infection|1|||
124662185|NCT04336475|448385409|FG001|Overall Study|upper respiratory infection|0|||
124662186|NCT04336475|448385408|FG000|Overall Study|Lost to Follow-up|0|||
124662187|NCT04336475|448385409|FG001|Overall Study|Lost to Follow-up|2|||
124662188|NCT03746405|448385425|FG000|Overall Study|Withdrawal by Subject|3|||
124662189|NCT03746405|448385426|FG001|Overall Study|Withdrawal by Subject|0|||
124662190|NCT03746405|448385425|FG000|Overall Study|technical difficulties|0|||
124662191|NCT03746405|448385426|FG001|Overall Study|technical difficulties|2|||
124662192|NCT01465230|448385428|FG000|Overall Study|Withdrawal by Subject|2|||
124662193|NCT02372383|448385432|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
124662194|NCT02372383|448385433|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
124662195|NCT02372383|448385434|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
124662196|NCT02171429|448385438|FG000|Overall Study|Other|0|||
124662197|NCT02171429|448385439|FG001|Overall Study|Other|1|||
124662198|NCT02171429|448385440|FG002|Overall Study|Other|1|||
124662199|NCT02171429|448385438|FG000|Overall Study|Non-Compliance|0|||
124662200|NCT02171429|448385439|FG001|Overall Study|Non-Compliance|0|||
124662201|NCT02171429|448385440|FG002|Overall Study|Non-Compliance|1|||
124662202|NCT02171429|448385438|FG000|Overall Study|Physician Decision|0|||
124662203|NCT02171429|448385439|FG001|Overall Study|Physician Decision|0|||
124662204|NCT02171429|448385440|FG002|Overall Study|Physician Decision|1|||
124662205|NCT02171429|448385438|FG000|Overall Study|Withdrawal by Subject|1|||
124662206|NCT02171429|448385439|FG001|Overall Study|Withdrawal by Subject|1|||
124662207|NCT02171429|448385440|FG002|Overall Study|Withdrawal by Subject|1|||
124662208|NCT02171429|448385438|FG000|Overall Study|Lost to Follow-up|0|||
124662209|NCT02171429|448385439|FG001|Overall Study|Lost to Follow-up|1|||
124662210|NCT02171429|448385440|FG002|Overall Study|Lost to Follow-up|0|||
124662211|NCT02171429|448385438|FG000|Overall Study|Death|0|||
124662212|NCT02171429|448385439|FG001|Overall Study|Death|0|||
124662213|NCT02171429|448385440|FG002|Overall Study|Death|1|||
124662214|NCT01704755|448385441|FG000|Overall Study|Adverse Event|4|||
124662215|NCT01704755|448385442|FG001|Overall Study|Adverse Event|1|||
124662216|NCT01704755|448385441|FG000|Overall Study|Lost to Follow-up|3|||
124662217|NCT01704755|448385442|FG001|Overall Study|Lost to Follow-up|4|||
124662218|NCT01704755|448385441|FG000|Overall Study|Withdrew consent|1|||
124662219|NCT01704755|448385442|FG001|Overall Study|Withdrew consent|1|||
124662220|NCT01704755|448385441|FG000|Overall Study|Other (not specified)|3|||
124662221|NCT01704755|448385442|FG001|Overall Study|Other (not specified)|1|||
124662222|NCT01704755|448385441|FG000|Overall Study|Withdrew consent and personal issues|1|||
124662223|NCT01704755|448385442|FG001|Overall Study|Withdrew consent and personal issues|0|||
124662224|NCT01763203|448385443|FG000|Overall Study|Death|4|||
124662225|NCT01763203|448385444|FG001|Overall Study|Death|7|||
124662226|NCT01763203|448385443|FG000|Overall Study|Lost to Follow-up|12|||
124662227|NCT01763203|448385444|FG001|Overall Study|Lost to Follow-up|12|||
124662228|NCT01763203|448385443|FG000|Overall Study|Withdrawal by Subject|8|||
124662229|NCT01763203|448385444|FG001|Overall Study|Withdrawal by Subject|12|||
124662230|NCT01763203|448385443|FG000|Overall Study|Moved out of study region|7|||
124662231|NCT01763203|448385444|FG001|Overall Study|Moved out of study region|10|||
124662232|NCT01763203|448385443|FG000|Overall Study|Physician Decision|2|||
124662233|NCT01763203|448385444|FG001|Overall Study|Physician Decision|1|||
124662234|NCT02187861|448385445|FG000|Overall Study|Adverse Event|2|||
124662235|NCT02187861|448385446|FG001|Overall Study|Adverse Event|1|||
124662236|NCT02187861|448385447|FG002|Overall Study|Adverse Event|2|||
124662237|NCT02187861|448385448|FG003|Overall Study|Adverse Event|1|||
124662238|NCT02187861|448385445|FG000|Overall Study|Death|0|||
124662239|NCT02187861|448385446|FG001|Overall Study|Death|3|||
124662240|NCT02187861|448385447|FG002|Overall Study|Death|1|||
124662241|NCT02187861|448385448|FG003|Overall Study|Death|2|||
124662242|NCT02187861|448385445|FG000|Overall Study|Physician Decision|0|||
124662243|NCT02187861|448385446|FG001|Overall Study|Physician Decision|1|||
124662244|NCT02187861|448385447|FG002|Overall Study|Physician Decision|0|||
124662245|NCT02187861|448385448|FG003|Overall Study|Physician Decision|3|||
124662246|NCT02187861|448385445|FG000|Overall Study|Progressive Disease|4|||
124662247|NCT02187861|448385446|FG001|Overall Study|Progressive Disease|42|||
124662248|NCT02187861|448385447|FG002|Overall Study|Progressive Disease|19|||
124662249|NCT02187861|448385448|FG003|Overall Study|Progressive Disease|22|||
124662250|NCT02187861|448385445|FG000|Overall Study|Withdrawal by Subject|0|||
124662251|NCT02187861|448385446|FG001|Overall Study|Withdrawal by Subject|0|||
124662252|NCT02187861|448385447|FG002|Overall Study|Withdrawal by Subject|3|||
124662253|NCT02187861|448385448|FG003|Overall Study|Withdrawal by Subject|3|||
124662254|NCT02187861|448385445|FG000|Overall Study|Other|0|||
124662255|NCT02187861|448385446|FG001|Overall Study|Other|1|||
124662256|NCT02187861|448385447|FG002|Overall Study|Other|7|||
124662257|NCT02187861|448385448|FG003|Overall Study|Other|1|||
124662258|NCT04105842|448385449|FG000|Overall Study|Withdrawal by Subject|2|||
124662259|NCT01639703|448385450|FG000|Overall Study|Withdrawal by Subject|5|||
124662260|NCT01639703|448385450|FG000|Overall Study|Other reason|7|||
124662261|NCT02768792|448385456|FG000|Overall Study|Adverse Event|1|||
124662262|NCT05980013|448385457|FG000|Overall Study|Withdrawal by Subject|0|||
124662263|NCT05980013|448385458|FG001|Overall Study|Withdrawal by Subject|1|||
124662264|NCT05980013|448385457|FG000|Overall Study|Device Error|0|||
124662265|NCT05980013|448385458|FG001|Overall Study|Device Error|1|||
124662266|NCT01768559|448385461|FG000|Overall Study|Randomized but not treated|0|||
124662267|NCT01768559|448385462|FG001|Overall Study|Randomized but not treated|0|||
124662268|NCT01768559|448385463|FG002|Overall Study|Randomized but not treated|1|||
124662269|NCT01768559|448385461|FG000|Overall Study|Adverse Event|15|||
124662270|NCT01768559|448385462|FG001|Overall Study|Adverse Event|2|||
124662271|NCT01768559|448385463|FG002|Overall Study|Adverse Event|5|||
124662272|NCT01768559|448385461|FG000|Overall Study|Lack of Efficacy|6|||
124662273|NCT01768559|448385462|FG001|Overall Study|Lack of Efficacy|4|||
124662274|NCT01768559|448385463|FG002|Overall Study|Lack of Efficacy|0|||
124662275|NCT01768559|448385461|FG000|Overall Study|Poor compliance to protocol|0|||
124662276|NCT01768559|448385462|FG001|Overall Study|Poor compliance to protocol|3|||
124662277|NCT01768559|448385463|FG002|Overall Study|Poor compliance to protocol|2|||
124662278|NCT01768559|448385461|FG000|Overall Study|Other than specified|9|||
124662279|NCT01768559|448385462|FG001|Overall Study|Other than specified|8|||
124662280|NCT01768559|448385463|FG002|Overall Study|Other than specified|5|||
124662281|NCT02782377|448385464|FG000|Overall Study|Physician Decision|5|||
124662282|NCT01188668|448385468|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
124662283|NCT01188668|448385468|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
124662284|NCT01188668|448385468|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
124662285|NCT00303472|448385469|FG000|Treatment Period|Adverse Event|0|||
124662286|NCT00303472|448385470|FG001|Treatment Period|Adverse Event|0|||
124662287|NCT00303472|448385471|FG002|Treatment Period|Adverse Event|0|||
124662288|NCT00303472|448385472|FG003|Treatment Period|Adverse Event|0|||
124662289|NCT00303472|448385473|FG004|Treatment Period|Adverse Event|1|||
124662290|NCT00303472|448385474|FG005|Treatment Period|Adverse Event|0|||
124662291|NCT00303472|448385475|FG006|Treatment Period|Adverse Event|0|||
124662292|NCT00303472|448385469|FG000|Treatment Period|Death|0|||
124662293|NCT00303472|448385470|FG001|Treatment Period|Death|0|||
124662294|NCT00303472|448385471|FG002|Treatment Period|Death|0|||
124662295|NCT00303472|448385472|FG003|Treatment Period|Death|1|||
124662296|NCT00303472|448385473|FG004|Treatment Period|Death|0|||
124662297|NCT00303472|448385474|FG005|Treatment Period|Death|0|||
124662298|NCT00303472|448385475|FG006|Treatment Period|Death|1|||
124662299|NCT00303472|448385469|FG000|Treatment Period|Withdrawal by Subject|0|||
124662300|NCT00303472|448385470|FG001|Treatment Period|Withdrawal by Subject|0|||
124662301|NCT00303472|448385471|FG002|Treatment Period|Withdrawal by Subject|0|||
124662302|NCT00303472|448385472|FG003|Treatment Period|Withdrawal by Subject|1|||
124662303|NCT00303472|448385473|FG004|Treatment Period|Withdrawal by Subject|0|||
124662304|NCT00303472|448385474|FG005|Treatment Period|Withdrawal by Subject|1|||
124662305|NCT00303472|448385475|FG006|Treatment Period|Withdrawal by Subject|0|||
124662306|NCT00303472|448385469|FG000|Treatment Period|Other|0|||
124662307|NCT00303472|448385470|FG001|Treatment Period|Other|0|||
124662308|NCT00303472|448385471|FG002|Treatment Period|Other|0|||
124662309|NCT00303472|448385472|FG003|Treatment Period|Other|0|||
124662310|NCT00303472|448385473|FG004|Treatment Period|Other|1|||
124662311|NCT00303472|448385474|FG005|Treatment Period|Other|0|||
124662312|NCT00303472|448385475|FG006|Treatment Period|Other|1|||
124662313|NCT00303472|448385469|FG000|Treatment Period|Disease Progression (to AML)|0|||
124662314|NCT00303472|448385470|FG001|Treatment Period|Disease Progression (to AML)|0|||
124662315|NCT00303472|448385471|FG002|Treatment Period|Disease Progression (to AML)|0|||
124662316|NCT00303472|448385472|FG003|Treatment Period|Disease Progression (to AML)|0|||
124662317|NCT00303472|448385473|FG004|Treatment Period|Disease Progression (to AML)|1|||
124662318|NCT00303472|448385474|FG005|Treatment Period|Disease Progression (to AML)|0|||
124662319|NCT00303472|448385475|FG006|Treatment Period|Disease Progression (to AML)|0|||
124662320|NCT00303472|448385469|FG000|Treatment Extension (Optional)|Adverse Event|1|||
124662321|NCT00303472|448385470|FG001|Treatment Extension (Optional)|Adverse Event|0|||
124662322|NCT00303472|448385471|FG002|Treatment Extension (Optional)|Adverse Event|1|||
124662323|NCT00303472|448385472|FG003|Treatment Extension (Optional)|Adverse Event|0|||
124662324|NCT00303472|448385473|FG004|Treatment Extension (Optional)|Adverse Event|0|||
124662325|NCT00303472|448385474|FG005|Treatment Extension (Optional)|Adverse Event|0|||
124662326|NCT00303472|448385475|FG006|Treatment Extension (Optional)|Adverse Event|0|||
124662327|NCT00303472|448385469|FG000|Treatment Extension (Optional)|Death|2|||
124662328|NCT00303472|448385470|FG001|Treatment Extension (Optional)|Death|0|||
124662329|NCT00303472|448385471|FG002|Treatment Extension (Optional)|Death|1|||
124662330|NCT00303472|448385472|FG003|Treatment Extension (Optional)|Death|0|||
124662331|NCT00303472|448385473|FG004|Treatment Extension (Optional)|Death|0|||
124662332|NCT00303472|448385474|FG005|Treatment Extension (Optional)|Death|0|||
124662333|NCT00303472|448385475|FG006|Treatment Extension (Optional)|Death|0|||
124662334|NCT00303472|448385469|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
124662335|NCT00303472|448385470|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
124662336|NCT00303472|448385471|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
124662337|NCT00303472|448385472|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
124662338|NCT00303472|448385473|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
124662339|NCT00303472|448385474|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
124662340|NCT00303472|448385475|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
124662341|NCT00303472|448385469|FG000|Treatment Extension (Optional)|Physician Decision|0|||
124662342|NCT00303472|448385470|FG001|Treatment Extension (Optional)|Physician Decision|4|||
124662343|NCT00303472|448385471|FG002|Treatment Extension (Optional)|Physician Decision|2|||
124662344|NCT00303472|448385472|FG003|Treatment Extension (Optional)|Physician Decision|3|||
124662345|NCT00303472|448385473|FG004|Treatment Extension (Optional)|Physician Decision|2|||
124662346|NCT00303472|448385474|FG005|Treatment Extension (Optional)|Physician Decision|0|||
124662347|NCT00303472|448385475|FG006|Treatment Extension (Optional)|Physician Decision|0|||
124662348|NCT00303472|448385469|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
124662349|NCT00303472|448385470|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
124662350|NCT00303472|448385471|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
124662351|NCT00303472|448385472|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
124662352|NCT00303472|448385473|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
124662353|NCT00303472|448385474|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
124662354|NCT00303472|448385475|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
124662355|NCT00303472|448385469|FG000|Treatment Extension (Optional)|Other|0|||
124662356|NCT00303472|448385470|FG001|Treatment Extension (Optional)|Other|2|||
124662357|NCT00303472|448385471|FG002|Treatment Extension (Optional)|Other|4|||
124662358|NCT00303472|448385472|FG003|Treatment Extension (Optional)|Other|2|||
124662359|NCT00303472|448385473|FG004|Treatment Extension (Optional)|Other|1|||
124662360|NCT00303472|448385474|FG005|Treatment Extension (Optional)|Other|0|||
124662361|NCT00303472|448385475|FG006|Treatment Extension (Optional)|Other|0|||
124662362|NCT00303472|448385469|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
124662363|NCT00303472|448385470|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
124662364|NCT00303472|448385471|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
124662365|NCT00303472|448385472|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
124662366|NCT00303472|448385473|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
124662367|NCT00303472|448385474|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
124662368|NCT00303472|448385475|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
124662369|NCT02081001|448385476|FG000|Overall Study|Adverse Event|0|||
124662370|NCT02081001|448385477|FG001|Overall Study|Adverse Event|0|||
124662371|NCT02081001|448385478|FG002|Overall Study|Adverse Event|0|||
124662372|NCT02081001|448385479|FG003|Overall Study|Adverse Event|0|||
124662373|NCT02081001|448385480|FG004|Overall Study|Adverse Event|1|||
124662374|NCT02081001|448385481|FG005|Overall Study|Adverse Event|0|||
124662375|NCT02081001|448385482|FG006|Overall Study|Adverse Event|0|||
124662376|NCT02081001|448385483|FG007|Overall Study|Adverse Event|0|||
124662377|NCT02081001|448385484|FG008|Overall Study|Adverse Event|0|||
124662378|NCT02081001|448385485|FG009|Overall Study|Adverse Event|0|||
124662379|NCT02081001|448385486|FG010|Overall Study|Adverse Event|0|||
124662380|NCT02081001|448385487|FG011|Overall Study|Adverse Event|0|||
124662381|NCT02347072|448385491|FG000|Overall Study|Adverse Event|2|||
124662382|NCT02347072|448385491|FG000|Overall Study|Withdrawal by Subject|6|||
124662383|NCT02347072|448385491|FG000|Overall Study|Physician Decision|1|||
124662384|NCT02347072|448385491|FG000|Overall Study|Lost to Follow-up|2|||
124662385|NCT02347072|448385491|FG000|Overall Study|Protocol Violation|1|||
124662386|NCT02347072|448385491|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
124662387|NCT03124537|448385495|FG000|Overall Study|Lost to Follow-up|3|||
124662388|NCT03124537|448385496|FG001|Overall Study|Lost to Follow-up|5|||
124662389|NCT03124537|448385495|FG000|Overall Study|App Crash, Incomplete Data|7|||
124662390|NCT03124537|448385496|FG001|Overall Study|App Crash, Incomplete Data|8|||
124662391|NCT03681184|448385499|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
124662392|NCT03681184|448385500|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
124662393|NCT00396383|448385503|FG000|Overall Study|Death|2|||
124662394|NCT00396383|448385503|FG000|Overall Study|Lost to Follow-up|1|||
124662395|NCT04318132|448385506|FG000|Overall Study|Protocol Violation|0|||
124662396|NCT04318132|448385507|FG001|Overall Study|Protocol Violation|0|||
124662397|NCT04318132|448385508|FG002|Overall Study|Protocol Violation|3|||
124662398|NCT04318132|448385509|FG003|Overall Study|Protocol Violation|0|||
124662399|NCT00585325|448385510|FG000|Overall Study|Withdrawal by Subject|1|||
124662400|NCT00585325|448385511|FG001|Overall Study|Withdrawal by Subject|1|||
124662401|NCT00893971|448385512|FG000|Overall Study|Physician Decision|3|||
124662402|NCT02526160|448387417|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
124662403|NCT02526160|448387418|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
124662404|NCT02526160|448387417|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
124662405|NCT02526160|448387418|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
124662406|NCT02526160|448387417|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
124662407|NCT02526160|448387418|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
124662408|NCT02526160|448387417|FG000|Open-Label Treatment Extension Period I|Death|0|||
124662409|NCT02526160|448387418|FG001|Open-Label Treatment Extension Period I|Death|1|||
124662410|NCT02526160|448387417|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
124662411|NCT02526160|448387418|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
124662412|NCT02526160|448387417|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
124662413|NCT02526160|448387418|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
124662414|NCT02526160|448387417|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
124662415|NCT02526160|448387418|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
124662416|NCT02526160|448387417|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
124662417|NCT02526160|448387418|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
124662418|NCT00314808|448387419|FG000|Overall Study|Disease Progression without AE|4|||
124662419|NCT00314808|448387419|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
124662420|NCT04304508|448387420|FG000|Overall Study|Subject Decision|29|||
124662421|NCT04304508|448387421|FG001|Overall Study|Subject Decision|39|||
124662422|NCT04304508|448387422|FG002|Overall Study|Subject Decision|37|||
124662423|NCT04304508|448387423|FG003|Overall Study|Subject Decision|48|||
124662424|NCT04304508|448387420|FG000|Overall Study|Death|6|||
124662425|NCT04304508|448387421|FG001|Overall Study|Death|1|||
124662426|NCT04304508|448387422|FG002|Overall Study|Death|8|||
124662427|NCT04304508|448387423|FG003|Overall Study|Death|5|||
124662428|NCT04304508|448387420|FG000|Overall Study|Non-compliance With Study Drug|3|||
124662429|NCT04304508|448387421|FG001|Overall Study|Non-compliance With Study Drug|1|||
124662430|NCT04304508|448387422|FG002|Overall Study|Non-compliance With Study Drug|2|||
124662431|NCT04304508|448387423|FG003|Overall Study|Non-compliance With Study Drug|0|||
124662432|NCT04304508|448387420|FG000|Overall Study|Switching To Other Therapy|1|||
124662433|NCT04304508|448387421|FG001|Overall Study|Switching To Other Therapy|1|||
124662434|NCT04304508|448387422|FG002|Overall Study|Switching To Other Therapy|1|||
124662435|NCT04304508|448387423|FG003|Overall Study|Switching To Other Therapy|2|||
124662436|NCT04304508|448387420|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
124662437|NCT04304508|448387421|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
124662438|NCT04304508|448387422|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
124662439|NCT04304508|448387423|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
124662440|NCT04304508|448387420|FG000|Overall Study|Withdrawal by Subject|7|||
124662441|NCT04304508|448387421|FG001|Overall Study|Withdrawal by Subject|5|||
124662442|NCT04304508|448387422|FG002|Overall Study|Withdrawal by Subject|11|||
124662443|NCT04304508|448387423|FG003|Overall Study|Withdrawal by Subject|6|||
124662444|NCT04304508|448387420|FG000|Overall Study|Logistical Difficulties|2|||
124662445|NCT04304508|448387421|FG001|Overall Study|Logistical Difficulties|2|||
124662446|NCT04304508|448387422|FG002|Overall Study|Logistical Difficulties|3|||
124662447|NCT04304508|448387423|FG003|Overall Study|Logistical Difficulties|2|||
124662448|NCT04304508|448387420|FG000|Overall Study|Missing Information|1|||
124662449|NCT04304508|448387421|FG001|Overall Study|Missing Information|2|||
124662450|NCT04304508|448387422|FG002|Overall Study|Missing Information|1|||
124662451|NCT04304508|448387423|FG003|Overall Study|Missing Information|3|||
124662452|NCT04304508|448387420|FG000|Overall Study|Other|7|||
124662453|NCT04304508|448387421|FG001|Overall Study|Other|6|||
124662454|NCT04304508|448387422|FG002|Overall Study|Other|5|||
124662455|NCT04304508|448387423|FG003|Overall Study|Other|4|||
124662456|NCT04304508|448387420|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
124662457|NCT04304508|448387421|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
124662458|NCT04304508|448387422|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
124662459|NCT04304508|448387423|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
124662460|NCT04304508|448387420|FG000|Overall Study|Physician Decision|3|||
124662461|NCT04304508|448387421|FG001|Overall Study|Physician Decision|4|||
124662462|NCT04304508|448387422|FG002|Overall Study|Physician Decision|9|||
124662463|NCT04304508|448387423|FG003|Overall Study|Physician Decision|7|||
124662464|NCT04304508|448387420|FG000|Overall Study|Study drug never administered|10|||
124662465|NCT04304508|448387421|FG001|Overall Study|Study drug never administered|4|||
124662466|NCT04304508|448387422|FG002|Overall Study|Study drug never administered|4|||
124662467|NCT04304508|448387423|FG003|Overall Study|Study drug never administered|4|||
124662468|NCT04304508|448387420|FG000|Overall Study|Adverse Event|49|||
124662469|NCT04304508|448387421|FG001|Overall Study|Adverse Event|50|||
124662470|NCT04304508|448387422|FG002|Overall Study|Adverse Event|51|||
124662471|NCT04304508|448387423|FG003|Overall Study|Adverse Event|56|||
124662472|NCT04304508|448387420|FG000|Overall Study|Lost to Follow-up|1|||
124662473|NCT04304508|448387421|FG001|Overall Study|Lost to Follow-up|5|||
124662474|NCT04304508|448387422|FG002|Overall Study|Lost to Follow-up|2|||
124662475|NCT04304508|448387423|FG003|Overall Study|Lost to Follow-up|3|||
124662476|NCT02688764|448387424|FG000|Overall Study|Adverse Event|3|||
124662477|NCT02688764|448387425|FG001|Overall Study|Adverse Event|3|||
124662478|NCT02688764|448387424|FG000|Overall Study|AE/Kidney transplant|1|||
124662479|NCT02688764|448387425|FG001|Overall Study|AE/Kidney transplant|0|||
124662480|NCT02688764|448387424|FG000|Overall Study|AE/Lack of efficacy|1|||
124662481|NCT02688764|448387425|FG001|Overall Study|AE/Lack of efficacy|0|||
124662482|NCT02688764|448387424|FG000|Overall Study|AE/Non-compl.|1|||
124662483|NCT02688764|448387425|FG001|Overall Study|AE/Non-compl.|0|||
124662484|NCT02688764|448387424|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
124662485|NCT02688764|448387425|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
124662486|NCT02688764|448387424|FG000|Overall Study|AE/Other|0|||
124662487|NCT02688764|448387425|FG001|Overall Study|AE/Other|1|||
124662488|NCT02688764|448387424|FG000|Overall Study|AE/Physician decision|1|||
124662489|NCT02688764|448387425|FG001|Overall Study|AE/Physician decision|0|||
124662490|NCT02688764|448387424|FG000|Overall Study|AE/Withd. parent|3|||
124662491|NCT02688764|448387425|FG001|Overall Study|AE/Withd. parent|0|||
124662492|NCT02688764|448387424|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
124662493|NCT02688764|448387425|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
124662494|NCT02688764|448387424|FG000|Overall Study|AE/Withd. subject|1|||
124662495|NCT02688764|448387425|FG001|Overall Study|AE/Withd. subject|0|||
124662496|NCT02688764|448387424|FG000|Overall Study|Kidney transplant|10|||
124662497|NCT02688764|448387425|FG001|Overall Study|Kidney transplant|4|||
124662498|NCT02688764|448387424|FG000|Overall Study|Lack of Efficacy|3|||
124662499|NCT02688764|448387425|FG001|Overall Study|Lack of Efficacy|2|||
124662500|NCT02688764|448387424|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
124662501|NCT02688764|448387425|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
124662502|NCT02688764|448387424|FG000|Overall Study|Non-compliance with study drug|4|||
124662503|NCT02688764|448387425|FG001|Overall Study|Non-compliance with study drug|0|||
124662504|NCT02688764|448387424|FG000|Overall Study|Non-compl./Physician decision|2|||
124662505|NCT02688764|448387425|FG001|Overall Study|Non-compl./Physician decision|0|||
124662506|NCT02688764|448387424|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
124662507|NCT02688764|448387425|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
124662508|NCT02688764|448387424|FG000|Overall Study|Non-compl./Withd. subject|0|||
124662509|NCT02688764|448387425|FG001|Overall Study|Non-compl./Withd. subject|2|||
124662510|NCT02688764|448387424|FG000|Overall Study|Phosphorus level outside safe range|0|||
124662511|NCT02688764|448387425|FG001|Overall Study|Phosphorus level outside safe range|1|||
124662512|NCT02688764|448387424|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
124662513|NCT02688764|448387425|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
124662514|NCT02688764|448387424|FG000|Overall Study|Study drug taste/Withd. parent|1|||
124662515|NCT02688764|448387425|FG001|Overall Study|Study drug taste/Withd. parent|0|||
124662516|NCT02688764|448387424|FG000|Overall Study|Subject moving out|2|||
124662517|NCT02688764|448387425|FG001|Overall Study|Subject moving out|0|||
124662518|NCT02688764|448387424|FG000|Overall Study|Subject taken off dialysis|1|||
124662519|NCT02688764|448387425|FG001|Overall Study|Subject taken off dialysis|0|||
124662520|NCT02688764|448387424|FG000|Overall Study|Withdrawal by parent|3|||
124662521|NCT02688764|448387425|FG001|Overall Study|Withdrawal by parent|0|||
124662522|NCT02113007|448387426|FG000|Overall Study|Progressive disease|2|||
124662523|NCT01775787|448387427|FG000|First 7-10 Days|Adverse Event|0|||
124662524|NCT01775787|448387428|FG001|First 7-10 Days|Adverse Event|1|||
124662525|NCT01775787|448387427|FG000|First 7-10 Days|family emergency|0|||
124662526|NCT01775787|448387428|FG001|First 7-10 Days|family emergency|1|||
124662527|NCT01775787|448387427|FG000|First 7-10 Days|time commitment|0|||
124662528|NCT01775787|448387428|FG001|First 7-10 Days|time commitment|2|||
124662529|NCT01775787|448387427|FG000|First 7-10 Days|concerns with using IV|1|||
124662530|NCT01775787|448387428|FG001|First 7-10 Days|concerns with using IV|2|||
124662531|NCT01775787|448387427|FG000|Second 7-10 Days|time commitment|0|||
124662532|NCT01775787|448387428|FG001|Second 7-10 Days|time commitment|1|||
124662533|NCT01775787|448387427|FG000|Second 7-10 Days|concerns with using IV|0|||
124662534|NCT01775787|448387428|FG001|Second 7-10 Days|concerns with using IV|1|||
124662535|NCT03252145|448387432|FG000|Overall Study|Withdrawal by Subject|1|||
124662536|NCT03252145|448387433|FG001|Overall Study|Withdrawal by Subject|0|||
124662537|NCT03252145|448387432|FG000|Overall Study|Complicating Disease|1|||
124662538|NCT03252145|448387433|FG001|Overall Study|Complicating Disease|2|||
124662539|NCT03091738|448387434|FG000|Overall Study|Adverse Event|1|||
124662540|NCT03091738|448387434|FG000|Overall Study|Lost to Follow-up|1|||
124662541|NCT00199849|448387439|FG000|Overall Study|Unrelated illness or complication|0|||
124662542|NCT00199849|448387440|FG001|Overall Study|Unrelated illness or complication|1|||
124662543|NCT00199849|448387441|FG002|Overall Study|Unrelated illness or complication|0|||
124662544|NCT00199849|448387439|FG000|Overall Study|Progressive disease requiring intervention|0|||
124662545|NCT00199849|448387440|FG001|Overall Study|Progressive disease requiring intervention|0|||
124662546|NCT00199849|448387441|FG002|Overall Study|Progressive disease requiring intervention|1|||
124662547|NCT00199849|448387439|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
124662548|NCT00199849|448387440|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
124662549|NCT00199849|448387441|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
124662550|NCT00759655|448387446|FG000|Overall Study|Termination of the study by sponsor|1|||
124662551|NCT03479008|448387450|FG000|Overall Study|Withdrawal by Subject|3|||
124662552|NCT01490840|448387451|FG000|Phase 1|Lost to Follow-up|1|||
124662553|NCT01490840|448387452|FG001|Phase 1|Lost to Follow-up|0|||
124662554|NCT01490840|448387451|FG000|Phase 1|Adverse Event|2|||
124662555|NCT01490840|448387452|FG001|Phase 1|Adverse Event|1|||
124662556|NCT01490840|448387451|FG000|Phase 1|Withdrawal by Subject|6|||
124662557|NCT01490840|448387452|FG001|Phase 1|Withdrawal by Subject|5|||
124662558|NCT01490840|448387451|FG000|Phase 1|Visit 6a omitted|1|||
124662559|NCT01490840|448387452|FG001|Phase 1|Visit 6a omitted|0|||
124662560|NCT01490840|448387451|FG000|Phase 2|Withdrawal by Subject|4|||
124662561|NCT01490840|448387452|FG001|Phase 2|Withdrawal by Subject|3|||
124662562|NCT01490840|448387451|FG000|Phase 2|Permanent interruption of fingolimod|0|||
124662563|NCT01490840|448387452|FG001|Phase 2|Permanent interruption of fingolimod|1|||
124662564|NCT01490840|448387451|FG000|Phase 2|Lost to Follow-up|1|||
124662565|NCT01490840|448387452|FG001|Phase 2|Lost to Follow-up|1|||
124662566|NCT01490840|448387451|FG000|Phase 2|Adverse Event|1|||
124662567|NCT01490840|448387452|FG001|Phase 2|Adverse Event|1|||
124662568|NCT01738919|448387458|FG000|Overall Study|Lost to Follow-up|1|||
124662569|NCT01738919|448387459|FG001|Overall Study|Lost to Follow-up|0|||
124662570|NCT01738919|448387458|FG000|Overall Study|Immigrated|0|||
124662571|NCT01738919|448387459|FG001|Overall Study|Immigrated|1|||
124662572|NCT01738919|448387458|FG000|Overall Study|Withdrawal by Subject|0|||
124662573|NCT01738919|448387459|FG001|Overall Study|Withdrawal by Subject|1|||
124662574|NCT01738919|448387458|FG000|Overall Study|Not treated in accordance to guidelines|0|||
124662575|NCT01738919|448387459|FG001|Overall Study|Not treated in accordance to guidelines|1|||
124662576|NCT00741598|448387463|FG000|Overall Study|Lost to Follow-up|3|||
124662577|NCT00741598|448387464|FG001|Overall Study|Lost to Follow-up|4|||
124662578|NCT00741598|448387463|FG000|Overall Study|Lack of Efficacy|1|||
124662579|NCT00741598|448387464|FG001|Overall Study|Lack of Efficacy|2|||
124662580|NCT00741598|448387463|FG000|Overall Study|Physician Decision|1|||
124662581|NCT00741598|448387464|FG001|Overall Study|Physician Decision|1|||
124662582|NCT00741598|448387463|FG000|Overall Study|Pregnancy|1|||
124662583|NCT00741598|448387464|FG001|Overall Study|Pregnancy|0|||
124662584|NCT00741598|448387463|FG000|Overall Study|Withdrawal by Subject|3|||
124662585|NCT00741598|448387464|FG001|Overall Study|Withdrawal by Subject|2|||
124662586|NCT02087670|448387465|FG000|Overall Study|Withdrawal by Subject|3|||
124662587|NCT02087670|448387466|FG001|Overall Study|Withdrawal by Subject|2|||
124662588|NCT01042392|448387467|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
124662589|NCT01042392|448387468|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
124662590|NCT01042392|448387469|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
124662591|NCT01042392|448387470|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
124662592|NCT01042392|448387467|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
124662593|NCT01042392|448387468|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
124662594|NCT01042392|448387469|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
124662595|NCT01042392|448387470|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
124662596|NCT01042392|448387467|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
124662597|NCT01042392|448387468|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
124662598|NCT01042392|448387469|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
124662599|NCT01042392|448387470|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
124662600|NCT01042392|448387467|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
124662601|NCT01042392|448387468|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
124662602|NCT01042392|448387469|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
124662603|NCT01042392|448387470|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
124662604|NCT01042392|448387467|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
124662605|NCT01042392|448387468|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
124662606|NCT01042392|448387469|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
124662607|NCT01042392|448387470|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
124662608|NCT01042392|448387467|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
124662609|NCT01042392|448387468|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
124662610|NCT01042392|448387469|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
124662611|NCT01042392|448387470|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
124662612|NCT01042392|448387467|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
124662613|NCT01042392|448387468|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
124662614|NCT01042392|448387469|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
124662615|NCT01042392|448387470|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
124662616|NCT01042392|448387467|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
124662617|NCT01042392|448387468|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
124662618|NCT01042392|448387469|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
124662619|NCT01042392|448387470|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
124662620|NCT01042392|448387467|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
124662621|NCT01042392|448387468|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
124662622|NCT01042392|448387469|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
124662623|NCT01042392|448387470|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
124662624|NCT02869893|448387473|FG000|Overall Study|participant aversion to IV|5|||
124662625|NCT02869893|448387473|FG000|Overall Study|participant fear of MRI scanner|2|||
124662626|NCT00435461|448387476|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
124662627|NCT00435461|448387477|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
124662628|NCT00435461|448387478|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
124662629|NCT00435461|448387476|FG000|Overall Study|Protocol Violation|6|||
124662630|NCT00435461|448387477|FG001|Overall Study|Protocol Violation|9|||
124662631|NCT00435461|448387478|FG002|Overall Study|Protocol Violation|10|||
124662632|NCT00435461|448387476|FG000|Overall Study|Participant randomized(inadequate score)|1|||
124662633|NCT00435461|448387477|FG001|Overall Study|Participant randomized(inadequate score)|0|||
124662634|NCT00435461|448387478|FG002|Overall Study|Participant randomized(inadequate score)|0|||
124662635|NCT00435461|448387476|FG000|Overall Study|Compliance less than 80 percent|1|||
124662636|NCT00435461|448387477|FG001|Overall Study|Compliance less than 80 percent|0|||
124662637|NCT00435461|448387478|FG002|Overall Study|Compliance less than 80 percent|0|||
124662638|NCT00435461|448387476|FG000|Overall Study|In error, two study medications switched|1|||
124662639|NCT00435461|448387477|FG001|Overall Study|In error, two study medications switched|0|||
124662640|NCT00435461|448387478|FG002|Overall Study|In error, two study medications switched|0|||
124662641|NCT00435461|448387476|FG000|Overall Study|Lack of Efficacy|2|||
124662642|NCT00435461|448387477|FG001|Overall Study|Lack of Efficacy|1|||
124662643|NCT00435461|448387478|FG002|Overall Study|Lack of Efficacy|0|||
124662644|NCT00435461|448387476|FG000|Overall Study|Withdrawal by Subject|1|||
124662645|NCT00435461|448387477|FG001|Overall Study|Withdrawal by Subject|0|||
124662646|NCT00435461|448387478|FG002|Overall Study|Withdrawal by Subject|2|||
124662647|NCT00435461|448387476|FG000|Overall Study|Randomized in error|1|||
124662648|NCT00435461|448387477|FG001|Overall Study|Randomized in error|0|||
124662649|NCT00435461|448387478|FG002|Overall Study|Randomized in error|0|||
124662650|NCT00435461|448387476|FG000|Overall Study|Participant could not tolerate symptoms|0|||
124662651|NCT00435461|448387477|FG001|Overall Study|Participant could not tolerate symptoms|0|||
124662652|NCT00435461|448387478|FG002|Overall Study|Participant could not tolerate symptoms|1|||
124662653|NCT00435461|448387476|FG000|Overall Study|Participant could not swallow capsule|0|||
124662654|NCT00435461|448387477|FG001|Overall Study|Participant could not swallow capsule|0|||
124662655|NCT00435461|448387478|FG002|Overall Study|Participant could not swallow capsule|1|||
124662656|NCT00435461|448387476|FG000|Overall Study|Pregnancy|2|||
124662657|NCT00435461|448387477|FG001|Overall Study|Pregnancy|0|||
124662658|NCT00435461|448387478|FG002|Overall Study|Pregnancy|0|||
124662659|NCT00435461|448387476|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
124662660|NCT00435461|448387477|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
124662661|NCT00435461|448387478|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
124662662|NCT00435461|448387476|FG000|Overall Study|Participant ended study one day early|1|||
124662663|NCT00435461|448387477|FG001|Overall Study|Participant ended study one day early|0|||
124662664|NCT00435461|448387478|FG002|Overall Study|Participant ended study one day early|0|||
124662665|NCT00435461|448387476|FG000|Overall Study|Noncompliance with study requirements|1|||
124662666|NCT00435461|448387477|FG001|Overall Study|Noncompliance with study requirements|1|||
124662667|NCT00435461|448387478|FG002|Overall Study|Noncompliance with study requirements|1|||
124662668|NCT00435461|448387476|FG000|Overall Study|Adverse Event|1|||
124662669|NCT00435461|448387477|FG001|Overall Study|Adverse Event|2|||
124662670|NCT00435461|448387478|FG002|Overall Study|Adverse Event|6|||
124662671|NCT00435461|448387476|FG000|Overall Study|Non-Compliance of diary|2|||
124662672|NCT00435461|448387477|FG001|Overall Study|Non-Compliance of diary|0|||
124662673|NCT00435461|448387478|FG002|Overall Study|Non-Compliance of diary|1|||
124662674|NCT00435461|448387476|FG000|Overall Study|Lost to Follow-up|1|||
124662675|NCT00435461|448387477|FG001|Overall Study|Lost to Follow-up|1|||
124662676|NCT00435461|448387478|FG002|Overall Study|Lost to Follow-up|2|||
124662677|NCT00837967|448387479|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
124662678|NCT00837967|448387480|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
124662679|NCT00551525|448387483|FG000|Overall Study|Protocol Violation|5|||
124662680|NCT04676724|448387484|FG000|Overall Study|Adverse Event|2|||
124662681|NCT04676724|448387485|FG001|Overall Study|Adverse Event|0|||
124662682|NCT04676724|448387484|FG000|Overall Study|Lost to Follow-up|1|||
124662683|NCT04676724|448387485|FG001|Overall Study|Lost to Follow-up|0|||
124662684|NCT04676724|448387484|FG000|Overall Study|Physician Decision|0|||
124662685|NCT04676724|448387485|FG001|Overall Study|Physician Decision|1|||
124662686|NCT04676724|448387484|FG000|Overall Study|Withdrawal by Subject|3|||
124662687|NCT04676724|448387485|FG001|Overall Study|Withdrawal by Subject|2|||
124662688|NCT02588092|448387499|FG000|Overall Study|Death|4|||
124662689|NCT02588092|448387500|FG001|Overall Study|Death|3|||
124662690|NCT02588092|448387501|FG002|Overall Study|Death|3|||
124662691|NCT02588092|448387502|FG003|Overall Study|Death|3|||
124662692|NCT02588092|448387503|FG004|Overall Study|Death|2|||
124662693|NCT02588092|448387504|FG005|Overall Study|Death|2|||
124662694|NCT02588092|448387505|FG006|Overall Study|Death|2|||
124662695|NCT02588092|448387506|FG007|Overall Study|Death|1|||
124662696|NCT02588092|448387507|FG008|Overall Study|Death|5|||
124662697|NCT02588092|448387508|FG009|Overall Study|Death|2|||
124662698|NCT02588092|448387499|FG000|Overall Study|Withdrawal by Subject|0|||
124662699|NCT02588092|448387500|FG001|Overall Study|Withdrawal by Subject|0|||
124662700|NCT02588092|448387501|FG002|Overall Study|Withdrawal by Subject|0|||
124662701|NCT02588092|448387502|FG003|Overall Study|Withdrawal by Subject|0|||
124662702|NCT02588092|448387503|FG004|Overall Study|Withdrawal by Subject|0|||
124662703|NCT02588092|448387504|FG005|Overall Study|Withdrawal by Subject|1|||
124662704|NCT02588092|448387505|FG006|Overall Study|Withdrawal by Subject|1|||
124662705|NCT02588092|448387506|FG007|Overall Study|Withdrawal by Subject|2|||
124662706|NCT02588092|448387507|FG008|Overall Study|Withdrawal by Subject|0|||
124662707|NCT02588092|448387508|FG009|Overall Study|Withdrawal by Subject|0|||
124662708|NCT02588092|448387499|FG000|Overall Study|Started Another Treatment|0|||
124662709|NCT02588092|448387500|FG001|Overall Study|Started Another Treatment|0|||
124662710|NCT02588092|448387501|FG002|Overall Study|Started Another Treatment|0|||
124662711|NCT02588092|448387502|FG003|Overall Study|Started Another Treatment|0|||
124662712|NCT02588092|448387503|FG004|Overall Study|Started Another Treatment|1|||
124662713|NCT02588092|448387504|FG005|Overall Study|Started Another Treatment|0|||
124662714|NCT02588092|448387505|FG006|Overall Study|Started Another Treatment|0|||
124662715|NCT02588092|448387506|FG007|Overall Study|Started Another Treatment|1|||
124662716|NCT02588092|448387507|FG008|Overall Study|Started Another Treatment|0|||
124662717|NCT02588092|448387508|FG009|Overall Study|Started Another Treatment|0|||
124662718|NCT02588092|448387499|FG000|Overall Study|Sponsor Decision|0|||
124662719|NCT02588092|448387500|FG001|Overall Study|Sponsor Decision|0|||
124662720|NCT02588092|448387501|FG002|Overall Study|Sponsor Decision|0|||
124662721|NCT02588092|448387502|FG003|Overall Study|Sponsor Decision|0|||
124662722|NCT02588092|448387503|FG004|Overall Study|Sponsor Decision|0|||
124662723|NCT02588092|448387504|FG005|Overall Study|Sponsor Decision|0|||
124662724|NCT02588092|448387505|FG006|Overall Study|Sponsor Decision|0|||
124662725|NCT02588092|448387506|FG007|Overall Study|Sponsor Decision|0|||
124662726|NCT02588092|448387507|FG008|Overall Study|Sponsor Decision|1|||
124662727|NCT02588092|448387508|FG009|Overall Study|Sponsor Decision|1|||
124662728|NCT01030718|448387511|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
124662729|NCT01030718|448387512|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
124544308|NCT05182840|447946756|FG008|Treatment Period|Adverse Event|16|||
124662730|NCT01030718|448387513|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
124662731|NCT01030718|448387511|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
124662732|NCT01030718|448387512|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
124662733|NCT01030718|448387513|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
124662734|NCT01030718|448387511|FG000|Studies CA180-031 and -036 Combined|Death|0|||
124662735|NCT01030718|448387512|FG001|Studies CA180-031 and -036 Combined|Death|1|||
124662736|NCT01030718|448387513|FG002|Studies CA180-031 and -036 Combined|Death|0|||
124662737|NCT01030718|448387511|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
124662738|NCT01030718|448387512|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
124662739|NCT01030718|448387513|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
124662740|NCT01030718|448387511|FG000|Study CA180-036 Only|insufficient effect|1|||
124662741|NCT01030718|448387512|FG001|Study CA180-036 Only|insufficient effect|1|||
124662742|NCT01030718|448387513|FG002|Study CA180-036 Only|insufficient effect|5|||
124662743|NCT01030718|448387511|FG000|Study CA180-036 Only|Adverse Event|2|||
124662744|NCT01030718|448387512|FG001|Study CA180-036 Only|Adverse Event|3|||
124662745|NCT01030718|448387513|FG002|Study CA180-036 Only|Adverse Event|0|||
124662746|NCT01030718|448387511|FG000|Study CA180-036 Only|Death|0|||
124662747|NCT01030718|448387512|FG001|Study CA180-036 Only|Death|1|||
124662748|NCT01030718|448387513|FG002|Study CA180-036 Only|Death|0|||
124662749|NCT01030718|448387511|FG000|Study CA180-036 Only|Other Reasons|0|||
124662750|NCT01030718|448387512|FG001|Study CA180-036 Only|Other Reasons|2|||
124662751|NCT01030718|448387513|FG002|Study CA180-036 Only|Other Reasons|0|||
124662752|NCT00099632|448387514|FG000|Overall Study|Lost to Follow-up|1|||
124662753|NCT00099632|448387515|FG001|Overall Study|Lost to Follow-up|0|||
124662754|NCT00099632|448387516|FG002|Overall Study|Lost to Follow-up|3|||
124662755|NCT00099632|448387517|FG003|Overall Study|Lost to Follow-up|1|||
124662756|NCT00099632|448387518|FG004|Overall Study|Lost to Follow-up|1|||
124662757|NCT00099632|448387519|FG005|Overall Study|Lost to Follow-up|0|||
124662758|NCT00099632|448387514|FG000|Overall Study|Withdrawal by Subject|0|||
124662759|NCT00099632|448387515|FG001|Overall Study|Withdrawal by Subject|1|||
124662760|NCT00099632|448387516|FG002|Overall Study|Withdrawal by Subject|0|||
124662761|NCT00099632|448387517|FG003|Overall Study|Withdrawal by Subject|0|||
124662762|NCT00099632|448387518|FG004|Overall Study|Withdrawal by Subject|0|||
124662763|NCT00099632|448387519|FG005|Overall Study|Withdrawal by Subject|1|||
124662764|NCT00099632|448387514|FG000|Overall Study|Protocol Violation|0|||
124662765|NCT00099632|448387515|FG001|Overall Study|Protocol Violation|0|||
124662766|NCT00099632|448387516|FG002|Overall Study|Protocol Violation|0|||
124662767|NCT00099632|448387517|FG003|Overall Study|Protocol Violation|0|||
124662768|NCT00099632|448387518|FG004|Overall Study|Protocol Violation|0|||
124662769|NCT00099632|448387519|FG005|Overall Study|Protocol Violation|1|||
124662770|NCT00423813|448387520|FG000|Overall Study|Adverse Event|11|||
124662771|NCT00423813|448387521|FG001|Overall Study|Adverse Event|30|||
124662772|NCT00423813|448387522|FG002|Overall Study|Adverse Event|40|||
124662773|NCT00423813|448387520|FG000|Overall Study|Withdrawal by Subject|6|||
124662774|NCT00423813|448387521|FG001|Overall Study|Withdrawal by Subject|8|||
124662775|NCT00423813|448387522|FG002|Overall Study|Withdrawal by Subject|5|||
124662776|NCT00423813|448387520|FG000|Overall Study|Lost to Follow-up|5|||
124662777|NCT00423813|448387521|FG001|Overall Study|Lost to Follow-up|4|||
124662778|NCT00423813|448387522|FG002|Overall Study|Lost to Follow-up|4|||
124662779|NCT00423813|448387520|FG000|Overall Study|Lack of Efficacy|23|||
124662780|NCT00423813|448387521|FG001|Overall Study|Lack of Efficacy|18|||
124662781|NCT00423813|448387522|FG002|Overall Study|Lack of Efficacy|19|||
124662782|NCT00423813|448387520|FG000|Overall Study|Physician Decision|2|||
124662783|NCT00423813|448387521|FG001|Overall Study|Physician Decision|0|||
124662784|NCT00423813|448387522|FG002|Overall Study|Physician Decision|0|||
124662785|NCT00423813|448387520|FG000|Overall Study|Sponsor Decision|0|||
124662786|NCT00423813|448387521|FG001|Overall Study|Sponsor Decision|1|||
124662787|NCT00423813|448387522|FG002|Overall Study|Sponsor Decision|0|||
124662788|NCT00423813|448387520|FG000|Overall Study|Protocol Violation|9|||
124662789|NCT00423813|448387521|FG001|Overall Study|Protocol Violation|4|||
124662790|NCT00423813|448387522|FG002|Overall Study|Protocol Violation|4|||
124662791|NCT00423813|448387520|FG000|Overall Study|Pregnancy|0|||
124662792|NCT00423813|448387521|FG001|Overall Study|Pregnancy|0|||
124662793|NCT00423813|448387522|FG002|Overall Study|Pregnancy|1|||
124662794|NCT00423813|448387520|FG000|Overall Study|Subject started night shift work|1|||
124662795|NCT00423813|448387521|FG001|Overall Study|Subject started night shift work|0|||
124662796|NCT00423813|448387522|FG002|Overall Study|Subject started night shift work|0|||
124662797|NCT00423813|448387520|FG000|Overall Study|Will start exclusionary medications|0|||
124662798|NCT00423813|448387521|FG001|Overall Study|Will start exclusionary medications|1|||
124662799|NCT00423813|448387522|FG002|Overall Study|Will start exclusionary medications|0|||
124662800|NCT00423813|448387520|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
124662801|NCT00423813|448387521|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
124662802|NCT00423813|448387522|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
124662803|NCT01386944|448387523|FG000|Overall Study|Adverse Event|26|||
124662804|NCT01386944|448387523|FG000|Overall Study|Lack of Efficacy|14|||
124662805|NCT01386944|448387523|FG000|Overall Study|Lost to Follow-up|8|||
124662806|NCT01386944|448387523|FG000|Overall Study|Unspecified reason|8|||
124662807|NCT03883477|448387524|FG000|Overall Study|Death|1|||
124662808|NCT03883477|448387525|FG001|Overall Study|Death|0|||
124662809|NCT03883477|448387524|FG000|Overall Study|Protocol Violation|0|||
124662810|NCT03883477|448387525|FG001|Overall Study|Protocol Violation|1|||
124662811|NCT03853291|448387526|FG000|Overall Study|Lost to Follow-up|1|||
124662812|NCT03853291|448387527|FG001|Overall Study|Lost to Follow-up|2|||
124662813|NCT03853291|448387528|FG002|Overall Study|Lost to Follow-up|0|||
124662814|NCT03853291|448387529|FG003|Overall Study|Lost to Follow-up|0|||
124662815|NCT03853291|448387530|FG004|Overall Study|Lost to Follow-up|0|||
124662816|NCT03853291|448387531|FG005|Overall Study|Lost to Follow-up|0|||
124662817|NCT03853291|448387526|FG000|Overall Study|Determined to be ineligible|1|||
124662818|NCT03853291|448387527|FG001|Overall Study|Determined to be ineligible|1|||
124662819|NCT03853291|448387528|FG002|Overall Study|Determined to be ineligible|0|||
124662820|NCT03853291|448387529|FG003|Overall Study|Determined to be ineligible|0|||
124662821|NCT03853291|448387530|FG004|Overall Study|Determined to be ineligible|0|||
124662822|NCT03853291|448387531|FG005|Overall Study|Determined to be ineligible|0|||
124662823|NCT02137226|448387541|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
124662824|NCT02137226|448387542|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
124662825|NCT02137226|448387543|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
124662826|NCT02137226|448387544|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
124662827|NCT02137226|448387545|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
124662828|NCT02137226|448387541|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
124662829|NCT02137226|448387542|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
124662830|NCT02137226|448387543|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
124662831|NCT02137226|448387544|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
124662832|NCT02137226|448387545|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
124662833|NCT02137226|448387541|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
124662834|NCT02137226|448387542|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
124662835|NCT02137226|448387543|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
124662836|NCT02137226|448387544|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
124662837|NCT02137226|448387545|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
124662838|NCT02137226|448387541|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
124662839|NCT02137226|448387542|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
124662840|NCT02137226|448387543|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
124662841|NCT02137226|448387544|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
124662842|NCT02137226|448387545|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
124662843|NCT02137226|448387541|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
124662844|NCT02137226|448387542|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
124662845|NCT02137226|448387543|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
124662846|NCT02137226|448387544|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
124662847|NCT02137226|448387545|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
124662848|NCT02137226|448387541|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
124662849|NCT02137226|448387542|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
124662850|NCT02137226|448387543|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
124662851|NCT02137226|448387544|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
124662852|NCT02137226|448387545|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
124662853|NCT02137226|448387541|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
124662854|NCT02137226|448387542|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
124662855|NCT02137226|448387543|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
124662856|NCT02137226|448387544|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
124662857|NCT02137226|448387545|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
124662858|NCT02137226|448387541|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
124662859|NCT02137226|448387542|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
124662860|NCT02137226|448387543|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
124662861|NCT02137226|448387544|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
124662862|NCT02137226|448387545|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
124662863|NCT02137226|448387541|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
124662864|NCT02137226|448387542|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
124662865|NCT02137226|448387543|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
124662866|NCT02137226|448387544|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
124662867|NCT02137226|448387545|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
124662868|NCT02137226|448387541|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
124662869|NCT02137226|448387542|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
124662870|NCT02137226|448387543|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
124662871|NCT02137226|448387544|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
124662872|NCT02137226|448387545|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
124662873|NCT02137226|448387541|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
124662874|NCT02137226|448387542|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
124662875|NCT02137226|448387543|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
124662876|NCT02137226|448387544|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
124662877|NCT02137226|448387545|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
124662878|NCT02137226|448387541|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
124662879|NCT02137226|448387542|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
124662880|NCT02137226|448387543|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
124662881|NCT02137226|448387544|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
124662882|NCT02137226|448387545|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
124662883|NCT03762681|448387548|FG000|Part 1|Withdrawal by Subject|0|||
124662884|NCT03762681|448387549|FG001|Part 1|Withdrawal by Subject|0|||
124662885|NCT03762681|448387550|FG002|Part 1|Withdrawal by Subject|0|||
124662886|NCT03762681|448387551|FG003|Part 1|Withdrawal by Subject|1|||
124662887|NCT03762681|448387552|FG004|Part 1|Withdrawal by Subject|0|||
124662888|NCT03762681|448387553|FG005|Part 1|Withdrawal by Subject|0|||
124662889|NCT03762681|448387554|FG006|Part 1|Withdrawal by Subject|0|||
124662890|NCT03762681|448387555|FG007|Part 1|Withdrawal by Subject|0|||
124662891|NCT03762681|448387548|FG000|Part 2a|Pandemic Travel Restrictions|0|||
124662892|NCT03762681|448387549|FG001|Part 2a|Pandemic Travel Restrictions|0|||
124662893|NCT03762681|448387550|FG002|Part 2a|Pandemic Travel Restrictions|0|||
124662894|NCT03762681|448387551|FG003|Part 2a|Pandemic Travel Restrictions|0|||
124662895|NCT03762681|448387552|FG004|Part 2a|Pandemic Travel Restrictions|0|||
124662896|NCT03762681|448387553|FG005|Part 2a|Pandemic Travel Restrictions|0|||
124662897|NCT03762681|448387554|FG006|Part 2a|Pandemic Travel Restrictions|0|||
124662898|NCT03762681|448387555|FG007|Part 2a|Pandemic Travel Restrictions|1|||
124662899|NCT00003896|448387560|FG000|Overall Study|Adverse Event|16|||
124662900|NCT00003896|448387560|FG000|Overall Study|Withdrawal by Subject|1|||
124662901|NCT00003896|448387560|FG000|Overall Study|Lack of Efficacy|1|||
124662902|NCT00003896|448387560|FG000|Overall Study|Death|3|||
124662903|NCT00003896|448387560|FG000|Overall Study|not protocol specified|3|||
124662904|NCT00003896|448387560|FG000|Overall Study|ineligible|5|||
124662905|NCT00985686|448387563|FG000|Overall Study|Lost to Follow-up|1|||
124662906|NCT00985686|448387564|FG001|Overall Study|Lost to Follow-up|1|||
124662907|NCT00985686|448387565|FG002|Overall Study|Lost to Follow-up|0|||
124662908|NCT00985686|448387566|FG003|Overall Study|Lost to Follow-up|2|||
124662909|NCT03134911|448387567|FG000|Overall Study|Screen failure|31|||
124662910|NCT03134911|448387567|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
124662911|NCT01087203|448387568|FG000|Overall Study|Lost to Follow-up|2|||
124662912|NCT01087203|448387569|FG001|Overall Study|Lost to Follow-up|0|||
124662913|NCT01087203|448387568|FG000|Overall Study|Withdrawal by Subject|2|||
124662914|NCT01087203|448387569|FG001|Overall Study|Withdrawal by Subject|6|||
124662915|NCT01087203|448387568|FG000|Overall Study|Lack of Efficacy|1|||
124662916|NCT01087203|448387569|FG001|Overall Study|Lack of Efficacy|2|||
124662917|NCT01087203|448387568|FG000|Overall Study|Study terminated by sponsor|27|||
124662918|NCT01087203|448387569|FG001|Overall Study|Study terminated by sponsor|27|||
124662919|NCT01670045|448387570|FG000|Overall Study|Withdrawal by Subject|3|||
124662920|NCT01670045|448387570|FG000|Overall Study|Adverse Event|1|||
124662921|NCT01670045|448387570|FG000|Overall Study|Death|1|||
124662922|NCT01670045|448387570|FG000|Overall Study|Lost to Follow-up|11|||
124662923|NCT02787083|448387575|FG000|Overall Study|Adverse Event|1|||
124662924|NCT02787083|448387576|FG001|Overall Study|Adverse Event|0|||
124662925|NCT02787083|448387575|FG000|Overall Study|Withdrawal by Subject|2|||
124662926|NCT02787083|448387576|FG001|Overall Study|Withdrawal by Subject|2|||
124662927|NCT02710084|448387577|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
124662928|NCT02710084|448387578|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
124662929|NCT05305989|448387579|FG000|Overall Study|Other|3|||
124662930|NCT05305989|448387580|FG001|Overall Study|Other|2|||
124662931|NCT05305989|448387581|FG002|Overall Study|Other|0|||
124662932|NCT05305989|448387579|FG000|Overall Study|Sponsor decision|2|||
124662933|NCT05305989|448387580|FG001|Overall Study|Sponsor decision|1|||
124662934|NCT05305989|448387581|FG002|Overall Study|Sponsor decision|0|||
124662935|NCT05305989|448387579|FG000|Overall Study|Protocol Violation|0|||
124662936|NCT05305989|448387580|FG001|Overall Study|Protocol Violation|1|||
124662937|NCT05305989|448387581|FG002|Overall Study|Protocol Violation|0|||
124662938|NCT05305989|448387579|FG000|Overall Study|Investigator decision|1|||
124662939|NCT05305989|448387580|FG001|Overall Study|Investigator decision|2|||
124662940|NCT05305989|448387581|FG002|Overall Study|Investigator decision|0|||
124662941|NCT05305989|448387579|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
124662942|NCT05305989|448387580|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
124662943|NCT05305989|448387581|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
124662944|NCT05305989|448387579|FG000|Overall Study|Adverse Event|1|||
124662945|NCT05305989|448387580|FG001|Overall Study|Adverse Event|1|||
124662946|NCT05305989|448387581|FG002|Overall Study|Adverse Event|0|||
124662947|NCT05305989|448387579|FG000|Overall Study|Enrolled but never dosed|3|||
124662948|NCT05305989|448387580|FG001|Overall Study|Enrolled but never dosed|2|||
124662949|NCT05305989|448387581|FG002|Overall Study|Enrolled but never dosed|1|||
124662950|NCT03162328|448387582|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
124662951|NCT03162328|448387583|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
124662952|NCT03162328|448387584|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
124662953|NCT03162328|448387582|FG000|Screening Period|Withdrawal by Subject|1|||
124662954|NCT03162328|448387583|FG001|Screening Period|Withdrawal by Subject|0|||
124662955|NCT03162328|448387584|FG002|Screening Period|Withdrawal by Subject|0|||
124662956|NCT03162328|448387582|FG000|Study Period|Withdrawal by Subject|0|||
124662957|NCT03162328|448387583|FG001|Study Period|Withdrawal by Subject|0|||
124662958|NCT03162328|448387584|FG002|Study Period|Withdrawal by Subject|1|||
124662959|NCT00282152|448387585|FG000|Overall Study|Withdrawal by Subject|1|||
124662960|NCT00282152|448387586|FG001|Overall Study|Withdrawal by Subject|0|||
124662961|NCT03301831|448387587|FG000|Overall Study|Lost to Follow-up|5|||
124662962|NCT03301831|448387588|FG001|Overall Study|Lost to Follow-up|3|||
124662963|NCT03301831|448387587|FG000|Overall Study|Protocol Violation|4|||
124662964|NCT03301831|448387588|FG001|Overall Study|Protocol Violation|0|||
124662965|NCT03301831|448387587|FG000|Overall Study|Withdrawal by Subject|11|||
124662966|NCT03301831|448387588|FG001|Overall Study|Withdrawal by Subject|0|||
124662967|NCT02182830|448387590|FG000|Overall Study|Not Treated|1|||
124662968|NCT02182830|448387591|FG001|Overall Study|Not Treated|1|||
124662969|NCT02182830|448387590|FG000|Overall Study|Trial stopped, reason missing|3|||
124662970|NCT02182830|448387591|FG001|Overall Study|Trial stopped, reason missing|3|||
124662971|NCT02182830|448387590|FG000|Overall Study|Consent withdrawn|8|||
124662972|NCT02182830|448387591|FG001|Overall Study|Consent withdrawn|8|||
124662973|NCT02182830|448387590|FG000|Overall Study|Lost to Follow-up|3|||
124662974|NCT02182830|448387591|FG001|Overall Study|Lost to Follow-up|3|||
124662975|NCT00154375|448387592|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
124662976|NCT00154375|448387593|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
124662977|NCT00154375|448387592|FG000|Overall Study|Adverse Event|18|||
124662978|NCT00154375|448387593|FG001|Overall Study|Adverse Event|20|||
124662979|NCT00154375|448387592|FG000|Overall Study|Withdrawal by Subject|14|||
124662980|NCT00154375|448387593|FG001|Overall Study|Withdrawal by Subject|10|||
124662981|NCT00154375|448387592|FG000|Overall Study|Death|5|||
124662982|NCT00154375|448387593|FG001|Overall Study|Death|13|||
124662983|NCT00154375|448387592|FG000|Overall Study|Study drug no longer required|5|||
124662984|NCT00154375|448387593|FG001|Overall Study|Study drug no longer required|3|||
124662985|NCT00154375|448387592|FG000|Overall Study|Lost to Follow-up|2|||
124662986|NCT00154375|448387593|FG001|Overall Study|Lost to Follow-up|1|||
124662987|NCT00154375|448387592|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124662988|NCT00154375|448387593|FG001|Overall Study|Abnormal laboratory value(s)|2|||
124662989|NCT00154375|448387592|FG000|Overall Study|Protocol Violation|0|||
124662990|NCT00154375|448387593|FG001|Overall Study|Protocol Violation|1|||
124662991|NCT00154375|448387592|FG000|Overall Study|Suspected progression of disease|44|||
124662992|NCT00154375|448387593|FG001|Overall Study|Suspected progression of disease|30|||
124662993|NCT03268005|448387594|FG000|Overall Study|Death|2|||
124662994|NCT03268005|448387595|FG001|Overall Study|Death|1|||
124662995|NCT03268005|448387594|FG000|Overall Study|Lost to Follow-up|2|||
124662996|NCT03268005|448387595|FG001|Overall Study|Lost to Follow-up|2|||
124662997|NCT03268005|448387594|FG000|Overall Study|Withdrawal by Subject|11|||
124662998|NCT03268005|448387595|FG001|Overall Study|Withdrawal by Subject|11|||
124662999|NCT00845676|448387599|FG000|Overall Study|Virologic breakthrough at week 20|1|||
124663000|NCT00845676|448387599|FG000|Overall Study|Adverse Event|1|||
124663001|NCT00481767|448387601|FG000|Overall Study|Withdrawal by Subject|16|||
124663002|NCT00481767|448387602|FG001|Overall Study|Withdrawal by Subject|11|||
124663003|NCT00481767|448387601|FG000|Overall Study|Lost to Follow-up|16|||
124663004|NCT00481767|448387602|FG001|Overall Study|Lost to Follow-up|10|||
124663005|NCT04378569|448389878|FG000|Overall Study|Adverse Event|0|||
124663006|NCT04378569|448389879|FG001|Overall Study|Adverse Event|0|||
124663007|NCT04378569|448389880|FG002|Overall Study|Adverse Event|2|||
124663008|NCT04378569|448389881|FG003|Overall Study|Adverse Event|0|||
124663009|NCT04378569|448389882|FG004|Overall Study|Adverse Event|3|||
124663010|NCT04378569|448389883|FG005|Overall Study|Adverse Event|3|||
124663011|NCT04378569|448389878|FG000|Overall Study|Lost to Follow-up|0|||
124663012|NCT04378569|448389879|FG001|Overall Study|Lost to Follow-up|3|||
124663013|NCT04378569|448389880|FG002|Overall Study|Lost to Follow-up|1|||
124663014|NCT04378569|448389881|FG003|Overall Study|Lost to Follow-up|0|||
124663015|NCT04378569|448389882|FG004|Overall Study|Lost to Follow-up|1|||
124663016|NCT04378569|448389883|FG005|Overall Study|Lost to Follow-up|1|||
124663017|NCT04378569|448389878|FG000|Overall Study|Protocol Violation|0|||
124663018|NCT04378569|448389879|FG001|Overall Study|Protocol Violation|0|||
124663019|NCT04378569|448389880|FG002|Overall Study|Protocol Violation|0|||
124663020|NCT04378569|448389881|FG003|Overall Study|Protocol Violation|0|||
124663021|NCT04378569|448389882|FG004|Overall Study|Protocol Violation|0|||
124663022|NCT04378569|448389883|FG005|Overall Study|Protocol Violation|1|||
124663023|NCT04378569|448389878|FG000|Overall Study|Withdrawal by Subject|0|||
124663024|NCT04378569|448389879|FG001|Overall Study|Withdrawal by Subject|6|||
124663025|NCT04378569|448389880|FG002|Overall Study|Withdrawal by Subject|7|||
124663026|NCT04378569|448389881|FG003|Overall Study|Withdrawal by Subject|4|||
124663027|NCT04378569|448389882|FG004|Overall Study|Withdrawal by Subject|5|||
124663028|NCT04378569|448389883|FG005|Overall Study|Withdrawal by Subject|4|||
124663029|NCT04378569|448389878|FG000|Overall Study|Lack of response|0|||
124663030|NCT04378569|448389879|FG001|Overall Study|Lack of response|0|||
124663031|NCT04378569|448389880|FG002|Overall Study|Lack of response|1|||
124663032|NCT04378569|448389881|FG003|Overall Study|Lack of response|0|||
124663033|NCT04378569|448389882|FG004|Overall Study|Lack of response|1|||
124663034|NCT04378569|448389883|FG005|Overall Study|Lack of response|1|||
124663035|NCT01962948|448389884|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
124663036|NCT01962948|448389885|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
124663037|NCT01962948|448389886|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
124663038|NCT01962948|448389887|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
124663039|NCT03630705|448389888|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
124663040|NCT03630705|448389889|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
124663041|NCT03630705|448389890|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
124663042|NCT03630705|448389891|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
124663043|NCT03630705|448389888|FG000|Overall Study|Lost to Follow-up|1|||
124663044|NCT03630705|448389889|FG001|Overall Study|Lost to Follow-up|2|||
124663045|NCT03630705|448389890|FG002|Overall Study|Lost to Follow-up|0|||
124663046|NCT03630705|448389891|FG003|Overall Study|Lost to Follow-up|0|||
124663047|NCT04727528|448389894|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
124663048|NCT04727528|448389895|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
124663049|NCT04727528|448389894|FG000|Open-label Period|Randomized who did not receive treatment|1|||
124663050|NCT04727528|448389895|FG001|Open-label Period|Randomized who did not receive treatment|0|||
124663051|NCT04727528|448389894|FG000|Double-blind Treatment Phase|Adverse Event|0|||
124663052|NCT04727528|448389895|FG001|Double-blind Treatment Phase|Adverse Event|1|||
124663053|NCT04727528|448389894|FG000|Double-blind Treatment Phase|Death|0|||
124663054|NCT04727528|448389895|FG001|Double-blind Treatment Phase|Death|1|||
124663055|NCT04727528|448389894|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
124663056|NCT04727528|448389895|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
124663057|NCT04727528|448389894|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
124663058|NCT04727528|448389895|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
124663059|NCT04727528|448389894|FG000|Double-blind Treatment Phase|Physician Decision|0|||
124663060|NCT04727528|448389895|FG001|Double-blind Treatment Phase|Physician Decision|1|||
124663061|NCT04727528|448389894|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
124663062|NCT04727528|448389895|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124663063|NCT01763827|448389896|FG000|Overall Study|Withdrawal by Subject|1|||
124663064|NCT01763827|448389897|FG001|Overall Study|Withdrawal by Subject|0|||
124663065|NCT01763827|448389898|FG002|Overall Study|Withdrawal by Subject|0|||
124663066|NCT01763827|448389899|FG003|Overall Study|Withdrawal by Subject|0|||
124663067|NCT01763827|448389900|FG004|Overall Study|Withdrawal by Subject|2|||
124663068|NCT01763827|448389901|FG005|Overall Study|Withdrawal by Subject|0|||
124663069|NCT01763827|448389896|FG000|Overall Study|Decision by sponsor|2|||
124663070|NCT01763827|448389897|FG001|Overall Study|Decision by sponsor|0|||
124663071|NCT01763827|448389898|FG002|Overall Study|Decision by sponsor|3|||
124663072|NCT01763827|448389899|FG003|Overall Study|Decision by sponsor|0|||
124663073|NCT01763827|448389900|FG004|Overall Study|Decision by sponsor|2|||
124663074|NCT01763827|448389901|FG005|Overall Study|Decision by sponsor|1|||
124663075|NCT01763827|448389896|FG000|Overall Study|Lost to Follow-up|0|||
124663076|NCT01763827|448389897|FG001|Overall Study|Lost to Follow-up|1|||
124663077|NCT01763827|448389898|FG002|Overall Study|Lost to Follow-up|1|||
124663078|NCT01763827|448389899|FG003|Overall Study|Lost to Follow-up|1|||
124663079|NCT01763827|448389900|FG004|Overall Study|Lost to Follow-up|2|||
124663080|NCT01763827|448389901|FG005|Overall Study|Lost to Follow-up|1|||
124663081|NCT01826981|448389902|FG000|Overall Study|Lack of Efficacy|0|||
124663082|NCT01826981|448389903|FG001|Overall Study|Lack of Efficacy|1|||
124663083|NCT01826981|448389904|FG002|Overall Study|Lack of Efficacy|0|||
124872819|NCT00500903|449155771|FG002|Overall Study|Reason Not Specified|2|||
124872820|NCT01648348|449155775|FG000|Overall Study|Cancel|1|||
124872821|NCT01648348|449155776|FG001|Overall Study|Cancel|0|||
124872822|NCT01648348|449155777|FG002|Overall Study|Cancel|0|||
124872823|NCT01648348|449155778|FG003|Overall Study|Cancel|0|||
124872824|NCT01648348|449155779|FG004|Overall Study|Cancel|3|||
124872825|NCT01648348|449155780|FG005|Overall Study|Cancel|6|||
124872826|NCT01648348|449155775|FG000|Overall Study|Replaced for MTD analysis|1|||
124872827|NCT01648348|449155776|FG001|Overall Study|Replaced for MTD analysis|0|||
124872828|NCT01648348|449155777|FG002|Overall Study|Replaced for MTD analysis|1|||
124872829|NCT01648348|449155778|FG003|Overall Study|Replaced for MTD analysis|0|||
124872830|NCT01648348|449155779|FG004|Overall Study|Replaced for MTD analysis|0|||
124872831|NCT01648348|449155780|FG005|Overall Study|Replaced for MTD analysis|0|||
124872832|NCT00696410|449155782|FG000|Overall Study|Lost to Follow-up|2|||
124872833|NCT00696410|449155783|FG001|Overall Study|Lost to Follow-up|0|||
124872834|NCT00696410|449155782|FG000|Overall Study|Withdrawal by Subject|8|||
124872835|NCT00696410|449155783|FG001|Overall Study|Withdrawal by Subject|0|||
124872836|NCT00696410|449155782|FG000|Overall Study|Physician Decision|3|||
124872837|NCT00696410|449155783|FG001|Overall Study|Physician Decision|0|||
124872838|NCT01951638|449155785|FG000|Treatment Period|Protocol Violation|0|||
124872839|NCT01951638|449155786|FG001|Treatment Period|Protocol Violation|0|||
124872840|NCT01951638|449155787|FG002|Treatment Period|Protocol Violation|0|||
124872841|NCT01951638|449155788|FG003|Treatment Period|Protocol Violation|2|||
124872842|NCT01951638|449155789|FG004|Treatment Period|Protocol Violation|0|||
124872843|NCT01951638|449155785|FG000|Treatment Period|Protocol-driven decision point|1|||
124872844|NCT01951638|449155786|FG001|Treatment Period|Protocol-driven decision point|3|||
124872845|NCT01951638|449155787|FG002|Treatment Period|Protocol-driven decision point|0|||
124872846|NCT01951638|449155788|FG003|Treatment Period|Protocol-driven decision point|0|||
124872847|NCT01951638|449155789|FG004|Treatment Period|Protocol-driven decision point|0|||
124872848|NCT01951638|449155785|FG000|Treatment Period|Logistical difficulties|0|||
124872849|NCT01951638|449155786|FG001|Treatment Period|Logistical difficulties|1|||
124872850|NCT01951638|449155787|FG002|Treatment Period|Logistical difficulties|1|||
124872851|NCT01951638|449155788|FG003|Treatment Period|Logistical difficulties|0|||
124872852|NCT01951638|449155789|FG004|Treatment Period|Logistical difficulties|0|||
124872853|NCT01951638|449155785|FG000|Treatment Period|Withdrawal by Subject|9|||
124872854|NCT01951638|449155786|FG001|Treatment Period|Withdrawal by Subject|6|||
124872855|NCT01951638|449155787|FG002|Treatment Period|Withdrawal by Subject|4|||
124872856|NCT01951638|449155788|FG003|Treatment Period|Withdrawal by Subject|5|||
124872857|NCT01951638|449155789|FG004|Treatment Period|Withdrawal by Subject|4|||
124872858|NCT01951638|449155785|FG000|Treatment Period|Death|0|||
124872859|NCT01951638|449155786|FG001|Treatment Period|Death|0|||
124872860|NCT01951638|449155787|FG002|Treatment Period|Death|0|||
124872861|NCT01951638|449155788|FG003|Treatment Period|Death|3|||
124872862|NCT01951638|449155789|FG004|Treatment Period|Death|1|||
124872863|NCT01951638|449155785|FG000|Treatment Period|Adverse Event|3|||
124872864|NCT01951638|449155786|FG001|Treatment Period|Adverse Event|4|||
124872865|NCT01951638|449155787|FG002|Treatment Period|Adverse Event|8|||
124872866|NCT01951638|449155788|FG003|Treatment Period|Adverse Event|6|||
124872867|NCT01951638|449155789|FG004|Treatment Period|Adverse Event|5|||
124872868|NCT01951638|449155785|FG000|Follow-up Period|Protocol Violation|0|||
124872869|NCT01951638|449155786|FG001|Follow-up Period|Protocol Violation|0|||
124872870|NCT01951638|449155787|FG002|Follow-up Period|Protocol Violation|0|||
124872871|NCT01951638|449155788|FG003|Follow-up Period|Protocol Violation|1|||
124872872|NCT01951638|449155789|FG004|Follow-up Period|Protocol Violation|0|||
124872873|NCT01951638|449155785|FG000|Follow-up Period|Logistical difficulties|0|||
124872874|NCT01951638|449155786|FG001|Follow-up Period|Logistical difficulties|2|||
124872875|NCT01951638|449155787|FG002|Follow-up Period|Logistical difficulties|0|||
124872876|NCT01951638|449155788|FG003|Follow-up Period|Logistical difficulties|0|||
124872877|NCT01951638|449155789|FG004|Follow-up Period|Logistical difficulties|1|||
124663084|NCT01826981|448389905|FG003|Overall Study|Lack of Efficacy|0|||
124663085|NCT01826981|448389906|FG004|Overall Study|Lack of Efficacy|5|||
124663086|NCT01826981|448389907|FG005|Overall Study|Lack of Efficacy|0|||
124872878|NCT01951638|449155785|FG000|Follow-up Period|Withdrawal by Subject|1|||
124872879|NCT01951638|449155786|FG001|Follow-up Period|Withdrawal by Subject|5|||
124872880|NCT01951638|449155787|FG002|Follow-up Period|Withdrawal by Subject|2|||
124872881|NCT01951638|449155788|FG003|Follow-up Period|Withdrawal by Subject|1|||
124872882|NCT01951638|449155789|FG004|Follow-up Period|Withdrawal by Subject|2|||
124872883|NCT01951638|449155785|FG000|Follow-up Period|Lost to Follow-up|0|||
124872884|NCT01951638|449155786|FG001|Follow-up Period|Lost to Follow-up|1|||
124872885|NCT01951638|449155787|FG002|Follow-up Period|Lost to Follow-up|0|||
124663087|NCT01826981|448389908|FG006|Overall Study|Lack of Efficacy|0|||
124663088|NCT01826981|448389909|FG007|Overall Study|Lack of Efficacy|8|||
124663089|NCT01826981|448389910|FG008|Overall Study|Lack of Efficacy|7|||
124663090|NCT01826981|448389911|FG009|Overall Study|Lack of Efficacy|0|||
124663091|NCT01826981|448389912|FG010|Overall Study|Lack of Efficacy|1|||
124663092|NCT01826981|448389913|FG011|Overall Study|Lack of Efficacy|0|||
124663093|NCT01826981|448389914|FG012|Overall Study|Lack of Efficacy|0|||
124663094|NCT01826981|448389915|FG013|Overall Study|Lack of Efficacy|3|||
124663095|NCT01826981|448389916|FG014|Overall Study|Lack of Efficacy|0|||
124663096|NCT01826981|448389902|FG000|Overall Study|Lost to Follow-up|0|||
124663097|NCT01826981|448389903|FG001|Overall Study|Lost to Follow-up|0|||
124663098|NCT01826981|448389904|FG002|Overall Study|Lost to Follow-up|0|||
124663099|NCT01826981|448389905|FG003|Overall Study|Lost to Follow-up|0|||
124663100|NCT01826981|448389906|FG004|Overall Study|Lost to Follow-up|1|||
124663101|NCT01826981|448389907|FG005|Overall Study|Lost to Follow-up|1|||
124663102|NCT01826981|448389908|FG006|Overall Study|Lost to Follow-up|0|||
124663103|NCT01826981|448389909|FG007|Overall Study|Lost to Follow-up|1|||
124663104|NCT01826981|448389910|FG008|Overall Study|Lost to Follow-up|0|||
124663105|NCT01826981|448389911|FG009|Overall Study|Lost to Follow-up|1|||
124663106|NCT01826981|448389912|FG010|Overall Study|Lost to Follow-up|1|||
124663107|NCT01826981|448389913|FG011|Overall Study|Lost to Follow-up|1|||
124663108|NCT01826981|448389914|FG012|Overall Study|Lost to Follow-up|1|||
124663109|NCT01826981|448389915|FG013|Overall Study|Lost to Follow-up|0|||
124663110|NCT01826981|448389916|FG014|Overall Study|Lost to Follow-up|0|||
124663111|NCT01826981|448389902|FG000|Overall Study|Withdrew Consent|0|||
124663112|NCT01826981|448389903|FG001|Overall Study|Withdrew Consent|0|||
124663113|NCT01826981|448389904|FG002|Overall Study|Withdrew Consent|0|||
124663114|NCT01826981|448389905|FG003|Overall Study|Withdrew Consent|0|||
124663115|NCT01826981|448389906|FG004|Overall Study|Withdrew Consent|0|||
124663116|NCT01826981|448389907|FG005|Overall Study|Withdrew Consent|0|||
124663117|NCT01826981|448389908|FG006|Overall Study|Withdrew Consent|1|||
124663118|NCT01826981|448389909|FG007|Overall Study|Withdrew Consent|1|||
124663119|NCT01826981|448389910|FG008|Overall Study|Withdrew Consent|0|||
124663120|NCT01826981|448389911|FG009|Overall Study|Withdrew Consent|0|||
124663121|NCT01826981|448389912|FG010|Overall Study|Withdrew Consent|0|||
124663122|NCT01826981|448389913|FG011|Overall Study|Withdrew Consent|1|||
124663123|NCT01826981|448389914|FG012|Overall Study|Withdrew Consent|0|||
124663124|NCT01826981|448389915|FG013|Overall Study|Withdrew Consent|1|||
124663125|NCT01826981|448389916|FG014|Overall Study|Withdrew Consent|0|||
124663126|NCT01826981|448389902|FG000|Overall Study|Adverse Event|0|||
124663127|NCT01826981|448389903|FG001|Overall Study|Adverse Event|0|||
124663128|NCT01826981|448389904|FG002|Overall Study|Adverse Event|0|||
124663129|NCT01826981|448389905|FG003|Overall Study|Adverse Event|0|||
124663130|NCT01826981|448389906|FG004|Overall Study|Adverse Event|1|||
124663131|NCT01826981|448389907|FG005|Overall Study|Adverse Event|0|||
124663132|NCT01826981|448389908|FG006|Overall Study|Adverse Event|0|||
124663133|NCT01826981|448389909|FG007|Overall Study|Adverse Event|0|||
124663134|NCT01826981|448389910|FG008|Overall Study|Adverse Event|0|||
124663135|NCT01826981|448389911|FG009|Overall Study|Adverse Event|0|||
124663136|NCT01826981|448389912|FG010|Overall Study|Adverse Event|0|||
124663137|NCT01826981|448389913|FG011|Overall Study|Adverse Event|0|||
124663138|NCT01826981|448389914|FG012|Overall Study|Adverse Event|0|||
124663139|NCT01826981|448389915|FG013|Overall Study|Adverse Event|0|||
124663140|NCT01826981|448389916|FG014|Overall Study|Adverse Event|0|||
124663141|NCT01826981|448389902|FG000|Overall Study|Upper G-I Haemorrhage|0|||
124663142|NCT01826981|448389903|FG001|Overall Study|Upper G-I Haemorrhage|0|||
124663143|NCT01826981|448389904|FG002|Overall Study|Upper G-I Haemorrhage|0|||
124663144|NCT01826981|448389905|FG003|Overall Study|Upper G-I Haemorrhage|0|||
124663145|NCT01826981|448389906|FG004|Overall Study|Upper G-I Haemorrhage|0|||
124663146|NCT01826981|448389907|FG005|Overall Study|Upper G-I Haemorrhage|0|||
124663147|NCT01826981|448389908|FG006|Overall Study|Upper G-I Haemorrhage|0|||
124663148|NCT01826981|448389909|FG007|Overall Study|Upper G-I Haemorrhage|0|||
124663149|NCT01826981|448389910|FG008|Overall Study|Upper G-I Haemorrhage|0|||
124663150|NCT01826981|448389911|FG009|Overall Study|Upper G-I Haemorrhage|0|||
124663151|NCT01826981|448389912|FG010|Overall Study|Upper G-I Haemorrhage|0|||
124663152|NCT01826981|448389913|FG011|Overall Study|Upper G-I Haemorrhage|0|||
124663153|NCT01826981|448389914|FG012|Overall Study|Upper G-I Haemorrhage|0|||
124663154|NCT01826981|448389915|FG013|Overall Study|Upper G-I Haemorrhage|1|||
124663155|NCT01826981|448389916|FG014|Overall Study|Upper G-I Haemorrhage|0|||
124663156|NCT01826981|448389902|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
124663157|NCT01826981|448389903|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
124663158|NCT01826981|448389904|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
124663159|NCT01826981|448389905|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
124663160|NCT01826981|448389906|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
124663161|NCT01826981|448389907|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
124663162|NCT01826981|448389908|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
124663163|NCT01826981|448389909|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
124663164|NCT01826981|448389910|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
124663165|NCT01826981|448389911|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
124663166|NCT01826981|448389912|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
124663167|NCT01826981|448389913|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
124663168|NCT01826981|448389914|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
124663169|NCT01826981|448389915|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
124663170|NCT01826981|448389916|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
124663171|NCT02906579|448389917|FG000|Overall Study|Adverse Event|1|||
124663172|NCT02906579|448389917|FG000|Overall Study|Physician Decision|1|||
124663173|NCT02030119|448389922|FG000|Overall Study|Withdrawal by Subject|3|||
124663174|NCT02030119|448389923|FG001|Overall Study|Withdrawal by Subject|1|||
124663175|NCT02030119|448389924|FG002|Overall Study|Withdrawal by Subject|5|||
124663176|NCT02030119|448389925|FG003|Overall Study|Withdrawal by Subject|3|||
124663177|NCT02030119|448389922|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
124663178|NCT02030119|448389923|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
124663179|NCT02030119|448389924|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
124663180|NCT02030119|448389925|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
124663181|NCT02793947|448389926|FG000|Overall Study|Death|1|||
124663182|NCT02793947|448389927|FG001|Overall Study|Death|0|||
124663183|NCT02793947|448389926|FG000|Overall Study|Physician Decision|1|||
124663184|NCT02793947|448389927|FG001|Overall Study|Physician Decision|5|||
124663185|NCT01310127|448389932|FG000|Overall Study|Protocol Violation|1|||
124663186|NCT01310127|448389933|FG001|Overall Study|Protocol Violation|1|||
124663187|NCT01310127|448389932|FG000|Overall Study|advanced psc cataract outlier|1|||
124663188|NCT01310127|448389933|FG001|Overall Study|advanced psc cataract outlier|0|||
124663189|NCT00412932|448389934|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
124663190|NCT00412932|448389934|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
124663191|NCT00412932|448389934|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
124663192|NCT00412932|448389934|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
124663193|NCT00412932|448389934|FG000|Olmesartan (Olm) 20 mg|Other|1|||
124663194|NCT00412932|448389934|FG000|Olmesartan 40 mg|Adverse Event|4|||
124663195|NCT00412932|448389934|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
124663196|NCT00412932|448389934|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
124663197|NCT00412932|448389934|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
124663198|NCT00412932|448389934|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
124663199|NCT00412932|448389934|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
124663200|NCT00412932|448389934|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
124663201|NCT01025284|448389942|FG000|Overall Study|Investigator Decision|0|||
124663202|NCT01025284|448389943|FG001|Overall Study|Investigator Decision|1|||
124663203|NCT01025284|448389944|FG002|Overall Study|Investigator Decision|0|||
124663204|NCT01025284|448389942|FG000|Overall Study|Withdrawal by Subject|0|||
124663205|NCT01025284|448389943|FG001|Overall Study|Withdrawal by Subject|1|||
124663206|NCT01025284|448389944|FG002|Overall Study|Withdrawal by Subject|0|||
124663207|NCT02753816|448389945|FG000|Overall Study|Protocol Violation|0|||
124663208|NCT02753816|448389946|FG001|Overall Study|Protocol Violation|1|||
124663209|NCT02753816|448389947|FG002|Overall Study|Protocol Violation|0|||
124663210|NCT00905567|448389948|FG000|Washout|Withdrawal by Subject|0|||
124663211|NCT00905567|448389949|FG001|Washout|Withdrawal by Subject|1|||
124663212|NCT02542397|448389950|FG000|Overall Study|Death|2|||
124663213|NCT02542397|448389950|FG000|Overall Study|Physician Decision|6|||
124663214|NCT02542397|448389950|FG000|Overall Study|Withdrawal by Subject|6|||
124663215|NCT02542397|448389950|FG000|Overall Study|Lost to Follow-up|2|||
124663216|NCT01473940|448389951|FG000|Induction Therapy|Death|0|||
124663217|NCT01473940|448389952|FG001|Induction Therapy|Death|0|||
124663218|NCT01473940|448389953|FG002|Induction Therapy|Death|1|||
124663219|NCT01473940|448389954|FG003|Induction Therapy|Death|1|||
124663220|NCT01473940|448389951|FG000|Induction Therapy|Progressive Disease|0|||
124663221|NCT01473940|448389952|FG001|Induction Therapy|Progressive Disease|1|||
124663222|NCT01473940|448389953|FG002|Induction Therapy|Progressive Disease|1|||
124663223|NCT01473940|448389954|FG003|Induction Therapy|Progressive Disease|0|||
124663224|NCT01473940|448389951|FG000|Maintenance Therapy|Progressive Disease|1|||
124663225|NCT01473940|448389952|FG001|Maintenance Therapy|Progressive Disease|2|||
124663226|NCT01473940|448389953|FG002|Maintenance Therapy|Progressive Disease|1|||
124663227|NCT01473940|448389954|FG003|Maintenance Therapy|Progressive Disease|4|||
124663228|NCT00547248|448389955|FG000|Overall Study|Protocol Violation|0|||
124663229|NCT00547248|448389956|FG001|Overall Study|Protocol Violation|0|||
124663230|NCT00547248|448389957|FG002|Overall Study|Protocol Violation|1|||
124663231|NCT00547248|448389958|FG003|Overall Study|Protocol Violation|1|||
124663232|NCT00547248|448389955|FG000|Overall Study|Migrated/moved from study area|0|||
124663233|NCT00547248|448389956|FG001|Overall Study|Migrated/moved from study area|0|||
124663234|NCT00547248|448389957|FG002|Overall Study|Migrated/moved from study area|2|||
124663235|NCT00547248|448389958|FG003|Overall Study|Migrated/moved from study area|0|||
124663236|NCT00547248|448389955|FG000|Overall Study|Withdrawal by Subject|0|||
124663237|NCT00547248|448389956|FG001|Overall Study|Withdrawal by Subject|0|||
124663238|NCT00547248|448389957|FG002|Overall Study|Withdrawal by Subject|7|||
124663239|NCT00547248|448389958|FG003|Overall Study|Withdrawal by Subject|1|||
124663240|NCT00534248|448389959|FG000|Overall Study|Adverse Event|19|||
124663241|NCT00534248|448389960|FG001|Overall Study|Adverse Event|29|||
124663242|NCT00534248|448389959|FG000|Overall Study|Lost to Follow-up|353|||
124663243|NCT00534248|448389960|FG001|Overall Study|Lost to Follow-up|375|||
124663244|NCT00534248|448389959|FG000|Overall Study|Other protocol specified criteria|13|||
124663245|NCT00534248|448389960|FG001|Overall Study|Other protocol specified criteria|3|||
124663246|NCT00534248|448389959|FG000|Overall Study|Physician Decision|10|||
124663247|NCT00534248|448389960|FG001|Overall Study|Physician Decision|7|||
124663248|NCT00534248|448389959|FG000|Overall Study|Protocol Violation|3|||
124663249|NCT00534248|448389960|FG001|Overall Study|Protocol Violation|4|||
124663250|NCT00534248|448389959|FG000|Overall Study|Withdrawal by Subject|263|||
124663251|NCT00534248|448389960|FG001|Overall Study|Withdrawal by Subject|255|||
124663252|NCT02532257|448389963|FG000|Overall Study|Adverse Event|2|||
124663253|NCT02532257|448389963|FG000|Overall Study|Physician Decision|4|||
124663254|NCT02532257|448389963|FG000|Overall Study|Withdrawal by Subject|3|||
124663255|NCT02532257|448389963|FG000|Overall Study|Progressive Disease|10|||
124663256|NCT02849171|448389964|FG000|Overall Study|Withdrawal by Subject|1|||
124663257|NCT02849171|448389964|FG000|Overall Study|Not treated|1|||
124663258|NCT02259400|448389967|FG000|Overall Study|Death|0|||
124663259|NCT02259400|448389968|FG001|Overall Study|Death|2|||
124663260|NCT00697593|448389970|FG000|Overall Study|Adverse Event|3|||
124663261|NCT00697593|448389970|FG000|Overall Study|Protocol Violation|1|||
124663262|NCT00697593|448389970|FG000|Overall Study|Lack of Efficacy|3|||
124663263|NCT00697593|448389970|FG000|Overall Study|Suspension of the study by sponsor|12|||
124663264|NCT02964338|448389974|FG000|Overall Study|Sponsor terminated study for futility|12|||
124663265|NCT02964338|448389975|FG001|Overall Study|Sponsor terminated study for futility|15|||
124663266|NCT02964338|448389976|FG002|Overall Study|Sponsor terminated study for futility|14|||
124663267|NCT02964338|448389974|FG000|Overall Study|Lack of Efficacy|0|||
124663268|NCT02964338|448389975|FG001|Overall Study|Lack of Efficacy|3|||
124663269|NCT02964338|448389976|FG002|Overall Study|Lack of Efficacy|0|||
124663270|NCT02964338|448389974|FG000|Overall Study|Lost to Follow-up|1|||
124663271|NCT02964338|448389975|FG001|Overall Study|Lost to Follow-up|0|||
124663272|NCT02964338|448389976|FG002|Overall Study|Lost to Follow-up|3|||
124663273|NCT02964338|448389974|FG000|Overall Study|Protocol Violation|0|||
124663274|NCT02964338|448389975|FG001|Overall Study|Protocol Violation|1|||
124663275|NCT02964338|448389976|FG002|Overall Study|Protocol Violation|0|||
124663276|NCT02964338|448389974|FG000|Overall Study|Withdrawal by Subject|1|||
124663277|NCT02964338|448389975|FG001|Overall Study|Withdrawal by Subject|3|||
124663278|NCT02964338|448389976|FG002|Overall Study|Withdrawal by Subject|1|||
124663279|NCT02964338|448389974|FG000|Overall Study|Adverse Event|2|||
124663280|NCT02964338|448389975|FG001|Overall Study|Adverse Event|1|||
124663281|NCT02964338|448389976|FG002|Overall Study|Adverse Event|1|||
124663282|NCT02964338|448389974|FG000|Overall Study|Non-compliant with e-diary|0|||
124663283|NCT02964338|448389975|FG001|Overall Study|Non-compliant with e-diary|1|||
124663284|NCT02964338|448389976|FG002|Overall Study|Non-compliant with e-diary|0|||
124663285|NCT02964338|448389974|FG000|Overall Study|Did not meet criteria|1|||
124663286|NCT02964338|448389975|FG001|Overall Study|Did not meet criteria|0|||
124663287|NCT02964338|448389976|FG002|Overall Study|Did not meet criteria|0|||
124663288|NCT00587795|448389977|FG000|Overall Study|Withdrawal by Subject|1|||
124663289|NCT00587795|448389978|FG001|Overall Study|Withdrawal by Subject|0|||
124663290|NCT05446142|448389987|FG000|Period 2|Adverse Event|1|||
124544309|NCT05182840|447946757|FG009|Treatment Period|Adverse Event|5|||
124663291|NCT05446142|448389988|FG001|Period 2|Adverse Event|0|||
124663292|NCT05446142|448389989|FG002|Period 2|Adverse Event|0|||
124663293|NCT05446142|448389990|FG003|Period 2|Adverse Event|0|||
124663294|NCT05446142|448389991|FG004|Period 2|Adverse Event|0|||
124663295|NCT05446142|448389992|FG005|Period 2|Adverse Event|0|||
124663296|NCT02098395|448389993|FG000|Overall Study|Protocol Violation|2|||
124663297|NCT02098395|448389994|FG001|Overall Study|Protocol Violation|2|||
124663298|NCT02098395|448389995|FG002|Overall Study|Protocol Violation|0|||
124663299|NCT02098395|448389996|FG003|Overall Study|Protocol Violation|7|||
124663300|NCT02098395|448389993|FG000|Overall Study|Withdrawal by Subject|10|||
124663301|NCT02098395|448389994|FG001|Overall Study|Withdrawal by Subject|10|||
124663302|NCT02098395|448389995|FG002|Overall Study|Withdrawal by Subject|5|||
124663303|NCT02098395|448389996|FG003|Overall Study|Withdrawal by Subject|13|||
124663304|NCT02098395|448389993|FG000|Overall Study|Adverse Event|12|||
124663305|NCT02098395|448389994|FG001|Overall Study|Adverse Event|19|||
124663306|NCT02098395|448389995|FG002|Overall Study|Adverse Event|34|||
124663307|NCT02098395|448389996|FG003|Overall Study|Adverse Event|2|||
124663308|NCT02098395|448389993|FG000|Overall Study|Lost to Follow-up|2|||
124663309|NCT02098395|448389994|FG001|Overall Study|Lost to Follow-up|1|||
124663310|NCT02098395|448389995|FG002|Overall Study|Lost to Follow-up|0|||
124663311|NCT02098395|448389996|FG003|Overall Study|Lost to Follow-up|3|||
124663312|NCT02098395|448389993|FG000|Overall Study|Unclassified|0|||
124663313|NCT02098395|448389994|FG001|Overall Study|Unclassified|0|||
124663314|NCT02098395|448389995|FG002|Overall Study|Unclassified|3|||
124663315|NCT02098395|448389996|FG003|Overall Study|Unclassified|2|||
124663316|NCT00547157|448389999|FG000|Overall Study|Other|1|||
124663317|NCT00547157|448390000|FG001|Overall Study|Other|0|||
124663318|NCT00547157|448389999|FG000|Overall Study|Death|38|||
124663319|NCT00547157|448390000|FG001|Overall Study|Death|18|||
124663320|NCT00547157|448389999|FG000|Overall Study|Withdrawal by Subject|3|||
124663321|NCT00547157|448390000|FG001|Overall Study|Withdrawal by Subject|1|||
124663322|NCT00547157|448389999|FG000|Overall Study|Administrative decision|3|||
124663323|NCT00547157|448390000|FG001|Overall Study|Administrative decision|2|||
124663324|NCT00547157|448389999|FG000|Overall Study|Lost to Follow-up|4|||
124663325|NCT00547157|448390000|FG001|Overall Study|Lost to Follow-up|2|||
124663326|NCT00110357|448390001|FG000|Overall Study|Deterioration without progression|2|||
124663327|NCT00110357|448390002|FG001|Overall Study|Deterioration without progression|0|||
124663328|NCT00110357|448390001|FG000|Overall Study|Disease progression/relapse|20|||
124663329|NCT00110357|448390002|FG001|Overall Study|Disease progression/relapse|15|||
124663330|NCT00110357|448390001|FG000|Overall Study|Study Closure|1|||
124663331|NCT00110357|448390002|FG001|Overall Study|Study Closure|0|||
124663332|NCT00110357|448390001|FG000|Overall Study|Study Drug Toxicity|1|||
124663333|NCT00110357|448390002|FG001|Overall Study|Study Drug Toxicity|3|||
124663334|NCT00110357|448390001|FG000|Overall Study|Withdrawal by Subject|3|||
124663335|NCT00110357|448390002|FG001|Overall Study|Withdrawal by Subject|1|||
124663336|NCT03382418|448390003|FG000|Overall Study|Withdrawal by Subject|1|||
124663337|NCT03382418|448390004|FG001|Overall Study|Withdrawal by Subject|0|||
124663338|NCT03382418|448390005|FG002|Overall Study|Withdrawal by Subject|0|||
124663339|NCT03382418|448390003|FG000|Overall Study|Lost to Follow-up|2|||
124663340|NCT03382418|448390004|FG001|Overall Study|Lost to Follow-up|3|||
124663341|NCT03382418|448390005|FG002|Overall Study|Lost to Follow-up|0|||
124663342|NCT04633226|448390006|FG000|Overall Study|Withdrawal by parent/guardian|4|||
124663343|NCT04633226|448390006|FG000|Overall Study|Randomized by mistake without study treatment|1|||
124663344|NCT01151345|448390008|FG000|First Intervention Period|Protocol Violation|0|||
124663345|NCT01151345|448390009|FG001|First Intervention Period|Protocol Violation|1|||
124872886|NCT01951638|449155788|FG003|Follow-up Period|Lost to Follow-up|1|||
124872887|NCT01951638|449155789|FG004|Follow-up Period|Lost to Follow-up|0|||
124872888|NCT01951638|449155785|FG000|Follow-up Period|Death|1|||
124872889|NCT01951638|449155786|FG001|Follow-up Period|Death|0|||
124872890|NCT01951638|449155787|FG002|Follow-up Period|Death|1|||
124872891|NCT01951638|449155788|FG003|Follow-up Period|Death|4|||
124872892|NCT01951638|449155789|FG004|Follow-up Period|Death|1|||
124872893|NCT01951638|449155785|FG000|Follow-up Period|Adverse Event|0|||
124872894|NCT01951638|449155786|FG001|Follow-up Period|Adverse Event|1|||
124872895|NCT01951638|449155787|FG002|Follow-up Period|Adverse Event|2|||
124872896|NCT01951638|449155788|FG003|Follow-up Period|Adverse Event|1|||
124872897|NCT01951638|449155789|FG004|Follow-up Period|Adverse Event|1|||
124872898|NCT00459342|449155792|FG000|Overall Study|Not eligible|1|||
124872899|NCT02686034|449155793|FG000|Run-In Period 1|Eligibility|12|||
124872900|NCT02686034|449155794|FG001|Run-In Period 1|Eligibility|10|||
124872901|NCT02686034|449155793|FG000|Run-In Period 1|Withdrawal by Subject|4|||
124872902|NCT02686034|449155794|FG001|Run-In Period 1|Withdrawal by Subject|3|||
124872903|NCT02686034|449155793|FG000|Run-In Period 1|Lost to Follow-up|4|||
124872904|NCT02686034|449155794|FG001|Run-In Period 1|Lost to Follow-up|4|||
124872905|NCT02686034|449155793|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
124872906|NCT02686034|449155794|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
124872907|NCT02686034|449155793|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
124872908|NCT02686034|449155794|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
124872909|NCT02686034|449155793|FG000|Randomized Controlled Period 2|Adverse Event|0|||
124872910|NCT02686034|449155794|FG001|Randomized Controlled Period 2|Adverse Event|2|||
124872911|NCT02686034|449155793|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
124872912|NCT02686034|449155794|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
124872913|NCT02686034|449155793|FG000|Open Label Period 3|Lost to Follow-up|0|||
124872914|NCT02686034|449155794|FG001|Open Label Period 3|Lost to Follow-up|1|||
124872915|NCT02243280|449157179|FG000|Treated|Adverse Event|1|||
124872916|NCT02243280|449157180|FG001|Treated|Adverse Event|0|||
124872917|NCT02243280|449157181|FG002|Treated|Adverse Event|0|||
124872918|NCT02243280|449157182|FG003|Treated|Adverse Event|0|||
124872919|NCT02243280|449157183|FG004|Treated|Adverse Event|0|||
124872920|NCT02243280|449157184|FG005|Treated|Adverse Event|0|||
124872921|NCT02243280|449157185|FG006|Treated|Adverse Event|0|||
124872922|NCT02243280|449157186|FG007|Treated|Adverse Event|0|||
124872923|NCT02243280|449157187|FG008|Treated|Adverse Event|0|||
124872924|NCT02243280|449157188|FG009|Treated|Adverse Event|0|||
124872925|NCT02243280|449157189|FG010|Treated|Adverse Event|1|||
124872926|NCT02243280|449157179|FG000|Treated|Lost to Follow-up|0|||
124872927|NCT02243280|449157180|FG001|Treated|Lost to Follow-up|0|||
124872928|NCT02243280|449157181|FG002|Treated|Lost to Follow-up|0|||
124872929|NCT02243280|449157182|FG003|Treated|Lost to Follow-up|0|||
124872930|NCT02243280|449157183|FG004|Treated|Lost to Follow-up|0|||
124872931|NCT02243280|449157184|FG005|Treated|Lost to Follow-up|0|||
124872932|NCT02243280|449157185|FG006|Treated|Lost to Follow-up|0|||
124872933|NCT02243280|449157186|FG007|Treated|Lost to Follow-up|0|||
124872934|NCT02243280|449157187|FG008|Treated|Lost to Follow-up|1|||
124872935|NCT02243280|449157188|FG009|Treated|Lost to Follow-up|0|||
124872936|NCT02243280|449157189|FG010|Treated|Lost to Follow-up|2|||
124872937|NCT00998400|449157194|FG000|Overall Study|Lack of interest/motivation|1|||
124872938|NCT00998400|449157195|FG001|Overall Study|Lack of interest/motivation|2|||
124872939|NCT00998400|449157194|FG000|Overall Study|Logistical problems|1|||
124872940|NCT00998400|449157195|FG001|Overall Study|Logistical problems|0|||
124872941|NCT01083641|449157196|FG000|Overall Study|Withdrawal by Subject|2|||
124872942|NCT03439189|449157197|FG000|Overall Study|Protocol Violation|19|||
124872943|NCT03439189|449157197|FG000|Overall Study|Lack of Efficacy|63|||
124872944|NCT01777321|449157198|FG000|Overall Study|Withdrawal by Subject|0|||
124872945|NCT01777321|449157199|FG001|Overall Study|Withdrawal by Subject|1|||
124872946|NCT01807156|449157200|FG000|Overall Study|Physician Decision|1|||
124872947|NCT03122119|449157203|FG000|Overall Study|Did not meet eligibility critria|1|||
124872948|NCT01493687|449157205|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
124872949|NCT01493687|449157206|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
124872950|NCT01493687|449157205|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
124872951|NCT01493687|449157206|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
124872952|NCT01493687|449157205|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
124872953|NCT01493687|449157206|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
124872954|NCT01493687|449157205|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
124872955|NCT01493687|449157206|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
124872956|NCT01493687|449157205|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
124872957|NCT01493687|449157206|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
124872958|NCT01493687|449157205|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
124872959|NCT01493687|449157206|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
124872960|NCT01493687|449157205|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
124663346|NCT04208412|448390011|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
124663347|NCT04208412|448390012|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
124663348|NCT04208412|448390011|FG000|Overall Study|Withdrawal by Subject|1|||
124663349|NCT04208412|448390012|FG001|Overall Study|Withdrawal by Subject|0|||
124663350|NCT04208412|448390011|FG000|Overall Study|Lost to Follow-up|0|||
124663351|NCT04208412|448390012|FG001|Overall Study|Lost to Follow-up|1|||
124663352|NCT00420628|448390017|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
124663353|NCT00420628|448390018|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
124663354|NCT00420628|448390017|FG000|Overall Study|Lost to Follow-up|3|||
124663355|NCT00420628|448390018|FG001|Overall Study|Lost to Follow-up|2|||
124663356|NCT00420628|448390017|FG000|Overall Study|Adverse Event|1|||
124663357|NCT00420628|448390018|FG001|Overall Study|Adverse Event|0|||
124663358|NCT05095311|448390028|FG000|Overall Study|Lost to Follow-up|7|||
124663359|NCT05095311|448390029|FG001|Overall Study|Lost to Follow-up|0|||
124663360|NCT05095311|448390030|FG002|Overall Study|Lost to Follow-up|0|||
124663361|NCT02588664|448390033|FG000|Overall Study|Death|56|||
124663362|NCT02588664|448390034|FG001|Overall Study|Death|55|||
124663363|NCT02588664|448390033|FG000|Overall Study|Lost to Follow-up|1305|||
124663364|NCT02588664|448390034|FG001|Overall Study|Lost to Follow-up|990|||
124663365|NCT01429298|448390035|FG000|Overall Study|Protocol Violation|4|||
124663366|NCT01429298|448390036|FG001|Overall Study|Protocol Violation|6|||
124663367|NCT03092791|448390040|FG000|Overall Study|Lost to Follow-up|0|||
124663368|NCT03092791|448390041|FG001|Overall Study|Lost to Follow-up|0|||
124663369|NCT03092791|448390042|FG002|Overall Study|Lost to Follow-up|0|||
124663370|NCT03092791|448390043|FG003|Overall Study|Lost to Follow-up|0|||
124663371|NCT03092791|448390044|FG004|Overall Study|Lost to Follow-up|0|||
124663372|NCT03092791|448390045|FG005|Overall Study|Lost to Follow-up|0|||
124663373|NCT03092791|448390046|FG006|Overall Study|Lost to Follow-up|1|||
124663374|NCT03092791|448390047|FG007|Overall Study|Lost to Follow-up|0|||
124663375|NCT03092791|448390040|FG000|Overall Study|Withdrawal of Consent|0|||
124663376|NCT03092791|448390041|FG001|Overall Study|Withdrawal of Consent|0|||
124663377|NCT03092791|448390042|FG002|Overall Study|Withdrawal of Consent|0|||
124663378|NCT03092791|448390043|FG003|Overall Study|Withdrawal of Consent|0|||
124663379|NCT03092791|448390044|FG004|Overall Study|Withdrawal of Consent|4|||
124663380|NCT03092791|448390045|FG005|Overall Study|Withdrawal of Consent|12|||
124663381|NCT03092791|448390046|FG006|Overall Study|Withdrawal of Consent|6|||
124663382|NCT03092791|448390047|FG007|Overall Study|Withdrawal of Consent|4|||
124663383|NCT03092791|448390040|FG000|Overall Study|Study Termination|0|||
124663384|NCT03092791|448390041|FG001|Overall Study|Study Termination|0|||
124663385|NCT03092791|448390042|FG002|Overall Study|Study Termination|0|||
124663386|NCT03092791|448390043|FG003|Overall Study|Study Termination|0|||
124663387|NCT03092791|448390044|FG004|Overall Study|Study Termination|55|||
124663388|NCT03092791|448390045|FG005|Overall Study|Study Termination|46|||
124663389|NCT03092791|448390046|FG006|Overall Study|Study Termination|53|||
124663390|NCT03092791|448390047|FG007|Overall Study|Study Termination|55|||
124663391|NCT03092791|448390040|FG000|Overall Study|Death|0|||
124663392|NCT03092791|448390041|FG001|Overall Study|Death|0|||
124663393|NCT03092791|448390042|FG002|Overall Study|Death|0|||
124663394|NCT03092791|448390043|FG003|Overall Study|Death|0|||
124663395|NCT03092791|448390044|FG004|Overall Study|Death|0|||
124663396|NCT03092791|448390045|FG005|Overall Study|Death|1|||
124663397|NCT03092791|448390046|FG006|Overall Study|Death|0|||
124663398|NCT03092791|448390047|FG007|Overall Study|Death|1|||
124663399|NCT03092791|448390040|FG000|Overall Study|Reason Not Specified|0|||
124663400|NCT03092791|448390041|FG001|Overall Study|Reason Not Specified|0|||
124663401|NCT03092791|448390042|FG002|Overall Study|Reason Not Specified|0|||
124663402|NCT03092791|448390043|FG003|Overall Study|Reason Not Specified|0|||
124663403|NCT03092791|448390044|FG004|Overall Study|Reason Not Specified|1|||
124663404|NCT03092791|448390045|FG005|Overall Study|Reason Not Specified|1|||
124663405|NCT03092791|448390046|FG006|Overall Study|Reason Not Specified|0|||
124663406|NCT03092791|448390047|FG007|Overall Study|Reason Not Specified|0|||
124663407|NCT02348008|448390048|FG000|Overall Study|Adverse Event|2|||
124663408|NCT02348008|448390049|FG001|Overall Study|Adverse Event|3|||
124663409|NCT02348008|448390050|FG002|Overall Study|Adverse Event|3|||
124663410|NCT02348008|448390048|FG000|Overall Study|Disease Progression|1|||
124663411|NCT02348008|448390049|FG001|Overall Study|Disease Progression|5|||
124663412|NCT02348008|448390050|FG002|Overall Study|Disease Progression|16|||
124663413|NCT02348008|448390048|FG000|Overall Study|Withdrawal by Subject|0|||
124663414|NCT02348008|448390049|FG001|Overall Study|Withdrawal by Subject|1|||
124663415|NCT02348008|448390050|FG002|Overall Study|Withdrawal by Subject|0|||
124663416|NCT02348008|448390048|FG000|Overall Study|Symptomatic Deterioration|0|||
124663417|NCT02348008|448390049|FG001|Overall Study|Symptomatic Deterioration|1|||
124663418|NCT02348008|448390050|FG002|Overall Study|Symptomatic Deterioration|0|||
124663419|NCT00792116|448390056|FG000|Overall Study|Lost to Follow-up|0|||
124663420|NCT00792116|448390057|FG001|Overall Study|Lost to Follow-up|1|||
124663421|NCT00792116|448390056|FG000|Overall Study|Discontnued intervention|1|||
124663422|NCT00792116|448390057|FG001|Overall Study|Discontnued intervention|0|||
124663423|NCT03335813|448391582|FG000|Overall Study|Withdrawal by Subject|1|||
124663424|NCT01724177|448391583|FG000|Overall Study|Adverse Event|8|||
124663425|NCT01724177|448391583|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
124663426|NCT01724177|448391583|FG000|Overall Study|Nervous participant|1|||
124663427|NCT01724177|448391583|FG000|Overall Study|Serious Adverse Event Related|1|||
124663428|NCT00141518|448391598|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
124663429|NCT00141518|448391599|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
124663430|NCT00141518|448391600|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
124663431|NCT00141518|448391598|FG000|Overall Study|Adverse Event|7|||
124663432|NCT00141518|448391599|FG001|Overall Study|Adverse Event|5|||
124663433|NCT00141518|448391600|FG002|Overall Study|Adverse Event|2|||
124663434|NCT00141518|448391598|FG000|Overall Study|Withdrawal by Subject|2|||
124663435|NCT00141518|448391599|FG001|Overall Study|Withdrawal by Subject|0|||
124663436|NCT00141518|448391600|FG002|Overall Study|Withdrawal by Subject|2|||
124663437|NCT00141518|448391598|FG000|Overall Study|Protocol Violation|1|||
124663438|NCT00141518|448391599|FG001|Overall Study|Protocol Violation|1|||
124663439|NCT00141518|448391600|FG002|Overall Study|Protocol Violation|2|||
124663440|NCT00141518|448391598|FG000|Overall Study|Lack of Efficacy|5|||
124663441|NCT00141518|448391599|FG001|Overall Study|Lack of Efficacy|0|||
124663442|NCT00141518|448391600|FG002|Overall Study|Lack of Efficacy|0|||
124663443|NCT01806168|448391602|FG000|Overall Study|Adverse Event|1|||
124663444|NCT01806168|448391603|FG001|Overall Study|Adverse Event|0|||
124663445|NCT01806168|448391604|FG002|Overall Study|Adverse Event|0|||
124663446|NCT01806168|448391602|FG000|Overall Study|Withdrawal by Subject|0|||
124663447|NCT01806168|448391603|FG001|Overall Study|Withdrawal by Subject|1|||
124663448|NCT01806168|448391604|FG002|Overall Study|Withdrawal by Subject|2|||
124663449|NCT01806168|448391602|FG000|Overall Study|Protocol Violation|0|||
124663450|NCT01806168|448391603|FG001|Overall Study|Protocol Violation|0|||
124663451|NCT01806168|448391604|FG002|Overall Study|Protocol Violation|1|||
124663452|NCT02438280|448391609|FG000|Overall Study|Physician Decision|1|||
124663453|NCT02438280|448391610|FG001|Overall Study|Physician Decision|0|||
124663454|NCT03066778|448391613|FG000|Overall Study|Death|195|||
124663455|NCT03066778|448391614|FG001|Overall Study|Death|205|||
124663456|NCT03066778|448391613|FG000|Overall Study|Withdrawal by Subject|5|||
124663457|NCT03066778|448391614|FG001|Overall Study|Withdrawal by Subject|7|||
124663458|NCT02328937|448391615|FG000|Period 1|Lost to Follow-up|0|||
124663459|NCT02328937|448391616|FG001|Period 1|Lost to Follow-up|0|||
124663460|NCT02328937|448391617|FG002|Period 1|Lost to Follow-up|0|||
124663461|NCT02328937|448391618|FG003|Period 1|Lost to Follow-up|1|||
124663462|NCT02328937|448391619|FG004|Period 1|Lost to Follow-up|0|||
124663463|NCT02328937|448391620|FG005|Period 1|Lost to Follow-up|0|||
124663464|NCT02328937|448391615|FG000|Period 2|Adverse Event|0|||
124663465|NCT02328937|448391616|FG001|Period 2|Adverse Event|0|||
124663466|NCT02328937|448391617|FG002|Period 2|Adverse Event|1|||
124663467|NCT02328937|448391618|FG003|Period 2|Adverse Event|0|||
124663468|NCT02328937|448391619|FG004|Period 2|Adverse Event|0|||
124663469|NCT02328937|448391620|FG005|Period 2|Adverse Event|0|||
124663470|NCT02091414|448391621|FG000|Overall Study|Withdrawal by Subject|2|||
124663471|NCT02091414|448391621|FG000|Overall Study|Death|2|||
124663472|NCT03665077|448391624|FG000|Overall Study|Lost to Follow-up|2|||
124663473|NCT03665077|448391624|FG000|Overall Study|Physician Decision|2|||
124663474|NCT02959918|448391625|FG000|Overall Study|Adverse Event|1|||
124663475|NCT02959918|448391626|FG001|Overall Study|Adverse Event|1|||
124663476|NCT02959918|448391627|FG002|Overall Study|Adverse Event|2|||
124663477|NCT02959918|448391628|FG003|Overall Study|Adverse Event|0|||
124663478|NCT02959918|448391629|FG004|Overall Study|Adverse Event|0|||
124663479|NCT02959918|448391630|FG005|Overall Study|Adverse Event|2|||
124663480|NCT02959918|448391631|FG006|Overall Study|Adverse Event|2|||
124663481|NCT02959918|448391632|FG007|Overall Study|Adverse Event|1|||
124663482|NCT02959918|448391633|FG008|Overall Study|Adverse Event|2|||
124663483|NCT02959918|448391634|FG009|Overall Study|Adverse Event|1|||
124663484|NCT02959918|448391635|FG010|Overall Study|Adverse Event|1|||
124663485|NCT02959918|448391636|FG011|Overall Study|Adverse Event|3|||
124663486|NCT02959918|448391637|FG012|Overall Study|Adverse Event|2|||
124663487|NCT02959918|448391638|FG013|Overall Study|Adverse Event|4|||
124663488|NCT02959918|448391625|FG000|Overall Study|Lost to Follow-up|0|||
124663489|NCT02959918|448391626|FG001|Overall Study|Lost to Follow-up|0|||
124663490|NCT02959918|448391627|FG002|Overall Study|Lost to Follow-up|0|||
124663491|NCT02959918|448391628|FG003|Overall Study|Lost to Follow-up|0|||
124663492|NCT02959918|448391629|FG004|Overall Study|Lost to Follow-up|0|||
124663493|NCT02959918|448391630|FG005|Overall Study|Lost to Follow-up|0|||
124663494|NCT02959918|448391631|FG006|Overall Study|Lost to Follow-up|0|||
124663495|NCT02959918|448391632|FG007|Overall Study|Lost to Follow-up|0|||
124663496|NCT02959918|448391633|FG008|Overall Study|Lost to Follow-up|0|||
124663497|NCT02959918|448391634|FG009|Overall Study|Lost to Follow-up|1|||
124663498|NCT02959918|448391635|FG010|Overall Study|Lost to Follow-up|0|||
124663499|NCT02959918|448391636|FG011|Overall Study|Lost to Follow-up|0|||
124663500|NCT02959918|448391637|FG012|Overall Study|Lost to Follow-up|1|||
124663501|NCT02959918|448391638|FG013|Overall Study|Lost to Follow-up|0|||
124663502|NCT02959918|448391625|FG000|Overall Study|Withdrawal by Subject|0|||
124663503|NCT02959918|448391626|FG001|Overall Study|Withdrawal by Subject|0|||
124663504|NCT02959918|448391627|FG002|Overall Study|Withdrawal by Subject|1|||
124663505|NCT02959918|448391628|FG003|Overall Study|Withdrawal by Subject|2|||
124663506|NCT02959918|448391629|FG004|Overall Study|Withdrawal by Subject|0|||
124663507|NCT02959918|448391630|FG005|Overall Study|Withdrawal by Subject|0|||
124663508|NCT02959918|448391631|FG006|Overall Study|Withdrawal by Subject|1|||
124663509|NCT02959918|448391632|FG007|Overall Study|Withdrawal by Subject|0|||
124663510|NCT02959918|448391633|FG008|Overall Study|Withdrawal by Subject|1|||
124663511|NCT02959918|448391634|FG009|Overall Study|Withdrawal by Subject|1|||
124663512|NCT02959918|448391635|FG010|Overall Study|Withdrawal by Subject|2|||
124663513|NCT02959918|448391636|FG011|Overall Study|Withdrawal by Subject|3|||
124663514|NCT02959918|448391637|FG012|Overall Study|Withdrawal by Subject|1|||
124663515|NCT02959918|448391638|FG013|Overall Study|Withdrawal by Subject|1|||
124663516|NCT02959918|448391625|FG000|Overall Study|Protocol Violation|0|||
124663517|NCT02959918|448391626|FG001|Overall Study|Protocol Violation|0|||
124663518|NCT02959918|448391627|FG002|Overall Study|Protocol Violation|1|||
124663519|NCT02959918|448391628|FG003|Overall Study|Protocol Violation|0|||
124663520|NCT02959918|448391629|FG004|Overall Study|Protocol Violation|0|||
124663521|NCT02959918|448391630|FG005|Overall Study|Protocol Violation|1|||
124663522|NCT02959918|448391631|FG006|Overall Study|Protocol Violation|0|||
124663523|NCT02959918|448391632|FG007|Overall Study|Protocol Violation|0|||
124663524|NCT02959918|448391633|FG008|Overall Study|Protocol Violation|2|||
124663525|NCT02959918|448391634|FG009|Overall Study|Protocol Violation|1|||
124663526|NCT02959918|448391635|FG010|Overall Study|Protocol Violation|0|||
124663527|NCT02959918|448391636|FG011|Overall Study|Protocol Violation|1|||
124663528|NCT02959918|448391637|FG012|Overall Study|Protocol Violation|1|||
124663529|NCT02959918|448391638|FG013|Overall Study|Protocol Violation|0|||
124663530|NCT02959918|448391625|FG000|Overall Study|Stopping Rule Met|1|||
124663531|NCT02959918|448391626|FG001|Overall Study|Stopping Rule Met|0|||
124663532|NCT02959918|448391627|FG002|Overall Study|Stopping Rule Met|3|||
124663533|NCT02959918|448391628|FG003|Overall Study|Stopping Rule Met|4|||
124663534|NCT02959918|448391629|FG004|Overall Study|Stopping Rule Met|5|||
124663535|NCT02959918|448391630|FG005|Overall Study|Stopping Rule Met|3|||
124663536|NCT02959918|448391631|FG006|Overall Study|Stopping Rule Met|2|||
124663537|NCT02959918|448391632|FG007|Overall Study|Stopping Rule Met|4|||
124663538|NCT02959918|448391633|FG008|Overall Study|Stopping Rule Met|1|||
124663539|NCT02959918|448391634|FG009|Overall Study|Stopping Rule Met|1|||
124663540|NCT02959918|448391635|FG010|Overall Study|Stopping Rule Met|3|||
124663541|NCT02959918|448391636|FG011|Overall Study|Stopping Rule Met|5|||
124663542|NCT02959918|448391637|FG012|Overall Study|Stopping Rule Met|2|||
124663543|NCT02959918|448391638|FG013|Overall Study|Stopping Rule Met|1|||
124663544|NCT02959918|448391625|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
124663545|NCT02959918|448391626|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
124663546|NCT02959918|448391627|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
124663547|NCT02959918|448391628|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
124663548|NCT02959918|448391629|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
124663549|NCT02959918|448391630|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
124663550|NCT02959918|448391631|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
124663551|NCT02959918|448391632|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
124663552|NCT02959918|448391633|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
124663553|NCT02959918|448391634|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
124663554|NCT02959918|448391635|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
124663555|NCT02959918|448391636|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
124663556|NCT02959918|448391637|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
124663557|NCT02959918|448391638|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
124663558|NCT02959918|448391625|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
124663559|NCT02959918|448391626|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
124663560|NCT02959918|448391627|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
124663561|NCT02959918|448391628|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
124663562|NCT02959918|448391629|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
124663563|NCT02959918|448391630|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
124663564|NCT02959918|448391631|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
124663565|NCT02959918|448391632|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
124663566|NCT02959918|448391633|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
124663567|NCT02959918|448391634|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
124663568|NCT02959918|448391635|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
124663569|NCT02959918|448391636|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
124663570|NCT02959918|448391637|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
124663571|NCT02959918|448391638|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
124663572|NCT02959918|448391625|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
124663573|NCT02959918|448391626|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
124663574|NCT02959918|448391627|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
124663575|NCT02959918|448391628|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
124872961|NCT01493687|449157206|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
124663576|NCT02959918|448391629|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
124663577|NCT02959918|448391630|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
124663578|NCT02959918|448391631|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
124663579|NCT02959918|448391632|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
124663580|NCT02959918|448391633|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
124663581|NCT02959918|448391634|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
124663582|NCT02959918|448391635|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
124663583|NCT02959918|448391636|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
124663584|NCT02959918|448391637|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
124663585|NCT02959918|448391638|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
124663586|NCT02959918|448391625|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
124663587|NCT02959918|448391626|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
124663588|NCT02959918|448391627|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
124663589|NCT02959918|448391628|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
124663590|NCT02959918|448391629|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
124663591|NCT02959918|448391630|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
124663592|NCT02959918|448391631|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
124663593|NCT02959918|448391632|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
124663594|NCT02959918|448391633|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
124663595|NCT02959918|448391634|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
124663596|NCT02959918|448391635|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
124663597|NCT02959918|448391636|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
124663598|NCT02959918|448391637|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
124663599|NCT02959918|448391638|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
124663600|NCT03231306|448391639|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
124663601|NCT03231306|448391639|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
124663602|NCT03231306|448391639|FG000|Overall Study|Treatment delay > 21 days|2|||
124663603|NCT03231306|448391639|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
124663604|NCT03231306|448391639|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
124663605|NCT03231306|448391639|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
124663606|NCT03231306|448391639|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
124663607|NCT03231306|448391639|FG000|Overall Study|More than 1 Reason|2|||
124663608|NCT02306850|448391640|FG000|Overall Study|Lack of Efficacy|2|||
124663609|NCT00237692|448391641|FG000|Overall Study|Lost to Follow-up|9|||
124663610|NCT00237692|448391642|FG001|Overall Study|Lost to Follow-up|3|||
124663611|NCT00237692|448391643|FG002|Overall Study|Lost to Follow-up|5|||
124663612|NCT00237692|448391644|FG003|Overall Study|Lost to Follow-up|3|||
124663613|NCT00237692|448391641|FG000|Overall Study|Death|1|||
124663614|NCT00237692|448391642|FG001|Overall Study|Death|2|||
124663615|NCT00237692|448391643|FG002|Overall Study|Death|2|||
124663616|NCT00237692|448391644|FG003|Overall Study|Death|3|||
124663617|NCT00237692|448391641|FG000|Overall Study|Excluded - did not meet criteria|4|||
124663618|NCT00237692|448391642|FG001|Overall Study|Excluded - did not meet criteria|3|||
124663619|NCT00237692|448391643|FG002|Overall Study|Excluded - did not meet criteria|5|||
124663620|NCT00237692|448391644|FG003|Overall Study|Excluded - did not meet criteria|9|||
124663621|NCT00237692|448391641|FG000|Overall Study|Withdrawal by Subject|4|||
124663622|NCT00237692|448391642|FG001|Overall Study|Withdrawal by Subject|6|||
124663623|NCT00237692|448391643|FG002|Overall Study|Withdrawal by Subject|10|||
124663624|NCT00237692|448391644|FG003|Overall Study|Withdrawal by Subject|4|||
124663625|NCT00685360|448391647|FG000|Overall Study|Lost to Follow-up|0|||
124663626|NCT00685360|448391648|FG001|Overall Study|Lost to Follow-up|1|||
124663627|NCT00685360|448391649|FG002|Overall Study|Lost to Follow-up|2|||
124663628|NCT00685360|448391647|FG000|Overall Study|Adverse Event|4|||
124663629|NCT00685360|448391648|FG001|Overall Study|Adverse Event|6|||
124663630|NCT00685360|448391649|FG002|Overall Study|Adverse Event|4|||
124663631|NCT00685360|448391647|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
124663632|NCT00685360|448391648|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
124663633|NCT00685360|448391649|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
124663634|NCT00685360|448391647|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
124663635|NCT00685360|448391648|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
124663636|NCT00685360|448391649|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
124663637|NCT00685360|448391647|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
124663638|NCT00685360|448391648|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
124663639|NCT00685360|448391649|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
124663640|NCT00685360|448391647|FG000|Overall Study|Protocol Deviation|0|||
124663641|NCT00685360|448391648|FG001|Overall Study|Protocol Deviation|1|||
124663642|NCT00685360|448391649|FG002|Overall Study|Protocol Deviation|1|||
124663643|NCT04865419|448391659|FG000|Overall Study|Other|1|||
124663644|NCT04865419|448391660|FG001|Overall Study|Other|2|||
124663645|NCT04865419|448391661|FG002|Overall Study|Other|2|||
124663646|NCT04865419|448391662|FG003|Overall Study|Other|1|||
124663647|NCT04865419|448391663|FG004|Overall Study|Other|3|||
124663648|NCT04865419|448391664|FG005|Overall Study|Other|0|||
124663649|NCT04865419|448391665|FG006|Overall Study|Other|0|||
124663650|NCT04865419|448391666|FG007|Overall Study|Other|1|||
124663651|NCT04865419|448391667|FG008|Overall Study|Other|0|||
124663652|NCT04865419|448391668|FG009|Overall Study|Other|0|||
124663653|NCT04865419|448391669|FG010|Overall Study|Other|0|||
124663654|NCT04865419|448391659|FG000|Overall Study|Withdrawal by Subject|0|||
124663655|NCT04865419|448391660|FG001|Overall Study|Withdrawal by Subject|1|||
124663656|NCT04865419|448391661|FG002|Overall Study|Withdrawal by Subject|1|||
124663657|NCT04865419|448391662|FG003|Overall Study|Withdrawal by Subject|0|||
124663658|NCT04865419|448391663|FG004|Overall Study|Withdrawal by Subject|0|||
124663659|NCT04865419|448391664|FG005|Overall Study|Withdrawal by Subject|0|||
124663660|NCT04865419|448391665|FG006|Overall Study|Withdrawal by Subject|0|||
124663661|NCT04865419|448391666|FG007|Overall Study|Withdrawal by Subject|1|||
124663662|NCT04865419|448391667|FG008|Overall Study|Withdrawal by Subject|2|||
124663663|NCT04865419|448391668|FG009|Overall Study|Withdrawal by Subject|1|||
124663664|NCT04865419|448391669|FG010|Overall Study|Withdrawal by Subject|0|||
124663665|NCT04865419|448391659|FG000|Overall Study|Study terminated by Sponsor|0|||
124663666|NCT04865419|448391660|FG001|Overall Study|Study terminated by Sponsor|0|||
124663667|NCT04865419|448391661|FG002|Overall Study|Study terminated by Sponsor|0|||
124663668|NCT04865419|448391662|FG003|Overall Study|Study terminated by Sponsor|2|||
124663669|NCT04865419|448391663|FG004|Overall Study|Study terminated by Sponsor|2|||
124663670|NCT04865419|448391664|FG005|Overall Study|Study terminated by Sponsor|0|||
124663671|NCT04865419|448391665|FG006|Overall Study|Study terminated by Sponsor|0|||
124663672|NCT04865419|448391666|FG007|Overall Study|Study terminated by Sponsor|0|||
124663673|NCT04865419|448391667|FG008|Overall Study|Study terminated by Sponsor|0|||
124663674|NCT04865419|448391668|FG009|Overall Study|Study terminated by Sponsor|0|||
124663675|NCT04865419|448391669|FG010|Overall Study|Study terminated by Sponsor|1|||
124663676|NCT04865419|448391659|FG000|Overall Study|Death|3|||
124663677|NCT04865419|448391660|FG001|Overall Study|Death|1|||
124663678|NCT04865419|448391661|FG002|Overall Study|Death|4|||
124663679|NCT04865419|448391662|FG003|Overall Study|Death|2|||
124663680|NCT04865419|448391663|FG004|Overall Study|Death|5|||
124663681|NCT04865419|448391664|FG005|Overall Study|Death|2|||
124663682|NCT04865419|448391665|FG006|Overall Study|Death|1|||
124663683|NCT04865419|448391666|FG007|Overall Study|Death|1|||
124663684|NCT04865419|448391667|FG008|Overall Study|Death|2|||
124663685|NCT04865419|448391668|FG009|Overall Study|Death|2|||
124663686|NCT04865419|448391669|FG010|Overall Study|Death|1|||
124663687|NCT04865419|448391659|FG000|Overall Study|Lost to Follow-up|0|||
124663688|NCT04865419|448391660|FG001|Overall Study|Lost to Follow-up|0|||
124663689|NCT04865419|448391661|FG002|Overall Study|Lost to Follow-up|0|||
124663690|NCT04865419|448391662|FG003|Overall Study|Lost to Follow-up|0|||
124663691|NCT04865419|448391663|FG004|Overall Study|Lost to Follow-up|0|||
124663692|NCT04865419|448391664|FG005|Overall Study|Lost to Follow-up|0|||
124663693|NCT04865419|448391665|FG006|Overall Study|Lost to Follow-up|0|||
124663694|NCT04865419|448391666|FG007|Overall Study|Lost to Follow-up|0|||
124663695|NCT04865419|448391667|FG008|Overall Study|Lost to Follow-up|0|||
124663696|NCT04865419|448391668|FG009|Overall Study|Lost to Follow-up|1|||
124663697|NCT04865419|448391669|FG010|Overall Study|Lost to Follow-up|0|||
124663698|NCT05415462|448391672|FG000|Overall Study|Death|18|||
124663699|NCT05415462|448391673|FG001|Overall Study|Death|10|||
124663700|NCT05415462|448391672|FG000|Overall Study|Lost to Follow-up|72|||
124663701|NCT05415462|448391673|FG001|Overall Study|Lost to Follow-up|64|||
124663702|NCT05415462|448391672|FG000|Overall Study|Physician Decision|5|||
124663703|NCT05415462|448391673|FG001|Overall Study|Physician Decision|5|||
124663704|NCT05415462|448391672|FG000|Overall Study|Protocol Deviation|1|||
124663705|NCT05415462|448391673|FG001|Overall Study|Protocol Deviation|0|||
124663706|NCT05415462|448391672|FG000|Overall Study|Withdrawal by Subject|129|||
124663707|NCT05415462|448391673|FG001|Overall Study|Withdrawal by Subject|101|||
124663708|NCT05415462|448391672|FG000|Overall Study|Other Than Specified|8|||
124663709|NCT05415462|448391673|FG001|Overall Study|Other Than Specified|8|||
124663710|NCT01348100|448391674|FG000|Overall Study|Subject Withdrew Consent|0|||
124663711|NCT01348100|448391675|FG001|Overall Study|Subject Withdrew Consent|0|||
124663712|NCT01348100|448391676|FG002|Overall Study|Subject Withdrew Consent|2|||
124663713|NCT01348100|448391677|FG003|Overall Study|Subject Withdrew Consent|0|||
124663714|NCT01348100|448391678|FG004|Overall Study|Subject Withdrew Consent|1|||
124663715|NCT01348100|448391679|FG005|Overall Study|Subject Withdrew Consent|0|||
124663716|NCT01348100|448391680|FG006|Overall Study|Subject Withdrew Consent|1|||
124663717|NCT01348100|448391674|FG000|Overall Study|Protocol Deviation|0|||
124663718|NCT01348100|448391675|FG001|Overall Study|Protocol Deviation|0|||
124663719|NCT01348100|448391676|FG002|Overall Study|Protocol Deviation|0|||
124663720|NCT01348100|448391677|FG003|Overall Study|Protocol Deviation|1|||
124663721|NCT01348100|448391678|FG004|Overall Study|Protocol Deviation|0|||
124663722|NCT01348100|448391679|FG005|Overall Study|Protocol Deviation|0|||
124663723|NCT01348100|448391680|FG006|Overall Study|Protocol Deviation|0|||
124663724|NCT01348100|448391674|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124663725|NCT01348100|448391675|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124663726|NCT01348100|448391676|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124663727|NCT01348100|448391677|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124663728|NCT01348100|448391678|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124663729|NCT01348100|448391679|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
124663730|NCT01348100|448391680|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124663731|NCT01348100|448391674|FG000|Overall Study|Lost to Follow-up|0|||
124663732|NCT01348100|448391675|FG001|Overall Study|Lost to Follow-up|0|||
124663733|NCT01348100|448391676|FG002|Overall Study|Lost to Follow-up|0|||
124663734|NCT01348100|448391677|FG003|Overall Study|Lost to Follow-up|0|||
124663735|NCT01348100|448391678|FG004|Overall Study|Lost to Follow-up|0|||
124663736|NCT01348100|448391679|FG005|Overall Study|Lost to Follow-up|0|||
124663737|NCT01348100|448391680|FG006|Overall Study|Lost to Follow-up|1|||
124663738|NCT01348100|448391674|FG000|Overall Study|Administrative Problems|0|||
124663739|NCT01348100|448391675|FG001|Overall Study|Administrative Problems|0|||
124663740|NCT01348100|448391676|FG002|Overall Study|Administrative Problems|0|||
124663741|NCT01348100|448391677|FG003|Overall Study|Administrative Problems|0|||
124663742|NCT01348100|448391678|FG004|Overall Study|Administrative Problems|0|||
124663743|NCT01348100|448391679|FG005|Overall Study|Administrative Problems|1|||
124663744|NCT01348100|448391680|FG006|Overall Study|Administrative Problems|1|||
124663745|NCT03882957|448391683|FG000|Overall Study|Did not complete all three arms|1|||
124663746|NCT04186221|448391688|FG000|Overall Study|Death|1|||
124663747|NCT01134393|448391689|FG000|Overall Study|Adverse Event|18|||
124663748|NCT01134393|448391689|FG000|Overall Study|Lack of Efficacy|2|||
124663749|NCT01134393|448391689|FG000|Overall Study|Protocol Violation|12|||
124663750|NCT01134393|448391689|FG000|Overall Study|Lost to Follow-up|3|||
124663751|NCT01134393|448391689|FG000|Overall Study|Withdrawal by Subject|11|||
124663752|NCT01134393|448391689|FG000|Overall Study|Other|6|||
124663753|NCT00531947|448391690|FG000|Overall Study|Adverse Event|5|||
124663754|NCT00531947|448391691|FG001|Overall Study|Adverse Event|10|||
124663755|NCT00531947|448391690|FG000|Overall Study|Lost to Follow-up|12|||
124663756|NCT00531947|448391691|FG001|Overall Study|Lost to Follow-up|9|||
124663757|NCT00531947|448391690|FG000|Overall Study|Withdrawal by Subject|14|||
124663758|NCT00531947|448391691|FG001|Overall Study|Withdrawal by Subject|19|||
124663759|NCT00531947|448391690|FG000|Overall Study|Protocol Violation|2|||
124663760|NCT00531947|448391691|FG001|Overall Study|Protocol Violation|1|||
124663761|NCT00531947|448391690|FG000|Overall Study|Non-Compliance|4|||
124663762|NCT00531947|448391691|FG001|Overall Study|Non-Compliance|7|||
124663763|NCT00531947|448391690|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
124663764|NCT00531947|448391691|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
124663765|NCT02903420|448391693|FG000|Overall Study|Death|3|||
124663766|NCT00980655|448391695|FG000|Overall Study|Adverse Event|13|||
124663767|NCT00980655|448391696|FG001|Overall Study|Adverse Event|31|||
124663768|NCT00980655|448391695|FG000|Overall Study|Death|0|||
124663769|NCT00980655|448391696|FG001|Overall Study|Death|7|||
124663770|NCT00980655|448391695|FG000|Overall Study|Protocol Violation|2|||
124663771|NCT00980655|448391696|FG001|Overall Study|Protocol Violation|7|||
124663772|NCT00980655|448391695|FG000|Overall Study|Withdrawal by Subject|0|||
124663773|NCT00980655|448391696|FG001|Overall Study|Withdrawal by Subject|4|||
124663774|NCT00980655|448391695|FG000|Overall Study|Lost to Follow-up|0|||
124663775|NCT00980655|448391696|FG001|Overall Study|Lost to Follow-up|1|||
124663776|NCT00980655|448391695|FG000|Overall Study|Parent/legal guardian request|1|||
124663777|NCT00980655|448391696|FG001|Overall Study|Parent/legal guardian request|0|||
124663778|NCT00980655|448391695|FG000|Overall Study|Other|0|||
124663779|NCT00980655|448391696|FG001|Overall Study|Other|1|||
124663780|NCT01124292|448391700|FG000|Overall Study|Lost to Follow-up|2|||
124663781|NCT01124292|448391701|FG001|Overall Study|Lost to Follow-up|4|||
124663782|NCT01124292|448391702|FG002|Overall Study|Lost to Follow-up|3|||
124663783|NCT01124292|448391700|FG000|Overall Study|Physician Decision|0|||
124663784|NCT01124292|448391701|FG001|Overall Study|Physician Decision|3|||
124663785|NCT01124292|448391702|FG002|Overall Study|Physician Decision|2|||
124663786|NCT01124292|448391700|FG000|Overall Study|Withdrawal by Subject|0|||
124663787|NCT01124292|448391701|FG001|Overall Study|Withdrawal by Subject|6|||
124663788|NCT01124292|448391702|FG002|Overall Study|Withdrawal by Subject|2|||
124663789|NCT01124292|448391700|FG000|Overall Study|medical issue unrelated to the study|0|||
124663790|NCT01124292|448391701|FG001|Overall Study|medical issue unrelated to the study|0|||
124663791|NCT01124292|448391702|FG002|Overall Study|medical issue unrelated to the study|2|||
124663792|NCT01124292|448391700|FG000|Overall Study|piercing track closed|0|||
124663793|NCT01124292|448391701|FG001|Overall Study|piercing track closed|2|||
124663794|NCT01124292|448391702|FG002|Overall Study|piercing track closed|1|||
124663795|NCT03373461|448391703|FG000|Part 2|Adverse Event|0|||
124663796|NCT03373461|448391704|FG001|Part 2|Adverse Event|1|||
124663797|NCT03373461|448391705|FG002|Part 2|Adverse Event|0|||
124663798|NCT03373461|448391706|FG003|Part 2|Adverse Event|0|||
124663799|NCT03373461|448391707|FG004|Part 2|Adverse Event|1|||
124663800|NCT03300180|448391708|FG000|Baseline|Withdrawal by Subject|4|||
124663801|NCT03300180|448391709|FG001|Baseline|Withdrawal by Subject|6|||
124663802|NCT03300180|448391710|FG002|Baseline|Withdrawal by Subject|4|||
124663803|NCT03300180|448391708|FG000|6 Month Outcome|Withdrawal by Subject|12|||
124663804|NCT03300180|448391709|FG001|6 Month Outcome|Withdrawal by Subject|12|||
124663805|NCT03300180|448391710|FG002|6 Month Outcome|Withdrawal by Subject|19|||
124663806|NCT03300180|448391708|FG000|6 Month Outcome|Death|2|||
124663807|NCT03300180|448391709|FG001|6 Month Outcome|Death|4|||
124663808|NCT03300180|448391710|FG002|6 Month Outcome|Death|3|||
124663809|NCT03300180|448391708|FG000|6 Month Outcome|Missed Assessment|43|||
124663810|NCT03300180|448391709|FG001|6 Month Outcome|Missed Assessment|52|||
124663811|NCT03300180|448391710|FG002|6 Month Outcome|Missed Assessment|46|||
124663812|NCT03300180|448391708|FG000|12 Month Outcome|Withdrawal by Subject|3|||
124663813|NCT03300180|448391709|FG001|12 Month Outcome|Withdrawal by Subject|6|||
124663814|NCT03300180|448391710|FG002|12 Month Outcome|Withdrawal by Subject|6|||
124663815|NCT03300180|448391708|FG000|12 Month Outcome|Death|9|||
124663816|NCT03300180|448391709|FG001|12 Month Outcome|Death|6|||
124663817|NCT03300180|448391710|FG002|12 Month Outcome|Death|6|||
124663818|NCT03300180|448391708|FG000|12 Month Outcome|Missed Assessment|62|||
124663819|NCT03300180|448391709|FG001|12 Month Outcome|Missed Assessment|59|||
124663820|NCT03300180|448391710|FG002|12 Month Outcome|Missed Assessment|58|||
124663821|NCT03300180|448391708|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
124663822|NCT03300180|448391709|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
124663823|NCT03300180|448391710|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
124663824|NCT03300180|448391708|FG000|18 Month Outcome Assessment|Death|8|||
124663825|NCT03300180|448391709|FG001|18 Month Outcome Assessment|Death|5|||
124663826|NCT03300180|448391710|FG002|18 Month Outcome Assessment|Death|5|||
124663827|NCT03300180|448391708|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
124663828|NCT03300180|448391709|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
124663829|NCT03300180|448391710|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
124663830|NCT03300180|448391708|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
124663831|NCT03300180|448391709|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
124663832|NCT03300180|448391710|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
124663833|NCT03300180|448391708|FG000|24 Month Outcome Assessment|Death|13|||
124663834|NCT03300180|448391709|FG001|24 Month Outcome Assessment|Death|13|||
124663835|NCT03300180|448391710|FG002|24 Month Outcome Assessment|Death|3|||
124663836|NCT03300180|448391708|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
124663837|NCT03300180|448391709|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
124663838|NCT03300180|448391710|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
124663839|NCT01941537|448391713|FG000|Overall Study|Lack of Efficacy|1|||
124663840|NCT01941537|448391714|FG001|Overall Study|Lack of Efficacy|2|||
124663841|NCT01941537|448391713|FG000|Overall Study|Lost to Follow-up|1|||
124663842|NCT01941537|448391714|FG001|Overall Study|Lost to Follow-up|0|||
124663843|NCT01941537|448391713|FG000|Overall Study|Pregnancy|1|||
124663844|NCT01941537|448391714|FG001|Overall Study|Pregnancy|0|||
124663845|NCT01941537|448391713|FG000|Overall Study|Adverse Event|1|||
124663846|NCT01941537|448391714|FG001|Overall Study|Adverse Event|0|||
124663847|NCT01941537|448391713|FG000|Overall Study|Withdrawal by Subject|0|||
124663848|NCT01941537|448391714|FG001|Overall Study|Withdrawal by Subject|1|||
124663849|NCT02557516|448391716|FG000|Overall Study|Adverse Event|1|||
124663850|NCT02557516|448391717|FG001|Overall Study|Adverse Event|0|||
124663851|NCT02557516|448391718|FG002|Overall Study|Adverse Event|2|||
124663852|NCT02557516|448391719|FG003|Overall Study|Adverse Event|1|||
124663853|NCT02557516|448391716|FG000|Overall Study|Disease progression|0|||
124663854|NCT02557516|448391717|FG001|Overall Study|Disease progression|2|||
124663855|NCT02557516|448391718|FG002|Overall Study|Disease progression|0|||
124663856|NCT02557516|448391719|FG003|Overall Study|Disease progression|0|||
124663857|NCT02557516|448391716|FG000|Overall Study|Physician Decision|0|||
124663858|NCT02557516|448391717|FG001|Overall Study|Physician Decision|2|||
124663859|NCT02557516|448391718|FG002|Overall Study|Physician Decision|0|||
124663860|NCT02557516|448391719|FG003|Overall Study|Physician Decision|0|||
124663861|NCT02557516|448391716|FG000|Overall Study|Sponsor decision|0|||
124663862|NCT02557516|448391717|FG001|Overall Study|Sponsor decision|1|||
124663863|NCT02557516|448391718|FG002|Overall Study|Sponsor decision|2|||
124663864|NCT02557516|448391719|FG003|Overall Study|Sponsor decision|8|||
124663865|NCT00588146|448393212|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
124663866|NCT00588146|448393213|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
124663867|NCT02823470|448393214|FG000|Overall Study|Adverse Event|1|||
124663868|NCT02823470|448393215|FG001|Overall Study|Adverse Event|0|||
124663869|NCT02823470|448393214|FG000|Overall Study|Study terminated by sponsor|8|||
124663870|NCT02823470|448393215|FG001|Overall Study|Study terminated by sponsor|15|||
124663871|NCT00463801|448393218|FG000|Overall Study|Protocol Violation|1|||
124663872|NCT00463801|448393218|FG000|Overall Study|Lack of Efficacy|2|||
124663873|NCT00463801|448393218|FG000|Overall Study|Adverse Event|4|||
124663874|NCT00463801|448393218|FG000|Overall Study|Lost to Follow-up|5|||
124663875|NCT00463801|448393218|FG000|Overall Study|No longer require therapy|1|||
124663876|NCT02315664|448393219|FG000|Overall Study|Lost to Follow-up|1|||
124663877|NCT02315664|448393220|FG001|Overall Study|Lost to Follow-up|1|||
124663878|NCT02315664|448393219|FG000|Overall Study|Withdrawal by Subject|0|||
124663879|NCT02315664|448393220|FG001|Overall Study|Withdrawal by Subject|3|||
124663880|NCT02501161|448393221|FG000|Overall Study|Adverse Event|2|||
124663881|NCT02501161|448393222|FG001|Overall Study|Adverse Event|6|||
124663882|NCT02501161|448393221|FG000|Overall Study|Lost to Follow-up|7|||
124663883|NCT02501161|448393222|FG001|Overall Study|Lost to Follow-up|4|||
124663884|NCT02501161|448393221|FG000|Overall Study|Withdrawal by Subject|10|||
124663885|NCT02501161|448393222|FG001|Overall Study|Withdrawal by Subject|15|||
124663886|NCT02501161|448393221|FG000|Overall Study|Other|3|||
124663887|NCT02501161|448393222|FG001|Overall Study|Other|0|||
124663888|NCT01990573|448393225|FG000|Overall Study|Physician Decision|0|||
124663889|NCT01990573|448393226|FG001|Overall Study|Physician Decision|0|||
124663890|NCT01990573|448393227|FG002|Overall Study|Physician Decision|1|||
124663891|NCT01957579|448393228|FG000|Overall Study|Withdrawal of concent|0|||
124663892|NCT01957579|448393229|FG001|Overall Study|Withdrawal of concent|1|||
124663893|NCT01957579|448393230|FG002|Overall Study|Withdrawal of concent|0|||
124663894|NCT01957579|448393231|FG003|Overall Study|Withdrawal of concent|0|||
124663895|NCT01957579|448393228|FG000|Overall Study|Death|0|||
124663896|NCT01957579|448393229|FG001|Overall Study|Death|0|||
124663897|NCT01957579|448393230|FG002|Overall Study|Death|2|||
124663898|NCT01957579|448393231|FG003|Overall Study|Death|0|||
124663899|NCT01639144|448393234|FG000|Overall Study|Withdrawal by Subject|4|||
124663900|NCT01639144|448393235|FG001|Overall Study|Withdrawal by Subject|2|||
124663901|NCT01639144|448393234|FG000|Overall Study|Physician Decision|2|||
124663902|NCT01639144|448393235|FG001|Overall Study|Physician Decision|0|||
124663903|NCT01639144|448393234|FG000|Overall Study|Met postoperative exclusion criteria|4|||
124663904|NCT01639144|448393235|FG001|Overall Study|Met postoperative exclusion criteria|3|||
124663905|NCT02630563|448393244|FG000|Overall Study|Administrative|1|||
124663906|NCT02239640|448393245|FG000|Overall Study|Withdrawal by Subject|3|||
124663907|NCT02239640|448393245|FG000|Overall Study|Lost to Follow-up|72|||
124663908|NCT02239640|448393245|FG000|Overall Study|Death|142|||
124663909|NCT02485483|448393246|FG000|Overall Study|Depression at baseline|15|||
124663910|NCT02485483|448393247|FG001|Overall Study|Depression at baseline|0|||
124663911|NCT02485483|448393246|FG000|Overall Study|Discontinued after baseline|39|||
124663912|NCT02485483|448393247|FG001|Overall Study|Discontinued after baseline|0|||
124663913|NCT02061813|448393248|FG000|Overall Study|Withdrawal by Subject|1|||
124663914|NCT02061813|448393248|FG000|Overall Study|Protocol Violation|2|||
124663915|NCT01705080|448393254|FG000|Overall Study|Missed visit|10|||
124663916|NCT01705080|448393255|FG001|Overall Study|Missed visit|4|||
124663917|NCT01705080|448393256|FG002|Overall Study|Missed visit|1|||
124663918|NCT01705080|448393254|FG000|Overall Study|Death|4|||
124663919|NCT01705080|448393255|FG001|Overall Study|Death|4|||
124663920|NCT01705080|448393256|FG002|Overall Study|Death|6|||
124663921|NCT01705080|448393254|FG000|Overall Study|Withdrawal by Subject|61|||
124663922|NCT01705080|448393255|FG001|Overall Study|Withdrawal by Subject|44|||
124663923|NCT01705080|448393256|FG002|Overall Study|Withdrawal by Subject|9|||
124663924|NCT00206427|448393258|FG000|Overall Study|Adverse Event|2|||
124663925|NCT00281697|448393262|FG000|Overall Study|> 60 days since last dose of study drug|4|||
124663926|NCT00281697|448393263|FG001|Overall Study|> 60 days since last dose of study drug|4|||
124663927|NCT00281697|448393262|FG000|Overall Study|Adverse Event|54|||
124663928|NCT00281697|448393263|FG001|Overall Study|Adverse Event|15|||
124663929|NCT00281697|448393262|FG000|Overall Study|Death|8|||
124663930|NCT00281697|448393263|FG001|Overall Study|Death|3|||
124663931|NCT00281697|448393262|FG000|Overall Study|Disease progression|279|||
124663932|NCT00281697|448393263|FG001|Overall Study|Disease progression|149|||
124663933|NCT00281697|448393262|FG000|Overall Study|Other|5|||
124663934|NCT00281697|448393263|FG001|Overall Study|Other|6|||
124663935|NCT00281697|448393262|FG000|Overall Study|Physician's decision to withdraw|15|||
124663936|NCT00281697|448393263|FG001|Overall Study|Physician's decision to withdraw|12|||
124663937|NCT00281697|448393262|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
124663938|NCT00281697|448393263|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
124663939|NCT00281697|448393262|FG000|Overall Study|Did not receive study drug|3|||
124663940|NCT00281697|448393263|FG001|Overall Study|Did not receive study drug|2|||
124663941|NCT03130959|448393270|FG000|Overall Study|Disease progression|19|||
124663942|NCT03130959|448393271|FG001|Overall Study|Disease progression|7|||
124663943|NCT03130959|448393272|FG002|Overall Study|Disease progression|12|||
124663944|NCT03130959|448393273|FG003|Overall Study|Disease progression|7|||
124663945|NCT03130959|448393274|FG004|Overall Study|Disease progression|12|||
124663946|NCT03130959|448393275|FG005|Overall Study|Disease progression|3|||
124663947|NCT03130959|448393276|FG006|Overall Study|Disease progression|6|||
124663948|NCT03130959|448393277|FG007|Overall Study|Disease progression|3|||
124663949|NCT03130959|448393278|FG008|Overall Study|Disease progression|15|||
124663950|NCT03130959|448393279|FG009|Overall Study|Disease progression|8|||
124663951|NCT03130959|448393270|FG000|Overall Study|Study drug toxicity|2|||
124663952|NCT03130959|448393271|FG001|Overall Study|Study drug toxicity|2|||
124663953|NCT03130959|448393272|FG002|Overall Study|Study drug toxicity|1|||
124663954|NCT03130959|448393273|FG003|Overall Study|Study drug toxicity|2|||
124663955|NCT03130959|448393274|FG004|Overall Study|Study drug toxicity|1|||
124663956|NCT03130959|448393275|FG005|Overall Study|Study drug toxicity|1|||
124663957|NCT03130959|448393276|FG006|Overall Study|Study drug toxicity|3|||
124663958|NCT03130959|448393277|FG007|Overall Study|Study drug toxicity|0|||
124663959|NCT03130959|448393278|FG008|Overall Study|Study drug toxicity|3|||
124663960|NCT03130959|448393279|FG009|Overall Study|Study drug toxicity|3|||
124663961|NCT03130959|448393270|FG000|Overall Study|Other reasons|0|||
124663962|NCT03130959|448393271|FG001|Overall Study|Other reasons|0|||
124663963|NCT03130959|448393272|FG002|Overall Study|Other reasons|0|||
124663964|NCT03130959|448393273|FG003|Overall Study|Other reasons|0|||
124663965|NCT03130959|448393274|FG004|Overall Study|Other reasons|0|||
124663966|NCT03130959|448393275|FG005|Overall Study|Other reasons|1|||
124663967|NCT03130959|448393276|FG006|Overall Study|Other reasons|1|||
124663968|NCT03130959|448393277|FG007|Overall Study|Other reasons|0|||
124663969|NCT03130959|448393278|FG008|Overall Study|Other reasons|0|||
124663970|NCT03130959|448393279|FG009|Overall Study|Other reasons|0|||
124663971|NCT03130959|448393270|FG000|Overall Study|Subject request to discontinue therapy|0|||
124663972|NCT03130959|448393271|FG001|Overall Study|Subject request to discontinue therapy|0|||
124663973|NCT03130959|448393272|FG002|Overall Study|Subject request to discontinue therapy|1|||
124663974|NCT03130959|448393273|FG003|Overall Study|Subject request to discontinue therapy|1|||
124663975|NCT03130959|448393274|FG004|Overall Study|Subject request to discontinue therapy|0|||
124663976|NCT03130959|448393275|FG005|Overall Study|Subject request to discontinue therapy|0|||
124663977|NCT03130959|448393276|FG006|Overall Study|Subject request to discontinue therapy|1|||
124663978|NCT03130959|448393277|FG007|Overall Study|Subject request to discontinue therapy|1|||
124663979|NCT03130959|448393278|FG008|Overall Study|Subject request to discontinue therapy|0|||
124663980|NCT03130959|448393279|FG009|Overall Study|Subject request to discontinue therapy|0|||
124663981|NCT03130959|448393270|FG000|Overall Study|Not reported|0|||
124663982|NCT03130959|448393271|FG001|Overall Study|Not reported|0|||
124663983|NCT03130959|448393272|FG002|Overall Study|Not reported|0|||
124663984|NCT03130959|448393273|FG003|Overall Study|Not reported|1|||
124663985|NCT03130959|448393274|FG004|Overall Study|Not reported|0|||
124663986|NCT03130959|448393275|FG005|Overall Study|Not reported|1|||
124663987|NCT03130959|448393276|FG006|Overall Study|Not reported|0|||
124663988|NCT03130959|448393277|FG007|Overall Study|Not reported|0|||
124663989|NCT03130959|448393278|FG008|Overall Study|Not reported|0|||
124663990|NCT03130959|448393279|FG009|Overall Study|Not reported|1|||
124663991|NCT03130959|448393270|FG000|Overall Study|Adverse Event unrelated to drug|0|||
124663992|NCT03130959|448393271|FG001|Overall Study|Adverse Event unrelated to drug|0|||
124663993|NCT03130959|448393272|FG002|Overall Study|Adverse Event unrelated to drug|1|||
124663994|NCT03130959|448393273|FG003|Overall Study|Adverse Event unrelated to drug|1|||
124663995|NCT03130959|448393274|FG004|Overall Study|Adverse Event unrelated to drug|1|||
124663996|NCT03130959|448393275|FG005|Overall Study|Adverse Event unrelated to drug|0|||
124663997|NCT03130959|448393276|FG006|Overall Study|Adverse Event unrelated to drug|1|||
124663998|NCT03130959|448393277|FG007|Overall Study|Adverse Event unrelated to drug|0|||
124663999|NCT03130959|448393278|FG008|Overall Study|Adverse Event unrelated to drug|1|||
124664000|NCT03130959|448393279|FG009|Overall Study|Adverse Event unrelated to drug|1|||
124664001|NCT03130959|448393270|FG000|Overall Study|Participant withdrew consent|0|||
124664002|NCT03130959|448393271|FG001|Overall Study|Participant withdrew consent|1|||
124664003|NCT03130959|448393272|FG002|Overall Study|Participant withdrew consent|0|||
124664004|NCT03130959|448393273|FG003|Overall Study|Participant withdrew consent|2|||
124664005|NCT03130959|448393274|FG004|Overall Study|Participant withdrew consent|1|||
124664006|NCT03130959|448393275|FG005|Overall Study|Participant withdrew consent|0|||
124664007|NCT03130959|448393276|FG006|Overall Study|Participant withdrew consent|0|||
124664008|NCT03130959|448393277|FG007|Overall Study|Participant withdrew consent|0|||
124664009|NCT03130959|448393278|FG008|Overall Study|Participant withdrew consent|0|||
124664010|NCT03130959|448393279|FG009|Overall Study|Participant withdrew consent|2|||
124664011|NCT03130959|448393270|FG000|Overall Study|Administrative reason by sponsor|1|||
124664012|NCT03130959|448393271|FG001|Overall Study|Administrative reason by sponsor|0|||
124664013|NCT03130959|448393272|FG002|Overall Study|Administrative reason by sponsor|1|||
124664014|NCT03130959|448393273|FG003|Overall Study|Administrative reason by sponsor|0|||
124664015|NCT03130959|448393274|FG004|Overall Study|Administrative reason by sponsor|0|||
124664016|NCT03130959|448393275|FG005|Overall Study|Administrative reason by sponsor|0|||
124664017|NCT03130959|448393276|FG006|Overall Study|Administrative reason by sponsor|0|||
124664018|NCT03130959|448393277|FG007|Overall Study|Administrative reason by sponsor|0|||
124664019|NCT03130959|448393278|FG008|Overall Study|Administrative reason by sponsor|0|||
124664020|NCT03130959|448393279|FG009|Overall Study|Administrative reason by sponsor|0|||
124664021|NCT03130959|448393270|FG000|Overall Study|Lost to Follow-up|1|||
124664022|NCT03130959|448393271|FG001|Overall Study|Lost to Follow-up|0|||
124664023|NCT03130959|448393272|FG002|Overall Study|Lost to Follow-up|0|||
124664024|NCT03130959|448393273|FG003|Overall Study|Lost to Follow-up|0|||
124664025|NCT03130959|448393274|FG004|Overall Study|Lost to Follow-up|0|||
124664026|NCT03130959|448393275|FG005|Overall Study|Lost to Follow-up|0|||
124664027|NCT03130959|448393276|FG006|Overall Study|Lost to Follow-up|0|||
124664028|NCT03130959|448393277|FG007|Overall Study|Lost to Follow-up|0|||
124664029|NCT03130959|448393278|FG008|Overall Study|Lost to Follow-up|0|||
124664030|NCT03130959|448393279|FG009|Overall Study|Lost to Follow-up|0|||
124664031|NCT02384538|448393280|FG000|Overall Study|Adverse Event|1|||
124664032|NCT02384538|448393281|FG001|Overall Study|Adverse Event|4|||
124664033|NCT02384538|448393280|FG000|Overall Study|Lack of Efficacy|4|||
124664034|NCT02384538|448393281|FG001|Overall Study|Lack of Efficacy|4|||
124664035|NCT02384538|448393280|FG000|Overall Study|Withdrew Consent|0|||
124664036|NCT02384538|448393281|FG001|Overall Study|Withdrew Consent|4|||
124664037|NCT02384538|448393280|FG000|Overall Study|Other|1|||
124664038|NCT02384538|448393281|FG001|Overall Study|Other|3|||
124664039|NCT04446429|448393282|FG000|Overall Study|Lost to Follow-up|6|||
124664040|NCT04446429|448393283|FG001|Overall Study|Lost to Follow-up|0|||
124664041|NCT02256917|448393284|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
124664042|NCT02256917|448393284|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
124664043|NCT02256917|448393284|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
124664044|NCT02256917|448393284|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
124664045|NCT02256917|448393284|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
124664046|NCT00313586|448393285|FG000|Overall Study|Disease progression|14|||
124664047|NCT00313586|448393286|FG001|Overall Study|Disease progression|19|||
124664048|NCT00313586|448393287|FG002|Overall Study|Disease progression|10|||
124664049|NCT00313586|448393288|FG003|Overall Study|Disease progression|3|||
124664050|NCT00313586|448393285|FG000|Overall Study|Adverse Event|12|||
124664051|NCT00313586|448393286|FG001|Overall Study|Adverse Event|18|||
124664052|NCT00313586|448393287|FG002|Overall Study|Adverse Event|3|||
124664053|NCT00313586|448393288|FG003|Overall Study|Adverse Event|10|||
124664054|NCT00313586|448393285|FG000|Overall Study|Death|11|||
124664055|NCT00313586|448393286|FG001|Overall Study|Death|8|||
124664056|NCT00313586|448393287|FG002|Overall Study|Death|1|||
124664057|NCT00313586|448393288|FG003|Overall Study|Death|7|||
124664058|NCT00313586|448393285|FG000|Overall Study|Withdrawal by Subject|13|||
124664059|NCT00313586|448393286|FG001|Overall Study|Withdrawal by Subject|6|||
124664060|NCT00313586|448393287|FG002|Overall Study|Withdrawal by Subject|6|||
124664061|NCT00313586|448393288|FG003|Overall Study|Withdrawal by Subject|2|||
124664062|NCT00313586|448393285|FG000|Overall Study|Alternative therapy|3|||
124664063|NCT00313586|448393286|FG001|Overall Study|Alternative therapy|6|||
124664064|NCT00313586|448393287|FG002|Overall Study|Alternative therapy|2|||
124664065|NCT00313586|448393288|FG003|Overall Study|Alternative therapy|0|||
124664066|NCT00313586|448393285|FG000|Overall Study|Other complicating disease|2|||
124664067|NCT00313586|448393286|FG001|Overall Study|Other complicating disease|2|||
124664068|NCT00313586|448393287|FG002|Overall Study|Other complicating disease|0|||
124664069|NCT00313586|448393288|FG003|Overall Study|Other complicating disease|0|||
124664070|NCT00313586|448393285|FG000|Overall Study|Did not achieve HI-major/better response|10|||
124664071|NCT00313586|448393286|FG001|Overall Study|Did not achieve HI-major/better response|7|||
124664072|NCT00313586|448393287|FG002|Overall Study|Did not achieve HI-major/better response|2|||
124664073|NCT00313586|448393288|FG003|Overall Study|Did not achieve HI-major/better response|1|||
124664074|NCT00313586|448393285|FG000|Overall Study|Physician Decision|2|||
124664075|NCT00313586|448393286|FG001|Overall Study|Physician Decision|1|||
124664076|NCT00313586|448393287|FG002|Overall Study|Physician Decision|0|||
124664077|NCT00313586|448393288|FG003|Overall Study|Physician Decision|0|||
124664078|NCT00313586|448393285|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
124664079|NCT00313586|448393286|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
124664080|NCT00313586|448393287|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
124664081|NCT00313586|448393288|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
124664082|NCT00313586|448393285|FG000|Overall Study|Lost insurance|0|||
124664083|NCT00313586|448393286|FG001|Overall Study|Lost insurance|1|||
124664084|NCT00313586|448393287|FG002|Overall Study|Lost insurance|0|||
124664085|NCT00313586|448393288|FG003|Overall Study|Lost insurance|0|||
124664086|NCT00313586|448393285|FG000|Overall Study|Moved|0|||
124664087|NCT00313586|448393286|FG001|Overall Study|Moved|1|||
124664088|NCT00313586|448393287|FG002|Overall Study|Moved|0|||
124664089|NCT00313586|448393288|FG003|Overall Study|Moved|0|||
124664090|NCT00313586|448393285|FG000|Overall Study|Death before starting treatment|1|||
124664091|NCT00313586|448393286|FG001|Overall Study|Death before starting treatment|0|||
124664092|NCT00313586|448393287|FG002|Overall Study|Death before starting treatment|0|||
124664093|NCT00313586|448393288|FG003|Overall Study|Death before starting treatment|0|||
124664094|NCT03076996|448393289|FG000|Overall Study|Withdrawal by Subject|2|||
124664095|NCT03076996|448393289|FG000|Overall Study|Lost to Follow-up|3|||
124664096|NCT03076996|448393289|FG000|Overall Study|Literacy precluded participation|1|||
124664097|NCT03117361|448393290|FG000|Overall Study|Progressive disease|5|||
124664098|NCT03117361|448393290|FG000|Overall Study|Death|1|||
124664099|NCT03117361|448393290|FG000|Overall Study|Physician Decision|2|||
124664100|NCT03117361|448393290|FG000|Overall Study|On study treatment at the end of study|1|||
124664101|NCT03117361|448393290|FG000|Overall Study|Treatment-related adverse event|1|||
124664102|NCT03280056|448393295|FG000|Overall Study|Withdrawal by Subject|12|||
124664103|NCT03280056|448393296|FG001|Overall Study|Withdrawal by Subject|14|||
124664104|NCT03280056|448393295|FG000|Overall Study|Death|9|||
124664105|NCT03280056|448393296|FG001|Overall Study|Death|2|||
124664106|NCT03280056|448393295|FG000|Overall Study|Adverse Event|1|||
124664107|NCT03280056|448393296|FG001|Overall Study|Adverse Event|3|||
124664108|NCT03280056|448393295|FG000|Overall Study|Lost to Follow-up|1|||
124664109|NCT03280056|448393296|FG001|Overall Study|Lost to Follow-up|1|||
124664110|NCT03280056|448393295|FG000|Overall Study|Physician Decision|0|||
124664111|NCT03280056|448393296|FG001|Overall Study|Physician Decision|1|||
124664112|NCT03280056|448393295|FG000|Overall Study|Early Discontinuation|1|||
124664113|NCT03280056|448393296|FG001|Overall Study|Early Discontinuation|0|||
124664114|NCT02144077|448393297|FG000|Overall Study|Withdrawal by Subject|3|||
124664115|NCT02144077|448393298|FG001|Overall Study|Withdrawal by Subject|3|||
124664116|NCT02144077|448393297|FG000|Overall Study|Adverse Event|2|||
124664117|NCT02144077|448393298|FG001|Overall Study|Adverse Event|3|||
124664118|NCT02144077|448393297|FG000|Overall Study|Lost to Follow-up|2|||
124664119|NCT02144077|448393298|FG001|Overall Study|Lost to Follow-up|2|||
124664120|NCT02144077|448393297|FG000|Overall Study|Protocol Violation|1|||
124664121|NCT02144077|448393298|FG001|Overall Study|Protocol Violation|2|||
124664122|NCT02144077|448393297|FG000|Overall Study|Death|0|||
124664123|NCT02144077|448393298|FG001|Overall Study|Death|1|||
124664124|NCT02144077|448393297|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
124664125|NCT02144077|448393298|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
124664126|NCT00610168|448393299|FG000|Overall Study|Withdrawal by Subject|2|||
124664127|NCT00610168|448393300|FG001|Overall Study|Withdrawal by Subject|0|||
124664128|NCT00943592|448393301|FG000|Overall Study|Death|3|||
124664129|NCT01247350|448393302|FG000|Overall Study|Adverse Event|0|||
124664130|NCT01247350|448393303|FG001|Overall Study|Adverse Event|0|||
124664131|NCT01247350|448393304|FG002|Overall Study|Adverse Event|1|||
124664132|NCT01247350|448393305|FG003|Overall Study|Adverse Event|0|||
124664133|NCT01247350|448393306|FG004|Overall Study|Adverse Event|0|||
124664134|NCT01247350|448393302|FG000|Overall Study|Withdrawal by Subject|0|||
124664135|NCT01247350|448393303|FG001|Overall Study|Withdrawal by Subject|0|||
124664136|NCT01247350|448393304|FG002|Overall Study|Withdrawal by Subject|0|||
124664137|NCT01247350|448393305|FG003|Overall Study|Withdrawal by Subject|1|||
124664138|NCT01247350|448393306|FG004|Overall Study|Withdrawal by Subject|0|||
124664139|NCT01247350|448393302|FG000|Overall Study|Entry criteria not met|0|||
124664140|NCT01247350|448393303|FG001|Overall Study|Entry criteria not met|0|||
124664141|NCT01247350|448393304|FG002|Overall Study|Entry criteria not met|0|||
124664142|NCT01247350|448393305|FG003|Overall Study|Entry criteria not met|0|||
124664143|NCT01247350|448393306|FG004|Overall Study|Entry criteria not met|1|||
124664144|NCT00169104|448393307|FG000|Overall Study|Withdrawal by Subject|2|||
124664145|NCT00169104|448393308|FG001|Overall Study|Withdrawal by Subject|0|||
124664146|NCT00169104|448393307|FG000|Overall Study|Protocol Violation|0|||
124664147|NCT00169104|448393308|FG001|Overall Study|Protocol Violation|1|||
124664148|NCT00169104|448393307|FG000|Overall Study|Physician Decision|0|||
124664149|NCT00169104|448393308|FG001|Overall Study|Physician Decision|1|||
124664150|NCT01540981|448393309|FG000|Overall Study|Withdrawal by Subject|1|||
124664151|NCT01540981|448393310|FG001|Overall Study|Withdrawal by Subject|0|||
124664152|NCT00397189|448393311|FG000|3 Weeks Period|Lost to Follow-up|5|||
124664153|NCT00397189|448393312|FG001|3 Weeks Period|Lost to Follow-up|4|||
124664154|NCT00397189|448393311|FG000|3 Weeks Period|Adverse Event|3|||
124664155|NCT00397189|448393312|FG001|3 Weeks Period|Adverse Event|2|||
124664156|NCT00397189|448393311|FG000|3 Weeks Period|Withdrawal by Subject|13|||
124664157|NCT00397189|448393312|FG001|3 Weeks Period|Withdrawal by Subject|9|||
124664158|NCT00397189|448393311|FG000|3 Weeks Period|Physician Decision|0|||
124664159|NCT00397189|448393312|FG001|3 Weeks Period|Physician Decision|2|||
124664160|NCT00397189|448393311|FG000|3 Weeks Period|Protocol Violation|0|||
124664161|NCT00397189|448393312|FG001|3 Weeks Period|Protocol Violation|3|||
124664162|NCT00397189|448393311|FG000|3 Weeks Period|Other|0|||
124664163|NCT00397189|448393312|FG001|3 Weeks Period|Other|2|||
124664164|NCT01535443|448393315|FG000|Overall Study|Physician Decision|3|||
124664165|NCT02457195|448393316|FG000|Overall Study|Adverse Event|3|||
124664166|NCT02457195|448393316|FG000|Overall Study|Protocol Violation|2|||
124664167|NCT02457195|448393316|FG000|Overall Study|Withdrawal by Subject|4|||
124664168|NCT02028507|448393317|FG000|Overall Study|Progressive Disease|122|||
124664169|NCT02028507|448393318|FG001|Overall Study|Progressive Disease|90|||
124664170|NCT02028507|448393319|FG002|Overall Study|Progressive Disease|102|||
124664171|NCT02028507|448393320|FG003|Overall Study|Progressive Disease|89|||
124664172|NCT02028507|448393317|FG000|Overall Study|Adverse Event|8|||
124664173|NCT02028507|448393318|FG001|Overall Study|Adverse Event|25|||
124664174|NCT02028507|448393319|FG002|Overall Study|Adverse Event|3|||
124664175|NCT02028507|448393320|FG003|Overall Study|Adverse Event|16|||
124664176|NCT02028507|448393317|FG000|Overall Study|Withdrawal by Subject|6|||
124664177|NCT02028507|448393318|FG001|Overall Study|Withdrawal by Subject|8|||
124664178|NCT02028507|448393319|FG002|Overall Study|Withdrawal by Subject|5|||
124664179|NCT02028507|448393320|FG003|Overall Study|Withdrawal by Subject|9|||
124664180|NCT02028507|448393317|FG000|Overall Study|Protocol Violation|2|||
124664181|NCT02028507|448393318|FG001|Overall Study|Protocol Violation|4|||
124664182|NCT02028507|448393319|FG002|Overall Study|Protocol Violation|1|||
124664183|NCT02028507|448393320|FG003|Overall Study|Protocol Violation|3|||
124664184|NCT02028507|448393317|FG000|Overall Study|Physician Decision|0|||
124664185|NCT02028507|448393318|FG001|Overall Study|Physician Decision|4|||
124664186|NCT02028507|448393319|FG002|Overall Study|Physician Decision|0|||
124664187|NCT02028507|448393320|FG003|Overall Study|Physician Decision|0|||
124664188|NCT02028507|448393317|FG000|Overall Study|Death|1|||
124664189|NCT02028507|448393318|FG001|Overall Study|Death|0|||
124664190|NCT02028507|448393319|FG002|Overall Study|Death|1|||
124664191|NCT02028507|448393320|FG003|Overall Study|Death|3|||
124664192|NCT02028507|448393317|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
124664193|NCT02028507|448393318|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
124664194|NCT02028507|448393319|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
124664195|NCT02028507|448393320|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
124664196|NCT02028507|448393317|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
124664197|NCT02028507|448393318|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
124664198|NCT02028507|448393319|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
124664199|NCT02028507|448393320|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
124664200|NCT02028507|448393317|FG000|Overall Study|Randomized But Not Treated|3|||
124664201|NCT02028507|448393318|FG001|Overall Study|Randomized But Not Treated|6|||
124664202|NCT02028507|448393319|FG002|Overall Study|Randomized But Not Treated|0|||
124664203|NCT02028507|448393320|FG003|Overall Study|Randomized But Not Treated|4|||
124664204|NCT02028507|448393317|FG000|Overall Study|Enzyme defect|0|||
124664205|NCT02028507|448393318|FG001|Overall Study|Enzyme defect|0|||
124664206|NCT02028507|448393319|FG002|Overall Study|Enzyme defect|0|||
124664207|NCT02028507|448393320|FG003|Overall Study|Enzyme defect|1|||
124664208|NCT02028507|448393317|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
124664209|NCT02028507|448393318|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
124664210|NCT02028507|448393319|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
124664211|NCT02028507|448393320|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
124664212|NCT02028507|448393317|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
124664213|NCT02028507|448393318|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
124664214|NCT02028507|448393319|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
124664215|NCT02028507|448393320|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
124664216|NCT02420262|448393323|FG000|Overall Study|Adverse Event|1|||
124664217|NCT02420262|448393324|FG001|Overall Study|Adverse Event|0|||
124664218|NCT02420262|448393323|FG000|Overall Study|Withdrawal by Subject|1|||
124664219|NCT02420262|448393324|FG001|Overall Study|Withdrawal by Subject|4|||
124664220|NCT02420262|448393323|FG000|Overall Study|Unclassified|0|||
124664221|NCT02420262|448393324|FG001|Overall Study|Unclassified|1|||
124664222|NCT00436826|448393328|FG000|Double Blind Period (DBP)|Adverse Event|2|||
124664223|NCT00436826|448393329|FG001|Double Blind Period (DBP)|Adverse Event|0|||
124664224|NCT00436826|448393330|FG002|Double Blind Period (DBP)|Adverse Event|0|||
124664225|NCT00436826|448393331|FG003|Double Blind Period (DBP)|Adverse Event|0|||
124664226|NCT00436826|448393332|FG004|Double Blind Period (DBP)|Adverse Event|0|||
124664227|NCT00436826|448393333|FG005|Double Blind Period (DBP)|Adverse Event|0|||
124664228|NCT00436826|448393328|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
124664229|NCT00436826|448393329|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
124664230|NCT00436826|448393330|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
124664231|NCT00436826|448393331|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
124664232|NCT00436826|448393332|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
124664233|NCT00436826|448393333|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
124664234|NCT00436826|448393328|FG000|Double Blind Period (DBP)|Other|10|||
124664235|NCT00436826|448393329|FG001|Double Blind Period (DBP)|Other|11|||
124664236|NCT00436826|448393330|FG002|Double Blind Period (DBP)|Other|0|||
124664237|NCT00436826|448393331|FG003|Double Blind Period (DBP)|Other|0|||
124664238|NCT00436826|448393332|FG004|Double Blind Period (DBP)|Other|0|||
124664239|NCT00436826|448393333|FG005|Double Blind Period (DBP)|Other|0|||
124664240|NCT00436826|448393328|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
124664241|NCT00436826|448393329|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
124664242|NCT00436826|448393330|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
124664243|NCT00436826|448393331|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
124664244|NCT00436826|448393332|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
124664245|NCT00436826|448393333|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
124664246|NCT00436826|448393328|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
124664247|NCT00436826|448393329|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
124664248|NCT00436826|448393330|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
124664249|NCT00436826|448393331|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
124664250|NCT00436826|448393332|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
124664251|NCT00436826|448393333|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
124664252|NCT00436826|448393328|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
124664253|NCT00436826|448393329|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
124664254|NCT00436826|448393330|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
124664255|NCT00436826|448393331|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
124711980|NCT00688467|448570700|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
124664256|NCT00436826|448393332|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
124664257|NCT00436826|448393333|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
124664258|NCT00784719|448393334|FG000|Overall Study|Adverse Event|0|||
124664259|NCT00784719|448393335|FG001|Overall Study|Adverse Event|2|||
124664260|NCT00784719|448393336|FG002|Overall Study|Adverse Event|0|||
124664261|NCT00784719|448393337|FG003|Overall Study|Adverse Event|0|||
124664262|NCT00784719|448393338|FG004|Overall Study|Adverse Event|1|||
124664263|NCT00784719|448393339|FG005|Overall Study|Adverse Event|1|||
124664264|NCT00784719|448393340|FG006|Overall Study|Adverse Event|1|||
124664265|NCT00784719|448393334|FG000|Overall Study|Lost to Follow-up|0|||
124664266|NCT00784719|448393335|FG001|Overall Study|Lost to Follow-up|0|||
124664267|NCT00784719|448393336|FG002|Overall Study|Lost to Follow-up|0|||
124664268|NCT00784719|448393337|FG003|Overall Study|Lost to Follow-up|0|||
124664269|NCT00784719|448393338|FG004|Overall Study|Lost to Follow-up|1|||
124664270|NCT00784719|448393339|FG005|Overall Study|Lost to Follow-up|1|||
124664271|NCT00784719|448393340|FG006|Overall Study|Lost to Follow-up|0|||
124664272|NCT00784719|448393334|FG000|Overall Study|Other|2|||
124664273|NCT00784719|448393335|FG001|Overall Study|Other|1|||
124664274|NCT00784719|448393336|FG002|Overall Study|Other|1|||
124664275|NCT00784719|448393337|FG003|Overall Study|Other|0|||
124664276|NCT00784719|448393338|FG004|Overall Study|Other|2|||
124664277|NCT00784719|448393339|FG005|Overall Study|Other|1|||
124664278|NCT00784719|448393340|FG006|Overall Study|Other|3|||
124664279|NCT00784719|448393334|FG000|Overall Study|Withdrawal by Subject|1|||
124664280|NCT00784719|448393335|FG001|Overall Study|Withdrawal by Subject|0|||
124664281|NCT00784719|448393336|FG002|Overall Study|Withdrawal by Subject|0|||
124664282|NCT00784719|448393337|FG003|Overall Study|Withdrawal by Subject|0|||
124664283|NCT00784719|448393338|FG004|Overall Study|Withdrawal by Subject|2|||
124664284|NCT00784719|448393339|FG005|Overall Study|Withdrawal by Subject|0|||
124664285|NCT00784719|448393340|FG006|Overall Study|Withdrawal by Subject|1|||
124664286|NCT06597084|448393341|FG000|Overall Study|Withdrawal by Subject|4|||
124664287|NCT06597084|448393342|FG001|Overall Study|Withdrawal by Subject|9|||
124664288|NCT06597084|448393341|FG000|Overall Study|Consent was not given by the patient until V2|0|||
124664289|NCT06597084|448393342|FG001|Overall Study|Consent was not given by the patient until V2|3|||
124664290|NCT06597084|448393341|FG000|Overall Study|Physician Decision|1|||
124664291|NCT06597084|448393342|FG001|Overall Study|Physician Decision|0|||
124664292|NCT06597084|448393341|FG000|Overall Study|Adverse Event|3|||
124664293|NCT06597084|448393342|FG001|Overall Study|Adverse Event|2|||
124664294|NCT06597084|448393341|FG000|Overall Study|Death|4|||
124664295|NCT06597084|448393342|FG001|Overall Study|Death|0|||
124664296|NCT06597084|448393341|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
124664297|NCT06597084|448393342|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
124664298|NCT06597084|448393341|FG000|Overall Study|Lost to Follow-up|4|||
124664299|NCT06597084|448393342|FG001|Overall Study|Lost to Follow-up|2|||
124664300|NCT06597084|448393341|FG000|Overall Study|Other. Not specified|1|||
124664301|NCT06597084|448393342|FG001|Overall Study|Other. Not specified|0|||
124664302|NCT01588405|448393343|FG000|Overall Study|Adverse Event|1|||
124664303|NCT01588405|448393343|FG000|Overall Study|Clinical Worsening|1|||
124664304|NCT02029274|448393347|FG000|Overall Study|Adverse Event|1|||
124664305|NCT02029274|448393348|FG001|Overall Study|Adverse Event|0|||
124664306|NCT02029274|448393349|FG002|Overall Study|Adverse Event|2|||
124664307|NCT02029274|448393350|FG003|Overall Study|Adverse Event|2|||
124664308|NCT03654729|448395261|FG000|Overall Study|Death|9|||
124664309|NCT03654729|448395262|FG001|Overall Study|Death|9|||
124664310|NCT03654729|448395263|FG002|Overall Study|Death|16|||
124664311|NCT03654729|448395261|FG000|Overall Study|Withdrawal by Subject|8|||
124664312|NCT03654729|448395262|FG001|Overall Study|Withdrawal by Subject|6|||
124664313|NCT03654729|448395263|FG002|Overall Study|Withdrawal by Subject|4|||
124664314|NCT03654729|448395261|FG000|Overall Study|Study terminated by Sponsor|3|||
124664315|NCT03654729|448395262|FG001|Overall Study|Study terminated by Sponsor|5|||
124664316|NCT03654729|448395263|FG002|Overall Study|Study terminated by Sponsor|4|||
124664317|NCT03654729|448395261|FG000|Overall Study|Not reported|2|||
124664318|NCT03654729|448395262|FG001|Overall Study|Not reported|4|||
124664319|NCT03654729|448395263|FG002|Overall Study|Not reported|5|||
124664320|NCT03654729|448395261|FG000|Overall Study|Progressive disease|3|||
124664321|NCT03654729|448395262|FG001|Overall Study|Progressive disease|0|||
124664322|NCT03654729|448395263|FG002|Overall Study|Progressive disease|0|||
124664323|NCT03654729|448395261|FG000|Overall Study|Lost to Follow-up|2|||
124664324|NCT03654729|448395262|FG001|Overall Study|Lost to Follow-up|0|||
124664325|NCT03654729|448395263|FG002|Overall Study|Lost to Follow-up|0|||
124664326|NCT03654729|448395261|FG000|Overall Study|Physician Decision|2|||
124664327|NCT03654729|448395262|FG001|Overall Study|Physician Decision|0|||
124664328|NCT03654729|448395263|FG002|Overall Study|Physician Decision|0|||
124664329|NCT03654729|448395261|FG000|Overall Study|Protocol Violation|1|||
124664330|NCT03654729|448395262|FG001|Overall Study|Protocol Violation|1|||
124664331|NCT03654729|448395263|FG002|Overall Study|Protocol Violation|0|||
124664332|NCT03654729|448395261|FG000|Overall Study|Non-compliance with study drug|0|||
124664333|NCT03654729|448395262|FG001|Overall Study|Non-compliance with study drug|1|||
124664334|NCT03654729|448395263|FG002|Overall Study|Non-compliance with study drug|0|||
124664335|NCT03654729|448395261|FG000|Overall Study|Site terminated by Sponsor|1|||
124664336|NCT03654729|448395262|FG001|Overall Study|Site terminated by Sponsor|0|||
124664337|NCT03654729|448395263|FG002|Overall Study|Site terminated by Sponsor|0|||
124664338|NCT01000974|448395267|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
124664339|NCT01000974|448395268|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
124664340|NCT01000974|448395269|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
124664341|NCT01000974|448395267|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
124664342|NCT01000974|448395268|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
124664343|NCT01000974|448395269|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
124664344|NCT01000974|448395267|FG000|Primary Vaccination Phase|Protocol Violation|40|||
124664345|NCT01000974|448395268|FG001|Primary Vaccination Phase|Protocol Violation|3|||
124664346|NCT01000974|448395269|FG002|Primary Vaccination Phase|Protocol Violation|2|||
124664347|NCT01000974|448395267|FG000|Primary Vaccination Phase|Adverse Event|14|||
124664348|NCT01000974|448395268|FG001|Primary Vaccination Phase|Adverse Event|2|||
124664349|NCT01000974|448395269|FG002|Primary Vaccination Phase|Adverse Event|2|||
124664350|NCT01000974|448395267|FG000|Primary Vaccination Phase|Other|4|||
124664351|NCT01000974|448395268|FG001|Primary Vaccination Phase|Other|9|||
124664352|NCT01000974|448395269|FG002|Primary Vaccination Phase|Other|12|||
124664353|NCT01000974|448395267|FG000|Booster Vaccination Phase|Protocol Violation|0|||
124664354|NCT01000974|448395268|FG001|Booster Vaccination Phase|Protocol Violation|0|||
124664355|NCT01000974|448395269|FG002|Booster Vaccination Phase|Protocol Violation|2|||
124664356|NCT01000974|448395267|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
124664357|NCT01000974|448395268|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
124664358|NCT01000974|448395269|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
124664359|NCT01000974|448395267|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
124664360|NCT01000974|448395268|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
124664361|NCT01000974|448395269|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
124664362|NCT01000974|448395267|FG000|Booster Vaccination Phase|Other|24|||
124664363|NCT01000974|448395268|FG001|Booster Vaccination Phase|Other|6|||
124664364|NCT01000974|448395269|FG002|Booster Vaccination Phase|Other|4|||
124664365|NCT02750332|448395270|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124664366|NCT02750332|448395271|FG001|Treatment Period 1|Withdrawal by Subject|1|||
124664367|NCT00621257|448395272|FG000|Overall Study|Lost to Follow-up|4|||
124664368|NCT00621257|448395273|FG001|Overall Study|Lost to Follow-up|0|||
124664369|NCT00621257|448395274|FG002|Overall Study|Lost to Follow-up|2|||
124664370|NCT00621257|448395275|FG003|Overall Study|Lost to Follow-up|4|||
124664371|NCT00621257|448395276|FG004|Overall Study|Lost to Follow-up|7|||
124664372|NCT00621257|448395272|FG000|Overall Study|Adverse Event|0|||
124664373|NCT00621257|448395273|FG001|Overall Study|Adverse Event|1|||
124664374|NCT00621257|448395274|FG002|Overall Study|Adverse Event|1|||
124664375|NCT00621257|448395275|FG003|Overall Study|Adverse Event|0|||
124664376|NCT00621257|448395276|FG004|Overall Study|Adverse Event|0|||
124664377|NCT00621257|448395272|FG000|Overall Study|Physician Decision|0|||
124664378|NCT00621257|448395273|FG001|Overall Study|Physician Decision|2|||
124664379|NCT00621257|448395274|FG002|Overall Study|Physician Decision|0|||
124664380|NCT00621257|448395275|FG003|Overall Study|Physician Decision|1|||
124664381|NCT00621257|448395276|FG004|Overall Study|Physician Decision|1|||
124664382|NCT00621257|448395272|FG000|Overall Study|Withdrawal by Subject|0|||
124664383|NCT00621257|448395273|FG001|Overall Study|Withdrawal by Subject|0|||
124664384|NCT00621257|448395274|FG002|Overall Study|Withdrawal by Subject|0|||
124664385|NCT00621257|448395275|FG003|Overall Study|Withdrawal by Subject|1|||
124664386|NCT00621257|448395276|FG004|Overall Study|Withdrawal by Subject|1|||
124664387|NCT01255904|448395277|FG000|Overall Study|Physician Decision|1|||
124664388|NCT01255904|448395278|FG001|Overall Study|Physician Decision|4|||
124664389|NCT00632125|448395280|FG000|Overall Study|Death|82|||
124664390|NCT00632125|448395280|FG000|Overall Study|Withdrawal by Subject|44|||
124664391|NCT00632125|448395280|FG000|Overall Study|Adverse Event|36|||
124664392|NCT00632125|448395280|FG000|Overall Study|Renal transplantation|17|||
124664393|NCT00632125|448395280|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
124664394|NCT00632125|448395280|FG000|Overall Study|Non-compliance|8|||
124664395|NCT00632125|448395280|FG000|Overall Study|Development of uncontrolled hypertension|5|||
124664396|NCT00632125|448395280|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
124664397|NCT00540644|448395283|FG000|Overall Study|Adverse Event|3|||
124664398|NCT00540644|448395284|FG001|Overall Study|Adverse Event|1|||
124664399|NCT00540644|448395283|FG000|Overall Study|Disease Progression|3|||
124664400|NCT00540644|448395284|FG001|Overall Study|Disease Progression|1|||
124664401|NCT00540644|448395283|FG000|Overall Study|Physician Decision|0|||
124664402|NCT00540644|448395284|FG001|Overall Study|Physician Decision|5|||
124664403|NCT00540644|448395283|FG000|Overall Study|Withdrawal by Subject|2|||
124664404|NCT00540644|448395284|FG001|Overall Study|Withdrawal by Subject|2|||
124664405|NCT00540644|448395283|FG000|Overall Study|Noncomplilance|1|||
124664406|NCT00540644|448395284|FG001|Overall Study|Noncomplilance|0|||
124664407|NCT00809094|448395285|FG000|Overall Study|Lost to Follow-up|0|||
124664408|NCT00809094|448395286|FG001|Overall Study|Lost to Follow-up|1|||
124664409|NCT00232557|448395288|FG000|Overall Study|Lost to Follow-up|3|||
124664410|NCT00232557|448395289|FG001|Overall Study|Lost to Follow-up|5|||
124664411|NCT01059773|448395290|FG000|Overall Study|Adverse Event|2|||
124664412|NCT01059773|448395291|FG001|Overall Study|Adverse Event|2|||
124664413|NCT01059773|448395290|FG000|Overall Study|Withdrawal by Subject|1|||
124664414|NCT01059773|448395291|FG001|Overall Study|Withdrawal by Subject|5|||
124664415|NCT01059773|448395290|FG000|Overall Study|Lost to Follow-up|1|||
124664416|NCT01059773|448395291|FG001|Overall Study|Lost to Follow-up|1|||
124664417|NCT01059773|448395290|FG000|Overall Study|Pregnancy|1|||
124664418|NCT01059773|448395291|FG001|Overall Study|Pregnancy|1|||
124664419|NCT01059773|448395290|FG000|Overall Study|Protocol Violation|6|||
124664420|NCT01059773|448395291|FG001|Overall Study|Protocol Violation|2|||
124664421|NCT01059773|448395290|FG000|Overall Study|Physician Decision|5|||
124664422|NCT01059773|448395291|FG001|Overall Study|Physician Decision|4|||
124664423|NCT01059773|448395290|FG000|Overall Study|Lack of Efficacy|3|||
124664424|NCT01059773|448395291|FG001|Overall Study|Lack of Efficacy|3|||
124664425|NCT01059773|448395290|FG000|Overall Study|Death|0|||
124664426|NCT01059773|448395291|FG001|Overall Study|Death|1|||
124664427|NCT01059773|448395290|FG000|Overall Study|Malignancy including squamous cell skin|0|||
124664428|NCT01059773|448395291|FG001|Overall Study|Malignancy including squamous cell skin|1|||
124664429|NCT01059773|448395290|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
124664430|NCT01059773|448395291|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
124664431|NCT01059773|448395290|FG000|Overall Study|Other|1|||
124664432|NCT01059773|448395291|FG001|Overall Study|Other|3|||
124664433|NCT01029262|448395293|FG000|Overall Study|Adverse Event|9|||
124664434|NCT01029262|448395294|FG001|Overall Study|Adverse Event|52|||
124664435|NCT01029262|448395293|FG000|Overall Study|Lack of therapeutic effect|57|||
124664436|NCT01029262|448395294|FG001|Overall Study|Lack of therapeutic effect|76|||
124664437|NCT01029262|448395293|FG000|Overall Study|Withdrawal by Subject|10|||
124664438|NCT01029262|448395294|FG001|Overall Study|Withdrawal by Subject|17|||
124664439|NCT01029262|448395293|FG000|Overall Study|Protocol Violation|2|||
124664440|NCT01029262|448395294|FG001|Overall Study|Protocol Violation|3|||
124664441|NCT01029262|448395293|FG000|Overall Study|Miscellaneous|1|||
124664442|NCT01029262|448395294|FG001|Overall Study|Miscellaneous|9|||
124664443|NCT01029262|448395293|FG000|Overall Study|Death|0|||
124664444|NCT01029262|448395294|FG001|Overall Study|Death|3|||
124664445|NCT03410992|448395295|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
124664446|NCT03410992|448395296|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
124664447|NCT03410992|448395297|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
124664448|NCT03410992|448395298|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
124664449|NCT03410992|448395299|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
124664450|NCT03410992|448395300|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
124664451|NCT03410992|448395301|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
124664452|NCT03410992|448395302|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
124664453|NCT03410992|448395303|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
124664454|NCT03410992|448395304|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
124664455|NCT03410992|448395305|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
124664456|NCT03410992|448395295|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
124664457|NCT03410992|448395296|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
124664458|NCT03410992|448395297|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
124664459|NCT03410992|448395298|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
124664460|NCT03410992|448395299|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
124664461|NCT03410992|448395300|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
124664462|NCT03410992|448395301|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
124664463|NCT03410992|448395302|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
124664464|NCT03410992|448395303|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
124664465|NCT03410992|448395304|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
124664466|NCT03410992|448395305|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
124664467|NCT03410992|448395295|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
124664468|NCT03410992|448395296|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
124664469|NCT03410992|448395297|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
124664470|NCT03410992|448395298|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
124664471|NCT03410992|448395299|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
124664472|NCT03410992|448395300|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
124664473|NCT03410992|448395301|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
124664474|NCT03410992|448395302|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
124664475|NCT03410992|448395303|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
124664476|NCT03410992|448395304|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
124664477|NCT03410992|448395305|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
124664478|NCT03410992|448395295|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
124664479|NCT03410992|448395296|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
124664480|NCT03410992|448395297|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
124664481|NCT03410992|448395298|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
124664482|NCT03410992|448395299|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
124664483|NCT03410992|448395300|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
124664484|NCT03410992|448395301|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
124664485|NCT03410992|448395302|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
124664486|NCT03410992|448395303|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
124664487|NCT03410992|448395304|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
124664488|NCT03410992|448395305|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
124664489|NCT03410992|448395295|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
124664490|NCT03410992|448395296|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
124664491|NCT03410992|448395297|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
124664492|NCT03410992|448395298|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
124664493|NCT03410992|448395299|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
124664494|NCT03410992|448395300|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
124664495|NCT03410992|448395301|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
124664496|NCT03410992|448395302|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
124664497|NCT03410992|448395303|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
124664498|NCT03410992|448395304|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
124664499|NCT03410992|448395305|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
124664500|NCT03410992|448395295|FG000|Week 16 Assessment|Incorrect escapers|0|||
124664501|NCT03410992|448395296|FG001|Week 16 Assessment|Incorrect escapers|6|||
124664502|NCT03410992|448395297|FG002|Week 16 Assessment|Incorrect escapers|0|||
124664503|NCT03410992|448395298|FG003|Week 16 Assessment|Incorrect escapers|0|||
124664504|NCT03410992|448395299|FG004|Week 16 Assessment|Incorrect escapers|0|||
124664505|NCT03410992|448395300|FG005|Week 16 Assessment|Incorrect escapers|0|||
124664506|NCT03410992|448395301|FG006|Week 16 Assessment|Incorrect escapers|0|||
124664507|NCT03410992|448395302|FG007|Week 16 Assessment|Incorrect escapers|0|||
124664508|NCT03410992|448395303|FG008|Week 16 Assessment|Incorrect escapers|0|||
124664509|NCT03410992|448395304|FG009|Week 16 Assessment|Incorrect escapers|0|||
124664510|NCT03410992|448395305|FG010|Week 16 Assessment|Incorrect escapers|0|||
124664511|NCT03410992|448395295|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
124664512|NCT03410992|448395296|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
124664513|NCT03410992|448395297|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
124664514|NCT03410992|448395298|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
124664515|NCT03410992|448395299|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
124664516|NCT03410992|448395300|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
124664517|NCT03410992|448395301|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
124664518|NCT03410992|448395302|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
124664519|NCT03410992|448395303|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
124664520|NCT03410992|448395304|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
124664521|NCT03410992|448395305|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
124664522|NCT03410992|448395295|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
124664523|NCT03410992|448395296|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
124664524|NCT03410992|448395297|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
124664525|NCT03410992|448395298|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
124664526|NCT03410992|448395299|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
124664527|NCT03410992|448395300|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
124664528|NCT03410992|448395301|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
124664529|NCT03410992|448395302|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
124664530|NCT03410992|448395303|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
124664531|NCT03410992|448395304|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
124664532|NCT03410992|448395305|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
124664533|NCT03410992|448395295|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
124664534|NCT03410992|448395296|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
124664535|NCT03410992|448395297|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
124664536|NCT03410992|448395298|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
124664537|NCT03410992|448395299|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
124664538|NCT03410992|448395300|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
124664539|NCT03410992|448395301|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
124664540|NCT03410992|448395302|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
124664541|NCT03410992|448395303|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
124664542|NCT03410992|448395304|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
124664543|NCT03410992|448395305|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
124664544|NCT03410992|448395295|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
124664545|NCT03410992|448395296|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
124664546|NCT03410992|448395297|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
124664547|NCT03410992|448395298|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
124664548|NCT03410992|448395299|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
124664549|NCT03410992|448395300|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
124664550|NCT03410992|448395301|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
124664551|NCT03410992|448395302|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
124664552|NCT03410992|448395303|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
124664553|NCT03410992|448395304|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
124664554|NCT03410992|448395305|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
124664555|NCT03410992|448395295|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
124664556|NCT03410992|448395296|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
124664557|NCT03410992|448395297|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
124664558|NCT03410992|448395298|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
124664559|NCT03410992|448395299|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
124664560|NCT03410992|448395300|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
124664561|NCT03410992|448395301|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
124664562|NCT03410992|448395302|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
124664563|NCT03410992|448395303|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
124664564|NCT03410992|448395304|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
124664565|NCT03410992|448395305|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
124664566|NCT03410992|448395295|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
124664567|NCT03410992|448395296|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
124664568|NCT03410992|448395297|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
124664569|NCT03410992|448395298|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
124664570|NCT03410992|448395299|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
124664571|NCT03410992|448395300|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
124664572|NCT03410992|448395301|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
124664573|NCT03410992|448395302|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
124664574|NCT03410992|448395303|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
124664575|NCT03410992|448395304|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
124664576|NCT03410992|448395305|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
124664577|NCT02260817|448395306|FG000|Overall Study|Lost to Follow-up|0|||
124664578|NCT02260817|448395307|FG001|Overall Study|Lost to Follow-up|14|||
124664579|NCT02260817|448395306|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
124664580|NCT02260817|448395307|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
124664581|NCT02260817|448395306|FG000|Overall Study|Observation, no biopsy|0|||
124664582|NCT02260817|448395307|FG001|Overall Study|Observation, no biopsy|1|||
124664583|NCT02260817|448395306|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
124664584|NCT02260817|448395307|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
124664585|NCT02260817|448395306|FG000|Overall Study|Protocol Violation|0|||
124664586|NCT02260817|448395307|FG001|Overall Study|Protocol Violation|14|||
124664587|NCT04435808|448395308|FG000|Overall Study|Study stopped by DSMB|0|||
124664588|NCT04435808|448395309|FG001|Overall Study|Study stopped by DSMB|1|||
124664589|NCT03299101|448395310|FG000|Overall Study|Lost to Follow-up|1|||
124664590|NCT03299101|448395310|FG000|Overall Study|Withdrawal by Subject|5|||
124664591|NCT03299101|448395310|FG000|Overall Study|Surgery was changed|3|||
124664592|NCT03299101|448395310|FG000|Overall Study|Not enough time to complete prehab|1|||
124664593|NCT01896193|448395312|FG000|Overall Study|Lack of Efficacy|20|||
124664594|NCT01896193|448395313|FG001|Overall Study|Lack of Efficacy|11|||
124664595|NCT01896193|448395312|FG000|Overall Study|Protocol Violation|0|||
124664596|NCT01896193|448395313|FG001|Overall Study|Protocol Violation|1|||
124664597|NCT01896193|448395312|FG000|Overall Study|Withdrew Consent|1|||
124664598|NCT01896193|448395313|FG001|Overall Study|Withdrew Consent|0|||
124664599|NCT00807612|448395314|FG000|Overall Study|Death|8|||
124664600|NCT00807612|448395314|FG000|Overall Study|Study early termination|5|||
124664601|NCT00807612|448395314|FG000|Overall Study|Withdrawal by Subject|1|||
124664602|NCT01300247|448395315|FG000|Overall Study|Death|1|||
124664603|NCT01300247|448395316|FG001|Overall Study|Death|1|||
124664604|NCT01300247|448395315|FG000|Overall Study|Lost to Follow-up|2|||
124664605|NCT01300247|448395316|FG001|Overall Study|Lost to Follow-up|0|||
124664606|NCT01300247|448395315|FG000|Overall Study|Withdrawal by Subject|1|||
124664607|NCT01300247|448395316|FG001|Overall Study|Withdrawal by Subject|0|||
124664608|NCT01300247|448395315|FG000|Overall Study|Non-Compliance|0|||
124664609|NCT01300247|448395316|FG001|Overall Study|Non-Compliance|1|||
124664610|NCT04819438|448395317|FG000|Overall Study|Withdrawal by Subject|1|||
124664611|NCT04819438|448395318|FG001|Overall Study|Withdrawal by Subject|0|||
124664612|NCT04819438|448395317|FG000|Overall Study|Adverse Event|0|||
124664613|NCT04819438|448395318|FG001|Overall Study|Adverse Event|1|||
124664614|NCT04819438|448395317|FG000|Overall Study|Protocol Violation|0|||
124664615|NCT04819438|448395318|FG001|Overall Study|Protocol Violation|1|||
124664616|NCT03465709|448395319|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
124664617|NCT03465709|448395319|FG000|Overall Study|Withdrawal by Subject|3|||
124664618|NCT05359952|448395320|FG000|Overall Study|Lost to Follow-up|1|||
124664619|NCT05359952|448395321|FG001|Overall Study|Lost to Follow-up|0|||
124664620|NCT02258659|448395322|FG000|Overall Study|Withdrawal by Subject|1|||
124664621|NCT04892446|448395323|FG000|Overall Study|Death|4|||
124664622|NCT04892446|448395324|FG001|Overall Study|Death|4|||
124664623|NCT04892446|448395325|FG002|Overall Study|Death|0|||
124664624|NCT04892446|448395323|FG000|Overall Study|Withdrew consent|3|||
124664625|NCT04892446|448395324|FG001|Overall Study|Withdrew consent|0|||
124664626|NCT04892446|448395325|FG002|Overall Study|Withdrew consent|1|||
124664627|NCT04892446|448395323|FG000|Overall Study|Investigator's discretion|1|||
124664628|NCT04892446|448395324|FG001|Overall Study|Investigator's discretion|1|||
124664629|NCT04892446|448395325|FG002|Overall Study|Investigator's discretion|0|||
124664630|NCT04892446|448395323|FG000|Overall Study|Study terminated by sponsor|0|||
124664631|NCT04892446|448395324|FG001|Overall Study|Study terminated by sponsor|0|||
124664632|NCT04892446|448395325|FG002|Overall Study|Study terminated by sponsor|2|||
124664633|NCT00272844|448395326|FG000|Overall Study|Withdrawal by Subject|5|||
124664634|NCT03060291|448395327|FG000|3-month Follow-up|Declined to respond|8|||
124664635|NCT03060291|448395328|FG001|3-month Follow-up|Declined to respond|10|||
124664636|NCT03060291|448395329|FG002|3-month Follow-up|Declined to respond|2|||
124664637|NCT03060291|448395327|FG000|6-month Follow-up|Declined to respond|7|||
124664638|NCT03060291|448395328|FG001|6-month Follow-up|Declined to respond|13|||
124664639|NCT03060291|448395329|FG002|6-month Follow-up|Declined to respond|4|||
124664640|NCT03060291|448395327|FG000|12-month Follow-up|Declined to respond|7|||
124664641|NCT03060291|448395328|FG001|12-month Follow-up|Declined to respond|16|||
124664642|NCT03060291|448395329|FG002|12-month Follow-up|Declined to respond|6|||
124664643|NCT01556932|448395333|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
124664644|NCT01556932|448395334|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
124664645|NCT01882803|448395335|FG000|Overall Study|Disease Progression|1|||
124664646|NCT01882803|448395335|FG000|Overall Study|Withdrawal by Subject|9|||
124664647|NCT01882803|448395335|FG000|Overall Study|Death|68|||
124664648|NCT01882803|448395335|FG000|Overall Study|Physician Decision|3|||
124664649|NCT01882803|448395335|FG000|Overall Study|Lost to Follow-up|3|||
124664650|NCT01882803|448395335|FG000|Overall Study|Follow-up Completed|39|||
124664651|NCT01882803|448395335|FG000|Overall Study|Study Terminated by the Sponsor|6|||
124664652|NCT01563913|448395336|FG000|Overall Study|Physician Decision|1|||
124664653|NCT01563913|448395337|FG001|Overall Study|Physician Decision|0|||
124664654|NCT01563913|448395336|FG000|Overall Study|Spouse Passed Away|1|||
124664655|NCT01563913|448395337|FG001|Overall Study|Spouse Passed Away|0|||
124664656|NCT02585713|448395339|FG000|Overall Study|Withdrew prior to treatment|2|||
124664657|NCT02585713|448395340|FG001|Overall Study|Withdrew prior to treatment|7|||
124664658|NCT02585713|448395339|FG000|Overall Study|Other|3|||
124664659|NCT02585713|448395340|FG001|Overall Study|Other|1|||
124664660|NCT03173456|448395345|FG000|Baseline|Medication dispensing system malfunction'|0|||
124664661|NCT03173456|448395346|FG001|Baseline|Medication dispensing system malfunction'|1|||
124664662|NCT03173456|448395347|FG002|Baseline|Medication dispensing system malfunction'|0|||
124664663|NCT03173456|448395348|FG003|Baseline|Medication dispensing system malfunction'|0|||
124664664|NCT03173456|448395349|FG004|Baseline|Medication dispensing system malfunction'|2|||
124664665|NCT03173456|448395345|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
124664666|NCT03173456|448395346|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
124664667|NCT03173456|448395347|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
124664668|NCT03173456|448395348|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
124664669|NCT03173456|448395349|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
124664670|NCT01733121|448395350|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
124664671|NCT01733121|448395351|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
124664672|NCT01733121|448395350|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
124664673|NCT01733121|448395351|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
124664674|NCT01733121|448395350|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
124664675|NCT01733121|448395351|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
124664676|NCT01733121|448395350|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
124664677|NCT01733121|448395351|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
124664678|NCT04501952|448395360|FG000|Overall Study|Adverse Event|0|||
124664679|NCT04501952|448395361|FG001|Overall Study|Adverse Event|3|||
124664680|NCT04501952|448395360|FG000|Overall Study|Investigator's Discretion|0|||
124664681|NCT04501952|448395361|FG001|Overall Study|Investigator's Discretion|1|||
124664682|NCT04501952|448395360|FG000|Overall Study|Protocol Violation|1|||
124664683|NCT04501952|448395361|FG001|Overall Study|Protocol Violation|1|||
124664684|NCT04501952|448395360|FG000|Overall Study|Withdrew Consent|5|||
124664685|NCT04501952|448395361|FG001|Overall Study|Withdrew Consent|4|||
124664686|NCT04501952|448395360|FG000|Overall Study|Lost to Follow-up|7|||
124664687|NCT04501952|448395361|FG001|Overall Study|Lost to Follow-up|2|||
124664688|NCT04501952|448395360|FG000|Overall Study|Randomized and Never Treated|13|||
124664689|NCT04501952|448395361|FG001|Overall Study|Randomized and Never Treated|9|||
124664690|NCT03061188|448395362|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
124664691|NCT03061188|448395363|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
124664692|NCT03061188|448395364|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
124664693|NCT03061188|448395365|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
124664694|NCT03061188|448395362|FG000|On Follow-up for 3 Years|Death|0|||
124664695|NCT03061188|448395363|FG001|On Follow-up for 3 Years|Death|3|||
124664696|NCT03061188|448395364|FG002|On Follow-up for 3 Years|Death|5|||
124664697|NCT03061188|448395365|FG003|On Follow-up for 3 Years|Death|4|||
124664698|NCT03061188|448395362|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
124664699|NCT03061188|448395363|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
124664700|NCT03061188|448395364|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
124664701|NCT03061188|448395365|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
124664702|NCT02080364|448395370|FG000|Baseline Period|Protocol Violation|2|||
124664703|NCT02080364|448395371|FG001|Baseline Period|Protocol Violation|1|||
124664704|NCT02080364|448395372|FG002|Baseline Period|Protocol Violation|0|||
124664705|NCT02080364|448395373|FG003|Baseline Period|Protocol Violation|0|||
124664706|NCT02080364|448395370|FG000|Baseline Period|Other|0|||
124664707|NCT02080364|448395371|FG001|Baseline Period|Other|1|||
124664708|NCT02080364|448395372|FG002|Baseline Period|Other|1|||
124664709|NCT02080364|448395373|FG003|Baseline Period|Other|0|||
124664710|NCT02080364|448395370|FG000|Treatment Period|Adverse Event|10|||
124664711|NCT02080364|448395371|FG001|Treatment Period|Adverse Event|15|||
124664712|NCT02080364|448395372|FG002|Treatment Period|Adverse Event|11|||
124664713|NCT02080364|448395373|FG003|Treatment Period|Adverse Event|14|||
124664714|NCT02080364|448395370|FG000|Treatment Period|Lost to Follow-up|2|||
124664715|NCT02080364|448395371|FG001|Treatment Period|Lost to Follow-up|3|||
124664716|NCT02080364|448395372|FG002|Treatment Period|Lost to Follow-up|5|||
124664717|NCT02080364|448395373|FG003|Treatment Period|Lost to Follow-up|0|||
124664718|NCT02080364|448395370|FG000|Treatment Period|Protocol Violation|5|||
124664719|NCT02080364|448395371|FG001|Treatment Period|Protocol Violation|3|||
124664720|NCT02080364|448395372|FG002|Treatment Period|Protocol Violation|5|||
124664721|NCT02080364|448395373|FG003|Treatment Period|Protocol Violation|1|||
124664722|NCT02080364|448395370|FG000|Treatment Period|Withdrawal by Subject|16|||
124664723|NCT02080364|448395371|FG001|Treatment Period|Withdrawal by Subject|16|||
124664724|NCT02080364|448395372|FG002|Treatment Period|Withdrawal by Subject|15|||
124664725|NCT02080364|448395373|FG003|Treatment Period|Withdrawal by Subject|10|||
124664726|NCT02080364|448395370|FG000|Treatment Period|Study Terminated by Sponsor|0|||
124664727|NCT02080364|448395371|FG001|Treatment Period|Study Terminated by Sponsor|0|||
124664728|NCT02080364|448395372|FG002|Treatment Period|Study Terminated by Sponsor|180|||
124664729|NCT02080364|448395373|FG003|Treatment Period|Study Terminated by Sponsor|183|||
124664730|NCT02080364|448395370|FG000|Treatment Period|Other|14|||
124664731|NCT02080364|448395371|FG001|Treatment Period|Other|12|||
124664732|NCT02080364|448395372|FG002|Treatment Period|Other|21|||
124664733|NCT02080364|448395373|FG003|Treatment Period|Other|16|||
124664734|NCT02609984|448395374|FG000|Overall Study|Death|29|||
124664735|NCT02609984|448395375|FG001|Overall Study|Death|26|||
124664736|NCT02609984|448395374|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
124664737|NCT02609984|448395375|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
124664738|NCT02609984|448395374|FG000|Overall Study|Lost to Follow-up|1|||
124664739|NCT02609984|448395375|FG001|Overall Study|Lost to Follow-up|2|||
124664740|NCT02609984|448395374|FG000|Overall Study|Withdrawal by Subject|0|||
124664741|NCT02609984|448395375|FG001|Overall Study|Withdrawal by Subject|1|||
124664742|NCT02609984|448395374|FG000|Overall Study|Disease Progression|2|||
124664743|NCT02609984|448395375|FG001|Overall Study|Disease Progression|0|||
124664744|NCT02504320|448395376|FG000|Treatment Period 1|Positive Drug Screen|0|||
124664745|NCT02504320|448395377|FG001|Treatment Period 1|Positive Drug Screen|0|||
124664746|NCT02504320|448395378|FG002|Treatment Period 1|Positive Drug Screen|1|||
124664747|NCT02504320|448395379|FG003|Treatment Period 1|Positive Drug Screen|0|||
124664748|NCT02504320|448395376|FG000|Treatment Period 2|Positive Drug Screen|0|||
124664749|NCT02504320|448395377|FG001|Treatment Period 2|Positive Drug Screen|1|||
124664750|NCT02504320|448395378|FG002|Treatment Period 2|Positive Drug Screen|0|||
124664751|NCT02504320|448395379|FG003|Treatment Period 2|Positive Drug Screen|0|||
124664752|NCT02504320|448395376|FG000|Treatment Period 3|Positive Drug Screen|0|||
124664753|NCT02504320|448395377|FG001|Treatment Period 3|Positive Drug Screen|0|||
124664754|NCT02504320|448395378|FG002|Treatment Period 3|Positive Drug Screen|0|||
124664755|NCT02504320|448395379|FG003|Treatment Period 3|Positive Drug Screen|1|||
124664756|NCT02504320|448395376|FG000|Treatment Period 3|Adverse Event|0|||
124664757|NCT02504320|448395377|FG001|Treatment Period 3|Adverse Event|0|||
124664758|NCT02504320|448395378|FG002|Treatment Period 3|Adverse Event|1|||
124664759|NCT02504320|448395379|FG003|Treatment Period 3|Adverse Event|0|||
124664760|NCT01210222|448395380|FG000|Overall Study|Ineligible|2|||
124664761|NCT01210222|448395380|FG000|Overall Study|Never treated|1|||
124664762|NCT02497404|448395381|FG000|Overall Study|Adverse Event|1|||
124664763|NCT01408901|448395382|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
124664764|NCT01408901|448395383|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
124664765|NCT01408901|448395384|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
124664766|NCT01408901|448395385|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
124664767|NCT01408901|448395382|FG000|6-Week Follow-Up|Death|1|||
124664768|NCT01408901|448395383|FG001|6-Week Follow-Up|Death|0|||
124664769|NCT01408901|448395384|FG002|6-Week Follow-Up|Death|0|||
124664770|NCT01408901|448395385|FG003|6-Week Follow-Up|Death|0|||
124664771|NCT01408901|448395382|FG000|6-Week Follow-Up|Cancelled visit|0|||
124664772|NCT01408901|448395383|FG001|6-Week Follow-Up|Cancelled visit|1|||
124664773|NCT01408901|448395384|FG002|6-Week Follow-Up|Cancelled visit|0|||
124664774|NCT01408901|448395385|FG003|6-Week Follow-Up|Cancelled visit|2|||
124664775|NCT01408901|448395382|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
124664776|NCT01408901|448395383|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
124664777|NCT01408901|448395384|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
124664778|NCT01408901|448395385|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
124664779|NCT01408901|448395382|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
124664780|NCT01408901|448395383|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
124664781|NCT01408901|448395384|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
124664782|NCT01408901|448395385|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
124664783|NCT01408901|448395382|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
124664784|NCT01408901|448395383|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
124664785|NCT01408901|448395384|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
124664786|NCT01408901|448395385|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
124664787|NCT01408901|448395382|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
124664788|NCT01408901|448395383|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
124664789|NCT01408901|448395384|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
124664790|NCT01408901|448395385|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
124664791|NCT01408901|448395382|FG000|26-Week Follow-Up|Death|0|||
124664792|NCT01408901|448395383|FG001|26-Week Follow-Up|Death|1|||
124664793|NCT01408901|448395384|FG002|26-Week Follow-Up|Death|0|||
124664794|NCT01408901|448395385|FG003|26-Week Follow-Up|Death|0|||
124664795|NCT04978337|448395386|FG000|Overall Study|Withdrawal by Subject|0|||
124664796|NCT04978337|448395387|FG001|Overall Study|Withdrawal by Subject|1|||
124664797|NCT03131687|448395394|FG000|Overall Study|Adverse Event|0|||
124664798|NCT03131687|448395395|FG001|Overall Study|Adverse Event|1|||
124664799|NCT03131687|448395396|FG002|Overall Study|Adverse Event|0|||
124664800|NCT03131687|448395397|FG003|Overall Study|Adverse Event|1|||
124664801|NCT03131687|448395398|FG004|Overall Study|Adverse Event|2|||
124664802|NCT03131687|448395399|FG005|Overall Study|Adverse Event|2|||
124664803|NCT03131687|448395394|FG000|Overall Study|Death|1|||
124664804|NCT03131687|448395395|FG001|Overall Study|Death|0|||
124664805|NCT03131687|448395396|FG002|Overall Study|Death|0|||
124664806|NCT03131687|448395397|FG003|Overall Study|Death|0|||
124664807|NCT03131687|448395398|FG004|Overall Study|Death|0|||
124664808|NCT03131687|448395399|FG005|Overall Study|Death|0|||
124664809|NCT03131687|448395394|FG000|Overall Study|Withdrawal by Subject|3|||
124664810|NCT03131687|448395395|FG001|Overall Study|Withdrawal by Subject|3|||
124664811|NCT03131687|448395396|FG002|Overall Study|Withdrawal by Subject|3|||
124664812|NCT03131687|448395397|FG003|Overall Study|Withdrawal by Subject|1|||
124664813|NCT03131687|448395398|FG004|Overall Study|Withdrawal by Subject|2|||
124664814|NCT03131687|448395399|FG005|Overall Study|Withdrawal by Subject|1|||
124664815|NCT03131687|448395394|FG000|Overall Study|Lost to Follow-up|1|||
124664816|NCT03131687|448395395|FG001|Overall Study|Lost to Follow-up|4|||
124664817|NCT03131687|448395396|FG002|Overall Study|Lost to Follow-up|0|||
124664818|NCT03131687|448395397|FG003|Overall Study|Lost to Follow-up|1|||
124664819|NCT03131687|448395398|FG004|Overall Study|Lost to Follow-up|4|||
124664820|NCT03131687|448395399|FG005|Overall Study|Lost to Follow-up|2|||
124664821|NCT03131687|448395394|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
124664822|NCT03131687|448395395|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
124664823|NCT03131687|448395396|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
124664824|NCT03131687|448395397|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
124664825|NCT03131687|448395398|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
124664826|NCT03131687|448395399|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
124664827|NCT03131687|448395394|FG000|Overall Study|Principle Investigator Decision|0|||
124664828|NCT03131687|448395395|FG001|Overall Study|Principle Investigator Decision|1|||
124664829|NCT03131687|448395396|FG002|Overall Study|Principle Investigator Decision|0|||
124664830|NCT03131687|448395397|FG003|Overall Study|Principle Investigator Decision|0|||
124664831|NCT03131687|448395398|FG004|Overall Study|Principle Investigator Decision|0|||
124664832|NCT03131687|448395399|FG005|Overall Study|Principle Investigator Decision|0|||
124664833|NCT03131687|448395394|FG000|Overall Study|Inadvertent Enrollment|0|||
124664834|NCT03131687|448395395|FG001|Overall Study|Inadvertent Enrollment|0|||
124664835|NCT03131687|448395396|FG002|Overall Study|Inadvertent Enrollment|0|||
124664836|NCT03131687|448395397|FG003|Overall Study|Inadvertent Enrollment|1|||
124664837|NCT03131687|448395398|FG004|Overall Study|Inadvertent Enrollment|0|||
124664838|NCT03131687|448395399|FG005|Overall Study|Inadvertent Enrollment|0|||
124664839|NCT01904032|448395409|FG000|Overall Study|Adverse Event|3|||
124664840|NCT01904032|448395410|FG001|Overall Study|Adverse Event|1|||
124664841|NCT01904032|448395409|FG000|Overall Study|Lost to Follow-up|4|||
124664842|NCT01904032|448395410|FG001|Overall Study|Lost to Follow-up|2|||
124664843|NCT04074330|448395418|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
124664844|NCT04074330|448395419|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
124664845|NCT04074330|448395420|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
124664846|NCT04074330|448395421|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
124664847|NCT04074330|448395422|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
124664848|NCT04074330|448395423|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
124664849|NCT04074330|448395424|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
124664850|NCT04074330|448395425|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
124664851|NCT04074330|448395426|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
124664852|NCT04074330|448395427|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
124664853|NCT04074330|448395418|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
124664854|NCT04074330|448395419|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
124664855|NCT04074330|448395420|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
124664856|NCT04074330|448395421|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
124664857|NCT04074330|448395422|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
124664858|NCT04074330|448395423|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
124664859|NCT04074330|448395424|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
124664860|NCT04074330|448395425|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
124664861|NCT04074330|448395426|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
124664862|NCT04074330|448395427|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
124664863|NCT04074330|448395418|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
124664864|NCT04074330|448395419|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
124664865|NCT04074330|448395420|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
124664866|NCT04074330|448395421|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
124664867|NCT04074330|448395422|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
124664868|NCT04074330|448395423|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
124664869|NCT04074330|448395424|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
124664870|NCT04074330|448395425|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
124664871|NCT04074330|448395426|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
124664872|NCT04074330|448395427|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
124664873|NCT04074330|448395418|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
124664874|NCT04074330|448395419|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
124664875|NCT04074330|448395420|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
124664876|NCT04074330|448395421|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
124664877|NCT04074330|448395422|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
124664878|NCT04074330|448395423|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
124664879|NCT04074330|448395424|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
124664880|NCT04074330|448395425|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
124664881|NCT04074330|448395426|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
124664882|NCT04074330|448395427|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
124664883|NCT04074330|448395418|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
124664884|NCT04074330|448395419|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
124664885|NCT04074330|448395420|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
124664886|NCT04074330|448395421|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
124664887|NCT04074330|448395422|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
124664888|NCT04074330|448395423|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
124664889|NCT04074330|448395424|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
124664890|NCT04074330|448395425|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
124664891|NCT04074330|448395426|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
124664892|NCT04074330|448395427|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
124664893|NCT04074330|448395418|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
124664894|NCT04074330|448395419|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
124664895|NCT04074330|448395420|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
124664896|NCT04074330|448395421|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
124664897|NCT04074330|448395422|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
124664898|NCT04074330|448395423|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
124664899|NCT04074330|448395424|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
124664900|NCT04074330|448395425|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
124664901|NCT04074330|448395426|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
124664902|NCT04074330|448395427|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
124664903|NCT04074330|448395418|FG000|Dose Expansion (up to 42 Months)|Death|0|||
124664904|NCT04074330|448395419|FG001|Dose Expansion (up to 42 Months)|Death|0|||
124664905|NCT04074330|448395420|FG002|Dose Expansion (up to 42 Months)|Death|0|||
124664906|NCT04074330|448395421|FG003|Dose Expansion (up to 42 Months)|Death|0|||
124664907|NCT04074330|448395422|FG004|Dose Expansion (up to 42 Months)|Death|0|||
124664908|NCT04074330|448395423|FG005|Dose Expansion (up to 42 Months)|Death|0|||
124664909|NCT04074330|448395424|FG006|Dose Expansion (up to 42 Months)|Death|0|||
124664910|NCT04074330|448395425|FG007|Dose Expansion (up to 42 Months)|Death|0|||
124664911|NCT04074330|448395426|FG008|Dose Expansion (up to 42 Months)|Death|1|||
124664912|NCT04074330|448395427|FG009|Dose Expansion (up to 42 Months)|Death|0|||
124664913|NCT04074330|448395418|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
124664914|NCT04074330|448395419|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
124664915|NCT04074330|448395420|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
124664916|NCT04074330|448395421|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
124664917|NCT04074330|448395422|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
124664918|NCT04074330|448395423|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
124664919|NCT04074330|448395424|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
124664920|NCT04074330|448395425|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
124664921|NCT04074330|448395426|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
124664922|NCT04074330|448395427|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
124664923|NCT01903993|448395428|FG000|Overall Study|Death|118|||
124664924|NCT01903993|448395429|FG001|Overall Study|Death|121|||
124664925|NCT01903993|448395428|FG000|Overall Study|Withdrawal by Subject|15|||
124664926|NCT01903993|448395429|FG001|Overall Study|Withdrawal by Subject|4|||
124664927|NCT01903993|448395428|FG000|Overall Study|Lost to Follow-up|2|||
124664928|NCT01903993|448395429|FG001|Overall Study|Lost to Follow-up|3|||
124664929|NCT01903993|448395428|FG000|Overall Study|Study Terminated by Sponsor|8|||
124664930|NCT01903993|448395429|FG001|Overall Study|Study Terminated by Sponsor|14|||
124664931|NCT01903993|448395428|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
124664932|NCT01903993|448395429|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
124664933|NCT00184093|448395430|FG000|Overall Study|Adverse Event|3|||
124664934|NCT00184093|448395430|FG000|Overall Study|Lost to Follow-up|3|||
124664935|NCT00184093|448395430|FG000|Overall Study|Physician Decision|1|||
124664936|NCT00184093|448395430|FG000|Overall Study|Withdrawal by Subject|2|||
124664937|NCT00972283|448395431|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
124664938|NCT00972283|448395432|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
124664939|NCT00972283|448395431|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
124664940|NCT00972283|448395432|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
124664941|NCT00972283|448395431|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
124664942|NCT00972283|448395432|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
124664943|NCT00972283|448395431|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
124664944|NCT00972283|448395432|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
124664945|NCT00972283|448395431|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
124664946|NCT00972283|448395432|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
124664947|NCT00972283|448395431|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
124664948|NCT00972283|448395432|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
124664949|NCT00972283|448395431|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
124664950|NCT00972283|448395432|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
124664951|NCT00972283|448395431|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
124664952|NCT00972283|448395432|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
124664953|NCT00972283|448395431|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
124664954|NCT00972283|448395432|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
124664955|NCT00972283|448395431|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
124664956|NCT00972283|448395432|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
124664957|NCT01868165|448395440|FG000|Overall Study|Withdrawal by Subject|36|||
124664958|NCT01868165|448395440|FG000|Overall Study|Physician Decision|2|||
124664959|NCT01868165|448395440|FG000|Overall Study|Lost to Follow-up|3|||
124664960|NCT01868165|448395440|FG000|Overall Study|Death|4|||
124664961|NCT02282163|448395443|FG000|Overall Study|Protocol Violation|1|||
124664962|NCT01603407|448395444|FG000|Overall Study|Adverse Event|1|||
124664963|NCT01603407|448395445|FG001|Overall Study|Adverse Event|1|||
124664964|NCT01603407|448395446|FG002|Overall Study|Adverse Event|1|||
124664965|NCT01603407|448395444|FG000|Overall Study|Protocol Violation|2|||
124664966|NCT01603407|448395445|FG001|Overall Study|Protocol Violation|2|||
124664967|NCT01603407|448395446|FG002|Overall Study|Protocol Violation|0|||
124664968|NCT01603407|448395444|FG000|Overall Study|Withdrawal by Subject|8|||
124664969|NCT01603407|448395445|FG001|Overall Study|Withdrawal by Subject|5|||
124664970|NCT01603407|448395446|FG002|Overall Study|Withdrawal by Subject|7|||
124664971|NCT01603407|448395444|FG000|Overall Study|Lost to Follow-up|0|||
124664972|NCT01603407|448395445|FG001|Overall Study|Lost to Follow-up|3|||
124664973|NCT01603407|448395446|FG002|Overall Study|Lost to Follow-up|2|||
124664974|NCT02500719|448395447|FG000|Overall Study|Lost to Follow-up|2|||
124664975|NCT02500719|448395448|FG001|Overall Study|Lost to Follow-up|3|||
124664976|NCT02500719|448395447|FG000|Overall Study|Trauma history|1|||
124664977|NCT02500719|448395448|FG001|Overall Study|Trauma history|0|||
124664978|NCT02500719|448395447|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
124664979|NCT02500719|448395448|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
124664980|NCT02500719|448395447|FG000|Overall Study|Did not meet criteria for PTSD|0|||
124664981|NCT02500719|448395448|FG001|Overall Study|Did not meet criteria for PTSD|1|||
124664982|NCT02500719|448395447|FG000|Overall Study|Claustrophobia|0|||
124664983|NCT02500719|448395448|FG001|Overall Study|Claustrophobia|1|||
124664984|NCT02500719|448395447|FG000|Overall Study|History of head trauma|0|||
124664985|NCT02500719|448395448|FG001|Overall Study|History of head trauma|1|||
124664986|NCT01990768|448395449|FG000|Intervention Started|Found to be ineligible|14|||
124664987|NCT01990768|448395450|FG001|Intervention Started|Found to be ineligible|13|||
124664988|NCT01990768|448395451|FG002|Intervention Started|Found to be ineligible|11|||
124664989|NCT01990768|448395449|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
124664990|NCT01990768|448395450|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
124664991|NCT01990768|448395451|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
124664992|NCT01990768|448395449|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
124664993|NCT01990768|448395450|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
124664994|NCT01990768|448395451|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
124664995|NCT01990768|448395449|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
124664996|NCT01990768|448395450|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
124664997|NCT01990768|448395451|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
124664998|NCT01990768|448395449|FG000|Intervention Started|Patient care priority|1|||
124664999|NCT01990768|448395450|FG001|Intervention Started|Patient care priority|2|||
124665000|NCT01990768|448395451|FG002|Intervention Started|Patient care priority|3|||
124665001|NCT01990768|448395449|FG000|Intervention Started|IV lost|2|||
124665002|NCT01990768|448395450|FG001|Intervention Started|IV lost|2|||
124665003|NCT01990768|448395451|FG002|Intervention Started|IV lost|2|||
124665004|NCT01990768|448395449|FG000|Intervention Started|Required CPR|1|||
124665005|NCT01990768|448395450|FG001|Intervention Started|Required CPR|1|||
124665006|NCT01990768|448395451|FG002|Intervention Started|Required CPR|0|||
124665007|NCT01990768|448395449|FG000|Intervention Started|Seizure or hx of seizure|0|||
124665008|NCT01990768|448395450|FG001|Intervention Started|Seizure or hx of seizure|0|||
124665009|NCT01990768|448395451|FG002|Intervention Started|Seizure or hx of seizure|2|||
124665010|NCT01990768|448395449|FG000|Intervention Started|Discovered to be pregnant|0|||
124665011|NCT01990768|448395450|FG001|Intervention Started|Discovered to be pregnant|1|||
124665012|NCT01990768|448395451|FG002|Intervention Started|Discovered to be pregnant|0|||
124665013|NCT01990768|448395449|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
124665014|NCT01990768|448395450|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
124665015|NCT01990768|448395451|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
124665016|NCT01990768|448395449|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
124665017|NCT01990768|448395450|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
124665018|NCT01990768|448395451|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
124665019|NCT01990768|448395449|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
124665020|NCT01990768|448395450|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
124665021|NCT01990768|448395451|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
124665022|NCT01990768|448395449|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
124665023|NCT01990768|448395450|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
124665024|NCT01990768|448395451|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
124665025|NCT01990768|448395449|FG000|Prehospital Study Drug Infusion|Death|3|||
124665026|NCT01990768|448395450|FG001|Prehospital Study Drug Infusion|Death|1|||
124665027|NCT01990768|448395451|FG002|Prehospital Study Drug Infusion|Death|1|||
124665028|NCT01990768|448395449|FG000|Prehospital Study Drug Infusion|Discharged|2|||
124665029|NCT01990768|448395450|FG001|Prehospital Study Drug Infusion|Discharged|1|||
124665030|NCT01990768|448395451|FG002|Prehospital Study Drug Infusion|Discharged|0|||
124665031|NCT01990768|448395449|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
124665032|NCT01990768|448395450|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
124665033|NCT01990768|448395451|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
124665034|NCT01990768|448395449|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
124665035|NCT01990768|448395450|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
124665036|NCT01990768|448395451|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
124665037|NCT01990768|448395449|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
124665038|NCT01990768|448395450|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
124665039|NCT01990768|448395451|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
124665040|NCT01990768|448395449|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
124665041|NCT01990768|448395450|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
124665042|NCT01990768|448395451|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
124665043|NCT01990768|448395449|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
124665044|NCT01990768|448395450|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
124665045|NCT01990768|448395451|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
124665046|NCT01990768|448395449|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
124665047|NCT01990768|448395450|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
124665048|NCT01990768|448395451|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
124665049|NCT01990768|448395449|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
124665050|NCT01990768|448395450|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
124665051|NCT01990768|448395451|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
124665052|NCT01990768|448395449|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
124665053|NCT01990768|448395450|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
124665054|NCT01990768|448395451|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
124665055|NCT01990768|448395449|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
124665056|NCT01990768|448395450|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
124665057|NCT01990768|448395451|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
124665058|NCT01990768|448395449|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
124665059|NCT01990768|448395450|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
124665060|NCT01990768|448395451|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
124665061|NCT01990768|448395449|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
124665062|NCT01990768|448395450|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
124665063|NCT01990768|448395451|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
124665064|NCT01990768|448395449|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
124665065|NCT01990768|448395450|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
124665066|NCT01990768|448395451|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
124665067|NCT01990768|448395449|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
124665068|NCT01990768|448395450|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
124665069|NCT01990768|448395451|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
124665070|NCT01990768|448395449|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
124665071|NCT01990768|448395450|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
124665072|NCT01990768|448395451|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
124665073|NCT01990768|448395449|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
124665074|NCT01990768|448395450|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
124665075|NCT01990768|448395451|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
124665076|NCT01990768|448395449|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
124665077|NCT01990768|448395450|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
124665078|NCT01990768|448395451|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
124665079|NCT01990768|448395449|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
124665080|NCT01990768|448395450|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
124665081|NCT01990768|448395451|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
124665082|NCT01990768|448395449|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
124665083|NCT01990768|448395450|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
124665084|NCT01990768|448395451|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
124665085|NCT01990768|448395449|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
124665086|NCT01990768|448395450|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
124665087|NCT01990768|448395451|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
124665088|NCT01990768|448395449|FG000|6-Month Follow-up|No contact information|5|||
124665089|NCT01990768|448395450|FG001|6-Month Follow-up|No contact information|6|||
124665090|NCT01990768|448395451|FG002|6-Month Follow-up|No contact information|5|||
124665091|NCT01990768|448395449|FG000|6-Month Follow-up|Homeless|4|||
124665092|NCT01990768|448395450|FG001|6-Month Follow-up|Homeless|3|||
124665093|NCT01990768|448395451|FG002|6-Month Follow-up|Homeless|6|||
124665094|NCT01990768|448395449|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
124665095|NCT01990768|448395450|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
124665096|NCT01990768|448395451|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
124665097|NCT01990768|448395449|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
124665098|NCT01990768|448395450|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
124665099|NCT01990768|448395451|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
124665100|NCT01990768|448395449|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
124665101|NCT01990768|448395450|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
124665102|NCT01990768|448395451|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
124665103|NCT03538691|448395452|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
124665104|NCT03538691|448395453|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
124665105|NCT03538691|448395454|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
124665106|NCT03538691|448395455|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
124665107|NCT03538691|448395452|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
124665108|NCT03538691|448395453|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
124665109|NCT03538691|448395454|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
124665110|NCT03538691|448395455|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
124665111|NCT03538691|448395452|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
124665112|NCT03538691|448395453|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
124665113|NCT03538691|448395454|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
124665114|NCT03538691|448395455|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
124665115|NCT03538691|448395452|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
124665116|NCT03538691|448395453|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
124665117|NCT03538691|448395454|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
124665118|NCT03538691|448395455|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
124665119|NCT03538691|448395452|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
124665120|NCT03538691|448395453|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
124665121|NCT03538691|448395454|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
124665122|NCT03538691|448395455|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
124665123|NCT03538691|448395452|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
124665124|NCT03538691|448395453|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
124665125|NCT03538691|448395454|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
124665126|NCT03538691|448395455|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
124665127|NCT03538691|448395452|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
124665128|NCT03538691|448395453|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
124665129|NCT03538691|448395454|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
124665130|NCT03538691|448395455|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
124665131|NCT03538691|448395452|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
124665132|NCT03538691|448395453|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
124665133|NCT03538691|448395454|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
124665134|NCT03538691|448395455|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
124665135|NCT03538691|448395452|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
124665136|NCT03538691|448395453|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
124665137|NCT03538691|448395454|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
124665138|NCT03538691|448395455|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
124665139|NCT03538691|448395452|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
124665140|NCT03538691|448395453|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
124665141|NCT03538691|448395454|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
124665142|NCT03538691|448395455|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
124665143|NCT03538691|448395452|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
124665144|NCT03538691|448395453|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
124665145|NCT03538691|448395454|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
124665146|NCT03538691|448395455|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
124665147|NCT03538691|448395452|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
124665148|NCT03538691|448395453|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
124665149|NCT03538691|448395454|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
124665150|NCT03538691|448395455|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
124665151|NCT03538691|448395452|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
124665152|NCT03538691|448395453|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
124665153|NCT03538691|448395454|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
124665154|NCT03538691|448395455|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
124665155|NCT03538691|448395452|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
124665156|NCT03538691|448395453|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
124665157|NCT03538691|448395454|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
124665158|NCT03538691|448395455|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
124665159|NCT03538691|448395452|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
124665160|NCT03538691|448395453|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
124665161|NCT03538691|448395454|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
124665162|NCT03538691|448395455|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
124665163|NCT03538691|448395452|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
124665164|NCT03538691|448395453|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
124665165|NCT03538691|448395454|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
124665166|NCT03538691|448395455|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
124665167|NCT03538691|448395452|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
124665168|NCT03538691|448395453|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
124665169|NCT03538691|448395454|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
124665170|NCT03538691|448395455|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
124665171|NCT03538691|448395452|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
124665172|NCT03538691|448395453|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
124665173|NCT03538691|448395454|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
124665174|NCT03538691|448395455|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
124665175|NCT03538691|448395452|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
124665176|NCT03538691|448395453|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
124665177|NCT03538691|448395454|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
124665178|NCT03538691|448395455|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
124665179|NCT03538691|448395452|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
124665180|NCT03538691|448395453|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
124665181|NCT03538691|448395454|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
124665182|NCT03538691|448395455|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
124665183|NCT03538691|448395452|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
124665184|NCT03538691|448395453|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
124665185|NCT03538691|448395454|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
124665186|NCT03538691|448395455|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
124665187|NCT03538691|448395452|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
124665188|NCT03538691|448395453|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
124665189|NCT03538691|448395454|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
124665190|NCT03538691|448395455|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
124665191|NCT03538691|448395452|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
124665192|NCT03538691|448395453|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
124665193|NCT03538691|448395454|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
124665194|NCT03538691|448395455|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
124665195|NCT03538691|448395452|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
124665196|NCT03538691|448395453|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
124665197|NCT03538691|448395454|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
124665198|NCT03538691|448395455|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
124665199|NCT03538691|448395452|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
124665200|NCT03538691|448395453|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
124665201|NCT03538691|448395454|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
124665202|NCT03538691|448395455|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
124665203|NCT03538691|448395452|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
124665204|NCT03538691|448395453|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
124665205|NCT03538691|448395454|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
124665206|NCT03538691|448395455|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
124665207|NCT03538691|448395452|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
124665208|NCT03538691|448395453|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
124665209|NCT03538691|448395454|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
124665210|NCT03538691|448395455|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
124665211|NCT03538691|448395452|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
124665212|NCT03538691|448395453|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
124665213|NCT03538691|448395454|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
124665214|NCT03538691|448395455|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
124665215|NCT01243177|448395458|FG000|Overall Study|Lack of Efficacy|47|||
124665216|NCT01243177|448395459|FG001|Overall Study|Lack of Efficacy|31|||
124665217|NCT01243177|448395458|FG000|Overall Study|Protocol Violation|11|||
124665218|NCT01243177|448395459|FG001|Overall Study|Protocol Violation|10|||
124665219|NCT01243177|448395458|FG000|Overall Study|Lost to Follow-up|15|||
124665220|NCT01243177|448395459|FG001|Overall Study|Lost to Follow-up|18|||
124665221|NCT01243177|448395458|FG000|Overall Study|Withdrawal by Subject|46|||
124665222|NCT01243177|448395459|FG001|Overall Study|Withdrawal by Subject|38|||
124665223|NCT01243177|448395458|FG000|Overall Study|AE, serious fatal|0|||
124665224|NCT01243177|448395459|FG001|Overall Study|AE, serious fatal|1|||
124665225|NCT01243177|448395458|FG000|Overall Study|SAE, non-fatal|7|||
124665226|NCT01243177|448395459|FG001|Overall Study|SAE, non-fatal|9|||
124665227|NCT01243177|448395458|FG000|Overall Study|AE, non-serious non-fatal|40|||
124665228|NCT01243177|448395459|FG001|Overall Study|AE, non-serious non-fatal|58|||
124665229|NCT01243177|448395458|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
124665230|NCT01243177|448395459|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
124665231|NCT01243177|448395458|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
124872962|NCT01493687|449157205|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
124872963|NCT01493687|449157206|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
124872964|NCT01493687|449157205|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
124872965|NCT01493687|449157206|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
124872966|NCT01493687|449157205|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
124872967|NCT01493687|449157206|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
124872968|NCT01493687|449157205|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
124872969|NCT01493687|449157206|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
124872970|NCT01493687|449157205|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
124872971|NCT01493687|449157206|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
124872972|NCT01493687|449157205|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
124872973|NCT01493687|449157206|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
124872974|NCT01493687|449157205|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
124872975|NCT01493687|449157206|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
124872976|NCT01493687|449157205|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
124872977|NCT01493687|449157206|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
124872978|NCT02364180|449157209|FG000|Overall Study|Screen Fail|1|||
124665232|NCT01243177|448395459|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
124665233|NCT01243177|448395458|FG000|Overall Study|Other Reason|11|||
124665234|NCT01243177|448395459|FG001|Overall Study|Other Reason|12|||
124665235|NCT05251233|448397356|FG000|Overall Study|Disease progression - did not start treatment|0|||
124665236|NCT05251233|448397357|FG001|Overall Study|Disease progression - did not start treatment|0|||
124665237|NCT05251233|448397358|FG002|Overall Study|Disease progression - did not start treatment|5|||
124665238|NCT05251233|448397356|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
124665239|NCT05251233|448397357|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
124665240|NCT05251233|448397358|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
124665241|NCT05251233|448397356|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
124665242|NCT05251233|448397357|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
124665243|NCT05251233|448397358|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
124665244|NCT05251233|448397356|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
124665245|NCT05251233|448397357|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
124665246|NCT05251233|448397358|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
124665247|NCT05251233|448397356|FG000|Overall Study|Death - did not start treatment|3|||
124665248|NCT05251233|448397357|FG001|Overall Study|Death - did not start treatment|0|||
124665249|NCT05251233|448397358|FG002|Overall Study|Death - did not start treatment|0|||
124665250|NCT05251233|448397356|FG000|Overall Study|Withdrawal by Subject|2|||
124665251|NCT05251233|448397357|FG001|Overall Study|Withdrawal by Subject|2|||
124665252|NCT05251233|448397358|FG002|Overall Study|Withdrawal by Subject|0|||
124665253|NCT05251233|448397356|FG000|Overall Study|Other complicating disease|2|||
124665254|NCT05251233|448397357|FG001|Overall Study|Other complicating disease|1|||
124665255|NCT05251233|448397358|FG002|Overall Study|Other complicating disease|0|||
124665256|NCT05251233|448397356|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
124665257|NCT05251233|448397357|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
124665258|NCT05251233|448397358|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
124665259|NCT05251233|448397356|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
124665260|NCT05251233|448397357|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
124665261|NCT05251233|448397358|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
124665262|NCT01919164|448397369|FG000|Overall Study|Adverse Event|6|||
124665263|NCT01919164|448397370|FG001|Overall Study|Adverse Event|4|||
124665264|NCT01919164|448397371|FG002|Overall Study|Adverse Event|9|||
124665265|NCT01919164|448397372|FG003|Overall Study|Adverse Event|3|||
124665266|NCT01919164|448397373|FG004|Overall Study|Adverse Event|2|||
124665267|NCT01919164|448397369|FG000|Overall Study|Lost to Follow-up|2|||
124665268|NCT01919164|448397370|FG001|Overall Study|Lost to Follow-up|2|||
124665269|NCT01919164|448397371|FG002|Overall Study|Lost to Follow-up|2|||
124665270|NCT01919164|448397372|FG003|Overall Study|Lost to Follow-up|0|||
124665271|NCT01919164|448397373|FG004|Overall Study|Lost to Follow-up|4|||
124665272|NCT01919164|448397369|FG000|Overall Study|Death|1|||
124665273|NCT01919164|448397370|FG001|Overall Study|Death|0|||
124665274|NCT01919164|448397371|FG002|Overall Study|Death|0|||
124665275|NCT01919164|448397372|FG003|Overall Study|Death|0|||
124665276|NCT01919164|448397373|FG004|Overall Study|Death|0|||
124665277|NCT01919164|448397369|FG000|Overall Study|Protocol Violation|6|||
124665278|NCT01919164|448397370|FG001|Overall Study|Protocol Violation|0|||
124665279|NCT01919164|448397371|FG002|Overall Study|Protocol Violation|3|||
124665280|NCT01919164|448397372|FG003|Overall Study|Protocol Violation|2|||
124665281|NCT01919164|448397373|FG004|Overall Study|Protocol Violation|2|||
124665282|NCT01919164|448397369|FG000|Overall Study|Disease progression|2|||
124665283|NCT01919164|448397370|FG001|Overall Study|Disease progression|2|||
124665284|NCT01919164|448397371|FG002|Overall Study|Disease progression|1|||
124665285|NCT01919164|448397372|FG003|Overall Study|Disease progression|2|||
124665286|NCT01919164|448397373|FG004|Overall Study|Disease progression|1|||
124665287|NCT01919164|448397369|FG000|Overall Study|Withdrew consent|13|||
124665288|NCT01919164|448397370|FG001|Overall Study|Withdrew consent|13|||
124665289|NCT01919164|448397371|FG002|Overall Study|Withdrew consent|14|||
124665290|NCT01919164|448397372|FG003|Overall Study|Withdrew consent|14|||
124665291|NCT01919164|448397373|FG004|Overall Study|Withdrew consent|9|||
124665292|NCT01919164|448397369|FG000|Overall Study|Other Un-specified|13|||
124665293|NCT01919164|448397370|FG001|Overall Study|Other Un-specified|9|||
124665294|NCT01919164|448397371|FG002|Overall Study|Other Un-specified|8|||
124665295|NCT01919164|448397372|FG003|Overall Study|Other Un-specified|7|||
124665296|NCT01919164|448397373|FG004|Overall Study|Other Un-specified|15|||
124665297|NCT00667992|448397376|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
124665298|NCT00667992|448397377|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
124665299|NCT00667992|448397376|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
124665300|NCT00667992|448397377|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
124665301|NCT00667992|448397376|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
124665302|NCT00667992|448397377|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
124665303|NCT00667992|448397376|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
124665304|NCT00667992|448397377|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
124665305|NCT00667992|448397376|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
124665306|NCT00667992|448397377|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
124665307|NCT00667992|448397376|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
124665308|NCT00667992|448397377|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
124665309|NCT00667992|448397376|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
124665310|NCT00667992|448397377|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
124665311|NCT00667992|448397376|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
124665312|NCT00667992|448397377|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
124665313|NCT00667992|448397376|FG000|Wash-out|Not within one doubling dilution|4|||
124665314|NCT00667992|448397377|FG001|Wash-out|Not within one doubling dilution|3|||
124665315|NCT00667992|448397376|FG000|Wash-out|Failure to wash-out|2|||
124665316|NCT00667992|448397377|FG001|Wash-out|Failure to wash-out|2|||
124665317|NCT00667992|448397376|FG000|Wash-out|Withdrawal by Subject|1|||
124665318|NCT00667992|448397377|FG001|Wash-out|Withdrawal by Subject|0|||
124665319|NCT00667992|448397376|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
124665320|NCT00667992|448397377|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
124665321|NCT00667992|448397376|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
124665322|NCT00667992|448397377|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
124665323|NCT02748057|448397381|FG000|Overall Study|Adverse Event|1|||
124665324|NCT02748057|448397382|FG001|Overall Study|Adverse Event|0|||
124665325|NCT02748057|448397381|FG000|Overall Study|Physician Decision|0|||
124665326|NCT02748057|448397382|FG001|Overall Study|Physician Decision|1|||
124665327|NCT02748057|448397381|FG000|Overall Study|Protocol Violation|2|||
124665328|NCT02748057|448397382|FG001|Overall Study|Protocol Violation|1|||
124665329|NCT02748057|448397381|FG000|Overall Study|Participant Moved|1|||
124665330|NCT02748057|448397382|FG001|Overall Study|Participant Moved|0|||
124665331|NCT02748057|448397381|FG000|Overall Study|Withdrawal by Subject|1|||
124665332|NCT02748057|448397382|FG001|Overall Study|Withdrawal by Subject|0|||
124665333|NCT00391872|448397391|FG000|Overall Study|Protocol Violation|7|||
124665334|NCT00391872|448397392|FG001|Overall Study|Protocol Violation|2|||
124665335|NCT00391872|448397391|FG000|Overall Study|Withdrawal by Subject|296|||
124665336|NCT00391872|448397392|FG001|Overall Study|Withdrawal by Subject|249|||
124665337|NCT00391872|448397391|FG000|Overall Study|Reason unknown|2|||
124665338|NCT00391872|448397392|FG001|Overall Study|Reason unknown|4|||
124665339|NCT00391872|448397391|FG000|Overall Study|Lost to Follow-up|2|||
124665340|NCT00391872|448397392|FG001|Overall Study|Lost to Follow-up|0|||
124665341|NCT00215644|448397396|FG000|Overall Study|Disease Progression|28|||
124665342|NCT00215644|448397397|FG001|Overall Study|Disease Progression|10|||
124665343|NCT00215644|448397396|FG000|Overall Study|Adverse Event|2|||
124665344|NCT00215644|448397397|FG001|Overall Study|Adverse Event|9|||
124665345|NCT00215644|448397396|FG000|Overall Study|Death|1|||
124665346|NCT00215644|448397397|FG001|Overall Study|Death|2|||
124665347|NCT00215644|448397396|FG000|Overall Study|Withdrawal by Subject|1|||
124665348|NCT00215644|448397397|FG001|Overall Study|Withdrawal by Subject|0|||
124665349|NCT00215644|448397396|FG000|Overall Study|Other|3|||
124665350|NCT00215644|448397397|FG001|Overall Study|Other|15|||
124665351|NCT00215644|448397396|FG000|Overall Study|Randomized but Not Treated|1|||
124665352|NCT00215644|448397397|FG001|Overall Study|Randomized but Not Treated|0|||
124665353|NCT02861664|448397400|FG000|Overall Study|Withdrawal of Consent|0|||
124665354|NCT02861664|448397401|FG001|Overall Study|Withdrawal of Consent|1|||
124665355|NCT01239394|448397402|FG000|Overall Study|Adverse Event|1|||
124665356|NCT00905632|448397404|FG000|Overall Study|Adverse Event|0|||
124665357|NCT00905632|448397405|FG001|Overall Study|Adverse Event|0|||
124665358|NCT00905632|448397406|FG002|Overall Study|Adverse Event|0|||
124665359|NCT00905632|448397407|FG003|Overall Study|Adverse Event|0|||
124665360|NCT00905632|448397408|FG004|Overall Study|Adverse Event|0|||
124665361|NCT00905632|448397409|FG005|Overall Study|Adverse Event|1|||
124665362|NCT00905632|448397410|FG006|Overall Study|Adverse Event|4|||
124665363|NCT02781818|448397414|FG000|Overall Study|Lost to Follow-up|4|||
124665364|NCT02781818|448397415|FG001|Overall Study|Lost to Follow-up|2|||
124665365|NCT02781818|448397416|FG002|Overall Study|Lost to Follow-up|1|||
124665366|NCT00524771|448397417|FG000|Overall Study|Protocol Violation|220|||
124665367|NCT00524771|448397418|FG001|Overall Study|Protocol Violation|585|||
124665368|NCT01223404|448397419|FG000|First Intervention (1 Day)|Adverse Event|0|||
124665369|NCT01223404|448397420|FG001|First Intervention (1 Day)|Adverse Event|0|||
124665370|NCT01223404|448397421|FG002|First Intervention (1 Day)|Adverse Event|0|||
124665371|NCT01223404|448397422|FG003|First Intervention (1 Day)|Adverse Event|1|||
124665372|NCT01223404|448397423|FG004|First Intervention (1 Day)|Adverse Event|0|||
124665373|NCT01223404|448397424|FG005|First Intervention (1 Day)|Adverse Event|0|||
124665374|NCT01223404|448397419|FG000|Second Intervention (1 Day)|Adverse Event|1|||
124665375|NCT01223404|448397420|FG001|Second Intervention (1 Day)|Adverse Event|0|||
124665376|NCT01223404|448397421|FG002|Second Intervention (1 Day)|Adverse Event|0|||
124665377|NCT01223404|448397422|FG003|Second Intervention (1 Day)|Adverse Event|0|||
124665378|NCT01223404|448397423|FG004|Second Intervention (1 Day)|Adverse Event|0|||
124665379|NCT01223404|448397424|FG005|Second Intervention (1 Day)|Adverse Event|0|||
124665380|NCT01223404|448397419|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
124665381|NCT01223404|448397420|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
124665382|NCT01223404|448397421|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
124665383|NCT01223404|448397422|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
124665384|NCT01223404|448397423|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
124665385|NCT01223404|448397424|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
124665386|NCT00707057|448397425|FG000|Overall Study|Withdrawal by Subject|8|||
124665387|NCT00707057|448397426|FG001|Overall Study|Withdrawal by Subject|3|||
124665388|NCT00707057|448397425|FG000|Overall Study|Dosed incorrectly|0|||
124665389|NCT00707057|448397426|FG001|Overall Study|Dosed incorrectly|1|||
124665390|NCT02492165|448397427|FG000|Overall Study|Withdrawal by Subject|0|||
124665391|NCT02492165|448397428|FG001|Overall Study|Withdrawal by Subject|1|||
124665392|NCT02492165|448397429|FG002|Overall Study|Withdrawal by Subject|0|||
124665393|NCT02492165|448397430|FG003|Overall Study|Withdrawal by Subject|0|||
124665394|NCT02915159|448397432|FG000|Overall Study|Participant no longer meets criteria|2|||
124665395|NCT02915159|448397433|FG001|Overall Study|Participant no longer meets criteria|0|||
124665396|NCT02915159|448397432|FG000|Overall Study|poor/non-compliance|1|||
124665397|NCT02915159|448397433|FG001|Overall Study|poor/non-compliance|0|||
124665398|NCT02915159|448397432|FG000|Overall Study|Participant withdrew consent|5|||
124665399|NCT02915159|448397433|FG001|Overall Study|Participant withdrew consent|1|||
124665400|NCT02915159|448397432|FG000|Overall Study|Request to discontinue treatment|1|||
124665401|NCT02915159|448397433|FG001|Overall Study|Request to discontinue treatment|2|||
124665402|NCT02915159|448397432|FG000|Overall Study|Adverse Event|2|||
124665403|NCT02915159|448397433|FG001|Overall Study|Adverse Event|2|||
124665404|NCT02915159|448397432|FG000|Overall Study|Lack of Efficacy|0|||
124665405|NCT02915159|448397433|FG001|Overall Study|Lack of Efficacy|3|||
124665406|NCT02821416|448397436|FG000|Overall Study|Adverse Event|0|||
124665407|NCT02821416|448397437|FG001|Overall Study|Adverse Event|1|||
124665408|NCT02821416|448397436|FG000|Overall Study|Withdrawal by Subject|2|||
124665409|NCT02821416|448397437|FG001|Overall Study|Withdrawal by Subject|0|||
124665410|NCT02821416|448397436|FG000|Overall Study|Lost to Follow-up|1|||
124665411|NCT02821416|448397437|FG001|Overall Study|Lost to Follow-up|0|||
124665412|NCT01001520|448397444|FG000|Medication Period 1|Withdrawal by Subject|2|||
124665413|NCT01001520|448397445|FG001|Medication Period 1|Withdrawal by Subject|2|||
124665414|NCT01001520|448397444|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
124665415|NCT01001520|448397445|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
124665416|NCT01001520|448397444|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
124665417|NCT01001520|448397445|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
124665418|NCT01001520|448397444|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
124665419|NCT01001520|448397445|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
124665420|NCT01001520|448397444|FG000|Washout Period|Withdrawal by Subject|2|||
124665421|NCT01001520|448397445|FG001|Washout Period|Withdrawal by Subject|1|||
124665422|NCT01001520|448397444|FG000|Medication Period 2|Withdrawal by Subject|0|||
124665423|NCT01001520|448397445|FG001|Medication Period 2|Withdrawal by Subject|3|||
124665424|NCT00613821|448397453|FG000|Overall Study|Withdrawal by Subject|1|||
124665425|NCT00613821|448397454|FG001|Overall Study|Withdrawal by Subject|0|||
124665426|NCT00613821|448397453|FG000|Overall Study|Physician Decision|1|||
124665427|NCT00613821|448397454|FG001|Overall Study|Physician Decision|1|||
124665428|NCT01266824|448397455|FG000|Overall Study|Study terminated prior to completion|2|||
124665429|NCT01266824|448397456|FG001|Overall Study|Study terminated prior to completion|3|||
124665430|NCT02302846|448397457|FG000|Overall Study|Withdrawal by Subject|1|||
124665431|NCT00872521|448397459|FG000|Completed PAD Induction|Patient choice|0|||
124665432|NCT00872521|448397460|FG001|Completed PAD Induction|Patient choice|1|||
124665433|NCT00872521|448397461|FG002|Completed PAD Induction|Patient choice|0|||
124665434|NCT00872521|448397459|FG000|Completed PAD Induction|Disease progression|0|||
124665435|NCT00872521|448397460|FG001|Completed PAD Induction|Disease progression|2|||
124665436|NCT00872521|448397461|FG002|Completed PAD Induction|Disease progression|0|||
124665437|NCT00872521|448397459|FG000|Completed PAD Induction|Adverse Event|4|||
124665438|NCT00872521|448397460|FG001|Completed PAD Induction|Adverse Event|0|||
124665439|NCT00872521|448397461|FG002|Completed PAD Induction|Adverse Event|0|||
124665440|NCT00872521|448397459|FG000|Completed PAD Induction|Death|1|||
124665441|NCT00872521|448397460|FG001|Completed PAD Induction|Death|1|||
124665442|NCT00872521|448397461|FG002|Completed PAD Induction|Death|0|||
124665443|NCT00872521|448397459|FG000|Primary Endpoint Analysis|Other|1|||
124665444|NCT00872521|448397460|FG001|Primary Endpoint Analysis|Other|2|||
124665445|NCT00872521|448397461|FG002|Primary Endpoint Analysis|Other|0|||
124665446|NCT00872521|448397459|FG000|Primary Endpoint Analysis|Patient choice|0|||
124665447|NCT00872521|448397460|FG001|Primary Endpoint Analysis|Patient choice|1|||
124665448|NCT00872521|448397461|FG002|Primary Endpoint Analysis|Patient choice|0|||
124665449|NCT00872521|448397459|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
124665450|NCT00872521|448397460|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
124665451|NCT00872521|448397461|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
124665452|NCT00872521|448397459|FG000|Primary Endpoint Analysis|Patient response missing|0|||
124665453|NCT00872521|448397460|FG001|Primary Endpoint Analysis|Patient response missing|0|||
124665454|NCT00872521|448397461|FG002|Primary Endpoint Analysis|Patient response missing|1|||
124665455|NCT00872521|448397459|FG000|Completed 3-month Follow up|Other|0|||
124665456|NCT00872521|448397460|FG001|Completed 3-month Follow up|Other|2|||
124665457|NCT00872521|448397461|FG002|Completed 3-month Follow up|Other|0|||
124665458|NCT00872521|448397459|FG000|Completed 3-month Follow up|Physician Decision|0|||
124665459|NCT00872521|448397460|FG001|Completed 3-month Follow up|Physician Decision|1|||
124665460|NCT00872521|448397461|FG002|Completed 3-month Follow up|Physician Decision|0|||
124665461|NCT00872521|448397459|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
124665462|NCT00872521|448397460|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
124665463|NCT00872521|448397461|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
124665464|NCT01468454|448397462|FG000|Overall Study|Did not have surgery after PET|9|||
124665465|NCT02620787|448397463|FG000|Overall Study|Adverse Event|1|||
124665466|NCT02620787|448397464|FG001|Overall Study|Adverse Event|0|||
124665467|NCT02620787|448397463|FG000|Overall Study|Eligibility Criteria Not Met|1|||
124665468|NCT02620787|448397464|FG001|Overall Study|Eligibility Criteria Not Met|0|||
124665469|NCT02982863|448397465|FG000|Overall Study|Not eligible patients|809|||
124665470|NCT02982863|448397466|FG001|Overall Study|Not eligible patients|4261|||
124665471|NCT02982863|448397467|FG002|Overall Study|Not eligible patients|1852|||
124665472|NCT02982863|448397468|FG003|Overall Study|Not eligible patients|1400|||
124665473|NCT02982863|448397469|FG004|Overall Study|Not eligible patients|492|||
124665474|NCT00705341|448397473|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
124665475|NCT00705341|448397474|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
124665476|NCT00705341|448397475|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
124665477|NCT00705341|448397476|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
124665478|NCT00705341|448397473|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
124665479|NCT00705341|448397474|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
124665480|NCT00705341|448397475|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
124665481|NCT00705341|448397476|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
124665482|NCT00791700|448397477|FG000|Overall Study|Insufficient clinical response|1|||
124665483|NCT00791700|448397478|FG001|Overall Study|Insufficient clinical response|4|||
124665484|NCT00791700|448397479|FG002|Overall Study|Insufficient clinical response|1|||
124665485|NCT00791700|448397480|FG003|Overall Study|Insufficient clinical response|8|||
124665486|NCT00791700|448397477|FG000|Overall Study|No longer willing to participate|1|||
124665487|NCT00791700|448397478|FG001|Overall Study|No longer willing to participate|1|||
124665488|NCT00791700|448397479|FG002|Overall Study|No longer willing to participate|0|||
124665489|NCT00791700|448397480|FG003|Overall Study|No longer willing to participate|8|||
124665490|NCT00791700|448397477|FG000|Overall Study|Non-compliance with study treatment|0|||
124665491|NCT00791700|448397478|FG001|Overall Study|Non-compliance with study treatment|2|||
124665492|NCT00791700|448397479|FG002|Overall Study|Non-compliance with study treatment|0|||
124665493|NCT00791700|448397480|FG003|Overall Study|Non-compliance with study treatment|4|||
124665494|NCT00791700|448397477|FG000|Overall Study|Withdrawn due to pregnancy|0|||
124665495|NCT00791700|448397478|FG001|Overall Study|Withdrawn due to pregnancy|0|||
124665496|NCT00791700|448397479|FG002|Overall Study|Withdrawn due to pregnancy|0|||
124665497|NCT00791700|448397480|FG003|Overall Study|Withdrawn due to pregnancy|1|||
124665498|NCT00791700|448397477|FG000|Overall Study|Other|0|||
124665499|NCT00791700|448397478|FG001|Overall Study|Other|1|||
124665500|NCT00791700|448397479|FG002|Overall Study|Other|0|||
124665501|NCT00791700|448397480|FG003|Overall Study|Other|1|||
124665502|NCT00791700|448397477|FG000|Overall Study|Death|0|||
124665503|NCT00791700|448397478|FG001|Overall Study|Death|0|||
124665504|NCT00791700|448397479|FG002|Overall Study|Death|0|||
124665505|NCT00791700|448397480|FG003|Overall Study|Death|1|||
124665506|NCT00791700|448397477|FG000|Overall Study|Lost to Follow-up|4|||
124665507|NCT00791700|448397478|FG001|Overall Study|Lost to Follow-up|3|||
124665508|NCT00791700|448397479|FG002|Overall Study|Lost to Follow-up|4|||
124665509|NCT00791700|448397480|FG003|Overall Study|Lost to Follow-up|6|||
124665510|NCT00791700|448397477|FG000|Overall Study|Adverse Event|0|||
124665511|NCT00791700|448397478|FG001|Overall Study|Adverse Event|0|||
124665512|NCT00791700|448397479|FG002|Overall Study|Adverse Event|1|||
124665513|NCT00791700|448397480|FG003|Overall Study|Adverse Event|1|||
124665514|NCT01720524|448397487|FG000|Part A|Insufficient Clinical Response|2|||
124665515|NCT01720524|448397488|FG001|Part A|Insufficient Clinical Response|4|||
124665516|NCT01720524|448397487|FG000|Part A|Adverse Event|2|||
124665517|NCT01720524|448397488|FG001|Part A|Adverse Event|2|||
124665518|NCT01720524|448397487|FG000|Part A|Death|2|||
124665519|NCT01720524|448397488|FG001|Part A|Death|1|||
124665520|NCT01720524|448397487|FG000|Part A|Lost to Follow-up|0|||
124665521|NCT01720524|448397488|FG001|Part A|Lost to Follow-up|1|||
124665522|NCT01720524|448397487|FG000|Part A|Missed 28 day follow-up visit|1|||
124665523|NCT01720524|448397488|FG001|Part A|Missed 28 day follow-up visit|1|||
124665524|NCT01720524|448397487|FG000|Part A|Withdrawal by Subject|0|||
124665525|NCT01720524|448397488|FG001|Part A|Withdrawal by Subject|1|||
124665526|NCT01720524|448397487|FG000|Part A|Other|0|||
124665527|NCT01720524|448397488|FG001|Part A|Other|1|||
124665528|NCT01720524|448397487|FG000|Part A|Lost to Follow-up|0|||
124665529|NCT01720524|448397488|FG001|Part A|Lost to Follow-up|1|||
124665530|NCT01720524|448397487|FG000|Part B|No longer willing to participate in study|1|||
124665531|NCT01720524|448397488|FG001|Part B|No longer willing to participate in study|4|||
124665532|NCT01720524|448397487|FG000|Part B|Other|2|||
124665533|NCT01720524|448397488|FG001|Part B|Other|0|||
124665534|NCT01720524|448397487|FG000|Part B|Lost to Follow-up|2|||
124665535|NCT01720524|448397488|FG001|Part B|Lost to Follow-up|3|||
124665536|NCT01720524|448397487|FG000|Part B|Death|0|||
124665537|NCT01720524|448397488|FG001|Part B|Death|2|||
124665538|NCT00996034|448397489|FG000|Overall Study|Lost to Follow-up|2|||
124665539|NCT00996034|448397489|FG000|Overall Study|withdrawn by PI|1|||
124665540|NCT00527826|448397493|FG000|Overall Study|Adverse Event|10|||
124665541|NCT00527826|448397494|FG001|Overall Study|Adverse Event|10|||
124665542|NCT00527826|448397493|FG000|Overall Study|Lost to Follow-up|3|||
124665543|NCT00527826|448397494|FG001|Overall Study|Lost to Follow-up|2|||
124665544|NCT00527826|448397493|FG000|Overall Study|Withdrawal by Subject|5|||
124665545|NCT00527826|448397494|FG001|Overall Study|Withdrawal by Subject|8|||
124665546|NCT00527826|448397493|FG000|Overall Study|Inclusion Criteria Not Met|3|||
124665547|NCT00527826|448397494|FG001|Overall Study|Inclusion Criteria Not Met|3|||
124665548|NCT00527826|448397493|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
124665549|NCT00527826|448397494|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
124665550|NCT00527826|448397493|FG000|Overall Study|Additional Intake of Viani forte|0|||
124665551|NCT00527826|448397494|FG001|Overall Study|Additional Intake of Viani forte|1|||
124665552|NCT00527826|448397493|FG000|Overall Study|Participant moved away|0|||
124665553|NCT00527826|448397494|FG001|Overall Study|Participant moved away|1|||
124665554|NCT00158262|448397495|FG000|Overall Study|Lost to Follow-up|1|||
124665555|NCT00158262|448397496|FG001|Overall Study|Lost to Follow-up|1|||
124665556|NCT02105285|448397499|FG000|Overall Study|Adverse Event|1|||
124665557|NCT02105285|448397500|FG001|Overall Study|Adverse Event|1|||
124665558|NCT02105285|448397501|FG002|Overall Study|Adverse Event|0|||
124665559|NCT02105285|448397499|FG000|Overall Study|Protocol Violation|0|||
124665560|NCT02105285|448397500|FG001|Overall Study|Protocol Violation|1|||
124665561|NCT02105285|448397501|FG002|Overall Study|Protocol Violation|0|||
124665562|NCT02105285|448397499|FG000|Overall Study|Withdrawal by Subject|1|||
124665563|NCT02105285|448397500|FG001|Overall Study|Withdrawal by Subject|0|||
124665564|NCT02105285|448397501|FG002|Overall Study|Withdrawal by Subject|0|||
124665565|NCT01421641|448397502|FG000|Overall Study|Protocol Violation|2|||
124665566|NCT01421641|448397503|FG001|Overall Study|Protocol Violation|2|||
124665567|NCT01436227|448397510|FG000|Overall Study|Adverse Event|7|||
124665568|NCT01436227|448397510|FG000|Overall Study|Death|1|||
124665569|NCT01436227|448397510|FG000|Overall Study|Lack of Efficacy|1|||
124665570|NCT01436227|448397510|FG000|Overall Study|Lost to Follow-up|3|||
124665571|NCT01436227|448397510|FG000|Overall Study|Physician Decision|1|||
124665572|NCT01436227|448397510|FG000|Overall Study|Withdrawal by Subject|7|||
124665573|NCT01436227|448397510|FG000|Overall Study|Disease progression, relapse|6|||
124665574|NCT05464420|448397514|FG000|Overall Study|Death|0|||
124665575|NCT05464420|448397515|FG001|Overall Study|Death|0|||
124665576|NCT05464420|448397516|FG002|Overall Study|Death|0|||
124665577|NCT05464420|448397517|FG003|Overall Study|Death|1|||
124665578|NCT05464420|448397514|FG000|Overall Study|Lost to Follow-up|16|||
124665579|NCT05464420|448397515|FG001|Overall Study|Lost to Follow-up|11|||
124665580|NCT05464420|448397516|FG002|Overall Study|Lost to Follow-up|11|||
124665581|NCT05464420|448397517|FG003|Overall Study|Lost to Follow-up|11|||
124665582|NCT05464420|448397514|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
124665583|NCT05464420|448397515|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
124665584|NCT05464420|448397516|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
124665585|NCT05464420|448397517|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
124665586|NCT05464420|448397514|FG000|Overall Study|Withdrawal by Subject|4|||
124665587|NCT05464420|448397515|FG001|Overall Study|Withdrawal by Subject|8|||
124665588|NCT05464420|448397516|FG002|Overall Study|Withdrawal by Subject|3|||
124665589|NCT05464420|448397517|FG003|Overall Study|Withdrawal by Subject|1|||
124665590|NCT05464420|448397514|FG000|Overall Study|Protocol Violation|0|||
124665591|NCT05464420|448397515|FG001|Overall Study|Protocol Violation|0|||
124665592|NCT05464420|448397516|FG002|Overall Study|Protocol Violation|1|||
124665593|NCT05464420|448397517|FG003|Overall Study|Protocol Violation|1|||
124665594|NCT05464420|448397514|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
124665595|NCT05464420|448397515|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
124665596|NCT05464420|448397516|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
124665597|NCT05464420|448397517|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
124665598|NCT01383018|448397518|FG000|Overall Study|Adverse Event|14|||
124665599|NCT01383018|448397518|FG000|Overall Study|Death|10|||
124665600|NCT01383018|448397518|FG000|Overall Study|Lost to Follow-up|5|||
124665601|NCT01383018|448397518|FG000|Overall Study|Physician Decision|5|||
124665602|NCT01383018|448397518|FG000|Overall Study|Withdrawal by Subject|9|||
124665603|NCT01383018|448397518|FG000|Overall Study|Subject not implanted|76|||
124665604|NCT01383018|448397518|FG000|Overall Study|Missed Visit|247|||
124665605|NCT01383018|448397518|FG000|Overall Study|Site closed early-not compliance related|7|||
124665606|NCT01383018|448397518|FG000|Overall Study|Patient moved away from site|1|||
124665607|NCT01383018|448397518|FG000|Overall Study|Subject Incarcerated|1|||
124665608|NCT03414229|448397521|FG000|Overall Study|Adverse Event|1|||
124665609|NCT03414229|448397522|FG001|Overall Study|Adverse Event|0|||
124665610|NCT03414229|448397523|FG002|Overall Study|Adverse Event|2|||
124665611|NCT03414229|448397524|FG003|Overall Study|Adverse Event|1|||
124665612|NCT03414229|448397521|FG000|Overall Study|Lack of Efficacy|7|||
124665613|NCT03414229|448397522|FG001|Overall Study|Lack of Efficacy|4|||
124665614|NCT03414229|448397523|FG002|Overall Study|Lack of Efficacy|1|||
124665615|NCT03414229|448397524|FG003|Overall Study|Lack of Efficacy|9|||
124665616|NCT03414229|448397521|FG000|Overall Study|Change in therapy|1|||
124665617|NCT03414229|448397522|FG001|Overall Study|Change in therapy|0|||
124665618|NCT03414229|448397523|FG002|Overall Study|Change in therapy|0|||
124665619|NCT03414229|448397524|FG003|Overall Study|Change in therapy|0|||
124665620|NCT03414229|448397521|FG000|Overall Study|Pregnancy|0|||
124665621|NCT03414229|448397522|FG001|Overall Study|Pregnancy|0|||
124665622|NCT03414229|448397523|FG002|Overall Study|Pregnancy|1|||
124665623|NCT03414229|448397524|FG003|Overall Study|Pregnancy|0|||
124665624|NCT03414229|448397521|FG000|Overall Study|Withdrawal by Subject|0|||
124665625|NCT03414229|448397522|FG001|Overall Study|Withdrawal by Subject|1|||
124665626|NCT03414229|448397523|FG002|Overall Study|Withdrawal by Subject|1|||
124665627|NCT03414229|448397524|FG003|Overall Study|Withdrawal by Subject|0|||
124665628|NCT04533438|448397528|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
124665629|NCT04533438|448397529|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
124665630|NCT05279131|448397530|FG000|Overall Study|Lost to Follow-up|1|||
124665631|NCT05279131|448397530|FG000|Overall Study|Death|1|||
124665632|NCT05279131|448397530|FG000|Overall Study|Physician Decision|1|||
124665633|NCT01066871|448397543|FG000|Overall Study|Lost to Follow-up|0|||
124665634|NCT01066871|448397544|FG001|Overall Study|Lost to Follow-up|2|||
124665635|NCT01066871|448397545|FG002|Overall Study|Lost to Follow-up|2|||
124665636|NCT01066871|448397546|FG003|Overall Study|Lost to Follow-up|0|||
124665637|NCT01066871|448397543|FG000|Overall Study|Protocol Violation|1|||
124665638|NCT01066871|448397544|FG001|Overall Study|Protocol Violation|0|||
124665639|NCT01066871|448397545|FG002|Overall Study|Protocol Violation|3|||
124665640|NCT01066871|448397546|FG003|Overall Study|Protocol Violation|2|||
124665641|NCT01066871|448397543|FG000|Overall Study|Lack of Efficacy|0|||
124665642|NCT01066871|448397544|FG001|Overall Study|Lack of Efficacy|0|||
124665643|NCT01066871|448397545|FG002|Overall Study|Lack of Efficacy|0|||
124665644|NCT01066871|448397546|FG003|Overall Study|Lack of Efficacy|1|||
124665645|NCT01066871|448397543|FG000|Overall Study|Withdrawal by Subject|3|||
124665646|NCT01066871|448397544|FG001|Overall Study|Withdrawal by Subject|1|||
124665647|NCT01066871|448397545|FG002|Overall Study|Withdrawal by Subject|0|||
124665648|NCT01066871|448397546|FG003|Overall Study|Withdrawal by Subject|0|||
124665649|NCT01066871|448397543|FG000|Overall Study|Other|0|||
124665650|NCT01066871|448397544|FG001|Overall Study|Other|2|||
124665651|NCT01066871|448397545|FG002|Overall Study|Other|1|||
124665652|NCT01066871|448397546|FG003|Overall Study|Other|2|||
124665653|NCT04162795|448397547|FG000|Overall Study|Other|16|||
124665654|NCT04162795|448397547|FG000|Overall Study|Screen failures|10|||
124665655|NCT04530838|448398933|FG000|Overall Study|Other|2|||
124665656|NCT04530838|448398934|FG001|Overall Study|Other|1|||
124665657|NCT04530838|448398935|FG002|Overall Study|Other|0|||
124665658|NCT04530838|448398933|FG000|Overall Study|Physician Decision|0|||
124665659|NCT04530838|448398934|FG001|Overall Study|Physician Decision|0|||
124665660|NCT04530838|448398935|FG002|Overall Study|Physician Decision|1|||
124665661|NCT04530838|448398933|FG000|Overall Study|Death|0|||
124665662|NCT04530838|448398934|FG001|Overall Study|Death|0|||
124665663|NCT04530838|448398935|FG002|Overall Study|Death|1|||
124665664|NCT04530838|448398933|FG000|Overall Study|Adverse Event|0|||
124665665|NCT04530838|448398934|FG001|Overall Study|Adverse Event|1|||
124665666|NCT04530838|448398935|FG002|Overall Study|Adverse Event|0|||
124665667|NCT04530838|448398933|FG000|Overall Study|No longer meets eligibility criteria|1|||
124665668|NCT04530838|448398934|FG001|Overall Study|No longer meets eligibility criteria|0|||
124665669|NCT04530838|448398935|FG002|Overall Study|No longer meets eligibility criteria|2|||
124665670|NCT04530838|448398933|FG000|Overall Study|Withdrawal by parent/guardian|5|||
124665671|NCT04530838|448398934|FG001|Overall Study|Withdrawal by parent/guardian|2|||
124665672|NCT04530838|448398935|FG002|Overall Study|Withdrawal by parent/guardian|2|||
124665673|NCT00803712|448398936|FG000|Overall Study|Noncompliance|3|||
124665674|NCT00803712|448398937|FG001|Overall Study|Noncompliance|0|||
124665675|NCT00803712|448398936|FG000|Overall Study|Adverse Event|5|||
124665676|NCT00803712|448398937|FG001|Overall Study|Adverse Event|0|||
124665677|NCT00803712|448398936|FG000|Overall Study|Death|8|||
124665678|NCT00803712|448398937|FG001|Overall Study|Death|7|||
124665679|NCT00803712|448398936|FG000|Overall Study|Lost to Follow-up|3|||
124665680|NCT00803712|448398937|FG001|Overall Study|Lost to Follow-up|1|||
124665681|NCT00803712|448398936|FG000|Overall Study|Withdrawal by Subject|2|||
124665682|NCT00803712|448398937|FG001|Overall Study|Withdrawal by Subject|4|||
124665683|NCT00803712|448398936|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
124665684|NCT00803712|448398937|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
124665685|NCT00803712|448398936|FG000|Overall Study|Protocol criteria (other)|0|||
124665686|NCT00803712|448398937|FG001|Overall Study|Protocol criteria (other)|2|||
124665687|NCT00803712|448398936|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
124665688|NCT00803712|448398937|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
124665689|NCT00803712|448398936|FG000|Overall Study|Administrative decision|2|||
124665690|NCT00803712|448398937|FG001|Overall Study|Administrative decision|3|||
124665691|NCT00803712|448398936|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
124665692|NCT00803712|448398937|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
124665693|NCT00669318|448398950|FG000|Overall Study|Withdrawal by Subject|2|||
124665694|NCT01073163|448398951|FG000|Overall Study|Adverse Event|1|||
124665695|NCT01073163|448398951|FG000|Overall Study|Disease Progression|1|||
124665696|NCT01073163|448398951|FG000|Overall Study|Early termination|1|||
124665697|NCT03272347|448398952|FG000|Overall Study|Death|0|||
124665698|NCT03272347|448398953|FG001|Overall Study|Death|0|||
124665699|NCT03272347|448398954|FG002|Overall Study|Death|0|||
124665700|NCT03272347|448398955|FG003|Overall Study|Death|1|||
124665701|NCT03272347|448398952|FG000|Overall Study|Lost to Follow-up|1|||
124665702|NCT03272347|448398953|FG001|Overall Study|Lost to Follow-up|3|||
124665703|NCT03272347|448398954|FG002|Overall Study|Lost to Follow-up|5|||
124665704|NCT03272347|448398955|FG003|Overall Study|Lost to Follow-up|1|||
124665705|NCT03272347|448398952|FG000|Overall Study|Physician Decision|4|||
124665706|NCT03272347|448398953|FG001|Overall Study|Physician Decision|2|||
124665707|NCT03272347|448398954|FG002|Overall Study|Physician Decision|5|||
124665708|NCT03272347|448398955|FG003|Overall Study|Physician Decision|4|||
124665709|NCT03272347|448398952|FG000|Overall Study|Screen Failure|1|||
124665710|NCT03272347|448398953|FG001|Overall Study|Screen Failure|0|||
124665711|NCT03272347|448398954|FG002|Overall Study|Screen Failure|0|||
124665712|NCT03272347|448398955|FG003|Overall Study|Screen Failure|0|||
124665713|NCT03272347|448398952|FG000|Overall Study|Withdrawal by Subject|5|||
124665714|NCT03272347|448398953|FG001|Overall Study|Withdrawal by Subject|1|||
124665715|NCT03272347|448398954|FG002|Overall Study|Withdrawal by Subject|2|||
124665716|NCT03272347|448398955|FG003|Overall Study|Withdrawal by Subject|1|||
124665717|NCT00703677|448398956|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
124665718|NCT04441788|448398959|FG000|Overall Study|Voluntary Withdrawl|0|||
124665719|NCT04441788|448398960|FG001|Overall Study|Voluntary Withdrawl|1|||
124665720|NCT04441788|448398961|FG002|Overall Study|Voluntary Withdrawl|0|||
124665721|NCT04441788|448398959|FG000|Overall Study|Ineligibility|1|||
124665722|NCT04441788|448398960|FG001|Overall Study|Ineligibility|0|||
124665723|NCT04441788|448398961|FG002|Overall Study|Ineligibility|0|||
124665724|NCT04441788|448398959|FG000|Overall Study|Adverse Event|0|||
124665725|NCT04441788|448398960|FG001|Overall Study|Adverse Event|0|||
124665726|NCT04441788|448398961|FG002|Overall Study|Adverse Event|4|||
124665727|NCT04441788|448398959|FG000|Overall Study|Study Terminated by Sponsor|16|||
124665728|NCT04441788|448398960|FG001|Overall Study|Study Terminated by Sponsor|16|||
124665729|NCT04441788|448398961|FG002|Overall Study|Study Terminated by Sponsor|12|||
124665730|NCT03859648|448398968|FG000|Overall Study|Lost to Follow-up|1|||
124665731|NCT03859648|448398968|FG000|Overall Study|Adverse Event|1|||
124665732|NCT01677182|448398969|FG000|Overall Study|Adverse Event|2|||
124665733|NCT01677182|448398970|FG001|Overall Study|Adverse Event|1|||
124665734|NCT01677182|448398971|FG002|Overall Study|Adverse Event|8|||
124665735|NCT01677182|448398969|FG000|Overall Study|Protocol Violation|5|||
124665736|NCT01677182|448398970|FG001|Overall Study|Protocol Violation|1|||
124665737|NCT01677182|448398971|FG002|Overall Study|Protocol Violation|4|||
124665738|NCT01677182|448398969|FG000|Overall Study|Lost to Follow-up|4|||
124665739|NCT01677182|448398970|FG001|Overall Study|Lost to Follow-up|0|||
124665740|NCT01677182|448398971|FG002|Overall Study|Lost to Follow-up|3|||
124665741|NCT01677182|448398969|FG000|Overall Study|Withdrawal by Subject|7|||
124665742|NCT01677182|448398970|FG001|Overall Study|Withdrawal by Subject|12|||
124665743|NCT01677182|448398971|FG002|Overall Study|Withdrawal by Subject|10|||
124665744|NCT01677182|448398969|FG000|Overall Study|Study termination|12|||
124665745|NCT01677182|448398970|FG001|Overall Study|Study termination|9|||
124665746|NCT01677182|448398971|FG002|Overall Study|Study termination|11|||
124665747|NCT01677182|448398969|FG000|Overall Study|Lack of Efficacy|3|||
124665748|NCT01677182|448398970|FG001|Overall Study|Lack of Efficacy|0|||
124665749|NCT01677182|448398971|FG002|Overall Study|Lack of Efficacy|1|||
124665750|NCT01677182|448398969|FG000|Overall Study|Other reasons|1|||
124665751|NCT01677182|448398970|FG001|Overall Study|Other reasons|5|||
124665752|NCT01677182|448398971|FG002|Overall Study|Other reasons|2|||
124665753|NCT00762762|448398974|FG000|Overall Study|Did not return for appointments|6|||
124665754|NCT00762762|448398975|FG001|Overall Study|Did not return for appointments|8|||
124665755|NCT02489448|448398976|FG000|Overall Study|Death|3|||
124665756|NCT02489448|448398976|FG000|Overall Study|Withdrawal by Subject|2|||
124665757|NCT01971567|448398977|FG000|Overall Study|Withdrawal by Subject|3|||
124665758|NCT01971567|448398978|FG001|Overall Study|Withdrawal by Subject|2|||
124665759|NCT01971567|448398977|FG000|Overall Study|Lost to Follow-up|1|||
124665760|NCT01971567|448398978|FG001|Overall Study|Lost to Follow-up|0|||
124665761|NCT00758498|448398982|FG000|Overall Study|Adverse Event|2|||
124665762|NCT00758498|448398983|FG001|Overall Study|Adverse Event|2|||
124665763|NCT00758498|448398984|FG002|Overall Study|Adverse Event|3|||
124665764|NCT00758498|448398982|FG000|Overall Study|Subject legally detained out of state|1|||
124665765|NCT00758498|448398983|FG001|Overall Study|Subject legally detained out of state|0|||
124665766|NCT00758498|448398984|FG002|Overall Study|Subject legally detained out of state|0|||
124665767|NCT00758498|448398982|FG000|Overall Study|Withdrawal by Subject|0|||
124665768|NCT00758498|448398983|FG001|Overall Study|Withdrawal by Subject|0|||
124665769|NCT00758498|448398984|FG002|Overall Study|Withdrawal by Subject|1|||
124665770|NCT00758498|448398982|FG000|Overall Study|Noncompliance to study procedures|0|||
124665771|NCT00758498|448398983|FG001|Overall Study|Noncompliance to study procedures|0|||
124665772|NCT00758498|448398984|FG002|Overall Study|Noncompliance to study procedures|1|||
124665773|NCT01516736|448398985|FG000|Overall Study|Withdrawal by Subject|10|||
124665774|NCT01516736|448398986|FG001|Overall Study|Withdrawal by Subject|4|||
124665775|NCT01516736|448398985|FG000|Overall Study|Adverse Event|4|||
124665776|NCT01516736|448398986|FG001|Overall Study|Adverse Event|5|||
124665777|NCT01516736|448398985|FG000|Overall Study|Death|3|||
124665778|NCT01516736|448398986|FG001|Overall Study|Death|1|||
124665779|NCT01516736|448398985|FG000|Overall Study|Physician Decision|2|||
124665780|NCT01516736|448398986|FG001|Overall Study|Physician Decision|1|||
124665781|NCT01516736|448398985|FG000|Overall Study|Lack of Efficacy|1|||
124665782|NCT01516736|448398986|FG001|Overall Study|Lack of Efficacy|0|||
124665783|NCT01516736|448398985|FG000|Overall Study|Protocol Violation|0|||
124665784|NCT01516736|448398986|FG001|Overall Study|Protocol Violation|1|||
124665785|NCT01516736|448398985|FG000|Overall Study|Other (not specified)|0|||
124665786|NCT01516736|448398986|FG001|Overall Study|Other (not specified)|1|||
124665787|NCT00878800|448398996|FG000|Overall Study|Adverse Event|0|||
124665788|NCT00878800|448398997|FG001|Overall Study|Adverse Event|0|||
124665789|NCT00878800|448398998|FG002|Overall Study|Adverse Event|2|||
124665790|NCT00878800|448398999|FG003|Overall Study|Adverse Event|0|||
124665791|NCT00878800|448399000|FG004|Overall Study|Adverse Event|1|||
124665792|NCT00878800|448398996|FG000|Overall Study|Progressive disease|1|||
124665793|NCT00878800|448398997|FG001|Overall Study|Progressive disease|5|||
124665794|NCT00878800|448398998|FG002|Overall Study|Progressive disease|6|||
124665795|NCT00878800|448398999|FG003|Overall Study|Progressive disease|5|||
124665796|NCT00878800|448399000|FG004|Overall Study|Progressive disease|13|||
124665797|NCT00878800|448398996|FG000|Overall Study|Withdrew consent|1|||
124665798|NCT00878800|448398997|FG001|Overall Study|Withdrew consent|1|||
124665799|NCT00878800|448398998|FG002|Overall Study|Withdrew consent|0|||
124665800|NCT00878800|448398999|FG003|Overall Study|Withdrew consent|1|||
124665801|NCT00878800|448399000|FG004|Overall Study|Withdrew consent|1|||
124665802|NCT00878800|448398996|FG000|Overall Study|Death|0|||
124665803|NCT00878800|448398997|FG001|Overall Study|Death|0|||
124665804|NCT00878800|448398998|FG002|Overall Study|Death|1|||
124665805|NCT00878800|448398999|FG003|Overall Study|Death|0|||
124665806|NCT00878800|448399000|FG004|Overall Study|Death|0|||
124665807|NCT00878800|448398996|FG000|Overall Study|Other|1|||
124665808|NCT00878800|448398997|FG001|Overall Study|Other|1|||
124665809|NCT00878800|448398998|FG002|Overall Study|Other|0|||
124665810|NCT00878800|448398999|FG003|Overall Study|Other|0|||
124665811|NCT00878800|448399000|FG004|Overall Study|Other|1|||
124665812|NCT00715299|448399001|FG000|Overall Study|Withdrawal by Subject|1|||
124665813|NCT00715299|448399001|FG000|Overall Study|Adverse Event|3|||
124665814|NCT00715299|448399001|FG000|Overall Study|failed the pre-screen exercise test|2|||
124665815|NCT00411450|448399002|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
124665816|NCT00614874|448399003|FG000|Overall Study|Protocol Violation|1|||
124665817|NCT00614874|448399003|FG000|Overall Study|Withdrawal by Subject|1|||
124665818|NCT01502033|448399004|FG000|Overall Study|1 participant had scalp discomfort|1|||
124665819|NCT01502033|448399004|FG000|Overall Study|1 participant had worsening depression|1|||
124665820|NCT01502033|448399004|FG000|Overall Study|1 participant went back to school|1|||
124665821|NCT01808261|448399005|FG000|Overall Study|Physician Decision|0|||
124665822|NCT01808261|448399006|FG001|Overall Study|Physician Decision|2|||
124665823|NCT01808261|448399005|FG000|Overall Study|Study Closed/Terminated|25|||
124665824|NCT01808261|448399006|FG001|Overall Study|Study Closed/Terminated|23|||
124665825|NCT01808261|448399005|FG000|Overall Study|Adverse event, non-fatal|2|||
124665826|NCT01808261|448399006|FG001|Overall Study|Adverse event, non-fatal|0|||
124665827|NCT01808261|448399005|FG000|Overall Study|Consent withdrawn by subject|6|||
124665828|NCT01808261|448399006|FG001|Overall Study|Consent withdrawn by subject|7|||
124665829|NCT01808261|448399005|FG000|Overall Study|Lost to Follow-up|3|||
124665830|NCT01808261|448399006|FG001|Overall Study|Lost to Follow-up|1|||
124665831|NCT00941304|448399007|FG000|Overall Study|Lost to Follow-up|1|||
124665832|NCT00941304|448399008|FG001|Overall Study|Lost to Follow-up|0|||
124665833|NCT00941304|448399009|FG002|Overall Study|Lost to Follow-up|0|||
124665834|NCT00941304|448399010|FG003|Overall Study|Lost to Follow-up|0|||
124665835|NCT00941304|448399011|FG004|Overall Study|Lost to Follow-up|0|||
124665836|NCT03293394|448399012|FG000|Follow-up (6 Months)|Adverse Event|4|||
124665837|NCT03293394|448399013|FG001|Follow-up (6 Months)|Adverse Event|2|||
124665838|NCT04004260|448399015|FG000|Overall Study|Withdrawal by Subject|7|||
124665839|NCT04004260|448399016|FG001|Overall Study|Withdrawal by Subject|3|||
124665840|NCT04004260|448399015|FG000|Overall Study|Lost to Follow-up|22|||
124665841|NCT04004260|448399016|FG001|Overall Study|Lost to Follow-up|12|||
124665842|NCT04004260|448399015|FG000|Overall Study|Did not engage in intervention|13|||
124665843|NCT04004260|448399016|FG001|Overall Study|Did not engage in intervention|17|||
124665844|NCT01765569|448399017|FG000|Period B|Withdrawal by Subject|1|||
124665845|NCT01765569|448399017|FG000|Period C|Death|1|||
124665846|NCT05568797|448399021|FG000|Overall Study|Adverse Event|0|||
124665847|NCT05568797|448399022|FG001|Overall Study|Adverse Event|8|||
124665848|NCT05568797|448399021|FG000|Overall Study|Lost to Follow-up|2|||
124665849|NCT05568797|448399022|FG001|Overall Study|Lost to Follow-up|3|||
124665850|NCT05568797|448399021|FG000|Overall Study|Withdrawal by Subject|1|||
124665851|NCT05568797|448399022|FG001|Overall Study|Withdrawal by Subject|10|||
124665852|NCT05568797|448399021|FG000|Overall Study|Other|2|||
124665853|NCT05568797|448399022|FG001|Overall Study|Other|2|||
124665854|NCT02401035|448399024|FG000|Overall Study|Withdrawal by Subject|1|||
124665855|NCT02401035|448399025|FG001|Overall Study|Withdrawal by Subject|0|||
124665856|NCT00869128|448399026|FG000|Overall Study|lack of Compliance|6|||
124665857|NCT00869128|448399027|FG001|Overall Study|lack of Compliance|6|||
124665858|NCT02998996|448399033|FG000|Overall Study|Lost to Follow-up|0|||
124665859|NCT02998996|448399034|FG001|Overall Study|Lost to Follow-up|0|||
124665860|NCT02998996|448399035|FG002|Overall Study|Lost to Follow-up|1|||
124665861|NCT02998996|448399036|FG003|Overall Study|Lost to Follow-up|0|||
124665862|NCT02998996|448399037|FG004|Overall Study|Lost to Follow-up|0|||
124665863|NCT02998996|448399038|FG005|Overall Study|Lost to Follow-up|0|||
124665864|NCT02998996|448399033|FG000|Overall Study|Pregnancy|0|||
124665865|NCT02998996|448399034|FG001|Overall Study|Pregnancy|1|||
124665866|NCT02998996|448399035|FG002|Overall Study|Pregnancy|0|||
124665867|NCT02998996|448399036|FG003|Overall Study|Pregnancy|0|||
124665868|NCT02998996|448399037|FG004|Overall Study|Pregnancy|0|||
124665869|NCT02998996|448399038|FG005|Overall Study|Pregnancy|0|||
124665870|NCT02998996|448399033|FG000|Overall Study|Family reasons|0|||
124665871|NCT02998996|448399034|FG001|Overall Study|Family reasons|0|||
124665872|NCT02998996|448399035|FG002|Overall Study|Family reasons|0|||
124665873|NCT02998996|448399036|FG003|Overall Study|Family reasons|0|||
124665874|NCT02998996|448399037|FG004|Overall Study|Family reasons|1|||
124665875|NCT02998996|448399038|FG005|Overall Study|Family reasons|0|||
124665876|NCT01118663|448399040|FG000|Overall Study|Adverse Event|2|||
124665877|NCT01118663|448399041|FG001|Overall Study|Adverse Event|1|||
124665878|NCT01118663|448399040|FG000|Overall Study|Withdrawal by Subject|0|||
124665879|NCT01118663|448399041|FG001|Overall Study|Withdrawal by Subject|1|||
124665880|NCT03046953|448399042|FG000|Overall Study|Relapse/progressive disease|21|||
124665881|NCT03046953|448399042|FG000|Overall Study|Death|2|||
124665882|NCT03046953|448399042|FG000|Overall Study|Withdrawal by Subject|3|||
124665883|NCT04039204|448399043|FG000|Overall Study|Withdrawal by Subject|0|||
124665884|NCT04039204|448399044|FG001|Overall Study|Withdrawal by Subject|2|||
124665885|NCT01189461|448399045|FG000|Overall Study|Lack of Efficacy|13|||
124665886|NCT01189461|448399045|FG000|Overall Study|Lost to Follow-up|1|||
124665887|NCT01189461|448399045|FG000|Overall Study|Withdrawal by Subject|6|||
124665888|NCT01189461|448399045|FG000|Overall Study|Protocol Violation|1|||
124665889|NCT01189461|448399045|FG000|Overall Study|Adverse Event|2|||
124665890|NCT01189461|448399045|FG000|Overall Study|Did not meet entrance criteria|3|||
124665891|NCT01189461|448399045|FG000|Overall Study|Other|8|||
124665892|NCT02716584|448399046|FG000|Overall Study|Lost to Follow-up|8|||
124665893|NCT02716584|448399047|FG001|Overall Study|Lost to Follow-up|5|||
124665894|NCT00656175|448399049|FG000|Overall Study|Adverse Event|1|||
124665895|NCT00656175|448399050|FG001|Overall Study|Adverse Event|0|||
124665896|NCT00656175|448399049|FG000|Overall Study|Transportation issues|0|||
124665897|NCT00656175|448399050|FG001|Overall Study|Transportation issues|1|||
124665898|NCT02149264|448399053|FG000|Overall Study|Withdrawal by Subject|9|||
124665899|NCT02149264|448399053|FG000|Overall Study|Adverse Event|7|||
124665900|NCT02149264|448399053|FG000|Overall Study|Physician Decision|3|||
124665901|NCT02149264|448399053|FG000|Overall Study|Protocol Violation|1|||
124665902|NCT03472521|448399054|FG000|Overall Study|Lost to Follow-up|3|||
124665903|NCT03472521|448399055|FG001|Overall Study|Lost to Follow-up|2|||
124665904|NCT03472521|448399054|FG000|Overall Study|Discontinued intervention|3|||
124665905|NCT03472521|448399055|FG001|Overall Study|Discontinued intervention|1|||
124665906|NCT02308228|448399063|FG000|Overall Study|Adverse Event|3|||
124665907|NCT02308228|448399064|FG001|Overall Study|Adverse Event|4|||
124665908|NCT02308228|448399063|FG000|Overall Study|Withdrawal by Subject|5|||
124665909|NCT02308228|448399064|FG001|Overall Study|Withdrawal by Subject|3|||
124665910|NCT03999749|448399065|FG000|Overall Study|Toxicity|16|||
124665911|NCT03999749|448399065|FG000|Overall Study|Withdrawal by Subject|3|||
124665912|NCT03999749|448399065|FG000|Overall Study|Disease progression|26|||
124665913|NCT03999749|448399065|FG000|Overall Study|Physician Decision|4|||
124665914|NCT03999749|448399065|FG000|Overall Study|Death|5|||
124665915|NCT03999749|448399065|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
124665916|NCT05259163|448400578|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
124665917|NCT05259163|448400579|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
124665918|NCT01381926|448400581|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
124665919|NCT01381926|448400582|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
124665920|NCT01381926|448400581|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
124665921|NCT01381926|448400582|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
124665922|NCT02100839|448400585|FG000|Multiple Ascending Dose|Adverse Event|2|||
124665923|NCT02100839|448400586|FG001|Multiple Ascending Dose|Adverse Event|0|||
124665924|NCT02100839|448400585|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
124665925|NCT02100839|448400586|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
124665926|NCT00940888|448400587|FG000|Overall Study|Unsuccessful Implant|4|||
124665927|NCT00940888|448400587|FG000|Overall Study|Death|461|||
124665928|NCT00940888|448400587|FG000|Overall Study|Withdrawn - Non-Death|364|||
124665929|NCT00940888|448400587|FG000|Overall Study|Lost to Follow-up|6|||
124665930|NCT01409915|448400591|FG000|Overall Study|Adverse Event|0|||
124665931|NCT01409915|448400592|FG001|Overall Study|Adverse Event|2|||
124665932|NCT01409915|448400591|FG000|Overall Study|Withdrawal by Subject|0|||
124665933|NCT01409915|448400592|FG001|Overall Study|Withdrawal by Subject|1|||
124665934|NCT01409915|448400591|FG000|Overall Study|Protocol Violation|1|||
124665935|NCT01409915|448400592|FG001|Overall Study|Protocol Violation|0|||
124665936|NCT04826484|448400594|FG000|Overall Study|Lost to Follow-up|2|||
124665937|NCT04826484|448400595|FG001|Overall Study|Lost to Follow-up|0|||
124665938|NCT02250300|448400596|FG000|Expansion Phase|Death|6|||
124665939|NCT02250300|448400597|FG001|Expansion Phase|Death|7|||
124665940|NCT02250300|448400598|FG002|Expansion Phase|Death|0|||
124665941|NCT02250300|448400599|FG003|Expansion Phase|Death|0|||
124665942|NCT01307891|448400605|FG000|Overall Study|Progressive Disease|3|||
124665943|NCT01307891|448400606|FG001|Overall Study|Progressive Disease|1|||
124665944|NCT03365934|448400607|FG000|Overall Study|Adverse Event|1|||
124665945|NCT03365934|448400607|FG000|Overall Study|Withdrawal by Subject|1|||
124665946|NCT02937740|448400609|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
124665947|NCT02937740|448400610|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
124665948|NCT02937740|448400609|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
124665949|NCT02937740|448400610|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
124665950|NCT02937740|448400609|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
124665951|NCT02937740|448400610|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
124665952|NCT02937740|448400609|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
124665953|NCT02937740|448400610|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
124665954|NCT02937740|448400609|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
124665955|NCT02937740|448400610|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
124665956|NCT02937740|448400609|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
124665957|NCT02937740|448400610|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
124665958|NCT04194489|448400611|FG000|Overall Study|Withdrawal by Subject|5|||
124665959|NCT04194489|448400611|FG000|Overall Study|Lost to Follow-up|48|||
124665960|NCT00305227|448400619|FG000|Overall Study|Lost to Follow-up|7|||
124665961|NCT00305227|448400620|FG001|Overall Study|Lost to Follow-up|6|||
124665962|NCT04085601|448400621|FG000|Overall Study|Lost to Follow-up|1|||
124665963|NCT04085601|448400622|FG001|Overall Study|Lost to Follow-up|0|||
124665964|NCT04085601|448400621|FG000|Overall Study|Death|1|||
124665965|NCT04085601|448400622|FG001|Overall Study|Death|1|||
124665966|NCT03492437|448400623|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124665967|NCT03492437|448400624|FG001|Treatment Period 2|Withdrawal by Subject|1|||
124665968|NCT04534517|448400626|FG000|Overall Study|Adverse Event|1|||
124665969|NCT04534517|448400626|FG000|Overall Study|Withdrawal by Subject|1|||
124665970|NCT04534517|448400626|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
124665971|NCT04534517|448400626|FG000|Overall Study|COVID-19 Related|1|||
124665972|NCT03872843|448400627|FG000|Overall Study|Lost to Follow-up|5|||
124665973|NCT03872843|448400628|FG001|Overall Study|Lost to Follow-up|7|||
124665974|NCT00823264|448400629|FG000|Overall Study|Protocol Violation|2|||
124665975|NCT00823264|448400630|FG001|Overall Study|Protocol Violation|0|||
124665976|NCT05133323|448400631|FG000|Overall Study|Lack of Efficacy|0|||
124665977|NCT05133323|448400632|FG001|Overall Study|Lack of Efficacy|0|||
124665978|NCT05133323|448400633|FG002|Overall Study|Lack of Efficacy|1|||
124665979|NCT05133323|448400631|FG000|Overall Study|Withdrawal by Subject|2|||
124665980|NCT05133323|448400632|FG001|Overall Study|Withdrawal by Subject|1|||
124665981|NCT05133323|448400633|FG002|Overall Study|Withdrawal by Subject|0|||
124665982|NCT00113295|448400634|FG000|Overall Study|Adverse Event|4|||
124665983|NCT00113295|448400635|FG001|Overall Study|Adverse Event|1|||
124665984|NCT00113295|448400634|FG000|Overall Study|Unrelated Medical Illness|1|||
124665985|NCT00113295|448400635|FG001|Overall Study|Unrelated Medical Illness|0|||
124665986|NCT01714544|448400636|FG000|Overall Study|Lost to Follow-up|1|||
124665987|NCT01714544|448400636|FG000|Overall Study|Physician Decision|1|||
124665988|NCT01714544|448400636|FG000|Overall Study|Withdrawal by Subject|1|||
124665989|NCT00577772|448400645|FG000|Overall Study|Lost to Follow-up|0|||
124665990|NCT00577772|448400646|FG001|Overall Study|Lost to Follow-up|1|||
124665991|NCT00572455|448400647|FG000|Stage I (14 Days)|Adverse Event|0|||
124665992|NCT00572455|448400648|FG001|Stage I (14 Days)|Adverse Event|0|||
124665993|NCT00572455|448400649|FG002|Stage I (14 Days)|Adverse Event|0|||
124665994|NCT00572455|448400650|FG003|Stage I (14 Days)|Adverse Event|0|||
124665995|NCT00572455|448400651|FG004|Stage I (14 Days)|Adverse Event|0|||
124665996|NCT00572455|448400652|FG005|Stage I (14 Days)|Adverse Event|3|||
124665997|NCT00572455|448400653|FG006|Stage I (14 Days)|Adverse Event|0|||
124665998|NCT00572455|448400654|FG007|Stage I (14 Days)|Adverse Event|0|||
124665999|NCT00572455|448400655|FG008|Stage I (14 Days)|Adverse Event|0|||
124666000|NCT00572455|448400656|FG009|Stage I (14 Days)|Adverse Event|0|||
124666001|NCT00572455|448400657|FG010|Stage I (14 Days)|Adverse Event|0|||
124666002|NCT00572455|448400658|FG011|Stage I (14 Days)|Adverse Event|0|||
124666003|NCT00572455|448400659|FG012|Stage I (14 Days)|Adverse Event|0|||
124666004|NCT00572455|448400660|FG013|Stage I (14 Days)|Adverse Event|0|||
124666005|NCT00572455|448400647|FG000|Stage I (14 Days)|Other|0|||
124666006|NCT00572455|448400648|FG001|Stage I (14 Days)|Other|0|||
124666007|NCT00572455|448400649|FG002|Stage I (14 Days)|Other|0|||
124666008|NCT00572455|448400650|FG003|Stage I (14 Days)|Other|0|||
124666009|NCT00572455|448400651|FG004|Stage I (14 Days)|Other|1|||
124666010|NCT00572455|448400652|FG005|Stage I (14 Days)|Other|0|||
124666011|NCT00572455|448400653|FG006|Stage I (14 Days)|Other|0|||
124666012|NCT00572455|448400654|FG007|Stage I (14 Days)|Other|0|||
124666013|NCT00572455|448400655|FG008|Stage I (14 Days)|Other|0|||
124666014|NCT00572455|448400656|FG009|Stage I (14 Days)|Other|0|||
124666015|NCT00572455|448400657|FG010|Stage I (14 Days)|Other|0|||
124666016|NCT00572455|448400658|FG011|Stage I (14 Days)|Other|0|||
124666017|NCT00572455|448400659|FG012|Stage I (14 Days)|Other|0|||
124666018|NCT00572455|448400660|FG013|Stage I (14 Days)|Other|0|||
124666019|NCT00572455|448400647|FG000|Stage II (28 Days)|Adverse Event|0|||
124666020|NCT00572455|448400648|FG001|Stage II (28 Days)|Adverse Event|0|||
124666021|NCT00572455|448400649|FG002|Stage II (28 Days)|Adverse Event|0|||
124666022|NCT00572455|448400650|FG003|Stage II (28 Days)|Adverse Event|0|||
124666023|NCT00572455|448400651|FG004|Stage II (28 Days)|Adverse Event|0|||
124666024|NCT00572455|448400652|FG005|Stage II (28 Days)|Adverse Event|0|||
124666025|NCT00572455|448400653|FG006|Stage II (28 Days)|Adverse Event|0|||
124666026|NCT00572455|448400654|FG007|Stage II (28 Days)|Adverse Event|0|||
124666027|NCT00572455|448400655|FG008|Stage II (28 Days)|Adverse Event|1|||
124666028|NCT00572455|448400656|FG009|Stage II (28 Days)|Adverse Event|3|||
124666029|NCT00572455|448400657|FG010|Stage II (28 Days)|Adverse Event|3|||
124666030|NCT00572455|448400658|FG011|Stage II (28 Days)|Adverse Event|4|||
124666031|NCT00572455|448400659|FG012|Stage II (28 Days)|Adverse Event|5|||
124666032|NCT00572455|448400660|FG013|Stage II (28 Days)|Adverse Event|1|||
124666033|NCT00572455|448400647|FG000|Stage II (28 Days)|Death|0|||
124666034|NCT00572455|448400648|FG001|Stage II (28 Days)|Death|0|||
124666035|NCT00572455|448400649|FG002|Stage II (28 Days)|Death|0|||
124666036|NCT00572455|448400650|FG003|Stage II (28 Days)|Death|0|||
124666037|NCT00572455|448400651|FG004|Stage II (28 Days)|Death|0|||
124666038|NCT00572455|448400652|FG005|Stage II (28 Days)|Death|0|||
124666039|NCT00572455|448400653|FG006|Stage II (28 Days)|Death|0|||
124666040|NCT00572455|448400654|FG007|Stage II (28 Days)|Death|0|||
124666041|NCT00572455|448400655|FG008|Stage II (28 Days)|Death|1|||
124666042|NCT00572455|448400656|FG009|Stage II (28 Days)|Death|0|||
124666043|NCT00572455|448400657|FG010|Stage II (28 Days)|Death|0|||
124666044|NCT00572455|448400658|FG011|Stage II (28 Days)|Death|0|||
124666045|NCT00572455|448400659|FG012|Stage II (28 Days)|Death|0|||
124666046|NCT00572455|448400660|FG013|Stage II (28 Days)|Death|0|||
124666047|NCT00572455|448400647|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
124666048|NCT00572455|448400648|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
124666049|NCT00572455|448400649|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
124666050|NCT00572455|448400650|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
124666051|NCT00572455|448400651|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
124666052|NCT00572455|448400652|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
124666053|NCT00572455|448400653|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
124666054|NCT00572455|448400654|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
124666055|NCT00572455|448400655|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
124666056|NCT00572455|448400656|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
124666057|NCT00572455|448400657|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
124666058|NCT00572455|448400658|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
124666059|NCT00572455|448400659|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
124666060|NCT00572455|448400660|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
124666061|NCT00572455|448400647|FG000|Stage II (28 Days)|Other|0|||
124666062|NCT00572455|448400648|FG001|Stage II (28 Days)|Other|0|||
124666063|NCT00572455|448400649|FG002|Stage II (28 Days)|Other|0|||
124666064|NCT00572455|448400650|FG003|Stage II (28 Days)|Other|0|||
124666065|NCT00572455|448400651|FG004|Stage II (28 Days)|Other|0|||
124666066|NCT00572455|448400652|FG005|Stage II (28 Days)|Other|0|||
124666067|NCT00572455|448400653|FG006|Stage II (28 Days)|Other|0|||
124666068|NCT00572455|448400654|FG007|Stage II (28 Days)|Other|0|||
124666069|NCT00572455|448400655|FG008|Stage II (28 Days)|Other|1|||
124666070|NCT00572455|448400656|FG009|Stage II (28 Days)|Other|0|||
124666071|NCT00572455|448400657|FG010|Stage II (28 Days)|Other|0|||
124666072|NCT00572455|448400658|FG011|Stage II (28 Days)|Other|0|||
124666073|NCT00572455|448400659|FG012|Stage II (28 Days)|Other|0|||
124666074|NCT00572455|448400660|FG013|Stage II (28 Days)|Other|0|||
124666075|NCT00572455|448400647|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
124666076|NCT00572455|448400648|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
124666077|NCT00572455|448400649|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
124666078|NCT00572455|448400650|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
124666079|NCT00572455|448400651|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
124666080|NCT00572455|448400652|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
124666081|NCT00572455|448400653|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
124666082|NCT00572455|448400654|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
124666083|NCT00572455|448400655|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
124666084|NCT00572455|448400656|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
124666085|NCT00572455|448400657|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
124666086|NCT00572455|448400658|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
124666087|NCT00572455|448400659|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
124666088|NCT00572455|448400660|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
124666089|NCT02824224|448400661|FG000|Overall Study|Discontinued, IUS expulsion|0|||
124666090|NCT02824224|448400662|FG001|Overall Study|Discontinued, IUS expulsion|1|||
124666091|NCT02824224|448400661|FG000|Overall Study|Did not show up for allocation visit|2|||
124666092|NCT02824224|448400662|FG001|Overall Study|Did not show up for allocation visit|0|||
124666093|NCT04152083|448400667|FG000|Overall Study|Lost to Follow-up|2|||
124666094|NCT04152083|448400668|FG001|Overall Study|Lost to Follow-up|1|||
124666095|NCT04152083|448400667|FG000|Overall Study|Adverse Event|1|||
124666096|NCT04152083|448400668|FG001|Overall Study|Adverse Event|0|||
124666097|NCT04152083|448400667|FG000|Overall Study|Randomized but not treated|3|||
124666098|NCT04152083|448400668|FG001|Overall Study|Randomized but not treated|2|||
124666099|NCT00856999|448400669|FG000|Overall Study|Withdrawal by Subject|5|||
124666100|NCT02465437|448400674|FG000|Overall Study|Physician Decision|0|||
124666101|NCT02465437|448400675|FG001|Overall Study|Physician Decision|0|||
124666102|NCT02465437|448400676|FG002|Overall Study|Physician Decision|1|||
124666103|NCT02465437|448400677|FG003|Overall Study|Physician Decision|0|||
124666104|NCT02465437|448400674|FG000|Overall Study|Withdrawal by Subject|1|||
124666105|NCT02465437|448400675|FG001|Overall Study|Withdrawal by Subject|0|||
124666106|NCT02465437|448400676|FG002|Overall Study|Withdrawal by Subject|0|||
124666107|NCT02465437|448400677|FG003|Overall Study|Withdrawal by Subject|1|||
124666108|NCT02465437|448400674|FG000|Overall Study|Adverse Event|0|||
124666109|NCT02465437|448400675|FG001|Overall Study|Adverse Event|1|||
124666110|NCT02465437|448400676|FG002|Overall Study|Adverse Event|0|||
124666111|NCT02465437|448400677|FG003|Overall Study|Adverse Event|0|||
124666112|NCT00003483|448400678|FG000|Overall Study|Not evaluable|1|||
124666113|NCT04131712|448400679|FG000|Overall Study|COVID related|0|||
124666114|NCT04131712|448400680|FG001|Overall Study|COVID related|0|||
124666115|NCT04131712|448400681|FG002|Overall Study|COVID related|2|||
124666116|NCT04131712|448400682|FG003|Overall Study|COVID related|0|||
124666117|NCT04131712|448400679|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
124666118|NCT04131712|448400680|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
124666119|NCT04131712|448400681|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
124666120|NCT04131712|448400682|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
124666121|NCT00873730|448400685|FG000|Overall Study|Protocol Deviation|5|||
124666122|NCT00873730|448400686|FG001|Overall Study|Protocol Deviation|2|||
124666123|NCT00873730|448400685|FG000|Overall Study|Adverse Event|0|||
124666124|NCT00873730|448400686|FG001|Overall Study|Adverse Event|2|||
124666125|NCT00873730|448400685|FG000|Overall Study|Withdrawal by Subject|0|||
124666126|NCT00873730|448400686|FG001|Overall Study|Withdrawal by Subject|1|||
124666127|NCT00873730|448400685|FG000|Overall Study|Sponsor decision|1|||
124666128|NCT00873730|448400686|FG001|Overall Study|Sponsor decision|0|||
124666129|NCT02299388|448400687|FG000|Overall Study|Withdrawal by Subject|0|||
124872979|NCT00089141|449157210|FG000|Overall Study|Termination of trial|18|||
124666130|NCT02299388|448400688|FG001|Overall Study|Withdrawal by Subject|1|||
124666131|NCT00103662|448400689|FG000|Overall Study|Entered Rescue Procedure|0|||
124666132|NCT00103662|448400690|FG001|Overall Study|Entered Rescue Procedure|7|||
124666133|NCT00103662|448400689|FG000|Overall Study|Death|7|||
124666134|NCT00103662|448400690|FG001|Overall Study|Death|7|||
124666135|NCT00103662|448400689|FG000|Overall Study|Elective Withdrawal|5|||
124666136|NCT00103662|448400690|FG001|Overall Study|Elective Withdrawal|5|||
124666137|NCT00103662|448400689|FG000|Overall Study|Lost to Follow-up|0|||
124666138|NCT00103662|448400690|FG001|Overall Study|Lost to Follow-up|1|||
124666139|NCT00103662|448400689|FG000|Overall Study|Other|6|||
124666140|NCT00103662|448400690|FG001|Overall Study|Other|9|||
124666141|NCT00103662|448400689|FG000|Overall Study|Failed mobilization|0|||
124666142|NCT00103662|448400690|FG001|Overall Study|Failed mobilization|4|||
124666143|NCT00103662|448400689|FG000|Overall Study|Intercurrent illness|1|||
124666144|NCT00103662|448400690|FG001|Overall Study|Intercurrent illness|0|||
124666145|NCT01869777|448400695|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
124666146|NCT00613366|448400696|FG000|Overall Study|Withdrawal by Subject|3|||
124666147|NCT00613366|448400697|FG001|Overall Study|Withdrawal by Subject|2|||
124666148|NCT01716663|448400701|FG000|Overall Study|Withdrawn prior to procedure|4|||
124666149|NCT01716663|448400701|FG000|Overall Study|Treated with non-study catheter|2|||
124666150|NCT03478371|448400708|FG000|Overall Study|non-compliance|1|||
124666151|NCT03478371|448400708|FG000|Overall Study|Lost to Follow-up|4|||
124666152|NCT00905424|448400709|FG000|Overall Study|Lost to Follow-up|3|||
124666153|NCT00905424|448400710|FG001|Overall Study|Lost to Follow-up|3|||
124666154|NCT00905424|448400709|FG000|Overall Study|Withdrawal by Subject|1|||
124666155|NCT00905424|448400710|FG001|Overall Study|Withdrawal by Subject|2|||
124666156|NCT00905424|448400709|FG000|Overall Study|Adverse Event|4|||
124666157|NCT00905424|448400710|FG001|Overall Study|Adverse Event|2|||
124666158|NCT00905424|448400709|FG000|Overall Study|Non-compliance with study medication|2|||
124666159|NCT00905424|448400710|FG001|Overall Study|Non-compliance with study medication|0|||
124666160|NCT00905424|448400709|FG000|Overall Study|Sponsor decision|1|||
124666161|NCT00905424|448400710|FG001|Overall Study|Sponsor decision|0|||
124666162|NCT00905424|448400709|FG000|Overall Study|Positive urine drug screen|0|||
124666163|NCT00905424|448400710|FG001|Overall Study|Positive urine drug screen|1|||
124666164|NCT00905424|448400709|FG000|Overall Study|Non-adherence to visit schedule|0|||
124666165|NCT00905424|448400710|FG001|Overall Study|Non-adherence to visit schedule|1|||
124666166|NCT03311841|448400713|FG000|14-day Wash-out|Adverse Event|0|||
124666167|NCT03311841|448400714|FG001|14-day Wash-out|Adverse Event|1|||
124666168|NCT03311841|448400715|FG002|14-day Wash-out|Adverse Event|0|||
124666169|NCT03311841|448400716|FG003|14-day Wash-out|Adverse Event|0|||
124666170|NCT03311841|448400717|FG004|14-day Wash-out|Adverse Event|0|||
124666171|NCT03311841|448400713|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
124666172|NCT03311841|448400714|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
124666173|NCT03311841|448400715|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
124666174|NCT03311841|448400716|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
124666175|NCT03311841|448400717|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
124666176|NCT03360019|448400718|FG000|Overall Study|Withdrawal by Subject|2|||
124666177|NCT03360019|448400719|FG001|Overall Study|Withdrawal by Subject|0|||
124666178|NCT03360019|448400720|FG002|Overall Study|Withdrawal by Subject|0|||
124666179|NCT03360019|448400718|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
124666180|NCT03360019|448400719|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
124666181|NCT03360019|448400720|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
124666182|NCT01462110|448400721|FG000|Overall Study|Adverse Event|1|||
124666183|NCT01462110|448400722|FG001|Overall Study|Adverse Event|0|||
124666184|NCT00964028|448400723|FG000|Overall Study|Withdrawal by Subject|0|||
124666185|NCT00964028|448400724|FG001|Overall Study|Withdrawal by Subject|1|||
124666186|NCT02385110|448400725|FG000|Overall Study|Early Death|1|||
124666187|NCT02385110|448400726|FG001|Overall Study|Early Death|0|||
124666188|NCT00534638|448400728|FG000|Overall Study|Withdrawal by Subject|3|||
124666189|NCT00534638|448400729|FG001|Overall Study|Withdrawal by Subject|4|||
124666190|NCT00534638|448400728|FG000|Overall Study|Migrated/moved from study area|13|||
124666191|NCT00534638|448400729|FG001|Overall Study|Migrated/moved from study area|11|||
124666192|NCT00534638|448400728|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
124666193|NCT00534638|448400729|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
124666194|NCT00534638|448400728|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
124666195|NCT00534638|448400729|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
124666196|NCT00534638|448400728|FG000|Overall Study|Other|1685|||
124666197|NCT00534638|448400729|FG001|Overall Study|Other|902|||
124666198|NCT00103285|448402431|FG000|Induction|Adverse Event|14|||
124666199|NCT00103285|448402432|FG001|Induction|Adverse Event|0|||
124666200|NCT00103285|448402433|FG002|Induction|Adverse Event|0|||
124666201|NCT00103285|448402434|FG003|Induction|Adverse Event|0|||
124666202|NCT00103285|448402435|FG004|Induction|Adverse Event|0|||
124666203|NCT00103285|448402436|FG005|Induction|Adverse Event|0|||
124666204|NCT00103285|448402437|FG006|Induction|Adverse Event|0|||
124666205|NCT00103285|448402438|FG007|Induction|Adverse Event|0|||
124666206|NCT00103285|448402431|FG000|Induction|Death|24|||
124666207|NCT00103285|448402432|FG001|Induction|Death|0|||
124666208|NCT00103285|448402433|FG002|Induction|Death|0|||
124666209|NCT00103285|448402434|FG003|Induction|Death|0|||
124666210|NCT00103285|448402435|FG004|Induction|Death|0|||
124666211|NCT00103285|448402436|FG005|Induction|Death|0|||
124666212|NCT00103285|448402437|FG006|Induction|Death|0|||
124666213|NCT00103285|448402438|FG007|Induction|Death|0|||
124666214|NCT00103285|448402431|FG000|Induction|Physician Decision|103|||
124666215|NCT00103285|448402432|FG001|Induction|Physician Decision|0|||
124666216|NCT00103285|448402433|FG002|Induction|Physician Decision|0|||
124666217|NCT00103285|448402434|FG003|Induction|Physician Decision|0|||
124666218|NCT00103285|448402435|FG004|Induction|Physician Decision|0|||
124666219|NCT00103285|448402436|FG005|Induction|Physician Decision|0|||
124666220|NCT00103285|448402437|FG006|Induction|Physician Decision|0|||
124666221|NCT00103285|448402438|FG007|Induction|Physician Decision|0|||
124666222|NCT00103285|448402431|FG000|Induction|Withdrawal by Subject|1|||
124666223|NCT00103285|448402432|FG001|Induction|Withdrawal by Subject|0|||
124666224|NCT00103285|448402433|FG002|Induction|Withdrawal by Subject|0|||
124666225|NCT00103285|448402434|FG003|Induction|Withdrawal by Subject|0|||
124666226|NCT00103285|448402435|FG004|Induction|Withdrawal by Subject|0|||
124666227|NCT00103285|448402436|FG005|Induction|Withdrawal by Subject|0|||
124666228|NCT00103285|448402437|FG006|Induction|Withdrawal by Subject|0|||
124666229|NCT00103285|448402438|FG007|Induction|Withdrawal by Subject|0|||
124666230|NCT00103285|448402431|FG000|Induction|Ineligible|43|||
124666231|NCT00103285|448402432|FG001|Induction|Ineligible|0|||
124666232|NCT00103285|448402433|FG002|Induction|Ineligible|0|||
124666233|NCT00103285|448402434|FG003|Induction|Ineligible|0|||
124666234|NCT00103285|448402435|FG004|Induction|Ineligible|0|||
124666235|NCT00103285|448402436|FG005|Induction|Ineligible|0|||
124666236|NCT00103285|448402437|FG006|Induction|Ineligible|0|||
124666237|NCT00103285|448402438|FG007|Induction|Ineligible|0|||
124666238|NCT00103285|448402431|FG000|Induction|Refusal|906|||
124666239|NCT00103285|448402432|FG001|Induction|Refusal|0|||
124666240|NCT00103285|448402433|FG002|Induction|Refusal|0|||
124666241|NCT00103285|448402434|FG003|Induction|Refusal|0|||
124666242|NCT00103285|448402435|FG004|Induction|Refusal|0|||
124666243|NCT00103285|448402436|FG005|Induction|Refusal|0|||
124666244|NCT00103285|448402437|FG006|Induction|Refusal|0|||
124666245|NCT00103285|448402438|FG007|Induction|Refusal|0|||
124666246|NCT00103285|448402431|FG000|Induction|Other|258|||
124666247|NCT00103285|448402432|FG001|Induction|Other|0|||
124666248|NCT00103285|448402433|FG002|Induction|Other|0|||
124666249|NCT00103285|448402434|FG003|Induction|Other|0|||
124666250|NCT00103285|448402435|FG004|Induction|Other|0|||
124666251|NCT00103285|448402436|FG005|Induction|Other|0|||
124666252|NCT00103285|448402437|FG006|Induction|Other|0|||
124666253|NCT00103285|448402438|FG007|Induction|Other|0|||
124666254|NCT00103285|448402431|FG000|Response Assignment|Adverse Event|0|||
124666255|NCT00103285|448402432|FG001|Response Assignment|Adverse Event|8|||
124666256|NCT00103285|448402433|FG002|Response Assignment|Adverse Event|3|||
124666257|NCT00103285|448402434|FG003|Response Assignment|Adverse Event|2|||
124666258|NCT00103285|448402435|FG004|Response Assignment|Adverse Event|3|||
124666259|NCT00103285|448402436|FG005|Response Assignment|Adverse Event|1|||
124666260|NCT00103285|448402437|FG006|Response Assignment|Adverse Event|1|||
124666261|NCT00103285|448402438|FG007|Response Assignment|Adverse Event|2|||
124666262|NCT00103285|448402431|FG000|Response Assignment|Death|0|||
124666263|NCT00103285|448402432|FG001|Response Assignment|Death|5|||
124666264|NCT00103285|448402433|FG002|Response Assignment|Death|2|||
124666265|NCT00103285|448402434|FG003|Response Assignment|Death|2|||
124666266|NCT00103285|448402435|FG004|Response Assignment|Death|3|||
124666267|NCT00103285|448402436|FG005|Response Assignment|Death|1|||
124666268|NCT00103285|448402437|FG006|Response Assignment|Death|0|||
124666269|NCT00103285|448402438|FG007|Response Assignment|Death|8|||
124666270|NCT00103285|448402431|FG000|Response Assignment|Lost to Follow-up|0|||
124666271|NCT00103285|448402432|FG001|Response Assignment|Lost to Follow-up|9|||
124666272|NCT00103285|448402433|FG002|Response Assignment|Lost to Follow-up|5|||
124666273|NCT00103285|448402434|FG003|Response Assignment|Lost to Follow-up|5|||
124666274|NCT00103285|448402435|FG004|Response Assignment|Lost to Follow-up|1|||
124666275|NCT00103285|448402436|FG005|Response Assignment|Lost to Follow-up|2|||
124666276|NCT00103285|448402437|FG006|Response Assignment|Lost to Follow-up|2|||
124666277|NCT00103285|448402438|FG007|Response Assignment|Lost to Follow-up|5|||
124666278|NCT00103285|448402431|FG000|Response Assignment|Physician Decision|0|||
124666279|NCT00103285|448402432|FG001|Response Assignment|Physician Decision|13|||
124666280|NCT00103285|448402433|FG002|Response Assignment|Physician Decision|14|||
124666281|NCT00103285|448402434|FG003|Response Assignment|Physician Decision|9|||
124666282|NCT00103285|448402435|FG004|Response Assignment|Physician Decision|13|||
124666283|NCT00103285|448402436|FG005|Response Assignment|Physician Decision|7|||
124666284|NCT00103285|448402437|FG006|Response Assignment|Physician Decision|4|||
124666285|NCT00103285|448402438|FG007|Response Assignment|Physician Decision|35|||
124666286|NCT00103285|448402431|FG000|Response Assignment|Protocol Violation|0|||
124666287|NCT00103285|448402432|FG001|Response Assignment|Protocol Violation|2|||
124666288|NCT00103285|448402433|FG002|Response Assignment|Protocol Violation|0|||
124666289|NCT00103285|448402434|FG003|Response Assignment|Protocol Violation|0|||
124666290|NCT00103285|448402435|FG004|Response Assignment|Protocol Violation|0|||
124666291|NCT00103285|448402436|FG005|Response Assignment|Protocol Violation|0|||
124666292|NCT00103285|448402437|FG006|Response Assignment|Protocol Violation|0|||
124666293|NCT00103285|448402438|FG007|Response Assignment|Protocol Violation|0|||
124666294|NCT00103285|448402431|FG000|Response Assignment|Withdrawal by Subject|0|||
124666295|NCT00103285|448402432|FG001|Response Assignment|Withdrawal by Subject|4|||
124666296|NCT00103285|448402433|FG002|Response Assignment|Withdrawal by Subject|1|||
124666297|NCT00103285|448402434|FG003|Response Assignment|Withdrawal by Subject|1|||
124666298|NCT00103285|448402435|FG004|Response Assignment|Withdrawal by Subject|2|||
124666299|NCT00103285|448402436|FG005|Response Assignment|Withdrawal by Subject|2|||
124666300|NCT00103285|448402437|FG006|Response Assignment|Withdrawal by Subject|0|||
124666301|NCT00103285|448402438|FG007|Response Assignment|Withdrawal by Subject|2|||
124666302|NCT00103285|448402431|FG000|Response Assignment|Ineligible|0|||
124666303|NCT00103285|448402432|FG001|Response Assignment|Ineligible|8|||
124666304|NCT00103285|448402433|FG002|Response Assignment|Ineligible|6|||
124666305|NCT00103285|448402434|FG003|Response Assignment|Ineligible|2|||
124666306|NCT00103285|448402435|FG004|Response Assignment|Ineligible|0|||
124666307|NCT00103285|448402436|FG005|Response Assignment|Ineligible|3|||
124666308|NCT00103285|448402437|FG006|Response Assignment|Ineligible|1|||
124666309|NCT00103285|448402438|FG007|Response Assignment|Ineligible|5|||
124666310|NCT00103285|448402431|FG000|Response Assignment|Refusal|0|||
124666311|NCT00103285|448402432|FG001|Response Assignment|Refusal|53|||
124666312|NCT00103285|448402433|FG002|Response Assignment|Refusal|5|||
124666313|NCT00103285|448402434|FG003|Response Assignment|Refusal|3|||
124666314|NCT00103285|448402435|FG004|Response Assignment|Refusal|25|||
124666315|NCT00103285|448402436|FG005|Response Assignment|Refusal|15|||
124666316|NCT00103285|448402437|FG006|Response Assignment|Refusal|30|||
124666317|NCT00103285|448402438|FG007|Response Assignment|Refusal|10|||
124666318|NCT00103285|448402431|FG000|Response Assignment|Other|0|||
124666319|NCT00103285|448402432|FG001|Response Assignment|Other|30|||
124666320|NCT00103285|448402433|FG002|Response Assignment|Other|48|||
124666321|NCT00103285|448402434|FG003|Response Assignment|Other|38|||
124666322|NCT00103285|448402435|FG004|Response Assignment|Other|37|||
124666323|NCT00103285|448402436|FG005|Response Assignment|Other|17|||
124666324|NCT00103285|448402437|FG006|Response Assignment|Other|11|||
124666325|NCT00103285|448402438|FG007|Response Assignment|Other|53|||
124666326|NCT02624947|448402441|FG000|Maternal Participants|Adverse Event|5|||
124666327|NCT02624947|448402442|FG001|Maternal Participants|Adverse Event|0|||
124666328|NCT02624947|448402441|FG000|Maternal Participants|Investigator Decision|5|||
124666329|NCT02624947|448402442|FG001|Maternal Participants|Investigator Decision|3|||
124666330|NCT02624947|448402441|FG000|Maternal Participants|Lost to Follow-up|54|||
124666331|NCT02624947|448402442|FG001|Maternal Participants|Lost to Follow-up|24|||
124666332|NCT02624947|448402441|FG000|Maternal Participants|Non Compliance|8|||
124666333|NCT02624947|448402442|FG001|Maternal Participants|Non Compliance|5|||
124666334|NCT02624947|448402441|FG000|Maternal Participants|Sponsor Request|1|||
124666335|NCT02624947|448402442|FG001|Maternal Participants|Sponsor Request|1|||
124666336|NCT02624947|448402441|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
124666337|NCT02624947|448402442|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
124666338|NCT02624947|448402441|FG000|Maternal Participants|Miscellaneous|23|||
124666339|NCT02624947|448402442|FG001|Maternal Participants|Miscellaneous|15|||
124666340|NCT02624947|448402441|FG000|Infant Participants|Adverse Event|18|||
124666341|NCT02624947|448402442|FG001|Infant Participants|Adverse Event|11|||
124666342|NCT02624947|448402441|FG000|Infant Participants|Investigator Decision|5|||
124666343|NCT02624947|448402442|FG001|Infant Participants|Investigator Decision|4|||
124666344|NCT02624947|448402441|FG000|Infant Participants|Lost to Follow-up|93|||
124666345|NCT02624947|448402442|FG001|Infant Participants|Lost to Follow-up|58|||
124666346|NCT02624947|448402441|FG000|Infant Participants|Non Compliance|17|||
124666347|NCT02624947|448402442|FG001|Infant Participants|Non Compliance|7|||
124666348|NCT02624947|448402441|FG000|Infant Participants|Sponsor Request|0|||
124666349|NCT02624947|448402442|FG001|Infant Participants|Sponsor Request|1|||
124666350|NCT02624947|448402441|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
124666351|NCT02624947|448402442|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
124666352|NCT02624947|448402441|FG000|Infant Participants|Miscellaneous|50|||
124666353|NCT02624947|448402442|FG001|Infant Participants|Miscellaneous|26|||
124666354|NCT03569098|448402448|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
124666355|NCT03569098|448402449|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
124666356|NCT03569098|448402450|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
124666357|NCT03569098|448402448|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
124666358|NCT03569098|448402449|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
124666359|NCT03569098|448402450|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
124666360|NCT03569098|448402448|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
124666361|NCT03569098|448402449|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
124666362|NCT03569098|448402450|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
124666363|NCT03569098|448402448|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
124666364|NCT03569098|448402449|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
124666365|NCT03569098|448402450|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
124666366|NCT03569098|448402448|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
124666367|NCT03569098|448402449|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
124666368|NCT03569098|448402450|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
124666369|NCT03569098|448402448|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
124666370|NCT03569098|448402449|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
124666371|NCT03569098|448402450|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
124666372|NCT03569098|448402448|FG000|Double-Blind Treatment Cycle 1|Other|1|||
124666373|NCT03569098|448402449|FG001|Double-Blind Treatment Cycle 1|Other|0|||
124666374|NCT03569098|448402450|FG002|Double-Blind Treatment Cycle 1|Other|1|||
124666375|NCT03569098|448402448|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
124666376|NCT03569098|448402449|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
124666377|NCT03569098|448402450|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
124666378|NCT03569098|448402448|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
124666379|NCT03569098|448402449|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
124666380|NCT03569098|448402450|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
124666381|NCT03569098|448402448|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
124666382|NCT03569098|448402449|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
124666383|NCT03569098|448402450|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
124666384|NCT03569098|448402448|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
124666385|NCT03569098|448402449|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
124666386|NCT03569098|448402450|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
124666387|NCT03569098|448402448|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
124666388|NCT03569098|448402449|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
124666389|NCT03569098|448402450|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
124666390|NCT03569098|448402448|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
124666391|NCT03569098|448402449|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
124666392|NCT03569098|448402450|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
124666393|NCT01697800|448402451|FG000|Overall Study|Death|0|||
124666394|NCT01697800|448402452|FG001|Overall Study|Death|1|||
124666395|NCT00954122|448402453|FG000|Overall Study|Withdrawal by Subject|5|||
124666396|NCT00954122|448402453|FG000|Overall Study|Adverse Event|1|||
124666397|NCT00954122|448402453|FG000|Overall Study|Safety Reason|1|||
124666398|NCT00522548|448402457|FG000|Overall Study|Adverse Event|2|||
124666399|NCT00522548|448402458|FG001|Overall Study|Adverse Event|2|||
124666400|NCT00522548|448402457|FG000|Overall Study|Withdrawal by Subject|0|||
124666401|NCT00522548|448402458|FG001|Overall Study|Withdrawal by Subject|2|||
124666402|NCT02121795|448402459|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
124666403|NCT02121795|448402460|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
124666404|NCT02121795|448402459|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
124666405|NCT02121795|448402460|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
124666406|NCT02121795|448402459|FG000|Double-Blind Phase|Lost to Follow-up|7|||
124666407|NCT02121795|448402460|FG001|Double-Blind Phase|Lost to Follow-up|4|||
124666408|NCT02121795|448402459|FG000|Double-Blind Phase|Physician Decision|2|||
124666409|NCT02121795|448402460|FG001|Double-Blind Phase|Physician Decision|5|||
124666410|NCT02121795|448402459|FG000|Double-Blind Phase|Adverse Event|5|||
124666411|NCT02121795|448402460|FG001|Double-Blind Phase|Adverse Event|0|||
124666412|NCT02121795|448402459|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
124666413|NCT02121795|448402460|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
124666414|NCT02121795|448402459|FG000|Double-Blind Phase|Protocol Violation|0|||
124666415|NCT02121795|448402460|FG001|Double-Blind Phase|Protocol Violation|3|||
124666416|NCT02121795|448402459|FG000|Double-Blind Phase|Death|1|||
124666417|NCT02121795|448402460|FG001|Double-Blind Phase|Death|1|||
124666418|NCT02121795|448402459|FG000|Open-Label Phase|Physician Decision|8|||
124666419|NCT02121795|448402460|FG001|Open-Label Phase|Physician Decision|8|||
124666420|NCT02121795|448402459|FG000|Open-Label Phase|Withdrawal by Subject|3|||
124666421|NCT02121795|448402460|FG001|Open-Label Phase|Withdrawal by Subject|2|||
124666422|NCT02121795|448402459|FG000|Open-Label Phase|Lost to Follow-up|1|||
124666423|NCT02121795|448402460|FG001|Open-Label Phase|Lost to Follow-up|0|||
124666424|NCT00994110|448402461|FG000|Overall Study|Withdrawal by Subject|9|||
124666425|NCT00994110|448402462|FG001|Overall Study|Withdrawal by Subject|9|||
124666426|NCT00994110|448402461|FG000|Overall Study|Not Treated|4|||
124666427|NCT00994110|448402462|FG001|Overall Study|Not Treated|8|||
124666428|NCT00994110|448402461|FG000|Overall Study|Adverse Event|1|||
124666429|NCT00994110|448402462|FG001|Overall Study|Adverse Event|0|||
124666430|NCT00994110|448402461|FG000|Overall Study|Patient not resected|41|||
124666431|NCT00994110|448402462|FG001|Overall Study|Patient not resected|52|||
124666432|NCT00994110|448402461|FG000|Overall Study|Pt not eligible|10|||
124666433|NCT00994110|448402462|FG001|Overall Study|Pt not eligible|5|||
124666434|NCT00666211|448402463|FG000|Overall Study|Withdrawal by Subject|10|||
124666435|NCT00666211|448402464|FG001|Overall Study|Withdrawal by Subject|13|||
124666436|NCT00666211|448402463|FG000|Overall Study|went off medication, no more pain|1|||
124666437|NCT00666211|448402464|FG001|Overall Study|went off medication, no more pain|0|||
124666438|NCT00666211|448402463|FG000|Overall Study|patient non-compliant|6|||
124666439|NCT00666211|448402464|FG001|Overall Study|patient non-compliant|6|||
124666440|NCT00666211|448402463|FG000|Overall Study|disease progression|1|||
124666441|NCT00666211|448402464|FG001|Overall Study|disease progression|8|||
124666442|NCT00666211|448402463|FG000|Overall Study|Lost to Follow-up|2|||
124666443|NCT00666211|448402464|FG001|Overall Study|Lost to Follow-up|0|||
124666444|NCT00666211|448402463|FG000|Overall Study|toxicity|0|||
124666445|NCT00666211|448402464|FG001|Overall Study|toxicity|2|||
124666446|NCT00666211|448402463|FG000|Overall Study|hospital admission|0|||
124666447|NCT00666211|448402464|FG001|Overall Study|hospital admission|5|||
124666448|NCT00666211|448402463|FG000|Overall Study|Death|0|||
124666449|NCT00666211|448402464|FG001|Overall Study|Death|2|||
124666450|NCT00666211|448402463|FG000|Overall Study|off tx for other complicating disease|0|||
124666451|NCT00666211|448402464|FG001|Overall Study|off tx for other complicating disease|1|||
124666452|NCT00666211|448402463|FG000|Overall Study|Physician Decision|0|||
124666453|NCT00666211|448402464|FG001|Overall Study|Physician Decision|1|||
124666454|NCT02683239|448402465|FG000|Overall Study|Protocol Violation|35|||
124666455|NCT02683239|448402466|FG001|Overall Study|Protocol Violation|23|||
124666456|NCT02683239|448402467|FG002|Overall Study|Protocol Violation|26|||
124666457|NCT02683239|448402468|FG003|Overall Study|Protocol Violation|4|||
124666458|NCT02683239|448402469|FG004|Overall Study|Protocol Violation|35|||
124666459|NCT02683239|448402470|FG005|Overall Study|Protocol Violation|4|||
124666460|NCT02683239|448402471|FG006|Overall Study|Protocol Violation|5|||
124666461|NCT02683239|448402465|FG000|Overall Study|Adverse Event|64|||
124666462|NCT02683239|448402466|FG001|Overall Study|Adverse Event|39|||
124666463|NCT02683239|448402467|FG002|Overall Study|Adverse Event|42|||
124666464|NCT02683239|448402468|FG003|Overall Study|Adverse Event|16|||
124666465|NCT02683239|448402469|FG004|Overall Study|Adverse Event|189|||
124666466|NCT02683239|448402470|FG005|Overall Study|Adverse Event|9|||
124666467|NCT02683239|448402471|FG006|Overall Study|Adverse Event|9|||
124666468|NCT02683239|448402465|FG000|Overall Study|Physician Decision|38|||
124666469|NCT02683239|448402466|FG001|Overall Study|Physician Decision|19|||
124666470|NCT02683239|448402467|FG002|Overall Study|Physician Decision|14|||
124666471|NCT02683239|448402468|FG003|Overall Study|Physician Decision|73|||
124666472|NCT02683239|448402469|FG004|Overall Study|Physician Decision|143|||
124666473|NCT02683239|448402470|FG005|Overall Study|Physician Decision|14|||
124666474|NCT02683239|448402471|FG006|Overall Study|Physician Decision|15|||
124666475|NCT02683239|448402465|FG000|Overall Study|Withdrawal by Subject|187|||
124666476|NCT02683239|448402466|FG001|Overall Study|Withdrawal by Subject|99|||
124666477|NCT02683239|448402467|FG002|Overall Study|Withdrawal by Subject|91|||
124666478|NCT02683239|448402468|FG003|Overall Study|Withdrawal by Subject|18|||
124666479|NCT02683239|448402469|FG004|Overall Study|Withdrawal by Subject|248|||
124666480|NCT02683239|448402470|FG005|Overall Study|Withdrawal by Subject|22|||
124666481|NCT02683239|448402471|FG006|Overall Study|Withdrawal by Subject|28|||
124666482|NCT02683239|448402465|FG000|Overall Study|Lost to Follow-up|77|||
124666483|NCT02683239|448402466|FG001|Overall Study|Lost to Follow-up|24|||
124666484|NCT02683239|448402467|FG002|Overall Study|Lost to Follow-up|25|||
124666485|NCT02683239|448402468|FG003|Overall Study|Lost to Follow-up|7|||
124666486|NCT02683239|448402469|FG004|Overall Study|Lost to Follow-up|88|||
124666487|NCT02683239|448402470|FG005|Overall Study|Lost to Follow-up|8|||
124666488|NCT02683239|448402471|FG006|Overall Study|Lost to Follow-up|11|||
124666489|NCT02683239|448402465|FG000|Overall Study|Death|9|||
124666490|NCT02683239|448402466|FG001|Overall Study|Death|5|||
124666491|NCT02683239|448402467|FG002|Overall Study|Death|8|||
124666492|NCT02683239|448402468|FG003|Overall Study|Death|0|||
124666493|NCT02683239|448402469|FG004|Overall Study|Death|12|||
124666494|NCT02683239|448402470|FG005|Overall Study|Death|1|||
124666495|NCT02683239|448402471|FG006|Overall Study|Death|0|||
124666496|NCT02683239|448402465|FG000|Overall Study|Lack of Efficacy|50|||
124666497|NCT02683239|448402466|FG001|Overall Study|Lack of Efficacy|23|||
124666498|NCT02683239|448402467|FG002|Overall Study|Lack of Efficacy|12|||
124666499|NCT02683239|448402468|FG003|Overall Study|Lack of Efficacy|2|||
124666500|NCT02683239|448402469|FG004|Overall Study|Lack of Efficacy|29|||
124666501|NCT02683239|448402470|FG005|Overall Study|Lack of Efficacy|2|||
124666502|NCT02683239|448402471|FG006|Overall Study|Lack of Efficacy|3|||
124666503|NCT02683239|448402465|FG000|Overall Study|Missing data|0|||
124666504|NCT02683239|448402466|FG001|Overall Study|Missing data|1|||
124666505|NCT02683239|448402467|FG002|Overall Study|Missing data|1|||
124666506|NCT02683239|448402468|FG003|Overall Study|Missing data|0|||
124666507|NCT02683239|448402469|FG004|Overall Study|Missing data|1|||
124666508|NCT02683239|448402470|FG005|Overall Study|Missing data|0|||
124666509|NCT02683239|448402471|FG006|Overall Study|Missing data|0|||
124666510|NCT02609386|448402472|FG000|Overall Study|Withdrawal by Subject|6|||
124666511|NCT02609386|448402473|FG001|Overall Study|Withdrawal by Subject|1|||
124666512|NCT02609386|448402472|FG000|Overall Study|Lost to Follow-up|3|||
124666513|NCT02609386|448402473|FG001|Overall Study|Lost to Follow-up|5|||
124666514|NCT02609386|448402472|FG000|Overall Study|Death|19|||
124666515|NCT02609386|448402473|FG001|Overall Study|Death|9|||
124666516|NCT02609386|448402472|FG000|Overall Study|Physician Decision|0|||
124666517|NCT02609386|448402473|FG001|Overall Study|Physician Decision|2|||
124666518|NCT03334188|448402477|FG000|Overall Study|Withdrawal by Subject|0|||
124666519|NCT03334188|448402478|FG001|Overall Study|Withdrawal by Subject|1|||
124666520|NCT03334188|448402477|FG000|Overall Study|Death|1|||
124666521|NCT03334188|448402478|FG001|Overall Study|Death|0|||
124666522|NCT03334188|448402477|FG000|Overall Study|Never had qualifying clinic visit|7|||
124666523|NCT03334188|448402478|FG001|Overall Study|Never had qualifying clinic visit|7|||
124666524|NCT03373760|448402479|FG000|Overall Study|Adverse Event|8|||
124666525|NCT03373760|448402479|FG000|Overall Study|Disease Progression|46|||
124666526|NCT03373760|448402479|FG000|Overall Study|Death|4|||
124666527|NCT01093586|448402480|FG000|Overall Study|Failed to engraft|3|||
124666528|NCT03442088|448402481|FG000|Overall Study|Adverse Event|1|||
124666529|NCT03442088|448402481|FG000|Overall Study|Lack of Efficacy|2|||
124666530|NCT03442088|448402481|FG000|Overall Study|Lost to Follow-up|2|||
124666531|NCT00105989|448402482|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
124666532|NCT00105989|448402483|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
124666533|NCT00105989|448402482|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
124666534|NCT00105989|448402483|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
124666535|NCT00105989|448402482|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
124666536|NCT00105989|448402483|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
124666537|NCT00105989|448402482|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
124666538|NCT00105989|448402483|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
124666539|NCT00105989|448402482|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
124666540|NCT00105989|448402483|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
124666541|NCT00105989|448402482|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
124666542|NCT00105989|448402483|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
124666543|NCT00105989|448402482|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
124666544|NCT00105989|448402483|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
124666545|NCT00105989|448402482|FG000|Acute - Open Label: Week 0-10|Death|1|||
124666546|NCT00105989|448402483|FG001|Acute - Open Label: Week 0-10|Death|0|||
124666547|NCT00105989|448402482|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
124666548|NCT00105989|448402483|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
124666549|NCT00105989|448402482|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
124666550|NCT00105989|448402483|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
124666551|NCT00105989|448402482|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
124666552|NCT00105989|448402483|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
124666553|NCT00105989|448402482|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
124666554|NCT00105989|448402483|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
124666555|NCT00105989|448402482|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
124666556|NCT00105989|448402483|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
124666557|NCT00105989|448402482|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
124666558|NCT00105989|448402483|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
124666559|NCT00105989|448402482|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
124666560|NCT00105989|448402483|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
124666561|NCT00105989|448402482|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
124666562|NCT00105989|448402483|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
124666563|NCT00105989|448402482|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
124666564|NCT00105989|448402483|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
124666565|NCT00105989|448402482|FG000|Continuation - Open Label:Week 10-34|Death|0|||
124666566|NCT00105989|448402483|FG001|Continuation - Open Label:Week 10-34|Death|0|||
124666567|NCT00105989|448402482|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
124666568|NCT00105989|448402483|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
124666569|NCT00105989|448402482|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
124666570|NCT00105989|448402483|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
124666571|NCT00105989|448402482|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
124666572|NCT00105989|448402483|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
124666573|NCT00105989|448402482|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
124666574|NCT00105989|448402483|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
124666575|NCT00105989|448402482|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
124666576|NCT00105989|448402483|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
124666577|NCT00105989|448402482|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
124666578|NCT00105989|448402483|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
124666579|NCT00105989|448402482|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
124666580|NCT00105989|448402483|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
124666581|NCT00105989|448402482|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
124666582|NCT00105989|448402483|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
124666583|NCT00105989|448402482|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
124666584|NCT00105989|448402483|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
124666585|NCT00105989|448402482|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
124666586|NCT00105989|448402483|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
124666587|NCT00105989|448402482|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
124666588|NCT00105989|448402483|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
124666589|NCT00105989|448402482|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
124666590|NCT00105989|448402483|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
124666591|NCT00357877|448402484|FG000|Overall Study|Death|2|||
124666592|NCT00357877|448402485|FG001|Overall Study|Death|1|||
124666593|NCT00357877|448402484|FG000|Overall Study|Lost to Follow-up|20|||
124666594|NCT00357877|448402485|FG001|Overall Study|Lost to Follow-up|23|||
124666595|NCT00357877|448402484|FG000|Overall Study|Withdrawal by Subject|3|||
124666596|NCT00357877|448402485|FG001|Overall Study|Withdrawal by Subject|3|||
124666597|NCT00357877|448402484|FG000|Overall Study|Administrative withdrawal|1|||
124666598|NCT00357877|448402485|FG001|Overall Study|Administrative withdrawal|1|||
124666599|NCT00357877|448402484|FG000|Overall Study|Other|0|||
124666600|NCT00357877|448402485|FG001|Overall Study|Other|2|||
124666601|NCT04668209|448402486|FG000|Overall Study|Withdrawal by Subject|2|||
124666602|NCT04668209|448402487|FG001|Overall Study|Withdrawal by Subject|2|||
124666603|NCT04668209|448402486|FG000|Overall Study|Lost to Follow-up|3|||
124666604|NCT04668209|448402487|FG001|Overall Study|Lost to Follow-up|4|||
124666605|NCT04668209|448402486|FG000|Overall Study|Subject Expired|2|||
124666606|NCT04668209|448402487|FG001|Overall Study|Subject Expired|0|||
124666607|NCT04668209|448402486|FG000|Overall Study|Withdrawn from study|0|||
124666608|NCT04668209|448402487|FG001|Overall Study|Withdrawn from study|1|||
124666609|NCT04668209|448402486|FG000|Overall Study|Adverse Event|0|||
124666610|NCT04668209|448402487|FG001|Overall Study|Adverse Event|1|||
124666611|NCT00766597|448402496|FG000|Overall Study|Unexpected closure of study|4|||
124666612|NCT00766597|448402496|FG000|Overall Study|Without CCR5-tropic virus|5|||
124666613|NCT01135524|448402498|FG000|Overall Study|Withdrawal by Subject|14|||
124666614|NCT01135524|448402498|FG000|Overall Study|Adverse Event|20|||
124666615|NCT01135524|448402498|FG000|Overall Study|Lost to Follow-up|3|||
124666616|NCT01135524|448402498|FG000|Overall Study|Administrative|151|||
124666617|NCT01135524|448402498|FG000|Overall Study|Lack of Efficacy|8|||
124666618|NCT03318003|448402499|FG000|Overall Study|Withdrawal by Subject|1|||
124666619|NCT03318003|448402500|FG001|Overall Study|Withdrawal by Subject|1|||
124666620|NCT03318003|448402499|FG000|Overall Study|fetal loss|0|||
124666621|NCT03318003|448402500|FG001|Overall Study|fetal loss|1|||
124666622|NCT02907463|448402501|FG000|Overall Study|Lost to Follow-up|17|||
124666623|NCT02907463|448402501|FG000|Overall Study|Death|10|||
124666624|NCT02907463|448402501|FG000|Overall Study|Withdrawal by Subject|4|||
124666625|NCT02907463|448402501|FG000|Overall Study|MIS Approach was not used|2|||
124666626|NCT02907463|448402501|FG000|Overall Study|Not Implanted with Study Device|2|||
124666627|NCT02907463|448402501|FG000|Overall Study|Device Explanted|1|||
124666628|NCT02907463|448402501|FG000|Overall Study|Missing Exit Form|1|||
124666629|NCT02427841|448402502|FG000|Overall Study|Lack of Efficacy|5|||
124666630|NCT02427841|448402502|FG000|Overall Study|Physician Decision|2|||
124666631|NCT02427841|448402502|FG000|Overall Study|Withdrawal by Subject|1|||
124666632|NCT00511810|448402503|FG000|Overall Study|Lost to Follow-up|1|||
124666633|NCT00511810|448402504|FG001|Overall Study|Lost to Follow-up|2|||
124666634|NCT00511810|448402503|FG000|Overall Study|Lack of Efficacy|0|||
124666635|NCT00511810|448402504|FG001|Overall Study|Lack of Efficacy|2|||
124666636|NCT00511810|448402503|FG000|Overall Study|Refused second scn|0|||
124666637|NCT00511810|448402504|FG001|Overall Study|Refused second scn|1|||
124666638|NCT02896569|448402505|FG000|Overall Study|Lost to Follow-up|2|||
124666639|NCT02896569|448402506|FG001|Overall Study|Lost to Follow-up|1|||
124666640|NCT02896569|448402505|FG000|Overall Study|Physician Decision|1|||
124666641|NCT02896569|448402506|FG001|Overall Study|Physician Decision|3|||
124666642|NCT02896569|448402505|FG000|Overall Study|Adverse Event|0|||
124666643|NCT02896569|448402506|FG001|Overall Study|Adverse Event|1|||
124666644|NCT02896569|448402505|FG000|Overall Study|Withdrawal by Subject|1|||
124666645|NCT02896569|448402506|FG001|Overall Study|Withdrawal by Subject|0|||
124666646|NCT00618826|448402510|FG000|Overall Study|Adverse Event|1|||
124666647|NCT01509664|448402512|FG000|Overall Study|Lost to Follow-up|15|||
124666648|NCT01509664|448402513|FG001|Overall Study|Lost to Follow-up|21|||
124666649|NCT00426764|448402518|FG000|Overall Study|Protocol Violation|1|||
124666650|NCT00426764|448402518|FG000|Overall Study|Withdrawal by Subject|4|||
124666651|NCT00426764|448402518|FG000|Overall Study|Physician Decision|6|||
124666652|NCT00426764|448402518|FG000|Overall Study|Compassionate Use|1|||
124666653|NCT00426764|448402518|FG000|Overall Study|Progressive Disease|83|||
124666654|NCT00426764|448402518|FG000|Overall Study|Adverse Event|24|||
124666655|NCT00426764|448402518|FG000|Overall Study|Other|1|||
124666656|NCT00426764|448402518|FG000|Overall Study|Death|1|||
124666657|NCT00426764|448402518|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
124666658|NCT05225389|448402519|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
124666659|NCT03804268|448402520|FG000|Overall Study|Adverse Event|2|||
124666660|NCT03804268|448402521|FG001|Overall Study|Adverse Event|2|||
124666661|NCT03804268|448402520|FG000|Overall Study|Withdrawal by Subject|2|||
124666662|NCT03804268|448402521|FG001|Overall Study|Withdrawal by Subject|0|||
124666663|NCT03804268|448402520|FG000|Overall Study|Lost to Follow-up|1|||
124666664|NCT03804268|448402521|FG001|Overall Study|Lost to Follow-up|0|||
124666665|NCT03804268|448402520|FG000|Overall Study|Physician Decision|2|||
124666666|NCT03804268|448402521|FG001|Overall Study|Physician Decision|0|||
124666667|NCT01737879|448402522|FG000|Overall Study|Death|1|||
124666668|NCT01737879|448402522|FG000|Overall Study|Sponsor decision|40|||
124666669|NCT01843803|448402523|FG000|Overall Study|not a Veteran, did not see provider|1|||
124666670|NCT01843803|448402524|FG001|Overall Study|not a Veteran, did not see provider|3|||
124666671|NCT05285787|448402525|FG000|Overall Study|Withdrawal by Subject|1|||
124666672|NCT02360280|448402529|FG000|Overall Study|Withdrawal by Subject|2|||
124666673|NCT02360280|448402530|FG001|Overall Study|Withdrawal by Subject|0|||
124666674|NCT02360280|448402529|FG000|Overall Study|Adverse Event|0|||
124666675|NCT02360280|448402530|FG001|Overall Study|Adverse Event|1|||
124666676|NCT02360280|448402529|FG000|Overall Study|Lost to Follow-up|1|||
124666677|NCT02360280|448402530|FG001|Overall Study|Lost to Follow-up|0|||
124666678|NCT02472886|448402531|FG000|Overall Study|Lack of Efficacy|0|||
124666679|NCT02472886|448402532|FG001|Overall Study|Lack of Efficacy|2|||
124666680|NCT02472886|448402533|FG002|Overall Study|Lack of Efficacy|1|||
124666681|NCT00320788|448402534|FG000|Overall Study|Adverse Event|0|||
124666682|NCT00320788|448402535|FG001|Overall Study|Adverse Event|0|||
124666683|NCT00320788|448402536|FG002|Overall Study|Adverse Event|0|||
124666684|NCT00320788|448402537|FG003|Overall Study|Adverse Event|1|||
124666685|NCT00320788|448402538|FG004|Overall Study|Adverse Event|0|||
124666686|NCT00320788|448402534|FG000|Overall Study|Death|0|||
124666687|NCT00320788|448402535|FG001|Overall Study|Death|0|||
124666688|NCT00320788|448402536|FG002|Overall Study|Death|1|||
124666689|NCT00320788|448402537|FG003|Overall Study|Death|0|||
124666690|NCT00320788|448402538|FG004|Overall Study|Death|1|||
124666691|NCT00320788|448402534|FG000|Overall Study|Lost to Follow-up|0|||
124666692|NCT00320788|448402535|FG001|Overall Study|Lost to Follow-up|2|||
124666693|NCT00320788|448402536|FG002|Overall Study|Lost to Follow-up|1|||
124666694|NCT00320788|448402537|FG003|Overall Study|Lost to Follow-up|0|||
124666695|NCT00320788|448402538|FG004|Overall Study|Lost to Follow-up|0|||
124666696|NCT00320788|448402534|FG000|Overall Study|Decision by the Sponsor|1|||
124666697|NCT00320788|448402535|FG001|Overall Study|Decision by the Sponsor|1|||
124666698|NCT00320788|448402536|FG002|Overall Study|Decision by the Sponsor|0|||
124666699|NCT00320788|448402537|FG003|Overall Study|Decision by the Sponsor|0|||
124666700|NCT00320788|448402538|FG004|Overall Study|Decision by the Sponsor|1|||
124666701|NCT00320788|448402534|FG000|Overall Study|Other|1|||
124666702|NCT00320788|448402535|FG001|Overall Study|Other|2|||
124666703|NCT00320788|448402536|FG002|Overall Study|Other|1|||
124666704|NCT00320788|448402537|FG003|Overall Study|Other|1|||
124666705|NCT00320788|448402538|FG004|Overall Study|Other|1|||
124666706|NCT00320788|448402534|FG000|Overall Study|Physician Decision|1|||
124666707|NCT00320788|448402535|FG001|Overall Study|Physician Decision|1|||
124666708|NCT00320788|448402536|FG002|Overall Study|Physician Decision|0|||
124666709|NCT00320788|448402537|FG003|Overall Study|Physician Decision|0|||
124666710|NCT00320788|448402538|FG004|Overall Study|Physician Decision|0|||
124666711|NCT00320788|448402534|FG000|Overall Study|Protocol Violation|0|||
124666712|NCT00320788|448402535|FG001|Overall Study|Protocol Violation|0|||
124666713|NCT00320788|448402536|FG002|Overall Study|Protocol Violation|0|||
124666714|NCT00320788|448402537|FG003|Overall Study|Protocol Violation|0|||
124666715|NCT00320788|448402538|FG004|Overall Study|Protocol Violation|1|||
124666716|NCT00320788|448402534|FG000|Overall Study|Withdrawal by Subject|3|||
124666717|NCT00320788|448402535|FG001|Overall Study|Withdrawal by Subject|0|||
124666718|NCT00320788|448402536|FG002|Overall Study|Withdrawal by Subject|0|||
124666719|NCT00320788|448402537|FG003|Overall Study|Withdrawal by Subject|3|||
124666720|NCT00320788|448402538|FG004|Overall Study|Withdrawal by Subject|1|||
124666721|NCT00627926|448402539|FG000|Overall Study|Adverse Event|26|||
124666722|NCT00627926|448402540|FG001|Overall Study|Adverse Event|37|||
124666723|NCT00627926|448402541|FG002|Overall Study|Adverse Event|36|||
124666724|NCT00627926|448402539|FG000|Overall Study|Death|1|||
124666725|NCT00627926|448402540|FG001|Overall Study|Death|0|||
124666726|NCT00627926|448402541|FG002|Overall Study|Death|0|||
124666727|NCT00627926|448402539|FG000|Overall Study|Lost to Follow-up|4|||
124666728|NCT00627926|448402540|FG001|Overall Study|Lost to Follow-up|3|||
124666729|NCT00627926|448402541|FG002|Overall Study|Lost to Follow-up|4|||
124666730|NCT00627926|448402539|FG000|Overall Study|Withdrawal by Subject|2|||
124666731|NCT00627926|448402540|FG001|Overall Study|Withdrawal by Subject|1|||
124666732|NCT00627926|448402541|FG002|Overall Study|Withdrawal by Subject|0|||
124666733|NCT00627926|448402539|FG000|Overall Study|Lack of Efficacy|118|||
124666734|NCT00627926|448402540|FG001|Overall Study|Lack of Efficacy|40|||
124666735|NCT00627926|448402541|FG002|Overall Study|Lack of Efficacy|38|||
124666736|NCT00627926|448402539|FG000|Overall Study|Noncompliance/unspecified|8|||
124666737|NCT00627926|448402540|FG001|Overall Study|Noncompliance/unspecified|23|||
124666738|NCT00627926|448402541|FG002|Overall Study|Noncompliance/unspecified|17|||
124666739|NCT05216835|448402544|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
124666740|NCT05216835|448402545|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
124666741|NCT05216835|448402546|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
124666742|NCT05216835|448402547|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
124666743|NCT05216835|448402548|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
124666744|NCT05216835|448402549|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
124666745|NCT05216835|448402550|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
124666746|NCT05216835|448402551|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
124666747|NCT05216835|448402544|FG000|Overall Study|Death|0|||
124666748|NCT05216835|448402545|FG001|Overall Study|Death|0|||
124666749|NCT05216835|448402546|FG002|Overall Study|Death|0|||
124666750|NCT05216835|448402547|FG003|Overall Study|Death|1|||
124666751|NCT05216835|448402548|FG004|Overall Study|Death|1|||
124666752|NCT05216835|448402549|FG005|Overall Study|Death|1|||
124666753|NCT05216835|448402550|FG006|Overall Study|Death|1|||
124666754|NCT05216835|448402551|FG007|Overall Study|Death|1|||
124666755|NCT05216835|448402544|FG000|Overall Study|Physician Decision|0|||
124666756|NCT05216835|448402545|FG001|Overall Study|Physician Decision|0|||
124666757|NCT05216835|448402546|FG002|Overall Study|Physician Decision|0|||
124666758|NCT05216835|448402547|FG003|Overall Study|Physician Decision|0|||
124666759|NCT05216835|448402548|FG004|Overall Study|Physician Decision|0|||
124666760|NCT05216835|448402549|FG005|Overall Study|Physician Decision|1|||
124666761|NCT05216835|448402550|FG006|Overall Study|Physician Decision|1|||
124666762|NCT05216835|448402551|FG007|Overall Study|Physician Decision|0|||
124666763|NCT05216835|448402544|FG000|Overall Study|Study terminated by Sponsor|0|||
124666764|NCT05216835|448402545|FG001|Overall Study|Study terminated by Sponsor|0|||
124666765|NCT05216835|448402546|FG002|Overall Study|Study terminated by Sponsor|0|||
124666766|NCT05216835|448402547|FG003|Overall Study|Study terminated by Sponsor|0|||
124666767|NCT05216835|448402548|FG004|Overall Study|Study terminated by Sponsor|0|||
124666768|NCT05216835|448402549|FG005|Overall Study|Study terminated by Sponsor|0|||
124666769|NCT05216835|448402550|FG006|Overall Study|Study terminated by Sponsor|0|||
124666770|NCT05216835|448402551|FG007|Overall Study|Study terminated by Sponsor|1|||
124666771|NCT05216835|448402544|FG000|Overall Study|Withdrawal by Subject|1|||
124666772|NCT05216835|448402545|FG001|Overall Study|Withdrawal by Subject|0|||
124666773|NCT05216835|448402546|FG002|Overall Study|Withdrawal by Subject|1|||
124666774|NCT05216835|448402547|FG003|Overall Study|Withdrawal by Subject|0|||
124666775|NCT05216835|448402548|FG004|Overall Study|Withdrawal by Subject|1|||
124666776|NCT05216835|448402549|FG005|Overall Study|Withdrawal by Subject|0|||
124666777|NCT05216835|448402550|FG006|Overall Study|Withdrawal by Subject|0|||
124666778|NCT05216835|448402551|FG007|Overall Study|Withdrawal by Subject|1|||
124666779|NCT05216835|448402544|FG000|Overall Study|Other|0|||
124666780|NCT05216835|448402545|FG001|Overall Study|Other|1|||
124666781|NCT05216835|448402546|FG002|Overall Study|Other|0|||
124666782|NCT05216835|448402547|FG003|Overall Study|Other|0|||
124666783|NCT05216835|448402548|FG004|Overall Study|Other|0|||
124666784|NCT05216835|448402549|FG005|Overall Study|Other|0|||
124666785|NCT05216835|448402550|FG006|Overall Study|Other|0|||
124666786|NCT05216835|448402551|FG007|Overall Study|Other|0|||
124666787|NCT02797678|448402573|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
124666788|NCT02797678|448402574|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
124666789|NCT02797678|448402575|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
124666790|NCT02797678|448402576|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
124666791|NCT02797678|448402573|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
124666792|NCT02797678|448402574|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
124666793|NCT02797678|448402575|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
124666794|NCT02797678|448402576|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
124666795|NCT02797678|448402573|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
124666796|NCT02797678|448402574|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
124666797|NCT02797678|448402575|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
124666798|NCT02797678|448402576|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
124666799|NCT00753675|448402580|FG000|Overall Study|other reason|11|||
124666800|NCT00753675|448402581|FG001|Overall Study|other reason|12|||
124666801|NCT00753675|448402582|FG002|Overall Study|other reason|13|||
124666802|NCT00753675|448402580|FG000|Overall Study|Death|1|||
124666803|NCT00753675|448402581|FG001|Overall Study|Death|2|||
124666804|NCT00753675|448402582|FG002|Overall Study|Death|4|||
124666805|NCT00753675|448402580|FG000|Overall Study|Adverse Event|11|||
124666806|NCT00753675|448402581|FG001|Overall Study|Adverse Event|9|||
124666807|NCT00753675|448402582|FG002|Overall Study|Adverse Event|4|||
124666808|NCT00753675|448402580|FG000|Overall Study|Objective progression of disease|35|||
124666809|NCT00753675|448402581|FG001|Overall Study|Objective progression of disease|35|||
124666810|NCT00753675|448402582|FG002|Overall Study|Objective progression of disease|35|||
124666811|NCT00753675|448402580|FG000|Overall Study|Withdrawal by Subject|0|||
124666812|NCT00753675|448402581|FG001|Overall Study|Withdrawal by Subject|1|||
124666813|NCT00753675|448402582|FG002|Overall Study|Withdrawal by Subject|0|||
124666814|NCT00753675|448402580|FG000|Overall Study|Lost to Follow-up|1|||
124666815|NCT00753675|448402581|FG001|Overall Study|Lost to Follow-up|0|||
124666816|NCT00753675|448402582|FG002|Overall Study|Lost to Follow-up|0|||
124666817|NCT03283930|448402586|FG000|Overall Study|Scheduling conflict|8|||
124666818|NCT03283930|448402587|FG001|Overall Study|Scheduling conflict|10|||
124666819|NCT03283930|448402586|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
124666820|NCT03283930|448402587|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
124666821|NCT03283930|448402586|FG000|Overall Study|Technical software issue|2|||
124666822|NCT03283930|448402587|FG001|Overall Study|Technical software issue|2|||
124666823|NCT02686164|448402588|FG000|Overall Study|Adverse Event|1|||
124666824|NCT02686164|448402588|FG000|Overall Study|Withdrawal of consent|1|||
124666825|NCT02686164|448402588|FG000|Overall Study|Clinical progression|1|||
124666826|NCT02106351|448402592|FG000|Treatment Cycle 1|Adverse Event|2|||
124666827|NCT02106351|448402593|FG001|Treatment Cycle 1|Adverse Event|0|||
124666828|NCT02106351|448402594|FG002|Treatment Cycle 1|Adverse Event|0|||
124666829|NCT02106351|448402592|FG000|Treatment Cycle 1|Consent withdrawn|1|||
124666830|NCT02106351|448402593|FG001|Treatment Cycle 1|Consent withdrawn|0|||
124666831|NCT02106351|448402594|FG002|Treatment Cycle 1|Consent withdrawn|2|||
124666832|NCT02106351|448402592|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
124666833|NCT02106351|448402593|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
124666834|NCT02106351|448402594|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
124666835|NCT02106351|448402592|FG000|Treatment Cycle 1|Other|0|||
124666836|NCT02106351|448402593|FG001|Treatment Cycle 1|Other|3|||
124666837|NCT02106351|448402594|FG002|Treatment Cycle 1|Other|1|||
124666838|NCT02106351|448402592|FG000|Treatment Cycle 1|Randomised but not treated|1|||
124666839|NCT02106351|448402593|FG001|Treatment Cycle 1|Randomised but not treated|0|||
124666840|NCT02106351|448402594|FG002|Treatment Cycle 1|Randomised but not treated|1|||
124666841|NCT02106351|448402592|FG000|Treatment Cycle 2|Adverse Event|0|||
124666842|NCT02106351|448402593|FG001|Treatment Cycle 2|Adverse Event|2|||
124666843|NCT02106351|448402594|FG002|Treatment Cycle 2|Adverse Event|0|||
124666844|NCT02106351|448402592|FG000|Treatment Cycle 2|Consent withdrawn|0|||
124666845|NCT02106351|448402593|FG001|Treatment Cycle 2|Consent withdrawn|1|||
124666846|NCT02106351|448402594|FG002|Treatment Cycle 2|Consent withdrawn|1|||
124666847|NCT02106351|448402592|FG000|Treatment Cycle 2|Other|0|||
124666848|NCT02106351|448402593|FG001|Treatment Cycle 2|Other|2|||
124666849|NCT02106351|448402594|FG002|Treatment Cycle 2|Other|2|||
124666850|NCT02106351|448402592|FG000|Treatment Cycle 3|Adverse Event|0|||
124666851|NCT02106351|448402593|FG001|Treatment Cycle 3|Adverse Event|1|||
124666852|NCT02106351|448402594|FG002|Treatment Cycle 3|Adverse Event|0|||
124666853|NCT02106351|448402592|FG000|Treatment Cycle 3|Consent withdrawn|0|||
124666854|NCT02106351|448402593|FG001|Treatment Cycle 3|Consent withdrawn|0|||
124666855|NCT02106351|448402594|FG002|Treatment Cycle 3|Consent withdrawn|2|||
124666856|NCT02106351|448402592|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
124666857|NCT02106351|448402593|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
124666858|NCT02106351|448402594|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
124666859|NCT02106351|448402592|FG000|Treatment Cycle 3|Other|0|||
124666860|NCT02106351|448402593|FG001|Treatment Cycle 3|Other|2|||
124666861|NCT02106351|448402594|FG002|Treatment Cycle 3|Other|3|||
124666862|NCT02106351|448402592|FG000|Treatment Cycle 4|Consent withdrawn|0|||
124666863|NCT02106351|448402593|FG001|Treatment Cycle 4|Consent withdrawn|0|||
124666864|NCT02106351|448402594|FG002|Treatment Cycle 4|Consent withdrawn|2|||
124666865|NCT02106351|448402592|FG000|Treatment Cycle 4|Other|0|||
124666866|NCT02106351|448402593|FG001|Treatment Cycle 4|Other|1|||
124666867|NCT02106351|448402594|FG002|Treatment Cycle 4|Other|0|||
124666868|NCT01931397|448402595|FG000|Overall Study|Physician Decision|2|||
124666869|NCT01931397|448402595|FG000|Overall Study|Withdrawal by Subject|8|||
124666870|NCT01931397|448402595|FG000|Overall Study|moved out of state|1|||
124666871|NCT00520039|448402596|FG000|Overall Study|Exclusion criteria met at first visit|7|||
124666872|NCT00520039|448402597|FG001|Overall Study|Exclusion criteria met at first visit|5|||
124666873|NCT05176717|448402599|FG000|Overall Study|Sponsor Decision|1|||
124666874|NCT05176717|448402600|FG001|Overall Study|Sponsor Decision|2|||
124666875|NCT05176717|448402601|FG002|Overall Study|Sponsor Decision|2|||
124666876|NCT03284853|448402602|FG000|Overall Study|Adverse Event|40|||
124666877|NCT03284853|448402603|FG001|Overall Study|Adverse Event|4|||
124666878|NCT03284853|448402602|FG000|Overall Study|Withdrawal by Subject|5|||
124666879|NCT03284853|448402603|FG001|Overall Study|Withdrawal by Subject|1|||
124666880|NCT03284853|448402602|FG000|Overall Study|Lost to Follow-up|1|||
124666881|NCT03284853|448402603|FG001|Overall Study|Lost to Follow-up|0|||
124666882|NCT03284853|448402602|FG000|Overall Study|Lack of Efficacy|1|||
124666883|NCT03284853|448402603|FG001|Overall Study|Lack of Efficacy|0|||
124666884|NCT03284853|448402602|FG000|Overall Study|Disallowed Concurrent Medication|1|||
124666885|NCT03284853|448402603|FG001|Overall Study|Disallowed Concurrent Medication|1|||
124666886|NCT03284853|448402602|FG000|Overall Study|Protocol Violation|3|||
124666887|NCT03284853|448402603|FG001|Overall Study|Protocol Violation|3|||
124666888|NCT03284853|448402602|FG000|Overall Study|Death|0|||
124666889|NCT03284853|448402603|FG001|Overall Study|Death|1|||
124666890|NCT03284853|448402602|FG000|Overall Study|Other - Reason not reported in CSR|4|||
124666891|NCT03284853|448402603|FG001|Overall Study|Other - Reason not reported in CSR|3|||
124666892|NCT00765817|448402605|FG000|Overall Study|Adverse Event|13|||
124666893|NCT00765817|448402606|FG001|Overall Study|Adverse Event|1|||
124666894|NCT00765817|448402605|FG000|Overall Study|Death|0|||
124666895|NCT00765817|448402606|FG001|Overall Study|Death|1|||
124666896|NCT00765817|448402605|FG000|Overall Study|Entry criteria not met|2|||
124666897|NCT00765817|448402606|FG001|Overall Study|Entry criteria not met|2|||
124666898|NCT00765817|448402605|FG000|Overall Study|Loss of glucose control|0|||
124666899|NCT00765817|448402606|FG001|Overall Study|Loss of glucose control|2|||
124666900|NCT00765817|448402605|FG000|Overall Study|Lost to Follow-up|1|||
124666901|NCT00765817|448402606|FG001|Overall Study|Lost to Follow-up|3|||
124666902|NCT00765817|448402605|FG000|Overall Study|Physician Decision|2|||
124666903|NCT00765817|448402606|FG001|Overall Study|Physician Decision|1|||
124666904|NCT00765817|448402605|FG000|Overall Study|Protocol Violation|1|||
124666905|NCT00765817|448402606|FG001|Overall Study|Protocol Violation|1|||
124666906|NCT00765817|448402605|FG000|Overall Study|Subject decision|7|||
124666907|NCT00765817|448402606|FG001|Overall Study|Subject decision|11|||
124666908|NCT00255164|448402609|FG000|Overall Study|Adverse Event|10|||
124666909|NCT00255164|448402610|FG001|Overall Study|Adverse Event|6|||
124666910|NCT00255164|448402611|FG002|Overall Study|Adverse Event|9|||
124666911|NCT00255164|448402609|FG000|Overall Study|Lost to Follow-up|4|||
124666912|NCT00255164|448402610|FG001|Overall Study|Lost to Follow-up|3|||
124666913|NCT00255164|448402611|FG002|Overall Study|Lost to Follow-up|4|||
124666914|NCT00255164|448402609|FG000|Overall Study|Withdrawal by Subject|18|||
124666915|NCT00255164|448402610|FG001|Overall Study|Withdrawal by Subject|17|||
124666916|NCT00255164|448402611|FG002|Overall Study|Withdrawal by Subject|8|||
124666917|NCT00255164|448402609|FG000|Overall Study|Noncompliance|0|||
124666918|NCT00255164|448402610|FG001|Overall Study|Noncompliance|1|||
124666919|NCT00255164|448402611|FG002|Overall Study|Noncompliance|2|||
124666920|NCT00255164|448402609|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
124666921|NCT00255164|448402610|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
124666922|NCT00255164|448402611|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
124666923|NCT00255164|448402609|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
124666924|NCT00255164|448402610|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
124666925|NCT00255164|448402611|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
124666926|NCT00255164|448402609|FG000|Overall Study|Possible Barrett's Esophagus|1|||
124666927|NCT00255164|448402610|FG001|Overall Study|Possible Barrett's Esophagus|3|||
124666928|NCT00255164|448402611|FG002|Overall Study|Possible Barrett's Esophagus|8|||
124666929|NCT00255164|448402609|FG000|Overall Study|Esophageal Stricture|0|||
124666930|NCT00255164|448402610|FG001|Overall Study|Esophageal Stricture|0|||
124666931|NCT00255164|448402611|FG002|Overall Study|Esophageal Stricture|1|||
124666932|NCT00255164|448402609|FG000|Overall Study|Therapeutic Failure|11|||
124666933|NCT00255164|448402610|FG001|Overall Study|Therapeutic Failure|2|||
124666934|NCT00255164|448402611|FG002|Overall Study|Therapeutic Failure|3|||
124666935|NCT05219968|448402612|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
124666936|NCT05219968|448402613|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
124666937|NCT05219968|448402614|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
124666938|NCT05219968|448402615|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
124666939|NCT05219968|448402616|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
124666940|NCT05219968|448402612|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
124666941|NCT05219968|448402613|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
124666942|NCT05219968|448402614|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
124666943|NCT05219968|448402615|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
124666944|NCT05219968|448402616|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
124666945|NCT05219968|448402612|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
124666946|NCT05219968|448402613|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
124666947|NCT05219968|448402614|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
124666948|NCT05219968|448402615|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
124666949|NCT05219968|448402616|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
124666950|NCT05219968|448402612|FG000|Week 24 Treatment Period|Adverse Event|3|||
124666951|NCT05219968|448402613|FG001|Week 24 Treatment Period|Adverse Event|0|||
124666952|NCT05219968|448402614|FG002|Week 24 Treatment Period|Adverse Event|0|||
124666953|NCT05219968|448402615|FG003|Week 24 Treatment Period|Adverse Event|0|||
124666954|NCT05219968|448402616|FG004|Week 24 Treatment Period|Adverse Event|0|||
124666955|NCT05219968|448402612|FG000|Week 24 Treatment Period|Physician Decision|0|||
124666956|NCT05219968|448402613|FG001|Week 24 Treatment Period|Physician Decision|1|||
124666957|NCT05219968|448402614|FG002|Week 24 Treatment Period|Physician Decision|0|||
124666958|NCT05219968|448402615|FG003|Week 24 Treatment Period|Physician Decision|0|||
124666959|NCT05219968|448402616|FG004|Week 24 Treatment Period|Physician Decision|0|||
124666960|NCT05219968|448402612|FG000|Week 24 Treatment Period|Other, not specified|3|||
124666961|NCT05219968|448402613|FG001|Week 24 Treatment Period|Other, not specified|0|||
124666962|NCT05219968|448402614|FG002|Week 24 Treatment Period|Other, not specified|0|||
124666963|NCT05219968|448402615|FG003|Week 24 Treatment Period|Other, not specified|0|||
124666964|NCT05219968|448402616|FG004|Week 24 Treatment Period|Other, not specified|0|||
124666965|NCT05219968|448402612|FG000|Safety Extension Period|Treatment administration failure|0|||
124666966|NCT05219968|448402613|FG001|Safety Extension Period|Treatment administration failure|0|||
124666967|NCT05219968|448402614|FG002|Safety Extension Period|Treatment administration failure|0|||
124666968|NCT05219968|448402615|FG003|Safety Extension Period|Treatment administration failure|1|||
124666969|NCT05219968|448402616|FG004|Safety Extension Period|Treatment administration failure|4|||
124666970|NCT05219968|448402612|FG000|Safety Extension Period|Bilateral dislodgement|0|||
124666971|NCT05219968|448402613|FG001|Safety Extension Period|Bilateral dislodgement|0|||
124666972|NCT05219968|448402614|FG002|Safety Extension Period|Bilateral dislodgement|4|||
124666973|NCT05219968|448402615|FG003|Safety Extension Period|Bilateral dislodgement|0|||
124666974|NCT05219968|448402616|FG004|Safety Extension Period|Bilateral dislodgement|1|||
124666975|NCT05219968|448402612|FG000|Safety Extension Period|Withdrawal by Subject|0|||
124666976|NCT05219968|448402613|FG001|Safety Extension Period|Withdrawal by Subject|0|||
124666977|NCT05219968|448402614|FG002|Safety Extension Period|Withdrawal by Subject|2|||
124666978|NCT05219968|448402615|FG003|Safety Extension Period|Withdrawal by Subject|0|||
124666979|NCT05219968|448402616|FG004|Safety Extension Period|Withdrawal by Subject|4|||
124666980|NCT05219968|448402612|FG000|Safety Extension Period|Adverse Event|0|||
124666981|NCT05219968|448402613|FG001|Safety Extension Period|Adverse Event|0|||
124666982|NCT05219968|448402614|FG002|Safety Extension Period|Adverse Event|2|||
124666983|NCT05219968|448402615|FG003|Safety Extension Period|Adverse Event|1|||
124666984|NCT05219968|448402616|FG004|Safety Extension Period|Adverse Event|1|||
124666985|NCT05219968|448402612|FG000|Safety Extension Period|Lost to Follow-up|0|||
124666986|NCT05219968|448402613|FG001|Safety Extension Period|Lost to Follow-up|0|||
124666987|NCT05219968|448402614|FG002|Safety Extension Period|Lost to Follow-up|0|||
124666988|NCT05219968|448402615|FG003|Safety Extension Period|Lost to Follow-up|1|||
124666989|NCT05219968|448402616|FG004|Safety Extension Period|Lost to Follow-up|0|||
124666990|NCT04587336|448402617|FG000|Overall Study|Lost to Follow-up|1|||
124666991|NCT04587336|448402618|FG001|Overall Study|Lost to Follow-up|0|||
124666992|NCT00452439|448404277|FG000|Overall Study|Lost to Follow-up|1|||
124666993|NCT00452439|448404278|FG001|Overall Study|Lost to Follow-up|1|||
124666994|NCT00452439|448404277|FG000|Overall Study|Refused Treatment|4|||
124666995|NCT00452439|448404278|FG001|Overall Study|Refused Treatment|3|||
124666996|NCT00452439|448404277|FG000|Overall Study|Death|3|||
124666997|NCT00452439|448404278|FG001|Overall Study|Death|1|||
124666998|NCT00452439|448404277|FG000|Overall Study|Bone Marrow Transplant|0|||
124666999|NCT00452439|448404278|FG001|Overall Study|Bone Marrow Transplant|1|||
124667000|NCT00452439|448404277|FG000|Overall Study|Too Ill to Continue|0|||
124667001|NCT00452439|448404278|FG001|Overall Study|Too Ill to Continue|1|||
124667002|NCT00452439|448404277|FG000|Overall Study|Failed to achieve complete response|2|||
124667003|NCT00452439|448404278|FG001|Overall Study|Failed to achieve complete response|0|||
124667004|NCT00452439|448404277|FG000|Overall Study|Relapse|3|||
124667005|NCT00452439|448404278|FG001|Overall Study|Relapse|0|||
124667006|NCT00452439|448404277|FG000|Overall Study|Fracture|1|||
124667007|NCT00452439|448404278|FG001|Overall Study|Fracture|0|||
124667008|NCT04147247|448404285|FG000|Overall Study|Progressive disease|3|||
124667009|NCT04147247|448404286|FG001|Overall Study|Progressive disease|3|||
124667010|NCT04147247|448404287|FG002|Overall Study|Progressive disease|4|||
124667011|NCT04147247|448404288|FG003|Overall Study|Progressive disease|4|||
124667012|NCT04147247|448404289|FG004|Overall Study|Progressive disease|3|||
124667013|NCT04147247|448404285|FG000|Overall Study|Physician Decision|0|||
124667014|NCT04147247|448404286|FG001|Overall Study|Physician Decision|1|||
124667015|NCT04147247|448404287|FG002|Overall Study|Physician Decision|0|||
124667016|NCT04147247|448404288|FG003|Overall Study|Physician Decision|0|||
124667017|NCT04147247|448404289|FG004|Overall Study|Physician Decision|0|||
124667018|NCT04147247|448404285|FG000|Overall Study|Clinical Disease Progression|0|||
124667019|NCT04147247|448404286|FG001|Overall Study|Clinical Disease Progression|0|||
124667020|NCT04147247|448404287|FG002|Overall Study|Clinical Disease Progression|0|||
124667021|NCT04147247|448404288|FG003|Overall Study|Clinical Disease Progression|0|||
124667022|NCT04147247|448404289|FG004|Overall Study|Clinical Disease Progression|1|||
124667023|NCT04147247|448404285|FG000|Overall Study|Adverse Event|0|||
124667024|NCT04147247|448404286|FG001|Overall Study|Adverse Event|0|||
124667025|NCT04147247|448404287|FG002|Overall Study|Adverse Event|1|||
124667026|NCT04147247|448404288|FG003|Overall Study|Adverse Event|0|||
124667027|NCT04147247|448404289|FG004|Overall Study|Adverse Event|1|||
124667028|NCT00130689|448404290|FG000|Overall Study|Progressive Disease|29|||
124667029|NCT00130689|448404290|FG000|Overall Study|Death|1|||
124667030|NCT00130689|448404290|FG000|Overall Study|Clinical Deterioration|4|||
124667031|NCT00130689|448404290|FG000|Overall Study|Withdrawal by Subject|3|||
124667032|NCT00130689|448404290|FG000|Overall Study|Ineligible|6|||
124667033|NCT00943397|448404291|FG000|Overall Study|Adverse Event|0|||
124667034|NCT00943397|448404292|FG001|Overall Study|Adverse Event|6|||
124667035|NCT00943397|448404291|FG000|Overall Study|Lost to Follow-up|0|||
124667036|NCT00943397|448404292|FG001|Overall Study|Lost to Follow-up|4|||
124667037|NCT00943397|448404291|FG000|Overall Study|Protocol Violation|2|||
124667038|NCT00943397|448404292|FG001|Overall Study|Protocol Violation|5|||
124667039|NCT00943397|448404291|FG000|Overall Study|Withdrawal by Subject|1|||
124667040|NCT00943397|448404292|FG001|Overall Study|Withdrawal by Subject|1|||
124667041|NCT00943397|448404291|FG000|Overall Study|Site terminated and other|12|||
124667042|NCT00943397|448404292|FG001|Overall Study|Site terminated and other|56|||
124667043|NCT04878055|448404293|FG000|Overall Study|Patient transferred in another department|0|||
124667044|NCT04878055|448404294|FG001|Overall Study|Patient transferred in another department|2|||
124667045|NCT04878055|448404293|FG000|Overall Study|Physician Decision|1|||
124667046|NCT04878055|448404294|FG001|Overall Study|Physician Decision|1|||
124667047|NCT04878055|448404293|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
124667048|NCT04878055|448404294|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
124667049|NCT04878055|448404293|FG000|Overall Study|Adverse Event|12|||
124667050|NCT04878055|448404294|FG001|Overall Study|Adverse Event|7|||
124667051|NCT04878055|448404293|FG000|Overall Study|Other|5|||
124667052|NCT04878055|448404294|FG001|Overall Study|Other|0|||
124667053|NCT04878055|448404293|FG000|Overall Study|Withdrawal by Subject|7|||
124667054|NCT04878055|448404294|FG001|Overall Study|Withdrawal by Subject|3|||
124667055|NCT04878055|448404293|FG000|Overall Study|Lost to Follow-up|10|||
124667056|NCT04878055|448404294|FG001|Overall Study|Lost to Follow-up|1|||
124667057|NCT01968811|448404295|FG000|Overall Study|Protocol Violation|4|||
124667058|NCT01968811|448404295|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
124667059|NCT01254656|448404296|FG000|Overall Study|Discontinued due to termination of study|40|||
124667060|NCT01254656|448404297|FG001|Overall Study|Discontinued due to termination of study|39|||
124667061|NCT01254656|448404298|FG002|Overall Study|Discontinued due to termination of study|13|||
124667062|NCT01254656|448404296|FG000|Overall Study|Lack of Efficacy|3|||
124667063|NCT01254656|448404297|FG001|Overall Study|Lack of Efficacy|0|||
124667064|NCT01254656|448404298|FG002|Overall Study|Lack of Efficacy|0|||
124667065|NCT01254656|448404296|FG000|Overall Study|Lost to Follow-up|1|||
124667066|NCT01254656|448404297|FG001|Overall Study|Lost to Follow-up|0|||
124667067|NCT01254656|448404298|FG002|Overall Study|Lost to Follow-up|2|||
124667068|NCT01254656|448404296|FG000|Overall Study|Withdrawal by Subject|2|||
124667069|NCT01254656|448404297|FG001|Overall Study|Withdrawal by Subject|2|||
124667070|NCT01254656|448404298|FG002|Overall Study|Withdrawal by Subject|1|||
124667071|NCT01254656|448404296|FG000|Overall Study|Pregnancy|0|||
124667072|NCT01254656|448404297|FG001|Overall Study|Pregnancy|0|||
124667073|NCT01254656|448404298|FG002|Overall Study|Pregnancy|2|||
124667074|NCT01254656|448404296|FG000|Overall Study|Adverse Event|1|||
124667075|NCT01254656|448404297|FG001|Overall Study|Adverse Event|1|||
124667076|NCT01254656|448404298|FG002|Overall Study|Adverse Event|0|||
124667077|NCT01254656|448404296|FG000|Overall Study|Death|0|||
124667078|NCT01254656|448404297|FG001|Overall Study|Death|1|||
124667079|NCT01254656|448404298|FG002|Overall Study|Death|0|||
124667080|NCT02532374|448404306|FG000|Overall Study|Withdrawal by Subject|1|||
124667081|NCT02532374|448404306|FG000|Overall Study|Physician Decision|1|||
124667082|NCT02254772|448404307|FG000|Overall Study|Ineligible|1|||
124667083|NCT02254772|448404307|FG000|Overall Study|Withdrawal by Subject|1|||
124667084|NCT05225558|448404308|FG000|Overall Study|Withdrawal by Subject|4|||
124667085|NCT05225558|448404309|FG001|Overall Study|Withdrawal by Subject|3|||
124667086|NCT05225558|448404308|FG000|Overall Study|Adverse Event|1|||
124667087|NCT05225558|448404309|FG001|Overall Study|Adverse Event|0|||
124667088|NCT05225558|448404308|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
124667089|NCT05225558|448404309|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
124667090|NCT05225558|448404308|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
124667091|NCT05225558|448404309|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
124667092|NCT03006562|448404310|FG000|Overall Study|Lost to Follow-up|0|||
124667093|NCT03006562|448404311|FG001|Overall Study|Lost to Follow-up|1|||
124667094|NCT03904420|448404312|FG000|Overall Study|Study terminated|2|||
124667095|NCT03904420|448404313|FG001|Overall Study|Study terminated|2|||
124667096|NCT00716456|448404314|FG000|Overall Study|Adverse Event|0|||
124667097|NCT00716456|448404315|FG001|Overall Study|Adverse Event|2|||
124667098|NCT00716456|448404316|FG002|Overall Study|Adverse Event|0|||
124667099|NCT00447772|448404317|FG000|Overall Study|Lack of Efficacy|3|||
124667100|NCT00447772|448404317|FG000|Overall Study|Insufficient compliance|6|||
124667101|NCT00447772|448404317|FG000|Overall Study|Discontinuation of drug therapy|1|||
124667102|NCT00447772|448404317|FG000|Overall Study|Lost to Follow-up|9|||
124667103|NCT00447772|448404317|FG000|Overall Study|Withdrawal by Subject|1|||
124667104|NCT00447772|448404317|FG000|Overall Study|Unable to attend all study visits|2|||
124667105|NCT00447772|448404317|FG000|Overall Study|Adverse Event|1|||
124667106|NCT00447772|448404317|FG000|Overall Study|Patient relocated|1|||
124667107|NCT00447772|448404317|FG000|Overall Study|Incomplete documentation at visit 1|1|||
124667108|NCT00447772|448404317|FG000|Overall Study|Chemotherapy for lung cancer|1|||
124667109|NCT00447772|448404317|FG000|Overall Study|Premature re-injection required|1|||
124667110|NCT00875563|448404319|FG000|Overall Study|Death|4|||
124667111|NCT00875563|448404319|FG000|Overall Study|Withdrawal by Subject|7|||
124667112|NCT00875563|448404319|FG000|Overall Study|No long-term (3-5 year) consent|6|||
124667113|NCT00875563|448404319|FG000|Overall Study|Still be eligible for follow-up|7|||
124667114|NCT05417412|448404320|FG000|Overall Study|Lost to Follow-up|2|||
124667115|NCT02592447|448404323|FG000|Overall Study|Lost to Follow-up|1|||
124667116|NCT02592447|448404324|FG001|Overall Study|Lost to Follow-up|0|||
124667117|NCT02592447|448404323|FG000|Overall Study|Ineligible after randomization|1|||
124667118|NCT02592447|448404324|FG001|Overall Study|Ineligible after randomization|0|||
124667119|NCT02592447|448404323|FG000|Overall Study|Withdrawal by Subject|0|||
124667120|NCT02592447|448404324|FG001|Overall Study|Withdrawal by Subject|1|||
124667121|NCT01841970|448404325|FG000|Overall Study|Withdrawal by Subject|1|||
124667122|NCT01841970|448404325|FG000|Overall Study|Physician Decision|2|||
124667123|NCT01841970|448404325|FG000|Overall Study|Lost to Follow-up|8|||
124667124|NCT02849743|448404327|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
124667125|NCT02849743|448404328|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
124667126|NCT02849743|448404327|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
124667127|NCT02849743|448404328|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
124667128|NCT01048541|448404331|FG000|Overall Study|Withdrawal by Subject|1|||
124667129|NCT01048541|448404332|FG001|Overall Study|Withdrawal by Subject|0|||
124667130|NCT00627497|448404333|FG000|Overall Study|Lost to Follow-up|1|||
124667131|NCT00627497|448404334|FG001|Overall Study|Lost to Follow-up|1|||
124667132|NCT00627497|448404335|FG002|Overall Study|Lost to Follow-up|0|||
124667133|NCT00627497|448404336|FG003|Overall Study|Lost to Follow-up|0|||
124667134|NCT00922116|448404337|FG000|Overall Study|Adverse Event|4|||
124667135|NCT00922116|448404337|FG000|Overall Study|Death|1|||
124667136|NCT00922116|448404337|FG000|Overall Study|Lost to Follow-up|1|||
124667137|NCT00922116|448404337|FG000|Overall Study|Withdrawal by Subject|4|||
124667138|NCT00922116|448404337|FG000|Overall Study|Other|5|||
124667139|NCT04607135|448404338|FG000|Overall Study|Physician Decision|1|||
124667140|NCT04607135|448404338|FG000|Overall Study|Withdrawal by Subject|1|||
124667141|NCT04607135|448404338|FG000|Overall Study|Equipment not working|3|||
124667142|NCT00807885|448404339|FG000|Overall Study|Lost to Follow-up|0|||
124667143|NCT00807885|448404340|FG001|Overall Study|Lost to Follow-up|0|||
124667144|NCT00807885|448404341|FG002|Overall Study|Lost to Follow-up|0|||
124667145|NCT00807885|448404342|FG003|Overall Study|Lost to Follow-up|0|||
124667146|NCT00807885|448404343|FG004|Overall Study|Lost to Follow-up|0|||
124667147|NCT00807885|448404344|FG005|Overall Study|Lost to Follow-up|1|||
124667148|NCT00807885|448404345|FG006|Overall Study|Lost to Follow-up|0|||
124667149|NCT00807885|448404346|FG007|Overall Study|Lost to Follow-up|0|||
124667150|NCT00807885|448404347|FG008|Overall Study|Lost to Follow-up|0|||
124667151|NCT02364388|448404348|FG000|Overall Study|Protocol Violation|1|||
124667152|NCT02364388|448404348|FG000|Overall Study|Technical Failure|3|||
124667153|NCT02364388|448404348|FG000|Overall Study|No OA/US data|2|||
124667154|NCT02364388|448404348|FG000|Overall Study|No Biopsy|2|||
124667155|NCT00327717|448404349|FG000|Overall Study|Adverse Event|6|||
124667156|NCT00327717|448404350|FG001|Overall Study|Adverse Event|6|||
124667157|NCT00327717|448404349|FG000|Overall Study|Lack of Efficacy|0|||
124667158|NCT00327717|448404350|FG001|Overall Study|Lack of Efficacy|1|||
124667159|NCT00327717|448404349|FG000|Overall Study|Withdrawal by Subject|3|||
124667160|NCT00327717|448404350|FG001|Overall Study|Withdrawal by Subject|7|||
124667161|NCT00805129|448404351|FG000|Overall Study|Not treated|1|||
124667162|NCT02499120|448404354|FG000|Overall Study|Death|52|||
124667163|NCT02499120|448404355|FG001|Overall Study|Death|43|||
124667164|NCT02499120|448404354|FG000|Overall Study|Lost to Follow-up|1|||
124667165|NCT02499120|448404355|FG001|Overall Study|Lost to Follow-up|2|||
124667166|NCT02499120|448404354|FG000|Overall Study|Participant refused further follow-up|1|||
124667167|NCT02499120|448404355|FG001|Overall Study|Participant refused further follow-up|0|||
124667168|NCT02499120|448404354|FG000|Overall Study|Withdrawal by Subject|2|||
124667169|NCT02499120|448404355|FG001|Overall Study|Withdrawal by Subject|5|||
124667170|NCT02499120|448404354|FG000|Overall Study|Other|9|||
124667171|NCT02499120|448404355|FG001|Overall Study|Other|10|||
124667172|NCT00181883|448404368|FG000|Overall Study|Lack of Efficacy|2|||
124667173|NCT00181883|448404368|FG000|Overall Study|Treatment Limiting AEs|3|||
124667174|NCT00181883|448404368|FG000|Overall Study|Withdrawal by Subject|4|||
124667175|NCT00181883|448404368|FG000|Overall Study|Lost to Follow-up|1|||
124667176|NCT00101868|448404369|FG000|Overall Study|Death|10|||
124667177|NCT00101868|448404370|FG001|Overall Study|Death|10|||
124667178|NCT00101868|448404369|FG000|Overall Study|Withdrawal by Subject|8|||
124667179|NCT00101868|448404370|FG001|Overall Study|Withdrawal by Subject|9|||
124667180|NCT00101868|448404369|FG000|Overall Study|Protocol Violation|3|||
124667181|NCT00101868|448404370|FG001|Overall Study|Protocol Violation|0|||
124667182|NCT00101868|448404369|FG000|Overall Study|Lost to Follow-up|8|||
124667183|NCT00101868|448404370|FG001|Overall Study|Lost to Follow-up|13|||
124667184|NCT00069823|448404371|FG000|Overall Study|Did not have follow-up diary cards|6|||
124667185|NCT00069823|448404372|FG001|Overall Study|Did not have follow-up diary cards|3|||
124667186|NCT02329327|448404373|FG000|Overall Study|Death|78|||
124667187|NCT02329327|448404374|FG001|Overall Study|Death|0|||
124667188|NCT02329327|448404373|FG000|Overall Study|Withdrawal by Subject|3|||
124667189|NCT02329327|448404374|FG001|Overall Study|Withdrawal by Subject|0|||
124667190|NCT02329327|448404373|FG000|Overall Study|Lost to Follow-up|4|||
124667191|NCT02329327|448404374|FG001|Overall Study|Lost to Follow-up|0|||
124667192|NCT03560869|448404375|FG000|Overall Study|Withdrawal by Subject|3|||
124667193|NCT03560869|448404376|FG001|Overall Study|Withdrawal by Subject|4|||
124667194|NCT03560869|448404375|FG000|Overall Study|Screening failure|4|||
124667195|NCT03560869|448404376|FG001|Overall Study|Screening failure|4|||
124667196|NCT03560869|448404375|FG000|Overall Study|Withdrawal by PI|0|||
124667197|NCT03560869|448404376|FG001|Overall Study|Withdrawal by PI|1|||
124667198|NCT01801111|448404377|FG000|Overall Study|Adverse Event|12|||
124667199|NCT01801111|448404377|FG000|Overall Study|Death|8|||
124667200|NCT01801111|448404377|FG000|Overall Study|Physician Decision|5|||
124667201|NCT01801111|448404377|FG000|Overall Study|Other|1|||
124667202|NCT01801111|448404377|FG000|Overall Study|Withdrawal by Subject|4|||
124667203|NCT01801111|448404377|FG000|Overall Study|Study Terminated by Sponsor|27|||
124667204|NCT01801111|448404377|FG000|Overall Study|Progressive Disease|81|||
124667205|NCT01210482|448404378|FG000|Overall Study|Protocol Violation|1|||
124667206|NCT01210482|448404378|FG000|Overall Study|Case Report Forms were not collected|18|||
124667207|NCT01210482|448404378|FG000|Overall Study|Duplicated|2|||
124667208|NCT01210482|448404378|FG000|Overall Study|No Drug Administration|28|||
124667209|NCT01223937|448404379|FG000|Overall Study|Withdrawal by Subject|3|||
124667210|NCT01223937|448404380|FG001|Overall Study|Withdrawal by Subject|2|||
124667211|NCT01223937|448404379|FG000|Overall Study|Lost to Follow-up|1|||
124667212|NCT01223937|448404380|FG001|Overall Study|Lost to Follow-up|4|||
124667213|NCT01223937|448404379|FG000|Overall Study|Adverse Event|1|||
124667214|NCT01223937|448404380|FG001|Overall Study|Adverse Event|4|||
124667215|NCT01223937|448404379|FG000|Overall Study|Protocol Violation|8|||
124667216|NCT01223937|448404380|FG001|Overall Study|Protocol Violation|7|||
124667217|NCT01223937|448404379|FG000|Overall Study|Other|4|||
124667218|NCT01223937|448404380|FG001|Overall Study|Other|1|||
124667219|NCT02058589|448404382|FG000|Overall Study|Serious Adverse Event|1|||
124667220|NCT02058589|448404383|FG001|Overall Study|Serious Adverse Event|1|||
124667221|NCT02058589|448404382|FG000|Overall Study|Non-Serious Adverse Event|1|||
124667222|NCT02058589|448404383|FG001|Overall Study|Non-Serious Adverse Event|0|||
124667223|NCT02058589|448404382|FG000|Overall Study|Withdrawal by Subject|0|||
124667224|NCT02058589|448404383|FG001|Overall Study|Withdrawal by Subject|1|||
124667225|NCT02532283|448404384|FG000|Overall Study|Adverse Event|0|||
124667226|NCT02532283|448404385|FG001|Overall Study|Adverse Event|1|||
124667227|NCT02532283|448404384|FG000|Overall Study|Death|1|||
124667228|NCT02532283|448404385|FG001|Overall Study|Death|0|||
124667229|NCT02532283|448404384|FG000|Overall Study|Lost to Follow-up|0|||
124667230|NCT02532283|448404385|FG001|Overall Study|Lost to Follow-up|1|||
124667231|NCT02532283|448404384|FG000|Overall Study|Withdrawal by Subject|8|||
124667232|NCT02532283|448404385|FG001|Overall Study|Withdrawal by Subject|3|||
124667233|NCT00490971|448404386|FG000|Acute/Continuation|Adverse Event|62|||
124667234|NCT00490971|448404387|FG001|Acute/Continuation|Adverse Event|13|||
124667235|NCT00490971|448404388|FG002|Acute/Continuation|Adverse Event|0|||
124667236|NCT00490971|448404389|FG003|Acute/Continuation|Adverse Event|0|||
124667237|NCT00490971|448404390|FG004|Acute/Continuation|Adverse Event|0|||
124667238|NCT00490971|448404386|FG000|Acute/Continuation|Death|2|||
124667239|NCT00490971|448404387|FG001|Acute/Continuation|Death|0|||
124667240|NCT00490971|448404388|FG002|Acute/Continuation|Death|0|||
124667241|NCT00490971|448404389|FG003|Acute/Continuation|Death|0|||
124667242|NCT00490971|448404390|FG004|Acute/Continuation|Death|0|||
124667243|NCT00490971|448404386|FG000|Acute/Continuation|Lack of Efficacy|106|||
124667244|NCT00490971|448404387|FG001|Acute/Continuation|Lack of Efficacy|12|||
124667245|NCT00490971|448404388|FG002|Acute/Continuation|Lack of Efficacy|0|||
124667246|NCT00490971|448404389|FG003|Acute/Continuation|Lack of Efficacy|0|||
124667247|NCT00490971|448404390|FG004|Acute/Continuation|Lack of Efficacy|0|||
124667248|NCT00490971|448404386|FG000|Acute/Continuation|Lost to Follow-up|23|||
124667249|NCT00490971|448404387|FG001|Acute/Continuation|Lost to Follow-up|7|||
124667250|NCT00490971|448404388|FG002|Acute/Continuation|Lost to Follow-up|0|||
124667251|NCT00490971|448404389|FG003|Acute/Continuation|Lost to Follow-up|0|||
124667252|NCT00490971|448404390|FG004|Acute/Continuation|Lost to Follow-up|0|||
124667253|NCT00490971|448404386|FG000|Acute/Continuation|Protocol Violation|10|||
124667254|NCT00490971|448404387|FG001|Acute/Continuation|Protocol Violation|2|||
124667255|NCT00490971|448404388|FG002|Acute/Continuation|Protocol Violation|0|||
124667256|NCT00490971|448404389|FG003|Acute/Continuation|Protocol Violation|0|||
124667257|NCT00490971|448404390|FG004|Acute/Continuation|Protocol Violation|0|||
124667258|NCT00490971|448404386|FG000|Acute/Continuation|Withdrawal by Subject|92|||
124667259|NCT00490971|448404387|FG001|Acute/Continuation|Withdrawal by Subject|24|||
124667260|NCT00490971|448404388|FG002|Acute/Continuation|Withdrawal by Subject|0|||
124667261|NCT00490971|448404389|FG003|Acute/Continuation|Withdrawal by Subject|0|||
124667262|NCT00490971|448404390|FG004|Acute/Continuation|Withdrawal by Subject|0|||
124667263|NCT00490971|448404386|FG000|Acute/Continuation|Other|11|||
124667264|NCT00490971|448404387|FG001|Acute/Continuation|Other|4|||
124667265|NCT00490971|448404388|FG002|Acute/Continuation|Other|0|||
124667266|NCT00490971|448404389|FG003|Acute/Continuation|Other|0|||
124667267|NCT00490971|448404390|FG004|Acute/Continuation|Other|0|||
124667268|NCT00490971|448404386|FG000|Maintenance|Adverse Event|0|||
124667269|NCT00490971|448404387|FG001|Maintenance|Adverse Event|0|||
124667270|NCT00490971|448404388|FG002|Maintenance|Adverse Event|4|||
124667271|NCT00490971|448404389|FG003|Maintenance|Adverse Event|5|||
124667272|NCT00490971|448404390|FG004|Maintenance|Adverse Event|7|||
124667273|NCT00490971|448404386|FG000|Maintenance|Death|0|||
124667274|NCT00490971|448404387|FG001|Maintenance|Death|0|||
124667275|NCT00490971|448404388|FG002|Maintenance|Death|0|||
124667276|NCT00490971|448404389|FG003|Maintenance|Death|2|||
124667277|NCT00490971|448404390|FG004|Maintenance|Death|0|||
124667278|NCT00490971|448404386|FG000|Maintenance|Lost to Follow-up|0|||
124667279|NCT00490971|448404387|FG001|Maintenance|Lost to Follow-up|0|||
124667280|NCT00490971|448404388|FG002|Maintenance|Lost to Follow-up|5|||
124667281|NCT00490971|448404389|FG003|Maintenance|Lost to Follow-up|8|||
124667282|NCT00490971|448404390|FG004|Maintenance|Lost to Follow-up|10|||
124667283|NCT00490971|448404386|FG000|Maintenance|Pregnancy|0|||
124667284|NCT00490971|448404387|FG001|Maintenance|Pregnancy|0|||
124667285|NCT00490971|448404388|FG002|Maintenance|Pregnancy|1|||
124667286|NCT00490971|448404389|FG003|Maintenance|Pregnancy|0|||
124667287|NCT00490971|448404390|FG004|Maintenance|Pregnancy|0|||
124667288|NCT00490971|448404386|FG000|Maintenance|Protocol Violation|0|||
124667289|NCT00490971|448404387|FG001|Maintenance|Protocol Violation|0|||
124667290|NCT00490971|448404388|FG002|Maintenance|Protocol Violation|4|||
124667291|NCT00490971|448404389|FG003|Maintenance|Protocol Violation|1|||
124667292|NCT00490971|448404390|FG004|Maintenance|Protocol Violation|1|||
124667293|NCT00490971|448404386|FG000|Maintenance|Withdrawal by Subject|0|||
124667294|NCT00490971|448404387|FG001|Maintenance|Withdrawal by Subject|0|||
124667295|NCT00490971|448404388|FG002|Maintenance|Withdrawal by Subject|26|||
124667296|NCT00490971|448404389|FG003|Maintenance|Withdrawal by Subject|28|||
124667297|NCT00490971|448404390|FG004|Maintenance|Withdrawal by Subject|18|||
124667298|NCT00490971|448404386|FG000|Maintenance|Other|0|||
124667299|NCT00490971|448404387|FG001|Maintenance|Other|0|||
124667300|NCT00490971|448404388|FG002|Maintenance|Other|11|||
124667301|NCT00490971|448404389|FG003|Maintenance|Other|9|||
124667302|NCT00490971|448404390|FG004|Maintenance|Other|3|||
124667303|NCT04376515|448404393|FG000|Overall Study|Found to have been vaccinated before study start|6|||
124667304|NCT04376515|448404394|FG001|Overall Study|Found to have been vaccinated before study start|6|||
124667305|NCT01683604|448404395|FG000|Overall Study|Adverse Event|2|||
124667306|NCT01683604|448404395|FG000|Overall Study|Lack of Efficacy|1|||
124667307|NCT01683604|448404395|FG000|Overall Study|Other|2|||
124667308|NCT03430856|448404397|FG000|Overall Study|Adverse Event|0|||
124667309|NCT03430856|448404398|FG001|Overall Study|Adverse Event|1|||
124667310|NCT03430856|448404399|FG002|Overall Study|Adverse Event|0|||
124667311|NCT03430856|448404397|FG000|Overall Study|Rescue criteria|1|||
124667312|NCT03430856|448404398|FG001|Overall Study|Rescue criteria|1|||
124667313|NCT03430856|448404399|FG002|Overall Study|Rescue criteria|0|||
124667314|NCT03430856|448404397|FG000|Overall Study|Voluntary withdrawal of consent|1|||
124667315|NCT03430856|448404398|FG001|Overall Study|Voluntary withdrawal of consent|1|||
124667316|NCT03430856|448404399|FG002|Overall Study|Voluntary withdrawal of consent|1|||
124667317|NCT01949142|448404404|FG000|Overall Study|Withdrawal of consent|1|||
124667318|NCT01949142|448404405|FG001|Overall Study|Withdrawal of consent|0|||
124667319|NCT01949142|448404404|FG000|Overall Study|Lost to Follow-up|1|||
124667320|NCT01949142|448404405|FG001|Overall Study|Lost to Follow-up|1|||
124667321|NCT01949142|448404404|FG000|Overall Study|Parent changed their mind|1|||
124667322|NCT01949142|448404405|FG001|Overall Study|Parent changed their mind|0|||
124667323|NCT00565604|448404407|FG000|Overall Study|Failure to treat|2|||
124667324|NCT00565604|448404407|FG000|Overall Study|Lost to Follow-up|2|||
124667325|NCT03512353|448406431|FG000|Overall Study|Sponsor Decision|3|||
124667326|NCT03512353|448406431|FG000|Overall Study|Death|1|||
124667327|NCT01845597|448406432|FG000|Overall Study|Death|8|||
124667328|NCT01845597|448406432|FG000|Overall Study|Lost to Follow-up|22|||
124667329|NCT02581488|448406435|FG000|Overall Study|Adverse Event|6|||
124667330|NCT02581488|448406436|FG001|Overall Study|Adverse Event|7|||
124667331|NCT02581488|448406435|FG000|Overall Study|Lost to Follow-up|1|||
124667332|NCT02581488|448406436|FG001|Overall Study|Lost to Follow-up|0|||
124667333|NCT02581488|448406435|FG000|Overall Study|Withdrawal by Subject|1|||
124667334|NCT02581488|448406436|FG001|Overall Study|Withdrawal by Subject|0|||
124667335|NCT02581488|448406435|FG000|Overall Study|Non-Compliance|1|||
124667336|NCT02581488|448406436|FG001|Overall Study|Non-Compliance|0|||
124667337|NCT02581488|448406435|FG000|Overall Study|Protocol Violation|0|||
124667338|NCT02581488|448406436|FG001|Overall Study|Protocol Violation|4|||
124667339|NCT01877668|448406437|FG000|Overall Study|Death|0|||
124667340|NCT01877668|448406438|FG001|Overall Study|Death|0|||
124667341|NCT01877668|448406439|FG002|Overall Study|Death|0|||
124667342|NCT01877668|448406440|FG003|Overall Study|Death|1|||
124667343|NCT01877668|448406441|FG004|Overall Study|Death|0|||
124667344|NCT01877668|448406437|FG000|Overall Study|No longer met study criteria|1|||
124667345|NCT01877668|448406438|FG001|Overall Study|No longer met study criteria|0|||
124667346|NCT01877668|448406439|FG002|Overall Study|No longer met study criteria|1|||
124667347|NCT01877668|448406440|FG003|Overall Study|No longer met study criteria|0|||
124667348|NCT01877668|448406441|FG004|Overall Study|No longer met study criteria|0|||
124667349|NCT01877668|448406437|FG000|Overall Study|Insufficient clinical response|0|||
124667350|NCT01877668|448406438|FG001|Overall Study|Insufficient clinical response|1|||
124667351|NCT01877668|448406439|FG002|Overall Study|Insufficient clinical response|2|||
124667352|NCT01877668|448406440|FG003|Overall Study|Insufficient clinical response|2|||
124667353|NCT01877668|448406441|FG004|Overall Study|Insufficient clinical response|0|||
124667354|NCT01877668|448406437|FG000|Overall Study|Lost to Follow-up|0|||
124667355|NCT01877668|448406438|FG001|Overall Study|Lost to Follow-up|2|||
124667356|NCT01877668|448406439|FG002|Overall Study|Lost to Follow-up|1|||
124667357|NCT01877668|448406440|FG003|Overall Study|Lost to Follow-up|0|||
124667358|NCT01877668|448406441|FG004|Overall Study|Lost to Follow-up|0|||
124667359|NCT01877668|448406437|FG000|Overall Study|Withdrawal by Subject|2|||
124667360|NCT01877668|448406438|FG001|Overall Study|Withdrawal by Subject|0|||
124667361|NCT01877668|448406439|FG002|Overall Study|Withdrawal by Subject|3|||
124667362|NCT01877668|448406440|FG003|Overall Study|Withdrawal by Subject|2|||
124667363|NCT01877668|448406441|FG004|Overall Study|Withdrawal by Subject|2|||
124667364|NCT01877668|448406437|FG000|Overall Study|Other|1|||
124667365|NCT01877668|448406438|FG001|Overall Study|Other|1|||
124667366|NCT01877668|448406439|FG002|Overall Study|Other|1|||
124667367|NCT01877668|448406440|FG003|Overall Study|Other|1|||
124667368|NCT01877668|448406441|FG004|Overall Study|Other|3|||
124667369|NCT01877668|448406437|FG000|Overall Study|Protocol Violation|1|||
124667370|NCT01877668|448406438|FG001|Overall Study|Protocol Violation|1|||
124667371|NCT01877668|448406439|FG002|Overall Study|Protocol Violation|0|||
124667372|NCT01877668|448406440|FG003|Overall Study|Protocol Violation|0|||
124667373|NCT01877668|448406441|FG004|Overall Study|Protocol Violation|3|||
124667374|NCT01877668|448406437|FG000|Overall Study|Adverse event related to study drug|2|||
124667375|NCT01877668|448406438|FG001|Overall Study|Adverse event related to study drug|2|||
124667376|NCT01877668|448406439|FG002|Overall Study|Adverse event related to study drug|2|||
124667377|NCT01877668|448406440|FG003|Overall Study|Adverse event related to study drug|2|||
124667378|NCT01877668|448406441|FG004|Overall Study|Adverse event related to study drug|1|||
124667379|NCT01877668|448406437|FG000|Overall Study|Adverse event unrelated to study drug|4|||
124667380|NCT01877668|448406438|FG001|Overall Study|Adverse event unrelated to study drug|1|||
124667381|NCT01877668|448406439|FG002|Overall Study|Adverse event unrelated to study drug|2|||
124667382|NCT01877668|448406440|FG003|Overall Study|Adverse event unrelated to study drug|0|||
124667383|NCT01877668|448406441|FG004|Overall Study|Adverse event unrelated to study drug|1|||
124667384|NCT01302418|448406442|FG000|Overall Study|Protocol Violation|9|||
124667385|NCT01302418|448406442|FG000|Overall Study|Non-evaluable|9|||
124667386|NCT00377637|448406444|FG000|Induction Phase|Adverse Event|12|||
124667387|NCT00377637|448406445|FG001|Induction Phase|Adverse Event|21|||
124667388|NCT00377637|448406446|FG002|Induction Phase|Adverse Event|0|||
124667389|NCT00377637|448406447|FG003|Induction Phase|Adverse Event|0|||
124667390|NCT00377637|448406444|FG000|Induction Phase|Deterioration/serum creatinine|2|||
124667391|NCT00377637|448406445|FG001|Induction Phase|Deterioration/serum creatinine|0|||
124667392|NCT00377637|448406446|FG002|Induction Phase|Deterioration/serum creatinine|0|||
124667393|NCT00377637|448406447|FG003|Induction Phase|Deterioration/serum creatinine|0|||
124667394|NCT00377637|448406444|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
124667395|NCT00377637|448406445|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
124667396|NCT00377637|448406446|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
124667397|NCT00377637|448406447|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
124667398|NCT00377637|448406444|FG000|Induction Phase|Lost to Follow-up|2|||
124667399|NCT00377637|448406445|FG001|Induction Phase|Lost to Follow-up|1|||
124667400|NCT00377637|448406446|FG002|Induction Phase|Lost to Follow-up|0|||
124667401|NCT00377637|448406447|FG003|Induction Phase|Lost to Follow-up|0|||
124667402|NCT00377637|448406444|FG000|Induction Phase|Death|1|||
124667403|NCT00377637|448406445|FG001|Induction Phase|Death|3|||
124667404|NCT00377637|448406446|FG002|Induction Phase|Death|0|||
124667405|NCT00377637|448406447|FG003|Induction Phase|Death|0|||
124667406|NCT00377637|448406444|FG000|Induction Phase|Withdrawal by Subject|5|||
124667407|NCT00377637|448406445|FG001|Induction Phase|Withdrawal by Subject|6|||
124667408|NCT00377637|448406446|FG002|Induction Phase|Withdrawal by Subject|0|||
124667409|NCT00377637|448406447|FG003|Induction Phase|Withdrawal by Subject|0|||
124667410|NCT00377637|448406444|FG000|Induction Phase|Physician Decision|3|||
124667411|NCT00377637|448406445|FG001|Induction Phase|Physician Decision|1|||
124667412|NCT00377637|448406446|FG002|Induction Phase|Physician Decision|0|||
124667413|NCT00377637|448406447|FG003|Induction Phase|Physician Decision|0|||
124667414|NCT00377637|448406444|FG000|Induction Phase|Sponsor decision|1|||
124667415|NCT00377637|448406445|FG001|Induction Phase|Sponsor decision|2|||
124667416|NCT00377637|448406446|FG002|Induction Phase|Sponsor decision|0|||
124667417|NCT00377637|448406447|FG003|Induction Phase|Sponsor decision|0|||
124667418|NCT00377637|448406444|FG000|Induction Phase|Non-Compliance|1|||
124667419|NCT00377637|448406445|FG001|Induction Phase|Non-Compliance|0|||
124667420|NCT00377637|448406446|FG002|Induction Phase|Non-Compliance|0|||
124667421|NCT00377637|448406447|FG003|Induction Phase|Non-Compliance|0|||
124667422|NCT00377637|448406444|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
124667423|NCT00377637|448406445|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
124667424|NCT00377637|448406446|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
124667425|NCT00377637|448406447|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
124667426|NCT00377637|448406444|FG000|Maintenance Phase|Adverse Event|0|||
124667427|NCT00377637|448406445|FG001|Maintenance Phase|Adverse Event|0|||
124667428|NCT00377637|448406446|FG002|Maintenance Phase|Adverse Event|29|||
124667429|NCT00377637|448406447|FG003|Maintenance Phase|Adverse Event|43|||
124667430|NCT00377637|448406444|FG000|Maintenance Phase|Physician Decision|0|||
124667431|NCT00377637|448406445|FG001|Maintenance Phase|Physician Decision|0|||
124667432|NCT00377637|448406446|FG002|Maintenance Phase|Physician Decision|5|||
124667433|NCT00377637|448406447|FG003|Maintenance Phase|Physician Decision|4|||
124667434|NCT00377637|448406444|FG000|Maintenance Phase|Lost to Follow-up|0|||
124667435|NCT00377637|448406445|FG001|Maintenance Phase|Lost to Follow-up|0|||
124667436|NCT00377637|448406446|FG002|Maintenance Phase|Lost to Follow-up|3|||
124667437|NCT00377637|448406447|FG003|Maintenance Phase|Lost to Follow-up|1|||
124667438|NCT00377637|448406444|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124667439|NCT00377637|448406445|FG001|Maintenance Phase|Withdrawal by Subject|0|||
124667440|NCT00377637|448406446|FG002|Maintenance Phase|Withdrawal by Subject|3|||
124667441|NCT00377637|448406447|FG003|Maintenance Phase|Withdrawal by Subject|3|||
124667442|NCT00377637|448406444|FG000|Maintenance Phase|Sponsor decision|0|||
124667443|NCT00377637|448406445|FG001|Maintenance Phase|Sponsor decision|0|||
124667444|NCT00377637|448406446|FG002|Maintenance Phase|Sponsor decision|2|||
124667445|NCT00377637|448406447|FG003|Maintenance Phase|Sponsor decision|3|||
124667446|NCT00377637|448406444|FG000|Maintenance Phase|Non-compliance|0|||
124667447|NCT00377637|448406445|FG001|Maintenance Phase|Non-compliance|0|||
124667448|NCT00377637|448406446|FG002|Maintenance Phase|Non-compliance|1|||
124667449|NCT00377637|448406447|FG003|Maintenance Phase|Non-compliance|1|||
124667450|NCT00377637|448406444|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
124667451|NCT00377637|448406445|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
124667452|NCT00377637|448406446|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
124667453|NCT00377637|448406447|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
124667454|NCT00377637|448406444|FG000|Maintenance Phase|Death|0|||
124667455|NCT00377637|448406445|FG001|Maintenance Phase|Death|0|||
124667456|NCT00377637|448406446|FG002|Maintenance Phase|Death|0|||
124667457|NCT00377637|448406447|FG003|Maintenance Phase|Death|1|||
124667458|NCT01111565|448406449|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
124667459|NCT01111565|448406450|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
124667460|NCT01111565|448406451|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
124667461|NCT01111565|448406452|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
124667462|NCT01111565|448406453|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
124667463|NCT01111565|448406449|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
124667464|NCT01111565|448406450|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
124667465|NCT01111565|448406451|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
124667466|NCT01111565|448406452|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
124667467|NCT01111565|448406453|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
124667468|NCT01111565|448406449|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
124667469|NCT01111565|448406450|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
124667470|NCT01111565|448406451|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
124667471|NCT01111565|448406452|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
124667472|NCT01111565|448406453|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
124667473|NCT01111565|448406449|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
124667474|NCT01111565|448406450|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
124667475|NCT01111565|448406451|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
124667476|NCT01111565|448406452|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
124667477|NCT01111565|448406453|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
124667478|NCT01111565|448406449|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
124667479|NCT01111565|448406450|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
124667480|NCT01111565|448406451|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
124667481|NCT01111565|448406452|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
124667482|NCT01111565|448406453|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
124667483|NCT01111565|448406449|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
124667484|NCT01111565|448406450|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
124667485|NCT01111565|448406451|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
124667486|NCT01111565|448406452|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
124667487|NCT01111565|448406453|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
124667488|NCT01111565|448406449|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
124667489|NCT01111565|448406450|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
124667490|NCT01111565|448406451|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
124667491|NCT01111565|448406452|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
124667492|NCT01111565|448406453|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
124667493|NCT01111565|448406449|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
124667494|NCT01111565|448406450|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
124667495|NCT01111565|448406451|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
124667496|NCT01111565|448406452|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
124667497|NCT01111565|448406453|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
124667498|NCT01111565|448406449|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
124667499|NCT01111565|448406450|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
124667500|NCT01111565|448406451|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
124667501|NCT01111565|448406452|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
124667502|NCT01111565|448406453|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
124667503|NCT01111565|448406449|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
124667504|NCT01111565|448406450|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
124667505|NCT01111565|448406451|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
124667506|NCT01111565|448406452|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
124667507|NCT01111565|448406453|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
124667508|NCT01111565|448406449|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
124667509|NCT01111565|448406450|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
124667510|NCT01111565|448406451|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
124667511|NCT01111565|448406452|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
124667512|NCT01111565|448406453|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
124667513|NCT01111565|448406449|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
124667514|NCT01111565|448406450|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
124667515|NCT01111565|448406451|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
124667516|NCT01111565|448406452|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
124667517|NCT01111565|448406453|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
124667518|NCT00368108|448406454|FG000|Overall Study|Adverse Event|38|||
124667519|NCT00368108|448406455|FG001|Overall Study|Adverse Event|26|||
124667520|NCT00368108|448406456|FG002|Overall Study|Adverse Event|44|||
124667521|NCT00368108|448406454|FG000|Overall Study|Abnormal Laboratory Value|0|||
124667522|NCT00368108|448406455|FG001|Overall Study|Abnormal Laboratory Value|0|||
124667523|NCT00368108|448406456|FG002|Overall Study|Abnormal Laboratory Value|3|||
124667524|NCT00368108|448406454|FG000|Overall Study|Protocol Violation|5|||
124667525|NCT00368108|448406455|FG001|Overall Study|Protocol Violation|9|||
124667526|NCT00368108|448406456|FG002|Overall Study|Protocol Violation|9|||
124667527|NCT00368108|448406454|FG000|Overall Study|Withdrawal by Subject|9|||
124667528|NCT00368108|448406455|FG001|Overall Study|Withdrawal by Subject|3|||
124667529|NCT00368108|448406456|FG002|Overall Study|Withdrawal by Subject|5|||
124667530|NCT00368108|448406454|FG000|Overall Study|Lack of Efficacy|7|||
124667531|NCT00368108|448406455|FG001|Overall Study|Lack of Efficacy|8|||
124667532|NCT00368108|448406456|FG002|Overall Study|Lack of Efficacy|5|||
124667533|NCT00368108|448406454|FG000|Overall Study|Physician Decision|2|||
124667534|NCT00368108|448406455|FG001|Overall Study|Physician Decision|0|||
124667535|NCT00368108|448406456|FG002|Overall Study|Physician Decision|1|||
124667536|NCT00368108|448406454|FG000|Overall Study|Other|3|||
124667537|NCT00368108|448406455|FG001|Overall Study|Other|7|||
124667538|NCT00368108|448406456|FG002|Overall Study|Other|1|||
124667539|NCT01089127|448406479|FG000|Overall Study|Adverse Event|5|||
124667540|NCT01089127|448406480|FG001|Overall Study|Adverse Event|1|||
124667541|NCT01089127|448406481|FG002|Overall Study|Adverse Event|1|||
124667542|NCT01089127|448406482|FG003|Overall Study|Adverse Event|0|||
124667543|NCT01089127|448406483|FG004|Overall Study|Adverse Event|0|||
124667544|NCT01089127|448406484|FG005|Overall Study|Adverse Event|1|||
124667545|NCT01089127|448406479|FG000|Overall Study|Subject withdrew consent|0|||
124667546|NCT01089127|448406480|FG001|Overall Study|Subject withdrew consent|1|||
124667547|NCT01089127|448406481|FG002|Overall Study|Subject withdrew consent|1|||
124667548|NCT01089127|448406482|FG003|Overall Study|Subject withdrew consent|1|||
124667549|NCT01089127|448406483|FG004|Overall Study|Subject withdrew consent|0|||
124667550|NCT01089127|448406484|FG005|Overall Study|Subject withdrew consent|2|||
124667551|NCT01089127|448406479|FG000|Overall Study|Abnormal test procedure result(s)|2|||
124667552|NCT01089127|448406480|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124667553|NCT01089127|448406481|FG002|Overall Study|Abnormal test procedure result(s)|0|||
124667554|NCT01089127|448406482|FG003|Overall Study|Abnormal test procedure result(s)|0|||
124667555|NCT01089127|448406483|FG004|Overall Study|Abnormal test procedure result(s)|0|||
124667556|NCT01089127|448406484|FG005|Overall Study|Abnormal test procedure result(s)|0|||
124667557|NCT01089127|448406479|FG000|Overall Study|Lost to Follow-up|1|||
124667558|NCT01089127|448406480|FG001|Overall Study|Lost to Follow-up|1|||
124667559|NCT01089127|448406481|FG002|Overall Study|Lost to Follow-up|0|||
124667560|NCT01089127|448406482|FG003|Overall Study|Lost to Follow-up|0|||
124667561|NCT01089127|448406483|FG004|Overall Study|Lost to Follow-up|1|||
124667562|NCT01089127|448406484|FG005|Overall Study|Lost to Follow-up|0|||
124667563|NCT01089127|448406479|FG000|Overall Study|Protocol deviation|0|||
124667564|NCT01089127|448406480|FG001|Overall Study|Protocol deviation|1|||
124667565|NCT01089127|448406481|FG002|Overall Study|Protocol deviation|0|||
124667566|NCT01089127|448406482|FG003|Overall Study|Protocol deviation|0|||
124667567|NCT01089127|448406483|FG004|Overall Study|Protocol deviation|1|||
124667568|NCT01089127|448406484|FG005|Overall Study|Protocol deviation|0|||
124667569|NCT03200548|448406485|FG000|Overall Study|Withdrawal by Subject|5|||
124667570|NCT03200548|448406486|FG001|Overall Study|Withdrawal by Subject|11|||
124667571|NCT03200548|448406487|FG002|Overall Study|Withdrawal by Subject|7|||
124667572|NCT03200548|448406488|FG003|Overall Study|Withdrawal by Subject|6|||
124667573|NCT03257436|448406491|FG000|Overall Study|Withdrawal by Subject|76|||
124667574|NCT03257436|448406491|FG000|Overall Study|Death|19|||
124667575|NCT03874013|448406500|FG000|Overall Study|Adverse Event|0|||
124667576|NCT03874013|448406501|FG001|Overall Study|Adverse Event|1|||
124667577|NCT01096160|448406503|FG000|Overall Study|Adverse Event|0|||
124667578|NCT01096160|448406504|FG001|Overall Study|Adverse Event|0|||
124667579|NCT01096160|448406505|FG002|Overall Study|Adverse Event|1|||
124667580|NCT01096160|448406506|FG003|Overall Study|Adverse Event|0|||
124667581|NCT01096160|448406507|FG004|Overall Study|Adverse Event|0|||
124667582|NCT01096160|448406508|FG005|Overall Study|Adverse Event|0|||
124667583|NCT01096160|448406509|FG006|Overall Study|Adverse Event|0|||
124667584|NCT01096160|448406510|FG007|Overall Study|Adverse Event|0|||
124667585|NCT01096160|448406511|FG008|Overall Study|Adverse Event|0|||
124667586|NCT01096160|448406512|FG009|Overall Study|Adverse Event|1|||
124667587|NCT01096160|448406503|FG000|Overall Study|Met stopping criteria per protocol|0|||
124667588|NCT01096160|448406504|FG001|Overall Study|Met stopping criteria per protocol|0|||
124667589|NCT01096160|448406505|FG002|Overall Study|Met stopping criteria per protocol|0|||
124667590|NCT01096160|448406506|FG003|Overall Study|Met stopping criteria per protocol|0|||
124667591|NCT01096160|448406507|FG004|Overall Study|Met stopping criteria per protocol|1|||
124667592|NCT01096160|448406508|FG005|Overall Study|Met stopping criteria per protocol|0|||
124667593|NCT01096160|448406509|FG006|Overall Study|Met stopping criteria per protocol|2|||
124667594|NCT01096160|448406510|FG007|Overall Study|Met stopping criteria per protocol|0|||
124667595|NCT01096160|448406511|FG008|Overall Study|Met stopping criteria per protocol|2|||
124667596|NCT01096160|448406512|FG009|Overall Study|Met stopping criteria per protocol|0|||
124667597|NCT01610037|448406514|FG000|All Patients|Adverse Event|27|||
124667598|NCT01610037|448406515|FG001|All Patients|Adverse Event|22|||
124667599|NCT01610037|448406516|FG002|All Patients|Adverse Event|26|||
124667600|NCT01610037|448406514|FG000|All Patients|Withdrawal by Subject|12|||
124667601|NCT01610037|448406515|FG001|All Patients|Withdrawal by Subject|10|||
124667602|NCT01610037|448406516|FG002|All Patients|Withdrawal by Subject|20|||
124667603|NCT01610037|448406514|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
124667604|NCT01610037|448406515|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
124667605|NCT01610037|448406516|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
124667606|NCT01610037|448406514|FG000|All Patients|Death|4|||
124667607|NCT01610037|448406515|FG001|All Patients|Death|2|||
124667608|NCT01610037|448406516|FG002|All Patients|Death|1|||
124667609|NCT01610037|448406514|FG000|All Patients|Protocol deviation|4|||
124667610|NCT01610037|448406515|FG001|All Patients|Protocol deviation|3|||
124667611|NCT01610037|448406516|FG002|All Patients|Protocol deviation|3|||
124667612|NCT01610037|448406514|FG000|All Patients|Abnormal laboratory value|1|||
124667613|NCT01610037|448406515|FG001|All Patients|Abnormal laboratory value|1|||
124667614|NCT01610037|448406516|FG002|All Patients|Abnormal laboratory value|0|||
124667615|NCT01610037|448406514|FG000|All Patients|Administrative problems|1|||
124667616|NCT01610037|448406515|FG001|All Patients|Administrative problems|4|||
124667617|NCT01610037|448406516|FG002|All Patients|Administrative problems|4|||
124667618|NCT01610037|448406514|FG000|All Patients|Lost to Follow-up|1|||
124667619|NCT01610037|448406515|FG001|All Patients|Lost to Follow-up|0|||
124667620|NCT01610037|448406516|FG002|All Patients|Lost to Follow-up|0|||
124667621|NCT01610037|448406514|FG000|All Patients|Abnormal test procedure result(s)|0|||
124667622|NCT01610037|448406515|FG001|All Patients|Abnormal test procedure result(s)|1|||
124667623|NCT01610037|448406516|FG002|All Patients|Abnormal test procedure result(s)|3|||
124667624|NCT01610037|448406514|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
124667625|NCT01610037|448406515|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
124667626|NCT01610037|448406516|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
124667627|NCT01610037|448406514|FG000|Treatment and Follow up Period|Death|10|||
124667628|NCT01610037|448406515|FG001|Treatment and Follow up Period|Death|5|||
124667629|NCT01610037|448406516|FG002|Treatment and Follow up Period|Death|4|||
124667630|NCT01610037|448406514|FG000|Treatment and Follow up Period|Administrative problems|1|||
124667631|NCT01610037|448406515|FG001|Treatment and Follow up Period|Administrative problems|3|||
124667632|NCT01610037|448406516|FG002|Treatment and Follow up Period|Administrative problems|2|||
124667633|NCT01610037|448406514|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
124667634|NCT01610037|448406515|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
124667635|NCT01610037|448406516|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
124667636|NCT00705757|448406517|FG000|Overall Study|Lack of Efficacy|5|||
124667637|NCT00705757|448406518|FG001|Overall Study|Lack of Efficacy|1|||
124667638|NCT00705757|448406519|FG002|Overall Study|Lack of Efficacy|3|||
124667639|NCT00705757|448406517|FG000|Overall Study|Lost to Follow-up|7|||
124667640|NCT00705757|448406518|FG001|Overall Study|Lost to Follow-up|6|||
124667641|NCT00705757|448406519|FG002|Overall Study|Lost to Follow-up|6|||
124667642|NCT00705757|448406517|FG000|Overall Study|Withdrawal by Subject|1|||
124667643|NCT00705757|448406518|FG001|Overall Study|Withdrawal by Subject|1|||
124667644|NCT00705757|448406519|FG002|Overall Study|Withdrawal by Subject|2|||
124667645|NCT06060496|448406520|FG000|Overall Study|Withdrawal by Subject|2|||
124667646|NCT06060496|448406520|FG000|Overall Study|Lost to Follow-up|2|||
124667647|NCT03990051|448406521|FG000|Masked Period|Lost to Follow-up|1|||
124667648|NCT03990051|448406522|FG001|Masked Period|Lost to Follow-up|0|||
124667649|NCT03990051|448406521|FG000|Long Term Period|Death|1|||
124667650|NCT03990051|448406522|FG001|Long Term Period|Death|1|||
124667651|NCT03990051|448406521|FG000|Long Term Period|Lost to Follow-up|7|||
124667652|NCT03990051|448406522|FG001|Long Term Period|Lost to Follow-up|2|||
124667653|NCT01411852|448406523|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
124667654|NCT01411852|448406524|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
124667655|NCT01411852|448406523|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
124667656|NCT01411852|448406524|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
124667657|NCT01411852|448406523|FG000|Prehospital Intervention Phase|Found to be under age|0|||
124667658|NCT01411852|448406524|FG001|Prehospital Intervention Phase|Found to be under age|1|||
124667659|NCT01411852|448406523|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
124667660|NCT01411852|448406524|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
124667661|NCT01411852|448406523|FG000|Hospital Intervention Phase|Severe head injury|5|||
124667662|NCT01411852|448406524|FG001|Hospital Intervention Phase|Severe head injury|4|||
124667663|NCT01411852|448406523|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
124667664|NCT01411852|448406524|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
124667665|NCT01411852|448406523|FG000|Hospital Intervention Phase|Miscommunication error|1|||
124667666|NCT01411852|448406524|FG001|Hospital Intervention Phase|Miscommunication error|2|||
124667667|NCT01411852|448406523|FG000|Hospital Intervention Phase|CPR administered|3|||
124667668|NCT01411852|448406524|FG001|Hospital Intervention Phase|CPR administered|1|||
124667669|NCT01411852|448406523|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
124667670|NCT01411852|448406524|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
124667671|NCT01411852|448406523|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
124667672|NCT01411852|448406524|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
124667673|NCT01411852|448406523|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
124667674|NCT01411852|448406524|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
124667675|NCT01411852|448406523|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
124667676|NCT01411852|448406524|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
124667677|NCT01411852|448406523|FG000|Hospital Intervention Phase|Other ineligible|2|||
124667678|NCT01411852|448406524|FG001|Hospital Intervention Phase|Other ineligible|2|||
124667679|NCT01411852|448406523|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
124667680|NCT01411852|448406524|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
124667681|NCT01411852|448406523|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
124667682|NCT01411852|448406524|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
124667683|NCT01411852|448406523|FG000|Hospital Intervention Phase|Vascular access failed|1|||
124667684|NCT01411852|448406524|FG001|Hospital Intervention Phase|Vascular access failed|0|||
124667685|NCT03193047|448406525|FG000|Overall Study|Physician Decision|1|||
124667686|NCT03193047|448406526|FG001|Overall Study|Physician Decision|0|||
124667687|NCT03193047|448406525|FG000|Overall Study|Participant Left State|1|||
124667688|NCT03193047|448406526|FG001|Overall Study|Participant Left State|0|||
124667689|NCT03743025|448406529|FG000|Overall Study|Surgery was cancelled|2|||
124667690|NCT03743025|448406530|FG001|Overall Study|Surgery was cancelled|1|||
124667691|NCT02420119|448406533|FG000|Overall Study|insufficient laboratory data|5|||
124667692|NCT00149396|448406534|FG000|Overall Study|Death|15|||
124667693|NCT00149396|448406534|FG000|Overall Study|Withdrawal by Subject|1|||
124667694|NCT00149396|448406534|FG000|Overall Study|Subject noncompliance|2|||
124667695|NCT00149396|448406534|FG000|Overall Study|other treatment|5|||
124667696|NCT00186485|448406537|FG000|Overall Study|Lost to Follow-up|3|||
124667697|NCT03126786|448406538|FG000|Overall Study|Adverse Event|3|||
124667698|NCT03126786|448406539|FG001|Overall Study|Adverse Event|0|||
124667699|NCT03126786|448406538|FG000|Overall Study|Lost to Follow-up|0|||
124667700|NCT03126786|448406539|FG001|Overall Study|Lost to Follow-up|1|||
124667701|NCT03126786|448406538|FG000|Overall Study|Withdrawal by Subject|3|||
124667702|NCT03126786|448406539|FG001|Overall Study|Withdrawal by Subject|1|||
124667703|NCT00991289|448406540|FG000|Overall Study|Adverse Event|1|||
124667704|NCT00991289|448406540|FG000|Overall Study|Physician Decision|2|||
124667705|NCT00991289|448406540|FG000|Overall Study|Withdrawal by Subject|3|||
124667706|NCT00991289|448406540|FG000|Overall Study|Lost to Follow-up|4|||
124667707|NCT00991289|448406540|FG000|Overall Study|Protocol Violation|2|||
124667708|NCT00227539|448406543|FG000|Overall Study|Protocol Violation|1|||
124667709|NCT00379899|448406544|FG000|Overall Study|Adverse Event|7|||
124667710|NCT00379899|448406545|FG001|Overall Study|Adverse Event|3|||
124667711|NCT00379899|448406544|FG000|Overall Study|Death|10|||
124667712|NCT00379899|448406545|FG001|Overall Study|Death|10|||
124667713|NCT00379899|448406544|FG000|Overall Study|Lost to Follow-up|2|||
124667714|NCT00379899|448406545|FG001|Overall Study|Lost to Follow-up|4|||
124667715|NCT00379899|448406544|FG000|Overall Study|Physician Decision|3|||
124667716|NCT00379899|448406545|FG001|Overall Study|Physician Decision|4|||
124667717|NCT00379899|448406544|FG000|Overall Study|Withdrawal by Subject|5|||
124667718|NCT00379899|448406545|FG001|Overall Study|Withdrawal by Subject|5|||
124667719|NCT00379899|448406544|FG000|Overall Study|Ineligibility determined|0|||
124667720|NCT00379899|448406545|FG001|Overall Study|Ineligibility determined|1|||
124667721|NCT00379899|448406544|FG000|Overall Study|Noncompliance|1|||
124667722|NCT00379899|448406545|FG001|Overall Study|Noncompliance|1|||
124667723|NCT00379899|448406544|FG000|Overall Study|Parathyroidectomy|0|||
124667724|NCT00379899|448406545|FG001|Overall Study|Parathyroidectomy|2|||
124667725|NCT00379899|448406544|FG000|Overall Study|Renal transplantation|5|||
124667726|NCT00379899|448406545|FG001|Overall Study|Renal transplantation|4|||
124667727|NCT00379899|448406544|FG000|Overall Study|Coronary artery bypass graft|1|||
124667728|NCT00379899|448406545|FG001|Overall Study|Coronary artery bypass graft|1|||
124667729|NCT00379899|448406544|FG000|Overall Study|Other protocol-specified criteria|3|||
124667730|NCT00379899|448406545|FG001|Overall Study|Other protocol-specified criteria|4|||
124667731|NCT00379899|448406544|FG000|Overall Study|Other|3|||
124667732|NCT00379899|448406545|FG001|Overall Study|Other|1|||
124667733|NCT01922258|448406548|FG000|Overall Study|Lost to Follow-up|1|||
124667734|NCT01922258|448406549|FG001|Overall Study|Lost to Follow-up|1|||
124667735|NCT01922258|448406548|FG000|Overall Study|Adverse Event|9|||
124667736|NCT01922258|448406549|FG001|Overall Study|Adverse Event|2|||
124667737|NCT01922258|448406548|FG000|Overall Study|Met Withdrawal Criteria|0|||
124667738|NCT01922258|448406549|FG001|Overall Study|Met Withdrawal Criteria|4|||
124667739|NCT01922258|448406548|FG000|Overall Study|Withdrawn by the Investigator|1|||
124667740|NCT01922258|448406549|FG001|Overall Study|Withdrawn by the Investigator|4|||
124667741|NCT01922258|448406548|FG000|Overall Study|Withdrawal by participant|5|||
124667742|NCT01922258|448406549|FG001|Overall Study|Withdrawal by participant|5|||
124667743|NCT00673257|448406550|FG000|Overall Study|Withdrawal by Subject|4|||
124667744|NCT00673257|448406550|FG000|Overall Study|Unable to obtain specimen|1|||
124667745|NCT04552132|448406551|FG000|Overall Study|Lost to Follow-up|4|||
124667746|NCT04552132|448406552|FG001|Overall Study|Lost to Follow-up|3|||
124667747|NCT04552132|448406551|FG000|Overall Study|Protocol Violation|1|||
124667748|NCT04552132|448406552|FG001|Overall Study|Protocol Violation|0|||
124667749|NCT02716779|448406553|FG000|Monotherapy|Adverse Event|0|||
124667750|NCT02716779|448406554|FG001|Monotherapy|Adverse Event|1|||
124667751|NCT02716779|448406555|FG002|Monotherapy|Adverse Event|1|||
124667752|NCT02716779|448406553|FG000|Combination Therapy|Adverse Event|0|||
124667753|NCT02716779|448406554|FG001|Combination Therapy|Adverse Event|2|||
124667754|NCT02716779|448406555|FG002|Combination Therapy|Adverse Event|1|||
124667755|NCT01951417|448406570|FG000|Overall Study|Withdrawal by Subject|1|||
124667756|NCT01951417|448406570|FG000|Overall Study|Protocol Violation|2|||
124667757|NCT01951417|448406570|FG000|Overall Study|Lost to Follow-up|6|||
124667758|NCT01051817|448406580|FG000|Overall Study|Adverse Event|0|||
124667759|NCT01051817|448406581|FG001|Overall Study|Adverse Event|2|||
124667760|NCT01051817|448406580|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
124667761|NCT01051817|448406581|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
124667762|NCT01051817|448406580|FG000|Overall Study|Withdrawal by Subject|3|||
124667763|NCT01051817|448406581|FG001|Overall Study|Withdrawal by Subject|5|||
124667764|NCT01051817|448406580|FG000|Overall Study|Protocol Violation|0|||
124667765|NCT01051817|448406581|FG001|Overall Study|Protocol Violation|1|||
124667766|NCT01026948|448406582|FG000|Overall Study|Physician Decision|8|||
124667767|NCT00096538|448406585|FG000|Overall Study|Withdrawal by Subject|1|||
124667768|NCT02824627|448406586|FG000|Overall Study|Adverse Event|1|||
124667769|NCT02824627|448406587|FG001|Overall Study|Adverse Event|2|||
124667770|NCT02824627|448406586|FG000|Overall Study|Lost to Follow-up|2|||
124667771|NCT02824627|448406587|FG001|Overall Study|Lost to Follow-up|1|||
124667772|NCT00672633|448406588|FG000|Overall Study|Withdrawal by Subject|0|||
124667773|NCT00672633|448406589|FG001|Overall Study|Withdrawal by Subject|1|||
124667774|NCT01938846|448406590|FG000|Overall Study|Progressive disease|26|||
124667775|NCT01938846|448406591|FG001|Overall Study|Progressive disease|18|||
124667776|NCT01938846|448406592|FG002|Overall Study|Progressive disease|16|||
124667777|NCT01938846|448406590|FG000|Overall Study|Adverse Event|8|||
124667778|NCT01938846|448406591|FG001|Overall Study|Adverse Event|4|||
124667779|NCT01938846|448406592|FG002|Overall Study|Adverse Event|3|||
124667780|NCT01938846|448406590|FG000|Overall Study|Withdrawal by Subject|2|||
124667781|NCT01938846|448406591|FG001|Overall Study|Withdrawal by Subject|2|||
124667782|NCT01938846|448406592|FG002|Overall Study|Withdrawal by Subject|1|||
124667783|NCT01938846|448406590|FG000|Overall Study|Other than listed|5|||
124667784|NCT01938846|448406591|FG001|Overall Study|Other than listed|1|||
124667785|NCT01938846|448406592|FG002|Overall Study|Other than listed|4|||
124667786|NCT02324361|448406600|FG000|Overall Study|Lost to Follow-up|5|||
124667787|NCT02324361|448406601|FG001|Overall Study|Lost to Follow-up|2|||
124667788|NCT00571662|448406604|FG000|Overall Study|Withdrawal by Subject|2|||
124667789|NCT00571662|448406604|FG000|Overall Study|psychiatric instability|1|||
124667790|NCT00571662|448406604|FG000|Overall Study|Adverse Event|5|||
124667791|NCT01839916|448406606|FG000|Overall Study|Death|9|||
124667792|NCT01839916|448406606|FG000|Overall Study|Physician Decision|17|||
124667793|NCT01839916|448406606|FG000|Overall Study|Relapse|12|||
124667794|NCT01839916|448406606|FG000|Overall Study|GVHD|2|||
124667795|NCT01839916|448406606|FG000|Overall Study|Graft Failure|1|||
124667796|NCT04235504|448406609|FG000|Study Phase|Withdrawal by Subject|5|||
124667797|NCT04235504|448406610|FG001|Study Phase|Withdrawal by Subject|2|||
124667798|NCT04235504|448406611|FG002|Study Phase|Withdrawal by Subject|0|||
124667799|NCT04235504|448406612|FG003|Study Phase|Withdrawal by Subject|0|||
124667800|NCT04235504|448406609|FG000|Continuation Phase|Withdrawal by Subject|0|||
124667801|NCT04235504|448406610|FG001|Continuation Phase|Withdrawal by Subject|4|||
124667802|NCT04235504|448406611|FG002|Continuation Phase|Withdrawal by Subject|0|||
124667803|NCT04235504|448406612|FG003|Continuation Phase|Withdrawal by Subject|0|||
124667804|NCT04235504|448406609|FG000|Continuation Phase|Adverse Event|0|||
124667805|NCT04235504|448406610|FG001|Continuation Phase|Adverse Event|1|||
124667806|NCT04235504|448406611|FG002|Continuation Phase|Adverse Event|0|||
124667807|NCT04235504|448406612|FG003|Continuation Phase|Adverse Event|0|||
124667808|NCT04235504|448406609|FG000|Continuation Phase|Physician Decision|1|||
124667809|NCT04235504|448406610|FG001|Continuation Phase|Physician Decision|2|||
124667810|NCT04235504|448406611|FG002|Continuation Phase|Physician Decision|1|||
124667811|NCT04235504|448406612|FG003|Continuation Phase|Physician Decision|0|||
124667812|NCT02143024|448406615|FG000|Overall Study|Lost to Follow-up|1|||
124667813|NCT02143024|448406616|FG001|Overall Study|Lost to Follow-up|1|||
124667814|NCT02143024|448406615|FG000|Overall Study|Withdrawal by Subject|1|||
124667815|NCT02143024|448406616|FG001|Overall Study|Withdrawal by Subject|0|||
124667816|NCT01945944|448406617|FG000|Overall Study|Adverse Event|0|||
124667817|NCT01945944|448406618|FG001|Overall Study|Adverse Event|2|||
124667818|NCT01945944|448406617|FG000|Overall Study|Physician Decision|1|||
124667819|NCT01945944|448406618|FG001|Overall Study|Physician Decision|0|||
124667820|NCT01945944|448406617|FG000|Overall Study|Withdrawal by Subject|0|||
124667821|NCT01945944|448406618|FG001|Overall Study|Withdrawal by Subject|1|||
124667822|NCT01395810|448406625|FG000|Overall Study|Adverse Event|0|||
124667823|NCT01395810|448406626|FG001|Overall Study|Adverse Event|1|||
124667824|NCT01395810|448406627|FG002|Overall Study|Adverse Event|0|||
124667825|NCT01395810|448406628|FG003|Overall Study|Adverse Event|0|||
124667826|NCT01395810|448406625|FG000|Overall Study|Lack of Efficacy|0|||
124667827|NCT01395810|448406626|FG001|Overall Study|Lack of Efficacy|1|||
124667828|NCT01395810|448406627|FG002|Overall Study|Lack of Efficacy|0|||
124667829|NCT01395810|448406628|FG003|Overall Study|Lack of Efficacy|0|||
124667830|NCT01395810|448406625|FG000|Overall Study|Withdrawal criteria|0|||
124667831|NCT01395810|448406626|FG001|Overall Study|Withdrawal criteria|2|||
124667832|NCT01395810|448406627|FG002|Overall Study|Withdrawal criteria|0|||
124667833|NCT01395810|448406628|FG003|Overall Study|Withdrawal criteria|0|||
124667834|NCT01395810|448406625|FG000|Overall Study|Unclassified|2|||
124667835|NCT01395810|448406626|FG001|Overall Study|Unclassified|0|||
124667836|NCT01395810|448406627|FG002|Overall Study|Unclassified|0|||
124667837|NCT01395810|448406628|FG003|Overall Study|Unclassified|0|||
124667838|NCT04265261|448406632|FG000|Overall Study|Adverse Event|2|||
124667839|NCT04265261|448406633|FG001|Overall Study|Adverse Event|0|||
124667840|NCT04265261|448406634|FG002|Overall Study|Adverse Event|0|||
124667841|NCT04265261|448406632|FG000|Overall Study|Death|1|||
124667842|NCT04265261|448406633|FG001|Overall Study|Death|0|||
124667843|NCT04265261|448406634|FG002|Overall Study|Death|0|||
124667844|NCT04265261|448406632|FG000|Overall Study|Lost to Follow-up|4|||
124667845|NCT04265261|448406633|FG001|Overall Study|Lost to Follow-up|1|||
124667846|NCT04265261|448406634|FG002|Overall Study|Lost to Follow-up|3|||
124667847|NCT04265261|448406632|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124667848|NCT04265261|448406633|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124667849|NCT04265261|448406634|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124667850|NCT04265261|448406632|FG000|Overall Study|Physician Decision|0|||
124667851|NCT04265261|448406633|FG001|Overall Study|Physician Decision|0|||
124667852|NCT04265261|448406634|FG002|Overall Study|Physician Decision|1|||
124667853|NCT04265261|448406632|FG000|Overall Study|Protocol Deviation|0|||
124667854|NCT04265261|448406633|FG001|Overall Study|Protocol Deviation|2|||
124667855|NCT04265261|448406634|FG002|Overall Study|Protocol Deviation|0|||
124667856|NCT04265261|448406632|FG000|Overall Study|Withdrawal by Subject|2|||
124667857|NCT04265261|448406633|FG001|Overall Study|Withdrawal by Subject|1|||
124667858|NCT04265261|448406634|FG002|Overall Study|Withdrawal by Subject|4|||
124667859|NCT00493012|448408808|FG000|Overall Study|Lost to Follow-up|18|||
124667860|NCT00493012|448408809|FG001|Overall Study|Lost to Follow-up|17|||
124667861|NCT03234036|448408813|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
124667862|NCT03234036|448408814|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
124667863|NCT03234036|448408815|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
124667864|NCT03234036|448408816|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
124667865|NCT04547140|448408819|FG000|Overall Study|Adverse Event|0|||
124667866|NCT04547140|448408820|FG001|Overall Study|Adverse Event|1|||
124667867|NCT04547140|448408819|FG000|Overall Study|Withdrawal by Subject|0|||
124667868|NCT04547140|448408820|FG001|Overall Study|Withdrawal by Subject|1|||
124667869|NCT04547140|448408819|FG000|Overall Study|Lost to Follow-up|3|||
124667870|NCT04547140|448408820|FG001|Overall Study|Lost to Follow-up|1|||
124667871|NCT04547140|448408819|FG000|Overall Study|Death|2|||
124667872|NCT04547140|448408820|FG001|Overall Study|Death|1|||
124667873|NCT04547140|448408819|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
124667874|NCT04547140|448408820|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
124667875|NCT04547140|448408819|FG000|Overall Study|Pregnancy|1|||
124667876|NCT04547140|448408820|FG001|Overall Study|Pregnancy|0|||
124667877|NCT04547140|448408819|FG000|Overall Study|Reason Not Specified|4|||
124667878|NCT04547140|448408820|FG001|Overall Study|Reason Not Specified|1|||
124667879|NCT04613739|448408821|FG000|Overall Study|Lost to Follow-up|6|||
124667880|NCT04613739|448408822|FG001|Overall Study|Lost to Follow-up|9|||
124667881|NCT04613739|448408821|FG000|Overall Study|potentially duplicative/fraudulent|1|||
124667882|NCT04613739|448408822|FG001|Overall Study|potentially duplicative/fraudulent|3|||
124667883|NCT00003537|448408823|FG000|Overall Study|Not evalauable|1|||
124667884|NCT00735943|448408830|FG000|Overall Study|Lost to Follow-up|1|||
124667885|NCT00735943|448408830|FG000|Overall Study|Adverse Event|1|||
124667886|NCT01719380|448408835|FG000|Overall Study|Adverse Event|0|||
124667887|NCT01719380|448408836|FG001|Overall Study|Adverse Event|0|||
124667888|NCT01719380|448408837|FG002|Overall Study|Adverse Event|1|||
124667889|NCT01719380|448408838|FG003|Overall Study|Adverse Event|2|||
124667890|NCT01719380|448408839|FG004|Overall Study|Adverse Event|0|||
124667891|NCT01719380|448408840|FG005|Overall Study|Adverse Event|1|||
124667892|NCT01719380|448408841|FG006|Overall Study|Adverse Event|0|||
124667893|NCT01719380|448408842|FG007|Overall Study|Adverse Event|1|||
124667894|NCT01719380|448408843|FG008|Overall Study|Adverse Event|4|||
124667895|NCT01719380|448408844|FG009|Overall Study|Adverse Event|3|||
124667896|NCT01719380|448408835|FG000|Overall Study|Death|0|||
124667897|NCT01719380|448408836|FG001|Overall Study|Death|1|||
124667898|NCT01719380|448408837|FG002|Overall Study|Death|0|||
124667899|NCT01719380|448408838|FG003|Overall Study|Death|0|||
124667900|NCT01719380|448408839|FG004|Overall Study|Death|0|||
124667901|NCT01719380|448408840|FG005|Overall Study|Death|0|||
124667902|NCT01719380|448408841|FG006|Overall Study|Death|0|||
124667903|NCT01719380|448408842|FG007|Overall Study|Death|0|||
124667904|NCT01719380|448408843|FG008|Overall Study|Death|3|||
124667905|NCT01719380|448408844|FG009|Overall Study|Death|3|||
124667906|NCT01719380|448408835|FG000|Overall Study|Participant/Guardian Decision|0|||
124667907|NCT01719380|448408836|FG001|Overall Study|Participant/Guardian Decision|0|||
124667908|NCT01719380|448408837|FG002|Overall Study|Participant/Guardian Decision|1|||
124667909|NCT01719380|448408838|FG003|Overall Study|Participant/Guardian Decision|0|||
124667910|NCT01719380|448408839|FG004|Overall Study|Participant/Guardian Decision|0|||
124667911|NCT01719380|448408840|FG005|Overall Study|Participant/Guardian Decision|0|||
124667912|NCT01719380|448408841|FG006|Overall Study|Participant/Guardian Decision|0|||
124667913|NCT01719380|448408842|FG007|Overall Study|Participant/Guardian Decision|0|||
124667914|NCT01719380|448408843|FG008|Overall Study|Participant/Guardian Decision|2|||
124667915|NCT01719380|448408844|FG009|Overall Study|Participant/Guardian Decision|2|||
124667916|NCT01719380|448408835|FG000|Overall Study|Physician Decision|0|||
124667917|NCT01719380|448408836|FG001|Overall Study|Physician Decision|0|||
124667918|NCT01719380|448408837|FG002|Overall Study|Physician Decision|2|||
124667919|NCT01719380|448408838|FG003|Overall Study|Physician Decision|0|||
124667920|NCT01719380|448408839|FG004|Overall Study|Physician Decision|0|||
124667921|NCT01719380|448408840|FG005|Overall Study|Physician Decision|0|||
124667922|NCT01719380|448408841|FG006|Overall Study|Physician Decision|0|||
124667923|NCT01719380|448408842|FG007|Overall Study|Physician Decision|0|||
124667924|NCT01719380|448408843|FG008|Overall Study|Physician Decision|1|||
124667925|NCT01719380|448408844|FG009|Overall Study|Physician Decision|1|||
124667926|NCT01719380|448408835|FG000|Overall Study|Lack of Efficacy|2|||
124667927|NCT01719380|448408836|FG001|Overall Study|Lack of Efficacy|6|||
124667928|NCT01719380|448408837|FG002|Overall Study|Lack of Efficacy|5|||
124667929|NCT01719380|448408838|FG003|Overall Study|Lack of Efficacy|6|||
124667930|NCT01719380|448408839|FG004|Overall Study|Lack of Efficacy|3|||
124667931|NCT01719380|448408840|FG005|Overall Study|Lack of Efficacy|7|||
124667932|NCT01719380|448408841|FG006|Overall Study|Lack of Efficacy|10|||
124667933|NCT01719380|448408842|FG007|Overall Study|Lack of Efficacy|6|||
124667934|NCT01719380|448408843|FG008|Overall Study|Lack of Efficacy|39|||
124667935|NCT01719380|448408844|FG009|Overall Study|Lack of Efficacy|42|||
124667936|NCT01719380|448408835|FG000|Overall Study|Progressive Disease|0|||
124667937|NCT01719380|448408836|FG001|Overall Study|Progressive Disease|0|||
124667938|NCT01719380|448408837|FG002|Overall Study|Progressive Disease|0|||
124667939|NCT01719380|448408838|FG003|Overall Study|Progressive Disease|0|||
124667940|NCT01719380|448408839|FG004|Overall Study|Progressive Disease|0|||
124667941|NCT01719380|448408840|FG005|Overall Study|Progressive Disease|0|||
124667942|NCT01719380|448408841|FG006|Overall Study|Progressive Disease|0|||
124667943|NCT01719380|448408842|FG007|Overall Study|Progressive Disease|0|||
124667944|NCT01719380|448408843|FG008|Overall Study|Progressive Disease|1|||
124667945|NCT01719380|448408844|FG009|Overall Study|Progressive Disease|0|||
124667946|NCT01064414|448408845|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
124667947|NCT01064414|448408846|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
124667948|NCT01064414|448408847|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
124667949|NCT01064414|448408845|FG000|Core Period: Baseline to Week 26|Death|0|||
124667950|NCT01064414|448408846|FG001|Core Period: Baseline to Week 26|Death|1|||
124667951|NCT01064414|448408847|FG002|Core Period: Baseline to Week 26|Death|0|||
124667952|NCT01064414|448408845|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
124667953|NCT01064414|448408846|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
124667954|NCT01064414|448408847|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
124667955|NCT01064414|448408845|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
124667956|NCT01064414|448408846|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
124667957|NCT01064414|448408847|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
124667958|NCT01064414|448408845|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
124667959|NCT01064414|448408846|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
124667960|NCT01064414|448408847|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
124667961|NCT01064414|448408845|FG000|Core Period: Baseline to Week 26|Other|4|||
124667962|NCT01064414|448408846|FG001|Core Period: Baseline to Week 26|Other|7|||
124667963|NCT01064414|448408847|FG002|Core Period: Baseline to Week 26|Other|2|||
124667964|NCT01064414|448408845|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
124667965|NCT01064414|448408846|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
124667966|NCT01064414|448408847|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
124667967|NCT01064414|448408845|FG000|Extension Period: Week 26 to Week 52|Death|0|||
124667968|NCT01064414|448408846|FG001|Extension Period: Week 26 to Week 52|Death|1|||
124667969|NCT01064414|448408847|FG002|Extension Period: Week 26 to Week 52|Death|0|||
124667970|NCT01064414|448408845|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
124667971|NCT01064414|448408846|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
124667972|NCT01064414|448408847|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
124667973|NCT01064414|448408845|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
124667974|NCT01064414|448408846|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
124667975|NCT01064414|448408847|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
124667976|NCT01064414|448408845|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
124667977|NCT01064414|448408846|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
124667978|NCT01064414|448408847|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
124667979|NCT01064414|448408845|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
124667980|NCT01064414|448408846|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
124667981|NCT01064414|448408847|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
124667982|NCT01064414|448408845|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
124667983|NCT01064414|448408846|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
124667984|NCT01064414|448408847|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
124667985|NCT01064414|448408845|FG000|Extension Period: Week 26 to Week 52|Other|5|||
124667986|NCT01064414|448408846|FG001|Extension Period: Week 26 to Week 52|Other|2|||
124667987|NCT01064414|448408847|FG002|Extension Period: Week 26 to Week 52|Other|1|||
124667988|NCT00249873|448408848|FG000|Overall Study|Not treated|7|||
124667989|NCT00249873|448408849|FG001|Overall Study|Not treated|8|||
124667990|NCT00249873|448408848|FG000|Overall Study|Significant thrombocytopenia|9|||
124667991|NCT00249873|448408849|FG001|Overall Study|Significant thrombocytopenia|8|||
124667992|NCT00249873|448408848|FG000|Overall Study|Severe allergic reaction|8|||
124667993|NCT00249873|448408849|FG001|Overall Study|Severe allergic reaction|1|||
124667994|NCT00249873|448408848|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
124667995|NCT00249873|448408849|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
124667996|NCT00249873|448408848|FG000|Overall Study|Other Serious Adverse Event|86|||
124667997|NCT00249873|448408849|FG001|Overall Study|Other Serious Adverse Event|97|||
124667998|NCT00249873|448408848|FG000|Overall Study|Qualifying condition not present|20|||
124667999|NCT00249873|448408849|FG001|Overall Study|Qualifying condition not present|23|||
124668000|NCT00249873|448408848|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
124668001|NCT00249873|448408849|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
124668002|NCT00249873|448408848|FG000|Overall Study|Withdrawal by Subject|504|||
124668003|NCT00249873|448408849|FG001|Overall Study|Withdrawal by Subject|466|||
124668004|NCT00249873|448408848|FG000|Overall Study|Lost to Follow-up|4|||
124668005|NCT00249873|448408849|FG001|Overall Study|Lost to Follow-up|7|||
124668006|NCT00249873|448408848|FG000|Overall Study|Minor bleeding|99|||
124668007|NCT00249873|448408849|FG001|Overall Study|Minor bleeding|37|||
124668008|NCT00249873|448408848|FG000|Overall Study|Non-compliance|41|||
124668009|NCT00249873|448408849|FG001|Overall Study|Non-compliance|46|||
124668010|NCT00249873|448408848|FG000|Overall Study|Other non serious Adverse Event|112|||
124668011|NCT00249873|448408849|FG001|Overall Study|Other non serious Adverse Event|108|||
124668012|NCT00249873|448408848|FG000|Overall Study|Other contraindicated medication|1|||
124668013|NCT00249873|448408849|FG001|Overall Study|Other contraindicated medication|0|||
124668014|NCT00249873|448408848|FG000|Overall Study|Patient not wish to continue after May08|3|||
124668015|NCT00249873|448408849|FG001|Overall Study|Patient not wish to continue after May08|4|||
124668016|NCT00249873|448408848|FG000|Overall Study|Physician withdrew consent|59|||
124668017|NCT00249873|448408849|FG001|Overall Study|Physician withdrew consent|60|||
124668018|NCT00249873|448408848|FG000|Overall Study|Open label clopidogrel required|31|||
124668019|NCT00249873|448408849|FG001|Overall Study|Open label clopidogrel required|42|||
124668020|NCT00249873|448408848|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
124668021|NCT00249873|448408849|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
124668022|NCT00249873|448408848|FG000|Overall Study|Oral anticoagulant required|159|||
124668023|NCT00249873|448408849|FG001|Overall Study|Oral anticoagulant required|157|||
124668024|NCT00249873|448408848|FG000|Overall Study|Study drug intolerance|5|||
124668025|NCT00249873|448408849|FG001|Overall Study|Study drug intolerance|0|||
124668026|NCT00249873|448408848|FG000|Overall Study|Surgery/ procedure|9|||
124668027|NCT00249873|448408849|FG001|Overall Study|Surgery/ procedure|9|||
124668028|NCT00249873|448408848|FG000|Overall Study|Event related to cardiac condition|12|||
124668029|NCT00249873|448408849|FG001|Overall Study|Event related to cardiac condition|21|||
124668030|NCT00249873|448408848|FG000|Overall Study|Thromboembolic/outcome event|82|||
124668031|NCT00249873|448408849|FG001|Overall Study|Thromboembolic/outcome event|122|||
124668032|NCT03286218|448408850|FG000|Qualification Phase Period 1|Adverse Event|1|||
124668033|NCT03286218|448408851|FG001|Qualification Phase Period 1|Adverse Event|0|||
124668034|NCT03286218|448408852|FG002|Qualification Phase Period 1|Adverse Event|0|||
124668035|NCT03286218|448408853|FG003|Qualification Phase Period 1|Adverse Event|0|||
124668036|NCT03286218|448408854|FG004|Qualification Phase Period 1|Adverse Event|0|||
124668037|NCT03286218|448408855|FG005|Qualification Phase Period 1|Adverse Event|0|||
124668038|NCT03286218|448408856|FG006|Qualification Phase Period 1|Adverse Event|0|||
124668039|NCT03286218|448408857|FG007|Qualification Phase Period 1|Adverse Event|0|||
124668040|NCT03286218|448408858|FG008|Qualification Phase Period 1|Adverse Event|0|||
124668041|NCT03286218|448408859|FG009|Qualification Phase Period 1|Adverse Event|0|||
124668042|NCT03286218|448408860|FG010|Qualification Phase Period 1|Adverse Event|0|||
124668043|NCT03286218|448408861|FG011|Qualification Phase Period 1|Adverse Event|0|||
124668044|NCT03286218|448408850|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
124668045|NCT03286218|448408851|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
124668046|NCT03286218|448408852|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
124668047|NCT03286218|448408853|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
124668048|NCT03286218|448408854|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
124668049|NCT03286218|448408855|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
124668050|NCT03286218|448408856|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
124668051|NCT03286218|448408857|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
124668052|NCT03286218|448408858|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
124668053|NCT03286218|448408859|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
124668054|NCT03286218|448408860|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
124668055|NCT03286218|448408861|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
124668056|NCT03286218|448408850|FG000|Qualification Phase Period 2|Adverse Event|0|||
124668057|NCT03286218|448408851|FG001|Qualification Phase Period 2|Adverse Event|1|||
124668058|NCT03286218|448408852|FG002|Qualification Phase Period 2|Adverse Event|0|||
124668059|NCT03286218|448408853|FG003|Qualification Phase Period 2|Adverse Event|0|||
124668060|NCT03286218|448408854|FG004|Qualification Phase Period 2|Adverse Event|0|||
124668061|NCT03286218|448408855|FG005|Qualification Phase Period 2|Adverse Event|0|||
124668062|NCT03286218|448408856|FG006|Qualification Phase Period 2|Adverse Event|0|||
124668063|NCT03286218|448408857|FG007|Qualification Phase Period 2|Adverse Event|0|||
124668064|NCT03286218|448408858|FG008|Qualification Phase Period 2|Adverse Event|0|||
124668065|NCT03286218|448408859|FG009|Qualification Phase Period 2|Adverse Event|0|||
124668066|NCT03286218|448408860|FG010|Qualification Phase Period 2|Adverse Event|0|||
124668067|NCT03286218|448408861|FG011|Qualification Phase Period 2|Adverse Event|0|||
124668068|NCT03286218|448408850|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
124668069|NCT03286218|448408851|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
124668070|NCT03286218|448408852|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
124668071|NCT03286218|448408853|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
124668072|NCT03286218|448408854|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
124668073|NCT03286218|448408855|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
124668074|NCT03286218|448408856|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
124668075|NCT03286218|448408857|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
124668076|NCT03286218|448408858|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
124668077|NCT03286218|448408859|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
124668078|NCT03286218|448408860|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
124668079|NCT03286218|448408861|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
124668080|NCT03286218|448408850|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
124668081|NCT03286218|448408851|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
124668082|NCT03286218|448408852|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
124668083|NCT03286218|448408853|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
124668084|NCT03286218|448408854|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
124668085|NCT03286218|448408855|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
124668086|NCT03286218|448408856|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
124668087|NCT03286218|448408857|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
124668088|NCT03286218|448408858|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
124668089|NCT03286218|448408859|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
124668090|NCT03286218|448408860|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
124668091|NCT03286218|448408861|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
124668092|NCT03286218|448408850|FG000|Qualification Phase Period 2|Protocol Violation|2|||
124668093|NCT03286218|448408851|FG001|Qualification Phase Period 2|Protocol Violation|0|||
124668094|NCT03286218|448408852|FG002|Qualification Phase Period 2|Protocol Violation|0|||
124668095|NCT03286218|448408853|FG003|Qualification Phase Period 2|Protocol Violation|0|||
124668096|NCT03286218|448408854|FG004|Qualification Phase Period 2|Protocol Violation|0|||
124668097|NCT03286218|448408855|FG005|Qualification Phase Period 2|Protocol Violation|0|||
124668098|NCT03286218|448408856|FG006|Qualification Phase Period 2|Protocol Violation|0|||
124668099|NCT03286218|448408857|FG007|Qualification Phase Period 2|Protocol Violation|0|||
124668100|NCT03286218|448408858|FG008|Qualification Phase Period 2|Protocol Violation|0|||
124668101|NCT03286218|448408859|FG009|Qualification Phase Period 2|Protocol Violation|0|||
124668102|NCT03286218|448408860|FG010|Qualification Phase Period 2|Protocol Violation|0|||
124668103|NCT03286218|448408861|FG011|Qualification Phase Period 2|Protocol Violation|0|||
124668104|NCT03286218|448408850|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
124668105|NCT03286218|448408851|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
124668106|NCT03286218|448408852|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
124668107|NCT03286218|448408853|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
124668108|NCT03286218|448408854|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
124668109|NCT03286218|448408855|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
124668110|NCT03286218|448408856|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
124668111|NCT03286218|448408857|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
124668112|NCT03286218|448408858|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
124668113|NCT03286218|448408859|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
124668114|NCT03286218|448408860|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
124668115|NCT03286218|448408861|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
124668116|NCT03286218|448408850|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
124668117|NCT03286218|448408851|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
124668118|NCT03286218|448408852|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
124668119|NCT03286218|448408853|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
124668120|NCT03286218|448408854|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
124668121|NCT03286218|448408855|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
124668122|NCT03286218|448408856|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
124668123|NCT03286218|448408857|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
124668124|NCT03286218|448408858|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
124668125|NCT03286218|448408859|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
124668126|NCT03286218|448408860|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
124668127|NCT03286218|448408861|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
124668128|NCT03286218|448408850|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
124668129|NCT03286218|448408851|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
124668130|NCT03286218|448408852|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
124668131|NCT03286218|448408853|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
124668132|NCT03286218|448408854|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
124668133|NCT03286218|448408855|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
124668134|NCT03286218|448408856|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
124668135|NCT03286218|448408857|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
124668136|NCT03286218|448408858|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
124668137|NCT03286218|448408859|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
124668138|NCT03286218|448408860|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
124668139|NCT03286218|448408861|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
124668140|NCT01348139|448408862|FG000|Period 1|Adverse Event|1|||
124668141|NCT01348139|448408863|FG001|Period 1|Adverse Event|0|||
124668142|NCT01348139|448408864|FG002|Period 1|Adverse Event|0|||
124668143|NCT01348139|448408865|FG003|Period 1|Adverse Event|0|||
124668144|NCT01348139|448408866|FG004|Period 1|Adverse Event|0|||
124668145|NCT01348139|448408867|FG005|Period 1|Adverse Event|0|||
124668146|NCT02762084|448408870|FG000|Overall Study|Withdrawal by Subject|1|||
124668147|NCT02762084|448408871|FG001|Overall Study|Withdrawal by Subject|0|||
124668148|NCT02762084|448408872|FG002|Overall Study|Withdrawal by Subject|0|||
124668149|NCT02762084|448408870|FG000|Overall Study|Adverse Event|0|||
124668150|NCT02762084|448408871|FG001|Overall Study|Adverse Event|0|||
124668151|NCT02762084|448408872|FG002|Overall Study|Adverse Event|1|||
124668152|NCT00165503|448408875|FG000|Overall Study|Death|1|||
124668153|NCT00165503|448408875|FG000|Overall Study|Lost to Follow-up|12|||
124668154|NCT00165503|448408875|FG000|Overall Study|Unresectable|3|||
124668155|NCT00643201|448408876|FG000|Randomized, Completed 6 Months of Study|Death|20|||
124668156|NCT00643201|448408877|FG001|Randomized, Completed 6 Months of Study|Death|26|||
124668157|NCT00643201|448408876|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
124668158|NCT00643201|448408877|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
124668159|NCT00643201|448408876|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
124668160|NCT00643201|448408877|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
124668161|NCT00643201|448408876|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
124668162|NCT00643201|448408877|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
124668163|NCT00643201|448408876|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
124668164|NCT00643201|448408877|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
124668165|NCT00643201|448408876|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
124668166|NCT00643201|448408877|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
124668167|NCT00643201|448408876|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
124668168|NCT00643201|448408877|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
124668169|NCT00643201|448408876|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
124668170|NCT00643201|448408877|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
124668171|NCT00643201|448408876|FG000|Randomized, Completed 6 Months of Study|Other|107|||
124668172|NCT00643201|448408877|FG001|Randomized, Completed 6 Months of Study|Other|107|||
124668173|NCT00643201|448408876|FG000|Completed Study Follow Up|Death|28|||
124668174|NCT00643201|448408877|FG001|Completed Study Follow Up|Death|34|||
124668175|NCT00643201|448408876|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
124668176|NCT00643201|448408877|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
124668177|NCT00643201|448408876|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
124668178|NCT00643201|448408877|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
124668179|NCT00643201|448408876|FG000|Completed Study Follow Up|non-specified|1|||
124668180|NCT00643201|448408877|FG001|Completed Study Follow Up|non-specified|0|||
124668181|NCT02976519|448408878|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
124668182|NCT02976519|448408879|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
124668183|NCT02976519|448408880|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
124668184|NCT02976519|448408881|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
124668185|NCT02976519|448408882|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
124668186|NCT02976519|448408883|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
124668187|NCT02976519|448408884|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
124668188|NCT02976519|448408878|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
124668189|NCT02976519|448408879|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
124668190|NCT02976519|448408880|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
124668191|NCT02976519|448408881|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
124668192|NCT02976519|448408882|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
124668193|NCT02976519|448408883|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
124668194|NCT02976519|448408884|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
124668195|NCT02976519|448408878|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
124668196|NCT02976519|448408879|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
124668197|NCT02976519|448408880|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
124668198|NCT02976519|448408881|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
124668199|NCT02976519|448408882|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
124668200|NCT02976519|448408883|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
124668201|NCT02976519|448408884|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
124668202|NCT02976519|448408878|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
124668203|NCT02976519|448408879|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
124668204|NCT02976519|448408880|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
124668205|NCT02976519|448408881|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
124668206|NCT02976519|448408882|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
124668207|NCT02976519|448408883|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
124668208|NCT02976519|448408884|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
124668209|NCT02976519|448408878|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
124668210|NCT02976519|448408879|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
124668211|NCT02976519|448408880|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
124668212|NCT02976519|448408881|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
124668213|NCT02976519|448408882|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
124668214|NCT02976519|448408883|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
124668215|NCT02976519|448408884|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
124668216|NCT02346708|448408885|FG000|Overall Study|Adverse Event|2|||
124668217|NCT02346708|448408886|FG001|Overall Study|Adverse Event|0|||
124668218|NCT02346708|448408885|FG000|Overall Study|Protocol Violation|0|||
124668219|NCT02346708|448408886|FG001|Overall Study|Protocol Violation|1|||
124668220|NCT00928434|448408889|FG000|Overall Study|Adverse Event|14|||
124668221|NCT00928434|448408890|FG001|Overall Study|Adverse Event|5|||
124668222|NCT00928434|448408891|FG002|Overall Study|Adverse Event|18|||
124668223|NCT00928434|448408889|FG000|Overall Study|Protocol Violation|5|||
124668224|NCT00928434|448408890|FG001|Overall Study|Protocol Violation|0|||
124668225|NCT00928434|448408891|FG002|Overall Study|Protocol Violation|8|||
124668226|NCT00928434|448408889|FG000|Overall Study|Physician Decision|2|||
124668227|NCT00928434|448408890|FG001|Overall Study|Physician Decision|0|||
124668228|NCT00928434|448408891|FG002|Overall Study|Physician Decision|3|||
124668229|NCT00928434|448408889|FG000|Overall Study|Lost to Follow-up|1|||
124668230|NCT00928434|448408890|FG001|Overall Study|Lost to Follow-up|0|||
124668231|NCT00928434|448408891|FG002|Overall Study|Lost to Follow-up|3|||
124668232|NCT00928434|448408889|FG000|Overall Study|Withdrawal by Subject|5|||
124668233|NCT00928434|448408890|FG001|Overall Study|Withdrawal by Subject|3|||
124668234|NCT00928434|448408891|FG002|Overall Study|Withdrawal by Subject|2|||
124668235|NCT00928434|448408889|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
124668236|NCT00928434|448408890|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
124668237|NCT00928434|448408891|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
124668238|NCT00928434|448408889|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
124668239|NCT00928434|448408890|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
124668240|NCT00928434|448408891|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
124668241|NCT00928434|448408889|FG000|Overall Study|Other (not meeting above criteria)|5|||
124668242|NCT00928434|448408890|FG001|Overall Study|Other (not meeting above criteria)|1|||
124668243|NCT00928434|448408891|FG002|Overall Study|Other (not meeting above criteria)|2|||
124668244|NCT01781962|448408892|FG000|Overall Study|Other Miscellaneous Reasons|5|||
124668245|NCT01001910|448408893|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
124668246|NCT01278342|448408896|FG000|Overall Study|Physician Decision|0|||
124668247|NCT01278342|448408897|FG001|Overall Study|Physician Decision|1|||
124668248|NCT01278342|448408898|FG002|Overall Study|Physician Decision|0|||
124668249|NCT01278342|448408896|FG000|Overall Study|Lost to Follow-up|1|||
124668250|NCT01278342|448408897|FG001|Overall Study|Lost to Follow-up|0|||
124668251|NCT01278342|448408898|FG002|Overall Study|Lost to Follow-up|0|||
124668252|NCT01278342|448408896|FG000|Overall Study|Administrative problems|2|||
124668253|NCT01278342|448408897|FG001|Overall Study|Administrative problems|0|||
124668254|NCT01278342|448408898|FG002|Overall Study|Administrative problems|0|||
124668255|NCT01278342|448408896|FG000|Overall Study|Other|1|||
124668256|NCT01278342|448408897|FG001|Overall Study|Other|0|||
124668257|NCT01278342|448408898|FG002|Overall Study|Other|0|||
124668258|NCT00313846|448408906|FG000|Overall Study|Withdrawal by Subject|2|||
124668259|NCT00313846|448408907|FG001|Overall Study|Withdrawal by Subject|0|||
124668260|NCT00313846|448408906|FG000|Overall Study|Adverse Event|1|||
124668261|NCT00313846|448408907|FG001|Overall Study|Adverse Event|8|||
124668262|NCT00313846|448408906|FG000|Overall Study|Administrative|2|||
124668263|NCT00313846|448408907|FG001|Overall Study|Administrative|3|||
124668264|NCT01462630|448408909|FG000|Overall Study|Did not initiate therapy|3|||
124668265|NCT01462630|448408909|FG000|Overall Study|Death|1|||
124668266|NCT01462630|448408909|FG000|Overall Study|Protocol Violation|2|||
124668267|NCT01462630|448408909|FG000|Overall Study|Adverse Event|1|||
124668268|NCT01765296|448408910|FG000|Overall Study|Protocol Violation|0|||
124668269|NCT01765296|448408911|FG001|Overall Study|Protocol Violation|5|||
124668270|NCT01765296|448408912|FG002|Overall Study|Protocol Violation|4|||
124668271|NCT01765296|448408910|FG000|Overall Study|Withdrawal by Subject|4|||
124668272|NCT01765296|448408911|FG001|Overall Study|Withdrawal by Subject|2|||
124668273|NCT01765296|448408912|FG002|Overall Study|Withdrawal by Subject|2|||
124668274|NCT01765296|448408910|FG000|Overall Study|Adverse Event|1|||
124668275|NCT01765296|448408911|FG001|Overall Study|Adverse Event|13|||
124668276|NCT01765296|448408912|FG002|Overall Study|Adverse Event|5|||
124668277|NCT01765296|448408910|FG000|Overall Study|Lack of Efficacy|0|||
124668278|NCT01765296|448408911|FG001|Overall Study|Lack of Efficacy|0|||
124668279|NCT01765296|448408912|FG002|Overall Study|Lack of Efficacy|2|||
124668280|NCT01619852|448408913|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
124668281|NCT01619852|448408914|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
124668282|NCT01619852|448408913|FG000|3 Month Follow up|Lost to Follow-up|31|||
124668283|NCT01619852|448408914|FG001|3 Month Follow up|Lost to Follow-up|34|||
124668284|NCT00970489|448408917|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
124668285|NCT00970489|448408918|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
124668286|NCT03933449|448408919|FG000|Overall Study|Adverse Event|6|||
124668287|NCT03933449|448408920|FG001|Overall Study|Adverse Event|4|||
124668288|NCT03933449|448408919|FG000|Overall Study|Death|55|||
124668289|NCT03933449|448408920|FG001|Overall Study|Death|57|||
124668290|NCT03933449|448408919|FG000|Overall Study|Sponsor Decision|1|||
124668291|NCT03933449|448408920|FG001|Overall Study|Sponsor Decision|0|||
124668292|NCT02659943|448408921|FG000|Overall Study|Switched to alternative treatment|1|||
124668293|NCT02659943|448408922|FG001|Overall Study|Switched to alternative treatment|1|||
124668294|NCT02659943|448408923|FG002|Overall Study|Switched to alternative treatment|0|||
124668295|NCT02659943|448408924|FG003|Overall Study|Switched to alternative treatment|2|||
124668296|NCT02659943|448408925|FG004|Overall Study|Switched to alternative treatment|1|||
124668297|NCT02659943|448408926|FG005|Overall Study|Switched to alternative treatment|0|||
124668298|NCT02659943|448408927|FG006|Overall Study|Switched to alternative treatment|1|||
124668299|NCT02659943|448408921|FG000|Overall Study|Disease progression on study|0|||
124668300|NCT02659943|448408922|FG001|Overall Study|Disease progression on study|1|||
124668301|NCT02659943|448408923|FG002|Overall Study|Disease progression on study|1|||
124668302|NCT02659943|448408924|FG003|Overall Study|Disease progression on study|1|||
124668303|NCT02659943|448408925|FG004|Overall Study|Disease progression on study|1|||
124668304|NCT02659943|448408926|FG005|Overall Study|Disease progression on study|4|||
124668305|NCT02659943|448408927|FG006|Overall Study|Disease progression on study|0|||
124668306|NCT02659943|448408921|FG000|Overall Study|Patient's condition per principal investigator|0|||
124668307|NCT02659943|448408922|FG001|Overall Study|Patient's condition per principal investigator|0|||
124668308|NCT02659943|448408923|FG002|Overall Study|Patient's condition per principal investigator|0|||
124668309|NCT02659943|448408924|FG003|Overall Study|Patient's condition per principal investigator|0|||
124668310|NCT02659943|448408925|FG004|Overall Study|Patient's condition per principal investigator|0|||
124668311|NCT02659943|448408926|FG005|Overall Study|Patient's condition per principal investigator|1|||
124668312|NCT02659943|448408927|FG006|Overall Study|Patient's condition per principal investigator|0|||
124668313|NCT02659943|448408921|FG000|Overall Study|Ineligible|0|||
124668314|NCT02659943|448408922|FG001|Overall Study|Ineligible|0|||
124668315|NCT02659943|448408923|FG002|Overall Study|Ineligible|0|||
124668316|NCT02659943|448408924|FG003|Overall Study|Ineligible|0|||
124668317|NCT02659943|448408925|FG004|Overall Study|Ineligible|0|||
124668318|NCT02659943|448408926|FG005|Overall Study|Ineligible|0|||
124668319|NCT02659943|448408927|FG006|Overall Study|Ineligible|1|||
124668320|NCT02659943|448408921|FG000|Overall Study|No longer meets eligibility|0|||
124668321|NCT02659943|448408922|FG001|Overall Study|No longer meets eligibility|0|||
124668322|NCT02659943|448408923|FG002|Overall Study|No longer meets eligibility|0|||
124668323|NCT02659943|448408924|FG003|Overall Study|No longer meets eligibility|0|||
124668324|NCT02659943|448408925|FG004|Overall Study|No longer meets eligibility|0|||
124668325|NCT02659943|448408926|FG005|Overall Study|No longer meets eligibility|0|||
124668326|NCT02659943|448408927|FG006|Overall Study|No longer meets eligibility|1|||
124668327|NCT02659943|448408921|FG000|Overall Study|No treatment, per protocol|0|||
124668328|NCT02659943|448408922|FG001|Overall Study|No treatment, per protocol|0|||
124668329|NCT02659943|448408923|FG002|Overall Study|No treatment, per protocol|0|||
124668330|NCT02659943|448408924|FG003|Overall Study|No treatment, per protocol|0|||
124668331|NCT02659943|448408925|FG004|Overall Study|No treatment, per protocol|0|||
124668332|NCT02659943|448408926|FG005|Overall Study|No treatment, per protocol|0|||
124668333|NCT02659943|448408927|FG006|Overall Study|No treatment, per protocol|3|||
124668334|NCT01576575|448408928|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
124668335|NCT01576575|448408928|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
124668336|NCT01576575|448408928|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
124668337|NCT01723072|448408929|FG000|Overall Study|Withdrawal by Subject|7|||
124668338|NCT01723072|448408930|FG001|Overall Study|Withdrawal by Subject|13|||
124668339|NCT01723072|448408929|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
124668340|NCT01723072|448408930|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
124668341|NCT01723072|448408929|FG000|Overall Study|Other|4|||
124668342|NCT01723072|448408930|FG001|Overall Study|Other|3|||
124668343|NCT03428100|448408931|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
124668344|NCT03428100|448408932|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
124668345|NCT03428100|448408933|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
124668346|NCT03428100|448408934|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
124668347|NCT03428100|448408935|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
124668348|NCT03428100|448408936|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
124668349|NCT03428100|448408937|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
124668350|NCT03428100|448408938|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
124668351|NCT03428100|448408939|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
124668352|NCT03428100|448408940|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
124668353|NCT03428100|448408941|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
124668354|NCT03428100|448408942|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
124668355|NCT03428100|448408943|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
124668356|NCT03428100|448408944|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
124668357|NCT03428100|448408945|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
124668358|NCT03428100|448408946|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
124668359|NCT03428100|448408947|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
124668360|NCT03428100|448408948|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
124668361|NCT03428100|448408949|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
124668362|NCT03428100|448408931|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
124668363|NCT03428100|448408932|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
124668364|NCT03428100|448408933|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
124668365|NCT03428100|448408934|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
124668366|NCT03428100|448408935|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
124668367|NCT03428100|448408936|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
124668368|NCT03428100|448408937|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
124668369|NCT03428100|448408938|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
124668370|NCT03428100|448408939|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
124668371|NCT03428100|448408940|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
124668372|NCT03428100|448408941|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
124668373|NCT03428100|448408942|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
124668374|NCT03428100|448408943|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
124668375|NCT03428100|448408944|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
124668376|NCT03428100|448408945|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
124668377|NCT03428100|448408946|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
124668378|NCT03428100|448408947|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
124668379|NCT03428100|448408948|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
124668380|NCT03428100|448408949|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
124668381|NCT03428100|448408931|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
124668382|NCT03428100|448408932|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
124668383|NCT03428100|448408933|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
124668384|NCT03428100|448408934|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
124668385|NCT03428100|448408935|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
124668386|NCT03428100|448408936|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
124668387|NCT03428100|448408937|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
124668388|NCT03428100|448408938|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
124668389|NCT03428100|448408939|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
124668390|NCT03428100|448408940|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
124668391|NCT03428100|448408941|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
124668392|NCT03428100|448408942|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
124668393|NCT03428100|448408943|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
124668394|NCT03428100|448408944|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
124668395|NCT03428100|448408945|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
124668396|NCT03428100|448408946|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
124668397|NCT03428100|448408947|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
124668398|NCT03428100|448408948|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
124668399|NCT03428100|448408949|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
124668400|NCT03428100|448408931|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
124668401|NCT03428100|448408932|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668402|NCT03428100|448408933|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668403|NCT03428100|448408934|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668404|NCT03428100|448408935|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668405|NCT03428100|448408936|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668406|NCT03428100|448408937|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668407|NCT03428100|448408938|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668408|NCT03428100|448408939|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668409|NCT03428100|448408940|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668410|NCT03428100|448408941|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668411|NCT03428100|448408942|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668412|NCT03428100|448408943|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668413|NCT03428100|448408944|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668414|NCT03428100|448408945|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668415|NCT03428100|448408946|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668416|NCT03428100|448408947|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668417|NCT03428100|448408948|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668418|NCT03428100|448408949|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
124668419|NCT03428100|448408931|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668420|NCT03428100|448408932|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
124668421|NCT03428100|448408933|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668422|NCT03428100|448408934|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668423|NCT03428100|448408935|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668424|NCT03428100|448408936|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668425|NCT03428100|448408937|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668426|NCT03428100|448408938|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668427|NCT03428100|448408939|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668428|NCT03428100|448408940|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668429|NCT03428100|448408941|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668430|NCT03428100|448408942|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668431|NCT03428100|448408943|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668432|NCT03428100|448408944|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668433|NCT03428100|448408945|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668434|NCT03428100|448408946|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668435|NCT03428100|448408947|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668436|NCT03428100|448408948|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668437|NCT03428100|448408949|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
124668438|NCT03428100|448408931|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
124668439|NCT03428100|448408932|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
124668440|NCT03428100|448408933|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
124668441|NCT03428100|448408934|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
124668442|NCT03428100|448408935|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
124668443|NCT03428100|448408936|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
124668444|NCT03428100|448408937|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
124668445|NCT03428100|448408938|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
124668446|NCT03428100|448408939|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
124668447|NCT03428100|448408940|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
124668448|NCT03428100|448408941|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
124668449|NCT03428100|448408942|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
124668450|NCT03428100|448408943|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
124668451|NCT03428100|448408944|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
124668452|NCT03428100|448408945|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
124668453|NCT03428100|448408946|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
124668454|NCT03428100|448408947|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
124668455|NCT03428100|448408948|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
124668456|NCT03428100|448408949|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
124668457|NCT03428100|448408931|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
124668458|NCT03428100|448408932|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
124668459|NCT03428100|448408933|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
124668460|NCT03428100|448408934|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
124668461|NCT03428100|448408935|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
124668462|NCT03428100|448408936|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
124668463|NCT03428100|448408937|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
124668464|NCT03428100|448408938|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
124668465|NCT03428100|448408939|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
124668466|NCT03428100|448408940|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
124668467|NCT03428100|448408941|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
124668468|NCT03428100|448408942|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
124668469|NCT03428100|448408943|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
124668470|NCT03428100|448408944|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
124668471|NCT03428100|448408945|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
124668472|NCT03428100|448408946|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
124668473|NCT03428100|448408947|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
124668474|NCT03428100|448408948|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
124668475|NCT03428100|448408949|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
124668476|NCT03428100|448408931|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
124668477|NCT03428100|448408932|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
124668478|NCT03428100|448408933|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
124668479|NCT03428100|448408934|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
124668480|NCT03428100|448408935|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
124668481|NCT03428100|448408936|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
124668482|NCT03428100|448408937|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
124668483|NCT03428100|448408938|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
124668484|NCT03428100|448408939|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
124668485|NCT03428100|448408940|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
124668486|NCT03428100|448408941|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
124668487|NCT03428100|448408942|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
124668488|NCT03428100|448408943|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
124668489|NCT03428100|448408944|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
124668490|NCT03428100|448408945|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
124668491|NCT03428100|448408946|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
124668492|NCT03428100|448408947|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
124668493|NCT03428100|448408948|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
124668494|NCT03428100|448408949|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
124668495|NCT03428100|448408931|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
124668496|NCT03428100|448408932|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
124668497|NCT03428100|448408933|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
124668498|NCT03428100|448408934|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
124668499|NCT03428100|448408935|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
124668500|NCT03428100|448408936|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
124668501|NCT03428100|448408937|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
124668502|NCT03428100|448408938|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
124668503|NCT03428100|448408939|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
124668504|NCT03428100|448408940|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
124668505|NCT03428100|448408941|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
124668506|NCT03428100|448408942|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
124668507|NCT03428100|448408943|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
124668508|NCT03428100|448408944|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
124668509|NCT03428100|448408945|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
124668510|NCT03428100|448408946|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
124668511|NCT03428100|448408947|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
124668512|NCT03428100|448408948|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
124668513|NCT03428100|448408949|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
124668514|NCT03428100|448408931|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
124668515|NCT03428100|448408932|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
124668516|NCT03428100|448408933|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
124668517|NCT03428100|448408934|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
124668518|NCT03428100|448408935|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
124668519|NCT03428100|448408936|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
124668520|NCT03428100|448408937|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
124668521|NCT03428100|448408938|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
124668522|NCT03428100|448408939|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
124668523|NCT03428100|448408940|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
124668524|NCT03428100|448408941|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
124668525|NCT03428100|448408942|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
124668526|NCT03428100|448408943|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
124668527|NCT03428100|448408944|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
124668528|NCT03428100|448408945|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
124668529|NCT03428100|448408946|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
124668530|NCT03428100|448408947|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
124668531|NCT03428100|448408948|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
124668532|NCT03428100|448408949|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
124668533|NCT03428100|448408931|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
124668534|NCT03428100|448408932|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
124668535|NCT03428100|448408933|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
124668536|NCT03428100|448408934|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
124668537|NCT03428100|448408935|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
124668538|NCT03428100|448408936|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
124668539|NCT03428100|448408937|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
124668540|NCT03428100|448408938|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
124668541|NCT03428100|448408939|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
124668542|NCT03428100|448408940|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
124668543|NCT03428100|448408941|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
124668544|NCT03428100|448408942|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
124668545|NCT03428100|448408943|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
124668546|NCT03428100|448408944|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
124668547|NCT03428100|448408945|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
124668548|NCT03428100|448408946|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
124668549|NCT03428100|448408947|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
124668550|NCT03428100|448408948|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
124668551|NCT03428100|448408949|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
124668552|NCT03428100|448408931|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
124668553|NCT03428100|448408932|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
124668554|NCT03428100|448408933|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
124668555|NCT03428100|448408934|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
124668556|NCT03428100|448408935|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
124668557|NCT03428100|448408936|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
124668558|NCT03428100|448408937|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
124668559|NCT03428100|448408938|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
124668560|NCT03428100|448408939|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
124668561|NCT03428100|448408940|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
124668562|NCT03428100|448408941|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
124668563|NCT03428100|448408942|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
124668564|NCT03428100|448408943|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
124668565|NCT03428100|448408944|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
124668566|NCT03428100|448408945|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
124668567|NCT03428100|448408946|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
124668568|NCT03428100|448408947|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
124668569|NCT03428100|448408948|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
124668570|NCT03428100|448408949|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
124668571|NCT03428100|448408931|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
124668572|NCT03428100|448408932|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
124668573|NCT03428100|448408933|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
124668574|NCT03428100|448408934|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
124668575|NCT03428100|448408935|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
124668576|NCT03428100|448408936|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
124668577|NCT03428100|448408937|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
124668578|NCT03428100|448408938|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
124668579|NCT03428100|448408939|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
124668580|NCT03428100|448408940|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
124668581|NCT03428100|448408941|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
124668582|NCT03428100|448408942|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
124668583|NCT03428100|448408943|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
124668584|NCT03428100|448408944|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
124668585|NCT03428100|448408945|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
124668586|NCT03428100|448408946|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
124668587|NCT03428100|448408947|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
124668588|NCT03428100|448408948|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
124668589|NCT03428100|448408949|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
124668590|NCT04556760|448408950|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
124668591|NCT04556760|448408951|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
124668592|NCT04556760|448408952|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
124668593|NCT04556760|448408953|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
124668594|NCT04556760|448408954|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
124668595|NCT04556760|448408955|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
124668596|NCT04556760|448408950|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
124668597|NCT04556760|448408951|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
124668598|NCT04556760|448408952|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
124668599|NCT04556760|448408953|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
124668600|NCT04556760|448408954|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
124668601|NCT04556760|448408955|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
124668602|NCT02168491|448408956|FG000|Overall Study|Withdrawal by Subject|1|||
124668603|NCT03380377|448408964|FG000|Overall Study|Physician Decision|1|||
124668604|NCT03380377|448408964|FG000|Overall Study|Withdrawal by Subject|1|||
124668605|NCT02600923|448408965|FG000|Overall Study|Death|10|||
124668606|NCT02600923|448408965|FG000|Overall Study|Adverse Event|3|||
124668607|NCT02600923|448408965|FG000|Overall Study|Global deterioration of health status|2|||
124668608|NCT02600923|448408965|FG000|Overall Study|Insufficient clinical response|6|||
124668609|NCT02600923|448408965|FG000|Overall Study|Lost to Follow-up|1|||
124668610|NCT02600923|448408965|FG000|Overall Study|Withdrawal by Subject|5|||
124668611|NCT02600923|448408965|FG000|Overall Study|Objective progression or relapse|50|||
124668612|NCT02600923|448408965|FG000|Overall Study|Study terminated by Sponsor|53|||
124668613|NCT02600923|448408965|FG000|Overall Study|Not treated|1|||
124668614|NCT02256839|448408966|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
124668615|NCT02256839|448408967|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
124668616|NCT01705977|448408973|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
124668617|NCT01705977|448408974|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
124668618|NCT01705977|448408973|FG000|Treatment Period (Year 1)|Adverse Event|57|||
124668619|NCT01705977|448408974|FG001|Treatment Period (Year 1)|Adverse Event|49|||
124668620|NCT01705977|448408973|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
124668621|NCT01705977|448408974|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
124668622|NCT01705977|448408973|FG000|Treatment Period (Year 1)|Site closure|3|||
124668623|NCT01705977|448408974|FG001|Treatment Period (Year 1)|Site closure|2|||
124668624|NCT01705977|448408973|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
124668625|NCT01705977|448408974|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
124668626|NCT01705977|448408973|FG000|Treatment Period (Year 1)|Physician Decision|48|||
124668627|NCT01705977|448408974|FG001|Treatment Period (Year 1)|Physician Decision|38|||
124668628|NCT01705977|448408973|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
124668629|NCT01705977|448408974|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
124668630|NCT01705977|448408973|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
124668631|NCT01705977|448408974|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
124668632|NCT01705977|448408973|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
124668633|NCT01705977|448408974|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
124668634|NCT01705977|448408973|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
124668635|NCT01705977|448408974|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
124668636|NCT01705977|448408973|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
124668637|NCT01705977|448408974|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
124668638|NCT01705977|448408973|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
124668639|NCT01705977|448408974|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
124668640|NCT00808067|448408976|FG000|Overall Study|Major/minor bleed|30|||
124668641|NCT00808067|448408977|FG001|Overall Study|Major/minor bleed|44|||
124668642|NCT00808067|448408976|FG000|Overall Study|Outcome event - other|33|||
124668643|NCT00808067|448408977|FG001|Overall Study|Outcome event - other|25|||
124668644|NCT00808067|448408976|FG000|Overall Study|Adverse Event|111|||
124668645|NCT00808067|448408977|FG001|Overall Study|Adverse Event|121|||
124668646|NCT00808067|448408976|FG000|Overall Study|Hospitalization (not including surgery)|18|||
124668647|NCT00808067|448408977|FG001|Overall Study|Hospitalization (not including surgery)|17|||
124668648|NCT00808067|448408976|FG000|Overall Study|Hospitalization due to surgery|37|||
124668649|NCT00808067|448408977|FG001|Overall Study|Hospitalization due to surgery|40|||
124668650|NCT00808067|448408976|FG000|Overall Study|Reduced creatinine clearance|53|||
124668651|NCT00808067|448408977|FG001|Overall Study|Reduced creatinine clearance|55|||
124668652|NCT00808067|448408976|FG000|Overall Study|Elevated LFT results|7|||
124668653|NCT00808067|448408977|FG001|Overall Study|Elevated LFT results|3|||
124668654|NCT00808067|448408976|FG000|Overall Study|Patient refused to take study medication|65|||
124668655|NCT00808067|448408977|FG001|Overall Study|Patient refused to take study medication|76|||
124668656|NCT00808067|448408976|FG000|Overall Study|Missing|1|||
124668657|NCT00808067|448408977|FG001|Overall Study|Missing|0|||
124668658|NCT00808067|448408976|FG000|Overall Study|Death|1|||
124668659|NCT00808067|448408977|FG001|Overall Study|Death|1|||
124668660|NCT00808067|448408976|FG000|Overall Study|Procedure|6|||
124668661|NCT00808067|448408977|FG001|Overall Study|Procedure|7|||
124668662|NCT00808067|448408976|FG000|Overall Study|Withdrawal by Subject|21|||
124668663|NCT00808067|448408977|FG001|Overall Study|Withdrawal by Subject|25|||
124668664|NCT00808067|448408976|FG000|Overall Study|Site closed|4|||
124668665|NCT00808067|448408977|FG001|Overall Study|Site closed|3|||
124668666|NCT00808067|448408976|FG000|Overall Study|Physician Decision|47|||
124668667|NCT00808067|448408977|FG001|Overall Study|Physician Decision|38|||
124668668|NCT00808067|448408976|FG000|Overall Study|Protocol Violation|3|||
124668669|NCT00808067|448408977|FG001|Overall Study|Protocol Violation|11|||
124668670|NCT00808067|448408976|FG000|Overall Study|Patient elected|7|||
124668671|NCT00808067|448408977|FG001|Overall Study|Patient elected|9|||
124668672|NCT00808067|448408976|FG000|Overall Study|Site closed for cause|19|||
124668673|NCT00808067|448408977|FG001|Overall Study|Site closed for cause|19|||
124668674|NCT00808067|448408976|FG000|Overall Study|Other reason not defined above|5|||
124668675|NCT00808067|448408977|FG001|Overall Study|Other reason not defined above|5|||
124668676|NCT00808067|448408976|FG000|Overall Study|Excluded from analysis|13|||
124668677|NCT00808067|448408977|FG001|Overall Study|Excluded from analysis|19|||
124668678|NCT05027815|448408986|FG000|Overall Study|Death|2|||
124668679|NCT05027815|448408987|FG001|Overall Study|Death|1|||
124668680|NCT03677869|448408988|FG000|Overall Study|Withdrawal by Subject|1|||
124668681|NCT03877224|448408989|FG000|Overall Study|Death|3|||
124668682|NCT03877224|448408990|FG001|Overall Study|Death|2|||
124668683|NCT03877224|448408989|FG000|Overall Study|Withdrawal by Subject|1|||
124668684|NCT03877224|448408990|FG001|Overall Study|Withdrawal by Subject|6|||
124668685|NCT03877224|448408989|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
124668686|NCT03877224|448408990|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
124668687|NCT00447902|448408991|FG000|Overall Study|Adverse Event|0|||
124668688|NCT00447902|448408992|FG001|Overall Study|Adverse Event|3|||
124668689|NCT00447902|448408991|FG000|Overall Study|Protocol Violation|1|||
124668690|NCT00447902|448408992|FG001|Overall Study|Protocol Violation|0|||
124668691|NCT00447902|448408991|FG000|Overall Study|Withdrawal by Subject|0|||
124668692|NCT00447902|448408992|FG001|Overall Study|Withdrawal by Subject|1|||
124668693|NCT00447902|448408991|FG000|Overall Study|included patients who discontinued|1|||
124668694|NCT00447902|448408992|FG001|Overall Study|included patients who discontinued|1|||
124668695|NCT00447902|448408991|FG000|Overall Study|Lack of Efficacy|2|||
124668696|NCT00447902|448408992|FG001|Overall Study|Lack of Efficacy|1|||
124668697|NCT04754542|448408993|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
124668698|NCT04754542|448408994|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
124668699|NCT01212094|448410570|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
124668700|NCT01212094|448410571|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
124668701|NCT01212094|448410572|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
124668702|NCT01212094|448410570|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
124668703|NCT01212094|448410571|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
124668704|NCT01212094|448410572|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
124668705|NCT01212094|448410570|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
124668706|NCT01212094|448410571|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
124668707|NCT01212094|448410572|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
124668708|NCT01212094|448410570|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
124668709|NCT01212094|448410571|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
124668710|NCT01212094|448410572|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
124668711|NCT01212094|448410570|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
124668712|NCT01212094|448410571|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
124668713|NCT01212094|448410572|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
124668714|NCT01212094|448410570|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
124668715|NCT01212094|448410571|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
124668716|NCT01212094|448410572|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
124668717|NCT02019550|448410575|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
124668718|NCT02019550|448410576|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
124668719|NCT04771013|448410581|FG000|Overall Study|Withdrawal by Subject|2|||
124668720|NCT04771013|448410582|FG001|Overall Study|Withdrawal by Subject|0|||
124668721|NCT04771013|448410581|FG000|Overall Study|Death|0|||
124668722|NCT04771013|448410582|FG001|Overall Study|Death|5|||
124668723|NCT04771013|448410581|FG000|Overall Study|Referred to another hospital before day 20|0|||
124668724|NCT04771013|448410582|FG001|Overall Study|Referred to another hospital before day 20|1|||
124668725|NCT02291029|448410587|FG000|Overall Study|Withdrawal by Subject|0|||
124668726|NCT02291029|448410588|FG001|Overall Study|Withdrawal by Subject|0|||
124668727|NCT02291029|448410589|FG002|Overall Study|Withdrawal by Subject|1|||
124668728|NCT02291029|448410590|FG003|Overall Study|Withdrawal by Subject|0|||
124668729|NCT02291029|448410591|FG004|Overall Study|Withdrawal by Subject|0|||
124668730|NCT02291029|448410592|FG005|Overall Study|Withdrawal by Subject|0|||
124668731|NCT02291029|448410587|FG000|Overall Study|Adverse Event|0|||
124668732|NCT02291029|448410588|FG001|Overall Study|Adverse Event|1|||
124668733|NCT02291029|448410589|FG002|Overall Study|Adverse Event|0|||
124668734|NCT02291029|448410590|FG003|Overall Study|Adverse Event|0|||
124668735|NCT02291029|448410591|FG004|Overall Study|Adverse Event|0|||
124668736|NCT02291029|448410592|FG005|Overall Study|Adverse Event|0|||
124668737|NCT01519817|448410594|FG000|Overall Study|Withdrawal by Subject|1|||
124668738|NCT01519817|448410595|FG001|Overall Study|Withdrawal by Subject|0|||
124668739|NCT01519817|448410596|FG002|Overall Study|Withdrawal by Subject|0|||
124668740|NCT01519817|448410597|FG003|Overall Study|Withdrawal by Subject|0|||
124668741|NCT01519817|448410594|FG000|Overall Study|Off study due to infection|0|||
124668742|NCT01519817|448410595|FG001|Overall Study|Off study due to infection|0|||
124668743|NCT01519817|448410596|FG002|Overall Study|Off study due to infection|0|||
124668744|NCT01519817|448410597|FG003|Overall Study|Off study due to infection|1|||
124668745|NCT02999789|448410600|FG000|Overall Study|Withdrawal by Subject|0|||
124668746|NCT02999789|448410601|FG001|Overall Study|Withdrawal by Subject|1|||
124668747|NCT02999789|448410600|FG000|Overall Study|Became ineligible|1|||
124668748|NCT02999789|448410601|FG001|Overall Study|Became ineligible|2|||
124668749|NCT00521365|448410603|FG000|Overall Study|Adverse Event|3|||
124668750|NCT00521365|448410603|FG000|Overall Study|Lost to Follow-up|6|||
124668751|NCT00521365|448410603|FG000|Overall Study|Protocol deviation|2|||
124668752|NCT00521365|448410603|FG000|Overall Study|Drug compliance|3|||
124668753|NCT00521365|448410603|FG000|Overall Study|Usage of not allowed drugs|6|||
124668754|NCT03627832|448410604|FG000|Overall Study|Withdrawal by Subject|10|||
124668755|NCT03627832|448410605|FG001|Overall Study|Withdrawal by Subject|1|||
124668756|NCT03150082|448410606|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
124668757|NCT03150082|448410607|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
124668758|NCT01051557|448410608|FG000|Overall Study|Physician Decision|1|||
124668759|NCT01051557|448410609|FG001|Overall Study|Physician Decision|0|||
124668760|NCT01051557|448410610|FG002|Overall Study|Physician Decision|0|||
124668761|NCT01051557|448410611|FG003|Overall Study|Physician Decision|0|||
124668762|NCT01051557|448410612|FG004|Overall Study|Physician Decision|0|||
124668763|NCT01051557|448410613|FG005|Overall Study|Physician Decision|0|||
124668764|NCT01051557|448410614|FG006|Overall Study|Physician Decision|0|||
124668765|NCT01051557|448410608|FG000|Overall Study|disease progression|3|||
124668766|NCT01051557|448410609|FG001|Overall Study|disease progression|3|||
124668767|NCT01051557|448410610|FG002|Overall Study|disease progression|5|||
124668768|NCT01051557|448410611|FG003|Overall Study|disease progression|2|||
124668769|NCT01051557|448410612|FG004|Overall Study|disease progression|4|||
124668770|NCT01051557|448410613|FG005|Overall Study|disease progression|3|||
124668771|NCT01051557|448410614|FG006|Overall Study|disease progression|1|||
124668772|NCT01051557|448410608|FG000|Overall Study|Withdrawal by Subject|0|||
124668773|NCT01051557|448410609|FG001|Overall Study|Withdrawal by Subject|0|||
124668774|NCT01051557|448410610|FG002|Overall Study|Withdrawal by Subject|1|||
124668775|NCT01051557|448410611|FG003|Overall Study|Withdrawal by Subject|0|||
124668776|NCT01051557|448410612|FG004|Overall Study|Withdrawal by Subject|2|||
124668777|NCT01051557|448410613|FG005|Overall Study|Withdrawal by Subject|0|||
124668778|NCT01051557|448410614|FG006|Overall Study|Withdrawal by Subject|1|||
124668779|NCT01051557|448410608|FG000|Overall Study|Adverse Event|0|||
124668780|NCT01051557|448410609|FG001|Overall Study|Adverse Event|0|||
124668781|NCT01051557|448410610|FG002|Overall Study|Adverse Event|0|||
124668782|NCT01051557|448410611|FG003|Overall Study|Adverse Event|1|||
124668783|NCT01051557|448410612|FG004|Overall Study|Adverse Event|1|||
124668784|NCT01051557|448410613|FG005|Overall Study|Adverse Event|3|||
124668785|NCT01051557|448410614|FG006|Overall Study|Adverse Event|4|||
124668786|NCT01178125|448410622|FG000|Overall Study|Lost to Follow-up|397|||
124668787|NCT01178125|448410622|FG000|Overall Study|Adverse Event|244|||
124668788|NCT01178125|448410622|FG000|Overall Study|Withdrawal by Subject|209|||
124668789|NCT01178125|448410622|FG000|Overall Study|Noncompliance|184|||
124668790|NCT01178125|448410622|FG000|Overall Study|Pregnancy|55|||
124668791|NCT01178125|448410622|FG000|Overall Study|Other Reason|39|||
124668792|NCT01178125|448410622|FG000|Overall Study|Sponsor Decision|28|||
124668793|NCT01178125|448410622|FG000|Overall Study|Protocol Violation|17|||
124668794|NCT01178125|448410622|FG000|Overall Study|Investigator Decision|5|||
124668795|NCT02948829|448410623|FG000|Overall Study|Lost to Follow-up|2|||
124668796|NCT02948829|448410623|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
124668797|NCT02948829|448410623|FG000|Overall Study|Pregnancy|1|||
124668798|NCT02948829|448410623|FG000|Overall Study|Other: Reason not Specified|8|||
124668799|NCT00369915|448410624|FG000|Overall Study|expected side effects|2|||
124668800|NCT00369915|448410625|FG001|Overall Study|expected side effects|1|||
124668801|NCT00369915|448410624|FG000|Overall Study|Withdrawal by Subject|4|||
124668802|NCT00369915|448410625|FG001|Overall Study|Withdrawal by Subject|1|||
124668803|NCT00369915|448410624|FG000|Overall Study|W/drawl by investigators|0|||
124668804|NCT00369915|448410625|FG001|Overall Study|W/drawl by investigators|1|||
124668805|NCT01711983|448410626|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
124668806|NCT01711983|448410626|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
124668807|NCT01711983|448410626|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
124668808|NCT01711983|448410626|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
124668809|NCT00737100|448410632|FG000|Overall Study|Adverse Event|6|||
124668810|NCT00737100|448410633|FG001|Overall Study|Adverse Event|5|||
124668811|NCT00737100|448410634|FG002|Overall Study|Adverse Event|3|||
124668812|NCT00737100|448410632|FG000|Overall Study|Lost to Follow-up|0|||
124668813|NCT00737100|448410633|FG001|Overall Study|Lost to Follow-up|1|||
124668814|NCT00737100|448410634|FG002|Overall Study|Lost to Follow-up|0|||
124668815|NCT00737100|448410632|FG000|Overall Study|Withdrawal by Subject|0|||
124668816|NCT00737100|448410633|FG001|Overall Study|Withdrawal by Subject|0|||
124668817|NCT00737100|448410634|FG002|Overall Study|Withdrawal by Subject|3|||
124668818|NCT00737100|448410632|FG000|Overall Study|Reason discontinued not explained above|1|||
124668819|NCT00737100|448410633|FG001|Overall Study|Reason discontinued not explained above|1|||
124668820|NCT00737100|448410634|FG002|Overall Study|Reason discontinued not explained above|1|||
124668821|NCT01447407|448410635|FG000|Overall Study|Withdrawal by Subject|2|||
124668822|NCT01447407|448410636|FG001|Overall Study|Withdrawal by Subject|0|||
124668823|NCT01447407|448410637|FG002|Overall Study|Withdrawal by Subject|0|||
124668824|NCT01447407|448410638|FG003|Overall Study|Withdrawal by Subject|1|||
124668825|NCT01447407|448410635|FG000|Overall Study|Physician Decision|0|||
124668826|NCT01447407|448410636|FG001|Overall Study|Physician Decision|0|||
124668827|NCT01447407|448410637|FG002|Overall Study|Physician Decision|1|||
124668828|NCT01447407|448410638|FG003|Overall Study|Physician Decision|1|||
124668829|NCT01265394|448410639|FG000|Overall Study|Subjects withdrawn|37|||
124668830|NCT03131167|448410640|FG000|Overall Study|Other (Unspecified)|0|||
124668831|NCT03131167|448410641|FG001|Overall Study|Other (Unspecified)|0|||
124668832|NCT03131167|448410642|FG002|Overall Study|Other (Unspecified)|0|||
124668833|NCT03131167|448410643|FG003|Overall Study|Other (Unspecified)|0|||
124668834|NCT03131167|448410644|FG004|Overall Study|Other (Unspecified)|0|||
124668835|NCT03131167|448410645|FG005|Overall Study|Other (Unspecified)|1|||
124668836|NCT03131167|448410646|FG006|Overall Study|Other (Unspecified)|0|||
124668837|NCT03131167|448410647|FG007|Overall Study|Other (Unspecified)|0|||
124668838|NCT03131167|448410648|FG008|Overall Study|Other (Unspecified)|0|||
124668839|NCT03131167|448410649|FG009|Overall Study|Other (Unspecified)|0|||
124668840|NCT03131167|448410650|FG010|Overall Study|Other (Unspecified)|0|||
124668841|NCT03131167|448410651|FG011|Overall Study|Other (Unspecified)|0|||
124668842|NCT03131167|448410652|FG012|Overall Study|Other (Unspecified)|0|||
124668843|NCT02221648|448410659|FG000|Overall Study|Withdrawal by Subject|3|||
124668844|NCT02221648|448410660|FG001|Overall Study|Withdrawal by Subject|3|||
124668845|NCT03489343|448410664|FG000|Overall Study|Documented progressive disease|1|||
124668846|NCT03489343|448410665|FG001|Overall Study|Documented progressive disease|0|||
124668847|NCT03489343|448410666|FG002|Overall Study|Documented progressive disease|3|||
124668848|NCT03489343|448410667|FG003|Overall Study|Documented progressive disease|1|||
124668849|NCT03489343|448410668|FG004|Overall Study|Documented progressive disease|3|||
124668850|NCT03489343|448410669|FG005|Overall Study|Documented progressive disease|5|||
124668851|NCT03489343|448410670|FG006|Overall Study|Documented progressive disease|4|||
124668852|NCT03489343|448410664|FG000|Overall Study|Adverse Event|0|||
124668853|NCT03489343|448410665|FG001|Overall Study|Adverse Event|1|||
124668854|NCT03489343|448410666|FG002|Overall Study|Adverse Event|0|||
124668855|NCT03489343|448410667|FG003|Overall Study|Adverse Event|0|||
124668856|NCT03489343|448410668|FG004|Overall Study|Adverse Event|0|||
124668857|NCT03489343|448410669|FG005|Overall Study|Adverse Event|1|||
124668858|NCT03489343|448410670|FG006|Overall Study|Adverse Event|0|||
124668859|NCT03489343|448410664|FG000|Overall Study|Withdrawal by Subject|0|||
124668860|NCT03489343|448410665|FG001|Overall Study|Withdrawal by Subject|0|||
124668861|NCT03489343|448410666|FG002|Overall Study|Withdrawal by Subject|0|||
124668862|NCT03489343|448410667|FG003|Overall Study|Withdrawal by Subject|1|||
124668863|NCT03489343|448410668|FG004|Overall Study|Withdrawal by Subject|0|||
124668864|NCT03489343|448410669|FG005|Overall Study|Withdrawal by Subject|1|||
124668865|NCT03489343|448410670|FG006|Overall Study|Withdrawal by Subject|1|||
124668866|NCT03489343|448410664|FG000|Overall Study|Clinical progression|0|||
124668867|NCT03489343|448410665|FG001|Overall Study|Clinical progression|0|||
124668868|NCT03489343|448410666|FG002|Overall Study|Clinical progression|0|||
124668869|NCT03489343|448410667|FG003|Overall Study|Clinical progression|1|||
124668870|NCT03489343|448410668|FG004|Overall Study|Clinical progression|0|||
124668871|NCT03489343|448410669|FG005|Overall Study|Clinical progression|0|||
124668872|NCT03489343|448410670|FG006|Overall Study|Clinical progression|1|||
124668873|NCT01166750|448410671|FG000|Overall Study|Lost to Follow-up|1|||
124668874|NCT01166750|448410672|FG001|Overall Study|Lost to Follow-up|0|||
124668875|NCT01585246|448410673|FG000|Overall Study|Lost to Follow-up|0|||
124668876|NCT01585246|448410674|FG001|Overall Study|Lost to Follow-up|0|||
124668877|NCT01585246|448410675|FG002|Overall Study|Lost to Follow-up|2|||
124668878|NCT01585246|448410676|FG003|Overall Study|Lost to Follow-up|1|||
124668879|NCT01585246|448410677|FG004|Overall Study|Lost to Follow-up|0|||
124668880|NCT01585246|448410673|FG000|Overall Study|Protocol Violation|0|||
124668881|NCT01585246|448410674|FG001|Overall Study|Protocol Violation|0|||
124668882|NCT01585246|448410675|FG002|Overall Study|Protocol Violation|0|||
124668883|NCT01585246|448410676|FG003|Overall Study|Protocol Violation|0|||
124668884|NCT01585246|448410677|FG004|Overall Study|Protocol Violation|1|||
124668885|NCT01585246|448410673|FG000|Overall Study|Withdrawal by Subject|0|||
124668886|NCT01585246|448410674|FG001|Overall Study|Withdrawal by Subject|0|||
124668887|NCT01585246|448410675|FG002|Overall Study|Withdrawal by Subject|1|||
124668888|NCT01585246|448410676|FG003|Overall Study|Withdrawal by Subject|2|||
124668889|NCT01585246|448410677|FG004|Overall Study|Withdrawal by Subject|1|||
124668890|NCT01585246|448410673|FG000|Overall Study|Other|0|||
124668891|NCT01585246|448410674|FG001|Overall Study|Other|1|||
124668892|NCT01585246|448410675|FG002|Overall Study|Other|1|||
124668893|NCT01585246|448410676|FG003|Overall Study|Other|1|||
124668894|NCT01585246|448410677|FG004|Overall Study|Other|0|||
124668895|NCT04396626|448410678|FG000|Overall Study|Premature termination of study|975|||
124668896|NCT02111174|448410681|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
124668897|NCT02111174|448410682|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
124668898|NCT02111174|448410681|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
124668899|NCT02111174|448410682|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
124668900|NCT02111174|448410681|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
124668901|NCT02111174|448410682|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
124668902|NCT02111174|448410681|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
124668903|NCT02111174|448410682|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
124668904|NCT00838097|448410683|FG000|Overall Study|Ineligibility determined|6|||
124668905|NCT00838097|448410683|FG000|Overall Study|Adverse Event|2|||
124668906|NCT00838097|448410683|FG000|Overall Study|Withdrawal by Subject|3|||
124668907|NCT00838097|448410683|FG000|Overall Study|Requirement for alternative therapy|2|||
124668908|NCT00838097|448410683|FG000|Overall Study|Physician Decision|4|||
124668909|NCT00838097|448410683|FG000|Overall Study|Lost to Follow-up|11|||
124668910|NCT00838097|448410683|FG000|Overall Study|Death|6|||
124668911|NCT00838097|448410683|FG000|Overall Study|Protocol-specified criteria|142|||
124668912|NCT00871234|448410684|FG000|Overall Study|Adverse Event|2|||
124668913|NCT00871234|448410684|FG000|Overall Study|Lost to Follow-up|3|||
124668914|NCT00792909|448410689|FG000|Overall Study|Withdrawal by Subject|0|||
124668915|NCT00792909|448410690|FG001|Overall Study|Withdrawal by Subject|1|||
124668916|NCT00792909|448410691|FG002|Overall Study|Withdrawal by Subject|0|||
124668917|NCT00128661|448410694|FG000|Overall Study|Adverse Event|14|||
124668918|NCT00128661|448410695|FG001|Overall Study|Adverse Event|11|||
124668919|NCT00128661|448410694|FG000|Overall Study|Lost to Follow-up|10|||
124668920|NCT00128661|448410695|FG001|Overall Study|Lost to Follow-up|7|||
124668921|NCT00128661|448410694|FG000|Overall Study|Withdrawal by Subject|243|||
124668922|NCT00128661|448410695|FG001|Overall Study|Withdrawal by Subject|232|||
124668923|NCT00128661|448410694|FG000|Overall Study|Other|7|||
124668924|NCT00128661|448410695|FG001|Overall Study|Other|8|||
124668925|NCT01261390|448410696|FG000|Overall Study|Significant Concurrent Illness|1|||
124668926|NCT01261390|448410697|FG001|Overall Study|Significant Concurrent Illness|0|||
124668927|NCT01261390|448410698|FG002|Overall Study|Significant Concurrent Illness|1|||
124668928|NCT01261390|448410699|FG003|Overall Study|Significant Concurrent Illness|0|||
124668929|NCT01261390|448410696|FG000|Overall Study|Dissatisfaction with Treatment|2|||
124668930|NCT01261390|448410697|FG001|Overall Study|Dissatisfaction with Treatment|1|||
124668931|NCT01261390|448410698|FG002|Overall Study|Dissatisfaction with Treatment|1|||
124668932|NCT01261390|448410699|FG003|Overall Study|Dissatisfaction with Treatment|2|||
124668933|NCT01261390|448410696|FG000|Overall Study|Relocation|0|||
124668934|NCT01261390|448410697|FG001|Overall Study|Relocation|1|||
124668935|NCT01261390|448410698|FG002|Overall Study|Relocation|0|||
124668936|NCT01261390|448410699|FG003|Overall Study|Relocation|0|||
124668937|NCT01261390|448410696|FG000|Overall Study|Loss of Interest in the Study|3|||
124668938|NCT01261390|448410697|FG001|Overall Study|Loss of Interest in the Study|1|||
124668939|NCT01261390|448410698|FG002|Overall Study|Loss of Interest in the Study|0|||
124668940|NCT01261390|448410699|FG003|Overall Study|Loss of Interest in the Study|0|||
124668941|NCT01261390|448410696|FG000|Overall Study|Lost to Follow-up|1|||
124668942|NCT01261390|448410697|FG001|Overall Study|Lost to Follow-up|6|||
124668943|NCT01261390|448410698|FG002|Overall Study|Lost to Follow-up|5|||
124668944|NCT01261390|448410699|FG003|Overall Study|Lost to Follow-up|6|||
124668945|NCT00977613|448410700|FG000|Overall Study|Lost to Follow-up|16|||
124668946|NCT04001803|448410705|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
124668947|NCT04001803|448410705|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
124668948|NCT04001803|448410705|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
124668949|NCT04001803|448410705|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
124668950|NCT04001803|448410705|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
124668951|NCT04001803|448410705|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
124668952|NCT04001803|448410705|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
124668953|NCT04001803|448410705|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
124668954|NCT04001803|448410705|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
124668955|NCT04001803|448410705|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
124668956|NCT05404711|448410706|FG000|Completed Study Visit|Withdrawal by Subject|1|||
124668957|NCT05404711|448410706|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
124668958|NCT05404711|448410706|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
124668959|NCT05404711|448410706|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
124668960|NCT05404711|448410706|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
124668961|NCT05404711|448410706|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
124668962|NCT02346877|448410709|FG000|Overall Study|Adverse Event|1|||
124668963|NCT02346877|448410710|FG001|Overall Study|Adverse Event|0|||
124668964|NCT02346877|448410709|FG000|Overall Study|Administrative Decision|1|||
124668965|NCT02346877|448410710|FG001|Overall Study|Administrative Decision|0|||
124668966|NCT02346877|448410709|FG000|Overall Study|Sponsor Decision|12|||
124668967|NCT02346877|448410710|FG001|Overall Study|Sponsor Decision|0|||
124668968|NCT02346877|448410709|FG000|Overall Study|Missing|5|||
124668969|NCT02346877|448410710|FG001|Overall Study|Missing|0|||
124668970|NCT00823134|448412448|FG000|Overall Study|Invalid measurement|1|||
124668971|NCT00419757|448412449|FG000|Overall Study|Adverse Event|1|||
124668972|NCT00419757|448412450|FG001|Overall Study|Adverse Event|4|||
124668973|NCT00419757|448412449|FG000|Overall Study|Lost to Follow-up|1|||
124668974|NCT00419757|448412450|FG001|Overall Study|Lost to Follow-up|4|||
124668975|NCT00419757|448412449|FG000|Overall Study|Withdrawal by Subject|7|||
124668976|NCT00419757|448412450|FG001|Overall Study|Withdrawal by Subject|1|||
124668977|NCT00419757|448412449|FG000|Overall Study|Protocol Violation|2|||
124668978|NCT00419757|448412450|FG001|Overall Study|Protocol Violation|3|||
124668979|NCT00419757|448412449|FG000|Overall Study|Study specific discontinuation criteria|4|||
124668980|NCT00419757|448412450|FG001|Overall Study|Study specific discontinuation criteria|8|||
124668981|NCT00419757|448412449|FG000|Overall Study|Multiple reasons|3|||
124668982|NCT00419757|448412450|FG001|Overall Study|Multiple reasons|1|||
124668983|NCT02922153|448412451|FG000|Overall Study|Death|8|||
124668984|NCT02922153|448412452|FG001|Overall Study|Death|1|||
124668985|NCT02922153|448412451|FG000|Overall Study|Lost to Follow-up|1|||
124668986|NCT02922153|448412452|FG001|Overall Study|Lost to Follow-up|0|||
124668987|NCT02922153|448412451|FG000|Overall Study|Physician Decision|1|||
124668988|NCT02922153|448412452|FG001|Overall Study|Physician Decision|1|||
124668989|NCT00327340|448412453|FG000|Overall Study|Withdrawal by Subject|1|||
124668990|NCT00327340|448412454|FG001|Overall Study|Withdrawal by Subject|5|||
124668991|NCT00327340|448412453|FG000|Overall Study|Physician Decision|1|||
124668992|NCT00327340|448412454|FG001|Overall Study|Physician Decision|1|||
124668993|NCT00327340|448412453|FG000|Overall Study|Disease Progression|10|||
124668994|NCT00327340|448412454|FG001|Overall Study|Disease Progression|19|||
124668995|NCT00327340|448412453|FG000|Overall Study|Symptomatic Disease|0|||
124668996|NCT00327340|448412454|FG001|Overall Study|Symptomatic Disease|2|||
124668997|NCT00327340|448412453|FG000|Overall Study|Adverse Event|3|||
124668998|NCT00327340|448412454|FG001|Overall Study|Adverse Event|3|||
124668999|NCT02692586|448412457|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
124669000|NCT02692586|448412457|FG000|Overall Study|Received adjunctive thrombolytics|2|||
124669001|NCT03506438|448412459|FG000|Overall Study|Lost to Follow-up|8|||
124669002|NCT03506438|448412460|FG001|Overall Study|Lost to Follow-up|7|||
124669003|NCT03506438|448412461|FG002|Overall Study|Lost to Follow-up|8|||
124669004|NCT03506438|448412462|FG003|Overall Study|Lost to Follow-up|7|||
124669005|NCT03506438|448412463|FG004|Overall Study|Lost to Follow-up|0|||
124669006|NCT03506438|448412464|FG005|Overall Study|Lost to Follow-up|0|||
124669007|NCT01128296|448412465|FG000|Overall Study|Physician Decision|0|||
124669008|NCT01128296|448412466|FG001|Overall Study|Physician Decision|0|||
124669009|NCT01128296|448412467|FG002|Overall Study|Physician Decision|0|||
124669010|NCT01128296|448412468|FG003|Overall Study|Physician Decision|0|||
124669011|NCT01128296|448412469|FG004|Overall Study|Physician Decision|0|||
124669012|NCT01128296|448412470|FG005|Overall Study|Physician Decision|3|||
124669013|NCT01128296|448412465|FG000|Overall Study|Withdrawal by Subject|0|||
124669014|NCT01128296|448412466|FG001|Overall Study|Withdrawal by Subject|0|||
124669015|NCT01128296|448412467|FG002|Overall Study|Withdrawal by Subject|0|||
124669016|NCT01128296|448412468|FG003|Overall Study|Withdrawal by Subject|0|||
124669017|NCT01128296|448412469|FG004|Overall Study|Withdrawal by Subject|0|||
124669018|NCT01128296|448412470|FG005|Overall Study|Withdrawal by Subject|2|||
124669019|NCT03316586|448412471|FG000|Overall Study|Adverse Event|2|||
124669020|NCT03316586|448412471|FG000|Overall Study|Physician Decision|3|||
124669021|NCT03316586|448412471|FG000|Overall Study|Lack of Efficacy|10|||
124669022|NCT03316586|448412471|FG000|Overall Study|still on treatment|1|||
124669023|NCT03316586|448412471|FG000|Overall Study|Patient needed radiation therapy|1|||
124669024|NCT03316586|448412471|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
124669025|NCT01396083|448412472|FG000|Overall Study|Adverse Event|2|||
124669026|NCT01396083|448412473|FG001|Overall Study|Adverse Event|28|||
124669027|NCT01396083|448412472|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124669028|NCT01396083|448412473|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
124669029|NCT01396083|448412472|FG000|Overall Study|Consent withdrawn|4|||
124669030|NCT01396083|448412473|FG001|Overall Study|Consent withdrawn|5|||
124669031|NCT01396083|448412472|FG000|Overall Study|Protocol deviation(s)|0|||
124669032|NCT01396083|448412473|FG001|Overall Study|Protocol deviation(s)|1|||
124669033|NCT01396083|448412472|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124669034|NCT01396083|448412473|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124669035|NCT01396083|448412472|FG000|Overall Study|Administrative problems|1|||
124669036|NCT01396083|448412473|FG001|Overall Study|Administrative problems|0|||
124669037|NCT01396083|448412472|FG000|Overall Study|Lost to Follow-up|1|||
124669038|NCT01396083|448412473|FG001|Overall Study|Lost to Follow-up|0|||
124669039|NCT02806713|448412474|FG000|Overall Study|Urethral injury during procedure|1|||
124669040|NCT02806713|448412475|FG001|Overall Study|Urethral injury during procedure|0|||
124669041|NCT02806713|448412474|FG000|Overall Study|cancelled surgery|1|||
124669042|NCT02806713|448412475|FG001|Overall Study|cancelled surgery|2|||
124669043|NCT00735709|448412476|FG000|Overall Study|Adverse Event|2|||
124669044|NCT00735709|448412477|FG001|Overall Study|Adverse Event|3|||
124669045|NCT00735709|448412478|FG002|Overall Study|Adverse Event|1|||
124669046|NCT00735709|448412479|FG003|Overall Study|Adverse Event|5|||
124669047|NCT00735709|448412476|FG000|Overall Study|Lack of Efficacy|8|||
124669048|NCT00735709|448412477|FG001|Overall Study|Lack of Efficacy|4|||
124669049|NCT00735709|448412478|FG002|Overall Study|Lack of Efficacy|2|||
124669050|NCT00735709|448412479|FG003|Overall Study|Lack of Efficacy|3|||
124669051|NCT00735709|448412476|FG000|Overall Study|Noncompliance|0|||
124669052|NCT00735709|448412477|FG001|Overall Study|Noncompliance|0|||
124669053|NCT00735709|448412478|FG002|Overall Study|Noncompliance|1|||
124669054|NCT00735709|448412479|FG003|Overall Study|Noncompliance|0|||
124669055|NCT00735709|448412476|FG000|Overall Study|Protocol deviations|1|||
124669056|NCT00735709|448412477|FG001|Overall Study|Protocol deviations|2|||
124669057|NCT00735709|448412478|FG002|Overall Study|Protocol deviations|1|||
124669058|NCT00735709|448412479|FG003|Overall Study|Protocol deviations|1|||
124669059|NCT00735709|448412476|FG000|Overall Study|Voluntary Withdrawal|1|||
124669060|NCT00735709|448412477|FG001|Overall Study|Voluntary Withdrawal|3|||
124669061|NCT00735709|448412478|FG002|Overall Study|Voluntary Withdrawal|5|||
124669062|NCT00735709|448412479|FG003|Overall Study|Voluntary Withdrawal|7|||
124669063|NCT00735709|448412476|FG000|Overall Study|Lost to Follow-up|0|||
124669064|NCT00735709|448412477|FG001|Overall Study|Lost to Follow-up|1|||
124669065|NCT00735709|448412478|FG002|Overall Study|Lost to Follow-up|1|||
124669066|NCT00735709|448412479|FG003|Overall Study|Lost to Follow-up|1|||
124669067|NCT00735709|448412476|FG000|Overall Study|Excluded medication|1|||
124669068|NCT00735709|448412477|FG001|Overall Study|Excluded medication|0|||
124669069|NCT00735709|448412478|FG002|Overall Study|Excluded medication|0|||
124669070|NCT00735709|448412479|FG003|Overall Study|Excluded medication|1|||
124669071|NCT01165307|448412480|FG000|Overall Study|Lost to Follow-up|11|||
124669072|NCT01165307|448412481|FG001|Overall Study|Lost to Follow-up|3|||
124669073|NCT01165307|448412480|FG000|Overall Study|Withdrawal by Subject|2|||
124669074|NCT01165307|448412481|FG001|Overall Study|Withdrawal by Subject|0|||
124669075|NCT01165307|448412480|FG000|Overall Study|Subject not available for contact|1|||
124669076|NCT01165307|448412481|FG001|Overall Study|Subject not available for contact|0|||
124669077|NCT01718483|448412485|FG000|Overall Study|Withdrawal by Subject|14|||
124669078|NCT01718483|448412486|FG001|Overall Study|Withdrawal by Subject|12|||
124669079|NCT01718483|448412485|FG000|Overall Study|Adverse Event|5|||
124669080|NCT01718483|448412486|FG001|Overall Study|Adverse Event|12|||
124669081|NCT01718483|448412485|FG000|Overall Study|Lost to Follow-up|8|||
124669082|NCT01718483|448412486|FG001|Overall Study|Lost to Follow-up|3|||
124669083|NCT01718483|448412485|FG000|Overall Study|Protocol Violation|4|||
124669084|NCT01718483|448412486|FG001|Overall Study|Protocol Violation|2|||
124669085|NCT01718483|448412485|FG000|Overall Study|Other|1|||
124669086|NCT01718483|448412486|FG001|Overall Study|Other|4|||
124669087|NCT01718483|448412485|FG000|Overall Study|Pregnancy|1|||
124669088|NCT01718483|448412486|FG001|Overall Study|Pregnancy|1|||
124669089|NCT01718483|448412485|FG000|Overall Study|Lack of Efficacy|1|||
124669090|NCT01718483|448412486|FG001|Overall Study|Lack of Efficacy|0|||
124669091|NCT01831427|448412489|FG000|Overall Study|Adverse Event|0|||
124669092|NCT01831427|448412490|FG001|Overall Study|Adverse Event|1|||
124669093|NCT01831427|448412491|FG002|Overall Study|Adverse Event|0|||
124669094|NCT01831427|448412492|FG003|Overall Study|Adverse Event|0|||
124669095|NCT01831427|448412493|FG004|Overall Study|Adverse Event|0|||
124669096|NCT01831427|448412494|FG005|Overall Study|Adverse Event|1|||
124669097|NCT01831427|448412495|FG006|Overall Study|Adverse Event|0|||
124669098|NCT01831427|448412496|FG007|Overall Study|Adverse Event|1|||
124669099|NCT01831427|448412497|FG008|Overall Study|Adverse Event|0|||
124669100|NCT01831427|448412498|FG009|Overall Study|Adverse Event|0|||
124669101|NCT01831427|448412499|FG010|Overall Study|Adverse Event|2|||
124669102|NCT01831427|448412489|FG000|Overall Study|Investigator's Discretion|0|||
124669103|NCT01831427|448412490|FG001|Overall Study|Investigator's Discretion|0|||
124669104|NCT01831427|448412491|FG002|Overall Study|Investigator's Discretion|0|||
124669105|NCT01831427|448412492|FG003|Overall Study|Investigator's Discretion|1|||
124669106|NCT01831427|448412493|FG004|Overall Study|Investigator's Discretion|0|||
124669107|NCT01831427|448412494|FG005|Overall Study|Investigator's Discretion|0|||
124669108|NCT01831427|448412495|FG006|Overall Study|Investigator's Discretion|0|||
124669109|NCT01831427|448412496|FG007|Overall Study|Investigator's Discretion|0|||
124669110|NCT01831427|448412497|FG008|Overall Study|Investigator's Discretion|0|||
124669111|NCT01831427|448412498|FG009|Overall Study|Investigator's Discretion|0|||
124669112|NCT01831427|448412499|FG010|Overall Study|Investigator's Discretion|0|||
124669113|NCT01831427|448412489|FG000|Overall Study|Withdrew Consent|0|||
124669114|NCT01831427|448412490|FG001|Overall Study|Withdrew Consent|0|||
124669115|NCT01831427|448412491|FG002|Overall Study|Withdrew Consent|0|||
124669116|NCT01831427|448412492|FG003|Overall Study|Withdrew Consent|0|||
124669117|NCT01831427|448412493|FG004|Overall Study|Withdrew Consent|0|||
124669118|NCT01831427|448412494|FG005|Overall Study|Withdrew Consent|0|||
124669119|NCT01831427|448412495|FG006|Overall Study|Withdrew Consent|2|||
124669120|NCT01831427|448412496|FG007|Overall Study|Withdrew Consent|0|||
124669121|NCT01831427|448412497|FG008|Overall Study|Withdrew Consent|0|||
124669122|NCT01831427|448412498|FG009|Overall Study|Withdrew Consent|1|||
124669123|NCT01831427|448412499|FG010|Overall Study|Withdrew Consent|1|||
124669124|NCT00536510|448412500|FG000|Overall Study|Adverse Event|27|||
124669125|NCT00536510|448412501|FG001|Overall Study|Adverse Event|4|||
124669126|NCT00536510|448412500|FG000|Overall Study|Lost to Follow-up|11|||
124669127|NCT00536510|448412501|FG001|Overall Study|Lost to Follow-up|8|||
124669128|NCT00536510|448412500|FG000|Overall Study|Protocol Violation|4|||
124669129|NCT00536510|448412501|FG001|Overall Study|Protocol Violation|5|||
124669130|NCT00536510|448412500|FG000|Overall Study|Withdrawal by Subject|16|||
124669131|NCT00536510|448412501|FG001|Overall Study|Withdrawal by Subject|9|||
124669132|NCT00536510|448412500|FG000|Overall Study|Flushing with Product|20|||
124669133|NCT00536510|448412501|FG001|Overall Study|Flushing with Product|0|||
124669134|NCT00536510|448412500|FG000|Overall Study|Laboratory Adverse Event|2|||
124669135|NCT00536510|448412501|FG001|Overall Study|Laboratory Adverse Event|1|||
124669136|NCT00536510|448412500|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
124669137|NCT00536510|448412501|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
124669138|NCT02169505|448412502|FG000|Overall Study|Withdrawal by Subject|1|||
124669139|NCT04110314|448412503|FG000|Overall Study|Did not meet inclusion criteria|35255|||
124669140|NCT04110314|448412504|FG001|Overall Study|Did not meet inclusion criteria|35104|||
124669141|NCT04110314|448412505|FG002|Overall Study|Did not meet inclusion criteria|35636|||
124669142|NCT04110314|448412506|FG003|Overall Study|Did not meet inclusion criteria|35135|||
124669143|NCT04110314|448412507|FG004|Overall Study|Did not meet inclusion criteria|35247|||
124669144|NCT04110314|448412508|FG005|Overall Study|Did not meet inclusion criteria|35727|||
124669145|NCT01004978|448412511|FG000|Overall Study|Disease progression|31|||
124669146|NCT01004978|448412512|FG001|Overall Study|Disease progression|48|||
124669147|NCT01004978|448412511|FG000|Overall Study|Adverse Event|42|||
124669148|NCT01004978|448412512|FG001|Overall Study|Adverse Event|22|||
124669149|NCT01004978|448412511|FG000|Overall Study|Death|3|||
124669150|NCT01004978|448412512|FG001|Overall Study|Death|2|||
124669151|NCT01004978|448412511|FG000|Overall Study|Withdrawal by Subject|16|||
124669152|NCT01004978|448412512|FG001|Overall Study|Withdrawal by Subject|16|||
124669153|NCT01004978|448412511|FG000|Overall Study|Alternative therapy|4|||
124669154|NCT01004978|448412512|FG001|Overall Study|Alternative therapy|8|||
124669155|NCT01004978|448412511|FG000|Overall Study|Physician Decision|6|||
124669156|NCT01004978|448412512|FG001|Overall Study|Physician Decision|3|||
124669157|NCT01004978|448412511|FG000|Overall Study|Other complicating disease|2|||
124669158|NCT01004978|448412512|FG001|Overall Study|Other complicating disease|2|||
124669159|NCT01004978|448412511|FG000|Overall Study|Protocol Violation|2|||
124669160|NCT01004978|448412512|FG001|Overall Study|Protocol Violation|3|||
124669161|NCT01004978|448412511|FG000|Overall Study|Non-compliance|3|||
124669162|NCT01004978|448412512|FG001|Overall Study|Non-compliance|2|||
124669163|NCT01004978|448412511|FG000|Overall Study|Ineligible|1|||
124669164|NCT01004978|448412512|FG001|Overall Study|Ineligible|0|||
124669165|NCT01004978|448412511|FG000|Overall Study|Unblinded|0|||
124669166|NCT01004978|448412512|FG001|Overall Study|Unblinded|1|||
124669167|NCT01004978|448412511|FG000|Overall Study|Performance status worsening|0|||
124669168|NCT01004978|448412512|FG001|Overall Study|Performance status worsening|1|||
124669169|NCT01004978|448412511|FG000|Overall Study|Never started treatment|8|||
124669170|NCT01004978|448412512|FG001|Overall Study|Never started treatment|9|||
124669171|NCT02326272|448412513|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124669172|NCT02326272|448412514|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
124669173|NCT02326272|448412515|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
124669174|NCT02326272|448412516|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124669175|NCT02326272|448412517|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124669176|NCT02326272|448412518|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124669177|NCT02326272|448412519|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124669178|NCT02326272|448412520|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124669179|NCT02326272|448412521|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124669180|NCT02326272|448412522|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124669181|NCT02326272|448412523|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124669182|NCT02326272|448412524|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124669183|NCT02326272|448412525|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124669184|NCT02326272|448412526|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124669185|NCT02326272|448412527|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124669186|NCT02326272|448412513|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
124669187|NCT02326272|448412514|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
124669188|NCT02326272|448412515|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124669189|NCT02326272|448412516|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124669190|NCT02326272|448412517|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124669191|NCT02326272|448412518|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124669192|NCT02326272|448412519|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124669193|NCT02326272|448412520|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124669194|NCT02326272|448412521|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124669195|NCT02326272|448412522|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124669196|NCT02326272|448412523|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124669197|NCT02326272|448412524|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124669198|NCT02326272|448412525|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124669199|NCT02326272|448412526|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124669200|NCT02326272|448412527|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
124669201|NCT02326272|448412513|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
124669202|NCT02326272|448412514|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
124669203|NCT02326272|448412515|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
124669204|NCT02326272|448412516|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124669205|NCT02326272|448412517|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124669206|NCT02326272|448412518|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124669207|NCT02326272|448412519|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124669208|NCT02326272|448412520|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124669209|NCT02326272|448412521|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124669210|NCT02326272|448412522|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124669211|NCT02326272|448412523|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124669212|NCT02326272|448412524|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124669213|NCT02326272|448412525|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124669214|NCT02326272|448412526|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124669215|NCT02326272|448412527|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124669216|NCT02326272|448412513|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
124669217|NCT02326272|448412514|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
124669218|NCT02326272|448412515|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
124669219|NCT02326272|448412516|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
124669220|NCT02326272|448412517|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
124669221|NCT02326272|448412518|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
124669222|NCT02326272|448412519|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
124669223|NCT02326272|448412520|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
124669224|NCT02326272|448412521|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
124669225|NCT02326272|448412522|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
124669226|NCT02326272|448412523|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
124669227|NCT02326272|448412524|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
124669228|NCT02326272|448412525|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
124669229|NCT02326272|448412526|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
124669230|NCT02326272|448412527|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
124669231|NCT02326272|448412513|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
124669232|NCT02326272|448412514|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
124669233|NCT02326272|448412515|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
124669234|NCT02326272|448412516|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
124669235|NCT02326272|448412517|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
124669236|NCT02326272|448412518|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
124669237|NCT02326272|448412519|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
124669238|NCT02326272|448412520|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
124669239|NCT02326272|448412521|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
124669240|NCT02326272|448412522|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
124669241|NCT02326272|448412523|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
124669242|NCT02326272|448412524|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
124669243|NCT02326272|448412525|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
124669244|NCT02326272|448412526|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
124669245|NCT02326272|448412527|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
124669246|NCT02326272|448412513|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
124669247|NCT02326272|448412514|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
124669248|NCT02326272|448412515|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
124669249|NCT02326272|448412516|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
124669250|NCT02326272|448412517|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
124669251|NCT02326272|448412518|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
124669252|NCT02326272|448412519|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
124669253|NCT02326272|448412520|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
124669254|NCT02326272|448412521|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
124669255|NCT02326272|448412522|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
124669256|NCT02326272|448412523|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
124669257|NCT02326272|448412524|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
124669258|NCT02326272|448412525|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
124669259|NCT02326272|448412526|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
124669260|NCT02326272|448412527|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
124669261|NCT02326272|448412513|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
124669262|NCT02326272|448412514|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
124669263|NCT02326272|448412515|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
124669264|NCT02326272|448412516|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
124669265|NCT02326272|448412517|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
124669266|NCT02326272|448412518|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
124669267|NCT02326272|448412519|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
124669268|NCT02326272|448412520|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
124669269|NCT02326272|448412521|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
124669270|NCT02326272|448412522|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
124669271|NCT02326272|448412523|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
124669272|NCT02326272|448412524|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
124669273|NCT02326272|448412525|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
124669274|NCT02326272|448412526|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
124669275|NCT02326272|448412527|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
124669276|NCT02326272|448412513|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124669277|NCT02326272|448412514|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124669278|NCT02326272|448412515|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124669279|NCT02326272|448412516|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124669280|NCT02326272|448412517|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
124669281|NCT02326272|448412518|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
124669282|NCT02326272|448412519|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
124669283|NCT02326272|448412520|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
124669284|NCT02326272|448412521|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
124669285|NCT02326272|448412522|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124669286|NCT02326272|448412523|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124669287|NCT02326272|448412524|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124669288|NCT02326272|448412525|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124669289|NCT02326272|448412526|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124669290|NCT02326272|448412527|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124669291|NCT02326272|448412513|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124669292|NCT02326272|448412514|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124669293|NCT02326272|448412515|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124669294|NCT02326272|448412516|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124669295|NCT02326272|448412517|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124669296|NCT02326272|448412518|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
124669297|NCT02326272|448412519|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
124669298|NCT02326272|448412520|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124669299|NCT02326272|448412521|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
124669300|NCT02326272|448412522|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
124669301|NCT02326272|448412523|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124669302|NCT02326272|448412524|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124669303|NCT02326272|448412525|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124669304|NCT02326272|448412526|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124669305|NCT02326272|448412527|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124669306|NCT02326272|448412513|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124669307|NCT02326272|448412514|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124669308|NCT02326272|448412515|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124669309|NCT02326272|448412516|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124669310|NCT02326272|448412517|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124669311|NCT02326272|448412518|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
124669312|NCT02326272|448412519|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124669313|NCT02326272|448412520|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
124669314|NCT02326272|448412521|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124669315|NCT02326272|448412522|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124669316|NCT02326272|448412523|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124669317|NCT02326272|448412524|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124669318|NCT02326272|448412525|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124669319|NCT02326272|448412526|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124669320|NCT02326272|448412527|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124669321|NCT02326272|448412513|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124669322|NCT02326272|448412514|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124669323|NCT02326272|448412515|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124669324|NCT02326272|448412516|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124669325|NCT02326272|448412517|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124669326|NCT02326272|448412518|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
124669327|NCT02326272|448412519|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124669328|NCT02326272|448412520|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124669329|NCT02326272|448412521|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124669330|NCT02326272|448412522|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124669331|NCT02326272|448412523|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124669332|NCT02326272|448412524|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124669333|NCT02326272|448412525|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124669334|NCT02326272|448412526|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124669335|NCT02326272|448412527|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124669336|NCT02326272|448412513|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
124669337|NCT02326272|448412514|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
124669338|NCT02326272|448412515|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
124669339|NCT02326272|448412516|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
124669340|NCT02326272|448412517|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
124669341|NCT02326272|448412518|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
124711981|NCT00688467|448570699|FG000|Treatment Period 2|Protocol Violation|0|||
124669342|NCT02326272|448412519|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
124669343|NCT02326272|448412520|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
124669344|NCT02326272|448412521|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
124669345|NCT02326272|448412522|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
124669346|NCT02326272|448412523|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
124669347|NCT02326272|448412524|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
124669348|NCT02326272|448412525|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
124669349|NCT02326272|448412526|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
124669350|NCT02326272|448412527|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
124669351|NCT02326272|448412513|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124669352|NCT02326272|448412514|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124669353|NCT02326272|448412515|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124669354|NCT02326272|448412516|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124669355|NCT02326272|448412517|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124669356|NCT02326272|448412518|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124669357|NCT02326272|448412519|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
124669358|NCT02326272|448412520|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124669359|NCT02326272|448412521|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124669360|NCT02326272|448412522|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124669361|NCT02326272|448412523|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124669362|NCT02326272|448412524|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124669363|NCT02326272|448412525|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124669364|NCT02326272|448412526|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124669365|NCT02326272|448412527|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
124669366|NCT02326272|448412513|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
124669367|NCT02326272|448412514|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
124669368|NCT02326272|448412515|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
124669369|NCT02326272|448412516|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
124669370|NCT02326272|448412517|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
124669371|NCT02326272|448412518|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
124669372|NCT02326272|448412519|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
124669373|NCT02326272|448412520|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
124669374|NCT02326272|448412521|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
124669375|NCT02326272|448412522|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
124669376|NCT02326272|448412523|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
124669377|NCT02326272|448412524|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
124669378|NCT02326272|448412525|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
124669379|NCT02326272|448412526|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
124669380|NCT02326272|448412527|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
124669381|NCT02326272|448412513|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124669382|NCT02326272|448412514|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124669383|NCT02326272|448412515|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124669384|NCT02326272|448412516|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124669385|NCT02326272|448412517|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124669386|NCT02326272|448412518|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
124669387|NCT02326272|448412519|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
124669388|NCT02326272|448412520|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
124669389|NCT02326272|448412521|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
124669390|NCT02326272|448412522|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124669391|NCT02326272|448412523|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124669392|NCT02326272|448412524|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124669393|NCT02326272|448412525|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124669394|NCT02326272|448412526|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124669395|NCT02326272|448412527|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124669396|NCT02326272|448412513|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
124669397|NCT02326272|448412514|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
124669398|NCT02326272|448412515|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
124669399|NCT02326272|448412516|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
124669400|NCT02326272|448412517|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
124669401|NCT02326272|448412518|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
124669402|NCT02326272|448412519|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
124669403|NCT02326272|448412520|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
124669404|NCT02326272|448412521|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
124669405|NCT02326272|448412522|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
124669406|NCT02326272|448412523|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
124669407|NCT02326272|448412524|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
124669408|NCT02326272|448412525|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
124669409|NCT02326272|448412526|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
124669410|NCT02326272|448412527|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
124669411|NCT02326272|448412513|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
124669412|NCT02326272|448412514|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
124669413|NCT02326272|448412515|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
124669414|NCT02326272|448412516|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
124669415|NCT02326272|448412517|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
124669416|NCT02326272|448412518|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
124669417|NCT02326272|448412519|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
124669418|NCT02326272|448412520|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
124669419|NCT02326272|448412521|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
124669420|NCT02326272|448412522|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
124669421|NCT02326272|448412523|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
124669422|NCT02326272|448412524|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
124669423|NCT02326272|448412525|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
124669424|NCT02326272|448412526|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
124669425|NCT02326272|448412527|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
124669426|NCT02326272|448412513|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
124669427|NCT02326272|448412514|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
124669428|NCT02326272|448412515|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
124669429|NCT02326272|448412516|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
124669430|NCT02326272|448412517|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
124669431|NCT02326272|448412518|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
124669432|NCT02326272|448412519|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
124669433|NCT02326272|448412520|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
124669434|NCT02326272|448412521|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
124669435|NCT02326272|448412522|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
124669436|NCT02326272|448412523|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
124669437|NCT02326272|448412524|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
124669438|NCT02326272|448412525|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
124669439|NCT02326272|448412526|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
124669440|NCT02326272|448412527|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
124669441|NCT02326272|448412513|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124669442|NCT02326272|448412514|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124669443|NCT02326272|448412515|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124669444|NCT02326272|448412516|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124669445|NCT02326272|448412517|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124669446|NCT02326272|448412518|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124669447|NCT02326272|448412519|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124669448|NCT02326272|448412520|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124669449|NCT02326272|448412521|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124669450|NCT02326272|448412522|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124669451|NCT02326272|448412523|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
124669452|NCT02326272|448412524|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
124669453|NCT02326272|448412525|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
124669454|NCT02326272|448412526|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
124669455|NCT02326272|448412527|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
124669456|NCT02326272|448412513|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124669457|NCT02326272|448412514|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124669458|NCT02326272|448412515|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124669459|NCT02326272|448412516|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124669460|NCT02326272|448412517|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124669461|NCT02326272|448412518|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124669462|NCT02326272|448412519|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124669463|NCT02326272|448412520|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124669464|NCT02326272|448412521|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124669465|NCT02326272|448412522|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124669466|NCT02326272|448412523|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
124669467|NCT02326272|448412524|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124669468|NCT02326272|448412525|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
124669469|NCT02326272|448412526|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124669470|NCT02326272|448412527|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124669471|NCT02326272|448412513|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124669472|NCT02326272|448412514|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124669473|NCT02326272|448412515|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124669474|NCT02326272|448412516|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124669475|NCT02326272|448412517|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124669476|NCT02326272|448412518|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124669477|NCT02326272|448412519|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124669478|NCT02326272|448412520|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124669479|NCT02326272|448412521|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124669480|NCT02326272|448412522|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124669481|NCT02326272|448412523|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124669482|NCT02326272|448412524|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
124669483|NCT02326272|448412525|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124669484|NCT02326272|448412526|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124669485|NCT02326272|448412527|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
124669486|NCT02326272|448412513|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124669487|NCT02326272|448412514|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124669488|NCT02326272|448412515|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124669489|NCT02326272|448412516|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124669490|NCT02326272|448412517|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124669491|NCT02326272|448412518|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124669492|NCT02326272|448412519|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124669493|NCT02326272|448412520|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124669494|NCT02326272|448412521|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124669495|NCT02326272|448412522|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124669496|NCT02326272|448412523|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
124669497|NCT02326272|448412524|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124669498|NCT02326272|448412525|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
124669499|NCT02326272|448412526|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124669500|NCT02326272|448412527|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
124669501|NCT02326272|448412513|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124669502|NCT02326272|448412514|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124669503|NCT02326272|448412515|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124669504|NCT02326272|448412516|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124669505|NCT02326272|448412517|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124669506|NCT02326272|448412518|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124669507|NCT02326272|448412519|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124669508|NCT02326272|448412520|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124669509|NCT02326272|448412521|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124669510|NCT02326272|448412522|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124669511|NCT02326272|448412523|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124669512|NCT02326272|448412524|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
124669513|NCT02326272|448412525|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124669514|NCT02326272|448412526|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124669515|NCT02326272|448412527|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
124669516|NCT02326272|448412513|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124669517|NCT02326272|448412514|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124669518|NCT02326272|448412515|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124669519|NCT02326272|448412516|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124669520|NCT02326272|448412517|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124669521|NCT02326272|448412518|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124669522|NCT02326272|448412519|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124669523|NCT02326272|448412520|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124669524|NCT02326272|448412521|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124669525|NCT02326272|448412522|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124669526|NCT02326272|448412523|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124669527|NCT02326272|448412524|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
124669528|NCT02326272|448412525|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
124669529|NCT02326272|448412526|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
124669530|NCT02326272|448412527|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
124669531|NCT02326272|448412513|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
124669532|NCT02326272|448412514|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
124669533|NCT02326272|448412515|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
124669534|NCT02326272|448412516|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
124669535|NCT02326272|448412517|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
124669536|NCT02326272|448412518|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
124669537|NCT02326272|448412519|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
124669538|NCT02326272|448412520|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
124669539|NCT02326272|448412521|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
124669540|NCT02326272|448412522|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
124669541|NCT02326272|448412523|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
124669542|NCT02326272|448412524|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
124669543|NCT02326272|448412525|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
124669544|NCT02326272|448412526|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
124669545|NCT02326272|448412527|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
124669546|NCT02326272|448412513|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
124669547|NCT02326272|448412514|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
124669548|NCT02326272|448412515|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
124669549|NCT02326272|448412516|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
124669550|NCT02326272|448412517|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
124669551|NCT02326272|448412518|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
124669552|NCT02326272|448412519|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
124669553|NCT02326272|448412520|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
124669554|NCT02326272|448412521|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
124669555|NCT02326272|448412522|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
124669556|NCT02326272|448412523|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
124669557|NCT02326272|448412524|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
124669558|NCT02326272|448412525|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
124669559|NCT02326272|448412526|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
124669560|NCT02326272|448412527|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
124669561|NCT00268983|448412528|FG000|Overall Study|Death|3|||
124669562|NCT00268983|448412529|FG001|Overall Study|Death|0|||
124669563|NCT00809445|448412535|FG000|1 Month Follow-up|Lost contact|1|||
124669564|NCT00809445|448412536|FG001|1 Month Follow-up|Lost contact|2|||
124669565|NCT00809445|448412537|FG002|1 Month Follow-up|Lost contact|1|||
124669566|NCT00809445|448412535|FG000|1 Month Follow-up|Withdrew consent|1|||
124669567|NCT00809445|448412536|FG001|1 Month Follow-up|Withdrew consent|1|||
124669568|NCT00809445|448412537|FG002|1 Month Follow-up|Withdrew consent|1|||
124669569|NCT00809445|448412535|FG000|1 Month Follow-up|Death|0|||
124669570|NCT00809445|448412536|FG001|1 Month Follow-up|Death|1|||
124669571|NCT00809445|448412537|FG002|1 Month Follow-up|Death|1|||
124669572|NCT00809445|448412535|FG000|1 Month Follow-up|Incarcerated|0|||
124669573|NCT00809445|448412536|FG001|1 Month Follow-up|Incarcerated|0|||
124669574|NCT00809445|448412537|FG002|1 Month Follow-up|Incarcerated|1|||
124669575|NCT00809445|448412535|FG000|6 Month Follow-up|Lost contact|16|||
124669576|NCT00809445|448412536|FG001|6 Month Follow-up|Lost contact|14|||
124669577|NCT00809445|448412537|FG002|6 Month Follow-up|Lost contact|14|||
124669578|NCT00809445|448412535|FG000|6 Month Follow-up|Death|2|||
124669579|NCT00809445|448412536|FG001|6 Month Follow-up|Death|1|||
124669580|NCT00809445|448412537|FG002|6 Month Follow-up|Death|1|||
124669581|NCT00809445|448412535|FG000|6 Month Follow-up|Incarcerated|6|||
124669582|NCT00809445|448412536|FG001|6 Month Follow-up|Incarcerated|8|||
124669583|NCT00809445|448412537|FG002|6 Month Follow-up|Incarcerated|8|||
124669584|NCT00809445|448412535|FG000|6 Month Follow-up|Withdrew consent|0|||
124669585|NCT00809445|448412536|FG001|6 Month Follow-up|Withdrew consent|0|||
124669586|NCT00809445|448412537|FG002|6 Month Follow-up|Withdrew consent|1|||
124669587|NCT00676403|448412538|FG000|Overall Study|Adverse Event|1|||
124669588|NCT00676403|448412539|FG001|Overall Study|Adverse Event|2|||
124669589|NCT00676403|448412540|FG002|Overall Study|Adverse Event|0|||
124669590|NCT00676403|448412541|FG003|Overall Study|Adverse Event|5|||
124669591|NCT00676403|448412542|FG004|Overall Study|Adverse Event|1|||
124669592|NCT00676403|448412543|FG005|Overall Study|Adverse Event|2|||
124669593|NCT00676403|448412538|FG000|Overall Study|Lost to Follow-up|0|||
124669594|NCT00676403|448412539|FG001|Overall Study|Lost to Follow-up|0|||
124669595|NCT00676403|448412540|FG002|Overall Study|Lost to Follow-up|0|||
124669596|NCT00676403|448412541|FG003|Overall Study|Lost to Follow-up|0|||
124669597|NCT00676403|448412542|FG004|Overall Study|Lost to Follow-up|0|||
124669598|NCT00676403|448412543|FG005|Overall Study|Lost to Follow-up|1|||
124669599|NCT00676403|448412538|FG000|Overall Study|Reason Unspecified|1|||
124669600|NCT00676403|448412539|FG001|Overall Study|Reason Unspecified|0|||
124669601|NCT00676403|448412540|FG002|Overall Study|Reason Unspecified|1|||
124669602|NCT00676403|448412541|FG003|Overall Study|Reason Unspecified|0|||
124669603|NCT00676403|448412542|FG004|Overall Study|Reason Unspecified|0|||
124669604|NCT00676403|448412543|FG005|Overall Study|Reason Unspecified|1|||
124669605|NCT00676403|448412538|FG000|Overall Study|Withdrawal by Subject|0|||
124669606|NCT00676403|448412539|FG001|Overall Study|Withdrawal by Subject|0|||
124669607|NCT00676403|448412540|FG002|Overall Study|Withdrawal by Subject|0|||
124669608|NCT00676403|448412541|FG003|Overall Study|Withdrawal by Subject|0|||
124669609|NCT00676403|448412542|FG004|Overall Study|Withdrawal by Subject|0|||
124669610|NCT00676403|448412543|FG005|Overall Study|Withdrawal by Subject|1|||
124669611|NCT02048722|448412546|FG000|2 Cycles of Treatment|Adverse Event|2|||
124669612|NCT02048722|448412546|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
124669613|NCT02048722|448412546|FG000|2 Cycles of Treatment|Progressive Disease|2|||
124669614|NCT02048722|448412546|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
124669615|NCT02048722|448412546|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
124669616|NCT02048722|448412546|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
124669617|NCT05209880|448412549|FG000|1-Month Follow-up|Spoke with Doctor|5|||
124669618|NCT05209880|448412550|FG001|1-Month Follow-up|Spoke with Doctor|5|||
124669619|NCT05209880|448412549|FG000|1-Month Follow-up|Lost to Follow-up|7|||
124669620|NCT05209880|448412550|FG001|1-Month Follow-up|Lost to Follow-up|9|||
124669621|NCT05209880|448412549|FG000|1-Month Follow-up|Discontinued|0|||
124669622|NCT05209880|448412550|FG001|1-Month Follow-up|Discontinued|1|||
124669623|NCT05209880|448412549|FG000|3-Month Follow-up|Spoke with Doctor|17|||
124669624|NCT05209880|448412550|FG001|3-Month Follow-up|Spoke with Doctor|7|||
124669625|NCT05209880|448412549|FG000|3-Month Follow-up|Lost to Follow-up|8|||
124669626|NCT05209880|448412550|FG001|3-Month Follow-up|Lost to Follow-up|10|||
124669627|NCT05209880|448412549|FG000|3-Month Follow-up|Discontinued|1|||
124669628|NCT05209880|448412550|FG001|3-Month Follow-up|Discontinued|3|||
124669629|NCT05209880|448412549|FG000|6-Month Follow-up|Spoke with Doctor|25|||
124669630|NCT05209880|448412550|FG001|6-Month Follow-up|Spoke with Doctor|14|||
124669631|NCT05209880|448412549|FG000|6-Month Follow-up|Lost to Follow-up|9|||
124669632|NCT05209880|448412550|FG001|6-Month Follow-up|Lost to Follow-up|14|||
124669633|NCT05209880|448412549|FG000|6-Month Follow-up|Discontinued|1|||
124669634|NCT05209880|448412550|FG001|6-Month Follow-up|Discontinued|3|||
124669635|NCT00321906|448412554|FG000|Overall Study|Adverse Event|36|||
124669636|NCT00321906|448412555|FG001|Overall Study|Adverse Event|44|||
124669637|NCT00321906|448412554|FG000|Overall Study|Death|9|||
124669638|NCT00321906|448412555|FG001|Overall Study|Death|6|||
124669639|NCT00321906|448412554|FG000|Overall Study|Lost to Follow-up|1|||
124669640|NCT00321906|448412555|FG001|Overall Study|Lost to Follow-up|2|||
124669641|NCT00321906|448412554|FG000|Overall Study|Withdrawal by Subject|0|||
124669642|NCT00321906|448412555|FG001|Overall Study|Withdrawal by Subject|4|||
124669643|NCT01272908|448412556|FG000|Initial Treatment Period|Adverse Event|1|||
124669644|NCT01272908|448412556|FG000|Initial Treatment Period|Lack of Efficacy|5|||
124669645|NCT01272908|448412556|FG000|Initial Treatment Period|Protocol Violation|1|||
124669646|NCT01272908|448412556|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
124669647|NCT01272908|448412556|FG000|Re-Treatment Period|Adverse Event|2|||
124669648|NCT01272908|448412556|FG000|Re-Treatment Period|Lack of Efficacy|3|||
124669649|NCT01272908|448412556|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
124669650|NCT01158261|448412557|FG000|Overall Study|Lost to Follow-up|9|||
124669651|NCT01158261|448412557|FG000|Overall Study|Death|7|||
124669652|NCT01158261|448412557|FG000|Overall Study|Withdrawal by Subject|1|||
124669653|NCT03143101|448412558|FG000|Overall Study|Withdrawal by Subject|0|||
124669654|NCT03143101|448412559|FG001|Overall Study|Withdrawal by Subject|1|||
124669655|NCT03143101|448412560|FG002|Overall Study|Withdrawal by Subject|0|||
124669656|NCT03143101|448412558|FG000|Overall Study|Lost to Follow-up|2|||
124669657|NCT03143101|448412559|FG001|Overall Study|Lost to Follow-up|2|||
124669658|NCT03143101|448412560|FG002|Overall Study|Lost to Follow-up|0|||
124669659|NCT01630135|448412562|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
124669660|NCT01630135|448412563|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
124669661|NCT03243305|448412566|FG000|Overall Study|Lost to Follow-up|250|||
124669662|NCT03243305|448412566|FG000|Overall Study|Withdrawal by Subject|170|||
124669663|NCT03243305|448412566|FG000|Overall Study|Pregnancy|104|||
124669664|NCT03243305|448412566|FG000|Overall Study|Non-Compliance with Study Drug|38|||
124669665|NCT03243305|448412566|FG000|Overall Study|Adverse Event|23|||
124669666|NCT03243305|448412566|FG000|Overall Study|No sexually active|26|||
124669667|NCT03243305|448412566|FG000|Overall Study|Physician Decision|22|||
124669668|NCT03243305|448412566|FG000|Overall Study|Protocol Violation|22|||
124669669|NCT03243305|448412566|FG000|Overall Study|Study method no longer primary method|12|||
124669670|NCT03243305|448412566|FG000|Overall Study|Study Terminated by Sponsor|1|||
124669671|NCT03243305|448412566|FG000|Overall Study|Early terminations|267|||
124669672|NCT01497067|448412572|FG000|Overall Study|Lost to Follow-up|56|||
124669673|NCT01497067|448412572|FG000|Overall Study|Adverse Event|3|||
124669674|NCT01497067|448412572|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
124669675|NCT01497067|448412572|FG000|Overall Study|Other|13|||
124669676|NCT01598610|448412575|FG000|Overall Study|Adverse Event|1|||
124669677|NCT04346199|448412576|FG000|Overall Study|Death|8|||
124669678|NCT04346199|448412577|FG001|Overall Study|Death|9|||
124669679|NCT04346199|448412576|FG000|Overall Study|Lost to Follow-up|0|||
124669680|NCT04346199|448412577|FG001|Overall Study|Lost to Follow-up|1|||
124669681|NCT04346199|448412576|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
124669682|NCT04346199|448412577|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
124669683|NCT04346199|448412576|FG000|Overall Study|Withdrawal by Subject|5|||
124669684|NCT04346199|448412577|FG001|Overall Study|Withdrawal by Subject|1|||
124669685|NCT00485069|448412578|FG000|Overall Study|Adverse Event|10|||
124669686|NCT00485069|448412579|FG001|Overall Study|Adverse Event|4|||
124669687|NCT00485069|448412578|FG000|Overall Study|Lack of Efficacy|2|||
124669688|NCT00485069|448412579|FG001|Overall Study|Lack of Efficacy|1|||
124669689|NCT00485069|448412578|FG000|Overall Study|Protocol Violation|0|||
124669690|NCT00485069|448412579|FG001|Overall Study|Protocol Violation|1|||
124669691|NCT00485069|448412578|FG000|Overall Study|Withdrawal by Subject|6|||
124669692|NCT00485069|448412579|FG001|Overall Study|Withdrawal by Subject|6|||
124669693|NCT02989402|448412580|FG000|Overall Study|Adverse event, or serious adverse event|4|||
124669694|NCT02989402|448412580|FG000|Overall Study|Death|2|||
124669695|NCT02989402|448412580|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
124669696|NCT02989402|448412580|FG000|Overall Study|Lost to Follow-up|8|||
124669697|NCT02989402|448412580|FG000|Overall Study|Patient no longer on monotherapy|1|||
124669698|NCT02989402|448412580|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
124669699|NCT02989402|448412580|FG000|Overall Study|Withdrawal by Subject|7|||
124669700|NCT02989402|448412580|FG000|Overall Study|Other|2|||
124669701|NCT03066830|448412581|FG000|Overall Study|At the Participant's own Request|16|||
124669702|NCT03066830|448412582|FG001|Overall Study|At the Participant's own Request|17|||
124669703|NCT03066830|448412581|FG000|Overall Study|Other|3|||
124669704|NCT03066830|448412582|FG001|Overall Study|Other|0|||
124669705|NCT03066830|448412581|FG000|Overall Study|Poor Compliance to Protocol|1|||
124669706|NCT03066830|448412582|FG001|Overall Study|Poor Compliance to Protocol|0|||
124669707|NCT03066830|448412581|FG000|Overall Study|Adverse Event|2|||
124669708|NCT03066830|448412582|FG001|Overall Study|Adverse Event|2|||
124669709|NCT03066830|448412581|FG000|Overall Study|Lost to Follow-up|11|||
124669710|NCT03066830|448412582|FG001|Overall Study|Lost to Follow-up|3|||
124669711|NCT02039778|448412583|FG000|Overall Study|Death|2|||
124669712|NCT02039778|448412583|FG000|Overall Study|Withdrawal by Subject|1|||
124669713|NCT02039778|448412583|FG000|Overall Study|Never started the protocol treatment|1|||
124669714|NCT00992017|448412600|FG000|Overall Study|Lost to Follow-up|2|||
124669715|NCT00992017|448412600|FG000|Overall Study|Withdrawal by Subject|2|||
124669716|NCT00992017|448412600|FG000|Overall Study|Unable to get to clinic|5|||
124669717|NCT00992017|448412600|FG000|Overall Study|Not adhere to study requirements|1|||
124669718|NCT02864407|448412601|FG000|Overall Study|Protocol Violation|3|||
124669719|NCT02864407|448412601|FG000|Overall Study|Lost to Follow-up|115|||
124669720|NCT02864407|448412601|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
124669721|NCT02864407|448412601|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
124669722|NCT02864407|448412601|FG000|Overall Study|Consent prior to the contract date|1|||
124669723|NCT01827592|448412612|FG000|Overall Study|Adverse Event|11|||
124669724|NCT01827592|448412613|FG001|Overall Study|Adverse Event|9|||
124669725|NCT01827592|448412614|FG002|Overall Study|Adverse Event|2|||
124669726|NCT01827592|448412612|FG000|Overall Study|Physician Decision|0|||
124669727|NCT01827592|448412613|FG001|Overall Study|Physician Decision|2|||
124669728|NCT01827592|448412614|FG002|Overall Study|Physician Decision|1|||
124669729|NCT01827592|448412612|FG000|Overall Study|Protocol Violation|2|||
124669730|NCT01827592|448412613|FG001|Overall Study|Protocol Violation|1|||
124669731|NCT01827592|448412614|FG002|Overall Study|Protocol Violation|0|||
124669732|NCT01827592|448412612|FG000|Overall Study|Lost to Follow-up|1|||
124669733|NCT01827592|448412613|FG001|Overall Study|Lost to Follow-up|2|||
124669734|NCT01827592|448412614|FG002|Overall Study|Lost to Follow-up|2|||
124669735|NCT01827592|448412612|FG000|Overall Study|Withdrawal by Subject|12|||
124669736|NCT01827592|448412613|FG001|Overall Study|Withdrawal by Subject|11|||
124669737|NCT01827592|448412614|FG002|Overall Study|Withdrawal by Subject|11|||
124669738|NCT01827592|448412612|FG000|Overall Study|Patient's substantial non-compliance|1|||
124669739|NCT01827592|448412613|FG001|Overall Study|Patient's substantial non-compliance|1|||
124669740|NCT01827592|448412614|FG002|Overall Study|Patient's substantial non-compliance|6|||
124669741|NCT01827592|448412612|FG000|Overall Study|Trial terminated by Sponsor|47|||
124669742|NCT01827592|448412613|FG001|Overall Study|Trial terminated by Sponsor|53|||
124669743|NCT01827592|448412614|FG002|Overall Study|Trial terminated by Sponsor|51|||
124669744|NCT01827592|448412612|FG000|Overall Study|Others|0|||
124669745|NCT01827592|448412613|FG001|Overall Study|Others|1|||
124669746|NCT01827592|448412614|FG002|Overall Study|Others|3|||
124669747|NCT02849080|448412615|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
124669748|NCT02849080|448412616|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
124669749|NCT02849080|448412617|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
124669750|NCT02849080|448412618|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
124669751|NCT02849080|448412615|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
124669752|NCT02849080|448412616|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
124669753|NCT02849080|448412617|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
124669754|NCT02849080|448412618|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
124669755|NCT02849080|448412615|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
124669756|NCT02849080|448412616|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
124669757|NCT02849080|448412617|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
124669758|NCT02849080|448412618|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
124669759|NCT02849080|448412615|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
124669760|NCT02849080|448412616|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
124669761|NCT02849080|448412617|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
124669762|NCT02849080|448412618|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
124669763|NCT02849080|448412615|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
124669764|NCT02849080|448412616|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
124669765|NCT02849080|448412617|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
124669766|NCT02849080|448412618|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
124669767|NCT02849080|448412615|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
124669768|NCT02849080|448412616|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
124669769|NCT02849080|448412617|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
124669770|NCT02849080|448412618|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
124669771|NCT02493517|448412619|FG000|Overall Study|Protocol Violation|1|||
124669772|NCT02493517|448412620|FG001|Overall Study|Protocol Violation|2|||
124669773|NCT02493517|448412619|FG000|Overall Study|Withdrawal by Subject|1|||
124669774|NCT02493517|448412620|FG001|Overall Study|Withdrawal by Subject|2|||
124669775|NCT02493517|448412619|FG000|Overall Study|Adverse Event|0|||
124669776|NCT02493517|448412620|FG001|Overall Study|Adverse Event|2|||
124669777|NCT02493517|448412619|FG000|Overall Study|Missed study visit|0|||
124669778|NCT02493517|448412620|FG001|Overall Study|Missed study visit|1|||
124669779|NCT03718429|448412622|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
124669780|NCT03718429|448412623|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
124669781|NCT03718429|448412624|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
124669782|NCT03718429|448412625|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
124669783|NCT04632225|448412627|FG000|Overall Study|Withdrawal by Subject|2|||
124669784|NCT04632225|448412628|FG001|Overall Study|Withdrawal by Subject|2|||
124669785|NCT00325819|448412629|FG000|Overall Study|Study product lost in mail|2|||
124669786|NCT00325819|448412630|FG001|Overall Study|Study product lost in mail|1|||
124669787|NCT00325819|448412629|FG000|Overall Study|Did not take a dose of study product|4|||
124669788|NCT00325819|448412630|FG001|Overall Study|Did not take a dose of study product|9|||
124669789|NCT00325819|448412629|FG000|Overall Study|Lost to Follow-up|3|||
124669790|NCT00325819|448412630|FG001|Overall Study|Lost to Follow-up|3|||
124669791|NCT01817075|448412631|FG000|Overall Study|Adverse Event|7|||
124669792|NCT01817075|448412632|FG001|Overall Study|Adverse Event|5|||
124669793|NCT01817075|448412631|FG000|Overall Study|Physician Decision|9|||
124669794|NCT01817075|448412632|FG001|Overall Study|Physician Decision|12|||
124669795|NCT01817075|448412631|FG000|Overall Study|Withdrawal by Subject|31|||
124669796|NCT01817075|448412632|FG001|Overall Study|Withdrawal by Subject|15|||
124669797|NCT01817075|448412631|FG000|Overall Study|Received Sorafenib after enrollment|0|||
124669798|NCT01817075|448412632|FG001|Overall Study|Received Sorafenib after enrollment|1|||
124669799|NCT01817075|448412631|FG000|Overall Study|Ineligible|0|||
124669800|NCT01817075|448412632|FG001|Overall Study|Ineligible|2|||
124669801|NCT00611806|448414136|FG000|Overall Study|Withdrawal by Subject|8|||
124669802|NCT00611806|448414137|FG001|Overall Study|Withdrawal by Subject|2|||
124669803|NCT00611806|448414136|FG000|Overall Study|Adverse Event|2|||
124669804|NCT00611806|448414137|FG001|Overall Study|Adverse Event|1|||
124669805|NCT00611806|448414136|FG000|Overall Study|Lost to Follow-up|6|||
124669806|NCT00611806|448414137|FG001|Overall Study|Lost to Follow-up|0|||
124669807|NCT02317991|448414138|FG000|Overall Study|Adverse Event|12|||
124669808|NCT02317991|448414138|FG000|Overall Study|Death|4|||
124669809|NCT02317991|448414138|FG000|Overall Study|Withdrawal by Subject|8|||
124669810|NCT02317991|448414138|FG000|Overall Study|Progressive Disease|41|||
124669811|NCT01921517|448414139|FG000|Overall Study|Lost to Follow-up|5|||
124669812|NCT01921517|448414140|FG001|Overall Study|Lost to Follow-up|0|||
124669813|NCT01921517|448414139|FG000|Overall Study|Newly diagnosed health concern|2|||
124669814|NCT01921517|448414140|FG001|Overall Study|Newly diagnosed health concern|0|||
124669815|NCT01921517|448414139|FG000|Overall Study|Physician Decision|0|||
124669816|NCT01921517|448414140|FG001|Overall Study|Physician Decision|2|||
124669817|NCT01921517|448414139|FG000|Overall Study|Withdrawal by Subject|7|||
124669818|NCT01921517|448414140|FG001|Overall Study|Withdrawal by Subject|3|||
124669819|NCT01921517|448414139|FG000|Overall Study|Subject missed final imaging|1|||
124669820|NCT01921517|448414140|FG001|Overall Study|Subject missed final imaging|4|||
124669821|NCT01325350|448414143|FG000|Overall Study|Adverse Event|3|||
124669822|NCT01325350|448414144|FG001|Overall Study|Adverse Event|3|||
124669823|NCT01325350|448414145|FG002|Overall Study|Adverse Event|3|||
124669824|NCT01325350|448414146|FG003|Overall Study|Adverse Event|1|||
124669825|NCT01325350|448414147|FG004|Overall Study|Adverse Event|2|||
124669826|NCT01325350|448414143|FG000|Overall Study|Pregnancy|0|||
124669827|NCT01325350|448414144|FG001|Overall Study|Pregnancy|0|||
124669828|NCT01325350|448414145|FG002|Overall Study|Pregnancy|1|||
124669829|NCT01325350|448414146|FG003|Overall Study|Pregnancy|0|||
124669830|NCT01325350|448414147|FG004|Overall Study|Pregnancy|1|||
124669831|NCT01325350|448414143|FG000|Overall Study|Lost to Follow-up|1|||
124669832|NCT01325350|448414144|FG001|Overall Study|Lost to Follow-up|0|||
124669833|NCT01325350|448414145|FG002|Overall Study|Lost to Follow-up|5|||
124669834|NCT01325350|448414146|FG003|Overall Study|Lost to Follow-up|1|||
124669835|NCT01325350|448414147|FG004|Overall Study|Lost to Follow-up|5|||
124669836|NCT01325350|448414143|FG000|Overall Study|Personal Reasons|2|||
124669837|NCT01325350|448414144|FG001|Overall Study|Personal Reasons|1|||
124669838|NCT01325350|448414145|FG002|Overall Study|Personal Reasons|6|||
124669839|NCT01325350|448414146|FG003|Overall Study|Personal Reasons|5|||
124669840|NCT01325350|448414147|FG004|Overall Study|Personal Reasons|3|||
124669841|NCT01325350|448414143|FG000|Overall Study|Protocol Violation|0|||
124669842|NCT01325350|448414144|FG001|Overall Study|Protocol Violation|0|||
124669843|NCT01325350|448414145|FG002|Overall Study|Protocol Violation|0|||
124669844|NCT01325350|448414146|FG003|Overall Study|Protocol Violation|1|||
124669845|NCT01325350|448414147|FG004|Overall Study|Protocol Violation|0|||
124669846|NCT01325350|448414143|FG000|Overall Study|Withdrawal by Subject|0|||
124669847|NCT01325350|448414144|FG001|Overall Study|Withdrawal by Subject|0|||
124669848|NCT01325350|448414145|FG002|Overall Study|Withdrawal by Subject|1|||
124669849|NCT01325350|448414146|FG003|Overall Study|Withdrawal by Subject|1|||
124669850|NCT01325350|448414147|FG004|Overall Study|Withdrawal by Subject|0|||
124669851|NCT01325350|448414143|FG000|Overall Study|Did Not Receive Treatment|0|||
124669852|NCT01325350|448414144|FG001|Overall Study|Did Not Receive Treatment|1|||
124669853|NCT01325350|448414145|FG002|Overall Study|Did Not Receive Treatment|1|||
124669854|NCT01325350|448414146|FG003|Overall Study|Did Not Receive Treatment|0|||
124669855|NCT01325350|448414147|FG004|Overall Study|Did Not Receive Treatment|1|||
124669856|NCT04155463|448414150|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
124669857|NCT04155463|448414151|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
124669858|NCT01914393|448414156|FG000|Overall Study|Protocol Violation|11|||
124669859|NCT01914393|448414157|FG001|Overall Study|Protocol Violation|3|||
124669860|NCT01914393|448414158|FG002|Overall Study|Protocol Violation|19|||
124669861|NCT01914393|448414156|FG000|Overall Study|Lack of Efficacy|11|||
124669862|NCT01914393|448414157|FG001|Overall Study|Lack of Efficacy|16|||
124669863|NCT01914393|448414158|FG002|Overall Study|Lack of Efficacy|5|||
124669864|NCT01914393|448414156|FG000|Overall Study|no reason given|14|||
124669865|NCT01914393|448414157|FG001|Overall Study|no reason given|8|||
124669866|NCT01914393|448414158|FG002|Overall Study|no reason given|16|||
124669867|NCT01914393|448414156|FG000|Overall Study|Adverse Event|29|||
124669868|NCT01914393|448414157|FG001|Overall Study|Adverse Event|18|||
124669869|NCT01914393|448414158|FG002|Overall Study|Adverse Event|31|||
124669870|NCT01914393|448414156|FG000|Overall Study|Withdrawal by Subject|38|||
124669871|NCT01914393|448414157|FG001|Overall Study|Withdrawal by Subject|20|||
124669872|NCT01914393|448414158|FG002|Overall Study|Withdrawal by Subject|47|||
124669873|NCT01914393|448414156|FG000|Overall Study|Lost to Follow-up|12|||
124669874|NCT01914393|448414157|FG001|Overall Study|Lost to Follow-up|6|||
124669875|NCT01914393|448414158|FG002|Overall Study|Lost to Follow-up|19|||
124669876|NCT01914393|448414156|FG000|Overall Study|subject never dosed|0|||
124669877|NCT01914393|448414157|FG001|Overall Study|subject never dosed|0|||
124669878|NCT01914393|448414158|FG002|Overall Study|subject never dosed|1|||
124669879|NCT01063855|448414159|FG000|Overall Study|Adverse Event|4|||
124669880|NCT01063855|448414160|FG001|Overall Study|Adverse Event|4|||
124669881|NCT01063855|448414159|FG000|Overall Study|Death|0|||
124669882|NCT01063855|448414160|FG001|Overall Study|Death|1|||
124669883|NCT01063855|448414159|FG000|Overall Study|Lost to Follow-up|8|||
124669884|NCT01063855|448414160|FG001|Overall Study|Lost to Follow-up|4|||
124669885|NCT01063855|448414159|FG000|Overall Study|Pregnancy|1|||
124669886|NCT01063855|448414160|FG001|Overall Study|Pregnancy|0|||
124669887|NCT01063855|448414159|FG000|Overall Study|Lack of Efficacy|0|||
124669888|NCT01063855|448414160|FG001|Overall Study|Lack of Efficacy|1|||
124669889|NCT01063855|448414159|FG000|Overall Study|Withdrawal by Subject|11|||
124669890|NCT01063855|448414160|FG001|Overall Study|Withdrawal by Subject|8|||
124669891|NCT01063855|448414159|FG000|Overall Study|Reason not specified|13|||
124669892|NCT01063855|448414160|FG001|Overall Study|Reason not specified|11|||
124669893|NCT02163395|448414163|FG000|Overall Study|Withdrawal by Subject|1|||
124669894|NCT02163395|448414163|FG000|Overall Study|Lost to Follow-up|3|||
124669895|NCT02163395|448414163|FG000|Overall Study|Adverse Event|1|||
124669896|NCT03713684|448414180|FG000|Overall Study|Adverse Event|1|||
124669897|NCT03713684|448414181|FG001|Overall Study|Adverse Event|3|||
124669898|NCT03713684|448414182|FG002|Overall Study|Adverse Event|1|||
124669899|NCT03713684|448414183|FG003|Overall Study|Adverse Event|0|||
124669900|NCT03713684|448414180|FG000|Overall Study|Poor compliance to protocol|2|||
124669901|NCT03713684|448414181|FG001|Overall Study|Poor compliance to protocol|1|||
124669902|NCT03713684|448414182|FG002|Overall Study|Poor compliance to protocol|0|||
124669903|NCT03713684|448414183|FG003|Overall Study|Poor compliance to protocol|1|||
124669904|NCT03713684|448414180|FG000|Overall Study|Withdrawal by Subject|14|||
124669905|NCT03713684|448414181|FG001|Overall Study|Withdrawal by Subject|6|||
124669906|NCT03713684|448414182|FG002|Overall Study|Withdrawal by Subject|14|||
124669907|NCT03713684|448414183|FG003|Overall Study|Withdrawal by Subject|16|||
124669908|NCT03713684|448414180|FG000|Overall Study|Other than specified|69|||
124669909|NCT03713684|448414181|FG001|Overall Study|Other than specified|77|||
124669910|NCT03713684|448414182|FG002|Overall Study|Other than specified|73|||
124669911|NCT03713684|448414183|FG003|Overall Study|Other than specified|70|||
124669912|NCT02185417|448414184|FG000|Overall Study|Death|448|||
124669913|NCT02185417|448414185|FG001|Overall Study|Death|446|||
124669914|NCT02185417|448414186|FG002|Overall Study|Death|0|||
124669915|NCT02185417|448414184|FG000|Overall Study|Withdrawal by Subject|7|||
124669916|NCT02185417|448414185|FG001|Overall Study|Withdrawal by Subject|12|||
124669917|NCT02185417|448414186|FG002|Overall Study|Withdrawal by Subject|0|||
124669918|NCT02595502|448414187|FG000|Period 1|Adverse Event|0|||
124669919|NCT02595502|448414188|FG001|Period 1|Adverse Event|1|||
124669920|NCT02595502|448414187|FG000|Period 1|Withdrawal by Subject|1|||
124669921|NCT02595502|448414188|FG001|Period 1|Withdrawal by Subject|0|||
124669922|NCT02595502|448414187|FG000|Period 1|Lost to Follow-up|0|||
124669923|NCT02595502|448414188|FG001|Period 1|Lost to Follow-up|1|||
124669924|NCT02595502|448414187|FG000|Period 2|Adverse Event|1|||
124669925|NCT02595502|448414188|FG001|Period 2|Adverse Event|1|||
124669926|NCT02595502|448414187|FG000|Period 2|Received incorrect lens at Period 1|0|||
124669927|NCT02595502|448414188|FG001|Period 2|Received incorrect lens at Period 1|1|||
124669928|NCT02595502|448414187|FG000|Period 3|Protocol Violation|0|||
124669929|NCT02595502|448414188|FG001|Period 3|Protocol Violation|1|||
124669930|NCT02595502|448414187|FG000|Period 3|Lost to Follow-up|1|||
124669931|NCT02595502|448414188|FG001|Period 3|Lost to Follow-up|0|||
124669932|NCT02595502|448414187|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
124669933|NCT02595502|448414188|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
124669934|NCT00974311|448414189|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
124669935|NCT00974311|448414190|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
124669936|NCT00974311|448414189|FG000|DB Phase (up to 24 Months)|Death|561|||
124669937|NCT00974311|448414190|FG001|DB Phase (up to 24 Months)|Death|298|||
124669938|NCT00974311|448414189|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
124669939|NCT00974311|448414190|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
124669940|NCT00974311|448414189|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
124669941|NCT00974311|448414190|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
124669942|NCT00974311|448414189|FG000|DB Phase (up to 24 Months)|Other|1|||
124669943|NCT00974311|448414190|FG001|DB Phase (up to 24 Months)|Other|0|||
124669944|NCT00974311|448414189|FG000|OLE Phase (up to 77 Months)|Death|14|||
124669945|NCT00974311|448414190|FG001|OLE Phase (up to 77 Months)|Death|21|||
124669946|NCT00974311|448414189|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
124669947|NCT00974311|448414190|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
124669948|NCT00974311|448414189|FG000|OLE Phase (up to 77 Months)|Other|15|||
124669949|NCT00974311|448414190|FG001|OLE Phase (up to 77 Months)|Other|2|||
124669950|NCT00974311|448414189|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
124669951|NCT00974311|448414190|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
124669952|NCT05556148|448414193|FG000|Overall Study|Early Termination|29|||
124669953|NCT05556148|448414193|FG000|Overall Study|Baseline Tasks Expired|4|||
124669954|NCT05556148|448414193|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
124669955|NCT05556148|448414193|FG000|Overall Study|No Longer Wished to Participate|1|||
124669956|NCT05556148|448414193|FG000|Overall Study|Bacterial Conjunctivitis|1|||
124669957|NCT00458003|448414194|FG000|Overall Study|Non protocol spinal anesthesia|1|||
124669958|NCT00458003|448414195|FG001|Overall Study|Non protocol spinal anesthesia|1|||
124669959|NCT00468585|448414198|FG000|Overall Study|Patient not treated|1|||
124669960|NCT00468585|448414199|FG001|Overall Study|Patient not treated|0|||
124669961|NCT00468585|448414200|FG002|Overall Study|Patient not treated|1|||
124669962|NCT00468585|448414201|FG003|Overall Study|Patient not treated|0|||
124669963|NCT00468585|448414198|FG000|Overall Study|Patient found to be ineligible|0|||
124669964|NCT00468585|448414199|FG001|Overall Study|Patient found to be ineligible|0|||
124669965|NCT00468585|448414200|FG002|Overall Study|Patient found to be ineligible|1|||
124669966|NCT00468585|448414201|FG003|Overall Study|Patient found to be ineligible|0|||
124669967|NCT00468585|448414198|FG000|Overall Study|Adverse Event|0|||
124669968|NCT00468585|448414199|FG001|Overall Study|Adverse Event|0|||
124669969|NCT00468585|448414200|FG002|Overall Study|Adverse Event|1|||
124669970|NCT00468585|448414201|FG003|Overall Study|Adverse Event|0|||
124669971|NCT00468585|448414198|FG000|Overall Study|Withdrawal by Subject|0|||
124669972|NCT00468585|448414199|FG001|Overall Study|Withdrawal by Subject|0|||
124669973|NCT00468585|448414200|FG002|Overall Study|Withdrawal by Subject|2|||
124669974|NCT00468585|448414201|FG003|Overall Study|Withdrawal by Subject|1|||
124669975|NCT02154139|448414202|FG000|Overall Study|Injection not administered|2|||
124669976|NCT02154139|448414202|FG000|Overall Study|Other|2|||
124669977|NCT02154139|448414202|FG000|Overall Study|Investigator transferred|3|||
124669978|NCT04073303|448414204|FG000|Overall Study|Adverse Event|0|||
124669979|NCT04073303|448414205|FG001|Overall Study|Adverse Event|2|||
124669980|NCT04073303|448414204|FG000|Overall Study|Withdrawal by Subject|16|||
124669981|NCT04073303|448414205|FG001|Overall Study|Withdrawal by Subject|36|||
124669982|NCT04073303|448414204|FG000|Overall Study|Lost to Follow-up|6|||
124669983|NCT04073303|448414205|FG001|Overall Study|Lost to Follow-up|1|||
124669984|NCT04073303|448414204|FG000|Overall Study|Protocol Deviation|0|||
124669985|NCT04073303|448414205|FG001|Overall Study|Protocol Deviation|4|||
124669986|NCT04073303|448414204|FG000|Overall Study|Other|1|||
124669987|NCT04073303|448414205|FG001|Overall Study|Other|1|||
124669988|NCT02899065|448414209|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
124669989|NCT02899065|448414210|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
124669990|NCT02899065|448414209|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
124669991|NCT02899065|448414210|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
124669992|NCT02899065|448414209|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
124669993|NCT02899065|448414210|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
124669994|NCT05227118|448414213|FG000|Overall Study|Adverse Event|0|||
124669995|NCT05227118|448414214|FG001|Overall Study|Adverse Event|0|||
124669996|NCT05227118|448414215|FG002|Overall Study|Adverse Event|1|||
124669997|NCT05227118|448414216|FG003|Overall Study|Adverse Event|0|||
124669998|NCT05227118|448414213|FG000|Overall Study|Withdrawal by Subject|0|||
124669999|NCT05227118|448414214|FG001|Overall Study|Withdrawal by Subject|0|||
124670000|NCT05227118|448414215|FG002|Overall Study|Withdrawal by Subject|2|||
124670001|NCT05227118|448414216|FG003|Overall Study|Withdrawal by Subject|0|||
124670002|NCT02689804|448414217|FG000|Overall Study|Withdrawal by Subject|2|||
124670003|NCT02689804|448414218|FG001|Overall Study|Withdrawal by Subject|0|||
124670004|NCT02417753|448414219|FG000|Overall Study|Death|1|||
124670005|NCT03113968|448414220|FG000|Overall Study|Withdrawal by Subject|31|||
124670006|NCT03113968|448414221|FG001|Overall Study|Withdrawal by Subject|4|||
124670007|NCT04805671|448414224|FG000|Overall Study|Death|2|||
124670008|NCT04805671|448414225|FG001|Overall Study|Death|7|||
124670009|NCT04805671|448414224|FG000|Overall Study|Lost to Follow-up|1|||
124670010|NCT04805671|448414225|FG001|Overall Study|Lost to Follow-up|0|||
124670011|NCT04805671|448414224|FG000|Overall Study|Withdrawal by Subject|9|||
124670012|NCT04805671|448414225|FG001|Overall Study|Withdrawal by Subject|7|||
124670013|NCT04805671|448414224|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
124670014|NCT04805671|448414225|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
124670015|NCT01657162|448414232|FG000|Overall Study|Adverse Event|26|||
124670016|NCT01657162|448414233|FG001|Overall Study|Adverse Event|36|||
124670017|NCT01657162|448414232|FG000|Overall Study|Withdrawal by Subject|13|||
124670018|NCT01657162|448414233|FG001|Overall Study|Withdrawal by Subject|13|||
124670019|NCT01657162|448414232|FG000|Overall Study|Continuing Significant Deterioration|9|||
124670020|NCT01657162|448414233|FG001|Overall Study|Continuing Significant Deterioration|3|||
124670021|NCT01657162|448414232|FG000|Overall Study|Refusal of Treatment|4|||
124670022|NCT01657162|448414233|FG001|Overall Study|Refusal of Treatment|6|||
124670023|NCT01657162|448414232|FG000|Overall Study|Lost to Follow-up|3|||
124670024|NCT01657162|448414233|FG001|Overall Study|Lost to Follow-up|4|||
124670025|NCT01657162|448414232|FG000|Overall Study|Death|2|||
124670026|NCT01657162|448414233|FG001|Overall Study|Death|3|||
124670027|NCT01657162|448414232|FG000|Overall Study|Inability to Complete Study Procedures|1|||
124670028|NCT01657162|448414233|FG001|Overall Study|Inability to Complete Study Procedures|7|||
124670029|NCT01657162|448414232|FG000|Overall Study|Protocol Violation|1|||
124670030|NCT01657162|448414233|FG001|Overall Study|Protocol Violation|0|||
124670031|NCT01657162|448414232|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
124670032|NCT01657162|448414233|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
124670033|NCT01657162|448414232|FG000|Overall Study|Other than Specified|0|||
124670034|NCT01657162|448414233|FG001|Overall Study|Other than Specified|2|||
124670035|NCT00901342|448414234|FG000|Overall Study|Adverse Event|1|||
124670036|NCT00901342|448414234|FG000|Overall Study|Death|4|||
124670037|NCT00901342|448414234|FG000|Overall Study|Disease progression|1|||
124670038|NCT00901342|448414234|FG000|Overall Study|Withdrawal by Subject|9|||
124670039|NCT03421379|448414236|FG000|Period 1|Withdrawal by Subject|0|||
124670040|NCT03421379|448414237|FG001|Period 1|Withdrawal by Subject|1|||
124670041|NCT03421379|448414236|FG000|Period 1|Physician Decision|1|||
124670042|NCT03421379|448414237|FG001|Period 1|Physician Decision|1|||
124670043|NCT03421379|448414236|FG000|Period 1|Did not receive treatment|1|||
124670044|NCT03421379|448414237|FG001|Period 1|Did not receive treatment|2|||
124670045|NCT02782741|448414238|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
124670046|NCT02782741|448414239|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
124670047|NCT02782741|448414240|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
124670048|NCT02782741|448414238|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
124670049|NCT02782741|448414239|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
124670050|NCT02782741|448414240|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
124670051|NCT02782741|448414238|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
124670052|NCT02782741|448414239|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
124670053|NCT02782741|448414240|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
124670054|NCT02782741|448414238|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
124670055|NCT02782741|448414239|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
124670056|NCT02782741|448414240|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
124670057|NCT02782741|448414238|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
124670058|NCT02782741|448414239|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
124670059|NCT02782741|448414240|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
124670060|NCT04157088|448414241|FG000|Overall Study|Study terminated by sponsor|23|||
124670061|NCT04157088|448414241|FG000|Overall Study|Withdrawal by Subject|4|||
124670062|NCT04157088|448414241|FG000|Overall Study|Lost to Follow-up|2|||
124670063|NCT04157088|448414241|FG000|Overall Study|Death|1|||
124670064|NCT02421419|448414242|FG000|Overall Study|Physician Decision|0|||
124670065|NCT02421419|448414243|FG001|Overall Study|Physician Decision|0|||
124670066|NCT02421419|448414244|FG002|Overall Study|Physician Decision|1|||
124670067|NCT00196105|448414250|FG000|Overall Study|Lost to Follow-up|4|||
124670068|NCT00196105|448414251|FG001|Overall Study|Lost to Follow-up|5|||
124670069|NCT00196105|448414252|FG002|Overall Study|Lost to Follow-up|7|||
124670070|NCT04863872|448414253|FG000|Overall Study|Withdrawal by Subject|4|||
124670071|NCT04863872|448414254|FG001|Overall Study|Withdrawal by Subject|15|||
124670072|NCT04863872|448414253|FG000|Overall Study|Death|5|||
124670073|NCT04863872|448414254|FG001|Overall Study|Death|2|||
124670074|NCT04863872|448414253|FG000|Overall Study|Lost to Follow-up|2|||
124670075|NCT04863872|448414254|FG001|Overall Study|Lost to Follow-up|1|||
124670076|NCT04058028|448414255|FG000|Overall Study|Withdrawal of Consent from Study|12|||
124670077|NCT04058028|448414256|FG001|Overall Study|Withdrawal of Consent from Study|8|||
124670078|NCT04058028|448414257|FG002|Overall Study|Withdrawal of Consent from Study|6|||
124670079|NCT04058028|448414258|FG003|Overall Study|Withdrawal of Consent from Study|7|||
124670080|NCT04058028|448414255|FG000|Overall Study|Decision by Sponsor|13|||
124670081|NCT04058028|448414256|FG001|Overall Study|Decision by Sponsor|4|||
124670082|NCT04058028|448414257|FG002|Overall Study|Decision by Sponsor|1|||
124670083|NCT04058028|448414258|FG003|Overall Study|Decision by Sponsor|35|||
124670084|NCT04058028|448414255|FG000|Overall Study|Lost to Follow-up|1|||
124670085|NCT04058028|448414256|FG001|Overall Study|Lost to Follow-up|1|||
124670086|NCT04058028|448414257|FG002|Overall Study|Lost to Follow-up|1|||
124670087|NCT04058028|448414258|FG003|Overall Study|Lost to Follow-up|0|||
124670088|NCT04058028|448414255|FG000|Overall Study|Death|0|||
124670089|NCT04058028|448414256|FG001|Overall Study|Death|1|||
124670090|NCT04058028|448414257|FG002|Overall Study|Death|0|||
124670091|NCT04058028|448414258|FG003|Overall Study|Death|0|||
124670092|NCT01691378|448414261|FG000|Overall Study|Withdrawal by Subject|2|||
124670093|NCT01691378|448414262|FG001|Overall Study|Withdrawal by Subject|0|||
124670094|NCT01691378|448414261|FG000|Overall Study|Lost to Follow-up|5|||
124670095|NCT01691378|448414262|FG001|Overall Study|Lost to Follow-up|2|||
124670096|NCT01819727|448414263|FG000|Overall Study|Adverse Event|8|||
124670097|NCT01819727|448414264|FG001|Overall Study|Adverse Event|9|||
124670098|NCT01819727|448414263|FG000|Overall Study|Death|1|||
124670099|NCT01819727|448414264|FG001|Overall Study|Death|0|||
124670100|NCT01819727|448414263|FG000|Overall Study|Lost to Follow-up|1|||
124670101|NCT01819727|448414264|FG001|Overall Study|Lost to Follow-up|1|||
124670102|NCT01819727|448414263|FG000|Overall Study|Physician Decision|3|||
124670103|NCT01819727|448414264|FG001|Overall Study|Physician Decision|2|||
124670104|NCT01819727|448414263|FG000|Overall Study|Pregnancy|1|||
124670105|NCT01819727|448414264|FG001|Overall Study|Pregnancy|0|||
124670106|NCT01819727|448414263|FG000|Overall Study|Protocol Violation|0|||
124670107|NCT01819727|448414264|FG001|Overall Study|Protocol Violation|2|||
124670108|NCT01819727|448414263|FG000|Overall Study|Study Terminated by Sponsor|0|||
124670109|NCT01819727|448414264|FG001|Overall Study|Study Terminated by Sponsor|1|||
124670110|NCT01819727|448414263|FG000|Overall Study|Withdrawal by Subject|6|||
124670111|NCT01819727|448414264|FG001|Overall Study|Withdrawal by Subject|11|||
124670112|NCT01819727|448414263|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
124670113|NCT01819727|448414264|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
124670114|NCT01819727|448414263|FG000|Overall Study|Quit due to lack of health benifits|0|||
124670115|NCT01819727|448414264|FG001|Overall Study|Quit due to lack of health benifits|1|||
124670116|NCT02998151|448414265|FG000|Overall Study|Withdrawal by Subject|3|||
124670117|NCT02998151|448414265|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
124670118|NCT02998151|448414265|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
124670119|NCT02155985|448414266|FG000|Overall Study|Withdrawal by Subject|0|||
124670120|NCT02155985|448414267|FG001|Overall Study|Withdrawal by Subject|0|||
124670121|NCT02155985|448414268|FG002|Overall Study|Withdrawal by Subject|1|||
124670122|NCT02155985|448414266|FG000|Overall Study|Lost to Follow-up|1|||
124670123|NCT02155985|448414267|FG001|Overall Study|Lost to Follow-up|0|||
124670124|NCT02155985|448414268|FG002|Overall Study|Lost to Follow-up|0|||
124670125|NCT02573259|448414271|FG000|Overall Study|Death|1|||
124670126|NCT02573259|448414272|FG001|Overall Study|Death|6|||
124670127|NCT02573259|448414273|FG002|Overall Study|Death|5|||
124670128|NCT02573259|448414274|FG003|Overall Study|Death|6|||
124670129|NCT02573259|448414275|FG004|Overall Study|Death|9|||
124670130|NCT02573259|448414276|FG005|Overall Study|Death|32|||
124670131|NCT02573259|448414277|FG006|Overall Study|Death|21|||
124670132|NCT02573259|448414271|FG000|Overall Study|Lost to Follow-up|0|||
124670133|NCT02573259|448414272|FG001|Overall Study|Lost to Follow-up|0|||
124670134|NCT02573259|448414273|FG002|Overall Study|Lost to Follow-up|0|||
124670135|NCT02573259|448414274|FG003|Overall Study|Lost to Follow-up|0|||
124670136|NCT02573259|448414275|FG004|Overall Study|Lost to Follow-up|0|||
124670137|NCT02573259|448414276|FG005|Overall Study|Lost to Follow-up|2|||
124670138|NCT02573259|448414277|FG006|Overall Study|Lost to Follow-up|1|||
124670139|NCT02573259|448414271|FG000|Overall Study|Participant refused further follow-up|0|||
124670140|NCT02573259|448414272|FG001|Overall Study|Participant refused further follow-up|2|||
124670141|NCT02573259|448414273|FG002|Overall Study|Participant refused further follow-up|1|||
124670142|NCT02573259|448414274|FG003|Overall Study|Participant refused further follow-up|0|||
124670143|NCT02573259|448414275|FG004|Overall Study|Participant refused further follow-up|3|||
124670144|NCT02573259|448414276|FG005|Overall Study|Participant refused further follow-up|20|||
124670145|NCT02573259|448414277|FG006|Overall Study|Participant refused further follow-up|7|||
124670146|NCT02573259|448414271|FG000|Overall Study|Other|0|||
124670147|NCT02573259|448414272|FG001|Overall Study|Other|0|||
124670148|NCT02573259|448414273|FG002|Overall Study|Other|0|||
124670149|NCT02573259|448414274|FG003|Overall Study|Other|0|||
124670150|NCT02573259|448414275|FG004|Overall Study|Other|1|||
124670151|NCT02573259|448414276|FG005|Overall Study|Other|4|||
124670152|NCT02573259|448414277|FG006|Overall Study|Other|5|||
124670153|NCT00751140|448414278|FG000|Overall Study|benign angioma excluded from analysis|1|||
124670154|NCT05212168|448414282|FG000|Overall Study|Lost to Follow-up|0|||
124670155|NCT05212168|448414283|FG001|Overall Study|Lost to Follow-up|3|||
124670156|NCT05212168|448414282|FG000|Overall Study|Study terminated by sponsor|30|||
124670157|NCT05212168|448414283|FG001|Overall Study|Study terminated by sponsor|27|||
124670158|NCT05212168|448414282|FG000|Overall Study|Other|4|||
124670159|NCT05212168|448414283|FG001|Overall Study|Other|7|||
124670160|NCT03811821|448414284|FG000|Overall Study|Adverse Event|1|||
124670161|NCT03811821|448414285|FG001|Overall Study|Adverse Event|1|||
124670162|NCT03811821|448414284|FG000|Overall Study|Withdrawal by Subject|5|||
124670163|NCT03811821|448414285|FG001|Overall Study|Withdrawal by Subject|4|||
124670164|NCT03811821|448414284|FG000|Overall Study|Lost to Follow-up|2|||
124670165|NCT03811821|448414285|FG001|Overall Study|Lost to Follow-up|2|||
124670166|NCT03811821|448414284|FG000|Overall Study|Contraindication for treatment|0|||
124670167|NCT03811821|448414285|FG001|Overall Study|Contraindication for treatment|1|||
124670168|NCT03811821|448414284|FG000|Overall Study|Tolerability|0|||
124670169|NCT03811821|448414285|FG001|Overall Study|Tolerability|3|||
124670170|NCT03811821|448414284|FG000|Overall Study|Comorbidities|0|||
124670171|NCT03811821|448414285|FG001|Overall Study|Comorbidities|2|||
124670172|NCT04888494|448414288|FG000|Overall Study|Lost to Follow-up|2|||
124670173|NCT04888494|448414289|FG001|Overall Study|Lost to Follow-up|3|||
124670174|NCT04888494|448414288|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
124670175|NCT04888494|448414289|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
124670176|NCT01298700|448416454|FG000|Overall Study|Adverse Event|50|||
124670177|NCT01298700|448416455|FG001|Overall Study|Adverse Event|51|||
124670178|NCT01298700|448416454|FG000|Overall Study|Lack of Efficacy|9|||
124670179|NCT01298700|448416455|FG001|Overall Study|Lack of Efficacy|14|||
124670180|NCT01298700|448416454|FG000|Overall Study|Lost to Follow-up|5|||
124670181|NCT01298700|448416455|FG001|Overall Study|Lost to Follow-up|2|||
124670182|NCT01298700|448416454|FG000|Overall Study|Withdrawal by Subject|12|||
124670183|NCT01298700|448416455|FG001|Overall Study|Withdrawal by Subject|9|||
124670184|NCT01298700|448416454|FG000|Overall Study|Protocol Violation|6|||
124670185|NCT01298700|448416455|FG001|Overall Study|Protocol Violation|4|||
124670186|NCT01298700|448416454|FG000|Overall Study|Other Miscellaneous Reasons|16|||
124670187|NCT01298700|448416455|FG001|Overall Study|Other Miscellaneous Reasons|15|||
124670188|NCT01298700|448416454|FG000|Overall Study|Did not Receive Study Drug|3|||
124670189|NCT01298700|448416455|FG001|Overall Study|Did not Receive Study Drug|5|||
124670190|NCT01716806|448416458|FG000|Overall Study|Patient withdrawal of consent|4|||
124670191|NCT01716806|448416459|FG001|Overall Study|Patient withdrawal of consent|2|||
124670192|NCT01716806|448416460|FG002|Overall Study|Patient withdrawal of consent|4|||
124670193|NCT01716806|448416461|FG003|Overall Study|Patient withdrawal of consent|3|||
124670194|NCT01716806|448416462|FG004|Overall Study|Patient withdrawal of consent|2|||
124670195|NCT01716806|448416463|FG005|Overall Study|Patient withdrawal of consent|0|||
124670196|NCT01716806|448416458|FG000|Overall Study|Lost to Follow-up|3|||
124670197|NCT01716806|448416459|FG001|Overall Study|Lost to Follow-up|3|||
124670198|NCT01716806|448416460|FG002|Overall Study|Lost to Follow-up|0|||
124670199|NCT01716806|448416461|FG003|Overall Study|Lost to Follow-up|2|||
124670200|NCT01716806|448416462|FG004|Overall Study|Lost to Follow-up|1|||
124670201|NCT01716806|448416463|FG005|Overall Study|Lost to Follow-up|0|||
124670202|NCT01716806|448416458|FG000|Overall Study|Death|13|||
124670203|NCT01716806|448416459|FG001|Overall Study|Death|9|||
124670204|NCT01716806|448416460|FG002|Overall Study|Death|12|||
124670205|NCT01716806|448416461|FG003|Overall Study|Death|4|||
124670206|NCT01716806|448416462|FG004|Overall Study|Death|10|||
124670207|NCT01716806|448416463|FG005|Overall Study|Death|5|||
124670208|NCT01716806|448416458|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
124670209|NCT01716806|448416459|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
124670210|NCT01716806|448416460|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
124670211|NCT01716806|448416461|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
124670212|NCT01716806|448416462|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
124670213|NCT01716806|448416463|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
124670214|NCT01716806|448416458|FG000|Overall Study|PI decision|0|||
124670215|NCT01716806|448416459|FG001|Overall Study|PI decision|0|||
124670216|NCT01716806|448416460|FG002|Overall Study|PI decision|0|||
124670217|NCT01716806|448416461|FG003|Overall Study|PI decision|0|||
124670218|NCT01716806|448416462|FG004|Overall Study|PI decision|1|||
124670219|NCT01716806|448416463|FG005|Overall Study|PI decision|0|||
124670220|NCT01716806|448416458|FG000|Overall Study|Change in performance status|1|||
124670221|NCT01716806|448416459|FG001|Overall Study|Change in performance status|0|||
124670222|NCT01716806|448416460|FG002|Overall Study|Change in performance status|0|||
124670223|NCT01716806|448416461|FG003|Overall Study|Change in performance status|0|||
124670224|NCT01716806|448416462|FG004|Overall Study|Change in performance status|0|||
124670225|NCT01716806|448416463|FG005|Overall Study|Change in performance status|0|||
124670226|NCT01716806|448416458|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
124670227|NCT01716806|448416459|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
124670228|NCT01716806|448416460|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
124670229|NCT01716806|448416461|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
124670230|NCT01716806|448416462|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
124670231|NCT01716806|448416463|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
124670232|NCT01716806|448416458|FG000|Overall Study|Sponsor direction|7|||
124670233|NCT01716806|448416459|FG001|Overall Study|Sponsor direction|8|||
124670234|NCT01716806|448416460|FG002|Overall Study|Sponsor direction|5|||
124670235|NCT01716806|448416461|FG003|Overall Study|Sponsor direction|12|||
124670236|NCT01716806|448416462|FG004|Overall Study|Sponsor direction|16|||
124670237|NCT01716806|448416463|FG005|Overall Study|Sponsor direction|1|||
124670238|NCT00956839|448416464|FG000|Overall Study|Lost to Follow-up|3|||
124670239|NCT00956839|448416465|FG001|Overall Study|Lost to Follow-up|0|||
124670240|NCT00956839|448416466|FG002|Overall Study|Lost to Follow-up|3|||
124670241|NCT03527277|448416469|FG000|Overall Study|Withdrawal by Subject|5|||
124670242|NCT03527277|448416470|FG001|Overall Study|Withdrawal by Subject|0|||
124670243|NCT03527277|448416469|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
124670244|NCT03527277|448416470|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
124670245|NCT03527277|448416469|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
124670246|NCT03527277|448416470|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
124670247|NCT00643760|448416471|FG000|Overall Study|Adverse Event|11|||
124670248|NCT00643760|448416472|FG001|Overall Study|Adverse Event|5|||
124670249|NCT00643760|448416473|FG002|Overall Study|Adverse Event|12|||
124670250|NCT00643760|448416474|FG003|Overall Study|Adverse Event|21|||
124670251|NCT00643760|448416475|FG004|Overall Study|Adverse Event|6|||
124670252|NCT00643760|448416471|FG000|Overall Study|Lack of Efficacy|3|||
124670253|NCT00643760|448416472|FG001|Overall Study|Lack of Efficacy|1|||
124670254|NCT00643760|448416473|FG002|Overall Study|Lack of Efficacy|0|||
124670255|NCT00643760|448416474|FG003|Overall Study|Lack of Efficacy|4|||
124670256|NCT00643760|448416475|FG004|Overall Study|Lack of Efficacy|3|||
124670257|NCT00643760|448416471|FG000|Overall Study|Protocol Violation|7|||
124670258|NCT00643760|448416472|FG001|Overall Study|Protocol Violation|6|||
124670259|NCT00643760|448416473|FG002|Overall Study|Protocol Violation|4|||
124670260|NCT00643760|448416474|FG003|Overall Study|Protocol Violation|4|||
124670261|NCT00643760|448416475|FG004|Overall Study|Protocol Violation|6|||
124670262|NCT00643760|448416471|FG000|Overall Study|Lost to Follow-up|6|||
124670263|NCT00643760|448416472|FG001|Overall Study|Lost to Follow-up|2|||
124670264|NCT00643760|448416473|FG002|Overall Study|Lost to Follow-up|1|||
124670265|NCT00643760|448416474|FG003|Overall Study|Lost to Follow-up|3|||
124670266|NCT00643760|448416475|FG004|Overall Study|Lost to Follow-up|3|||
124670267|NCT00643760|448416471|FG000|Overall Study|Investigator Discretion|0|||
124670268|NCT00643760|448416472|FG001|Overall Study|Investigator Discretion|0|||
124670269|NCT00643760|448416473|FG002|Overall Study|Investigator Discretion|0|||
124670270|NCT00643760|448416474|FG003|Overall Study|Investigator Discretion|2|||
124670271|NCT00643760|448416475|FG004|Overall Study|Investigator Discretion|0|||
124670272|NCT00643760|448416471|FG000|Overall Study|Withdrawal by Subject|3|||
124670273|NCT00643760|448416472|FG001|Overall Study|Withdrawal by Subject|1|||
124670274|NCT00643760|448416473|FG002|Overall Study|Withdrawal by Subject|2|||
124670275|NCT00643760|448416474|FG003|Overall Study|Withdrawal by Subject|4|||
124670276|NCT00643760|448416475|FG004|Overall Study|Withdrawal by Subject|1|||
124670277|NCT03934216|448416476|FG000|Overall Study|Other Reasons|5|||
124670278|NCT03934216|448416477|FG001|Overall Study|Other Reasons|5|||
124670279|NCT03934216|448416476|FG000|Overall Study|Adverse Event|22|||
124670280|NCT03934216|448416477|FG001|Overall Study|Adverse Event|11|||
124670281|NCT03934216|448416476|FG000|Overall Study|Lack of Efficacy|8|||
124670282|NCT03934216|448416477|FG001|Overall Study|Lack of Efficacy|7|||
124670283|NCT03934216|448416476|FG000|Overall Study|Lost to Follow-up|2|||
124670284|NCT03934216|448416477|FG001|Overall Study|Lost to Follow-up|0|||
124670285|NCT03934216|448416476|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124670286|NCT03934216|448416477|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124670287|NCT03934216|448416476|FG000|Overall Study|Pregnancy|1|||
124670288|NCT03934216|448416477|FG001|Overall Study|Pregnancy|0|||
124670289|NCT03934216|448416476|FG000|Overall Study|Withdrawal by Subject|18|||
124670290|NCT03934216|448416477|FG001|Overall Study|Withdrawal by Subject|6|||
124670291|NCT03934216|448416476|FG000|Overall Study|Randomized but not treated|1|||
124670292|NCT03934216|448416477|FG001|Overall Study|Randomized but not treated|1|||
124670293|NCT00048035|448416484|FG000|Core Period|Early Withdrawals|4|||
124670294|NCT00048035|448416485|FG001|Core Period|Early Withdrawals|2|||
124670295|NCT00048035|448416486|FG002|Core Period|Early Withdrawals|1|||
124670296|NCT00048035|448416487|FG003|Core Period|Early Withdrawals|1|||
124670297|NCT00048035|448416488|FG004|Core Period|Early Withdrawals|1|||
124670298|NCT00048035|448416489|FG005|Core Period|Early Withdrawals|1|||
124670299|NCT00048035|448416490|FG006|Core Period|Early Withdrawals|0|||
124670300|NCT00048035|448416491|FG007|Core Period|Early Withdrawals|0|||
124670301|NCT00048035|448416484|FG000|Extension Year 1|Early Withdrawals|0|||
124670302|NCT00048035|448416485|FG001|Extension Year 1|Early Withdrawals|0|||
124670303|NCT00048035|448416486|FG002|Extension Year 1|Early Withdrawals|0|||
124670304|NCT00048035|448416487|FG003|Extension Year 1|Early Withdrawals|0|||
124670305|NCT00048035|448416488|FG004|Extension Year 1|Early Withdrawals|0|||
124670306|NCT00048035|448416489|FG005|Extension Year 1|Early Withdrawals|0|||
124670307|NCT00048035|448416490|FG006|Extension Year 1|Early Withdrawals|11|||
124670308|NCT00048035|448416491|FG007|Extension Year 1|Early Withdrawals|11|||
124670309|NCT00048035|448416484|FG000|Extension Year 2|Early Withdrawals|0|||
124670310|NCT00048035|448416485|FG001|Extension Year 2|Early Withdrawals|0|||
124670311|NCT00048035|448416486|FG002|Extension Year 2|Early Withdrawals|0|||
124670312|NCT00048035|448416487|FG003|Extension Year 2|Early Withdrawals|0|||
124670313|NCT00048035|448416488|FG004|Extension Year 2|Early Withdrawals|0|||
124670314|NCT00048035|448416489|FG005|Extension Year 2|Early Withdrawals|0|||
124670315|NCT00048035|448416490|FG006|Extension Year 2|Early Withdrawals|3|||
124670316|NCT00048035|448416491|FG007|Extension Year 2|Early Withdrawals|3|||
124670317|NCT02035553|448416492|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
124670318|NCT02035553|448416493|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
124670319|NCT02035553|448416492|FG000|Overall Study|Adverse Event|10|||
124670320|NCT02035553|448416493|FG001|Overall Study|Adverse Event|6|||
124670321|NCT02035553|448416492|FG000|Overall Study|Physician Decision|3|||
124670322|NCT02035553|448416493|FG001|Overall Study|Physician Decision|2|||
124670323|NCT02035553|448416492|FG000|Overall Study|Lack of Efficacy|1|||
124670324|NCT02035553|448416493|FG001|Overall Study|Lack of Efficacy|1|||
124670325|NCT02035553|448416492|FG000|Overall Study|Withdrawal by Subject|4|||
124670326|NCT02035553|448416493|FG001|Overall Study|Withdrawal by Subject|7|||
124670327|NCT02035553|448416492|FG000|Overall Study|Non-compliance with Study Drug|0|||
124670328|NCT02035553|448416493|FG001|Overall Study|Non-compliance with Study Drug|1|||
124670329|NCT02035553|448416492|FG000|Overall Study|Lost to Follow-up|0|||
124670330|NCT02035553|448416493|FG001|Overall Study|Lost to Follow-up|1|||
124670331|NCT02035553|448416492|FG000|Overall Study|Other Reason|0|||
124670332|NCT02035553|448416493|FG001|Overall Study|Other Reason|4|||
124670333|NCT05137717|448416494|FG000|Overall Study|Death|2|||
124670334|NCT05137717|448416494|FG000|Overall Study|Withdrawal by Subject|6|||
124670335|NCT02619617|448416495|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
124670336|NCT02619617|448416496|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
124670337|NCT02619617|448416495|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
124670338|NCT02619617|448416496|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
124670339|NCT00509899|448416497|FG000|Overall Study|Progressive disease|1|||
124670340|NCT00509899|448416498|FG001|Overall Study|Progressive disease|3|||
124670341|NCT00509899|448416499|FG002|Overall Study|Progressive disease|5|||
124670342|NCT00509899|448416500|FG003|Overall Study|Progressive disease|1|||
124670343|NCT00509899|448416501|FG004|Overall Study|Progressive disease|0|||
124670344|NCT00509899|448416502|FG005|Overall Study|Progressive disease|1|||
124670345|NCT00509899|448416503|FG006|Overall Study|Progressive disease|0|||
124670346|NCT00509899|448416504|FG007|Overall Study|Progressive disease|0|||
124670347|NCT00509899|448416497|FG000|Overall Study|Unacceptable Toxicity|1|||
124670348|NCT00509899|448416498|FG001|Overall Study|Unacceptable Toxicity|0|||
124670349|NCT00509899|448416499|FG002|Overall Study|Unacceptable Toxicity|0|||
124670350|NCT00509899|448416500|FG003|Overall Study|Unacceptable Toxicity|2|||
124670351|NCT00509899|448416501|FG004|Overall Study|Unacceptable Toxicity|0|||
124670352|NCT00509899|448416502|FG005|Overall Study|Unacceptable Toxicity|0|||
124670353|NCT00509899|448416503|FG006|Overall Study|Unacceptable Toxicity|0|||
124670354|NCT00509899|448416504|FG007|Overall Study|Unacceptable Toxicity|0|||
124670355|NCT00509899|448416497|FG000|Overall Study|Withdrawal by Subject|6|||
124670356|NCT00509899|448416498|FG001|Overall Study|Withdrawal by Subject|2|||
124670357|NCT00509899|448416499|FG002|Overall Study|Withdrawal by Subject|3|||
124670358|NCT00509899|448416500|FG003|Overall Study|Withdrawal by Subject|0|||
124670359|NCT00509899|448416501|FG004|Overall Study|Withdrawal by Subject|3|||
124670360|NCT00509899|448416502|FG005|Overall Study|Withdrawal by Subject|2|||
124670361|NCT00509899|448416503|FG006|Overall Study|Withdrawal by Subject|0|||
124670362|NCT00509899|448416504|FG007|Overall Study|Withdrawal by Subject|0|||
124670363|NCT00509899|448416497|FG000|Overall Study|Physician Decision|4|||
124670364|NCT00509899|448416498|FG001|Overall Study|Physician Decision|2|||
124670365|NCT00509899|448416499|FG002|Overall Study|Physician Decision|7|||
124670366|NCT00509899|448416500|FG003|Overall Study|Physician Decision|0|||
124670367|NCT00509899|448416501|FG004|Overall Study|Physician Decision|1|||
124670368|NCT00509899|448416502|FG005|Overall Study|Physician Decision|4|||
124670369|NCT00509899|448416503|FG006|Overall Study|Physician Decision|0|||
124670370|NCT00509899|448416504|FG007|Overall Study|Physician Decision|0|||
124670371|NCT00509899|448416497|FG000|Overall Study|Intercurrent Illness|1|||
124670372|NCT00509899|448416498|FG001|Overall Study|Intercurrent Illness|0|||
124670373|NCT00509899|448416499|FG002|Overall Study|Intercurrent Illness|0|||
124670374|NCT00509899|448416500|FG003|Overall Study|Intercurrent Illness|1|||
124670375|NCT00509899|448416501|FG004|Overall Study|Intercurrent Illness|0|||
124670376|NCT00509899|448416502|FG005|Overall Study|Intercurrent Illness|1|||
124670377|NCT00509899|448416503|FG006|Overall Study|Intercurrent Illness|0|||
124670378|NCT00509899|448416504|FG007|Overall Study|Intercurrent Illness|0|||
124670379|NCT00509899|448416497|FG000|Overall Study|Death|2|||
124670380|NCT00509899|448416498|FG001|Overall Study|Death|2|||
124670381|NCT00509899|448416499|FG002|Overall Study|Death|3|||
124670382|NCT00509899|448416500|FG003|Overall Study|Death|0|||
124670383|NCT00509899|448416501|FG004|Overall Study|Death|1|||
124670384|NCT00509899|448416502|FG005|Overall Study|Death|1|||
124670385|NCT00509899|448416503|FG006|Overall Study|Death|1|||
124670386|NCT00509899|448416504|FG007|Overall Study|Death|1|||
124670387|NCT00509899|448416497|FG000|Overall Study|Lack of Efficacy|1|||
124670388|NCT00509899|448416498|FG001|Overall Study|Lack of Efficacy|0|||
124670389|NCT00509899|448416499|FG002|Overall Study|Lack of Efficacy|2|||
124670390|NCT00509899|448416500|FG003|Overall Study|Lack of Efficacy|0|||
124670391|NCT00509899|448416501|FG004|Overall Study|Lack of Efficacy|0|||
124670392|NCT00509899|448416502|FG005|Overall Study|Lack of Efficacy|1|||
124670393|NCT00509899|448416503|FG006|Overall Study|Lack of Efficacy|0|||
124670394|NCT00509899|448416504|FG007|Overall Study|Lack of Efficacy|0|||
124670395|NCT02735980|448416505|FG000|Overall Study|Adverse Event|0|||
124670396|NCT02735980|448416506|FG001|Overall Study|Adverse Event|4|||
124670397|NCT02735980|448416507|FG002|Overall Study|Adverse Event|1|||
124670398|NCT02735980|448416505|FG000|Overall Study|Death|5|||
124670399|NCT02735980|448416506|FG001|Overall Study|Death|4|||
124670400|NCT02735980|448416507|FG002|Overall Study|Death|0|||
124670401|NCT02735980|448416505|FG000|Overall Study|Physician Decision|3|||
124670402|NCT02735980|448416506|FG001|Overall Study|Physician Decision|1|||
124670403|NCT02735980|448416507|FG002|Overall Study|Physician Decision|0|||
124670404|NCT02735980|448416505|FG000|Overall Study|Screen failure|1|||
124670405|NCT02735980|448416506|FG001|Overall Study|Screen failure|0|||
124670406|NCT02735980|448416507|FG002|Overall Study|Screen failure|0|||
124670407|NCT02735980|448416505|FG000|Overall Study|Withdrawal by Subject|1|||
124670408|NCT02735980|448416506|FG001|Overall Study|Withdrawal by Subject|2|||
124670409|NCT02735980|448416507|FG002|Overall Study|Withdrawal by Subject|0|||
124670410|NCT01854697|448416508|FG000|Overall Study|Adverse Event|1|||
124670411|NCT01854697|448416509|FG001|Overall Study|Adverse Event|0|||
124670412|NCT01854697|448416510|FG002|Overall Study|Adverse Event|0|||
124670413|NCT01854697|448416511|FG003|Overall Study|Adverse Event|0|||
124670414|NCT01854697|448416512|FG004|Overall Study|Adverse Event|1|||
124670415|NCT01854697|448416508|FG000|Overall Study|Lost to Follow-up|4|||
124670416|NCT01854697|448416509|FG001|Overall Study|Lost to Follow-up|1|||
124670417|NCT01854697|448416510|FG002|Overall Study|Lost to Follow-up|1|||
124670418|NCT01854697|448416511|FG003|Overall Study|Lost to Follow-up|2|||
124670419|NCT01854697|448416512|FG004|Overall Study|Lost to Follow-up|0|||
124670420|NCT01854697|448416508|FG000|Overall Study|To enter another AbbVie study|1|||
124670421|NCT01854697|448416509|FG001|Overall Study|To enter another AbbVie study|0|||
124670422|NCT01854697|448416510|FG002|Overall Study|To enter another AbbVie study|0|||
124670423|NCT01854697|448416511|FG003|Overall Study|To enter another AbbVie study|0|||
124670424|NCT01854697|448416512|FG004|Overall Study|To enter another AbbVie study|1|||
124670425|NCT01854697|448416508|FG000|Overall Study|Withdrew Consent|0|||
124670426|NCT01854697|448416509|FG001|Overall Study|Withdrew Consent|1|||
124670427|NCT01854697|448416510|FG002|Overall Study|Withdrew Consent|0|||
124670428|NCT01854697|448416511|FG003|Overall Study|Withdrew Consent|1|||
124670429|NCT01854697|448416512|FG004|Overall Study|Withdrew Consent|0|||
124670430|NCT01854697|448416508|FG000|Overall Study|Other|0|||
124670431|NCT01854697|448416509|FG001|Overall Study|Other|1|||
124670432|NCT01854697|448416510|FG002|Overall Study|Other|1|||
124670433|NCT01854697|448416511|FG003|Overall Study|Other|0|||
124670434|NCT01854697|448416512|FG004|Overall Study|Other|0|||
124670435|NCT05081388|448416513|FG000|Overall Study|Adverse Event|1|||
124670436|NCT05081388|448416514|FG001|Overall Study|Adverse Event|0|||
124670437|NCT05081388|448416515|FG002|Overall Study|Adverse Event|0|||
124670438|NCT05081388|448416516|FG003|Overall Study|Adverse Event|0|||
124670439|NCT05081388|448416517|FG004|Overall Study|Adverse Event|0|||
124670440|NCT05081388|448416513|FG000|Overall Study|Lost to Follow-up|0|||
124670441|NCT05081388|448416514|FG001|Overall Study|Lost to Follow-up|1|||
124670442|NCT05081388|448416515|FG002|Overall Study|Lost to Follow-up|0|||
124670443|NCT05081388|448416516|FG003|Overall Study|Lost to Follow-up|0|||
124670444|NCT05081388|448416517|FG004|Overall Study|Lost to Follow-up|0|||
124670445|NCT05081388|448416513|FG000|Overall Study|Subject decision|0|||
124670446|NCT05081388|448416514|FG001|Overall Study|Subject decision|0|||
124670447|NCT05081388|448416515|FG002|Overall Study|Subject decision|0|||
124670448|NCT05081388|448416516|FG003|Overall Study|Subject decision|1|||
124670449|NCT05081388|448416517|FG004|Overall Study|Subject decision|0|||
124670450|NCT04176939|448416524|FG000|Overall Study|Withdrawal by Subject|5|||
124670451|NCT04176939|448416524|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
124670452|NCT04176939|448416524|FG000|Overall Study|Lost to Follow-up|2|||
124670453|NCT04176939|448416524|FG000|Overall Study|Unspecified reason|4|||
124670454|NCT04176939|448416524|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
124670455|NCT02157519|448416527|FG000|Overall Study|Death|3|||
124670456|NCT02157519|448416528|FG001|Overall Study|Death|1|||
124670457|NCT02157519|448416527|FG000|Overall Study|Withdrawal by Subject|7|||
124670458|NCT02157519|448416528|FG001|Overall Study|Withdrawal by Subject|0|||
124670459|NCT02157519|448416527|FG000|Overall Study|Lost to Follow-up|1|||
124670460|NCT02157519|448416528|FG001|Overall Study|Lost to Follow-up|0|||
124670461|NCT01656395|448416529|FG000|Overall Study|Adverse Event|1|||
124670462|NCT01656395|448416530|FG001|Overall Study|Adverse Event|14|||
124670463|NCT01656395|448416531|FG002|Overall Study|Adverse Event|5|||
124670464|NCT01656395|448416532|FG003|Overall Study|Adverse Event|4|||
124670465|NCT01656395|448416533|FG004|Overall Study|Adverse Event|5|||
124670466|NCT01656395|448416534|FG005|Overall Study|Adverse Event|7|||
124670467|NCT01656395|448416535|FG006|Overall Study|Adverse Event|0|||
124670468|NCT01656395|448416536|FG007|Overall Study|Adverse Event|0|||
124670469|NCT01656395|448416529|FG000|Overall Study|Lack of Efficacy|1|||
124670470|NCT01656395|448416530|FG001|Overall Study|Lack of Efficacy|8|||
124670471|NCT01656395|448416531|FG002|Overall Study|Lack of Efficacy|6|||
124670472|NCT01656395|448416532|FG003|Overall Study|Lack of Efficacy|1|||
124670473|NCT01656395|448416533|FG004|Overall Study|Lack of Efficacy|1|||
124670474|NCT01656395|448416534|FG005|Overall Study|Lack of Efficacy|6|||
124670475|NCT01656395|448416535|FG006|Overall Study|Lack of Efficacy|0|||
124670476|NCT01656395|448416536|FG007|Overall Study|Lack of Efficacy|0|||
124670477|NCT01656395|448416529|FG000|Overall Study|Lost to Follow-up|1|||
124670478|NCT01656395|448416530|FG001|Overall Study|Lost to Follow-up|0|||
124670479|NCT01656395|448416531|FG002|Overall Study|Lost to Follow-up|0|||
124670480|NCT01656395|448416532|FG003|Overall Study|Lost to Follow-up|0|||
124670481|NCT01656395|448416533|FG004|Overall Study|Lost to Follow-up|0|||
124670482|NCT01656395|448416534|FG005|Overall Study|Lost to Follow-up|0|||
124670483|NCT01656395|448416535|FG006|Overall Study|Lost to Follow-up|0|||
124670484|NCT01656395|448416536|FG007|Overall Study|Lost to Follow-up|0|||
124670485|NCT01656395|448416529|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124670486|NCT01656395|448416530|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124670487|NCT01656395|448416531|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124670488|NCT01656395|448416532|FG003|Overall Study|Non-Compliance with Study Drug|0|||
124670489|NCT01656395|448416533|FG004|Overall Study|Non-Compliance with Study Drug|1|||
124670490|NCT01656395|448416534|FG005|Overall Study|Non-Compliance with Study Drug|1|||
124670491|NCT01656395|448416535|FG006|Overall Study|Non-Compliance with Study Drug|0|||
124670492|NCT01656395|448416536|FG007|Overall Study|Non-Compliance with Study Drug|0|||
124670493|NCT01656395|448416529|FG000|Overall Study|Other|0|||
124670494|NCT01656395|448416530|FG001|Overall Study|Other|0|||
124670495|NCT01656395|448416531|FG002|Overall Study|Other|1|||
124670496|NCT01656395|448416532|FG003|Overall Study|Other|0|||
124670497|NCT01656395|448416533|FG004|Overall Study|Other|0|||
124670498|NCT01656395|448416534|FG005|Overall Study|Other|1|||
124670499|NCT01656395|448416535|FG006|Overall Study|Other|0|||
124670500|NCT01656395|448416536|FG007|Overall Study|Other|0|||
124670501|NCT01656395|448416529|FG000|Overall Study|Physician Decision|2|||
124670502|NCT01656395|448416530|FG001|Overall Study|Physician Decision|3|||
124670503|NCT01656395|448416531|FG002|Overall Study|Physician Decision|3|||
124670504|NCT01656395|448416532|FG003|Overall Study|Physician Decision|2|||
124670505|NCT01656395|448416533|FG004|Overall Study|Physician Decision|3|||
124670506|NCT01656395|448416534|FG005|Overall Study|Physician Decision|3|||
124670507|NCT01656395|448416535|FG006|Overall Study|Physician Decision|0|||
124670508|NCT01656395|448416536|FG007|Overall Study|Physician Decision|0|||
124670509|NCT01656395|448416529|FG000|Overall Study|Pregnancy|0|||
124670510|NCT01656395|448416530|FG001|Overall Study|Pregnancy|0|||
124670511|NCT01656395|448416531|FG002|Overall Study|Pregnancy|1|||
124670512|NCT01656395|448416532|FG003|Overall Study|Pregnancy|0|||
124670513|NCT01656395|448416533|FG004|Overall Study|Pregnancy|0|||
124670514|NCT01656395|448416534|FG005|Overall Study|Pregnancy|0|||
124670515|NCT01656395|448416535|FG006|Overall Study|Pregnancy|0|||
124670516|NCT01656395|448416536|FG007|Overall Study|Pregnancy|0|||
124670517|NCT01656395|448416529|FG000|Overall Study|Progressive Disease|0|||
124670518|NCT01656395|448416530|FG001|Overall Study|Progressive Disease|0|||
124670519|NCT01656395|448416531|FG002|Overall Study|Progressive Disease|0|||
124670520|NCT01656395|448416532|FG003|Overall Study|Progressive Disease|0|||
124670521|NCT01656395|448416533|FG004|Overall Study|Progressive Disease|0|||
124670522|NCT01656395|448416534|FG005|Overall Study|Progressive Disease|1|||
124670523|NCT01656395|448416535|FG006|Overall Study|Progressive Disease|0|||
124670524|NCT01656395|448416536|FG007|Overall Study|Progressive Disease|0|||
124670525|NCT01656395|448416529|FG000|Overall Study|Protocol Violation|6|||
124670526|NCT01656395|448416530|FG001|Overall Study|Protocol Violation|6|||
124670527|NCT01656395|448416531|FG002|Overall Study|Protocol Violation|9|||
124670528|NCT01656395|448416532|FG003|Overall Study|Protocol Violation|2|||
124670529|NCT01656395|448416533|FG004|Overall Study|Protocol Violation|4|||
124670530|NCT01656395|448416534|FG005|Overall Study|Protocol Violation|10|||
124670531|NCT01656395|448416535|FG006|Overall Study|Protocol Violation|0|||
124670532|NCT01656395|448416536|FG007|Overall Study|Protocol Violation|0|||
124670533|NCT01656395|448416529|FG000|Overall Study|Screen Failure|2|||
124670534|NCT01656395|448416530|FG001|Overall Study|Screen Failure|1|||
124670535|NCT01656395|448416531|FG002|Overall Study|Screen Failure|7|||
124670536|NCT01656395|448416532|FG003|Overall Study|Screen Failure|1|||
124670537|NCT01656395|448416533|FG004|Overall Study|Screen Failure|0|||
124670538|NCT01656395|448416534|FG005|Overall Study|Screen Failure|8|||
124670539|NCT01656395|448416535|FG006|Overall Study|Screen Failure|0|||
124670540|NCT01656395|448416536|FG007|Overall Study|Screen Failure|0|||
124670541|NCT01656395|448416529|FG000|Overall Study|Withdrawal by Subject|3|||
124670542|NCT01656395|448416530|FG001|Overall Study|Withdrawal by Subject|1|||
124670543|NCT01656395|448416531|FG002|Overall Study|Withdrawal by Subject|4|||
124670544|NCT01656395|448416532|FG003|Overall Study|Withdrawal by Subject|2|||
124670545|NCT01656395|448416533|FG004|Overall Study|Withdrawal by Subject|0|||
124670546|NCT01656395|448416534|FG005|Overall Study|Withdrawal by Subject|3|||
124670547|NCT01656395|448416535|FG006|Overall Study|Withdrawal by Subject|0|||
124670548|NCT01656395|448416536|FG007|Overall Study|Withdrawal by Subject|0|||
124670549|NCT03075267|448416537|FG000|Overall Study|Protocol Violation|1|||
124670550|NCT03075267|448416538|FG001|Overall Study|Protocol Violation|0|||
124670551|NCT03075267|448416539|FG002|Overall Study|Protocol Violation|0|||
124670552|NCT00274742|448416542|FG000|Overall Study|Adverse Event|0|||
124670553|NCT00274742|448416543|FG001|Overall Study|Adverse Event|4|||
124670554|NCT00274742|448416544|FG002|Overall Study|Adverse Event|1|||
124670555|NCT00274742|448416545|FG003|Overall Study|Adverse Event|4|||
124670556|NCT00274742|448416546|FG004|Overall Study|Adverse Event|12|||
124670557|NCT00274742|448416547|FG005|Overall Study|Adverse Event|3|||
124670558|NCT00274742|448416542|FG000|Overall Study|Lost to Follow-up|0|||
124670559|NCT00274742|448416543|FG001|Overall Study|Lost to Follow-up|0|||
124670560|NCT00274742|448416544|FG002|Overall Study|Lost to Follow-up|0|||
124670561|NCT00274742|448416545|FG003|Overall Study|Lost to Follow-up|0|||
124670562|NCT00274742|448416546|FG004|Overall Study|Lost to Follow-up|1|||
124670563|NCT00274742|448416547|FG005|Overall Study|Lost to Follow-up|0|||
124670564|NCT00274742|448416542|FG000|Overall Study|End of Study|0|||
124670565|NCT00274742|448416543|FG001|Overall Study|End of Study|0|||
124670566|NCT00274742|448416544|FG002|Overall Study|End of Study|0|||
124670567|NCT00274742|448416545|FG003|Overall Study|End of Study|1|||
124670568|NCT00274742|448416546|FG004|Overall Study|End of Study|0|||
124670569|NCT00274742|448416547|FG005|Overall Study|End of Study|0|||
124670570|NCT00274742|448416542|FG000|Overall Study|Disease Progression|0|||
124670571|NCT00274742|448416543|FG001|Overall Study|Disease Progression|1|||
124670572|NCT00274742|448416544|FG002|Overall Study|Disease Progression|1|||
124670573|NCT00274742|448416545|FG003|Overall Study|Disease Progression|0|||
124670574|NCT00274742|448416546|FG004|Overall Study|Disease Progression|1|||
124670575|NCT00274742|448416547|FG005|Overall Study|Disease Progression|0|||
124670576|NCT00274742|448416542|FG000|Overall Study|Other|0|||
124670577|NCT00274742|448416543|FG001|Overall Study|Other|3|||
124670578|NCT00274742|448416544|FG002|Overall Study|Other|0|||
124670579|NCT00274742|448416545|FG003|Overall Study|Other|0|||
124670580|NCT00274742|448416546|FG004|Overall Study|Other|2|||
124670581|NCT00274742|448416547|FG005|Overall Study|Other|0|||
124670582|NCT01529606|448416554|FG000|Overall Study|Lost to Follow-up|21|||
124670583|NCT01529606|448416555|FG001|Overall Study|Lost to Follow-up|18|||
124670584|NCT01746862|448416558|FG000|Overall Study|Withdrawal by Subject|1|||
124670585|NCT01746862|448416559|FG001|Overall Study|Withdrawal by Subject|1|||
124670586|NCT01746862|448416558|FG000|Overall Study|Protocol Violation|1|||
124670587|NCT01746862|448416559|FG001|Overall Study|Protocol Violation|0|||
124670588|NCT01746862|448416558|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
124670589|NCT01746862|448416559|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
124670590|NCT01746862|448416558|FG000|Overall Study|Entered puberty during the study|1|||
124670591|NCT01746862|448416559|FG001|Overall Study|Entered puberty during the study|0|||
124670592|NCT04742673|448416560|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
124670593|NCT04742673|448416561|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
124670594|NCT01900444|448416562|FG000|Overall Study|Protocol Violation|2|||
124670595|NCT01900444|448416562|FG000|Overall Study|Lost to Follow-up|1|||
124670596|NCT00072384|448416566|FG000|Overall Study|Physician Decision|1|||
124670597|NCT00072384|448416566|FG000|Overall Study|Ineligible|8|||
124670598|NCT01825200|448416567|FG000|Overall Study|Lost to Follow-up|5|||
124670599|NCT01825200|448416568|FG001|Overall Study|Lost to Follow-up|6|||
124670600|NCT01825200|448416567|FG000|Overall Study|Withdrawal by Subject|0|||
124670601|NCT01825200|448416568|FG001|Overall Study|Withdrawal by Subject|1|||
124670602|NCT00490035|448416569|FG000|Overall Study|AE, non-serious non-fatal|3|||
124670603|NCT00490035|448416570|FG001|Overall Study|AE, non-serious non-fatal|4|||
124670604|NCT00490035|448416571|FG002|Overall Study|AE, non-serious non-fatal|4|||
124670605|NCT00490035|448416572|FG003|Overall Study|AE, non-serious non-fatal|5|||
124670606|NCT00490035|448416569|FG000|Overall Study|Lost to Follow-up|2|||
124670607|NCT00490035|448416570|FG001|Overall Study|Lost to Follow-up|0|||
124670608|NCT00490035|448416571|FG002|Overall Study|Lost to Follow-up|1|||
124670609|NCT00490035|448416572|FG003|Overall Study|Lost to Follow-up|0|||
124670610|NCT00490035|448416569|FG000|Overall Study|Withdrawal by Subject|2|||
124670611|NCT00490035|448416570|FG001|Overall Study|Withdrawal by Subject|1|||
124670612|NCT00490035|448416571|FG002|Overall Study|Withdrawal by Subject|1|||
124670613|NCT00490035|448416572|FG003|Overall Study|Withdrawal by Subject|0|||
124670614|NCT00490035|448416569|FG000|Overall Study|Other reason|0|||
124670615|NCT00490035|448416570|FG001|Overall Study|Other reason|1|||
124670616|NCT00490035|448416571|FG002|Overall Study|Other reason|3|||
124670617|NCT00490035|448416572|FG003|Overall Study|Other reason|1|||
124670618|NCT00490035|448416569|FG000|Overall Study|AE, serious fatal|1|||
124670619|NCT00490035|448416570|FG001|Overall Study|AE, serious fatal|0|||
124670620|NCT00490035|448416571|FG002|Overall Study|AE, serious fatal|0|||
124670621|NCT00490035|448416572|FG003|Overall Study|AE, serious fatal|0|||
124670622|NCT00490035|448416569|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
124670623|NCT00490035|448416570|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
124670624|NCT00490035|448416571|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
124670625|NCT00490035|448416572|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
124670626|NCT00490035|448416569|FG000|Overall Study|AE of unknown type|0|||
124670627|NCT00490035|448416570|FG001|Overall Study|AE of unknown type|0|||
124670628|NCT00490035|448416571|FG002|Overall Study|AE of unknown type|2|||
124670629|NCT00490035|448416572|FG003|Overall Study|AE of unknown type|0|||
124670630|NCT06058390|448416576|FG000|Overall Study|Lost to Follow-up|0|||
124670631|NCT06058390|448416577|FG001|Overall Study|Lost to Follow-up|0|||
124670632|NCT06058390|448416578|FG002|Overall Study|Lost to Follow-up|2|||
124670633|NCT06058390|448416579|FG003|Overall Study|Lost to Follow-up|1|||
124670634|NCT06058390|448416576|FG000|Overall Study|Physician Decision|0|||
124670635|NCT06058390|448416577|FG001|Overall Study|Physician Decision|0|||
124670636|NCT06058390|448416578|FG002|Overall Study|Physician Decision|0|||
124670637|NCT06058390|448416579|FG003|Overall Study|Physician Decision|1|||
124670638|NCT06058390|448416576|FG000|Overall Study|Participants did not receive any study intervention|0|||
124670639|NCT06058390|448416577|FG001|Overall Study|Participants did not receive any study intervention|0|||
124670640|NCT06058390|448416578|FG002|Overall Study|Participants did not receive any study intervention|0|||
124670641|NCT06058390|448416579|FG003|Overall Study|Participants did not receive any study intervention|1|||
124670642|NCT03361306|448416582|FG000|Overall Study|Death|6|||
124670643|NCT04817332|448416585|FG000|Overall Study|Lost to Follow-up|3|||
124670644|NCT04817332|448416586|FG001|Overall Study|Lost to Follow-up|3|||
124670645|NCT04817332|448416585|FG000|Overall Study|Protocol Violation|2|||
124670646|NCT04817332|448416586|FG001|Overall Study|Protocol Violation|0|||
124670647|NCT04795466|448416592|FG000|Overall Study|Adverse Event|3|||
124670648|NCT04795466|448416593|FG001|Overall Study|Adverse Event|1|||
124670649|NCT04795466|448416592|FG000|Overall Study|Physician Decision|1|||
124670650|NCT04795466|448416593|FG001|Overall Study|Physician Decision|0|||
124670651|NCT04795466|448416592|FG000|Overall Study|Withdrawal by Subject|2|||
124670652|NCT04795466|448416593|FG001|Overall Study|Withdrawal by Subject|1|||
124670653|NCT05635045|448416594|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
124670654|NCT05635045|448416595|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
124670655|NCT05635045|448416596|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
124670656|NCT05635045|448416597|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
124670657|NCT02131064|448416603|FG000|Overall Study|Death|5|||
124670658|NCT02131064|448416604|FG001|Overall Study|Death|6|||
124670659|NCT02131064|448416603|FG000|Overall Study|Lost to Follow-up|4|||
124670660|NCT02131064|448416604|FG001|Overall Study|Lost to Follow-up|8|||
124670661|NCT02131064|448416603|FG000|Overall Study|Withdrawal by Subject|14|||
124670662|NCT02131064|448416604|FG001|Overall Study|Withdrawal by Subject|18|||
124670663|NCT02131064|448416603|FG000|Overall Study|Other|2|||
124670664|NCT02131064|448416604|FG001|Overall Study|Other|2|||
124670665|NCT00810069|448416607|FG000|Lead-in Period I|Adverse Event|43|||
124670666|NCT00810069|448416608|FG001|Lead-in Period I|Adverse Event|0|||
124670667|NCT00810069|448416609|FG002|Lead-in Period I|Adverse Event|0|||
124670668|NCT00810069|448416607|FG000|Lead-in Period I|Lack of Efficacy|1|||
124670669|NCT00810069|448416608|FG001|Lead-in Period I|Lack of Efficacy|0|||
124670670|NCT00810069|448416609|FG002|Lead-in Period I|Lack of Efficacy|0|||
124670671|NCT00810069|448416607|FG000|Lead-in Period I|Lost to Follow-up|19|||
124670672|NCT00810069|448416608|FG001|Lead-in Period I|Lost to Follow-up|0|||
124670673|NCT00810069|448416609|FG002|Lead-in Period I|Lost to Follow-up|0|||
124670674|NCT00810069|448416607|FG000|Lead-in Period I|Physician Decision|1|||
124670675|NCT00810069|448416608|FG001|Lead-in Period I|Physician Decision|0|||
124670676|NCT00810069|448416609|FG002|Lead-in Period I|Physician Decision|0|||
124670677|NCT00810069|448416607|FG000|Lead-in Period I|Protocol Violation|1|||
124670678|NCT00810069|448416608|FG001|Lead-in Period I|Protocol Violation|0|||
124670679|NCT00810069|448416609|FG002|Lead-in Period I|Protocol Violation|0|||
124670680|NCT00810069|448416607|FG000|Lead-in Period I|Withdrawal by Subject|46|||
124670681|NCT00810069|448416608|FG001|Lead-in Period I|Withdrawal by Subject|0|||
124670682|NCT00810069|448416609|FG002|Lead-in Period I|Withdrawal by Subject|0|||
124670683|NCT00810069|448416607|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
124670684|NCT00810069|448416608|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
124670685|NCT00810069|448416609|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
124670686|NCT00810069|448416607|FG000|Lead-in Period I|Randomization criteria not met|158|||
124670687|NCT00810069|448416608|FG001|Lead-in Period I|Randomization criteria not met|0|||
124670688|NCT00810069|448416609|FG002|Lead-in Period I|Randomization criteria not met|0|||
124670689|NCT00810069|448416607|FG000|Double-Blind Period II|Adverse Event|0|||
124670690|NCT00810069|448416608|FG001|Double-Blind Period II|Adverse Event|9|||
124670691|NCT00810069|448416609|FG002|Double-Blind Period II|Adverse Event|8|||
124670692|NCT00810069|448416607|FG000|Double-Blind Period II|Lack of Efficacy|0|||
124670693|NCT00810069|448416608|FG001|Double-Blind Period II|Lack of Efficacy|7|||
124670694|NCT00810069|448416609|FG002|Double-Blind Period II|Lack of Efficacy|12|||
124670695|NCT00810069|448416607|FG000|Double-Blind Period II|Lost to Follow-up|0|||
124670696|NCT00810069|448416608|FG001|Double-Blind Period II|Lost to Follow-up|9|||
124670697|NCT00810069|448416609|FG002|Double-Blind Period II|Lost to Follow-up|9|||
124670698|NCT00810069|448416607|FG000|Double-Blind Period II|Physician Decision|0|||
124670699|NCT00810069|448416608|FG001|Double-Blind Period II|Physician Decision|0|||
124670700|NCT00810069|448416609|FG002|Double-Blind Period II|Physician Decision|1|||
124670701|NCT00810069|448416607|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
124670702|NCT00810069|448416608|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
124670703|NCT00810069|448416609|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
124670704|NCT00810069|448416607|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
124670705|NCT00810069|448416608|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
124670706|NCT00810069|448416609|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
124670707|NCT00810069|448416607|FG000|Double-Blind Period II|Clinical relapse|0|||
124670708|NCT00810069|448416608|FG001|Double-Blind Period II|Clinical relapse|3|||
124670709|NCT00810069|448416609|FG002|Double-Blind Period II|Clinical relapse|0|||
124670710|NCT00810069|448416607|FG000|Double-Blind Period II|Protocol Violation|0|||
124670711|NCT00810069|448416608|FG001|Double-Blind Period II|Protocol Violation|7|||
124670712|NCT00810069|448416609|FG002|Double-Blind Period II|Protocol Violation|6|||
124670713|NCT00971867|448416613|FG000|Overall Study|Adverse Event|4|||
124670714|NCT00971867|448416613|FG000|Overall Study|Participant Withdrew Consent|1|||
124670715|NCT00971867|448416613|FG000|Overall Study|Disease Progression|6|||
124670716|NCT04767373|448416614|FG000|Overall Study|Death|6|||
124670717|NCT04767373|448416615|FG001|Overall Study|Death|3|||
124670718|NCT04767373|448416614|FG000|Overall Study|Lost to Follow-up|67|||
124670719|NCT04767373|448416615|FG001|Overall Study|Lost to Follow-up|35|||
124670720|NCT04767373|448416614|FG000|Overall Study|Physician Decision|15|||
124670721|NCT04767373|448416615|FG001|Overall Study|Physician Decision|4|||
124670722|NCT04767373|448416614|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124670723|NCT04767373|448416615|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
124670724|NCT04767373|448416614|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
124670725|NCT04767373|448416615|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
124670726|NCT04767373|448416614|FG000|Overall Study|Other|1|||
124670727|NCT04767373|448416615|FG001|Overall Study|Other|2|||
124670728|NCT02983045|448416617|FG000|Overall Study|Withdrawal by Subject|0|||
124670729|NCT02983045|448416618|FG001|Overall Study|Withdrawal by Subject|1|||
124670730|NCT02983045|448416619|FG002|Overall Study|Withdrawal by Subject|0|||
124670731|NCT02983045|448416620|FG003|Overall Study|Withdrawal by Subject|5|||
124670732|NCT02983045|448416621|FG004|Overall Study|Withdrawal by Subject|0|||
124670733|NCT02983045|448416622|FG005|Overall Study|Withdrawal by Subject|72|||
124670734|NCT02983045|448416623|FG006|Overall Study|Withdrawal by Subject|0|||
124670735|NCT02983045|448416624|FG007|Overall Study|Withdrawal by Subject|0|||
124670736|NCT02983045|448416625|FG008|Overall Study|Withdrawal by Subject|0|||
124670737|NCT02983045|448416626|FG009|Overall Study|Withdrawal by Subject|2|||
124670738|NCT02983045|448416617|FG000|Overall Study|Lost to Follow-up|0|||
124670739|NCT02983045|448416618|FG001|Overall Study|Lost to Follow-up|0|||
124670740|NCT02983045|448416619|FG002|Overall Study|Lost to Follow-up|0|||
124670741|NCT02983045|448416620|FG003|Overall Study|Lost to Follow-up|0|||
124670742|NCT02983045|448416621|FG004|Overall Study|Lost to Follow-up|0|||
124670743|NCT02983045|448416622|FG005|Overall Study|Lost to Follow-up|10|||
124670744|NCT02983045|448416623|FG006|Overall Study|Lost to Follow-up|0|||
124670745|NCT02983045|448416624|FG007|Overall Study|Lost to Follow-up|0|||
124670746|NCT02983045|448416625|FG008|Overall Study|Lost to Follow-up|0|||
124670747|NCT02983045|448416626|FG009|Overall Study|Lost to Follow-up|0|||
124670748|NCT00593918|448416627|FG000|Overall Study|Withdrawal by Subject|5|||
124670749|NCT00593918|448416628|FG001|Overall Study|Withdrawal by Subject|24|||
124670750|NCT02658669|448416629|FG000|Overall Study|Lost to Follow-up|7|||
124670751|NCT02658669|448416630|FG001|Overall Study|Lost to Follow-up|5|||
124670752|NCT03727841|448416631|FG000|Overall Study|Physician Decision|3|||
124670753|NCT03727841|448416632|FG001|Overall Study|Physician Decision|1|||
124670754|NCT01601496|448416633|FG000|Overall Study|Physician Decision|1|||
124670755|NCT01601496|448416633|FG000|Overall Study|Withdrawal by Subject|1|||
124670756|NCT01601496|448416633|FG000|Overall Study|Lost to Follow-up|6|||
124670757|NCT01601496|448416633|FG000|Overall Study|Death|4|||
124670758|NCT01601496|448416633|FG000|Overall Study|Other: patient refusal to continue|3|||
124670759|NCT03771963|448416641|FG000|Overall Study|Lost to Follow-up|22|||
124670760|NCT03771963|448416641|FG000|Overall Study|Withdrawal of Consent|10|||
124670761|NCT03014206|448416642|FG000|Overall Study|Registration Violation|12|||
124670762|NCT05502302|448416643|FG000|Overall Study|Lost to Follow-up|6|||
124670763|NCT05502302|448416643|FG000|Overall Study|Death|2|||
124670764|NCT01628848|448416650|FG000|Overall Study|Adverse Event|9|||
124670765|NCT01628848|448416651|FG001|Overall Study|Adverse Event|7|||
124670766|NCT01628848|448416650|FG000|Overall Study|Lack of Efficacy|0|||
124670767|NCT01628848|448416651|FG001|Overall Study|Lack of Efficacy|4|||
124670768|NCT01628848|448416650|FG000|Overall Study|Withdrawal by Subject|0|||
124670769|NCT01628848|448416651|FG001|Overall Study|Withdrawal by Subject|2|||
124670770|NCT01628848|448416650|FG000|Overall Study|Physician Decision|3|||
124670771|NCT01628848|448416651|FG001|Overall Study|Physician Decision|1|||
124670772|NCT00003471|448416652|FG000|Overall Study|Not evaluable|4|||
124670773|NCT02104895|448416653|FG000|Overall Study|Withdrawal by Subject|0|||
124670774|NCT02104895|448416654|FG001|Overall Study|Withdrawal by Subject|14|||
124670775|NCT02895295|448416657|FG000|Overall Study|Survey Non-response|71|||
124670776|NCT02895295|448416658|FG001|Overall Study|Survey Non-response|94|||
124670777|NCT02895295|448416659|FG002|Overall Study|Survey Non-response|92|||
124670778|NCT01367249|448416660|FG000|Overall Study|Withdrawal by Subject|6|||
124670779|NCT01367249|448416661|FG001|Overall Study|Withdrawal by Subject|6|||
124670780|NCT01367249|448416660|FG000|Overall Study|Other|3|||
124670781|NCT01367249|448416661|FG001|Overall Study|Other|10|||
124670782|NCT00960804|448416664|FG000|Overall Study|Adverse Event|1|||
124670783|NCT00960804|448416665|FG001|Overall Study|Adverse Event|0|||
124670784|NCT00960804|448416666|FG002|Overall Study|Adverse Event|0|||
124670785|NCT00960804|448416664|FG000|Overall Study|Withdrawal by Subject|1|||
124670786|NCT00960804|448416665|FG001|Overall Study|Withdrawal by Subject|0|||
124670787|NCT00960804|448416666|FG002|Overall Study|Withdrawal by Subject|0|||
124670788|NCT00960804|448416664|FG000|Overall Study|Study terminated by the sponsor|5|||
124670789|NCT00960804|448416665|FG001|Overall Study|Study terminated by the sponsor|4|||
124670790|NCT00960804|448416666|FG002|Overall Study|Study terminated by the sponsor|10|||
124670791|NCT00490919|448416667|FG000|Open-label Run-in Period|Adverse Event|239|||
124670792|NCT00490919|448416668|FG001|Open-label Run-in Period|Adverse Event|0|||
124670793|NCT00490919|448416669|FG002|Open-label Run-in Period|Adverse Event|0|||
124670794|NCT00490919|448416667|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
124670795|NCT00490919|448416668|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
124670796|NCT00490919|448416669|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
124670797|NCT00490919|448416667|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
124670798|NCT00490919|448416668|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
124670799|NCT00490919|448416669|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
124670800|NCT00490919|448416667|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
124670801|NCT00490919|448416668|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
124670802|NCT00490919|448416669|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
124670803|NCT00490919|448416667|FG000|Open-label Run-in Period|Administrative|40|||
124670804|NCT00490919|448416668|FG001|Open-label Run-in Period|Administrative|0|||
124670805|NCT00490919|448416669|FG002|Open-label Run-in Period|Administrative|0|||
124670806|NCT00490919|448416667|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
124670807|NCT00490919|448416668|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
124670808|NCT00490919|448416669|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
124670809|NCT00490919|448416667|FG000|Double-blind Phase|Adverse Event|0|||
124670810|NCT00490919|448416668|FG001|Double-blind Phase|Adverse Event|40|||
124670811|NCT00490919|448416669|FG002|Double-blind Phase|Adverse Event|20|||
124670812|NCT00490919|448416667|FG000|Double-blind Phase|Withdrawal by Subject|0|||
124670813|NCT00490919|448416668|FG001|Double-blind Phase|Withdrawal by Subject|10|||
124670814|NCT00490919|448416669|FG002|Double-blind Phase|Withdrawal by Subject|11|||
124670815|NCT00490919|448416667|FG000|Double-blind Phase|Lost to Follow-up|0|||
124670816|NCT00490919|448416668|FG001|Double-blind Phase|Lost to Follow-up|8|||
124670817|NCT00490919|448416669|FG002|Double-blind Phase|Lost to Follow-up|11|||
124670818|NCT00490919|448416667|FG000|Double-blind Phase|Lack of Efficacy|0|||
124670819|NCT00490919|448416668|FG001|Double-blind Phase|Lack of Efficacy|22|||
124670820|NCT00490919|448416669|FG002|Double-blind Phase|Lack of Efficacy|36|||
124670821|NCT00490919|448416667|FG000|Double-blind Phase|Administrative|0|||
124670822|NCT00490919|448416668|FG001|Double-blind Phase|Administrative|6|||
124670823|NCT00490919|448416669|FG002|Double-blind Phase|Administrative|6|||
124670824|NCT02358031|448417998|FG000|Overall Study|Death|253|||
124670825|NCT02358031|448417999|FG001|Overall Study|Death|237|||
124670826|NCT02358031|448418000|FG002|Overall Study|Death|266|||
124670827|NCT02358031|448417998|FG000|Overall Study|Lost to Follow-up|1|||
124670828|NCT02358031|448417999|FG001|Overall Study|Lost to Follow-up|1|||
124670829|NCT02358031|448418000|FG002|Overall Study|Lost to Follow-up|0|||
124670830|NCT02358031|448417998|FG000|Overall Study|Withdrawal by Subject|19|||
124670831|NCT02358031|448417999|FG001|Overall Study|Withdrawal by Subject|14|||
124670832|NCT02358031|448418000|FG002|Overall Study|Withdrawal by Subject|18|||
124670833|NCT02358031|448417998|FG000|Overall Study|Sponsor Decision|26|||
124670834|NCT02358031|448417999|FG001|Overall Study|Sponsor Decision|28|||
124670835|NCT02358031|448418000|FG002|Overall Study|Sponsor Decision|16|||
124670836|NCT05664581|448418001|FG000|Overall Study|Withdrawal by Subject|2|||
124670837|NCT03101150|448418004|FG000|Overall Study|Lost to Follow-up|2|||
124670838|NCT03101150|448418005|FG001|Overall Study|Lost to Follow-up|4|||
124670839|NCT03101150|448418004|FG000|Overall Study|Miscarriage|3|||
124670840|NCT03101150|448418005|FG001|Overall Study|Miscarriage|6|||
124670841|NCT03163446|448418006|FG000|Overall Study|Unable to return for Day 180 visit|2|||
124670842|NCT03163446|448418007|FG001|Overall Study|Unable to return for Day 180 visit|0|||
124670843|NCT03163446|448418006|FG000|Overall Study|Withdrawal by Subject|2|||
124670844|NCT03163446|448418007|FG001|Overall Study|Withdrawal by Subject|6|||
124670845|NCT03163446|448418006|FG000|Overall Study|Death|16|||
124670846|NCT03163446|448418007|FG001|Overall Study|Death|5|||
124670847|NCT03163446|448418006|FG000|Overall Study|Lost to Follow-up|6|||
124670848|NCT03163446|448418007|FG001|Overall Study|Lost to Follow-up|5|||
124670849|NCT03163446|448418006|FG000|Overall Study|Physician Decision|1|||
124670850|NCT03163446|448418007|FG001|Overall Study|Physician Decision|1|||
124670851|NCT03163446|448418006|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
124670852|NCT03163446|448418007|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
124670853|NCT01317641|448418008|FG000|Overall Study|Not treated|0|||
124670854|NCT01317641|448418009|FG001|Overall Study|Not treated|0|||
124670855|NCT01317641|448418010|FG002|Overall Study|Not treated|0|||
124670856|NCT01317641|448418011|FG003|Overall Study|Not treated|0|||
124670857|NCT01317641|448418012|FG004|Overall Study|Not treated|0|||
124670858|NCT01317641|448418013|FG005|Overall Study|Not treated|0|||
124670859|NCT01317641|448418014|FG006|Overall Study|Not treated|0|||
124670860|NCT01317641|448418015|FG007|Overall Study|Not treated|1|||
124670861|NCT01317641|448418016|FG008|Overall Study|Not treated|1|||
124670862|NCT01317641|448418008|FG000|Overall Study|Adverse Event|0|||
124670863|NCT01317641|448418009|FG001|Overall Study|Adverse Event|1|||
124670864|NCT01317641|448418010|FG002|Overall Study|Adverse Event|0|||
124670865|NCT01317641|448418011|FG003|Overall Study|Adverse Event|1|||
124670866|NCT01317641|448418012|FG004|Overall Study|Adverse Event|0|||
124670867|NCT01317641|448418013|FG005|Overall Study|Adverse Event|0|||
124670868|NCT01317641|448418014|FG006|Overall Study|Adverse Event|2|||
124670869|NCT01317641|448418015|FG007|Overall Study|Adverse Event|1|||
124670870|NCT01317641|448418016|FG008|Overall Study|Adverse Event|0|||
124670871|NCT01317641|448418008|FG000|Overall Study|Protocol Violation|1|||
124670872|NCT01317641|448418009|FG001|Overall Study|Protocol Violation|0|||
124670873|NCT01317641|448418010|FG002|Overall Study|Protocol Violation|0|||
124670874|NCT01317641|448418011|FG003|Overall Study|Protocol Violation|0|||
124670875|NCT01317641|448418012|FG004|Overall Study|Protocol Violation|0|||
124670876|NCT01317641|448418013|FG005|Overall Study|Protocol Violation|0|||
124670877|NCT01317641|448418014|FG006|Overall Study|Protocol Violation|0|||
124670878|NCT01317641|448418015|FG007|Overall Study|Protocol Violation|0|||
124670879|NCT01317641|448418016|FG008|Overall Study|Protocol Violation|0|||
124670880|NCT01317641|448418008|FG000|Overall Study|Disease progression|0|||
124670881|NCT01317641|448418009|FG001|Overall Study|Disease progression|0|||
124670882|NCT01317641|448418010|FG002|Overall Study|Disease progression|0|||
124670883|NCT01317641|448418011|FG003|Overall Study|Disease progression|0|||
124670884|NCT01317641|448418012|FG004|Overall Study|Disease progression|0|||
124670885|NCT01317641|448418013|FG005|Overall Study|Disease progression|0|||
124670886|NCT01317641|448418014|FG006|Overall Study|Disease progression|0|||
124670887|NCT01317641|448418015|FG007|Overall Study|Disease progression|3|||
124670888|NCT01317641|448418016|FG008|Overall Study|Disease progression|4|||
124670889|NCT01317641|448418008|FG000|Overall Study|Withdrawal by Subject|0|||
124670890|NCT01317641|448418009|FG001|Overall Study|Withdrawal by Subject|0|||
124670891|NCT01317641|448418010|FG002|Overall Study|Withdrawal by Subject|0|||
124670892|NCT01317641|448418011|FG003|Overall Study|Withdrawal by Subject|0|||
124670893|NCT01317641|448418012|FG004|Overall Study|Withdrawal by Subject|0|||
124670894|NCT01317641|448418013|FG005|Overall Study|Withdrawal by Subject|0|||
124670895|NCT01317641|448418014|FG006|Overall Study|Withdrawal by Subject|1|||
124670896|NCT01317641|448418015|FG007|Overall Study|Withdrawal by Subject|0|||
124670897|NCT01317641|448418016|FG008|Overall Study|Withdrawal by Subject|0|||
124670898|NCT01228591|448418019|FG000|Baseline|Lack of Efficacy|1|||
124670899|NCT01228591|448418020|FG001|Baseline|Lack of Efficacy|2|||
124670900|NCT02787304|448418021|FG000|Overall Study|Adverse Event|9|||
124670901|NCT02787304|448418022|FG001|Overall Study|Adverse Event|3|||
124670902|NCT02787304|448418023|FG002|Overall Study|Adverse Event|8|||
124670903|NCT02787304|448418024|FG003|Overall Study|Adverse Event|1|||
124670904|NCT02787304|448418021|FG000|Overall Study|Withdrawal by Subject|1|||
124670905|NCT02787304|448418022|FG001|Overall Study|Withdrawal by Subject|4|||
124670906|NCT02787304|448418023|FG002|Overall Study|Withdrawal by Subject|0|||
124670907|NCT02787304|448418024|FG003|Overall Study|Withdrawal by Subject|0|||
124670908|NCT02787304|448418021|FG000|Overall Study|Lost to Follow-up|1|||
124670909|NCT02787304|448418022|FG001|Overall Study|Lost to Follow-up|0|||
124670910|NCT02787304|448418023|FG002|Overall Study|Lost to Follow-up|0|||
124670911|NCT02787304|448418024|FG003|Overall Study|Lost to Follow-up|1|||
124670912|NCT02787304|448418021|FG000|Overall Study|Noncompliance with study drug|0|||
124670913|NCT02787304|448418022|FG001|Overall Study|Noncompliance with study drug|0|||
124670914|NCT02787304|448418023|FG002|Overall Study|Noncompliance with study drug|1|||
124670915|NCT02787304|448418024|FG003|Overall Study|Noncompliance with study drug|0|||
124670916|NCT02787304|448418021|FG000|Overall Study|Physician Decision|0|||
124670917|NCT02787304|448418022|FG001|Overall Study|Physician Decision|0|||
124670918|NCT02787304|448418023|FG002|Overall Study|Physician Decision|1|||
124670919|NCT02787304|448418024|FG003|Overall Study|Physician Decision|0|||
124670920|NCT02787304|448418021|FG000|Overall Study|Study terminated by sponsor|25|||
124670921|NCT02787304|448418022|FG001|Overall Study|Study terminated by sponsor|31|||
124670922|NCT02787304|448418023|FG002|Overall Study|Study terminated by sponsor|31|||
124670923|NCT02787304|448418024|FG003|Overall Study|Study terminated by sponsor|32|||
124670924|NCT01051921|448418025|FG000|Overall Study|Physician Decision|9|||
124670925|NCT01051921|448418025|FG000|Overall Study|Adverse Event|8|||
124670926|NCT01051921|448418025|FG000|Overall Study|Withdrawal by Subject|7|||
124670927|NCT01051921|448418025|FG000|Overall Study|Lost to Follow-up|4|||
124670928|NCT01051921|448418025|FG000|Overall Study|virological failure|1|||
124670929|NCT01051921|448418025|FG000|Overall Study|patient moved|1|||
124670930|NCT00379834|448418026|FG000|Overall Study|Time constraints|2|||
124670931|NCT01775670|448418035|FG000|Overall Study|Lost to Follow-up|1|||
124670932|NCT01775670|448418036|FG001|Overall Study|Lost to Follow-up|1|||
124670933|NCT01001429|448418037|FG000|Overall Study|surgery cancelled|0|||
124670934|NCT01001429|448418038|FG001|Overall Study|surgery cancelled|1|||
124670935|NCT02063672|448418045|FG000|Overall Study|Ongoing Follow-up|27|||
124670936|NCT02063672|448418046|FG001|Overall Study|Ongoing Follow-up|14|||
124670937|NCT02063672|448418045|FG000|Overall Study|Death|5|||
124670938|NCT02063672|448418046|FG001|Overall Study|Death|3|||
124670939|NCT02063672|448418045|FG000|Overall Study|Lost to Follow-up|1|||
124670940|NCT02063672|448418046|FG001|Overall Study|Lost to Follow-up|3|||
124670941|NCT02063672|448418045|FG000|Overall Study|Withdrawal by Subject|2|||
124670942|NCT02063672|448418046|FG001|Overall Study|Withdrawal by Subject|2|||
124670943|NCT01053741|448418047|FG000|2nd Study Intervention|Physician Decision|0|||
124670944|NCT01053741|448418048|FG001|2nd Study Intervention|Physician Decision|1|||
124670945|NCT00619827|448418050|FG000|Overall Study|Adverse Event|1|||
124670946|NCT00619827|448418051|FG001|Overall Study|Adverse Event|2|||
124670947|NCT00619827|448418050|FG000|Overall Study|Withdrawal by Subject|2|||
124670948|NCT00619827|448418051|FG001|Overall Study|Withdrawal by Subject|2|||
124670949|NCT00104052|448418052|FG000|Overall Study|Adverse Event|1|||
124670950|NCT00104052|448418052|FG000|Overall Study|Lack of Efficacy|26|||
124670951|NCT00104052|448418052|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
124670952|NCT02498678|448418053|FG000|Overall Study|interference from the surgical team|0|||
124670953|NCT02498678|448418054|FG001|Overall Study|interference from the surgical team|2|||
124670954|NCT01484951|448418060|FG000|Overall Study|Adverse Event|3|||
124670955|NCT01484951|448418060|FG000|Overall Study|Personal Reasons|1|||
124670956|NCT01484951|448418060|FG000|Overall Study|Non-Compliance|1|||
124670957|NCT00917124|448418065|FG000|Overall Study|Protocol Violation|4|||
124670958|NCT00917124|448418066|FG001|Overall Study|Protocol Violation|6|||
124670959|NCT00115778|448418067|FG000|Overall Study|Withdrawal by Subject|0|||
124670960|NCT00115778|448418068|FG001|Overall Study|Withdrawal by Subject|1|||
124670961|NCT00528424|448418071|FG000|Overall Study|Lost to Follow-up|13|||
124670962|NCT00528424|448418071|FG000|Overall Study|Withdrew consent|2|||
124670963|NCT00528424|448418071|FG000|Overall Study|Administrative reason|2|||
124670964|NCT00528424|448418071|FG000|Overall Study|Other|12|||
124670965|NCT02087774|448418076|FG000|Overall Study|Were absent day of data collection|8|||
124670966|NCT02087774|448418077|FG001|Overall Study|Were absent day of data collection|20|||
124670967|NCT00661089|448418078|FG000|Overall Study|1 subject withdrawal|0|||
124670968|NCT00661089|448418079|FG001|Overall Study|1 subject withdrawal|1|||
124670969|NCT00661089|448418078|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
124670970|NCT00661089|448418079|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
124670971|NCT04144322|448418083|FG000|Overall Study|Lack of Efficacy|2|||
124670972|NCT04144322|448418084|FG001|Overall Study|Lack of Efficacy|2|||
124670973|NCT00385918|448418087|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
124670974|NCT00385918|448418088|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
124670975|NCT00385918|448418089|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
124670976|NCT00385918|448418087|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
124670977|NCT00385918|448418088|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
124670978|NCT00385918|448418089|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
124670979|NCT00385918|448418087|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
124670980|NCT00385918|448418088|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
124670981|NCT00385918|448418089|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
124670982|NCT00385918|448418087|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
124670983|NCT00385918|448418088|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
124670984|NCT00385918|448418089|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
124670985|NCT00385918|448418087|FG000|Intervention Phase After Randomization|Physician Decision|1|||
124670986|NCT00385918|448418088|FG001|Intervention Phase After Randomization|Physician Decision|0|||
124670987|NCT00385918|448418089|FG002|Intervention Phase After Randomization|Physician Decision|0|||
124670988|NCT00385918|448418087|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
124670989|NCT00385918|448418088|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
124670990|NCT00385918|448418089|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
124670991|NCT01676701|448418090|FG000|Overall Study|Protocol Violation|1|||
124670992|NCT01676701|448418091|FG001|Overall Study|Protocol Violation|0|||
124670993|NCT01676701|448418090|FG000|Overall Study|Sponsor Decision|3|||
124670994|NCT01676701|448418091|FG001|Overall Study|Sponsor Decision|4|||
124670995|NCT02227784|448418100|FG000|Double-Blind Phase|Adverse Event|3|||
124670996|NCT02227784|448418101|FG001|Double-Blind Phase|Adverse Event|2|||
124670997|NCT02227784|448418102|FG002|Double-Blind Phase|Adverse Event|1|||
124670998|NCT02227784|448418103|FG003|Double-Blind Phase|Adverse Event|3|||
124670999|NCT02227784|448418104|FG004|Double-Blind Phase|Adverse Event|0|||
124671000|NCT02227784|448418100|FG000|Double-Blind Phase|Physician Decision|1|||
124671001|NCT02227784|448418101|FG001|Double-Blind Phase|Physician Decision|0|||
124671002|NCT02227784|448418102|FG002|Double-Blind Phase|Physician Decision|0|||
124671003|NCT02227784|448418103|FG003|Double-Blind Phase|Physician Decision|1|||
124671004|NCT02227784|448418104|FG004|Double-Blind Phase|Physician Decision|0|||
124671005|NCT02227784|448418100|FG000|Double-Blind Phase|Protocol Violation|0|||
124671006|NCT02227784|448418101|FG001|Double-Blind Phase|Protocol Violation|0|||
124671007|NCT02227784|448418102|FG002|Double-Blind Phase|Protocol Violation|1|||
124671008|NCT02227784|448418103|FG003|Double-Blind Phase|Protocol Violation|1|||
124671009|NCT02227784|448418104|FG004|Double-Blind Phase|Protocol Violation|0|||
124671010|NCT02227784|448418100|FG000|Double-Blind Phase|Sponsor Decision|34|||
124671011|NCT02227784|448418101|FG001|Double-Blind Phase|Sponsor Decision|15|||
124671012|NCT02227784|448418102|FG002|Double-Blind Phase|Sponsor Decision|14|||
124671013|NCT02227784|448418103|FG003|Double-Blind Phase|Sponsor Decision|32|||
124671014|NCT02227784|448418104|FG004|Double-Blind Phase|Sponsor Decision|0|||
124671015|NCT02227784|448418100|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
124671016|NCT02227784|448418101|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
124671017|NCT02227784|448418102|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
124671018|NCT02227784|448418103|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
124671019|NCT02227784|448418104|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
124671020|NCT02227784|448418100|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
124671021|NCT02227784|448418101|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
124671022|NCT02227784|448418102|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
124671023|NCT02227784|448418103|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
124671024|NCT02227784|448418104|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
124671025|NCT02227784|448418100|FG000|Open-Label Extension Phase (OLE)|Death|0|||
124671026|NCT02227784|448418101|FG001|Open-Label Extension Phase (OLE)|Death|0|||
124671027|NCT02227784|448418102|FG002|Open-Label Extension Phase (OLE)|Death|0|||
124671028|NCT02227784|448418103|FG003|Open-Label Extension Phase (OLE)|Death|0|||
124671029|NCT02227784|448418104|FG004|Open-Label Extension Phase (OLE)|Death|1|||
124671030|NCT02227784|448418100|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
124671031|NCT02227784|448418101|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
124671032|NCT02227784|448418102|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
124671033|NCT02227784|448418103|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
124671034|NCT02227784|448418104|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
124671035|NCT02227784|448418100|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
124671036|NCT02227784|448418101|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
124671037|NCT02227784|448418102|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
124671038|NCT02227784|448418103|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
124671039|NCT02227784|448418104|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
124671040|NCT02155699|448418105|FG000|Overall Study|Withdrawal by Subject|0|||
124671041|NCT02155699|448418106|FG001|Overall Study|Withdrawal by Subject|3|||
124671042|NCT02155699|448418107|FG002|Overall Study|Withdrawal by Subject|6|||
124671043|NCT02155699|448418108|FG003|Overall Study|Withdrawal by Subject|1|||
124671044|NCT02155699|448418105|FG000|Overall Study|Lost to Follow-up|0|||
124671045|NCT02155699|448418106|FG001|Overall Study|Lost to Follow-up|0|||
124671046|NCT02155699|448418107|FG002|Overall Study|Lost to Follow-up|0|||
124671047|NCT02155699|448418108|FG003|Overall Study|Lost to Follow-up|3|||
124671048|NCT02155699|448418105|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
124671049|NCT02155699|448418106|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
124671050|NCT02155699|448418107|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
124671051|NCT02155699|448418108|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
124671052|NCT03834506|448418112|FG000|Overall Study|Death|336|||
124671053|NCT03834506|448418113|FG001|Overall Study|Death|326|||
124671054|NCT03834506|448418112|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
124671055|NCT03834506|448418113|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
124671056|NCT03834506|448418112|FG000|Overall Study|Withdrawal by Subject|10|||
124671057|NCT03834506|448418113|FG001|Overall Study|Withdrawal by Subject|8|||
124671058|NCT03834506|448418112|FG000|Overall Study|Sponsor decision|165|||
124671059|NCT03834506|448418113|FG001|Overall Study|Sponsor decision|178|||
124671060|NCT03834506|448418112|FG000|Overall Study|Physician Decision|3|||
124671061|NCT03834506|448418113|FG001|Overall Study|Physician Decision|1|||
124671062|NCT03834506|448418112|FG000|Overall Study|Lost to Follow-up|0|||
124671063|NCT03834506|448418113|FG001|Overall Study|Lost to Follow-up|1|||
124671064|NCT04577794|448418114|FG000|Overall Study|Adverse Event|1|||
124671065|NCT04577794|448418115|FG001|Overall Study|Adverse Event|1|||
124671066|NCT03311945|448418117|FG000|Overall Study|Adverse Event|2|||
124671067|NCT03311945|448418117|FG000|Overall Study|Lack of Efficacy|1|||
124671068|NCT01107925|448418118|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
124671069|NCT01107925|448418119|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
124671070|NCT01107925|448418120|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
124671071|NCT01107925|448418121|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
124671072|NCT01107925|448418122|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
124671073|NCT01107925|448418123|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
124671074|NCT01107925|448418118|FG000|Period 2|Withdrawal by Subject|0|||
124671075|NCT01107925|448418119|FG001|Period 2|Withdrawal by Subject|1|||
124671076|NCT01107925|448418120|FG002|Period 2|Withdrawal by Subject|0|||
124671077|NCT01107925|448418121|FG003|Period 2|Withdrawal by Subject|0|||
124671078|NCT01107925|448418122|FG004|Period 2|Withdrawal by Subject|0|||
124671079|NCT01107925|448418123|FG005|Period 2|Withdrawal by Subject|1|||
124671080|NCT04877990|448418124|FG000|Treatment|Other reasons|3|||
124671081|NCT04877990|448418125|FG001|Treatment|Other reasons|1|||
124671082|NCT04877990|448418124|FG000|Treatment|Administrative reasons by sponsor|17|||
124671083|NCT04877990|448418125|FG001|Treatment|Administrative reasons by sponsor|33|||
124671084|NCT04877990|448418124|FG000|Treatment|Withdrawal by Subject|2|||
124671085|NCT04877990|448418125|FG001|Treatment|Withdrawal by Subject|6|||
124671086|NCT04877990|448418124|FG000|Treatment|Adverse Event|2|||
124671087|NCT04877990|448418125|FG001|Treatment|Adverse Event|1|||
124671088|NCT03839394|448418126|FG000|Overall Study|Lost to Follow-up|6|||
124671089|NCT03839394|448418127|FG001|Overall Study|Lost to Follow-up|8|||
124671090|NCT03839394|448418126|FG000|Overall Study|Withdrawal by Subject|0|||
124671091|NCT03839394|448418127|FG001|Overall Study|Withdrawal by Subject|2|||
124671092|NCT01619878|448418128|FG000|6 Week Follow-up Phase|Adverse Event|1|||
124671093|NCT01619878|448418128|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
124671094|NCT01619878|448418128|FG000|Follow-up at 12 Months of Age|Death|2|||
124671095|NCT04821830|448418129|FG000|Overall Study|Withdrawal by Subject|1|||
124671096|NCT04821830|448418130|FG001|Overall Study|Withdrawal by Subject|0|||
124671097|NCT03110354|448419890|FG000|Overall Study|Death|1|||
124671098|NCT03110354|448419891|FG001|Overall Study|Death|0|||
124671099|NCT03110354|448419892|FG002|Overall Study|Death|0|||
124671100|NCT03110354|448419893|FG003|Overall Study|Death|1|||
124671101|NCT03110354|448419894|FG004|Overall Study|Death|0|||
124671102|NCT03110354|448419890|FG000|Overall Study|Start of new therapy|0|||
124671103|NCT03110354|448419891|FG001|Overall Study|Start of new therapy|0|||
124671104|NCT03110354|448419892|FG002|Overall Study|Start of new therapy|0|||
124671105|NCT03110354|448419893|FG003|Overall Study|Start of new therapy|0|||
124671106|NCT03110354|448419894|FG004|Overall Study|Start of new therapy|1|||
124671107|NCT03110354|448419890|FG000|Overall Study|Failure to achieve response|2|||
124671108|NCT03110354|448419891|FG001|Overall Study|Failure to achieve response|3|||
124671109|NCT03110354|448419892|FG002|Overall Study|Failure to achieve response|0|||
124671110|NCT03110354|448419893|FG003|Overall Study|Failure to achieve response|2|||
124671111|NCT03110354|448419894|FG004|Overall Study|Failure to achieve response|1|||
124671112|NCT03110354|448419890|FG000|Overall Study|Progressive disease|1|||
124671113|NCT03110354|448419891|FG001|Overall Study|Progressive disease|1|||
124671114|NCT03110354|448419892|FG002|Overall Study|Progressive disease|3|||
124671115|NCT03110354|448419893|FG003|Overall Study|Progressive disease|4|||
124671116|NCT03110354|448419894|FG004|Overall Study|Progressive disease|2|||
124671117|NCT03110354|448419890|FG000|Overall Study|Adverse Event|0|||
124671118|NCT03110354|448419891|FG001|Overall Study|Adverse Event|0|||
124671119|NCT03110354|448419892|FG002|Overall Study|Adverse Event|0|||
124671120|NCT03110354|448419893|FG003|Overall Study|Adverse Event|2|||
124671121|NCT03110354|448419894|FG004|Overall Study|Adverse Event|2|||
124671122|NCT03110354|448419890|FG000|Overall Study|Other|0|||
124671123|NCT03110354|448419891|FG001|Overall Study|Other|0|||
124671124|NCT03110354|448419892|FG002|Overall Study|Other|0|||
124671125|NCT03110354|448419893|FG003|Overall Study|Other|1|||
124671126|NCT03110354|448419894|FG004|Overall Study|Other|1|||
124671127|NCT00239720|448419896|FG000|Overall Study|Adverse Event|1|||
124671128|NCT00239720|448419897|FG001|Overall Study|Adverse Event|0|||
124671129|NCT00239720|448419896|FG000|Overall Study|Lost to Follow-up|0|||
124671130|NCT00239720|448419897|FG001|Overall Study|Lost to Follow-up|1|||
124671131|NCT02515630|448419898|FG000|Overall Study|Withdrawal by Subject|5|||
124671132|NCT02515630|448419898|FG000|Overall Study|Adverse Event|4|||
124671133|NCT02515630|448419898|FG000|Overall Study|Physician Decision|4|||
124671134|NCT02515630|448419898|FG000|Overall Study|Death|2|||
124671135|NCT02515630|448419898|FG000|Overall Study|Disease Progression|1|||
124671136|NCT00483652|448419899|FG000|Double-blind Treatment Period|Protocol Violation|2|||
124671137|NCT00483652|448419900|FG001|Double-blind Treatment Period|Protocol Violation|1|||
124671138|NCT00483652|448419899|FG000|Double-blind Treatment Period|Adverse Event|3|||
124671139|NCT00483652|448419900|FG001|Double-blind Treatment Period|Adverse Event|4|||
124671140|NCT00483652|448419899|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
124671141|NCT00483652|448419900|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
124671142|NCT00483652|448419899|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
124671143|NCT00483652|448419900|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
124671144|NCT00473655|448419905|FG000|Overall Study|Lost to Follow-up|9|||
124671145|NCT00473655|448419906|FG001|Overall Study|Lost to Follow-up|5|||
124671146|NCT00473655|448419907|FG002|Overall Study|Lost to Follow-up|8|||
124671147|NCT02219685|448419908|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
124671148|NCT02219685|448419909|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
124671149|NCT02219685|448419908|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
124671150|NCT02219685|448419909|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
124671151|NCT02869789|448419910|FG000|Overall Study|Disease progression|184|||
124671152|NCT02869789|448419911|FG001|Overall Study|Disease progression|109|||
124671153|NCT02869789|448419912|FG002|Overall Study|Disease progression|260|||
124671154|NCT02869789|448419913|FG003|Overall Study|Disease progression|19|||
124671155|NCT02869789|448419910|FG000|Overall Study|Study drug toxicity|90|||
124671156|NCT02869789|448419911|FG001|Overall Study|Study drug toxicity|32|||
124671157|NCT02869789|448419912|FG002|Overall Study|Study drug toxicity|55|||
124671158|NCT02869789|448419913|FG003|Overall Study|Study drug toxicity|14|||
124671159|NCT02869789|448419910|FG000|Overall Study|Death|7|||
124671160|NCT02869789|448419911|FG001|Overall Study|Death|3|||
124671161|NCT02869789|448419912|FG002|Overall Study|Death|5|||
124671162|NCT02869789|448419913|FG003|Overall Study|Death|1|||
124671163|NCT02869789|448419910|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
124671164|NCT02869789|448419911|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
124671165|NCT02869789|448419912|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
124671166|NCT02869789|448419913|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
124671167|NCT02869789|448419910|FG000|Overall Study|Participant request to discontinue study treatment|10|||
124671168|NCT02869789|448419911|FG001|Overall Study|Participant request to discontinue study treatment|5|||
124466428|NCT02814565|447666395|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
124671169|NCT02869789|448419912|FG002|Overall Study|Participant request to discontinue study treatment|5|||
124671170|NCT02869789|448419913|FG003|Overall Study|Participant request to discontinue study treatment|3|||
124671171|NCT02869789|448419910|FG000|Overall Study|Withdrawal by Subject|5|||
124671172|NCT02869789|448419911|FG001|Overall Study|Withdrawal by Subject|2|||
124671173|NCT02869789|448419912|FG002|Overall Study|Withdrawal by Subject|7|||
124671174|NCT02869789|448419913|FG003|Overall Study|Withdrawal by Subject|2|||
124671175|NCT02869789|448419910|FG000|Overall Study|Lost to Follow-up|0|||
124671176|NCT02869789|448419911|FG001|Overall Study|Lost to Follow-up|0|||
124671177|NCT02869789|448419912|FG002|Overall Study|Lost to Follow-up|2|||
124671178|NCT02869789|448419913|FG003|Overall Study|Lost to Follow-up|0|||
124671179|NCT02869789|448419910|FG000|Overall Study|Maximum clinical benefit|5|||
124671180|NCT02869789|448419911|FG001|Overall Study|Maximum clinical benefit|2|||
124671181|NCT02869789|448419912|FG002|Overall Study|Maximum clinical benefit|1|||
124671182|NCT02869789|448419913|FG003|Overall Study|Maximum clinical benefit|0|||
124671183|NCT02869789|448419910|FG000|Overall Study|Poor/Non-compliance|0|||
124671184|NCT02869789|448419911|FG001|Overall Study|Poor/Non-compliance|2|||
124671185|NCT02869789|448419912|FG002|Overall Study|Poor/Non-compliance|1|||
124671186|NCT02869789|448419913|FG003|Overall Study|Poor/Non-compliance|0|||
124671187|NCT02869789|448419910|FG000|Overall Study|Participant no longer meets study criteria|0|||
124671188|NCT02869789|448419911|FG001|Overall Study|Participant no longer meets study criteria|1|||
124671189|NCT02869789|448419912|FG002|Overall Study|Participant no longer meets study criteria|1|||
124671190|NCT02869789|448419913|FG003|Overall Study|Participant no longer meets study criteria|0|||
124671191|NCT02869789|448419910|FG000|Overall Study|Administrative reason by sponsor|0|||
124671192|NCT02869789|448419911|FG001|Overall Study|Administrative reason by sponsor|0|||
124671193|NCT02869789|448419912|FG002|Overall Study|Administrative reason by sponsor|1|||
124671194|NCT02869789|448419913|FG003|Overall Study|Administrative reason by sponsor|0|||
124671195|NCT02869789|448419910|FG000|Overall Study|Other reasons|4|||
124671196|NCT02869789|448419911|FG001|Overall Study|Other reasons|8|||
124671197|NCT02869789|448419912|FG002|Overall Study|Other reasons|6|||
124671198|NCT02869789|448419913|FG003|Overall Study|Other reasons|0|||
124671199|NCT01566604|448419916|FG000|Overall Study|Patient's inability to use the device|1|||
124671200|NCT01566604|448419917|FG001|Overall Study|Patient's inability to use the device|0|||
124671201|NCT01566604|448419916|FG000|Overall Study|Administrative problems|1|||
124671202|NCT01566604|448419917|FG001|Overall Study|Administrative problems|0|||
124671203|NCT01566604|448419916|FG000|Overall Study|Lack of Efficacy|1|||
124671204|NCT01566604|448419917|FG001|Overall Study|Lack of Efficacy|2|||
124671205|NCT01566604|448419916|FG000|Overall Study|Protocol deviation|2|||
124671206|NCT01566604|448419917|FG001|Overall Study|Protocol deviation|0|||
124671207|NCT01566604|448419916|FG000|Overall Study|Abnormal laboratory value|2|||
124671208|NCT01566604|448419917|FG001|Overall Study|Abnormal laboratory value|0|||
124671209|NCT01566604|448419916|FG000|Overall Study|Death|4|||
124671210|NCT01566604|448419917|FG001|Overall Study|Death|1|||
124671211|NCT01566604|448419916|FG000|Overall Study|Adverse Event|4|||
124671212|NCT01566604|448419917|FG001|Overall Study|Adverse Event|2|||
124671213|NCT01566604|448419916|FG000|Overall Study|Withdrawal by Subject|9|||
124671214|NCT01566604|448419917|FG001|Overall Study|Withdrawal by Subject|6|||
124671215|NCT03225170|448419918|FG000|Overall Study|Lost to Follow-up|4|||
124671216|NCT03225170|448419919|FG001|Overall Study|Lost to Follow-up|4|||
124671217|NCT03225170|448419920|FG002|Overall Study|Lost to Follow-up|0|||
124671218|NCT03225170|448419918|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
124671219|NCT03225170|448419919|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
124671220|NCT03225170|448419920|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
124671221|NCT00731822|448419933|FG000|Overall Study|Adverse Event|2|||
124671222|NCT00731822|448419934|FG001|Overall Study|Adverse Event|1|||
124671223|NCT00731822|448419933|FG000|Overall Study|Protocol Violation|1|||
124671224|NCT00731822|448419934|FG001|Overall Study|Protocol Violation|0|||
124671225|NCT00731822|448419933|FG000|Overall Study|Lost to Follow-up|1|||
124671226|NCT00731822|448419934|FG001|Overall Study|Lost to Follow-up|0|||
124671227|NCT02127658|448419940|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
124671228|NCT02127658|448419941|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
124671229|NCT02127658|448419940|FG000|Overall Study|Withdrawal by Subject|0|||
124671230|NCT02127658|448419941|FG001|Overall Study|Withdrawal by Subject|2|||
124671231|NCT02127658|448419940|FG000|Overall Study|Physician Decision|0|||
124671232|NCT02127658|448419941|FG001|Overall Study|Physician Decision|1|||
124671233|NCT01534273|448419942|FG000|Period 1|Physician Decision|0|||
124671234|NCT01534273|448419943|FG001|Period 1|Physician Decision|0|||
124671235|NCT01534273|448419944|FG002|Period 1|Physician Decision|0|||
124671236|NCT01534273|448419945|FG003|Period 1|Physician Decision|1|||
124671237|NCT01534273|448419946|FG004|Period 1|Physician Decision|0|||
124671238|NCT01534273|448419947|FG005|Period 1|Physician Decision|0|||
124671239|NCT01534273|448419948|FG006|Period 1|Physician Decision|0|||
124671240|NCT01435759|448419954|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
124671241|NCT01435759|448419955|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
124671242|NCT01435759|448419956|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
124671243|NCT01435759|448419957|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
124671244|NCT01435759|448419958|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
124671245|NCT01435759|448419959|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
124671246|NCT01435759|448419954|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
124671247|NCT01435759|448419955|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
124671248|NCT01435759|448419956|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
124671249|NCT01435759|448419957|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
124671250|NCT01435759|448419958|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
124671251|NCT01435759|448419959|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
124671252|NCT01435759|448419954|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
124671253|NCT01435759|448419955|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
124671254|NCT01435759|448419956|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
124671255|NCT01435759|448419957|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
124671256|NCT01435759|448419958|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
124671257|NCT01435759|448419959|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
124671258|NCT01435759|448419954|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
124671259|NCT01435759|448419955|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
124671260|NCT01435759|448419956|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
124671261|NCT01435759|448419957|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
124671262|NCT01435759|448419958|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
124671263|NCT01435759|448419959|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
124671264|NCT01435759|448419954|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
124671265|NCT01435759|448419955|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
124671266|NCT01435759|448419956|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
124671267|NCT01435759|448419957|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
124671268|NCT01435759|448419958|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
124671269|NCT01435759|448419959|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
124671270|NCT01435759|448419954|FG000|Antidepressant Lead-in Phase|Other|119|||
124671271|NCT01435759|448419955|FG001|Antidepressant Lead-in Phase|Other|0|||
124671272|NCT01435759|448419956|FG002|Antidepressant Lead-in Phase|Other|0|||
124671273|NCT01435759|448419957|FG003|Antidepressant Lead-in Phase|Other|0|||
124671274|NCT01435759|448419958|FG004|Antidepressant Lead-in Phase|Other|0|||
124671275|NCT01435759|448419959|FG005|Antidepressant Lead-in Phase|Other|0|||
124671276|NCT01435759|448419954|FG000|Double-blind Phase|Adverse Event|7|||
124671277|NCT01435759|448419955|FG001|Double-blind Phase|Adverse Event|0|||
124671278|NCT01435759|448419956|FG002|Double-blind Phase|Adverse Event|1|||
124671279|NCT01435759|448419957|FG003|Double-blind Phase|Adverse Event|1|||
124671280|NCT01435759|448419958|FG004|Double-blind Phase|Adverse Event|1|||
124671281|NCT01435759|448419959|FG005|Double-blind Phase|Adverse Event|3|||
124671282|NCT01435759|448419954|FG000|Double-blind Phase|Protocol Violation|2|||
124671283|NCT01435759|448419955|FG001|Double-blind Phase|Protocol Violation|0|||
124671284|NCT01435759|448419956|FG002|Double-blind Phase|Protocol Violation|1|||
124671285|NCT01435759|448419957|FG003|Double-blind Phase|Protocol Violation|2|||
124671286|NCT01435759|448419958|FG004|Double-blind Phase|Protocol Violation|0|||
124671287|NCT01435759|448419959|FG005|Double-blind Phase|Protocol Violation|1|||
124671288|NCT01435759|448419954|FG000|Double-blind Phase|Withdrawal by Subject|17|||
124671289|NCT01435759|448419955|FG001|Double-blind Phase|Withdrawal by Subject|4|||
124671290|NCT01435759|448419956|FG002|Double-blind Phase|Withdrawal by Subject|3|||
124671291|NCT01435759|448419957|FG003|Double-blind Phase|Withdrawal by Subject|4|||
124671292|NCT01435759|448419958|FG004|Double-blind Phase|Withdrawal by Subject|2|||
124671293|NCT01435759|448419959|FG005|Double-blind Phase|Withdrawal by Subject|2|||
124671294|NCT01435759|448419954|FG000|Double-blind Phase|Lost to Follow-up|31|||
124671295|NCT01435759|448419955|FG001|Double-blind Phase|Lost to Follow-up|1|||
124671296|NCT01435759|448419956|FG002|Double-blind Phase|Lost to Follow-up|2|||
124671297|NCT01435759|448419957|FG003|Double-blind Phase|Lost to Follow-up|0|||
124671298|NCT01435759|448419958|FG004|Double-blind Phase|Lost to Follow-up|3|||
124671299|NCT01435759|448419959|FG005|Double-blind Phase|Lost to Follow-up|3|||
124671300|NCT01435759|448419954|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
124671301|NCT01435759|448419955|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
124671302|NCT01435759|448419956|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
124671303|NCT01435759|448419957|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
124671304|NCT01435759|448419958|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
124671305|NCT01435759|448419959|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
124671306|NCT01435759|448419954|FG000|Double-blind Phase|Other|8|||
124671307|NCT01435759|448419955|FG001|Double-blind Phase|Other|2|||
124671308|NCT01435759|448419956|FG002|Double-blind Phase|Other|0|||
124671309|NCT01435759|448419957|FG003|Double-blind Phase|Other|2|||
124671310|NCT01435759|448419958|FG004|Double-blind Phase|Other|0|||
124671311|NCT01435759|448419959|FG005|Double-blind Phase|Other|0|||
124671312|NCT00570401|448419962|FG000|Overall Study|Adverse Event|2|||
124671313|NCT02849587|448419963|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
124671314|NCT02849587|448419964|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
124671315|NCT02849587|448419965|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
124671316|NCT02849587|448419963|FG000|Overall Study|Withdrawal by Subject|0|||
124671317|NCT02849587|448419964|FG001|Overall Study|Withdrawal by Subject|1|||
124671318|NCT02849587|448419965|FG002|Overall Study|Withdrawal by Subject|0|||
124671319|NCT00549549|448419979|FG000|Overall Study|Adverse Event|5|||
124671320|NCT00549549|448419980|FG001|Overall Study|Adverse Event|3|||
124671321|NCT00549549|448419981|FG002|Overall Study|Adverse Event|1|||
124671322|NCT00549549|448419982|FG003|Overall Study|Adverse Event|9|||
124671323|NCT00549549|448419979|FG000|Overall Study|Lack of Efficacy|9|||
124671324|NCT00549549|448419980|FG001|Overall Study|Lack of Efficacy|6|||
124671325|NCT00549549|448419981|FG002|Overall Study|Lack of Efficacy|4|||
124671326|NCT00549549|448419982|FG003|Overall Study|Lack of Efficacy|2|||
124671327|NCT00549549|448419979|FG000|Overall Study|Lost to Follow-up|1|||
124671328|NCT00549549|448419980|FG001|Overall Study|Lost to Follow-up|0|||
124671329|NCT00549549|448419981|FG002|Overall Study|Lost to Follow-up|1|||
124671330|NCT00549549|448419982|FG003|Overall Study|Lost to Follow-up|2|||
124671331|NCT00549549|448419979|FG000|Overall Study|Withdrawal by Subject|0|||
124671332|NCT00549549|448419980|FG001|Overall Study|Withdrawal by Subject|4|||
124671333|NCT00549549|448419981|FG002|Overall Study|Withdrawal by Subject|1|||
124671334|NCT00549549|448419982|FG003|Overall Study|Withdrawal by Subject|0|||
124671335|NCT00549549|448419979|FG000|Overall Study|Other|9|||
124671336|NCT00549549|448419980|FG001|Overall Study|Other|9|||
124671337|NCT00549549|448419981|FG002|Overall Study|Other|9|||
124671338|NCT00549549|448419982|FG003|Overall Study|Other|11|||
124671339|NCT00549549|448419979|FG000|Overall Study|Randomized but not treated|0|||
124671340|NCT00549549|448419980|FG001|Overall Study|Randomized but not treated|0|||
124671341|NCT00549549|448419981|FG002|Overall Study|Randomized but not treated|1|||
124671342|NCT00549549|448419982|FG003|Overall Study|Randomized but not treated|1|||
124671343|NCT02688933|448419985|FG000|Overall Study|Adverse Event|3|||
124671344|NCT02688933|448419986|FG001|Overall Study|Adverse Event|1|||
124671345|NCT02688933|448419985|FG000|Overall Study|Lack of Efficacy|2|||
124671346|NCT02688933|448419986|FG001|Overall Study|Lack of Efficacy|2|||
124671347|NCT02688933|448419985|FG000|Overall Study|Poor compliance to protocol|7|||
124671348|NCT02688933|448419986|FG001|Overall Study|Poor compliance to protocol|4|||
124872980|NCT00089141|449157211|FG001|Overall Study|Termination of trial|24|||
124872981|NCT00508261|449157212|FG000|Overall Study|Other|0|||
124872982|NCT00508261|449157213|FG001|Overall Study|Other|1|||
124872983|NCT00508261|449157214|FG002|Overall Study|Other|1|||
124872984|NCT00508261|449157215|FG003|Overall Study|Other|0|||
124872985|NCT00508261|449157212|FG000|Overall Study|Serious Adverse Event|0|||
124872986|NCT00508261|449157213|FG001|Overall Study|Serious Adverse Event|1|||
124872987|NCT00508261|449157214|FG002|Overall Study|Serious Adverse Event|0|||
124671349|NCT02688933|448419985|FG000|Overall Study|Hypoglycemia|2|||
124671350|NCT02688933|448419986|FG001|Overall Study|Hypoglycemia|0|||
124671351|NCT02688933|448419985|FG000|Overall Study|Other than Specified|14|||
124671352|NCT02688933|448419986|FG001|Overall Study|Other than Specified|25|||
124671353|NCT02688933|448419985|FG000|Overall Study|Lost to Follow-up|1|||
124671354|NCT02688933|448419986|FG001|Overall Study|Lost to Follow-up|5|||
124671355|NCT00248651|448419987|FG000|Overall Study|Withdrawal by Subject|28|||
124671356|NCT00248651|448419988|FG001|Overall Study|Withdrawal by Subject|40|||
124671357|NCT00248651|448419989|FG002|Overall Study|Withdrawal by Subject|32|||
124671358|NCT00828113|448419990|FG000|Overall Study|Withdrawal by Subject|27|||
124671359|NCT00828113|448419991|FG001|Overall Study|Withdrawal by Subject|26|||
124671360|NCT00828113|448419990|FG000|Overall Study|Lost to Follow-up|3|||
124671361|NCT00828113|448419991|FG001|Overall Study|Lost to Follow-up|5|||
124671362|NCT01275144|448419992|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
124671363|NCT01275144|448419993|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
124671364|NCT01365130|448419994|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
124671365|NCT05547386|448419996|FG000|Overall Study|Withdrawal by Subject|7|||
124671366|NCT04622969|448419997|FG000|Overall Study|Withdrawal by Subject|2|||
124671367|NCT04622969|448419998|FG001|Overall Study|Withdrawal by Subject|3|||
124671368|NCT05607576|448419999|FG000|Overall Study|immediate sensor error|2|||
124671369|NCT05607576|448419999|FG000|Overall Study|Physician Decision|2|||
124671370|NCT04467515|448420000|FG000|Overall Study|Lost to Follow-up|1|||
124671371|NCT04467515|448420001|FG001|Overall Study|Lost to Follow-up|0|||
124671372|NCT04467515|448420002|FG002|Overall Study|Lost to Follow-up|0|||
124671373|NCT04467515|448420000|FG000|Overall Study|Withdrawal by Subject|1|||
124671374|NCT04467515|448420001|FG001|Overall Study|Withdrawal by Subject|0|||
124671375|NCT04467515|448420002|FG002|Overall Study|Withdrawal by Subject|1|||
124671376|NCT04467515|448420000|FG000|Overall Study|Progressive Disease|0|||
124671377|NCT04467515|448420001|FG001|Overall Study|Progressive Disease|1|||
124671378|NCT04467515|448420002|FG002|Overall Study|Progressive Disease|3|||
124671379|NCT04467515|448420000|FG000|Overall Study|Death|0|||
124671380|NCT04467515|448420001|FG001|Overall Study|Death|1|||
124671381|NCT04467515|448420002|FG002|Overall Study|Death|0|||
124671382|NCT04391842|448420005|FG000|Overall Study|Withdrawal by Subject|2|||
124671383|NCT00810199|448420006|FG000|Overall Study|Adverse Event|24|||
124671384|NCT00810199|448420007|FG001|Overall Study|Adverse Event|26|||
124671385|NCT00810199|448420006|FG000|Overall Study|Death|4|||
124671386|NCT00810199|448420007|FG001|Overall Study|Death|6|||
124671387|NCT00810199|448420006|FG000|Overall Study|Withdrew consent|9|||
124671388|NCT00810199|448420007|FG001|Overall Study|Withdrew consent|12|||
124671389|NCT00810199|448420006|FG000|Overall Study|Insufficient therapeutic response|5|||
124671390|NCT00810199|448420007|FG001|Overall Study|Insufficient therapeutic response|14|||
124671391|NCT00810199|448420006|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
124671392|NCT00810199|448420007|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
124671393|NCT00810199|448420006|FG000|Overall Study|Administrative/Other|5|||
124671394|NCT00810199|448420007|FG001|Overall Study|Administrative/Other|6|||
124671395|NCT00810199|448420006|FG000|Overall Study|Protocol Violation|2|||
124671396|NCT00810199|448420007|FG001|Overall Study|Protocol Violation|6|||
124671397|NCT00810199|448420006|FG000|Overall Study|Failure to return|1|||
124671398|NCT00810199|448420007|FG001|Overall Study|Failure to return|4|||
124671399|NCT00810199|448420006|FG000|Overall Study|Did not receive study drug|2|||
124671400|NCT00810199|448420007|FG001|Overall Study|Did not receive study drug|1|||
124671401|NCT02287038|448420008|FG000|Overall Study|Stopped attending appointments|3|||
124671402|NCT02287038|448420009|FG001|Overall Study|Stopped attending appointments|2|||
124671403|NCT02287038|448420008|FG000|Overall Study|Anxiety after starting medication|0|||
124671404|NCT02287038|448420009|FG001|Overall Study|Anxiety after starting medication|1|||
124671405|NCT02287038|448420008|FG000|Overall Study|Nausea after starting medication|1|||
124671406|NCT02287038|448420009|FG001|Overall Study|Nausea after starting medication|0|||
124671407|NCT02287038|448420008|FG000|Overall Study|Abnormal ECG after starting medication|1|||
124671408|NCT02287038|448420009|FG001|Overall Study|Abnormal ECG after starting medication|0|||
124671409|NCT02283658|448420023|FG000|Overall Study|Withdrawal by Subject|1|||
124671410|NCT00689338|448420024|FG000|Overall Study|Death|65|||
124671411|NCT00689338|448420024|FG000|Overall Study|Adverse Event|13|||
124671412|NCT00689338|448420024|FG000|Overall Study|Insufficient Clinical Response|1|||
124671413|NCT00689338|448420024|FG000|Overall Study|Lack of Efficacy|6|||
124671414|NCT00689338|448420024|FG000|Overall Study|Other|8|||
124671415|NCT00689338|448420024|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
124671416|NCT00689338|448420024|FG000|Overall Study|Lost to Follow-up|5|||
124671417|NCT00689338|448420024|FG000|Overall Study|Withdrawal by Subject|3|||
124671418|NCT00689338|448420024|FG000|Overall Study|Protocol Violation|15|||
124671419|NCT00715403|448420025|FG000|Overall Study|Progressive disease|0|||
124671420|NCT00715403|448420026|FG001|Overall Study|Progressive disease|1|||
124671421|NCT00715403|448420027|FG002|Overall Study|Progressive disease|3|||
124671422|NCT00715403|448420028|FG003|Overall Study|Progressive disease|9|||
124671423|NCT00715403|448420029|FG004|Overall Study|Progressive disease|5|||
124671424|NCT00715403|448420030|FG005|Overall Study|Progressive disease|14|||
124671425|NCT00715403|448420031|FG006|Overall Study|Progressive disease|1|||
124671426|NCT00715403|448420025|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
124671427|NCT00715403|448420026|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
124671428|NCT00715403|448420027|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
124671429|NCT00715403|448420028|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
124671430|NCT00715403|448420029|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
124671431|NCT00715403|448420030|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
124671432|NCT00715403|448420031|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
124671433|NCT00715403|448420025|FG000|Overall Study|Other Adverse Event than DLT|1|||
124671434|NCT00715403|448420026|FG001|Overall Study|Other Adverse Event than DLT|0|||
124671435|NCT00715403|448420027|FG002|Overall Study|Other Adverse Event than DLT|0|||
124671436|NCT00715403|448420028|FG003|Overall Study|Other Adverse Event than DLT|0|||
124671437|NCT00715403|448420029|FG004|Overall Study|Other Adverse Event than DLT|0|||
124671438|NCT00715403|448420030|FG005|Overall Study|Other Adverse Event than DLT|2|||
124671439|NCT00715403|448420031|FG006|Overall Study|Other Adverse Event than DLT|0|||
124671440|NCT00715403|448420025|FG000|Overall Study|Protocol Violation|0|||
124671441|NCT00715403|448420026|FG001|Overall Study|Protocol Violation|0|||
124671442|NCT00715403|448420027|FG002|Overall Study|Protocol Violation|0|||
124671443|NCT00715403|448420028|FG003|Overall Study|Protocol Violation|0|||
124671444|NCT00715403|448420029|FG004|Overall Study|Protocol Violation|0|||
124671445|NCT00715403|448420030|FG005|Overall Study|Protocol Violation|1|||
124671446|NCT00715403|448420031|FG006|Overall Study|Protocol Violation|0|||
124671447|NCT00715403|448420025|FG000|Overall Study|Other reason not defined above|0|||
124671448|NCT00715403|448420026|FG001|Overall Study|Other reason not defined above|0|||
124671449|NCT00715403|448420027|FG002|Overall Study|Other reason not defined above|1|||
124671450|NCT00715403|448420028|FG003|Overall Study|Other reason not defined above|0|||
124671451|NCT00715403|448420029|FG004|Overall Study|Other reason not defined above|1|||
124671452|NCT00715403|448420030|FG005|Overall Study|Other reason not defined above|1|||
124671453|NCT00715403|448420031|FG006|Overall Study|Other reason not defined above|0|||
124671454|NCT02700048|448420032|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
124671455|NCT02700048|448420033|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
124671456|NCT02175225|448420034|FG000|Overall Study|Withdrawal by Subject|1|||
124671457|NCT02175225|448420035|FG001|Overall Study|Withdrawal by Subject|2|||
124671458|NCT02175225|448420034|FG000|Overall Study|Lost to Follow-up|6|||
124671459|NCT02175225|448420035|FG001|Overall Study|Lost to Follow-up|7|||
124671460|NCT02175225|448420034|FG000|Overall Study|Study drug not administered|1|||
124671461|NCT02175225|448420035|FG001|Overall Study|Study drug not administered|2|||
124671462|NCT02340000|448420038|FG000|Time Period 1|Withdrawal by Subject|6|||
124671463|NCT02340000|448420039|FG001|Time Period 1|Withdrawal by Subject|8|||
124671464|NCT02340000|448420038|FG000|Time Period 1|Lost to Follow-up|6|||
124671465|NCT02340000|448420039|FG001|Time Period 1|Lost to Follow-up|7|||
124671466|NCT02340000|448420038|FG000|Time Period 2|Withdrawal by Subject|9|||
124671467|NCT02340000|448420039|FG001|Time Period 2|Withdrawal by Subject|7|||
124671468|NCT02340000|448420038|FG000|Time Period 2|Lost to Follow-up|10|||
124671469|NCT02340000|448420039|FG001|Time Period 2|Lost to Follow-up|8|||
124671470|NCT01883895|448420040|FG000|Overall Study|Lost to Follow-up|2|||
124671471|NCT01190813|448420041|FG000|Overall Study|Lost to Follow-up|1|||
124671472|NCT01190813|448420042|FG001|Overall Study|Lost to Follow-up|2|||
124671473|NCT01190813|448420041|FG000|Overall Study|Withdrawal by Subject|2|||
124671474|NCT01190813|448420042|FG001|Overall Study|Withdrawal by Subject|1|||
124671475|NCT01190813|448420041|FG000|Overall Study|Refused study treatment after randomized|1|||
124671476|NCT01190813|448420042|FG001|Overall Study|Refused study treatment after randomized|0|||
124671477|NCT01190813|448420041|FG000|Overall Study|Adverse Event|0|||
124671478|NCT01190813|448420042|FG001|Overall Study|Adverse Event|1|||
124671479|NCT00807365|448420043|FG000|Overall Study|Study Terminated|5|||
124671480|NCT03810456|448420046|FG000|Treatment|Urgent Family Matters|3|||
124671481|NCT03810456|448420047|FG001|Treatment|Urgent Family Matters|0|||
124671482|NCT03810456|448420048|FG002|Treatment|Urgent Family Matters|0|||
124671483|NCT03810456|448420046|FG000|Treatment|Scheduling Conflicts|0|||
124671484|NCT03810456|448420047|FG001|Treatment|Scheduling Conflicts|11|||
124671485|NCT03810456|448420048|FG002|Treatment|Scheduling Conflicts|0|||
124671486|NCT03810456|448420046|FG000|Treatment|No Longer Interested|0|||
124671487|NCT03810456|448420047|FG001|Treatment|No Longer Interested|12|||
124671488|NCT03810456|448420048|FG002|Treatment|No Longer Interested|0|||
124671489|NCT03810456|448420046|FG000|Treatment|Transportation Issues|0|||
124872988|NCT00508261|449157215|FG003|Overall Study|Serious Adverse Event|0|||
124872989|NCT00508261|449157212|FG000|Overall Study|Withdrawal by Subject|3|||
124671490|NCT03810456|448420047|FG001|Treatment|Transportation Issues|1|||
124671491|NCT03810456|448420048|FG002|Treatment|Transportation Issues|0|||
124671492|NCT03810456|448420046|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
124671493|NCT03810456|448420047|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
124671494|NCT03810456|448420048|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
124671495|NCT03810456|448420046|FG000|1 Month Follow-Up|Relocated to Different State|1|||
124671496|NCT03810456|448420047|FG001|1 Month Follow-Up|Relocated to Different State|0|||
124671497|NCT03810456|448420048|FG002|1 Month Follow-Up|Relocated to Different State|1|||
124671498|NCT03810456|448420046|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
124671499|NCT03810456|448420047|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
124671500|NCT03810456|448420048|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
124671501|NCT03810456|448420046|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
124671502|NCT03810456|448420047|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
124671503|NCT03810456|448420048|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
124671504|NCT03810456|448420046|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
124671505|NCT03810456|448420047|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
124671506|NCT03810456|448420048|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
124671507|NCT03810456|448420046|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
124671508|NCT03810456|448420047|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
124671509|NCT03810456|448420048|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
124671510|NCT03810456|448420046|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
124671511|NCT03810456|448420047|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
124671512|NCT03810456|448420048|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
124671513|NCT01094288|448422095|FG000|Overall Study|Adverse Event|0|||
124671514|NCT01094288|448422096|FG001|Overall Study|Adverse Event|3|||
124671515|NCT01094288|448422097|FG002|Overall Study|Adverse Event|1|||
124671516|NCT01094288|448422098|FG003|Overall Study|Adverse Event|1|||
124671517|NCT01094288|448422099|FG004|Overall Study|Adverse Event|0|||
124671518|NCT01094288|448422100|FG005|Overall Study|Adverse Event|0|||
124671519|NCT01094288|448422101|FG006|Overall Study|Adverse Event|0|||
124671520|NCT01094288|448422102|FG007|Overall Study|Adverse Event|0|||
124671521|NCT01094288|448422095|FG000|Overall Study|Withdrawal by Subject|0|||
124671522|NCT01094288|448422096|FG001|Overall Study|Withdrawal by Subject|1|||
124671523|NCT01094288|448422097|FG002|Overall Study|Withdrawal by Subject|2|||
124671524|NCT01094288|448422098|FG003|Overall Study|Withdrawal by Subject|0|||
124671525|NCT01094288|448422099|FG004|Overall Study|Withdrawal by Subject|0|||
124671526|NCT01094288|448422100|FG005|Overall Study|Withdrawal by Subject|0|||
124671527|NCT01094288|448422101|FG006|Overall Study|Withdrawal by Subject|0|||
124671528|NCT01094288|448422102|FG007|Overall Study|Withdrawal by Subject|2|||
124671529|NCT01094288|448422095|FG000|Overall Study|Initiation of Alternative Therapy|0|||
124671530|NCT01094288|448422096|FG001|Overall Study|Initiation of Alternative Therapy|0|||
124671531|NCT01094288|448422097|FG002|Overall Study|Initiation of Alternative Therapy|1|||
124671532|NCT01094288|448422098|FG003|Overall Study|Initiation of Alternative Therapy|0|||
124671533|NCT01094288|448422099|FG004|Overall Study|Initiation of Alternative Therapy|0|||
124671534|NCT01094288|448422100|FG005|Overall Study|Initiation of Alternative Therapy|0|||
124671535|NCT01094288|448422101|FG006|Overall Study|Initiation of Alternative Therapy|0|||
124671536|NCT01094288|448422102|FG007|Overall Study|Initiation of Alternative Therapy|0|||
124671537|NCT01094288|448422095|FG000|Overall Study|Reason not Specified|2|||
124671538|NCT01094288|448422096|FG001|Overall Study|Reason not Specified|3|||
124671539|NCT01094288|448422097|FG002|Overall Study|Reason not Specified|0|||
124671540|NCT01094288|448422098|FG003|Overall Study|Reason not Specified|1|||
124671541|NCT01094288|448422099|FG004|Overall Study|Reason not Specified|0|||
124671542|NCT01094288|448422100|FG005|Overall Study|Reason not Specified|0|||
124671543|NCT01094288|448422101|FG006|Overall Study|Reason not Specified|0|||
124671544|NCT01094288|448422102|FG007|Overall Study|Reason not Specified|0|||
124671545|NCT01094288|448422095|FG000|Overall Study|Ongoing Participants|0|||
124671546|NCT01094288|448422096|FG001|Overall Study|Ongoing Participants|3|||
124671547|NCT01094288|448422097|FG002|Overall Study|Ongoing Participants|0|||
124671548|NCT01094288|448422098|FG003|Overall Study|Ongoing Participants|0|||
124671549|NCT01094288|448422099|FG004|Overall Study|Ongoing Participants|0|||
124671550|NCT01094288|448422100|FG005|Overall Study|Ongoing Participants|0|||
124671551|NCT01094288|448422101|FG006|Overall Study|Ongoing Participants|0|||
124671552|NCT01094288|448422102|FG007|Overall Study|Ongoing Participants|0|||
124671553|NCT02611882|448422103|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
124671554|NCT02611882|448422104|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
124671555|NCT02611882|448422105|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
124671556|NCT01317940|448422106|FG000|Overall Study|Death|1|||
124671557|NCT01317940|448422107|FG001|Overall Study|Death|0|||
124872990|NCT00508261|449157213|FG001|Overall Study|Withdrawal by Subject|4|||
124671558|NCT01317940|448422108|FG002|Overall Study|Death|1|||
124671559|NCT01317940|448422109|FG003|Overall Study|Death|0|||
124671560|NCT01317940|448422110|FG004|Overall Study|Death|0|||
124671561|NCT01317940|448422111|FG005|Overall Study|Death|0|||
124671562|NCT01317940|448422106|FG000|Overall Study|Lost to Follow-up|0|||
124671563|NCT01317940|448422107|FG001|Overall Study|Lost to Follow-up|0|||
124671564|NCT01317940|448422108|FG002|Overall Study|Lost to Follow-up|1|||
124671565|NCT01317940|448422109|FG003|Overall Study|Lost to Follow-up|1|||
124671566|NCT01317940|448422110|FG004|Overall Study|Lost to Follow-up|1|||
124671567|NCT01317940|448422111|FG005|Overall Study|Lost to Follow-up|0|||
124671568|NCT01317940|448422106|FG000|Overall Study|Change in therapy plan|0|||
124671569|NCT01317940|448422107|FG001|Overall Study|Change in therapy plan|0|||
124671570|NCT01317940|448422108|FG002|Overall Study|Change in therapy plan|3|||
124671571|NCT01317940|448422109|FG003|Overall Study|Change in therapy plan|0|||
124671572|NCT01317940|448422110|FG004|Overall Study|Change in therapy plan|0|||
124671573|NCT01317940|448422111|FG005|Overall Study|Change in therapy plan|0|||
124671574|NCT04152200|448422112|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
124671575|NCT04152200|448422113|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
124671576|NCT04980014|448422114|FG000|Overall Study|Participants who are Duplicated|1|||
124671577|NCT04980014|448422114|FG000|Overall Study|Follow-up Failure|13|||
124671578|NCT04980014|448422114|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
124671579|NCT04980014|448422114|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
124671580|NCT04980014|448422114|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
124671581|NCT00593814|448422115|FG000|Overall Study|Death|7|||
124671582|NCT00593814|448422116|FG001|Overall Study|Death|0|||
124671583|NCT00593814|448422115|FG000|Overall Study|Withdrawal by Subject|7|||
124671584|NCT00593814|448422116|FG001|Overall Study|Withdrawal by Subject|0|||
124671585|NCT00593814|448422115|FG000|Overall Study|Lost to Follow-up|7|||
124671586|NCT00593814|448422116|FG001|Overall Study|Lost to Follow-up|0|||
124671587|NCT00593814|448422115|FG000|Overall Study|Physician Decision|3|||
124671588|NCT00593814|448422116|FG001|Overall Study|Physician Decision|0|||
124671589|NCT00715559|448422117|FG000|Overall Study|medication not tolerated - nausea|1|||
124671590|NCT02699996|448422118|FG000|Overall Study|Withdrawal by Subject|5|||
124671591|NCT02699996|448422119|FG001|Overall Study|Withdrawal by Subject|2|||
124671592|NCT01095835|448422122|FG000|Overall Study|Adverse Event|8|||
124671593|NCT01095835|448422123|FG001|Overall Study|Adverse Event|6|||
124671594|NCT01095835|448422124|FG002|Overall Study|Adverse Event|6|||
124671595|NCT01095835|448422122|FG000|Overall Study|Lack of Efficacy|0|||
124671596|NCT01095835|448422123|FG001|Overall Study|Lack of Efficacy|1|||
124671597|NCT01095835|448422124|FG002|Overall Study|Lack of Efficacy|0|||
124671598|NCT01095835|448422122|FG000|Overall Study|Physician Decision|0|||
124671599|NCT01095835|448422123|FG001|Overall Study|Physician Decision|0|||
124671600|NCT01095835|448422124|FG002|Overall Study|Physician Decision|1|||
124671601|NCT01095835|448422122|FG000|Overall Study|Withdrawal by Subject|1|||
124671602|NCT01095835|448422123|FG001|Overall Study|Withdrawal by Subject|3|||
124671603|NCT01095835|448422124|FG002|Overall Study|Withdrawal by Subject|0|||
124671604|NCT01095835|448422122|FG000|Overall Study|Non study compliance|0|||
124671605|NCT01095835|448422123|FG001|Overall Study|Non study compliance|0|||
124671606|NCT01095835|448422124|FG002|Overall Study|Non study compliance|1|||
124671607|NCT01095835|448422122|FG000|Overall Study|Protocol Violation|1|||
124671608|NCT01095835|448422123|FG001|Overall Study|Protocol Violation|2|||
124671609|NCT01095835|448422124|FG002|Overall Study|Protocol Violation|0|||
124671610|NCT01198002|448422125|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
124671611|NCT01198002|448422126|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
124671612|NCT01198002|448422127|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
124671613|NCT01198002|448422125|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
124671614|NCT01198002|448422126|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
124671615|NCT01198002|448422127|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
124671616|NCT01198002|448422125|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
124671617|NCT01198002|448422126|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
124671618|NCT01198002|448422127|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
124671619|NCT01198002|448422125|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
124671620|NCT01198002|448422126|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
124671621|NCT01198002|448422127|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
124671622|NCT01198002|448422125|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
124671623|NCT01198002|448422126|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
124671624|NCT01198002|448422127|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
124671625|NCT01198002|448422125|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
124671626|NCT01198002|448422126|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
124671627|NCT01198002|448422127|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
124671628|NCT01198002|448422125|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
124671629|NCT01198002|448422126|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
124671630|NCT01198002|448422127|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
124671631|NCT01198002|448422125|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
124671632|NCT01198002|448422126|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
124671633|NCT01198002|448422127|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
124671634|NCT01198002|448422125|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
124671635|NCT01198002|448422126|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
124671636|NCT01198002|448422127|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
124671637|NCT01198002|448422125|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
124671638|NCT01198002|448422126|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
124671639|NCT01198002|448422127|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
124671640|NCT01198002|448422125|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
124671641|NCT01198002|448422126|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
124671642|NCT01198002|448422127|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
124671643|NCT01198002|448422125|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
124671644|NCT01198002|448422126|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
124671645|NCT01198002|448422127|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
124671646|NCT01198002|448422125|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
124671647|NCT01198002|448422126|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
124671648|NCT01198002|448422127|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
124671649|NCT01198002|448422125|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
124671650|NCT01198002|448422126|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
124671651|NCT01198002|448422127|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
124671652|NCT01198002|448422125|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
124671653|NCT01198002|448422126|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
124671654|NCT01198002|448422127|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
124671655|NCT00116688|448422131|FG000|Overall Study|Protocol deviation|1|||
124671656|NCT00116688|448422132|FG001|Overall Study|Protocol deviation|0|||
124671657|NCT00116688|448422131|FG000|Overall Study|Noncompliance|3|||
124671658|NCT00116688|448422132|FG001|Overall Study|Noncompliance|1|||
124671659|NCT00116688|448422131|FG000|Overall Study|Adverse Event|11|||
124671660|NCT00116688|448422132|FG001|Overall Study|Adverse Event|0|||
124671661|NCT00116688|448422131|FG000|Overall Study|Withdrawal by Subject|26|||
124671662|NCT00116688|448422132|FG001|Overall Study|Withdrawal by Subject|2|||
124671663|NCT00116688|448422131|FG000|Overall Study|Requirement for alternative therapy|11|||
124671664|NCT00116688|448422132|FG001|Overall Study|Requirement for alternative therapy|1|||
124671665|NCT00116688|448422131|FG000|Overall Study|Physician Decision|7|||
124671666|NCT00116688|448422132|FG001|Overall Study|Physician Decision|0|||
124671667|NCT00116688|448422131|FG000|Overall Study|Lost to Follow-up|3|||
124671668|NCT00116688|448422132|FG001|Overall Study|Lost to Follow-up|0|||
124671669|NCT00116688|448422131|FG000|Overall Study|Death|15|||
124671670|NCT00116688|448422132|FG001|Overall Study|Death|0|||
124671671|NCT00116688|448422131|FG000|Overall Study|Protocol-specified criteria|3|||
124671672|NCT00116688|448422132|FG001|Overall Study|Protocol-specified criteria|0|||
124671673|NCT00116688|448422131|FG000|Overall Study|Pregnancy|1|||
124671674|NCT00116688|448422132|FG001|Overall Study|Pregnancy|0|||
124671675|NCT00116688|448422131|FG000|Overall Study|Other|11|||
124671676|NCT00116688|448422132|FG001|Overall Study|Other|0|||
124671677|NCT04006145|448422134|FG000|Overall Study|Lost to Follow-up|0|||
124671678|NCT04006145|448422135|FG001|Overall Study|Lost to Follow-up|1|||
124671679|NCT04006145|448422134|FG000|Overall Study|Other|1|||
124671680|NCT04006145|448422135|FG001|Overall Study|Other|2|||
124671681|NCT00010257|448422136|FG000|Overall Study|Withdrawal by Subject|1|||
124671682|NCT00010257|448422137|FG001|Overall Study|Withdrawal by Subject|0|||
124671683|NCT01249417|448422143|FG000|Randomised Population|Study treatment not received|0|||
124671684|NCT01249417|448422144|FG001|Randomised Population|Study treatment not received|0|||
124671685|NCT01249417|448422145|FG002|Randomised Population|Study treatment not received|2|||
124671686|NCT01249417|448422143|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
124671687|NCT01249417|448422144|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
124671688|NCT01249417|448422145|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
124671689|NCT01249417|448422143|FG000|Treatment Phase - ITT Population|Other|0|||
124671690|NCT01249417|448422144|FG001|Treatment Phase - ITT Population|Other|0|||
124671691|NCT01249417|448422145|FG002|Treatment Phase - ITT Population|Other|1|||
124671692|NCT01249417|448422143|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
124671693|NCT01249417|448422144|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
124671694|NCT01249417|448422145|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
124671695|NCT01249417|448422143|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
124671696|NCT01249417|448422144|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
124671697|NCT01249417|448422145|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
124671698|NCT01249417|448422143|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
124671699|NCT01249417|448422144|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
124671700|NCT01249417|448422145|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
124671701|NCT01607593|448422146|FG000|Overall Study|Adverse Event|15|||
124671702|NCT01607593|448422146|FG000|Overall Study|Lack of Efficacy|16|||
124671703|NCT01607593|448422146|FG000|Overall Study|Lost to Follow-up|25|||
124671704|NCT01607593|448422146|FG000|Overall Study|Continuation|33|||
124671705|NCT01607593|448422146|FG000|Overall Study|Other|4|||
124671706|NCT00126594|448422148|FG000|Overall Study|Ineligible|2|||
124671707|NCT00126594|448422149|FG001|Overall Study|Ineligible|0|||
124671708|NCT00126594|448422148|FG000|Overall Study|Withdrawal by Subject|0|||
124671709|NCT00126594|448422149|FG001|Overall Study|Withdrawal by Subject|4|||
124671710|NCT00126594|448422148|FG000|Overall Study|Physician Decision|1|||
124671711|NCT00126594|448422149|FG001|Overall Study|Physician Decision|3|||
124671712|NCT00126594|448422148|FG000|Overall Study|Adverse Event|7|||
124671713|NCT00126594|448422149|FG001|Overall Study|Adverse Event|5|||
124671714|NCT00126594|448422148|FG000|Overall Study|Non-compliance|0|||
124671715|NCT00126594|448422149|FG001|Overall Study|Non-compliance|1|||
124671716|NCT00126594|448422148|FG000|Overall Study|Disease Progression|29|||
124671717|NCT00126594|448422149|FG001|Overall Study|Disease Progression|24|||
124671718|NCT03769649|448422150|FG000|Overall Study|Lost to Follow-up|4|||
124671719|NCT01290718|448422153|FG000|Overall Study|Early termination of the study|4|||
124671720|NCT00243919|448422154|FG000|Overall Study|Death|3|||
124671721|NCT00243919|448422155|FG001|Overall Study|Death|4|||
124671722|NCT00243919|448422156|FG002|Overall Study|Death|6|||
124671723|NCT00243919|448422154|FG000|Overall Study|Withdrawal by Subject|6|||
124671724|NCT00243919|448422155|FG001|Overall Study|Withdrawal by Subject|6|||
124671725|NCT00243919|448422156|FG002|Overall Study|Withdrawal by Subject|2|||
124671726|NCT00243919|448422154|FG000|Overall Study|Lost to Follow-up|6|||
124671727|NCT00243919|448422155|FG001|Overall Study|Lost to Follow-up|7|||
124671728|NCT00243919|448422156|FG002|Overall Study|Lost to Follow-up|3|||
124671729|NCT00243919|448422154|FG000|Overall Study|Administrative Error|1|||
124671730|NCT00243919|448422155|FG001|Overall Study|Administrative Error|0|||
124671731|NCT00243919|448422156|FG002|Overall Study|Administrative Error|0|||
124671732|NCT00243919|448422154|FG000|Overall Study|Physician Decision|1|||
124671733|NCT00243919|448422155|FG001|Overall Study|Physician Decision|1|||
124671734|NCT00243919|448422156|FG002|Overall Study|Physician Decision|0|||
124671735|NCT02059239|448422159|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
124671736|NCT02059239|448422160|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
124671737|NCT02059239|448422159|FG000|Overall Study|Physician Decision|1|||
124671738|NCT02059239|448422160|FG001|Overall Study|Physician Decision|0|||
124671739|NCT01268267|448422161|FG000|Overall Study|Protocol Violation|1|||
124671740|NCT03669549|448422168|FG000|Overall Study|Adverse Event|4|||
124671741|NCT03669549|448422168|FG000|Overall Study|Withdrawal by Subject|1|||
124671742|NCT03669549|448422168|FG000|Overall Study|Study terminated by the Sponsor|1|||
124671743|NCT04919317|448422169|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
124671744|NCT04919317|448422170|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
124671745|NCT04919317|448422169|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
124671746|NCT04919317|448422170|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
124671747|NCT02974868|448422171|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
124671748|NCT02974868|448422172|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
124671749|NCT02974868|448422173|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
124671750|NCT02974868|448422174|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
124671751|NCT02974868|448422171|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
124671752|NCT02974868|448422172|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
124671753|NCT02974868|448422173|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
124671754|NCT02974868|448422174|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
124671755|NCT02974868|448422171|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
124671756|NCT02974868|448422172|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
124671757|NCT02974868|448422173|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
124671758|NCT02974868|448422174|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
124671759|NCT02974868|448422171|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
124671760|NCT02974868|448422172|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
124671761|NCT02974868|448422173|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
124671762|NCT02974868|448422174|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
124671763|NCT00230048|448422175|FG000|Overall Study|Lost to Follow-up|13|||
124671764|NCT00230048|448422176|FG001|Overall Study|Lost to Follow-up|18|||
124671765|NCT00297648|448422179|FG000|Overall Study|Adverse Event|13|||
124671766|NCT00297648|448422179|FG000|Overall Study|Lack of Efficacy|18|||
124671767|NCT00297648|448422179|FG000|Overall Study|Lost to Follow-up|1|||
124671768|NCT00297648|448422179|FG000|Overall Study|Withdrawal by Subject|3|||
124671769|NCT00297648|448422179|FG000|Overall Study|Other: Incompliance|1|||
124671770|NCT01443858|448422180|FG000|Overall Study|Withdrawal by Subject|9|||
124671771|NCT01443858|448422181|FG001|Overall Study|Withdrawal by Subject|8|||
124671772|NCT01443858|448422182|FG002|Overall Study|Withdrawal by Subject|5|||
124671773|NCT01443858|448422180|FG000|Overall Study|Lack of Efficacy|1|||
124671774|NCT01443858|448422181|FG001|Overall Study|Lack of Efficacy|0|||
124671775|NCT01443858|448422182|FG002|Overall Study|Lack of Efficacy|0|||
124671776|NCT01443858|448422180|FG000|Overall Study|Lost to Follow-up|5|||
124671777|NCT01443858|448422181|FG001|Overall Study|Lost to Follow-up|5|||
124671778|NCT01443858|448422182|FG002|Overall Study|Lost to Follow-up|2|||
124671779|NCT03589807|448422183|FG000|Overall Study|Lost to Follow-up|0|||
124671780|NCT03589807|448422184|FG001|Overall Study|Lost to Follow-up|2|||
124671781|NCT03589807|448422185|FG002|Overall Study|Lost to Follow-up|2|||
124671782|NCT03589807|448422186|FG003|Overall Study|Lost to Follow-up|3|||
124671783|NCT03589807|448422187|FG004|Overall Study|Lost to Follow-up|1|||
124671784|NCT03589807|448422188|FG005|Overall Study|Lost to Follow-up|1|||
124671785|NCT03589807|448422183|FG000|Overall Study|Withdrawal by Subject|0|||
124671786|NCT03589807|448422184|FG001|Overall Study|Withdrawal by Subject|5|||
124671787|NCT03589807|448422185|FG002|Overall Study|Withdrawal by Subject|0|||
124671788|NCT03589807|448422186|FG003|Overall Study|Withdrawal by Subject|0|||
124671789|NCT03589807|448422187|FG004|Overall Study|Withdrawal by Subject|0|||
124671790|NCT03589807|448422188|FG005|Overall Study|Withdrawal by Subject|0|||
124671791|NCT03589807|448422183|FG000|Overall Study|Protocol Violation|0|||
124671792|NCT03589807|448422184|FG001|Overall Study|Protocol Violation|0|||
124671793|NCT03589807|448422185|FG002|Overall Study|Protocol Violation|0|||
124671794|NCT03589807|448422186|FG003|Overall Study|Protocol Violation|1|||
124671795|NCT03589807|448422187|FG004|Overall Study|Protocol Violation|0|||
124671796|NCT03589807|448422188|FG005|Overall Study|Protocol Violation|0|||
124671797|NCT03589807|448422183|FG000|Overall Study|Enrolled but treatment not administered|0|||
124671798|NCT03589807|448422184|FG001|Overall Study|Enrolled but treatment not administered|0|||
124671799|NCT03589807|448422185|FG002|Overall Study|Enrolled but treatment not administered|0|||
124671800|NCT03589807|448422186|FG003|Overall Study|Enrolled but treatment not administered|0|||
124671801|NCT03589807|448422187|FG004|Overall Study|Enrolled but treatment not administered|1|||
124671802|NCT03589807|448422188|FG005|Overall Study|Enrolled but treatment not administered|0|||
124671803|NCT03586050|448422189|FG000|Overall Study|Death|3|||
124671804|NCT03586050|448422189|FG000|Overall Study|Withdrawal by Subject|2|||
124671805|NCT01211145|448422190|FG000|Overall Study|Reason not specified|3|||
124671806|NCT01211145|448422191|FG001|Overall Study|Reason not specified|2|||
124671807|NCT01211145|448422192|FG002|Overall Study|Reason not specified|2|||
124671808|NCT01211145|448422193|FG003|Overall Study|Reason not specified|1|||
124671809|NCT01211145|448422190|FG000|Overall Study|Lost to Follow-up|3|||
124671810|NCT01211145|448422191|FG001|Overall Study|Lost to Follow-up|2|||
124671811|NCT01211145|448422192|FG002|Overall Study|Lost to Follow-up|1|||
124671812|NCT01211145|448422193|FG003|Overall Study|Lost to Follow-up|2|||
124671813|NCT01211145|448422190|FG000|Overall Study|Study-specific withdrawal criteria|1|||
124671814|NCT01211145|448422191|FG001|Overall Study|Study-specific withdrawal criteria|0|||
124671815|NCT01211145|448422192|FG002|Overall Study|Study-specific withdrawal criteria|0|||
124671816|NCT01211145|448422193|FG003|Overall Study|Study-specific withdrawal criteria|0|||
124671817|NCT01211145|448422190|FG000|Overall Study|Severe noncompliance to protocol|1|||
124671818|NCT01211145|448422191|FG001|Overall Study|Severe noncompliance to protocol|0|||
124671819|NCT01211145|448422192|FG002|Overall Study|Severe noncompliance to protocol|0|||
124671820|NCT01211145|448422193|FG003|Overall Study|Severe noncompliance to protocol|0|||
124671821|NCT01211145|448422190|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
124671822|NCT01211145|448422191|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
124671823|NCT01211145|448422192|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
124671824|NCT01211145|448422193|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
124671825|NCT01211145|448422190|FG000|Overall Study|Patient decision|2|||
124671826|NCT01211145|448422191|FG001|Overall Study|Patient decision|1|||
124671827|NCT01211145|448422192|FG002|Overall Study|Patient decision|0|||
124671828|NCT01211145|448422193|FG003|Overall Study|Patient decision|2|||
124671829|NCT04202497|448422194|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
124671830|NCT04202497|448422195|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
124671831|NCT04202497|448422196|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
124671832|NCT04202497|448422197|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
124671833|NCT02115607|448422198|FG000|Overall Study|Withdrawal by Subject|1|||
124872991|NCT00508261|449157214|FG002|Overall Study|Withdrawal by Subject|4|||
124671834|NCT00102596|448422199|FG000|Part A|Screen failures|6|||
124671835|NCT00102596|448422200|FG001|Part A|Screen failures|0|||
124671836|NCT00102596|448422199|FG000|Part A|Adverse Event|1|||
124671837|NCT00102596|448422200|FG001|Part A|Adverse Event|0|||
124671838|NCT00069264|448422201|FG000|Overall Study|Adverse Event|3|||
124671839|NCT00069264|448422201|FG000|Overall Study|Progressive Disease|23|||
124671840|NCT00069264|448422201|FG000|Overall Study|Withdrawal by Subject|3|||
124671841|NCT00069264|448422201|FG000|Overall Study|Discon Therapy|3|||
124671842|NCT05067972|448422202|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
124671843|NCT05067972|448422203|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
124671844|NCT05067972|448422204|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
124671845|NCT05067972|448422205|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
124671846|NCT05067972|448422206|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
124671847|NCT05067972|448422207|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
124671848|NCT05067972|448422208|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
124671849|NCT05067972|448422202|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
124671850|NCT05067972|448422203|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
124671851|NCT05067972|448422204|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
124671852|NCT05067972|448422205|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
124671853|NCT05067972|448422206|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
124671854|NCT05067972|448422207|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
124671855|NCT05067972|448422208|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
124671856|NCT05067972|448422202|FG000|Part 1: Treatment|Progressive Disease|3|||
124671857|NCT05067972|448422203|FG001|Part 1: Treatment|Progressive Disease|3|||
124671858|NCT05067972|448422204|FG002|Part 1: Treatment|Progressive Disease|4|||
124671859|NCT05067972|448422205|FG003|Part 1: Treatment|Progressive Disease|2|||
124671860|NCT05067972|448422206|FG004|Part 1: Treatment|Progressive Disease|3|||
124671861|NCT05067972|448422207|FG005|Part 1: Treatment|Progressive Disease|0|||
124671862|NCT05067972|448422208|FG006|Part 1: Treatment|Progressive Disease|2|||
124671863|NCT05067972|448422202|FG000|Part 1: Treatment|Physician Decision|0|||
124671864|NCT05067972|448422203|FG001|Part 1: Treatment|Physician Decision|0|||
124671865|NCT05067972|448422204|FG002|Part 1: Treatment|Physician Decision|0|||
124671866|NCT05067972|448422205|FG003|Part 1: Treatment|Physician Decision|1|||
124671867|NCT05067972|448422206|FG004|Part 1: Treatment|Physician Decision|0|||
124671868|NCT05067972|448422207|FG005|Part 1: Treatment|Physician Decision|0|||
124671869|NCT05067972|448422208|FG006|Part 1: Treatment|Physician Decision|0|||
124671870|NCT05067972|448422202|FG000|Part 1: Treatment|Death|0|||
124671871|NCT05067972|448422203|FG001|Part 1: Treatment|Death|0|||
124671872|NCT05067972|448422204|FG002|Part 1: Treatment|Death|0|||
124671873|NCT05067972|448422205|FG003|Part 1: Treatment|Death|2|||
124671874|NCT05067972|448422206|FG004|Part 1: Treatment|Death|0|||
124671875|NCT05067972|448422207|FG005|Part 1: Treatment|Death|0|||
124671876|NCT05067972|448422208|FG006|Part 1: Treatment|Death|0|||
124671877|NCT05067972|448422202|FG000|Part 1: Treatment|Adverse Event|0|||
124671878|NCT05067972|448422203|FG001|Part 1: Treatment|Adverse Event|0|||
124671879|NCT05067972|448422204|FG002|Part 1: Treatment|Adverse Event|0|||
124671880|NCT05067972|448422205|FG003|Part 1: Treatment|Adverse Event|0|||
124671881|NCT05067972|448422206|FG004|Part 1: Treatment|Adverse Event|0|||
124671882|NCT05067972|448422207|FG005|Part 1: Treatment|Adverse Event|2|||
124671883|NCT05067972|448422208|FG006|Part 1: Treatment|Adverse Event|1|||
124671884|NCT05067972|448422202|FG000|Part 1: Follow-up|Adverse Event|0|||
124671885|NCT05067972|448422203|FG001|Part 1: Follow-up|Adverse Event|0|||
124671886|NCT05067972|448422204|FG002|Part 1: Follow-up|Adverse Event|0|||
124671887|NCT05067972|448422205|FG003|Part 1: Follow-up|Adverse Event|0|||
124671888|NCT05067972|448422206|FG004|Part 1: Follow-up|Adverse Event|0|||
124671889|NCT05067972|448422207|FG005|Part 1: Follow-up|Adverse Event|1|||
124671890|NCT05067972|448422208|FG006|Part 1: Follow-up|Adverse Event|0|||
124671891|NCT05067972|448422202|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
124671892|NCT05067972|448422203|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
124671893|NCT05067972|448422204|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
124671894|NCT05067972|448422205|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
124671895|NCT05067972|448422206|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
124671896|NCT05067972|448422207|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
124671897|NCT05067972|448422208|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
124671898|NCT05067972|448422202|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
124671899|NCT05067972|448422203|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
124671900|NCT05067972|448422204|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
124671901|NCT05067972|448422205|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
124671902|NCT05067972|448422206|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
124671903|NCT05067972|448422207|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
124671904|NCT05067972|448422208|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
124671905|NCT05067972|448422202|FG000|Part 1: Follow-up|Physician Decision|0|||
124671906|NCT05067972|448422203|FG001|Part 1: Follow-up|Physician Decision|0|||
124671907|NCT05067972|448422204|FG002|Part 1: Follow-up|Physician Decision|0|||
124671908|NCT05067972|448422205|FG003|Part 1: Follow-up|Physician Decision|1|||
124671909|NCT05067972|448422206|FG004|Part 1: Follow-up|Physician Decision|0|||
124671910|NCT05067972|448422207|FG005|Part 1: Follow-up|Physician Decision|0|||
124671911|NCT05067972|448422208|FG006|Part 1: Follow-up|Physician Decision|0|||
124671912|NCT05067972|448422202|FG000|Part 1: Follow-up|Death|1|||
124671913|NCT05067972|448422203|FG001|Part 1: Follow-up|Death|2|||
124671914|NCT05067972|448422204|FG002|Part 1: Follow-up|Death|1|||
124671915|NCT05067972|448422205|FG003|Part 1: Follow-up|Death|0|||
124671916|NCT05067972|448422206|FG004|Part 1: Follow-up|Death|1|||
124671917|NCT05067972|448422207|FG005|Part 1: Follow-up|Death|0|||
124671918|NCT05067972|448422208|FG006|Part 1: Follow-up|Death|1|||
124671919|NCT01091246|448422209|FG000|Overall Study|Lost to Follow-up|23|||
124671920|NCT01091246|448422210|FG001|Overall Study|Lost to Follow-up|11|||
124671921|NCT01091246|448422211|FG002|Overall Study|Lost to Follow-up|7|||
124671922|NCT01091246|448422209|FG000|Overall Study|Adverse Event|1|||
124671923|NCT01091246|448422210|FG001|Overall Study|Adverse Event|0|||
124671924|NCT01091246|448422211|FG002|Overall Study|Adverse Event|1|||
124671925|NCT01091246|448422209|FG000|Overall Study|Withdrawal by Subject|9|||
124671926|NCT01091246|448422210|FG001|Overall Study|Withdrawal by Subject|5|||
124671927|NCT01091246|448422211|FG002|Overall Study|Withdrawal by Subject|4|||
124671928|NCT01091246|448422209|FG000|Overall Study|Subject not dosed|2|||
124671929|NCT01091246|448422210|FG001|Overall Study|Subject not dosed|0|||
124671930|NCT01091246|448422211|FG002|Overall Study|Subject not dosed|1|||
124671931|NCT01676012|448422215|FG000|Overall Study|Adverse Event|2|||
124671932|NCT01676012|448422215|FG000|Overall Study|incomplete set of videos|1|||
124671933|NCT02667301|448422219|FG000|Overall Study|Adverse Event|1|||
124671934|NCT02667301|448422219|FG000|Overall Study|Lack of Efficacy|1|||
124671935|NCT03528551|448422221|FG000|Overall Study|Lost to Follow-up|0|||
124671936|NCT03528551|448422222|FG001|Overall Study|Lost to Follow-up|1|||
124671937|NCT03528551|448422223|FG002|Overall Study|Lost to Follow-up|0|||
124671938|NCT03528551|448422221|FG000|Overall Study|Transferred to other arm/group|2|||
124671939|NCT03528551|448422222|FG001|Overall Study|Transferred to other arm/group|3|||
124671940|NCT03528551|448422223|FG002|Overall Study|Transferred to other arm/group|0|||
124671941|NCT03528551|448422221|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124671942|NCT03528551|448422222|FG001|Overall Study|Withdrawal by parent/guardian|5|||
124671943|NCT03528551|448422223|FG002|Overall Study|Withdrawal by parent/guardian|0|||
124671944|NCT03528551|448422221|FG000|Overall Study|Protocol Violation|0|||
124671945|NCT03528551|448422222|FG001|Overall Study|Protocol Violation|3|||
124671946|NCT03528551|448422223|FG002|Overall Study|Protocol Violation|0|||
124671947|NCT03528551|448422221|FG000|Overall Study|Withdrawal by Subject|0|||
124671948|NCT03528551|448422222|FG001|Overall Study|Withdrawal by Subject|7|||
124671949|NCT03528551|448422223|FG002|Overall Study|Withdrawal by Subject|0|||
124671950|NCT00846586|448422224|FG000|Overall Study|Adverse Event|20|||
124671951|NCT00846586|448422225|FG001|Overall Study|Adverse Event|10|||
124671952|NCT00846586|448422224|FG000|Overall Study|Subject withdrew consent|8|||
124671953|NCT00846586|448422225|FG001|Overall Study|Subject withdrew consent|10|||
124671954|NCT00846586|448422224|FG000|Overall Study|Administrative problems|5|||
124671955|NCT00846586|448422225|FG001|Overall Study|Administrative problems|4|||
124671956|NCT00846586|448422224|FG000|Overall Study|Death|2|||
124671957|NCT00846586|448422225|FG001|Overall Study|Death|0|||
124671958|NCT00846586|448422224|FG000|Overall Study|Protocol deviation|2|||
124671959|NCT00846586|448422225|FG001|Overall Study|Protocol deviation|6|||
124671960|NCT00846586|448422224|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124671961|NCT00846586|448422225|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124671962|NCT00846586|448422224|FG000|Overall Study|Lost to Follow-up|1|||
124671963|NCT00846586|448422225|FG001|Overall Study|Lost to Follow-up|4|||
124671964|NCT00846586|448422224|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124671965|NCT00846586|448422225|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124671966|NCT00735007|448422226|FG000|Overall Study|Adverse Event|4|||
124671967|NCT00735007|448422226|FG000|Overall Study|Protocol Violation|1|||
124671968|NCT01061606|448422227|FG000|Overall Study|Adverse Event|1|||
124671969|NCT01061606|448422227|FG000|Overall Study|Death|1|||
124671970|NCT01061606|448422227|FG000|Overall Study|Disease Progression|4|||
124671971|NCT01061606|448422227|FG000|Overall Study|alternative therapy|2|||
124671972|NCT01789047|448422228|FG000|Overall Study|Adverse Event|3|||
124671973|NCT01789047|448422229|FG001|Overall Study|Adverse Event|2|||
124671974|NCT01789047|448422228|FG000|Overall Study|Withdrawal by Subject|1|||
124671975|NCT01789047|448422229|FG001|Overall Study|Withdrawal by Subject|2|||
124671976|NCT03644017|448422230|FG000|Overall Study|Access Abandonment|5|||
124671977|NCT03644017|448422230|FG000|Overall Study|Kidney Transplant|2|||
124671978|NCT02668640|448422231|FG000|Overall Study|Lost to Follow-up|13|||
124671979|NCT02668640|448422231|FG000|Overall Study|Other, not specified|1|||
124671980|NCT03669588|448422232|FG000|Overall Study|Adverse Event|1|||
124671981|NCT03669588|448422233|FG001|Overall Study|Adverse Event|0|||
124671982|NCT03669588|448422232|FG000|Overall Study|Physician Decision|0|||
124671983|NCT03669588|448422233|FG001|Overall Study|Physician Decision|1|||
124671984|NCT03669588|448422232|FG000|Overall Study|Protocol Violation|1|||
124671985|NCT03669588|448422233|FG001|Overall Study|Protocol Violation|0|||
124671986|NCT03669588|448422232|FG000|Overall Study|Sponsor Decision|1|||
124671987|NCT03669588|448422233|FG001|Overall Study|Sponsor Decision|1|||
124671988|NCT03669588|448422232|FG000|Overall Study|Withdrawal by Subject|1|||
124671989|NCT03669588|448422233|FG001|Overall Study|Withdrawal by Subject|4|||
124671990|NCT03669588|448422232|FG000|Overall Study|Rescue Therapy Needed|0|||
124671991|NCT03669588|448422233|FG001|Overall Study|Rescue Therapy Needed|1|||
124671992|NCT00369343|448422235|FG000|Double-blind Phase|Adverse Event|19|||
124671993|NCT00369343|448422236|FG001|Double-blind Phase|Adverse Event|4|||
124671994|NCT00369343|448422235|FG000|Double-blind Phase|Failed to return|2|||
124671995|NCT00369343|448422236|FG001|Double-blind Phase|Failed to return|0|||
124671996|NCT00369343|448422235|FG000|Double-blind Phase|Lost to Follow-up|9|||
124671997|NCT00369343|448422236|FG001|Double-blind Phase|Lost to Follow-up|2|||
124671998|NCT00369343|448422235|FG000|Double-blind Phase|Protocol Violation|2|||
124671999|NCT00369343|448422236|FG001|Double-blind Phase|Protocol Violation|0|||
124672000|NCT00369343|448422235|FG000|Double-blind Phase|Withdrawal by Subject|8|||
124672001|NCT00369343|448422236|FG001|Double-blind Phase|Withdrawal by Subject|6|||
124672002|NCT00369343|448422235|FG000|Double-blind Phase|Lack of Efficacy|0|||
124672003|NCT00369343|448422236|FG001|Double-blind Phase|Lack of Efficacy|4|||
124672004|NCT00369343|448422235|FG000|Double-blind Phase|Protocol deviation|4|||
124672005|NCT00369343|448422236|FG001|Double-blind Phase|Protocol deviation|0|||
124672006|NCT00369343|448422235|FG000|Open-label Phase|Adverse Event|19|||
124672007|NCT00369343|448422236|FG001|Open-label Phase|Adverse Event|7|||
124672008|NCT00369343|448422235|FG000|Open-label Phase|Failed to return|4|||
124672009|NCT00369343|448422236|FG001|Open-label Phase|Failed to return|0|||
124672010|NCT00369343|448422235|FG000|Open-label Phase|Physician Decision|2|||
124672011|NCT00369343|448422236|FG001|Open-label Phase|Physician Decision|0|||
124672012|NCT00369343|448422235|FG000|Open-label Phase|Lost to Follow-up|5|||
124672013|NCT00369343|448422236|FG001|Open-label Phase|Lost to Follow-up|3|||
124672014|NCT00369343|448422235|FG000|Open-label Phase|inadvertently reported study completers|3|||
124672015|NCT00369343|448422236|FG001|Open-label Phase|inadvertently reported study completers|2|||
124672016|NCT00369343|448422235|FG000|Open-label Phase|Protocol Violation|1|||
124672017|NCT00369343|448422236|FG001|Open-label Phase|Protocol Violation|3|||
124672018|NCT00369343|448422235|FG000|Open-label Phase|Withdrawal by Subject|15|||
124672019|NCT00369343|448422236|FG001|Open-label Phase|Withdrawal by Subject|6|||
124672020|NCT00369343|448422235|FG000|Open-label Phase|Lack of Efficacy|4|||
124672021|NCT00369343|448422236|FG001|Open-label Phase|Lack of Efficacy|3|||
124672022|NCT00369343|448422235|FG000|Open-label Phase|Lack of continuance tolerability|3|||
124672023|NCT00369343|448422236|FG001|Open-label Phase|Lack of continuance tolerability|4|||
124872992|NCT00508261|449157215|FG003|Overall Study|Withdrawal by Subject|0|||
124672024|NCT00369343|448422235|FG000|Open-label Phase|did not take study drug|1|||
124672025|NCT00369343|448422236|FG001|Open-label Phase|did not take study drug|2|||
124672026|NCT01100502|448422237|FG000|Overall Study|Withdrawal by Subject|18|||
124672027|NCT01100502|448422238|FG001|Overall Study|Withdrawal by Subject|25|||
124672028|NCT01100502|448422237|FG000|Overall Study|Lost to Follow-up|13|||
124672029|NCT01100502|448422238|FG001|Overall Study|Lost to Follow-up|28|||
124672030|NCT01100502|448422237|FG000|Overall Study|Site request to end participation in study|0|||
124672031|NCT01100502|448422238|FG001|Overall Study|Site request to end participation in study|1|||
124672032|NCT01100502|448422237|FG000|Overall Study|Death|45|||
124672033|NCT01100502|448422238|FG001|Overall Study|Death|40|||
124672034|NCT02322749|448422239|FG000|Period 2|Adverse Event|0|||
124672035|NCT02322749|448422240|FG001|Period 2|Adverse Event|0|||
124672036|NCT02322749|448422241|FG002|Period 2|Adverse Event|0|||
124672037|NCT02322749|448422242|FG003|Period 2|Adverse Event|1|||
124672038|NCT02322749|448422243|FG004|Period 2|Adverse Event|0|||
124672039|NCT02322749|448422244|FG005|Period 2|Adverse Event|0|||
124672040|NCT02322749|448422239|FG000|Period 2|Withdrawal by Subject|0|||
124672041|NCT02322749|448422240|FG001|Period 2|Withdrawal by Subject|0|||
124672042|NCT02322749|448422241|FG002|Period 2|Withdrawal by Subject|0|||
124672043|NCT02322749|448422242|FG003|Period 2|Withdrawal by Subject|1|||
124672044|NCT02322749|448422243|FG004|Period 2|Withdrawal by Subject|0|||
124872993|NCT00508261|449157212|FG000|Overall Study|Migrated/ moved from study area|0|||
124672045|NCT02322749|448422244|FG005|Period 2|Withdrawal by Subject|0|||
124672046|NCT02322749|448422239|FG000|Period 3|Withdrawal by Subject|0|||
124672047|NCT02322749|448422240|FG001|Period 3|Withdrawal by Subject|0|||
124672048|NCT02322749|448422241|FG002|Period 3|Withdrawal by Subject|1|||
124672049|NCT02322749|448422242|FG003|Period 3|Withdrawal by Subject|0|||
124672050|NCT02322749|448422243|FG004|Period 3|Withdrawal by Subject|0|||
124672051|NCT02322749|448422244|FG005|Period 3|Withdrawal by Subject|0|||
124672052|NCT00073918|448422249|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
124672053|NCT00073918|448422249|FG000|Overall Study|Rapid disease progression|2|||
124672054|NCT00073918|448422249|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
124672055|NCT04414787|448422262|FG000|Overall Study|Patient Death|18|||
124672056|NCT04414787|448422263|FG001|Overall Study|Patient Death|18|||
124672057|NCT04414787|448422264|FG002|Overall Study|Patient Death|15|||
124672058|NCT04414787|448422265|FG003|Overall Study|Patient Death|15|||
124672059|NCT04414787|448422262|FG000|Overall Study|Patient Hospitalization|1|||
124672060|NCT04414787|448422263|FG001|Overall Study|Patient Hospitalization|1|||
124672061|NCT04414787|448422264|FG002|Overall Study|Patient Hospitalization|2|||
124672062|NCT04414787|448422265|FG003|Overall Study|Patient Hospitalization|2|||
124672063|NCT04414787|448422262|FG000|Overall Study|Lost to Follow-up|7|||
124672064|NCT04414787|448422263|FG001|Overall Study|Lost to Follow-up|7|||
124672065|NCT04414787|448422264|FG002|Overall Study|Lost to Follow-up|5|||
124672066|NCT04414787|448422265|FG003|Overall Study|Lost to Follow-up|5|||
124672067|NCT04414787|448422262|FG000|Overall Study|Residence in post-acute care facility|3|||
124672068|NCT04414787|448422263|FG001|Overall Study|Residence in post-acute care facility|3|||
124672069|NCT04414787|448422264|FG002|Overall Study|Residence in post-acute care facility|5|||
124672070|NCT04414787|448422265|FG003|Overall Study|Residence in post-acute care facility|5|||
124672071|NCT00919633|448422266|FG000|Overall Study|Adverse Event|1|||
124672072|NCT00919633|448422267|FG001|Overall Study|Adverse Event|9|||
124672073|NCT00919633|448422268|FG002|Overall Study|Adverse Event|12|||
124672074|NCT00919633|448422269|FG003|Overall Study|Adverse Event|10|||
124672075|NCT00919633|448422266|FG000|Overall Study|Death|0|||
124672076|NCT00919633|448422267|FG001|Overall Study|Death|0|||
124672077|NCT00919633|448422268|FG002|Overall Study|Death|2|||
124672078|NCT00919633|448422269|FG003|Overall Study|Death|0|||
124672079|NCT00919633|448422266|FG000|Overall Study|Lack of Efficacy|17|||
124672080|NCT00919633|448422267|FG001|Overall Study|Lack of Efficacy|3|||
124672081|NCT00919633|448422268|FG002|Overall Study|Lack of Efficacy|2|||
124672082|NCT00919633|448422269|FG003|Overall Study|Lack of Efficacy|3|||
124672083|NCT00919633|448422266|FG000|Overall Study|Withdrawal by Subject|1|||
124672084|NCT00919633|448422267|FG001|Overall Study|Withdrawal by Subject|2|||
124672085|NCT00919633|448422268|FG002|Overall Study|Withdrawal by Subject|4|||
124672086|NCT00919633|448422269|FG003|Overall Study|Withdrawal by Subject|3|||
124672087|NCT00919633|448422266|FG000|Overall Study|Lost to Follow-up|3|||
124672088|NCT00919633|448422267|FG001|Overall Study|Lost to Follow-up|1|||
124672089|NCT00919633|448422268|FG002|Overall Study|Lost to Follow-up|0|||
124672090|NCT00919633|448422269|FG003|Overall Study|Lost to Follow-up|2|||
124672091|NCT00919633|448422266|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
124672092|NCT00919633|448422267|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
124672093|NCT00919633|448422268|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
124672094|NCT00919633|448422269|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
124672095|NCT00919633|448422266|FG000|Overall Study|Protocol Violation|0|||
124672096|NCT00919633|448422267|FG001|Overall Study|Protocol Violation|0|||
124672097|NCT00919633|448422268|FG002|Overall Study|Protocol Violation|0|||
124672098|NCT00919633|448422269|FG003|Overall Study|Protocol Violation|1|||
124672099|NCT00919633|448422266|FG000|Overall Study|Physician Decision|0|||
124672100|NCT00919633|448422267|FG001|Overall Study|Physician Decision|0|||
124672101|NCT00919633|448422268|FG002|Overall Study|Physician Decision|0|||
124672102|NCT00919633|448422269|FG003|Overall Study|Physician Decision|1|||
124672103|NCT00919633|448422266|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
124672104|NCT00919633|448422267|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
124672105|NCT00919633|448422268|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
124672106|NCT00919633|448422269|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
124672107|NCT00919633|448422266|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
124672108|NCT00919633|448422267|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
124672109|NCT00919633|448422268|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
124672110|NCT00919633|448422269|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
124672111|NCT01121263|448422270|FG000|Overall Study|Death|3|||
124672112|NCT01121263|448422271|FG001|Overall Study|Death|2|||
124672113|NCT01121263|448422270|FG000|Overall Study|Lost to Follow-up|22|||
124672114|NCT01121263|448422271|FG001|Overall Study|Lost to Follow-up|12|||
124672115|NCT01121263|448422270|FG000|Overall Study|Withdrawal by Subject|0|||
124672116|NCT01121263|448422271|FG001|Overall Study|Withdrawal by Subject|1|||
124672117|NCT02481050|448423930|FG000|Overall Study|Adverse Event|1|||
124672118|NCT02481050|448423930|FG000|Overall Study|Disease Progression|47|||
124672119|NCT02481050|448423930|FG000|Overall Study|Withdrawal by Subject|7|||
124672120|NCT02481050|448423930|FG000|Overall Study|Other|3|||
124672121|NCT01386606|448423931|FG000|Overall Study|Adverse Event|0|||
124672122|NCT01386606|448423932|FG001|Overall Study|Adverse Event|1|||
124672123|NCT01386606|448423933|FG002|Overall Study|Adverse Event|0|||
124672124|NCT01386606|448423934|FG003|Overall Study|Adverse Event|0|||
124672125|NCT01386606|448423931|FG000|Overall Study|Withdrawal by Subject|0|||
124672126|NCT01386606|448423932|FG001|Overall Study|Withdrawal by Subject|1|||
124672127|NCT01386606|448423933|FG002|Overall Study|Withdrawal by Subject|1|||
124672128|NCT01386606|448423934|FG003|Overall Study|Withdrawal by Subject|0|||
124672129|NCT01386606|448423931|FG000|Overall Study|Protocol Violation|1|||
124672130|NCT01386606|448423932|FG001|Overall Study|Protocol Violation|0|||
124672131|NCT01386606|448423933|FG002|Overall Study|Protocol Violation|1|||
124672132|NCT01386606|448423934|FG003|Overall Study|Protocol Violation|1|||
124672133|NCT01386606|448423931|FG000|Overall Study|Lost to Follow-up|2|||
124672134|NCT01386606|448423932|FG001|Overall Study|Lost to Follow-up|0|||
124672135|NCT01386606|448423933|FG002|Overall Study|Lost to Follow-up|0|||
124672136|NCT01386606|448423934|FG003|Overall Study|Lost to Follow-up|0|||
124672137|NCT01386606|448423931|FG000|Overall Study|Subject incarcerated|0|||
124672138|NCT01386606|448423932|FG001|Overall Study|Subject incarcerated|1|||
124672139|NCT01386606|448423933|FG002|Overall Study|Subject incarcerated|0|||
124672140|NCT01386606|448423934|FG003|Overall Study|Subject incarcerated|0|||
124672141|NCT01386606|448423931|FG000|Overall Study|Unable to draw PK|1|||
124672142|NCT01386606|448423932|FG001|Overall Study|Unable to draw PK|0|||
124672143|NCT01386606|448423933|FG002|Overall Study|Unable to draw PK|0|||
124672144|NCT01386606|448423934|FG003|Overall Study|Unable to draw PK|0|||
124672145|NCT01386606|448423931|FG000|Overall Study|T levels too high|0|||
124672146|NCT01386606|448423932|FG001|Overall Study|T levels too high|1|||
124672147|NCT01386606|448423933|FG002|Overall Study|T levels too high|1|||
124672148|NCT01386606|448423934|FG003|Overall Study|T levels too high|0|||
124672149|NCT03246347|448423937|FG000|Overall Study|On Study|23|||
124672150|NCT01022203|448423938|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
124672151|NCT01022203|448423939|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
124672152|NCT01022203|448423938|FG000|Post Treatment Assessment|Physician Decision|2|||
124672153|NCT01022203|448423939|FG001|Post Treatment Assessment|Physician Decision|0|||
124672154|NCT01022203|448423938|FG000|Post Treatment Assessment|Adverse Event|0|||
124672155|NCT01022203|448423939|FG001|Post Treatment Assessment|Adverse Event|2|||
124672156|NCT01022203|448423938|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
124672157|NCT01022203|448423939|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
124672158|NCT00903201|448423940|FG000|Overall Study|Adverse Event|1|||
124672159|NCT00903201|448423941|FG001|Overall Study|Adverse Event|4|||
124672160|NCT00903201|448423942|FG002|Overall Study|Adverse Event|0|||
124672161|NCT00903201|448423940|FG000|Overall Study|Protocol Violation|2|||
124672162|NCT00903201|448423941|FG001|Overall Study|Protocol Violation|1|||
124672163|NCT00903201|448423942|FG002|Overall Study|Protocol Violation|0|||
124672164|NCT00903201|448423940|FG000|Overall Study|Lost to Follow-up|0|||
124672165|NCT00903201|448423941|FG001|Overall Study|Lost to Follow-up|1|||
124672166|NCT00903201|448423942|FG002|Overall Study|Lost to Follow-up|0|||
124672167|NCT00903201|448423940|FG000|Overall Study|Physician Decision|1|||
124672168|NCT00903201|448423941|FG001|Overall Study|Physician Decision|0|||
124672169|NCT00903201|448423942|FG002|Overall Study|Physician Decision|1|||
124672170|NCT00903201|448423940|FG000|Overall Study|Withdrawal by Subject|1|||
124672171|NCT00903201|448423941|FG001|Overall Study|Withdrawal by Subject|0|||
124672172|NCT00903201|448423942|FG002|Overall Study|Withdrawal by Subject|1|||
124672173|NCT04069715|448423944|FG000|Overall Study|Lost to Follow-up|1|||
124672174|NCT04069715|448423945|FG001|Overall Study|Lost to Follow-up|1|||
124672175|NCT04069715|448423944|FG000|Overall Study|Physician Decision|1|||
124672176|NCT04069715|448423945|FG001|Overall Study|Physician Decision|1|||
124672177|NCT04069715|448423944|FG000|Overall Study|Withdrawal by Subject|3|||
124672178|NCT04069715|448423945|FG001|Overall Study|Withdrawal by Subject|3|||
124672179|NCT03205150|448423946|FG000|Overall Study|Protocol deviation|1|||
124672180|NCT03205150|448423947|FG001|Overall Study|Protocol deviation|3|||
124672181|NCT03205150|448423948|FG002|Overall Study|Protocol deviation|0|||
124672182|NCT03205150|448423946|FG000|Overall Study|Patient/guardian decision|0|||
124672183|NCT03205150|448423947|FG001|Overall Study|Patient/guardian decision|3|||
124672184|NCT03205150|448423948|FG002|Overall Study|Patient/guardian decision|0|||
124672185|NCT03205150|448423946|FG000|Overall Study|Adverse Event|1|||
124672186|NCT03205150|448423947|FG001|Overall Study|Adverse Event|1|||
124672187|NCT03205150|448423948|FG002|Overall Study|Adverse Event|1|||
124672188|NCT03205150|448423946|FG000|Overall Study|Lost to Follow-up|0|||
124672189|NCT03205150|448423947|FG001|Overall Study|Lost to Follow-up|0|||
124672190|NCT03205150|448423948|FG002|Overall Study|Lost to Follow-up|1|||
124672191|NCT02723188|448423949|FG000|Overall Study|Withdrawal by Subject|1|||
124672192|NCT02723188|448423950|FG001|Overall Study|Withdrawal by Subject|0|||
124672193|NCT02723188|448423951|FG002|Overall Study|Withdrawal by Subject|0|||
124672194|NCT03652818|448423958|FG000|Overall Study|Adverse Event|1|||
124672195|NCT03652818|448423959|FG001|Overall Study|Adverse Event|0|||
124672196|NCT03652818|448423960|FG002|Overall Study|Adverse Event|0|||
124672197|NCT03652818|448423961|FG003|Overall Study|Adverse Event|0|||
124672198|NCT03652818|448423962|FG004|Overall Study|Adverse Event|0|||
124672199|NCT03652818|448423958|FG000|Overall Study|Physician Decision|1|||
124672200|NCT03652818|448423959|FG001|Overall Study|Physician Decision|0|||
124672201|NCT03652818|448423960|FG002|Overall Study|Physician Decision|0|||
124672202|NCT03652818|448423961|FG003|Overall Study|Physician Decision|0|||
124672203|NCT03652818|448423962|FG004|Overall Study|Physician Decision|0|||
124672204|NCT03652818|448423958|FG000|Overall Study|Lost to Follow-up|0|||
124672205|NCT03652818|448423959|FG001|Overall Study|Lost to Follow-up|1|||
124672206|NCT03652818|448423960|FG002|Overall Study|Lost to Follow-up|2|||
124672207|NCT03652818|448423961|FG003|Overall Study|Lost to Follow-up|1|||
124672208|NCT03652818|448423962|FG004|Overall Study|Lost to Follow-up|1|||
124672209|NCT01930539|448423965|FG000|Overall Study|Withdrawal by Subject|2|||
124672210|NCT01930539|448423966|FG001|Overall Study|Withdrawal by Subject|2|||
124672211|NCT01241279|448423967|FG000|Overall Study|Lost to Follow-up|0|||
124672212|NCT01241279|448423968|FG001|Overall Study|Lost to Follow-up|1|||
124672213|NCT00301834|448423971|FG000|Overall Study|Death|1|||
124672214|NCT01811732|448423972|FG000|Overall Study|Lost to Follow-up|24|||
124672215|NCT01811732|448423973|FG001|Overall Study|Lost to Follow-up|30|||
124872994|NCT00508261|449157213|FG001|Overall Study|Migrated/ moved from study area|1|||
124672216|NCT01811732|448423972|FG000|Overall Study|Withdrawal by Subject|16|||
124672217|NCT01811732|448423973|FG001|Overall Study|Withdrawal by Subject|10|||
124672218|NCT01811732|448423972|FG000|Overall Study|Adverse Event|3|||
124672219|NCT01811732|448423973|FG001|Overall Study|Adverse Event|9|||
124672220|NCT01811732|448423972|FG000|Overall Study|Lack of Efficacy|3|||
124672221|NCT01811732|448423973|FG001|Overall Study|Lack of Efficacy|1|||
124672222|NCT01811732|448423972|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
124672223|NCT01811732|448423973|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
124672224|NCT01811732|448423972|FG000|Overall Study|Physician Decision|2|||
124672225|NCT01811732|448423973|FG001|Overall Study|Physician Decision|0|||
124672226|NCT01811732|448423972|FG000|Overall Study|Death|1|||
124672227|NCT01811732|448423973|FG001|Overall Study|Death|1|||
124672228|NCT01811732|448423972|FG000|Overall Study|Insufficient venous access|0|||
124672229|NCT01811732|448423973|FG001|Overall Study|Insufficient venous access|1|||
124672230|NCT01811732|448423972|FG000|Overall Study|Protocol Violation|0|||
124672231|NCT01811732|448423973|FG001|Overall Study|Protocol Violation|1|||
124672232|NCT01811732|448423972|FG000|Overall Study|Subject incarcerated|1|||
124672233|NCT01811732|448423973|FG001|Overall Study|Subject incarcerated|2|||
124672234|NCT01811732|448423972|FG000|Overall Study|Admitted to another facility|1|||
124672235|NCT01811732|448423973|FG001|Overall Study|Admitted to another facility|0|||
124672236|NCT01811732|448423972|FG000|Overall Study|Correct study drug not available on site|1|||
124672237|NCT01811732|448423973|FG001|Overall Study|Correct study drug not available on site|0|||
124672238|NCT01405560|448423974|FG000|Overall Study|Physician Decision|1|||
124672239|NCT01783743|448423975|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
124672240|NCT01783743|448423976|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
124672241|NCT01783743|448423975|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
124672242|NCT01783743|448423976|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
124672243|NCT01783743|448423975|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
124672244|NCT01783743|448423976|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
124672245|NCT02771275|448423977|FG000|Overall Study|Reoperation|3|||
124672246|NCT02771275|448423977|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
124672247|NCT03191799|448423978|FG000|Overall Study|Withdrawal by Subject|4|||
124672248|NCT03191799|448423978|FG000|Overall Study|Physician Decision|2|||
124672249|NCT03191799|448423978|FG000|Overall Study|Lost to Follow-up|1|||
124672250|NCT03191799|448423978|FG000|Overall Study|Death|2|||
124672251|NCT01240382|448423991|FG000|Overall Study|Adverse Event|2|||
124672252|NCT01240382|448423992|FG001|Overall Study|Adverse Event|1|||
124672253|NCT01240382|448423991|FG000|Overall Study|Lack of Efficacy|0|||
124672254|NCT01240382|448423992|FG001|Overall Study|Lack of Efficacy|2|||
124672255|NCT01240382|448423991|FG000|Overall Study|Fear of adverse events|0|||
124672256|NCT01240382|448423992|FG001|Overall Study|Fear of adverse events|1|||
124672257|NCT02456727|448424000|FG000|Overall Study|Lost to Follow-up|63|||
124672258|NCT02456727|448424001|FG001|Overall Study|Lost to Follow-up|65|||
124672259|NCT02456727|448424000|FG000|Overall Study|Death|2|||
124672260|NCT02456727|448424001|FG001|Overall Study|Death|1|||
124672261|NCT02456727|448424000|FG000|Overall Study|Withdrawal by Subject|1|||
124672262|NCT02456727|448424001|FG001|Overall Study|Withdrawal by Subject|10|||
124672263|NCT02456727|448424000|FG000|Overall Study|Never Initiated Treatment|43|||
124672264|NCT02456727|448424001|FG001|Overall Study|Never Initiated Treatment|30|||
124672265|NCT02643693|448424002|FG000|Overall Study|Physician Decision|0|||
124672266|NCT02643693|448424003|FG001|Overall Study|Physician Decision|1|||
124672267|NCT02643693|448424004|FG002|Overall Study|Physician Decision|0|||
124672268|NCT02643693|448424005|FG003|Overall Study|Physician Decision|0|||
124672269|NCT02643693|448424006|FG004|Overall Study|Physician Decision|0|||
124672270|NCT02643693|448424007|FG005|Overall Study|Physician Decision|0|||
124672271|NCT02643693|448424002|FG000|Overall Study|Withdrawal by Subject|0|||
124672272|NCT02643693|448424003|FG001|Overall Study|Withdrawal by Subject|1|||
124672273|NCT02643693|448424004|FG002|Overall Study|Withdrawal by Subject|0|||
124672274|NCT02643693|448424005|FG003|Overall Study|Withdrawal by Subject|0|||
124672275|NCT02643693|448424006|FG004|Overall Study|Withdrawal by Subject|0|||
124672276|NCT02643693|448424007|FG005|Overall Study|Withdrawal by Subject|0|||
124672277|NCT02643693|448424002|FG000|Overall Study|Protocol Adherence Issues|2|||
124672278|NCT02643693|448424003|FG001|Overall Study|Protocol Adherence Issues|0|||
124672279|NCT02643693|448424004|FG002|Overall Study|Protocol Adherence Issues|1|||
124672280|NCT02643693|448424005|FG003|Overall Study|Protocol Adherence Issues|0|||
124672281|NCT02643693|448424006|FG004|Overall Study|Protocol Adherence Issues|0|||
124672282|NCT02643693|448424007|FG005|Overall Study|Protocol Adherence Issues|1|||
124672283|NCT00492297|448424008|FG000|Treatment|Death|2|||
124672284|NCT00492297|448424008|FG000|Treatment|Study terminated by sponsor|3|||
124672285|NCT00492297|448424008|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
124672286|NCT00492297|448424008|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
124672287|NCT00492297|448424008|FG000|Survival Only Follow-up|Death|46|||
124672288|NCT00492297|448424008|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
124672289|NCT00492297|448424008|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
124672290|NCT01408706|448424009|FG000|Overall Study|Physician Decision|1|||
124672291|NCT01408706|448424010|FG001|Overall Study|Physician Decision|0|||
124672292|NCT00698815|448424012|FG000|Overall Study|Death|1|||
124672293|NCT00698815|448424013|FG001|Overall Study|Death|2|||
124672294|NCT00698815|448424014|FG002|Overall Study|Death|4|||
124672295|NCT00698815|448424012|FG000|Overall Study|Withdrawal by Subject|6|||
124672296|NCT00698815|448424013|FG001|Overall Study|Withdrawal by Subject|3|||
124672297|NCT00698815|448424014|FG002|Overall Study|Withdrawal by Subject|2|||
124672298|NCT00698815|448424012|FG000|Overall Study|MD discretion|2|||
124672299|NCT00698815|448424013|FG001|Overall Study|MD discretion|7|||
124672300|NCT00698815|448424014|FG002|Overall Study|MD discretion|2|||
124672301|NCT00698815|448424012|FG000|Overall Study|Did not receive protocol treatment|1|||
124672302|NCT00698815|448424013|FG001|Overall Study|Did not receive protocol treatment|2|||
124672303|NCT00698815|448424014|FG002|Overall Study|Did not receive protocol treatment|2|||
124672304|NCT03903172|448424015|FG000|Overall Study|screen fail|4|||
124672305|NCT03903172|448424016|FG001|Overall Study|screen fail|1|||
124672306|NCT01545388|448424017|FG000|Overall Study|Adverse Event|2|||
124672307|NCT01545388|448424018|FG001|Overall Study|Adverse Event|4|||
124672308|NCT01545388|448424019|FG002|Overall Study|Adverse Event|1|||
124672309|NCT01545388|448424017|FG000|Overall Study|Lack of Efficacy|3|||
124672310|NCT01545388|448424018|FG001|Overall Study|Lack of Efficacy|2|||
124672311|NCT01545388|448424019|FG002|Overall Study|Lack of Efficacy|5|||
124672312|NCT01545388|448424017|FG000|Overall Study|Participant moved or relocated|1|||
124672313|NCT01545388|448424018|FG001|Overall Study|Participant moved or relocated|0|||
124672314|NCT01545388|448424019|FG002|Overall Study|Participant moved or relocated|0|||
124672315|NCT01545388|448424017|FG000|Overall Study|Withdrawal by Subject|1|||
124672316|NCT01545388|448424018|FG001|Overall Study|Withdrawal by Subject|4|||
124672317|NCT01545388|448424019|FG002|Overall Study|Withdrawal by Subject|2|||
124672318|NCT01545388|448424017|FG000|Overall Study|Other|1|||
124672319|NCT01545388|448424018|FG001|Overall Study|Other|1|||
124672320|NCT01545388|448424019|FG002|Overall Study|Other|0|||
124672321|NCT01701245|448424020|FG000|Overall Study|Protocol Violation|1|||
124672322|NCT01701245|448424021|FG001|Overall Study|Protocol Violation|3|||
124672323|NCT01701245|448424020|FG000|Overall Study|Did not complete the open label period|11|||
124672324|NCT01701245|448424021|FG001|Overall Study|Did not complete the open label period|12|||
124672325|NCT01255163|448424022|FG000|Overall Study|Withdrawal by Subject|1|||
124672326|NCT01255163|448424023|FG001|Overall Study|Withdrawal by Subject|0|||
124672327|NCT01255163|448424022|FG000|Overall Study|Lost to Follow-up|2|||
124672328|NCT01255163|448424023|FG001|Overall Study|Lost to Follow-up|0|||
124672329|NCT01255163|448424022|FG000|Overall Study|Adverse Event|0|||
124672330|NCT01255163|448424023|FG001|Overall Study|Adverse Event|2|||
124672331|NCT01255163|448424022|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
124672332|NCT01255163|448424023|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
124672333|NCT01867008|448424030|FG000|Overall Study|Withdrawal by Subject|1|||
124672334|NCT05518539|448424031|FG000|Overall Study|Lost to Follow-up|6|||
124672335|NCT02053493|448424034|FG000|Overall Study|Withdrawal by Subject|1|||
124672336|NCT02053493|448424035|FG001|Overall Study|Withdrawal by Subject|1|||
124672337|NCT04613518|448424038|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
124672338|NCT04613518|448424039|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
124672339|NCT04613518|448424040|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
124672340|NCT04613518|448424038|FG000|Double-Blind Treatment Period|Adverse Event|2|||
124672341|NCT04613518|448424039|FG001|Double-Blind Treatment Period|Adverse Event|0|||
124672342|NCT04613518|448424040|FG002|Double-Blind Treatment Period|Adverse Event|1|||
124672343|NCT04613518|448424038|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
124672344|NCT04613518|448424039|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
124672345|NCT04613518|448424040|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
124672346|NCT04613518|448424038|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
124672347|NCT04613518|448424039|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
124672348|NCT04613518|448424040|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
124672349|NCT04613518|448424038|FG000|Double-Blind Treatment Period|Other Reasons|2|||
124872995|NCT00508261|449157214|FG002|Overall Study|Migrated/ moved from study area|0|||
124672350|NCT04613518|448424039|FG001|Double-Blind Treatment Period|Other Reasons|0|||
124672351|NCT04613518|448424040|FG002|Double-Blind Treatment Period|Other Reasons|0|||
124672352|NCT04613518|448424038|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
124672353|NCT04613518|448424039|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
124672354|NCT04613518|448424040|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
124672355|NCT04613518|448424038|FG000|Open-Label Treatment Period|Adverse Event|1|||
124672356|NCT04613518|448424039|FG001|Open-Label Treatment Period|Adverse Event|0|||
124672357|NCT04613518|448424040|FG002|Open-Label Treatment Period|Adverse Event|3|||
124672358|NCT04613518|448424038|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
124672359|NCT04613518|448424039|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
124672360|NCT04613518|448424040|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
124672361|NCT04613518|448424038|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
124672362|NCT04613518|448424039|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
124672363|NCT04613518|448424040|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
124672364|NCT04613518|448424038|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
124672365|NCT04613518|448424039|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
124672366|NCT04613518|448424040|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
124672367|NCT04613518|448424038|FG000|Open-Label Treatment Period|Other reasons|1|||
124672368|NCT04613518|448424039|FG001|Open-Label Treatment Period|Other reasons|0|||
124672369|NCT04613518|448424040|FG002|Open-Label Treatment Period|Other reasons|0|||
124672370|NCT01619865|448424043|FG000|Overall Study|Adverse Event|1|||
124672371|NCT01619865|448424043|FG000|Overall Study|Death|2|||
124672372|NCT01619865|448424043|FG000|Overall Study|subject not able to comply|1|||
124672373|NCT00791999|448424044|FG000|Overall Study|Protocol planed withdrawal|14|||
124672374|NCT00791999|448424045|FG001|Overall Study|Protocol planed withdrawal|11|||
124672375|NCT00791999|448424046|FG002|Overall Study|Protocol planed withdrawal|11|||
124672376|NCT00791999|448424047|FG003|Overall Study|Protocol planed withdrawal|45|||
124672377|NCT00791999|448424044|FG000|Overall Study|Withdrawal by Subject|0|||
124672378|NCT00791999|448424045|FG001|Overall Study|Withdrawal by Subject|1|||
124672379|NCT00791999|448424046|FG002|Overall Study|Withdrawal by Subject|0|||
124672380|NCT00791999|448424047|FG003|Overall Study|Withdrawal by Subject|2|||
124672381|NCT00791999|448424044|FG000|Overall Study|Protocol Violation|3|||
124672382|NCT00791999|448424045|FG001|Overall Study|Protocol Violation|0|||
124672383|NCT00791999|448424046|FG002|Overall Study|Protocol Violation|1|||
124672384|NCT00791999|448424047|FG003|Overall Study|Protocol Violation|0|||
124672385|NCT00791999|448424044|FG000|Overall Study|Adverse Event|3|||
124672386|NCT00791999|448424045|FG001|Overall Study|Adverse Event|3|||
124672387|NCT00791999|448424046|FG002|Overall Study|Adverse Event|7|||
124672388|NCT00791999|448424047|FG003|Overall Study|Adverse Event|3|||
124672389|NCT00791999|448424044|FG000|Overall Study|Lack of Efficacy|0|||
124672390|NCT00791999|448424045|FG001|Overall Study|Lack of Efficacy|1|||
124672391|NCT00791999|448424046|FG002|Overall Study|Lack of Efficacy|0|||
124672392|NCT00791999|448424047|FG003|Overall Study|Lack of Efficacy|2|||
124672393|NCT00791999|448424044|FG000|Overall Study|Reason other than those above|1|||
124672394|NCT00791999|448424045|FG001|Overall Study|Reason other than those above|0|||
124672395|NCT00791999|448424046|FG002|Overall Study|Reason other than those above|1|||
124672396|NCT00791999|448424047|FG003|Overall Study|Reason other than those above|0|||
124672397|NCT05616013|448424048|FG000|Overall Study|Adverse Event|6|||
124672398|NCT05616013|448424049|FG001|Overall Study|Adverse Event|12|||
124672399|NCT05616013|448424050|FG002|Overall Study|Adverse Event|8|||
124672400|NCT05616013|448424051|FG003|Overall Study|Adverse Event|4|||
124672401|NCT05616013|448424052|FG004|Overall Study|Adverse Event|6|||
124672402|NCT05616013|448424053|FG005|Overall Study|Adverse Event|8|||
124672403|NCT05616013|448424054|FG006|Overall Study|Adverse Event|3|||
124672404|NCT05616013|448424055|FG007|Overall Study|Adverse Event|6|||
124672405|NCT05616013|448424056|FG008|Overall Study|Adverse Event|1|||
124672406|NCT05616013|448424048|FG000|Overall Study|Lost to Follow-up|5|||
124672407|NCT05616013|448424049|FG001|Overall Study|Lost to Follow-up|4|||
124672408|NCT05616013|448424050|FG002|Overall Study|Lost to Follow-up|3|||
124672409|NCT05616013|448424051|FG003|Overall Study|Lost to Follow-up|2|||
124672410|NCT05616013|448424052|FG004|Overall Study|Lost to Follow-up|0|||
124672411|NCT05616013|448424053|FG005|Overall Study|Lost to Follow-up|5|||
124672412|NCT05616013|448424054|FG006|Overall Study|Lost to Follow-up|2|||
124672413|NCT05616013|448424055|FG007|Overall Study|Lost to Follow-up|1|||
124672414|NCT05616013|448424056|FG008|Overall Study|Lost to Follow-up|2|||
124672415|NCT05616013|448424048|FG000|Overall Study|Non-compliance with study requirements|2|||
124672416|NCT05616013|448424049|FG001|Overall Study|Non-compliance with study requirements|2|||
124672417|NCT05616013|448424050|FG002|Overall Study|Non-compliance with study requirements|2|||
124672418|NCT05616013|448424051|FG003|Overall Study|Non-compliance with study requirements|3|||
124672419|NCT05616013|448424052|FG004|Overall Study|Non-compliance with study requirements|0|||
124672420|NCT05616013|448424053|FG005|Overall Study|Non-compliance with study requirements|2|||
124672421|NCT05616013|448424054|FG006|Overall Study|Non-compliance with study requirements|1|||
124672422|NCT05616013|448424055|FG007|Overall Study|Non-compliance with study requirements|1|||
124672423|NCT05616013|448424056|FG008|Overall Study|Non-compliance with study requirements|4|||
124672424|NCT05616013|448424048|FG000|Overall Study|Withdrawal by Subject|11|||
124672425|NCT05616013|448424049|FG001|Overall Study|Withdrawal by Subject|9|||
124672426|NCT05616013|448424050|FG002|Overall Study|Withdrawal by Subject|8|||
124672427|NCT05616013|448424051|FG003|Overall Study|Withdrawal by Subject|6|||
124672428|NCT05616013|448424052|FG004|Overall Study|Withdrawal by Subject|3|||
124672429|NCT05616013|448424053|FG005|Overall Study|Withdrawal by Subject|4|||
124672430|NCT05616013|448424054|FG006|Overall Study|Withdrawal by Subject|6|||
124672431|NCT05616013|448424055|FG007|Overall Study|Withdrawal by Subject|5|||
124672432|NCT05616013|448424056|FG008|Overall Study|Withdrawal by Subject|4|||
124672433|NCT05616013|448424048|FG000|Overall Study|Physician Decision|0|||
124672434|NCT05616013|448424049|FG001|Overall Study|Physician Decision|0|||
124672435|NCT05616013|448424050|FG002|Overall Study|Physician Decision|1|||
124672436|NCT05616013|448424051|FG003|Overall Study|Physician Decision|0|||
124672437|NCT05616013|448424052|FG004|Overall Study|Physician Decision|0|||
124672438|NCT05616013|448424053|FG005|Overall Study|Physician Decision|1|||
124672439|NCT05616013|448424054|FG006|Overall Study|Physician Decision|3|||
124672440|NCT05616013|448424055|FG007|Overall Study|Physician Decision|0|||
124672441|NCT05616013|448424056|FG008|Overall Study|Physician Decision|0|||
124672442|NCT05616013|448424048|FG000|Overall Study|Protocol Violation|0|||
124672443|NCT05616013|448424049|FG001|Overall Study|Protocol Violation|0|||
124672444|NCT05616013|448424050|FG002|Overall Study|Protocol Violation|0|||
124672445|NCT05616013|448424051|FG003|Overall Study|Protocol Violation|0|||
124672446|NCT05616013|448424052|FG004|Overall Study|Protocol Violation|0|||
124672447|NCT05616013|448424053|FG005|Overall Study|Protocol Violation|0|||
124672448|NCT05616013|448424054|FG006|Overall Study|Protocol Violation|1|||
124672449|NCT05616013|448424055|FG007|Overall Study|Protocol Violation|0|||
124672450|NCT05616013|448424056|FG008|Overall Study|Protocol Violation|2|||
124672451|NCT05616013|448424048|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
124672452|NCT05616013|448424049|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
124672453|NCT05616013|448424050|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
124672454|NCT05616013|448424051|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
124672455|NCT05616013|448424052|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
124672456|NCT05616013|448424053|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
124672457|NCT05616013|448424054|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
124672458|NCT05616013|448424055|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
124672459|NCT05616013|448424056|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
124672460|NCT05616013|448424048|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
124672461|NCT05616013|448424049|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
124672462|NCT05616013|448424050|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
124672463|NCT05616013|448424051|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
124672464|NCT05616013|448424052|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
124672465|NCT05616013|448424053|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
124672466|NCT05616013|448424054|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
124672467|NCT05616013|448424055|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
124672468|NCT05616013|448424056|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
124672469|NCT05616013|448424048|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
124672470|NCT05616013|448424049|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
124672471|NCT05616013|448424050|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
124672472|NCT05616013|448424051|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
124672473|NCT05616013|448424052|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
124672474|NCT05616013|448424053|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
124672475|NCT05616013|448424054|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
124672476|NCT05616013|448424055|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
124672477|NCT05616013|448424056|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
124672478|NCT05616013|448424048|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
124672479|NCT05616013|448424049|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
124672480|NCT05616013|448424050|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
124672481|NCT05616013|448424051|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
124672482|NCT05616013|448424052|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
124672483|NCT05616013|448424053|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
124672484|NCT05616013|448424054|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
124672485|NCT05616013|448424055|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
124672486|NCT05616013|448424056|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
124672487|NCT05616013|448424048|FG000|Overall Study|Participant Decision, Time Constraints|0|||
124672488|NCT05616013|448424049|FG001|Overall Study|Participant Decision, Time Constraints|1|||
124672489|NCT05616013|448424050|FG002|Overall Study|Participant Decision, Time Constraints|0|||
124672490|NCT05616013|448424051|FG003|Overall Study|Participant Decision, Time Constraints|0|||
124672491|NCT05616013|448424052|FG004|Overall Study|Participant Decision, Time Constraints|0|||
124672492|NCT05616013|448424053|FG005|Overall Study|Participant Decision, Time Constraints|0|||
124672493|NCT05616013|448424054|FG006|Overall Study|Participant Decision, Time Constraints|0|||
124672494|NCT05616013|448424055|FG007|Overall Study|Participant Decision, Time Constraints|0|||
124672495|NCT05616013|448424056|FG008|Overall Study|Participant Decision, Time Constraints|0|||
124672496|NCT05616013|448424048|FG000|Overall Study|Prohibited Concomitant Medication|0|||
124672497|NCT05616013|448424049|FG001|Overall Study|Prohibited Concomitant Medication|0|||
124672498|NCT05616013|448424050|FG002|Overall Study|Prohibited Concomitant Medication|1|||
124672499|NCT05616013|448424051|FG003|Overall Study|Prohibited Concomitant Medication|0|||
124672500|NCT05616013|448424052|FG004|Overall Study|Prohibited Concomitant Medication|0|||
124672501|NCT05616013|448424053|FG005|Overall Study|Prohibited Concomitant Medication|0|||
124672502|NCT05616013|448424054|FG006|Overall Study|Prohibited Concomitant Medication|0|||
124672503|NCT05616013|448424055|FG007|Overall Study|Prohibited Concomitant Medication|0|||
124672504|NCT05616013|448424056|FG008|Overall Study|Prohibited Concomitant Medication|0|||
124672505|NCT05616013|448424048|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
124672506|NCT05616013|448424049|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
124672507|NCT05616013|448424050|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
124672508|NCT05616013|448424051|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
124672509|NCT05616013|448424052|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
124672510|NCT05616013|448424053|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
124672511|NCT05616013|448424054|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
124672512|NCT05616013|448424055|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
124672513|NCT05616013|448424056|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
124672514|NCT05616013|448424048|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
124672515|NCT05616013|448424049|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
124672516|NCT05616013|448424050|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
124672517|NCT05616013|448424051|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
124672518|NCT05616013|448424052|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
124672519|NCT05616013|448424053|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
124672520|NCT05616013|448424054|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
124672521|NCT05616013|448424055|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
124672522|NCT05616013|448424056|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
124672523|NCT05616013|448424048|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
124672524|NCT05616013|448424049|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
124672525|NCT05616013|448424050|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
124672526|NCT05616013|448424051|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
124672527|NCT05616013|448424052|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
124672528|NCT05616013|448424053|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
124672529|NCT05616013|448424054|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
124672530|NCT05616013|448424055|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
124672531|NCT05616013|448424056|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
124672532|NCT05616013|448424048|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
124672533|NCT05616013|448424049|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
124672534|NCT05616013|448424050|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
124672535|NCT05616013|448424051|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
124672536|NCT05616013|448424052|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
124672537|NCT05616013|448424053|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
124672538|NCT05616013|448424054|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
124672539|NCT05616013|448424055|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
124672540|NCT05616013|448424056|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
124672541|NCT05616013|448424048|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
124672542|NCT05616013|448424049|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
124672543|NCT05616013|448424050|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
124672544|NCT05616013|448424051|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
124672545|NCT05616013|448424052|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
124672546|NCT05616013|448424053|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
124672547|NCT05616013|448424054|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
124672548|NCT05616013|448424055|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
124672549|NCT05616013|448424056|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
124672550|NCT05116202|448424057|FG000|Overall Study|Study Terminated by Sponsor|21|||
124672551|NCT05116202|448424058|FG001|Overall Study|Study Terminated by Sponsor|38|||
124672552|NCT05116202|448424059|FG002|Overall Study|Study Terminated by Sponsor|17|||
124672553|NCT05116202|448424060|FG003|Overall Study|Study Terminated by Sponsor|18|||
124672554|NCT05116202|448424061|FG004|Overall Study|Study Terminated by Sponsor|0|||
124672555|NCT05116202|448424057|FG000|Overall Study|Withdrawal by Subject|0|||
124672556|NCT05116202|448424058|FG001|Overall Study|Withdrawal by Subject|1|||
124672557|NCT05116202|448424059|FG002|Overall Study|Withdrawal by Subject|1|||
124672558|NCT05116202|448424060|FG003|Overall Study|Withdrawal by Subject|1|||
124672559|NCT05116202|448424061|FG004|Overall Study|Withdrawal by Subject|1|||
124672560|NCT05116202|448424057|FG000|Overall Study|Lost to Follow-up|0|||
124672561|NCT05116202|448424058|FG001|Overall Study|Lost to Follow-up|0|||
124672562|NCT05116202|448424059|FG002|Overall Study|Lost to Follow-up|0|||
124672563|NCT05116202|448424060|FG003|Overall Study|Lost to Follow-up|0|||
124672564|NCT05116202|448424061|FG004|Overall Study|Lost to Follow-up|2|||
124672565|NCT05116202|448424057|FG000|Overall Study|Death|1|||
124672566|NCT05116202|448424058|FG001|Overall Study|Death|1|||
124672567|NCT05116202|448424059|FG002|Overall Study|Death|2|||
124672568|NCT05116202|448424060|FG003|Overall Study|Death|1|||
124672569|NCT05116202|448424061|FG004|Overall Study|Death|5|||
124672570|NCT05158140|448424074|FG000|Overall Study|Death|0|||
124672571|NCT05158140|448424075|FG001|Overall Study|Death|0|||
124672572|NCT05158140|448424076|FG002|Overall Study|Death|0|||
124672573|NCT05158140|448424077|FG003|Overall Study|Death|1|||
124672574|NCT05158140|448424074|FG000|Overall Study|Lost to Follow-up|3|||
124672575|NCT05158140|448424075|FG001|Overall Study|Lost to Follow-up|6|||
124672576|NCT05158140|448424076|FG002|Overall Study|Lost to Follow-up|4|||
124672577|NCT05158140|448424077|FG003|Overall Study|Lost to Follow-up|3|||
124672578|NCT05158140|448424074|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124672579|NCT05158140|448424075|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124672580|NCT05158140|448424076|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
124672581|NCT05158140|448424077|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
124672582|NCT05158140|448424074|FG000|Overall Study|Withdrawal by Subject|3|||
124672583|NCT05158140|448424075|FG001|Overall Study|Withdrawal by Subject|7|||
124672584|NCT05158140|448424076|FG002|Overall Study|Withdrawal by Subject|3|||
124672585|NCT05158140|448424077|FG003|Overall Study|Withdrawal by Subject|7|||
124672586|NCT01526785|448424078|FG000|Overall Study|Study Terminated by Sponsor|8|||
124672587|NCT01526785|448424078|FG000|Overall Study|Death|2|||
124672588|NCT01526785|448424078|FG000|Overall Study|Physician Decision|1|||
124672589|NCT01526785|448424078|FG000|Overall Study|Withdrawal by Subject|2|||
124672590|NCT02007720|448424079|FG000|Overall Study|Withdrawal by Subject|9|||
124672591|NCT02007720|448424080|FG001|Overall Study|Withdrawal by Subject|11|||
124672592|NCT02007720|448424079|FG000|Overall Study|study terminated by sponsor|58|||
124672593|NCT02007720|448424080|FG001|Overall Study|study terminated by sponsor|54|||
124672594|NCT02007720|448424079|FG000|Overall Study|technical problem|4|||
124672595|NCT02007720|448424080|FG001|Overall Study|technical problem|2|||
124672596|NCT02007720|448424079|FG000|Overall Study|patient followd less than 165 days|11|||
124672597|NCT02007720|448424080|FG001|Overall Study|patient followd less than 165 days|5|||
124672598|NCT04194814|448424083|FG000|Overall Study|Physician Decision|3|||
124672599|NCT04194814|448424084|FG001|Overall Study|Physician Decision|0|||
124672600|NCT04194814|448424083|FG000|Overall Study|Withdrawal by Subject|0|||
124672601|NCT04194814|448424084|FG001|Overall Study|Withdrawal by Subject|2|||
124711982|NCT00688467|448570700|FG001|Treatment Period 2|Protocol Violation|1|||
124711983|NCT00688467|448570699|FG000|Treatment Period 2|Adverse Event|0|||
124711984|NCT00688467|448570700|FG001|Treatment Period 2|Adverse Event|1|||
124711985|NCT00690794|448570704|FG000|Overall Study|Adverse Event|12|||
124672602|NCT04113694|448425821|FG000|Overall Study|Adverse Event|2|||
124672603|NCT04113694|448425821|FG000|Overall Study|Lost to Follow-up|2|||
124672604|NCT04113694|448425821|FG000|Overall Study|Withdrawal by Subject|6|||
124672605|NCT04113694|448425821|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
124672606|NCT03638128|448425826|FG000|Overall Study|Withdrawal by Subject|1|||
124672607|NCT03638128|448425827|FG001|Overall Study|Withdrawal by Subject|7|||
124672608|NCT03638128|448425828|FG002|Overall Study|Withdrawal by Subject|6|||
124672609|NCT03638128|448425826|FG000|Overall Study|Sponsor Decision|15|||
124672610|NCT03638128|448425827|FG001|Overall Study|Sponsor Decision|12|||
124672611|NCT03638128|448425828|FG002|Overall Study|Sponsor Decision|19|||
124672612|NCT03638128|448425826|FG000|Overall Study|Lost to Follow-up|0|||
124672613|NCT03638128|448425827|FG001|Overall Study|Lost to Follow-up|0|||
124672614|NCT03638128|448425828|FG002|Overall Study|Lost to Follow-up|1|||
124672615|NCT00329108|448425829|FG000|Overall Study|Adverse Event|2|||
124672616|NCT00329108|448425830|FG001|Overall Study|Adverse Event|2|||
124672617|NCT00329108|448425829|FG000|Overall Study|Lack of Efficacy|3|||
124672618|NCT00329108|448425830|FG001|Overall Study|Lack of Efficacy|3|||
124672619|NCT00329108|448425829|FG000|Overall Study|Withdrawal by Subject|0|||
124672620|NCT00329108|448425830|FG001|Overall Study|Withdrawal by Subject|2|||
124672621|NCT00329108|448425829|FG000|Overall Study|symptomatic deterioration|1|||
124672622|NCT00329108|448425830|FG001|Overall Study|symptomatic deterioration|1|||
124672623|NCT00329108|448425829|FG000|Overall Study|Subject no longer willing to participate|2|||
124672624|NCT00329108|448425830|FG001|Overall Study|Subject no longer willing to participate|2|||
124672625|NCT00329108|448425829|FG000|Overall Study|study terminated by sponsor|1|||
124672626|NCT00329108|448425830|FG001|Overall Study|study terminated by sponsor|0|||
124672627|NCT00329108|448425829|FG000|Overall Study|withdrew patient after SAE resolved|1|||
124672628|NCT00329108|448425830|FG001|Overall Study|withdrew patient after SAE resolved|0|||
124672629|NCT00329108|448425829|FG000|Overall Study|Protocol Violation|0|||
124672630|NCT00329108|448425830|FG001|Overall Study|Protocol Violation|2|||
124672631|NCT01389232|448425831|FG000|Overall Study|Had scaffold removed|15|||
124672632|NCT01389232|448425831|FG000|Overall Study|Personal reasons|2|||
124672633|NCT01389232|448425831|FG000|Overall Study|Adverse Event|1|||
124672634|NCT01389232|448425831|FG000|Overall Study|Death|1|||
124672635|NCT00945243|448425833|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
124672636|NCT02990000|448425834|FG000|Overall Study|Failed to provide data beyond baseline|36|||
124672637|NCT02990000|448425835|FG001|Overall Study|Failed to provide data beyond baseline|34|||
124672638|NCT04969289|448425836|FG000|Overall Study|Lost to Follow-up|13|||
124672639|NCT04969289|448425837|FG001|Overall Study|Lost to Follow-up|9|||
124672640|NCT00557466|448425838|FG000|Overall Study|Adverse Event|3|||
124672641|NCT00557466|448425839|FG001|Overall Study|Adverse Event|1|||
124672642|NCT00557466|448425840|FG002|Overall Study|Adverse Event|4|||
124672643|NCT00557466|448425841|FG003|Overall Study|Adverse Event|1|||
124672644|NCT00557466|448425842|FG004|Overall Study|Adverse Event|2|||
124672645|NCT00557466|448425843|FG005|Overall Study|Adverse Event|4|||
124672646|NCT00557466|448425838|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124672647|NCT00557466|448425839|FG001|Overall Study|Abnormal laboratory value(s)|2|||
124672648|NCT00557466|448425840|FG002|Overall Study|Abnormal laboratory value(s)|0|||
124672649|NCT00557466|448425841|FG003|Overall Study|Abnormal laboratory value(s)|0|||
124672650|NCT00557466|448425842|FG004|Overall Study|Abnormal laboratory value(s)|0|||
124672651|NCT00557466|448425843|FG005|Overall Study|Abnormal laboratory value(s)|0|||
124672652|NCT00557466|448425838|FG000|Overall Study|Protocol deviation|0|||
124672653|NCT00557466|448425839|FG001|Overall Study|Protocol deviation|1|||
124672654|NCT00557466|448425840|FG002|Overall Study|Protocol deviation|0|||
124672655|NCT00557466|448425841|FG003|Overall Study|Protocol deviation|2|||
124672656|NCT00557466|448425842|FG004|Overall Study|Protocol deviation|0|||
124672657|NCT00557466|448425843|FG005|Overall Study|Protocol deviation|0|||
124672658|NCT00557466|448425838|FG000|Overall Study|Subject withdrew consent|0|||
124672659|NCT00557466|448425839|FG001|Overall Study|Subject withdrew consent|0|||
124672660|NCT00557466|448425840|FG002|Overall Study|Subject withdrew consent|0|||
124672661|NCT00557466|448425841|FG003|Overall Study|Subject withdrew consent|0|||
124672662|NCT00557466|448425842|FG004|Overall Study|Subject withdrew consent|1|||
124672663|NCT00557466|448425843|FG005|Overall Study|Subject withdrew consent|2|||
124672664|NCT00557466|448425838|FG000|Overall Study|Administrative problems|0|||
124672665|NCT00557466|448425839|FG001|Overall Study|Administrative problems|1|||
124672666|NCT00557466|448425840|FG002|Overall Study|Administrative problems|1|||
124672667|NCT00557466|448425841|FG003|Overall Study|Administrative problems|0|||
124672668|NCT00557466|448425842|FG004|Overall Study|Administrative problems|0|||
124711986|NCT00690794|448570705|FG001|Overall Study|Adverse Event|10|||
124672669|NCT00557466|448425843|FG005|Overall Study|Administrative problems|0|||
124672670|NCT00557466|448425838|FG000|Overall Study|Abnormal test procedure results|0|||
124672671|NCT00557466|448425839|FG001|Overall Study|Abnormal test procedure results|0|||
124672672|NCT00557466|448425840|FG002|Overall Study|Abnormal test procedure results|1|||
124672673|NCT00557466|448425841|FG003|Overall Study|Abnormal test procedure results|0|||
124672674|NCT00557466|448425842|FG004|Overall Study|Abnormal test procedure results|0|||
124672675|NCT00557466|448425843|FG005|Overall Study|Abnormal test procedure results|0|||
124672676|NCT00557466|448425838|FG000|Overall Study|Lost to Follow-up|0|||
124672677|NCT00557466|448425839|FG001|Overall Study|Lost to Follow-up|0|||
124672678|NCT00557466|448425840|FG002|Overall Study|Lost to Follow-up|0|||
124672679|NCT00557466|448425841|FG003|Overall Study|Lost to Follow-up|1|||
124672680|NCT00557466|448425842|FG004|Overall Study|Lost to Follow-up|0|||
124672681|NCT00557466|448425843|FG005|Overall Study|Lost to Follow-up|0|||
124672682|NCT01307787|448425850|FG000|Overall Study|Withdrawal by Subject|2|||
124672683|NCT01307787|448425851|FG001|Overall Study|Withdrawal by Subject|0|||
124672684|NCT00789321|448425855|FG000|Overall Study|Adverse Event|0|||
124672685|NCT00789321|448425856|FG001|Overall Study|Adverse Event|1|||
124672686|NCT01965327|448425859|FG000|Overall Study|Physician Decision|2|||
124672687|NCT03342001|448425860|FG000|Overall Study|Adverse Event|1|||
124672688|NCT03342001|448425860|FG000|Overall Study|Lost to Follow-up|1|||
124672689|NCT04161391|448425863|FG000|Overall Study|Adverse Event|0|||
124672690|NCT04161391|448425864|FG001|Overall Study|Adverse Event|1|||
124672691|NCT04161391|448425865|FG002|Overall Study|Adverse Event|0|||
124672692|NCT04161391|448425866|FG003|Overall Study|Adverse Event|1|||
124672693|NCT04161391|448425867|FG004|Overall Study|Adverse Event|0|||
124672694|NCT04161391|448425868|FG005|Overall Study|Adverse Event|0|||
124672695|NCT04161391|448425869|FG006|Overall Study|Adverse Event|0|||
124672696|NCT04161391|448425870|FG007|Overall Study|Adverse Event|3|||
124672697|NCT04161391|448425871|FG008|Overall Study|Adverse Event|0|||
124672698|NCT04161391|448425863|FG000|Overall Study|Death|0|||
124672699|NCT04161391|448425864|FG001|Overall Study|Death|0|||
124672700|NCT04161391|448425865|FG002|Overall Study|Death|0|||
124672701|NCT04161391|448425866|FG003|Overall Study|Death|0|||
124672702|NCT04161391|448425867|FG004|Overall Study|Death|0|||
124672703|NCT04161391|448425868|FG005|Overall Study|Death|0|||
124672704|NCT04161391|448425869|FG006|Overall Study|Death|0|||
124672705|NCT04161391|448425870|FG007|Overall Study|Death|1|||
124672706|NCT04161391|448425871|FG008|Overall Study|Death|0|||
124672707|NCT04161391|448425863|FG000|Overall Study|Physician Decision|0|||
124672708|NCT04161391|448425864|FG001|Overall Study|Physician Decision|0|||
124672709|NCT04161391|448425865|FG002|Overall Study|Physician Decision|1|||
124672710|NCT04161391|448425866|FG003|Overall Study|Physician Decision|2|||
124672711|NCT04161391|448425867|FG004|Overall Study|Physician Decision|0|||
124672712|NCT04161391|448425868|FG005|Overall Study|Physician Decision|0|||
124672713|NCT04161391|448425869|FG006|Overall Study|Physician Decision|2|||
124672714|NCT04161391|448425870|FG007|Overall Study|Physician Decision|0|||
124672715|NCT04161391|448425871|FG008|Overall Study|Physician Decision|0|||
124672716|NCT04161391|448425863|FG000|Overall Study|Progressive Disease|4|||
124672717|NCT04161391|448425864|FG001|Overall Study|Progressive Disease|3|||
124672718|NCT04161391|448425865|FG002|Overall Study|Progressive Disease|3|||
124672719|NCT04161391|448425866|FG003|Overall Study|Progressive Disease|5|||
124672720|NCT04161391|448425867|FG004|Overall Study|Progressive Disease|3|||
124672721|NCT04161391|448425868|FG005|Overall Study|Progressive Disease|3|||
124672722|NCT04161391|448425869|FG006|Overall Study|Progressive Disease|5|||
124672723|NCT04161391|448425870|FG007|Overall Study|Progressive Disease|2|||
124672724|NCT04161391|448425871|FG008|Overall Study|Progressive Disease|2|||
124672725|NCT01162343|448425874|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
124672726|NCT01162343|448425874|FG000|Overall Study|Refused psychiatrist assessment|12|||
124672727|NCT03964207|448425875|FG000|First Treatment|Withdrawal by Subject|1|||
124672728|NCT03964207|448425876|FG001|First Treatment|Withdrawal by Subject|2|||
124672729|NCT03964207|448425875|FG000|First Treatment|Protocol Violation|1|||
124672730|NCT03964207|448425876|FG001|First Treatment|Protocol Violation|0|||
124672731|NCT03964207|448425875|FG000|First Treatment|Lost to Follow-up|1|||
124672732|NCT03964207|448425876|FG001|First Treatment|Lost to Follow-up|0|||
124672733|NCT03964207|448425875|FG000|Second Treatment|Lost to Follow-up|0|||
124672734|NCT03964207|448425876|FG001|Second Treatment|Lost to Follow-up|1|||
124672735|NCT03964207|448425875|FG000|Second Treatment|Adverse Event|1|||
124672736|NCT03964207|448425876|FG001|Second Treatment|Adverse Event|2|||
124672737|NCT01699750|448425884|FG000|Overall Study|Withdrew Consent|0|||
124672738|NCT01699750|448425885|FG001|Overall Study|Withdrew Consent|1|||
124672739|NCT01699750|448425884|FG000|Overall Study|Other|0|||
124672740|NCT01699750|448425885|FG001|Overall Study|Other|2|||
124672741|NCT02737358|448425886|FG000|Overall Study|Withdrawal by Subject|7|||
124672742|NCT02737358|448425887|FG001|Overall Study|Withdrawal by Subject|12|||
124672743|NCT02737358|448425886|FG000|Overall Study|Lost to Follow-up|2|||
124672744|NCT02737358|448425887|FG001|Overall Study|Lost to Follow-up|3|||
124672745|NCT02119299|448425888|FG000|Overall Study|Withdrawal by Subject|7|||
124672746|NCT02119299|448425888|FG000|Overall Study|Lack of Efficacy|1|||
124672747|NCT02119299|448425888|FG000|Overall Study|Pregnancy|1|||
124672748|NCT00744939|448425889|FG000|Overall Study|Withdrawal by Subject|9|||
124672749|NCT00744939|448425889|FG000|Overall Study|Protocol Violation|13|||
124672750|NCT00744939|448425889|FG000|Overall Study|Death|24|||
124672751|NCT00744939|448425889|FG000|Overall Study|distance|4|||
124672752|NCT00744939|448425889|FG000|Overall Study|Lost to Follow-up|12|||
124672753|NCT00744939|448425889|FG000|Overall Study|Medical history exclusionary|1|||
124672754|NCT00744939|448425889|FG000|Overall Study|Did not receive Magnevist|7|||
124672755|NCT00744939|448425889|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
124672756|NCT00744939|448425889|FG000|Overall Study|coma|1|||
124672757|NCT00744939|448425889|FG000|Overall Study|incorrect race|1|||
124672758|NCT02452047|448425890|FG000|Overall Study|Adverse Event|0|||
124672759|NCT02452047|448425891|FG001|Overall Study|Adverse Event|1|||
124672760|NCT02452047|448425892|FG002|Overall Study|Adverse Event|1|||
124672761|NCT02452047|448425890|FG000|Overall Study|Death|1|||
124672762|NCT02452047|448425891|FG001|Overall Study|Death|3|||
124672763|NCT02452047|448425892|FG002|Overall Study|Death|1|||
124672764|NCT02452047|448425890|FG000|Overall Study|Physician Decision|1|||
124672765|NCT02452047|448425891|FG001|Overall Study|Physician Decision|0|||
124672766|NCT02452047|448425892|FG002|Overall Study|Physician Decision|0|||
124672767|NCT02452047|448425890|FG000|Overall Study|Lost to Follow-up|1|||
124672768|NCT02452047|448425891|FG001|Overall Study|Lost to Follow-up|1|||
124672769|NCT02452047|448425892|FG002|Overall Study|Lost to Follow-up|0|||
124672770|NCT02452047|448425890|FG000|Overall Study|Withdrawal by Subject|1|||
124672771|NCT02452047|448425891|FG001|Overall Study|Withdrawal by Subject|0|||
124672772|NCT02452047|448425892|FG002|Overall Study|Withdrawal by Subject|0|||
124672773|NCT00288912|448425893|FG000|Overall Study|Developed exclusion criterion|4|||
124672774|NCT00288912|448425894|FG001|Overall Study|Developed exclusion criterion|6|||
124672775|NCT00288912|448425895|FG002|Overall Study|Developed exclusion criterion|7|||
124672776|NCT00288912|448425893|FG000|Overall Study|Lost to Follow-up|9|||
124672777|NCT00288912|448425894|FG001|Overall Study|Lost to Follow-up|6|||
124672778|NCT00288912|448425895|FG002|Overall Study|Lost to Follow-up|9|||
124672779|NCT00288912|448425893|FG000|Overall Study|Withdrawal by Subject|4|||
124672780|NCT00288912|448425894|FG001|Overall Study|Withdrawal by Subject|5|||
124672781|NCT00288912|448425895|FG002|Overall Study|Withdrawal by Subject|12|||
124672782|NCT02026141|448425899|FG000|Overall Study|Protocol Violation|0|||
124672783|NCT02026141|448425900|FG001|Overall Study|Protocol Violation|1|||
124672784|NCT00728494|448425905|FG000|Overall Study|Adverse Event|7|||
124672785|NCT00728494|448425906|FG001|Overall Study|Adverse Event|0|||
124672786|NCT00728494|448425905|FG000|Overall Study|Withdrawal by Subject|0|||
124672787|NCT00728494|448425906|FG001|Overall Study|Withdrawal by Subject|2|||
124672788|NCT00728494|448425905|FG000|Overall Study|Lack of Efficacy|2|||
124672789|NCT00728494|448425906|FG001|Overall Study|Lack of Efficacy|4|||
124672790|NCT00728494|448425905|FG000|Overall Study|No data available|0|||
124672791|NCT00728494|448425906|FG001|Overall Study|No data available|1|||
124672792|NCT03439137|448425907|FG000|Overall Study|Adverse Event|16|||
124672793|NCT03439137|448425908|FG001|Overall Study|Adverse Event|12|||
124672794|NCT03439137|448425907|FG000|Overall Study|Physician Decision|0|||
124672795|NCT03439137|448425908|FG001|Overall Study|Physician Decision|5|||
124672796|NCT03439137|448425907|FG000|Overall Study|Withdrawal by Subject|14|||
124672797|NCT03439137|448425908|FG001|Overall Study|Withdrawal by Subject|4|||
124672798|NCT03439137|448425907|FG000|Overall Study|Conducting rescue therapy|2|||
124672799|NCT03439137|448425908|FG001|Overall Study|Conducting rescue therapy|1|||
124672800|NCT03439137|448425907|FG000|Overall Study|Difficult to control Hb|10|||
124672801|NCT03439137|448425908|FG001|Overall Study|Difficult to control Hb|2|||
124672802|NCT03439137|448425907|FG000|Overall Study|Initiation of a renal transplant|0|||
124672803|NCT03439137|448425908|FG001|Overall Study|Initiation of a renal transplant|2|||
124672804|NCT00748241|448425909|FG000|Overall Study|Implant failure|1|||
124672805|NCT00748241|448425909|FG000|Overall Study|Lost to Follow-up|5|||
124672806|NCT00748241|448425909|FG000|Overall Study|Death|2|||
124672807|NCT00888654|448425913|FG000|Overall Study|Problems swallowing oral meds.|1|||
124672808|NCT00888654|448425913|FG000|Overall Study|Not enough oral meds before surgery|3|||
124672809|NCT00888654|448425913|FG000|Overall Study|Surgery aborted|2|||
124672810|NCT00888654|448425913|FG000|Overall Study|Withdrawal by Subject|1|||
124672811|NCT00888654|448425913|FG000|Overall Study|Inelig. due to contraindication of med|1|||
124672812|NCT00888654|448425913|FG000|Overall Study|Change in surg date|1|||
124672813|NCT00888654|448425913|FG000|Overall Study|Stopped meds due to headaches|1|||
124672814|NCT01663402|448425916|FG000|Overall Study|Randomized but not treated|19|||
124672815|NCT01663402|448425917|FG001|Overall Study|Randomized but not treated|11|||
124672816|NCT01663402|448425916|FG000|Overall Study|Adverse Event|347|||
124672817|NCT01663402|448425917|FG001|Overall Study|Adverse Event|362|||
124672818|NCT01663402|448425916|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
124672819|NCT01663402|448425917|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
124672820|NCT01663402|448425916|FG000|Overall Study|Poor compliance to protocol|529|||
124672821|NCT01663402|448425917|FG001|Overall Study|Poor compliance to protocol|454|||
124672822|NCT01663402|448425916|FG000|Overall Study|Physician Decision|77|||
124672823|NCT01663402|448425917|FG001|Overall Study|Physician Decision|62|||
124672824|NCT01663402|448425916|FG000|Overall Study|Site terminated by sponsor|1|||
124672825|NCT01663402|448425917|FG001|Overall Study|Site terminated by sponsor|3|||
124672826|NCT01663402|448425916|FG000|Overall Study|Participant moved|139|||
124672827|NCT01663402|448425917|FG001|Overall Study|Participant moved|104|||
124672828|NCT01663402|448425916|FG000|Overall Study|Withdrawal by Subject|118|||
124672829|NCT01663402|448425917|FG001|Overall Study|Withdrawal by Subject|91|||
124672830|NCT01663402|448425916|FG000|Overall Study|Related to study drug administration|96|||
124672831|NCT01663402|448425917|FG001|Overall Study|Related to study drug administration|105|||
124672832|NCT01663402|448425916|FG000|Overall Study|Lost to Follow-up|17|||
124672833|NCT01663402|448425917|FG001|Overall Study|Lost to Follow-up|15|||
124672834|NCT01663402|448425916|FG000|Overall Study|Other than specified above|172|||
124672835|NCT01663402|448425917|FG001|Overall Study|Other than specified above|147|||
124672836|NCT03575702|448425920|FG000|Overall Study|Withdrawal by Subject|1|||
124672837|NCT03575702|448425921|FG001|Overall Study|Withdrawal by Subject|1|||
124672838|NCT03575702|448425920|FG000|Overall Study|Lost to Follow-up|1|||
124672839|NCT03575702|448425921|FG001|Overall Study|Lost to Follow-up|2|||
124672840|NCT03575702|448425920|FG000|Overall Study|Protocol Violation|0|||
124672841|NCT03575702|448425921|FG001|Overall Study|Protocol Violation|1|||
124672842|NCT03575702|448425920|FG000|Overall Study|Patient non compliance|4|||
124672843|NCT03575702|448425921|FG001|Overall Study|Patient non compliance|0|||
124672844|NCT02495389|448425922|FG000|Overall Study|Withdrawal by Subject|40|||
124672845|NCT01802385|448425924|FG000|Overall Study|Death|106|||
124672846|NCT01802385|448425925|FG001|Overall Study|Death|120|||
124672847|NCT03834493|448425926|FG000|Overall Study|Participants Ongoing|311|||
124672848|NCT03834493|448425927|FG001|Overall Study|Participants Ongoing|324|||
124672849|NCT03834493|448425926|FG000|Overall Study|Withdrawal by Subject|20|||
124672850|NCT03834493|448425927|FG001|Overall Study|Withdrawal by Subject|17|||
124672851|NCT03834493|448425926|FG000|Overall Study|Physician Decision|1|||
124672852|NCT03834493|448425927|FG001|Overall Study|Physician Decision|0|||
124672853|NCT03834493|448425926|FG000|Overall Study|Death|289|||
124672854|NCT03834493|448425927|FG001|Overall Study|Death|282|||
124672855|NCT05559905|448425928|FG000|Overall Study|Withdrawal by Subject|1|||
124672856|NCT05559905|448425929|FG001|Overall Study|Withdrawal by Subject|0|||
124672857|NCT05559905|448425930|FG002|Overall Study|Withdrawal by Subject|0|||
124672858|NCT05559905|448425928|FG000|Overall Study|Not Reported|1|||
124672859|NCT05559905|448425929|FG001|Overall Study|Not Reported|0|||
124672860|NCT05559905|448425930|FG002|Overall Study|Not Reported|0|||
124672861|NCT04003103|448425931|FG000|Overall Study|Death|1|||
124672862|NCT04003103|448425932|FG001|Overall Study|Death|0|||
124672863|NCT04003103|448425933|FG002|Overall Study|Death|0|||
124672864|NCT04003103|448425931|FG000|Overall Study|Lost to Follow-up|4|||
124672865|NCT04003103|448425932|FG001|Overall Study|Lost to Follow-up|3|||
124672866|NCT04003103|448425933|FG002|Overall Study|Lost to Follow-up|2|||
124672867|NCT04003103|448425931|FG000|Overall Study|Withdrawal by Subject|10|||
124672868|NCT04003103|448425932|FG001|Overall Study|Withdrawal by Subject|1|||
124672869|NCT04003103|448425933|FG002|Overall Study|Withdrawal by Subject|1|||
124672870|NCT04003103|448425931|FG000|Overall Study|Status not recorded|0|||
124672871|NCT04003103|448425932|FG001|Overall Study|Status not recorded|2|||
124672872|NCT04003103|448425933|FG002|Overall Study|Status not recorded|0|||
124672873|NCT03829462|448425935|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
124672874|NCT03829462|448425936|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
124672875|NCT03829462|448425935|FG000|Overall Study|No treatment due to progression disease|0|||
124672876|NCT03829462|448425936|FG001|Overall Study|No treatment due to progression disease|1|||
124672877|NCT01494818|448425939|FG000|Overall Study|Relocation|1|||
124672878|NCT01494818|448425940|FG001|Overall Study|Relocation|2|||
124672879|NCT01494818|448425939|FG000|Overall Study|Lost to Follow-up|1|||
124672880|NCT01494818|448425940|FG001|Overall Study|Lost to Follow-up|0|||
124672881|NCT01077323|448425941|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
124672882|NCT01077323|448425942|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
124672883|NCT01077323|448425943|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
124672884|NCT01077323|448425941|FG000|Overall Study|Dispensing of drug in baseline period|0|||
124672885|NCT01077323|448425942|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
124672886|NCT01077323|448425943|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
124672887|NCT01077323|448425941|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
124672888|NCT01077323|448425942|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
124672889|NCT01077323|448425943|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
124672890|NCT01710020|448425944|FG000|Period 1|Protocol Violation|1|||
124672891|NCT00427908|448425945|FG000|Primary Phase|Lost to Follow-up|4|||
124672892|NCT00427908|448425946|FG001|Primary Phase|Lost to Follow-up|0|||
124672893|NCT00427908|448425947|FG002|Primary Phase|Lost to Follow-up|2|||
124672894|NCT00427908|448425948|FG003|Primary Phase|Lost to Follow-up|0|||
124672895|NCT00427908|448425945|FG000|Primary Phase|Withdrawal by Subject|1|||
124672896|NCT00427908|448425946|FG001|Primary Phase|Withdrawal by Subject|2|||
124672897|NCT00427908|448425947|FG002|Primary Phase|Withdrawal by Subject|1|||
124672898|NCT00427908|448425948|FG003|Primary Phase|Withdrawal by Subject|0|||
124672899|NCT00427908|448425945|FG000|Primary Phase|Adverse Event|0|||
124672900|NCT00427908|448425946|FG001|Primary Phase|Adverse Event|1|||
124672901|NCT00427908|448425947|FG002|Primary Phase|Adverse Event|0|||
124672902|NCT00427908|448425948|FG003|Primary Phase|Adverse Event|0|||
124672903|NCT02984982|448425949|FG000|Overall Study|Adverse Event|2|||
124672904|NCT02984982|448425950|FG001|Overall Study|Adverse Event|5|||
124672905|NCT02984982|448425949|FG000|Overall Study|Poor Compliance to Protocol|4|||
124672906|NCT02984982|448425950|FG001|Overall Study|Poor Compliance to Protocol|4|||
124672907|NCT02984982|448425949|FG000|Overall Study|Withdrawal by Subject|2|||
124672908|NCT02984982|448425950|FG001|Overall Study|Withdrawal by Subject|0|||
124672909|NCT02984982|448425949|FG000|Overall Study|Randomized but not treated|0|||
124672910|NCT02984982|448425950|FG001|Overall Study|Randomized but not treated|1|||
124672911|NCT02153918|448425951|FG000|Overall Study|Refused further treatment|1|||
124672912|NCT02616783|448425952|FG000|Overall Study|Randomized but Not Treated|1|||
124672913|NCT02616783|448425953|FG001|Overall Study|Randomized but Not Treated|0|||
124672914|NCT02616783|448425952|FG000|Overall Study|Adverse Event|1|||
124672915|NCT02616783|448425953|FG001|Overall Study|Adverse Event|0|||
124672916|NCT02616783|448425952|FG000|Overall Study|Death|1|||
124672917|NCT02616783|448425953|FG001|Overall Study|Death|0|||
124672918|NCT02616783|448425952|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124672919|NCT02616783|448425953|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124672920|NCT02616783|448425952|FG000|Overall Study|Protocol Violation|1|||
124672921|NCT02616783|448425953|FG001|Overall Study|Protocol Violation|1|||
124672922|NCT02616783|448425952|FG000|Overall Study|Withdrew Consent|1|||
124672923|NCT02616783|448425953|FG001|Overall Study|Withdrew Consent|1|||
124672924|NCT04344301|448425954|FG000|Overall Study|Withdrawal by Subject|1|||
124672925|NCT04344301|448425955|FG001|Overall Study|Withdrawal by Subject|0|||
124672926|NCT04344301|448425954|FG000|Overall Study|Death|0|||
124672927|NCT04344301|448425955|FG001|Overall Study|Death|1|||
124672928|NCT01747499|448425956|FG000|Overall Study|Steroid refractory aGvHD|1|||
124672929|NCT01747499|448425957|FG001|Overall Study|Steroid refractory aGvHD|0|||
124672930|NCT01747499|448425958|FG002|Overall Study|Steroid refractory aGvHD|0|||
124672931|NCT01747499|448425959|FG003|Overall Study|Steroid refractory aGvHD|1|||
124672932|NCT01747499|448425960|FG004|Overall Study|Steroid refractory aGvHD|4|||
124672933|NCT01747499|448425956|FG000|Overall Study|Physician Decision|0|||
124672934|NCT01747499|448425957|FG001|Overall Study|Physician Decision|1|||
124672935|NCT01747499|448425958|FG002|Overall Study|Physician Decision|0|||
124672936|NCT01747499|448425959|FG003|Overall Study|Physician Decision|0|||
124672937|NCT01747499|448425960|FG004|Overall Study|Physician Decision|2|||
124672938|NCT01747499|448425956|FG000|Overall Study|Death|0|||
124672939|NCT01747499|448425957|FG001|Overall Study|Death|0|||
124672940|NCT01747499|448425958|FG002|Overall Study|Death|0|||
124672941|NCT01747499|448425959|FG003|Overall Study|Death|1|||
124672942|NCT01747499|448425960|FG004|Overall Study|Death|1|||
124672943|NCT01747499|448425956|FG000|Overall Study|Withdrawal by Subject|0|||
124672944|NCT01747499|448425957|FG001|Overall Study|Withdrawal by Subject|0|||
124672945|NCT01747499|448425958|FG002|Overall Study|Withdrawal by Subject|0|||
124672946|NCT01747499|448425959|FG003|Overall Study|Withdrawal by Subject|0|||
124672947|NCT01747499|448425960|FG004|Overall Study|Withdrawal by Subject|6|||
124672948|NCT01747499|448425956|FG000|Overall Study|Developed AML and death|0|||
124672949|NCT01747499|448425957|FG001|Overall Study|Developed AML and death|0|||
124672950|NCT01747499|448425958|FG002|Overall Study|Developed AML and death|0|||
124672951|NCT01747499|448425959|FG003|Overall Study|Developed AML and death|0|||
124672952|NCT01747499|448425960|FG004|Overall Study|Developed AML and death|1|||
124672953|NCT01747499|448425956|FG000|Overall Study|Determined not to be eligible|0|||
124672954|NCT01747499|448425957|FG001|Overall Study|Determined not to be eligible|0|||
124672955|NCT01747499|448425958|FG002|Overall Study|Determined not to be eligible|0|||
124672956|NCT01747499|448425959|FG003|Overall Study|Determined not to be eligible|0|||
124672957|NCT01747499|448425960|FG004|Overall Study|Determined not to be eligible|1|||
124672958|NCT05214118|448425963|FG000|Overall Study|Lost to Follow-up|0|||
124672959|NCT05214118|448425964|FG001|Overall Study|Lost to Follow-up|2|||
124672960|NCT05214118|448425963|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
124672961|NCT05214118|448425964|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
124672962|NCT05214118|448425963|FG000|Overall Study|moved|1|||
124672963|NCT05214118|448425964|FG001|Overall Study|moved|0|||
124672964|NCT04010461|448425965|FG000|Overall Study|COVID based withdrawal|5|||
124672965|NCT04010461|448425965|FG000|Overall Study|Withdrawal by Subject|5|||
124672966|NCT04010461|448425965|FG000|Overall Study|Adverse Event|1|||
124672967|NCT04010461|448425965|FG000|Overall Study|No Motor Threshold obtainable|1|||
124672968|NCT04010461|448425965|FG000|Overall Study|Physician Decision|1|||
124672969|NCT03797898|448425966|FG000|Overall Study|Lost to Follow-up|60|||
124672970|NCT03797898|448425967|FG001|Overall Study|Lost to Follow-up|69|||
124672971|NCT03797898|448425966|FG000|Overall Study|Withdrawal by Subject|9|||
124672972|NCT03797898|448425967|FG001|Overall Study|Withdrawal by Subject|7|||
124672973|NCT03797898|448425966|FG000|Overall Study|Became ineligible|5|||
124672974|NCT03797898|448425967|FG001|Overall Study|Became ineligible|2|||
124672975|NCT00086190|448425968|FG000|Overall Study|Adverse Event|6|||
124672976|NCT00086190|448425969|FG001|Overall Study|Adverse Event|2|||
124672977|NCT00086190|448425970|FG002|Overall Study|Adverse Event|2|||
124672978|NCT00086190|448425968|FG000|Overall Study|Withdrawal by Subject|0|||
124672979|NCT00086190|448425969|FG001|Overall Study|Withdrawal by Subject|2|||
124672980|NCT00086190|448425970|FG002|Overall Study|Withdrawal by Subject|2|||
124672981|NCT00086190|448425968|FG000|Overall Study|Protocol Violation|1|||
124672982|NCT00086190|448425969|FG001|Overall Study|Protocol Violation|0|||
124672983|NCT00086190|448425970|FG002|Overall Study|Protocol Violation|0|||
124672984|NCT00086190|448425968|FG000|Overall Study|Moved|1|||
124672985|NCT00086190|448425969|FG001|Overall Study|Moved|0|||
124672986|NCT00086190|448425970|FG002|Overall Study|Moved|0|||
124672987|NCT00086190|448425968|FG000|Overall Study|Worsening depression|0|||
124672988|NCT00086190|448425969|FG001|Overall Study|Worsening depression|0|||
124672989|NCT00086190|448425970|FG002|Overall Study|Worsening depression|2|||
124672990|NCT03902613|448425974|FG000|Overall Study|Physician Decision|1|||
124672991|NCT02027025|448425975|FG000|Overall Study|Adverse Event|0|||
124672992|NCT02027025|448425976|FG001|Overall Study|Adverse Event|1|||
124672993|NCT02027025|448425977|FG002|Overall Study|Adverse Event|1|||
124672994|NCT02027025|448425975|FG000|Overall Study|Protocol Violation|1|||
124672995|NCT02027025|448425976|FG001|Overall Study|Protocol Violation|0|||
124672996|NCT02027025|448425977|FG002|Overall Study|Protocol Violation|0|||
124672997|NCT02027025|448425975|FG000|Overall Study|Lost to Follow-up|0|||
124672998|NCT02027025|448425976|FG001|Overall Study|Lost to Follow-up|2|||
124672999|NCT02027025|448425977|FG002|Overall Study|Lost to Follow-up|0|||
124673000|NCT02027025|448425975|FG000|Overall Study|Withdrawal by Subject|0|||
124673001|NCT02027025|448425976|FG001|Overall Study|Withdrawal by Subject|1|||
124673002|NCT02027025|448425977|FG002|Overall Study|Withdrawal by Subject|0|||
124673003|NCT02027025|448425975|FG000|Overall Study|Sponsor's decision|0|||
124673004|NCT02027025|448425976|FG001|Overall Study|Sponsor's decision|1|||
124673005|NCT02027025|448425977|FG002|Overall Study|Sponsor's decision|0|||
124673006|NCT01939314|448425980|FG000|Overall Study|Withdrawal by Subject|3|||
124673007|NCT01939314|448425981|FG001|Overall Study|Withdrawal by Subject|1|||
124673008|NCT01939314|448425980|FG000|Overall Study|Protocol Violation|1|||
124673009|NCT01939314|448425981|FG001|Overall Study|Protocol Violation|0|||
124673010|NCT01939314|448425980|FG000|Overall Study|Pregnancy|0|||
124673011|NCT01939314|448425981|FG001|Overall Study|Pregnancy|1|||
124673012|NCT01939314|448425980|FG000|Overall Study|Lost to Follow-up|5|||
124673013|NCT01939314|448425981|FG001|Overall Study|Lost to Follow-up|6|||
124673014|NCT02370511|448425983|FG000|Overall Study|Death|10|||
124673015|NCT02370511|448425984|FG001|Overall Study|Death|7|||
124673016|NCT02370511|448425985|FG002|Overall Study|Death|1|||
124673017|NCT02370511|448425983|FG000|Overall Study|Withdrawal by Subject|2|||
124673018|NCT02370511|448425984|FG001|Overall Study|Withdrawal by Subject|0|||
124673019|NCT02370511|448425985|FG002|Overall Study|Withdrawal by Subject|0|||
124673020|NCT02370511|448425983|FG000|Overall Study|Lost to Follow-up|0|||
124673021|NCT02370511|448425984|FG001|Overall Study|Lost to Follow-up|4|||
124673022|NCT02370511|448425985|FG002|Overall Study|Lost to Follow-up|0|||
124673023|NCT03882918|448425989|FG000|Overall Study|Study terminated by sponsor|98|||
124673024|NCT03882918|448425989|FG000|Overall Study|Protocol Violation|1|||
124673025|NCT03882918|448425989|FG000|Overall Study|Other|9|||
124673026|NCT03882918|448425989|FG000|Overall Study|Lack of Efficacy|14|||
124673027|NCT03882918|448425989|FG000|Overall Study|Adverse Event|13|||
124673028|NCT03882918|448425989|FG000|Overall Study|Withdrawal by Subject|5|||
124673029|NCT02357459|448428068|FG000|Overall Study|Adverse Event|0|||
124673030|NCT02357459|448428069|FG001|Overall Study|Adverse Event|1|||
124673031|NCT02357459|448428070|FG002|Overall Study|Adverse Event|1|||
124673032|NCT02357459|448428068|FG000|Overall Study|Withdrawal by Subject|5|||
124673033|NCT02357459|448428069|FG001|Overall Study|Withdrawal by Subject|3|||
124673034|NCT02357459|448428070|FG002|Overall Study|Withdrawal by Subject|3|||
124673035|NCT02357459|448428068|FG000|Overall Study|Physician Decision|0|||
124673036|NCT02357459|448428069|FG001|Overall Study|Physician Decision|2|||
124673037|NCT02357459|448428070|FG002|Overall Study|Physician Decision|0|||
124673038|NCT02357459|448428068|FG000|Overall Study|Protocol Violation|1|||
124673039|NCT02357459|448428069|FG001|Overall Study|Protocol Violation|1|||
124673040|NCT02357459|448428070|FG002|Overall Study|Protocol Violation|0|||
124673041|NCT02357459|448428068|FG000|Overall Study|Lost to Follow-up|1|||
124673042|NCT02357459|448428069|FG001|Overall Study|Lost to Follow-up|3|||
124673043|NCT02357459|448428070|FG002|Overall Study|Lost to Follow-up|0|||
124673044|NCT02357459|448428068|FG000|Overall Study|Lack of Efficacy|7|||
124673045|NCT02357459|448428069|FG001|Overall Study|Lack of Efficacy|4|||
124673046|NCT02357459|448428070|FG002|Overall Study|Lack of Efficacy|4|||
124673047|NCT02357459|448428068|FG000|Overall Study|Patient Relocated|2|||
124673048|NCT02357459|448428069|FG001|Overall Study|Patient Relocated|0|||
124673049|NCT02357459|448428070|FG002|Overall Study|Patient Relocated|0|||
124673050|NCT02357459|448428068|FG000|Overall Study|Instruction from PCP|1|||
124673051|NCT02357459|448428069|FG001|Overall Study|Instruction from PCP|0|||
124673052|NCT02357459|448428070|FG002|Overall Study|Instruction from PCP|0|||
124673053|NCT02357459|448428068|FG000|Overall Study|Incarceration|0|||
124673054|NCT02357459|448428069|FG001|Overall Study|Incarceration|0|||
124673055|NCT02357459|448428070|FG002|Overall Study|Incarceration|1|||
124673056|NCT02357459|448428068|FG000|Overall Study|Pre-planned Knee surgery|0|||
124673057|NCT02357459|448428069|FG001|Overall Study|Pre-planned Knee surgery|0|||
124673058|NCT02357459|448428070|FG002|Overall Study|Pre-planned Knee surgery|2|||
124673059|NCT02357459|448428068|FG000|Overall Study|Job Commitments|0|||
124673060|NCT02357459|448428069|FG001|Overall Study|Job Commitments|0|||
124673061|NCT02357459|448428070|FG002|Overall Study|Job Commitments|1|||
124673062|NCT01251952|448428071|FG000|Overall Study|Adverse Event|1|||
124673063|NCT02486692|448428072|FG000|Overall Study|did not login for randomization|4|||
124673064|NCT02486692|448428073|FG001|Overall Study|did not login for randomization|7|||
124673065|NCT00496769|448428074|FG000|Double Blind|>=1 reason assigned per patient|558|||
124673066|NCT00496769|448428075|FG001|Double Blind|>=1 reason assigned per patient|649|||
124673067|NCT00496769|448428076|FG002|Double Blind|>=1 reason assigned per patient|0|||
124673068|NCT00496769|448428074|FG000|Open Label|>=1 reason assigned per patient|0|||
124673069|NCT00496769|448428075|FG001|Open Label|>=1 reason assigned per patient|0|||
124673070|NCT00496769|448428076|FG002|Open Label|>=1 reason assigned per patient|1011|||
124673071|NCT03028142|448428077|FG000|Overall Study|Adverse Event|1|||
124673072|NCT03028142|448428078|FG001|Overall Study|Adverse Event|1|||
124673073|NCT03028142|448428079|FG002|Overall Study|Adverse Event|0|||
124673074|NCT03028142|448428080|FG003|Overall Study|Adverse Event|0|||
124673075|NCT03028142|448428081|FG004|Overall Study|Adverse Event|0|||
124673076|NCT03028142|448428082|FG005|Overall Study|Adverse Event|1|||
124673077|NCT03028142|448428077|FG000|Overall Study|Withdrawal by Subject|0|||
124673078|NCT03028142|448428078|FG001|Overall Study|Withdrawal by Subject|0|||
124673079|NCT03028142|448428079|FG002|Overall Study|Withdrawal by Subject|0|||
124673080|NCT03028142|448428080|FG003|Overall Study|Withdrawal by Subject|0|||
124673081|NCT03028142|448428081|FG004|Overall Study|Withdrawal by Subject|1|||
124673082|NCT03028142|448428082|FG005|Overall Study|Withdrawal by Subject|0|||
124673083|NCT02810418|448428085|FG000|Arm A Dose Escalation|Adverse Event|2|||
124673084|NCT02810418|448428086|FG001|Arm A Dose Escalation|Adverse Event|1|||
124673085|NCT02810418|448428087|FG002|Arm A Dose Escalation|Adverse Event|0|||
124673086|NCT02810418|448428088|FG003|Arm A Dose Escalation|Adverse Event|0|||
124673087|NCT02810418|448428089|FG004|Arm A Dose Escalation|Adverse Event|0|||
124673088|NCT02810418|448428090|FG005|Arm A Dose Escalation|Adverse Event|0|||
124673089|NCT02810418|448428091|FG006|Arm A Dose Escalation|Adverse Event|0|||
124673090|NCT02810418|448428085|FG000|Dose Expansion|Adverse Event|0|||
124673091|NCT02810418|448428086|FG001|Dose Expansion|Adverse Event|1|||
124673092|NCT02810418|448428087|FG002|Dose Expansion|Adverse Event|1|||
124673093|NCT02810418|448428088|FG003|Dose Expansion|Adverse Event|0|||
124673094|NCT02810418|448428089|FG004|Dose Expansion|Adverse Event|0|||
124673095|NCT02810418|448428090|FG005|Dose Expansion|Adverse Event|0|||
124673096|NCT02810418|448428091|FG006|Dose Expansion|Adverse Event|0|||
124673097|NCT02810418|448428085|FG000|Dose Expansion|Physician Decision|0|||
124673098|NCT02810418|448428086|FG001|Dose Expansion|Physician Decision|0|||
124673099|NCT02810418|448428087|FG002|Dose Expansion|Physician Decision|2|||
124673100|NCT02810418|448428088|FG003|Dose Expansion|Physician Decision|0|||
124673101|NCT02810418|448428089|FG004|Dose Expansion|Physician Decision|0|||
124673102|NCT02810418|448428090|FG005|Dose Expansion|Physician Decision|0|||
124673103|NCT02810418|448428091|FG006|Dose Expansion|Physician Decision|0|||
124673104|NCT02810418|448428085|FG000|Arm B Dose Escalation|Adverse Event|0|||
124673105|NCT02810418|448428086|FG001|Arm B Dose Escalation|Adverse Event|0|||
124673106|NCT02810418|448428087|FG002|Arm B Dose Escalation|Adverse Event|0|||
124673107|NCT02810418|448428088|FG003|Arm B Dose Escalation|Adverse Event|0|||
124673108|NCT02810418|448428089|FG004|Arm B Dose Escalation|Adverse Event|1|||
124673109|NCT02810418|448428090|FG005|Arm B Dose Escalation|Adverse Event|2|||
124673110|NCT02810418|448428091|FG006|Arm B Dose Escalation|Adverse Event|0|||
124673111|NCT02224625|448428092|FG000|Irritation|Adverse Event|6|||
124673112|NCT02224625|448428092|FG000|Sensitization|Adverse Event|55|||
124673113|NCT02812186|448428093|FG000|Period 1|Post randomization screen failure|5|||
124673114|NCT02812186|448428094|FG001|Period 1|Post randomization screen failure|9|||
124673115|NCT02812186|448428093|FG000|Period 1|nonevaluable data sets|6|||
124673116|NCT02812186|448428094|FG001|Period 1|nonevaluable data sets|6|||
124673117|NCT02579629|448428109|FG000|Overall Study|Withdrawal by Subject|0|||
124673118|NCT02579629|448428110|FG001|Overall Study|Withdrawal by Subject|1|||
124673119|NCT02579629|448428111|FG002|Overall Study|Withdrawal by Subject|0|||
124673120|NCT02579629|448428109|FG000|Overall Study|Screen Failure|2|||
124673121|NCT02579629|448428110|FG001|Overall Study|Screen Failure|0|||
124673122|NCT02579629|448428111|FG002|Overall Study|Screen Failure|2|||
124673123|NCT00830219|448428114|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
124673124|NCT00830219|448428115|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
124673125|NCT01294423|448428116|FG000|Overall Study|Adverse Event|1|||
124673126|NCT01294423|448428117|FG001|Overall Study|Adverse Event|2|||
124673127|NCT01294423|448428118|FG002|Overall Study|Adverse Event|3|||
124673128|NCT01294423|448428116|FG000|Overall Study|Withdrawal by Subject|1|||
124673129|NCT01294423|448428117|FG001|Overall Study|Withdrawal by Subject|2|||
124673130|NCT01294423|448428118|FG002|Overall Study|Withdrawal by Subject|2|||
124673131|NCT01294423|448428116|FG000|Overall Study|subject no longer meets study criteria|2|||
124673132|NCT01294423|448428117|FG001|Overall Study|subject no longer meets study criteria|5|||
124673133|NCT01294423|448428118|FG002|Overall Study|subject no longer meets study criteria|2|||
124673134|NCT01294423|448428116|FG000|Overall Study|poor/non-compliance|1|||
124673135|NCT01294423|448428117|FG001|Overall Study|poor/non-compliance|0|||
124673136|NCT01294423|448428118|FG002|Overall Study|poor/non-compliance|1|||
124673137|NCT01145482|448428119|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
124673138|NCT01145482|448428120|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
124673139|NCT04635839|448428121|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
124673140|NCT04635839|448428122|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
124673141|NCT00896493|448428123|FG000|Overall Study|Early disease relapse|3|||
124673142|NCT02870868|448428124|FG000|Overall Study|Withdrawal by Subject|2|||
124673143|NCT02870868|448428125|FG001|Overall Study|Withdrawal by Subject|1|||
124673144|NCT01739335|448428126|FG000|Overall Study|Lost to Follow-up|7|||
124673145|NCT01739335|448428127|FG001|Overall Study|Lost to Follow-up|4|||
124673146|NCT01739335|448428126|FG000|Overall Study|Ineligible patient randomized|0|||
124673147|NCT01739335|448428127|FG001|Overall Study|Ineligible patient randomized|1|||
124673148|NCT01868646|448428130|FG000|Overall Study|Do not meet inclusion criteria|3|||
124673149|NCT01868646|448428131|FG001|Overall Study|Do not meet inclusion criteria|5|||
124673150|NCT00785356|448428138|FG000|Overall Study|Study prematurely terminated|8|||
124673151|NCT01232790|448428140|FG000|Randomization|Withdrawal by Subject|2|||
124673152|NCT01232790|448428141|FG001|Randomization|Withdrawal by Subject|0|||
124673153|NCT01232790|448428140|FG000|Randomization|Protocol Violation|0|||
124673154|NCT01232790|448428141|FG001|Randomization|Protocol Violation|1|||
124673155|NCT01232790|448428140|FG000|Randomization|Physician Decision|0|||
124673156|NCT01232790|448428141|FG001|Randomization|Physician Decision|1|||
124673157|NCT01232790|448428140|FG000|Initial Assessment|Withdrawal by Subject|0|||
124673158|NCT01232790|448428141|FG001|Initial Assessment|Withdrawal by Subject|1|||
124673159|NCT01232790|448428140|FG000|First Crossover|Withdrawal by Subject|1|||
124673160|NCT01232790|448428141|FG001|First Crossover|Withdrawal by Subject|0|||
124673161|NCT01232790|448428140|FG000|Second Crossover|Withdrawal by Subject|1|||
124673162|NCT01232790|448428141|FG001|Second Crossover|Withdrawal by Subject|2|||
124673163|NCT03238417|448428142|FG000|Overall|non-response|955|||
124673164|NCT03238417|448428143|FG001|Overall|non-response|1920|||
124673165|NCT03238417|448428142|FG000|Overall|partial completion|48|||
124673166|NCT03238417|448428143|FG001|Overall|partial completion|68|||
124673167|NCT03238417|448428142|FG000|Baseline|Partial completion|17|||
124673168|NCT03238417|448428143|FG001|Baseline|Partial completion|48|||
124673169|NCT03238417|448428142|FG000|Baseline|non-response|372|||
124673170|NCT03238417|448428143|FG001|Baseline|non-response|669|||
124673171|NCT03238417|448428142|FG000|12-month|non-response|296|||
124673172|NCT03238417|448428143|FG001|12-month|non-response|669|||
124673173|NCT03238417|448428142|FG000|12-month|partial completion|23|||
124673174|NCT03238417|448428143|FG001|12-month|partial completion|37|||
124673175|NCT03238417|448428142|FG000|24-month|non-response|287|||
124673176|NCT03238417|448428143|FG001|24-month|non-response|594|||
124673177|NCT03238417|448428142|FG000|24-month|partial completion|8|||
124673178|NCT03238417|448428143|FG001|24-month|partial completion|31|||
124673179|NCT00083915|448428144|FG000|Overall Study|Death|6|||
124673180|NCT00083915|448428145|FG001|Overall Study|Death|3|||
124673181|NCT00083915|448428144|FG000|Overall Study|Physician Decision|11|||
124673182|NCT00083915|448428145|FG001|Overall Study|Physician Decision|6|||
124673183|NCT00083915|448428144|FG000|Overall Study|Withdrawal by Subject|8|||
124673184|NCT00083915|448428145|FG001|Overall Study|Withdrawal by Subject|3|||
124673185|NCT00083915|448428144|FG000|Overall Study|disease progression|18|||
124673186|NCT00083915|448428145|FG001|Overall Study|disease progression|23|||
124673187|NCT00083915|448428144|FG000|Overall Study|Failure to collect|3|||
124673188|NCT00083915|448428145|FG001|Overall Study|Failure to collect|0|||
124673189|NCT00083915|448428144|FG000|Overall Study|No response|3|||
124673190|NCT00083915|448428145|FG001|Overall Study|No response|1|||
124673191|NCT00083915|448428144|FG000|Overall Study|Insurance issues|1|||
124673192|NCT00083915|448428145|FG001|Overall Study|Insurance issues|1|||
124673193|NCT01239797|448428146|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
124673194|NCT01239797|448428147|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
124673195|NCT01239797|448428146|FG000|Randomized Participants|Participant withdrew consent|1|||
124673196|NCT01239797|448428147|FG001|Randomized Participants|Participant withdrew consent|7|||
124673197|NCT01239797|448428146|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
124673198|NCT01239797|448428147|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
124673199|NCT01239797|448428146|FG000|Treated Participants|Disease progression|185|||
124673200|NCT01239797|448428147|FG001|Treated Participants|Disease progression|185|||
124673201|NCT01239797|448428146|FG000|Treated Participants|Study drug toxicity|39|||
124673202|NCT01239797|448428147|FG001|Treated Participants|Study drug toxicity|45|||
124673203|NCT01239797|448428146|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
124673204|NCT01239797|448428147|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
124673205|NCT01239797|448428146|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
124711987|NCT00690794|448570704|FG000|Overall Study|Lost to Follow-up|1|||
124673206|NCT01239797|448428147|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
124673207|NCT01239797|448428146|FG000|Treated Participants|Administrative reason by sponsor|13|||
124673208|NCT01239797|448428147|FG001|Treated Participants|Administrative reason by sponsor|4|||
124673209|NCT01239797|448428146|FG000|Treated Participants|Other reasons|14|||
124673210|NCT01239797|448428147|FG001|Treated Participants|Other reasons|14|||
124673211|NCT01239797|448428146|FG000|Treated Participants|Participant withdrew consent|6|||
124673212|NCT01239797|448428147|FG001|Treated Participants|Participant withdrew consent|11|||
124673213|NCT01239797|448428146|FG000|Treated Participants|Death|1|||
124673214|NCT01239797|448428147|FG001|Treated Participants|Death|1|||
124673215|NCT01239797|448428146|FG000|Treated Participants|Participant no longer meets study criteria|1|||
124673216|NCT01239797|448428147|FG001|Treated Participants|Participant no longer meets study criteria|1|||
124673217|NCT01239797|448428146|FG000|Treated Participants|Poor/non-compliance|0|||
124673218|NCT01239797|448428147|FG001|Treated Participants|Poor/non-compliance|1|||
124673219|NCT00853762|448428153|FG000|Overall Study|Premature Termination|16|||
124673220|NCT00853762|448428154|FG001|Overall Study|Premature Termination|15|||
124673221|NCT00853762|448428155|FG002|Overall Study|Premature Termination|14|||
124673222|NCT00853762|448428156|FG003|Overall Study|Premature Termination|21|||
124673223|NCT00853762|448428153|FG000|Overall Study|Protocol Violation|0|||
124673224|NCT00853762|448428154|FG001|Overall Study|Protocol Violation|0|||
124673225|NCT00853762|448428155|FG002|Overall Study|Protocol Violation|0|||
124673226|NCT00853762|448428156|FG003|Overall Study|Protocol Violation|1|||
124673227|NCT00853762|448428153|FG000|Overall Study|Withdrawal by Subject|0|||
124673228|NCT00853762|448428154|FG001|Overall Study|Withdrawal by Subject|0|||
124673229|NCT00853762|448428155|FG002|Overall Study|Withdrawal by Subject|1|||
124673230|NCT00853762|448428156|FG003|Overall Study|Withdrawal by Subject|0|||
124673231|NCT00853762|448428153|FG000|Overall Study|Other|0|||
124673232|NCT00853762|448428154|FG001|Overall Study|Other|2|||
124673233|NCT00853762|448428155|FG002|Overall Study|Other|0|||
124673234|NCT00853762|448428156|FG003|Overall Study|Other|0|||
124673235|NCT00853762|448428153|FG000|Overall Study|Randomised but not Treated|0|||
124673236|NCT00853762|448428154|FG001|Overall Study|Randomised but not Treated|2|||
124673237|NCT00853762|448428155|FG002|Overall Study|Randomised but not Treated|2|||
124673238|NCT00853762|448428156|FG003|Overall Study|Randomised but not Treated|0|||
124673239|NCT02000921|448428160|FG000|Overall Study|Withdrawal by Subject|3|||
124673240|NCT02000921|448428161|FG001|Overall Study|Withdrawal by Subject|10|||
124673241|NCT02000921|448428162|FG002|Overall Study|Withdrawal by Subject|5|||
124673242|NCT02000921|448428160|FG000|Overall Study|Lost to Follow-up|2|||
124673243|NCT02000921|448428161|FG001|Overall Study|Lost to Follow-up|4|||
124673244|NCT02000921|448428162|FG002|Overall Study|Lost to Follow-up|5|||
124673245|NCT02000921|448428160|FG000|Overall Study|Physician Decision|0|||
124673246|NCT02000921|448428161|FG001|Overall Study|Physician Decision|2|||
124673247|NCT02000921|448428162|FG002|Overall Study|Physician Decision|0|||
124673248|NCT02051296|448428167|FG000|Overall Study|Lost to Follow-up|1|||
124673249|NCT02051296|448428168|FG001|Overall Study|Lost to Follow-up|2|||
124673250|NCT02051296|448428167|FG000|Overall Study|withdraw prior to treatment|7|||
124673251|NCT02051296|448428168|FG001|Overall Study|withdraw prior to treatment|7|||
124673252|NCT02631941|448428171|FG000|Overall Study|Physician Decision|0|||
124673253|NCT02631941|448428172|FG001|Overall Study|Physician Decision|1|||
124673254|NCT02631941|448428173|FG002|Overall Study|Physician Decision|0|||
124673255|NCT02631941|448428174|FG003|Overall Study|Physician Decision|0|||
124673256|NCT02631941|448428175|FG004|Overall Study|Physician Decision|0|||
124673257|NCT02631941|448428176|FG005|Overall Study|Physician Decision|0|||
124673258|NCT02631941|448428177|FG006|Overall Study|Physician Decision|0|||
124673259|NCT02631941|448428178|FG007|Overall Study|Physician Decision|0|||
124673260|NCT02631941|448428179|FG008|Overall Study|Physician Decision|0|||
124673261|NCT02631941|448428180|FG009|Overall Study|Physician Decision|0|||
124673262|NCT02631941|448428171|FG000|Overall Study|Adverse Event|0|||
124673263|NCT02631941|448428172|FG001|Overall Study|Adverse Event|1|||
124673264|NCT02631941|448428173|FG002|Overall Study|Adverse Event|0|||
124673265|NCT02631941|448428174|FG003|Overall Study|Adverse Event|0|||
124673266|NCT02631941|448428175|FG004|Overall Study|Adverse Event|0|||
124673267|NCT02631941|448428176|FG005|Overall Study|Adverse Event|0|||
124673268|NCT02631941|448428177|FG006|Overall Study|Adverse Event|0|||
124673269|NCT02631941|448428178|FG007|Overall Study|Adverse Event|0|||
124673270|NCT02631941|448428179|FG008|Overall Study|Adverse Event|0|||
124673271|NCT02631941|448428180|FG009|Overall Study|Adverse Event|0|||
124673272|NCT02631941|448428171|FG000|Overall Study|Withdrawal by Subject|0|||
124673273|NCT02631941|448428172|FG001|Overall Study|Withdrawal by Subject|0|||
124673274|NCT02631941|448428173|FG002|Overall Study|Withdrawal by Subject|0|||
124673275|NCT02631941|448428174|FG003|Overall Study|Withdrawal by Subject|0|||
124673276|NCT02631941|448428175|FG004|Overall Study|Withdrawal by Subject|1|||
124673277|NCT02631941|448428176|FG005|Overall Study|Withdrawal by Subject|0|||
124673278|NCT02631941|448428177|FG006|Overall Study|Withdrawal by Subject|0|||
124673279|NCT02631941|448428178|FG007|Overall Study|Withdrawal by Subject|1|||
124673280|NCT02631941|448428179|FG008|Overall Study|Withdrawal by Subject|0|||
124673281|NCT02631941|448428180|FG009|Overall Study|Withdrawal by Subject|0|||
124673282|NCT02631941|448428171|FG000|Overall Study|Lost to Follow-up|0|||
124673283|NCT02631941|448428172|FG001|Overall Study|Lost to Follow-up|0|||
124673284|NCT02631941|448428173|FG002|Overall Study|Lost to Follow-up|0|||
124673285|NCT02631941|448428174|FG003|Overall Study|Lost to Follow-up|0|||
124673286|NCT02631941|448428175|FG004|Overall Study|Lost to Follow-up|0|||
124673287|NCT02631941|448428176|FG005|Overall Study|Lost to Follow-up|0|||
124673288|NCT02631941|448428177|FG006|Overall Study|Lost to Follow-up|0|||
124673289|NCT02631941|448428178|FG007|Overall Study|Lost to Follow-up|0|||
124673290|NCT02631941|448428179|FG008|Overall Study|Lost to Follow-up|1|||
124673291|NCT02631941|448428180|FG009|Overall Study|Lost to Follow-up|0|||
124711988|NCT00690794|448570705|FG001|Overall Study|Lost to Follow-up|4|||
124673292|NCT01225549|448428182|FG000|Period 4 - Washout|Disallowed medication|0|||
124673293|NCT01225549|448428183|FG001|Period 4 - Washout|Disallowed medication|1|||
124673294|NCT01225549|448428184|FG002|Period 4 - Washout|Disallowed medication|0|||
124673295|NCT01225549|448428185|FG003|Period 4 - Washout|Disallowed medication|0|||
124673296|NCT01225549|448428186|FG004|Period 4 - Washout|Disallowed medication|0|||
124673297|NCT01225549|448428187|FG005|Period 4 - Washout|Disallowed medication|0|||
124673298|NCT01225549|448428188|FG006|Period 4 - Washout|Disallowed medication|0|||
124673299|NCT01225549|448428189|FG007|Period 4 - Washout|Disallowed medication|0|||
124673300|NCT01225549|448428190|FG008|Period 4 - Washout|Disallowed medication|0|||
124673301|NCT01225549|448428191|FG009|Period 4 - Washout|Disallowed medication|0|||
124673302|NCT01225549|448428182|FG000|Period 6 - Washout|Disallowed medication|0|||
124673303|NCT01225549|448428183|FG001|Period 6 - Washout|Disallowed medication|0|||
124673304|NCT01225549|448428184|FG002|Period 6 - Washout|Disallowed medication|0|||
124673305|NCT01225549|448428185|FG003|Period 6 - Washout|Disallowed medication|1|||
124673306|NCT01225549|448428186|FG004|Period 6 - Washout|Disallowed medication|0|||
124673307|NCT01225549|448428187|FG005|Period 6 - Washout|Disallowed medication|0|||
124673308|NCT01225549|448428188|FG006|Period 6 - Washout|Disallowed medication|0|||
124673309|NCT01225549|448428189|FG007|Period 6 - Washout|Disallowed medication|0|||
124673310|NCT01225549|448428190|FG008|Period 6 - Washout|Disallowed medication|0|||
124673311|NCT01225549|448428191|FG009|Period 6 - Washout|Disallowed medication|0|||
124673312|NCT02858401|448428192|FG000|Overall Study|Withdrew Consent|0|||
124673313|NCT02858401|448428193|FG001|Overall Study|Withdrew Consent|0|||
124673314|NCT02858401|448428194|FG002|Overall Study|Withdrew Consent|0|||
124673315|NCT02858401|448428195|FG003|Overall Study|Withdrew Consent|0|||
124673316|NCT02858401|448428196|FG004|Overall Study|Withdrew Consent|0|||
124673317|NCT02858401|448428197|FG005|Overall Study|Withdrew Consent|1|||
124673318|NCT02858401|448428198|FG006|Overall Study|Withdrew Consent|0|||
124673319|NCT02858401|448428192|FG000|Overall Study|Lost to Follow-up|0|||
124673320|NCT02858401|448428193|FG001|Overall Study|Lost to Follow-up|1|||
124673321|NCT02858401|448428194|FG002|Overall Study|Lost to Follow-up|0|||
124673322|NCT02858401|448428195|FG003|Overall Study|Lost to Follow-up|0|||
124673323|NCT02858401|448428196|FG004|Overall Study|Lost to Follow-up|0|||
124673324|NCT02858401|448428197|FG005|Overall Study|Lost to Follow-up|0|||
124673325|NCT02858401|448428198|FG006|Overall Study|Lost to Follow-up|0|||
124673326|NCT03722576|448428199|FG000|Overall Study|Withdrawal by Subject|3|||
124673327|NCT03722576|448428199|FG000|Overall Study|Adverse Event|2|||
124673328|NCT03722576|448428199|FG000|Overall Study|Physician Decision|1|||
124673329|NCT03722576|448428199|FG000|Overall Study|Lost to Follow-up|1|||
124673330|NCT02513550|448428202|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
124673331|NCT02513550|448428203|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
124673332|NCT02513550|448428204|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
124673333|NCT02513550|448428205|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
124673334|NCT02513550|448428206|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
124673335|NCT02513550|448428207|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
124673336|NCT02513550|448428202|FG000|Double Blind Treatment Period|Adverse Event|5|||
124673337|NCT02513550|448428203|FG001|Double Blind Treatment Period|Adverse Event|13|||
124673338|NCT02513550|448428204|FG002|Double Blind Treatment Period|Adverse Event|17|||
124673339|NCT02513550|448428205|FG003|Double Blind Treatment Period|Adverse Event|0|||
124673340|NCT02513550|448428206|FG004|Double Blind Treatment Period|Adverse Event|1|||
124673341|NCT02513550|448428207|FG005|Double Blind Treatment Period|Adverse Event|0|||
124673342|NCT02513550|448428202|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
124673343|NCT02513550|448428203|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
124673344|NCT02513550|448428204|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
124673345|NCT02513550|448428205|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
124673346|NCT02513550|448428206|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
124872996|NCT00508261|449157215|FG003|Overall Study|Migrated/ moved from study area|0|||
124673347|NCT02513550|448428207|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
124673348|NCT02513550|448428202|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
124673349|NCT02513550|448428203|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
124673350|NCT02513550|448428204|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
124673351|NCT02513550|448428205|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
124673352|NCT02513550|448428206|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
124673353|NCT02513550|448428207|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
124673354|NCT02513550|448428202|FG000|Double Blind Treatment Period|Protocol Violation|1|||
124673355|NCT02513550|448428203|FG001|Double Blind Treatment Period|Protocol Violation|1|||
124673356|NCT02513550|448428204|FG002|Double Blind Treatment Period|Protocol Violation|4|||
124673357|NCT02513550|448428205|FG003|Double Blind Treatment Period|Protocol Violation|0|||
124673358|NCT02513550|448428206|FG004|Double Blind Treatment Period|Protocol Violation|0|||
124673359|NCT02513550|448428207|FG005|Double Blind Treatment Period|Protocol Violation|0|||
124673360|NCT02513550|448428202|FG000|Double Blind Treatment Period|Physician Decision|2|||
124673361|NCT02513550|448428203|FG001|Double Blind Treatment Period|Physician Decision|0|||
124673362|NCT02513550|448428204|FG002|Double Blind Treatment Period|Physician Decision|4|||
124673363|NCT02513550|448428205|FG003|Double Blind Treatment Period|Physician Decision|0|||
124673364|NCT02513550|448428206|FG004|Double Blind Treatment Period|Physician Decision|0|||
124673365|NCT02513550|448428207|FG005|Double Blind Treatment Period|Physician Decision|0|||
124673366|NCT02513550|448428202|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
124872997|NCT00508261|449157212|FG000|Overall Study|Lost to Follow-up|0|||
124673367|NCT02513550|448428203|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
124673368|NCT02513550|448428204|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
124673369|NCT02513550|448428205|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
124673370|NCT02513550|448428206|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
124673371|NCT02513550|448428207|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
124673372|NCT02513550|448428202|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
124673373|NCT02513550|448428203|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
124673374|NCT02513550|448428204|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
124673375|NCT02513550|448428205|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
124673376|NCT02513550|448428206|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
124673377|NCT02513550|448428207|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
124673378|NCT02513550|448428202|FG000|Double Blind Treatment Period|Due to personal business|2|||
124673379|NCT02513550|448428203|FG001|Double Blind Treatment Period|Due to personal business|0|||
124673380|NCT02513550|448428204|FG002|Double Blind Treatment Period|Due to personal business|1|||
124673381|NCT02513550|448428205|FG003|Double Blind Treatment Period|Due to personal business|0|||
124673382|NCT02513550|448428206|FG004|Double Blind Treatment Period|Due to personal business|0|||
124673383|NCT02513550|448428207|FG005|Double Blind Treatment Period|Due to personal business|0|||
124673384|NCT02513550|448428202|FG000|Double Blind Treatment Period|Death|1|||
124673385|NCT02513550|448428203|FG001|Double Blind Treatment Period|Death|0|||
124673386|NCT02513550|448428204|FG002|Double Blind Treatment Period|Death|2|||
124673387|NCT02513550|448428205|FG003|Double Blind Treatment Period|Death|0|||
124673388|NCT02513550|448428206|FG004|Double Blind Treatment Period|Death|0|||
124673389|NCT02513550|448428207|FG005|Double Blind Treatment Period|Death|0|||
124673390|NCT02513550|448428202|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
124673391|NCT02513550|448428203|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
124673392|NCT02513550|448428204|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
124673393|NCT02513550|448428205|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124673394|NCT02513550|448428206|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124673395|NCT02513550|448428207|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124673396|NCT02513550|448428202|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
124673397|NCT02513550|448428203|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
124673398|NCT02513550|448428204|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
124673399|NCT02513550|448428205|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
124673400|NCT02513550|448428206|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
124673401|NCT02513550|448428207|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
124673402|NCT02513550|448428202|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
124673403|NCT02513550|448428203|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
124673404|NCT02513550|448428204|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
124673405|NCT02513550|448428205|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124673406|NCT02513550|448428206|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124673407|NCT02513550|448428207|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124673408|NCT02513550|448428202|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
124673409|NCT02513550|448428203|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
124673410|NCT02513550|448428204|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
124673411|NCT02513550|448428205|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
124673412|NCT02513550|448428206|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
124673413|NCT02513550|448428207|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
124673414|NCT02513550|448428202|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
124673415|NCT02513550|448428203|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
124673416|NCT02513550|448428204|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
124673417|NCT02513550|448428205|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
124872998|NCT00508261|449157213|FG001|Overall Study|Lost to Follow-up|1|||
124673418|NCT02513550|448428206|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
124673419|NCT02513550|448428207|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
124673420|NCT02513550|448428202|FG000|Post-Treatment Follow-up Period|Death|0|||
124673421|NCT02513550|448428203|FG001|Post-Treatment Follow-up Period|Death|0|||
124673422|NCT02513550|448428204|FG002|Post-Treatment Follow-up Period|Death|1|||
124673423|NCT02513550|448428205|FG003|Post-Treatment Follow-up Period|Death|0|||
124673424|NCT02513550|448428206|FG004|Post-Treatment Follow-up Period|Death|0|||
124673425|NCT02513550|448428207|FG005|Post-Treatment Follow-up Period|Death|0|||
124673426|NCT02513550|448428202|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
124673427|NCT02513550|448428203|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
124673428|NCT02513550|448428204|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
124673429|NCT02513550|448428205|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
124673430|NCT02513550|448428206|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
124673431|NCT02513550|448428207|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
124673432|NCT02513550|448428202|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
124673433|NCT02513550|448428203|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
124673434|NCT02513550|448428204|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
124673435|NCT02513550|448428205|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
124673436|NCT02513550|448428206|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
124673437|NCT02513550|448428207|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
124673438|NCT02513550|448428202|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
124673439|NCT02513550|448428203|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
124673440|NCT02513550|448428204|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
124673441|NCT02513550|448428205|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
124673442|NCT02513550|448428206|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
124673443|NCT02513550|448428207|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
124673444|NCT00192114|448428208|FG000|Overall Study|Objective Tumor Progression|19|||
124673445|NCT00192114|448428208|FG000|Overall Study|Adverse Event|2|||
124673446|NCT00192114|448428208|FG000|Overall Study|Clinical Progression|2|||
124673447|NCT00192114|448428208|FG000|Overall Study|Death|1|||
124673448|NCT02204917|448428210|FG000|Overall Study|Protocol Violation|1|||
124673449|NCT00749398|448428211|FG000|Overall Study|Lack of Efficacy|7|||
124673450|NCT00749398|448428211|FG000|Overall Study|Adverse Event|4|||
124673451|NCT00749398|448428211|FG000|Overall Study|Serious adverse event|11|||
124673452|NCT00749398|448428211|FG000|Overall Study|Withdrawal by Subject|17|||
124673453|NCT00749398|448428211|FG000|Overall Study|Lost to Follow-up|11|||
124673454|NCT00749398|448428211|FG000|Overall Study|Reason not specified|2|||
124673455|NCT00749398|448428211|FG000|Overall Study|Unknown reason|1|||
124673456|NCT02277028|448428217|FG000|Overall Study|Lost to Follow-up|1|||
124673457|NCT02277028|448428218|FG001|Overall Study|Lost to Follow-up|0|||
124673458|NCT02277028|448428217|FG000|Overall Study|Withdrawal by Subject|0|||
124673459|NCT02277028|448428218|FG001|Overall Study|Withdrawal by Subject|1|||
124673460|NCT02718911|448428219|FG000|Overall Study|Adverse Event|0|||
124673461|NCT02718911|448428220|FG001|Overall Study|Adverse Event|0|||
124673462|NCT02718911|448428221|FG002|Overall Study|Adverse Event|0|||
124673463|NCT02718911|448428222|FG003|Overall Study|Adverse Event|0|||
124673464|NCT02718911|448428223|FG004|Overall Study|Adverse Event|0|||
124673465|NCT02718911|448428224|FG005|Overall Study|Adverse Event|0|||
124673466|NCT02718911|448428225|FG006|Overall Study|Adverse Event|0|||
124673467|NCT02718911|448428226|FG007|Overall Study|Adverse Event|0|||
124673468|NCT02718911|448428227|FG008|Overall Study|Adverse Event|0|||
124673469|NCT02718911|448428228|FG009|Overall Study|Adverse Event|2|||
124673470|NCT02718911|448428219|FG000|Overall Study|Death|2|||
124673471|NCT02718911|448428220|FG001|Overall Study|Death|3|||
124673472|NCT02718911|448428221|FG002|Overall Study|Death|1|||
124673473|NCT02718911|448428222|FG003|Overall Study|Death|0|||
124673474|NCT02718911|448428223|FG004|Overall Study|Death|1|||
124673475|NCT02718911|448428224|FG005|Overall Study|Death|3|||
124673476|NCT02718911|448428225|FG006|Overall Study|Death|1|||
124673477|NCT02718911|448428226|FG007|Overall Study|Death|1|||
124673478|NCT02718911|448428227|FG008|Overall Study|Death|4|||
124673479|NCT02718911|448428228|FG009|Overall Study|Death|3|||
124673480|NCT02718911|448428219|FG000|Overall Study|Lost to Follow-up|0|||
124673481|NCT02718911|448428220|FG001|Overall Study|Lost to Follow-up|0|||
124673482|NCT02718911|448428221|FG002|Overall Study|Lost to Follow-up|0|||
124673483|NCT02718911|448428222|FG003|Overall Study|Lost to Follow-up|0|||
124673484|NCT02718911|448428223|FG004|Overall Study|Lost to Follow-up|0|||
124673485|NCT02718911|448428224|FG005|Overall Study|Lost to Follow-up|0|||
124673486|NCT02718911|448428225|FG006|Overall Study|Lost to Follow-up|0|||
124673487|NCT02718911|448428226|FG007|Overall Study|Lost to Follow-up|0|||
124673488|NCT02718911|448428227|FG008|Overall Study|Lost to Follow-up|1|||
124673489|NCT02718911|448428228|FG009|Overall Study|Lost to Follow-up|0|||
124673490|NCT02718911|448428219|FG000|Overall Study|Physician Decision|2|||
124673491|NCT02718911|448428220|FG001|Overall Study|Physician Decision|0|||
124673492|NCT02718911|448428221|FG002|Overall Study|Physician Decision|1|||
124673493|NCT02718911|448428222|FG003|Overall Study|Physician Decision|1|||
124673494|NCT02718911|448428223|FG004|Overall Study|Physician Decision|0|||
124673495|NCT02718911|448428224|FG005|Overall Study|Physician Decision|0|||
124673496|NCT02718911|448428225|FG006|Overall Study|Physician Decision|0|||
124673497|NCT02718911|448428226|FG007|Overall Study|Physician Decision|1|||
124673498|NCT02718911|448428227|FG008|Overall Study|Physician Decision|2|||
124673499|NCT02718911|448428228|FG009|Overall Study|Physician Decision|1|||
124673500|NCT02718911|448428219|FG000|Overall Study|Withdrawal by Subject|0|||
124673501|NCT02718911|448428220|FG001|Overall Study|Withdrawal by Subject|0|||
124673502|NCT02718911|448428221|FG002|Overall Study|Withdrawal by Subject|0|||
124673503|NCT02718911|448428222|FG003|Overall Study|Withdrawal by Subject|0|||
124673504|NCT02718911|448428223|FG004|Overall Study|Withdrawal by Subject|1|||
124673505|NCT02718911|448428224|FG005|Overall Study|Withdrawal by Subject|0|||
124673506|NCT02718911|448428225|FG006|Overall Study|Withdrawal by Subject|0|||
124673507|NCT02718911|448428226|FG007|Overall Study|Withdrawal by Subject|0|||
124673508|NCT02718911|448428227|FG008|Overall Study|Withdrawal by Subject|1|||
124673509|NCT02718911|448428228|FG009|Overall Study|Withdrawal by Subject|4|||
124673510|NCT02718911|448428219|FG000|Overall Study|Reason Not Collected|0|||
124673511|NCT02718911|448428220|FG001|Overall Study|Reason Not Collected|0|||
124673512|NCT02718911|448428221|FG002|Overall Study|Reason Not Collected|1|||
124673513|NCT02718911|448428222|FG003|Overall Study|Reason Not Collected|0|||
124673514|NCT02718911|448428223|FG004|Overall Study|Reason Not Collected|0|||
124673515|NCT02718911|448428224|FG005|Overall Study|Reason Not Collected|0|||
124673516|NCT02718911|448428225|FG006|Overall Study|Reason Not Collected|2|||
124673517|NCT02718911|448428226|FG007|Overall Study|Reason Not Collected|1|||
124673518|NCT02718911|448428227|FG008|Overall Study|Reason Not Collected|4|||
124673519|NCT02718911|448428228|FG009|Overall Study|Reason Not Collected|9|||
124673520|NCT05002972|448428229|FG000|Overall Study|Withdrawal by Subject|2|||
124673521|NCT01172873|448428233|FG000|Overall Study|Withdrawal by Subject|3|||
124673522|NCT01172873|448428234|FG001|Overall Study|Withdrawal by Subject|2|||
124673523|NCT00983372|448428235|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
124673524|NCT00983372|448428235|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
124673525|NCT00983372|448428235|FG000|Diltiazem ER Alone|Adverse Event|1|||
124673526|NCT00372424|448428236|FG000|Overall Study|Adverse Event|2|||
124673527|NCT00372424|448428236|FG000|Overall Study|Withdrawal by Subject|1|||
124673528|NCT00372424|448428236|FG000|Overall Study|Death|1|||
124673529|NCT00372424|448428236|FG000|Overall Study|Objective Progression or Relapse|14|||
124673530|NCT00372424|448428236|FG000|Overall Study|Other|7|||
124673531|NCT00372424|448428236|FG000|Overall Study|Enrolled, Not Treated|1|||
124673532|NCT00072410|448428237|FG000|Overall Study|Progressive disease|0|||
124673533|NCT00072410|448428238|FG001|Overall Study|Progressive disease|3|||
124673534|NCT01419314|448428240|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
124673535|NCT01419314|448428241|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
124673536|NCT01419314|448428240|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
124673537|NCT01419314|448428241|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
124673538|NCT01419314|448428240|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
124673539|NCT01419314|448428241|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
124673540|NCT00732069|448428242|FG000|Washout After First Study Drug|Adverse Event|1|||
124673541|NCT00732069|448428243|FG001|Washout After First Study Drug|Adverse Event|0|||
124673542|NCT00732069|448428244|FG002|Washout After First Study Drug|Adverse Event|0|||
124673543|NCT00732069|448428245|FG003|Washout After First Study Drug|Adverse Event|0|||
124673544|NCT00732069|448428246|FG004|Washout After First Study Drug|Adverse Event|0|||
124673545|NCT00732069|448428247|FG005|Washout After First Study Drug|Adverse Event|0|||
124673546|NCT00969228|448428255|FG000|Overall Study|Adverse Event|1|||
124673547|NCT00969228|448428256|FG001|Overall Study|Adverse Event|0|||
124673548|NCT00969228|448428255|FG000|Overall Study|Withdrawal by Subject|4|||
124673549|NCT00969228|448428256|FG001|Overall Study|Withdrawal by Subject|0|||
124673550|NCT00969228|448428255|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
124673551|NCT00969228|448428256|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
124673552|NCT02563899|448428257|FG000|Overall Study|Protocol Violation|1|||
124673553|NCT02563899|448428258|FG001|Overall Study|Protocol Violation|0|||
124673554|NCT02563899|448428259|FG002|Overall Study|Protocol Violation|0|||
124673555|NCT02563899|448428260|FG003|Overall Study|Protocol Violation|0|||
124673556|NCT02563899|448428257|FG000|Overall Study|Withdrawal by Subject|0|||
124673557|NCT02563899|448428258|FG001|Overall Study|Withdrawal by Subject|0|||
124673558|NCT02563899|448428259|FG002|Overall Study|Withdrawal by Subject|1|||
124673559|NCT02563899|448428260|FG003|Overall Study|Withdrawal by Subject|0|||
124673560|NCT02100124|448428267|FG000|Overall Study|Lost to Follow-up|5|||
124673561|NCT02100124|448428268|FG001|Overall Study|Lost to Follow-up|11|||
124673562|NCT02100124|448428269|FG002|Overall Study|Lost to Follow-up|3|||
124673563|NCT02100124|448428267|FG000|Overall Study|Withdrawal by Subject|1|||
124673564|NCT02100124|448428268|FG001|Overall Study|Withdrawal by Subject|0|||
124673565|NCT02100124|448428269|FG002|Overall Study|Withdrawal by Subject|0|||
124673566|NCT04350827|448428270|FG000|Overall Study|Lost to Follow-up|1|||
124673567|NCT04350827|448428271|FG001|Overall Study|Lost to Follow-up|2|||
124673568|NCT02188160|448430211|FG000|Overall Study|Adverse Event|1|||
124673569|NCT02188160|448430212|FG001|Overall Study|Adverse Event|0|||
124673570|NCT02188160|448430211|FG000|Overall Study|Use of an excluded medication|0|||
124673571|NCT02188160|448430212|FG001|Overall Study|Use of an excluded medication|1|||
124673572|NCT01655901|448430215|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
124673573|NCT01655901|448430216|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
124673574|NCT01655901|448430217|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
124673575|NCT01655901|448430218|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
124673576|NCT01655901|448430219|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
124673577|NCT01655901|448430220|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
124673578|NCT03256578|448430223|FG000|Overall Study|Excluded Post Randomization|66|||
124673579|NCT03256578|448430224|FG001|Overall Study|Excluded Post Randomization|56|||
124673580|NCT02371616|448430225|FG000|Overall Study|Protocol Violation|2|||
124673581|NCT02371616|448430226|FG001|Overall Study|Protocol Violation|1|||
124673582|NCT02371616|448430225|FG000|Overall Study|Adverse Event|0|||
124673583|NCT02371616|448430226|FG001|Overall Study|Adverse Event|1|||
124673584|NCT02371616|448430225|FG000|Overall Study|Withdrawal of Consent|1|||
124673585|NCT02371616|448430226|FG001|Overall Study|Withdrawal of Consent|0|||
124673586|NCT02371616|448430225|FG000|Overall Study|Other (Not specified)|1|||
124673587|NCT02371616|448430226|FG001|Overall Study|Other (Not specified)|5|||
124673588|NCT00754741|448430227|FG000|Overall Study|Died or disenrolled|57|||
124673589|NCT00754741|448430228|FG001|Overall Study|Died or disenrolled|69|||
124673590|NCT00754741|448430229|FG002|Overall Study|Died or disenrolled|54|||
124673591|NCT00922636|448430230|FG000|Overall Study|Adverse Event|3|||
124673592|NCT00922636|448430231|FG001|Overall Study|Adverse Event|3|||
124673593|NCT00922636|448430232|FG002|Overall Study|Adverse Event|2|||
124673594|NCT00922636|448430233|FG003|Overall Study|Adverse Event|3|||
124673595|NCT00922636|448430234|FG004|Overall Study|Adverse Event|2|||
124673596|NCT00922636|448430230|FG000|Overall Study|Lack of Efficacy|1|||
124673597|NCT00922636|448430231|FG001|Overall Study|Lack of Efficacy|7|||
124673598|NCT00922636|448430232|FG002|Overall Study|Lack of Efficacy|3|||
124673599|NCT00922636|448430233|FG003|Overall Study|Lack of Efficacy|2|||
124673600|NCT00922636|448430234|FG004|Overall Study|Lack of Efficacy|4|||
124673601|NCT00922636|448430230|FG000|Overall Study|Sponsor Decision|0|||
124673602|NCT00922636|448430231|FG001|Overall Study|Sponsor Decision|0|||
124673603|NCT00922636|448430232|FG002|Overall Study|Sponsor Decision|2|||
124673604|NCT00922636|448430233|FG003|Overall Study|Sponsor Decision|0|||
124673605|NCT00922636|448430234|FG004|Overall Study|Sponsor Decision|0|||
124673606|NCT00922636|448430230|FG000|Overall Study|Withdrawal by Subject|0|||
124673607|NCT00922636|448430231|FG001|Overall Study|Withdrawal by Subject|0|||
124673608|NCT00922636|448430232|FG002|Overall Study|Withdrawal by Subject|5|||
124673609|NCT00922636|448430233|FG003|Overall Study|Withdrawal by Subject|2|||
124673610|NCT00922636|448430234|FG004|Overall Study|Withdrawal by Subject|4|||
124673611|NCT00922636|448430230|FG000|Overall Study|Protocol Violation|0|||
124673612|NCT00922636|448430231|FG001|Overall Study|Protocol Violation|0|||
124673613|NCT00922636|448430232|FG002|Overall Study|Protocol Violation|2|||
124673614|NCT00922636|448430233|FG003|Overall Study|Protocol Violation|2|||
124673615|NCT00922636|448430234|FG004|Overall Study|Protocol Violation|0|||
124673616|NCT00922636|448430230|FG000|Overall Study|Entry Criteria Not Met|0|||
124673617|NCT00922636|448430231|FG001|Overall Study|Entry Criteria Not Met|0|||
124673618|NCT00922636|448430232|FG002|Overall Study|Entry Criteria Not Met|1|||
124673619|NCT00922636|448430233|FG003|Overall Study|Entry Criteria Not Met|1|||
124673620|NCT00922636|448430234|FG004|Overall Study|Entry Criteria Not Met|0|||
124673621|NCT00922636|448430230|FG000|Overall Study|Parent/Caregiver Decision|2|||
124673622|NCT00922636|448430231|FG001|Overall Study|Parent/Caregiver Decision|4|||
124673623|NCT00922636|448430232|FG002|Overall Study|Parent/Caregiver Decision|3|||
124673624|NCT00922636|448430233|FG003|Overall Study|Parent/Caregiver Decision|5|||
124673625|NCT00922636|448430234|FG004|Overall Study|Parent/Caregiver Decision|2|||
124673626|NCT00922636|448430230|FG000|Overall Study|Lost to Follow-up|1|||
124673627|NCT00922636|448430231|FG001|Overall Study|Lost to Follow-up|2|||
124673628|NCT00922636|448430232|FG002|Overall Study|Lost to Follow-up|2|||
124673629|NCT00922636|448430233|FG003|Overall Study|Lost to Follow-up|2|||
124673630|NCT00922636|448430234|FG004|Overall Study|Lost to Follow-up|4|||
124673631|NCT01573000|448430235|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
124673632|NCT01573000|448430236|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
124673633|NCT01573000|448430235|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
124673634|NCT01573000|448430236|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
124673635|NCT01573000|448430235|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
124673636|NCT01573000|448430236|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
124673637|NCT01573000|448430235|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
124673638|NCT01573000|448430236|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
124673639|NCT01573000|448430235|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
124673640|NCT01573000|448430236|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
124673641|NCT01573000|448430235|FG000|Crossover Phase|Lack of Efficacy|0|||
124673642|NCT01573000|448430236|FG001|Crossover Phase|Lack of Efficacy|13|||
124673643|NCT01573000|448430235|FG000|Crossover Phase|Lost to Follow-up|0|||
124673644|NCT01573000|448430236|FG001|Crossover Phase|Lost to Follow-up|2|||
124673645|NCT01573000|448430235|FG000|Crossover Phase|Death|0|||
124673646|NCT01573000|448430236|FG001|Crossover Phase|Death|3|||
124673647|NCT01573000|448430235|FG000|Long-Term Follow-Up|Death|3|||
124673648|NCT01573000|448430236|FG001|Long-Term Follow-Up|Death|0|||
124673649|NCT01573000|448430235|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
124673650|NCT01573000|448430236|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
124673651|NCT03353792|448430237|FG000|Overall Study|Lost to Follow-up|1|||
124673652|NCT03353792|448430238|FG001|Overall Study|Lost to Follow-up|0|||
124673653|NCT03353792|448430237|FG000|Overall Study|Participant Unable to Manage Device|1|||
124673654|NCT03353792|448430238|FG001|Overall Study|Participant Unable to Manage Device|0|||
124673655|NCT01433159|448430242|FG000|Overall Study|Adverse Event|1|||
124673656|NCT01433159|448430243|FG001|Overall Study|Adverse Event|0|||
124673657|NCT01433159|448430242|FG000|Overall Study|Physician Decision|1|||
124673658|NCT01433159|448430243|FG001|Overall Study|Physician Decision|0|||
124673659|NCT01433159|448430242|FG000|Overall Study|Protocol Violation|0|||
124673660|NCT01433159|448430243|FG001|Overall Study|Protocol Violation|1|||
124673661|NCT01100853|448430244|FG000|Overall Study|Lost to Follow-up|11|||
124673662|NCT01100853|448430245|FG001|Overall Study|Lost to Follow-up|6|||
124673663|NCT01100853|448430244|FG000|Overall Study|Received <4 study injections|10|||
124673664|NCT01100853|448430245|FG001|Overall Study|Received <4 study injections|13|||
124673665|NCT01100853|448430244|FG000|Overall Study|Withdrawal by Subject|6|||
124673666|NCT01100853|448430245|FG001|Overall Study|Withdrawal by Subject|4|||
124673667|NCT01190891|448430246|FG000|Overall Study|Protocol Violation|1|||
124673668|NCT01190891|448430247|FG001|Overall Study|Protocol Violation|0|||
124673669|NCT01190891|448430246|FG000|Overall Study|Withdrawal by Subject|5|||
124673670|NCT01190891|448430247|FG001|Overall Study|Withdrawal by Subject|0|||
124673671|NCT00266708|448430248|FG000|Overall Study|No renal function|1|||
124673672|NCT00266708|448430249|FG001|Overall Study|No renal function|1|||
124673673|NCT00266708|448430248|FG000|Overall Study|Refused biopsy|3|||
124673674|NCT00266708|448430249|FG001|Overall Study|Refused biopsy|6|||
124673675|NCT00266708|448430248|FG000|Overall Study|Asthma|0|||
124673676|NCT00266708|448430249|FG001|Overall Study|Asthma|2|||
124673677|NCT01926028|448430250|FG000|Overall Study|Lost to Follow-up|7|||
124673678|NCT01926028|448430251|FG001|Overall Study|Lost to Follow-up|6|||
124673679|NCT01926028|448430252|FG002|Overall Study|Lost to Follow-up|0|||
124673680|NCT01926028|448430250|FG000|Overall Study|Physician Decision|1|||
124673681|NCT01926028|448430251|FG001|Overall Study|Physician Decision|5|||
124673682|NCT01926028|448430252|FG002|Overall Study|Physician Decision|0|||
124673683|NCT01926028|448430250|FG000|Overall Study|Withdrawal by Subject|9|||
124673684|NCT01926028|448430251|FG001|Overall Study|Withdrawal by Subject|9|||
124673685|NCT01926028|448430252|FG002|Overall Study|Withdrawal by Subject|2|||
124673686|NCT01926028|448430250|FG000|Overall Study|Non compliance or other reasons|4|||
124673687|NCT01926028|448430251|FG001|Overall Study|Non compliance or other reasons|2|||
124673688|NCT01926028|448430252|FG002|Overall Study|Non compliance or other reasons|0|||
124673689|NCT01130272|448430253|FG000|Overall Study|Adverse Event|2|||
124673690|NCT01130272|448430254|FG001|Overall Study|Adverse Event|5|||
124673691|NCT01130272|448430255|FG002|Overall Study|Adverse Event|6|||
124673692|NCT01130272|448430256|FG003|Overall Study|Adverse Event|22|||
124673693|NCT01130272|448430257|FG004|Overall Study|Adverse Event|7|||
124673694|NCT01130272|448430253|FG000|Overall Study|IVRS-confirmed constipation|0|||
124673695|NCT01130272|448430254|FG001|Overall Study|IVRS-confirmed constipation|1|||
124673696|NCT01130272|448430255|FG002|Overall Study|IVRS-confirmed constipation|1|||
124673697|NCT01130272|448430256|FG003|Overall Study|IVRS-confirmed constipation|2|||
124673698|NCT01130272|448430257|FG004|Overall Study|IVRS-confirmed constipation|0|||
124673699|NCT01130272|448430253|FG000|Overall Study|Rescue medications due to diarrhea|3|||
124673700|NCT01130272|448430254|FG001|Overall Study|Rescue medications due to diarrhea|5|||
124673701|NCT01130272|448430255|FG002|Overall Study|Rescue medications due to diarrhea|8|||
124673702|NCT01130272|448430256|FG003|Overall Study|Rescue medications due to diarrhea|8|||
124673703|NCT01130272|448430257|FG004|Overall Study|Rescue medications due to diarrhea|6|||
124673704|NCT01130272|448430253|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
124673705|NCT01130272|448430254|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
124673706|NCT01130272|448430255|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
124673707|NCT01130272|448430256|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
124673708|NCT01130272|448430257|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
124673709|NCT01130272|448430253|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
124673710|NCT01130272|448430254|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
124673711|NCT01130272|448430255|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
124673712|NCT01130272|448430256|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
124673713|NCT01130272|448430257|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
124673714|NCT01130272|448430253|FG000|Overall Study|Protocol Violation|0|||
124673715|NCT01130272|448430254|FG001|Overall Study|Protocol Violation|0|||
124673716|NCT01130272|448430255|FG002|Overall Study|Protocol Violation|3|||
124673717|NCT01130272|448430256|FG003|Overall Study|Protocol Violation|5|||
124673718|NCT01130272|448430257|FG004|Overall Study|Protocol Violation|5|||
124673719|NCT01130272|448430253|FG000|Overall Study|Lost to Follow-up|4|||
124673720|NCT01130272|448430254|FG001|Overall Study|Lost to Follow-up|3|||
124673721|NCT01130272|448430255|FG002|Overall Study|Lost to Follow-up|4|||
124673722|NCT01130272|448430256|FG003|Overall Study|Lost to Follow-up|7|||
124673723|NCT01130272|448430257|FG004|Overall Study|Lost to Follow-up|6|||
124673724|NCT01130272|448430253|FG000|Overall Study|Withdrawal by Subject|4|||
124673725|NCT01130272|448430254|FG001|Overall Study|Withdrawal by Subject|11|||
124673726|NCT01130272|448430255|FG002|Overall Study|Withdrawal by Subject|10|||
124673727|NCT01130272|448430256|FG003|Overall Study|Withdrawal by Subject|9|||
124673728|NCT01130272|448430257|FG004|Overall Study|Withdrawal by Subject|8|||
124673729|NCT01130272|448430253|FG000|Overall Study|Physician Decision|1|||
124673730|NCT01130272|448430254|FG001|Overall Study|Physician Decision|1|||
124673731|NCT01130272|448430255|FG002|Overall Study|Physician Decision|0|||
124673732|NCT01130272|448430256|FG003|Overall Study|Physician Decision|1|||
124673733|NCT01130272|448430257|FG004|Overall Study|Physician Decision|2|||
124673734|NCT01130272|448430253|FG000|Overall Study|Sponsor decision|6|||
124673735|NCT01130272|448430254|FG001|Overall Study|Sponsor decision|15|||
124673736|NCT01130272|448430255|FG002|Overall Study|Sponsor decision|16|||
124673737|NCT01130272|448430256|FG003|Overall Study|Sponsor decision|13|||
124673738|NCT01130272|448430257|FG004|Overall Study|Sponsor decision|16|||
124673739|NCT01130272|448430253|FG000|Overall Study|Study arm discontinued|38|||
124673740|NCT01130272|448430254|FG001|Overall Study|Study arm discontinued|0|||
124673741|NCT01130272|448430255|FG002|Overall Study|Study arm discontinued|0|||
124673742|NCT01130272|448430256|FG003|Overall Study|Study arm discontinued|0|||
124673743|NCT01130272|448430257|FG004|Overall Study|Study arm discontinued|0|||
124673744|NCT01548404|448430258|FG000|Overall Study|Adverse Event|3|||
124673745|NCT01548404|448430259|FG001|Overall Study|Adverse Event|1|||
124673746|NCT01548404|448430258|FG000|Overall Study|Physician Decision|2|||
124673747|NCT01548404|448430259|FG001|Overall Study|Physician Decision|1|||
124673748|NCT01548404|448430258|FG000|Overall Study|Inadequate response to study treatment|23|||
124673749|NCT01548404|448430259|FG001|Overall Study|Inadequate response to study treatment|7|||
124673750|NCT01548404|448430258|FG000|Overall Study|Lost to Follow-up|2|||
124673751|NCT01548404|448430259|FG001|Overall Study|Lost to Follow-up|0|||
124673752|NCT01548404|448430258|FG000|Overall Study|Withdrawal by Subject|0|||
124673753|NCT01548404|448430259|FG001|Overall Study|Withdrawal by Subject|3|||
124673754|NCT01548404|448430258|FG000|Overall Study|Other than specified above|0|||
124673755|NCT01548404|448430259|FG001|Overall Study|Other than specified above|2|||
124673756|NCT00737048|448430260|FG000|Overall Study|Physician Decision|0|||
124673757|NCT00737048|448430261|FG001|Overall Study|Physician Decision|0|||
124673758|NCT00737048|448430262|FG002|Overall Study|Physician Decision|1|||
124673759|NCT00737048|448430260|FG000|Overall Study|Adverse Event|0|||
124673760|NCT00737048|448430261|FG001|Overall Study|Adverse Event|1|||
124673761|NCT00737048|448430262|FG002|Overall Study|Adverse Event|0|||
124673762|NCT00737048|448430260|FG000|Overall Study|Worsening of the symptoms|3|||
124673763|NCT00737048|448430261|FG001|Overall Study|Worsening of the symptoms|5|||
124673764|NCT00737048|448430262|FG002|Overall Study|Worsening of the symptoms|3|||
124673765|NCT00641056|448430263|FG000|Overall Study|Adverse Event|12|||
124673766|NCT00641056|448430264|FG001|Overall Study|Adverse Event|2|||
124673767|NCT00641056|448430263|FG000|Overall Study|Lost to Follow-up|2|||
124673768|NCT00641056|448430264|FG001|Overall Study|Lost to Follow-up|1|||
124673769|NCT00641056|448430263|FG000|Overall Study|Physician Decision|3|||
124673770|NCT00641056|448430264|FG001|Overall Study|Physician Decision|1|||
124673771|NCT00641056|448430263|FG000|Overall Study|Protocol Violation|2|||
124673772|NCT00641056|448430264|FG001|Overall Study|Protocol Violation|0|||
124673773|NCT00641056|448430263|FG000|Overall Study|Entry Criteria Not Met|3|||
124673774|NCT00641056|448430264|FG001|Overall Study|Entry Criteria Not Met|0|||
124673775|NCT00641056|448430263|FG000|Overall Study|Subject Decision|6|||
124673776|NCT00641056|448430264|FG001|Overall Study|Subject Decision|19|||
124673777|NCT00641056|448430263|FG000|Overall Study|Sponsor Decision|1|||
124673778|NCT00641056|448430264|FG001|Overall Study|Sponsor Decision|2|||
124673779|NCT02351934|448430265|FG000|Allocation|POD weight<pre-op weight|3|||
124673780|NCT02351934|448430266|FG001|Allocation|POD weight<pre-op weight|0|||
124673781|NCT02351934|448430265|FG000|Allocation|Hypotension preventing administration|2|||
124673782|NCT02351934|448430266|FG001|Allocation|Hypotension preventing administration|0|||
124673783|NCT02351934|448430265|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
124673784|NCT02351934|448430266|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
124673785|NCT02351934|448430265|FG000|Follow-Up|POD weight<pre-op weight|3|||
124673786|NCT02351934|448430266|FG001|Follow-Up|POD weight<pre-op weight|0|||
124673787|NCT02351934|448430265|FG000|Follow-Up|Acute Kidney Injury|1|||
124673788|NCT02351934|448430266|FG001|Follow-Up|Acute Kidney Injury|0|||
124673789|NCT02351934|448430265|FG000|Follow-Up|Early dismissal|3|||
124673790|NCT02351934|448430266|FG001|Follow-Up|Early dismissal|0|||
124673791|NCT02351934|448430265|FG000|Follow-Up|Hypotension|3|||
124673792|NCT02351934|448430266|FG001|Follow-Up|Hypotension|0|||
124673793|NCT02351934|448430265|FG000|Follow-Up|No documentation|2|||
124673794|NCT02351934|448430266|FG001|Follow-Up|No documentation|0|||
124673795|NCT02351934|448430265|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
124673796|NCT02351934|448430266|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
124673797|NCT02351934|448430265|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
124673798|NCT02351934|448430266|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
124673799|NCT01309386|448430272|FG000|Overall Study|Other|2|||
124673800|NCT01309386|448430273|FG001|Overall Study|Other|0|||
124673801|NCT01309386|448430272|FG000|Overall Study|Withdrawal by Subject|2|||
124673802|NCT01309386|448430273|FG001|Overall Study|Withdrawal by Subject|0|||
124673803|NCT01309386|448430272|FG000|Overall Study|Progressive disease|9|||
124673804|NCT01309386|448430273|FG001|Overall Study|Progressive disease|11|||
124673805|NCT01309386|448430272|FG000|Overall Study|Physician Decision|1|||
124673806|NCT01309386|448430273|FG001|Overall Study|Physician Decision|1|||
124673807|NCT01309386|448430272|FG000|Overall Study|Lack of Efficacy|3|||
124673808|NCT01309386|448430273|FG001|Overall Study|Lack of Efficacy|1|||
124673809|NCT01309386|448430272|FG000|Overall Study|Adverse Event|5|||
124673810|NCT01309386|448430273|FG001|Overall Study|Adverse Event|8|||
124673811|NCT02062437|448430274|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
124673812|NCT02062437|448430274|FG000|Overall Study|Patient not available for the 2y visit|18|||
124673813|NCT02062437|448430274|FG000|Overall Study|Death|2|||
124673814|NCT02062437|448430274|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
124673815|NCT01674725|448430275|FG000|Overall Study|Adverse Event|1|||
124673816|NCT01674725|448430276|FG001|Overall Study|Adverse Event|0|||
124673817|NCT01674725|448430275|FG000|Overall Study|Did not receive study drug|1|||
124673818|NCT01674725|448430276|FG001|Overall Study|Did not receive study drug|0|||
124673819|NCT01674725|448430275|FG000|Overall Study|Withdrawal by Subject|1|||
124673820|NCT01674725|448430276|FG001|Overall Study|Withdrawal by Subject|0|||
124673821|NCT01674725|448430275|FG000|Overall Study|Lost to Follow-up|0|||
124673822|NCT01674725|448430276|FG001|Overall Study|Lost to Follow-up|1|||
124673823|NCT00960193|448430277|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
124673824|NCT01249131|448430286|FG000|Washout Period of 10 Days|Adverse Event|0|||
124673825|NCT01249131|448430287|FG001|Washout Period of 10 Days|Adverse Event|0|||
124673826|NCT01249131|448430288|FG002|Washout Period of 10 Days|Adverse Event|0|||
124673827|NCT01249131|448430289|FG003|Washout Period of 10 Days|Adverse Event|0|||
124673828|NCT01249131|448430290|FG004|Washout Period of 10 Days|Adverse Event|1|||
124673829|NCT01249131|448430291|FG005|Washout Period of 10 Days|Adverse Event|0|||
124673830|NCT00891813|448430293|FG000|Overall Study|Adverse Event|3|||
124673831|NCT00891813|448430293|FG000|Overall Study|Withdrawal by Subject|1|||
124673832|NCT00891813|448430293|FG000|Overall Study|Patient Noncompliance|6|||
124673833|NCT00891813|448430293|FG000|Overall Study|Protocol Violation|2|||
124673834|NCT00113607|448430296|FG000|Overall Study|Adverse Event|40|||
124673835|NCT00113607|448430297|FG001|Overall Study|Adverse Event|71|||
124673836|NCT00113607|448430296|FG000|Overall Study|Death|8|||
124673837|NCT00113607|448430297|FG001|Overall Study|Death|8|||
124673838|NCT00113607|448430296|FG000|Overall Study|Withdrawal by Subject|50|||
124673839|NCT00113607|448430297|FG001|Overall Study|Withdrawal by Subject|58|||
124673840|NCT00113607|448430296|FG000|Overall Study|Lost to Follow-up|0|||
124673841|NCT00113607|448430297|FG001|Overall Study|Lost to Follow-up|2|||
124673842|NCT00113607|448430296|FG000|Overall Study|Disease Progression|180|||
124673843|NCT00113607|448430297|FG001|Overall Study|Disease Progression|142|||
124673844|NCT00113607|448430296|FG000|Overall Study|Complete Response (Confirmed)|14|||
124673845|NCT00113607|448430297|FG001|Overall Study|Complete Response (Confirmed)|24|||
124673846|NCT00113607|448430296|FG000|Overall Study|Other|43|||
124673847|NCT00113607|448430297|FG001|Overall Study|Other|32|||
124673848|NCT01222104|448430298|FG000|Overall Study|Lost to Follow-up|37|||
124673849|NCT01222104|448430298|FG000|Overall Study|Death|10|||
124673850|NCT01418339|448430299|FG000|Overall Study|Adverse Event|5|||
124673851|NCT01418339|448430300|FG001|Overall Study|Adverse Event|2|||
124673852|NCT01418339|448430299|FG000|Overall Study|Subject Withdrew Consent|1|||
124673853|NCT01418339|448430300|FG001|Overall Study|Subject Withdrew Consent|2|||
124673854|NCT01418339|448430299|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
124673855|NCT01418339|448430300|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
124673856|NCT03885908|448430301|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
124673857|NCT03885908|448430302|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
124673858|NCT03885908|448430301|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
124673859|NCT03885908|448430302|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
124673860|NCT03885908|448430301|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
124673861|NCT03885908|448430302|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
124673862|NCT03885908|448430301|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
124673863|NCT03885908|448430302|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
124673864|NCT00909844|448430303|FG000|Overall Study|Adverse Event|1|||
124673865|NCT00909844|448430303|FG000|Overall Study|Withdrawal by Subject|1|||
124673866|NCT00909844|448430303|FG000|Overall Study|Lost to Follow-up|2|||
124673867|NCT00706004|448430304|FG000|Overall Study|Did not meet eligibility criteria|2|||
124673868|NCT01064479|448430305|FG000|Overall Study|Death|10|||
124673869|NCT01064479|448430306|FG001|Overall Study|Death|11|||
124673870|NCT01064479|448430305|FG000|Overall Study|Withdrawal by Subject|2|||
124673871|NCT01064479|448430306|FG001|Overall Study|Withdrawal by Subject|2|||
124673872|NCT01064479|448430305|FG000|Overall Study|Disease progression|1|||
124673873|NCT01064479|448430306|FG001|Overall Study|Disease progression|1|||
124673874|NCT01064479|448430305|FG000|Overall Study|Toxicity|1|||
124673875|NCT01064479|448430306|FG001|Overall Study|Toxicity|1|||
124673876|NCT01064479|448430305|FG000|Overall Study|Other|1|||
124673877|NCT01064479|448430306|FG001|Overall Study|Other|2|||
124673878|NCT04219189|448430308|FG000|Overall Study|Withdrawal by Subject|1|||
124673879|NCT04219189|448430309|FG001|Overall Study|Withdrawal by Subject|2|||
124673880|NCT04219189|448430308|FG000|Overall Study|Protocol Violation|0|||
124673881|NCT04219189|448430309|FG001|Overall Study|Protocol Violation|1|||
124673882|NCT04219189|448430308|FG000|Overall Study|Lost to Follow-up|0|||
124673883|NCT04219189|448430309|FG001|Overall Study|Lost to Follow-up|1|||
124673884|NCT04219189|448430308|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
124673885|NCT04219189|448430309|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
124673886|NCT03101020|448430310|FG000|Overall Study|Lack of time to participate|1|||
124673887|NCT03101020|448430311|FG001|Overall Study|Lack of time to participate|0|||
124673888|NCT03101020|448430310|FG000|Overall Study|Ran over by a car|0|||
124673889|NCT03101020|448430311|FG001|Overall Study|Ran over by a car|1|||
124673890|NCT03101020|448430310|FG000|Overall Study|Withdrawal by Subject|0|||
124673891|NCT03101020|448430311|FG001|Overall Study|Withdrawal by Subject|2|||
124673892|NCT03585270|448430314|FG000|Overall Study|Withdrawal by Subject|2|||
124673893|NCT03585270|448430315|FG001|Overall Study|Withdrawal by Subject|6|||
124673894|NCT03585270|448430314|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
124673895|NCT03585270|448430315|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
124673896|NCT03585270|448430314|FG000|Overall Study|Adverse Event|5|||
124673897|NCT03585270|448430315|FG001|Overall Study|Adverse Event|2|||
124673898|NCT03585270|448430314|FG000|Overall Study|Lost to Follow-up|1|||
124673899|NCT03585270|448430315|FG001|Overall Study|Lost to Follow-up|4|||
124673900|NCT03585270|448430314|FG000|Overall Study|Death|5|||
124673901|NCT03585270|448430315|FG001|Overall Study|Death|3|||
124673902|NCT03585270|448430314|FG000|Overall Study|Other reasons|2|||
124673903|NCT03585270|448430315|FG001|Overall Study|Other reasons|2|||
124673904|NCT03292016|448430316|FG000|Second Washout|Adverse Event|0|||
124673905|NCT03292016|448430317|FG001|Second Washout|Adverse Event|1|||
124673906|NCT03292016|448430318|FG002|Second Washout|Adverse Event|0|||
124673907|NCT03292016|448430319|FG003|Second Washout|Adverse Event|0|||
124673908|NCT03292016|448430320|FG004|Second Washout|Adverse Event|0|||
124673909|NCT03292016|448430321|FG005|Second Washout|Adverse Event|0|||
124673910|NCT01038687|448430326|FG000|Overall Study|Adverse Event|0|||
124673911|NCT01038687|448430327|FG001|Overall Study|Adverse Event|2|||
124673912|NCT01038687|448430328|FG002|Overall Study|Adverse Event|1|||
124673913|NCT01076543|448430330|FG000|Overall Study|Withdrawal by Subject|2|||
124673914|NCT01076543|448430331|FG001|Overall Study|Withdrawal by Subject|0|||
124673915|NCT01076543|448430332|FG002|Overall Study|Withdrawal by Subject|0|||
124673916|NCT01076543|448430333|FG003|Overall Study|Withdrawal by Subject|0|||
124673917|NCT01076543|448430334|FG004|Overall Study|Withdrawal by Subject|0|||
124673918|NCT01076543|448430335|FG005|Overall Study|Withdrawal by Subject|0|||
124673919|NCT00338741|448430336|FG000|Overall Study|Lost to Follow-up|2|||
124673920|NCT00338741|448430337|FG001|Overall Study|Lost to Follow-up|0|||
124673921|NCT05222880|448430338|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
124673922|NCT05222880|448430338|FG000|Overall Study|Withdrew Consent during Study|1|||
124673923|NCT05222880|448430338|FG000|Overall Study|COVID-19 Related|1|||
124673924|NCT00617357|448430343|FG000|Overall Study|Lost to Follow-up|7|||
124673925|NCT00617357|448430343|FG000|Overall Study|Death|5|||
124673926|NCT00617357|448430343|FG000|Overall Study|insurance concerns|2|||
124428490|NCT02898077|447530846|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
124428491|NCT02898077|447530847|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
124428492|NCT02898077|447530846|FG000|Overall Study|Lost to Follow-up|4|||
124428493|NCT02898077|447530847|FG001|Overall Study|Lost to Follow-up|3|||
124673927|NCT00617357|448430343|FG000|Overall Study|Withdrawal by Subject|1|||
124673928|NCT00617357|448430343|FG000|Overall Study|Physician Decision|1|||
124673929|NCT01764841|448430344|FG000|Overall Study|Logistical Difficulties|0|||
124673930|NCT01764841|448430345|FG001|Overall Study|Logistical Difficulties|1|||
124673931|NCT01764841|448430346|FG002|Overall Study|Logistical Difficulties|0|||
124673932|NCT01764841|448430347|FG003|Overall Study|Logistical Difficulties|0|||
124673933|NCT01764841|448430344|FG000|Overall Study|Death|3|||
124673934|NCT01764841|448430345|FG001|Overall Study|Death|0|||
124673935|NCT01764841|448430346|FG002|Overall Study|Death|1|||
124673936|NCT01764841|448430347|FG003|Overall Study|Death|4|||
124673937|NCT01764841|448430344|FG000|Overall Study|No Follow Up|1|||
124673938|NCT01764841|448430345|FG001|Overall Study|No Follow Up|0|||
124673939|NCT01764841|448430346|FG002|Overall Study|No Follow Up|1|||
124673940|NCT01764841|448430347|FG003|Overall Study|No Follow Up|0|||
124673941|NCT01764841|448430344|FG000|Overall Study|Protocol Violation|0|||
124673942|NCT01764841|448430345|FG001|Overall Study|Protocol Violation|1|||
124673943|NCT01764841|448430346|FG002|Overall Study|Protocol Violation|0|||
124673944|NCT01764841|448430347|FG003|Overall Study|Protocol Violation|0|||
124673945|NCT01764841|448430344|FG000|Overall Study|Withdrawal by Subject|16|||
124673946|NCT01764841|448430345|FG001|Overall Study|Withdrawal by Subject|24|||
124673947|NCT01764841|448430346|FG002|Overall Study|Withdrawal by Subject|11|||
124673948|NCT01764841|448430347|FG003|Overall Study|Withdrawal by Subject|15|||
124673949|NCT01764841|448430344|FG000|Overall Study|Lost to Follow-up|3|||
124673950|NCT01764841|448430345|FG001|Overall Study|Lost to Follow-up|0|||
124673951|NCT01764841|448430346|FG002|Overall Study|Lost to Follow-up|1|||
124673952|NCT01764841|448430347|FG003|Overall Study|Lost to Follow-up|0|||
124673953|NCT01791985|448430349|FG000|Overall Study|Adverse Event|7|||
124673954|NCT01791985|448430349|FG000|Overall Study|Withdrawal by Subject|1|||
124673955|NCT01103323|448430350|FG000|Without/Before Drug Switch|Adverse Event|50|||
124673956|NCT01103323|448430351|FG001|Without/Before Drug Switch|Adverse Event|7|||
124673957|NCT01103323|448430350|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
124673958|NCT01103323|448430351|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
124673959|NCT01103323|448430350|FG000|Without/Before Drug Switch|Protocol Violation|2|||
124673960|NCT01103323|448430351|FG001|Without/Before Drug Switch|Protocol Violation|0|||
124428494|NCT02898077|447530846|FG000|Overall Study|Physician Decision|0|||
124428495|NCT02898077|447530847|FG001|Overall Study|Physician Decision|2|||
124673961|NCT01103323|448430350|FG000|Without/Before Drug Switch|Physician Decision|2|||
124673962|NCT01103323|448430351|FG001|Without/Before Drug Switch|Physician Decision|0|||
124673963|NCT01103323|448430350|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
124673964|NCT01103323|448430351|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
124673965|NCT01103323|448430350|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
124673966|NCT01103323|448430351|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
124673967|NCT01103323|448430350|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
124673968|NCT01103323|448430351|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
124673969|NCT02314728|448430357|FG000|Overall Study|Protocol Violation|1|||
124673970|NCT02314728|448430358|FG001|Overall Study|Protocol Violation|0|||
124673971|NCT02314728|448430357|FG000|Overall Study|Lost to Follow-up|0|||
124673972|NCT02314728|448430358|FG001|Overall Study|Lost to Follow-up|1|||
124673973|NCT01791595|448430359|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
124673974|NCT01791595|448430360|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
124673975|NCT01791595|448430361|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
124673976|NCT01791595|448430362|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
124673977|NCT01791595|448430363|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
124673978|NCT01791595|448430364|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
124673979|NCT01791595|448430365|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
124673980|NCT01791595|448430359|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
124673981|NCT01791595|448430360|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
124673982|NCT01791595|448430361|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
124673983|NCT01791595|448430362|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
124673984|NCT01791595|448430363|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
124673985|NCT01791595|448430364|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
124673986|NCT01791595|448430365|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
124673987|NCT01791595|448430359|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
124673988|NCT01791595|448430360|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
124673989|NCT01791595|448430361|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
124673990|NCT01791595|448430362|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
124673991|NCT01791595|448430363|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
124673992|NCT01791595|448430364|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
124673993|NCT01791595|448430365|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
124673994|NCT01791595|448430359|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
124673995|NCT01791595|448430360|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
124673996|NCT01791595|448430361|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
124673997|NCT01791595|448430362|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
124673998|NCT01791595|448430363|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
124673999|NCT01791595|448430364|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
124674000|NCT01791595|448430365|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
124674001|NCT01791595|448430359|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
124674002|NCT01791595|448430360|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
124674003|NCT01791595|448430361|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
124674004|NCT01791595|448430362|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
124674005|NCT01791595|448430363|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
124674006|NCT01791595|448430364|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
124674007|NCT01791595|448430365|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
124674008|NCT01791595|448430359|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
124674009|NCT01791595|448430360|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
124674010|NCT01791595|448430361|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
124674011|NCT01791595|448430362|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
124674012|NCT01791595|448430363|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
124674013|NCT01791595|448430364|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
124674014|NCT01791595|448430365|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
124674015|NCT01791595|448430359|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
124674016|NCT01791595|448430360|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
124674017|NCT01791595|448430361|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
124674018|NCT01791595|448430362|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
124674019|NCT01791595|448430363|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
124674020|NCT01791595|448430364|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
124674021|NCT01791595|448430365|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
124674022|NCT01791595|448430359|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
124674023|NCT01791595|448430360|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
124674024|NCT01791595|448430361|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
124674025|NCT01791595|448430362|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
124674026|NCT01791595|448430363|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
124674027|NCT01791595|448430364|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
124674028|NCT01791595|448430365|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
124674029|NCT01791595|448430359|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
124674030|NCT01791595|448430360|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
124674031|NCT01791595|448430361|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
124674032|NCT01791595|448430362|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
124674033|NCT01791595|448430363|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
124674034|NCT01791595|448430364|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
124674035|NCT01791595|448430365|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
124674036|NCT01791595|448430359|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
124674037|NCT01791595|448430360|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
124674038|NCT01791595|448430361|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
124674039|NCT01791595|448430362|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
124674040|NCT01791595|448430363|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
124674041|NCT01791595|448430364|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
124674042|NCT01791595|448430365|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
124674043|NCT01791595|448430359|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
124674044|NCT01791595|448430360|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
124674045|NCT01791595|448430361|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
124674046|NCT01791595|448430362|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
124674047|NCT01791595|448430363|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
124674048|NCT01791595|448430364|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
124674049|NCT01791595|448430365|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
124674050|NCT01791595|448430359|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
124674051|NCT01791595|448430360|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
124872999|NCT00508261|449157214|FG002|Overall Study|Lost to Follow-up|1|||
124428496|NCT02898077|447530846|FG000|Overall Study|Sponsor Decision|32|||
124428497|NCT02898077|447530847|FG001|Overall Study|Sponsor Decision|13|||
124428498|NCT02898077|447530846|FG000|Overall Study|Withdrawal by Subject|6|||
124428499|NCT02898077|447530847|FG001|Overall Study|Withdrawal by Subject|3|||
124428500|NCT02898077|447530846|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
124428501|NCT02898077|447530847|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
124428502|NCT02898077|447530846|FG000|Overall Study|Ended extension period|3|||
124428503|NCT02898077|447530847|FG001|Overall Study|Ended extension period|0|||
124428504|NCT04410523|447530848|FG000|Overall Study|Study terminated by sponsor|1|||
124428505|NCT04410523|447530849|FG001|Overall Study|Study terminated by sponsor|3|||
124428506|NCT04410523|447530850|FG002|Overall Study|Study terminated by sponsor|2|||
124428507|NCT04410523|447530851|FG003|Overall Study|Study terminated by sponsor|6|||
124428508|NCT04410523|447530852|FG004|Overall Study|Study terminated by sponsor|3|||
124428509|NCT04410523|447530853|FG005|Overall Study|Study terminated by sponsor|4|||
124428510|NCT04410523|447530848|FG000|Overall Study|Adverse Event|1|||
124428511|NCT04410523|447530849|FG001|Overall Study|Adverse Event|0|||
124428512|NCT04410523|447530850|FG002|Overall Study|Adverse Event|0|||
124428513|NCT04410523|447530851|FG003|Overall Study|Adverse Event|0|||
124428514|NCT04410523|447530852|FG004|Overall Study|Adverse Event|0|||
124428515|NCT04410523|447530853|FG005|Overall Study|Adverse Event|2|||
124428516|NCT04410523|447530848|FG000|Overall Study|Lost to Follow-up|0|||
124428517|NCT04410523|447530849|FG001|Overall Study|Lost to Follow-up|1|||
124428518|NCT04410523|447530850|FG002|Overall Study|Lost to Follow-up|0|||
124428519|NCT04410523|447530851|FG003|Overall Study|Lost to Follow-up|0|||
124428520|NCT04410523|447530852|FG004|Overall Study|Lost to Follow-up|0|||
124428521|NCT04410523|447530853|FG005|Overall Study|Lost to Follow-up|0|||
124428522|NCT04410523|447530848|FG000|Overall Study|Physician Decision|0|||
124428523|NCT04410523|447530849|FG001|Overall Study|Physician Decision|1|||
124428524|NCT04410523|447530850|FG002|Overall Study|Physician Decision|0|||
124428525|NCT04410523|447530851|FG003|Overall Study|Physician Decision|0|||
124428526|NCT04410523|447530852|FG004|Overall Study|Physician Decision|0|||
124428527|NCT04410523|447530853|FG005|Overall Study|Physician Decision|0|||
124428528|NCT04410523|447530848|FG000|Overall Study|Pregnancy|0|||
124428529|NCT04410523|447530849|FG001|Overall Study|Pregnancy|0|||
124428530|NCT04410523|447530850|FG002|Overall Study|Pregnancy|0|||
124428531|NCT04410523|447530851|FG003|Overall Study|Pregnancy|0|||
124428532|NCT04410523|447530852|FG004|Overall Study|Pregnancy|0|||
124428533|NCT04410523|447530853|FG005|Overall Study|Pregnancy|1|||
124428534|NCT04410523|447530848|FG000|Overall Study|Protocol deviation|0|||
124428535|NCT04410523|447530849|FG001|Overall Study|Protocol deviation|0|||
124428536|NCT04410523|447530850|FG002|Overall Study|Protocol deviation|0|||
124428537|NCT04410523|447530851|FG003|Overall Study|Protocol deviation|0|||
124428538|NCT04410523|447530852|FG004|Overall Study|Protocol deviation|0|||
124428539|NCT04410523|447530853|FG005|Overall Study|Protocol deviation|2|||
124428540|NCT04410523|447530848|FG000|Overall Study|Subject decision|2|||
124428541|NCT04410523|447530849|FG001|Overall Study|Subject decision|0|||
124428542|NCT04410523|447530850|FG002|Overall Study|Subject decision|0|||
124428543|NCT04410523|447530851|FG003|Overall Study|Subject decision|1|||
124428544|NCT04410523|447530852|FG004|Overall Study|Subject decision|0|||
124428545|NCT04410523|447530853|FG005|Overall Study|Subject decision|1|||
124428546|NCT00621777|447530854|FG000|Open Phase|Adverse Event|20|||
124428547|NCT00621777|447530855|FG001|Open Phase|Adverse Event|0|||
124428548|NCT00621777|447530854|FG000|Open Phase|Did not abstain during open phase|56|||
124428549|NCT00621777|447530855|FG001|Open Phase|Did not abstain during open phase|0|||
124428550|NCT00621777|447530854|FG000|Open Phase|Withdrawal by Subject|17|||
124428551|NCT00621777|447530855|FG001|Open Phase|Withdrawal by Subject|0|||
124428552|NCT00621777|447530854|FG000|Open Phase|administrative|13|||
124428553|NCT00621777|447530855|FG001|Open Phase|administrative|0|||
124428554|NCT00621777|447530854|FG000|Open Phase|Lost to Follow-up|10|||
124428555|NCT00621777|447530855|FG001|Open Phase|Lost to Follow-up|0|||
124428556|NCT00621777|447530854|FG000|Randomized Phase|Adverse Event|3|||
124428557|NCT00621777|447530855|FG001|Randomized Phase|Adverse Event|3|||
124674052|NCT01791595|448430361|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
124674053|NCT01791595|448430362|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
124674054|NCT01791595|448430363|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
124674055|NCT01791595|448430364|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
124428558|NCT00621777|447530854|FG000|Randomized Phase|Lost to Follow-up|3|||
124428559|NCT00621777|447530855|FG001|Randomized Phase|Lost to Follow-up|3|||
124674056|NCT01791595|448430365|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
124674057|NCT01791595|448430359|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
124428560|NCT00621777|447530854|FG000|Randomized Phase|Withdrawal by Subject|1|||
124428561|NCT00621777|447530855|FG001|Randomized Phase|Withdrawal by Subject|9|||
124428562|NCT00621777|447530854|FG000|Randomized Phase|administrative|0|||
124428563|NCT00621777|447530855|FG001|Randomized Phase|administrative|3|||
124428564|NCT00621777|447530854|FG000|Randomized Phase|Death|0|||
124428565|NCT00621777|447530855|FG001|Randomized Phase|Death|1|||
124428567|NCT01239043|447530857|FG000|Overall Study|Protocol Violation|2|||
124428568|NCT01239043|447530858|FG001|Overall Study|Protocol Violation|1|||
124674058|NCT01791595|448430360|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
124674059|NCT01791595|448430361|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
124674060|NCT01791595|448430362|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
124428609|NCT01519089|447530876|FG000|Overall Study|Adverse Event|4|||
124428610|NCT01519089|447530877|FG001|Overall Study|Adverse Event|4|||
124428611|NCT01519089|447530876|FG000|Overall Study|Lack of Efficacy|0|||
124428612|NCT01519089|447530877|FG001|Overall Study|Lack of Efficacy|2|||
124428613|NCT01519089|447530876|FG000|Overall Study|Lost to Follow-up|1|||
124428614|NCT01519089|447530877|FG001|Overall Study|Lost to Follow-up|0|||
124428615|NCT01519089|447530876|FG000|Overall Study|Withdrawal by Subject|0|||
124428616|NCT01519089|447530877|FG001|Overall Study|Withdrawal by Subject|2|||
124428617|NCT01519089|447530876|FG000|Overall Study|Other|2|||
124428618|NCT01519089|447530877|FG001|Overall Study|Other|6|||
124428619|NCT01519089|447530876|FG000|Overall Study|Not received study drug|0|||
124428620|NCT01519089|447530877|FG001|Overall Study|Not received study drug|1|||
124428621|NCT00127205|447530878|FG000|Overall Study|Adverse Event|228|||
124428622|NCT00127205|447530879|FG001|Overall Study|Adverse Event|387|||
124428623|NCT00127205|447530880|FG002|Overall Study|Adverse Event|273|||
124674061|NCT01791595|448430363|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
124674062|NCT01791595|448430364|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
124674063|NCT01791595|448430365|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
124428624|NCT00127205|447530878|FG000|Overall Study|Death|8|||
124674064|NCT01791595|448430359|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
124674065|NCT01791595|448430360|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
124674066|NCT01791595|448430361|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
124428625|NCT00127205|447530879|FG001|Overall Study|Death|6|||
124428626|NCT00127205|447530880|FG002|Overall Study|Death|5|||
124428627|NCT00127205|447530878|FG000|Overall Study|Withdrawal by Subject|318|||
124428628|NCT00127205|447530879|FG001|Overall Study|Withdrawal by Subject|310|||
124674067|NCT01791595|448430362|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
124428629|NCT00127205|447530880|FG002|Overall Study|Withdrawal by Subject|172|||
124428630|NCT00127205|447530878|FG000|Overall Study|Other-non protocol specified|142|||
124428631|NCT00127205|447530879|FG001|Overall Study|Other-non protocol specified|129|||
124428632|NCT00127205|447530880|FG002|Overall Study|Other-non protocol specified|77|||
124428633|NCT00127205|447530878|FG000|Overall Study|Data not reported|6|||
124674068|NCT01791595|448430363|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
124674069|NCT01791595|448430364|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
124674070|NCT01791595|448430365|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
124674071|NCT01791595|448430359|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
124674072|NCT01791595|448430360|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
124674073|NCT01791595|448430361|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
124674074|NCT01791595|448430362|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
124674075|NCT01791595|448430363|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
124674076|NCT01791595|448430364|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
124674077|NCT01791595|448430365|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
124674078|NCT01791595|448430359|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
124674079|NCT01791595|448430360|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
124674080|NCT01791595|448430361|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
124674081|NCT01791595|448430362|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
124674082|NCT01791595|448430363|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
124674083|NCT01791595|448430364|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
124674084|NCT01791595|448430365|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
124674085|NCT01791595|448430359|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
124674086|NCT01791595|448430360|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
124674087|NCT01791595|448430361|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
124674088|NCT01791595|448430362|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
124674089|NCT01791595|448430363|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
124674090|NCT01791595|448430364|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
124674091|NCT01791595|448430365|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
124674092|NCT01791595|448430359|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
124674093|NCT01791595|448430360|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
124674094|NCT01791595|448430361|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
124674095|NCT01791595|448430362|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
124674096|NCT01791595|448430363|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
124674097|NCT01791595|448430364|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
124674098|NCT01791595|448430365|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
124674099|NCT03118934|448430366|FG000|Overall Study|Adverse Event|0|||
124674100|NCT03118934|448430367|FG001|Overall Study|Adverse Event|0|||
124428634|NCT00127205|447530879|FG001|Overall Study|Data not reported|10|||
124428635|NCT00127205|447530880|FG002|Overall Study|Data not reported|1|||
124428636|NCT00127205|447530878|FG000|Overall Study|Progression|127|||
124428637|NCT00127205|447530879|FG001|Overall Study|Progression|131|||
124428638|NCT00127205|447530880|FG002|Overall Study|Progression|84|||
124428639|NCT00224887|447530884|FG000|Overall Study|Pregnancy|6|||
124428640|NCT00224887|447530885|FG001|Overall Study|Pregnancy|6|||
124428641|NCT03582943|447530890|FG000|Allocated to Groups|Withdrawal by Subject|1|||
124428642|NCT03582943|447530891|FG001|Allocated to Groups|Withdrawal by Subject|1|||
124428643|NCT03582943|447530890|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
124428644|NCT03582943|447530891|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
124428645|NCT03582943|447530890|FG000|Analyzed|Protocol Violation|4|||
124428646|NCT03582943|447530891|FG001|Analyzed|Protocol Violation|1|||
124428647|NCT05032872|447530892|FG000|Overall Study|Adverse Event|1|||
124428648|NCT05032872|447530893|FG001|Overall Study|Adverse Event|0|||
124428649|NCT05032872|447530892|FG000|Overall Study|Lost to Follow-up|2|||
124428650|NCT05032872|447530893|FG001|Overall Study|Lost to Follow-up|4|||
124428651|NCT05032872|447530892|FG000|Overall Study|Withdrawal by Subject|4|||
124428652|NCT05032872|447530893|FG001|Overall Study|Withdrawal by Subject|3|||
124428653|NCT00488475|447530894|FG000|Overall Study|Other|1754|||
124428654|NCT00798590|447530915|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
124428655|NCT00798590|447530916|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
124428656|NCT01163292|447530922|FG000|Overall Study|Lack of Efficacy|9|||
124428657|NCT01163292|447530923|FG001|Overall Study|Lack of Efficacy|0|||
124428658|NCT01163292|447530922|FG000|Overall Study|Adverse Event|6|||
124428659|NCT01163292|447530923|FG001|Overall Study|Adverse Event|0|||
124428660|NCT01163292|447530922|FG000|Overall Study|Initiation of biological therapy|0|||
124428661|NCT01163292|447530923|FG001|Overall Study|Initiation of biological therapy|15|||
124428662|NCT01163292|447530922|FG000|Overall Study|Sufficient response to adalimumab|8|||
124428663|NCT01163292|447530923|FG001|Overall Study|Sufficient response to adalimumab|0|||
124428664|NCT01163292|447530922|FG000|Overall Study|Refusal to receive adalimumab|7|||
124428665|NCT01163292|447530923|FG001|Overall Study|Refusal to receive adalimumab|0|||
124428666|NCT01163292|447530922|FG000|Overall Study|Economic reasons|6|||
124674101|NCT03118934|448430368|FG002|Overall Study|Adverse Event|0|||
124428667|NCT01163292|447530923|FG001|Overall Study|Economic reasons|0|||
124428668|NCT01163292|447530922|FG000|Overall Study|No further visits|5|||
124428669|NCT01163292|447530923|FG001|Overall Study|No further visits|7|||
124428670|NCT00680992|447530926|FG000|Overall Study|Complete Resection (as per protocol)|25|||
124428671|NCT00680992|447530927|FG001|Overall Study|Complete Resection (as per protocol)|121|||
124428672|NCT00680992|447530928|FG002|Overall Study|Complete Resection (as per protocol)|0|||
124428673|NCT00680992|447530926|FG000|Overall Study|Administrative Decision|83|||
124428674|NCT00680992|447530927|FG001|Overall Study|Administrative Decision|42|||
124428675|NCT00680992|447530928|FG002|Overall Study|Administrative Decision|5|||
124428676|NCT00680992|447530926|FG000|Overall Study|End of Trial|32|||
124428677|NCT00680992|447530927|FG001|Overall Study|End of Trial|12|||
124428678|NCT00680992|447530928|FG002|Overall Study|End of Trial|3|||
124428679|NCT00680992|447530926|FG000|Overall Study|Withdrawal by Subject|33|||
124428680|NCT00680992|447530927|FG001|Overall Study|Withdrawal by Subject|11|||
124428681|NCT00680992|447530928|FG002|Overall Study|Withdrawal by Subject|1|||
124428682|NCT00680992|447530926|FG000|Overall Study|Adverse Event|21|||
124428683|NCT00680992|447530927|FG001|Overall Study|Adverse Event|19|||
124428684|NCT00680992|447530928|FG002|Overall Study|Adverse Event|1|||
124428685|NCT00680992|447530926|FG000|Overall Study|Other|19|||
124428686|NCT00680992|447530927|FG001|Overall Study|Other|14|||
124428687|NCT00680992|447530928|FG002|Overall Study|Other|1|||
124428688|NCT00680992|447530926|FG000|Overall Study|Disease Progression|21|||
124428689|NCT00680992|447530927|FG001|Overall Study|Disease Progression|9|||
124674102|NCT03118934|448430369|FG003|Overall Study|Adverse Event|0|||
124428690|NCT00680992|447530928|FG002|Overall Study|Disease Progression|0|||
124428691|NCT00680992|447530926|FG000|Overall Study|Lost to Follow-up|12|||
124674103|NCT03118934|448430370|FG004|Overall Study|Adverse Event|0|||
124674104|NCT03118934|448430371|FG005|Overall Study|Adverse Event|1|||
124674105|NCT03118934|448430366|FG000|Overall Study|Physician Decision|0|||
124674106|NCT03118934|448430367|FG001|Overall Study|Physician Decision|0|||
124674107|NCT03118934|448430368|FG002|Overall Study|Physician Decision|0|||
124674108|NCT03118934|448430369|FG003|Overall Study|Physician Decision|0|||
124674109|NCT03118934|448430370|FG004|Overall Study|Physician Decision|0|||
124674110|NCT03118934|448430371|FG005|Overall Study|Physician Decision|1|||
124674111|NCT03118934|448430366|FG000|Overall Study|Discontinued prior to exposure|0|||
124674112|NCT03118934|448430367|FG001|Overall Study|Discontinued prior to exposure|1|||
124674113|NCT03118934|448430368|FG002|Overall Study|Discontinued prior to exposure|1|||
124674114|NCT03118934|448430369|FG003|Overall Study|Discontinued prior to exposure|1|||
124674115|NCT03118934|448430370|FG004|Overall Study|Discontinued prior to exposure|2|||
124674116|NCT03118934|448430371|FG005|Overall Study|Discontinued prior to exposure|0|||
124674117|NCT02895347|448430372|FG000|Overall Study|Withdrawal by Subject|3|||
124674118|NCT02895347|448430373|FG001|Overall Study|Withdrawal by Subject|1|||
124674119|NCT03177148|448430377|FG000|Overall Study|Lost to Follow-up|50|||
124674120|NCT03177148|448430378|FG001|Overall Study|Lost to Follow-up|1|||
124674121|NCT03177148|448430377|FG000|Overall Study|Death|1|||
124674122|NCT03177148|448430378|FG001|Overall Study|Death|0|||
124674123|NCT00577317|448430383|FG000|Overall Study|Study Terminated|0|||
124674124|NCT00577317|448430384|FG001|Overall Study|Study Terminated|2|||
124674125|NCT04460326|448430385|FG000|Completed at Least 4 Meals|Early discharge|5|||
124674126|NCT04460326|448430386|FG001|Completed at Least 4 Meals|Early discharge|5|||
124674127|NCT04460326|448430385|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
124674128|NCT04460326|448430386|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
124674129|NCT04460326|448430385|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
124674130|NCT04460326|448430386|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
124674131|NCT04460326|448430385|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
124674132|NCT04460326|448430386|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
124674133|NCT04460326|448430385|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
124674134|NCT04460326|448430386|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
124674135|NCT04460326|448430385|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
124674136|NCT04460326|448430386|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
124674137|NCT03160716|448430387|FG000|Overall Study|Lost to Follow-up|1|||
124674138|NCT04794751|448430389|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
124674139|NCT04794751|448430390|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
124674140|NCT04794751|448430389|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
124674141|NCT04794751|448430390|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
124428692|NCT00680992|447530927|FG001|Overall Study|Lost to Follow-up|14|||
124428693|NCT00680992|447530928|FG002|Overall Study|Lost to Follow-up|0|||
124428694|NCT00680992|447530926|FG000|Overall Study|Noncompliance|4|||
124428695|NCT00680992|447530927|FG001|Overall Study|Noncompliance|6|||
124674142|NCT04794751|448430389|FG000|Period 1|Protocol Violation|0|||
124674143|NCT04794751|448430390|FG001|Period 1|Protocol Violation|2|||
124674144|NCT04794751|448430389|FG000|Period 1|Withdrawal by Subject|0|||
124674145|NCT04794751|448430390|FG001|Period 1|Withdrawal by Subject|1|||
124674146|NCT04794751|448430389|FG000|Period 2|Withdrawal by Subject|0|||
124674147|NCT04794751|448430390|FG001|Period 2|Withdrawal by Subject|1|||
124428696|NCT00680992|447530928|FG002|Overall Study|Noncompliance|0|||
124674148|NCT04794751|448430389|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
124428697|NCT00680992|447530926|FG000|Overall Study|Requirement for Alternative Therapy|8|||
124428698|NCT00680992|447530927|FG001|Overall Study|Requirement for Alternative Therapy|2|||
124428699|NCT00680992|447530928|FG002|Overall Study|Requirement for Alternative Therapy|0|||
124428700|NCT00680992|447530926|FG000|Overall Study|Pregnancy|5|||
124428701|NCT00680992|447530927|FG001|Overall Study|Pregnancy|0|||
124428702|NCT00680992|447530928|FG002|Overall Study|Pregnancy|1|||
124674149|NCT04794751|448430390|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
124674150|NCT04794751|448430389|FG000|Period 2|Protocol Violation|1|||
124674151|NCT04794751|448430390|FG001|Period 2|Protocol Violation|0|||
124674152|NCT00875810|448430391|FG000|Overall Study|Withdrawal by Subject|1|||
124674153|NCT00875810|448430391|FG000|Overall Study|Physician Decision|3|||
124674154|NCT00875810|448430391|FG000|Overall Study|Lost to Follow-up|39|||
124674155|NCT00875810|448430391|FG000|Overall Study|Patient enroled but not implanted|2|||
124674156|NCT00875810|448430391|FG000|Overall Study|Device explanted|1|||
124428703|NCT00680992|447530926|FG000|Overall Study|Death|5|||
124428704|NCT00680992|447530927|FG001|Overall Study|Death|1|||
124428705|NCT00680992|447530928|FG002|Overall Study|Death|0|||
124428706|NCT00680992|447530926|FG000|Overall Study|Ineligibility Determined|0|||
124428707|NCT00680992|447530927|FG001|Overall Study|Ineligibility Determined|1|||
124428708|NCT00680992|447530928|FG002|Overall Study|Ineligibility Determined|0|||
124428709|NCT01585155|447530929|FG000|Overall Study|Adverse Event|1|||
124428710|NCT01585155|447530929|FG000|Overall Study|Lack of Efficacy|2|||
124428711|NCT01585155|447530929|FG000|Overall Study|Worsening ulcerative colitis|2|||
124428712|NCT01397422|447530930|FG000|Overall Study|Adverse Event|0|||
124428713|NCT01397422|447530931|FG001|Overall Study|Adverse Event|3|||
124674157|NCT00780975|448430392|FG000|Overall Study|Progressive disease|3|||
124674158|NCT00780975|448430392|FG000|Overall Study|Toxicity|5|||
124674159|NCT03044314|448430394|FG000|Overall Study|Physician Decision|2|||
124674160|NCT03044314|448430394|FG000|Overall Study|Withdrawal by Subject|1|||
124674161|NCT03044314|448430394|FG000|Overall Study|Connector tubing not available|1|||
124674162|NCT00794664|448430400|FG000|Treatment Period|Withdrawal by Subject|0|||
124674163|NCT00794664|448430401|FG001|Treatment Period|Withdrawal by Subject|2|||
124674164|NCT00794664|448430400|FG000|Treatment Period|Protocol non-compliance|0|||
124674165|NCT00794664|448430401|FG001|Treatment Period|Protocol non-compliance|1|||
124674166|NCT00794664|448430400|FG000|Treatment Period|Other|0|||
124674167|NCT00794664|448430401|FG001|Treatment Period|Other|1|||
124674168|NCT00794664|448430400|FG000|Treatment Period|Adverse Event|1|||
124674169|NCT00794664|448430401|FG001|Treatment Period|Adverse Event|8|||
124428714|NCT01397422|447530932|FG002|Overall Study|Adverse Event|3|||
124428715|NCT01397422|447530933|FG003|Overall Study|Adverse Event|8|||
124428716|NCT01397422|447530930|FG000|Overall Study|Withdrawal by Subject|1|||
124428717|NCT01397422|447530931|FG001|Overall Study|Withdrawal by Subject|0|||
124428718|NCT01397422|447530932|FG002|Overall Study|Withdrawal by Subject|0|||
124428719|NCT01397422|447530933|FG003|Overall Study|Withdrawal by Subject|0|||
124428720|NCT01397422|447530930|FG000|Overall Study|Increased bradykinesia related to PD|1|||
124428721|NCT01397422|447530931|FG001|Overall Study|Increased bradykinesia related to PD|0|||
124428722|NCT01397422|447530932|FG002|Overall Study|Increased bradykinesia related to PD|0|||
124428723|NCT01397422|447530933|FG003|Overall Study|Increased bradykinesia related to PD|0|||
124428724|NCT00513305|447530934|FG000|Overall Study|Adverse Event|6|||
124428725|NCT00513305|447530935|FG001|Overall Study|Adverse Event|2|||
124428726|NCT00513305|447530934|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
124428727|NCT00513305|447530935|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
124428728|NCT00513305|447530934|FG000|Overall Study|Lack of Efficacy|8|||
124428729|NCT00513305|447530935|FG001|Overall Study|Lack of Efficacy|13|||
124428730|NCT00513305|447530934|FG000|Overall Study|Withdrawal by Subject|1|||
124428731|NCT00513305|447530935|FG001|Overall Study|Withdrawal by Subject|2|||
124428732|NCT00513305|447530934|FG000|Overall Study|Disease progression|8|||
124428733|NCT00513305|447530935|FG001|Overall Study|Disease progression|5|||
124428734|NCT00513305|447530934|FG000|Overall Study|Eligible for stem cell transplant|1|||
124428735|NCT00513305|447530935|FG001|Overall Study|Eligible for stem cell transplant|0|||
124428736|NCT00513305|447530934|FG000|Overall Study|Hematologic counts did not recover|1|||
124428737|NCT00513305|447530935|FG001|Overall Study|Hematologic counts did not recover|0|||
124428738|NCT00513305|447530934|FG000|Overall Study|Physician Decision|1|||
124428739|NCT00513305|447530935|FG001|Overall Study|Physician Decision|0|||
124428740|NCT00513305|447530934|FG000|Overall Study|Persistent hypocellularity|0|||
124428741|NCT00513305|447530935|FG001|Overall Study|Persistent hypocellularity|1|||
124428742|NCT00513305|447530934|FG000|Overall Study|Sponsor Decision|0|||
124428743|NCT00513305|447530935|FG001|Overall Study|Sponsor Decision|2|||
124428744|NCT02297139|447530944|FG000|Overall Study|Disease progression|0|||
124674170|NCT00794664|448430400|FG000|Follow-up Period|Other|1|||
124674171|NCT00794664|448430401|FG001|Follow-up Period|Other|2|||
124428745|NCT02297139|447530945|FG001|Overall Study|Disease progression|1|||
124428746|NCT02297139|447530944|FG000|Overall Study|Study drug toxicity|0|||
124428747|NCT02297139|447530945|FG001|Overall Study|Study drug toxicity|4|||
124428748|NCT02297139|447530944|FG000|Overall Study|Participant request to discontinue study treatment|0|||
124674172|NCT00794664|448430400|FG000|Follow-up Period|Withdrawal by Subject|0|||
124674173|NCT00794664|448430401|FG001|Follow-up Period|Withdrawal by Subject|2|||
124428749|NCT02297139|447530945|FG001|Overall Study|Participant request to discontinue study treatment|1|||
124674174|NCT00794664|448430400|FG000|Follow-up Period|Protocol non-compliance|0|||
124428750|NCT02297139|447530944|FG000|Overall Study|Maximum clinical benefit|1|||
124428751|NCT02297139|447530945|FG001|Overall Study|Maximum clinical benefit|0|||
124428752|NCT02297139|447530944|FG000|Overall Study|Administrative reason by sponsor|0|||
124428753|NCT02297139|447530945|FG001|Overall Study|Administrative reason by sponsor|2|||
124428754|NCT02297139|447530944|FG000|Overall Study|Other reasons|0|||
124428755|NCT02297139|447530945|FG001|Overall Study|Other reasons|8|||
124428756|NCT03798691|447530950|FG000|Overall Study|Lost to Follow-up|2|||
124428757|NCT03798691|447530951|FG001|Overall Study|Lost to Follow-up|2|||
124428758|NCT05148962|447530952|FG000|Overall Study|Withdrawal by Subject|1|||
124428759|NCT05148962|447530953|FG001|Overall Study|Withdrawal by Subject|1|||
124428760|NCT05148962|447530954|FG002|Overall Study|Withdrawal by Subject|0|||
124428761|NCT05148962|447530955|FG003|Overall Study|Withdrawal by Subject|1|||
124428762|NCT05148962|447530956|FG004|Overall Study|Withdrawal by Subject|0|||
124428763|NCT05148962|447530952|FG000|Overall Study|Participant was early terminated per protocol|0|||
124428764|NCT05148962|447530953|FG001|Overall Study|Participant was early terminated per protocol|0|||
124428765|NCT05148962|447530954|FG002|Overall Study|Participant was early terminated per protocol|3|||
124428766|NCT05148962|447530955|FG003|Overall Study|Participant was early terminated per protocol|5|||
124428767|NCT05148962|447530956|FG004|Overall Study|Participant was early terminated per protocol|2|||
124428768|NCT05148962|447530952|FG000|Overall Study|Miscellaneous|0|||
124428769|NCT05148962|447530953|FG001|Overall Study|Miscellaneous|0|||
124428770|NCT05148962|447530954|FG002|Overall Study|Miscellaneous|0|||
124428771|NCT05148962|447530955|FG003|Overall Study|Miscellaneous|1|||
124428772|NCT05148962|447530956|FG004|Overall Study|Miscellaneous|0|||
124428773|NCT01525238|447530961|FG000|Overall Study|Withdrawal by Subject|1|||
124428774|NCT01525238|447530962|FG001|Overall Study|Withdrawal by Subject|0|||
124428775|NCT01525238|447530963|FG002|Overall Study|Withdrawal by Subject|0|||
124428776|NCT00607724|447530964|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
124428777|NCT00607724|447530965|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
124428778|NCT00607724|447530966|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
124428779|NCT00607724|447530967|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
124428780|NCT00607724|447530968|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
124428781|NCT00607724|447530969|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
124428782|NCT00607724|447530970|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
124428783|NCT00607724|447530964|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
124428784|NCT00607724|447530965|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
124428785|NCT00607724|447530966|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
124428786|NCT00607724|447530967|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
124428787|NCT00607724|447530968|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
124428788|NCT00607724|447530969|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
124428789|NCT00607724|447530970|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
124428790|NCT00607724|447530964|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
124428791|NCT00607724|447530965|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
124428792|NCT00607724|447530966|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
124428793|NCT00607724|447530967|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
124428794|NCT00607724|447530968|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
124428795|NCT00607724|447530969|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
124428796|NCT00607724|447530970|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
124674175|NCT00794664|448430401|FG001|Follow-up Period|Protocol non-compliance|1|||
124428797|NCT00607724|447530964|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
124428798|NCT00607724|447530965|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
124428799|NCT00607724|447530966|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
124428800|NCT00607724|447530967|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
124428801|NCT00607724|447530968|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
124428802|NCT00607724|447530969|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
124674176|NCT01305564|448430406|FG000|Overall Study|Death|21|||
124674177|NCT01305564|448430406|FG000|Overall Study|Lost to Follow-up|12|||
124674178|NCT01305564|448430406|FG000|Overall Study|Withdrawal by Subject|1|||
124674179|NCT01305564|448430406|FG000|Overall Study|Physician Decision|3|||
124674180|NCT01419535|448430408|FG000|Overall Study|could not maintain iv line|1|||
124674181|NCT01419535|448430409|FG001|Overall Study|could not maintain iv line|1|||
124674182|NCT01419535|448430408|FG000|Overall Study|Withdrawal by Subject|0|||
124674183|NCT01419535|448430409|FG001|Overall Study|Withdrawal by Subject|1|||
124674184|NCT01814007|448430414|FG000|Overall Study|Withdrawal by Subject|1|||
124674185|NCT01548599|448432001|FG000|Overall Study|Lost to Follow-up|0|||
124674186|NCT01548599|448432002|FG001|Overall Study|Lost to Follow-up|1|||
124428803|NCT00607724|447530970|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
124428804|NCT00607724|447530964|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
124674187|NCT01548599|448432001|FG000|Overall Study|Withdrawal by Subject|4|||
124873000|NCT00508261|449157215|FG003|Overall Study|Lost to Follow-up|1|||
124428805|NCT00607724|447530965|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
124428806|NCT00607724|447530966|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
124674188|NCT01548599|448432002|FG001|Overall Study|Withdrawal by Subject|0|||
124674189|NCT01548599|448432001|FG000|Overall Study|Death|2|||
124674190|NCT01548599|448432002|FG001|Overall Study|Death|1|||
124674191|NCT05630196|448432003|FG000|Overall Study|Adverse Event|2|||
124674192|NCT05630196|448432004|FG001|Overall Study|Adverse Event|1|||
124674193|NCT05630196|448432003|FG000|Overall Study|Lost to Follow-up|1|||
124674194|NCT05630196|448432004|FG001|Overall Study|Lost to Follow-up|1|||
124674195|NCT05630196|448432003|FG000|Overall Study|Protocol Violation|2|||
124674196|NCT05630196|448432004|FG001|Overall Study|Protocol Violation|3|||
124674197|NCT05630196|448432003|FG000|Overall Study|Physician Decision|1|||
124674198|NCT05630196|448432004|FG001|Overall Study|Physician Decision|0|||
124674199|NCT05630196|448432003|FG000|Overall Study|Withdrawal by Subject|3|||
124674200|NCT05630196|448432004|FG001|Overall Study|Withdrawal by Subject|4|||
124674201|NCT00916578|448432005|FG000|Overall Study|Physician Decision|2|||
124674202|NCT00916578|448432005|FG000|Overall Study|Withdrawal by Subject|3|||
124674203|NCT00916578|448432005|FG000|Overall Study|Insurance Denial|2|||
124674204|NCT00352118|448432007|FG000|Overall Study|Physician Decision|4|||
124674205|NCT02308046|448432010|FG000|Overall Study|Negative yeast culture at Baseline|32|||
124674206|NCT02308046|448432011|FG001|Overall Study|Negative yeast culture at Baseline|33|||
124674207|NCT02308046|448432010|FG000|Overall Study|Positive for STD at Baseline|1|||
124674208|NCT02308046|448432011|FG001|Overall Study|Positive for STD at Baseline|2|||
124674209|NCT02308046|448432010|FG000|Overall Study|Lost to Follow-up|1|||
124674210|NCT02308046|448432011|FG001|Overall Study|Lost to Follow-up|3|||
124674211|NCT04040439|448432014|FG000|Overall Study|Invalid registration|11|||
124674212|NCT04040439|448432014|FG000|Overall Study|No IC* on publication of study results|2|||
124674213|NCT03102762|448432015|FG000|Overall Study|Lost to Follow-up|1|||
124674214|NCT03102762|448432016|FG001|Overall Study|Lost to Follow-up|0|||
124674215|NCT00958074|448432017|FG000|Overall Study|Withdrawal by Subject|0|||
124674216|NCT00958074|448432018|FG001|Overall Study|Withdrawal by Subject|1|||
124674217|NCT00752089|448432023|FG000|Overall Study|Adverse Event|1|||
124674218|NCT00752089|448432023|FG000|Overall Study|Protocol Deviation|2|||
124674219|NCT00752089|448432023|FG000|Overall Study|Could not attend visit 9|1|||
124674220|NCT00752089|448432023|FG000|Overall Study|Not capable of wearing partial denture|1|||
124674221|NCT00752089|448432023|FG000|Overall Study|Cannot continue the study|1|||
124674222|NCT02900352|448432024|FG000|Overall Study|Lost to Follow-up|28|||
124674223|NCT02900352|448432025|FG001|Overall Study|Lost to Follow-up|17|||
124674224|NCT03074695|448432026|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
124674225|NCT03074695|448432027|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
124674226|NCT03074695|448432026|FG000|Overall Study|Research staff not available|1|||
124674227|NCT03074695|448432027|FG001|Overall Study|Research staff not available|2|||
124674228|NCT03074695|448432026|FG000|Overall Study|Did not receive neuraxial block|2|||
124674229|NCT03074695|448432027|FG001|Overall Study|Did not receive neuraxial block|2|||
124674230|NCT01774981|448432028|FG000|Overall Study|Adverse Event|0|||
124674231|NCT01774981|448432029|FG001|Overall Study|Adverse Event|0|||
124674232|NCT01774981|448432030|FG002|Overall Study|Adverse Event|0|||
124674233|NCT01774981|448432031|FG003|Overall Study|Adverse Event|0|||
124674234|NCT01774981|448432032|FG004|Overall Study|Adverse Event|0|||
124674235|NCT01774981|448432033|FG005|Overall Study|Adverse Event|1|||
124674236|NCT01774981|448432034|FG006|Overall Study|Adverse Event|0|||
124674237|NCT01774981|448432035|FG007|Overall Study|Adverse Event|0|||
124674238|NCT01774981|448432028|FG000|Overall Study|Withdrawal by Subject|0|||
124674239|NCT01774981|448432029|FG001|Overall Study|Withdrawal by Subject|0|||
124674240|NCT01774981|448432030|FG002|Overall Study|Withdrawal by Subject|0|||
124674241|NCT01774981|448432031|FG003|Overall Study|Withdrawal by Subject|0|||
124674242|NCT01774981|448432032|FG004|Overall Study|Withdrawal by Subject|0|||
124674243|NCT01774981|448432033|FG005|Overall Study|Withdrawal by Subject|0|||
124674244|NCT01774981|448432034|FG006|Overall Study|Withdrawal by Subject|0|||
124674245|NCT01774981|448432035|FG007|Overall Study|Withdrawal by Subject|1|||
124674246|NCT01774981|448432028|FG000|Overall Study|Death|0|||
124674247|NCT01774981|448432029|FG001|Overall Study|Death|0|||
124674248|NCT01774981|448432030|FG002|Overall Study|Death|0|||
124674249|NCT01774981|448432031|FG003|Overall Study|Death|0|||
124674250|NCT01774981|448432032|FG004|Overall Study|Death|1|||
124674251|NCT01774981|448432033|FG005|Overall Study|Death|0|||
124674252|NCT01774981|448432034|FG006|Overall Study|Death|0|||
124674253|NCT01774981|448432035|FG007|Overall Study|Death|0|||
124674254|NCT01324102|448432036|FG000|Overall Study|illness|1|||
124674255|NCT01324102|448432037|FG001|Overall Study|illness|6|||
124674256|NCT00386334|448432038|FG000|Double Blind Period|Adverse Event|9|||
124674257|NCT00386334|448432039|FG001|Double Blind Period|Adverse Event|14|||
124674258|NCT00386334|448432038|FG000|Double Blind Period|Protocol Violation|1|||
124674259|NCT00386334|448432039|FG001|Double Blind Period|Protocol Violation|1|||
124674260|NCT00386334|448432038|FG000|Double Blind Period|Withdrawal by Subject|9|||
124674261|NCT00386334|448432039|FG001|Double Blind Period|Withdrawal by Subject|13|||
124674262|NCT00386334|448432038|FG000|Double Blind Period|Lack of Efficacy|20|||
124674263|NCT00386334|448432039|FG001|Double Blind Period|Lack of Efficacy|11|||
124674264|NCT00386334|448432038|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
124428807|NCT00607724|447530967|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
124428808|NCT00607724|447530968|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
124428809|NCT00607724|447530969|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
124428810|NCT00607724|447530970|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
124428811|NCT03738423|447530971|FG000|Overall Study|Withdrawal by Subject|9|||
124428812|NCT03738423|447530972|FG001|Overall Study|Withdrawal by Subject|12|||
124428813|NCT03738423|447530973|FG002|Overall Study|Withdrawal by Subject|9|||
124428814|NCT03738423|447530974|FG003|Overall Study|Withdrawal by Subject|12|||
124428815|NCT03738423|447530975|FG004|Overall Study|Withdrawal by Subject|10|||
124428816|NCT03738423|447530971|FG000|Overall Study|Lack of Efficacy|3|||
124428817|NCT03738423|447530972|FG001|Overall Study|Lack of Efficacy|1|||
124428818|NCT03738423|447530973|FG002|Overall Study|Lack of Efficacy|1|||
124428819|NCT03738423|447530974|FG003|Overall Study|Lack of Efficacy|1|||
124428820|NCT03738423|447530975|FG004|Overall Study|Lack of Efficacy|2|||
124428821|NCT03738423|447530971|FG000|Overall Study|Lost to Follow-up|1|||
124428822|NCT03738423|447530972|FG001|Overall Study|Lost to Follow-up|0|||
124428823|NCT03738423|447530973|FG002|Overall Study|Lost to Follow-up|1|||
124428824|NCT03738423|447530974|FG003|Overall Study|Lost to Follow-up|1|||
124428825|NCT03738423|447530975|FG004|Overall Study|Lost to Follow-up|0|||
124428826|NCT03738423|447530971|FG000|Overall Study|Protocol Violation|1|||
124428827|NCT03738423|447530972|FG001|Overall Study|Protocol Violation|0|||
124428828|NCT03738423|447530973|FG002|Overall Study|Protocol Violation|0|||
124428829|NCT03738423|447530974|FG003|Overall Study|Protocol Violation|0|||
124428830|NCT03738423|447530975|FG004|Overall Study|Protocol Violation|1|||
124428831|NCT03738423|447530971|FG000|Overall Study|Physician Decision|0|||
124428832|NCT03738423|447530972|FG001|Overall Study|Physician Decision|0|||
124428833|NCT03738423|447530973|FG002|Overall Study|Physician Decision|1|||
124428834|NCT03738423|447530974|FG003|Overall Study|Physician Decision|0|||
124428835|NCT03738423|447530975|FG004|Overall Study|Physician Decision|1|||
124428836|NCT03738423|447530971|FG000|Overall Study|Death|0|||
124428837|NCT03738423|447530972|FG001|Overall Study|Death|0|||
124428838|NCT03738423|447530973|FG002|Overall Study|Death|0|||
124428839|NCT03738423|447530974|FG003|Overall Study|Death|0|||
124674265|NCT00386334|448432039|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
124674266|NCT00386334|448432038|FG000|Double Blind Period|Other|3|||
124674267|NCT00386334|448432039|FG001|Double Blind Period|Other|3|||
124674268|NCT00386334|448432038|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
124674269|NCT00386334|448432039|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
124674270|NCT00902577|448432040|FG000|Overall Study|Withdrawal by Subject|6|||
124674271|NCT00902577|448432040|FG000|Overall Study|FMISO production failure|2|||
124674272|NCT00001566|448432041|FG000|Overall Study|patients' choice to discontinue protocol|3|||
124674273|NCT00001566|448432041|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
124674274|NCT00001566|448432041|FG000|Overall Study|Death|13|||
124674275|NCT00001566|448432041|FG000|Overall Study|Lost to Follow-up|1|||
124674276|NCT00001566|448432041|FG000|Overall Study|unable to complete initial apheresis|1|||
124674277|NCT02914834|448432042|FG000|Overall Study|Study halted due to COVID|1|||
124674278|NCT02914834|448432043|FG001|Overall Study|Study halted due to COVID|1|||
124674279|NCT02914834|448432042|FG000|Overall Study|1 subject withdrew|0|||
124674280|NCT02914834|448432043|FG001|Overall Study|1 subject withdrew|1|||
124674281|NCT00106002|448432046|FG000|Overall Study|Did not take any study drug|1|||
124674282|NCT00106002|448432046|FG000|Overall Study|Ineligible after Registration|1|||
124674283|NCT01245101|448432049|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
124674284|NCT01245101|448432050|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
124674285|NCT01245101|448432049|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
124674286|NCT01245101|448432050|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
124674287|NCT01245101|448432049|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
124674288|NCT01245101|448432050|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
124674289|NCT04456686|448432051|FG000|Overall Study|Adverse Event|2|||
124674290|NCT04456686|448432052|FG001|Overall Study|Adverse Event|1|||
124674291|NCT04456686|448432051|FG000|Overall Study|Lack of Efficacy|3|||
124674292|NCT04456686|448432052|FG001|Overall Study|Lack of Efficacy|1|||
124674293|NCT04456686|448432051|FG000|Overall Study|Withdrew consent|3|||
124674294|NCT04456686|448432052|FG001|Overall Study|Withdrew consent|1|||
124674295|NCT04456686|448432051|FG000|Overall Study|Physician Decision|2|||
124674296|NCT04456686|448432052|FG001|Overall Study|Physician Decision|2|||
124674297|NCT04456686|448432051|FG000|Overall Study|Withdrawal by Subject|5|||
124674298|NCT04456686|448432052|FG001|Overall Study|Withdrawal by Subject|1|||
124428840|NCT03738423|447530975|FG004|Overall Study|Death|1|||
124428841|NCT03738423|447530971|FG000|Overall Study|Randomized but never treated|0|||
124428842|NCT03738423|447530972|FG001|Overall Study|Randomized but never treated|0|||
124428843|NCT03738423|447530973|FG002|Overall Study|Randomized but never treated|1|||
124428844|NCT03738423|447530974|FG003|Overall Study|Randomized but never treated|1|||
124428845|NCT03738423|447530975|FG004|Overall Study|Randomized but never treated|0|||
124428846|NCT01241604|447530976|FG000|Screening Period|Screen Failure|3|||
124674299|NCT04456686|448432051|FG000|Overall Study|Protocol Violation|0|||
124674300|NCT04456686|448432052|FG001|Overall Study|Protocol Violation|1|||
124674301|NCT00473083|448432057|FG000|Overall Study|Adverse Event|1|||
124428847|NCT01241604|447530977|FG001|Screening Period|Screen Failure|0|||
124428848|NCT01241604|447530978|FG002|Screening Period|Screen Failure|0|||
124428849|NCT01593787|447530979|FG000|Overall Study|Adverse Event|1|||
124428850|NCT01593787|447530980|FG001|Overall Study|Adverse Event|0|||
124428851|NCT01593787|447530981|FG002|Overall Study|Adverse Event|0|||
124428852|NCT00151281|447530982|FG000|Overall Study|Not evaluable|3|||
124428853|NCT01865747|447530983|FG000|Overall Study (ITT)|Adverse Event|32|||
124428854|NCT01865747|447530984|FG001|Overall Study (ITT)|Adverse Event|31|||
124428855|NCT01865747|447530983|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
124428856|NCT01865747|447530984|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
124428857|NCT01865747|447530983|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
124428858|NCT01865747|447530984|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
124428859|NCT01865747|447530983|FG000|Overall Study (ITT)|Protocol Violation|1|||
124428860|NCT01865747|447530984|FG001|Overall Study (ITT)|Protocol Violation|1|||
124428861|NCT01865747|447530983|FG000|Overall Study (ITT)|Physician Decision|5|||
124428862|NCT01865747|447530984|FG001|Overall Study (ITT)|Physician Decision|2|||
124428863|NCT01865747|447530983|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
124428864|NCT01865747|447530984|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
124428865|NCT01865747|447530983|FG000|Overall Study (ITT)|Sponsor Decision|0|||
124428866|NCT01865747|447530984|FG001|Overall Study (ITT)|Sponsor Decision|1|||
124428867|NCT01865747|447530983|FG000|Overall Study (ITT)|Progressive Disease|122|||
124428868|NCT01865747|447530984|FG001|Overall Study (ITT)|Progressive Disease|158|||
124428869|NCT01865747|447530983|FG000|Overall Study (ITT)|Reason Not Provided|0|||
124428870|NCT01865747|447530984|FG001|Overall Study (ITT)|Reason Not Provided|1|||
124428871|NCT01865747|447530983|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
124428872|NCT01865747|447530984|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
124428873|NCT01865747|447530983|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
124428874|NCT01865747|447530984|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
124428875|NCT01865747|447530983|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
124428876|NCT01865747|447530984|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
124428877|NCT01865747|447530983|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
124428878|NCT01865747|447530984|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
124428879|NCT01865747|447530983|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
124428880|NCT01865747|447530984|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
124428881|NCT01865747|447530983|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
124428882|NCT01865747|447530984|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
124428883|NCT01865747|447530983|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
124428884|NCT01865747|447530984|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
124428885|NCT01865747|447530983|FG000|Primary Intent to Treat (PITT)|Other|0|||
124428886|NCT01865747|447530984|FG001|Primary Intent to Treat (PITT)|Other|1|||
124428887|NCT02592876|447530985|FG000|Overall Study|Withdrawal by Subject|3|||
124428888|NCT02592876|447530986|FG001|Overall Study|Withdrawal by Subject|3|||
124428889|NCT02592876|447530985|FG000|Overall Study|Study Termination by Sponsor|32|||
124428890|NCT02592876|447530986|FG001|Overall Study|Study Termination by Sponsor|27|||
124428891|NCT02592876|447530985|FG000|Overall Study|Lost to Follow-up|0|||
124428892|NCT02592876|447530986|FG001|Overall Study|Lost to Follow-up|1|||
124428893|NCT02592876|447530985|FG000|Overall Study|Death|6|||
124428894|NCT02592876|447530986|FG001|Overall Study|Death|9|||
124428895|NCT01133418|447530989|FG000|Overall Study|Lost to Follow-up|5|||
124428896|NCT01133418|447530990|FG001|Overall Study|Lost to Follow-up|6|||
124428897|NCT00611975|447530991|FG000|Overall Study|Withdrawal by Subject|3|||
124428898|NCT00611975|447530992|FG001|Overall Study|Withdrawal by Subject|7|||
124428899|NCT00611975|447530991|FG000|Overall Study|Pregnancy|2|||
124428900|NCT00611975|447530992|FG001|Overall Study|Pregnancy|1|||
124428901|NCT01077271|447533201|FG000|Overall Study|Parental desire|8|||
124428902|NCT01077271|447533201|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
124428903|NCT01077271|447533201|FG000|Overall Study|Noncompliance|2|||
124428904|NCT01077271|447533201|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
124428905|NCT01077271|447533201|FG000|Overall Study|Changed doctors|2|||
124428906|NCT01077271|447533201|FG000|Overall Study|Parents thought too many injections|2|||
124428907|NCT01077271|447533201|FG000|Overall Study|End of RSV season nearly reached|1|||
124428908|NCT01077271|447533201|FG000|Overall Study|Mother unconvinced of the necessity|1|||
124674302|NCT00473083|448432058|FG001|Overall Study|Adverse Event|0|||
124674303|NCT00473083|448432059|FG002|Overall Study|Adverse Event|0|||
124428909|NCT03333876|447533202|FG000|Screening Period|Screen Failure|4|||
124428910|NCT03333876|447533202|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
124428911|NCT03333876|447533202|FG000|Mandibular Advancement|Adverse Event|2|||
124428912|NCT03333876|447533202|FG000|Mandibular Advancement|Product Damage|2|||
124428913|NCT00095498|447533203|FG000|Overall Study|Physician Decision|9|||
124428914|NCT00095498|447533204|FG001|Overall Study|Physician Decision|10|||
124428915|NCT00095498|447533205|FG002|Overall Study|Physician Decision|8|||
124674304|NCT02915835|448432060|FG000|Overall Study|Physician Decision|1|||
124674305|NCT02915835|448432061|FG001|Overall Study|Physician Decision|0|||
124428916|NCT00095498|447533203|FG000|Overall Study|Adverse Event|1|||
124674306|NCT02915835|448432060|FG000|Overall Study|Withdrawal by Subject|0|||
124674307|NCT02915835|448432061|FG001|Overall Study|Withdrawal by Subject|1|||
124674308|NCT03093181|448432064|FG000|Overall Study|Withdrawal by Subject|2|||
124674309|NCT03093181|448432065|FG001|Overall Study|Withdrawal by Subject|1|||
124674310|NCT03093181|448432066|FG002|Overall Study|Withdrawal by Subject|2|||
124674311|NCT03093181|448432064|FG000|Overall Study|Other (Not specified)|1|||
124674312|NCT03093181|448432065|FG001|Overall Study|Other (Not specified)|0|||
124674313|NCT03093181|448432066|FG002|Overall Study|Other (Not specified)|0|||
124674314|NCT03093181|448432064|FG000|Overall Study|Adverse Event|0|||
124674315|NCT03093181|448432065|FG001|Overall Study|Adverse Event|1|||
124674316|NCT03093181|448432066|FG002|Overall Study|Adverse Event|0|||
124674317|NCT03093181|448432064|FG000|Overall Study|Other (Protocol violation)|0|||
124674318|NCT03093181|448432065|FG001|Overall Study|Other (Protocol violation)|0|||
124674319|NCT03093181|448432066|FG002|Overall Study|Other (Protocol violation)|1|||
124674320|NCT04210986|448432067|FG000|Overall Study|Lost to Follow-up|5|||
124674321|NCT04210986|448432068|FG001|Overall Study|Lost to Follow-up|2|||
124674322|NCT04210986|448432067|FG000|Overall Study|Withdrawal by Subject|3|||
124674323|NCT04210986|448432068|FG001|Overall Study|Withdrawal by Subject|1|||
124674324|NCT04210986|448432067|FG000|Overall Study|Protocol Violation|1|||
124674325|NCT04210986|448432068|FG001|Overall Study|Protocol Violation|1|||
124674326|NCT04210986|448432067|FG000|Overall Study|Physician Decision|0|||
124674327|NCT04210986|448432068|FG001|Overall Study|Physician Decision|1|||
124674328|NCT02378662|448432069|FG000|Overall Study|Early Discontinuation|2|||
124674329|NCT02378662|448432070|FG001|Overall Study|Early Discontinuation|0|||
124674330|NCT01159574|448432071|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
124674331|NCT01159574|448432071|FG000|Treatment Phase|Adverse Event|3|||
124674332|NCT01159574|448432071|FG000|Treatment Phase|Death|6|||
124674333|NCT01159574|448432071|FG000|Treatment Phase|Physician Decision|2|||
124674334|NCT01159574|448432071|FG000|Treatment Phase|Withdrawal by Subject|7|||
124674335|NCT01159574|448432071|FG000|Treatment Phase|still on treatment|2|||
124674336|NCT01159574|448432071|FG000|Follow Up Phase|Lost to Follow-up|2|||
124674337|NCT01159574|448432071|FG000|Follow Up Phase|still being followed for overall surviva|18|||
124674338|NCT02666222|448432072|FG000|Overall Study|Death|2|||
124674339|NCT01474486|448432074|FG000|Overall Study|Death|2|||
124674340|NCT01474486|448432074|FG000|Overall Study|Withdrawal by Subject|4|||
124674341|NCT01474486|448432074|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
124674342|NCT03504917|448432075|FG000|Blinded Treatment Period|Protocol Violation|1|||
124674343|NCT03504917|448432076|FG001|Blinded Treatment Period|Protocol Violation|0|||
124674344|NCT03504917|448432075|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
124674345|NCT03504917|448432076|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
124674346|NCT03504917|448432075|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
124674347|NCT03504917|448432076|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
124674348|NCT03504917|448432075|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
124674349|NCT03504917|448432076|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
124674350|NCT03504917|448432075|FG000|Blinded Treatment Period|Adverse Event|4|||
124674351|NCT03504917|448432076|FG001|Blinded Treatment Period|Adverse Event|4|||
124674352|NCT03504917|448432075|FG000|Blinded Treatment Period|Physician Decision|1|||
124674353|NCT03504917|448432076|FG001|Blinded Treatment Period|Physician Decision|0|||
124674354|NCT03504917|448432075|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
124428917|NCT00095498|447533204|FG001|Overall Study|Adverse Event|0|||
124428918|NCT00095498|447533205|FG002|Overall Study|Adverse Event|1|||
124428919|NCT00095498|447533203|FG000|Overall Study|Withdrawal by Subject|15|||
124428920|NCT00095498|447533204|FG001|Overall Study|Withdrawal by Subject|16|||
124674355|NCT03504917|448432076|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
124674356|NCT03504917|448432075|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
124674357|NCT03504917|448432076|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
124674358|NCT03504917|448432075|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
124674359|NCT03504917|448432076|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
124674360|NCT03504917|448432075|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
124674361|NCT03504917|448432076|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
124674362|NCT03504917|448432075|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
124674363|NCT03504917|448432076|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
124674364|NCT03504917|448432075|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
124674365|NCT03504917|448432076|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
124674366|NCT03504917|448432075|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
124674367|NCT03504917|448432076|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
124674368|NCT03504917|448432075|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
124674369|NCT03504917|448432076|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
124674370|NCT03504917|448432075|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
124674371|NCT03504917|448432076|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
124873001|NCT00180479|449157216|FG000|Overall Study|Death|4|||
124428921|NCT00095498|447533205|FG002|Overall Study|Withdrawal by Subject|15|||
124428922|NCT00095498|447533203|FG000|Overall Study|Disease progression|0|||
124428923|NCT00095498|447533204|FG001|Overall Study|Disease progression|1|||
124428924|NCT00095498|447533205|FG002|Overall Study|Disease progression|1|||
124428925|NCT00095498|447533203|FG000|Overall Study|Ineligibility determined|3|||
124428926|NCT00095498|447533204|FG001|Overall Study|Ineligibility determined|0|||
124428927|NCT00095498|447533205|FG002|Overall Study|Ineligibility determined|2|||
124428928|NCT00095498|447533203|FG000|Overall Study|Lost to Follow-up|1|||
124428929|NCT00095498|447533204|FG001|Overall Study|Lost to Follow-up|1|||
124428930|NCT00095498|447533205|FG002|Overall Study|Lost to Follow-up|2|||
124428931|NCT00095498|447533203|FG000|Overall Study|Noncompliance|1|||
124428932|NCT00095498|447533204|FG001|Overall Study|Noncompliance|0|||
124428933|NCT00095498|447533205|FG002|Overall Study|Noncompliance|1|||
124428934|NCT00095498|447533203|FG000|Overall Study|Other|6|||
124428935|NCT00095498|447533204|FG001|Overall Study|Other|7|||
124428936|NCT00095498|447533205|FG002|Overall Study|Other|6|||
124428937|NCT00095498|447533203|FG000|Overall Study|Protocol Violation|0|||
124428938|NCT00095498|447533204|FG001|Overall Study|Protocol Violation|0|||
124428939|NCT00095498|447533205|FG002|Overall Study|Protocol Violation|1|||
124428940|NCT00095498|447533203|FG000|Overall Study|Requirement for alternative therapy|1|||
124428941|NCT00095498|447533204|FG001|Overall Study|Requirement for alternative therapy|0|||
124428942|NCT00095498|447533205|FG002|Overall Study|Requirement for alternative therapy|2|||
124428943|NCT05020327|447533206|FG000|Overall Study|Physician Decision|3|||
124428944|NCT05020327|447533207|FG001|Overall Study|Physician Decision|0|||
124428945|NCT05020327|447533208|FG002|Overall Study|Physician Decision|0|||
124428946|NCT05020327|447533206|FG000|Overall Study|Withdrawal by Subject|1|||
124428947|NCT05020327|447533207|FG001|Overall Study|Withdrawal by Subject|1|||
124428948|NCT05020327|447533208|FG002|Overall Study|Withdrawal by Subject|0|||
124428949|NCT05020327|447533206|FG000|Overall Study|personal/cultural, ineligible|12|||
124428950|NCT05020327|447533207|FG001|Overall Study|personal/cultural, ineligible|0|||
124428951|NCT05020327|447533208|FG002|Overall Study|personal/cultural, ineligible|0|||
124428952|NCT04684394|447533209|FG000|Overall Study|Death|1|||
124428953|NCT04684394|447533210|FG001|Overall Study|Death|2|||
124428954|NCT04684394|447533209|FG000|Overall Study|Lost to Follow-up|1|||
124428955|NCT04684394|447533210|FG001|Overall Study|Lost to Follow-up|0|||
124428956|NCT04684394|447533209|FG000|Overall Study|Withdrawal by Subject|2|||
124428957|NCT04684394|447533210|FG001|Overall Study|Withdrawal by Subject|0|||
124428958|NCT04684394|447533209|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
124428959|NCT04684394|447533210|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
124428960|NCT00591370|447533212|FG000|Overall Study|Not Treated|2|||
124428961|NCT03439254|447533213|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
124428962|NCT03439254|447533214|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
124428963|NCT03439254|447533215|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
124428964|NCT03439254|447533216|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
124428965|NCT03439254|447533217|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
124428966|NCT03439254|447533218|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
124428967|NCT03439254|447533213|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
124428968|NCT03439254|447533214|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
124428969|NCT03439254|447533215|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
124428970|NCT03439254|447533216|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
124428971|NCT03439254|447533217|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
124428972|NCT03439254|447533218|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
124428973|NCT03439254|447533213|FG000|Double-blind Phase (18 Months)|Death|1|||
124428974|NCT03439254|447533214|FG001|Double-blind Phase (18 Months)|Death|2|||
124428975|NCT03439254|447533215|FG002|Double-blind Phase (18 Months)|Death|2|||
124428976|NCT03439254|447533216|FG003|Double-blind Phase (18 Months)|Death|0|||
124428977|NCT03439254|447533217|FG004|Double-blind Phase (18 Months)|Death|0|||
124428978|NCT03439254|447533218|FG005|Double-blind Phase (18 Months)|Death|0|||
124428979|NCT03439254|447533213|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
124428980|NCT03439254|447533214|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
124428981|NCT03439254|447533215|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
124428982|NCT03439254|447533216|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
124428983|NCT03439254|447533217|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
124428984|NCT03439254|447533218|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
124428985|NCT03439254|447533213|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
124428986|NCT03439254|447533214|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
124428987|NCT03439254|447533215|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
124428988|NCT03439254|447533216|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
124428989|NCT03439254|447533217|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
124428990|NCT03439254|447533218|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
124428991|NCT03439254|447533213|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
124428992|NCT03439254|447533214|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
124873002|NCT00180479|449157217|FG001|Overall Study|Death|2|||
124428993|NCT03439254|447533215|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
124428994|NCT03439254|447533216|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
124428995|NCT03439254|447533217|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
124428996|NCT03439254|447533218|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
124428997|NCT03439254|447533213|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
124428998|NCT03439254|447533214|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
124428999|NCT03439254|447533215|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
124429000|NCT03439254|447533216|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
124429001|NCT03439254|447533217|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
124429002|NCT03439254|447533218|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
124674372|NCT03504917|448432075|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
124674373|NCT03504917|448432076|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
124674374|NCT04233879|448432077|FG000|Overall Study|Death|2|||
124674375|NCT04233879|448432078|FG001|Overall Study|Death|0|||
124674376|NCT04233879|448432077|FG000|Overall Study|Lost to Follow-up|3|||
124429003|NCT03439254|447533213|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
124429004|NCT03439254|447533214|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
124429005|NCT03439254|447533215|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
124429006|NCT03439254|447533216|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
124429007|NCT03439254|447533217|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
124429008|NCT03439254|447533218|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
124429009|NCT03439254|447533213|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
124429010|NCT03439254|447533214|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
124429011|NCT03439254|447533215|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
124429012|NCT03439254|447533216|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
124429013|NCT03439254|447533217|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
124429014|NCT03439254|447533218|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
124429015|NCT03439254|447533213|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
124429016|NCT03439254|447533214|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
124429017|NCT03439254|447533215|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
124429018|NCT03439254|447533216|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
124429019|NCT03439254|447533217|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
124429020|NCT03439254|447533218|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
124429021|NCT03439254|447533213|FG000|Double-blind Phase (18 Months)|Site closure|0|||
124429022|NCT03439254|447533214|FG001|Double-blind Phase (18 Months)|Site closure|0|||
124429023|NCT03439254|447533215|FG002|Double-blind Phase (18 Months)|Site closure|1|||
124429024|NCT03439254|447533216|FG003|Double-blind Phase (18 Months)|Site closure|0|||
124429025|NCT03439254|447533217|FG004|Double-blind Phase (18 Months)|Site closure|0|||
124429026|NCT03439254|447533218|FG005|Double-blind Phase (18 Months)|Site closure|0|||
124429027|NCT03439254|447533213|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
124429028|NCT03439254|447533214|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
124674377|NCT04233879|448432078|FG001|Overall Study|Lost to Follow-up|8|||
124429029|NCT03439254|447533215|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
124429030|NCT03439254|447533216|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
124429031|NCT03439254|447533217|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
124429032|NCT03439254|447533218|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
124429033|NCT03439254|447533213|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
124429034|NCT03439254|447533214|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
124429035|NCT03439254|447533215|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
124674378|NCT04233879|448432077|FG000|Overall Study|Physician Decision|4|||
124674379|NCT04233879|448432078|FG001|Overall Study|Physician Decision|4|||
124674380|NCT04233879|448432077|FG000|Overall Study|Withdrawal by Subject|7|||
124674381|NCT04233879|448432078|FG001|Overall Study|Withdrawal by Subject|10|||
124674382|NCT04233879|448432077|FG000|Overall Study|Other|281|||
124674383|NCT04233879|448432078|FG001|Overall Study|Other|279|||
124674384|NCT01673178|448432094|FG000|Overall Study|Lost to Follow-up|0|||
124674385|NCT01673178|448432095|FG001|Overall Study|Lost to Follow-up|1|||
124674386|NCT01673178|448432096|FG002|Overall Study|Lost to Follow-up|0|||
124674387|NCT01673178|448432097|FG003|Overall Study|Lost to Follow-up|0|||
124674388|NCT01673178|448432098|FG004|Overall Study|Lost to Follow-up|0|||
124674389|NCT01673178|448432094|FG000|Overall Study|Withdrawal by Subject|0|||
124674390|NCT01673178|448432095|FG001|Overall Study|Withdrawal by Subject|0|||
124674391|NCT01673178|448432096|FG002|Overall Study|Withdrawal by Subject|1|||
124674392|NCT01673178|448432097|FG003|Overall Study|Withdrawal by Subject|4|||
124674393|NCT01673178|448432098|FG004|Overall Study|Withdrawal by Subject|2|||
124674394|NCT01673178|448432094|FG000|Overall Study|Protocol Violation|1|||
124674395|NCT01673178|448432095|FG001|Overall Study|Protocol Violation|1|||
124674396|NCT01673178|448432096|FG002|Overall Study|Protocol Violation|0|||
124674397|NCT01673178|448432097|FG003|Overall Study|Protocol Violation|1|||
124674398|NCT01673178|448432098|FG004|Overall Study|Protocol Violation|0|||
124674399|NCT01673178|448432094|FG000|Overall Study|Adverse Event|1|||
124674400|NCT01673178|448432095|FG001|Overall Study|Adverse Event|0|||
124674401|NCT01673178|448432096|FG002|Overall Study|Adverse Event|0|||
124674402|NCT01673178|448432097|FG003|Overall Study|Adverse Event|2|||
124674403|NCT01673178|448432098|FG004|Overall Study|Adverse Event|0|||
124674404|NCT01673178|448432094|FG000|Overall Study|Other|1|||
124674405|NCT01673178|448432095|FG001|Overall Study|Other|0|||
124674406|NCT01673178|448432096|FG002|Overall Study|Other|2|||
124674407|NCT01673178|448432097|FG003|Overall Study|Other|1|||
124674408|NCT01673178|448432098|FG004|Overall Study|Other|0|||
124674409|NCT01405898|448432100|FG000|Overall Study|Withdrawal by Subject|2|||
124674410|NCT01405898|448432101|FG001|Overall Study|Withdrawal by Subject|2|||
124674411|NCT03106077|448432106|FG000|Overall Study|Screen Failure|94|||
124674412|NCT03106077|448432107|FG001|Overall Study|Screen Failure|0|||
124674413|NCT00449163|448432108|FG000|Overall Study|Physician Decision|3|||
124674414|NCT00606307|448432111|FG000|Overall Study|Adverse Event|2|||
124674415|NCT00606307|448432111|FG000|Overall Study|Withdrawal by Subject|2|||
124674416|NCT00606307|448432111|FG000|Overall Study|Disease progression|6|||
124674417|NCT00606307|448432111|FG000|Overall Study|QTc prolongation|1|||
124674418|NCT02008526|448432119|FG000|Overall Study|Death|0|||
124674419|NCT02008526|448432120|FG001|Overall Study|Death|2|||
124674420|NCT02008526|448432121|FG002|Overall Study|Death|1|||
124674421|NCT02008526|448432119|FG000|Overall Study|Withdrawal by Subject|3|||
124674422|NCT02008526|448432120|FG001|Overall Study|Withdrawal by Subject|3|||
124674423|NCT02008526|448432121|FG002|Overall Study|Withdrawal by Subject|2|||
124674424|NCT02008526|448432119|FG000|Overall Study|Lost to Follow-up|5|||
124674425|NCT02008526|448432120|FG001|Overall Study|Lost to Follow-up|9|||
124674426|NCT02008526|448432121|FG002|Overall Study|Lost to Follow-up|6|||
124674427|NCT00492726|448432123|FG000|Overall Study|Adverse Event|10|||
124674428|NCT00492726|448432124|FG001|Overall Study|Adverse Event|6|||
124429036|NCT03439254|447533216|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
124429037|NCT03439254|447533217|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
124429038|NCT03439254|447533218|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
124429039|NCT03439254|447533213|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
124429040|NCT03439254|447533214|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
124429041|NCT03439254|447533215|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
124429042|NCT03439254|447533216|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
124429043|NCT03439254|447533217|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
124429044|NCT03439254|447533218|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
124429045|NCT03439254|447533213|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
124429046|NCT03439254|447533214|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
124429047|NCT03439254|447533215|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
124429048|NCT03439254|447533216|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
124429049|NCT03439254|447533217|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
124429050|NCT03439254|447533218|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
124674429|NCT00492726|448432123|FG000|Overall Study|Death|7|||
124674430|NCT00492726|448432124|FG001|Overall Study|Death|2|||
124674431|NCT00492726|448432123|FG000|Overall Study|Lack of Efficacy|0|||
124674432|NCT00492726|448432124|FG001|Overall Study|Lack of Efficacy|2|||
124674433|NCT00492726|448432123|FG000|Overall Study|Lost to Follow-up|27|||
124674434|NCT00492726|448432124|FG001|Overall Study|Lost to Follow-up|19|||
124674435|NCT00492726|448432123|FG000|Overall Study|Physician Decision|0|||
124674436|NCT00492726|448432124|FG001|Overall Study|Physician Decision|1|||
124674437|NCT00492726|448432123|FG000|Overall Study|Withdrawal by Subject|6|||
124674438|NCT00492726|448432124|FG001|Overall Study|Withdrawal by Subject|3|||
124674439|NCT00492726|448432123|FG000|Overall Study|Non compliant with study medication|0|||
124674440|NCT00492726|448432124|FG001|Overall Study|Non compliant with study medication|3|||
124674441|NCT04386902|448432125|FG000|Overall Study|Withdrawal by Subject|5|||
124674442|NCT04386902|448432125|FG000|Overall Study|Technical problems in the recording|5|||
124674443|NCT00828711|448432126|FG000|Overall Study|Lost to Follow-up|1|||
124429051|NCT03439254|447533213|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
124429052|NCT03439254|447533214|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
124429053|NCT03439254|447533215|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
124429054|NCT03439254|447533216|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
124429055|NCT03439254|447533217|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
124429056|NCT03439254|447533218|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
124429057|NCT03439254|447533213|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
124429058|NCT03439254|447533214|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
124429059|NCT03439254|447533215|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
124429060|NCT03439254|447533216|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
124429061|NCT03439254|447533217|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
124429062|NCT03439254|447533218|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
124429063|NCT03439254|447533213|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
124429064|NCT03439254|447533214|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
124429065|NCT03439254|447533215|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
124429066|NCT03439254|447533216|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
124429067|NCT03439254|447533217|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
124429068|NCT03439254|447533218|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
124429069|NCT03439254|447533213|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
124429070|NCT03439254|447533214|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
124429071|NCT03439254|447533215|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
124429072|NCT03439254|447533216|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
124674444|NCT00828711|448432127|FG001|Overall Study|Lost to Follow-up|0|||
124674445|NCT00828711|448432128|FG002|Overall Study|Lost to Follow-up|0|||
124674446|NCT02230891|448432129|FG000|Baseline|Did not meet inclusion|0|||
124674447|NCT02230891|448432130|FG001|Baseline|Did not meet inclusion|1|||
124674448|NCT02230891|448432131|FG002|Baseline|Did not meet inclusion|1|||
124674449|NCT02230891|448432129|FG000|2 Week|Withdrawal by Subject|2|||
124674450|NCT02230891|448432130|FG001|2 Week|Withdrawal by Subject|2|||
124674451|NCT02230891|448432131|FG002|2 Week|Withdrawal by Subject|0|||
124674452|NCT02230891|448432129|FG000|2 Week|Consent withdrawn|1|||
124674453|NCT02230891|448432130|FG001|2 Week|Consent withdrawn|0|||
124674454|NCT02230891|448432131|FG002|2 Week|Consent withdrawn|0|||
124674455|NCT02230891|448432129|FG000|6 Month|Withdrawal by Subject|1|||
124674456|NCT02230891|448432130|FG001|6 Month|Withdrawal by Subject|1|||
124674457|NCT02230891|448432131|FG002|6 Month|Withdrawal by Subject|1|||
124429073|NCT03439254|447533217|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
124429074|NCT03439254|447533218|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
124429075|NCT03439254|447533213|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
124429076|NCT03439254|447533214|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
124429077|NCT03439254|447533215|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
124429078|NCT03439254|447533216|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
124429079|NCT03439254|447533217|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
124429080|NCT03439254|447533218|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
124429081|NCT03439254|447533213|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
124429082|NCT03439254|447533214|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
124429083|NCT03439254|447533215|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
124429084|NCT03439254|447533216|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
124429085|NCT03439254|447533217|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
124429086|NCT03439254|447533218|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
124429087|NCT03439254|447533213|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
124429088|NCT03439254|447533214|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
124429089|NCT03439254|447533215|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
124429090|NCT03439254|447533216|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
124429091|NCT03439254|447533217|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
124429092|NCT03439254|447533218|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
124429093|NCT03439254|447533213|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
124429094|NCT03439254|447533214|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
124429095|NCT03439254|447533215|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
124429096|NCT03439254|447533216|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
124674458|NCT02230891|448432129|FG000|6 Month|Physician Decision|0|||
124674459|NCT02230891|448432130|FG001|6 Month|Physician Decision|2|||
124674460|NCT02230891|448432131|FG002|6 Month|Physician Decision|0|||
124674461|NCT02230891|448432129|FG000|12 Month|Death|1|||
124674462|NCT02230891|448432130|FG001|12 Month|Death|0|||
124674463|NCT02230891|448432131|FG002|12 Month|Death|0|||
124674464|NCT02230891|448432129|FG000|12 Month|Lost to Follow-up|0|||
124674465|NCT02230891|448432130|FG001|12 Month|Lost to Follow-up|1|||
124429097|NCT03439254|447533217|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
124429098|NCT03439254|447533218|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
124429099|NCT02075476|447533220|FG000|Overall Study|Death|2|||
124429100|NCT02075476|447533221|FG001|Overall Study|Death|2|||
124429101|NCT02075476|447533220|FG000|Overall Study|Lost to Follow-up|1|||
124429102|NCT02075476|447533221|FG001|Overall Study|Lost to Follow-up|3|||
124429103|NCT00095056|447533222|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
124429104|NCT00095056|447533223|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
124429105|NCT00095056|447533222|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
124429106|NCT00095056|447533223|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
124429107|NCT00095056|447533222|FG000|Phase A (Weeks 0-12)|Death|1|||
124429108|NCT00095056|447533223|FG001|Phase A (Weeks 0-12)|Death|0|||
124429109|NCT00095056|447533222|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
124429110|NCT00095056|447533223|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
124429111|NCT00095056|447533222|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
124429112|NCT00095056|447533223|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
124429113|NCT00095056|447533222|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
124429114|NCT00095056|447533223|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
124429115|NCT00095056|447533222|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
124429116|NCT00095056|447533223|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
124429117|NCT00095056|447533222|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
124429118|NCT00095056|447533223|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
124429119|NCT00095056|447533222|FG000|Phase B (Weeks 12-54)|Death|3|||
124429120|NCT00095056|447533223|FG001|Phase B (Weeks 12-54)|Death|1|||
124429121|NCT00095056|447533222|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
124429122|NCT00095056|447533223|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
124429123|NCT00095056|447533222|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
124429124|NCT00095056|447533223|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
124429125|NCT00923260|447533229|FG000|Overall Study|Lost to Follow-up|1|||
124429126|NCT00923260|447533230|FG001|Overall Study|Lost to Follow-up|1|||
124429127|NCT03377699|447533236|FG000|Overall Study|Withdrawal by Subject|2|||
124429128|NCT03377699|447533237|FG001|Overall Study|Withdrawal by Subject|9|||
124429129|NCT03377699|447533236|FG000|Overall Study|Lost to Follow-up|1|||
124429130|NCT03377699|447533237|FG001|Overall Study|Lost to Follow-up|1|||
124429131|NCT03377699|447533236|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
124429132|NCT03377699|447533237|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
124429133|NCT03377699|447533236|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
124429134|NCT03377699|447533237|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
124429135|NCT03377699|447533236|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
124429136|NCT03377699|447533237|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
124429137|NCT03377699|447533236|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
124429138|NCT03377699|447533237|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
124429139|NCT02580305|447533238|FG000|Overall Study|Adverse Event|15|||
124429140|NCT02580305|447533239|FG001|Overall Study|Adverse Event|19|||
124429141|NCT02580305|447533240|FG002|Overall Study|Adverse Event|10|||
124429142|NCT02580305|447533238|FG000|Overall Study|Lack of Efficacy|5|||
124429143|NCT02580305|447533239|FG001|Overall Study|Lack of Efficacy|0|||
124429144|NCT02580305|447533240|FG002|Overall Study|Lack of Efficacy|2|||
124429145|NCT02580305|447533238|FG000|Overall Study|Protocol Violation|4|||
124429146|NCT02580305|447533239|FG001|Overall Study|Protocol Violation|9|||
124429147|NCT02580305|447533240|FG002|Overall Study|Protocol Violation|6|||
124429148|NCT02580305|447533238|FG000|Overall Study|Lost to Follow-up|4|||
124429149|NCT02580305|447533239|FG001|Overall Study|Lost to Follow-up|4|||
124429150|NCT02580305|447533240|FG002|Overall Study|Lost to Follow-up|2|||
124429151|NCT02580305|447533238|FG000|Overall Study|Withdrawal by Subject|11|||
124429152|NCT02580305|447533239|FG001|Overall Study|Withdrawal by Subject|9|||
124429153|NCT02580305|447533240|FG002|Overall Study|Withdrawal by Subject|7|||
124674466|NCT02230891|448432131|FG002|12 Month|Lost to Follow-up|0|||
124674467|NCT02230891|448432129|FG000|12 Month|Withdrawal by Subject|0|||
124429154|NCT02580305|447533238|FG000|Overall Study|Randomized in error and never treated|4|||
124429155|NCT02580305|447533239|FG001|Overall Study|Randomized in error and never treated|8|||
124429156|NCT02580305|447533240|FG002|Overall Study|Randomized in error and never treated|5|||
124429157|NCT00941070|447533242|FG000|Overall Study|Patient non-compliant|1|||
124429158|NCT01416389|447533245|FG000|Overall Study|Lost to Follow-up|1|||
124429159|NCT01416389|447533246|FG001|Overall Study|Lost to Follow-up|0|||
124429160|NCT01416389|447533245|FG000|Overall Study|Started New Therapy|2|||
124429161|NCT01416389|447533246|FG001|Overall Study|Started New Therapy|0|||
124429162|NCT01125514|447533247|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
124429163|NCT01125514|447533247|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
124429164|NCT01125514|447533247|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
124429165|NCT01125514|447533247|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
124674468|NCT02230891|448432130|FG001|12 Month|Withdrawal by Subject|2|||
124674469|NCT02230891|448432131|FG002|12 Month|Withdrawal by Subject|0|||
124674470|NCT02230891|448432129|FG000|18 Month End of Study|Death|0|||
124674471|NCT02230891|448432130|FG001|18 Month End of Study|Death|0|||
124674472|NCT02230891|448432131|FG002|18 Month End of Study|Death|1|||
124674473|NCT02230891|448432129|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
124674474|NCT02230891|448432130|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
124674475|NCT02230891|448432131|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
124674476|NCT02033759|448432133|FG000|Overall Study|Withdrawal by Subject|2|||
124674477|NCT02033759|448432134|FG001|Overall Study|Withdrawal by Subject|1|||
124674478|NCT02033759|448432133|FG000|Overall Study|Protocol Violation|1|||
124674479|NCT02033759|448432134|FG001|Overall Study|Protocol Violation|1|||
124674480|NCT03141359|448432140|FG000|Overall Study|Death|32|||
124674481|NCT03141359|448432140|FG000|Overall Study|Still On Study (in follow up)|29|||
124674482|NCT01081626|448432141|FG000|Overall Study|Dosing error|1|||
124674483|NCT01081626|448432142|FG001|Overall Study|Dosing error|1|||
124674484|NCT01081626|448432141|FG000|Overall Study|Missing Estradiol|25|||
124674485|NCT01081626|448432142|FG001|Overall Study|Missing Estradiol|28|||
124674486|NCT01081626|448432141|FG000|Overall Study|Low antral follicle count|1|||
124674487|NCT01081626|448432142|FG001|Overall Study|Low antral follicle count|0|||
124674488|NCT01081626|448432141|FG000|Overall Study|Overstimulation|0|||
124674489|NCT01081626|448432142|FG001|Overall Study|Overstimulation|1|||
124674490|NCT01081626|448432141|FG000|Overall Study|Lost to Follow-up|0|||
124674491|NCT01081626|448432142|FG001|Overall Study|Lost to Follow-up|1|||
124674492|NCT01081626|448432141|FG000|Overall Study|Other|33|||
124674493|NCT01081626|448432142|FG001|Overall Study|Other|30|||
124674494|NCT00870727|448433489|FG000|Overall Study|Lost to Follow-up|0|||
124674495|NCT00870727|448433490|FG001|Overall Study|Lost to Follow-up|1|||
124674496|NCT00870727|448433489|FG000|Overall Study|Lack of Efficacy|1|||
124674497|NCT00870727|448433490|FG001|Overall Study|Lack of Efficacy|3|||
124674498|NCT00870727|448433489|FG000|Overall Study|Adverse Event|0|||
124674499|NCT00870727|448433490|FG001|Overall Study|Adverse Event|1|||
124674500|NCT00720278|448433491|FG000|Overall Study|Adverse Event|5|||
124674501|NCT00720278|448433492|FG001|Overall Study|Adverse Event|3|||
124674502|NCT00720278|448433493|FG002|Overall Study|Adverse Event|4|||
124674503|NCT00720278|448433491|FG000|Overall Study|Withdrawal by Subject|0|||
124674504|NCT00720278|448433492|FG001|Overall Study|Withdrawal by Subject|1|||
124674505|NCT00720278|448433493|FG002|Overall Study|Withdrawal by Subject|0|||
124674506|NCT00720278|448433491|FG000|Overall Study|Lost to Follow-up|0|||
124674507|NCT00720278|448433492|FG001|Overall Study|Lost to Follow-up|0|||
124674508|NCT00720278|448433493|FG002|Overall Study|Lost to Follow-up|1|||
124674509|NCT00720278|448433491|FG000|Overall Study|Non-compliance|1|||
124674510|NCT00720278|448433492|FG001|Overall Study|Non-compliance|0|||
124674511|NCT00720278|448433493|FG002|Overall Study|Non-compliance|0|||
124674512|NCT00720278|448433491|FG000|Overall Study|eligibility criteria violation|1|||
124674513|NCT00720278|448433492|FG001|Overall Study|eligibility criteria violation|0|||
124674514|NCT00720278|448433493|FG002|Overall Study|eligibility criteria violation|1|||
124674515|NCT01712516|448433494|FG000|Overall Study|Technical problems|0|||
124674516|NCT01712516|448433495|FG001|Overall Study|Technical problems|0|||
124674517|NCT01712516|448433496|FG002|Overall Study|Technical problems|0|||
124674518|NCT01712516|448433497|FG003|Overall Study|Technical problems|2|||
124674519|NCT01712516|448433494|FG000|Overall Study|Lost to Follow-up|0|||
124674520|NCT01712516|448433495|FG001|Overall Study|Lost to Follow-up|0|||
124674521|NCT01712516|448433496|FG002|Overall Study|Lost to Follow-up|2|||
124674522|NCT01712516|448433497|FG003|Overall Study|Lost to Follow-up|1|||
124674523|NCT01712516|448433494|FG000|Overall Study|Death|0|||
124674524|NCT01712516|448433495|FG001|Overall Study|Death|1|||
124674525|NCT01712516|448433496|FG002|Overall Study|Death|0|||
124674526|NCT01712516|448433497|FG003|Overall Study|Death|0|||
124674527|NCT01712516|448433494|FG000|Overall Study|Protocol deviation|1|||
124674528|NCT01712516|448433495|FG001|Overall Study|Protocol deviation|0|||
124674529|NCT01712516|448433496|FG002|Overall Study|Protocol deviation|1|||
124674530|NCT01712516|448433497|FG003|Overall Study|Protocol deviation|0|||
124674531|NCT01712516|448433494|FG000|Overall Study|Physician Decision|2|||
124674532|NCT01712516|448433495|FG001|Overall Study|Physician Decision|0|||
124674533|NCT01712516|448433496|FG002|Overall Study|Physician Decision|0|||
124674534|NCT01712516|448433497|FG003|Overall Study|Physician Decision|1|||
124674535|NCT01712516|448433494|FG000|Overall Study|Withdrawal by Subject|3|||
124674536|NCT01712516|448433495|FG001|Overall Study|Withdrawal by Subject|9|||
124674537|NCT01712516|448433496|FG002|Overall Study|Withdrawal by Subject|3|||
124674538|NCT01712516|448433497|FG003|Overall Study|Withdrawal by Subject|9|||
124674539|NCT01181167|448433501|FG000|Overall Study|Adverse Event|11|||
124674540|NCT01181167|448433502|FG001|Overall Study|Adverse Event|21|||
124674541|NCT01181167|448433501|FG000|Overall Study|Lost to Follow-up|1|||
124674542|NCT01181167|448433502|FG001|Overall Study|Lost to Follow-up|0|||
124674543|NCT01181167|448433501|FG000|Overall Study|Physician Decision|2|||
124674544|NCT01181167|448433502|FG001|Overall Study|Physician Decision|3|||
124674545|NCT01181167|448433501|FG000|Overall Study|Protocol Violation|3|||
124674546|NCT01181167|448433502|FG001|Overall Study|Protocol Violation|0|||
124674547|NCT01181167|448433501|FG000|Overall Study|Withdrawal by Subject|6|||
124429166|NCT01125514|447533247|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
124429167|NCT01125514|447533247|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
124429168|NCT02755818|447533250|FG000|Overall Study|Withdrawal by Subject|0|||
124429169|NCT02755818|447533251|FG001|Overall Study|Withdrawal by Subject|0|||
124429170|NCT02755818|447533252|FG002|Overall Study|Withdrawal by Subject|0|||
124429171|NCT02755818|447533253|FG003|Overall Study|Withdrawal by Subject|2|||
124429172|NCT02755818|447533250|FG000|Overall Study|withdrawal by PI|0|||
124429173|NCT02755818|447533251|FG001|Overall Study|withdrawal by PI|0|||
124429174|NCT02755818|447533252|FG002|Overall Study|withdrawal by PI|1|||
124429175|NCT02755818|447533253|FG003|Overall Study|withdrawal by PI|1|||
124429176|NCT02535091|447533254|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
124429177|NCT02535091|447533255|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
124429178|NCT02535091|447533256|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
124429179|NCT02535091|447533254|FG000|Overall Study|Withdrawal by Subject|14|||
124429180|NCT02535091|447533255|FG001|Overall Study|Withdrawal by Subject|5|||
124429181|NCT02535091|447533256|FG002|Overall Study|Withdrawal by Subject|121|||
124429182|NCT02535091|447533254|FG000|Overall Study|Adverse Event|9|||
124429183|NCT02535091|447533255|FG001|Overall Study|Adverse Event|4|||
124429184|NCT02535091|447533256|FG002|Overall Study|Adverse Event|170|||
124429185|NCT02535091|447533254|FG000|Overall Study|Other|4|||
124429186|NCT02535091|447533255|FG001|Overall Study|Other|3|||
124429187|NCT02535091|447533256|FG002|Overall Study|Other|81|||
124429188|NCT02535091|447533254|FG000|Overall Study|Lost to Follow-up|0|||
124429189|NCT02535091|447533255|FG001|Overall Study|Lost to Follow-up|1|||
124429190|NCT02535091|447533256|FG002|Overall Study|Lost to Follow-up|19|||
124674548|NCT01181167|448433502|FG001|Overall Study|Withdrawal by Subject|8|||
124674549|NCT00161213|448433503|FG000|Overall Study|Withdrawal by Subject|1|||
124674550|NCT00161213|448433503|FG000|Overall Study|Evaluable for toxicity but not response|1|||
124674551|NCT03103503|448433504|FG000|Overall Study|Death|64|||
124429191|NCT02535091|447533254|FG000|Overall Study|Protocol Violation|0|||
124429192|NCT02535091|447533255|FG001|Overall Study|Protocol Violation|1|||
124429193|NCT02535091|447533256|FG002|Overall Study|Protocol Violation|11|||
124674552|NCT03103503|448433504|FG000|Overall Study|Physician Decision|57|||
124674553|NCT03103503|448433504|FG000|Overall Study|Withdrawal by Subject|10|||
124674554|NCT03103503|448433504|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
124674555|NCT03103503|448433504|FG000|Overall Study|Lost to Follow-up|3|||
124674556|NCT03103503|448433504|FG000|Overall Study|Study Closure|757|||
124674557|NCT01384877|448433505|FG000|Treatment 2|Lost to Follow-up|2|||
124674558|NCT01384877|448433506|FG001|Treatment 2|Lost to Follow-up|2|||
124674559|NCT01586195|448433507|FG000|Overall Study|Death|11|||
124674560|NCT01586195|448433507|FG000|Overall Study|Withdrawal of Consent|5|||
124674561|NCT01586195|448433507|FG000|Overall Study|Started new anti-melanoma therapy|1|||
124674562|NCT01586195|448433507|FG000|Overall Study|Reason not specified|9|||
124674563|NCT02683109|448433510|FG000|Overall Study|Adverse Event|1|||
124674564|NCT02683109|448433511|FG001|Overall Study|Adverse Event|0|||
124674565|NCT00183430|448433512|FG000|Overall Study|Adverse Event|1|||
124674566|NCT00183430|448433513|FG001|Overall Study|Adverse Event|0|||
124674567|NCT00183430|448433512|FG000|Overall Study|Lost to Follow-up|3|||
124674568|NCT00183430|448433513|FG001|Overall Study|Lost to Follow-up|0|||
124674569|NCT00183430|448433512|FG000|Overall Study|did not meet inclusion criteria|1|||
124674570|NCT00183430|448433513|FG001|Overall Study|did not meet inclusion criteria|0|||
124674571|NCT00183430|448433512|FG000|Overall Study|Withdrawal by Subject|1|||
124429194|NCT02535091|447533254|FG000|Overall Study|Pregnancy|0|||
124429195|NCT02535091|447533255|FG001|Overall Study|Pregnancy|0|||
124429196|NCT02535091|447533256|FG002|Overall Study|Pregnancy|7|||
124429197|NCT03223662|447533257|FG000|Overall Study|Physician Decision|1|||
124429198|NCT03223662|447533257|FG000|Overall Study|Study closure|1|||
124429199|NCT02217475|447533258|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
124429200|NCT02217475|447533259|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
124429201|NCT02217475|447533260|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
124429202|NCT02217475|447533258|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
124674572|NCT00183430|448433513|FG001|Overall Study|Withdrawal by Subject|0|||
124429203|NCT02217475|447533259|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
124674573|NCT01587885|448433514|FG000|Treatment Period 1|Failure to Return|0|||
124674574|NCT01587885|448433515|FG001|Treatment Period 1|Failure to Return|1|||
124429204|NCT02217475|447533260|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
124429205|NCT02217475|447533258|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
124674575|NCT01587885|448433514|FG000|Treatment Period 1|Protocol Violation|0|||
124674576|NCT01587885|448433515|FG001|Treatment Period 1|Protocol Violation|2|||
124674577|NCT00975416|448433518|FG000|Overall Study|early discharge from tx|3|||
124674578|NCT00975416|448433519|FG001|Overall Study|early discharge from tx|5|||
124674579|NCT03555149|448433524|FG000|Overall Study|Death|18|||
124674580|NCT03555149|448433525|FG001|Overall Study|Death|15|||
124674581|NCT03555149|448433526|FG002|Overall Study|Death|15|||
124674582|NCT03555149|448433527|FG003|Overall Study|Death|4|||
124674583|NCT03555149|448433528|FG004|Overall Study|Death|4|||
124674584|NCT03555149|448433529|FG005|Overall Study|Death|11|||
124674585|NCT03555149|448433530|FG006|Overall Study|Death|12|||
124674586|NCT03555149|448433531|FG007|Overall Study|Death|1|||
124674587|NCT03555149|448433524|FG000|Overall Study|Lost to Follow-up|1|||
124674588|NCT03555149|448433525|FG001|Overall Study|Lost to Follow-up|0|||
124674589|NCT03555149|448433526|FG002|Overall Study|Lost to Follow-up|0|||
124674590|NCT03555149|448433527|FG003|Overall Study|Lost to Follow-up|0|||
124674591|NCT03555149|448433528|FG004|Overall Study|Lost to Follow-up|0|||
124674592|NCT03555149|448433529|FG005|Overall Study|Lost to Follow-up|1|||
124674593|NCT03555149|448433530|FG006|Overall Study|Lost to Follow-up|0|||
124674594|NCT03555149|448433531|FG007|Overall Study|Lost to Follow-up|0|||
124674595|NCT03555149|448433524|FG000|Overall Study|Physician Decision|1|||
124674596|NCT03555149|448433525|FG001|Overall Study|Physician Decision|0|||
124674597|NCT03555149|448433526|FG002|Overall Study|Physician Decision|0|||
124674598|NCT03555149|448433527|FG003|Overall Study|Physician Decision|0|||
124674599|NCT03555149|448433528|FG004|Overall Study|Physician Decision|0|||
124674600|NCT03555149|448433529|FG005|Overall Study|Physician Decision|0|||
124674601|NCT03555149|448433530|FG006|Overall Study|Physician Decision|0|||
124674602|NCT03555149|448433531|FG007|Overall Study|Physician Decision|0|||
124674603|NCT03555149|448433524|FG000|Overall Study|Study Terminated By Sponsor|1|||
124674604|NCT03555149|448433525|FG001|Overall Study|Study Terminated By Sponsor|0|||
124674605|NCT03555149|448433526|FG002|Overall Study|Study Terminated By Sponsor|0|||
124674606|NCT03555149|448433527|FG003|Overall Study|Study Terminated By Sponsor|0|||
124674607|NCT03555149|448433528|FG004|Overall Study|Study Terminated By Sponsor|0|||
124674608|NCT03555149|448433529|FG005|Overall Study|Study Terminated By Sponsor|2|||
124674609|NCT03555149|448433530|FG006|Overall Study|Study Terminated By Sponsor|3|||
124674610|NCT03555149|448433531|FG007|Overall Study|Study Terminated By Sponsor|1|||
124674611|NCT03555149|448433524|FG000|Overall Study|Withdrawal by Subject|3|||
124674612|NCT03555149|448433525|FG001|Overall Study|Withdrawal by Subject|0|||
124674613|NCT03555149|448433526|FG002|Overall Study|Withdrawal by Subject|0|||
124674614|NCT03555149|448433527|FG003|Overall Study|Withdrawal by Subject|2|||
124674615|NCT03555149|448433528|FG004|Overall Study|Withdrawal by Subject|0|||
124674616|NCT03555149|448433529|FG005|Overall Study|Withdrawal by Subject|1|||
124674617|NCT03555149|448433530|FG006|Overall Study|Withdrawal by Subject|0|||
124674618|NCT03555149|448433531|FG007|Overall Study|Withdrawal by Subject|0|||
124674619|NCT03863353|448433535|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
124674620|NCT03863353|448433536|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
124674621|NCT05817669|448433537|FG000|Overall Study|Prohibited medication used|1|||
124674622|NCT05817669|448433538|FG001|Overall Study|Prohibited medication used|2|||
124674623|NCT05817669|448433537|FG000|Overall Study|Adverse Event|1|||
124674624|NCT05817669|448433538|FG001|Overall Study|Adverse Event|0|||
124429206|NCT02217475|447533259|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
124429207|NCT02217475|447533260|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
124429208|NCT02217475|447533258|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
124429209|NCT02217475|447533259|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
124429210|NCT02217475|447533260|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
124429211|NCT02217475|447533258|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
124429212|NCT02217475|447533259|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
124429213|NCT02217475|447533260|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
124674625|NCT05817669|448433537|FG000|Overall Study|Withdrawal by Subject|1|||
124674626|NCT05817669|448433538|FG001|Overall Study|Withdrawal by Subject|2|||
124674627|NCT03810183|448433539|FG000|Overall Study|Study terminated by Sponsor|2|||
124674628|NCT03810183|448433540|FG001|Overall Study|Study terminated by Sponsor|1|||
124674629|NCT00323063|448433542|FG000|Overall Study|Adverse Event|1|||
124674630|NCT00323063|448433543|FG001|Overall Study|Adverse Event|0|||
124674631|NCT00323063|448433542|FG000|Overall Study|brain mets discovered prior to treatment|1|||
124674632|NCT00323063|448433543|FG001|Overall Study|brain mets discovered prior to treatment|0|||
124674633|NCT03786380|448433544|FG000|Overall Study|Adverse Event|1|||
124674634|NCT03786380|448433545|FG001|Overall Study|Adverse Event|0|||
124674635|NCT03786380|448433546|FG002|Overall Study|Adverse Event|0|||
124674636|NCT03786380|448433547|FG003|Overall Study|Adverse Event|3|||
124674637|NCT03786380|448433548|FG004|Overall Study|Adverse Event|1|||
124674638|NCT03786380|448433544|FG000|Overall Study|Lack of Efficacy|0|||
124674639|NCT03786380|448433545|FG001|Overall Study|Lack of Efficacy|0|||
124674640|NCT03786380|448433546|FG002|Overall Study|Lack of Efficacy|0|||
124674641|NCT03786380|448433547|FG003|Overall Study|Lack of Efficacy|0|||
124674642|NCT03786380|448433548|FG004|Overall Study|Lack of Efficacy|1|||
124873003|NCT00180479|449157216|FG000|Overall Study|Lost to Follow-up|9|||
124429214|NCT02217475|447533258|FG000|Discontinued After Period 1|Adverse Event|1|||
124429215|NCT02217475|447533259|FG001|Discontinued After Period 1|Adverse Event|2|||
124429216|NCT02217475|447533260|FG002|Discontinued After Period 1|Adverse Event|0|||
124429217|NCT02217475|447533258|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
124429218|NCT02217475|447533259|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
124429219|NCT02217475|447533260|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
124429220|NCT02217475|447533258|FG000|Discontinued After Period 1|Physician Decision|0|||
124429221|NCT02217475|447533259|FG001|Discontinued After Period 1|Physician Decision|0|||
124429222|NCT02217475|447533260|FG002|Discontinued After Period 1|Physician Decision|1|||
124429223|NCT02217475|447533258|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
124429224|NCT02217475|447533259|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
124429225|NCT02217475|447533260|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
124429226|NCT02217475|447533258|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
124429227|NCT02217475|447533259|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
124429228|NCT02217475|447533260|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
124429229|NCT02217475|447533258|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
124429230|NCT02217475|447533259|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
124429231|NCT02217475|447533260|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
124429232|NCT02217475|447533258|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
124429233|NCT02217475|447533259|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
124429234|NCT02217475|447533260|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
124429235|NCT02217475|447533258|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
124429236|NCT02217475|447533259|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
124429237|NCT02217475|447533260|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
124429238|NCT02643472|447533261|FG000|Overall Study|Death|2|||
124429239|NCT02643472|447533262|FG001|Overall Study|Death|5|||
124429240|NCT02643472|447533261|FG000|Overall Study|Withdrawal by Subject|3|||
124429241|NCT02643472|447533262|FG001|Overall Study|Withdrawal by Subject|2|||
124429242|NCT02643472|447533261|FG000|Overall Study|Protocol Violation|0|||
124429243|NCT02643472|447533262|FG001|Overall Study|Protocol Violation|1|||
124429244|NCT02643472|447533261|FG000|Overall Study|Lost to Follow-up|22|||
124429245|NCT02643472|447533262|FG001|Overall Study|Lost to Follow-up|26|||
124429246|NCT01215188|447533263|FG000|Overall Study|Lost to Follow-up|22|||
124429247|NCT01215188|447533264|FG001|Overall Study|Lost to Follow-up|22|||
124429248|NCT01215188|447533265|FG002|Overall Study|Lost to Follow-up|16|||
124429249|NCT01215188|447533263|FG000|Overall Study|Adverse Event|1|||
124429250|NCT01215188|447533264|FG001|Overall Study|Adverse Event|1|||
124429251|NCT01215188|447533265|FG002|Overall Study|Adverse Event|3|||
124429252|NCT01215188|447533263|FG000|Overall Study|Physician Decision|2|||
124429253|NCT01215188|447533264|FG001|Overall Study|Physician Decision|1|||
124429254|NCT01215188|447533265|FG002|Overall Study|Physician Decision|0|||
124429255|NCT01215188|447533263|FG000|Overall Study|Lack of Efficacy|0|||
124429256|NCT01215188|447533264|FG001|Overall Study|Lack of Efficacy|0|||
124429257|NCT01215188|447533265|FG002|Overall Study|Lack of Efficacy|1|||
124429258|NCT01215188|447533263|FG000|Overall Study|Protocol Violation|1|||
124429259|NCT01215188|447533264|FG001|Overall Study|Protocol Violation|1|||
124429260|NCT01215188|447533265|FG002|Overall Study|Protocol Violation|1|||
124429261|NCT01215188|447533263|FG000|Overall Study|Withdrawal by Subject|32|||
124429262|NCT01215188|447533264|FG001|Overall Study|Withdrawal by Subject|34|||
124674643|NCT03786380|448433544|FG000|Overall Study|Withdrawal by Subject|1|||
124674644|NCT03786380|448433545|FG001|Overall Study|Withdrawal by Subject|2|||
124674645|NCT03786380|448433546|FG002|Overall Study|Withdrawal by Subject|2|||
124674646|NCT03786380|448433547|FG003|Overall Study|Withdrawal by Subject|1|||
124674647|NCT03786380|448433548|FG004|Overall Study|Withdrawal by Subject|2|||
124674648|NCT03786380|448433544|FG000|Overall Study|Lost to Follow-up|3|||
124674649|NCT03786380|448433545|FG001|Overall Study|Lost to Follow-up|0|||
124674650|NCT03786380|448433546|FG002|Overall Study|Lost to Follow-up|1|||
124674651|NCT03786380|448433547|FG003|Overall Study|Lost to Follow-up|2|||
124674652|NCT03786380|448433548|FG004|Overall Study|Lost to Follow-up|0|||
124674653|NCT03786380|448433544|FG000|Overall Study|Physician Decision|0|||
124674654|NCT03786380|448433545|FG001|Overall Study|Physician Decision|0|||
124674655|NCT03786380|448433546|FG002|Overall Study|Physician Decision|1|||
124674656|NCT03786380|448433547|FG003|Overall Study|Physician Decision|0|||
124674657|NCT03786380|448433548|FG004|Overall Study|Physician Decision|0|||
124674658|NCT03786380|448433544|FG000|Overall Study|Study Terminated by the Sponsor|30|||
124674659|NCT03786380|448433545|FG001|Overall Study|Study Terminated by the Sponsor|20|||
124674660|NCT03786380|448433546|FG002|Overall Study|Study Terminated by the Sponsor|50|||
124429263|NCT01215188|447533265|FG002|Overall Study|Withdrawal by Subject|31|||
124429264|NCT01012414|447533266|FG000|Overall Study|Withdrawal by Subject|2|||
124429265|NCT01012414|447533266|FG000|Overall Study|Lost to Follow-up|1|||
124429266|NCT01012414|447533266|FG000|Overall Study|Trial was stopped before completed|7|||
124429267|NCT00506441|447533267|FG000|Period 1; Open-label Period|Adverse Event|21|||
124674661|NCT03786380|448433547|FG003|Overall Study|Study Terminated by the Sponsor|57|||
124674662|NCT03786380|448433548|FG004|Overall Study|Study Terminated by the Sponsor|23|||
124674663|NCT03786380|448433544|FG000|Overall Study|Reason Not Specified|0|||
124674664|NCT03786380|448433545|FG001|Overall Study|Reason Not Specified|0|||
124674665|NCT03786380|448433546|FG002|Overall Study|Reason Not Specified|0|||
124674666|NCT03786380|448433547|FG003|Overall Study|Reason Not Specified|0|||
124674667|NCT03786380|448433548|FG004|Overall Study|Reason Not Specified|1|||
124674668|NCT01664091|448433549|FG000|Overall Study|Death|1|||
124674669|NCT01664091|448433549|FG000|Overall Study|Disease Progression|2|||
124674670|NCT01664091|448433549|FG000|Overall Study|Lost to Follow-up|2|||
124674671|NCT01664091|448433549|FG000|Overall Study|Withdrawal by Subject|1|||
124674672|NCT00726609|448433552|FG000|Overall Study|Adverse Event|10|||
124674673|NCT00726609|448433552|FG000|Overall Study|Withdrawal by Subject|2|||
124674674|NCT00726609|448433552|FG000|Overall Study|Lack of Efficacy|25|||
124674675|NCT00726609|448433552|FG000|Overall Study|Other|16|||
124674676|NCT00726609|448433552|FG000|Overall Study|Missing|42|||
124674677|NCT00726609|448433552|FG000|Overall Study|Other|3|||
124674678|NCT03327324|448433559|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
124674679|NCT03327324|448433560|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
124674680|NCT03327324|448433561|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
124674681|NCT03327324|448433562|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
124674682|NCT03327324|448433563|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
124674683|NCT03327324|448433564|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
124674684|NCT03327324|448433559|FG000|Baseline (Month 0-Month 3)|Refused|0|||
124674685|NCT03327324|448433560|FG001|Baseline (Month 0-Month 3)|Refused|0|||
124674686|NCT03327324|448433561|FG002|Baseline (Month 0-Month 3)|Refused|0|||
124674687|NCT03327324|448433562|FG003|Baseline (Month 0-Month 3)|Refused|0|||
124674688|NCT03327324|448433563|FG004|Baseline (Month 0-Month 3)|Refused|1|||
124674689|NCT03327324|448433564|FG005|Baseline (Month 0-Month 3)|Refused|0|||
124674690|NCT03327324|448433559|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
124674691|NCT03327324|448433560|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
124674692|NCT03327324|448433561|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
124674693|NCT03327324|448433562|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
124674694|NCT03327324|448433563|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
124674695|NCT03327324|448433564|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
124674696|NCT03327324|448433559|FG000|Baseline (Month 0-Month 3)|Death|0|||
124674697|NCT03327324|448433560|FG001|Baseline (Month 0-Month 3)|Death|0|||
124674698|NCT03327324|448433561|FG002|Baseline (Month 0-Month 3)|Death|0|||
124674699|NCT03327324|448433562|FG003|Baseline (Month 0-Month 3)|Death|0|||
124674700|NCT03327324|448433563|FG004|Baseline (Month 0-Month 3)|Death|1|||
124674701|NCT03327324|448433564|FG005|Baseline (Month 0-Month 3)|Death|0|||
124674702|NCT03327324|448433559|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
124674703|NCT03327324|448433560|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
124674704|NCT03327324|448433561|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
124674705|NCT03327324|448433562|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
124674706|NCT03327324|448433563|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
124674707|NCT03327324|448433564|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
124674708|NCT03327324|448433559|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
124674709|NCT03327324|448433560|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
124674710|NCT03327324|448433561|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
124674711|NCT03327324|448433562|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
124674712|NCT03327324|448433563|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
124674713|NCT03327324|448433564|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
124674714|NCT03327324|448433559|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
124674715|NCT03327324|448433560|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
124674716|NCT03327324|448433561|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
124674717|NCT03327324|448433562|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
124674718|NCT03327324|448433563|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
124674719|NCT03327324|448433564|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
124674720|NCT03327324|448433559|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
124674721|NCT03327324|448433560|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
124674722|NCT03327324|448433561|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
124674723|NCT03327324|448433562|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
124674724|NCT03327324|448433563|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
124873004|NCT00180479|449157217|FG001|Overall Study|Lost to Follow-up|7|||
124429268|NCT00506441|447533268|FG001|Period 1; Open-label Period|Adverse Event|0|||
124429269|NCT00506441|447533267|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
124429270|NCT00506441|447533268|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
124429271|NCT00506441|447533267|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
124429272|NCT00506441|447533268|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
124429273|NCT00506441|447533267|FG000|Period 1; Open-label Period|Physician Decision|5|||
124429274|NCT00506441|447533268|FG001|Period 1; Open-label Period|Physician Decision|0|||
124429275|NCT00506441|447533267|FG000|Period 1; Open-label Period|Protocol Violation|9|||
124429276|NCT00506441|447533268|FG001|Period 1; Open-label Period|Protocol Violation|0|||
124429277|NCT00506441|447533267|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
124429278|NCT00506441|447533268|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
124429279|NCT00506441|447533267|FG000|Period 1; Open-label Period|Other Reasons|13|||
124429280|NCT00506441|447533268|FG001|Period 1; Open-label Period|Other Reasons|0|||
124429281|NCT00506441|447533267|FG000|Period 2; Double-blind Period|Adverse Event|0|||
124429282|NCT00506441|447533268|FG001|Period 2; Double-blind Period|Adverse Event|1|||
124429283|NCT00506441|447533267|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
124429284|NCT00506441|447533268|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
124429285|NCT00506441|447533267|FG000|Period 2; Double-blind Period|Physician Decision|1|||
124429286|NCT00506441|447533268|FG001|Period 2; Double-blind Period|Physician Decision|1|||
124429287|NCT00506441|447533267|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
124429288|NCT00506441|447533268|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
124429289|NCT00506441|447533267|FG000|Period 2; Double-blind Period|Other Reason|1|||
124429290|NCT00506441|447533268|FG001|Period 2; Double-blind Period|Other Reason|1|||
124429291|NCT02601300|447533269|FG000|Induction Phase|Lack of Efficacy|2|||
124429292|NCT02601300|447533269|FG000|Induction Phase|Protocol Violation|1|||
124429293|NCT02601300|447533269|FG000|Extension Phase|Withdrawal by Subject|3|||
124429294|NCT02601300|447533269|FG000|Extension Phase|Adverse Event|4|||
124429295|NCT02601300|447533269|FG000|Extension Phase|Lack of Efficacy|10|||
124429296|NCT01127763|447533271|FG000|Overall Study|Adverse Event|2|||
124429297|NCT01127763|447533271|FG000|Overall Study|Withdrawal by Subject|1|||
124429298|NCT01127763|447533271|FG000|Overall Study|Physician Decision|2|||
124429299|NCT00528931|447533274|FG000|Overall Study|Lost to Follow-up|1|||
124429300|NCT00992225|447533275|FG000|Overall Study|Entry Criteria Not Met|8|||
124429301|NCT00992225|447533275|FG000|Overall Study|Adverse Event|2|||
124429302|NCT00291642|447533278|FG000|Overall Study|Adverse Event|1|||
124429303|NCT00291642|447533279|FG001|Overall Study|Adverse Event|0|||
124429304|NCT00291642|447533280|FG002|Overall Study|Adverse Event|1|||
124429305|NCT00291642|447533281|FG003|Overall Study|Adverse Event|0|||
124429306|NCT00291642|447533282|FG004|Overall Study|Adverse Event|1|||
124429307|NCT00291642|447533278|FG000|Overall Study|Patient missed visit|0|||
124429308|NCT00291642|447533279|FG001|Overall Study|Patient missed visit|0|||
124429309|NCT00291642|447533280|FG002|Overall Study|Patient missed visit|1|||
124429310|NCT00291642|447533281|FG003|Overall Study|Patient missed visit|0|||
124429311|NCT00291642|447533282|FG004|Overall Study|Patient missed visit|0|||
124429312|NCT00291642|447533278|FG000|Overall Study|Intake of prohibited medication|1|||
124429313|NCT00291642|447533279|FG001|Overall Study|Intake of prohibited medication|0|||
124429314|NCT00291642|447533280|FG002|Overall Study|Intake of prohibited medication|0|||
124429315|NCT00291642|447533281|FG003|Overall Study|Intake of prohibited medication|0|||
124429316|NCT00291642|447533282|FG004|Overall Study|Intake of prohibited medication|0|||
124429317|NCT02576587|447533287|FG000|Baseline|Equipment failure|0|||
124429318|NCT02576587|447533288|FG001|Baseline|Equipment failure|1|||
124429319|NCT02576587|447533287|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
124429320|NCT02576587|447533288|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
124429321|NCT02576587|447533287|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
124429322|NCT02576587|447533288|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
124429323|NCT02576587|447533287|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
124429324|NCT02576587|447533288|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
124429325|NCT00532493|447533289|FG000|Overall Study|Death|1|||
124429326|NCT00532493|447533290|FG001|Overall Study|Death|1|||
124429327|NCT00532493|447533289|FG000|Overall Study|Lost to Follow-up|10|||
124429328|NCT00532493|447533290|FG001|Overall Study|Lost to Follow-up|7|||
124429329|NCT00532493|447533289|FG000|Overall Study|Withdrawal by Subject|7|||
124429330|NCT00532493|447533290|FG001|Overall Study|Withdrawal by Subject|9|||
124429331|NCT00532493|447533289|FG000|Overall Study|Physician Decision|1|||
124429332|NCT00532493|447533290|FG001|Overall Study|Physician Decision|6|||
124429333|NCT00532493|447533289|FG000|Overall Study|Adverse Event|6|||
124429334|NCT00532493|447533290|FG001|Overall Study|Adverse Event|5|||
124429335|NCT00532493|447533289|FG000|Overall Study|Protocol Deviation|1|||
124429336|NCT00532493|447533290|FG001|Overall Study|Protocol Deviation|0|||
124429337|NCT00532493|447533289|FG000|Overall Study|Subject Moved Away|3|||
124429338|NCT00532493|447533290|FG001|Overall Study|Subject Moved Away|1|||
124429339|NCT00532493|447533289|FG000|Overall Study|Contraindicative Medication|1|||
124429340|NCT00532493|447533290|FG001|Overall Study|Contraindicative Medication|0|||
124429341|NCT01769326|447533293|FG000|Overall Study|Lost to Follow-up|1|||
124674725|NCT03327324|448433564|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
124674726|NCT03327324|448433559|FG000|Intervention (Month 3-Month 6)|Death|1|||
124674727|NCT03327324|448433560|FG001|Intervention (Month 3-Month 6)|Death|0|||
124674728|NCT03327324|448433561|FG002|Intervention (Month 3-Month 6)|Death|1|||
124674729|NCT03327324|448433562|FG003|Intervention (Month 3-Month 6)|Death|1|||
124674730|NCT03327324|448433563|FG004|Intervention (Month 3-Month 6)|Death|1|||
124674731|NCT03327324|448433564|FG005|Intervention (Month 3-Month 6)|Death|0|||
124674732|NCT03327324|448433559|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
124674733|NCT03327324|448433560|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
124674734|NCT03327324|448433561|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
124674735|NCT03327324|448433562|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
124674736|NCT03327324|448433563|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
124674737|NCT03327324|448433564|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
124674738|NCT03327324|448433559|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
124674739|NCT03327324|448433560|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
124674740|NCT03327324|448433561|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
124674741|NCT03327324|448433562|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
124674742|NCT03327324|448433563|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
124674743|NCT03327324|448433564|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
124674744|NCT03327324|448433559|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
124674745|NCT03327324|448433560|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
124674746|NCT03327324|448433561|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
124674747|NCT03327324|448433562|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
124674748|NCT03327324|448433563|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
124674749|NCT03327324|448433564|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
124674750|NCT03327324|448433559|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
124674751|NCT03327324|448433560|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
124674752|NCT03327324|448433561|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
124674753|NCT03327324|448433562|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
124674754|NCT03327324|448433563|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
124674755|NCT03327324|448433564|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
124674756|NCT03327324|448433559|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
124674757|NCT03327324|448433560|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
124674758|NCT03327324|448433561|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
124674759|NCT03327324|448433562|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
124674760|NCT03327324|448433563|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
124674761|NCT03327324|448433564|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
124429342|NCT01769326|447533294|FG001|Overall Study|Lost to Follow-up|2|||
124429343|NCT01769326|447533295|FG002|Overall Study|Lost to Follow-up|0|||
124429344|NCT01769326|447533296|FG003|Overall Study|Lost to Follow-up|0|||
124429345|NCT01769326|447533293|FG000|Overall Study|unrelated injry|1|||
124429346|NCT01769326|447533294|FG001|Overall Study|unrelated injry|1|||
124429347|NCT01769326|447533295|FG002|Overall Study|unrelated injry|0|||
124429348|NCT01769326|447533296|FG003|Overall Study|unrelated injry|0|||
124429349|NCT01769326|447533293|FG000|Overall Study|got a job|0|||
124429350|NCT01769326|447533294|FG001|Overall Study|got a job|1|||
124429351|NCT01769326|447533295|FG002|Overall Study|got a job|0|||
124429352|NCT01769326|447533296|FG003|Overall Study|got a job|0|||
124429353|NCT01769326|447533293|FG000|Overall Study|Got sick and could not complete study|0|||
124429354|NCT01769326|447533294|FG001|Overall Study|Got sick and could not complete study|0|||
124429355|NCT01769326|447533295|FG002|Overall Study|Got sick and could not complete study|1|||
124429356|NCT01769326|447533296|FG003|Overall Study|Got sick and could not complete study|0|||
124429357|NCT01036438|447533297|FG000|Overall Study|Adverse Event|7|||
124429358|NCT01036438|447533298|FG001|Overall Study|Adverse Event|8|||
124429359|NCT01036438|447533297|FG000|Overall Study|Death|0|||
124429360|NCT01036438|447533298|FG001|Overall Study|Death|1|||
124429361|NCT01036438|447533297|FG000|Overall Study|No effect of study treatment|3|||
124429362|NCT01036438|447533298|FG001|Overall Study|No effect of study treatment|1|||
124429363|NCT02153073|447533299|FG000|Overall Study|Case Report Forms Uncollected|230|||
124429364|NCT02153073|447533299|FG000|Overall Study|Protocol Deviation|68|||
124429365|NCT03702231|447533300|FG000|Overall Study|Withdrawal by Subject|1|||
124429366|NCT03702231|447533301|FG001|Overall Study|Withdrawal by Subject|0|||
124429367|NCT03702231|447533302|FG002|Overall Study|Withdrawal by Subject|0|||
124429368|NCT03702231|447533300|FG000|Overall Study|Protocol Violation|0|||
124429369|NCT03702231|447533301|FG001|Overall Study|Protocol Violation|0|||
124429370|NCT03702231|447533302|FG002|Overall Study|Protocol Violation|1|||
124429371|NCT03702231|447533300|FG000|Overall Study|Change in CLL Treatment|0|||
124429372|NCT03702231|447533301|FG001|Overall Study|Change in CLL Treatment|0|||
124429373|NCT03702231|447533302|FG002|Overall Study|Change in CLL Treatment|1|||
124429374|NCT03702231|447533300|FG000|Overall Study|COVID Pandemic|1|||
124429375|NCT03702231|447533301|FG001|Overall Study|COVID Pandemic|4|||
124429376|NCT03702231|447533302|FG002|Overall Study|COVID Pandemic|1|||
124429377|NCT03702231|447533300|FG000|Overall Study|Non-compliance|0|||
124429378|NCT03702231|447533301|FG001|Overall Study|Non-compliance|0|||
124429379|NCT03702231|447533302|FG002|Overall Study|Non-compliance|1|||
124429380|NCT01278173|447533303|FG000|Overall Study|Lack of Efficacy|13|||
124429381|NCT01278173|447533303|FG000|Overall Study|Adverse Event|8|||
124429382|NCT01278173|447533303|FG000|Overall Study|Administrative or other reason|4|||
124429383|NCT01278173|447533303|FG000|Overall Study|Protocol Violation|1|||
124429384|NCT01278173|447533303|FG000|Overall Study|Withdrawal by Subject|1|||
124429385|NCT00738894|447533304|FG000|Overall Study|Lost to Follow-up|23|||
124429386|NCT00738894|447533305|FG001|Overall Study|Lost to Follow-up|13|||
124429387|NCT00738894|447533304|FG000|Overall Study|Withdrawal by Subject|10|||
124429388|NCT00738894|447533305|FG001|Overall Study|Withdrawal by Subject|15|||
124429389|NCT00738894|447533304|FG000|Overall Study|Physician Decision|4|||
124429390|NCT00738894|447533305|FG001|Overall Study|Physician Decision|5|||
124429391|NCT00738894|447533304|FG000|Overall Study|Death|2|||
124429392|NCT00738894|447533305|FG001|Overall Study|Death|0|||
124429393|NCT02546921|447533312|FG000|Overall Study|Adverse Event|0|||
124429394|NCT02546921|447533313|FG001|Overall Study|Adverse Event|5|||
124429395|NCT02546921|447533314|FG002|Overall Study|Adverse Event|2|||
124429396|NCT02546921|447533315|FG003|Overall Study|Adverse Event|0|||
124429397|NCT02546921|447533316|FG004|Overall Study|Adverse Event|0|||
124429398|NCT02546921|447533317|FG005|Overall Study|Adverse Event|0|||
124429399|NCT02546921|447533318|FG006|Overall Study|Adverse Event|0|||
124429400|NCT02546921|447533312|FG000|Overall Study|Evidence of Disease Progression|1|||
124429401|NCT02546921|447533313|FG001|Overall Study|Evidence of Disease Progression|0|||
124429402|NCT02546921|447533314|FG002|Overall Study|Evidence of Disease Progression|0|||
124429403|NCT02546921|447533315|FG003|Overall Study|Evidence of Disease Progression|0|||
124429404|NCT02546921|447533316|FG004|Overall Study|Evidence of Disease Progression|1|||
124429405|NCT02546921|447533317|FG005|Overall Study|Evidence of Disease Progression|0|||
124429406|NCT02546921|447533318|FG006|Overall Study|Evidence of Disease Progression|0|||
124429407|NCT02546921|447533312|FG000|Overall Study|Patient Choice|0|||
124429408|NCT02546921|447533313|FG001|Overall Study|Patient Choice|1|||
124429409|NCT02546921|447533314|FG002|Overall Study|Patient Choice|0|||
124429410|NCT02546921|447533315|FG003|Overall Study|Patient Choice|0|||
124429411|NCT02546921|447533316|FG004|Overall Study|Patient Choice|0|||
124429412|NCT02546921|447533317|FG005|Overall Study|Patient Choice|1|||
124429413|NCT02546921|447533318|FG006|Overall Study|Patient Choice|0|||
124429414|NCT03772587|447533324|FG000|Overall Study|COVID-19|0|||
124429415|NCT03772587|447533325|FG001|Overall Study|COVID-19|0|||
124429416|NCT03772587|447533326|FG002|Overall Study|COVID-19|1|||
124429417|NCT03772587|447533327|FG003|Overall Study|COVID-19|1|||
124429418|NCT03772587|447533328|FG004|Overall Study|COVID-19|0|||
124429419|NCT03772587|447533324|FG000|Overall Study|Withdrawal by Subject|1|||
124429420|NCT03772587|447533325|FG001|Overall Study|Withdrawal by Subject|0|||
124429421|NCT03772587|447533326|FG002|Overall Study|Withdrawal by Subject|0|||
124429422|NCT03772587|447533327|FG003|Overall Study|Withdrawal by Subject|0|||
124429423|NCT03772587|447533328|FG004|Overall Study|Withdrawal by Subject|0|||
124429424|NCT01942785|447533332|FG000|Overall Study|Adverse Event|2|||
124429425|NCT01942785|447533332|FG000|Overall Study|Withdrawal by Subject|1|||
124429426|NCT01942785|447533332|FG000|Overall Study|Protocol Violation|1|||
124429427|NCT02227199|447533333|FG000|Overall Study|Physician Decision|0|||
124429428|NCT02227199|447533334|FG001|Overall Study|Physician Decision|0|||
124429429|NCT02227199|447533335|FG002|Overall Study|Physician Decision|1|||
124429430|NCT02227199|447533333|FG000|Overall Study|Adverse Event|0|||
124429431|NCT02227199|447533334|FG001|Overall Study|Adverse Event|0|||
124429432|NCT02227199|447533335|FG002|Overall Study|Adverse Event|3|||
124429433|NCT05597787|447533336|FG000|Overall Study|Withdrawal by Subject|0|||
124429434|NCT05597787|447533337|FG001|Overall Study|Withdrawal by Subject|0|||
124429435|NCT05597787|447533338|FG002|Overall Study|Withdrawal by Subject|1|||
124429436|NCT01934790|447533340|FG000|Treatment|Adverse Event|3|||
124429437|NCT01934790|447533340|FG000|Treatment|Clinical progression|6|||
124429438|NCT01934790|447533340|FG000|Treatment|Radiological progression|4|||
124429439|NCT01934790|447533340|FG000|Treatment|Withdrawal by Subject|2|||
124429440|NCT01934790|447533340|FG000|Treatment|Study drug never administered|1|||
124429441|NCT01934790|447533340|FG000|Active Follow up|Death|20|||
124429442|NCT01934790|447533340|FG000|Active Follow up|Physician Decision|2|||
124674762|NCT03327324|448433559|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
124674763|NCT03327324|448433560|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
124674764|NCT03327324|448433561|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
124674765|NCT03327324|448433562|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
124674766|NCT03327324|448433563|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
124674767|NCT03327324|448433564|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
124674768|NCT03327324|448433559|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
124674769|NCT03327324|448433560|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
124674770|NCT03327324|448433561|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
124674771|NCT03327324|448433562|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
124674772|NCT03327324|448433563|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
124674773|NCT03327324|448433564|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
124674774|NCT03080935|448433567|FG000|Overall Study|Death|34|||
124674775|NCT03080935|448433568|FG001|Overall Study|Death|50|||
124674776|NCT03080935|448433567|FG000|Overall Study|Lost to Follow-up|5|||
124674777|NCT03080935|448433568|FG001|Overall Study|Lost to Follow-up|4|||
124674778|NCT03080935|448433567|FG000|Overall Study|Withdrawal by Subject|11|||
124674779|NCT03080935|448433568|FG001|Overall Study|Withdrawal by Subject|15|||
124674780|NCT01614470|448433569|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
124674781|NCT01614470|448433570|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
124674782|NCT01614470|448433571|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
124674783|NCT01614470|448433569|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
124674784|NCT01614470|448433570|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
124674785|NCT01614470|448433571|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
124674786|NCT02175121|448433572|FG000|Overall Study|Lack of Efficacy|1|||
124674787|NCT02175121|448433573|FG001|Overall Study|Lack of Efficacy|0|||
124674788|NCT02175121|448433574|FG002|Overall Study|Lack of Efficacy|0|||
124674789|NCT02175121|448433575|FG003|Overall Study|Lack of Efficacy|0|||
124674790|NCT02175121|448433576|FG004|Overall Study|Lack of Efficacy|0|||
124674791|NCT02175121|448433572|FG000|Overall Study|Lost to Follow-up|0|||
124674792|NCT02175121|448433573|FG001|Overall Study|Lost to Follow-up|1|||
124674793|NCT02175121|448433574|FG002|Overall Study|Lost to Follow-up|0|||
124674794|NCT02175121|448433575|FG003|Overall Study|Lost to Follow-up|1|||
124674795|NCT02175121|448433576|FG004|Overall Study|Lost to Follow-up|0|||
124674796|NCT02175121|448433572|FG000|Overall Study|Personal emergency|0|||
124674797|NCT02175121|448433573|FG001|Overall Study|Personal emergency|0|||
124674798|NCT02175121|448433574|FG002|Overall Study|Personal emergency|0|||
124674799|NCT02175121|448433575|FG003|Overall Study|Personal emergency|0|||
124674800|NCT02175121|448433576|FG004|Overall Study|Personal emergency|1|||
124674801|NCT02175121|448433572|FG000|Overall Study|Schedule conflict|0|||
124674802|NCT02175121|448433573|FG001|Overall Study|Schedule conflict|0|||
124429443|NCT01934790|447533340|FG000|Active Follow up|Progressive disease|1|||
124429444|NCT01934790|447533340|FG000|Active Follow up|Other reason|1|||
124674803|NCT02175121|448433574|FG002|Overall Study|Schedule conflict|1|||
124674804|NCT02175121|448433575|FG003|Overall Study|Schedule conflict|0|||
124674805|NCT02175121|448433576|FG004|Overall Study|Schedule conflict|0|||
124674806|NCT02175121|448433572|FG000|Overall Study|Time issues|0|||
124674807|NCT02175121|448433573|FG001|Overall Study|Time issues|0|||
124674808|NCT02175121|448433574|FG002|Overall Study|Time issues|1|||
124674809|NCT02175121|448433575|FG003|Overall Study|Time issues|0|||
124674810|NCT02175121|448433576|FG004|Overall Study|Time issues|0|||
124674811|NCT02557399|448433577|FG000|Overall Study|Adverse Event|6|||
124674812|NCT02557399|448433578|FG001|Overall Study|Adverse Event|5|||
124674813|NCT02557399|448433577|FG000|Overall Study|Protocol Violation|0|||
124674814|NCT02557399|448433578|FG001|Overall Study|Protocol Violation|1|||
124674815|NCT02557399|448433577|FG000|Overall Study|Protocol-defined stopping criteria|0|||
124674816|NCT02557399|448433578|FG001|Overall Study|Protocol-defined stopping criteria|1|||
124674817|NCT02557399|448433577|FG000|Overall Study|Withdrawal by Subject|1|||
124674818|NCT02557399|448433578|FG001|Overall Study|Withdrawal by Subject|1|||
124674819|NCT02848664|448433579|FG000|Overall Study|Withdrawal by Subject|2|||
124674820|NCT02848664|448433579|FG000|Overall Study|Adverse Event|1|||
124674821|NCT02848664|448433579|FG000|Overall Study|no assistance for device training|1|||
124674822|NCT00402727|448433580|FG000|Overall Study|Adverse Event|10|||
124674823|NCT00402727|448433581|FG001|Overall Study|Adverse Event|6|||
124674824|NCT00402727|448433580|FG000|Overall Study|Death|1|||
124674825|NCT00402727|448433581|FG001|Overall Study|Death|0|||
124674826|NCT00402727|448433580|FG000|Overall Study|Lack of Efficacy|1|||
124674827|NCT00402727|448433581|FG001|Overall Study|Lack of Efficacy|3|||
124674828|NCT00402727|448433580|FG000|Overall Study|Lost to Follow-up|24|||
124674829|NCT00402727|448433581|FG001|Overall Study|Lost to Follow-up|11|||
124674830|NCT00402727|448433580|FG000|Overall Study|Physician Decision|1|||
124674831|NCT00402727|448433581|FG001|Overall Study|Physician Decision|1|||
124674832|NCT00402727|448433580|FG000|Overall Study|Protocol Violation|0|||
124674833|NCT00402727|448433581|FG001|Overall Study|Protocol Violation|4|||
124674834|NCT00402727|448433580|FG000|Overall Study|Withdrawal by Subject|3|||
124674835|NCT00402727|448433581|FG001|Overall Study|Withdrawal by Subject|7|||
124674836|NCT00402727|448433580|FG000|Overall Study|supply problems|2|||
124674837|NCT00402727|448433581|FG001|Overall Study|supply problems|1|||
124674838|NCT00402727|448433580|FG000|Overall Study|non-compliance|0|||
124674839|NCT00402727|448433581|FG001|Overall Study|non-compliance|1|||
124674840|NCT03372798|448433582|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
124674841|NCT03372798|448433583|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
124674842|NCT03372798|448433582|FG000|Overall Study|Failure of imaging probe|0|||
124674843|NCT03372798|448433583|FG001|Overall Study|Failure of imaging probe|1|||
124674844|NCT01687218|448433584|FG000|Overall Study|Withdrawal by Subject|2|||
124674845|NCT01687218|448433585|FG001|Overall Study|Withdrawal by Subject|3|||
124674846|NCT01687218|448433586|FG002|Overall Study|Withdrawal by Subject|0|||
124674847|NCT01687218|448433587|FG003|Overall Study|Withdrawal by Subject|1|||
124674848|NCT01687218|448433588|FG004|Overall Study|Withdrawal by Subject|1|||
124674849|NCT01687218|448433589|FG005|Overall Study|Withdrawal by Subject|0|||
124674850|NCT01687218|448433584|FG000|Overall Study|Relocated, no follow-up planned|1|||
124674851|NCT01687218|448433585|FG001|Overall Study|Relocated, no follow-up planned|0|||
124674852|NCT01687218|448433586|FG002|Overall Study|Relocated, no follow-up planned|1|||
124674853|NCT01687218|448433587|FG003|Overall Study|Relocated, no follow-up planned|1|||
124674854|NCT01687218|448433588|FG004|Overall Study|Relocated, no follow-up planned|0|||
124674855|NCT01687218|448433589|FG005|Overall Study|Relocated, no follow-up planned|0|||
124674856|NCT03139552|448433600|FG000|Overall Study|unable to attend tasting due to schedule|3|||
124674857|NCT00887484|448433607|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
124674858|NCT00887484|448433607|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
124674859|NCT00887484|448433607|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
124674860|NCT01204671|448433608|FG000|Overall Study|Adverse Event|4|||
124674861|NCT01204671|448433609|FG001|Overall Study|Adverse Event|3|||
124674862|NCT01204671|448433610|FG002|Overall Study|Adverse Event|3|||
124674863|NCT01204671|448433611|FG003|Overall Study|Adverse Event|3|||
124674864|NCT01204671|448433612|FG004|Overall Study|Adverse Event|1|||
124674865|NCT01204671|448433608|FG000|Overall Study|Withdrawal by Subject|2|||
124674866|NCT01204671|448433609|FG001|Overall Study|Withdrawal by Subject|3|||
124674867|NCT01204671|448433610|FG002|Overall Study|Withdrawal by Subject|4|||
124674868|NCT01204671|448433611|FG003|Overall Study|Withdrawal by Subject|5|||
124674869|NCT01204671|448433612|FG004|Overall Study|Withdrawal by Subject|3|||
124674870|NCT01204671|448433608|FG000|Overall Study|Lost to Follow-up|7|||
124429445|NCT00552929|447533343|FG000|Overall Study|Lost to Follow-up|0|||
124429446|NCT00552929|447533344|FG001|Overall Study|Lost to Follow-up|0|||
124429447|NCT00552929|447533345|FG002|Overall Study|Lost to Follow-up|0|||
124429448|NCT00552929|447533346|FG003|Overall Study|Lost to Follow-up|0|||
124429449|NCT00552929|447533347|FG004|Overall Study|Lost to Follow-up|0|||
124429450|NCT00552929|447533348|FG005|Overall Study|Lost to Follow-up|0|||
124429451|NCT00552929|447533349|FG006|Overall Study|Lost to Follow-up|0|||
124429452|NCT00552929|447533350|FG007|Overall Study|Lost to Follow-up|0|||
124429453|NCT00552929|447533351|FG008|Overall Study|Lost to Follow-up|1|||
124429454|NCT00552929|447533352|FG009|Overall Study|Lost to Follow-up|0|||
124429455|NCT00552929|447533343|FG000|Overall Study|Not Eligible|0|||
124429456|NCT00552929|447533344|FG001|Overall Study|Not Eligible|0|||
124429457|NCT00552929|447533345|FG002|Overall Study|Not Eligible|0|||
124429458|NCT00552929|447533346|FG003|Overall Study|Not Eligible|0|||
124429459|NCT00552929|447533347|FG004|Overall Study|Not Eligible|0|||
124429460|NCT00552929|447533348|FG005|Overall Study|Not Eligible|1|||
124429461|NCT00552929|447533349|FG006|Overall Study|Not Eligible|0|||
124429462|NCT00552929|447533350|FG007|Overall Study|Not Eligible|0|||
124429463|NCT00552929|447533351|FG008|Overall Study|Not Eligible|0|||
124429464|NCT00552929|447533352|FG009|Overall Study|Not Eligible|0|||
124429465|NCT01200290|447533353|FG000|Treatment Period|Adverse Event|1|||
124429466|NCT01200290|447533353|FG000|Post-Treatment Follow-Up Period|Death|2|||
124429467|NCT01144377|447533358|FG000|52 Week Treatment Period|Adverse Event|0|||
124429468|NCT01144377|447533359|FG001|52 Week Treatment Period|Adverse Event|0|||
124429469|NCT01144377|447533360|FG002|52 Week Treatment Period|Adverse Event|3|||
124429470|NCT01144377|447533361|FG003|52 Week Treatment Period|Adverse Event|2|||
124429471|NCT01144377|447533362|FG004|52 Week Treatment Period|Adverse Event|1|||
124429472|NCT01144377|447533358|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
124429473|NCT01144377|447533359|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
124674871|NCT01204671|448433609|FG001|Overall Study|Lost to Follow-up|8|||
124674872|NCT01204671|448433610|FG002|Overall Study|Lost to Follow-up|6|||
124674873|NCT01204671|448433611|FG003|Overall Study|Lost to Follow-up|4|||
124674874|NCT01204671|448433612|FG004|Overall Study|Lost to Follow-up|0|||
124674875|NCT01204671|448433608|FG000|Overall Study|Unknown Completion Status|1|||
124674876|NCT01204671|448433609|FG001|Overall Study|Unknown Completion Status|1|||
124674877|NCT01204671|448433610|FG002|Overall Study|Unknown Completion Status|0|||
124674878|NCT01204671|448433611|FG003|Overall Study|Unknown Completion Status|0|||
124674879|NCT01204671|448433612|FG004|Overall Study|Unknown Completion Status|0|||
124674880|NCT01204671|448433608|FG000|Overall Study|Physician Decision|0|||
124674881|NCT01204671|448433609|FG001|Overall Study|Physician Decision|0|||
124674882|NCT01204671|448433610|FG002|Overall Study|Physician Decision|0|||
124674883|NCT01204671|448433611|FG003|Overall Study|Physician Decision|1|||
124674884|NCT01204671|448433612|FG004|Overall Study|Physician Decision|0|||
124674885|NCT00264147|448433613|FG000|Treatment I Period|Adverse Event|3|||
124674886|NCT00264147|448433614|FG001|Treatment I Period|Adverse Event|6|||
124674887|NCT00264147|448433615|FG002|Treatment I Period|Adverse Event|3|||
124674888|NCT00264147|448433616|FG003|Treatment I Period|Adverse Event|5|||
124674889|NCT00264147|448433617|FG004|Treatment I Period|Adverse Event|7|||
124674890|NCT00264147|448433618|FG005|Treatment I Period|Adverse Event|0|||
124674891|NCT00264147|448433613|FG000|Treatment I Period|Laboratory Adverse Event|0|||
124674892|NCT00264147|448433614|FG001|Treatment I Period|Laboratory Adverse Event|0|||
124674893|NCT00264147|448433615|FG002|Treatment I Period|Laboratory Adverse Event|0|||
124674894|NCT00264147|448433616|FG003|Treatment I Period|Laboratory Adverse Event|1|||
124674895|NCT00264147|448433617|FG004|Treatment I Period|Laboratory Adverse Event|0|||
124674896|NCT00264147|448433618|FG005|Treatment I Period|Laboratory Adverse Event|0|||
124674897|NCT00264147|448433613|FG000|Treatment I Period|Lack of Efficacy|6|||
124674898|NCT00264147|448433614|FG001|Treatment I Period|Lack of Efficacy|2|||
124674899|NCT00264147|448433615|FG002|Treatment I Period|Lack of Efficacy|8|||
124674900|NCT00264147|448433616|FG003|Treatment I Period|Lack of Efficacy|0|||
124674901|NCT00264147|448433617|FG004|Treatment I Period|Lack of Efficacy|1|||
124674902|NCT00264147|448433618|FG005|Treatment I Period|Lack of Efficacy|0|||
124674903|NCT00264147|448433613|FG000|Treatment I Period|Lost to Follow-up|1|||
124674904|NCT00264147|448433614|FG001|Treatment I Period|Lost to Follow-up|0|||
124674905|NCT00264147|448433615|FG002|Treatment I Period|Lost to Follow-up|0|||
124674906|NCT00264147|448433616|FG003|Treatment I Period|Lost to Follow-up|1|||
124674907|NCT00264147|448433617|FG004|Treatment I Period|Lost to Follow-up|1|||
124429474|NCT01144377|447533360|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
124429475|NCT01144377|447533361|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
124674908|NCT00264147|448433618|FG005|Treatment I Period|Lost to Follow-up|0|||
124674909|NCT00264147|448433613|FG000|Treatment I Period|Protocol Violation|2|||
124429476|NCT01144377|447533362|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
124429477|NCT01144377|447533358|FG000|52 Week Treatment Period|Protocol Violation|0|||
124429478|NCT01144377|447533359|FG001|52 Week Treatment Period|Protocol Violation|0|||
124674910|NCT00264147|448433614|FG001|Treatment I Period|Protocol Violation|2|||
124429479|NCT01144377|447533360|FG002|52 Week Treatment Period|Protocol Violation|0|||
124429480|NCT01144377|447533361|FG003|52 Week Treatment Period|Protocol Violation|0|||
124429481|NCT01144377|447533362|FG004|52 Week Treatment Period|Protocol Violation|1|||
124429482|NCT01144377|447533358|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
124429483|NCT01144377|447533359|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
124429484|NCT01144377|447533360|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
124429485|NCT01144377|447533361|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
124429486|NCT01144377|447533362|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
124429487|NCT01144377|447533358|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
124429488|NCT01144377|447533359|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
124429489|NCT01144377|447533360|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
124429490|NCT01144377|447533361|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
124429491|NCT01144377|447533362|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
124429492|NCT01144377|447533358|FG000|52 Week Treatment Period|Sponsor Decision|0|||
124429493|NCT01144377|447533359|FG001|52 Week Treatment Period|Sponsor Decision|0|||
124429494|NCT01144377|447533360|FG002|52 Week Treatment Period|Sponsor Decision|0|||
124429495|NCT01144377|447533361|FG003|52 Week Treatment Period|Sponsor Decision|0|||
124429496|NCT01144377|447533362|FG004|52 Week Treatment Period|Sponsor Decision|1|||
124429497|NCT01144377|447533358|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
124429498|NCT01144377|447533359|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
124429499|NCT01144377|447533360|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
124429500|NCT01144377|447533361|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
124429501|NCT01144377|447533362|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
124429502|NCT01144377|447533358|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
124429503|NCT01144377|447533359|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
124429504|NCT01144377|447533360|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
124429505|NCT01144377|447533361|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
124674911|NCT00264147|448433615|FG002|Treatment I Period|Protocol Violation|0|||
124674912|NCT00264147|448433616|FG003|Treatment I Period|Protocol Violation|0|||
124674913|NCT00264147|448433617|FG004|Treatment I Period|Protocol Violation|0|||
124674914|NCT00264147|448433618|FG005|Treatment I Period|Protocol Violation|0|||
124674915|NCT00264147|448433613|FG000|Treatment I Period|Withdrawal by Subject|2|||
124674916|NCT00264147|448433614|FG001|Treatment I Period|Withdrawal by Subject|0|||
124674917|NCT00264147|448433615|FG002|Treatment I Period|Withdrawal by Subject|0|||
124674918|NCT00264147|448433616|FG003|Treatment I Period|Withdrawal by Subject|2|||
124674919|NCT00264147|448433617|FG004|Treatment I Period|Withdrawal by Subject|2|||
124674920|NCT00264147|448433618|FG005|Treatment I Period|Withdrawal by Subject|0|||
124674921|NCT00264147|448433613|FG000|Treatment I Period|Patient out of town for an extended time|0|||
124674922|NCT00264147|448433614|FG001|Treatment I Period|Patient out of town for an extended time|1|||
124674923|NCT00264147|448433615|FG002|Treatment I Period|Patient out of town for an extended time|0|||
124674924|NCT00264147|448433616|FG003|Treatment I Period|Patient out of town for an extended time|0|||
124674925|NCT00264147|448433617|FG004|Treatment I Period|Patient out of town for an extended time|0|||
124674926|NCT00264147|448433618|FG005|Treatment I Period|Patient out of town for an extended time|0|||
124674927|NCT00264147|448433613|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
124674928|NCT00264147|448433614|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
124674929|NCT00264147|448433615|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
124674930|NCT00264147|448433616|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
124674931|NCT00264147|448433617|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
124674932|NCT00264147|448433618|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
124674933|NCT00264147|448433613|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
124674934|NCT00264147|448433614|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
124674935|NCT00264147|448433615|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
124674936|NCT00264147|448433616|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
124674937|NCT00264147|448433617|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
124674938|NCT00264147|448433618|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
124674939|NCT00264147|448433613|FG000|Treatment II Period|Adverse Event|0|||
124674940|NCT00264147|448433614|FG001|Treatment II Period|Adverse Event|0|||
124674941|NCT00264147|448433615|FG002|Treatment II Period|Adverse Event|0|||
124674942|NCT00264147|448433616|FG003|Treatment II Period|Adverse Event|0|||
124674943|NCT00264147|448433617|FG004|Treatment II Period|Adverse Event|9|||
124674944|NCT00264147|448433618|FG005|Treatment II Period|Adverse Event|9|||
124674945|NCT00264147|448433613|FG000|Treatment II Period|Laboratory Adverse Event|0|||
124674946|NCT00264147|448433614|FG001|Treatment II Period|Laboratory Adverse Event|0|||
124674947|NCT00264147|448433615|FG002|Treatment II Period|Laboratory Adverse Event|0|||
124674948|NCT00264147|448433616|FG003|Treatment II Period|Laboratory Adverse Event|0|||
124674949|NCT00264147|448433617|FG004|Treatment II Period|Laboratory Adverse Event|0|||
124674950|NCT00264147|448433618|FG005|Treatment II Period|Laboratory Adverse Event|1|||
124674951|NCT00264147|448433613|FG000|Treatment II Period|Lack of Efficacy|0|||
124674952|NCT00264147|448433614|FG001|Treatment II Period|Lack of Efficacy|0|||
124674953|NCT00264147|448433615|FG002|Treatment II Period|Lack of Efficacy|0|||
124674954|NCT00264147|448433616|FG003|Treatment II Period|Lack of Efficacy|0|||
124674955|NCT00264147|448433617|FG004|Treatment II Period|Lack of Efficacy|20|||
124674956|NCT00264147|448433618|FG005|Treatment II Period|Lack of Efficacy|19|||
124674957|NCT00264147|448433613|FG000|Treatment II Period|Lost to Follow-up|0|||
124674958|NCT00264147|448433614|FG001|Treatment II Period|Lost to Follow-up|0|||
124674959|NCT00264147|448433615|FG002|Treatment II Period|Lost to Follow-up|0|||
124674960|NCT00264147|448433616|FG003|Treatment II Period|Lost to Follow-up|0|||
124674961|NCT00264147|448433617|FG004|Treatment II Period|Lost to Follow-up|1|||
124674962|NCT00264147|448433618|FG005|Treatment II Period|Lost to Follow-up|1|||
124674963|NCT00264147|448433613|FG000|Treatment II Period|Withdrawal by Subject|0|||
124674964|NCT00264147|448433614|FG001|Treatment II Period|Withdrawal by Subject|0|||
124674965|NCT00264147|448433615|FG002|Treatment II Period|Withdrawal by Subject|0|||
124674966|NCT00264147|448433616|FG003|Treatment II Period|Withdrawal by Subject|0|||
124674967|NCT00264147|448433617|FG004|Treatment II Period|Withdrawal by Subject|3|||
124674968|NCT00264147|448433618|FG005|Treatment II Period|Withdrawal by Subject|2|||
124674969|NCT00264147|448433613|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
124674970|NCT00264147|448433614|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
124674971|NCT00264147|448433615|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
124674972|NCT00264147|448433616|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
124674973|NCT00264147|448433617|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
124674974|NCT00264147|448433618|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
124674975|NCT01316224|448433619|FG000|Overall Study|Protocol Violation|3|||
124674976|NCT01316224|448433619|FG000|Overall Study|Adverse Event|3|||
124429506|NCT01144377|447533362|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
124429507|NCT01144377|447533358|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
124429508|NCT01144377|447533359|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
124429509|NCT01144377|447533360|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
124429510|NCT01144377|447533361|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
124429511|NCT01144377|447533362|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
124429512|NCT02489968|447533363|FG000|Open-label Treatment Period|Adverse Event|14|||
124674977|NCT01316224|448433619|FG000|Overall Study|Lack of Efficacy|1|||
124674978|NCT01316224|448433619|FG000|Overall Study|Withdrawal by Subject|1|||
124674979|NCT01316224|448433619|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
124429513|NCT02489968|447533364|FG001|Open-label Treatment Period|Adverse Event|7|||
124429514|NCT02489968|447533365|FG002|Open-label Treatment Period|Adverse Event|0|||
124429515|NCT02489968|447533366|FG003|Open-label Treatment Period|Adverse Event|0|||
124429516|NCT02489968|447533367|FG004|Open-label Treatment Period|Adverse Event|0|||
124429517|NCT02489968|447533368|FG005|Open-label Treatment Period|Adverse Event|0|||
124429518|NCT02489968|447533363|FG000|Open-label Treatment Period|Protocol Violation|2|||
124429519|NCT02489968|447533364|FG001|Open-label Treatment Period|Protocol Violation|2|||
124429520|NCT02489968|447533365|FG002|Open-label Treatment Period|Protocol Violation|0|||
124429521|NCT02489968|447533366|FG003|Open-label Treatment Period|Protocol Violation|0|||
124429522|NCT02489968|447533367|FG004|Open-label Treatment Period|Protocol Violation|0|||
124429523|NCT02489968|447533368|FG005|Open-label Treatment Period|Protocol Violation|0|||
124429524|NCT02489968|447533363|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
124429525|NCT02489968|447533364|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
124429526|NCT02489968|447533365|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
124429527|NCT02489968|447533366|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
124429528|NCT02489968|447533367|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
124429529|NCT02489968|447533368|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
124429530|NCT02489968|447533363|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
124429531|NCT02489968|447533364|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
124429532|NCT02489968|447533365|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
124429533|NCT02489968|447533366|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
124429534|NCT02489968|447533367|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
124429535|NCT02489968|447533368|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
124429536|NCT02489968|447533363|FG000|Open-label Treatment Period|Other than specified above|204|||
124429537|NCT02489968|447533364|FG001|Open-label Treatment Period|Other than specified above|189|||
124429538|NCT02489968|447533365|FG002|Open-label Treatment Period|Other than specified above|0|||
124429539|NCT02489968|447533366|FG003|Open-label Treatment Period|Other than specified above|0|||
124429540|NCT02489968|447533367|FG004|Open-label Treatment Period|Other than specified above|0|||
124429541|NCT02489968|447533368|FG005|Open-label Treatment Period|Other than specified above|0|||
124429542|NCT02489968|447533363|FG000|Double-blind Treatment Period|Adverse Event|0|||
124429543|NCT02489968|447533364|FG001|Double-blind Treatment Period|Adverse Event|0|||
124429544|NCT02489968|447533365|FG002|Double-blind Treatment Period|Adverse Event|2|||
124429545|NCT02489968|447533366|FG003|Double-blind Treatment Period|Adverse Event|6|||
124429546|NCT02489968|447533367|FG004|Double-blind Treatment Period|Adverse Event|4|||
124429547|NCT02489968|447533368|FG005|Double-blind Treatment Period|Adverse Event|5|||
124429548|NCT02489968|447533363|FG000|Double-blind Treatment Period|Protocol Violation|0|||
124429549|NCT02489968|447533364|FG001|Double-blind Treatment Period|Protocol Violation|0|||
124674980|NCT01316224|448433619|FG000|Overall Study|Other|1|||
124674981|NCT03234465|448433620|FG000|Overall Study|Adverse Event|4|||
124674982|NCT03234465|448433621|FG001|Overall Study|Adverse Event|2|||
124429550|NCT02489968|447533365|FG002|Double-blind Treatment Period|Protocol Violation|0|||
124429551|NCT02489968|447533366|FG003|Double-blind Treatment Period|Protocol Violation|0|||
124429552|NCT02489968|447533367|FG004|Double-blind Treatment Period|Protocol Violation|1|||
124429553|NCT02489968|447533368|FG005|Double-blind Treatment Period|Protocol Violation|1|||
124429554|NCT02489968|447533363|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
124429555|NCT02489968|447533364|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
124429556|NCT02489968|447533365|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
124429557|NCT02489968|447533366|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
124429558|NCT02489968|447533367|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
124429559|NCT02489968|447533368|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
124429560|NCT02489968|447533363|FG000|Double-blind Treatment Period|Other than specified above|0|||
124429561|NCT02489968|447533364|FG001|Double-blind Treatment Period|Other than specified above|0|||
124429562|NCT02489968|447533365|FG002|Double-blind Treatment Period|Other than specified above|0|||
124429563|NCT02489968|447533366|FG003|Double-blind Treatment Period|Other than specified above|0|||
124429564|NCT02489968|447533367|FG004|Double-blind Treatment Period|Other than specified above|1|||
124429565|NCT02489968|447533368|FG005|Double-blind Treatment Period|Other than specified above|0|||
124429566|NCT00836745|447535079|FG000|Overall Study|Death|2|||
124429567|NCT00836745|447535079|FG000|Overall Study|Lost to Follow-up|10|||
124429568|NCT00836745|447535079|FG000|Overall Study|Adverse Event|3|||
124429569|NCT00836745|447535079|FG000|Overall Study|Objective progression or relapse|4|||
124429570|NCT00836745|447535079|FG000|Overall Study|Other|2|||
124429571|NCT02121301|447535080|FG000|Overall Study|Protocol Violation|1|||
124429572|NCT02121301|447535081|FG001|Overall Study|Protocol Violation|4|||
124674983|NCT03234465|448433620|FG000|Overall Study|Death|0|||
124674984|NCT03234465|448433621|FG001|Overall Study|Death|1|||
124674985|NCT03234465|448433620|FG000|Overall Study|Lost to Follow-up|1|||
124429573|NCT02121301|447535082|FG002|Overall Study|Protocol Violation|1|||
124429574|NCT00436852|447535086|FG000|Overall Study|Death|23|||
124429575|NCT00436852|447535087|FG001|Overall Study|Death|34|||
124429576|NCT00436852|447535086|FG000|Overall Study|Lack of Efficacy|9|||
124429577|NCT00436852|447535087|FG001|Overall Study|Lack of Efficacy|7|||
124429578|NCT00436852|447535086|FG000|Overall Study|Withdrawal by Subject|2|||
124429579|NCT00436852|447535087|FG001|Overall Study|Withdrawal by Subject|4|||
124429580|NCT00436852|447535086|FG000|Overall Study|Ineligible|1|||
124429581|NCT00436852|447535087|FG001|Overall Study|Ineligible|0|||
124429582|NCT00370682|447535088|FG000|Overall Study|Moved from area|0|||
124429583|NCT00370682|447535089|FG001|Overall Study|Moved from area|2|||
124429584|NCT00370682|447535090|FG002|Overall Study|Moved from area|0|||
124429585|NCT00370682|447535088|FG000|Overall Study|Lost to Follow-up|0|||
124429586|NCT00370682|447535089|FG001|Overall Study|Lost to Follow-up|1|||
124429587|NCT00370682|447535090|FG002|Overall Study|Lost to Follow-up|1|||
124429588|NCT00943852|447535091|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124429589|NCT00943852|447535092|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124429590|NCT00943852|447535093|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124429591|NCT00943852|447535094|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
124429592|NCT00943852|447535095|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124429593|NCT00943852|447535096|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124429594|NCT00943852|447535097|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124429595|NCT00943852|447535098|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124429596|NCT00943852|447535099|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124429597|NCT00943852|447535100|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
124429598|NCT00943852|447535091|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
124429599|NCT00943852|447535092|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
124429600|NCT00943852|447535093|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
124429601|NCT00943852|447535094|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
124674986|NCT03234465|448433621|FG001|Overall Study|Lost to Follow-up|1|||
124674987|NCT03234465|448433620|FG000|Overall Study|Withdrawal by Subject|12|||
124674988|NCT03234465|448433621|FG001|Overall Study|Withdrawal by Subject|27|||
124674989|NCT03234465|448433620|FG000|Overall Study|Symptomatic deterioration|0|||
124674990|NCT03234465|448433621|FG001|Overall Study|Symptomatic deterioration|1|||
124429602|NCT00943852|447535095|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
124429603|NCT00943852|447535096|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
124429604|NCT00943852|447535097|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
124429605|NCT00943852|447535098|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
124429606|NCT00943852|447535099|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
124429607|NCT00943852|447535100|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
124674991|NCT03234465|448433620|FG000|Overall Study|Non-compliance|2|||
124674992|NCT03234465|448433621|FG001|Overall Study|Non-compliance|0|||
124674993|NCT03234465|448433620|FG000|Overall Study|Other|14|||
124674994|NCT03234465|448433621|FG001|Overall Study|Other|8|||
124674995|NCT01274533|448433622|FG000|Overall Study|Withdrawal by Subject|1|||
124674996|NCT01274533|448433622|FG000|Overall Study|Non-compliance|1|||
124674997|NCT01274533|448433622|FG000|Overall Study|Disease progression|2|||
124674998|NCT01118052|448433624|FG000|Overall Study|Never treated|2|||
124674999|NCT02949947|448433625|FG000|Overall Study|Non Compliance|0|||
124675000|NCT02949947|448433626|FG001|Overall Study|Non Compliance|1|||
124675001|NCT02949947|448433625|FG000|Overall Study|Insurance change|1|||
124675002|NCT02949947|448433626|FG001|Overall Study|Insurance change|0|||
124675003|NCT02247466|448433627|FG000|Overall Study|Procedure changed to open surgery|0|||
124675004|NCT02247466|448433628|FG001|Overall Study|Procedure changed to open surgery|3|||
124675005|NCT01618968|448433629|FG000|Overall Study|Adverse Event|1|||
124675006|NCT01618968|448433630|FG001|Overall Study|Adverse Event|0|||
124675007|NCT01618968|448433631|FG002|Overall Study|Adverse Event|0|||
124675008|NCT01618968|448433632|FG003|Overall Study|Adverse Event|0|||
124675009|NCT01618968|448433629|FG000|Overall Study|Death|0|||
124675010|NCT01618968|448433630|FG001|Overall Study|Death|0|||
124675011|NCT01618968|448433631|FG002|Overall Study|Death|0|||
124675012|NCT01618968|448433632|FG003|Overall Study|Death|1|||
124675013|NCT02404545|448433633|FG000|Overall Study|Sponsor Termination|6|||
124675014|NCT02404545|448433634|FG001|Overall Study|Sponsor Termination|6|||
124675015|NCT00721799|448433635|FG000|Overall Study|Withdrawal by Subject|7|||
124675016|NCT00721799|448433635|FG000|Overall Study|withdraw by subject after scan 1|1|||
124675017|NCT05965752|448433640|FG000|Overall Study|Adverse Event|0|||
124675018|NCT05965752|448433641|FG001|Overall Study|Adverse Event|1|||
124675019|NCT05965752|448433642|FG002|Overall Study|Adverse Event|0|||
124675020|NCT05965752|448433643|FG003|Overall Study|Adverse Event|1|||
124675021|NCT05965752|448433644|FG004|Overall Study|Adverse Event|3|||
124675022|NCT05965752|448433640|FG000|Overall Study|Lost to Follow-up|2|||
124675023|NCT05965752|448433641|FG001|Overall Study|Lost to Follow-up|0|||
124675024|NCT05965752|448433642|FG002|Overall Study|Lost to Follow-up|1|||
124675025|NCT05965752|448433643|FG003|Overall Study|Lost to Follow-up|1|||
124675026|NCT05965752|448433644|FG004|Overall Study|Lost to Follow-up|1|||
124675027|NCT05965752|448433640|FG000|Overall Study|Withdrawal by Subject|2|||
124675028|NCT05965752|448433641|FG001|Overall Study|Withdrawal by Subject|2|||
124675029|NCT05965752|448433642|FG002|Overall Study|Withdrawal by Subject|1|||
124675030|NCT05965752|448433643|FG003|Overall Study|Withdrawal by Subject|5|||
124675031|NCT05965752|448433644|FG004|Overall Study|Withdrawal by Subject|0|||
124675032|NCT05965752|448433640|FG000|Overall Study|Disease Relapse|1|||
124675033|NCT05965752|448433641|FG001|Overall Study|Disease Relapse|0|||
124675034|NCT05965752|448433642|FG002|Overall Study|Disease Relapse|1|||
124675035|NCT05965752|448433643|FG003|Overall Study|Disease Relapse|0|||
124675036|NCT05965752|448433644|FG004|Overall Study|Disease Relapse|0|||
124675037|NCT05965752|448433640|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
124675038|NCT05965752|448433641|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
124675039|NCT05965752|448433642|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
124675040|NCT05965752|448433643|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
124675041|NCT05965752|448433644|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
124675042|NCT05965752|448433640|FG000|Overall Study|Unable to Return for Study Visits|0|||
124675043|NCT05965752|448433641|FG001|Overall Study|Unable to Return for Study Visits|1|||
124675044|NCT05965752|448433642|FG002|Overall Study|Unable to Return for Study Visits|0|||
124675045|NCT05965752|448433643|FG003|Overall Study|Unable to Return for Study Visits|3|||
124675046|NCT05965752|448433644|FG004|Overall Study|Unable to Return for Study Visits|1|||
124675047|NCT05965752|448433640|FG000|Overall Study|Early Termination|0|||
124675048|NCT05965752|448433641|FG001|Overall Study|Early Termination|0|||
124675049|NCT05965752|448433642|FG002|Overall Study|Early Termination|1|||
124675050|NCT05965752|448433643|FG003|Overall Study|Early Termination|0|||
124675051|NCT05965752|448433644|FG004|Overall Study|Early Termination|0|||
124675052|NCT05965752|448433640|FG000|Overall Study|Reported Unwanted Symptoms|0|||
124675053|NCT05965752|448433641|FG001|Overall Study|Reported Unwanted Symptoms|0|||
124675054|NCT05965752|448433642|FG002|Overall Study|Reported Unwanted Symptoms|0|||
124675055|NCT05965752|448433643|FG003|Overall Study|Reported Unwanted Symptoms|0|||
124675056|NCT05965752|448433644|FG004|Overall Study|Reported Unwanted Symptoms|1|||
124675057|NCT05965752|448433640|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
124675058|NCT05965752|448433641|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
124675059|NCT05965752|448433642|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
124675060|NCT05965752|448433643|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
124675061|NCT05965752|448433644|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
124675062|NCT03630393|448435832|FG000|Overall Study|Death|1|||
124675063|NCT03630393|448435833|FG001|Overall Study|Death|0|||
124675064|NCT00408499|448435834|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
124675065|NCT00408499|448435835|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
124675066|NCT00408499|448435836|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
124675067|NCT00408499|448435837|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
124675068|NCT00408499|448435838|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
124675069|NCT00408499|448435834|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
124675070|NCT00408499|448435835|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
124675071|NCT00408499|448435836|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
124675072|NCT00408499|448435837|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
124675073|NCT00408499|448435838|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
124675074|NCT00408499|448435834|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
124675075|NCT00408499|448435835|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
124675076|NCT00408499|448435836|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
124675077|NCT00408499|448435837|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
124675078|NCT00408499|448435838|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
124675079|NCT00408499|448435834|FG000|Phase II- MTD Expansion|Adverse Event|0|||
124675080|NCT00408499|448435835|FG001|Phase II- MTD Expansion|Adverse Event|0|||
124675081|NCT00408499|448435836|FG002|Phase II- MTD Expansion|Adverse Event|0|||
124675082|NCT00408499|448435837|FG003|Phase II- MTD Expansion|Adverse Event|0|||
124675083|NCT00408499|448435838|FG004|Phase II- MTD Expansion|Adverse Event|9|||
124675084|NCT00408499|448435834|FG000|Phase II- MTD Expansion|Death|0|||
124675085|NCT00408499|448435835|FG001|Phase II- MTD Expansion|Death|0|||
124675086|NCT00408499|448435836|FG002|Phase II- MTD Expansion|Death|0|||
124675087|NCT00408499|448435837|FG003|Phase II- MTD Expansion|Death|0|||
124675088|NCT00408499|448435838|FG004|Phase II- MTD Expansion|Death|2|||
124675089|NCT00408499|448435834|FG000|Phase II- MTD Expansion|Physician Decision|0|||
124675090|NCT00408499|448435835|FG001|Phase II- MTD Expansion|Physician Decision|0|||
124675091|NCT00408499|448435836|FG002|Phase II- MTD Expansion|Physician Decision|0|||
124675092|NCT00408499|448435837|FG003|Phase II- MTD Expansion|Physician Decision|0|||
124675093|NCT00408499|448435838|FG004|Phase II- MTD Expansion|Physician Decision|1|||
124675094|NCT00408499|448435834|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
124675095|NCT00408499|448435835|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
124675096|NCT00408499|448435836|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
124675097|NCT00408499|448435837|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
124675098|NCT00408499|448435838|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
124675099|NCT00408499|448435834|FG000|Phase II- MTD Expansion|treatment delay|0|||
124675100|NCT00408499|448435835|FG001|Phase II- MTD Expansion|treatment delay|0|||
124675101|NCT00408499|448435836|FG002|Phase II- MTD Expansion|treatment delay|0|||
124675102|NCT00408499|448435837|FG003|Phase II- MTD Expansion|treatment delay|0|||
124675103|NCT00408499|448435838|FG004|Phase II- MTD Expansion|treatment delay|3|||
124675104|NCT00997334|448435840|FG000|Overall Study|still on therapy|12|||
124675105|NCT00997334|448435840|FG000|Overall Study|Adverse Event|3|||
124675106|NCT00997334|448435840|FG000|Overall Study|Patient non-compliance|1|||
124675107|NCT00997334|448435840|FG000|Overall Study|Withdrawal by Subject|3|||
124675108|NCT00997334|448435840|FG000|Overall Study|Death|2|||
124675109|NCT00997334|448435840|FG000|Overall Study|Urgent Palliative Care|2|||
124675110|NCT00997334|448435840|FG000|Overall Study|No lesion amenable|1|||
124675111|NCT00997334|448435840|FG000|Overall Study|Ineligible|1|||
124675112|NCT03312738|448435842|FG000|Overall Study|Progressive disease|58|||
124675113|NCT03312738|448435843|FG001|Overall Study|Progressive disease|67|||
124675114|NCT03312738|448435842|FG000|Overall Study|Patient/guardian decision|13|||
124675115|NCT03312738|448435843|FG001|Overall Study|Patient/guardian decision|5|||
124675116|NCT03312738|448435842|FG000|Overall Study|Adverse Event|5|||
124675117|NCT03312738|448435843|FG001|Overall Study|Adverse Event|3|||
124675118|NCT03312738|448435842|FG000|Overall Study|Protocol deviation|2|||
124675119|NCT03312738|448435843|FG001|Overall Study|Protocol deviation|0|||
124675120|NCT03312738|448435842|FG000|Overall Study|Technical problems|0|||
124675121|NCT03312738|448435843|FG001|Overall Study|Technical problems|1|||
124675122|NCT03312738|448435842|FG000|Overall Study|Physician Decision|2|||
124675123|NCT03312738|448435843|FG001|Overall Study|Physician Decision|3|||
124675124|NCT02466399|448435850|FG000|Overall Study|Adverse Event|1|||
124675125|NCT02466399|448435851|FG001|Overall Study|Adverse Event|0|||
124675126|NCT02466399|448435850|FG000|Overall Study|Early exit due to family emergency|1|||
124675127|NCT02466399|448435851|FG001|Overall Study|Early exit due to family emergency|0|||
124675128|NCT03408899|448435852|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
124675129|NCT00606008|448435853|FG000|Overall Study|Adverse Event|1|||
124675130|NCT00606008|448435853|FG000|Overall Study|Withdrawal by Subject|4|||
124675131|NCT02014272|448435854|FG000|Intervention Period 1|Withdrawal by Subject|1|||
124675132|NCT02014272|448435855|FG001|Intervention Period 1|Withdrawal by Subject|0|||
124675133|NCT02014272|448435854|FG000|Intervention Period 1|Adverse Event|0|||
124675134|NCT02014272|448435855|FG001|Intervention Period 1|Adverse Event|1|||
124675135|NCT01863771|448435856|FG000|Induction Phase|Adverse Event|9|||
124675136|NCT01863771|448435857|FG001|Induction Phase|Adverse Event|0|||
124675137|NCT01863771|448435858|FG002|Induction Phase|Adverse Event|0|||
124429608|NCT00943852|447535091|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
124429609|NCT00943852|447535092|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
124429610|NCT00943852|447535093|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
124429611|NCT00943852|447535094|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
124429612|NCT00943852|447535095|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
124429613|NCT00943852|447535096|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
124675138|NCT01863771|448435859|FG003|Induction Phase|Adverse Event|0|||
124675139|NCT01863771|448435856|FG000|Induction Phase|Lack of Efficacy|10|||
124675140|NCT01863771|448435857|FG001|Induction Phase|Lack of Efficacy|0|||
124675141|NCT01863771|448435858|FG002|Induction Phase|Lack of Efficacy|0|||
124675142|NCT01863771|448435859|FG003|Induction Phase|Lack of Efficacy|0|||
124675143|NCT01863771|448435856|FG000|Induction Phase|Withdrawal by Subject|2|||
124675144|NCT01863771|448435857|FG001|Induction Phase|Withdrawal by Subject|0|||
124675145|NCT01863771|448435858|FG002|Induction Phase|Withdrawal by Subject|0|||
124675146|NCT01863771|448435859|FG003|Induction Phase|Withdrawal by Subject|0|||
124675147|NCT01863771|448435856|FG000|Maintenance Phase|Adverse Event|0|||
124675148|NCT01863771|448435857|FG001|Maintenance Phase|Adverse Event|0|||
124675149|NCT01863771|448435858|FG002|Maintenance Phase|Adverse Event|1|||
124675150|NCT01863771|448435859|FG003|Maintenance Phase|Adverse Event|1|||
124675151|NCT01863771|448435856|FG000|Maintenance Phase|Lack of Efficacy|0|||
124675152|NCT01863771|448435857|FG001|Maintenance Phase|Lack of Efficacy|3|||
124675153|NCT01863771|448435858|FG002|Maintenance Phase|Lack of Efficacy|7|||
124675154|NCT01863771|448435859|FG003|Maintenance Phase|Lack of Efficacy|38|||
124675155|NCT01863771|448435856|FG000|Maintenance Phase|Physician Decision|0|||
124675156|NCT01863771|448435857|FG001|Maintenance Phase|Physician Decision|0|||
124675157|NCT01863771|448435858|FG002|Maintenance Phase|Physician Decision|2|||
124675158|NCT01863771|448435859|FG003|Maintenance Phase|Physician Decision|1|||
124675159|NCT01863771|448435856|FG000|Maintenance Phase|Pregnancy|0|||
124675160|NCT01863771|448435857|FG001|Maintenance Phase|Pregnancy|1|||
124675161|NCT01863771|448435858|FG002|Maintenance Phase|Pregnancy|0|||
124675162|NCT01863771|448435859|FG003|Maintenance Phase|Pregnancy|0|||
124675163|NCT01863771|448435856|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124675164|NCT01863771|448435857|FG001|Maintenance Phase|Withdrawal by Subject|1|||
124675165|NCT01863771|448435858|FG002|Maintenance Phase|Withdrawal by Subject|2|||
124675166|NCT01863771|448435859|FG003|Maintenance Phase|Withdrawal by Subject|3|||
124675167|NCT00883181|448435860|FG000|Overall Study|Hematological Adverse Event|26|||
124675168|NCT00883181|448435860|FG000|Overall Study|Non-hematological Adverse Event|55|||
124675169|NCT00883181|448435860|FG000|Overall Study|Disease Progression|94|||
124675170|NCT00883181|448435860|FG000|Overall Study|Administrative Reason|24|||
124675171|NCT00883181|448435860|FG000|Overall Study|Withdrawal by Subject|4|||
124675172|NCT00883181|448435860|FG000|Overall Study|Death|31|||
124675173|NCT00883181|448435860|FG000|Overall Study|Other|38|||
124675174|NCT00883181|448435860|FG000|Overall Study|Protocol Deviation|3|||
124675175|NCT00883181|448435860|FG000|Overall Study|Noncompliance|3|||
124675176|NCT01218308|448435861|FG000|Overall Study|Adverse Event|1|||
124675177|NCT01218308|448435862|FG001|Overall Study|Adverse Event|2|||
124675178|NCT01218308|448435861|FG000|Overall Study|Protocol Violation|0|||
124675179|NCT01218308|448435862|FG001|Overall Study|Protocol Violation|2|||
124675180|NCT01218308|448435861|FG000|Overall Study|Withdrawal by Subject|61|||
124675181|NCT01218308|448435862|FG001|Overall Study|Withdrawal by Subject|64|||
124675182|NCT01218308|448435861|FG000|Overall Study|Lost to Follow-up|27|||
124675183|NCT01218308|448435862|FG001|Overall Study|Lost to Follow-up|31|||
124675184|NCT01218308|448435861|FG000|Overall Study|Other|14|||
124675185|NCT01218308|448435862|FG001|Overall Study|Other|21|||
124429614|NCT00943852|447535097|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
124429615|NCT00943852|447535098|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
124429616|NCT00943852|447535099|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
124429617|NCT00943852|447535100|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
124429618|NCT00943852|447535091|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124429619|NCT00943852|447535092|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124429620|NCT00943852|447535093|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124429621|NCT00943852|447535094|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124429622|NCT00943852|447535095|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124429623|NCT00943852|447535096|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124429624|NCT00943852|447535097|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124429625|NCT00943852|447535098|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
124429626|NCT00943852|447535099|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124429627|NCT00943852|447535100|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
124429628|NCT00943852|447535091|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
124429629|NCT00943852|447535092|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
124429630|NCT00943852|447535093|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
124429631|NCT00943852|447535094|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
124429632|NCT00943852|447535095|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
124429633|NCT00943852|447535096|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
124429634|NCT00943852|447535097|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
124429635|NCT00943852|447535098|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
124429636|NCT00943852|447535099|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
124429637|NCT00943852|447535100|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
124429638|NCT02141620|447535101|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
124429639|NCT02141620|447535102|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
124429640|NCT03651622|447535103|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
124429641|NCT03651622|447535104|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
124429642|NCT03651622|447535105|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
124429643|NCT03651622|447535103|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
124675186|NCT00547339|448435863|FG000|Overall Study|Physician Decision|0|||
124675187|NCT00547339|448435864|FG001|Overall Study|Physician Decision|0|||
124675188|NCT00547339|448435865|FG002|Overall Study|Physician Decision|1|||
124675189|NCT00547339|448435866|FG003|Overall Study|Physician Decision|0|||
124675190|NCT01248455|448435871|FG000|Overall Study|switched to alternate treatment|1|||
124675191|NCT00426270|448435872|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
124675192|NCT00426270|448435872|FG000|Overall Study|Adverse Event|5|||
124675193|NCT01450813|448435873|FG000|Overall Study|Physician Decision|1|||
124675194|NCT01450813|448435874|FG001|Overall Study|Physician Decision|1|||
124675195|NCT01450813|448435875|FG002|Overall Study|Physician Decision|0|||
124675196|NCT01450813|448435876|FG003|Overall Study|Physician Decision|3|||
124675197|NCT02709746|448435880|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
124675198|NCT02709746|448435881|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
124675199|NCT02709746|448435882|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
124675200|NCT02709746|448435883|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
124675201|NCT02709746|448435884|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
124675202|NCT02709746|448435880|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
124675203|NCT02709746|448435881|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
124675204|NCT02709746|448435882|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
124675205|NCT02709746|448435883|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
124675206|NCT02709746|448435884|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
124675207|NCT02709746|448435880|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
124675208|NCT02709746|448435881|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
124675209|NCT02709746|448435882|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
124675210|NCT02709746|448435883|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
124675211|NCT02709746|448435884|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
124675212|NCT02709746|448435880|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
124675213|NCT02709746|448435881|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
124675214|NCT02709746|448435882|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
124675215|NCT02709746|448435883|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
124675216|NCT02709746|448435884|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
124675217|NCT02709746|448435880|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
124675218|NCT02709746|448435881|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
124429644|NCT03651622|447535104|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
124429645|NCT03651622|447535105|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
124429646|NCT03651622|447535103|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
124429647|NCT03651622|447535104|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
124429648|NCT03651622|447535105|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
124429649|NCT03651622|447535103|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
124429650|NCT03651622|447535104|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
124429651|NCT03651622|447535105|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
124429652|NCT03651622|447535103|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
124429653|NCT03651622|447535104|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
124429654|NCT03651622|447535105|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
124429655|NCT00307684|447535106|FG000|Open Label Phase|Lack of Efficacy|0|||
124429656|NCT00307684|447535107|FG001|Open Label Phase|Lack of Efficacy|0|||
124429657|NCT00307684|447535108|FG002|Open Label Phase|Lack of Efficacy|3|||
124429658|NCT00307684|447535106|FG000|Open Label Phase|Adverse Event|0|||
124429659|NCT00307684|447535107|FG001|Open Label Phase|Adverse Event|0|||
124429660|NCT00307684|447535108|FG002|Open Label Phase|Adverse Event|16|||
124429661|NCT00307684|447535106|FG000|Open Label Phase|Withdrawal by Subject|0|||
124429662|NCT00307684|447535107|FG001|Open Label Phase|Withdrawal by Subject|0|||
124429663|NCT00307684|447535108|FG002|Open Label Phase|Withdrawal by Subject|15|||
124429664|NCT00307684|447535106|FG000|Open Label Phase|Lost to Follow-up|0|||
124429665|NCT00307684|447535107|FG001|Open Label Phase|Lost to Follow-up|0|||
124429666|NCT00307684|447535108|FG002|Open Label Phase|Lost to Follow-up|11|||
124429667|NCT00307684|447535106|FG000|Open Label Phase|non compliance|0|||
124429668|NCT00307684|447535107|FG001|Open Label Phase|non compliance|0|||
124429669|NCT00307684|447535108|FG002|Open Label Phase|non compliance|5|||
124429670|NCT00307684|447535106|FG000|Open Label Phase|other|0|||
124429671|NCT00307684|447535107|FG001|Open Label Phase|other|0|||
124429672|NCT00307684|447535108|FG002|Open Label Phase|other|6|||
124429673|NCT00307684|447535106|FG000|Double Blind Phase|Lack of Efficacy|2|||
124429674|NCT00307684|447535107|FG001|Double Blind Phase|Lack of Efficacy|5|||
124429675|NCT00307684|447535108|FG002|Double Blind Phase|Lack of Efficacy|0|||
124429676|NCT01744392|447535109|FG000|Overall Study|Physician Decision|1|||
124429677|NCT00858364|447535116|FG000|Overall Study|Administrative Decision|3|||
124429678|NCT00858364|447535117|FG001|Overall Study|Administrative Decision|2|||
124429679|NCT00858364|447535116|FG000|Overall Study|Adverse Event|5|||
124429680|NCT00858364|447535117|FG001|Overall Study|Adverse Event|2|||
124429681|NCT00858364|447535116|FG000|Overall Study|Withdrawal by Subject|44|||
124429682|NCT00858364|447535117|FG001|Overall Study|Withdrawal by Subject|118|||
124429683|NCT00858364|447535116|FG000|Overall Study|Ineligibility Determined|1|||
124429684|NCT00858364|447535117|FG001|Overall Study|Ineligibility Determined|10|||
124429685|NCT00858364|447535116|FG000|Overall Study|Lost to Follow-up|24|||
124429686|NCT00858364|447535117|FG001|Overall Study|Lost to Follow-up|54|||
124429687|NCT00858364|447535116|FG000|Overall Study|Noncompliance|3|||
124429688|NCT00858364|447535117|FG001|Overall Study|Noncompliance|4|||
124429689|NCT00858364|447535116|FG000|Overall Study|Protocol Deviation|0|||
124429690|NCT00858364|447535117|FG001|Overall Study|Protocol Deviation|2|||
124429691|NCT00858364|447535116|FG000|Overall Study|Other|9|||
124429692|NCT00858364|447535117|FG001|Overall Study|Other|17|||
124429693|NCT00858364|447535116|FG000|Overall Study|Missing|1|||
124429694|NCT00858364|447535117|FG001|Overall Study|Missing|1|||
124429695|NCT00858364|447535116|FG000|Overall Study|Still on-study|114|||
124429696|NCT00858364|447535117|FG001|Overall Study|Still on-study|247|||
124429697|NCT01655693|447535118|FG000|Overall Study|Progression of Disease|92|||
124429698|NCT01655693|447535119|FG001|Overall Study|Progression of Disease|76|||
124429699|NCT01655693|447535120|FG002|Overall Study|Progression of Disease|58|||
124429700|NCT01655693|447535118|FG000|Overall Study|Death|8|||
124429701|NCT01655693|447535119|FG001|Overall Study|Death|9|||
124429702|NCT01655693|447535120|FG002|Overall Study|Death|12|||
124429703|NCT01655693|447535118|FG000|Overall Study|Serious Adverse Event|3|||
124429704|NCT01655693|447535119|FG001|Overall Study|Serious Adverse Event|15|||
124429705|NCT01655693|447535120|FG002|Overall Study|Serious Adverse Event|11|||
124429706|NCT01655693|447535118|FG000|Overall Study|Withdrawal by Subject|3|||
124675219|NCT02709746|448435882|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
124675220|NCT02709746|448435883|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
124675221|NCT02709746|448435884|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
124429707|NCT01655693|447535119|FG001|Overall Study|Withdrawal by Subject|2|||
124429708|NCT01655693|447535120|FG002|Overall Study|Withdrawal by Subject|20|||
124429709|NCT01655693|447535118|FG000|Overall Study|Adverse Event|3|||
124429710|NCT01655693|447535119|FG001|Overall Study|Adverse Event|11|||
124429711|NCT01655693|447535120|FG002|Overall Study|Adverse Event|3|||
124429712|NCT01655693|447535118|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
124429713|NCT01655693|447535119|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
124429714|NCT01655693|447535120|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
124429715|NCT01655693|447535118|FG000|Overall Study|Non-Compliance|0|||
124429716|NCT01655693|447535119|FG001|Overall Study|Non-Compliance|0|||
124429717|NCT01655693|447535120|FG002|Overall Study|Non-Compliance|7|||
124429718|NCT01655693|447535118|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
124429719|NCT01655693|447535119|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
124429720|NCT01655693|447535120|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
124429721|NCT01655693|447535118|FG000|Overall Study|Protocol Violation|1|||
124429722|NCT01655693|447535119|FG001|Overall Study|Protocol Violation|0|||
124429723|NCT01655693|447535120|FG002|Overall Study|Protocol Violation|3|||
124429724|NCT01655693|447535118|FG000|Overall Study|Lost to Follow-up|1|||
124429725|NCT01655693|447535119|FG001|Overall Study|Lost to Follow-up|0|||
124429726|NCT01655693|447535120|FG002|Overall Study|Lost to Follow-up|1|||
124429727|NCT01655693|447535118|FG000|Overall Study|Screening Failure|1|||
124429728|NCT01655693|447535119|FG001|Overall Study|Screening Failure|0|||
124429729|NCT01655693|447535120|FG002|Overall Study|Screening Failure|0|||
124429730|NCT01655693|447535118|FG000|Overall Study|Other|8|||
124429731|NCT01655693|447535119|FG001|Overall Study|Other|6|||
124429732|NCT01655693|447535120|FG002|Overall Study|Other|15|||
124429733|NCT00929110|447535123|FG000|Overall Study|Adverse Event|40|||
124429734|NCT00929110|447535124|FG001|Overall Study|Adverse Event|29|||
124429735|NCT00929110|447535125|FG002|Overall Study|Adverse Event|18|||
124429736|NCT00929110|447535123|FG000|Overall Study|Subject withdrew consent|40|||
124429737|NCT00929110|447535124|FG001|Overall Study|Subject withdrew consent|23|||
124429738|NCT00929110|447535125|FG002|Overall Study|Subject withdrew consent|26|||
124429739|NCT00929110|447535123|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
124429740|NCT00929110|447535124|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
124429741|NCT00929110|447535125|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
124429742|NCT00929110|447535123|FG000|Overall Study|Lost to Follow-up|7|||
124429743|NCT00929110|447535124|FG001|Overall Study|Lost to Follow-up|7|||
124429744|NCT00929110|447535125|FG002|Overall Study|Lost to Follow-up|3|||
124429745|NCT00929110|447535123|FG000|Overall Study|Protocol deviation|5|||
124429746|NCT00929110|447535124|FG001|Overall Study|Protocol deviation|2|||
124429747|NCT00929110|447535125|FG002|Overall Study|Protocol deviation|4|||
124429748|NCT00929110|447535123|FG000|Overall Study|Administrative problems|4|||
124429749|NCT00929110|447535124|FG001|Overall Study|Administrative problems|1|||
124429750|NCT00929110|447535125|FG002|Overall Study|Administrative problems|2|||
124429751|NCT00929110|447535123|FG000|Overall Study|Death|2|||
124429752|NCT00929110|447535124|FG001|Overall Study|Death|2|||
124429753|NCT00929110|447535125|FG002|Overall Study|Death|2|||
124429754|NCT00929110|447535123|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124429755|NCT00929110|447535124|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124429756|NCT00929110|447535125|FG002|Overall Study|Abnormal laboratory value(s)|0|||
124429757|NCT00929110|447535123|FG000|Overall Study|Abnormal test procedure result(s)|0|||
124429758|NCT00929110|447535124|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124429759|NCT00929110|447535125|FG002|Overall Study|Abnormal test procedure result(s)|1|||
124429760|NCT00929110|447535123|FG000|Overall Study|Patient inability to use the device|0|||
124429761|NCT00929110|447535124|FG001|Overall Study|Patient inability to use the device|1|||
124429762|NCT00929110|447535125|FG002|Overall Study|Patient inability to use the device|0|||
124429763|NCT03001076|447535130|FG000|Overall Study|Withdrawal by patient|2|||
124429764|NCT03001076|447535131|FG001|Overall Study|Withdrawal by patient|0|||
124429765|NCT03001076|447535130|FG000|Overall Study|Other|1|||
124429766|NCT03001076|447535131|FG001|Overall Study|Other|0|||
124429767|NCT03001076|447535130|FG000|Overall Study|Adverse Event|3|||
124429768|NCT03001076|447535131|FG001|Overall Study|Adverse Event|3|||
124429769|NCT03001076|447535130|FG000|Overall Study|Sponsor decision|1|||
124429770|NCT03001076|447535131|FG001|Overall Study|Sponsor decision|0|||
124429771|NCT03001076|447535130|FG000|Overall Study|Lost to Follow-up|0|||
124429772|NCT03001076|447535131|FG001|Overall Study|Lost to Follow-up|2|||
124429773|NCT00948766|447535132|FG000|Core Study|Adverse Event|73|||
124429774|NCT00948766|447535133|FG001|Core Study|Adverse Event|51|||
124429775|NCT00948766|447535132|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
124429776|NCT00948766|447535133|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
124429777|NCT00948766|447535132|FG000|Core Study|Patient Withdrew Consent|27|||
124429778|NCT00948766|447535133|FG001|Core Study|Patient Withdrew Consent|46|||
124429779|NCT00948766|447535132|FG000|Core Study|Lost to Follow-up|3|||
124429780|NCT00948766|447535133|FG001|Core Study|Lost to Follow-up|2|||
124429781|NCT00948766|447535132|FG000|Core Study|Administrative Problems|2|||
124429782|NCT00948766|447535133|FG001|Core Study|Administrative Problems|2|||
124429783|NCT00948766|447535132|FG000|Core Study|Death|1|||
124429784|NCT00948766|447535133|FG001|Core Study|Death|1|||
124675222|NCT02709746|448435880|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
124675223|NCT02709746|448435881|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
124675224|NCT02709746|448435882|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
124675225|NCT02709746|448435883|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
124429785|NCT00948766|447535132|FG000|Core Study|Protocol Deviation|8|||
124429786|NCT00948766|447535133|FG001|Core Study|Protocol Deviation|10|||
124429787|NCT00948766|447535132|FG000|Extension Study|Adverse Event|43|||
124429788|NCT00948766|447535133|FG001|Extension Study|Adverse Event|0|||
124429789|NCT00948766|447535132|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
124429790|NCT00948766|447535133|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
124429791|NCT00948766|447535132|FG000|Extension Study|Study Drug No Longer Required|1|||
124429792|NCT00948766|447535133|FG001|Extension Study|Study Drug No Longer Required|0|||
124429793|NCT00948766|447535132|FG000|Extension Study|Patient Withdrew Consent|32|||
124429794|NCT00948766|447535133|FG001|Extension Study|Patient Withdrew Consent|0|||
124429795|NCT00948766|447535132|FG000|Extension Study|Lost to Follow-up|8|||
124429796|NCT00948766|447535133|FG001|Extension Study|Lost to Follow-up|0|||
124429797|NCT00948766|447535132|FG000|Extension Study|Administrative Problems|1|||
124429798|NCT00948766|447535133|FG001|Extension Study|Administrative Problems|0|||
124429799|NCT00948766|447535132|FG000|Extension Study|Death|4|||
124429800|NCT00948766|447535133|FG001|Extension Study|Death|0|||
124429801|NCT00287690|447535137|FG000|Overall Study|Protocol Violation|20|||
124429802|NCT00287690|447535138|FG001|Overall Study|Protocol Violation|26|||
124429803|NCT03592745|447535139|FG000|Overall Study|Adverse Event|0|||
124429804|NCT03592745|447535140|FG001|Overall Study|Adverse Event|2|||
124429805|NCT03592745|447535139|FG000|Overall Study|Lost to Follow-up|2|||
124429806|NCT03592745|447535140|FG001|Overall Study|Lost to Follow-up|0|||
124429807|NCT03592745|447535139|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
124429808|NCT03592745|447535140|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
124429809|NCT03590366|447535141|FG000|Overall Study|Adverse Event|0|||
124429810|NCT03590366|447535142|FG001|Overall Study|Adverse Event|3|||
124429811|NCT03590366|447535141|FG000|Overall Study|Lost to Follow-up|3|||
124429812|NCT03590366|447535142|FG001|Overall Study|Lost to Follow-up|3|||
124429813|NCT03590366|447535141|FG000|Overall Study|Withdrawal by Subject|0|||
124429814|NCT03590366|447535142|FG001|Overall Study|Withdrawal by Subject|2|||
124429815|NCT05017103|447535143|FG000|Overall Study|Death|2|||
124429816|NCT01081665|447535144|FG000|Overall Study|Death|41|||
124429817|NCT01081665|447535144|FG000|Overall Study|Lost to Follow-up|18|||
124429818|NCT01081665|447535144|FG000|Overall Study|Withdrawal by Subject|17|||
124429819|NCT01081665|447535144|FG000|Overall Study|Change of dialysis unit|10|||
124429820|NCT01081665|447535144|FG000|Overall Study|Regulation of iPTH|5|||
124429821|NCT01081665|447535144|FG000|Overall Study|Change in renal replacement therapy|2|||
124429822|NCT01081665|447535144|FG000|Overall Study|Adverse Event|1|||
124429823|NCT01081665|447535144|FG000|Overall Study|Lack of Efficacy|1|||
124429824|NCT03406078|447535150|FG000|Overall Study|Death|1|||
124429825|NCT03406078|447535151|FG001|Overall Study|Death|0|||
124429826|NCT03406078|447535150|FG000|Overall Study|Lost to Follow-up|0|||
124429827|NCT03406078|447535151|FG001|Overall Study|Lost to Follow-up|1|||
124429828|NCT03406078|447535150|FG000|Overall Study|Withdrawal by Subject|5|||
124429829|NCT03406078|447535151|FG001|Overall Study|Withdrawal by Subject|2|||
124429830|NCT01413503|447535152|FG000|Overall Study|Lost to Follow-up|1|||
124429831|NCT01373151|447535153|FG000|Period 1|Lack of Efficacy|3|||
124429832|NCT01373151|447535154|FG001|Period 1|Lack of Efficacy|0|||
124429833|NCT01373151|447535155|FG002|Period 1|Lack of Efficacy|0|||
124429834|NCT01373151|447535156|FG003|Period 1|Lack of Efficacy|0|||
124429835|NCT01373151|447535157|FG004|Period 1|Lack of Efficacy|1|||
124429836|NCT01373151|447535158|FG005|Period 1|Lack of Efficacy|0|||
124429837|NCT01373151|447535159|FG006|Period 1|Lack of Efficacy|0|||
124429838|NCT01373151|447535153|FG000|Period 1|Adverse Event|0|||
124429839|NCT01373151|447535154|FG001|Period 1|Adverse Event|0|||
124429840|NCT01373151|447535155|FG002|Period 1|Adverse Event|1|||
124429841|NCT01373151|447535156|FG003|Period 1|Adverse Event|0|||
124429842|NCT01373151|447535157|FG004|Period 1|Adverse Event|4|||
124429843|NCT01373151|447535158|FG005|Period 1|Adverse Event|3|||
124429844|NCT01373151|447535159|FG006|Period 1|Adverse Event|0|||
124429845|NCT01373151|447535153|FG000|Period 1|Withdrawal by Subject|2|||
124429846|NCT01373151|447535154|FG001|Period 1|Withdrawal by Subject|0|||
124429847|NCT01373151|447535155|FG002|Period 1|Withdrawal by Subject|3|||
124429848|NCT01373151|447535156|FG003|Period 1|Withdrawal by Subject|1|||
124429849|NCT01373151|447535157|FG004|Period 1|Withdrawal by Subject|0|||
124429850|NCT01373151|447535158|FG005|Period 1|Withdrawal by Subject|1|||
124429851|NCT01373151|447535159|FG006|Period 1|Withdrawal by Subject|0|||
124429852|NCT01373151|447535153|FG000|Period 2|Lack of Efficacy|9|||
124429853|NCT01373151|447535154|FG001|Period 2|Lack of Efficacy|0|||
124429854|NCT01373151|447535155|FG002|Period 2|Lack of Efficacy|0|||
124429855|NCT01373151|447535156|FG003|Period 2|Lack of Efficacy|1|||
124429856|NCT01373151|447535157|FG004|Period 2|Lack of Efficacy|2|||
124429857|NCT01373151|447535158|FG005|Period 2|Lack of Efficacy|0|||
124429858|NCT01373151|447535159|FG006|Period 2|Lack of Efficacy|3|||
124429859|NCT01373151|447535153|FG000|Period 2|Adverse Event|0|||
124429860|NCT01373151|447535154|FG001|Period 2|Adverse Event|0|||
124429861|NCT01373151|447535155|FG002|Period 2|Adverse Event|3|||
124429862|NCT01373151|447535156|FG003|Period 2|Adverse Event|3|||
124429863|NCT01373151|447535157|FG004|Period 2|Adverse Event|0|||
124429864|NCT01373151|447535158|FG005|Period 2|Adverse Event|0|||
124429865|NCT01373151|447535159|FG006|Period 2|Adverse Event|1|||
124429866|NCT01373151|447535153|FG000|Period 2|subject request to discontinue|0|||
124429867|NCT01373151|447535154|FG001|Period 2|subject request to discontinue|1|||
124429868|NCT01373151|447535155|FG002|Period 2|subject request to discontinue|0|||
124429869|NCT01373151|447535156|FG003|Period 2|subject request to discontinue|0|||
124429870|NCT01373151|447535157|FG004|Period 2|subject request to discontinue|0|||
124429871|NCT01373151|447535158|FG005|Period 2|subject request to discontinue|0|||
124429872|NCT01373151|447535159|FG006|Period 2|subject request to discontinue|0|||
124429873|NCT01373151|447535153|FG000|Period 2|Withdrawal by Subject|0|||
124429874|NCT01373151|447535154|FG001|Period 2|Withdrawal by Subject|0|||
124429875|NCT01373151|447535155|FG002|Period 2|Withdrawal by Subject|0|||
124429876|NCT01373151|447535156|FG003|Period 2|Withdrawal by Subject|1|||
124429877|NCT01373151|447535157|FG004|Period 2|Withdrawal by Subject|0|||
124675226|NCT02709746|448435884|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
124675227|NCT02709746|448435880|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
124675228|NCT02709746|448435881|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
124675229|NCT02709746|448435882|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
124675230|NCT02709746|448435883|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
124675231|NCT02709746|448435884|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
124675232|NCT02709746|448435880|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
124675233|NCT02709746|448435881|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
124675234|NCT02709746|448435882|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
124675235|NCT02709746|448435883|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
124675236|NCT02709746|448435884|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
124675237|NCT02709746|448435880|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
124675238|NCT02709746|448435881|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
124675239|NCT02709746|448435882|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
124675240|NCT02709746|448435883|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
124675241|NCT02709746|448435884|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
124675242|NCT02709746|448435880|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
124675243|NCT02709746|448435881|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
124675244|NCT02709746|448435882|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
124675245|NCT02709746|448435883|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
124675246|NCT02709746|448435884|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
124675247|NCT02709746|448435880|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
124675248|NCT02709746|448435881|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
124675249|NCT02709746|448435882|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
124429878|NCT01373151|447535158|FG005|Period 2|Withdrawal by Subject|0|||
124429879|NCT01373151|447535159|FG006|Period 2|Withdrawal by Subject|0|||
124429880|NCT01373151|447535153|FG000|Period 2|Other|0|||
124429881|NCT01373151|447535154|FG001|Period 2|Other|0|||
124429882|NCT01373151|447535155|FG002|Period 2|Other|1|||
124429883|NCT01373151|447535156|FG003|Period 2|Other|0|||
124429884|NCT01373151|447535157|FG004|Period 2|Other|0|||
124429885|NCT01373151|447535158|FG005|Period 2|Other|0|||
124429886|NCT01373151|447535159|FG006|Period 2|Other|1|||
124429887|NCT03026075|447535163|FG000|Overall Study|Physician Decision|1|||
124429888|NCT03117998|447535165|FG000|Overall Study|Adverse Event|1|||
124429889|NCT03117998|447535166|FG001|Overall Study|Adverse Event|0|||
124429890|NCT03117998|447535167|FG002|Overall Study|Adverse Event|0|||
124429891|NCT03117998|447535168|FG003|Overall Study|Adverse Event|0|||
124429892|NCT03117998|447535169|FG004|Overall Study|Adverse Event|0|||
124429893|NCT03117998|447535170|FG005|Overall Study|Adverse Event|0|||
124429894|NCT03117998|447535165|FG000|Overall Study|Withdrawal by Subject|0|||
124429895|NCT03117998|447535166|FG001|Overall Study|Withdrawal by Subject|0|||
124429896|NCT03117998|447535167|FG002|Overall Study|Withdrawal by Subject|2|||
124429897|NCT03117998|447535168|FG003|Overall Study|Withdrawal by Subject|3|||
124429898|NCT03117998|447535169|FG004|Overall Study|Withdrawal by Subject|3|||
124429899|NCT03117998|447535170|FG005|Overall Study|Withdrawal by Subject|0|||
124429900|NCT03117998|447535165|FG000|Overall Study|Physician Decision|0|||
124429901|NCT03117998|447535166|FG001|Overall Study|Physician Decision|1|||
124429902|NCT03117998|447535167|FG002|Overall Study|Physician Decision|1|||
124429903|NCT03117998|447535168|FG003|Overall Study|Physician Decision|0|||
124429904|NCT03117998|447535169|FG004|Overall Study|Physician Decision|0|||
124429905|NCT03117998|447535170|FG005|Overall Study|Physician Decision|0|||
124429906|NCT03117998|447535165|FG000|Overall Study|Lost to Follow-up|0|||
124429907|NCT03117998|447535166|FG001|Overall Study|Lost to Follow-up|0|||
124429908|NCT03117998|447535167|FG002|Overall Study|Lost to Follow-up|0|||
124429909|NCT03117998|447535168|FG003|Overall Study|Lost to Follow-up|1|||
124429910|NCT03117998|447535169|FG004|Overall Study|Lost to Follow-up|4|||
124429911|NCT03117998|447535170|FG005|Overall Study|Lost to Follow-up|0|||
124429912|NCT03117998|447535165|FG000|Overall Study|Subject noncompliance|0|||
124429913|NCT03117998|447535166|FG001|Overall Study|Subject noncompliance|0|||
124429914|NCT03117998|447535167|FG002|Overall Study|Subject noncompliance|1|||
124429915|NCT03117998|447535168|FG003|Overall Study|Subject noncompliance|0|||
124429916|NCT03117998|447535169|FG004|Overall Study|Subject noncompliance|0|||
124429917|NCT03117998|447535170|FG005|Overall Study|Subject noncompliance|2|||
124429918|NCT03117998|447535165|FG000|Overall Study|Protocol Violation|0|||
124429919|NCT03117998|447535166|FG001|Overall Study|Protocol Violation|0|||
124429920|NCT03117998|447535167|FG002|Overall Study|Protocol Violation|0|||
124429921|NCT03117998|447535168|FG003|Overall Study|Protocol Violation|0|||
124429922|NCT03117998|447535169|FG004|Overall Study|Protocol Violation|0|||
124429923|NCT03117998|447535170|FG005|Overall Study|Protocol Violation|1|||
124429924|NCT00293059|447535171|FG000|Overall Study|Adverse Event|12|||
124429925|NCT00293059|447535172|FG001|Overall Study|Adverse Event|4|||
124429926|NCT00293059|447535171|FG000|Overall Study|Lack of Efficacy|2|||
124429927|NCT00293059|447535172|FG001|Overall Study|Lack of Efficacy|0|||
124429928|NCT00293059|447535171|FG000|Overall Study|Lost to Follow-up|2|||
124429929|NCT00293059|447535172|FG001|Overall Study|Lost to Follow-up|3|||
124429930|NCT00293059|447535171|FG000|Overall Study|Pregnancy|1|||
124429931|NCT00293059|447535172|FG001|Overall Study|Pregnancy|1|||
124429932|NCT00293059|447535171|FG000|Overall Study|Protocol Violation|2|||
124429933|NCT00293059|447535172|FG001|Overall Study|Protocol Violation|0|||
124429934|NCT00293059|447535171|FG000|Overall Study|Withdrawal by Subject|11|||
124429935|NCT00293059|447535172|FG001|Overall Study|Withdrawal by Subject|5|||
124429936|NCT00293059|447535171|FG000|Overall Study|Participant moved out of state|1|||
124429937|NCT00293059|447535172|FG001|Overall Study|Participant moved out of state|0|||
124429938|NCT00293059|447535171|FG000|Overall Study|Participant stopped study drug|1|||
124429939|NCT00293059|447535172|FG001|Overall Study|Participant stopped study drug|0|||
124429940|NCT00293059|447535171|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
124429941|NCT00293059|447535172|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
124429942|NCT00293059|447535171|FG000|Overall Study|missing|3|||
124429943|NCT00293059|447535172|FG001|Overall Study|missing|5|||
124429944|NCT00350103|447535174|FG000|Overall Study|Adverse Event|12|||
124429945|NCT00350103|447535175|FG001|Overall Study|Adverse Event|29|||
124429946|NCT00350103|447535176|FG002|Overall Study|Adverse Event|17|||
124429947|NCT00350103|447535174|FG000|Overall Study|Lack of Efficacy|5|||
124429948|NCT00350103|447535175|FG001|Overall Study|Lack of Efficacy|1|||
124429949|NCT00350103|447535176|FG002|Overall Study|Lack of Efficacy|3|||
124429950|NCT00350103|447535174|FG000|Overall Study|Withdrawal by Subject|6|||
124429951|NCT00350103|447535175|FG001|Overall Study|Withdrawal by Subject|6|||
124429952|NCT00350103|447535176|FG002|Overall Study|Withdrawal by Subject|8|||
124429953|NCT00350103|447535174|FG000|Overall Study|Protocol Violation|0|||
124429954|NCT00350103|447535175|FG001|Overall Study|Protocol Violation|0|||
124429955|NCT00350103|447535176|FG002|Overall Study|Protocol Violation|1|||
124429956|NCT00350103|447535174|FG000|Overall Study|Unsatisfactory Compliance|2|||
124429957|NCT00350103|447535175|FG001|Overall Study|Unsatisfactory Compliance|2|||
124429958|NCT00350103|447535176|FG002|Overall Study|Unsatisfactory Compliance|1|||
124429959|NCT00350103|447535174|FG000|Overall Study|Investigator´s decision|1|||
124429960|NCT00350103|447535175|FG001|Overall Study|Investigator´s decision|1|||
124429961|NCT00350103|447535176|FG002|Overall Study|Investigator´s decision|0|||
124429962|NCT00350103|447535174|FG000|Overall Study|Exclusion criteria met|0|||
124429963|NCT00350103|447535175|FG001|Overall Study|Exclusion criteria met|0|||
124429964|NCT00350103|447535176|FG002|Overall Study|Exclusion criteria met|1|||
124429965|NCT00350103|447535174|FG000|Overall Study|Patient relocated|0|||
124429966|NCT00350103|447535175|FG001|Overall Study|Patient relocated|0|||
124429967|NCT00350103|447535176|FG002|Overall Study|Patient relocated|1|||
124429968|NCT00350103|447535174|FG000|Overall Study|Need for prohibited medication|1|||
124429969|NCT00350103|447535175|FG001|Overall Study|Need for prohibited medication|0|||
124429970|NCT00350103|447535176|FG002|Overall Study|Need for prohibited medication|0|||
124429971|NCT00350103|447535174|FG000|Overall Study|Personal reasons|0|||
124429972|NCT00350103|447535175|FG001|Overall Study|Personal reasons|0|||
124429973|NCT00350103|447535176|FG002|Overall Study|Personal reasons|1|||
124429974|NCT00350103|447535174|FG000|Overall Study|Patient stopped feeling pain|1|||
124429975|NCT00350103|447535175|FG001|Overall Study|Patient stopped feeling pain|0|||
124429976|NCT00350103|447535176|FG002|Overall Study|Patient stopped feeling pain|0|||
124675250|NCT02709746|448435883|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
124675251|NCT02709746|448435884|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
124675252|NCT02709746|448435880|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
124429977|NCT00350103|447535174|FG000|Overall Study|PR greater than 250ms|0|||
124429978|NCT00350103|447535175|FG001|Overall Study|PR greater than 250ms|0|||
124675253|NCT02709746|448435881|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
124675254|NCT02709746|448435882|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
124711989|NCT00690794|448570704|FG000|Overall Study|Withdrawal by Subject|0|||
124429979|NCT00350103|447535176|FG002|Overall Study|PR greater than 250ms|1|||
124429980|NCT00350103|447535174|FG000|Overall Study|Wrong calculation of QT interval|0|||
124429981|NCT00350103|447535175|FG001|Overall Study|Wrong calculation of QT interval|0|||
124429982|NCT00350103|447535176|FG002|Overall Study|Wrong calculation of QT interval|1|||
124429983|NCT00350103|447535174|FG000|Overall Study|Sponsor mistake|1|||
124429984|NCT00350103|447535175|FG001|Overall Study|Sponsor mistake|0|||
124429985|NCT00350103|447535176|FG002|Overall Study|Sponsor mistake|0|||
124675255|NCT02709746|448435883|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
124675256|NCT02709746|448435884|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
124675257|NCT02709746|448435880|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
124675258|NCT02709746|448435881|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
124675259|NCT02709746|448435882|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
124675260|NCT02709746|448435883|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
124675261|NCT02709746|448435884|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
124675262|NCT02709746|448435880|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
124675263|NCT02709746|448435881|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
124675264|NCT02709746|448435882|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
124675265|NCT02709746|448435883|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
124675266|NCT02709746|448435884|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
124429986|NCT00350103|447535174|FG000|Overall Study|Randomization mistake|0|||
124429987|NCT00350103|447535175|FG001|Overall Study|Randomization mistake|1|||
124429988|NCT00350103|447535176|FG002|Overall Study|Randomization mistake|1|||
124429989|NCT00350103|447535174|FG000|Overall Study|Sponsor´s decision|0|||
124429990|NCT00350103|447535175|FG001|Overall Study|Sponsor´s decision|1|||
124429991|NCT00350103|447535176|FG002|Overall Study|Sponsor´s decision|0|||
124429992|NCT00350103|447535174|FG000|Overall Study|Lost, Reason unknown|1|||
124429993|NCT00350103|447535175|FG001|Overall Study|Lost, Reason unknown|1|||
124429994|NCT00350103|447535176|FG002|Overall Study|Lost, Reason unknown|0|||
124429995|NCT00438672|447535177|FG000|Overall Study|Lost to Follow-up|7|||
124429996|NCT00438672|447535178|FG001|Overall Study|Lost to Follow-up|9|||
124429997|NCT01468181|447535182|FG000|Overall Study|Adverse Event|8|||
124429998|NCT01468181|447535183|FG001|Overall Study|Adverse Event|1|||
124429999|NCT01468181|447535184|FG002|Overall Study|Adverse Event|6|||
124430000|NCT01468181|447535185|FG003|Overall Study|Adverse Event|2|||
124430001|NCT01468181|447535186|FG004|Overall Study|Adverse Event|2|||
124430002|NCT01468181|447535182|FG000|Overall Study|Protocol Violation|2|||
124430003|NCT01468181|447535183|FG001|Overall Study|Protocol Violation|0|||
124430004|NCT01468181|447535184|FG002|Overall Study|Protocol Violation|1|||
124430005|NCT01468181|447535185|FG003|Overall Study|Protocol Violation|0|||
124430006|NCT01468181|447535186|FG004|Overall Study|Protocol Violation|1|||
124430007|NCT01468181|447535182|FG000|Overall Study|Physician Decision|0|||
124430008|NCT01468181|447535183|FG001|Overall Study|Physician Decision|0|||
124430009|NCT01468181|447535184|FG002|Overall Study|Physician Decision|0|||
124430010|NCT01468181|447535185|FG003|Overall Study|Physician Decision|1|||
124430011|NCT01468181|447535186|FG004|Overall Study|Physician Decision|1|||
124430012|NCT01468181|447535182|FG000|Overall Study|Lost to Follow-up|0|||
124430013|NCT01468181|447535183|FG001|Overall Study|Lost to Follow-up|0|||
124430014|NCT01468181|447535184|FG002|Overall Study|Lost to Follow-up|1|||
124430015|NCT01468181|447535185|FG003|Overall Study|Lost to Follow-up|0|||
124430016|NCT01468181|447535186|FG004|Overall Study|Lost to Follow-up|1|||
124430017|NCT01468181|447535182|FG000|Overall Study|Withdrawal by Subject|0|||
124430018|NCT01468181|447535183|FG001|Overall Study|Withdrawal by Subject|1|||
124430019|NCT01468181|447535184|FG002|Overall Study|Withdrawal by Subject|0|||
124430020|NCT01468181|447535185|FG003|Overall Study|Withdrawal by Subject|0|||
124675267|NCT02709746|448435880|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
124675268|NCT02709746|448435881|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
124675269|NCT02709746|448435882|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
124675270|NCT02709746|448435883|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
124675271|NCT02709746|448435884|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
124675272|NCT02709746|448435880|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
124675273|NCT02709746|448435881|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
124675274|NCT02709746|448435882|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
124675275|NCT02709746|448435883|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
124675276|NCT02709746|448435884|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
124675277|NCT02709746|448435880|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
124675278|NCT02709746|448435881|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
124675279|NCT02709746|448435882|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
124675280|NCT02709746|448435883|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
124675281|NCT02709746|448435884|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
124675282|NCT00095979|448435887|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
124675283|NCT01483118|448435888|FG000|Overall Study|Lost to Follow-up|12|||
124675284|NCT01483118|448435889|FG001|Overall Study|Lost to Follow-up|16|||
124675285|NCT03322293|448435895|FG000|Overall Study|Lost to Follow-up|0|||
124675286|NCT03322293|448435896|FG001|Overall Study|Lost to Follow-up|0|||
124675287|NCT03322293|448435897|FG002|Overall Study|Lost to Follow-up|1|||
124675288|NCT02089347|448435898|FG000|Overall Study|Protocol Violation|1|||
124675289|NCT02089347|448435899|FG001|Overall Study|Protocol Violation|0|||
124675290|NCT02783066|448435900|FG000|Overall Study|Withdrawal by Subject|13|||
124675291|NCT03712280|448435902|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
124675292|NCT03712280|448435903|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
124675293|NCT03712280|448435904|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
124675294|NCT03712280|448435905|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
124675295|NCT03712280|448435902|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
124675296|NCT03712280|448435903|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
124675297|NCT03712280|448435904|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
124430021|NCT01468181|447535186|FG004|Overall Study|Withdrawal by Subject|0|||
124430022|NCT02712905|447535187|FG000|Monotherapy|Death|2|||
124430023|NCT02712905|447535188|FG001|Monotherapy|Death|5|||
124430024|NCT02712905|447535189|FG002|Monotherapy|Death|0|||
124430025|NCT02712905|447535190|FG003|Monotherapy|Death|3|||
124430026|NCT02712905|447535191|FG004|Monotherapy|Death|15|||
124430027|NCT02712905|447535192|FG005|Monotherapy|Death|1|||
124430028|NCT02712905|447535193|FG006|Monotherapy|Death|3|||
124430029|NCT02712905|447535194|FG007|Monotherapy|Death|3|||
124430030|NCT02712905|447535195|FG008|Monotherapy|Death|0|||
124430031|NCT02712905|447535196|FG009|Monotherapy|Death|27|||
124430032|NCT02712905|447535197|FG010|Monotherapy|Death|2|||
124430033|NCT02712905|447535198|FG011|Monotherapy|Death|5|||
124430034|NCT02712905|447535199|FG012|Monotherapy|Death|0|||
124430035|NCT02712905|447535200|FG013|Monotherapy|Death|0|||
124430036|NCT02712905|447535201|FG014|Monotherapy|Death|0|||
124430037|NCT02712905|447535202|FG015|Monotherapy|Death|0|||
124430038|NCT02712905|447535203|FG016|Monotherapy|Death|0|||
124430039|NCT02712905|447535204|FG017|Monotherapy|Death|0|||
124430040|NCT02712905|447535187|FG000|Monotherapy|Lost to Follow-up|0|||
124430041|NCT02712905|447535188|FG001|Monotherapy|Lost to Follow-up|1|||
124430042|NCT02712905|447535189|FG002|Monotherapy|Lost to Follow-up|0|||
124430043|NCT02712905|447535190|FG003|Monotherapy|Lost to Follow-up|1|||
124430044|NCT02712905|447535191|FG004|Monotherapy|Lost to Follow-up|0|||
124430045|NCT02712905|447535192|FG005|Monotherapy|Lost to Follow-up|0|||
124430046|NCT02712905|447535193|FG006|Monotherapy|Lost to Follow-up|0|||
124430047|NCT02712905|447535194|FG007|Monotherapy|Lost to Follow-up|0|||
124430048|NCT02712905|447535195|FG008|Monotherapy|Lost to Follow-up|0|||
124430049|NCT02712905|447535196|FG009|Monotherapy|Lost to Follow-up|2|||
124430050|NCT02712905|447535197|FG010|Monotherapy|Lost to Follow-up|0|||
124430051|NCT02712905|447535198|FG011|Monotherapy|Lost to Follow-up|0|||
124430052|NCT02712905|447535199|FG012|Monotherapy|Lost to Follow-up|0|||
124430053|NCT02712905|447535200|FG013|Monotherapy|Lost to Follow-up|0|||
124430054|NCT02712905|447535201|FG014|Monotherapy|Lost to Follow-up|0|||
124430055|NCT02712905|447535202|FG015|Monotherapy|Lost to Follow-up|0|||
124430056|NCT02712905|447535203|FG016|Monotherapy|Lost to Follow-up|0|||
124430057|NCT02712905|447535204|FG017|Monotherapy|Lost to Follow-up|0|||
124430058|NCT02712905|447535187|FG000|Monotherapy|Physician Decision|1|||
124430059|NCT02712905|447535188|FG001|Monotherapy|Physician Decision|0|||
124430060|NCT02712905|447535189|FG002|Monotherapy|Physician Decision|0|||
124430061|NCT02712905|447535190|FG003|Monotherapy|Physician Decision|1|||
124430062|NCT02712905|447535191|FG004|Monotherapy|Physician Decision|0|||
124430063|NCT02712905|447535192|FG005|Monotherapy|Physician Decision|0|||
124430064|NCT02712905|447535193|FG006|Monotherapy|Physician Decision|0|||
124430065|NCT02712905|447535194|FG007|Monotherapy|Physician Decision|0|||
124430066|NCT02712905|447535195|FG008|Monotherapy|Physician Decision|0|||
124430067|NCT02712905|447535196|FG009|Monotherapy|Physician Decision|1|||
124430068|NCT02712905|447535197|FG010|Monotherapy|Physician Decision|0|||
124430069|NCT02712905|447535198|FG011|Monotherapy|Physician Decision|0|||
124430070|NCT02712905|447535199|FG012|Monotherapy|Physician Decision|0|||
124430071|NCT02712905|447535200|FG013|Monotherapy|Physician Decision|0|||
124430072|NCT02712905|447535201|FG014|Monotherapy|Physician Decision|0|||
124430073|NCT02712905|447535202|FG015|Monotherapy|Physician Decision|0|||
124430074|NCT02712905|447535203|FG016|Monotherapy|Physician Decision|0|||
124430075|NCT02712905|447535204|FG017|Monotherapy|Physician Decision|0|||
124430076|NCT02712905|447535187|FG000|Monotherapy|Study Terminated by Sponsor|0|||
124430077|NCT02712905|447535188|FG001|Monotherapy|Study Terminated by Sponsor|0|||
124430078|NCT02712905|447535189|FG002|Monotherapy|Study Terminated by Sponsor|0|||
124430079|NCT02712905|447535190|FG003|Monotherapy|Study Terminated by Sponsor|0|||
124430080|NCT02712905|447535191|FG004|Monotherapy|Study Terminated by Sponsor|1|||
124430081|NCT02712905|447535192|FG005|Monotherapy|Study Terminated by Sponsor|0|||
124430082|NCT02712905|447535193|FG006|Monotherapy|Study Terminated by Sponsor|0|||
124430083|NCT02712905|447535194|FG007|Monotherapy|Study Terminated by Sponsor|0|||
124430084|NCT02712905|447535195|FG008|Monotherapy|Study Terminated by Sponsor|0|||
124430085|NCT02712905|447535196|FG009|Monotherapy|Study Terminated by Sponsor|2|||
124430086|NCT02712905|447535197|FG010|Monotherapy|Study Terminated by Sponsor|0|||
124430087|NCT02712905|447535198|FG011|Monotherapy|Study Terminated by Sponsor|0|||
124430088|NCT02712905|447535199|FG012|Monotherapy|Study Terminated by Sponsor|0|||
124675298|NCT03712280|448435905|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
124675299|NCT03712280|448435902|FG000|Overall Study|Adverse Event|0|||
124675300|NCT03712280|448435903|FG001|Overall Study|Adverse Event|0|||
124675301|NCT03712280|448435904|FG002|Overall Study|Adverse Event|1|||
124675302|NCT03712280|448435905|FG003|Overall Study|Adverse Event|0|||
124675303|NCT00551369|448435906|FG000|Overall Study|Protocol Violation|5|||
124430089|NCT02712905|447535200|FG013|Monotherapy|Study Terminated by Sponsor|0|||
124430090|NCT02712905|447535201|FG014|Monotherapy|Study Terminated by Sponsor|0|||
124430091|NCT02712905|447535202|FG015|Monotherapy|Study Terminated by Sponsor|0|||
124430092|NCT02712905|447535203|FG016|Monotherapy|Study Terminated by Sponsor|0|||
124430093|NCT02712905|447535204|FG017|Monotherapy|Study Terminated by Sponsor|0|||
124430094|NCT02712905|447535187|FG000|Monotherapy|Withdrawal by Subject|0|||
124430095|NCT02712905|447535188|FG001|Monotherapy|Withdrawal by Subject|0|||
124430096|NCT02712905|447535189|FG002|Monotherapy|Withdrawal by Subject|1|||
124430097|NCT02712905|447535190|FG003|Monotherapy|Withdrawal by Subject|0|||
124430098|NCT02712905|447535191|FG004|Monotherapy|Withdrawal by Subject|2|||
124430099|NCT02712905|447535192|FG005|Monotherapy|Withdrawal by Subject|0|||
124430100|NCT02712905|447535193|FG006|Monotherapy|Withdrawal by Subject|0|||
124430101|NCT02712905|447535194|FG007|Monotherapy|Withdrawal by Subject|0|||
124675304|NCT00551369|448435906|FG000|Overall Study|Withdrawal by Subject|1|||
124430102|NCT02712905|447535195|FG008|Monotherapy|Withdrawal by Subject|0|||
124430103|NCT02712905|447535196|FG009|Monotherapy|Withdrawal by Subject|4|||
124430104|NCT02712905|447535197|FG010|Monotherapy|Withdrawal by Subject|1|||
124430105|NCT02712905|447535198|FG011|Monotherapy|Withdrawal by Subject|2|||
124430106|NCT02712905|447535199|FG012|Monotherapy|Withdrawal by Subject|0|||
124430107|NCT02712905|447535200|FG013|Monotherapy|Withdrawal by Subject|0|||
124430108|NCT02712905|447535201|FG014|Monotherapy|Withdrawal by Subject|0|||
124430109|NCT02712905|447535202|FG015|Monotherapy|Withdrawal by Subject|0|||
124430110|NCT02712905|447535203|FG016|Monotherapy|Withdrawal by Subject|0|||
124430111|NCT02712905|447535204|FG017|Monotherapy|Withdrawal by Subject|0|||
124430112|NCT02712905|447535187|FG000|Monotherapy|Started New Cancer Drug|0|||
124430113|NCT02712905|447535188|FG001|Monotherapy|Started New Cancer Drug|0|||
124430114|NCT02712905|447535189|FG002|Monotherapy|Started New Cancer Drug|0|||
124430115|NCT02712905|447535190|FG003|Monotherapy|Started New Cancer Drug|0|||
124430116|NCT02712905|447535191|FG004|Monotherapy|Started New Cancer Drug|0|||
124430117|NCT02712905|447535192|FG005|Monotherapy|Started New Cancer Drug|1|||
124430118|NCT02712905|447535193|FG006|Monotherapy|Started New Cancer Drug|0|||
124430119|NCT02712905|447535194|FG007|Monotherapy|Started New Cancer Drug|0|||
124430120|NCT02712905|447535195|FG008|Monotherapy|Started New Cancer Drug|0|||
124430121|NCT02712905|447535196|FG009|Monotherapy|Started New Cancer Drug|0|||
124430122|NCT02712905|447535197|FG010|Monotherapy|Started New Cancer Drug|0|||
124430123|NCT02712905|447535198|FG011|Monotherapy|Started New Cancer Drug|0|||
124430124|NCT02712905|447535199|FG012|Monotherapy|Started New Cancer Drug|0|||
124430125|NCT02712905|447535200|FG013|Monotherapy|Started New Cancer Drug|0|||
124430126|NCT02712905|447535201|FG014|Monotherapy|Started New Cancer Drug|0|||
124430127|NCT02712905|447535202|FG015|Monotherapy|Started New Cancer Drug|0|||
124430128|NCT02712905|447535203|FG016|Monotherapy|Started New Cancer Drug|0|||
124430129|NCT02712905|447535204|FG017|Monotherapy|Started New Cancer Drug|0|||
124430130|NCT02712905|447535187|FG000|Monotherapy|Adverse Event|0|||
124430131|NCT02712905|447535188|FG001|Monotherapy|Adverse Event|0|||
124430132|NCT02712905|447535189|FG002|Monotherapy|Adverse Event|0|||
124430133|NCT02712905|447535190|FG003|Monotherapy|Adverse Event|0|||
124430134|NCT02712905|447535191|FG004|Monotherapy|Adverse Event|0|||
124430135|NCT02712905|447535192|FG005|Monotherapy|Adverse Event|0|||
124430136|NCT02712905|447535193|FG006|Monotherapy|Adverse Event|0|||
124430137|NCT02712905|447535194|FG007|Monotherapy|Adverse Event|0|||
124430138|NCT02712905|447535195|FG008|Monotherapy|Adverse Event|1|||
124430139|NCT02712905|447535196|FG009|Monotherapy|Adverse Event|0|||
124430140|NCT02712905|447535197|FG010|Monotherapy|Adverse Event|0|||
124430141|NCT02712905|447535198|FG011|Monotherapy|Adverse Event|0|||
124430142|NCT02712905|447535199|FG012|Monotherapy|Adverse Event|0|||
124430143|NCT02712905|447535200|FG013|Monotherapy|Adverse Event|0|||
124430144|NCT02712905|447535201|FG014|Monotherapy|Adverse Event|0|||
124430145|NCT02712905|447535202|FG015|Monotherapy|Adverse Event|0|||
124430146|NCT02712905|447535203|FG016|Monotherapy|Adverse Event|0|||
124430147|NCT02712905|447535204|FG017|Monotherapy|Adverse Event|0|||
124430148|NCT02712905|447535187|FG000|Combination Therapy|Death|0|||
124430149|NCT02712905|447535188|FG001|Combination Therapy|Death|0|||
124675305|NCT00551369|448435906|FG000|Overall Study|Not treated per protocol and re|1|||
124675306|NCT05379920|448435910|FG000|Overall Study|Lost to Follow-up|0|||
124675307|NCT05379920|448435911|FG001|Overall Study|Lost to Follow-up|5|||
124675308|NCT05379920|448435912|FG002|Overall Study|Lost to Follow-up|0|||
124675309|NCT05379920|448435913|FG003|Overall Study|Lost to Follow-up|0|||
124675310|NCT00719901|448435915|FG000|Overall Study|Adverse Event|5|||
124675311|NCT00719901|448435915|FG000|Overall Study|Withdrawal by Subject|1|||
124675312|NCT00719901|448435915|FG000|Overall Study|Alternate Treatment|1|||
124675313|NCT00719901|448435915|FG000|Overall Study|Disease Progression|3|||
124675314|NCT00719901|448435915|FG000|Overall Study|Availability of Study Drug|1|||
124675315|NCT01122173|448435916|FG000|Overall Study|Lost to Follow-up|3|||
124675316|NCT01122173|448435916|FG000|Overall Study|Withdrawal by Subject|3|||
124675317|NCT01122173|448435916|FG000|Overall Study|Left study for other reasons|3|||
124675318|NCT01184872|448435917|FG000|Overall Study|Adverse Event|3|||
124675319|NCT01184872|448435918|FG001|Overall Study|Adverse Event|4|||
124675320|NCT01184872|448435917|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
124675321|NCT01184872|448435918|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124675322|NCT01184872|448435917|FG000|Overall Study|Withdrawal by Subject|2|||
124675323|NCT01184872|448435918|FG001|Overall Study|Withdrawal by Subject|0|||
124675324|NCT01184872|448435917|FG000|Overall Study|Lost to Follow-up|0|||
124430150|NCT02712905|447535189|FG002|Combination Therapy|Death|0|||
124430151|NCT02712905|447535190|FG003|Combination Therapy|Death|0|||
124430152|NCT02712905|447535191|FG004|Combination Therapy|Death|0|||
124430153|NCT02712905|447535192|FG005|Combination Therapy|Death|0|||
124675325|NCT01184872|448435918|FG001|Overall Study|Lost to Follow-up|1|||
124675326|NCT01184872|448435917|FG000|Overall Study|Administrative problems|1|||
124675327|NCT01184872|448435918|FG001|Overall Study|Administrative problems|1|||
124430154|NCT02712905|447535193|FG006|Combination Therapy|Death|0|||
124430155|NCT02712905|447535194|FG007|Combination Therapy|Death|0|||
124430156|NCT02712905|447535195|FG008|Combination Therapy|Death|0|||
124430157|NCT02712905|447535196|FG009|Combination Therapy|Death|0|||
124430158|NCT02712905|447535197|FG010|Combination Therapy|Death|0|||
124430159|NCT02712905|447535198|FG011|Combination Therapy|Death|0|||
124430160|NCT02712905|447535199|FG012|Combination Therapy|Death|5|||
124430161|NCT02712905|447535200|FG013|Combination Therapy|Death|6|||
124675328|NCT01184872|448435917|FG000|Overall Study|Protocol deviation|1|||
124675329|NCT01184872|448435918|FG001|Overall Study|Protocol deviation|0|||
124675330|NCT03426345|448435919|FG000|Overall Study|Adverse Event|4|||
124675331|NCT03426345|448435920|FG001|Overall Study|Adverse Event|4|||
124675332|NCT03426345|448435919|FG000|Overall Study|Lack of Efficacy|1|||
124675333|NCT03426345|448435920|FG001|Overall Study|Lack of Efficacy|0|||
124675334|NCT03426345|448435919|FG000|Overall Study|Withdrawal by Subject|5|||
124675335|NCT03426345|448435920|FG001|Overall Study|Withdrawal by Subject|6|||
124675336|NCT03426345|448435919|FG000|Overall Study|Lost to Follow-up|3|||
124675337|NCT03426345|448435920|FG001|Overall Study|Lost to Follow-up|1|||
124675338|NCT03426345|448435919|FG000|Overall Study|Protocol Deviation|3|||
124675339|NCT03426345|448435920|FG001|Overall Study|Protocol Deviation|4|||
124675340|NCT03426345|448435919|FG000|Overall Study|Reason Not Specified|1|||
124675341|NCT03426345|448435920|FG001|Overall Study|Reason Not Specified|2|||
124430162|NCT02712905|447535201|FG014|Combination Therapy|Death|1|||
124430163|NCT02712905|447535202|FG015|Combination Therapy|Death|3|||
124430164|NCT02712905|447535203|FG016|Combination Therapy|Death|1|||
124430165|NCT02712905|447535204|FG017|Combination Therapy|Death|3|||
124675342|NCT03426345|448435919|FG000|Overall Study|Missing Completion Status|1|||
124675343|NCT03426345|448435920|FG001|Overall Study|Missing Completion Status|0|||
124675344|NCT00116142|448435921|FG000|Overall Study|Adverse Event|8|||
124675345|NCT00116142|448435922|FG001|Overall Study|Adverse Event|7|||
124675346|NCT00116142|448435921|FG000|Overall Study|Protocol Violation|2|||
124675347|NCT00116142|448435922|FG001|Overall Study|Protocol Violation|1|||
124675348|NCT00116142|448435921|FG000|Overall Study|Withdrawal by Subject|5|||
124675349|NCT00116142|448435922|FG001|Overall Study|Withdrawal by Subject|5|||
124675350|NCT00116142|448435921|FG000|Overall Study|Physician Decision|3|||
124675351|NCT00116142|448435922|FG001|Overall Study|Physician Decision|1|||
124675352|NCT00116142|448435921|FG000|Overall Study|Delayed Radiation Therapy|1|||
124675353|NCT00116142|448435922|FG001|Overall Study|Delayed Radiation Therapy|0|||
124675354|NCT00116142|448435921|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
124675355|NCT00116142|448435922|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
124675356|NCT00116142|448435921|FG000|Overall Study|Patient stopped due to depression|0|||
124675357|NCT00116142|448435922|FG001|Overall Study|Patient stopped due to depression|1|||
124675358|NCT00116142|448435921|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
124675359|NCT00116142|448435922|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
124675360|NCT00116142|448435921|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
124675361|NCT00116142|448435922|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
124675362|NCT00116142|448435921|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
124675363|NCT00116142|448435922|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
124675364|NCT00644059|448435923|FG000|Overall Study|Lost to Follow-up|37|||
124675365|NCT00644059|448435924|FG001|Overall Study|Lost to Follow-up|34|||
124675366|NCT00644059|448435925|FG002|Overall Study|Lost to Follow-up|16|||
124675367|NCT00644059|448435923|FG000|Overall Study|Withdrawal by Subject|52|||
124675368|NCT00644059|448435924|FG001|Overall Study|Withdrawal by Subject|60|||
124675369|NCT00644059|448435925|FG002|Overall Study|Withdrawal by Subject|30|||
124675370|NCT00644059|448435923|FG000|Overall Study|Adverse Event|8|||
124675371|NCT00644059|448435924|FG001|Overall Study|Adverse Event|5|||
124675372|NCT00644059|448435925|FG002|Overall Study|Adverse Event|1|||
124675373|NCT00644059|448435923|FG000|Overall Study|Inappropriate Enrollment|1|||
124675374|NCT00644059|448435924|FG001|Overall Study|Inappropriate Enrollment|3|||
124675375|NCT00644059|448435925|FG002|Overall Study|Inappropriate Enrollment|0|||
124675376|NCT00644059|448435923|FG000|Overall Study|Protocol Deviation/violation|20|||
124675377|NCT00644059|448435924|FG001|Overall Study|Protocol Deviation/violation|19|||
124675378|NCT00644059|448435925|FG002|Overall Study|Protocol Deviation/violation|15|||
124675379|NCT00644059|448435923|FG000|Overall Study|Unable to classify|6|||
124675380|NCT00644059|448435924|FG001|Overall Study|Unable to classify|2|||
124675381|NCT00644059|448435925|FG002|Overall Study|Unable to classify|3|||
124675382|NCT02133508|448435926|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
124430166|NCT02712905|447535187|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
124430167|NCT02712905|447535188|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
124430168|NCT02712905|447535189|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
124430169|NCT02712905|447535190|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
124430170|NCT02712905|447535191|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
124430171|NCT02712905|447535192|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
124430172|NCT02712905|447535193|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
124430173|NCT02712905|447535194|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
124430174|NCT02712905|447535195|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
124430175|NCT02712905|447535196|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
124430176|NCT02712905|447535197|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
124430177|NCT02712905|447535198|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
124430178|NCT02712905|447535199|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
124430179|NCT02712905|447535200|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
124430180|NCT02712905|447535201|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
124430181|NCT02712905|447535202|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
124430182|NCT02712905|447535203|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
124430183|NCT02712905|447535204|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
124430184|NCT02712905|447535187|FG000|Combination Therapy|Withdrawal by Subject|0|||
124430185|NCT02712905|447535188|FG001|Combination Therapy|Withdrawal by Subject|0|||
124430186|NCT02712905|447535189|FG002|Combination Therapy|Withdrawal by Subject|0|||
124430187|NCT02712905|447535190|FG003|Combination Therapy|Withdrawal by Subject|0|||
124430188|NCT02712905|447535191|FG004|Combination Therapy|Withdrawal by Subject|0|||
124430189|NCT02712905|447535192|FG005|Combination Therapy|Withdrawal by Subject|0|||
124430190|NCT02712905|447535193|FG006|Combination Therapy|Withdrawal by Subject|0|||
124675383|NCT02133508|448435926|FG000|Overall Study|Death|12|||
124675384|NCT02133508|448435926|FG000|Overall Study|Lost to Follow-up|2|||
124675385|NCT02497469|448435933|FG000|Overall Study|Randomized but not Treated|0|||
124675386|NCT02497469|448435934|FG001|Overall Study|Randomized but not Treated|2|||
124675387|NCT02497469|448435933|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
124430191|NCT02712905|447535194|FG007|Combination Therapy|Withdrawal by Subject|0|||
124430192|NCT02712905|447535195|FG008|Combination Therapy|Withdrawal by Subject|0|||
124430193|NCT02712905|447535196|FG009|Combination Therapy|Withdrawal by Subject|0|||
124430194|NCT02712905|447535197|FG010|Combination Therapy|Withdrawal by Subject|0|||
124430195|NCT02712905|447535198|FG011|Combination Therapy|Withdrawal by Subject|0|||
124675388|NCT02497469|448435934|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
124675389|NCT02497469|448435933|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
124675390|NCT02497469|448435934|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
124675391|NCT02497469|448435933|FG000|Overall Study|Significant Protocol Deviation|4|||
124675392|NCT02497469|448435934|FG001|Overall Study|Significant Protocol Deviation|5|||
124675393|NCT02497469|448435933|FG000|Overall Study|Lost to Follow-up|14|||
124675394|NCT02497469|448435934|FG001|Overall Study|Lost to Follow-up|4|||
124675395|NCT02497469|448435933|FG000|Overall Study|Voluntary Withdrawal|39|||
124675396|NCT02497469|448435934|FG001|Overall Study|Voluntary Withdrawal|41|||
124675397|NCT02497469|448435933|FG000|Overall Study|Pregnancy|1|||
124675398|NCT02497469|448435934|FG001|Overall Study|Pregnancy|1|||
124675399|NCT02497469|448435933|FG000|Overall Study|Lack of Efficacy|86|||
124675400|NCT02497469|448435934|FG001|Overall Study|Lack of Efficacy|40|||
124675401|NCT02497469|448435933|FG000|Overall Study|Reason not Specified|6|||
124675402|NCT02497469|448435934|FG001|Overall Study|Reason not Specified|6|||
124675403|NCT04076917|448435936|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
124675404|NCT04076917|448435936|FG000|Overall Study|Study closure|13|||
124430196|NCT02712905|447535199|FG012|Combination Therapy|Withdrawal by Subject|0|||
124675405|NCT04076917|448435936|FG000|Overall Study|Physician Decision|3|||
124675406|NCT04076917|448435936|FG000|Overall Study|Death|1|||
124430197|NCT02712905|447535200|FG013|Combination Therapy|Withdrawal by Subject|0|||
124430198|NCT02712905|447535201|FG014|Combination Therapy|Withdrawal by Subject|0|||
124430199|NCT02712905|447535202|FG015|Combination Therapy|Withdrawal by Subject|1|||
124430200|NCT02712905|447535203|FG016|Combination Therapy|Withdrawal by Subject|0|||
124430201|NCT02712905|447535204|FG017|Combination Therapy|Withdrawal by Subject|2|||
124430202|NCT02712905|447535187|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124430203|NCT02712905|447535188|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124430204|NCT02712905|447535189|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124430205|NCT02712905|447535190|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124430206|NCT02712905|447535191|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124430207|NCT02712905|447535192|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124430208|NCT02712905|447535193|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124430209|NCT02712905|447535194|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124430210|NCT02712905|447535195|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124430211|NCT02712905|447535196|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124430212|NCT02712905|447535197|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124430213|NCT02712905|447535198|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124430214|NCT02712905|447535199|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124430215|NCT02712905|447535200|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124430216|NCT02712905|447535201|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124430217|NCT02712905|447535202|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
124430218|NCT02712905|447535203|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124430219|NCT02712905|447535204|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
124430220|NCT04828837|447535205|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
124430221|NCT04828837|447535206|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
124430222|NCT04828837|447535205|FG000|Overall Study|Lost to Follow-up|2|||
124430223|NCT04828837|447535206|FG001|Overall Study|Lost to Follow-up|6|||
124430224|NCT04828837|447535205|FG000|Overall Study|Lack of Efficacy|1|||
124430225|NCT04828837|447535206|FG001|Overall Study|Lack of Efficacy|0|||
124430226|NCT04828837|447535205|FG000|Overall Study|Admitted due to pneumothorax.|1|||
124430227|NCT04828837|447535206|FG001|Overall Study|Admitted due to pneumothorax.|0|||
124430228|NCT04828837|447535205|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
124430229|NCT04828837|447535206|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
124430230|NCT00320528|447535207|FG000|Study Period II|Adverse Event|3|||
124430231|NCT00320528|447535208|FG001|Study Period II|Adverse Event|4|||
124430232|NCT00320528|447535209|FG002|Study Period II|Adverse Event|8|||
124430233|NCT00320528|447535207|FG000|Study Period II|Parent/Caregiver Decision|8|||
124430234|NCT00320528|447535208|FG001|Study Period II|Parent/Caregiver Decision|3|||
124430235|NCT00320528|447535209|FG002|Study Period II|Parent/Caregiver Decision|11|||
124430236|NCT00320528|447535207|FG000|Study Period II|Withdrawal by Subject|0|||
124430237|NCT00320528|447535208|FG001|Study Period II|Withdrawal by Subject|1|||
124430238|NCT00320528|447535209|FG002|Study Period II|Withdrawal by Subject|1|||
124430239|NCT00320528|447535207|FG000|Study Period II|Entry Criteria Exclusion|0|||
124430240|NCT00320528|447535208|FG001|Study Period II|Entry Criteria Exclusion|2|||
124430241|NCT00320528|447535209|FG002|Study Period II|Entry Criteria Exclusion|2|||
124430242|NCT00320528|447535207|FG000|Study Period III|Adverse Event|1|||
124430243|NCT00320528|447535208|FG001|Study Period III|Adverse Event|0|||
124430244|NCT00320528|447535209|FG002|Study Period III|Adverse Event|0|||
124430245|NCT00320528|447535207|FG000|Study Period III|Lost to Follow-up|1|||
124675407|NCT04076917|448435936|FG000|Overall Study|Lost to Follow-up|1|||
124430246|NCT00320528|447535208|FG001|Study Period III|Lost to Follow-up|0|||
124430247|NCT00320528|447535209|FG002|Study Period III|Lost to Follow-up|0|||
124430248|NCT00320528|447535207|FG000|Study Period III|Withdrawal by Subject|1|||
124430249|NCT00320528|447535208|FG001|Study Period III|Withdrawal by Subject|1|||
124675408|NCT04076917|448435936|FG000|Overall Study|Withdrawal by Subject|1|||
124675409|NCT04076917|448435936|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
124675410|NCT01774591|448435939|FG000|Overall Study|Physician Decision|1|||
124430250|NCT00320528|447535209|FG002|Study Period III|Withdrawal by Subject|2|||
124430251|NCT00320528|447535207|FG000|Study Period III|Lack of Efficacy|2|||
124430252|NCT00320528|447535208|FG001|Study Period III|Lack of Efficacy|0|||
124430253|NCT00320528|447535209|FG002|Study Period III|Lack of Efficacy|0|||
124430254|NCT00320528|447535207|FG000|Study Period III|Parent/Caregiver Decision|14|||
124675411|NCT01774591|448435940|FG001|Overall Study|Physician Decision|1|||
124675412|NCT01774591|448435939|FG000|Overall Study|Withdrawal by Subject|0|||
124675413|NCT01774591|448435940|FG001|Overall Study|Withdrawal by Subject|1|||
124675414|NCT01774591|448435939|FG000|Overall Study|Adverse Event|0|||
124675415|NCT01774591|448435940|FG001|Overall Study|Adverse Event|2|||
124675416|NCT01787552|448435941|FG000|Overall Study|Withdrawal by Subject|2|||
124675417|NCT01787552|448435942|FG001|Overall Study|Withdrawal by Subject|0|||
124675418|NCT01787552|448435943|FG002|Overall Study|Withdrawal by Subject|0|||
124430255|NCT00320528|447535208|FG001|Study Period III|Parent/Caregiver Decision|3|||
124430256|NCT00320528|447535209|FG002|Study Period III|Parent/Caregiver Decision|11|||
124430257|NCT00320528|447535207|FG000|Study Period III|Protocol Violation|0|||
124430258|NCT00320528|447535208|FG001|Study Period III|Protocol Violation|1|||
124430259|NCT00320528|447535209|FG002|Study Period III|Protocol Violation|0|||
124430260|NCT00320528|447535207|FG000|Study Period III|Physician Decision|0|||
124430261|NCT00320528|447535208|FG001|Study Period III|Physician Decision|1|||
124430262|NCT00320528|447535209|FG002|Study Period III|Physician Decision|2|||
124430263|NCT00320528|447535207|FG000|Study Period III|Sponsor Decision|0|||
124430264|NCT00320528|447535208|FG001|Study Period III|Sponsor Decision|0|||
124430265|NCT00320528|447535209|FG002|Study Period III|Sponsor Decision|1|||
124430266|NCT00320528|447535207|FG000|Study Period III|Atomoxetine Commercially Available|68|||
124430267|NCT00320528|447535208|FG001|Study Period III|Atomoxetine Commercially Available|25|||
124430268|NCT00320528|447535209|FG002|Study Period III|Atomoxetine Commercially Available|90|||
124430269|NCT00545753|447535210|FG000|Overall Study|Withdrawal by Subject|0|||
124430270|NCT00545753|447535211|FG001|Overall Study|Withdrawal by Subject|1|||
124430271|NCT00545753|447535212|FG002|Overall Study|Withdrawal by Subject|10|||
124430272|NCT00545753|447535210|FG000|Overall Study|Lost to Follow-up|13|||
124430273|NCT00545753|447535211|FG001|Overall Study|Lost to Follow-up|3|||
124430274|NCT00545753|447535212|FG002|Overall Study|Lost to Follow-up|12|||
124430275|NCT00545753|447535210|FG000|Overall Study|Protocol Violation|3|||
124430276|NCT00545753|447535211|FG001|Overall Study|Protocol Violation|1|||
124430277|NCT00545753|447535212|FG002|Overall Study|Protocol Violation|4|||
124430278|NCT05453201|447535213|FG000|Overall Study|Withdrawal by Subject|1|||
124430279|NCT04577001|447535216|FG000|Overall Study|Subject became ineligible|0|||
124430280|NCT04577001|447535217|FG001|Overall Study|Subject became ineligible|1|||
124430281|NCT03465904|447535221|FG000|Overall Study|Withdrawal by Subject|9|||
124430282|NCT03465904|447535222|FG001|Overall Study|Withdrawal by Subject|5|||
124430283|NCT03465904|447535221|FG000|Overall Study|Lost to Follow-up|11|||
124430284|NCT03465904|447535222|FG001|Overall Study|Lost to Follow-up|9|||
124430285|NCT03465904|447535221|FG000|Overall Study|Protocol Violation|20|||
124430286|NCT03465904|447535222|FG001|Overall Study|Protocol Violation|15|||
124430287|NCT01305200|447535223|FG000|Overall Study|Physician Decision|4|||
124430288|NCT01305200|447535224|FG001|Overall Study|Physician Decision|6|||
124430289|NCT01305200|447535225|FG002|Overall Study|Physician Decision|1|||
124430290|NCT01305200|447535223|FG000|Overall Study|Withdrawal by Subject|24|||
124430291|NCT01305200|447535224|FG001|Overall Study|Withdrawal by Subject|21|||
124430292|NCT01305200|447535225|FG002|Overall Study|Withdrawal by Subject|1|||
124430293|NCT01305200|447535223|FG000|Overall Study|Ineligible|1|||
124430294|NCT01305200|447535224|FG001|Overall Study|Ineligible|2|||
124430295|NCT01305200|447535225|FG002|Overall Study|Ineligible|1|||
124430296|NCT01305200|447535223|FG000|Overall Study|Death|0|||
124430297|NCT01305200|447535224|FG001|Overall Study|Death|2|||
124430298|NCT01305200|447535225|FG002|Overall Study|Death|0|||
124430299|NCT05618912|447535226|FG000|Overall Study|Lost to Follow-up|14|||
124430300|NCT05618912|447535227|FG001|Overall Study|Lost to Follow-up|19|||
124430301|NCT05110690|447535228|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
124430302|NCT05110690|447535228|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
124430303|NCT05110690|447535228|FG000|Completion of Intervention|Lost to Follow-up|1|||
124430304|NCT05110690|447535228|FG000|Completion of Intervention|Death|1|||
124430305|NCT05110690|447535228|FG000|Completion of Intervention|Withdrawal by Subject|2|||
124430306|NCT01022112|447535231|FG000|Overall Study|Adverse Event|1|||
124430307|NCT01022112|447535232|FG001|Overall Study|Adverse Event|2|||
124430308|NCT01022112|447535233|FG002|Overall Study|Adverse Event|0|||
124430309|NCT01022112|447535234|FG003|Overall Study|Adverse Event|1|||
124430310|NCT01022112|447535235|FG004|Overall Study|Adverse Event|0|||
124430311|NCT01022112|447535231|FG000|Overall Study|Lack of Efficacy|1|||
124430312|NCT01022112|447535232|FG001|Overall Study|Lack of Efficacy|0|||
124430313|NCT01022112|447535233|FG002|Overall Study|Lack of Efficacy|0|||
124430314|NCT01022112|447535234|FG003|Overall Study|Lack of Efficacy|0|||
124430315|NCT01022112|447535235|FG004|Overall Study|Lack of Efficacy|1|||
124430316|NCT01022112|447535231|FG000|Overall Study|Physician Decision|0|||
124430317|NCT01022112|447535232|FG001|Overall Study|Physician Decision|0|||
124430318|NCT01022112|447535233|FG002|Overall Study|Physician Decision|1|||
124430319|NCT01022112|447535234|FG003|Overall Study|Physician Decision|0|||
124430320|NCT01022112|447535235|FG004|Overall Study|Physician Decision|1|||
124430321|NCT01022112|447535231|FG000|Overall Study|Withdrawal by Subject|0|||
124430322|NCT01022112|447535232|FG001|Overall Study|Withdrawal by Subject|1|||
124430323|NCT01022112|447535233|FG002|Overall Study|Withdrawal by Subject|2|||
124675419|NCT01787552|448435944|FG003|Overall Study|Withdrawal by Subject|4|||
124430324|NCT01022112|447535234|FG003|Overall Study|Withdrawal by Subject|2|||
124430325|NCT01022112|447535235|FG004|Overall Study|Withdrawal by Subject|1|||
124430326|NCT01022112|447535231|FG000|Overall Study|Fasting plasma glucose level increased|1|||
124430327|NCT01022112|447535232|FG001|Overall Study|Fasting plasma glucose level increased|0|||
124430328|NCT01022112|447535233|FG002|Overall Study|Fasting plasma glucose level increased|0|||
124430329|NCT01022112|447535234|FG003|Overall Study|Fasting plasma glucose level increased|0|||
124430330|NCT01022112|447535235|FG004|Overall Study|Fasting plasma glucose level increased|7|||
124430331|NCT00925353|447535236|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
124430332|NCT01302067|447537007|FG000|Overall Study|Death|0|||
124430333|NCT01302067|447537008|FG001|Overall Study|Death|0|||
124430334|NCT01302067|447537009|FG002|Overall Study|Death|1|||
124430335|NCT01302067|447537007|FG000|Overall Study|Physician Decision|9|||
124430336|NCT01302067|447537008|FG001|Overall Study|Physician Decision|5|||
124430337|NCT01302067|447537009|FG002|Overall Study|Physician Decision|14|||
124430338|NCT01302067|447537007|FG000|Overall Study|Lack of Efficacy|8|||
124430339|NCT01302067|447537008|FG001|Overall Study|Lack of Efficacy|4|||
124430340|NCT01302067|447537009|FG002|Overall Study|Lack of Efficacy|2|||
124430341|NCT01302067|447537007|FG000|Overall Study|Lost to Follow-up|9|||
124430342|NCT01302067|447537008|FG001|Overall Study|Lost to Follow-up|4|||
124430343|NCT01302067|447537009|FG002|Overall Study|Lost to Follow-up|15|||
124430344|NCT01302067|447537007|FG000|Overall Study|Withdrawal by Subject|13|||
124430345|NCT01302067|447537008|FG001|Overall Study|Withdrawal by Subject|6|||
124430346|NCT01302067|447537009|FG002|Overall Study|Withdrawal by Subject|10|||
124430347|NCT01302067|447537007|FG000|Overall Study|Other|1|||
124675420|NCT01787552|448435941|FG000|Overall Study|Physician Decision|2|||
124675421|NCT01787552|448435942|FG001|Overall Study|Physician Decision|2|||
124675422|NCT01787552|448435943|FG002|Overall Study|Physician Decision|1|||
124430348|NCT01302067|447537008|FG001|Overall Study|Other|1|||
124430349|NCT01302067|447537009|FG002|Overall Study|Other|3|||
124430350|NCT01302067|447537007|FG000|Overall Study|Protocol Violation|11|||
124430351|NCT01302067|447537008|FG001|Overall Study|Protocol Violation|0|||
124430352|NCT01302067|447537009|FG002|Overall Study|Protocol Violation|8|||
124430353|NCT01302067|447537007|FG000|Overall Study|Adverse Event|27|||
124430354|NCT01302067|447537008|FG001|Overall Study|Adverse Event|14|||
124430355|NCT01302067|447537009|FG002|Overall Study|Adverse Event|45|||
124430356|NCT03241927|447537011|FG000|Overall Study|study terminated|1|||
124430357|NCT03241927|447537012|FG001|Overall Study|study terminated|0|||
124430358|NCT01198756|447537013|FG000|Overall Study|Adverse Event|0|||
124430359|NCT01198756|447537014|FG001|Overall Study|Adverse Event|0|||
124430360|NCT01198756|447537015|FG002|Overall Study|Adverse Event|0|||
124430361|NCT01198756|447537016|FG003|Overall Study|Adverse Event|1|||
124430362|NCT01198756|447537013|FG000|Overall Study|Protocol Violation|0|||
124430363|NCT01198756|447537014|FG001|Overall Study|Protocol Violation|0|||
124430364|NCT01198756|447537015|FG002|Overall Study|Protocol Violation|0|||
124430365|NCT01198756|447537016|FG003|Overall Study|Protocol Violation|2|||
124430366|NCT01198756|447537013|FG000|Overall Study|Withdrawal by Subject|9|||
124430367|NCT01198756|447537014|FG001|Overall Study|Withdrawal by Subject|4|||
124430368|NCT01198756|447537015|FG002|Overall Study|Withdrawal by Subject|7|||
124430369|NCT01198756|447537016|FG003|Overall Study|Withdrawal by Subject|5|||
124430370|NCT01198756|447537013|FG000|Overall Study|Lost to Follow-up|29|||
124430371|NCT01198756|447537014|FG001|Overall Study|Lost to Follow-up|36|||
124430372|NCT01198756|447537015|FG002|Overall Study|Lost to Follow-up|23|||
124430373|NCT01198756|447537016|FG003|Overall Study|Lost to Follow-up|18|||
124430374|NCT01290315|447537017|FG000|Overall Study|Adverse Event|0|||
124430375|NCT01290315|447537018|FG001|Overall Study|Adverse Event|0|||
124430376|NCT01290315|447537019|FG002|Overall Study|Adverse Event|0|||
124430377|NCT01290315|447537020|FG003|Overall Study|Adverse Event|3|||
124430378|NCT01290315|447537017|FG000|Overall Study|Selection criteria/compliance|2|||
124430379|NCT01290315|447537018|FG001|Overall Study|Selection criteria/compliance|1|||
124430380|NCT01290315|447537019|FG002|Overall Study|Selection criteria/compliance|0|||
124430381|NCT01290315|447537020|FG003|Overall Study|Selection criteria/compliance|2|||
124430382|NCT01290315|447537017|FG000|Overall Study|Lost to Follow-up|0|||
124430383|NCT01290315|447537018|FG001|Overall Study|Lost to Follow-up|1|||
124430384|NCT01290315|447537019|FG002|Overall Study|Lost to Follow-up|0|||
124430385|NCT01290315|447537020|FG003|Overall Study|Lost to Follow-up|0|||
124430386|NCT01290315|447537017|FG000|Overall Study|Withdrawal by Subject|1|||
124430387|NCT01290315|447537018|FG001|Overall Study|Withdrawal by Subject|1|||
124675423|NCT01787552|448435944|FG003|Overall Study|Physician Decision|2|||
124675424|NCT01787552|448435941|FG000|Overall Study|Death|0|||
124675425|NCT01787552|448435942|FG001|Overall Study|Death|0|||
124430388|NCT01290315|447537019|FG002|Overall Study|Withdrawal by Subject|0|||
124430389|NCT01290315|447537020|FG003|Overall Study|Withdrawal by Subject|0|||
124430390|NCT00591721|447537021|FG000|Overall Study|Withdrawal by Subject|10|||
124430391|NCT00591721|447537022|FG001|Overall Study|Withdrawal by Subject|10|||
124430392|NCT00591721|447537021|FG000|Overall Study|Lost to Follow-up|1|||
124430393|NCT00591721|447537022|FG001|Overall Study|Lost to Follow-up|4|||
124430394|NCT00591721|447537021|FG000|Overall Study|Intervention not received|10|||
124430395|NCT00591721|447537022|FG001|Overall Study|Intervention not received|8|||
124430396|NCT00423943|447537023|FG000|Overall Study|Withdrawal by Subject|3|||
124430397|NCT00423943|447537024|FG001|Overall Study|Withdrawal by Subject|1|||
124430398|NCT02383056|447537029|FG000|Overall Study|Adverse Event|1|||
124430399|NCT02383056|447537030|FG001|Overall Study|Adverse Event|0|||
124430400|NCT02383056|447537029|FG000|Overall Study|Lost to Follow-up|0|||
124430401|NCT02383056|447537030|FG001|Overall Study|Lost to Follow-up|2|||
124430402|NCT03828747|447537031|FG000|Double-Blind Treatment Period|Adverse Event|6|||
124430403|NCT03828747|447537032|FG001|Double-Blind Treatment Period|Adverse Event|6|||
124675426|NCT01787552|448435943|FG002|Overall Study|Death|0|||
124675427|NCT01787552|448435944|FG003|Overall Study|Death|1|||
124675428|NCT01787552|448435941|FG000|Overall Study|Adverse Event|2|||
124675429|NCT01787552|448435942|FG001|Overall Study|Adverse Event|5|||
124675430|NCT01787552|448435943|FG002|Overall Study|Adverse Event|2|||
124675431|NCT01787552|448435944|FG003|Overall Study|Adverse Event|16|||
124675432|NCT01787552|448435941|FG000|Overall Study|Study terminated by Sponsor|0|||
124675433|NCT01787552|448435942|FG001|Overall Study|Study terminated by Sponsor|0|||
124675434|NCT01787552|448435943|FG002|Overall Study|Study terminated by Sponsor|1|||
124675435|NCT01787552|448435944|FG003|Overall Study|Study terminated by Sponsor|3|||
124675436|NCT01787552|448435941|FG000|Overall Study|Progressive Disease|2|||
124430404|NCT03828747|447537031|FG000|Double-Blind Treatment Period|Death|1|||
124675437|NCT01787552|448435942|FG001|Overall Study|Progressive Disease|2|||
124675438|NCT01787552|448435943|FG002|Overall Study|Progressive Disease|1|||
124430405|NCT03828747|447537032|FG001|Double-Blind Treatment Period|Death|1|||
124675439|NCT01787552|448435944|FG003|Overall Study|Progressive Disease|1|||
124430406|NCT03828747|447537031|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124430407|NCT03828747|447537032|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
124430408|NCT03828747|447537031|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
124430409|NCT03828747|447537032|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
124430410|NCT03828747|447537031|FG000|Double-Blind Treatment Period|Physician Decision|1|||
124430411|NCT03828747|447537032|FG001|Double-Blind Treatment Period|Physician Decision|4|||
124430412|NCT03828747|447537031|FG000|Double-Blind Treatment Period|Various reasons|5|||
124430413|NCT03828747|447537032|FG001|Double-Blind Treatment Period|Various reasons|3|||
124430414|NCT03828747|447537031|FG000|Open-Label Extension|Adverse Event|9|||
124430415|NCT03828747|447537032|FG001|Open-Label Extension|Adverse Event|7|||
124430416|NCT03828747|447537031|FG000|Open-Label Extension|Death|0|||
124430417|NCT03828747|447537032|FG001|Open-Label Extension|Death|2|||
124430418|NCT03828747|447537031|FG000|Open-Label Extension|Lost to Follow-up|4|||
124430419|NCT03828747|447537032|FG001|Open-Label Extension|Lost to Follow-up|0|||
124430420|NCT03828747|447537031|FG000|Open-Label Extension|Withdrawal by Subject|31|||
124430421|NCT03828747|447537032|FG001|Open-Label Extension|Withdrawal by Subject|30|||
124430422|NCT03828747|447537031|FG000|Open-Label Extension|Various reasons|4|||
124430423|NCT03828747|447537032|FG001|Open-Label Extension|Various reasons|4|||
124430424|NCT03828747|447537031|FG000|Open-Label Extension|Physician Decision|6|||
124430425|NCT03828747|447537032|FG001|Open-Label Extension|Physician Decision|2|||
124430426|NCT05816330|447537033|FG000|Overall Study|Withdrawal by Subject|4|||
124430427|NCT05816330|447537034|FG001|Overall Study|Withdrawal by Subject|1|||
124430428|NCT03245151|447537035|FG000|Overall Study|Withdrawal by Subject|2|||
124430429|NCT03245151|447537036|FG001|Overall Study|Withdrawal by Subject|0|||
124430430|NCT03245151|447537037|FG002|Overall Study|Withdrawal by Subject|0|||
124430431|NCT03245151|447537038|FG003|Overall Study|Withdrawal by Subject|2|||
124430432|NCT03245151|447537039|FG004|Overall Study|Withdrawal by Subject|1|||
124430433|NCT03245151|447537035|FG000|Overall Study|Death|3|||
124430434|NCT03245151|447537036|FG001|Overall Study|Death|14|||
124430435|NCT03245151|447537037|FG002|Overall Study|Death|9|||
124430436|NCT03245151|447537038|FG003|Overall Study|Death|16|||
124430437|NCT03245151|447537039|FG004|Overall Study|Death|7|||
124430438|NCT03245151|447537035|FG000|Overall Study|Sponsor's decision|0|||
124430439|NCT03245151|447537036|FG001|Overall Study|Sponsor's decision|1|||
124430440|NCT03245151|447537037|FG002|Overall Study|Sponsor's decision|0|||
124430441|NCT03245151|447537038|FG003|Overall Study|Sponsor's decision|0|||
124430442|NCT03245151|447537039|FG004|Overall Study|Sponsor's decision|0|||
124430443|NCT03900416|447537040|FG000|Six Week Follow-up|Lost to Follow-up|1|||
124430444|NCT03900416|447537041|FG001|Six Week Follow-up|Lost to Follow-up|0|||
124430445|NCT03900416|447537040|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
124430446|NCT03900416|447537041|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
124430447|NCT03900416|447537040|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
124430448|NCT03900416|447537041|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
124430449|NCT03900416|447537040|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
124430450|NCT03900416|447537041|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
124430451|NCT03900416|447537040|FG000|Twelve Week Follow-up|Adverse Event|1|||
124430452|NCT03900416|447537041|FG001|Twelve Week Follow-up|Adverse Event|1|||
124430453|NCT03900416|447537040|FG000|Six Month Follow-up|Lost to Follow-up|4|||
124430454|NCT03900416|447537041|FG001|Six Month Follow-up|Lost to Follow-up|3|||
124430455|NCT03900416|447537040|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
124430456|NCT03900416|447537041|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
124430457|NCT02663518|447537049|FG000|Part 1: Phase 1a Escalation|Death|0|||
124430458|NCT02663518|447537050|FG001|Part 1: Phase 1a Escalation|Death|0|||
124430459|NCT02663518|447537051|FG002|Part 1: Phase 1a Escalation|Death|1|||
124430460|NCT02663518|447537052|FG003|Part 1: Phase 1a Escalation|Death|0|||
124675440|NCT03055936|448435950|FG000|Overall Study|Adverse Event|0|||
124675441|NCT03055936|448435951|FG001|Overall Study|Adverse Event|1|||
124675442|NCT03055936|448435952|FG002|Overall Study|Adverse Event|1|||
124675443|NCT03055936|448435953|FG003|Overall Study|Adverse Event|1|||
124675444|NCT03055936|448435950|FG000|Overall Study|Personal reason|2|||
124675445|NCT03055936|448435951|FG001|Overall Study|Personal reason|0|||
124675446|NCT03055936|448435952|FG002|Overall Study|Personal reason|1|||
124675447|NCT03055936|448435953|FG003|Overall Study|Personal reason|0|||
124675448|NCT03167242|448435954|FG000|Overall Study|Patient/Guardian Decision|0|||
124675449|NCT03167242|448435955|FG001|Overall Study|Patient/Guardian Decision|1|||
124675450|NCT03167242|448435956|FG002|Overall Study|Patient/Guardian Decision|2|||
124675451|NCT03167242|448435957|FG003|Overall Study|Patient/Guardian Decision|1|||
124675452|NCT03167242|448435958|FG004|Overall Study|Patient/Guardian Decision|1|||
124430461|NCT02663518|447537053|FG004|Part 1: Phase 1a Escalation|Death|0|||
124430462|NCT02663518|447537054|FG005|Part 1: Phase 1a Escalation|Death|0|||
124430463|NCT02663518|447537055|FG006|Part 1: Phase 1a Escalation|Death|0|||
124430464|NCT02663518|447537056|FG007|Part 1: Phase 1a Escalation|Death|0|||
124430465|NCT02663518|447537057|FG008|Part 1: Phase 1a Escalation|Death|0|||
124430466|NCT02663518|447537058|FG009|Part 1: Phase 1a Escalation|Death|0|||
124430467|NCT02663518|447537059|FG010|Part 1: Phase 1a Escalation|Death|0|||
124430468|NCT02663518|447537060|FG011|Part 1: Phase 1a Escalation|Death|0|||
124430469|NCT02663518|447537061|FG012|Part 1: Phase 1a Escalation|Death|0|||
124675453|NCT03167242|448435959|FG005|Overall Study|Patient/Guardian Decision|1|||
124675454|NCT03167242|448435960|FG006|Overall Study|Patient/Guardian Decision|0|||
124675455|NCT03167242|448435961|FG007|Overall Study|Patient/Guardian Decision|0|||
124675456|NCT03167242|448435962|FG008|Overall Study|Patient/Guardian Decision|0|||
124675457|NCT03167242|448435963|FG009|Overall Study|Patient/Guardian Decision|0|||
124675458|NCT03167242|448435964|FG010|Overall Study|Patient/Guardian Decision|1|||
124675459|NCT03167242|448435965|FG011|Overall Study|Patient/Guardian Decision|0|||
124675460|NCT03167242|448435954|FG000|Overall Study|Lost to Follow-up|0|||
124675461|NCT03167242|448435955|FG001|Overall Study|Lost to Follow-up|0|||
124675462|NCT03167242|448435956|FG002|Overall Study|Lost to Follow-up|1|||
124675463|NCT03167242|448435957|FG003|Overall Study|Lost to Follow-up|0|||
124675464|NCT03167242|448435958|FG004|Overall Study|Lost to Follow-up|0|||
124675465|NCT03167242|448435959|FG005|Overall Study|Lost to Follow-up|1|||
124675466|NCT03167242|448435960|FG006|Overall Study|Lost to Follow-up|2|||
124675467|NCT03167242|448435961|FG007|Overall Study|Lost to Follow-up|1|||
124675468|NCT03167242|448435962|FG008|Overall Study|Lost to Follow-up|0|||
124675469|NCT03167242|448435963|FG009|Overall Study|Lost to Follow-up|0|||
124675470|NCT03167242|448435964|FG010|Overall Study|Lost to Follow-up|1|||
124675471|NCT03167242|448435965|FG011|Overall Study|Lost to Follow-up|1|||
124675472|NCT03167242|448435954|FG000|Overall Study|Reason not provided|0|||
124675473|NCT03167242|448435955|FG001|Overall Study|Reason not provided|0|||
124675474|NCT03167242|448435956|FG002|Overall Study|Reason not provided|0|||
124675475|NCT03167242|448435957|FG003|Overall Study|Reason not provided|0|||
124675476|NCT03167242|448435958|FG004|Overall Study|Reason not provided|0|||
124675477|NCT03167242|448435959|FG005|Overall Study|Reason not provided|0|||
124675478|NCT03167242|448435960|FG006|Overall Study|Reason not provided|0|||
124675479|NCT03167242|448435961|FG007|Overall Study|Reason not provided|0|||
124675480|NCT03167242|448435962|FG008|Overall Study|Reason not provided|1|||
124675481|NCT03167242|448435963|FG009|Overall Study|Reason not provided|0|||
124675482|NCT03167242|448435964|FG010|Overall Study|Reason not provided|0|||
124675483|NCT03167242|448435965|FG011|Overall Study|Reason not provided|0|||
124675484|NCT01909804|448435966|FG000|Overall Study|Randomized but Never Treated|0|||
124675485|NCT01909804|448435967|FG001|Overall Study|Randomized but Never Treated|0|||
124675486|NCT01909804|448435968|FG002|Overall Study|Randomized but Never Treated|0|||
124675487|NCT01909804|448435969|FG003|Overall Study|Randomized but Never Treated|0|||
124675488|NCT01909804|448435970|FG004|Overall Study|Randomized but Never Treated|0|||
124675489|NCT01909804|448435971|FG005|Overall Study|Randomized but Never Treated|0|||
124675490|NCT01909804|448435972|FG006|Overall Study|Randomized but Never Treated|1|||
124675491|NCT01909804|448435973|FG007|Overall Study|Randomized but Never Treated|0|||
124675492|NCT01909804|448435974|FG008|Overall Study|Randomized but Never Treated|0|||
124675493|NCT01909804|448435975|FG009|Overall Study|Randomized but Never Treated|0|||
124675494|NCT01909804|448435976|FG010|Overall Study|Randomized but Never Treated|0|||
124675495|NCT01909804|448435977|FG011|Overall Study|Randomized but Never Treated|1|||
124675496|NCT01909804|448435966|FG000|Overall Study|Death|0|||
124675497|NCT01909804|448435967|FG001|Overall Study|Death|0|||
124675498|NCT01909804|448435968|FG002|Overall Study|Death|0|||
124675499|NCT01909804|448435969|FG003|Overall Study|Death|0|||
124675500|NCT01909804|448435970|FG004|Overall Study|Death|0|||
124675501|NCT01909804|448435971|FG005|Overall Study|Death|0|||
124675502|NCT01909804|448435972|FG006|Overall Study|Death|0|||
124430470|NCT02663518|447537062|FG013|Part 1: Phase 1a Escalation|Death|0|||
124675503|NCT01909804|448435973|FG007|Overall Study|Death|0|||
124675504|NCT01909804|448435974|FG008|Overall Study|Death|0|||
124675505|NCT01909804|448435975|FG009|Overall Study|Death|0|||
124430471|NCT02663518|447537049|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124430472|NCT02663518|447537050|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124430473|NCT02663518|447537051|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
124430474|NCT02663518|447537052|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124430475|NCT02663518|447537053|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124430476|NCT02663518|447537054|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124430477|NCT02663518|447537055|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124430478|NCT02663518|447537056|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124430479|NCT02663518|447537057|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124430480|NCT02663518|447537058|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124430481|NCT02663518|447537059|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124430482|NCT02663518|447537060|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124430483|NCT02663518|447537061|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124430484|NCT02663518|447537062|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
124430485|NCT02663518|447537049|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
124430486|NCT02663518|447537050|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
124430487|NCT02663518|447537051|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
124430488|NCT02663518|447537052|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
124430489|NCT02663518|447537053|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124430490|NCT02663518|447537054|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124430491|NCT02663518|447537055|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124430492|NCT02663518|447537056|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124430493|NCT02663518|447537057|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124430494|NCT02663518|447537058|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124430495|NCT02663518|447537059|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124430496|NCT02663518|447537060|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124430497|NCT02663518|447537061|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124430498|NCT02663518|447537062|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
124430499|NCT02663518|447537049|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
124430500|NCT02663518|447537050|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124430501|NCT02663518|447537051|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
124430502|NCT02663518|447537052|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
124430503|NCT02663518|447537053|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124430504|NCT02663518|447537054|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124430505|NCT02663518|447537055|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124430506|NCT02663518|447537056|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124430507|NCT02663518|447537057|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124430508|NCT02663518|447537058|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124430509|NCT02663518|447537059|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124430510|NCT02663518|447537060|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124430511|NCT02663518|447537061|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124430512|NCT02663518|447537062|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
124430513|NCT02663518|447537049|FG000|Part 1: Phase 1a Escalation|Other|0|||
124430514|NCT02663518|447537050|FG001|Part 1: Phase 1a Escalation|Other|0|||
124430515|NCT02663518|447537051|FG002|Part 1: Phase 1a Escalation|Other|2|||
124430516|NCT02663518|447537052|FG003|Part 1: Phase 1a Escalation|Other|0|||
124430517|NCT02663518|447537053|FG004|Part 1: Phase 1a Escalation|Other|0|||
124675506|NCT01909804|448435976|FG010|Overall Study|Death|1|||
124675507|NCT01909804|448435977|FG011|Overall Study|Death|0|||
124675508|NCT01909804|448435966|FG000|Overall Study|Lack of Efficacy|4|||
124675509|NCT01909804|448435967|FG001|Overall Study|Lack of Efficacy|1|||
124675510|NCT01909804|448435968|FG002|Overall Study|Lack of Efficacy|0|||
124675511|NCT01909804|448435969|FG003|Overall Study|Lack of Efficacy|0|||
124675512|NCT01909804|448435970|FG004|Overall Study|Lack of Efficacy|7|||
124430518|NCT02663518|447537054|FG005|Part 1: Phase 1a Escalation|Other|0|||
124675513|NCT01909804|448435971|FG005|Overall Study|Lack of Efficacy|3|||
124675514|NCT01909804|448435972|FG006|Overall Study|Lack of Efficacy|1|||
124675515|NCT01909804|448435973|FG007|Overall Study|Lack of Efficacy|1|||
124430519|NCT02663518|447537055|FG006|Part 1: Phase 1a Escalation|Other|0|||
124430520|NCT02663518|447537056|FG007|Part 1: Phase 1a Escalation|Other|0|||
124430521|NCT02663518|447537057|FG008|Part 1: Phase 1a Escalation|Other|0|||
124430522|NCT02663518|447537058|FG009|Part 1: Phase 1a Escalation|Other|0|||
124675516|NCT01909804|448435974|FG008|Overall Study|Lack of Efficacy|0|||
124675517|NCT01909804|448435975|FG009|Overall Study|Lack of Efficacy|1|||
124675518|NCT01909804|448435976|FG010|Overall Study|Lack of Efficacy|0|||
124430523|NCT02663518|447537059|FG010|Part 1: Phase 1a Escalation|Other|0|||
124430524|NCT02663518|447537060|FG011|Part 1: Phase 1a Escalation|Other|0|||
124675519|NCT01909804|448435977|FG011|Overall Study|Lack of Efficacy|1|||
124675520|NCT01909804|448435966|FG000|Overall Study|Withdrew Consent|0|||
124675521|NCT01909804|448435967|FG001|Overall Study|Withdrew Consent|0|||
124675522|NCT01909804|448435968|FG002|Overall Study|Withdrew Consent|0|||
124675523|NCT01909804|448435969|FG003|Overall Study|Withdrew Consent|0|||
124675524|NCT01909804|448435970|FG004|Overall Study|Withdrew Consent|1|||
124675525|NCT01909804|448435971|FG005|Overall Study|Withdrew Consent|1|||
124675526|NCT01909804|448435972|FG006|Overall Study|Withdrew Consent|0|||
124675527|NCT01909804|448435973|FG007|Overall Study|Withdrew Consent|0|||
124675528|NCT01909804|448435974|FG008|Overall Study|Withdrew Consent|0|||
124675529|NCT01909804|448435975|FG009|Overall Study|Withdrew Consent|0|||
124675530|NCT01909804|448435976|FG010|Overall Study|Withdrew Consent|0|||
124675531|NCT01909804|448435977|FG011|Overall Study|Withdrew Consent|0|||
124675532|NCT01909804|448435966|FG000|Overall Study|Protocol Violation|0|||
124675533|NCT01909804|448435967|FG001|Overall Study|Protocol Violation|0|||
124675534|NCT01909804|448435968|FG002|Overall Study|Protocol Violation|0|||
124675535|NCT01909804|448435969|FG003|Overall Study|Protocol Violation|0|||
124675536|NCT01909804|448435970|FG004|Overall Study|Protocol Violation|0|||
124675537|NCT01909804|448435971|FG005|Overall Study|Protocol Violation|0|||
124675538|NCT01909804|448435972|FG006|Overall Study|Protocol Violation|0|||
124675539|NCT01909804|448435973|FG007|Overall Study|Protocol Violation|0|||
124675540|NCT01909804|448435974|FG008|Overall Study|Protocol Violation|0|||
124675541|NCT01909804|448435975|FG009|Overall Study|Protocol Violation|0|||
124675542|NCT01909804|448435976|FG010|Overall Study|Protocol Violation|0|||
124675543|NCT01909804|448435977|FG011|Overall Study|Protocol Violation|1|||
124675544|NCT02144701|448435979|FG000|Overall Study|development of relapse, GVHD or death|9|||
124675545|NCT02144701|448435980|FG001|Overall Study|development of relapse, GVHD or death|3|||
124675546|NCT03217591|448435981|FG000|Overall Study|Adverse Event|1|||
124675547|NCT03217591|448435982|FG001|Overall Study|Adverse Event|2|||
124675548|NCT03217591|448435983|FG002|Overall Study|Adverse Event|6|||
124675549|NCT03217591|448435981|FG000|Overall Study|Withdrawal by Subject|0|||
124675550|NCT03217591|448435982|FG001|Overall Study|Withdrawal by Subject|1|||
124675551|NCT03217591|448435983|FG002|Overall Study|Withdrawal by Subject|3|||
124675552|NCT03217591|448435981|FG000|Overall Study|Lost to Follow-up|1|||
124675553|NCT03217591|448435982|FG001|Overall Study|Lost to Follow-up|0|||
124675554|NCT03217591|448435983|FG002|Overall Study|Lost to Follow-up|0|||
124675555|NCT03217591|448435981|FG000|Overall Study|Protocol Violation|1|||
124675556|NCT03217591|448435982|FG001|Overall Study|Protocol Violation|0|||
124675557|NCT03217591|448435983|FG002|Overall Study|Protocol Violation|1|||
124675558|NCT00249834|448435984|FG000|Overall Study|Ovarian stimulation failed|1|||
124675559|NCT00249834|448435985|FG001|Overall Study|Ovarian stimulation failed|0|||
124675560|NCT00249834|448435986|FG002|Overall Study|Ovarian stimulation failed|0|||
124675561|NCT00249834|448435987|FG003|Overall Study|Ovarian stimulation failed|0|||
124675562|NCT00249834|448435988|FG004|Overall Study|Ovarian stimulation failed|0|||
124675563|NCT00249834|448435989|FG005|Overall Study|Ovarian stimulation failed|0|||
124675564|NCT00249834|448435990|FG006|Overall Study|Ovarian stimulation failed|0|||
124675565|NCT00249834|448435991|FG007|Overall Study|Ovarian stimulation failed|0|||
124675566|NCT00249834|448435984|FG000|Overall Study|Failure of down-regulation|0|||
124675567|NCT00249834|448435985|FG001|Overall Study|Failure of down-regulation|0|||
124675568|NCT00249834|448435986|FG002|Overall Study|Failure of down-regulation|0|||
124675569|NCT00249834|448435987|FG003|Overall Study|Failure of down-regulation|0|||
124675570|NCT00249834|448435988|FG004|Overall Study|Failure of down-regulation|0|||
124675571|NCT00249834|448435989|FG005|Overall Study|Failure of down-regulation|0|||
124675572|NCT00249834|448435990|FG006|Overall Study|Failure of down-regulation|1|||
124675573|NCT00249834|448435991|FG007|Overall Study|Failure of down-regulation|0|||
124675574|NCT00249834|448435984|FG000|Overall Study|Protocol Violation|0|||
124675575|NCT00249834|448435985|FG001|Overall Study|Protocol Violation|19|||
124675576|NCT00249834|448435986|FG002|Overall Study|Protocol Violation|14|||
124675577|NCT00249834|448435987|FG003|Overall Study|Protocol Violation|8|||
124675578|NCT00249834|448435988|FG004|Overall Study|Protocol Violation|5|||
124675579|NCT00249834|448435989|FG005|Overall Study|Protocol Violation|2|||
124675580|NCT00249834|448435990|FG006|Overall Study|Protocol Violation|0|||
124675581|NCT00249834|448435991|FG007|Overall Study|Protocol Violation|0|||
124675582|NCT00269152|448435995|FG000|Overall Study|Adverse Event|9|||
124675583|NCT00269152|448435996|FG001|Overall Study|Adverse Event|3|||
124675584|NCT00269152|448435995|FG000|Overall Study|Withdrawal by Subject|7|||
124675585|NCT00269152|448435996|FG001|Overall Study|Withdrawal by Subject|3|||
124675586|NCT00269152|448435995|FG000|Overall Study|Physician Decision|2|||
124675587|NCT00269152|448435996|FG001|Overall Study|Physician Decision|3|||
124675588|NCT00269152|448435995|FG000|Overall Study|Protocol Violation|0|||
124675589|NCT00269152|448435996|FG001|Overall Study|Protocol Violation|1|||
124675590|NCT04249427|448435997|FG000|Overall Study|Adverse Event|3|||
124675591|NCT04249427|448435998|FG001|Overall Study|Adverse Event|1|||
124675592|NCT04249427|448435997|FG000|Overall Study|Lack of Efficacy|0|||
124675593|NCT04249427|448435998|FG001|Overall Study|Lack of Efficacy|1|||
124675594|NCT04249427|448435997|FG000|Overall Study|Withdrawal by Subject|1|||
124430525|NCT02663518|447537061|FG012|Part 1: Phase 1a Escalation|Other|0|||
124430526|NCT02663518|447537062|FG013|Part 1: Phase 1a Escalation|Other|0|||
124430527|NCT02663518|447537049|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
124430528|NCT02663518|447537050|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
124430529|NCT02663518|447537051|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
124430530|NCT02663518|447537052|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
124430531|NCT02663518|447537053|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
124430532|NCT02663518|447537054|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
124430533|NCT02663518|447537055|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
124430534|NCT02663518|447537056|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
124430535|NCT02663518|447537057|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
124430536|NCT02663518|447537058|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
124675595|NCT04249427|448435998|FG001|Overall Study|Withdrawal by Subject|2|||
124675596|NCT03886272|448435999|FG000|Period 1|Withdrawal by Subject|0|||
124675597|NCT03886272|448436000|FG001|Period 1|Withdrawal by Subject|0|||
124675598|NCT03886272|448436001|FG002|Period 1|Withdrawal by Subject|0|||
124675599|NCT03886272|448436002|FG003|Period 1|Withdrawal by Subject|0|||
124675600|NCT03886272|448436003|FG004|Period 1|Withdrawal by Subject|0|||
124430537|NCT02663518|447537059|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
124430538|NCT02663518|447537060|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
124675601|NCT03886272|448436004|FG005|Period 1|Withdrawal by Subject|1|||
124430539|NCT02663518|447537061|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
124430540|NCT02663518|447537062|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
124430541|NCT02663518|447537049|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124430542|NCT02663518|447537050|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124430543|NCT02663518|447537051|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124430544|NCT02663518|447537052|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124430545|NCT02663518|447537053|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
124430546|NCT02663518|447537054|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124430547|NCT02663518|447537055|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
124430548|NCT02663518|447537056|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
124430549|NCT02663518|447537057|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124430550|NCT02663518|447537058|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124430551|NCT02663518|447537059|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124430552|NCT02663518|447537060|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124430553|NCT02663518|447537061|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124430554|NCT02663518|447537062|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
124430555|NCT02663518|447537049|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124430556|NCT02663518|447537050|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124430557|NCT02663518|447537051|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124430558|NCT02663518|447537052|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124430559|NCT02663518|447537053|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
124430560|NCT02663518|447537054|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124430561|NCT02663518|447537055|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124430562|NCT02663518|447537056|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124430563|NCT02663518|447537057|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124430564|NCT02663518|447537058|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124430565|NCT02663518|447537059|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124430566|NCT02663518|447537060|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124430567|NCT02663518|447537061|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124430568|NCT02663518|447537062|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
124430569|NCT02663518|447537049|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124430570|NCT02663518|447537050|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124430571|NCT02663518|447537051|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124430572|NCT02663518|447537052|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124430573|NCT02663518|447537053|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
124430574|NCT02663518|447537054|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
124430575|NCT02663518|447537055|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
124430576|NCT02663518|447537056|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
124430577|NCT02663518|447537057|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124430578|NCT02663518|447537058|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124430579|NCT02663518|447537059|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124430580|NCT02663518|447537060|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124430581|NCT02663518|447537061|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124430582|NCT02663518|447537062|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
124430583|NCT02663518|447537049|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
124430584|NCT02663518|447537050|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
124430585|NCT02663518|447537051|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
124430586|NCT02663518|447537052|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
124430587|NCT02663518|447537053|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
124430588|NCT02663518|447537054|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
124430589|NCT02663518|447537055|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
124430590|NCT02663518|447537056|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
124430591|NCT02663518|447537057|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
124430592|NCT02663518|447537058|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
124430593|NCT02663518|447537059|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
124430594|NCT02663518|447537060|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
124430595|NCT02663518|447537061|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
124430596|NCT02663518|447537062|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
124430597|NCT02663518|447537049|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124430598|NCT02663518|447537050|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124430599|NCT02663518|447537051|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124675602|NCT03886272|448436005|FG006|Period 1|Withdrawal by Subject|0|||
124675603|NCT00931632|448436006|FG000|Overall Study|Withdrawal by Subject|2|||
124675604|NCT00931632|448436007|FG001|Overall Study|Withdrawal by Subject|3|||
124675605|NCT00931632|448436006|FG000|Overall Study|Adverse Event|19|||
124675606|NCT00931632|448436007|FG001|Overall Study|Adverse Event|15|||
124675607|NCT03188055|448436010|FG000|Overall Study|Unavailable for training|0|||
124430600|NCT02663518|447537052|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124430601|NCT02663518|447537053|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124430602|NCT02663518|447537054|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124430603|NCT02663518|447537055|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
124430604|NCT02663518|447537056|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124430605|NCT02663518|447537057|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124430606|NCT02663518|447537058|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124430607|NCT02663518|447537059|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124430608|NCT02663518|447537060|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124430609|NCT02663518|447537061|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124430610|NCT02663518|447537062|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
124430611|NCT02663518|447537049|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
124430612|NCT02663518|447537050|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
124430613|NCT02663518|447537051|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
124430614|NCT02663518|447537052|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
124430615|NCT02663518|447537053|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
124430616|NCT02663518|447537054|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
124430617|NCT02663518|447537055|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
124430618|NCT02663518|447537056|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
124430619|NCT02663518|447537057|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
124430620|NCT02663518|447537058|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
124430621|NCT02663518|447537059|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
124430622|NCT02663518|447537060|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
124430623|NCT02663518|447537061|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
124430624|NCT02663518|447537062|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
124430625|NCT02663518|447537049|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124430626|NCT02663518|447537050|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124430627|NCT02663518|447537051|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124430628|NCT02663518|447537052|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124430629|NCT02663518|447537053|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124430630|NCT02663518|447537054|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124430631|NCT02663518|447537055|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124430632|NCT02663518|447537056|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124430633|NCT02663518|447537057|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124430634|NCT02663518|447537058|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124430635|NCT02663518|447537059|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124430636|NCT02663518|447537060|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124430637|NCT02663518|447537061|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
124430638|NCT02663518|447537062|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
124430639|NCT02663518|447537049|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124430640|NCT02663518|447537050|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124430641|NCT02663518|447537051|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124430642|NCT02663518|447537052|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124430643|NCT02663518|447537053|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124430644|NCT02663518|447537054|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124430645|NCT02663518|447537055|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124430646|NCT02663518|447537056|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124430647|NCT02663518|447537057|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124430648|NCT02663518|447537058|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124430649|NCT02663518|447537059|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124430650|NCT02663518|447537060|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
124430651|NCT02663518|447537061|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124430652|NCT02663518|447537062|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
124430653|NCT02663518|447537049|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124430654|NCT02663518|447537050|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124430655|NCT02663518|447537051|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124430656|NCT02663518|447537052|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124430657|NCT02663518|447537053|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124430658|NCT02663518|447537054|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124430659|NCT02663518|447537055|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124430660|NCT02663518|447537056|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124430661|NCT02663518|447537057|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124430662|NCT02663518|447537058|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
124675608|NCT03188055|448436011|FG001|Overall Study|Unavailable for training|0|||
124430663|NCT02663518|447537059|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
124430664|NCT02663518|447537060|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
124675609|NCT03188055|448436012|FG002|Overall Study|Unavailable for training|19|||
124675610|NCT03188055|448436013|FG003|Overall Study|Unavailable for training|0|||
124430665|NCT02663518|447537061|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
124430666|NCT02663518|447537062|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
124430667|NCT02663518|447537049|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
124430668|NCT02663518|447537050|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
124430669|NCT02663518|447537051|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
124430670|NCT02663518|447537052|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
124430671|NCT02663518|447537053|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
124430672|NCT02663518|447537054|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
124430673|NCT02663518|447537055|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
124430674|NCT02663518|447537056|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
124430675|NCT02663518|447537057|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
124430676|NCT02663518|447537058|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
124430677|NCT02663518|447537059|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
124430678|NCT02663518|447537060|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
124430679|NCT02663518|447537061|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
124430680|NCT02663518|447537062|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
124430681|NCT02663518|447537049|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124430682|NCT02663518|447537050|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124430683|NCT02663518|447537051|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124430684|NCT02663518|447537052|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124430685|NCT02663518|447537053|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124430686|NCT02663518|447537054|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124430687|NCT02663518|447537055|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124430688|NCT02663518|447537056|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124430689|NCT02663518|447537057|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124430690|NCT02663518|447537058|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124430691|NCT02663518|447537059|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124675611|NCT03188055|448436014|FG004|Overall Study|Unavailable for training|0|||
124430692|NCT02663518|447537060|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124430693|NCT02663518|447537061|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
124430694|NCT02663518|447537062|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
124430695|NCT03896152|447537063|FG000|Overall Study|Patient/guardian decision|1|||
124430696|NCT03896152|447537064|FG001|Overall Study|Patient/guardian decision|1|||
124430697|NCT03896152|447537063|FG000|Overall Study|Adverse Event|0|||
124430698|NCT03896152|447537064|FG001|Overall Study|Adverse Event|1|||
124430699|NCT03896152|447537063|FG000|Overall Study|Physician Decision|1|||
124430700|NCT03896152|447537064|FG001|Overall Study|Physician Decision|0|||
124430701|NCT03896152|447537063|FG000|Overall Study|Technical problems|1|||
124430702|NCT03896152|447537064|FG001|Overall Study|Technical problems|0|||
124430703|NCT00772330|447537065|FG000|Overall Study|Lost to Follow-up|3|||
124430704|NCT01353859|447537066|FG000|Overall Study|Adverse Event|3|||
124430705|NCT01353859|447537066|FG000|Overall Study|Lack of Efficacy|1|||
124430706|NCT01153321|447537067|FG000|Overall Study|Development of study withdrawal criteria|0|||
124430707|NCT01153321|447537068|FG001|Overall Study|Development of study withdrawal criteria|1|||
124430708|NCT01153321|447537067|FG000|Overall Study|Withdrawal by Subject|0|||
124430709|NCT01153321|447537068|FG001|Overall Study|Withdrawal by Subject|1|||
124430710|NCT01153321|447537067|FG000|Overall Study|Adverse Event|1|||
124430711|NCT01153321|447537068|FG001|Overall Study|Adverse Event|1|||
124430712|NCT00911937|447537069|FG000|Overall Study|Death|1|||
124430713|NCT00911937|447537070|FG001|Overall Study|Death|0|||
124430714|NCT00911937|447537069|FG000|Overall Study|Lost to Follow-up|8|||
124430715|NCT00911937|447537070|FG001|Overall Study|Lost to Follow-up|5|||
124430716|NCT00911937|447537069|FG000|Overall Study|Withdrawal by Subject|10|||
124430717|NCT00911937|447537070|FG001|Overall Study|Withdrawal by Subject|7|||
124430718|NCT00911937|447537069|FG000|Overall Study|Withdrawn due to pregnancy|1|||
124430719|NCT00911937|447537070|FG001|Overall Study|Withdrawn due to pregnancy|0|||
124430720|NCT00911937|447537069|FG000|Overall Study|Adverse Event|11|||
124430721|NCT00911937|447537070|FG001|Overall Study|Adverse Event|25|||
124430722|NCT00911937|447537069|FG000|Overall Study|Lack of Efficacy|11|||
124430723|NCT00911937|447537070|FG001|Overall Study|Lack of Efficacy|6|||
124430724|NCT00911937|447537069|FG000|Overall Study|Did not meet inclusion criteria|9|||
124675612|NCT03188055|448436015|FG005|Overall Study|Unavailable for training|0|||
124675613|NCT03188055|448436010|FG000|Overall Study|Lost to Follow-up|0|||
124430725|NCT00911937|447537070|FG001|Overall Study|Did not meet inclusion criteria|11|||
124675614|NCT03188055|448436011|FG001|Overall Study|Lost to Follow-up|18|||
124675615|NCT03188055|448436012|FG002|Overall Study|Lost to Follow-up|0|||
124675616|NCT03188055|448436013|FG003|Overall Study|Lost to Follow-up|11|||
124430726|NCT00911937|447537069|FG000|Overall Study|Protocol Violation|14|||
124430727|NCT00911937|447537070|FG001|Overall Study|Protocol Violation|23|||
124430728|NCT00911937|447537069|FG000|Overall Study|Randomized but not treated|13|||
124675617|NCT03188055|448436014|FG004|Overall Study|Lost to Follow-up|0|||
124675618|NCT03188055|448436015|FG005|Overall Study|Lost to Follow-up|0|||
124675619|NCT03188055|448436010|FG000|Overall Study|Withdrawal by Subject|0|||
124675620|NCT03188055|448436011|FG001|Overall Study|Withdrawal by Subject|1|||
124675621|NCT03188055|448436012|FG002|Overall Study|Withdrawal by Subject|0|||
124675622|NCT03188055|448436013|FG003|Overall Study|Withdrawal by Subject|1|||
124675623|NCT03188055|448436014|FG004|Overall Study|Withdrawal by Subject|0|||
124675624|NCT03188055|448436015|FG005|Overall Study|Withdrawal by Subject|0|||
124675625|NCT04356937|448436022|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
124675626|NCT04356937|448436023|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
124675627|NCT03533751|448436024|FG000|Overall Study|Withdrawal by Subject|12|||
124430729|NCT00911937|447537070|FG001|Overall Study|Randomized but not treated|13|||
124430730|NCT00911937|447537069|FG000|Overall Study|Other|9|||
124430731|NCT00911937|447537070|FG001|Overall Study|Other|5|||
124430732|NCT00424385|447537074|FG000|Cohort 0|Withdrawal by Subject|5|||
124430733|NCT00424385|447537074|FG000|Cohort 0|Physician Decision|1|||
124430734|NCT00424385|447537074|FG000|Cohort 1|Withdrawal by Subject|1|||
124430735|NCT02683876|447537075|FG000|Overall Study|samples damaged during shipping|2|||
124430736|NCT02683876|447537076|FG001|Overall Study|samples damaged during shipping|0|||
124430737|NCT03231800|447537083|FG000|Overall Study|Lost to Follow-up|0|||
124430738|NCT03231800|447537084|FG001|Overall Study|Lost to Follow-up|2|||
124430739|NCT03231800|447537083|FG000|Overall Study|Protocol Violation|1|||
124430740|NCT03231800|447537084|FG001|Overall Study|Protocol Violation|1|||
124430741|NCT03231800|447537083|FG000|Overall Study|reason not provided|2|||
124430742|NCT03231800|447537084|FG001|Overall Study|reason not provided|0|||
124430743|NCT00859222|447537085|FG000|Overall Study|Adverse Event|2|||
124430744|NCT00859222|447537086|FG001|Overall Study|Adverse Event|3|||
124430745|NCT00859222|447537087|FG002|Overall Study|Adverse Event|6|||
124430746|NCT00859222|447537088|FG003|Overall Study|Adverse Event|24|||
124430747|NCT00859222|447537089|FG004|Overall Study|Adverse Event|15|||
124430748|NCT00859222|447537085|FG000|Overall Study|DLT|1|||
124430749|NCT00859222|447537086|FG001|Overall Study|DLT|0|||
124430750|NCT00859222|447537087|FG002|Overall Study|DLT|0|||
124430751|NCT00859222|447537088|FG003|Overall Study|DLT|0|||
124430752|NCT00859222|447537089|FG004|Overall Study|DLT|0|||
124430753|NCT00400725|447537100|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
124430754|NCT00400725|447537101|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
124430755|NCT00400725|447537102|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
124430756|NCT00400725|447537100|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
124430757|NCT00400725|447537101|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
124430758|NCT00400725|447537102|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
124430759|NCT00400725|447537100|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
124430760|NCT00400725|447537101|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
124430761|NCT00400725|447537102|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
124430762|NCT00400725|447537100|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
124430763|NCT00400725|447537101|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
124430764|NCT00400725|447537102|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
124430765|NCT00400725|447537100|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
124430766|NCT00400725|447537101|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
124430767|NCT00400725|447537102|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
124430768|NCT00400725|447537100|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
124430769|NCT00400725|447537101|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
124430770|NCT00400725|447537102|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
124430771|NCT00400725|447537100|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
124430772|NCT00400725|447537101|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
124430773|NCT00400725|447537102|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
124430774|NCT00400725|447537100|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
124430775|NCT00400725|447537101|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
124430776|NCT00400725|447537102|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
124430777|NCT00400725|447537100|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
124430778|NCT00400725|447537101|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
124430779|NCT00400725|447537102|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
124430780|NCT04075994|447537103|FG000|Overall Study|Withdrawal by Subject|8|||
124430781|NCT04075994|447537104|FG001|Overall Study|Withdrawal by Subject|9|||
124430782|NCT04075994|447537103|FG000|Overall Study|Adverse Event|2|||
124430783|NCT04075994|447537104|FG001|Overall Study|Adverse Event|2|||
124430784|NCT04075994|447537103|FG000|Overall Study|Investigator withdrew|3|||
124430785|NCT04075994|447537104|FG001|Overall Study|Investigator withdrew|1|||
124430786|NCT01941719|447537108|FG000|Overall Study|Lost to Follow-up|20|||
124430787|NCT01941719|447537109|FG001|Overall Study|Lost to Follow-up|19|||
124430788|NCT03980808|447537113|FG000|Overall Study|Lost to Follow-up|2|||
124430789|NCT03980808|447537114|FG001|Overall Study|Lost to Follow-up|2|||
124430790|NCT02703259|447537123|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
124675628|NCT03533751|448436025|FG001|Overall Study|Withdrawal by Subject|6|||
124430791|NCT02703259|447537124|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
124430792|NCT02703259|447537123|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
124430793|NCT02703259|447537124|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
124430794|NCT02703259|447537123|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
124430795|NCT02703259|447537124|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
124430796|NCT04738292|447537129|FG000|Overall Study|Death|1|||
124430797|NCT02285153|447537130|FG000|Overall Study|Adverse Event|1|||
124430798|NCT02285153|447537131|FG001|Overall Study|Adverse Event|0|||
124430799|NCT02544451|447537132|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
124430800|NCT02544451|447537133|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
124430801|NCT02544451|447537134|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
124430802|NCT02544451|447537135|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
124675629|NCT03533751|448436026|FG002|Overall Study|Withdrawal by Subject|11|||
124675630|NCT03533751|448436027|FG003|Overall Study|Withdrawal by Subject|9|||
124675631|NCT03533751|448436028|FG004|Overall Study|Withdrawal by Subject|10|||
124675632|NCT03533751|448436024|FG000|Overall Study|Adverse Event|4|||
124675633|NCT03533751|448436025|FG001|Overall Study|Adverse Event|7|||
124675634|NCT03533751|448436026|FG002|Overall Study|Adverse Event|2|||
124675635|NCT03533751|448436027|FG003|Overall Study|Adverse Event|4|||
124675636|NCT03533751|448436028|FG004|Overall Study|Adverse Event|5|||
124675637|NCT03533751|448436024|FG000|Overall Study|Physician Decision|0|||
124675638|NCT03533751|448436025|FG001|Overall Study|Physician Decision|2|||
124675639|NCT03533751|448436026|FG002|Overall Study|Physician Decision|1|||
124675640|NCT03533751|448436027|FG003|Overall Study|Physician Decision|2|||
124675641|NCT03533751|448436028|FG004|Overall Study|Physician Decision|1|||
124675642|NCT03533751|448436024|FG000|Overall Study|Sponsor Decision|0|||
124675643|NCT03533751|448436025|FG001|Overall Study|Sponsor Decision|0|||
124430803|NCT02544451|447537132|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
124675644|NCT03533751|448436026|FG002|Overall Study|Sponsor Decision|1|||
124675645|NCT03533751|448436027|FG003|Overall Study|Sponsor Decision|1|||
124675646|NCT03533751|448436028|FG004|Overall Study|Sponsor Decision|0|||
124675647|NCT03533751|448436024|FG000|Overall Study|Lost to Follow-up|3|||
124675648|NCT03533751|448436025|FG001|Overall Study|Lost to Follow-up|7|||
124675649|NCT03533751|448436026|FG002|Overall Study|Lost to Follow-up|6|||
124675650|NCT03533751|448436027|FG003|Overall Study|Lost to Follow-up|4|||
124675651|NCT03533751|448436028|FG004|Overall Study|Lost to Follow-up|3|||
124675652|NCT03533751|448436024|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
124675653|NCT03533751|448436025|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
124675654|NCT03533751|448436026|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
124675655|NCT03533751|448436027|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
124675656|NCT03533751|448436028|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
124675657|NCT03533751|448436024|FG000|Overall Study|Other|0|||
124675658|NCT03533751|448436025|FG001|Overall Study|Other|2|||
124675659|NCT03533751|448436026|FG002|Overall Study|Other|1|||
124675660|NCT03533751|448436027|FG003|Overall Study|Other|0|||
124675661|NCT03533751|448436028|FG004|Overall Study|Other|3|||
124675662|NCT05117060|448436029|FG000|Overall Study|Adverse Event|3|||
124675663|NCT05117060|448436030|FG001|Overall Study|Adverse Event|5|||
124675664|NCT05117060|448436031|FG002|Overall Study|Adverse Event|6|||
124675665|NCT05117060|448436032|FG003|Overall Study|Adverse Event|1|||
124675666|NCT05117060|448436029|FG000|Overall Study|Lost to Follow-up|0|||
124675667|NCT05117060|448436030|FG001|Overall Study|Lost to Follow-up|0|||
124675668|NCT05117060|448436031|FG002|Overall Study|Lost to Follow-up|0|||
124675669|NCT05117060|448436032|FG003|Overall Study|Lost to Follow-up|1|||
124675670|NCT05117060|448436029|FG000|Overall Study|Lack of Efficacy|4|||
124675671|NCT05117060|448436030|FG001|Overall Study|Lack of Efficacy|5|||
124675672|NCT05117060|448436031|FG002|Overall Study|Lack of Efficacy|2|||
124675673|NCT05117060|448436032|FG003|Overall Study|Lack of Efficacy|6|||
124675674|NCT05117060|448436029|FG000|Overall Study|Withdrawal by Subject|8|||
124675675|NCT05117060|448436030|FG001|Overall Study|Withdrawal by Subject|5|||
124675676|NCT05117060|448436031|FG002|Overall Study|Withdrawal by Subject|5|||
124675677|NCT05117060|448436032|FG003|Overall Study|Withdrawal by Subject|6|||
124675678|NCT05117060|448436029|FG000|Overall Study|Other|2|||
124675679|NCT05117060|448436030|FG001|Overall Study|Other|1|||
124675680|NCT05117060|448436031|FG002|Overall Study|Other|3|||
124675681|NCT05117060|448436032|FG003|Overall Study|Other|1|||
124675682|NCT05079321|448436033|FG000|Overall Study|Withdrawal by Subject|2|||
124675683|NCT05079321|448436034|FG001|Overall Study|Withdrawal by Subject|2|||
124675684|NCT05079321|448436033|FG000|Overall Study|Lost to Follow-up|0|||
124675685|NCT05079321|448436034|FG001|Overall Study|Lost to Follow-up|1|||
124675686|NCT02003144|448436035|FG000|Open Label Maintenance Phase|Other than specified|2|||
124430804|NCT02544451|447537133|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
124675687|NCT02003144|448436036|FG001|Open Label Maintenance Phase|Other than specified|4|||
124675688|NCT02003144|448436035|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
124675689|NCT02003144|448436036|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
124675690|NCT02003144|448436035|FG000|Open Label Maintenance Phase|Pregnancy|0|||
124675691|NCT02003144|448436036|FG001|Open Label Maintenance Phase|Pregnancy|2|||
124675692|NCT02003144|448436035|FG000|Open Label Maintenance Phase|Physician Decision|1|||
124675693|NCT02003144|448436036|FG001|Open Label Maintenance Phase|Physician Decision|1|||
124675694|NCT02003144|448436035|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
124675695|NCT02003144|448436036|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
124675696|NCT02003144|448436035|FG000|Open Label Maintenance Phase|Adverse Event|2|||
124675697|NCT02003144|448436036|FG001|Open Label Maintenance Phase|Adverse Event|1|||
124675698|NCT04158219|448436037|FG000|Overall Study|Lost to Follow-up|1|||
124675699|NCT02074514|448436038|FG000|Overall Study|Lack of Efficacy|3|||
124675700|NCT02074514|448436039|FG001|Overall Study|Lack of Efficacy|2|||
124675701|NCT02074514|448436038|FG000|Overall Study|Lost to Follow-up|0|||
124675702|NCT02074514|448436039|FG001|Overall Study|Lost to Follow-up|1|||
124675703|NCT02074514|448436038|FG000|Overall Study|Withdrew Consent|0|||
124675704|NCT02074514|448436039|FG001|Overall Study|Withdrew Consent|1|||
124675705|NCT01274351|448436040|FG000|Overall Study|Lost to Follow-up|1|||
124675706|NCT01274351|448436040|FG000|Overall Study|patient not compliant with the protocol|1|||
124675707|NCT01274351|448436040|FG000|Overall Study|Pregnancy|1|||
124430805|NCT02544451|447537134|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
124430806|NCT02544451|447537135|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
124430807|NCT02544451|447537132|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
124430808|NCT02544451|447537133|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
124430809|NCT02544451|447537134|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
124430810|NCT02544451|447537135|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
124430811|NCT02544451|447537132|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
124430812|NCT02544451|447537133|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
124430813|NCT02544451|447537134|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
124430814|NCT02544451|447537135|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
124430815|NCT02544451|447537132|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
124675708|NCT01274351|448436040|FG000|Overall Study|Death|2|||
124675709|NCT01274351|448436040|FG000|Overall Study|Withdrawal by Subject|3|||
124675710|NCT01274351|448436040|FG000|Overall Study|Adverse Event|8|||
124675711|NCT01274351|448436040|FG000|Overall Study|progression of disease|3|||
124675712|NCT01274351|448436040|FG000|Overall Study|hospitalization|1|||
124675713|NCT02873689|448437900|FG000|Overall Study|Lack of Efficacy|1|||
124430816|NCT02544451|447537133|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
124675714|NCT02873689|448437901|FG001|Overall Study|Lack of Efficacy|0|||
124675715|NCT02873689|448437900|FG000|Overall Study|Withdrawal by Subject|2|||
124675716|NCT02873689|448437901|FG001|Overall Study|Withdrawal by Subject|2|||
124675717|NCT02873689|448437900|FG000|Overall Study|Protocol Violation|1|||
124675718|NCT02873689|448437901|FG001|Overall Study|Protocol Violation|0|||
124675719|NCT02873689|448437900|FG000|Overall Study|Adverse Event|2|||
124675720|NCT02873689|448437901|FG001|Overall Study|Adverse Event|2|||
124675721|NCT02873689|448437900|FG000|Overall Study|Randomized but not Treated|1|||
124675722|NCT02873689|448437901|FG001|Overall Study|Randomized but not Treated|1|||
124675723|NCT00350545|448437902|FG000|Overall Study|Withdrawal by Subject|2|||
124675724|NCT02997163|448437909|FG000|Overall Study|Adverse Event|1|||
124675725|NCT02997163|448437910|FG001|Overall Study|Adverse Event|0|||
124675726|NCT02997163|448437911|FG002|Overall Study|Adverse Event|0|||
124675727|NCT02997163|448437912|FG003|Overall Study|Adverse Event|1|||
124675728|NCT02337764|448437913|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
124675729|NCT02337764|448437913|FG000|Overall Study|Voluntary Withdrawal|12|||
124675730|NCT02337764|448437913|FG000|Overall Study|Lack of Efficacy|2|||
124675731|NCT01855958|448437925|FG000|Overall Study|Withdrawal by Subject|1|||
124675732|NCT01855958|448437926|FG001|Overall Study|Withdrawal by Subject|0|||
124675733|NCT00368251|448437929|FG000|Overall Study|SAE, non-fatal|1|||
124675734|NCT00368251|448437930|FG001|Overall Study|SAE, non-fatal|0|||
124675735|NCT00368251|448437931|FG002|Overall Study|SAE, non-fatal|0|||
124675736|NCT00368251|448437929|FG000|Overall Study|AE, non-serious non-fatal|0|||
124675737|NCT00368251|448437930|FG001|Overall Study|AE, non-serious non-fatal|0|||
124675738|NCT00368251|448437931|FG002|Overall Study|AE, non-serious non-fatal|1|||
124675739|NCT00607893|448437933|FG000|Overall Study|Lost to Follow-up|4|||
124675740|NCT00607893|448437934|FG001|Overall Study|Lost to Follow-up|0|||
124675741|NCT00607893|448437933|FG000|Overall Study|withdrew due to loss of interest|0|||
124675742|NCT00607893|448437934|FG001|Overall Study|withdrew due to loss of interest|1|||
124675743|NCT00607893|448437933|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
124675744|NCT00607893|448437934|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
124675745|NCT00607893|448437933|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
124675746|NCT00607893|448437934|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
124675747|NCT00607893|448437933|FG000|Overall Study|Declined to be treated|1|||
124675748|NCT00607893|448437934|FG001|Overall Study|Declined to be treated|0|||
124675749|NCT00607893|448437933|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
124675750|NCT00607893|448437934|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
124675751|NCT02669849|448437937|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
124675752|NCT02669849|448437938|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
124675753|NCT02669849|448437939|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
124675754|NCT02669849|448437937|FG000|Overall Study|Lost to Follow-up|1|||
124675755|NCT02669849|448437938|FG001|Overall Study|Lost to Follow-up|0|||
124675756|NCT02669849|448437939|FG002|Overall Study|Lost to Follow-up|3|||
124675757|NCT02669849|448437937|FG000|Overall Study|Death|1|||
124675758|NCT02669849|448437938|FG001|Overall Study|Death|1|||
124675759|NCT02669849|448437939|FG002|Overall Study|Death|2|||
124675760|NCT02669849|448437937|FG000|Overall Study|Study terminated by sponsor|16|||
124675761|NCT02669849|448437938|FG001|Overall Study|Study terminated by sponsor|1|||
124675762|NCT02669849|448437939|FG002|Overall Study|Study terminated by sponsor|14|||
124675763|NCT02669849|448437937|FG000|Overall Study|Other|0|||
124675764|NCT02669849|448437938|FG001|Overall Study|Other|0|||
124675765|NCT02669849|448437939|FG002|Overall Study|Other|2|||
124675766|NCT04745351|448437943|FG000|Overall Study|Death|51|||
124675767|NCT04745351|448437944|FG001|Overall Study|Death|25|||
124675768|NCT04745351|448437943|FG000|Overall Study|Lost to Follow-up|9|||
124675769|NCT04745351|448437944|FG001|Overall Study|Lost to Follow-up|3|||
124675770|NCT04745351|448437943|FG000|Overall Study|Randomized but Never Treated|3|||
124675771|NCT04745351|448437944|FG001|Overall Study|Randomized but Never Treated|3|||
124675772|NCT04745351|448437943|FG000|Overall Study|Adverse Event|4|||
124675773|NCT04745351|448437944|FG001|Overall Study|Adverse Event|0|||
124675774|NCT04745351|448437943|FG000|Overall Study|Withdrew Consent|1|||
124675775|NCT04745351|448437944|FG001|Overall Study|Withdrew Consent|2|||
124675776|NCT04745351|448437943|FG000|Overall Study|Investigator's Discretion|2|||
124675777|NCT04745351|448437944|FG001|Overall Study|Investigator's Discretion|0|||
124675778|NCT04745351|448437943|FG000|Overall Study|Protocol Violation|1|||
124675779|NCT04745351|448437944|FG001|Overall Study|Protocol Violation|0|||
124675780|NCT03499795|448437947|FG000|Overall Study|Adverse Event|1|||
124675781|NCT03499795|448437947|FG000|Overall Study|Lost to Follow-up|1|||
124675782|NCT03636256|448437950|FG000|Overall Study|Lost to Follow-up|3|||
124675783|NCT03636256|448437951|FG001|Overall Study|Lost to Follow-up|0|||
124675784|NCT03636256|448437952|FG002|Overall Study|Lost to Follow-up|2|||
124675785|NCT03636256|448437953|FG003|Overall Study|Lost to Follow-up|1|||
124675786|NCT03636256|448437954|FG004|Overall Study|Lost to Follow-up|0|||
124675787|NCT03636256|448437955|FG005|Overall Study|Lost to Follow-up|4|||
124675788|NCT03636256|448437956|FG006|Overall Study|Lost to Follow-up|2|||
124675789|NCT03636256|448437957|FG007|Overall Study|Lost to Follow-up|0|||
124675790|NCT03636256|448437958|FG008|Overall Study|Lost to Follow-up|4|||
124675791|NCT03636256|448437950|FG000|Overall Study|Withdrawal by Subject|0|||
124675792|NCT03636256|448437951|FG001|Overall Study|Withdrawal by Subject|0|||
124675793|NCT03636256|448437952|FG002|Overall Study|Withdrawal by Subject|0|||
124675794|NCT03636256|448437953|FG003|Overall Study|Withdrawal by Subject|0|||
124675795|NCT03636256|448437954|FG004|Overall Study|Withdrawal by Subject|0|||
124675796|NCT03636256|448437955|FG005|Overall Study|Withdrawal by Subject|0|||
124675797|NCT03636256|448437956|FG006|Overall Study|Withdrawal by Subject|0|||
124675798|NCT03636256|448437957|FG007|Overall Study|Withdrawal by Subject|0|||
124675799|NCT03636256|448437958|FG008|Overall Study|Withdrawal by Subject|1|||
124675800|NCT01516216|448437961|FG000|Overall Study|Adverse Event|2|||
124675801|NCT01516216|448437962|FG001|Overall Study|Adverse Event|4|||
124675802|NCT01516216|448437961|FG000|Overall Study|Disease Progression|38|||
124675803|NCT01516216|448437962|FG001|Overall Study|Disease Progression|34|||
124675804|NCT01516216|448437961|FG000|Overall Study|Withdrawal by Subject|9|||
124430817|NCT02544451|447537134|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
124430818|NCT02544451|447537135|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
124430819|NCT02544451|447537132|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
124430820|NCT02544451|447537133|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
124430821|NCT02544451|447537134|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
124430822|NCT02544451|447537135|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
124430823|NCT01489891|447537136|FG000|Overall Study|Endoscopy failure|1|||
124430824|NCT01489891|447537137|FG001|Overall Study|Endoscopy failure|0|||
124430825|NCT00998790|447537138|FG000|Overall Study|Withdrawal by Subject|21|||
124430826|NCT00888927|447537139|FG000|Overall Study|Adverse Event|0|||
124430827|NCT00888927|447537140|FG001|Overall Study|Adverse Event|0|||
124430828|NCT00888927|447537141|FG002|Overall Study|Adverse Event|0|||
124430829|NCT00888927|447537142|FG003|Overall Study|Adverse Event|1|||
124430830|NCT00888927|447537139|FG000|Overall Study|Withdrawal of consent|0|||
124430831|NCT00888927|447537140|FG001|Overall Study|Withdrawal of consent|0|||
124430832|NCT00888927|447537141|FG002|Overall Study|Withdrawal of consent|0|||
124430833|NCT00888927|447537142|FG003|Overall Study|Withdrawal of consent|1|||
124430834|NCT03459443|447537143|FG000|Overall Study|Lack of Efficacy|3|||
124430835|NCT03459443|447537143|FG000|Overall Study|Adverse Event|1|||
124430836|NCT03459443|447537143|FG000|Overall Study|Sponsor's decision to close the study|18|||
124430837|NCT01080716|447537144|FG000|Part 1|Physician Decision|1|||
124430838|NCT01080716|447537145|FG001|Part 1|Physician Decision|0|||
124430839|NCT01080716|447537146|FG002|Part 1|Physician Decision|0|||
124430840|NCT01080716|447537147|FG003|Part 1|Physician Decision|0|||
124430841|NCT01056718|447537148|FG000|Overall Study|Withdrawal by Subject|2|||
124430842|NCT01056718|447537148|FG000|Overall Study|Ischemia on baseline stress test|1|||
124430843|NCT05086276|447537149|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
124430844|NCT05086276|447537150|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
124430845|NCT00777088|447537151|FG000|Overall Study|PED Treatment not attempted|1|||
124430846|NCT00760474|447537153|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
124430847|NCT00760474|447537154|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
124430848|NCT00760474|447537153|FG000|Placebo Washout Period|Other|0|||
124430849|NCT00760474|447537154|FG001|Placebo Washout Period|Other|1|||
124430850|NCT00760474|447537153|FG000|Period 2 (P2)|Lost to Follow-up|1|||
124430851|NCT00760474|447537154|FG001|Period 2 (P2)|Lost to Follow-up|0|||
124430852|NCT00760474|447537153|FG000|Period 2 (P2)|Adverse Event|0|||
124430853|NCT00760474|447537154|FG001|Period 2 (P2)|Adverse Event|1|||
124430854|NCT00515853|447537155|FG000|Overall Study|Lost to Follow-up|9|||
124430855|NCT00515853|447537156|FG001|Overall Study|Lost to Follow-up|13|||
124430856|NCT00515853|447537155|FG000|Overall Study|Withdrawal by Subject|6|||
124430857|NCT00515853|447537156|FG001|Overall Study|Withdrawal by Subject|4|||
124430858|NCT02101385|447537157|FG000|Study Treatment|Disease Progression|9|||
124430859|NCT02101385|447537158|FG001|Study Treatment|Disease Progression|3|||
124430860|NCT02101385|447537157|FG000|Study Treatment|Alternative therapy|0|||
124430861|NCT02101385|447537158|FG001|Study Treatment|Alternative therapy|1|||
124430862|NCT02101385|447537157|FG000|Study Treatment|No treatment, per protocol criteria|0|||
124675805|NCT01516216|448437962|FG001|Overall Study|Withdrawal by Subject|11|||
124430863|NCT02101385|447537158|FG001|Study Treatment|No treatment, per protocol criteria|4|||
124430864|NCT02101385|447537157|FG000|Study Treatment|Patient Non compliance|0|||
124675806|NCT01516216|448437961|FG000|Overall Study|Potentially Curative Resection|6|||
124675807|NCT01516216|448437962|FG001|Overall Study|Potentially Curative Resection|12|||
124675808|NCT01516216|448437961|FG000|Overall Study|Nonadherence|2|||
124675809|NCT01516216|448437962|FG001|Overall Study|Nonadherence|3|||
124675810|NCT01516216|448437961|FG000|Overall Study|Physician Decision|6|||
124675811|NCT01516216|448437962|FG001|Overall Study|Physician Decision|3|||
124675812|NCT01516216|448437961|FG000|Overall Study|Prolonged Treatment Delay|5|||
124675813|NCT01516216|448437962|FG001|Overall Study|Prolonged Treatment Delay|1|||
124675814|NCT01516216|448437961|FG000|Overall Study|Intercurrent Illness|1|||
124675815|NCT01516216|448437962|FG001|Overall Study|Intercurrent Illness|0|||
124675816|NCT01516216|448437961|FG000|Overall Study|Death|1|||
124675817|NCT01516216|448437962|FG001|Overall Study|Death|1|||
124675818|NCT01117870|448437963|FG000|Overall Study|Inability to place needle|1|||
124675819|NCT01117870|448437964|FG001|Overall Study|Inability to place needle|0|||
124675820|NCT01065818|448437965|FG000|Overall Study|Withdrawal by Subject|1|||
124675821|NCT01065818|448437965|FG000|Overall Study|Not a candidate for surgery|1|||
124675822|NCT01079780|448437967|FG000|Overall Study|Disease progression|43|||
124675823|NCT01079780|448437968|FG001|Overall Study|Disease progression|7|||
124675824|NCT01079780|448437969|FG002|Overall Study|Disease progression|31|||
124675825|NCT01079780|448437967|FG000|Overall Study|Adverse Event|13|||
124675826|NCT01079780|448437968|FG001|Overall Study|Adverse Event|5|||
124675827|NCT01079780|448437969|FG002|Overall Study|Adverse Event|7|||
124675828|NCT01079780|448437967|FG000|Overall Study|Death|2|||
124675829|NCT01079780|448437968|FG001|Overall Study|Death|0|||
124675830|NCT01079780|448437969|FG002|Overall Study|Death|2|||
124675831|NCT01079780|448437967|FG000|Overall Study|Withdrawal by Subject|6|||
124675832|NCT01079780|448437968|FG001|Overall Study|Withdrawal by Subject|4|||
124675833|NCT01079780|448437969|FG002|Overall Study|Withdrawal by Subject|4|||
124675834|NCT01079780|448437967|FG000|Overall Study|Alternative therapy|2|||
124675835|NCT01079780|448437968|FG001|Overall Study|Alternative therapy|0|||
124675836|NCT01079780|448437969|FG002|Overall Study|Alternative therapy|2|||
124675837|NCT01079780|448437967|FG000|Overall Study|Physician Decision|1|||
124675838|NCT01079780|448437968|FG001|Overall Study|Physician Decision|0|||
124675839|NCT01079780|448437969|FG002|Overall Study|Physician Decision|1|||
124675840|NCT01079780|448437967|FG000|Overall Study|Error made in lesion measurement|1|||
124675841|NCT01079780|448437968|FG001|Overall Study|Error made in lesion measurement|0|||
124675842|NCT01079780|448437969|FG002|Overall Study|Error made in lesion measurement|0|||
124675843|NCT01079780|448437967|FG000|Overall Study|Patient had surgery|1|||
124675844|NCT01079780|448437968|FG001|Overall Study|Patient had surgery|0|||
124675845|NCT01079780|448437969|FG002|Overall Study|Patient had surgery|0|||
124675846|NCT01079780|448437967|FG000|Overall Study|Treatment cycle delay|0|||
124675847|NCT01079780|448437968|FG001|Overall Study|Treatment cycle delay|0|||
124675848|NCT01079780|448437969|FG002|Overall Study|Treatment cycle delay|1|||
124675849|NCT01079780|448437967|FG000|Overall Study|Never started treatment|1|||
124675850|NCT01079780|448437968|FG001|Overall Study|Never started treatment|0|||
124675851|NCT01079780|448437969|FG002|Overall Study|Never started treatment|2|||
124675852|NCT03435055|448437970|FG000|Screening|Physician Decision|2|||
124675853|NCT03435055|448437970|FG000|Received Intervention|Did not complete nitrous administration|3|||
124675854|NCT01178294|448437971|FG000|Overall Study|Adverse Event|4|||
124675855|NCT01178294|448437971|FG000|Overall Study|Lost to Follow-up|2|||
124675856|NCT01178294|448437971|FG000|Overall Study|Lack of Efficacy|1|||
124675857|NCT01178294|448437971|FG000|Overall Study|Death|1|||
124675858|NCT01178294|448437971|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
124675859|NCT01178294|448437971|FG000|Overall Study|Subject status is terminal|1|||
124675860|NCT01178294|448437971|FG000|Overall Study|Completion status could not be verified|1|||
124675861|NCT03176771|448437974|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
124675862|NCT03176771|448437975|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
124675863|NCT03176771|448437976|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
124675864|NCT03176771|448437977|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
124675865|NCT03176771|448437978|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
124675866|NCT03176771|448437974|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
124675867|NCT03176771|448437975|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
124675868|NCT03176771|448437976|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
124430865|NCT02101385|447537158|FG001|Study Treatment|Patient Non compliance|2|||
124675869|NCT03176771|448437977|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
124675870|NCT03176771|448437978|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
124675871|NCT03176771|448437974|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
124675872|NCT03176771|448437975|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
124675873|NCT03176771|448437976|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
124675874|NCT03176771|448437977|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
124675875|NCT03176771|448437978|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
124675876|NCT03176771|448437974|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
124675877|NCT03176771|448437975|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
124675878|NCT03176771|448437976|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
124675879|NCT03176771|448437977|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
124675880|NCT03176771|448437978|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
124675881|NCT03176771|448437974|FG000|Double-Blind Extension Period|Adverse Event|0|||
124430866|NCT02101385|447537157|FG000|Study Treatment|Withdrawal by Subject|5|||
124430867|NCT02101385|447537158|FG001|Study Treatment|Withdrawal by Subject|2|||
124430868|NCT02101385|447537157|FG000|Study Treatment|screen failure|1|||
124430869|NCT02101385|447537158|FG001|Study Treatment|screen failure|0|||
124430870|NCT02101385|447537157|FG000|Study Treatment|AE/Side Effects/Complications|8|||
124430871|NCT02101385|447537158|FG001|Study Treatment|AE/Side Effects/Complications|0|||
124430872|NCT02101385|447537157|FG000|Study Treatment|Lost to Follow-up|1|||
124430873|NCT02101385|447537158|FG001|Study Treatment|Lost to Follow-up|0|||
124430874|NCT02101385|447537157|FG000|Study Treatment|Disease Progression before treatment|1|||
124430875|NCT02101385|447537158|FG001|Study Treatment|Disease Progression before treatment|0|||
124430876|NCT02101385|447537157|FG000|Study Treatment|Death|1|||
124430877|NCT02101385|447537158|FG001|Study Treatment|Death|0|||
124430878|NCT02101385|447537157|FG000|Follow up|Lost to Follow-up|4|||
124430879|NCT02101385|447537158|FG001|Follow up|Lost to Follow-up|9|||
124430880|NCT02101385|447537157|FG000|Follow up|Refused to follow up|5|||
124430881|NCT02101385|447537158|FG001|Follow up|Refused to follow up|4|||
124430882|NCT02101385|447537157|FG000|Follow up|Death|21|||
124430883|NCT02101385|447537158|FG001|Follow up|Death|39|||
124430884|NCT02101385|447537157|FG000|Follow up|study completed|33|||
124430885|NCT02101385|447537158|FG001|Follow up|study completed|52|||
124430886|NCT02101385|447537157|FG000|Follow up|screen failure|2|||
124430887|NCT02101385|447537158|FG001|Follow up|screen failure|0|||
124430888|NCT02101385|447537157|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
124430889|NCT02101385|447537158|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
124430890|NCT02101385|447537157|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
124430891|NCT02101385|447537158|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
124430892|NCT02101385|447537157|FG000|Follow up|Withdrawal by Subject|2|||
124430893|NCT02101385|447537158|FG001|Follow up|Withdrawal by Subject|2|||
124430894|NCT02101385|447537157|FG000|Follow up|PI requested closure of site|0|||
124430895|NCT02101385|447537158|FG001|Follow up|PI requested closure of site|5|||
124430896|NCT02432196|447537159|FG000|Overall Study|Exit - did not receive study device|1|||
124675882|NCT03176771|448437975|FG001|Double-Blind Extension Period|Adverse Event|0|||
124430897|NCT02432196|447537159|FG000|Overall Study|Death|2|||
124430898|NCT02432196|447537159|FG000|Overall Study|Reoperation|3|||
124430899|NCT05038163|447537160|FG000|Stage 1|Did not complete survey|374|||
124430900|NCT05038163|447537161|FG001|Stage 1|Did not complete survey|0|||
124430901|NCT05038163|447537162|FG002|Stage 1|Did not complete survey|0|||
124430902|NCT05038163|447537163|FG003|Stage 1|Did not complete survey|0|||
124430903|NCT05038163|447537164|FG004|Stage 1|Did not complete survey|0|||
124430904|NCT05038163|447537165|FG005|Stage 1|Did not complete survey|0|||
124430905|NCT05038163|447537160|FG000|Stage 2|Did not complete Stage 2 survey|0|||
124430906|NCT05038163|447537161|FG001|Stage 2|Did not complete Stage 2 survey|29|||
124430907|NCT05038163|447537162|FG002|Stage 2|Did not complete Stage 2 survey|30|||
124430908|NCT05038163|447537163|FG003|Stage 2|Did not complete Stage 2 survey|24|||
124430909|NCT05038163|447537164|FG004|Stage 2|Did not complete Stage 2 survey|21|||
124430910|NCT05038163|447537165|FG005|Stage 2|Did not complete Stage 2 survey|100|||
124430911|NCT01147536|447537166|FG000|Overall Study|Administrative study close|2|||
124430912|NCT01147536|447537166|FG000|Overall Study|Death|1|||
124430913|NCT03762200|447537169|FG000|Overall Study|Death|2|||
124430914|NCT02631577|447537170|FG000|Overall Study|Death|1|||
124430915|NCT02631577|447537171|FG001|Overall Study|Death|7|||
124430916|NCT02631577|447537170|FG000|Overall Study|Withdrawal by Subject|0|||
124430917|NCT02631577|447537171|FG001|Overall Study|Withdrawal by Subject|3|||
124430918|NCT03973931|447537177|FG000|Overall Study|Lost to Follow-up|47|||
124430919|NCT03973931|447537178|FG001|Overall Study|Lost to Follow-up|63|||
124430920|NCT03973931|447537179|FG002|Overall Study|Lost to Follow-up|51|||
124430921|NCT03973931|447537180|FG003|Overall Study|Lost to Follow-up|54|||
124430922|NCT03973931|447537177|FG000|Overall Study|opted out|6|||
124430923|NCT03973931|447537178|FG001|Overall Study|opted out|5|||
124430924|NCT03973931|447537179|FG002|Overall Study|opted out|5|||
124430925|NCT03973931|447537180|FG003|Overall Study|opted out|1|||
124430926|NCT02738203|447538702|FG000|Overall Study|Failed IUD Insertion|2|||
124430927|NCT02738203|447538703|FG001|Overall Study|Failed IUD Insertion|2|||
124430928|NCT02738203|447538702|FG000|Overall Study|Protocol Violation|0|||
124675883|NCT03176771|448437976|FG002|Double-Blind Extension Period|Adverse Event|0|||
124675884|NCT03176771|448437977|FG003|Double-Blind Extension Period|Adverse Event|15|||
124675885|NCT03176771|448437978|FG004|Double-Blind Extension Period|Adverse Event|18|||
124675886|NCT03176771|448437974|FG000|Double-Blind Extension Period|Death|0|||
124675887|NCT03176771|448437975|FG001|Double-Blind Extension Period|Death|0|||
124675888|NCT03176771|448437976|FG002|Double-Blind Extension Period|Death|0|||
124675889|NCT03176771|448437977|FG003|Double-Blind Extension Period|Death|3|||
124675890|NCT03176771|448437978|FG004|Double-Blind Extension Period|Death|4|||
124675891|NCT03176771|448437974|FG000|Double-Blind Extension Period|Physician Decision|0|||
124675892|NCT03176771|448437975|FG001|Double-Blind Extension Period|Physician Decision|0|||
124675893|NCT03176771|448437976|FG002|Double-Blind Extension Period|Physician Decision|0|||
124675894|NCT03176771|448437977|FG003|Double-Blind Extension Period|Physician Decision|3|||
124675895|NCT03176771|448437978|FG004|Double-Blind Extension Period|Physician Decision|1|||
124675896|NCT03176771|448437974|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
124675897|NCT03176771|448437975|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
124675898|NCT03176771|448437976|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
124675899|NCT03176771|448437977|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
124675900|NCT03176771|448437978|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
124675901|NCT02732639|448437979|FG000|Overall Study|Lost to Follow-up|1|||
124675902|NCT02662569|448437981|FG000|Overall Study|Withdrawal by Subject|6|||
124675903|NCT02662569|448437982|FG001|Overall Study|Withdrawal by Subject|1|||
124675904|NCT02662569|448437983|FG002|Overall Study|Withdrawal by Subject|6|||
124675905|NCT02662569|448437984|FG003|Overall Study|Withdrawal by Subject|4|||
124430929|NCT02738203|447538703|FG001|Overall Study|Protocol Violation|1|||
124430930|NCT00901186|447538707|FG000|Overall Study|Lack of Efficacy|0|||
124430931|NCT00901186|447538708|FG001|Overall Study|Lack of Efficacy|1|||
124430932|NCT00901186|447538707|FG000|Overall Study|Abnormal laboratory values|0|||
124675906|NCT02662569|448437981|FG000|Overall Study|Lost to Follow-up|1|||
124675907|NCT02662569|448437982|FG001|Overall Study|Lost to Follow-up|0|||
124675908|NCT02662569|448437983|FG002|Overall Study|Lost to Follow-up|0|||
124675909|NCT02662569|448437984|FG003|Overall Study|Lost to Follow-up|0|||
124430933|NCT00901186|447538708|FG001|Overall Study|Abnormal laboratory values|1|||
124430934|NCT00901186|447538707|FG000|Overall Study|Lost to Follow-up|2|||
124430935|NCT00901186|447538708|FG001|Overall Study|Lost to Follow-up|0|||
124430936|NCT00901186|447538707|FG000|Overall Study|Adverse Event|2|||
124430937|NCT00901186|447538708|FG001|Overall Study|Adverse Event|4|||
124430938|NCT00901186|447538707|FG000|Overall Study|Administration problems|0|||
124430939|NCT00901186|447538708|FG001|Overall Study|Administration problems|1|||
124430940|NCT00901186|447538707|FG000|Overall Study|Protocol deviations|5|||
124430941|NCT00901186|447538708|FG001|Overall Study|Protocol deviations|4|||
124430942|NCT00581555|447538709|FG000|Overall Study|Adverse Event|4|||
124430943|NCT00581555|447538710|FG001|Overall Study|Adverse Event|3|||
124430944|NCT00581555|447538709|FG000|Overall Study|Physician Decision|3|||
124430945|NCT00581555|447538710|FG001|Overall Study|Physician Decision|2|||
124430946|NCT00581555|447538709|FG000|Overall Study|Withdrawal by Subject|18|||
124430947|NCT00581555|447538710|FG001|Overall Study|Withdrawal by Subject|9|||
124430948|NCT00581555|447538709|FG000|Overall Study|Lost to Follow-up|2|||
124430949|NCT00581555|447538710|FG001|Overall Study|Lost to Follow-up|2|||
124430950|NCT00581555|447538709|FG000|Overall Study|Other reasons|16|||
124430951|NCT00581555|447538710|FG001|Overall Study|Other reasons|4|||
124430952|NCT03507777|447538711|FG000|Overall Study|Lost to Follow-up|5|||
124430953|NCT03507777|447538712|FG001|Overall Study|Lost to Follow-up|7|||
124430954|NCT03507777|447538711|FG000|Overall Study|Withdrawal by Subject|6|||
124430955|NCT03507777|447538712|FG001|Overall Study|Withdrawal by Subject|11|||
124430956|NCT03507777|447538711|FG000|Overall Study|Death|30|||
124430957|NCT03507777|447538712|FG001|Overall Study|Death|44|||
124430958|NCT03507777|447538711|FG000|Overall Study|Other Reasons|3|||
124430959|NCT03507777|447538712|FG001|Overall Study|Other Reasons|8|||
124430960|NCT01552603|447538713|FG000|Overall Study|Physician Decision|1|||
124430961|NCT04797650|447538718|FG000|Overall Study|Reason Not Specified|5|||
124430962|NCT04797650|447538719|FG001|Overall Study|Reason Not Specified|12|||
124430963|NCT04797650|447538720|FG002|Overall Study|Reason Not Specified|5|||
124430964|NCT04797650|447538718|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
124430965|NCT04797650|447538719|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
124430966|NCT04797650|447538720|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
124430967|NCT04797650|447538718|FG000|Overall Study|Lack of Efficacy|1|||
124430968|NCT04797650|447538719|FG001|Overall Study|Lack of Efficacy|0|||
124430969|NCT04797650|447538720|FG002|Overall Study|Lack of Efficacy|1|||
124430970|NCT04797650|447538718|FG000|Overall Study|Non-compliance with Study Drug|0|||
124430971|NCT04797650|447538719|FG001|Overall Study|Non-compliance with Study Drug|0|||
124430972|NCT04797650|447538720|FG002|Overall Study|Non-compliance with Study Drug|2|||
124430973|NCT04797650|447538718|FG000|Overall Study|Lost to Follow-up|4|||
124430974|NCT04797650|447538719|FG001|Overall Study|Lost to Follow-up|6|||
124675910|NCT00630916|448437988|FG000|Overall Study|Death|110|||
124675911|NCT00630916|448437988|FG000|Overall Study|Explant|8|||
124675912|NCT00630916|448437988|FG000|Overall Study|Lost to Follow-up|5|||
124675913|NCT00630916|448437988|FG000|Overall Study|Withdrawal by Subject|30|||
124675914|NCT00630916|448437988|FG000|Overall Study|Protocol Violation|7|||
124675915|NCT00630916|448437988|FG000|Overall Study|Physician Decision|47|||
124675916|NCT00630916|448437988|FG000|Overall Study|Lack of Efficacy|3|||
124675917|NCT01299584|448437995|FG000|Overall Study|Protocol Violation|9|||
124675918|NCT04079790|448437996|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
124675919|NCT04079790|448437997|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
124675920|NCT04079790|448437998|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
124675921|NCT04079790|448437999|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
124675922|NCT04079790|448437996|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
124430975|NCT04797650|447538720|FG002|Overall Study|Lost to Follow-up|1|||
124430976|NCT00657020|447538721|FG000|PERIOD 1|Adverse Event|0|||
124430977|NCT00657020|447538722|FG001|PERIOD 1|Adverse Event|1|||
124430978|NCT01144052|447538723|FG000|Overall Study|Withdrawal by Subject|1|||
124430979|NCT01144052|447538724|FG001|Overall Study|Withdrawal by Subject|1|||
124430980|NCT00774930|447538730|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
124430981|NCT00774930|447538731|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
124430982|NCT00774930|447538730|FG000|DB Phase|Adverse Event|1|||
124430983|NCT00774930|447538731|FG001|DB Phase|Adverse Event|2|||
124430984|NCT00774930|447538730|FG000|DB Phase|Subject Decision|1|||
124675923|NCT04079790|448437997|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
124675924|NCT04079790|448437998|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
124675925|NCT04079790|448437999|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
124675926|NCT04079790|448437996|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
124675927|NCT04079790|448437997|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
124430985|NCT00774930|447538731|FG001|DB Phase|Subject Decision|5|||
124430986|NCT00774930|447538730|FG000|DB Phase|Sponsor Decision|0|||
124430987|NCT00774930|447538731|FG001|DB Phase|Sponsor Decision|1|||
124430988|NCT00774930|447538730|FG000|DB Phase|Disease Progression|1|||
124430989|NCT00774930|447538731|FG001|DB Phase|Disease Progression|1|||
124430990|NCT00774930|447538730|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
124430991|NCT00774930|447538731|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
124675928|NCT04079790|448437998|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
124675929|NCT04079790|448437999|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
124675930|NCT00390689|448438000|FG000|Overall Study|Adverse Event|2|||
124675931|NCT00390689|448438001|FG001|Overall Study|Adverse Event|5|||
124675932|NCT00390689|448438002|FG002|Overall Study|Adverse Event|2|||
124675933|NCT00390689|448438000|FG000|Overall Study|Lack of Efficacy|0|||
124675934|NCT00390689|448438001|FG001|Overall Study|Lack of Efficacy|0|||
124675935|NCT00390689|448438002|FG002|Overall Study|Lack of Efficacy|1|||
124675936|NCT00390689|448438000|FG000|Overall Study|Protocol Violation|1|||
124675937|NCT00390689|448438001|FG001|Overall Study|Protocol Violation|0|||
124675938|NCT00390689|448438002|FG002|Overall Study|Protocol Violation|0|||
124675939|NCT00390689|448438000|FG000|Overall Study|Investigator's judgement|2|||
124675940|NCT00390689|448438001|FG001|Overall Study|Investigator's judgement|0|||
124675941|NCT00390689|448438002|FG002|Overall Study|Investigator's judgement|0|||
124675942|NCT01253161|448438003|FG000|Overall Study|Adverse Event|1|||
124675943|NCT01924533|448438005|FG000|Overall Study|Death|181|||
124675944|NCT01924533|448438006|FG001|Overall Study|Death|200|||
124675945|NCT01924533|448438005|FG000|Overall Study|Lost to Follow-up|0|||
124675946|NCT01924533|448438006|FG001|Overall Study|Lost to Follow-up|1|||
124675947|NCT01924533|448438005|FG000|Overall Study|Withdrawal by Subject|7|||
124675948|NCT01924533|448438006|FG001|Overall Study|Withdrawal by Subject|3|||
124675949|NCT01924533|448438005|FG000|Overall Study|Other Eligibility criteria|1|||
124675950|NCT01924533|448438006|FG001|Overall Study|Other Eligibility criteria|1|||
124675951|NCT02747927|448438007|FG000|Overall Study|Adverse Event|5|||
124675952|NCT02747927|448438008|FG001|Overall Study|Adverse Event|14|||
124675953|NCT02747927|448438007|FG000|Overall Study|Lost to Follow-up|22|||
124675954|NCT02747927|448438008|FG001|Overall Study|Lost to Follow-up|43|||
124675955|NCT02747927|448438007|FG000|Overall Study|Pregnancy|34|||
124675956|NCT02747927|448438008|FG001|Overall Study|Pregnancy|66|||
124675957|NCT02747927|448438007|FG000|Overall Study|Protocol Violation|2|||
124675958|NCT02747927|448438008|FG001|Overall Study|Protocol Violation|4|||
124675959|NCT02747927|448438007|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
124675960|NCT02747927|448438008|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
124675961|NCT02747927|448438007|FG000|Overall Study|Reason not Specified|11|||
124675962|NCT02747927|448438008|FG001|Overall Study|Reason not Specified|27|||
124675963|NCT05412134|448438009|FG000|Overall Study|Lost to Follow-up|2|||
124675964|NCT05412134|448438010|FG001|Overall Study|Lost to Follow-up|0|||
124675965|NCT04275336|448438012|FG000|Overall Study|First venipuncture failed|4|||
124675966|NCT04275336|448438013|FG001|Overall Study|First venipuncture failed|6|||
124675967|NCT04275336|448438014|FG002|Overall Study|First venipuncture failed|5|||
124675968|NCT04275336|448438012|FG000|Overall Study|Unscheduled venipuncture|9|||
124675969|NCT04275336|448438013|FG001|Overall Study|Unscheduled venipuncture|13|||
124675970|NCT04275336|448438014|FG002|Overall Study|Unscheduled venipuncture|7|||
124675971|NCT04275336|448438012|FG000|Overall Study|Failed specimen of saliva|4|||
124675972|NCT04275336|448438013|FG001|Overall Study|Failed specimen of saliva|3|||
124675973|NCT04275336|448438014|FG002|Overall Study|Failed specimen of saliva|4|||
124675974|NCT00423046|448438021|FG000|Overall Study|Other|340|||
124675975|NCT00423046|448438022|FG001|Overall Study|Other|345|||
124675976|NCT00830128|448438023|FG000|Overall Study|Adverse Event|5|||
124675977|NCT00830128|448438023|FG000|Overall Study|Lack of Efficacy|7|||
124675978|NCT00830128|448438023|FG000|Overall Study|Protocol Violation|1|||
124675979|NCT00830128|448438023|FG000|Overall Study|Withdrawal by Subject|2|||
124675980|NCT00830128|448438023|FG000|Overall Study|Family obligation|1|||
124675981|NCT00830128|448438023|FG000|Overall Study|Relocation|1|||
124430992|NCT00774930|447538730|FG000|IOL Phase|Adverse Event|1|||
124430993|NCT00774930|447538731|FG001|IOL Phase|Adverse Event|1|||
124430994|NCT00774930|447538730|FG000|IOL Phase|Subject Decision|4|||
124430995|NCT00774930|447538731|FG001|IOL Phase|Subject Decision|3|||
124430996|NCT00774930|447538730|FG000|IOL Phase|Physician Decision|3|||
124430997|NCT00774930|447538731|FG001|IOL Phase|Physician Decision|2|||
124430998|NCT00774930|447538730|FG000|IOL Phase|Sponsor Decision|1|||
124430999|NCT00774930|447538731|FG001|IOL Phase|Sponsor Decision|0|||
124675982|NCT00830128|448438023|FG000|Overall Study|Work obligation|1|||
124675983|NCT00830128|448438023|FG000|Overall Study|Operating a vehicle|1|||
124675984|NCT05401565|448438024|FG000|Overall Study|Lost to Follow-up|1|||
124675985|NCT05401565|448438025|FG001|Overall Study|Lost to Follow-up|0|||
124675986|NCT05401565|448438024|FG000|Overall Study|Adverse Event|2|||
124675987|NCT05401565|448438025|FG001|Overall Study|Adverse Event|0|||
124675988|NCT01218802|448438034|FG000|Overall Study|Lost to Follow-up|5|||
124675989|NCT01218802|448438035|FG001|Overall Study|Lost to Follow-up|6|||
124675990|NCT01218802|448438034|FG000|Overall Study|Withdrawal by Subject|3|||
124675991|NCT01218802|448438035|FG001|Overall Study|Withdrawal by Subject|10|||
124675992|NCT01218802|448438034|FG000|Overall Study|Adverse Event|0|||
124675993|NCT01218802|448438035|FG001|Overall Study|Adverse Event|2|||
124675994|NCT01218802|448438034|FG000|Overall Study|Incarcerated|2|||
124675995|NCT01218802|448438035|FG001|Overall Study|Incarcerated|0|||
124431000|NCT00774930|447538730|FG000|IOL Phase|Disease Progression|2|||
124431001|NCT00774930|447538731|FG001|IOL Phase|Disease Progression|1|||
124675996|NCT03329885|448438036|FG000|Overall Study|Sponsor discontinued the study early|0|||
124675997|NCT03329885|448438037|FG001|Overall Study|Sponsor discontinued the study early|0|||
124675998|NCT03329885|448438038|FG002|Overall Study|Sponsor discontinued the study early|0|||
124675999|NCT03329885|448438039|FG003|Overall Study|Sponsor discontinued the study early|0|||
124676000|NCT03329885|448438040|FG004|Overall Study|Sponsor discontinued the study early|0|||
124676001|NCT03329885|448438041|FG005|Overall Study|Sponsor discontinued the study early|0|||
124676002|NCT03329885|448438042|FG006|Overall Study|Sponsor discontinued the study early|1|||
124676003|NCT03329885|448438043|FG007|Overall Study|Sponsor discontinued the study early|1|||
124676004|NCT03329885|448438044|FG008|Overall Study|Sponsor discontinued the study early|0|||
124676005|NCT03368807|448438049|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
124676006|NCT03368807|448438049|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
124676007|NCT03368807|448438049|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
124676008|NCT03368807|448438049|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
124676009|NCT00843492|448438050|FG000|Overall Study|Adverse Event|0|||
124676010|NCT00843492|448438051|FG001|Overall Study|Adverse Event|3|||
124676011|NCT00843492|448438050|FG000|Overall Study|Lost to Follow-up|4|||
124676012|NCT00843492|448438051|FG001|Overall Study|Lost to Follow-up|4|||
124676013|NCT00843492|448438050|FG000|Overall Study|Withdrawal by Subject|0|||
124676014|NCT00843492|448438051|FG001|Overall Study|Withdrawal by Subject|4|||
124676015|NCT00843492|448438050|FG000|Overall Study|Immobilization Stopped|1|||
124676016|NCT00843492|448438051|FG001|Overall Study|Immobilization Stopped|0|||
124676017|NCT00843492|448438050|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
124676018|NCT00843492|448438051|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
124676019|NCT00843492|448438050|FG000|Overall Study|Orthopedic Surgery|0|||
124676020|NCT00843492|448438051|FG001|Overall Study|Orthopedic Surgery|2|||
124676021|NCT00843492|448438050|FG000|Overall Study|Visit Not Performed|1|||
124676022|NCT00843492|448438051|FG001|Overall Study|Visit Not Performed|0|||
124676023|NCT00843492|448438050|FG000|Overall Study|Deep-vein Thrombosis|1|||
124676024|NCT00843492|448438051|FG001|Overall Study|Deep-vein Thrombosis|0|||
124676025|NCT01677741|448438053|FG000|Overall Study|Death|0|||
124676026|NCT01677741|448438054|FG001|Overall Study|Death|0|||
124676027|NCT01677741|448438055|FG002|Overall Study|Death|0|||
124676028|NCT01677741|448438056|FG003|Overall Study|Death|1|||
124676029|NCT01677741|448438057|FG004|Overall Study|Death|0|||
124676030|NCT01677741|448438058|FG005|Overall Study|Death|1|||
124676031|NCT01677741|448438059|FG006|Overall Study|Death|0|||
124676032|NCT01677741|448438060|FG007|Overall Study|Death|0|||
124676033|NCT01677741|448438053|FG000|Overall Study|Withdrawal by Subject|2|||
124676034|NCT01677741|448438054|FG001|Overall Study|Withdrawal by Subject|7|||
124676035|NCT01677741|448438055|FG002|Overall Study|Withdrawal by Subject|5|||
124676036|NCT01677741|448438056|FG003|Overall Study|Withdrawal by Subject|4|||
124676037|NCT01677741|448438057|FG004|Overall Study|Withdrawal by Subject|11|||
124676038|NCT01677741|448438058|FG005|Overall Study|Withdrawal by Subject|20|||
124676039|NCT01677741|448438059|FG006|Overall Study|Withdrawal by Subject|4|||
124676040|NCT01677741|448438060|FG007|Overall Study|Withdrawal by Subject|2|||
124676041|NCT01677741|448438053|FG000|Overall Study|Enrolled in a rollover study|0|||
124676042|NCT01677741|448438054|FG001|Overall Study|Enrolled in a rollover study|3|||
124676043|NCT01677741|448438055|FG002|Overall Study|Enrolled in a rollover study|2|||
124676044|NCT01677741|448438056|FG003|Overall Study|Enrolled in a rollover study|1|||
124431002|NCT00774930|447538730|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
124676045|NCT01677741|448438057|FG004|Overall Study|Enrolled in a rollover study|6|||
124676046|NCT01677741|448438058|FG005|Overall Study|Enrolled in a rollover study|6|||
124676047|NCT01677741|448438059|FG006|Overall Study|Enrolled in a rollover study|7|||
124676048|NCT01677741|448438060|FG007|Overall Study|Enrolled in a rollover study|0|||
124676049|NCT01677741|448438053|FG000|Overall Study|Progressive disease|1|||
124676050|NCT01677741|448438054|FG001|Overall Study|Progressive disease|0|||
124676051|NCT01677741|448438055|FG002|Overall Study|Progressive disease|1|||
124676052|NCT01677741|448438056|FG003|Overall Study|Progressive disease|0|||
124676053|NCT01677741|448438057|FG004|Overall Study|Progressive disease|0|||
124676054|NCT01677741|448438058|FG005|Overall Study|Progressive disease|1|||
124431003|NCT00774930|447538731|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
124431004|NCT00774930|447538730|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
124431005|NCT00774930|447538731|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
124431006|NCT00774930|447538730|FG000|IOL Phase|Other|1|||
124431007|NCT00774930|447538731|FG001|IOL Phase|Other|0|||
124431008|NCT00774930|447538730|FG000|IOL Phase|Brain radiation|0|||
124431009|NCT00774930|447538731|FG001|IOL Phase|Brain radiation|1|||
124431010|NCT00774930|447538730|FG000|LTOLE Phase|Adverse Event|7|||
124431011|NCT00774930|447538731|FG001|LTOLE Phase|Adverse Event|3|||
124431012|NCT00774930|447538730|FG000|LTOLE Phase|Subject decision|0|||
124431013|NCT00774930|447538731|FG001|LTOLE Phase|Subject decision|5|||
124431014|NCT00774930|447538730|FG000|LTOLE Phase|Physician Decision|4|||
124431015|NCT00774930|447538731|FG001|LTOLE Phase|Physician Decision|1|||
124431016|NCT00774930|447538730|FG000|LTOLE Phase|Sponsor decision|2|||
124431017|NCT00774930|447538731|FG001|LTOLE Phase|Sponsor decision|1|||
124431018|NCT00774930|447538730|FG000|LTOLE Phase|Disease Progression|2|||
124431019|NCT00774930|447538731|FG001|LTOLE Phase|Disease Progression|5|||
124431020|NCT00774930|447538730|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
124431021|NCT00774930|447538731|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
124431022|NCT00774930|447538730|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
124431023|NCT00774930|447538731|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
124431024|NCT01631227|447538736|FG000|Overall Study|withdrawn consent|27|||
124431025|NCT01631227|447538737|FG001|Overall Study|withdrawn consent|21|||
124431026|NCT01631227|447538736|FG000|Overall Study|Adverse Event|1|||
124431027|NCT01631227|447538737|FG001|Overall Study|Adverse Event|0|||
124431028|NCT01631227|447538736|FG000|Overall Study|administrative|2|||
124431029|NCT01631227|447538737|FG001|Overall Study|administrative|1|||
124431030|NCT00766363|447538738|FG000|Overall Study|Withdrawal by Subject|1|||
124431031|NCT00766363|447538739|FG001|Overall Study|Withdrawal by Subject|0|||
124431032|NCT00766363|447538740|FG002|Overall Study|Withdrawal by Subject|0|||
124431033|NCT00766363|447538741|FG003|Overall Study|Withdrawal by Subject|0|||
124431034|NCT00766363|447538738|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
124431035|NCT00766363|447538739|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
124431036|NCT00766363|447538740|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
124431037|NCT00766363|447538741|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
124431038|NCT03020576|447538742|FG000|Overall Study|Withdrawal by Subject|1|||
124431039|NCT03020576|447538743|FG001|Overall Study|Withdrawal by Subject|2|||
124431040|NCT01177800|447538745|FG000|Overall Study|Adverse Event|9|||
124431041|NCT01177800|447538746|FG001|Overall Study|Adverse Event|3|||
124431042|NCT01177800|447538745|FG000|Overall Study|Protocol Violation|0|||
124431043|NCT01177800|447538746|FG001|Overall Study|Protocol Violation|1|||
124676055|NCT01677741|448438059|FG006|Overall Study|Progressive disease|0|||
124676056|NCT01677741|448438060|FG007|Overall Study|Progressive disease|0|||
124676057|NCT01973218|448438061|FG000|Overall Study|Adverse Event|1|||
124676058|NCT01973218|448438062|FG001|Overall Study|Adverse Event|0|||
124676059|NCT01973218|448438061|FG000|Overall Study|Withdrawal by Subject|1|||
124676060|NCT01973218|448438062|FG001|Overall Study|Withdrawal by Subject|0|||
124676061|NCT01441973|448438067|FG000|Overall Study|Disease progression|8|||
124676062|NCT01441973|448438068|FG001|Overall Study|Disease progression|6|||
124676063|NCT01441973|448438067|FG000|Overall Study|Adverse event unrelated to study drug|3|||
124676064|NCT01441973|448438068|FG001|Overall Study|Adverse event unrelated to study drug|2|||
124676065|NCT01441973|448438067|FG000|Overall Study|Participant request to discontinue|1|||
124676066|NCT01441973|448438068|FG001|Overall Study|Participant request to discontinue|1|||
124676067|NCT01441973|448438067|FG000|Overall Study|Poor compliance/noncompliance|0|||
124676068|NCT01441973|448438068|FG001|Overall Study|Poor compliance/noncompliance|1|||
124676069|NCT01441973|448438067|FG000|Overall Study|Administrative reason by sponsor|3|||
124676070|NCT01441973|448438068|FG001|Overall Study|Administrative reason by sponsor|5|||
124676071|NCT01441973|448438067|FG000|Overall Study|Participant withdrew consent|0|||
124676072|NCT01441973|448438068|FG001|Overall Study|Participant withdrew consent|1|||
124676073|NCT01149655|448438069|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
124676074|NCT01149655|448438070|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
124676075|NCT01149655|448438071|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
124676076|NCT01149655|448438072|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
124676077|NCT01149655|448438069|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
124676078|NCT01149655|448438070|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
124676079|NCT01149655|448438071|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
124676080|NCT01149655|448438072|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
124431044|NCT01177800|447538745|FG000|Overall Study|Physician Decision|1|||
124431045|NCT01177800|447538746|FG001|Overall Study|Physician Decision|0|||
124431046|NCT01177800|447538745|FG000|Overall Study|Withdrawal of informed consent|0|||
124431047|NCT01177800|447538746|FG001|Overall Study|Withdrawal of informed consent|1|||
124431048|NCT03527550|447538747|FG000|Overall Study|Lost to Follow-up|4|||
124431049|NCT03527550|447538748|FG001|Overall Study|Lost to Follow-up|2|||
124431050|NCT03527550|447538747|FG000|Overall Study|Withdrawal by Subject|4|||
124431051|NCT03527550|447538748|FG001|Overall Study|Withdrawal by Subject|1|||
124676081|NCT01149655|448438069|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
124676082|NCT01149655|448438070|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
124676083|NCT01149655|448438071|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
124676084|NCT01149655|448438072|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
124676085|NCT01149655|448438069|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
124676086|NCT01149655|448438070|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
124676087|NCT01149655|448438071|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
124676088|NCT01149655|448438072|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
124676089|NCT01149655|448438069|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
124676090|NCT01149655|448438070|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
124676091|NCT01149655|448438071|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
124676092|NCT01149655|448438072|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
124676093|NCT01149655|448438069|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
124676094|NCT01149655|448438070|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
124676095|NCT01149655|448438071|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
124676096|NCT01149655|448438072|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
124676097|NCT01149655|448438069|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
124676098|NCT01149655|448438070|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
124676099|NCT01149655|448438071|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
124676100|NCT01149655|448438072|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
124676101|NCT01149655|448438069|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
124676102|NCT01149655|448438070|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
124676103|NCT01149655|448438071|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
124676104|NCT01149655|448438072|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
124676105|NCT01149655|448438069|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
124676106|NCT01149655|448438070|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
124676107|NCT01149655|448438071|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
124676108|NCT01149655|448438072|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
124676109|NCT01149655|448438069|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
124676110|NCT01149655|448438070|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
124676111|NCT01149655|448438071|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
124676112|NCT01149655|448438072|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
124676113|NCT01149655|448438069|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
124676114|NCT01149655|448438070|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
124676115|NCT01149655|448438071|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
124676116|NCT01149655|448438072|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
124676117|NCT01149655|448438069|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
124676118|NCT01149655|448438070|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
124676119|NCT01149655|448438071|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
124676120|NCT01149655|448438072|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
124676121|NCT01149655|448438069|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
124676122|NCT01149655|448438070|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
124676123|NCT01149655|448438071|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
124676124|NCT01149655|448438072|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
124676125|NCT01149655|448438069|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
124676126|NCT01149655|448438070|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
124676127|NCT01149655|448438071|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
124676128|NCT01149655|448438072|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
124676129|NCT01149655|448438069|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
124676130|NCT01149655|448438070|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
124676131|NCT01149655|448438071|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
124676132|NCT01149655|448438072|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
124676133|NCT01149655|448438069|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
124676134|NCT01149655|448438070|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
124676135|NCT01149655|448438071|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
124676136|NCT01149655|448438072|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
124676137|NCT04030598|448438073|FG000|Overall Study|Voluntary Withdrawal|0|||
124676138|NCT04030598|448438074|FG001|Overall Study|Voluntary Withdrawal|1|||
124676139|NCT04030598|448438075|FG002|Overall Study|Voluntary Withdrawal|0|||
124676140|NCT01324947|448438076|FG000|Overall Study|Adverse Event|7|||
124676141|NCT01324947|448438076|FG000|Overall Study|Death|10|||
124676142|NCT01324947|448438076|FG000|Overall Study|Other|3|||
124676143|NCT01324947|448438076|FG000|Overall Study|Progressive Disease|50|||
124676144|NCT01324947|448438076|FG000|Overall Study|Withdrawal by Subject|3|||
124676145|NCT01324947|448438076|FG000|Overall Study|1 discontinued before starting drug|1|||
124676146|NCT01603602|448439583|FG000|Overall Study|Adverse Event|1|||
124676147|NCT01603602|448439584|FG001|Overall Study|Adverse Event|0|||
124676148|NCT01603602|448439585|FG002|Overall Study|Adverse Event|0|||
124676149|NCT01603602|448439583|FG000|Overall Study|Personal Reasons|1|||
124676150|NCT01603602|448439584|FG001|Overall Study|Personal Reasons|0|||
124676151|NCT01603602|448439585|FG002|Overall Study|Personal Reasons|1|||
124676152|NCT04748718|448439589|FG000|Overall Study|Lost to Follow-up|50|||
124676153|NCT01935089|448439590|FG000|Overall Study|Adverse Event|2|||
124676154|NCT01935089|448439590|FG000|Overall Study|Withdrawal by Subject|1|||
124676155|NCT00723229|448439591|FG000|First Intervention|Lost to Follow-up|7|||
124676156|NCT00723229|448439592|FG001|First Intervention|Lost to Follow-up|3|||
124676157|NCT02337491|448439593|FG000|Overall Study|Death|1|||
124676158|NCT02337491|448439594|FG001|Overall Study|Death|1|||
124676159|NCT02337491|448439593|FG000|Overall Study|Adverse Event|0|||
124676160|NCT02337491|448439594|FG001|Overall Study|Adverse Event|1|||
124676161|NCT02337491|448439593|FG000|Overall Study|Withdrawal by Subject|3|||
124676162|NCT02337491|448439594|FG001|Overall Study|Withdrawal by Subject|0|||
124676163|NCT02337491|448439593|FG000|Overall Study|Progressive Disease|44|||
124676164|NCT02337491|448439594|FG001|Overall Study|Progressive Disease|28|||
124676165|NCT02337491|448439593|FG000|Overall Study|On Treatment|2|||
124676166|NCT02337491|448439594|FG001|Overall Study|On Treatment|0|||
124676167|NCT03530293|448439599|FG000|Pre-randomization|Adverse Event|12|||
124676168|NCT03530293|448439600|FG001|Pre-randomization|Adverse Event|0|||
124676169|NCT03530293|448439601|FG002|Pre-randomization|Adverse Event|0|||
124676170|NCT03530293|448439599|FG000|Pre-randomization|Protocol Violation|2|||
124676171|NCT03530293|448439600|FG001|Pre-randomization|Protocol Violation|0|||
124676172|NCT03530293|448439601|FG002|Pre-randomization|Protocol Violation|0|||
124676173|NCT03530293|448439599|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
124676174|NCT03530293|448439600|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
124676175|NCT03530293|448439601|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
124676176|NCT03530293|448439599|FG000|Pre-randomization|Withdrawal by Subject|5|||
124676177|NCT03530293|448439600|FG001|Pre-randomization|Withdrawal by Subject|0|||
124676178|NCT03530293|448439601|FG002|Pre-randomization|Withdrawal by Subject|0|||
124676179|NCT03530293|448439599|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
124676180|NCT03530293|448439600|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
124676181|NCT03530293|448439601|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
124676182|NCT03530293|448439599|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
124676183|NCT03530293|448439600|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
124676184|NCT03530293|448439601|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
124676185|NCT03530293|448439599|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
124676186|NCT03530293|448439600|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
124676187|NCT03530293|448439601|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
124676188|NCT03530293|448439599|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
124676189|NCT03530293|448439600|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
124676190|NCT03530293|448439601|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
124676191|NCT03530293|448439599|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
124676192|NCT03530293|448439600|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
124676193|NCT03530293|448439601|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
124676194|NCT01668797|448439602|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
124676195|NCT01668797|448439603|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
124676196|NCT01668797|448439604|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
124431052|NCT03527550|447538747|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
124431053|NCT03527550|447538748|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
124431054|NCT01097707|447538749|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
124431055|NCT01097707|447538750|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
124431056|NCT01097707|447538751|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
124431057|NCT01097707|447538752|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
124431058|NCT01097707|447538753|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
124431059|NCT01097707|447538749|FG000|Overall Study|Adverse Event|4|||
124676197|NCT01668797|448439605|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
124676198|NCT01668797|448439602|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
124676199|NCT01668797|448439603|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
124676200|NCT01668797|448439604|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
124676201|NCT01668797|448439605|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
124676202|NCT01668797|448439602|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
124676203|NCT01668797|448439603|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
124676204|NCT01668797|448439604|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
124676205|NCT01668797|448439605|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
124676206|NCT01668797|448439602|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
124676207|NCT01668797|448439603|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
124676208|NCT01668797|448439604|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
124676209|NCT01668797|448439605|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
124676210|NCT01668797|448439602|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
124431060|NCT01097707|447538750|FG001|Overall Study|Adverse Event|2|||
124431061|NCT01097707|447538751|FG002|Overall Study|Adverse Event|3|||
124676211|NCT01668797|448439603|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
124676212|NCT01668797|448439604|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
124676213|NCT01668797|448439605|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
124676214|NCT01668797|448439602|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
124676215|NCT01668797|448439603|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
124676216|NCT01668797|448439604|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
124431062|NCT01097707|447538752|FG003|Overall Study|Adverse Event|1|||
124431063|NCT01097707|447538753|FG004|Overall Study|Adverse Event|3|||
124676217|NCT01668797|448439605|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
124676218|NCT01668797|448439602|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
124676219|NCT01668797|448439603|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
124676220|NCT01668797|448439604|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
124676221|NCT01668797|448439605|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
124431064|NCT01097707|447538749|FG000|Overall Study|Entry Criteria Not Met|2|||
124431065|NCT01097707|447538750|FG001|Overall Study|Entry Criteria Not Met|1|||
124431066|NCT01097707|447538751|FG002|Overall Study|Entry Criteria Not Met|1|||
124431067|NCT01097707|447538752|FG003|Overall Study|Entry Criteria Not Met|0|||
124676222|NCT01668797|448439602|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
124676223|NCT01668797|448439603|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
124676224|NCT01668797|448439604|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
124676225|NCT01668797|448439605|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
124676226|NCT01668797|448439602|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
124676227|NCT01668797|448439603|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
124676228|NCT01668797|448439604|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
124676229|NCT01668797|448439605|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
124676230|NCT01668797|448439602|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
124676231|NCT01668797|448439603|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
124676232|NCT01668797|448439604|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
124676233|NCT01668797|448439605|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
124676234|NCT01668797|448439602|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
124676235|NCT01668797|448439603|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
124676236|NCT01668797|448439604|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
124676237|NCT01668797|448439605|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
124676238|NCT01668797|448439602|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
124676239|NCT01668797|448439603|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
124676240|NCT01668797|448439604|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
124676241|NCT01668797|448439605|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
124676242|NCT01668797|448439602|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
124676243|NCT01668797|448439603|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
124676244|NCT01668797|448439604|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
124676245|NCT01668797|448439605|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
124676246|NCT01668797|448439602|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
124676247|NCT01668797|448439603|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
124676248|NCT01668797|448439604|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
124676249|NCT01668797|448439605|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
124676250|NCT01668797|448439602|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
124676251|NCT01668797|448439603|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
124676252|NCT01668797|448439604|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
124676253|NCT01668797|448439605|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
124676254|NCT01668797|448439602|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
124676255|NCT01668797|448439603|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
124676256|NCT01668797|448439604|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
124676257|NCT01668797|448439605|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
124431068|NCT01097707|447538753|FG004|Overall Study|Entry Criteria Not Met|1|||
124431069|NCT01097707|447538749|FG000|Overall Study|Lack of Efficacy|1|||
124431070|NCT01097707|447538750|FG001|Overall Study|Lack of Efficacy|0|||
124431071|NCT01097707|447538751|FG002|Overall Study|Lack of Efficacy|0|||
124431072|NCT01097707|447538752|FG003|Overall Study|Lack of Efficacy|1|||
124431073|NCT01097707|447538753|FG004|Overall Study|Lack of Efficacy|0|||
124431074|NCT01097707|447538749|FG000|Overall Study|Lost to Follow-up|1|||
124431075|NCT01097707|447538750|FG001|Overall Study|Lost to Follow-up|1|||
124431076|NCT01097707|447538751|FG002|Overall Study|Lost to Follow-up|2|||
124431077|NCT01097707|447538752|FG003|Overall Study|Lost to Follow-up|0|||
124431078|NCT01097707|447538753|FG004|Overall Study|Lost to Follow-up|3|||
124431079|NCT01097707|447538749|FG000|Overall Study|Protocol Violation|2|||
124431080|NCT01097707|447538750|FG001|Overall Study|Protocol Violation|2|||
124431081|NCT01097707|447538751|FG002|Overall Study|Protocol Violation|3|||
124431082|NCT01097707|447538752|FG003|Overall Study|Protocol Violation|2|||
124431083|NCT01097707|447538753|FG004|Overall Study|Protocol Violation|2|||
124431084|NCT01097707|447538749|FG000|Overall Study|Sponsor Decision|31|||
124431085|NCT01097707|447538750|FG001|Overall Study|Sponsor Decision|31|||
124431086|NCT01097707|447538751|FG002|Overall Study|Sponsor Decision|34|||
124431087|NCT01097707|447538752|FG003|Overall Study|Sponsor Decision|35|||
124431088|NCT01097707|447538753|FG004|Overall Study|Sponsor Decision|36|||
124431089|NCT01097707|447538749|FG000|Overall Study|Withdrawal by Subject|3|||
124431090|NCT01097707|447538750|FG001|Overall Study|Withdrawal by Subject|6|||
124431091|NCT01097707|447538751|FG002|Overall Study|Withdrawal by Subject|1|||
124431092|NCT01097707|447538752|FG003|Overall Study|Withdrawal by Subject|4|||
124431093|NCT01097707|447538753|FG004|Overall Study|Withdrawal by Subject|3|||
124431094|NCT01097707|447538749|FG000|Overall Study|Reason unknown|0|||
124431095|NCT01097707|447538750|FG001|Overall Study|Reason unknown|0|||
124431096|NCT01097707|447538751|FG002|Overall Study|Reason unknown|0|||
124431097|NCT01097707|447538752|FG003|Overall Study|Reason unknown|0|||
124431098|NCT01097707|447538753|FG004|Overall Study|Reason unknown|1|||
124431099|NCT01498679|447538755|FG000|Overall Study|Adverse Event|1|||
124431100|NCT01498679|447538756|FG001|Overall Study|Adverse Event|4|||
124431101|NCT01498679|447538755|FG000|Overall Study|Lack of Efficacy|72|||
124431102|NCT01498679|447538756|FG001|Overall Study|Lack of Efficacy|12|||
124431103|NCT01498679|447538755|FG000|Overall Study|Protocol Violation|4|||
124431104|NCT01498679|447538756|FG001|Overall Study|Protocol Violation|0|||
124431105|NCT01498679|447538755|FG000|Overall Study|Physician Decision|0|||
124431106|NCT01498679|447538756|FG001|Overall Study|Physician Decision|2|||
124431107|NCT01498679|447538755|FG000|Overall Study|Withdrawal by Subject|12|||
124431108|NCT01498679|447538756|FG001|Overall Study|Withdrawal by Subject|4|||
124431109|NCT00700427|447538757|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
124431110|NCT00700427|447538758|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
124431111|NCT00700427|447538759|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
124431112|NCT00700427|447538760|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
124431113|NCT00700427|447538761|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
124431114|NCT00700427|447538757|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
124431115|NCT00700427|447538758|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
124431116|NCT00700427|447538759|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
124431117|NCT00700427|447538760|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
124431118|NCT00700427|447538761|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
124431119|NCT00700427|447538757|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
124431120|NCT00700427|447538758|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
124431121|NCT00700427|447538759|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
124431122|NCT00700427|447538760|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
124431123|NCT00700427|447538761|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
124431124|NCT00700427|447538757|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
124431125|NCT00700427|447538758|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
124431126|NCT00700427|447538759|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
124431127|NCT00700427|447538760|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
124431128|NCT00700427|447538761|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
124431129|NCT00700427|447538757|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
124431130|NCT00700427|447538758|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
124431131|NCT00700427|447538759|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
124431132|NCT00700427|447538760|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
124431133|NCT00700427|447538761|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
124431134|NCT00700427|447538757|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
124431135|NCT00700427|447538758|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
124431136|NCT00700427|447538759|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
124431137|NCT00700427|447538760|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
124431138|NCT00700427|447538761|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
124431139|NCT00700427|447538757|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
124431140|NCT00700427|447538758|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
124431141|NCT00700427|447538759|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
124431142|NCT00700427|447538760|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
124431143|NCT00700427|447538761|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
124431144|NCT00700427|447538757|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
124431145|NCT00700427|447538758|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
124431146|NCT00700427|447538759|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
124431147|NCT00700427|447538760|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
124431148|NCT00700427|447538761|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
124431149|NCT00700427|447538757|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
124431150|NCT00700427|447538758|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
124431151|NCT00700427|447538759|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
124431152|NCT00700427|447538760|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
124431153|NCT00700427|447538761|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
124431154|NCT00700427|447538757|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
124431155|NCT00700427|447538758|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
124431156|NCT00700427|447538759|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
124431157|NCT00700427|447538760|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
124431158|NCT00700427|447538761|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
124431159|NCT00700427|447538757|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
124431160|NCT00700427|447538758|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
124431161|NCT00700427|447538759|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
124431162|NCT00700427|447538760|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
124431163|NCT00700427|447538761|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
124431164|NCT00700427|447538757|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
124431165|NCT00700427|447538758|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
124431166|NCT00700427|447538759|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
124431167|NCT00700427|447538760|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
124431168|NCT00700427|447538761|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
124431169|NCT00700427|447538757|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
124431170|NCT00700427|447538758|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
124431171|NCT00700427|447538759|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
124431172|NCT00700427|447538760|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
124431173|NCT00700427|447538761|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
124431174|NCT00700427|447538757|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
124431175|NCT00700427|447538758|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
124431176|NCT00700427|447538759|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
124431177|NCT00700427|447538760|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
124431178|NCT00700427|447538761|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
124431179|NCT00700427|447538757|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
124431180|NCT00700427|447538758|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
124431181|NCT00700427|447538759|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
124431182|NCT00700427|447538760|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
124431183|NCT00700427|447538761|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
124431184|NCT00700427|447538757|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
124431185|NCT00700427|447538758|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
124431186|NCT00700427|447538759|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
124431187|NCT00700427|447538760|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
124676258|NCT01668797|448439602|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
124676259|NCT01668797|448439603|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
124676260|NCT01668797|448439604|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
124676261|NCT01668797|448439605|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
124676262|NCT01668797|448439602|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
124676263|NCT01668797|448439603|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
124676264|NCT01668797|448439604|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
124676265|NCT01668797|448439605|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
124676266|NCT01668797|448439602|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
124676267|NCT01668797|448439603|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
124676268|NCT01668797|448439604|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
124676269|NCT01668797|448439605|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
124676270|NCT01668797|448439602|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
124676271|NCT01668797|448439603|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
124676272|NCT01668797|448439604|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
124431188|NCT00700427|447538761|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
124431189|NCT00700427|447538757|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
124431190|NCT00700427|447538758|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
124431191|NCT00700427|447538759|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
124431192|NCT00700427|447538760|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
124431193|NCT00700427|447538761|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
124431194|NCT00700427|447538757|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
124431195|NCT00700427|447538758|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
124431196|NCT00700427|447538759|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
124431197|NCT00700427|447538760|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
124431198|NCT00700427|447538761|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
124431199|NCT00700427|447538757|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
124431200|NCT00700427|447538758|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
124431201|NCT00700427|447538759|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
124431202|NCT00700427|447538760|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
124431203|NCT00700427|447538761|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
124431204|NCT00700427|447538757|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
124431205|NCT00700427|447538758|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
124431206|NCT00700427|447538759|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
124431207|NCT00700427|447538760|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
124431208|NCT00700427|447538761|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
124431209|NCT00700427|447538757|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
124431210|NCT00700427|447538758|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
124431211|NCT00700427|447538759|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
124431212|NCT00700427|447538760|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
124431213|NCT00700427|447538761|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
124431214|NCT00700427|447538757|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
124431215|NCT00700427|447538758|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
124431216|NCT00700427|447538759|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
124431217|NCT00700427|447538760|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
124431218|NCT00700427|447538761|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
124431219|NCT00700427|447538757|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
124431220|NCT00700427|447538758|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
124431221|NCT00700427|447538759|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
124431222|NCT00700427|447538760|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
124431223|NCT00700427|447538761|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
124431224|NCT00700427|447538757|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
124431225|NCT00700427|447538758|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
124431226|NCT00700427|447538759|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
124431227|NCT00700427|447538760|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
124431228|NCT00700427|447538761|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
124431229|NCT00700427|447538757|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
124431230|NCT00700427|447538758|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
124431231|NCT00700427|447538759|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
124431232|NCT00700427|447538760|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
124431233|NCT00700427|447538761|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
124431234|NCT00700427|447538757|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
124431235|NCT00700427|447538758|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
124431236|NCT00700427|447538759|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
124431237|NCT00700427|447538760|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
124431238|NCT00700427|447538761|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
124431239|NCT00700427|447538757|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
124431240|NCT00700427|447538758|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
124431241|NCT00700427|447538759|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
124431242|NCT00700427|447538760|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
124431243|NCT00700427|447538761|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
124431244|NCT00700427|447538757|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
124431245|NCT00700427|447538758|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
124431246|NCT00700427|447538759|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
124431247|NCT00700427|447538760|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
124431248|NCT00700427|447538761|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
124431249|NCT00700427|447538757|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
124676273|NCT01668797|448439605|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
124676274|NCT01668797|448439602|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
124676275|NCT01668797|448439603|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
124676276|NCT01668797|448439604|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
124676277|NCT01668797|448439605|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
124676278|NCT01668797|448439602|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
124676279|NCT01668797|448439603|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
124676280|NCT01668797|448439604|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
124676281|NCT01668797|448439605|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
124676282|NCT01668797|448439602|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
124676283|NCT01668797|448439603|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
124676284|NCT01668797|448439604|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
124676285|NCT01668797|448439605|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
124676286|NCT01668797|448439602|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
124676287|NCT01668797|448439603|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
124676288|NCT01668797|448439604|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
124676289|NCT01668797|448439605|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
124676290|NCT01668797|448439602|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
124676291|NCT01668797|448439603|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
124676292|NCT01668797|448439604|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
124676293|NCT01668797|448439605|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
124676294|NCT02530385|448439606|FG000|Overall Study|Withdrawal by Subject|0|||
124676295|NCT02530385|448439607|FG001|Overall Study|Withdrawal by Subject|1|||
124676296|NCT01569022|448439609|FG000|First Intervention|Lost to Follow-up|2|||
124676297|NCT01569022|448439610|FG001|First Intervention|Lost to Follow-up|1|||
124676298|NCT01569022|448439609|FG000|Second Intervention|Lost to Follow-up|2|||
124676299|NCT01569022|448439610|FG001|Second Intervention|Lost to Follow-up|2|||
124676300|NCT00433836|448439615|FG000|Overall Study|Adverse Event|7|||
124676301|NCT00433836|448439616|FG001|Overall Study|Adverse Event|0|||
124676302|NCT00433836|448439615|FG000|Overall Study|Lost to Follow-up|3|||
124676303|NCT00433836|448439616|FG001|Overall Study|Lost to Follow-up|0|||
124676304|NCT00433836|448439615|FG000|Overall Study|Withdrawal by Subject|2|||
124676305|NCT00433836|448439616|FG001|Overall Study|Withdrawal by Subject|1|||
124676306|NCT00433836|448439615|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124676307|NCT00433836|448439616|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124676308|NCT00433836|448439615|FG000|Overall Study|Protocol Violation|0|||
124676309|NCT00433836|448439616|FG001|Overall Study|Protocol Violation|2|||
124676310|NCT00433836|448439615|FG000|Overall Study|Condition no longer requires study drug|0|||
124676311|NCT00433836|448439616|FG001|Overall Study|Condition no longer requires study drug|1|||
124676312|NCT00433836|448439615|FG000|Overall Study|Abnormal laboratory values|0|||
124676313|NCT00433836|448439616|FG001|Overall Study|Abnormal laboratory values|1|||
124676314|NCT02446691|448439617|FG000|Overall Study|Withdrawal by Subject|2|||
124676315|NCT02446691|448439617|FG000|Overall Study|Lost to Follow-up|8|||
124676316|NCT02446691|448439617|FG000|Overall Study|Protocol Violation|1|||
124676317|NCT00472420|448439618|FG000|Induction Treatment Period|Physician Decision|9|||
124676318|NCT00472420|448439618|FG000|Induction Treatment Period|Adverse Event|3|||
124676319|NCT00472420|448439618|FG000|Induction Treatment Period|Non-compliance|1|||
124676320|NCT00472420|448439618|FG000|Induction Treatment Period|Death|3|||
124676321|NCT00472420|448439618|FG000|Follow-up Period|Death|5|||
124676322|NCT00472420|448439618|FG000|Follow-up Period|Physician Decision|9|||
124676323|NCT00472420|448439618|FG000|Follow-up Period|Lost to Follow-up|2|||
124676324|NCT00472420|448439618|FG000|Follow-up Period|Protocol Violation|1|||
124676325|NCT00686972|448439619|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
124676326|NCT01026493|448439622|FG000|Overall Study|Protocol Violation|0|||
124676327|NCT01026493|448439623|FG001|Overall Study|Protocol Violation|1|||
124676328|NCT01026493|448439624|FG002|Overall Study|Protocol Violation|0|||
124676329|NCT01026493|448439625|FG003|Overall Study|Protocol Violation|0|||
124431250|NCT00700427|447538758|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
124431251|NCT00700427|447538759|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
124431252|NCT00700427|447538760|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
124676330|NCT01026493|448439626|FG004|Overall Study|Protocol Violation|2|||
124676331|NCT01026493|448439627|FG005|Overall Study|Protocol Violation|3|||
124676332|NCT01026493|448439628|FG006|Overall Study|Protocol Violation|4|||
124676333|NCT01026493|448439629|FG007|Overall Study|Protocol Violation|1|||
124431253|NCT00700427|447538761|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
124431254|NCT00700427|447538757|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
124431255|NCT00700427|447538758|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
124431256|NCT00700427|447538759|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
124431257|NCT00700427|447538760|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
124431258|NCT00700427|447538761|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
124431259|NCT00700427|447538757|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
124431260|NCT00700427|447538758|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
124431261|NCT00700427|447538759|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
124431262|NCT00700427|447538760|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
124431263|NCT00700427|447538761|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
124431264|NCT00700427|447538757|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
124431265|NCT00700427|447538758|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
124431266|NCT00700427|447538759|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
124431267|NCT00700427|447538760|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
124431268|NCT00700427|447538761|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
124431269|NCT00700427|447538757|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
124431270|NCT00700427|447538758|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
124431271|NCT00700427|447538759|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
124676334|NCT02674516|448439630|FG000|Overall Study|Lost to Follow-up|3|||
124676335|NCT02674516|448439631|FG001|Overall Study|Lost to Follow-up|0|||
124676336|NCT02674516|448439630|FG000|Overall Study|Protocol Violation|0|||
124676337|NCT02674516|448439631|FG001|Overall Study|Protocol Violation|4|||
124676338|NCT02674516|448439630|FG000|Overall Study|Knowledge of study hypothesis|1|||
124676339|NCT02674516|448439631|FG001|Overall Study|Knowledge of study hypothesis|0|||
124676340|NCT02295644|448439633|FG000|Overall Study|Did not meet inclusion criterion|0|||
124676341|NCT02295644|448439634|FG001|Overall Study|Did not meet inclusion criterion|0|||
124676342|NCT02295644|448439635|FG002|Overall Study|Did not meet inclusion criterion|1|||
124676343|NCT02295644|448439636|FG003|Overall Study|Did not meet inclusion criterion|2|||
124676344|NCT00572832|448439639|FG000|Overall Study|Lost to Follow-up|0|||
124676345|NCT00572832|448439640|FG001|Overall Study|Lost to Follow-up|11|||
124676346|NCT00572832|448439639|FG000|Overall Study|Pregnancy|0|||
124676347|NCT00572832|448439640|FG001|Overall Study|Pregnancy|1|||
124676348|NCT00324155|448439646|FG000|Enrolled and Randomized|No longer met study criteria|3|||
124676349|NCT00324155|448439647|FG001|Enrolled and Randomized|No longer met study criteria|0|||
124676350|NCT00324155|448439646|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
124676351|NCT00324155|448439647|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
124676352|NCT00324155|448439646|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
124676353|NCT00324155|448439647|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
124676354|NCT00324155|448439646|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
124676355|NCT00324155|448439647|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
124676356|NCT00324155|448439646|FG000|Received Treatment in Induction Phase|Death|8|||
124676357|NCT00324155|448439647|FG001|Received Treatment in Induction Phase|Death|15|||
124676358|NCT00324155|448439646|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
124676359|NCT00324155|448439647|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
124676360|NCT00324155|448439646|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
124676361|NCT00324155|448439647|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
124676362|NCT00324155|448439646|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
124676363|NCT00324155|448439647|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
124676364|NCT00324155|448439646|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
124431272|NCT00700427|447538760|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
124431273|NCT00700427|447538761|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
124431274|NCT00700427|447538757|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
124431275|NCT00700427|447538758|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
124431276|NCT00700427|447538759|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
124431277|NCT00700427|447538760|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
124431278|NCT00700427|447538761|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
124431279|NCT00700427|447538757|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
124431280|NCT00700427|447538758|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
124431281|NCT00700427|447538759|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
124431282|NCT00700427|447538760|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
124431283|NCT00700427|447538761|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
124431284|NCT00700427|447538757|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
124431285|NCT00700427|447538758|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
124431286|NCT00700427|447538759|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
124431287|NCT00700427|447538760|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
124431288|NCT00700427|447538761|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
124431289|NCT00700427|447538757|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
124676365|NCT00324155|448439647|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
124676366|NCT00324155|448439646|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
124431290|NCT00700427|447538758|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
124431291|NCT00700427|447538759|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
124431292|NCT00700427|447538760|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
124431293|NCT00700427|447538761|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
124431294|NCT00700427|447538757|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
124431295|NCT00700427|447538758|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
124431296|NCT00700427|447538759|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
124431297|NCT00700427|447538760|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
124431298|NCT00700427|447538761|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
124431299|NCT03212989|447538763|FG000|Overall Study|Physician Decision|8|||
124431300|NCT01801735|447538766|FG000|Overall Study|Adverse Event|79|||
124431301|NCT01801735|447538766|FG000|Overall Study|Lack of Efficacy|28|||
124431302|NCT01801735|447538766|FG000|Overall Study|Withdrawal by Subject|27|||
124676367|NCT00324155|448439647|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
124676368|NCT00324155|448439646|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
124676369|NCT00324155|448439647|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
124676370|NCT00324155|448439646|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
124676371|NCT00324155|448439647|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
124676372|NCT00324155|448439646|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
124676373|NCT00324155|448439647|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
124676374|NCT00324155|448439646|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
124676375|NCT00324155|448439647|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
124676376|NCT00324155|448439646|FG000|Follow-up Phase|On-going participants still on drug|11|||
124676377|NCT00324155|448439647|FG001|Follow-up Phase|On-going participants still on drug|6|||
124676378|NCT03307174|448439648|FG000|Overall Study|Unplanned ICU Administrion|5|||
124676379|NCT03307174|448439649|FG001|Overall Study|Unplanned ICU Administrion|3|||
124676380|NCT03307174|448439648|FG000|Overall Study|Aborted Surgery|1|||
124676381|NCT03307174|448439649|FG001|Overall Study|Aborted Surgery|2|||
124676382|NCT03307174|448439648|FG000|Overall Study|Hypotension|6|||
124676383|NCT03307174|448439649|FG001|Overall Study|Hypotension|0|||
124676384|NCT03307174|448439648|FG000|Overall Study|Nonfunctional epidural|1|||
124676385|NCT03307174|448439649|FG001|Overall Study|Nonfunctional epidural|1|||
124676386|NCT03307174|448439648|FG000|Overall Study|Planned epidural removal|1|||
124676387|NCT03307174|448439649|FG001|Overall Study|Planned epidural removal|0|||
124676388|NCT03307174|448439648|FG000|Overall Study|Intrathecal catheter placement|0|||
124676389|NCT03307174|448439649|FG001|Overall Study|Intrathecal catheter placement|1|||
124676390|NCT03444584|448439650|FG000|Overall Study|Withdrawal by Subject|0|||
124676391|NCT03444584|448439651|FG001|Overall Study|Withdrawal by Subject|1|||
124676392|NCT03444584|448439650|FG000|Overall Study|Other|0|||
124676393|NCT03444584|448439651|FG001|Overall Study|Other|1|||
124676394|NCT00846053|448439654|FG000|Overall Study|Physician Decision|3|||
124676395|NCT00846053|448439655|FG001|Overall Study|Physician Decision|0|||
124676396|NCT00111761|448439656|FG000|Part 1|Physician Decision|0|||
124676397|NCT00111761|448439657|FG001|Part 1|Physician Decision|1|||
124676398|NCT00111761|448439656|FG000|Part 1|Death|0|||
124676399|NCT00111761|448439657|FG001|Part 1|Death|2|||
124676400|NCT00111761|448439656|FG000|Part 1|Other|0|||
124676401|NCT00111761|448439657|FG001|Part 1|Other|1|||
124676402|NCT00111761|448439656|FG000|Part 1|Withdrawal by Subject|0|||
124431303|NCT01801735|447538766|FG000|Overall Study|Protocol Violation|25|||
124431304|NCT01801735|447538766|FG000|Overall Study|Lost to Follow-up|15|||
124431305|NCT01801735|447538766|FG000|Overall Study|Non-compliance with Trial Drug|13|||
124431306|NCT01801735|447538766|FG000|Overall Study|Physician Decision|3|||
124431307|NCT01801735|447538766|FG000|Overall Study|Death|1|||
124431308|NCT01801735|447538766|FG000|Overall Study|Other, including site closure|19|||
124676403|NCT00111761|448439657|FG001|Part 1|Withdrawal by Subject|1|||
124676404|NCT00111761|448439656|FG000|Part 2|Adverse Event|1|||
124676405|NCT00111761|448439657|FG001|Part 2|Adverse Event|0|||
124676406|NCT00111761|448439656|FG000|Part 2|Physician Decision|1|||
124676407|NCT00111761|448439657|FG001|Part 2|Physician Decision|0|||
124676408|NCT00111761|448439656|FG000|Part 2|Death|1|||
124431309|NCT00620282|447538767|FG000|Overall Study|Adverse Event|0|||
124431310|NCT00620282|447538768|FG001|Overall Study|Adverse Event|1|||
124431311|NCT00620282|447538769|FG002|Overall Study|Adverse Event|0|||
124431312|NCT00620282|447538767|FG000|Overall Study|Arterial line unable to be placed|0|||
124431313|NCT00620282|447538768|FG001|Overall Study|Arterial line unable to be placed|0|||
124431314|NCT00620282|447538769|FG002|Overall Study|Arterial line unable to be placed|1|||
124431315|NCT00620282|447538767|FG000|Overall Study|Withdrawal by Subject|0|||
124431316|NCT00620282|447538768|FG001|Overall Study|Withdrawal by Subject|1|||
124431317|NCT00620282|447538769|FG002|Overall Study|Withdrawal by Subject|0|||
124676409|NCT00111761|448439657|FG001|Part 2|Death|0|||
124431318|NCT01258595|447538770|FG000|Overall Study|Lost to Follow-up|1|||
124431319|NCT01258595|447538771|FG001|Overall Study|Lost to Follow-up|0|||
124431320|NCT01258595|447538770|FG000|Overall Study|Withdrawal by Subject|0|||
124676410|NCT00111761|448439656|FG000|Part 2|Disease progression|3|||
124676411|NCT00111761|448439657|FG001|Part 2|Disease progression|0|||
124676412|NCT00111761|448439656|FG000|Part 2|Protocol-specified criteria|1|||
124431321|NCT01258595|447538771|FG001|Overall Study|Withdrawal by Subject|1|||
124431322|NCT01820585|447538772|FG000|Overall Study|Adverse Event|9|||
124431323|NCT01820585|447538773|FG001|Overall Study|Adverse Event|13|||
124431324|NCT01820585|447538774|FG002|Overall Study|Adverse Event|23|||
124431325|NCT01820585|447538775|FG003|Overall Study|Adverse Event|34|||
124431326|NCT01820585|447538772|FG000|Overall Study|Lack of Efficacy|9|||
124431327|NCT01820585|447538773|FG001|Overall Study|Lack of Efficacy|7|||
124431328|NCT01820585|447538774|FG002|Overall Study|Lack of Efficacy|5|||
124431329|NCT01820585|447538775|FG003|Overall Study|Lack of Efficacy|1|||
124431330|NCT01820585|447538772|FG000|Overall Study|Withdrawal by Subject|3|||
124431331|NCT01820585|447538773|FG001|Overall Study|Withdrawal by Subject|7|||
124431332|NCT01820585|447538774|FG002|Overall Study|Withdrawal by Subject|3|||
124431333|NCT01820585|447538775|FG003|Overall Study|Withdrawal by Subject|8|||
124431334|NCT01820585|447538772|FG000|Overall Study|Lost to Follow-up|3|||
124431335|NCT01820585|447538773|FG001|Overall Study|Lost to Follow-up|3|||
124431336|NCT01820585|447538774|FG002|Overall Study|Lost to Follow-up|0|||
124431337|NCT01820585|447538775|FG003|Overall Study|Lost to Follow-up|3|||
124431338|NCT01820585|447538772|FG000|Overall Study|Protocol Violation|3|||
124431339|NCT01820585|447538773|FG001|Overall Study|Protocol Violation|1|||
124431340|NCT01820585|447538774|FG002|Overall Study|Protocol Violation|1|||
124431341|NCT01820585|447538775|FG003|Overall Study|Protocol Violation|1|||
124431342|NCT01820585|447538772|FG000|Overall Study|Subject non-compliance|0|||
124431343|NCT01820585|447538773|FG001|Overall Study|Subject non-compliance|0|||
124431344|NCT01820585|447538774|FG002|Overall Study|Subject non-compliance|1|||
124431345|NCT01820585|447538775|FG003|Overall Study|Subject non-compliance|2|||
124431346|NCT01820585|447538772|FG000|Overall Study|at sponsor request|0|||
124431347|NCT01820585|447538773|FG001|Overall Study|at sponsor request|0|||
124431348|NCT01820585|447538774|FG002|Overall Study|at sponsor request|1|||
124431349|NCT01820585|447538775|FG003|Overall Study|at sponsor request|0|||
124431350|NCT01820585|447538772|FG000|Overall Study|Pregnancy|0|||
124431351|NCT01820585|447538773|FG001|Overall Study|Pregnancy|1|||
124431352|NCT01820585|447538774|FG002|Overall Study|Pregnancy|0|||
124431353|NCT01820585|447538775|FG003|Overall Study|Pregnancy|0|||
124431354|NCT00548262|447538776|FG000|Overall Study|Death|21|||
124431355|NCT00548262|447538776|FG000|Overall Study|Adverse Event|2|||
124431356|NCT00548262|447538776|FG000|Overall Study|Lack of Efficacy|4|||
124431357|NCT00548262|447538776|FG000|Overall Study|Lost to Follow-up|1|||
124431358|NCT00548262|447538776|FG000|Overall Study|Other|3|||
124431359|NCT00548262|447538776|FG000|Overall Study|Withdrawal by Subject|1|||
124431360|NCT01712659|447538777|FG000|Dose Escalation|Physician Decision|0|||
124431361|NCT01712659|447538778|FG001|Dose Escalation|Physician Decision|1|||
124431362|NCT01712659|447538779|FG002|Dose Escalation|Physician Decision|0|||
124431363|NCT01712659|447538780|FG003|Dose Escalation|Physician Decision|0|||
124431364|NCT01712659|447538781|FG004|Dose Escalation|Physician Decision|0|||
124431365|NCT01712659|447538777|FG000|Dose Escalation|Unable to take study drug|0|||
124431366|NCT01712659|447538778|FG001|Dose Escalation|Unable to take study drug|1|||
124431367|NCT01712659|447538779|FG002|Dose Escalation|Unable to take study drug|0|||
124431368|NCT01712659|447538780|FG003|Dose Escalation|Unable to take study drug|0|||
124431369|NCT01712659|447538781|FG004|Dose Escalation|Unable to take study drug|0|||
124431370|NCT01712659|447538777|FG000|Dose Expansion|Early disease progression|1|||
124431371|NCT01712659|447538778|FG001|Dose Expansion|Early disease progression|0|||
124431372|NCT01712659|447538779|FG002|Dose Expansion|Early disease progression|0|||
124431373|NCT01712659|447538780|FG003|Dose Expansion|Early disease progression|0|||
124431374|NCT01712659|447538781|FG004|Dose Expansion|Early disease progression|0|||
124431375|NCT01712659|447538777|FG000|Dose Expansion|Physician Decision|1|||
124431376|NCT01712659|447538778|FG001|Dose Expansion|Physician Decision|0|||
124431377|NCT01712659|447538779|FG002|Dose Expansion|Physician Decision|0|||
124431378|NCT01712659|447538780|FG003|Dose Expansion|Physician Decision|0|||
124431379|NCT01712659|447538781|FG004|Dose Expansion|Physician Decision|0|||
124431380|NCT00844532|447538785|FG000|Overall Study|Death|16|||
124676413|NCT00111761|448439657|FG001|Part 2|Protocol-specified criteria|0|||
124676414|NCT00111761|448439656|FG000|Part 2|Other|1|||
124676415|NCT00111761|448439657|FG001|Part 2|Other|0|||
124676416|NCT00746551|448439658|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
124676417|NCT00746551|448439659|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
124676418|NCT00746551|448439658|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
124431381|NCT00844532|447538785|FG000|Overall Study|Withdrawal by Subject|16|||
124431382|NCT00844532|447538785|FG000|Overall Study|Lost to Follow-up|7|||
124431383|NCT03189745|447538786|FG000|Overall Study|Conflict in work schedule of participant|1|||
124431384|NCT03189745|447538787|FG001|Overall Study|Conflict in work schedule of participant|1|||
124431385|NCT00895154|447538788|FG000|Overall Study|Lost to Follow-up|1|||
124431386|NCT00895154|447538789|FG001|Overall Study|Lost to Follow-up|1|||
124431387|NCT00895154|447538788|FG000|Overall Study|Withdrawal by Subject|0|||
124431388|NCT00895154|447538789|FG001|Overall Study|Withdrawal by Subject|1|||
124431389|NCT02729831|447538790|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
124676419|NCT00746551|448439659|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
124676420|NCT00746551|448439658|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
124431390|NCT02729831|447538791|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
124676421|NCT00746551|448439659|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
124676422|NCT00171249|448439662|FG000|Overall Study|Withdrawal by Subject|2|||
124676423|NCT00171249|448439663|FG001|Overall Study|Withdrawal by Subject|0|||
124676424|NCT00171249|448439664|FG002|Overall Study|Withdrawal by Subject|0|||
124676425|NCT00171249|448439665|FG003|Overall Study|Withdrawal by Subject|6|||
124676426|NCT00171249|448439666|FG004|Overall Study|Withdrawal by Subject|0|||
124676427|NCT00171249|448439667|FG005|Overall Study|Withdrawal by Subject|0|||
124676428|NCT00171249|448439668|FG006|Overall Study|Withdrawal by Subject|0|||
124676429|NCT00171249|448439662|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
124676430|NCT00171249|448439663|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
124676431|NCT00171249|448439664|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
124676432|NCT00171249|448439665|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
124676433|NCT00171249|448439666|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
124676434|NCT00171249|448439667|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
124676435|NCT00171249|448439668|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
124676436|NCT00171249|448439662|FG000|Overall Study|Death|7|||
124676437|NCT00171249|448439663|FG001|Overall Study|Death|1|||
124676438|NCT00171249|448439664|FG002|Overall Study|Death|0|||
124676439|NCT00171249|448439665|FG003|Overall Study|Death|4|||
124676440|NCT00171249|448439666|FG004|Overall Study|Death|0|||
124676441|NCT00171249|448439667|FG005|Overall Study|Death|3|||
124676442|NCT00171249|448439668|FG006|Overall Study|Death|1|||
124676443|NCT00171249|448439662|FG000|Overall Study|Other|10|||
124676444|NCT00171249|448439663|FG001|Overall Study|Other|0|||
124676445|NCT00171249|448439664|FG002|Overall Study|Other|0|||
124676446|NCT00171249|448439665|FG003|Overall Study|Other|43|||
124676447|NCT00171249|448439666|FG004|Overall Study|Other|0|||
124676448|NCT00171249|448439667|FG005|Overall Study|Other|2|||
124676449|NCT00171249|448439668|FG006|Overall Study|Other|0|||
124676450|NCT00171249|448439662|FG000|Overall Study|No Longer Requires Study Drug|4|||
124676451|NCT00171249|448439663|FG001|Overall Study|No Longer Requires Study Drug|0|||
124676452|NCT00171249|448439664|FG002|Overall Study|No Longer Requires Study Drug|0|||
124676453|NCT00171249|448439665|FG003|Overall Study|No Longer Requires Study Drug|3|||
124676454|NCT00171249|448439666|FG004|Overall Study|No Longer Requires Study Drug|0|||
124676455|NCT00171249|448439667|FG005|Overall Study|No Longer Requires Study Drug|5|||
124676456|NCT00171249|448439668|FG006|Overall Study|No Longer Requires Study Drug|0|||
124676457|NCT00171249|448439662|FG000|Overall Study|Administrative Problems|1|||
124676458|NCT00171249|448439663|FG001|Overall Study|Administrative Problems|0|||
124676459|NCT00171249|448439664|FG002|Overall Study|Administrative Problems|0|||
124676460|NCT00171249|448439665|FG003|Overall Study|Administrative Problems|2|||
124676461|NCT00171249|448439666|FG004|Overall Study|Administrative Problems|0|||
124676462|NCT00171249|448439667|FG005|Overall Study|Administrative Problems|0|||
124676463|NCT00171249|448439668|FG006|Overall Study|Administrative Problems|0|||
124676464|NCT00171249|448439662|FG000|Overall Study|Adverse Event|3|||
124676465|NCT00171249|448439663|FG001|Overall Study|Adverse Event|1|||
124676466|NCT00171249|448439664|FG002|Overall Study|Adverse Event|0|||
124676467|NCT00171249|448439665|FG003|Overall Study|Adverse Event|15|||
124676468|NCT00171249|448439666|FG004|Overall Study|Adverse Event|0|||
124676469|NCT00171249|448439667|FG005|Overall Study|Adverse Event|2|||
124676470|NCT00171249|448439668|FG006|Overall Study|Adverse Event|0|||
124676471|NCT00171249|448439662|FG000|Overall Study|Lost to Follow-up|5|||
124676472|NCT00171249|448439663|FG001|Overall Study|Lost to Follow-up|0|||
124431391|NCT02729831|447538792|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
124431392|NCT02729831|447538793|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
124431393|NCT02729831|447538790|FG000|1 Week Post-visit|Lost to Follow-up|43|||
124431394|NCT02729831|447538791|FG001|1 Week Post-visit|Lost to Follow-up|40|||
124431395|NCT02729831|447538792|FG002|1 Week Post-visit|Lost to Follow-up|38|||
124431396|NCT02729831|447538793|FG003|1 Week Post-visit|Lost to Follow-up|36|||
124431397|NCT02729831|447538790|FG000|6 Month Follow-up|Lost to Follow-up|54|||
124431398|NCT02729831|447538791|FG001|6 Month Follow-up|Lost to Follow-up|51|||
124676473|NCT00171249|448439664|FG002|Overall Study|Lost to Follow-up|0|||
124676474|NCT00171249|448439665|FG003|Overall Study|Lost to Follow-up|9|||
124431399|NCT02729831|447538792|FG002|6 Month Follow-up|Lost to Follow-up|48|||
124431400|NCT02729831|447538793|FG003|6 Month Follow-up|Lost to Follow-up|42|||
124431401|NCT02729831|447538790|FG000|6 Month Follow-up|Death|1|||
124431402|NCT02729831|447538791|FG001|6 Month Follow-up|Death|3|||
124431403|NCT02729831|447538792|FG002|6 Month Follow-up|Death|0|||
124676475|NCT00171249|448439666|FG004|Overall Study|Lost to Follow-up|0|||
124676476|NCT00171249|448439667|FG005|Overall Study|Lost to Follow-up|0|||
124676477|NCT00171249|448439668|FG006|Overall Study|Lost to Follow-up|0|||
124676478|NCT03608826|448439670|FG000|Overall Study|Death|3|||
124676479|NCT03608826|448439670|FG000|Overall Study|Heart Transplant|3|||
124431404|NCT02729831|447538793|FG003|6 Month Follow-up|Death|1|||
124431405|NCT03381339|447538794|FG000|Overall Study|Protocol Violation|4|||
124431406|NCT03381339|447538795|FG001|Overall Study|Protocol Violation|3|||
124431407|NCT03381339|447538794|FG000|Overall Study|Lost to Follow-up|0|||
124431408|NCT03381339|447538795|FG001|Overall Study|Lost to Follow-up|1|||
124431409|NCT04664400|447538801|FG000|Overall Study|Withdrawal by Subject|2|||
124431410|NCT01011153|447538806|FG000|Overall Study|Less than 78 cases completed|8|||
124431411|NCT01011153|447538807|FG001|Overall Study|Less than 78 cases completed|11|||
124431412|NCT01011153|447538808|FG002|Overall Study|Less than 78 cases completed|9|||
124431413|NCT03014479|447538809|FG000|Overall Study|Adverse Event|0|||
124431414|NCT03014479|447538810|FG001|Overall Study|Adverse Event|1|||
124431415|NCT03014479|447538809|FG000|Overall Study|Voluntary Withdrawal|0|||
124431416|NCT03014479|447538810|FG001|Overall Study|Voluntary Withdrawal|2|||
124431417|NCT03014479|447538809|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
124431418|NCT03014479|447538810|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
124431419|NCT02217501|447538819|FG000|Overall Study|Death|3|||
124431420|NCT02217501|447538820|FG001|Overall Study|Death|4|||
124431421|NCT01394978|447538821|FG000|Overall Study|Withdrawal by Subject|2|||
124431422|NCT01394978|447538822|FG001|Overall Study|Withdrawal by Subject|4|||
124431423|NCT01394978|447538821|FG000|Overall Study|Lost to Follow-up|13|||
124431424|NCT01394978|447538822|FG001|Overall Study|Lost to Follow-up|20|||
124431425|NCT01394978|447538821|FG000|Overall Study|Death|6|||
124431426|NCT01394978|447538822|FG001|Overall Study|Death|7|||
124676480|NCT03608826|448439670|FG000|Overall Study|Physician Decision|4|||
124676481|NCT03122171|448439683|FG000|Overall Study|Withdrawal by Subject|1|||
124676482|NCT00720499|448439700|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
124676483|NCT00720499|448439701|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
124676484|NCT00720499|448439700|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
124676485|NCT00720499|448439701|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
124676486|NCT00720499|448439700|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
124676487|NCT00720499|448439701|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
124676488|NCT01326871|448439706|FG000|Overall Study|Major surgery|0|||
124676489|NCT01326871|448439707|FG001|Overall Study|Major surgery|1|||
124676490|NCT01326871|448439708|FG002|Overall Study|Major surgery|0|||
124676491|NCT01326871|448439706|FG000|Overall Study|SAE and death|0|||
124676492|NCT01326871|448439707|FG001|Overall Study|SAE and death|2|||
124676493|NCT01326871|448439708|FG002|Overall Study|SAE and death|0|||
124676494|NCT01326871|448439706|FG000|Overall Study|Physician decision and decreased performance status|0|||
124676495|NCT01326871|448439707|FG001|Overall Study|Physician decision and decreased performance status|1|||
124676496|NCT01326871|448439708|FG002|Overall Study|Physician decision and decreased performance status|0|||
124676497|NCT01326871|448439706|FG000|Overall Study|Disease progression|0|||
124676498|NCT01326871|448439707|FG001|Overall Study|Disease progression|11|||
124676499|NCT01326871|448439708|FG002|Overall Study|Disease progression|5|||
124431427|NCT01081132|447538823|FG000|Overall Study|Lack of Efficacy|25|||
124676500|NCT01326871|448439706|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
124676501|NCT01326871|448439707|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
124676502|NCT01326871|448439708|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
124676503|NCT01326871|448439706|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
124431428|NCT01081132|447538824|FG001|Overall Study|Lack of Efficacy|9|||
124431429|NCT01081132|447538823|FG000|Overall Study|Withdrawal by Subject|13|||
124431430|NCT01081132|447538824|FG001|Overall Study|Withdrawal by Subject|16|||
124676504|NCT01326871|448439707|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
124676505|NCT01326871|448439708|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
124676506|NCT01326871|448439706|FG000|Overall Study|Withdrawal by Subject|0|||
124676507|NCT01326871|448439707|FG001|Overall Study|Withdrawal by Subject|1|||
124676508|NCT01326871|448439708|FG002|Overall Study|Withdrawal by Subject|0|||
124676509|NCT01326871|448439706|FG000|Overall Study|DLT|0|||
124676510|NCT01326871|448439707|FG001|Overall Study|DLT|2|||
124676511|NCT01326871|448439708|FG002|Overall Study|DLT|0|||
124676512|NCT01326871|448439706|FG000|Overall Study|SAE, disease progression and subject decision|0|||
124676513|NCT01326871|448439707|FG001|Overall Study|SAE, disease progression and subject decision|1|||
124676514|NCT01326871|448439708|FG002|Overall Study|SAE, disease progression and subject decision|0|||
124676515|NCT01326871|448439706|FG000|Overall Study|Death|0|||
124676516|NCT01326871|448439707|FG001|Overall Study|Death|1|||
124676517|NCT01326871|448439708|FG002|Overall Study|Death|0|||
124676518|NCT01326871|448439706|FG000|Overall Study|Other|0|||
124676519|NCT01326871|448439707|FG001|Overall Study|Other|3|||
124676520|NCT01326871|448439708|FG002|Overall Study|Other|0|||
124676521|NCT01326871|448439706|FG000|Overall Study|SAE and disease progression|0|||
124676522|NCT01326871|448439707|FG001|Overall Study|SAE and disease progression|0|||
124676523|NCT01326871|448439708|FG002|Overall Study|SAE and disease progression|1|||
124676524|NCT01326871|448439706|FG000|Overall Study|SAE and physician decision|0|||
124676525|NCT01326871|448439707|FG001|Overall Study|SAE and physician decision|0|||
124676526|NCT01326871|448439708|FG002|Overall Study|SAE and physician decision|1|||
124676527|NCT01326871|448439706|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
124676528|NCT01326871|448439707|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
124676529|NCT01326871|448439708|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
124431431|NCT01081132|447538823|FG000|Overall Study|Lost to Follow-up|4|||
124676530|NCT01326871|448439706|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
124431432|NCT01081132|447538824|FG001|Overall Study|Lost to Follow-up|11|||
124676531|NCT01326871|448439707|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
124676532|NCT01326871|448439708|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
124676533|NCT01326871|448439706|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
124676534|NCT01326871|448439707|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
124676535|NCT01326871|448439708|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
124676536|NCT01326871|448439706|FG000|Overall Study|Physician Decision|0|||
124676537|NCT01326871|448439707|FG001|Overall Study|Physician Decision|0|||
124676538|NCT01326871|448439708|FG002|Overall Study|Physician Decision|1|||
124676539|NCT01326871|448439706|FG000|Overall Study|SAE|0|||
124676540|NCT01326871|448439707|FG001|Overall Study|SAE|0|||
124676541|NCT01326871|448439708|FG002|Overall Study|SAE|1|||
124676542|NCT01326871|448439706|FG000|Overall Study|Disease progression and death|0|||
124676543|NCT01326871|448439707|FG001|Overall Study|Disease progression and death|0|||
124676544|NCT01326871|448439708|FG002|Overall Study|Disease progression and death|1|||
124676545|NCT01326871|448439706|FG000|Overall Study|Subject decision|0|||
124676546|NCT01326871|448439707|FG001|Overall Study|Subject decision|0|||
124676547|NCT01326871|448439708|FG002|Overall Study|Subject decision|1|||
124676548|NCT01200329|448439714|FG000|Overall Study|Lack of financial coverage|2|||
124676549|NCT01200329|448439714|FG000|Overall Study|Progressive disease|1|||
124676550|NCT03641508|448439719|FG000|First Injection|Lost to Follow-up|2|||
124676551|NCT03641508|448439720|FG001|First Injection|Lost to Follow-up|0|||
124676552|NCT03642990|448439721|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
124676553|NCT03642990|448439721|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
124676554|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
124676555|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
124676556|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
124676557|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
124676558|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
124676559|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
124676560|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
124676561|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
124676562|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
124676563|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
124676564|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
124676565|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
124676566|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
124676567|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
124676568|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
124676569|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
124676570|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
124676571|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
124676572|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
124676573|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
124676574|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
124676575|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
124676576|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
124676577|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
124676578|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
124676579|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
124676580|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
124676581|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
124676582|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
124676583|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
124676584|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
124676585|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
124676586|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
124676587|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
124676588|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
124676589|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
124676590|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
124676591|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
124676592|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
124676593|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
124676594|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
124676595|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
124676596|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
124676597|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
124676598|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
124676599|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
124676600|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
124676601|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
124676602|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
124676603|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
124676604|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
124676605|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
124676606|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
124676607|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
124676608|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
124676609|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
124676610|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
124676611|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
124676612|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
124676613|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
124676614|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
124676615|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
124676616|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
124676617|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
124676618|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
124676619|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
124676620|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
124676621|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
124676622|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
124676623|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
124676624|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
124676625|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
124676626|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
124676627|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
124676628|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
124676629|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
124676630|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
124676631|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
124676632|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
124676633|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
124676634|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
124676635|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
124676636|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
124676637|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
124676638|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
124676639|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
124676640|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
124676641|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
124676642|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
124676643|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
124676644|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
124676645|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
124676646|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
124676647|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
124676648|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
124676649|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
124676650|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
124676651|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
124676652|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
124676653|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
124676654|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
124676655|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
124676656|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
124676657|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
124676658|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
124676659|NCT02717195|448439723|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
124676660|NCT02717195|448439724|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
124676661|NCT02717195|448439725|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
124676662|NCT02717195|448439726|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
124676663|NCT02717195|448439727|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
124676664|NCT02717195|448439723|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
124431433|NCT01081132|447538823|FG000|Overall Study|Adverse Event|3|||
124431434|NCT01081132|447538824|FG001|Overall Study|Adverse Event|9|||
124676665|NCT02717195|448439724|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
124676666|NCT02717195|448439725|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
124676667|NCT02717195|448439726|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
124676668|NCT02717195|448439727|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
124676669|NCT02717195|448439723|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
124676670|NCT02717195|448439724|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
124676671|NCT02717195|448439725|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
124676672|NCT02717195|448439726|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
124676673|NCT02717195|448439727|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
124676674|NCT02717195|448439723|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
124676675|NCT02717195|448439724|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
124676676|NCT02717195|448439725|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
124676677|NCT02717195|448439726|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
124676678|NCT02717195|448439727|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
124676679|NCT02717195|448439723|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
124676680|NCT02717195|448439724|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
124676681|NCT02717195|448439725|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
124676682|NCT02717195|448439726|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
124676683|NCT02717195|448439727|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
124676684|NCT02717195|448439723|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
124676685|NCT02717195|448439724|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
124676686|NCT02717195|448439725|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
124676687|NCT02717195|448439726|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
124676688|NCT02717195|448439727|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
124676689|NCT02717195|448439723|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
124676690|NCT02717195|448439724|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
124676691|NCT02717195|448439725|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
124676692|NCT02717195|448439726|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
124676693|NCT02717195|448439727|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
124676694|NCT02717195|448439723|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
124676695|NCT02717195|448439724|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
124676696|NCT02717195|448439725|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
124676697|NCT02717195|448439726|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
124676698|NCT02717195|448439727|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
124676699|NCT02717195|448439723|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
124676700|NCT02717195|448439724|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
124676701|NCT02717195|448439725|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
124676702|NCT02717195|448439726|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
124676703|NCT02717195|448439727|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
124676704|NCT02717195|448439723|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
124676705|NCT02717195|448439724|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
124676706|NCT02717195|448439725|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
124676707|NCT02717195|448439726|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
124676708|NCT02717195|448439727|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
124676709|NCT02717195|448439723|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
124676710|NCT02717195|448439724|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
124676711|NCT02717195|448439725|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
124676712|NCT02717195|448439726|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
124676713|NCT02717195|448439727|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
124676714|NCT02717195|448439723|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
124676715|NCT02717195|448439724|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
124676716|NCT02717195|448439725|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
124676717|NCT02717195|448439726|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
124676718|NCT02717195|448439727|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
124676719|NCT02717195|448439723|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
124676720|NCT02717195|448439724|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
124676721|NCT02717195|448439725|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
124676722|NCT02717195|448439726|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
124676723|NCT02717195|448439727|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
124676724|NCT02717195|448439723|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
124676725|NCT02717195|448439724|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
124431435|NCT01081132|447538823|FG000|Overall Study|Non Compliance|4|||
124431436|NCT01081132|447538824|FG001|Overall Study|Non Compliance|2|||
124431437|NCT01081132|447538823|FG000|Overall Study|Lack Of Compliance|0|||
124676726|NCT02717195|448439725|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
124676727|NCT02717195|448439726|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
124676728|NCT02717195|448439727|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
124676729|NCT02717195|448439723|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
124676730|NCT02717195|448439724|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
124676731|NCT02717195|448439725|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
124676732|NCT02717195|448439726|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
124676733|NCT02717195|448439727|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
124676734|NCT00855218|448439728|FG000|Overall Study|Adverse Event|43|||
124676735|NCT00855218|448439729|FG001|Overall Study|Adverse Event|27|||
124676736|NCT00855218|448439728|FG000|Overall Study|Withdrawal by Subject|10|||
124676737|NCT00855218|448439729|FG001|Overall Study|Withdrawal by Subject|6|||
124676738|NCT00855218|448439728|FG000|Overall Study|Physician Decision|18|||
124431438|NCT01081132|447538824|FG001|Overall Study|Lack Of Compliance|1|||
124431439|NCT01081132|447538823|FG000|Overall Study|Missed Visits|1|||
124431440|NCT01081132|447538824|FG001|Overall Study|Missed Visits|1|||
124431441|NCT01081132|447538823|FG000|Overall Study|Stopped Taking Meds|2|||
124431442|NCT01081132|447538824|FG001|Overall Study|Stopped Taking Meds|0|||
124431443|NCT01081132|447538823|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
124431444|NCT01081132|447538824|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
124431445|NCT01081132|447538823|FG000|Overall Study|Declined Taper Phase|0|||
124431446|NCT01081132|447538824|FG001|Overall Study|Declined Taper Phase|1|||
124431447|NCT01081132|447538823|FG000|Overall Study|Protocol Violation|3|||
124431448|NCT01081132|447538824|FG001|Overall Study|Protocol Violation|1|||
124431449|NCT02019667|447538825|FG000|First Intervention (6 Months)|Adverse Event|0|||
124431450|NCT02019667|447538826|FG001|First Intervention (6 Months)|Adverse Event|1|||
124431451|NCT02019667|447538825|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
124431452|NCT02019667|447538826|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
124431453|NCT02019667|447538825|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
124431454|NCT02019667|447538826|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
124431455|NCT01905150|447538832|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
124431456|NCT01905150|447538833|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
124431457|NCT03981861|447538834|FG000|Overall Study|Withdrawal by Subject|3|||
124676739|NCT00855218|448439729|FG001|Overall Study|Physician Decision|11|||
124676740|NCT00855218|448439728|FG000|Overall Study|Lost to Follow-up|0|||
124676741|NCT00855218|448439729|FG001|Overall Study|Lost to Follow-up|1|||
124676742|NCT00855218|448439728|FG000|Overall Study|Protocol Violation|5|||
124676743|NCT00855218|448439729|FG001|Overall Study|Protocol Violation|9|||
124676744|NCT00855218|448439728|FG000|Overall Study|non-compliant with study drug|3|||
124676745|NCT00855218|448439729|FG001|Overall Study|non-compliant with study drug|1|||
124676746|NCT00855218|448439728|FG000|Overall Study|patient convenience|2|||
124676747|NCT00855218|448439729|FG001|Overall Study|patient convenience|0|||
124676748|NCT00855218|448439728|FG000|Overall Study|technical problems|2|||
124676749|NCT00855218|448439729|FG001|Overall Study|technical problems|1|||
124676750|NCT00855218|448439728|FG000|Overall Study|Still treated with study medication|0|||
124676751|NCT00855218|448439729|FG001|Overall Study|Still treated with study medication|1|||
124676752|NCT00855218|448439728|FG000|Overall Study|Untreatable disease progression|54|||
124676753|NCT00855218|448439729|FG001|Overall Study|Untreatable disease progression|67|||
124676754|NCT00855218|448439728|FG000|Overall Study|Second malignancy|0|||
124676755|NCT00855218|448439729|FG001|Overall Study|Second malignancy|1|||
124676756|NCT00855218|448439728|FG000|Overall Study|Progression measurement proven|7|||
124676757|NCT00855218|448439729|FG001|Overall Study|Progression measurement proven|15|||
124676758|NCT00855218|448439728|FG000|Overall Study|Clinical endpoint reached|10|||
124676759|NCT00855218|448439729|FG001|Overall Study|Clinical endpoint reached|13|||
124676760|NCT00764790|448439730|FG000|Overall Study|Protocol Violation|0|||
124676761|NCT00764790|448439731|FG001|Overall Study|Protocol Violation|0|||
124676762|NCT00764790|448439732|FG002|Overall Study|Protocol Violation|1|||
124676763|NCT00764790|448439730|FG000|Overall Study|Withdrawal by Subject|10|||
124676764|NCT00764790|448439731|FG001|Overall Study|Withdrawal by Subject|12|||
124676765|NCT00764790|448439732|FG002|Overall Study|Withdrawal by Subject|6|||
124676766|NCT00764790|448439730|FG000|Overall Study|Lost to Follow-up|28|||
124676767|NCT00764790|448439731|FG001|Overall Study|Lost to Follow-up|29|||
124676768|NCT00764790|448439732|FG002|Overall Study|Lost to Follow-up|23|||
124431458|NCT00432666|447540267|FG000|Main Period|Adverse Event|1|||
124431459|NCT00432666|447540268|FG001|Main Period|Adverse Event|1|||
124431460|NCT00432666|447540267|FG000|Main Period|Consent Withdrawn|1|||
124431461|NCT00432666|447540268|FG001|Main Period|Consent Withdrawn|0|||
124431462|NCT00432666|447540267|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
124431463|NCT00432666|447540268|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
124431464|NCT00432666|447540267|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
124431465|NCT00432666|447540268|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
124431466|NCT00432666|447540267|FG000|Open-Label Extension Period|Adverse Event|5|||
124431467|NCT00432666|447540268|FG001|Open-Label Extension Period|Adverse Event|0|||
124431468|NCT00432666|447540267|FG000|Open-Label Extension Period|Consent withdrawn|10|||
124431469|NCT00432666|447540268|FG001|Open-Label Extension Period|Consent withdrawn|0|||
124431470|NCT00432666|447540267|FG000|Open-Label Extension Period|Physician Decision|3|||
124431471|NCT00432666|447540268|FG001|Open-Label Extension Period|Physician Decision|0|||
124431472|NCT00978627|447540269|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
124431473|NCT00978627|447540270|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
124431474|NCT00978627|447540269|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
124431475|NCT00978627|447540270|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
124431476|NCT00978627|447540269|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
124431477|NCT00978627|447540270|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
124431478|NCT00978627|447540269|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
124431479|NCT00978627|447540270|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
124431480|NCT00978627|447540269|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
124431481|NCT00978627|447540270|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
124431482|NCT00978627|447540269|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
124431483|NCT00978627|447540270|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
124431484|NCT00978627|447540269|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
124431485|NCT00978627|447540270|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
124431486|NCT00978627|447540269|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
124431487|NCT00978627|447540270|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
124431488|NCT00978627|447540269|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
124431489|NCT00978627|447540270|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
124431490|NCT02516332|447540271|FG000|Overall Study|Withdrawal by Subject|2|||
124431491|NCT02516332|447540272|FG001|Overall Study|Withdrawal by Subject|1|||
124676769|NCT03191552|448439733|FG000|Overall Study|Lost to Follow-up|1|||
124676770|NCT03191552|448439734|FG001|Overall Study|Lost to Follow-up|0|||
124431492|NCT02516332|447540273|FG002|Overall Study|Withdrawal by Subject|2|||
124676771|NCT03191552|448439735|FG002|Overall Study|Lost to Follow-up|0|||
124676772|NCT03191552|448439733|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
124676773|NCT03191552|448439734|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
124676774|NCT03191552|448439735|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
124431493|NCT03037931|447540274|FG000|Overall Study|Death|354|||
124676775|NCT01265498|448439736|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
124676776|NCT01265498|448439737|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
124676777|NCT00617279|448439740|FG000|Overall Study|Study terminated by Sponsor|10|||
124676778|NCT00617279|448439741|FG001|Overall Study|Study terminated by Sponsor|15|||
124676779|NCT00617279|448439740|FG000|Overall Study|Graft abandonment|2|||
124676780|NCT00617279|448439741|FG001|Overall Study|Graft abandonment|0|||
124676781|NCT00617279|448439740|FG000|Overall Study|Lost to Follow-up|1|||
124676782|NCT00617279|448439741|FG001|Overall Study|Lost to Follow-up|0|||
124676783|NCT00617279|448439740|FG000|Overall Study|Death|1|||
124676784|NCT00617279|448439741|FG001|Overall Study|Death|2|||
124676785|NCT00921024|448439744|FG000|Overall Study|Lost to Follow-up|2|||
124676786|NCT00921024|448439745|FG001|Overall Study|Lost to Follow-up|0|||
124676787|NCT00921024|448439744|FG000|Overall Study|Received concomittant therapy|2|||
124676788|NCT00921024|448439745|FG001|Overall Study|Received concomittant therapy|0|||
124676789|NCT00921024|448439744|FG000|Overall Study|Withdrawal by Subject|0|||
124676790|NCT00921024|448439745|FG001|Overall Study|Withdrawal by Subject|3|||
124676791|NCT03225287|448439746|FG000|Overall Study|Adverse Event|0|||
124676792|NCT03225287|448439747|FG001|Overall Study|Adverse Event|0|||
124431494|NCT03037931|447540275|FG001|Overall Study|Death|367|||
124431495|NCT03037931|447540274|FG000|Overall Study|Lost to Follow-up|7|||
124431496|NCT03037931|447540275|FG001|Overall Study|Lost to Follow-up|4|||
124431497|NCT03037931|447540274|FG000|Overall Study|Withdrawal by Subject|48|||
124431498|NCT03037931|447540275|FG001|Overall Study|Withdrawal by Subject|41|||
124431499|NCT00605215|447540276|FG000|Overall Study|Death|0|||
124431500|NCT00605215|447540277|FG001|Overall Study|Death|0|||
124431501|NCT00605215|447540278|FG002|Overall Study|Death|1|||
124431502|NCT00605215|447540276|FG000|Overall Study|Adverse Event|19|||
124431503|NCT00605215|447540277|FG001|Overall Study|Adverse Event|21|||
124431504|NCT00605215|447540278|FG002|Overall Study|Adverse Event|26|||
124431505|NCT00605215|447540276|FG000|Overall Study|Refusal to sign the re-consent form|8|||
124431506|NCT00605215|447540277|FG001|Overall Study|Refusal to sign the re-consent form|3|||
124431507|NCT00605215|447540278|FG002|Overall Study|Refusal to sign the re-consent form|3|||
124431508|NCT00605215|447540276|FG000|Overall Study|Withdrawal by Subject|39|||
124431509|NCT00605215|447540277|FG001|Overall Study|Withdrawal by Subject|37|||
124431510|NCT00605215|447540278|FG002|Overall Study|Withdrawal by Subject|27|||
124431511|NCT00605215|447540276|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
124431512|NCT00605215|447540277|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
124431513|NCT00605215|447540278|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
124431514|NCT00605215|447540276|FG000|Overall Study|Protocol Violation|3|||
124431515|NCT00605215|447540277|FG001|Overall Study|Protocol Violation|4|||
124431516|NCT00605215|447540278|FG002|Overall Study|Protocol Violation|1|||
124431517|NCT00605215|447540276|FG000|Overall Study|Pregnancy|8|||
124431518|NCT00605215|447540277|FG001|Overall Study|Pregnancy|5|||
124431519|NCT00605215|447540278|FG002|Overall Study|Pregnancy|4|||
124431520|NCT00605215|447540276|FG000|Overall Study|Lost to Follow-up|8|||
124431521|NCT00605215|447540277|FG001|Overall Study|Lost to Follow-up|5|||
124431522|NCT00605215|447540278|FG002|Overall Study|Lost to Follow-up|2|||
124431523|NCT00605215|447540276|FG000|Overall Study|Other than specified|0|||
124431524|NCT00605215|447540277|FG001|Overall Study|Other than specified|2|||
124431525|NCT00605215|447540278|FG002|Overall Study|Other than specified|1|||
124431526|NCT02914275|447540279|FG000|Overall Study|Lost to Follow-up|84|||
124431527|NCT02914275|447540280|FG001|Overall Study|Lost to Follow-up|29|||
124431528|NCT02914275|447540279|FG000|Overall Study|Withdrawal by Subject|26|||
124431529|NCT02914275|447540280|FG001|Overall Study|Withdrawal by Subject|10|||
124431530|NCT02914275|447540279|FG000|Overall Study|Protocol Violation|1|||
124431531|NCT02914275|447540280|FG001|Overall Study|Protocol Violation|1|||
124431532|NCT02914275|447540279|FG000|Overall Study|Physician Decision|3|||
124431533|NCT02914275|447540280|FG001|Overall Study|Physician Decision|1|||
124431534|NCT02914275|447540279|FG000|Overall Study|Other|4|||
124431535|NCT02914275|447540280|FG001|Overall Study|Other|1|||
124431536|NCT02914275|447540279|FG000|Overall Study|Excluded due to invalid informed consent|3|||
124676793|NCT03225287|448439748|FG002|Overall Study|Adverse Event|1|||
124431537|NCT02914275|447540280|FG001|Overall Study|Excluded due to invalid informed consent|0|||
124431538|NCT02704754|447540285|FG000|Overall Study|Lost to Follow-up|1|||
124431539|NCT02704754|447540286|FG001|Overall Study|Lost to Follow-up|1|||
124431540|NCT02704754|447540285|FG000|Overall Study|Lack of Efficacy|1|||
124431541|NCT02704754|447540286|FG001|Overall Study|Lack of Efficacy|0|||
124431542|NCT02704754|447540285|FG000|Overall Study|Withdrawal by Subject|1|||
124431543|NCT02704754|447540286|FG001|Overall Study|Withdrawal by Subject|0|||
124676794|NCT03225287|448439746|FG000|Overall Study|Protocol non-compliance|0|||
124431544|NCT03809429|447540290|FG000|Overall Study|Withdrawal by Subject|7|||
124431545|NCT03809429|447540291|FG001|Overall Study|Withdrawal by Subject|3|||
124431546|NCT03809429|447540290|FG000|Overall Study|Adverse Event|6|||
124431547|NCT03809429|447540291|FG001|Overall Study|Adverse Event|9|||
124431548|NCT03809429|447540290|FG000|Overall Study|COVID-19|3|||
124431549|NCT03809429|447540291|FG001|Overall Study|COVID-19|1|||
124431550|NCT03809429|447540290|FG000|Overall Study|Participant was discontinued by investigator|12|||
124676795|NCT03225287|448439747|FG001|Overall Study|Protocol non-compliance|0|||
124676796|NCT03225287|448439748|FG002|Overall Study|Protocol non-compliance|1|||
124431551|NCT03809429|447540291|FG001|Overall Study|Participant was discontinued by investigator|7|||
124431552|NCT04214600|447540293|FG000|Overall Study|Lost to Follow-up|9|||
124431553|NCT04214600|447540294|FG001|Overall Study|Lost to Follow-up|14|||
124431554|NCT02366468|447540295|FG000|Overall Study|Adverse Event|2|||
124431555|NCT02366468|447540296|FG001|Overall Study|Adverse Event|0|||
124431556|NCT02366468|447540295|FG000|Overall Study|Withdrawal by Subject|1|||
124431557|NCT02366468|447540296|FG001|Overall Study|Withdrawal by Subject|5|||
124431558|NCT02366468|447540295|FG000|Overall Study|Lost to Follow-up|2|||
124431559|NCT02366468|447540296|FG001|Overall Study|Lost to Follow-up|0|||
124431560|NCT02366468|447540295|FG000|Overall Study|Death|1|||
124431561|NCT02366468|447540296|FG001|Overall Study|Death|2|||
124431562|NCT02366468|447540295|FG000|Overall Study|Other|0|||
124431563|NCT02366468|447540296|FG001|Overall Study|Other|2|||
124431564|NCT00446043|447540297|FG000|Overall Study|Adverse Event|9|||
124431565|NCT00446043|447540297|FG000|Overall Study|Withdrawal by Subject|70|||
124431566|NCT00446043|447540297|FG000|Overall Study|Protocol Violation|2|||
124431567|NCT00446043|447540297|FG000|Overall Study|Lost to Follow-up|42|||
124431568|NCT00446043|447540297|FG000|Overall Study|Pregnancy|2|||
124676797|NCT03225287|448439746|FG000|Overall Study|Subject withdraws consent|3|||
124676798|NCT03225287|448439747|FG001|Overall Study|Subject withdraws consent|0|||
124676799|NCT03225287|448439748|FG002|Overall Study|Subject withdraws consent|0|||
124431569|NCT04772898|447540298|FG000|Overall Study|Withdrawal by Subject|0|||
124431570|NCT04772898|447540299|FG001|Overall Study|Withdrawal by Subject|1|||
124431571|NCT02947087|447540300|FG000|Overall Study|Withdrawal by Subject|3|||
124431572|NCT02947087|447540301|FG001|Overall Study|Withdrawal by Subject|2|||
124431573|NCT01879722|447540305|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
124431574|NCT01879722|447540306|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
124431575|NCT01879722|447540307|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
124431576|NCT01879722|447540308|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
124431577|NCT01879722|447540309|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
124431578|NCT01879722|447540310|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
124431579|NCT01879722|447540311|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
124431580|NCT01879722|447540312|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
124431581|NCT01879722|447540313|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
124431582|NCT01879722|447540314|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
124431583|NCT01879722|447540305|FG000|Overall Study|Voluntary Withdrawal|0|||
124431584|NCT01879722|447540306|FG001|Overall Study|Voluntary Withdrawal|0|||
124431585|NCT01879722|447540307|FG002|Overall Study|Voluntary Withdrawal|0|||
124431586|NCT01879722|447540308|FG003|Overall Study|Voluntary Withdrawal|0|||
124431587|NCT01879722|447540309|FG004|Overall Study|Voluntary Withdrawal|0|||
124431588|NCT01879722|447540310|FG005|Overall Study|Voluntary Withdrawal|0|||
124431589|NCT01879722|447540311|FG006|Overall Study|Voluntary Withdrawal|0|||
124431590|NCT01879722|447540312|FG007|Overall Study|Voluntary Withdrawal|0|||
124431591|NCT01879722|447540313|FG008|Overall Study|Voluntary Withdrawal|1|||
124431592|NCT01879722|447540314|FG009|Overall Study|Voluntary Withdrawal|0|||
124431593|NCT01253304|447540317|FG000|Overall Study|Adverse Event|0|||
124431594|NCT01253304|447540318|FG001|Overall Study|Adverse Event|0|||
124431595|NCT01253304|447540319|FG002|Overall Study|Adverse Event|0|||
124431596|NCT01253304|447540320|FG003|Overall Study|Adverse Event|1|||
124431597|NCT01327495|447540321|FG000|Overall Study|Adverse Event|2|||
124431598|NCT01327495|447540322|FG001|Overall Study|Adverse Event|1|||
124431599|NCT01327495|447540323|FG002|Overall Study|Adverse Event|1|||
124431600|NCT01327495|447540324|FG003|Overall Study|Adverse Event|0|||
124431601|NCT01327495|447540325|FG004|Overall Study|Adverse Event|0|||
124431602|NCT01327495|447540326|FG005|Overall Study|Adverse Event|2|||
124431603|NCT01327495|447540321|FG000|Overall Study|Withdrawal by Subject|0|||
124431604|NCT01327495|447540322|FG001|Overall Study|Withdrawal by Subject|1|||
124431605|NCT01327495|447540323|FG002|Overall Study|Withdrawal by Subject|1|||
124431606|NCT01327495|447540324|FG003|Overall Study|Withdrawal by Subject|0|||
124431607|NCT01327495|447540325|FG004|Overall Study|Withdrawal by Subject|1|||
124431608|NCT01327495|447540326|FG005|Overall Study|Withdrawal by Subject|0|||
124431609|NCT01327495|447540321|FG000|Overall Study|Physician Decision|0|||
124431610|NCT01327495|447540322|FG001|Overall Study|Physician Decision|0|||
124431611|NCT01327495|447540323|FG002|Overall Study|Physician Decision|0|||
124431612|NCT01327495|447540324|FG003|Overall Study|Physician Decision|0|||
124431613|NCT01327495|447540325|FG004|Overall Study|Physician Decision|2|||
124431614|NCT01327495|447540326|FG005|Overall Study|Physician Decision|0|||
124431615|NCT00006011|447540328|FG000|Overall Study|Disease progression|13|||
124431616|NCT00006011|447540329|FG001|Overall Study|Disease progression|6|||
124431617|NCT00006011|447540330|FG002|Overall Study|Disease progression|26|||
124431618|NCT00006011|447540328|FG000|Overall Study|Refused further treatment|15|||
124431619|NCT00006011|447540329|FG001|Overall Study|Refused further treatment|13|||
124431620|NCT00006011|447540330|FG002|Overall Study|Refused further treatment|26|||
124431621|NCT00006011|447540328|FG000|Overall Study|Adverse Event|15|||
124431622|NCT00006011|447540329|FG001|Overall Study|Adverse Event|39|||
124431623|NCT00006011|447540330|FG002|Overall Study|Adverse Event|5|||
124431624|NCT00006011|447540328|FG000|Overall Study|Death|0|||
124431625|NCT00006011|447540329|FG001|Overall Study|Death|1|||
124431626|NCT00006011|447540330|FG002|Overall Study|Death|2|||
124431627|NCT00006011|447540328|FG000|Overall Study|Other|4|||
124431628|NCT00006011|447540329|FG001|Overall Study|Other|2|||
124431629|NCT00006011|447540330|FG002|Overall Study|Other|5|||
124431630|NCT00006011|447540328|FG000|Overall Study|Ineligible|18|||
124431631|NCT00006011|447540329|FG001|Overall Study|Ineligible|16|||
124431632|NCT00006011|447540330|FG002|Overall Study|Ineligible|9|||
124431633|NCT02207569|447540335|FG000|1-Month|Death|6|||
124431634|NCT02207569|447540335|FG000|1-Month|Withdrawal by Subject|2|||
124431635|NCT02207569|447540335|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
124431636|NCT02207569|447540335|FG000|6-Month|Death|8|||
124431637|NCT02207569|447540335|FG000|6-Month|Withdrawal by Subject|2|||
124431638|NCT02207569|447540335|FG000|12-Month|Death|14|||
124431639|NCT02207569|447540335|FG000|12-Month|Withdrawal by Subject|2|||
124431640|NCT02207569|447540335|FG000|24-Month|Death|23|||
124431641|NCT02207569|447540335|FG000|24-Month|Withdrawal by Subject|3|||
124431642|NCT02207569|447540335|FG000|36-Month|Death|23|||
124431643|NCT02207569|447540335|FG000|36-Month|Withdrawal by Subject|4|||
124431644|NCT02207569|447540335|FG000|48-Month|Death|25|||
124431645|NCT02207569|447540335|FG000|48-Month|Withdrawal by Subject|2|||
124431646|NCT02207569|447540335|FG000|48-Month|Lost to Follow-up|4|||
124431647|NCT02207569|447540335|FG000|60-Month|Death|1|||
124431648|NCT02207569|447540335|FG000|60-Month|Lost to Follow-up|1|||
124431649|NCT02207569|447540335|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
124431650|NCT02207569|447540335|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
124431651|NCT01844687|447540337|FG000|Visit 1|Protocol Violation|3|||
124431652|NCT01844687|447540337|FG000|Visit 1|Lost to Follow-up|5|||
124431653|NCT01844687|447540337|FG000|Visit 2|Withdrawal by Subject|1|||
124431654|NCT01844687|447540337|FG000|Visit 2|Protocol Violation|1|||
124431655|NCT01844687|447540337|FG000|Visit 3|Lost to Follow-up|1|||
124431656|NCT01844687|447540337|FG000|Visit 3|Withdrawal by Subject|3|||
124431657|NCT01844687|447540337|FG000|Visit 3|child care problems|1|||
124431658|NCT01844687|447540337|FG000|Visit 4|Pregnancy|1|||
124431659|NCT01844687|447540337|FG000|Visit 4|Lost to Follow-up|1|||
124431660|NCT01844687|447540337|FG000|Visit 4|Withdrawal by Subject|2|||
124431661|NCT05383508|447540340|FG000|Overall Study|Withdrawal by Subject|1|||
124431662|NCT05383508|447540341|FG001|Overall Study|Withdrawal by Subject|0|||
124431663|NCT05383508|447540342|FG002|Overall Study|Withdrawal by Subject|1|||
124431664|NCT05383508|447540343|FG003|Overall Study|Withdrawal by Subject|1|||
124431665|NCT05383508|447540344|FG004|Overall Study|Withdrawal by Subject|2|||
124431666|NCT05383508|447540345|FG005|Overall Study|Withdrawal by Subject|0|||
124676800|NCT03225287|448439746|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
124676801|NCT03225287|448439747|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
124431667|NCT03047395|447540346|FG000|Overall Study|Adverse Event|142|||
124431668|NCT03047395|447540346|FG000|Overall Study|Withdrawal by Subject|155|||
124431669|NCT03047395|447540346|FG000|Overall Study|Lost to Follow-up|144|||
124431670|NCT03047395|447540346|FG000|Overall Study|COVID-19 Infection|2|||
124431671|NCT03047395|447540346|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
124431672|NCT03047395|447540346|FG000|Overall Study|Other, Not Specified|117|||
124431673|NCT00635427|447540351|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
124431674|NCT00635427|447540352|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
124431675|NCT00635427|447540353|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
124431676|NCT00635427|447540354|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
124431677|NCT00635427|447540355|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
124431678|NCT00635427|447540351|FG000|Overall Study|Death|0|||
124431679|NCT00635427|447540352|FG001|Overall Study|Death|0|||
124431680|NCT00635427|447540353|FG002|Overall Study|Death|0|||
124431681|NCT00635427|447540354|FG003|Overall Study|Death|1|||
124431682|NCT00635427|447540355|FG004|Overall Study|Death|0|||
124431683|NCT00635427|447540351|FG000|Overall Study|Termination Of Study By Sponsor|12|||
124676802|NCT03225287|448439748|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
124676803|NCT03225287|448439746|FG000|Overall Study|Trial drug not effective|0|||
124676804|NCT03225287|448439747|FG001|Overall Study|Trial drug not effective|1|||
124676805|NCT03225287|448439748|FG002|Overall Study|Trial drug not effective|0|||
124431684|NCT00635427|447540352|FG001|Overall Study|Termination Of Study By Sponsor|6|||
124431685|NCT00635427|447540353|FG002|Overall Study|Termination Of Study By Sponsor|10|||
124431686|NCT00635427|447540354|FG003|Overall Study|Termination Of Study By Sponsor|6|||
124431687|NCT00635427|447540355|FG004|Overall Study|Termination Of Study By Sponsor|6|||
124431688|NCT00635427|447540351|FG000|Overall Study|Withdrawal Of Consent|0|||
124431689|NCT00635427|447540352|FG001|Overall Study|Withdrawal Of Consent|0|||
124431690|NCT00635427|447540353|FG002|Overall Study|Withdrawal Of Consent|0|||
124431691|NCT00635427|447540354|FG003|Overall Study|Withdrawal Of Consent|2|||
124431692|NCT00635427|447540355|FG004|Overall Study|Withdrawal Of Consent|2|||
124431693|NCT03484273|447540358|FG000|Overall Study|Equipment Malfunction|1|||
124431694|NCT03484273|447540358|FG000|Overall Study|Data excluded from analysis|1|||
124431695|NCT02081417|447540359|FG000|Overall Study|Lost to Follow-up|26|||
124431696|NCT02081417|447540360|FG001|Overall Study|Lost to Follow-up|23|||
124431697|NCT02081417|447540359|FG000|Overall Study|Moved Away|1|||
124431698|NCT02081417|447540360|FG001|Overall Study|Moved Away|2|||
124431699|NCT02081417|447540359|FG000|Overall Study|Incarcerated|2|||
124431700|NCT02081417|447540360|FG001|Overall Study|Incarcerated|2|||
124431701|NCT02081417|447540359|FG000|Overall Study|Death|4|||
124431702|NCT02081417|447540360|FG001|Overall Study|Death|3|||
124431703|NCT02081417|447540359|FG000|Overall Study|Withdrawal by Subject|4|||
124431704|NCT02081417|447540360|FG001|Overall Study|Withdrawal by Subject|0|||
124431705|NCT02081417|447540359|FG000|Overall Study|Admitted to Residential Treatment|2|||
124431706|NCT02081417|447540360|FG001|Overall Study|Admitted to Residential Treatment|0|||
124431707|NCT02081417|447540359|FG000|Overall Study|Did not start treatment|17|||
124431708|NCT02081417|447540360|FG001|Overall Study|Did not start treatment|21|||
124431709|NCT01157676|447540361|FG000|Randomization|Death|1|||
124431710|NCT01157676|447540362|FG001|Randomization|Death|1|||
124431711|NCT01157676|447540361|FG000|Randomization|unresectable|2|||
124431712|NCT01157676|447540362|FG001|Randomization|unresectable|3|||
124431713|NCT01157676|447540361|FG000|Randomization|Withdrawal by Subject|17|||
124431714|NCT01157676|447540362|FG001|Randomization|Withdrawal by Subject|13|||
124431715|NCT01157676|447540361|FG000|Randomization|Physician Decision|1|||
124431716|NCT01157676|447540362|FG001|Randomization|Physician Decision|0|||
124431717|NCT01157676|447540361|FG000|Surgery|underwent open cystectomy|0|||
124431718|NCT01157676|447540362|FG001|Surgery|underwent open cystectomy|4|||
124431719|NCT01157676|447540361|FG000|Surgery|converted to open procedure|0|||
124431720|NCT01157676|447540362|FG001|Surgery|converted to open procedure|5|||
124431721|NCT01157676|447540361|FG000|Surgery|underwent robotic cystectomy|1|||
124431722|NCT01157676|447540362|FG001|Surgery|underwent robotic cystectomy|0|||
124431723|NCT01263665|447540366|FG000|Overall Study|Withdrew Consent|1|||
124431724|NCT01263665|447540366|FG000|Overall Study|Lost to Follow-up|3|||
124431725|NCT01263665|447540366|FG000|Overall Study|Death|2|||
124431726|NCT01263665|447540366|FG000|Overall Study|Amputation above the ankle|1|||
124431727|NCT01263665|447540366|FG000|Overall Study|Surgical Bypass|2|||
124431728|NCT00324675|447540369|FG000|Overall Study|Adverse Event|1|||
124431729|NCT00324675|447540370|FG001|Overall Study|Adverse Event|0|||
124431730|NCT00252577|447540371|FG000|Overall Study|Lost to Follow-up|20|||
124431731|NCT00560066|447540374|FG000|Overall Study|Death|2|||
124431732|NCT00560066|447540375|FG001|Overall Study|Death|1|||
124431733|NCT00560066|447540374|FG000|Overall Study|Withdrawal by Subject|0|||
124431734|NCT00560066|447540375|FG001|Overall Study|Withdrawal by Subject|3|||
124431735|NCT00560066|447540374|FG000|Overall Study|Lost to Follow-up|4|||
124676806|NCT03225287|448439746|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
124431736|NCT00560066|447540375|FG001|Overall Study|Lost to Follow-up|10|||
124431737|NCT00560066|447540374|FG000|Overall Study|Protocol Violation|0|||
124431738|NCT00560066|447540375|FG001|Overall Study|Protocol Violation|1|||
124431739|NCT00560066|447540374|FG000|Overall Study|Administrative reason|0|||
124431740|NCT00560066|447540375|FG001|Overall Study|Administrative reason|5|||
124431741|NCT00560066|447540374|FG000|Overall Study|Missing primary reason|0|||
124431742|NCT00560066|447540375|FG001|Overall Study|Missing primary reason|2|||
124431743|NCT02442336|447540377|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
124431744|NCT02442336|447540377|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
124431745|NCT02442336|447540377|FG000|Overall Study|Lost to Follow-up|11|||
124431746|NCT01993927|447540378|FG000|Overall Study|Case Report Forms Uncollected|18|||
124431747|NCT01993927|447540378|FG000|Overall Study|Protocol Violation|11|||
124431748|NCT01747551|447540384|FG000|Overall Study|Progressive Disease|24|||
124676807|NCT03225287|448439747|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
124676808|NCT03225287|448439748|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
124676809|NCT03225287|448439746|FG000|Overall Study|Stem cell transplantation|0|||
124676810|NCT03225287|448439747|FG001|Overall Study|Stem cell transplantation|1|||
124676811|NCT03225287|448439748|FG002|Overall Study|Stem cell transplantation|0|||
124676812|NCT01296412|448439754|FG000|Overall Study|Adverse Event|8|||
124431749|NCT01747551|447540385|FG001|Overall Study|Progressive Disease|17|||
124431750|NCT01747551|447540384|FG000|Overall Study|Death|3|||
124431751|NCT01747551|447540385|FG001|Overall Study|Death|1|||
124431752|NCT01747551|447540384|FG000|Overall Study|Adverse Event|7|||
124676813|NCT01296412|448439755|FG001|Overall Study|Adverse Event|29|||
124676814|NCT01296412|448439754|FG000|Overall Study|Lack of Efficacy|1|||
124676815|NCT01296412|448439755|FG001|Overall Study|Lack of Efficacy|0|||
124676816|NCT01296412|448439754|FG000|Overall Study|Lost to Follow-up|10|||
124676817|NCT01296412|448439755|FG001|Overall Study|Lost to Follow-up|7|||
124431753|NCT01747551|447540385|FG001|Overall Study|Adverse Event|1|||
124676818|NCT01296412|448439754|FG000|Overall Study|Non-compliance with study drug|1|||
124676819|NCT01296412|448439755|FG001|Overall Study|Non-compliance with study drug|2|||
124676820|NCT01296412|448439754|FG000|Overall Study|Other reason not specified|20|||
124676821|NCT01296412|448439755|FG001|Overall Study|Other reason not specified|15|||
124676822|NCT01296412|448439754|FG000|Overall Study|Physician Decision|1|||
124676823|NCT01296412|448439755|FG001|Overall Study|Physician Decision|3|||
124676824|NCT01296412|448439754|FG000|Overall Study|Pregnancy|0|||
124676825|NCT01296412|448439755|FG001|Overall Study|Pregnancy|1|||
124676826|NCT01296412|448439754|FG000|Overall Study|Withdrawal by Subject|10|||
124676827|NCT01296412|448439755|FG001|Overall Study|Withdrawal by Subject|13|||
124676828|NCT02160626|448439757|FG000|Overall Study|Adverse Event|1|||
124676829|NCT02160626|448439758|FG001|Overall Study|Adverse Event|0|||
124676830|NCT02160626|448439759|FG002|Overall Study|Adverse Event|0|||
124676831|NCT02160626|448439757|FG000|Overall Study|Schedule not conducive to study visits|0|||
124676832|NCT02160626|448439758|FG001|Overall Study|Schedule not conducive to study visits|0|||
124676833|NCT02160626|448439759|FG002|Overall Study|Schedule not conducive to study visits|1|||
124676834|NCT02160626|448439757|FG000|Overall Study|Withdrawal by Subject|0|||
124676835|NCT02160626|448439758|FG001|Overall Study|Withdrawal by Subject|1|||
124676836|NCT02160626|448439759|FG002|Overall Study|Withdrawal by Subject|0|||
124676837|NCT04239924|448439760|FG000|Overall Study|Lost to Follow-up|2|||
124431754|NCT01747551|447540384|FG000|Overall Study|Prolonged Treatment Delay|2|||
124431755|NCT01747551|447540385|FG001|Overall Study|Prolonged Treatment Delay|0|||
124431756|NCT01747551|447540384|FG000|Overall Study|Withdrawal by Subject|3|||
124431757|NCT01747551|447540385|FG001|Overall Study|Withdrawal by Subject|1|||
124431758|NCT01747551|447540384|FG000|Overall Study|Physician Decision|2|||
124431759|NCT01747551|447540385|FG001|Overall Study|Physician Decision|1|||
124431760|NCT01747551|447540384|FG000|Overall Study|Other|2|||
124431761|NCT01747551|447540385|FG001|Overall Study|Other|0|||
124431762|NCT01142115|447540386|FG000|First Intervention|Lack of Efficacy|1|||
124431763|NCT01142115|447540387|FG001|First Intervention|Lack of Efficacy|1|||
124431764|NCT01142115|447540386|FG000|First Intervention|Adverse Event|1|||
124431765|NCT01142115|447540387|FG001|First Intervention|Adverse Event|0|||
124676838|NCT00499122|448442122|FG000|Overall Study|Withdrawal by Subject|2|||
124676839|NCT00903968|448442123|FG000|Overall Study|Adverse Event|0|||
124676840|NCT00903968|448442124|FG001|Overall Study|Adverse Event|0|||
124676841|NCT00903968|448442125|FG002|Overall Study|Adverse Event|0|||
124676842|NCT00903968|448442126|FG003|Overall Study|Adverse Event|0|||
124676843|NCT00903968|448442127|FG004|Overall Study|Adverse Event|0|||
124676844|NCT00903968|448442128|FG005|Overall Study|Adverse Event|0|||
124431766|NCT00633880|447540388|FG000|Open Label Titration|Lack of Efficacy|1|||
124431767|NCT00633880|447540389|FG001|Open Label Titration|Lack of Efficacy|0|||
124431768|NCT00633880|447540390|FG002|Open Label Titration|Lack of Efficacy|0|||
124431769|NCT00633880|447540388|FG000|Open Label Titration|Adverse Event|13|||
124431770|NCT00633880|447540389|FG001|Open Label Titration|Adverse Event|0|||
124431771|NCT00633880|447540390|FG002|Open Label Titration|Adverse Event|0|||
124431772|NCT00633880|447540388|FG000|Open Label Titration|Treatment Failure|55|||
124676845|NCT00903968|448442129|FG006|Overall Study|Adverse Event|1|||
124676846|NCT00903968|448442130|FG007|Overall Study|Adverse Event|8|||
124676847|NCT00903968|448442123|FG000|Overall Study|DLT|0|||
124676848|NCT00903968|448442124|FG001|Overall Study|DLT|0|||
124676849|NCT00903968|448442125|FG002|Overall Study|DLT|0|||
124676850|NCT00903968|448442126|FG003|Overall Study|DLT|0|||
124676851|NCT00903968|448442127|FG004|Overall Study|DLT|0|||
124676852|NCT00903968|448442128|FG005|Overall Study|DLT|0|||
124431773|NCT00633880|447540389|FG001|Open Label Titration|Treatment Failure|0|||
124676853|NCT00903968|448442129|FG006|Overall Study|DLT|2|||
124676854|NCT00903968|448442130|FG007|Overall Study|DLT|0|||
124676855|NCT00903968|448442123|FG000|Overall Study|Withdrawal by Subject|1|||
124676856|NCT00903968|448442124|FG001|Overall Study|Withdrawal by Subject|0|||
124431774|NCT00633880|447540390|FG002|Open Label Titration|Treatment Failure|0|||
124431775|NCT00633880|447540388|FG000|Open Label Titration|Protocol Violation|6|||
124431776|NCT00633880|447540389|FG001|Open Label Titration|Protocol Violation|0|||
124676857|NCT00903968|448442125|FG002|Overall Study|Withdrawal by Subject|1|||
124431777|NCT00633880|447540390|FG002|Open Label Titration|Protocol Violation|0|||
124431778|NCT00633880|447540388|FG000|Open Label Titration|Physician Decision|1|||
124431779|NCT00633880|447540389|FG001|Open Label Titration|Physician Decision|0|||
124431780|NCT00633880|447540390|FG002|Open Label Titration|Physician Decision|0|||
124431781|NCT00633880|447540388|FG000|Open Label Titration|Withdrawal by Subject|4|||
124431782|NCT00633880|447540389|FG001|Open Label Titration|Withdrawal by Subject|0|||
124431783|NCT00633880|447540390|FG002|Open Label Titration|Withdrawal by Subject|0|||
124431784|NCT03208036|447540392|FG000|Baseline Assessment|Withdrawal by Subject|1|||
124431785|NCT03208036|447540393|FG001|Baseline Assessment|Withdrawal by Subject|1|||
124431786|NCT03208036|447540392|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
124431787|NCT03208036|447540393|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
124431788|NCT03208036|447540392|FG000|Intervention|Withdrawal by Subject|3|||
124431789|NCT03208036|447540393|FG001|Intervention|Withdrawal by Subject|2|||
124431790|NCT03208036|447540392|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
124431791|NCT03208036|447540393|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
124431792|NCT02091206|447540394|FG000|Treatment Period|Adverse Event|0|||
124431793|NCT02091206|447540395|FG001|Treatment Period|Adverse Event|1|||
124431794|NCT02091206|447540396|FG002|Treatment Period|Adverse Event|0|||
124431795|NCT02091206|447540397|FG003|Treatment Period|Adverse Event|0|||
124431796|NCT02091206|447540394|FG000|Treatment Period|Met withdrawal criteria|0|||
124431797|NCT02091206|447540395|FG001|Treatment Period|Met withdrawal criteria|0|||
124431798|NCT02091206|447540396|FG002|Treatment Period|Met withdrawal criteria|1|||
124431799|NCT02091206|447540397|FG003|Treatment Period|Met withdrawal criteria|0|||
124431800|NCT02091206|447540394|FG000|Taper Period|Participant refused study drug|1|||
124431801|NCT02091206|447540395|FG001|Taper Period|Participant refused study drug|0|||
124431802|NCT02091206|447540396|FG002|Taper Period|Participant refused study drug|0|||
124431803|NCT02091206|447540397|FG003|Taper Period|Participant refused study drug|1|||
124431804|NCT02091206|447540394|FG000|Taper Period|Lost to Follow-up|0|||
124431805|NCT02091206|447540395|FG001|Taper Period|Lost to Follow-up|0|||
124431806|NCT02091206|447540396|FG002|Taper Period|Lost to Follow-up|0|||
124431807|NCT02091206|447540397|FG003|Taper Period|Lost to Follow-up|1|||
124431808|NCT00700778|447540398|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
124431809|NCT04927247|447540399|FG000|Overall Study|Other|2|||
124431810|NCT04927247|447540400|FG001|Overall Study|Other|1|||
124431811|NCT04927247|447540399|FG000|Overall Study|Physician Decision|0|||
124431812|NCT04927247|447540400|FG001|Overall Study|Physician Decision|1|||
124431813|NCT04927247|447540399|FG000|Overall Study|Adverse Event|1|||
124431814|NCT04927247|447540400|FG001|Overall Study|Adverse Event|0|||
124431815|NCT00591851|447540401|FG000|Overall Study|Withdrawal by Subject|3|||
124431816|NCT00591851|447540401|FG000|Overall Study|Adverse Event|2|||
124431817|NCT00591851|447540401|FG000|Overall Study|Progressive Disease|1|||
124431818|NCT00847808|447540407|FG000|Overall Study|Adverse Event|7|||
124431819|NCT00847808|447540407|FG000|Overall Study|Protocol Violation|1|||
124431820|NCT00847808|447540407|FG000|Overall Study|Lost to Follow-up|1|||
124431821|NCT00847808|447540407|FG000|Overall Study|Withdrawal by Subject|4|||
124431822|NCT00847808|447540407|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
124431823|NCT00847808|447540407|FG000|Overall Study|Participant Took Excluded Medication|1|||
124431824|NCT00969709|447541986|FG000|Overall Study|Adverse Event|3|||
124431825|NCT00969709|447541987|FG001|Overall Study|Adverse Event|13|||
124431826|NCT00969709|447541988|FG002|Overall Study|Adverse Event|26|||
124431827|NCT00969709|447541989|FG003|Overall Study|Adverse Event|12|||
124431828|NCT00969709|447541986|FG000|Overall Study|Lack of Efficacy|7|||
124431829|NCT00969709|447541987|FG001|Overall Study|Lack of Efficacy|4|||
124431830|NCT00969709|447541988|FG002|Overall Study|Lack of Efficacy|1|||
124431831|NCT00969709|447541989|FG003|Overall Study|Lack of Efficacy|3|||
124431832|NCT00969709|447541986|FG000|Overall Study|Protocol Violation|9|||
124431833|NCT00969709|447541987|FG001|Overall Study|Protocol Violation|5|||
124431834|NCT00969709|447541988|FG002|Overall Study|Protocol Violation|9|||
124431835|NCT00969709|447541989|FG003|Overall Study|Protocol Violation|10|||
124431836|NCT00969709|447541986|FG000|Overall Study|Withdrawal by Subject|9|||
124431837|NCT00969709|447541987|FG001|Overall Study|Withdrawal by Subject|12|||
124431838|NCT00969709|447541988|FG002|Overall Study|Withdrawal by Subject|11|||
124431839|NCT00969709|447541989|FG003|Overall Study|Withdrawal by Subject|23|||
124431840|NCT00969709|447541986|FG000|Overall Study|Lost to Follow-up|10|||
124431841|NCT00969709|447541987|FG001|Overall Study|Lost to Follow-up|14|||
124431842|NCT00969709|447541988|FG002|Overall Study|Lost to Follow-up|8|||
124431843|NCT00969709|447541989|FG003|Overall Study|Lost to Follow-up|15|||
124431844|NCT00969709|447541986|FG000|Overall Study|Other reasons|0|||
124431845|NCT00969709|447541987|FG001|Overall Study|Other reasons|0|||
124431846|NCT00969709|447541988|FG002|Overall Study|Other reasons|3|||
124431847|NCT00969709|447541989|FG003|Overall Study|Other reasons|0|||
124431848|NCT02980731|447541990|FG000|Overall Study|Death|63|||
124431849|NCT02980731|447541990|FG000|Overall Study|Withdrawal by Subject|6|||
124431850|NCT02980731|447541990|FG000|Overall Study|Lost to Follow-up|5|||
124676858|NCT00903968|448442126|FG003|Overall Study|Withdrawal by Subject|0|||
124431851|NCT02980731|447541990|FG000|Overall Study|Study terminated by Sponsor|4|||
124431852|NCT02980731|447541990|FG000|Overall Study|Completed survival follow-up period|65|||
124431853|NCT02980731|447541990|FG000|Overall Study|COVID-19 infection|1|||
124431854|NCT02980731|447541990|FG000|Overall Study|Other, not specified|66|||
124431855|NCT01342341|447541991|FG000|Overall Study|Lost to Follow-up|4|||
124676859|NCT00903968|448442127|FG004|Overall Study|Withdrawal by Subject|1|||
124676860|NCT00903968|448442128|FG005|Overall Study|Withdrawal by Subject|1|||
124676861|NCT00903968|448442129|FG006|Overall Study|Withdrawal by Subject|0|||
124676862|NCT00903968|448442130|FG007|Overall Study|Withdrawal by Subject|4|||
124676863|NCT00903968|448442123|FG000|Overall Study|Non-Compliance|0|||
124676864|NCT00903968|448442124|FG001|Overall Study|Non-Compliance|0|||
124676865|NCT00903968|448442125|FG002|Overall Study|Non-Compliance|0|||
124431856|NCT01342341|447541992|FG001|Overall Study|Lost to Follow-up|4|||
124431857|NCT01238900|447541993|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
124431858|NCT01238900|447541993|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
124431859|NCT00616902|447541994|FG000|Overall Study|Termination of study|6|||
124431860|NCT00616902|447541995|FG001|Overall Study|Termination of study|6|||
124431861|NCT03725085|447541996|FG000|Overall Study|Lost to Follow-up|2|||
124431862|NCT01119105|447541997|FG000|Overall Study|Withdrawal by Subject|1|||
124431863|NCT01119105|447541998|FG001|Overall Study|Withdrawal by Subject|1|||
124431864|NCT01119105|447541999|FG002|Overall Study|Withdrawal by Subject|1|||
124431865|NCT01119105|447541997|FG000|Overall Study|Lost to Follow-up|0|||
124431866|NCT01119105|447541998|FG001|Overall Study|Lost to Follow-up|2|||
124431867|NCT01119105|447541999|FG002|Overall Study|Lost to Follow-up|5|||
124431868|NCT01119105|447541997|FG000|Overall Study|Adverse Event|1|||
124431869|NCT01119105|447541998|FG001|Overall Study|Adverse Event|0|||
124431870|NCT01119105|447541999|FG002|Overall Study|Adverse Event|1|||
124431871|NCT01119105|447541997|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
124431872|NCT01119105|447541998|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
124431873|NCT01119105|447541999|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
124431874|NCT01119105|447541997|FG000|Overall Study|Other|1|||
124431875|NCT01119105|447541998|FG001|Overall Study|Other|1|||
124431876|NCT01119105|447541999|FG002|Overall Study|Other|0|||
124431877|NCT01775475|447542000|FG000|Overall Study|Death|3|||
124676866|NCT00903968|448442126|FG003|Overall Study|Non-Compliance|0|||
124676867|NCT00903968|448442127|FG004|Overall Study|Non-Compliance|0|||
124676868|NCT00903968|448442128|FG005|Overall Study|Non-Compliance|1|||
124676869|NCT00903968|448442129|FG006|Overall Study|Non-Compliance|0|||
124676870|NCT00903968|448442130|FG007|Overall Study|Non-Compliance|0|||
124676871|NCT00903968|448442123|FG000|Overall Study|Physician Decision|0|||
124676872|NCT00903968|448442124|FG001|Overall Study|Physician Decision|0|||
124676873|NCT00903968|448442125|FG002|Overall Study|Physician Decision|0|||
124676874|NCT00903968|448442126|FG003|Overall Study|Physician Decision|0|||
124676875|NCT00903968|448442127|FG004|Overall Study|Physician Decision|0|||
124431878|NCT01775475|447542001|FG001|Overall Study|Death|3|||
124431879|NCT02245737|447542007|FG000|Overall Study|Adverse Event|23|||
124431880|NCT02245737|447542008|FG001|Overall Study|Adverse Event|26|||
124431881|NCT02245737|447542009|FG002|Overall Study|Adverse Event|33|||
124431882|NCT02245737|447542007|FG000|Overall Study|Condition Worsened|9|||
124431883|NCT02245737|447542008|FG001|Overall Study|Condition Worsened|10|||
124431884|NCT02245737|447542009|FG002|Overall Study|Condition Worsened|9|||
124431885|NCT02245737|447542007|FG000|Overall Study|Death|2|||
124431886|NCT02245737|447542008|FG001|Overall Study|Death|4|||
124431887|NCT02245737|447542009|FG002|Overall Study|Death|4|||
124431888|NCT02245737|447542007|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
124431889|NCT02245737|447542008|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
124431890|NCT02245737|447542009|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
124431891|NCT02245737|447542007|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
124431892|NCT02245737|447542008|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
124431893|NCT02245737|447542009|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
124431894|NCT02245737|447542007|FG000|Overall Study|Lost to Follow-up|2|||
124676876|NCT00903968|448442128|FG005|Overall Study|Physician Decision|1|||
124676877|NCT00903968|448442129|FG006|Overall Study|Physician Decision|0|||
124676878|NCT00903968|448442130|FG007|Overall Study|Physician Decision|0|||
124676879|NCT00903968|448442123|FG000|Overall Study|Progressive Disease|2|||
124676880|NCT00903968|448442124|FG001|Overall Study|Progressive Disease|3|||
124676881|NCT00903968|448442125|FG002|Overall Study|Progressive Disease|2|||
124676882|NCT00903968|448442126|FG003|Overall Study|Progressive Disease|3|||
124676883|NCT00903968|448442127|FG004|Overall Study|Progressive Disease|3|||
124676884|NCT00903968|448442128|FG005|Overall Study|Progressive Disease|3|||
124676885|NCT00903968|448442129|FG006|Overall Study|Progressive Disease|0|||
124676886|NCT00903968|448442130|FG007|Overall Study|Progressive Disease|18|||
124676887|NCT00903968|448442123|FG000|Overall Study|Lack of Efficacy|0|||
124676888|NCT00903968|448442124|FG001|Overall Study|Lack of Efficacy|0|||
124676889|NCT00903968|448442125|FG002|Overall Study|Lack of Efficacy|0|||
124676890|NCT00903968|448442126|FG003|Overall Study|Lack of Efficacy|0|||
124431895|NCT02245737|447542008|FG001|Overall Study|Lost to Follow-up|5|||
124431896|NCT02245737|447542009|FG002|Overall Study|Lost to Follow-up|4|||
124431897|NCT02245737|447542007|FG000|Overall Study|Other-determined by Investigator|9|||
124431898|NCT02245737|447542008|FG001|Overall Study|Other-determined by Investigator|10|||
124431899|NCT02245737|447542009|FG002|Overall Study|Other-determined by Investigator|10|||
124431900|NCT02245737|447542007|FG000|Overall Study|Physician Decision|6|||
124431901|NCT02245737|447542008|FG001|Overall Study|Physician Decision|3|||
124431902|NCT02245737|447542009|FG002|Overall Study|Physician Decision|6|||
124431903|NCT02245737|447542007|FG000|Overall Study|Protocol Violation|3|||
124431904|NCT02245737|447542008|FG001|Overall Study|Protocol Violation|2|||
124431905|NCT02245737|447542009|FG002|Overall Study|Protocol Violation|3|||
124431906|NCT02245737|447542007|FG000|Overall Study|Withdrawal by Subject|40|||
124431907|NCT02245737|447542008|FG001|Overall Study|Withdrawal by Subject|41|||
124431908|NCT02245737|447542009|FG002|Overall Study|Withdrawal by Subject|44|||
124431909|NCT02245737|447542007|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
124431910|NCT02245737|447542008|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
124431911|NCT02245737|447542009|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
124431912|NCT02245737|447542007|FG000|Overall Study|Sponsor Decision|445|||
124431913|NCT02245737|447542008|FG001|Overall Study|Sponsor Decision|430|||
124431914|NCT02245737|447542009|FG002|Overall Study|Sponsor Decision|432|||
124431915|NCT00618618|447542011|FG000|Overall Study|Patient Request|0|||
124431916|NCT00618618|447542012|FG001|Overall Study|Patient Request|0|||
124431917|NCT00618618|447542013|FG002|Overall Study|Patient Request|2|||
124431918|NCT00618618|447542014|FG003|Overall Study|Patient Request|0|||
124431919|NCT00618618|447542011|FG000|Overall Study|Inability to Complete Study Procedures|0|||
124431920|NCT00618618|447542012|FG001|Overall Study|Inability to Complete Study Procedures|1|||
124431921|NCT00618618|447542013|FG002|Overall Study|Inability to Complete Study Procedures|0|||
124431922|NCT00618618|447542014|FG003|Overall Study|Inability to Complete Study Procedures|0|||
124431923|NCT00618618|447542011|FG000|Overall Study|Lost to Follow-up|3|||
124431924|NCT00618618|447542012|FG001|Overall Study|Lost to Follow-up|0|||
124431925|NCT00618618|447542013|FG002|Overall Study|Lost to Follow-up|0|||
124431926|NCT00618618|447542014|FG003|Overall Study|Lost to Follow-up|1|||
124431927|NCT00618618|447542011|FG000|Overall Study|Non-compliance|1|||
124431928|NCT00618618|447542012|FG001|Overall Study|Non-compliance|1|||
124431929|NCT00618618|447542013|FG002|Overall Study|Non-compliance|0|||
124676891|NCT00903968|448442127|FG004|Overall Study|Lack of Efficacy|0|||
124431930|NCT00618618|447542014|FG003|Overall Study|Non-compliance|0|||
124676892|NCT00903968|448442128|FG005|Overall Study|Lack of Efficacy|0|||
124676893|NCT00903968|448442129|FG006|Overall Study|Lack of Efficacy|0|||
124676894|NCT00903968|448442130|FG007|Overall Study|Lack of Efficacy|3|||
124431931|NCT00618618|447542011|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
124431932|NCT00618618|447542012|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
124431933|NCT00618618|447542013|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
124431934|NCT00618618|447542014|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
124431935|NCT00618618|447542011|FG000|Overall Study|Death|0|||
124431936|NCT00618618|447542012|FG001|Overall Study|Death|1|||
124431937|NCT00618618|447542013|FG002|Overall Study|Death|0|||
124431938|NCT00618618|447542014|FG003|Overall Study|Death|0|||
124431939|NCT02929329|447542017|FG000|Overall Study|Withdrawal by Subject|24|||
124431940|NCT02929329|447542018|FG001|Overall Study|Withdrawal by Subject|21|||
124431941|NCT02929329|447542017|FG000|Overall Study|Lost to Follow-up|26|||
124431942|NCT02929329|447542018|FG001|Overall Study|Lost to Follow-up|20|||
124431943|NCT02929329|447542017|FG000|Overall Study|Death|1054|||
124431944|NCT02929329|447542018|FG001|Overall Study|Death|1051|||
124431945|NCT00309959|447542025|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
124431946|NCT01983254|447542026|FG000|Overall Study|Death|6|||
124431947|NCT01983254|447542027|FG001|Overall Study|Death|6|||
124431948|NCT01983254|447542026|FG000|Overall Study|Lost to Follow-up|17|||
124431949|NCT01983254|447542027|FG001|Overall Study|Lost to Follow-up|16|||
124431950|NCT01983254|447542026|FG000|Overall Study|too ill|11|||
124676895|NCT04539275|448442131|FG000|Overall Study|Death|2|||
124431951|NCT01983254|447542027|FG001|Overall Study|too ill|8|||
124431952|NCT00434213|447542028|FG000|Overall Study|Adverse Event|12|||
124431953|NCT00434213|447542028|FG000|Overall Study|Lack of Efficacy|9|||
124676896|NCT04539275|448442132|FG001|Overall Study|Death|4|||
124676897|NCT04539275|448442131|FG000|Overall Study|Lost to Follow-up|1|||
124676898|NCT04539275|448442132|FG001|Overall Study|Lost to Follow-up|1|||
124676899|NCT04539275|448442131|FG000|Overall Study|Withdrawal by Subject|3|||
124676900|NCT04539275|448442132|FG001|Overall Study|Withdrawal by Subject|0|||
124676901|NCT01373164|448442137|FG000|Overall Study|Lost to Follow-up|0|||
124676902|NCT01373164|448442138|FG001|Overall Study|Lost to Follow-up|0|||
124431954|NCT00434213|447542028|FG000|Overall Study|Lost to Follow-up|14|||
124431955|NCT00434213|447542028|FG000|Overall Study|Withdrawal by Subject|7|||
124431956|NCT00434213|447542028|FG000|Overall Study|Protocol Violation|3|||
124431957|NCT00434213|447542028|FG000|Overall Study|Unable to comply with study visit window|2|||
124431958|NCT00434213|447542028|FG000|Overall Study|Application site reaction|1|||
124431959|NCT00434213|447542028|FG000|Overall Study|Non-compliant to study schedule|1|||
124431960|NCT00768079|447542029|FG000|Overall Study|Lost to Follow-up|2|||
124431961|NCT00768079|447542030|FG001|Overall Study|Lost to Follow-up|0|||
124431962|NCT00768079|447542031|FG002|Overall Study|Lost to Follow-up|4|||
124431963|NCT00768079|447542029|FG000|Overall Study|Participant incarcerated|0|||
124431964|NCT00768079|447542030|FG001|Overall Study|Participant incarcerated|1|||
124431965|NCT00768079|447542031|FG002|Overall Study|Participant incarcerated|0|||
124431966|NCT01859988|447542039|FG000|Overall Study|Withdrawal by Subject|6|||
124431967|NCT01859988|447542040|FG001|Overall Study|Withdrawal by Subject|3|||
124431968|NCT01859988|447542041|FG002|Overall Study|Withdrawal by Subject|4|||
124431969|NCT01859988|447542042|FG003|Overall Study|Withdrawal by Subject|3|||
124431970|NCT01859988|447542043|FG004|Overall Study|Withdrawal by Subject|2|||
124431971|NCT01859988|447542044|FG005|Overall Study|Withdrawal by Subject|2|||
124431972|NCT01859988|447542039|FG000|Overall Study|Lack of Efficacy|1|||
124431973|NCT01859988|447542040|FG001|Overall Study|Lack of Efficacy|1|||
124431974|NCT01859988|447542041|FG002|Overall Study|Lack of Efficacy|5|||
124431975|NCT01859988|447542042|FG003|Overall Study|Lack of Efficacy|0|||
124431976|NCT01859988|447542043|FG004|Overall Study|Lack of Efficacy|7|||
124431977|NCT01859988|447542044|FG005|Overall Study|Lack of Efficacy|9|||
124431978|NCT01859988|447542039|FG000|Overall Study|Physician Decision|1|||
124431979|NCT01859988|447542040|FG001|Overall Study|Physician Decision|3|||
124676903|NCT01373164|448442139|FG002|Overall Study|Lost to Follow-up|1|||
124431980|NCT01859988|447542041|FG002|Overall Study|Physician Decision|1|||
124431981|NCT01859988|447542042|FG003|Overall Study|Physician Decision|3|||
124431982|NCT01859988|447542043|FG004|Overall Study|Physician Decision|4|||
124431983|NCT01859988|447542044|FG005|Overall Study|Physician Decision|1|||
124431984|NCT01859988|447542039|FG000|Overall Study|Adverse Event|2|||
124431985|NCT01859988|447542040|FG001|Overall Study|Adverse Event|1|||
124431986|NCT01859988|447542041|FG002|Overall Study|Adverse Event|3|||
124431987|NCT01859988|447542042|FG003|Overall Study|Adverse Event|1|||
124431988|NCT01859988|447542043|FG004|Overall Study|Adverse Event|2|||
124431989|NCT01859988|447542044|FG005|Overall Study|Adverse Event|2|||
124431990|NCT01859988|447542039|FG000|Overall Study|Lost to Follow-up|1|||
124431991|NCT01859988|447542040|FG001|Overall Study|Lost to Follow-up|2|||
124431992|NCT01859988|447542041|FG002|Overall Study|Lost to Follow-up|3|||
124431993|NCT01859988|447542042|FG003|Overall Study|Lost to Follow-up|0|||
124431994|NCT01859988|447542043|FG004|Overall Study|Lost to Follow-up|3|||
124431995|NCT01859988|447542044|FG005|Overall Study|Lost to Follow-up|2|||
124431996|NCT01859988|447542039|FG000|Overall Study|Protocol Violation|0|||
124431997|NCT01859988|447542040|FG001|Overall Study|Protocol Violation|0|||
124431998|NCT01859988|447542041|FG002|Overall Study|Protocol Violation|1|||
124431999|NCT01859988|447542042|FG003|Overall Study|Protocol Violation|0|||
124432000|NCT01859988|447542043|FG004|Overall Study|Protocol Violation|0|||
124432001|NCT01859988|447542044|FG005|Overall Study|Protocol Violation|0|||
124432002|NCT01859988|447542039|FG000|Overall Study|Other than specified above|0|||
124432003|NCT01859988|447542040|FG001|Overall Study|Other than specified above|2|||
124432004|NCT01859988|447542041|FG002|Overall Study|Other than specified above|11|||
124432005|NCT01859988|447542042|FG003|Overall Study|Other than specified above|3|||
124432006|NCT01859988|447542043|FG004|Overall Study|Other than specified above|5|||
124432007|NCT01859988|447542044|FG005|Overall Study|Other than specified above|3|||
124432008|NCT02706899|447542049|FG000|Overall Study|Withdrawal by Subject|1|||
124432009|NCT02706899|447542050|FG001|Overall Study|Withdrawal by Subject|0|||
124432010|NCT02706899|447542049|FG000|Overall Study|Death|8|||
124432011|NCT02706899|447542050|FG001|Overall Study|Death|0|||
124432012|NCT02706899|447542049|FG000|Overall Study|Study Termination by Sponsor|4|||
124432013|NCT02706899|447542050|FG001|Overall Study|Study Termination by Sponsor|6|||
124432014|NCT01435616|447542051|FG000|Overall Study|Adverse Event|39|||
124432015|NCT01435616|447542052|FG001|Overall Study|Adverse Event|21|||
124432016|NCT01435616|447542051|FG000|Overall Study|Death|7|||
124432017|NCT01435616|447542052|FG001|Overall Study|Death|2|||
124432018|NCT01435616|447542051|FG000|Overall Study|Lost to Follow-up|22|||
124432019|NCT01435616|447542052|FG001|Overall Study|Lost to Follow-up|13|||
124432020|NCT01435616|447542051|FG000|Overall Study|Protocol Violation|16|||
124432021|NCT01435616|447542052|FG001|Overall Study|Protocol Violation|13|||
124432022|NCT01435616|447542051|FG000|Overall Study|Withdrawal by Subject|66|||
124432023|NCT01435616|447542052|FG001|Overall Study|Withdrawal by Subject|24|||
124432024|NCT01435616|447542051|FG000|Overall Study|Physician Decision|20|||
124432025|NCT01435616|447542052|FG001|Overall Study|Physician Decision|7|||
124432026|NCT01435616|447542051|FG000|Overall Study|Sponsor Decision|1|||
124432027|NCT01435616|447542052|FG001|Overall Study|Sponsor Decision|0|||
124432028|NCT00371683|447542053|FG000|DB Treatment Period-Randomized Patients|Death|1|||
124676904|NCT01373164|448442140|FG003|Overall Study|Lost to Follow-up|2|||
124676905|NCT01373164|448442141|FG004|Overall Study|Lost to Follow-up|0|||
124676906|NCT01373164|448442137|FG000|Overall Study|Withdrawal by Subject|0|||
124676907|NCT01373164|448442138|FG001|Overall Study|Withdrawal by Subject|1|||
124676908|NCT01373164|448442139|FG002|Overall Study|Withdrawal by Subject|0|||
124676909|NCT01373164|448442140|FG003|Overall Study|Withdrawal by Subject|10|||
124676910|NCT01373164|448442141|FG004|Overall Study|Withdrawal by Subject|2|||
124676911|NCT01799941|448442146|FG000|Overall Study|Adverse Event|34|||
124676912|NCT01799941|448442146|FG000|Overall Study|Withdrawal by Subject|21|||
124676913|NCT01799941|448442146|FG000|Overall Study|Death|2|||
124676914|NCT01799941|448442146|FG000|Overall Study|Investigator Decision|4|||
124676915|NCT01799941|448442146|FG000|Overall Study|Lack of Efficacy|3|||
124676916|NCT01799941|448442146|FG000|Overall Study|Lost to Follow-up|17|||
124676917|NCT01799941|448442146|FG000|Overall Study|Other|15|||
124676918|NCT00420745|448442147|FG000|Overall Study|Adverse Event|2|||
124676919|NCT00420745|448442148|FG001|Overall Study|Adverse Event|2|||
124676920|NCT00420745|448442147|FG000|Overall Study|Lost to Follow-up|10|||
124676921|NCT00420745|448442148|FG001|Overall Study|Lost to Follow-up|2|||
124676922|NCT00420745|448442147|FG000|Overall Study|Protocol Violation|1|||
124676923|NCT00420745|448442148|FG001|Overall Study|Protocol Violation|0|||
124676924|NCT00420745|448442147|FG000|Overall Study|Physician Decision|1|||
124676925|NCT00420745|448442148|FG001|Overall Study|Physician Decision|1|||
124676926|NCT00420745|448442147|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
124676927|NCT00420745|448442148|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
124676928|NCT00420745|448442147|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
124676929|NCT00420745|448442148|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
124676930|NCT01125930|448442156|FG000|Overall Study|Adverse Event|0|||
124676931|NCT01125930|448442157|FG001|Overall Study|Adverse Event|1|||
124676932|NCT01125930|448442156|FG000|Overall Study|Withdrawal by Subject|1|||
124676933|NCT01125930|448442157|FG001|Overall Study|Withdrawal by Subject|6|||
124676934|NCT01125930|448442156|FG000|Overall Study|Protocol Violation|0|||
124676935|NCT01125930|448442157|FG001|Overall Study|Protocol Violation|1|||
124676936|NCT01125930|448442156|FG000|Overall Study|Lost to Follow-up|0|||
124676937|NCT01125930|448442157|FG001|Overall Study|Lost to Follow-up|2|||
124676938|NCT01715831|448442158|FG000|Overall Study|Adverse Event|1|||
124676939|NCT02426684|448442159|FG000|Overall Study|Physician Decision|1|||
124676940|NCT02419807|448442160|FG000|Overall Study|Withdrawal by Subject|4|||
124676941|NCT02419807|448442160|FG000|Overall Study|Physician Decision|1|||
124676942|NCT02419807|448442160|FG000|Overall Study|Protocol Violation|5|||
124676943|NCT04018066|448442163|FG000|Overall Study|participants started taking medications during the study period|3|||
124676944|NCT04018066|448442163|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
124676945|NCT03817528|448442164|FG000|Overall Study|Withdrawal by Subject|1|||
124676946|NCT03817528|448442164|FG000|Overall Study|Adverse Event|2|||
124676947|NCT01663623|448442171|FG000|Overall Study|Adverse Event|3|||
124676948|NCT01663623|448442172|FG001|Overall Study|Adverse Event|7|||
124676949|NCT01663623|448442171|FG000|Overall Study|Lack of Efficacy|5|||
124676950|NCT01663623|448442172|FG001|Overall Study|Lack of Efficacy|6|||
124676951|NCT01663623|448442171|FG000|Overall Study|Protocol Violation|0|||
124676952|NCT01663623|448442172|FG001|Overall Study|Protocol Violation|1|||
124676953|NCT01663623|448442171|FG000|Overall Study|Other-Study closed/terminated|1|||
124676954|NCT01663623|448442172|FG001|Overall Study|Other-Study closed/terminated|1|||
124676955|NCT01663623|448442171|FG000|Overall Study|Physician Decision|1|||
124676956|NCT01663623|448442172|FG001|Overall Study|Physician Decision|4|||
124676957|NCT01663623|448442171|FG000|Overall Study|Withdrawal by Subject|2|||
124676958|NCT01663623|448442172|FG001|Overall Study|Withdrawal by Subject|1|||
124676959|NCT02251275|448442173|FG000|Overall Study|Adverse Event|23|||
124676960|NCT02251275|448442174|FG001|Overall Study|Adverse Event|60|||
124676961|NCT02251275|448442175|FG002|Overall Study|Adverse Event|28|||
124676962|NCT02251275|448442176|FG003|Overall Study|Adverse Event|0|||
124676963|NCT02251275|448442177|FG004|Overall Study|Adverse Event|0|||
124676964|NCT02251275|448442173|FG000|Overall Study|Lost to Follow-up|5|||
124676965|NCT02251275|448442174|FG001|Overall Study|Lost to Follow-up|6|||
124676966|NCT02251275|448442175|FG002|Overall Study|Lost to Follow-up|4|||
124676967|NCT02251275|448442176|FG003|Overall Study|Lost to Follow-up|0|||
124676968|NCT02251275|448442177|FG004|Overall Study|Lost to Follow-up|0|||
124676969|NCT02251275|448442173|FG000|Overall Study|Physician Decision|19|||
124676970|NCT02251275|448442174|FG001|Overall Study|Physician Decision|30|||
124676971|NCT02251275|448442175|FG002|Overall Study|Physician Decision|26|||
124676972|NCT02251275|448442176|FG003|Overall Study|Physician Decision|0|||
124676973|NCT02251275|448442177|FG004|Overall Study|Physician Decision|1|||
124676974|NCT02251275|448442173|FG000|Overall Study|Protocol Deviation|0|||
124676975|NCT02251275|448442174|FG001|Overall Study|Protocol Deviation|0|||
124676976|NCT02251275|448442175|FG002|Overall Study|Protocol Deviation|1|||
124676977|NCT02251275|448442176|FG003|Overall Study|Protocol Deviation|0|||
124676978|NCT02251275|448442177|FG004|Overall Study|Protocol Deviation|0|||
124676979|NCT02251275|448442173|FG000|Overall Study|Withdrawal by Subject|25|||
124676980|NCT02251275|448442174|FG001|Overall Study|Withdrawal by Subject|51|||
124676981|NCT02251275|448442175|FG002|Overall Study|Withdrawal by Subject|35|||
124676982|NCT02251275|448442176|FG003|Overall Study|Withdrawal by Subject|1|||
124676983|NCT02251275|448442177|FG004|Overall Study|Withdrawal by Subject|0|||
124676984|NCT00856180|448442183|FG000|Overall Study|Adverse Event|4|||
124676985|NCT00856180|448442183|FG000|Overall Study|Progressive Disease|16|||
124676986|NCT02265510|448442184|FG000|Overall Study|Withdrawal by Subject|1|||
124676987|NCT02265510|448442185|FG001|Overall Study|Withdrawal by Subject|1|||
124676988|NCT02265510|448442186|FG002|Overall Study|Withdrawal by Subject|2|||
124676989|NCT02265510|448442187|FG003|Overall Study|Withdrawal by Subject|1|||
124676990|NCT02265510|448442188|FG004|Overall Study|Withdrawal by Subject|0|||
124676991|NCT02265510|448442189|FG005|Overall Study|Withdrawal by Subject|2|||
124676992|NCT02265510|448442190|FG006|Overall Study|Withdrawal by Subject|0|||
124676993|NCT02265510|448442191|FG007|Overall Study|Withdrawal by Subject|2|||
124676994|NCT02265510|448442192|FG008|Overall Study|Withdrawal by Subject|0|||
124676995|NCT02265510|448442193|FG009|Overall Study|Withdrawal by Subject|0|||
124676996|NCT02265510|448442194|FG010|Overall Study|Withdrawal by Subject|0|||
124676997|NCT02265510|448442195|FG011|Overall Study|Withdrawal by Subject|0|||
124676998|NCT02265510|448442196|FG012|Overall Study|Withdrawal by Subject|1|||
124432029|NCT00371683|447542054|FG001|DB Treatment Period-Randomized Patients|Death|1|||
124432030|NCT00371683|447542053|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
124432031|NCT00371683|447542054|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
124432032|NCT00371683|447542053|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
124432033|NCT00371683|447542054|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
124432034|NCT00371683|447542053|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
124432035|NCT00371683|447542054|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
124676999|NCT02265510|448442197|FG013|Overall Study|Withdrawal by Subject|0|||
124677000|NCT02265510|448442184|FG000|Overall Study|Disease Progression|0|||
124677001|NCT02265510|448442185|FG001|Overall Study|Disease Progression|1|||
124677002|NCT02265510|448442186|FG002|Overall Study|Disease Progression|2|||
124677003|NCT02265510|448442187|FG003|Overall Study|Disease Progression|1|||
124677004|NCT02265510|448442188|FG004|Overall Study|Disease Progression|1|||
124677005|NCT02265510|448442189|FG005|Overall Study|Disease Progression|0|||
124677006|NCT02265510|448442190|FG006|Overall Study|Disease Progression|0|||
124677007|NCT02265510|448442191|FG007|Overall Study|Disease Progression|0|||
124677008|NCT02265510|448442192|FG008|Overall Study|Disease Progression|0|||
124677009|NCT02265510|448442193|FG009|Overall Study|Disease Progression|0|||
124677010|NCT02265510|448442194|FG010|Overall Study|Disease Progression|0|||
124677011|NCT02265510|448442195|FG011|Overall Study|Disease Progression|0|||
124677012|NCT02265510|448442196|FG012|Overall Study|Disease Progression|0|||
124677013|NCT02265510|448442197|FG013|Overall Study|Disease Progression|0|||
124677014|NCT02265510|448442184|FG000|Overall Study|Death|2|||
124677015|NCT02265510|448442185|FG001|Overall Study|Death|0|||
124677016|NCT02265510|448442186|FG002|Overall Study|Death|2|||
124677017|NCT02265510|448442187|FG003|Overall Study|Death|2|||
124677018|NCT02265510|448442188|FG004|Overall Study|Death|1|||
124677019|NCT02265510|448442189|FG005|Overall Study|Death|3|||
124677020|NCT02265510|448442190|FG006|Overall Study|Death|2|||
124677021|NCT02265510|448442191|FG007|Overall Study|Death|1|||
124677022|NCT02265510|448442192|FG008|Overall Study|Death|3|||
124677023|NCT02265510|448442193|FG009|Overall Study|Death|3|||
124677024|NCT02265510|448442194|FG010|Overall Study|Death|4|||
124677025|NCT02265510|448442195|FG011|Overall Study|Death|12|||
124677026|NCT02265510|448442196|FG012|Overall Study|Death|7|||
124677027|NCT02265510|448442197|FG013|Overall Study|Death|6|||
124677028|NCT02265510|448442184|FG000|Overall Study|Lost to Follow-up|0|||
124677029|NCT02265510|448442185|FG001|Overall Study|Lost to Follow-up|0|||
124677030|NCT02265510|448442186|FG002|Overall Study|Lost to Follow-up|0|||
124677031|NCT02265510|448442187|FG003|Overall Study|Lost to Follow-up|0|||
124677032|NCT02265510|448442188|FG004|Overall Study|Lost to Follow-up|1|||
124677033|NCT02265510|448442189|FG005|Overall Study|Lost to Follow-up|0|||
124677034|NCT02265510|448442190|FG006|Overall Study|Lost to Follow-up|0|||
124677035|NCT02265510|448442191|FG007|Overall Study|Lost to Follow-up|0|||
124677036|NCT02265510|448442192|FG008|Overall Study|Lost to Follow-up|0|||
124677037|NCT02265510|448442193|FG009|Overall Study|Lost to Follow-up|2|||
124677038|NCT02265510|448442194|FG010|Overall Study|Lost to Follow-up|0|||
124677039|NCT02265510|448442195|FG011|Overall Study|Lost to Follow-up|0|||
124677040|NCT02265510|448442196|FG012|Overall Study|Lost to Follow-up|0|||
124677041|NCT02265510|448442197|FG013|Overall Study|Lost to Follow-up|2|||
124677042|NCT02265510|448442184|FG000|Overall Study|Other|0|||
124677043|NCT02265510|448442185|FG001|Overall Study|Other|1|||
124677044|NCT02265510|448442186|FG002|Overall Study|Other|0|||
124677045|NCT02265510|448442187|FG003|Overall Study|Other|0|||
124677046|NCT02265510|448442188|FG004|Overall Study|Other|0|||
124758646|NCT01463306|448739820|FG000|Overall Study|Withdrawal by Subject|19|||
124758647|NCT01463306|448739821|FG001|Overall Study|Withdrawal by Subject|9|||
124758648|NCT01463306|448739822|FG002|Overall Study|Withdrawal by Subject|1|||
124758649|NCT01463306|448739820|FG000|Overall Study|Other|26|||
124758650|NCT01463306|448739821|FG001|Overall Study|Other|13|||
124758651|NCT01463306|448739822|FG002|Overall Study|Other|0|||
124758652|NCT01463306|448739820|FG000|Overall Study|Approval expiry at site|1|||
124758653|NCT01463306|448739821|FG001|Overall Study|Approval expiry at site|0|||
124758654|NCT01463306|448739822|FG002|Overall Study|Approval expiry at site|0|||
124432036|NCT00371683|447542053|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
124432037|NCT00371683|447542054|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
124432038|NCT00371683|447542053|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
124432039|NCT00371683|447542054|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
124432040|NCT00371683|447542053|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
124432041|NCT00371683|447542054|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
124432042|NCT00371683|447542053|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
124432043|NCT00371683|447542054|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
124432044|NCT00371683|447542053|FG000|Follow-Up Period - Randomized Patients|Death|0|||
124432045|NCT00371683|447542054|FG001|Follow-Up Period - Randomized Patients|Death|2|||
124432046|NCT00371683|447542053|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
124432047|NCT00371683|447542054|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
124432048|NCT00371683|447542053|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
124432049|NCT00371683|447542054|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
124432050|NCT03122223|447542055|FG000|Overall Study|Withdrawal by Subject|2|||
124432051|NCT03122223|447542056|FG001|Overall Study|Withdrawal by Subject|2|||
124432052|NCT03122223|447542057|FG002|Overall Study|Withdrawal by Subject|1|||
124758655|NCT02679287|448739823|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
124758656|NCT02679287|448739824|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
124758657|NCT02679287|448739823|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
124758658|NCT02679287|448739824|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
124758659|NCT02679287|448739823|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
124432053|NCT03122223|447542058|FG003|Overall Study|Withdrawal by Subject|0|||
124432054|NCT03122223|447542055|FG000|Overall Study|Lost to Follow-up|0|||
124432055|NCT03122223|447542056|FG001|Overall Study|Lost to Follow-up|2|||
124432056|NCT03122223|447542057|FG002|Overall Study|Lost to Follow-up|2|||
124677047|NCT02265510|448442189|FG005|Overall Study|Other|0|||
124677048|NCT02265510|448442190|FG006|Overall Study|Other|0|||
124677049|NCT02265510|448442191|FG007|Overall Study|Other|0|||
124677050|NCT02265510|448442192|FG008|Overall Study|Other|0|||
124758660|NCT02679287|448739824|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
124677051|NCT02265510|448442193|FG009|Overall Study|Other|0|||
124677052|NCT02265510|448442194|FG010|Overall Study|Other|0|||
124677053|NCT02265510|448442195|FG011|Overall Study|Other|0|||
124677054|NCT02265510|448442196|FG012|Overall Study|Other|0|||
124677055|NCT02265510|448442197|FG013|Overall Study|Other|0|||
124677056|NCT02265510|448442184|FG000|Overall Study|Study Terminated by Sponsor|0|||
124677057|NCT02265510|448442185|FG001|Overall Study|Study Terminated by Sponsor|0|||
124677058|NCT02265510|448442186|FG002|Overall Study|Study Terminated by Sponsor|0|||
124677059|NCT02265510|448442187|FG003|Overall Study|Study Terminated by Sponsor|0|||
124677060|NCT02265510|448442188|FG004|Overall Study|Study Terminated by Sponsor|0|||
124677061|NCT02265510|448442189|FG005|Overall Study|Study Terminated by Sponsor|1|||
124677062|NCT02265510|448442190|FG006|Overall Study|Study Terminated by Sponsor|1|||
124677063|NCT02265510|448442191|FG007|Overall Study|Study Terminated by Sponsor|1|||
124677064|NCT02265510|448442192|FG008|Overall Study|Study Terminated by Sponsor|1|||
124677065|NCT02265510|448442193|FG009|Overall Study|Study Terminated by Sponsor|2|||
124677066|NCT02265510|448442194|FG010|Overall Study|Study Terminated by Sponsor|1|||
124677067|NCT02265510|448442195|FG011|Overall Study|Study Terminated by Sponsor|4|||
124677068|NCT02265510|448442196|FG012|Overall Study|Study Terminated by Sponsor|1|||
124677069|NCT02265510|448442197|FG013|Overall Study|Study Terminated by Sponsor|2|||
124677070|NCT01004614|448442198|FG000|Washout|Withdrawal by Subject|0|||
124677071|NCT01004614|448442199|FG001|Washout|Withdrawal by Subject|1|||
124677072|NCT01004614|448442200|FG002|Washout|Withdrawal by Subject|0|||
124677073|NCT01004614|448442201|FG003|Washout|Withdrawal by Subject|0|||
124677074|NCT02111083|448442202|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
124677075|NCT02111083|448442203|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
124677076|NCT01462942|448442206|FG000|Overall Study|Adverse Event|7|||
124677077|NCT01462942|448442207|FG001|Overall Study|Adverse Event|12|||
124677078|NCT01462942|448442208|FG002|Overall Study|Adverse Event|10|||
124677079|NCT01462942|448442209|FG003|Overall Study|Adverse Event|11|||
124677080|NCT01462942|448442210|FG004|Overall Study|Adverse Event|11|||
124677081|NCT01462942|448442206|FG000|Overall Study|Other, including COPD exacerbation|3|||
124677082|NCT01462942|448442207|FG001|Overall Study|Other, including COPD exacerbation|5|||
124677083|NCT01462942|448442208|FG002|Overall Study|Other, including COPD exacerbation|2|||
124677084|NCT01462942|448442209|FG003|Overall Study|Other, including COPD exacerbation|8|||
124677085|NCT01462942|448442210|FG004|Overall Study|Other, including COPD exacerbation|5|||
124677086|NCT01462942|448442206|FG000|Overall Study|Withdrawal by Subject|14|||
124677087|NCT01462942|448442207|FG001|Overall Study|Withdrawal by Subject|10|||
124677088|NCT01462942|448442208|FG002|Overall Study|Withdrawal by Subject|14|||
124677089|NCT01462942|448442209|FG003|Overall Study|Withdrawal by Subject|16|||
124677090|NCT01462942|448442210|FG004|Overall Study|Withdrawal by Subject|19|||
124677091|NCT01462942|448442206|FG000|Overall Study|Lack of Efficacy|6|||
124677092|NCT01462942|448442207|FG001|Overall Study|Lack of Efficacy|0|||
124677093|NCT01462942|448442208|FG002|Overall Study|Lack of Efficacy|4|||
124677094|NCT01462942|448442209|FG003|Overall Study|Lack of Efficacy|5|||
124432057|NCT03122223|447542058|FG003|Overall Study|Lost to Follow-up|0|||
124432058|NCT03122223|447542055|FG000|Overall Study|Participant unable to adhere|1|||
124432059|NCT03122223|447542056|FG001|Overall Study|Participant unable to adhere|1|||
124432060|NCT03122223|447542057|FG002|Overall Study|Participant unable to adhere|1|||
124432061|NCT03122223|447542058|FG003|Overall Study|Participant unable to adhere|0|||
124432062|NCT03181789|447542059|FG000|Overall Study|Withdrawal by Subject|0|||
124432063|NCT03181789|447542060|FG001|Overall Study|Withdrawal by Subject|1|||
124432064|NCT03181789|447542061|FG002|Overall Study|Withdrawal by Subject|1|||
124432065|NCT03181789|447542062|FG003|Overall Study|Withdrawal by Subject|0|||
124432066|NCT03181789|447542059|FG000|Overall Study|Lost to Follow-up|7|||
124432067|NCT03181789|447542060|FG001|Overall Study|Lost to Follow-up|1|||
124432068|NCT03181789|447542061|FG002|Overall Study|Lost to Follow-up|0|||
124432069|NCT03181789|447542062|FG003|Overall Study|Lost to Follow-up|0|||
124432070|NCT03181789|447542059|FG000|Overall Study|Participant unable to adhere to visit|0|||
124432071|NCT03181789|447542060|FG001|Overall Study|Participant unable to adhere to visit|1|||
124432072|NCT03181789|447542061|FG002|Overall Study|Participant unable to adhere to visit|0|||
124432073|NCT03181789|447542062|FG003|Overall Study|Participant unable to adhere to visit|0|||
124432074|NCT01151410|447542063|FG000|Overall Study|Withdrawal by Subject|3|||
124432075|NCT01151410|447542064|FG001|Overall Study|Withdrawal by Subject|5|||
124432076|NCT01151410|447542063|FG000|Overall Study|Lost to Follow-up|3|||
124432077|NCT01151410|447542064|FG001|Overall Study|Lost to Follow-up|4|||
124432078|NCT01151410|447542063|FG000|Overall Study|Adverse Event|1|||
124432079|NCT01151410|447542064|FG001|Overall Study|Adverse Event|2|||
124432080|NCT01151410|447542063|FG000|Overall Study|Protocol deviation|2|||
124432081|NCT01151410|447542064|FG001|Overall Study|Protocol deviation|1|||
124432082|NCT01151410|447542063|FG000|Overall Study|Administrative problems|1|||
124432083|NCT01151410|447542064|FG001|Overall Study|Administrative problems|1|||
124432084|NCT01151410|447542063|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124432085|NCT01151410|447542064|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124432086|NCT01151410|447542063|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124432087|NCT01151410|447542064|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124432088|NCT02624791|447542065|FG000|Overall Study|Withdrawal by Subject|2|||
124432089|NCT02624791|447542066|FG001|Overall Study|Withdrawal by Subject|0|||
124432090|NCT02624791|447542067|FG002|Overall Study|Withdrawal by Subject|0|||
124432091|NCT02624791|447542068|FG003|Overall Study|Withdrawal by Subject|0|||
124432092|NCT02624791|447542069|FG004|Overall Study|Withdrawal by Subject|0|||
124432093|NCT02624791|447542070|FG005|Overall Study|Withdrawal by Subject|0|||
124677095|NCT01462942|448442210|FG004|Overall Study|Lack of Efficacy|3|||
124677096|NCT01462942|448442206|FG000|Overall Study|Lost to Follow-up|0|||
124677097|NCT01462942|448442207|FG001|Overall Study|Lost to Follow-up|1|||
124677098|NCT01462942|448442208|FG002|Overall Study|Lost to Follow-up|1|||
124677099|NCT01462942|448442209|FG003|Overall Study|Lost to Follow-up|1|||
124677100|NCT01462942|448442210|FG004|Overall Study|Lost to Follow-up|1|||
124432094|NCT00735475|447542071|FG000|Overall Study|Adverse Event|0|||
124432095|NCT00735475|447542072|FG001|Overall Study|Adverse Event|1|||
124432096|NCT00735475|447542071|FG000|Overall Study|Death|1|||
124432097|NCT00735475|447542072|FG001|Overall Study|Death|1|||
124432098|NCT00735475|447542071|FG000|Overall Study|Lost to Follow-up|3|||
124432099|NCT00735475|447542072|FG001|Overall Study|Lost to Follow-up|3|||
124677101|NCT01462942|448442206|FG000|Overall Study|Protocol Violation|4|||
124677102|NCT01462942|448442207|FG001|Overall Study|Protocol Violation|6|||
124677103|NCT01462942|448442208|FG002|Overall Study|Protocol Violation|9|||
124677104|NCT01462942|448442209|FG003|Overall Study|Protocol Violation|9|||
124432100|NCT00735475|447542071|FG000|Overall Study|Physician Decision|0|||
124432101|NCT00735475|447542072|FG001|Overall Study|Physician Decision|1|||
124432102|NCT00735475|447542071|FG000|Overall Study|Withdrawal by Subject|4|||
124432103|NCT00735475|447542072|FG001|Overall Study|Withdrawal by Subject|5|||
124432104|NCT04602221|447542076|FG000|Overall Study|Discontinuation of trial treatment|0|||
124432105|NCT04602221|447542077|FG001|Overall Study|Discontinuation of trial treatment|0|||
124432106|NCT04602221|447542078|FG002|Overall Study|Discontinuation of trial treatment|1|||
124432107|NCT04602221|447542079|FG003|Overall Study|Discontinuation of trial treatment|0|||
124677105|NCT01462942|448442210|FG004|Overall Study|Protocol Violation|6|||
124432108|NCT04602221|447542080|FG004|Overall Study|Discontinuation of trial treatment|0|||
124432109|NCT04602221|447542081|FG005|Overall Study|Discontinuation of trial treatment|0|||
124432110|NCT04602221|447542082|FG006|Overall Study|Discontinuation of trial treatment|0|||
124677106|NCT01027845|448442211|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
124677107|NCT01027845|448442212|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
124677108|NCT01027845|448442213|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
124677109|NCT01027845|448442214|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
124677110|NCT01027845|448442211|FG000|Primary Vaccination Phase|Adverse Event|1|||
124432111|NCT04602221|447542083|FG007|Overall Study|Discontinuation of trial treatment|0|||
124432112|NCT04602221|447542084|FG008|Overall Study|Discontinuation of trial treatment|0|||
124432113|NCT04602221|447542085|FG009|Overall Study|Discontinuation of trial treatment|0|||
124432114|NCT04602221|447542086|FG010|Overall Study|Discontinuation of trial treatment|0|||
124432115|NCT04602221|447542087|FG011|Overall Study|Discontinuation of trial treatment|0|||
124432116|NCT04602221|447542088|FG012|Overall Study|Discontinuation of trial treatment|0|||
124432117|NCT04602221|447542089|FG013|Overall Study|Discontinuation of trial treatment|0|||
124432118|NCT04602221|447542090|FG014|Overall Study|Discontinuation of trial treatment|0|||
124432119|NCT04602221|447542091|FG015|Overall Study|Discontinuation of trial treatment|0|||
124432120|NCT04602221|447542092|FG016|Overall Study|Discontinuation of trial treatment|0|||
124432121|NCT04602221|447542093|FG017|Overall Study|Discontinuation of trial treatment|0|||
124432122|NCT04602221|447542076|FG000|Overall Study|Other than listed|0|||
124432123|NCT04602221|447542077|FG001|Overall Study|Other than listed|0|||
124432124|NCT04602221|447542078|FG002|Overall Study|Other than listed|0|||
124432125|NCT04602221|447542079|FG003|Overall Study|Other than listed|0|||
124432126|NCT04602221|447542080|FG004|Overall Study|Other than listed|0|||
124432127|NCT04602221|447542081|FG005|Overall Study|Other than listed|0|||
124432128|NCT04602221|447542082|FG006|Overall Study|Other than listed|0|||
124432129|NCT04602221|447542083|FG007|Overall Study|Other than listed|0|||
124432130|NCT04602221|447542084|FG008|Overall Study|Other than listed|0|||
124432131|NCT04602221|447542085|FG009|Overall Study|Other than listed|0|||
124432132|NCT04602221|447542086|FG010|Overall Study|Other than listed|0|||
124432133|NCT04602221|447542087|FG011|Overall Study|Other than listed|0|||
124432134|NCT04602221|447542088|FG012|Overall Study|Other than listed|0|||
124432135|NCT04602221|447542089|FG013|Overall Study|Other than listed|0|||
124432136|NCT04602221|447542090|FG014|Overall Study|Other than listed|0|||
124432137|NCT04602221|447542091|FG015|Overall Study|Other than listed|1|||
124677111|NCT01027845|448442212|FG001|Primary Vaccination Phase|Adverse Event|0|||
124677112|NCT01027845|448442213|FG002|Primary Vaccination Phase|Adverse Event|0|||
124677113|NCT01027845|448442214|FG003|Primary Vaccination Phase|Adverse Event|0|||
124677114|NCT01027845|448442211|FG000|Primary Vaccination Phase|Protocol Violation|1|||
124677115|NCT01027845|448442212|FG001|Primary Vaccination Phase|Protocol Violation|0|||
124677116|NCT01027845|448442213|FG002|Primary Vaccination Phase|Protocol Violation|0|||
124677117|NCT01027845|448442214|FG003|Primary Vaccination Phase|Protocol Violation|0|||
124677118|NCT01027845|448442211|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
124677119|NCT01027845|448442212|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
124677120|NCT01027845|448442213|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
124677121|NCT01027845|448442214|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
124677122|NCT01027845|448442211|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
124432138|NCT04602221|447542092|FG016|Overall Study|Other than listed|0|||
124432139|NCT04602221|447542093|FG017|Overall Study|Other than listed|1|||
124432140|NCT04602221|447542076|FG000|Overall Study|Withdrawal by Subject|0|||
124432141|NCT04602221|447542077|FG001|Overall Study|Withdrawal by Subject|0|||
124432142|NCT04602221|447542078|FG002|Overall Study|Withdrawal by Subject|0|||
124432143|NCT04602221|447542079|FG003|Overall Study|Withdrawal by Subject|0|||
124432144|NCT04602221|447542080|FG004|Overall Study|Withdrawal by Subject|0|||
124432145|NCT04602221|447542081|FG005|Overall Study|Withdrawal by Subject|0|||
124432146|NCT04602221|447542082|FG006|Overall Study|Withdrawal by Subject|0|||
124432147|NCT04602221|447542083|FG007|Overall Study|Withdrawal by Subject|0|||
124677123|NCT01027845|448442212|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
124677124|NCT01027845|448442213|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
124677125|NCT01027845|448442214|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
124677126|NCT01027845|448442211|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
124677127|NCT01027845|448442212|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
124677128|NCT01027845|448442213|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
124677129|NCT01027845|448442214|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
124432148|NCT04602221|447542084|FG008|Overall Study|Withdrawal by Subject|0|||
124432149|NCT04602221|447542085|FG009|Overall Study|Withdrawal by Subject|0|||
124432150|NCT04602221|447542086|FG010|Overall Study|Withdrawal by Subject|0|||
124432151|NCT04602221|447542087|FG011|Overall Study|Withdrawal by Subject|0|||
124432152|NCT04602221|447542088|FG012|Overall Study|Withdrawal by Subject|1|||
124432153|NCT04602221|447542089|FG013|Overall Study|Withdrawal by Subject|0|||
124432154|NCT04602221|447542090|FG014|Overall Study|Withdrawal by Subject|0|||
124432155|NCT04602221|447542091|FG015|Overall Study|Withdrawal by Subject|0|||
124432156|NCT04602221|447542092|FG016|Overall Study|Withdrawal by Subject|0|||
124432157|NCT04602221|447542093|FG017|Overall Study|Withdrawal by Subject|0|||
124432158|NCT04602221|447542076|FG000|Overall Study|Lost to Follow-up|0|||
124432159|NCT04602221|447542077|FG001|Overall Study|Lost to Follow-up|0|||
124432160|NCT04602221|447542078|FG002|Overall Study|Lost to Follow-up|0|||
124432161|NCT04602221|447542079|FG003|Overall Study|Lost to Follow-up|0|||
124432162|NCT04602221|447542080|FG004|Overall Study|Lost to Follow-up|0|||
124432163|NCT04602221|447542081|FG005|Overall Study|Lost to Follow-up|1|||
124432164|NCT04602221|447542082|FG006|Overall Study|Lost to Follow-up|0|||
124432165|NCT04602221|447542083|FG007|Overall Study|Lost to Follow-up|0|||
124432166|NCT04602221|447542084|FG008|Overall Study|Lost to Follow-up|0|||
124432167|NCT04602221|447542085|FG009|Overall Study|Lost to Follow-up|0|||
124432168|NCT04602221|447542086|FG010|Overall Study|Lost to Follow-up|0|||
124432169|NCT04602221|447542087|FG011|Overall Study|Lost to Follow-up|0|||
124432170|NCT04602221|447542088|FG012|Overall Study|Lost to Follow-up|0|||
124432171|NCT04602221|447542089|FG013|Overall Study|Lost to Follow-up|0|||
124432172|NCT04602221|447542090|FG014|Overall Study|Lost to Follow-up|0|||
124432173|NCT04602221|447542091|FG015|Overall Study|Lost to Follow-up|0|||
124432174|NCT04602221|447542092|FG016|Overall Study|Lost to Follow-up|0|||
124432175|NCT04602221|447542093|FG017|Overall Study|Lost to Follow-up|0|||
124432176|NCT01237587|447542096|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
124432177|NCT01237587|447542097|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
124677130|NCT00368550|448442215|FG000|Overall Study|Adverse Event|7|||
124677131|NCT00368550|448442216|FG001|Overall Study|Adverse Event|4|||
124677132|NCT00368550|448442215|FG000|Overall Study|Lack of Efficacy|4|||
124432178|NCT01237587|447542096|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
124432179|NCT01237587|447542097|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
124432180|NCT01237587|447542096|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
124432181|NCT01237587|447542097|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
124432182|NCT01237587|447542096|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
124432183|NCT01237587|447542097|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
124432184|NCT01237587|447542096|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
124432185|NCT01237587|447542097|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
124432186|NCT01237587|447542096|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
124432187|NCT01237587|447542097|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
124432188|NCT01237587|447542096|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
124432189|NCT01237587|447542097|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
124432190|NCT01237587|447542096|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
124432191|NCT01237587|447542097|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
124432192|NCT01237587|447542096|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
124432193|NCT01237587|447542097|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
124432194|NCT01237587|447542096|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
124432195|NCT01237587|447542097|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
124432196|NCT01237587|447542096|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
124432197|NCT01237587|447542097|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
124432198|NCT01237587|447542096|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
124432199|NCT01237587|447542097|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
124432200|NCT01237587|447542096|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
124432201|NCT01237587|447542097|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
124432202|NCT01237587|447542096|FG000|Taper Phase|Adverse Event|0|||
124432203|NCT01237587|447542097|FG001|Taper Phase|Adverse Event|2|||
124432204|NCT01237587|447542096|FG000|Taper Phase|Protocol Violation|2|||
124432205|NCT01237587|447542097|FG001|Taper Phase|Protocol Violation|0|||
124432206|NCT01237587|447542096|FG000|Taper Phase|Lack of Efficacy|2|||
124432207|NCT01237587|447542097|FG001|Taper Phase|Lack of Efficacy|5|||
124432208|NCT01237587|447542096|FG000|Taper Phase|Parent/Guardian Decision|0|||
124432209|NCT01237587|447542097|FG001|Taper Phase|Parent/Guardian Decision|2|||
124432210|NCT01237587|447542096|FG000|Taper Phase|Sponsor Decision|1|||
124432211|NCT01237587|447542097|FG001|Taper Phase|Sponsor Decision|0|||
124432212|NCT01237587|447542096|FG000|Taper Phase|Withdrawal by Subject|0|||
124432213|NCT01237587|447542097|FG001|Taper Phase|Withdrawal by Subject|1|||
124432214|NCT02656329|447542098|FG000|Overall Study|Lost to Follow-up|2|||
124432215|NCT02656329|447542099|FG001|Overall Study|Lost to Follow-up|3|||
124432216|NCT02656329|447542098|FG000|Overall Study|Withdrawal by Subject|7|||
124432217|NCT02656329|447542099|FG001|Overall Study|Withdrawal by Subject|6|||
124432218|NCT02656329|447542098|FG000|Overall Study|Study termination by Sponsor|150|||
124432219|NCT02656329|447542099|FG001|Overall Study|Study termination by Sponsor|142|||
124432220|NCT02656329|447542098|FG000|Overall Study|Other than specified above|5|||
124432221|NCT02656329|447542099|FG001|Overall Study|Other than specified above|6|||
124432222|NCT01139580|447542100|FG000|Overall Study|Adverse Event|5|||
124432223|NCT01139580|447542101|FG001|Overall Study|Adverse Event|4|||
124432224|NCT01139580|447542100|FG000|Overall Study|Lost to Follow-up|9|||
124432225|NCT01139580|447542101|FG001|Overall Study|Lost to Follow-up|1|||
124432226|NCT01139580|447542100|FG000|Overall Study|Lack of Efficacy|0|||
124677133|NCT00368550|448442216|FG001|Overall Study|Lack of Efficacy|9|||
124432227|NCT01139580|447542101|FG001|Overall Study|Lack of Efficacy|2|||
124432228|NCT01139580|447542100|FG000|Overall Study|Withdrawal by Subject|6|||
124432229|NCT01139580|447542101|FG001|Overall Study|Withdrawal by Subject|9|||
124432230|NCT01139580|447542100|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
124432231|NCT01139580|447542101|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
124432232|NCT01139580|447542100|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
124432233|NCT01139580|447542101|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
124432234|NCT01139580|447542100|FG000|Overall Study|Misrandomized|1|||
124432235|NCT01139580|447542101|FG001|Overall Study|Misrandomized|0|||
124432236|NCT01139580|447542100|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
124432237|NCT01139580|447542101|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
124677134|NCT00368550|448442215|FG000|Overall Study|Withdrawal by Subject|17|||
124677135|NCT00368550|448442216|FG001|Overall Study|Withdrawal by Subject|10|||
124677136|NCT00486044|448442217|FG000|Overall Study|Withdrawal by Subject|2|||
124677137|NCT00486044|448442218|FG001|Overall Study|Withdrawal by Subject|1|||
124677138|NCT00486044|448442217|FG000|Overall Study|Adverse Event|0|||
124677139|NCT00486044|448442218|FG001|Overall Study|Adverse Event|1|||
124432238|NCT01139580|447542100|FG000|Overall Study|Participant Randomization in Error|0|||
124432239|NCT01139580|447542101|FG001|Overall Study|Participant Randomization in Error|1|||
124432240|NCT00911768|447542103|FG000|Overall Study|Protocol Violation|5|||
124432241|NCT00911768|447542104|FG001|Overall Study|Protocol Violation|4|||
124432242|NCT00911768|447542103|FG000|Overall Study|Withdrawal by Subject|1|||
124432243|NCT00911768|447542104|FG001|Overall Study|Withdrawal by Subject|0|||
124432244|NCT01758900|447542105|FG000|Overall Study|difficulty for further intubation|7|||
124432245|NCT01758900|447542106|FG001|Overall Study|difficulty for further intubation|8|||
124432246|NCT00935818|447542108|FG000|Overall Study|Withdrawal by Subject|45|||
124432247|NCT00935818|447542109|FG001|Overall Study|Withdrawal by Subject|50|||
124432248|NCT00935818|447542108|FG000|Overall Study|Lost to Follow-up|40|||
124432249|NCT00935818|447542109|FG001|Overall Study|Lost to Follow-up|42|||
124432250|NCT00935818|447542108|FG000|Overall Study|Adverse Event|6|||
124432251|NCT00935818|447542109|FG001|Overall Study|Adverse Event|7|||
124432252|NCT00935818|447542108|FG000|Overall Study|Physician Decision|0|||
124432253|NCT00935818|447542109|FG001|Overall Study|Physician Decision|1|||
124432254|NCT01370590|447542110|FG000|Period 1|Adverse Event|8|||
124432255|NCT01370590|447542111|FG001|Period 1|Adverse Event|4|||
124432256|NCT01370590|447542110|FG000|Period 1|Lost to Follow-up|2|||
124432257|NCT01370590|447542111|FG001|Period 1|Lost to Follow-up|2|||
124432258|NCT01370590|447542110|FG000|Period 1|Protocol Violation|2|||
124432259|NCT01370590|447542111|FG001|Period 1|Protocol Violation|2|||
124432260|NCT01370590|447542110|FG000|Period 1|Withdrawal by Subject|4|||
124432261|NCT01370590|447542111|FG001|Period 1|Withdrawal by Subject|2|||
124432262|NCT01370590|447542110|FG000|Period 1|Could not access randomization system|0|||
124432263|NCT01370590|447542111|FG001|Period 1|Could not access randomization system|1|||
124432264|NCT01370590|447542110|FG000|Crossover Washout Period|Adverse Event|1|||
124432265|NCT01370590|447542111|FG001|Crossover Washout Period|Adverse Event|4|||
124432266|NCT01370590|447542110|FG000|Crossover Washout Period|Lost to Follow-up|2|||
124677140|NCT00486044|448442217|FG000|Overall Study|Lost to Follow-up|0|||
124432267|NCT01370590|447542111|FG001|Crossover Washout Period|Lost to Follow-up|0|||
124432268|NCT01370590|447542110|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
124432269|NCT01370590|447542111|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
124432270|NCT01370590|447542110|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
124432271|NCT01370590|447542111|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
124432272|NCT01370590|447542110|FG000|Period 2|Adverse Event|0|||
124432273|NCT01370590|447542111|FG001|Period 2|Adverse Event|1|||
124432274|NCT01370590|447542110|FG000|Period 2|Withdrawal by Subject|1|||
124432275|NCT01370590|447542111|FG001|Period 2|Withdrawal by Subject|1|||
124432276|NCT05172050|447542112|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
124432277|NCT05172050|447542113|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
124677141|NCT00486044|448442218|FG001|Overall Study|Lost to Follow-up|1|||
124677142|NCT01670292|448442223|FG000|Overall Study|Lost to Follow-up|14|||
124677143|NCT03154086|448442229|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
124677144|NCT03154086|448442230|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
124677145|NCT03154086|448442231|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
124432278|NCT05172050|447542114|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
124432279|NCT05172050|447542112|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
124432280|NCT05172050|447542113|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
124432281|NCT05172050|447542114|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
124432282|NCT05172050|447542112|FG000|Overall Study|Other|2|||
124677146|NCT03154086|448442232|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
124432283|NCT05172050|447542113|FG001|Overall Study|Other|2|||
124432284|NCT05172050|447542114|FG002|Overall Study|Other|1|||
124432285|NCT04617275|447542115|FG000|Treatment Period|Adverse Event|1|||
124432286|NCT04617275|447542116|FG001|Treatment Period|Adverse Event|6|||
124432287|NCT04617275|447542117|FG002|Treatment Period|Adverse Event|4|||
124677147|NCT03154086|448442233|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
124677148|NCT03154086|448442234|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
124677149|NCT03154086|448442235|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
124677150|NCT03154086|448442236|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
124677151|NCT03154086|448442237|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
124677152|NCT03154086|448442238|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
124677153|NCT03154086|448442239|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
124677154|NCT03154086|448442240|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
124677155|NCT03154086|448442241|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
124677156|NCT03154086|448442242|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
124677157|NCT03154086|448442243|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
124677158|NCT03154086|448442229|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
124677159|NCT03154086|448442230|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
124677160|NCT03154086|448442231|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
124677161|NCT03154086|448442232|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
124677162|NCT03154086|448442233|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
124677163|NCT03154086|448442234|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
124677164|NCT03154086|448442235|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
124677165|NCT03154086|448442236|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
124677166|NCT03154086|448442237|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
124677167|NCT03154086|448442238|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
124677168|NCT03154086|448442239|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
124677169|NCT03154086|448442240|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
124677170|NCT03154086|448442241|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
124677171|NCT03154086|448442242|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
124677172|NCT03154086|448442243|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
124677173|NCT03154086|448442229|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
124677174|NCT03154086|448442230|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
124677175|NCT03154086|448442231|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
124677176|NCT03154086|448442232|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
124677177|NCT03154086|448442233|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
124677178|NCT03154086|448442234|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
124677179|NCT03154086|448442235|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
124677180|NCT03154086|448442236|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
124677181|NCT03154086|448442237|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
124677182|NCT03154086|448442238|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
124677183|NCT03154086|448442239|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
124677184|NCT03154086|448442240|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
124677185|NCT03154086|448442241|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
124677186|NCT03154086|448442242|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
124677187|NCT03154086|448442243|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
124677188|NCT03154086|448442229|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
124677189|NCT03154086|448442230|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
124677190|NCT03154086|448442231|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
124677191|NCT03154086|448442232|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
124677192|NCT03154086|448442233|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
124677193|NCT03154086|448442234|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
124677194|NCT03154086|448442235|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
124677195|NCT03154086|448442236|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
124677196|NCT03154086|448442237|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
124677197|NCT03154086|448442238|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
124677198|NCT03154086|448442239|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
124677199|NCT03154086|448442240|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
124677200|NCT03154086|448442241|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
124677201|NCT03154086|448442242|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
124677202|NCT03154086|448442243|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
124677203|NCT03154086|448442229|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
124677204|NCT03154086|448442230|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
124432288|NCT04617275|447542118|FG003|Treatment Period|Adverse Event|6|||
124677205|NCT03154086|448442231|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
124677206|NCT03154086|448442232|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
124432289|NCT04617275|447542119|FG004|Treatment Period|Adverse Event|7|||
124677207|NCT03154086|448442233|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
124677208|NCT03154086|448442234|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
124677209|NCT03154086|448442235|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
124677210|NCT03154086|448442236|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
124677211|NCT03154086|448442237|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
124677212|NCT03154086|448442238|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
124677213|NCT03154086|448442239|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
124677214|NCT03154086|448442240|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
124677215|NCT03154086|448442241|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
124677216|NCT03154086|448442242|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
124677217|NCT03154086|448442243|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
124677218|NCT03154086|448442229|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
124677219|NCT03154086|448442230|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
124677220|NCT03154086|448442231|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
124677221|NCT03154086|448442232|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
124677222|NCT03154086|448442233|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
124677223|NCT03154086|448442234|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
124677224|NCT03154086|448442235|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
124677225|NCT03154086|448442236|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
124677226|NCT03154086|448442237|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
124677227|NCT03154086|448442238|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
124677228|NCT03154086|448442239|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
124677229|NCT03154086|448442240|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
124677230|NCT03154086|448442241|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
124677231|NCT03154086|448442242|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
124677232|NCT03154086|448442243|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
124432290|NCT04617275|447542120|FG005|Treatment Period|Adverse Event|8|||
124432291|NCT04617275|447542121|FG006|Treatment Period|Adverse Event|0|||
124432292|NCT04617275|447542122|FG007|Treatment Period|Adverse Event|12|||
124432293|NCT04617275|447542115|FG000|Treatment Period|Lost to Follow-up|0|||
124432294|NCT04617275|447542116|FG001|Treatment Period|Lost to Follow-up|0|||
124432295|NCT04617275|447542117|FG002|Treatment Period|Lost to Follow-up|2|||
124432296|NCT04617275|447542118|FG003|Treatment Period|Lost to Follow-up|0|||
124432297|NCT04617275|447542119|FG004|Treatment Period|Lost to Follow-up|0|||
124432298|NCT04617275|447542120|FG005|Treatment Period|Lost to Follow-up|3|||
124432299|NCT04617275|447542121|FG006|Treatment Period|Lost to Follow-up|0|||
124432300|NCT04617275|447542122|FG007|Treatment Period|Lost to Follow-up|2|||
124432301|NCT04617275|447542115|FG000|Treatment Period|No longer meets eligibility criteria|0|||
124432302|NCT04617275|447542116|FG001|Treatment Period|No longer meets eligibility criteria|0|||
124432303|NCT04617275|447542117|FG002|Treatment Period|No longer meets eligibility criteria|0|||
124432304|NCT04617275|447542118|FG003|Treatment Period|No longer meets eligibility criteria|1|||
124432305|NCT04617275|447542119|FG004|Treatment Period|No longer meets eligibility criteria|0|||
124432306|NCT04617275|447542120|FG005|Treatment Period|No longer meets eligibility criteria|0|||
124432307|NCT04617275|447542121|FG006|Treatment Period|No longer meets eligibility criteria|0|||
124432308|NCT04617275|447542122|FG007|Treatment Period|No longer meets eligibility criteria|0|||
124432309|NCT04617275|447542115|FG000|Treatment Period|Other|0|||
124432310|NCT04617275|447542116|FG001|Treatment Period|Other|1|||
124432311|NCT04617275|447542117|FG002|Treatment Period|Other|0|||
124432312|NCT04617275|447542118|FG003|Treatment Period|Other|0|||
124432313|NCT04617275|447542119|FG004|Treatment Period|Other|0|||
124432314|NCT04617275|447542120|FG005|Treatment Period|Other|0|||
124432315|NCT04617275|447542121|FG006|Treatment Period|Other|0|||
124432316|NCT04617275|447542122|FG007|Treatment Period|Other|0|||
124432317|NCT04617275|447542115|FG000|Treatment Period|Withdrawal by Subject|2|||
124432318|NCT04617275|447542116|FG001|Treatment Period|Withdrawal by Subject|0|||
124432319|NCT04617275|447542117|FG002|Treatment Period|Withdrawal by Subject|0|||
124432320|NCT04617275|447542118|FG003|Treatment Period|Withdrawal by Subject|2|||
124432321|NCT04617275|447542119|FG004|Treatment Period|Withdrawal by Subject|2|||
124432322|NCT04617275|447542120|FG005|Treatment Period|Withdrawal by Subject|0|||
124432323|NCT04617275|447542121|FG006|Treatment Period|Withdrawal by Subject|1|||
124432324|NCT04617275|447542122|FG007|Treatment Period|Withdrawal by Subject|2|||
124432325|NCT04617275|447542115|FG000|Follow-up Period|Adverse Event|1|||
124432326|NCT04617275|447542116|FG001|Follow-up Period|Adverse Event|1|||
124432327|NCT04617275|447542117|FG002|Follow-up Period|Adverse Event|2|||
124677233|NCT03154086|448442229|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
124677234|NCT03154086|448442230|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
124677235|NCT03154086|448442231|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
124432328|NCT04617275|447542118|FG003|Follow-up Period|Adverse Event|3|||
124677236|NCT03154086|448442232|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
124677237|NCT03154086|448442233|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
124677238|NCT03154086|448442234|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
124677239|NCT03154086|448442235|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
124432329|NCT04617275|447542119|FG004|Follow-up Period|Adverse Event|4|||
124432330|NCT04617275|447542120|FG005|Follow-up Period|Adverse Event|3|||
124432331|NCT04617275|447542121|FG006|Follow-up Period|Adverse Event|0|||
124432332|NCT04617275|447542122|FG007|Follow-up Period|Adverse Event|3|||
124432333|NCT04617275|447542115|FG000|Follow-up Period|Lost to Follow-up|0|||
124432334|NCT04617275|447542116|FG001|Follow-up Period|Lost to Follow-up|1|||
124432335|NCT04617275|447542117|FG002|Follow-up Period|Lost to Follow-up|2|||
124432336|NCT04617275|447542118|FG003|Follow-up Period|Lost to Follow-up|0|||
124432337|NCT04617275|447542119|FG004|Follow-up Period|Lost to Follow-up|0|||
124677240|NCT03154086|448442236|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
124677241|NCT03154086|448442237|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
124677242|NCT03154086|448442238|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
124677243|NCT03154086|448442239|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
124677244|NCT03154086|448442240|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
124677245|NCT03154086|448442241|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
124677246|NCT03154086|448442242|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
124677247|NCT03154086|448442243|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
124677248|NCT01603277|448442244|FG000|Overall Study|Adverse Event|1|||
124677249|NCT01603277|448442245|FG001|Overall Study|Adverse Event|2|||
124677250|NCT01603277|448442244|FG000|Overall Study|Physician Decision|0|||
124677251|NCT01603277|448442245|FG001|Overall Study|Physician Decision|1|||
124677252|NCT01603277|448442244|FG000|Overall Study|Protocol Violation|6|||
124677253|NCT01603277|448442245|FG001|Overall Study|Protocol Violation|10|||
124677254|NCT01603277|448442244|FG000|Overall Study|Withdrawal by Subject|5|||
124677255|NCT01603277|448442245|FG001|Overall Study|Withdrawal by Subject|4|||
124677256|NCT01603277|448442244|FG000|Overall Study|Non-Compliance|2|||
124677257|NCT01603277|448442245|FG001|Overall Study|Non-Compliance|1|||
124677258|NCT04494646|448442250|FG000|Overall Study|Adverse Event|0|||
124677259|NCT04494646|448442251|FG001|Overall Study|Adverse Event|1|||
124677260|NCT04494646|448442250|FG000|Overall Study|Withdrawal by Subject|0|||
124677261|NCT04494646|448442251|FG001|Overall Study|Withdrawal by Subject|1|||
124677262|NCT02785939|448442254|FG000|Overall Study|Progression|25|||
124677263|NCT02785939|448442255|FG001|Overall Study|Progression|8|||
124677264|NCT02785939|448442254|FG000|Overall Study|Adverse Event|3|||
124677265|NCT02785939|448442255|FG001|Overall Study|Adverse Event|1|||
124677266|NCT02785939|448442254|FG000|Overall Study|Death|1|||
124677267|NCT02785939|448442255|FG001|Overall Study|Death|0|||
124677268|NCT02785939|448442254|FG000|Overall Study|Refusal|1|||
124677269|NCT02785939|448442255|FG001|Overall Study|Refusal|0|||
124677270|NCT02785939|448442254|FG000|Overall Study|Deteriorating health|1|||
124432338|NCT04617275|447542120|FG005|Follow-up Period|Lost to Follow-up|4|||
124432339|NCT04617275|447542121|FG006|Follow-up Period|Lost to Follow-up|0|||
124432340|NCT04617275|447542122|FG007|Follow-up Period|Lost to Follow-up|3|||
124432341|NCT04617275|447542115|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
124432342|NCT04617275|447542116|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
124677271|NCT02785939|448442255|FG001|Overall Study|Deteriorating health|0|||
124677272|NCT02785939|448442254|FG000|Overall Study|Not protocol specified|0|||
124677273|NCT02785939|448442255|FG001|Overall Study|Not protocol specified|1|||
124677274|NCT04465422|448442256|FG000|Overall Study|Lost to Follow-up|0|||
124677275|NCT04465422|448442257|FG001|Overall Study|Lost to Follow-up|2|||
124677276|NCT01692119|448442260|FG000|Overall Study|Protocol Violation|3|||
124677277|NCT01692119|448442261|FG001|Overall Study|Protocol Violation|1|||
124677278|NCT01692119|448442260|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
124677279|NCT01692119|448442261|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
124677280|NCT02147626|448442262|FG000|Overall Study|Lost to Follow-up|4|||
124677281|NCT02147626|448442263|FG001|Overall Study|Lost to Follow-up|4|||
124677282|NCT02147626|448442262|FG000|Overall Study|Pregnancy|1|||
124677283|NCT02147626|448442263|FG001|Overall Study|Pregnancy|2|||
124677284|NCT02147626|448442262|FG000|Overall Study|Withdrawal by Subject|0|||
124677285|NCT02147626|448442263|FG001|Overall Study|Withdrawal by Subject|1|||
124677286|NCT00997893|448442264|FG000|Overall Study|Adverse Event|1|||
124677287|NCT00997893|448442265|FG001|Overall Study|Adverse Event|0|||
124677288|NCT00997893|448442266|FG002|Overall Study|Adverse Event|0|||
124677289|NCT00997893|448442264|FG000|Overall Study|Unable to meet study timelines|1|||
124677290|NCT00997893|448442265|FG001|Overall Study|Unable to meet study timelines|0|||
124677291|NCT00997893|448442266|FG002|Overall Study|Unable to meet study timelines|0|||
124677292|NCT00997893|448442264|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
124677293|NCT00997893|448442265|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
124677294|NCT00997893|448442266|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
124677295|NCT01142336|448442267|FG000|Overall Study|Adverse Event|1|||
124677296|NCT01142336|448442268|FG001|Overall Study|Adverse Event|1|||
124677297|NCT01142336|448442267|FG000|Overall Study|Lost to Follow-up|0|||
124677298|NCT01142336|448442268|FG001|Overall Study|Lost to Follow-up|1|||
124677299|NCT01704261|448442269|FG000|Overall Study|Withdrawal by Subject|12|||
124677300|NCT01704261|448442270|FG001|Overall Study|Withdrawal by Subject|15|||
124677301|NCT01704261|448442269|FG000|Overall Study|Lost to Follow-up|1|||
124677302|NCT01704261|448442270|FG001|Overall Study|Lost to Follow-up|0|||
124677303|NCT02722967|448442271|FG000|Overall Study|Adverse Event|1|||
124677304|NCT02722967|448442272|FG001|Overall Study|Adverse Event|0|||
124677305|NCT02722967|448442273|FG002|Overall Study|Adverse Event|0|||
124677306|NCT02722967|448442271|FG000|Overall Study|Lost to Follow-up|0|||
124677307|NCT02722967|448442272|FG001|Overall Study|Lost to Follow-up|1|||
124677308|NCT02722967|448442273|FG002|Overall Study|Lost to Follow-up|0|||
124677309|NCT02722967|448442271|FG000|Overall Study|Non-compliance with patch wearing|2|||
124677310|NCT02722967|448442272|FG001|Overall Study|Non-compliance with patch wearing|1|||
124677311|NCT02722967|448442273|FG002|Overall Study|Non-compliance with patch wearing|1|||
124677312|NCT02722967|448442271|FG000|Overall Study|Withdrawal by Subject|1|||
124677313|NCT02722967|448442272|FG001|Overall Study|Withdrawal by Subject|0|||
124677314|NCT02722967|448442273|FG002|Overall Study|Withdrawal by Subject|1|||
124677315|NCT02722967|448442271|FG000|Overall Study|Physician Decision|1|||
124677316|NCT02722967|448442272|FG001|Overall Study|Physician Decision|0|||
124677317|NCT02722967|448442273|FG002|Overall Study|Physician Decision|0|||
124677318|NCT02722967|448442271|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
124677319|NCT02722967|448442272|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
124677320|NCT02722967|448442273|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
124677321|NCT02391337|448442274|FG000|6 Months Follow-up|Death|5|||
124677322|NCT02391337|448442275|FG001|6 Months Follow-up|Death|4|||
124677323|NCT02391337|448442274|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
124677324|NCT02391337|448442275|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
124677325|NCT02391337|448442274|FG000|12 Months Follow-up|Death|2|||
124677326|NCT02391337|448442275|FG001|12 Months Follow-up|Death|0|||
124677327|NCT02391337|448442274|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
124677328|NCT02391337|448442275|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
124677329|NCT02391337|448442274|FG000|12 Months Follow-up|Lost to Follow-up|0|||
124677330|NCT02391337|448442275|FG001|12 Months Follow-up|Lost to Follow-up|2|||
124677331|NCT03704064|448442276|FG000|Overall Study|Lost to Follow-up|8|||
124677332|NCT03704064|448442277|FG001|Overall Study|Lost to Follow-up|4|||
124677333|NCT03704064|448442276|FG000|Overall Study|Withdrawal by Subject|1|||
124677334|NCT03704064|448442277|FG001|Overall Study|Withdrawal by Subject|1|||
124677335|NCT03704064|448442276|FG000|Overall Study|No longer available for study visits|0|||
124677336|NCT03704064|448442277|FG001|Overall Study|No longer available for study visits|1|||
124677337|NCT03704064|448442276|FG000|Overall Study|Censoring event|1|||
124677338|NCT03704064|448442277|FG001|Overall Study|Censoring event|0|||
124677339|NCT00071981|448442283|FG000|Overall Study|Lack of Efficacy|37|||
124677340|NCT00071981|448442284|FG001|Overall Study|Lack of Efficacy|29|||
124677341|NCT00071981|448442285|FG002|Overall Study|Lack of Efficacy|30|||
124432343|NCT04617275|447542117|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
124432344|NCT04617275|447542118|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
124432345|NCT04617275|447542119|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
124432346|NCT04617275|447542120|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
124432347|NCT04617275|447542121|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
124432348|NCT04617275|447542122|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
124432349|NCT04617275|447542115|FG000|Follow-up Period|Other|0|||
124432350|NCT04617275|447542116|FG001|Follow-up Period|Other|1|||
124432351|NCT04617275|447542117|FG002|Follow-up Period|Other|0|||
124432352|NCT04617275|447542118|FG003|Follow-up Period|Other|0|||
124432353|NCT04617275|447542119|FG004|Follow-up Period|Other|0|||
124432354|NCT04617275|447542120|FG005|Follow-up Period|Other|0|||
124432355|NCT04617275|447542121|FG006|Follow-up Period|Other|0|||
124432356|NCT04617275|447542122|FG007|Follow-up Period|Other|0|||
124432357|NCT04617275|447542115|FG000|Follow-up Period|Withdrawal by Subject|2|||
124432358|NCT04617275|447542116|FG001|Follow-up Period|Withdrawal by Subject|0|||
124432359|NCT04617275|447542117|FG002|Follow-up Period|Withdrawal by Subject|0|||
124432360|NCT04617275|447542118|FG003|Follow-up Period|Withdrawal by Subject|2|||
124432361|NCT04617275|447542119|FG004|Follow-up Period|Withdrawal by Subject|2|||
124432362|NCT04617275|447542120|FG005|Follow-up Period|Withdrawal by Subject|0|||
124432363|NCT04617275|447542121|FG006|Follow-up Period|Withdrawal by Subject|1|||
124432364|NCT04617275|447542122|FG007|Follow-up Period|Withdrawal by Subject|2|||
124432365|NCT04927884|447542129|FG000|Overall Study|Progressive Disease|2|||
124432366|NCT05593445|447542132|FG000|12-Week DBVC Period|Adverse Event|1|||
124432367|NCT05593445|447542133|FG001|12-Week DBVC Period|Adverse Event|0|||
124432368|NCT05593445|447542134|FG002|12-Week DBVC Period|Adverse Event|0|||
124432369|NCT05593445|447542135|FG003|12-Week DBVC Period|Adverse Event|0|||
124432370|NCT05593445|447542132|FG000|12-Week DBVC Period|Physician Decision|0|||
124432371|NCT05593445|447542133|FG001|12-Week DBVC Period|Physician Decision|1|||
124432372|NCT05593445|447542134|FG002|12-Week DBVC Period|Physician Decision|0|||
124432373|NCT05593445|447542135|FG003|12-Week DBVC Period|Physician Decision|0|||
124432374|NCT05593445|447542132|FG000|12-Week DBVC Period|Protocol Violation|0|||
124432375|NCT05593445|447542133|FG001|12-Week DBVC Period|Protocol Violation|1|||
124432376|NCT05593445|447542134|FG002|12-Week DBVC Period|Protocol Violation|0|||
124432377|NCT05593445|447542135|FG003|12-Week DBVC Period|Protocol Violation|0|||
124432378|NCT05593445|447542132|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
124432379|NCT05593445|447542133|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
124432380|NCT05593445|447542134|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
124432381|NCT05593445|447542135|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
124432382|NCT05593445|447542132|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
124432383|NCT05593445|447542133|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
124432384|NCT05593445|447542134|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
124432385|NCT05593445|447542135|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
124432386|NCT05593445|447542132|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
124432387|NCT05593445|447542133|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
124432388|NCT05593445|447542134|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
124432389|NCT05593445|447542135|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
124432390|NCT05593445|447542132|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
124432391|NCT05593445|447542133|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
124432392|NCT05593445|447542134|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
124432393|NCT05593445|447542135|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
124432394|NCT05593445|447542132|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124432395|NCT05593445|447542133|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124432396|NCT05593445|447542134|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
124432397|NCT05593445|447542135|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124432398|NCT00727311|447542136|FG000|Overall Study|Did not receive drug|316|||
124432399|NCT00727311|447542136|FG000|Overall Study|Missing end of therapy data|205|||
124432400|NCT00727311|447542136|FG000|Overall Study|Adverse Event|58|||
124432401|NCT00727311|447542136|FG000|Overall Study|Lack of Efficacy|242|||
124432402|NCT00727311|447542136|FG000|Overall Study|Lost to Follow-up|73|||
124432403|NCT00727311|447542136|FG000|Overall Study|Withdrawal by Subject|77|||
124432404|NCT00727311|447542136|FG000|Overall Study|Other|97|||
124432405|NCT00727311|447542136|FG000|Overall Study|Multiple reasons|39|||
124432406|NCT00266227|447543737|FG000|Initial Treatment|Adverse Event|0|||
124432407|NCT00266227|447543738|FG001|Initial Treatment|Adverse Event|0|||
124432408|NCT00266227|447543739|FG002|Initial Treatment|Adverse Event|13|||
124432409|NCT00266227|447543737|FG000|Initial Treatment|Lost to Follow-up|0|||
124677342|NCT00071981|448442286|FG003|Overall Study|Lack of Efficacy|43|||
124677343|NCT00071981|448442283|FG000|Overall Study|Adverse Event|4|||
124432410|NCT00266227|447543738|FG001|Initial Treatment|Lost to Follow-up|0|||
124432411|NCT00266227|447543739|FG002|Initial Treatment|Lost to Follow-up|6|||
124432412|NCT00266227|447543737|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
124432413|NCT00266227|447543738|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
124432414|NCT00266227|447543739|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
124677344|NCT00071981|448442284|FG001|Overall Study|Adverse Event|4|||
124677345|NCT00071981|448442285|FG002|Overall Study|Adverse Event|3|||
124677346|NCT00071981|448442286|FG003|Overall Study|Adverse Event|1|||
124677347|NCT00071981|448442283|FG000|Overall Study|Death|0|||
124677348|NCT00071981|448442284|FG001|Overall Study|Death|0|||
124677349|NCT00071981|448442285|FG002|Overall Study|Death|1|||
124677350|NCT00071981|448442286|FG003|Overall Study|Death|1|||
124677351|NCT00071981|448442283|FG000|Overall Study|Withdrawal by Subject|3|||
124677352|NCT00071981|448442284|FG001|Overall Study|Withdrawal by Subject|1|||
124677353|NCT00071981|448442285|FG002|Overall Study|Withdrawal by Subject|0|||
124677354|NCT00071981|448442286|FG003|Overall Study|Withdrawal by Subject|0|||
124677355|NCT00071981|448442283|FG000|Overall Study|No protocol therapy|2|||
124677356|NCT00071981|448442284|FG001|Overall Study|No protocol therapy|5|||
124677357|NCT00071981|448442285|FG002|Overall Study|No protocol therapy|1|||
124677358|NCT00071981|448442286|FG003|Overall Study|No protocol therapy|0|||
124677359|NCT00071981|448442283|FG000|Overall Study|others (not specified in the study)|0|||
124677360|NCT00071981|448442284|FG001|Overall Study|others (not specified in the study)|2|||
124677361|NCT00071981|448442285|FG002|Overall Study|others (not specified in the study)|2|||
124677362|NCT00071981|448442286|FG003|Overall Study|others (not specified in the study)|0|||
124677363|NCT00467519|448442287|FG000|Overall Study|Protocol Violation|8|||
124677364|NCT00467519|448442288|FG001|Overall Study|Protocol Violation|4|||
124677365|NCT00467519|448442287|FG000|Overall Study|Lost to Follow-up|2|||
124677366|NCT00467519|448442288|FG001|Overall Study|Lost to Follow-up|9|||
124677367|NCT00467519|448442287|FG000|Overall Study|Withdrawal by Subject|4|||
124677368|NCT00467519|448442288|FG001|Overall Study|Withdrawal by Subject|10|||
124677369|NCT01123655|448442289|FG000|Overall Study|Medication for RA had to be changed|1|||
124432415|NCT00266227|447543737|FG000|Initial Treatment|Physician decision to withdraw|0|||
124432416|NCT00266227|447543738|FG001|Initial Treatment|Physician decision to withdraw|0|||
124432417|NCT00266227|447543739|FG002|Initial Treatment|Physician decision to withdraw|12|||
124432418|NCT00266227|447543737|FG000|Initial Treatment|Pregnancy|0|||
124432419|NCT00266227|447543738|FG001|Initial Treatment|Pregnancy|0|||
124432420|NCT00266227|447543739|FG002|Initial Treatment|Pregnancy|1|||
124432421|NCT00266227|447543737|FG000|Retreatment: Up to Week 48|Death|1|||
124677370|NCT01123655|448442290|FG001|Overall Study|Medication for RA had to be changed|0|||
124432422|NCT00266227|447543738|FG001|Retreatment: Up to Week 48|Death|0|||
124432423|NCT00266227|447543739|FG002|Retreatment: Up to Week 48|Death|0|||
124432424|NCT00266227|447543737|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
124432425|NCT00266227|447543738|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
124432426|NCT00266227|447543739|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
124432427|NCT00266227|447543737|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
124432428|NCT00266227|447543738|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
124432429|NCT00266227|447543739|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
124432430|NCT00266227|447543737|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
124432431|NCT00266227|447543738|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
124432432|NCT00266227|447543739|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
124432433|NCT00266227|447543737|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
124432434|NCT00266227|447543738|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
124432435|NCT00266227|447543739|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
124432436|NCT00266227|447543737|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
124432437|NCT00266227|447543738|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
124432438|NCT00266227|447543739|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
124432439|NCT00266227|447543737|FG000|Retreatment: Week 48 to Week 72|Death|1|||
124432440|NCT00266227|447543738|FG001|Retreatment: Week 48 to Week 72|Death|1|||
124432441|NCT00266227|447543739|FG002|Retreatment: Week 48 to Week 72|Death|0|||
124432442|NCT00266227|447543737|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
124432443|NCT00266227|447543738|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
124432444|NCT00266227|447543739|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
124432445|NCT00266227|447543737|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
124432446|NCT00266227|447543738|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
124432447|NCT00266227|447543739|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
124432448|NCT00266227|447543737|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
124432449|NCT00266227|447543738|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
124677371|NCT01123655|448442291|FG002|Overall Study|Medication for RA had to be changed|0|||
124432450|NCT00266227|447543739|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
124677372|NCT01123655|448442289|FG000|Overall Study|new illness|0|||
124432451|NCT00266227|447543737|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
124432452|NCT00266227|447543738|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
124432453|NCT00266227|447543739|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
124432454|NCT03836716|447543747|FG000|Overall Study|Adverse Event|3|||
124677373|NCT01123655|448442290|FG001|Overall Study|new illness|1|||
124677374|NCT01123655|448442291|FG002|Overall Study|new illness|0|||
124677375|NCT01123655|448442289|FG000|Overall Study|began prohibitive drug|0|||
124677376|NCT01123655|448442290|FG001|Overall Study|began prohibitive drug|0|||
124432455|NCT03836716|447543747|FG000|Overall Study|Death|22|||
124432456|NCT03836716|447543747|FG000|Overall Study|Withdrawal by Subject|8|||
124432457|NCT03836716|447543747|FG000|Overall Study|Study terminated by sponsor|87|||
124432458|NCT04988867|447543750|FG000|Overall Study|Study terminated by Sponsor|12|||
124432459|NCT04988867|447543750|FG000|Overall Study|Adverse Event|2|||
124432460|NCT04988867|447543750|FG000|Overall Study|Study drug noncompliance|1|||
124432461|NCT00037830|447543751|FG000|Overall Study|Adverse Event|2|||
124432462|NCT00037830|447543752|FG001|Overall Study|Adverse Event|0|||
124432463|NCT00037830|447543753|FG002|Overall Study|Adverse Event|0|||
124432464|NCT00037830|447543751|FG000|Overall Study|Withdrawal by Subject|4|||
124432465|NCT00037830|447543752|FG001|Overall Study|Withdrawal by Subject|5|||
124432466|NCT00037830|447543753|FG002|Overall Study|Withdrawal by Subject|1|||
124432467|NCT00037830|447543751|FG000|Overall Study|Protocol Violation|2|||
124432468|NCT00037830|447543752|FG001|Overall Study|Protocol Violation|2|||
124432469|NCT00037830|447543753|FG002|Overall Study|Protocol Violation|0|||
124432470|NCT00037830|447543751|FG000|Overall Study|Unrelated Medical Problem|2|||
124432471|NCT00037830|447543752|FG001|Overall Study|Unrelated Medical Problem|0|||
124432472|NCT00037830|447543753|FG002|Overall Study|Unrelated Medical Problem|0|||
124432473|NCT01699503|447543756|FG000|Overall Study|Death|31|||
124432474|NCT01699503|447543757|FG001|Overall Study|Death|40|||
124432475|NCT01699503|447543756|FG000|Overall Study|Withdrawal by Subject|65|||
124432476|NCT01699503|447543757|FG001|Overall Study|Withdrawal by Subject|57|||
124432477|NCT01699503|447543756|FG000|Overall Study|Lost to Follow-up|121|||
124432478|NCT01699503|447543757|FG001|Overall Study|Lost to Follow-up|117|||
124432479|NCT01699503|447543756|FG000|Overall Study|Excluded due to quality|783|||
124432480|NCT01699503|447543757|FG001|Overall Study|Excluded due to quality|791|||
124432481|NCT01004848|447543759|FG000|Overall Study|Lost to Follow-up|55|||
124432482|NCT01004848|447543760|FG001|Overall Study|Lost to Follow-up|45|||
124432483|NCT01160289|447543761|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
124432484|NCT01160289|447543762|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
124432485|NCT01160289|447543763|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
124432486|NCT01160289|447543764|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
124432487|NCT01160289|447543765|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
124432488|NCT01160289|447543766|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
124432489|NCT01160289|447543761|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
124432490|NCT01160289|447543762|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
124432491|NCT01160289|447543763|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
124432492|NCT01160289|447543764|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
124432493|NCT01160289|447543765|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
124432494|NCT01160289|447543766|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
124432495|NCT01160289|447543761|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
124432496|NCT01160289|447543762|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
124432497|NCT01160289|447543763|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
124432498|NCT01160289|447543764|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
124432499|NCT01160289|447543765|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
124432500|NCT01160289|447543766|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
124432501|NCT01160289|447543761|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
124677377|NCT01123655|448442291|FG002|Overall Study|began prohibitive drug|1|||
124677378|NCT00062166|448442292|FG000|Overall Study|Withdrawal by Subject|6|||
124677379|NCT00833755|448442293|FG000|Overall Study|Physician Decision|4|||
124677380|NCT00833755|448442294|FG001|Overall Study|Physician Decision|4|||
124677381|NCT00833755|448442295|FG002|Overall Study|Physician Decision|2|||
124677382|NCT00833755|448442296|FG003|Overall Study|Physician Decision|6|||
124677383|NCT00833755|448442293|FG000|Overall Study|Subject had scheduling issues|0|||
124677384|NCT00833755|448442294|FG001|Overall Study|Subject had scheduling issues|1|||
124677385|NCT00833755|448442295|FG002|Overall Study|Subject had scheduling issues|0|||
124677386|NCT00833755|448442296|FG003|Overall Study|Subject had scheduling issues|0|||
124677387|NCT02475369|448442299|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
124677388|NCT02475369|448442300|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
124432502|NCT01160289|447543762|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
124432503|NCT01160289|447543763|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
124432504|NCT01160289|447543764|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
124432505|NCT01160289|447543765|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
124432506|NCT01160289|447543766|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
124432507|NCT01160289|447543761|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
124432508|NCT01160289|447543762|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
124677389|NCT02908347|448442303|FG000|Overall Study|Adverse Event|0|||
124677390|NCT02908347|448442304|FG001|Overall Study|Adverse Event|1|||
124677391|NCT02908347|448442303|FG000|Overall Study|Lost to Follow-up|1|||
124432509|NCT01160289|447543763|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
124677392|NCT02908347|448442304|FG001|Overall Study|Lost to Follow-up|0|||
124677393|NCT03054428|448442309|FG000|Overall Study|Physician Decision|0|||
124677394|NCT03054428|448442310|FG001|Overall Study|Physician Decision|1|||
124677395|NCT03054428|448442311|FG002|Overall Study|Physician Decision|1|||
124677396|NCT03054428|448442309|FG000|Overall Study|Lack of Efficacy|3|||
124677397|NCT03054428|448442310|FG001|Overall Study|Lack of Efficacy|1|||
124677398|NCT03054428|448442311|FG002|Overall Study|Lack of Efficacy|0|||
124677399|NCT03054428|448442309|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
124677400|NCT03054428|448442310|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
124677401|NCT03054428|448442311|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
124677402|NCT03054428|448442309|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
124677403|NCT03054428|448442310|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
124677404|NCT03054428|448442311|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
124677405|NCT03054428|448442309|FG000|Overall Study|Transitioned to OLE study|76|||
124677406|NCT03054428|448442310|FG001|Overall Study|Transitioned to OLE study|76|||
124677407|NCT03054428|448442311|FG002|Overall Study|Transitioned to OLE study|73|||
124677408|NCT03054428|448442309|FG000|Overall Study|Withdrawal by Subject|3|||
124677409|NCT03054428|448442310|FG001|Overall Study|Withdrawal by Subject|2|||
124677410|NCT03054428|448442311|FG002|Overall Study|Withdrawal by Subject|3|||
124677411|NCT03054428|448442309|FG000|Overall Study|Lost to Follow-up|0|||
124677412|NCT03054428|448442310|FG001|Overall Study|Lost to Follow-up|0|||
124677413|NCT03054428|448442311|FG002|Overall Study|Lost to Follow-up|1|||
124677414|NCT01093846|448442312|FG000|Overall Study|Adverse Event|0|||
124677415|NCT01093846|448442313|FG001|Overall Study|Adverse Event|0|||
124677416|NCT01093846|448442314|FG002|Overall Study|Adverse Event|1|||
124677417|NCT01093846|448442312|FG000|Overall Study|Lack of Efficacy|0|||
124677418|NCT01093846|448442313|FG001|Overall Study|Lack of Efficacy|0|||
124677419|NCT01093846|448442314|FG002|Overall Study|Lack of Efficacy|4|||
124677420|NCT01093846|448442312|FG000|Overall Study|Condition no longer required study drug|1|||
124677421|NCT01093846|448442313|FG001|Overall Study|Condition no longer required study drug|1|||
124677422|NCT01093846|448442314|FG002|Overall Study|Condition no longer required study drug|1|||
124677423|NCT01093846|448442312|FG000|Overall Study|Administrative Problems|18|||
124677424|NCT01093846|448442313|FG001|Overall Study|Administrative Problems|17|||
124677425|NCT01093846|448442314|FG002|Overall Study|Administrative Problems|15|||
124677426|NCT01416571|448442315|FG000|Overall Study|Lost to Follow-up|2|||
124677427|NCT00753519|448444226|FG000|Overall Study|Withdrawal by Subject|0|||
124677428|NCT00753519|448444227|FG001|Overall Study|Withdrawal by Subject|2|||
124677429|NCT00296244|448444237|FG000|Overall Study|Underwent retransplant|0|||
124677430|NCT00296244|448444238|FG001|Overall Study|Underwent retransplant|1|||
124677431|NCT00427934|448444239|FG000|Overall Study|Adverse Event|1|||
124677432|NCT00427934|448444240|FG001|Overall Study|Adverse Event|0|||
124677433|NCT00427934|448444241|FG002|Overall Study|Adverse Event|5|||
124677434|NCT00427934|448444242|FG003|Overall Study|Adverse Event|4|||
124677435|NCT00427934|448444239|FG000|Overall Study|Lack of Efficacy|0|||
124677436|NCT00427934|448444240|FG001|Overall Study|Lack of Efficacy|0|||
124677437|NCT00427934|448444241|FG002|Overall Study|Lack of Efficacy|5|||
124677438|NCT00427934|448444242|FG003|Overall Study|Lack of Efficacy|2|||
124432510|NCT01160289|447543764|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
124432511|NCT01160289|447543765|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
124432512|NCT01160289|447543766|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
124432513|NCT01160289|447543761|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
124432514|NCT01160289|447543762|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
124432515|NCT01160289|447543763|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
124432516|NCT01160289|447543764|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
124432517|NCT01160289|447543765|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
124432518|NCT01160289|447543766|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
124432519|NCT01160289|447543761|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
124432520|NCT01160289|447543762|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
124432521|NCT01160289|447543763|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
124432522|NCT01160289|447543764|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
124432523|NCT01160289|447543765|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
124432524|NCT01160289|447543766|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
124432525|NCT01160289|447543761|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
124432526|NCT01160289|447543762|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
124677439|NCT00427934|448444239|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
124677440|NCT00427934|448444240|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
124677441|NCT00427934|448444241|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
124677442|NCT00427934|448444242|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
124677443|NCT00427934|448444239|FG000|Overall Study|Other|0|||
124677444|NCT00427934|448444240|FG001|Overall Study|Other|0|||
124677445|NCT00427934|448444241|FG002|Overall Study|Other|11|||
124677446|NCT00427934|448444242|FG003|Overall Study|Other|5|||
124677447|NCT00427934|448444239|FG000|Overall Study|Withdrawal by Subject|0|||
124677448|NCT00427934|448444240|FG001|Overall Study|Withdrawal by Subject|0|||
124677449|NCT00427934|448444241|FG002|Overall Study|Withdrawal by Subject|1|||
124677450|NCT00427934|448444242|FG003|Overall Study|Withdrawal by Subject|3|||
124677451|NCT03098979|448444249|FG000|Overall Study|Adverse Event|1|||
124677452|NCT03098979|448444250|FG001|Overall Study|Adverse Event|0|||
124677453|NCT03098979|448444251|FG002|Overall Study|Adverse Event|1|||
124677454|NCT03098979|448444252|FG003|Overall Study|Adverse Event|4|||
124677455|NCT03098979|448444253|FG004|Overall Study|Adverse Event|6|||
124677456|NCT03098979|448444254|FG005|Overall Study|Adverse Event|1|||
124677457|NCT03098979|448444249|FG000|Overall Study|Withdrawal by Subject|2|||
124677458|NCT03098979|448444250|FG001|Overall Study|Withdrawal by Subject|1|||
124677459|NCT03098979|448444251|FG002|Overall Study|Withdrawal by Subject|1|||
124432527|NCT01160289|447543763|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
124432528|NCT01160289|447543764|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
124432529|NCT01160289|447543765|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
124432530|NCT01160289|447543766|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
124432531|NCT01160289|447543761|FG000|Post-Randomization Period|Adverse Event|0|||
124432532|NCT01160289|447543762|FG001|Post-Randomization Period|Adverse Event|4|||
124432533|NCT01160289|447543763|FG002|Post-Randomization Period|Adverse Event|4|||
124432534|NCT01160289|447543764|FG003|Post-Randomization Period|Adverse Event|2|||
124432535|NCT01160289|447543765|FG004|Post-Randomization Period|Adverse Event|0|||
124432536|NCT01160289|447543766|FG005|Post-Randomization Period|Adverse Event|0|||
124432537|NCT01160289|447543761|FG000|Post-Randomization Period|Death|0|||
124432538|NCT01160289|447543762|FG001|Post-Randomization Period|Death|0|||
124432539|NCT01160289|447543763|FG002|Post-Randomization Period|Death|0|||
124432540|NCT01160289|447543764|FG003|Post-Randomization Period|Death|1|||
124677460|NCT03098979|448444252|FG003|Overall Study|Withdrawal by Subject|1|||
124677461|NCT03098979|448444253|FG004|Overall Study|Withdrawal by Subject|2|||
124677462|NCT03098979|448444254|FG005|Overall Study|Withdrawal by Subject|1|||
124677463|NCT03098979|448444249|FG000|Overall Study|Death|1|||
124677464|NCT03098979|448444250|FG001|Overall Study|Death|0|||
124677465|NCT03098979|448444251|FG002|Overall Study|Death|2|||
124677466|NCT03098979|448444252|FG003|Overall Study|Death|0|||
124677467|NCT03098979|448444253|FG004|Overall Study|Death|1|||
124677468|NCT03098979|448444254|FG005|Overall Study|Death|0|||
124677469|NCT03098979|448444249|FG000|Overall Study|Physician Decision|2|||
124677470|NCT03098979|448444250|FG001|Overall Study|Physician Decision|1|||
124677471|NCT03098979|448444251|FG002|Overall Study|Physician Decision|0|||
124677472|NCT03098979|448444252|FG003|Overall Study|Physician Decision|0|||
124677473|NCT03098979|448444253|FG004|Overall Study|Physician Decision|0|||
124432541|NCT01160289|447543765|FG004|Post-Randomization Period|Death|0|||
124432542|NCT01160289|447543766|FG005|Post-Randomization Period|Death|0|||
124677474|NCT03098979|448444254|FG005|Overall Study|Physician Decision|0|||
124677475|NCT03098979|448444249|FG000|Overall Study|Non-compliance|0|||
124677476|NCT03098979|448444250|FG001|Overall Study|Non-compliance|0|||
124677477|NCT03098979|448444251|FG002|Overall Study|Non-compliance|0|||
124677478|NCT03098979|448444252|FG003|Overall Study|Non-compliance|0|||
124432543|NCT01160289|447543761|FG000|Post-Randomization Period|Lack of Efficacy|0|||
124432544|NCT01160289|447543762|FG001|Post-Randomization Period|Lack of Efficacy|1|||
124432545|NCT01160289|447543763|FG002|Post-Randomization Period|Lack of Efficacy|0|||
124432546|NCT01160289|447543764|FG003|Post-Randomization Period|Lack of Efficacy|3|||
124432547|NCT01160289|447543765|FG004|Post-Randomization Period|Lack of Efficacy|0|||
124432548|NCT01160289|447543766|FG005|Post-Randomization Period|Lack of Efficacy|0|||
124432549|NCT01160289|447543761|FG000|Post-Randomization Period|Lost to Follow-up|0|||
124432550|NCT01160289|447543762|FG001|Post-Randomization Period|Lost to Follow-up|3|||
124432551|NCT01160289|447543763|FG002|Post-Randomization Period|Lost to Follow-up|2|||
124432552|NCT01160289|447543764|FG003|Post-Randomization Period|Lost to Follow-up|5|||
124432553|NCT01160289|447543765|FG004|Post-Randomization Period|Lost to Follow-up|3|||
124432554|NCT01160289|447543766|FG005|Post-Randomization Period|Lost to Follow-up|4|||
124432555|NCT01160289|447543761|FG000|Post-Randomization Period|Physician Decision|0|||
124432556|NCT01160289|447543762|FG001|Post-Randomization Period|Physician Decision|0|||
124432557|NCT01160289|447543763|FG002|Post-Randomization Period|Physician Decision|1|||
124432558|NCT01160289|447543764|FG003|Post-Randomization Period|Physician Decision|0|||
124432559|NCT01160289|447543765|FG004|Post-Randomization Period|Physician Decision|0|||
124432560|NCT01160289|447543766|FG005|Post-Randomization Period|Physician Decision|0|||
124432561|NCT01160289|447543761|FG000|Post-Randomization Period|Protocol Violation|0|||
124432562|NCT01160289|447543762|FG001|Post-Randomization Period|Protocol Violation|4|||
124432563|NCT01160289|447543763|FG002|Post-Randomization Period|Protocol Violation|2|||
124432564|NCT01160289|447543764|FG003|Post-Randomization Period|Protocol Violation|0|||
124432565|NCT01160289|447543765|FG004|Post-Randomization Period|Protocol Violation|1|||
124432566|NCT01160289|447543766|FG005|Post-Randomization Period|Protocol Violation|3|||
124432567|NCT01160289|447543761|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
124432568|NCT01160289|447543762|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
124432569|NCT01160289|447543763|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
124432570|NCT01160289|447543764|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
124432571|NCT01160289|447543765|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
124432572|NCT01160289|447543766|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
124432573|NCT01160289|447543761|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
124432574|NCT01160289|447543762|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
124432575|NCT01160289|447543763|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
124432576|NCT01160289|447543764|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
124432577|NCT01160289|447543765|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
124432578|NCT01160289|447543766|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
124432579|NCT01160289|447543761|FG000|Post-Randomization Period|Sponsor Decision|0|||
124432580|NCT01160289|447543762|FG001|Post-Randomization Period|Sponsor Decision|1|||
124432581|NCT01160289|447543763|FG002|Post-Randomization Period|Sponsor Decision|0|||
124432582|NCT01160289|447543764|FG003|Post-Randomization Period|Sponsor Decision|0|||
124432583|NCT01160289|447543765|FG004|Post-Randomization Period|Sponsor Decision|0|||
124432584|NCT01160289|447543766|FG005|Post-Randomization Period|Sponsor Decision|0|||
124432585|NCT03292432|447543769|FG000|Overall Study|Lost to Follow-up|11|||
124432586|NCT03292432|447543770|FG001|Overall Study|Lost to Follow-up|8|||
124432587|NCT03292432|447543769|FG000|Overall Study|Death|2|||
124432588|NCT03292432|447543770|FG001|Overall Study|Death|1|||
124432589|NCT03292432|447543769|FG000|Overall Study|Withdrawal by Subject|1|||
124432590|NCT03292432|447543770|FG001|Overall Study|Withdrawal by Subject|2|||
124432591|NCT03292432|447543769|FG000|Overall Study|Site closed before any data collected|1|||
124432592|NCT03292432|447543770|FG001|Overall Study|Site closed before any data collected|0|||
124432593|NCT01236534|447543775|FG000|Overall Study|Adverse Event|3|||
124432594|NCT01236534|447543776|FG001|Overall Study|Adverse Event|0|||
124432595|NCT01014143|447543777|FG000|Second Intervention|Lost to Follow-up|2|||
124432596|NCT01014143|447543778|FG001|Second Intervention|Lost to Follow-up|0|||
124432597|NCT01014143|447543779|FG002|Second Intervention|Lost to Follow-up|0|||
124432598|NCT02038543|447543786|FG000|Overall Study|Screen Failure|0|||
124432599|NCT02038543|447543787|FG001|Overall Study|Screen Failure|0|||
124432600|NCT02038543|447543788|FG002|Overall Study|Screen Failure|0|||
124432601|NCT02038543|447543789|FG003|Overall Study|Screen Failure|1|||
124432602|NCT02038543|447543786|FG000|Overall Study|Withdrawal by Subject|0|||
124432603|NCT02038543|447543787|FG001|Overall Study|Withdrawal by Subject|0|||
124432604|NCT02038543|447543788|FG002|Overall Study|Withdrawal by Subject|0|||
124432605|NCT02038543|447543789|FG003|Overall Study|Withdrawal by Subject|1|||
124432606|NCT04638920|447543790|FG000|Overall Study|Withdrawal by Subject|5|||
124432607|NCT03775434|447543791|FG000|Overall Study|Adverse Event|2|||
124432608|NCT03775434|447543791|FG000|Overall Study|Withdrawal by Subject|1|||
124432609|NCT02334423|447543792|FG000|Overall Study|Protocol Violation|10|||
124432610|NCT02334423|447543793|FG001|Overall Study|Protocol Violation|3|||
124432611|NCT02930226|447543794|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
124432612|NCT02930226|447543795|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
124432613|NCT02930226|447543796|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
124432614|NCT02930226|447543797|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
124677479|NCT03098979|448444253|FG004|Overall Study|Non-compliance|0|||
124677480|NCT03098979|448444254|FG005|Overall Study|Non-compliance|1|||
124677481|NCT03098979|448444249|FG000|Overall Study|Protocol Violation|0|||
124677482|NCT03098979|448444250|FG001|Overall Study|Protocol Violation|0|||
124677483|NCT03098979|448444251|FG002|Overall Study|Protocol Violation|0|||
124677484|NCT03098979|448444252|FG003|Overall Study|Protocol Violation|0|||
124677485|NCT03098979|448444253|FG004|Overall Study|Protocol Violation|0|||
124677486|NCT03098979|448444254|FG005|Overall Study|Protocol Violation|1|||
124677487|NCT03736967|448444255|FG000|Overall Study|Withdrawal by Subject|26|||
124677488|NCT03736967|448444256|FG001|Overall Study|Withdrawal by Subject|25|||
124677489|NCT03736967|448444257|FG002|Overall Study|Withdrawal by Subject|23|||
124677490|NCT03736967|448444258|FG003|Overall Study|Withdrawal by Subject|26|||
124432615|NCT02930226|447543798|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
124677491|NCT03736967|448444255|FG000|Overall Study|Lost to Follow-up|3|||
124677492|NCT03736967|448444256|FG001|Overall Study|Lost to Follow-up|2|||
124677493|NCT03736967|448444257|FG002|Overall Study|Lost to Follow-up|1|||
124677494|NCT03736967|448444258|FG003|Overall Study|Lost to Follow-up|1|||
124677495|NCT03736967|448444255|FG000|Overall Study|Physician Decision|1|||
124677496|NCT03736967|448444256|FG001|Overall Study|Physician Decision|0|||
124677497|NCT03736967|448444257|FG002|Overall Study|Physician Decision|0|||
124677498|NCT03736967|448444258|FG003|Overall Study|Physician Decision|1|||
124677499|NCT03736967|448444255|FG000|Overall Study|Adverse Event|0|||
124677500|NCT03736967|448444256|FG001|Overall Study|Adverse Event|1|||
124677501|NCT03736967|448444257|FG002|Overall Study|Adverse Event|0|||
124677502|NCT03736967|448444258|FG003|Overall Study|Adverse Event|1|||
124677503|NCT03736967|448444255|FG000|Overall Study|Death|0|||
124677504|NCT03736967|448444256|FG001|Overall Study|Death|0|||
124677505|NCT03736967|448444257|FG002|Overall Study|Death|0|||
124677506|NCT03736967|448444258|FG003|Overall Study|Death|1|||
124677507|NCT03736967|448444255|FG000|Overall Study|Randomized but never treated|1|||
124677508|NCT03736967|448444256|FG001|Overall Study|Randomized but never treated|0|||
124677509|NCT03736967|448444257|FG002|Overall Study|Randomized but never treated|0|||
124677510|NCT03736967|448444258|FG003|Overall Study|Randomized but never treated|0|||
124677511|NCT02369653|448444259|FG000|Overall Study|Lost to Follow-up|0|||
124677512|NCT02369653|448444260|FG001|Overall Study|Lost to Follow-up|1|||
124677513|NCT02369653|448444259|FG000|Overall Study|Administrative reason by sponsor|0|||
124677514|NCT02369653|448444260|FG001|Overall Study|Administrative reason by sponsor|1|||
124677515|NCT02369653|448444259|FG000|Overall Study|Death|1|||
124677516|NCT02369653|448444260|FG001|Overall Study|Death|2|||
124677517|NCT02369653|448444259|FG000|Overall Study|Participant withdrew consent|13|||
124677518|NCT02369653|448444260|FG001|Overall Study|Participant withdrew consent|3|||
124677519|NCT01458587|448444261|FG000|Overall Study|Withdrawal by Subject|1|||
124677520|NCT01458587|448444262|FG001|Overall Study|Withdrawal by Subject|0|||
124677521|NCT01006629|448444263|FG000|Overall Study|Adverse Event|1|||
124677522|NCT01006629|448444263|FG000|Overall Study|Parent refused to continue participation|1|||
124677523|NCT01006629|448444263|FG000|Overall Study|Parent unable to perform site visit|4|||
124677524|NCT01118299|448444264|FG000|Overall Study|Death|7|||
124677525|NCT01118299|448444265|FG001|Overall Study|Death|5|||
124677526|NCT01118299|448444264|FG000|Overall Study|Withdrawal by Subject|8|||
124677527|NCT01118299|448444265|FG001|Overall Study|Withdrawal by Subject|8|||
124677528|NCT01118299|448444264|FG000|Overall Study|Lost to Follow-up|2|||
124677529|NCT01118299|448444265|FG001|Overall Study|Lost to Follow-up|1|||
124677530|NCT01118299|448444264|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
124677531|NCT01118299|448444265|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
124677532|NCT04459338|448444267|FG000|Overall Study|Loss of IV during study|1|||
124677533|NCT04459338|448444268|FG001|Overall Study|Loss of IV during study|0|||
124677534|NCT03157089|448444269|FG000|Overall Study|Treated only with pembrolizumab|1|||
124677535|NCT03157089|448444270|FG001|Overall Study|Treated only with pembrolizumab|0|||
124677536|NCT03157089|448444269|FG000|Overall Study|Adverse Event|5|||
124677537|NCT03157089|448444270|FG001|Overall Study|Adverse Event|4|||
124677538|NCT03157089|448444269|FG000|Overall Study|Progressive disease|6|||
124677539|NCT03157089|448444270|FG001|Overall Study|Progressive disease|8|||
124677540|NCT02932943|448444271|FG000|Overall Study|Lost to Follow-up|0|||
124677541|NCT02932943|448444272|FG001|Overall Study|Lost to Follow-up|2|||
124677542|NCT02932943|448444271|FG000|Overall Study|Adverse Event|2|||
124677543|NCT02932943|448444272|FG001|Overall Study|Adverse Event|2|||
124677544|NCT02932943|448444271|FG000|Overall Study|Withdrawal by Subject|3|||
124677545|NCT02932943|448444272|FG001|Overall Study|Withdrawal by Subject|3|||
124677546|NCT01454284|448444273|FG000|Overall Study|Adverse Event|20|||
124677547|NCT01454284|448444274|FG001|Overall Study|Adverse Event|7|||
124677548|NCT01454284|448444273|FG000|Overall Study|Death|0|||
124677549|NCT01454284|448444274|FG001|Overall Study|Death|3|||
124677550|NCT01454284|448444273|FG000|Overall Study|Lost to Follow-up|13|||
124677551|NCT01454284|448444274|FG001|Overall Study|Lost to Follow-up|8|||
124677552|NCT01454284|448444273|FG000|Overall Study|Protocol Violation|9|||
124677553|NCT01454284|448444274|FG001|Overall Study|Protocol Violation|6|||
124677554|NCT01454284|448444273|FG000|Overall Study|Withdrawal by Subject|58|||
124677555|NCT01454284|448444274|FG001|Overall Study|Withdrawal by Subject|36|||
124677556|NCT01454284|448444273|FG000|Overall Study|Physician Decision|16|||
124677557|NCT01454284|448444274|FG001|Overall Study|Physician Decision|11|||
124677558|NCT01454284|448444273|FG000|Overall Study|Sponsor Decision|0|||
124677559|NCT01454284|448444274|FG001|Overall Study|Sponsor Decision|2|||
124677560|NCT02665117|448444275|FG000|Overall Study|Physician Decision|1|||
124677561|NCT02665117|448444276|FG001|Overall Study|Physician Decision|0|||
124677562|NCT03248037|448444277|FG000|Overall Study|Withdrawal by Subject|6|||
124432616|NCT02930226|447543799|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
124432617|NCT00652327|447543802|FG000|Overall Study|Adverse Event|0|||
124432618|NCT00652327|447543803|FG001|Overall Study|Adverse Event|2|||
124432619|NCT00652327|447543802|FG000|Overall Study|Lost to Follow-up|0|||
124432620|NCT00652327|447543803|FG001|Overall Study|Lost to Follow-up|3|||
124432621|NCT01076647|447543804|FG000|Overall Study|Adverse Event|4|||
124432622|NCT01076647|447543805|FG001|Overall Study|Adverse Event|1|||
124432623|NCT01076647|447543804|FG000|Overall Study|Lack of Efficacy|0|||
124432624|NCT01076647|447543805|FG001|Overall Study|Lack of Efficacy|1|||
124432625|NCT01076647|447543804|FG000|Overall Study|Protocol Violation|7|||
124432626|NCT01076647|447543805|FG001|Overall Study|Protocol Violation|9|||
124432627|NCT01076647|447543804|FG000|Overall Study|Withdrawal criteria|2|||
124432628|NCT01076647|447543805|FG001|Overall Study|Withdrawal criteria|2|||
124432629|NCT01076647|447543804|FG000|Overall Study|Unclassified|12|||
124432630|NCT01076647|447543805|FG001|Overall Study|Unclassified|12|||
124432631|NCT01871805|447543809|FG000|Phase I|Death|7|||
124432632|NCT01871805|447543810|FG001|Phase I|Death|4|||
124677563|NCT03248037|448444278|FG001|Overall Study|Withdrawal by Subject|9|||
124677564|NCT03248037|448444277|FG000|Overall Study|Adverse Event|15|||
124677565|NCT03248037|448444278|FG001|Overall Study|Adverse Event|0|||
124677566|NCT02300610|448444279|FG000|Overall Study|Withdrawal by Subject|1|||
124677567|NCT02300610|448444280|FG001|Overall Study|Withdrawal by Subject|0|||
124677568|NCT02300610|448444281|FG002|Overall Study|Withdrawal by Subject|1|||
124677569|NCT01829347|448444282|FG000|VTI-210|Death|5|||
124677570|NCT01829347|448444283|FG001|VTI-210|Death|3|||
124677571|NCT01829347|448444282|FG000|VTI-210|Withdrawal by Subject|1|||
124677572|NCT01829347|448444283|FG001|VTI-210|Withdrawal by Subject|0|||
124677573|NCT01829347|448444282|FG000|VTI-210E|Death|2|||
124677574|NCT01829347|448444283|FG001|VTI-210E|Death|1|||
124677575|NCT01829347|448444282|FG000|VTI-210E|Study terminated prematurely|1|||
124677576|NCT01829347|448444283|FG001|VTI-210E|Study terminated prematurely|5|||
124677577|NCT01259245|448444293|FG000|Overall Study|Withdrawal by Subject|27|||
124677578|NCT01259245|448444294|FG001|Overall Study|Withdrawal by Subject|24|||
124677579|NCT01259245|448444293|FG000|Overall Study|Death|1|||
124677580|NCT01259245|448444294|FG001|Overall Study|Death|2|||
124677581|NCT02152007|448444295|FG000|Overall Study|Withdrawal by Subject|1|||
124432633|NCT01871805|447543811|FG002|Phase I|Death|6|||
124432634|NCT01871805|447543812|FG003|Phase I|Death|2|||
124677582|NCT01302899|448444302|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
124677583|NCT01302899|448444303|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
124677584|NCT01302899|448444302|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
124677585|NCT01302899|448444303|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
124677586|NCT03363906|448444308|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
124677587|NCT03363906|448444309|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
124677588|NCT03363906|448444308|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
124677589|NCT03363906|448444309|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
124677590|NCT03363906|448444308|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
124677591|NCT03363906|448444309|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
124677592|NCT03363906|448444308|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
124432635|NCT01871805|447543813|FG004|Phase I|Death|9|||
124432636|NCT01871805|447543814|FG005|Phase I|Death|0|||
124432637|NCT01871805|447543809|FG000|Phase I|Alive in Survival Follow-up|0|||
124432638|NCT01871805|447543810|FG001|Phase I|Alive in Survival Follow-up|2|||
124432639|NCT01871805|447543811|FG002|Phase I|Alive in Survival Follow-up|4|||
124432640|NCT01871805|447543812|FG003|Phase I|Alive in Survival Follow-up|5|||
124432641|NCT01871805|447543813|FG004|Phase I|Alive in Survival Follow-up|4|||
124432642|NCT01871805|447543814|FG005|Phase I|Alive in Survival Follow-up|0|||
124432643|NCT01871805|447543809|FG000|Phase I|Lost to Follow-up|0|||
124432644|NCT01871805|447543810|FG001|Phase I|Lost to Follow-up|1|||
124432645|NCT01871805|447543811|FG002|Phase I|Lost to Follow-up|3|||
124432646|NCT01871805|447543812|FG003|Phase I|Lost to Follow-up|0|||
124677593|NCT03363906|448444309|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
124677594|NCT02714153|448444311|FG000|Overall Study|Death|1|||
124677595|NCT00485303|448444313|FG000|Overall Study|Adverse Event|5|||
124677596|NCT00485303|448444313|FG000|Overall Study|Progressive Disease|44|||
124432647|NCT01871805|447543813|FG004|Phase I|Lost to Follow-up|0|||
124677597|NCT00485303|448444313|FG000|Overall Study|Other|3|||
124677598|NCT00485303|448444313|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
124677599|NCT00485303|448444313|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
124677600|NCT00087178|448444315|FG000|Overall Study|No follow up data|5|||
124677601|NCT00087178|448444316|FG001|Overall Study|No follow up data|15|||
124677602|NCT00087178|448444315|FG000|Overall Study|No clinical assessment|1|||
124677603|NCT00087178|448444316|FG001|Overall Study|No clinical assessment|2|||
124677604|NCT00087178|448444315|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
124432648|NCT01871805|447543814|FG005|Phase I|Lost to Follow-up|0|||
124432649|NCT01871805|447543809|FG000|Phase II|Death|0|||
124432650|NCT01871805|447543810|FG001|Phase II|Death|0|||
124432651|NCT01871805|447543811|FG002|Phase II|Death|0|||
124432652|NCT01871805|447543812|FG003|Phase II|Death|0|||
124677605|NCT00087178|448444316|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
124677606|NCT02783911|448444317|FG000|Overall Study|Lost to Follow-up|3|||
124677607|NCT02783911|448444318|FG001|Overall Study|Lost to Follow-up|32|||
124677608|NCT01776554|448444322|FG000|Overall Study|Adverse Event|1|||
124677609|NCT01776554|448444323|FG001|Overall Study|Adverse Event|0|||
124677610|NCT01776554|448444322|FG000|Overall Study|Withdrawal by Subject|3|||
124677611|NCT01776554|448444323|FG001|Overall Study|Withdrawal by Subject|8|||
124677612|NCT01776554|448444322|FG000|Overall Study|Lost to Follow-up|6|||
124677613|NCT01776554|448444323|FG001|Overall Study|Lost to Follow-up|9|||
124677614|NCT01776554|448444322|FG000|Overall Study|Administrative Reason|2|||
124677615|NCT01776554|448444323|FG001|Overall Study|Administrative Reason|5|||
124677616|NCT01776554|448444322|FG000|Overall Study|Protocol Violation|1|||
124677617|NCT01776554|448444323|FG001|Overall Study|Protocol Violation|0|||
124677618|NCT01776554|448444322|FG000|Overall Study|Unclassified|4|||
124677619|NCT01776554|448444323|FG001|Overall Study|Unclassified|1|||
124677620|NCT01041859|448444324|FG000|Open-Label Titration|Adverse Event|69|||
124677621|NCT01041859|448444325|FG001|Open-Label Titration|Adverse Event|0|||
124677622|NCT01041859|448444326|FG002|Open-Label Titration|Adverse Event|0|||
124677623|NCT01041859|448444324|FG000|Open-Label Titration|Lack of Efficacy|3|||
124677624|NCT01041859|448444325|FG001|Open-Label Titration|Lack of Efficacy|0|||
124677625|NCT01041859|448444326|FG002|Open-Label Titration|Lack of Efficacy|0|||
124677626|NCT01041859|448444324|FG000|Open-Label Titration|Lost to Follow-up|1|||
124677627|NCT01041859|448444325|FG001|Open-Label Titration|Lost to Follow-up|0|||
124677628|NCT01041859|448444326|FG002|Open-Label Titration|Lost to Follow-up|0|||
124677629|NCT01041859|448444324|FG000|Open-Label Titration|Physician Decision|1|||
124677630|NCT01041859|448444325|FG001|Open-Label Titration|Physician Decision|0|||
124677631|NCT01041859|448444326|FG002|Open-Label Titration|Physician Decision|0|||
124677632|NCT01041859|448444324|FG000|Open-Label Titration|Protocol Violation|1|||
124677633|NCT01041859|448444325|FG001|Open-Label Titration|Protocol Violation|0|||
124677634|NCT01041859|448444326|FG002|Open-Label Titration|Protocol Violation|0|||
124677635|NCT01041859|448444324|FG000|Open-Label Titration|Other|7|||
124677636|NCT01041859|448444325|FG001|Open-Label Titration|Other|0|||
124677637|NCT01041859|448444326|FG002|Open-Label Titration|Other|0|||
124677638|NCT01041859|448444324|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
124677639|NCT01041859|448444325|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
124677640|NCT01041859|448444326|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
124677641|NCT01041859|448444324|FG000|Open-Label Titration|Withdrawal by Subject|11|||
124677642|NCT01041859|448444325|FG001|Open-Label Titration|Withdrawal by Subject|0|||
124677643|NCT01041859|448444326|FG002|Open-Label Titration|Withdrawal by Subject|0|||
124677644|NCT01041859|448444324|FG000|Double-Blind Maintenance|Adverse Event|0|||
124677645|NCT01041859|448444325|FG001|Double-Blind Maintenance|Adverse Event|23|||
124677646|NCT01041859|448444326|FG002|Double-Blind Maintenance|Adverse Event|13|||
124677647|NCT01041859|448444324|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
124677648|NCT01041859|448444325|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
124677649|NCT01041859|448444326|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
124677650|NCT01041859|448444324|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
124677651|NCT01041859|448444325|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
124677652|NCT01041859|448444326|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
124677653|NCT01041859|448444324|FG000|Double-Blind Maintenance|Physician Decision|0|||
124677654|NCT01041859|448444325|FG001|Double-Blind Maintenance|Physician Decision|2|||
124677655|NCT01041859|448444326|FG002|Double-Blind Maintenance|Physician Decision|1|||
124677656|NCT01041859|448444324|FG000|Double-Blind Maintenance|Protocol Violation|0|||
124677657|NCT01041859|448444325|FG001|Double-Blind Maintenance|Protocol Violation|1|||
124677658|NCT01041859|448444326|FG002|Double-Blind Maintenance|Protocol Violation|3|||
124677659|NCT01041859|448444324|FG000|Double-Blind Maintenance|Other|0|||
124677660|NCT01041859|448444325|FG001|Double-Blind Maintenance|Other|6|||
124677661|NCT01041859|448444326|FG002|Double-Blind Maintenance|Other|2|||
124677662|NCT01041859|448444324|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
124677663|NCT01041859|448444325|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
124677664|NCT01041859|448444326|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
124677665|NCT01041859|448444324|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
124677666|NCT01041859|448444325|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
124677667|NCT01041859|448444326|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
124432653|NCT01871805|447543813|FG004|Phase II|Death|0|||
124677668|NCT00885118|448444330|FG000|Overall Study|Adverse Event|1|||
124677669|NCT00885118|448444331|FG001|Overall Study|Adverse Event|0|||
124677670|NCT00885118|448444332|FG002|Overall Study|Adverse Event|0|||
124677671|NCT00885118|448444333|FG003|Overall Study|Adverse Event|0|||
124677672|NCT00885118|448444334|FG004|Overall Study|Adverse Event|0|||
124677673|NCT00885118|448444330|FG000|Overall Study|Withdrawal by Subject|0|||
124677674|NCT00885118|448444331|FG001|Overall Study|Withdrawal by Subject|0|||
124677675|NCT00885118|448444332|FG002|Overall Study|Withdrawal by Subject|0|||
124677676|NCT00885118|448444333|FG003|Overall Study|Withdrawal by Subject|0|||
124677677|NCT00885118|448444334|FG004|Overall Study|Withdrawal by Subject|1|||
124677678|NCT00885118|448444330|FG000|Overall Study|Other reason not defined above|0|||
124677679|NCT00885118|448444331|FG001|Overall Study|Other reason not defined above|0|||
124677680|NCT00885118|448444332|FG002|Overall Study|Other reason not defined above|1|||
124677681|NCT00885118|448444333|FG003|Overall Study|Other reason not defined above|0|||
124677682|NCT00885118|448444334|FG004|Overall Study|Other reason not defined above|0|||
124677683|NCT03087058|448444340|FG000|Overall Study|Withdrawal by Subject|2|||
124677684|NCT03087058|448444341|FG001|Overall Study|Withdrawal by Subject|0|||
124677685|NCT03087058|448444342|FG002|Overall Study|Withdrawal by Subject|0|||
124677686|NCT02577029|448444343|FG000|Overall Study|Adverse Event|1|||
124677687|NCT02577029|448444344|FG001|Overall Study|Adverse Event|0|||
124677688|NCT02577029|448444345|FG002|Overall Study|Adverse Event|2|||
124677689|NCT02577029|448444346|FG003|Overall Study|Adverse Event|0|||
124677690|NCT02577029|448444347|FG004|Overall Study|Adverse Event|1|||
124677691|NCT02577029|448444348|FG005|Overall Study|Adverse Event|0|||
124677692|NCT02577029|448444349|FG006|Overall Study|Adverse Event|0|||
124677693|NCT02577029|448444350|FG007|Overall Study|Adverse Event|0|||
124677694|NCT02577029|448444343|FG000|Overall Study|Withdrawal by Subject|0|||
124677695|NCT02577029|448444344|FG001|Overall Study|Withdrawal by Subject|0|||
124677696|NCT02577029|448444345|FG002|Overall Study|Withdrawal by Subject|0|||
124677697|NCT02577029|448444346|FG003|Overall Study|Withdrawal by Subject|0|||
124677698|NCT02577029|448444347|FG004|Overall Study|Withdrawal by Subject|0|||
124677699|NCT02577029|448444348|FG005|Overall Study|Withdrawal by Subject|1|||
124677700|NCT02577029|448444349|FG006|Overall Study|Withdrawal by Subject|0|||
124677701|NCT02577029|448444350|FG007|Overall Study|Withdrawal by Subject|0|||
124677702|NCT02577029|448444343|FG000|Overall Study|Sponsor Termination of the Study|9|||
124677703|NCT02577029|448444344|FG001|Overall Study|Sponsor Termination of the Study|2|||
124677704|NCT02577029|448444345|FG002|Overall Study|Sponsor Termination of the Study|5|||
124677705|NCT02577029|448444346|FG003|Overall Study|Sponsor Termination of the Study|12|||
124677706|NCT02577029|448444347|FG004|Overall Study|Sponsor Termination of the Study|10|||
124677707|NCT02577029|448444348|FG005|Overall Study|Sponsor Termination of the Study|12|||
124677708|NCT02577029|448444349|FG006|Overall Study|Sponsor Termination of the Study|12|||
124677709|NCT02577029|448444350|FG007|Overall Study|Sponsor Termination of the Study|12|||
124677710|NCT02078817|448444351|FG000|Overall Study|Withdrawal by Subject|1|||
124677711|NCT01420536|448444352|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
124677712|NCT01420536|448444353|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
124677713|NCT01652690|448444355|FG000|Overall Study|Withdrawal by Subject|16|||
124677714|NCT01652690|448444356|FG001|Overall Study|Withdrawal by Subject|4|||
124677715|NCT01652690|448444355|FG000|Overall Study|Other|8|||
124677716|NCT01652690|448444356|FG001|Overall Study|Other|9|||
124677717|NCT01652690|448444355|FG000|Overall Study|Lost to Follow-up|6|||
124677718|NCT01652690|448444356|FG001|Overall Study|Lost to Follow-up|6|||
124677719|NCT01652690|448444355|FG000|Overall Study|Death|5|||
124677720|NCT01652690|448444356|FG001|Overall Study|Death|2|||
124677721|NCT03415178|448444357|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
124677722|NCT03415178|448444358|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
124677723|NCT03415178|448444357|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
124677724|NCT03415178|448444358|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
124677725|NCT01884597|448444359|FG000|Overall Study|Adverse Event|0|||
124677726|NCT01884597|448444360|FG001|Overall Study|Adverse Event|0|||
124677727|NCT01884597|448444361|FG002|Overall Study|Adverse Event|1|||
124677728|NCT01884597|448444359|FG000|Overall Study|Lack of Efficacy|1|||
124677729|NCT01884597|448444360|FG001|Overall Study|Lack of Efficacy|0|||
124677730|NCT01884597|448444361|FG002|Overall Study|Lack of Efficacy|0|||
124677731|NCT01884597|448444359|FG000|Overall Study|Death|0|||
124677732|NCT01884597|448444360|FG001|Overall Study|Death|1|||
124677733|NCT01884597|448444361|FG002|Overall Study|Death|0|||
124677734|NCT02097823|448444362|FG000|Overall Study|Withdrawal by Subject|1|||
124677735|NCT02097823|448444363|FG001|Overall Study|Withdrawal by Subject|1|||
124677736|NCT03082729|448444365|FG000|Overall Study|Lost to Follow-up|7|||
124677737|NCT03082729|448444365|FG000|Overall Study|Physician Decision|2|||
124677738|NCT03082729|448444365|FG000|Overall Study|Withdrawal by Subject|1|||
124677739|NCT03082729|448444365|FG000|Overall Study|Lack of Efficacy|9|||
124677740|NCT03082729|448444365|FG000|Overall Study|Adverse Event|4|||
124677741|NCT03082729|448444365|FG000|Overall Study|Protocol Violation|6|||
124677742|NCT03082729|448444365|FG000|Overall Study|Fear of study procedure|1|||
124677743|NCT03082729|448444365|FG000|Overall Study|Scheduling conflict|1|||
124677744|NCT00959751|448445805|FG000|Overall Study|Lost to Follow-up|2|||
124677745|NCT00959751|448445806|FG001|Overall Study|Lost to Follow-up|3|||
124677746|NCT00959751|448445805|FG000|Overall Study|Consent Withdrawn|0|||
124677747|NCT00959751|448445806|FG001|Overall Study|Consent Withdrawn|1|||
124677748|NCT00959751|448445805|FG000|Overall Study|Non-compliance to Study Procedures|0|||
124677749|NCT00959751|448445806|FG001|Overall Study|Non-compliance to Study Procedures|1|||
124677750|NCT00959751|448445805|FG000|Overall Study|No migraine headache without aura|7|||
124677751|NCT00959751|448445806|FG001|Overall Study|No migraine headache without aura|7|||
124677752|NCT00434252|448445807|FG000|Overall Study|Lack of Efficacy|50|||
124677753|NCT00434252|448445808|FG001|Overall Study|Lack of Efficacy|100|||
124677754|NCT00434252|448445807|FG000|Overall Study|Adverse Event|6|||
124677755|NCT00434252|448445808|FG001|Overall Study|Adverse Event|13|||
124677756|NCT00434252|448445807|FG000|Overall Study|Death|1|||
124677757|NCT00434252|448445808|FG001|Overall Study|Death|2|||
124677758|NCT00434252|448445807|FG000|Overall Study|Lost to Follow-up|0|||
124677759|NCT00434252|448445808|FG001|Overall Study|Lost to Follow-up|1|||
124677760|NCT00434252|448445807|FG000|Overall Study|Physician Decision|4|||
124677761|NCT00434252|448445808|FG001|Overall Study|Physician Decision|8|||
124677762|NCT00434252|448445807|FG000|Overall Study|Withdrawal by Subject|3|||
124677763|NCT00434252|448445808|FG001|Overall Study|Withdrawal by Subject|7|||
124677764|NCT02807259|448445809|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
124677765|NCT02807259|448445810|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
124677766|NCT02807259|448445809|FG000|Midline (3 Months)|migration, refusal, not available|30|||
124677767|NCT02807259|448445810|FG001|Midline (3 Months)|migration, refusal, not available|34|||
124677768|NCT02807259|448445809|FG000|Endline (3 Months)|migration, refusal, not available|35|||
124677769|NCT02807259|448445810|FG001|Endline (3 Months)|migration, refusal, not available|87|||
124677770|NCT03861039|448445811|FG000|Overall Study|Adverse Event|2|||
124677771|NCT03861039|448445812|FG001|Overall Study|Adverse Event|5|||
124677772|NCT03861039|448445813|FG002|Overall Study|Adverse Event|11|||
124677773|NCT03861039|448445811|FG000|Overall Study|Withdrawal by Subject|1|||
124677774|NCT03861039|448445812|FG001|Overall Study|Withdrawal by Subject|3|||
124677775|NCT03861039|448445813|FG002|Overall Study|Withdrawal by Subject|4|||
124677776|NCT01673386|448445814|FG000|Overall Study|Study terminated by sponsor|16|||
124677777|NCT01673386|448445815|FG001|Overall Study|Study terminated by sponsor|22|||
124677778|NCT01673386|448445814|FG000|Overall Study|Adverse Event|5|||
124677779|NCT01673386|448445815|FG001|Overall Study|Adverse Event|2|||
124677780|NCT01673386|448445814|FG000|Overall Study|Progressive disease|4|||
124677781|NCT01673386|448445815|FG001|Overall Study|Progressive disease|1|||
124677782|NCT01673386|448445814|FG000|Overall Study|Withdrawal by Subject|0|||
124677783|NCT01673386|448445815|FG001|Overall Study|Withdrawal by Subject|2|||
124677784|NCT02934178|448445816|FG000|Received Vaccination 2|Death|0|||
124677785|NCT02934178|448445817|FG001|Received Vaccination 2|Death|1|||
124677786|NCT02934178|448445816|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
124677787|NCT02934178|448445817|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
124677788|NCT01898078|448445820|FG000|Overall Study|Progressive Disease|1|||
124677789|NCT01898078|448445821|FG001|Overall Study|Progressive Disease|5|||
124677790|NCT01898078|448445820|FG000|Overall Study|Adverse Event|2|||
124677791|NCT01898078|448445821|FG001|Overall Study|Adverse Event|1|||
124677792|NCT01898078|448445820|FG000|Overall Study|Withdrawal by Subject|1|||
124677793|NCT01898078|448445821|FG001|Overall Study|Withdrawal by Subject|1|||
124677794|NCT01898078|448445820|FG000|Overall Study|Symptomatic Deterioration|2|||
124677795|NCT01898078|448445821|FG001|Overall Study|Symptomatic Deterioration|0|||
124677796|NCT01898078|448445820|FG000|Overall Study|Reason not Specified|0|||
124677797|NCT01898078|448445821|FG001|Overall Study|Reason not Specified|1|||
124677798|NCT01075048|448445823|FG000|Overall Study|Death|4|||
124677799|NCT01075048|448445824|FG001|Overall Study|Death|17|||
124677800|NCT01075048|448445825|FG002|Overall Study|Death|12|||
124677801|NCT01075048|448445823|FG000|Overall Study|Start of other or new therapy|4|||
124677802|NCT01075048|448445824|FG001|Overall Study|Start of other or new therapy|36|||
124677803|NCT01075048|448445825|FG002|Overall Study|Start of other or new therapy|46|||
124677804|NCT01075048|448445823|FG000|Overall Study|Withdrawal by Subject|1|||
124677805|NCT01075048|448445824|FG001|Overall Study|Withdrawal by Subject|6|||
124677806|NCT01075048|448445825|FG002|Overall Study|Withdrawal by Subject|3|||
124677807|NCT01075048|448445823|FG000|Overall Study|Lost to Follow-up|0|||
124677808|NCT01075048|448445824|FG001|Overall Study|Lost to Follow-up|1|||
124677809|NCT01075048|448445825|FG002|Overall Study|Lost to Follow-up|1|||
124677810|NCT01287936|448445829|FG000|Overall Study|Lost to Follow-up|0|||
124677811|NCT01287936|448445830|FG001|Overall Study|Lost to Follow-up|1|||
124677812|NCT01287936|448445831|FG002|Overall Study|Lost to Follow-up|1|||
124677813|NCT01140906|448445832|FG000|Overall Study|Adverse Event|7|||
124677814|NCT01140906|448445833|FG001|Overall Study|Adverse Event|10|||
124677815|NCT01140906|448445834|FG002|Overall Study|Adverse Event|17|||
124677816|NCT01140906|448445835|FG003|Overall Study|Adverse Event|7|||
124677817|NCT01140906|448445832|FG000|Overall Study|Lack of Efficacy|6|||
124677818|NCT01140906|448445833|FG001|Overall Study|Lack of Efficacy|8|||
124677819|NCT01140906|448445834|FG002|Overall Study|Lack of Efficacy|2|||
124677820|NCT01140906|448445835|FG003|Overall Study|Lack of Efficacy|1|||
124677821|NCT01140906|448445832|FG000|Overall Study|Non-compliance|0|||
124677822|NCT01140906|448445833|FG001|Overall Study|Non-compliance|1|||
124677823|NCT01140906|448445834|FG002|Overall Study|Non-compliance|0|||
124677824|NCT01140906|448445835|FG003|Overall Study|Non-compliance|1|||
124432654|NCT01871805|447543814|FG005|Phase II|Death|45|||
124432655|NCT01871805|447543809|FG000|Phase II|Alive in Survival Follow-up|0|||
124432656|NCT01871805|447543810|FG001|Phase II|Alive in Survival Follow-up|0|||
124432657|NCT01871805|447543811|FG002|Phase II|Alive in Survival Follow-up|0|||
124677825|NCT01140906|448445832|FG000|Overall Study|Protocol Violation|5|||
124677826|NCT01140906|448445833|FG001|Overall Study|Protocol Violation|3|||
124677827|NCT01140906|448445834|FG002|Overall Study|Protocol Violation|2|||
124677828|NCT01140906|448445835|FG003|Overall Study|Protocol Violation|1|||
124677829|NCT01140906|448445832|FG000|Overall Study|Withdrawal of consent|6|||
124677830|NCT01140906|448445833|FG001|Overall Study|Withdrawal of consent|6|||
124677831|NCT01140906|448445834|FG002|Overall Study|Withdrawal of consent|2|||
124677832|NCT01140906|448445835|FG003|Overall Study|Withdrawal of consent|2|||
124677833|NCT01140906|448445832|FG000|Overall Study|Lost to Follow-up|1|||
124677834|NCT01140906|448445833|FG001|Overall Study|Lost to Follow-up|1|||
124677835|NCT01140906|448445834|FG002|Overall Study|Lost to Follow-up|0|||
124677836|NCT01140906|448445835|FG003|Overall Study|Lost to Follow-up|2|||
124677837|NCT01140906|448445832|FG000|Overall Study|Administrative or other reason|0|||
124677838|NCT01140906|448445833|FG001|Overall Study|Administrative or other reason|5|||
124677839|NCT01140906|448445834|FG002|Overall Study|Administrative or other reason|3|||
124677840|NCT01140906|448445835|FG003|Overall Study|Administrative or other reason|2|||
124677841|NCT00703534|448445836|FG000|Overall Study|Adverse Event|14|||
124677842|NCT00703534|448445837|FG001|Overall Study|Adverse Event|3|||
124677843|NCT00703534|448445836|FG000|Overall Study|Withdrawal by Subject|8|||
124677844|NCT00703534|448445837|FG001|Overall Study|Withdrawal by Subject|7|||
124677845|NCT00703534|448445836|FG000|Overall Study|Incorrect Enrollment|6|||
124677846|NCT00703534|448445837|FG001|Overall Study|Incorrect Enrollment|6|||
124677847|NCT00703534|448445836|FG000|Overall Study|Lost to Follow-up|1|||
124677848|NCT00703534|448445837|FG001|Overall Study|Lost to Follow-up|4|||
124677849|NCT00703534|448445836|FG000|Overall Study|Severe Non Compliance|1|||
124677850|NCT00703534|448445837|FG001|Overall Study|Severe Non Compliance|5|||
124677851|NCT00900562|448445838|FG000|Overall Study|Progressive disease|9|||
124677852|NCT00900562|448445839|FG001|Overall Study|Progressive disease|5|||
124677853|NCT00900562|448445838|FG000|Overall Study|Toxicity|1|||
124677854|NCT00900562|448445839|FG001|Overall Study|Toxicity|0|||
124677855|NCT00900562|448445838|FG000|Overall Study|Death|1|||
124677856|NCT00900562|448445839|FG001|Overall Study|Death|1|||
124677857|NCT00900562|448445838|FG000|Overall Study|Withdrawal by Subject|0|||
124677858|NCT00900562|448445839|FG001|Overall Study|Withdrawal by Subject|1|||
124677859|NCT00900562|448445838|FG000|Overall Study|Unrelated adverse event|1|||
124677860|NCT00900562|448445839|FG001|Overall Study|Unrelated adverse event|0|||
124677861|NCT03587636|448445840|FG000|Overall Study|Lost to Follow-up|2|||
124677862|NCT03587636|448445841|FG001|Overall Study|Lost to Follow-up|5|||
124677863|NCT02058095|448445842|FG000|Overall Study|Adverse Event|1|||
124677864|NCT02058095|448445843|FG001|Overall Study|Adverse Event|0|||
124677865|NCT00316004|448445844|FG000|Overall Study|Subject was not given study fluid.|14|||
124677866|NCT00316004|448445845|FG001|Overall Study|Subject was not given study fluid.|14|||
124677867|NCT00316004|448445846|FG002|Overall Study|Subject was not given study fluid.|21|||
124677868|NCT03743194|448445854|FG000|Overall Study|Protocol Violation|7|||
124677869|NCT03743194|448445855|FG001|Overall Study|Protocol Violation|7|||
124677870|NCT03743194|448445854|FG000|Overall Study|Physician Decision|0|||
124677871|NCT03743194|448445855|FG001|Overall Study|Physician Decision|2|||
124677872|NCT02897349|448445858|FG000|Overall Study|Lost to Follow-up|2|||
124677873|NCT02897349|448445859|FG001|Overall Study|Lost to Follow-up|2|||
124677874|NCT02897349|448445858|FG000|Overall Study|Adverse Event|3|||
124677875|NCT02897349|448445859|FG001|Overall Study|Adverse Event|3|||
124677876|NCT02897349|448445858|FG000|Overall Study|Other than listed above|0|||
124677877|NCT02897349|448445859|FG001|Overall Study|Other than listed above|1|||
124677878|NCT01027949|448445865|FG000|Overall Study|Death|174|||
124677879|NCT01027949|448445865|FG000|Overall Study|Progressive Disease|163|||
124677880|NCT01027949|448445865|FG000|Overall Study|Adverse Event|172|||
124677881|NCT01027949|448445865|FG000|Overall Study|Withdrawal by Subject|113|||
124677882|NCT01027949|448445865|FG000|Overall Study|Lost to Follow-up|17|||
124677883|NCT01027949|448445865|FG000|Overall Study|Protocol Violation|13|||
124677884|NCT01027949|448445865|FG000|Overall Study|PI Decision|8|||
124677885|NCT01027949|448445865|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
124677886|NCT01027949|448445865|FG000|Overall Study|Non-compliance with Study Procedures|7|||
124677887|NCT01027949|448445865|FG000|Overall Study|Lung Transplant|5|||
124677888|NCT01027949|448445865|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
124432658|NCT01871805|447543812|FG003|Phase II|Alive in Survival Follow-up|0|||
124677889|NCT01027949|448445865|FG000|Overall Study|Use of Excluded Medication|2|||
124677890|NCT01027949|448445865|FG000|Overall Study|Patient Self-discontinuation|1|||
124677891|NCT01027949|448445865|FG000|Overall Study|Pregnancy|1|||
124677892|NCT01027949|448445865|FG000|Overall Study|Surgery|1|||
124677893|NCT00671749|448445868|FG000|Overall Study|Adverse Event|2|||
124677894|NCT00671749|448445868|FG000|Overall Study|Withdrawal by Subject|4|||
124677895|NCT00671749|448445868|FG000|Overall Study|Protocol Violation|1|||
124677896|NCT00671749|448445868|FG000|Overall Study|Lost to Follow-up|1|||
124677897|NCT02515227|448445869|FG000|Overall Study|Adverse Event|0|||
124677898|NCT02515227|448445870|FG001|Overall Study|Adverse Event|2|||
124677899|NCT02515227|448445869|FG000|Overall Study|Progressive disease|2|||
124677900|NCT02515227|448445870|FG001|Overall Study|Progressive disease|9|||
124677901|NCT03451071|448445871|FG000|First Vaccine|Withdrawal by Subject|1|||
124677902|NCT03451071|448445871|FG000|Second Vaccine|Lost to Follow-up|19|||
124677903|NCT03451071|448445871|FG000|Third Vaccine|Lost to Follow-up|22|||
124677904|NCT03451071|448445871|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
124677905|NCT02834975|448445872|FG000|Overall Study|Physician Decision|2|||
124677906|NCT02834975|448445872|FG000|Overall Study|Adverse Event|1|||
124677907|NCT02834975|448445872|FG000|Overall Study|Withdrawal by Subject|1|||
124677908|NCT02834975|448445872|FG000|Overall Study|Lack of Efficacy|1|||
124677909|NCT03558516|448445874|FG000|Overall Study|Protocol Violation|2|||
124677910|NCT03558516|448445875|FG001|Overall Study|Protocol Violation|2|||
124677911|NCT00676143|448445876|FG000|Overall Study|Adverse Event|34|||
124677912|NCT00676143|448445877|FG001|Overall Study|Adverse Event|60|||
124677913|NCT00676143|448445876|FG000|Overall Study|Death|4|||
124677914|NCT00676143|448445877|FG001|Overall Study|Death|4|||
124677915|NCT00676143|448445876|FG000|Overall Study|Lack of Efficacy|0|||
124677916|NCT00676143|448445877|FG001|Overall Study|Lack of Efficacy|6|||
124677917|NCT00676143|448445876|FG000|Overall Study|Lost to Follow-up|0|||
124677918|NCT00676143|448445877|FG001|Overall Study|Lost to Follow-up|13|||
124677919|NCT00676143|448445876|FG000|Overall Study|Physician Decision|5|||
124677920|NCT00676143|448445877|FG001|Overall Study|Physician Decision|8|||
124677921|NCT00676143|448445876|FG000|Overall Study|Protocol Violation|4|||
124677922|NCT00676143|448445877|FG001|Overall Study|Protocol Violation|8|||
124677923|NCT00676143|448445876|FG000|Overall Study|Withdrawal by Subject|24|||
124677924|NCT00676143|448445877|FG001|Overall Study|Withdrawal by Subject|42|||
124677925|NCT00676143|448445876|FG000|Overall Study|Discontinuation of study by sponsor|65|||
124677926|NCT00676143|448445877|FG001|Overall Study|Discontinuation of study by sponsor|88|||
124677927|NCT00676143|448445876|FG000|Overall Study|Failed to return|2|||
124677928|NCT00676143|448445877|FG001|Overall Study|Failed to return|1|||
124677929|NCT00676143|448445876|FG000|Overall Study|Loss of caregiver|5|||
124677930|NCT00676143|448445877|FG001|Overall Study|Loss of caregiver|3|||
124677931|NCT00676143|448445876|FG000|Overall Study|Other|11|||
124677932|NCT00676143|448445877|FG001|Overall Study|Other|20|||
124677933|NCT00676143|448445876|FG000|Overall Study|Participant participation unknown|1|||
124677934|NCT00676143|448445877|FG001|Overall Study|Participant participation unknown|4|||
124677935|NCT00676143|448445876|FG000|Overall Study|Vasogenic edema recurrence|1|||
124677936|NCT00676143|448445877|FG001|Overall Study|Vasogenic edema recurrence|3|||
124677937|NCT00929669|448445878|FG000|Overall Study|elevated glucose levels|1|||
124677938|NCT02065557|448445881|FG000|Induction Period|Withdrawal by Subject|2|||
124677939|NCT02065557|448445882|FG001|Induction Period|Withdrawal by Subject|1|||
124677940|NCT02065557|448445883|FG002|Induction Period|Withdrawal by Subject|0|||
124677941|NCT02065557|448445884|FG003|Induction Period|Withdrawal by Subject|0|||
124677942|NCT02065557|448445885|FG004|Induction Period|Withdrawal by Subject|0|||
124677943|NCT02065557|448445886|FG005|Induction Period|Withdrawal by Subject|0|||
124677944|NCT02065557|448445881|FG000|Induction Period|Lack of Efficacy|2|||
124677945|NCT02065557|448445882|FG001|Induction Period|Lack of Efficacy|1|||
124677946|NCT02065557|448445883|FG002|Induction Period|Lack of Efficacy|1|||
124677947|NCT02065557|448445884|FG003|Induction Period|Lack of Efficacy|0|||
124677948|NCT02065557|448445885|FG004|Induction Period|Lack of Efficacy|0|||
124677949|NCT02065557|448445886|FG005|Induction Period|Lack of Efficacy|0|||
124677950|NCT02065557|448445881|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
124677951|NCT02065557|448445882|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
124677952|NCT02065557|448445883|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
124677953|NCT02065557|448445884|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
124677954|NCT02065557|448445885|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
124677955|NCT02065557|448445886|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
124677956|NCT02065557|448445881|FG000|Induction Period|Non-Responder at Week 8|4|||
124677957|NCT02065557|448445882|FG001|Induction Period|Non-Responder at Week 8|4|||
124677958|NCT02065557|448445883|FG002|Induction Period|Non-Responder at Week 8|0|||
124677959|NCT02065557|448445884|FG003|Induction Period|Non-Responder at Week 8|0|||
124677960|NCT02065557|448445885|FG004|Induction Period|Non-Responder at Week 8|0|||
124677961|NCT02065557|448445886|FG005|Induction Period|Non-Responder at Week 8|0|||
124873005|NCT00180479|449157216|FG000|Overall Study|Withdrawal by Subject|3|||
124873006|NCT00180479|449157217|FG001|Overall Study|Withdrawal by Subject|3|||
124873007|NCT00180479|449157216|FG000|Overall Study|Informed consent not signed|0|||
124873008|NCT00180479|449157217|FG001|Overall Study|Informed consent not signed|1|||
124873009|NCT00526630|449157226|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
124873010|NCT00526630|449157227|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
124873011|NCT00526630|449157226|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
124873012|NCT00526630|449157227|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
124873013|NCT03518125|449157229|FG000|Overall Study|Lost to Follow-up|0|||
124873014|NCT03518125|449157230|FG001|Overall Study|Lost to Follow-up|2|||
124873015|NCT03518125|449157231|FG002|Overall Study|Lost to Follow-up|0|||
124873016|NCT03518125|449157232|FG003|Overall Study|Lost to Follow-up|0|||
124873017|NCT03518125|449157233|FG004|Overall Study|Lost to Follow-up|3|||
124873018|NCT03518125|449157234|FG005|Overall Study|Lost to Follow-up|5|||
124873019|NCT03518125|449157229|FG000|Overall Study|Physician Decision|0|||
124873020|NCT03518125|449157230|FG001|Overall Study|Physician Decision|1|||
124873021|NCT03518125|449157231|FG002|Overall Study|Physician Decision|0|||
124873022|NCT03518125|449157232|FG003|Overall Study|Physician Decision|0|||
124873023|NCT03518125|449157233|FG004|Overall Study|Physician Decision|0|||
124873024|NCT03518125|449157234|FG005|Overall Study|Physician Decision|0|||
124432659|NCT01871805|447543813|FG004|Phase II|Alive in Survival Follow-up|0|||
124432660|NCT01871805|447543814|FG005|Phase II|Alive in Survival Follow-up|29|||
124432661|NCT01871805|447543809|FG000|Phase II|Lost to Follow-up|0|||
124432662|NCT01871805|447543810|FG001|Phase II|Lost to Follow-up|0|||
124432663|NCT01871805|447543811|FG002|Phase II|Lost to Follow-up|0|||
124432664|NCT01871805|447543812|FG003|Phase II|Lost to Follow-up|0|||
124432665|NCT01871805|447543813|FG004|Phase II|Lost to Follow-up|0|||
124432666|NCT01871805|447543814|FG005|Phase II|Lost to Follow-up|13|||
124432667|NCT03412747|447543817|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
124432668|NCT03412747|447543818|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
124432669|NCT03412747|447543819|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
124432670|NCT03412747|447543817|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
124432671|NCT03412747|447543818|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
124432672|NCT03412747|447543819|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
124432673|NCT03412747|447543817|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
124432674|NCT03412747|447543818|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
124432675|NCT03412747|447543819|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
124432676|NCT03412747|447543817|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
124432677|NCT03412747|447543818|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
124432678|NCT03412747|447543819|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
124432679|NCT03412747|447543817|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
124432680|NCT03412747|447543818|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
124432681|NCT03412747|447543819|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
124432682|NCT03412747|447543817|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
124432683|NCT03412747|447543818|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
124432684|NCT03412747|447543819|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
124432685|NCT03412747|447543817|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
124432686|NCT03412747|447543818|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
124432687|NCT03412747|447543819|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
124432688|NCT03412747|447543817|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
124432689|NCT03412747|447543818|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
124432690|NCT03412747|447543819|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
124432691|NCT03412747|447543817|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
124432692|NCT03412747|447543818|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
124432693|NCT03412747|447543819|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
124432694|NCT03412747|447543817|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
124432695|NCT03412747|447543818|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
124432696|NCT03412747|447543819|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
124432697|NCT03412747|447543817|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
124432698|NCT03412747|447543818|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
124432699|NCT03412747|447543819|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
124432700|NCT03412747|447543817|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
124432701|NCT03412747|447543818|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
124432702|NCT03412747|447543819|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
124873025|NCT03518125|449157229|FG000|Overall Study|Withdrawal by Subject|1|||
124432703|NCT03412747|447543817|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
124432704|NCT03412747|447543818|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
124432705|NCT03412747|447543819|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
124873026|NCT03518125|449157230|FG001|Overall Study|Withdrawal by Subject|1|||
124873027|NCT03518125|449157231|FG002|Overall Study|Withdrawal by Subject|0|||
124873028|NCT03518125|449157232|FG003|Overall Study|Withdrawal by Subject|1|||
124873029|NCT03518125|449157233|FG004|Overall Study|Withdrawal by Subject|1|||
124873030|NCT03518125|449157234|FG005|Overall Study|Withdrawal by Subject|3|||
124873031|NCT03518125|449157229|FG000|Overall Study|Missed Day 394 Visit|1|||
124873032|NCT03518125|449157230|FG001|Overall Study|Missed Day 394 Visit|0|||
124873033|NCT03518125|449157231|FG002|Overall Study|Missed Day 394 Visit|0|||
124677962|NCT02065557|448445881|FG000|Induction Period|Adverse Event|1|||
124677963|NCT02065557|448445882|FG001|Induction Period|Adverse Event|1|||
124677964|NCT02065557|448445883|FG002|Induction Period|Adverse Event|0|||
124677965|NCT02065557|448445884|FG003|Induction Period|Adverse Event|0|||
124677966|NCT02065557|448445885|FG004|Induction Period|Adverse Event|0|||
124677967|NCT02065557|448445886|FG005|Induction Period|Adverse Event|0|||
124677968|NCT02065557|448445881|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
124677969|NCT02065557|448445882|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
124677970|NCT02065557|448445883|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
124677971|NCT02065557|448445884|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
124677972|NCT02065557|448445885|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
124677973|NCT02065557|448445886|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
124677974|NCT02065557|448445881|FG000|Maintenance Period|Withdrawal by Subject|0|||
124677975|NCT02065557|448445882|FG001|Maintenance Period|Withdrawal by Subject|0|||
124677976|NCT02065557|448445883|FG002|Maintenance Period|Withdrawal by Subject|0|||
124677977|NCT02065557|448445884|FG003|Maintenance Period|Withdrawal by Subject|0|||
124677978|NCT02065557|448445885|FG004|Maintenance Period|Withdrawal by Subject|2|||
124677979|NCT02065557|448445886|FG005|Maintenance Period|Withdrawal by Subject|1|||
124677980|NCT02065557|448445881|FG000|Maintenance Period|Lack of Efficacy|0|||
124677981|NCT02065557|448445882|FG001|Maintenance Period|Lack of Efficacy|0|||
124677982|NCT02065557|448445883|FG002|Maintenance Period|Lack of Efficacy|0|||
124677983|NCT02065557|448445884|FG003|Maintenance Period|Lack of Efficacy|0|||
124677984|NCT02065557|448445885|FG004|Maintenance Period|Lack of Efficacy|5|||
124677985|NCT02065557|448445886|FG005|Maintenance Period|Lack of Efficacy|2|||
124677986|NCT02065557|448445881|FG000|Maintenance Period|Subject Non-Compliance|0|||
124677987|NCT02065557|448445882|FG001|Maintenance Period|Subject Non-Compliance|0|||
124677988|NCT02065557|448445883|FG002|Maintenance Period|Subject Non-Compliance|0|||
124677989|NCT02065557|448445884|FG003|Maintenance Period|Subject Non-Compliance|0|||
124677990|NCT02065557|448445885|FG004|Maintenance Period|Subject Non-Compliance|0|||
124677991|NCT02065557|448445886|FG005|Maintenance Period|Subject Non-Compliance|1|||
124677992|NCT00250588|448445887|FG000|Overall Study|Withdrawal by Subject|3|||
124677993|NCT00250588|448445888|FG001|Overall Study|Withdrawal by Subject|6|||
124677994|NCT00250588|448445889|FG002|Overall Study|Withdrawal by Subject|0|||
124677995|NCT00250588|448445887|FG000|Overall Study|Lost to Follow-up|6|||
124677996|NCT00250588|448445888|FG001|Overall Study|Lost to Follow-up|13|||
124677997|NCT00250588|448445889|FG002|Overall Study|Lost to Follow-up|13|||
124677998|NCT00706797|448445892|FG000|Overall Study|Lack of Efficacy|3|||
124677999|NCT00706797|448445893|FG001|Overall Study|Lack of Efficacy|0|||
124678000|NCT00706797|448445892|FG000|Overall Study|Adverse Event|0|||
124678001|NCT00706797|448445893|FG001|Overall Study|Adverse Event|3|||
124678002|NCT00706797|448445892|FG000|Overall Study|Withdrawal by Subject|8|||
124678003|NCT00706797|448445893|FG001|Overall Study|Withdrawal by Subject|1|||
124678004|NCT00706797|448445892|FG000|Overall Study|Death|1|||
124678005|NCT00706797|448445893|FG001|Overall Study|Death|0|||
124678006|NCT00706797|448445892|FG000|Overall Study|Discontinuation of study by sponsor|52|||
124678007|NCT00706797|448445893|FG001|Overall Study|Discontinuation of study by sponsor|63|||
124678008|NCT00706797|448445892|FG000|Overall Study|Protocol Violation|3|||
124432706|NCT03412747|447543817|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
124432707|NCT03412747|447543818|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
124432708|NCT03412747|447543819|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
124432709|NCT03412747|447543817|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
124432710|NCT03412747|447543818|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
124432711|NCT03412747|447543819|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
124432712|NCT03412747|447543817|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
124432713|NCT03412747|447543818|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
124432714|NCT03412747|447543819|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
124432715|NCT00468104|447543822|FG000|First Intervention|Protocol Violation|2|||
124432716|NCT00468104|447543823|FG001|First Intervention|Protocol Violation|1|||
124432717|NCT00468104|447543822|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
124432718|NCT00468104|447543823|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
124432719|NCT00468104|447543822|FG000|First Intervention|died within 3 weeks|1|||
124432720|NCT00468104|447543823|FG001|First Intervention|died within 3 weeks|0|||
124432721|NCT00468104|447543822|FG000|First Intervention|malposition/blocked chest tube tube|2|||
124432722|NCT00468104|447543823|FG001|First Intervention|malposition/blocked chest tube tube|0|||
124432723|NCT00468104|447543822|FG000|First Intervention|large lung mass with minimal effusion|1|||
124432724|NCT00468104|447543823|FG001|First Intervention|large lung mass with minimal effusion|0|||
124678009|NCT00706797|448445893|FG001|Overall Study|Protocol Violation|2|||
124678010|NCT00706797|448445892|FG000|Overall Study|Lost to Follow-up|1|||
124678011|NCT00706797|448445893|FG001|Overall Study|Lost to Follow-up|2|||
124678012|NCT00706797|448445892|FG000|Overall Study|Other|1|||
124678013|NCT00706797|448445893|FG001|Overall Study|Other|0|||
124678014|NCT00112957|448445901|FG000|Overall Study|Progressive disease|18|||
124678015|NCT00112957|448445901|FG000|Overall Study|Physician Decision|1|||
124678016|NCT02309359|448445904|FG000|Overall Study|Adverse Event|4|||
124678017|NCT02309359|448445905|FG001|Overall Study|Adverse Event|5|||
124678018|NCT02309359|448445906|FG002|Overall Study|Adverse Event|5|||
124678019|NCT02309359|448445907|FG003|Overall Study|Adverse Event|4|||
124678020|NCT02309359|448445908|FG004|Overall Study|Adverse Event|4|||
124678021|NCT02309359|448445904|FG000|Overall Study|Death|1|||
124678022|NCT02309359|448445905|FG001|Overall Study|Death|0|||
124678023|NCT02309359|448445906|FG002|Overall Study|Death|0|||
124678024|NCT02309359|448445907|FG003|Overall Study|Death|0|||
124678025|NCT02309359|448445908|FG004|Overall Study|Death|0|||
124678026|NCT02309359|448445904|FG000|Overall Study|Withdrawal by Subject|2|||
124678027|NCT02309359|448445905|FG001|Overall Study|Withdrawal by Subject|2|||
124678028|NCT02309359|448445906|FG002|Overall Study|Withdrawal by Subject|4|||
124432725|NCT00468104|447543822|FG000|First Intervention|associated prolonged pneumothorax|1|||
124432726|NCT00468104|447543823|FG001|First Intervention|associated prolonged pneumothorax|0|||
124432727|NCT00468104|447543822|FG000|First Intervention|trapped lung|1|||
124432728|NCT00468104|447543823|FG001|First Intervention|trapped lung|0|||
124432729|NCT00468104|447543822|FG000|Second Intervention|Withdrawal by Subject|5|||
124432730|NCT00468104|447543823|FG001|Second Intervention|Withdrawal by Subject|2|||
124432731|NCT00468104|447543822|FG000|Second Intervention|discarded for malposition of chest tube|0|||
124432732|NCT00468104|447543823|FG001|Second Intervention|discarded for malposition of chest tube|2|||
124432733|NCT00141219|447543824|FG000|Overall Study|Protocol violations|5|||
124432734|NCT00141219|447543825|FG001|Overall Study|Protocol violations|4|||
124432735|NCT00141219|447543824|FG000|Overall Study|Adverse Event|8|||
124432736|NCT00141219|447543825|FG001|Overall Study|Adverse Event|6|||
124432737|NCT00141219|447543824|FG000|Overall Study|Lack of Efficacy|5|||
124432738|NCT00141219|447543825|FG001|Overall Study|Lack of Efficacy|4|||
124432739|NCT00141219|447543824|FG000|Overall Study|Withdrawal by Subject|6|||
124432740|NCT00141219|447543825|FG001|Overall Study|Withdrawal by Subject|2|||
124432741|NCT02224690|447543826|FG000|Overall Study|Adverse Event|8|||
124432742|NCT02224690|447543827|FG001|Overall Study|Adverse Event|1|||
124432743|NCT02224690|447543826|FG000|Overall Study|Met Withdrawal Criteria|4|||
124432744|NCT02224690|447543827|FG001|Overall Study|Met Withdrawal Criteria|0|||
124432745|NCT02224690|447543826|FG000|Overall Study|Use of G-tube|1|||
124678029|NCT02309359|448445907|FG003|Overall Study|Withdrawal by Subject|4|||
124678030|NCT02309359|448445908|FG004|Overall Study|Withdrawal by Subject|0|||
124432746|NCT02224690|447543827|FG001|Overall Study|Use of G-tube|0|||
124432747|NCT02224690|447543826|FG000|Overall Study|Did not meet eligibility criteria|1|||
124432748|NCT02224690|447543827|FG001|Overall Study|Did not meet eligibility criteria|0|||
124432749|NCT00122460|447543829|FG000|Overall Study|investigational study phase ongoing|7|||
124432750|NCT00122460|447543830|FG001|Overall Study|investigational study phase ongoing|1|||
124432751|NCT01506609|447543831|FG000|Overall Study|Adverse Event Related to Progression|0|||
124432752|NCT01506609|447543832|FG001|Overall Study|Adverse Event Related to Progression|0|||
124678031|NCT02309359|448445904|FG000|Overall Study|Lack of Efficacy|3|||
124678032|NCT02309359|448445905|FG001|Overall Study|Lack of Efficacy|1|||
124678033|NCT02309359|448445906|FG002|Overall Study|Lack of Efficacy|0|||
124678034|NCT02309359|448445907|FG003|Overall Study|Lack of Efficacy|0|||
124678035|NCT02309359|448445908|FG004|Overall Study|Lack of Efficacy|3|||
124873034|NCT03518125|449157232|FG003|Overall Study|Missed Day 394 Visit|0|||
124873035|NCT03518125|449157233|FG004|Overall Study|Missed Day 394 Visit|0|||
124873036|NCT03518125|449157234|FG005|Overall Study|Missed Day 394 Visit|0|||
124873037|NCT00106184|449157237|FG000|Overall Study|Withdrawal by Subject|3|||
124873038|NCT00106184|449157238|FG001|Overall Study|Withdrawal by Subject|2|||
124873039|NCT00409682|449157247|FG000|Open-label Induction Period|Adverse Event|1|||
124873040|NCT00409682|449157248|FG001|Open-label Induction Period|Adverse Event|0|||
124873041|NCT00409682|449157249|FG002|Open-label Induction Period|Adverse Event|0|||
124873042|NCT00409682|449157247|FG000|Open-label Induction Period|Lack of Efficacy|1|||
124873043|NCT00409682|449157248|FG001|Open-label Induction Period|Lack of Efficacy|0|||
124873044|NCT00409682|449157249|FG002|Open-label Induction Period|Lack of Efficacy|0|||
124873045|NCT00409682|449157247|FG000|Open-label Induction Period|Protocol Violation|1|||
124873046|NCT00409682|449157248|FG001|Open-label Induction Period|Protocol Violation|0|||
124873047|NCT00409682|449157249|FG002|Open-label Induction Period|Protocol Violation|0|||
124873048|NCT00409682|449157247|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
124873049|NCT00409682|449157248|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
124873050|NCT00409682|449157249|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
124873051|NCT00409682|449157247|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
124873052|NCT00409682|449157248|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
124873053|NCT00409682|449157249|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
124873054|NCT00409682|449157247|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
124873055|NCT00409682|449157248|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
124873056|NCT00409682|449157249|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
124873057|NCT00409682|449157247|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
124873058|NCT00409682|449157248|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
124873059|NCT00409682|449157249|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
124873060|NCT00409682|449157247|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
124873061|NCT00409682|449157248|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
124873062|NCT00409682|449157249|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
124873063|NCT00409682|449157247|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
124873064|NCT00409682|449157248|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
124873065|NCT00409682|449157249|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
124873066|NCT00409682|449157247|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
124873067|NCT00409682|449157248|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
124873068|NCT00409682|449157249|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
124873069|NCT01896869|449157250|FG000|Overall Study|Withdrawal by Subject|0|||
124873070|NCT01896869|449157251|FG001|Overall Study|Withdrawal by Subject|6|||
124873071|NCT01896869|449157250|FG000|Overall Study|Lost to Follow-up|1|||
124873072|NCT01896869|449157251|FG001|Overall Study|Lost to Follow-up|0|||
124873073|NCT01089374|449157259|FG000|Overall Study|Lost to Follow-up|3|||
124873074|NCT01089374|449157260|FG001|Overall Study|Lost to Follow-up|0|||
124873075|NCT01089374|449157259|FG000|Overall Study|Withdrawal by Subject|1|||
124873076|NCT01089374|449157260|FG001|Overall Study|Withdrawal by Subject|0|||
124873077|NCT01089374|449157259|FG000|Overall Study|Study closed early - low accrual|6|||
124873078|NCT01089374|449157260|FG001|Overall Study|Study closed early - low accrual|0|||
124678036|NCT02309359|448445904|FG000|Overall Study|Lost to Follow-up|0|||
124678037|NCT02309359|448445905|FG001|Overall Study|Lost to Follow-up|0|||
124678038|NCT02309359|448445906|FG002|Overall Study|Lost to Follow-up|0|||
124678039|NCT02309359|448445907|FG003|Overall Study|Lost to Follow-up|1|||
124678040|NCT02309359|448445908|FG004|Overall Study|Lost to Follow-up|0|||
124678041|NCT02309359|448445904|FG000|Overall Study|Other|2|||
124678042|NCT02309359|448445905|FG001|Overall Study|Other|0|||
124678043|NCT02309359|448445906|FG002|Overall Study|Other|2|||
124678044|NCT02309359|448445907|FG003|Overall Study|Other|3|||
124678045|NCT02309359|448445908|FG004|Overall Study|Other|2|||
124678046|NCT00701363|448445909|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
124678047|NCT00701363|448445910|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
124678048|NCT00701363|448445911|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
124678049|NCT00701363|448445912|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
124678050|NCT00701363|448445909|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
124678051|NCT00701363|448445910|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
124678052|NCT00701363|448445911|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
124678053|NCT00701363|448445912|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
124678054|NCT00701363|448445909|FG000|Treatment Phase 1|Adverse Event|7|||
124678055|NCT00701363|448445910|FG001|Treatment Phase 1|Adverse Event|0|||
124873079|NCT02856113|449157261|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
124873080|NCT02856113|449157262|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
124873081|NCT02856113|449157261|FG000|Overall Study|Significant Protocol Deviation|1|||
124873082|NCT02856113|449157262|FG001|Overall Study|Significant Protocol Deviation|0|||
124873083|NCT02856113|449157261|FG000|Overall Study|Lost to Follow-up|3|||
124873084|NCT02856113|449157262|FG001|Overall Study|Lost to Follow-up|5|||
124873085|NCT02856113|449157261|FG000|Overall Study|Voluntary Withdrawal|3|||
124873086|NCT02856113|449157262|FG001|Overall Study|Voluntary Withdrawal|5|||
124873087|NCT02856113|449157261|FG000|Overall Study|Pregnancy|0|||
124873088|NCT02856113|449157262|FG001|Overall Study|Pregnancy|1|||
124873089|NCT02856113|449157261|FG000|Overall Study|Principal Investigator Discretion|2|||
124873090|NCT02856113|449157262|FG001|Overall Study|Principal Investigator Discretion|1|||
124873091|NCT02856113|449157261|FG000|Overall Study|Randomized but not Treated|1|||
124873092|NCT02856113|449157262|FG001|Overall Study|Randomized but not Treated|0|||
124873093|NCT02856113|449157261|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
124873094|NCT02856113|449157262|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
124873095|NCT03494166|449157263|FG000|Overall Study|Death|0|||
124873096|NCT03494166|449157264|FG001|Overall Study|Death|0|||
124873097|NCT03494166|449157265|FG002|Overall Study|Death|0|||
124873098|NCT03494166|449157266|FG003|Overall Study|Death|1|||
124873099|NCT03494166|449157267|FG004|Overall Study|Death|3|||
124873100|NCT03494166|449157268|FG005|Overall Study|Death|0|||
124873101|NCT03494166|449157263|FG000|Overall Study|Lost to Follow-up|2|||
124873102|NCT03494166|449157264|FG001|Overall Study|Lost to Follow-up|2|||
124873103|NCT03494166|449157265|FG002|Overall Study|Lost to Follow-up|2|||
124873104|NCT03494166|449157266|FG003|Overall Study|Lost to Follow-up|2|||
124873105|NCT03494166|449157267|FG004|Overall Study|Lost to Follow-up|14|||
124873106|NCT03494166|449157268|FG005|Overall Study|Lost to Follow-up|0|||
124873107|NCT03494166|449157263|FG000|Overall Study|Withdrawal by Subject|10|||
124873108|NCT03494166|449157264|FG001|Overall Study|Withdrawal by Subject|7|||
124873109|NCT03494166|449157265|FG002|Overall Study|Withdrawal by Subject|0|||
124873110|NCT03494166|449157266|FG003|Overall Study|Withdrawal by Subject|5|||
124873111|NCT03494166|449157267|FG004|Overall Study|Withdrawal by Subject|3|||
124873112|NCT03494166|449157268|FG005|Overall Study|Withdrawal by Subject|17|||
124873113|NCT03494166|449157263|FG000|Overall Study|Screen failure|1|||
124873114|NCT03494166|449157264|FG001|Overall Study|Screen failure|0|||
124873115|NCT03494166|449157265|FG002|Overall Study|Screen failure|0|||
124873116|NCT03494166|449157266|FG003|Overall Study|Screen failure|0|||
124873117|NCT03494166|449157267|FG004|Overall Study|Screen failure|1|||
124873118|NCT03494166|449157268|FG005|Overall Study|Screen failure|0|||
124873119|NCT02857426|449157269|FG000|Overall Study|Disease progression|34|||
124873120|NCT02857426|449157270|FG001|Overall Study|Disease progression|13|||
124873121|NCT02857426|449157269|FG000|Overall Study|Study drug toxicity|4|||
124873122|NCT02857426|449157270|FG001|Overall Study|Study drug toxicity|1|||
124873123|NCT02857426|449157269|FG000|Overall Study|Death|1|||
124873124|NCT02857426|449157270|FG001|Overall Study|Death|0|||
124678056|NCT00701363|448445911|FG002|Treatment Phase 1|Adverse Event|0|||
124678057|NCT00701363|448445912|FG003|Treatment Phase 1|Adverse Event|0|||
124678058|NCT00701363|448445909|FG000|Treatment Phase 1|Protocol Violation|1|||
124678059|NCT00701363|448445910|FG001|Treatment Phase 1|Protocol Violation|0|||
124678060|NCT00701363|448445911|FG002|Treatment Phase 1|Protocol Violation|0|||
124678061|NCT00701363|448445912|FG003|Treatment Phase 1|Protocol Violation|0|||
124678062|NCT00701363|448445909|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
124678063|NCT00701363|448445910|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
124678064|NCT00701363|448445911|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
124678065|NCT00701363|448445912|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
124678066|NCT00701363|448445909|FG000|Treatment Phase 1|Lack of Efficacy|1|||
124678067|NCT00701363|448445910|FG001|Treatment Phase 1|Lack of Efficacy|0|||
124678068|NCT00701363|448445911|FG002|Treatment Phase 1|Lack of Efficacy|0|||
124678069|NCT00701363|448445912|FG003|Treatment Phase 1|Lack of Efficacy|0|||
124678070|NCT00701363|448445909|FG000|Treatment Phase 2|Adverse Event|0|||
124678071|NCT00701363|448445910|FG001|Treatment Phase 2|Adverse Event|0|||
124678072|NCT00701363|448445911|FG002|Treatment Phase 2|Adverse Event|1|||
124678073|NCT00701363|448445912|FG003|Treatment Phase 2|Adverse Event|0|||
124678074|NCT00701363|448445909|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
124678075|NCT00701363|448445910|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
124678076|NCT00701363|448445911|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
124678077|NCT00701363|448445912|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
124678078|NCT00863707|448445915|FG000|Overall Study|Randomized, but drug not received|4|||
124678079|NCT00863707|448445916|FG001|Overall Study|Randomized, but drug not received|3|||
124678080|NCT00289276|448445917|FG000|Second Part of FAST Study (Expansion)|Death|0|||
124678081|NCT00289276|448445918|FG001|Second Part of FAST Study (Expansion)|Death|2|||
124873125|NCT02857426|449157269|FG000|Overall Study|Adverse event unrelated to study drug|6|||
124873126|NCT02857426|449157270|FG001|Overall Study|Adverse event unrelated to study drug|2|||
124873127|NCT02857426|449157269|FG000|Overall Study|Participant withdrew consent|1|||
124873128|NCT02857426|449157270|FG001|Overall Study|Participant withdrew consent|1|||
124873129|NCT02857426|449157269|FG000|Overall Study|Maximum clinical benefit|1|||
124873130|NCT02857426|449157270|FG001|Overall Study|Maximum clinical benefit|0|||
124873131|NCT02857426|449157269|FG000|Overall Study|Completed treatment|0|||
124678082|NCT00289276|448445917|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
124678083|NCT00289276|448445918|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
124678084|NCT00869960|448445919|FG000|Overall Study|Lost to Follow-up|2|||
124678085|NCT02029417|448445920|FG000|Overall Study|Death|1|||
124678086|NCT02029417|448445920|FG000|Overall Study|Adverse Event|1|||
124678087|NCT03040726|448445921|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
124678088|NCT03040726|448445922|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
124678089|NCT03040726|448445921|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
124678090|NCT03040726|448445922|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
124678091|NCT03040726|448445921|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
124678092|NCT03040726|448445922|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
124678093|NCT03040726|448445921|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
124678094|NCT03040726|448445922|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
124678095|NCT03040726|448445921|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
124678096|NCT03040726|448445922|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
124678097|NCT00465179|448445924|FG000|Overall Study|Adverse Event|4|||
124678098|NCT00465179|448445924|FG000|Overall Study|Withdrawal by Subject|2|||
124678099|NCT00465179|448445924|FG000|Overall Study|Progression of Disease|47|||
124678100|NCT00262925|448445930|FG000|Overall Study|Lack of Efficacy|3|||
124678101|NCT00262925|448445930|FG000|Overall Study|Adverse Event|4|||
124678102|NCT00262925|448445930|FG000|Overall Study|Death|2|||
124678103|NCT00262925|448445930|FG000|Overall Study|alternative therapy|1|||
124678104|NCT00262925|448445930|FG000|Overall Study|Other|1|||
124678105|NCT04682301|448445932|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
124678106|NCT04682301|448445932|FG000|Overall Study|Death|2|||
124678107|NCT02781324|448445934|FG000|Overall Study|Withdrawal by Subject|1|||
124678108|NCT02781324|448445935|FG001|Overall Study|Withdrawal by Subject|0|||
124678109|NCT02781324|448445934|FG000|Overall Study|Physician Decision|1|||
124678110|NCT02781324|448445935|FG001|Overall Study|Physician Decision|2|||
124678111|NCT00834041|448445936|FG000|Overall Study|Withdrawal by Subject|1|||
124678112|NCT00834041|448445937|FG001|Overall Study|Withdrawal by Subject|0|||
124678113|NCT00834041|448445936|FG000|Overall Study|Lost to Follow-up|0|||
124678114|NCT00834041|448445937|FG001|Overall Study|Lost to Follow-up|1|||
124678115|NCT03321721|448445941|FG000|Overall Study|Lost to Follow-up|4|||
124678116|NCT03321721|448445942|FG001|Overall Study|Lost to Follow-up|8|||
124678117|NCT03321721|448445943|FG002|Overall Study|Lost to Follow-up|11|||
124678118|NCT00666237|448445944|FG000|Overall Study|Death|5|||
124678119|NCT00666237|448445945|FG001|Overall Study|Death|5|||
124678120|NCT00666237|448445944|FG000|Overall Study|Lost to Follow-up|29|||
124678121|NCT00666237|448445945|FG001|Overall Study|Lost to Follow-up|25|||
124678122|NCT00750269|448448026|FG000|Overall Study|Protocol Violation|0|||
124678123|NCT00750269|448448027|FG001|Overall Study|Protocol Violation|1|||
124678124|NCT00750269|448448028|FG002|Overall Study|Protocol Violation|1|||
124678125|NCT00750269|448448029|FG003|Overall Study|Protocol Violation|2|||
124432753|NCT01506609|447543833|FG002|Overall Study|Adverse Event Related to Progression|0|||
124432754|NCT01506609|447543834|FG003|Overall Study|Adverse Event Related to Progression|3|||
124432755|NCT01506609|447543835|FG004|Overall Study|Adverse Event Related to Progression|7|||
124432756|NCT01506609|447543836|FG005|Overall Study|Adverse Event Related to Progression|3|||
124432757|NCT01506609|447543831|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
124432758|NCT01506609|447543832|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
124432759|NCT01506609|447543833|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
124432760|NCT01506609|447543834|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
124432761|NCT01506609|447543835|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
124432762|NCT01506609|447543836|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
124432763|NCT01506609|447543831|FG000|Overall Study|Withdrawal by Subject|0|||
124432764|NCT01506609|447543832|FG001|Overall Study|Withdrawal by Subject|0|||
124432765|NCT01506609|447543833|FG002|Overall Study|Withdrawal by Subject|0|||
124432766|NCT01506609|447543834|FG003|Overall Study|Withdrawal by Subject|9|||
124432767|NCT01506609|447543835|FG004|Overall Study|Withdrawal by Subject|7|||
124432768|NCT01506609|447543836|FG005|Overall Study|Withdrawal by Subject|7|||
124432769|NCT01506609|447543831|FG000|Overall Study|Lost to Follow-up|0|||
124432770|NCT01506609|447543832|FG001|Overall Study|Lost to Follow-up|0|||
124432771|NCT01506609|447543833|FG002|Overall Study|Lost to Follow-up|0|||
124432772|NCT01506609|447543834|FG003|Overall Study|Lost to Follow-up|1|||
124432773|NCT01506609|447543835|FG004|Overall Study|Lost to Follow-up|2|||
124432774|NCT01506609|447543836|FG005|Overall Study|Lost to Follow-up|0|||
124432775|NCT01506609|447543831|FG000|Overall Study|Sponsor Discontinued Study|0|||
124432776|NCT01506609|447543832|FG001|Overall Study|Sponsor Discontinued Study|0|||
124432777|NCT01506609|447543833|FG002|Overall Study|Sponsor Discontinued Study|0|||
124432778|NCT01506609|447543834|FG003|Overall Study|Sponsor Discontinued Study|2|||
124432779|NCT01506609|447543835|FG004|Overall Study|Sponsor Discontinued Study|2|||
124432780|NCT01506609|447543836|FG005|Overall Study|Sponsor Discontinued Study|0|||
124432781|NCT01506609|447543831|FG000|Overall Study|Progressive Disease per Protocol|1|||
124432782|NCT01506609|447543832|FG001|Overall Study|Progressive Disease per Protocol|0|||
124432783|NCT01506609|447543833|FG002|Overall Study|Progressive Disease per Protocol|0|||
124432784|NCT01506609|447543834|FG003|Overall Study|Progressive Disease per Protocol|64|||
124432785|NCT01506609|447543835|FG004|Overall Study|Progressive Disease per Protocol|57|||
124432786|NCT01506609|447543836|FG005|Overall Study|Progressive Disease per Protocol|74|||
124432787|NCT01506609|447543831|FG000|Overall Study|Other, Not Specified|0|||
124432788|NCT01506609|447543832|FG001|Overall Study|Other, Not Specified|0|||
124432789|NCT01506609|447543833|FG002|Overall Study|Other, Not Specified|0|||
124432790|NCT01506609|447543834|FG003|Overall Study|Other, Not Specified|10|||
124432791|NCT01506609|447543835|FG004|Overall Study|Other, Not Specified|7|||
124432792|NCT01506609|447543836|FG005|Overall Study|Other, Not Specified|3|||
124432793|NCT01506609|447543831|FG000|Overall Study|Missing / Unknown Reason|1|||
124432794|NCT01506609|447543832|FG001|Overall Study|Missing / Unknown Reason|0|||
124432795|NCT01506609|447543833|FG002|Overall Study|Missing / Unknown Reason|1|||
124432796|NCT01506609|447543834|FG003|Overall Study|Missing / Unknown Reason|4|||
124432797|NCT01506609|447543835|FG004|Overall Study|Missing / Unknown Reason|4|||
124432798|NCT01506609|447543836|FG005|Overall Study|Missing / Unknown Reason|2|||
124678126|NCT00750269|448448030|FG004|Overall Study|Protocol Violation|4|||
124678127|NCT00750269|448448026|FG000|Overall Study|Withdrawal by Subject|0|||
124678128|NCT00750269|448448027|FG001|Overall Study|Withdrawal by Subject|0|||
124678129|NCT00750269|448448028|FG002|Overall Study|Withdrawal by Subject|2|||
124678130|NCT00750269|448448029|FG003|Overall Study|Withdrawal by Subject|2|||
124678131|NCT00750269|448448030|FG004|Overall Study|Withdrawal by Subject|2|||
124873132|NCT02857426|449157270|FG001|Overall Study|Completed treatment|2|||
124873133|NCT02110901|449157274|FG000|Overall Study|Death|6|||
124873134|NCT02110901|449157275|FG001|Overall Study|Death|3|||
124873135|NCT02110901|449157274|FG000|Overall Study|Lost to Follow-up|12|||
124873136|NCT02110901|449157275|FG001|Overall Study|Lost to Follow-up|8|||
124873137|NCT02110901|449157274|FG000|Overall Study|Withdrawal by Subject|7|||
124873138|NCT02110901|449157275|FG001|Overall Study|Withdrawal by Subject|3|||
124873139|NCT02110901|449157274|FG000|Overall Study|received a kidney transplant|5|||
124873140|NCT02110901|449157275|FG001|Overall Study|received a kidney transplant|0|||
124432799|NCT00381615|447543839|FG000|Overall Study|Withdrawal by Subject|1|||
124432800|NCT00381615|447543840|FG001|Overall Study|Withdrawal by Subject|3|||
124432801|NCT00381615|447543841|FG002|Overall Study|Withdrawal by Subject|0|||
124678132|NCT00750269|448448026|FG000|Overall Study|Physician Decision|0|||
124678133|NCT00750269|448448027|FG001|Overall Study|Physician Decision|0|||
124432802|NCT00381615|447543842|FG003|Overall Study|Withdrawal by Subject|1|||
124432803|NCT00381615|447543839|FG000|Overall Study|Lost to Follow-up|3|||
124432804|NCT00381615|447543840|FG001|Overall Study|Lost to Follow-up|2|||
124432805|NCT00381615|447543841|FG002|Overall Study|Lost to Follow-up|0|||
124432806|NCT00381615|447543842|FG003|Overall Study|Lost to Follow-up|1|||
124432807|NCT00381615|447543839|FG000|Overall Study|Protocol Violation|0|||
124873141|NCT00758459|449157276|FG000|Overall Study|Adverse Event|3|||
124873142|NCT00758459|449157277|FG001|Overall Study|Adverse Event|2|||
124873143|NCT00758459|449157276|FG000|Overall Study|Protocol Violation|0|||
124873144|NCT00758459|449157277|FG001|Overall Study|Protocol Violation|1|||
124873145|NCT00758459|449157276|FG000|Overall Study|Withdrawal by Subject|0|||
124873146|NCT00758459|449157277|FG001|Overall Study|Withdrawal by Subject|1|||
124873147|NCT01780935|449157279|FG000|Overall Study|Admin problems due to early termination|321|||
124873148|NCT01780935|449157280|FG001|Overall Study|Admin problems due to early termination|309|||
124873149|NCT01780935|449157279|FG000|Overall Study|Adverse Event|2|||
124873150|NCT01780935|449157280|FG001|Overall Study|Adverse Event|4|||
124873151|NCT01780935|449157279|FG000|Overall Study|Death|1|||
124873152|NCT01780935|449157280|FG001|Overall Study|Death|6|||
124873153|NCT01780935|449157279|FG000|Overall Study|Lost to Follow-up|2|||
124873154|NCT01780935|449157280|FG001|Overall Study|Lost to Follow-up|6|||
124873155|NCT01780935|449157279|FG000|Overall Study|Physician Decision|1|||
124873156|NCT01780935|449157280|FG001|Overall Study|Physician Decision|1|||
124873157|NCT01780935|449157279|FG000|Overall Study|Protocol deviation|0|||
124873158|NCT01780935|449157280|FG001|Overall Study|Protocol deviation|1|||
124873159|NCT01780935|449157279|FG000|Overall Study|Patient withdrew consent|8|||
124873160|NCT01780935|449157280|FG001|Overall Study|Patient withdrew consent|9|||
124873161|NCT00855595|449157281|FG000|Overall Study|Withdrawal by Subject|1|||
124873162|NCT00855595|449157282|FG001|Overall Study|Withdrawal by Subject|2|||
124873163|NCT00855595|449157281|FG000|Overall Study|Lost to Follow-up|3|||
124873164|NCT00855595|449157282|FG001|Overall Study|Lost to Follow-up|3|||
124873165|NCT00855595|449157281|FG000|Overall Study|Adverse Event|1|||
124678134|NCT00750269|448448028|FG002|Overall Study|Physician Decision|0|||
124678135|NCT00750269|448448029|FG003|Overall Study|Physician Decision|0|||
124678136|NCT00750269|448448030|FG004|Overall Study|Physician Decision|2|||
124678137|NCT00750269|448448026|FG000|Overall Study|Patient too large for positioning|0|||
124678138|NCT00750269|448448027|FG001|Overall Study|Patient too large for positioning|0|||
124678139|NCT00750269|448448028|FG002|Overall Study|Patient too large for positioning|1|||
124678140|NCT00750269|448448029|FG003|Overall Study|Patient too large for positioning|0|||
124678141|NCT00750269|448448030|FG004|Overall Study|Patient too large for positioning|0|||
124678142|NCT00750269|448448026|FG000|Overall Study|Site error|0|||
124678143|NCT00750269|448448027|FG001|Overall Study|Site error|0|||
124678144|NCT00750269|448448028|FG002|Overall Study|Site error|0|||
124678145|NCT00750269|448448029|FG003|Overall Study|Site error|1|||
124678146|NCT00750269|448448030|FG004|Overall Study|Site error|0|||
124678147|NCT00750269|448448026|FG000|Overall Study|SBRT plan could not be drawn|0|||
124678148|NCT00750269|448448027|FG001|Overall Study|SBRT plan could not be drawn|0|||
124678149|NCT00750269|448448028|FG002|Overall Study|SBRT plan could not be drawn|0|||
124678150|NCT00750269|448448029|FG003|Overall Study|SBRT plan could not be drawn|0|||
124678151|NCT00750269|448448030|FG004|Overall Study|SBRT plan could not be drawn|1|||
124678152|NCT00750269|448448026|FG000|Overall Study|Fiducials could not be placed|0|||
124678153|NCT00750269|448448027|FG001|Overall Study|Fiducials could not be placed|0|||
124678154|NCT00750269|448448028|FG002|Overall Study|Fiducials could not be placed|0|||
124678155|NCT00750269|448448029|FG003|Overall Study|Fiducials could not be placed|0|||
124678156|NCT00750269|448448030|FG004|Overall Study|Fiducials could not be placed|1|||
124678157|NCT02791269|448448031|FG000|Overall Study|Lost to Follow-up|0|||
124873166|NCT00855595|449157282|FG001|Overall Study|Adverse Event|1|||
124873167|NCT00855595|449157281|FG000|Overall Study|patient moved out of state|1|||
124873168|NCT00855595|449157282|FG001|Overall Study|patient moved out of state|0|||
124873169|NCT00855595|449157281|FG000|Overall Study|patient left country|0|||
124873170|NCT00855595|449157282|FG001|Overall Study|patient left country|1|||
124873171|NCT00166296|449157283|FG000|Overall Study|Withdrawal by Subject|1|||
124873172|NCT00166296|449157284|FG001|Overall Study|Withdrawal by Subject|3|||
124873173|NCT00166296|449157283|FG000|Overall Study|Adverse Event|2|||
124873174|NCT00166296|449157284|FG001|Overall Study|Adverse Event|4|||
124873175|NCT00166296|449157283|FG000|Overall Study|Lost to Follow-up|4|||
124873176|NCT00166296|449157284|FG001|Overall Study|Lost to Follow-up|2|||
124873177|NCT04035200|449157285|FG000|Overall Study|Lost to Follow-up|0|||
124873178|NCT04035200|449157286|FG001|Overall Study|Lost to Follow-up|1|||
124873179|NCT04035200|449157287|FG002|Overall Study|Lost to Follow-up|0|||
124873180|NCT04035200|449157285|FG000|Overall Study|Withdrawal by Subject|1|||
124873181|NCT04035200|449157286|FG001|Overall Study|Withdrawal by Subject|4|||
124873182|NCT04035200|449157287|FG002|Overall Study|Withdrawal by Subject|4|||
124873183|NCT04035200|449157285|FG000|Overall Study|COVID-19|1|||
124873184|NCT04035200|449157286|FG001|Overall Study|COVID-19|0|||
124873185|NCT04035200|449157287|FG002|Overall Study|COVID-19|0|||
124873186|NCT04035200|449157285|FG000|Overall Study|Early Termination|0|||
124873187|NCT04035200|449157286|FG001|Overall Study|Early Termination|1|||
124873188|NCT04035200|449157287|FG002|Overall Study|Early Termination|0|||
124678158|NCT02791269|448448032|FG001|Overall Study|Lost to Follow-up|1|||
124678159|NCT00336544|448448033|FG000|Overall Study|Lack of Efficacy|8|||
124873189|NCT04035200|449157285|FG000|Overall Study|Non-compliance|0|||
124873190|NCT04035200|449157286|FG001|Overall Study|Non-compliance|1|||
124873191|NCT04035200|449157287|FG002|Overall Study|Non-compliance|0|||
124873192|NCT00946296|449157288|FG000|Overall Study|Physician Decision|3|||
124873193|NCT00946296|449157289|FG001|Overall Study|Physician Decision|0|||
124873194|NCT01422408|449157294|FG000|Overall Study|Adverse Event|1|||
124678160|NCT00336544|448448034|FG001|Overall Study|Lack of Efficacy|5|||
124678161|NCT00336544|448448033|FG000|Overall Study|Adverse Event|4|||
124678162|NCT00336544|448448034|FG001|Overall Study|Adverse Event|9|||
124678163|NCT00336544|448448033|FG000|Overall Study|Withdrawal by Subject|4|||
124678164|NCT00336544|448448034|FG001|Overall Study|Withdrawal by Subject|3|||
124678165|NCT00336544|448448033|FG000|Overall Study|Other|3|||
124678166|NCT00336544|448448034|FG001|Overall Study|Other|5|||
124678167|NCT01649765|448448035|FG000|Overall Study|Adverse Event|5|||
124678168|NCT01649765|448448036|FG001|Overall Study|Adverse Event|3|||
124678169|NCT01649765|448448035|FG000|Overall Study|Lack of Efficacy|1|||
124678170|NCT01649765|448448036|FG001|Overall Study|Lack of Efficacy|1|||
124678171|NCT01649765|448448035|FG000|Overall Study|Physician Decision|0|||
124678172|NCT01649765|448448036|FG001|Overall Study|Physician Decision|3|||
124678173|NCT01649765|448448035|FG000|Overall Study|Protocol Violation|1|||
124678174|NCT01649765|448448036|FG001|Overall Study|Protocol Violation|0|||
124678175|NCT01649765|448448035|FG000|Overall Study|Withdrawal by Subject|2|||
124678176|NCT01649765|448448036|FG001|Overall Study|Withdrawal by Subject|1|||
124678177|NCT01648764|448448037|FG000|Overall Study|Progressive Disease|0|||
124678178|NCT01648764|448448038|FG001|Overall Study|Progressive Disease|1|||
124678179|NCT01648764|448448039|FG002|Overall Study|Progressive Disease|0|||
124678180|NCT01648764|448448040|FG003|Overall Study|Progressive Disease|0|||
124678181|NCT01648764|448448041|FG004|Overall Study|Progressive Disease|0|||
124678182|NCT01648764|448448042|FG005|Overall Study|Progressive Disease|1|||
124678183|NCT01648764|448448043|FG006|Overall Study|Progressive Disease|1|||
124678184|NCT01648764|448448044|FG007|Overall Study|Progressive Disease|0|||
124678185|NCT01648764|448448045|FG008|Overall Study|Progressive Disease|0|||
124678186|NCT01648764|448448046|FG009|Overall Study|Progressive Disease|2|||
124678187|NCT01648764|448448047|FG010|Overall Study|Progressive Disease|0|||
124678188|NCT01648764|448448048|FG011|Overall Study|Progressive Disease|1|||
124678189|NCT01648764|448448049|FG012|Overall Study|Progressive Disease|2|||
124678190|NCT01648764|448448050|FG013|Overall Study|Progressive Disease|1|||
124678191|NCT01648764|448448037|FG000|Overall Study|Adverse Event|0|||
124678192|NCT01648764|448448038|FG001|Overall Study|Adverse Event|0|||
124678193|NCT01648764|448448039|FG002|Overall Study|Adverse Event|0|||
124678194|NCT01648764|448448040|FG003|Overall Study|Adverse Event|0|||
124678195|NCT01648764|448448041|FG004|Overall Study|Adverse Event|0|||
124678196|NCT01648764|448448042|FG005|Overall Study|Adverse Event|1|||
124678197|NCT01648764|448448043|FG006|Overall Study|Adverse Event|0|||
124678198|NCT01648764|448448044|FG007|Overall Study|Adverse Event|0|||
124678199|NCT01648764|448448045|FG008|Overall Study|Adverse Event|0|||
124678200|NCT01648764|448448046|FG009|Overall Study|Adverse Event|1|||
124678201|NCT01648764|448448047|FG010|Overall Study|Adverse Event|0|||
124678202|NCT01648764|448448048|FG011|Overall Study|Adverse Event|3|||
124678203|NCT01648764|448448049|FG012|Overall Study|Adverse Event|1|||
124678204|NCT01648764|448448050|FG013|Overall Study|Adverse Event|1|||
124678205|NCT01648764|448448037|FG000|Overall Study|Death|0|||
124678206|NCT01648764|448448038|FG001|Overall Study|Death|0|||
124678207|NCT01648764|448448039|FG002|Overall Study|Death|0|||
124678208|NCT01648764|448448040|FG003|Overall Study|Death|0|||
124678209|NCT01648764|448448041|FG004|Overall Study|Death|0|||
124678210|NCT01648764|448448042|FG005|Overall Study|Death|0|||
124678211|NCT01648764|448448043|FG006|Overall Study|Death|1|||
124678212|NCT01648764|448448044|FG007|Overall Study|Death|0|||
124678213|NCT01648764|448448045|FG008|Overall Study|Death|0|||
124678214|NCT01648764|448448046|FG009|Overall Study|Death|0|||
124678215|NCT01648764|448448047|FG010|Overall Study|Death|0|||
124678216|NCT01648764|448448048|FG011|Overall Study|Death|0|||
124678217|NCT01648764|448448049|FG012|Overall Study|Death|0|||
124432808|NCT00381615|447543840|FG001|Overall Study|Protocol Violation|0|||
124678218|NCT01648764|448448050|FG013|Overall Study|Death|1|||
124678219|NCT01648764|448448037|FG000|Overall Study|Withdrawal by Subject|0|||
124678220|NCT01648764|448448038|FG001|Overall Study|Withdrawal by Subject|0|||
124678221|NCT01648764|448448039|FG002|Overall Study|Withdrawal by Subject|0|||
124432809|NCT00381615|447543841|FG002|Overall Study|Protocol Violation|1|||
124678222|NCT01648764|448448040|FG003|Overall Study|Withdrawal by Subject|0|||
124678223|NCT01648764|448448041|FG004|Overall Study|Withdrawal by Subject|0|||
124678224|NCT01648764|448448042|FG005|Overall Study|Withdrawal by Subject|0|||
124678225|NCT01648764|448448043|FG006|Overall Study|Withdrawal by Subject|2|||
124678226|NCT01648764|448448044|FG007|Overall Study|Withdrawal by Subject|0|||
124678227|NCT01648764|448448045|FG008|Overall Study|Withdrawal by Subject|0|||
124678228|NCT01648764|448448046|FG009|Overall Study|Withdrawal by Subject|0|||
124678229|NCT01648764|448448047|FG010|Overall Study|Withdrawal by Subject|0|||
124678230|NCT01648764|448448048|FG011|Overall Study|Withdrawal by Subject|0|||
124678231|NCT01648764|448448049|FG012|Overall Study|Withdrawal by Subject|1|||
124678232|NCT01648764|448448050|FG013|Overall Study|Withdrawal by Subject|0|||
124678233|NCT01648764|448448037|FG000|Overall Study|Investigator Decision|0|||
124678234|NCT01648764|448448038|FG001|Overall Study|Investigator Decision|0|||
124678235|NCT01648764|448448039|FG002|Overall Study|Investigator Decision|0|||
124678236|NCT01648764|448448040|FG003|Overall Study|Investigator Decision|0|||
124678237|NCT01648764|448448041|FG004|Overall Study|Investigator Decision|0|||
124432810|NCT00381615|447543842|FG003|Overall Study|Protocol Violation|0|||
124432811|NCT02595073|447543843|FG000|Overall Study|Progressive Disease|0|||
124432812|NCT02595073|447543844|FG001|Overall Study|Progressive Disease|1|||
124432813|NCT02595073|447543843|FG000|Overall Study|Protocol Violation|2|||
124432814|NCT02595073|447543844|FG001|Overall Study|Protocol Violation|0|||
124432815|NCT02962960|447543845|FG000|Overall Study|Withdrawal by Subject|1|||
124678238|NCT01648764|448448042|FG005|Overall Study|Investigator Decision|0|||
124432816|NCT02962960|447543846|FG001|Overall Study|Withdrawal by Subject|1|||
124432817|NCT02962960|447543847|FG002|Overall Study|Withdrawal by Subject|0|||
124432818|NCT02962960|447543845|FG000|Overall Study|Adverse Event|1|||
124432819|NCT02962960|447543846|FG001|Overall Study|Adverse Event|1|||
124432820|NCT02962960|447543847|FG002|Overall Study|Adverse Event|0|||
124432821|NCT02962960|447543845|FG000|Overall Study|Protocol Violation|1|||
124432822|NCT02962960|447543846|FG001|Overall Study|Protocol Violation|0|||
124432823|NCT02962960|447543847|FG002|Overall Study|Protocol Violation|0|||
124432824|NCT04860297|447543850|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
124432825|NCT04860297|447543851|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
124432826|NCT04860297|447543852|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
124432827|NCT04860297|447543853|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
124432828|NCT04860297|447543854|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
124432829|NCT04860297|447543855|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
124678239|NCT01648764|448448043|FG006|Overall Study|Investigator Decision|1|||
124678240|NCT01648764|448448044|FG007|Overall Study|Investigator Decision|0|||
124678241|NCT01648764|448448045|FG008|Overall Study|Investigator Decision|0|||
124678242|NCT01648764|448448046|FG009|Overall Study|Investigator Decision|0|||
124678243|NCT01648764|448448047|FG010|Overall Study|Investigator Decision|0|||
124678244|NCT01648764|448448048|FG011|Overall Study|Investigator Decision|1|||
124678245|NCT01648764|448448049|FG012|Overall Study|Investigator Decision|0|||
124678246|NCT01648764|448448050|FG013|Overall Study|Investigator Decision|0|||
124678247|NCT00715208|448448051|FG000|Overall Study|Withdrawal by Subject|1|||
124678248|NCT00715208|448448052|FG001|Overall Study|Withdrawal by Subject|1|||
124678249|NCT00715208|448448051|FG000|Overall Study|Adverse Event|0|||
124678250|NCT00715208|448448052|FG001|Overall Study|Adverse Event|6|||
124678251|NCT00715208|448448051|FG000|Overall Study|Lack of Efficacy|0|||
124678252|NCT00715208|448448052|FG001|Overall Study|Lack of Efficacy|2|||
124678253|NCT01316614|448448053|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
124678254|NCT01316614|448448053|FG000|Overall Study|Cytology slides not available for review|4|||
124678255|NCT01316614|448448053|FG000|Overall Study|Cystic lesion|5|||
124678256|NCT01316614|448448053|FG000|Overall Study|Inadequate number of passes|2|||
124678257|NCT01316614|448448053|FG000|Overall Study|Medically unstable|1|||
124678258|NCT00076570|448448054|FG000|Overall Study|Drug intolerance|8|||
124678259|NCT00076570|448448055|FG001|Overall Study|Drug intolerance|8|||
124678260|NCT03427411|448448056|FG000|Overall Study|Screen failure - platelets too low|0|||
124678261|NCT03427411|448448057|FG001|Overall Study|Screen failure - platelets too low|1|||
124678262|NCT04889040|448448058|FG000|Overall Study|Withdrawal by Subject|3|||
124678263|NCT04889040|448448059|FG001|Overall Study|Withdrawal by Subject|3|||
124678264|NCT04889040|448448058|FG000|Overall Study|Lost to Follow-up|0|||
124678265|NCT04889040|448448059|FG001|Overall Study|Lost to Follow-up|1|||
124678266|NCT04889040|448448058|FG000|Overall Study|Adverse Event|2|||
124678267|NCT04889040|448448059|FG001|Overall Study|Adverse Event|1|||
124678268|NCT00998946|448448060|FG000|Overall Study|Lost to Follow-up|1|||
124678269|NCT00998946|448448060|FG000|Overall Study|Withdrawal by Subject|1|||
124678270|NCT00998946|448448060|FG000|Overall Study|Death|2|||
124678271|NCT00998946|448448060|FG000|Overall Study|Reason Unspecified|3|||
124678272|NCT00998946|448448060|FG000|Overall Study|Enrolled but not Dosed|2|||
124678273|NCT00977197|448448063|FG000|Overall Study|Withdrawal by Subject|3|||
124678274|NCT00977197|448448064|FG001|Overall Study|Withdrawal by Subject|4|||
124678275|NCT00977197|448448063|FG000|Overall Study|Adverse Event|3|||
124678276|NCT00977197|448448064|FG001|Overall Study|Adverse Event|1|||
124678277|NCT00977197|448448063|FG000|Overall Study|Lack of Efficacy|1|||
124678278|NCT00977197|448448064|FG001|Overall Study|Lack of Efficacy|0|||
124678279|NCT00977197|448448063|FG000|Overall Study|Lost to Follow-up|1|||
124678280|NCT00977197|448448064|FG001|Overall Study|Lost to Follow-up|3|||
124678281|NCT00977197|448448063|FG000|Overall Study|Nonadherence|1|||
124678282|NCT00977197|448448064|FG001|Overall Study|Nonadherence|1|||
124678283|NCT00784875|448448065|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
124678284|NCT00784875|448448066|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
124678285|NCT00784875|448448067|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
124678286|NCT00784875|448448068|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
124678287|NCT00784875|448448065|FG000|Period A - Baseline|Adverse Event|0|||
124678288|NCT00784875|448448066|FG001|Period A - Baseline|Adverse Event|0|||
124432830|NCT04860297|447543856|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
124432831|NCT04860297|447543857|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
124678289|NCT00784875|448448067|FG002|Period A - Baseline|Adverse Event|0|||
124678290|NCT00784875|448448068|FG003|Period A - Baseline|Adverse Event|8|||
124432832|NCT04860297|447543850|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
124432833|NCT04860297|447543851|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
124432834|NCT04860297|447543852|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
124873195|NCT01422408|449157294|FG000|Overall Study|Withdrawal by Subject|3|||
124873196|NCT03185481|449157295|FG000|Overall Study|Adverse Event|1|||
124873197|NCT03185481|449157295|FG000|Overall Study|Study Terminated by Sponsor|4|||
124873198|NCT00701038|449157296|FG000|Overall Study|study amended pilot group of patients|4|||
124873199|NCT00701038|449157297|FG001|Overall Study|study amended pilot group of patients|4|||
124873200|NCT00386022|449157299|FG000|Plus Estrogen|Lost to Follow-up|2|||
124873201|NCT00386022|449157300|FG001|Plus Estrogen|Lost to Follow-up|0|||
124873202|NCT00386022|449157299|FG000|Plus Estrogen|Adverse Event|0|||
124873203|NCT00386022|449157300|FG001|Plus Estrogen|Adverse Event|1|||
124873204|NCT01064297|449157304|FG000|Overall Study|Lost to Follow-up|791|||
124873205|NCT01064297|449157305|FG001|Overall Study|Lost to Follow-up|48|||
124873206|NCT01064297|449157306|FG002|Overall Study|Lost to Follow-up|133|||
124873207|NCT00168038|449157312|FG000|Overall Study|Adverse Event|1|||
124873208|NCT00168038|449157312|FG000|Overall Study|Therapy failure|1|||
124873209|NCT01345630|449158835|FG000|Overall Study|Adverse Event|22|||
124873210|NCT01345630|449158836|FG001|Overall Study|Adverse Event|23|||
124873211|NCT01345630|449158835|FG000|Overall Study|Lost to Follow-up|17|||
124873212|NCT01345630|449158836|FG001|Overall Study|Lost to Follow-up|16|||
124873213|NCT01345630|449158835|FG000|Overall Study|Protocol Violation|4|||
124873214|NCT01345630|449158836|FG001|Overall Study|Protocol Violation|1|||
124873215|NCT01345630|449158835|FG000|Overall Study|Medication error without associated AE|0|||
124873216|NCT01345630|449158836|FG001|Overall Study|Medication error without associated AE|1|||
124873217|NCT01345630|449158835|FG000|Overall Study|Study terminated by sponsor|254|||
124873218|NCT01345630|449158836|FG001|Overall Study|Study terminated by sponsor|285|||
124873219|NCT01345630|449158835|FG000|Overall Study|Other reasons|6|||
124873220|NCT01345630|449158836|FG001|Overall Study|Other reasons|8|||
124873221|NCT01345630|449158835|FG000|Overall Study|Withdrawn due to pregnancy|1|||
124873222|NCT01345630|449158836|FG001|Overall Study|Withdrawn due to pregnancy|2|||
124873223|NCT01345630|449158835|FG000|Overall Study|No longer willing to participate|9|||
124873224|NCT01345630|449158836|FG001|Overall Study|No longer willing to participate|12|||
124873225|NCT01345630|449158835|FG000|Overall Study|Insufficient clinical response|48|||
124873226|NCT01345630|449158836|FG001|Overall Study|Insufficient clinical response|11|||
124873227|NCT04233372|449158837|FG000|Overall Study|Lost to Follow-up|104|||
124873228|NCT04233372|449158837|FG000|Overall Study|Adverse Event|8|||
124873229|NCT04233372|449158837|FG000|Overall Study|Withdrawal by Subject|2|||
124873230|NCT01090310|449158838|FG000|Core Study|Adverse Event|2|||
124873231|NCT01090310|449158839|FG001|Core Study|Adverse Event|2|||
124873232|NCT01090310|449158840|FG002|Core Study|Adverse Event|1|||
124873233|NCT01090310|449158841|FG003|Core Study|Adverse Event|1|||
124873234|NCT01090310|449158838|FG000|Core Study|Subject withdrew consent|0|||
124873235|NCT01090310|449158839|FG001|Core Study|Subject withdrew consent|3|||
124873236|NCT01090310|449158840|FG002|Core Study|Subject withdrew consent|1|||
124873237|NCT01090310|449158841|FG003|Core Study|Subject withdrew consent|1|||
124873238|NCT01090310|449158838|FG000|Core Study|Abnormal test procedure result|0|||
124873239|NCT01090310|449158839|FG001|Core Study|Abnormal test procedure result|0|||
124873240|NCT01090310|449158840|FG002|Core Study|Abnormal test procedure result|1|||
124873241|NCT01090310|449158841|FG003|Core Study|Abnormal test procedure result|0|||
124873242|NCT01090310|449158838|FG000|Core Study|Administrative reasons|5|||
124873243|NCT01090310|449158839|FG001|Core Study|Administrative reasons|6|||
124873244|NCT01090310|449158840|FG002|Core Study|Administrative reasons|4|||
124873245|NCT01090310|449158841|FG003|Core Study|Administrative reasons|4|||
124873246|NCT01090310|449158838|FG000|Core Study|Protocol deviation|1|||
124873247|NCT01090310|449158839|FG001|Core Study|Protocol deviation|0|||
124873248|NCT01090310|449158840|FG002|Core Study|Protocol deviation|0|||
124873249|NCT01090310|449158841|FG003|Core Study|Protocol deviation|1|||
124873250|NCT01090310|449158838|FG000|Extension Study|Aministrative problems|13|||
124873251|NCT01090310|449158839|FG001|Extension Study|Aministrative problems|15|||
124432835|NCT04860297|447543853|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
124432836|NCT04860297|447543854|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
124873252|NCT01090310|449158840|FG002|Extension Study|Aministrative problems|14|||
124873253|NCT01090310|449158841|FG003|Extension Study|Aministrative problems|18|||
124873254|NCT01090310|449158838|FG000|Extension Study|Adverse Event|0|||
124432837|NCT04860297|447543855|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
124432838|NCT04860297|447543856|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
124873255|NCT01090310|449158839|FG001|Extension Study|Adverse Event|0|||
124873256|NCT01090310|449158840|FG002|Extension Study|Adverse Event|0|||
124873257|NCT01090310|449158841|FG003|Extension Study|Adverse Event|1|||
124873258|NCT01090310|449158838|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
124873259|NCT01090310|449158839|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
124873260|NCT01090310|449158840|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
124873261|NCT01090310|449158841|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
124873262|NCT01090310|449158838|FG000|Extension Study|Subject withdrew consent|0|||
124873263|NCT01090310|449158839|FG001|Extension Study|Subject withdrew consent|1|||
124873264|NCT01090310|449158840|FG002|Extension Study|Subject withdrew consent|0|||
124873265|NCT01090310|449158841|FG003|Extension Study|Subject withdrew consent|0|||
124432839|NCT04860297|447543857|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
124873266|NCT00695786|449158842|FG000|Overall Study|Adverse Event|0|||
124873267|NCT00695786|449158843|FG001|Overall Study|Adverse Event|3|||
124873268|NCT00695786|449158844|FG002|Overall Study|Adverse Event|4|||
124873269|NCT00695786|449158845|FG003|Overall Study|Adverse Event|2|||
124873270|NCT00695786|449158842|FG000|Overall Study|Lost to Follow-up|0|||
124873271|NCT00695786|449158843|FG001|Overall Study|Lost to Follow-up|5|||
124873272|NCT00695786|449158844|FG002|Overall Study|Lost to Follow-up|1|||
124873273|NCT00695786|449158845|FG003|Overall Study|Lost to Follow-up|1|||
124873274|NCT00695786|449158842|FG000|Overall Study|Withdrawal by Subject|0|||
124873275|NCT00695786|449158843|FG001|Overall Study|Withdrawal by Subject|4|||
124873276|NCT00695786|449158844|FG002|Overall Study|Withdrawal by Subject|3|||
124873277|NCT00695786|449158845|FG003|Overall Study|Withdrawal by Subject|1|||
124873278|NCT00695786|449158842|FG000|Overall Study|Deemed Ineligible|1|||
124873279|NCT00695786|449158843|FG001|Overall Study|Deemed Ineligible|0|||
124873280|NCT00695786|449158844|FG002|Overall Study|Deemed Ineligible|0|||
124873281|NCT00695786|449158845|FG003|Overall Study|Deemed Ineligible|0|||
124873282|NCT00695786|449158842|FG000|Overall Study|Lack of Efficacy|0|||
124873283|NCT00695786|449158843|FG001|Overall Study|Lack of Efficacy|0|||
124873284|NCT00695786|449158844|FG002|Overall Study|Lack of Efficacy|0|||
124873285|NCT00695786|449158845|FG003|Overall Study|Lack of Efficacy|4|||
124873286|NCT01364922|449158846|FG000|Open-label (OL) Period|Adverse Event|7|||
124873287|NCT01364922|449158847|FG001|Open-label (OL) Period|Adverse Event|0|||
124873288|NCT01364922|449158848|FG002|Open-label (OL) Period|Adverse Event|0|||
124873289|NCT01364922|449158846|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
124873290|NCT01364922|449158847|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
124873291|NCT01364922|449158848|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
124873292|NCT01364922|449158846|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
124873293|NCT01364922|449158847|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
124873294|NCT01364922|449158848|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
124873295|NCT01364922|449158846|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
124873296|NCT01364922|449158847|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
124873297|NCT01364922|449158848|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
124873298|NCT01364922|449158846|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
124873299|NCT01364922|449158847|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
124873300|NCT01364922|449158848|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
124873301|NCT01364922|449158846|FG000|Open-label (OL) Period|Other, Unspecified|1|||
124873302|NCT01364922|449158847|FG001|Open-label (OL) Period|Other, Unspecified|0|||
124873303|NCT01364922|449158848|FG002|Open-label (OL) Period|Other, Unspecified|0|||
124873304|NCT01364922|449158846|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
124873305|NCT01364922|449158847|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
124873306|NCT01364922|449158848|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
124873307|NCT01364922|449158846|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
124873308|NCT01364922|449158847|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
124873309|NCT01364922|449158848|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
124873310|NCT01364922|449158846|FG000|Double-Blind (DB) Period|Adverse Event|0|||
124873311|NCT01364922|449158847|FG001|Double-Blind (DB) Period|Adverse Event|0|||
124873312|NCT01364922|449158848|FG002|Double-Blind (DB) Period|Adverse Event|1|||
124873313|NCT01364922|449158846|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
124873314|NCT01364922|449158847|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
124873315|NCT01364922|449158848|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
124873316|NCT01787097|449158852|FG000|Overall Study|Withdrawal by Subject|1|||
124873317|NCT01787097|449158853|FG001|Overall Study|Withdrawal by Subject|0|||
124873318|NCT01787097|449158854|FG002|Overall Study|Withdrawal by Subject|0|||
124873319|NCT01787097|449158855|FG003|Overall Study|Withdrawal by Subject|0|||
124873320|NCT00949884|449158856|FG000|Overall Study|Adverse Event|14|||
124873321|NCT00949884|449158857|FG001|Overall Study|Adverse Event|3|||
124432840|NCT04860297|447543850|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
124432841|NCT04860297|447543851|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
124432842|NCT04860297|447543852|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
124432843|NCT04860297|447543853|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
124432844|NCT04860297|447543854|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
124432845|NCT04860297|447543855|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
124432846|NCT04860297|447543856|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
124873322|NCT00949884|449158858|FG002|Overall Study|Adverse Event|12|||
124873323|NCT00949884|449158856|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
124873324|NCT00949884|449158857|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
124873325|NCT00949884|449158858|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
124873326|NCT00949884|449158856|FG000|Overall Study|Lost to Follow-up|7|||
124873327|NCT00949884|449158857|FG001|Overall Study|Lost to Follow-up|5|||
124873328|NCT00949884|449158858|FG002|Overall Study|Lost to Follow-up|5|||
124873329|NCT00949884|449158856|FG000|Overall Study|Physician Decision|5|||
124873330|NCT00949884|449158857|FG001|Overall Study|Physician Decision|0|||
124873331|NCT00949884|449158858|FG002|Overall Study|Physician Decision|6|||
124873332|NCT00949884|449158856|FG000|Overall Study|Treatment non-compliance|5|||
124873333|NCT00949884|449158857|FG001|Overall Study|Treatment non-compliance|0|||
124432847|NCT04860297|447543857|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
124873334|NCT00949884|449158858|FG002|Overall Study|Treatment non-compliance|8|||
124873335|NCT00949884|449158856|FG000|Overall Study|Withdrawal by Subject|13|||
124873336|NCT00949884|449158857|FG001|Overall Study|Withdrawal by Subject|4|||
124873337|NCT00949884|449158858|FG002|Overall Study|Withdrawal by Subject|16|||
124873338|NCT00949884|449158856|FG000|Overall Study|Lack of Efficacy|4|||
124873339|NCT00949884|449158857|FG001|Overall Study|Lack of Efficacy|2|||
124873340|NCT00949884|449158858|FG002|Overall Study|Lack of Efficacy|7|||
124873341|NCT00949884|449158856|FG000|Overall Study|Study terminated by sponsor|0|||
124873342|NCT00949884|449158857|FG001|Overall Study|Study terminated by sponsor|0|||
124873343|NCT00949884|449158858|FG002|Overall Study|Study terminated by sponsor|1|||
124873344|NCT00944658|449158859|FG000|Treatment 12 Weeks|Adverse Event|0|||
124873345|NCT00944658|449158860|FG001|Treatment 12 Weeks|Adverse Event|2|||
124873346|NCT02832622|449158866|FG000|Overall Study|MPP not programmed|1259|||
124873347|NCT02832622|449158866|FG000|Overall Study|Withdrawal by Subject|123|||
124873348|NCT02832622|449158866|FG000|Overall Study|Death|119|||
124873349|NCT02832622|449158866|FG000|Overall Study|Unsuccessful CRT implant|93|||
124873350|NCT02832622|449158866|FG000|Overall Study|Lost to Follow-up|45|||
124873351|NCT02832622|449158866|FG000|Overall Study|Patient non-compliance|42|||
124873352|NCT02832622|449158866|FG000|Overall Study|Withdrawal by other reasons|25|||
124873353|NCT02832622|449158866|FG000|Overall Study|System explant|24|||
124873354|NCT02832622|449158866|FG000|Overall Study|Physician Decision|6|||
124873355|NCT02472652|449158867|FG000|Overall Study|Lost to Follow-up|1|||
124873356|NCT03704584|449158868|FG000|Overall Study|Withdrawal by Subject|1|||
124873357|NCT03704584|449158869|FG001|Overall Study|Withdrawal by Subject|0|||
124873358|NCT03185832|449158870|FG000|Overall Study|Death|9|||
124678291|NCT00784875|448448065|FG000|Period A - Baseline|Protocol Violation|0|||
124873359|NCT03185832|449158871|FG001|Overall Study|Death|14|||
124873360|NCT03185832|449158872|FG002|Overall Study|Death|9|||
124873361|NCT03185832|449158873|FG003|Overall Study|Death|7|||
124873362|NCT03185832|449158870|FG000|Overall Study|Withdrawn - vital status available|0|||
124873363|NCT03185832|449158871|FG001|Overall Study|Withdrawn - vital status available|1|||
124873364|NCT03185832|449158872|FG002|Overall Study|Withdrawn - vital status available|1|||
124873365|NCT03185832|449158873|FG003|Overall Study|Withdrawn - vital status available|4|||
124873366|NCT02323646|449158875|FG000|Treatment Course 1|Adverse Event|1|||
124873367|NCT02323646|449158876|FG001|Treatment Course 1|Adverse Event|0|||
124873368|NCT02323646|449158877|FG002|Treatment Course 1|Adverse Event|1|||
124873369|NCT02323646|449158875|FG000|Treatment Course 1|Heavy Bleeding|1|||
124873370|NCT02323646|449158876|FG001|Treatment Course 1|Heavy Bleeding|1|||
124873371|NCT02323646|449158877|FG002|Treatment Course 1|Heavy Bleeding|0|||
124873372|NCT02323646|449158875|FG000|Treatment Course 1|Lost to Follow-up|1|||
124873373|NCT02323646|449158876|FG001|Treatment Course 1|Lost to Follow-up|0|||
124873374|NCT02323646|449158877|FG002|Treatment Course 1|Lost to Follow-up|2|||
124873375|NCT02323646|449158875|FG000|Treatment Course 1|Withdrawal by Subject|0|||
124873376|NCT02323646|449158876|FG001|Treatment Course 1|Withdrawal by Subject|2|||
124873377|NCT02323646|449158877|FG002|Treatment Course 1|Withdrawal by Subject|0|||
124873378|NCT02323646|449158875|FG000|Treatment Course 2|Adverse Event|1|||
124873379|NCT02323646|449158876|FG001|Treatment Course 2|Adverse Event|0|||
124873380|NCT02323646|449158877|FG002|Treatment Course 2|Adverse Event|1|||
124873381|NCT02323646|449158875|FG000|Treatment Course 2|Lost to Follow-up|0|||
124873382|NCT02323646|449158876|FG001|Treatment Course 2|Lost to Follow-up|0|||
124873383|NCT02323646|449158877|FG002|Treatment Course 2|Lost to Follow-up|1|||
124873384|NCT02323646|449158875|FG000|Treatment Course 2|Non-compliance|0|||
124873385|NCT02323646|449158876|FG001|Treatment Course 2|Non-compliance|1|||
124873386|NCT02323646|449158877|FG002|Treatment Course 2|Non-compliance|1|||
124873387|NCT00521144|449158878|FG000|Overall Study|Not Treated|0|||
124432848|NCT04860297|447543850|FG000|Part B (Booster Dose)|Other Than Specified|0|||
124432849|NCT04860297|447543851|FG001|Part B (Booster Dose)|Other Than Specified|0|||
124432850|NCT04860297|447543852|FG002|Part B (Booster Dose)|Other Than Specified|0|||
124432851|NCT04860297|447543853|FG003|Part B (Booster Dose)|Other Than Specified|0|||
124432852|NCT04860297|447543854|FG004|Part B (Booster Dose)|Other Than Specified|0|||
124432853|NCT04860297|447543855|FG005|Part B (Booster Dose)|Other Than Specified|1|||
124432854|NCT04860297|447543856|FG006|Part B (Booster Dose)|Other Than Specified|1|||
124432855|NCT04860297|447543857|FG007|Part B (Booster Dose)|Other Than Specified|0|||
124873388|NCT00521144|449158879|FG001|Overall Study|Not Treated|0|||
124873389|NCT00521144|449158880|FG002|Overall Study|Not Treated|0|||
124873390|NCT00521144|449158881|FG003|Overall Study|Not Treated|1|||
124873391|NCT00521144|449158882|FG004|Overall Study|Not Treated|0|||
124873392|NCT00521144|449158878|FG000|Overall Study|Adverse Event|0|||
124873393|NCT00521144|449158879|FG001|Overall Study|Adverse Event|1|||
124873394|NCT00521144|449158880|FG002|Overall Study|Adverse Event|0|||
124873395|NCT00521144|449158881|FG003|Overall Study|Adverse Event|0|||
124873396|NCT00521144|449158882|FG004|Overall Study|Adverse Event|1|||
124873397|NCT00521144|449158878|FG000|Overall Study|Progressive Disease|4|||
124873398|NCT00521144|449158879|FG001|Overall Study|Progressive Disease|2|||
124873399|NCT00521144|449158880|FG002|Overall Study|Progressive Disease|2|||
124873400|NCT00521144|449158881|FG003|Overall Study|Progressive Disease|0|||
124873401|NCT00521144|449158882|FG004|Overall Study|Progressive Disease|6|||
124873402|NCT01370525|449158883|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
124873403|NCT01370525|449158884|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
124873404|NCT01370525|449158883|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
124873405|NCT01370525|449158884|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124873406|NCT01370525|449158883|FG000|Overall Study|Adverse Event|0|||
124873407|NCT01370525|449158884|FG001|Overall Study|Adverse Event|1|||
124873408|NCT01370525|449158883|FG000|Overall Study|Protocol Violation|2|||
124873409|NCT01370525|449158884|FG001|Overall Study|Protocol Violation|1|||
124873410|NCT01370525|449158883|FG000|Overall Study|Lost to follow up|2|||
124873411|NCT01370525|449158884|FG001|Overall Study|Lost to follow up|6|||
124873412|NCT05131165|449158891|FG000|Overall Study|Death|1|||
124873413|NCT05131165|449158892|FG001|Overall Study|Death|1|||
124873414|NCT05131165|449158893|FG002|Overall Study|Death|0|||
124873415|NCT05131165|449158891|FG000|Overall Study|Lost to Follow-up|2|||
124873416|NCT05131165|449158892|FG001|Overall Study|Lost to Follow-up|2|||
124873417|NCT05131165|449158893|FG002|Overall Study|Lost to Follow-up|5|||
124873418|NCT05131165|449158891|FG000|Overall Study|Transferred out of clinic|1|||
124873419|NCT05131165|449158892|FG001|Overall Study|Transferred out of clinic|0|||
124873420|NCT05131165|449158893|FG002|Overall Study|Transferred out of clinic|3|||
124873421|NCT05131165|449158891|FG000|Overall Study|Dropped out|1|||
124873422|NCT05131165|449158892|FG001|Overall Study|Dropped out|2|||
124873423|NCT05131165|449158893|FG002|Overall Study|Dropped out|0|||
124873424|NCT02459262|449158899|FG000|Overall Study|Withdrawal by Subject|0|||
124873425|NCT02459262|449158900|FG001|Overall Study|Withdrawal by Subject|0|||
124873426|NCT02459262|449158901|FG002|Overall Study|Withdrawal by Subject|0|||
124873427|NCT02459262|449158902|FG003|Overall Study|Withdrawal by Subject|0|||
124873428|NCT02459262|449158903|FG004|Overall Study|Withdrawal by Subject|0|||
124873429|NCT02459262|449158904|FG005|Overall Study|Withdrawal by Subject|0|||
124873430|NCT02459262|449158905|FG006|Overall Study|Withdrawal by Subject|0|||
124873431|NCT02459262|449158906|FG007|Overall Study|Withdrawal by Subject|0|||
124873432|NCT02459262|449158907|FG008|Overall Study|Withdrawal by Subject|0|||
124873433|NCT02459262|449158908|FG009|Overall Study|Withdrawal by Subject|1|||
124873434|NCT02459262|449158909|FG010|Overall Study|Withdrawal by Subject|0|||
124873435|NCT05168579|449158910|FG000|Overall Study|Lack of Consent|1|||
124873436|NCT05168579|449158911|FG001|Overall Study|Lack of Consent|0|||
124873437|NCT05168579|449158910|FG000|Overall Study|Conflicts with time|2|||
124873438|NCT05168579|449158911|FG001|Overall Study|Conflicts with time|0|||
124873439|NCT05168579|449158910|FG000|Overall Study|Time slots were full|3|||
124873440|NCT05168579|449158911|FG001|Overall Study|Time slots were full|0|||
124873441|NCT05168579|449158910|FG000|Overall Study|Lost to Follow-up|0|||
124873442|NCT05168579|449158911|FG001|Overall Study|Lost to Follow-up|15|||
124873443|NCT01242748|449158912|FG000|Overall Study|Adverse Event|10|||
124873444|NCT01242748|449158913|FG001|Overall Study|Adverse Event|5|||
124873445|NCT01242748|449158912|FG000|Overall Study|Lost to Follow-up|6|||
124873446|NCT01242748|449158913|FG001|Overall Study|Lost to Follow-up|2|||
124873447|NCT01242748|449158912|FG000|Overall Study|Physician Decision|3|||
124873448|NCT01242748|449158913|FG001|Overall Study|Physician Decision|2|||
124873449|NCT01242748|449158912|FG000|Overall Study|Protocol Violation|1|||
124873450|NCT01242748|449158913|FG001|Overall Study|Protocol Violation|0|||
124873451|NCT01242748|449158912|FG000|Overall Study|Withdrawal by Subject|10|||
124873452|NCT01242748|449158913|FG001|Overall Study|Withdrawal by Subject|2|||
124873453|NCT01242748|449158912|FG000|Overall Study|Miscellaneous reasons|8|||
124873454|NCT01242748|449158913|FG001|Overall Study|Miscellaneous reasons|3|||
124873455|NCT00840801|449158914|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
124873456|NCT00840801|449158915|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
124873457|NCT00840801|449158916|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
124873458|NCT00840801|449158914|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
124873459|NCT00840801|449158915|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
124678292|NCT00784875|448448066|FG001|Period A - Baseline|Protocol Violation|0|||
124678293|NCT00784875|448448067|FG002|Period A - Baseline|Protocol Violation|0|||
124873460|NCT00840801|449158916|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
124678294|NCT00784875|448448068|FG003|Period A - Baseline|Protocol Violation|25|||
124873461|NCT00840801|449158914|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
124873462|NCT00840801|449158915|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
124873463|NCT00840801|449158916|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
124873464|NCT00840801|449158914|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
124873465|NCT00840801|449158915|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
124873466|NCT00840801|449158916|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
124873467|NCT00508404|449158925|FG000|Overall Study|Ongoing at Data Cut-off|12|||
124873468|NCT00508404|449158925|FG000|Overall Study|Adverse Event|2|||
124873469|NCT00508404|449158925|FG000|Overall Study|Death|16|||
124873470|NCT00508404|449158925|FG000|Overall Study|Physician Decision|2|||
124873471|NCT00508404|449158925|FG000|Overall Study|Withdrawal by Subject|3|||
124873472|NCT00508404|449158925|FG000|Overall Study|Protocol-specified Criteria|2|||
124873473|NCT00508404|449158925|FG000|Overall Study|Lost to Follow-up|2|||
124873474|NCT00508404|449158925|FG000|Overall Study|Other - Not Specified|3|||
124873475|NCT01591382|449158926|FG000|Overall Study|Discharged Prior to Study Completion|2|||
124873476|NCT01591382|449158927|FG001|Overall Study|Discharged Prior to Study Completion|1|||
124873477|NCT01591382|449158926|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
124873478|NCT01591382|449158927|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
124873479|NCT03170375|449158928|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
124873480|NCT03170375|449158929|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
124873481|NCT03170375|449158930|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
124873482|NCT03170375|449158928|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
124873483|NCT03170375|449158929|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
124873484|NCT03170375|449158930|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
124873485|NCT00855062|449158931|FG000|Step1|Early Study Closure|5|||
124873486|NCT00855062|449158932|FG001|Step1|Early Study Closure|7|||
124873487|NCT00855062|449158931|FG000|Step1|Adverse Event|1|||
124873488|NCT00855062|449158932|FG001|Step1|Adverse Event|1|||
124873489|NCT00855062|449158931|FG000|Step1|Protocol Violation|1|||
124873490|NCT00855062|449158932|FG001|Step1|Protocol Violation|0|||
124873491|NCT00855062|449158931|FG000|Step1|Pregnancy|1|||
124873492|NCT00855062|449158932|FG001|Step1|Pregnancy|0|||
124873493|NCT00855062|449158931|FG000|Step1|Withdrawal by Subject|2|||
124873494|NCT00855062|449158932|FG001|Step1|Withdrawal by Subject|3|||
124873495|NCT00855062|449158931|FG000|Step2|Early Study Closure|6|||
124873496|NCT00855062|449158932|FG001|Step2|Early Study Closure|2|||
124873497|NCT00855062|449158931|FG000|Step2|Adverse Event|0|||
124873498|NCT00855062|449158932|FG001|Step2|Adverse Event|3|||
124873499|NCT00855062|449158931|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
124873500|NCT00855062|449158932|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
124873501|NCT01376323|449158934|FG000|Overall Study|Adverse Event|1|||
124873502|NCT01376323|449158935|FG001|Overall Study|Adverse Event|0|||
124873503|NCT01376323|449158936|FG002|Overall Study|Adverse Event|0|||
124873504|NCT01376323|449158937|FG003|Overall Study|Adverse Event|2|||
124873505|NCT01376323|449158938|FG004|Overall Study|Adverse Event|0|||
124873506|NCT01376323|449158934|FG000|Overall Study|Lost to Follow-up|0|||
124873507|NCT01376323|449158935|FG001|Overall Study|Lost to Follow-up|0|||
124873508|NCT01376323|449158936|FG002|Overall Study|Lost to Follow-up|0|||
124873509|NCT01376323|449158937|FG003|Overall Study|Lost to Follow-up|2|||
124873510|NCT01376323|449158938|FG004|Overall Study|Lost to Follow-up|0|||
124873511|NCT01376323|449158934|FG000|Overall Study|Physician Decision|1|||
124873512|NCT01376323|449158935|FG001|Overall Study|Physician Decision|0|||
124873513|NCT01376323|449158936|FG002|Overall Study|Physician Decision|2|||
124873514|NCT01376323|449158937|FG003|Overall Study|Physician Decision|1|||
124873515|NCT01376323|449158938|FG004|Overall Study|Physician Decision|1|||
124873516|NCT01376323|449158934|FG000|Overall Study|Withdrawal by Subject|0|||
124873517|NCT01376323|449158935|FG001|Overall Study|Withdrawal by Subject|1|||
124873518|NCT01376323|449158936|FG002|Overall Study|Withdrawal by Subject|1|||
124873519|NCT01376323|449158937|FG003|Overall Study|Withdrawal by Subject|0|||
124873520|NCT01376323|449158938|FG004|Overall Study|Withdrawal by Subject|0|||
124873521|NCT01960725|449158939|FG000|Overall Study|Lost to Follow-up|4|||
124873522|NCT01960725|449158940|FG001|Overall Study|Lost to Follow-up|3|||
124873523|NCT01960725|449158939|FG000|Overall Study|Withdrawal by Subject|1|||
124873524|NCT01960725|449158940|FG001|Overall Study|Withdrawal by Subject|0|||
124873525|NCT01960725|449158939|FG000|Overall Study|unable to obtain blood sample|1|||
124873526|NCT01960725|449158940|FG001|Overall Study|unable to obtain blood sample|2|||
124873527|NCT02634788|449158941|FG000|Overall Study|Adverse Event|0|||
124873528|NCT02634788|449158942|FG001|Overall Study|Adverse Event|8|||
124873529|NCT02634788|449158943|FG002|Overall Study|Adverse Event|3|||
124873530|NCT02634788|449158944|FG003|Overall Study|Adverse Event|1|||
124873531|NCT02634788|449158941|FG000|Overall Study|Lack of Efficacy|4|||
124873532|NCT02634788|449158942|FG001|Overall Study|Lack of Efficacy|0|||
124873533|NCT02634788|449158943|FG002|Overall Study|Lack of Efficacy|1|||
124873534|NCT02634788|449158944|FG003|Overall Study|Lack of Efficacy|4|||
124873535|NCT02634788|449158941|FG000|Overall Study|Lost to Follow-up|0|||
124873536|NCT02634788|449158942|FG001|Overall Study|Lost to Follow-up|1|||
124873537|NCT02634788|449158943|FG002|Overall Study|Lost to Follow-up|0|||
124873538|NCT02634788|449158944|FG003|Overall Study|Lost to Follow-up|0|||
124873539|NCT02634788|449158941|FG000|Overall Study|Withdrawal by Subject|0|||
124873540|NCT02634788|449158942|FG001|Overall Study|Withdrawal by Subject|1|||
124873541|NCT02634788|449158943|FG002|Overall Study|Withdrawal by Subject|1|||
124873542|NCT02634788|449158944|FG003|Overall Study|Withdrawal by Subject|0|||
124873543|NCT02831257|449158945|FG000|Overall Study|Lack of Efficacy|3|||
124873544|NCT02831257|449158945|FG000|Overall Study|Adverse Event|2|||
124873545|NCT02831257|449158945|FG000|Overall Study|Physician Decision|1|||
124873546|NCT02831257|449158945|FG000|Overall Study|Withdrawal by Subject|6|||
124873547|NCT01281202|449158946|FG000|Overall Study|Adverse Event|2|||
124873548|NCT01281202|449158947|FG001|Overall Study|Adverse Event|0|||
124873549|NCT01281202|449158946|FG000|Overall Study|Withdrawal by Subject|2|||
124873550|NCT01281202|449158947|FG001|Overall Study|Withdrawal by Subject|2|||
124873551|NCT01281202|449158946|FG000|Overall Study|Protocol Violation|11|||
124873552|NCT01281202|449158947|FG001|Overall Study|Protocol Violation|10|||
124873553|NCT01281202|449158946|FG000|Overall Study|Administrative|2|||
124873554|NCT01281202|449158947|FG001|Overall Study|Administrative|8|||
124873555|NCT01281202|449158946|FG000|Overall Study|Lost to Follow-up|11|||
124873556|NCT01281202|449158947|FG001|Overall Study|Lost to Follow-up|13|||
124873557|NCT01281202|449158946|FG000|Overall Study|Incarceration|0|||
124873558|NCT01281202|449158947|FG001|Overall Study|Incarceration|3|||
124873559|NCT03138733|449158948|FG000|Overall Study|Death|17|||
124873560|NCT03138733|449158949|FG001|Overall Study|Death|18|||
124873561|NCT03138733|449158948|FG000|Overall Study|Withdrawal by Subject|11|||
124873562|NCT03138733|449158949|FG001|Overall Study|Withdrawal by Subject|6|||
124873563|NCT03138733|449158948|FG000|Overall Study|Lost to Follow-up|3|||
124873564|NCT03138733|449158949|FG001|Overall Study|Lost to Follow-up|2|||
124873565|NCT03138733|449158948|FG000|Overall Study|Adverse Event|1|||
124873566|NCT03138733|449158949|FG001|Overall Study|Adverse Event|0|||
124873567|NCT03138733|449158948|FG000|Overall Study|Protocol Violation|1|||
124873568|NCT03138733|449158949|FG001|Overall Study|Protocol Violation|3|||
124873569|NCT03138733|449158948|FG000|Overall Study|Administrative or logistical reason|1|||
124873570|NCT03138733|449158949|FG001|Overall Study|Administrative or logistical reason|0|||
124873571|NCT03138733|449158948|FG000|Overall Study|The patient was transferred to another hospital|1|||
124873572|NCT03138733|449158949|FG001|Overall Study|The patient was transferred to another hospital|0|||
124873573|NCT02612064|449158960|FG000|Overall Study|Withdrawal by Subject|1|||
124873574|NCT02612064|449158961|FG001|Overall Study|Withdrawal by Subject|1|||
124873575|NCT02612064|449158960|FG000|Overall Study|Other|0|||
124873576|NCT02612064|449158961|FG001|Overall Study|Other|2|||
124873577|NCT01669798|449158962|FG000|Overall Study|Physician Decision|5|||
124873578|NCT00717860|449158964|FG000|Overall Study|Clinical adverse experience|5|||
124873579|NCT00717860|449158965|FG001|Overall Study|Clinical adverse experience|9|||
124873580|NCT00717860|449158964|FG000|Overall Study|Laboratory adverse experience|2|||
124873581|NCT00717860|449158965|FG001|Overall Study|Laboratory adverse experience|2|||
124873582|NCT00717860|449158964|FG000|Overall Study|Lack of Efficacy|7|||
124873583|NCT00717860|449158965|FG001|Overall Study|Lack of Efficacy|13|||
124873584|NCT00717860|449158964|FG000|Overall Study|Discontinued for other reason|6|||
124873585|NCT00717860|449158965|FG001|Overall Study|Discontinued for other reason|1|||
124873586|NCT00717860|449158964|FG000|Overall Study|Withdrew consent|7|||
124873587|NCT00717860|449158965|FG001|Overall Study|Withdrew consent|3|||
124873588|NCT00698646|449158969|FG000|Overall Study|Adverse Event|8|||
124873589|NCT00698646|449158970|FG001|Overall Study|Adverse Event|7|||
124873590|NCT00698646|449158971|FG002|Overall Study|Adverse Event|8|||
124873591|NCT00698646|449158969|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
124873592|NCT00698646|449158970|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
124873593|NCT00698646|449158971|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
124873594|NCT00698646|449158969|FG000|Overall Study|Protocol Deviation|6|||
124873595|NCT00698646|449158970|FG001|Overall Study|Protocol Deviation|2|||
124873596|NCT00698646|449158971|FG002|Overall Study|Protocol Deviation|3|||
124873597|NCT00698646|449158969|FG000|Overall Study|Withdrawal by Subject|10|||
124873598|NCT00698646|449158970|FG001|Overall Study|Withdrawal by Subject|11|||
124873599|NCT00698646|449158971|FG002|Overall Study|Withdrawal by Subject|8|||
124873600|NCT00698646|449158969|FG000|Overall Study|Lost to Follow-up|0|||
124873601|NCT00698646|449158970|FG001|Overall Study|Lost to Follow-up|0|||
124873602|NCT00698646|449158971|FG002|Overall Study|Lost to Follow-up|2|||
124873603|NCT00698646|449158969|FG000|Overall Study|Administrative problems|1|||
124873604|NCT00698646|449158970|FG001|Overall Study|Administrative problems|0|||
124873605|NCT00698646|449158971|FG002|Overall Study|Administrative problems|1|||
124873606|NCT00279201|449158972|FG000|Initiation|Death|1|||
124873607|NCT00279201|449158973|FG001|Initiation|Death|5|||
124873608|NCT00279201|449158974|FG002|Initiation|Death|0|||
124873609|NCT00279201|449158975|FG003|Initiation|Death|0|||
124873610|NCT00279201|449158976|FG004|Initiation|Death|0|||
124873611|NCT00279201|449158977|FG005|Initiation|Death|0|||
124873612|NCT00279201|449158972|FG000|Initiation|Adverse Event|6|||
124873613|NCT00279201|449158973|FG001|Initiation|Adverse Event|15|||
124873614|NCT00279201|449158974|FG002|Initiation|Adverse Event|0|||
124873615|NCT00279201|449158975|FG003|Initiation|Adverse Event|0|||
124873616|NCT00279201|449158976|FG004|Initiation|Adverse Event|0|||
124873617|NCT00279201|449158977|FG005|Initiation|Adverse Event|0|||
124873618|NCT00279201|449158972|FG000|Initiation|Lost to Follow-up|42|||
124873619|NCT00279201|449158973|FG001|Initiation|Lost to Follow-up|41|||
124873620|NCT00279201|449158974|FG002|Initiation|Lost to Follow-up|0|||
124873621|NCT00279201|449158975|FG003|Initiation|Lost to Follow-up|0|||
124873622|NCT00279201|449158976|FG004|Initiation|Lost to Follow-up|0|||
124873623|NCT00279201|449158977|FG005|Initiation|Lost to Follow-up|0|||
124873624|NCT00279201|449158972|FG000|Initiation|Entry Criteria Exclusion|7|||
124873625|NCT00279201|449158973|FG001|Initiation|Entry Criteria Exclusion|9|||
124873626|NCT00279201|449158974|FG002|Initiation|Entry Criteria Exclusion|0|||
124873627|NCT00279201|449158975|FG003|Initiation|Entry Criteria Exclusion|0|||
124873628|NCT00279201|449158976|FG004|Initiation|Entry Criteria Exclusion|0|||
124873629|NCT00279201|449158977|FG005|Initiation|Entry Criteria Exclusion|0|||
124873630|NCT00279201|449158972|FG000|Initiation|Protocol Violation|9|||
124873631|NCT00279201|449158973|FG001|Initiation|Protocol Violation|10|||
124873632|NCT00279201|449158974|FG002|Initiation|Protocol Violation|0|||
124873633|NCT00279201|449158975|FG003|Initiation|Protocol Violation|0|||
124873634|NCT00279201|449158976|FG004|Initiation|Protocol Violation|0|||
124873635|NCT00279201|449158977|FG005|Initiation|Protocol Violation|0|||
124873636|NCT00279201|449158972|FG000|Initiation|Withdrawal by Subject|35|||
124873637|NCT00279201|449158973|FG001|Initiation|Withdrawal by Subject|41|||
124873638|NCT00279201|449158974|FG002|Initiation|Withdrawal by Subject|0|||
124873639|NCT00279201|449158975|FG003|Initiation|Withdrawal by Subject|0|||
124873640|NCT00279201|449158976|FG004|Initiation|Withdrawal by Subject|0|||
124873641|NCT00279201|449158977|FG005|Initiation|Withdrawal by Subject|0|||
124873642|NCT00279201|449158972|FG000|Initiation|Physician Decision|15|||
124873643|NCT00279201|449158973|FG001|Initiation|Physician Decision|18|||
124873644|NCT00279201|449158974|FG002|Initiation|Physician Decision|0|||
124873645|NCT00279201|449158975|FG003|Initiation|Physician Decision|0|||
124873646|NCT00279201|449158976|FG004|Initiation|Physician Decision|0|||
124873647|NCT00279201|449158977|FG005|Initiation|Physician Decision|0|||
124873648|NCT00279201|449158972|FG000|Initiation|Sponsor Decision|13|||
124678295|NCT00784875|448448065|FG000|Period A - Baseline|Withdrawal by Subject|0|||
124678296|NCT00784875|448448066|FG001|Period A - Baseline|Withdrawal by Subject|0|||
124873649|NCT00279201|449158973|FG001|Initiation|Sponsor Decision|5|||
124873650|NCT00279201|449158974|FG002|Initiation|Sponsor Decision|0|||
124873651|NCT00279201|449158975|FG003|Initiation|Sponsor Decision|0|||
124873652|NCT00279201|449158976|FG004|Initiation|Sponsor Decision|0|||
124873653|NCT00279201|449158977|FG005|Initiation|Sponsor Decision|0|||
124873654|NCT00279201|449158972|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
124873655|NCT00279201|449158973|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
124873656|NCT00279201|449158974|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
124873657|NCT00279201|449158975|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
124873658|NCT00279201|449158976|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
124873659|NCT00279201|449158977|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
124873660|NCT00279201|449158972|FG000|Maintenance|Lack of Efficacy|32|||
124873661|NCT00279201|449158973|FG001|Maintenance|Lack of Efficacy|30|||
124873662|NCT00279201|449158974|FG002|Maintenance|Lack of Efficacy|0|||
124873663|NCT00279201|449158975|FG003|Maintenance|Lack of Efficacy|0|||
124873664|NCT00279201|449158976|FG004|Maintenance|Lack of Efficacy|0|||
124873665|NCT00279201|449158977|FG005|Maintenance|Lack of Efficacy|0|||
124873666|NCT00279201|449158972|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
124873667|NCT00279201|449158973|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
124873668|NCT00279201|449158974|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
124873669|NCT00279201|449158975|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
124873670|NCT00279201|449158976|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
124873671|NCT00279201|449158977|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
124873672|NCT00279201|449158972|FG000|Maintenance|Adverse Event|4|||
124873673|NCT00279201|449158973|FG001|Maintenance|Adverse Event|4|||
124873674|NCT00279201|449158974|FG002|Maintenance|Adverse Event|0|||
124873675|NCT00279201|449158975|FG003|Maintenance|Adverse Event|0|||
124873676|NCT00279201|449158976|FG004|Maintenance|Adverse Event|0|||
124873677|NCT00279201|449158977|FG005|Maintenance|Adverse Event|0|||
124873678|NCT00279201|449158972|FG000|Maintenance|Death|4|||
124873679|NCT00279201|449158973|FG001|Maintenance|Death|4|||
124873680|NCT00279201|449158974|FG002|Maintenance|Death|0|||
124873681|NCT00279201|449158975|FG003|Maintenance|Death|0|||
124873682|NCT00279201|449158976|FG004|Maintenance|Death|0|||
124873683|NCT00279201|449158977|FG005|Maintenance|Death|0|||
124873684|NCT00279201|449158972|FG000|Maintenance|Lost to Follow-up|17|||
124873685|NCT00279201|449158973|FG001|Maintenance|Lost to Follow-up|13|||
124873686|NCT00279201|449158974|FG002|Maintenance|Lost to Follow-up|0|||
124873687|NCT00279201|449158975|FG003|Maintenance|Lost to Follow-up|0|||
124873688|NCT00279201|449158976|FG004|Maintenance|Lost to Follow-up|0|||
124873689|NCT00279201|449158977|FG005|Maintenance|Lost to Follow-up|0|||
124873690|NCT00279201|449158972|FG000|Maintenance|Entry Criteria Exclusion|1|||
124873691|NCT00279201|449158973|FG001|Maintenance|Entry Criteria Exclusion|4|||
124873692|NCT00279201|449158974|FG002|Maintenance|Entry Criteria Exclusion|0|||
124873693|NCT00279201|449158975|FG003|Maintenance|Entry Criteria Exclusion|0|||
124873694|NCT00279201|449158976|FG004|Maintenance|Entry Criteria Exclusion|0|||
124873695|NCT00279201|449158977|FG005|Maintenance|Entry Criteria Exclusion|0|||
124873696|NCT00279201|449158972|FG000|Maintenance|Protocol Violation|16|||
124873697|NCT00279201|449158973|FG001|Maintenance|Protocol Violation|24|||
124873698|NCT00279201|449158974|FG002|Maintenance|Protocol Violation|0|||
124873699|NCT00279201|449158975|FG003|Maintenance|Protocol Violation|0|||
124873700|NCT00279201|449158976|FG004|Maintenance|Protocol Violation|0|||
124873701|NCT00279201|449158977|FG005|Maintenance|Protocol Violation|0|||
124873702|NCT00279201|449158972|FG000|Maintenance|Withdrawal by Subject|18|||
124873703|NCT00279201|449158973|FG001|Maintenance|Withdrawal by Subject|18|||
124873704|NCT00279201|449158974|FG002|Maintenance|Withdrawal by Subject|0|||
124873705|NCT00279201|449158975|FG003|Maintenance|Withdrawal by Subject|0|||
124873706|NCT00279201|449158976|FG004|Maintenance|Withdrawal by Subject|0|||
124873707|NCT00279201|449158977|FG005|Maintenance|Withdrawal by Subject|0|||
124873708|NCT00279201|449158972|FG000|Maintenance|Physician Decision|9|||
124873709|NCT00279201|449158973|FG001|Maintenance|Physician Decision|9|||
124873710|NCT00279201|449158974|FG002|Maintenance|Physician Decision|0|||
124873711|NCT00279201|449158975|FG003|Maintenance|Physician Decision|0|||
124873712|NCT00279201|449158976|FG004|Maintenance|Physician Decision|0|||
124873713|NCT00279201|449158977|FG005|Maintenance|Physician Decision|0|||
124873714|NCT00279201|449158972|FG000|Maintenance|Sponsor Decision|4|||
124873715|NCT00279201|449158973|FG001|Maintenance|Sponsor Decision|0|||
124873716|NCT00279201|449158974|FG002|Maintenance|Sponsor Decision|0|||
124873717|NCT00279201|449158975|FG003|Maintenance|Sponsor Decision|0|||
124873718|NCT00279201|449158976|FG004|Maintenance|Sponsor Decision|0|||
124873719|NCT00279201|449158977|FG005|Maintenance|Sponsor Decision|0|||
124873720|NCT00279201|449158972|FG000|Maintenance|HbA1c>7.5%|123|||
124873721|NCT00279201|449158973|FG001|Maintenance|HbA1c>7.5%|126|||
124873722|NCT00279201|449158974|FG002|Maintenance|HbA1c>7.5%|0|||
124873723|NCT00279201|449158975|FG003|Maintenance|HbA1c>7.5%|0|||
124873724|NCT00279201|449158976|FG004|Maintenance|HbA1c>7.5%|0|||
124873725|NCT00279201|449158977|FG005|Maintenance|HbA1c>7.5%|0|||
124873726|NCT00279201|449158972|FG000|Intensification Addendum|Withdrawal by Subject|0|||
124873727|NCT00279201|449158973|FG001|Intensification Addendum|Withdrawal by Subject|0|||
124873728|NCT00279201|449158974|FG002|Intensification Addendum|Withdrawal by Subject|12|||
124873729|NCT00279201|449158975|FG003|Intensification Addendum|Withdrawal by Subject|14|||
124873730|NCT00279201|449158976|FG004|Intensification Addendum|Withdrawal by Subject|9|||
124873731|NCT00279201|449158977|FG005|Intensification Addendum|Withdrawal by Subject|18|||
124873732|NCT00279201|449158972|FG000|Intensification Addendum|Lost to Follow-up|0|||
124873733|NCT00279201|449158973|FG001|Intensification Addendum|Lost to Follow-up|0|||
124873734|NCT00279201|449158974|FG002|Intensification Addendum|Lost to Follow-up|4|||
124873735|NCT00279201|449158975|FG003|Intensification Addendum|Lost to Follow-up|6|||
124873736|NCT00279201|449158976|FG004|Intensification Addendum|Lost to Follow-up|7|||
124873737|NCT00279201|449158977|FG005|Intensification Addendum|Lost to Follow-up|7|||
124873738|NCT00279201|449158972|FG000|Intensification Addendum|Protocol Violation|0|||
124873739|NCT00279201|449158973|FG001|Intensification Addendum|Protocol Violation|0|||
124873740|NCT00279201|449158974|FG002|Intensification Addendum|Protocol Violation|2|||
124873741|NCT00279201|449158975|FG003|Intensification Addendum|Protocol Violation|2|||
124873742|NCT00279201|449158976|FG004|Intensification Addendum|Protocol Violation|6|||
124873743|NCT00279201|449158977|FG005|Intensification Addendum|Protocol Violation|6|||
124873744|NCT00279201|449158972|FG000|Intensification Addendum|Adverse Event|0|||
124873745|NCT00279201|449158973|FG001|Intensification Addendum|Adverse Event|0|||
124873746|NCT00279201|449158974|FG002|Intensification Addendum|Adverse Event|0|||
124873747|NCT00279201|449158975|FG003|Intensification Addendum|Adverse Event|4|||
124873748|NCT00279201|449158976|FG004|Intensification Addendum|Adverse Event|1|||
124873749|NCT00279201|449158977|FG005|Intensification Addendum|Adverse Event|3|||
124873750|NCT00279201|449158972|FG000|Intensification Addendum|Physician Decision|0|||
124873751|NCT00279201|449158973|FG001|Intensification Addendum|Physician Decision|0|||
124873752|NCT00279201|449158974|FG002|Intensification Addendum|Physician Decision|4|||
124873753|NCT00279201|449158975|FG003|Intensification Addendum|Physician Decision|1|||
124873754|NCT00279201|449158976|FG004|Intensification Addendum|Physician Decision|3|||
124873755|NCT00279201|449158977|FG005|Intensification Addendum|Physician Decision|2|||
124873756|NCT00279201|449158972|FG000|Intensification Addendum|Sponsor Decision|0|||
124873757|NCT00279201|449158973|FG001|Intensification Addendum|Sponsor Decision|0|||
124873758|NCT00279201|449158974|FG002|Intensification Addendum|Sponsor Decision|0|||
124873759|NCT00279201|449158975|FG003|Intensification Addendum|Sponsor Decision|0|||
124873760|NCT00279201|449158976|FG004|Intensification Addendum|Sponsor Decision|1|||
124873761|NCT00279201|449158977|FG005|Intensification Addendum|Sponsor Decision|1|||
124873762|NCT00279201|449158972|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
124873763|NCT00279201|449158973|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
124873764|NCT00279201|449158974|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
124873765|NCT00279201|449158975|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
124873766|NCT00279201|449158976|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
124873767|NCT00279201|449158977|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
124873768|NCT00279201|449158972|FG000|Intensification Addendum|Lack of Efficacy|0|||
124873769|NCT00279201|449158973|FG001|Intensification Addendum|Lack of Efficacy|0|||
124873770|NCT00279201|449158974|FG002|Intensification Addendum|Lack of Efficacy|0|||
124873771|NCT00279201|449158975|FG003|Intensification Addendum|Lack of Efficacy|1|||
124873772|NCT00279201|449158976|FG004|Intensification Addendum|Lack of Efficacy|1|||
124873773|NCT00279201|449158977|FG005|Intensification Addendum|Lack of Efficacy|0|||
124873774|NCT00279201|449158972|FG000|Intensification Addendum|Death|0|||
124873775|NCT00279201|449158973|FG001|Intensification Addendum|Death|0|||
124873776|NCT00279201|449158974|FG002|Intensification Addendum|Death|0|||
124873777|NCT00279201|449158975|FG003|Intensification Addendum|Death|0|||
124873778|NCT00279201|449158976|FG004|Intensification Addendum|Death|1|||
124873779|NCT00279201|449158977|FG005|Intensification Addendum|Death|0|||
124873780|NCT00316173|449158978|FG000|Run-in Phase|Adverse Event|1|||
124873781|NCT00316173|449158979|FG001|Run-in Phase|Adverse Event|0|||
124873782|NCT00316173|449158978|FG000|Run-in Phase|Protocol Violation|1|||
124873783|NCT00316173|449158979|FG001|Run-in Phase|Protocol Violation|0|||
124873784|NCT00316173|449158978|FG000|Run-in Phase|Study Follow-up Stopped|5|||
124873785|NCT00316173|449158979|FG001|Run-in Phase|Study Follow-up Stopped|0|||
124873786|NCT00316173|449158978|FG000|Treatment Phase|Adverse Event|0|||
124873787|NCT00316173|449158979|FG001|Treatment Phase|Adverse Event|1|||
124873788|NCT00316173|449158978|FG000|Treatment Phase|Lack of Efficacy|0|||
124873789|NCT00316173|449158979|FG001|Treatment Phase|Lack of Efficacy|3|||
124873790|NCT00316173|449158978|FG000|Treatment Phase|Lost to Follow-up|0|||
124873791|NCT00316173|449158979|FG001|Treatment Phase|Lost to Follow-up|3|||
124873792|NCT00316173|449158978|FG000|Treatment Phase|Withdrawal by Subject|0|||
124873793|NCT00316173|449158979|FG001|Treatment Phase|Withdrawal by Subject|1|||
124873794|NCT00316173|449158978|FG000|Treatment Phase|Study Follow-up Stopped|0|||
124873795|NCT00316173|449158979|FG001|Treatment Phase|Study Follow-up Stopped|34|||
124873796|NCT02390531|449158980|FG000|Overall Study|Death|0|||
124873797|NCT02390531|449158981|FG001|Overall Study|Death|2|||
124873798|NCT02390531|449158982|FG002|Overall Study|Death|0|||
124873799|NCT02390531|449158983|FG003|Overall Study|Death|1|||
124873800|NCT02390531|449158984|FG004|Overall Study|Death|0|||
124873801|NCT02390531|449158985|FG005|Overall Study|Death|0|||
124873802|NCT02390531|449158986|FG006|Overall Study|Death|0|||
124873803|NCT02390531|449158987|FG007|Overall Study|Death|1|||
124873804|NCT02390531|449158980|FG000|Overall Study|Protocol Violation|0|||
124873805|NCT02390531|449158981|FG001|Overall Study|Protocol Violation|0|||
124873806|NCT02390531|449158982|FG002|Overall Study|Protocol Violation|0|||
124873807|NCT02390531|449158983|FG003|Overall Study|Protocol Violation|0|||
124873808|NCT02390531|449158984|FG004|Overall Study|Protocol Violation|1|||
124873809|NCT02390531|449158985|FG005|Overall Study|Protocol Violation|0|||
124873810|NCT02390531|449158986|FG006|Overall Study|Protocol Violation|2|||
124873811|NCT02390531|449158987|FG007|Overall Study|Protocol Violation|0|||
124873812|NCT00511875|449158988|FG000|Overall Study|Lost to Follow-up|4|||
124678297|NCT00784875|448448067|FG002|Period A - Baseline|Withdrawal by Subject|0|||
124678298|NCT00784875|448448068|FG003|Period A - Baseline|Withdrawal by Subject|27|||
124678299|NCT00784875|448448065|FG000|Period A - Baseline|Physician Decision|0|||
124678300|NCT00784875|448448066|FG001|Period A - Baseline|Physician Decision|0|||
124432856|NCT04860297|447543850|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
124432857|NCT04860297|447543851|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
124432858|NCT04860297|447543852|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
124432859|NCT04860297|447543853|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
124432860|NCT04860297|447543854|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
124432861|NCT04860297|447543855|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
124432862|NCT04860297|447543856|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
124432863|NCT04860297|447543857|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
124432864|NCT04860297|447543850|FG000|Part B (Booster Dose)|Death|0|||
124432865|NCT04860297|447543851|FG001|Part B (Booster Dose)|Death|0|||
124432866|NCT04860297|447543852|FG002|Part B (Booster Dose)|Death|0|||
124432867|NCT04860297|447543853|FG003|Part B (Booster Dose)|Death|0|||
124432868|NCT04860297|447543854|FG004|Part B (Booster Dose)|Death|1|||
124432869|NCT04860297|447543855|FG005|Part B (Booster Dose)|Death|2|||
124432870|NCT04860297|447543856|FG006|Part B (Booster Dose)|Death|1|||
124432871|NCT04860297|447543857|FG007|Part B (Booster Dose)|Death|0|||
124432872|NCT04860297|447543850|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
124432873|NCT04860297|447543851|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
124432874|NCT04860297|447543852|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
124432875|NCT04860297|447543853|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
124432876|NCT04860297|447543854|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
124432877|NCT04860297|447543855|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
124432878|NCT04860297|447543856|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
124432879|NCT04860297|447543857|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
124432880|NCT00468559|447543864|FG000|Open-label Treatment Phase|Adverse Event|5|||
124432881|NCT00468559|447543865|FG001|Open-label Treatment Phase|Adverse Event|0|||
124432882|NCT00468559|447543866|FG002|Open-label Treatment Phase|Adverse Event|0|||
124432883|NCT00468559|447543864|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
124432884|NCT00468559|447543865|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
124432885|NCT00468559|447543866|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
124432886|NCT00468559|447543864|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
124432887|NCT00468559|447543865|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
124432888|NCT00468559|447543866|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
124432889|NCT00468559|447543864|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
124432890|NCT00468559|447543865|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
124432891|NCT00468559|447543866|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
124432892|NCT00468559|447543864|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
124432893|NCT00468559|447543865|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
124432894|NCT00468559|447543866|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
124432895|NCT04811131|447543867|FG000|Overall Study|Adverse Event|0|||
124432896|NCT04811131|447543868|FG001|Overall Study|Adverse Event|0|||
124432897|NCT04811131|447543869|FG002|Overall Study|Adverse Event|1|||
124432898|NCT04811131|447543870|FG003|Overall Study|Adverse Event|0|||
124432899|NCT04811131|447543867|FG000|Overall Study|Lack of Efficacy|0|||
124678301|NCT00784875|448448067|FG002|Period A - Baseline|Physician Decision|0|||
124678302|NCT00784875|448448068|FG003|Period A - Baseline|Physician Decision|2|||
124678303|NCT00784875|448448065|FG000|Period A - Baseline|Sponsor Decision|0|||
124432900|NCT04811131|447543868|FG001|Overall Study|Lack of Efficacy|0|||
124432901|NCT04811131|447543869|FG002|Overall Study|Lack of Efficacy|0|||
124432902|NCT04811131|447543870|FG003|Overall Study|Lack of Efficacy|1|||
124678304|NCT00784875|448448066|FG001|Period A - Baseline|Sponsor Decision|0|||
124873813|NCT00511875|449158989|FG001|Overall Study|Lost to Follow-up|0|||
124873814|NCT00511875|449158988|FG000|Overall Study|Missing variables|1|||
124873815|NCT00511875|449158989|FG001|Overall Study|Missing variables|0|||
124873816|NCT02618616|449158990|FG000|Overall Study|Lack of Efficacy|4|||
124873817|NCT02618616|449158991|FG001|Overall Study|Lack of Efficacy|0|||
124873818|NCT02618616|449158990|FG000|Overall Study|Pregnancy|0|||
124873819|NCT02618616|449158991|FG001|Overall Study|Pregnancy|1|||
124678305|NCT00784875|448448067|FG002|Period A - Baseline|Sponsor Decision|0|||
124678306|NCT00784875|448448068|FG003|Period A - Baseline|Sponsor Decision|113|||
124678307|NCT00784875|448448065|FG000|Period A - Baseline|Lost to Follow-up|0|||
124678308|NCT00784875|448448066|FG001|Period A - Baseline|Lost to Follow-up|0|||
124678309|NCT00784875|448448067|FG002|Period A - Baseline|Lost to Follow-up|0|||
124678310|NCT00784875|448448068|FG003|Period A - Baseline|Lost to Follow-up|2|||
124678311|NCT00784875|448448065|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
124678312|NCT00784875|448448066|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
124678313|NCT00784875|448448067|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
124678314|NCT00784875|448448068|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
124678315|NCT00784875|448448065|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
124678316|NCT00784875|448448066|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
124678317|NCT00784875|448448067|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
124678318|NCT00784875|448448068|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
124678319|NCT00784875|448448065|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
124678320|NCT00784875|448448066|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
124678321|NCT00784875|448448067|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
124678322|NCT00784875|448448068|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
124678323|NCT00784875|448448065|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
124678324|NCT00784875|448448066|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
124678325|NCT00784875|448448067|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
124678326|NCT00784875|448448068|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
124678327|NCT00784875|448448065|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
124678328|NCT00784875|448448066|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
124678329|NCT00784875|448448067|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
124678330|NCT00784875|448448068|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
124678331|NCT00784875|448448065|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
124678332|NCT00784875|448448066|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
124678333|NCT00784875|448448067|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
124678334|NCT00784875|448448068|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
124678335|NCT00784875|448448065|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
124678336|NCT00784875|448448066|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
124678337|NCT00784875|448448067|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
124678338|NCT00784875|448448068|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
124873820|NCT02618616|449158990|FG000|Overall Study|Adverse Event|8|||
124873821|NCT02618616|449158991|FG001|Overall Study|Adverse Event|0|||
124873822|NCT02618616|449158990|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
124873823|NCT02618616|449158991|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
124432903|NCT04811131|447543867|FG000|Overall Study|Lost to Follow-up|0|||
124678339|NCT00784875|448448065|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
124678340|NCT00784875|448448066|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
124678341|NCT00784875|448448067|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
124873824|NCT02618616|449158990|FG000|Overall Study|Consent withdrawn by subject|8|||
124873825|NCT02618616|449158991|FG001|Overall Study|Consent withdrawn by subject|5|||
124873826|NCT02618616|449158990|FG000|Overall Study|Lost to Follow-up|0|||
124873827|NCT02618616|449158991|FG001|Overall Study|Lost to Follow-up|1|||
124873828|NCT04225988|449158992|FG000|Overall Study|Withdrawal by Subject|2|||
124873829|NCT04225988|449158993|FG001|Overall Study|Withdrawal by Subject|0|||
124873830|NCT00766675|449160102|FG000|Overall Study|Adverse Event|16|||
124873831|NCT00766675|449160102|FG000|Overall Study|Lost to Follow-up|2|||
124873832|NCT00766675|449160102|FG000|Overall Study|Withdrawal by Subject|11|||
124873833|NCT00766675|449160102|FG000|Overall Study|Protocol Violation|8|||
124873834|NCT00766675|449160102|FG000|Overall Study|Participant took prohibited medication|1|||
124873835|NCT00766675|449160102|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
124873836|NCT00766675|449160102|FG000|Overall Study|Insufficient therapy|1|||
124432904|NCT04811131|447543868|FG001|Overall Study|Lost to Follow-up|1|||
124432905|NCT04811131|447543869|FG002|Overall Study|Lost to Follow-up|0|||
124432906|NCT04811131|447543870|FG003|Overall Study|Lost to Follow-up|0|||
124432907|NCT04811131|447543867|FG000|Overall Study|Sponsor request|31|||
124432908|NCT04811131|447543868|FG001|Overall Study|Sponsor request|35|||
124432909|NCT04811131|447543869|FG002|Overall Study|Sponsor request|27|||
124432910|NCT04811131|447543870|FG003|Overall Study|Sponsor request|10|||
124432911|NCT04811131|447543867|FG000|Overall Study|Withdrawal by Subject|3|||
124432912|NCT04811131|447543868|FG001|Overall Study|Withdrawal by Subject|1|||
124432913|NCT04811131|447543869|FG002|Overall Study|Withdrawal by Subject|3|||
124432914|NCT04811131|447543870|FG003|Overall Study|Withdrawal by Subject|1|||
124432915|NCT01528345|447543872|FG000|Overall Study|Adverse Event|10|||
124432916|NCT01528345|447543873|FG001|Overall Study|Adverse Event|1|||
124432917|NCT01528345|447543872|FG000|Overall Study|Death|1|||
124432918|NCT01528345|447543873|FG001|Overall Study|Death|1|||
124432919|NCT01528345|447543872|FG000|Overall Study|Non-compliance with study treatment|1|||
124432920|NCT01528345|447543873|FG001|Overall Study|Non-compliance with study treatment|0|||
124432921|NCT01528345|447543872|FG000|Overall Study|Progressive Disease|26|||
124432922|NCT01528345|447543873|FG001|Overall Study|Progressive Disease|40|||
124432923|NCT01528345|447543872|FG000|Overall Study|Study Terminated by Sponsor|4|||
124432924|NCT01528345|447543873|FG001|Overall Study|Study Terminated by Sponsor|8|||
124432925|NCT01528345|447543872|FG000|Overall Study|Subject/Guardian Decision|5|||
124432926|NCT01528345|447543873|FG001|Overall Study|Subject/Guardian Decision|0|||
124432927|NCT01131182|447543875|FG000|Overall Study|Withdrawal by Subject|1|||
124432928|NCT01131182|447543876|FG001|Overall Study|Withdrawal by Subject|1|||
124432929|NCT01131182|447543875|FG000|Overall Study|Lost to Follow-up|14|||
124432930|NCT01131182|447543876|FG001|Overall Study|Lost to Follow-up|15|||
124432931|NCT01131182|447543875|FG000|Overall Study|Other Reason|1|||
124432932|NCT01131182|447543876|FG001|Overall Study|Other Reason|0|||
124432933|NCT01146782|447543877|FG000|Screening Cohort|Screen Failure|187|||
124432934|NCT01146782|447543877|FG000|Screening Cohort|Lost to Follow-up|4|||
124432935|NCT01146782|447543877|FG000|Screening Cohort|Physician Decision|1|||
124432936|NCT01146782|447543877|FG000|Screening Cohort|Withdrawal by Subject|29|||
124432937|NCT01146782|447543877|FG000|Safety Cohort|Screen Failure|61|||
124432938|NCT01146782|447543877|FG000|Safety Cohort|Withdrawal by Subject|4|||
124432939|NCT01146782|447543877|FG000|Safety Cohort|Control AHI <5|4|||
124432940|NCT01146782|447543877|FG000|Safety Cohort|TST <4 hrs|14|||
124432941|NCT01146782|447543877|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
124432942|NCT01146782|447543877|FG000|Primary Endpoint Cohort|Physician Decision|1|||
124432943|NCT02270515|447543878|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
124432944|NCT02270515|447543878|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
124432945|NCT02270515|447543878|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
124432946|NCT02270515|447543878|FG000|Intervention Period 1: 0-6 Months|Death|7|||
124432947|NCT02270515|447543878|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
124432948|NCT02270515|447543878|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
124432949|NCT02270515|447543878|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
124432950|NCT02270515|447543878|FG000|Intervention Period 2: 6-12 Months|Death|5|||
124432951|NCT02270515|447543878|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
124432952|NCT02270515|447543878|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
124432953|NCT02270515|447543878|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
124432954|NCT02270515|447543878|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
124432955|NCT02270515|447543878|FG000|Intervention Period 3: 12-18 Months|Death|3|||
124432956|NCT02270515|447543878|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
124432957|NCT01892540|447543880|FG000|Overall Study|Did not complete PET/MRI|0|||
124432958|NCT01892540|447543881|FG001|Overall Study|Did not complete PET/MRI|0|||
124678342|NCT00784875|448448068|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
124678343|NCT00784875|448448065|FG000|Period C|Adverse Event|1|||
124873837|NCT02240108|449160103|FG000|Overall Study|Other than specified|8|||
124873838|NCT02240108|449160104|FG001|Overall Study|Other than specified|6|||
124873839|NCT02240108|449160103|FG000|Overall Study|Adverse Event|1|||
124873840|NCT02240108|449160104|FG001|Overall Study|Adverse Event|9|||
124873841|NCT02240108|449160103|FG000|Overall Study|Pregnancy|1|||
124432959|NCT01892540|447543882|FG002|Overall Study|Did not complete PET/MRI|2|||
124873842|NCT02240108|449160104|FG001|Overall Study|Pregnancy|0|||
124873843|NCT02240108|449160103|FG000|Overall Study|Withdrawal by Subject|4|||
124873844|NCT02240108|449160104|FG001|Overall Study|Withdrawal by Subject|9|||
124873845|NCT02240108|449160103|FG000|Overall Study|StudyTerminated by Sponsor|0|||
124873846|NCT02240108|449160104|FG001|Overall Study|StudyTerminated by Sponsor|1|||
124873847|NCT03938454|449160105|FG000|Overall Study|Protocol Violation|1|||
124873848|NCT03938454|449160105|FG000|Overall Study|Withdrawal by Subject|2|||
124873849|NCT03938454|449160105|FG000|Overall Study|Lost to Follow-up|3|||
124873850|NCT01142388|449160106|FG000|Overall Study|Lack of Efficacy|21|||
124873851|NCT01142388|449160107|FG001|Overall Study|Lack of Efficacy|31|||
124873852|NCT01142388|449160106|FG000|Overall Study|Adverse Event|9|||
124873853|NCT01142388|449160107|FG001|Overall Study|Adverse Event|5|||
124873854|NCT01142388|449160106|FG000|Overall Study|Death|3|||
124873855|NCT01142388|449160107|FG001|Overall Study|Death|2|||
124873856|NCT01142388|449160106|FG000|Overall Study|Withdrawal by Subject|5|||
124873857|NCT01142388|449160107|FG001|Overall Study|Withdrawal by Subject|3|||
124873858|NCT01142388|449160106|FG000|Overall Study|Alternative therapy|1|||
124873859|NCT01142388|449160107|FG001|Overall Study|Alternative therapy|0|||
124873860|NCT01142388|449160106|FG000|Overall Study|Other complications|0|||
124873861|NCT01142388|449160107|FG001|Overall Study|Other complications|2|||
124873862|NCT01142388|449160106|FG000|Overall Study|Other|1|||
124873863|NCT01142388|449160107|FG001|Overall Study|Other|1|||
124873864|NCT01142388|449160106|FG000|Overall Study|Never started therapy|7|||
124873865|NCT01142388|449160107|FG001|Overall Study|Never started therapy|3|||
124873866|NCT04244396|449160112|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
124873867|NCT04244396|449160112|FG000|Overall Study|Withdrawal by Subject|2|||
124873868|NCT04244396|449160112|FG000|Overall Study|Study termination|37|||
124873869|NCT00335452|449160115|FG000|Overall Study|Death|156|||
124873870|NCT00335452|449160116|FG001|Overall Study|Death|144|||
124873871|NCT00335452|449160117|FG002|Overall Study|Death|158|||
124873872|NCT00335452|449160118|FG003|Overall Study|Death|129|||
124873873|NCT00335452|449160115|FG000|Overall Study|Lost to Follow-up|2|||
124873874|NCT00335452|449160116|FG001|Overall Study|Lost to Follow-up|3|||
124432960|NCT01892540|447543880|FG000|Overall Study|Did not fit in scanner|0|||
124432961|NCT01892540|447543881|FG001|Overall Study|Did not fit in scanner|0|||
124432962|NCT01892540|447543882|FG002|Overall Study|Did not fit in scanner|1|||
124873875|NCT00335452|449160117|FG002|Overall Study|Lost to Follow-up|1|||
124873876|NCT00335452|449160118|FG003|Overall Study|Lost to Follow-up|2|||
124873877|NCT01750879|449160132|FG000|Overall Study|Adverse Event|8|||
124873878|NCT01750879|449160133|FG001|Overall Study|Adverse Event|0|||
124873879|NCT01750879|449160132|FG000|Overall Study|Lack of Efficacy|1|||
124873880|NCT01750879|449160133|FG001|Overall Study|Lack of Efficacy|0|||
124873881|NCT01750879|449160132|FG000|Overall Study|Withdrawal by Subject|1|||
124873882|NCT01750879|449160133|FG001|Overall Study|Withdrawal by Subject|0|||
124873883|NCT01750879|449160132|FG000|Overall Study|Did not complete per protocol|0|||
124873884|NCT01750879|449160133|FG001|Overall Study|Did not complete per protocol|3|||
124873885|NCT02421666|449160134|FG000|6-month Follow-up|Lost to Follow-up|8|||
124873886|NCT02421666|449160135|FG001|6-month Follow-up|Lost to Follow-up|7|||
124873887|NCT02421666|449160134|FG000|6-month Follow-up|Withdrawal by Subject|5|||
124873888|NCT02421666|449160135|FG001|6-month Follow-up|Withdrawal by Subject|6|||
124873889|NCT02421666|449160134|FG000|12-month Follow-up|Lost to Follow-up|5|||
124873890|NCT02421666|449160135|FG001|12-month Follow-up|Lost to Follow-up|5|||
124873891|NCT02421666|449160134|FG000|12-month Follow-up|Withdrawal by Subject|6|||
124873892|NCT02421666|449160135|FG001|12-month Follow-up|Withdrawal by Subject|11|||
124873893|NCT02093663|449160140|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
124873894|NCT02093663|449160141|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
124873895|NCT02093663|449160142|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
124873896|NCT02093663|449160143|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
124873897|NCT02093663|449160144|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
124873898|NCT02093663|449160140|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
124873899|NCT02093663|449160141|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
124873900|NCT02093663|449160142|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
124873901|NCT02093663|449160143|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
124873902|NCT02093663|449160144|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
124873903|NCT02093663|449160140|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
124873904|NCT02093663|449160141|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
124873905|NCT02093663|449160142|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
124873906|NCT02093663|449160143|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
124873907|NCT02093663|449160144|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
124873908|NCT02093663|449160140|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
124873909|NCT02093663|449160141|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
124873910|NCT02093663|449160142|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
124873911|NCT02093663|449160143|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
124873912|NCT02093663|449160144|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
124873913|NCT02093663|449160140|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
124873914|NCT02093663|449160141|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
124873915|NCT02093663|449160142|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
124873916|NCT02093663|449160143|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
124873917|NCT02093663|449160144|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
124873918|NCT02093663|449160140|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
124873919|NCT02093663|449160141|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
124873920|NCT02093663|449160142|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
124873921|NCT02093663|449160143|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
124873922|NCT02093663|449160144|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
124873923|NCT02093663|449160140|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
124873924|NCT02093663|449160141|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
124873925|NCT02093663|449160142|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
124873926|NCT02093663|449160143|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
124873927|NCT02093663|449160144|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
124873928|NCT02093663|449160140|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
124873929|NCT02093663|449160141|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
124873930|NCT02093663|449160142|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
124873931|NCT02093663|449160143|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
124873932|NCT02093663|449160144|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
124873933|NCT02093663|449160140|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
124873934|NCT02093663|449160141|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
124873935|NCT02093663|449160142|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
124873936|NCT02093663|449160143|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
124873937|NCT02093663|449160144|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
124873938|NCT02277990|449160169|FG000|Overall Study|Death|170|||
124873939|NCT02277990|449160170|FG001|Overall Study|Death|188|||
124873940|NCT02277990|449160169|FG000|Overall Study|Withdrawal by Subject|64|||
124873941|NCT02277990|449160170|FG001|Overall Study|Withdrawal by Subject|53|||
124873942|NCT02277990|449160169|FG000|Overall Study|Physician Decision|40|||
124873943|NCT02277990|449160170|FG001|Overall Study|Physician Decision|34|||
124873944|NCT02277990|449160169|FG000|Overall Study|Lost to Follow-up|66|||
124873945|NCT02277990|449160170|FG001|Overall Study|Lost to Follow-up|69|||
124873946|NCT02277990|449160169|FG000|Overall Study|Had other reason|26|||
124873947|NCT02277990|449160170|FG001|Overall Study|Had other reason|32|||
124873948|NCT04711603|449160171|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
124873949|NCT04711603|449160172|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
124873950|NCT04711603|449160173|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
124873951|NCT04711603|449160174|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
124873952|NCT04711603|449160171|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
124873953|NCT04711603|449160172|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
124873954|NCT04711603|449160173|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
124873955|NCT04711603|449160174|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
124873956|NCT04711603|449160171|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
124873957|NCT04711603|449160172|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
124873958|NCT04711603|449160173|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
124873959|NCT04711603|449160174|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
124873960|NCT04711603|449160171|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
124873961|NCT04711603|449160172|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
124873962|NCT04711603|449160173|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
124873963|NCT04711603|449160174|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
124873964|NCT04711603|449160171|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
124873965|NCT04711603|449160172|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
124873966|NCT04711603|449160173|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
124873967|NCT04711603|449160174|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
124873968|NCT04711603|449160171|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
124873969|NCT04711603|449160172|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
124873970|NCT04711603|449160173|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
124873971|NCT04711603|449160174|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
124873972|NCT04711603|449160171|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
124873973|NCT04711603|449160172|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
124873974|NCT04711603|449160173|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
124873975|NCT04711603|449160174|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
124873976|NCT04711603|449160171|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
124873977|NCT04711603|449160172|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
124873978|NCT04711603|449160173|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
124873979|NCT04711603|449160174|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
124873980|NCT04711603|449160171|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
124873981|NCT04711603|449160172|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
124873982|NCT04711603|449160173|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
124873983|NCT04711603|449160174|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
124873984|NCT04711603|449160171|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
124873985|NCT04711603|449160172|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
124969471|NCT00334542|449517400|FG000|Overall Study|New cancer diagnosis|1|||
124969472|NCT00013611|449517401|FG000|Overall Study|Lost to Follow-up|91|||
124969473|NCT00013611|449517402|FG001|Overall Study|Lost to Follow-up|100|||
124969474|NCT02094898|449517408|FG000|Overall Study|Clinical Worsening|2|||
124969475|NCT02094898|449517408|FG000|Overall Study|Adverse Event|2|||
124969476|NCT02094898|449517408|FG000|Overall Study|Lack of Efficacy|1|||
124969477|NCT03520075|449517409|FG000|Phase 1 (Dose Escalation)|Death|2|||
124969478|NCT03520075|449517410|FG001|Phase 1 (Dose Escalation)|Death|2|||
124969479|NCT03520075|449517411|FG002|Phase 1 (Dose Escalation)|Death|3|||
124969480|NCT03520075|449517412|FG003|Phase 1 (Dose Escalation)|Death|2|||
124969481|NCT03520075|449517413|FG004|Phase 1 (Dose Escalation)|Death|6|||
124969482|NCT03520075|449517414|FG005|Phase 1 (Dose Escalation)|Death|5|||
124969483|NCT03520075|449517415|FG006|Phase 1 (Dose Escalation)|Death|3|||
124969484|NCT03520075|449517416|FG007|Phase 1 (Dose Escalation)|Death|2|||
124969485|NCT03520075|449517417|FG008|Phase 1 (Dose Escalation)|Death|3|||
124969486|NCT03520075|449517418|FG009|Phase 1 (Dose Escalation)|Death|1|||
124969487|NCT03520075|449517419|FG010|Phase 1 (Dose Escalation)|Death|5|||
124969488|NCT03520075|449517420|FG011|Phase 1 (Dose Escalation)|Death|7|||
124969489|NCT03520075|449517421|FG012|Phase 1 (Dose Escalation)|Death|11|||
124969490|NCT03520075|449517422|FG013|Phase 1 (Dose Escalation)|Death|0|||
124969491|NCT03520075|449517423|FG014|Phase 1 (Dose Escalation)|Death|0|||
124969492|NCT03520075|449517424|FG015|Phase 1 (Dose Escalation)|Death|0|||
124969493|NCT03520075|449517425|FG016|Phase 1 (Dose Escalation)|Death|0|||
124969494|NCT03520075|449517426|FG017|Phase 1 (Dose Escalation)|Death|0|||
124969495|NCT03520075|449517427|FG018|Phase 1 (Dose Escalation)|Death|0|||
124969496|NCT03520075|449517409|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
124873986|NCT04711603|449160173|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
124873987|NCT04711603|449160174|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
124873988|NCT04711603|449160171|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
124873989|NCT04711603|449160172|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
124873990|NCT04711603|449160173|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
124873991|NCT04711603|449160174|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
124873992|NCT04711603|449160171|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
124873993|NCT04711603|449160172|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
124873994|NCT04711603|449160173|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
124873995|NCT04711603|449160174|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
124873996|NCT04252742|449160178|FG000|Overall Study|Decision by sponsor|0|||
124873997|NCT04252742|449160179|FG001|Overall Study|Decision by sponsor|2|||
124873998|NCT04252742|449160178|FG000|Overall Study|Withdrawal by Subject|15|||
124873999|NCT04252742|449160179|FG001|Overall Study|Withdrawal by Subject|9|||
124874000|NCT04252742|449160178|FG000|Overall Study|Lost to Follow-up|0|||
124874001|NCT04252742|449160179|FG001|Overall Study|Lost to Follow-up|1|||
124874002|NCT04270747|449160181|FG000|Through Week 16|Adverse Event|1|||
124874003|NCT04270747|449160182|FG001|Through Week 16|Adverse Event|2|||
124874004|NCT04270747|449160183|FG002|Through Week 16|Adverse Event|0|||
124874005|NCT04270747|449160181|FG000|Through Week 16|Death|0|||
124874006|NCT04270747|449160182|FG001|Through Week 16|Death|2|||
124874007|NCT04270747|449160183|FG002|Through Week 16|Death|0|||
124874008|NCT04270747|449160181|FG000|Through Week 16|Consent Withdrawn|3|||
124874009|NCT04270747|449160182|FG001|Through Week 16|Consent Withdrawn|3|||
124874010|NCT04270747|449160183|FG002|Through Week 16|Consent Withdrawn|0|||
124874011|NCT04270747|449160181|FG000|Through Week 16|Physician Decision|1|||
124874012|NCT04270747|449160182|FG001|Through Week 16|Physician Decision|1|||
124874013|NCT04270747|449160183|FG002|Through Week 16|Physician Decision|0|||
124874014|NCT04270747|449160181|FG000|Through Week 16|Lost to Follow-up|2|||
124874015|NCT04270747|449160182|FG001|Through Week 16|Lost to Follow-up|0|||
124874016|NCT04270747|449160183|FG002|Through Week 16|Lost to Follow-up|0|||
124874017|NCT04270747|449160181|FG000|Through Week 16|Protocol Violation|1|||
124432963|NCT00604825|447543883|FG000|Overall Study|Adverse Event|2|||
124874018|NCT04270747|449160182|FG001|Through Week 16|Protocol Violation|2|||
124874019|NCT04270747|449160183|FG002|Through Week 16|Protocol Violation|0|||
124874020|NCT04270747|449160181|FG000|Through Week 16|Protocol Specified Criteria|6|||
124874021|NCT04270747|449160182|FG001|Through Week 16|Protocol Specified Criteria|7|||
124874022|NCT04270747|449160183|FG002|Through Week 16|Protocol Specified Criteria|0|||
124874023|NCT04270747|449160181|FG000|Through Week 16|Miscellaneous|1|||
124874024|NCT04270747|449160182|FG001|Through Week 16|Miscellaneous|1|||
124874025|NCT04270747|449160183|FG002|Through Week 16|Miscellaneous|0|||
124874026|NCT04270747|449160181|FG000|Post Week 16|Adverse Event|7|||
124874027|NCT04270747|449160182|FG001|Post Week 16|Adverse Event|5|||
124874028|NCT04270747|449160183|FG002|Post Week 16|Adverse Event|1|||
124874029|NCT04270747|449160181|FG000|Post Week 16|Death|2|||
124874030|NCT04270747|449160182|FG001|Post Week 16|Death|0|||
124874031|NCT04270747|449160183|FG002|Post Week 16|Death|2|||
124874032|NCT04270747|449160181|FG000|Post Week 16|Consent Withdrawn|4|||
124874033|NCT04270747|449160182|FG001|Post Week 16|Consent Withdrawn|3|||
124874034|NCT04270747|449160183|FG002|Post Week 16|Consent Withdrawn|6|||
124874035|NCT04270747|449160181|FG000|Post Week 16|Physician Decision|3|||
124874036|NCT04270747|449160182|FG001|Post Week 16|Physician Decision|1|||
124874037|NCT04270747|449160183|FG002|Post Week 16|Physician Decision|1|||
124874038|NCT04270747|449160181|FG000|Post Week 16|Lost to Follow-up|2|||
124874039|NCT04270747|449160182|FG001|Post Week 16|Lost to Follow-up|1|||
124874040|NCT04270747|449160183|FG002|Post Week 16|Lost to Follow-up|0|||
124874041|NCT04270747|449160181|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
124874042|NCT04270747|449160182|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
124874043|NCT04270747|449160183|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
124874044|NCT04270747|449160181|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
124874045|NCT04270747|449160182|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
124874046|NCT04270747|449160183|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
124874047|NCT04270747|449160181|FG000|Post Week 16|Miscellaneous|1|||
124874048|NCT04270747|449160182|FG001|Post Week 16|Miscellaneous|0|||
124874049|NCT04270747|449160183|FG002|Post Week 16|Miscellaneous|1|||
124874050|NCT01784068|449160186|FG000|NTCS Phase|Adverse Event|5|||
124874051|NCT01784068|449160187|FG001|NTCS Phase|Adverse Event|0|||
124874052|NCT01784068|449160186|FG000|NTCS Phase|Physician Decision|2|||
124874053|NCT01784068|449160187|FG001|NTCS Phase|Physician Decision|0|||
124874054|NCT01784068|449160186|FG000|NTCS Phase|Patient/guardian decision|3|||
124874055|NCT01784068|449160187|FG001|NTCS Phase|Patient/guardian decision|0|||
124874056|NCT01784068|449160186|FG000|NTCS Phase|Death|2|||
124874057|NCT01784068|449160187|FG001|NTCS Phase|Death|0|||
124874058|NCT01784068|449160186|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
124874059|NCT01784068|449160187|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
124874060|NCT01784068|449160186|FG000|TFR Phase|Physician Decision|0|||
124874061|NCT01784068|449160187|FG001|TFR Phase|Physician Decision|1|||
124874062|NCT01784068|449160186|FG000|TFR Phase|Patient/guardian decision|0|||
124874063|NCT01784068|449160187|FG001|TFR Phase|Patient/guardian decision|3|||
124874064|NCT01784068|449160186|FG000|TFR Phase|Death|0|||
124874065|NCT01784068|449160187|FG001|TFR Phase|Death|1|||
124874066|NCT01784068|449160186|FG000|TFR Phase|Lack of Efficacy|0|||
124874067|NCT01784068|449160187|FG001|TFR Phase|Lack of Efficacy|88|||
124874068|NCT05614089|449160188|FG000|Overall Study|Pregnancy|5|||
124874069|NCT05614089|449160189|FG001|Overall Study|Pregnancy|2|||
124874070|NCT05614089|449160188|FG000|Overall Study|Lost to Follow-up|5|||
124874071|NCT05614089|449160189|FG001|Overall Study|Lost to Follow-up|1|||
124874072|NCT05614089|449160188|FG000|Overall Study|Death|0|||
124874073|NCT05614089|449160189|FG001|Overall Study|Death|1|||
124874074|NCT05614089|449160188|FG000|Overall Study|Adverse Event|1|||
124874075|NCT05614089|449160189|FG001|Overall Study|Adverse Event|0|||
124874076|NCT05701995|449160195|FG000|Pre-Treatment|Randomization Error|1|||
124874077|NCT05701995|449160196|FG001|Pre-Treatment|Randomization Error|1|||
124874078|NCT05701995|449160195|FG000|Treatment|Withdrawal by Subject|8|||
124874079|NCT05701995|449160196|FG001|Treatment|Withdrawal by Subject|4|||
124874080|NCT05701995|449160195|FG000|Treatment|Lost to Follow-up|2|||
124874081|NCT05701995|449160196|FG001|Treatment|Lost to Follow-up|3|||
124874082|NCT05701995|449160195|FG000|Treatment|Adverse Event|3|||
124874083|NCT05701995|449160196|FG001|Treatment|Adverse Event|1|||
124874084|NCT05701995|449160195|FG000|Treatment|Other Reason|1|||
124874085|NCT05701995|449160196|FG001|Treatment|Other Reason|1|||
124874086|NCT05701995|449160195|FG000|Treatment|Death|1|||
124874087|NCT05701995|449160196|FG001|Treatment|Death|0|||
124874088|NCT05701995|449160195|FG000|Treatment|Physician Decision|0|||
124874089|NCT05701995|449160196|FG001|Treatment|Physician Decision|1|||
124874090|NCT04987762|449160200|FG000|Overall Study|Study was Terminated by Sponsor|103|||
124874091|NCT00504426|449160206|FG000|Overall Study|Adverse Event|0|||
124874092|NCT00504426|449160207|FG001|Overall Study|Adverse Event|0|||
124874093|NCT00504426|449160208|FG002|Overall Study|Adverse Event|2|||
124874094|NCT00504426|449160209|FG003|Overall Study|Adverse Event|0|||
124874095|NCT00504426|449160206|FG000|Overall Study|Protocol Violation|1|||
124874096|NCT00504426|449160207|FG001|Overall Study|Protocol Violation|1|||
124874097|NCT00504426|449160208|FG002|Overall Study|Protocol Violation|2|||
124874098|NCT00504426|449160209|FG003|Overall Study|Protocol Violation|0|||
124874099|NCT00504426|449160206|FG000|Overall Study|Withdrawal by Subject|2|||
124874100|NCT00504426|449160207|FG001|Overall Study|Withdrawal by Subject|0|||
124874101|NCT00504426|449160208|FG002|Overall Study|Withdrawal by Subject|0|||
124874102|NCT00504426|449160209|FG003|Overall Study|Withdrawal by Subject|0|||
124874103|NCT03988166|449160210|FG000|Overall Study|Lost to Follow-up|2|||
124874104|NCT03988166|449160210|FG000|Overall Study|Death|1|||
124874105|NCT03248375|449160211|FG000|Overall Study|Lost to Follow-up|5|||
124874106|NCT04992546|449160212|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
124874107|NCT04992546|449160212|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
124874108|NCT04992546|449160212|FG000|Open-Label Treatment Period|Adverse Event|3|||
124874109|NCT04992546|449160212|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
124874110|NCT00633464|449160214|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
124874111|NCT00633464|449160215|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
124874112|NCT00633464|449160214|FG000|Overall Study|Never Treated (Randomized in error)|0|||
124874113|NCT00633464|449160215|FG001|Overall Study|Never Treated (Randomized in error)|1|||
124874114|NCT04058353|449160216|FG000|Overall Study|Adverse Event|2|||
124874115|NCT04058353|449160217|FG001|Overall Study|Adverse Event|1|||
124874116|NCT04058353|449160216|FG000|Overall Study|Physician Decision|1|||
124874117|NCT04058353|449160217|FG001|Overall Study|Physician Decision|0|||
124874118|NCT04058353|449160216|FG000|Overall Study|Other|1|||
124874119|NCT04058353|449160217|FG001|Overall Study|Other|0|||
124874120|NCT00542880|449160219|FG000|Period 1|Eligibility criteria not fulfilled|2|||
124874121|NCT00542880|449160220|FG001|Period 1|Eligibility criteria not fulfilled|6|||
124874122|NCT00542880|449160219|FG000|Period 1|Adverse Event|2|||
124874123|NCT00542880|449160220|FG001|Period 1|Adverse Event|2|||
124874124|NCT00542880|449160219|FG000|Period 1|Development of study-specific criteria|1|||
124874125|NCT00542880|449160220|FG001|Period 1|Development of study-specific criteria|2|||
124874126|NCT00542880|449160219|FG000|Period 1|Withdrawal by Subject|1|||
124874127|NCT00542880|449160220|FG001|Period 1|Withdrawal by Subject|1|||
124874128|NCT00542880|449160219|FG000|Period 1|Protocol Violation|0|||
124874129|NCT00542880|449160220|FG001|Period 1|Protocol Violation|1|||
124432964|NCT00604825|447543884|FG001|Overall Study|Adverse Event|6|||
124874130|NCT00542880|449160219|FG000|Period 2|Adverse Event|5|||
124874131|NCT00542880|449160220|FG001|Period 2|Adverse Event|7|||
124874132|NCT00542880|449160219|FG000|Period 2|Eligibility not fulfilled|0|||
124874133|NCT00542880|449160220|FG001|Period 2|Eligibility not fulfilled|1|||
124432965|NCT00604825|447543885|FG002|Overall Study|Adverse Event|7|||
124432966|NCT00604825|447543886|FG003|Overall Study|Adverse Event|4|||
124432967|NCT00604825|447543883|FG000|Overall Study|Lost to Follow-up|0|||
124432968|NCT00604825|447543884|FG001|Overall Study|Lost to Follow-up|3|||
124432969|NCT00604825|447543885|FG002|Overall Study|Lost to Follow-up|1|||
124432970|NCT00604825|447543886|FG003|Overall Study|Lost to Follow-up|0|||
124432971|NCT00604825|447543883|FG000|Overall Study|Protocol Violation|0|||
124432972|NCT00604825|447543884|FG001|Overall Study|Protocol Violation|1|||
124432973|NCT00604825|447543885|FG002|Overall Study|Protocol Violation|0|||
124432974|NCT00604825|447543886|FG003|Overall Study|Protocol Violation|0|||
124678344|NCT00784875|448448066|FG001|Period C|Adverse Event|0|||
124678345|NCT00784875|448448067|FG002|Period C|Adverse Event|4|||
124678346|NCT00784875|448448068|FG003|Period C|Adverse Event|2|||
124678347|NCT00784875|448448065|FG000|Period C|Protocol Violation|0|||
124678348|NCT00784875|448448066|FG001|Period C|Protocol Violation|0|||
124678349|NCT00784875|448448067|FG002|Period C|Protocol Violation|1|||
124432975|NCT00604825|447543883|FG000|Overall Study|Withdrawal by Subject|4|||
124432976|NCT00604825|447543884|FG001|Overall Study|Withdrawal by Subject|3|||
124432977|NCT00604825|447543885|FG002|Overall Study|Withdrawal by Subject|5|||
124432978|NCT00604825|447543886|FG003|Overall Study|Withdrawal by Subject|5|||
124432979|NCT00604825|447543883|FG000|Overall Study|Lack of Efficacy|3|||
124432980|NCT00604825|447543884|FG001|Overall Study|Lack of Efficacy|2|||
124432981|NCT00604825|447543885|FG002|Overall Study|Lack of Efficacy|1|||
124432982|NCT00604825|447543886|FG003|Overall Study|Lack of Efficacy|0|||
124432983|NCT00604825|447543883|FG000|Overall Study|Did not meet eligibility criteria|0|||
124432984|NCT00604825|447543884|FG001|Overall Study|Did not meet eligibility criteria|0|||
124432985|NCT00604825|447543885|FG002|Overall Study|Did not meet eligibility criteria|2|||
124432986|NCT00604825|447543886|FG003|Overall Study|Did not meet eligibility criteria|0|||
124432987|NCT00604825|447543883|FG000|Overall Study|Physician Decision|0|||
124432988|NCT00604825|447543884|FG001|Overall Study|Physician Decision|0|||
124432989|NCT00604825|447543885|FG002|Overall Study|Physician Decision|0|||
124432990|NCT00604825|447543886|FG003|Overall Study|Physician Decision|1|||
124432991|NCT00604825|447543883|FG000|Overall Study|Exclusion criterion met|0|||
124432992|NCT00604825|447543884|FG001|Overall Study|Exclusion criterion met|0|||
124432993|NCT00604825|447543885|FG002|Overall Study|Exclusion criterion met|0|||
124432994|NCT00604825|447543886|FG003|Overall Study|Exclusion criterion met|1|||
124432995|NCT02317432|447543888|FG000|Overall Study|Death|4|||
124432996|NCT02317432|447543889|FG001|Overall Study|Death|1|||
124432997|NCT02317432|447543888|FG000|Overall Study|Lost to Follow-up|0|||
124432998|NCT02317432|447543889|FG001|Overall Study|Lost to Follow-up|5|||
124432999|NCT02317432|447543888|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
124433000|NCT02317432|447543889|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
124433001|NCT05559476|447543892|FG000|Overall Study|Adverse Event|2|||
124433002|NCT05559476|447543893|FG001|Overall Study|Adverse Event|0|||
124433003|NCT05559476|447543892|FG000|Overall Study|Lost to Follow-up|13|||
124433004|NCT05559476|447543893|FG001|Overall Study|Lost to Follow-up|12|||
124433005|NCT05559476|447543892|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
124433006|NCT05559476|447543893|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
124678350|NCT00784875|448448068|FG003|Period C|Protocol Violation|2|||
124678351|NCT00784875|448448065|FG000|Period C|Lack of Efficacy|0|||
124433007|NCT05559476|447543892|FG000|Overall Study|Other|0|||
124433008|NCT05559476|447543893|FG001|Overall Study|Other|2|||
124433009|NCT03992846|447543894|FG000|Overall Study|Adverse Event|8|||
124433010|NCT03992846|447543895|FG001|Overall Study|Adverse Event|6|||
124433011|NCT03992846|447543896|FG002|Overall Study|Adverse Event|3|||
124433012|NCT03992846|447543894|FG000|Overall Study|Lost to Follow-up|0|||
124433013|NCT03992846|447543895|FG001|Overall Study|Lost to Follow-up|1|||
124433014|NCT03992846|447543896|FG002|Overall Study|Lost to Follow-up|1|||
124433015|NCT03992846|447543894|FG000|Overall Study|Pregnancy|2|||
124433016|NCT03992846|447543895|FG001|Overall Study|Pregnancy|0|||
124433017|NCT03992846|447543896|FG002|Overall Study|Pregnancy|1|||
124433018|NCT03992846|447543894|FG000|Overall Study|Protocol Violation|1|||
124433019|NCT03992846|447543895|FG001|Overall Study|Protocol Violation|2|||
124433020|NCT03992846|447543896|FG002|Overall Study|Protocol Violation|0|||
124433021|NCT03992846|447543894|FG000|Overall Study|Withdrawal by Subject|8|||
124433022|NCT03992846|447543895|FG001|Overall Study|Withdrawal by Subject|10|||
124433023|NCT03992846|447543896|FG002|Overall Study|Withdrawal by Subject|20|||
124433024|NCT03992846|447543894|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
124433025|NCT03992846|447543895|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
124433026|NCT03992846|447543896|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
124433027|NCT03647488|447545365|FG000|Overall Study|Progressive disease|10|||
124433028|NCT03647488|447545366|FG001|Overall Study|Progressive disease|0|||
124433029|NCT03647488|447545367|FG002|Overall Study|Progressive disease|0|||
124433030|NCT03647488|447545365|FG000|Overall Study|Adverse Event|5|||
124433031|NCT03647488|447545366|FG001|Overall Study|Adverse Event|0|||
124433032|NCT03647488|447545367|FG002|Overall Study|Adverse Event|0|||
124433033|NCT03647488|447545365|FG000|Overall Study|Clinical progression|2|||
124678352|NCT00784875|448448066|FG001|Period C|Lack of Efficacy|0|||
124874134|NCT00542880|449160219|FG000|Period 2|Discontinuation criteria|2|||
124874135|NCT00542880|449160220|FG001|Period 2|Discontinuation criteria|0|||
124874136|NCT00542880|449160219|FG000|Period 2|Severe non-compliance|0|||
124874137|NCT00542880|449160220|FG001|Period 2|Severe non-compliance|1|||
124874138|NCT00542880|449160219|FG000|Period 2|Other|0|||
124874139|NCT00542880|449160220|FG001|Period 2|Other|1|||
124874140|NCT00542880|449160219|FG000|Period 3|Adverse Event|0|||
124874141|NCT00542880|449160220|FG001|Period 3|Adverse Event|2|||
124874142|NCT00696384|449160221|FG000|Open Label Phase|Adverse Event|27|||
124874143|NCT00696384|449160222|FG001|Open Label Phase|Adverse Event|0|||
124874144|NCT00696384|449160223|FG002|Open Label Phase|Adverse Event|0|||
124874145|NCT00696384|449160221|FG000|Open Label Phase|Protocol Violation|18|||
124874146|NCT00696384|449160222|FG001|Open Label Phase|Protocol Violation|0|||
124874147|NCT00696384|449160223|FG002|Open Label Phase|Protocol Violation|0|||
124874148|NCT00696384|449160221|FG000|Open Label Phase|Lost to Follow-up|24|||
124874149|NCT00696384|449160222|FG001|Open Label Phase|Lost to Follow-up|0|||
124874150|NCT00696384|449160223|FG002|Open Label Phase|Lost to Follow-up|0|||
124874151|NCT00696384|449160221|FG000|Open Label Phase|Withdrawal by Subject|37|||
124874152|NCT00696384|449160222|FG001|Open Label Phase|Withdrawal by Subject|0|||
124874153|NCT00696384|449160223|FG002|Open Label Phase|Withdrawal by Subject|0|||
124874154|NCT00696384|449160221|FG000|Open Label Phase|Other|6|||
124874155|NCT00696384|449160222|FG001|Open Label Phase|Other|0|||
124874156|NCT00696384|449160223|FG002|Open Label Phase|Other|0|||
124874157|NCT00696384|449160221|FG000|Open Label Phase|Lack of Efficacy|3|||
124874158|NCT00696384|449160222|FG001|Open Label Phase|Lack of Efficacy|0|||
124874159|NCT00696384|449160223|FG002|Open Label Phase|Lack of Efficacy|0|||
124874160|NCT00696384|449160221|FG000|Open Label Phase|Physician Decision|4|||
124874161|NCT00696384|449160222|FG001|Open Label Phase|Physician Decision|0|||
124874162|NCT00696384|449160223|FG002|Open Label Phase|Physician Decision|0|||
124874163|NCT00696384|449160221|FG000|Double Blind Phase|Adverse Event|0|||
124874164|NCT00696384|449160222|FG001|Double Blind Phase|Adverse Event|2|||
124874165|NCT00696384|449160223|FG002|Double Blind Phase|Adverse Event|2|||
124874166|NCT00696384|449160221|FG000|Double Blind Phase|Lost to Follow-up|0|||
124874167|NCT00696384|449160222|FG001|Double Blind Phase|Lost to Follow-up|2|||
124874168|NCT00696384|449160223|FG002|Double Blind Phase|Lost to Follow-up|1|||
124874169|NCT00696384|449160221|FG000|Double Blind Phase|Withdrawal by Subject|0|||
124874170|NCT00696384|449160222|FG001|Double Blind Phase|Withdrawal by Subject|4|||
124874171|NCT00696384|449160223|FG002|Double Blind Phase|Withdrawal by Subject|3|||
124874172|NCT00696384|449160221|FG000|Double Blind Phase|Lack of Efficacy|0|||
124874173|NCT00696384|449160222|FG001|Double Blind Phase|Lack of Efficacy|1|||
124874174|NCT00696384|449160223|FG002|Double Blind Phase|Lack of Efficacy|0|||
124874175|NCT00696384|449160221|FG000|Double Blind Phase|Physician Decision|0|||
124874176|NCT00696384|449160222|FG001|Double Blind Phase|Physician Decision|2|||
124874177|NCT00696384|449160223|FG002|Double Blind Phase|Physician Decision|0|||
124874178|NCT02027402|449160225|FG000|Overall Study|Withdrawal by Subject|4|||
124874179|NCT02027402|449160226|FG001|Overall Study|Withdrawal by Subject|1|||
124874180|NCT04179721|449160232|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
124874181|NCT04179721|449160233|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
124433034|NCT03647488|447545366|FG001|Overall Study|Clinical progression|0|||
124433035|NCT03647488|447545367|FG002|Overall Study|Clinical progression|0|||
124874182|NCT04179721|449160232|FG000|Overall Study|Lost to Follow-up|0|||
124874183|NCT04179721|449160233|FG001|Overall Study|Lost to Follow-up|1|||
124874184|NCT01984697|449161986|FG000|Overall Study|Adverse Event|0|||
124874185|NCT01984697|449161987|FG001|Overall Study|Adverse Event|0|||
124874186|NCT01984697|449161988|FG002|Overall Study|Adverse Event|2|||
124874187|NCT01984697|449161989|FG003|Overall Study|Adverse Event|0|||
124874188|NCT01984697|449161990|FG004|Overall Study|Adverse Event|0|||
124874189|NCT01984697|449161986|FG000|Overall Study|Lost to Follow-up|14|||
124874190|NCT01984697|449161987|FG001|Overall Study|Lost to Follow-up|5|||
124874191|NCT01984697|449161988|FG002|Overall Study|Lost to Follow-up|10|||
124874192|NCT01984697|449161989|FG003|Overall Study|Lost to Follow-up|6|||
124874193|NCT01984697|449161990|FG004|Overall Study|Lost to Follow-up|21|||
124874194|NCT01984697|449161986|FG000|Overall Study|Physician Decision|3|||
124874195|NCT01984697|449161987|FG001|Overall Study|Physician Decision|0|||
124874196|NCT01984697|449161988|FG002|Overall Study|Physician Decision|0|||
124874197|NCT01984697|449161989|FG003|Overall Study|Physician Decision|1|||
124874198|NCT01984697|449161990|FG004|Overall Study|Physician Decision|0|||
124874199|NCT01984697|449161986|FG000|Overall Study|Protocol Violation|8|||
124874200|NCT01984697|449161987|FG001|Overall Study|Protocol Violation|5|||
124874201|NCT01984697|449161988|FG002|Overall Study|Protocol Violation|3|||
124874202|NCT01984697|449161989|FG003|Overall Study|Protocol Violation|2|||
124874203|NCT01984697|449161990|FG004|Overall Study|Protocol Violation|0|||
124874204|NCT01984697|449161986|FG000|Overall Study|Withdrawal by Subject|15|||
124874205|NCT01984697|449161987|FG001|Overall Study|Withdrawal by Subject|21|||
124874206|NCT01984697|449161988|FG002|Overall Study|Withdrawal by Subject|13|||
124678353|NCT00784875|448448067|FG002|Period C|Lack of Efficacy|1|||
124874207|NCT01984697|449161989|FG003|Overall Study|Withdrawal by Subject|11|||
124874208|NCT01984697|449161990|FG004|Overall Study|Withdrawal by Subject|13|||
124874209|NCT01984697|449161986|FG000|Overall Study|Missed last follow-up visit|1|||
124874210|NCT01984697|449161987|FG001|Overall Study|Missed last follow-up visit|0|||
124874211|NCT01984697|449161988|FG002|Overall Study|Missed last follow-up visit|0|||
124433036|NCT03647488|447545365|FG000|Overall Study|Participant refused to take investigational product|1|||
124874212|NCT01984697|449161989|FG003|Overall Study|Missed last follow-up visit|0|||
124874213|NCT01984697|449161990|FG004|Overall Study|Missed last follow-up visit|0|||
124874214|NCT01984697|449161986|FG000|Overall Study|Death|0|||
124874215|NCT01984697|449161987|FG001|Overall Study|Death|0|||
124874216|NCT01984697|449161988|FG002|Overall Study|Death|0|||
124874217|NCT01984697|449161989|FG003|Overall Study|Death|1|||
124874218|NCT01984697|449161990|FG004|Overall Study|Death|0|||
124874219|NCT01984697|449161986|FG000|Overall Study|Pregnancy|2|||
124874220|NCT01984697|449161987|FG001|Overall Study|Pregnancy|0|||
124874221|NCT01984697|449161988|FG002|Overall Study|Pregnancy|1|||
124874222|NCT01984697|449161989|FG003|Overall Study|Pregnancy|0|||
124874223|NCT01984697|449161990|FG004|Overall Study|Pregnancy|1|||
124874224|NCT03308825|449161991|FG000|Overall Study|Lost to Follow-up|2|||
124874225|NCT03308825|449161992|FG001|Overall Study|Lost to Follow-up|2|||
124874226|NCT03308825|449161993|FG002|Overall Study|Lost to Follow-up|1|||
124874227|NCT03308825|449161994|FG003|Overall Study|Lost to Follow-up|0|||
124874228|NCT03308825|449161991|FG000|Overall Study|Protocol Violation|0|||
124874229|NCT03308825|449161992|FG001|Overall Study|Protocol Violation|2|||
124874230|NCT03308825|449161993|FG002|Overall Study|Protocol Violation|0|||
124874231|NCT03308825|449161994|FG003|Overall Study|Protocol Violation|0|||
124874232|NCT04737109|449161995|FG000|Study Treatment|Disease Progression|5|||
124874233|NCT04737109|449161996|FG001|Study Treatment|Disease Progression|0|||
124874234|NCT04737109|449161997|FG002|Study Treatment|Disease Progression|0|||
124874235|NCT04737109|449161998|FG003|Study Treatment|Disease Progression|0|||
124874236|NCT04737109|449161995|FG000|Study Treatment|Death on study|1|||
124874237|NCT04737109|449161996|FG001|Study Treatment|Death on study|0|||
124874238|NCT04737109|449161997|FG002|Study Treatment|Death on study|0|||
124874239|NCT04737109|449161998|FG003|Study Treatment|Death on study|0|||
124874240|NCT02259517|449161999|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
124874241|NCT02259517|449162000|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
124874242|NCT02259517|449162001|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
124874243|NCT02259517|449161999|FG000|Overall Study|Withdrawal by Subject|0|||
124433037|NCT03647488|447545366|FG001|Overall Study|Participant refused to take investigational product|0|||
124433038|NCT03647488|447545367|FG002|Overall Study|Participant refused to take investigational product|0|||
124433039|NCT00565851|447545368|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
124433040|NCT00565851|447545369|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
124433041|NCT00565851|447545370|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
124433042|NCT00565851|447545371|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
124433043|NCT00565851|447545372|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
124433044|NCT00565851|447545373|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
124433045|NCT00565851|447545374|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
124433046|NCT00565851|447545375|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
124433047|NCT00565851|447545368|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
124433048|NCT00565851|447545369|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
124433049|NCT00565851|447545370|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
124433050|NCT00565851|447545371|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
124433051|NCT00565851|447545372|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
124433052|NCT00565851|447545373|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
124433053|NCT00565851|447545374|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
124433054|NCT00565851|447545375|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
124433055|NCT00775463|447545376|FG000|Overall Study|Withdrawal by Subject|0|||
124678354|NCT00784875|448448068|FG003|Period C|Lack of Efficacy|0|||
124678355|NCT00784875|448448065|FG000|Period C|Withdrawal by Subject|1|||
124678356|NCT00784875|448448066|FG001|Period C|Withdrawal by Subject|1|||
124874244|NCT02259517|449162000|FG001|Overall Study|Withdrawal by Subject|0|||
124874245|NCT02259517|449162001|FG002|Overall Study|Withdrawal by Subject|3|||
124874246|NCT01289418|449162002|FG000|Day 8 Survey|email address invalid|283|||
124874247|NCT01289418|449162002|FG000|Day 8 Survey|participants did not complete the survey|1935|||
124874248|NCT01289418|449162002|FG000|Day 29 Survey|email address invalid|283|||
124874249|NCT01289418|449162002|FG000|Day 29 Survey|participants did not complete the survey|2185|||
124874250|NCT03928028|449162011|FG000|Overall Study|Physician Decision|9|||
124874251|NCT03928028|449162012|FG001|Overall Study|Physician Decision|6|||
124874252|NCT03928028|449162013|FG002|Overall Study|Physician Decision|3|||
124874253|NCT03928028|449162011|FG000|Overall Study|Withdrawal by Subject|12|||
124874254|NCT03928028|449162012|FG001|Overall Study|Withdrawal by Subject|3|||
124874255|NCT03928028|449162013|FG002|Overall Study|Withdrawal by Subject|3|||
124874256|NCT04669600|449162017|FG000|Overall Study|Withdrawal by Subject|1|||
124874257|NCT04669600|449162017|FG000|Overall Study|Other|6|||
124874258|NCT00710606|449162020|FG000|Overall Study|Adverse Event|0|||
124874259|NCT00710606|449162021|FG001|Overall Study|Adverse Event|2|||
124874260|NCT00514683|449162026|FG000|Overall Study|Not treated|2|||
124874261|NCT00514683|449162027|FG001|Overall Study|Not treated|1|||
124874262|NCT00514683|449162028|FG002|Overall Study|Not treated|0|||
124678357|NCT00784875|448448067|FG002|Period C|Withdrawal by Subject|2|||
124874263|NCT00514683|449162029|FG003|Overall Study|Not treated|0|||
124874264|NCT00514683|449162030|FG004|Overall Study|Not treated|1|||
124874265|NCT00514683|449162026|FG000|Overall Study|Adverse Event|21|||
124874266|NCT00514683|449162027|FG001|Overall Study|Adverse Event|20|||
124874267|NCT00514683|449162028|FG002|Overall Study|Adverse Event|15|||
124874268|NCT00514683|449162029|FG003|Overall Study|Adverse Event|13|||
124874269|NCT00514683|449162030|FG004|Overall Study|Adverse Event|27|||
124874270|NCT00514683|449162026|FG000|Overall Study|Protocol Violation|1|||
124874271|NCT00514683|449162027|FG001|Overall Study|Protocol Violation|1|||
124874272|NCT00514683|449162028|FG002|Overall Study|Protocol Violation|0|||
124874273|NCT00514683|449162029|FG003|Overall Study|Protocol Violation|1|||
124874274|NCT00514683|449162030|FG004|Overall Study|Protocol Violation|0|||
124874275|NCT00514683|449162026|FG000|Overall Study|Withdrawal by Subject|2|||
124874276|NCT00514683|449162027|FG001|Overall Study|Withdrawal by Subject|2|||
124874277|NCT00514683|449162028|FG002|Overall Study|Withdrawal by Subject|1|||
124874278|NCT00514683|449162029|FG003|Overall Study|Withdrawal by Subject|0|||
124874279|NCT00514683|449162030|FG004|Overall Study|Withdrawal by Subject|4|||
124874280|NCT00514683|449162026|FG000|Overall Study|Reason other than listed above|0|||
124874281|NCT00514683|449162027|FG001|Overall Study|Reason other than listed above|1|||
124874282|NCT00514683|449162028|FG002|Overall Study|Reason other than listed above|2|||
124874283|NCT00514683|449162029|FG003|Overall Study|Reason other than listed above|0|||
124874284|NCT00514683|449162030|FG004|Overall Study|Reason other than listed above|1|||
124874285|NCT02736825|449162031|FG000|Overall Study|Lost to Follow-up|10|||
124874286|NCT02736825|449162032|FG001|Overall Study|Lost to Follow-up|11|||
124874287|NCT02736825|449162031|FG000|Overall Study|Early Termination|0|||
124874288|NCT02736825|449162032|FG001|Overall Study|Early Termination|1|||
124874289|NCT00790452|449162034|FG000|Overall Study|Drug supply issue|1|||
124874290|NCT00790452|449162035|FG001|Overall Study|Drug supply issue|0|||
124874291|NCT01564368|449162036|FG000|Overall Study|Ineligible|18|||
124874292|NCT01564368|449162036|FG000|Overall Study|Not Randomized in Parent study|116|||
124874293|NCT01564368|449162036|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
124874294|NCT01564368|449162036|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
124874295|NCT01373931|449162039|FG000|Lead-in Period|Adverse Event|2|||
124874296|NCT01373931|449162040|FG001|Lead-in Period|Adverse Event|0|||
124874297|NCT01373931|449162039|FG000|Period 1|Adverse Event|2|||
124874298|NCT01373931|449162040|FG001|Period 1|Adverse Event|0|||
124874299|NCT01373931|449162039|FG000|Period 1|Withdrawal by Subject|0|||
124874300|NCT01373931|449162040|FG001|Period 1|Withdrawal by Subject|2|||
124874301|NCT04857034|449162041|FG000|Placebo-Controlled Period|Request to discontinue|2|||
124874302|NCT04857034|449162042|FG001|Placebo-Controlled Period|Request to discontinue|2|||
124874303|NCT04857034|449162043|FG002|Placebo-Controlled Period|Request to discontinue|0|||
124874304|NCT04857034|449162044|FG003|Placebo-Controlled Period|Request to discontinue|0|||
124874305|NCT04857034|449162045|FG004|Placebo-Controlled Period|Request to discontinue|0|||
124874306|NCT04857034|449162041|FG000|Placebo-Controlled Period|withdrew consent|1|||
124874307|NCT04857034|449162042|FG001|Placebo-Controlled Period|withdrew consent|1|||
124874308|NCT04857034|449162043|FG002|Placebo-Controlled Period|withdrew consent|2|||
124874309|NCT04857034|449162044|FG003|Placebo-Controlled Period|withdrew consent|0|||
124874310|NCT04857034|449162045|FG004|Placebo-Controlled Period|withdrew consent|0|||
124874311|NCT04857034|449162041|FG000|Placebo-Controlled Period|Pregnancy|1|||
124874312|NCT04857034|449162042|FG001|Placebo-Controlled Period|Pregnancy|1|||
124874313|NCT04857034|449162043|FG002|Placebo-Controlled Period|Pregnancy|0|||
124874314|NCT04857034|449162044|FG003|Placebo-Controlled Period|Pregnancy|0|||
124874315|NCT04857034|449162045|FG004|Placebo-Controlled Period|Pregnancy|0|||
124874316|NCT04857034|449162041|FG000|Placebo-Controlled Period|Ongoing study period|0|||
124874317|NCT04857034|449162042|FG001|Placebo-Controlled Period|Ongoing study period|1|||
124874318|NCT04857034|449162043|FG002|Placebo-Controlled Period|Ongoing study period|0|||
124874319|NCT04857034|449162044|FG003|Placebo-Controlled Period|Ongoing study period|0|||
124874320|NCT04857034|449162045|FG004|Placebo-Controlled Period|Ongoing study period|0|||
124874321|NCT04857034|449162041|FG000|Active Treatment Period|Lack of Efficacy|1|||
124874322|NCT04857034|449162042|FG001|Active Treatment Period|Lack of Efficacy|0|||
124874323|NCT04857034|449162043|FG002|Active Treatment Period|Lack of Efficacy|0|||
124874324|NCT04857034|449162044|FG003|Active Treatment Period|Lack of Efficacy|0|||
124874325|NCT04857034|449162045|FG004|Active Treatment Period|Lack of Efficacy|0|||
124874326|NCT04857034|449162041|FG000|Active Treatment Period|request to discontinue|0|||
124874327|NCT04857034|449162042|FG001|Active Treatment Period|request to discontinue|1|||
124874328|NCT04857034|449162043|FG002|Active Treatment Period|request to discontinue|0|||
124874329|NCT04857034|449162044|FG003|Active Treatment Period|request to discontinue|1|||
124874330|NCT04857034|449162045|FG004|Active Treatment Period|request to discontinue|0|||
124874331|NCT04857034|449162041|FG000|Active Treatment Period|administrative reason by sponsor|1|||
124874332|NCT04857034|449162042|FG001|Active Treatment Period|administrative reason by sponsor|5|||
124874333|NCT04857034|449162043|FG002|Active Treatment Period|administrative reason by sponsor|0|||
124874334|NCT04857034|449162044|FG003|Active Treatment Period|administrative reason by sponsor|2|||
124874335|NCT04857034|449162045|FG004|Active Treatment Period|administrative reason by sponsor|2|||
124874336|NCT04857034|449162041|FG000|Active Treatment Period|other reasons|1|||
124874337|NCT04857034|449162042|FG001|Active Treatment Period|other reasons|1|||
124874338|NCT04857034|449162043|FG002|Active Treatment Period|other reasons|0|||
124874339|NCT04857034|449162044|FG003|Active Treatment Period|other reasons|0|||
124874340|NCT04857034|449162045|FG004|Active Treatment Period|other reasons|1|||
124874341|NCT04857034|449162041|FG000|Active Treatment Period|Ongoing Study Period|2|||
124874342|NCT04857034|449162042|FG001|Active Treatment Period|Ongoing Study Period|4|||
124874343|NCT04857034|449162043|FG002|Active Treatment Period|Ongoing Study Period|0|||
124874344|NCT04857034|449162044|FG003|Active Treatment Period|Ongoing Study Period|1|||
124874345|NCT04857034|449162045|FG004|Active Treatment Period|Ongoing Study Period|0|||
124874346|NCT02940574|449162046|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
124874347|NCT02940574|449162047|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
124874348|NCT02940574|449162046|FG000|1-year Follow-up|Lost to Follow-up|3|||
124874349|NCT02940574|449162047|FG001|1-year Follow-up|Lost to Follow-up|4|||
124874350|NCT00387894|449162048|FG000|Overall Study|Withdrawal by Subject|1|||
124874351|NCT00659490|449162049|FG000|Overall Study|Lost to Follow-up|2|||
124874352|NCT00659490|449162050|FG001|Overall Study|Lost to Follow-up|0|||
124874353|NCT00659490|449162051|FG002|Overall Study|Lost to Follow-up|1|||
124874354|NCT00827541|449162056|FG000|Overall Study|Exitus|1|||
124874355|NCT00827541|449162057|FG001|Overall Study|Exitus|8|||
124874356|NCT00827541|449162056|FG000|Overall Study|Other|1|||
124874357|NCT00827541|449162057|FG001|Overall Study|Other|3|||
124874358|NCT00827541|449162056|FG000|Overall Study|Pathogen not susceptible|1|||
124874359|NCT00827541|449162057|FG001|Overall Study|Pathogen not susceptible|0|||
124874360|NCT00827541|449162056|FG000|Overall Study|Lack of effectiveness|1|||
124874361|NCT00827541|449162057|FG001|Overall Study|Lack of effectiveness|0|||
124874362|NCT00520975|449162058|FG000|Overall Study|Disease progression|31|||
124874363|NCT00520975|449162059|FG001|Overall Study|Disease progression|23|||
124874364|NCT00520975|449162058|FG000|Overall Study|Adverse Event|7|||
124874365|NCT00520975|449162059|FG001|Overall Study|Adverse Event|10|||
124874366|NCT00520975|449162058|FG000|Overall Study|Death|0|||
124874367|NCT00520975|449162059|FG001|Overall Study|Death|2|||
124874368|NCT00520975|449162058|FG000|Overall Study|Withdrawal by Subject|3|||
124874369|NCT00520975|449162059|FG001|Overall Study|Withdrawal by Subject|5|||
124874370|NCT00520975|449162058|FG000|Overall Study|Other therapy|2|||
124874371|NCT00520975|449162059|FG001|Overall Study|Other therapy|4|||
124874372|NCT00520975|449162058|FG000|Overall Study|Other reasons|4|||
124433056|NCT00775463|447545377|FG001|Overall Study|Withdrawal by Subject|1|||
124433057|NCT00775463|447545376|FG000|Overall Study|Adverse Event|7|||
124433058|NCT00775463|447545377|FG001|Overall Study|Adverse Event|9|||
124433059|NCT00775463|447545376|FG000|Overall Study|Protocol Violation|2|||
124433060|NCT00775463|447545377|FG001|Overall Study|Protocol Violation|2|||
124433061|NCT00775463|447545376|FG000|Overall Study|Lost to Follow-up|1|||
124433062|NCT00775463|447545377|FG001|Overall Study|Lost to Follow-up|0|||
124433063|NCT00775463|447545376|FG000|Overall Study|Lack of Efficacy|1|||
124433064|NCT00775463|447545377|FG001|Overall Study|Lack of Efficacy|1|||
124433065|NCT01789567|447545380|FG000|Overall Study|Death|6|||
124433066|NCT00091169|447545381|FG000|Overall Study|Disease progression|3|||
124433067|NCT00091169|447545382|FG001|Overall Study|Disease progression|1|||
124433068|NCT00091169|447545381|FG000|Overall Study|Adverse Event|11|||
124433069|NCT00091169|447545382|FG001|Overall Study|Adverse Event|17|||
124874373|NCT00520975|449162059|FG001|Overall Study|Other reasons|2|||
124874374|NCT00520975|449162058|FG000|Overall Study|Not start protocol therapy|1|||
124874375|NCT00520975|449162059|FG001|Overall Study|Not start protocol therapy|2|||
124874376|NCT04810221|449162060|FG000|Overall Study|Physician Decision|3|||
124874377|NCT03642938|449162061|FG000|Overall Study|Withdrawal by Subject|0|||
124874378|NCT03642938|449162062|FG001|Overall Study|Withdrawal by Subject|0|||
124433070|NCT00091169|447545381|FG000|Overall Study|Death|4|||
124433071|NCT00091169|447545382|FG001|Overall Study|Death|1|||
124874379|NCT03642938|449162063|FG002|Overall Study|Withdrawal by Subject|0|||
124874380|NCT03642938|449162064|FG003|Overall Study|Withdrawal by Subject|1|||
124874381|NCT00105235|449162065|FG000|Overall Study|Death|4|||
124874382|NCT00105235|449162065|FG000|Overall Study|Physician Decision|1|||
124874383|NCT00105235|449162065|FG000|Overall Study|Withdrawal by Subject|2|||
124874384|NCT01964326|449162066|FG000|Overall Study|Adverse Event|48|||
124874385|NCT01964326|449162066|FG000|Overall Study|Death|2|||
124874386|NCT01964326|449162066|FG000|Overall Study|Protocol Violation|4|||
124874387|NCT01964326|449162066|FG000|Overall Study|Lost to Follow-up|88|||
124874388|NCT01964326|449162066|FG000|Overall Study|Withdrawal by Subject|87|||
124874389|NCT01964326|449162066|FG000|Overall Study|Pregnancy|1|||
124874390|NCT01964326|449162066|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
124874391|NCT01964326|449162066|FG000|Overall Study|Physician Decision|55|||
124874392|NCT01964326|449162066|FG000|Overall Study|Investigator Discretion|1|||
124874393|NCT01964326|449162066|FG000|Overall Study|Other|9|||
124874394|NCT01964326|449162066|FG000|Overall Study|Did not meet eligibility criteria|1|||
124874395|NCT01995539|449162067|FG000|Overall Study|Screening Failure|1|||
124874396|NCT01995539|449162067|FG000|Overall Study|Withdrawal by Investigator|15|||
124874397|NCT01995539|449162067|FG000|Overall Study|Withdrawal by Subject|11|||
124874398|NCT01995539|449162067|FG000|Overall Study|Lost to Follow-up|5|||
124874399|NCT01995539|449162067|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
124874400|NCT00261495|449162068|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
124874401|NCT00261495|449162069|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
124874402|NCT00261495|449162068|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
124874403|NCT00261495|449162069|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
124874404|NCT00261495|449162068|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
124874405|NCT00261495|449162069|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
124874406|NCT00261495|449162068|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
124874407|NCT00261495|449162069|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
124874408|NCT00261495|449162068|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
124874409|NCT00261495|449162069|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
124874410|NCT00261495|449162068|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
124874411|NCT00261495|449162069|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
124874412|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
124874413|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
124874414|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
124874415|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
124874416|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
124874417|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
124874418|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
124874419|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
124874420|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
124874421|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
124874422|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
124874423|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
124874424|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
124874425|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
124874426|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
124874427|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
124874428|NCT00261495|449162068|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
124874429|NCT00261495|449162069|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
124874430|NCT00261495|449162068|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
124874431|NCT00261495|449162069|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
124874432|NCT00261495|449162068|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
124874433|NCT00261495|449162069|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
124874434|NCT00261495|449162068|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
124874435|NCT00261495|449162069|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
124874436|NCT00261495|449162068|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
124874437|NCT00261495|449162069|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
124874438|NCT00261495|449162068|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
124874439|NCT00261495|449162069|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
124874440|NCT00261495|449162068|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
124874441|NCT00261495|449162069|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
124874442|NCT03953898|449162072|FG000|Overall Study|Lack of Efficacy|8|||
124678358|NCT00784875|448448068|FG003|Period C|Withdrawal by Subject|0|||
124678359|NCT00784875|448448065|FG000|Period C|Physician Decision|0|||
124874443|NCT03953898|449162072|FG000|Overall Study|Death|3|||
124678360|NCT00784875|448448066|FG001|Period C|Physician Decision|0|||
124678361|NCT00784875|448448067|FG002|Period C|Physician Decision|1|||
124874444|NCT03953898|449162072|FG000|Overall Study|Withdrawal by Subject|2|||
124874445|NCT03953898|449162072|FG000|Overall Study|Adverse Event|1|||
124874446|NCT01932697|449162073|FG000|Overall Study|Received a different amount of tx|1|||
124874447|NCT01932697|449162074|FG001|Overall Study|Received a different amount of tx|0|||
124874448|NCT01932697|449162073|FG000|Overall Study|Ineligible|1|||
124874449|NCT01932697|449162074|FG001|Overall Study|Ineligible|0|||
124874450|NCT01119768|449162075|FG000|Treatment Period|Lack of Efficacy|18|||
124874451|NCT01119768|449162076|FG001|Treatment Period|Lack of Efficacy|25|||
124874452|NCT01059643|449162077|FG000|Overall Study|Adverse Event|3|||
124874453|NCT01059643|449162077|FG000|Overall Study|Withdrawal by Subject|2|||
124874454|NCT01059643|449162077|FG000|Overall Study|Physician Decision|1|||
124874455|NCT00643123|449162084|FG000|Overall Study|Lost to Follow-up|4|||
124874456|NCT00643123|449162085|FG001|Overall Study|Lost to Follow-up|0|||
124874457|NCT00643123|449162084|FG000|Overall Study|Withdrawal by Subject|1|||
124874458|NCT00643123|449162085|FG001|Overall Study|Withdrawal by Subject|1|||
124874459|NCT02923739|449162086|FG000|Overall Study|Withdrawal by Subject|2|||
124874460|NCT02923739|449162087|FG001|Overall Study|Withdrawal by Subject|0|||
124874461|NCT02923739|449162088|FG002|Overall Study|Withdrawal by Subject|0|||
124874462|NCT02923739|449162089|FG003|Overall Study|Withdrawal by Subject|0|||
124874463|NCT02923739|449162086|FG000|Overall Study|Failed Screening|3|||
124874464|NCT02923739|449162087|FG001|Overall Study|Failed Screening|0|||
124874465|NCT02923739|449162088|FG002|Overall Study|Failed Screening|0|||
124874466|NCT02923739|449162089|FG003|Overall Study|Failed Screening|0|||
124874467|NCT01059630|449162094|FG000|Overall Study|Death|100|||
124874468|NCT01059630|449162095|FG001|Overall Study|Death|84|||
124874469|NCT01059630|449162094|FG000|Overall Study|Lost to Follow-up|4|||
124874470|NCT01059630|449162095|FG001|Overall Study|Lost to Follow-up|1|||
124874471|NCT01059630|449162094|FG000|Overall Study|Physician Decision|2|||
124874472|NCT01059630|449162095|FG001|Overall Study|Physician Decision|4|||
124874473|NCT01059630|449162094|FG000|Overall Study|Withdrawal by Subject|21|||
124874474|NCT01059630|449162095|FG001|Overall Study|Withdrawal by Subject|14|||
124874475|NCT00763958|449162098|FG000|Overall Study|did not meet final criteria|4|||
124874476|NCT00763958|449162099|FG001|Overall Study|did not meet final criteria|4|||
124874477|NCT00763958|449162098|FG000|Overall Study|Lost to Follow-up|10|||
124874478|NCT00763958|449162099|FG001|Overall Study|Lost to Follow-up|2|||
124874479|NCT00763958|449162098|FG000|Overall Study|Believed they were receiving placebo|0|||
124874480|NCT00763958|449162099|FG001|Overall Study|Believed they were receiving placebo|5|||
124874481|NCT04681729|449162100|FG000|Overall Study|Lack of Efficacy|2|||
124874482|NCT04681729|449162101|FG001|Overall Study|Lack of Efficacy|2|||
124874483|NCT04681729|449162100|FG000|Overall Study|Withdrawal by Subject|8|||
124874484|NCT04681729|449162101|FG001|Overall Study|Withdrawal by Subject|9|||
124874485|NCT02535364|449162103|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
124874486|NCT02535364|449162103|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
124874487|NCT02535364|449162103|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
124874488|NCT02535364|449162103|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
124874489|NCT02535364|449162103|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
124874490|NCT02535364|449162103|FG000|Part B Screening|Death|2|||
124874491|NCT02535364|449162103|FG000|Part B Screening|Physician Decision|1|||
124874492|NCT02535364|449162103|FG000|Part B Screening|Withdrawal by Subject|1|||
124874493|NCT02535364|449162103|FG000|Part B Screening|Adverse Event|1|||
124874494|NCT02535364|449162103|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
124874495|NCT02535364|449162103|FG000|Study Treatment|Death|1|||
124874496|NCT02535364|449162103|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
124874497|NCT02535364|449162103|FG000|12-Month Follow-up Period|Disease progression|22|||
124874498|NCT02535364|449162103|FG000|12-Month Follow-up Period|Death|5|||
124874499|NCT02535364|449162103|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
124874500|NCT02535364|449162103|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
124874501|NCT02535364|449162103|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
124874502|NCT04766086|449162106|FG000|Overall Study|Lost to Follow-up|3|||
124874503|NCT04766086|449162107|FG001|Overall Study|Lost to Follow-up|5|||
124874504|NCT04766086|449162108|FG002|Overall Study|Lost to Follow-up|3|||
124874505|NCT04766086|449162106|FG000|Overall Study|Withdrawal by Subject|1|||
124874506|NCT04766086|449162107|FG001|Overall Study|Withdrawal by Subject|1|||
124874507|NCT04766086|449162108|FG002|Overall Study|Withdrawal by Subject|2|||
124874508|NCT04766086|449162106|FG000|Overall Study|Other|0|||
124874509|NCT04766086|449162107|FG001|Overall Study|Other|0|||
124678362|NCT00784875|448448068|FG003|Period C|Physician Decision|1|||
124874510|NCT04766086|449162108|FG002|Overall Study|Other|1|||
124874511|NCT02496767|449162120|FG000|Open-label Lead-in Phase|Adverse Event|176|||
124874512|NCT02496767|449162121|FG001|Open-label Lead-in Phase|Adverse Event|0|||
124874513|NCT02496767|449162122|FG002|Open-label Lead-in Phase|Adverse Event|0|||
124874514|NCT02496767|449162123|FG003|Open-label Lead-in Phase|Adverse Event|0|||
124874515|NCT02496767|449162124|FG004|Open-label Lead-in Phase|Adverse Event|0|||
124874516|NCT02496767|449162125|FG005|Open-label Lead-in Phase|Adverse Event|0|||
124874517|NCT02496767|449162126|FG006|Open-label Lead-in Phase|Adverse Event|0|||
124874518|NCT02496767|449162127|FG007|Open-label Lead-in Phase|Adverse Event|0|||
124874519|NCT02496767|449162120|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
124874520|NCT02496767|449162121|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
124874521|NCT02496767|449162122|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
124874522|NCT02496767|449162123|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
124874523|NCT02496767|449162124|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
124874524|NCT02496767|449162125|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
124874525|NCT02496767|449162126|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
124874526|NCT02496767|449162127|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
124874527|NCT02496767|449162120|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
124874528|NCT02496767|449162121|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
124874529|NCT02496767|449162122|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
124874530|NCT02496767|449162123|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
124874531|NCT02496767|449162124|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
124874532|NCT02496767|449162125|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
124874533|NCT02496767|449162126|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
124874534|NCT02496767|449162127|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
124874535|NCT02496767|449162120|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
124874536|NCT02496767|449162121|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
124874537|NCT02496767|449162122|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
124874538|NCT02496767|449162123|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
124874539|NCT02496767|449162124|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
124874540|NCT02496767|449162125|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
124874541|NCT02496767|449162126|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
124874542|NCT02496767|449162127|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
124874543|NCT02496767|449162120|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
124874544|NCT02496767|449162121|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
124874545|NCT02496767|449162122|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
124874546|NCT02496767|449162123|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
124874547|NCT02496767|449162124|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
124874548|NCT02496767|449162125|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
124874549|NCT02496767|449162126|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
124874550|NCT02496767|449162127|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
124874551|NCT02496767|449162120|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
124874552|NCT02496767|449162121|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
124874553|NCT02496767|449162122|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
124874554|NCT02496767|449162123|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
124874555|NCT02496767|449162124|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
124874556|NCT02496767|449162125|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
124874557|NCT02496767|449162126|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
124874558|NCT02496767|449162127|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
124874559|NCT02496767|449162120|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
124874560|NCT02496767|449162121|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
124874561|NCT02496767|449162122|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
124874562|NCT02496767|449162123|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
124874563|NCT02496767|449162124|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
124874564|NCT02496767|449162125|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
124874565|NCT02496767|449162126|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
124874566|NCT02496767|449162127|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
124874567|NCT02496767|449162120|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
124874568|NCT02496767|449162121|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
124874569|NCT02496767|449162122|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
124874570|NCT02496767|449162123|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
124874571|NCT02496767|449162124|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
124874572|NCT02496767|449162125|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
124874573|NCT02496767|449162126|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
124874574|NCT02496767|449162127|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
124874575|NCT02496767|449162120|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
124678363|NCT00784875|448448065|FG000|Period C|Sponsor Decision|5|||
124678364|NCT00784875|448448066|FG001|Period C|Sponsor Decision|5|||
124678365|NCT00784875|448448067|FG002|Period C|Sponsor Decision|4|||
124874576|NCT02496767|449162121|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
124874577|NCT02496767|449162122|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
124874578|NCT02496767|449162123|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
124874579|NCT02496767|449162124|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
124874580|NCT02496767|449162125|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
124874581|NCT02496767|449162126|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
124874582|NCT02496767|449162127|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
124874583|NCT02496767|449162120|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
124874584|NCT02496767|449162121|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
124874585|NCT02496767|449162122|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
124874586|NCT02496767|449162123|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
124874587|NCT02496767|449162124|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
124874588|NCT02496767|449162125|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
124874589|NCT02496767|449162126|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
124874590|NCT02496767|449162127|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
124874591|NCT02496767|449162120|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
124874592|NCT02496767|449162121|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
124874593|NCT02496767|449162122|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
124874594|NCT02496767|449162123|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
124874595|NCT02496767|449162124|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
124874596|NCT02496767|449162125|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
124874597|NCT02496767|449162126|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
124874598|NCT02496767|449162127|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
124874599|NCT02496767|449162120|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
124874600|NCT02496767|449162121|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
124874601|NCT02496767|449162122|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
124874602|NCT02496767|449162123|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
124874603|NCT02496767|449162124|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
124874604|NCT02496767|449162125|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
124874605|NCT02496767|449162126|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
124874606|NCT02496767|449162127|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
124874607|NCT02496767|449162120|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
124874608|NCT02496767|449162121|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
124874609|NCT02496767|449162122|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
124874610|NCT02496767|449162123|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
124874611|NCT02496767|449162124|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
124874612|NCT02496767|449162125|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
124874613|NCT02496767|449162126|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
124874614|NCT02496767|449162127|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
124874615|NCT02496767|449162120|FG000|Double-blind, Withdrawal Phase|Death|0|||
124874616|NCT02496767|449162121|FG001|Double-blind, Withdrawal Phase|Death|0|||
124874617|NCT02496767|449162122|FG002|Double-blind, Withdrawal Phase|Death|0|||
124874618|NCT02496767|449162123|FG003|Double-blind, Withdrawal Phase|Death|0|||
124874619|NCT02496767|449162124|FG004|Double-blind, Withdrawal Phase|Death|0|||
124874620|NCT02496767|449162125|FG005|Double-blind, Withdrawal Phase|Death|0|||
124874621|NCT02496767|449162126|FG006|Double-blind, Withdrawal Phase|Death|1|||
124874622|NCT02496767|449162127|FG007|Double-blind, Withdrawal Phase|Death|2|||
124874623|NCT02496767|449162120|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
124874624|NCT02496767|449162121|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
124874625|NCT02496767|449162122|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
124874626|NCT02496767|449162123|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
124874627|NCT02496767|449162124|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
124874628|NCT02496767|449162125|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
124874629|NCT02496767|449162126|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
124874630|NCT02496767|449162127|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
124874631|NCT02889133|449162128|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
124874632|NCT02889133|449162129|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
124874633|NCT02889133|449162128|FG000|Completed Primary Outcome|Manufacturing error|3|||
124874634|NCT02889133|449162129|FG001|Completed Primary Outcome|Manufacturing error|8|||
124874635|NCT02889133|449162128|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
124874636|NCT02889133|449162129|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
124874637|NCT02889133|449162128|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
124874638|NCT02889133|449162129|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
124874639|NCT02889133|449162128|FG000|Completed Primary Outcome|Protocol Violation|1|||
124874640|NCT02889133|449162129|FG001|Completed Primary Outcome|Protocol Violation|0|||
124874641|NCT02889133|449162128|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
124874642|NCT02889133|449162129|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
124874643|NCT02889133|449162128|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
124874644|NCT02889133|449162129|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
124874645|NCT02889133|449162128|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
124874646|NCT02889133|449162129|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
124874647|NCT02889133|449162128|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
124874648|NCT02889133|449162129|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
124874649|NCT02889133|449162128|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
124874650|NCT02889133|449162129|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
124874651|NCT05687032|449162130|FG000|Treatment Phase|Adverse Event|13|||
124874652|NCT05687032|449162130|FG000|Treatment Phase|Death|1|||
124874653|NCT05687032|449162130|FG000|Treatment Phase|Physician Decision|3|||
124874654|NCT05687032|449162130|FG000|Treatment Phase|Progressive disease|9|||
124874655|NCT05687032|449162130|FG000|Treatment Phase|Withdrawal by Subject|5|||
124874656|NCT05687032|449162130|FG000|Follow-Up Phase|Death|16|||
124874657|NCT05687032|449162130|FG000|Follow-Up Phase|Ongoing|26|||
124874658|NCT05479604|449162133|FG000|Overall Study|Lost to Follow-up|1|||
124874659|NCT05479604|449162134|FG001|Overall Study|Lost to Follow-up|5|||
124874660|NCT01678131|449162139|FG000|Overall Study|Adverse Event|0|||
124874661|NCT01678131|449162140|FG001|Overall Study|Adverse Event|1|||
124874662|NCT01678131|449162141|FG002|Overall Study|Adverse Event|0|||
124874663|NCT01678131|449162139|FG000|Overall Study|Withdrawal by Subject|0|||
124874664|NCT01678131|449162140|FG001|Overall Study|Withdrawal by Subject|0|||
124874665|NCT01678131|449162141|FG002|Overall Study|Withdrawal by Subject|2|||
124874666|NCT00112580|449162142|FG000|Overall Study|Adverse Event|1|||
124874667|NCT00112580|449162143|FG001|Overall Study|Adverse Event|2|||
124874668|NCT00112580|449162142|FG000|Overall Study|Disease progression|5|||
124874669|NCT00112580|449162143|FG001|Overall Study|Disease progression|16|||
124874670|NCT00112580|449162142|FG000|Overall Study|Participant withdrew consent|2|||
124874671|NCT00112580|449162143|FG001|Overall Study|Participant withdrew consent|1|||
124874672|NCT05619003|449162145|FG000|Overall Study|Adverse Event|1|||
124874673|NCT03444376|449162146|FG000|Part A|Disease relapse or Progression|1|||
124874674|NCT03444376|449162146|FG000|Part A|Withdrawal by Subject|2|||
124874675|NCT03444376|449162146|FG000|Part A|Adverse Event|1|||
124874676|NCT03444376|449162146|FG000|Part B|Disease relapse or Progression|18|||
124874677|NCT03444376|449162146|FG000|Part B|Withdrawal by Subject|2|||
124874678|NCT03444376|449162146|FG000|Part B|Adverse Event|2|||
124874679|NCT03444376|449162146|FG000|Part B|Physician Decision|1|||
124874680|NCT03444376|449162146|FG000|Part C|Disease relapse or Progression|43|||
124874681|NCT03444376|449162146|FG000|Part C|Withdrawal by Subject|5|||
124874682|NCT03444376|449162146|FG000|Part C|Adverse Event|2|||
124874683|NCT03444376|449162146|FG000|Part C|Physician Decision|2|||
124874684|NCT03444376|449162146|FG000|Part C|Death|1|||
124874685|NCT00685945|449163503|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
124874686|NCT03183388|449163504|FG000|Overall Study|Lost to Follow-up|3|||
124874687|NCT03183388|449163505|FG001|Overall Study|Lost to Follow-up|5|||
124874688|NCT03183388|449163504|FG000|Overall Study|Physician Decision|1|||
124874689|NCT03183388|449163505|FG001|Overall Study|Physician Decision|4|||
124874690|NCT03183388|449163504|FG000|Overall Study|Withdrawal by Subject|4|||
124874691|NCT03183388|449163505|FG001|Overall Study|Withdrawal by Subject|1|||
124874692|NCT03183388|449163504|FG000|Overall Study|Moved|1|||
124874693|NCT03183388|449163505|FG001|Overall Study|Moved|0|||
124874694|NCT03183388|449163504|FG000|Overall Study|Met Exclusion Criteria|2|||
124874695|NCT03183388|449163505|FG001|Overall Study|Met Exclusion Criteria|2|||
124874696|NCT03183388|449163504|FG000|Overall Study|COVID Pandemic Related|2|||
124874697|NCT03183388|449163505|FG001|Overall Study|COVID Pandemic Related|4|||
124874698|NCT00847405|449163506|FG000|First Intervention|Adverse Event|0|||
124874699|NCT00847405|449163507|FG001|First Intervention|Adverse Event|1|||
124874700|NCT00847405|449163506|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
124874701|NCT00847405|449163507|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
124874702|NCT01728792|449163508|FG000|Overall Study|Withdrawal of Consent|1|||
124874703|NCT01728792|449163509|FG001|Overall Study|Withdrawal of Consent|1|||
124874704|NCT01728792|449163510|FG002|Overall Study|Withdrawal of Consent|0|||
124874705|NCT01728792|449163511|FG003|Overall Study|Withdrawal of Consent|1|||
124874706|NCT01728792|449163512|FG004|Overall Study|Withdrawal of Consent|0|||
124433072|NCT00091169|447545381|FG000|Overall Study|Withdrawal by Subject|10|||
124433073|NCT00091169|447545382|FG001|Overall Study|Withdrawal by Subject|13|||
124433074|NCT00091169|447545381|FG000|Overall Study|Other|3|||
124433075|NCT00091169|447545382|FG001|Overall Study|Other|4|||
124433076|NCT00091169|447545381|FG000|Overall Study|Not start protocol therapy|26|||
124433077|NCT00091169|447545382|FG001|Overall Study|Not start protocol therapy|17|||
124433078|NCT00872989|447545383|FG000|Overall Study|Adverse Event|7|||
124433079|NCT00872989|447545384|FG001|Overall Study|Adverse Event|15|||
124433080|NCT00872989|447545383|FG000|Overall Study|Withdrawal by Subject|8|||
124433081|NCT00872989|447545384|FG001|Overall Study|Withdrawal by Subject|5|||
124433082|NCT00872989|447545383|FG000|Overall Study|Progression/relapse|47|||
124433083|NCT00872989|447545384|FG001|Overall Study|Progression/relapse|35|||
124433084|NCT00872989|447545383|FG000|Overall Study|Not protocol specified|3|||
124433085|NCT00872989|447545384|FG001|Overall Study|Not protocol specified|8|||
124433086|NCT02407990|447545385|FG000|Overall Study|Death|2|||
124433087|NCT02407990|447545386|FG001|Overall Study|Death|22|||
124433088|NCT02407990|447545387|FG002|Overall Study|Death|23|||
124433089|NCT02407990|447545388|FG003|Overall Study|Death|7|||
124433090|NCT02407990|447545389|FG004|Overall Study|Death|17|||
124433091|NCT02407990|447545390|FG005|Overall Study|Death|16|||
124433092|NCT02407990|447545391|FG006|Overall Study|Death|10|||
124433093|NCT02407990|447545392|FG007|Overall Study|Death|248|||
124433094|NCT02407990|447545385|FG000|Overall Study|Lost to Follow-up|0|||
124433095|NCT02407990|447545386|FG001|Overall Study|Lost to Follow-up|1|||
124433096|NCT02407990|447545387|FG002|Overall Study|Lost to Follow-up|0|||
124433097|NCT02407990|447545388|FG003|Overall Study|Lost to Follow-up|0|||
124433098|NCT02407990|447545389|FG004|Overall Study|Lost to Follow-up|0|||
124433099|NCT02407990|447545390|FG005|Overall Study|Lost to Follow-up|0|||
124433100|NCT02407990|447545391|FG006|Overall Study|Lost to Follow-up|0|||
124433101|NCT02407990|447545392|FG007|Overall Study|Lost to Follow-up|17|||
124433102|NCT02407990|447545385|FG000|Overall Study|Progressive Disease|0|||
124433103|NCT02407990|447545386|FG001|Overall Study|Progressive Disease|0|||
124433104|NCT02407990|447545387|FG002|Overall Study|Progressive Disease|0|||
124433105|NCT02407990|447545388|FG003|Overall Study|Progressive Disease|0|||
124433106|NCT02407990|447545389|FG004|Overall Study|Progressive Disease|0|||
124433107|NCT02407990|447545390|FG005|Overall Study|Progressive Disease|0|||
124433108|NCT02407990|447545391|FG006|Overall Study|Progressive Disease|0|||
124433109|NCT02407990|447545392|FG007|Overall Study|Progressive Disease|1|||
124433110|NCT02407990|447545385|FG000|Overall Study|Withdrawal by Subject|0|||
124433111|NCT02407990|447545386|FG001|Overall Study|Withdrawal by Subject|0|||
124433112|NCT02407990|447545387|FG002|Overall Study|Withdrawal by Subject|0|||
124433113|NCT02407990|447545388|FG003|Overall Study|Withdrawal by Subject|0|||
124433114|NCT02407990|447545389|FG004|Overall Study|Withdrawal by Subject|1|||
124433115|NCT02407990|447545390|FG005|Overall Study|Withdrawal by Subject|0|||
124433116|NCT02407990|447545391|FG006|Overall Study|Withdrawal by Subject|0|||
124433117|NCT02407990|447545392|FG007|Overall Study|Withdrawal by Subject|30|||
124433118|NCT02407990|447545385|FG000|Overall Study|Study Terminated by Sponsor|1|||
124433119|NCT02407990|447545386|FG001|Overall Study|Study Terminated by Sponsor|3|||
124433120|NCT02407990|447545387|FG002|Overall Study|Study Terminated by Sponsor|3|||
124433121|NCT02407990|447545388|FG003|Overall Study|Study Terminated by Sponsor|0|||
124433122|NCT02407990|447545389|FG004|Overall Study|Study Terminated by Sponsor|3|||
124433123|NCT02407990|447545390|FG005|Overall Study|Study Terminated by Sponsor|4|||
124433124|NCT02407990|447545391|FG006|Overall Study|Study Terminated by Sponsor|3|||
124433125|NCT02407990|447545392|FG007|Overall Study|Study Terminated by Sponsor|37|||
124433126|NCT02407990|447545385|FG000|Overall Study|Logistics|0|||
124433127|NCT02407990|447545386|FG001|Overall Study|Logistics|0|||
124874707|NCT01728792|449163508|FG000|Overall Study|Lost to Follow-up|2|||
124874708|NCT01728792|449163509|FG001|Overall Study|Lost to Follow-up|1|||
124874709|NCT01728792|449163510|FG002|Overall Study|Lost to Follow-up|4|||
124874710|NCT01728792|449163511|FG003|Overall Study|Lost to Follow-up|2|||
124874711|NCT01728792|449163512|FG004|Overall Study|Lost to Follow-up|0|||
124874712|NCT04277455|449163515|FG000|Overall Study|Lost to Follow-up|1|||
124874713|NCT00949715|449163516|FG000|Overall Study|Physician Decision|1|||
124874714|NCT00949715|449163517|FG001|Overall Study|Physician Decision|0|||
124874715|NCT00949715|449163516|FG000|Overall Study|Lost to Follow-up|1|||
124874716|NCT00949715|449163517|FG001|Overall Study|Lost to Follow-up|0|||
124874717|NCT00949715|449163516|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
124874718|NCT00949715|449163517|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
124874719|NCT01352585|449163522|FG000|Overall Study|Adverse Event|2|||
124874720|NCT01352585|449163523|FG001|Overall Study|Adverse Event|1|||
124874721|NCT01352585|449163522|FG000|Overall Study|Lost to Follow-up|1|||
124874722|NCT01352585|449163523|FG001|Overall Study|Lost to Follow-up|0|||
124874723|NCT01352585|449163522|FG000|Overall Study|Other|5|||
124874724|NCT01352585|449163523|FG001|Overall Study|Other|2|||
124874725|NCT02276066|449163526|FG000|Overall Study|Lost to Follow-up|21|||
124874726|NCT02276066|449163527|FG001|Overall Study|Lost to Follow-up|11|||
124874727|NCT05050578|449163528|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
124874728|NCT05050578|449163529|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
124874729|NCT05050578|449163528|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
124874730|NCT05050578|449163529|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
124874731|NCT05050578|449163528|FG000|Period 2, 30 Days|Protocol Violation|0|||
124874732|NCT05050578|449163529|FG001|Period 2, 30 Days|Protocol Violation|1|||
124874733|NCT03386032|449163530|FG000|Overall Study|Lack of Efficacy|6|||
124874734|NCT03386032|449163531|FG001|Overall Study|Lack of Efficacy|2|||
124874735|NCT03386032|449163532|FG002|Overall Study|Lack of Efficacy|0|||
124874736|NCT03386032|449163530|FG000|Overall Study|Adverse Event|2|||
124874737|NCT03386032|449163531|FG001|Overall Study|Adverse Event|2|||
124874738|NCT03386032|449163532|FG002|Overall Study|Adverse Event|0|||
124874739|NCT03386032|449163530|FG000|Overall Study|Withdrawal by Subject|1|||
124874740|NCT03386032|449163531|FG001|Overall Study|Withdrawal by Subject|0|||
124874741|NCT03386032|449163532|FG002|Overall Study|Withdrawal by Subject|0|||
124874742|NCT03386032|449163530|FG000|Overall Study|Lost to Follow-up|9|||
124874743|NCT03386032|449163531|FG001|Overall Study|Lost to Follow-up|3|||
124874744|NCT03386032|449163532|FG002|Overall Study|Lost to Follow-up|0|||
124874745|NCT02710292|449163538|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
124874746|NCT02710292|449163539|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
124874747|NCT02710292|449163538|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
124874748|NCT02710292|449163539|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
124874749|NCT04525547|449163540|FG000|Overall Study|Not treated with Ofev|2|||
124874750|NCT04525547|449163540|FG000|Overall Study|Off-label use|2|||
124874751|NCT04525547|449163540|FG000|Overall Study|Lost to Follow-up|1|||
124874752|NCT00800202|449163541|FG000|Overall Study|Adverse Event|7|||
124874753|NCT00800202|449163542|FG001|Overall Study|Adverse Event|6|||
124874754|NCT00800202|449163541|FG000|Overall Study|Death|1|||
124874755|NCT00800202|449163542|FG001|Overall Study|Death|0|||
124874756|NCT00800202|449163541|FG000|Overall Study|Other|5|||
124874757|NCT00800202|449163542|FG001|Overall Study|Other|0|||
124874758|NCT00800202|449163541|FG000|Overall Study|Disease Progression|54|||
124874759|NCT00800202|449163542|FG001|Overall Study|Disease Progression|18|||
124874760|NCT04425902|449163543|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
124874761|NCT02901626|449163552|FG000|Overall Study|Lost to Follow-up|1|||
124874762|NCT02901626|449163553|FG001|Overall Study|Lost to Follow-up|1|||
124874763|NCT00331344|449163554|FG000|Phase I|Adverse Event|0|||
124874764|NCT00331344|449163555|FG001|Phase I|Adverse Event|0|||
124874765|NCT00331344|449163556|FG002|Phase I|Adverse Event|0|||
124874766|NCT00331344|449163557|FG003|Phase I|Adverse Event|1|||
124874767|NCT00331344|449163558|FG004|Phase I|Adverse Event|2|||
124874768|NCT00331344|449163559|FG005|Phase I|Adverse Event|2|||
124874769|NCT00331344|449163560|FG006|Phase I|Adverse Event|0|||
124874770|NCT00331344|449163561|FG007|Phase I|Adverse Event|1|||
124874771|NCT00331344|449163562|FG008|Phase I|Adverse Event|0|||
124874772|NCT00331344|449163554|FG000|Phase II|Death|0|||
124874773|NCT00331344|449163555|FG001|Phase II|Death|0|||
124874774|NCT00331344|449163556|FG002|Phase II|Death|0|||
124874775|NCT00331344|449163557|FG003|Phase II|Death|0|||
124874776|NCT00331344|449163558|FG004|Phase II|Death|0|||
124874777|NCT00331344|449163559|FG005|Phase II|Death|0|||
124874778|NCT00331344|449163560|FG006|Phase II|Death|0|||
124874779|NCT00331344|449163561|FG007|Phase II|Death|0|||
124874780|NCT00331344|449163562|FG008|Phase II|Death|4|||
124874781|NCT05674890|449163563|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
124874782|NCT05674890|449163564|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
124874783|NCT05674890|449163563|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
124874784|NCT05674890|449163564|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
124874785|NCT05674890|449163563|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
124874786|NCT05674890|449163564|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
124874787|NCT02228967|449163565|FG000|Overall Study|Lost to Follow-up|146|||
124874788|NCT02228967|449163566|FG001|Overall Study|Lost to Follow-up|142|||
124874789|NCT02228967|449163565|FG000|Overall Study|Withdrawal by Subject|13|||
124874790|NCT02228967|449163566|FG001|Overall Study|Withdrawal by Subject|18|||
124874791|NCT00642902|449163567|FG000|Overall Study|Adverse Event|0|||
124874792|NCT00642902|449163568|FG001|Overall Study|Adverse Event|1|||
124874793|NCT00642902|449163569|FG002|Overall Study|Adverse Event|3|||
124874794|NCT00642902|449163570|FG003|Overall Study|Adverse Event|1|||
124874795|NCT00642902|449163567|FG000|Overall Study|Lost to Follow-up|1|||
124874796|NCT00642902|449163568|FG001|Overall Study|Lost to Follow-up|1|||
124874797|NCT00642902|449163569|FG002|Overall Study|Lost to Follow-up|0|||
124874798|NCT00642902|449163570|FG003|Overall Study|Lost to Follow-up|0|||
124874799|NCT00642902|449163567|FG000|Overall Study|Lack of Efficacy|0|||
124874800|NCT00642902|449163568|FG001|Overall Study|Lack of Efficacy|3|||
124874801|NCT00642902|449163569|FG002|Overall Study|Lack of Efficacy|3|||
124874802|NCT00642902|449163570|FG003|Overall Study|Lack of Efficacy|0|||
124874803|NCT00642902|449163567|FG000|Overall Study|Death|1|||
124874804|NCT00642902|449163568|FG001|Overall Study|Death|0|||
124874805|NCT00642902|449163569|FG002|Overall Study|Death|0|||
124874806|NCT00642902|449163570|FG003|Overall Study|Death|0|||
124874807|NCT00642902|449163567|FG000|Overall Study|Premature termination of clinical trial|37|||
124874808|NCT00642902|449163568|FG001|Overall Study|Premature termination of clinical trial|32|||
124874809|NCT00642902|449163569|FG002|Overall Study|Premature termination of clinical trial|35|||
124874810|NCT00642902|449163570|FG003|Overall Study|Premature termination of clinical trial|35|||
124874811|NCT00642902|449163567|FG000|Overall Study|Randomized, but not treated|0|||
124874812|NCT00642902|449163568|FG001|Overall Study|Randomized, but not treated|0|||
124874813|NCT00642902|449163569|FG002|Overall Study|Randomized, but not treated|1|||
124874814|NCT00642902|449163570|FG003|Overall Study|Randomized, but not treated|0|||
124874815|NCT00642902|449163567|FG000|Overall Study|Other|1|||
124874816|NCT00642902|449163568|FG001|Overall Study|Other|5|||
124874817|NCT00642902|449163569|FG002|Overall Study|Other|1|||
124874818|NCT00642902|449163570|FG003|Overall Study|Other|4|||
124874819|NCT01538472|449163571|FG000|Overall Study|Disease Progression|3|||
124874820|NCT01538472|449163571|FG000|Overall Study|Death|1|||
124874821|NCT02309112|449163572|FG000|Overall Study|Withdrawal by Subject|1|||
124874822|NCT02309112|449163573|FG001|Overall Study|Withdrawal by Subject|0|||
124874823|NCT02309112|449163574|FG002|Overall Study|Withdrawal by Subject|1|||
124874824|NCT02309112|449163572|FG000|Overall Study|Lost to Follow-up|0|||
124874825|NCT02309112|449163573|FG001|Overall Study|Lost to Follow-up|1|||
124874826|NCT02309112|449163574|FG002|Overall Study|Lost to Follow-up|0|||
124874827|NCT03815019|449163575|FG000|Overall Study|Withdrawal by Subject|6|||
124874828|NCT03815019|449163576|FG001|Overall Study|Withdrawal by Subject|8|||
124874829|NCT03759834|449163577|FG000|Overall Study|Withdrawal by Subject|1|||
124874830|NCT03937219|449163578|FG000|Overall Study|Death|223|||
124874831|NCT03937219|449163579|FG001|Overall Study|Death|211|||
124874832|NCT03937219|449163578|FG000|Overall Study|Withdrawal by Subject|17|||
124874833|NCT03937219|449163579|FG001|Overall Study|Withdrawal by Subject|25|||
124874834|NCT03937219|449163578|FG000|Overall Study|Lost to Follow-up|3|||
124874835|NCT03937219|449163579|FG001|Overall Study|Lost to Follow-up|4|||
124874836|NCT04803214|449163580|FG000|Overall Study|Adverse Event|1|||
124874837|NCT04803214|449163581|FG001|Overall Study|Adverse Event|0|||
124874838|NCT04803214|449163580|FG000|Overall Study|Withdrawal by Subject|1|||
124874839|NCT04803214|449163581|FG001|Overall Study|Withdrawal by Subject|2|||
124874840|NCT04803214|449163580|FG000|Overall Study|Lost to Follow-up|2|||
124874841|NCT04803214|449163581|FG001|Overall Study|Lost to Follow-up|4|||
124874842|NCT04803214|449163580|FG000|Overall Study|Physician Decision|1|||
124874843|NCT04803214|449163581|FG001|Overall Study|Physician Decision|1|||
124874844|NCT04803214|449163580|FG000|Overall Study|Missed 12 month visit|0|||
124874845|NCT04803214|449163581|FG001|Overall Study|Missed 12 month visit|3|||
124874846|NCT03764072|449163584|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
124874847|NCT03764072|449163585|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
124874848|NCT03764072|449163586|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
124874849|NCT03764072|449163587|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
124874850|NCT03764072|449163588|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
124874851|NCT03764072|449163589|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
124874852|NCT03764072|449163584|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
124874853|NCT03764072|449163585|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
124874854|NCT03764072|449163586|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
124874855|NCT03764072|449163587|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
124874856|NCT03764072|449163588|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
124874857|NCT03764072|449163589|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
124874858|NCT03764072|449163584|FG000|Overall Study|Lost to Follow-up|0|||
124874859|NCT03764072|449163585|FG001|Overall Study|Lost to Follow-up|0|||
124874860|NCT03764072|449163586|FG002|Overall Study|Lost to Follow-up|0|||
124874861|NCT03764072|449163587|FG003|Overall Study|Lost to Follow-up|0|||
124874862|NCT03764072|449163588|FG004|Overall Study|Lost to Follow-up|1|||
124874863|NCT03764072|449163589|FG005|Overall Study|Lost to Follow-up|0|||
124874864|NCT00558064|449163592|FG000|Overall Study|Adverse Event|3|||
124874865|NCT00558064|449163593|FG001|Overall Study|Adverse Event|2|||
124874866|NCT00558064|449163592|FG000|Overall Study|Lack of Efficacy|0|||
124874867|NCT00558064|449163593|FG001|Overall Study|Lack of Efficacy|1|||
124874868|NCT00558064|449163592|FG000|Overall Study|Protocol Violation|1|||
124874869|NCT00558064|449163593|FG001|Overall Study|Protocol Violation|0|||
124874870|NCT00558064|449163592|FG000|Overall Study|Lost to Follow-up|0|||
124874871|NCT00558064|449163593|FG001|Overall Study|Lost to Follow-up|1|||
124874872|NCT00558064|449163592|FG000|Overall Study|Withdrawal by Subject|0|||
124874873|NCT00558064|449163593|FG001|Overall Study|Withdrawal by Subject|1|||
124874874|NCT00558064|449163592|FG000|Overall Study|No visit within allowance period|1|||
124874875|NCT00558064|449163593|FG001|Overall Study|No visit within allowance period|0|||
124874876|NCT00982930|449163599|FG000|Overall Study|Adverse Event|1|||
124874877|NCT00982930|449163599|FG000|Overall Study|Withdrawal by Subject|1|||
124874878|NCT00982930|449163599|FG000|Overall Study|Administrative Problems|2|||
124874879|NCT00941798|449163600|FG000|Overall Study|Withdrawal by Subject|72|||
124874880|NCT00941798|449163601|FG001|Overall Study|Withdrawal by Subject|74|||
124874881|NCT00941798|449163600|FG000|Overall Study|Adverse Event|43|||
124874882|NCT00941798|449163601|FG001|Overall Study|Adverse Event|23|||
124874883|NCT00941798|449163600|FG000|Overall Study|Lost to Follow-up|29|||
124874884|NCT00941798|449163601|FG001|Overall Study|Lost to Follow-up|23|||
124874885|NCT00941798|449163600|FG000|Overall Study|Protocol Violation|17|||
124874886|NCT00941798|449163601|FG001|Overall Study|Protocol Violation|20|||
124874887|NCT00941798|449163600|FG000|Overall Study|Administrative problems|13|||
124874888|NCT00941798|449163601|FG001|Overall Study|Administrative problems|23|||
124874889|NCT00941798|449163600|FG000|Overall Study|Lack of Efficacy|10|||
124874890|NCT00941798|449163601|FG001|Overall Study|Lack of Efficacy|17|||
124874891|NCT00941798|449163600|FG000|Overall Study|Patient's inability to use device|6|||
124874892|NCT00941798|449163601|FG001|Overall Study|Patient's inability to use device|1|||
124874893|NCT00941798|449163600|FG000|Overall Study|Abnormal test procedure results|3|||
124874894|NCT00941798|449163601|FG001|Overall Study|Abnormal test procedure results|1|||
124874895|NCT00941798|449163600|FG000|Overall Study|Abnormal laboratory values|1|||
124874896|NCT00941798|449163601|FG001|Overall Study|Abnormal laboratory values|2|||
124874897|NCT00941798|449163600|FG000|Overall Study|Death|0|||
124874898|NCT00941798|449163601|FG001|Overall Study|Death|1|||
124874899|NCT01489189|449163602|FG000|Overall Study|Withdrawal by Subject|20|||
124874900|NCT01489189|449163603|FG001|Overall Study|Withdrawal by Subject|23|||
124874901|NCT01489189|449163602|FG000|Overall Study|Death|10|||
124874902|NCT01489189|449163603|FG001|Overall Study|Death|8|||
124874903|NCT01489189|449163602|FG000|Overall Study|Missed Visit|1|||
124874904|NCT01489189|449163603|FG001|Overall Study|Missed Visit|4|||
124874905|NCT05597722|449163604|FG000|Overall Study|Study was terminated|6|||
124874906|NCT05597722|449163605|FG001|Overall Study|Study was terminated|1|||
124874907|NCT04108000|449163606|FG000|Overall Study|Death of patient|1|||
124874908|NCT04108000|449163607|FG001|Overall Study|Death of patient|0|||
124874909|NCT04108000|449163608|FG002|Overall Study|Death of patient|1|||
124874910|NCT04108000|449163609|FG003|Overall Study|Death of patient|0|||
124874911|NCT04108000|449163606|FG000|Overall Study|Withdrawal by Subject|2|||
124874912|NCT04108000|449163607|FG001|Overall Study|Withdrawal by Subject|2|||
124874913|NCT04108000|449163608|FG002|Overall Study|Withdrawal by Subject|0|||
124874914|NCT04108000|449163609|FG003|Overall Study|Withdrawal by Subject|0|||
124874915|NCT04108000|449163606|FG000|Overall Study|Death of surrogate partner|0|||
124874916|NCT04108000|449163607|FG001|Overall Study|Death of surrogate partner|1|||
124874917|NCT04108000|449163608|FG002|Overall Study|Death of surrogate partner|0|||
124874918|NCT04108000|449163609|FG003|Overall Study|Death of surrogate partner|1|||
124874919|NCT03750006|449163612|FG000|Overall Study|Withdrawal by Subject|8|||
124874920|NCT03750006|449163612|FG000|Overall Study|COVID PANDEMIC|11|||
124874921|NCT03881696|449163622|FG000|Overall Study|Adverse Event|2|||
124874922|NCT03881696|449163623|FG001|Overall Study|Adverse Event|0|||
124874923|NCT03881696|449163622|FG000|Overall Study|Withdrawal by Subject|2|||
124874924|NCT03881696|449163623|FG001|Overall Study|Withdrawal by Subject|0|||
124874925|NCT03881696|449163622|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
124874926|NCT03881696|449163623|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
124874927|NCT03881696|449163622|FG000|Overall Study|Failure to meet continuation criteria|1|||
124874928|NCT03881696|449163623|FG001|Overall Study|Failure to meet continuation criteria|0|||
124874929|NCT04082884|449164597|FG000|Overall Study|Withdrawal by Subject|1|||
124874930|NCT01649232|449164598|FG000|Overall Study|Physician Decision|2|||
124874931|NCT01649232|449164599|FG001|Overall Study|Physician Decision|0|||
124874932|NCT02347657|449164600|FG000|Overall Study|Physician Decision|0|||
124874933|NCT02347657|449164601|FG001|Overall Study|Physician Decision|1|||
124874934|NCT02347657|449164600|FG000|Overall Study|Adverse Event|8|||
124874935|NCT02347657|449164601|FG001|Overall Study|Adverse Event|4|||
124874936|NCT02347657|449164600|FG000|Overall Study|Withdrawal by Subject|6|||
124874937|NCT02347657|449164601|FG001|Overall Study|Withdrawal by Subject|7|||
124874938|NCT02347657|449164600|FG000|Overall Study|Randomized but not treated|1|||
124874939|NCT02347657|449164601|FG001|Overall Study|Randomized but not treated|0|||
124874940|NCT02347657|449164600|FG000|Overall Study|Other|3|||
124874941|NCT02347657|449164601|FG001|Overall Study|Other|3|||
124874942|NCT00621543|449164602|FG000|Overall Study|Lost to Follow-up|23|||
124874943|NCT02709005|449164605|FG000|Overall Study|Lost to Follow-up|1|||
124874944|NCT02709005|449164606|FG001|Overall Study|Lost to Follow-up|1|||
124874945|NCT02709005|449164605|FG000|Overall Study|Withdrawal by Subject|3|||
124874946|NCT02709005|449164606|FG001|Overall Study|Withdrawal by Subject|0|||
124874947|NCT00499863|449164611|FG000|Overall Study|Lack of Efficacy|21|||
124874948|NCT00499863|449164612|FG001|Overall Study|Lack of Efficacy|27|||
124874949|NCT00499863|449164611|FG000|Overall Study|Protocol Violation|12|||
124874950|NCT00499863|449164612|FG001|Overall Study|Protocol Violation|7|||
124874951|NCT00499863|449164611|FG000|Overall Study|Withdrawal by Subject|6|||
124874952|NCT00499863|449164612|FG001|Overall Study|Withdrawal by Subject|4|||
124874953|NCT00499863|449164611|FG000|Overall Study|Adverse Event|8|||
124874954|NCT00499863|449164612|FG001|Overall Study|Adverse Event|2|||
124874955|NCT00499863|449164611|FG000|Overall Study|Sponsor decision|2|||
124874956|NCT00499863|449164612|FG001|Overall Study|Sponsor decision|2|||
124874957|NCT00499863|449164611|FG000|Overall Study|Lost to Follow-up|1|||
124874958|NCT00499863|449164612|FG001|Overall Study|Lost to Follow-up|1|||
124874959|NCT00571701|449164613|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
124874960|NCT00571701|449164614|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
124874961|NCT00571701|449164613|FG000|First Intervention 12 Months|Death|1|||
124874962|NCT00571701|449164614|FG001|First Intervention 12 Months|Death|0|||
124874963|NCT00571701|449164613|FG000|Second Intervention 12 Months|Adverse Event|0|||
124874964|NCT00571701|449164614|FG001|Second Intervention 12 Months|Adverse Event|1|||
124874965|NCT00571701|449164613|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
124874966|NCT00571701|449164614|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
124874967|NCT03351738|449164619|FG000|Overall Study|Withdrawal by Subject|0|||
124874968|NCT03351738|449164620|FG001|Overall Study|Withdrawal by Subject|1|||
124874969|NCT03351738|449164621|FG002|Overall Study|Withdrawal by Subject|0|||
124874970|NCT03351738|449164622|FG003|Overall Study|Withdrawal by Subject|1|||
124874971|NCT03351738|449164623|FG004|Overall Study|Withdrawal by Subject|0|||
124874972|NCT03351738|449164624|FG005|Overall Study|Withdrawal by Subject|0|||
124874973|NCT01375205|449164627|FG000|Overall Study|Lost to Follow-up|15|||
124874974|NCT01375205|449164628|FG001|Overall Study|Lost to Follow-up|12|||
124874975|NCT01375205|449164627|FG000|Overall Study|Withdrawal by Subject|6|||
124874976|NCT01375205|449164628|FG001|Overall Study|Withdrawal by Subject|1|||
124874977|NCT03056534|449164630|FG000|Overall Study|Participant withdrew consent|8|||
124874978|NCT03056534|449164630|FG000|Overall Study|Participant not able to return|6|||
124874979|NCT03056534|449164630|FG000|Overall Study|Lost to Follow-up|37|||
124874980|NCT03056534|449164630|FG000|Overall Study|Investigator judgment|1|||
124874981|NCT03056534|449164630|FG000|Overall Study|Death|4|||
124874982|NCT03056534|449164630|FG000|Overall Study|Adverse Event|1|||
124874983|NCT03056534|449164630|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
124874984|NCT02063828|449164631|FG000|Overall Study|Withdrawal by Subject|4|||
124874985|NCT02063828|449164632|FG001|Overall Study|Withdrawal by Subject|6|||
124874986|NCT02063828|449164633|FG002|Overall Study|Withdrawal by Subject|3|||
124874987|NCT02063828|449164631|FG000|Overall Study|Death|0|||
124874988|NCT02063828|449164632|FG001|Overall Study|Death|0|||
124874989|NCT02063828|449164633|FG002|Overall Study|Death|1|||
124874990|NCT00532155|449164634|FG000|Overall Study|Adverse Event|66|||
124874991|NCT00532155|449164635|FG001|Overall Study|Adverse Event|123|||
124874992|NCT00532155|449164634|FG000|Overall Study|Lack of Efficacy|332|||
124874993|NCT00532155|449164635|FG001|Overall Study|Lack of Efficacy|255|||
124874994|NCT00532155|449164634|FG000|Overall Study|Protocol Violation|1|||
124874995|NCT00532155|449164635|FG001|Overall Study|Protocol Violation|3|||
124874996|NCT00532155|449164634|FG000|Overall Study|Lost to Follow-up|2|||
124874997|NCT00532155|449164635|FG001|Overall Study|Lost to Follow-up|0|||
124874998|NCT00532155|449164634|FG000|Overall Study|Physician Decision|16|||
124874999|NCT00532155|449164635|FG001|Overall Study|Physician Decision|15|||
124875000|NCT00532155|449164634|FG000|Overall Study|Withdrawal by Subject|23|||
124875001|NCT00532155|449164635|FG001|Overall Study|Withdrawal by Subject|44|||
124875002|NCT00532155|449164634|FG000|Overall Study|Consent withdrawn|5|||
124875003|NCT00532155|449164635|FG001|Overall Study|Consent withdrawn|7|||
124875004|NCT00532155|449164634|FG000|Overall Study|Moved|1|||
124875005|NCT00532155|449164635|FG001|Overall Study|Moved|0|||
124875006|NCT00532155|449164634|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
124875007|NCT00532155|449164635|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
124875008|NCT00532155|449164634|FG000|Overall Study|Occurence of a second cancer|0|||
124875009|NCT00532155|449164635|FG001|Overall Study|Occurence of a second cancer|1|||
124875010|NCT00532155|449164634|FG000|Overall Study|Occurence of a secondary cancer|0|||
124875011|NCT00532155|449164635|FG001|Overall Study|Occurence of a secondary cancer|1|||
124875012|NCT00532155|449164634|FG000|Overall Study|Promotor ended study|1|||
124875013|NCT00532155|449164635|FG001|Overall Study|Promotor ended study|0|||
124875014|NCT00532155|449164634|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
124875015|NCT00532155|449164635|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
124875016|NCT00532155|449164634|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
124875017|NCT00532155|449164635|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
124875018|NCT00532155|449164634|FG000|Overall Study|Study stopped|1|||
124875019|NCT00532155|449164635|FG001|Overall Study|Study stopped|0|||
124433128|NCT02407990|447545387|FG002|Overall Study|Logistics|0|||
124433129|NCT02407990|447545388|FG003|Overall Study|Logistics|0|||
124875020|NCT00532155|449164634|FG000|Overall Study|Study terminated by sponsor|1|||
124875021|NCT00532155|449164635|FG001|Overall Study|Study terminated by sponsor|0|||
124875022|NCT00532155|449164634|FG000|Overall Study|Study termination stop further treatment|4|||
124875023|NCT00532155|449164635|FG001|Overall Study|Study termination stop further treatment|0|||
124875024|NCT00532155|449164634|FG000|Overall Study|Did not receive study medication|2|||
124875025|NCT00532155|449164635|FG001|Overall Study|Did not receive study medication|6|||
124875026|NCT03483038|449164636|FG000|Overall Study|Subjects still in follow-up|18|||
124875027|NCT02134925|449164637|FG000|Overall Study|Withdrawal by Subject|1|||
124875028|NCT02134925|449164638|FG001|Overall Study|Withdrawal by Subject|0|||
124875029|NCT02134925|449164637|FG000|Overall Study|Cancel|1|||
124875030|NCT02134925|449164638|FG001|Overall Study|Cancel|6|||
124875031|NCT02158884|449164643|FG000|Baseline Assessment|Missed performance assessment|3|||
124875032|NCT02158884|449164643|FG000|Baseline Assessment|Missed SMFA|1|||
124875033|NCT02158884|449164643|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
124875034|NCT02158884|449164643|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
124875035|NCT02158884|449164643|FG000|6 Month Assessment|Missed SMFA|20|||
124875036|NCT02158884|449164643|FG000|12 Month Assessment|Missed SMFA|17|||
124875037|NCT01313286|449164650|FG000|Period 1|Withdrawal by Subject|2|||
124875038|NCT01313286|449164651|FG001|Period 1|Withdrawal by Subject|0|||
124875039|NCT02034708|449164652|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
124875040|NCT02034708|449164653|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
124875041|NCT02034708|449164652|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
124875042|NCT02034708|449164653|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
124875043|NCT02034708|449164652|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
124875044|NCT02034708|449164653|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
124875045|NCT02034708|449164652|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
124875046|NCT02034708|449164653|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
124875047|NCT00654901|449164654|FG000|Overall Study|Lost to Follow-up|1|||
124875048|NCT00654901|449164655|FG001|Overall Study|Lost to Follow-up|0|||
124875049|NCT00654901|449164656|FG002|Overall Study|Lost to Follow-up|1|||
124875050|NCT00654901|449164657|FG003|Overall Study|Lost to Follow-up|0|||
124875051|NCT00654901|449164654|FG000|Overall Study|Withdrawal by Subject|3|||
124875052|NCT00654901|449164655|FG001|Overall Study|Withdrawal by Subject|0|||
124875053|NCT00654901|449164656|FG002|Overall Study|Withdrawal by Subject|1|||
124875054|NCT00654901|449164657|FG003|Overall Study|Withdrawal by Subject|0|||
124875055|NCT04241094|449164666|FG000|Overall Study|Dropped out of treatment|4|||
124875056|NCT04241094|449164666|FG000|Overall Study|Ineligible after clinical assessment|2|||
124875057|NCT04241094|449164666|FG000|Overall Study|Lost to Follow-up|2|||
124875058|NCT02332590|449164669|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
124875059|NCT02332590|449164670|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
124875060|NCT02332590|449164669|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
124875061|NCT02332590|449164670|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
124875062|NCT02332590|449164669|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
124875063|NCT02332590|449164670|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
124875064|NCT02332590|449164669|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
124875065|NCT02332590|449164670|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
124875066|NCT02332590|449164669|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
124875067|NCT02332590|449164670|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
124875068|NCT02332590|449164669|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
124875069|NCT02332590|449164670|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
124875070|NCT02332590|449164669|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
124875071|NCT02332590|449164670|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
124875072|NCT02332590|449164669|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
124875073|NCT02332590|449164670|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
124875074|NCT02332590|449164669|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
124875075|NCT02332590|449164670|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
124875076|NCT04739761|449164675|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
124875077|NCT04739761|449164676|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
124875078|NCT04739761|449164675|FG000|Overall Study|By complete response from the participant|1|||
124875079|NCT04739761|449164676|FG001|Overall Study|By complete response from the participant|0|||
124875080|NCT04739761|449164675|FG000|Overall Study|Lost to Follow-up|3|||
124875081|NCT04739761|449164676|FG001|Overall Study|Lost to Follow-up|3|||
124875082|NCT04739761|449164675|FG000|Overall Study|Death|13|||
124875083|NCT04739761|449164676|FG001|Overall Study|Death|13|||
124875084|NCT04739761|449164675|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
124875085|NCT04739761|449164676|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
124875086|NCT04739761|449164675|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
124875087|NCT04739761|449164676|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
124875088|NCT04739761|449164675|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
124875089|NCT04739761|449164676|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
124875090|NCT04739761|449164675|FG000|Overall Study|Adverse Event|0|||
124875091|NCT04739761|449164676|FG001|Overall Study|Adverse Event|3|||
124433130|NCT02407990|447545389|FG004|Overall Study|Logistics|0|||
124875092|NCT04739761|449164675|FG000|Overall Study|Participant decision|1|||
124875093|NCT04739761|449164676|FG001|Overall Study|Participant decision|0|||
124875094|NCT04739761|449164675|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
124875095|NCT04739761|449164676|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
124875096|NCT04739761|449164675|FG000|Overall Study|Participant immediately started next line of treatment|1|||
124875097|NCT04739761|449164676|FG001|Overall Study|Participant immediately started next line of treatment|0|||
124875098|NCT04739761|449164675|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
124875099|NCT04739761|449164676|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
124875100|NCT04739761|449164675|FG000|Overall Study|Lack of clinical benefit|1|||
124875101|NCT04739761|449164676|FG001|Overall Study|Lack of clinical benefit|0|||
124875102|NCT04739761|449164675|FG000|Overall Study|Disease progression|5|||
124875103|NCT04739761|449164676|FG001|Overall Study|Disease progression|5|||
124875104|NCT04739761|449164675|FG000|Overall Study|Withdrawal by Subject|14|||
124875105|NCT04739761|449164676|FG001|Overall Study|Withdrawal by Subject|13|||
124875106|NCT04739761|449164675|FG000|Overall Study|Protocol Violation|1|||
124875107|NCT04739761|449164676|FG001|Overall Study|Protocol Violation|0|||
124875108|NCT04739761|449164675|FG000|Overall Study|Physician Decision|2|||
124875109|NCT04739761|449164676|FG001|Overall Study|Physician Decision|0|||
124875110|NCT01582789|449165835|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
124875111|NCT01582789|449165836|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
124875112|NCT01191840|449165844|FG000|Overall Study|withdrew consent|2|||
124875113|NCT01191840|449165845|FG001|Overall Study|withdrew consent|1|||
124875114|NCT01191840|449165844|FG000|Overall Study|Subject discontinued treatment|1|||
124875115|NCT01191840|449165845|FG001|Overall Study|Subject discontinued treatment|2|||
124875116|NCT01191840|449165844|FG000|Overall Study|Lost to Follow-up|4|||
124875117|NCT01191840|449165845|FG001|Overall Study|Lost to Follow-up|6|||
124875118|NCT01191840|449165844|FG000|Overall Study|Non Staph Infection|4|||
124875119|NCT01191840|449165845|FG001|Overall Study|Non Staph Infection|3|||
124875120|NCT01191840|449165844|FG000|Overall Study|ineligible at enrollment|1|||
124875121|NCT01191840|449165845|FG001|Overall Study|ineligible at enrollment|0|||
124875122|NCT01191840|449165844|FG000|Overall Study|IRB approval lapse|0|||
124875123|NCT01191840|449165845|FG001|Overall Study|IRB approval lapse|2|||
124875124|NCT01191840|449165844|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
124875125|NCT01191840|449165845|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
124875126|NCT01191840|449165844|FG000|Overall Study|Withdrawal by Subject|2|||
124875127|NCT01191840|449165845|FG001|Overall Study|Withdrawal by Subject|0|||
124875128|NCT01392300|449165846|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
124875129|NCT01392300|449165847|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
124875130|NCT01392300|449165848|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
124875131|NCT01392300|449165846|FG000|Main Period (MP)|Withdrawal by Subject|5|||
124433131|NCT02407990|447545390|FG005|Overall Study|Logistics|0|||
124678366|NCT00784875|448448068|FG003|Period C|Sponsor Decision|2|||
124875132|NCT01392300|449165847|FG001|Main Period (MP)|Withdrawal by Subject|1|||
124875133|NCT01392300|449165848|FG002|Main Period (MP)|Withdrawal by Subject|0|||
124875134|NCT01392300|449165846|FG000|Main Period (MP)|Lost to Follow-up|3|||
124875135|NCT01392300|449165847|FG001|Main Period (MP)|Lost to Follow-up|3|||
124875136|NCT01392300|449165848|FG002|Main Period (MP)|Lost to Follow-up|0|||
124875137|NCT01392300|449165846|FG000|Main Period (MP)|Non-compliance|1|||
124875138|NCT01392300|449165847|FG001|Main Period (MP)|Non-compliance|0|||
124875139|NCT01392300|449165848|FG002|Main Period (MP)|Non-compliance|0|||
124875140|NCT01392300|449165846|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
124875141|NCT01392300|449165847|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
124875142|NCT01392300|449165848|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
124875143|NCT01392300|449165846|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
124875144|NCT01392300|449165847|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
124875145|NCT01392300|449165848|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
124875146|NCT01392300|449165846|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
124875147|NCT01392300|449165847|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
124875148|NCT01392300|449165848|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
124875149|NCT01392300|449165846|FG000|Open Label Extension (OLEX) Period|Death|0|||
124875150|NCT01392300|449165847|FG001|Open Label Extension (OLEX) Period|Death|0|||
124875151|NCT01392300|449165848|FG002|Open Label Extension (OLEX) Period|Death|4|||
124875152|NCT01392300|449165846|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
124875153|NCT01392300|449165847|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
124875154|NCT01392300|449165848|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
124875155|NCT01392300|449165846|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
124875156|NCT01392300|449165847|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
124875157|NCT01392300|449165848|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
124875158|NCT01392300|449165846|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
124875159|NCT01392300|449165847|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
124875160|NCT01392300|449165848|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
124875161|NCT01802437|449165853|FG000|Overall Study|Lost to Follow-up|1|||
124875162|NCT01802437|449165854|FG001|Overall Study|Lost to Follow-up|0|||
124875163|NCT01802437|449165853|FG000|Overall Study|Withdrawal by Subject|3|||
124875164|NCT01802437|449165854|FG001|Overall Study|Withdrawal by Subject|4|||
124875165|NCT01682213|449165862|FG000|Overall Study|Withdrawal by Subject|2|||
124875166|NCT00742079|449165863|FG000|Overall Study|Lost to Follow-up|0|||
124875167|NCT00742079|449165864|FG001|Overall Study|Lost to Follow-up|1|||
124875168|NCT01181726|449165865|FG000|First Intervention|Adverse Event|1|||
124875169|NCT01181726|449165866|FG001|First Intervention|Adverse Event|0|||
124875170|NCT01264380|449165867|FG000|Period C|Disease Progression|0|||
124875171|NCT01264380|449165868|FG001|Period C|Disease Progression|0|||
124875172|NCT01264380|449165869|FG002|Period C|Disease Progression|4|||
124875173|NCT01264380|449165867|FG000|Period C|Death|0|||
124875174|NCT01264380|449165868|FG001|Period C|Death|0|||
124875175|NCT01264380|449165869|FG002|Period C|Death|2|||
124875176|NCT01264380|449165867|FG000|Period C|Follow-up for survival status|0|||
124875177|NCT01264380|449165868|FG001|Period C|Follow-up for survival status|0|||
124875178|NCT01264380|449165869|FG002|Period C|Follow-up for survival status|6|||
124875179|NCT01264380|449165867|FG000|Period C|Withdrawal by Subject|0|||
124875180|NCT01264380|449165868|FG001|Period C|Withdrawal by Subject|0|||
124875181|NCT01264380|449165869|FG002|Period C|Withdrawal by Subject|1|||
124875182|NCT01264380|449165867|FG000|Period C|Adverse Event|0|||
124875183|NCT01264380|449165868|FG001|Period C|Adverse Event|0|||
124875184|NCT01264380|449165869|FG002|Period C|Adverse Event|1|||
124875185|NCT01147822|449165870|FG000|Overall Study|Lost to Follow-up|14|||
124875186|NCT01147822|449165871|FG001|Overall Study|Lost to Follow-up|6|||
124875187|NCT01147822|449165870|FG000|Overall Study|Withdrawal by Subject|10|||
124875188|NCT01147822|449165871|FG001|Overall Study|Withdrawal by Subject|16|||
124875189|NCT01147822|449165870|FG000|Overall Study|Physician Decision|9|||
124875190|NCT01147822|449165871|FG001|Overall Study|Physician Decision|8|||
124875191|NCT01147822|449165870|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
124875192|NCT01147822|449165871|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
124875193|NCT01147822|449165870|FG000|Overall Study|Protocol Violation|1|||
124875194|NCT01147822|449165871|FG001|Overall Study|Protocol Violation|1|||
124875195|NCT04382924|449165873|FG000|Overall Study|Death|2|||
124875196|NCT04382924|449165874|FG001|Overall Study|Death|5|||
124875197|NCT04382924|449165875|FG002|Overall Study|Death|4|||
124875198|NCT04382924|449165873|FG000|Overall Study|Protocol Violation|0|||
124875199|NCT04382924|449165874|FG001|Overall Study|Protocol Violation|1|||
124875200|NCT04382924|449165875|FG002|Overall Study|Protocol Violation|1|||
124875201|NCT04382924|449165873|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
124875202|NCT04382924|449165874|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
124875203|NCT04382924|449165875|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
124875204|NCT04382924|449165873|FG000|Overall Study|Withdrawal by Subject|6|||
124875205|NCT04382924|449165874|FG001|Overall Study|Withdrawal by Subject|3|||
124875206|NCT04382924|449165875|FG002|Overall Study|Withdrawal by Subject|6|||
124875207|NCT02013388|449165878|FG000|Overall Study|work emergency|1|||
124875208|NCT02013388|449165879|FG001|Overall Study|work emergency|0|||
124875209|NCT02013388|449165880|FG002|Overall Study|work emergency|0|||
124875210|NCT02013388|449165881|FG003|Overall Study|work emergency|0|||
124875211|NCT02013388|449165882|FG004|Overall Study|work emergency|1|||
124875212|NCT02013388|449165883|FG005|Overall Study|work emergency|0|||
124875213|NCT02013388|449165884|FG006|Overall Study|work emergency|0|||
124875214|NCT02013388|449165885|FG007|Overall Study|work emergency|0|||
124875215|NCT00429663|449165886|FG000|Overall Study|Lost to Follow-up|24|||
124875216|NCT00429663|449165887|FG001|Overall Study|Lost to Follow-up|31|||
124875217|NCT00429663|449165886|FG000|Overall Study|Physician Decision|6|||
124875218|NCT00429663|449165887|FG001|Overall Study|Physician Decision|3|||
124875219|NCT00429663|449165886|FG000|Overall Study|Withdrawal by Subject|2|||
124875220|NCT00429663|449165887|FG001|Overall Study|Withdrawal by Subject|5|||
124875221|NCT00429663|449165886|FG000|Overall Study|Death|4|||
124875222|NCT00429663|449165887|FG001|Overall Study|Death|0|||
124875223|NCT04207840|449165888|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
124875224|NCT04207840|449165889|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
124875225|NCT04207840|449165890|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
124875226|NCT04207840|449165888|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
124875227|NCT04207840|449165889|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
124875228|NCT04207840|449165890|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
124875229|NCT03243422|449165891|FG000|Overall Study|Death|20|||
124433132|NCT02407990|447545391|FG006|Overall Study|Logistics|0|||
124875230|NCT03243422|449165892|FG001|Overall Study|Death|21|||
124875231|NCT03243422|449165891|FG000|Overall Study|Lost to Follow-up|9|||
124875232|NCT03243422|449165892|FG001|Overall Study|Lost to Follow-up|21|||
124875233|NCT03243422|449165891|FG000|Overall Study|Withdrawal by Subject|22|||
124875234|NCT03243422|449165892|FG001|Overall Study|Withdrawal by Subject|8|||
124875235|NCT03261271|449165896|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
124875236|NCT03261271|449165897|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
124875237|NCT02173054|449165898|FG000|Overall Study|lack of compliance|1|||
124875238|NCT02173054|449165899|FG001|Overall Study|lack of compliance|0|||
124875239|NCT02173054|449165900|FG002|Overall Study|lack of compliance|0|||
124875240|NCT02173054|449165898|FG000|Overall Study|Withdrawal by Subject|0|||
124875241|NCT02173054|449165899|FG001|Overall Study|Withdrawal by Subject|0|||
124875242|NCT02173054|449165900|FG002|Overall Study|Withdrawal by Subject|1|||
124875243|NCT01559454|449165903|FG000|Overall Study|Lost to Follow-up|3|||
124875244|NCT01559454|449165904|FG001|Overall Study|Lost to Follow-up|2|||
124875245|NCT01559454|449165903|FG000|Overall Study|Withdrawal by Subject|0|||
124875246|NCT01559454|449165904|FG001|Overall Study|Withdrawal by Subject|1|||
124875247|NCT01559454|449165903|FG000|Overall Study|Physician Decision|0|||
124875248|NCT01559454|449165904|FG001|Overall Study|Physician Decision|1|||
124875249|NCT01559454|449165903|FG000|Overall Study|Protocol Violation|0|||
124875250|NCT01559454|449165904|FG001|Overall Study|Protocol Violation|1|||
124875251|NCT01559454|449165903|FG000|Overall Study|Lack of Efficacy|0|||
124875252|NCT01559454|449165904|FG001|Overall Study|Lack of Efficacy|1|||
124875253|NCT01114204|449165905|FG000|Overall Study|Adverse Event|3|||
124875254|NCT01114204|449165906|FG001|Overall Study|Adverse Event|2|||
124875255|NCT01114204|449165905|FG000|Overall Study|Lost to Follow-up|1|||
124875256|NCT01114204|449165906|FG001|Overall Study|Lost to Follow-up|0|||
124875257|NCT01114204|449165905|FG000|Overall Study|Withdrawal by Subject|10|||
124875258|NCT01114204|449165906|FG001|Overall Study|Withdrawal by Subject|6|||
124875259|NCT01114204|449165905|FG000|Overall Study|Death|1|||
124875260|NCT01114204|449165906|FG001|Overall Study|Death|0|||
124875261|NCT01114204|449165905|FG000|Overall Study|Other-Personal reasons|2|||
124875262|NCT01114204|449165906|FG001|Overall Study|Other-Personal reasons|0|||
124875263|NCT01114204|449165905|FG000|Overall Study|Other-Medical monitor request|1|||
124875264|NCT01114204|449165906|FG001|Overall Study|Other-Medical monitor request|0|||
124875265|NCT01114204|449165905|FG000|Overall Study|Other-Participant request|2|||
124875266|NCT01114204|449165906|FG001|Overall Study|Other-Participant request|0|||
124875267|NCT01114204|449165905|FG000|Overall Study|Other-Protocol Violation|1|||
124875268|NCT01114204|449165906|FG001|Overall Study|Other-Protocol Violation|0|||
124875269|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
124875270|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
124875271|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
124875272|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
124433133|NCT02407990|447545392|FG007|Overall Study|Logistics|1|||
124433134|NCT02407990|447545385|FG000|Overall Study|Rolled into long-term extension study|0|||
124875273|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
124875274|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
124875275|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
124875276|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
124875277|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
124875278|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
124875279|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
124875280|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
124875281|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
124875282|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
124875283|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
124875284|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
124875285|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
124875286|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
124875287|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
124875288|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
124875289|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Death|2|||
124875290|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Death|2|||
124875291|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Death|0|||
124875292|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Death|0|||
124875293|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Death|0|||
124875294|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
124875295|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
124875296|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
124875297|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
124875298|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
124875299|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
124875300|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
124875301|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
124875302|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
124875303|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
124875304|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
124875305|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
124875306|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
124875307|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
124875308|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
124875309|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
124875310|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
124875311|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
124875312|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
124875313|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
124875314|NCT03420781|449165914|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
124875315|NCT03420781|449165915|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
124875316|NCT03420781|449165916|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
124875317|NCT03420781|449165917|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
124875318|NCT03420781|449165918|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
124875319|NCT03420781|449165914|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
124875320|NCT03420781|449165915|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
124875321|NCT03420781|449165916|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
124875322|NCT03420781|449165917|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
124875323|NCT03420781|449165918|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
124433135|NCT02407990|447545386|FG001|Overall Study|Rolled into long-term extension study|0|||
124433136|NCT02407990|447545387|FG002|Overall Study|Rolled into long-term extension study|0|||
124433137|NCT02407990|447545388|FG003|Overall Study|Rolled into long-term extension study|0|||
124433138|NCT02407990|447545389|FG004|Overall Study|Rolled into long-term extension study|0|||
124433139|NCT02407990|447545390|FG005|Overall Study|Rolled into long-term extension study|0|||
124433140|NCT02407990|447545391|FG006|Overall Study|Rolled into long-term extension study|0|||
124433141|NCT02407990|447545392|FG007|Overall Study|Rolled into long-term extension study|1|||
124433142|NCT00734097|447545393|FG000|Screening|Protocol Violation|12|||
124433143|NCT00734097|447545393|FG000|Screening|Withdrawal by Subject|5|||
124433144|NCT00734097|447545393|FG000|Screening|Lost to Follow-up|2|||
124433145|NCT00734097|447545393|FG000|Screening|Unconfirmed pregnancy|1|||
124433146|NCT00734097|447545393|FG000|Open Label|Lost to Follow-up|7|||
124433147|NCT00734097|447545393|FG000|Open Label|Withdrawal by Subject|5|||
124433148|NCT00734097|447545393|FG000|Open Label|Protocol Violation|4|||
124433149|NCT02233543|447545400|FG000|Period 1|Withdrawal by Subject|1|||
124433150|NCT02233543|447545401|FG001|Period 1|Withdrawal by Subject|0|||
124433151|NCT02233543|447545400|FG000|Period 1|Participants required other treatment.|2|||
124433152|NCT02233543|447545401|FG001|Period 1|Participants required other treatment.|3|||
124875324|NCT03420781|449165914|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
124875325|NCT03420781|449165915|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
124875326|NCT03420781|449165916|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
124433153|NCT02233543|447545400|FG000|Period 2|Adverse Event|1|||
124875327|NCT03420781|449165917|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
124433154|NCT02233543|447545401|FG001|Period 2|Adverse Event|0|||
124433155|NCT02233543|447545400|FG000|Period 2|Participant required other treatment.|0|||
124678367|NCT00784875|448448065|FG000|Period D|Adverse Event|0|||
124678368|NCT00784875|448448066|FG001|Period D|Adverse Event|2|||
124678369|NCT00784875|448448067|FG002|Period D|Adverse Event|2|||
124433156|NCT02233543|447545401|FG001|Period 2|Participant required other treatment.|1|||
124433157|NCT02233543|447545400|FG000|Period 2|COPD exacerbation|1|||
124433158|NCT02233543|447545401|FG001|Period 2|COPD exacerbation|0|||
124433159|NCT03573583|447545402|FG000|Overall Study|Lost to Follow-up|1|||
124433160|NCT03573583|447545403|FG001|Overall Study|Lost to Follow-up|0|||
124433161|NCT03573583|447545402|FG000|Overall Study|Withdrawal by Subject|1|||
124433162|NCT03573583|447545403|FG001|Overall Study|Withdrawal by Subject|1|||
124433163|NCT03730480|447545408|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
124433164|NCT01227577|447545409|FG000|Overall Study|Protocol deviation|3|||
124433165|NCT01227577|447545409|FG000|Overall Study|Death|3|||
124433166|NCT01227577|447545409|FG000|Overall Study|Administrative problems|2|||
124433167|NCT01227577|447545409|FG000|Overall Study|Lost to Follow-up|1|||
124433168|NCT01227577|447545409|FG000|Overall Study|Withdrawal by Subject|4|||
124433169|NCT01227577|447545409|FG000|Overall Study|Lack of Efficacy|5|||
124433170|NCT01227577|447545409|FG000|Overall Study|Adverse Event|17|||
124433171|NCT00852540|447545410|FG000|Overall Study|Adverse Event|10|||
124433172|NCT00852540|447545411|FG001|Overall Study|Adverse Event|3|||
124433173|NCT00852540|447545410|FG000|Overall Study|Lack of Efficacy|15|||
124433174|NCT00852540|447545411|FG001|Overall Study|Lack of Efficacy|3|||
124433175|NCT00852540|447545410|FG000|Overall Study|Protocol Violation|1|||
124433176|NCT00852540|447545411|FG001|Overall Study|Protocol Violation|2|||
124433177|NCT00852540|447545410|FG000|Overall Study|Lost to Follow-up|2|||
124433178|NCT00852540|447545411|FG001|Overall Study|Lost to Follow-up|3|||
124433179|NCT00852540|447545410|FG000|Overall Study|Investigator Discretion|2|||
124433180|NCT00852540|447545411|FG001|Overall Study|Investigator Discretion|3|||
124433181|NCT00852540|447545410|FG000|Overall Study|Withdrawal by Subject|3|||
124433182|NCT00852540|447545411|FG001|Overall Study|Withdrawal by Subject|1|||
124433183|NCT00852540|447545410|FG000|Overall Study|Did Not Receive Study Drug|3|||
124433184|NCT00852540|447545411|FG001|Overall Study|Did Not Receive Study Drug|3|||
124433185|NCT01639495|447545412|FG000|Overall Study|Lost to Follow-up|6|||
124433186|NCT01639495|447545412|FG000|Overall Study|Consented but didn't have study catheter|4|||
124433187|NCT01639495|447545412|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
124433188|NCT01639495|447545412|FG000|Overall Study|No radiofrequency energy applied|2|||
124433189|NCT01183234|447545413|FG000|First Intervention|Adverse Event|1|||
124433190|NCT01183234|447545414|FG001|First Intervention|Adverse Event|0|||
124433191|NCT01639560|447545417|FG000|Overall Study|Withdrawal by Subject|9|||
124433192|NCT01639560|447545418|FG001|Overall Study|Withdrawal by Subject|14|||
124433193|NCT01639560|447545417|FG000|Overall Study|Lack of Efficacy|1|||
124433194|NCT01639560|447545418|FG001|Overall Study|Lack of Efficacy|2|||
124433195|NCT01639560|447545417|FG000|Overall Study|Lost to Follow-up|9|||
124433196|NCT01639560|447545418|FG001|Overall Study|Lost to Follow-up|11|||
124433197|NCT01639560|447545417|FG000|Overall Study|Adverse Event|0|||
124433198|NCT01639560|447545418|FG001|Overall Study|Adverse Event|2|||
124433199|NCT01156792|447545422|FG000|Overall Study|Adverse Event|1|||
124433200|NCT01156792|447545422|FG000|Overall Study|Lack of Efficacy|36|||
124433201|NCT01156792|447545422|FG000|Overall Study|Protocol Violation|6|||
124433202|NCT01156792|447545422|FG000|Overall Study|Lost to Follow-up|3|||
124433203|NCT01156792|447545422|FG000|Overall Study|Physician Decision|3|||
124433204|NCT01156792|447545422|FG000|Overall Study|Withdrawal by Subject|9|||
124433205|NCT01156792|447545422|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
124433206|NCT01474434|447545423|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
124433207|NCT01474434|447545424|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
124433208|NCT01474434|447545425|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
124433209|NCT01474434|447545426|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
124433210|NCT01474434|447545423|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
124433211|NCT01474434|447545424|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
124433212|NCT01474434|447545425|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
124433213|NCT01474434|447545426|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
124433214|NCT01474434|447545423|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
124433215|NCT01474434|447545424|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
124433216|NCT01474434|447545425|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
124433217|NCT01474434|447545426|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
124433218|NCT02971761|447545430|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
124433219|NCT01605916|447545431|FG000|Overall Study|Adverse Event|1|||
124433220|NCT01605916|447545432|FG001|Overall Study|Adverse Event|0|||
124678370|NCT00784875|448448068|FG003|Period D|Adverse Event|0|||
124433221|NCT01605916|447545433|FG002|Overall Study|Adverse Event|0|||
124433222|NCT01605916|447545434|FG003|Overall Study|Adverse Event|1|||
124433223|NCT01605916|447545435|FG004|Overall Study|Adverse Event|0|||
124433224|NCT01605916|447545431|FG000|Overall Study|Lack of Efficacy|2|||
124433225|NCT01605916|447545432|FG001|Overall Study|Lack of Efficacy|3|||
124433226|NCT01605916|447545433|FG002|Overall Study|Lack of Efficacy|3|||
124678371|NCT00784875|448448065|FG000|Period D|Protocol Violation|1|||
124678372|NCT00784875|448448066|FG001|Period D|Protocol Violation|0|||
124433227|NCT01605916|447545434|FG003|Overall Study|Lack of Efficacy|5|||
124433228|NCT01605916|447545435|FG004|Overall Study|Lack of Efficacy|4|||
124433229|NCT01605916|447545431|FG000|Overall Study|Withdrawal by Subject|1|||
124433230|NCT01605916|447545432|FG001|Overall Study|Withdrawal by Subject|1|||
124433231|NCT01605916|447545433|FG002|Overall Study|Withdrawal by Subject|0|||
124433232|NCT01605916|447545434|FG003|Overall Study|Withdrawal by Subject|0|||
124433233|NCT01605916|447545435|FG004|Overall Study|Withdrawal by Subject|2|||
124433234|NCT02549196|447545445|FG000|Overall Study|Protocol Violation|0|||
124433235|NCT02549196|447545446|FG001|Overall Study|Protocol Violation|0|||
124433236|NCT02549196|447545447|FG002|Overall Study|Protocol Violation|0|||
124433237|NCT02549196|447545448|FG003|Overall Study|Protocol Violation|1|||
124433238|NCT02549196|447545445|FG000|Overall Study|Withdrawal by Subject|1|||
124433239|NCT02549196|447545446|FG001|Overall Study|Withdrawal by Subject|0|||
124433240|NCT02549196|447545447|FG002|Overall Study|Withdrawal by Subject|1|||
124433241|NCT02549196|447545448|FG003|Overall Study|Withdrawal by Subject|0|||
124433242|NCT01103362|447545451|FG000|Overall Study|study terminated|596|||
124433243|NCT03265938|447545453|FG000|Overall Study|Withdrawal by Subject|1|||
124433244|NCT03265938|447545453|FG000|Overall Study|Physician Decision|1|||
124433245|NCT03265938|447545453|FG000|Overall Study|friable mass|6|||
124433246|NCT02679508|447545454|FG000|Healing Phase|Protocol Violation|1|||
124433247|NCT02679508|447545455|FG001|Healing Phase|Protocol Violation|1|||
124433248|NCT02679508|447545454|FG000|Healing Phase|Lost to Follow-up|1|||
124433249|NCT02679508|447545455|FG001|Healing Phase|Lost to Follow-up|0|||
124433250|NCT02679508|447545454|FG000|Maintenance Phase|Adverse Event|12|||
124433251|NCT02679508|447545455|FG001|Maintenance Phase|Adverse Event|2|||
124433252|NCT02679508|447545454|FG000|Maintenance Phase|Lost to Follow-up|0|||
124433253|NCT02679508|447545455|FG001|Maintenance Phase|Lost to Follow-up|1|||
124433254|NCT02679508|447545454|FG000|Maintenance Phase|Withdrawal by Subject|15|||
124433255|NCT02679508|447545455|FG001|Maintenance Phase|Withdrawal by Subject|8|||
124433256|NCT02679508|447545454|FG000|Maintenance Phase|Other|5|||
124433257|NCT02679508|447545455|FG001|Maintenance Phase|Other|4|||
124433258|NCT03143166|447545456|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
124433259|NCT03538301|447545459|FG000|Overall Study|Adverse Event|1|||
124433260|NCT03538301|447545460|FG001|Overall Study|Adverse Event|4|||
124433261|NCT03538301|447545461|FG002|Overall Study|Adverse Event|4|||
124433262|NCT03538301|447545459|FG000|Overall Study|Death|1|||
124433263|NCT03538301|447545460|FG001|Overall Study|Death|1|||
124433264|NCT03538301|447545461|FG002|Overall Study|Death|0|||
124433265|NCT03538301|447545459|FG000|Overall Study|Physician Decision|0|||
124433266|NCT03538301|447545460|FG001|Overall Study|Physician Decision|1|||
124433267|NCT03538301|447545461|FG002|Overall Study|Physician Decision|0|||
124433268|NCT03538301|447545459|FG000|Overall Study|Protocol Violation|0|||
124433269|NCT03538301|447545460|FG001|Overall Study|Protocol Violation|0|||
124433270|NCT03538301|447545461|FG002|Overall Study|Protocol Violation|1|||
124433271|NCT03538301|447545459|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
124433272|NCT03538301|447545460|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
124433273|NCT03538301|447545461|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
124433274|NCT02842151|447545464|FG000|Overall Study|Adverse Event|1|||
124433275|NCT02842151|447545464|FG000|Overall Study|Subject moved too far away|1|||
124433276|NCT01879553|447545465|FG000|Overall Study|Withdrawal by Subject|1|||
124433277|NCT01879553|447545466|FG001|Overall Study|Withdrawal by Subject|0|||
124433278|NCT02559895|447545468|FG000|Overall Study|Adverse Event|3|||
124433279|NCT02559895|447545469|FG001|Overall Study|Adverse Event|3|||
124433280|NCT02559895|447545470|FG002|Overall Study|Adverse Event|2|||
124433281|NCT02559895|447545471|FG003|Overall Study|Adverse Event|1|||
124433282|NCT02559895|447545468|FG000|Overall Study|Lack of Efficacy|2|||
124433283|NCT02559895|447545469|FG001|Overall Study|Lack of Efficacy|3|||
124433284|NCT02559895|447545470|FG002|Overall Study|Lack of Efficacy|2|||
124433285|NCT02559895|447545471|FG003|Overall Study|Lack of Efficacy|8|||
124433286|NCT02559895|447545468|FG000|Overall Study|Lost to Follow-up|22|||
124433287|NCT02559895|447545469|FG001|Overall Study|Lost to Follow-up|16|||
124433288|NCT02559895|447545470|FG002|Overall Study|Lost to Follow-up|12|||
124433289|NCT02559895|447545471|FG003|Overall Study|Lost to Follow-up|17|||
124433290|NCT02559895|447545468|FG000|Overall Study|Physician Decision|1|||
124433291|NCT02559895|447545469|FG001|Overall Study|Physician Decision|1|||
124433292|NCT02559895|447545470|FG002|Overall Study|Physician Decision|3|||
124433293|NCT02559895|447545471|FG003|Overall Study|Physician Decision|0|||
124433294|NCT02559895|447545468|FG000|Overall Study|Withdrawal by Subject|16|||
124433295|NCT02559895|447545469|FG001|Overall Study|Withdrawal by Subject|9|||
124433296|NCT02559895|447545470|FG002|Overall Study|Withdrawal by Subject|20|||
124433297|NCT02559895|447545471|FG003|Overall Study|Withdrawal by Subject|9|||
124433298|NCT02559895|447545468|FG000|Overall Study|Study Burden|10|||
124433299|NCT02559895|447545469|FG001|Overall Study|Study Burden|16|||
124433300|NCT02559895|447545470|FG002|Overall Study|Study Burden|12|||
124433301|NCT02559895|447545471|FG003|Overall Study|Study Burden|22|||
124433302|NCT02559895|447545468|FG000|Overall Study|Other|1|||
124433303|NCT02559895|447545469|FG001|Overall Study|Other|5|||
124433304|NCT02559895|447545470|FG002|Overall Study|Other|3|||
124433305|NCT02559895|447545471|FG003|Overall Study|Other|3|||
124433306|NCT04540887|447545477|FG000|Overall Study|Withdrawal by Subject|2|||
124433307|NCT01262027|447545478|FG000|Overall Study|Adverse Event|1|||
124433308|NCT01262027|447545478|FG000|Overall Study|Withdrawal by Subject|3|||
124433309|NCT01262027|447545478|FG000|Overall Study|Protocol Violation|1|||
124433310|NCT02665338|447545483|FG000|Overall Study|Withdrawal by Subject|0|||
124433311|NCT02665338|447545484|FG001|Overall Study|Withdrawal by Subject|1|||
124433312|NCT00589121|447545485|FG000|Overall Study|Protocol Violation|2|||
124433313|NCT00589121|447545486|FG001|Overall Study|Protocol Violation|6|||
124433314|NCT00589121|447545485|FG000|Overall Study|No protocol treatment received|0|||
124433315|NCT00589121|447545486|FG001|Overall Study|No protocol treatment received|1|||
124433316|NCT01028027|447545487|FG000|Overall Study|Lost to Follow-up|4|||
124433317|NCT01028027|447545488|FG001|Overall Study|Lost to Follow-up|1|||
124433318|NCT01028027|447545487|FG000|Overall Study|Withdrawal by Subject|5|||
124433319|NCT01028027|447545488|FG001|Overall Study|Withdrawal by Subject|3|||
124433320|NCT01028027|447545487|FG000|Overall Study|Adverse Event|4|||
124433321|NCT01028027|447545488|FG001|Overall Study|Adverse Event|7|||
124433322|NCT01028027|447545487|FG000|Overall Study|Protocol Violation|3|||
124433323|NCT01028027|447545488|FG001|Overall Study|Protocol Violation|1|||
124433324|NCT01028027|447545487|FG000|Overall Study|Lack of Efficacy|0|||
124433325|NCT01028027|447545488|FG001|Overall Study|Lack of Efficacy|1|||
124433326|NCT05000931|447545497|FG000|Overall Study|Lost to Follow-up|1|||
124433327|NCT03562975|447545498|FG000|Overall Study|Death|1|||
124433328|NCT03562975|447545498|FG000|Overall Study|Lost to Follow-up|1|||
124433329|NCT03562975|447545498|FG000|Overall Study|Withdrawal by Subject|1|||
124433330|NCT00979134|447545499|FG000|Overall Study|Disease progression|18|||
124433331|NCT00979134|447545500|FG001|Overall Study|Disease progression|2|||
124433332|NCT00979134|447545501|FG002|Overall Study|Disease progression|5|||
124433333|NCT00979134|447545499|FG000|Overall Study|Adverse Event|0|||
124433334|NCT00979134|447545500|FG001|Overall Study|Adverse Event|0|||
124433335|NCT00979134|447545501|FG002|Overall Study|Adverse Event|2|||
124433336|NCT00979134|447545499|FG000|Overall Study|Withdrawal by Subject|1|||
124433337|NCT00979134|447545500|FG001|Overall Study|Withdrawal by Subject|1|||
124433338|NCT00979134|447545501|FG002|Overall Study|Withdrawal by Subject|2|||
124433339|NCT00979134|447545499|FG000|Overall Study|Lost to Follow-up|2|||
124433340|NCT00979134|447545500|FG001|Overall Study|Lost to Follow-up|2|||
124433341|NCT00979134|447545501|FG002|Overall Study|Lost to Follow-up|0|||
124433342|NCT00979134|447545499|FG000|Overall Study|Death|4|||
124433343|NCT00979134|447545500|FG001|Overall Study|Death|0|||
124433344|NCT00979134|447545501|FG002|Overall Study|Death|26|||
124433345|NCT00979134|447545499|FG000|Overall Study|Other|8|||
124433346|NCT00979134|447545500|FG001|Overall Study|Other|1|||
124433347|NCT00979134|447545501|FG002|Overall Study|Other|5|||
124433348|NCT05180500|447545502|FG000|Overall Study|Adverse Event|1|||
124433349|NCT05180500|447545503|FG001|Overall Study|Adverse Event|0|||
124433350|NCT05180500|447545502|FG000|Overall Study|Withdrawal by Subject|2|||
124433351|NCT05180500|447545503|FG001|Overall Study|Withdrawal by Subject|0|||
124433352|NCT05917470|447545504|FG000|Overall Study|Progressive Disease|1|||
124433353|NCT05917470|447545505|FG001|Overall Study|Progressive Disease|1|||
124433354|NCT05917470|447545506|FG002|Overall Study|Progressive Disease|2|||
124433355|NCT05917470|447545507|FG003|Overall Study|Progressive Disease|3|||
124433356|NCT05917470|447545508|FG004|Overall Study|Progressive Disease|1|||
124433357|NCT05917470|447545509|FG005|Overall Study|Progressive Disease|1|||
124433358|NCT05917470|447545510|FG006|Overall Study|Progressive Disease|0|||
124433359|NCT05917470|447545511|FG007|Overall Study|Progressive Disease|0|||
124433360|NCT05917470|447545504|FG000|Overall Study|Withdrawal by Subject|0|||
124433361|NCT05917470|447545505|FG001|Overall Study|Withdrawal by Subject|0|||
124433362|NCT05917470|447545506|FG002|Overall Study|Withdrawal by Subject|1|||
124433363|NCT05917470|447545507|FG003|Overall Study|Withdrawal by Subject|0|||
124433364|NCT05917470|447545508|FG004|Overall Study|Withdrawal by Subject|0|||
124433365|NCT05917470|447545509|FG005|Overall Study|Withdrawal by Subject|0|||
124433366|NCT05917470|447545510|FG006|Overall Study|Withdrawal by Subject|0|||
124433367|NCT05917470|447545511|FG007|Overall Study|Withdrawal by Subject|0|||
124433368|NCT05917470|447545504|FG000|Overall Study|Sponsor Decision|0|||
124433369|NCT05917470|447545505|FG001|Overall Study|Sponsor Decision|0|||
124433370|NCT05917470|447545506|FG002|Overall Study|Sponsor Decision|1|||
124433371|NCT05917470|447545507|FG003|Overall Study|Sponsor Decision|0|||
124433372|NCT05917470|447545508|FG004|Overall Study|Sponsor Decision|2|||
124433373|NCT05917470|447545509|FG005|Overall Study|Sponsor Decision|1|||
124433374|NCT05917470|447545510|FG006|Overall Study|Sponsor Decision|3|||
124433375|NCT05917470|447545511|FG007|Overall Study|Sponsor Decision|3|||
124433376|NCT05917470|447545504|FG000|Overall Study|Adverse Event|0|||
124433377|NCT05917470|447545505|FG001|Overall Study|Adverse Event|0|||
124433378|NCT05917470|447545506|FG002|Overall Study|Adverse Event|0|||
124433379|NCT05917470|447545507|FG003|Overall Study|Adverse Event|0|||
124433380|NCT05917470|447545508|FG004|Overall Study|Adverse Event|0|||
124433381|NCT05917470|447545509|FG005|Overall Study|Adverse Event|1|||
124433382|NCT05917470|447545510|FG006|Overall Study|Adverse Event|0|||
124433383|NCT05917470|447545511|FG007|Overall Study|Adverse Event|0|||
124433384|NCT03694275|447548120|FG000|Overall Study|Adverse Event|0|||
124433385|NCT03694275|447548121|FG001|Overall Study|Adverse Event|1|||
124433386|NCT03694275|447548120|FG000|Overall Study|Reason not Specified|0|||
124433387|NCT03694275|447548121|FG001|Overall Study|Reason not Specified|1|||
124433388|NCT03695237|447548122|FG000|Overall Study|Withdrawal by Subject|1|||
124433389|NCT03695237|447548123|FG001|Overall Study|Withdrawal by Subject|3|||
124433390|NCT03695237|447548122|FG000|Overall Study|Lost to Follow-up|1|||
124433391|NCT03695237|447548123|FG001|Overall Study|Lost to Follow-up|2|||
124875328|NCT03420781|449165918|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
124433392|NCT03695237|447548122|FG000|Overall Study|Other, Not Specified|8|||
124433393|NCT03695237|447548123|FG001|Overall Study|Other, Not Specified|2|||
124433394|NCT03541174|447548124|FG000|Part 1 Double-Blind|Adverse Event|6|||
124433395|NCT03541174|447548125|FG001|Part 1 Double-Blind|Adverse Event|5|||
124433396|NCT03541174|447548126|FG002|Part 1 Double-Blind|Adverse Event|2|||
124433397|NCT03541174|447548127|FG003|Part 1 Double-Blind|Adverse Event|0|||
124433398|NCT03541174|447548128|FG004|Part 1 Double-Blind|Adverse Event|0|||
124433399|NCT03541174|447548129|FG005|Part 1 Double-Blind|Adverse Event|0|||
124433400|NCT03541174|447548124|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
124433401|NCT03541174|447548125|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
124433402|NCT03541174|447548126|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
124433403|NCT03541174|447548127|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
124433404|NCT03541174|447548128|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
124433405|NCT03541174|447548129|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
124433406|NCT03541174|447548124|FG000|Part 1 Double-Blind|Other reasons|3|||
124433407|NCT03541174|447548125|FG001|Part 1 Double-Blind|Other reasons|2|||
124433408|NCT03541174|447548126|FG002|Part 1 Double-Blind|Other reasons|3|||
124433409|NCT03541174|447548127|FG003|Part 1 Double-Blind|Other reasons|0|||
124433410|NCT03541174|447548128|FG004|Part 1 Double-Blind|Other reasons|0|||
124433411|NCT03541174|447548129|FG005|Part 1 Double-Blind|Other reasons|0|||
124433412|NCT03541174|447548124|FG000|Part 2 Single-Blind|Adverse Event|0|||
124433413|NCT03541174|447548125|FG001|Part 2 Single-Blind|Adverse Event|0|||
124433414|NCT03541174|447548126|FG002|Part 2 Single-Blind|Adverse Event|0|||
124433415|NCT03541174|447548127|FG003|Part 2 Single-Blind|Adverse Event|25|||
124433416|NCT03541174|447548128|FG004|Part 2 Single-Blind|Adverse Event|0|||
124433417|NCT03541174|447548129|FG005|Part 2 Single-Blind|Adverse Event|0|||
124433418|NCT03541174|447548124|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
124433419|NCT03541174|447548125|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
124433420|NCT03541174|447548126|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
124433421|NCT03541174|447548127|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
124433422|NCT03541174|447548128|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
124433423|NCT03541174|447548129|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
124433424|NCT03541174|447548124|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
124433425|NCT03541174|447548125|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
124433426|NCT03541174|447548126|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
124433427|NCT03541174|447548127|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
124433428|NCT03541174|447548128|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
124433429|NCT03541174|447548129|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
124433430|NCT03541174|447548124|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
124433431|NCT03541174|447548125|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
124433432|NCT03541174|447548126|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
124433433|NCT03541174|447548127|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
124433434|NCT03541174|447548128|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
124433435|NCT03541174|447548129|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
124433436|NCT03541174|447548124|FG000|Part 2 Single-Blind|Death|0|||
124433437|NCT03541174|447548125|FG001|Part 2 Single-Blind|Death|0|||
124433438|NCT03541174|447548126|FG002|Part 2 Single-Blind|Death|0|||
124433439|NCT03541174|447548127|FG003|Part 2 Single-Blind|Death|5|||
124433440|NCT03541174|447548128|FG004|Part 2 Single-Blind|Death|0|||
124433441|NCT03541174|447548129|FG005|Part 2 Single-Blind|Death|0|||
124433442|NCT03541174|447548124|FG000|Part 2 Single-Blind|Pregnancy|0|||
124433443|NCT03541174|447548125|FG001|Part 2 Single-Blind|Pregnancy|0|||
124433444|NCT03541174|447548126|FG002|Part 2 Single-Blind|Pregnancy|0|||
124433445|NCT03541174|447548127|FG003|Part 2 Single-Blind|Pregnancy|1|||
124433446|NCT03541174|447548128|FG004|Part 2 Single-Blind|Pregnancy|0|||
124433447|NCT03541174|447548129|FG005|Part 2 Single-Blind|Pregnancy|0|||
124433448|NCT03541174|447548124|FG000|Part 2 Single-Blind|Other reasons|0|||
124433449|NCT03541174|447548125|FG001|Part 2 Single-Blind|Other reasons|0|||
124433450|NCT03541174|447548126|FG002|Part 2 Single-Blind|Other reasons|0|||
124433451|NCT03541174|447548127|FG003|Part 2 Single-Blind|Other reasons|32|||
124433452|NCT03541174|447548128|FG004|Part 2 Single-Blind|Other reasons|0|||
124433453|NCT03541174|447548129|FG005|Part 2 Single-Blind|Other reasons|0|||
124433454|NCT03541174|447548124|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
124433455|NCT03541174|447548125|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
124433456|NCT03541174|447548126|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
124433457|NCT03541174|447548127|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
124433458|NCT03541174|447548128|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
124433459|NCT03541174|447548129|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
124433460|NCT03541174|447548124|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
124433461|NCT03541174|447548125|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
124433462|NCT03541174|447548126|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
124433463|NCT03541174|447548127|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
124433464|NCT03541174|447548128|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
124433465|NCT03541174|447548129|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
124433466|NCT03541174|447548124|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
124433467|NCT03541174|447548125|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
124433468|NCT03541174|447548126|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
124433469|NCT03541174|447548127|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
124433470|NCT03541174|447548128|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
124433471|NCT03541174|447548129|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
124433472|NCT03541174|447548124|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
124433473|NCT03541174|447548125|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
124433474|NCT03541174|447548126|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
124433475|NCT03541174|447548127|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
124433476|NCT03541174|447548128|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
124678373|NCT00784875|448448067|FG002|Period D|Protocol Violation|0|||
124969497|NCT03520075|449517410|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124433477|NCT03541174|447548129|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
124433478|NCT03541174|447548124|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
124433479|NCT03541174|447548125|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
124433480|NCT03541174|447548126|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
124433481|NCT03541174|447548127|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
124433482|NCT03541174|447548128|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
124433483|NCT03541174|447548129|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
124433484|NCT02217332|447548132|FG000|Overall Study|Adverse Event|3|||
124433485|NCT02217332|447548132|FG000|Overall Study|Dose interruption >1 month|1|||
124433486|NCT02217332|447548132|FG000|Overall Study|Protocol Violation (eligibility)|1|||
124433487|NCT02217332|447548132|FG000|Overall Study|Withdrawal by Subject|1|||
124433488|NCT02217332|447548132|FG000|Overall Study|Lost to Follow-up|1|||
124433489|NCT04058366|447548133|FG000|Overall Study|Adverse Event|14|||
124433490|NCT04058366|447548133|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
124433491|NCT04058366|447548133|FG000|Overall Study|Commercial drug is available for participants|6|||
124433492|NCT04058366|447548133|FG000|Overall Study|Death|1|||
124433493|NCT04058366|447548133|FG000|Overall Study|Other non-compliance|2|||
124433494|NCT04058366|447548133|FG000|Overall Study|Other|6|||
124433495|NCT00603304|447548134|FG000|Overall Study|Lost to Follow-up|5|||
124433496|NCT00603304|447548135|FG001|Overall Study|Lost to Follow-up|7|||
124433497|NCT00603304|447548134|FG000|Overall Study|Withdrawal by Subject|8|||
124433498|NCT00603304|447548135|FG001|Overall Study|Withdrawal by Subject|5|||
124433499|NCT00603304|447548134|FG000|Overall Study|Protocol Violation|1|||
124433500|NCT00603304|447548135|FG001|Overall Study|Protocol Violation|0|||
124433501|NCT00603304|447548134|FG000|Overall Study|Adverse Event|4|||
124433502|NCT00603304|447548135|FG001|Overall Study|Adverse Event|2|||
124433503|NCT00603304|447548134|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
124433504|NCT00603304|447548135|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
124433505|NCT00603304|447548134|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
124433506|NCT00603304|447548135|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
124433507|NCT00603304|447548134|FG000|Overall Study|Exclusionary Medication|2|||
124433508|NCT00603304|447548135|FG001|Overall Study|Exclusionary Medication|3|||
124433509|NCT00603304|447548134|FG000|Overall Study|Non-Compliant|0|||
124433510|NCT00603304|447548135|FG001|Overall Study|Non-Compliant|1|||
124433511|NCT00603304|447548134|FG000|Overall Study|Moved Away|0|||
124433512|NCT00603304|447548135|FG001|Overall Study|Moved Away|2|||
124433513|NCT00603304|447548134|FG000|Overall Study|Other|2|||
124433514|NCT00603304|447548135|FG001|Overall Study|Other|0|||
124433515|NCT00603304|447548134|FG000|Overall Study|Patient Decision|2|||
124433516|NCT00603304|447548135|FG001|Overall Study|Patient Decision|0|||
124433517|NCT02480153|447548136|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
124433518|NCT02480153|447548137|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
124433519|NCT02480153|447548138|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
124433520|NCT02480153|447548136|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
124433521|NCT02480153|447548137|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
124433522|NCT02480153|447548138|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
124433523|NCT02480153|447548136|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
124433524|NCT02480153|447548137|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
124433525|NCT02480153|447548138|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
124433526|NCT02480153|447548136|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
124433527|NCT02480153|447548137|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
124433528|NCT02480153|447548138|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
124433529|NCT02480153|447548136|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
124433530|NCT02480153|447548137|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
124433531|NCT02480153|447548138|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
124433532|NCT02480153|447548136|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
124433533|NCT02480153|447548137|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
124433534|NCT02480153|447548138|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
124433535|NCT02480153|447548136|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
124433536|NCT02480153|447548137|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
124433537|NCT02480153|447548138|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
124433538|NCT02480153|447548136|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
124433539|NCT02480153|447548137|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
124433540|NCT02480153|447548138|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
124433541|NCT02480153|447548136|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
124433542|NCT02480153|447548137|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
124433543|NCT02480153|447548138|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
124433544|NCT02480153|447548136|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
124433545|NCT02480153|447548137|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
124433546|NCT02480153|447548138|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
124433547|NCT02480153|447548136|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
124433548|NCT02480153|447548137|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
124433549|NCT02480153|447548138|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
124433550|NCT02480153|447548136|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
124433551|NCT02480153|447548137|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
124433552|NCT02480153|447548138|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
124433553|NCT02480153|447548136|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
124433554|NCT02480153|447548137|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
124433555|NCT02480153|447548138|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
124433556|NCT02480153|447548136|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
124433557|NCT02480153|447548137|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
124433558|NCT02480153|447548138|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
124433559|NCT02480153|447548136|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
124433560|NCT02480153|447548137|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
124433561|NCT02480153|447548138|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
124433562|NCT02480153|447548136|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
124433563|NCT02480153|447548137|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
124433564|NCT02480153|447548138|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
124433565|NCT02480153|447548136|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
124433566|NCT02480153|447548137|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
124433567|NCT02480153|447548138|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
124433568|NCT02480153|447548136|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
124433569|NCT02480153|447548137|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
124433570|NCT02480153|447548138|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
124433571|NCT00512317|447548139|FG000|Overall Study|Insufficient clinical response|36|||
124433572|NCT00512317|447548139|FG000|Overall Study|Withdrawal by Subject|23|||
124433573|NCT00512317|447548139|FG000|Overall Study|Sponsor closure of study|21|||
124433574|NCT00512317|447548139|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
124433575|NCT00512317|447548139|FG000|Overall Study|Adverse Event|13|||
124433576|NCT00512317|447548139|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
124433577|NCT00512317|447548139|FG000|Overall Study|Lost to Follow-up|2|||
124433578|NCT00512317|447548139|FG000|Overall Study|Other|2|||
124433579|NCT04433585|447548140|FG000|Overall Study|Withdrawal by Subject|15|||
124433580|NCT04433585|447548141|FG001|Overall Study|Withdrawal by Subject|3|||
124433581|NCT04433585|447548142|FG002|Overall Study|Withdrawal by Subject|15|||
124433582|NCT04433585|447548143|FG003|Overall Study|Withdrawal by Subject|6|||
124433583|NCT04433585|447548140|FG000|Overall Study|Adverse Event|10|||
124433584|NCT04433585|447548141|FG001|Overall Study|Adverse Event|4|||
124433585|NCT04433585|447548142|FG002|Overall Study|Adverse Event|1|||
124433586|NCT04433585|447548143|FG003|Overall Study|Adverse Event|0|||
124433587|NCT04433585|447548140|FG000|Overall Study|Due to the conflict in Ukraine|2|||
124433588|NCT04433585|447548141|FG001|Overall Study|Due to the conflict in Ukraine|1|||
124433589|NCT04433585|447548142|FG002|Overall Study|Due to the conflict in Ukraine|1|||
124433590|NCT04433585|447548143|FG003|Overall Study|Due to the conflict in Ukraine|2|||
124433591|NCT04433585|447548140|FG000|Overall Study|Physician Decision|1|||
124433592|NCT04433585|447548141|FG001|Overall Study|Physician Decision|2|||
124433593|NCT04433585|447548142|FG002|Overall Study|Physician Decision|0|||
124433594|NCT04433585|447548143|FG003|Overall Study|Physician Decision|0|||
124433595|NCT04433585|447548140|FG000|Overall Study|Lost to Follow-up|1|||
124433596|NCT04433585|447548141|FG001|Overall Study|Lost to Follow-up|1|||
124433597|NCT04433585|447548142|FG002|Overall Study|Lost to Follow-up|1|||
124433598|NCT04433585|447548143|FG003|Overall Study|Lost to Follow-up|0|||
124433599|NCT04433585|447548140|FG000|Overall Study|Lack of Efficacy|0|||
124433600|NCT04433585|447548141|FG001|Overall Study|Lack of Efficacy|1|||
124433601|NCT04433585|447548142|FG002|Overall Study|Lack of Efficacy|1|||
124433602|NCT04433585|447548143|FG003|Overall Study|Lack of Efficacy|1|||
124433603|NCT04433585|447548140|FG000|Overall Study|Death|0|||
124433604|NCT04433585|447548141|FG001|Overall Study|Death|1|||
124433605|NCT04433585|447548142|FG002|Overall Study|Death|0|||
124433606|NCT04433585|447548143|FG003|Overall Study|Death|0|||
124433607|NCT03606668|447548146|FG000|Overall Study|Screen Failure|1|||
124433608|NCT03606668|447548146|FG000|Overall Study|Lost to Follow-up|1|||
124433609|NCT00495586|447548147|FG000|Overall Study|Withdrawal by Subject|4|||
124433610|NCT00495586|447548148|FG001|Overall Study|Withdrawal by Subject|4|||
124433611|NCT02057523|447548149|FG000|Overall Study|Withdrawal by Subject|1|||
124875329|NCT03420781|449165914|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
124433612|NCT02057523|447548149|FG000|Overall Study|Lack of Efficacy|1|||
124433613|NCT00158860|447548150|FG000|Overall Study|Adverse Event|3|||
124433614|NCT00158860|447548151|FG001|Overall Study|Adverse Event|6|||
124433615|NCT00158860|447548150|FG000|Overall Study|Lost to Follow-up|11|||
124875330|NCT03420781|449165915|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
124433616|NCT00158860|447548151|FG001|Overall Study|Lost to Follow-up|17|||
124433617|NCT00158860|447548150|FG000|Overall Study|Protocol Violation|8|||
124433618|NCT00158860|447548151|FG001|Overall Study|Protocol Violation|23|||
124433619|NCT00158860|447548150|FG000|Overall Study|Withdrawal by Subject|7|||
124433620|NCT00158860|447548151|FG001|Overall Study|Withdrawal by Subject|17|||
124433621|NCT00158860|447548150|FG000|Overall Study|MOVING OUT OF STATE|1|||
124433622|NCT00158860|447548151|FG001|Overall Study|MOVING OUT OF STATE|0|||
124433623|NCT00158860|447548150|FG000|Overall Study|Pregnancy|3|||
124433624|NCT00158860|447548151|FG001|Overall Study|Pregnancy|3|||
124433625|NCT00158860|447548150|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
124433626|NCT00158860|447548151|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
124433627|NCT00158860|447548150|FG000|Overall Study|SPONSOR REQUEST|0|||
124433628|NCT00158860|447548151|FG001|Overall Study|SPONSOR REQUEST|1|||
124433629|NCT00158860|447548150|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
124433630|NCT00158860|447548151|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
124433631|NCT00158860|447548150|FG000|Overall Study|Closed per sponsor|0|||
124433632|NCT00158860|447548151|FG001|Overall Study|Closed per sponsor|1|||
124433633|NCT01029652|447548155|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
124433634|NCT01029652|447548156|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
124433635|NCT01029652|447548155|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
124433636|NCT01029652|447548156|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
124433637|NCT01029652|447548155|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
124433638|NCT01029652|447548156|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
124433639|NCT01029652|447548155|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
124433640|NCT01029652|447548156|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
124433641|NCT01029652|447548155|FG000|Core Study (0-12 Weeks)|Death|0|||
124433642|NCT01029652|447548156|FG001|Core Study (0-12 Weeks)|Death|1|||
124433643|NCT01029652|447548155|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
124433644|NCT01029652|447548156|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
124433645|NCT01029652|447548155|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
124433646|NCT01029652|447548156|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
124433647|NCT01029652|447548155|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
124433648|NCT01029652|447548156|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
124433649|NCT01029652|447548155|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
124433650|NCT01029652|447548156|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
124433651|NCT01029652|447548155|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
124433652|NCT01029652|447548156|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
124433653|NCT01029652|447548155|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
124433654|NCT01029652|447548156|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
124433655|NCT01029652|447548155|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
124433656|NCT01029652|447548156|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
124433657|NCT02313233|447548157|FG000|Overall Study|Withdrawal by Subject|1|||
124433658|NCT02313233|447548158|FG001|Overall Study|Withdrawal by Subject|2|||
124433659|NCT02313233|447548157|FG000|Overall Study|Administrative reason|1|||
124433660|NCT02313233|447548158|FG001|Overall Study|Administrative reason|1|||
124433661|NCT02095951|447548159|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
124433662|NCT02095951|447548160|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
124433663|NCT03618823|447548161|FG000|Overall Study|Lost to Follow-up|63|||
124433664|NCT03618823|447548162|FG001|Overall Study|Lost to Follow-up|61|||
124433665|NCT00964886|447548165|FG000|Overall Study|Lost to Follow-up|2|||
124433666|NCT00964886|447548166|FG001|Overall Study|Lost to Follow-up|2|||
124433667|NCT00964886|447548167|FG002|Overall Study|Lost to Follow-up|6|||
124433668|NCT00964886|447548168|FG003|Overall Study|Lost to Follow-up|4|||
124433669|NCT00964886|447548165|FG000|Overall Study|Withdrawal by Subject|6|||
124433670|NCT00964886|447548166|FG001|Overall Study|Withdrawal by Subject|2|||
124433671|NCT00964886|447548167|FG002|Overall Study|Withdrawal by Subject|5|||
124433672|NCT00964886|447548168|FG003|Overall Study|Withdrawal by Subject|3|||
124433673|NCT00964886|447548165|FG000|Overall Study|Adverse Event|3|||
124433674|NCT00964886|447548166|FG001|Overall Study|Adverse Event|1|||
124433675|NCT00964886|447548167|FG002|Overall Study|Adverse Event|5|||
124433676|NCT00964886|447548168|FG003|Overall Study|Adverse Event|2|||
124433677|NCT00964886|447548165|FG000|Overall Study|Protocol Violation|0|||
124433678|NCT00964886|447548166|FG001|Overall Study|Protocol Violation|2|||
124433679|NCT00964886|447548167|FG002|Overall Study|Protocol Violation|0|||
124433680|NCT00964886|447548168|FG003|Overall Study|Protocol Violation|0|||
124433681|NCT00523640|447548170|FG000|Overall Study|Death|1|||
124433682|NCT01621568|447548173|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
124433683|NCT01621568|447548174|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
124433684|NCT01621568|447548173|FG000|Week 5-6 No Treatment|Death|1|||
124433685|NCT01621568|447548174|FG001|Week 5-6 No Treatment|Death|0|||
124433686|NCT02399254|447548175|FG000|Overall Study|Physician Decision|2|||
124433687|NCT00564889|447548178|FG000|Overall Study|Death|7|||
124433688|NCT00564889|447548178|FG000|Overall Study|Adverse Event|12|||
124433689|NCT00564889|447548178|FG000|Overall Study|Alternative treatment|3|||
124433690|NCT00564889|447548178|FG000|Overall Study|Disease progression|3|||
124433691|NCT00564889|447548178|FG000|Overall Study|Other, not specified|4|||
124433692|NCT03500159|447548179|FG000|Overall Study|Study Terminated|2|||
124433693|NCT03500159|447548180|FG001|Overall Study|Study Terminated|1|||
124433694|NCT02292927|447548187|FG000|Overall Study|Protocol Violation|13|||
124433695|NCT02292927|447548188|FG001|Overall Study|Protocol Violation|7|||
124433696|NCT03545503|447548190|FG000|Overall Study|Protocol Violation|14|||
124433697|NCT03545503|447548191|FG001|Overall Study|Protocol Violation|16|||
124433698|NCT00862719|447548196|FG000|Overall Study|Disease Progression|5|||
124433699|NCT00862719|447548197|FG001|Overall Study|Disease Progression|0|||
124433700|NCT00862719|447548198|FG002|Overall Study|Disease Progression|1|||
124433701|NCT00862719|447548199|FG003|Overall Study|Disease Progression|0|||
124433702|NCT00862719|447548196|FG000|Overall Study|Death|5|||
124433703|NCT00862719|447548197|FG001|Overall Study|Death|6|||
124433704|NCT00862719|447548198|FG002|Overall Study|Death|1|||
124433705|NCT00862719|447548199|FG003|Overall Study|Death|1|||
124433706|NCT00862719|447548196|FG000|Overall Study|Engraftment failure|0|||
124433707|NCT00862719|447548197|FG001|Overall Study|Engraftment failure|0|||
124433708|NCT00862719|447548198|FG002|Overall Study|Engraftment failure|1|||
124433709|NCT00862719|447548199|FG003|Overall Study|Engraftment failure|0|||
124433710|NCT00862719|447548196|FG000|Overall Study|Veno-Occlusive Disease|0|||
124433711|NCT00862719|447548197|FG001|Overall Study|Veno-Occlusive Disease|0|||
124433712|NCT00862719|447548198|FG002|Overall Study|Veno-Occlusive Disease|1|||
124433713|NCT00862719|447548199|FG003|Overall Study|Veno-Occlusive Disease|0|||
124433714|NCT00470366|447548200|FG000|Overall Study|Adverse Event|3|||
124433715|NCT00470366|447548200|FG000|Overall Study|Poor compliance|1|||
124433716|NCT04493502|447548201|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
124433717|NCT04493502|447548202|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
124433718|NCT04493502|447548201|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
124433719|NCT04493502|447548202|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
124433720|NCT04493502|447548201|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
124433721|NCT04493502|447548202|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
124433722|NCT04493502|447548201|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
124433723|NCT04493502|447548202|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
124433724|NCT04493502|447548201|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
124433725|NCT04493502|447548202|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
124433726|NCT04493502|447548201|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
124433727|NCT04493502|447548202|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
124433728|NCT04493502|447548201|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
124433729|NCT04493502|447548202|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
124433730|NCT04493502|447548201|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
124433731|NCT04493502|447548202|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
124433732|NCT04493502|447548201|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
124433733|NCT04493502|447548202|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
124433734|NCT04493502|447548201|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
124433735|NCT04493502|447548202|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
124433736|NCT04493502|447548201|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
124433737|NCT04493502|447548202|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
124433738|NCT04493502|447548201|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
124433739|NCT04493502|447548202|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
124433740|NCT04493502|447548201|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
124433741|NCT04493502|447548202|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
124433742|NCT02751320|447548203|FG000|Overall Study|Adverse Event|2|||
124433743|NCT02751320|447548203|FG000|Overall Study|Withdrawal by Subject|1|||
124433744|NCT01021215|447548204|FG000|Overall Study|Lost to Follow-up|3|||
124433745|NCT01021215|447548205|FG001|Overall Study|Lost to Follow-up|0|||
124433746|NCT00296400|447548206|FG000|Overall Study|Adverse Event|7|||
124433747|NCT00296400|447548207|FG001|Overall Study|Adverse Event|7|||
124433748|NCT00296400|447548208|FG002|Overall Study|Adverse Event|7|||
124433749|NCT00296400|447548206|FG000|Overall Study|Withdrawal by Subject|5|||
124433750|NCT00296400|447548207|FG001|Overall Study|Withdrawal by Subject|6|||
124433751|NCT00296400|447548208|FG002|Overall Study|Withdrawal by Subject|2|||
124433752|NCT00296400|447548206|FG000|Overall Study|Incorrect enrollment|2|||
124433753|NCT00296400|447548207|FG001|Overall Study|Incorrect enrollment|0|||
124433754|NCT00296400|447548208|FG002|Overall Study|Incorrect enrollment|0|||
124433755|NCT00296400|447548206|FG000|Overall Study|Protocol Violation|1|||
124433756|NCT00296400|447548207|FG001|Overall Study|Protocol Violation|1|||
124433757|NCT00296400|447548208|FG002|Overall Study|Protocol Violation|1|||
124433758|NCT00296400|447548206|FG000|Overall Study|Lost to Follow-up|1|||
124433759|NCT00296400|447548207|FG001|Overall Study|Lost to Follow-up|1|||
124433760|NCT00296400|447548208|FG002|Overall Study|Lost to Follow-up|2|||
124433761|NCT00296400|447548206|FG000|Overall Study|Study specific discontinuation criteria|0|||
124678374|NCT00784875|448448068|FG003|Period D|Protocol Violation|0|||
124678375|NCT00784875|448448065|FG000|Period D|Withdrawal by Subject|2|||
124433762|NCT00296400|447548207|FG001|Overall Study|Study specific discontinuation criteria|0|||
124433763|NCT00296400|447548208|FG002|Overall Study|Study specific discontinuation criteria|1|||
124433764|NCT00296400|447548206|FG000|Overall Study|Visit 10 was performed earlier|0|||
124433765|NCT00296400|447548207|FG001|Overall Study|Visit 10 was performed earlier|1|||
124433766|NCT00296400|447548208|FG002|Overall Study|Visit 10 was performed earlier|0|||
124433767|NCT00296400|447548206|FG000|Overall Study|Pregnancy|1|||
124433768|NCT00296400|447548207|FG001|Overall Study|Pregnancy|2|||
124433769|NCT00296400|447548208|FG002|Overall Study|Pregnancy|0|||
124433770|NCT01014533|447548209|FG000|Overall Study|Protocol Violation|3|||
124433771|NCT01014533|447548210|FG001|Overall Study|Protocol Violation|2|||
124433772|NCT01014533|447548209|FG000|Overall Study|Withdrawal by Subject|2|||
124433773|NCT01014533|447548210|FG001|Overall Study|Withdrawal by Subject|0|||
124433774|NCT01014533|447548209|FG000|Overall Study|unable to come to appointment|0|||
124433775|NCT01014533|447548210|FG001|Overall Study|unable to come to appointment|3|||
124433776|NCT00412061|447548212|FG000|Double Blind Phase|Disease Progression|101|||
124433777|NCT00412061|447548213|FG001|Double Blind Phase|Disease Progression|154|||
124433778|NCT00412061|447548212|FG000|Double Blind Phase|Adverse Event|61|||
124433779|NCT00412061|447548213|FG001|Double Blind Phase|Adverse Event|16|||
124433780|NCT00412061|447548212|FG000|Double Blind Phase|Final Primary Analysis|26|||
124433781|NCT00412061|447548213|FG001|Double Blind Phase|Final Primary Analysis|14|||
124433782|NCT00412061|447548212|FG000|Double Blind Phase|Withdrawal by Subject|18|||
124433783|NCT00412061|447548213|FG001|Double Blind Phase|Withdrawal by Subject|20|||
124433784|NCT00412061|447548212|FG000|Double Blind Phase|Death|6|||
124433785|NCT00412061|447548213|FG001|Double Blind Phase|Death|3|||
124433786|NCT00412061|447548212|FG000|Double Blind Phase|Protocol Violation|3|||
124433787|NCT00412061|447548213|FG001|Double Blind Phase|Protocol Violation|4|||
124433788|NCT00412061|447548212|FG000|Double Blind Phase|New Cander Therapy|1|||
124433789|NCT00412061|447548213|FG001|Double Blind Phase|New Cander Therapy|1|||
124433790|NCT00412061|447548212|FG000|Double Blind Phase|Lost to Follow-up|0|||
124433791|NCT00412061|447548213|FG001|Double Blind Phase|Lost to Follow-up|1|||
124433792|NCT00412061|447548212|FG000|Open Label Phase|Disease Progression|0|||
124433793|NCT00412061|447548213|FG001|Open Label Phase|Disease Progression|86|||
124433794|NCT00412061|447548212|FG000|Open Label Phase|Adverse Event|0|||
124433795|NCT00412061|447548213|FG001|Open Label Phase|Adverse Event|46|||
124433796|NCT00412061|447548212|FG000|Open Label Phase|Withdrawal by Subject|0|||
124433797|NCT00412061|447548213|FG001|Open Label Phase|Withdrawal by Subject|15|||
124433798|NCT00412061|447548212|FG000|Open Label Phase|Administrative Problems|0|||
124433799|NCT00412061|447548213|FG001|Open Label Phase|Administrative Problems|13|||
124433800|NCT00412061|447548212|FG000|Open Label Phase|Death|0|||
124433801|NCT00412061|447548213|FG001|Open Label Phase|Death|7|||
124433802|NCT00412061|447548212|FG000|Open Label Phase|Lost to Follow-up|0|||
124433803|NCT00412061|447548213|FG001|Open Label Phase|Lost to Follow-up|2|||
124433804|NCT00412061|447548212|FG000|Open Label Phase|New Cancer Therapy|0|||
124433805|NCT00412061|447548213|FG001|Open Label Phase|New Cancer Therapy|1|||
124433806|NCT01942590|447548214|FG000|Overall Study|Withdrawal by Subject|0|||
124433807|NCT01942590|447548215|FG001|Overall Study|Withdrawal by Subject|1|||
124433808|NCT01942590|447548214|FG000|Overall Study|Adverse Event|1|||
124433809|NCT01942590|447548215|FG001|Overall Study|Adverse Event|0|||
124433810|NCT01011387|447548219|FG000|Overall Study|Withdrawal by Subject|3|||
124433811|NCT01011387|447548219|FG000|Overall Study|Adverse Event|2|||
124433812|NCT01011387|447548219|FG000|Overall Study|Protocol Violation|1|||
124433813|NCT02433340|447548220|FG000|Overall Study|Adverse Event|0|||
124433814|NCT02433340|447548221|FG001|Overall Study|Adverse Event|0|||
124433815|NCT02433340|447548222|FG002|Overall Study|Adverse Event|1|||
124433816|NCT02433340|447548223|FG003|Overall Study|Adverse Event|0|||
124433817|NCT02433340|447548220|FG000|Overall Study|Withdrawal by Subject|1|||
124433818|NCT02433340|447548221|FG001|Overall Study|Withdrawal by Subject|0|||
124433819|NCT02433340|447548222|FG002|Overall Study|Withdrawal by Subject|1|||
124433820|NCT02433340|447548223|FG003|Overall Study|Withdrawal by Subject|2|||
124433821|NCT02433340|447548220|FG000|Overall Study|Lost to Follow-up|0|||
124433822|NCT02433340|447548221|FG001|Overall Study|Lost to Follow-up|1|||
124433823|NCT02433340|447548222|FG002|Overall Study|Lost to Follow-up|0|||
124433824|NCT02433340|447548223|FG003|Overall Study|Lost to Follow-up|0|||
124433825|NCT02433340|447548220|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
124433826|NCT02433340|447548221|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
124433827|NCT02433340|447548222|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
124433828|NCT02433340|447548223|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
124433829|NCT02433340|447548220|FG000|Overall Study|Other|0|||
124433830|NCT02433340|447548221|FG001|Overall Study|Other|1|||
124433831|NCT02433340|447548222|FG002|Overall Study|Other|0|||
124433832|NCT02433340|447548223|FG003|Overall Study|Other|0|||
124433833|NCT01178385|447548224|FG000|Overall Study|Withdrawal by Subject|2|||
124433834|NCT01178385|447548225|FG001|Overall Study|Withdrawal by Subject|0|||
124433835|NCT01226095|447548226|FG000|Overall Study|Poor compliance|1|||
124433836|NCT01688830|447548229|FG000|Overall Study|Lost to Follow-up|0|||
124433837|NCT01688830|447548230|FG001|Overall Study|Lost to Follow-up|0|||
124433838|NCT01688830|447548231|FG002|Overall Study|Lost to Follow-up|0|||
124678376|NCT00784875|448448066|FG001|Period D|Withdrawal by Subject|0|||
124875331|NCT03420781|449165916|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
124678377|NCT00784875|448448067|FG002|Period D|Withdrawal by Subject|2|||
124678378|NCT00784875|448448068|FG003|Period D|Withdrawal by Subject|0|||
124678379|NCT00784875|448448065|FG000|Period D|Physician Decision|0|||
124678380|NCT00784875|448448066|FG001|Period D|Physician Decision|1|||
124678381|NCT00784875|448448067|FG002|Period D|Physician Decision|0|||
124678382|NCT00784875|448448068|FG003|Period D|Physician Decision|0|||
124678383|NCT00784875|448448065|FG000|Period D|Sponsor Decision|1|||
124678384|NCT00784875|448448066|FG001|Period D|Sponsor Decision|1|||
124678385|NCT00784875|448448067|FG002|Period D|Sponsor Decision|1|||
124678386|NCT00784875|448448068|FG003|Period D|Sponsor Decision|0|||
124678387|NCT00784875|448448065|FG000|Period D|Lost to Follow-up|1|||
124678388|NCT00784875|448448066|FG001|Period D|Lost to Follow-up|0|||
124678389|NCT00784875|448448067|FG002|Period D|Lost to Follow-up|1|||
124678390|NCT00784875|448448068|FG003|Period D|Lost to Follow-up|1|||
124678391|NCT02842866|448448069|FG000|Overall Study|Serious Adverse Event|0|||
124678392|NCT02842866|448448070|FG001|Overall Study|Serious Adverse Event|1|||
124678393|NCT02842866|448448069|FG000|Overall Study|Protocol Violation|4|||
124678394|NCT02842866|448448070|FG001|Overall Study|Protocol Violation|2|||
124678395|NCT02842866|448448069|FG000|Overall Study|Lost to Follow-up|2|||
124678396|NCT02842866|448448070|FG001|Overall Study|Lost to Follow-up|0|||
124678397|NCT02842866|448448069|FG000|Overall Study|Withdrawal by Subject|1|||
124678398|NCT02842866|448448070|FG001|Overall Study|Withdrawal by Subject|0|||
124678399|NCT01901185|448448073|FG000|Overall Study|Withdrawal by Subject|2|||
124678400|NCT03502798|448448074|FG000|Overall Study|equipment failure|0|||
124678401|NCT03502798|448448075|FG001|Overall Study|equipment failure|7|||
124433839|NCT01688830|447548232|FG003|Overall Study|Lost to Follow-up|0|||
124433840|NCT01688830|447548233|FG004|Overall Study|Lost to Follow-up|0|||
124433841|NCT01688830|447548234|FG005|Overall Study|Lost to Follow-up|0|||
124433842|NCT01688830|447548235|FG006|Overall Study|Lost to Follow-up|0|||
124433843|NCT01688830|447548236|FG007|Overall Study|Lost to Follow-up|0|||
124433844|NCT01688830|447548237|FG008|Overall Study|Lost to Follow-up|0|||
124433845|NCT01688830|447548238|FG009|Overall Study|Lost to Follow-up|0|||
124433846|NCT01688830|447548239|FG010|Overall Study|Lost to Follow-up|1|||
124433847|NCT01688830|447548240|FG011|Overall Study|Lost to Follow-up|0|||
124433848|NCT01688830|447548241|FG012|Overall Study|Lost to Follow-up|0|||
124433849|NCT01688830|447548242|FG013|Overall Study|Lost to Follow-up|0|||
124433850|NCT01688830|447548243|FG014|Overall Study|Lost to Follow-up|0|||
124433851|NCT01688830|447548244|FG015|Overall Study|Lost to Follow-up|0|||
124433852|NCT01688830|447548245|FG016|Overall Study|Lost to Follow-up|0|||
124433853|NCT01688830|447548246|FG017|Overall Study|Lost to Follow-up|0|||
124433854|NCT01688830|447548247|FG018|Overall Study|Lost to Follow-up|0|||
124433855|NCT01688830|447548248|FG019|Overall Study|Lost to Follow-up|0|||
124433856|NCT01688830|447548249|FG020|Overall Study|Lost to Follow-up|0|||
124433857|NCT01285609|447548250|FG000|Randomized|Progressive Disease|41|||
124433858|NCT01285609|447548251|FG001|Randomized|Progressive Disease|61|||
124433859|NCT01285609|447548250|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
124433860|NCT01285609|447548251|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
124433861|NCT01285609|447548250|FG000|Randomized|Study Drug Toxicity|13|||
124433862|NCT01285609|447548251|FG001|Randomized|Study Drug Toxicity|14|||
124433863|NCT01285609|447548250|FG000|Randomized|Death|5|||
124433864|NCT01285609|447548251|FG001|Randomized|Death|7|||
124433865|NCT01285609|447548250|FG000|Randomized|Withdrawal by Subject|8|||
124433866|NCT01285609|447548251|FG001|Randomized|Withdrawal by Subject|11|||
124433867|NCT01285609|447548250|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
124433868|NCT01285609|447548251|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
124433869|NCT01285609|447548250|FG000|Randomized|Undisclosed Reasons|1|||
124433870|NCT01285609|447548251|FG001|Randomized|Undisclosed Reasons|0|||
124433871|NCT01285609|447548250|FG000|Randomized|Randomized but not Treated|4|||
124433872|NCT01285609|447548251|FG001|Randomized|Randomized but not Treated|4|||
124433873|NCT01285609|447548250|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
124433874|NCT01285609|447548251|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
124433875|NCT01285609|447548250|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
124433876|NCT01285609|447548251|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
124433877|NCT01285609|447548250|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
124433878|NCT01285609|447548251|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
124433879|NCT01285609|447548250|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
124433880|NCT01285609|447548251|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
124433881|NCT01285609|447548250|FG000|Treated With Blinded Therapy|Death|11|||
124433882|NCT01285609|447548251|FG001|Treated With Blinded Therapy|Death|3|||
124433883|NCT01285609|447548250|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
124875332|NCT03420781|449165917|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
124433884|NCT01285609|447548251|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
124433885|NCT01285609|447548250|FG000|Treated With Blinded Therapy|Not Reported|0|||
124433886|NCT01285609|447548251|FG001|Treated With Blinded Therapy|Not Reported|2|||
124433887|NCT01285609|447548250|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
124433888|NCT01285609|447548251|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
124433889|NCT01285609|447548250|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
124433890|NCT01285609|447548251|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
124433891|NCT01285609|447548250|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
124433892|NCT01285609|447548251|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
124433893|NCT01285609|447548250|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
124433894|NCT01285609|447548251|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
124433895|NCT01285609|447548250|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
124433896|NCT01285609|447548251|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
124433897|NCT01285609|447548250|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
124875333|NCT03420781|449165918|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
124875334|NCT00215540|449165929|FG000|Overall Study|Withdrew from study medication|1|||
124433898|NCT01285609|447548251|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
124433899|NCT01285609|447548250|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
124433900|NCT01285609|447548251|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
124433901|NCT01285609|447548250|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
124433902|NCT01285609|447548251|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
124433903|NCT01285609|447548250|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
124433904|NCT01285609|447548251|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
124433905|NCT01285609|447548250|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
124678402|NCT00296335|448448076|FG000|Overall Study|Recurrence|3|||
124875335|NCT00215540|449165930|FG001|Overall Study|Withdrew from study medication|0|||
124678403|NCT00296335|448448077|FG001|Overall Study|Recurrence|51|||
124678404|NCT00296335|448448076|FG000|Overall Study|Adverse Event|17|||
124678405|NCT00296335|448448077|FG001|Overall Study|Adverse Event|27|||
124678406|NCT00296335|448448076|FG000|Overall Study|Lost to Follow-up|7|||
124678407|NCT00296335|448448077|FG001|Overall Study|Lost to Follow-up|33|||
124678408|NCT00296335|448448076|FG000|Overall Study|Physician Decision|3|||
124678409|NCT00296335|448448077|FG001|Overall Study|Physician Decision|11|||
124678410|NCT01401322|448448078|FG000|Overall Study|Withdrawal by Subject|1|||
124678411|NCT01401322|448448078|FG000|Overall Study|Physician Decision|1|||
124678412|NCT02737722|448448079|FG000|Overall Study|Physician Decision|0|||
124678413|NCT02737722|448448080|FG001|Overall Study|Physician Decision|0|||
124678414|NCT02737722|448448081|FG002|Overall Study|Physician Decision|1|||
124678415|NCT02737722|448448082|FG003|Overall Study|Physician Decision|0|||
124678416|NCT00284856|448448097|FG000|Overall Study|Adverse Event|3|||
124678417|NCT00284856|448448098|FG001|Overall Study|Adverse Event|3|||
124678418|NCT00284856|448448099|FG002|Overall Study|Adverse Event|3|||
124678419|NCT00284856|448448097|FG000|Overall Study|Lack of Efficacy|2|||
124678420|NCT00284856|448448098|FG001|Overall Study|Lack of Efficacy|1|||
124678421|NCT00284856|448448099|FG002|Overall Study|Lack of Efficacy|8|||
124678422|NCT00284856|448448097|FG000|Overall Study|Lost to Follow-up|25|||
124678423|NCT00284856|448448098|FG001|Overall Study|Lost to Follow-up|21|||
124678424|NCT00284856|448448099|FG002|Overall Study|Lost to Follow-up|22|||
124678425|NCT00284856|448448097|FG000|Overall Study|Protocol Violation|5|||
124678426|NCT00284856|448448098|FG001|Overall Study|Protocol Violation|4|||
124678427|NCT00284856|448448099|FG002|Overall Study|Protocol Violation|5|||
124678428|NCT00284856|448448097|FG000|Overall Study|Withdrawal by Subject|12|||
124678429|NCT00284856|448448098|FG001|Overall Study|Withdrawal by Subject|16|||
124678430|NCT00284856|448448099|FG002|Overall Study|Withdrawal by Subject|18|||
124678431|NCT00284856|448448097|FG000|Overall Study|Other|4|||
124678432|NCT00284856|448448098|FG001|Overall Study|Other|5|||
124678433|NCT00284856|448448099|FG002|Overall Study|Other|4|||
124678434|NCT01192815|448448101|FG000|Overall Study|Withdrawal by Subject|1|||
124433906|NCT01285609|447548251|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
124433907|NCT04822597|447548252|FG000|Overall Study|Withdrawal by Subject|0|||
124433908|NCT04822597|447548253|FG001|Overall Study|Withdrawal by Subject|1|||
124433909|NCT04822597|447548254|FG002|Overall Study|Withdrawal by Subject|1|||
124433910|NCT04822597|447548255|FG003|Overall Study|Withdrawal by Subject|0|||
124433911|NCT04822597|447548252|FG000|Overall Study|Physician Decision|0|||
124433912|NCT04822597|447548253|FG001|Overall Study|Physician Decision|0|||
124433913|NCT04822597|447548254|FG002|Overall Study|Physician Decision|1|||
124433914|NCT04822597|447548255|FG003|Overall Study|Physician Decision|1|||
124433915|NCT04822597|447548252|FG000|Overall Study|Subject withdrawn after enrollment|0|||
124433916|NCT04822597|447548253|FG001|Overall Study|Subject withdrawn after enrollment|1|||
124433917|NCT04822597|447548254|FG002|Overall Study|Subject withdrawn after enrollment|0|||
124433918|NCT04822597|447548255|FG003|Overall Study|Subject withdrawn after enrollment|1|||
124433919|NCT04822597|447548252|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
124433920|NCT04822597|447548253|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
124433921|NCT04822597|447548254|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
124433922|NCT04822597|447548255|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
124433923|NCT05326815|447548266|FG000|Overall Study|Withdrawal by Subject|3|||
124433924|NCT05326815|447548266|FG000|Overall Study|Did not complete required labs|6|||
124433925|NCT05326815|447548266|FG000|Overall Study|Screen fail- abnormal labs|5|||
124433926|NCT00925132|447548267|FG000|Overall Study|Withdrawal by Subject|2|||
124433927|NCT00925132|447548268|FG001|Overall Study|Withdrawal by Subject|0|||
124433928|NCT00925132|447548269|FG002|Overall Study|Withdrawal by Subject|0|||
124433929|NCT00925132|447548270|FG003|Overall Study|Withdrawal by Subject|0|||
124433930|NCT00925132|447548271|FG004|Overall Study|Withdrawal by Subject|1|||
124433931|NCT00925132|447548267|FG000|Overall Study|Removed due to disease progression|0|||
124433932|NCT00925132|447548268|FG001|Overall Study|Removed due to disease progression|0|||
124433933|NCT00925132|447548269|FG002|Overall Study|Removed due to disease progression|0|||
124433934|NCT00925132|447548270|FG003|Overall Study|Removed due to disease progression|0|||
124433935|NCT00925132|447548271|FG004|Overall Study|Removed due to disease progression|4|||
124433936|NCT02545933|447548272|FG000|Overall Study|Adverse Event|3|||
124433937|NCT02545933|447548273|FG001|Overall Study|Adverse Event|0|||
124433938|NCT02545933|447548274|FG002|Overall Study|Adverse Event|0|||
124433939|NCT02545933|447548272|FG000|Overall Study|Withdrawal by Subject|2|||
124433940|NCT02545933|447548273|FG001|Overall Study|Withdrawal by Subject|3|||
124433941|NCT02545933|447548274|FG002|Overall Study|Withdrawal by Subject|3|||
124433942|NCT02545933|447548272|FG000|Overall Study|Protocol Violation|1|||
124433943|NCT02545933|447548273|FG001|Overall Study|Protocol Violation|0|||
124433944|NCT02545933|447548274|FG002|Overall Study|Protocol Violation|1|||
124433945|NCT03149549|447548275|FG000|Study Discontinuation--Treatment Period|Death|0|||
124433946|NCT03149549|447548276|FG001|Study Discontinuation--Treatment Period|Death|0|||
124433947|NCT03149549|447548277|FG002|Study Discontinuation--Treatment Period|Death|0|||
124433948|NCT03149549|447548278|FG003|Study Discontinuation--Treatment Period|Death|1|||
124433949|NCT03149549|447548279|FG004|Study Discontinuation--Treatment Period|Death|2|||
124433950|NCT03149549|447548280|FG005|Study Discontinuation--Treatment Period|Death|1|||
124433951|NCT03149549|447548281|FG006|Study Discontinuation--Treatment Period|Death|1|||
124433952|NCT03149549|447548282|FG007|Study Discontinuation--Treatment Period|Death|2|||
124433953|NCT03149549|447548283|FG008|Study Discontinuation--Treatment Period|Death|4|||
124433954|NCT03149549|447548284|FG009|Study Discontinuation--Treatment Period|Death|1|||
124433955|NCT03149549|447548285|FG010|Study Discontinuation--Treatment Period|Death|0|||
124433956|NCT03149549|447548286|FG011|Study Discontinuation--Treatment Period|Death|0|||
124433957|NCT03149549|447548287|FG012|Study Discontinuation--Treatment Period|Death|1|||
124433958|NCT03149549|447548275|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124433959|NCT03149549|447548276|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124433960|NCT03149549|447548277|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124433961|NCT03149549|447548278|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124433962|NCT03149549|447548279|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124433963|NCT03149549|447548280|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124433964|NCT03149549|447548281|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124433965|NCT03149549|447548282|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
124433966|NCT03149549|447548283|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124433967|NCT03149549|447548284|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124433968|NCT03149549|447548285|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124433969|NCT03149549|447548286|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
124433970|NCT03149549|447548287|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
124433971|NCT03149549|447548275|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
124433972|NCT03149549|447548276|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
124433973|NCT03149549|447548277|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
124433974|NCT03149549|447548278|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
124433975|NCT03149549|447548279|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
124433976|NCT03149549|447548280|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
124433977|NCT03149549|447548281|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
124433978|NCT03149549|447548282|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
124433979|NCT03149549|447548283|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
124433980|NCT03149549|447548284|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
124433981|NCT03149549|447548285|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
124433982|NCT03149549|447548286|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
124433983|NCT03149549|447548287|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
124433984|NCT03149549|447548275|FG000|Study Discontinuation--Treatment Period|Other|0|||
124433985|NCT03149549|447548276|FG001|Study Discontinuation--Treatment Period|Other|0|||
124875336|NCT00215540|449165931|FG002|Overall Study|Withdrew from study medication|0|||
124875337|NCT02799472|449165938|FG000|Overall Study|Withdrawal by Subject|2|||
124433986|NCT03149549|447548277|FG002|Study Discontinuation--Treatment Period|Other|0|||
124433987|NCT03149549|447548278|FG003|Study Discontinuation--Treatment Period|Other|0|||
124433988|NCT03149549|447548279|FG004|Study Discontinuation--Treatment Period|Other|0|||
124875338|NCT02799472|449165939|FG001|Overall Study|Withdrawal by Subject|4|||
124433989|NCT03149549|447548280|FG005|Study Discontinuation--Treatment Period|Other|0|||
124433990|NCT03149549|447548281|FG006|Study Discontinuation--Treatment Period|Other|0|||
124433991|NCT03149549|447548282|FG007|Study Discontinuation--Treatment Period|Other|1|||
124433992|NCT03149549|447548283|FG008|Study Discontinuation--Treatment Period|Other|0|||
124433993|NCT03149549|447548284|FG009|Study Discontinuation--Treatment Period|Other|1|||
124433994|NCT03149549|447548285|FG010|Study Discontinuation--Treatment Period|Other|0|||
124433995|NCT03149549|447548286|FG011|Study Discontinuation--Treatment Period|Other|0|||
124433996|NCT03149549|447548287|FG012|Study Discontinuation--Treatment Period|Other|0|||
124433997|NCT03149549|447548275|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
124433998|NCT03149549|447548276|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
124433999|NCT03149549|447548277|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
124434000|NCT03149549|447548278|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
124434001|NCT03149549|447548279|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
124434002|NCT03149549|447548280|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
124434003|NCT03149549|447548281|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
124434004|NCT03149549|447548282|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
124434005|NCT03149549|447548283|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
124434006|NCT03149549|447548284|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
124434007|NCT03149549|447548285|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
124434008|NCT03149549|447548286|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
124434009|NCT03149549|447548287|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
124434010|NCT03149549|447548275|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
124434011|NCT03149549|447548276|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
124434012|NCT03149549|447548277|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
124434013|NCT03149549|447548278|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
124434014|NCT03149549|447548279|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
124434015|NCT03149549|447548280|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
124434016|NCT03149549|447548281|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
124434017|NCT03149549|447548282|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
124434018|NCT03149549|447548283|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
124434019|NCT03149549|447548284|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
124434020|NCT03149549|447548285|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
124434021|NCT03149549|447548286|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
124434022|NCT03149549|447548287|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
124434023|NCT03149549|447548275|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
124434024|NCT03149549|447548276|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
124434025|NCT03149549|447548277|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
124434026|NCT03149549|447548278|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
124434027|NCT03149549|447548279|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
124434028|NCT03149549|447548280|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
124434029|NCT03149549|447548281|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
124434030|NCT03149549|447548282|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
124434031|NCT03149549|447548283|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
124434032|NCT03149549|447548284|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
124434033|NCT03149549|447548285|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
124434034|NCT03149549|447548286|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
124434035|NCT03149549|447548287|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
124434036|NCT03149549|447548275|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
124434037|NCT03149549|447548276|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
124434038|NCT03149549|447548277|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
124434039|NCT03149549|447548278|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
124434040|NCT03149549|447548279|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
124434041|NCT03149549|447548280|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
124434042|NCT03149549|447548281|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
124434043|NCT03149549|447548282|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
124434044|NCT03149549|447548283|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
124434045|NCT03149549|447548284|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
124434046|NCT03149549|447548285|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
124434047|NCT03149549|447548286|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
124434048|NCT03149549|447548287|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
124434049|NCT03149549|447548275|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
124434050|NCT03149549|447548276|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
124434051|NCT03149549|447548277|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
124434052|NCT03149549|447548278|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
124434053|NCT03149549|447548279|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
124678435|NCT01192815|448448101|FG000|Overall Study|Lack of Efficacy|1|||
124434054|NCT03149549|447548280|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
124434055|NCT03149549|447548281|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
124434056|NCT03149549|447548282|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
124434057|NCT03149549|447548283|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
124434058|NCT03149549|447548284|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
124434059|NCT03149549|447548285|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
124434060|NCT03149549|447548286|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
124434061|NCT03149549|447548287|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
124434062|NCT00867308|447548292|FG000|Overall Study|Death|1|||
124434063|NCT00867308|447548293|FG001|Overall Study|Death|0|||
124434064|NCT00867308|447548292|FG000|Overall Study|Adverse Event|1|||
124434065|NCT00867308|447548293|FG001|Overall Study|Adverse Event|4|||
124434066|NCT00867308|447548292|FG000|Overall Study|Lack of Efficacy|6|||
124434067|NCT00867308|447548293|FG001|Overall Study|Lack of Efficacy|12|||
124434068|NCT00867308|447548292|FG000|Overall Study|Withdrawal by Subject|1|||
124434069|NCT00867308|447548293|FG001|Overall Study|Withdrawal by Subject|2|||
124434070|NCT01034176|447549422|FG000|Overall Study|Physician Decision|2|||
124434071|NCT01034176|447549423|FG001|Overall Study|Physician Decision|0|||
124434072|NCT01034176|447549422|FG000|Overall Study|Withdrawal by Subject|0|||
124434073|NCT01034176|447549423|FG001|Overall Study|Withdrawal by Subject|1|||
124434074|NCT01034176|447549422|FG000|Overall Study|Lost to Follow-up|0|||
124434075|NCT01034176|447549423|FG001|Overall Study|Lost to Follow-up|1|||
124434076|NCT03207009|447549426|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
124434077|NCT04343872|447549427|FG000|Overall Study|Lost to Follow-up|6|||
124434078|NCT04343872|447549428|FG001|Overall Study|Lost to Follow-up|3|||
124434079|NCT03241225|447549429|FG000|Overall Study|Lost to Follow-up|2|||
124434080|NCT03241225|447549430|FG001|Overall Study|Lost to Follow-up|1|||
124434081|NCT03241225|447549429|FG000|Overall Study|Protocol Violation|4|||
124434082|NCT03241225|447549430|FG001|Overall Study|Protocol Violation|1|||
124434083|NCT03241225|447549429|FG000|Overall Study|Withdrawal by Subject|1|||
124434084|NCT03241225|447549430|FG001|Overall Study|Withdrawal by Subject|0|||
124434085|NCT01635920|447549435|FG000|Overall Study|Adverse Event|1|||
124434086|NCT01635920|447549436|FG001|Overall Study|Adverse Event|0|||
124434087|NCT01635920|447549435|FG000|Overall Study|Lost to Follow-up|0|||
124434088|NCT01635920|447549436|FG001|Overall Study|Lost to Follow-up|1|||
124434089|NCT01635920|447549435|FG000|Overall Study|Subject decision|2|||
124434090|NCT01635920|447549436|FG001|Overall Study|Subject decision|0|||
124434091|NCT00007345|447549437|FG000|Overall Study|Refused further treatment|0|||
124434092|NCT00007345|447549438|FG001|Overall Study|Refused further treatment|7|||
124434093|NCT00007345|447549437|FG000|Overall Study|Switched to alternative treatment|0|||
124434094|NCT00007345|447549438|FG001|Overall Study|Switched to alternative treatment|3|||
124434095|NCT00007345|447549437|FG000|Overall Study|Intercurrent illness|1|||
124434096|NCT00007345|447549438|FG001|Overall Study|Intercurrent illness|0|||
124434097|NCT00007345|447549437|FG000|Overall Study|Death on study|1|||
124434098|NCT00007345|447549438|FG001|Overall Study|Death on study|1|||
124434099|NCT00194987|447549439|FG000|Overall Study|Withdrawal by Subject|0|||
124434100|NCT00194987|447549440|FG001|Overall Study|Withdrawal by Subject|3|||
124434101|NCT01664598|447549441|FG000|Overall Study|Sponsor Decision|1|||
124434102|NCT01664598|447549441|FG000|Overall Study|Withdrawal of Informed Consent|4|||
124434103|NCT01664598|447549441|FG000|Overall Study|Adverse Event|1|||
124434104|NCT04187989|447549442|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
124434105|NCT04187989|447549443|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
124434106|NCT04187989|447549442|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
124434107|NCT04187989|447549443|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
124434108|NCT04279392|447549449|FG000|Overall Study|Physician Decision|1|||
124434109|NCT04279392|447549450|FG001|Overall Study|Physician Decision|0|||
124434110|NCT04289051|447549455|FG000|Overall Study|Lost to Follow-up|0|||
124434111|NCT04289051|447549456|FG001|Overall Study|Lost to Follow-up|0|||
124434112|NCT04289051|447549457|FG002|Overall Study|Lost to Follow-up|2|||
124434113|NCT01901341|447549458|FG000|Overall Study|Adverse Event|4|||
124434114|NCT01901341|447549459|FG001|Overall Study|Adverse Event|2|||
124434115|NCT01901341|447549458|FG000|Overall Study|Lack of Efficacy|0|||
124434116|NCT01901341|447549459|FG001|Overall Study|Lack of Efficacy|2|||
124434117|NCT01901341|447549458|FG000|Overall Study|Lost to Follow-up|0|||
124434118|NCT01901341|447549459|FG001|Overall Study|Lost to Follow-up|1|||
124434119|NCT01901341|447549458|FG000|Overall Study|Protocol Violation|2|||
124434120|NCT01901341|447549459|FG001|Overall Study|Protocol Violation|0|||
124434121|NCT01901341|447549458|FG000|Overall Study|Study Terminated by Sponsor|13|||
124434122|NCT01901341|447549459|FG001|Overall Study|Study Terminated by Sponsor|15|||
124434123|NCT01901341|447549458|FG000|Overall Study|Withdrawal by Subject|1|||
124875339|NCT02799472|449165938|FG000|Overall Study|Lack of Efficacy|2|||
124875340|NCT02799472|449165939|FG001|Overall Study|Lack of Efficacy|0|||
124434124|NCT01901341|447549459|FG001|Overall Study|Withdrawal by Subject|1|||
124434125|NCT01981473|447549463|FG000|Overall Study|Incorrect diagnosis of RA|0|||
124434126|NCT01981473|447549464|FG001|Overall Study|Incorrect diagnosis of RA|0|||
124434127|NCT01981473|447549465|FG002|Overall Study|Incorrect diagnosis of RA|1|||
124434128|NCT01981473|447549463|FG000|Overall Study|Received treatment for < 6 months|0|||
124434129|NCT01981473|447549464|FG001|Overall Study|Received treatment for < 6 months|0|||
124434130|NCT01981473|447549465|FG002|Overall Study|Received treatment for < 6 months|1|||
124434131|NCT01981473|447549463|FG000|Overall Study|Received treatment for >24 months|2|||
124434132|NCT01981473|447549464|FG001|Overall Study|Received treatment for >24 months|0|||
124434133|NCT01981473|447549465|FG002|Overall Study|Received treatment for >24 months|6|||
124434134|NCT02937454|447549467|FG000|Overall Study|Adverse Event|0|||
124434135|NCT02937454|447549468|FG001|Overall Study|Adverse Event|1|||
124434136|NCT02937454|447549467|FG000|Overall Study|Death|98|||
124434137|NCT02937454|447549468|FG001|Overall Study|Death|95|||
124434138|NCT02937454|447549467|FG000|Overall Study|Lost to Follow-up|1|||
124434139|NCT02937454|447549468|FG001|Overall Study|Lost to Follow-up|1|||
124434140|NCT02937454|447549467|FG000|Overall Study|Physician Decision|0|||
124434141|NCT02937454|447549468|FG001|Overall Study|Physician Decision|1|||
124434142|NCT02937454|447549467|FG000|Overall Study|Protocol Violation|6|||
124434143|NCT02937454|447549468|FG001|Overall Study|Protocol Violation|10|||
124434144|NCT02937454|447549467|FG000|Overall Study|Withdrawal by Subject|27|||
124434145|NCT02937454|447549468|FG001|Overall Study|Withdrawal by Subject|15|||
124434146|NCT02937454|447549467|FG000|Overall Study|Other|8|||
124434147|NCT02937454|447549468|FG001|Overall Study|Other|5|||
124434148|NCT02630693|447549471|FG000|Overall Study|No receive treatment|0|||
124434149|NCT02630693|447549472|FG001|Overall Study|No receive treatment|1|||
124434150|NCT00993668|447549476|FG000|Single-Blind Period|Adverse Event|1|||
124434151|NCT00993668|447549477|FG001|Single-Blind Period|Adverse Event|1|||
124434152|NCT00993668|447549476|FG000|Single-Blind Period|Lack of Efficacy|0|||
124434153|NCT00993668|447549477|FG001|Single-Blind Period|Lack of Efficacy|1|||
124434154|NCT00993668|447549476|FG000|Single-Blind Period|Lost to Follow-up|3|||
124434155|NCT00993668|447549477|FG001|Single-Blind Period|Lost to Follow-up|1|||
124434156|NCT00993668|447549476|FG000|Open-Label Period|Adverse Event|9|||
124434157|NCT00993668|447549477|FG001|Open-Label Period|Adverse Event|8|||
124434158|NCT00993668|447549476|FG000|Open-Label Period|Lack of Efficacy|4|||
124434159|NCT00993668|447549477|FG001|Open-Label Period|Lack of Efficacy|3|||
124434160|NCT00993668|447549476|FG000|Open-Label Period|Withdrawal by Subject|4|||
124434161|NCT00993668|447549477|FG001|Open-Label Period|Withdrawal by Subject|3|||
124434162|NCT00993668|447549476|FG000|Open-Label Period|Lost to Follow-up|6|||
124434163|NCT00993668|447549477|FG001|Open-Label Period|Lost to Follow-up|1|||
124434164|NCT00682890|447549488|FG000|Overall Study|Lost to Follow-up|1|||
124434165|NCT00682890|447549489|FG001|Overall Study|Lost to Follow-up|1|||
124434166|NCT00682890|447549488|FG000|Overall Study|subject moved away|0|||
124434167|NCT00682890|447549489|FG001|Overall Study|subject moved away|1|||
124434168|NCT00682890|447549488|FG000|Overall Study|heavy menstrual bleeding|1|||
124434169|NCT00682890|447549489|FG001|Overall Study|heavy menstrual bleeding|0|||
124434170|NCT02884908|447549490|FG000|Overall Study|Lost to Follow-up|13|||
124434171|NCT02884908|447549491|FG001|Overall Study|Lost to Follow-up|18|||
124434172|NCT01605019|447549493|FG000|Overall Study|pt did not meet transplant endpoint|3|||
124434173|NCT01605019|447549494|FG001|Overall Study|pt did not meet transplant endpoint|0|||
124434174|NCT00324116|447549495|FG000|Overall Study|Adverse Event|5|||
124434175|NCT00324116|447549495|FG000|Overall Study|Lack of Efficacy|17|||
124434176|NCT00324116|447549495|FG000|Overall Study|Withdrawal by Subject|5|||
124434177|NCT00324116|447549495|FG000|Overall Study|Other|5|||
124434178|NCT01806623|447549496|FG000|Overall Study|Withdrawal by Subject|1|||
124434179|NCT01806623|447549496|FG000|Overall Study|Adverse Event|1|||
124434180|NCT01806623|447549496|FG000|Overall Study|Did not meet the inclusion criteria|56|||
124434181|NCT01737827|447549497|FG000|Overall Study|Adverse Event|3|||
124434182|NCT01737827|447549498|FG001|Overall Study|Adverse Event|6|||
124434183|NCT01737827|447549499|FG002|Overall Study|Adverse Event|0|||
124434184|NCT01737827|447549497|FG000|Overall Study|Lost to Follow-up|0|||
124434185|NCT01737827|447549498|FG001|Overall Study|Lost to Follow-up|1|||
124434186|NCT01737827|447549499|FG002|Overall Study|Lost to Follow-up|0|||
124434187|NCT01737827|447549497|FG000|Overall Study|Physician Decision|0|||
124434188|NCT01737827|447549498|FG001|Overall Study|Physician Decision|2|||
124434189|NCT01737827|447549499|FG002|Overall Study|Physician Decision|0|||
124434190|NCT01737827|447549497|FG000|Overall Study|Progressive Disease|5|||
124434191|NCT01737827|447549498|FG001|Overall Study|Progressive Disease|16|||
124434192|NCT01737827|447549499|FG002|Overall Study|Progressive Disease|2|||
124434193|NCT01737827|447549497|FG000|Overall Study|Study Terminated by Sponsor|0|||
124434194|NCT01737827|447549498|FG001|Overall Study|Study Terminated by Sponsor|1|||
124434195|NCT01737827|447549499|FG002|Overall Study|Study Terminated by Sponsor|0|||
124434196|NCT01737827|447549497|FG000|Overall Study|Subject/Guardian Decision|0|||
124434197|NCT01737827|447549498|FG001|Overall Study|Subject/Guardian Decision|2|||
124434198|NCT01737827|447549499|FG002|Overall Study|Subject/Guardian Decision|0|||
124434199|NCT01451827|447549500|FG000|Overall Study|Adverse Event|2|||
124434200|NCT01451827|447549501|FG001|Overall Study|Adverse Event|0|||
124434201|NCT01451827|447549502|FG002|Overall Study|Adverse Event|1|||
124434202|NCT01451827|447549503|FG003|Overall Study|Adverse Event|1|||
124434203|NCT01451827|447549500|FG000|Overall Study|Protocol deviation|1|||
124434204|NCT01451827|447549501|FG001|Overall Study|Protocol deviation|0|||
124434205|NCT01451827|447549502|FG002|Overall Study|Protocol deviation|0|||
124434206|NCT01451827|447549503|FG003|Overall Study|Protocol deviation|0|||
124434207|NCT01451827|447549500|FG000|Overall Study|Lost to Follow-up|0|||
124434208|NCT01451827|447549501|FG001|Overall Study|Lost to Follow-up|3|||
124434209|NCT01451827|447549502|FG002|Overall Study|Lost to Follow-up|0|||
124434210|NCT01451827|447549503|FG003|Overall Study|Lost to Follow-up|2|||
124434211|NCT01451827|447549500|FG000|Overall Study|Participant met withdrawal criteria|0|||
124434212|NCT01451827|447549501|FG001|Overall Study|Participant met withdrawal criteria|2|||
124434213|NCT01451827|447549502|FG002|Overall Study|Participant met withdrawal criteria|0|||
124434214|NCT01451827|447549503|FG003|Overall Study|Participant met withdrawal criteria|0|||
124434215|NCT01451827|447549500|FG000|Overall Study|Withdrawal by Subject|0|||
124434216|NCT01451827|447549501|FG001|Overall Study|Withdrawal by Subject|0|||
124434217|NCT01451827|447549502|FG002|Overall Study|Withdrawal by Subject|1|||
124434218|NCT01451827|447549503|FG003|Overall Study|Withdrawal by Subject|1|||
124434219|NCT02413333|447549504|FG000|Period 1|Adverse Event|1|||
124434220|NCT02413333|447549505|FG001|Period 1|Adverse Event|0|||
124434221|NCT02413333|447549504|FG000|Period 1|Reason Not Specified|0|||
124434222|NCT02413333|447549505|FG001|Period 1|Reason Not Specified|1|||
124434223|NCT02413333|447549504|FG000|Period 2|Protocol Deviation|1|||
124434224|NCT02413333|447549505|FG001|Period 2|Protocol Deviation|0|||
124434225|NCT02996474|447549506|FG000|Overall Study|Physician Decision|5|||
124434226|NCT00540046|447549507|FG000|Overall Study|Lost to Follow-up|33|||
124434227|NCT00540046|447549508|FG001|Overall Study|Lost to Follow-up|23|||
124434228|NCT02891837|447549509|FG000|Overall Study|Lost to Follow-up|2|||
124434229|NCT02891837|447549510|FG001|Overall Study|Lost to Follow-up|0|||
124434230|NCT02891837|447549509|FG000|Overall Study|Withdrawal by Subject|1|||
124434231|NCT02891837|447549510|FG001|Overall Study|Withdrawal by Subject|0|||
124434232|NCT00185965|447549511|FG000|Overall Study|Adverse Event|0|||
124434233|NCT00185965|447549512|FG001|Overall Study|Adverse Event|1|||
124434234|NCT02533531|447549513|FG000|Overall Study|Device did not turn on|1|||
124434235|NCT02047903|447549514|FG000|Overall Study|Adverse Event|14|||
124434236|NCT02047903|447549514|FG000|Overall Study|Serious adverse event|10|||
124434237|NCT02047903|447549514|FG000|Overall Study|Withdrawal by Subject|16|||
124434238|NCT02047903|447549514|FG000|Overall Study|Lost to Follow-up|4|||
124434239|NCT02047903|447549514|FG000|Overall Study|Reason not listed|6|||
124434240|NCT02047903|447549514|FG000|Overall Study|Not Treated|9|||
124434241|NCT03616977|447549518|FG000|Period 1|Physician Decision|0|||
124434242|NCT03616977|447549519|FG001|Period 1|Physician Decision|1|||
124434243|NCT03616977|447549518|FG000|Period 3|Adverse Event|1|||
124434244|NCT03616977|447549519|FG001|Period 3|Adverse Event|1|||
124434245|NCT01323972|447549521|FG000|Overall Study|Withdrawal by Subject|1|||
124434246|NCT01323972|447549522|FG001|Overall Study|Withdrawal by Subject|0|||
124434247|NCT01323972|447549523|FG002|Overall Study|Withdrawal by Subject|1|||
124434248|NCT01323972|447549524|FG003|Overall Study|Withdrawal by Subject|0|||
124434249|NCT01323972|447549521|FG000|Overall Study|Migrated/moved from study area|1|||
124434250|NCT01323972|447549522|FG001|Overall Study|Migrated/moved from study area|2|||
124434251|NCT01323972|447549523|FG002|Overall Study|Migrated/moved from study area|0|||
124434252|NCT01323972|447549524|FG003|Overall Study|Migrated/moved from study area|0|||
124434253|NCT01323972|447549521|FG000|Overall Study|Lost to Follow-up|0|||
124434254|NCT01323972|447549522|FG001|Overall Study|Lost to Follow-up|1|||
124434255|NCT01323972|447549523|FG002|Overall Study|Lost to Follow-up|1|||
124434256|NCT01323972|447549524|FG003|Overall Study|Lost to Follow-up|1|||
124434257|NCT02008877|447549525|FG000|Overall Study|Inevaluable|0|||
124434258|NCT02008877|447549526|FG001|Overall Study|Inevaluable|1|||
124434259|NCT02008877|447549527|FG002|Overall Study|Inevaluable|0|||
124434260|NCT01049217|447549530|FG000|Overall Study|Adverse Event|2|||
124434261|NCT01049217|447549531|FG001|Overall Study|Adverse Event|1|||
124434262|NCT01049217|447549530|FG000|Overall Study|Lack of Efficacy|1|||
124434263|NCT01049217|447549531|FG001|Overall Study|Lack of Efficacy|1|||
124434264|NCT01049217|447549530|FG000|Overall Study|Lost to Follow-up|3|||
124434265|NCT01049217|447549531|FG001|Overall Study|Lost to Follow-up|8|||
124434266|NCT01049217|447549530|FG000|Overall Study|Withdrawal by Subject|4|||
124434267|NCT01049217|447549531|FG001|Overall Study|Withdrawal by Subject|3|||
124434268|NCT01049217|447549530|FG000|Overall Study|Protocol Violation|1|||
124434269|NCT01049217|447549531|FG001|Overall Study|Protocol Violation|3|||
124434270|NCT01049217|447549530|FG000|Overall Study|Pregnancy|1|||
124434271|NCT01049217|447549531|FG001|Overall Study|Pregnancy|0|||
124434272|NCT01049217|447549530|FG000|Overall Study|Study Terminated by Sponsor|43|||
124434273|NCT01049217|447549531|FG001|Overall Study|Study Terminated by Sponsor|43|||
124434274|NCT01049217|447549530|FG000|Overall Study|Other|1|||
124434275|NCT01049217|447549531|FG001|Overall Study|Other|2|||
124434276|NCT01049217|447549530|FG000|Overall Study|Randomized but not Treated|0|||
124434277|NCT01049217|447549531|FG001|Overall Study|Randomized but not Treated|2|||
124434278|NCT02412371|447549532|FG000|Overall Study|Withdrawal by Subject|0|||
124434279|NCT02412371|447549533|FG001|Overall Study|Withdrawal by Subject|2|||
124434280|NCT02412371|447549534|FG002|Overall Study|Withdrawal by Subject|0|||
124434281|NCT02412371|447549535|FG003|Overall Study|Withdrawal by Subject|1|||
124678436|NCT03451045|448448103|FG000|Overall Study|Lack of Efficacy|3|||
124434282|NCT02412371|447549536|FG004|Overall Study|Withdrawal by Subject|1|||
124434283|NCT02412371|447549537|FG005|Overall Study|Withdrawal by Subject|0|||
124434284|NCT02412371|447549532|FG000|Overall Study|Sponsor Discontinued Study|1|||
124434285|NCT02412371|447549533|FG001|Overall Study|Sponsor Discontinued Study|4|||
124434286|NCT02412371|447549534|FG002|Overall Study|Sponsor Discontinued Study|6|||
124434287|NCT02412371|447549535|FG003|Overall Study|Sponsor Discontinued Study|4|||
124434288|NCT02412371|447549536|FG004|Overall Study|Sponsor Discontinued Study|5|||
124434289|NCT02412371|447549537|FG005|Overall Study|Sponsor Discontinued Study|0|||
124434290|NCT02412371|447549532|FG000|Overall Study|Death|4|||
124434291|NCT02412371|447549533|FG001|Overall Study|Death|2|||
124434292|NCT02412371|447549534|FG002|Overall Study|Death|1|||
124434293|NCT02412371|447549535|FG003|Overall Study|Death|3|||
124434294|NCT02412371|447549536|FG004|Overall Study|Death|5|||
124434295|NCT02412371|447549537|FG005|Overall Study|Death|2|||
124434296|NCT02412371|447549532|FG000|Overall Study|Other|2|||
124434297|NCT02412371|447549533|FG001|Overall Study|Other|1|||
124434298|NCT02412371|447549534|FG002|Overall Study|Other|0|||
124434299|NCT02412371|447549535|FG003|Overall Study|Other|0|||
124434300|NCT02412371|447549536|FG004|Overall Study|Other|1|||
124434301|NCT02412371|447549537|FG005|Overall Study|Other|3|||
124434302|NCT00903682|447549538|FG000|Overall Study|Adverse Event|6|||
124434303|NCT00903682|447549539|FG001|Overall Study|Adverse Event|13|||
124434304|NCT00903682|447549538|FG000|Overall Study|Lost to Follow-up|1|||
124434305|NCT00903682|447549539|FG001|Overall Study|Lost to Follow-up|0|||
124434306|NCT00903682|447549538|FG000|Overall Study|Withdrawal by Subject|5|||
124434307|NCT00903682|447549539|FG001|Overall Study|Withdrawal by Subject|0|||
124434308|NCT00903682|447549538|FG000|Overall Study|Pregnancy|0|||
124434309|NCT00903682|447549539|FG001|Overall Study|Pregnancy|1|||
124434310|NCT00903682|447549538|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
124434311|NCT00903682|447549539|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
124434312|NCT00903682|447549538|FG000|Overall Study|Subject Non-Compliant|1|||
124434313|NCT00903682|447549539|FG001|Overall Study|Subject Non-Compliant|0|||
124434314|NCT00903682|447549538|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
124434315|NCT00903682|447549539|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
124434316|NCT00903682|447549538|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
124434317|NCT00903682|447549539|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
124434318|NCT02495792|447549540|FG000|Overall Study|Lost to Follow-up|5|||
124434319|NCT02495792|447549541|FG001|Overall Study|Lost to Follow-up|9|||
124434320|NCT02495792|447549540|FG000|Overall Study|Protocol Violation|32|||
124434321|NCT02495792|447549541|FG001|Overall Study|Protocol Violation|31|||
124434322|NCT02053792|447549542|FG000|Overall Study|Physician Decision|0|||
124434323|NCT02053792|447549543|FG001|Overall Study|Physician Decision|1|||
124434324|NCT02053792|447549542|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
124434325|NCT02053792|447549543|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
124434326|NCT02053792|447549542|FG000|Overall Study|Lack of Efficacy|1|||
124434327|NCT02053792|447549543|FG001|Overall Study|Lack of Efficacy|0|||
124434328|NCT02053792|447549542|FG000|Overall Study|Adverse Event|1|||
124434329|NCT02053792|447549543|FG001|Overall Study|Adverse Event|0|||
124434330|NCT02053792|447549542|FG000|Overall Study|Withdrawal by Subject|2|||
124434331|NCT02053792|447549543|FG001|Overall Study|Withdrawal by Subject|2|||
124434332|NCT02053792|447549542|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
124434333|NCT02053792|447549543|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
124434334|NCT02053792|447549542|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
124434335|NCT02053792|447549543|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
124434336|NCT03141905|447549546|FG000|Overall Study|Death|3|||
124434337|NCT03141905|447549547|FG001|Overall Study|Death|2|||
124434338|NCT03141905|447549546|FG000|Overall Study|Withdrawal by Subject|1|||
124434339|NCT03141905|447549547|FG001|Overall Study|Withdrawal by Subject|0|||
124434340|NCT03141905|447549546|FG000|Overall Study|Lost to Follow-up|3|||
124434341|NCT03141905|447549547|FG001|Overall Study|Lost to Follow-up|7|||
124434342|NCT03141905|447549546|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
124434343|NCT03141905|447549547|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
124434344|NCT02502799|447551839|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
124434345|NCT02502799|447551840|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
124434346|NCT02502799|447551841|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
124434347|NCT02502799|447551842|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
124434348|NCT02502799|447551839|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
124434349|NCT02502799|447551840|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
124434350|NCT02502799|447551841|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
124434351|NCT02502799|447551842|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
124434352|NCT02502799|447551839|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
124434353|NCT02502799|447551840|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
124434354|NCT02502799|447551841|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
124434355|NCT02502799|447551842|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
124434356|NCT02502799|447551839|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
124434357|NCT02502799|447551840|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
124434358|NCT02502799|447551841|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
124434359|NCT02502799|447551842|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
124434360|NCT02502799|447551839|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
124434361|NCT02502799|447551840|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
124434362|NCT02502799|447551841|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
124434363|NCT02502799|447551842|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
124434364|NCT01076192|447551854|FG000|Overall Study|Other|197|||
124434365|NCT05087979|447551855|FG000|Overall Study|Converted to general anesthesia|1|||
124434366|NCT05087979|447551856|FG001|Overall Study|Converted to general anesthesia|0|||
124434367|NCT02924428|447551857|FG000|Overall Study|Adverse Event|1|||
124434368|NCT02924428|447551858|FG001|Overall Study|Adverse Event|0|||
124434369|NCT02924428|447551857|FG000|Overall Study|Physician Decision|1|||
124434370|NCT02924428|447551858|FG001|Overall Study|Physician Decision|0|||
124434371|NCT02924428|447551857|FG000|Overall Study|Lost to Follow-up|2|||
124434372|NCT02924428|447551858|FG001|Overall Study|Lost to Follow-up|4|||
124434373|NCT02924428|447551857|FG000|Overall Study|Pregnancy|0|||
124434374|NCT02924428|447551858|FG001|Overall Study|Pregnancy|1|||
124434375|NCT01850446|447551859|FG000|Overall Study|Lack of Efficacy|1|||
124434376|NCT01850446|447551860|FG001|Overall Study|Lack of Efficacy|0|||
124434377|NCT01850446|447551859|FG000|Overall Study|Withdrawal by Subject|4|||
124434378|NCT01850446|447551860|FG001|Overall Study|Withdrawal by Subject|0|||
124434379|NCT01850446|447551859|FG000|Overall Study|Protocol Violation|0|||
124434380|NCT01850446|447551860|FG001|Overall Study|Protocol Violation|2|||
124434381|NCT00759915|447551861|FG000|Overall Study|Withdrawal by Subject|1|||
124434382|NCT00759915|447551862|FG001|Overall Study|Withdrawal by Subject|0|||
124434383|NCT00759915|447551861|FG000|Overall Study|Adverse Event|0|||
124434384|NCT00759915|447551862|FG001|Overall Study|Adverse Event|1|||
124434385|NCT02074553|447551863|FG000|Intervention Period 1|Family Emergency|0|||
124434386|NCT02074553|447551864|FG001|Intervention Period 1|Family Emergency|0|||
124434387|NCT02074553|447551865|FG002|Intervention Period 1|Family Emergency|0|||
124434388|NCT02074553|447551866|FG003|Intervention Period 1|Family Emergency|1|||
124434389|NCT02074553|447551867|FG004|Intervention Period 1|Family Emergency|0|||
124434390|NCT02074553|447551868|FG005|Intervention Period 1|Family Emergency|0|||
124434391|NCT02074553|447551869|FG006|Intervention Period 1|Family Emergency|0|||
124434392|NCT02074553|447551870|FG007|Intervention Period 1|Family Emergency|0|||
124434393|NCT02074553|447551863|FG000|Washout Period 1|Adverse Event|1|||
124434394|NCT02074553|447551864|FG001|Washout Period 1|Adverse Event|0|||
124434395|NCT02074553|447551865|FG002|Washout Period 1|Adverse Event|0|||
124434396|NCT02074553|447551866|FG003|Washout Period 1|Adverse Event|0|||
124434397|NCT02074553|447551867|FG004|Washout Period 1|Adverse Event|0|||
124434398|NCT02074553|447551868|FG005|Washout Period 1|Adverse Event|0|||
124434399|NCT02074553|447551869|FG006|Washout Period 1|Adverse Event|0|||
124434400|NCT02074553|447551870|FG007|Washout Period 1|Adverse Event|0|||
124434401|NCT02074553|447551863|FG000|Washout Period 1|Physician Decision|0|||
124434402|NCT02074553|447551864|FG001|Washout Period 1|Physician Decision|0|||
124434403|NCT02074553|447551865|FG002|Washout Period 1|Physician Decision|0|||
124434404|NCT02074553|447551866|FG003|Washout Period 1|Physician Decision|1|||
124434405|NCT02074553|447551867|FG004|Washout Period 1|Physician Decision|0|||
124434406|NCT02074553|447551868|FG005|Washout Period 1|Physician Decision|0|||
124434407|NCT02074553|447551869|FG006|Washout Period 1|Physician Decision|0|||
124434408|NCT02074553|447551870|FG007|Washout Period 1|Physician Decision|0|||
124434409|NCT02074553|447551863|FG000|Washout Period 1|Other|0|||
124434410|NCT02074553|447551864|FG001|Washout Period 1|Other|0|||
124434411|NCT02074553|447551865|FG002|Washout Period 1|Other|0|||
124434412|NCT02074553|447551866|FG003|Washout Period 1|Other|0|||
124434413|NCT02074553|447551867|FG004|Washout Period 1|Other|0|||
124434414|NCT02074553|447551868|FG005|Washout Period 1|Other|1|||
124434415|NCT02074553|447551869|FG006|Washout Period 1|Other|0|||
124434416|NCT02074553|447551870|FG007|Washout Period 1|Other|0|||
124434417|NCT02074553|447551863|FG000|Washout Period 2|Adverse Event|0|||
124434418|NCT02074553|447551864|FG001|Washout Period 2|Adverse Event|0|||
124434419|NCT02074553|447551865|FG002|Washout Period 2|Adverse Event|0|||
124434420|NCT02074553|447551866|FG003|Washout Period 2|Adverse Event|0|||
124434421|NCT02074553|447551867|FG004|Washout Period 2|Adverse Event|0|||
124434422|NCT02074553|447551868|FG005|Washout Period 2|Adverse Event|0|||
124434423|NCT02074553|447551869|FG006|Washout Period 2|Adverse Event|1|||
124434424|NCT02074553|447551870|FG007|Washout Period 2|Adverse Event|0|||
124434425|NCT02074553|447551863|FG000|Washout Period 2|Physician Decision|0|||
124678437|NCT03451045|448448104|FG001|Overall Study|Lack of Efficacy|2|||
124434426|NCT02074553|447551864|FG001|Washout Period 2|Physician Decision|0|||
124434427|NCT02074553|447551865|FG002|Washout Period 2|Physician Decision|0|||
124434428|NCT02074553|447551866|FG003|Washout Period 2|Physician Decision|0|||
124434429|NCT02074553|447551867|FG004|Washout Period 2|Physician Decision|0|||
124434430|NCT02074553|447551868|FG005|Washout Period 2|Physician Decision|1|||
124434431|NCT02074553|447551869|FG006|Washout Period 2|Physician Decision|0|||
124434432|NCT02074553|447551870|FG007|Washout Period 2|Physician Decision|0|||
124434433|NCT02074553|447551863|FG000|Washout Period 2|Lost to Follow-up|0|||
124434434|NCT02074553|447551864|FG001|Washout Period 2|Lost to Follow-up|0|||
124434435|NCT02074553|447551865|FG002|Washout Period 2|Lost to Follow-up|1|||
124434436|NCT02074553|447551866|FG003|Washout Period 2|Lost to Follow-up|0|||
124434437|NCT02074553|447551867|FG004|Washout Period 2|Lost to Follow-up|0|||
124434438|NCT02074553|447551868|FG005|Washout Period 2|Lost to Follow-up|0|||
124434439|NCT02074553|447551869|FG006|Washout Period 2|Lost to Follow-up|0|||
124434440|NCT02074553|447551870|FG007|Washout Period 2|Lost to Follow-up|0|||
124434441|NCT02074553|447551863|FG000|Washout Period 3|Physician Decision|0|||
124434442|NCT02074553|447551864|FG001|Washout Period 3|Physician Decision|0|||
124434443|NCT02074553|447551865|FG002|Washout Period 3|Physician Decision|0|||
124434444|NCT02074553|447551866|FG003|Washout Period 3|Physician Decision|0|||
124434445|NCT02074553|447551867|FG004|Washout Period 3|Physician Decision|0|||
124434446|NCT02074553|447551868|FG005|Washout Period 3|Physician Decision|0|||
124434447|NCT02074553|447551869|FG006|Washout Period 3|Physician Decision|0|||
124434448|NCT02074553|447551870|FG007|Washout Period 3|Physician Decision|1|||
124434449|NCT01658150|447551871|FG000|Overall Study|Withdrawal by Subject|1|||
124434450|NCT02342743|447551872|FG000|Baseline Period|Withdrawal by Subject|3|||
124434451|NCT02342743|447551872|FG000|Baseline Period|Lost to Follow-up|2|||
124434452|NCT02342743|447551872|FG000|Baseline Period|Change in prophylactic medication|3|||
124434453|NCT02342743|447551872|FG000|Baseline Period|Screening failure regarding baseline|7|||
124434454|NCT02342743|447551872|FG000|Treatment Period|Withdrawal by Subject|2|||
124434455|NCT02342743|447551872|FG000|Treatment Period|Lost to Follow-up|8|||
124434456|NCT02342743|447551872|FG000|Treatment Period|Change in prophylactic medication|1|||
124434457|NCT04875676|447551873|FG000|Overall Study|Lost to Follow-up|1|||
124434458|NCT04875676|447551874|FG001|Overall Study|Lost to Follow-up|0|||
124434459|NCT04875676|447551875|FG002|Overall Study|Lost to Follow-up|0|||
124434460|NCT03646656|447551876|FG000|Overall Study|Lost to Follow-up|1|||
124434461|NCT03646656|447551877|FG001|Overall Study|Lost to Follow-up|0|||
124434462|NCT03646656|447551876|FG000|Overall Study|Withdrawal by Subject|2|||
124434463|NCT03646656|447551877|FG001|Overall Study|Withdrawal by Subject|0|||
124434464|NCT03602066|447551878|FG000|Overall Study|Withdrawal by Subject|2|||
124434465|NCT03602066|447551879|FG001|Overall Study|Withdrawal by Subject|0|||
124434466|NCT03602066|447551878|FG000|Overall Study|Physician Decision|1|||
124434467|NCT03602066|447551879|FG001|Overall Study|Physician Decision|0|||
124434468|NCT00092495|447551880|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
124434469|NCT00092495|447551881|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
124434470|NCT00092495|447551882|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
124434471|NCT00092495|447551883|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
124434472|NCT00092495|447551884|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
124434473|NCT00092495|447551880|FG000|Base Study Vaccination Period|Extended|0|||
124434474|NCT00092495|447551881|FG001|Base Study Vaccination Period|Extended|0|||
124434475|NCT00092495|447551882|FG002|Base Study Vaccination Period|Extended|0|||
124434476|NCT00092495|447551883|FG003|Base Study Vaccination Period|Extended|1|||
124434477|NCT00092495|447551884|FG004|Base Study Vaccination Period|Extended|0|||
124434478|NCT00092495|447551880|FG000|Base Study Vaccination Period|*Clinical AE|1|||
124434479|NCT00092495|447551881|FG001|Base Study Vaccination Period|*Clinical AE|0|||
124434480|NCT00092495|447551882|FG002|Base Study Vaccination Period|*Clinical AE|1|||
124434481|NCT00092495|447551883|FG003|Base Study Vaccination Period|*Clinical AE|2|||
124434482|NCT00092495|447551884|FG004|Base Study Vaccination Period|*Clinical AE|0|||
124434483|NCT00092495|447551880|FG000|Base Study Vaccination Period|*Other reasons|1|||
124434484|NCT00092495|447551881|FG001|Base Study Vaccination Period|*Other reasons|0|||
124434485|NCT00092495|447551882|FG002|Base Study Vaccination Period|*Other reasons|0|||
124434486|NCT00092495|447551883|FG003|Base Study Vaccination Period|*Other reasons|1|||
124434487|NCT00092495|447551884|FG004|Base Study Vaccination Period|*Other reasons|0|||
124434488|NCT00092495|447551880|FG000|Base Study Vaccination Period|*Pregnancy|0|||
124434489|NCT00092495|447551881|FG001|Base Study Vaccination Period|*Pregnancy|2|||
124434490|NCT00092495|447551882|FG002|Base Study Vaccination Period|*Pregnancy|5|||
124434491|NCT00092495|447551883|FG003|Base Study Vaccination Period|*Pregnancy|7|||
124434492|NCT00092495|447551884|FG004|Base Study Vaccination Period|*Pregnancy|0|||
124434493|NCT00092495|447551880|FG000|Base Study Vaccination Period|Adverse Event|1|||
124434494|NCT00092495|447551881|FG001|Base Study Vaccination Period|Adverse Event|0|||
124434495|NCT00092495|447551882|FG002|Base Study Vaccination Period|Adverse Event|0|||
124434496|NCT00092495|447551883|FG003|Base Study Vaccination Period|Adverse Event|3|||
124434497|NCT00092495|447551884|FG004|Base Study Vaccination Period|Adverse Event|0|||
124434498|NCT00092495|447551880|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
124434499|NCT00092495|447551881|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
124434500|NCT00092495|447551882|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
124434501|NCT00092495|447551883|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
124434502|NCT00092495|447551884|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
124678438|NCT03451045|448448105|FG002|Overall Study|Lack of Efficacy|2|||
124434503|NCT00092495|447551880|FG000|Base Study Vaccination Period|Moved|3|||
124434504|NCT00092495|447551881|FG001|Base Study Vaccination Period|Moved|1|||
124434505|NCT00092495|447551882|FG002|Base Study Vaccination Period|Moved|2|||
124434506|NCT00092495|447551883|FG003|Base Study Vaccination Period|Moved|2|||
124434507|NCT00092495|447551884|FG004|Base Study Vaccination Period|Moved|0|||
124434508|NCT00092495|447551880|FG000|Base Study Vaccination Period|Other|1|||
124434509|NCT00092495|447551881|FG001|Base Study Vaccination Period|Other|1|||
124434510|NCT00092495|447551882|FG002|Base Study Vaccination Period|Other|0|||
124434511|NCT00092495|447551883|FG003|Base Study Vaccination Period|Other|2|||
124434512|NCT00092495|447551884|FG004|Base Study Vaccination Period|Other|0|||
124434513|NCT00092495|447551880|FG000|Base Study Vaccination Period|Pregnancy|2|||
124434514|NCT00092495|447551881|FG001|Base Study Vaccination Period|Pregnancy|0|||
124434515|NCT00092495|447551882|FG002|Base Study Vaccination Period|Pregnancy|0|||
124434516|NCT00092495|447551883|FG003|Base Study Vaccination Period|Pregnancy|0|||
124434517|NCT00092495|447551884|FG004|Base Study Vaccination Period|Pregnancy|0|||
124434518|NCT00092495|447551880|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
124434519|NCT00092495|447551881|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
124434520|NCT00092495|447551882|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
124434521|NCT00092495|447551883|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
124434522|NCT00092495|447551884|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
124434523|NCT00092495|447551880|FG000|Base Study Vaccination Period|Protocol Violation|1|||
124434524|NCT00092495|447551881|FG001|Base Study Vaccination Period|Protocol Violation|0|||
124434525|NCT00092495|447551882|FG002|Base Study Vaccination Period|Protocol Violation|0|||
124434526|NCT00092495|447551883|FG003|Base Study Vaccination Period|Protocol Violation|0|||
124434527|NCT00092495|447551884|FG004|Base Study Vaccination Period|Protocol Violation|0|||
124434528|NCT00092495|447551880|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
124434529|NCT00092495|447551881|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
124434530|NCT00092495|447551882|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
124434531|NCT00092495|447551883|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
124434532|NCT00092495|447551884|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
124434533|NCT00092495|447551880|FG000|Base Study Follow-up Period|Extended|0|||
124434534|NCT00092495|447551881|FG001|Base Study Follow-up Period|Extended|0|||
124434535|NCT00092495|447551882|FG002|Base Study Follow-up Period|Extended|1|||
124434536|NCT00092495|447551883|FG003|Base Study Follow-up Period|Extended|2|||
124434537|NCT00092495|447551884|FG004|Base Study Follow-up Period|Extended|0|||
124434538|NCT00092495|447551880|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
124434539|NCT00092495|447551881|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
124434540|NCT00092495|447551882|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
124434541|NCT00092495|447551883|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
124434542|NCT00092495|447551884|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
124434543|NCT00092495|447551880|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
124434544|NCT00092495|447551881|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
124434545|NCT00092495|447551882|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
124434546|NCT00092495|447551883|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
124434547|NCT00092495|447551884|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
124434548|NCT00938470|447551887|FG000|Overall Study|Disease Progression|3|||
124434549|NCT00938470|447551888|FG001|Overall Study|Disease Progression|0|||
124434550|NCT00938470|447551887|FG000|Overall Study|Alternate Treatment|1|||
124434551|NCT00938470|447551888|FG001|Overall Study|Alternate Treatment|0|||
124434552|NCT00938470|447551887|FG000|Overall Study|Death|3|||
124434553|NCT00938470|447551888|FG001|Overall Study|Death|2|||
124434554|NCT00938470|447551887|FG000|Overall Study|Other Reason|0|||
124434555|NCT00938470|447551888|FG001|Overall Study|Other Reason|1|||
124434556|NCT01171807|447551889|FG000|Overall Study|Treatment failure|2|||
124434557|NCT01171807|447551890|FG001|Overall Study|Treatment failure|4|||
124434558|NCT01171807|447551889|FG000|Overall Study|Non compliance|1|||
124434559|NCT01171807|447551890|FG001|Overall Study|Non compliance|0|||
124434560|NCT01171807|447551889|FG000|Overall Study|Lost to Follow-up|3|||
124434561|NCT01171807|447551890|FG001|Overall Study|Lost to Follow-up|0|||
124434562|NCT04101318|447551891|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
124434563|NCT04101318|447551892|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
124434564|NCT04101318|447551891|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
124434565|NCT04101318|447551892|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
124434566|NCT04101318|447551891|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
124434567|NCT04101318|447551892|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
124434568|NCT00822172|447551893|FG000|Overall Study|Adverse Event|10|||
124434569|NCT00822172|447551894|FG001|Overall Study|Adverse Event|12|||
124434570|NCT00822172|447551893|FG000|Overall Study|Death|1|||
124434571|NCT00822172|447551894|FG001|Overall Study|Death|0|||
124434572|NCT00822172|447551893|FG000|Overall Study|Lost to Follow-up|3|||
124434573|NCT00822172|447551894|FG001|Overall Study|Lost to Follow-up|1|||
124434574|NCT00822172|447551893|FG000|Overall Study|Withdrawal by Subject|1|||
124434575|NCT00822172|447551894|FG001|Overall Study|Withdrawal by Subject|4|||
124434576|NCT00822172|447551893|FG000|Overall Study|site closed|0|||
124434577|NCT00822172|447551894|FG001|Overall Study|site closed|1|||
124434578|NCT00822172|447551893|FG000|Overall Study|Other|0|||
124875341|NCT02799472|449165938|FG000|Overall Study|Lost to Follow-up|0|||
124434579|NCT00822172|447551894|FG001|Overall Study|Other|1|||
124434580|NCT01874431|447551895|FG000|Overall Study|Physician Decision|0|||
124434581|NCT01874431|447551896|FG001|Overall Study|Physician Decision|0|||
124434582|NCT01874431|447551897|FG002|Overall Study|Physician Decision|1|||
124434583|NCT01874431|447551898|FG003|Overall Study|Physician Decision|0|||
124434584|NCT01874431|447551899|FG004|Overall Study|Physician Decision|0|||
124434585|NCT01874431|447551900|FG005|Overall Study|Physician Decision|0|||
124434586|NCT01874431|447551901|FG006|Overall Study|Physician Decision|0|||
124434587|NCT01874431|447551902|FG007|Overall Study|Physician Decision|0|||
124434588|NCT01874431|447551895|FG000|Overall Study|Adverse Event|5|||
124434589|NCT01874431|447551896|FG001|Overall Study|Adverse Event|4|||
124434590|NCT01874431|447551897|FG002|Overall Study|Adverse Event|6|||
124434591|NCT01874431|447551898|FG003|Overall Study|Adverse Event|5|||
124434592|NCT01874431|447551899|FG004|Overall Study|Adverse Event|2|||
124434593|NCT01874431|447551900|FG005|Overall Study|Adverse Event|8|||
124434594|NCT01874431|447551901|FG006|Overall Study|Adverse Event|2|||
124434595|NCT01874431|447551902|FG007|Overall Study|Adverse Event|3|||
124434596|NCT01874431|447551895|FG000|Overall Study|Protocol Violation|1|||
124434597|NCT01874431|447551896|FG001|Overall Study|Protocol Violation|1|||
124434598|NCT01874431|447551897|FG002|Overall Study|Protocol Violation|1|||
124434599|NCT01874431|447551898|FG003|Overall Study|Protocol Violation|0|||
124434600|NCT01874431|447551899|FG004|Overall Study|Protocol Violation|3|||
124434601|NCT01874431|447551900|FG005|Overall Study|Protocol Violation|2|||
124434602|NCT01874431|447551901|FG006|Overall Study|Protocol Violation|1|||
124434603|NCT01874431|447551902|FG007|Overall Study|Protocol Violation|1|||
124434604|NCT01874431|447551895|FG000|Overall Study|Non-compliance|0|||
124434605|NCT01874431|447551896|FG001|Overall Study|Non-compliance|0|||
124434606|NCT01874431|447551897|FG002|Overall Study|Non-compliance|0|||
124434607|NCT01874431|447551898|FG003|Overall Study|Non-compliance|0|||
124434608|NCT01874431|447551899|FG004|Overall Study|Non-compliance|1|||
124434609|NCT01874431|447551900|FG005|Overall Study|Non-compliance|0|||
124434610|NCT01874431|447551901|FG006|Overall Study|Non-compliance|1|||
124434611|NCT01874431|447551902|FG007|Overall Study|Non-compliance|0|||
124434612|NCT01874431|447551895|FG000|Overall Study|Logistical difficulties|0|||
124434613|NCT01874431|447551896|FG001|Overall Study|Logistical difficulties|0|||
124434614|NCT01874431|447551897|FG002|Overall Study|Logistical difficulties|0|||
124434615|NCT01874431|447551898|FG003|Overall Study|Logistical difficulties|0|||
124434616|NCT01874431|447551899|FG004|Overall Study|Logistical difficulties|0|||
124434617|NCT01874431|447551900|FG005|Overall Study|Logistical difficulties|0|||
124434618|NCT01874431|447551901|FG006|Overall Study|Logistical difficulties|1|||
124434619|NCT01874431|447551902|FG007|Overall Study|Logistical difficulties|0|||
124434620|NCT01874431|447551895|FG000|Overall Study|Withdrawal by Subject|0|||
124434621|NCT01874431|447551896|FG001|Overall Study|Withdrawal by Subject|0|||
124434622|NCT01874431|447551897|FG002|Overall Study|Withdrawal by Subject|1|||
124434623|NCT01874431|447551898|FG003|Overall Study|Withdrawal by Subject|2|||
124434624|NCT01874431|447551899|FG004|Overall Study|Withdrawal by Subject|1|||
124434625|NCT01874431|447551900|FG005|Overall Study|Withdrawal by Subject|1|||
124434626|NCT01874431|447551901|FG006|Overall Study|Withdrawal by Subject|3|||
124434627|NCT01874431|447551902|FG007|Overall Study|Withdrawal by Subject|0|||
124434628|NCT01874431|447551895|FG000|Overall Study|Sponsor decision|0|||
124434629|NCT01874431|447551896|FG001|Overall Study|Sponsor decision|0|||
124434630|NCT01874431|447551897|FG002|Overall Study|Sponsor decision|0|||
124434631|NCT01874431|447551898|FG003|Overall Study|Sponsor decision|0|||
124434632|NCT01874431|447551899|FG004|Overall Study|Sponsor decision|1|||
124434633|NCT01874431|447551900|FG005|Overall Study|Sponsor decision|0|||
124434634|NCT01874431|447551901|FG006|Overall Study|Sponsor decision|0|||
124434635|NCT01874431|447551902|FG007|Overall Study|Sponsor decision|0|||
124434636|NCT01874431|447551895|FG000|Overall Study|Lost to Follow-up|0|||
124434637|NCT01874431|447551896|FG001|Overall Study|Lost to Follow-up|0|||
124434638|NCT01874431|447551897|FG002|Overall Study|Lost to Follow-up|1|||
124434639|NCT01874431|447551898|FG003|Overall Study|Lost to Follow-up|0|||
124434640|NCT01874431|447551899|FG004|Overall Study|Lost to Follow-up|0|||
124434641|NCT01874431|447551900|FG005|Overall Study|Lost to Follow-up|0|||
124434642|NCT01874431|447551901|FG006|Overall Study|Lost to Follow-up|0|||
124434643|NCT01874431|447551902|FG007|Overall Study|Lost to Follow-up|0|||
124434644|NCT00757588|447551903|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
124434645|NCT00757588|447551904|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
124434646|NCT00757588|447551903|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
124434647|NCT00757588|447551904|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
124434648|NCT00757588|447551903|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
124434649|NCT00757588|447551904|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
124434650|NCT00757588|447551903|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
124434651|NCT00757588|447551904|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
124434652|NCT00757588|447551903|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
124434653|NCT00757588|447551904|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
124434654|NCT00757588|447551903|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
124434655|NCT00757588|447551904|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
124678439|NCT03451045|448448103|FG000|Overall Study|Physician Decision|1|||
124434656|NCT00757588|447551903|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
124434657|NCT00757588|447551904|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
124434658|NCT00757588|447551903|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
124434659|NCT00757588|447551904|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
124434660|NCT00757588|447551903|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
124434661|NCT00757588|447551904|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
124434662|NCT00757588|447551903|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
124434663|NCT00757588|447551904|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
124434664|NCT00757588|447551903|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
124434665|NCT00757588|447551904|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
124434666|NCT00757588|447551903|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
124434667|NCT00757588|447551904|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
124434668|NCT00757588|447551903|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
124434669|NCT00757588|447551904|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
124434670|NCT00757588|447551903|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
124434671|NCT00757588|447551904|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
124434672|NCT00757588|447551903|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
124434673|NCT00757588|447551904|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
124434674|NCT00757588|447551903|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
124434675|NCT00757588|447551904|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
124434676|NCT01888900|447551910|FG000|Overall Study|failed treatment|0|||
124434677|NCT01888900|447551911|FG001|Overall Study|failed treatment|2|||
124434678|NCT03932812|447551912|FG000|Overall Study|Lost to Follow-up|12|||
124434679|NCT03932812|447551913|FG001|Overall Study|Lost to Follow-up|14|||
124434680|NCT03932812|447551912|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
124434681|NCT03932812|447551913|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
124434682|NCT01383499|447551917|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
124434683|NCT01383499|447551918|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
124434684|NCT01383499|447551919|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
124434685|NCT01383499|447551920|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
124434686|NCT04275089|447551921|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
124434687|NCT02585232|447551922|FG000|Overall Study|Lost to Follow-up|8|||
124434688|NCT02585232|447551923|FG001|Overall Study|Lost to Follow-up|8|||
124434689|NCT02585232|447551922|FG000|Overall Study|Withdrawal by Subject|4|||
124434690|NCT02585232|447551923|FG001|Overall Study|Withdrawal by Subject|8|||
124434691|NCT02257567|447551924|FG000|Overall Study|Adverse Event|0|||
124434692|NCT02257567|447551925|FG001|Overall Study|Adverse Event|0|||
124434693|NCT02257567|447551926|FG002|Overall Study|Adverse Event|0|||
124434694|NCT02257567|447551927|FG003|Overall Study|Adverse Event|1|||
124434695|NCT02257567|447551928|FG004|Overall Study|Adverse Event|1|||
124434696|NCT02257567|447551929|FG005|Overall Study|Adverse Event|0|||
124434697|NCT02257567|447551930|FG006|Overall Study|Adverse Event|0|||
124678440|NCT03451045|448448104|FG001|Overall Study|Physician Decision|1|||
124875342|NCT02799472|449165939|FG001|Overall Study|Lost to Follow-up|1|||
124434698|NCT02257567|447551931|FG007|Overall Study|Adverse Event|0|||
124434699|NCT02257567|447551932|FG008|Overall Study|Adverse Event|1|||
124434700|NCT02257567|447551933|FG009|Overall Study|Adverse Event|0|||
124434701|NCT02257567|447551934|FG010|Overall Study|Adverse Event|0|||
124434702|NCT02257567|447551924|FG000|Overall Study|Death|2|||
124434703|NCT02257567|447551925|FG001|Overall Study|Death|2|||
124434704|NCT02257567|447551926|FG002|Overall Study|Death|2|||
124434705|NCT02257567|447551927|FG003|Overall Study|Death|4|||
124434706|NCT02257567|447551928|FG004|Overall Study|Death|15|||
124434707|NCT02257567|447551929|FG005|Overall Study|Death|11|||
124434708|NCT02257567|447551930|FG006|Overall Study|Death|26|||
124434709|NCT02257567|447551931|FG007|Overall Study|Death|30|||
124434710|NCT02257567|447551932|FG008|Overall Study|Death|2|||
124434711|NCT02257567|447551933|FG009|Overall Study|Death|18|||
124434712|NCT02257567|447551934|FG010|Overall Study|Death|65|||
124434713|NCT02257567|447551924|FG000|Overall Study|Lost to Follow-up|0|||
124434714|NCT02257567|447551925|FG001|Overall Study|Lost to Follow-up|0|||
124434715|NCT02257567|447551926|FG002|Overall Study|Lost to Follow-up|0|||
124434716|NCT02257567|447551927|FG003|Overall Study|Lost to Follow-up|0|||
124434717|NCT02257567|447551928|FG004|Overall Study|Lost to Follow-up|2|||
124434718|NCT02257567|447551929|FG005|Overall Study|Lost to Follow-up|2|||
124434719|NCT02257567|447551930|FG006|Overall Study|Lost to Follow-up|0|||
124434720|NCT02257567|447551931|FG007|Overall Study|Lost to Follow-up|0|||
124434721|NCT02257567|447551932|FG008|Overall Study|Lost to Follow-up|0|||
124434722|NCT02257567|447551933|FG009|Overall Study|Lost to Follow-up|1|||
124434723|NCT02257567|447551934|FG010|Overall Study|Lost to Follow-up|1|||
124434724|NCT02257567|447551924|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124434725|NCT02257567|447551925|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124434726|NCT02257567|447551926|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124434727|NCT02257567|447551927|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124434728|NCT02257567|447551928|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
124434729|NCT02257567|447551929|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124434730|NCT02257567|447551930|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
124434731|NCT02257567|447551931|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124434732|NCT02257567|447551932|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124434733|NCT02257567|447551933|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124434734|NCT02257567|447551934|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
124434735|NCT02257567|447551924|FG000|Overall Study|Physician Decision|0|||
124434736|NCT02257567|447551925|FG001|Overall Study|Physician Decision|0|||
124434737|NCT02257567|447551926|FG002|Overall Study|Physician Decision|0|||
124434738|NCT02257567|447551927|FG003|Overall Study|Physician Decision|0|||
124434739|NCT02257567|447551928|FG004|Overall Study|Physician Decision|0|||
124434740|NCT02257567|447551929|FG005|Overall Study|Physician Decision|0|||
124434741|NCT02257567|447551930|FG006|Overall Study|Physician Decision|0|||
124434742|NCT02257567|447551931|FG007|Overall Study|Physician Decision|2|||
124434743|NCT02257567|447551932|FG008|Overall Study|Physician Decision|0|||
124434744|NCT02257567|447551933|FG009|Overall Study|Physician Decision|1|||
124434745|NCT02257567|447551934|FG010|Overall Study|Physician Decision|0|||
124434746|NCT02257567|447551924|FG000|Overall Study|Withdrawal by Subject|0|||
124434747|NCT02257567|447551925|FG001|Overall Study|Withdrawal by Subject|0|||
124434748|NCT02257567|447551926|FG002|Overall Study|Withdrawal by Subject|2|||
124434749|NCT02257567|447551927|FG003|Overall Study|Withdrawal by Subject|0|||
124434750|NCT02257567|447551928|FG004|Overall Study|Withdrawal by Subject|0|||
124434751|NCT02257567|447551929|FG005|Overall Study|Withdrawal by Subject|6|||
124434752|NCT02257567|447551930|FG006|Overall Study|Withdrawal by Subject|6|||
124434753|NCT02257567|447551931|FG007|Overall Study|Withdrawal by Subject|6|||
124434754|NCT02257567|447551932|FG008|Overall Study|Withdrawal by Subject|1|||
124434755|NCT02257567|447551933|FG009|Overall Study|Withdrawal by Subject|1|||
124434756|NCT02257567|447551934|FG010|Overall Study|Withdrawal by Subject|10|||
124434757|NCT03038438|447551935|FG000|Overall Study|Death|3|||
124434758|NCT03038438|447551935|FG000|Overall Study|Lost to Follow-up|8|||
124434759|NCT03038438|447551935|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
124434760|NCT03038438|447551935|FG000|Overall Study|Withdrawal by Subject|5|||
124434761|NCT03038438|447551935|FG000|Overall Study|No 36-Month Follow-Up|18|||
124434762|NCT03215810|447551936|FG000|Overall Study|Still responding to nivolumab|1|||
124434763|NCT03215810|447551936|FG000|Overall Study|Insufficient TIL growth|1|||
124434764|NCT03215810|447551936|FG000|Overall Study|Decline in performance status|1|||
124434765|NCT03215810|447551936|FG000|Overall Study|Withdrawal by Subject|1|||
124434766|NCT01656733|447551941|FG000|Overall Study|No permission to collect birth outcomes|0|||
124875343|NCT01226511|449165940|FG000|Acute Treatment Period|Adverse Event|7|||
124875344|NCT01226511|449165941|FG001|Acute Treatment Period|Adverse Event|6|||
124875345|NCT01226511|449165940|FG000|Acute Treatment Period|Lack of Efficacy|2|||
124875346|NCT01226511|449165941|FG001|Acute Treatment Period|Lack of Efficacy|1|||
124875347|NCT01226511|449165940|FG000|Acute Treatment Period|Lost to Follow-up|3|||
124875348|NCT01226511|449165941|FG001|Acute Treatment Period|Lost to Follow-up|6|||
124875349|NCT01226511|449165940|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
124875350|NCT01226511|449165941|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
124875351|NCT01226511|449165940|FG000|Acute Treatment Period|Protocol Violation|5|||
124875352|NCT01226511|449165941|FG001|Acute Treatment Period|Protocol Violation|5|||
124875353|NCT01226511|449165940|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
124875354|NCT01226511|449165941|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
124875355|NCT01226511|449165940|FG000|Extension Treatment Period|Adverse Event|8|||
124875356|NCT01226511|449165941|FG001|Extension Treatment Period|Adverse Event|8|||
124875357|NCT01226511|449165940|FG000|Extension Treatment Period|Lack of Efficacy|3|||
124875358|NCT01226511|449165941|FG001|Extension Treatment Period|Lack of Efficacy|2|||
124875359|NCT01226511|449165940|FG000|Extension Treatment Period|Lost to Follow-up|4|||
124875360|NCT01226511|449165941|FG001|Extension Treatment Period|Lost to Follow-up|3|||
124875361|NCT01226511|449165940|FG000|Extension Treatment Period|Protocol Violation|2|||
124875362|NCT01226511|449165941|FG001|Extension Treatment Period|Protocol Violation|2|||
124875363|NCT01226511|449165940|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
124875364|NCT01226511|449165941|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
124875365|NCT01226511|449165940|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
124875366|NCT01226511|449165941|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
124875367|NCT01226511|449165940|FG000|Extension Treatment Period|Sponsor Decision|1|||
124875368|NCT01226511|449165941|FG001|Extension Treatment Period|Sponsor Decision|1|||
124875369|NCT01226511|449165940|FG000|Taper Period|Adverse Event|1|||
124875370|NCT01226511|449165941|FG001|Taper Period|Adverse Event|0|||
124875371|NCT01226511|449165940|FG000|Taper Period|Lost to Follow-up|2|||
124875372|NCT01226511|449165941|FG001|Taper Period|Lost to Follow-up|2|||
124875373|NCT01226511|449165940|FG000|Taper Period|Protocol Violation|1|||
124875374|NCT01226511|449165941|FG001|Taper Period|Protocol Violation|0|||
124875375|NCT01226511|449165940|FG000|Taper Period|Parent/Caregiver Decision|1|||
124434767|NCT01656733|447551942|FG001|Overall Study|No permission to collect birth outcomes|1|||
124434768|NCT01656733|447551941|FG000|Overall Study|Delivery at another hospital|0|||
124434769|NCT01656733|447551942|FG001|Overall Study|Delivery at another hospital|2|||
124434770|NCT01656733|447551941|FG000|Overall Study|Spontaneous abortion|0|||
124434771|NCT01656733|447551942|FG001|Overall Study|Spontaneous abortion|1|||
124434772|NCT03625895|447551943|FG000|Overall Study|Protocol Violation|585|||
124434773|NCT01065844|447551944|FG000|Overall Study|Adverse Event|5|||
124434774|NCT02679573|447551945|FG000|Overall Study|Adverse Event|13|||
124434775|NCT02679573|447551946|FG001|Overall Study|Adverse Event|6|||
124434776|NCT02679573|447551945|FG000|Overall Study|Lack of Efficacy|12|||
124434777|NCT02679573|447551946|FG001|Overall Study|Lack of Efficacy|15|||
124434778|NCT02679573|447551945|FG000|Overall Study|Could not complete required study visits|6|||
124434779|NCT02679573|447551946|FG001|Overall Study|Could not complete required study visits|2|||
124434780|NCT02679573|447551945|FG000|Overall Study|Withdrawal by Subject|2|||
124434781|NCT02679573|447551946|FG001|Overall Study|Withdrawal by Subject|9|||
124434782|NCT02679573|447551945|FG000|Overall Study|Death|2|||
124434783|NCT02679573|447551946|FG001|Overall Study|Death|0|||
124434784|NCT02679573|447551945|FG000|Overall Study|Physician Decision|2|||
124434785|NCT02679573|447551946|FG001|Overall Study|Physician Decision|4|||
124434786|NCT02679573|447551945|FG000|Overall Study|Lost to Follow-up|0|||
124434787|NCT02679573|447551946|FG001|Overall Study|Lost to Follow-up|3|||
124434788|NCT02476279|447551947|FG000|Overall Study|Lost to Follow-up|1|||
124434789|NCT02476279|447551948|FG001|Overall Study|Lost to Follow-up|1|||
124434790|NCT00577473|447551951|FG000|Overall Study|Protocol Violation|1|||
124434791|NCT00577473|447551952|FG001|Overall Study|Protocol Violation|4|||
124434792|NCT00577473|447551951|FG000|Overall Study|Adverse Event|8|||
124434793|NCT00577473|447551952|FG001|Overall Study|Adverse Event|5|||
124434794|NCT00577473|447551951|FG000|Overall Study|Withdrawal by Subject|2|||
124434795|NCT00577473|447551952|FG001|Overall Study|Withdrawal by Subject|6|||
124434796|NCT00577473|447551951|FG000|Overall Study|Physician Decision|2|||
124434797|NCT00577473|447551952|FG001|Overall Study|Physician Decision|2|||
124434798|NCT00577473|447551951|FG000|Overall Study|Lack of Efficacy|8|||
124434799|NCT00577473|447551952|FG001|Overall Study|Lack of Efficacy|7|||
124434800|NCT01502631|447551955|FG000|Overall Study|Adverse Event|5|||
124434801|NCT01502631|447551956|FG001|Overall Study|Adverse Event|8|||
124434802|NCT01502631|447551955|FG000|Overall Study|Lost to Follow-up|2|||
124434803|NCT01502631|447551956|FG001|Overall Study|Lost to Follow-up|2|||
124434804|NCT01502631|447551955|FG000|Overall Study|Participant withdrew consent|2|||
124434805|NCT01502631|447551956|FG001|Overall Study|Participant withdrew consent|4|||
124434806|NCT01502631|447551955|FG000|Overall Study|Participant non-compliant|1|||
124434807|NCT01502631|447551956|FG001|Overall Study|Participant non-compliant|0|||
124434808|NCT01502631|447551955|FG000|Overall Study|Investigator's decision|0|||
124678441|NCT03451045|448448105|FG002|Overall Study|Physician Decision|1|||
124678442|NCT03451045|448448103|FG000|Overall Study|Withdrawal by Subject|4|||
124678443|NCT03451045|448448104|FG001|Overall Study|Withdrawal by Subject|0|||
124434809|NCT01502631|447551956|FG001|Overall Study|Investigator's decision|1|||
124434810|NCT01502631|447551955|FG000|Overall Study|Other|10|||
124434811|NCT01502631|447551956|FG001|Overall Study|Other|5|||
124434812|NCT02084056|447551957|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
124434813|NCT02084056|447551958|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
124434814|NCT02084056|447551959|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
124434815|NCT02084056|447551960|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
124434816|NCT02084056|447551957|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
124678444|NCT03451045|448448105|FG002|Overall Study|Withdrawal by Subject|5|||
124434817|NCT02084056|447551958|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
124434818|NCT02084056|447551959|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
124434819|NCT02084056|447551960|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
124434820|NCT01293487|447551961|FG000|Overall Study|Lost to Follow-up|0|||
124434821|NCT01293487|447551962|FG001|Overall Study|Lost to Follow-up|0|||
124434822|NCT01293487|447551963|FG002|Overall Study|Lost to Follow-up|0|||
124434823|NCT01293487|447551964|FG003|Overall Study|Lost to Follow-up|1|||
124434824|NCT01293487|447551965|FG004|Overall Study|Lost to Follow-up|0|||
124434825|NCT01293487|447551966|FG005|Overall Study|Lost to Follow-up|0|||
124434826|NCT01293487|447551967|FG006|Overall Study|Lost to Follow-up|0|||
124875376|NCT01226511|449165941|FG001|Taper Period|Parent/Caregiver Decision|1|||
124875377|NCT00674570|449165943|FG000|Overall Study|Withdrawal by Subject|0|||
124875378|NCT00674570|449165944|FG001|Overall Study|Withdrawal by Subject|2|||
124434827|NCT01293487|447551968|FG007|Overall Study|Lost to Follow-up|0|||
124434828|NCT01293487|447551961|FG000|Overall Study|Withdrawal by Subject|0|||
124434829|NCT01293487|447551962|FG001|Overall Study|Withdrawal by Subject|0|||
124434830|NCT01293487|447551963|FG002|Overall Study|Withdrawal by Subject|0|||
124434831|NCT01293487|447551964|FG003|Overall Study|Withdrawal by Subject|0|||
124434832|NCT01293487|447551965|FG004|Overall Study|Withdrawal by Subject|0|||
124434833|NCT01293487|447551966|FG005|Overall Study|Withdrawal by Subject|0|||
124434834|NCT01293487|447551967|FG006|Overall Study|Withdrawal by Subject|0|||
124434835|NCT01293487|447551968|FG007|Overall Study|Withdrawal by Subject|2|||
124434836|NCT00395460|447551969|FG000|Overall Study|Withdrawal by Subject|1|||
124434837|NCT00395460|447551970|FG001|Overall Study|Withdrawal by Subject|0|||
124434838|NCT04223830|447551977|FG000|Overall Study|Lost to Follow-up|9|||
124434839|NCT04223830|447551977|FG000|Overall Study|Adverse Event|1|||
124434840|NCT01964924|447551978|FG000|Trametinib Monotherapy|Progression|19|||
124434841|NCT01964924|447551979|FG001|Trametinib Monotherapy|Progression|0|||
124434842|NCT00577577|447551981|FG000|Overall Study|Adverse Event|3|||
124434843|NCT00577577|447551982|FG001|Overall Study|Adverse Event|2|||
124434844|NCT00577577|447551981|FG000|Overall Study|Lost to Follow-up|1|||
124434845|NCT00577577|447551982|FG001|Overall Study|Lost to Follow-up|0|||
124434846|NCT00577577|447551981|FG000|Overall Study|Protocol Violation|0|||
124434847|NCT00577577|447551982|FG001|Overall Study|Protocol Violation|3|||
124434848|NCT00577577|447551981|FG000|Overall Study|Transportation|1|||
124434849|NCT00577577|447551982|FG001|Overall Study|Transportation|0|||
124434850|NCT01153958|447551983|FG000|Overall Study|Study Terminated|36|||
124434851|NCT01153958|447551984|FG001|Overall Study|Study Terminated|32|||
124434852|NCT01034163|447551989|FG000|Overall Study|Treatment completed as per protocol|8|||
124434853|NCT01034163|447551990|FG001|Overall Study|Treatment completed as per protocol|7|||
124434854|NCT01034163|447551989|FG000|Overall Study|Withdrawal by Subject|8|||
124434855|NCT01034163|447551990|FG001|Overall Study|Withdrawal by Subject|2|||
124434856|NCT01034163|447551989|FG000|Overall Study|Protocol deviation|1|||
124434857|NCT01034163|447551990|FG001|Overall Study|Protocol deviation|0|||
124434858|NCT01034163|447551989|FG000|Overall Study|Disease progression|3|||
124434859|NCT01034163|447551990|FG001|Overall Study|Disease progression|4|||
124434860|NCT01034163|447551989|FG000|Overall Study|Adverse Event|6|||
124434861|NCT01034163|447551990|FG001|Overall Study|Adverse Event|0|||
124434862|NCT01034163|447551989|FG000|Overall Study|Administrative problems|0|||
124434863|NCT01034163|447551990|FG001|Overall Study|Administrative problems|1|||
124434864|NCT01034163|447551989|FG000|Overall Study|Abnormal laboratory value|1|||
124434865|NCT01034163|447551990|FG001|Overall Study|Abnormal laboratory value|0|||
124434866|NCT02424734|447551991|FG000|Overall Study|Treatment stopped to be discharged home|2|||
124434867|NCT02424734|447551992|FG001|Overall Study|Treatment stopped to be discharged home|2|||
124434868|NCT02424734|447551993|FG002|Overall Study|Treatment stopped to be discharged home|0|||
124434869|NCT00528645|447551994|FG000|Overall Study|Adverse Event|3|||
124434870|NCT00116753|447551995|FG000|Overall Study|Adverse Event|16|||
124434871|NCT00116753|447551996|FG001|Overall Study|Adverse Event|10|||
124434872|NCT00116753|447551997|FG002|Overall Study|Adverse Event|7|||
124434873|NCT00116753|447551995|FG000|Overall Study|Withdrawal by Subject|11|||
124434874|NCT00116753|447551996|FG001|Overall Study|Withdrawal by Subject|12|||
124434875|NCT00116753|447551997|FG002|Overall Study|Withdrawal by Subject|8|||
124434876|NCT00116753|447551995|FG000|Overall Study|Lost to Follow-up|0|||
124434877|NCT00116753|447551996|FG001|Overall Study|Lost to Follow-up|2|||
124434878|NCT00116753|447551997|FG002|Overall Study|Lost to Follow-up|1|||
124434879|NCT00116753|447551995|FG000|Overall Study|Protocol Violation|0|||
124434880|NCT00116753|447551996|FG001|Overall Study|Protocol Violation|0|||
124434881|NCT00116753|447551997|FG002|Overall Study|Protocol Violation|1|||
124434882|NCT00116753|447551995|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
124434883|NCT00116753|447551996|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
124434884|NCT00116753|447551997|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
124434885|NCT00116753|447551995|FG000|Overall Study|Disease Progression|3|||
124434886|NCT00116753|447551996|FG001|Overall Study|Disease Progression|4|||
124434887|NCT00116753|447551997|FG002|Overall Study|Disease Progression|3|||
124434888|NCT00116753|447551995|FG000|Overall Study|Abnormal Echocardiogram|0|||
124434889|NCT00116753|447551996|FG001|Overall Study|Abnormal Echocardiogram|0|||
124434890|NCT00116753|447551997|FG002|Overall Study|Abnormal Echocardiogram|1|||
124434891|NCT00116753|447551995|FG000|Overall Study|Progressive Parkinson's Disease|1|||
124434892|NCT00116753|447551996|FG001|Overall Study|Progressive Parkinson's Disease|0|||
124434893|NCT00116753|447551997|FG002|Overall Study|Progressive Parkinson's Disease|0|||
124434894|NCT00116753|447551995|FG000|Overall Study|Dosing Error|0|||
124434895|NCT00116753|447551996|FG001|Overall Study|Dosing Error|1|||
124434896|NCT00116753|447551997|FG002|Overall Study|Dosing Error|0|||
124434897|NCT01642251|447551998|FG000|Overall Study|Progressive disease|0|||
124434898|NCT01642251|447551999|FG001|Overall Study|Progressive disease|0|||
124434899|NCT01642251|447552000|FG002|Overall Study|Progressive disease|3|||
124434900|NCT01642251|447552001|FG003|Overall Study|Progressive disease|3|||
124434901|NCT01642251|447551998|FG000|Overall Study|Adverse Event|0|||
124434902|NCT01642251|447551999|FG001|Overall Study|Adverse Event|0|||
124434903|NCT01642251|447552000|FG002|Overall Study|Adverse Event|5|||
124434904|NCT01642251|447552001|FG003|Overall Study|Adverse Event|4|||
124434905|NCT01642251|447551998|FG000|Overall Study|Death|0|||
124434906|NCT01642251|447551999|FG001|Overall Study|Death|0|||
124434907|NCT01642251|447552000|FG002|Overall Study|Death|1|||
124434908|NCT01642251|447552001|FG003|Overall Study|Death|3|||
124434909|NCT01642251|447551998|FG000|Overall Study|Withdrawal by Subject|0|||
124434910|NCT01642251|447551999|FG001|Overall Study|Withdrawal by Subject|0|||
124434911|NCT01642251|447552000|FG002|Overall Study|Withdrawal by Subject|1|||
124434912|NCT01642251|447552001|FG003|Overall Study|Withdrawal by Subject|3|||
124434913|NCT01642251|447551998|FG000|Overall Study|Alternative therapy|0|||
124434914|NCT01642251|447551999|FG001|Overall Study|Alternative therapy|0|||
124434915|NCT01642251|447552000|FG002|Overall Study|Alternative therapy|0|||
124434916|NCT01642251|447552001|FG003|Overall Study|Alternative therapy|2|||
124434917|NCT01642251|447551998|FG000|Overall Study|Other complicating disease|0|||
124434918|NCT01642251|447551999|FG001|Overall Study|Other complicating disease|0|||
124434919|NCT01642251|447552000|FG002|Overall Study|Other complicating disease|1|||
124434920|NCT01642251|447552001|FG003|Overall Study|Other complicating disease|0|||
124434921|NCT01642251|447551998|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
124434922|NCT01642251|447551999|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
124434923|NCT01642251|447552000|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
124434924|NCT01642251|447552001|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
124434925|NCT01445301|447552002|FG000|Overall Study|Adverse Event|15|||
124434926|NCT01445301|447552003|FG001|Overall Study|Adverse Event|25|||
124434927|NCT01445301|447552004|FG002|Overall Study|Adverse Event|4|||
124434928|NCT01445301|447552002|FG000|Overall Study|Lack of Efficacy|0|||
124434929|NCT01445301|447552003|FG001|Overall Study|Lack of Efficacy|1|||
124434930|NCT01445301|447552004|FG002|Overall Study|Lack of Efficacy|0|||
124434931|NCT01445301|447552002|FG000|Overall Study|Protocol Violation|1|||
124434932|NCT01445301|447552003|FG001|Overall Study|Protocol Violation|0|||
124434933|NCT01445301|447552004|FG002|Overall Study|Protocol Violation|0|||
124434934|NCT01445301|447552002|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
124434935|NCT01445301|447552003|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
124434936|NCT01445301|447552004|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
124434937|NCT01445301|447552002|FG000|Overall Study|Physician Decision|0|||
124434938|NCT01445301|447552003|FG001|Overall Study|Physician Decision|2|||
124434939|NCT01445301|447552004|FG002|Overall Study|Physician Decision|0|||
124434940|NCT01445301|447552002|FG000|Overall Study|Withdrawal by Subject|5|||
124434941|NCT01445301|447552003|FG001|Overall Study|Withdrawal by Subject|6|||
124434942|NCT01445301|447552004|FG002|Overall Study|Withdrawal by Subject|4|||
124434943|NCT00752557|447552005|FG000|Overall Study|Withdrawal by Subject|4|||
124434944|NCT00752557|447552006|FG001|Overall Study|Withdrawal by Subject|3|||
124434945|NCT00752557|447552007|FG002|Overall Study|Withdrawal by Subject|3|||
124434946|NCT00752557|447552005|FG000|Overall Study|Unspecified resaons|0|||
124434947|NCT00752557|447552006|FG001|Overall Study|Unspecified resaons|2|||
124434948|NCT00752557|447552007|FG002|Overall Study|Unspecified resaons|2|||
124434949|NCT00752557|447552005|FG000|Overall Study|Lost to Follow-up|1|||
124434950|NCT00752557|447552006|FG001|Overall Study|Lost to Follow-up|0|||
124434951|NCT00752557|447552007|FG002|Overall Study|Lost to Follow-up|1|||
124434952|NCT02150343|447552012|FG000|Overall Study|Adverse Event|2|||
124434953|NCT02150343|447552013|FG001|Overall Study|Adverse Event|0|||
124434954|NCT02150343|447552014|FG002|Overall Study|Adverse Event|1|||
124434955|NCT02150343|447552015|FG003|Overall Study|Adverse Event|1|||
124434956|NCT02150343|447552012|FG000|Overall Study|Withdrawal by Subject|13|||
124434957|NCT02150343|447552013|FG001|Overall Study|Withdrawal by Subject|10|||
124434958|NCT02150343|447552014|FG002|Overall Study|Withdrawal by Subject|9|||
124434959|NCT02150343|447552015|FG003|Overall Study|Withdrawal by Subject|4|||
124434960|NCT02150343|447552012|FG000|Overall Study|Lost to Follow-up|4|||
124434961|NCT02150343|447552013|FG001|Overall Study|Lost to Follow-up|4|||
124434962|NCT02150343|447552014|FG002|Overall Study|Lost to Follow-up|2|||
124434963|NCT02150343|447552015|FG003|Overall Study|Lost to Follow-up|3|||
124434964|NCT02150343|447552012|FG000|Overall Study|Other|2|||
124434965|NCT02150343|447552013|FG001|Overall Study|Other|6|||
124434966|NCT02150343|447552014|FG002|Overall Study|Other|0|||
124434967|NCT02150343|447552015|FG003|Overall Study|Other|2|||
124434968|NCT03683823|447552019|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
124434969|NCT03683823|447552020|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
124434970|NCT03683823|447552019|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
124434971|NCT03683823|447552020|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
124434972|NCT03683823|447552019|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
124434973|NCT03683823|447552020|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
124434974|NCT03965351|447552022|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
124434975|NCT03965351|447552023|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
124434976|NCT03965351|447552022|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
124434977|NCT03965351|447552023|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
124434978|NCT00490724|447552024|FG000|Period I|Physician Decision|0|||
124434979|NCT00490724|447552025|FG001|Period I|Physician Decision|0|||
124434980|NCT00490724|447552026|FG002|Period I|Physician Decision|1|||
124434981|NCT00490724|447552024|FG000|Period II|Treatment Discontinuation|3|||
124434982|NCT00490724|447552025|FG001|Period II|Treatment Discontinuation|1|||
124434983|NCT00490724|447552026|FG002|Period II|Treatment Discontinuation|3|||
124434984|NCT00994682|447552027|FG000|Double Bilnd|Withdrawal by Subject|5|||
124434985|NCT00994682|447552028|FG001|Double Bilnd|Withdrawal by Subject|6|||
124434986|NCT00994682|447552027|FG000|Double Bilnd|Lost to Follow-up|3|||
124434987|NCT00994682|447552028|FG001|Double Bilnd|Lost to Follow-up|3|||
124434988|NCT00994682|447552027|FG000|Double Bilnd|Adverse Event|1|||
124434989|NCT00994682|447552028|FG001|Double Bilnd|Adverse Event|0|||
124434990|NCT00994682|447552027|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
124434991|NCT00994682|447552028|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
124875379|NCT00674570|449165945|FG002|Overall Study|Withdrawal by Subject|0|||
124875380|NCT01337986|449165946|FG000|Overall Study|Adverse Event|2|||
124875381|NCT01337986|449165947|FG001|Overall Study|Adverse Event|2|||
124875382|NCT01337986|449165946|FG000|Overall Study|Lost to Follow-up|1|||
124875383|NCT01337986|449165947|FG001|Overall Study|Lost to Follow-up|0|||
124434992|NCT00994682|447552027|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
124434993|NCT00994682|447552028|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
124434994|NCT00994682|447552027|FG000|Pioglitazone Open Label|Physician Decision|6|||
124434995|NCT00994682|447552028|FG001|Pioglitazone Open Label|Physician Decision|1|||
124434996|NCT02859324|447552031|FG000|Overall Study|Death|4|||
124434997|NCT02859324|447552032|FG001|Overall Study|Death|6|||
124434998|NCT02859324|447552033|FG002|Overall Study|Death|5|||
124434999|NCT02859324|447552031|FG000|Overall Study|Other reasons|3|||
124435000|NCT02859324|447552032|FG001|Overall Study|Other reasons|3|||
124435001|NCT02859324|447552033|FG002|Overall Study|Other reasons|0|||
124435002|NCT02680002|447554400|FG000|Overall Study|Lost to Follow-up|5|||
124435003|NCT02680002|447554401|FG001|Overall Study|Lost to Follow-up|1|||
124435004|NCT02680002|447554402|FG002|Overall Study|Lost to Follow-up|4|||
124435005|NCT02680002|447554403|FG003|Overall Study|Lost to Follow-up|2|||
124435006|NCT02680002|447554404|FG004|Overall Study|Lost to Follow-up|0|||
124435007|NCT02680002|447554405|FG005|Overall Study|Lost to Follow-up|2|||
124435008|NCT02680002|447554400|FG000|Overall Study|Physician Decision|5|||
124435009|NCT02680002|447554401|FG001|Overall Study|Physician Decision|1|||
124435010|NCT02680002|447554402|FG002|Overall Study|Physician Decision|1|||
124435011|NCT02680002|447554403|FG003|Overall Study|Physician Decision|1|||
124435012|NCT02680002|447554404|FG004|Overall Study|Physician Decision|1|||
124435013|NCT02680002|447554405|FG005|Overall Study|Physician Decision|1|||
124435014|NCT02680002|447554400|FG000|Overall Study|Protocol Violation|1|||
124435015|NCT02680002|447554401|FG001|Overall Study|Protocol Violation|0|||
124435016|NCT02680002|447554402|FG002|Overall Study|Protocol Violation|1|||
124435017|NCT02680002|447554403|FG003|Overall Study|Protocol Violation|0|||
124435018|NCT02680002|447554404|FG004|Overall Study|Protocol Violation|1|||
124435019|NCT02680002|447554405|FG005|Overall Study|Protocol Violation|2|||
124435020|NCT02680002|447554400|FG000|Overall Study|Withdrawal by Subject|0|||
124435021|NCT02680002|447554401|FG001|Overall Study|Withdrawal by Subject|0|||
124435022|NCT02680002|447554402|FG002|Overall Study|Withdrawal by Subject|1|||
124435023|NCT02680002|447554403|FG003|Overall Study|Withdrawal by Subject|0|||
124435024|NCT02680002|447554404|FG004|Overall Study|Withdrawal by Subject|2|||
124435025|NCT02680002|447554405|FG005|Overall Study|Withdrawal by Subject|2|||
124435026|NCT02680002|447554400|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
124435027|NCT02680002|447554401|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
124435028|NCT02680002|447554402|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
124435029|NCT02680002|447554403|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
124435030|NCT02680002|447554404|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
124435031|NCT02680002|447554405|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
124435032|NCT02680002|447554400|FG000|Overall Study|Other|0|||
124435033|NCT02680002|447554401|FG001|Overall Study|Other|1|||
124435034|NCT02680002|447554402|FG002|Overall Study|Other|0|||
124435035|NCT02680002|447554403|FG003|Overall Study|Other|0|||
124435036|NCT02680002|447554404|FG004|Overall Study|Other|1|||
124435037|NCT02680002|447554405|FG005|Overall Study|Other|0|||
124435038|NCT02680002|447554400|FG000|Overall Study|Adverse Event|0|||
124435039|NCT02680002|447554401|FG001|Overall Study|Adverse Event|0|||
124435040|NCT02680002|447554402|FG002|Overall Study|Adverse Event|0|||
124435041|NCT02680002|447554403|FG003|Overall Study|Adverse Event|0|||
124435042|NCT02680002|447554404|FG004|Overall Study|Adverse Event|1|||
124435043|NCT02680002|447554405|FG005|Overall Study|Adverse Event|2|||
124435044|NCT03527173|447554408|FG000|Overall Study|Lost to Follow-up|4|||
124435045|NCT03527173|447554409|FG001|Overall Study|Lost to Follow-up|2|||
124435046|NCT03527173|447554408|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
124435047|NCT03527173|447554409|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
124435048|NCT03527173|447554408|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
124435049|NCT03527173|447554409|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
124435050|NCT03527173|447554408|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
124435051|NCT03527173|447554409|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
124435052|NCT01248780|447554414|FG000|Overall Study|Lack of Efficacy|2|||
124435053|NCT01248780|447554415|FG001|Overall Study|Lack of Efficacy|0|||
124435054|NCT01248780|447554414|FG000|Overall Study|Lost to Follow-up|0|||
124435055|NCT01248780|447554415|FG001|Overall Study|Lost to Follow-up|1|||
124435056|NCT01248780|447554414|FG000|Overall Study|Death|0|||
124435057|NCT01248780|447554415|FG001|Overall Study|Death|1|||
124435058|NCT01248780|447554414|FG000|Overall Study|Adverse Event|2|||
124435059|NCT01248780|447554415|FG001|Overall Study|Adverse Event|7|||
124435060|NCT01248780|447554414|FG000|Overall Study|Protocol Violation|1|||
124435061|NCT01248780|447554415|FG001|Overall Study|Protocol Violation|1|||
124435062|NCT01248780|447554414|FG000|Overall Study|Withdrawal by Subject|4|||
124435063|NCT01248780|447554415|FG001|Overall Study|Withdrawal by Subject|4|||
124435064|NCT01248780|447554414|FG000|Overall Study|Not treated|0|||
124435065|NCT01248780|447554415|FG001|Overall Study|Not treated|1|||
124435066|NCT04097301|447554416|FG000|Overall Study|Death|1|||
124435067|NCT04097301|447554416|FG000|Overall Study|Withdrawal by Subject|1|||
124435068|NCT04097301|447554416|FG000|Overall Study|Screening Failure|5|||
124435069|NCT00203476|447554417|FG000|Overall Study|Lost to Follow-up|1|||
124435070|NCT00203476|447554418|FG001|Overall Study|Lost to Follow-up|0|||
124435071|NCT00203476|447554419|FG002|Overall Study|Lost to Follow-up|0|||
124435072|NCT00203476|447554417|FG000|Overall Study|Withdrawal by Subject|0|||
124435073|NCT00203476|447554418|FG001|Overall Study|Withdrawal by Subject|1|||
124435074|NCT00203476|447554419|FG002|Overall Study|Withdrawal by Subject|0|||
124435075|NCT01190514|447554420|FG000|First Intervention (Period 1)|Adverse Event|1|||
124435076|NCT01190514|447554421|FG001|First Intervention (Period 1)|Adverse Event|0|||
124435077|NCT01190514|447554422|FG002|First Intervention (Period 1)|Adverse Event|0|||
124435078|NCT01190514|447554423|FG003|First Intervention (Period 1)|Adverse Event|0|||
124435079|NCT01190514|447554420|FG000|Third Intervention (Period 3)|Adverse Event|1|||
124435080|NCT01190514|447554421|FG001|Third Intervention (Period 3)|Adverse Event|0|||
124435081|NCT01190514|447554422|FG002|Third Intervention (Period 3)|Adverse Event|0|||
124435082|NCT01190514|447554423|FG003|Third Intervention (Period 3)|Adverse Event|0|||
124435083|NCT01813929|447554424|FG000|Overall Study|Withdrawal by Subject|0|||
124435084|NCT01813929|447554425|FG001|Overall Study|Withdrawal by Subject|1|||
124435085|NCT03103763|447554426|FG000|Overall Study|Death|15|||
124435086|NCT03103763|447554427|FG001|Overall Study|Death|5|||
124435087|NCT03103763|447554428|FG002|Overall Study|Death|5|||
124435088|NCT03103763|447554426|FG000|Overall Study|Withdrawal by Subject|0|||
124435089|NCT03103763|447554427|FG001|Overall Study|Withdrawal by Subject|3|||
124435090|NCT03103763|447554428|FG002|Overall Study|Withdrawal by Subject|2|||
124435091|NCT01970345|447554429|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
124435092|NCT01970345|447554430|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
124435093|NCT01970345|447554429|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
124435094|NCT01970345|447554430|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
124435095|NCT01346475|447554433|FG000|First Intervention|Lost to Follow-up|4|||
124435096|NCT01346475|447554434|FG001|First Intervention|Lost to Follow-up|3|||
124435097|NCT00558259|447554437|FG000|Overall Study|Adverse Event|50|||
124435098|NCT00558259|447554438|FG001|Overall Study|Adverse Event|81|||
124435099|NCT00558259|447554437|FG000|Overall Study|Protocol Violation|9|||
124435100|NCT00558259|447554438|FG001|Overall Study|Protocol Violation|5|||
124435101|NCT00558259|447554437|FG000|Overall Study|Withdrawal by Subject|12|||
124435102|NCT00558259|447554438|FG001|Overall Study|Withdrawal by Subject|13|||
124435103|NCT02874924|447554439|FG000|Overall Study|Adverse Event|2|||
124435104|NCT02874924|447554440|FG001|Overall Study|Adverse Event|0|||
124435105|NCT02874924|447554441|FG002|Overall Study|Adverse Event|0|||
124435106|NCT02874924|447554439|FG000|Overall Study|Withdrawal by Subject|1|||
124435107|NCT02874924|447554440|FG001|Overall Study|Withdrawal by Subject|0|||
124435108|NCT02874924|447554441|FG002|Overall Study|Withdrawal by Subject|0|||
124435109|NCT02029846|447554444|FG000|Overall Study|n=1 each arm|1|||
124435110|NCT02029846|447554445|FG001|Overall Study|n=1 each arm|1|||
124435111|NCT02966301|447554446|FG000|Overall Study|Death|2|||
124435112|NCT02966301|447554446|FG000|Overall Study|Withdrawal by Subject|1|||
124435113|NCT00700258|447554447|FG000|Overall Study|Premature discontinuation of documentation|136|||
124435114|NCT00700258|447554447|FG000|Overall Study|Type of study end not documented|1|||
124435115|NCT00700258|447554447|FG000|Overall Study|Lost to Follow-up|81|||
124435116|NCT00700258|447554447|FG000|Overall Study|Premature discontinuation of therapy|1013|||
124435117|NCT00370331|447554449|FG000|Overall Study|Adverse Event|4|||
124435118|NCT00370331|447554450|FG001|Overall Study|Adverse Event|13|||
124435119|NCT00370331|447554449|FG000|Overall Study|Withdrawal by Subject|2|||
124435120|NCT00370331|447554450|FG001|Overall Study|Withdrawal by Subject|4|||
124435121|NCT00370331|447554449|FG000|Overall Study|Lost to Follow-up|0|||
124435122|NCT00370331|447554450|FG001|Overall Study|Lost to Follow-up|3|||
124435123|NCT00370331|447554449|FG000|Overall Study|Lack of Efficacy|0|||
124435124|NCT00370331|447554450|FG001|Overall Study|Lack of Efficacy|1|||
124435125|NCT00370331|447554449|FG000|Overall Study|Non-compliance|0|||
124435126|NCT00370331|447554450|FG001|Overall Study|Non-compliance|1|||
124435127|NCT00370331|447554449|FG000|Overall Study|Protocol Violation|1|||
124435128|NCT00370331|447554450|FG001|Overall Study|Protocol Violation|1|||
124435129|NCT00738582|447554453|FG000|Combination Therapy|Completed Combination Therapy|1|||
124435130|NCT00738582|447554454|FG001|Combination Therapy|Completed Combination Therapy|0|||
124435131|NCT00738582|447554453|FG000|Combination Therapy|Physician Decision|1|||
124435132|NCT00738582|447554454|FG001|Combination Therapy|Physician Decision|0|||
124435133|NCT00738582|447554453|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
124435134|NCT00738582|447554454|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
124435135|NCT00738582|447554453|FG000|Combination Therapy|Other|5|||
124435136|NCT00738582|447554454|FG001|Combination Therapy|Other|0|||
124435137|NCT00738582|447554453|FG000|Combination Therapy|Adverse Event|16|||
124435138|NCT00738582|447554454|FG001|Combination Therapy|Adverse Event|0|||
124435139|NCT00738582|447554453|FG000|Combination Therapy|Progressive Disease|9|||
124435140|NCT00738582|447554454|FG001|Combination Therapy|Progressive Disease|0|||
124435141|NCT00738582|447554453|FG000|Maintenance Therapy|Other|0|||
124435142|NCT00738582|447554454|FG001|Maintenance Therapy|Other|2|||
124435143|NCT00738582|447554453|FG000|Maintenance Therapy|Adverse Event|0|||
124435144|NCT00738582|447554454|FG001|Maintenance Therapy|Adverse Event|6|||
124435145|NCT00738582|447554453|FG000|Maintenance Therapy|Progressive Disease|0|||
124435146|NCT00738582|447554454|FG001|Maintenance Therapy|Progressive Disease|47|||
124435147|NCT00738582|447554453|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
124435148|NCT00738582|447554454|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
124435149|NCT00642772|447554455|FG000|Overall Study|Lost to Follow-up|3|||
124435150|NCT00642772|447554455|FG000|Overall Study|Withdrawal by Subject|7|||
124435151|NCT01052103|447554456|FG000|Overall Study|Adverse Event|10|||
124435152|NCT01052103|447554457|FG001|Overall Study|Adverse Event|6|||
124435153|NCT01052103|447554456|FG000|Overall Study|Entry Criteria Not Met|3|||
124435154|NCT01052103|447554457|FG001|Overall Study|Entry Criteria Not Met|1|||
124435155|NCT01052103|447554456|FG000|Overall Study|Lost to Follow-up|3|||
124435156|NCT01052103|447554457|FG001|Overall Study|Lost to Follow-up|5|||
124435157|NCT01052103|447554456|FG000|Overall Study|Protocol Violation|10|||
124435158|NCT01052103|447554457|FG001|Overall Study|Protocol Violation|4|||
124435159|NCT01052103|447554456|FG000|Overall Study|Scheduling conflict|2|||
124435160|NCT01052103|447554457|FG001|Overall Study|Scheduling conflict|1|||
124435161|NCT01052103|447554456|FG000|Overall Study|Sponsor Decision|2|||
124435162|NCT01052103|447554457|FG001|Overall Study|Sponsor Decision|0|||
124435163|NCT01052103|447554456|FG000|Overall Study|Withdrawal by Subject|3|||
124435164|NCT01052103|447554457|FG001|Overall Study|Withdrawal by Subject|6|||
124435165|NCT01052103|447554456|FG000|Overall Study|Perceived Lack of Efficacy|1|||
124435166|NCT01052103|447554457|FG001|Overall Study|Perceived Lack of Efficacy|0|||
124435167|NCT00545051|447554461|FG000|Overall Study|Adverse Event|7|||
124435168|NCT00545051|447554462|FG001|Overall Study|Adverse Event|3|||
124435169|NCT00545051|447554461|FG000|Overall Study|Death|1|||
124435170|NCT00545051|447554462|FG001|Overall Study|Death|0|||
124435171|NCT00545051|447554461|FG000|Overall Study|Violation of inclusion/exclusion|0|||
124435172|NCT00545051|447554462|FG001|Overall Study|Violation of inclusion/exclusion|2|||
124435173|NCT00545051|447554461|FG000|Overall Study|Protocol Violation|1|||
124435174|NCT00545051|447554462|FG001|Overall Study|Protocol Violation|0|||
124435175|NCT00545051|447554461|FG000|Overall Study|Withdrawal by Subject|0|||
124435176|NCT00545051|447554462|FG001|Overall Study|Withdrawal by Subject|1|||
124435177|NCT00545051|447554461|FG000|Overall Study|Administrative reasons|0|||
124435178|NCT00545051|447554462|FG001|Overall Study|Administrative reasons|1|||
124435179|NCT05398237|447554463|FG000|Overall Study|Withdrawal by Subject|1|||
124435180|NCT00903006|447554464|FG000|Overall Study|Withdrawal by Subject|2|||
124435181|NCT00903006|447554465|FG001|Overall Study|Withdrawal by Subject|0|||
124435182|NCT00903006|447554466|FG002|Overall Study|Withdrawal by Subject|0|||
124435183|NCT00903006|447554467|FG003|Overall Study|Withdrawal by Subject|0|||
124435184|NCT00903006|447554464|FG000|Overall Study|Progressive Disease|0|||
124435185|NCT00903006|447554465|FG001|Overall Study|Progressive Disease|3|||
124435186|NCT00903006|447554466|FG002|Overall Study|Progressive Disease|1|||
124435187|NCT00903006|447554467|FG003|Overall Study|Progressive Disease|0|||
124435188|NCT03271021|447554468|FG000|Overall Study|Adverse Event|3|||
124435189|NCT03271021|447554469|FG001|Overall Study|Adverse Event|2|||
124435190|NCT03271021|447554468|FG000|Overall Study|Withdrawal by Subject|36|||
124435191|NCT03271021|447554469|FG001|Overall Study|Withdrawal by Subject|53|||
124435192|NCT03271021|447554468|FG000|Overall Study|Lost to Follow-up|34|||
124435193|NCT03271021|447554469|FG001|Overall Study|Lost to Follow-up|39|||
124435194|NCT03271021|447554468|FG000|Overall Study|Protocol Violation|6|||
124435195|NCT03271021|447554469|FG001|Overall Study|Protocol Violation|4|||
124435196|NCT03271021|447554468|FG000|Overall Study|Abnormal Lab Results|1|||
124435197|NCT03271021|447554469|FG001|Overall Study|Abnormal Lab Results|0|||
124435198|NCT03271021|447554468|FG000|Overall Study|Miscellaneous|9|||
124435199|NCT03271021|447554469|FG001|Overall Study|Miscellaneous|8|||
124435200|NCT01079663|447554472|FG000|Overall Study|Adverse Event|0|||
124435201|NCT01079663|447554473|FG001|Overall Study|Adverse Event|2|||
124435202|NCT01079663|447554472|FG000|Overall Study|Protocol Violation|0|||
124435203|NCT01079663|447554473|FG001|Overall Study|Protocol Violation|2|||
124435204|NCT00297232|447554476|FG000|Overall Study|Lack of Efficacy|7|||
124435205|NCT00297232|447554476|FG000|Overall Study|Lost to Follow-up|10|||
124435206|NCT00297232|447554476|FG000|Overall Study|Adverse Event|63|||
124435207|NCT00297232|447554476|FG000|Overall Study|Voluntary Withdrawal|120|||
124435208|NCT00297232|447554476|FG000|Overall Study|Subject was Noncompliant|9|||
124435209|NCT00297232|447554476|FG000|Overall Study|Death|9|||
124435210|NCT00297232|447554476|FG000|Overall Study|Anti-natalizumab Positive|8|||
124435211|NCT00297232|447554476|FG000|Overall Study|Switched to Commercial Tysabri|22|||
124435212|NCT00297232|447554476|FG000|Overall Study|Disease Progression|8|||
124435213|NCT00297232|447554476|FG000|Overall Study|Fear of PML|10|||
124435214|NCT00297232|447554476|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
124435215|NCT00297232|447554476|FG000|Overall Study|Miscellaneous|5|||
124435216|NCT00297232|447554476|FG000|Overall Study|Sponsor Decision|34|||
124435217|NCT00297232|447554476|FG000|Overall Study|Subject Relocated|7|||
124435218|NCT00297232|447554476|FG000|Overall Study|Subject Withdrew Consent|37|||
124435219|NCT00297232|447554476|FG000|Overall Study|Persistently Positive Antibodies|11|||
124435220|NCT00297232|447554476|FG000|Overall Study|Investigator Withdrew From Program|19|||
124435221|NCT00297232|447554476|FG000|Overall Study|Did Not Enroll to Week 264|34|||
124435222|NCT00297232|447554476|FG000|Overall Study|Did Not Enroll to Week 480|17|||
124435223|NCT00297232|447554476|FG000|Overall Study|No data available after Week 264|161|||
124435224|NCT00297232|447554476|FG000|Overall Study|Other|1|||
124435225|NCT00190749|447554480|FG000|Overall Study|Lost to Follow-up|8|||
124435226|NCT00190749|447554481|FG001|Overall Study|Lost to Follow-up|11|||
124435227|NCT00190749|447554480|FG000|Overall Study|Withdrawal by Subject|10|||
124435228|NCT00190749|447554481|FG001|Overall Study|Withdrawal by Subject|6|||
124435229|NCT00190749|447554480|FG000|Overall Study|Protocol Violation|5|||
124435230|NCT00190749|447554481|FG001|Overall Study|Protocol Violation|4|||
124435231|NCT00190749|447554480|FG000|Overall Study|Adverse Event|0|||
124435232|NCT00190749|447554481|FG001|Overall Study|Adverse Event|5|||
124435233|NCT00190749|447554480|FG000|Overall Study|Lack of Efficacy|2|||
124435234|NCT00190749|447554481|FG001|Overall Study|Lack of Efficacy|3|||
124435235|NCT00190749|447554480|FG000|Overall Study|Reason Not Specified|0|||
124435236|NCT00190749|447554481|FG001|Overall Study|Reason Not Specified|2|||
124435237|NCT00190749|447554480|FG000|Overall Study|Sponsor Decision|1|||
124435238|NCT00190749|447554481|FG001|Overall Study|Sponsor Decision|0|||
124435239|NCT02729753|447554482|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
124435240|NCT02729753|447554483|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
124435241|NCT01200589|447554484|FG000|Overall Study|Withdrawal by Subject|13|||
124435242|NCT01200589|447554485|FG001|Overall Study|Withdrawal by Subject|11|||
124435243|NCT01200589|447554484|FG000|Overall Study|Physician Decision|2|||
124435244|NCT01200589|447554485|FG001|Overall Study|Physician Decision|2|||
124435245|NCT01200589|447554484|FG000|Overall Study|Lost to Follow-up|5|||
124435246|NCT01200589|447554485|FG001|Overall Study|Lost to Follow-up|4|||
124435247|NCT01200589|447554484|FG000|Overall Study|Study terminated|170|||
124435248|NCT01200589|447554485|FG001|Overall Study|Study terminated|172|||
124435249|NCT01090427|447554486|FG000|After Controlled Period|Death|0|||
124435250|NCT01090427|447554487|FG001|After Controlled Period|Death|0|||
124435251|NCT01090427|447554488|FG002|After Controlled Period|Death|0|||
124435252|NCT01090427|447554489|FG003|After Controlled Period|Death|0|||
124435253|NCT01090427|447554490|FG004|After Controlled Period|Death|0|||
124435254|NCT01090427|447554491|FG005|After Controlled Period|Death|1|||
124435255|NCT01090427|447554492|FG006|After Controlled Period|Death|0|||
124435256|NCT01090427|447554486|FG000|After Controlled Period|Lack of Efficacy|0|||
124435257|NCT01090427|447554487|FG001|After Controlled Period|Lack of Efficacy|0|||
124435258|NCT01090427|447554488|FG002|After Controlled Period|Lack of Efficacy|0|||
124435259|NCT01090427|447554489|FG003|After Controlled Period|Lack of Efficacy|0|||
124435260|NCT01090427|447554490|FG004|After Controlled Period|Lack of Efficacy|0|||
124435261|NCT01090427|447554491|FG005|After Controlled Period|Lack of Efficacy|3|||
124435262|NCT01090427|447554492|FG006|After Controlled Period|Lack of Efficacy|2|||
124435263|NCT01090427|447554486|FG000|After Controlled Period|Adverse Event|0|||
124435264|NCT01090427|447554487|FG001|After Controlled Period|Adverse Event|0|||
124435265|NCT01090427|447554488|FG002|After Controlled Period|Adverse Event|0|||
124435266|NCT01090427|447554489|FG003|After Controlled Period|Adverse Event|2|||
124435267|NCT01090427|447554490|FG004|After Controlled Period|Adverse Event|0|||
124435268|NCT01090427|447554491|FG005|After Controlled Period|Adverse Event|1|||
124435269|NCT01090427|447554492|FG006|After Controlled Period|Adverse Event|0|||
124435270|NCT01154010|447554493|FG000|Overall Study|Lost to Follow-up|0|||
124435271|NCT01154010|447554494|FG001|Overall Study|Lost to Follow-up|1|||
124435272|NCT00439231|447554495|FG000|Overall Study|Lack of Efficacy|28|||
124435273|NCT00986973|447554499|FG000|Overall Study|Withdrawn by study team|1|||
124435274|NCT00598273|447554500|FG000|Overall Study|Adverse Event|4|||
124435275|NCT00598273|447554501|FG001|Overall Study|Adverse Event|5|||
124435276|NCT00598273|447554502|FG002|Overall Study|Adverse Event|2|||
124435277|NCT00598273|447554500|FG000|Overall Study|Death|6|||
124435278|NCT00598273|447554501|FG001|Overall Study|Death|12|||
124435279|NCT00598273|447554502|FG002|Overall Study|Death|8|||
124435280|NCT00598273|447554500|FG000|Overall Study|Lost to Follow-up|8|||
124435281|NCT00598273|447554501|FG001|Overall Study|Lost to Follow-up|3|||
124435282|NCT00598273|447554502|FG002|Overall Study|Lost to Follow-up|5|||
124435283|NCT00598273|447554500|FG000|Overall Study|Physician Decision|0|||
124435284|NCT00598273|447554501|FG001|Overall Study|Physician Decision|0|||
124435285|NCT00598273|447554502|FG002|Overall Study|Physician Decision|1|||
124435286|NCT00598273|447554500|FG000|Overall Study|Withdrawal by Subject|12|||
124435287|NCT00598273|447554501|FG001|Overall Study|Withdrawal by Subject|10|||
124435288|NCT00598273|447554502|FG002|Overall Study|Withdrawal by Subject|10|||
124435289|NCT00598273|447554500|FG000|Overall Study|Noncompliance|3|||
124435290|NCT00598273|447554501|FG001|Overall Study|Noncompliance|2|||
124435291|NCT00598273|447554502|FG002|Overall Study|Noncompliance|3|||
124435292|NCT00598273|447554500|FG000|Overall Study|Relocation|0|||
124435293|NCT00598273|447554501|FG001|Overall Study|Relocation|2|||
124435294|NCT00598273|447554502|FG002|Overall Study|Relocation|4|||
124435295|NCT00598273|447554500|FG000|Overall Study|Renal transplant|1|||
124435296|NCT00598273|447554501|FG001|Overall Study|Renal transplant|0|||
124435297|NCT00598273|447554502|FG002|Overall Study|Renal transplant|1|||
124875384|NCT01337986|449165946|FG000|Overall Study|Protocol Violation|0|||
124435298|NCT00598273|447554500|FG000|Overall Study|Site elected to close|1|||
124435299|NCT00598273|447554501|FG001|Overall Study|Site elected to close|0|||
124435300|NCT00598273|447554502|FG002|Overall Study|Site elected to close|0|||
124435301|NCT00598273|447554500|FG000|Overall Study|Started dialysis|6|||
124435302|NCT00598273|447554501|FG001|Overall Study|Started dialysis|4|||
124435303|NCT00598273|447554502|FG002|Overall Study|Started dialysis|5|||
124435304|NCT01465347|447554503|FG000|Overall Study|Withdrawal by Subject|1|||
124435305|NCT01465347|447554504|FG001|Overall Study|Withdrawal by Subject|1|||
124435306|NCT01465347|447554503|FG000|Overall Study|Physician Decision|0|||
124875385|NCT01337986|449165947|FG001|Overall Study|Protocol Violation|3|||
124435307|NCT01465347|447554504|FG001|Overall Study|Physician Decision|1|||
124435308|NCT01465347|447554503|FG000|Overall Study|Admitted to hospice|0|||
124435309|NCT01465347|447554504|FG001|Overall Study|Admitted to hospice|1|||
124435310|NCT01590082|447554505|FG000|Overall Study|Withdrawal by Subject|1|||
124435311|NCT01590082|447554506|FG001|Overall Study|Withdrawal by Subject|0|||
124435312|NCT01590082|447554505|FG000|Overall Study|Ineligible|1|||
124435313|NCT01590082|447554506|FG001|Overall Study|Ineligible|0|||
124435314|NCT02414932|447554507|FG000|Overall Study|Withdrawal by Subject|2|||
124435315|NCT02414932|447554508|FG001|Overall Study|Withdrawal by Subject|3|||
124435316|NCT02414932|447554507|FG000|Overall Study|Adverse Event|1|||
124435317|NCT02414932|447554508|FG001|Overall Study|Adverse Event|0|||
124435318|NCT00906945|447554509|FG000|Overall Study|Found to be not eligible|0|||
124435319|NCT00906945|447554510|FG001|Overall Study|Found to be not eligible|0|||
124435320|NCT00906945|447554511|FG002|Overall Study|Found to be not eligible|0|||
124435321|NCT00906945|447554512|FG003|Overall Study|Found to be not eligible|1|||
124435322|NCT00906945|447554513|FG004|Overall Study|Found to be not eligible|1|||
124875386|NCT04461795|449165949|FG000|Overall Study|Lost to Follow-up|2|||
124875387|NCT04461795|449165949|FG000|Overall Study|Withdrawal by Subject|2|||
124875388|NCT04461795|449165949|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
124875389|NCT00058422|449165950|FG000|Overall Study|Not treated|2|||
124875390|NCT00185640|449165951|FG000|Overall Study|Not Eligible|4|||
124875391|NCT00185640|449165951|FG000|Overall Study|Withdrawal by Subject|3|||
124875392|NCT00185640|449165951|FG000|Overall Study|Death|138|||
124875393|NCT01520402|449165954|FG000|Overall Study|Withdrawal by Subject|2|||
124875394|NCT01520402|449165954|FG000|Overall Study|Physician Decision|3|||
124875395|NCT01722162|449165956|FG000|Overall Study|Withdrawal by Subject|1|||
124875396|NCT01722162|449165957|FG001|Overall Study|Withdrawal by Subject|1|||
124875397|NCT01722162|449165956|FG000|Overall Study|Found ineligible|1|||
124875398|NCT01722162|449165957|FG001|Overall Study|Found ineligible|0|||
124875399|NCT01722162|449165956|FG000|Overall Study|Unrelated to study adverse event|2|||
124875400|NCT01722162|449165957|FG001|Overall Study|Unrelated to study adverse event|2|||
124875401|NCT01722162|449165956|FG000|Overall Study|Adverse Event|1|||
124875402|NCT01722162|449165957|FG001|Overall Study|Adverse Event|1|||
124875403|NCT01722162|449165956|FG000|Overall Study|Insurance denial post enrollment|0|||
124875404|NCT01722162|449165957|FG001|Overall Study|Insurance denial post enrollment|1|||
124875405|NCT01722162|449165956|FG000|Overall Study|Noncompliance|0|||
124875406|NCT01722162|449165957|FG001|Overall Study|Noncompliance|1|||
124875407|NCT03124199|449165958|FG000|Overall Study|Lost to Follow-up|4|||
124875408|NCT04074590|449165959|FG000|Overall Study|Adverse Event|1|||
124875409|NCT04074590|449165960|FG001|Overall Study|Adverse Event|0|||
124875410|NCT04074590|449165959|FG000|Overall Study|Physician Decision|1|||
124875411|NCT04074590|449165960|FG001|Overall Study|Physician Decision|0|||
124875412|NCT04074590|449165959|FG000|Overall Study|Withdrawal by Subject|2|||
124875413|NCT04074590|449165960|FG001|Overall Study|Withdrawal by Subject|0|||
124875414|NCT00691132|449165964|FG000|Overall Study|Adverse Event|2|||
124875415|NCT00691132|449165965|FG001|Overall Study|Adverse Event|3|||
124875416|NCT00691132|449165964|FG000|Overall Study|Withdrawal by Subject|10|||
124875417|NCT00691132|449165965|FG001|Overall Study|Withdrawal by Subject|10|||
124875418|NCT02719990|449165972|FG000|Overall Study|Physician Decision|2|||
124875419|NCT02719990|449165972|FG000|Overall Study|Withdrawal by Subject|2|||
124875420|NCT02719990|449165972|FG000|Overall Study|Study Terminated By Sponsor|32|||
124875421|NCT02010632|449165973|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
124875422|NCT02010632|449165974|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
124875423|NCT06387472|449165978|FG000|Overall Study|Withdrawal by Subject|1|||
124875424|NCT06387472|449165978|FG000|Overall Study|Lost to Follow-up|2|||
124875425|NCT06387472|449165978|FG000|Overall Study|Physician Decision|1|||
124875426|NCT01061333|449165980|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
124875427|NCT01061333|449165981|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
124875428|NCT02044848|449168508|FG000|Overall Study|Administrative Problems|2|||
124875429|NCT02044848|449168509|FG001|Overall Study|Administrative Problems|3|||
124875430|NCT00045708|449168510|FG000|Phase 1|early progressive disease|0|||
124875431|NCT00045708|449168511|FG001|Phase 1|early progressive disease|1|||
124875432|NCT00045708|449168512|FG002|Phase 1|early progressive disease|0|||
124875433|NCT01679236|449168513|FG000|Overall Study|Lost to Follow-up|15|||
124435323|NCT00906945|447554514|FG005|Overall Study|Found to be not eligible|1|||
124435324|NCT00906945|447554509|FG000|Overall Study|Physician Decision|0|||
124435325|NCT00906945|447554510|FG001|Overall Study|Physician Decision|0|||
124875434|NCT01679236|449168514|FG001|Overall Study|Lost to Follow-up|15|||
124435326|NCT00906945|447554511|FG002|Overall Study|Physician Decision|0|||
124435327|NCT00906945|447554512|FG003|Overall Study|Physician Decision|0|||
124435328|NCT00906945|447554513|FG004|Overall Study|Physician Decision|0|||
124875435|NCT03237858|449168518|FG000|Overall Study|Death|19|||
124875436|NCT03237858|449168518|FG000|Overall Study|Withdrawal by Subject|37|||
124875437|NCT01160484|449168519|FG000|Overall Study|Lack of Efficacy|9|||
124875438|NCT01160484|449168519|FG000|Overall Study|Adverse Event|6|||
124875439|NCT01160484|449168519|FG000|Overall Study|Withdrawal by Subject|2|||
124875440|NCT01160484|449168519|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
124875441|NCT00803101|449168520|FG000|Overall Study|Death / Serious Adverse Event|4|||
124435329|NCT00906945|447554514|FG005|Overall Study|Physician Decision|1|||
124875442|NCT00803101|449168521|FG001|Overall Study|Death / Serious Adverse Event|6|||
124875443|NCT00803101|449168520|FG000|Overall Study|Withdrawal by Subject|6|||
124875444|NCT00803101|449168521|FG001|Overall Study|Withdrawal by Subject|4|||
124875445|NCT00803101|449168520|FG000|Overall Study|Lost to Follow-up|2|||
124875446|NCT00803101|449168521|FG001|Overall Study|Lost to Follow-up|2|||
124875447|NCT00803101|449168520|FG000|Overall Study|Protocol Violation|1|||
124875448|NCT00803101|449168521|FG001|Overall Study|Protocol Violation|7|||
124875449|NCT00803101|449168520|FG000|Overall Study|Surgery finished outside protocol window|1|||
124875450|NCT00803101|449168521|FG001|Overall Study|Surgery finished outside protocol window|1|||
124875451|NCT00803101|449168520|FG000|Overall Study|Patient died outside SAE report period|1|||
124875452|NCT00803101|449168521|FG001|Overall Study|Patient died outside SAE report period|0|||
124875453|NCT00803101|449168520|FG000|Overall Study|Patient did not attend scheduled visit|2|||
124875454|NCT00803101|449168521|FG001|Overall Study|Patient did not attend scheduled visit|1|||
124875455|NCT00803101|449168520|FG000|Overall Study|Patient did not have surgery|1|||
124875456|NCT00803101|449168521|FG001|Overall Study|Patient did not have surgery|1|||
124875457|NCT01782742|449168522|FG000|Double-blind Treatment Phase|Adverse Event|1|||
124875458|NCT01782742|449168523|FG001|Double-blind Treatment Phase|Adverse Event|0|||
124875459|NCT01679301|449168526|FG000|Screening Period|screen failure|3|||
124875460|NCT01679301|449168527|FG001|Screening Period|screen failure|0|||
124875461|NCT01679301|449168528|FG002|Screening Period|screen failure|0|||
124875462|NCT04858802|449168529|FG000|Overall Study|Lost to Follow-up|1|||
124875463|NCT04858802|449168530|FG001|Overall Study|Lost to Follow-up|1|||
124875464|NCT04858802|449168529|FG000|Overall Study|Withdrawal by Subject|1|||
124875465|NCT04858802|449168530|FG001|Overall Study|Withdrawal by Subject|1|||
124875466|NCT02026232|449168531|FG000|Overall Study|incomplete visit/missing data|3|||
124875467|NCT02026232|449168532|FG001|Overall Study|incomplete visit/missing data|2|||
124875468|NCT01529008|449168533|FG000|Bone Marrow Harvesting|Physician Decision|1|||
124875469|NCT01529008|449168534|FG001|Bone Marrow Harvesting|Physician Decision|1|||
124875470|NCT01529008|449168533|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
124875471|NCT01529008|449168534|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
124875472|NCT01529008|449168533|FG000|Treatment|Adverse Event|6|||
124875473|NCT01529008|449168534|FG001|Treatment|Adverse Event|0|||
124875474|NCT01529008|449168533|FG000|Treatment|Other|3|||
124875475|NCT01529008|449168534|FG001|Treatment|Other|1|||
124875476|NCT01529008|449168533|FG000|Efficacy Analysis|Protocol Violation|2|||
124875477|NCT01529008|449168534|FG001|Efficacy Analysis|Protocol Violation|0|||
124875478|NCT01529008|449168533|FG000|Efficacy Analysis|Physician Decision|0|||
124875479|NCT01529008|449168534|FG001|Efficacy Analysis|Physician Decision|1|||
124875480|NCT01529008|449168533|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
124875481|NCT01529008|449168534|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
124875482|NCT02305381|449168535|FG000|Overall Study|Unclassified|5|||
124875483|NCT02305381|449168536|FG001|Overall Study|Unclassified|5|||
124875484|NCT02305381|449168537|FG002|Overall Study|Unclassified|7|||
124875485|NCT05056870|449168540|FG000|Period 1|Site COVID-19 Related|3|||
124875486|NCT05056870|449168541|FG001|Period 1|Site COVID-19 Related|3|||
124875487|NCT05056870|449168540|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
124875488|NCT05056870|449168541|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
124875489|NCT05056870|449168540|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
124875490|NCT05056870|449168541|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
124875491|NCT05056870|449168540|FG000|Period 2|COVID-19 Related|1|||
124875492|NCT05056870|449168541|FG001|Period 2|COVID-19 Related|0|||
124875493|NCT05056870|449168540|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
124875494|NCT05056870|449168541|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
124875495|NCT05044325|449168542|FG000|Part A:Treatment Period 1|Adverse Event|0|||
124875496|NCT05044325|449168543|FG001|Part A:Treatment Period 1|Adverse Event|0|||
124875497|NCT05044325|449168544|FG002|Part A:Treatment Period 1|Adverse Event|0|||
124875498|NCT05044325|449168545|FG003|Part A:Treatment Period 1|Adverse Event|0|||
124875499|NCT05044325|449168546|FG004|Part A:Treatment Period 1|Adverse Event|0|||
124875500|NCT05044325|449168547|FG005|Part A:Treatment Period 1|Adverse Event|1|||
124875501|NCT05044325|449168548|FG006|Part A:Treatment Period 1|Adverse Event|0|||
124875502|NCT05044325|449168549|FG007|Part A:Treatment Period 1|Adverse Event|1|||
124875503|NCT05044325|449168550|FG008|Part A:Treatment Period 1|Adverse Event|0|||
124875504|NCT05044325|449168551|FG009|Part A:Treatment Period 1|Adverse Event|0|||
124875505|NCT05044325|449168542|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
124875506|NCT05044325|449168543|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
124875507|NCT05044325|449168544|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
124875508|NCT05044325|449168545|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
124875509|NCT05044325|449168546|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
124875510|NCT05044325|449168547|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
124875511|NCT05044325|449168548|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
124875512|NCT05044325|449168549|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
124875513|NCT05044325|449168550|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
124875514|NCT05044325|449168551|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
124875515|NCT05044325|449168542|FG000|Part A:Treatment Period 1|Physician Decision|0|||
124875516|NCT05044325|449168543|FG001|Part A:Treatment Period 1|Physician Decision|0|||
124875517|NCT05044325|449168544|FG002|Part A:Treatment Period 1|Physician Decision|0|||
124875518|NCT05044325|449168545|FG003|Part A:Treatment Period 1|Physician Decision|0|||
124875519|NCT05044325|449168546|FG004|Part A:Treatment Period 1|Physician Decision|0|||
124875520|NCT05044325|449168547|FG005|Part A:Treatment Period 1|Physician Decision|0|||
124875521|NCT05044325|449168548|FG006|Part A:Treatment Period 1|Physician Decision|1|||
124875522|NCT05044325|449168549|FG007|Part A:Treatment Period 1|Physician Decision|0|||
124875523|NCT05044325|449168550|FG008|Part A:Treatment Period 1|Physician Decision|0|||
124875524|NCT05044325|449168551|FG009|Part A:Treatment Period 1|Physician Decision|0|||
124875525|NCT05044325|449168542|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875526|NCT05044325|449168543|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875527|NCT05044325|449168544|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
124875528|NCT05044325|449168545|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875529|NCT05044325|449168546|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875530|NCT05044325|449168547|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875531|NCT05044325|449168548|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875532|NCT05044325|449168549|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875533|NCT05044325|449168550|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875534|NCT05044325|449168551|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
124875535|NCT05044325|449168542|FG000|Part A:Treatment Period 2|Adverse Event|0|||
124875536|NCT05044325|449168543|FG001|Part A:Treatment Period 2|Adverse Event|1|||
124875537|NCT05044325|449168544|FG002|Part A:Treatment Period 2|Adverse Event|0|||
124875538|NCT05044325|449168545|FG003|Part A:Treatment Period 2|Adverse Event|0|||
124875539|NCT05044325|449168546|FG004|Part A:Treatment Period 2|Adverse Event|1|||
124875540|NCT05044325|449168547|FG005|Part A:Treatment Period 2|Adverse Event|1|||
124875541|NCT05044325|449168548|FG006|Part A:Treatment Period 2|Adverse Event|0|||
124875542|NCT05044325|449168549|FG007|Part A:Treatment Period 2|Adverse Event|0|||
124875543|NCT05044325|449168550|FG008|Part A:Treatment Period 2|Adverse Event|0|||
124875544|NCT05044325|449168551|FG009|Part A:Treatment Period 2|Adverse Event|0|||
124875545|NCT05044325|449168542|FG000|Part A:Treatment Period 2|Physician Decision|0|||
124875546|NCT05044325|449168543|FG001|Part A:Treatment Period 2|Physician Decision|0|||
124875547|NCT05044325|449168544|FG002|Part A:Treatment Period 2|Physician Decision|0|||
124875548|NCT05044325|449168545|FG003|Part A:Treatment Period 2|Physician Decision|0|||
124875549|NCT05044325|449168546|FG004|Part A:Treatment Period 2|Physician Decision|0|||
124875550|NCT05044325|449168547|FG005|Part A:Treatment Period 2|Physician Decision|1|||
124875551|NCT05044325|449168548|FG006|Part A:Treatment Period 2|Physician Decision|0|||
124875552|NCT05044325|449168549|FG007|Part A:Treatment Period 2|Physician Decision|0|||
124875553|NCT05044325|449168550|FG008|Part A:Treatment Period 2|Physician Decision|0|||
124875554|NCT05044325|449168551|FG009|Part A:Treatment Period 2|Physician Decision|0|||
124875555|NCT05044325|449168542|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
124875556|NCT05044325|449168543|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
124875557|NCT05044325|449168544|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
124875558|NCT05044325|449168545|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
124875559|NCT05044325|449168546|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
124875560|NCT05044325|449168547|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
124875561|NCT05044325|449168548|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
124875562|NCT05044325|449168549|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
124875563|NCT05044325|449168550|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
124875564|NCT05044325|449168551|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
124875565|NCT02243202|449168552|FG000|Overall Study|Adverse Event|5|||
124875566|NCT02243202|449168553|FG001|Overall Study|Adverse Event|6|||
124875567|NCT02243202|449168554|FG002|Overall Study|Adverse Event|10|||
124875568|NCT02243202|449168555|FG003|Overall Study|Adverse Event|4|||
124875569|NCT02243202|449168552|FG000|Overall Study|Lost to Follow-up|9|||
124875570|NCT02243202|449168553|FG001|Overall Study|Lost to Follow-up|9|||
124875571|NCT02243202|449168554|FG002|Overall Study|Lost to Follow-up|14|||
124435330|NCT01210664|447554516|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
124435331|NCT01210664|447554517|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
124435332|NCT01210664|447554518|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
124435333|NCT01210664|447554519|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
124435334|NCT01210664|447554516|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
124875572|NCT02243202|449168555|FG003|Overall Study|Lost to Follow-up|11|||
124875573|NCT02243202|449168552|FG000|Overall Study|Protocol Violation|3|||
124875574|NCT02243202|449168553|FG001|Overall Study|Protocol Violation|1|||
124875575|NCT02243202|449168554|FG002|Overall Study|Protocol Violation|2|||
124875576|NCT02243202|449168555|FG003|Overall Study|Protocol Violation|1|||
124875577|NCT02243202|449168552|FG000|Overall Study|Withdrawal by Subject|7|||
124875578|NCT02243202|449168553|FG001|Overall Study|Withdrawal by Subject|6|||
124875579|NCT02243202|449168554|FG002|Overall Study|Withdrawal by Subject|4|||
124875580|NCT02243202|449168555|FG003|Overall Study|Withdrawal by Subject|4|||
124875581|NCT02243202|449168552|FG000|Overall Study|Other|1|||
124875582|NCT02243202|449168553|FG001|Overall Study|Other|3|||
124875583|NCT02243202|449168554|FG002|Overall Study|Other|1|||
124875584|NCT02243202|449168555|FG003|Overall Study|Other|2|||
124875585|NCT02243202|449168552|FG000|Overall Study|Randomized but not received treatment|0|||
124875586|NCT02243202|449168553|FG001|Overall Study|Randomized but not received treatment|0|||
124875587|NCT02243202|449168554|FG002|Overall Study|Randomized but not received treatment|0|||
124875588|NCT02243202|449168555|FG003|Overall Study|Randomized but not received treatment|1|||
124875589|NCT00991341|449168557|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
124875590|NCT00991341|449168558|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
124875591|NCT00991341|449168557|FG000|Overall Study|Death|3|||
124875592|NCT00991341|449168558|FG001|Overall Study|Death|0|||
124875593|NCT00991341|449168557|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
124875594|NCT00991341|449168558|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
124875595|NCT00991341|449168557|FG000|Overall Study|Physician Decision|1|||
124875596|NCT00991341|449168558|FG001|Overall Study|Physician Decision|2|||
124875597|NCT00991341|449168557|FG000|Overall Study|Withdrawal by Subject|3|||
124875598|NCT00991341|449168558|FG001|Overall Study|Withdrawal by Subject|4|||
124435335|NCT01210664|447554517|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
124435336|NCT01210664|447554518|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
124435337|NCT01210664|447554519|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
124435338|NCT01210664|447554516|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
124435339|NCT01210664|447554517|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
124435340|NCT01210664|447554518|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
124435341|NCT01210664|447554519|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
124435342|NCT01853644|447554520|FG000|Registration and Treatment Start|Did not start treatment|1|||
124435343|NCT01853644|447554520|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
124435344|NCT01853644|447554520|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
124435345|NCT01853644|447554520|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
124435346|NCT01853644|447554520|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
124435347|NCT01853644|447554520|FG000|Continued Treatment After First Response|Adverse Event|2|||
124435348|NCT01853644|447554520|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
124435349|NCT02891408|447554521|FG000|Overall Study|Lost to Follow-up|0|||
124435350|NCT02891408|447554522|FG001|Overall Study|Lost to Follow-up|0|||
124435351|NCT02891408|447554523|FG002|Overall Study|Lost to Follow-up|1|||
124435352|NCT02891408|447554524|FG003|Overall Study|Lost to Follow-up|0|||
124435353|NCT02891408|447554525|FG004|Overall Study|Lost to Follow-up|0|||
124435354|NCT02891408|447554526|FG005|Overall Study|Lost to Follow-up|0|||
124435355|NCT02891408|447554527|FG006|Overall Study|Lost to Follow-up|0|||
124435356|NCT01054170|447554528|FG000|Overall Study|Protocol Violation|1|||
124435357|NCT01054170|447554529|FG001|Overall Study|Protocol Violation|0|||
124435358|NCT01054170|447554528|FG000|Overall Study|Withdrawal by Subject|3|||
124435359|NCT01054170|447554529|FG001|Overall Study|Withdrawal by Subject|2|||
124435360|NCT01054170|447554528|FG000|Overall Study|Adverse Event|0|||
124435361|NCT01054170|447554529|FG001|Overall Study|Adverse Event|4|||
124435362|NCT00709852|447554530|FG000|Period 1|Adverse Event|2|||
124435363|NCT00709852|447554531|FG001|Period 1|Adverse Event|0|||
124435364|NCT00709852|447554530|FG000|Period 1|Withdrawal by Subject|4|||
124435365|NCT00709852|447554531|FG001|Period 1|Withdrawal by Subject|2|||
124435366|NCT00709852|447554530|FG000|Period 1|Protocol Violation|1|||
124435367|NCT00709852|447554531|FG001|Period 1|Protocol Violation|0|||
124435368|NCT00709852|447554530|FG000|Period 1|Defective scanner|0|||
124435369|NCT00709852|447554531|FG001|Period 1|Defective scanner|1|||
124435370|NCT00709852|447554530|FG000|Period 1|Lost to Follow-up|1|||
124435371|NCT00709852|447554531|FG001|Period 1|Lost to Follow-up|0|||
124435372|NCT00709852|447554530|FG000|Period 2|Protocol Violation|4|||
124435373|NCT00709852|447554531|FG001|Period 2|Protocol Violation|1|||
124435374|NCT00709852|447554530|FG000|Period 2|Adverse Event|1|||
124435375|NCT00709852|447554531|FG001|Period 2|Adverse Event|1|||
124435376|NCT00709852|447554530|FG000|Period 2|Lost to Follow-up|1|||
124435377|NCT00709852|447554531|FG001|Period 2|Lost to Follow-up|0|||
124435378|NCT00709852|447554530|FG000|Period 2|No 72-hour follow-up|3|||
124435379|NCT00709852|447554531|FG001|Period 2|No 72-hour follow-up|0|||
124435380|NCT02951767|447554532|FG000|Overall Study|Study Terminated By Sponsor|9|||
124435381|NCT02951767|447554532|FG000|Overall Study|Withdrawal by Subject|11|||
124435382|NCT02951767|447554532|FG000|Overall Study|Death|96|||
124435383|NCT02951767|447554532|FG000|Overall Study|Lost to Follow-up|2|||
124435384|NCT02951767|447554532|FG000|Overall Study|Physician Decision|1|||
124435385|NCT00196976|447554533|FG000|Primary Study|Migrated from study area|0|||
124435386|NCT00196976|447554534|FG001|Primary Study|Migrated from study area|0|||
124435387|NCT00196976|447554535|FG002|Primary Study|Migrated from study area|0|||
124435388|NCT00196976|447554536|FG003|Primary Study|Migrated from study area|0|||
124435389|NCT00196976|447554537|FG004|Primary Study|Migrated from study area|0|||
124435390|NCT00196976|447554538|FG005|Primary Study|Migrated from study area|0|||
124435391|NCT00196976|447554539|FG006|Primary Study|Migrated from study area|0|||
124435392|NCT00196976|447554540|FG007|Primary Study|Migrated from study area|1|||
124435393|NCT00196976|447554541|FG008|Primary Study|Migrated from study area|0|||
124435394|NCT00196976|447554542|FG009|Primary Study|Migrated from study area|0|||
124435395|NCT00196976|447554543|FG010|Primary Study|Migrated from study area|0|||
124435396|NCT00196976|447554544|FG011|Primary Study|Migrated from study area|0|||
124435397|NCT00196976|447554545|FG012|Primary Study|Migrated from study area|0|||
124435398|NCT00196976|447554546|FG013|Primary Study|Migrated from study area|0|||
124435399|NCT00196976|447554533|FG000|Primary Study|Protocol Violation|0|||
124435400|NCT00196976|447554534|FG001|Primary Study|Protocol Violation|1|||
124435401|NCT00196976|447554535|FG002|Primary Study|Protocol Violation|1|||
124435402|NCT00196976|447554536|FG003|Primary Study|Protocol Violation|0|||
124435403|NCT00196976|447554537|FG004|Primary Study|Protocol Violation|0|||
124435404|NCT00196976|447554538|FG005|Primary Study|Protocol Violation|0|||
124435405|NCT00196976|447554539|FG006|Primary Study|Protocol Violation|0|||
124435406|NCT00196976|447554540|FG007|Primary Study|Protocol Violation|0|||
124435407|NCT00196976|447554541|FG008|Primary Study|Protocol Violation|0|||
124435408|NCT00196976|447554542|FG009|Primary Study|Protocol Violation|0|||
124435409|NCT00196976|447554543|FG010|Primary Study|Protocol Violation|0|||
124435410|NCT00196976|447554544|FG011|Primary Study|Protocol Violation|0|||
124435411|NCT00196976|447554545|FG012|Primary Study|Protocol Violation|0|||
124435412|NCT00196976|447554546|FG013|Primary Study|Protocol Violation|0|||
124435413|NCT00196976|447554533|FG000|Primary Study|Withdrawal by Subject|1|||
124435414|NCT00196976|447554534|FG001|Primary Study|Withdrawal by Subject|0|||
124435415|NCT00196976|447554535|FG002|Primary Study|Withdrawal by Subject|1|||
124435416|NCT00196976|447554536|FG003|Primary Study|Withdrawal by Subject|1|||
124435417|NCT00196976|447554537|FG004|Primary Study|Withdrawal by Subject|2|||
124435418|NCT00196976|447554538|FG005|Primary Study|Withdrawal by Subject|1|||
124435419|NCT00196976|447554539|FG006|Primary Study|Withdrawal by Subject|0|||
124435420|NCT00196976|447554540|FG007|Primary Study|Withdrawal by Subject|0|||
124435421|NCT00196976|447554541|FG008|Primary Study|Withdrawal by Subject|0|||
124435422|NCT00196976|447554542|FG009|Primary Study|Withdrawal by Subject|1|||
124435423|NCT00196976|447554543|FG010|Primary Study|Withdrawal by Subject|0|||
124435424|NCT00196976|447554544|FG011|Primary Study|Withdrawal by Subject|0|||
124435425|NCT00196976|447554545|FG012|Primary Study|Withdrawal by Subject|0|||
124435426|NCT00196976|447554546|FG013|Primary Study|Withdrawal by Subject|0|||
124435427|NCT00196976|447554533|FG000|Primary Study|Lost to Follow-up|0|||
124435428|NCT00196976|447554534|FG001|Primary Study|Lost to Follow-up|0|||
124435429|NCT00196976|447554535|FG002|Primary Study|Lost to Follow-up|0|||
124435430|NCT00196976|447554536|FG003|Primary Study|Lost to Follow-up|0|||
124435431|NCT00196976|447554537|FG004|Primary Study|Lost to Follow-up|1|||
124435432|NCT00196976|447554538|FG005|Primary Study|Lost to Follow-up|1|||
124435433|NCT00196976|447554539|FG006|Primary Study|Lost to Follow-up|0|||
124435434|NCT00196976|447554540|FG007|Primary Study|Lost to Follow-up|2|||
124435435|NCT00196976|447554541|FG008|Primary Study|Lost to Follow-up|0|||
124435436|NCT00196976|447554542|FG009|Primary Study|Lost to Follow-up|0|||
124435437|NCT00196976|447554543|FG010|Primary Study|Lost to Follow-up|0|||
124435438|NCT00196976|447554544|FG011|Primary Study|Lost to Follow-up|0|||
124435439|NCT00196976|447554545|FG012|Primary Study|Lost to Follow-up|0|||
124435440|NCT00196976|447554546|FG013|Primary Study|Lost to Follow-up|0|||
124435441|NCT00196976|447554533|FG000|Primary Study|Other|0|||
124435442|NCT00196976|447554534|FG001|Primary Study|Other|0|||
124435443|NCT00196976|447554535|FG002|Primary Study|Other|2|||
124435444|NCT00196976|447554536|FG003|Primary Study|Other|0|||
124435445|NCT00196976|447554537|FG004|Primary Study|Other|0|||
124435446|NCT00196976|447554538|FG005|Primary Study|Other|0|||
124435447|NCT00196976|447554539|FG006|Primary Study|Other|0|||
124435448|NCT00196976|447554540|FG007|Primary Study|Other|0|||
124435449|NCT00196976|447554541|FG008|Primary Study|Other|0|||
124435450|NCT00196976|447554542|FG009|Primary Study|Other|0|||
124435451|NCT00196976|447554543|FG010|Primary Study|Other|0|||
124435452|NCT00196976|447554544|FG011|Primary Study|Other|0|||
124435453|NCT00196976|447554545|FG012|Primary Study|Other|0|||
124435454|NCT00196976|447554546|FG013|Primary Study|Other|0|||
124435455|NCT00196976|447554533|FG000|Booster Study|Withdrawal by Subject|0|||
124435456|NCT00196976|447554534|FG001|Booster Study|Withdrawal by Subject|0|||
124435457|NCT00196976|447554535|FG002|Booster Study|Withdrawal by Subject|0|||
124435458|NCT00196976|447554536|FG003|Booster Study|Withdrawal by Subject|0|||
124435459|NCT00196976|447554537|FG004|Booster Study|Withdrawal by Subject|0|||
124435460|NCT00196976|447554538|FG005|Booster Study|Withdrawal by Subject|0|||
124435461|NCT00196976|447554539|FG006|Booster Study|Withdrawal by Subject|0|||
124435462|NCT00196976|447554540|FG007|Booster Study|Withdrawal by Subject|0|||
124435463|NCT00196976|447554541|FG008|Booster Study|Withdrawal by Subject|0|||
124435464|NCT00196976|447554542|FG009|Booster Study|Withdrawal by Subject|0|||
124435465|NCT00196976|447554543|FG010|Booster Study|Withdrawal by Subject|1|||
124435466|NCT00196976|447554544|FG011|Booster Study|Withdrawal by Subject|0|||
124435467|NCT00196976|447554545|FG012|Booster Study|Withdrawal by Subject|0|||
124435468|NCT00196976|447554546|FG013|Booster Study|Withdrawal by Subject|0|||
124435469|NCT00196976|447554533|FG000|Booster Study|Lost to Follow-up|0|||
124435470|NCT00196976|447554534|FG001|Booster Study|Lost to Follow-up|0|||
124435471|NCT00196976|447554535|FG002|Booster Study|Lost to Follow-up|0|||
124435472|NCT00196976|447554536|FG003|Booster Study|Lost to Follow-up|0|||
124435473|NCT00196976|447554537|FG004|Booster Study|Lost to Follow-up|0|||
124435474|NCT00196976|447554538|FG005|Booster Study|Lost to Follow-up|0|||
124435475|NCT00196976|447554539|FG006|Booster Study|Lost to Follow-up|0|||
124435476|NCT00196976|447554540|FG007|Booster Study|Lost to Follow-up|0|||
124435477|NCT00196976|447554541|FG008|Booster Study|Lost to Follow-up|0|||
124435478|NCT00196976|447554542|FG009|Booster Study|Lost to Follow-up|0|||
124435479|NCT00196976|447554543|FG010|Booster Study|Lost to Follow-up|1|||
124435480|NCT00196976|447554544|FG011|Booster Study|Lost to Follow-up|2|||
124678445|NCT03451045|448448103|FG000|Overall Study|Pregnancy|0|||
124678446|NCT03451045|448448104|FG001|Overall Study|Pregnancy|0|||
124678447|NCT03451045|448448105|FG002|Overall Study|Pregnancy|2|||
124678448|NCT03451045|448448103|FG000|Overall Study|Adverse Event|7|||
124678449|NCT03451045|448448104|FG001|Overall Study|Adverse Event|1|||
124678450|NCT03451045|448448105|FG002|Overall Study|Adverse Event|3|||
124678451|NCT03451045|448448103|FG000|Overall Study|Non-compliance with study|2|||
124678452|NCT03451045|448448104|FG001|Overall Study|Non-compliance with study|0|||
124678453|NCT03451045|448448105|FG002|Overall Study|Non-compliance with study|1|||
124678454|NCT03451045|448448103|FG000|Overall Study|any other reason|10|||
124678455|NCT03451045|448448104|FG001|Overall Study|any other reason|2|||
124678456|NCT03451045|448448105|FG002|Overall Study|any other reason|13|||
124875599|NCT00246337|449168559|FG000|Overall Study|Lost to Follow-up|3|||
124875600|NCT00246337|449168560|FG001|Overall Study|Lost to Follow-up|0|||
124875601|NCT00246337|449168561|FG002|Overall Study|Lost to Follow-up|0|||
124875602|NCT00246337|449168562|FG003|Overall Study|Lost to Follow-up|0|||
124875603|NCT00246337|449168563|FG004|Overall Study|Lost to Follow-up|2|||
124875604|NCT00246337|449168564|FG005|Overall Study|Lost to Follow-up|2|||
124875605|NCT00246337|449168565|FG006|Overall Study|Lost to Follow-up|1|||
124875606|NCT00246337|449168566|FG007|Overall Study|Lost to Follow-up|2|||
124875607|NCT00246337|449168567|FG008|Overall Study|Lost to Follow-up|0|||
124875608|NCT00246337|449168559|FG000|Overall Study|Protocol Violation|1|||
124875609|NCT00246337|449168560|FG001|Overall Study|Protocol Violation|0|||
124875610|NCT00246337|449168561|FG002|Overall Study|Protocol Violation|0|||
124875611|NCT00246337|449168562|FG003|Overall Study|Protocol Violation|0|||
124875612|NCT00246337|449168563|FG004|Overall Study|Protocol Violation|1|||
124875613|NCT00246337|449168564|FG005|Overall Study|Protocol Violation|0|||
124875614|NCT00246337|449168565|FG006|Overall Study|Protocol Violation|1|||
124875615|NCT00246337|449168566|FG007|Overall Study|Protocol Violation|1|||
124875616|NCT00246337|449168567|FG008|Overall Study|Protocol Violation|0|||
124875617|NCT00246337|449168559|FG000|Overall Study|Withdrawal by Subject|2|||
124875618|NCT00246337|449168560|FG001|Overall Study|Withdrawal by Subject|0|||
124875619|NCT00246337|449168561|FG002|Overall Study|Withdrawal by Subject|0|||
124875620|NCT00246337|449168562|FG003|Overall Study|Withdrawal by Subject|0|||
124875621|NCT00246337|449168563|FG004|Overall Study|Withdrawal by Subject|0|||
124875622|NCT00246337|449168564|FG005|Overall Study|Withdrawal by Subject|0|||
124875623|NCT00246337|449168565|FG006|Overall Study|Withdrawal by Subject|1|||
124875624|NCT00246337|449168566|FG007|Overall Study|Withdrawal by Subject|1|||
124875625|NCT00246337|449168567|FG008|Overall Study|Withdrawal by Subject|0|||
124875626|NCT00246337|449168559|FG000|Overall Study|Lack of Qualifying Event|8|||
124875627|NCT00246337|449168560|FG001|Overall Study|Lack of Qualifying Event|2|||
124875628|NCT00246337|449168561|FG002|Overall Study|Lack of Qualifying Event|1|||
124875629|NCT00246337|449168562|FG003|Overall Study|Lack of Qualifying Event|1|||
124875630|NCT00246337|449168563|FG004|Overall Study|Lack of Qualifying Event|1|||
124875631|NCT00246337|449168564|FG005|Overall Study|Lack of Qualifying Event|3|||
124875632|NCT00246337|449168565|FG006|Overall Study|Lack of Qualifying Event|3|||
124678457|NCT04142242|448448108|FG000|Stage I|Non-compliance with the protocol|1|||
124678458|NCT04142242|448448109|FG001|Stage I|Non-compliance with the protocol|0|||
124875633|NCT00246337|449168566|FG007|Overall Study|Lack of Qualifying Event|2|||
124875634|NCT00246337|449168567|FG008|Overall Study|Lack of Qualifying Event|5|||
124875635|NCT00246337|449168559|FG000|Overall Study|Site Terminated|10|||
124875636|NCT00246337|449168560|FG001|Overall Study|Site Terminated|0|||
124875637|NCT00246337|449168561|FG002|Overall Study|Site Terminated|0|||
124875638|NCT00246337|449168562|FG003|Overall Study|Site Terminated|0|||
124875639|NCT00246337|449168563|FG004|Overall Study|Site Terminated|0|||
124875640|NCT00246337|449168564|FG005|Overall Study|Site Terminated|7|||
124678459|NCT04142242|448448110|FG002|Stage I|Non-compliance with the protocol|0|||
124678460|NCT04142242|448448111|FG003|Stage I|Non-compliance with the protocol|0|||
124678461|NCT04142242|448448112|FG004|Stage I|Non-compliance with the protocol|0|||
124678462|NCT04142242|448448113|FG005|Stage I|Non-compliance with the protocol|1|||
124678463|NCT04142242|448448108|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
124678464|NCT04142242|448448109|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
124678465|NCT04142242|448448110|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
124678466|NCT04142242|448448111|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
124678467|NCT04142242|448448112|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
124678468|NCT04142242|448448113|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
124875641|NCT00246337|449168565|FG006|Overall Study|Site Terminated|1|||
124875642|NCT00246337|449168566|FG007|Overall Study|Site Terminated|6|||
124875643|NCT00246337|449168567|FG008|Overall Study|Site Terminated|2|||
124875644|NCT00246337|449168559|FG000|Overall Study|Abnormal baseline lab values|7|||
124875645|NCT00246337|449168560|FG001|Overall Study|Abnormal baseline lab values|0|||
124875646|NCT00246337|449168561|FG002|Overall Study|Abnormal baseline lab values|2|||
124875647|NCT00246337|449168562|FG003|Overall Study|Abnormal baseline lab values|0|||
124875648|NCT00246337|449168563|FG004|Overall Study|Abnormal baseline lab values|0|||
124875649|NCT00246337|449168564|FG005|Overall Study|Abnormal baseline lab values|2|||
124875650|NCT00246337|449168565|FG006|Overall Study|Abnormal baseline lab values|2|||
124875651|NCT00246337|449168566|FG007|Overall Study|Abnormal baseline lab values|0|||
124875652|NCT00246337|449168567|FG008|Overall Study|Abnormal baseline lab values|4|||
124875653|NCT00246337|449168559|FG000|Overall Study|Overwhelmed|0|||
124875654|NCT00246337|449168560|FG001|Overall Study|Overwhelmed|0|||
124875655|NCT00246337|449168561|FG002|Overall Study|Overwhelmed|0|||
124875656|NCT00246337|449168562|FG003|Overall Study|Overwhelmed|0|||
124875657|NCT00246337|449168563|FG004|Overall Study|Overwhelmed|0|||
124875658|NCT00246337|449168564|FG005|Overall Study|Overwhelmed|1|||
124875659|NCT00246337|449168565|FG006|Overall Study|Overwhelmed|0|||
124875660|NCT00246337|449168566|FG007|Overall Study|Overwhelmed|0|||
124875661|NCT00246337|449168567|FG008|Overall Study|Overwhelmed|0|||
124875662|NCT00246337|449168559|FG000|Overall Study|Protocol Violator|1|||
124875663|NCT00246337|449168560|FG001|Overall Study|Protocol Violator|0|||
124875664|NCT00246337|449168561|FG002|Overall Study|Protocol Violator|0|||
124875665|NCT00246337|449168562|FG003|Overall Study|Protocol Violator|0|||
124875666|NCT00246337|449168563|FG004|Overall Study|Protocol Violator|0|||
124875667|NCT00246337|449168564|FG005|Overall Study|Protocol Violator|0|||
124875668|NCT00246337|449168565|FG006|Overall Study|Protocol Violator|0|||
124875669|NCT00246337|449168566|FG007|Overall Study|Protocol Violator|0|||
124875670|NCT00246337|449168567|FG008|Overall Study|Protocol Violator|0|||
124875671|NCT00246337|449168559|FG000|Overall Study|Reported as completing trial in error|0|||
124875672|NCT00246337|449168560|FG001|Overall Study|Reported as completing trial in error|0|||
124875673|NCT00246337|449168561|FG002|Overall Study|Reported as completing trial in error|0|||
124875674|NCT00246337|449168562|FG003|Overall Study|Reported as completing trial in error|0|||
124875675|NCT00246337|449168563|FG004|Overall Study|Reported as completing trial in error|0|||
124875676|NCT00246337|449168564|FG005|Overall Study|Reported as completing trial in error|0|||
124875677|NCT00246337|449168565|FG006|Overall Study|Reported as completing trial in error|0|||
124875678|NCT00246337|449168566|FG007|Overall Study|Reported as completing trial in error|1|||
124875679|NCT00246337|449168567|FG008|Overall Study|Reported as completing trial in error|0|||
124875680|NCT01966003|449168568|FG000|Overall Study|Death|43|||
124875681|NCT01966003|449168569|FG001|Overall Study|Death|36|||
124875682|NCT01966003|449168568|FG000|Overall Study|Protocol Violation|6|||
124875683|NCT01966003|449168569|FG001|Overall Study|Protocol Violation|4|||
124875684|NCT01966003|449168568|FG000|Overall Study|Lost to Follow-up|4|||
124875685|NCT01966003|449168569|FG001|Overall Study|Lost to Follow-up|3|||
124875686|NCT01966003|449168568|FG000|Overall Study|Physician Decision|12|||
124875687|NCT01966003|449168569|FG001|Overall Study|Physician Decision|13|||
124875688|NCT01966003|449168568|FG000|Overall Study|Withdrawal by Subject|29|||
124875689|NCT01966003|449168569|FG001|Overall Study|Withdrawal by Subject|19|||
124875690|NCT01966003|449168568|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
124875691|NCT01966003|449168569|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
124875692|NCT01966003|449168568|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
124875693|NCT01966003|449168569|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
124875694|NCT01966003|449168568|FG000|Overall Study|Other|1|||
124875695|NCT01966003|449168569|FG001|Overall Study|Other|1|||
124875696|NCT03633929|449168571|FG000|Overall Study|Lost to Follow-up|1|||
124875697|NCT03633929|449168571|FG000|Overall Study|Did not login to software. Did not participate|3|||
124875698|NCT02287584|449168575|FG000|the Double-blind Phase|Adverse Event|17|||
124875699|NCT02287584|449168576|FG001|the Double-blind Phase|Adverse Event|17|||
124875700|NCT02287584|449168577|FG002|the Double-blind Phase|Adverse Event|12|||
124875701|NCT02287584|449168578|FG003|the Double-blind Phase|Adverse Event|0|||
124875702|NCT02287584|449168579|FG004|the Double-blind Phase|Adverse Event|0|||
124875703|NCT02287584|449168580|FG005|the Double-blind Phase|Adverse Event|0|||
124875704|NCT02287584|449168575|FG000|the Double-blind Phase|Lack of Efficacy|18|||
124875705|NCT02287584|449168576|FG001|the Double-blind Phase|Lack of Efficacy|8|||
124875706|NCT02287584|449168577|FG002|the Double-blind Phase|Lack of Efficacy|8|||
124875707|NCT02287584|449168578|FG003|the Double-blind Phase|Lack of Efficacy|0|||
124875708|NCT02287584|449168579|FG004|the Double-blind Phase|Lack of Efficacy|0|||
124875709|NCT02287584|449168580|FG005|the Double-blind Phase|Lack of Efficacy|0|||
124875710|NCT02287584|449168575|FG000|the Double-blind Phase|Lost to Follow-up|0|||
124875711|NCT02287584|449168576|FG001|the Double-blind Phase|Lost to Follow-up|1|||
124875712|NCT02287584|449168577|FG002|the Double-blind Phase|Lost to Follow-up|1|||
124875713|NCT02287584|449168578|FG003|the Double-blind Phase|Lost to Follow-up|0|||
124875714|NCT02287584|449168579|FG004|the Double-blind Phase|Lost to Follow-up|0|||
124875715|NCT02287584|449168580|FG005|the Double-blind Phase|Lost to Follow-up|0|||
124875716|NCT02287584|449168575|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
124875717|NCT02287584|449168576|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
124875718|NCT02287584|449168577|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
124875719|NCT02287584|449168578|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
124875720|NCT02287584|449168579|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
124875721|NCT02287584|449168580|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
124875722|NCT02287584|449168575|FG000|the Double-blind Phase|Pregnancy|0|||
124875723|NCT02287584|449168576|FG001|the Double-blind Phase|Pregnancy|1|||
124875724|NCT02287584|449168577|FG002|the Double-blind Phase|Pregnancy|0|||
124875725|NCT02287584|449168578|FG003|the Double-blind Phase|Pregnancy|0|||
124875726|NCT02287584|449168579|FG004|the Double-blind Phase|Pregnancy|0|||
124875727|NCT02287584|449168580|FG005|the Double-blind Phase|Pregnancy|0|||
124875728|NCT02287584|449168575|FG000|the Double-blind Phase|Protocol Violation|0|||
124875729|NCT02287584|449168576|FG001|the Double-blind Phase|Protocol Violation|3|||
124875730|NCT02287584|449168577|FG002|the Double-blind Phase|Protocol Violation|0|||
124875731|NCT02287584|449168578|FG003|the Double-blind Phase|Protocol Violation|0|||
124875732|NCT02287584|449168579|FG004|the Double-blind Phase|Protocol Violation|0|||
124875733|NCT02287584|449168580|FG005|the Double-blind Phase|Protocol Violation|0|||
124875734|NCT02287584|449168575|FG000|the Double-blind Phase|other reasons|0|||
124875735|NCT02287584|449168576|FG001|the Double-blind Phase|other reasons|0|||
124875736|NCT02287584|449168577|FG002|the Double-blind Phase|other reasons|1|||
124875737|NCT02287584|449168578|FG003|the Double-blind Phase|other reasons|0|||
124875738|NCT02287584|449168579|FG004|the Double-blind Phase|other reasons|0|||
124875739|NCT02287584|449168580|FG005|the Double-blind Phase|other reasons|0|||
124875740|NCT02287584|449168575|FG000|the Open-label Phase|Did not receive drug|0|||
124875741|NCT02287584|449168576|FG001|the Open-label Phase|Did not receive drug|0|||
124875742|NCT02287584|449168577|FG002|the Open-label Phase|Did not receive drug|0|||
124875743|NCT02287584|449168578|FG003|the Open-label Phase|Did not receive drug|7|||
124875744|NCT02287584|449168579|FG004|the Open-label Phase|Did not receive drug|6|||
124875745|NCT02287584|449168580|FG005|the Open-label Phase|Did not receive drug|4|||
124875746|NCT02287584|449168575|FG000|the Open-label Phase|Adverse Event|0|||
124875747|NCT02287584|449168576|FG001|the Open-label Phase|Adverse Event|0|||
124875748|NCT02287584|449168577|FG002|the Open-label Phase|Adverse Event|0|||
124875749|NCT02287584|449168578|FG003|the Open-label Phase|Adverse Event|15|||
124875750|NCT02287584|449168579|FG004|the Open-label Phase|Adverse Event|12|||
124875751|NCT02287584|449168580|FG005|the Open-label Phase|Adverse Event|16|||
124875752|NCT02287584|449168575|FG000|the Open-label Phase|Lack of Efficacy|0|||
124875753|NCT02287584|449168576|FG001|the Open-label Phase|Lack of Efficacy|0|||
124875754|NCT02287584|449168577|FG002|the Open-label Phase|Lack of Efficacy|0|||
124875755|NCT02287584|449168578|FG003|the Open-label Phase|Lack of Efficacy|8|||
124875756|NCT02287584|449168579|FG004|the Open-label Phase|Lack of Efficacy|3|||
124875757|NCT02287584|449168580|FG005|the Open-label Phase|Lack of Efficacy|7|||
124875758|NCT02287584|449168575|FG000|the Open-label Phase|Lost to Follow-up|0|||
124875759|NCT02287584|449168576|FG001|the Open-label Phase|Lost to Follow-up|0|||
124875760|NCT02287584|449168577|FG002|the Open-label Phase|Lost to Follow-up|0|||
124875761|NCT02287584|449168578|FG003|the Open-label Phase|Lost to Follow-up|4|||
124875762|NCT02287584|449168579|FG004|the Open-label Phase|Lost to Follow-up|1|||
124875763|NCT02287584|449168580|FG005|the Open-label Phase|Lost to Follow-up|2|||
124875764|NCT02287584|449168575|FG000|the Open-label Phase|Withdrawal by Subject|0|||
124875765|NCT02287584|449168576|FG001|the Open-label Phase|Withdrawal by Subject|0|||
124875766|NCT02287584|449168577|FG002|the Open-label Phase|Withdrawal by Subject|0|||
124875767|NCT02287584|449168578|FG003|the Open-label Phase|Withdrawal by Subject|18|||
124875768|NCT02287584|449168579|FG004|the Open-label Phase|Withdrawal by Subject|29|||
124875769|NCT02287584|449168580|FG005|the Open-label Phase|Withdrawal by Subject|21|||
124875770|NCT02287584|449168575|FG000|the Open-label Phase|non-compliance|0|||
124875771|NCT02287584|449168576|FG001|the Open-label Phase|non-compliance|0|||
124875772|NCT02287584|449168577|FG002|the Open-label Phase|non-compliance|0|||
124875773|NCT02287584|449168578|FG003|the Open-label Phase|non-compliance|2|||
124875774|NCT02287584|449168579|FG004|the Open-label Phase|non-compliance|5|||
124875775|NCT02287584|449168580|FG005|the Open-label Phase|non-compliance|1|||
124875776|NCT02287584|449168575|FG000|the Open-label Phase|other reasons|0|||
124875777|NCT02287584|449168576|FG001|the Open-label Phase|other reasons|0|||
124875778|NCT02287584|449168577|FG002|the Open-label Phase|other reasons|0|||
124875779|NCT02287584|449168578|FG003|the Open-label Phase|other reasons|3|||
124875780|NCT02287584|449168579|FG004|the Open-label Phase|other reasons|6|||
124875781|NCT02287584|449168580|FG005|the Open-label Phase|other reasons|6|||
124875782|NCT02798211|449168589|FG000|Period 1|Adverse Event|1|||
124875783|NCT02798211|449168590|FG001|Period 1|Adverse Event|1|||
124875784|NCT02798211|449168591|FG002|Period 1|Adverse Event|0|||
124875785|NCT02798211|449168592|FG003|Period 1|Adverse Event|0|||
124875786|NCT02798211|449168593|FG004|Period 1|Adverse Event|0|||
124875787|NCT02798211|449168594|FG005|Period 1|Adverse Event|0|||
124875788|NCT02798211|449168589|FG000|Period 1|Lost to Follow-up|2|||
124875789|NCT02798211|449168590|FG001|Period 1|Lost to Follow-up|1|||
124875790|NCT02798211|449168591|FG002|Period 1|Lost to Follow-up|0|||
124875791|NCT02798211|449168592|FG003|Period 1|Lost to Follow-up|0|||
124875792|NCT02798211|449168593|FG004|Period 1|Lost to Follow-up|0|||
124875793|NCT02798211|449168594|FG005|Period 1|Lost to Follow-up|0|||
124875794|NCT02798211|449168589|FG000|Period 1|Protocol Violation|0|||
124875795|NCT02798211|449168590|FG001|Period 1|Protocol Violation|0|||
124875796|NCT02798211|449168591|FG002|Period 1|Protocol Violation|2|||
124875797|NCT02798211|449168592|FG003|Period 1|Protocol Violation|0|||
124875798|NCT02798211|449168593|FG004|Period 1|Protocol Violation|0|||
124875799|NCT02798211|449168594|FG005|Period 1|Protocol Violation|0|||
124875800|NCT02798211|449168589|FG000|Period 1|Withdrawal by Subject|1|||
124875801|NCT02798211|449168590|FG001|Period 1|Withdrawal by Subject|1|||
124875802|NCT02798211|449168591|FG002|Period 1|Withdrawal by Subject|0|||
124875803|NCT02798211|449168592|FG003|Period 1|Withdrawal by Subject|0|||
124875804|NCT02798211|449168593|FG004|Period 1|Withdrawal by Subject|0|||
124875805|NCT02798211|449168594|FG005|Period 1|Withdrawal by Subject|0|||
124875806|NCT02798211|449168589|FG000|Period 1|Death|0|||
124875807|NCT02798211|449168590|FG001|Period 1|Death|0|||
124875808|NCT02798211|449168591|FG002|Period 1|Death|1|||
124875809|NCT02798211|449168592|FG003|Period 1|Death|0|||
124875810|NCT02798211|449168593|FG004|Period 1|Death|0|||
124875811|NCT02798211|449168594|FG005|Period 1|Death|0|||
124875812|NCT02798211|449168589|FG000|Period 1|Withdrawal of Informed Consent|2|||
124875813|NCT02798211|449168590|FG001|Period 1|Withdrawal of Informed Consent|7|||
124875814|NCT02798211|449168591|FG002|Period 1|Withdrawal of Informed Consent|3|||
124875815|NCT02798211|449168592|FG003|Period 1|Withdrawal of Informed Consent|0|||
124875816|NCT02798211|449168593|FG004|Period 1|Withdrawal of Informed Consent|0|||
124875817|NCT02798211|449168594|FG005|Period 1|Withdrawal of Informed Consent|0|||
124875818|NCT02798211|449168589|FG000|Period 2|Withdrawal by Subject|2|||
124875819|NCT02798211|449168590|FG001|Period 2|Withdrawal by Subject|0|||
124875820|NCT02798211|449168591|FG002|Period 2|Withdrawal by Subject|0|||
124875821|NCT02798211|449168592|FG003|Period 2|Withdrawal by Subject|0|||
124875822|NCT02798211|449168593|FG004|Period 2|Withdrawal by Subject|2|||
124435481|NCT00196976|447554545|FG012|Booster Study|Lost to Follow-up|0|||
124435482|NCT00196976|447554546|FG013|Booster Study|Lost to Follow-up|0|||
124435483|NCT02689518|447554547|FG000|Overall Study|Withdrawal by Subject|3|||
124435484|NCT00825825|447554548|FG000|First Medication Period (14 Days)|Adverse Event|1|||
124435485|NCT00825825|447554549|FG001|First Medication Period (14 Days)|Adverse Event|0|||
124435486|NCT00825825|447554550|FG002|First Medication Period (14 Days)|Adverse Event|0|||
124435487|NCT00825825|447554551|FG003|First Medication Period (14 Days)|Adverse Event|0|||
124435488|NCT00825825|447554552|FG004|First Medication Period (14 Days)|Adverse Event|0|||
124435489|NCT00825825|447554553|FG005|First Medication Period (14 Days)|Adverse Event|1|||
124435490|NCT00825825|447554548|FG000|First Medication Period (14 Days)|Physician Decision|2|||
124435491|NCT00825825|447554549|FG001|First Medication Period (14 Days)|Physician Decision|0|||
124435492|NCT00825825|447554550|FG002|First Medication Period (14 Days)|Physician Decision|1|||
124435493|NCT00825825|447554551|FG003|First Medication Period (14 Days)|Physician Decision|0|||
124435494|NCT00825825|447554552|FG004|First Medication Period (14 Days)|Physician Decision|0|||
124435495|NCT00825825|447554553|FG005|First Medication Period (14 Days)|Physician Decision|1|||
124435496|NCT00825825|447554548|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
124435497|NCT00825825|447554549|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
124435498|NCT00825825|447554550|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
124435499|NCT00825825|447554551|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
124435500|NCT00825825|447554552|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
124435501|NCT00825825|447554553|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
124435502|NCT00825825|447554548|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
124435503|NCT00825825|447554549|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
124435504|NCT00825825|447554550|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
124435505|NCT00825825|447554551|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
124435506|NCT00825825|447554552|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
124435507|NCT00825825|447554553|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
124435508|NCT00825825|447554548|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
124435509|NCT00825825|447554549|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
124435510|NCT00825825|447554550|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
124435511|NCT00825825|447554551|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
124435512|NCT00825825|447554552|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
124435513|NCT00825825|447554553|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
124435514|NCT00825825|447554548|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
124435515|NCT00825825|447554549|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
124435516|NCT00825825|447554550|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
124435517|NCT00825825|447554551|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
124435518|NCT00825825|447554552|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
124435519|NCT00825825|447554553|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
124435520|NCT00825825|447554548|FG000|Third Medication Period (14 Days)|poor data quality|0|||
124435521|NCT00825825|447554549|FG001|Third Medication Period (14 Days)|poor data quality|1|||
124435522|NCT00825825|447554550|FG002|Third Medication Period (14 Days)|poor data quality|0|||
124435523|NCT00825825|447554551|FG003|Third Medication Period (14 Days)|poor data quality|0|||
124435524|NCT00825825|447554552|FG004|Third Medication Period (14 Days)|poor data quality|0|||
124435525|NCT00825825|447554553|FG005|Third Medication Period (14 Days)|poor data quality|0|||
124435526|NCT01920854|447554554|FG000|Overall Study|Withdrawal by Subject|1|||
124435527|NCT01920854|447554555|FG001|Overall Study|Withdrawal by Subject|0|||
124435528|NCT01920854|447554556|FG002|Overall Study|Withdrawal by Subject|0|||
124435529|NCT01920854|447554557|FG003|Overall Study|Withdrawal by Subject|0|||
124435530|NCT01920854|447554558|FG004|Overall Study|Withdrawal by Subject|1|||
124435531|NCT01920854|447554559|FG005|Overall Study|Withdrawal by Subject|0|||
124875823|NCT02798211|449168594|FG005|Period 2|Withdrawal by Subject|2|||
124875824|NCT02798211|449168589|FG000|Period 2|Adverse Event|5|||
124875825|NCT02798211|449168590|FG001|Period 2|Adverse Event|0|||
124435532|NCT01920854|447554560|FG006|Overall Study|Withdrawal by Subject|1|||
124435533|NCT00757783|447554561|FG000|Overall Study|Adverse Event|0|||
124435534|NCT00757783|447554562|FG001|Overall Study|Adverse Event|2|||
124435535|NCT00757783|447554561|FG000|Overall Study|Lost to Follow-up|1|||
124875826|NCT02798211|449168591|FG002|Period 2|Adverse Event|0|||
124875827|NCT02798211|449168592|FG003|Period 2|Adverse Event|0|||
124875828|NCT02798211|449168593|FG004|Period 2|Adverse Event|1|||
124875829|NCT02798211|449168594|FG005|Period 2|Adverse Event|0|||
124875830|NCT02798211|449168589|FG000|Period 2|Lack of Efficacy|1|||
124875831|NCT02798211|449168590|FG001|Period 2|Lack of Efficacy|0|||
124875832|NCT02798211|449168591|FG002|Period 2|Lack of Efficacy|0|||
124875833|NCT02798211|449168592|FG003|Period 2|Lack of Efficacy|1|||
124875834|NCT02798211|449168593|FG004|Period 2|Lack of Efficacy|0|||
124875835|NCT02798211|449168594|FG005|Period 2|Lack of Efficacy|1|||
124875836|NCT02798211|449168589|FG000|Period 2|Lost to Follow-up|3|||
124875837|NCT02798211|449168590|FG001|Period 2|Lost to Follow-up|0|||
124875838|NCT02798211|449168591|FG002|Period 2|Lost to Follow-up|0|||
124875839|NCT02798211|449168592|FG003|Period 2|Lost to Follow-up|0|||
124875840|NCT02798211|449168593|FG004|Period 2|Lost to Follow-up|2|||
124875841|NCT02798211|449168594|FG005|Period 2|Lost to Follow-up|0|||
124875842|NCT02798211|449168589|FG000|Period 2|Physician Decision|1|||
124875843|NCT02798211|449168590|FG001|Period 2|Physician Decision|0|||
124875844|NCT02798211|449168591|FG002|Period 2|Physician Decision|0|||
124875845|NCT02798211|449168592|FG003|Period 2|Physician Decision|1|||
124875846|NCT02798211|449168593|FG004|Period 2|Physician Decision|1|||
124875847|NCT02798211|449168594|FG005|Period 2|Physician Decision|0|||
124875848|NCT02798211|449168589|FG000|Period 2|Pregnancy|0|||
124875849|NCT02798211|449168590|FG001|Period 2|Pregnancy|0|||
124875850|NCT02798211|449168591|FG002|Period 2|Pregnancy|0|||
124875851|NCT02798211|449168592|FG003|Period 2|Pregnancy|2|||
124875852|NCT02798211|449168593|FG004|Period 2|Pregnancy|0|||
124875853|NCT02798211|449168594|FG005|Period 2|Pregnancy|0|||
124875854|NCT02798211|449168589|FG000|Period 2|Technical problems|1|||
124875855|NCT02798211|449168590|FG001|Period 2|Technical problems|0|||
124875856|NCT02798211|449168591|FG002|Period 2|Technical problems|0|||
124875857|NCT02798211|449168592|FG003|Period 2|Technical problems|1|||
124875858|NCT02798211|449168593|FG004|Period 2|Technical problems|0|||
124875859|NCT02798211|449168594|FG005|Period 2|Technical problems|0|||
124875860|NCT02798211|449168589|FG000|Period 2|Withdrawal of Informed Consent|1|||
124875861|NCT02798211|449168590|FG001|Period 2|Withdrawal of Informed Consent|0|||
124875862|NCT02798211|449168591|FG002|Period 2|Withdrawal of Informed Consent|0|||
124875863|NCT02798211|449168592|FG003|Period 2|Withdrawal of Informed Consent|2|||
124875864|NCT02798211|449168593|FG004|Period 2|Withdrawal of Informed Consent|2|||
124875865|NCT02798211|449168594|FG005|Period 2|Withdrawal of Informed Consent|3|||
124875866|NCT01982435|449168595|FG000|Overall Study|Adverse Event|1|||
124875867|NCT01982435|449168596|FG001|Overall Study|Adverse Event|0|||
124875868|NCT05292534|449168597|FG000|Overall Study|Protocol Violation|3|||
124875869|NCT05292534|449168598|FG001|Overall Study|Protocol Violation|4|||
124875870|NCT05292534|449168597|FG000|Overall Study|Withdrawal by Subject|0|||
124875871|NCT05292534|449168598|FG001|Overall Study|Withdrawal by Subject|1|||
124875872|NCT04887948|449168599|FG000|Overall Study|Death|1|||
124875873|NCT04887948|449168600|FG001|Overall Study|Death|0|||
124875874|NCT04887948|449168601|FG002|Overall Study|Death|0|||
124875875|NCT04887948|449168599|FG000|Overall Study|Lost to Follow-up|1|||
124875876|NCT04887948|449168600|FG001|Overall Study|Lost to Follow-up|0|||
124875877|NCT04887948|449168601|FG002|Overall Study|Lost to Follow-up|3|||
124875878|NCT04887948|449168599|FG000|Overall Study|Physician Decision|0|||
124875879|NCT04887948|449168600|FG001|Overall Study|Physician Decision|4|||
124875880|NCT04887948|449168601|FG002|Overall Study|Physician Decision|1|||
124875881|NCT04887948|449168599|FG000|Overall Study|Protocol Violation|1|||
124875882|NCT04887948|449168600|FG001|Overall Study|Protocol Violation|1|||
124875883|NCT04887948|449168601|FG002|Overall Study|Protocol Violation|0|||
124875884|NCT04887948|449168599|FG000|Overall Study|Withdrawal by Subject|0|||
124875885|NCT04887948|449168600|FG001|Overall Study|Withdrawal by Subject|6|||
124875886|NCT04887948|449168601|FG002|Overall Study|Withdrawal by Subject|1|||
124875887|NCT04887948|449168599|FG000|Overall Study|No longer met eligibility criteria|1|||
124875888|NCT04887948|449168600|FG001|Overall Study|No longer met eligibility criteria|2|||
124875889|NCT04887948|449168601|FG002|Overall Study|No longer met eligibility criteria|1|||
124875890|NCT04887948|449168599|FG000|Overall Study|Other|2|||
124875891|NCT04887948|449168600|FG001|Overall Study|Other|1|||
124875892|NCT04887948|449168601|FG002|Overall Study|Other|1|||
124875893|NCT03086018|449168603|FG000|Final Testing for End of Trial|Adverse Event|1|||
124875894|NCT03086018|449168603|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
124875895|NCT01782872|449168604|FG000|Overall Study|Protocol Violation|0|||
124875896|NCT01782872|449168605|FG001|Overall Study|Protocol Violation|0|||
124875897|NCT01782872|449168606|FG002|Overall Study|Protocol Violation|0|||
124875898|NCT01782872|449168607|FG003|Overall Study|Protocol Violation|1|||
124875899|NCT01782872|449168604|FG000|Overall Study|Withdrawal by Subject|0|||
124875900|NCT01782872|449168605|FG001|Overall Study|Withdrawal by Subject|1|||
124875901|NCT01782872|449168606|FG002|Overall Study|Withdrawal by Subject|0|||
124875902|NCT01782872|449168607|FG003|Overall Study|Withdrawal by Subject|0|||
124875903|NCT01892345|449168608|FG000|Overall Study|Adverse Event|0|||
124875904|NCT01892345|449168609|FG001|Overall Study|Adverse Event|2|||
124875905|NCT01892345|449168608|FG000|Overall Study|Death|1|||
124875906|NCT01892345|449168609|FG001|Overall Study|Death|0|||
124875907|NCT01892345|449168608|FG000|Overall Study|Lost to Follow-up|3|||
124875908|NCT01892345|449168609|FG001|Overall Study|Lost to Follow-up|0|||
124875909|NCT01892345|449168608|FG000|Overall Study|Withdrawal by Subject|12|||
124875910|NCT01892345|449168609|FG001|Overall Study|Withdrawal by Subject|1|||
124875911|NCT00638235|449168610|FG000|Overall Study|Lost to Follow-up|31|||
124875912|NCT00638235|449168611|FG001|Overall Study|Lost to Follow-up|3|||
124875913|NCT00638235|449168612|FG002|Overall Study|Lost to Follow-up|18|||
124875914|NCT00638235|449168613|FG003|Overall Study|Lost to Follow-up|10|||
124875915|NCT00638235|449168614|FG004|Overall Study|Lost to Follow-up|13|||
124875916|NCT00638235|449168615|FG005|Overall Study|Lost to Follow-up|26|||
124875917|NCT00638235|449168616|FG006|Overall Study|Lost to Follow-up|0|||
124875918|NCT00638235|449168617|FG007|Overall Study|Lost to Follow-up|1|||
124875919|NCT00638235|449168618|FG008|Overall Study|Lost to Follow-up|18|||
124875920|NCT02748694|449168619|FG000|Overall Study|Voluntary Withdrawal|0|||
124875921|NCT02748694|449168620|FG001|Overall Study|Voluntary Withdrawal|0|||
124875922|NCT02748694|449168621|FG002|Overall Study|Voluntary Withdrawal|0|||
124875923|NCT02748694|449168622|FG003|Overall Study|Voluntary Withdrawal|0|||
124875924|NCT02748694|449168623|FG004|Overall Study|Voluntary Withdrawal|0|||
124875925|NCT02748694|449168624|FG005|Overall Study|Voluntary Withdrawal|0|||
124875926|NCT02748694|449168625|FG006|Overall Study|Voluntary Withdrawal|0|||
124875927|NCT02748694|449168626|FG007|Overall Study|Voluntary Withdrawal|0|||
124875928|NCT02748694|449168627|FG008|Overall Study|Voluntary Withdrawal|0|||
124875929|NCT02748694|449168628|FG009|Overall Study|Voluntary Withdrawal|0|||
124875930|NCT02748694|449168629|FG010|Overall Study|Voluntary Withdrawal|0|||
124875931|NCT02748694|449168630|FG011|Overall Study|Voluntary Withdrawal|0|||
124875932|NCT02748694|449168631|FG012|Overall Study|Voluntary Withdrawal|0|||
124875933|NCT02748694|449168632|FG013|Overall Study|Voluntary Withdrawal|0|||
124875934|NCT02748694|449168633|FG014|Overall Study|Voluntary Withdrawal|2|||
124875935|NCT01473381|449168634|FG000|Overall Study|Adverse Event|8|||
124875936|NCT01473381|449168635|FG001|Overall Study|Adverse Event|20|||
124875937|NCT01473381|449168636|FG002|Overall Study|Adverse Event|25|||
124875938|NCT01473381|449168637|FG003|Overall Study|Adverse Event|17|||
124875939|NCT01473381|449168634|FG000|Overall Study|Insufficient Therapeutic Response|10|||
124875940|NCT01473381|449168635|FG001|Overall Study|Insufficient Therapeutic Response|1|||
124875941|NCT01473381|449168636|FG002|Overall Study|Insufficient Therapeutic Response|2|||
124875942|NCT01473381|449168637|FG003|Overall Study|Insufficient Therapeutic Response|3|||
124875943|NCT01473381|449168634|FG000|Overall Study|Protocol Violation|17|||
124875944|NCT01473381|449168635|FG001|Overall Study|Protocol Violation|23|||
124875945|NCT01473381|449168636|FG002|Overall Study|Protocol Violation|19|||
124875946|NCT01473381|449168637|FG003|Overall Study|Protocol Violation|17|||
124875947|NCT01473381|449168634|FG000|Overall Study|Withdrawal of Consent|20|||
124875948|NCT01473381|449168635|FG001|Overall Study|Withdrawal of Consent|21|||
124875949|NCT01473381|449168636|FG002|Overall Study|Withdrawal of Consent|20|||
124875950|NCT01473381|449168637|FG003|Overall Study|Withdrawal of Consent|26|||
124875951|NCT01473381|449168634|FG000|Overall Study|Lost to Follow-up|25|||
124875952|NCT01473381|449168635|FG001|Overall Study|Lost to Follow-up|28|||
124875953|NCT01473381|449168636|FG002|Overall Study|Lost to Follow-up|35|||
124875954|NCT01473381|449168637|FG003|Overall Study|Lost to Follow-up|23|||
124875955|NCT01473381|449168634|FG000|Overall Study|Other Reasons|0|||
124875956|NCT01473381|449168635|FG001|Overall Study|Other Reasons|0|||
124875957|NCT01473381|449168636|FG002|Overall Study|Other Reasons|1|||
124875958|NCT01473381|449168637|FG003|Overall Study|Other Reasons|3|||
124875959|NCT02487810|449168641|FG000|Overall Study|Withdrawal by Subject|1|||
124875960|NCT02487810|449168642|FG001|Overall Study|Withdrawal by Subject|0|||
124875961|NCT01889186|449168643|FG000|Overall Study|Adverse event- not related to progression|18|||
124875962|NCT01889186|449168644|FG001|Overall Study|Adverse event- not related to progression|5|||
124875963|NCT01889186|449168643|FG000|Overall Study|Adverse event- related to progression|7|||
124875964|NCT01889186|449168644|FG001|Overall Study|Adverse event- related to progression|2|||
124875965|NCT01889186|449168643|FG000|Overall Study|COVID-19 logistical restrictions|1|||
124435536|NCT00757783|447554562|FG001|Overall Study|Lost to Follow-up|1|||
124435537|NCT00757783|447554561|FG000|Overall Study|Protocol Violation|1|||
124435538|NCT00757783|447554562|FG001|Overall Study|Protocol Violation|0|||
124435539|NCT00757783|447554561|FG000|Overall Study|Withdrawal by Subject|2|||
124435540|NCT00757783|447554562|FG001|Overall Study|Withdrawal by Subject|1|||
124435541|NCT00757783|447554561|FG000|Overall Study|Other|1|||
124435542|NCT00757783|447554562|FG001|Overall Study|Other|2|||
124435543|NCT02054520|447554563|FG000|Overall Study|Adverse Event|1|||
124875966|NCT01889186|449168644|FG001|Overall Study|COVID-19 logistical restrictions|0|||
124875967|NCT01889186|449168643|FG000|Overall Study|Investigator request|1|||
124875968|NCT01889186|449168644|FG001|Overall Study|Investigator request|1|||
124875969|NCT01889186|449168643|FG000|Overall Study|Progressive disease- Richter's|12|||
124875970|NCT01889186|449168644|FG001|Overall Study|Progressive disease- Richter's|7|||
124435544|NCT02054520|447554564|FG001|Overall Study|Adverse Event|4|||
124875971|NCT01889186|449168643|FG000|Overall Study|Progressive disease per protocol|46|||
124875972|NCT01889186|449168644|FG001|Overall Study|Progressive disease per protocol|17|||
124875973|NCT01889186|449168643|FG000|Overall Study|Stem cell transplant|2|||
124875974|NCT01889186|449168644|FG001|Overall Study|Stem cell transplant|1|||
124875975|NCT01889186|449168643|FG000|Overall Study|Withdrew consent|2|||
124875976|NCT01889186|449168644|FG001|Overall Study|Withdrew consent|3|||
124875977|NCT01889186|449168643|FG000|Overall Study|Other, not specified|18|||
124875978|NCT01889186|449168644|FG001|Overall Study|Other, not specified|15|||
124875979|NCT02569437|449168649|FG000|Overall Study|Lost to Follow-up|12|||
124875980|NCT02569437|449168650|FG001|Overall Study|Lost to Follow-up|14|||
124875981|NCT00441701|449168651|FG000|Overall Study|Adverse Event|3|||
124875982|NCT00441701|449168652|FG001|Overall Study|Adverse Event|2|||
124875983|NCT00441701|449168653|FG002|Overall Study|Adverse Event|1|||
124875984|NCT00441701|449168654|FG003|Overall Study|Adverse Event|0|||
124875985|NCT00441701|449168655|FG004|Overall Study|Adverse Event|2|||
124875986|NCT00441701|449168656|FG005|Overall Study|Adverse Event|2|||
124875987|NCT00441701|449168657|FG006|Overall Study|Adverse Event|0|||
124435545|NCT02054520|447554565|FG002|Overall Study|Adverse Event|2|||
124435546|NCT02054520|447554566|FG003|Overall Study|Adverse Event|1|||
124435547|NCT02054520|447554567|FG004|Overall Study|Adverse Event|1|||
124435548|NCT02054520|447554568|FG005|Overall Study|Adverse Event|0|||
124435549|NCT02054520|447554563|FG000|Overall Study|Lack of Efficacy|7|||
124435550|NCT02054520|447554564|FG001|Overall Study|Lack of Efficacy|0|||
124435551|NCT02054520|447554565|FG002|Overall Study|Lack of Efficacy|2|||
124435552|NCT02054520|447554566|FG003|Overall Study|Lack of Efficacy|1|||
124678469|NCT04142242|448448108|FG000|Stage II|Non-compliance with the protocol|0|||
124678470|NCT04142242|448448109|FG001|Stage II|Non-compliance with the protocol|0|||
124678471|NCT04142242|448448110|FG002|Stage II|Non-compliance with the protocol|0|||
124678472|NCT04142242|448448111|FG003|Stage II|Non-compliance with the protocol|2|||
124678473|NCT04142242|448448112|FG004|Stage II|Non-compliance with the protocol|0|||
124678474|NCT04142242|448448113|FG005|Stage II|Non-compliance with the protocol|0|||
124678475|NCT04142242|448448108|FG000|Stage II|Lost to Follow-up|0|||
124678476|NCT04142242|448448109|FG001|Stage II|Lost to Follow-up|0|||
124678477|NCT04142242|448448110|FG002|Stage II|Lost to Follow-up|1|||
124678478|NCT04142242|448448111|FG003|Stage II|Lost to Follow-up|2|||
124678479|NCT04142242|448448112|FG004|Stage II|Lost to Follow-up|0|||
124435553|NCT02054520|447554567|FG004|Overall Study|Lack of Efficacy|3|||
124435554|NCT02054520|447554568|FG005|Overall Study|Lack of Efficacy|2|||
124435555|NCT02054520|447554563|FG000|Overall Study|Withdrawal by Subject|1|||
124435556|NCT02054520|447554564|FG001|Overall Study|Withdrawal by Subject|0|||
124435557|NCT02054520|447554565|FG002|Overall Study|Withdrawal by Subject|0|||
124435558|NCT02054520|447554566|FG003|Overall Study|Withdrawal by Subject|2|||
124435559|NCT02054520|447554567|FG004|Overall Study|Withdrawal by Subject|1|||
124435560|NCT02054520|447554568|FG005|Overall Study|Withdrawal by Subject|0|||
124435561|NCT02054520|447554563|FG000|Overall Study|Physician Decision|0|||
124435562|NCT02054520|447554564|FG001|Overall Study|Physician Decision|1|||
124435563|NCT02054520|447554565|FG002|Overall Study|Physician Decision|0|||
124435564|NCT02054520|447554566|FG003|Overall Study|Physician Decision|1|||
124435565|NCT02054520|447554567|FG004|Overall Study|Physician Decision|0|||
124678480|NCT04142242|448448113|FG005|Stage II|Lost to Follow-up|0|||
124678481|NCT04142242|448448108|FG000|Stage II|Withdrawal by Subject|0|||
124678482|NCT04142242|448448109|FG001|Stage II|Withdrawal by Subject|0|||
124678483|NCT04142242|448448110|FG002|Stage II|Withdrawal by Subject|5|||
124678484|NCT04142242|448448111|FG003|Stage II|Withdrawal by Subject|9|||
124678485|NCT04142242|448448112|FG004|Stage II|Withdrawal by Subject|0|||
124678486|NCT04142242|448448113|FG005|Stage II|Withdrawal by Subject|0|||
124678487|NCT05219162|448448114|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
124678488|NCT05219162|448448114|FG000|Overall Study|Withdrawal by Subject|23|||
124678489|NCT04609514|448448117|FG000|Overall Study|Lost to Follow-up|5|||
124678490|NCT04609514|448448118|FG001|Overall Study|Lost to Follow-up|4|||
124678491|NCT04609514|448448117|FG000|Overall Study|Withdrawal by PI|0|||
124678492|NCT04609514|448448118|FG001|Overall Study|Withdrawal by PI|2|||
124678493|NCT00909870|448448119|FG000|Overall Study|Adverse Event|13|||
124678494|NCT00909870|448448120|FG001|Overall Study|Adverse Event|7|||
124678495|NCT00909870|448448119|FG000|Overall Study|Protocol Violation|1|||
124678496|NCT00909870|448448120|FG001|Overall Study|Protocol Violation|2|||
124875988|NCT00441701|449168658|FG007|Overall Study|Adverse Event|0|||
124875989|NCT00441701|449168659|FG008|Overall Study|Adverse Event|0|||
124875990|NCT00441701|449168660|FG009|Overall Study|Adverse Event|0|||
124875991|NCT00441701|449168651|FG000|Overall Study|Lack of Efficacy|2|||
124435566|NCT02054520|447554568|FG005|Overall Study|Physician Decision|1|||
124678497|NCT00909870|448448119|FG000|Overall Study|Withdrawal by Subject|5|||
124678498|NCT00909870|448448120|FG001|Overall Study|Withdrawal by Subject|8|||
124678499|NCT00909870|448448119|FG000|Overall Study|Lost to Follow-up|3|||
124435567|NCT02054520|447554563|FG000|Overall Study|Study terminated by Sponsor|0|||
124678500|NCT00909870|448448120|FG001|Overall Study|Lost to Follow-up|3|||
124678501|NCT00909870|448448119|FG000|Overall Study|Physician Decision|0|||
124875992|NCT00441701|449168652|FG001|Overall Study|Lack of Efficacy|0|||
124678502|NCT00909870|448448120|FG001|Overall Study|Physician Decision|2|||
124678503|NCT00909870|448448119|FG000|Overall Study|Other|1|||
124678504|NCT00909870|448448120|FG001|Overall Study|Other|5|||
124678505|NCT02792504|448448123|FG000|Overall Study|Lost to Follow-up|24|||
124875993|NCT00441701|449168653|FG002|Overall Study|Lack of Efficacy|2|||
124875994|NCT00441701|449168654|FG003|Overall Study|Lack of Efficacy|2|||
124875995|NCT00441701|449168655|FG004|Overall Study|Lack of Efficacy|0|||
124875996|NCT00441701|449168656|FG005|Overall Study|Lack of Efficacy|1|||
124875997|NCT00441701|449168657|FG006|Overall Study|Lack of Efficacy|0|||
124875998|NCT00441701|449168658|FG007|Overall Study|Lack of Efficacy|0|||
124875999|NCT00441701|449168659|FG008|Overall Study|Lack of Efficacy|0|||
124876000|NCT00441701|449168660|FG009|Overall Study|Lack of Efficacy|0|||
124876001|NCT00441701|449168651|FG000|Overall Study|Withdrawal by Subject|0|||
124876002|NCT00441701|449168652|FG001|Overall Study|Withdrawal by Subject|2|||
124876003|NCT00441701|449168653|FG002|Overall Study|Withdrawal by Subject|1|||
124876004|NCT00441701|449168654|FG003|Overall Study|Withdrawal by Subject|1|||
124876005|NCT00441701|449168655|FG004|Overall Study|Withdrawal by Subject|0|||
124876006|NCT00441701|449168656|FG005|Overall Study|Withdrawal by Subject|0|||
124876007|NCT00441701|449168657|FG006|Overall Study|Withdrawal by Subject|0|||
124876008|NCT00441701|449168658|FG007|Overall Study|Withdrawal by Subject|0|||
124876009|NCT00441701|449168659|FG008|Overall Study|Withdrawal by Subject|0|||
124876010|NCT00441701|449168660|FG009|Overall Study|Withdrawal by Subject|0|||
124876011|NCT00077064|449168661|FG000|Overall Study|Adverse Event|0|||
124876012|NCT00077064|449168662|FG001|Overall Study|Adverse Event|4|||
124876013|NCT00077064|449168661|FG000|Overall Study|Patient refusal|0|||
124876014|NCT00077064|449168662|FG001|Overall Study|Patient refusal|2|||
124876015|NCT04710927|449168666|FG000|Overall Study|Lost to Follow-up|7|||
124876016|NCT04710927|449168667|FG001|Overall Study|Lost to Follow-up|6|||
124876017|NCT04710927|449168668|FG002|Overall Study|Lost to Follow-up|5|||
124876018|NCT02007434|449168671|FG000|Overall Study|Lost to Follow-up|0|||
124876019|NCT02007434|449168672|FG001|Overall Study|Lost to Follow-up|1|||
124876020|NCT02007434|449168673|FG002|Overall Study|Lost to Follow-up|0|||
124876021|NCT02007434|449168674|FG003|Overall Study|Lost to Follow-up|0|||
124876022|NCT02007434|449168675|FG004|Overall Study|Lost to Follow-up|0|||
124876023|NCT02007434|449168676|FG005|Overall Study|Lost to Follow-up|0|||
124876024|NCT02007434|449168677|FG006|Overall Study|Lost to Follow-up|0|||
124876025|NCT02007434|449168678|FG007|Overall Study|Lost to Follow-up|0|||
124876026|NCT02007434|449168671|FG000|Overall Study|Non-compliance|1|||
124876027|NCT02007434|449168672|FG001|Overall Study|Non-compliance|0|||
124876028|NCT02007434|449168673|FG002|Overall Study|Non-compliance|1|||
124876029|NCT02007434|449168674|FG003|Overall Study|Non-compliance|0|||
124876030|NCT02007434|449168675|FG004|Overall Study|Non-compliance|0|||
124876031|NCT02007434|449168676|FG005|Overall Study|Non-compliance|0|||
124876032|NCT02007434|449168677|FG006|Overall Study|Non-compliance|0|||
124876033|NCT02007434|449168678|FG007|Overall Study|Non-compliance|0|||
124876034|NCT01287611|449168679|FG000|Overall Study|Lost to Follow-up|29|||
124876035|NCT01287611|449168680|FG001|Overall Study|Lost to Follow-up|16|||
124876036|NCT01287611|449168679|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
124876037|NCT01287611|449168680|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
124435568|NCT02054520|447554564|FG001|Overall Study|Study terminated by Sponsor|0|||
124435569|NCT02054520|447554565|FG002|Overall Study|Study terminated by Sponsor|2|||
124435570|NCT02054520|447554566|FG003|Overall Study|Study terminated by Sponsor|1|||
124435571|NCT02054520|447554567|FG004|Overall Study|Study terminated by Sponsor|0|||
124435572|NCT02054520|447554568|FG005|Overall Study|Study terminated by Sponsor|0|||
124435573|NCT02372136|447554573|FG000|Overall Study|Death|3|||
124435574|NCT02372136|447554574|FG001|Overall Study|Death|1|||
124435575|NCT00985946|447554575|FG000|Overall Study|Lost to Follow-up|6|||
124435576|NCT00985946|447554575|FG000|Overall Study|Withdrawal by Subject|1|||
124435577|NCT02471833|447554576|FG000|Overall Study|Lost to Follow-up|1|||
124435578|NCT02471833|447554577|FG001|Overall Study|Lost to Follow-up|0|||
124435579|NCT02471833|447554578|FG002|Overall Study|Lost to Follow-up|0|||
124435580|NCT02471833|447554576|FG000|Overall Study|Withdrawal by Subject|2|||
124435581|NCT02471833|447554577|FG001|Overall Study|Withdrawal by Subject|1|||
124435582|NCT02471833|447554578|FG002|Overall Study|Withdrawal by Subject|5|||
124876038|NCT02192970|449168683|FG000|Overall Study|Lost to Follow-up|6|||
124876039|NCT02192970|449168684|FG001|Overall Study|Lost to Follow-up|0|||
124876040|NCT03299686|449168697|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
124876041|NCT03299686|449168698|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
124876042|NCT03299686|449168697|FG000|Treatment Epoch|Physician Decision|1|||
124876043|NCT03299686|449168698|FG001|Treatment Epoch|Physician Decision|0|||
124876044|NCT03299686|449168697|FG000|Treatment Epoch|Adverse Event|8|||
124435583|NCT00112047|447554581|FG000|Randomized Phase|Lost to Follow-up|26|||
124435584|NCT00112047|447554582|FG001|Randomized Phase|Lost to Follow-up|33|||
124876045|NCT03299686|449168698|FG001|Treatment Epoch|Adverse Event|4|||
124876046|NCT03299686|449168697|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
124876047|NCT03299686|449168698|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
124435585|NCT00112047|447554581|FG000|Randomized Phase|Adverse Event|10|||
124435586|NCT00112047|447554582|FG001|Randomized Phase|Adverse Event|10|||
124876048|NCT03745222|449168699|FG000|Overall Study|Withdrawal by Subject|0|||
124876049|NCT03745222|449168700|FG001|Overall Study|Withdrawal by Subject|1|||
124876050|NCT03745222|449168701|FG002|Overall Study|Withdrawal by Subject|0|||
124876051|NCT01959347|449168702|FG000|Overall Study|Protocol Violation|9|||
124876052|NCT01959347|449168703|FG001|Overall Study|Protocol Violation|7|||
124876053|NCT03954743|449168704|FG000|Overall Study|Adverse Event|1|||
124876054|NCT03954743|449168705|FG001|Overall Study|Adverse Event|0|||
124876055|NCT03954743|449168704|FG000|Overall Study|Lost to Follow-up|6|||
124876056|NCT03954743|449168705|FG001|Overall Study|Lost to Follow-up|4|||
124876057|NCT03954743|449168704|FG000|Overall Study|Protocol Violation|1|||
124876058|NCT03954743|449168705|FG001|Overall Study|Protocol Violation|0|||
124876059|NCT03954743|449168704|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
124876060|NCT03954743|449168705|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
124876061|NCT03954743|449168704|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
124876062|NCT03954743|449168705|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124876063|NCT00860067|449168708|FG000|Overall Study|Lost to Follow-up|46|||
124876064|NCT00860067|449168709|FG001|Overall Study|Lost to Follow-up|9|||
124876065|NCT00860067|449168710|FG002|Overall Study|Lost to Follow-up|9|||
124876066|NCT00860067|449168708|FG000|Overall Study|Withdrawal by Subject|4|||
124876067|NCT00860067|449168709|FG001|Overall Study|Withdrawal by Subject|0|||
124876068|NCT00860067|449168710|FG002|Overall Study|Withdrawal by Subject|0|||
124876069|NCT00860067|449168708|FG000|Overall Study|Pregnancy|1|||
124876070|NCT00860067|449168709|FG001|Overall Study|Pregnancy|0|||
124876071|NCT00860067|449168710|FG002|Overall Study|Pregnancy|0|||
124876072|NCT01282801|449168711|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
124876073|NCT01282801|449168712|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
124876074|NCT02387996|449168715|FG000|Overall Study|Disease Progression|167|||
124876075|NCT02387996|449168715|FG000|Overall Study|Study Drug Toxicity|31|||
124876076|NCT02387996|449168715|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
124876077|NCT02387996|449168715|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
124876078|NCT02387996|449168715|FG000|Overall Study|Subject Withdrew Consent|5|||
124876079|NCT02387996|449168715|FG000|Overall Study|Lost to Follow-up|1|||
124876080|NCT02387996|449168715|FG000|Overall Study|Poor/Non-Compliance|1|||
124876081|NCT02387996|449168715|FG000|Overall Study|Other Reasons|5|||
124876082|NCT02387996|449168715|FG000|Overall Study|Death|1|||
124876083|NCT01060553|449168716|FG000|Overall Study|Lost to Follow-up|3|||
124876084|NCT01060553|449168717|FG001|Overall Study|Lost to Follow-up|5|||
124876085|NCT01060553|449168716|FG000|Overall Study|Withdrawal by Subject|5|||
124876086|NCT01060553|449168717|FG001|Overall Study|Withdrawal by Subject|5|||
124876087|NCT01060553|449168716|FG000|Overall Study|Lack of Efficacy|1|||
124876088|NCT01060553|449168717|FG001|Overall Study|Lack of Efficacy|0|||
124876089|NCT04707196|449168720|FG000|Overall Study|Withdrawal by Subject|9|||
124876090|NCT04707196|449168721|FG001|Overall Study|Withdrawal by Subject|6|||
124876091|NCT04707196|449168720|FG000|Overall Study|Lost to Follow-up|1|||
124876092|NCT04707196|449168721|FG001|Overall Study|Lost to Follow-up|0|||
124876093|NCT04707196|449168720|FG000|Overall Study|Protocol Violation|4|||
124876094|NCT04707196|449168721|FG001|Overall Study|Protocol Violation|1|||
124876095|NCT04707196|449168720|FG000|Overall Study|Adverse Event|2|||
124876096|NCT04707196|449168721|FG001|Overall Study|Adverse Event|2|||
124876097|NCT04707196|449168720|FG000|Overall Study|Death|3|||
124876098|NCT04707196|449168721|FG001|Overall Study|Death|1|||
124876099|NCT04707196|449168720|FG000|Overall Study|Non-compliance with study drug|1|||
124876100|NCT04707196|449168721|FG001|Overall Study|Non-compliance with study drug|0|||
124876101|NCT04707196|449168720|FG000|Overall Study|Progressive disease|9|||
124876102|NCT04707196|449168721|FG001|Overall Study|Progressive disease|10|||
124876103|NCT01862796|449168722|FG000|Overall Study|Prohibited medications|0|||
124876104|NCT01862796|449168723|FG001|Overall Study|Prohibited medications|0|||
124876105|NCT01862796|449168724|FG002|Overall Study|Prohibited medications|1|||
124876106|NCT05375955|449168742|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
124876107|NCT05375955|449168743|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
124876108|NCT05375955|449168744|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
124876109|NCT05375955|449168745|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
124876110|NCT05375955|449168746|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
124876111|NCT05375955|449168747|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
124876112|NCT05375955|449168748|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
124876113|NCT05375955|449168742|FG000|Treatment (12 Weeks)|Physician Decision|4|||
124876114|NCT05375955|449168743|FG001|Treatment (12 Weeks)|Physician Decision|1|||
124876115|NCT05375955|449168744|FG002|Treatment (12 Weeks)|Physician Decision|3|||
124876116|NCT05375955|449168745|FG003|Treatment (12 Weeks)|Physician Decision|0|||
124876117|NCT05375955|449168746|FG004|Treatment (12 Weeks)|Physician Decision|0|||
124876118|NCT05375955|449168747|FG005|Treatment (12 Weeks)|Physician Decision|1|||
124876119|NCT05375955|449168748|FG006|Treatment (12 Weeks)|Physician Decision|0|||
124876120|NCT05375955|449168742|FG000|Treatment (12 Weeks)|Other|0|||
124876121|NCT05375955|449168743|FG001|Treatment (12 Weeks)|Other|1|||
124876122|NCT05375955|449168744|FG002|Treatment (12 Weeks)|Other|0|||
124876123|NCT05375955|449168745|FG003|Treatment (12 Weeks)|Other|0|||
124876124|NCT05375955|449168746|FG004|Treatment (12 Weeks)|Other|0|||
124876125|NCT05375955|449168747|FG005|Treatment (12 Weeks)|Other|0|||
124876126|NCT05375955|449168748|FG006|Treatment (12 Weeks)|Other|0|||
124876127|NCT05375955|449168742|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
124876128|NCT05375955|449168743|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
124876129|NCT05375955|449168744|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
124876130|NCT05375955|449168745|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
124876131|NCT05375955|449168746|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
124876132|NCT05375955|449168747|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
124876133|NCT05375955|449168748|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
124876134|NCT05375955|449168742|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
124876135|NCT05375955|449168743|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
124876136|NCT05375955|449168744|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
124876137|NCT05375955|449168745|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
124876138|NCT05375955|449168746|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
124876139|NCT05375955|449168747|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
124876140|NCT05375955|449168748|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
124876141|NCT05375955|449168742|FG000|Treatment (12 Weeks)|Pregnancy|0|||
124876142|NCT05375955|449168743|FG001|Treatment (12 Weeks)|Pregnancy|0|||
124876143|NCT05375955|449168744|FG002|Treatment (12 Weeks)|Pregnancy|1|||
124876144|NCT05375955|449168745|FG003|Treatment (12 Weeks)|Pregnancy|0|||
124876145|NCT05375955|449168746|FG004|Treatment (12 Weeks)|Pregnancy|0|||
124876146|NCT05375955|449168747|FG005|Treatment (12 Weeks)|Pregnancy|0|||
124876147|NCT05375955|449168748|FG006|Treatment (12 Weeks)|Pregnancy|0|||
124876148|NCT05375955|449168742|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
124876149|NCT05375955|449168743|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
124876150|NCT05375955|449168744|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
124876151|NCT05375955|449168745|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
124876152|NCT05375955|449168746|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
124876153|NCT05375955|449168747|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
124876154|NCT05375955|449168748|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
124876155|NCT05375955|449168742|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
124876156|NCT05375955|449168743|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
124876157|NCT05375955|449168744|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
124876158|NCT05375955|449168745|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
124876159|NCT05375955|449168746|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
124876160|NCT05375955|449168747|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
124876161|NCT05375955|449168748|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
124876162|NCT05375955|449168742|FG000|Follow-up (up to 5 Weeks)|Other|0|||
124876163|NCT05375955|449168743|FG001|Follow-up (up to 5 Weeks)|Other|1|||
124876164|NCT05375955|449168744|FG002|Follow-up (up to 5 Weeks)|Other|0|||
124876165|NCT05375955|449168745|FG003|Follow-up (up to 5 Weeks)|Other|0|||
124876166|NCT05375955|449168746|FG004|Follow-up (up to 5 Weeks)|Other|0|||
124876167|NCT05375955|449168747|FG005|Follow-up (up to 5 Weeks)|Other|0|||
124876168|NCT05375955|449168748|FG006|Follow-up (up to 5 Weeks)|Other|0|||
124876169|NCT05375955|449168742|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
124876170|NCT05375955|449168743|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
124876171|NCT05375955|449168744|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
124876172|NCT05375955|449168745|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
124876173|NCT05375955|449168746|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
124876174|NCT05375955|449168747|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
124876175|NCT05375955|449168748|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
124876176|NCT05375955|449168742|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
124876177|NCT05375955|449168743|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
124876178|NCT05375955|449168744|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
124876179|NCT05375955|449168745|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
124435587|NCT00112047|447554581|FG000|Randomized Phase|Withrawal of consent|10|||
124876180|NCT05375955|449168746|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
124876181|NCT05375955|449168747|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
124876182|NCT05375955|449168748|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
124876183|NCT01320943|449168749|FG000|Overall Study|Lost to Follow-up|1|||
124876184|NCT01320943|449168750|FG001|Overall Study|Lost to Follow-up|0|||
124876185|NCT01320943|449168749|FG000|Overall Study|Physician Decision|0|||
124876186|NCT01320943|449168750|FG001|Overall Study|Physician Decision|1|||
124876187|NCT01320943|449168749|FG000|Overall Study|Randomized but not Treated|0|||
124876188|NCT01320943|449168750|FG001|Overall Study|Randomized but not Treated|1|||
124876189|NCT00733980|449168751|FG000|Overall Study|Adverse Event|5|||
124876190|NCT00733980|449168752|FG001|Overall Study|Adverse Event|2|||
124435588|NCT00112047|447554582|FG001|Randomized Phase|Withrawal of consent|18|||
124435589|NCT00112047|447554581|FG000|Randomized Phase|Sub-optimal virological response|3|||
124435590|NCT00112047|447554582|FG001|Randomized Phase|Sub-optimal virological response|13|||
124435591|NCT00112047|447554581|FG000|Randomized Phase|Noncompliance|8|||
124435592|NCT00112047|447554582|FG001|Randomized Phase|Noncompliance|4|||
124435593|NCT00112047|447554581|FG000|Randomized Phase|Protocol Violation|2|||
124435594|NCT00112047|447554582|FG001|Randomized Phase|Protocol Violation|0|||
124435595|NCT00112047|447554581|FG000|Randomized Phase|Pregnancy|3|||
124435596|NCT00112047|447554582|FG001|Randomized Phase|Pregnancy|1|||
124435597|NCT00112047|447554581|FG000|Randomized Phase|Death|1|||
124435598|NCT00112047|447554582|FG001|Randomized Phase|Death|3|||
124435599|NCT00112047|447554581|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
124435600|NCT00112047|447554582|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
124435601|NCT00112047|447554581|FG000|Randomized Phase|Inability to swallow pills|0|||
124435602|NCT00112047|447554582|FG001|Randomized Phase|Inability to swallow pills|1|||
124678506|NCT02792504|448448123|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
124678507|NCT00848497|448448124|FG000|Overall Study|Screen failure|2|||
124678508|NCT00848497|448448125|FG001|Overall Study|Screen failure|0|||
124678509|NCT00848497|448448124|FG000|Overall Study|Withdrawal by Subject|0|||
124678510|NCT00848497|448448125|FG001|Overall Study|Withdrawal by Subject|1|||
124678511|NCT01114724|448448126|FG000|Overall Study|Death|8|||
124678512|NCT01114724|448448126|FG000|Overall Study|Lost to Follow-up|1|||
124678513|NCT01114724|448448126|FG000|Overall Study|Withdrawal by Subject|1|||
124678514|NCT02966834|448448130|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
124678515|NCT02966834|448448131|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
124678516|NCT02966834|448448132|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
124678517|NCT02966834|448448133|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
124678518|NCT02966834|448448134|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
124678519|NCT02966834|448448135|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
124678520|NCT02966834|448448130|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
124678521|NCT02966834|448448131|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
124678522|NCT02966834|448448132|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
124678523|NCT02966834|448448133|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
124678524|NCT02966834|448448134|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
124678525|NCT02966834|448448135|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
124678526|NCT02966834|448448130|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
124678527|NCT02966834|448448131|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
124678528|NCT02966834|448448132|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
124678529|NCT02966834|448448133|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
124678530|NCT02966834|448448134|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
124678531|NCT02966834|448448135|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
124678532|NCT02966834|448448130|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
124678533|NCT02966834|448448131|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
124678534|NCT02966834|448448132|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
124678535|NCT02966834|448448133|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
124678536|NCT02966834|448448134|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
124678537|NCT02966834|448448135|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
124678538|NCT02966834|448448130|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
124678539|NCT02966834|448448131|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
124876191|NCT00733980|449168751|FG000|Overall Study|Lack of Efficacy|0|||
124876192|NCT00733980|449168752|FG001|Overall Study|Lack of Efficacy|1|||
124435603|NCT00112047|447554581|FG000|Randomized Phase|Incarceration|3|||
124435604|NCT00112047|447554582|FG001|Randomized Phase|Incarceration|2|||
124435605|NCT00112047|447554581|FG000|Randomized Phase|Moved out of State|0|||
124435606|NCT00112047|447554582|FG001|Randomized Phase|Moved out of State|1|||
124435607|NCT00112047|447554581|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
124435608|NCT00112047|447554582|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
124435609|NCT00112047|447554581|FG000|Randomized Phase|High Hepatitis B DNA|0|||
124435610|NCT00112047|447554582|FG001|Randomized Phase|High Hepatitis B DNA|1|||
124435611|NCT00112047|447554581|FG000|Atripla Phase|Adverse Event|2|||
124435612|NCT00112047|447554582|FG001|Atripla Phase|Adverse Event|1|||
124435613|NCT00112047|447554581|FG000|Atripla Phase|Lost to Follow-up|5|||
124678540|NCT02966834|448448132|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
124678541|NCT02966834|448448133|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
124678542|NCT02966834|448448134|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
124678543|NCT02966834|448448135|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
124678544|NCT02966834|448448130|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
124678545|NCT02966834|448448131|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
124678546|NCT02966834|448448132|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
124435614|NCT00112047|447554582|FG001|Atripla Phase|Lost to Follow-up|7|||
124435615|NCT00112047|447554581|FG000|Atripla Phase|Pregnancy|0|||
124435616|NCT00112047|447554582|FG001|Atripla Phase|Pregnancy|1|||
124876193|NCT00733980|449168751|FG000|Overall Study|Protocol Violation|2|||
124876194|NCT00733980|449168752|FG001|Overall Study|Protocol Violation|1|||
124876195|NCT00733980|449168751|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
124876196|NCT00733980|449168752|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
124876197|NCT00733980|449168751|FG000|Overall Study|Lost to Follow-up|6|||
124876198|NCT00733980|449168752|FG001|Overall Study|Lost to Follow-up|11|||
124876199|NCT00733980|449168751|FG000|Overall Study|Physician Decision|2|||
124876200|NCT00733980|449168752|FG001|Overall Study|Physician Decision|3|||
124876201|NCT00733980|449168751|FG000|Overall Study|Withdrawal by Subject|6|||
124876202|NCT00733980|449168752|FG001|Overall Study|Withdrawal by Subject|2|||
124876203|NCT00779779|449168753|FG000|Overall Study|Adverse Event|1|||
124876204|NCT00779779|449168753|FG000|Overall Study|Protocol Violation|14|||
124876205|NCT00779779|449168753|FG000|Overall Study|Withdrawal by Subject|4|||
124876206|NCT00779779|449168753|FG000|Overall Study|Lost to Follow-up|5|||
124876207|NCT00404495|449168754|FG000|Overall Study|Death|37|||
124876208|NCT00404495|449168755|FG001|Overall Study|Death|11|||
124876209|NCT00404495|449168754|FG000|Overall Study|Lost to Follow-up|5|||
124876210|NCT00404495|449168755|FG001|Overall Study|Lost to Follow-up|0|||
124876211|NCT00404495|449168754|FG000|Overall Study|Other|1|||
124435617|NCT00112047|447554581|FG000|Atripla Phase|Death|0|||
124435618|NCT00112047|447554582|FG001|Atripla Phase|Death|2|||
124435619|NCT00112047|447554581|FG000|Atripla Phase|Withdrew consent|7|||
124435620|NCT00112047|447554582|FG001|Atripla Phase|Withdrew consent|7|||
124435621|NCT00112047|447554581|FG000|Atripla Phase|Sub-optimal virological response|0|||
124435622|NCT00112047|447554582|FG001|Atripla Phase|Sub-optimal virological response|1|||
124435623|NCT00112047|447554581|FG000|Atripla Phase|Non-compliance|1|||
124435624|NCT00112047|447554582|FG001|Atripla Phase|Non-compliance|0|||
124435625|NCT00112047|447554581|FG000|Atripla Phase|Other|3|||
124435626|NCT00112047|447554582|FG001|Atripla Phase|Other|1|||
124435627|NCT01307579|447554583|FG000|Overall Study|Death|3|||
124435628|NCT01307579|447554584|FG001|Overall Study|Death|6|||
124435629|NCT01307579|447554583|FG000|Overall Study|Physician Decision|26|||
124435630|NCT01307579|447554584|FG001|Overall Study|Physician Decision|29|||
124435631|NCT01307579|447554583|FG000|Overall Study|Withdrawal by Subject|7|||
124435632|NCT01307579|447554584|FG001|Overall Study|Withdrawal by Subject|3|||
124435633|NCT01307579|447554583|FG000|Overall Study|Institutional diagnosis of IFD|21|||
124435634|NCT01307579|447554584|FG001|Overall Study|Institutional diagnosis of IFD|36|||
124435635|NCT01307579|447554583|FG000|Overall Study|Begin conditioning for HSCT|42|||
124435636|NCT01307579|447554584|FG001|Overall Study|Begin conditioning for HSCT|44|||
124435637|NCT01307579|447554583|FG000|Overall Study|Refractory or relapsed AML|38|||
124435638|NCT01307579|447554584|FG001|Overall Study|Refractory or relapsed AML|23|||
124435639|NCT01307579|447554583|FG000|Overall Study|Ineligible|3|||
124435640|NCT01307579|447554584|FG001|Overall Study|Ineligible|4|||
124435641|NCT00812331|447556579|FG000|Overall Study|Adverse Event|1|||
124435642|NCT00812331|447556580|FG001|Overall Study|Adverse Event|0|||
124435643|NCT00812331|447556581|FG002|Overall Study|Adverse Event|0|||
124435644|NCT00812331|447556582|FG003|Overall Study|Adverse Event|0|||
124435645|NCT00812331|447556583|FG004|Overall Study|Adverse Event|0|||
124435646|NCT01506453|447556584|FG000|Overall Study|Withdrawal prior to treatment|0|||
124435647|NCT01506453|447556585|FG001|Overall Study|Withdrawal prior to treatment|2|||
124435648|NCT00055601|447556593|FG000|Overall Study|Protocol Violation|1|||
124435649|NCT00055601|447556594|FG001|Overall Study|Protocol Violation|1|||
124876212|NCT00404495|449168755|FG001|Overall Study|Other|0|||
124435650|NCT00055601|447556593|FG000|Overall Study|No protocol treatment received|1|||
124435651|NCT00055601|447556594|FG001|Overall Study|No protocol treatment received|1|||
124435652|NCT00117845|447556595|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
124876213|NCT00404495|449168754|FG000|Overall Study|Withdrawal by Subject|1|||
124435653|NCT00910689|447556596|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
124435654|NCT00910689|447556597|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
124435655|NCT00910689|447556598|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
124876214|NCT00404495|449168755|FG001|Overall Study|Withdrawal by Subject|0|||
124876215|NCT01493960|449170583|FG000|Overall Study|Adverse Event|0|||
124876216|NCT01493960|449170584|FG001|Overall Study|Adverse Event|1|||
124435656|NCT00910689|447556599|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
124435657|NCT00910689|447556596|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
124876217|NCT01493960|449170583|FG000|Overall Study|Lack of Efficacy|15|||
124876218|NCT01493960|449170584|FG001|Overall Study|Lack of Efficacy|9|||
124876219|NCT01493960|449170583|FG000|Overall Study|Protocol Violation|3|||
124876220|NCT01493960|449170584|FG001|Overall Study|Protocol Violation|0|||
124876221|NCT01493960|449170583|FG000|Overall Study|Withdrawal by Subject|10|||
124876222|NCT01493960|449170584|FG001|Overall Study|Withdrawal by Subject|4|||
124876223|NCT01493960|449170583|FG000|Overall Study|Non-specified|4|||
124876224|NCT01493960|449170584|FG001|Overall Study|Non-specified|4|||
124876225|NCT00975221|449170589|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
124876226|NCT00975221|449170590|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
124876227|NCT00975221|449170589|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
124876228|NCT00975221|449170590|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
124876229|NCT00975221|449170589|FG000|Titration Phase (Weeks 1-12)|Other|0|||
124876230|NCT00975221|449170590|FG001|Titration Phase (Weeks 1-12)|Other|1|||
124876231|NCT00975221|449170589|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
124876232|NCT00975221|449170590|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
124876233|NCT00975221|449170589|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
124876234|NCT00975221|449170590|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
124876235|NCT00975221|449170589|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
124876236|NCT00975221|449170590|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
124876237|NCT03935217|449170593|FG000|Overall Study|Adverse Event|1|||
124876238|NCT03935217|449170594|FG001|Overall Study|Adverse Event|0|||
124876239|NCT03935217|449170593|FG000|Overall Study|Lost to Follow-up|0|||
124876240|NCT03935217|449170594|FG001|Overall Study|Lost to Follow-up|1|||
124876241|NCT03935217|449170593|FG000|Overall Study|Withdrawal by Subject|0|||
124876242|NCT03935217|449170594|FG001|Overall Study|Withdrawal by Subject|2|||
124876243|NCT03559218|449170595|FG000|Overall Study|Withdrawal by Subject|1|||
124876244|NCT03559218|449170596|FG001|Overall Study|Withdrawal by Subject|0|||
124876245|NCT02790073|449170598|FG000|Overall Study|Death|1|||
124876246|NCT02790073|449170598|FG000|Overall Study|Withdrawal from HD|1|||
124876247|NCT02790073|449170598|FG000|Overall Study|Withdrawal by Subject|1|||
124876248|NCT02487498|449170602|FG000|Period: Period 1|Adverse Event|2|||
124876249|NCT02487498|449170603|FG001|Period: Period 1|Adverse Event|4|||
124876250|NCT02487498|449170602|FG000|Period: Period 1|Subject/guardian decision|2|||
124876251|NCT02487498|449170603|FG001|Period: Period 1|Subject/guardian decision|4|||
124876252|NCT02487498|449170602|FG000|Period: Period 1|Lost to Follow-up|0|||
124876253|NCT02487498|449170603|FG001|Period: Period 1|Lost to Follow-up|2|||
124876254|NCT02487498|449170602|FG000|Period: Period 1|Lack of Efficacy|1|||
124876255|NCT02487498|449170603|FG001|Period: Period 1|Lack of Efficacy|0|||
124876256|NCT02487498|449170602|FG000|Period: Period 1|Physician Decision|0|||
124876257|NCT02487498|449170603|FG001|Period: Period 1|Physician Decision|1|||
124876258|NCT02487498|449170602|FG000|Period: Period 1|Protocol deviation|1|||
124876259|NCT02487498|449170603|FG001|Period: Period 1|Protocol deviation|0|||
124876260|NCT02487498|449170602|FG000|Period: Washout|Subject/guardian decision|0|||
124876261|NCT02487498|449170603|FG001|Period: Washout|Subject/guardian decision|5|||
124876262|NCT02487498|449170602|FG000|Period: Washout|Lack of Efficacy|1|||
124876263|NCT02487498|449170603|FG001|Period: Washout|Lack of Efficacy|1|||
124876264|NCT02487498|449170602|FG000|Period: Washout|Physician Decision|1|||
124876265|NCT02487498|449170603|FG001|Period: Washout|Physician Decision|0|||
124876266|NCT02487498|449170602|FG000|Period: Washout|Non-compliance with study treatment|0|||
124876267|NCT02487498|449170603|FG001|Period: Washout|Non-compliance with study treatment|1|||
124876268|NCT02487498|449170602|FG000|Period: Period 2|Adverse Event|2|||
124876269|NCT02487498|449170603|FG001|Period: Period 2|Adverse Event|2|||
124876270|NCT02487498|449170602|FG000|Period: Period 2|Subject/guardian decision|2|||
124876271|NCT02487498|449170603|FG001|Period: Period 2|Subject/guardian decision|1|||
124876272|NCT02487498|449170602|FG000|Period: Period 2|Lost to Follow-up|1|||
124876273|NCT02487498|449170603|FG001|Period: Period 2|Lost to Follow-up|1|||
124876274|NCT02487498|449170602|FG000|Period: Period 2|Death|0|||
124876275|NCT02487498|449170603|FG001|Period: Period 2|Death|1|||
124876276|NCT02487498|449170602|FG000|Period: Period 2|Physician Decision|1|||
124876277|NCT02487498|449170603|FG001|Period: Period 2|Physician Decision|0|||
124876278|NCT00676130|449170606|FG000|Overall Study|Lost to Follow-up|0|||
124876279|NCT00676130|449170607|FG001|Overall Study|Lost to Follow-up|1|||
124876280|NCT00676130|449170606|FG000|Overall Study|Found ineligible|3|||
124876281|NCT00676130|449170607|FG001|Overall Study|Found ineligible|2|||
124876282|NCT00676130|449170606|FG000|Overall Study|Withdrawal by Subject|0|||
124876283|NCT00676130|449170607|FG001|Overall Study|Withdrawal by Subject|1|||
124876284|NCT00755222|449170608|FG000|Overall Study|Withdrawal by Subject|4|||
124876285|NCT00755222|449170609|FG001|Overall Study|Withdrawal by Subject|2|||
124876286|NCT00755222|449170608|FG000|Overall Study|Adverse Event|2|||
124876287|NCT00755222|449170609|FG001|Overall Study|Adverse Event|0|||
124876288|NCT00755222|449170608|FG000|Overall Study|Protocol Violation|2|||
124876289|NCT00755222|449170609|FG001|Overall Study|Protocol Violation|0|||
124876290|NCT01330316|449170625|FG000|Overall Study|Adverse Event|2|||
124876291|NCT01330316|449170626|FG001|Overall Study|Adverse Event|2|||
124876292|NCT01330316|449170625|FG000|Overall Study|Lack of Efficacy|0|||
124876293|NCT01330316|449170626|FG001|Overall Study|Lack of Efficacy|10|||
124876294|NCT01330316|449170625|FG000|Overall Study|Lost to Follow-up|0|||
124876295|NCT01330316|449170626|FG001|Overall Study|Lost to Follow-up|1|||
124876296|NCT01330316|449170625|FG000|Overall Study|Withdrawal by Subject|0|||
124876297|NCT01330316|449170626|FG001|Overall Study|Withdrawal by Subject|1|||
124876298|NCT01330316|449170625|FG000|Overall Study|other than above|0|||
124876299|NCT01330316|449170626|FG001|Overall Study|other than above|1|||
124876300|NCT03010462|449170627|FG000|Overall Study|Withdrawal by Subject|3|||
124876301|NCT03010462|449170628|FG001|Overall Study|Withdrawal by Subject|1|||
124876302|NCT02207725|449170629|FG000|Overall Study|Did Not Receive Treatment|0|||
124876303|NCT02207725|449170630|FG001|Overall Study|Did Not Receive Treatment|1|||
124876304|NCT02207725|449170631|FG002|Overall Study|Did Not Receive Treatment|1|||
124876305|NCT02207725|449170632|FG003|Overall Study|Did Not Receive Treatment|1|||
124876306|NCT03145766|449170633|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
124876307|NCT03145766|449170634|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
124876308|NCT03145766|449170635|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
124876309|NCT03145766|449170636|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
124876310|NCT03145766|449170637|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
124876311|NCT03145766|449170633|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
124876312|NCT03145766|449170634|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
124876313|NCT03145766|449170635|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
124876314|NCT03145766|449170636|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
124876315|NCT03145766|449170637|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
124876316|NCT03145766|449170633|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
124876317|NCT03145766|449170634|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
124876318|NCT03145766|449170635|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
124876319|NCT03145766|449170636|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
124876320|NCT03145766|449170637|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
124876321|NCT03145766|449170633|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
124876322|NCT03145766|449170634|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
124876323|NCT03145766|449170635|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
124876324|NCT03145766|449170636|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
124876325|NCT03145766|449170637|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
124876326|NCT03145766|449170633|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
124876327|NCT03145766|449170634|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
124876328|NCT03145766|449170635|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
124876329|NCT03145766|449170636|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
124876330|NCT03145766|449170637|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
124876331|NCT03145766|449170633|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
124876332|NCT03145766|449170634|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
124876333|NCT03145766|449170635|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
124876334|NCT03145766|449170636|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
124876335|NCT03145766|449170637|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
124876336|NCT03145766|449170633|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
124876337|NCT03145766|449170634|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
124876338|NCT03145766|449170635|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
124876339|NCT03145766|449170636|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
124876340|NCT03145766|449170637|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
124876341|NCT01492686|449170641|FG000|Double-blind Phase|Adverse Event|0|||
124876342|NCT01492686|449170642|FG001|Double-blind Phase|Adverse Event|2|||
124876343|NCT01492686|449170641|FG000|Double-blind Phase|Physician Decision|0|||
124876344|NCT01492686|449170642|FG001|Double-blind Phase|Physician Decision|1|||
124876345|NCT01492686|449170641|FG000|Double-blind Phase|Withdrawal by Subject|0|||
124876346|NCT01492686|449170642|FG001|Double-blind Phase|Withdrawal by Subject|2|||
124876347|NCT01492686|449170641|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
124876348|NCT01492686|449170642|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
124876349|NCT01492686|449170641|FG000|Open-label Phase|Adverse Event|1|||
124876350|NCT01492686|449170642|FG001|Open-label Phase|Adverse Event|2|||
124876351|NCT01492686|449170641|FG000|Open-label Phase|Physician Decision|1|||
124876352|NCT01492686|449170642|FG001|Open-label Phase|Physician Decision|0|||
124876353|NCT01492686|449170641|FG000|Open-label Phase|Withdrawal by Subject|6|||
124876354|NCT01492686|449170642|FG001|Open-label Phase|Withdrawal by Subject|7|||
124876355|NCT01492686|449170641|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
124876356|NCT01492686|449170642|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
124876357|NCT04026165|449170650|FG000|Run-in Placebo Period|Enrollment Error|13|||
124876358|NCT04026165|449170651|FG001|Run-in Placebo Period|Enrollment Error|0|||
124876359|NCT04026165|449170652|FG002|Run-in Placebo Period|Enrollment Error|0|||
124876360|NCT04026165|449170653|FG003|Run-in Placebo Period|Enrollment Error|0|||
124876361|NCT04026165|449170650|FG000|Run-in Placebo Period|Run-in Failure|4|||
124876362|NCT04026165|449170651|FG001|Run-in Placebo Period|Run-in Failure|0|||
124876363|NCT04026165|449170652|FG002|Run-in Placebo Period|Run-in Failure|0|||
124876364|NCT04026165|449170653|FG003|Run-in Placebo Period|Run-in Failure|0|||
124876365|NCT04026165|449170650|FG000|Run-in Placebo Period|Protocol Violation|2|||
124876366|NCT04026165|449170651|FG001|Run-in Placebo Period|Protocol Violation|0|||
124876367|NCT04026165|449170652|FG002|Run-in Placebo Period|Protocol Violation|0|||
124876368|NCT04026165|449170653|FG003|Run-in Placebo Period|Protocol Violation|0|||
124876369|NCT04026165|449170650|FG000|Run-in Placebo Period|Withdrew Consent|2|||
124876370|NCT04026165|449170651|FG001|Run-in Placebo Period|Withdrew Consent|0|||
124876371|NCT04026165|449170652|FG002|Run-in Placebo Period|Withdrew Consent|0|||
124876372|NCT04026165|449170653|FG003|Run-in Placebo Period|Withdrew Consent|0|||
124876373|NCT04026165|449170650|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
124876374|NCT04026165|449170651|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
124876375|NCT04026165|449170652|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
124876376|NCT04026165|449170653|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
124876377|NCT04026165|449170650|FG000|Run-in SEL Period|Run-in Failure|0|||
124876378|NCT04026165|449170651|FG001|Run-in SEL Period|Run-in Failure|26|||
124876379|NCT04026165|449170652|FG002|Run-in SEL Period|Run-in Failure|0|||
124876380|NCT04026165|449170653|FG003|Run-in SEL Period|Run-in Failure|0|||
124876381|NCT04026165|449170650|FG000|Run-in SEL Period|Withdrew Consent|0|||
124876382|NCT04026165|449170651|FG001|Run-in SEL Period|Withdrew Consent|10|||
124876383|NCT04026165|449170652|FG002|Run-in SEL Period|Withdrew Consent|0|||
124876384|NCT04026165|449170653|FG003|Run-in SEL Period|Withdrew Consent|0|||
124876385|NCT04026165|449170650|FG000|Run-in SEL Period|Enrollment Error|0|||
124876386|NCT04026165|449170651|FG001|Run-in SEL Period|Enrollment Error|4|||
124876387|NCT04026165|449170652|FG002|Run-in SEL Period|Enrollment Error|0|||
124876388|NCT04026165|449170653|FG003|Run-in SEL Period|Enrollment Error|0|||
124876389|NCT04026165|449170650|FG000|Run-in SEL Period|Protocol Violation|0|||
124876390|NCT04026165|449170651|FG001|Run-in SEL Period|Protocol Violation|3|||
124876391|NCT04026165|449170652|FG002|Run-in SEL Period|Protocol Violation|0|||
124876392|NCT04026165|449170653|FG003|Run-in SEL Period|Protocol Violation|0|||
124876393|NCT04026165|449170650|FG000|Run-in SEL Period|Investigator's Discretion|0|||
124876394|NCT04026165|449170651|FG001|Run-in SEL Period|Investigator's Discretion|2|||
124876395|NCT04026165|449170652|FG002|Run-in SEL Period|Investigator's Discretion|0|||
124876396|NCT04026165|449170653|FG003|Run-in SEL Period|Investigator's Discretion|0|||
124876397|NCT04026165|449170650|FG000|Run-in SEL Period|Death|0|||
124876398|NCT04026165|449170651|FG001|Run-in SEL Period|Death|1|||
124876399|NCT04026165|449170652|FG002|Run-in SEL Period|Death|0|||
124876400|NCT04026165|449170653|FG003|Run-in SEL Period|Death|0|||
124876401|NCT04026165|449170650|FG000|Randomized Period|Withdrew Consent|0|||
124435658|NCT00910689|447556597|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
124435659|NCT00910689|447556598|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
124435660|NCT00910689|447556599|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
124876402|NCT04026165|449170651|FG001|Randomized Period|Withdrew Consent|0|||
124876403|NCT04026165|449170652|FG002|Randomized Period|Withdrew Consent|5|||
124876404|NCT04026165|449170653|FG003|Randomized Period|Withdrew Consent|8|||
124876405|NCT04026165|449170650|FG000|Randomized Period|Death|0|||
124876406|NCT04026165|449170651|FG001|Randomized Period|Death|0|||
124876407|NCT04026165|449170652|FG002|Randomized Period|Death|5|||
124876408|NCT04026165|449170653|FG003|Randomized Period|Death|7|||
124678547|NCT02966834|448448133|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
124435661|NCT00910689|447556596|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
124435662|NCT00910689|447556597|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
124435663|NCT00910689|447556598|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
124435664|NCT00910689|447556599|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
124435665|NCT00910689|447556596|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
124435666|NCT00910689|447556597|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
124435667|NCT00910689|447556598|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
124435668|NCT00910689|447556599|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
124435669|NCT00910689|447556596|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
124435670|NCT00910689|447556597|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
124435671|NCT00910689|447556598|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
124678548|NCT02966834|448448134|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
124678549|NCT02966834|448448135|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
124678550|NCT01387269|448448140|FG000|Overall Study|Death|38|||
124678551|NCT01387269|448448141|FG001|Overall Study|Death|20|||
124435672|NCT00910689|447556599|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
124435673|NCT00910689|447556596|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
124435674|NCT00910689|447556597|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
124435675|NCT00910689|447556598|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
124435676|NCT00910689|447556599|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
124435677|NCT00910689|447556596|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
124435678|NCT00910689|447556597|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
124435679|NCT00910689|447556598|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
124435680|NCT00910689|447556599|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
124435681|NCT00910689|447556596|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
124435682|NCT00910689|447556597|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
124435683|NCT00910689|447556598|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
124435684|NCT00910689|447556599|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
124435685|NCT00910689|447556596|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
124435686|NCT00910689|447556597|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
124435687|NCT00910689|447556598|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
124435688|NCT00910689|447556599|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
124435689|NCT00910689|447556596|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
124678552|NCT01387269|448448140|FG000|Overall Study|Other|8|||
124678553|NCT01387269|448448141|FG001|Overall Study|Other|7|||
124678554|NCT01387269|448448140|FG000|Overall Study|Unrelated AE|12|||
124678555|NCT01387269|448448141|FG001|Overall Study|Unrelated AE|3|||
124678556|NCT01387269|448448140|FG000|Overall Study|Withdrawal by patient|32|||
124678557|NCT01387269|448448141|FG001|Overall Study|Withdrawal by patient|10|||
124678558|NCT01387269|448448140|FG000|Overall Study|Study drug-related AE|1|||
124678559|NCT01387269|448448141|FG001|Overall Study|Study drug-related AE|0|||
124678560|NCT01387269|448448140|FG000|Overall Study|Lost to Follow-up|1|||
124678561|NCT01387269|448448141|FG001|Overall Study|Lost to Follow-up|0|||
124678562|NCT01981616|448448147|FG000|Overall Study|Adverse Event|0|||
124678563|NCT01981616|448448148|FG001|Overall Study|Adverse Event|1|||
124678564|NCT01981616|448448147|FG000|Overall Study|Protocol Violation|1|||
124678565|NCT01981616|448448148|FG001|Overall Study|Protocol Violation|0|||
124678566|NCT01020123|448448150|FG000|Main Period|Withdrawal by Subject|6|||
124678567|NCT01020123|448448151|FG001|Main Period|Withdrawal by Subject|5|||
124678568|NCT01020123|448448152|FG002|Main Period|Withdrawal by Subject|3|||
124678569|NCT01020123|448448153|FG003|Main Period|Withdrawal by Subject|1|||
124678570|NCT01020123|448448154|FG004|Main Period|Withdrawal by Subject|6|||
124678571|NCT01020123|448448155|FG005|Main Period|Withdrawal by Subject|3|||
124678572|NCT01020123|448448156|FG006|Main Period|Withdrawal by Subject|2|||
124678573|NCT01020123|448448150|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
124678574|NCT01020123|448448151|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
124678575|NCT01020123|448448152|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
124678576|NCT01020123|448448153|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
124678577|NCT01020123|448448154|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
124435690|NCT00910689|447556597|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
124435691|NCT00910689|447556598|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
124435692|NCT00910689|447556599|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
124435693|NCT00910689|447556596|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
124435694|NCT00910689|447556597|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
124435695|NCT00910689|447556598|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
124435696|NCT00910689|447556599|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
124435697|NCT00910689|447556596|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
124435698|NCT00910689|447556597|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
124435699|NCT00910689|447556598|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
124678578|NCT01020123|448448155|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
124678579|NCT01020123|448448156|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
124678580|NCT01020123|448448150|FG000|Main Period|Adverse Event|5|||
124678581|NCT01020123|448448151|FG001|Main Period|Adverse Event|2|||
124876409|NCT04026165|449170650|FG000|Randomized Period|Investigator's Discretion|0|||
124876410|NCT04026165|449170651|FG001|Randomized Period|Investigator's Discretion|0|||
124876411|NCT04026165|449170652|FG002|Randomized Period|Investigator's Discretion|2|||
124876412|NCT04026165|449170653|FG003|Randomized Period|Investigator's Discretion|2|||
124876413|NCT04026165|449170650|FG000|Randomized Period|Lost to Follow-up|0|||
124876414|NCT04026165|449170651|FG001|Randomized Period|Lost to Follow-up|0|||
124876415|NCT04026165|449170652|FG002|Randomized Period|Lost to Follow-up|2|||
124876416|NCT04026165|449170653|FG003|Randomized Period|Lost to Follow-up|2|||
124876417|NCT02255357|449170654|FG000|Overall Study|Physician Decision|10|||
124876418|NCT02255357|449170655|FG001|Overall Study|Physician Decision|24|||
124876419|NCT05061537|449170656|FG000|Treatment Phase|Progressive disease|0|||
124876420|NCT05061537|449170657|FG001|Treatment Phase|Progressive disease|1|||
124876421|NCT05061537|449170658|FG002|Treatment Phase|Progressive disease|2|||
124876422|NCT05061537|449170659|FG003|Treatment Phase|Progressive disease|0|||
124876423|NCT05061537|449170660|FG004|Treatment Phase|Progressive disease|0|||
124876424|NCT05061537|449170656|FG000|Treatment Phase|Adverse Event|0|||
124876425|NCT05061537|449170657|FG001|Treatment Phase|Adverse Event|0|||
124876426|NCT05061537|449170658|FG002|Treatment Phase|Adverse Event|2|||
124876427|NCT05061537|449170659|FG003|Treatment Phase|Adverse Event|0|||
124876428|NCT05061537|449170660|FG004|Treatment Phase|Adverse Event|0|||
124876429|NCT05061537|449170656|FG000|Treatment Phase|Global deterioration of health status|0|||
124876430|NCT05061537|449170657|FG001|Treatment Phase|Global deterioration of health status|1|||
124876431|NCT05061537|449170658|FG002|Treatment Phase|Global deterioration of health status|0|||
124435700|NCT00910689|447556599|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
124435701|NCT00910689|447556596|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
124435702|NCT00910689|447556597|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
124876432|NCT05061537|449170659|FG003|Treatment Phase|Global deterioration of health status|0|||
124876433|NCT05061537|449170660|FG004|Treatment Phase|Global deterioration of health status|0|||
124876434|NCT05061537|449170656|FG000|Follow up|Other|2|||
124876435|NCT05061537|449170657|FG001|Follow up|Other|0|||
124876436|NCT05061537|449170658|FG002|Follow up|Other|2|||
124876437|NCT05061537|449170659|FG003|Follow up|Other|0|||
124876438|NCT05061537|449170660|FG004|Follow up|Other|0|||
124876439|NCT05061537|449170656|FG000|Follow up|Study terminated by sponsor|0|||
124876440|NCT05061537|449170657|FG001|Follow up|Study terminated by sponsor|0|||
124876441|NCT05061537|449170658|FG002|Follow up|Study terminated by sponsor|2|||
124876442|NCT05061537|449170659|FG003|Follow up|Study terminated by sponsor|0|||
124876443|NCT05061537|449170660|FG004|Follow up|Study terminated by sponsor|0|||
124876444|NCT05061537|449170656|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
124876445|NCT05061537|449170657|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
124876446|NCT05061537|449170658|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
124435703|NCT00910689|447556598|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
124435704|NCT00910689|447556599|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
124435705|NCT00910689|447556596|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
124435706|NCT00910689|447556597|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
124435707|NCT00910689|447556598|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
124435708|NCT00910689|447556599|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
124435709|NCT00910689|447556596|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
124435710|NCT00910689|447556597|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
124435711|NCT00910689|447556598|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
124435712|NCT00910689|447556599|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
124435713|NCT00910689|447556596|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
124435714|NCT00910689|447556597|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
124435715|NCT00910689|447556598|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
124435716|NCT00910689|447556599|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
124435717|NCT00910689|447556596|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
124435718|NCT00910689|447556597|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
124435719|NCT00910689|447556598|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
124435720|NCT00910689|447556599|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
124435721|NCT00910689|447556596|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
124435722|NCT00910689|447556597|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
124435723|NCT00910689|447556598|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
124435724|NCT00910689|447556599|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
124435725|NCT00910689|447556596|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
124435726|NCT00910689|447556597|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
124876447|NCT05061537|449170659|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
124876448|NCT05061537|449170660|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
124876449|NCT05061537|449170656|FG000|Long-term Follow-up|Death|0|||
124876450|NCT05061537|449170657|FG001|Long-term Follow-up|Death|1|||
124876451|NCT05061537|449170658|FG002|Long-term Follow-up|Death|0|||
124876452|NCT05061537|449170659|FG003|Long-term Follow-up|Death|0|||
124876453|NCT05061537|449170660|FG004|Long-term Follow-up|Death|0|||
124876454|NCT01674621|449170671|FG000|Overall Study|Adverse Event|3|||
124876455|NCT01674621|449170672|FG001|Overall Study|Adverse Event|2|||
124876456|NCT01674621|449170673|FG002|Overall Study|Adverse Event|5|||
124876457|NCT01674621|449170674|FG003|Overall Study|Adverse Event|5|||
124876458|NCT01674621|449170675|FG004|Overall Study|Adverse Event|1|||
124876459|NCT01674621|449170671|FG000|Overall Study|Inability to Complete Study Procedures|0|||
124876460|NCT01674621|449170672|FG001|Overall Study|Inability to Complete Study Procedures|0|||
124876461|NCT01674621|449170673|FG002|Overall Study|Inability to Complete Study Procedures|0|||
124876462|NCT01674621|449170674|FG003|Overall Study|Inability to Complete Study Procedures|0|||
124876463|NCT01674621|449170675|FG004|Overall Study|Inability to Complete Study Procedures|2|||
124876464|NCT01674621|449170671|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
124876465|NCT01674621|449170672|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
124876466|NCT01674621|449170673|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
124876467|NCT01674621|449170674|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
124876468|NCT01674621|449170675|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
124876469|NCT01674621|449170671|FG000|Overall Study|Withdrawal by Subject|2|||
124876470|NCT01674621|449170672|FG001|Overall Study|Withdrawal by Subject|5|||
124876471|NCT01674621|449170673|FG002|Overall Study|Withdrawal by Subject|2|||
124876472|NCT01674621|449170674|FG003|Overall Study|Withdrawal by Subject|0|||
124876473|NCT01674621|449170675|FG004|Overall Study|Withdrawal by Subject|1|||
124876474|NCT01674621|449170671|FG000|Overall Study|Other than specified|0|||
124876475|NCT01674621|449170672|FG001|Overall Study|Other than specified|1|||
124876476|NCT01674621|449170673|FG002|Overall Study|Other than specified|0|||
124876477|NCT01674621|449170674|FG003|Overall Study|Other than specified|0|||
124876478|NCT01674621|449170675|FG004|Overall Study|Other than specified|2|||
124876479|NCT01859793|449170676|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
124876480|NCT01859793|449170677|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
124876481|NCT01859793|449170676|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
124876482|NCT01859793|449170677|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
124876483|NCT01859793|449170676|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
124876484|NCT01859793|449170677|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
124876485|NCT01859793|449170676|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
124876486|NCT01859793|449170677|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
124876487|NCT01735396|449170678|FG000|Overall Study|not evaluable|1|||
124876488|NCT01148862|449170679|FG000|Second Intervention|Withdrawal by Subject|0|||
124876489|NCT01148862|449170680|FG001|Second Intervention|Withdrawal by Subject|2|||
124876490|NCT03724396|449170682|FG000|Overall Study|Lost to Follow-up|1|||
124876491|NCT03724396|449170683|FG001|Overall Study|Lost to Follow-up|1|||
124876492|NCT03724396|449170682|FG000|Overall Study|Withdrawal by Subject|1|||
124876493|NCT03724396|449170683|FG001|Overall Study|Withdrawal by Subject|0|||
124876494|NCT05158296|449170684|FG000|Overall Study|Sponsor Decision|2|||
124876495|NCT05158296|449170685|FG001|Overall Study|Sponsor Decision|3|||
124876496|NCT05158296|449170686|FG002|Overall Study|Sponsor Decision|2|||
124876497|NCT02404389|449170687|FG000|Overall Study|Adverse Event|1|||
124876498|NCT02404389|449170688|FG001|Overall Study|Adverse Event|0|||
124876499|NCT02404389|449170689|FG002|Overall Study|Adverse Event|1|||
124876500|NCT02404389|449170690|FG003|Overall Study|Adverse Event|0|||
124876501|NCT02404389|449170691|FG004|Overall Study|Adverse Event|2|||
124876502|NCT02404389|449170687|FG000|Overall Study|Subject/guardian decision|1|||
124876503|NCT02404389|449170688|FG001|Overall Study|Subject/guardian decision|0|||
124876504|NCT02404389|449170689|FG002|Overall Study|Subject/guardian decision|0|||
124876505|NCT02404389|449170690|FG003|Overall Study|Subject/guardian decision|1|||
124876506|NCT02404389|449170691|FG004|Overall Study|Subject/guardian decision|1|||
124876507|NCT00652938|449170698|FG000|Overall Study|Adverse Event|1|||
124876508|NCT00652938|449170699|FG001|Overall Study|Adverse Event|0|||
124876509|NCT00652938|449170700|FG002|Overall Study|Adverse Event|2|||
124678582|NCT01020123|448448152|FG002|Main Period|Adverse Event|2|||
124876510|NCT00652938|449170698|FG000|Overall Study|Withdrawal by Subject|0|||
124876511|NCT00652938|449170699|FG001|Overall Study|Withdrawal by Subject|6|||
124876512|NCT00652938|449170700|FG002|Overall Study|Withdrawal by Subject|1|||
124876513|NCT00652938|449170698|FG000|Overall Study|Lost to Follow-up|0|||
124876514|NCT00652938|449170699|FG001|Overall Study|Lost to Follow-up|0|||
124876515|NCT00652938|449170700|FG002|Overall Study|Lost to Follow-up|2|||
124876516|NCT00652938|449170698|FG000|Overall Study|fear of blood sampling|0|||
124876517|NCT00652938|449170699|FG001|Overall Study|fear of blood sampling|1|||
124876518|NCT00652938|449170700|FG002|Overall Study|fear of blood sampling|0|||
124876519|NCT01412801|449170701|FG000|Overall Study|Death|0|||
124876520|NCT01412801|449170702|FG001|Overall Study|Death|1|||
124876521|NCT01412801|449170703|FG002|Overall Study|Death|0|||
124876522|NCT01412801|449170704|FG003|Overall Study|Death|4|||
124876523|NCT01412801|449170705|FG004|Overall Study|Death|2|||
124876524|NCT01412801|449170706|FG005|Overall Study|Death|2|||
124876525|NCT01412801|449170701|FG000|Overall Study|Lost to Follow-up|1|||
124876526|NCT01412801|449170702|FG001|Overall Study|Lost to Follow-up|2|||
124876527|NCT01412801|449170703|FG002|Overall Study|Lost to Follow-up|4|||
124876528|NCT01412801|449170704|FG003|Overall Study|Lost to Follow-up|0|||
124435727|NCT00910689|447556598|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
124435728|NCT00910689|447556599|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
124435729|NCT00910689|447556596|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
124435730|NCT00910689|447556597|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
124435731|NCT00910689|447556598|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
124435732|NCT00910689|447556599|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
124435733|NCT00910689|447556596|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
124435734|NCT00910689|447556597|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
124435735|NCT00910689|447556598|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
124435736|NCT00910689|447556599|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
124435737|NCT00484289|447556605|FG000|Long Term Phase|Adverse Event|1|||
124435738|NCT00484289|447556606|FG001|Long Term Phase|Adverse Event|17|||
124435739|NCT00484289|447556607|FG002|Long Term Phase|Adverse Event|5|||
124435740|NCT00484289|447556605|FG000|Long Term Phase|Withdrawal by Subject|0|||
124435741|NCT00484289|447556606|FG001|Long Term Phase|Withdrawal by Subject|7|||
124435742|NCT00484289|447556607|FG002|Long Term Phase|Withdrawal by Subject|6|||
124435743|NCT00484289|447556605|FG000|Long Term Phase|Inadequate response|2|||
124435744|NCT00484289|447556606|FG001|Long Term Phase|Inadequate response|7|||
124435745|NCT00484289|447556607|FG002|Long Term Phase|Inadequate response|4|||
124435746|NCT00484289|447556605|FG000|Long Term Phase|Other Reason|0|||
124435747|NCT00484289|447556606|FG001|Long Term Phase|Other Reason|5|||
124435748|NCT00484289|447556607|FG002|Long Term Phase|Other Reason|1|||
124435749|NCT00484289|447556605|FG000|Post Marketing Phase|Adverse Event|0|||
124435750|NCT00484289|447556606|FG001|Post Marketing Phase|Adverse Event|1|||
124435751|NCT00484289|447556607|FG002|Post Marketing Phase|Adverse Event|0|||
124435752|NCT02349425|447556608|FG000|Period 1|Adverse Event|1|||
124435753|NCT02349425|447556609|FG001|Period 1|Adverse Event|1|||
124435754|NCT02349425|447556610|FG002|Period 1|Adverse Event|0|||
124435755|NCT02349425|447556611|FG003|Period 1|Adverse Event|0|||
124435756|NCT02349425|447556608|FG000|Period 2|Adverse Event|0|||
124435757|NCT02349425|447556609|FG001|Period 2|Adverse Event|1|||
124435758|NCT02349425|447556610|FG002|Period 2|Adverse Event|1|||
124435759|NCT02349425|447556611|FG003|Period 2|Adverse Event|0|||
124435760|NCT02134977|447556612|FG000|Overall Study|Protocol Deviation|102|||
124435761|NCT01773291|447556613|FG000|Overall Study|Protocol Violation|1|||
124435762|NCT01773291|447556614|FG001|Overall Study|Protocol Violation|0|||
124435763|NCT01773291|447556615|FG002|Overall Study|Protocol Violation|0|||
124435764|NCT01773291|447556613|FG000|Overall Study|Withdrawal by Subject|0|||
124435765|NCT01773291|447556614|FG001|Overall Study|Withdrawal by Subject|0|||
124435766|NCT01773291|447556615|FG002|Overall Study|Withdrawal by Subject|1|||
124435767|NCT00107120|447556617|FG000|Overall Study|Adverse Event|4|||
124435768|NCT00107120|447556618|FG001|Overall Study|Adverse Event|1|||
124435769|NCT00107120|447556617|FG000|Overall Study|Lack of Efficacy|5|||
124435770|NCT00107120|447556618|FG001|Overall Study|Lack of Efficacy|5|||
124435771|NCT00107120|447556617|FG000|Overall Study|Protocol Violation|3|||
124435772|NCT00107120|447556618|FG001|Overall Study|Protocol Violation|0|||
124435773|NCT00107120|447556617|FG000|Overall Study|Withdrawal by Subject|8|||
124435774|NCT00107120|447556618|FG001|Overall Study|Withdrawal by Subject|9|||
124435775|NCT00107120|447556617|FG000|Overall Study|Lost to Follow-up|8|||
124435776|NCT00107120|447556618|FG001|Overall Study|Lost to Follow-up|6|||
124435777|NCT00107120|447556617|FG000|Overall Study|Pregnancy|0|||
124435778|NCT00107120|447556618|FG001|Overall Study|Pregnancy|1|||
124435779|NCT00107120|447556617|FG000|Overall Study|moving away from site|1|||
124435780|NCT00107120|447556618|FG001|Overall Study|moving away from site|1|||
124435781|NCT00107120|447556617|FG000|Overall Study|death of parent|0|||
124435782|NCT00107120|447556618|FG001|Overall Study|death of parent|1|||
124435783|NCT00896051|447556622|FG000|Overall Study|Adverse Event|2|||
124435784|NCT00896051|447556623|FG001|Overall Study|Adverse Event|1|||
124435785|NCT00896051|447556622|FG000|Overall Study|Lost to Follow-up|3|||
124435786|NCT00896051|447556623|FG001|Overall Study|Lost to Follow-up|2|||
124435787|NCT00896051|447556622|FG000|Overall Study|Withdrawal by Subject|3|||
124435788|NCT00896051|447556623|FG001|Overall Study|Withdrawal by Subject|2|||
124435789|NCT00896051|447556622|FG000|Overall Study|Subject noncompliant|1|||
124435790|NCT00896051|447556623|FG001|Overall Study|Subject noncompliant|3|||
124435791|NCT00896051|447556622|FG000|Overall Study|Other|1|||
124435792|NCT00896051|447556623|FG001|Overall Study|Other|1|||
124435793|NCT02935452|447556624|FG000|Overall Study|work and life commintment|3|||
124435794|NCT02935452|447556625|FG001|Overall Study|work and life commintment|1|||
124435795|NCT00876928|447556626|FG000|Overall Study|Lost to Follow-up|2|||
124435796|NCT00876928|447556627|FG001|Overall Study|Lost to Follow-up|5|||
124435797|NCT00876928|447556626|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
124435798|NCT00876928|447556627|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
124435799|NCT01143038|447556630|FG000|Overall Study|Withdrawal by Subject|4|||
124435800|NCT01143038|447556630|FG000|Overall Study|Requirement for alternative therapy|5|||
124435801|NCT01143038|447556630|FG000|Overall Study|Adverse Event|3|||
124435802|NCT01143038|447556630|FG000|Overall Study|Lost to Follow-up|2|||
124435803|NCT01143038|447556630|FG000|Overall Study|Protocol Deviation|1|||
124435804|NCT01143038|447556630|FG000|Overall Study|Death|1|||
124876529|NCT01412801|449170705|FG004|Overall Study|Lost to Follow-up|1|||
124876530|NCT01412801|449170706|FG005|Overall Study|Lost to Follow-up|1|||
124876531|NCT01412801|449170701|FG000|Overall Study|Withdrawal by Subject|3|||
124876532|NCT01412801|449170702|FG001|Overall Study|Withdrawal by Subject|2|||
124876533|NCT01412801|449170703|FG002|Overall Study|Withdrawal by Subject|1|||
124876534|NCT01412801|449170704|FG003|Overall Study|Withdrawal by Subject|0|||
124876535|NCT01412801|449170705|FG004|Overall Study|Withdrawal by Subject|0|||
124876536|NCT01412801|449170706|FG005|Overall Study|Withdrawal by Subject|0|||
124876537|NCT01412801|449170701|FG000|Overall Study|Relocated to another area|0|||
124876538|NCT01412801|449170702|FG001|Overall Study|Relocated to another area|0|||
124876539|NCT01412801|449170703|FG002|Overall Study|Relocated to another area|2|||
124876540|NCT01412801|449170704|FG003|Overall Study|Relocated to another area|0|||
124876541|NCT01412801|449170705|FG004|Overall Study|Relocated to another area|0|||
124876542|NCT01412801|449170706|FG005|Overall Study|Relocated to another area|0|||
124876543|NCT02978443|449170707|FG000|Overall Study|Withdrawal by Subject|1|||
124876544|NCT02978443|449170707|FG000|Overall Study|Adverse Event|3|||
124876545|NCT02978443|449170707|FG000|Overall Study|Disease Progression on study|6|||
124876546|NCT02978443|449170707|FG000|Overall Study|Death|1|||
124876547|NCT02978443|449170707|FG000|Overall Study|Physician Decision|1|||
124876548|NCT02978443|449170707|FG000|Overall Study|Switch to alternative therapy|1|||
124876549|NCT02978443|449170707|FG000|Overall Study|Refused further treatment|1|||
124876550|NCT01547299|449170708|FG000|Overall Study|Withdrawal by Subject|2|||
124876551|NCT01547299|449170709|FG001|Overall Study|Withdrawal by Subject|2|||
124876552|NCT01987817|449170710|FG000|Overall Study|Adverse Event|4|||
124876553|NCT01987817|449170711|FG001|Overall Study|Adverse Event|0|||
124876554|NCT01987817|449170710|FG000|Overall Study|Withdrawal by Subject|1|||
124876555|NCT01987817|449170711|FG001|Overall Study|Withdrawal by Subject|1|||
124876556|NCT01987817|449170710|FG000|Overall Study|Physician Decision|1|||
124876557|NCT01987817|449170711|FG001|Overall Study|Physician Decision|0|||
124876558|NCT01576718|449170712|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
124876559|NCT01576718|449170713|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124876560|NCT01576718|449170714|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124876561|NCT01576718|449170715|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124876562|NCT01576718|449170716|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124876563|NCT01576718|449170717|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124876564|NCT01576718|449170718|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124876565|NCT01576718|449170712|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
124876566|NCT01576718|449170713|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124876567|NCT01576718|449170714|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124876568|NCT01576718|449170715|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124876569|NCT01576718|449170716|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124876570|NCT01576718|449170717|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124876571|NCT01576718|449170718|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124876572|NCT01576718|449170712|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
124876573|NCT01576718|449170713|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124876574|NCT01576718|449170714|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124876575|NCT01576718|449170715|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124876576|NCT01576718|449170716|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124876577|NCT01576718|449170717|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124876578|NCT01576718|449170718|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124876579|NCT01576718|449170712|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
124876580|NCT01576718|449170713|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124876581|NCT01576718|449170714|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124876582|NCT01576718|449170715|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124876583|NCT01576718|449170716|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124876584|NCT01576718|449170717|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124876585|NCT01576718|449170718|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124876586|NCT01576718|449170712|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
124876587|NCT01576718|449170713|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124876588|NCT01576718|449170714|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124876589|NCT01576718|449170715|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124876590|NCT01576718|449170716|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124876591|NCT01576718|449170717|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124876592|NCT01576718|449170718|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124876593|NCT01576718|449170712|FG000|Treatment Period|Adverse Event|0|||
124876594|NCT01576718|449170713|FG001|Treatment Period|Adverse Event|1|||
124876595|NCT01576718|449170714|FG002|Treatment Period|Adverse Event|1|||
124876596|NCT01576718|449170715|FG003|Treatment Period|Adverse Event|1|||
124876597|NCT01576718|449170716|FG004|Treatment Period|Adverse Event|1|||
124876598|NCT01576718|449170717|FG005|Treatment Period|Adverse Event|1|||
124876599|NCT01576718|449170718|FG006|Treatment Period|Adverse Event|0|||
124876600|NCT01576718|449170712|FG000|Treatment Period|Withdrawal by Subject|0|||
124876601|NCT01576718|449170713|FG001|Treatment Period|Withdrawal by Subject|1|||
124876602|NCT01576718|449170714|FG002|Treatment Period|Withdrawal by Subject|1|||
124876603|NCT01576718|449170715|FG003|Treatment Period|Withdrawal by Subject|0|||
124876604|NCT01576718|449170716|FG004|Treatment Period|Withdrawal by Subject|2|||
124876605|NCT01576718|449170717|FG005|Treatment Period|Withdrawal by Subject|4|||
124876606|NCT01576718|449170718|FG006|Treatment Period|Withdrawal by Subject|2|||
124876607|NCT01576718|449170712|FG000|Treatment Period|Physician Decision|0|||
124876608|NCT01576718|449170713|FG001|Treatment Period|Physician Decision|1|||
124876609|NCT01576718|449170714|FG002|Treatment Period|Physician Decision|1|||
124876610|NCT01576718|449170715|FG003|Treatment Period|Physician Decision|1|||
124876611|NCT01576718|449170716|FG004|Treatment Period|Physician Decision|1|||
124876612|NCT01576718|449170717|FG005|Treatment Period|Physician Decision|0|||
124876613|NCT01576718|449170718|FG006|Treatment Period|Physician Decision|0|||
124876614|NCT01576718|449170712|FG000|Treatment Period|Protocol Violation|0|||
124876615|NCT01576718|449170713|FG001|Treatment Period|Protocol Violation|5|||
124876616|NCT01576718|449170714|FG002|Treatment Period|Protocol Violation|4|||
124876617|NCT01576718|449170715|FG003|Treatment Period|Protocol Violation|10|||
124876618|NCT01576718|449170716|FG004|Treatment Period|Protocol Violation|6|||
124876619|NCT01576718|449170717|FG005|Treatment Period|Protocol Violation|8|||
124876620|NCT01576718|449170718|FG006|Treatment Period|Protocol Violation|12|||
124876621|NCT01576718|449170712|FG000|Treatment Period|Sponsor request|0|||
124876622|NCT01576718|449170713|FG001|Treatment Period|Sponsor request|1|||
124435805|NCT01248065|447556631|FG000|Overall Study|Lost to Follow-up|3|||
124435806|NCT01248065|447556632|FG001|Overall Study|Lost to Follow-up|5|||
124435807|NCT01248065|447556631|FG000|Overall Study|Withdrawal by Subject|14|||
124435808|NCT01248065|447556632|FG001|Overall Study|Withdrawal by Subject|11|||
124435809|NCT01248065|447556631|FG000|Overall Study|Adverse Event|3|||
124876623|NCT01576718|449170714|FG002|Treatment Period|Sponsor request|0|||
124876624|NCT01576718|449170715|FG003|Treatment Period|Sponsor request|0|||
124876625|NCT01576718|449170716|FG004|Treatment Period|Sponsor request|0|||
124876626|NCT01576718|449170717|FG005|Treatment Period|Sponsor request|1|||
124876627|NCT01576718|449170718|FG006|Treatment Period|Sponsor request|0|||
124876628|NCT01576718|449170712|FG000|Treatment Period|Met stopping criteria|0|||
124435810|NCT01248065|447556632|FG001|Overall Study|Adverse Event|0|||
124876629|NCT01576718|449170713|FG001|Treatment Period|Met stopping criteria|16|||
124876630|NCT01576718|449170714|FG002|Treatment Period|Met stopping criteria|13|||
124876631|NCT01576718|449170715|FG003|Treatment Period|Met stopping criteria|19|||
124876632|NCT01576718|449170716|FG004|Treatment Period|Met stopping criteria|16|||
124876633|NCT01576718|449170717|FG005|Treatment Period|Met stopping criteria|33|||
124876634|NCT01576718|449170718|FG006|Treatment Period|Met stopping criteria|15|||
124876635|NCT01576718|449170712|FG000|Treatment Period|Lost to Follow-up|0|||
124876636|NCT01576718|449170713|FG001|Treatment Period|Lost to Follow-up|0|||
124876637|NCT01576718|449170714|FG002|Treatment Period|Lost to Follow-up|0|||
124678583|NCT01020123|448448153|FG003|Main Period|Adverse Event|1|||
124678584|NCT01020123|448448154|FG004|Main Period|Adverse Event|1|||
124678585|NCT01020123|448448155|FG005|Main Period|Adverse Event|2|||
124678586|NCT01020123|448448156|FG006|Main Period|Adverse Event|1|||
124678587|NCT01020123|448448150|FG000|Main Period|Protocol Violation|4|||
124678588|NCT01020123|448448151|FG001|Main Period|Protocol Violation|4|||
124678589|NCT01020123|448448152|FG002|Main Period|Protocol Violation|2|||
124678590|NCT01020123|448448153|FG003|Main Period|Protocol Violation|5|||
124678591|NCT01020123|448448154|FG004|Main Period|Protocol Violation|2|||
124678592|NCT01020123|448448155|FG005|Main Period|Protocol Violation|3|||
124678593|NCT01020123|448448156|FG006|Main Period|Protocol Violation|2|||
124678594|NCT01020123|448448150|FG000|Main Period|Lost to Follow-up|0|||
124678595|NCT01020123|448448151|FG001|Main Period|Lost to Follow-up|2|||
124678596|NCT01020123|448448152|FG002|Main Period|Lost to Follow-up|0|||
124678597|NCT01020123|448448153|FG003|Main Period|Lost to Follow-up|0|||
124678598|NCT01020123|448448154|FG004|Main Period|Lost to Follow-up|0|||
124678599|NCT01020123|448448155|FG005|Main Period|Lost to Follow-up|0|||
124678600|NCT01020123|448448156|FG006|Main Period|Lost to Follow-up|0|||
124678601|NCT01020123|448448150|FG000|Main Period|Unclasified|2|||
124678602|NCT01020123|448448151|FG001|Main Period|Unclasified|0|||
124678603|NCT01020123|448448152|FG002|Main Period|Unclasified|1|||
124678604|NCT01020123|448448153|FG003|Main Period|Unclasified|0|||
124678605|NCT01020123|448448154|FG004|Main Period|Unclasified|1|||
124678606|NCT01020123|448448155|FG005|Main Period|Unclasified|3|||
124678607|NCT01020123|448448156|FG006|Main Period|Unclasified|6|||
124678608|NCT01020123|448448150|FG000|Extention Period|Withdrawal by Subject|2|||
124678609|NCT01020123|448448151|FG001|Extention Period|Withdrawal by Subject|1|||
124678610|NCT01020123|448448152|FG002|Extention Period|Withdrawal by Subject|1|||
124678611|NCT01020123|448448153|FG003|Extention Period|Withdrawal by Subject|0|||
124678612|NCT01020123|448448154|FG004|Extention Period|Withdrawal by Subject|0|||
124678613|NCT01020123|448448155|FG005|Extention Period|Withdrawal by Subject|0|||
124678614|NCT01020123|448448156|FG006|Extention Period|Withdrawal by Subject|0|||
124678615|NCT01020123|448448150|FG000|Extention Period|Adverse Event|0|||
124678616|NCT01020123|448448151|FG001|Extention Period|Adverse Event|0|||
124678617|NCT01020123|448448152|FG002|Extention Period|Adverse Event|0|||
124678618|NCT01020123|448448153|FG003|Extention Period|Adverse Event|1|||
124678619|NCT01020123|448448154|FG004|Extention Period|Adverse Event|0|||
124678620|NCT01020123|448448155|FG005|Extention Period|Adverse Event|0|||
124678621|NCT01020123|448448156|FG006|Extention Period|Adverse Event|0|||
124678622|NCT01020123|448448150|FG000|Extention Period|Protocol Violation|1|||
124678623|NCT01020123|448448151|FG001|Extention Period|Protocol Violation|1|||
124435811|NCT01248065|447556631|FG000|Overall Study|Third treatment failure event|3|||
124435812|NCT01248065|447556632|FG001|Overall Study|Third treatment failure event|1|||
124435813|NCT01248065|447556631|FG000|Overall Study|Other|3|||
124435814|NCT01248065|447556632|FG001|Overall Study|Other|5|||
124435815|NCT03010176|447556637|FG000|Overall Study|Death|21|||
124435816|NCT03010176|447556638|FG001|Overall Study|Death|35|||
124435817|NCT03010176|447556639|FG002|Overall Study|Death|19|||
124435818|NCT03010176|447556640|FG003|Overall Study|Death|19|||
124435819|NCT03010176|447556641|FG004|Overall Study|Death|14|||
124435820|NCT03010176|447556642|FG005|Overall Study|Death|0|||
124435821|NCT03010176|447556637|FG000|Overall Study|Lost to Follow-up|0|||
124435822|NCT03010176|447556638|FG001|Overall Study|Lost to Follow-up|0|||
124435823|NCT03010176|447556639|FG002|Overall Study|Lost to Follow-up|0|||
124435824|NCT03010176|447556640|FG003|Overall Study|Lost to Follow-up|0|||
124435825|NCT03010176|447556641|FG004|Overall Study|Lost to Follow-up|1|||
124435826|NCT03010176|447556642|FG005|Overall Study|Lost to Follow-up|0|||
124435827|NCT03010176|447556637|FG000|Overall Study|Physician Decision|0|||
124435828|NCT03010176|447556638|FG001|Overall Study|Physician Decision|4|||
124435829|NCT03010176|447556639|FG002|Overall Study|Physician Decision|0|||
124435830|NCT03010176|447556640|FG003|Overall Study|Physician Decision|1|||
124435831|NCT03010176|447556641|FG004|Overall Study|Physician Decision|0|||
124435832|NCT03010176|447556642|FG005|Overall Study|Physician Decision|0|||
124435833|NCT03010176|447556637|FG000|Overall Study|Sponsor Decision|0|||
124435834|NCT03010176|447556638|FG001|Overall Study|Sponsor Decision|4|||
124678624|NCT01020123|448448152|FG002|Extention Period|Protocol Violation|1|||
124678625|NCT01020123|448448153|FG003|Extention Period|Protocol Violation|0|||
124678626|NCT01020123|448448154|FG004|Extention Period|Protocol Violation|0|||
124678627|NCT01020123|448448155|FG005|Extention Period|Protocol Violation|0|||
124678628|NCT01020123|448448156|FG006|Extention Period|Protocol Violation|1|||
124678629|NCT01020123|448448150|FG000|Extention Period|Lost to Follow-up|0|||
124678630|NCT01020123|448448151|FG001|Extention Period|Lost to Follow-up|0|||
124678631|NCT01020123|448448152|FG002|Extention Period|Lost to Follow-up|0|||
124678632|NCT01020123|448448153|FG003|Extention Period|Lost to Follow-up|0|||
124678633|NCT01020123|448448154|FG004|Extention Period|Lost to Follow-up|0|||
124678634|NCT01020123|448448155|FG005|Extention Period|Lost to Follow-up|2|||
124678635|NCT01020123|448448156|FG006|Extention Period|Lost to Follow-up|0|||
124678636|NCT04711005|448448157|FG000|Overall Study|Withdrawal by Subject|0|||
124678637|NCT04711005|448448158|FG001|Overall Study|Withdrawal by Subject|0|||
124678638|NCT04711005|448448159|FG002|Overall Study|Withdrawal by Subject|0|||
124678639|NCT04711005|448448160|FG003|Overall Study|Withdrawal by Subject|0|||
124678640|NCT04711005|448448161|FG004|Overall Study|Withdrawal by Subject|0|||
124678641|NCT04711005|448448162|FG005|Overall Study|Withdrawal by Subject|0|||
124678642|NCT04711005|448448163|FG006|Overall Study|Withdrawal by Subject|0|||
124678643|NCT04711005|448448164|FG007|Overall Study|Withdrawal by Subject|1|||
124678644|NCT04711005|448448165|FG008|Overall Study|Withdrawal by Subject|0|||
124678645|NCT04711005|448448166|FG009|Overall Study|Withdrawal by Subject|0|||
124678646|NCT04711005|448448157|FG000|Overall Study|Physician Decision|0|||
124678647|NCT04711005|448448158|FG001|Overall Study|Physician Decision|0|||
124678648|NCT04711005|448448159|FG002|Overall Study|Physician Decision|0|||
124678649|NCT04711005|448448160|FG003|Overall Study|Physician Decision|0|||
124678650|NCT04711005|448448161|FG004|Overall Study|Physician Decision|0|||
124678651|NCT04711005|448448162|FG005|Overall Study|Physician Decision|0|||
124678652|NCT04711005|448448163|FG006|Overall Study|Physician Decision|0|||
124678653|NCT04711005|448448164|FG007|Overall Study|Physician Decision|2|||
124678654|NCT04711005|448448165|FG008|Overall Study|Physician Decision|1|||
124678655|NCT04711005|448448166|FG009|Overall Study|Physician Decision|0|||
124678656|NCT03824561|448448167|FG000|Overall Study|Protocol Violation|19|||
124678657|NCT01773928|448448168|FG000|Overall Study|Adverse Event|0|||
124678658|NCT01773928|448448169|FG001|Overall Study|Adverse Event|0|||
124678659|NCT01773928|448448170|FG002|Overall Study|Adverse Event|0|||
124678660|NCT01773928|448448171|FG003|Overall Study|Adverse Event|0|||
124876638|NCT01576718|449170715|FG003|Treatment Period|Lost to Follow-up|0|||
124876639|NCT01576718|449170716|FG004|Treatment Period|Lost to Follow-up|1|||
124876640|NCT01576718|449170717|FG005|Treatment Period|Lost to Follow-up|0|||
124678661|NCT01773928|448448172|FG004|Overall Study|Adverse Event|0|||
124678662|NCT01773928|448448173|FG005|Overall Study|Adverse Event|0|||
124678663|NCT01773928|448448174|FG006|Overall Study|Adverse Event|0|||
124678664|NCT01773928|448448175|FG007|Overall Study|Adverse Event|1|||
124678665|NCT01773928|448448176|FG008|Overall Study|Adverse Event|0|||
124435835|NCT03010176|447556639|FG002|Overall Study|Sponsor Decision|4|||
124435836|NCT03010176|447556640|FG003|Overall Study|Sponsor Decision|1|||
124435837|NCT03010176|447556641|FG004|Overall Study|Sponsor Decision|6|||
124435838|NCT03010176|447556642|FG005|Overall Study|Sponsor Decision|0|||
124435839|NCT03010176|447556637|FG000|Overall Study|Withdrawal by Subject|11|||
124435840|NCT03010176|447556638|FG001|Overall Study|Withdrawal by Subject|9|||
124678666|NCT01773928|448448168|FG000|Overall Study|Physician Decision|0|||
124678667|NCT01773928|448448169|FG001|Overall Study|Physician Decision|0|||
124678668|NCT01773928|448448170|FG002|Overall Study|Physician Decision|0|||
124678669|NCT01773928|448448171|FG003|Overall Study|Physician Decision|1|||
124876641|NCT01576718|449170718|FG006|Treatment Period|Lost to Follow-up|0|||
124876642|NCT01576718|449170712|FG000|Treatment Period|Noncompliance to study medication|0|||
124876643|NCT01576718|449170713|FG001|Treatment Period|Noncompliance to study medication|0|||
124876644|NCT01576718|449170714|FG002|Treatment Period|Noncompliance to study medication|0|||
124876645|NCT01576718|449170715|FG003|Treatment Period|Noncompliance to study medication|0|||
124876646|NCT01576718|449170716|FG004|Treatment Period|Noncompliance to study medication|0|||
124876647|NCT01576718|449170717|FG005|Treatment Period|Noncompliance to study medication|1|||
124876648|NCT01576718|449170718|FG006|Treatment Period|Noncompliance to study medication|1|||
124876649|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
124876650|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
124876651|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
124876652|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
124876653|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
124876654|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
124876655|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
124876656|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
124876657|NCT01336621|449170719|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
124876658|NCT01336621|449170719|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
124876659|NCT01336621|449170719|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
124876660|NCT01336621|449170719|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
124435841|NCT03010176|447556639|FG002|Overall Study|Withdrawal by Subject|3|||
124435842|NCT03010176|447556640|FG003|Overall Study|Withdrawal by Subject|0|||
124435843|NCT03010176|447556641|FG004|Overall Study|Withdrawal by Subject|4|||
124678670|NCT01773928|448448172|FG004|Overall Study|Physician Decision|0|||
124678671|NCT01773928|448448173|FG005|Overall Study|Physician Decision|0|||
124678672|NCT01773928|448448174|FG006|Overall Study|Physician Decision|0|||
124678673|NCT01773928|448448175|FG007|Overall Study|Physician Decision|0|||
124678674|NCT01773928|448448176|FG008|Overall Study|Physician Decision|0|||
124678675|NCT01773928|448448168|FG000|Overall Study|Withdrawal by Subject|5|||
124678676|NCT01773928|448448169|FG001|Overall Study|Withdrawal by Subject|4|||
124678677|NCT01773928|448448170|FG002|Overall Study|Withdrawal by Subject|4|||
124678678|NCT01773928|448448171|FG003|Overall Study|Withdrawal by Subject|4|||
124678679|NCT01773928|448448172|FG004|Overall Study|Withdrawal by Subject|7|||
124678680|NCT01773928|448448173|FG005|Overall Study|Withdrawal by Subject|1|||
124678681|NCT01773928|448448174|FG006|Overall Study|Withdrawal by Subject|0|||
124678682|NCT01773928|448448175|FG007|Overall Study|Withdrawal by Subject|0|||
124678683|NCT01773928|448448176|FG008|Overall Study|Withdrawal by Subject|1|||
124678684|NCT01773928|448448168|FG000|Overall Study|Lost to Follow-up|0|||
124678685|NCT01773928|448448169|FG001|Overall Study|Lost to Follow-up|0|||
124678686|NCT01773928|448448170|FG002|Overall Study|Lost to Follow-up|0|||
124678687|NCT01773928|448448171|FG003|Overall Study|Lost to Follow-up|0|||
124678688|NCT01773928|448448172|FG004|Overall Study|Lost to Follow-up|0|||
124678689|NCT01773928|448448173|FG005|Overall Study|Lost to Follow-up|1|||
124678690|NCT01773928|448448174|FG006|Overall Study|Lost to Follow-up|0|||
124678691|NCT01773928|448448175|FG007|Overall Study|Lost to Follow-up|0|||
124678692|NCT01773928|448448176|FG008|Overall Study|Lost to Follow-up|0|||
124435844|NCT03010176|447556642|FG005|Overall Study|Withdrawal by Subject|0|||
124435845|NCT00321373|447556643|FG000|Overall Study|Adverse Event|0|||
124435846|NCT00321373|447556644|FG001|Overall Study|Adverse Event|0|||
124435847|NCT00321373|447556645|FG002|Overall Study|Adverse Event|1|||
124435848|NCT00321373|447556643|FG000|Overall Study|Lost to Follow-up|1|||
124435849|NCT00321373|447556644|FG001|Overall Study|Lost to Follow-up|0|||
124435850|NCT00321373|447556645|FG002|Overall Study|Lost to Follow-up|1|||
124435851|NCT00321373|447556643|FG000|Overall Study|Withdrawal by Subject|1|||
124435852|NCT00321373|447556644|FG001|Overall Study|Withdrawal by Subject|0|||
124435853|NCT00321373|447556645|FG002|Overall Study|Withdrawal by Subject|0|||
124435854|NCT00321373|447556643|FG000|Overall Study|Other|0|||
124435855|NCT00321373|447556644|FG001|Overall Study|Other|0|||
124435856|NCT00321373|447556645|FG002|Overall Study|Other|1|||
124435857|NCT01774487|447556646|FG000|Overall Study|Did not tolerate taste|4|||
124435858|NCT01774487|447556647|FG001|Overall Study|Did not tolerate taste|4|||
124435859|NCT00461032|447556648|FG000|Overall Study|Adverse Event|5|||
124435860|NCT00461032|447556649|FG001|Overall Study|Adverse Event|6|||
124435861|NCT00461032|447556648|FG000|Overall Study|Lack of Efficacy|5|||
124435862|NCT00461032|447556649|FG001|Overall Study|Lack of Efficacy|1|||
124435863|NCT00461032|447556648|FG000|Overall Study|Lost to Follow-up|7|||
124435864|NCT00461032|447556649|FG001|Overall Study|Lost to Follow-up|12|||
124435865|NCT00461032|447556648|FG000|Overall Study|Protocol Violation|4|||
124435866|NCT00461032|447556649|FG001|Overall Study|Protocol Violation|4|||
124435867|NCT00461032|447556648|FG000|Overall Study|Withdrawal by Subject|7|||
124435868|NCT00461032|447556649|FG001|Overall Study|Withdrawal by Subject|15|||
124678693|NCT01773928|448448168|FG000|Overall Study|Subject misrepresented age|0|||
124678694|NCT01773928|448448169|FG001|Overall Study|Subject misrepresented age|1|||
124678695|NCT01773928|448448170|FG002|Overall Study|Subject misrepresented age|0|||
124435869|NCT00461032|447556648|FG000|Overall Study|Patient Moved or Relocated|2|||
124435870|NCT00461032|447556649|FG001|Overall Study|Patient Moved or Relocated|1|||
124435871|NCT00461032|447556648|FG000|Overall Study|Other|7|||
124435872|NCT00461032|447556649|FG001|Overall Study|Other|5|||
124435873|NCT04447846|447556650|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
124435874|NCT01878214|447556651|FG000|Overall Study|Withdrawal by Subject|18|||
124435875|NCT01878214|447556652|FG001|Overall Study|Withdrawal by Subject|7|||
124435876|NCT01878214|447556651|FG000|Overall Study|Death|0|||
124435877|NCT01878214|447556652|FG001|Overall Study|Death|1|||
124435878|NCT01878214|447556651|FG000|Overall Study|Lost to Follow-up|35|||
124435879|NCT01878214|447556652|FG001|Overall Study|Lost to Follow-up|36|||
124435880|NCT00946101|447556653|FG000|Overall Study|Lost to Follow-up|2|||
124435881|NCT00946101|447556654|FG001|Overall Study|Lost to Follow-up|1|||
124435882|NCT00946101|447556653|FG000|Overall Study|Withdrawal of consent|2|||
124435883|NCT00946101|447556654|FG001|Overall Study|Withdrawal of consent|0|||
124435884|NCT00946101|447556653|FG000|Overall Study|Physician Decision|0|||
124435885|NCT00946101|447556654|FG001|Overall Study|Physician Decision|1|||
124435886|NCT00552240|447556663|FG000|Overall Study|Adverse Event|9|||
124435887|NCT00552240|447556664|FG001|Overall Study|Adverse Event|9|||
124435888|NCT00552240|447556663|FG000|Overall Study|Protocol Violation|1|||
124678696|NCT01773928|448448171|FG003|Overall Study|Subject misrepresented age|0|||
124678697|NCT01773928|448448172|FG004|Overall Study|Subject misrepresented age|0|||
124678698|NCT01773928|448448173|FG005|Overall Study|Subject misrepresented age|0|||
124678699|NCT01773928|448448174|FG006|Overall Study|Subject misrepresented age|0|||
124678700|NCT01773928|448448175|FG007|Overall Study|Subject misrepresented age|0|||
124678701|NCT01773928|448448176|FG008|Overall Study|Subject misrepresented age|0|||
124678702|NCT01773928|448448168|FG000|Overall Study|Subject met exclusion criteria|0|||
124678703|NCT01773928|448448169|FG001|Overall Study|Subject met exclusion criteria|0|||
124678704|NCT01773928|448448170|FG002|Overall Study|Subject met exclusion criteria|0|||
124678705|NCT01773928|448448171|FG003|Overall Study|Subject met exclusion criteria|0|||
124678706|NCT01773928|448448172|FG004|Overall Study|Subject met exclusion criteria|0|||
124678707|NCT01773928|448448173|FG005|Overall Study|Subject met exclusion criteria|0|||
124678708|NCT01773928|448448174|FG006|Overall Study|Subject met exclusion criteria|0|||
124678709|NCT01773928|448448175|FG007|Overall Study|Subject met exclusion criteria|0|||
124678710|NCT01773928|448448176|FG008|Overall Study|Subject met exclusion criteria|1|||
124678711|NCT01773928|448448168|FG000|Overall Study|Randomized, had to leave, never returned|0|||
124678712|NCT01773928|448448169|FG001|Overall Study|Randomized, had to leave, never returned|0|||
124678713|NCT01773928|448448170|FG002|Overall Study|Randomized, had to leave, never returned|0|||
124678714|NCT01773928|448448171|FG003|Overall Study|Randomized, had to leave, never returned|1|||
124678715|NCT01773928|448448172|FG004|Overall Study|Randomized, had to leave, never returned|0|||
124678716|NCT01773928|448448173|FG005|Overall Study|Randomized, had to leave, never returned|0|||
124678717|NCT01773928|448448174|FG006|Overall Study|Randomized, had to leave, never returned|0|||
124678718|NCT01773928|448448175|FG007|Overall Study|Randomized, had to leave, never returned|0|||
124678719|NCT01773928|448448176|FG008|Overall Study|Randomized, had to leave, never returned|0|||
124678720|NCT01773928|448448168|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
124876661|NCT01336621|449170719|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
124678721|NCT01773928|448448169|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
124678722|NCT01773928|448448170|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
124678723|NCT01773928|448448171|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
124678724|NCT01773928|448448172|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
124678725|NCT01773928|448448173|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
124678726|NCT01773928|448448174|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
124678727|NCT01773928|448448175|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
124678728|NCT01773928|448448176|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
124678729|NCT03092752|448448177|FG000|Overall Study|Aged <40 years|14209|||
124678730|NCT03092752|448448177|FG000|Overall Study|At least one claim with T2DM|61299|||
124678731|NCT03092752|448448177|FG000|Overall Study|Having no claim of study drugs|29282|||
124678732|NCT03092752|448448177|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
124678733|NCT03092752|448448177|FG000|Overall Study|<6 month history|245900|||
124678734|NCT01499810|448448186|FG000|Overall Study|Lost to Follow-up|10|||
124678735|NCT01499810|448448186|FG000|Overall Study|Protocol Violation|1|||
124678736|NCT01499810|448448186|FG000|Overall Study|Withdrawal by Subject|1|||
124678737|NCT02273167|448448192|FG000|Overall Study|Adverse Event|1|||
124678738|NCT02273167|448448193|FG001|Overall Study|Adverse Event|0|||
124678739|NCT02273167|448448194|FG002|Overall Study|Adverse Event|0|||
124678740|NCT02273167|448448192|FG000|Overall Study|Protocol Violation|3|||
124678741|NCT02273167|448448193|FG001|Overall Study|Protocol Violation|1|||
124678742|NCT02273167|448448194|FG002|Overall Study|Protocol Violation|1|||
124678743|NCT02273167|448448192|FG000|Overall Study|Lost to Follow-up|0|||
124435889|NCT00552240|447556664|FG001|Overall Study|Protocol Violation|1|||
124435890|NCT00552240|447556663|FG000|Overall Study|Lost to Follow-up|5|||
124678744|NCT02273167|448448193|FG001|Overall Study|Lost to Follow-up|1|||
124678745|NCT02273167|448448194|FG002|Overall Study|Lost to Follow-up|1|||
124678746|NCT02273167|448448192|FG000|Overall Study|Withdrawal by Subject|10|||
124876662|NCT01336621|449170719|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
124876663|NCT00682643|449170724|FG000|Overall Study|Adverse Event|12|||
124876664|NCT00682643|449170725|FG001|Overall Study|Adverse Event|23|||
124876665|NCT00682643|449170724|FG000|Overall Study|Lack of Efficacy|2|||
124876666|NCT00682643|449170725|FG001|Overall Study|Lack of Efficacy|0|||
124876667|NCT00682643|449170724|FG000|Overall Study|Protocol Violation|38|||
124876668|NCT00682643|449170725|FG001|Overall Study|Protocol Violation|76|||
124876669|NCT00682643|449170724|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
124876670|NCT00682643|449170725|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
124876671|NCT00682643|449170724|FG000|Overall Study|Lost to Follow-up|1|||
124876672|NCT00682643|449170725|FG001|Overall Study|Lost to Follow-up|6|||
124876673|NCT00682643|449170724|FG000|Overall Study|Physician Decision|2|||
124876674|NCT00682643|449170725|FG001|Overall Study|Physician Decision|6|||
124876675|NCT00682643|449170724|FG000|Overall Study|Withdrawal by Subject|19|||
124876676|NCT00682643|449170725|FG001|Overall Study|Withdrawal by Subject|53|||
124876677|NCT00682643|449170724|FG000|Overall Study|Did Not Receive Study Drug|1|||
124876678|NCT00682643|449170725|FG001|Overall Study|Did Not Receive Study Drug|1|||
124876679|NCT00263328|449170729|FG000|Overall Study|Death|0|||
124876680|NCT00263328|449170730|FG001|Overall Study|Death|0|||
124876681|NCT00263328|449170731|FG002|Overall Study|Death|1|||
124876682|NCT00263328|449170729|FG000|Overall Study|Lost to Follow-up|1|||
124876683|NCT00263328|449170730|FG001|Overall Study|Lost to Follow-up|1|||
124876684|NCT00263328|449170731|FG002|Overall Study|Lost to Follow-up|0|||
124876685|NCT00263328|449170729|FG000|Overall Study|Withdrawal by Subject|3|||
124876686|NCT00263328|449170730|FG001|Overall Study|Withdrawal by Subject|0|||
124876687|NCT00263328|449170731|FG002|Overall Study|Withdrawal by Subject|1|||
124876688|NCT00263328|449170729|FG000|Overall Study|Other|3|||
124876689|NCT00263328|449170730|FG001|Overall Study|Other|0|||
124876690|NCT00263328|449170731|FG002|Overall Study|Other|1|||
124876691|NCT00263328|449170729|FG000|Overall Study|Adverse Event|1|||
124876692|NCT00263328|449170730|FG001|Overall Study|Adverse Event|1|||
124876693|NCT00263328|449170731|FG002|Overall Study|Adverse Event|4|||
124876694|NCT00622180|449170732|FG000|Overall Study|Lost to Follow-up|1|||
124876695|NCT00622180|449170733|FG001|Overall Study|Lost to Follow-up|2|||
124678747|NCT02273167|448448193|FG001|Overall Study|Withdrawal by Subject|12|||
124678748|NCT02273167|448448194|FG002|Overall Study|Withdrawal by Subject|11|||
124678749|NCT02273167|448448192|FG000|Overall Study|Various|10|||
124678750|NCT02273167|448448193|FG001|Overall Study|Various|9|||
124678751|NCT02273167|448448194|FG002|Overall Study|Various|8|||
124678752|NCT03353220|448448198|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
124678753|NCT03353220|448448199|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
124678754|NCT03370172|448449606|FG000|Overall Study|Withdrawal by Subject|0|||
124678755|NCT03370172|448449607|FG001|Overall Study|Withdrawal by Subject|1|||
124678756|NCT00849056|448449611|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
124678757|NCT00849056|448449612|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
124678758|NCT00849056|448449611|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
124678759|NCT00849056|448449612|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
124678760|NCT00849056|448449611|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
124678761|NCT00849056|448449612|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
124678762|NCT00849056|448449611|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
124678763|NCT00849056|448449612|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
124678764|NCT00849056|448449611|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
124678765|NCT00849056|448449612|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
124678766|NCT00849056|448449611|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
124678767|NCT00849056|448449612|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
124678768|NCT00849056|448449611|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
124876696|NCT04512066|449170736|FG000|Double-blind Treatment Period|Adverse Event|6|||
124876697|NCT04512066|449170737|FG001|Double-blind Treatment Period|Adverse Event|4|||
124678769|NCT00849056|448449612|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
124678770|NCT00849056|448449611|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
124876698|NCT04512066|449170738|FG002|Double-blind Treatment Period|Adverse Event|5|||
124876699|NCT04512066|449170739|FG003|Double-blind Treatment Period|Adverse Event|1|||
124876700|NCT04512066|449170740|FG004|Double-blind Treatment Period|Adverse Event|0|||
124876701|NCT04512066|449170741|FG005|Double-blind Treatment Period|Adverse Event|0|||
124876702|NCT04512066|449170736|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
124876703|NCT04512066|449170737|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
124876704|NCT04512066|449170738|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
124876705|NCT04512066|449170739|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
124876706|NCT04512066|449170740|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
124876707|NCT04512066|449170741|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
124876708|NCT04512066|449170736|FG000|Double-blind Treatment Period|Physician Decision|1|||
124876709|NCT04512066|449170737|FG001|Double-blind Treatment Period|Physician Decision|0|||
124876710|NCT04512066|449170738|FG002|Double-blind Treatment Period|Physician Decision|1|||
124876711|NCT04512066|449170739|FG003|Double-blind Treatment Period|Physician Decision|0|||
124876712|NCT04512066|449170740|FG004|Double-blind Treatment Period|Physician Decision|0|||
124876713|NCT04512066|449170741|FG005|Double-blind Treatment Period|Physician Decision|0|||
124876714|NCT04512066|449170736|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
124876715|NCT04512066|449170737|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
124876716|NCT04512066|449170738|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
124876717|NCT04512066|449170739|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
124876718|NCT04512066|449170740|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
124876719|NCT04512066|449170741|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
124876720|NCT04512066|449170736|FG000|Extension Period|Adverse Event|0|||
124876721|NCT04512066|449170737|FG001|Extension Period|Adverse Event|1|||
124876722|NCT04512066|449170738|FG002|Extension Period|Adverse Event|4|||
124876723|NCT04512066|449170739|FG003|Extension Period|Adverse Event|3|||
124876724|NCT04512066|449170740|FG004|Extension Period|Adverse Event|1|||
124876725|NCT04512066|449170741|FG005|Extension Period|Adverse Event|3|||
124876726|NCT04512066|449170736|FG000|Extension Period|Death|0|||
124876727|NCT04512066|449170737|FG001|Extension Period|Death|0|||
124876728|NCT04512066|449170738|FG002|Extension Period|Death|0|||
124876729|NCT04512066|449170739|FG003|Extension Period|Death|0|||
124876730|NCT04512066|449170740|FG004|Extension Period|Death|0|||
124876731|NCT04512066|449170741|FG005|Extension Period|Death|1|||
124876732|NCT04512066|449170736|FG000|Extension Period|Lack of Efficacy|0|||
124876733|NCT04512066|449170737|FG001|Extension Period|Lack of Efficacy|4|||
124876734|NCT04512066|449170738|FG002|Extension Period|Lack of Efficacy|4|||
124876735|NCT04512066|449170739|FG003|Extension Period|Lack of Efficacy|1|||
124876736|NCT04512066|449170740|FG004|Extension Period|Lack of Efficacy|3|||
124876737|NCT04512066|449170741|FG005|Extension Period|Lack of Efficacy|3|||
124876738|NCT04512066|449170736|FG000|Extension Period|Lost to Follow-up|0|||
124876739|NCT04512066|449170737|FG001|Extension Period|Lost to Follow-up|1|||
124876740|NCT04512066|449170738|FG002|Extension Period|Lost to Follow-up|5|||
124876741|NCT04512066|449170739|FG003|Extension Period|Lost to Follow-up|2|||
124876742|NCT04512066|449170740|FG004|Extension Period|Lost to Follow-up|3|||
124876743|NCT04512066|449170741|FG005|Extension Period|Lost to Follow-up|2|||
124876744|NCT04512066|449170736|FG000|Extension Period|Non-compliance with study drug|0|||
124876745|NCT04512066|449170737|FG001|Extension Period|Non-compliance with study drug|1|||
124876746|NCT04512066|449170738|FG002|Extension Period|Non-compliance with study drug|0|||
124876747|NCT04512066|449170739|FG003|Extension Period|Non-compliance with study drug|0|||
124876748|NCT04512066|449170740|FG004|Extension Period|Non-compliance with study drug|0|||
124876749|NCT04512066|449170741|FG005|Extension Period|Non-compliance with study drug|1|||
124876750|NCT04512066|449170736|FG000|Extension Period|Other|0|||
124876751|NCT04512066|449170737|FG001|Extension Period|Other|2|||
124876752|NCT04512066|449170738|FG002|Extension Period|Other|0|||
124876753|NCT04512066|449170739|FG003|Extension Period|Other|0|||
124876754|NCT04512066|449170740|FG004|Extension Period|Other|0|||
124876755|NCT04512066|449170741|FG005|Extension Period|Other|0|||
124876756|NCT04512066|449170736|FG000|Extension Period|Physician Decision|0|||
124876757|NCT04512066|449170737|FG001|Extension Period|Physician Decision|2|||
124876758|NCT04512066|449170738|FG002|Extension Period|Physician Decision|0|||
124876759|NCT04512066|449170739|FG003|Extension Period|Physician Decision|1|||
124876760|NCT04512066|449170740|FG004|Extension Period|Physician Decision|1|||
124435891|NCT00552240|447556664|FG001|Overall Study|Lost to Follow-up|6|||
124435892|NCT00552240|447556663|FG000|Overall Study|Withdrawal by Subject|2|||
124435893|NCT00552240|447556664|FG001|Overall Study|Withdrawal by Subject|2|||
124435894|NCT00552240|447556663|FG000|Overall Study|Lack of Efficacy|6|||
124435895|NCT00552240|447556664|FG001|Overall Study|Lack of Efficacy|0|||
124435896|NCT00552240|447556663|FG000|Overall Study|Other|1|||
124435897|NCT00552240|447556664|FG001|Overall Study|Other|0|||
124876761|NCT04512066|449170741|FG005|Extension Period|Physician Decision|0|||
124876762|NCT04512066|449170736|FG000|Extension Period|Withdrawal by Subject|0|||
124876763|NCT04512066|449170737|FG001|Extension Period|Withdrawal by Subject|3|||
124876764|NCT04512066|449170738|FG002|Extension Period|Withdrawal by Subject|7|||
124876765|NCT04512066|449170739|FG003|Extension Period|Withdrawal by Subject|11|||
124435898|NCT02783768|447556665|FG000|Overall Study|Lost to Follow-up|1|||
124435899|NCT02783768|447556666|FG001|Overall Study|Lost to Follow-up|0|||
124876766|NCT04512066|449170740|FG004|Extension Period|Withdrawal by Subject|8|||
124876767|NCT04512066|449170741|FG005|Extension Period|Withdrawal by Subject|4|||
124876768|NCT01833143|449170742|FG000|Overall Study|Not Treated|1|||
124876769|NCT03995784|449170743|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
124876770|NCT00284141|449172815|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
124876771|NCT00284141|449172815|FG000|Overall Study|Adverse Event|19|||
124876772|NCT00284141|449172815|FG000|Overall Study|Participant's request|9|||
124876773|NCT00284141|449172815|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
124876774|NCT00284141|449172815|FG000|Overall Study|Clinical deterioration / death|2|||
124876775|NCT00284141|449172815|FG000|Overall Study|General decline|1|||
124876776|NCT00284141|449172815|FG000|Overall Study|Pneumonia|1|||
124876777|NCT00284141|449172815|FG000|Overall Study|Did not take study medication|2|||
124876778|NCT00284141|449172815|FG000|Overall Study|Ongoing treatment|2|||
124876779|NCT00332332|449172816|FG000|Overall Study|Adverse Event|13|||
124876780|NCT00332332|449172816|FG000|Overall Study|Death|1|||
124876781|NCT00332332|449172816|FG000|Overall Study|Withdrawal by Subject|8|||
124876782|NCT00332332|449172816|FG000|Overall Study|Physician Decision|1|||
124876783|NCT00332332|449172816|FG000|Overall Study|Lost to Follow-up|3|||
124876784|NCT00332332|449172816|FG000|Overall Study|Protocol deviation|4|||
124876785|NCT00332332|449172816|FG000|Overall Study|Noncompliance|2|||
124876786|NCT00332332|449172816|FG000|Overall Study|Disease progression|2|||
124876787|NCT00332332|449172816|FG000|Overall Study|Other|18|||
124876788|NCT00332332|449172816|FG000|Overall Study|Did not receive study treatment|16|||
124876789|NCT01108458|449172817|FG000|Overall Study|Withdrawal by Subject|1|||
124876790|NCT01382602|449172818|FG000|Overall Study|Protocol Violation|0|||
124876791|NCT01382602|449172819|FG001|Overall Study|Protocol Violation|3|||
124876792|NCT01382602|449172818|FG000|Overall Study|Withdrawal by Subject|0|||
124876793|NCT01382602|449172819|FG001|Overall Study|Withdrawal by Subject|1|||
124876794|NCT04170686|449172820|FG000|Screening|Physician Decision|12|||
124876795|NCT04170686|449172821|FG001|Screening|Physician Decision|13|||
124876796|NCT04170686|449172820|FG000|Randomization and Treatment|Lost to Follow-up|26|||
124876797|NCT04170686|449172821|FG001|Randomization and Treatment|Lost to Follow-up|15|||
124876798|NCT03328143|449172822|FG000|Overall Study|Declined|3|||
124876799|NCT03328143|449172822|FG000|Overall Study|Required increased sedation|4|||
124876800|NCT03328143|449172822|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
124876801|NCT03328143|449172822|FG000|Overall Study|Surgery cancelled|1|||
124876802|NCT02801669|449172823|FG000|Overall Study|Death|66|||
124876803|NCT02801669|449172824|FG001|Overall Study|Death|69|||
124876804|NCT02801669|449172823|FG000|Overall Study|Withdrawal by Subject|81|||
124876805|NCT02801669|449172824|FG001|Overall Study|Withdrawal by Subject|77|||
124876806|NCT02801669|449172823|FG000|Overall Study|Other|4|||
124876807|NCT02801669|449172824|FG001|Overall Study|Other|6|||
124876808|NCT02696564|449172825|FG000|Overall Study|Death|1|||
124876809|NCT02696564|449172826|FG001|Overall Study|Death|2|||
124876810|NCT02696564|449172825|FG000|Overall Study|Withdrawal by Subject|3|||
124876811|NCT02696564|449172826|FG001|Overall Study|Withdrawal by Subject|2|||
124876812|NCT02696564|449172825|FG000|Overall Study|Lost to Follow-up|3|||
124876813|NCT02696564|449172826|FG001|Overall Study|Lost to Follow-up|3|||
124876814|NCT02696564|449172825|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
124876815|NCT02696564|449172826|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
124876816|NCT02696564|449172825|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
124876817|NCT02696564|449172826|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
124876818|NCT02696564|449172825|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
124876819|NCT02696564|449172826|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
124876820|NCT02696564|449172825|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
124876821|NCT02696564|449172826|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
124876822|NCT02696564|449172825|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
124876823|NCT02696564|449172826|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
124876824|NCT00615264|449172828|FG000|Overall Study|Withdrawal by Subject|17|||
124435900|NCT01323647|447556667|FG000|Overall Study|Migrated/moved from study area|2|||
124876825|NCT00615264|449172829|FG001|Overall Study|Withdrawal by Subject|19|||
124876826|NCT00615264|449172828|FG000|Overall Study|Lost to Follow-up|6|||
124876827|NCT00615264|449172829|FG001|Overall Study|Lost to Follow-up|13|||
124876828|NCT00615264|449172828|FG000|Overall Study|Adverse Event|8|||
124678771|NCT00849056|448449612|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
124678772|NCT00849056|448449611|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
124876829|NCT00615264|449172829|FG001|Overall Study|Adverse Event|5|||
124876830|NCT00615264|449172828|FG000|Overall Study|Death|1|||
124876831|NCT00615264|449172829|FG001|Overall Study|Death|1|||
124876832|NCT00615264|449172828|FG000|Overall Study|Protocol Violation|11|||
124876833|NCT00615264|449172829|FG001|Overall Study|Protocol Violation|7|||
124876834|NCT00615264|449172828|FG000|Overall Study|Not defined|7|||
124876835|NCT00615264|449172829|FG001|Overall Study|Not defined|4|||
124876836|NCT00615264|449172828|FG000|Overall Study|Dermal Hypersensitivity|0|||
124876837|NCT00615264|449172829|FG001|Overall Study|Dermal Hypersensitivity|3|||
124435901|NCT01323647|447556668|FG001|Overall Study|Migrated/moved from study area|0|||
124435902|NCT01323647|447556667|FG000|Overall Study|Withdrawal by Subject|5|||
124435903|NCT01323647|447556668|FG001|Overall Study|Withdrawal by Subject|0|||
124435904|NCT01323647|447556667|FG000|Overall Study|Lost to Follow-up|2|||
124435905|NCT01323647|447556668|FG001|Overall Study|Lost to Follow-up|0|||
124544310|NCT05182840|447946748|FG000|Treatment Period|Not treated with study drug|0|||
124544311|NCT05182840|447946749|FG001|Treatment Period|Not treated with study drug|0|||
124544312|NCT05182840|447946750|FG002|Treatment Period|Not treated with study drug|0|||
124544313|NCT05182840|447946751|FG003|Treatment Period|Not treated with study drug|1|||
124544314|NCT05182840|447946752|FG004|Treatment Period|Not treated with study drug|0|||
124678773|NCT00849056|448449612|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
124678774|NCT00849056|448449611|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
124678775|NCT00849056|448449612|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
124678776|NCT00849056|448449611|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
124678777|NCT00849056|448449612|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
124678778|NCT00849056|448449611|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
124678779|NCT00849056|448449612|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
124678780|NCT00849056|448449611|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
124678781|NCT00849056|448449612|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
124678782|NCT00849056|448449611|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
124678783|NCT00849056|448449612|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
124678784|NCT00849056|448449611|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
124678785|NCT00849056|448449612|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
124678786|NCT00849056|448449611|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
124678787|NCT00849056|448449612|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
124678788|NCT02711137|448449613|FG000|Overall Study|Death|1|||
124678789|NCT02711137|448449614|FG001|Overall Study|Death|4|||
124678790|NCT02711137|448449615|FG002|Overall Study|Death|5|||
124678791|NCT02711137|448449616|FG003|Overall Study|Death|5|||
124678792|NCT02711137|448449617|FG004|Overall Study|Death|3|||
124678793|NCT02711137|448449618|FG005|Overall Study|Death|1|||
124678794|NCT02711137|448449619|FG006|Overall Study|Death|61|||
124678795|NCT02711137|448449620|FG007|Overall Study|Death|3|||
124678796|NCT02711137|448449621|FG008|Overall Study|Death|0|||
124678797|NCT02711137|448449622|FG009|Overall Study|Death|1|||
124678798|NCT02711137|448449623|FG010|Overall Study|Death|1|||
124678799|NCT02711137|448449624|FG011|Overall Study|Death|1|||
124678800|NCT02711137|448449625|FG012|Overall Study|Death|0|||
124678801|NCT02711137|448449626|FG013|Overall Study|Death|0|||
124678802|NCT02711137|448449627|FG014|Overall Study|Death|0|||
124678803|NCT02711137|448449613|FG000|Overall Study|Study Terminated by Sponsor|0|||
124678804|NCT02711137|448449614|FG001|Overall Study|Study Terminated by Sponsor|0|||
124678805|NCT02711137|448449615|FG002|Overall Study|Study Terminated by Sponsor|1|||
124678806|NCT02711137|448449616|FG003|Overall Study|Study Terminated by Sponsor|0|||
124678807|NCT02711137|448449617|FG004|Overall Study|Study Terminated by Sponsor|0|||
124678808|NCT02711137|448449618|FG005|Overall Study|Study Terminated by Sponsor|0|||
124678809|NCT02711137|448449619|FG006|Overall Study|Study Terminated by Sponsor|1|||
124678810|NCT02711137|448449620|FG007|Overall Study|Study Terminated by Sponsor|0|||
124678811|NCT02711137|448449621|FG008|Overall Study|Study Terminated by Sponsor|0|||
124678812|NCT02711137|448449622|FG009|Overall Study|Study Terminated by Sponsor|0|||
124678813|NCT02711137|448449623|FG010|Overall Study|Study Terminated by Sponsor|0|||
124678814|NCT02711137|448449624|FG011|Overall Study|Study Terminated by Sponsor|0|||
124678815|NCT02711137|448449625|FG012|Overall Study|Study Terminated by Sponsor|0|||
124678816|NCT02711137|448449626|FG013|Overall Study|Study Terminated by Sponsor|0|||
124678817|NCT02711137|448449627|FG014|Overall Study|Study Terminated by Sponsor|0|||
124678818|NCT02711137|448449613|FG000|Overall Study|Physician Decision|1|||
124678819|NCT02711137|448449614|FG001|Overall Study|Physician Decision|0|||
124678820|NCT02711137|448449615|FG002|Overall Study|Physician Decision|2|||
124678821|NCT02711137|448449616|FG003|Overall Study|Physician Decision|1|||
124678822|NCT02711137|448449617|FG004|Overall Study|Physician Decision|1|||
124678823|NCT02711137|448449618|FG005|Overall Study|Physician Decision|0|||
124678824|NCT02711137|448449619|FG006|Overall Study|Physician Decision|12|||
124678825|NCT02711137|448449620|FG007|Overall Study|Physician Decision|2|||
124678826|NCT02711137|448449621|FG008|Overall Study|Physician Decision|1|||
124678827|NCT02711137|448449622|FG009|Overall Study|Physician Decision|1|||
124678828|NCT02711137|448449623|FG010|Overall Study|Physician Decision|3|||
124544315|NCT05182840|447946753|FG005|Treatment Period|Not treated with study drug|0|||
124544316|NCT05182840|447946754|FG006|Treatment Period|Not treated with study drug|1|||
124678829|NCT02711137|448449624|FG011|Overall Study|Physician Decision|2|||
124678830|NCT02711137|448449625|FG012|Overall Study|Physician Decision|1|||
124678831|NCT02711137|448449626|FG013|Overall Study|Physician Decision|1|||
124678832|NCT02711137|448449627|FG014|Overall Study|Physician Decision|2|||
124544317|NCT05182840|447946755|FG007|Treatment Period|Not treated with study drug|1|||
124544318|NCT05182840|447946756|FG008|Treatment Period|Not treated with study drug|0|||
124678833|NCT02711137|448449613|FG000|Overall Study|Other|0|||
124678834|NCT02711137|448449614|FG001|Overall Study|Other|1|||
124678835|NCT02711137|448449615|FG002|Overall Study|Other|0|||
124678836|NCT02711137|448449616|FG003|Overall Study|Other|0|||
124876838|NCT03430063|449172830|FG000|Overall Study|Adverse Event|0|||
124678837|NCT02711137|448449617|FG004|Overall Study|Other|0|||
124678838|NCT02711137|448449618|FG005|Overall Study|Other|0|||
124678839|NCT02711137|448449619|FG006|Overall Study|Other|3|||
124678840|NCT02711137|448449620|FG007|Overall Study|Other|0|||
124678841|NCT02711137|448449621|FG008|Overall Study|Other|0|||
124678842|NCT02711137|448449622|FG009|Overall Study|Other|0|||
124678843|NCT02711137|448449623|FG010|Overall Study|Other|0|||
124678844|NCT02711137|448449624|FG011|Overall Study|Other|0|||
124678845|NCT02711137|448449625|FG012|Overall Study|Other|0|||
124678846|NCT02711137|448449626|FG013|Overall Study|Other|0|||
124678847|NCT02711137|448449627|FG014|Overall Study|Other|1|||
124678848|NCT02711137|448449613|FG000|Overall Study|Withdrawal by Subject|1|||
124678849|NCT02711137|448449614|FG001|Overall Study|Withdrawal by Subject|0|||
124678850|NCT02711137|448449615|FG002|Overall Study|Withdrawal by Subject|0|||
124678851|NCT02711137|448449616|FG003|Overall Study|Withdrawal by Subject|1|||
124678852|NCT02711137|448449617|FG004|Overall Study|Withdrawal by Subject|1|||
124678853|NCT02711137|448449618|FG005|Overall Study|Withdrawal by Subject|0|||
124876839|NCT03430063|449172831|FG001|Overall Study|Adverse Event|1|||
124876840|NCT03430063|449172832|FG002|Overall Study|Adverse Event|0|||
124876841|NCT03430063|449172830|FG000|Overall Study|Death|3|||
124876842|NCT03430063|449172831|FG001|Overall Study|Death|2|||
124876843|NCT03430063|449172832|FG002|Overall Study|Death|3|||
124876844|NCT03430063|449172830|FG000|Overall Study|Lost to Follow-up|0|||
124876845|NCT03430063|449172831|FG001|Overall Study|Lost to Follow-up|1|||
124876846|NCT03430063|449172832|FG002|Overall Study|Lost to Follow-up|0|||
124876847|NCT03430063|449172830|FG000|Overall Study|Withdrawal by Subject|0|||
124876848|NCT03430063|449172831|FG001|Overall Study|Withdrawal by Subject|0|||
124876849|NCT03430063|449172832|FG002|Overall Study|Withdrawal by Subject|1|||
124876850|NCT03430063|449172830|FG000|Overall Study|Withdrawal of consent|3|||
124876851|NCT03430063|449172831|FG001|Overall Study|Withdrawal of consent|1|||
124876852|NCT03430063|449172832|FG002|Overall Study|Withdrawal of consent|2|||
124876853|NCT03430063|449172830|FG000|Overall Study|Progressive disease|1|||
124876854|NCT03430063|449172831|FG001|Overall Study|Progressive disease|2|||
124876855|NCT03430063|449172832|FG002|Overall Study|Progressive disease|1|||
124876856|NCT03430063|449172830|FG000|Overall Study|Other un-specified|1|||
124876857|NCT03430063|449172831|FG001|Overall Study|Other un-specified|1|||
124876858|NCT03430063|449172832|FG002|Overall Study|Other un-specified|0|||
124876859|NCT03430063|449172830|FG000|Overall Study|Randomized, but never treated|0|||
124876860|NCT03430063|449172831|FG001|Overall Study|Randomized, but never treated|0|||
124876861|NCT03430063|449172832|FG002|Overall Study|Randomized, but never treated|1|||
124876862|NCT02228395|449172837|FG000|First Intervention Period|No longer willing to participate|1|||
124876863|NCT02228395|449172838|FG001|First Intervention Period|No longer willing to participate|0|||
124876864|NCT02228395|449172839|FG002|First Intervention Period|No longer willing to participate|0|||
124876865|NCT02228395|449172837|FG000|First Intervention Period|Unable to comply with study dates|0|||
124876866|NCT02228395|449172838|FG001|First Intervention Period|Unable to comply with study dates|1|||
124876867|NCT02228395|449172839|FG002|First Intervention Period|Unable to comply with study dates|1|||
124876868|NCT00985985|449172840|FG000|Overall Study|Adverse Event|4|||
124876869|NCT00985985|449172841|FG001|Overall Study|Adverse Event|2|||
124876870|NCT00985985|449172842|FG002|Overall Study|Adverse Event|2|||
124876871|NCT00985985|449172843|FG003|Overall Study|Adverse Event|2|||
124876872|NCT00985985|449172840|FG000|Overall Study|Lost to Follow-up|4|||
124876873|NCT00985985|449172841|FG001|Overall Study|Lost to Follow-up|11|||
124876874|NCT00985985|449172842|FG002|Overall Study|Lost to Follow-up|2|||
124876875|NCT00985985|449172843|FG003|Overall Study|Lost to Follow-up|3|||
124876876|NCT00985985|449172840|FG000|Overall Study|Protocol Violation|1|||
124876877|NCT00985985|449172841|FG001|Overall Study|Protocol Violation|2|||
124876878|NCT00985985|449172842|FG002|Overall Study|Protocol Violation|0|||
124876879|NCT00985985|449172843|FG003|Overall Study|Protocol Violation|1|||
124876880|NCT00985985|449172840|FG000|Overall Study|Lack of Efficacy|5|||
124876881|NCT00985985|449172841|FG001|Overall Study|Lack of Efficacy|6|||
124876882|NCT00985985|449172842|FG002|Overall Study|Lack of Efficacy|1|||
124876883|NCT00985985|449172843|FG003|Overall Study|Lack of Efficacy|3|||
124435906|NCT01236339|447556676|FG000|Overall Study|Termination of study by sponsor|11|||
124678854|NCT02711137|448449619|FG006|Overall Study|Withdrawal by Subject|7|||
124876884|NCT00985985|449172840|FG000|Overall Study|Withdrawal by Subject|4|||
124876885|NCT00985985|449172841|FG001|Overall Study|Withdrawal by Subject|2|||
124876886|NCT00985985|449172842|FG002|Overall Study|Withdrawal by Subject|2|||
124876887|NCT00985985|449172843|FG003|Overall Study|Withdrawal by Subject|2|||
124876888|NCT00985985|449172840|FG000|Overall Study|Other Reason|6|||
124876889|NCT00985985|449172841|FG001|Overall Study|Other Reason|1|||
124876890|NCT00985985|449172842|FG002|Overall Study|Other Reason|4|||
124876891|NCT00985985|449172843|FG003|Overall Study|Other Reason|2|||
124876892|NCT00509236|449172844|FG000|Overall Study|Adverse Event|7|||
124876893|NCT00509236|449172845|FG001|Overall Study|Adverse Event|9|||
124876894|NCT00509236|449172844|FG000|Overall Study|Withdrawal by Subject|5|||
124876895|NCT00509236|449172845|FG001|Overall Study|Withdrawal by Subject|10|||
124876896|NCT00509236|449172844|FG000|Overall Study|Protocol Violation|3|||
124876897|NCT00509236|449172845|FG001|Overall Study|Protocol Violation|0|||
124678855|NCT02711137|448449620|FG007|Overall Study|Withdrawal by Subject|0|||
124678856|NCT02711137|448449621|FG008|Overall Study|Withdrawal by Subject|0|||
124678857|NCT02711137|448449622|FG009|Overall Study|Withdrawal by Subject|0|||
124544319|NCT05182840|447946757|FG009|Treatment Period|Not treated with study drug|0|||
124544320|NCT02161380|447946758|FG000|Overall Study|Lost to Follow-up|0|||
124544321|NCT02161380|447946759|FG001|Overall Study|Lost to Follow-up|1|||
124544322|NCT02161380|447946760|FG002|Overall Study|Lost to Follow-up|0|||
124544323|NCT02161380|447946761|FG003|Overall Study|Lost to Follow-up|0|||
124544324|NCT02268214|447946768|FG000|Overall Study|Subject no longer meets study criteria|0|||
124544325|NCT02268214|447946769|FG001|Overall Study|Subject no longer meets study criteria|2|||
124544326|NCT02268214|447946770|FG002|Overall Study|Subject no longer meets study criteria|0|||
124544327|NCT02268214|447946768|FG000|Overall Study|Pregnancy|2|||
124435907|NCT01236339|447556677|FG001|Overall Study|Termination of study by sponsor|13|||
124435908|NCT02054741|447556681|FG000|Overall Study|Protocol Violation|13|||
124435909|NCT02054741|447556682|FG001|Overall Study|Protocol Violation|2|||
124435910|NCT02054741|447556681|FG000|Overall Study|Withdrawal by Subject|10|||
124435911|NCT02054741|447556682|FG001|Overall Study|Withdrawal by Subject|5|||
124435912|NCT02054741|447556681|FG000|Overall Study|Death|94|||
124435913|NCT02054741|447556682|FG001|Overall Study|Death|90|||
124435914|NCT02054741|447556681|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
124435915|NCT02054741|447556682|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
124435916|NCT01945060|447556683|FG000|Overall Study|Lost to follow up|1|||
124435917|NCT01945060|447556684|FG001|Overall Study|Lost to follow up|0|||
124435918|NCT01945060|447556683|FG000|Overall Study|Distress related to IV access|0|||
124435919|NCT01945060|447556684|FG001|Overall Study|Distress related to IV access|1|||
124435920|NCT00402597|447556687|FG000|Overall Study|Death|15|||
124678858|NCT02711137|448449623|FG010|Overall Study|Withdrawal by Subject|0|||
124678859|NCT02711137|448449624|FG011|Overall Study|Withdrawal by Subject|0|||
124678860|NCT02711137|448449625|FG012|Overall Study|Withdrawal by Subject|0|||
124678861|NCT02711137|448449626|FG013|Overall Study|Withdrawal by Subject|1|||
124678862|NCT02711137|448449627|FG014|Overall Study|Withdrawal by Subject|0|||
124678863|NCT02711137|448449613|FG000|Overall Study|Lost to Follow-up|1|||
124678864|NCT02711137|448449614|FG001|Overall Study|Lost to Follow-up|0|||
124678865|NCT02711137|448449615|FG002|Overall Study|Lost to Follow-up|0|||
124678866|NCT02711137|448449616|FG003|Overall Study|Lost to Follow-up|0|||
124678867|NCT02711137|448449617|FG004|Overall Study|Lost to Follow-up|0|||
124678868|NCT02711137|448449618|FG005|Overall Study|Lost to Follow-up|0|||
124678869|NCT02711137|448449619|FG006|Overall Study|Lost to Follow-up|2|||
124678870|NCT02711137|448449620|FG007|Overall Study|Lost to Follow-up|0|||
124678871|NCT02711137|448449621|FG008|Overall Study|Lost to Follow-up|0|||
124678872|NCT02711137|448449622|FG009|Overall Study|Lost to Follow-up|0|||
124678873|NCT02711137|448449623|FG010|Overall Study|Lost to Follow-up|0|||
124678874|NCT02711137|448449624|FG011|Overall Study|Lost to Follow-up|0|||
124678875|NCT02711137|448449625|FG012|Overall Study|Lost to Follow-up|0|||
124678876|NCT02711137|448449626|FG013|Overall Study|Lost to Follow-up|0|||
124678877|NCT02711137|448449627|FG014|Overall Study|Lost to Follow-up|0|||
124678878|NCT03427892|448449628|FG000|Overall Study|Lost to Follow-up|2|||
124678879|NCT00548327|448449629|FG000|Overall Study|Adverse Event|0|||
124678880|NCT00548327|448449630|FG001|Overall Study|Adverse Event|1|||
124678881|NCT00274456|448449631|FG000|Overall Study|Still on treatment|2|||
124678882|NCT00274456|448449632|FG001|Overall Study|Still on treatment|3|||
124435921|NCT00402597|447556688|FG001|Overall Study|Death|7|||
124544328|NCT02268214|447946769|FG001|Overall Study|Pregnancy|2|||
124678883|NCT00274456|448449633|FG002|Overall Study|Still on treatment|5|||
124876898|NCT00509236|449172844|FG000|Overall Study|Excluded Medication|1|||
124876899|NCT00509236|449172845|FG001|Overall Study|Excluded Medication|1|||
124876900|NCT00509236|449172844|FG000|Overall Study|Scheduled Kidney Transplant|1|||
124876901|NCT00509236|449172845|FG001|Overall Study|Scheduled Kidney Transplant|0|||
124876902|NCT00792103|449172846|FG000|Overall Study|Enrolled, not treated|15|||
124876903|NCT00792103|449172846|FG000|Overall Study|Lost to Follow-up|17|||
124876904|NCT00792103|449172846|FG000|Overall Study|Adverse Event|25|||
124876905|NCT00792103|449172846|FG000|Overall Study|Withdrawal by Subject|52|||
124876906|NCT00792103|449172846|FG000|Overall Study|Protocol Violation|10|||
124876907|NCT00792103|449172846|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
124876908|NCT03587142|449172847|FG000|Overall Study|Lost to Follow-up|5|||
124876909|NCT03587142|449172848|FG001|Overall Study|Lost to Follow-up|3|||
124876910|NCT03587142|449172847|FG000|Overall Study|Did not complete the f4 visit|3|||
124876911|NCT03587142|449172848|FG001|Overall Study|Did not complete the f4 visit|7|||
124876912|NCT02768662|449172849|FG000|Overall Study|Adverse Event|1|||
124876913|NCT02768662|449172849|FG000|Overall Study|Lost to Follow-up|4|||
124876914|NCT02768662|449172849|FG000|Overall Study|Withdrawal by Subject|3|||
124876915|NCT02768662|449172849|FG000|Overall Study|Study terminated by Sponsor|78|||
124876916|NCT03673462|449172850|FG000|Overall Study|Adverse Event|11|||
124876917|NCT03673462|449172851|FG001|Overall Study|Adverse Event|1|||
124876918|NCT03673462|449172850|FG000|Overall Study|Protocol Violation|25|||
124876919|NCT03673462|449172851|FG001|Overall Study|Protocol Violation|11|||
124876920|NCT03673462|449172850|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
124876921|NCT03673462|449172851|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
124876922|NCT03673462|449172850|FG000|Overall Study|Lost to Follow-up|102|||
124876923|NCT03673462|449172851|FG001|Overall Study|Lost to Follow-up|19|||
124876924|NCT03502616|449172852|FG000|Up to Week 16|Withdrawal by Subject|1|||
124876925|NCT03502616|449172853|FG001|Up to Week 16|Withdrawal by Subject|2|||
124876926|NCT03502616|449172852|FG000|Up to Week 16|Lost to Follow-up|0|||
124876927|NCT03502616|449172853|FG001|Up to Week 16|Lost to Follow-up|1|||
124876928|NCT03502616|449172852|FG000|Up to Week 16|Randomized, but not treated|1|||
124876929|NCT03502616|449172853|FG001|Up to Week 16|Randomized, but not treated|0|||
124876930|NCT03502616|449172852|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
124876931|NCT03502616|449172853|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
124876932|NCT03502616|449172852|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
124876933|NCT03502616|449172853|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
124876934|NCT00770432|449172858|FG000|Overall Study|Other|4|||
124876935|NCT00770432|449172859|FG001|Overall Study|Other|6|||
124876936|NCT00770432|449172858|FG000|Overall Study|Non-compliance|0|||
124876937|NCT00770432|449172859|FG001|Overall Study|Non-compliance|1|||
124876938|NCT01364597|449172860|FG000|Overall Study|Adverse Event|4|||
124876939|NCT01364597|449172861|FG001|Overall Study|Adverse Event|5|||
124876940|NCT01364597|449172862|FG002|Overall Study|Adverse Event|16|||
124876941|NCT01364597|449172863|FG003|Overall Study|Adverse Event|7|||
124876942|NCT01364597|449172860|FG000|Overall Study|Lack of Efficacy|4|||
124876943|NCT01364597|449172861|FG001|Overall Study|Lack of Efficacy|4|||
124876944|NCT01364597|449172862|FG002|Overall Study|Lack of Efficacy|23|||
124876945|NCT01364597|449172863|FG003|Overall Study|Lack of Efficacy|8|||
124876946|NCT01364597|449172860|FG000|Overall Study|Protocol Violation|0|||
124876947|NCT01364597|449172861|FG001|Overall Study|Protocol Violation|0|||
124876948|NCT01364597|449172862|FG002|Overall Study|Protocol Violation|2|||
124876949|NCT01364597|449172863|FG003|Overall Study|Protocol Violation|0|||
124876950|NCT01364597|449172860|FG000|Overall Study|Lost to Follow-up|0|||
124876951|NCT01364597|449172861|FG001|Overall Study|Lost to Follow-up|0|||
124876952|NCT01364597|449172862|FG002|Overall Study|Lost to Follow-up|5|||
124876953|NCT01364597|449172863|FG003|Overall Study|Lost to Follow-up|3|||
124876954|NCT01364597|449172860|FG000|Overall Study|Withdrawal by Subject|4|||
124876955|NCT01364597|449172861|FG001|Overall Study|Withdrawal by Subject|1|||
124876956|NCT01364597|449172862|FG002|Overall Study|Withdrawal by Subject|18|||
124876957|NCT01364597|449172863|FG003|Overall Study|Withdrawal by Subject|6|||
124876958|NCT01364597|449172860|FG000|Overall Study|Non compliance|1|||
124876959|NCT01364597|449172861|FG001|Overall Study|Non compliance|0|||
124876960|NCT01364597|449172862|FG002|Overall Study|Non compliance|1|||
124876961|NCT01364597|449172863|FG003|Overall Study|Non compliance|0|||
124876962|NCT01364597|449172860|FG000|Overall Study|Lack of compliance|1|||
124876963|NCT01364597|449172861|FG001|Overall Study|Lack of compliance|0|||
124876964|NCT01364597|449172862|FG002|Overall Study|Lack of compliance|0|||
124876965|NCT01364597|449172863|FG003|Overall Study|Lack of compliance|0|||
124876966|NCT01364597|449172860|FG000|Overall Study|End of treatment epilepsy|1|||
124876967|NCT01364597|449172861|FG001|Overall Study|End of treatment epilepsy|0|||
124876968|NCT01364597|449172862|FG002|Overall Study|End of treatment epilepsy|0|||
124876969|NCT01364597|449172863|FG003|Overall Study|End of treatment epilepsy|0|||
124876970|NCT01364597|449172860|FG000|Overall Study|No Seizures|1|||
124876971|NCT01364597|449172861|FG001|Overall Study|No Seizures|0|||
124876972|NCT01364597|449172862|FG002|Overall Study|No Seizures|0|||
124876973|NCT01364597|449172863|FG003|Overall Study|No Seizures|0|||
124876974|NCT01364597|449172860|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
124876975|NCT01364597|449172861|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
124876976|NCT01364597|449172862|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
124876977|NCT01364597|449172863|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
124876978|NCT01364597|449172860|FG000|Overall Study|Cure|1|||
124876979|NCT01364597|449172861|FG001|Overall Study|Cure|0|||
124876980|NCT01364597|449172862|FG002|Overall Study|Cure|0|||
124876981|NCT01364597|449172863|FG003|Overall Study|Cure|0|||
124876982|NCT01364597|449172860|FG000|Overall Study|Patient was moving|0|||
124876983|NCT01364597|449172861|FG001|Overall Study|Patient was moving|1|||
124876984|NCT01364597|449172862|FG002|Overall Study|Patient was moving|0|||
124876985|NCT01364597|449172863|FG003|Overall Study|Patient was moving|0|||
124876986|NCT01364597|449172860|FG000|Overall Study|Seizures resolved|0|||
124876987|NCT01364597|449172861|FG001|Overall Study|Seizures resolved|0|||
124876988|NCT01364597|449172862|FG002|Overall Study|Seizures resolved|1|||
124876989|NCT01364597|449172863|FG003|Overall Study|Seizures resolved|0|||
124876990|NCT01364597|449172860|FG000|Overall Study|Patient became seizure-free after surgery|0|||
124876991|NCT01364597|449172861|FG001|Overall Study|Patient became seizure-free after surgery|0|||
124876992|NCT01364597|449172862|FG002|Overall Study|Patient became seizure-free after surgery|1|||
124876993|NCT01364597|449172863|FG003|Overall Study|Patient became seizure-free after surgery|0|||
124876994|NCT01364597|449172860|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
124876995|NCT01364597|449172861|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
124876996|NCT01364597|449172862|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
124876997|NCT01364597|449172863|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
124876998|NCT01364597|449172860|FG000|Overall Study|Patient cured from Epilepsy|0|||
124876999|NCT01364597|449172861|FG001|Overall Study|Patient cured from Epilepsy|0|||
124877000|NCT01364597|449172862|FG002|Overall Study|Patient cured from Epilepsy|1|||
124877001|NCT01364597|449172863|FG003|Overall Study|Patient cured from Epilepsy|0|||
124877002|NCT01364597|449172860|FG000|Overall Study|Investigator decision|0|||
124877003|NCT01364597|449172861|FG001|Overall Study|Investigator decision|0|||
124877004|NCT01364597|449172862|FG002|Overall Study|Investigator decision|1|||
124877005|NCT01364597|449172863|FG003|Overall Study|Investigator decision|0|||
124877006|NCT01364597|449172860|FG000|Overall Study|Sponsor recommended discontinuation|0|||
124877007|NCT01364597|449172861|FG001|Overall Study|Sponsor recommended discontinuation|0|||
124877008|NCT01364597|449172862|FG002|Overall Study|Sponsor recommended discontinuation|0|||
124877009|NCT01364597|449172863|FG003|Overall Study|Sponsor recommended discontinuation|1|||
124877010|NCT01364597|449172860|FG000|Overall Study|Parents went abroad with the patient|0|||
124877011|NCT01364597|449172861|FG001|Overall Study|Parents went abroad with the patient|0|||
124877012|NCT01364597|449172862|FG002|Overall Study|Parents went abroad with the patient|1|||
124877013|NCT01364597|449172863|FG003|Overall Study|Parents went abroad with the patient|0|||
124877014|NCT01364597|449172860|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
124877015|NCT01364597|449172861|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
124877016|NCT01364597|449172862|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
124877017|NCT01364597|449172863|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
124435922|NCT00402597|447556689|FG002|Overall Study|Death|6|||
124877018|NCT01364597|449172860|FG000|Overall Study|BRV administration dropout|0|||
124877019|NCT01364597|449172861|FG001|Overall Study|BRV administration dropout|0|||
124435923|NCT00402597|447556690|FG003|Overall Study|Death|4|||
124877020|NCT01364597|449172862|FG002|Overall Study|BRV administration dropout|1|||
124877021|NCT01364597|449172863|FG003|Overall Study|BRV administration dropout|0|||
124877022|NCT01364597|449172860|FG000|Overall Study|Dropout|0|||
124877023|NCT01364597|449172861|FG001|Overall Study|Dropout|0|||
124877024|NCT01364597|449172862|FG002|Overall Study|Dropout|3|||
124877025|NCT01364597|449172863|FG003|Overall Study|Dropout|1|||
124435924|NCT00402597|447556691|FG004|Overall Study|Death|6|||
124877026|NCT01364597|449172860|FG000|Overall Study|Unreliable subject|0|||
124877027|NCT01364597|449172861|FG001|Overall Study|Unreliable subject|0|||
124877028|NCT01364597|449172862|FG002|Overall Study|Unreliable subject|0|||
124877029|NCT01364597|449172863|FG003|Overall Study|Unreliable subject|1|||
124877030|NCT01364597|449172860|FG000|Overall Study|Other|0|||
124877031|NCT01364597|449172861|FG001|Overall Study|Other|0|||
124877032|NCT01364597|449172862|FG002|Overall Study|Other|0|||
124877033|NCT01364597|449172863|FG003|Overall Study|Other|1|||
124877034|NCT01498822|449172864|FG000|Overall Study|Protocol Violation|8|||
124435925|NCT00402597|447556687|FG000|Overall Study|Adverse Event|81|||
124435926|NCT00402597|447556688|FG001|Overall Study|Adverse Event|18|||
124435927|NCT00402597|447556689|FG002|Overall Study|Adverse Event|106|||
124435928|NCT00402597|447556690|FG003|Overall Study|Adverse Event|39|||
124435929|NCT00402597|447556691|FG004|Overall Study|Adverse Event|71|||
124435930|NCT00402597|447556687|FG000|Overall Study|Lost to Follow-up|8|||
124435931|NCT00402597|447556688|FG001|Overall Study|Lost to Follow-up|1|||
124435932|NCT00402597|447556689|FG002|Overall Study|Lost to Follow-up|8|||
124435933|NCT00402597|447556690|FG003|Overall Study|Lost to Follow-up|2|||
124435934|NCT00402597|447556691|FG004|Overall Study|Lost to Follow-up|3|||
124435935|NCT00402597|447556687|FG000|Overall Study|Withdrawal by Subject|57|||
124435936|NCT00402597|447556688|FG001|Overall Study|Withdrawal by Subject|16|||
124435937|NCT00402597|447556689|FG002|Overall Study|Withdrawal by Subject|65|||
124877035|NCT01498822|449172865|FG001|Overall Study|Protocol Violation|4|||
124877036|NCT01498822|449172864|FG000|Overall Study|Other Reason|5|||
124678884|NCT00274456|448449634|FG003|Overall Study|Still on treatment|1|||
124678885|NCT00274456|448449631|FG000|Overall Study|Unacceptable toxicity|10|||
124678886|NCT00274456|448449632|FG001|Overall Study|Unacceptable toxicity|5|||
124678887|NCT00274456|448449633|FG002|Overall Study|Unacceptable toxicity|12|||
124678888|NCT00274456|448449634|FG003|Overall Study|Unacceptable toxicity|16|||
124678889|NCT00274456|448449631|FG000|Overall Study|Adverse Event|0|||
124678890|NCT00274456|448449632|FG001|Overall Study|Adverse Event|1|||
124678891|NCT00274456|448449633|FG002|Overall Study|Adverse Event|2|||
124678892|NCT00274456|448449634|FG003|Overall Study|Adverse Event|2|||
124678893|NCT00274456|448449631|FG000|Overall Study|Physician Decision|7|||
124678894|NCT00274456|448449632|FG001|Overall Study|Physician Decision|5|||
124678895|NCT00274456|448449633|FG002|Overall Study|Physician Decision|6|||
124678896|NCT00274456|448449634|FG003|Overall Study|Physician Decision|13|||
124678897|NCT00274456|448449631|FG000|Overall Study|Lost to Follow-up|0|||
124678898|NCT00274456|448449632|FG001|Overall Study|Lost to Follow-up|0|||
124678899|NCT00274456|448449633|FG002|Overall Study|Lost to Follow-up|1|||
124435938|NCT00402597|447556690|FG003|Overall Study|Withdrawal by Subject|15|||
124435939|NCT00402597|447556691|FG004|Overall Study|Withdrawal by Subject|24|||
124435940|NCT00402597|447556687|FG000|Overall Study|reason not specified|30|||
124435941|NCT00402597|447556688|FG001|Overall Study|reason not specified|4|||
124435942|NCT00402597|447556689|FG002|Overall Study|reason not specified|27|||
124435943|NCT00402597|447556690|FG003|Overall Study|reason not specified|14|||
124435944|NCT00402597|447556691|FG004|Overall Study|reason not specified|20|||
124435945|NCT01442779|447556692|FG000|Overall Study|Withdrawal by Subject|3|||
124435946|NCT01442779|447556692|FG000|Overall Study|Death|3|||
124435947|NCT01442779|447556692|FG000|Overall Study|Non-compliance|1|||
124435948|NCT03426605|447556693|FG000|Overall Study|AML relapse or progression|2|||
124435949|NCT03426605|447556694|FG001|Overall Study|AML relapse or progression|1|||
124435950|NCT03426605|447556695|FG002|Overall Study|AML relapse or progression|2|||
124435951|NCT03426605|447556696|FG003|Overall Study|AML relapse or progression|2|||
124435952|NCT03426605|447556693|FG000|Overall Study|Treatment failure|3|||
124435953|NCT03426605|447556694|FG001|Overall Study|Treatment failure|2|||
124435954|NCT03426605|447556695|FG002|Overall Study|Treatment failure|0|||
124435955|NCT03426605|447556696|FG003|Overall Study|Treatment failure|0|||
124435956|NCT03426605|447556693|FG000|Overall Study|Adverse Event|1|||
124435957|NCT03426605|447556694|FG001|Overall Study|Adverse Event|0|||
124678900|NCT00274456|448449634|FG003|Overall Study|Lost to Follow-up|0|||
124678901|NCT00274456|448449631|FG000|Overall Study|Withdrawal by Subject|18|||
124678902|NCT00274456|448449632|FG001|Overall Study|Withdrawal by Subject|13|||
124678903|NCT00274456|448449633|FG002|Overall Study|Withdrawal by Subject|9|||
124678904|NCT00274456|448449634|FG003|Overall Study|Withdrawal by Subject|13|||
124877037|NCT01498822|449172865|FG001|Overall Study|Other Reason|2|||
124435958|NCT03426605|447556695|FG002|Overall Study|Adverse Event|1|||
124435959|NCT03426605|447556696|FG003|Overall Study|Adverse Event|1|||
124435960|NCT03426605|447556693|FG000|Overall Study|Withdrawal by Subject|0|||
124435961|NCT03426605|447556694|FG001|Overall Study|Withdrawal by Subject|0|||
124435962|NCT03426605|447556695|FG002|Overall Study|Withdrawal by Subject|1|||
124435963|NCT03426605|447556696|FG003|Overall Study|Withdrawal by Subject|1|||
124435964|NCT01048671|447556697|FG000|Overall Study|Protocol Violation|0|||
124435965|NCT01048671|447556698|FG001|Overall Study|Protocol Violation|1|||
124435966|NCT01048671|447556699|FG002|Overall Study|Protocol Violation|1|||
124678905|NCT03255187|448449638|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
124877038|NCT01498822|449172864|FG000|Overall Study|Lack of Efficacy|7|||
124435967|NCT03814187|447556700|FG000|Overall Study|Sponsor's Administrative Decision|0|||
124877039|NCT01498822|449172865|FG001|Overall Study|Lack of Efficacy|2|||
124678906|NCT03255187|448449639|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
124678907|NCT03255187|448449638|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
124678908|NCT03255187|448449639|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
124435968|NCT03814187|447556701|FG001|Overall Study|Sponsor's Administrative Decision|0|||
124435969|NCT03814187|447556702|FG002|Overall Study|Sponsor's Administrative Decision|272|||
124435970|NCT03814187|447556700|FG000|Overall Study|Death|80|||
124435971|NCT03814187|447556701|FG001|Overall Study|Death|81|||
124435972|NCT03814187|447556702|FG002|Overall Study|Death|4|||
124435973|NCT03814187|447556700|FG000|Overall Study|Withdrew Consent|77|||
124435974|NCT03814187|447556701|FG001|Overall Study|Withdrew Consent|78|||
124435975|NCT03814187|447556702|FG002|Overall Study|Withdrew Consent|2|||
124435976|NCT03814187|447556700|FG000|Overall Study|Lost to Follow-up|47|||
124435977|NCT03814187|447556701|FG001|Overall Study|Lost to Follow-up|52|||
124435978|NCT03814187|447556702|FG002|Overall Study|Lost to Follow-up|1|||
124435979|NCT03814187|447556700|FG000|Overall Study|Adverse Event|22|||
124435980|NCT03814187|447556701|FG001|Overall Study|Adverse Event|23|||
124435981|NCT03814187|447556702|FG002|Overall Study|Adverse Event|0|||
124435982|NCT03814187|447556700|FG000|Overall Study|Physician Decision|7|||
124435983|NCT03814187|447556701|FG001|Overall Study|Physician Decision|4|||
124435984|NCT03814187|447556702|FG002|Overall Study|Physician Decision|2|||
124435985|NCT03814187|447556700|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
124435986|NCT03814187|447556701|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
124435987|NCT03814187|447556702|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
124678909|NCT00375752|448449640|FG000|Overall Study|Lack of Efficacy|4|||
124678910|NCT00375752|448449641|FG001|Overall Study|Lack of Efficacy|4|||
124678911|NCT00375752|448449640|FG000|Overall Study|Adverse Event|1|||
124678912|NCT00375752|448449641|FG001|Overall Study|Adverse Event|6|||
124678913|NCT00375752|448449640|FG000|Overall Study|Withdrawal by Subject|6|||
124678914|NCT00375752|448449641|FG001|Overall Study|Withdrawal by Subject|1|||
124678915|NCT00375752|448449640|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
124678916|NCT00375752|448449641|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
124678917|NCT00375752|448449640|FG000|Overall Study|Protocol Violation|0|||
124678918|NCT00375752|448449641|FG001|Overall Study|Protocol Violation|2|||
124678919|NCT00375752|448449640|FG000|Overall Study|Administrative Problems|0|||
124678920|NCT00375752|448449641|FG001|Overall Study|Administrative Problems|1|||
124678921|NCT02034006|448449642|FG000|Overall Study|Withdrawal by Subject|7|||
124678922|NCT02034006|448449642|FG000|Overall Study|Lost to Follow-up|5|||
124678923|NCT02034006|448449642|FG000|Overall Study|Death|1|||
124678924|NCT02034006|448449642|FG000|Overall Study|Pregnancy|1|||
124678925|NCT00109343|448449646|FG000|Overall Study|Adverse Event|1|||
124678926|NCT00109343|448449647|FG001|Overall Study|Adverse Event|0|||
124678927|NCT00109343|448449648|FG002|Overall Study|Adverse Event|2|||
124678928|NCT00109343|448449646|FG000|Overall Study|Lack of Efficacy|1|||
124678929|NCT00109343|448449647|FG001|Overall Study|Lack of Efficacy|0|||
124678930|NCT00109343|448449648|FG002|Overall Study|Lack of Efficacy|0|||
124678931|NCT00109343|448449646|FG000|Overall Study|Lost to Follow-up|35|||
124678932|NCT00109343|448449647|FG001|Overall Study|Lost to Follow-up|20|||
124678933|NCT00109343|448449648|FG002|Overall Study|Lost to Follow-up|14|||
124678934|NCT00109343|448449646|FG000|Overall Study|Protocol Violation|1|||
124678935|NCT00109343|448449647|FG001|Overall Study|Protocol Violation|2|||
124678936|NCT00109343|448449648|FG002|Overall Study|Protocol Violation|2|||
124678937|NCT00109343|448449646|FG000|Overall Study|Withdrawal by Subject|15|||
124678938|NCT00109343|448449647|FG001|Overall Study|Withdrawal by Subject|11|||
124678939|NCT00109343|448449648|FG002|Overall Study|Withdrawal by Subject|10|||
124678940|NCT00109343|448449646|FG000|Overall Study|Subject Moved|6|||
124678941|NCT00109343|448449647|FG001|Overall Study|Subject Moved|2|||
124678942|NCT00109343|448449648|FG002|Overall Study|Subject Moved|1|||
124678943|NCT00109343|448449646|FG000|Overall Study|Other|5|||
124678944|NCT00109343|448449647|FG001|Overall Study|Other|2|||
124678945|NCT00109343|448449648|FG002|Overall Study|Other|1|||
124678946|NCT01799889|448449649|FG000|Overall Study|Adverse Event|4|||
124678947|NCT01799889|448449650|FG001|Overall Study|Adverse Event|4|||
124678948|NCT01799889|448449651|FG002|Overall Study|Adverse Event|5|||
124678949|NCT01799889|448449652|FG003|Overall Study|Adverse Event|1|||
124435988|NCT03814187|447556700|FG000|Overall Study|Other reasons|34|||
124435989|NCT03814187|447556701|FG001|Overall Study|Other reasons|40|||
124435990|NCT03814187|447556702|FG002|Overall Study|Other reasons|2|||
124435991|NCT00513604|447556703|FG000|Overall Study|Not treated|2|||
124435992|NCT00513604|447556704|FG001|Overall Study|Not treated|0|||
124435993|NCT00513604|447556705|FG002|Overall Study|Not treated|1|||
124544329|NCT02268214|447946770|FG002|Overall Study|Pregnancy|1|||
124678950|NCT01799889|448449653|FG004|Overall Study|Adverse Event|11|||
124678951|NCT01799889|448449654|FG005|Overall Study|Adverse Event|1|||
124678952|NCT01799889|448449655|FG006|Overall Study|Adverse Event|5|||
124678953|NCT01799889|448449656|FG007|Overall Study|Adverse Event|2|||
124678954|NCT01799889|448449657|FG008|Overall Study|Adverse Event|3|||
124678955|NCT01799889|448449658|FG009|Overall Study|Adverse Event|1|||
124678956|NCT01799889|448449659|FG010|Overall Study|Adverse Event|1|||
124678957|NCT01799889|448449660|FG011|Overall Study|Adverse Event|0|||
124678958|NCT01799889|448449649|FG000|Overall Study|Death|1|||
124678959|NCT01799889|448449650|FG001|Overall Study|Death|0|||
124678960|NCT01799889|448449651|FG002|Overall Study|Death|5|||
124678961|NCT01799889|448449652|FG003|Overall Study|Death|3|||
124678962|NCT01799889|448449653|FG004|Overall Study|Death|1|||
124678963|NCT01799889|448449654|FG005|Overall Study|Death|0|||
124678964|NCT01799889|448449655|FG006|Overall Study|Death|0|||
124678965|NCT01799889|448449656|FG007|Overall Study|Death|0|||
124678966|NCT01799889|448449657|FG008|Overall Study|Death|1|||
124877040|NCT01498822|449172864|FG000|Overall Study|AE, non-serious non-fatal|8|||
124877041|NCT01498822|449172865|FG001|Overall Study|AE, non-serious non-fatal|17|||
124877042|NCT01498822|449172864|FG000|Overall Study|SAE, non-fatal|2|||
124877043|NCT01498822|449172865|FG001|Overall Study|SAE, non-fatal|2|||
124877044|NCT01498822|449172864|FG000|Overall Study|Adverse Event, serious fatal|1|||
124877045|NCT01498822|449172865|FG001|Overall Study|Adverse Event, serious fatal|1|||
124877046|NCT01498822|449172864|FG000|Overall Study|Withdrawal by Subject|15|||
124877047|NCT01498822|449172865|FG001|Overall Study|Withdrawal by Subject|25|||
124877048|NCT01498822|449172864|FG000|Overall Study|Lost to Follow-up|8|||
124877049|NCT01498822|449172865|FG001|Overall Study|Lost to Follow-up|3|||
124877050|NCT03579290|449172873|FG000|Overall Study|Lost to Follow-up|9|||
124877051|NCT03131960|449172876|FG000|Overall Study|Adverse Event|0|||
124877052|NCT03131960|449172877|FG001|Overall Study|Adverse Event|1|||
124877053|NCT04404478|449172879|FG000|Overall Study|Withdrawal by Subject|1|||
124877054|NCT04404478|449172880|FG001|Overall Study|Withdrawal by Subject|3|||
124877055|NCT02904902|449172881|FG000|Overall Study|Withdrawal by Subject|1|||
124877056|NCT02002182|449172884|FG000|Overall Study|Withdraw from study|3|||
124877057|NCT02002182|449172885|FG001|Overall Study|Withdraw from study|1|||
124877058|NCT02002182|449172884|FG000|Overall Study|Health Reasons|1|||
124877059|NCT02002182|449172885|FG001|Overall Study|Health Reasons|0|||
124877060|NCT02002182|449172884|FG000|Overall Study|Death|1|||
124877061|NCT02002182|449172885|FG001|Overall Study|Death|0|||
124877062|NCT01597505|449172888|FG000|Overall Study|Physician Decision|5|||
124877063|NCT01597505|449172889|FG001|Overall Study|Physician Decision|0|||
124877064|NCT01597505|449172888|FG000|Overall Study|Adverse Event|19|||
124877065|NCT01597505|449172889|FG001|Overall Study|Adverse Event|7|||
124877066|NCT01597505|449172888|FG000|Overall Study|Lost to Follow-up|4|||
124877067|NCT01597505|449172889|FG001|Overall Study|Lost to Follow-up|2|||
124877068|NCT01597505|449172888|FG000|Overall Study|Withdrawal by Subject|10|||
124877069|NCT01597505|449172889|FG001|Overall Study|Withdrawal by Subject|18|||
124877070|NCT01597505|449172888|FG000|Overall Study|Other|5|||
124877071|NCT01597505|449172889|FG001|Overall Study|Other|6|||
124877072|NCT01597505|449172888|FG000|Overall Study|Missing|1|||
124877073|NCT01597505|449172889|FG001|Overall Study|Missing|0|||
124877074|NCT00895622|449172899|FG000|Overall Study|Protocol Violation|5|||
124877075|NCT00895622|449172900|FG001|Overall Study|Protocol Violation|4|||
124877076|NCT00895622|449172901|FG002|Overall Study|Protocol Violation|4|||
124877077|NCT01490125|449172902|FG000|Period I|Adverse Event|4|||
124877078|NCT01490125|449172903|FG001|Period I|Adverse Event|1|||
124877079|NCT01490125|449172904|FG002|Period I|Adverse Event|1|||
124877080|NCT01490125|449172905|FG003|Period I|Adverse Event|3|||
124877081|NCT01490125|449172906|FG004|Period I|Adverse Event|2|||
124877082|NCT01490125|449172907|FG005|Period I|Adverse Event|4|||
124877083|NCT01490125|449172902|FG000|Period I|Protocol Violation|1|||
124877084|NCT01490125|449172903|FG001|Period I|Protocol Violation|1|||
124877085|NCT01490125|449172904|FG002|Period I|Protocol Violation|1|||
124877086|NCT01490125|449172905|FG003|Period I|Protocol Violation|1|||
124877087|NCT01490125|449172906|FG004|Period I|Protocol Violation|0|||
124877088|NCT01490125|449172907|FG005|Period I|Protocol Violation|0|||
124877089|NCT01490125|449172902|FG000|Period I|Withdrawal by Subject|1|||
124435994|NCT00513604|447556706|FG003|Overall Study|Not treated|0|||
124435995|NCT00513604|447556707|FG004|Overall Study|Not treated|0|||
124435996|NCT00513604|447556703|FG000|Overall Study|Death during treatment|0|||
124678967|NCT01799889|448449658|FG009|Overall Study|Death|0|||
124678968|NCT01799889|448449659|FG010|Overall Study|Death|1|||
124877090|NCT01490125|449172903|FG001|Period I|Withdrawal by Subject|3|||
124877091|NCT01490125|449172904|FG002|Period I|Withdrawal by Subject|2|||
124877092|NCT01490125|449172905|FG003|Period I|Withdrawal by Subject|1|||
124877093|NCT01490125|449172906|FG004|Period I|Withdrawal by Subject|2|||
124877094|NCT01490125|449172907|FG005|Period I|Withdrawal by Subject|1|||
124435997|NCT00513604|447556704|FG001|Overall Study|Death during treatment|3|||
124435998|NCT00513604|447556705|FG002|Overall Study|Death during treatment|2|||
124678969|NCT01799889|448449660|FG011|Overall Study|Death|0|||
124678970|NCT01799889|448449649|FG000|Overall Study|Lack of Efficacy|1|||
124877095|NCT01490125|449172902|FG000|Period II|Adverse Event|2|||
124877096|NCT01490125|449172903|FG001|Period II|Adverse Event|3|||
124877097|NCT01490125|449172904|FG002|Period II|Adverse Event|2|||
124877098|NCT01490125|449172905|FG003|Period II|Adverse Event|2|||
124877099|NCT01490125|449172906|FG004|Period II|Adverse Event|4|||
124678971|NCT01799889|448449650|FG001|Overall Study|Lack of Efficacy|1|||
124877100|NCT01490125|449172907|FG005|Period II|Adverse Event|2|||
124877101|NCT01490125|449172902|FG000|Period II|Protocol Violation|0|||
124877102|NCT01490125|449172903|FG001|Period II|Protocol Violation|0|||
124877103|NCT01490125|449172904|FG002|Period II|Protocol Violation|1|||
124877104|NCT01490125|449172905|FG003|Period II|Protocol Violation|1|||
124877105|NCT01490125|449172906|FG004|Period II|Protocol Violation|0|||
124877106|NCT01490125|449172907|FG005|Period II|Protocol Violation|0|||
124877107|NCT01490125|449172902|FG000|Period II|Lost to Follow-up|0|||
124877108|NCT01490125|449172903|FG001|Period II|Lost to Follow-up|1|||
124877109|NCT01490125|449172904|FG002|Period II|Lost to Follow-up|0|||
124877110|NCT01490125|449172905|FG003|Period II|Lost to Follow-up|0|||
124877111|NCT01490125|449172906|FG004|Period II|Lost to Follow-up|0|||
124877112|NCT01490125|449172907|FG005|Period II|Lost to Follow-up|0|||
124877113|NCT01490125|449172902|FG000|Period II|Withdrawal by Subject|1|||
124877114|NCT01490125|449172903|FG001|Period II|Withdrawal by Subject|0|||
124877115|NCT01490125|449172904|FG002|Period II|Withdrawal by Subject|0|||
124877116|NCT01490125|449172905|FG003|Period II|Withdrawal by Subject|0|||
124877117|NCT01490125|449172906|FG004|Period II|Withdrawal by Subject|0|||
124877118|NCT01490125|449172907|FG005|Period II|Withdrawal by Subject|0|||
124877119|NCT01490125|449172902|FG000|Period III|Adverse Event|3|||
124877120|NCT01490125|449172903|FG001|Period III|Adverse Event|1|||
124877121|NCT01490125|449172904|FG002|Period III|Adverse Event|0|||
124877122|NCT01490125|449172905|FG003|Period III|Adverse Event|1|||
124877123|NCT01490125|449172906|FG004|Period III|Adverse Event|0|||
124877124|NCT01490125|449172907|FG005|Period III|Adverse Event|0|||
124877125|NCT01490125|449172902|FG000|Period III|Death|0|||
124877126|NCT01490125|449172903|FG001|Period III|Death|0|||
124877127|NCT01490125|449172904|FG002|Period III|Death|0|||
124877128|NCT01490125|449172905|FG003|Period III|Death|1|||
124877129|NCT01490125|449172906|FG004|Period III|Death|0|||
124877130|NCT01490125|449172907|FG005|Period III|Death|0|||
124877131|NCT01490125|449172902|FG000|Period III|Lack of Efficacy|0|||
124877132|NCT01490125|449172903|FG001|Period III|Lack of Efficacy|0|||
124877133|NCT01490125|449172904|FG002|Period III|Lack of Efficacy|0|||
124877134|NCT01490125|449172905|FG003|Period III|Lack of Efficacy|0|||
124877135|NCT01490125|449172906|FG004|Period III|Lack of Efficacy|1|||
124877136|NCT01490125|449172907|FG005|Period III|Lack of Efficacy|0|||
124877137|NCT02237508|449172909|FG000|Overall Study|Withdrawal by Subject|0|||
124877138|NCT02237508|449172910|FG001|Overall Study|Withdrawal by Subject|2|||
124877139|NCT02237508|449172911|FG002|Overall Study|Withdrawal by Subject|0|||
124877140|NCT02237508|449172912|FG003|Overall Study|Withdrawal by Subject|1|||
124877141|NCT02237508|449172913|FG004|Overall Study|Withdrawal by Subject|0|||
124877142|NCT02237508|449172914|FG005|Overall Study|Withdrawal by Subject|1|||
124877143|NCT02237508|449172915|FG006|Overall Study|Withdrawal by Subject|1|||
124877144|NCT02237508|449172916|FG007|Overall Study|Withdrawal by Subject|0|||
124877145|NCT02237508|449172917|FG008|Overall Study|Withdrawal by Subject|1|||
124877146|NCT02237508|449172918|FG009|Overall Study|Withdrawal by Subject|0|||
124877147|NCT02237508|449172909|FG000|Overall Study|Physician Decision|0|||
124877148|NCT02237508|449172910|FG001|Overall Study|Physician Decision|1|||
124877149|NCT02237508|449172911|FG002|Overall Study|Physician Decision|0|||
124877150|NCT02237508|449172912|FG003|Overall Study|Physician Decision|0|||
124877151|NCT02237508|449172913|FG004|Overall Study|Physician Decision|0|||
124877152|NCT02237508|449172914|FG005|Overall Study|Physician Decision|0|||
124877153|NCT02237508|449172915|FG006|Overall Study|Physician Decision|0|||
124877154|NCT02237508|449172916|FG007|Overall Study|Physician Decision|0|||
124877155|NCT02237508|449172917|FG008|Overall Study|Physician Decision|0|||
124877156|NCT02237508|449172918|FG009|Overall Study|Physician Decision|0|||
124877157|NCT02237508|449172909|FG000|Overall Study|Protocol Violation|0|||
124877158|NCT02237508|449172910|FG001|Overall Study|Protocol Violation|0|||
124877159|NCT02237508|449172911|FG002|Overall Study|Protocol Violation|1|||
124877160|NCT02237508|449172912|FG003|Overall Study|Protocol Violation|0|||
124877161|NCT02237508|449172913|FG004|Overall Study|Protocol Violation|0|||
124877162|NCT02237508|449172914|FG005|Overall Study|Protocol Violation|0|||
124877163|NCT02237508|449172915|FG006|Overall Study|Protocol Violation|0|||
124877164|NCT02237508|449172916|FG007|Overall Study|Protocol Violation|0|||
124877165|NCT02237508|449172917|FG008|Overall Study|Protocol Violation|0|||
124877166|NCT02237508|449172918|FG009|Overall Study|Protocol Violation|0|||
124877167|NCT04954586|449172919|FG000|Overall Study|Withdrawal by Subject|5|||
124877168|NCT04000594|449172920|FG000|Overall Study|Withdrawal by Subject|1|||
124877169|NCT04000594|449172921|FG001|Overall Study|Withdrawal by Subject|0|||
124877170|NCT04000594|449172922|FG002|Overall Study|Withdrawal by Subject|0|||
124877171|NCT04522180|449172923|FG000|Overall Study|Investigator judgement|3|||
124877172|NCT04522180|449172924|FG001|Overall Study|Investigator judgement|4|||
124877173|NCT04522180|449172923|FG000|Overall Study|Voluntary withdrawal|1|||
124877174|NCT04522180|449172924|FG001|Overall Study|Voluntary withdrawal|0|||
124877175|NCT04522180|449172923|FG000|Overall Study|Pregnancy|0|||
124877176|NCT04522180|449172924|FG001|Overall Study|Pregnancy|1|||
124877177|NCT04522180|449172923|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
124877178|NCT04522180|449172924|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
124877179|NCT04522180|449172923|FG000|Overall Study|Reason not specified|8|||
124877180|NCT04522180|449172924|FG001|Overall Study|Reason not specified|5|||
124877181|NCT01905046|449172925|FG000|Months 13-24|Withdrawal by Subject|10|||
124877182|NCT01905046|449172926|FG001|Months 13-24|Withdrawal by Subject|10|||
124877183|NCT01905046|449172925|FG000|Months 13-24|Adverse Event|3|||
124877184|NCT01905046|449172926|FG001|Months 13-24|Adverse Event|2|||
124877185|NCT01905046|449172925|FG000|Months 13-24|Protocol Violation|3|||
124877186|NCT01905046|449172926|FG001|Months 13-24|Protocol Violation|3|||
124877187|NCT01905046|449172925|FG000|Months 13-24|Physician Decision|1|||
124877188|NCT01905046|449172926|FG001|Months 13-24|Physician Decision|0|||
124877189|NCT03489057|449172931|FG000|Overall Study|Lost to Follow-up|16|||
124877190|NCT03489057|449172932|FG001|Overall Study|Lost to Follow-up|16|||
124877191|NCT03489057|449172933|FG002|Overall Study|Lost to Follow-up|14|||
124877192|NCT03489057|449172934|FG003|Overall Study|Lost to Follow-up|14|||
124877193|NCT03489057|449172931|FG000|Overall Study|Withdrawal by Subject|12|||
124877194|NCT03489057|449172932|FG001|Overall Study|Withdrawal by Subject|12|||
124877195|NCT03489057|449172933|FG002|Overall Study|Withdrawal by Subject|8|||
124877196|NCT03489057|449172934|FG003|Overall Study|Withdrawal by Subject|8|||
124877197|NCT03489057|449172931|FG000|Overall Study|Protocol Violation|7|||
124877198|NCT03489057|449172932|FG001|Overall Study|Protocol Violation|7|||
124877199|NCT03489057|449172933|FG002|Overall Study|Protocol Violation|2|||
124877200|NCT03489057|449172934|FG003|Overall Study|Protocol Violation|2|||
124877201|NCT01368900|449172937|FG000|Overall Study|Lost to Follow-up|7|||
124877202|NCT04027348|449172940|FG000|Overall Study|Adverse Event|2|||
124877203|NCT02487472|449172941|FG000|Overall Study|Did not complete telephonic interviews|9|||
124877204|NCT02487472|449172941|FG000|Overall Study|Other|2|||
124877205|NCT02277743|449172942|FG000|Overall Study|Protocol Violation|1|||
124877206|NCT02277743|449172943|FG001|Overall Study|Protocol Violation|1|||
124877207|NCT02277743|449172944|FG002|Overall Study|Protocol Violation|1|||
124877208|NCT02277743|449172942|FG000|Overall Study|Adverse Event|10|||
124877209|NCT02277743|449172943|FG001|Overall Study|Adverse Event|6|||
124877210|NCT02277743|449172944|FG002|Overall Study|Adverse Event|6|||
124877211|NCT02277743|449172942|FG000|Overall Study|Lack of Efficacy|11|||
124877212|NCT02277743|449172943|FG001|Overall Study|Lack of Efficacy|4|||
124877213|NCT02277743|449172944|FG002|Overall Study|Lack of Efficacy|3|||
124877214|NCT02277743|449172942|FG000|Overall Study|Other than specified above|18|||
124877215|NCT02277743|449172943|FG001|Overall Study|Other than specified above|5|||
124877216|NCT02277743|449172944|FG002|Overall Study|Other than specified above|16|||
124877217|NCT01224158|449172945|FG000|Overall Study|Withdrawal by Subject|1|||
124877218|NCT01224158|449172946|FG001|Overall Study|Withdrawal by Subject|0|||
124877219|NCT02055157|449172949|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
124877220|NCT02055157|449172950|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
124877221|NCT02055157|449172951|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
124877222|NCT02055157|449172952|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
124877223|NCT02055157|449172949|FG000|Initial 6 Months|Adverse Event|0|||
124877224|NCT02055157|449172950|FG001|Initial 6 Months|Adverse Event|0|||
124877225|NCT02055157|449172951|FG002|Initial 6 Months|Adverse Event|0|||
124877226|NCT02055157|449172952|FG003|Initial 6 Months|Adverse Event|1|||
124877227|NCT02055157|449172949|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
124877228|NCT02055157|449172950|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
124877229|NCT02055157|449172951|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
124877230|NCT02055157|449172952|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
124877231|NCT02055157|449172949|FG000|18-month Extension|Investigator decision|0|||
124877232|NCT02055157|449172950|FG001|18-month Extension|Investigator decision|1|||
124877233|NCT02055157|449172951|FG002|18-month Extension|Investigator decision|0|||
124877234|NCT02055157|449172952|FG003|18-month Extension|Investigator decision|0|||
124877235|NCT02055157|449172949|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
124877236|NCT02055157|449172950|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
124877237|NCT02055157|449172951|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
124877238|NCT02055157|449172952|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
124877239|NCT03976466|449172953|FG000|Overall Study|Lost to Follow-up|1|||
124435999|NCT00513604|447556706|FG003|Overall Study|Death during treatment|0|||
124436000|NCT00513604|447556707|FG004|Overall Study|Death during treatment|0|||
124436001|NCT02009761|447556708|FG000|Overall Study|Adverse Event|4|||
124877240|NCT03976466|449172954|FG001|Overall Study|Lost to Follow-up|3|||
124877241|NCT00733499|449172955|FG000|Pre-operative|Protocol Violation|0|||
124877242|NCT00733499|449172956|FG001|Pre-operative|Protocol Violation|1|||
124877243|NCT00733499|449172955|FG000|3 Months Follow-up|Death|1|||
124877244|NCT00733499|449172956|FG001|3 Months Follow-up|Death|2|||
124877245|NCT00733499|449172955|FG000|6 Months Follow-up|Death|0|||
124877246|NCT00733499|449172956|FG001|6 Months Follow-up|Death|2|||
124877247|NCT00733499|449172955|FG000|6 Months Follow-up|Adverse Event|0|||
124678972|NCT01799889|448449651|FG002|Overall Study|Lack of Efficacy|0|||
124877248|NCT00733499|449172956|FG001|6 Months Follow-up|Adverse Event|1|||
124877249|NCT00733499|449172955|FG000|12 Months Follow-up|Death|2|||
124877250|NCT00733499|449172956|FG001|12 Months Follow-up|Death|1|||
124877251|NCT00733499|449172955|FG000|24 Months Follow-up|Death|0|||
124877252|NCT00733499|449172956|FG001|24 Months Follow-up|Death|1|||
124877253|NCT00733499|449172955|FG000|5 Year Followup|Adverse Event|2|||
124877254|NCT00733499|449172956|FG001|5 Year Followup|Adverse Event|2|||
124877255|NCT00733499|449172955|FG000|5 Year Followup|Non device related AE|0|||
124877256|NCT00733499|449172956|FG001|5 Year Followup|Non device related AE|1|||
124877257|NCT00733499|449172955|FG000|5 Year Followup|Revision of Study Implant|0|||
124877258|NCT00733499|449172956|FG001|5 Year Followup|Revision of Study Implant|1|||
124877259|NCT00733499|449172955|FG000|5 Year Followup|Lost to Follow-up|2|||
124877260|NCT00733499|449172956|FG001|5 Year Followup|Lost to Follow-up|0|||
124877261|NCT00733499|449172955|FG000|5 Year Followup|Death|13|||
124877262|NCT00733499|449172956|FG001|5 Year Followup|Death|19|||
124877263|NCT00733499|449172955|FG000|5 Year Followup|missing, unable to locate|0|||
124877264|NCT00733499|449172956|FG001|5 Year Followup|missing, unable to locate|1|||
124877265|NCT00733499|449172955|FG000|5 Year Followup|Withdrawal by Subject|4|||
124877266|NCT00733499|449172956|FG001|5 Year Followup|Withdrawal by Subject|1|||
124877267|NCT00733499|449172955|FG000|10 Year Followup|Death|9|||
124877268|NCT00733499|449172956|FG001|10 Year Followup|Death|7|||
124877269|NCT00733499|449172955|FG000|10 Year Followup|Adverse Event|3|||
124877270|NCT00733499|449172956|FG001|10 Year Followup|Adverse Event|3|||
124877271|NCT00733499|449172955|FG000|10 Year Followup|Lost to Follow-up|3|||
124877272|NCT00733499|449172956|FG001|10 Year Followup|Lost to Follow-up|2|||
124877273|NCT00733499|449172955|FG000|10 Year Followup|Withdrawal by Subject|5|||
124877274|NCT00733499|449172956|FG001|10 Year Followup|Withdrawal by Subject|5|||
124877275|NCT00733499|449172955|FG000|10 Year Followup|missing, unable to locate|0|||
124877276|NCT00733499|449172956|FG001|10 Year Followup|missing, unable to locate|2|||
124877277|NCT01552954|449172957|FG000|Overall Study|Adverse Event|1|||
124877278|NCT01552954|449172958|FG001|Overall Study|Adverse Event|2|||
124877279|NCT01552954|449172957|FG000|Overall Study|Lost to Follow-up|1|||
124877280|NCT01552954|449172958|FG001|Overall Study|Lost to Follow-up|1|||
124877281|NCT01552954|449172957|FG000|Overall Study|Withdrawal by Subject|1|||
124678973|NCT01799889|448449652|FG003|Overall Study|Lack of Efficacy|1|||
124877282|NCT01552954|449172958|FG001|Overall Study|Withdrawal by Subject|1|||
124877283|NCT01552954|449172957|FG000|Overall Study|Protocol Violation|1|||
124877284|NCT01552954|449172958|FG001|Overall Study|Protocol Violation|2|||
124877285|NCT01552954|449172957|FG000|Overall Study|diagnosed DM|1|||
124877286|NCT01552954|449172958|FG001|Overall Study|diagnosed DM|0|||
124877287|NCT03929562|449172959|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
124877288|NCT03929562|449172960|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
124877289|NCT03929562|449172959|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
124877290|NCT03929562|449172960|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
124877291|NCT03929562|449172959|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
124877292|NCT03929562|449172960|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
124877293|NCT04843930|449172961|FG000|Randomization|Withdrawal by Subject|6|||
124877294|NCT04843930|449172962|FG001|Randomization|Withdrawal by Subject|6|||
124877295|NCT04843930|449172963|FG002|Randomization|Withdrawal by Subject|0|||
124877296|NCT04843930|449172964|FG003|Randomization|Withdrawal by Subject|0|||
124877297|NCT04843930|449172961|FG000|Week 6 Assessment|Adverse Event|3|||
124877298|NCT04843930|449172962|FG001|Week 6 Assessment|Adverse Event|0|||
124877299|NCT04843930|449172963|FG002|Week 6 Assessment|Adverse Event|0|||
124877300|NCT04843930|449172964|FG003|Week 6 Assessment|Adverse Event|0|||
124877301|NCT04843930|449172961|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
124877302|NCT04843930|449172962|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
124877303|NCT04843930|449172963|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
124877304|NCT04843930|449172964|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
124877305|NCT04843930|449172961|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
124877306|NCT04843930|449172962|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
124877307|NCT04843930|449172963|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
124877308|NCT04843930|449172964|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
124877309|NCT01931735|449172965|FG000|Randomized Phase|Lost to Follow-up|2|||
124877310|NCT01931735|449172966|FG001|Randomized Phase|Lost to Follow-up|2|||
124877311|NCT01931735|449172967|FG002|Randomized Phase|Lost to Follow-up|5|||
124877312|NCT01931735|449172968|FG003|Randomized Phase|Lost to Follow-up|0|||
124877313|NCT01931735|449172965|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
124877314|NCT01931735|449172966|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
124877315|NCT01931735|449172967|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
124877316|NCT01931735|449172968|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
124877317|NCT01931735|449172965|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
124877318|NCT01931735|449172966|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
124877319|NCT01931735|449172967|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
124877320|NCT01931735|449172968|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
124877321|NCT02552238|449172975|FG000|Overall Study|Withdrawal by Subject|2|||
124877322|NCT02552238|449172975|FG000|Overall Study|Adverse Event|2|||
124877323|NCT02036645|449172976|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877324|NCT02036645|449172977|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877325|NCT02036645|449172978|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877326|NCT02036645|449172979|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877327|NCT02036645|449172980|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877328|NCT02036645|449172981|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877329|NCT02036645|449172982|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
124877330|NCT02036645|449172983|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877331|NCT02036645|449172984|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877332|NCT02036645|449172985|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877333|NCT02036645|449172986|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877334|NCT02036645|449172987|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
124877335|NCT02036645|449172976|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877336|NCT02036645|449172977|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877337|NCT02036645|449172978|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877338|NCT02036645|449172979|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
124877339|NCT02036645|449172980|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877340|NCT02036645|449172981|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124678974|NCT01799889|448449653|FG004|Overall Study|Lack of Efficacy|2|||
124678975|NCT01799889|448449654|FG005|Overall Study|Lack of Efficacy|2|||
124678976|NCT01799889|448449655|FG006|Overall Study|Lack of Efficacy|0|||
124678977|NCT01799889|448449656|FG007|Overall Study|Lack of Efficacy|0|||
124678978|NCT01799889|448449657|FG008|Overall Study|Lack of Efficacy|2|||
124678979|NCT01799889|448449658|FG009|Overall Study|Lack of Efficacy|0|||
124678980|NCT01799889|448449659|FG010|Overall Study|Lack of Efficacy|1|||
124877341|NCT02036645|449172982|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877342|NCT02036645|449172983|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877343|NCT02036645|449172984|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877344|NCT02036645|449172985|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877345|NCT02036645|449172986|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124877346|NCT02036645|449172987|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
124678981|NCT01799889|448449660|FG011|Overall Study|Lack of Efficacy|0|||
124678982|NCT01799889|448449649|FG000|Overall Study|Lost to Follow-up|0|||
124678983|NCT01799889|448449650|FG001|Overall Study|Lost to Follow-up|1|||
124678984|NCT01799889|448449651|FG002|Overall Study|Lost to Follow-up|0|||
124678985|NCT01799889|448449652|FG003|Overall Study|Lost to Follow-up|0|||
124678986|NCT01799889|448449653|FG004|Overall Study|Lost to Follow-up|0|||
124678987|NCT01799889|448449654|FG005|Overall Study|Lost to Follow-up|0|||
124678988|NCT01799889|448449655|FG006|Overall Study|Lost to Follow-up|0|||
124436002|NCT01047293|447556717|FG000|Overall Study|DLT criteria not fulfilled|1|||
124436003|NCT01047293|447556718|FG001|Overall Study|DLT criteria not fulfilled|1|||
124436004|NCT01047293|447556719|FG002|Overall Study|DLT criteria not fulfilled|0|||
124436005|NCT01047293|447556720|FG003|Overall Study|DLT criteria not fulfilled|0|||
124436006|NCT01272804|447556721|FG000|Overall Study|Adverse Event|1|||
124436007|NCT01272804|447556722|FG001|Overall Study|Adverse Event|0|||
124436008|NCT01272804|447556723|FG002|Overall Study|Adverse Event|0|||
124436009|NCT01272804|447556724|FG003|Overall Study|Adverse Event|0|||
124436010|NCT01272804|447556725|FG004|Overall Study|Adverse Event|2|||
124436011|NCT01272804|447556726|FG005|Overall Study|Adverse Event|1|||
124436012|NCT02318797|447556727|FG000|Overall Study|Death|3|||
124436013|NCT02318797|447556728|FG001|Overall Study|Death|6|||
124436014|NCT02318797|447556727|FG000|Overall Study|Lost to Follow-up|85|||
124436015|NCT02318797|447556728|FG001|Overall Study|Lost to Follow-up|96|||
124436016|NCT02673515|447556730|FG000|Overall Study|Lack of motivation|2|||
124436017|NCT02673515|447556731|FG001|Overall Study|Lack of motivation|1|||
124436018|NCT02112708|447556732|FG000|Baseline|Physician Decision|16|||
124436019|NCT02112708|447556733|FG001|Baseline|Physician Decision|11|||
124436020|NCT02112708|447556732|FG000|Baseline|Lost to Follow-up|12|||
124436021|NCT02112708|447556733|FG001|Baseline|Lost to Follow-up|0|||
124436022|NCT02112708|447556732|FG000|4 Month|Death|0|||
124436023|NCT02112708|447556733|FG001|4 Month|Death|1|||
124436024|NCT02112708|447556732|FG000|4 Month|Withdrawal by Subject|12|||
124436025|NCT02112708|447556733|FG001|4 Month|Withdrawal by Subject|0|||
124436026|NCT01796548|447556734|FG000|Overall Study|Lost to Follow-up|1|||
124436027|NCT01796548|447556734|FG000|Overall Study|Other|2|||
124436028|NCT04227704|447556738|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
124436029|NCT04227704|447556739|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
124436030|NCT04227704|447556740|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
124436031|NCT04227704|447556738|FG000|Overall Study|due to C/S being cancelled|1|||
124436032|NCT04227704|447556739|FG001|Overall Study|due to C/S being cancelled|0|||
124436033|NCT04227704|447556740|FG002|Overall Study|due to C/S being cancelled|0|||
124436034|NCT03432260|447556751|FG000|Overall Study|Lost to Follow-up|1|||
124436035|NCT03432260|447556752|FG001|Overall Study|Lost to Follow-up|1|||
124436036|NCT03432260|447556753|FG002|Overall Study|Lost to Follow-up|0|||
124436037|NCT03432260|447556754|FG003|Overall Study|Lost to Follow-up|0|||
124436038|NCT03432260|447556755|FG004|Overall Study|Lost to Follow-up|1|||
124436039|NCT01775124|447556757|FG000|Core Period|Disease Progression|0|||
124436040|NCT01775124|447556758|FG001|Core Period|Disease Progression|1|||
124436041|NCT01775124|447556757|FG000|Core Period|Physician Decision|1|||
124436042|NCT01775124|447556758|FG001|Core Period|Physician Decision|1|||
124436043|NCT01775124|447556757|FG000|Core Period|Death|0|||
124436044|NCT01775124|447556758|FG001|Core Period|Death|1|||
124436045|NCT01775124|447556757|FG000|Core Period|Administrative problems|1|||
124436046|NCT01775124|447556758|FG001|Core Period|Administrative problems|0|||
124436047|NCT01775124|447556757|FG000|Core Period|Withdrawal by Subject|4|||
124678989|NCT01799889|448449656|FG007|Overall Study|Lost to Follow-up|0|||
124678990|NCT01799889|448449657|FG008|Overall Study|Lost to Follow-up|0|||
124678991|NCT01799889|448449658|FG009|Overall Study|Lost to Follow-up|0|||
124678992|NCT01799889|448449659|FG010|Overall Study|Lost to Follow-up|0|||
124678993|NCT01799889|448449660|FG011|Overall Study|Lost to Follow-up|0|||
124678994|NCT01799889|448449649|FG000|Overall Study|Physician Decision|3|||
124678995|NCT01799889|448449650|FG001|Overall Study|Physician Decision|2|||
124436048|NCT01775124|447556758|FG001|Core Period|Withdrawal by Subject|2|||
124436049|NCT01775124|447556757|FG000|Core Period|Adverse Event|5|||
124436050|NCT01775124|447556758|FG001|Core Period|Adverse Event|5|||
124436051|NCT01775124|447556757|FG000|Extension Period|Adverse Event|3|||
124436052|NCT01775124|447556758|FG001|Extension Period|Adverse Event|2|||
124436053|NCT01775124|447556757|FG000|Extension Period|Physician Decision|0|||
124436054|NCT01775124|447556758|FG001|Extension Period|Physician Decision|2|||
124436055|NCT01775124|447556757|FG000|Extension Period|Administrative problems|0|||
124436056|NCT01775124|447556758|FG001|Extension Period|Administrative problems|1|||
124436057|NCT01775124|447556757|FG000|Extension Period|Lost to Follow-up|0|||
124436058|NCT01775124|447556758|FG001|Extension Period|Lost to Follow-up|1|||
124436059|NCT01775124|447556757|FG000|Extension Period|Withdrawal by Subject|9|||
124678996|NCT01799889|448449651|FG002|Overall Study|Physician Decision|4|||
124678997|NCT01799889|448449652|FG003|Overall Study|Physician Decision|4|||
124678998|NCT01799889|448449653|FG004|Overall Study|Physician Decision|5|||
124678999|NCT01799889|448449654|FG005|Overall Study|Physician Decision|5|||
124679000|NCT01799889|448449655|FG006|Overall Study|Physician Decision|5|||
124436060|NCT01775124|447556758|FG001|Extension Period|Withdrawal by Subject|12|||
124436061|NCT01589237|447558064|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
124877347|NCT01778556|449172988|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
124877348|NCT01778556|449172989|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
124877349|NCT01778556|449172988|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
124877350|NCT01778556|449172989|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
124877351|NCT01778556|449172988|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
124877352|NCT01778556|449172989|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
124877353|NCT01778556|449172988|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
124877354|NCT01778556|449172989|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
124877355|NCT03188120|449172990|FG000|Overall Study|Adverse Event|4|||
124877356|NCT03188120|449172990|FG000|Overall Study|Insufficient Effectiveness|8|||
124877357|NCT03188120|449172990|FG000|Overall Study|Improved|12|||
124877358|NCT03188120|449172990|FG000|Overall Study|Lost to Follow-up|7|||
124877359|NCT03188120|449172990|FG000|Overall Study|Other than specified|3|||
124877360|NCT03188120|449172990|FG000|Overall Study|No visit after the first visit|13|||
124877361|NCT00782496|449172991|FG000|Overall Study|Lost to Follow-up|14|||
124877362|NCT00782496|449172992|FG001|Overall Study|Lost to Follow-up|15|||
124877363|NCT01874145|449172998|FG000|Core Period|Non-compliance|1|||
124877364|NCT01874145|449172999|FG001|Core Period|Non-compliance|0|||
124877365|NCT01874145|449172998|FG000|Core Period|Protocol Violation|1|||
124877366|NCT01874145|449172999|FG001|Core Period|Protocol Violation|1|||
124877367|NCT01874145|449172998|FG000|Core Period|Physician Decision|1|||
124877368|NCT01874145|449172999|FG001|Core Period|Physician Decision|1|||
124877369|NCT01874145|449172998|FG000|Core Period|Adverse Event|0|||
124877370|NCT01874145|449172999|FG001|Core Period|Adverse Event|1|||
124877371|NCT01874145|449172998|FG000|Core Period|Withdrawal by Subject|0|||
124877372|NCT01874145|449172999|FG001|Core Period|Withdrawal by Subject|4|||
124877373|NCT01874145|449172998|FG000|Extension Period|Adverse Event|3|||
124877374|NCT01874145|449172999|FG001|Extension Period|Adverse Event|2|||
124877375|NCT01874145|449172998|FG000|Extension Period|Withdrawal by Subject|2|||
124877376|NCT01874145|449172999|FG001|Extension Period|Withdrawal by Subject|1|||
124877377|NCT01874145|449172998|FG000|Extension Period|Lost to Follow-up|1|||
124877378|NCT01874145|449172999|FG001|Extension Period|Lost to Follow-up|1|||
124877379|NCT02178566|449173000|FG000|Overall Study|patient did not complete due to noncompliance|0|||
124877380|NCT02178566|449173001|FG001|Overall Study|patient did not complete due to noncompliance|1|||
124877381|NCT02070484|449173006|FG000|Overall Study|Withdrawal by Subject|1|||
124877382|NCT02070484|449173007|FG001|Overall Study|Withdrawal by Subject|0|||
124877383|NCT02658630|449173010|FG000|Overall Study|Withdrawal by Subject|4|||
124877384|NCT03238300|449173011|FG000|Baseline (Before Intervention)|Physician Decision|0|||
124877385|NCT03238300|449173012|FG001|Baseline (Before Intervention)|Physician Decision|1|||
124877386|NCT03238300|449173011|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
124877387|NCT03238300|449173012|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
124877388|NCT03238300|449173011|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
124877389|NCT03238300|449173012|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
124877390|NCT03238300|449173011|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
124877391|NCT03238300|449173012|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
124877392|NCT03520400|449173015|FG000|Overall Study|Physician Decision|15|||
124877393|NCT03520400|449173016|FG001|Overall Study|Physician Decision|7|||
124877394|NCT01654601|449173017|FG000|1st Administration|Withdrawal by Subject|2|||
124877395|NCT01654601|449173018|FG001|1st Administration|Withdrawal by Subject|0|||
124877396|NCT01654601|449173017|FG000|1st Administration|Protocol Violation|0|||
124877397|NCT01654601|449173018|FG001|1st Administration|Protocol Violation|2|||
124877398|NCT01654601|449173017|FG000|2nd Administration|Adverse Event|1|||
124436062|NCT01589237|447558065|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
124436063|NCT01589237|447558066|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
124436064|NCT01589237|447558067|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
124877399|NCT01654601|449173018|FG001|2nd Administration|Adverse Event|0|||
124877400|NCT01654601|449173017|FG000|2nd Administration|Protocol Violation|0|||
124877401|NCT01654601|449173018|FG001|2nd Administration|Protocol Violation|1|||
124877402|NCT04398537|449173019|FG000|Overall Study|Physician Decision|10|||
124877403|NCT04398537|449173020|FG001|Overall Study|Physician Decision|15|||
124877404|NCT01862991|449175209|FG000|Overall Study|Lost to Follow-up|2|||
124877405|NCT01862991|449175210|FG001|Overall Study|Lost to Follow-up|1|||
124877406|NCT01862991|449175211|FG002|Overall Study|Lost to Follow-up|1|||
124877407|NCT01862991|449175209|FG000|Overall Study|Protocol Violation|1|||
124877408|NCT01862991|449175210|FG001|Overall Study|Protocol Violation|0|||
124877409|NCT01862991|449175211|FG002|Overall Study|Protocol Violation|0|||
124877410|NCT01572389|449175213|FG000|Overall Study|Death|1|||
124877411|NCT01572389|449175214|FG001|Overall Study|Death|3|||
124877412|NCT01572389|449175213|FG000|Overall Study|Withdrawal by Subject|14|||
124544330|NCT02268214|447946768|FG000|Overall Study|Lost to Follow-up|3|||
124679001|NCT01799889|448449656|FG007|Overall Study|Physician Decision|2|||
124877413|NCT01572389|449175214|FG001|Overall Study|Withdrawal by Subject|2|||
124877414|NCT01572389|449175213|FG000|Overall Study|Lost to Follow-up|25|||
124877415|NCT01572389|449175214|FG001|Overall Study|Lost to Follow-up|14|||
124877416|NCT01572389|449175213|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
124877417|NCT01572389|449175214|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
124877418|NCT01287520|449175215|FG000|Overall Study|Adverse Event|2|||
124877419|NCT01287520|449175216|FG001|Overall Study|Adverse Event|2|||
124877420|NCT01287520|449175217|FG002|Overall Study|Adverse Event|2|||
124877421|NCT01287520|449175218|FG003|Overall Study|Adverse Event|1|||
124877422|NCT01287520|449175219|FG004|Overall Study|Adverse Event|1|||
124877423|NCT01287520|449175220|FG005|Overall Study|Adverse Event|2|||
124877424|NCT01287520|449175221|FG006|Overall Study|Adverse Event|0|||
124877425|NCT01287520|449175222|FG007|Overall Study|Adverse Event|2|||
124877426|NCT01287520|449175223|FG008|Overall Study|Adverse Event|0|||
124877427|NCT01287520|449175215|FG000|Overall Study|Physician Decision|1|||
124877428|NCT01287520|449175216|FG001|Overall Study|Physician Decision|1|||
124877429|NCT01287520|449175217|FG002|Overall Study|Physician Decision|2|||
124877430|NCT01287520|449175218|FG003|Overall Study|Physician Decision|0|||
124877431|NCT01287520|449175219|FG004|Overall Study|Physician Decision|1|||
124877432|NCT01287520|449175220|FG005|Overall Study|Physician Decision|1|||
124877433|NCT01287520|449175221|FG006|Overall Study|Physician Decision|0|||
124877434|NCT01287520|449175222|FG007|Overall Study|Physician Decision|1|||
124877435|NCT01287520|449175223|FG008|Overall Study|Physician Decision|0|||
124877436|NCT01287520|449175215|FG000|Overall Study|Progressive disease|0|||
124877437|NCT01287520|449175216|FG001|Overall Study|Progressive disease|4|||
124877438|NCT01287520|449175217|FG002|Overall Study|Progressive disease|1|||
124877439|NCT01287520|449175218|FG003|Overall Study|Progressive disease|6|||
124877440|NCT01287520|449175219|FG004|Overall Study|Progressive disease|1|||
124877441|NCT01287520|449175220|FG005|Overall Study|Progressive disease|0|||
124877442|NCT01287520|449175221|FG006|Overall Study|Progressive disease|2|||
124436065|NCT01589237|447558064|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
124436066|NCT01589237|447558065|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
124877443|NCT01287520|449175222|FG007|Overall Study|Progressive disease|2|||
124436067|NCT01589237|447558066|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
124436068|NCT01589237|447558067|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
124436069|NCT01589237|447558064|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
124436070|NCT01589237|447558065|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
124436071|NCT01589237|447558066|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
124436072|NCT01589237|447558067|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
124436073|NCT01589237|447558064|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
124436074|NCT01589237|447558065|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
124436075|NCT01589237|447558066|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
124436076|NCT01589237|447558067|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
124436077|NCT02594163|447558068|FG000|Treatment Period|Progressive disease|2|||
124436078|NCT02594163|447558069|FG001|Treatment Period|Progressive disease|3|||
124436079|NCT02594163|447558068|FG000|Treatment Period|Adverse Event|1|||
124436080|NCT02594163|447558069|FG001|Treatment Period|Adverse Event|5|||
124436081|NCT02594163|447558068|FG000|Treatment Period|Physician Decision|1|||
124436082|NCT02594163|447558069|FG001|Treatment Period|Physician Decision|3|||
124436083|NCT02594163|447558068|FG000|Treatment Period|Study termination by sponsor|2|||
124436084|NCT02594163|447558069|FG001|Treatment Period|Study termination by sponsor|1|||
124436085|NCT02594163|447558068|FG000|Treatment Period|Other, Non-AE|1|||
124436086|NCT02594163|447558069|FG001|Treatment Period|Other, Non-AE|0|||
124436087|NCT02594163|447558068|FG000|Follow-up Period|Withdrawal by Subject|0|||
124436088|NCT02594163|447558069|FG001|Follow-up Period|Withdrawal by Subject|1|||
124436089|NCT02594163|447558068|FG000|Follow-up Period|Study Termination by Sponsor|6|||
124436090|NCT02594163|447558069|FG001|Follow-up Period|Study Termination by Sponsor|4|||
124436091|NCT02594163|447558068|FG000|Follow-up Period|Lost to Follow-up|1|||
124436092|NCT02594163|447558069|FG001|Follow-up Period|Lost to Follow-up|0|||
124436093|NCT02594163|447558068|FG000|Follow-up Period|Death|2|||
124436094|NCT02594163|447558069|FG001|Follow-up Period|Death|5|||
124436095|NCT02594163|447558068|FG000|Follow-up Period|Adverse Event|0|||
124436096|NCT02594163|447558069|FG001|Follow-up Period|Adverse Event|1|||
124436097|NCT02594163|447558068|FG000|Follow-up Period|Progressive Disease|2|||
124436098|NCT02594163|447558069|FG001|Follow-up Period|Progressive Disease|0|||
124436099|NCT02594163|447558068|FG000|Follow-up Period|Physician Decision|0|||
124877444|NCT01287520|449175223|FG008|Overall Study|Progressive disease|4|||
124436100|NCT02594163|447558069|FG001|Follow-up Period|Physician Decision|1|||
124436101|NCT01022268|447558072|FG000|Overall Study|Withdrawal by Subject|1|||
124436102|NCT01022268|447558073|FG001|Overall Study|Withdrawal by Subject|0|||
124877445|NCT01287520|449175215|FG000|Overall Study|Withdrawal by Subject|0|||
124877446|NCT01287520|449175216|FG001|Overall Study|Withdrawal by Subject|0|||
124877447|NCT01287520|449175217|FG002|Overall Study|Withdrawal by Subject|0|||
124436103|NCT01022268|447558072|FG000|Overall Study|Withdrawal by Subject|1|||
124436104|NCT01022268|447558073|FG001|Overall Study|Withdrawal by Subject|0|||
124877448|NCT01287520|449175218|FG003|Overall Study|Withdrawal by Subject|0|||
124877449|NCT01287520|449175219|FG004|Overall Study|Withdrawal by Subject|0|||
124877450|NCT01287520|449175220|FG005|Overall Study|Withdrawal by Subject|1|||
124877451|NCT01287520|449175221|FG006|Overall Study|Withdrawal by Subject|0|||
124877452|NCT01287520|449175222|FG007|Overall Study|Withdrawal by Subject|0|||
124436105|NCT00189488|447558074|FG000|Overall Study|Ineligibility determined|1|||
124436106|NCT00189488|447558075|FG001|Overall Study|Ineligibility determined|0|||
124436107|NCT00189488|447558074|FG000|Overall Study|Protocol deviation|2|||
124436108|NCT00189488|447558075|FG001|Overall Study|Protocol deviation|1|||
124436109|NCT00189488|447558074|FG000|Overall Study|Adverse Event|2|||
124436110|NCT00189488|447558075|FG001|Overall Study|Adverse Event|1|||
124436111|NCT00189488|447558074|FG000|Overall Study|Withdrawal by Subject|2|||
124436112|NCT00189488|447558075|FG001|Overall Study|Withdrawal by Subject|6|||
124436113|NCT00189488|447558074|FG000|Overall Study|Disease progression|2|||
124436114|NCT00189488|447558075|FG001|Overall Study|Disease progression|4|||
124436115|NCT00189488|447558074|FG000|Overall Study|Administrative Decision|0|||
124436116|NCT00189488|447558075|FG001|Overall Study|Administrative Decision|2|||
124436117|NCT00189488|447558074|FG000|Overall Study|Death|5|||
124436118|NCT00189488|447558075|FG001|Overall Study|Death|8|||
124436119|NCT00189488|447558074|FG000|Overall Study|Other|1|||
124436120|NCT00189488|447558075|FG001|Overall Study|Other|0|||
124436121|NCT02831387|447558076|FG000|Overall Study|Withdrawal by Subject|1|||
124436122|NCT02831387|447558077|FG001|Overall Study|Withdrawal by Subject|1|||
124436123|NCT02831387|447558076|FG000|Overall Study|Discontinued due to stock recovery|0|||
124436124|NCT02831387|447558077|FG001|Overall Study|Discontinued due to stock recovery|1|||
124436125|NCT00192647|447558078|FG000|Overall Study|Death|1|||
124436126|NCT00192647|447558079|FG001|Overall Study|Death|1|||
124436127|NCT00192647|447558078|FG000|Overall Study|Adverse Event|35|||
124436128|NCT00192647|447558079|FG001|Overall Study|Adverse Event|29|||
124436129|NCT00192647|447558078|FG000|Overall Study|Laboratory Test Abnormality|4|||
124436130|NCT00192647|447558079|FG001|Overall Study|Laboratory Test Abnormality|2|||
124436131|NCT00192647|447558078|FG000|Overall Study|Insufficient Therapeutic Response|53|||
124436132|NCT00192647|447558079|FG001|Overall Study|Insufficient Therapeutic Response|83|||
124436133|NCT00192647|447558078|FG000|Overall Study|Entry Criteria Violation|6|||
124436134|NCT00192647|447558079|FG001|Overall Study|Entry Criteria Violation|6|||
124436135|NCT00192647|447558078|FG000|Overall Study|Protocol Violation|3|||
124436136|NCT00192647|447558079|FG001|Overall Study|Protocol Violation|1|||
124436137|NCT00192647|447558078|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
124436138|NCT00192647|447558079|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
124436139|NCT00192647|447558078|FG000|Overall Study|Failure to Return|11|||
124436140|NCT00192647|447558079|FG001|Overall Study|Failure to Return|13|||
124436141|NCT00192647|447558078|FG000|Overall Study|Other/Administrative|5|||
124436142|NCT00192647|447558079|FG001|Overall Study|Other/Administrative|3|||
124436143|NCT01828073|447558080|FG000|Overall Study|Lost to Follow-up|1|||
124436144|NCT01828073|447558081|FG001|Overall Study|Lost to Follow-up|2|||
124436145|NCT02915302|447558082|FG000|Overall Study|Adverse Event|3|||
124436146|NCT02915302|447558083|FG001|Overall Study|Adverse Event|0|||
124436147|NCT02915302|447558082|FG000|Overall Study|Protocol Violation|20|||
124436148|NCT02915302|447558083|FG001|Overall Study|Protocol Violation|27|||
124436149|NCT02915302|447558082|FG000|Overall Study|Lost to Follow-up|19|||
124436150|NCT02915302|447558083|FG001|Overall Study|Lost to Follow-up|22|||
124436151|NCT02915302|447558082|FG000|Overall Study|Withdrawal by Subject|22|||
124436152|NCT02915302|447558083|FG001|Overall Study|Withdrawal by Subject|29|||
124436153|NCT02915302|447558082|FG000|Overall Study|Other|1|||
124436154|NCT02915302|447558083|FG001|Overall Study|Other|0|||
124436155|NCT00690443|447558084|FG000|Overall Study|Adverse Event|1|||
124436156|NCT00690443|447558085|FG001|Overall Study|Adverse Event|2|||
124436157|NCT01877837|447558086|FG000|Overall Study|Lost to Follow-up|1|||
124436158|NCT01877837|447558086|FG000|Overall Study|Ineligible|4|||
124436159|NCT00645801|447558088|FG000|Overall Study|unclear if patient took all the medication.|1|||
124436160|NCT00645801|447558089|FG001|Overall Study|unclear if patient took all the medication.|0|||
124436161|NCT00645801|447558088|FG000|Overall Study|Lost to Follow-up|19|||
124679002|NCT01799889|448449657|FG008|Overall Study|Physician Decision|6|||
124679003|NCT01799889|448449658|FG009|Overall Study|Physician Decision|0|||
124679004|NCT01799889|448449659|FG010|Overall Study|Physician Decision|0|||
124679005|NCT01799889|448449660|FG011|Overall Study|Physician Decision|1|||
124679006|NCT01799889|448449649|FG000|Overall Study|Progressive Disease|30|||
124679007|NCT01799889|448449650|FG001|Overall Study|Progressive Disease|26|||
124679008|NCT01799889|448449651|FG002|Overall Study|Progressive Disease|25|||
124436162|NCT00645801|447558089|FG001|Overall Study|Lost to Follow-up|15|||
124436163|NCT00705679|447558090|FG000|Overall Study|Adverse Event|1|||
124436164|NCT00705679|447558091|FG001|Overall Study|Adverse Event|1|||
124436165|NCT00705679|447558092|FG002|Overall Study|Adverse Event|0|||
124436166|NCT00705679|447558093|FG003|Overall Study|Adverse Event|0|||
124436167|NCT00705679|447558094|FG004|Overall Study|Adverse Event|0|||
124436168|NCT00705679|447558090|FG000|Overall Study|Death|0|||
124436169|NCT00705679|447558091|FG001|Overall Study|Death|0|||
124436170|NCT00705679|447558092|FG002|Overall Study|Death|3|||
124436171|NCT00705679|447558093|FG003|Overall Study|Death|2|||
124436172|NCT00705679|447558094|FG004|Overall Study|Death|1|||
124436173|NCT00705679|447558090|FG000|Overall Study|Lost to Follow-up|32|||
124679009|NCT01799889|448449652|FG003|Overall Study|Progressive Disease|30|||
124679010|NCT01799889|448449653|FG004|Overall Study|Progressive Disease|23|||
124679011|NCT01799889|448449654|FG005|Overall Study|Progressive Disease|9|||
124436174|NCT00705679|447558091|FG001|Overall Study|Lost to Follow-up|60|||
124436175|NCT00705679|447558092|FG002|Overall Study|Lost to Follow-up|44|||
124436176|NCT00705679|447558093|FG003|Overall Study|Lost to Follow-up|30|||
124436177|NCT00705679|447558094|FG004|Overall Study|Lost to Follow-up|35|||
124436178|NCT00705679|447558090|FG000|Overall Study|Physician Decision|0|||
124436179|NCT00705679|447558091|FG001|Overall Study|Physician Decision|1|||
124436180|NCT00705679|447558092|FG002|Overall Study|Physician Decision|0|||
124436181|NCT00705679|447558093|FG003|Overall Study|Physician Decision|1|||
124436182|NCT00705679|447558094|FG004|Overall Study|Physician Decision|0|||
124436183|NCT00705679|447558090|FG000|Overall Study|Withdrawal by Subject|32|||
124436184|NCT00705679|447558091|FG001|Overall Study|Withdrawal by Subject|77|||
124436185|NCT00705679|447558092|FG002|Overall Study|Withdrawal by Subject|68|||
124436186|NCT00705679|447558093|FG003|Overall Study|Withdrawal by Subject|47|||
124436187|NCT00705679|447558094|FG004|Overall Study|Withdrawal by Subject|33|||
124436188|NCT00932113|447558095|FG000|Overall Study|Lost to Follow-up|1|||
124436189|NCT00932113|447558096|FG001|Overall Study|Lost to Follow-up|0|||
124436190|NCT01403610|447558097|FG000|Overall Study|Withdrawal by Subject|2|||
124436191|NCT01403610|447558098|FG001|Overall Study|Withdrawal by Subject|0|||
124436192|NCT01403610|447558099|FG002|Overall Study|Withdrawal by Subject|0|||
124436193|NCT01403610|447558100|FG003|Overall Study|Withdrawal by Subject|0|||
124679012|NCT01799889|448449655|FG006|Overall Study|Progressive Disease|8|||
124436194|NCT01403610|447558097|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
124436195|NCT01403610|447558098|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
124436196|NCT01403610|447558099|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
124436197|NCT01403610|447558100|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
124436198|NCT00686725|447558103|FG000|Overall Study|Adverse Event|1|||
124436199|NCT00686725|447558104|FG001|Overall Study|Adverse Event|1|||
124436200|NCT00686725|447558103|FG000|Overall Study|Progressive Disease|17|||
124436201|NCT00686725|447558104|FG001|Overall Study|Progressive Disease|23|||
124436202|NCT00686725|447558103|FG000|Overall Study|Lost to Follow-up|7|||
124436203|NCT00686725|447558104|FG001|Overall Study|Lost to Follow-up|5|||
124436204|NCT00686725|447558103|FG000|Overall Study|Death|6|||
124436205|NCT00686725|447558104|FG001|Overall Study|Death|3|||
124436206|NCT00686725|447558103|FG000|Overall Study|Withdrawal by Subject|13|||
124436207|NCT00686725|447558104|FG001|Overall Study|Withdrawal by Subject|4|||
124436208|NCT00686725|447558103|FG000|Overall Study|Protocol Violation|1|||
124436209|NCT00686725|447558104|FG001|Overall Study|Protocol Violation|3|||
124436210|NCT00686725|447558103|FG000|Overall Study|Other|1|||
124436211|NCT00686725|447558104|FG001|Overall Study|Other|3|||
124436212|NCT03064035|447558107|FG000|Overall Study|Did not receive allocated intervention|4|||
124436213|NCT03064035|447558108|FG001|Overall Study|Did not receive allocated intervention|2|||
124436214|NCT03064035|447558107|FG000|Overall Study|Lost to Follow-up|1|||
124436215|NCT03064035|447558108|FG001|Overall Study|Lost to Follow-up|1|||
124436216|NCT02090959|447558111|FG000|Overall Study|Withdrawal by Subject|10|||
124436217|NCT02090959|447558111|FG000|Overall Study|Adverse Event|1|||
124436218|NCT02090959|447558111|FG000|Overall Study|Investigator decision|2|||
124436219|NCT02090959|447558111|FG000|Overall Study|Study termination|6|||
124436220|NCT02090959|447558111|FG000|Overall Study|Enrolled but not treated|1|||
124436221|NCT02090959|447558111|FG000|Overall Study|Transfer for compassionate use medicine|4|||
124436222|NCT02090959|447558111|FG000|Overall Study|Move to medical need program|3|||
124436223|NCT02090959|447558111|FG000|Overall Study|Entered in to other study|34|||
124436224|NCT02090959|447558111|FG000|Overall Study|Switched to commercial supply|88|||
124436225|NCT02090959|447558111|FG000|Overall Study|Other than specified|2|||
124436226|NCT04256629|447558119|FG000|Overall Study|Adverse Event|0|||
124436227|NCT04256629|447558120|FG001|Overall Study|Adverse Event|0|||
124436228|NCT04256629|447558121|FG002|Overall Study|Adverse Event|0|||
124436229|NCT04256629|447558122|FG003|Overall Study|Adverse Event|0|||
124436230|NCT04256629|447558123|FG004|Overall Study|Adverse Event|0|||
124436231|NCT04256629|447558124|FG005|Overall Study|Adverse Event|1|||
124436232|NCT04256629|447558119|FG000|Overall Study|Protocol Violation|0|||
124436233|NCT04256629|447558120|FG001|Overall Study|Protocol Violation|1|||
124436234|NCT04256629|447558121|FG002|Overall Study|Protocol Violation|0|||
124436235|NCT04256629|447558122|FG003|Overall Study|Protocol Violation|0|||
124436236|NCT04256629|447558123|FG004|Overall Study|Protocol Violation|0|||
124679013|NCT01799889|448449656|FG007|Overall Study|Progressive Disease|13|||
124436237|NCT04256629|447558124|FG005|Overall Study|Protocol Violation|0|||
124436238|NCT02647866|447558125|FG000|Overall Study|Adverse Event|0|||
124436239|NCT02647866|447558126|FG001|Overall Study|Adverse Event|0|||
124436240|NCT02647866|447558127|FG002|Overall Study|Adverse Event|2|||
124436241|NCT02647866|447558128|FG003|Overall Study|Adverse Event|2|||
124436242|NCT02647866|447558129|FG004|Overall Study|Adverse Event|1|||
124436243|NCT02647866|447558125|FG000|Overall Study|Disease Worsening|3|||
124436244|NCT02647866|447558126|FG001|Overall Study|Disease Worsening|1|||
124436245|NCT02647866|447558127|FG002|Overall Study|Disease Worsening|0|||
124436246|NCT02647866|447558128|FG003|Overall Study|Disease Worsening|0|||
124436247|NCT02647866|447558129|FG004|Overall Study|Disease Worsening|1|||
124436248|NCT02647866|447558125|FG000|Overall Study|Withdrawal by Subject|1|||
124436249|NCT02647866|447558126|FG001|Overall Study|Withdrawal by Subject|1|||
124877453|NCT01287520|449175223|FG008|Overall Study|Withdrawal by Subject|1|||
124877454|NCT00708435|449175224|FG000|Overall Study|Death / Serious Adverse Event|10|||
124877455|NCT00708435|449175225|FG001|Overall Study|Death / Serious Adverse Event|5|||
124877456|NCT00708435|449175224|FG000|Overall Study|Lost to Follow-up|9|||
124877457|NCT00708435|449175225|FG001|Overall Study|Lost to Follow-up|4|||
124877458|NCT00708435|449175224|FG000|Overall Study|Withdrawal by Subject|3|||
124877459|NCT00708435|449175225|FG001|Overall Study|Withdrawal by Subject|7|||
124877460|NCT00708435|449175224|FG000|Overall Study|Adverse Event|1|||
124877461|NCT00708435|449175225|FG001|Overall Study|Adverse Event|0|||
124877462|NCT00708435|449175224|FG000|Overall Study|Protocol Violation|0|||
124877463|NCT00708435|449175225|FG001|Overall Study|Protocol Violation|1|||
124877464|NCT00708435|449175224|FG000|Overall Study|Intervention by primary care physician|1|||
124877465|NCT00708435|449175225|FG001|Overall Study|Intervention by primary care physician|0|||
124877466|NCT00708435|449175224|FG000|Overall Study|Refused hospitalization|1|||
124877467|NCT00708435|449175225|FG001|Overall Study|Refused hospitalization|0|||
124877468|NCT01691521|449175231|FG000|Overall Study|Adverse Event|4|||
124877469|NCT01691521|449175232|FG001|Overall Study|Adverse Event|0|||
124877470|NCT01691521|449175233|FG002|Overall Study|Adverse Event|1|||
124877471|NCT01691521|449175231|FG000|Overall Study|Lack of Efficacy|1|||
124877472|NCT01691521|449175232|FG001|Overall Study|Lack of Efficacy|1|||
124877473|NCT01691521|449175233|FG002|Overall Study|Lack of Efficacy|2|||
124877474|NCT01691521|449175231|FG000|Overall Study|Protocol Violation|0|||
124877475|NCT01691521|449175232|FG001|Overall Study|Protocol Violation|3|||
124877476|NCT01691521|449175233|FG002|Overall Study|Protocol Violation|0|||
124877477|NCT01691521|449175231|FG000|Overall Study|Lost to Follow-up|0|||
124877478|NCT01691521|449175232|FG001|Overall Study|Lost to Follow-up|2|||
124877479|NCT01691521|449175233|FG002|Overall Study|Lost to Follow-up|2|||
124877480|NCT01691521|449175231|FG000|Overall Study|Physician Decision|2|||
124877481|NCT01691521|449175232|FG001|Overall Study|Physician Decision|1|||
124877482|NCT01691521|449175233|FG002|Overall Study|Physician Decision|0|||
124877483|NCT01691521|449175231|FG000|Overall Study|Withdrawal by Subject|5|||
124877484|NCT01691521|449175232|FG001|Overall Study|Withdrawal by Subject|9|||
124877485|NCT01691521|449175233|FG002|Overall Study|Withdrawal by Subject|4|||
124877486|NCT04503096|449175234|FG000|Overall Study|Withdrawal by Subject|3|||
124877487|NCT01480596|449175235|FG000|Overall Study|Adverse Event|3|||
124877488|NCT01480596|449175236|FG001|Overall Study|Adverse Event|0|||
124877489|NCT01480596|449175235|FG000|Overall Study|MG exacerbation or change in medication|2|||
124877490|NCT01480596|449175236|FG001|Overall Study|MG exacerbation or change in medication|2|||
124877491|NCT02343003|449175238|FG000|Overall Study|Withdrawal by Subject|9|||
124877492|NCT02343003|449175239|FG001|Overall Study|Withdrawal by Subject|4|||
124877493|NCT02343003|449175238|FG000|Overall Study|Lost to Follow-up|5|||
124877494|NCT02343003|449175239|FG001|Overall Study|Lost to Follow-up|1|||
124877495|NCT02343003|449175238|FG000|Overall Study|Protocol Violation|1|||
124877496|NCT02343003|449175239|FG001|Overall Study|Protocol Violation|0|||
124877497|NCT02343003|449175238|FG000|Overall Study|Death|0|||
124877498|NCT02343003|449175239|FG001|Overall Study|Death|1|||
124877499|NCT02343003|449175238|FG000|Overall Study|exclusion criteria met|1|||
124877500|NCT02343003|449175239|FG001|Overall Study|exclusion criteria met|1|||
124877501|NCT02343003|449175238|FG000|Overall Study|terminated by sponsor|2|||
124877502|NCT02343003|449175239|FG001|Overall Study|terminated by sponsor|0|||
124877503|NCT01153269|449175241|FG000|Overall Study|Withdrawal by Subject|1|||
124877504|NCT01153269|449175241|FG000|Overall Study|Antiretroviral therapy break|1|||
124877505|NCT00988221|449175244|FG000|Part I|Adverse Event|0|||
124436250|NCT02647866|447558127|FG002|Overall Study|Withdrawal by Subject|2|||
124436251|NCT02647866|447558128|FG003|Overall Study|Withdrawal by Subject|4|||
124436252|NCT02647866|447558129|FG004|Overall Study|Withdrawal by Subject|4|||
124436253|NCT02647866|447558125|FG000|Overall Study|Physician Decision|0|||
124436254|NCT02647866|447558126|FG001|Overall Study|Physician Decision|1|||
124679014|NCT01799889|448449657|FG008|Overall Study|Progressive Disease|18|||
124679015|NCT01799889|448449658|FG009|Overall Study|Progressive Disease|5|||
124679016|NCT01799889|448449659|FG010|Overall Study|Progressive Disease|3|||
124877506|NCT00988221|449175245|FG001|Part I|Adverse Event|1|||
124877507|NCT00988221|449175246|FG002|Part I|Adverse Event|2|||
124877508|NCT00988221|449175247|FG003|Part I|Adverse Event|0|||
124877509|NCT00988221|449175244|FG000|Part I|Insufficient Therapeutic Response|4|||
124877510|NCT00988221|449175245|FG001|Part I|Insufficient Therapeutic Response|6|||
124877511|NCT00988221|449175246|FG002|Part I|Insufficient Therapeutic Response|5|||
124877512|NCT00988221|449175247|FG003|Part I|Insufficient Therapeutic Response|0|||
124877513|NCT00988221|449175244|FG000|Part I|Refused Treatment|0|||
124877514|NCT00988221|449175245|FG001|Part I|Refused Treatment|2|||
124877515|NCT00988221|449175246|FG002|Part I|Refused Treatment|1|||
124877516|NCT00988221|449175247|FG003|Part I|Refused Treatment|0|||
124877517|NCT00988221|449175244|FG000|Part I|Lost to Follow-up|0|||
124877518|NCT00988221|449175245|FG001|Part I|Lost to Follow-up|1|||
124877519|NCT00988221|449175246|FG002|Part I|Lost to Follow-up|0|||
124877520|NCT00988221|449175247|FG003|Part I|Lost to Follow-up|0|||
124877521|NCT00988221|449175244|FG000|Part II|Adverse Event|1|||
124436255|NCT02647866|447558127|FG002|Overall Study|Physician Decision|1|||
124436256|NCT02647866|447558128|FG003|Overall Study|Physician Decision|0|||
124877522|NCT00988221|449175245|FG001|Part II|Adverse Event|0|||
124877523|NCT00988221|449175246|FG002|Part II|Adverse Event|0|||
124877524|NCT00988221|449175247|FG003|Part II|Adverse Event|1|||
124877525|NCT00988221|449175244|FG000|Part II|Withdrawal by Subject|0|||
124877526|NCT00988221|449175245|FG001|Part II|Withdrawal by Subject|0|||
124877527|NCT00988221|449175246|FG002|Part II|Withdrawal by Subject|2|||
124877528|NCT00988221|449175247|FG003|Part II|Withdrawal by Subject|2|||
124877529|NCT00988221|449175244|FG000|Part II|Reason not Specified|0|||
124877530|NCT00988221|449175245|FG001|Part II|Reason not Specified|0|||
124877531|NCT00988221|449175246|FG002|Part II|Reason not Specified|1|||
124877532|NCT00988221|449175247|FG003|Part II|Reason not Specified|0|||
124877533|NCT00988221|449175244|FG000|Part III|Adverse Event|1|||
124877534|NCT00988221|449175245|FG001|Part III|Adverse Event|0|||
124877535|NCT00988221|449175246|FG002|Part III|Adverse Event|1|||
124877536|NCT00988221|449175247|FG003|Part III|Adverse Event|0|||
124877537|NCT00988221|449175244|FG000|Part III|Insufficient Therapeutic Response|0|||
124877538|NCT00988221|449175245|FG001|Part III|Insufficient Therapeutic Response|1|||
124877539|NCT00988221|449175246|FG002|Part III|Insufficient Therapeutic Response|1|||
124877540|NCT00988221|449175247|FG003|Part III|Insufficient Therapeutic Response|0|||
124877541|NCT00988221|449175244|FG000|Part III|Refused Treatment|0|||
124877542|NCT00988221|449175245|FG001|Part III|Refused Treatment|0|||
124877543|NCT00988221|449175246|FG002|Part III|Refused Treatment|1|||
124877544|NCT00988221|449175247|FG003|Part III|Refused Treatment|0|||
124877545|NCT02756832|449175250|FG000|Overall Study|Lost for Observation after Baseline|6|||
124877546|NCT02756832|449175250|FG000|Overall Study|Lost for Observation|13|||
124877547|NCT02756832|449175250|FG000|Overall Study|Patient's Unwillingness|12|||
124877548|NCT02756832|449175250|FG000|Overall Study|Insufficient Efficacy|2|||
124877549|NCT02756832|449175250|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
124877550|NCT02756832|449175250|FG000|Overall Study|Reason not Specified|9|||
124877551|NCT02756832|449175250|FG000|Overall Study|Protocol Deviation|10|||
124877552|NCT01781390|449175251|FG000|Overall Study|Withdrawal of Consent|0|||
124877553|NCT01781390|449175252|FG001|Overall Study|Withdrawal of Consent|3|||
124877554|NCT01781390|449175253|FG002|Overall Study|Withdrawal of Consent|1|||
124877555|NCT01781390|449175251|FG000|Overall Study|Lost to Follow-up|1|||
124877556|NCT01781390|449175252|FG001|Overall Study|Lost to Follow-up|1|||
124877557|NCT01781390|449175253|FG002|Overall Study|Lost to Follow-up|1|||
124877558|NCT01781390|449175251|FG000|Overall Study|Adverse Event|1|||
124877559|NCT01781390|449175252|FG001|Overall Study|Adverse Event|2|||
124877560|NCT01781390|449175253|FG002|Overall Study|Adverse Event|1|||
124877561|NCT01781390|449175251|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
124877562|NCT01781390|449175252|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
124436257|NCT02647866|447558129|FG004|Overall Study|Physician Decision|2|||
124436258|NCT02647866|447558125|FG000|Overall Study|Death|0|||
124436259|NCT02647866|447558126|FG001|Overall Study|Death|1|||
124436260|NCT02647866|447558127|FG002|Overall Study|Death|0|||
124436261|NCT02647866|447558128|FG003|Overall Study|Death|0|||
124436262|NCT02647866|447558129|FG004|Overall Study|Death|0|||
124436263|NCT02647866|447558125|FG000|Overall Study|Subject moved to different country|1|||
124436264|NCT02647866|447558126|FG001|Overall Study|Subject moved to different country|0|||
124436265|NCT02647866|447558127|FG002|Overall Study|Subject moved to different country|0|||
124436266|NCT02647866|447558128|FG003|Overall Study|Subject moved to different country|0|||
124436267|NCT02647866|447558129|FG004|Overall Study|Subject moved to different country|0|||
124436268|NCT00069108|447558130|FG000|Overall Study|Withdrawal by Subject|5|||
124436269|NCT00069108|447558131|FG001|Overall Study|Withdrawal by Subject|9|||
124436270|NCT00069108|447558130|FG000|Overall Study|Adverse Event|64|||
124436271|NCT00069108|447558131|FG001|Overall Study|Adverse Event|42|||
124436272|NCT00069108|447558130|FG000|Overall Study|Death|6|||
124436273|NCT00069108|447558131|FG001|Overall Study|Death|6|||
124436274|NCT00069108|447558130|FG000|Overall Study|Administration|15|||
124436275|NCT00069108|447558131|FG001|Overall Study|Administration|4|||
124679017|NCT01799889|448449660|FG011|Overall Study|Progressive Disease|1|||
124679018|NCT01799889|448449649|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
124679019|NCT01799889|448449650|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
124679020|NCT01799889|448449651|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
124679021|NCT01799889|448449652|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
124679022|NCT01799889|448449653|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
124679023|NCT01799889|448449654|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
124679024|NCT01799889|448449655|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
124679025|NCT01799889|448449656|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
124679026|NCT01799889|448449657|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
124679027|NCT01799889|448449658|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
124679028|NCT01799889|448449659|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
124679029|NCT01799889|448449660|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
124679030|NCT01799889|448449649|FG000|Overall Study|Study Terminated By Sponsor|1|||
124679031|NCT01799889|448449650|FG001|Overall Study|Study Terminated By Sponsor|0|||
124679032|NCT01799889|448449651|FG002|Overall Study|Study Terminated By Sponsor|0|||
124679033|NCT01799889|448449652|FG003|Overall Study|Study Terminated By Sponsor|0|||
124679034|NCT01799889|448449653|FG004|Overall Study|Study Terminated By Sponsor|2|||
124679035|NCT01799889|448449654|FG005|Overall Study|Study Terminated By Sponsor|1|||
124679036|NCT01799889|448449655|FG006|Overall Study|Study Terminated By Sponsor|0|||
124679037|NCT01799889|448449656|FG007|Overall Study|Study Terminated By Sponsor|2|||
124679038|NCT01799889|448449657|FG008|Overall Study|Study Terminated By Sponsor|1|||
124679039|NCT01799889|448449658|FG009|Overall Study|Study Terminated By Sponsor|1|||
124679040|NCT01799889|448449659|FG010|Overall Study|Study Terminated By Sponsor|0|||
124679041|NCT01799889|448449660|FG011|Overall Study|Study Terminated By Sponsor|0|||
124679042|NCT01799889|448449649|FG000|Overall Study|Withdrawal by Subject|1|||
124679043|NCT01799889|448449650|FG001|Overall Study|Withdrawal by Subject|6|||
124679044|NCT01799889|448449651|FG002|Overall Study|Withdrawal by Subject|4|||
124679045|NCT01799889|448449652|FG003|Overall Study|Withdrawal by Subject|0|||
124679046|NCT01799889|448449653|FG004|Overall Study|Withdrawal by Subject|5|||
124679047|NCT01799889|448449654|FG005|Overall Study|Withdrawal by Subject|1|||
124679048|NCT01799889|448449655|FG006|Overall Study|Withdrawal by Subject|3|||
124679049|NCT01799889|448449656|FG007|Overall Study|Withdrawal by Subject|1|||
124679050|NCT01799889|448449657|FG008|Overall Study|Withdrawal by Subject|2|||
124679051|NCT01799889|448449658|FG009|Overall Study|Withdrawal by Subject|1|||
124679052|NCT01799889|448449659|FG010|Overall Study|Withdrawal by Subject|1|||
124679053|NCT01799889|448449660|FG011|Overall Study|Withdrawal by Subject|1|||
124679054|NCT01799889|448449649|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124679055|NCT01799889|448449650|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124679056|NCT01799889|448449651|FG002|Overall Study|Non-Compliance With Study Drug|0|||
124679057|NCT01799889|448449652|FG003|Overall Study|Non-Compliance With Study Drug|0|||
124679058|NCT01799889|448449653|FG004|Overall Study|Non-Compliance With Study Drug|0|||
124877563|NCT01781390|449175253|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
124877564|NCT01216163|449175257|FG000|Overall Study|Withdrawal by Subject|1|||
124877565|NCT01216163|449175258|FG001|Overall Study|Withdrawal by Subject|1|||
124679059|NCT01799889|448449654|FG005|Overall Study|Non-Compliance With Study Drug|1|||
124877566|NCT01216163|449175259|FG002|Overall Study|Withdrawal by Subject|0|||
124436276|NCT00069108|447558130|FG000|Overall Study|Insufficient therapy|117|||
124679060|NCT01799889|448449655|FG006|Overall Study|Non-Compliance With Study Drug|0|||
124679061|NCT01799889|448449656|FG007|Overall Study|Non-Compliance With Study Drug|0|||
124436277|NCT00069108|447558131|FG001|Overall Study|Insufficient therapy|144|||
124436278|NCT00069108|447558130|FG000|Overall Study|Violation criteria|1|||
124436279|NCT00069108|447558131|FG001|Overall Study|Violation criteria|4|||
124436280|NCT00069108|447558130|FG000|Overall Study|Refused treatment|5|||
124436281|NCT00069108|447558131|FG001|Overall Study|Refused treatment|10|||
124877567|NCT03879408|449175260|FG000|Overall Study|Lost to Follow-up|0|||
124877568|NCT03879408|449175261|FG001|Overall Study|Lost to Follow-up|3|||
124877569|NCT03879408|449175262|FG002|Overall Study|Lost to Follow-up|2|||
124877570|NCT03879408|449175263|FG003|Overall Study|Lost to Follow-up|1|||
124877571|NCT03879408|449175264|FG004|Overall Study|Lost to Follow-up|0|||
124877572|NCT03879408|449175260|FG000|Overall Study|Withdrawal by Subject|2|||
124877573|NCT03879408|449175261|FG001|Overall Study|Withdrawal by Subject|1|||
124877574|NCT03879408|449175262|FG002|Overall Study|Withdrawal by Subject|1|||
124877575|NCT03879408|449175263|FG003|Overall Study|Withdrawal by Subject|0|||
124877576|NCT03879408|449175264|FG004|Overall Study|Withdrawal by Subject|1|||
124877577|NCT00728962|449175265|FG000|Implant Placement Surgery|Adverse Event|8|||
124877578|NCT00728962|449175265|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
124877579|NCT00728962|449175265|FG000|Implant Placement Surgery|Protocol Violation|1|||
124877580|NCT00728962|449175265|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
124877581|NCT00728962|449175265|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
124877582|NCT05807919|449175266|FG000|Overall Study|Received antibiotics - excluded|0|||
124877583|NCT05807919|449175267|FG001|Overall Study|Received antibiotics - excluded|1|||
124877584|NCT05807919|449175266|FG000|Overall Study|Withdrawal by Subject|0|||
124877585|NCT05807919|449175267|FG001|Overall Study|Withdrawal by Subject|3|||
124877586|NCT05807919|449175266|FG000|Overall Study|Adverse Event|1|||
124877587|NCT05807919|449175267|FG001|Overall Study|Adverse Event|1|||
124877588|NCT02739347|449175272|FG000|Overall Study|Adverse Event|3|||
124877589|NCT02739347|449175273|FG001|Overall Study|Adverse Event|0|||
124877590|NCT02739347|449175272|FG000|Overall Study|Protocol Violation|0|||
124877591|NCT02739347|449175273|FG001|Overall Study|Protocol Violation|1|||
124877592|NCT02739347|449175272|FG000|Overall Study|Lost to Follow-up|0|||
124877593|NCT02739347|449175273|FG001|Overall Study|Lost to Follow-up|2|||
124877594|NCT03324880|449175277|FG000|Overall Study|Adverse Event|0|||
124877595|NCT03324880|449175278|FG001|Overall Study|Adverse Event|2|||
124877596|NCT03324880|449175277|FG000|Overall Study|Withdrawal by Subject|2|||
124877597|NCT03324880|449175278|FG001|Overall Study|Withdrawal by Subject|2|||
124877598|NCT03324880|449175277|FG000|Overall Study|Lost to Follow-up|0|||
124877599|NCT03324880|449175278|FG001|Overall Study|Lost to Follow-up|1|||
124877600|NCT03324880|449175277|FG000|Overall Study|Product Recall|0|||
124877601|NCT03324880|449175278|FG001|Overall Study|Product Recall|1|||
124877602|NCT03300570|449175279|FG000|Overall Study|Adverse Event|0|||
124877603|NCT03300570|449175280|FG001|Overall Study|Adverse Event|1|||
124877604|NCT03300570|449175279|FG000|Overall Study|Withdrawal by Subject|1|||
124877605|NCT03300570|449175280|FG001|Overall Study|Withdrawal by Subject|0|||
124877606|NCT03300570|449175279|FG000|Overall Study|Inadequate bowel prep|1|||
124877607|NCT03300570|449175280|FG001|Overall Study|Inadequate bowel prep|0|||
124877608|NCT00116272|449175281|FG000|Overall Study|Lost to Follow-up|11|||
124877609|NCT00116272|449175282|FG001|Overall Study|Lost to Follow-up|6|||
124877610|NCT01235403|449175284|FG000|Overall Study|Adverse Event|14|||
124877611|NCT01235403|449175284|FG000|Overall Study|Lost to Follow-up|2|||
124877612|NCT01235403|449175284|FG000|Overall Study|Withdrawal by Subject|4|||
124877613|NCT01235403|449175284|FG000|Overall Study|Lack of Efficacy|2|||
124877614|NCT01235403|449175284|FG000|Overall Study|Other reasons for premature termination|4|||
124877615|NCT02296190|449175287|FG000|Overall Study|Lost to Follow-up|0|||
124877616|NCT02296190|449175288|FG001|Overall Study|Lost to Follow-up|0|||
124877617|NCT02296190|449175289|FG002|Overall Study|Lost to Follow-up|0|||
124877618|NCT02296190|449175290|FG003|Overall Study|Lost to Follow-up|0|||
124877619|NCT02296190|449175291|FG004|Overall Study|Lost to Follow-up|1|||
124877620|NCT02296190|449175292|FG005|Overall Study|Lost to Follow-up|0|||
124877621|NCT02296190|449175287|FG000|Overall Study|Failure to induce PSVT|6|||
124877622|NCT02296190|449175288|FG001|Overall Study|Failure to induce PSVT|10|||
124877623|NCT02296190|449175289|FG002|Overall Study|Failure to induce PSVT|5|||
124877624|NCT02296190|449175290|FG003|Overall Study|Failure to induce PSVT|13|||
124877625|NCT02296190|449175291|FG004|Overall Study|Failure to induce PSVT|8|||
124877626|NCT02296190|449175292|FG005|Overall Study|Failure to induce PSVT|0|||
124877627|NCT02296190|449175287|FG000|Overall Study|Physician Decision|1|||
124877628|NCT02296190|449175288|FG001|Overall Study|Physician Decision|1|||
124877629|NCT02296190|449175289|FG002|Overall Study|Physician Decision|0|||
124877630|NCT02296190|449175290|FG003|Overall Study|Physician Decision|1|||
124436282|NCT01415531|447558133|FG000|Overall Study|Adverse Event|7|||
124436283|NCT01415531|447558134|FG001|Overall Study|Adverse Event|10|||
124679062|NCT01799889|448449657|FG008|Overall Study|Non-Compliance With Study Drug|0|||
124679063|NCT01799889|448449658|FG009|Overall Study|Non-Compliance With Study Drug|0|||
124877631|NCT02296190|449175291|FG004|Overall Study|Physician Decision|2|||
124436284|NCT01415531|447558133|FG000|Overall Study|Lack of Efficacy|3|||
124436285|NCT01415531|447558134|FG001|Overall Study|Lack of Efficacy|2|||
124436286|NCT01415531|447558133|FG000|Overall Study|Protocol Violation|0|||
124436287|NCT01415531|447558134|FG001|Overall Study|Protocol Violation|1|||
124436288|NCT01415531|447558133|FG000|Overall Study|Withdrawal by Subject|5|||
124436289|NCT01415531|447558134|FG001|Overall Study|Withdrawal by Subject|4|||
124436290|NCT01415531|447558133|FG000|Overall Study|Lost to Follow-up|6|||
124436291|NCT01415531|447558134|FG001|Overall Study|Lost to Follow-up|14|||
124436292|NCT01415531|447558133|FG000|Overall Study|Lack of Compliance|1|||
124436293|NCT01415531|447558134|FG001|Overall Study|Lack of Compliance|4|||
124436294|NCT01415531|447558133|FG000|Overall Study|Other Reasons|3|||
124436295|NCT01415531|447558134|FG001|Overall Study|Other Reasons|2|||
124436296|NCT02319525|447558136|FG000|Overall Study|Withdrawal by Subject|2|||
124436297|NCT02319525|447558137|FG001|Overall Study|Withdrawal by Subject|1|||
124436298|NCT00938860|447558138|FG000|Overall Study|Adverse Event|2|||
124436299|NCT00938860|447558139|FG001|Overall Study|Adverse Event|1|||
124436300|NCT00938860|447558138|FG000|Overall Study|Abnormal laboratory values|2|||
124436301|NCT00938860|447558139|FG001|Overall Study|Abnormal laboratory values|2|||
124436302|NCT00938860|447558138|FG000|Overall Study|Withdrawal by Subject|11|||
124436303|NCT00938860|447558139|FG001|Overall Study|Withdrawal by Subject|8|||
124436304|NCT00938860|447558138|FG000|Overall Study|Lost to Follow-up|4|||
124436305|NCT00938860|447558139|FG001|Overall Study|Lost to Follow-up|4|||
124436306|NCT00938860|447558138|FG000|Overall Study|Administration problems|2|||
124436307|NCT00938860|447558139|FG001|Overall Study|Administration problems|0|||
124436308|NCT00938860|447558138|FG000|Overall Study|Death|1|||
124436309|NCT00938860|447558139|FG001|Overall Study|Death|1|||
124436310|NCT00938860|447558138|FG000|Overall Study|Protocol Violation|3|||
124436311|NCT00938860|447558139|FG001|Overall Study|Protocol Violation|1|||
124436312|NCT00232544|447558140|FG000|Overall Study|Lost to Follow-up|20|||
124436313|NCT00232544|447558141|FG001|Overall Study|Lost to Follow-up|15|||
124436314|NCT00336895|447558142|FG000|Overall Study|diarrhea|1|||
124436315|NCT00336895|447558142|FG000|Overall Study|nausea and upset stomach|1|||
124436316|NCT00336895|447558142|FG000|Overall Study|Physician Decision|1|||
124436317|NCT00336895|447558142|FG000|Overall Study|screen failed|1|||
124877632|NCT02296190|449175292|FG005|Overall Study|Physician Decision|0|||
124877633|NCT02296190|449175287|FG000|Overall Study|Withdrawal by Subject|0|||
124877634|NCT02296190|449175288|FG001|Overall Study|Withdrawal by Subject|1|||
124877635|NCT02296190|449175289|FG002|Overall Study|Withdrawal by Subject|0|||
124877636|NCT02296190|449175290|FG003|Overall Study|Withdrawal by Subject|0|||
124877637|NCT02296190|449175291|FG004|Overall Study|Withdrawal by Subject|0|||
124877638|NCT02296190|449175292|FG005|Overall Study|Withdrawal by Subject|0|||
124877639|NCT02296190|449175287|FG000|Overall Study|PSVT < 5 minutes|5|||
124436318|NCT02481947|447558143|FG000|Overall Study|Withdrawal by Subject|24|||
124436319|NCT02481947|447558144|FG001|Overall Study|Withdrawal by Subject|10|||
124436320|NCT02481947|447558143|FG000|Overall Study|Lost to Follow-up|11|||
124436321|NCT02481947|447558144|FG001|Overall Study|Lost to Follow-up|5|||
124436322|NCT02481947|447558143|FG000|Overall Study|Adverse Event|6|||
124436323|NCT02481947|447558144|FG001|Overall Study|Adverse Event|11|||
124436324|NCT02481947|447558143|FG000|Overall Study|Physician Decision|4|||
124436325|NCT02481947|447558144|FG001|Overall Study|Physician Decision|5|||
124436326|NCT02481947|447558143|FG000|Overall Study|Protocol Violation|1|||
124877640|NCT02296190|449175288|FG001|Overall Study|PSVT < 5 minutes|6|||
124877641|NCT02296190|449175289|FG002|Overall Study|PSVT < 5 minutes|6|||
124877642|NCT02296190|449175290|FG003|Overall Study|PSVT < 5 minutes|6|||
124877643|NCT02296190|449175291|FG004|Overall Study|PSVT < 5 minutes|5|||
124877644|NCT02296190|449175292|FG005|Overall Study|PSVT < 5 minutes|0|||
124877645|NCT02296190|449175287|FG000|Overall Study|Patient was given Propofol|0|||
124877646|NCT02296190|449175288|FG001|Overall Study|Patient was given Propofol|1|||
124877647|NCT02296190|449175289|FG002|Overall Study|Patient was given Propofol|0|||
124877648|NCT02296190|449175290|FG003|Overall Study|Patient was given Propofol|1|||
124877649|NCT02296190|449175291|FG004|Overall Study|Patient was given Propofol|0|||
124877650|NCT02296190|449175292|FG005|Overall Study|Patient was given Propofol|0|||
124877651|NCT02296190|449175287|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
124877652|NCT02296190|449175288|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
124877653|NCT02296190|449175289|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
124877654|NCT02296190|449175290|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
124877655|NCT02296190|449175291|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
124877656|NCT02296190|449175292|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
124877657|NCT02296190|449175287|FG000|Overall Study|Blood pressure <100 after sedation|0|||
124877658|NCT02296190|449175288|FG001|Overall Study|Blood pressure <100 after sedation|0|||
124877659|NCT02296190|449175289|FG002|Overall Study|Blood pressure <100 after sedation|0|||
124877660|NCT02296190|449175290|FG003|Overall Study|Blood pressure <100 after sedation|1|||
124877661|NCT02296190|449175291|FG004|Overall Study|Blood pressure <100 after sedation|0|||
124877662|NCT02296190|449175292|FG005|Overall Study|Blood pressure <100 after sedation|0|||
124877663|NCT02296190|449175287|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
124877664|NCT02296190|449175288|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
124877665|NCT02296190|449175289|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
124877666|NCT02296190|449175290|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
124877667|NCT02296190|449175291|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
124679064|NCT01799889|448449659|FG010|Overall Study|Non-Compliance With Study Drug|0|||
124679065|NCT01799889|448449660|FG011|Overall Study|Non-Compliance With Study Drug|0|||
124679066|NCT03944616|448449661|FG000|Overall Study|Lost to Follow-up|0|||
124679067|NCT03944616|448449662|FG001|Overall Study|Lost to Follow-up|2|||
124679068|NCT01721798|448449663|FG000|Overall Study|Death|0|||
124679069|NCT01721798|448449664|FG001|Overall Study|Death|0|||
124679070|NCT01721798|448449665|FG002|Overall Study|Death|1|||
124679071|NCT01721798|448449666|FG003|Overall Study|Death|1|||
124679072|NCT01721798|448449663|FG000|Overall Study|Lost to Follow-up|2|||
124679073|NCT01721798|448449664|FG001|Overall Study|Lost to Follow-up|2|||
124679074|NCT01721798|448449665|FG002|Overall Study|Lost to Follow-up|9|||
124679075|NCT01721798|448449666|FG003|Overall Study|Lost to Follow-up|9|||
124679076|NCT01721798|448449663|FG000|Overall Study|Pregnancy|0|||
124679077|NCT01721798|448449664|FG001|Overall Study|Pregnancy|0|||
124679078|NCT01721798|448449665|FG002|Overall Study|Pregnancy|1|||
124679079|NCT01721798|448449666|FG003|Overall Study|Pregnancy|1|||
124679080|NCT01721798|448449663|FG000|Overall Study|Withdrawal by Subject|1|||
124679081|NCT01721798|448449664|FG001|Overall Study|Withdrawal by Subject|0|||
124679082|NCT01721798|448449665|FG002|Overall Study|Withdrawal by Subject|2|||
124679083|NCT01721798|448449666|FG003|Overall Study|Withdrawal by Subject|1|||
124679084|NCT01721798|448449663|FG000|Overall Study|Not eligible for 24 month visit|1|||
124436327|NCT02481947|447558144|FG001|Overall Study|Protocol Violation|5|||
124436328|NCT05249829|447558145|FG000|Overall Study|Participant Relocation|0|||
124436329|NCT05249829|447558146|FG001|Overall Study|Participant Relocation|1|||
124436330|NCT05249829|447558147|FG002|Overall Study|Participant Relocation|2|||
124436331|NCT05249829|447558148|FG003|Overall Study|Participant Relocation|2|||
124436332|NCT05249829|447558145|FG000|Overall Study|Withdrawal by Subject|9|||
124679085|NCT01721798|448449664|FG001|Overall Study|Not eligible for 24 month visit|0|||
124679086|NCT01721798|448449665|FG002|Overall Study|Not eligible for 24 month visit|8|||
124679087|NCT01721798|448449666|FG003|Overall Study|Not eligible for 24 month visit|7|||
124679088|NCT01294046|448449667|FG000|Overall Study|Infection and surgical explant|1|||
124679089|NCT01294046|448449667|FG000|Overall Study|Eligibility criteria expanded|1|||
124679090|NCT01294046|448449667|FG000|Overall Study|Stimulation response inadqequate|1|||
124679091|NCT01499511|448449670|FG000|Overall Study|Death|1|||
124679092|NCT01499511|448449671|FG001|Overall Study|Death|0|||
124679093|NCT00091819|448449672|FG000|Overall Study|Adverse Event|1|||
124679094|NCT00091819|448449673|FG001|Overall Study|Adverse Event|1|||
124679095|NCT00091819|448449672|FG000|Overall Study|Death|4|||
124679096|NCT00091819|448449673|FG001|Overall Study|Death|5|||
124679097|NCT00091819|448449672|FG000|Overall Study|Lost to Follow-up|26|||
124877668|NCT02296190|449175292|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
124877669|NCT02296190|449175287|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
124679098|NCT00091819|448449673|FG001|Overall Study|Lost to Follow-up|23|||
124679099|NCT00091819|448449672|FG000|Overall Study|Withdrawal by Subject|5|||
124679100|NCT00091819|448449673|FG001|Overall Study|Withdrawal by Subject|8|||
124679101|NCT00091819|448449672|FG000|Overall Study|Protocol Violation|1|||
124679102|NCT00091819|448449673|FG001|Overall Study|Protocol Violation|2|||
124679103|NCT00091819|448449672|FG000|Overall Study|Other|2|||
124877670|NCT02296190|449175288|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
124877671|NCT02296190|449175289|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
124877672|NCT02296190|449175290|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
124877673|NCT02296190|449175291|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
124877674|NCT02296190|449175292|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
124877675|NCT02296190|449175287|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
124877676|NCT02296190|449175288|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
124877677|NCT02296190|449175289|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
124877678|NCT02296190|449175290|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
124877679|NCT02296190|449175291|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
124877680|NCT02296190|449175292|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
124877681|NCT02296190|449175287|FG000|Overall Study|Lab result not available in time|1|||
124877682|NCT02296190|449175288|FG001|Overall Study|Lab result not available in time|0|||
124877683|NCT02296190|449175289|FG002|Overall Study|Lab result not available in time|0|||
124877684|NCT02296190|449175290|FG003|Overall Study|Lab result not available in time|0|||
124877685|NCT02296190|449175291|FG004|Overall Study|Lab result not available in time|0|||
124877686|NCT02296190|449175292|FG005|Overall Study|Lab result not available in time|0|||
124877687|NCT00990340|449175293|FG000|First 14-day Treatment|Not Compliant|2|||
124877688|NCT00990340|449175294|FG001|First 14-day Treatment|Not Compliant|1|||
124877689|NCT00990340|449175293|FG000|First 14-day Treatment|Lost to Follow-up|2|||
124877690|NCT00990340|449175294|FG001|First 14-day Treatment|Lost to Follow-up|1|||
124877691|NCT00990340|449175293|FG000|First 14-day Treatment|Protocol Violation|2|||
124877692|NCT00990340|449175294|FG001|First 14-day Treatment|Protocol Violation|2|||
124877693|NCT04615182|449175295|FG000|Overall Study|Re-transplanted|2|||
124877694|NCT04615182|449175295|FG000|Overall Study|Protocol Violation|6|||
124877695|NCT04615182|449175295|FG000|Overall Study|Death|6|||
124877696|NCT04615182|449175295|FG000|Overall Study|Death and protocol violation|1|||
124877697|NCT00402337|449175300|FG000|Overall Study|Adverse Event|0|||
124877698|NCT00402337|449175301|FG001|Overall Study|Adverse Event|2|||
124877699|NCT00402337|449175302|FG002|Overall Study|Adverse Event|2|||
124877700|NCT00402337|449175303|FG003|Overall Study|Adverse Event|3|||
124877701|NCT00402337|449175304|FG004|Overall Study|Adverse Event|2|||
124877702|NCT00402337|449175300|FG000|Overall Study|Noncompliance|0|||
124877703|NCT00402337|449175301|FG001|Overall Study|Noncompliance|0|||
124877704|NCT00402337|449175302|FG002|Overall Study|Noncompliance|0|||
124877705|NCT00402337|449175303|FG003|Overall Study|Noncompliance|0|||
124877706|NCT00402337|449175304|FG004|Overall Study|Noncompliance|2|||
124877707|NCT00402337|449175300|FG000|Overall Study|Withdrawal by Subject|5|||
124877708|NCT00402337|449175301|FG001|Overall Study|Withdrawal by Subject|3|||
124877709|NCT00402337|449175302|FG002|Overall Study|Withdrawal by Subject|1|||
124877710|NCT00402337|449175303|FG003|Overall Study|Withdrawal by Subject|6|||
124877711|NCT00402337|449175304|FG004|Overall Study|Withdrawal by Subject|4|||
124877712|NCT00402337|449175300|FG000|Overall Study|Lost to Follow-up|0|||
124877713|NCT00402337|449175301|FG001|Overall Study|Lost to Follow-up|0|||
124877714|NCT00402337|449175302|FG002|Overall Study|Lost to Follow-up|1|||
124877715|NCT00402337|449175303|FG003|Overall Study|Lost to Follow-up|2|||
124877716|NCT00402337|449175304|FG004|Overall Study|Lost to Follow-up|0|||
124877717|NCT00402337|449175300|FG000|Overall Study|Physician Decision|0|||
124877718|NCT00402337|449175301|FG001|Overall Study|Physician Decision|0|||
124877719|NCT00402337|449175302|FG002|Overall Study|Physician Decision|0|||
124877720|NCT00402337|449175303|FG003|Overall Study|Physician Decision|1|||
124877721|NCT00402337|449175304|FG004|Overall Study|Physician Decision|0|||
124877722|NCT00402337|449175300|FG000|Overall Study|Other Reason|0|||
124877723|NCT00402337|449175301|FG001|Overall Study|Other Reason|1|||
124877724|NCT00402337|449175302|FG002|Overall Study|Other Reason|0|||
124877725|NCT00402337|449175303|FG003|Overall Study|Other Reason|0|||
124877726|NCT00402337|449175304|FG004|Overall Study|Other Reason|0|||
124877727|NCT02821819|449175305|FG000|Overall Study|Protocol Violation|1|||
124877728|NCT00110890|449175309|FG000|Overall Study|Adverse Event|30|||
124877729|NCT00110890|449175310|FG001|Overall Study|Adverse Event|7|||
124877730|NCT00110890|449175309|FG000|Overall Study|Death|16|||
124877731|NCT00110890|449175310|FG001|Overall Study|Death|9|||
124877732|NCT00110890|449175309|FG000|Overall Study|Lost to Follow-up|3|||
124877733|NCT00110890|449175310|FG001|Overall Study|Lost to Follow-up|1|||
124877734|NCT00110890|449175309|FG000|Overall Study|Physician Decision|4|||
124877735|NCT00110890|449175310|FG001|Overall Study|Physician Decision|5|||
124877736|NCT00110890|449175309|FG000|Overall Study|Withdrawal by Subject|17|||
124877737|NCT00110890|449175310|FG001|Overall Study|Withdrawal by Subject|5|||
124877738|NCT00110890|449175309|FG000|Overall Study|Protocol Deviation|1|||
124877739|NCT00110890|449175310|FG001|Overall Study|Protocol Deviation|0|||
124877740|NCT00110890|449175309|FG000|Overall Study|Noncompliance|10|||
124679104|NCT00091819|448449673|FG001|Overall Study|Other|3|||
124877741|NCT00110890|449175310|FG001|Overall Study|Noncompliance|0|||
124877742|NCT00110890|449175309|FG000|Overall Study|Kidney Transplant|16|||
124877743|NCT00110890|449175310|FG001|Overall Study|Kidney Transplant|12|||
124877744|NCT00110890|449175309|FG000|Overall Study|Invest. Product Commercially Available|217|||
124877745|NCT00110890|449175310|FG001|Overall Study|Invest. Product Commercially Available|110|||
124877746|NCT00110890|449175309|FG000|Overall Study|Other|34|||
124877747|NCT00110890|449175310|FG001|Overall Study|Other|23|||
124679105|NCT00091819|448449672|FG000|Overall Study|Never received study treatment|3|||
124679106|NCT00091819|448449673|FG001|Overall Study|Never received study treatment|4|||
124679107|NCT03692949|448449675|FG000|Overall Study|Lost to Follow-up|0|||
124679108|NCT03692949|448449676|FG001|Overall Study|Lost to Follow-up|0|||
124679109|NCT03692949|448449677|FG002|Overall Study|Lost to Follow-up|0|||
124679110|NCT03692949|448449678|FG003|Overall Study|Lost to Follow-up|0|||
124679111|NCT03692949|448449679|FG004|Overall Study|Lost to Follow-up|0|||
124679112|NCT03692949|448449680|FG005|Overall Study|Lost to Follow-up|0|||
124679113|NCT03692949|448449681|FG006|Overall Study|Lost to Follow-up|0|||
124679114|NCT03692949|448449682|FG007|Overall Study|Lost to Follow-up|1|||
124679115|NCT02592824|448449683|FG000|Overall Study|Protocol Violation|5|||
124679116|NCT02592824|448449684|FG001|Overall Study|Protocol Violation|3|||
124679117|NCT02592824|448449683|FG000|Overall Study|Lost to Follow-up|2|||
124679118|NCT02592824|448449684|FG001|Overall Study|Lost to Follow-up|1|||
124679119|NCT01286129|448449685|FG000|Overall Study|Withdrawal by Subject|4|||
124679120|NCT01286129|448449686|FG001|Overall Study|Withdrawal by Subject|1|||
124679121|NCT01286129|448449685|FG000|Overall Study|Could not comply with study requirements|4|||
124679122|NCT01286129|448449686|FG001|Overall Study|Could not comply with study requirements|4|||
124679123|NCT01604785|448449687|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
124679124|NCT01604785|448449688|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
124679125|NCT01394276|448449691|FG000|Overall Study|Related Adverse event (AEs)|15|||
124679126|NCT01394276|448449691|FG000|Overall Study|Not related AEs|9|||
124679127|NCT01394276|448449691|FG000|Overall Study|Remission of disease|2|||
124679128|NCT01394276|448449691|FG000|Overall Study|Insufficient therapeutic effect|17|||
124679129|NCT01394276|448449691|FG000|Overall Study|Insufficient compliance|9|||
124679130|NCT01394276|448449691|FG000|Overall Study|Lost to Follow-up|5|||
124679131|NCT01394276|448449691|FG000|Overall Study|Participant moved to another site|1|||
124679132|NCT01394276|448449691|FG000|Overall Study|Pregnancy|1|||
124679133|NCT01394276|448449691|FG000|Overall Study|unavailability of drug at the Hospital|2|||
124679134|NCT01394276|448449691|FG000|Overall Study|Symptoms of concurrent diseases|1|||
124679135|NCT05049122|448449692|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
124679136|NCT05049122|448449692|FG000|Overall Study|Participant moved|1|||
124679137|NCT05049122|448449692|FG000|Overall Study|At the direction of the doctor|1|||
124679138|NCT02187783|448449693|FG000|Overall Study|Adverse Event|8|||
124679139|NCT02187783|448449693|FG000|Overall Study|Death|3|||
124679140|NCT02187783|448449693|FG000|Overall Study|Progressive disease|80|||
124679141|NCT02187783|448449693|FG000|Overall Study|Protocol Violation|3|||
124679142|NCT02187783|448449693|FG000|Overall Study|Physician Decision|2|||
124679143|NCT02187783|448449693|FG000|Overall Study|Withdrawal by Subject|9|||
124679144|NCT02187783|448449693|FG000|Overall Study|Study terminated by sponsor|1|||
124679145|NCT00471497|448449694|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
124679146|NCT00471497|448449695|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
124679147|NCT00471497|448449696|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
124679148|NCT00471497|448449694|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
124679149|NCT00471497|448449695|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
124679150|NCT00471497|448449696|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
124679151|NCT00471497|448449694|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
124679152|NCT00471497|448449695|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
124679153|NCT00471497|448449696|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
124679154|NCT00471497|448449694|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
124679155|NCT00471497|448449695|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
124679156|NCT00471497|448449696|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
124679157|NCT00471497|448449694|FG000|Core Treatment Phase|Lost to Follow-up|6|||
124679158|NCT00471497|448449695|FG001|Core Treatment Phase|Lost to Follow-up|6|||
124679159|NCT00471497|448449696|FG002|Core Treatment Phase|Lost to Follow-up|3|||
124679160|NCT00471497|448449694|FG000|Core Treatment Phase|Death|3|||
124679161|NCT00471497|448449695|FG001|Core Treatment Phase|Death|9|||
124679162|NCT00471497|448449696|FG002|Core Treatment Phase|Death|3|||
124679163|NCT00471497|448449694|FG000|Core Treatment Phase|Disease Progression|10|||
124877748|NCT00110890|449175309|FG000|Overall Study|Ineligibility determined|3|||
124877749|NCT00110890|449175310|FG001|Overall Study|Ineligibility determined|0|||
124679164|NCT00471497|448449695|FG001|Core Treatment Phase|Disease Progression|2|||
124877750|NCT00110890|449175309|FG000|Overall Study|Requirement for alternative therapy|0|||
124877751|NCT00110890|449175310|FG001|Overall Study|Requirement for alternative therapy|1|||
124877752|NCT00110890|449175309|FG000|Overall Study|Disease progression|0|||
124877753|NCT00110890|449175310|FG001|Overall Study|Disease progression|1|||
124877754|NCT00110890|449175309|FG000|Overall Study|Parathyroidectomy|0|||
124877755|NCT00110890|449175310|FG001|Overall Study|Parathyroidectomy|1|||
124877756|NCT00110890|449175309|FG000|Overall Study|Did not enter follow-up phase|10|||
124877757|NCT00110890|449175310|FG001|Overall Study|Did not enter follow-up phase|4|||
124877758|NCT01975220|449175311|FG000|Test Period 1|Not treated|0|||
124877759|NCT01975220|449175312|FG001|Test Period 1|Not treated|1|||
124877760|NCT01975220|449175313|FG002|Test Period 1|Not treated|0|||
124877761|NCT01975220|449175314|FG003|Test Period 1|Not treated|0|||
124877762|NCT01975220|449175315|FG004|Test Period 1|Not treated|0|||
124877763|NCT01975220|449175316|FG005|Test Period 1|Not treated|0|||
124877764|NCT02839343|449175317|FG000|Overall Study|Withdrawal by Subject|3|||
124877765|NCT02839343|449175318|FG001|Overall Study|Withdrawal by Subject|1|||
124877766|NCT02839343|449175317|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
124877767|NCT02839343|449175318|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
124877768|NCT02839343|449175317|FG000|Overall Study|Adverse Event|1|||
124877769|NCT02839343|449175318|FG001|Overall Study|Adverse Event|0|||
124877770|NCT01852058|449175319|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
124877771|NCT01852058|449175320|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877772|NCT01852058|449175321|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877773|NCT01852058|449175322|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877774|NCT01852058|449175323|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877775|NCT01852058|449175324|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877776|NCT01852058|449175325|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877777|NCT01852058|449175326|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877778|NCT01852058|449175327|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877779|NCT01852058|449175328|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877780|NCT01852058|449175329|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877781|NCT01852058|449175330|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
124877782|NCT01852058|449175319|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877783|NCT01852058|449175320|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877784|NCT01852058|449175321|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877785|NCT01852058|449175322|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877786|NCT01852058|449175323|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
124877787|NCT01852058|449175324|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877788|NCT01852058|449175325|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877789|NCT01852058|449175326|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877790|NCT01852058|449175327|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877791|NCT01852058|449175328|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877792|NCT01852058|449175329|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877793|NCT01852058|449175330|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
124877794|NCT01852058|449175319|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877795|NCT01852058|449175320|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877796|NCT01852058|449175321|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877797|NCT01852058|449175322|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877798|NCT01852058|449175323|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
124877799|NCT01852058|449175324|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
124877800|NCT01852058|449175325|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877801|NCT01852058|449175326|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877802|NCT01852058|449175327|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877803|NCT01852058|449175328|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877804|NCT01852058|449175329|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877805|NCT01852058|449175330|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
124877806|NCT01852058|449175319|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877807|NCT01852058|449175320|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877808|NCT01852058|449175321|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877809|NCT01852058|449175322|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877810|NCT01852058|449175323|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
124436333|NCT05249829|447558146|FG001|Overall Study|Withdrawal by Subject|17|||
124877811|NCT01852058|449175324|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877812|NCT01852058|449175325|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877813|NCT01852058|449175326|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877814|NCT01852058|449175327|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877815|NCT01852058|449175328|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877816|NCT01852058|449175329|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877817|NCT01852058|449175330|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
124877818|NCT01852058|449175319|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877819|NCT01852058|449175320|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877820|NCT01852058|449175321|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877821|NCT01852058|449175322|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877822|NCT01852058|449175323|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
124877823|NCT01852058|449175324|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
124877824|NCT01852058|449175325|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877825|NCT01852058|449175326|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877826|NCT01852058|449175327|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877827|NCT01852058|449175328|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877828|NCT01852058|449175329|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877829|NCT01852058|449175330|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
124877830|NCT01852058|449175319|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877831|NCT01852058|449175320|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877832|NCT01852058|449175321|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877833|NCT01852058|449175322|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
124877834|NCT01852058|449175323|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877835|NCT01852058|449175324|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877836|NCT01852058|449175325|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877837|NCT01852058|449175326|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877838|NCT01852058|449175327|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877839|NCT01852058|449175328|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877840|NCT01852058|449175329|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877841|NCT01852058|449175330|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
124877842|NCT01852058|449175319|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877843|NCT01852058|449175320|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877844|NCT01852058|449175321|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877845|NCT01852058|449175322|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877846|NCT01852058|449175323|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
124877847|NCT01852058|449175324|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
124877848|NCT01852058|449175325|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877849|NCT01852058|449175326|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877850|NCT01852058|449175327|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877851|NCT01852058|449175328|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877852|NCT01852058|449175329|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877853|NCT01852058|449175330|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
124877854|NCT01852058|449175319|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877855|NCT01852058|449175320|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877856|NCT01852058|449175321|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877857|NCT01852058|449175322|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877858|NCT01852058|449175323|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877859|NCT01852058|449175324|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877860|NCT01852058|449175325|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877861|NCT01852058|449175326|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
124877862|NCT01852058|449175327|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877863|NCT01852058|449175328|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877864|NCT01852058|449175329|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877865|NCT01852058|449175330|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
124877866|NCT01852058|449175319|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877867|NCT01852058|449175320|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877868|NCT01852058|449175321|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877869|NCT01852058|449175322|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877870|NCT01852058|449175323|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877871|NCT01852058|449175324|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877872|NCT01852058|449175325|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877873|NCT01852058|449175326|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877874|NCT01852058|449175327|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
124877875|NCT01852058|449175328|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877876|NCT01852058|449175329|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877877|NCT01852058|449175330|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
124877878|NCT01301274|449175334|FG000|Overall Study|Physician Decision|2|||
124436334|NCT05249829|447558147|FG002|Overall Study|Withdrawal by Subject|40|||
124436335|NCT05249829|447558148|FG003|Overall Study|Withdrawal by Subject|35|||
124436336|NCT05249829|447558145|FG000|Overall Study|Physician Decision|1|||
124436337|NCT05249829|447558146|FG001|Overall Study|Physician Decision|0|||
124436338|NCT05249829|447558147|FG002|Overall Study|Physician Decision|0|||
124436339|NCT05249829|447558148|FG003|Overall Study|Physician Decision|0|||
124436340|NCT05249829|447558145|FG000|Overall Study|Lost to Follow-up|16|||
124436341|NCT05249829|447558146|FG001|Overall Study|Lost to Follow-up|16|||
124436342|NCT05249829|447558147|FG002|Overall Study|Lost to Follow-up|57|||
124436343|NCT05249829|447558148|FG003|Overall Study|Lost to Follow-up|60|||
124436344|NCT05249829|447558145|FG000|Overall Study|Adverse Event|2|||
124436345|NCT05249829|447558146|FG001|Overall Study|Adverse Event|2|||
124436346|NCT05249829|447558147|FG002|Overall Study|Adverse Event|2|||
124436347|NCT05249829|447558148|FG003|Overall Study|Adverse Event|2|||
124436348|NCT05249829|447558145|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
124436349|NCT05249829|447558146|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
124436350|NCT05249829|447558147|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
124436351|NCT05249829|447558148|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
124436352|NCT05249829|447558145|FG000|Overall Study|Protocol Violation|2|||
124436353|NCT05249829|447558146|FG001|Overall Study|Protocol Violation|0|||
124436354|NCT05249829|447558147|FG002|Overall Study|Protocol Violation|5|||
124436355|NCT05249829|447558148|FG003|Overall Study|Protocol Violation|3|||
124436356|NCT05249829|447558145|FG000|Overall Study|Death|0|||
124436357|NCT05249829|447558146|FG001|Overall Study|Death|1|||
124436358|NCT05249829|447558147|FG002|Overall Study|Death|2|||
124436359|NCT05249829|447558148|FG003|Overall Study|Death|4|||
124436360|NCT01535560|447558153|FG000|Overall Study|Adverse Event|12|||
124436361|NCT01535560|447558154|FG001|Overall Study|Adverse Event|7|||
124436362|NCT01535560|447558153|FG000|Overall Study|Lost to Follow-up|1|||
124436363|NCT01535560|447558154|FG001|Overall Study|Lost to Follow-up|3|||
124436364|NCT01535560|447558153|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
124436365|NCT01535560|447558154|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
124436366|NCT01535560|447558153|FG000|Overall Study|Treatment Failure|21|||
124436367|NCT01535560|447558154|FG001|Overall Study|Treatment Failure|83|||
124436368|NCT01535560|447558153|FG000|Overall Study|Other|0|||
124436369|NCT01535560|447558154|FG001|Overall Study|Other|1|||
124436370|NCT01535560|447558153|FG000|Overall Study|Randomized in Error|0|||
124436371|NCT01535560|447558154|FG001|Overall Study|Randomized in Error|1|||
124436372|NCT01815138|447558159|FG000|Overall Study|Withdrawal by Subject|0|||
124436373|NCT01815138|447558160|FG001|Overall Study|Withdrawal by Subject|1|||
124436374|NCT01815138|447558159|FG000|Overall Study|Physician Decision|8|||
124436375|NCT01815138|447558160|FG001|Overall Study|Physician Decision|5|||
124436376|NCT03426267|447558163|FG000|Overall Study|Physician Decision|1|||
124436377|NCT03426267|447558164|FG001|Overall Study|Physician Decision|4|||
124436378|NCT03426267|447558163|FG000|Overall Study|Lost to Follow-up|1|||
124436379|NCT03426267|447558164|FG001|Overall Study|Lost to Follow-up|0|||
124436380|NCT03426267|447558163|FG000|Overall Study|Withdrawal by Subject|4|||
124436381|NCT03426267|447558164|FG001|Overall Study|Withdrawal by Subject|10|||
124436382|NCT03426267|447558163|FG000|Overall Study|Protocol Violation|1|||
124436383|NCT03426267|447558164|FG001|Overall Study|Protocol Violation|3|||
124436384|NCT03426267|447558163|FG000|Overall Study|Adverse Event|9|||
124436385|NCT03426267|447558164|FG001|Overall Study|Adverse Event|27|||
124436386|NCT03426267|447558163|FG000|Overall Study|Prohibited Treatment Intake|2|||
124436387|NCT03426267|447558164|FG001|Overall Study|Prohibited Treatment Intake|3|||
124436388|NCT03426267|447558163|FG000|Overall Study|Lack of Efficacy|0|||
124436389|NCT03426267|447558164|FG001|Overall Study|Lack of Efficacy|25|||
124436390|NCT03426267|447558163|FG000|Overall Study|other|3|||
124436391|NCT03426267|447558164|FG001|Overall Study|other|0|||
124436392|NCT00609765|447558165|FG000|Overall Study|Study ended prior to 12 months|1|||
124436393|NCT02649946|447558168|FG000|Overall Study|Withdrawal by Subject|1|||
124436394|NCT02649946|447558169|FG001|Overall Study|Withdrawal by Subject|1|||
124436395|NCT02649946|447558168|FG000|Overall Study|Death|7|||
124436396|NCT02649946|447558169|FG001|Overall Study|Death|9|||
124436397|NCT02649946|447558168|FG000|Overall Study|Physician Decision|1|||
124436398|NCT02649946|447558169|FG001|Overall Study|Physician Decision|0|||
124436399|NCT02649946|447558168|FG000|Overall Study|Lost to Follow-up|2|||
124436400|NCT02649946|447558169|FG001|Overall Study|Lost to Follow-up|1|||
124436401|NCT02649946|447558168|FG000|Overall Study|Erroneously enrolled|1|||
124436402|NCT02649946|447558169|FG001|Overall Study|Erroneously enrolled|0|||
124436403|NCT02649946|447558168|FG000|Overall Study|Missed 6-month follow-up visit|0|||
124436404|NCT02649946|447558169|FG001|Overall Study|Missed 6-month follow-up visit|4|||
124436405|NCT00950950|447558170|FG000|Overall Study|Adverse Event|1|||
124436406|NCT00950950|447558171|FG001|Overall Study|Adverse Event|0|||
124436407|NCT00950950|447558170|FG000|Overall Study|Withdrawal by Subject|0|||
124436408|NCT00950950|447558171|FG001|Overall Study|Withdrawal by Subject|1|||
124436409|NCT02232243|447558179|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
124436410|NCT02232243|447558180|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
124436411|NCT02232243|447558181|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
124544331|NCT02268214|447946769|FG001|Overall Study|Lost to Follow-up|3|||
124679165|NCT00471497|448449696|FG002|Core Treatment Phase|Disease Progression|4|||
124679166|NCT00471497|448449694|FG000|Core Treatment Phase|Protocol Violation|6|||
124679167|NCT00471497|448449695|FG001|Core Treatment Phase|Protocol Violation|15|||
124436412|NCT00704405|447558182|FG000|Overall Study (NC Population)|Adverse Event|1|||
124436413|NCT00704405|447558183|FG001|Overall Study (NC Population)|Adverse Event|0|||
124436414|NCT00704405|447558184|FG002|Overall Study (NC Population)|Adverse Event|0|||
124436415|NCT00704405|447558185|FG003|Overall Study (NC Population)|Adverse Event|0|||
124436416|NCT00704405|447558186|FG004|Overall Study (NC Population)|Adverse Event|0|||
124436417|NCT00704405|447558182|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
124436418|NCT00704405|447558183|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
124436419|NCT00704405|447558184|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
124436420|NCT00704405|447558185|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
124436421|NCT00704405|447558186|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
124436422|NCT00704405|447558182|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
124436423|NCT00704405|447558183|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
124436424|NCT00704405|447558184|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
124436425|NCT00704405|447558185|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
124436426|NCT00704405|447558186|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
124436427|NCT00704405|447558182|FG000|Overall Study (NC Population)|Other|0|||
124436428|NCT00704405|447558183|FG001|Overall Study (NC Population)|Other|0|||
124436429|NCT00704405|447558184|FG002|Overall Study (NC Population)|Other|0|||
124436430|NCT00704405|447558185|FG003|Overall Study (NC Population)|Other|0|||
124436431|NCT00704405|447558186|FG004|Overall Study (NC Population)|Other|1|||
124436432|NCT00704405|447558182|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
124436433|NCT00704405|447558183|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
124436434|NCT00704405|447558184|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
124436435|NCT00704405|447558185|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
124436436|NCT00704405|447558186|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
124436437|NCT00704405|447558182|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
124436438|NCT00704405|447558183|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
124436439|NCT00704405|447558184|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
124436440|NCT00704405|447558185|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
124436441|NCT00704405|447558186|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
124436442|NCT00928018|447558187|FG000|Overall Study|Withdrawal by Subject|1|||
124436443|NCT00928018|447558188|FG001|Overall Study|Withdrawal by Subject|0|||
124436444|NCT03218397|447558189|FG000|Overall Study|Prior positive blood culture|8|||
124436445|NCT03218397|447558190|FG001|Overall Study|Prior positive blood culture|13|||
124436446|NCT03218397|447558189|FG000|Overall Study|Comfort care|8|||
124436447|NCT03218397|447558190|FG001|Overall Study|Comfort care|5|||
124436448|NCT03218397|447558189|FG000|Overall Study|Comfort care and positive blood culture|1|||
124436449|NCT03218397|447558190|FG001|Overall Study|Comfort care and positive blood culture|0|||
124436450|NCT03218397|447558189|FG000|Overall Study|Comfort care and mixed culture|0|||
124436451|NCT03218397|447558190|FG001|Overall Study|Comfort care and mixed culture|1|||
124436452|NCT03218397|447558189|FG000|Overall Study|Mixed culture|2|||
124436453|NCT03218397|447558190|FG001|Overall Study|Mixed culture|2|||
124436454|NCT03218397|447558189|FG000|Overall Study|Inaccessible hospital records|2|||
124436455|NCT03218397|447558190|FG001|Overall Study|Inaccessible hospital records|5|||
124436456|NCT03218397|447558189|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
124436457|NCT03218397|447558190|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
124436458|NCT03218397|447558189|FG000|Overall Study|Randomized during laboratory off hours|2|||
124436459|NCT03218397|447558190|FG001|Overall Study|Randomized during laboratory off hours|1|||
124436460|NCT00943111|447558191|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
124436461|NCT00943111|447558192|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
124436462|NCT00943111|447558193|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
124436463|NCT00943111|447558191|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
124436464|NCT00943111|447558192|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
124436465|NCT00943111|447558193|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
124436466|NCT00943111|447558191|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
124436467|NCT00943111|447558192|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
124436468|NCT00943111|447558193|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
124436469|NCT00943111|447558191|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
124436470|NCT00943111|447558192|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
124436471|NCT00943111|447558193|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
124436472|NCT00943111|447558191|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
124436473|NCT00943111|447558192|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
124436474|NCT00943111|447558193|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
124544332|NCT02268214|447946770|FG002|Overall Study|Lost to Follow-up|4|||
124679168|NCT00471497|448449696|FG002|Core Treatment Phase|Protocol Violation|11|||
124679169|NCT00471497|448449694|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
124877879|NCT01301274|449175335|FG001|Overall Study|Physician Decision|1|||
124877880|NCT00661661|449175336|FG000|Overall Study|Adverse Event|99|||
124877881|NCT00661661|449175337|FG001|Overall Study|Adverse Event|24|||
124877882|NCT00661661|449175336|FG000|Overall Study|Lack of Efficacy|3|||
124877883|NCT00661661|449175337|FG001|Overall Study|Lack of Efficacy|2|||
124877884|NCT00661661|449175336|FG000|Overall Study|Lost to Follow-up|0|||
124877885|NCT00661661|449175337|FG001|Overall Study|Lost to Follow-up|1|||
124877886|NCT00661661|449175336|FG000|Overall Study|Withdrawal by Subject|15|||
124877887|NCT00661661|449175337|FG001|Overall Study|Withdrawal by Subject|5|||
124877888|NCT00661661|449175336|FG000|Overall Study|Other|22|||
124877889|NCT00661661|449175337|FG001|Overall Study|Other|7|||
124877890|NCT00661661|449175336|FG000|Overall Study|Not assigned treatment|1|||
124877891|NCT00661661|449175337|FG001|Overall Study|Not assigned treatment|0|||
124877892|NCT01893827|449175338|FG000|Overall Study|Lost to Follow-up|19|||
124877893|NCT01893827|449175339|FG001|Overall Study|Lost to Follow-up|26|||
124877894|NCT04182880|449175340|FG000|Overall Study|Pregnancy|1|||
124877895|NCT04182880|449175341|FG001|Overall Study|Pregnancy|0|||
124877896|NCT03389477|449175342|FG000|Step 1|Withdrawal by Subject|1|||
124877897|NCT03389477|449175343|FG001|Step 1|Withdrawal by Subject|0|||
124877898|NCT03389477|449175342|FG000|Step 2|Withdrawal by Subject|1|||
124877899|NCT03389477|449175343|FG001|Step 2|Withdrawal by Subject|2|||
124877900|NCT03389477|449175342|FG000|Step 2|Disease progression|1|||
124877901|NCT03389477|449175343|FG001|Step 2|Disease progression|0|||
124877902|NCT03389477|449175342|FG000|Step 2|Death|0|||
124877903|NCT03389477|449175343|FG001|Step 2|Death|1|||
124877904|NCT03389477|449175342|FG000|Step 2|Poor performance status and nutrition|0|||
124877905|NCT03389477|449175343|FG001|Step 2|Poor performance status and nutrition|1|||
124877906|NCT03389477|449175342|FG000|Step 3|Withdrawal after 3 cycles|0|||
124877907|NCT03389477|449175343|FG001|Step 3|Withdrawal after 3 cycles|1|||
124877908|NCT03389477|449175342|FG000|Step 3|Still receiving active treatment|4|||
124877909|NCT03389477|449175343|FG001|Step 3|Still receiving active treatment|0|||
124877910|NCT03389477|449175342|FG000|Step 3|Progressive disease after 2 cycles|1|||
124877911|NCT03389477|449175343|FG001|Step 3|Progressive disease after 2 cycles|0|||
124877912|NCT03403426|449175348|FG000|Overall Study|Death|1|||
124877913|NCT03403426|449175348|FG000|Overall Study|Lost to Follow-up|2|||
124877914|NCT00445679|449175351|FG000|Overall Study|Adverse Event|22|||
124877915|NCT00445679|449175352|FG001|Overall Study|Adverse Event|12|||
124877916|NCT00445679|449175353|FG002|Overall Study|Adverse Event|30|||
124877917|NCT00445679|449175354|FG003|Overall Study|Adverse Event|19|||
124877918|NCT00445679|449175351|FG000|Overall Study|Failed to return|1|||
124877919|NCT00445679|449175352|FG001|Overall Study|Failed to return|3|||
124877920|NCT00445679|449175353|FG002|Overall Study|Failed to return|2|||
124877921|NCT00445679|449175354|FG003|Overall Study|Failed to return|2|||
124877922|NCT00445679|449175351|FG000|Overall Study|Physician Decision|0|||
124877923|NCT00445679|449175352|FG001|Overall Study|Physician Decision|0|||
124877924|NCT00445679|449175353|FG002|Overall Study|Physician Decision|1|||
124877925|NCT00445679|449175354|FG003|Overall Study|Physician Decision|0|||
124877926|NCT00445679|449175351|FG000|Overall Study|Lost to Follow-up|10|||
124877927|NCT00445679|449175352|FG001|Overall Study|Lost to Follow-up|6|||
124877928|NCT00445679|449175353|FG002|Overall Study|Lost to Follow-up|6|||
124877929|NCT00445679|449175354|FG003|Overall Study|Lost to Follow-up|5|||
124877930|NCT00445679|449175351|FG000|Overall Study|Compliance|3|||
124436475|NCT00943111|447558191|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
124436476|NCT00943111|447558192|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
124436477|NCT00943111|447558193|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
124436478|NCT00943111|447558191|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
124436479|NCT00943111|447558192|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
124436480|NCT00943111|447558193|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
124877931|NCT00445679|449175352|FG001|Overall Study|Compliance|2|||
124877932|NCT00445679|449175353|FG002|Overall Study|Compliance|1|||
124436481|NCT00943111|447558191|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
124436482|NCT00943111|447558192|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
124679170|NCT00471497|448449695|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
124877933|NCT00445679|449175354|FG003|Overall Study|Compliance|2|||
124877934|NCT00445679|449175351|FG000|Overall Study|Withdrawal of Informed Consent|0|||
124877935|NCT00445679|449175352|FG001|Overall Study|Withdrawal of Informed Consent|0|||
124877936|NCT00445679|449175353|FG002|Overall Study|Withdrawal of Informed Consent|1|||
124877937|NCT00445679|449175354|FG003|Overall Study|Withdrawal of Informed Consent|0|||
124877938|NCT00445679|449175351|FG000|Overall Study|Protocol Violation|2|||
124877939|NCT00445679|449175352|FG001|Overall Study|Protocol Violation|3|||
124877940|NCT00445679|449175353|FG002|Overall Study|Protocol Violation|3|||
124877941|NCT00445679|449175354|FG003|Overall Study|Protocol Violation|1|||
124877942|NCT00445679|449175351|FG000|Overall Study|Withdrawal by Subject|8|||
124877943|NCT00445679|449175352|FG001|Overall Study|Withdrawal by Subject|14|||
124436483|NCT00943111|447558193|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
124877944|NCT00445679|449175353|FG002|Overall Study|Withdrawal by Subject|20|||
124877945|NCT00445679|449175354|FG003|Overall Study|Withdrawal by Subject|18|||
124877946|NCT00445679|449175351|FG000|Overall Study|Lack of Efficacy|2|||
124877947|NCT00445679|449175352|FG001|Overall Study|Lack of Efficacy|6|||
124877948|NCT00445679|449175353|FG002|Overall Study|Lack of Efficacy|2|||
124877949|NCT00445679|449175354|FG003|Overall Study|Lack of Efficacy|0|||
124877950|NCT02636270|449175356|FG000|Overall Study|Adverse Event|1|||
124877951|NCT02636270|449175357|FG001|Overall Study|Adverse Event|0|||
124877952|NCT02636270|449175358|FG002|Overall Study|Adverse Event|0|||
124877953|NCT02636270|449175356|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
124877954|NCT02636270|449175357|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
124877955|NCT02636270|449175358|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
124877956|NCT01119898|449175359|FG000|Overall Study|Adverse Event|4|||
124877957|NCT01119898|449175360|FG001|Overall Study|Adverse Event|5|||
124877958|NCT01119898|449175359|FG000|Overall Study|Withdrawal by Subject|1|||
124877959|NCT01119898|449175360|FG001|Overall Study|Withdrawal by Subject|4|||
124877960|NCT01119898|449175359|FG000|Overall Study|Lack of Efficacy|0|||
124877961|NCT01119898|449175360|FG001|Overall Study|Lack of Efficacy|2|||
124877962|NCT01119898|449175359|FG000|Overall Study|Protocol Violation|1|||
124877963|NCT01119898|449175360|FG001|Overall Study|Protocol Violation|1|||
124877964|NCT01119898|449175359|FG000|Overall Study|Medical procedure|1|||
124877965|NCT01119898|449175360|FG001|Overall Study|Medical procedure|0|||
124877966|NCT01119898|449175359|FG000|Overall Study|Randomized in error did not participate|1|||
124877967|NCT01119898|449175360|FG001|Overall Study|Randomized in error did not participate|0|||
124877968|NCT01806584|449175361|FG000|Overall Study|Adverse Event|2|||
124877969|NCT01806584|449175362|FG001|Overall Study|Adverse Event|1|||
124877970|NCT01806584|449175361|FG000|Overall Study|Death|1|||
124877971|NCT01806584|449175362|FG001|Overall Study|Death|0|||
124877972|NCT01806584|449175361|FG000|Overall Study|Lost to Follow-up|0|||
124877973|NCT01806584|449175362|FG001|Overall Study|Lost to Follow-up|2|||
124877974|NCT01806584|449175361|FG000|Overall Study|Study terminated by sponsor|9|||
124877975|NCT01806584|449175362|FG001|Overall Study|Study terminated by sponsor|14|||
124877976|NCT01806584|449175361|FG000|Overall Study|Withdrawal by Subject|1|||
124877977|NCT01806584|449175362|FG001|Overall Study|Withdrawal by Subject|1|||
124877978|NCT01806584|449175361|FG000|Overall Study|Other unspecified|1|||
124877979|NCT01806584|449175362|FG001|Overall Study|Other unspecified|0|||
124877980|NCT03021668|449175363|FG000|Overall Study|Physician Decision|0|||
124877981|NCT03021668|449175364|FG001|Overall Study|Physician Decision|1|||
124877982|NCT00909428|449175365|FG000|Overall Study|Lost to Follow-up|13|||
124436484|NCT01946438|447558194|FG000|Overall Study|Adverse Event|0|||
124436485|NCT01946438|447558195|FG001|Overall Study|Adverse Event|0|||
124877983|NCT00909428|449175366|FG001|Overall Study|Lost to Follow-up|10|||
124436486|NCT01946438|447558196|FG002|Overall Study|Adverse Event|0|||
124877984|NCT00909428|449175367|FG002|Overall Study|Lost to Follow-up|9|||
124877985|NCT01122381|449175368|FG000|Overall Study|study terminated early|0|||
124877986|NCT01122381|449175369|FG001|Overall Study|study terminated early|1|||
124877987|NCT03474549|449175370|FG000|Overall Study|Death|31|||
124877988|NCT03474549|449175370|FG000|Overall Study|Lost to Follow-up|4|||
124877989|NCT03474549|449175370|FG000|Overall Study|Withdrawal by Subject|2|||
124877990|NCT03445065|449175375|FG000|Overall Study|Withdrawal by Subject|3|||
124877991|NCT03445065|449175376|FG001|Overall Study|Withdrawal by Subject|6|||
124877992|NCT03445065|449175377|FG002|Overall Study|Withdrawal by Subject|2|||
124877993|NCT03445065|449175378|FG003|Overall Study|Withdrawal by Subject|2|||
124877994|NCT03445065|449175375|FG000|Overall Study|Other|4|||
124877995|NCT03445065|449175376|FG001|Overall Study|Other|3|||
124877996|NCT03445065|449175377|FG002|Overall Study|Other|3|||
124877997|NCT03445065|449175378|FG003|Overall Study|Other|1|||
124877998|NCT03315130|449175379|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
124877999|NCT03315130|449175380|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
124878000|NCT03315130|449175381|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
124878001|NCT03315130|449175382|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
124878002|NCT03315130|449175379|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
124878003|NCT03315130|449175380|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
124878004|NCT03315130|449175381|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
124878005|NCT03315130|449175382|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
124878006|NCT03315130|449175379|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
124878007|NCT03315130|449175380|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
124878008|NCT03315130|449175381|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
124878009|NCT03315130|449175382|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
124878010|NCT03315130|449175379|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
124878011|NCT03315130|449175380|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
124878012|NCT03315130|449175381|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
124878013|NCT03315130|449175382|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
124878014|NCT03315130|449175379|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
124878015|NCT03315130|449175380|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
124878016|NCT03315130|449175381|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
124878017|NCT03315130|449175382|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
124878018|NCT03315130|449175379|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
124878019|NCT03315130|449175380|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
124878020|NCT03315130|449175381|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
124878021|NCT03315130|449175382|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
124878022|NCT03535337|449175389|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
124878023|NCT03535337|449175390|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
124878024|NCT03535337|449175391|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
124878025|NCT03535337|449175392|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
124878026|NCT03535337|449175393|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
124878027|NCT03535337|449175394|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
124878028|NCT03535337|449175395|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
124878029|NCT03535337|449175396|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
124878030|NCT03535337|449175397|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
124878031|NCT03535337|449175398|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
124878032|NCT02089230|449175399|FG000|Overall Study|Death|0|||
124878033|NCT02089230|449175400|FG001|Overall Study|Death|0|||
124878034|NCT02089230|449175401|FG002|Overall Study|Death|2|||
124878035|NCT02089230|449175399|FG000|Overall Study|Seeking Alternative Therapy|0|||
124878036|NCT02089230|449175400|FG001|Overall Study|Seeking Alternative Therapy|0|||
124878037|NCT02089230|449175401|FG002|Overall Study|Seeking Alternative Therapy|4|||
124878038|NCT02272725|449175402|FG000|Overall Study|equipment malfunction|2|||
124878039|NCT02272725|449175403|FG001|Overall Study|equipment malfunction|0|||
124878040|NCT03610737|449177250|FG000|Overall Study|Withdrawal by Subject|1|||
124878041|NCT03610737|449177251|FG001|Overall Study|Withdrawal by Subject|5|||
124878042|NCT03610737|449177250|FG000|Overall Study|Death|1|||
124878043|NCT03610737|449177251|FG001|Overall Study|Death|0|||
124878044|NCT03610737|449177250|FG000|Overall Study|Not treated|5|||
124878045|NCT03610737|449177251|FG001|Overall Study|Not treated|2|||
124878046|NCT03610737|449177250|FG000|Overall Study|Missed Visit|1|||
124436487|NCT01946438|447558197|FG003|Overall Study|Adverse Event|1|||
124436488|NCT01946438|447558194|FG000|Overall Study|Serious Adverse event|1|||
124436489|NCT01946438|447558195|FG001|Overall Study|Serious Adverse event|0|||
124436490|NCT01946438|447558196|FG002|Overall Study|Serious Adverse event|0|||
124436491|NCT01946438|447558197|FG003|Overall Study|Serious Adverse event|0|||
124436492|NCT01946438|447558194|FG000|Overall Study|Protocol Violation|0|||
124436493|NCT01946438|447558195|FG001|Overall Study|Protocol Violation|0|||
124878047|NCT03610737|449177251|FG001|Overall Study|Missed Visit|2|||
124878048|NCT02991482|449177252|FG000|Overall Study|Disease progression|56|||
124878049|NCT02991482|449177253|FG001|Overall Study|Disease progression|47|||
124878050|NCT02991482|449177252|FG000|Overall Study|Death|4|||
124878051|NCT02991482|449177253|FG001|Overall Study|Death|4|||
124679171|NCT00471497|448449696|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
124878052|NCT02991482|449177252|FG000|Overall Study|Adverse Event|1|||
124878053|NCT02991482|449177253|FG001|Overall Study|Adverse Event|6|||
124878054|NCT02991482|449177252|FG000|Overall Study|Patient decision|1|||
124436494|NCT01946438|447558196|FG002|Overall Study|Protocol Violation|1|||
124436495|NCT01946438|447558197|FG003|Overall Study|Protocol Violation|0|||
124878055|NCT02991482|449177253|FG001|Overall Study|Patient decision|1|||
124878056|NCT02991482|449177252|FG000|Overall Study|Physician Decision|0|||
124878057|NCT02991482|449177253|FG001|Overall Study|Physician Decision|6|||
124878058|NCT02991482|449177252|FG000|Overall Study|Clinical deterioration|1|||
124878059|NCT02991482|449177253|FG001|Overall Study|Clinical deterioration|0|||
124878060|NCT02991482|449177252|FG000|Overall Study|Patient feeling too unwell|1|||
124878061|NCT02991482|449177253|FG001|Overall Study|Patient feeling too unwell|0|||
124878062|NCT02991482|449177252|FG000|Overall Study|Worsening of performance status|0|||
124878063|NCT02991482|449177253|FG001|Overall Study|Worsening of performance status|1|||
124878064|NCT02991482|449177252|FG000|Overall Study|Death prior to study drug initiation|1|||
124878065|NCT02991482|449177253|FG001|Overall Study|Death prior to study drug initiation|0|||
124878066|NCT02991482|449177252|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
124878067|NCT02991482|449177253|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
124878068|NCT02396537|449177254|FG000|Overall Study|Protocol Violation|0|||
124878069|NCT02396537|449177255|FG001|Overall Study|Protocol Violation|1|||
124878070|NCT00871403|449177256|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
124878071|NCT00871403|449177257|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
124878072|NCT00871403|449177258|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
124878073|NCT00871403|449177256|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
124878074|NCT00871403|449177257|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
124878075|NCT00871403|449177258|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
124878076|NCT00871403|449177256|FG000|Combination Treatment Phase|Adverse Event|0|||
124878077|NCT00871403|449177257|FG001|Combination Treatment Phase|Adverse Event|17|||
124878078|NCT00871403|449177258|FG002|Combination Treatment Phase|Adverse Event|2|||
124878079|NCT00871403|449177256|FG000|Combination Treatment Phase|Disease Progression|0|||
124878080|NCT00871403|449177257|FG001|Combination Treatment Phase|Disease Progression|8|||
124878081|NCT00871403|449177258|FG002|Combination Treatment Phase|Disease Progression|5|||
124878082|NCT00871403|449177256|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
124878083|NCT00871403|449177257|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
124878084|NCT00871403|449177258|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
124878085|NCT00871403|449177256|FG000|Combination Treatment Phase|Physician Decision|0|||
124878086|NCT00871403|449177257|FG001|Combination Treatment Phase|Physician Decision|1|||
124878087|NCT00871403|449177258|FG002|Combination Treatment Phase|Physician Decision|3|||
124878088|NCT00871403|449177256|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
124878089|NCT00871403|449177257|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
124878090|NCT00871403|449177258|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
124878091|NCT00871403|449177256|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
124679172|NCT00471497|448449694|FG000|Core Treatment Phase|Administrative problems|14|||
124679173|NCT00471497|448449695|FG001|Core Treatment Phase|Administrative problems|14|||
124679174|NCT00471497|448449696|FG002|Core Treatment Phase|Administrative problems|12|||
124679175|NCT00471497|448449694|FG000|Core Treatment Phase|Adverse Event|43|||
124679176|NCT00471497|448449695|FG001|Core Treatment Phase|Adverse Event|53|||
124679177|NCT00471497|448449696|FG002|Core Treatment Phase|Adverse Event|89|||
124878092|NCT00871403|449177257|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
124878093|NCT00871403|449177258|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
124878094|NCT00787319|449177259|FG000|Overall Study|Lost to Follow-up|2|||
124878095|NCT00787319|449177259|FG000|Overall Study|Withdrawal by Subject|15|||
124878096|NCT00787319|449177259|FG000|Overall Study|Adverse Event|3|||
124878097|NCT00787319|449177259|FG000|Overall Study|Objective progression or relapse|30|||
124878098|NCT00787319|449177259|FG000|Overall Study|Lack of Efficacy|1|||
124878099|NCT00787319|449177259|FG000|Overall Study|Budget exhausted/exceeded|1|||
124878100|NCT00787319|449177259|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
124878101|NCT00787319|449177259|FG000|Overall Study|No health insurance reimbursement|2|||
124436496|NCT01946438|447558194|FG000|Overall Study|Withdrawal by Subject|1|||
124679178|NCT00471497|448449694|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
124679179|NCT00471497|448449695|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
124679180|NCT00471497|448449696|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
124679181|NCT00471497|448449694|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
124679182|NCT00471497|448449695|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
124679183|NCT00471497|448449696|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
124679184|NCT00471497|448449694|FG000|Extension Phase|Adverse Event|9|||
124679185|NCT00471497|448449695|FG001|Extension Phase|Adverse Event|5|||
124679186|NCT00471497|448449696|FG002|Extension Phase|Adverse Event|1|||
124679187|NCT00471497|448449694|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
124679188|NCT00471497|448449695|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
124679189|NCT00471497|448449696|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
124679190|NCT00471497|448449694|FG000|Extension Phase|Withdrawal by Subject|3|||
124679191|NCT00471497|448449695|FG001|Extension Phase|Withdrawal by Subject|1|||
124679192|NCT00471497|448449696|FG002|Extension Phase|Withdrawal by Subject|0|||
124679193|NCT00471497|448449694|FG000|Extension Phase|Lost to Follow-up|2|||
124679194|NCT00471497|448449695|FG001|Extension Phase|Lost to Follow-up|0|||
124679195|NCT00471497|448449696|FG002|Extension Phase|Lost to Follow-up|0|||
124679196|NCT00471497|448449694|FG000|Extension Phase|Death|1|||
124679197|NCT00471497|448449695|FG001|Extension Phase|Death|0|||
124679198|NCT00471497|448449696|FG002|Extension Phase|Death|0|||
124679199|NCT00471497|448449694|FG000|Extension Phase|Disease progression|2|||
124679200|NCT00471497|448449695|FG001|Extension Phase|Disease progression|0|||
124679201|NCT00471497|448449696|FG002|Extension Phase|Disease progression|0|||
124679202|NCT00471497|448449694|FG000|Extension Phase|Protocol Violation|2|||
124679203|NCT00471497|448449695|FG001|Extension Phase|Protocol Violation|2|||
124679204|NCT00471497|448449696|FG002|Extension Phase|Protocol Violation|0|||
124679205|NCT01654276|448449697|FG000|Overall Study|Lack of Efficacy|1|||
124679206|NCT01654276|448449697|FG000|Overall Study|Lost to Follow-up|4|||
124679207|NCT01654276|448449697|FG000|Overall Study|Withdrawal by Subject|1|||
124679208|NCT01991795|448449698|FG000|Overall Study|Lost to Follow-up|6|||
124679209|NCT01991795|448449699|FG001|Overall Study|Lost to Follow-up|4|||
124679210|NCT01991795|448449698|FG000|Overall Study|Withdrawal by Subject|117|||
124679211|NCT01991795|448449699|FG001|Overall Study|Withdrawal by Subject|94|||
124679212|NCT01991795|448449698|FG000|Overall Study|Site prematurely closed by sponsor|26|||
124679213|NCT01991795|448449699|FG001|Overall Study|Site prematurely closed by sponsor|25|||
124679214|NCT03344757|448449700|FG000|Overall Study|Withdrawal by Subject|18|||
124679215|NCT03344757|448449701|FG001|Overall Study|Withdrawal by Subject|16|||
124679216|NCT03344757|448449700|FG000|Overall Study|Lost to Follow-up|0|||
124679217|NCT03344757|448449701|FG001|Overall Study|Lost to Follow-up|2|||
124679218|NCT02121210|448449702|FG000|Overall Study|Adverse Event|5|||
124679219|NCT02121210|448449703|FG001|Overall Study|Adverse Event|7|||
124679220|NCT02121210|448449702|FG000|Overall Study|Lack of Efficacy|2|||
124679221|NCT02121210|448449703|FG001|Overall Study|Lack of Efficacy|0|||
124679222|NCT02121210|448449702|FG000|Overall Study|Other than specified above|0|||
124679223|NCT02121210|448449703|FG001|Overall Study|Other than specified above|2|||
124679224|NCT01316575|448449704|FG000|Overall Study|Withdrawal by Subject|2|||
124679225|NCT01316575|448449705|FG001|Overall Study|Withdrawal by Subject|0|||
124679226|NCT01316575|448449704|FG000|Overall Study|Required alternate treatment|0|||
124679227|NCT01316575|448449705|FG001|Overall Study|Required alternate treatment|1|||
124679228|NCT01232283|448449706|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
124679229|NCT01232283|448449707|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
124436497|NCT01946438|447558195|FG001|Overall Study|Withdrawal by Subject|0|||
124436498|NCT01946438|447558196|FG002|Overall Study|Withdrawal by Subject|0|||
124436499|NCT01946438|447558197|FG003|Overall Study|Withdrawal by Subject|0|||
124436500|NCT01078454|447558199|FG000|Overall Study|Adverse Event|1|||
124436501|NCT01078454|447558200|FG001|Overall Study|Adverse Event|1|||
124436502|NCT01078454|447558199|FG000|Overall Study|Death|0|||
124436503|NCT01078454|447558200|FG001|Overall Study|Death|1|||
124436504|NCT00409773|447560197|FG000|Overall Study|Adverse Event|3|||
124436505|NCT00409773|447560198|FG001|Overall Study|Adverse Event|4|||
124436506|NCT00409773|447560199|FG002|Overall Study|Adverse Event|4|||
124436507|NCT00409773|447560200|FG003|Overall Study|Adverse Event|2|||
124436508|NCT00409773|447560201|FG004|Overall Study|Adverse Event|6|||
124436509|NCT00409773|447560197|FG000|Overall Study|Lost to Follow-up|6|||
124436510|NCT00409773|447560198|FG001|Overall Study|Lost to Follow-up|1|||
124436511|NCT00409773|447560199|FG002|Overall Study|Lost to Follow-up|2|||
124436512|NCT00409773|447560200|FG003|Overall Study|Lost to Follow-up|3|||
124679230|NCT01232283|448449708|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
124679231|NCT01232283|448449709|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
124679232|NCT01232283|448449710|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
124436513|NCT00409773|447560201|FG004|Overall Study|Lost to Follow-up|1|||
124436514|NCT00409773|447560197|FG000|Overall Study|Physician Decision|0|||
124436515|NCT00409773|447560198|FG001|Overall Study|Physician Decision|0|||
124679233|NCT01232283|448449711|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
124878102|NCT00787319|449177259|FG000|Overall Study|Stabilized disease findings|3|||
124878103|NCT00787319|449177259|FG000|Overall Study|Inactive disease|5|||
124878104|NCT02312856|449177260|FG000|Overall Study|Death|1|||
124878105|NCT02312856|449177260|FG000|Overall Study|Lost to Follow-up|3|||
124878106|NCT01932294|449177261|FG000|Overall Study|Death|43|||
124878107|NCT01932294|449177261|FG000|Overall Study|Lost to Follow-up|8|||
124878108|NCT01932294|449177261|FG000|Overall Study|VAD Implantation|20|||
124878109|NCT01932294|449177261|FG000|Overall Study|Heart Transplantation|16|||
124878110|NCT01932294|449177261|FG000|Overall Study|Transferred to other hospitals|12|||
124878111|NCT04415151|449177262|FG000|Overall Study|Death|1|||
124878112|NCT04415151|449177263|FG001|Overall Study|Death|1|||
124878113|NCT04415151|449177262|FG000|Overall Study|Withdrawal by Subject|1|||
124878114|NCT04415151|449177263|FG001|Overall Study|Withdrawal by Subject|0|||
124878115|NCT03075904|449177269|FG000|Overall Study|Physician Decision|3|||
124878116|NCT03075904|449177269|FG000|Overall Study|Need for Medication not Permitted|1|||
124878117|NCT00659984|449177270|FG000|Overall Study|Adverse Event|1|||
124878118|NCT00927355|449177273|FG000|Overall Study|Adverse Event|1|||
124878119|NCT00927355|449177274|FG001|Overall Study|Adverse Event|1|||
124878120|NCT01800201|449177275|FG000|Overall Study|Withdrawal by Subject|2|||
124878121|NCT01800201|449177276|FG001|Overall Study|Withdrawal by Subject|0|||
124878122|NCT01800201|449177275|FG000|Overall Study|patient privacy concerns|1|||
124878123|NCT01800201|449177276|FG001|Overall Study|patient privacy concerns|1|||
124878124|NCT01800201|449177275|FG000|Overall Study|did not want to use device|0|||
124878125|NCT01800201|449177276|FG001|Overall Study|did not want to use device|1|||
124878126|NCT01800201|449177275|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
124878127|NCT01800201|449177276|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
124878128|NCT03541044|449177277|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
124878129|NCT03541044|449177278|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
124878130|NCT03541044|449177277|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
124878131|NCT03541044|449177278|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
124878132|NCT02635724|449177279|FG000|Overall Study|Withdrawal by Subject|0|||
124878133|NCT02635724|449177280|FG001|Overall Study|Withdrawal by Subject|1|||
124878134|NCT02635724|449177281|FG002|Overall Study|Withdrawal by Subject|0|||
124878135|NCT01446796|449177288|FG000|Overall Study|Withdrawal by Subject|1|||
124878136|NCT01446796|449177289|FG001|Overall Study|Withdrawal by Subject|0|||
124878137|NCT02424591|449177290|FG000|Overall Study|Protocol Violation|2|||
124878138|NCT02424591|449177291|FG001|Overall Study|Protocol Violation|3|||
124878139|NCT00312702|449177292|FG000|Immunization Phase|Lost to Follow-up|0|||
124878140|NCT00312702|449177293|FG001|Immunization Phase|Lost to Follow-up|1|||
124878141|NCT00312702|449177294|FG002|Immunization Phase|Lost to Follow-up|0|||
124878142|NCT01453348|449177295|FG000|Overall Study|Death|0|||
124878143|NCT01453348|449177296|FG001|Overall Study|Death|0|||
124878144|NCT01453348|449177297|FG002|Overall Study|Death|1|||
124878145|NCT01453348|449177295|FG000|Overall Study|Withdrawal by Subject|0|||
124878146|NCT01453348|449177296|FG001|Overall Study|Withdrawal by Subject|1|||
124878147|NCT01453348|449177297|FG002|Overall Study|Withdrawal by Subject|0|||
124878148|NCT01453348|449177295|FG000|Overall Study|Protocol Violation|1|||
124878149|NCT01453348|449177296|FG001|Overall Study|Protocol Violation|0|||
124878150|NCT01453348|449177297|FG002|Overall Study|Protocol Violation|0|||
124878151|NCT04359771|449177299|FG000|Overall Study|Lack of Efficacy|2|||
124878152|NCT04359771|449177300|FG001|Overall Study|Lack of Efficacy|2|||
124878153|NCT04581200|449177303|FG000|Overall Study|Lost to Follow-up|6|||
124878154|NCT04581200|449177304|FG001|Overall Study|Lost to Follow-up|5|||
124878155|NCT00622713|449177307|FG000|Overall Study|Adverse Event|35|||
124878156|NCT00622713|449177307|FG000|Overall Study|Administrative problems|4|||
124878157|NCT00622713|449177307|FG000|Overall Study|Withdrawal by Subject|11|||
124878158|NCT00622713|449177307|FG000|Overall Study|Lost to Follow-up|5|||
124878159|NCT00622713|449177307|FG000|Overall Study|Death|2|||
124878160|NCT00622713|449177307|FG000|Overall Study|Subject no longer required study drug|1|||
124878161|NCT00622713|449177307|FG000|Overall Study|Did not meet eligibility criteria|1|||
124878162|NCT01462162|449177308|FG000|Overall Study|Adverse Event|5|||
124878163|NCT01462162|449177308|FG000|Overall Study|Lack of Efficacy|4|||
124878164|NCT01462162|449177308|FG000|Overall Study|Abnormal laboratory parameters|1|||
124878165|NCT01462162|449177308|FG000|Overall Study|Other|2|||
124679234|NCT01232283|448449712|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
124679235|NCT01232283|448449713|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
124679236|NCT01232283|448449714|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
124679237|NCT01232283|448449715|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
124679238|NCT01232283|448449706|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
124679239|NCT01232283|448449707|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
124679240|NCT01232283|448449708|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
124679241|NCT01232283|448449709|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
124679242|NCT01232283|448449710|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
124679243|NCT01232283|448449711|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
124679244|NCT01232283|448449712|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
124679245|NCT01232283|448449713|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
124679246|NCT01232283|448449714|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
124679247|NCT01232283|448449715|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
124679248|NCT01232283|448449706|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
124679249|NCT01232283|448449707|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
124679250|NCT01232283|448449708|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
124679251|NCT01232283|448449709|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
124679252|NCT01232283|448449710|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
124679253|NCT01232283|448449711|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
124679254|NCT01232283|448449712|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
124679255|NCT01232283|448449713|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
124679256|NCT01232283|448449714|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
124679257|NCT01232283|448449715|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
124679258|NCT01232283|448449706|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
124679259|NCT01232283|448449707|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
124679260|NCT01232283|448449708|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
124679261|NCT01232283|448449709|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
124679262|NCT01232283|448449710|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
124679263|NCT01232283|448449711|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
124679264|NCT01232283|448449712|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
124679265|NCT01232283|448449713|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
124679266|NCT01232283|448449714|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
124679267|NCT01232283|448449715|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
124679268|NCT01232283|448449706|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
124679269|NCT01232283|448449707|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
124679270|NCT01232283|448449708|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
124679271|NCT01232283|448449709|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
124679272|NCT01232283|448449710|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
124679273|NCT01232283|448449711|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
124679274|NCT01232283|448449712|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
124679275|NCT01232283|448449713|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
124679276|NCT01232283|448449714|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
124679277|NCT01232283|448449715|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
124679278|NCT01232283|448449706|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
124679279|NCT01232283|448449707|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
124679280|NCT01232283|448449708|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
124679281|NCT01232283|448449709|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
124679282|NCT01232283|448449710|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
124679283|NCT01232283|448449711|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
124679284|NCT01232283|448449712|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
124679285|NCT01232283|448449713|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
124679286|NCT01232283|448449714|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
124679287|NCT01232283|448449715|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
124679288|NCT01232283|448449706|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
124679289|NCT01232283|448449707|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
124679290|NCT01232283|448449708|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
124878166|NCT03485911|449177309|FG000|Part 1|Perceived lack of efficacy|1|||
124878167|NCT03485911|449177310|FG001|Part 1|Perceived lack of efficacy|1|||
124878168|NCT03485911|449177311|FG002|Part 1|Perceived lack of efficacy|2|||
124878169|NCT03485911|449177312|FG003|Part 1|Perceived lack of efficacy|0|||
124878170|NCT03485911|449177309|FG000|Part 1|Subject withdrew consent|0|||
124878171|NCT03485911|449177310|FG001|Part 1|Subject withdrew consent|1|||
124878172|NCT03485911|449177311|FG002|Part 1|Subject withdrew consent|0|||
124878173|NCT03485911|449177312|FG003|Part 1|Subject withdrew consent|1|||
124878174|NCT03485911|449177309|FG000|Part 1|Lab abnormalities/AEs|3|||
124878175|NCT03485911|449177310|FG001|Part 1|Lab abnormalities/AEs|1|||
124878176|NCT03485911|449177311|FG002|Part 1|Lab abnormalities/AEs|1|||
124878177|NCT03485911|449177312|FG003|Part 1|Lab abnormalities/AEs|0|||
124878178|NCT03485911|449177309|FG000|Part 1|Withdrew Consent prior to dosing|0|||
124878179|NCT03485911|449177310|FG001|Part 1|Withdrew Consent prior to dosing|0|||
124878180|NCT03485911|449177311|FG002|Part 1|Withdrew Consent prior to dosing|0|||
124878181|NCT03485911|449177312|FG003|Part 1|Withdrew Consent prior to dosing|1|||
124436516|NCT00409773|447560199|FG002|Overall Study|Physician Decision|0|||
124436517|NCT00409773|447560200|FG003|Overall Study|Physician Decision|2|||
124436518|NCT00409773|447560201|FG004|Overall Study|Physician Decision|0|||
124436519|NCT00409773|447560197|FG000|Overall Study|Protocol Violation|0|||
124436520|NCT00409773|447560198|FG001|Overall Study|Protocol Violation|2|||
124436521|NCT00409773|447560199|FG002|Overall Study|Protocol Violation|3|||
124436522|NCT00409773|447560200|FG003|Overall Study|Protocol Violation|3|||
124436523|NCT00409773|447560201|FG004|Overall Study|Protocol Violation|1|||
124436524|NCT00409773|447560197|FG000|Overall Study|Withdrawal by Subject|0|||
124436525|NCT00409773|447560198|FG001|Overall Study|Withdrawal by Subject|0|||
124436526|NCT00409773|447560199|FG002|Overall Study|Withdrawal by Subject|0|||
124436527|NCT00409773|447560200|FG003|Overall Study|Withdrawal by Subject|2|||
124436528|NCT00409773|447560201|FG004|Overall Study|Withdrawal by Subject|1|||
124436529|NCT00409773|447560197|FG000|Overall Study|Lack of Eligibility|0|||
124436530|NCT00409773|447560198|FG001|Overall Study|Lack of Eligibility|0|||
124436531|NCT00409773|447560199|FG002|Overall Study|Lack of Eligibility|0|||
124436532|NCT00409773|447560200|FG003|Overall Study|Lack of Eligibility|0|||
124436533|NCT00409773|447560201|FG004|Overall Study|Lack of Eligibility|1|||
124436534|NCT00153062|447560202|FG000|Overall Study|Death|360|||
124436535|NCT00153062|447560203|FG001|Overall Study|Death|352|||
124436536|NCT00153062|447560204|FG002|Overall Study|Death|369|||
124436537|NCT00153062|447560205|FG003|Overall Study|Death|365|||
124436538|NCT00153062|447560202|FG000|Overall Study|Withdrawal by Subject|14|||
124436539|NCT00153062|447560203|FG001|Overall Study|Withdrawal by Subject|30|||
124436540|NCT00153062|447560204|FG002|Overall Study|Withdrawal by Subject|27|||
124436541|NCT00153062|447560205|FG003|Overall Study|Withdrawal by Subject|28|||
124436542|NCT00153062|447560202|FG000|Overall Study|Lost to Follow-up|12|||
124436543|NCT00153062|447560203|FG001|Overall Study|Lost to Follow-up|20|||
124436544|NCT00153062|447560204|FG002|Overall Study|Lost to Follow-up|15|||
124436545|NCT00153062|447560205|FG003|Overall Study|Lost to Follow-up|16|||
124436546|NCT00153062|447560202|FG000|Overall Study|Adverse Event|0|||
124436547|NCT00153062|447560203|FG001|Overall Study|Adverse Event|1|||
124436548|NCT00153062|447560204|FG002|Overall Study|Adverse Event|1|||
124436549|NCT00153062|447560205|FG003|Overall Study|Adverse Event|0|||
124436550|NCT00153062|447560202|FG000|Overall Study|Protocol Violation|0|||
124436551|NCT00153062|447560203|FG001|Overall Study|Protocol Violation|2|||
124436552|NCT00153062|447560204|FG002|Overall Study|Protocol Violation|1|||
124436553|NCT00153062|447560205|FG003|Overall Study|Protocol Violation|1|||
124436554|NCT00153062|447560202|FG000|Overall Study|No disposition data available|1|||
124436555|NCT00153062|447560203|FG001|Overall Study|No disposition data available|1|||
124436556|NCT00153062|447560204|FG002|Overall Study|No disposition data available|1|||
124436557|NCT00153062|447560205|FG003|Overall Study|No disposition data available|1|||
124878182|NCT03485911|449177309|FG000|Part 1|Other NOS|0|||
124878183|NCT03485911|449177310|FG001|Part 1|Other NOS|0|||
124878184|NCT03485911|449177311|FG002|Part 1|Other NOS|0|||
124878185|NCT03485911|449177312|FG003|Part 1|Other NOS|1|||
124878186|NCT03485911|449177309|FG000|Part 2|Perceived lack of efficacy|5|||
124436558|NCT00153062|447560202|FG000|Overall Study|Other|0|||
124436559|NCT00153062|447560203|FG001|Overall Study|Other|0|||
124436560|NCT00153062|447560204|FG002|Overall Study|Other|1|||
124436561|NCT00153062|447560205|FG003|Overall Study|Other|0|||
124436562|NCT02359877|447560206|FG000|Overall Study|Withdrawal by Subject|1|||
124436563|NCT02359877|447560207|FG001|Overall Study|Withdrawal by Subject|0|||
124436564|NCT02359877|447560208|FG002|Overall Study|Withdrawal by Subject|0|||
124878187|NCT03485911|449177310|FG001|Part 2|Perceived lack of efficacy|3|||
124878188|NCT03485911|449177311|FG002|Part 2|Perceived lack of efficacy|0|||
124878189|NCT03485911|449177312|FG003|Part 2|Perceived lack of efficacy|2|||
124878190|NCT03485911|449177309|FG000|Part 2|Subject withdrew consent|1|||
124878191|NCT03485911|449177310|FG001|Part 2|Subject withdrew consent|0|||
124878192|NCT03485911|449177311|FG002|Part 2|Subject withdrew consent|2|||
124436565|NCT02359877|447560209|FG003|Overall Study|Withdrawal by Subject|2|||
124436566|NCT02359877|447560206|FG000|Overall Study|Adverse Event|0|||
124436567|NCT02359877|447560207|FG001|Overall Study|Adverse Event|0|||
124878193|NCT03485911|449177312|FG003|Part 2|Subject withdrew consent|1|||
124878194|NCT03485911|449177309|FG000|Part 2|Lab abnormalities/AEs|1|||
124878195|NCT03485911|449177310|FG001|Part 2|Lab abnormalities/AEs|2|||
124878196|NCT03485911|449177311|FG002|Part 2|Lab abnormalities/AEs|0|||
124878197|NCT03485911|449177312|FG003|Part 2|Lab abnormalities/AEs|0|||
124878198|NCT03485911|449177309|FG000|Part 2|Other NOS|0|||
124878199|NCT03485911|449177310|FG001|Part 2|Other NOS|1|||
124878200|NCT03485911|449177311|FG002|Part 2|Other NOS|0|||
124878201|NCT03485911|449177312|FG003|Part 2|Other NOS|0|||
124878202|NCT03485911|449177309|FG000|Part 2|Intercurrent illness/new medical condition|1|||
124878203|NCT03485911|449177310|FG001|Part 2|Intercurrent illness/new medical condition|0|||
124878204|NCT03485911|449177311|FG002|Part 2|Intercurrent illness/new medical condition|0|||
124878205|NCT03485911|449177312|FG003|Part 2|Intercurrent illness/new medical condition|0|||
124878206|NCT03485911|449177309|FG000|Part 2|Investigator judgement|1|||
124878207|NCT03485911|449177310|FG001|Part 2|Investigator judgement|0|||
124878208|NCT03485911|449177311|FG002|Part 2|Investigator judgement|0|||
124878209|NCT03485911|449177312|FG003|Part 2|Investigator judgement|0|||
124878210|NCT03485911|449177309|FG000|Part 3|Perceived lack of efficacy|2|||
124878211|NCT03485911|449177310|FG001|Part 3|Perceived lack of efficacy|2|||
124878212|NCT03485911|449177311|FG002|Part 3|Perceived lack of efficacy|2|||
124878213|NCT03485911|449177312|FG003|Part 3|Perceived lack of efficacy|0|||
124878214|NCT03485911|449177309|FG000|Part 3|Subject withdrew consent|1|||
124878215|NCT03485911|449177310|FG001|Part 3|Subject withdrew consent|4|||
124878216|NCT03485911|449177311|FG002|Part 3|Subject withdrew consent|0|||
124878217|NCT03485911|449177312|FG003|Part 3|Subject withdrew consent|1|||
124878218|NCT03485911|449177309|FG000|Part 3|Lab abnormalities/AEs|1|||
124878219|NCT03485911|449177310|FG001|Part 3|Lab abnormalities/AEs|1|||
124878220|NCT03485911|449177311|FG002|Part 3|Lab abnormalities/AEs|0|||
124878221|NCT03485911|449177312|FG003|Part 3|Lab abnormalities/AEs|2|||
124878222|NCT03485911|449177309|FG000|Part 3|Other NOS|1|||
124878223|NCT03485911|449177310|FG001|Part 3|Other NOS|1|||
124878224|NCT03485911|449177311|FG002|Part 3|Other NOS|0|||
124878225|NCT03485911|449177312|FG003|Part 3|Other NOS|0|||
124878226|NCT03485911|449177309|FG000|Part 3|Intercurrent illness/new medical condition|0|||
124878227|NCT03485911|449177310|FG001|Part 3|Intercurrent illness/new medical condition|1|||
124878228|NCT03485911|449177311|FG002|Part 3|Intercurrent illness/new medical condition|1|||
124878229|NCT03485911|449177312|FG003|Part 3|Intercurrent illness/new medical condition|0|||
124878230|NCT03485911|449177309|FG000|Part 3|Sponsor discontinuation|1|||
124878231|NCT03485911|449177310|FG001|Part 3|Sponsor discontinuation|0|||
124436568|NCT02359877|447560208|FG002|Overall Study|Adverse Event|0|||
124878232|NCT03485911|449177311|FG002|Part 3|Sponsor discontinuation|0|||
124878233|NCT03485911|449177312|FG003|Part 3|Sponsor discontinuation|0|||
124878234|NCT03485911|449177309|FG000|Part 3|Berotralstat provided by alternative means|13|||
124878235|NCT03485911|449177310|FG001|Part 3|Berotralstat provided by alternative means|13|||
124878236|NCT03485911|449177311|FG002|Part 3|Berotralstat provided by alternative means|7|||
124878237|NCT03485911|449177312|FG003|Part 3|Berotralstat provided by alternative means|7|||
124878238|NCT00909480|449177313|FG000|Overall Study|Adverse Event|5|||
124878239|NCT00909480|449177314|FG001|Overall Study|Adverse Event|3|||
124436569|NCT02359877|447560209|FG003|Overall Study|Adverse Event|1|||
124436570|NCT01919814|447560216|FG000|Overall Study|Adverse Event|1|||
124436571|NCT01919814|447560217|FG001|Overall Study|Adverse Event|0|||
124436572|NCT01919814|447560216|FG000|Overall Study|Protocol Violation|1|||
124878240|NCT00909480|449177313|FG000|Overall Study|Protocol Violation|6|||
124878241|NCT00909480|449177314|FG001|Overall Study|Protocol Violation|8|||
124878242|NCT00909480|449177313|FG000|Overall Study|Withdrawal criteria|9|||
124878243|NCT00909480|449177314|FG001|Overall Study|Withdrawal criteria|11|||
124878244|NCT00909480|449177313|FG000|Overall Study|Unclassified|18|||
124878245|NCT00909480|449177314|FG001|Overall Study|Unclassified|19|||
124878246|NCT01215357|449177315|FG000|Overall Study|Withdrawal by Subject|3|||
124878247|NCT01215357|449177315|FG000|Overall Study|Protocol Violation|9|||
124878248|NCT05266963|449177321|FG000|Drug Period A|Withdrawal by Subject|0|||
124436573|NCT01919814|447560217|FG001|Overall Study|Protocol Violation|0|||
124436574|NCT01919814|447560216|FG000|Overall Study|Withdrawal by Subject|1|||
124878249|NCT05266963|449177322|FG001|Drug Period A|Withdrawal by Subject|1|||
124436575|NCT01919814|447560217|FG001|Overall Study|Withdrawal by Subject|0|||
124878250|NCT04296890|449177328|FG000|Overall Study|Withdrawal by Subject|1|||
124878251|NCT04296890|449177328|FG000|Overall Study|Death|62|||
124878252|NCT04296890|449177328|FG000|Overall Study|Lost to Follow-up|3|||
124878253|NCT04296890|449177328|FG000|Overall Study|Other than specified|2|||
124878254|NCT05400746|449177329|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
124878255|NCT05400746|449177330|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
124878256|NCT05400746|449177331|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
124878257|NCT05454410|449177332|FG000|Overall Study|Withdrawal by Subject|0|||
124878258|NCT05454410|449177333|FG001|Overall Study|Withdrawal by Subject|0|||
124878259|NCT05454410|449177334|FG002|Overall Study|Withdrawal by Subject|1|||
124878260|NCT05454410|449177335|FG003|Overall Study|Withdrawal by Subject|1|||
124878261|NCT05004688|449177337|FG000|Overall Study|Protocol Violation|7|||
124436576|NCT00275262|447560218|FG000|Overall Study|Adverse Event|2|||
124436577|NCT00275262|447560219|FG001|Overall Study|Adverse Event|0|||
124878262|NCT05004688|449177337|FG000|Overall Study|Physician Decision|2|||
124878263|NCT05004688|449177337|FG000|Overall Study|Withdrawal by Subject|2|||
124878264|NCT01395823|449177349|FG000|Overall Study|Death|4|||
124878265|NCT01395823|449177350|FG001|Overall Study|Death|4|||
124878266|NCT01395823|449177349|FG000|Overall Study|Physician Decision|3|||
124878267|NCT01395823|449177350|FG001|Overall Study|Physician Decision|1|||
124878268|NCT01395823|449177349|FG000|Overall Study|Lost to Follow-up|1|||
124878269|NCT01395823|449177350|FG001|Overall Study|Lost to Follow-up|0|||
124878270|NCT01395823|449177349|FG000|Overall Study|Transplant|1|||
124878271|NCT01395823|449177350|FG001|Overall Study|Transplant|0|||
124878272|NCT01395823|449177349|FG000|Overall Study|GI symptoms|1|||
124878273|NCT01395823|449177350|FG001|Overall Study|GI symptoms|0|||
124878274|NCT01395823|449177349|FG000|Overall Study|Withdrawal by Subject|5|||
124878275|NCT01395823|449177350|FG001|Overall Study|Withdrawal by Subject|4|||
124878276|NCT05076149|449177351|FG000|Overall Study|Adverse Event|3|||
124878277|NCT05076149|449177352|FG001|Overall Study|Adverse Event|9|||
124878278|NCT05076149|449177351|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
124878279|NCT05076149|449177352|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
124878280|NCT05076149|449177351|FG000|Overall Study|Lost to Follow-up|0|||
124878281|NCT05076149|449177352|FG001|Overall Study|Lost to Follow-up|1|||
124878282|NCT05076149|449177351|FG000|Overall Study|Commercial drug is available for participant|0|||
124878283|NCT05076149|449177352|FG001|Overall Study|Commercial drug is available for participant|1|||
124878284|NCT05076149|449177351|FG000|Overall Study|Other non compliance|1|||
124878285|NCT05076149|449177352|FG001|Overall Study|Other non compliance|1|||
124878286|NCT05076149|449177351|FG000|Overall Study|Physician Decision|0|||
124878287|NCT05076149|449177352|FG001|Overall Study|Physician Decision|1|||
124878288|NCT05076149|449177351|FG000|Overall Study|Other|5|||
124878289|NCT05076149|449177352|FG001|Overall Study|Other|4|||
124878290|NCT00717314|449177353|FG000|Overall Study|Adverse Event|3|||
124878291|NCT00717314|449177354|FG001|Overall Study|Adverse Event|2|||
124878292|NCT00717314|449177353|FG000|Overall Study|Protocol Violation|1|||
124878293|NCT00717314|449177354|FG001|Overall Study|Protocol Violation|0|||
124878294|NCT00717314|449177353|FG000|Overall Study|Lost to Follow-up|1|||
124878295|NCT00717314|449177354|FG001|Overall Study|Lost to Follow-up|5|||
124878296|NCT00717314|449177353|FG000|Overall Study|Withdrawal by Subject|1|||
124878297|NCT00717314|449177354|FG001|Overall Study|Withdrawal by Subject|3|||
124878298|NCT02087501|449177355|FG000|Overall Study|Death|7|||
124878299|NCT02087501|449177355|FG000|Overall Study|Open repair of aneurysm|1|||
124878300|NCT02087501|449177355|FG000|Overall Study|Lost to Follow-up|2|||
124878301|NCT00094328|449177357|FG000|Overall Study|Lost to Follow-up|1|||
124878302|NCT03682705|449177358|FG000|Overall Study|Adverse Event|1|||
124878303|NCT03682705|449177359|FG001|Overall Study|Adverse Event|1|||
124878304|NCT03682705|449177360|FG002|Overall Study|Adverse Event|1|||
124878305|NCT03682705|449177361|FG003|Overall Study|Adverse Event|0|||
124878306|NCT03682705|449177362|FG004|Overall Study|Adverse Event|1|||
124878307|NCT03682705|449177363|FG005|Overall Study|Adverse Event|1|||
124878308|NCT03682705|449177358|FG000|Overall Study|Withdrawal by Subject|1|||
124878309|NCT03682705|449177359|FG001|Overall Study|Withdrawal by Subject|3|||
124878310|NCT03682705|449177360|FG002|Overall Study|Withdrawal by Subject|2|||
124878311|NCT03682705|449177361|FG003|Overall Study|Withdrawal by Subject|4|||
124878312|NCT03682705|449177362|FG004|Overall Study|Withdrawal by Subject|0|||
124878313|NCT03682705|449177363|FG005|Overall Study|Withdrawal by Subject|1|||
124878314|NCT03682705|449177358|FG000|Overall Study|Other, not specified|0|||
124436578|NCT00275262|447560218|FG000|Overall Study|Disease progression|2|||
124436579|NCT00275262|447560219|FG001|Overall Study|Disease progression|5|||
124679291|NCT01232283|448449709|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
124679292|NCT01232283|448449710|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
124679293|NCT01232283|448449711|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
124679294|NCT01232283|448449712|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
124878315|NCT03682705|449177359|FG001|Overall Study|Other, not specified|0|||
124436580|NCT00275262|447560218|FG000|Overall Study|Lost to Follow-up|0|||
124436581|NCT00275262|447560219|FG001|Overall Study|Lost to Follow-up|2|||
124436582|NCT00275262|447560218|FG000|Overall Study|Protocol Violation|0|||
124436583|NCT00275262|447560219|FG001|Overall Study|Protocol Violation|2|||
124436584|NCT00275262|447560218|FG000|Overall Study|Death|1|||
124436585|NCT00275262|447560219|FG001|Overall Study|Death|0|||
124436586|NCT00275262|447560218|FG000|Overall Study|Started Chemotherapy|1|||
124436587|NCT00275262|447560219|FG001|Overall Study|Started Chemotherapy|0|||
124878316|NCT03682705|449177360|FG002|Overall Study|Other, not specified|0|||
124878317|NCT03682705|449177361|FG003|Overall Study|Other, not specified|1|||
124878318|NCT03682705|449177362|FG004|Overall Study|Other, not specified|2|||
124436588|NCT02164383|447560220|FG000|Overall Study|Lost to Follow-up|1|||
124436589|NCT02164383|447560221|FG001|Overall Study|Lost to Follow-up|0|||
124878319|NCT03682705|449177363|FG005|Overall Study|Other, not specified|0|||
124878320|NCT03682705|449177358|FG000|Overall Study|Lost to Follow-up|0|||
124878321|NCT03682705|449177359|FG001|Overall Study|Lost to Follow-up|0|||
124878322|NCT03682705|449177360|FG002|Overall Study|Lost to Follow-up|0|||
124878323|NCT03682705|449177361|FG003|Overall Study|Lost to Follow-up|0|||
124878324|NCT03682705|449177362|FG004|Overall Study|Lost to Follow-up|3|||
124878325|NCT03682705|449177363|FG005|Overall Study|Lost to Follow-up|0|||
124878326|NCT00117156|449177364|FG000|Overall Study|Adverse Event|9|||
124878327|NCT00117156|449177364|FG000|Overall Study|Physician Decision|1|||
124878328|NCT00117156|449177364|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
124878329|NCT01919970|449177365|FG000|Overall Study|Withdrawal by Subject|3|||
124878330|NCT01919970|449177366|FG001|Overall Study|Withdrawal by Subject|0|||
124878331|NCT04043962|449177367|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
124878332|NCT04043962|449177367|FG000|Post-Treatment|Withdrawal by Subject|5|||
124878333|NCT04043962|449177367|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
124878334|NCT04631705|449177370|FG000|Overall Study|Withdrawal by Subject|0|||
124878335|NCT04631705|449177371|FG001|Overall Study|Withdrawal by Subject|0|||
124878336|NCT04631705|449177372|FG002|Overall Study|Withdrawal by Subject|0|||
124878337|NCT04631705|449177373|FG003|Overall Study|Withdrawal by Subject|0|||
124878338|NCT04631705|449177374|FG004|Overall Study|Withdrawal by Subject|0|||
124878339|NCT04631705|449177375|FG005|Overall Study|Withdrawal by Subject|0|||
124878340|NCT04631705|449177376|FG006|Overall Study|Withdrawal by Subject|1|||
124878341|NCT04631705|449177377|FG007|Overall Study|Withdrawal by Subject|0|||
124878342|NCT04631705|449177378|FG008|Overall Study|Withdrawal by Subject|0|||
124878343|NCT02130284|449177379|FG000|Overall Study|Withdrawal by Subject|3|||
124878344|NCT02130284|449177379|FG000|Overall Study|Subject Withdrew Consent|1|||
124878345|NCT02130284|449177379|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
124878346|NCT02130284|449177379|FG000|Overall Study|Subject was screened as backup for study|3|||
124878347|NCT02130284|449177379|FG000|Overall Study|Screen Failure|1|||
124878348|NCT01875185|449177380|FG000|Overall Study|study was terminated|52|||
124878349|NCT01875185|449177381|FG001|Overall Study|study was terminated|48|||
124878350|NCT01521884|449177382|FG000|Overall Study|Non Responders|10|||
124878351|NCT01521884|449177382|FG000|Overall Study|Adverse Event|5|||
124878352|NCT01521884|449177382|FG000|Overall Study|Pregnancy|1|||
124878353|NCT01521884|449177382|FG000|Overall Study|Withdrawal by Subject|1|||
124878354|NCT01521884|449177382|FG000|Overall Study|Physician Decision|2|||
124878355|NCT01521884|449177382|FG000|Overall Study|Protocol Violation|3|||
124878356|NCT01521884|449177382|FG000|Overall Study|Participant non-eligible|1|||
124878357|NCT01521884|449177382|FG000|Overall Study|Lost to Follow-up|4|||
124878358|NCT03565068|449177383|FG000|Overall Study|Protocol Violation|0|||
124878359|NCT03565068|449177384|FG001|Overall Study|Protocol Violation|0|||
124878360|NCT03565068|449177385|FG002|Overall Study|Protocol Violation|0|||
124878361|NCT03565068|449177386|FG003|Overall Study|Protocol Violation|0|||
124878362|NCT03565068|449177387|FG004|Overall Study|Protocol Violation|1|||
124878363|NCT03565068|449177388|FG005|Overall Study|Protocol Violation|0|||
124878364|NCT03565068|449177389|FG006|Overall Study|Protocol Violation|0|||
124878365|NCT03565068|449177390|FG007|Overall Study|Protocol Violation|1|||
124878366|NCT03565068|449177391|FG008|Overall Study|Protocol Violation|0|||
124436590|NCT01290029|447560234|FG000|Overall Study|Other|2|||
124878367|NCT03565068|449177383|FG000|Overall Study|Sponsor decision|0|||
124878368|NCT03565068|449177384|FG001|Overall Study|Sponsor decision|0|||
124878369|NCT03565068|449177385|FG002|Overall Study|Sponsor decision|0|||
124436591|NCT02336178|447560235|FG000|Overall Study|Lost to Follow-up|1|||
124436592|NCT02336178|447560235|FG000|Overall Study|Protocol Violation|1|||
124878370|NCT03565068|449177386|FG003|Overall Study|Sponsor decision|0|||
124878371|NCT03565068|449177387|FG004|Overall Study|Sponsor decision|1|||
124878372|NCT03565068|449177388|FG005|Overall Study|Sponsor decision|1|||
124878373|NCT03565068|449177389|FG006|Overall Study|Sponsor decision|0|||
124679295|NCT01232283|448449713|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
124679296|NCT01232283|448449714|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
124679297|NCT01232283|448449715|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
124679298|NCT01232283|448449706|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
124679299|NCT01232283|448449707|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
124679300|NCT01232283|448449708|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
124679301|NCT01232283|448449709|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
124679302|NCT01232283|448449710|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
124679303|NCT01232283|448449711|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
124679304|NCT01232283|448449712|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
124679305|NCT01232283|448449713|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
124679306|NCT01232283|448449714|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
124679307|NCT01232283|448449715|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
124679308|NCT01232283|448449706|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
124679309|NCT01232283|448449707|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
124679310|NCT01232283|448449708|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
124679311|NCT01232283|448449709|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
124679312|NCT01232283|448449710|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
124679313|NCT01232283|448449711|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
124679314|NCT01232283|448449712|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
124679315|NCT01232283|448449713|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
124679316|NCT01232283|448449714|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
124878374|NCT03565068|449177390|FG007|Overall Study|Sponsor decision|0|||
124878375|NCT03565068|449177391|FG008|Overall Study|Sponsor decision|0|||
124878376|NCT03565068|449177383|FG000|Overall Study|Withdrawal by Subject|0|||
124878377|NCT03565068|449177384|FG001|Overall Study|Withdrawal by Subject|0|||
124878378|NCT03565068|449177385|FG002|Overall Study|Withdrawal by Subject|1|||
124878379|NCT03565068|449177386|FG003|Overall Study|Withdrawal by Subject|0|||
124878380|NCT03565068|449177387|FG004|Overall Study|Withdrawal by Subject|2|||
124878381|NCT03565068|449177388|FG005|Overall Study|Withdrawal by Subject|0|||
124878382|NCT03565068|449177389|FG006|Overall Study|Withdrawal by Subject|1|||
124878383|NCT03565068|449177390|FG007|Overall Study|Withdrawal by Subject|5|||
124878384|NCT03565068|449177391|FG008|Overall Study|Withdrawal by Subject|1|||
124878385|NCT03565068|449177383|FG000|Overall Study|Physician Decision|0|||
124878386|NCT03565068|449177384|FG001|Overall Study|Physician Decision|0|||
124878387|NCT03565068|449177385|FG002|Overall Study|Physician Decision|0|||
124679317|NCT01232283|448449715|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
124679318|NCT01232283|448449706|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
124679319|NCT01232283|448449707|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
124679320|NCT01232283|448449708|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
124679321|NCT01232283|448449709|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
124679322|NCT01232283|448449710|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
124679323|NCT01232283|448449711|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
124679324|NCT01232283|448449712|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
124679325|NCT01232283|448449713|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
124878388|NCT03565068|449177386|FG003|Overall Study|Physician Decision|0|||
124436593|NCT02336178|447560235|FG000|Overall Study|Withdrawal by Subject|1|||
124436594|NCT02336178|447560235|FG000|Overall Study|Other|1|||
124878389|NCT03565068|449177387|FG004|Overall Study|Physician Decision|0|||
124878390|NCT03565068|449177388|FG005|Overall Study|Physician Decision|0|||
124878391|NCT03565068|449177389|FG006|Overall Study|Physician Decision|0|||
124878392|NCT03565068|449177390|FG007|Overall Study|Physician Decision|1|||
124878393|NCT03565068|449177391|FG008|Overall Study|Physician Decision|0|||
124878394|NCT03565068|449177383|FG000|Overall Study|Lost to Follow-up|0|||
124878395|NCT03565068|449177384|FG001|Overall Study|Lost to Follow-up|0|||
124878396|NCT03565068|449177385|FG002|Overall Study|Lost to Follow-up|0|||
124878397|NCT03565068|449177386|FG003|Overall Study|Lost to Follow-up|0|||
124878398|NCT03565068|449177387|FG004|Overall Study|Lost to Follow-up|0|||
124878399|NCT03565068|449177388|FG005|Overall Study|Lost to Follow-up|0|||
124878400|NCT03565068|449177389|FG006|Overall Study|Lost to Follow-up|0|||
124878401|NCT03565068|449177390|FG007|Overall Study|Lost to Follow-up|1|||
124878402|NCT03565068|449177391|FG008|Overall Study|Lost to Follow-up|0|||
124878403|NCT00085202|449177392|FG000|Overall Study|Still on therapy|2|||
124878404|NCT00085202|449177393|FG001|Overall Study|Still on therapy|0|||
124878405|NCT00085202|449177392|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
124878406|NCT00085202|449177393|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
124878407|NCT00085202|449177392|FG000|Overall Study|Excessive toxicity|6|||
124878408|NCT00085202|449177393|FG001|Overall Study|Excessive toxicity|5|||
124878409|NCT00085202|449177392|FG000|Overall Study|Non-specified|3|||
124878410|NCT00085202|449177393|FG001|Overall Study|Non-specified|5|||
124878411|NCT00085202|449177392|FG000|Overall Study|Withdrawal by Subject|2|||
124878412|NCT00085202|449177393|FG001|Overall Study|Withdrawal by Subject|1|||
124878413|NCT00085202|449177392|FG000|Overall Study|Physician Decision|4|||
124878414|NCT00085202|449177393|FG001|Overall Study|Physician Decision|1|||
124878415|NCT00085202|449177392|FG000|Overall Study|Progressive disease|1|||
124878416|NCT00085202|449177393|FG001|Overall Study|Progressive disease|11|||
124878417|NCT01435655|449177399|FG000|Overall Study|Death|2|||
124878418|NCT01435655|449177399|FG000|Overall Study|Other|1|||
124878419|NCT01436201|449177400|FG000|Overall Study|Adverse Event|2|||
124878420|NCT01436201|449177400|FG000|Overall Study|Withdrawal by Subject|1|||
124878421|NCT01436201|449177400|FG000|Overall Study|Protocol Violation|1|||
124878422|NCT01353222|449177402|FG000|Overall Study|Death|30|||
124878423|NCT01353222|449177403|FG001|Overall Study|Death|30|||
124878424|NCT01353222|449177402|FG000|Overall Study|Withdrawal by Subject|8|||
124878425|NCT01353222|449177403|FG001|Overall Study|Withdrawal by Subject|5|||
124878426|NCT01353222|449177402|FG000|Overall Study|Study Terminated|31|||
124878427|NCT01353222|449177403|FG001|Overall Study|Study Terminated|37|||
124878428|NCT01353222|449177402|FG000|Overall Study|Site closed research department|1|||
124878429|NCT01353222|449177403|FG001|Overall Study|Site closed research department|0|||
124878430|NCT00116844|449177404|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
124878431|NCT00116844|449177405|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
124878432|NCT00116844|449177404|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
124878433|NCT00116844|449177405|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
124878434|NCT00116844|449177404|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
124878435|NCT00116844|449177405|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
124878436|NCT00116844|449177404|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
124878437|NCT00116844|449177405|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
124878438|NCT00116844|449177404|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
124878439|NCT00116844|449177405|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
124878440|NCT00116844|449177404|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
124878441|NCT00116844|449177405|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
124436595|NCT00618982|447560236|FG000|Overall Study|Adverse Event|23|||
124436596|NCT00618982|447560236|FG000|Overall Study|Withdrawal by Subject|1|||
124436597|NCT00618982|447560236|FG000|Overall Study|Protocol Violation|1|||
124436598|NCT00618982|447560236|FG000|Overall Study|ongoing, still treated with study med.|25|||
124436599|NCT01776541|447560242|FG000|Overall Study|Administrative Reason|6|||
124436600|NCT01776541|447560243|FG001|Overall Study|Administrative Reason|2|||
124679326|NCT01232283|448449714|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
124878442|NCT00116844|449177404|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
124878443|NCT00116844|449177405|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
124878444|NCT00116844|449177404|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
124878445|NCT00116844|449177405|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
124878446|NCT00116844|449177404|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
124878447|NCT00116844|449177405|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
124878448|NCT00738101|449177409|FG000|Overall Study|Physician Decision|5|||
124878449|NCT00738101|449177409|FG000|Overall Study|Death|1|||
124878450|NCT00738101|449177409|FG000|Overall Study|Repeat enrollment|1|||
124878451|NCT02202434|449179253|FG000|Overall Study|Death|70|||
124878452|NCT02202434|449179254|FG001|Overall Study|Death|39|||
124436601|NCT01776541|447560242|FG000|Overall Study|Death|4|||
124436602|NCT01776541|447560243|FG001|Overall Study|Death|0|||
124436603|NCT01776541|447560242|FG000|Overall Study|Lost to Follow-up|27|||
124878453|NCT02202434|449179255|FG002|Overall Study|Death|13|||
124878454|NCT02202434|449179256|FG003|Overall Study|Death|27|||
124878455|NCT02202434|449179253|FG000|Overall Study|Lost to Follow-up|1|||
124878456|NCT02202434|449179254|FG001|Overall Study|Lost to Follow-up|1|||
124878457|NCT02202434|449179255|FG002|Overall Study|Lost to Follow-up|1|||
124878458|NCT02202434|449179256|FG003|Overall Study|Lost to Follow-up|0|||
124878459|NCT02202434|449179253|FG000|Overall Study|Physician Decision|2|||
124878460|NCT02202434|449179254|FG001|Overall Study|Physician Decision|3|||
124878461|NCT02202434|449179255|FG002|Overall Study|Physician Decision|0|||
124878462|NCT02202434|449179256|FG003|Overall Study|Physician Decision|0|||
124878463|NCT02202434|449179253|FG000|Overall Study|Withdrawal by Subject|13|||
124878464|NCT02202434|449179254|FG001|Overall Study|Withdrawal by Subject|14|||
124878465|NCT02202434|449179255|FG002|Overall Study|Withdrawal by Subject|1|||
124878466|NCT02202434|449179256|FG003|Overall Study|Withdrawal by Subject|4|||
124878467|NCT02202434|449179253|FG000|Overall Study|Completed Study|1|||
124878468|NCT02202434|449179254|FG001|Overall Study|Completed Study|0|||
124878469|NCT02202434|449179255|FG002|Overall Study|Completed Study|0|||
124878470|NCT02202434|449179256|FG003|Overall Study|Completed Study|0|||
124878471|NCT02202434|449179253|FG000|Overall Study|Visit Missed|21|||
124878472|NCT02202434|449179254|FG001|Overall Study|Visit Missed|12|||
124878473|NCT02202434|449179255|FG002|Overall Study|Visit Missed|0|||
124878474|NCT02202434|449179256|FG003|Overall Study|Visit Missed|5|||
124878475|NCT02202434|449179253|FG000|Overall Study|Other|1|||
124878476|NCT02202434|449179254|FG001|Overall Study|Other|0|||
124878477|NCT02202434|449179255|FG002|Overall Study|Other|0|||
124878478|NCT02202434|449179256|FG003|Overall Study|Other|1|||
124878479|NCT03075501|449179257|FG000|Overall Study|Scheduling difficulties|15|||
124878480|NCT03075501|449179258|FG001|Overall Study|Scheduling difficulties|9|||
124878481|NCT01062763|449179262|FG000|Overall Study|Adverse Event|3|||
124878482|NCT01062763|449179263|FG001|Overall Study|Adverse Event|4|||
124878483|NCT02494921|449179264|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
124878484|NCT02494921|449179265|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
124878485|NCT02494921|449179266|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
124878486|NCT02494921|449179267|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
124878487|NCT02494921|449179268|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
124878488|NCT02494921|449179264|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
124878489|NCT02494921|449179265|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
124878490|NCT02494921|449179266|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
124878491|NCT02494921|449179267|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
124878492|NCT02494921|449179268|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
124878493|NCT02494921|449179264|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
124878494|NCT02494921|449179265|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
124878495|NCT02494921|449179266|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
124878496|NCT02494921|449179267|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
124878497|NCT02494921|449179268|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
124878498|NCT02714868|449179269|FG000|Overall Study|Withdrawal by Subject|3|||
124878499|NCT02714868|449179270|FG001|Overall Study|Withdrawal by Subject|0|||
124878500|NCT02714868|449179269|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
124878501|NCT02714868|449179270|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
124878502|NCT02714868|449179269|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
124878503|NCT02714868|449179270|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
124878504|NCT03505476|449179276|FG000|Overall Study|Physician Decision|18|||
124878505|NCT03505476|449179276|FG000|Overall Study|Device Malfunctioned|101|||
124878506|NCT03505476|449179276|FG000|Overall Study|Data Corrupt|6|||
124878507|NCT03505476|449179276|FG000|Overall Study|Device application insufficiant|3|||
124878508|NCT00539643|449179277|FG000|Overall Study|Adverse Event|1|||
124878509|NCT00539643|449179278|FG001|Overall Study|Adverse Event|0|||
124878510|NCT00539643|449179277|FG000|Overall Study|Death|2|||
124878511|NCT00539643|449179278|FG001|Overall Study|Death|1|||
124878512|NCT00539643|449179277|FG000|Overall Study|Physician Decision|3|||
124878513|NCT00539643|449179278|FG001|Overall Study|Physician Decision|1|||
124878514|NCT00539643|449179277|FG000|Overall Study|Withdrawal by Subject|0|||
124679327|NCT01232283|448449715|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
124878515|NCT00539643|449179278|FG001|Overall Study|Withdrawal by Subject|1|||
124878516|NCT02508532|449179281|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
124679328|NCT01232283|448449706|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
124878517|NCT02508532|449179282|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
124878518|NCT02508532|449179283|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
124878519|NCT02508532|449179284|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
124878520|NCT02508532|449179285|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
124878521|NCT02508532|449179286|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
124878522|NCT02508532|449179287|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
124878523|NCT02508532|449179288|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
124878524|NCT02508532|449179289|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
124436604|NCT01776541|447560243|FG001|Overall Study|Lost to Follow-up|48|||
124436605|NCT01776541|447560242|FG000|Overall Study|Unclassified|5|||
124436606|NCT01776541|447560243|FG001|Overall Study|Unclassified|4|||
124436607|NCT01776541|447560242|FG000|Overall Study|Protocol Violation|2|||
124436608|NCT01776541|447560243|FG001|Overall Study|Protocol Violation|1|||
124436609|NCT01776541|447560242|FG000|Overall Study|Withdrawal by Subject|12|||
124436610|NCT01776541|447560243|FG001|Overall Study|Withdrawal by Subject|20|||
124436611|NCT00156819|447560244|FG000|Overall Study|Lost to Follow-up|1|||
124436612|NCT00156819|447560245|FG001|Overall Study|Lost to Follow-up|1|||
124436613|NCT00156819|447560246|FG002|Overall Study|Lost to Follow-up|3|||
124436614|NCT00522873|447560247|FG000|Overall Study|Adverse Event|41|||
124436615|NCT00522873|447560248|FG001|Overall Study|Adverse Event|26|||
124436616|NCT00522873|447560247|FG000|Overall Study|Withdrawal by Subject|20|||
124436617|NCT00522873|447560248|FG001|Overall Study|Withdrawal by Subject|9|||
124436618|NCT00522873|447560247|FG000|Overall Study|Protocol Violation|14|||
124436619|NCT00522873|447560248|FG001|Overall Study|Protocol Violation|4|||
124436620|NCT00522873|447560247|FG000|Overall Study|Lost to Follow-up|11|||
124436621|NCT00522873|447560248|FG001|Overall Study|Lost to Follow-up|3|||
124436622|NCT00522873|447560247|FG000|Overall Study|Personal Reasons|8|||
124436623|NCT00522873|447560248|FG001|Overall Study|Personal Reasons|1|||
124436624|NCT00522873|447560247|FG000|Overall Study|Medication Errors|1|||
124436625|NCT00522873|447560248|FG001|Overall Study|Medication Errors|1|||
124436626|NCT00522873|447560247|FG000|Overall Study|Never Received Medication|1|||
124436627|NCT00522873|447560248|FG001|Overall Study|Never Received Medication|0|||
124436628|NCT00799513|447560251|FG000|Overall Study|Physician Decision|1|||
124436629|NCT00799513|447560251|FG000|Overall Study|Adverse Event|1|||
124436630|NCT00666679|447560252|FG000|First Intervention|Lost to Follow-up|1|||
124436631|NCT00666679|447560253|FG001|First Intervention|Lost to Follow-up|0|||
124436632|NCT00666679|447560252|FG000|First Intervention|Protocol Violation|1|||
124436633|NCT00666679|447560253|FG001|First Intervention|Protocol Violation|0|||
124436634|NCT00666679|447560252|FG000|First Intervention|Withdrawal by Subject|1|||
124436635|NCT00666679|447560253|FG001|First Intervention|Withdrawal by Subject|0|||
124436636|NCT00666679|447560252|FG000|First Intervention|Randomized did not start treatment|1|||
124436637|NCT00666679|447560253|FG001|First Intervention|Randomized did not start treatment|1|||
124436638|NCT00666679|447560252|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
124436639|NCT00666679|447560253|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
124436640|NCT00666679|447560252|FG000|Washout Period of 1 Week|Protocol Violation|0|||
124436641|NCT00666679|447560253|FG001|Washout Period of 1 Week|Protocol Violation|1|||
124436642|NCT00666679|447560252|FG000|Second Intervention|Adverse Event|1|||
124436643|NCT00666679|447560253|FG001|Second Intervention|Adverse Event|0|||
124436644|NCT00666679|447560252|FG000|Second Intervention|Death|0|||
124436645|NCT00666679|447560253|FG001|Second Intervention|Death|1|||
124436646|NCT05062759|447560256|FG000|Overall Study|Death|0|||
124436647|NCT05062759|447560257|FG001|Overall Study|Death|1|||
124436648|NCT05062759|447560256|FG000|Overall Study|Lost to Follow-up|1|||
124436649|NCT05062759|447560257|FG001|Overall Study|Lost to Follow-up|0|||
124436650|NCT02781844|447560258|FG000|Treatment Period 1|Adverse Event|0|||
124436651|NCT02781844|447560259|FG001|Treatment Period 1|Adverse Event|0|||
124436652|NCT02781844|447560260|FG002|Treatment Period 1|Adverse Event|0|||
124436653|NCT02781844|447560261|FG003|Treatment Period 1|Adverse Event|0|||
124436654|NCT02781844|447560262|FG004|Treatment Period 1|Adverse Event|0|||
124436655|NCT02781844|447560263|FG005|Treatment Period 1|Adverse Event|1|||
124436656|NCT02781844|447560264|FG006|Treatment Period 1|Adverse Event|0|||
124436657|NCT02781844|447560265|FG007|Treatment Period 1|Adverse Event|0|||
124436658|NCT02518490|447560266|FG000|Overall Study|Withdrawal by Subject|1|||
124436659|NCT02518490|447560267|FG001|Overall Study|Withdrawal by Subject|1|||
124436660|NCT00346632|447560268|FG000|Overall Study|Progressive Disease|2|||
124436661|NCT00346632|447560269|FG001|Overall Study|Progressive Disease|2|||
124436662|NCT00346632|447560270|FG002|Overall Study|Progressive Disease|4|||
124436663|NCT00346632|447560271|FG003|Overall Study|Progressive Disease|3|||
124436664|NCT00346632|447560272|FG004|Overall Study|Progressive Disease|3|||
124436665|NCT00346632|447560273|FG005|Overall Study|Progressive Disease|1|||
124436666|NCT00346632|447560274|FG006|Overall Study|Progressive Disease|2|||
124436667|NCT00346632|447560275|FG007|Overall Study|Progressive Disease|2|||
124436668|NCT00346632|447560276|FG008|Overall Study|Progressive Disease|2|||
124436669|NCT00346632|447560277|FG009|Overall Study|Progressive Disease|2|||
124436670|NCT00346632|447560268|FG000|Overall Study|Adverse Event|0|||
124436671|NCT00346632|447560269|FG001|Overall Study|Adverse Event|0|||
124436672|NCT00346632|447560270|FG002|Overall Study|Adverse Event|0|||
124436673|NCT00346632|447560271|FG003|Overall Study|Adverse Event|0|||
124436674|NCT00346632|447560272|FG004|Overall Study|Adverse Event|1|||
124436675|NCT00346632|447560273|FG005|Overall Study|Adverse Event|1|||
124436676|NCT00346632|447560274|FG006|Overall Study|Adverse Event|1|||
124436677|NCT00346632|447560275|FG007|Overall Study|Adverse Event|0|||
124436678|NCT00346632|447560276|FG008|Overall Study|Adverse Event|0|||
124436679|NCT00346632|447560277|FG009|Overall Study|Adverse Event|0|||
124436680|NCT00346632|447560268|FG000|Overall Study|Death|0|||
124436681|NCT00346632|447560269|FG001|Overall Study|Death|0|||
124436682|NCT00346632|447560270|FG002|Overall Study|Death|1|||
124436683|NCT00346632|447560271|FG003|Overall Study|Death|0|||
124436684|NCT00346632|447560272|FG004|Overall Study|Death|0|||
124436685|NCT00346632|447560273|FG005|Overall Study|Death|0|||
124436686|NCT00346632|447560274|FG006|Overall Study|Death|0|||
124436687|NCT00346632|447560275|FG007|Overall Study|Death|0|||
124436688|NCT00346632|447560276|FG008|Overall Study|Death|0|||
124436689|NCT00346632|447560277|FG009|Overall Study|Death|0|||
124436690|NCT00346632|447560268|FG000|Overall Study|Protocol Violation|0|||
124436691|NCT00346632|447560269|FG001|Overall Study|Protocol Violation|0|||
124436692|NCT00346632|447560270|FG002|Overall Study|Protocol Violation|0|||
124436693|NCT00346632|447560271|FG003|Overall Study|Protocol Violation|0|||
124436694|NCT00346632|447560272|FG004|Overall Study|Protocol Violation|0|||
124436695|NCT00346632|447560273|FG005|Overall Study|Protocol Violation|0|||
124436696|NCT00346632|447560274|FG006|Overall Study|Protocol Violation|1|||
124436697|NCT00346632|447560275|FG007|Overall Study|Protocol Violation|0|||
124436698|NCT00346632|447560276|FG008|Overall Study|Protocol Violation|0|||
124436699|NCT00346632|447560277|FG009|Overall Study|Protocol Violation|0|||
124436700|NCT00346632|447560268|FG000|Overall Study|Withdrawal by Subject|0|||
124436701|NCT00346632|447560269|FG001|Overall Study|Withdrawal by Subject|0|||
124436702|NCT00346632|447560270|FG002|Overall Study|Withdrawal by Subject|0|||
124436703|NCT00346632|447560271|FG003|Overall Study|Withdrawal by Subject|0|||
124436704|NCT00346632|447560272|FG004|Overall Study|Withdrawal by Subject|0|||
124436705|NCT00346632|447560273|FG005|Overall Study|Withdrawal by Subject|0|||
124436706|NCT00346632|447560274|FG006|Overall Study|Withdrawal by Subject|1|||
124436707|NCT00346632|447560275|FG007|Overall Study|Withdrawal by Subject|0|||
124436708|NCT00346632|447560276|FG008|Overall Study|Withdrawal by Subject|0|||
124436709|NCT00346632|447560277|FG009|Overall Study|Withdrawal by Subject|0|||
124436710|NCT00346632|447560268|FG000|Overall Study|Switched to alternative treatment|0|||
124436711|NCT00346632|447560269|FG001|Overall Study|Switched to alternative treatment|0|||
124436712|NCT00346632|447560270|FG002|Overall Study|Switched to alternative treatment|1|||
124436713|NCT00346632|447560271|FG003|Overall Study|Switched to alternative treatment|0|||
124436714|NCT00346632|447560272|FG004|Overall Study|Switched to alternative treatment|0|||
124436715|NCT00346632|447560273|FG005|Overall Study|Switched to alternative treatment|0|||
124436716|NCT00346632|447560274|FG006|Overall Study|Switched to alternative treatment|0|||
124436717|NCT00346632|447560275|FG007|Overall Study|Switched to alternative treatment|0|||
124436718|NCT00346632|447560276|FG008|Overall Study|Switched to alternative treatment|0|||
124436719|NCT00346632|447560277|FG009|Overall Study|Switched to alternative treatment|0|||
124436720|NCT00346632|447560268|FG000|Overall Study|Not Stated|1|||
124436721|NCT00346632|447560269|FG001|Overall Study|Not Stated|1|||
124436722|NCT00346632|447560270|FG002|Overall Study|Not Stated|0|||
124436723|NCT00346632|447560271|FG003|Overall Study|Not Stated|0|||
124436724|NCT00346632|447560272|FG004|Overall Study|Not Stated|0|||
124436725|NCT00346632|447560273|FG005|Overall Study|Not Stated|0|||
124436726|NCT00346632|447560274|FG006|Overall Study|Not Stated|0|||
124436727|NCT00346632|447560275|FG007|Overall Study|Not Stated|2|||
124436728|NCT00346632|447560276|FG008|Overall Study|Not Stated|2|||
124436729|NCT00346632|447560277|FG009|Overall Study|Not Stated|1|||
124436730|NCT00918580|447560278|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
124436731|NCT00918580|447560278|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
124436732|NCT00918580|447560278|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
124436733|NCT00918580|447560278|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
124436734|NCT00918580|447560278|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
124436735|NCT00918580|447560278|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
124436736|NCT00918580|447560278|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
124436737|NCT04882995|447560279|FG000|Overall Study|Withdrawal by Subject|1|||
124436738|NCT04882995|447560280|FG001|Overall Study|Withdrawal by Subject|2|||
124436739|NCT04882995|447560279|FG000|Overall Study|Protocol Violation|4|||
124436740|NCT04882995|447560280|FG001|Overall Study|Protocol Violation|4|||
124436741|NCT04882995|447560279|FG000|Overall Study|Surgery postponed due to COVID|1|||
124436742|NCT04882995|447560280|FG001|Overall Study|Surgery postponed due to COVID|1|||
124436743|NCT00262951|447560287|FG000|Overall Study|Progressive disease/relapse|3|||
124436744|NCT00262951|447560287|FG000|Overall Study|Adverse Event|7|||
124436745|NCT00262951|447560287|FG000|Overall Study|Death|1|||
124436746|NCT00262951|447560287|FG000|Overall Study|Withdrawal by Subject|1|||
124436747|NCT00262951|447560287|FG000|Overall Study|Alternative treatment|3|||
124436748|NCT00262951|447560287|FG000|Overall Study|Off treatment for other disease|1|||
124436749|NCT01577745|447560288|FG000|Overall Study|Withdrawal by Subject|0|||
124436750|NCT01577745|447560289|FG001|Overall Study|Withdrawal by Subject|1|||
124878525|NCT02508532|449179281|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
124878526|NCT02508532|449179282|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
124878527|NCT02508532|449179283|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
124878528|NCT02508532|449179284|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
124878529|NCT02508532|449179285|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
124878530|NCT02508532|449179286|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
124878531|NCT02508532|449179287|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
124878532|NCT02508532|449179288|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
124878533|NCT02508532|449179289|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
124878534|NCT02508532|449179281|FG000|Part 2 - Treatment|Disease Progression|0|||
124878535|NCT02508532|449179282|FG001|Part 2 - Treatment|Disease Progression|0|||
124878536|NCT02508532|449179283|FG002|Part 2 - Treatment|Disease Progression|0|||
124878537|NCT02508532|449179284|FG003|Part 2 - Treatment|Disease Progression|0|||
124878538|NCT02508532|449179285|FG004|Part 2 - Treatment|Disease Progression|0|||
124878539|NCT02508532|449179286|FG005|Part 2 - Treatment|Disease Progression|0|||
124878540|NCT02508532|449179287|FG006|Part 2 - Treatment|Disease Progression|0|||
124878541|NCT02508532|449179288|FG007|Part 2 - Treatment|Disease Progression|0|||
124878542|NCT02508532|449179289|FG008|Part 2 - Treatment|Disease Progression|118|||
124878543|NCT02508532|449179281|FG000|Part 2 - Treatment|Adverse Event|0|||
124878544|NCT02508532|449179282|FG001|Part 2 - Treatment|Adverse Event|0|||
124878545|NCT02508532|449179283|FG002|Part 2 - Treatment|Adverse Event|0|||
124878546|NCT02508532|449179284|FG003|Part 2 - Treatment|Adverse Event|0|||
124878547|NCT02508532|449179285|FG004|Part 2 - Treatment|Adverse Event|0|||
124878548|NCT02508532|449179286|FG005|Part 2 - Treatment|Adverse Event|0|||
124878549|NCT02508532|449179287|FG006|Part 2 - Treatment|Adverse Event|0|||
124878550|NCT02508532|449179288|FG007|Part 2 - Treatment|Adverse Event|0|||
124878551|NCT02508532|449179289|FG008|Part 2 - Treatment|Adverse Event|49|||
124878552|NCT02508532|449179281|FG000|Part 2 - Treatment|Physician Decision|0|||
124878553|NCT02508532|449179282|FG001|Part 2 - Treatment|Physician Decision|0|||
124878554|NCT02508532|449179283|FG002|Part 2 - Treatment|Physician Decision|0|||
124436751|NCT01577745|447560290|FG002|Overall Study|Withdrawal by Subject|0|||
124436752|NCT01577745|447560291|FG003|Overall Study|Withdrawal by Subject|3|||
124436753|NCT01577745|447560292|FG004|Overall Study|Withdrawal by Subject|2|||
124436754|NCT01577745|447560293|FG005|Overall Study|Withdrawal by Subject|0|||
124436755|NCT01577745|447560288|FG000|Overall Study|Death|3|||
124436756|NCT01577745|447560289|FG001|Overall Study|Death|2|||
124436757|NCT01577745|447560290|FG002|Overall Study|Death|2|||
124436758|NCT01577745|447560291|FG003|Overall Study|Death|1|||
124436759|NCT01577745|447560292|FG004|Overall Study|Death|1|||
124436760|NCT01577745|447560293|FG005|Overall Study|Death|3|||
124436761|NCT01577745|447560288|FG000|Overall Study|Physician Decision|0|||
124436762|NCT01577745|447560289|FG001|Overall Study|Physician Decision|0|||
124436763|NCT01577745|447560290|FG002|Overall Study|Physician Decision|0|||
124436764|NCT01577745|447560291|FG003|Overall Study|Physician Decision|1|||
124436765|NCT01577745|447560292|FG004|Overall Study|Physician Decision|1|||
124436766|NCT01577745|447560293|FG005|Overall Study|Physician Decision|0|||
124436767|NCT01577745|447560288|FG000|Overall Study|Lost to Follow-up|0|||
124436768|NCT01577745|447560289|FG001|Overall Study|Lost to Follow-up|0|||
124436769|NCT01577745|447560290|FG002|Overall Study|Lost to Follow-up|0|||
124436770|NCT01577745|447560291|FG003|Overall Study|Lost to Follow-up|0|||
124436771|NCT01577745|447560292|FG004|Overall Study|Lost to Follow-up|0|||
124436772|NCT01577745|447560293|FG005|Overall Study|Lost to Follow-up|1|||
124436773|NCT01577745|447560288|FG000|Overall Study|Alternative Therapy|0|||
124436774|NCT01577745|447560289|FG001|Overall Study|Alternative Therapy|0|||
124436775|NCT01577745|447560290|FG002|Overall Study|Alternative Therapy|0|||
124436776|NCT01577745|447560291|FG003|Overall Study|Alternative Therapy|1|||
124436777|NCT01577745|447560292|FG004|Overall Study|Alternative Therapy|1|||
124436778|NCT01577745|447560293|FG005|Overall Study|Alternative Therapy|0|||
124436779|NCT00394082|447560296|FG000|Overall Study|Unacceptable toxicity|15|||
124878555|NCT02508532|449179284|FG003|Part 2 - Treatment|Physician Decision|0|||
124878556|NCT02508532|449179285|FG004|Part 2 - Treatment|Physician Decision|0|||
124878557|NCT02508532|449179286|FG005|Part 2 - Treatment|Physician Decision|0|||
124878558|NCT02508532|449179287|FG006|Part 2 - Treatment|Physician Decision|0|||
124878559|NCT02508532|449179288|FG007|Part 2 - Treatment|Physician Decision|0|||
124436780|NCT00394082|447560296|FG000|Overall Study|Adverse Event|4|||
124436781|NCT00394082|447560296|FG000|Overall Study|Physician Decision|4|||
124436782|NCT00394082|447560296|FG000|Overall Study|Withdrawal by Subject|2|||
124878560|NCT02508532|449179289|FG008|Part 2 - Treatment|Physician Decision|12|||
124878561|NCT02508532|449179281|FG000|Part 2 - Treatment|Administrative|0|||
124878562|NCT02508532|449179282|FG001|Part 2 - Treatment|Administrative|0|||
124544333|NCT02268214|447946768|FG000|Overall Study|Lack of Efficacy|1|||
124544334|NCT02268214|447946769|FG001|Overall Study|Lack of Efficacy|0|||
124544335|NCT02268214|447946770|FG002|Overall Study|Lack of Efficacy|2|||
124544336|NCT02268214|447946768|FG000|Overall Study|Adverse Event|11|||
124544337|NCT02268214|447946769|FG001|Overall Study|Adverse Event|14|||
124544338|NCT02268214|447946770|FG002|Overall Study|Adverse Event|9|||
124878563|NCT02508532|449179283|FG002|Part 2 - Treatment|Administrative|0|||
124436783|NCT00394082|447560296|FG000|Overall Study|Other|1|||
124544339|NCT02268214|447946768|FG000|Overall Study|Withdrawal by Subject|4|||
124544340|NCT02268214|447946769|FG001|Overall Study|Withdrawal by Subject|5|||
124544341|NCT02268214|447946770|FG002|Overall Study|Withdrawal by Subject|10|||
124544342|NCT02268214|447946768|FG000|Overall Study|Subject request to discontinue treatment|10|||
124544343|NCT02268214|447946769|FG001|Overall Study|Subject request to discontinue treatment|8|||
124544344|NCT02268214|447946770|FG002|Overall Study|Subject request to discontinue treatment|6|||
124544345|NCT02268214|447946768|FG000|Overall Study|Poor/non-compliance|2|||
124544346|NCT02268214|447946769|FG001|Overall Study|Poor/non-compliance|1|||
124544347|NCT02268214|447946770|FG002|Overall Study|Poor/non-compliance|2|||
124544348|NCT02268214|447946768|FG000|Overall Study|Other reasons|7|||
124544349|NCT02268214|447946769|FG001|Overall Study|Other reasons|3|||
124544350|NCT02268214|447946770|FG002|Overall Study|Other reasons|3|||
124544351|NCT02268214|447946768|FG000|Overall Study|Not entering long-term period|2|||
124544352|NCT02268214|447946769|FG001|Overall Study|Not entering long-term period|3|||
124544353|NCT02268214|447946770|FG002|Overall Study|Not entering long-term period|5|||
124679329|NCT01232283|448449707|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
124679330|NCT01232283|448449708|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
124679331|NCT01232283|448449709|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
124679332|NCT01232283|448449710|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
124679333|NCT01232283|448449711|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
124679334|NCT01232283|448449712|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
124679335|NCT01232283|448449713|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
124679336|NCT01232283|448449714|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
124679337|NCT01232283|448449715|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
124679338|NCT01232283|448449706|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
124679339|NCT01232283|448449707|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
124679340|NCT01232283|448449708|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
124679341|NCT01232283|448449709|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
124679342|NCT01232283|448449710|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
124679343|NCT01232283|448449711|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
124679344|NCT01232283|448449712|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
124679345|NCT01232283|448449713|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
124679346|NCT01232283|448449714|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
124679347|NCT01232283|448449715|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
124679348|NCT01232283|448449706|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
124679349|NCT01232283|448449707|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
124679350|NCT01232283|448449708|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
124679351|NCT01232283|448449709|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
124679352|NCT01232283|448449710|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
124679353|NCT01232283|448449711|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
124679354|NCT01232283|448449712|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
124679355|NCT01232283|448449713|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
124679356|NCT01232283|448449714|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
124679357|NCT01232283|448449715|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
124679358|NCT01232283|448449706|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
124679359|NCT01232283|448449707|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
124679360|NCT01232283|448449708|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
124679361|NCT01232283|448449709|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
124679362|NCT01232283|448449710|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
124679363|NCT01232283|448449711|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
124679364|NCT01232283|448449712|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
124679365|NCT01232283|448449713|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
124679366|NCT01232283|448449714|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
124544354|NCT04342390|447946771|FG000|Overall Study|Lost to Follow-up|3|||
124544355|NCT04342390|447946772|FG001|Overall Study|Lost to Follow-up|0|||
124679367|NCT01232283|448449715|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
124679368|NCT01232283|448449706|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
124679369|NCT01232283|448449707|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
124679370|NCT01232283|448449708|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
124679371|NCT01232283|448449709|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
124679372|NCT01232283|448449710|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
124679373|NCT01232283|448449711|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
124679374|NCT01232283|448449712|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
124679375|NCT01232283|448449713|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
124679376|NCT01232283|448449714|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
124679377|NCT01232283|448449715|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
124679378|NCT01232283|448449706|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
124679379|NCT01232283|448449707|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
124679380|NCT01232283|448449708|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
124878564|NCT02508532|449179284|FG003|Part 2 - Treatment|Administrative|0|||
124878565|NCT02508532|449179285|FG004|Part 2 - Treatment|Administrative|0|||
124878566|NCT02508532|449179286|FG005|Part 2 - Treatment|Administrative|0|||
124878567|NCT02508532|449179287|FG006|Part 2 - Treatment|Administrative|0|||
124878568|NCT02508532|449179288|FG007|Part 2 - Treatment|Administrative|0|||
124878569|NCT02508532|449179289|FG008|Part 2 - Treatment|Administrative|3|||
124878570|NCT02508532|449179281|FG000|Part 2 - Treatment|Sponsor Decision|0|||
124878571|NCT02508532|449179282|FG001|Part 2 - Treatment|Sponsor Decision|0|||
124878572|NCT02508532|449179283|FG002|Part 2 - Treatment|Sponsor Decision|0|||
124878573|NCT02508532|449179284|FG003|Part 2 - Treatment|Sponsor Decision|0|||
124878574|NCT02508532|449179285|FG004|Part 2 - Treatment|Sponsor Decision|0|||
124878575|NCT02508532|449179286|FG005|Part 2 - Treatment|Sponsor Decision|0|||
124878576|NCT02508532|449179287|FG006|Part 2 - Treatment|Sponsor Decision|0|||
124878577|NCT02508532|449179288|FG007|Part 2 - Treatment|Sponsor Decision|0|||
124878578|NCT02508532|449179289|FG008|Part 2 - Treatment|Sponsor Decision|28|||
124878579|NCT02508532|449179281|FG000|Part 2 - Treatment|Death|0|||
124878580|NCT02508532|449179282|FG001|Part 2 - Treatment|Death|0|||
124878581|NCT02508532|449179283|FG002|Part 2 - Treatment|Death|0|||
124878582|NCT02508532|449179284|FG003|Part 2 - Treatment|Death|0|||
124878583|NCT02508532|449179285|FG004|Part 2 - Treatment|Death|0|||
124878584|NCT02508532|449179286|FG005|Part 2 - Treatment|Death|0|||
124878585|NCT02508532|449179287|FG006|Part 2 - Treatment|Death|0|||
124878586|NCT02508532|449179288|FG007|Part 2 - Treatment|Death|0|||
124878587|NCT02508532|449179289|FG008|Part 2 - Treatment|Death|1|||
124878588|NCT02508532|449179281|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
124878589|NCT02508532|449179282|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
124878590|NCT02508532|449179283|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
124878591|NCT02508532|449179284|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
124878592|NCT02508532|449179285|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
124878593|NCT02508532|449179286|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
124878594|NCT02508532|449179287|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
124878595|NCT02508532|449179288|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
124878596|NCT02508532|449179289|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
124878597|NCT02508532|449179281|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
124878598|NCT02508532|449179282|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
124878599|NCT02508532|449179283|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
124878600|NCT02508532|449179284|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
124878601|NCT02508532|449179285|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
124878602|NCT02508532|449179286|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
124878603|NCT02508532|449179287|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
124878604|NCT02508532|449179288|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
124878605|NCT02508532|449179289|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
124878606|NCT02508532|449179281|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
124878607|NCT02508532|449179282|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
124878608|NCT02508532|449179283|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
124878609|NCT02508532|449179284|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
124878610|NCT02508532|449179285|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
124878611|NCT02508532|449179286|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
124878612|NCT02508532|449179287|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
124878613|NCT02508532|449179288|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
124878614|NCT02508532|449179289|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
124878615|NCT02508532|449179281|FG000|Part 1 and Part 2 End of Study|Death|0|||
124878616|NCT02508532|449179282|FG001|Part 1 and Part 2 End of Study|Death|4|||
124878617|NCT02508532|449179283|FG002|Part 1 and Part 2 End of Study|Death|2|||
124878618|NCT02508532|449179284|FG003|Part 1 and Part 2 End of Study|Death|4|||
124878619|NCT02508532|449179285|FG004|Part 1 and Part 2 End of Study|Death|3|||
124878620|NCT02508532|449179286|FG005|Part 1 and Part 2 End of Study|Death|0|||
124878621|NCT02508532|449179287|FG006|Part 1 and Part 2 End of Study|Death|0|||
124878622|NCT02508532|449179288|FG007|Part 1 and Part 2 End of Study|Death|1|||
124878623|NCT02508532|449179289|FG008|Part 1 and Part 2 End of Study|Death|111|||
124878624|NCT02508532|449179281|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
124878625|NCT02508532|449179282|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
124878626|NCT02508532|449179283|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
124878627|NCT02508532|449179284|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
124878628|NCT02508532|449179285|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
124878629|NCT02508532|449179286|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
124878630|NCT02508532|449179287|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
124436784|NCT02344004|447560298|FG000|Overall Study|Adverse Event|11|||
124679381|NCT01232283|448449709|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
124679382|NCT01232283|448449710|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
124679383|NCT01232283|448449711|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
124679384|NCT01232283|448449712|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
124679385|NCT01232283|448449713|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
124679386|NCT01232283|448449714|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
124878631|NCT02508532|449179288|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
124878632|NCT02508532|449179289|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
124878633|NCT02508532|449179281|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
124878634|NCT02508532|449179282|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
124878635|NCT02508532|449179283|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
124878636|NCT02508532|449179284|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
124878637|NCT02508532|449179285|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
124878638|NCT02508532|449179286|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
124878639|NCT02508532|449179287|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
124878640|NCT02508532|449179288|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
124878641|NCT02508532|449179289|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
124878642|NCT02508532|449179281|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
124878643|NCT02508532|449179282|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
124878644|NCT02508532|449179283|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
124878645|NCT02508532|449179284|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
124878646|NCT02508532|449179285|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
124878647|NCT02508532|449179286|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
124878648|NCT02508532|449179287|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
124878649|NCT02508532|449179288|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
124878650|NCT02508532|449179289|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
124878651|NCT02508532|449179281|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
124878652|NCT02508532|449179282|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
124878653|NCT02508532|449179283|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
124544359|NCT04410978|447946788|FG000|Overall Study|Poor compliance to protocol|2|||
124544360|NCT04410978|447946789|FG001|Overall Study|Poor compliance to protocol|4|||
124544361|NCT04410978|447946788|FG000|Overall Study|Withdrawal by Subject|64|||
124544362|NCT04410978|447946789|FG001|Overall Study|Withdrawal by Subject|66|||
124544363|NCT04410978|447946788|FG000|Overall Study|Other|6|||
124544364|NCT04410978|447946789|FG001|Overall Study|Other|7|||
124544365|NCT04410978|447946788|FG000|Overall Study|Missing study status|1|||
124544366|NCT04410978|447946789|FG001|Overall Study|Missing study status|0|||
124544367|NCT00948896|447946793|FG000|Randomization to 24 Months of Age|Death|1|||
124544368|NCT00948896|447946794|FG001|Randomization to 24 Months of Age|Death|0|||
124544369|NCT00948896|447946795|FG002|Randomization to 24 Months of Age|Death|0|||
124544370|NCT00948896|447946796|FG003|Randomization to 24 Months of Age|Death|0|||
124544371|NCT00948896|447946797|FG004|Randomization to 24 Months of Age|Death|2|||
124544372|NCT00948896|447946798|FG005|Randomization to 24 Months of Age|Death|1|||
124544373|NCT00948896|447946799|FG006|Randomization to 24 Months of Age|Death|2|||
124544374|NCT00948896|447946800|FG007|Randomization to 24 Months of Age|Death|1|||
124544375|NCT00948896|447946793|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
124544376|NCT00948896|447946794|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
124544377|NCT00948896|447946795|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
124544378|NCT00948896|447946796|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
124436785|NCT02344004|447560299|FG001|Overall Study|Adverse Event|1|||
124436786|NCT02344004|447560298|FG000|Overall Study|Death|9|||
124436787|NCT02344004|447560299|FG001|Overall Study|Death|7|||
124436788|NCT02344004|447560298|FG000|Overall Study|Physician Decision|4|||
124436789|NCT02344004|447560299|FG001|Overall Study|Physician Decision|1|||
124436790|NCT02344004|447560298|FG000|Overall Study|Withdrawal by Subject|22|||
124436791|NCT02344004|447560299|FG001|Overall Study|Withdrawal by Subject|5|||
124436792|NCT02344004|447560298|FG000|Overall Study|Rescue Medication|2|||
124436793|NCT02344004|447560299|FG001|Overall Study|Rescue Medication|0|||
124436794|NCT02344004|447560298|FG000|Overall Study|Other Not Specified|12|||
124436795|NCT02344004|447560299|FG001|Overall Study|Other Not Specified|0|||
124436796|NCT02344004|447560298|FG000|Overall Study|Protocol Violation|1|||
124436797|NCT02344004|447560299|FG001|Overall Study|Protocol Violation|0|||
124436798|NCT02842827|447560300|FG000|Overall Study|Adverse Event|0|||
124436799|NCT02842827|447560301|FG001|Overall Study|Adverse Event|1|||
124436800|NCT02842827|447560302|FG002|Overall Study|Adverse Event|0|||
124436801|NCT02842827|447560303|FG003|Overall Study|Adverse Event|1|||
124436802|NCT02842827|447560304|FG004|Overall Study|Adverse Event|0|||
124436803|NCT02842827|447560305|FG005|Overall Study|Adverse Event|1|||
124436804|NCT02842827|447560306|FG006|Overall Study|Adverse Event|0|||
124436805|NCT02842827|447560307|FG007|Overall Study|Adverse Event|0|||
124436806|NCT02842827|447560300|FG000|Overall Study|Death|1|||
124436807|NCT02842827|447560301|FG001|Overall Study|Death|0|||
124436808|NCT02842827|447560302|FG002|Overall Study|Death|2|||
124436809|NCT02842827|447560303|FG003|Overall Study|Death|3|||
124436810|NCT02842827|447560304|FG004|Overall Study|Death|2|||
124436811|NCT02842827|447560305|FG005|Overall Study|Death|1|||
124436812|NCT02842827|447560306|FG006|Overall Study|Death|0|||
124436813|NCT02842827|447560307|FG007|Overall Study|Death|4|||
124436814|NCT02842827|447560300|FG000|Overall Study|Physician Decision|1|||
124436815|NCT02842827|447560301|FG001|Overall Study|Physician Decision|3|||
124436816|NCT02842827|447560302|FG002|Overall Study|Physician Decision|0|||
124436817|NCT02842827|447560303|FG003|Overall Study|Physician Decision|0|||
124436818|NCT02842827|447560304|FG004|Overall Study|Physician Decision|1|||
124436819|NCT02842827|447560305|FG005|Overall Study|Physician Decision|4|||
124436820|NCT02842827|447560306|FG006|Overall Study|Physician Decision|2|||
124436821|NCT02842827|447560307|FG007|Overall Study|Physician Decision|1|||
124436822|NCT02842827|447560300|FG000|Overall Study|Protocol Defined Disease Progression|0|||
124436823|NCT02842827|447560301|FG001|Overall Study|Protocol Defined Disease Progression|0|||
124436824|NCT02842827|447560302|FG002|Overall Study|Protocol Defined Disease Progression|0|||
124436825|NCT02842827|447560303|FG003|Overall Study|Protocol Defined Disease Progression|0|||
124436826|NCT02842827|447560304|FG004|Overall Study|Protocol Defined Disease Progression|0|||
124436827|NCT02842827|447560305|FG005|Overall Study|Protocol Defined Disease Progression|1|||
124436828|NCT02842827|447560306|FG006|Overall Study|Protocol Defined Disease Progression|0|||
124436829|NCT02842827|447560307|FG007|Overall Study|Protocol Defined Disease Progression|0|||
124436830|NCT02842827|447560300|FG000|Overall Study|Participant Withdrawal of Consent|1|||
124436831|NCT02842827|447560301|FG001|Overall Study|Participant Withdrawal of Consent|2|||
124436832|NCT02842827|447560302|FG002|Overall Study|Participant Withdrawal of Consent|2|||
124436833|NCT02842827|447560303|FG003|Overall Study|Participant Withdrawal of Consent|2|||
124544379|NCT00948896|447946797|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
124544380|NCT00948896|447946798|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
124544381|NCT00948896|447946799|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
124436834|NCT02842827|447560304|FG004|Overall Study|Participant Withdrawal of Consent|2|||
124436835|NCT02842827|447560305|FG005|Overall Study|Participant Withdrawal of Consent|1|||
124436836|NCT02842827|447560306|FG006|Overall Study|Participant Withdrawal of Consent|2|||
124544382|NCT00948896|447946800|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
124436837|NCT02842827|447560307|FG007|Overall Study|Participant Withdrawal of Consent|1|||
124878654|NCT02508532|449179284|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
124878655|NCT02508532|449179285|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
124878656|NCT02508532|449179286|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
124878657|NCT02508532|449179287|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
124436838|NCT03801915|447560313|FG000|Overall Study|Screen failure|0|||
124436839|NCT03801915|447560314|FG001|Overall Study|Screen failure|0|||
124436840|NCT03801915|447560315|FG002|Overall Study|Screen failure|1|||
124436841|NCT03801915|447560313|FG000|Overall Study|Ineligible|1|||
124436842|NCT03801915|447560314|FG001|Overall Study|Ineligible|0|||
124436843|NCT03801915|447560315|FG002|Overall Study|Ineligible|0|||
124436844|NCT03801915|447560313|FG000|Overall Study|Physician Decision|2|||
124436845|NCT03801915|447560314|FG001|Overall Study|Physician Decision|1|||
124436846|NCT03801915|447560315|FG002|Overall Study|Physician Decision|0|||
124436847|NCT02308020|447560318|FG000|Overall Study|Lost to Follow-up|1|||
124436848|NCT02308020|447560319|FG001|Overall Study|Lost to Follow-up|7|||
124436849|NCT02308020|447560320|FG002|Overall Study|Lost to Follow-up|0|||
124436850|NCT02308020|447560321|FG003|Overall Study|Lost to Follow-up|0|||
124436851|NCT02308020|447560322|FG004|Overall Study|Lost to Follow-up|1|||
124436852|NCT02308020|447560323|FG005|Overall Study|Lost to Follow-up|2|||
124436853|NCT02308020|447560318|FG000|Overall Study|Sponsor Decision|0|||
124436854|NCT02308020|447560319|FG001|Overall Study|Sponsor Decision|8|||
124436855|NCT02308020|447560320|FG002|Overall Study|Sponsor Decision|0|||
124436856|NCT02308020|447560321|FG003|Overall Study|Sponsor Decision|2|||
124679387|NCT01232283|448449715|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
124679388|NCT01232283|448449706|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
124679389|NCT01232283|448449707|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
124679390|NCT01232283|448449708|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
124679391|NCT01232283|448449709|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
124436857|NCT02308020|447560322|FG004|Overall Study|Sponsor Decision|2|||
124436858|NCT02308020|447560323|FG005|Overall Study|Sponsor Decision|1|||
124436859|NCT02308020|447560318|FG000|Overall Study|Withdrawal by Subject|3|||
124436860|NCT02308020|447560319|FG001|Overall Study|Withdrawal by Subject|5|||
124436861|NCT02308020|447560320|FG002|Overall Study|Withdrawal by Subject|3|||
124436862|NCT02308020|447560321|FG003|Overall Study|Withdrawal by Subject|2|||
124436863|NCT02308020|447560322|FG004|Overall Study|Withdrawal by Subject|1|||
124436864|NCT02308020|447560323|FG005|Overall Study|Withdrawal by Subject|2|||
124436865|NCT01211288|447560324|FG000|Overall Study|Lost to Follow-up|1|||
124436866|NCT01211288|447560325|FG001|Overall Study|Lost to Follow-up|1|||
124436867|NCT04217590|447560326|FG000|Overall Study|Other|1|||
124436868|NCT04217590|447560327|FG001|Overall Study|Other|1|||
124436869|NCT04217590|447560326|FG000|Overall Study|Withdrawal by Subject|3|||
124436870|NCT04217590|447560327|FG001|Overall Study|Withdrawal by Subject|1|||
124436871|NCT04217590|447560326|FG000|Overall Study|Death|0|||
124436872|NCT04217590|447560327|FG001|Overall Study|Death|1|||
124436873|NCT01242800|447560339|FG000|Overall Study|Patient refusal|0|||
124436874|NCT01242800|447560340|FG001|Overall Study|Patient refusal|10|||
124436875|NCT01242800|447560339|FG000|Overall Study|Physician Decision|0|||
124436876|NCT01242800|447560340|FG001|Overall Study|Physician Decision|1|||
124436877|NCT01242800|447560339|FG000|Overall Study|Disease progression|0|||
124436878|NCT01242800|447560340|FG001|Overall Study|Disease progression|3|||
124436879|NCT01242800|447560339|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
124436880|NCT01242800|447560340|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
124436881|NCT01242800|447560339|FG000|Overall Study|Reasons not reported|0|||
124436882|NCT01242800|447560340|FG001|Overall Study|Reasons not reported|4|||
124436883|NCT00953745|447560341|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
124436884|NCT00953745|447560342|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
124436885|NCT00953745|447560341|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
124436886|NCT00953745|447560342|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
124436887|NCT00953745|447560341|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
124436888|NCT00953745|447560342|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
124436889|NCT00953745|447560341|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
124436890|NCT00953745|447560342|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
124436891|NCT00953745|447560341|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
124436892|NCT00953745|447560342|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
124436893|NCT00953745|447560341|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
124436894|NCT00953745|447560342|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
124679392|NCT01232283|448449710|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
124436895|NCT01395888|447560345|FG000|2-week Run-in Period|Adverse Event|2|||
124436896|NCT01395888|447560346|FG001|2-week Run-in Period|Adverse Event|0|||
124436897|NCT01395888|447560347|FG002|2-week Run-in Period|Adverse Event|0|||
124436898|NCT01395888|447560345|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
124436899|NCT01395888|447560346|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
124679393|NCT01232283|448449711|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
124436900|NCT01395888|447560347|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
124436901|NCT01395888|447560345|FG000|2-week Run-in Period|Lost to Follow-up|1|||
124436902|NCT01395888|447560346|FG001|2-week Run-in Period|Lost to Follow-up|0|||
124436903|NCT01395888|447560347|FG002|2-week Run-in Period|Lost to Follow-up|0|||
124436904|NCT01395888|447560345|FG000|2-week Run-in Period|Protocol Violation|2|||
124436905|NCT01395888|447560346|FG001|2-week Run-in Period|Protocol Violation|0|||
124436906|NCT01395888|447560347|FG002|2-week Run-in Period|Protocol Violation|0|||
124436907|NCT01395888|447560345|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
124436908|NCT01395888|447560346|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
124436909|NCT01395888|447560347|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
124436910|NCT01395888|447560345|FG000|Treatment Period (TP)|Adverse Event|0|||
124436911|NCT01395888|447560346|FG001|Treatment Period (TP)|Adverse Event|7|||
124436912|NCT01395888|447560347|FG002|Treatment Period (TP)|Adverse Event|6|||
124436913|NCT01395888|447560345|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
124436914|NCT01395888|447560346|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
124436915|NCT01395888|447560347|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
124436916|NCT01395888|447560345|FG000|Treatment Period (TP)|Protocol Violation|0|||
124436917|NCT01395888|447560346|FG001|Treatment Period (TP)|Protocol Violation|1|||
124436918|NCT01395888|447560347|FG002|Treatment Period (TP)|Protocol Violation|5|||
124436919|NCT01395888|447560345|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
124436920|NCT01395888|447560346|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
124436921|NCT01395888|447560347|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
124436922|NCT01395888|447560345|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
124436923|NCT01395888|447560346|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
124436924|NCT01395888|447560347|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
124436925|NCT01679405|447560350|FG000|Overall Study|Death|2|||
124436926|NCT01679405|447560351|FG001|Overall Study|Death|5|||
124436927|NCT00126503|447560352|FG000|Overall Study|disease progression|23|||
124436928|NCT00126503|447560353|FG001|Overall Study|disease progression|14|||
124436929|NCT00126503|447560352|FG000|Overall Study|Withdrawal by Subject|0|||
124436930|NCT00126503|447560353|FG001|Overall Study|Withdrawal by Subject|1|||
124436931|NCT00126503|447560352|FG000|Overall Study|alternative therapy|1|||
124436932|NCT00126503|447560353|FG001|Overall Study|alternative therapy|1|||
124436933|NCT00126503|447560352|FG000|Overall Study|other complicating disease|4|||
124436934|NCT00126503|447560353|FG001|Overall Study|other complicating disease|1|||
124436935|NCT00126503|447560352|FG000|Overall Study|Death|3|||
124436936|NCT00126503|447560353|FG001|Overall Study|Death|0|||
124436937|NCT00126503|447560352|FG000|Overall Study|Adverse Event|13|||
124436938|NCT00126503|447560353|FG001|Overall Study|Adverse Event|3|||
124436939|NCT00126503|447560352|FG000|Overall Study|non-compliant|1|||
124436940|NCT00126503|447560353|FG001|Overall Study|non-compliant|0|||
124436941|NCT00126503|447560352|FG000|Overall Study|Physician Decision|2|||
124436942|NCT00126503|447560353|FG001|Overall Study|Physician Decision|1|||
124436943|NCT02457559|447560355|FG000|Overall Study|Progressive Disease|1|||
124436944|NCT02457559|447560356|FG001|Overall Study|Progressive Disease|2|||
124436945|NCT02457559|447560357|FG002|Overall Study|Progressive Disease|3|||
124436946|NCT02457559|447560358|FG003|Overall Study|Progressive Disease|0|||
124436947|NCT02457559|447560359|FG004|Overall Study|Progressive Disease|0|||
124436948|NCT02457559|447560360|FG005|Overall Study|Progressive Disease|2|||
124436949|NCT02457559|447560361|FG006|Overall Study|Progressive Disease|1|||
124436950|NCT02457559|447560362|FG007|Overall Study|Progressive Disease|0|||
124436951|NCT02457559|447560363|FG008|Overall Study|Progressive Disease|1|||
124436952|NCT02457559|447560364|FG009|Overall Study|Progressive Disease|1|||
124436953|NCT02457559|447560365|FG010|Overall Study|Progressive Disease|1|||
124436954|NCT02457559|447560355|FG000|Overall Study|Investigator's Discretion|0|||
124436955|NCT02457559|447560356|FG001|Overall Study|Investigator's Discretion|0|||
124436956|NCT02457559|447560357|FG002|Overall Study|Investigator's Discretion|2|||
124436957|NCT02457559|447560358|FG003|Overall Study|Investigator's Discretion|0|||
124436958|NCT02457559|447560359|FG004|Overall Study|Investigator's Discretion|1|||
124436959|NCT02457559|447560360|FG005|Overall Study|Investigator's Discretion|0|||
124436960|NCT02457559|447560361|FG006|Overall Study|Investigator's Discretion|1|||
124436961|NCT02457559|447560362|FG007|Overall Study|Investigator's Discretion|0|||
124436962|NCT02457559|447560363|FG008|Overall Study|Investigator's Discretion|1|||
124436963|NCT02457559|447560364|FG009|Overall Study|Investigator's Discretion|0|||
124436964|NCT02457559|447560365|FG010|Overall Study|Investigator's Discretion|1|||
124436965|NCT02457559|447560355|FG000|Overall Study|Adverse Event|0|||
124436966|NCT02457559|447560356|FG001|Overall Study|Adverse Event|1|||
124436967|NCT02457559|447560357|FG002|Overall Study|Adverse Event|2|||
124436968|NCT02457559|447560358|FG003|Overall Study|Adverse Event|0|||
124436969|NCT02457559|447560359|FG004|Overall Study|Adverse Event|0|||
124436970|NCT02457559|447560360|FG005|Overall Study|Adverse Event|0|||
124436971|NCT02457559|447560361|FG006|Overall Study|Adverse Event|0|||
124436972|NCT02457559|447560362|FG007|Overall Study|Adverse Event|0|||
124436973|NCT02457559|447560363|FG008|Overall Study|Adverse Event|0|||
124436974|NCT02457559|447560364|FG009|Overall Study|Adverse Event|0|||
124436975|NCT02457559|447560365|FG010|Overall Study|Adverse Event|0|||
124436976|NCT02457559|447560355|FG000|Overall Study|Reason not Specified|1|||
124878658|NCT02508532|449179288|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
124878659|NCT02508532|449179289|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
124878660|NCT02508532|449179281|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
124878661|NCT02508532|449179282|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
124878662|NCT02508532|449179283|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
124878663|NCT02508532|449179284|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
124878664|NCT02508532|449179285|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
124878665|NCT02508532|449179286|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
124878666|NCT02508532|449179287|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
124878667|NCT02508532|449179288|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
124878668|NCT02508532|449179289|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
124878669|NCT03097861|449179290|FG000|Overall Study|Adverse Event|3|||
124878670|NCT03097861|449179291|FG001|Overall Study|Adverse Event|8|||
124878671|NCT03097861|449179292|FG002|Overall Study|Adverse Event|4|||
124878672|NCT03097861|449179290|FG000|Overall Study|Investigator Decision|0|||
124878673|NCT03097861|449179291|FG001|Overall Study|Investigator Decision|1|||
124878674|NCT03097861|449179292|FG002|Overall Study|Investigator Decision|0|||
124878675|NCT03097861|449179290|FG000|Overall Study|Lost to Follow-up|0|||
124878676|NCT03097861|449179291|FG001|Overall Study|Lost to Follow-up|7|||
124878677|NCT03097861|449179292|FG002|Overall Study|Lost to Follow-up|1|||
124878678|NCT03097861|449179290|FG000|Overall Study|Withdrawal by Subject|1|||
124878679|NCT03097861|449179291|FG001|Overall Study|Withdrawal by Subject|5|||
124878680|NCT03097861|449179292|FG002|Overall Study|Withdrawal by Subject|3|||
124878681|NCT03097861|449179290|FG000|Overall Study|Reason not provided|3|||
124878682|NCT03097861|449179291|FG001|Overall Study|Reason not provided|1|||
124878683|NCT03097861|449179292|FG002|Overall Study|Reason not provided|1|||
124878684|NCT02281760|449179293|FG000|Overall Study|Withdrawal by Subject|1|||
124878685|NCT01576367|449179294|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124878686|NCT01576367|449179294|FG000|Overall Study|Moved to commercial use after 6 months|1|||
124878687|NCT00954733|449179298|FG000|Overall Study|blood gas machine did not work|1|||
124878688|NCT03592277|449179299|FG000|Overall Study|Withdrawal by Subject|6|||
124878689|NCT03592277|449179300|FG001|Overall Study|Withdrawal by Subject|8|||
124878690|NCT03528174|449179301|FG000|Overall Study|Adverse Event|1|||
124878691|NCT03528174|449179301|FG000|Overall Study|sensors dislodged|1|||
124878692|NCT03002038|449179302|FG000|Overall Study|Adverse Event|3|||
124878693|NCT03002038|449179303|FG001|Overall Study|Adverse Event|1|||
124878694|NCT03002038|449179302|FG000|Overall Study|Withdrawal by Subject|8|||
124878695|NCT03002038|449179303|FG001|Overall Study|Withdrawal by Subject|4|||
124878696|NCT03002038|449179302|FG000|Overall Study|Immigration to another region|0|||
124878697|NCT03002038|449179303|FG001|Overall Study|Immigration to another region|2|||
124878698|NCT01719237|449179311|FG000|Overall Study|Physician Decision|0|||
124878699|NCT01719237|449179312|FG001|Overall Study|Physician Decision|1|||
124878700|NCT02712398|449179313|FG000|Overall Study|Withdrawal by Subject|6|||
124878701|NCT02712398|449179313|FG000|Overall Study|Lost to Follow-up|6|||
124878702|NCT02712398|449179313|FG000|Overall Study|Sponsor Decision|1|||
124878703|NCT02712398|449179313|FG000|Overall Study|Physician Decision|1|||
124878704|NCT02712398|449179313|FG000|Overall Study|Death|2|||
124878705|NCT02712398|449179313|FG000|Overall Study|Re-operation|21|||
124878706|NCT01725386|449179315|FG000|Overall Study|Death|84|||
124878707|NCT01725386|449179316|FG001|Overall Study|Death|40|||
124878708|NCT01725386|449179315|FG000|Overall Study|Lost to Follow-up|81|||
124878709|NCT01725386|449179316|FG001|Overall Study|Lost to Follow-up|6|||
124878710|NCT01725386|449179315|FG000|Overall Study|Withdrawal by Subject|10|||
124878711|NCT01725386|449179316|FG001|Overall Study|Withdrawal by Subject|0|||
124878712|NCT03812536|449179321|FG000|Overall Study|Protocol Violation|2|||
124878713|NCT03812536|449179322|FG001|Overall Study|Protocol Violation|0|||
124878714|NCT03812536|449179321|FG000|Overall Study|Withdrawal by Subject|1|||
124878715|NCT03812536|449179322|FG001|Overall Study|Withdrawal by Subject|1|||
124878716|NCT02914314|449179323|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
124878717|NCT02914314|449179324|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
124878718|NCT02914314|449179325|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
124878719|NCT02914314|449179326|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
124679394|NCT01232283|448449712|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
124679395|NCT01232283|448449713|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
124679396|NCT01232283|448449714|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
124679397|NCT01232283|448449715|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
124679398|NCT01232283|448449706|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
124679399|NCT01232283|448449707|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
124679400|NCT01232283|448449708|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
124679401|NCT01232283|448449709|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
124679402|NCT01232283|448449710|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
124679403|NCT01232283|448449711|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
124679404|NCT01232283|448449712|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
124436977|NCT02457559|447560356|FG001|Overall Study|Reason not Specified|0|||
124436978|NCT02457559|447560357|FG002|Overall Study|Reason not Specified|0|||
124436979|NCT02457559|447560358|FG003|Overall Study|Reason not Specified|0|||
124436980|NCT02457559|447560359|FG004|Overall Study|Reason not Specified|0|||
124436981|NCT02457559|447560360|FG005|Overall Study|Reason not Specified|0|||
124436982|NCT02457559|447560361|FG006|Overall Study|Reason not Specified|0|||
124436983|NCT02457559|447560362|FG007|Overall Study|Reason not Specified|0|||
124436984|NCT02457559|447560363|FG008|Overall Study|Reason not Specified|0|||
124436985|NCT02457559|447560364|FG009|Overall Study|Reason not Specified|2|||
124436986|NCT02457559|447560365|FG010|Overall Study|Reason not Specified|0|||
124436987|NCT02457559|447560355|FG000|Overall Study|Death|0|||
124436988|NCT02457559|447560356|FG001|Overall Study|Death|0|||
124436989|NCT02457559|447560357|FG002|Overall Study|Death|0|||
124436990|NCT02457559|447560358|FG003|Overall Study|Death|0|||
124436991|NCT02457559|447560359|FG004|Overall Study|Death|0|||
124436992|NCT02457559|447560360|FG005|Overall Study|Death|0|||
124436993|NCT02457559|447560361|FG006|Overall Study|Death|0|||
124436994|NCT02457559|447560362|FG007|Overall Study|Death|0|||
124436995|NCT02457559|447560363|FG008|Overall Study|Death|1|||
124436996|NCT02457559|447560364|FG009|Overall Study|Death|1|||
124436997|NCT02457559|447560365|FG010|Overall Study|Death|0|||
124436998|NCT00998335|447560370|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
124436999|NCT00998335|447560371|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
124437000|NCT03169101|447560373|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
124437001|NCT03169101|447560374|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
124437002|NCT03169101|447560375|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
124437003|NCT03169101|447560376|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
124437004|NCT02641496|447560379|FG000|Overall Study|Lost to Follow-up|13|||
124437005|NCT02641496|447560380|FG001|Overall Study|Lost to Follow-up|12|||
124437006|NCT02641496|447560379|FG000|Overall Study|Withdrawal by Subject|1|||
124437007|NCT02641496|447560380|FG001|Overall Study|Withdrawal by Subject|0|||
124437008|NCT03075410|447560381|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
124437009|NCT03075410|447560382|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
124437010|NCT03075410|447560383|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
124437011|NCT03075410|447560384|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
124437012|NCT03075410|447560385|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
124437013|NCT03075410|447560386|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
124437014|NCT03075410|447560387|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
124437015|NCT03075410|447560388|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
124437016|NCT03075410|447560389|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
124437017|NCT03075410|447560381|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
124437018|NCT03075410|447560382|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
124437019|NCT03075410|447560383|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
124437020|NCT03075410|447560384|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
124437021|NCT03075410|447560385|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
124437022|NCT03075410|447560386|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
124437023|NCT03075410|447560387|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
124437024|NCT03075410|447560388|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
124679405|NCT01232283|448449713|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
124878720|NCT02914314|449179323|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
124878721|NCT02914314|449179324|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
124878722|NCT02914314|449179325|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
124878723|NCT02914314|449179326|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
124878724|NCT02914314|449179323|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
124878725|NCT02914314|449179324|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
124878726|NCT02914314|449179325|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
124878727|NCT02914314|449179326|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
124878728|NCT02914314|449179323|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
124878729|NCT02914314|449179324|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
124878730|NCT02914314|449179325|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
124878731|NCT02914314|449179326|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
124878732|NCT02914314|449179323|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
124878733|NCT02914314|449179324|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
124878734|NCT02914314|449179325|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
124878735|NCT02914314|449179326|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
124878736|NCT01306201|449179329|FG000|Overall Study|Arrhythmia|4|||
124878737|NCT01306201|449179329|FG000|Overall Study|Files could not be processed|3|||
124878738|NCT01306201|449179329|FG000|Overall Study|Files unreadable|3|||
124878739|NCT04702568|449179330|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
124878740|NCT04702568|449179331|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
124878741|NCT04702568|449179330|FG000|Overall Study|Pregnancy|1|||
124878742|NCT04702568|449179331|FG001|Overall Study|Pregnancy|0|||
124878743|NCT04702568|449179330|FG000|Overall Study|Bone marrow transplant|1|||
124878744|NCT04702568|449179331|FG001|Overall Study|Bone marrow transplant|0|||
124878745|NCT04702568|449179330|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
124878746|NCT04702568|449179331|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
124878747|NCT04702568|449179330|FG000|Overall Study|Withdrawal by Subject|0|||
124878748|NCT04702568|449179331|FG001|Overall Study|Withdrawal by Subject|2|||
124878749|NCT04599101|449179336|FG000|Overall Study|Lost to Follow-up|5|||
124878750|NCT04599101|449179337|FG001|Overall Study|Lost to Follow-up|5|||
124878751|NCT00098254|449179340|FG000|Overall Study|Adverse Event|2|||
124878752|NCT00098254|449179340|FG000|Overall Study|Death|1|||
124878753|NCT04146896|449179341|FG000|Overall Study|Adverse Event|5|||
124878754|NCT04146896|449179342|FG001|Overall Study|Adverse Event|8|||
124878755|NCT04146896|449179341|FG000|Overall Study|Lack of Efficacy|3|||
124878756|NCT04146896|449179342|FG001|Overall Study|Lack of Efficacy|2|||
124878757|NCT04146896|449179341|FG000|Overall Study|Lost to Follow-up|0|||
124878758|NCT04146896|449179342|FG001|Overall Study|Lost to Follow-up|1|||
124878759|NCT04146896|449179341|FG000|Overall Study|Non-compliance|5|||
124878760|NCT04146896|449179342|FG001|Overall Study|Non-compliance|4|||
124878761|NCT04146896|449179341|FG000|Overall Study|Withdrawal by Subject|3|||
124878762|NCT04146896|449179342|FG001|Overall Study|Withdrawal by Subject|5|||
124878763|NCT04146896|449179341|FG000|Overall Study|Randomized in error|1|||
124878764|NCT04146896|449179342|FG001|Overall Study|Randomized in error|2|||
124878765|NCT02118337|449179343|FG000|Overall Study|Other|1|||
124878766|NCT02118337|449179344|FG001|Overall Study|Other|0|||
124878767|NCT02118337|449179345|FG002|Overall Study|Other|0|||
124878768|NCT02118337|449179346|FG003|Overall Study|Other|0|||
124878769|NCT02118337|449179347|FG004|Overall Study|Other|2|||
124878770|NCT02118337|449179348|FG005|Overall Study|Other|3|||
124878771|NCT02118337|449179349|FG006|Overall Study|Other|1|||
124878772|NCT02118337|449179350|FG007|Overall Study|Other|28|||
124878773|NCT02118337|449179351|FG008|Overall Study|Other|15|||
124878774|NCT02118337|449179343|FG000|Overall Study|Lost to Follow-up|0|||
124437025|NCT03075410|447560389|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
124437026|NCT00790751|447560392|FG000|Overall Study|Protocol non-compliance|16|||
124437027|NCT00790751|447560393|FG001|Overall Study|Protocol non-compliance|16|||
124437028|NCT00790751|447560394|FG002|Overall Study|Protocol non-compliance|10|||
124878775|NCT02118337|449179344|FG001|Overall Study|Lost to Follow-up|0|||
124878776|NCT02118337|449179345|FG002|Overall Study|Lost to Follow-up|0|||
124878777|NCT02118337|449179346|FG003|Overall Study|Lost to Follow-up|0|||
124878778|NCT02118337|449179347|FG004|Overall Study|Lost to Follow-up|0|||
124878779|NCT02118337|449179348|FG005|Overall Study|Lost to Follow-up|0|||
124878780|NCT02118337|449179349|FG006|Overall Study|Lost to Follow-up|0|||
124878781|NCT02118337|449179350|FG007|Overall Study|Lost to Follow-up|1|||
124878782|NCT02118337|449179351|FG008|Overall Study|Lost to Follow-up|0|||
124878783|NCT02118337|449179343|FG000|Overall Study|Withdrawal by Subject|1|||
124878784|NCT02118337|449179344|FG001|Overall Study|Withdrawal by Subject|3|||
124437029|NCT00790751|447560395|FG003|Overall Study|Protocol non-compliance|11|||
124878785|NCT02118337|449179345|FG002|Overall Study|Withdrawal by Subject|2|||
124878786|NCT02118337|449179346|FG003|Overall Study|Withdrawal by Subject|1|||
124878787|NCT02118337|449179347|FG004|Overall Study|Withdrawal by Subject|2|||
124878788|NCT02118337|449179348|FG005|Overall Study|Withdrawal by Subject|2|||
124878789|NCT02118337|449179349|FG006|Overall Study|Withdrawal by Subject|1|||
124878790|NCT02118337|449179350|FG007|Overall Study|Withdrawal by Subject|4|||
124878791|NCT02118337|449179351|FG008|Overall Study|Withdrawal by Subject|2|||
124437030|NCT00790751|447560392|FG000|Overall Study|Lost to Follow-up|4|||
124679406|NCT01232283|448449714|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
124679407|NCT01232283|448449715|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
124679408|NCT01232283|448449706|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
124679409|NCT01232283|448449707|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
124679410|NCT01232283|448449708|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
124679411|NCT01232283|448449709|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
124679412|NCT01232283|448449710|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
124679413|NCT01232283|448449711|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
124679414|NCT01232283|448449712|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
124679415|NCT01232283|448449713|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
124679416|NCT01232283|448449714|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
124679417|NCT01232283|448449715|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
124679418|NCT01232283|448449706|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
124679419|NCT01232283|448449707|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
124679420|NCT01232283|448449708|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
124679421|NCT01232283|448449709|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
124679422|NCT01232283|448449710|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
124679423|NCT01232283|448449711|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
124679424|NCT01232283|448449712|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
124679425|NCT01232283|448449713|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
124679426|NCT01232283|448449714|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
124679427|NCT01232283|448449715|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
124679428|NCT01232283|448449706|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
124679429|NCT01232283|448449707|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
124679430|NCT01232283|448449708|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
124679431|NCT01232283|448449709|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
124679432|NCT01232283|448449710|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
124679433|NCT01232283|448449711|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
124679434|NCT01232283|448449712|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
124679435|NCT01232283|448449713|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
124679436|NCT01232283|448449714|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
124679437|NCT01232283|448449715|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
124679438|NCT01232283|448449706|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
124679439|NCT01232283|448449707|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
124679440|NCT01232283|448449708|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
124679441|NCT01232283|448449709|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
124679442|NCT01232283|448449710|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
124679443|NCT01232283|448449711|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
124679444|NCT01232283|448449712|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
124679445|NCT01232283|448449713|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
124679446|NCT01232283|448449714|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
124679447|NCT01232283|448449715|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
124679448|NCT01232283|448449706|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
124679449|NCT01232283|448449707|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
124679450|NCT01232283|448449708|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
124679451|NCT01232283|448449709|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
124679452|NCT01232283|448449710|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
124679453|NCT01232283|448449711|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
124878792|NCT02118337|449179343|FG000|Overall Study|Death|2|||
124878793|NCT02118337|449179344|FG001|Overall Study|Death|2|||
124878794|NCT02118337|449179345|FG002|Overall Study|Death|1|||
124878795|NCT02118337|449179346|FG003|Overall Study|Death|2|||
124878796|NCT02118337|449179347|FG004|Overall Study|Death|5|||
124878797|NCT02118337|449179348|FG005|Overall Study|Death|1|||
124878798|NCT02118337|449179349|FG006|Overall Study|Death|2|||
124878799|NCT02118337|449179350|FG007|Overall Study|Death|9|||
124878800|NCT02118337|449179351|FG008|Overall Study|Death|4|||
124878801|NCT01515189|449179353|FG000|Induction|Disease Progression|109|||
124878802|NCT01515189|449179354|FG001|Induction|Disease Progression|155|||
124878803|NCT01515189|449179353|FG000|Induction|Study drug toxicity|86|||
124878804|NCT01515189|449179354|FG001|Induction|Study drug toxicity|36|||
124878805|NCT01515189|449179353|FG000|Induction|Death|24|||
124878806|NCT01515189|449179354|FG001|Induction|Death|17|||
124878807|NCT01515189|449179353|FG000|Induction|Adverse Event|14|||
124878808|NCT01515189|449179354|FG001|Induction|Adverse Event|9|||
124878809|NCT01515189|449179353|FG000|Induction|Withdrawal by Subject|3|||
124878810|NCT01515189|449179354|FG001|Induction|Withdrawal by Subject|9|||
124878811|NCT01515189|449179353|FG000|Induction|No longer meets study criteria|0|||
124878812|NCT01515189|449179354|FG001|Induction|No longer meets study criteria|2|||
124878813|NCT01515189|449179353|FG000|Induction|Lost to Follow-up|1|||
124878814|NCT01515189|449179354|FG001|Induction|Lost to Follow-up|0|||
124878815|NCT01515189|449179353|FG000|Induction|Other|0|||
124878816|NCT01515189|449179354|FG001|Induction|Other|4|||
124878817|NCT01515189|449179353|FG000|First Re-Induction Phase|Disease progression|6|||
124878818|NCT01515189|449179354|FG001|First Re-Induction Phase|Disease progression|14|||
124878819|NCT01515189|449179353|FG000|First Re-Induction Phase|Study drug toxicity|5|||
124878820|NCT01515189|449179354|FG001|First Re-Induction Phase|Study drug toxicity|0|||
124878821|NCT01515189|449179353|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
124878822|NCT01515189|449179354|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
124878823|NCT01515189|449179353|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
124878824|NCT01515189|449179354|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
124878825|NCT01515189|449179353|FG000|First Re-Induction Phase|Other|1|||
124878826|NCT01515189|449179354|FG001|First Re-Induction Phase|Other|0|||
124878827|NCT01126060|449179355|FG000|Overall Study|Protocol Violation|0|||
124878828|NCT01126060|449179356|FG001|Overall Study|Protocol Violation|2|||
124878829|NCT04838613|449179358|FG000|Overall Study|Withdrawal by Subject|3|||
124878830|NCT04838613|449179359|FG001|Overall Study|Withdrawal by Subject|6|||
124878831|NCT04838613|449179358|FG000|Overall Study|Protocol Deviation|3|||
124878832|NCT04838613|449179359|FG001|Overall Study|Protocol Deviation|2|||
124878833|NCT04838613|449179358|FG000|Overall Study|Technical Problems|0|||
124878834|NCT04838613|449179359|FG001|Overall Study|Technical Problems|5|||
124878835|NCT04838613|449179358|FG000|Overall Study|Physician Decision|2|||
124878836|NCT04838613|449179359|FG001|Overall Study|Physician Decision|0|||
124878837|NCT01686581|449179360|FG000|Overall Study|Side-effects or Health Problems|15|||
124878838|NCT01686581|449179360|FG000|Overall Study|Lack of Efficacy|90|||
124878839|NCT01686581|449179360|FG000|Overall Study|Participant Concerned about Risks|6|||
124878840|NCT01686581|449179360|FG000|Overall Study|Thinks Injections Too Painful|8|||
124878841|NCT01686581|449179360|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
124878842|NCT01686581|449179360|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
124878843|NCT01686581|449179360|FG000|Overall Study|Thinks it is Inconvenient|17|||
124878844|NCT01686581|449179360|FG000|Overall Study|Other Miscellaneous Reasons|36|||
124878845|NCT01686581|449179360|FG000|Overall Study|Reason Missing|1|||
124878846|NCT02217280|449179363|FG000|Overall Study|Withdrawal by Subject|2|||
124878847|NCT02217280|449179363|FG000|Overall Study|Post-consent sceen fail|2|||
124878848|NCT00736489|449179366|FG000|Period 1|Lost to Follow-up|1|||
124878849|NCT00736489|449179367|FG001|Period 1|Lost to Follow-up|0|||
124878850|NCT00736489|449179368|FG002|Period 1|Lost to Follow-up|0|||
124878851|NCT00736489|449179369|FG003|Period 1|Lost to Follow-up|0|||
124878852|NCT00736489|449179370|FG004|Period 1|Lost to Follow-up|0|||
124878853|NCT00736489|449179371|FG005|Period 1|Lost to Follow-up|0|||
124878854|NCT00736489|449179366|FG000|Period 1|Withdrawal by Subject|0|||
124878855|NCT00736489|449179367|FG001|Period 1|Withdrawal by Subject|0|||
124878856|NCT00736489|449179368|FG002|Period 1|Withdrawal by Subject|0|||
124878857|NCT00736489|449179369|FG003|Period 1|Withdrawal by Subject|0|||
124878858|NCT00736489|449179370|FG004|Period 1|Withdrawal by Subject|0|||
124878859|NCT00736489|449179371|FG005|Period 1|Withdrawal by Subject|1|||
124878860|NCT01933880|449179372|FG000|Overall Study|Withdrawal by Subject|5|||
124878861|NCT01933880|449179373|FG001|Overall Study|Withdrawal by Subject|0|||
124878862|NCT01933880|449179372|FG000|Overall Study|Lack of Efficacy|1|||
124878863|NCT01933880|449179373|FG001|Overall Study|Lack of Efficacy|0|||
124878864|NCT01933880|449179372|FG000|Overall Study|Concomitant medication Interference|0|||
124878865|NCT01933880|449179373|FG001|Overall Study|Concomitant medication Interference|1|||
124878866|NCT01933880|449179372|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
124878867|NCT01933880|449179373|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
124878868|NCT01933880|449179372|FG000|Overall Study|Other|4|||
124878869|NCT01933880|449179373|FG001|Overall Study|Other|0|||
124878870|NCT01933880|449179372|FG000|Overall Study|Protocol Violation|1|||
124878871|NCT01933880|449179373|FG001|Overall Study|Protocol Violation|0|||
124878872|NCT02395133|449179374|FG000|Overall Study|Adverse Event|4|||
124878873|NCT02395133|449179375|FG001|Overall Study|Adverse Event|1|||
124878874|NCT02395133|449179376|FG002|Overall Study|Adverse Event|3|||
124878875|NCT02395133|449179377|FG003|Overall Study|Adverse Event|0|||
124878876|NCT02395133|449179374|FG000|Overall Study|Lack of Efficacy|1|||
124878877|NCT02395133|449179375|FG001|Overall Study|Lack of Efficacy|0|||
124878878|NCT02395133|449179376|FG002|Overall Study|Lack of Efficacy|1|||
124878879|NCT02395133|449179377|FG003|Overall Study|Lack of Efficacy|1|||
124878880|NCT02395133|449179374|FG000|Overall Study|Protocol Violation|1|||
124878881|NCT02395133|449179375|FG001|Overall Study|Protocol Violation|1|||
124878882|NCT02395133|449179376|FG002|Overall Study|Protocol Violation|0|||
124878883|NCT02395133|449179377|FG003|Overall Study|Protocol Violation|3|||
124878884|NCT02395133|449179374|FG000|Overall Study|Lost to Follow-up|0|||
124878885|NCT02395133|449179375|FG001|Overall Study|Lost to Follow-up|1|||
124878886|NCT02395133|449179376|FG002|Overall Study|Lost to Follow-up|1|||
124878887|NCT02395133|449179377|FG003|Overall Study|Lost to Follow-up|0|||
124878888|NCT02395133|449179374|FG000|Overall Study|Pregnancy|0|||
124878889|NCT02395133|449179375|FG001|Overall Study|Pregnancy|0|||
124878890|NCT02395133|449179376|FG002|Overall Study|Pregnancy|3|||
124878891|NCT02395133|449179377|FG003|Overall Study|Pregnancy|0|||
124878892|NCT02395133|449179374|FG000|Overall Study|Consent withdrawn with no reason given|1|||
124878893|NCT02395133|449179375|FG001|Overall Study|Consent withdrawn with no reason given|3|||
124878894|NCT02395133|449179376|FG002|Overall Study|Consent withdrawn with no reason given|0|||
124878895|NCT02395133|449179377|FG003|Overall Study|Consent withdrawn with no reason given|2|||
124878896|NCT02395133|449179374|FG000|Overall Study|Consent withdrawn with personal reason|0|||
124878897|NCT02395133|449179375|FG001|Overall Study|Consent withdrawn with personal reason|1|||
124878898|NCT02395133|449179376|FG002|Overall Study|Consent withdrawn with personal reason|0|||
124878899|NCT02395133|449179377|FG003|Overall Study|Consent withdrawn with personal reason|3|||
124878900|NCT02395133|449179374|FG000|Overall Study|Sponsor decision|2|||
124878901|NCT02395133|449179375|FG001|Overall Study|Sponsor decision|0|||
124878902|NCT02395133|449179376|FG002|Overall Study|Sponsor decision|0|||
124878903|NCT02395133|449179377|FG003|Overall Study|Sponsor decision|1|||
124878904|NCT02395133|449179374|FG000|Overall Study|Other than specified above|5|||
124878905|NCT02395133|449179375|FG001|Overall Study|Other than specified above|2|||
124878906|NCT02395133|449179376|FG002|Overall Study|Other than specified above|2|||
124878907|NCT02395133|449179377|FG003|Overall Study|Other than specified above|4|||
124878908|NCT00962247|449179378|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
124878909|NCT00962247|449179378|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
124878910|NCT02234063|449179379|FG000|Overall Study|Lost to Follow-up|235|||
124878911|NCT02234063|449179380|FG001|Overall Study|Lost to Follow-up|42|||
124878912|NCT02234063|449179379|FG000|Overall Study|Withdrawal by Subject|20|||
124878913|NCT02234063|449179380|FG001|Overall Study|Withdrawal by Subject|1|||
124878914|NCT02946918|449179381|FG000|Overall Study|Patient unblinded himself|1|||
124878915|NCT02946918|449179382|FG001|Overall Study|Patient unblinded himself|0|||
124878916|NCT02946918|449179381|FG000|Overall Study|Physician Decision|0|||
124878917|NCT02946918|449179382|FG001|Overall Study|Physician Decision|2|||
124878918|NCT02946918|449179381|FG000|Overall Study|Ran out of study medication|0|||
124878919|NCT02946918|449179382|FG001|Overall Study|Ran out of study medication|1|||
124878920|NCT01125722|449179383|FG000|Overall Study|Withdrawal by Subject|2|||
124878921|NCT01125722|449179384|FG001|Overall Study|Withdrawal by Subject|1|||
124878922|NCT01125722|449179383|FG000|Overall Study|Lost to Follow-up|1|||
124878923|NCT01125722|449179384|FG001|Overall Study|Lost to Follow-up|0|||
124878924|NCT00069784|449179385|FG000|Overall Study|Adverse Event|105|||
124878925|NCT00069784|449179386|FG001|Overall Study|Adverse Event|0|||
124878926|NCT00069784|449179385|FG000|Overall Study|Withdrawal by Subject|1090|||
124878927|NCT00069784|449179386|FG001|Overall Study|Withdrawal by Subject|0|||
124878928|NCT00069784|449179385|FG000|Overall Study|Other|17|||
124878929|NCT00069784|449179386|FG001|Overall Study|Other|0|||
124878930|NCT00709059|449179394|FG000|Overall Study|Lost to Follow-up|34|||
124878931|NCT00709059|449179394|FG000|Overall Study|Withdrawal by Subject|19|||
124878932|NCT00709059|449179394|FG000|Overall Study|Physician Decision|7|||
124878933|NCT00709059|449179394|FG000|Overall Study|Disease complication|3|||
124878934|NCT00709059|449179394|FG000|Overall Study|Side effects|20|||
124878935|NCT00709059|449179394|FG000|Overall Study|Serious side effects|11|||
124878936|NCT01786330|449179395|FG000|Overall Study|Withdrawal by Subject|0|||
124878937|NCT01786330|449179396|FG001|Overall Study|Withdrawal by Subject|1|||
124878938|NCT01786330|449179395|FG000|Overall Study|Lost to Follow-up|0|||
124878939|NCT01786330|449179396|FG001|Overall Study|Lost to Follow-up|1|||
124878940|NCT01786330|449179395|FG000|Overall Study|Excluded intraoperatively|0|||
124878941|NCT01786330|449179396|FG001|Overall Study|Excluded intraoperatively|1|||
124878942|NCT01786330|449179395|FG000|Overall Study|Protocol Violation|1|||
124878943|NCT01786330|449179396|FG001|Overall Study|Protocol Violation|0|||
124878944|NCT02172625|449179397|FG000|Overall Study|Adverse Event|0|||
124878945|NCT02172625|449179398|FG001|Overall Study|Adverse Event|1|||
124878946|NCT02172625|449179397|FG000|Overall Study|Pregnancy|0|||
124878947|NCT02172625|449179398|FG001|Overall Study|Pregnancy|1|||
124878948|NCT02172625|449179397|FG000|Overall Study|car accident|0|||
124878949|NCT02172625|449179398|FG001|Overall Study|car accident|1|||
124878950|NCT00976703|449180940|FG000|Overall Study|Physician Decision|1|||
124878951|NCT00976703|449180941|FG001|Overall Study|Physician Decision|1|||
124878952|NCT00976703|449180940|FG000|Overall Study|ineligible for study|2|||
124878953|NCT00976703|449180941|FG001|Overall Study|ineligible for study|2|||
124878954|NCT00369681|449180944|FG000|Overall Study|Death|1|||
124878955|NCT03585296|449180948|FG000|Overall Study|Adverse Event|1|||
124878956|NCT03585296|449180948|FG000|Overall Study|Lost to Follow-up|2|||
124878957|NCT03585296|449180948|FG000|Overall Study|Withdrawal by Subject|2|||
124878958|NCT00462670|449180952|FG000|Overall Study|Adverse Event|3|||
124878959|NCT00462670|449180953|FG001|Overall Study|Adverse Event|5|||
124878960|NCT00462670|449180952|FG000|Overall Study|Lack of Efficacy|1|||
124878961|NCT00462670|449180953|FG001|Overall Study|Lack of Efficacy|0|||
124679454|NCT01232283|448449712|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
124437031|NCT00790751|447560393|FG001|Overall Study|Lost to Follow-up|9|||
124437032|NCT00790751|447560394|FG002|Overall Study|Lost to Follow-up|4|||
124679455|NCT01232283|448449713|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
124878962|NCT00462670|449180952|FG000|Overall Study|Protocol Violation|1|||
124878963|NCT00462670|449180953|FG001|Overall Study|Protocol Violation|0|||
124878964|NCT00462670|449180952|FG000|Overall Study|Resolution of signs and symptoms|0|||
124878965|NCT00462670|449180953|FG001|Overall Study|Resolution of signs and symptoms|2|||
124878966|NCT00633932|449180954|FG000|Overall Study|Adverse Event|1|||
124878967|NCT00633932|449180955|FG001|Overall Study|Adverse Event|3|||
124878968|NCT00633932|449180956|FG002|Overall Study|Adverse Event|4|||
124878969|NCT00633932|449180954|FG000|Overall Study|Withdrawal by Subject|3|||
124878970|NCT00633932|449180955|FG001|Overall Study|Withdrawal by Subject|9|||
124878971|NCT00633932|449180956|FG002|Overall Study|Withdrawal by Subject|1|||
124878972|NCT00633932|449180954|FG000|Overall Study|Lost to Follow-up|1|||
124878973|NCT00633932|449180955|FG001|Overall Study|Lost to Follow-up|0|||
124878974|NCT00633932|449180956|FG002|Overall Study|Lost to Follow-up|2|||
124878975|NCT00633932|449180954|FG000|Overall Study|Protocol Violation|5|||
124878976|NCT00633932|449180955|FG001|Overall Study|Protocol Violation|2|||
124878977|NCT00633932|449180956|FG002|Overall Study|Protocol Violation|3|||
124878978|NCT00633932|449180954|FG000|Overall Study|Physician Decision|0|||
124878979|NCT00633932|449180955|FG001|Overall Study|Physician Decision|0|||
124878980|NCT00633932|449180956|FG002|Overall Study|Physician Decision|1|||
124878981|NCT00633932|449180954|FG000|Overall Study|Doctor's judgement|1|||
124878982|NCT00633932|449180955|FG001|Overall Study|Doctor's judgement|0|||
124878983|NCT00633932|449180956|FG002|Overall Study|Doctor's judgement|0|||
124878984|NCT00633932|449180954|FG000|Overall Study|Moved Away|1|||
124878985|NCT00633932|449180955|FG001|Overall Study|Moved Away|0|||
124878986|NCT00633932|449180956|FG002|Overall Study|Moved Away|0|||
124878987|NCT00482274|449180958|FG000|Overall Study|Adverse Event|1|||
124878988|NCT02948959|449180959|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
124878989|NCT02948959|449180960|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
124878990|NCT02948959|449180959|FG000|52 Weeks Treatment Period|Adverse Event|2|||
124878991|NCT02948959|449180960|FG001|52 Weeks Treatment Period|Adverse Event|5|||
124878992|NCT02948959|449180959|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
124878993|NCT02948959|449180960|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
124878994|NCT02948959|449180959|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
124878995|NCT02948959|449180960|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
124878996|NCT02948959|449180959|FG000|52 Weeks Treatment Period|Randomized by error|0|||
124878997|NCT02948959|449180960|FG001|52 Weeks Treatment Period|Randomized by error|5|||
124878998|NCT02948959|449180959|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
124878999|NCT02948959|449180960|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
124879000|NCT02948959|449180959|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
124879001|NCT02948959|449180960|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
124879002|NCT02948959|449180959|FG000|52 Weeks Treatment Period|Change of residence location|0|||
124879003|NCT02948959|449180960|FG001|52 Weeks Treatment Period|Change of residence location|1|||
124879004|NCT02948959|449180959|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
124879005|NCT02948959|449180960|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
124879006|NCT02948959|449180959|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
124437033|NCT00790751|447560395|FG003|Overall Study|Lost to Follow-up|5|||
124437034|NCT00790751|447560392|FG000|Overall Study|Adverse Event|5|||
124437035|NCT00790751|447560393|FG001|Overall Study|Adverse Event|3|||
124437036|NCT00790751|447560394|FG002|Overall Study|Adverse Event|5|||
124437037|NCT00790751|447560395|FG003|Overall Study|Adverse Event|4|||
124437038|NCT00790751|447560392|FG000|Overall Study|Requirement for restricted medication|0|||
124437039|NCT00790751|447560393|FG001|Overall Study|Requirement for restricted medication|2|||
124437040|NCT00790751|447560394|FG002|Overall Study|Requirement for restricted medication|0|||
124437041|NCT00790751|447560395|FG003|Overall Study|Requirement for restricted medication|0|||
124437042|NCT00790751|447560392|FG000|Overall Study|Death|0|||
124437043|NCT00790751|447560393|FG001|Overall Study|Death|0|||
124437044|NCT00790751|447560394|FG002|Overall Study|Death|1|||
124437045|NCT00790751|447560395|FG003|Overall Study|Death|0|||
124437046|NCT00790751|447560392|FG000|Overall Study|Physician Decision|0|||
124437047|NCT00790751|447560393|FG001|Overall Study|Physician Decision|0|||
124437048|NCT00790751|447560394|FG002|Overall Study|Physician Decision|0|||
124437049|NCT00790751|447560395|FG003|Overall Study|Physician Decision|1|||
124437050|NCT00346268|447562358|FG000|Overall Study|Adverse Event|1|||
124437051|NCT00346268|447562359|FG001|Overall Study|Adverse Event|0|||
124437052|NCT00346268|447562358|FG000|Overall Study|Protocol Violation|1|||
124437053|NCT00346268|447562359|FG001|Overall Study|Protocol Violation|0|||
124437054|NCT00346268|447562358|FG000|Overall Study|Participant refused|0|||
124437055|NCT00346268|447562359|FG001|Overall Study|Participant refused|3|||
124437056|NCT00031551|447562360|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
124437057|NCT00031551|447562361|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
124437058|NCT00743275|447562362|FG000|Overall Study|Protocol Violation|0|||
124879007|NCT02948959|449180960|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
124879008|NCT02948959|449180959|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
124879009|NCT02948959|449180960|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
124879010|NCT02948959|449180959|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
124879011|NCT02948959|449180960|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
124879012|NCT02948959|449180959|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
124879013|NCT02948959|449180960|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
124879014|NCT02948959|449180959|FG000|12 Weeks Follow-up Period|Study site closure|1|||
124879015|NCT02948959|449180960|FG001|12 Weeks Follow-up Period|Study site closure|0|||
124879016|NCT00154310|449180965|FG000|Overall Study|Adverse Event|19|||
124879017|NCT00154310|449180966|FG001|Overall Study|Adverse Event|9|||
124437059|NCT00743275|447562363|FG001|Overall Study|Protocol Violation|1|||
124437060|NCT00477334|447562375|FG000|Overall Study|Discontinued prior to taking study drug|106|||
124437061|NCT00477334|447562376|FG001|Overall Study|Discontinued prior to taking study drug|53|||
124544383|NCT00948896|447946793|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
124879018|NCT00154310|449180965|FG000|Overall Study|Lack of Efficacy|5|||
124879019|NCT00154310|449180966|FG001|Overall Study|Lack of Efficacy|4|||
124879020|NCT00154310|449180965|FG000|Overall Study|Protocol Violation|4|||
124879021|NCT00154310|449180966|FG001|Overall Study|Protocol Violation|2|||
124879022|NCT00154310|449180965|FG000|Overall Study|Withdrawal by Subject|9|||
124879023|NCT00154310|449180966|FG001|Overall Study|Withdrawal by Subject|3|||
124879024|NCT00154310|449180965|FG000|Overall Study|Lost to Follow-up|0|||
124879025|NCT00154310|449180966|FG001|Overall Study|Lost to Follow-up|8|||
124879026|NCT00154310|449180965|FG000|Overall Study|Administrative problems|0|||
124879027|NCT00154310|449180966|FG001|Overall Study|Administrative problems|1|||
124879028|NCT00154310|449180965|FG000|Overall Study|Death|0|||
124879029|NCT00154310|449180966|FG001|Overall Study|Death|1|||
124879030|NCT01346514|449180971|FG000|Overall Study|Lost to Follow-up|19|||
124879031|NCT01346514|449180972|FG001|Overall Study|Lost to Follow-up|30|||
124879032|NCT01346514|449180971|FG000|Overall Study|Withdrawal by Subject|7|||
124879033|NCT01346514|449180972|FG001|Overall Study|Withdrawal by Subject|3|||
124879034|NCT01346514|449180971|FG000|Overall Study|Death|3|||
124879035|NCT01346514|449180972|FG001|Overall Study|Death|4|||
124879036|NCT01054573|449180983|FG000|Overall Study|Adverse Event|1|||
124879037|NCT01054573|449180984|FG001|Overall Study|Adverse Event|0|||
124879038|NCT01054573|449180985|FG002|Overall Study|Adverse Event|1|||
124879039|NCT01054573|449180986|FG003|Overall Study|Adverse Event|1|||
124879040|NCT01054573|449180983|FG000|Overall Study|Lost to Follow-up|0|||
124879041|NCT01054573|449180984|FG001|Overall Study|Lost to Follow-up|2|||
124879042|NCT01054573|449180985|FG002|Overall Study|Lost to Follow-up|0|||
124879043|NCT01054573|449180986|FG003|Overall Study|Lost to Follow-up|0|||
124879044|NCT01054573|449180983|FG000|Overall Study|Withdrawal by Subject|0|||
124879045|NCT01054573|449180984|FG001|Overall Study|Withdrawal by Subject|2|||
124879046|NCT01054573|449180985|FG002|Overall Study|Withdrawal by Subject|2|||
124879047|NCT01054573|449180986|FG003|Overall Study|Withdrawal by Subject|1|||
124879048|NCT00979602|449180987|FG000|Overall Study|Serious Adverse Event|5|||
124879049|NCT00979602|449180988|FG001|Overall Study|Serious Adverse Event|3|||
124879050|NCT00979602|449180987|FG000|Overall Study|Protocol Violation|3|||
124879051|NCT00979602|449180988|FG001|Overall Study|Protocol Violation|0|||
124879052|NCT00979602|449180987|FG000|Overall Study|Withdrawal by Subject|31|||
124879053|NCT00979602|449180988|FG001|Overall Study|Withdrawal by Subject|25|||
124879054|NCT00979602|449180987|FG000|Overall Study|Lost to Follow-up|100|||
124879055|NCT00979602|449180988|FG001|Overall Study|Lost to Follow-up|96|||
124879056|NCT00979602|449180987|FG000|Overall Study|Migrated/moved from study area|3|||
124879057|NCT00979602|449180988|FG001|Overall Study|Migrated/moved from study area|6|||
124879058|NCT00979602|449180987|FG000|Overall Study|Others|3|||
124879059|NCT00979602|449180988|FG001|Overall Study|Others|3|||
124879060|NCT00152009|449180989|FG000|Overall Study|Adverse Event|9|||
124879061|NCT00152009|449180990|FG001|Overall Study|Adverse Event|13|||
124879062|NCT00152009|449180991|FG002|Overall Study|Adverse Event|20|||
124879063|NCT00152009|449180992|FG003|Overall Study|Adverse Event|1|||
124879064|NCT00152009|449180989|FG000|Overall Study|Protocol Violation|3|||
124879065|NCT00152009|449180990|FG001|Overall Study|Protocol Violation|0|||
124879066|NCT00152009|449180991|FG002|Overall Study|Protocol Violation|0|||
124879067|NCT00152009|449180992|FG003|Overall Study|Protocol Violation|1|||
124679456|NCT01232283|448449714|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
124679457|NCT01232283|448449715|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
124879068|NCT00152009|449180989|FG000|Overall Study|Withdrawal by Subject|2|||
124879069|NCT00152009|449180990|FG001|Overall Study|Withdrawal by Subject|3|||
124679458|NCT01232283|448449706|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
124879070|NCT00152009|449180991|FG002|Overall Study|Withdrawal by Subject|4|||
124879071|NCT00152009|449180992|FG003|Overall Study|Withdrawal by Subject|9|||
124879072|NCT00152009|449180989|FG000|Overall Study|Lost to Follow-up|2|||
124879073|NCT00152009|449180990|FG001|Overall Study|Lost to Follow-up|4|||
124879074|NCT00152009|449180991|FG002|Overall Study|Lost to Follow-up|3|||
124879075|NCT00152009|449180992|FG003|Overall Study|Lost to Follow-up|3|||
124879076|NCT00152009|449180989|FG000|Overall Study|Lack of Efficacy|8|||
124879077|NCT00152009|449180990|FG001|Overall Study|Lack of Efficacy|6|||
124879078|NCT00152009|449180991|FG002|Overall Study|Lack of Efficacy|7|||
124879079|NCT00152009|449180992|FG003|Overall Study|Lack of Efficacy|15|||
124879080|NCT00152009|449180989|FG000|Overall Study|ECG abnormalities|2|||
124879081|NCT00152009|449180990|FG001|Overall Study|ECG abnormalities|2|||
124879082|NCT00152009|449180991|FG002|Overall Study|ECG abnormalities|2|||
124879083|NCT00152009|449180992|FG003|Overall Study|ECG abnormalities|1|||
124879084|NCT00152009|449180989|FG000|Overall Study|Sponsor's decision|3|||
124879085|NCT00152009|449180990|FG001|Overall Study|Sponsor's decision|3|||
124879086|NCT00152009|449180991|FG002|Overall Study|Sponsor's decision|1|||
124879087|NCT00152009|449180992|FG003|Overall Study|Sponsor's decision|3|||
124879088|NCT00393523|449180993|FG000|Overall Study|Lost to Follow-up|0|||
124879089|NCT00393523|449180994|FG001|Overall Study|Lost to Follow-up|0|||
124879090|NCT00393523|449180995|FG002|Overall Study|Lost to Follow-up|0|||
124879091|NCT00393523|449180996|FG003|Overall Study|Lost to Follow-up|2|||
124879092|NCT00393523|449180997|FG004|Overall Study|Lost to Follow-up|1|||
124879093|NCT00393523|449180993|FG000|Overall Study|Protocol Violation|6|||
124879094|NCT00393523|449180994|FG001|Overall Study|Protocol Violation|2|||
124879095|NCT00393523|449180995|FG002|Overall Study|Protocol Violation|0|||
124879096|NCT00393523|449180996|FG003|Overall Study|Protocol Violation|1|||
124879097|NCT00393523|449180997|FG004|Overall Study|Protocol Violation|0|||
124879098|NCT00393523|449180993|FG000|Overall Study|Withdrawal by Subject|6|||
124879099|NCT00393523|449180994|FG001|Overall Study|Withdrawal by Subject|7|||
124879100|NCT00393523|449180995|FG002|Overall Study|Withdrawal by Subject|2|||
124879101|NCT00393523|449180996|FG003|Overall Study|Withdrawal by Subject|3|||
124879102|NCT00393523|449180997|FG004|Overall Study|Withdrawal by Subject|0|||
124879103|NCT00393523|449180993|FG000|Overall Study|Difficulties in specimen collection|0|||
124879104|NCT00393523|449180994|FG001|Overall Study|Difficulties in specimen collection|0|||
124879105|NCT00393523|449180995|FG002|Overall Study|Difficulties in specimen collection|1|||
124879106|NCT00393523|449180996|FG003|Overall Study|Difficulties in specimen collection|0|||
124879107|NCT00393523|449180997|FG004|Overall Study|Difficulties in specimen collection|0|||
124879108|NCT00393523|449180993|FG000|Overall Study|Vaccine supply issue|0|||
124879109|NCT00393523|449180994|FG001|Overall Study|Vaccine supply issue|0|||
124879110|NCT00393523|449180995|FG002|Overall Study|Vaccine supply issue|1|||
124437062|NCT00477334|447562375|FG000|Overall Study|Adverse Event|1|||
124437063|NCT00477334|447562376|FG001|Overall Study|Adverse Event|2|||
124437064|NCT00477334|447562375|FG000|Overall Study|Withdrawal by Subject|2|||
124437065|NCT00477334|447562376|FG001|Overall Study|Withdrawal by Subject|1|||
124437066|NCT00477334|447562375|FG000|Overall Study|Lost to Follow-up|15|||
124437067|NCT00477334|447562376|FG001|Overall Study|Lost to Follow-up|4|||
124437068|NCT00477334|447562375|FG000|Overall Study|Administrative Problems|39|||
124437069|NCT00477334|447562376|FG001|Overall Study|Administrative Problems|15|||
124437070|NCT00477334|447562375|FG000|Overall Study|Protocol Violation|7|||
124437071|NCT00477334|447562376|FG001|Overall Study|Protocol Violation|1|||
124437072|NCT02572882|447562377|FG000|Overall Study|Withdrawal by Subject|1|||
124437073|NCT02572882|447562377|FG000|Overall Study|Participant received kidney transplant|1|||
124437074|NCT02354508|447562381|FG000|Period 1: Core Phase|Adverse Event|1|||
124437075|NCT02354508|447562382|FG001|Period 1: Core Phase|Adverse Event|1|||
124437076|NCT02354508|447562383|FG002|Period 1: Core Phase|Adverse Event|2|||
124879111|NCT00393523|449180996|FG003|Overall Study|Vaccine supply issue|0|||
124879112|NCT00393523|449180997|FG004|Overall Study|Vaccine supply issue|0|||
124879113|NCT00423852|449181002|FG000|Overall Study|Removed pior to the high-dose portion|3|||
124879114|NCT04772053|449181003|FG000|Overall Study|Physician Decision|2|||
124879115|NCT04772053|449181003|FG000|Overall Study|Withdrawal by Subject|3|||
124879116|NCT04772053|449181003|FG000|Overall Study|Study Terminated by Sponsor|1|||
124879117|NCT03787680|449181008|FG000|Overall Study|Physician Decision|2|||
124879118|NCT03787680|449181009|FG001|Overall Study|Physician Decision|3|||
124879119|NCT03787680|449181008|FG000|Overall Study|Adverse Event|7|||
124879120|NCT03787680|449181009|FG001|Overall Study|Adverse Event|3|||
124879121|NCT03787680|449181008|FG000|Overall Study|Withdrawal by Subject|2|||
124879122|NCT03787680|449181009|FG001|Overall Study|Withdrawal by Subject|1|||
124879123|NCT02541383|449181010|FG000|Overall Study|Death|50|||
124879124|NCT02541383|449181011|FG001|Overall Study|Death|37|||
124879125|NCT02541383|449181012|FG002|Overall Study|Death|48|||
124879126|NCT02541383|449181013|FG003|Overall Study|Death|41|||
124879127|NCT02541383|449181014|FG004|Overall Study|Death|21|||
124879128|NCT02541383|449181015|FG005|Overall Study|Death|25|||
124879129|NCT02541383|449181010|FG000|Overall Study|Lost to Follow-up|5|||
124879130|NCT02541383|449181011|FG001|Overall Study|Lost to Follow-up|3|||
124879131|NCT02541383|449181012|FG002|Overall Study|Lost to Follow-up|1|||
124437077|NCT02354508|447562381|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
124437078|NCT02354508|447562382|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
124437079|NCT02354508|447562383|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
124437080|NCT02354508|447562381|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
124437081|NCT02354508|447562382|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
124437082|NCT02354508|447562383|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
124879132|NCT02541383|449181013|FG003|Overall Study|Lost to Follow-up|1|||
124879133|NCT02541383|449181014|FG004|Overall Study|Lost to Follow-up|3|||
124879134|NCT02541383|449181015|FG005|Overall Study|Lost to Follow-up|0|||
124879135|NCT02541383|449181010|FG000|Overall Study|Consent withdrawn|5|||
124879136|NCT02541383|449181011|FG001|Overall Study|Consent withdrawn|6|||
124879137|NCT02541383|449181012|FG002|Overall Study|Consent withdrawn|1|||
124879138|NCT02541383|449181013|FG003|Overall Study|Consent withdrawn|1|||
124879139|NCT02541383|449181014|FG004|Overall Study|Consent withdrawn|0|||
124679459|NCT01232283|448449707|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
124679460|NCT01232283|448449708|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
124679461|NCT01232283|448449709|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
124679462|NCT01232283|448449710|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
124679463|NCT01232283|448449711|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
124679464|NCT01232283|448449712|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
124679465|NCT01232283|448449713|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
124679466|NCT01232283|448449714|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
124679467|NCT01232283|448449715|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
124679468|NCT01232283|448449706|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
124679469|NCT01232283|448449707|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
124679470|NCT01232283|448449708|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
124679471|NCT01232283|448449709|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
124679472|NCT01232283|448449710|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
124679473|NCT01232283|448449711|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
124679474|NCT01232283|448449712|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
124679475|NCT01232283|448449713|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
124679476|NCT01232283|448449714|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
124679477|NCT01232283|448449715|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
124679478|NCT01232283|448449706|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
124679479|NCT01232283|448449707|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
124679480|NCT01232283|448449708|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
124679481|NCT01232283|448449709|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
124679482|NCT01232283|448449710|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
124679483|NCT01232283|448449711|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
124679484|NCT01232283|448449712|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
124679485|NCT01232283|448449713|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
124679486|NCT01232283|448449714|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
124879140|NCT02541383|449181015|FG005|Overall Study|Consent withdrawn|0|||
124879141|NCT02541383|449181010|FG000|Overall Study|Sponsor's decision|1|||
124879142|NCT02541383|449181011|FG001|Overall Study|Sponsor's decision|1|||
124879143|NCT02541383|449181012|FG002|Overall Study|Sponsor's decision|0|||
124879144|NCT02541383|449181013|FG003|Overall Study|Sponsor's decision|0|||
124879145|NCT02541383|449181014|FG004|Overall Study|Sponsor's decision|0|||
124879146|NCT02541383|449181015|FG005|Overall Study|Sponsor's decision|0|||
124879147|NCT05458024|449181018|FG000|Overall Study|Withdrawal by Subject|1|||
124879148|NCT05458024|449181019|FG001|Overall Study|Withdrawal by Subject|1|||
124879149|NCT05229653|449181021|FG000|Overall Study|Lost to Follow-up|1|||
124879150|NCT05229653|449181022|FG001|Overall Study|Lost to Follow-up|0|||
124879151|NCT01845974|449181023|FG000|Overall Study|screen failure|1|||
124879152|NCT01845974|449181024|FG001|Overall Study|screen failure|0|||
124879153|NCT02667886|449181025|FG000|Dose Escalation (Part A)|Adverse Event|1|||
124879154|NCT02667886|449181026|FG001|Dose Escalation (Part A)|Adverse Event|3|||
124879155|NCT02667886|449181027|FG002|Dose Escalation (Part A)|Adverse Event|1|||
124879156|NCT02667886|449181028|FG003|Dose Escalation (Part A)|Adverse Event|0|||
124879157|NCT02667886|449181029|FG004|Dose Escalation (Part A)|Adverse Event|0|||
124879158|NCT02667886|449181025|FG000|Dose Escalation (Part A)|Disease Progression|1|||
124879159|NCT02667886|449181026|FG001|Dose Escalation (Part A)|Disease Progression|4|||
124879160|NCT02667886|449181027|FG002|Dose Escalation (Part A)|Disease Progression|3|||
124879161|NCT02667886|449181028|FG003|Dose Escalation (Part A)|Disease Progression|0|||
124879162|NCT02667886|449181029|FG004|Dose Escalation (Part A)|Disease Progression|0|||
124879163|NCT02667886|449181025|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
124879164|NCT02667886|449181026|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
124879165|NCT02667886|449181027|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
124879166|NCT02667886|449181028|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
124879167|NCT02667886|449181029|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
124879168|NCT02667886|449181025|FG000|Dose Expansion (Part B)|Adverse Event|0|||
124879169|NCT02667886|449181026|FG001|Dose Expansion (Part B)|Adverse Event|0|||
124879170|NCT02667886|449181027|FG002|Dose Expansion (Part B)|Adverse Event|0|||
124879171|NCT02667886|449181028|FG003|Dose Expansion (Part B)|Adverse Event|9|||
124879172|NCT02667886|449181029|FG004|Dose Expansion (Part B)|Adverse Event|0|||
124879173|NCT02667886|449181025|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
124879174|NCT02667886|449181026|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
124879175|NCT02667886|449181027|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
124879176|NCT02667886|449181028|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
124879177|NCT02667886|449181029|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
124879178|NCT02667886|449181025|FG000|Dose Expansion (Part B)|Disease Progression|0|||
124879179|NCT02667886|449181026|FG001|Dose Expansion (Part B)|Disease Progression|0|||
124879180|NCT02667886|449181027|FG002|Dose Expansion (Part B)|Disease Progression|0|||
124879181|NCT02667886|449181028|FG003|Dose Expansion (Part B)|Disease Progression|38|||
124879182|NCT02667886|449181029|FG004|Dose Expansion (Part B)|Disease Progression|0|||
124879183|NCT02667886|449181025|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
124879184|NCT02667886|449181026|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
124879185|NCT02667886|449181027|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
124879186|NCT02667886|449181028|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
124879187|NCT02667886|449181029|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
124879188|NCT02667886|449181025|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
124879189|NCT02667886|449181026|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
124879190|NCT02667886|449181027|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
124879191|NCT02667886|449181028|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
124437083|NCT02354508|447562381|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
124437084|NCT02354508|447562382|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
124437085|NCT02354508|447562383|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
124437086|NCT02354508|447562381|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
124437087|NCT02354508|447562382|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
124437088|NCT02354508|447562383|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
124437089|NCT02354508|447562381|FG000|Period 2: Extension Phase|Physician Decision|5|||
124437090|NCT02354508|447562382|FG001|Period 2: Extension Phase|Physician Decision|0|||
124437091|NCT02354508|447562383|FG002|Period 2: Extension Phase|Physician Decision|1|||
124437092|NCT02354508|447562381|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
124879192|NCT02667886|449181029|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
124879193|NCT02667886|449181025|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
124879194|NCT02667886|449181026|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
124879195|NCT02667886|449181027|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
124879196|NCT02667886|449181028|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
124879197|NCT02667886|449181029|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
124879198|NCT00594217|449181030|FG000|Overall Study|Withdrawal by Subject|1|||
124879199|NCT00594217|449181031|FG001|Overall Study|Withdrawal by Subject|3|||
124879200|NCT03635489|449181032|FG000|Overall Study|Death|19|||
124879201|NCT03635489|449181033|FG001|Overall Study|Death|13|||
124879202|NCT03635489|449181032|FG000|Overall Study|Lost to Follow-up|1|||
124879203|NCT03635489|449181033|FG001|Overall Study|Lost to Follow-up|2|||
124437093|NCT02354508|447562382|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
124879204|NCT03635489|449181032|FG000|Overall Study|Withdrawal by Subject|1|||
124879205|NCT03635489|449181033|FG001|Overall Study|Withdrawal by Subject|2|||
124879206|NCT03635489|449181032|FG000|Overall Study|Study Ended by Sponsor|28|||
124879207|NCT03635489|449181033|FG001|Overall Study|Study Ended by Sponsor|34|||
124879208|NCT00943306|449181034|FG000|Overall Study|Physician Decision|1|||
124879209|NCT00943306|449181034|FG000|Overall Study|Death|1|||
124879210|NCT00943306|449181034|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
124879211|NCT01036022|449181035|FG000|Overall Study|Adverse Event|1|||
124879212|NCT01036022|449181036|FG001|Overall Study|Adverse Event|3|||
124879213|NCT01036022|449181037|FG002|Overall Study|Adverse Event|2|||
124879214|NCT01036022|449181038|FG003|Overall Study|Adverse Event|1|||
124879215|NCT01036022|449181039|FG004|Overall Study|Adverse Event|0|||
124879216|NCT01036022|449181040|FG005|Overall Study|Adverse Event|2|||
124879217|NCT01036022|449181035|FG000|Overall Study|Lack of Efficacy|1|||
124879218|NCT01036022|449181036|FG001|Overall Study|Lack of Efficacy|1|||
124879219|NCT01036022|449181037|FG002|Overall Study|Lack of Efficacy|1|||
124879220|NCT01036022|449181038|FG003|Overall Study|Lack of Efficacy|0|||
124879221|NCT01036022|449181039|FG004|Overall Study|Lack of Efficacy|1|||
124879222|NCT01036022|449181040|FG005|Overall Study|Lack of Efficacy|1|||
124879223|NCT01036022|449181035|FG000|Overall Study|Physician Decision|0|||
124879224|NCT01036022|449181036|FG001|Overall Study|Physician Decision|0|||
124879225|NCT01036022|449181037|FG002|Overall Study|Physician Decision|1|||
124879226|NCT01036022|449181038|FG003|Overall Study|Physician Decision|0|||
124879227|NCT01036022|449181039|FG004|Overall Study|Physician Decision|0|||
124879228|NCT01036022|449181040|FG005|Overall Study|Physician Decision|0|||
124879229|NCT01036022|449181035|FG000|Overall Study|Withdrawal by Subject|0|||
124879230|NCT01036022|449181036|FG001|Overall Study|Withdrawal by Subject|0|||
124879231|NCT01036022|449181037|FG002|Overall Study|Withdrawal by Subject|0|||
124879232|NCT01036022|449181038|FG003|Overall Study|Withdrawal by Subject|1|||
124679487|NCT01232283|448449715|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
124679488|NCT01232283|448449706|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
124879233|NCT01036022|449181039|FG004|Overall Study|Withdrawal by Subject|2|||
124879234|NCT01036022|449181040|FG005|Overall Study|Withdrawal by Subject|0|||
124879235|NCT00576732|449181041|FG000|DOUBLE BLIND|Adverse Event|0|||
124879236|NCT00576732|449181042|FG001|DOUBLE BLIND|Adverse Event|0|||
124879237|NCT00576732|449181043|FG002|DOUBLE BLIND|Adverse Event|1|||
124879238|NCT00576732|449181044|FG003|DOUBLE BLIND|Adverse Event|0|||
124879239|NCT00576732|449181045|FG004|DOUBLE BLIND|Adverse Event|0|||
124879240|NCT00576732|449181046|FG005|DOUBLE BLIND|Adverse Event|0|||
124879241|NCT00576732|449181041|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
124879242|NCT00576732|449181042|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
124879243|NCT00576732|449181043|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
124879244|NCT00576732|449181044|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
124879245|NCT00576732|449181045|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
124879246|NCT00576732|449181046|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
124879247|NCT00576732|449181041|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
124879248|NCT00576732|449181042|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
124879249|NCT00576732|449181043|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
124879250|NCT00576732|449181044|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
124879251|NCT00576732|449181045|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
124879252|NCT00576732|449181046|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
124879253|NCT00576732|449181041|FG000|DOUBLE BLIND|OTHER|0|||
124879254|NCT00576732|449181042|FG001|DOUBLE BLIND|OTHER|2|||
124679489|NCT01232283|448449707|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
124679490|NCT01232283|448449708|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
124879255|NCT00576732|449181043|FG002|DOUBLE BLIND|OTHER|1|||
124879256|NCT00576732|449181044|FG003|DOUBLE BLIND|OTHER|0|||
124679491|NCT01232283|448449709|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
124879257|NCT00576732|449181045|FG004|DOUBLE BLIND|OTHER|0|||
124879258|NCT00576732|449181046|FG005|DOUBLE BLIND|OTHER|0|||
124879259|NCT00576732|449181041|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
124879260|NCT00576732|449181042|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
124437094|NCT02354508|447562383|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
124437095|NCT02354508|447562381|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
124437096|NCT02354508|447562382|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
124437097|NCT02354508|447562383|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
124437098|NCT02354508|447562381|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
124437099|NCT02354508|447562382|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
124437100|NCT02354508|447562383|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
124437101|NCT03587974|447562384|FG000|Overall Study|caregiver demented, care recipient died|3|||
124437102|NCT03587974|447562385|FG001|Overall Study|caregiver demented, care recipient died|3|||
124437103|NCT03587974|447562384|FG000|Overall Study|Withdrawal by Subject|2|||
124437104|NCT03587974|447562385|FG001|Overall Study|Withdrawal by Subject|1|||
124437105|NCT04371198|447562386|FG000|Overall Study|inadequate sample|4|||
124437106|NCT03486457|447562389|FG000|Up to Month 3|Adverse Event|2|||
124437107|NCT03486457|447562390|FG001|Up to Month 3|Adverse Event|5|||
124437108|NCT03486457|447562389|FG000|Up to Month 3|Lack of Efficacy|1|||
124437109|NCT03486457|447562390|FG001|Up to Month 3|Lack of Efficacy|0|||
124437110|NCT03486457|447562389|FG000|Up to Month 3|Withdrawal by Subject|1|||
124437111|NCT03486457|447562390|FG001|Up to Month 3|Withdrawal by Subject|0|||
124437112|NCT03486457|447562389|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
124437113|NCT03486457|447562390|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
124437114|NCT03486457|447562389|FG000|Up to Month 3|Other|1|||
124437115|NCT03486457|447562390|FG001|Up to Month 3|Other|0|||
124437116|NCT03486457|447562389|FG000|Month 3 to Month 6|Adverse Event|2|||
124437117|NCT03486457|447562390|FG001|Month 3 to Month 6|Adverse Event|0|||
124437118|NCT03486457|447562389|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
124437119|NCT03486457|447562390|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
124437120|NCT03486457|447562389|FG000|Month 3 to Month 6|Pregnancy|0|||
124437121|NCT03486457|447562390|FG001|Month 3 to Month 6|Pregnancy|1|||
124437122|NCT03486457|447562389|FG000|Month 3 to Month 6|Other|1|||
124437123|NCT03486457|447562390|FG001|Month 3 to Month 6|Other|0|||
124437124|NCT00372229|447562391|FG000|Study Phase|Graft loss|0|||
124437125|NCT00372229|447562392|FG001|Study Phase|Graft loss|3|||
124437126|NCT00372229|447562391|FG000|Study Phase|Protocol Violation|3|||
124437127|NCT00372229|447562392|FG001|Study Phase|Protocol Violation|4|||
124437128|NCT00372229|447562391|FG000|Study Phase|Consent withdrawn|16|||
124437129|NCT00372229|447562392|FG001|Study Phase|Consent withdrawn|14|||
124437130|NCT00372229|447562391|FG000|Study Phase|Refused treatment/did not cooperate|3|||
124437131|NCT00372229|447562392|FG001|Study Phase|Refused treatment/did not cooperate|1|||
124437132|NCT00372229|447562391|FG000|Study Phase|Death|3|||
124437133|NCT00372229|447562392|FG001|Study Phase|Death|2|||
124437134|NCT00372229|447562391|FG000|Study Phase|Reason not specified|3|||
124437135|NCT00372229|447562392|FG001|Study Phase|Reason not specified|2|||
124437136|NCT00372229|447562391|FG000|Study Phase|Lost to Follow-up|3|||
124437137|NCT00372229|447562392|FG001|Study Phase|Lost to Follow-up|3|||
124437138|NCT00372229|447562391|FG000|Follow-Up Phase|Graft loss|8|||
124437139|NCT00372229|447562392|FG001|Follow-Up Phase|Graft loss|7|||
124437140|NCT00372229|447562391|FG000|Follow-Up Phase|Consent withdrawn|13|||
124437141|NCT00372229|447562392|FG001|Follow-Up Phase|Consent withdrawn|19|||
124437142|NCT00372229|447562391|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
124437143|NCT00372229|447562392|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
124437144|NCT00372229|447562391|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
124437145|NCT00372229|447562392|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
124437146|NCT00372229|447562391|FG000|Follow-Up Phase|Death|9|||
124437147|NCT00372229|447562392|FG001|Follow-Up Phase|Death|12|||
124437148|NCT00372229|447562391|FG000|Follow-Up Phase|Administrative|1|||
124437149|NCT00372229|447562392|FG001|Follow-Up Phase|Administrative|0|||
124437150|NCT00372229|447562391|FG000|Follow-Up Phase|Reason not specified|2|||
124437151|NCT00372229|447562392|FG001|Follow-Up Phase|Reason not specified|3|||
124437152|NCT00372229|447562391|FG000|Follow-Up Phase|Lost to Follow-up|12|||
124437153|NCT00372229|447562392|FG001|Follow-Up Phase|Lost to Follow-up|10|||
124437154|NCT03536143|447562393|FG000|Overall Study|Early termination, Sponsor decision|1|||
124437155|NCT01590017|447562394|FG000|Overall Study|Adverse Event|1|||
124437156|NCT01590017|447562394|FG000|Overall Study|Withdrawal by Subject|1|||
124437157|NCT01590017|447562394|FG000|Overall Study|Lack of Efficacy|1|||
124437158|NCT01590017|447562394|FG000|Overall Study|Physician Decision|1|||
124437159|NCT00093808|447562395|FG000|Overall Study|Cancel participation before receiving tx|1|||
124437160|NCT00093808|447562395|FG000|Overall Study|Protocol Violation|1|||
124437161|NCT00871780|447562396|FG000|Overall Study|Enrolled But Not Treated|6|||
124437162|NCT00871780|447562396|FG000|Overall Study|Withdrawal by Subject|9|||
124437163|NCT00871780|447562396|FG000|Overall Study|Adverse Event|6|||
124437164|NCT00871780|447562396|FG000|Overall Study|Voluntary Discontinuation|4|||
124437165|NCT00871780|447562396|FG000|Overall Study|Death|1|||
124437166|NCT00871780|447562396|FG000|Overall Study|Physician Decision|1|||
124437167|NCT02527343|447562397|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
124437168|NCT02527343|447562398|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
124437169|NCT02527343|447562399|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
124437170|NCT02527343|447562400|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
124437171|NCT02527343|447562401|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
124437172|NCT02527343|447562402|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
124437173|NCT02527343|447562397|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
124437174|NCT02527343|447562398|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
124437175|NCT02527343|447562399|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
124437176|NCT02527343|447562400|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
124437177|NCT02527343|447562401|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
124437178|NCT02527343|447562402|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
124437179|NCT02527343|447562397|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
124879261|NCT00576732|449181043|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
124879262|NCT00576732|449181044|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
124879263|NCT00576732|449181045|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
124879264|NCT00576732|449181046|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
124879265|NCT00576732|449181041|FG000|DOUBLE BLIND|Protocol Violation|1|||
124879266|NCT00576732|449181042|FG001|DOUBLE BLIND|Protocol Violation|0|||
124879267|NCT00576732|449181043|FG002|DOUBLE BLIND|Protocol Violation|0|||
124879268|NCT00576732|449181044|FG003|DOUBLE BLIND|Protocol Violation|0|||
124879269|NCT00576732|449181045|FG004|DOUBLE BLIND|Protocol Violation|0|||
124879270|NCT00576732|449181046|FG005|DOUBLE BLIND|Protocol Violation|0|||
124879271|NCT00576732|449181041|FG000|OPEN LABEL|Adverse Event|0|||
124879272|NCT00576732|449181042|FG001|OPEN LABEL|Adverse Event|0|||
124879273|NCT00576732|449181043|FG002|OPEN LABEL|Adverse Event|0|||
124879274|NCT00576732|449181044|FG003|OPEN LABEL|Adverse Event|4|||
124879275|NCT00576732|449181045|FG004|OPEN LABEL|Adverse Event|0|||
124879276|NCT00576732|449181046|FG005|OPEN LABEL|Adverse Event|1|||
124879277|NCT00576732|449181041|FG000|OPEN LABEL|Lost to Follow-up|0|||
124879278|NCT00576732|449181042|FG001|OPEN LABEL|Lost to Follow-up|0|||
124879279|NCT00576732|449181043|FG002|OPEN LABEL|Lost to Follow-up|0|||
124879280|NCT00576732|449181044|FG003|OPEN LABEL|Lost to Follow-up|2|||
124879281|NCT00576732|449181045|FG004|OPEN LABEL|Lost to Follow-up|1|||
124879282|NCT00576732|449181046|FG005|OPEN LABEL|Lost to Follow-up|1|||
124879283|NCT00576732|449181041|FG000|OPEN LABEL|Withdrawal by Subject|0|||
124879284|NCT00576732|449181042|FG001|OPEN LABEL|Withdrawal by Subject|0|||
124879285|NCT00576732|449181043|FG002|OPEN LABEL|Withdrawal by Subject|0|||
124879286|NCT00576732|449181044|FG003|OPEN LABEL|Withdrawal by Subject|1|||
124879287|NCT00576732|449181045|FG004|OPEN LABEL|Withdrawal by Subject|0|||
124879288|NCT00576732|449181046|FG005|OPEN LABEL|Withdrawal by Subject|1|||
124879289|NCT00576732|449181041|FG000|OPEN LABEL|OTHER|0|||
124879290|NCT00576732|449181042|FG001|OPEN LABEL|OTHER|0|||
124879291|NCT00576732|449181043|FG002|OPEN LABEL|OTHER|0|||
124879292|NCT00576732|449181044|FG003|OPEN LABEL|OTHER|0|||
124879293|NCT00576732|449181045|FG004|OPEN LABEL|OTHER|0|||
124879294|NCT00576732|449181046|FG005|OPEN LABEL|OTHER|2|||
124879295|NCT00576732|449181041|FG000|OPEN LABEL|Lack of Efficacy|0|||
124879296|NCT00576732|449181042|FG001|OPEN LABEL|Lack of Efficacy|0|||
124879297|NCT00576732|449181043|FG002|OPEN LABEL|Lack of Efficacy|0|||
124879298|NCT00576732|449181044|FG003|OPEN LABEL|Lack of Efficacy|2|||
124879299|NCT00576732|449181045|FG004|OPEN LABEL|Lack of Efficacy|2|||
124879300|NCT00576732|449181046|FG005|OPEN LABEL|Lack of Efficacy|3|||
124879301|NCT00576732|449181041|FG000|OPEN LABEL|Protocol Violation|0|||
124879302|NCT00576732|449181042|FG001|OPEN LABEL|Protocol Violation|0|||
124879303|NCT00576732|449181043|FG002|OPEN LABEL|Protocol Violation|0|||
124879304|NCT00576732|449181044|FG003|OPEN LABEL|Protocol Violation|2|||
124879305|NCT00576732|449181045|FG004|OPEN LABEL|Protocol Violation|1|||
124879306|NCT00576732|449181046|FG005|OPEN LABEL|Protocol Violation|0|||
124879307|NCT05096208|449181049|FG000|Overall Study|Lost to Follow-up|3|||
124879308|NCT05096208|449181050|FG001|Overall Study|Lost to Follow-up|5|||
124879309|NCT05096208|449181051|FG002|Overall Study|Lost to Follow-up|5|||
124879310|NCT05096208|449181052|FG003|Overall Study|Lost to Follow-up|2|||
124879311|NCT05096208|449181049|FG000|Overall Study|Withdrawal by Subject|0|||
124437180|NCT02527343|447562398|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
124437181|NCT02527343|447562399|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
124437182|NCT02527343|447562400|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
124879312|NCT05096208|449181050|FG001|Overall Study|Withdrawal by Subject|1|||
124879313|NCT05096208|449181051|FG002|Overall Study|Withdrawal by Subject|2|||
124879314|NCT05096208|449181052|FG003|Overall Study|Withdrawal by Subject|3|||
124879315|NCT05096208|449181049|FG000|Overall Study|No longer met eligibility criteria|1|||
124879316|NCT05096208|449181050|FG001|Overall Study|No longer met eligibility criteria|0|||
124879317|NCT05096208|449181051|FG002|Overall Study|No longer met eligibility criteria|0|||
124879318|NCT05096208|449181052|FG003|Overall Study|No longer met eligibility criteria|0|||
124879319|NCT05096208|449181049|FG000|Overall Study|Other|0|||
124879320|NCT05096208|449181050|FG001|Overall Study|Other|0|||
124879321|NCT05096208|449181051|FG002|Overall Study|Other|1|||
124879322|NCT05096208|449181052|FG003|Overall Study|Other|0|||
124879323|NCT02213328|449181054|FG000|Overall Study|Withdrawal by Subject|10|||
124879324|NCT02213328|449181054|FG000|Overall Study|Physician Decision|2|||
124879325|NCT02213328|449181054|FG000|Overall Study|Lost to Follow-up|16|||
124879326|NCT02487095|449181059|FG000|Dose Expansion|Unable to scan/restage participant|0|||
124879327|NCT02487095|449181060|FG001|Dose Expansion|Unable to scan/restage participant|0|||
124879328|NCT02487095|449181061|FG002|Dose Expansion|Unable to scan/restage participant|0|||
124879329|NCT02487095|449181062|FG003|Dose Expansion|Unable to scan/restage participant|0|||
124879330|NCT02487095|449181063|FG004|Dose Expansion|Unable to scan/restage participant|1|||
124879331|NCT01807650|449181064|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
124879332|NCT01807650|449181064|FG000|Overall Study|Adverse Event|5|||
124437183|NCT02527343|447562401|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
124437184|NCT02527343|447562402|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
124437185|NCT02527343|447562397|FG000|RT Period: Weeks 1 to 52|Other|4|||
124437186|NCT02527343|447562398|FG001|RT Period: Weeks 1 to 52|Other|3|||
124879333|NCT01807650|449181064|FG000|Overall Study|Other|2|||
124879334|NCT02969525|449181069|FG000|Double-Blind Period|Adverse Event|0|||
124879335|NCT02969525|449181070|FG001|Double-Blind Period|Adverse Event|0|||
124879336|NCT02969525|449181071|FG002|Double-Blind Period|Adverse Event|1|||
124879337|NCT02969525|449181072|FG003|Double-Blind Period|Adverse Event|1|||
124879338|NCT02969525|449181073|FG004|Double-Blind Period|Adverse Event|0|||
124879339|NCT02969525|449181074|FG005|Double-Blind Period|Adverse Event|0|||
124879340|NCT02969525|449181075|FG006|Double-Blind Period|Adverse Event|0|||
124879341|NCT02969525|449181076|FG007|Double-Blind Period|Adverse Event|0|||
124879342|NCT02969525|449181077|FG008|Double-Blind Period|Adverse Event|0|||
124879343|NCT02969525|449181078|FG009|Double-Blind Period|Adverse Event|0|||
124879344|NCT02969525|449181079|FG010|Double-Blind Period|Adverse Event|0|||
124879345|NCT02969525|449181080|FG011|Double-Blind Period|Adverse Event|0|||
124879346|NCT02969525|449181069|FG000|Double-Blind Period|LOW EGFR|0|||
124879347|NCT02969525|449181070|FG001|Double-Blind Period|LOW EGFR|0|||
124437187|NCT02527343|447562399|FG002|RT Period: Weeks 1 to 52|Other|0|||
124879348|NCT02969525|449181071|FG002|Double-Blind Period|LOW EGFR|0|||
124879349|NCT02969525|449181072|FG003|Double-Blind Period|LOW EGFR|1|||
124879350|NCT02969525|449181073|FG004|Double-Blind Period|LOW EGFR|0|||
124879351|NCT02969525|449181074|FG005|Double-Blind Period|LOW EGFR|0|||
124879352|NCT02969525|449181075|FG006|Double-Blind Period|LOW EGFR|0|||
124879353|NCT02969525|449181076|FG007|Double-Blind Period|LOW EGFR|0|||
124879354|NCT02969525|449181077|FG008|Double-Blind Period|LOW EGFR|0|||
124879355|NCT02969525|449181078|FG009|Double-Blind Period|LOW EGFR|0|||
124879356|NCT02969525|449181079|FG010|Double-Blind Period|LOW EGFR|0|||
124879357|NCT02969525|449181080|FG011|Double-Blind Period|LOW EGFR|0|||
124879358|NCT02969525|449181069|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
124879359|NCT02969525|449181070|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124879360|NCT02969525|449181071|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124879361|NCT02969525|449181072|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
124879362|NCT02969525|449181073|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124437188|NCT02527343|447562400|FG003|RT Period: Weeks 1 to 52|Other|0|||
124437189|NCT02527343|447562401|FG004|RT Period: Weeks 1 to 52|Other|0|||
124437190|NCT02527343|447562402|FG005|RT Period: Weeks 1 to 52|Other|0|||
124437191|NCT02527343|447562397|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
124437192|NCT02527343|447562398|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
124437193|NCT02527343|447562399|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
124437194|NCT02527343|447562400|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
124437195|NCT02527343|447562401|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
124437196|NCT02527343|447562402|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
124437197|NCT02527343|447562397|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
124437198|NCT02527343|447562398|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
124437199|NCT02527343|447562399|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
124437200|NCT02527343|447562400|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
124437201|NCT02527343|447562401|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
124437202|NCT02527343|447562402|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
124437203|NCT02527343|447562397|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
124437204|NCT02527343|447562398|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
124437205|NCT02527343|447562399|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
124437206|NCT02527343|447562400|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
124437207|NCT02527343|447562401|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
124437208|NCT02527343|447562402|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
124679492|NCT01232283|448449710|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
124879363|NCT02969525|449181074|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124879364|NCT02969525|449181075|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124879365|NCT02969525|449181076|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124679493|NCT01232283|448449711|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
124879366|NCT02969525|449181077|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124879367|NCT02969525|449181078|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124879368|NCT02969525|449181079|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124879369|NCT02969525|449181080|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
124879370|NCT02969525|449181069|FG000|Dose-Blind Period|Adverse Event|0|||
124879371|NCT02969525|449181070|FG001|Dose-Blind Period|Adverse Event|0|||
124879372|NCT02969525|449181071|FG002|Dose-Blind Period|Adverse Event|0|||
124879373|NCT02969525|449181072|FG003|Dose-Blind Period|Adverse Event|0|||
124879374|NCT02969525|449181073|FG004|Dose-Blind Period|Adverse Event|0|||
124879375|NCT02969525|449181074|FG005|Dose-Blind Period|Adverse Event|0|||
124879376|NCT02969525|449181075|FG006|Dose-Blind Period|Adverse Event|0|||
124879377|NCT02969525|449181076|FG007|Dose-Blind Period|Adverse Event|0|||
124879378|NCT02969525|449181077|FG008|Dose-Blind Period|Adverse Event|0|||
124879379|NCT02969525|449181078|FG009|Dose-Blind Period|Adverse Event|1|||
124879380|NCT02969525|449181079|FG010|Dose-Blind Period|Adverse Event|1|||
124879381|NCT02969525|449181080|FG011|Dose-Blind Period|Adverse Event|1|||
124879382|NCT02969525|449181069|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
124879383|NCT02969525|449181070|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
124879384|NCT02969525|449181071|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
124879385|NCT02969525|449181072|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
124879386|NCT02969525|449181073|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
124437209|NCT02527343|447562397|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
124437210|NCT02527343|447562398|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
124437211|NCT02527343|447562399|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
124437212|NCT02527343|447562400|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
124437213|NCT02527343|447562401|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
124437214|NCT02527343|447562402|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
124437215|NCT02527343|447562397|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
124437216|NCT02527343|447562398|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
124437217|NCT02527343|447562399|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
124437218|NCT02527343|447562400|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
124437219|NCT02527343|447562401|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
124437220|NCT02527343|447562402|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
124879387|NCT02969525|449181074|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
124879388|NCT02969525|449181075|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
124879389|NCT02969525|449181076|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
124879390|NCT02969525|449181077|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
124879391|NCT02969525|449181078|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
124879392|NCT02969525|449181079|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
124879393|NCT02969525|449181080|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
124437221|NCT02527343|447562397|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
124437222|NCT02527343|447562398|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
124437223|NCT02527343|447562399|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
124437224|NCT02527343|447562400|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
124437225|NCT02527343|447562401|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
124437226|NCT02527343|447562402|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
124879394|NCT02969525|449181069|FG000|Dose-Blind Period|Non-cooperating patient|0|||
124879395|NCT02969525|449181070|FG001|Dose-Blind Period|Non-cooperating patient|0|||
124879396|NCT02969525|449181071|FG002|Dose-Blind Period|Non-cooperating patient|0|||
124879397|NCT02969525|449181072|FG003|Dose-Blind Period|Non-cooperating patient|0|||
124879398|NCT02969525|449181073|FG004|Dose-Blind Period|Non-cooperating patient|0|||
124879399|NCT02969525|449181074|FG005|Dose-Blind Period|Non-cooperating patient|0|||
124879400|NCT02969525|449181075|FG006|Dose-Blind Period|Non-cooperating patient|0|||
124879401|NCT02969525|449181076|FG007|Dose-Blind Period|Non-cooperating patient|0|||
124879402|NCT02969525|449181077|FG008|Dose-Blind Period|Non-cooperating patient|0|||
124879403|NCT02969525|449181078|FG009|Dose-Blind Period|Non-cooperating patient|0|||
124879404|NCT02969525|449181079|FG010|Dose-Blind Period|Non-cooperating patient|0|||
124879405|NCT02969525|449181080|FG011|Dose-Blind Period|Non-cooperating patient|1|||
124879406|NCT02969525|449181069|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879407|NCT02969525|449181070|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879408|NCT02969525|449181071|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879409|NCT02969525|449181072|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879410|NCT02969525|449181073|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879411|NCT02969525|449181074|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124437227|NCT02527343|447562397|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
124437228|NCT02527343|447562398|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
124437229|NCT02527343|447562399|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
124544384|NCT00948896|447946794|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
124679494|NCT01232283|448449712|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
124879412|NCT02969525|449181075|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879413|NCT02969525|449181076|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879414|NCT02969525|449181077|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879415|NCT02969525|449181078|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124879416|NCT02969525|449181079|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
124879417|NCT02969525|449181080|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
124437230|NCT02527343|447562400|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
124437231|NCT02527343|447562401|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
124437232|NCT02527343|447562402|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
124437233|NCT02527343|447562397|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
124437234|NCT02527343|447562398|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
124437235|NCT02527343|447562399|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
124437236|NCT02527343|447562400|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
124437237|NCT02527343|447562401|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
124437238|NCT02527343|447562402|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
124437239|NCT02527343|447562397|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
124437240|NCT02527343|447562398|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
124437241|NCT02527343|447562399|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
124437242|NCT02527343|447562400|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
124437243|NCT02527343|447562401|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
124437244|NCT02527343|447562402|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
124437245|NCT00701220|447562403|FG000|Overall Study|Withdrawal by Subject|0|||
124437246|NCT00701220|447562404|FG001|Overall Study|Withdrawal by Subject|2|||
124437247|NCT00701220|447562403|FG000|Overall Study|Protocol Violation|2|||
124437248|NCT00701220|447562404|FG001|Overall Study|Protocol Violation|0|||
124437249|NCT03235284|447562405|FG000|Overall Study|Adverse Event|1|||
124879418|NCT00524030|449181081|FG000|Overall Study|Lack of Efficacy|10|||
124879419|NCT00524030|449181082|FG001|Overall Study|Lack of Efficacy|24|||
124879420|NCT00524030|449181081|FG000|Overall Study|Lost to Follow-up|0|||
124879421|NCT00524030|449181082|FG001|Overall Study|Lost to Follow-up|2|||
124879422|NCT00524030|449181081|FG000|Overall Study|Withdrawal by Subject|3|||
124879423|NCT00524030|449181082|FG001|Overall Study|Withdrawal by Subject|8|||
124879424|NCT00524030|449181081|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
124879425|NCT00524030|449181082|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
124879426|NCT00524030|449181081|FG000|Overall Study|Protocol Violation|0|||
124879427|NCT00524030|449181082|FG001|Overall Study|Protocol Violation|1|||
124879428|NCT00524030|449181081|FG000|Overall Study|Pregnancy|1|||
124437250|NCT03235284|447562406|FG001|Overall Study|Adverse Event|2|||
124437251|NCT03235284|447562407|FG002|Overall Study|Adverse Event|1|||
124437252|NCT00440999|447562410|FG000|Overall Study|Adverse Event|0|||
124437253|NCT00440999|447562411|FG001|Overall Study|Adverse Event|2|||
124437254|NCT00440999|447562410|FG000|Overall Study|Lack of Efficacy|6|||
124437255|NCT00440999|447562411|FG001|Overall Study|Lack of Efficacy|7|||
124437256|NCT00440999|447562410|FG000|Overall Study|Lost to Follow-up|19|||
124437257|NCT00440999|447562411|FG001|Overall Study|Lost to Follow-up|12|||
124437258|NCT00440999|447562410|FG000|Overall Study|Protocol Violation|1|||
124437259|NCT00440999|447562411|FG001|Overall Study|Protocol Violation|0|||
124437260|NCT00440999|447562410|FG000|Overall Study|Withdrawal by Subject|2|||
124437261|NCT00440999|447562411|FG001|Overall Study|Withdrawal by Subject|5|||
124437262|NCT00440999|447562410|FG000|Overall Study|Subjets missed the visit|1|||
124437263|NCT00440999|447562411|FG001|Overall Study|Subjets missed the visit|0|||
124437264|NCT00440999|447562410|FG000|Overall Study|Mixed infection at entry|1|||
124437265|NCT00440999|447562411|FG001|Overall Study|Mixed infection at entry|0|||
124437266|NCT00440999|447562410|FG000|Overall Study|P. falciparum malaria|5|||
124437267|NCT00440999|447562411|FG001|Overall Study|P. falciparum malaria|14|||
124437268|NCT00440999|447562410|FG000|Overall Study|Subj left hosp without inform staff|0|||
124437269|NCT00440999|447562411|FG001|Overall Study|Subj left hosp without inform staff|1|||
124437270|NCT02483585|447562412|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
124437271|NCT02483585|447562413|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
124437272|NCT02483585|447562412|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
124437273|NCT02483585|447562413|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
124679495|NCT01232283|448449713|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
124437274|NCT02483585|447562412|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
124437275|NCT02483585|447562413|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
124437276|NCT02483585|447562412|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
124437277|NCT02483585|447562413|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
124437278|NCT02483585|447562412|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
124437279|NCT02483585|447562413|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
124437280|NCT02483585|447562412|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
124437281|NCT02483585|447562413|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
124437282|NCT02483585|447562412|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
124679496|NCT01232283|448449714|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
124437283|NCT02483585|447562413|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
124437284|NCT01324440|447562418|FG000|Overall Study|Subject moved|0|||
124437285|NCT01324440|447562419|FG001|Overall Study|Subject moved|1|||
124679497|NCT01232283|448449715|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
124879429|NCT00524030|449181082|FG001|Overall Study|Pregnancy|0|||
124879430|NCT00524030|449181081|FG000|Overall Study|Adverse Event|3|||
124879431|NCT00524030|449181082|FG001|Overall Study|Adverse Event|21|||
124437286|NCT00903630|447562420|FG000|Phase 2|Adverse Event|0|||
124437287|NCT00903630|447562421|FG001|Phase 2|Adverse Event|0|||
124437288|NCT00903630|447562422|FG002|Phase 2|Adverse Event|1|||
124437289|NCT04025580|447562423|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
124437290|NCT04025580|447562424|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
124437291|NCT04025580|447562425|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
124437292|NCT02325557|447562426|FG000|Overall Study|Progressive disease|1|||
124437293|NCT02325557|447562427|FG001|Overall Study|Progressive disease|0|||
124437294|NCT02325557|447562428|FG002|Overall Study|Progressive disease|0|||
124437295|NCT02325557|447562429|FG003|Overall Study|Progressive disease|0|||
124437296|NCT02325557|447562426|FG000|Overall Study|Withdrawal by Subject|4|||
124437297|NCT02325557|447562427|FG001|Overall Study|Withdrawal by Subject|0|||
124437298|NCT02325557|447562428|FG002|Overall Study|Withdrawal by Subject|0|||
124879432|NCT00524030|449181081|FG000|Overall Study|Death|0|||
124879433|NCT00524030|449181082|FG001|Overall Study|Death|1|||
124879434|NCT01816763|449182445|FG000|Overall Study|The main reason for an incomplete survey|4|||
124879435|NCT01816763|449182446|FG001|Overall Study|The main reason for an incomplete survey|15|||
124879436|NCT01816763|449182447|FG002|Overall Study|The main reason for an incomplete survey|11|||
124879437|NCT00311155|449182450|FG000|Overall Study|Adverse Event|21|||
124879438|NCT00311155|449182450|FG000|Overall Study|Withdrawal by Subject|17|||
124879439|NCT00311155|449182450|FG000|Overall Study|Did not meet entry criteria|55|||
124879440|NCT00429494|449182452|FG000|Overall Study|Withdrawal by Subject|9|||
124879441|NCT00429494|449182452|FG000|Overall Study|Death|6|||
124879442|NCT02392611|449182457|FG000|Overall Study|Adverse Event|0|||
124437299|NCT02325557|447562429|FG003|Overall Study|Withdrawal by Subject|15|||
124437300|NCT02325557|447562426|FG000|Overall Study|Death|5|||
124437301|NCT02325557|447562427|FG001|Overall Study|Death|1|||
124437302|NCT02325557|447562428|FG002|Overall Study|Death|1|||
124437303|NCT02325557|447562429|FG003|Overall Study|Death|16|||
124437304|NCT02325557|447562426|FG000|Overall Study|Lost to Follow-up|0|||
124437305|NCT02325557|447562427|FG001|Overall Study|Lost to Follow-up|0|||
124437306|NCT02325557|447562428|FG002|Overall Study|Lost to Follow-up|1|||
124437307|NCT02325557|447562429|FG003|Overall Study|Lost to Follow-up|1|||
124437308|NCT02325557|447562426|FG000|Overall Study|Other|0|||
124437309|NCT02325557|447562427|FG001|Overall Study|Other|0|||
124437310|NCT02325557|447562428|FG002|Overall Study|Other|0|||
124437311|NCT02325557|447562429|FG003|Overall Study|Other|5|||
124437312|NCT00138671|447562430|FG000|Overall Study|Death|0|||
124437313|NCT00138671|447562431|FG001|Overall Study|Death|3|||
124437314|NCT00138671|447562430|FG000|Overall Study|Adverse Event|6|||
124437315|NCT00138671|447562431|FG001|Overall Study|Adverse Event|3|||
124437316|NCT00138671|447562430|FG000|Overall Study|Lost to Follow-up|1|||
124437317|NCT00138671|447562431|FG001|Overall Study|Lost to Follow-up|2|||
124437318|NCT00138671|447562430|FG000|Overall Study|Withdrawal by Subject|3|||
124437319|NCT00138671|447562431|FG001|Overall Study|Withdrawal by Subject|5|||
124437320|NCT00138671|447562430|FG000|Overall Study|Other|3|||
124437321|NCT00138671|447562431|FG001|Overall Study|Other|3|||
124437322|NCT01488487|447562432|FG000|Overall Study|Adverse Event|6|||
124437323|NCT01488487|447562432|FG000|Overall Study|Death|1|||
124437324|NCT01488487|447562432|FG000|Overall Study|Withdrawal by Subject|2|||
124437325|NCT01136772|447562435|FG000|Overall Study|Adverse Event|15|||
124437326|NCT01136772|447562436|FG001|Overall Study|Adverse Event|14|||
124437327|NCT01136772|447562435|FG000|Overall Study|Lack of Efficacy|42|||
124437328|NCT01136772|447562436|FG001|Overall Study|Lack of Efficacy|39|||
124437329|NCT01136772|447562435|FG000|Overall Study|Administrative|14|||
124437330|NCT01136772|447562436|FG001|Overall Study|Administrative|12|||
124437331|NCT01136772|447562435|FG000|Overall Study|Withdrawal by Subject|33|||
124437332|NCT01136772|447562436|FG001|Overall Study|Withdrawal by Subject|36|||
124437333|NCT01136772|447562435|FG000|Overall Study|Did not receive injection|10|||
124437334|NCT01136772|447562436|FG001|Overall Study|Did not receive injection|7|||
124437335|NCT01136772|447562435|FG000|Overall Study|Did not follow up after first injection|2|||
124437336|NCT01136772|447562436|FG001|Overall Study|Did not follow up after first injection|2|||
124437337|NCT01602562|447562442|FG000|Overall Study|Adverse Event|3|||
124437338|NCT01602562|447562443|FG001|Overall Study|Adverse Event|1|||
124437339|NCT01602562|447562442|FG000|Overall Study|Physician Decision|1|||
124437340|NCT01602562|447562443|FG001|Overall Study|Physician Decision|1|||
124437341|NCT01602562|447562442|FG000|Overall Study|Withdrawal by Subject|1|||
124879443|NCT02392611|449182458|FG001|Overall Study|Adverse Event|0|||
124437342|NCT01602562|447562443|FG001|Overall Study|Withdrawal by Subject|1|||
124437343|NCT03881553|447562444|FG000|Overall Study|Discharged prior to participation|1|||
124879444|NCT02392611|449182459|FG002|Overall Study|Adverse Event|0|||
124879445|NCT02392611|449182460|FG003|Overall Study|Adverse Event|1|||
124437344|NCT03881553|447562445|FG001|Overall Study|Discharged prior to participation|1|||
124437345|NCT03881553|447562446|FG002|Overall Study|Discharged prior to participation|0|||
124437346|NCT03881553|447562444|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
124437347|NCT03881553|447562445|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
124437348|NCT03881553|447562446|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
124437349|NCT01959516|447562448|FG000|Epoch 1|Adverse Event|4|||
124437350|NCT01959516|447562449|FG001|Epoch 1|Adverse Event|1|||
124437351|NCT01959516|447562448|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
124437352|NCT01959516|447562449|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
124437353|NCT01959516|447562448|FG000|Epoch 1|Subject withdrew consent|3|||
124437354|NCT01959516|447562449|FG001|Epoch 1|Subject withdrew consent|2|||
124437355|NCT01959516|447562448|FG000|Epoch 1|Administrative problems|1|||
124437356|NCT01959516|447562449|FG001|Epoch 1|Administrative problems|0|||
124437357|NCT01959516|447562448|FG000|Epoch 1|Use of prohibited treatment|1|||
124437358|NCT01959516|447562449|FG001|Epoch 1|Use of prohibited treatment|0|||
124437359|NCT01959516|447562448|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
124437360|NCT01959516|447562449|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
124437361|NCT01959516|447562448|FG000|Epoch 1|Protocol deviation|0|||
124437362|NCT01959516|447562449|FG001|Epoch 1|Protocol deviation|1|||
124437363|NCT01959516|447562448|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
124437364|NCT01959516|447562449|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
124437365|NCT01959516|447562448|FG000|Epoch 2|Subject withdrew consent|1|||
124437366|NCT01959516|447562449|FG001|Epoch 2|Subject withdrew consent|0|||
124437367|NCT01959516|447562448|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
124437368|NCT01959516|447562449|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
124437369|NCT01477333|447562450|FG000|Overall Study|Adverse Event|1|||
124437370|NCT01477333|447562450|FG000|Overall Study|Withdrawal by Subject|1|||
124437371|NCT01477333|447562450|FG000|Overall Study|Clinical Deterioration|1|||
124437372|NCT00928746|447562456|FG000|Overall Study|Adverse Event|2|||
124437373|NCT00928746|447562456|FG000|Overall Study|Protocol Violation|1|||
124437374|NCT00928746|447562456|FG000|Overall Study|Withdrawal by Subject|1|||
124437375|NCT00928746|447562456|FG000|Overall Study|Other|2|||
124437376|NCT02004353|447562462|FG000|Overall Study|Voluntary participation|1334|||
124437377|NCT01691768|447562463|FG000|Overall Study|Death|0|||
124437378|NCT01691768|447562464|FG001|Overall Study|Death|2|||
124437379|NCT01691768|447562463|FG000|Overall Study|Lost to Follow-up|4|||
124437380|NCT01691768|447562464|FG001|Overall Study|Lost to Follow-up|3|||
124437381|NCT01691768|447562463|FG000|Overall Study|Withdrawal by Subject|10|||
124437382|NCT01691768|447562464|FG001|Overall Study|Withdrawal by Subject|9|||
124437383|NCT01691768|447562463|FG000|Overall Study|Relocated|0|||
124437384|NCT01691768|447562464|FG001|Overall Study|Relocated|1|||
124437385|NCT01691768|447562463|FG000|Overall Study|Investigator decision|1|||
124437386|NCT01691768|447562464|FG001|Overall Study|Investigator decision|1|||
124437387|NCT02581631|447562465|FG000|Overall Study|Disease progression|29|||
124437388|NCT02581631|447562466|FG001|Overall Study|Disease progression|19|||
124437389|NCT02581631|447562467|FG002|Overall Study|Disease progression|13|||
124437390|NCT02581631|447562468|FG003|Overall Study|Disease progression|5|||
124437391|NCT02581631|447562469|FG004|Overall Study|Disease progression|8|||
124437392|NCT02581631|447562465|FG000|Overall Study|Study drug toxicity|4|||
124437393|NCT02581631|447562466|FG001|Overall Study|Study drug toxicity|6|||
124437394|NCT02581631|447562467|FG002|Overall Study|Study drug toxicity|7|||
124437395|NCT02581631|447562468|FG003|Overall Study|Study drug toxicity|0|||
124437396|NCT02581631|447562469|FG004|Overall Study|Study drug toxicity|3|||
124437397|NCT02581631|447562465|FG000|Overall Study|AE unrelated to study drug|3|||
124879446|NCT02392611|449182461|FG004|Overall Study|Adverse Event|0|||
124879447|NCT02392611|449182462|FG005|Overall Study|Adverse Event|0|||
124879448|NCT02392611|449182463|FG006|Overall Study|Adverse Event|0|||
124437398|NCT02581631|447562466|FG001|Overall Study|AE unrelated to study drug|1|||
124437399|NCT02581631|447562467|FG002|Overall Study|AE unrelated to study drug|1|||
124437400|NCT02581631|447562468|FG003|Overall Study|AE unrelated to study drug|0|||
124437401|NCT02581631|447562469|FG004|Overall Study|AE unrelated to study drug|2|||
124437402|NCT02581631|447562465|FG000|Overall Study|Request to discontinue|1|||
124437403|NCT02581631|447562466|FG001|Overall Study|Request to discontinue|0|||
124437404|NCT02581631|447562467|FG002|Overall Study|Request to discontinue|3|||
124437405|NCT02581631|447562468|FG003|Overall Study|Request to discontinue|0|||
124437406|NCT02581631|447562469|FG004|Overall Study|Request to discontinue|1|||
124437407|NCT02581631|447562465|FG000|Overall Study|participant withdrew consent|3|||
124437408|NCT02581631|447562466|FG001|Overall Study|participant withdrew consent|0|||
124879449|NCT02392611|449182464|FG007|Overall Study|Adverse Event|0|||
124879450|NCT02392611|449182465|FG008|Overall Study|Adverse Event|0|||
124437409|NCT02581631|447562467|FG002|Overall Study|participant withdrew consent|1|||
124437410|NCT02581631|447562468|FG003|Overall Study|participant withdrew consent|0|||
124437411|NCT02581631|447562469|FG004|Overall Study|participant withdrew consent|0|||
124437412|NCT02581631|447562465|FG000|Overall Study|Maximum clinical benefit|1|||
124679498|NCT01232283|448449706|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
124679499|NCT01232283|448449707|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
124879451|NCT02392611|449182457|FG000|Overall Study|Progressive disease|0|||
124437413|NCT02581631|447562466|FG001|Overall Study|Maximum clinical benefit|7|||
124437414|NCT02581631|447562467|FG002|Overall Study|Maximum clinical benefit|1|||
124437415|NCT02581631|447562468|FG003|Overall Study|Maximum clinical benefit|3|||
124879452|NCT02392611|449182458|FG001|Overall Study|Progressive disease|0|||
124437416|NCT02581631|447562469|FG004|Overall Study|Maximum clinical benefit|13|||
124437417|NCT02581631|447562465|FG000|Overall Study|Other Reasons|1|||
124679500|NCT01232283|448449708|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
124679501|NCT01232283|448449709|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
124679502|NCT01232283|448449710|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
124679503|NCT01232283|448449711|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
124679504|NCT01232283|448449712|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
124679505|NCT01232283|448449713|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
124679506|NCT01232283|448449714|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
124679507|NCT01232283|448449715|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
124679508|NCT00402831|448449716|FG000|Overall Study|Lost to Follow-up|1|||
124679509|NCT00402831|448449717|FG001|Overall Study|Lost to Follow-up|2|||
124679510|NCT00402831|448449716|FG000|Overall Study|Non-compliance with protocol|0|||
124679511|NCT00402831|448449717|FG001|Overall Study|Non-compliance with protocol|1|||
124679512|NCT03883386|448449728|FG000|First Assignment|Lost to Follow-up|1|||
124679513|NCT03883386|448449729|FG001|First Assignment|Lost to Follow-up|0|||
124679514|NCT03883386|448449728|FG000|First Assignment|Withdrawal by Subject|1|||
124679515|NCT03883386|448449729|FG001|First Assignment|Withdrawal by Subject|1|||
124679516|NCT02814526|448449730|FG000|Overall Study|Adverse Event|4|||
124679517|NCT02814526|448449731|FG001|Overall Study|Adverse Event|3|||
124679518|NCT02814526|448449730|FG000|Overall Study|Death|1|||
124679519|NCT02814526|448449731|FG001|Overall Study|Death|1|||
124679520|NCT02814526|448449730|FG000|Overall Study|Lost to Follow-up|3|||
124679521|NCT02814526|448449731|FG001|Overall Study|Lost to Follow-up|4|||
124679522|NCT02814526|448449730|FG000|Overall Study|non site physician decision|1|||
124679523|NCT02814526|448449731|FG001|Overall Study|non site physician decision|0|||
124679524|NCT02814526|448449730|FG000|Overall Study|participant noncompliance|1|||
124679525|NCT02814526|448449731|FG001|Overall Study|participant noncompliance|1|||
124679526|NCT02814526|448449730|FG000|Overall Study|Withdrawal by Subject|20|||
124679527|NCT02814526|448449731|FG001|Overall Study|Withdrawal by Subject|14|||
124679528|NCT02814526|448449730|FG000|Overall Study|safety risk|2|||
124679529|NCT02814526|448449731|FG001|Overall Study|safety risk|1|||
124679530|NCT02814526|448449730|FG000|Overall Study|early termination-study terminated|1|||
124679531|NCT02814526|448449731|FG001|Overall Study|early termination-study terminated|2|||
124679532|NCT02814526|448449730|FG000|Overall Study|Other|0|||
124679533|NCT02814526|448449731|FG001|Overall Study|Other|4|||
124679534|NCT00251758|448449732|FG000|Overall Study|Adverse Event|7|||
124679535|NCT00251758|448449733|FG001|Overall Study|Adverse Event|9|||
124679536|NCT00251758|448449734|FG002|Overall Study|Adverse Event|11|||
124879453|NCT02392611|449182459|FG002|Overall Study|Progressive disease|0|||
124679537|NCT00251758|448449732|FG000|Overall Study|Lost to Follow-up|4|||
124679538|NCT00251758|448449733|FG001|Overall Study|Lost to Follow-up|2|||
124679539|NCT00251758|448449734|FG002|Overall Study|Lost to Follow-up|5|||
124679540|NCT00251758|448449732|FG000|Overall Study|Withdrawal by Subject|13|||
124679541|NCT00251758|448449733|FG001|Overall Study|Withdrawal by Subject|7|||
124679542|NCT00251758|448449734|FG002|Overall Study|Withdrawal by Subject|3|||
124437418|NCT02581631|447562466|FG001|Overall Study|Other Reasons|0|||
124879454|NCT02392611|449182460|FG003|Overall Study|Progressive disease|2|||
124879455|NCT02392611|449182461|FG004|Overall Study|Progressive disease|1|||
124879456|NCT02392611|449182462|FG005|Overall Study|Progressive disease|0|||
124879457|NCT02392611|449182463|FG006|Overall Study|Progressive disease|0|||
124879458|NCT02392611|449182464|FG007|Overall Study|Progressive disease|0|||
124879459|NCT02392611|449182465|FG008|Overall Study|Progressive disease|0|||
124879460|NCT02392611|449182457|FG000|Overall Study|Death|1|||
124879461|NCT02392611|449182458|FG001|Overall Study|Death|0|||
124879462|NCT02392611|449182459|FG002|Overall Study|Death|0|||
124879463|NCT02392611|449182460|FG003|Overall Study|Death|0|||
124879464|NCT02392611|449182461|FG004|Overall Study|Death|0|||
124879465|NCT02392611|449182462|FG005|Overall Study|Death|1|||
124879466|NCT02392611|449182463|FG006|Overall Study|Death|0|||
124879467|NCT02392611|449182464|FG007|Overall Study|Death|0|||
124879468|NCT02392611|449182465|FG008|Overall Study|Death|0|||
124879469|NCT02392611|449182457|FG000|Overall Study|Withdrawal by Subject|0|||
124879470|NCT02392611|449182458|FG001|Overall Study|Withdrawal by Subject|0|||
124879471|NCT02392611|449182459|FG002|Overall Study|Withdrawal by Subject|0|||
124879472|NCT02392611|449182460|FG003|Overall Study|Withdrawal by Subject|1|||
124879473|NCT02392611|449182461|FG004|Overall Study|Withdrawal by Subject|0|||
124879474|NCT02392611|449182462|FG005|Overall Study|Withdrawal by Subject|0|||
124879475|NCT02392611|449182463|FG006|Overall Study|Withdrawal by Subject|0|||
124437419|NCT02581631|447562467|FG002|Overall Study|Other Reasons|2|||
124437420|NCT02581631|447562468|FG003|Overall Study|Other Reasons|2|||
124437421|NCT02581631|447562469|FG004|Overall Study|Other Reasons|3|||
124437422|NCT02581631|447562465|FG000|Overall Study|Poor/Non-Compliance|0|||
124437423|NCT02581631|447562466|FG001|Overall Study|Poor/Non-Compliance|0|||
124437424|NCT02581631|447562467|FG002|Overall Study|Poor/Non-Compliance|1|||
124437425|NCT02581631|447562468|FG003|Overall Study|Poor/Non-Compliance|0|||
124437426|NCT02581631|447562469|FG004|Overall Study|Poor/Non-Compliance|0|||
124437427|NCT00819390|447562470|FG000|Overall Study|Lost to Follow-up|1|||
124437428|NCT00819390|447562471|FG001|Overall Study|Lost to Follow-up|1|||
124437429|NCT00819390|447562472|FG002|Overall Study|Lost to Follow-up|0|||
124437430|NCT00819390|447562473|FG003|Overall Study|Lost to Follow-up|0|||
124437431|NCT00819390|447562470|FG000|Overall Study|Withdrawal by Subject|2|||
124437432|NCT00819390|447562471|FG001|Overall Study|Withdrawal by Subject|0|||
124437433|NCT00819390|447562472|FG002|Overall Study|Withdrawal by Subject|0|||
124437434|NCT00819390|447562473|FG003|Overall Study|Withdrawal by Subject|0|||
124437435|NCT00819390|447562470|FG000|Overall Study|Adverse Event|0|||
124437436|NCT00819390|447562471|FG001|Overall Study|Adverse Event|0|||
124437437|NCT00819390|447562472|FG002|Overall Study|Adverse Event|1|||
124437438|NCT00819390|447562473|FG003|Overall Study|Adverse Event|0|||
124437439|NCT01759368|447562474|FG000|Overall Study|Lost to Follow-up|1|||
124437440|NCT01759368|447562475|FG001|Overall Study|Lost to Follow-up|0|||
124437441|NCT01191268|447562482|FG000|Overall Study|Withdrawal by Subject|19|||
124437442|NCT01191268|447562483|FG001|Overall Study|Withdrawal by Subject|25|||
124437443|NCT01191268|447562484|FG002|Overall Study|Withdrawal by Subject|21|||
124437444|NCT01191268|447562482|FG000|Overall Study|Adverse Event|21|||
124437445|NCT01191268|447562483|FG001|Overall Study|Adverse Event|13|||
124437446|NCT01191268|447562484|FG002|Overall Study|Adverse Event|8|||
124437447|NCT01191268|447562482|FG000|Overall Study|Physician Decision|6|||
124437448|NCT01191268|447562483|FG001|Overall Study|Physician Decision|8|||
124437449|NCT01191268|447562484|FG002|Overall Study|Physician Decision|9|||
124437450|NCT01191268|447562482|FG000|Overall Study|Lost to Follow-up|8|||
124437451|NCT01191268|447562483|FG001|Overall Study|Lost to Follow-up|5|||
124437452|NCT01191268|447562484|FG002|Overall Study|Lost to Follow-up|9|||
124437453|NCT01191268|447562482|FG000|Overall Study|Entry Criteria Not Met|3|||
124437454|NCT01191268|447562483|FG001|Overall Study|Entry Criteria Not Met|1|||
124437455|NCT01191268|447562484|FG002|Overall Study|Entry Criteria Not Met|1|||
124437456|NCT01191268|447562482|FG000|Overall Study|Death|0|||
124437457|NCT01191268|447562483|FG001|Overall Study|Death|1|||
124437458|NCT01191268|447562484|FG002|Overall Study|Death|3|||
124437459|NCT01191268|447562482|FG000|Overall Study|Protocol Violation|1|||
124437460|NCT01191268|447562483|FG001|Overall Study|Protocol Violation|0|||
124437461|NCT01191268|447562484|FG002|Overall Study|Protocol Violation|1|||
124437462|NCT01191268|447562482|FG000|Overall Study|Sponsor Decision|0|||
124437463|NCT01191268|447562483|FG001|Overall Study|Sponsor Decision|2|||
124679543|NCT00251758|448449732|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
124679544|NCT00251758|448449733|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
124679545|NCT00251758|448449734|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
124679546|NCT00251758|448449732|FG000|Overall Study|Lack of Efficacy|3|||
124679547|NCT00251758|448449733|FG001|Overall Study|Lack of Efficacy|0|||
124679548|NCT00251758|448449734|FG002|Overall Study|Lack of Efficacy|0|||
124679549|NCT00251758|448449732|FG000|Overall Study|Noncompliant|0|||
124679550|NCT00251758|448449733|FG001|Overall Study|Noncompliant|2|||
124679551|NCT00251758|448449734|FG002|Overall Study|Noncompliant|2|||
124679552|NCT00251758|448449732|FG000|Overall Study|Pregnancy|0|||
124437464|NCT01191268|447562484|FG002|Overall Study|Sponsor Decision|0|||
124437465|NCT01270971|447562487|FG000|Overall Study|Withdrawal by Subject|24|||
124679553|NCT00251758|448449733|FG001|Overall Study|Pregnancy|1|||
124679554|NCT00251758|448449734|FG002|Overall Study|Pregnancy|0|||
124679555|NCT00251758|448449732|FG000|Overall Study|Per Subject Request|0|||
124679556|NCT00251758|448449733|FG001|Overall Study|Per Subject Request|0|||
124679557|NCT00251758|448449734|FG002|Overall Study|Per Subject Request|1|||
124679558|NCT00251758|448449732|FG000|Overall Study|Per Investigator Request|1|||
124679559|NCT00251758|448449733|FG001|Overall Study|Per Investigator Request|0|||
124679560|NCT00251758|448449734|FG002|Overall Study|Per Investigator Request|0|||
124679561|NCT03573297|448449746|FG000|Open Label Treatment Period|Adverse Event|67|||
124679562|NCT03573297|448449747|FG001|Open Label Treatment Period|Adverse Event|0|||
124679563|NCT03573297|448449748|FG002|Open Label Treatment Period|Adverse Event|0|||
124437466|NCT01270971|447562488|FG001|Overall Study|Withdrawal by Subject|11|||
124437467|NCT01270971|447562487|FG000|Overall Study|Lost to Follow-up|18|||
124437468|NCT01270971|447562488|FG001|Overall Study|Lost to Follow-up|5|||
124437469|NCT01270971|447562487|FG000|Overall Study|Adverse Event|1|||
124437470|NCT01270971|447562488|FG001|Overall Study|Adverse Event|2|||
124437471|NCT01270971|447562487|FG000|Overall Study|Non compliance|2|||
124437472|NCT01270971|447562488|FG001|Overall Study|Non compliance|2|||
124437473|NCT01270971|447562487|FG000|Overall Study|Non-specific|7|||
124437474|NCT01270971|447562488|FG001|Overall Study|Non-specific|3|||
124437475|NCT01588496|447562492|FG000|Overall Study|Withdrawal by Subject|0|||
124437476|NCT01588496|447562493|FG001|Overall Study|Withdrawal by Subject|1|||
124879476|NCT02392611|449182464|FG007|Overall Study|Withdrawal by Subject|0|||
124879477|NCT02392611|449182465|FG008|Overall Study|Withdrawal by Subject|0|||
124879478|NCT02392611|449182457|FG000|Overall Study|Lost to Follow-up|0|||
124879479|NCT02392611|449182458|FG001|Overall Study|Lost to Follow-up|0|||
124879480|NCT02392611|449182459|FG002|Overall Study|Lost to Follow-up|0|||
124879481|NCT02392611|449182460|FG003|Overall Study|Lost to Follow-up|0|||
124879482|NCT02392611|449182461|FG004|Overall Study|Lost to Follow-up|0|||
124879483|NCT02392611|449182462|FG005|Overall Study|Lost to Follow-up|0|||
124879484|NCT02392611|449182463|FG006|Overall Study|Lost to Follow-up|1|||
124879485|NCT02392611|449182464|FG007|Overall Study|Lost to Follow-up|0|||
124879486|NCT02392611|449182465|FG008|Overall Study|Lost to Follow-up|0|||
124879487|NCT02392611|449182457|FG000|Overall Study|Enrolled, not treated|0|||
124879488|NCT02392611|449182458|FG001|Overall Study|Enrolled, not treated|0|||
124879489|NCT02392611|449182459|FG002|Overall Study|Enrolled, not treated|0|||
124879490|NCT02392611|449182460|FG003|Overall Study|Enrolled, not treated|2|||
124879491|NCT02392611|449182461|FG004|Overall Study|Enrolled, not treated|0|||
124879492|NCT02392611|449182462|FG005|Overall Study|Enrolled, not treated|0|||
124879493|NCT02392611|449182463|FG006|Overall Study|Enrolled, not treated|0|||
124879494|NCT02392611|449182464|FG007|Overall Study|Enrolled, not treated|0|||
124879495|NCT02392611|449182465|FG008|Overall Study|Enrolled, not treated|0|||
124879496|NCT02110732|449182481|FG000|Overall Study|Physician Decision|5|||
124879497|NCT02110732|449182482|FG001|Overall Study|Physician Decision|2|||
124879498|NCT02110732|449182481|FG000|Overall Study|Lost to Follow-up|1|||
124879499|NCT02110732|449182482|FG001|Overall Study|Lost to Follow-up|1|||
124879500|NCT04836858|449182483|FG000|Overall Study|Adverse Event|0|||
124879501|NCT04836858|449182484|FG001|Overall Study|Adverse Event|0|||
124879502|NCT04836858|449182485|FG002|Overall Study|Adverse Event|0|||
124879503|NCT04836858|449182486|FG003|Overall Study|Adverse Event|1|||
124879504|NCT04836858|449182483|FG000|Overall Study|Lost to Follow-up|1|||
124879505|NCT04836858|449182484|FG001|Overall Study|Lost to Follow-up|0|||
124437477|NCT01588496|447562494|FG002|Overall Study|Withdrawal by Subject|0|||
124437478|NCT03333837|447562497|FG000|Overall Study|Adverse Event|2|||
124437479|NCT03333837|447562498|FG001|Overall Study|Adverse Event|1|||
124437480|NCT03333837|447562499|FG002|Overall Study|Adverse Event|1|||
124437481|NCT03333837|447562500|FG003|Overall Study|Adverse Event|1|||
124437482|NCT03333837|447562501|FG004|Overall Study|Adverse Event|0|||
124437483|NCT03333837|447562497|FG000|Overall Study|Caregiver withdrew|0|||
124437484|NCT03333837|447562498|FG001|Overall Study|Caregiver withdrew|2|||
124437485|NCT03333837|447562499|FG002|Overall Study|Caregiver withdrew|1|||
124437486|NCT03333837|447562500|FG003|Overall Study|Caregiver withdrew|0|||
124437487|NCT03333837|447562501|FG004|Overall Study|Caregiver withdrew|0|||
124437488|NCT03333837|447562497|FG000|Overall Study|Withdrawal by Subject|0|||
124437489|NCT03333837|447562498|FG001|Overall Study|Withdrawal by Subject|0|||
124437490|NCT03333837|447562499|FG002|Overall Study|Withdrawal by Subject|1|||
124437491|NCT03333837|447562500|FG003|Overall Study|Withdrawal by Subject|1|||
124437492|NCT03333837|447562501|FG004|Overall Study|Withdrawal by Subject|3|||
124437493|NCT03333837|447562497|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
124437494|NCT03333837|447562498|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
124437495|NCT03333837|447562499|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
124437496|NCT03333837|447562500|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
124437497|NCT03333837|447562501|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
124437498|NCT00705523|447562502|FG000|Overall Study|Lost to Follow-up|2|||
124437499|NCT00705523|447562503|FG001|Overall Study|Lost to Follow-up|3|||
124437500|NCT01013285|447562506|FG000|Overall Study|Death|48|||
124437501|NCT01013285|447562507|FG001|Overall Study|Death|89|||
124437502|NCT02003573|447562508|FG000|Overall Study|Progressive disease|2|||
124437503|NCT02003573|447562509|FG001|Overall Study|Progressive disease|0|||
124437504|NCT02003573|447562510|FG002|Overall Study|Progressive disease|1|||
124437505|NCT02003573|447562508|FG000|Overall Study|Other Adverse event|0|||
124437506|NCT02003573|447562509|FG001|Overall Study|Other Adverse event|1|||
124437507|NCT02003573|447562510|FG002|Overall Study|Other Adverse event|1|||
124437508|NCT02003573|447562508|FG000|Overall Study|Refuse to take trial medication|0|||
124437509|NCT02003573|447562509|FG001|Overall Study|Refuse to take trial medication|1|||
124679564|NCT03573297|448449749|FG003|Open Label Treatment Period|Adverse Event|0|||
124879506|NCT04836858|449182485|FG002|Overall Study|Lost to Follow-up|0|||
124879507|NCT04836858|449182486|FG003|Overall Study|Lost to Follow-up|0|||
124879508|NCT04836858|449182483|FG000|Overall Study|Subject/Guardian decision|3|||
124879509|NCT04836858|449182484|FG001|Overall Study|Subject/Guardian decision|0|||
124879510|NCT04836858|449182485|FG002|Overall Study|Subject/Guardian decision|0|||
124879511|NCT04836858|449182486|FG003|Overall Study|Subject/Guardian decision|1|||
124879512|NCT04836858|449182483|FG000|Overall Study|Randomized but not treated|4|||
124879513|NCT04836858|449182484|FG001|Overall Study|Randomized but not treated|0|||
124437510|NCT02003573|447562510|FG002|Overall Study|Refuse to take trial medication|1|||
124437511|NCT02003573|447562508|FG000|Overall Study|Other than specified|1|||
124437512|NCT02003573|447562509|FG001|Overall Study|Other than specified|2|||
124437513|NCT02003573|447562510|FG002|Overall Study|Other than specified|3|||
124437514|NCT02640157|447562515|FG000|Overall Study|Adverse Event|2|||
124437515|NCT02640157|447562516|FG001|Overall Study|Adverse Event|2|||
124437516|NCT02640157|447562517|FG002|Overall Study|Adverse Event|1|||
124437517|NCT02640157|447562515|FG000|Overall Study|Withdrew consent|2|||
124679565|NCT03573297|448449746|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
124679566|NCT03573297|448449747|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
124679567|NCT03573297|448449748|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
124679568|NCT03573297|448449749|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
124679569|NCT03573297|448449746|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
124679570|NCT03573297|448449747|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
124679571|NCT03573297|448449748|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
124679572|NCT03573297|448449749|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
124879514|NCT04836858|449182485|FG002|Overall Study|Randomized but not treated|0|||
124879515|NCT04836858|449182486|FG003|Overall Study|Randomized but not treated|0|||
124437518|NCT02640157|447562516|FG001|Overall Study|Withdrew consent|0|||
124437519|NCT02640157|447562517|FG002|Overall Study|Withdrew consent|2|||
124437520|NCT02640157|447562515|FG000|Overall Study|Lost to Follow-up|9|||
124437521|NCT02640157|447562516|FG001|Overall Study|Lost to Follow-up|2|||
124437522|NCT02640157|447562517|FG002|Overall Study|Lost to Follow-up|7|||
124437523|NCT02640157|447562515|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
124437524|NCT02640157|447562516|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
124437525|NCT02640157|447562517|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
124437526|NCT04677179|447562518|FG000|Induction Treatment Period|Adverse Event|1|||
124437527|NCT04677179|447562519|FG001|Induction Treatment Period|Adverse Event|0|||
124437528|NCT04677179|447562520|FG002|Induction Treatment Period|Adverse Event|0|||
124437529|NCT04677179|447562521|FG003|Induction Treatment Period|Adverse Event|0|||
124437530|NCT04677179|447562522|FG004|Induction Treatment Period|Adverse Event|0|||
124437531|NCT04677179|447562523|FG005|Induction Treatment Period|Adverse Event|0|||
124437532|NCT04677179|447562524|FG006|Induction Treatment Period|Adverse Event|0|||
124437533|NCT04677179|447562525|FG007|Induction Treatment Period|Adverse Event|0|||
124437534|NCT04677179|447562526|FG008|Induction Treatment Period|Adverse Event|0|||
124437535|NCT04677179|447562527|FG009|Induction Treatment Period|Adverse Event|0|||
124437536|NCT04677179|447562518|FG000|Induction Treatment Period|Physician Decision|1|||
124437537|NCT04677179|447562519|FG001|Induction Treatment Period|Physician Decision|0|||
124437538|NCT04677179|447562520|FG002|Induction Treatment Period|Physician Decision|1|||
124437539|NCT04677179|447562521|FG003|Induction Treatment Period|Physician Decision|0|||
124437540|NCT04677179|447562522|FG004|Induction Treatment Period|Physician Decision|0|||
124437541|NCT04677179|447562523|FG005|Induction Treatment Period|Physician Decision|0|||
124437542|NCT04677179|447562524|FG006|Induction Treatment Period|Physician Decision|0|||
124437543|NCT04677179|447562525|FG007|Induction Treatment Period|Physician Decision|0|||
124437544|NCT04677179|447562526|FG008|Induction Treatment Period|Physician Decision|0|||
124437545|NCT04677179|447562527|FG009|Induction Treatment Period|Physician Decision|0|||
124437546|NCT04677179|447562518|FG000|Induction Treatment Period|Protocol Violation|0|||
124437547|NCT04677179|447562519|FG001|Induction Treatment Period|Protocol Violation|1|||
124437548|NCT04677179|447562520|FG002|Induction Treatment Period|Protocol Violation|0|||
124437549|NCT04677179|447562521|FG003|Induction Treatment Period|Protocol Violation|0|||
124437550|NCT04677179|447562522|FG004|Induction Treatment Period|Protocol Violation|0|||
124437551|NCT04677179|447562523|FG005|Induction Treatment Period|Protocol Violation|0|||
124437552|NCT04677179|447562524|FG006|Induction Treatment Period|Protocol Violation|0|||
124437553|NCT04677179|447562525|FG007|Induction Treatment Period|Protocol Violation|0|||
124437554|NCT04677179|447562526|FG008|Induction Treatment Period|Protocol Violation|0|||
124437555|NCT04677179|447562527|FG009|Induction Treatment Period|Protocol Violation|0|||
124437556|NCT04677179|447562518|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
124437557|NCT04677179|447562519|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
124437558|NCT04677179|447562520|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
124437559|NCT04677179|447562521|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
124437560|NCT04677179|447562522|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
124437561|NCT04677179|447562523|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
124437562|NCT04677179|447562524|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
124879516|NCT00597714|449182489|FG000|Overall Study|Death|56|||
124879517|NCT00597714|449182490|FG001|Overall Study|Death|46|||
124879518|NCT00597714|449182491|FG002|Overall Study|Death|0|||
124879519|NCT00597714|449182489|FG000|Overall Study|Recipient death|0|||
124879520|NCT00597714|449182490|FG001|Overall Study|Recipient death|0|||
124879521|NCT00597714|449182491|FG002|Overall Study|Recipient death|10|||
124879522|NCT01350141|449182492|FG000|Overall Study|Lost to Follow-up|1|||
124437563|NCT04677179|447562525|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
124437564|NCT04677179|447562526|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
124437565|NCT04677179|447562527|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
124437566|NCT04677179|447562518|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
124437567|NCT04677179|447562519|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
124437568|NCT04677179|447562520|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
124437569|NCT04677179|447562521|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
124437570|NCT04677179|447562522|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
124437571|NCT04677179|447562523|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
124437572|NCT04677179|447562524|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
124437573|NCT04677179|447562525|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
124437574|NCT04677179|447562526|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
124437575|NCT04677179|447562527|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
124437576|NCT04677179|447562518|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
124437577|NCT04677179|447562519|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
124879523|NCT01350141|449182493|FG001|Overall Study|Lost to Follow-up|0|||
124879524|NCT01350141|449182494|FG002|Overall Study|Lost to Follow-up|1|||
124437578|NCT04677179|447562520|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
124879525|NCT01350141|449182492|FG000|Overall Study|Withdrawal by Subject|1|||
124879526|NCT01350141|449182493|FG001|Overall Study|Withdrawal by Subject|0|||
124879527|NCT01350141|449182494|FG002|Overall Study|Withdrawal by Subject|0|||
124879528|NCT01350141|449182492|FG000|Overall Study|Randomized but not treated|1|||
124879529|NCT01350141|449182493|FG001|Overall Study|Randomized but not treated|0|||
124879530|NCT01350141|449182494|FG002|Overall Study|Randomized but not treated|0|||
124879531|NCT00519896|449182495|FG000|Overall Study|Protocol Violation|1|||
124879532|NCT00519896|449182495|FG000|Overall Study|Adverse Event|1|||
124879533|NCT00810082|449182496|FG000|Overall Study|Lost to Follow-up|0|||
124879534|NCT00810082|449182497|FG001|Overall Study|Lost to Follow-up|4|||
124879535|NCT01588990|449182498|FG000|Phase A|Withdrawal by Subject|5|||
124879536|NCT01588990|449182498|FG000|Phase A|Physician Decision|11|||
124879537|NCT01588990|449182498|FG000|Phase A|Other|14|||
124879538|NCT01588990|449182498|FG000|Phase A|Lost to Follow-up|1|||
124879539|NCT01588990|449182498|FG000|Phase A|Death|5|||
124879540|NCT01588990|449182498|FG000|Phase A|Adverse Event|28|||
124879541|NCT01588990|449182498|FG000|Phase A|Still on therapy at end of study|6|||
124879542|NCT01588990|449182498|FG000|Phase B|Adverse Event|2|||
124879543|NCT01588990|449182498|FG000|Phase B|Still on therapy at end of study|5|||
124879544|NCT01588990|449182498|FG000|Phase B|Withdrawal by Subject|3|||
124879545|NCT01588990|449182498|FG000|Phase B|Physician Decision|4|||
124879546|NCT01588990|449182498|FG000|Phase B|Other|2|||
124437579|NCT04677179|447562521|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
124437580|NCT04677179|447562522|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
124437581|NCT04677179|447562523|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
124437582|NCT04677179|447562524|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
124437583|NCT04677179|447562525|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
124879547|NCT02367716|449182499|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
124879548|NCT01641926|449182507|FG000|Overall Study|Adverse Event|5|||
124879549|NCT01641926|449182508|FG001|Overall Study|Adverse Event|2|||
124879550|NCT01641926|449182509|FG002|Overall Study|Adverse Event|3|||
124437584|NCT04677179|447562526|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
124437585|NCT04677179|447562527|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
124437586|NCT04677179|447562518|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
124437587|NCT04677179|447562519|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
124437588|NCT04677179|447562520|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
124437589|NCT04677179|447562521|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
124437590|NCT04677179|447562522|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
124437591|NCT04677179|447562523|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
124437592|NCT04677179|447562524|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
124437593|NCT04677179|447562525|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
124437594|NCT04677179|447562526|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
124437595|NCT04677179|447562527|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
124437596|NCT04677179|447562518|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
124437597|NCT04677179|447562519|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
124437598|NCT04677179|447562520|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
124437599|NCT04677179|447562521|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
124437600|NCT04677179|447562522|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
124437601|NCT04677179|447562523|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
124437602|NCT04677179|447562524|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
124437603|NCT04677179|447562525|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
124437604|NCT04677179|447562526|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
124437605|NCT04677179|447562527|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
124437606|NCT04677179|447562518|FG000|Extension Treatment Period|Lack of Efficacy|0|||
124437607|NCT04677179|447562519|FG001|Extension Treatment Period|Lack of Efficacy|0|||
124437608|NCT04677179|447562520|FG002|Extension Treatment Period|Lack of Efficacy|0|||
124437609|NCT04677179|447562521|FG003|Extension Treatment Period|Lack of Efficacy|0|||
124437610|NCT04677179|447562522|FG004|Extension Treatment Period|Lack of Efficacy|0|||
124437611|NCT04677179|447562523|FG005|Extension Treatment Period|Lack of Efficacy|0|||
124437612|NCT04677179|447562524|FG006|Extension Treatment Period|Lack of Efficacy|6|||
124437613|NCT04677179|447562525|FG007|Extension Treatment Period|Lack of Efficacy|0|||
124437614|NCT04677179|447562526|FG008|Extension Treatment Period|Lack of Efficacy|0|||
124437615|NCT04677179|447562527|FG009|Extension Treatment Period|Lack of Efficacy|0|||
124437616|NCT04677179|447562518|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
124437617|NCT04677179|447562519|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
124437618|NCT04677179|447562520|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
124437619|NCT04677179|447562521|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
124437620|NCT04677179|447562522|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
124437621|NCT04677179|447562523|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
124437622|NCT04677179|447562524|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
124437623|NCT04677179|447562525|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
124437624|NCT04677179|447562526|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
124437625|NCT04677179|447562527|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
124437626|NCT04677179|447562518|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
124437627|NCT04677179|447562519|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
124437628|NCT04677179|447562520|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
124437629|NCT04677179|447562521|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
124437630|NCT04677179|447562522|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
124437631|NCT04677179|447562523|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
124437632|NCT04677179|447562524|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
124437633|NCT04677179|447562525|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
124437634|NCT04677179|447562526|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
124437635|NCT04677179|447562527|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
124437636|NCT04677179|447562518|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
124437637|NCT04677179|447562519|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
124437638|NCT04677179|447562520|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
124437639|NCT04677179|447562521|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
124437640|NCT04677179|447562522|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
124437641|NCT04677179|447562523|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
124437642|NCT04677179|447562524|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
124437643|NCT04677179|447562525|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
124437644|NCT04677179|447562526|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
124437645|NCT04677179|447562527|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
124437646|NCT04677179|447562518|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
124437647|NCT04677179|447562519|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
124437648|NCT04677179|447562520|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
124437649|NCT04677179|447562521|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
124437650|NCT04677179|447562522|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
124437651|NCT04677179|447562523|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
124437652|NCT04677179|447562524|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
124437653|NCT04677179|447562525|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
124437654|NCT04677179|447562526|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
124437655|NCT04677179|447562527|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
124437656|NCT04677179|447562518|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124437657|NCT04677179|447562519|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124437658|NCT04677179|447562520|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124437659|NCT04677179|447562521|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124437660|NCT04677179|447562522|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124437661|NCT04677179|447562523|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124437662|NCT04677179|447562524|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124437663|NCT04677179|447562525|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
124437664|NCT04677179|447562526|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124437665|NCT04677179|447562527|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
124437666|NCT04677179|447562518|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124437667|NCT04677179|447562519|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124437668|NCT04677179|447562520|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124437669|NCT04677179|447562521|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124437670|NCT04677179|447562522|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124437671|NCT04677179|447562523|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124437672|NCT04677179|447562524|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124437673|NCT04677179|447562525|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
124437674|NCT04677179|447562526|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
124437675|NCT04677179|447562527|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
124437676|NCT04677179|447562518|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
124437677|NCT04677179|447562519|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
124437678|NCT04677179|447562520|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
124437679|NCT04677179|447562521|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
124437680|NCT04677179|447562522|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
124879551|NCT01641926|449182510|FG003|Overall Study|Adverse Event|1|||
124879552|NCT01641926|449182507|FG000|Overall Study|Lost to Follow-up|2|||
124879553|NCT01641926|449182508|FG001|Overall Study|Lost to Follow-up|2|||
124879554|NCT01641926|449182509|FG002|Overall Study|Lost to Follow-up|1|||
124437681|NCT04677179|447562523|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
124437682|NCT04677179|447562524|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
124437683|NCT04677179|447562525|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
124437684|NCT04677179|447562526|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
124437685|NCT04677179|447562527|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
124437686|NCT02374671|447562528|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
124437687|NCT02374671|447562529|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
124679573|NCT03573297|448449746|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
124679574|NCT03573297|448449747|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
124679575|NCT03573297|448449748|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
124679576|NCT03573297|448449749|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
124679577|NCT03573297|448449746|FG000|Open Label Treatment Period|Pregnancy|1|||
124679578|NCT03573297|448449747|FG001|Open Label Treatment Period|Pregnancy|0|||
124679579|NCT03573297|448449748|FG002|Open Label Treatment Period|Pregnancy|0|||
124679580|NCT03573297|448449749|FG003|Open Label Treatment Period|Pregnancy|0|||
124679581|NCT03573297|448449746|FG000|Open Label Treatment Period|Protocol Violation|17|||
124679582|NCT03573297|448449747|FG001|Open Label Treatment Period|Protocol Violation|0|||
124679583|NCT03573297|448449748|FG002|Open Label Treatment Period|Protocol Violation|0|||
124679584|NCT03573297|448449749|FG003|Open Label Treatment Period|Protocol Violation|0|||
124679585|NCT03573297|448449746|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
124679586|NCT03573297|448449747|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
124679587|NCT03573297|448449748|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
124679588|NCT03573297|448449749|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
124679589|NCT03573297|448449746|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
124679590|NCT03573297|448449747|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
124679591|NCT03573297|448449748|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
124879555|NCT01641926|449182510|FG003|Overall Study|Lost to Follow-up|0|||
124879556|NCT01641926|449182507|FG000|Overall Study|Physician Decision|6|||
124879557|NCT01641926|449182508|FG001|Overall Study|Physician Decision|5|||
124879558|NCT01641926|449182509|FG002|Overall Study|Physician Decision|0|||
124679592|NCT03573297|448449749|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
124879559|NCT01641926|449182510|FG003|Overall Study|Physician Decision|1|||
124879560|NCT01641926|449182507|FG000|Overall Study|Protocol Violation|1|||
124879561|NCT01641926|449182508|FG001|Overall Study|Protocol Violation|0|||
124879562|NCT01641926|449182509|FG002|Overall Study|Protocol Violation|0|||
124879563|NCT01641926|449182510|FG003|Overall Study|Protocol Violation|1|||
124437688|NCT02374671|447562530|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
124437689|NCT02374671|447562528|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
124437690|NCT02374671|447562529|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
124437691|NCT02374671|447562530|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
124437692|NCT02374671|447562528|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
124437693|NCT02374671|447562529|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
124437694|NCT02374671|447562530|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
124437695|NCT02374671|447562528|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
124437696|NCT02374671|447562529|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
124437697|NCT02374671|447562530|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
124437698|NCT02374671|447562528|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
124437699|NCT02374671|447562529|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
124437700|NCT02374671|447562530|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
124437701|NCT03866473|447562533|FG000|Phase 1|Death|1|||
124437702|NCT03866473|447562534|FG001|Phase 1|Death|0|||
124437703|NCT03866473|447562533|FG000|Phase 2|Death|0|||
124437704|NCT03866473|447562534|FG001|Phase 2|Death|2|||
124437705|NCT03866473|447562533|FG000|Phase 2|Dropped|1|||
124437706|NCT03866473|447562534|FG001|Phase 2|Dropped|1|||
124437707|NCT03866473|447562533|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
124437708|NCT03866473|447562534|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
124437709|NCT03110185|447562535|FG000|Overall Study|Death|0|||
124437710|NCT03110185|447562536|FG001|Overall Study|Death|1|||
124437711|NCT03110185|447562535|FG000|Overall Study|Withdrawal by Subject|2|||
124437712|NCT03110185|447562536|FG001|Overall Study|Withdrawal by Subject|7|||
124437713|NCT03110185|447562535|FG000|Overall Study|Time Constraints|0|||
124437714|NCT03110185|447562536|FG001|Overall Study|Time Constraints|6|||
124437715|NCT03110185|447562535|FG000|Overall Study|Conflict with care|5|||
124437716|NCT03110185|447562536|FG001|Overall Study|Conflict with care|12|||
124437717|NCT03110185|447562535|FG000|Overall Study|Protocol Violation|1|||
124437718|NCT03110185|447562536|FG001|Overall Study|Protocol Violation|4|||
124437719|NCT03110185|447562535|FG000|Overall Study|MRI Incompatible|2|||
124437720|NCT03110185|447562536|FG001|Overall Study|MRI Incompatible|0|||
124437721|NCT03110185|447562535|FG000|Overall Study|Patient Refusal|0|||
124437722|NCT03110185|447562536|FG001|Overall Study|Patient Refusal|1|||
124437723|NCT00600886|447562537|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
124437724|NCT00600886|447562538|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
124437725|NCT00600886|447562537|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
124437726|NCT00600886|447562538|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
124437727|NCT00600886|447562537|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
124437728|NCT00600886|447562538|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
124437729|NCT00600886|447562537|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
124437730|NCT00600886|447562538|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
124437731|NCT00600886|447562537|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
124437732|NCT00600886|447562538|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
124437733|NCT00600886|447562537|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
124437734|NCT00600886|447562538|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
124437735|NCT00600886|447562537|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
124437736|NCT00600886|447562538|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
124437737|NCT00600886|447562537|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
124437738|NCT00600886|447562538|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
124437739|NCT00600886|447562537|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
124437740|NCT00600886|447562538|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
124437741|NCT00600886|447562537|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
124437742|NCT00600886|447562538|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
124437743|NCT00600886|447562537|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
124437744|NCT00600886|447562538|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
124437745|NCT00600886|447562537|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
124437746|NCT00600886|447562538|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
124437747|NCT00600886|447562537|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
124437748|NCT00600886|447562538|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
124679593|NCT03573297|448449746|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
124679594|NCT03573297|448449747|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
124679595|NCT03573297|448449748|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
124437749|NCT00600886|447562537|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
124437750|NCT00600886|447562538|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
124679596|NCT03573297|448449749|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
124679597|NCT03573297|448449746|FG000|Open Label Treatment Period|Other, Not Specified|7|||
124437751|NCT00600886|447562537|FG000|Extension - Same Treatment (FAS)|Death|1|||
124679598|NCT03573297|448449747|FG001|Open Label Treatment Period|Other, Not Specified|0|||
124679599|NCT03573297|448449748|FG002|Open Label Treatment Period|Other, Not Specified|0|||
124679600|NCT03573297|448449749|FG003|Open Label Treatment Period|Other, Not Specified|0|||
124679601|NCT03573297|448449746|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
124679602|NCT03573297|448449747|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
124679603|NCT03573297|448449748|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
124679604|NCT03573297|448449749|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
124679605|NCT03573297|448449746|FG000|Double-Blind Treatment Period|Adverse Event|0|||
124679606|NCT03573297|448449747|FG001|Double-Blind Treatment Period|Adverse Event|1|||
124679607|NCT03573297|448449748|FG002|Double-Blind Treatment Period|Adverse Event|5|||
124679608|NCT03573297|448449749|FG003|Double-Blind Treatment Period|Adverse Event|1|||
124679609|NCT03573297|448449746|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
124679610|NCT03573297|448449747|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
124679611|NCT03573297|448449748|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
124679612|NCT03573297|448449749|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
124679613|NCT03573297|448449746|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124679614|NCT03573297|448449747|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
124679615|NCT03573297|448449748|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
124679616|NCT03573297|448449749|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
124679617|NCT03573297|448449746|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124679618|NCT03573297|448449747|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
124679619|NCT03573297|448449748|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
124679620|NCT03573297|448449749|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
124679621|NCT03573297|448449746|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
124679622|NCT03573297|448449747|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
124679623|NCT03573297|448449748|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
124679624|NCT03573297|448449749|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
124679625|NCT03573297|448449746|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
124679626|NCT03573297|448449747|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
124679627|NCT03573297|448449748|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
124679628|NCT03573297|448449749|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
124679629|NCT03573297|448449746|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
124679630|NCT03573297|448449747|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
124679631|NCT03573297|448449748|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
124679632|NCT03573297|448449749|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
124679633|NCT06996301|448449750|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
124879564|NCT01641926|449182507|FG000|Overall Study|Withdrawal by Subject|13|||
124879565|NCT01641926|449182508|FG001|Overall Study|Withdrawal by Subject|5|||
124879566|NCT01641926|449182509|FG002|Overall Study|Withdrawal by Subject|6|||
124879567|NCT01641926|449182510|FG003|Overall Study|Withdrawal by Subject|1|||
124879568|NCT01641926|449182507|FG000|Overall Study|Not Treated|1|||
124879569|NCT01641926|449182508|FG001|Overall Study|Not Treated|1|||
124879570|NCT01641926|449182509|FG002|Overall Study|Not Treated|1|||
124879571|NCT01641926|449182510|FG003|Overall Study|Not Treated|0|||
124879572|NCT01111838|449182511|FG000|Overall Study|Patient Ineligible|2|||
124879573|NCT01111838|449182511|FG000|Overall Study|Not Treated|3|||
124879574|NCT01111838|449182511|FG000|Overall Study|Clinical deterioration|1|||
124879575|NCT01111838|449182511|FG000|Overall Study|Other Complicating Disease|1|||
124879576|NCT03303469|449182512|FG000|Overall Study|Lost to Follow-up|2|||
124879577|NCT02567825|449182519|FG000|Overall Study|No follow-up post-randomization|5|||
124879578|NCT02567825|449182520|FG001|Overall Study|No follow-up post-randomization|1|||
124879579|NCT02567825|449182519|FG000|Overall Study|Follow-up less than 23 months|16|||
124879580|NCT02567825|449182520|FG001|Overall Study|Follow-up less than 23 months|20|||
124879581|NCT04741802|449182522|FG000|Overall Study|Death|1|||
124879582|NCT04741802|449182522|FG000|Overall Study|Lost to Follow-up|11|||
124879583|NCT01785563|449182525|FG000|Overall Study|Physician Decision|10|||
124879584|NCT01785563|449182525|FG000|Overall Study|Withdrawal by Subject|1|||
124879585|NCT01785563|449182525|FG000|Overall Study|Protocol Violation|2|||
124879586|NCT01540565|449182526|FG000|Overall Study|Ineligible|2|||
124879587|NCT04399356|449182527|FG000|Overall Study|Lost to Follow-up|1|||
124879588|NCT04399356|449182528|FG001|Overall Study|Lost to Follow-up|1|||
124879589|NCT04399356|449182527|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
124879590|NCT04399356|449182528|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
124879591|NCT04399356|449182527|FG000|Overall Study|Withdrawal by Subject|1|||
124879592|NCT04399356|449182528|FG001|Overall Study|Withdrawal by Subject|0|||
124879593|NCT01834222|449182533|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
124879594|NCT04251065|449182534|FG000|Overall Study|Death|2|||
124879595|NCT04251065|449182534|FG000|Overall Study|Lack of Efficacy|3|||
124879596|NCT04251065|449182534|FG000|Overall Study|Death|1|||
124879597|NCT04091360|449182535|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
124879598|NCT04091360|449182536|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
124879599|NCT04091360|449182537|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
124879600|NCT04091360|449182538|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
124879601|NCT04091360|449182539|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
124879602|NCT04091360|449182540|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
124879603|NCT04091360|449182541|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
124879604|NCT04091360|449182542|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
124879605|NCT04091360|449182543|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
124879606|NCT04091360|449182544|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
124879607|NCT04091360|449182535|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
124879608|NCT04091360|449182536|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
124879609|NCT04091360|449182537|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
124879610|NCT04091360|449182538|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
124879611|NCT04091360|449182539|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
124879612|NCT04091360|449182540|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
124879613|NCT04091360|449182541|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
124879614|NCT04091360|449182542|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
124879615|NCT04091360|449182543|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
124879616|NCT04091360|449182544|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
124879617|NCT04091360|449182535|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
124879618|NCT04091360|449182536|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
124679634|NCT06996301|448449751|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
124679635|NCT06996301|448449750|FG000|Overall Study|Patients with discordant diagnostic results|107|||
124679636|NCT06996301|448449751|FG001|Overall Study|Patients with discordant diagnostic results|90|||
124679637|NCT06996301|448449750|FG000|Overall Study|Lost to Follow-up|31|||
124679638|NCT06996301|448449751|FG001|Overall Study|Lost to Follow-up|56|||
124679639|NCT06996301|448449750|FG000|Overall Study|Withdrawal by Subject|12|||
124679640|NCT06996301|448449751|FG001|Overall Study|Withdrawal by Subject|7|||
124679641|NCT00661388|448449755|FG000|Overall Study|Adverse Event|14|||
124679642|NCT00661388|448449755|FG000|Overall Study|Protocol Violation|7|||
124679643|NCT00661388|448449755|FG000|Overall Study|Renal transplantation|1|||
124679644|NCT00661388|448449755|FG000|Overall Study|Dialysis initiation|1|||
124679645|NCT00661388|448449755|FG000|Overall Study|Administrative reasons|1|||
124879619|NCT04091360|449182537|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
124879620|NCT04091360|449182538|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
124879621|NCT04091360|449182539|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
124879622|NCT04091360|449182540|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
124879623|NCT04091360|449182541|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
124879624|NCT04091360|449182542|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
124879625|NCT04091360|449182543|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
124879626|NCT04091360|449182544|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
124879627|NCT00980005|449182547|FG000|Overall Study|Withdrawal by Subject|6|||
124679646|NCT01171534|448451204|FG000|Overall Study|Lost to Follow-up|0|||
124679647|NCT01171534|448451205|FG001|Overall Study|Lost to Follow-up|2|||
124679648|NCT01171534|448451204|FG000|Overall Study|screen failure|0|||
124679649|NCT01171534|448451205|FG001|Overall Study|screen failure|1|||
124679650|NCT00362232|448451206|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
124679651|NCT00362232|448451207|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
124679652|NCT00362232|448451206|FG000|Treatment (12 +/- 2 Days)|Death|1|||
124679653|NCT00362232|448451207|FG001|Treatment (12 +/- 2 Days)|Death|3|||
124679654|NCT00362232|448451206|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
124679655|NCT00362232|448451207|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
124679656|NCT00362232|448451206|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
124679657|NCT00362232|448451207|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
124679658|NCT00362232|448451206|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
124679659|NCT00362232|448451207|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
124679660|NCT00362232|448451206|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
124679661|NCT00362232|448451207|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
124679662|NCT00362232|448451206|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
124879628|NCT00980005|449182548|FG001|Overall Study|Withdrawal by Subject|17|||
124879629|NCT00980005|449182547|FG000|Overall Study|Lost to Follow-up|37|||
124879630|NCT00980005|449182548|FG001|Overall Study|Lost to Follow-up|43|||
124879631|NCT00980005|449182547|FG000|Overall Study|Other|4|||
124679663|NCT00362232|448451207|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
124679664|NCT00362232|448451206|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
124679665|NCT00362232|448451207|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
124679666|NCT00362232|448451206|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
124679667|NCT00362232|448451207|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
124679668|NCT00362232|448451206|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
124679669|NCT00362232|448451207|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
124679670|NCT00362232|448451206|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
124679671|NCT00362232|448451207|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
124679672|NCT00362232|448451206|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
124679673|NCT00362232|448451207|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
124679674|NCT00362232|448451206|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
124679675|NCT00362232|448451207|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
124679676|NCT02472405|448451210|FG000|Overall Study|Lost to Follow-up|9|||
124679677|NCT02472405|448451210|FG000|Overall Study|Adverse Event|1|||
124679678|NCT01715298|448451211|FG000|Overall Study|Lost to Follow-up|0|||
124679679|NCT01715298|448451212|FG001|Overall Study|Lost to Follow-up|2|||
124679680|NCT01715298|448451211|FG000|Overall Study|Patient/guardian decision|7|||
124679681|NCT01715298|448451212|FG001|Overall Study|Patient/guardian decision|9|||
124679682|NCT00726453|448451214|FG000|Primary Enrollment Group|Death|18|||
124679683|NCT00726453|448451215|FG001|Primary Enrollment Group|Death|0|||
124679684|NCT00726453|448451214|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
124679685|NCT00726453|448451215|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
124679686|NCT00726453|448451214|FG000|38 mm Length Group|Death|0|||
124679687|NCT00726453|448451215|FG001|38 mm Length Group|Death|3|||
124437752|NCT00600886|447562538|FG001|Extension - Same Treatment (FAS)|Death|1|||
124437753|NCT00600886|447562537|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
124437754|NCT00600886|447562538|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
124437755|NCT00600886|447562537|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
124437756|NCT00600886|447562538|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
124437757|NCT00600886|447562537|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
124437758|NCT00600886|447562538|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
124437759|NCT00600886|447562537|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
124437760|NCT00600886|447562538|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
124437761|NCT00600886|447562537|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
124437762|NCT00600886|447562538|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
124437763|NCT00600886|447562537|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
124437764|NCT00600886|447562538|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
124437765|NCT00600886|447562537|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
124437766|NCT00600886|447562538|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
124437767|NCT00600886|447562537|FG000|Extension - After Crossover (CAS)|Death|1|||
124437768|NCT00600886|447562538|FG001|Extension - After Crossover (CAS)|Death|0|||
124437769|NCT02523599|447562539|FG000|Overall Study|Adverse Event|1|||
124437770|NCT02523599|447562540|FG001|Overall Study|Adverse Event|0|||
124437771|NCT02523599|447562539|FG000|Overall Study|Physician Decision|1|||
124437772|NCT02523599|447562540|FG001|Overall Study|Physician Decision|0|||
124437773|NCT02523599|447562539|FG000|Overall Study|Lost to Follow-up|4|||
124437774|NCT02523599|447562540|FG001|Overall Study|Lost to Follow-up|1|||
124437775|NCT02523599|447562539|FG000|Overall Study|Did not return for Day 30 visit|2|||
124437776|NCT02523599|447562540|FG001|Overall Study|Did not return for Day 30 visit|0|||
124437777|NCT01427751|447562541|FG000|Overall Study|Adverse Event|18|||
124437778|NCT01427751|447562542|FG001|Overall Study|Adverse Event|2|||
124437779|NCT01427751|447562541|FG000|Overall Study|No further treatment benefit expected|5|||
124437780|NCT01427751|447562542|FG001|Overall Study|No further treatment benefit expected|1|||
124437781|NCT01427751|447562541|FG000|Overall Study|Lost to Follow-up|3|||
124437782|NCT01427751|447562542|FG001|Overall Study|Lost to Follow-up|1|||
124437783|NCT01427751|447562541|FG000|Overall Study|Withdrawal of consent|2|||
124437784|NCT01427751|447562542|FG001|Overall Study|Withdrawal of consent|2|||
124437785|NCT01427751|447562541|FG000|Overall Study|Protocol Violation|6|||
124437786|NCT01427751|447562542|FG001|Overall Study|Protocol Violation|4|||
124437787|NCT01427751|447562541|FG000|Overall Study|Death|2|||
124437788|NCT01427751|447562542|FG001|Overall Study|Death|0|||
124437789|NCT01427751|447562541|FG000|Overall Study|Other miscellaneous reasons|6|||
124437790|NCT01427751|447562542|FG001|Overall Study|Other miscellaneous reasons|4|||
124679688|NCT00941928|448451216|FG000|Overall Study|Withdrawal by Subject|1|||
124679689|NCT00941928|448451216|FG000|Overall Study|Disease Progression|1|||
124437791|NCT05330312|447562543|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
124437792|NCT05330312|447562544|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
124437793|NCT05330312|447562545|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
124437794|NCT05330312|447562543|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
124437795|NCT05330312|447562544|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
124679690|NCT00577408|448451217|FG000|Overall Study|Stopped attending study visits|9|||
124679691|NCT00577408|448451218|FG001|Overall Study|Stopped attending study visits|11|||
124679692|NCT00577408|448451217|FG000|Overall Study|Continued opioid use|3|||
124437796|NCT05330312|447562545|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
124679693|NCT00577408|448451218|FG001|Overall Study|Continued opioid use|2|||
124679694|NCT00577408|448451217|FG000|Overall Study|Non-compliance with study meds|0|||
124679695|NCT00577408|448451218|FG001|Overall Study|Non-compliance with study meds|3|||
124437797|NCT05330312|447562543|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
124679696|NCT00577408|448451217|FG000|Overall Study|Refused Oral Naltrexone|0|||
124679697|NCT00577408|448451218|FG001|Overall Study|Refused Oral Naltrexone|1|||
124679698|NCT00577408|448451217|FG000|Overall Study|Moved out of state|0|||
124679699|NCT00577408|448451218|FG001|Overall Study|Moved out of state|1|||
124679700|NCT00577408|448451217|FG000|Overall Study|Scheduling Issues|0|||
124679701|NCT00577408|448451218|FG001|Overall Study|Scheduling Issues|3|||
124679702|NCT00577408|448451217|FG000|Overall Study|Death|0|||
124679703|NCT00577408|448451218|FG001|Overall Study|Death|1|||
124679704|NCT00577408|448451217|FG000|Overall Study|Psychiatric hospitalization|0|||
124679705|NCT00577408|448451218|FG001|Overall Study|Psychiatric hospitalization|1|||
124879632|NCT00980005|449182548|FG001|Overall Study|Other|3|||
124879633|NCT00572624|449182549|FG000|Overall Study|Lost to Follow-up|10|||
124879634|NCT00572624|449182550|FG001|Overall Study|Lost to Follow-up|4|||
124879635|NCT00572624|449182549|FG000|Overall Study|Wanted to do a different diet program|1|||
124879636|NCT00572624|449182550|FG001|Overall Study|Wanted to do a different diet program|0|||
124879637|NCT00572624|449182549|FG000|Overall Study|Medication change|1|||
124879638|NCT00572624|449182550|FG001|Overall Study|Medication change|0|||
124879639|NCT00572624|449182549|FG000|Overall Study|Started a new job-- no time for study|1|||
124879640|NCT00572624|449182550|FG001|Overall Study|Started a new job-- no time for study|0|||
124879641|NCT00572624|449182549|FG000|Overall Study|Admitted to being a smoker|1|||
124879642|NCT00572624|449182550|FG001|Overall Study|Admitted to being a smoker|0|||
124879643|NCT00572624|449182549|FG000|Overall Study|Refused to do the stress test|1|||
124879644|NCT00572624|449182550|FG001|Overall Study|Refused to do the stress test|0|||
124879645|NCT00572624|449182549|FG000|Overall Study|Problem with vascular access|1|||
124879646|NCT00572624|449182550|FG001|Overall Study|Problem with vascular access|0|||
124879647|NCT00572624|449182549|FG000|Overall Study|Health issues unrelated to the study|1|||
124879648|NCT00572624|449182550|FG001|Overall Study|Health issues unrelated to the study|0|||
124879649|NCT00744263|449182551|FG000|Overall Study|Death|3006|||
124879650|NCT00744263|449182552|FG001|Overall Study|Death|3005|||
124879651|NCT00744263|449182551|FG000|Overall Study|Lost to Follow-up|2038|||
124879652|NCT00744263|449182552|FG001|Overall Study|Lost to Follow-up|2135|||
124879653|NCT00744263|449182551|FG000|Overall Study|Withdrawal by Subject|166|||
124879654|NCT00744263|449182552|FG001|Overall Study|Withdrawal by Subject|150|||
124879655|NCT00744263|449182551|FG000|Overall Study|Physician Decision|20|||
124879656|NCT00744263|449182552|FG001|Overall Study|Physician Decision|23|||
124879657|NCT00744263|449182551|FG000|Overall Study|Protocol Violation|3|||
124879658|NCT00744263|449182552|FG001|Overall Study|Protocol Violation|5|||
124879659|NCT00744263|449182551|FG000|Overall Study|Adverse Event|1|||
124879660|NCT00744263|449182552|FG001|Overall Study|Adverse Event|0|||
124879661|NCT00744263|449182551|FG000|Overall Study|Other|2|||
124879662|NCT00744263|449182552|FG001|Overall Study|Other|2|||
124879663|NCT00130793|449182555|FG000|Overall Study|Lost to Follow-up|1|||
124879664|NCT00130793|449182556|FG001|Overall Study|Lost to Follow-up|4|||
124879665|NCT00130793|449182555|FG000|Overall Study|Withdrew consent|2|||
124879666|NCT00130793|449182556|FG001|Overall Study|Withdrew consent|0|||
124879667|NCT00211237|449182557|FG000|Baseline|Withdrew|1|||
124879668|NCT00211237|449182558|FG001|Baseline|Withdrew|3|||
124879669|NCT00211237|449182559|FG002|Baseline|Withdrew|0|||
124879670|NCT00211237|449182557|FG000|Baseline|Refused random assignment|1|||
124879671|NCT00211237|449182558|FG001|Baseline|Refused random assignment|0|||
124879672|NCT00211237|449182559|FG002|Baseline|Refused random assignment|0|||
124879673|NCT00211237|449182557|FG000|1 Month|Death|2|||
124879674|NCT00211237|449182558|FG001|1 Month|Death|1|||
124879675|NCT00211237|449182559|FG002|1 Month|Death|0|||
124879676|NCT00211237|449182557|FG000|1 Month|Lost to Follow-up|0|||
124879677|NCT00211237|449182558|FG001|1 Month|Lost to Follow-up|2|||
124879678|NCT00211237|449182559|FG002|1 Month|Lost to Follow-up|0|||
124879679|NCT00211237|449182557|FG000|1 Month|Withdrew|0|||
124879680|NCT00211237|449182558|FG001|1 Month|Withdrew|4|||
124879681|NCT00211237|449182559|FG002|1 Month|Withdrew|0|||
124879682|NCT00211237|449182557|FG000|1 Month|Additional surgery needed|1|||
124879683|NCT00211237|449182558|FG001|1 Month|Additional surgery needed|0|||
124879684|NCT00211237|449182559|FG002|1 Month|Additional surgery needed|0|||
124879685|NCT00211237|449182557|FG000|1 Month|Non-medical problem|0|||
124879686|NCT00211237|449182558|FG001|1 Month|Non-medical problem|2|||
124879687|NCT00211237|449182559|FG002|1 Month|Non-medical problem|0|||
124879688|NCT00211237|449182557|FG000|3 Months|Death|7|||
124879689|NCT00211237|449182558|FG001|3 Months|Death|3|||
124437798|NCT05330312|447562544|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
124879690|NCT00211237|449182559|FG002|3 Months|Death|0|||
124879691|NCT00211237|449182557|FG000|3 Months|Could not comply with protocol|1|||
124879692|NCT00211237|449182558|FG001|3 Months|Could not comply with protocol|0|||
124437799|NCT05330312|447562545|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
124679706|NCT00656617|448451219|FG000|Overall Study|Adverse Event|1|||
124679707|NCT00656617|448451219|FG000|Overall Study|Death|2|||
124679708|NCT00656617|448451219|FG000|Overall Study|Insurance Issues|2|||
124879693|NCT00211237|449182559|FG002|3 Months|Could not comply with protocol|0|||
124879694|NCT00211237|449182557|FG000|3 Months|Withdrew|0|||
124879695|NCT00211237|449182558|FG001|3 Months|Withdrew|1|||
124879696|NCT00211237|449182559|FG002|3 Months|Withdrew|0|||
124879697|NCT00211237|449182557|FG000|3 Months|Non-medical problem|0|||
124879698|NCT00211237|449182558|FG001|3 Months|Non-medical problem|0|||
124879699|NCT00211237|449182559|FG002|3 Months|Non-medical problem|1|||
124879700|NCT00211237|449182557|FG000|6 Months|Death|6|||
124879701|NCT00211237|449182558|FG001|6 Months|Death|0|||
124879702|NCT00211237|449182559|FG002|6 Months|Death|3|||
124879703|NCT00211237|449182557|FG000|6 Months|Lost to Follow-up|2|||
124879704|NCT00211237|449182558|FG001|6 Months|Lost to Follow-up|0|||
124879705|NCT00211237|449182559|FG002|6 Months|Lost to Follow-up|0|||
124879706|NCT00211237|449182557|FG000|6 Months|Could not comply with protocol|0|||
124879707|NCT00211237|449182558|FG001|6 Months|Could not comply with protocol|2|||
124879708|NCT00211237|449182559|FG002|6 Months|Could not comply with protocol|0|||
124879709|NCT00211237|449182557|FG000|12 Months|Death|8|||
124879710|NCT00211237|449182558|FG001|12 Months|Death|2|||
124879711|NCT00211237|449182559|FG002|12 Months|Death|3|||
124879712|NCT00211237|449182557|FG000|12 Months|Lost to Follow-up|1|||
124879713|NCT00211237|449182558|FG001|12 Months|Lost to Follow-up|0|||
124879714|NCT00211237|449182559|FG002|12 Months|Lost to Follow-up|1|||
124879715|NCT00211237|449182557|FG000|12 Months|Withdrew|0|||
124879716|NCT00211237|449182558|FG001|12 Months|Withdrew|0|||
124879717|NCT00211237|449182559|FG002|12 Months|Withdrew|1|||
124879718|NCT00211237|449182557|FG000|12 Months|unrelated medical problem|0|||
124879719|NCT00211237|449182558|FG001|12 Months|unrelated medical problem|0|||
124879720|NCT00211237|449182559|FG002|12 Months|unrelated medical problem|1|||
124879721|NCT01013792|449182564|FG000|Overall Study|Study suspended|2|||
124879722|NCT01013792|449182565|FG001|Overall Study|Study suspended|1|||
124879723|NCT01013792|449182564|FG000|Overall Study|Adverse Event|0|||
124879724|NCT01013792|449182565|FG001|Overall Study|Adverse Event|3|||
124879725|NCT01013792|449182564|FG000|Overall Study|Lost to Follow-up|0|||
124879726|NCT01013792|449182565|FG001|Overall Study|Lost to Follow-up|1|||
124879727|NCT02100722|449182569|FG000|Overall Study|Withdrawal pre-procedure|4|||
124879728|NCT02100722|449182570|FG001|Overall Study|Withdrawal pre-procedure|9|||
124879729|NCT02100722|449182569|FG000|Overall Study|Withdrawal post-procedure|0|||
124879730|NCT02100722|449182570|FG001|Overall Study|Withdrawal post-procedure|3|||
124879731|NCT02100722|449182569|FG000|Overall Study|Lost to Follow-up|2|||
124879732|NCT02100722|449182570|FG001|Overall Study|Lost to Follow-up|2|||
124879733|NCT02100722|449182569|FG000|Overall Study|Continuing on study|751|||
124879734|NCT02100722|449182570|FG001|Overall Study|Continuing on study|729|||
124879735|NCT03500640|449182575|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
124879736|NCT03500640|449182576|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
124879737|NCT03500640|449182577|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
124879738|NCT03500640|449182575|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
124879739|NCT03500640|449182576|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
124879740|NCT03500640|449182577|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
124879741|NCT03500640|449182575|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
124879742|NCT03500640|449182576|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
124879743|NCT03500640|449182577|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
124879744|NCT03500640|449182575|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
124879745|NCT03500640|449182576|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
124879746|NCT03500640|449182577|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
124879747|NCT03500640|449182575|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
124879748|NCT03500640|449182576|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
124879749|NCT03500640|449182577|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
124879750|NCT03500640|449182575|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
124879751|NCT03500640|449182576|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
124879752|NCT03500640|449182577|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
124879753|NCT03500640|449182575|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
124879754|NCT03500640|449182576|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
124879755|NCT03500640|449182577|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
124879756|NCT03500640|449182575|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
124879757|NCT03500640|449182576|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
124879758|NCT03500640|449182577|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
124437800|NCT05330312|447562543|FG000|Pivotal Investigation - Part 2|Death|1|||
124679709|NCT00656617|448451219|FG000|Overall Study|Move to different clinical trial|2|||
124679710|NCT02765035|448451232|FG000|First Intervention (90 Days)|Adverse Event|1|||
124679711|NCT02765035|448451233|FG001|First Intervention (90 Days)|Adverse Event|1|||
124879759|NCT03500640|449182575|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
124679712|NCT02765035|448451232|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
124679713|NCT02765035|448451233|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
124679714|NCT02349386|448451235|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
124679715|NCT02349386|448451236|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
124879760|NCT03500640|449182576|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
124879761|NCT03500640|449182577|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
124879762|NCT03500640|449182575|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
124879763|NCT03500640|449182576|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
124879764|NCT03500640|449182577|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
124879765|NCT01650519|449182578|FG000|Overall Study|Withdrawal by Subject|1|||
124879766|NCT01650519|449182579|FG001|Overall Study|Withdrawal by Subject|0|||
124879767|NCT01279343|449182582|FG000|Overall Study|Did not receive treatment|2|||
124879768|NCT01279343|449182583|FG001|Overall Study|Did not receive treatment|6|||
124879769|NCT01250119|449184093|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
124879770|NCT01250119|449184094|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
124879771|NCT01250119|449184093|FG000|Diagnostic Phase|Participants Not Tested|44|||
124879772|NCT01250119|449184094|FG001|Diagnostic Phase|Participants Not Tested|0|||
124879773|NCT01250119|449184093|FG000|Treatment Phase|Progressive Disease|0|||
124879774|NCT01250119|449184094|FG001|Treatment Phase|Progressive Disease|32|||
124879775|NCT01250119|449184093|FG000|Treatment Phase|Death|0|||
124879776|NCT01250119|449184094|FG001|Treatment Phase|Death|2|||
124879777|NCT01250119|449184093|FG000|Treatment Phase|Withdrawal by Subject|0|||
124879778|NCT01250119|449184094|FG001|Treatment Phase|Withdrawal by Subject|1|||
124879779|NCT01250119|449184093|FG000|Treatment Phase|Adverse Event|0|||
124879780|NCT01250119|449184094|FG001|Treatment Phase|Adverse Event|2|||
124879781|NCT01250119|449184093|FG000|Treatment Phase|Unknown reason|0|||
124879782|NCT01250119|449184094|FG001|Treatment Phase|Unknown reason|4|||
124879783|NCT02887989|449184098|FG000|Overall Study|Withdrawal by Subject|8|||
124879784|NCT02887989|449184099|FG001|Overall Study|Withdrawal by Subject|11|||
124879785|NCT02887989|449184098|FG000|Overall Study|Death|1|||
124879786|NCT02887989|449184099|FG001|Overall Study|Death|0|||
124879787|NCT05648357|449184100|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
124879788|NCT00255346|449184101|FG000|Overall Study|Adverse Event|1|||
124879789|NCT00255346|449184102|FG001|Overall Study|Adverse Event|0|||
124879790|NCT00255346|449184103|FG002|Overall Study|Adverse Event|0|||
124879791|NCT00255346|449184104|FG003|Overall Study|Adverse Event|0|||
124879792|NCT00255346|449184105|FG004|Overall Study|Adverse Event|0|||
124879793|NCT00409786|449184108|FG000|Overall Study|Withdrawal by Subject|3|||
124879794|NCT02440594|449184112|FG000|Overall Study|Lost to Follow-up|34|||
124879795|NCT02440594|449184113|FG001|Overall Study|Lost to Follow-up|33|||
124879796|NCT02440594|449184114|FG002|Overall Study|Lost to Follow-up|54|||
124879797|NCT02440594|449184115|FG003|Overall Study|Lost to Follow-up|47|||
124879798|NCT02440594|449184116|FG004|Overall Study|Lost to Follow-up|5|||
124879799|NCT02440594|449184117|FG005|Overall Study|Lost to Follow-up|4|||
124879800|NCT02440594|449184118|FG006|Overall Study|Lost to Follow-up|28|||
124879801|NCT02440594|449184119|FG007|Overall Study|Lost to Follow-up|48|||
124879802|NCT02440594|449184112|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
124879803|NCT02440594|449184113|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
124879804|NCT02440594|449184114|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
124879805|NCT02440594|449184115|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
124879806|NCT02440594|449184116|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
124879807|NCT02440594|449184117|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
124879808|NCT02440594|449184118|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
124879809|NCT02440594|449184119|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
124879810|NCT02440594|449184112|FG000|Overall Study|Withdrawal by Subject|81|||
124879811|NCT02440594|449184113|FG001|Overall Study|Withdrawal by Subject|67|||
124879812|NCT02440594|449184114|FG002|Overall Study|Withdrawal by Subject|59|||
124879813|NCT02440594|449184115|FG003|Overall Study|Withdrawal by Subject|38|||
124879814|NCT02440594|449184116|FG004|Overall Study|Withdrawal by Subject|2|||
124879815|NCT02440594|449184117|FG005|Overall Study|Withdrawal by Subject|2|||
124879816|NCT02440594|449184118|FG006|Overall Study|Withdrawal by Subject|7|||
124879817|NCT02440594|449184119|FG007|Overall Study|Withdrawal by Subject|7|||
124879818|NCT02440594|449184112|FG000|Overall Study|Administratively w/drawn|3|||
124879819|NCT02440594|449184113|FG001|Overall Study|Administratively w/drawn|2|||
124879820|NCT02440594|449184114|FG002|Overall Study|Administratively w/drawn|0|||
124879821|NCT02440594|449184115|FG003|Overall Study|Administratively w/drawn|0|||
124879822|NCT02440594|449184116|FG004|Overall Study|Administratively w/drawn|0|||
124879823|NCT02440594|449184117|FG005|Overall Study|Administratively w/drawn|0|||
124879824|NCT02440594|449184118|FG006|Overall Study|Administratively w/drawn|2|||
124879825|NCT02440594|449184119|FG007|Overall Study|Administratively w/drawn|1|||
124879826|NCT00584805|449184120|FG000|Overall Study|No longer at risk of exposure|39|||
124879827|NCT00584805|449184120|FG000|Overall Study|Relocation|36|||
124879828|NCT00584805|449184120|FG000|Overall Study|Withdrawal by Subject|18|||
124879829|NCT00584805|449184120|FG000|Overall Study|Non-compliance|1|||
124879830|NCT00584805|449184120|FG000|Overall Study|Lost to follow up|3|||
124879831|NCT00584805|449184120|FG000|Overall Study|Screen failures|2|||
124879832|NCT01993823|449184121|FG000|Overall Study|Requested by the patient|6|||
124879833|NCT01993823|449184122|FG001|Overall Study|Requested by the patient|11|||
124879834|NCT01993823|449184121|FG000|Overall Study|Protocol Violation|0|||
124879835|NCT01993823|449184122|FG001|Overall Study|Protocol Violation|1|||
124879836|NCT01993823|449184121|FG000|Overall Study|Lost to Follow-up|1|||
124879837|NCT01993823|449184122|FG001|Overall Study|Lost to Follow-up|4|||
124879838|NCT02341456|449184123|FG000|Overall Study|Disease progression|2|||
124879839|NCT02341456|449184124|FG001|Overall Study|Disease progression|3|||
124879840|NCT02341456|449184125|FG002|Overall Study|Disease progression|1|||
124879841|NCT02341456|449184123|FG000|Overall Study|Death|1|||
124879842|NCT02341456|449184124|FG001|Overall Study|Death|1|||
124879843|NCT02341456|449184125|FG002|Overall Study|Death|1|||
124879844|NCT02341456|449184123|FG000|Overall Study|Withdrawal by Subject|0|||
124879845|NCT02341456|449184124|FG001|Overall Study|Withdrawal by Subject|1|||
124879846|NCT02341456|449184125|FG002|Overall Study|Withdrawal by Subject|1|||
124879847|NCT02341456|449184123|FG000|Overall Study|Moved to local access programme.|0|||
124879848|NCT02341456|449184124|FG001|Overall Study|Moved to local access programme.|1|||
124879849|NCT02341456|449184125|FG002|Overall Study|Moved to local access programme.|1|||
124879850|NCT02341456|449184123|FG000|Overall Study|Physician Decision|1|||
124879851|NCT02341456|449184124|FG001|Overall Study|Physician Decision|0|||
124879852|NCT02341456|449184125|FG002|Overall Study|Physician Decision|0|||
124879853|NCT00301080|449184127|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
124879854|NCT00301080|449184128|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
124879855|NCT00301080|449184129|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
124879856|NCT00301080|449184130|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
124879857|NCT00301080|449184131|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
124879858|NCT03066622|449184133|FG000|Overall Study|Lost to Follow-up|24|||
124879859|NCT03066622|449184134|FG001|Overall Study|Lost to Follow-up|25|||
124879860|NCT03066622|449184133|FG000|Overall Study|Withdrawal by Subject|2|||
124879861|NCT03066622|449184134|FG001|Overall Study|Withdrawal by Subject|1|||
124879862|NCT00641719|449184135|FG000|Overall Study|Lack of Efficacy|1|||
124879863|NCT00641719|449184136|FG001|Overall Study|Lack of Efficacy|2|||
124879864|NCT00641719|449184135|FG000|Overall Study|Adverse Event|24|||
124879865|NCT00641719|449184136|FG001|Overall Study|Adverse Event|29|||
124879866|NCT00641719|449184135|FG000|Overall Study|Withdrawal by Subject|4|||
124879867|NCT00641719|449184136|FG001|Overall Study|Withdrawal by Subject|4|||
124879868|NCT00641719|449184135|FG000|Overall Study|Reason Not Specified|1|||
124879869|NCT00641719|449184136|FG001|Overall Study|Reason Not Specified|2|||
124879870|NCT03469349|449184137|FG000|Overall Study|Withdrawal by Subject|1|||
124879871|NCT03469349|449184138|FG001|Overall Study|Withdrawal by Subject|3|||
124879872|NCT03469349|449184137|FG000|Overall Study|Progressive Disease|0|||
124879873|NCT03469349|449184138|FG001|Overall Study|Progressive Disease|1|||
124879874|NCT03469349|449184137|FG000|Overall Study|Lost to Follow-up|2|||
124879875|NCT03469349|449184138|FG001|Overall Study|Lost to Follow-up|2|||
124879876|NCT03469349|449184137|FG000|Overall Study|Adverse Event|2|||
124879877|NCT03469349|449184138|FG001|Overall Study|Adverse Event|4|||
124879878|NCT02306265|449184139|FG000|Overall Study|Withdrawal by Subject|1|||
124879879|NCT04488003|449184140|FG000|Assessed for Eligibility|Screen Failure|24|||
124879880|NCT04488003|449184141|FG001|Assessed for Eligibility|Screen Failure|0|||
124879881|NCT04488003|449184142|FG002|Assessed for Eligibility|Screen Failure|0|||
124879882|NCT04488003|449184140|FG000|Assessed for Eligibility|Adverse Event|1|||
124879883|NCT04488003|449184141|FG001|Assessed for Eligibility|Adverse Event|0|||
124879884|NCT04488003|449184142|FG002|Assessed for Eligibility|Adverse Event|0|||
124879885|NCT04488003|449184140|FG000|Assessed for Eligibility|Death|1|||
124879886|NCT04488003|449184141|FG001|Assessed for Eligibility|Death|0|||
124879887|NCT04488003|449184142|FG002|Assessed for Eligibility|Death|0|||
124879888|NCT04488003|449184140|FG000|Assessed for Eligibility|Physician Decision|1|||
124879889|NCT04488003|449184141|FG001|Assessed for Eligibility|Physician Decision|0|||
124879890|NCT04488003|449184142|FG002|Assessed for Eligibility|Physician Decision|0|||
124879891|NCT04488003|449184140|FG000|Allocated to Treatment|Progressive Disease|51|||
124879892|NCT04488003|449184141|FG001|Allocated to Treatment|Progressive Disease|0|||
124879893|NCT04488003|449184142|FG002|Allocated to Treatment|Progressive Disease|0|||
124879894|NCT04488003|449184140|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
124879895|NCT04488003|449184141|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
124879896|NCT04488003|449184142|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
124879897|NCT04488003|449184140|FG000|Allocated to Treatment|Adverse Event|6|||
124879898|NCT04488003|449184141|FG001|Allocated to Treatment|Adverse Event|0|||
124879899|NCT04488003|449184142|FG002|Allocated to Treatment|Adverse Event|0|||
124879900|NCT04488003|449184140|FG000|Allocated to Treatment|Other|5|||
124879901|NCT04488003|449184141|FG001|Allocated to Treatment|Other|0|||
124879902|NCT04488003|449184142|FG002|Allocated to Treatment|Other|0|||
124879903|NCT04488003|449184140|FG000|Allocated to Treatment|Physician Decision|4|||
124879904|NCT04488003|449184141|FG001|Allocated to Treatment|Physician Decision|0|||
124879905|NCT04488003|449184142|FG002|Allocated to Treatment|Physician Decision|0|||
124879906|NCT04488003|449184140|FG000|Allocated to Treatment|Death|4|||
124879907|NCT04488003|449184141|FG001|Allocated to Treatment|Death|0|||
124879908|NCT04488003|449184142|FG002|Allocated to Treatment|Death|0|||
124879909|NCT03447730|449184143|FG000|Overall Study|Adverse Event|0|||
124879910|NCT03447730|449184144|FG001|Overall Study|Adverse Event|2|||
124879911|NCT03447730|449184145|FG002|Overall Study|Adverse Event|0|||
124879912|NCT00692406|449184151|FG000|Overall Study|PI dropped, bad data|57|||
124879913|NCT04145037|449184152|FG000|Overall Study|Study terminated|2|||
124879914|NCT04145037|449184153|FG001|Overall Study|Study terminated|0|||
124879915|NCT04145037|449184152|FG000|Overall Study|Withdrawal by Subject|1|||
124879916|NCT04145037|449184153|FG001|Overall Study|Withdrawal by Subject|0|||
124879917|NCT04145037|449184152|FG000|Overall Study|Lost to Follow-up|1|||
124879918|NCT04145037|449184153|FG001|Overall Study|Lost to Follow-up|0|||
124879919|NCT02307513|449184156|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
124879920|NCT02307513|449184157|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
124879921|NCT02307513|449184156|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
124879922|NCT02307513|449184157|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
124879923|NCT02307513|449184156|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
124879924|NCT02307513|449184157|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
124879925|NCT02307513|449184156|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
124879926|NCT02307513|449184157|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
124879927|NCT02307513|449184156|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
124879928|NCT02307513|449184157|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
124879929|NCT02307513|449184156|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
124879930|NCT02307513|449184157|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
124879931|NCT02307513|449184156|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
124879932|NCT02307513|449184157|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
124879933|NCT02307513|449184156|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
124879934|NCT02307513|449184157|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
124879935|NCT02307513|449184156|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
124879936|NCT02307513|449184157|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
124879937|NCT02307513|449184156|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
124879938|NCT02307513|449184157|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
124879939|NCT02307513|449184156|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
124879940|NCT02307513|449184157|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
124879941|NCT02307513|449184156|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
124879942|NCT02307513|449184157|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
124879943|NCT02307513|449184156|FG000|Long-term Extension|Physician Decision|1|||
124879944|NCT02307513|449184157|FG001|Long-term Extension|Physician Decision|0|||
124879945|NCT05952297|449184159|FG000|Overall Study|Withdrawal by Subject|1|||
124879946|NCT05952297|449184160|FG001|Overall Study|Withdrawal by Subject|0|||
124879947|NCT00525265|449184163|FG000|Overall Study|Protocol Violation|1|||
124879948|NCT00525265|449184164|FG001|Overall Study|Protocol Violation|0|||
124879949|NCT03107377|449184165|FG000|Overall Study|Adverse Event|3|||
124879950|NCT03107377|449184166|FG001|Overall Study|Adverse Event|3|||
124879951|NCT03107377|449184165|FG000|Overall Study|Protocol Violation|9|||
124879952|NCT03107377|449184166|FG001|Overall Study|Protocol Violation|12|||
124879953|NCT03107377|449184165|FG000|Overall Study|Physician Decision|3|||
124879954|NCT03107377|449184166|FG001|Overall Study|Physician Decision|6|||
124879955|NCT03107377|449184165|FG000|Overall Study|Pregnancy|7|||
124879956|NCT03107377|449184166|FG001|Overall Study|Pregnancy|7|||
124879957|NCT03107377|449184165|FG000|Overall Study|Withdrawal by Subject|16|||
124437801|NCT05330312|447562544|FG001|Pivotal Investigation - Part 2|Death|4|||
124437802|NCT05330312|447562545|FG002|Pivotal Investigation - Part 2|Death|0|||
124437803|NCT03319849|447562546|FG000|Overall Study|Adverse Event|1|||
124437804|NCT03319849|447562547|FG001|Overall Study|Adverse Event|0|||
124679716|NCT02349386|448451237|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
124879958|NCT03107377|449184166|FG001|Overall Study|Withdrawal by Subject|22|||
124879959|NCT03107377|449184165|FG000|Overall Study|Lost to Follow-up|37|||
124879960|NCT03107377|449184166|FG001|Overall Study|Lost to Follow-up|34|||
124879961|NCT03107377|449184165|FG000|Overall Study|Other reason not specified|16|||
124879962|NCT03107377|449184166|FG001|Overall Study|Other reason not specified|15|||
124879963|NCT00453102|449184167|FG000|Overall Study|Withdrawal by Subject|2|||
124879964|NCT05796518|449184170|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
124879965|NCT02690077|449184173|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
124879966|NCT02690077|449184174|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
124879967|NCT02690077|449184173|FG000|Overall Study|Withdrawal by Subject|0|||
124879968|NCT02690077|449184174|FG001|Overall Study|Withdrawal by Subject|5|||
124879969|NCT02690077|449184173|FG000|Overall Study|Excluded by IRB|0|||
124879970|NCT02690077|449184174|FG001|Overall Study|Excluded by IRB|2|||
124437805|NCT03319849|447562546|FG000|Overall Study|Physician Decision|0|||
124437806|NCT03319849|447562547|FG001|Overall Study|Physician Decision|1|||
124437807|NCT03319849|447562546|FG000|Overall Study|Withdrawal by Subject|0|||
124879971|NCT05672680|449184175|FG000|Overall Study|Patient Did Not Complete the Form|5|||
124879972|NCT05672680|449184176|FG001|Overall Study|Patient Did Not Complete the Form|4|||
124879973|NCT05672680|449184175|FG000|Overall Study|Procedure Aborted|1|||
124879974|NCT05672680|449184176|FG001|Overall Study|Procedure Aborted|0|||
124879975|NCT05408468|449184177|FG000|Overall Study|Lost to Follow-up|3|||
124879976|NCT05408468|449184178|FG001|Overall Study|Lost to Follow-up|1|||
124879977|NCT05408468|449184177|FG000|Overall Study|Physician Decision|1|||
124879978|NCT05408468|449184178|FG001|Overall Study|Physician Decision|0|||
124879979|NCT05408468|449184177|FG000|Overall Study|Overwhelmed by clinical situation|3|||
124879980|NCT05408468|449184178|FG001|Overall Study|Overwhelmed by clinical situation|0|||
124879981|NCT05408468|449184177|FG000|Overall Study|Personal illness precluding participation|1|||
124879982|NCT05408468|449184178|FG001|Overall Study|Personal illness precluding participation|0|||
124879983|NCT05408468|449184177|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
124879984|NCT05408468|449184178|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
124879985|NCT00747123|449184179|FG000|Overall Study|Investigator's request|0|||
124879986|NCT00747123|449184180|FG001|Overall Study|Investigator's request|0|||
124879987|NCT00747123|449184181|FG002|Overall Study|Investigator's request|1|||
124879988|NCT00747123|449184182|FG003|Overall Study|Investigator's request|0|||
124879989|NCT00747123|449184179|FG000|Overall Study|Withdrew consent|0|||
124879990|NCT00747123|449184180|FG001|Overall Study|Withdrew consent|1|||
124879991|NCT00747123|449184181|FG002|Overall Study|Withdrew consent|0|||
124879992|NCT00747123|449184182|FG003|Overall Study|Withdrew consent|0|||
124879993|NCT00747123|449184179|FG000|Overall Study|Adverse Event|0|||
124879994|NCT00747123|449184180|FG001|Overall Study|Adverse Event|1|||
124879995|NCT00747123|449184181|FG002|Overall Study|Adverse Event|0|||
124879996|NCT00747123|449184182|FG003|Overall Study|Adverse Event|1|||
124879997|NCT04186403|449184183|FG000|Overall Study|Adverse Event|1|||
124879998|NCT04186403|449184184|FG001|Overall Study|Adverse Event|8|||
124879999|NCT04186403|449184183|FG000|Overall Study|Lost to Follow-up|7|||
124880000|NCT04186403|449184184|FG001|Overall Study|Lost to Follow-up|3|||
124880001|NCT04186403|449184183|FG000|Overall Study|Physician Decision|1|||
124880002|NCT04186403|449184184|FG001|Overall Study|Physician Decision|0|||
124880003|NCT04186403|449184183|FG000|Overall Study|Withdrawal by Subject|7|||
124880004|NCT04186403|449184184|FG001|Overall Study|Withdrawal by Subject|8|||
124880005|NCT04186403|449184183|FG000|Overall Study|Other: Not Related to Covid-19|3|||
124880006|NCT04186403|449184184|FG001|Overall Study|Other: Not Related to Covid-19|0|||
124880007|NCT00405639|449184196|FG000|Overall Study|Withdrawal by Subject|1|||
124880008|NCT00405639|449184197|FG001|Overall Study|Withdrawal by Subject|0|||
124880009|NCT00405639|449184196|FG000|Overall Study|Adverse Event|1|||
124880010|NCT00405639|449184197|FG001|Overall Study|Adverse Event|0|||
124880011|NCT00405639|449184196|FG000|Overall Study|Seizure prior to receiving BNP|1|||
124880012|NCT00405639|449184197|FG001|Overall Study|Seizure prior to receiving BNP|0|||
124880013|NCT01483937|449184198|FG000|Overall Study|Withdrawal by Subject|4|||
124880014|NCT01483937|449184199|FG001|Overall Study|Withdrawal by Subject|3|||
124880015|NCT00265330|449184200|FG000|Overall Study|Adverse Event|41|||
124880016|NCT00265330|449184200|FG000|Overall Study|Lost to Follow-up|8|||
124880017|NCT00265330|449184200|FG000|Overall Study|Withdrawal by Subject|34|||
124880018|NCT00265330|449184200|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
124880019|NCT00265330|449184200|FG000|Overall Study|Lack of Efficacy|4|||
124880020|NCT00265330|449184200|FG000|Overall Study|Family Scheduling Conflicts|1|||
124880021|NCT00265330|449184200|FG000|Overall Study|Began Taking Formulary Geodon|1|||
124880022|NCT00265330|449184200|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
124880023|NCT00265330|449184200|FG000|Overall Study|Site Closed by Sponsor|1|||
124880024|NCT00265330|449184200|FG000|Overall Study|Principal Investigators Request|1|||
124880025|NCT00265330|449184200|FG000|Overall Study|Withdrew Consent|1|||
124880026|NCT00265330|449184200|FG000|Overall Study|Protocol Violation|1|||
124880027|NCT03108157|449184203|FG000|Overall Study|Protocol Violation|15|||
124880028|NCT03108157|449184204|FG001|Overall Study|Protocol Violation|4|||
124880029|NCT04534114|449184205|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
124880030|NCT04534114|449184206|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
124880031|NCT04534114|449184207|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
124880032|NCT04534114|449184208|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
124880033|NCT04534114|449184205|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
124437808|NCT03319849|447562547|FG001|Overall Study|Withdrawal by Subject|1|||
124437809|NCT03319849|447562546|FG000|Overall Study|COVID-19|0|||
124880034|NCT04534114|449184206|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
124437810|NCT03319849|447562547|FG001|Overall Study|COVID-19|1|||
124437811|NCT03319849|447562546|FG000|Overall Study|Other|1|||
124437812|NCT03319849|447562547|FG001|Overall Study|Other|2|||
124880035|NCT04534114|449184207|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
124880036|NCT04534114|449184208|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
124437813|NCT03319849|447562546|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
124880037|NCT04534114|449184205|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
124880038|NCT04534114|449184206|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
124880039|NCT04534114|449184207|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
124880040|NCT04534114|449184208|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
124437814|NCT03319849|447562547|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
124437815|NCT03319849|447562546|FG000|Overall Study|Lost to Follow-up|0|||
124679717|NCT02349386|448451238|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
124679718|NCT02349386|448451235|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
124679719|NCT02349386|448451236|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
124679720|NCT02349386|448451237|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
124679721|NCT02349386|448451238|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
124679722|NCT02349386|448451235|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
124679723|NCT02349386|448451236|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
124679724|NCT02349386|448451237|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
124679725|NCT02349386|448451238|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
124679726|NCT02349386|448451235|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
124679727|NCT02349386|448451236|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
124679728|NCT02349386|448451237|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
124679729|NCT02349386|448451238|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
124679730|NCT02349386|448451235|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
124679731|NCT02349386|448451236|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
124679732|NCT02349386|448451237|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
124679733|NCT02349386|448451238|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
124679734|NCT02349386|448451235|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
124679735|NCT02349386|448451236|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
124679736|NCT02349386|448451237|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
124679737|NCT02349386|448451238|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
124679738|NCT01712178|448451239|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
124679739|NCT01712178|448451240|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
124679740|NCT01712178|448451239|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
124679741|NCT01712178|448451240|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
124679742|NCT01712178|448451239|FG000|Overall Study|Lost to Follow-up|0|||
124679743|NCT01712178|448451240|FG001|Overall Study|Lost to Follow-up|1|||
124679744|NCT02765165|448451241|FG000|Treatment Period|Progressive disease|3|||
124679745|NCT02765165|448451242|FG001|Treatment Period|Progressive disease|2|||
124679746|NCT02765165|448451243|FG002|Treatment Period|Progressive disease|3|||
124679747|NCT02765165|448451244|FG003|Treatment Period|Progressive disease|3|||
124679748|NCT02765165|448451245|FG004|Treatment Period|Progressive disease|4|||
124679749|NCT02765165|448451246|FG005|Treatment Period|Progressive disease|2|||
124679750|NCT02765165|448451247|FG006|Treatment Period|Progressive disease|2|||
124679751|NCT02765165|448451241|FG000|Treatment Period|Physician Decision|0|||
124679752|NCT02765165|448451242|FG001|Treatment Period|Physician Decision|1|||
124679753|NCT02765165|448451243|FG002|Treatment Period|Physician Decision|0|||
124679754|NCT02765165|448451244|FG003|Treatment Period|Physician Decision|0|||
124679755|NCT02765165|448451245|FG004|Treatment Period|Physician Decision|0|||
124679756|NCT02765165|448451246|FG005|Treatment Period|Physician Decision|0|||
124679757|NCT02765165|448451247|FG006|Treatment Period|Physician Decision|0|||
124679758|NCT02765165|448451241|FG000|Treatment Period|Adverse Event|0|||
124679759|NCT02765165|448451242|FG001|Treatment Period|Adverse Event|1|||
124679760|NCT02765165|448451243|FG002|Treatment Period|Adverse Event|0|||
124679761|NCT02765165|448451244|FG003|Treatment Period|Adverse Event|0|||
124679762|NCT02765165|448451245|FG004|Treatment Period|Adverse Event|0|||
124679763|NCT02765165|448451246|FG005|Treatment Period|Adverse Event|0|||
124679764|NCT02765165|448451247|FG006|Treatment Period|Adverse Event|0|||
124679765|NCT02765165|448451241|FG000|Treatment Period|Withdrawal by Subject|0|||
124679766|NCT02765165|448451242|FG001|Treatment Period|Withdrawal by Subject|0|||
124679767|NCT02765165|448451243|FG002|Treatment Period|Withdrawal by Subject|0|||
124679768|NCT02765165|448451244|FG003|Treatment Period|Withdrawal by Subject|0|||
124679769|NCT02765165|448451245|FG004|Treatment Period|Withdrawal by Subject|2|||
124679770|NCT02765165|448451246|FG005|Treatment Period|Withdrawal by Subject|0|||
124679771|NCT02765165|448451247|FG006|Treatment Period|Withdrawal by Subject|0|||
124679772|NCT02765165|448451241|FG000|Treatment Period|Study terminated|0|||
124679773|NCT02765165|448451242|FG001|Treatment Period|Study terminated|0|||
124679774|NCT02765165|448451243|FG002|Treatment Period|Study terminated|0|||
124679775|NCT02765165|448451244|FG003|Treatment Period|Study terminated|0|||
124679776|NCT02765165|448451245|FG004|Treatment Period|Study terminated|0|||
124679777|NCT02765165|448451246|FG005|Treatment Period|Study terminated|1|||
124679778|NCT02765165|448451247|FG006|Treatment Period|Study terminated|2|||
124679779|NCT02765165|448451241|FG000|Post-treatment Follow-up|Death|1|||
124679780|NCT02765165|448451242|FG001|Post-treatment Follow-up|Death|2|||
124679781|NCT02765165|448451243|FG002|Post-treatment Follow-up|Death|1|||
124679782|NCT02765165|448451244|FG003|Post-treatment Follow-up|Death|1|||
124679783|NCT02765165|448451245|FG004|Post-treatment Follow-up|Death|1|||
124679784|NCT02765165|448451246|FG005|Post-treatment Follow-up|Death|1|||
124679785|NCT02765165|448451247|FG006|Post-treatment Follow-up|Death|0|||
124880041|NCT04534114|449184205|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
124880042|NCT04534114|449184206|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
124880043|NCT04534114|449184207|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
124880044|NCT04534114|449184208|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
124880045|NCT04534114|449184205|FG000|Main Treatment Period|Physician Decision|0|||
124880046|NCT04534114|449184206|FG001|Main Treatment Period|Physician Decision|0|||
124880047|NCT04534114|449184207|FG002|Main Treatment Period|Physician Decision|0|||
124880048|NCT04534114|449184208|FG003|Main Treatment Period|Physician Decision|1|||
124880049|NCT04534114|449184205|FG000|Main Treatment Period|Death|1|||
124880050|NCT04534114|449184206|FG001|Main Treatment Period|Death|0|||
124880051|NCT04534114|449184207|FG002|Main Treatment Period|Death|0|||
124880052|NCT04534114|449184208|FG003|Main Treatment Period|Death|1|||
124880053|NCT04534114|449184205|FG000|Main Treatment Period|Other reason|1|||
124880054|NCT04534114|449184206|FG001|Main Treatment Period|Other reason|1|||
124880055|NCT04534114|449184207|FG002|Main Treatment Period|Other reason|0|||
124880056|NCT04534114|449184208|FG003|Main Treatment Period|Other reason|0|||
124880057|NCT04534114|449184205|FG000|Main Treatment Period|Participant decision|1|||
124880058|NCT04534114|449184206|FG001|Main Treatment Period|Participant decision|3|||
124880059|NCT04534114|449184207|FG002|Main Treatment Period|Participant decision|3|||
124880060|NCT04534114|449184208|FG003|Main Treatment Period|Participant decision|1|||
124880061|NCT04534114|449184205|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
124880062|NCT04534114|449184206|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
124880063|NCT04534114|449184207|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
124880064|NCT04534114|449184208|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
124880065|NCT04534114|449184205|FG000|Main Treatment Period|Adverse Event|4|||
124880066|NCT04534114|449184206|FG001|Main Treatment Period|Adverse Event|2|||
124880067|NCT04534114|449184207|FG002|Main Treatment Period|Adverse Event|1|||
124880068|NCT04534114|449184208|FG003|Main Treatment Period|Adverse Event|2|||
124880069|NCT04534114|449184205|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
124880070|NCT04534114|449184206|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
124880071|NCT04534114|449184207|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
124880072|NCT04534114|449184208|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
124880073|NCT04534114|449184205|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
124880074|NCT04534114|449184206|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
124880075|NCT04534114|449184207|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
124880076|NCT04534114|449184208|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
124880077|NCT04534114|449184205|FG000|Extension Treatment Period|Other reason|0|||
124880078|NCT04534114|449184206|FG001|Extension Treatment Period|Other reason|1|||
124880079|NCT04534114|449184207|FG002|Extension Treatment Period|Other reason|0|||
124880080|NCT04534114|449184208|FG003|Extension Treatment Period|Other reason|0|||
124880081|NCT04534114|449184205|FG000|Extension Treatment Period|Death|0|||
124880082|NCT04534114|449184206|FG001|Extension Treatment Period|Death|0|||
124880083|NCT04534114|449184207|FG002|Extension Treatment Period|Death|1|||
124880084|NCT04534114|449184208|FG003|Extension Treatment Period|Death|2|||
124880085|NCT04534114|449184205|FG000|Extension Treatment Period|Adverse Event|0|||
124880086|NCT04534114|449184206|FG001|Extension Treatment Period|Adverse Event|1|||
124880087|NCT04534114|449184207|FG002|Extension Treatment Period|Adverse Event|0|||
124880088|NCT04534114|449184208|FG003|Extension Treatment Period|Adverse Event|1|||
124880089|NCT04534114|449184205|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
124880090|NCT04534114|449184206|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
124880091|NCT04534114|449184207|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
124880092|NCT04534114|449184208|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
124880093|NCT03287414|449184209|FG000|Treatment Epoch|Adverse Event|0|||
124880094|NCT03287414|449184210|FG001|Treatment Epoch|Adverse Event|1|||
124880095|NCT03287414|449184209|FG000|Treatment Epoch|Study terminated by sponsor|2|||
124880096|NCT03287414|449184210|FG001|Treatment Epoch|Study terminated by sponsor|2|||
124880097|NCT03287414|449184209|FG000|Treatment Epoch|Subject/Guardian decision|4|||
124880098|NCT03287414|449184210|FG001|Treatment Epoch|Subject/Guardian decision|0|||
124880099|NCT03287414|449184209|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
124880100|NCT03287414|449184210|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
124880101|NCT03287414|449184209|FG000|Treatment Epoch|Withdrawal by Subject|1|||
124880102|NCT03287414|449184210|FG001|Treatment Epoch|Withdrawal by Subject|0|||
124880103|NCT03287414|449184209|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
124880104|NCT03287414|449184210|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
124880105|NCT03287414|449184209|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
124880106|NCT03287414|449184210|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
124880107|NCT02759185|449184211|FG000|Stage 1|Adverse Event|0|||
124880108|NCT02759185|449184212|FG001|Stage 1|Adverse Event|1|||
124880109|NCT02759185|449184213|FG002|Stage 1|Adverse Event|3|||
124880110|NCT02759185|449184214|FG003|Stage 1|Adverse Event|0|||
124880111|NCT02759185|449184215|FG004|Stage 1|Adverse Event|0|||
124880112|NCT02759185|449184216|FG005|Stage 1|Adverse Event|0|||
124880113|NCT02759185|449184217|FG006|Stage 1|Adverse Event|0|||
124880114|NCT02759185|449184211|FG000|Stage 1|Withdrawal by Subject|1|||
124880115|NCT02759185|449184212|FG001|Stage 1|Withdrawal by Subject|0|||
124880116|NCT02759185|449184213|FG002|Stage 1|Withdrawal by Subject|0|||
124880117|NCT02759185|449184214|FG003|Stage 1|Withdrawal by Subject|0|||
124880118|NCT02759185|449184215|FG004|Stage 1|Withdrawal by Subject|0|||
124880119|NCT02759185|449184216|FG005|Stage 1|Withdrawal by Subject|0|||
124880120|NCT02759185|449184217|FG006|Stage 1|Withdrawal by Subject|0|||
124880121|NCT02759185|449184211|FG000|Stage 2|Adverse Event|0|||
124880122|NCT02759185|449184212|FG001|Stage 2|Adverse Event|0|||
124880123|NCT02759185|449184213|FG002|Stage 2|Adverse Event|0|||
124880124|NCT02759185|449184214|FG003|Stage 2|Adverse Event|0|||
124880125|NCT02759185|449184215|FG004|Stage 2|Adverse Event|1|||
124880126|NCT02759185|449184216|FG005|Stage 2|Adverse Event|2|||
124880127|NCT02759185|449184217|FG006|Stage 2|Adverse Event|0|||
124880128|NCT02759185|449184211|FG000|Stage 2|Withdrawal by Subject|0|||
124880129|NCT02759185|449184212|FG001|Stage 2|Withdrawal by Subject|0|||
124880130|NCT02759185|449184213|FG002|Stage 2|Withdrawal by Subject|0|||
124880131|NCT02759185|449184214|FG003|Stage 2|Withdrawal by Subject|0|||
124880132|NCT02759185|449184215|FG004|Stage 2|Withdrawal by Subject|1|||
124880133|NCT02759185|449184216|FG005|Stage 2|Withdrawal by Subject|1|||
124880134|NCT02759185|449184217|FG006|Stage 2|Withdrawal by Subject|1|||
124880135|NCT02613221|449184220|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
124880136|NCT02613221|449184220|FG000|Overall Study|Adverse Event|2|||
124880137|NCT02613221|449184220|FG000|Overall Study|Voluntary Discontinuation|1|||
124880138|NCT02613221|449184220|FG000|Overall Study|Delayed Treatment|1|||
124880139|NCT02613221|449184220|FG000|Overall Study|Enrolled but Not Treated|1|||
124880140|NCT02668016|449184223|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
124880141|NCT02668016|449184223|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
124880142|NCT02668016|449184223|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
124880143|NCT02668016|449184223|FG000|Month 4|Withdrawal due to severe symptoms|1|||
124880144|NCT02668016|449184223|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
124880145|NCT02668016|449184223|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
124880146|NCT02668016|449184223|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
124880147|NCT02668016|449184223|FG000|Month 6|Withdrawal due to severe symptoms|2|||
124880148|NCT02668016|449184223|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
124880149|NCT02668016|449184223|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
124880150|NCT02668016|449184223|FG000|Month 8|Withdrawal due to severe symptoms|1|||
124880151|NCT02668016|449184223|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
124880152|NCT02668016|449184223|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
124880153|NCT02668016|449184223|FG000|Month 10|Withdrawal due to severe symptoms|1|||
124880154|NCT02668016|449184223|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
124880155|NCT00399763|449184228|FG000|Overall Study|Lost to Follow-up|2|||
124880156|NCT00399763|449184229|FG001|Overall Study|Lost to Follow-up|3|||
124880157|NCT05067933|449184237|FG000|Overall Study|Withdrawal by Subject|2|||
124880158|NCT05067933|449184238|FG001|Overall Study|Withdrawal by Subject|0|||
124880159|NCT05067933|449184239|FG002|Overall Study|Withdrawal by Subject|0|||
124880160|NCT05067933|449184240|FG003|Overall Study|Withdrawal by Subject|0|||
124880161|NCT05067933|449184241|FG004|Overall Study|Withdrawal by Subject|0|||
124880162|NCT05067933|449184242|FG005|Overall Study|Withdrawal by Subject|0|||
124880163|NCT05067933|449184237|FG000|Overall Study|Lost to Follow-up|1|||
124679786|NCT02765165|448451241|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
124679787|NCT02765165|448451242|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
124679788|NCT02765165|448451243|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
124679789|NCT02765165|448451244|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
124880164|NCT05067933|449184238|FG001|Overall Study|Lost to Follow-up|1|||
124880165|NCT05067933|449184239|FG002|Overall Study|Lost to Follow-up|1|||
124880166|NCT05067933|449184240|FG003|Overall Study|Lost to Follow-up|2|||
124880167|NCT05067933|449184241|FG004|Overall Study|Lost to Follow-up|1|||
124880168|NCT05067933|449184242|FG005|Overall Study|Lost to Follow-up|0|||
124880169|NCT05067933|449184237|FG000|Overall Study|Miscellaneous|1|||
124880170|NCT05067933|449184238|FG001|Overall Study|Miscellaneous|0|||
124880171|NCT05067933|449184239|FG002|Overall Study|Miscellaneous|0|||
124880172|NCT05067933|449184240|FG003|Overall Study|Miscellaneous|0|||
124880173|NCT05067933|449184241|FG004|Overall Study|Miscellaneous|0|||
124880174|NCT05067933|449184242|FG005|Overall Study|Miscellaneous|0|||
124437816|NCT03319849|447562547|FG001|Overall Study|Lost to Follow-up|2|||
124880175|NCT05067933|449184237|FG000|Overall Study|Death|0|||
124880176|NCT05067933|449184238|FG001|Overall Study|Death|0|||
124880177|NCT05067933|449184239|FG002|Overall Study|Death|0|||
124880178|NCT05067933|449184240|FG003|Overall Study|Death|1|||
124880179|NCT05067933|449184241|FG004|Overall Study|Death|0|||
124880180|NCT05067933|449184242|FG005|Overall Study|Death|0|||
124880181|NCT01065350|449184248|FG000|Overall Study|Received incorrect drug allocation|0|||
124880182|NCT01065350|449184249|FG001|Overall Study|Received incorrect drug allocation|1|||
124880183|NCT01657266|449184253|FG000|Overall Study|Lost to Follow-up|2|||
124880184|NCT01657266|449184254|FG001|Overall Study|Lost to Follow-up|2|||
124880185|NCT01657266|449184253|FG000|Overall Study|Adverse Event|2|||
124880186|NCT01657266|449184254|FG001|Overall Study|Adverse Event|3|||
124880187|NCT03443713|449184264|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
124880188|NCT03443713|449184265|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
124880189|NCT03443713|449184266|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
124880190|NCT01672853|449184269|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
124880191|NCT01672853|449184270|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
124880192|NCT01672853|449184271|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
124880193|NCT01672853|449184269|FG000|Overall Study|Pregnancy|0|||
124880194|NCT01672853|449184270|FG001|Overall Study|Pregnancy|1|||
124880195|NCT01672853|449184271|FG002|Overall Study|Pregnancy|0|||
124880196|NCT01672853|449184269|FG000|Overall Study|Investigator's Discretion|1|||
124880197|NCT01672853|449184270|FG001|Overall Study|Investigator's Discretion|0|||
124880198|NCT01672853|449184271|FG002|Overall Study|Investigator's Discretion|0|||
124880199|NCT01672853|449184269|FG000|Overall Study|Withdrew Consent|5|||
124880200|NCT01672853|449184270|FG001|Overall Study|Withdrew Consent|5|||
124880201|NCT01672853|449184271|FG002|Overall Study|Withdrew Consent|5|||
124880202|NCT01672853|449184269|FG000|Overall Study|Adverse Event|4|||
124880203|NCT01672853|449184270|FG001|Overall Study|Adverse Event|6|||
124880204|NCT01672853|449184271|FG002|Overall Study|Adverse Event|8|||
124880205|NCT01672853|449184269|FG000|Overall Study|Lost to Follow-up|0|||
124880206|NCT01672853|449184270|FG001|Overall Study|Lost to Follow-up|1|||
124880207|NCT01672853|449184271|FG002|Overall Study|Lost to Follow-up|0|||
124880208|NCT01672853|449184269|FG000|Overall Study|Randomized but Never Treated|0|||
124880209|NCT01672853|449184270|FG001|Overall Study|Randomized but Never Treated|0|||
124880210|NCT01672853|449184271|FG002|Overall Study|Randomized but Never Treated|1|||
124880211|NCT02944656|449184273|FG000|Overall Study|No longer eligible|3|||
124880212|NCT02944656|449184274|FG001|Overall Study|No longer eligible|0|||
124880213|NCT02944656|449184273|FG000|Overall Study|Lost to Follow-up|7|||
124880214|NCT02944656|449184274|FG001|Overall Study|Lost to Follow-up|10|||
124880215|NCT02243631|449185467|FG000|Overall Study|no synovial fluid on second aspirate|0|||
124880216|NCT02243631|449185468|FG001|Overall Study|no synovial fluid on second aspirate|1|||
124880217|NCT01992549|449185471|FG000|Overall Study|Lost to Follow-up|2|||
124880218|NCT01992549|449185471|FG000|Overall Study|Serious Adverse Event|1|||
124880219|NCT01992549|449185471|FG000|Overall Study|Product Switch to Extend Half Life|1|||
124880220|NCT01590771|449185472|FG000|Overall Study|Other Protocol Specified Criteria|5|||
124880221|NCT01590771|449185473|FG001|Overall Study|Other Protocol Specified Criteria|14|||
124880222|NCT01590771|449185472|FG000|Overall Study|Withdrawal by Subject|8|||
124880223|NCT01590771|449185473|FG001|Overall Study|Withdrawal by Subject|15|||
124880224|NCT01590771|449185472|FG000|Overall Study|Protocol Violation|1|||
124880225|NCT01590771|449185473|FG001|Overall Study|Protocol Violation|2|||
124880226|NCT01590771|449185472|FG000|Overall Study|Lost to Follow-up|1|||
124880227|NCT01590771|449185473|FG001|Overall Study|Lost to Follow-up|1|||
124880228|NCT01590771|449185472|FG000|Overall Study|Lack of Efficacy|1|||
124880229|NCT01590771|449185473|FG001|Overall Study|Lack of Efficacy|0|||
124880230|NCT01590771|449185472|FG000|Overall Study|Adverse Event|3|||
124880231|NCT01590771|449185473|FG001|Overall Study|Adverse Event|7|||
124880232|NCT01785628|449185474|FG000|Overall Study|Lost to Follow-up|2|||
124880233|NCT01785628|449185475|FG001|Overall Study|Lost to Follow-up|3|||
124880234|NCT00840996|449185476|FG000|Overall Study|Withdrawal by Subject|1|||
124437817|NCT03938545|447563973|FG000|Overall Study|Lost to Follow-up|0|||
124437818|NCT03938545|447563974|FG001|Overall Study|Lost to Follow-up|0|||
124880235|NCT00840996|449185477|FG001|Overall Study|Withdrawal by Subject|0|||
124880236|NCT01900054|449185478|FG000|Overall Study|Physician Decision|1|||
124880237|NCT01900054|449185478|FG000|Overall Study|Withdrawal by Subject|1|||
124880238|NCT03285295|449185481|FG000|Alinity s HBsAg|Protocol Violation|11|||
124880239|NCT03285295|449185482|FG001|Alinity s HBsAg|Protocol Violation|0|||
124880240|NCT03285295|449185483|FG002|Alinity s HBsAg|Protocol Violation|0|||
124880241|NCT03285295|449185484|FG003|Alinity s HBsAg|Protocol Violation|0|||
124880242|NCT03285295|449185485|FG004|Alinity s HBsAg|Protocol Violation|0|||
124880243|NCT03285295|449185481|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
124880244|NCT03285295|449185482|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
124880245|NCT03285295|449185483|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
124880246|NCT03285295|449185484|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
124880247|NCT03285295|449185485|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
124437819|NCT03938545|447563975|FG002|Overall Study|Lost to Follow-up|0|||
124679790|NCT02765165|448451245|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
124679791|NCT02765165|448451246|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
124679792|NCT02765165|448451247|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
124679793|NCT02765165|448451241|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
124679794|NCT02765165|448451242|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
124679795|NCT02765165|448451243|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
124679796|NCT02765165|448451244|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
124679797|NCT02765165|448451245|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
124679798|NCT02765165|448451246|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
124679799|NCT02765165|448451247|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
124679800|NCT02765165|448451241|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
124679801|NCT02765165|448451242|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
124679802|NCT02765165|448451243|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
124679803|NCT02765165|448451244|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
124679804|NCT02765165|448451245|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
124880248|NCT03285295|449185481|FG000|Alinity s HBsAg|No Results Generated|74|||
124880249|NCT03285295|449185482|FG001|Alinity s HBsAg|No Results Generated|6|||
124880250|NCT03285295|449185483|FG002|Alinity s HBsAg|No Results Generated|0|||
124437820|NCT03938545|447563976|FG003|Overall Study|Lost to Follow-up|1|||
124437821|NCT03938545|447563973|FG000|Overall Study|Non-compliance with study drug|0|||
124437822|NCT03938545|447563974|FG001|Overall Study|Non-compliance with study drug|0|||
124437823|NCT03938545|447563975|FG002|Overall Study|Non-compliance with study drug|1|||
124437824|NCT03938545|447563976|FG003|Overall Study|Non-compliance with study drug|0|||
124437825|NCT03938545|447563973|FG000|Overall Study|Pregnancy|1|||
124437826|NCT03938545|447563974|FG001|Overall Study|Pregnancy|0|||
124437827|NCT03938545|447563975|FG002|Overall Study|Pregnancy|0|||
124437828|NCT03938545|447563976|FG003|Overall Study|Pregnancy|0|||
124437829|NCT03938545|447563973|FG000|Overall Study|Study terminated by sponsor|6|||
124437830|NCT03938545|447563974|FG001|Overall Study|Study terminated by sponsor|4|||
124437831|NCT03938545|447563975|FG002|Overall Study|Study terminated by sponsor|2|||
124437832|NCT03938545|447563976|FG003|Overall Study|Study terminated by sponsor|4|||
124437833|NCT03938545|447563973|FG000|Overall Study|Withdrawal by Subject|0|||
124437834|NCT03938545|447563974|FG001|Overall Study|Withdrawal by Subject|1|||
124679805|NCT02765165|448451246|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
124679806|NCT02765165|448451247|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
124679807|NCT02765165|448451241|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
124679808|NCT02765165|448451242|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
124679809|NCT02765165|448451243|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
124679810|NCT02765165|448451244|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
124679811|NCT02765165|448451245|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
124679812|NCT02765165|448451246|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
124679813|NCT02765165|448451247|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
124679814|NCT02765165|448451241|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
124679815|NCT02765165|448451242|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
124679816|NCT02765165|448451243|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
124679817|NCT02765165|448451244|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
124679818|NCT02765165|448451245|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
124679819|NCT02765165|448451246|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
124679820|NCT02765165|448451247|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
124679821|NCT00321763|448451249|FG000|Overall Study|Adverse Event|1|||
124679822|NCT00321763|448451250|FG001|Overall Study|Adverse Event|1|||
124679823|NCT00321763|448451251|FG002|Overall Study|Adverse Event|0|||
124679824|NCT00321763|448451252|FG003|Overall Study|Adverse Event|1|||
124679825|NCT00321763|448451249|FG000|Overall Study|Withdrawal by Subject|2|||
124679826|NCT00321763|448451250|FG001|Overall Study|Withdrawal by Subject|0|||
124679827|NCT00321763|448451251|FG002|Overall Study|Withdrawal by Subject|1|||
124679828|NCT00321763|448451252|FG003|Overall Study|Withdrawal by Subject|0|||
124679829|NCT00321763|448451249|FG000|Overall Study|Lost to Follow-up|3|||
124679830|NCT00321763|448451250|FG001|Overall Study|Lost to Follow-up|1|||
124679831|NCT00321763|448451251|FG002|Overall Study|Lost to Follow-up|5|||
124679832|NCT00321763|448451252|FG003|Overall Study|Lost to Follow-up|4|||
124679833|NCT00410163|448451253|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
124679834|NCT00410163|448451254|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
124679835|NCT00410163|448451253|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
124679836|NCT00410163|448451254|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
124679837|NCT00410163|448451253|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
124679838|NCT00410163|448451254|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
124679839|NCT00410163|448451253|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
124437835|NCT03938545|447563975|FG002|Overall Study|Withdrawal by Subject|0|||
124437836|NCT03938545|447563976|FG003|Overall Study|Withdrawal by Subject|0|||
124679840|NCT00410163|448451254|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
124679841|NCT00410163|448451253|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
124679842|NCT00410163|448451254|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
124679843|NCT00410163|448451253|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
124679844|NCT00410163|448451254|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
124679845|NCT00410163|448451253|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
124679846|NCT00410163|448451254|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
124679847|NCT00410163|448451253|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
124679848|NCT00410163|448451254|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
124679849|NCT00410163|448451253|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
124679850|NCT00410163|448451254|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
124679851|NCT00410163|448451253|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
124679852|NCT00410163|448451254|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
124679853|NCT00410163|448451253|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
124679854|NCT00410163|448451254|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
124679855|NCT00410163|448451253|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
124679856|NCT00410163|448451254|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
124679857|NCT00410163|448451253|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
124679858|NCT00410163|448451254|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
124679859|NCT00410163|448451253|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
124679860|NCT00410163|448451254|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
124679861|NCT00961415|448451255|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
124679862|NCT00961415|448451256|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
124679863|NCT00961415|448451257|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
124679864|NCT00961415|448451255|FG000|Induction Treatment Phase|Death|77|||
124679865|NCT00961415|448451256|FG001|Induction Treatment Phase|Death|0|||
124679866|NCT00961415|448451257|FG002|Induction Treatment Phase|Death|0|||
124679867|NCT00961415|448451255|FG000|Induction Treatment Phase|Protocol Violation|1|||
124679868|NCT00961415|448451256|FG001|Induction Treatment Phase|Protocol Violation|0|||
124679869|NCT00961415|448451257|FG002|Induction Treatment Phase|Protocol Violation|0|||
124679870|NCT00961415|448451255|FG000|Induction Treatment Phase|Physician Decision|2|||
124679871|NCT00961415|448451256|FG001|Induction Treatment Phase|Physician Decision|0|||
124679872|NCT00961415|448451257|FG002|Induction Treatment Phase|Physician Decision|0|||
124679873|NCT00961415|448451255|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
124679874|NCT00961415|448451256|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
124679875|NCT00961415|448451257|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
124679876|NCT00961415|448451255|FG000|Induction Treatment Phase|Other Reason|5|||
124679877|NCT00961415|448451256|FG001|Induction Treatment Phase|Other Reason|0|||
124679878|NCT00961415|448451257|FG002|Induction Treatment Phase|Other Reason|0|||
124679879|NCT00961415|448451255|FG000|Maintenance Treatment Phase|Death|0|||
124679880|NCT00961415|448451256|FG001|Maintenance Treatment Phase|Death|42|||
124679881|NCT00961415|448451257|FG002|Maintenance Treatment Phase|Death|34|||
124679882|NCT00961415|448451255|FG000|Maintenance Treatment Phase|Investigators decision|0|||
124679883|NCT00961415|448451256|FG001|Maintenance Treatment Phase|Investigators decision|2|||
124679884|NCT00961415|448451257|FG002|Maintenance Treatment Phase|Investigators decision|0|||
124679885|NCT00961415|448451255|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124679886|NCT00961415|448451256|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
124679887|NCT00961415|448451257|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
124679888|NCT00961415|448451255|FG000|Maintenance Treatment Phase|Other reason|0|||
124679889|NCT00961415|448451256|FG001|Maintenance Treatment Phase|Other reason|1|||
124679890|NCT00961415|448451257|FG002|Maintenance Treatment Phase|Other reason|3|||
124679891|NCT04759131|448451260|FG000|Overall Study|Investigator's discretion|1|||
124679892|NCT04759131|448451261|FG001|Overall Study|Investigator's discretion|0|||
124679893|NCT04759131|448451260|FG000|Overall Study|Subject withdrawal|1|||
124679894|NCT04759131|448451261|FG001|Overall Study|Subject withdrawal|0|||
124679895|NCT05144945|448451262|FG000|Overall Study|Withdrawal by Subject|1|||
124679896|NCT05144945|448451263|FG001|Overall Study|Withdrawal by Subject|0|||
124679897|NCT03426878|448451267|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
124679898|NCT03426878|448451267|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
124679899|NCT03426878|448451267|FG000|Overall Study|Declined to receive results|3|||
124679900|NCT03426878|448451267|FG000|Overall Study|Received negative results by mailed letter|65|||
124679901|NCT03426878|448451267|FG000|Overall Study|Lost to Follow-up|177|||
124679902|NCT00465517|448451268|FG000|Overall Study|Adverse Event|7|||
124437837|NCT03938545|447563973|FG000|Overall Study|Adverse Event|1|||
124437838|NCT03938545|447563974|FG001|Overall Study|Adverse Event|0|||
124437839|NCT03938545|447563975|FG002|Overall Study|Adverse Event|0|||
124437840|NCT03938545|447563976|FG003|Overall Study|Adverse Event|0|||
124437841|NCT02186223|447563977|FG000|Overall Study|Not eligible for device placement|6|||
124437842|NCT02186223|447563977|FG000|Overall Study|Unable to obtain femoral access|3|||
124679903|NCT00465517|448451269|FG001|Overall Study|Adverse Event|3|||
124679904|NCT00465517|448451268|FG000|Overall Study|Lost to Follow-up|1|||
124679905|NCT00465517|448451269|FG001|Overall Study|Lost to Follow-up|0|||
124679906|NCT00465517|448451268|FG000|Overall Study|Withdrawal by Subject|4|||
124679907|NCT00465517|448451269|FG001|Overall Study|Withdrawal by Subject|1|||
124679908|NCT05233761|448451276|FG000|Treatment Period A|Withdrawal by Subject|12|||
124679909|NCT05233761|448451277|FG001|Treatment Period A|Withdrawal by Subject|10|||
124679910|NCT05233761|448451276|FG000|Treatment Period A|Lost to Follow-up|6|||
124679911|NCT05233761|448451277|FG001|Treatment Period A|Lost to Follow-up|12|||
124679912|NCT05233761|448451276|FG000|Treatment Period A|Protocol Violation|8|||
124679913|NCT05233761|448451277|FG001|Treatment Period A|Protocol Violation|15|||
124679914|NCT00560404|448451280|FG000|Overall Study|Adverse Event|2|||
124679915|NCT00560404|448451281|FG001|Overall Study|Adverse Event|3|||
124679916|NCT00560404|448451280|FG000|Overall Study|Death|3|||
124679917|NCT00560404|448451281|FG001|Overall Study|Death|3|||
124679918|NCT00560404|448451280|FG000|Overall Study|Protocol Violation|12|||
124679919|NCT00560404|448451281|FG001|Overall Study|Protocol Violation|7|||
124679920|NCT00560404|448451280|FG000|Overall Study|Administrative Reasons|1|||
124679921|NCT00560404|448451281|FG001|Overall Study|Administrative Reasons|1|||
124679922|NCT00560404|448451280|FG000|Overall Study|Withdrew Consent|4|||
124679923|NCT00560404|448451281|FG001|Overall Study|Withdrew Consent|0|||
124679924|NCT00560404|448451280|FG000|Overall Study|Failure to return|1|||
124679925|NCT00560404|448451281|FG001|Overall Study|Failure to return|2|||
124679926|NCT00560404|448451280|FG000|Overall Study|Other withdrawal reason|13|||
124679927|NCT00560404|448451281|FG001|Overall Study|Other withdrawal reason|5|||
124679928|NCT04513366|448451288|FG000|Treatment Phase|Withdrawal by Subject|6|||
124679929|NCT04513366|448451289|FG001|Treatment Phase|Withdrawal by Subject|8|||
124679930|NCT04513366|448451290|FG002|Treatment Phase|Withdrawal by Subject|3|||
124679931|NCT04513366|448451288|FG000|Treatment Phase|Lost to Follow-up|1|||
124679932|NCT04513366|448451289|FG001|Treatment Phase|Lost to Follow-up|2|||
124679933|NCT04513366|448451290|FG002|Treatment Phase|Lost to Follow-up|5|||
124679934|NCT04513366|448451288|FG000|Treatment Phase|Other than Specified|1|||
124679935|NCT04513366|448451289|FG001|Treatment Phase|Other than Specified|0|||
124679936|NCT04513366|448451290|FG002|Treatment Phase|Other than Specified|2|||
124679937|NCT04513366|448451288|FG000|Treatment Phase|Physician Decision|2|||
124679938|NCT04513366|448451289|FG001|Treatment Phase|Physician Decision|0|||
124679939|NCT04513366|448451290|FG002|Treatment Phase|Physician Decision|0|||
124679940|NCT04513366|448451288|FG000|Treatment Phase|Adverse Event|0|||
124679941|NCT04513366|448451289|FG001|Treatment Phase|Adverse Event|1|||
124679942|NCT04513366|448451290|FG002|Treatment Phase|Adverse Event|1|||
124679943|NCT04513366|448451288|FG000|Extension Phase|Withdrawal by Subject|3|||
124679944|NCT04513366|448451289|FG001|Extension Phase|Withdrawal by Subject|1|||
124679945|NCT04513366|448451290|FG002|Extension Phase|Withdrawal by Subject|1|||
124679946|NCT04513366|448451288|FG000|Extension Phase|Other than Specified|4|||
124679947|NCT04513366|448451289|FG001|Extension Phase|Other than Specified|0|||
124679948|NCT04513366|448451290|FG002|Extension Phase|Other than Specified|1|||
124679949|NCT04513366|448451288|FG000|Extension Phase|Lost to Follow-up|1|||
124679950|NCT04513366|448451289|FG001|Extension Phase|Lost to Follow-up|1|||
124679951|NCT04513366|448451290|FG002|Extension Phase|Lost to Follow-up|1|||
124679952|NCT04513366|448451288|FG000|Extension Phase|Sponsor Decision|0|||
124679953|NCT04513366|448451289|FG001|Extension Phase|Sponsor Decision|1|||
124679954|NCT04513366|448451290|FG002|Extension Phase|Sponsor Decision|0|||
124679955|NCT04513366|448451288|FG000|Extension Phase|Death|0|||
124679956|NCT04513366|448451289|FG001|Extension Phase|Death|1|||
124679957|NCT04513366|448451290|FG002|Extension Phase|Death|0|||
124679958|NCT04513366|448451288|FG000|Extension Phase|Adverse Event|0|||
124679959|NCT04513366|448451289|FG001|Extension Phase|Adverse Event|0|||
124437843|NCT02186223|447563977|FG000|Overall Study|Death|3|||
124437844|NCT02186223|447563977|FG000|Overall Study|Device in place less than 48 hours|9|||
124437845|NCT02079610|447563981|FG000|Overall Study|Withdrawal by Subject|1|||
124437846|NCT02079610|447563982|FG001|Overall Study|Withdrawal by Subject|1|||
124437847|NCT01111474|447563983|FG000|Overall Study|Lost to Follow-up|12|||
124437848|NCT01016977|447563984|FG000|Overall Study|Lost to Follow-up|1|||
124437849|NCT01016977|447563985|FG001|Overall Study|Lost to Follow-up|0|||
124437850|NCT01016977|447563984|FG000|Overall Study|Withdrawal by Subject|2|||
124679960|NCT04513366|448451290|FG002|Extension Phase|Adverse Event|1|||
124679961|NCT00392223|448451291|FG000|Overall Study|Adverse Event|5|||
124679962|NCT00392223|448451292|FG001|Overall Study|Adverse Event|4|||
124437851|NCT01016977|447563985|FG001|Overall Study|Withdrawal by Subject|2|||
124437852|NCT01236365|447563986|FG000|Overall Study|Lost to Follow-up|0|||
124679963|NCT00392223|448451291|FG000|Overall Study|Lost to Follow-up|1|||
124437853|NCT01236365|447563987|FG001|Overall Study|Lost to Follow-up|2|||
124679964|NCT00392223|448451292|FG001|Overall Study|Lost to Follow-up|4|||
124679965|NCT00392223|448451291|FG000|Overall Study|Protocol Violation|0|||
124679966|NCT00392223|448451292|FG001|Overall Study|Protocol Violation|3|||
124679967|NCT00392223|448451291|FG000|Overall Study|Withdrawal by Subject|3|||
124679968|NCT00392223|448451292|FG001|Overall Study|Withdrawal by Subject|2|||
124679969|NCT02657551|448451295|FG000|Overall Study|Adverse Event|2|||
124880251|NCT03285295|449185484|FG003|Alinity s HBsAg|No Results Generated|0|||
124880252|NCT03285295|449185485|FG004|Alinity s HBsAg|No Results Generated|0|||
124880253|NCT03285295|449185481|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
124679970|NCT02657551|448451295|FG000|Overall Study|Withdrawal by Subject|1|||
124679971|NCT02657551|448451295|FG000|Overall Study|Non-Compliance|1|||
124679972|NCT02657551|448451295|FG000|Overall Study|Progression / Relapse|4|||
124679973|NCT04478266|448451297|FG000|Overall Study|Adverse Event|20|||
124679974|NCT04478266|448451298|FG001|Overall Study|Adverse Event|21|||
124679975|NCT04478266|448451297|FG000|Overall Study|Progressive disease|146|||
124679976|NCT04478266|448451298|FG001|Overall Study|Progressive disease|168|||
124679977|NCT04478266|448451297|FG000|Overall Study|Poor compliance to protocol|1|||
124679978|NCT04478266|448451298|FG001|Overall Study|Poor compliance to protocol|0|||
124679979|NCT04478266|448451297|FG000|Overall Study|Withdrawal by Subject|19|||
124679980|NCT04478266|448451298|FG001|Overall Study|Withdrawal by Subject|16|||
124679981|NCT04478266|448451297|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
124679982|NCT04478266|448451298|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
124679983|NCT04478266|448451297|FG000|Overall Study|Study terminated by sponsor|33|||
124679984|NCT04478266|448451298|FG001|Overall Study|Study terminated by sponsor|35|||
124679985|NCT04478266|448451297|FG000|Overall Study|Other: unspecified|5|||
124679986|NCT04478266|448451298|FG001|Overall Study|Other: unspecified|7|||
124679987|NCT04478266|448451297|FG000|Overall Study|Randomized but not treated|1|||
124679988|NCT04478266|448451298|FG001|Overall Study|Randomized but not treated|1|||
124679989|NCT04798027|448451304|FG000|Overall Study|Protocol Violation|0|||
124679990|NCT04798027|448451305|FG001|Overall Study|Protocol Violation|0|||
124679991|NCT04798027|448451306|FG002|Overall Study|Protocol Violation|0|||
124679992|NCT04798027|448451307|FG003|Overall Study|Protocol Violation|0|||
124679993|NCT04798027|448451308|FG004|Overall Study|Protocol Violation|1|||
124679994|NCT04798027|448451309|FG005|Overall Study|Protocol Violation|0|||
124679995|NCT04798027|448451310|FG006|Overall Study|Protocol Violation|0|||
124679996|NCT04798027|448451311|FG007|Overall Study|Protocol Violation|1|||
124679997|NCT04798027|448451312|FG008|Overall Study|Protocol Violation|0|||
124679998|NCT04798027|448451304|FG000|Overall Study|Withdrawal by Subject|1|||
124679999|NCT04798027|448451305|FG001|Overall Study|Withdrawal by Subject|0|||
124680000|NCT04798027|448451306|FG002|Overall Study|Withdrawal by Subject|1|||
124680001|NCT04798027|448451307|FG003|Overall Study|Withdrawal by Subject|1|||
124680002|NCT04798027|448451308|FG004|Overall Study|Withdrawal by Subject|1|||
124680003|NCT04798027|448451309|FG005|Overall Study|Withdrawal by Subject|1|||
124680004|NCT04798027|448451310|FG006|Overall Study|Withdrawal by Subject|3|||
124680005|NCT04798027|448451311|FG007|Overall Study|Withdrawal by Subject|2|||
124680006|NCT04798027|448451312|FG008|Overall Study|Withdrawal by Subject|2|||
124680007|NCT04798027|448451304|FG000|Overall Study|Lost to Follow-up|1|||
124680008|NCT04798027|448451305|FG001|Overall Study|Lost to Follow-up|3|||
124680009|NCT04798027|448451306|FG002|Overall Study|Lost to Follow-up|0|||
124680010|NCT04798027|448451307|FG003|Overall Study|Lost to Follow-up|0|||
124680011|NCT04798027|448451308|FG004|Overall Study|Lost to Follow-up|0|||
124680012|NCT04798027|448451309|FG005|Overall Study|Lost to Follow-up|1|||
124680013|NCT04798027|448451310|FG006|Overall Study|Lost to Follow-up|0|||
124680014|NCT04798027|448451311|FG007|Overall Study|Lost to Follow-up|0|||
124680015|NCT04798027|448451312|FG008|Overall Study|Lost to Follow-up|1|||
124680016|NCT04798027|448451304|FG000|Overall Study|Withdrawal by Sponsor|8|||
124680017|NCT04798027|448451305|FG001|Overall Study|Withdrawal by Sponsor|22|||
124680018|NCT04798027|448451306|FG002|Overall Study|Withdrawal by Sponsor|9|||
124680019|NCT04798027|448451307|FG003|Overall Study|Withdrawal by Sponsor|26|||
124680020|NCT04798027|448451308|FG004|Overall Study|Withdrawal by Sponsor|24|||
124680021|NCT04798027|448451309|FG005|Overall Study|Withdrawal by Sponsor|11|||
124680022|NCT04798027|448451310|FG006|Overall Study|Withdrawal by Sponsor|25|||
124680023|NCT04798027|448451311|FG007|Overall Study|Withdrawal by Sponsor|26|||
124680024|NCT04798027|448451312|FG008|Overall Study|Withdrawal by Sponsor|11|||
124680025|NCT03104374|448451313|FG000|Period 1|Adverse Event|7|||
124680026|NCT03104374|448451314|FG001|Period 1|Adverse Event|7|||
124680027|NCT03104374|448451315|FG002|Period 1|Adverse Event|12|||
124680028|NCT03104374|448451316|FG003|Period 1|Adverse Event|14|||
124680029|NCT03104374|448451313|FG000|Period 1|Withdrawal by Subject|18|||
124680030|NCT03104374|448451314|FG001|Period 1|Withdrawal by Subject|9|||
124680031|NCT03104374|448451315|FG002|Period 1|Withdrawal by Subject|10|||
124680032|NCT03104374|448451316|FG003|Period 1|Withdrawal by Subject|17|||
124680033|NCT03104374|448451313|FG000|Period 1|Lost to Follow-up|4|||
124680034|NCT03104374|448451314|FG001|Period 1|Lost to Follow-up|4|||
124680035|NCT03104374|448451315|FG002|Period 1|Lost to Follow-up|6|||
124680036|NCT03104374|448451316|FG003|Period 1|Lost to Follow-up|8|||
124680037|NCT03104374|448451313|FG000|Period 1|Lack of Efficacy|6|||
124680038|NCT03104374|448451314|FG001|Period 1|Lack of Efficacy|7|||
124680039|NCT03104374|448451315|FG002|Period 1|Lack of Efficacy|12|||
124680040|NCT03104374|448451316|FG003|Period 1|Lack of Efficacy|6|||
124880254|NCT03285295|449185482|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
124880255|NCT03285295|449185483|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
124680041|NCT03104374|448451313|FG000|Period 1|Other|2|||
124680042|NCT03104374|448451314|FG001|Period 1|Other|2|||
124880256|NCT03285295|449185484|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
124680043|NCT03104374|448451315|FG002|Period 1|Other|4|||
124680044|NCT03104374|448451316|FG003|Period 1|Other|7|||
124680045|NCT03104374|448451313|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
124680046|NCT03104374|448451314|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
124680047|NCT03104374|448451315|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
124680048|NCT03104374|448451316|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
124680049|NCT03104374|448451313|FG000|Period 2|Adverse Event|4|||
124680050|NCT03104374|448451314|FG001|Period 2|Adverse Event|7|||
124680051|NCT03104374|448451315|FG002|Period 2|Adverse Event|10|||
124680052|NCT03104374|448451316|FG003|Period 2|Adverse Event|10|||
124680053|NCT03104374|448451313|FG000|Period 2|Withdrawal by Subject|3|||
124680054|NCT03104374|448451314|FG001|Period 2|Withdrawal by Subject|7|||
124680055|NCT03104374|448451315|FG002|Period 2|Withdrawal by Subject|13|||
124680056|NCT03104374|448451316|FG003|Period 2|Withdrawal by Subject|16|||
124680057|NCT03104374|448451313|FG000|Period 2|Lost to Follow-up|2|||
124680058|NCT03104374|448451314|FG001|Period 2|Lost to Follow-up|2|||
124680059|NCT03104374|448451315|FG002|Period 2|Lost to Follow-up|3|||
124680060|NCT03104374|448451316|FG003|Period 2|Lost to Follow-up|5|||
124680061|NCT03104374|448451313|FG000|Period 2|Lack of Efficacy|2|||
124680062|NCT03104374|448451314|FG001|Period 2|Lack of Efficacy|4|||
124680063|NCT03104374|448451315|FG002|Period 2|Lack of Efficacy|7|||
124680064|NCT03104374|448451316|FG003|Period 2|Lack of Efficacy|4|||
124680065|NCT03104374|448451313|FG000|Period 2|COVID-19 Infection|0|||
124680066|NCT03104374|448451314|FG001|Period 2|COVID-19 Infection|0|||
124680067|NCT03104374|448451315|FG002|Period 2|COVID-19 Infection|1|||
124680068|NCT03104374|448451316|FG003|Period 2|COVID-19 Infection|0|||
124680069|NCT03104374|448451313|FG000|Period 2|Other|3|||
124680070|NCT03104374|448451314|FG001|Period 2|Other|2|||
124680071|NCT03104374|448451315|FG002|Period 2|Other|2|||
124680072|NCT03104374|448451316|FG003|Period 2|Other|4|||
124680073|NCT00094445|448451319|FG000|Overall Study|Withdrawal by Subject|3|||
124680074|NCT00094445|448451319|FG000|Overall Study|Lost to Follow-up|1|||
124680075|NCT00094445|448451319|FG000|Overall Study|Progressive Disease|2|||
124680076|NCT00769561|448451324|FG000|Overall Study|Withdrawal by Subject|2|||
124680077|NCT00769561|448451325|FG001|Overall Study|Withdrawal by Subject|2|||
124680078|NCT00769561|448451324|FG000|Overall Study|Lost to Follow-up|1|||
124680079|NCT00769561|448451325|FG001|Overall Study|Lost to Follow-up|3|||
124680080|NCT04585893|448451326|FG000|Overall Study|Death|1|||
124680081|NCT04585893|448451327|FG001|Overall Study|Death|0|||
124680082|NCT03729362|448452682|FG000|Overall Study|Withdrawal by Subject|2|||
124680083|NCT03729362|448452683|FG001|Overall Study|Withdrawal by Subject|0|||
124680084|NCT03729362|448452682|FG000|Overall Study|Physician Decision|1|||
124680085|NCT03729362|448452683|FG001|Overall Study|Physician Decision|0|||
124680086|NCT03729362|448452682|FG000|Overall Study|COVID-19 Pandemic|1|||
124680087|NCT03729362|448452683|FG001|Overall Study|COVID-19 Pandemic|0|||
124680088|NCT03729362|448452682|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
124680089|NCT03729362|448452683|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
124680090|NCT03729362|448452682|FG000|Overall Study|Adverse Event|0|||
124680091|NCT03729362|448452683|FG001|Overall Study|Adverse Event|1|||
124680092|NCT03729362|448452682|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
124680093|NCT03729362|448452683|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
124680094|NCT01113749|448452684|FG000|Overall Study|Lost to Follow-up|1|||
124680095|NCT01113749|448452685|FG001|Overall Study|Lost to Follow-up|2|||
124680096|NCT00961064|448452686|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
124680097|NCT00961064|448452686|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
124680098|NCT00961064|448452686|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
124680099|NCT00961064|448452686|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
124680100|NCT00961064|448452686|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
124680101|NCT00961064|448452686|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
124680102|NCT00961064|448452686|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
124680103|NCT00961064|448452686|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
124680104|NCT00576758|448452687|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
124680105|NCT00576758|448452688|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
124680106|NCT00576758|448452687|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
124680107|NCT00576758|448452688|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
124680108|NCT00576758|448452687|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
124680109|NCT00576758|448452688|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
124680110|NCT00576758|448452687|FG000|Induction Treatment Period|Death|1|||
124880257|NCT03285295|449185485|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
124880258|NCT03285295|449185481|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
124680111|NCT00576758|448452688|FG001|Induction Treatment Period|Death|0|||
124680112|NCT00576758|448452687|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
124437854|NCT01236365|447563986|FG000|Overall Study|Moved Out of State|1|||
124437855|NCT01236365|447563987|FG001|Overall Study|Moved Out of State|0|||
124437856|NCT01236365|447563986|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
124437857|NCT01236365|447563987|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
124437858|NCT00717067|447563988|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
124437859|NCT00717067|447563989|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
124437860|NCT00717067|447563990|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
124437861|NCT00717067|447563991|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
124437862|NCT00717067|447563992|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
124437863|NCT01689337|447563993|FG000|Overall Study|Study Discontinuation|1|||
124437864|NCT00824161|447563994|FG000|Overall Study|Withdrawal by Subject|1|||
124437865|NCT00824161|447563994|FG000|Overall Study|Screen Failure|1|||
124437866|NCT04754477|447563995|FG000|Overall Study|Withdrawal by Subject|1|||
124437867|NCT01347762|447563996|FG000|Overall Study|Lost to Follow-up|0|||
124437868|NCT01347762|447563997|FG001|Overall Study|Lost to Follow-up|1|||
124437869|NCT01347762|447563998|FG002|Overall Study|Lost to Follow-up|6|||
124437870|NCT01347762|447563999|FG003|Overall Study|Lost to Follow-up|5|||
124437871|NCT01347762|447563996|FG000|Overall Study|Withdrawal by Subject|4|||
124437872|NCT01347762|447563997|FG001|Overall Study|Withdrawal by Subject|1|||
124437873|NCT01347762|447563998|FG002|Overall Study|Withdrawal by Subject|3|||
124437874|NCT01347762|447563999|FG003|Overall Study|Withdrawal by Subject|3|||
124437875|NCT03406260|447564000|FG000|Period 1|Adverse Event|0|||
124437876|NCT03406260|447564001|FG001|Period 1|Adverse Event|0|||
124680113|NCT00576758|448452688|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
124680114|NCT00576758|448452687|FG000|Induction Treatment Period|Withdrew consent|1|||
124680115|NCT00576758|448452688|FG001|Induction Treatment Period|Withdrew consent|0|||
124680116|NCT00576758|448452687|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
124680117|NCT00576758|448452688|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
124680118|NCT00576758|448452687|FG000|Extension Treatment Period|Death|1|||
124680119|NCT00576758|448452688|FG001|Extension Treatment Period|Death|1|||
124680120|NCT00576758|448452687|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
124680121|NCT00576758|448452688|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
124680122|NCT00576758|448452687|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
124680123|NCT00576758|448452688|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
124680124|NCT00576758|448452687|FG000|Extension Treatment Period|Administrative/Other|3|||
124680125|NCT00576758|448452688|FG001|Extension Treatment Period|Administrative/Other|1|||
124680126|NCT00576758|448452687|FG000|Follow-up Period|Administrative/Other|6|||
124680127|NCT00576758|448452688|FG001|Follow-up Period|Administrative/Other|8|||
124680128|NCT00576758|448452687|FG000|Follow-up Period|Death|3|||
124680129|NCT00576758|448452688|FG001|Follow-up Period|Death|3|||
124680130|NCT00576758|448452687|FG000|Follow-up Period|Insufficient therapeutic response|16|||
124437877|NCT03406260|447564002|FG002|Period 1|Adverse Event|0|||
124437878|NCT03406260|447564003|FG003|Period 1|Adverse Event|0|||
124437879|NCT03406260|447564004|FG004|Period 1|Adverse Event|1|||
124437880|NCT03406260|447564005|FG005|Period 1|Adverse Event|0|||
124437881|NCT04745026|447564006|FG000|Overall Study|Physician Decision|1|||
124437882|NCT04745026|447564007|FG001|Overall Study|Physician Decision|0|||
124437883|NCT04745026|447564006|FG000|Overall Study|Adverse Event|2|||
124437884|NCT04745026|447564007|FG001|Overall Study|Adverse Event|2|||
124437885|NCT04745026|447564006|FG000|Overall Study|Protocol Violation|1|||
124437886|NCT04745026|447564007|FG001|Overall Study|Protocol Violation|3|||
124437887|NCT04745026|447564006|FG000|Overall Study|Lost to Follow-up|4|||
124437888|NCT04745026|447564007|FG001|Overall Study|Lost to Follow-up|3|||
124437889|NCT04745026|447564006|FG000|Overall Study|Withdrawal by Subject|5|||
124680131|NCT00576758|448452688|FG001|Follow-up Period|Insufficient therapeutic response|5|||
124680132|NCT00576758|448452687|FG000|Follow-up Period|Withdrew consent|2|||
124680133|NCT00576758|448452688|FG001|Follow-up Period|Withdrew consent|1|||
124680134|NCT00761319|448452689|FG000|Overall Study|Protocol Violation|21|||
124680135|NCT00761319|448452690|FG001|Overall Study|Protocol Violation|14|||
124680136|NCT00761319|448452689|FG000|Overall Study|Adverse Event|11|||
124680137|NCT00761319|448452690|FG001|Overall Study|Adverse Event|7|||
124680138|NCT00761319|448452689|FG000|Overall Study|Withdrawal by Subject|8|||
124680139|NCT00761319|448452690|FG001|Overall Study|Withdrawal by Subject|7|||
124680140|NCT00761319|448452689|FG000|Overall Study|Noncompliance|4|||
124680141|NCT00761319|448452690|FG001|Overall Study|Noncompliance|3|||
124437890|NCT04745026|447564007|FG001|Overall Study|Withdrawal by Subject|5|||
124680142|NCT00761319|448452689|FG000|Overall Study|Lost to Follow-up|1|||
124680143|NCT00761319|448452690|FG001|Overall Study|Lost to Follow-up|1|||
124680144|NCT00761319|448452689|FG000|Overall Study|Nonspecified|2|||
124437891|NCT01205152|447564008|FG000|Overall Study|Death|1|||
124437892|NCT00249002|447564009|FG000|Overall Study|Adverse Event|2|||
124437893|NCT00249002|447564009|FG000|Overall Study|Study cancellation|3|||
124437894|NCT00249002|447564009|FG000|Overall Study|Other|2|||
124437895|NCT03256851|447564010|FG000|Overall Study|Withdrawal by Subject|1|||
124437896|NCT03256851|447564011|FG001|Overall Study|Withdrawal by Subject|0|||
124437897|NCT02208999|447564012|FG000|Overall Study|Lost to Follow-up|1|||
124680145|NCT00761319|448452690|FG001|Overall Study|Nonspecified|2|||
124680146|NCT00761319|448452689|FG000|Overall Study|Missing|1|||
124680147|NCT00761319|448452690|FG001|Overall Study|Missing|0|||
124680148|NCT01432951|448452693|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
124680149|NCT00853385|448452694|FG000|Overall Study|Death|0|||
124680150|NCT00853385|448452695|FG001|Overall Study|Death|0|||
124680151|NCT00853385|448452696|FG002|Overall Study|Death|0|||
124680152|NCT00853385|448452697|FG003|Overall Study|Death|0|||
124680153|NCT00853385|448452698|FG004|Overall Study|Death|1|||
124680154|NCT00853385|448452694|FG000|Overall Study|Adverse Event|24|||
124680155|NCT00853385|448452695|FG001|Overall Study|Adverse Event|24|||
124680156|NCT00853385|448452696|FG002|Overall Study|Adverse Event|2|||
124680157|NCT00853385|448452697|FG003|Overall Study|Adverse Event|5|||
124680158|NCT00853385|448452698|FG004|Overall Study|Adverse Event|22|||
124680159|NCT00853385|448452694|FG000|Overall Study|Lack of Efficacy|6|||
124680160|NCT00853385|448452695|FG001|Overall Study|Lack of Efficacy|7|||
124680161|NCT00853385|448452696|FG002|Overall Study|Lack of Efficacy|3|||
124680162|NCT00853385|448452697|FG003|Overall Study|Lack of Efficacy|3|||
124680163|NCT00853385|448452698|FG004|Overall Study|Lack of Efficacy|6|||
124680164|NCT00853385|448452694|FG000|Overall Study|Lost to Follow-up|2|||
124680165|NCT00853385|448452695|FG001|Overall Study|Lost to Follow-up|1|||
124680166|NCT00853385|448452696|FG002|Overall Study|Lost to Follow-up|0|||
124680167|NCT00853385|448452697|FG003|Overall Study|Lost to Follow-up|0|||
124680168|NCT00853385|448452698|FG004|Overall Study|Lost to Follow-up|0|||
124680169|NCT00853385|448452694|FG000|Overall Study|Withdrawal by Subject|4|||
124680170|NCT00853385|448452695|FG001|Overall Study|Withdrawal by Subject|2|||
124680171|NCT00853385|448452696|FG002|Overall Study|Withdrawal by Subject|0|||
124680172|NCT00853385|448452697|FG003|Overall Study|Withdrawal by Subject|1|||
124680173|NCT00853385|448452698|FG004|Overall Study|Withdrawal by Subject|1|||
124680174|NCT00853385|448452694|FG000|Overall Study|Other|18|||
124680175|NCT00853385|448452695|FG001|Overall Study|Other|9|||
124680176|NCT00853385|448452696|FG002|Overall Study|Other|4|||
124680177|NCT00853385|448452697|FG003|Overall Study|Other|4|||
124680178|NCT00853385|448452698|FG004|Overall Study|Other|12|||
124680179|NCT00915525|448452701|FG000|Overall Study|Protocol Violation|9|||
124680180|NCT00915525|448452702|FG001|Overall Study|Protocol Violation|4|||
124680181|NCT00915525|448452701|FG000|Overall Study|Withdrawal by Subject|59|||
124680182|NCT00915525|448452702|FG001|Overall Study|Withdrawal by Subject|21|||
124680183|NCT00915525|448452701|FG000|Overall Study|Lost to Follow-up|27|||
124680184|NCT00915525|448452702|FG001|Overall Study|Lost to Follow-up|16|||
124680185|NCT00915525|448452701|FG000|Overall Study|Pregnancy|2|||
124680186|NCT00915525|448452702|FG001|Overall Study|Pregnancy|0|||
124680187|NCT00915525|448452701|FG000|Overall Study|Lack of Efficacy|15|||
124680188|NCT00915525|448452702|FG001|Overall Study|Lack of Efficacy|32|||
124680189|NCT00915525|448452701|FG000|Overall Study|Adverse Event|29|||
124680190|NCT00915525|448452702|FG001|Overall Study|Adverse Event|13|||
124680191|NCT00915525|448452701|FG000|Overall Study|Missing|12|||
124680192|NCT00915525|448452702|FG001|Overall Study|Missing|1|||
124680193|NCT00915525|448452701|FG000|Overall Study|Other Reason|35|||
124680194|NCT00915525|448452702|FG001|Overall Study|Other Reason|12|||
124680195|NCT00915525|448452701|FG000|Overall Study|Site Closed|27|||
124680196|NCT00915525|448452702|FG001|Overall Study|Site Closed|9|||
124680197|NCT00915525|448452701|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
124680198|NCT00915525|448452702|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
124680199|NCT00915525|448452701|FG000|Overall Study|Study Burden|28|||
124680200|NCT00915525|448452702|FG001|Overall Study|Study Burden|12|||
124680201|NCT00915525|448452701|FG000|Overall Study|Non-Compliance|3|||
124680202|NCT00915525|448452702|FG001|Overall Study|Non-Compliance|1|||
124680203|NCT00915525|448452701|FG000|Overall Study|Patient Moved|15|||
124680204|NCT00915525|448452702|FG001|Overall Study|Patient Moved|9|||
124880259|NCT03285295|449185482|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
124880260|NCT03285295|449185483|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
124880261|NCT03285295|449185484|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
124880262|NCT03285295|449185485|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
124437898|NCT00319839|447564013|FG000|Overall Study|Adverse Event|5|||
124680205|NCT00984867|448452710|FG000|Overall Study|Adverse Event|3|||
124680206|NCT00984867|448452711|FG001|Overall Study|Adverse Event|7|||
124680207|NCT00984867|448452710|FG000|Overall Study|Death|1|||
124680208|NCT00984867|448452711|FG001|Overall Study|Death|0|||
124680209|NCT00984867|448452710|FG000|Overall Study|Withdrawal by Subject|13|||
124437899|NCT00319839|447564013|FG000|Overall Study|Withdrawal by Subject|1|||
124680210|NCT00984867|448452711|FG001|Overall Study|Withdrawal by Subject|4|||
124680211|NCT00984867|448452710|FG000|Overall Study|Lost to Follow-up|3|||
124680212|NCT00984867|448452711|FG001|Overall Study|Lost to Follow-up|4|||
124680213|NCT00984867|448452710|FG000|Overall Study|Poor/non-compliance|0|||
124680214|NCT00984867|448452711|FG001|Overall Study|Poor/non-compliance|1|||
124680215|NCT00984867|448452710|FG000|Overall Study|Subject no longer meets study criteria|1|||
124680216|NCT00984867|448452711|FG001|Overall Study|Subject no longer meets study criteria|1|||
124680217|NCT00984867|448452710|FG000|Overall Study|site closing|1|||
124680218|NCT00984867|448452711|FG001|Overall Study|site closing|0|||
124680219|NCT00984867|448452710|FG000|Overall Study|lack of efficacy and subject compliance|1|||
124680220|NCT00984867|448452711|FG001|Overall Study|lack of efficacy and subject compliance|0|||
124680221|NCT03482024|448452716|FG000|Overall Study|Physician Decision|1|||
124680222|NCT03482024|448452717|FG001|Overall Study|Physician Decision|0|||
124680223|NCT03482024|448452718|FG002|Overall Study|Physician Decision|0|||
124680224|NCT03482024|448452719|FG003|Overall Study|Physician Decision|0|||
124680225|NCT03482024|448452720|FG004|Overall Study|Physician Decision|0|||
124680226|NCT03937778|448452721|FG000|Overall Study|Withdrawal by Subject|1|||
124680227|NCT03937778|448452721|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
124680228|NCT00819039|448452722|FG000|Overall Study|Physician Decision|1|||
124680229|NCT00819039|448452723|FG001|Overall Study|Physician Decision|0|||
124680230|NCT00819039|448452724|FG002|Overall Study|Physician Decision|1|||
124680231|NCT00819039|448452722|FG000|Overall Study|Protocol Violation|1|||
124680232|NCT00819039|448452723|FG001|Overall Study|Protocol Violation|0|||
124680233|NCT00819039|448452724|FG002|Overall Study|Protocol Violation|0|||
124680234|NCT01240694|448452725|FG000|Overall Study|Adverse Event|9|||
124680235|NCT01240694|448452725|FG000|Overall Study|Lack of Efficacy|6|||
124680236|NCT01240694|448452725|FG000|Overall Study|Withdrawal by Subject|6|||
124680237|NCT01240694|448452725|FG000|Overall Study|Protocol Violation|2|||
124680238|NCT01240694|448452725|FG000|Overall Study|Lost to Follow-up|2|||
124680239|NCT01240694|448452725|FG000|Overall Study|Other than specified|3|||
124680240|NCT01240694|448452725|FG000|Overall Study|Withdrawn due to early study termination|107|||
124680241|NCT01881425|448452726|FG000|Overall Study|Death|5|||
124680242|NCT01881425|448452727|FG001|Overall Study|Death|1|||
124680243|NCT01881425|448452726|FG000|Overall Study|Withdrawal by Subject|8|||
124680244|NCT01881425|448452727|FG001|Overall Study|Withdrawal by Subject|3|||
124680245|NCT01881425|448452726|FG000|Overall Study|Physician Decision|2|||
124680246|NCT01881425|448452727|FG001|Overall Study|Physician Decision|1|||
124680247|NCT01881425|448452726|FG000|Overall Study|Adverse Event|3|||
124680248|NCT01881425|448452727|FG001|Overall Study|Adverse Event|0|||
124680249|NCT01881425|448452726|FG000|Overall Study|General Anesthesia panic attack|0|||
124680250|NCT01881425|448452727|FG001|Overall Study|General Anesthesia panic attack|1|||
124680251|NCT01881425|448452726|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
124680252|NCT01881425|448452727|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
124680253|NCT01881425|448452726|FG000|Overall Study|Lost to Follow-up|7|||
124680254|NCT01881425|448452727|FG001|Overall Study|Lost to Follow-up|2|||
124680255|NCT01200355|448452732|FG000|Overall Study|Death|7|||
124680256|NCT01200355|448452733|FG001|Overall Study|Death|2|||
124680257|NCT03185208|448452734|FG000|Overall Study|Did not start study medication|0|||
124680258|NCT03185208|448452735|FG001|Overall Study|Did not start study medication|3|||
124680259|NCT03834350|448452736|FG000|Overall Study|Withdrawal by Subject|1|||
124680260|NCT02410629|448452737|FG000|Overall Study|Family cannot commit to the study|2|||
124680261|NCT02410629|448452738|FG001|Overall Study|Family cannot commit to the study|1|||
124680262|NCT02410629|448452737|FG000|Overall Study|Subject returned to work|1|||
124680263|NCT02410629|448452738|FG001|Overall Study|Subject returned to work|0|||
124680264|NCT02410629|448452737|FG000|Overall Study|Subject moved back to home country|0|||
124680265|NCT02410629|448452738|FG001|Overall Study|Subject moved back to home country|1|||
124680266|NCT02410629|448452737|FG000|Overall Study|Subject underwent heart surgery|0|||
124680267|NCT02410629|448452738|FG001|Overall Study|Subject underwent heart surgery|1|||
124680268|NCT01206764|448452739|FG000|Overall Study|Adverse Event|20|||
124680269|NCT01206764|448452739|FG000|Overall Study|Abnormal laboratory value|2|||
124680270|NCT01206764|448452739|FG000|Overall Study|Abnormal test procedure result|1|||
124680271|NCT01206764|448452739|FG000|Overall Study|Patient withdrew consent|5|||
124680272|NCT01206764|448452739|FG000|Overall Study|Lost to Follow-up|6|||
124680273|NCT01206764|448452739|FG000|Overall Study|Death|11|||
124680274|NCT01206764|448452739|FG000|Overall Study|New cancer therapy|2|||
124680275|NCT01206764|448452739|FG000|Overall Study|Disease progression|88|||
124680276|NCT01206764|448452739|FG000|Overall Study|Protocol deviation|3|||
124680277|NCT01186770|448452740|FG000|Overall Study|Ineligibility|0|||
124680278|NCT01186770|448452741|FG001|Overall Study|Ineligibility|0|||
124680279|NCT01186770|448452742|FG002|Overall Study|Ineligibility|2|||
124680280|NCT01186770|448452743|FG003|Overall Study|Ineligibility|0|||
124680281|NCT01186770|448452740|FG000|Overall Study|Protocol Violation|7|||
124680282|NCT01186770|448452741|FG001|Overall Study|Protocol Violation|9|||
124680283|NCT01186770|448452742|FG002|Overall Study|Protocol Violation|12|||
124680284|NCT01186770|448452743|FG003|Overall Study|Protocol Violation|14|||
124880263|NCT03285295|449185481|FG000|Alinity s HTLV I/II|No Results Generated|70|||
124880264|NCT03285295|449185482|FG001|Alinity s HTLV I/II|No Results Generated|0|||
124880265|NCT03285295|449185483|FG002|Alinity s HTLV I/II|No Results Generated|0|||
124880266|NCT03285295|449185484|FG003|Alinity s HTLV I/II|No Results Generated|0|||
124880267|NCT03285295|449185485|FG004|Alinity s HTLV I/II|No Results Generated|0|||
124880268|NCT03285295|449185481|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
124880269|NCT03285295|449185482|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
124880270|NCT03285295|449185483|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
124680285|NCT01186770|448452740|FG000|Overall Study|Adverse Event|2|||
124680286|NCT01186770|448452741|FG001|Overall Study|Adverse Event|9|||
124680287|NCT01186770|448452742|FG002|Overall Study|Adverse Event|7|||
124680288|NCT01186770|448452743|FG003|Overall Study|Adverse Event|9|||
124680289|NCT01186770|448452740|FG000|Overall Study|Withdrawal by Subject|15|||
124880271|NCT03285295|449185484|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
124880272|NCT03285295|449185485|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
124437900|NCT00986674|447564014|FG000|Overall Study|Lack of Efficacy|28|||
124437901|NCT00986674|447564015|FG001|Overall Study|Lack of Efficacy|25|||
124437902|NCT00986674|447564016|FG002|Overall Study|Lack of Efficacy|23|||
124437903|NCT00986674|447564014|FG000|Overall Study|Adverse Event|4|||
124437904|NCT00986674|447564015|FG001|Overall Study|Adverse Event|8|||
124437905|NCT00986674|447564016|FG002|Overall Study|Adverse Event|9|||
124437906|NCT00986674|447564014|FG000|Overall Study|Death|5|||
124437907|NCT00986674|447564015|FG001|Overall Study|Death|0|||
124437908|NCT00986674|447564016|FG002|Overall Study|Death|4|||
124437909|NCT00986674|447564014|FG000|Overall Study|Withdrawal by Subject|6|||
124437910|NCT00986674|447564015|FG001|Overall Study|Withdrawal by Subject|2|||
124437911|NCT00986674|447564016|FG002|Overall Study|Withdrawal by Subject|1|||
124437912|NCT00986674|447564014|FG000|Overall Study|alternative therapy|0|||
124437913|NCT00986674|447564015|FG001|Overall Study|alternative therapy|0|||
124437914|NCT00986674|447564016|FG002|Overall Study|alternative therapy|1|||
124437915|NCT00986674|447564014|FG000|Overall Study|not start protocol therapy|4|||
124437916|NCT00986674|447564015|FG001|Overall Study|not start protocol therapy|3|||
124437917|NCT00986674|447564016|FG002|Overall Study|not start protocol therapy|1|||
124437918|NCT00986674|447564014|FG000|Overall Study|unknown/not specify|0|||
124437919|NCT00986674|447564015|FG001|Overall Study|unknown/not specify|7|||
124437920|NCT00986674|447564016|FG002|Overall Study|unknown/not specify|9|||
124437921|NCT02128542|447564017|FG000|Overall Study|Lost to Follow-up|3|||
124437922|NCT02128542|447564018|FG001|Overall Study|Lost to Follow-up|0|||
124437923|NCT02128542|447564017|FG000|Overall Study|Withdrew Consent|1|||
124437924|NCT02128542|447564018|FG001|Overall Study|Withdrew Consent|0|||
124437925|NCT01853137|447564019|FG000|Overall Study|Lost to Follow-up|4|||
124437926|NCT01853137|447564020|FG001|Overall Study|Lost to Follow-up|1|||
124437927|NCT00825916|447564021|FG000|Overall Study|Lost to Follow-up|4|||
124437928|NCT00825916|447564022|FG001|Overall Study|Lost to Follow-up|2|||
124437929|NCT00825916|447564023|FG002|Overall Study|Lost to Follow-up|1|||
124437930|NCT01778023|447564024|FG000|Overall Study|Withdrawal by Subject|0|||
124437931|NCT01778023|447564025|FG001|Overall Study|Withdrawal by Subject|3|||
124437932|NCT01098097|447564026|FG000|Overall Study|Adverse Event|17|||
124437933|NCT01098097|447564026|FG000|Overall Study|Lost to Follow-up|18|||
124437934|NCT01098097|447564026|FG000|Overall Study|Status unknown|16|||
124437935|NCT01098097|447564026|FG000|Overall Study|No reason reported|31|||
124437936|NCT01411215|447564027|FG000|Overall Study|Adverse Event|1|||
124437937|NCT01411215|447564028|FG001|Overall Study|Adverse Event|2|||
124437938|NCT01411215|447564027|FG000|Overall Study|Lack of Efficacy|2|||
124437939|NCT01411215|447564028|FG001|Overall Study|Lack of Efficacy|4|||
124437940|NCT01411215|447564027|FG000|Overall Study|Lost to Follow-up|12|||
124437941|NCT01411215|447564028|FG001|Overall Study|Lost to Follow-up|18|||
124437942|NCT01411215|447564027|FG000|Overall Study|Did not meet entrance criteria|0|||
124680290|NCT01186770|448452741|FG001|Overall Study|Withdrawal by Subject|13|||
124437943|NCT01411215|447564028|FG001|Overall Study|Did not meet entrance criteria|1|||
124437944|NCT01411215|447564027|FG000|Overall Study|Study terminated by sponsor|2|||
124437945|NCT01411215|447564028|FG001|Overall Study|Study terminated by sponsor|15|||
124437946|NCT01411215|447564027|FG000|Overall Study|Protocol Violation|3|||
124437947|NCT01411215|447564028|FG001|Overall Study|Protocol Violation|5|||
124437948|NCT01411215|447564027|FG000|Overall Study|Withdrawal by Subject|34|||
124437949|NCT01411215|447564028|FG001|Overall Study|Withdrawal by Subject|21|||
124437950|NCT01411215|447564027|FG000|Overall Study|Other|12|||
124437951|NCT01411215|447564028|FG001|Overall Study|Other|17|||
124437952|NCT01411215|447564027|FG000|Overall Study|Screen failure|0|||
124680291|NCT01186770|448452742|FG002|Overall Study|Withdrawal by Subject|11|||
124680292|NCT01186770|448452743|FG003|Overall Study|Withdrawal by Subject|17|||
124680293|NCT01186770|448452740|FG000|Overall Study|Lost to Follow-up|10|||
124680294|NCT01186770|448452741|FG001|Overall Study|Lost to Follow-up|6|||
124680295|NCT01186770|448452742|FG002|Overall Study|Lost to Follow-up|14|||
124680296|NCT01186770|448452743|FG003|Overall Study|Lost to Follow-up|9|||
124680297|NCT01186770|448452740|FG000|Overall Study|Insufficient response to treatment|7|||
124680298|NCT01186770|448452741|FG001|Overall Study|Insufficient response to treatment|8|||
124680299|NCT01186770|448452742|FG002|Overall Study|Insufficient response to treatment|5|||
124680300|NCT01186770|448452743|FG003|Overall Study|Insufficient response to treatment|7|||
124680301|NCT01186770|448452740|FG000|Overall Study|Other than specified|0|||
124680302|NCT01186770|448452741|FG001|Overall Study|Other than specified|1|||
124680303|NCT01186770|448452742|FG002|Overall Study|Other than specified|1|||
124680304|NCT01186770|448452743|FG003|Overall Study|Other than specified|2|||
124680305|NCT02567188|448452744|FG000|Overall Study|Death|10|||
124680306|NCT02567188|448452744|FG000|Overall Study|Terminated Mircera Treatment|9|||
124680307|NCT02567188|448452744|FG000|Overall Study|Lost to Follow-up|5|||
124680308|NCT02567188|448452744|FG000|Overall Study|Adverse Event|1|||
124680309|NCT02567188|448452744|FG000|Overall Study|Withdrawal by Subject|1|||
124680310|NCT02567188|448452744|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
124680311|NCT02567188|448452744|FG000|Overall Study|Moved and Changed Clinic|1|||
124680312|NCT02567188|448452744|FG000|Overall Study|Started Hemodialysis|2|||
124680313|NCT02567188|448452744|FG000|Overall Study|Protocol Violation|5|||
124680314|NCT01033136|448452745|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
124680315|NCT01033136|448452746|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
124680316|NCT00797563|448452748|FG000|Overall Study|Adverse Event|1|||
124680317|NCT00688597|448452749|FG000|Overall Study|Adverse Event|2|||
124680318|NCT00688597|448452750|FG001|Overall Study|Adverse Event|0|||
124680319|NCT00688597|448452751|FG002|Overall Study|Adverse Event|0|||
124680320|NCT00688597|448452749|FG000|Overall Study|Physician Decision|1|||
124680321|NCT00688597|448452750|FG001|Overall Study|Physician Decision|0|||
124680322|NCT00688597|448452751|FG002|Overall Study|Physician Decision|0|||
124680323|NCT05853120|448452752|FG000|Overall Study|Lost to Follow-up|4|||
124680324|NCT05853120|448452753|FG001|Overall Study|Lost to Follow-up|4|||
124680325|NCT05853120|448452752|FG000|Overall Study|Physician Decision|3|||
124680326|NCT05853120|448452753|FG001|Overall Study|Physician Decision|0|||
124680327|NCT05853120|448452752|FG000|Overall Study|Withdrawal by Subject|5|||
124680328|NCT05853120|448452753|FG001|Overall Study|Withdrawal by Subject|2|||
124680329|NCT02763566|448452758|FG000|Overall Study|Lost to Follow-up|1|||
124680330|NCT02763566|448452759|FG001|Overall Study|Lost to Follow-up|4|||
124680331|NCT02763566|448452760|FG002|Overall Study|Lost to Follow-up|0|||
124680332|NCT02763566|448452761|FG003|Overall Study|Lost to Follow-up|1|||
124680333|NCT02763566|448452758|FG000|Overall Study|On study treatment at study conclusion|114|||
124680334|NCT02763566|448452759|FG001|Overall Study|On study treatment at study conclusion|34|||
124680335|NCT02763566|448452760|FG002|Overall Study|On study treatment at study conclusion|54|||
124680336|NCT02763566|448452761|FG003|Overall Study|On study treatment at study conclusion|13|||
124680337|NCT02763566|448452758|FG000|Overall Study|Withdrawal by Subject|3|||
124680338|NCT02763566|448452759|FG001|Overall Study|Withdrawal by Subject|1|||
124680339|NCT02763566|448452760|FG002|Overall Study|Withdrawal by Subject|0|||
124680340|NCT02763566|448452761|FG003|Overall Study|Withdrawal by Subject|0|||
124680341|NCT02855268|448452762|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
124680342|NCT02855268|448452763|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
124680343|NCT02855268|448452762|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
124680344|NCT02855268|448452763|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
124680345|NCT02855268|448452762|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
124437953|NCT01411215|447564028|FG001|Overall Study|Screen failure|1|||
124437954|NCT00848926|447564029|FG000|Treatment Period|Progressive disease|45|||
124437955|NCT00848926|447564029|FG000|Treatment Period|Adverse Event|20|||
124437956|NCT00848926|447564029|FG000|Treatment Period|Physician Decision|12|||
124437957|NCT00848926|447564029|FG000|Treatment Period|Withdrawal by Subject|7|||
124437958|NCT00848926|447564029|FG000|Follow-up Period|Lost to Follow-up|7|||
124437959|NCT00848926|447564029|FG000|Follow-up Period|Withdrawal by Subject|3|||
124437960|NCT00848926|447564029|FG000|Follow-up Period|Other|2|||
124437961|NCT02924064|447564032|FG000|Overall Study|Adverse Event|2|||
124437962|NCT02924064|447564033|FG001|Overall Study|Adverse Event|2|||
124680346|NCT02855268|448452763|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
124680347|NCT02855268|448452762|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
124437963|NCT02924064|447564032|FG000|Overall Study|Lost to Follow-up|0|||
124437964|NCT02924064|447564033|FG001|Overall Study|Lost to Follow-up|2|||
124680348|NCT02855268|448452763|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
124680349|NCT02855268|448452762|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
124680350|NCT02855268|448452763|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
124680351|NCT02855268|448452762|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
124680352|NCT02855268|448452763|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
124680353|NCT00639509|448452764|FG000|Overall Study|Death|1|||
124437965|NCT02924064|447564032|FG000|Overall Study|Physician Decision|0|||
124680354|NCT05722015|448452773|FG000|Overall Study|Death|57|||
124680355|NCT05722015|448452774|FG001|Overall Study|Death|37|||
124680356|NCT05722015|448452773|FG000|Overall Study|Lost to Follow-up|1|||
124680357|NCT05722015|448452774|FG001|Overall Study|Lost to Follow-up|0|||
124680358|NCT05722015|448452773|FG000|Overall Study|Withdrawal by Subject|5|||
124680359|NCT05722015|448452774|FG001|Overall Study|Withdrawal by Subject|1|||
124680360|NCT05722015|448452773|FG000|Overall Study|Participants Ongoing|188|||
124680361|NCT05722015|448452774|FG001|Overall Study|Participants Ongoing|88|||
124680362|NCT04058717|448452775|FG000|Randomization Period|Lost to Follow-up|2|||
124680363|NCT04058717|448452776|FG001|Randomization Period|Lost to Follow-up|3|||
124680364|NCT04058717|448452777|FG002|Randomization Period|Lost to Follow-up|4|||
124680365|NCT04058717|448452778|FG003|Randomization Period|Lost to Follow-up|4|||
124680366|NCT04058717|448452775|FG000|Randomization Period|Withdrawal by Subject|1|||
124680367|NCT04058717|448452776|FG001|Randomization Period|Withdrawal by Subject|3|||
124680368|NCT04058717|448452777|FG002|Randomization Period|Withdrawal by Subject|3|||
124680369|NCT04058717|448452778|FG003|Randomization Period|Withdrawal by Subject|3|||
124680370|NCT04058717|448452775|FG000|Randomization Period|PI decision|0|||
124680371|NCT04058717|448452776|FG001|Randomization Period|PI decision|1|||
124680372|NCT04058717|448452777|FG002|Randomization Period|PI decision|0|||
124680373|NCT04058717|448452778|FG003|Randomization Period|PI decision|0|||
124680374|NCT00671788|448452779|FG000|Overall Study|Adverse Event|8|||
124680375|NCT00671788|448452779|FG000|Overall Study|Refused further treatment|3|||
124680376|NCT00671788|448452779|FG000|Overall Study|Ineligible|1|||
124680377|NCT00671788|448452779|FG000|Overall Study|MD Decision|1|||
124680378|NCT00671788|448452779|FG000|Overall Study|Other|1|||
124880273|NCT03285295|449185481|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
124880274|NCT03285295|449185482|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
124880275|NCT03285295|449185483|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
124880276|NCT03285295|449185484|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
124880277|NCT03285295|449185485|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
124437966|NCT02924064|447564033|FG001|Overall Study|Physician Decision|2|||
124437967|NCT02924064|447564032|FG000|Overall Study|Protocol Violation|1|||
124437968|NCT02924064|447564033|FG001|Overall Study|Protocol Violation|3|||
124437969|NCT02924064|447564032|FG000|Overall Study|Withdrawal by Subject|4|||
124437970|NCT02924064|447564033|FG001|Overall Study|Withdrawal by Subject|5|||
124437971|NCT02924064|447564032|FG000|Overall Study|Other|17|||
124437972|NCT02924064|447564033|FG001|Overall Study|Other|29|||
124437973|NCT04507126|447564034|FG000|Overall Study|Withdrawal by Subject|1|||
124437974|NCT04507126|447564034|FG000|Overall Study|Protocol Violation|2|||
124437975|NCT04507126|447564034|FG000|Overall Study|Physician Decision|1|||
124437976|NCT00966277|447564036|FG000|Overall Study|Withdrawal by Subject|3|||
124437977|NCT00966277|447564037|FG001|Overall Study|Withdrawal by Subject|0|||
124437978|NCT00966277|447564036|FG000|Overall Study|Ineligible|1|||
124437979|NCT00966277|447564037|FG001|Overall Study|Ineligible|3|||
124437980|NCT00966277|447564036|FG000|Overall Study|Treatment Plan Changed|0|||
124437981|NCT00966277|447564037|FG001|Overall Study|Treatment Plan Changed|1|||
124437982|NCT01100034|447564038|FG000|Overall Study|Lost to Follow-up|11|||
124437983|NCT01100034|447564038|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
124437984|NCT01100034|447564038|FG000|Overall Study|Withdrawal by Subject|4|||
124437985|NCT01100034|447564038|FG000|Overall Study|Sponsor decision|21|||
124437986|NCT01100034|447564038|FG000|Overall Study|Participated in another clinical trial|1|||
124437987|NCT01100034|447564038|FG000|Overall Study|Participants moved to another hospital|4|||
124437988|NCT01100034|447564038|FG000|Overall Study|Site closed due to non-responsiveness|1|||
124437989|NCT00455325|447564039|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
124437990|NCT00455325|447564040|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
124437991|NCT00455325|447564041|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
124437992|NCT00455325|447564042|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
124437993|NCT00455325|447564039|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
124437994|NCT00455325|447564040|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
124437995|NCT00455325|447564041|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
124437996|NCT00455325|447564042|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
124437997|NCT00455325|447564039|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
124437998|NCT00455325|447564040|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
124437999|NCT00455325|447564041|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
124438000|NCT00455325|447564042|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
124438001|NCT00455325|447564039|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
124880278|NCT03285295|449185481|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
124680379|NCT01832766|448452780|FG000|Washout|Lost to Follow-up|0|||
124680380|NCT01832766|448452781|FG001|Washout|Lost to Follow-up|1|||
124680381|NCT01925417|448452784|FG000|Overall Study|Withdrawal by Subject|2|||
124680382|NCT01925417|448452784|FG000|Overall Study|Death|1|||
124438002|NCT00455325|447564040|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
124438003|NCT00455325|447564041|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
124438004|NCT00455325|447564042|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
124680383|NCT03479905|448452785|FG000|Overall Study|Other airway method used|4|||
124880279|NCT03285295|449185482|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
124680384|NCT03479905|448452786|FG001|Overall Study|Other airway method used|5|||
124680385|NCT03479905|448452787|FG002|Overall Study|Other airway method used|5|||
124680386|NCT00720759|448452788|FG000|Overall Study|Lost to Follow-up|0|||
124680387|NCT00720759|448452789|FG001|Overall Study|Lost to Follow-up|1|||
124680388|NCT00720759|448452790|FG002|Overall Study|Lost to Follow-up|1|||
124680389|NCT00720759|448452791|FG003|Overall Study|Lost to Follow-up|0|||
124680390|NCT02598661|448452794|FG000|Overall Study|Death|27|||
124680391|NCT02598661|448452795|FG001|Overall Study|Death|34|||
124680392|NCT02598661|448452796|FG002|Overall Study|Death|14|||
124680393|NCT02598661|448452797|FG003|Overall Study|Death|1|||
124680394|NCT02598661|448452798|FG004|Overall Study|Death|0|||
124680395|NCT02598661|448452794|FG000|Overall Study|Lost to Follow-up|2|||
124680396|NCT02598661|448452795|FG001|Overall Study|Lost to Follow-up|3|||
124680397|NCT02598661|448452796|FG002|Overall Study|Lost to Follow-up|2|||
124680398|NCT02598661|448452797|FG003|Overall Study|Lost to Follow-up|0|||
124680399|NCT02598661|448452798|FG004|Overall Study|Lost to Follow-up|0|||
124680400|NCT02598661|448452794|FG000|Overall Study|Withdrawal by Subject|13|||
124680401|NCT02598661|448452795|FG001|Overall Study|Withdrawal by Subject|24|||
124680402|NCT02598661|448452796|FG002|Overall Study|Withdrawal by Subject|14|||
124680403|NCT02598661|448452797|FG003|Overall Study|Withdrawal by Subject|1|||
124680404|NCT02598661|448452798|FG004|Overall Study|Withdrawal by Subject|1|||
124680405|NCT02598661|448452794|FG000|Overall Study|Adverse Event|0|||
124680406|NCT02598661|448452795|FG001|Overall Study|Adverse Event|0|||
124680407|NCT02598661|448452796|FG002|Overall Study|Adverse Event|1|||
124680408|NCT02598661|448452797|FG003|Overall Study|Adverse Event|0|||
124680409|NCT02598661|448452798|FG004|Overall Study|Adverse Event|0|||
124680410|NCT02598661|448452794|FG000|Overall Study|Randomized, Never Treated|0|||
124680411|NCT02598661|448452795|FG001|Overall Study|Randomized, Never Treated|0|||
124680412|NCT02598661|448452796|FG002|Overall Study|Randomized, Never Treated|0|||
124680413|NCT02598661|448452797|FG003|Overall Study|Randomized, Never Treated|0|||
124680414|NCT02598661|448452798|FG004|Overall Study|Randomized, Never Treated|1|||
124680415|NCT01366092|448452799|FG000|Overall Study|Progressive cGVHD|2|||
124680416|NCT01366092|448452799|FG000|Overall Study|Physician Decision|1|||
124680417|NCT01366092|448452799|FG000|Overall Study|Withdrawal by Subject|1|||
124680418|NCT03074500|448452800|FG000|Overall Study|Lost to Follow-up|1|||
124680419|NCT03074500|448452801|FG001|Overall Study|Lost to Follow-up|0|||
124680420|NCT03074500|448452802|FG002|Overall Study|Lost to Follow-up|0|||
124680421|NCT03074500|448452800|FG000|Overall Study|Lack of Efficacy|0|||
124680422|NCT03074500|448452801|FG001|Overall Study|Lack of Efficacy|1|||
124680423|NCT03074500|448452802|FG002|Overall Study|Lack of Efficacy|0|||
124438005|NCT00455325|447564039|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
124438006|NCT00455325|447564040|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
124438007|NCT00455325|447564041|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
124438008|NCT00455325|447564042|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
124680424|NCT03074500|448452800|FG000|Overall Study|Adverse Event|0|||
124680425|NCT03074500|448452801|FG001|Overall Study|Adverse Event|0|||
124680426|NCT03074500|448452802|FG002|Overall Study|Adverse Event|1|||
124680427|NCT03608163|448452803|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
124438009|NCT00455325|447564039|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
124438010|NCT00455325|447564040|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
124438011|NCT00455325|447564041|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
124438012|NCT00455325|447564042|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
124438013|NCT00455325|447564039|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
124438014|NCT00455325|447564040|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
124438015|NCT00455325|447564041|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
124438016|NCT00455325|447564042|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
124438017|NCT04620811|447564043|FG000|Overall Study|Withdrawal by Subject|18|||
124438018|NCT04620811|447564044|FG001|Overall Study|Withdrawal by Subject|15|||
124438019|NCT04620811|447564043|FG000|Overall Study|Adverse Event|6|||
124438020|NCT04620811|447564044|FG001|Overall Study|Adverse Event|11|||
124438021|NCT04620811|447564043|FG000|Overall Study|Lost to Follow-up|4|||
124680428|NCT03608163|448452804|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
124680429|NCT02659865|448453894|FG000|Period 1|Withdrawal by Subject|1|||
124680430|NCT02659865|448453895|FG001|Period 1|Withdrawal by Subject|0|||
124680431|NCT02659865|448453896|FG002|Period 1|Withdrawal by Subject|0|||
124438022|NCT04620811|447564044|FG001|Overall Study|Lost to Follow-up|8|||
124438023|NCT04620811|447564043|FG000|Overall Study|Physician Decision|1|||
124680432|NCT02659865|448453897|FG003|Period 1|Withdrawal by Subject|0|||
124680433|NCT02659865|448453898|FG004|Period 1|Withdrawal by Subject|0|||
124680434|NCT02659865|448453894|FG000|Period 1|Adverse Event|0|||
124680435|NCT02659865|448453895|FG001|Period 1|Adverse Event|0|||
124680436|NCT02659865|448453896|FG002|Period 1|Adverse Event|0|||
124680437|NCT02659865|448453897|FG003|Period 1|Adverse Event|0|||
124680438|NCT02659865|448453898|FG004|Period 1|Adverse Event|1|||
124680439|NCT02100631|448453900|FG000|Overall Study|Withdrawal by Subject|1|||
124680440|NCT02100631|448453901|FG001|Overall Study|Withdrawal by Subject|0|||
124680441|NCT02100631|448453902|FG002|Overall Study|Withdrawal by Subject|0|||
124680442|NCT02100631|448453900|FG000|Overall Study|Lost to Follow-up|3|||
124680443|NCT02100631|448453901|FG001|Overall Study|Lost to Follow-up|4|||
124680444|NCT02100631|448453902|FG002|Overall Study|Lost to Follow-up|0|||
124680445|NCT02100631|448453900|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
124680446|NCT02100631|448453901|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
124680447|NCT02100631|448453902|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
124680448|NCT03979313|448453903|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
124680449|NCT03979313|448453904|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
124680450|NCT03979313|448453903|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
124680451|NCT03979313|448453904|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
124680452|NCT03979313|448453903|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
124680453|NCT03979313|448453904|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
124680454|NCT03979313|448453903|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
124680455|NCT03979313|448453904|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
124680456|NCT03979313|448453903|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
124680457|NCT03979313|448453904|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
124680458|NCT03979313|448453903|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
124680459|NCT03979313|448453904|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
124680460|NCT03979313|448453903|FG000|All Subjects|Any Other Reason|16|||
124680461|NCT03979313|448453904|FG001|All Subjects|Any Other Reason|23|||
124680462|NCT03979313|448453903|FG000|All Subjects|Covid-19|1|||
124680463|NCT03979313|448453904|FG001|All Subjects|Covid-19|3|||
124680464|NCT03979313|448453903|FG000|All Subjects|Withdrawal by Subject|35|||
124680465|NCT03979313|448453904|FG001|All Subjects|Withdrawal by Subject|44|||
124680466|NCT03979313|448453903|FG000|All Subjects|Death|0|||
124680467|NCT03979313|448453904|FG001|All Subjects|Death|5|||
124680468|NCT03979313|448453903|FG000|All Subjects|Lost to Follow-up|28|||
124680469|NCT03979313|448453904|FG001|All Subjects|Lost to Follow-up|61|||
124680470|NCT00089648|448453905|FG000|Overall Study|Adverse Event|7|||
124680471|NCT00089648|448453905|FG000|Overall Study|Withdrawal by Subject|1|||
124680472|NCT00089648|448453905|FG000|Overall Study|Lack of Efficacy|33|||
124680473|NCT00300053|448453906|FG000|Overall Study|Patient/Caregiver Preference|2|||
124680474|NCT00300053|448453907|FG001|Overall Study|Patient/Caregiver Preference|2|||
124680475|NCT00300053|448453908|FG002|Overall Study|Patient/Caregiver Preference|3|||
124680476|NCT00300053|448453906|FG000|Overall Study|Death|0|||
124680477|NCT00300053|448453907|FG001|Overall Study|Death|0|||
124680478|NCT00300053|448453908|FG002|Overall Study|Death|3|||
124680479|NCT00300053|448453906|FG000|Overall Study|Lost to Follow-up|0|||
124680480|NCT00300053|448453907|FG001|Overall Study|Lost to Follow-up|1|||
124680481|NCT00300053|448453908|FG002|Overall Study|Lost to Follow-up|0|||
124680482|NCT00423605|448453909|FG000|Overall Study|Adverse Event|129|||
124680483|NCT00423605|448453909|FG000|Overall Study|Withdrawal by Subject|36|||
124680484|NCT00423605|448453909|FG000|Overall Study|Lost to Follow-up|15|||
124680485|NCT00423605|448453909|FG000|Overall Study|Lack of Efficacy|38|||
124680486|NCT00423605|448453909|FG000|Overall Study|Sponsor Decision|3|||
124438024|NCT04620811|447564044|FG001|Overall Study|Physician Decision|4|||
124438025|NCT04620811|447564043|FG000|Overall Study|Sponsor Decision|0|||
124438026|NCT04620811|447564044|FG001|Overall Study|Sponsor Decision|1|||
124438027|NCT04620811|447564043|FG000|Overall Study|Elevation of ALT or AST|1|||
124438028|NCT04620811|447564044|FG001|Overall Study|Elevation of ALT or AST|0|||
124438029|NCT04620811|447564043|FG000|Overall Study|Other|3|||
124438030|NCT04620811|447564044|FG001|Overall Study|Other|5|||
124438031|NCT02294227|447564045|FG000|Overall Study|Death|0|||
124438032|NCT02294227|447564046|FG001|Overall Study|Death|0|||
124438033|NCT02294227|447564047|FG002|Overall Study|Death|1|||
124438034|NCT02294227|447564045|FG000|Overall Study|Subject/Guardian Decision|6|||
124438035|NCT02294227|447564046|FG001|Overall Study|Subject/Guardian Decision|3|||
124438036|NCT02294227|447564047|FG002|Overall Study|Subject/Guardian Decision|7|||
124438037|NCT02294227|447564045|FG000|Overall Study|Physician Decision|1|||
124438038|NCT02294227|447564046|FG001|Overall Study|Physician Decision|2|||
124438039|NCT02294227|447564047|FG002|Overall Study|Physician Decision|1|||
124438040|NCT02294227|447564045|FG000|Overall Study|Lost to Follow-up|1|||
124438041|NCT02294227|447564046|FG001|Overall Study|Lost to Follow-up|0|||
124438042|NCT02294227|447564047|FG002|Overall Study|Lost to Follow-up|0|||
124680487|NCT00423605|448453909|FG000|Overall Study|Physician Decision|8|||
124680488|NCT00423605|448453909|FG000|Overall Study|Protocol Violation|7|||
124438043|NCT02294227|447564045|FG000|Overall Study|Lack of Efficacy|11|||
124438044|NCT02294227|447564046|FG001|Overall Study|Lack of Efficacy|12|||
124680489|NCT00423605|448453909|FG000|Overall Study|Not one of the pre-specified options|5|||
124680490|NCT03261401|448453914|FG000|Overall Study|Withdrawal by Subject|0|||
124680491|NCT03261401|448453915|FG001|Overall Study|Withdrawal by Subject|0|||
124680492|NCT03261401|448453916|FG002|Overall Study|Withdrawal by Subject|0|||
124680493|NCT03261401|448453917|FG003|Overall Study|Withdrawal by Subject|0|||
124680494|NCT03261401|448453918|FG004|Overall Study|Withdrawal by Subject|0|||
124680495|NCT03261401|448453919|FG005|Overall Study|Withdrawal by Subject|1|||
124438045|NCT02294227|447564047|FG002|Overall Study|Lack of Efficacy|8|||
124438046|NCT02294227|447564045|FG000|Overall Study|Adverse Event|6|||
124438047|NCT02294227|447564046|FG001|Overall Study|Adverse Event|8|||
124438048|NCT02294227|447564047|FG002|Overall Study|Adverse Event|2|||
124438049|NCT01768637|447564048|FG000|Overall Study|Lost to Follow-up|2|||
124438050|NCT01768637|447564049|FG001|Overall Study|Lost to Follow-up|7|||
124438051|NCT01768637|447564048|FG000|Overall Study|Difficult blood draw|1|||
124438052|NCT01768637|447564049|FG001|Overall Study|Difficult blood draw|0|||
124438053|NCT00887432|447564050|FG000|Overall Study|Start Excluded Therapy|3|||
124438054|NCT00887432|447564051|FG001|Overall Study|Start Excluded Therapy|0|||
124438055|NCT00887432|447564050|FG000|Overall Study|Did not complete treatment|6|||
124438056|NCT00887432|447564051|FG001|Overall Study|Did not complete treatment|8|||
124438057|NCT00887432|447564050|FG000|Overall Study|Protocol Violation|2|||
124438058|NCT00887432|447564051|FG001|Overall Study|Protocol Violation|3|||
124438059|NCT00887432|447564050|FG000|Overall Study|Withdrawal by Subject|3|||
124438060|NCT00887432|447564051|FG001|Overall Study|Withdrawal by Subject|2|||
124438061|NCT00887432|447564050|FG000|Overall Study|Lost to Follow-up|1|||
124438062|NCT00887432|447564051|FG001|Overall Study|Lost to Follow-up|0|||
124438063|NCT00887432|447564050|FG000|Overall Study|No reason provided|0|||
124438064|NCT00887432|447564051|FG001|Overall Study|No reason provided|1|||
124438065|NCT01636960|447564052|FG000|Induction Phase|Adverse Event|2|||
124438066|NCT01636960|447564052|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
124438067|NCT01636960|447564052|FG000|Maintenance Phase|Adverse Event|3|||
124438068|NCT01636960|447564052|FG000|Maintenance Phase|Progressive disease|1|||
124438069|NCT01580969|447564055|FG000|Overall Study|Physician Decision|3|||
124438070|NCT01580969|447564056|FG001|Overall Study|Physician Decision|0|||
124438071|NCT01580969|447564057|FG002|Overall Study|Physician Decision|0|||
124438072|NCT01209780|447564058|FG000|Overall Study|Adverse Event|0|||
124438073|NCT01209780|447564059|FG001|Overall Study|Adverse Event|1|||
124680496|NCT03261401|448453920|FG006|Overall Study|Withdrawal by Subject|0|||
124680497|NCT03261401|448453921|FG007|Overall Study|Withdrawal by Subject|0|||
124438074|NCT01209780|447564060|FG002|Overall Study|Adverse Event|0|||
124438075|NCT01209780|447564061|FG003|Overall Study|Adverse Event|0|||
124438076|NCT01209780|447564062|FG004|Overall Study|Adverse Event|0|||
124438077|NCT01209780|447564058|FG000|Overall Study|Withdrawal by Subject|9|||
124438078|NCT01209780|447564059|FG001|Overall Study|Withdrawal by Subject|2|||
124438079|NCT01209780|447564060|FG002|Overall Study|Withdrawal by Subject|1|||
124438080|NCT01209780|447564061|FG003|Overall Study|Withdrawal by Subject|1|||
124438081|NCT01209780|447564062|FG004|Overall Study|Withdrawal by Subject|0|||
124438082|NCT01209780|447564058|FG000|Overall Study|Lost to Follow-up|17|||
124438083|NCT01209780|447564059|FG001|Overall Study|Lost to Follow-up|12|||
124438084|NCT01209780|447564060|FG002|Overall Study|Lost to Follow-up|3|||
124438085|NCT01209780|447564061|FG003|Overall Study|Lost to Follow-up|9|||
124438086|NCT01209780|447564062|FG004|Overall Study|Lost to Follow-up|4|||
124438087|NCT01209780|447564058|FG000|Overall Study|Protocol Violation|0|||
124680498|NCT03261401|448453922|FG008|Overall Study|Withdrawal by Subject|0|||
124680499|NCT03261401|448453923|FG009|Overall Study|Withdrawal by Subject|0|||
124680500|NCT03261401|448453924|FG010|Overall Study|Withdrawal by Subject|0|||
124680501|NCT03261401|448453925|FG011|Overall Study|Withdrawal by Subject|0|||
124680502|NCT03261401|448453926|FG012|Overall Study|Withdrawal by Subject|0|||
124680503|NCT03261401|448453914|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
124680504|NCT03261401|448453915|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
124680505|NCT03261401|448453916|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
124680506|NCT03261401|448453917|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
124680507|NCT03261401|448453918|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
124680508|NCT03261401|448453919|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
124680509|NCT03261401|448453920|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
124680510|NCT03261401|448453921|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
124680511|NCT03261401|448453922|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
124680512|NCT03261401|448453923|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
124680513|NCT03261401|448453924|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
124438088|NCT01209780|447564059|FG001|Overall Study|Protocol Violation|1|||
124438089|NCT01209780|447564060|FG002|Overall Study|Protocol Violation|0|||
124438090|NCT01209780|447564061|FG003|Overall Study|Protocol Violation|0|||
124438091|NCT01209780|447564062|FG004|Overall Study|Protocol Violation|0|||
124438092|NCT01209780|447564058|FG000|Overall Study|Inappropriate enrollment|0|||
124438093|NCT01209780|447564059|FG001|Overall Study|Inappropriate enrollment|2|||
124438094|NCT01209780|447564060|FG002|Overall Study|Inappropriate enrollment|0|||
124438095|NCT01209780|447564061|FG003|Overall Study|Inappropriate enrollment|0|||
124680514|NCT03261401|448453925|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
124680515|NCT03261401|448453926|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
124438096|NCT01209780|447564062|FG004|Overall Study|Inappropriate enrollment|1|||
124544385|NCT00948896|447946795|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
124438097|NCT02709096|447564066|FG000|Overall Study|non-compliance|1|||
124438098|NCT02709096|447564067|FG001|Overall Study|non-compliance|1|||
124438099|NCT00511472|447564068|FG000|Overall Study|Clinical Adverse Event|1|||
124680516|NCT01983930|448453932|FG000|Overall Study|Withdrawal by Subject|9|||
124680517|NCT01983930|448453933|FG001|Overall Study|Withdrawal by Subject|8|||
124680518|NCT01983930|448453932|FG000|Overall Study|Adverse Event|0|||
124680519|NCT01983930|448453933|FG001|Overall Study|Adverse Event|1|||
124680520|NCT00141921|448453937|FG000|Overall Study|Remain on Study|28|||
124680521|NCT00141921|448453937|FG000|Overall Study|Withdrawal by Subject|42|||
124680522|NCT00141921|448453937|FG000|Overall Study|Lost to Follow-up|19|||
124680523|NCT00141921|448453937|FG000|Overall Study|Noncompliance|17|||
124680524|NCT00141921|448453937|FG000|Overall Study|Disease Progression|7|||
124680525|NCT00141921|448453937|FG000|Overall Study|Protocol Deviation|7|||
124680526|NCT00141921|448453937|FG000|Overall Study|Adverse Event|5|||
124680527|NCT00141921|448453937|FG000|Overall Study|Administrative Decision|2|||
124680528|NCT00141921|448453937|FG000|Overall Study|Pregnancy|4|||
124680529|NCT00141921|448453937|FG000|Overall Study|Ineligibility Determined|2|||
124680530|NCT00141921|448453937|FG000|Overall Study|Other|8|||
124680531|NCT02471339|448453940|FG000|Overall Study|Did not provide follow-up data|2|||
124680532|NCT02471339|448453941|FG001|Overall Study|Did not provide follow-up data|0|||
124680533|NCT00626639|448453942|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
124680534|NCT00626639|448453943|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
124680535|NCT00634504|448453944|FG000|Overall Study|Protocol Violation|1|||
124680536|NCT00634504|448453945|FG001|Overall Study|Protocol Violation|0|||
124680537|NCT05001620|448453948|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
124680538|NCT05001620|448453949|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
124680539|NCT00481676|448453952|FG000|Overall Study|Adverse Event|0|||
124680540|NCT00481676|448453953|FG001|Overall Study|Adverse Event|1|||
124680541|NCT00481676|448453952|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124680542|NCT00481676|448453953|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
124680543|NCT00481676|448453952|FG000|Overall Study|Administrative problem|1|||
124680544|NCT00481676|448453953|FG001|Overall Study|Administrative problem|0|||
124680545|NCT01513590|448453954|FG000|Overall Study|Adverse Event|2|||
124680546|NCT01513590|448453955|FG001|Overall Study|Adverse Event|3|||
124680547|NCT01513590|448453954|FG000|Overall Study|Withdrawal Criteria|3|||
124680548|NCT01513590|448453955|FG001|Overall Study|Withdrawal Criteria|0|||
124680549|NCT01513590|448453954|FG000|Overall Study|Unclassified|5|||
124680550|NCT01513590|448453955|FG001|Overall Study|Unclassified|10|||
124680551|NCT01056276|448453956|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
124680552|NCT01056276|448453957|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
124680553|NCT01056276|448453956|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
124680554|NCT01056276|448453957|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
124680555|NCT01056276|448453956|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
124680556|NCT01056276|448453957|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
124680557|NCT01056276|448453956|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
124680558|NCT01056276|448453957|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
124680559|NCT01056276|448453956|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
124680560|NCT01056276|448453957|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
124680561|NCT01056276|448453956|FG000|Treatment Period-Cycles 1-8|Death|3|||
124680562|NCT01056276|448453957|FG001|Treatment Period-Cycles 1-8|Death|1|||
124438100|NCT00511472|447564069|FG001|Overall Study|Clinical Adverse Event|2|||
124680563|NCT01056276|448453956|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
124680564|NCT01056276|448453957|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
124680565|NCT01056276|448453956|FG000|Maintenance Therapy|Toxicity|0|||
124680566|NCT01056276|448453957|FG001|Maintenance Therapy|Toxicity|2|||
124680567|NCT01056276|448453956|FG000|Maintenance Therapy|Progressive Disease|0|||
124680568|NCT01056276|448453957|FG001|Maintenance Therapy|Progressive Disease|9|||
124680569|NCT01056276|448453956|FG000|Maintenance Therapy|Physician Decision|0|||
124680570|NCT01056276|448453957|FG001|Maintenance Therapy|Physician Decision|1|||
124680571|NCT01056276|448453956|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
124680572|NCT01056276|448453957|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
124680573|NCT01056276|448453956|FG000|Maintenance Therapy|Intercurrent Illness|0|||
124680574|NCT01056276|448453957|FG001|Maintenance Therapy|Intercurrent Illness|1|||
124680575|NCT01056276|448453956|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
124680576|NCT01056276|448453957|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
124680577|NCT04424901|448453960|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
124680578|NCT04424901|448453961|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
124680579|NCT00147238|448453962|FG000|Overall Study|Inevaluable|8|||
124680580|NCT00297167|448453963|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
124680581|NCT00297167|448453964|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
124680582|NCT00297167|448453965|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
124680583|NCT00297167|448453963|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
124680584|NCT00297167|448453964|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
124680585|NCT00297167|448453965|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
124680586|NCT02701634|448453969|FG000|Overall Study|Adverse Event|2|||
124680587|NCT02701634|448453970|FG001|Overall Study|Adverse Event|3|||
124680588|NCT02701634|448453969|FG000|Overall Study|Death|1|||
124680589|NCT02701634|448453970|FG001|Overall Study|Death|0|||
124680590|NCT02701634|448453969|FG000|Overall Study|Investigator's Discretion|7|||
124680591|NCT02701634|448453970|FG001|Overall Study|Investigator's Discretion|4|||
124680592|NCT02701634|448453969|FG000|Overall Study|Study terminated by Sponsor|15|||
124680593|NCT02701634|448453970|FG001|Overall Study|Study terminated by Sponsor|17|||
124680594|NCT02701634|448453969|FG000|Overall Study|Withdrew Consent|6|||
124680595|NCT02701634|448453970|FG001|Overall Study|Withdrew Consent|7|||
124680596|NCT02701634|448453969|FG000|Overall Study|Randomized but not treated|1|||
124680597|NCT02701634|448453970|FG001|Overall Study|Randomized but not treated|0|||
124680598|NCT04009837|448453977|FG000|Overall Study|Withdrawal by Subject|5|||
124680599|NCT04009837|448453978|FG001|Overall Study|Withdrawal by Subject|4|||
124680600|NCT04009837|448453977|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
124680601|NCT04009837|448453978|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
124680602|NCT01572792|448453981|FG000|Lead-in Study|Lost to Follow-up|5|||
124680603|NCT01572792|448453982|FG001|Lead-in Study|Lost to Follow-up|9|||
124680604|NCT01572792|448453983|FG002|Lead-in Study|Lost to Follow-up|4|||
124680605|NCT01572792|448453984|FG003|Lead-in Study|Lost to Follow-up|2|||
124680606|NCT01572792|448453985|FG004|Lead-in Study|Lost to Follow-up|4|||
124680607|NCT01572792|448453981|FG000|Lead-in Study|Withdrawal by Subject|22|||
124680608|NCT01572792|448453982|FG001|Lead-in Study|Withdrawal by Subject|11|||
124680609|NCT01572792|448453983|FG002|Lead-in Study|Withdrawal by Subject|12|||
124680610|NCT01572792|448453984|FG003|Lead-in Study|Withdrawal by Subject|24|||
124680611|NCT01572792|448453985|FG004|Lead-in Study|Withdrawal by Subject|11|||
124680612|NCT01572792|448453981|FG000|Lead-in Study|Protocol Violation|19|||
124680613|NCT01572792|448453982|FG001|Lead-in Study|Protocol Violation|10|||
124680614|NCT01572792|448453983|FG002|Lead-in Study|Protocol Violation|12|||
124680615|NCT01572792|448453984|FG003|Lead-in Study|Protocol Violation|13|||
124680616|NCT01572792|448453985|FG004|Lead-in Study|Protocol Violation|21|||
124680617|NCT01572792|448453981|FG000|Lead-in Study|Lack of Efficacy|20|||
124680618|NCT01572792|448453982|FG001|Lead-in Study|Lack of Efficacy|5|||
124680619|NCT01572792|448453983|FG002|Lead-in Study|Lack of Efficacy|4|||
124680620|NCT01572792|448453984|FG003|Lead-in Study|Lack of Efficacy|8|||
124680621|NCT01572792|448453985|FG004|Lead-in Study|Lack of Efficacy|10|||
124680622|NCT01572792|448453981|FG000|Lead-in Study|Adverse Event|21|||
124680623|NCT01572792|448453982|FG001|Lead-in Study|Adverse Event|21|||
124680624|NCT01572792|448453983|FG002|Lead-in Study|Adverse Event|22|||
124680625|NCT01572792|448453984|FG003|Lead-in Study|Adverse Event|16|||
124680626|NCT01572792|448453985|FG004|Lead-in Study|Adverse Event|14|||
124680627|NCT01572792|448453981|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
124680628|NCT01572792|448453982|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
124680629|NCT01572792|448453983|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
124680630|NCT01572792|448453984|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
124680631|NCT01572792|448453985|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
124680632|NCT01572792|448453981|FG000|Extension Study|Lost to Follow-up|6|||
124680633|NCT01572792|448453982|FG001|Extension Study|Lost to Follow-up|2|||
124680634|NCT01572792|448453983|FG002|Extension Study|Lost to Follow-up|0|||
124680635|NCT01572792|448453984|FG003|Extension Study|Lost to Follow-up|3|||
124438101|NCT00511472|447564068|FG000|Overall Study|Laboratory Adverse Event|0|||
124438102|NCT00511472|447564069|FG001|Overall Study|Laboratory Adverse Event|2|||
124680636|NCT01572792|448453985|FG004|Extension Study|Lost to Follow-up|3|||
124438103|NCT00511472|447564068|FG000|Overall Study|Not reported|2|||
124680637|NCT01572792|448453981|FG000|Extension Study|Withdrawal by Subject|7|||
124680638|NCT01572792|448453982|FG001|Extension Study|Withdrawal by Subject|6|||
124680639|NCT01572792|448453983|FG002|Extension Study|Withdrawal by Subject|11|||
124680640|NCT01572792|448453984|FG003|Extension Study|Withdrawal by Subject|8|||
124680641|NCT01572792|448453985|FG004|Extension Study|Withdrawal by Subject|14|||
124680642|NCT01572792|448453981|FG000|Extension Study|Protocol Violation|0|||
124680643|NCT01572792|448453982|FG001|Extension Study|Protocol Violation|4|||
124438104|NCT00511472|447564069|FG001|Overall Study|Not reported|2|||
124680644|NCT01572792|448453983|FG002|Extension Study|Protocol Violation|3|||
124680645|NCT01572792|448453984|FG003|Extension Study|Protocol Violation|4|||
124680646|NCT01572792|448453985|FG004|Extension Study|Protocol Violation|3|||
124680647|NCT01572792|448453981|FG000|Extension Study|Lack of Efficacy|2|||
124680648|NCT01572792|448453982|FG001|Extension Study|Lack of Efficacy|3|||
124680649|NCT01572792|448453983|FG002|Extension Study|Lack of Efficacy|3|||
124680650|NCT01572792|448453984|FG003|Extension Study|Lack of Efficacy|2|||
124680651|NCT01572792|448453985|FG004|Extension Study|Lack of Efficacy|2|||
124680652|NCT01572792|448453981|FG000|Extension Study|Adverse Event|7|||
124438105|NCT00505284|447564070|FG000|Overall Study|Adverse Event|3|||
124438106|NCT00505284|447564071|FG001|Overall Study|Adverse Event|7|||
124438107|NCT00505284|447564072|FG002|Overall Study|Adverse Event|9|||
124438108|NCT00505284|447564073|FG003|Overall Study|Adverse Event|14|||
124438109|NCT00505284|447564074|FG004|Overall Study|Adverse Event|22|||
124438110|NCT00505284|447564070|FG000|Overall Study|Protocol Violation|0|||
124438111|NCT00505284|447564071|FG001|Overall Study|Protocol Violation|1|||
124438112|NCT00505284|447564072|FG002|Overall Study|Protocol Violation|1|||
124438113|NCT00505284|447564073|FG003|Overall Study|Protocol Violation|0|||
124438114|NCT00505284|447564074|FG004|Overall Study|Protocol Violation|0|||
124438115|NCT00505284|447564070|FG000|Overall Study|Withdrawal by Subject|2|||
124438116|NCT00505284|447564071|FG001|Overall Study|Withdrawal by Subject|6|||
124438117|NCT00505284|447564072|FG002|Overall Study|Withdrawal by Subject|1|||
124438118|NCT00505284|447564073|FG003|Overall Study|Withdrawal by Subject|0|||
124438119|NCT00505284|447564074|FG004|Overall Study|Withdrawal by Subject|6|||
124438120|NCT00505284|447564070|FG000|Overall Study|Lack of Efficacy|0|||
124438121|NCT00505284|447564071|FG001|Overall Study|Lack of Efficacy|1|||
124438122|NCT00505284|447564072|FG002|Overall Study|Lack of Efficacy|1|||
124438123|NCT00505284|447564073|FG003|Overall Study|Lack of Efficacy|1|||
124438124|NCT00505284|447564074|FG004|Overall Study|Lack of Efficacy|1|||
124438125|NCT00505284|447564070|FG000|Overall Study|Physician Decision|0|||
124438126|NCT00505284|447564071|FG001|Overall Study|Physician Decision|1|||
124438127|NCT00505284|447564072|FG002|Overall Study|Physician Decision|0|||
124438128|NCT00505284|447564073|FG003|Overall Study|Physician Decision|0|||
124438129|NCT00505284|447564074|FG004|Overall Study|Physician Decision|0|||
124438130|NCT00505284|447564070|FG000|Overall Study|Other|5|||
124438131|NCT00505284|447564071|FG001|Overall Study|Other|0|||
124438132|NCT00505284|447564072|FG002|Overall Study|Other|0|||
124438133|NCT00505284|447564073|FG003|Overall Study|Other|4|||
124438134|NCT00505284|447564074|FG004|Overall Study|Other|4|||
124438135|NCT01575028|447564075|FG000|Overall Study|Physician Decision|0|||
124438136|NCT01575028|447564076|FG001|Overall Study|Physician Decision|1|||
124438137|NCT00529958|447564077|FG000|2-Year Follow-up|Lost to Follow-up|1|||
124438138|NCT00529958|447564078|FG001|2-Year Follow-up|Lost to Follow-up|2|||
124438139|NCT00529958|447564079|FG002|2-Year Follow-up|Lost to Follow-up|2|||
124438140|NCT00529958|447564077|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
124438141|NCT00529958|447564078|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
124438142|NCT00529958|447564079|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
124438143|NCT00529958|447564077|FG000|5-Year Follow-up|Lost to Follow-up|2|||
124438144|NCT00529958|447564078|FG001|5-Year Follow-up|Lost to Follow-up|3|||
124438145|NCT00529958|447564079|FG002|5-Year Follow-up|Lost to Follow-up|1|||
124438146|NCT00529958|447564077|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
124438147|NCT00529958|447564078|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
124438148|NCT00529958|447564079|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
124438149|NCT03534284|447564081|FG000|Overall Study|Death|2|||
124438150|NCT03534284|447564082|FG001|Overall Study|Death|3|||
124438151|NCT03534284|447564083|FG002|Overall Study|Death|3|||
124438152|NCT03534284|447564081|FG000|Overall Study|Withdrawal by Subject|5|||
124438153|NCT03534284|447564082|FG001|Overall Study|Withdrawal by Subject|0|||
124438154|NCT03534284|447564083|FG002|Overall Study|Withdrawal by Subject|0|||
124438155|NCT03316300|447564084|FG000|Overall Study|Withdrawal by Subject|3|||
124438156|NCT03316300|447564085|FG001|Overall Study|Withdrawal by Subject|2|||
124438157|NCT03316300|447564084|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
124438158|NCT03316300|447564085|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
124438159|NCT03316300|447564084|FG000|Overall Study|Adverse Event|1|||
124438160|NCT03316300|447564085|FG001|Overall Study|Adverse Event|0|||
124438161|NCT03316300|447564084|FG000|Overall Study|COVID-19|0|||
124438162|NCT03316300|447564085|FG001|Overall Study|COVID-19|1|||
124438163|NCT04737187|447564086|FG000|Overall Study|Switched to marketed drug|32|||
124438164|NCT04737187|447564087|FG001|Overall Study|Switched to marketed drug|4|||
124438165|NCT04737187|447564086|FG000|Overall Study|Radiological Progressive Disease|145|||
124438166|NCT04737187|447564087|FG001|Overall Study|Radiological Progressive Disease|146|||
124438167|NCT04737187|447564086|FG000|Overall Study|Clinical Progressive Disease|20|||
124438168|NCT04737187|447564087|FG001|Overall Study|Clinical Progressive Disease|20|||
124438169|NCT04737187|447564086|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
124680653|NCT01572792|448453982|FG001|Extension Study|Adverse Event|6|||
124438170|NCT04737187|447564087|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
124438171|NCT04737187|447564086|FG000|Overall Study|Adverse Event|16|||
124438172|NCT04737187|447564087|FG001|Overall Study|Adverse Event|16|||
124438173|NCT04737187|447564086|FG000|Overall Study|Physician Decision|2|||
124438174|NCT04737187|447564087|FG001|Overall Study|Physician Decision|0|||
124438175|NCT04737187|447564086|FG000|Overall Study|Withdrawal by Subject|5|||
124438176|NCT04737187|447564087|FG001|Overall Study|Withdrawal by Subject|8|||
124438177|NCT03756129|447564088|FG000|Overall Study|Adverse Event|1|||
124438178|NCT03756129|447564089|FG001|Overall Study|Adverse Event|1|||
124438179|NCT03756129|447564090|FG002|Overall Study|Adverse Event|0|||
124438180|NCT03756129|447564091|FG003|Overall Study|Adverse Event|2|||
124438181|NCT03756129|447564092|FG004|Overall Study|Adverse Event|0|||
124438182|NCT03756129|447564093|FG005|Overall Study|Adverse Event|0|||
124438183|NCT03756129|447564088|FG000|Overall Study|Withdrawal by Subject|2|||
124438184|NCT03756129|447564089|FG001|Overall Study|Withdrawal by Subject|1|||
124438185|NCT03756129|447564090|FG002|Overall Study|Withdrawal by Subject|3|||
124438186|NCT03756129|447564091|FG003|Overall Study|Withdrawal by Subject|1|||
124438187|NCT03756129|447564092|FG004|Overall Study|Withdrawal by Subject|1|||
124438188|NCT03756129|447564093|FG005|Overall Study|Withdrawal by Subject|3|||
124438189|NCT03756129|447564088|FG000|Overall Study|Lost to Follow-up|0|||
124438190|NCT03756129|447564089|FG001|Overall Study|Lost to Follow-up|0|||
124438191|NCT03756129|447564090|FG002|Overall Study|Lost to Follow-up|0|||
124438192|NCT03756129|447564091|FG003|Overall Study|Lost to Follow-up|0|||
124438193|NCT03756129|447564092|FG004|Overall Study|Lost to Follow-up|0|||
124438194|NCT03756129|447564093|FG005|Overall Study|Lost to Follow-up|1|||
124438195|NCT03756129|447564088|FG000|Overall Study|Physician Decision|0|||
124438196|NCT03756129|447564089|FG001|Overall Study|Physician Decision|0|||
124438197|NCT03756129|447564090|FG002|Overall Study|Physician Decision|0|||
124438198|NCT03756129|447564091|FG003|Overall Study|Physician Decision|0|||
124438199|NCT03756129|447564092|FG004|Overall Study|Physician Decision|0|||
124438200|NCT03756129|447564093|FG005|Overall Study|Physician Decision|1|||
124438201|NCT03035201|447564094|FG000|Overall Study|Death|9|||
124438202|NCT03035201|447564095|FG001|Overall Study|Death|12|||
124438203|NCT03035201|447564096|FG002|Overall Study|Death|9|||
124438204|NCT03035201|447564097|FG003|Overall Study|Death|10|||
124438205|NCT03035201|447564094|FG000|Overall Study|Withdrawal by Subject|51|||
124438206|NCT03035201|447564095|FG001|Overall Study|Withdrawal by Subject|49|||
124438207|NCT03035201|447564096|FG002|Overall Study|Withdrawal by Subject|37|||
124438208|NCT03035201|447564097|FG003|Overall Study|Withdrawal by Subject|46|||
124438209|NCT03035201|447564094|FG000|Overall Study|Lost to Follow-up|67|||
124438210|NCT03035201|447564095|FG001|Overall Study|Lost to Follow-up|51|||
124438211|NCT03035201|447564096|FG002|Overall Study|Lost to Follow-up|64|||
124438212|NCT03035201|447564097|FG003|Overall Study|Lost to Follow-up|69|||
124438213|NCT01050790|447564098|FG000|Overall Study|Adverse Event|1|||
124438214|NCT03705832|447564099|FG000|Overall Study|Physician Decision|0|||
124438215|NCT03705832|447564100|FG001|Overall Study|Physician Decision|1|||
124438216|NCT03705832|447564099|FG000|Overall Study|Withdrawal by Subject|1|||
124438217|NCT03705832|447564100|FG001|Overall Study|Withdrawal by Subject|0|||
124438218|NCT01880528|447564101|FG000|Overall Study|Other|1|||
124438219|NCT01880528|447564102|FG001|Overall Study|Other|1|||
124438220|NCT01439360|447564103|FG000|Overall Study|Adverse Event|4|||
124438221|NCT01439360|447564104|FG001|Overall Study|Adverse Event|16|||
124438222|NCT01439360|447564103|FG000|Overall Study|Lost to Follow-up|43|||
124438223|NCT01439360|447564104|FG001|Overall Study|Lost to Follow-up|58|||
124438224|NCT01439360|447564103|FG000|Overall Study|Others|10|||
124438225|NCT01439360|447564104|FG001|Overall Study|Others|5|||
124438226|NCT01439360|447564103|FG000|Overall Study|Protocol Violation|1|||
124438227|NCT01439360|447564104|FG001|Overall Study|Protocol Violation|0|||
124438228|NCT01439360|447564103|FG000|Overall Study|Withdrawal by Subject|140|||
124438229|NCT01439360|447564104|FG001|Overall Study|Withdrawal by Subject|129|||
124438230|NCT01912456|447566057|FG000|Period 1|Physician Decision|0|||
124438231|NCT01912456|447566058|FG001|Period 1|Physician Decision|0|||
124438232|NCT01912456|447566059|FG002|Period 1|Physician Decision|1|||
124438233|NCT01912456|447566060|FG003|Period 1|Physician Decision|0|||
124438234|NCT01912456|447566057|FG000|Period 1|non-compliance|1|||
124438235|NCT01912456|447566058|FG001|Period 1|non-compliance|0|||
124438236|NCT01912456|447566059|FG002|Period 1|non-compliance|0|||
124438237|NCT01912456|447566060|FG003|Period 1|non-compliance|1|||
124438238|NCT01912456|447566057|FG000|Period 1|Adverse Event|1|||
124438239|NCT01912456|447566058|FG001|Period 1|Adverse Event|0|||
124438240|NCT01912456|447566059|FG002|Period 1|Adverse Event|0|||
124438241|NCT01912456|447566060|FG003|Period 1|Adverse Event|1|||
124438242|NCT01912456|447566057|FG000|Period 1|Withdrawal by Subject|0|||
124438243|NCT01912456|447566058|FG001|Period 1|Withdrawal by Subject|1|||
124438244|NCT01912456|447566059|FG002|Period 1|Withdrawal by Subject|1|||
124438245|NCT01912456|447566060|FG003|Period 1|Withdrawal by Subject|1|||
124438246|NCT01912456|447566057|FG000|Period 2|Lack of Efficacy|0|||
124438247|NCT01912456|447566058|FG001|Period 2|Lack of Efficacy|2|||
124438248|NCT01912456|447566059|FG002|Period 2|Lack of Efficacy|0|||
124438249|NCT01912456|447566060|FG003|Period 2|Lack of Efficacy|0|||
124438250|NCT01912456|447566057|FG000|Period 2|Adverse Event|0|||
124438251|NCT01912456|447566058|FG001|Period 2|Adverse Event|0|||
124438252|NCT01912456|447566059|FG002|Period 2|Adverse Event|0|||
124438253|NCT01912456|447566060|FG003|Period 2|Adverse Event|1|||
124438254|NCT01201343|447566061|FG000|Overall Study|Adverse Event|6|||
124438255|NCT01201343|447566061|FG000|Overall Study|Withdrawal by Subject|5|||
124438256|NCT01201343|447566061|FG000|Overall Study|Lost to Follow-up|2|||
124438257|NCT01201343|447566061|FG000|Overall Study|Lack of Efficacy|2|||
124680654|NCT01572792|448453983|FG002|Extension Study|Adverse Event|5|||
124680655|NCT01572792|448453984|FG003|Extension Study|Adverse Event|6|||
124680656|NCT01572792|448453985|FG004|Extension Study|Adverse Event|4|||
124680657|NCT01572792|448453981|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
124680658|NCT01572792|448453982|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
124680659|NCT01572792|448453983|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
124680660|NCT01572792|448453984|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
124680661|NCT01572792|448453985|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
124680662|NCT03530696|448453986|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
124680663|NCT03530696|448453987|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
124680664|NCT02472353|448453988|FG000|Overall Study|Lost to Follow-up|1|||
124680665|NCT02472353|448453989|FG001|Overall Study|Lost to Follow-up|1|||
124680666|NCT02472353|448453988|FG000|Overall Study|Withdrawal by Subject|2|||
124680667|NCT02472353|448453989|FG001|Overall Study|Withdrawal by Subject|1|||
124680668|NCT02472353|448453988|FG000|Overall Study|Study Termination|1|||
124680669|NCT02472353|448453989|FG001|Overall Study|Study Termination|4|||
124680670|NCT01129128|448453990|FG000|Overall Study|Lost to Follow-up|2|||
124680671|NCT01129128|448453991|FG001|Overall Study|Lost to Follow-up|2|||
124680672|NCT01129128|448453992|FG002|Overall Study|Lost to Follow-up|1|||
124680673|NCT01129128|448453990|FG000|Overall Study|Protocol Violation|0|||
124680674|NCT01129128|448453991|FG001|Overall Study|Protocol Violation|1|||
124680675|NCT01129128|448453992|FG002|Overall Study|Protocol Violation|0|||
124680676|NCT01129128|448453990|FG000|Overall Study|Withdrawal by Subject|0|||
124680677|NCT01129128|448453991|FG001|Overall Study|Withdrawal by Subject|1|||
124680678|NCT01129128|448453992|FG002|Overall Study|Withdrawal by Subject|3|||
124680679|NCT01129128|448453990|FG000|Overall Study|Physician Decision|1|||
124680680|NCT01129128|448453991|FG001|Overall Study|Physician Decision|0|||
124680681|NCT01129128|448453992|FG002|Overall Study|Physician Decision|0|||
124680682|NCT01047319|448454002|FG000|Overall Study|Teva requested participant withdrawal|3|||
124680683|NCT01047319|448454003|FG001|Overall Study|Teva requested participant withdrawal|0|||
124680684|NCT01047319|448454004|FG002|Overall Study|Teva requested participant withdrawal|1|||
124680685|NCT01047319|448454002|FG000|Overall Study|Protocol Violation|3|||
124680686|NCT01047319|448454003|FG001|Overall Study|Protocol Violation|2|||
124680687|NCT01047319|448454004|FG002|Overall Study|Protocol Violation|4|||
124680688|NCT01047319|448454002|FG000|Overall Study|Lack of Efficacy|4|||
124680689|NCT01047319|448454003|FG001|Overall Study|Lack of Efficacy|3|||
124680690|NCT01047319|448454004|FG002|Overall Study|Lack of Efficacy|3|||
124680691|NCT01047319|448454002|FG000|Overall Study|Death|5|||
124680692|NCT01047319|448454003|FG001|Overall Study|Death|1|||
124680693|NCT01047319|448454004|FG002|Overall Study|Death|5|||
124680694|NCT01047319|448454002|FG000|Overall Study|Pregnancy|13|||
124680695|NCT01047319|448454003|FG001|Overall Study|Pregnancy|8|||
124680696|NCT01047319|448454004|FG002|Overall Study|Pregnancy|8|||
124438258|NCT01201343|447566061|FG000|Overall Study|Participant wrongly included in trial|1|||
124438259|NCT01201343|447566061|FG000|Overall Study|Randomized, not treated|3|||
124438260|NCT00001962|447566065|FG000|Overall Study|Lack of Efficacy|18|||
124438261|NCT00001962|447566065|FG000|Overall Study|Lack of Accrual|6|||
124438262|NCT00001962|447566065|FG000|Overall Study|Death|1|||
124438263|NCT00001962|447566065|FG000|Overall Study|Lost to Follow-up|2|||
124438264|NCT00001962|447566065|FG000|Overall Study|Adverse Event|1|||
124438265|NCT01036763|447566066|FG000|Overall Study|Adverse Event|25|||
124438266|NCT01036763|447566066|FG000|Overall Study|Lost to Follow-up|28|||
124438267|NCT01036763|447566066|FG000|Overall Study|Other reason (not specified)|40|||
124438268|NCT01672723|447566067|FG000|First Intervention|Adverse Event|3|||
124438269|NCT01672723|447566068|FG001|First Intervention|Adverse Event|0|||
124438270|NCT01177722|447566071|FG000|Overall Study|Serious Adverse Event|0|||
124438271|NCT01177722|447566072|FG001|Overall Study|Serious Adverse Event|0|||
124438272|NCT01177722|447566073|FG002|Overall Study|Serious Adverse Event|1|||
124438273|NCT01177722|447566074|FG003|Overall Study|Serious Adverse Event|0|||
124438274|NCT01177722|447566071|FG000|Overall Study|Protocol Violation|0|||
124438275|NCT01177722|447566072|FG001|Overall Study|Protocol Violation|0|||
124438276|NCT01177722|447566073|FG002|Overall Study|Protocol Violation|1|||
124438277|NCT01177722|447566074|FG003|Overall Study|Protocol Violation|0|||
124438278|NCT01177722|447566071|FG000|Overall Study|Lost to Follow-up|3|||
124438279|NCT01177722|447566072|FG001|Overall Study|Lost to Follow-up|4|||
124438280|NCT01177722|447566073|FG002|Overall Study|Lost to Follow-up|3|||
124438281|NCT01177722|447566074|FG003|Overall Study|Lost to Follow-up|1|||
124438282|NCT01177722|447566071|FG000|Overall Study|Withdrawal by Subject|10|||
124438283|NCT01177722|447566072|FG001|Overall Study|Withdrawal by Subject|6|||
124438284|NCT01177722|447566073|FG002|Overall Study|Withdrawal by Subject|4|||
124438285|NCT01177722|447566074|FG003|Overall Study|Withdrawal by Subject|6|||
124680697|NCT01047319|448454002|FG000|Overall Study|Physician Decision|12|||
124680698|NCT01047319|448454003|FG001|Overall Study|Physician Decision|9|||
124680699|NCT01047319|448454004|FG002|Overall Study|Physician Decision|10|||
124680700|NCT01047319|448454002|FG000|Overall Study|Lost to Follow-up|14|||
124438286|NCT01060540|447566075|FG000|Overall Study|Withdrawal by Subject|10|||
124680701|NCT01047319|448454003|FG001|Overall Study|Lost to Follow-up|10|||
124680702|NCT01047319|448454004|FG002|Overall Study|Lost to Follow-up|10|||
124680703|NCT01047319|448454002|FG000|Overall Study|Adverse Event|16|||
124680704|NCT01047319|448454003|FG001|Overall Study|Adverse Event|27|||
124680705|NCT01047319|448454004|FG002|Overall Study|Adverse Event|21|||
124680706|NCT01047319|448454002|FG000|Overall Study|Withdrawal by Subject|77|||
124680707|NCT01047319|448454003|FG001|Overall Study|Withdrawal by Subject|75|||
124680708|NCT01047319|448454004|FG002|Overall Study|Withdrawal by Subject|87|||
124680709|NCT01047319|448454002|FG000|Overall Study|Study terminated by Sponsor|198|||
124680710|NCT01047319|448454003|FG001|Overall Study|Study terminated by Sponsor|215|||
124680711|NCT01047319|448454004|FG002|Overall Study|Study terminated by Sponsor|203|||
124680712|NCT01288430|448455640|FG000|Part 1|Progressive disease|2|||
124680713|NCT01288430|448455641|FG001|Part 1|Progressive disease|1|||
124680714|NCT01288430|448455642|FG002|Part 1|Progressive disease|1|||
124680715|NCT01288430|448455643|FG003|Part 1|Progressive disease|6|||
124680716|NCT01288430|448455644|FG004|Part 1|Progressive disease|2|||
124680717|NCT01288430|448455645|FG005|Part 1|Progressive disease|4|||
124680718|NCT01288430|448455646|FG006|Part 1|Progressive disease|2|||
124680719|NCT01288430|448455647|FG007|Part 1|Progressive disease|0|||
124680720|NCT01288430|448455648|FG008|Part 1|Progressive disease|0|||
124680721|NCT01288430|448455649|FG009|Part 1|Progressive disease|0|||
124680722|NCT01288430|448455640|FG000|Part 1|Clinical disease progression|0|||
124680723|NCT01288430|448455641|FG001|Part 1|Clinical disease progression|0|||
124680724|NCT01288430|448455642|FG002|Part 1|Clinical disease progression|1|||
124680725|NCT01288430|448455643|FG003|Part 1|Clinical disease progression|0|||
124680726|NCT01288430|448455644|FG004|Part 1|Clinical disease progression|0|||
124680727|NCT01288430|448455645|FG005|Part 1|Clinical disease progression|2|||
124680728|NCT01288430|448455646|FG006|Part 1|Clinical disease progression|2|||
124680729|NCT01288430|448455647|FG007|Part 1|Clinical disease progression|0|||
124680730|NCT01288430|448455648|FG008|Part 1|Clinical disease progression|0|||
124680731|NCT01288430|448455649|FG009|Part 1|Clinical disease progression|0|||
124680732|NCT01288430|448455640|FG000|Part 1|Death due to disease progression|0|||
124680733|NCT01288430|448455641|FG001|Part 1|Death due to disease progression|0|||
124680734|NCT01288430|448455642|FG002|Part 1|Death due to disease progression|0|||
124680735|NCT01288430|448455643|FG003|Part 1|Death due to disease progression|0|||
124680736|NCT01288430|448455644|FG004|Part 1|Death due to disease progression|1|||
124680737|NCT01288430|448455645|FG005|Part 1|Death due to disease progression|0|||
124680738|NCT01288430|448455646|FG006|Part 1|Death due to disease progression|0|||
124680739|NCT01288430|448455647|FG007|Part 1|Death due to disease progression|0|||
124680740|NCT01288430|448455648|FG008|Part 1|Death due to disease progression|0|||
124680741|NCT01288430|448455649|FG009|Part 1|Death due to disease progression|0|||
124680742|NCT01288430|448455640|FG000|Part 1|Adverse Event|0|||
124680743|NCT01288430|448455641|FG001|Part 1|Adverse Event|0|||
124680744|NCT01288430|448455642|FG002|Part 1|Adverse Event|3|||
124680745|NCT01288430|448455643|FG003|Part 1|Adverse Event|1|||
124880280|NCT03285295|449185483|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
124880281|NCT03285295|449185484|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
124680746|NCT01288430|448455644|FG004|Part 1|Adverse Event|0|||
124680747|NCT01288430|448455645|FG005|Part 1|Adverse Event|0|||
124680748|NCT01288430|448455646|FG006|Part 1|Adverse Event|2|||
124680749|NCT01288430|448455647|FG007|Part 1|Adverse Event|0|||
124680750|NCT01288430|448455648|FG008|Part 1|Adverse Event|0|||
124680751|NCT01288430|448455649|FG009|Part 1|Adverse Event|0|||
124680752|NCT01288430|448455640|FG000|Part 1|Other|0|||
124680753|NCT01288430|448455641|FG001|Part 1|Other|2|||
124680754|NCT01288430|448455642|FG002|Part 1|Other|0|||
124680755|NCT01288430|448455643|FG003|Part 1|Other|0|||
124680756|NCT01288430|448455644|FG004|Part 1|Other|0|||
124680757|NCT01288430|448455645|FG005|Part 1|Other|0|||
124680758|NCT01288430|448455646|FG006|Part 1|Other|1|||
124680759|NCT01288430|448455647|FG007|Part 1|Other|0|||
124680760|NCT01288430|448455648|FG008|Part 1|Other|0|||
124680761|NCT01288430|448455649|FG009|Part 1|Other|0|||
124680762|NCT01288430|448455640|FG000|Part 2|Progressive disease|0|||
124680763|NCT01288430|448455641|FG001|Part 2|Progressive disease|0|||
124680764|NCT01288430|448455642|FG002|Part 2|Progressive disease|0|||
124680765|NCT01288430|448455643|FG003|Part 2|Progressive disease|0|||
124680766|NCT01288430|448455644|FG004|Part 2|Progressive disease|0|||
124680767|NCT01288430|448455645|FG005|Part 2|Progressive disease|0|||
124680768|NCT01288430|448455646|FG006|Part 2|Progressive disease|0|||
124680769|NCT01288430|448455647|FG007|Part 2|Progressive disease|8|||
124680770|NCT01288430|448455648|FG008|Part 2|Progressive disease|7|||
124680771|NCT01288430|448455649|FG009|Part 2|Progressive disease|2|||
124680772|NCT01288430|448455640|FG000|Part 2|Clinical disease progression|0|||
124680773|NCT01288430|448455641|FG001|Part 2|Clinical disease progression|0|||
124680774|NCT01288430|448455642|FG002|Part 2|Clinical disease progression|0|||
124680775|NCT01288430|448455643|FG003|Part 2|Clinical disease progression|0|||
124680776|NCT01288430|448455644|FG004|Part 2|Clinical disease progression|0|||
124680777|NCT01288430|448455645|FG005|Part 2|Clinical disease progression|0|||
124680778|NCT01288430|448455646|FG006|Part 2|Clinical disease progression|0|||
124680779|NCT01288430|448455647|FG007|Part 2|Clinical disease progression|2|||
124680780|NCT01288430|448455648|FG008|Part 2|Clinical disease progression|0|||
124680781|NCT01288430|448455649|FG009|Part 2|Clinical disease progression|0|||
124680782|NCT01288430|448455640|FG000|Part 2|Withdrawal by Subject|0|||
124680783|NCT01288430|448455641|FG001|Part 2|Withdrawal by Subject|0|||
124680784|NCT01288430|448455642|FG002|Part 2|Withdrawal by Subject|0|||
124680785|NCT01288430|448455643|FG003|Part 2|Withdrawal by Subject|0|||
124680786|NCT01288430|448455644|FG004|Part 2|Withdrawal by Subject|0|||
124680787|NCT01288430|448455645|FG005|Part 2|Withdrawal by Subject|0|||
124680788|NCT01288430|448455646|FG006|Part 2|Withdrawal by Subject|0|||
124680789|NCT01288430|448455647|FG007|Part 2|Withdrawal by Subject|1|||
124680790|NCT01288430|448455648|FG008|Part 2|Withdrawal by Subject|4|||
124680791|NCT01288430|448455649|FG009|Part 2|Withdrawal by Subject|0|||
124680792|NCT01288430|448455640|FG000|Part 2|Adverse Event|0|||
124680793|NCT01288430|448455641|FG001|Part 2|Adverse Event|0|||
124680794|NCT01288430|448455642|FG002|Part 2|Adverse Event|0|||
124680795|NCT01288430|448455643|FG003|Part 2|Adverse Event|0|||
124680796|NCT01288430|448455644|FG004|Part 2|Adverse Event|0|||
124680797|NCT01288430|448455645|FG005|Part 2|Adverse Event|0|||
124680798|NCT01288430|448455646|FG006|Part 2|Adverse Event|0|||
124680799|NCT01288430|448455647|FG007|Part 2|Adverse Event|1|||
124680800|NCT01288430|448455648|FG008|Part 2|Adverse Event|1|||
124680801|NCT01288430|448455649|FG009|Part 2|Adverse Event|0|||
124680802|NCT01288430|448455640|FG000|Part 2|Other|0|||
124680803|NCT01288430|448455641|FG001|Part 2|Other|0|||
124680804|NCT01288430|448455642|FG002|Part 2|Other|0|||
124680805|NCT01288430|448455643|FG003|Part 2|Other|0|||
124680806|NCT01288430|448455644|FG004|Part 2|Other|0|||
124680807|NCT01288430|448455645|FG005|Part 2|Other|0|||
124680808|NCT01288430|448455646|FG006|Part 2|Other|0|||
124680809|NCT01288430|448455647|FG007|Part 2|Other|0|||
124680810|NCT01288430|448455648|FG008|Part 2|Other|0|||
124680811|NCT01288430|448455649|FG009|Part 2|Other|1|||
124680812|NCT03836053|448455655|FG000|Overall Study|Protocol-specified criteria|0|||
124680813|NCT03836053|448455656|FG001|Overall Study|Protocol-specified criteria|2|||
124680814|NCT03836053|448455657|FG002|Overall Study|Protocol-specified criteria|1|||
124680815|NCT03836053|448455655|FG000|Overall Study|Death|1|||
124680816|NCT03836053|448455656|FG001|Overall Study|Death|6|||
124680817|NCT03836053|448455657|FG002|Overall Study|Death|4|||
124680818|NCT03836053|448455655|FG000|Overall Study|Withdrawal of consent from study|0|||
124880282|NCT03285295|449185485|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
124680819|NCT03836053|448455656|FG001|Overall Study|Withdrawal of consent from study|0|||
124680820|NCT03836053|448455657|FG002|Overall Study|Withdrawal of consent from study|1|||
124680821|NCT03836053|448455655|FG000|Overall Study|Decision by sponsor|0|||
124680822|NCT03836053|448455656|FG001|Overall Study|Decision by sponsor|2|||
124680823|NCT03836053|448455657|FG002|Overall Study|Decision by sponsor|4|||
124680824|NCT04006457|448455658|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
124680825|NCT04006457|448455659|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
124680826|NCT04006457|448455660|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
124680827|NCT04006457|448455658|FG000|Main Study: Treatment Period 1|Death|1|||
124680828|NCT04006457|448455659|FG001|Main Study: Treatment Period 1|Death|1|||
124680829|NCT04006457|448455660|FG002|Main Study: Treatment Period 1|Death|0|||
124680830|NCT04006457|448455658|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
124680831|NCT04006457|448455659|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
124680832|NCT04006457|448455660|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
124680833|NCT04006457|448455658|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
124680834|NCT04006457|448455659|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
124680835|NCT04006457|448455660|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
124680836|NCT04006457|448455658|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
124680837|NCT04006457|448455659|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
124680838|NCT04006457|448455660|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
124680839|NCT04006457|448455658|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
124680840|NCT04006457|448455659|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
124680841|NCT04006457|448455660|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
124680842|NCT04006457|448455658|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
124680843|NCT04006457|448455659|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
124680844|NCT04006457|448455660|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
124680845|NCT04006457|448455658|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
124680846|NCT04006457|448455659|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
124680847|NCT04006457|448455660|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
124680848|NCT04006457|448455658|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
124680849|NCT04006457|448455659|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
124680850|NCT04006457|448455660|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
124680851|NCT04006457|448455658|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
124680852|NCT04006457|448455659|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
124680853|NCT04006457|448455660|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
124680854|NCT04006457|448455658|FG000|Main Study: Treatment Period 1|Other|10|||
124680855|NCT04006457|448455659|FG001|Main Study: Treatment Period 1|Other|4|||
124680856|NCT04006457|448455660|FG002|Main Study: Treatment Period 1|Other|0|||
124680857|NCT04006457|448455658|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
124680858|NCT04006457|448455659|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
124680859|NCT04006457|448455660|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
124680860|NCT04006457|448455658|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
124680861|NCT04006457|448455659|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
124680862|NCT04006457|448455660|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
124680863|NCT04006457|448455658|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
124680864|NCT04006457|448455659|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
124680865|NCT04006457|448455660|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
124680866|NCT04006457|448455658|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
124680867|NCT04006457|448455659|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
124680868|NCT04006457|448455660|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
124680869|NCT04006457|448455658|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
124680870|NCT04006457|448455659|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
124680871|NCT04006457|448455660|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
124680872|NCT04006457|448455658|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
124680873|NCT04006457|448455659|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
124680874|NCT04006457|448455660|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
124680875|NCT04006457|448455658|FG000|Main Study: Treatment Period 2|Other|2|||
124680876|NCT04006457|448455659|FG001|Main Study: Treatment Period 2|Other|3|||
124680877|NCT04006457|448455660|FG002|Main Study: Treatment Period 2|Other|0|||
124680878|NCT04006457|448455658|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
124680879|NCT04006457|448455659|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
124680880|NCT04006457|448455660|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
124680881|NCT04006457|448455658|FG000|Main Study: Treatment Period 2|Ongoing|86|||
124680882|NCT04006457|448455659|FG001|Main Study: Treatment Period 2|Ongoing|96|||
124680883|NCT04006457|448455660|FG002|Main Study: Treatment Period 2|Ongoing|0|||
124680884|NCT04006457|448455658|FG000|Main Study Observation Period|Adverse Event|1|||
124680885|NCT04006457|448455659|FG001|Main Study Observation Period|Adverse Event|1|||
124680886|NCT04006457|448455660|FG002|Main Study Observation Period|Adverse Event|0|||
124680887|NCT04006457|448455658|FG000|Main Study Observation Period|Lost to Follow-up|0|||
124680888|NCT04006457|448455659|FG001|Main Study Observation Period|Lost to Follow-up|1|||
124680889|NCT04006457|448455660|FG002|Main Study Observation Period|Lost to Follow-up|0|||
124680890|NCT04006457|448455658|FG000|Main Study Observation Period|Pregnancy|1|||
124680891|NCT04006457|448455659|FG001|Main Study Observation Period|Pregnancy|0|||
124680892|NCT04006457|448455660|FG002|Main Study Observation Period|Pregnancy|0|||
124680893|NCT04006457|448455658|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
124880283|NCT03285295|449185481|FG000|Alinity s Anti-HCV|No Results Generated|71|||
124880284|NCT03285295|449185482|FG001|Alinity s Anti-HCV|No Results Generated|0|||
124680894|NCT04006457|448455659|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
124680895|NCT04006457|448455660|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
124680896|NCT04006457|448455658|FG000|Main Study Observation Period|Other|8|||
124680897|NCT04006457|448455659|FG001|Main Study Observation Period|Other|16|||
124680898|NCT04006457|448455660|FG002|Main Study Observation Period|Other|0|||
124680899|NCT04006457|448455658|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
124438287|NCT01060540|447566076|FG001|Overall Study|Withdrawal by Subject|20|||
124438288|NCT01060540|447566075|FG000|Overall Study|Lost to Follow-up|52|||
124438289|NCT01060540|447566076|FG001|Overall Study|Lost to Follow-up|43|||
124438290|NCT01060540|447566075|FG000|Overall Study|Death|2|||
124438291|NCT01060540|447566076|FG001|Overall Study|Death|1|||
124438292|NCT01060540|447566075|FG000|Overall Study|Physician Decision|0|||
124680900|NCT04006457|448455659|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
124680901|NCT04006457|448455660|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
124680902|NCT04006457|448455658|FG000|Main Study Observation Period|Ongoing|2|||
124680903|NCT04006457|448455659|FG001|Main Study Observation Period|Ongoing|1|||
124680904|NCT04006457|448455660|FG002|Main Study Observation Period|Ongoing|0|||
124680905|NCT04006457|448455658|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
124680906|NCT04006457|448455659|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
124680907|NCT04006457|448455660|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
124680908|NCT04486716|448455661|FG000|Core Phase|Subject decision|6|||
124680909|NCT04486716|448455661|FG000|Core Phase|Adverse Event|5|||
124680910|NCT04486716|448455661|FG000|Core Phase|Lost to Follow-up|1|||
124680911|NCT04486716|448455661|FG000|Core Phase|Physician Decision|1|||
124680912|NCT04486716|448455661|FG000|Core Phase|Enrolled subjects not treated|9|||
124680913|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
124680914|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
124680915|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
124680916|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
124680917|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
124680918|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
124680919|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
124680920|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
124680921|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
124680922|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
124680923|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
124438293|NCT01060540|447566076|FG001|Overall Study|Physician Decision|1|||
124438294|NCT00596427|447566080|FG000|Overall Study|Withdrawal by Subject|2|||
124438295|NCT00596427|447566081|FG001|Overall Study|Withdrawal by Subject|2|||
124438296|NCT00596427|447566080|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
124438297|NCT00596427|447566081|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
124438298|NCT00596427|447566080|FG000|Overall Study|Protocol Violation|1|||
124438299|NCT00596427|447566081|FG001|Overall Study|Protocol Violation|0|||
124438300|NCT00320541|447566082|FG000|Overall Study|Adverse Event|21|||
124438301|NCT00320541|447566083|FG001|Overall Study|Adverse Event|19|||
124438302|NCT00320541|447566082|FG000|Overall Study|Protocol Violation|0|||
124438303|NCT00320541|447566083|FG001|Overall Study|Protocol Violation|1|||
124438304|NCT00320541|447566082|FG000|Overall Study|Withdrawal by Subject|12|||
124438305|NCT00320541|447566083|FG001|Overall Study|Withdrawal by Subject|16|||
124438306|NCT00320541|447566082|FG000|Overall Study|Physician Decision|9|||
124438307|NCT00320541|447566083|FG001|Overall Study|Physician Decision|13|||
124438308|NCT00320541|447566082|FG000|Overall Study|Other|3|||
124438309|NCT00320541|447566083|FG001|Overall Study|Other|4|||
124438310|NCT00320541|447566082|FG000|Overall Study|Sponsor Decision|2|||
124438311|NCT00320541|447566083|FG001|Overall Study|Sponsor Decision|1|||
124438312|NCT00320541|447566082|FG000|Overall Study|Death due to Study Disease|1|||
124438313|NCT00320541|447566083|FG001|Overall Study|Death due to Study Disease|3|||
124680924|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
124680925|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
124680926|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
124680927|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
124680928|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
124680929|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
124438314|NCT00320541|447566082|FG000|Overall Study|Death due to Adverse Event(s)|1|||
124438315|NCT00320541|447566083|FG001|Overall Study|Death due to Adverse Event(s)|0|||
124438316|NCT00320541|447566082|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
124438317|NCT00320541|447566083|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
124438318|NCT03057977|447566086|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
124438319|NCT03057977|447566087|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
124438320|NCT03057977|447566086|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
124438321|NCT03057977|447566087|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
124438322|NCT03057977|447566086|FG000|Discontinuation From Treatment|Protocol Violation|6|||
124880285|NCT03285295|449185483|FG002|Alinity s Anti-HCV|No Results Generated|0|||
124438323|NCT03057977|447566087|FG001|Discontinuation From Treatment|Protocol Violation|5|||
124438324|NCT03057977|447566086|FG000|Discontinuation From Treatment|Not treated|4|||
124438325|NCT03057977|447566087|FG001|Discontinuation From Treatment|Not treated|0|||
124438326|NCT03057977|447566086|FG000|Discontinuation From Treatment|Adverse Event|343|||
124438327|NCT03057977|447566087|FG001|Discontinuation From Treatment|Adverse Event|337|||
124438328|NCT03057977|447566086|FG000|Discontinuation From Treatment|Reason Unknown|0|||
124438329|NCT03057977|447566087|FG001|Discontinuation From Treatment|Reason Unknown|1|||
124438330|NCT03057977|447566086|FG000|Discontinuation From Treatment|Personal Reasons|1|||
124438331|NCT03057977|447566087|FG001|Discontinuation From Treatment|Personal Reasons|1|||
124438332|NCT03057977|447566086|FG000|Discontinuation From Treatment|Unblinded medication|1|||
124438333|NCT03057977|447566087|FG001|Discontinuation From Treatment|Unblinded medication|0|||
124438334|NCT03057977|447566086|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
124438335|NCT03057977|447566087|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
124438336|NCT03057977|447566086|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
124438337|NCT03057977|447566087|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
124438338|NCT03057977|447566086|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
124438339|NCT03057977|447566087|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
124438340|NCT03057977|447566086|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
124438341|NCT03057977|447566087|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
124438342|NCT03057977|447566086|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
124438343|NCT03057977|447566087|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
124438344|NCT03057977|447566086|FG000|Discontinuation From Treatment|Not attending study visit|3|||
124438345|NCT03057977|447566087|FG001|Discontinuation From Treatment|Not attending study visit|10|||
124438346|NCT03057977|447566086|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
124438347|NCT03057977|447566087|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
124438348|NCT03057977|447566086|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
124438349|NCT03057977|447566087|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
124438350|NCT03057977|447566086|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
124438351|NCT03057977|447566087|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
124438352|NCT03057977|447566086|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
124438353|NCT03057977|447566087|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
124438354|NCT03057977|447566086|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
124438355|NCT03057977|447566087|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
124438356|NCT02401867|447566088|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
124438357|NCT02401867|447566088|FG000|Analysis|Cervical assay could not be conducted|9|||
124438358|NCT02502097|447566089|FG000|Period 1|Adverse Event|0|||
124438359|NCT02502097|447566090|FG001|Period 1|Adverse Event|0|||
124438360|NCT02502097|447566091|FG002|Period 1|Adverse Event|1|||
124680930|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
124680931|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
124680932|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
124680933|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
124680934|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
124680935|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
124880286|NCT03285295|449185484|FG003|Alinity s Anti-HCV|No Results Generated|0|||
124880287|NCT03285295|449185485|FG004|Alinity s Anti-HCV|No Results Generated|0|||
124438361|NCT02502097|447566092|FG003|Period 1|Adverse Event|0|||
124438362|NCT02502097|447566089|FG000|Wash Out Period|Adverse Event|0|||
124438363|NCT02502097|447566090|FG001|Wash Out Period|Adverse Event|1|||
124438364|NCT02502097|447566091|FG002|Wash Out Period|Adverse Event|1|||
124438365|NCT02502097|447566092|FG003|Wash Out Period|Adverse Event|1|||
124438366|NCT02502097|447566089|FG000|Period 2|Adverse Event|0|||
124438367|NCT02502097|447566090|FG001|Period 2|Adverse Event|0|||
124438368|NCT02502097|447566091|FG002|Period 2|Adverse Event|1|||
124438369|NCT02502097|447566092|FG003|Period 2|Adverse Event|0|||
124438370|NCT01201317|447566093|FG000|Overall Study|Withdrawal by Subject|5|||
124438371|NCT01201317|447566094|FG001|Overall Study|Withdrawal by Subject|0|||
124438372|NCT01201317|447566095|FG002|Overall Study|Withdrawal by Subject|3|||
124438373|NCT01201317|447566093|FG000|Overall Study|Adverse Event|2|||
124438374|NCT01201317|447566094|FG001|Overall Study|Adverse Event|2|||
124680936|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
124680937|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
124880288|NCT03285295|449185481|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
124438375|NCT01201317|447566095|FG002|Overall Study|Adverse Event|2|||
124438376|NCT01201317|447566093|FG000|Overall Study|Screen failure|1|||
124438377|NCT01201317|447566094|FG001|Overall Study|Screen failure|1|||
124438378|NCT01201317|447566095|FG002|Overall Study|Screen failure|0|||
124680938|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
124680939|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
124680940|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
124680941|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
124680942|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
124680943|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
124680944|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
124680945|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
124680946|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
124680947|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
124680948|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
124680949|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
124680950|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
124680951|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
124880289|NCT03285295|449185482|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
124880290|NCT03285295|449185483|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
124880291|NCT03285295|449185484|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
124880292|NCT03285295|449185485|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
124880293|NCT03285295|449185481|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
124680952|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
124680953|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
124680954|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
124680955|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
124680956|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
124680957|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
124680958|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
124680959|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
124680960|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
124680961|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
124680962|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
124680963|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
124680964|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
124680965|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
124680966|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
124680967|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
124680968|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
124680969|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
124680970|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
124680971|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
124680972|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
124680973|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
124680974|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
124680975|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
124680976|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
124680977|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
124680978|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
124680979|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
124680980|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
124680981|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
124680982|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
124680983|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
124680984|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
124680985|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
124680986|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
124680987|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
124680988|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
124680989|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
124680990|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
124680991|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
124680992|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
124680993|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
124880294|NCT03285295|449185482|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
124680994|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
124680995|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
124680996|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
124680997|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
124680998|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
124680999|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
124681000|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
124681001|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
124681002|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
124681003|NCT00090103|448455668|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
124681004|NCT00090103|448455669|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
124681005|NCT00090103|448455670|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
124681006|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
124681007|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
124681008|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
124681009|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
124681010|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
124681011|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
124681012|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
124681013|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
124681014|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
124681015|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
124681016|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
124681017|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
124681018|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
124681019|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
124681020|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
124681021|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
124681022|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
124681023|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
124681024|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
124681025|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
124681026|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
124681027|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
124681028|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
124681029|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
124681030|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
124681031|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
124681032|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
124681033|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
124681034|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
124681035|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
124681036|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
124681037|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
124681038|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
124681039|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
124681040|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
124681041|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
124681042|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
124681043|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
124681044|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
124681045|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
124681046|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
124681047|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
124681048|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
124681049|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
124681050|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
124681051|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
124681052|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
124681053|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
124681054|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Death|1|||
124681055|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Death|0|||
124681056|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Death|1|||
124681057|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
124681058|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
124681059|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
124681060|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
124681061|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
124681062|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
124681063|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
124681064|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
124681065|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
124681066|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
124681067|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
124681068|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
124681069|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
124681070|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
124681071|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
124681072|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
124681073|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
124681074|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
124681075|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
124681076|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
124681077|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
124681078|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Depression|0|||
124681079|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Depression|1|||
124681080|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Depression|0|||
124681081|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
124681082|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
124681083|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
124681084|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Jailed|0|||
124681085|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Jailed|1|||
124681086|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Jailed|0|||
124681087|NCT00090103|448455668|FG000|16-Week Safety Follow-up Period|Other|0|||
124681088|NCT00090103|448455669|FG001|16-Week Safety Follow-up Period|Other|1|||
124681089|NCT00090103|448455670|FG002|16-Week Safety Follow-up Period|Other|0|||
124681090|NCT04476043|448455671|FG000|Overall Study|Withdrawal by Subject|1|||
124438379|NCT01201317|447566093|FG000|Overall Study|Protocol Violation|0|||
124438380|NCT01201317|447566094|FG001|Overall Study|Protocol Violation|1|||
124438381|NCT01201317|447566095|FG002|Overall Study|Protocol Violation|1|||
124438382|NCT01201317|447566093|FG000|Overall Study|Death|0|||
124438383|NCT01201317|447566094|FG001|Overall Study|Death|1|||
124438384|NCT01201317|447566095|FG002|Overall Study|Death|0|||
124438385|NCT01201317|447566093|FG000|Overall Study|Study-specific withdrawal criteria|0|||
124438386|NCT01201317|447566094|FG001|Overall Study|Study-specific withdrawal criteria|0|||
124438387|NCT01201317|447566095|FG002|Overall Study|Study-specific withdrawal criteria|1|||
124438388|NCT01201317|447566093|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
124438389|NCT01201317|447566094|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
124438390|NCT01201317|447566095|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
124438391|NCT01201317|447566093|FG000|Overall Study|Decrease in renal function|0|||
124438392|NCT01201317|447566094|FG001|Overall Study|Decrease in renal function|1|||
124438393|NCT01201317|447566095|FG002|Overall Study|Decrease in renal function|0|||
124438394|NCT01201317|447566093|FG000|Overall Study|Lack of Efficacy|1|||
124438395|NCT01201317|447566094|FG001|Overall Study|Lack of Efficacy|0|||
124438396|NCT01201317|447566095|FG002|Overall Study|Lack of Efficacy|0|||
124438397|NCT01201317|447566093|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
124438398|NCT01201317|447566094|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
124438399|NCT01201317|447566095|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
124438400|NCT00252733|447566096|FG000|Overall Study|Withdrawal by Subject|73|||
124438401|NCT00252733|447566097|FG001|Overall Study|Withdrawal by Subject|67|||
124438402|NCT00252733|447566096|FG000|Overall Study|Death|7|||
124438403|NCT00252733|447566097|FG001|Overall Study|Death|5|||
124681091|NCT04476043|448455672|FG001|Overall Study|Withdrawal by Subject|3|||
124681092|NCT04476043|448455673|FG002|Overall Study|Withdrawal by Subject|4|||
124681093|NCT04476043|448455674|FG003|Overall Study|Withdrawal by Subject|1|||
124681094|NCT04476043|448455671|FG000|Overall Study|Lost to Follow-up|1|||
124681095|NCT04476043|448455672|FG001|Overall Study|Lost to Follow-up|1|||
124880295|NCT03285295|449185483|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
124438404|NCT00252733|447566096|FG000|Overall Study|Lost to Follow-up|12|||
124438405|NCT00252733|447566097|FG001|Overall Study|Lost to Follow-up|6|||
124438406|NCT00252733|447566096|FG000|Overall Study|Multiple Reasons|14|||
124681096|NCT04476043|448455673|FG002|Overall Study|Lost to Follow-up|2|||
124681097|NCT04476043|448455674|FG003|Overall Study|Lost to Follow-up|1|||
124438407|NCT00252733|447566097|FG001|Overall Study|Multiple Reasons|14|||
124438408|NCT01350336|447566098|FG000|Overall Study|Lost to Follow-up|31|||
124880296|NCT03285295|449185484|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
124880297|NCT03285295|449185485|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
124438409|NCT01350336|447566098|FG000|Overall Study|Withdrawal by Subject|14|||
124438410|NCT01350336|447566098|FG000|Overall Study|Physician Decision|8|||
124438411|NCT01350336|447566098|FG000|Overall Study|Death|4|||
124438412|NCT01491672|447566099|FG000|Overall Study|Lost to Follow-up|0|||
124438413|NCT01491672|447566100|FG001|Overall Study|Lost to Follow-up|4|||
124438414|NCT01491672|447566101|FG002|Overall Study|Lost to Follow-up|1|||
124438415|NCT01491672|447566099|FG000|Overall Study|Withdrawal by Subject|6|||
124438416|NCT01491672|447566100|FG001|Overall Study|Withdrawal by Subject|7|||
124438417|NCT01491672|447566101|FG002|Overall Study|Withdrawal by Subject|0|||
124438418|NCT01491672|447566099|FG000|Overall Study|Adverse Event|8|||
124438419|NCT01491672|447566100|FG001|Overall Study|Adverse Event|10|||
124438420|NCT01491672|447566101|FG002|Overall Study|Adverse Event|4|||
124438421|NCT01491672|447566099|FG000|Overall Study|Disease progression|42|||
124438422|NCT01491672|447566100|FG001|Overall Study|Disease progression|34|||
124438423|NCT01491672|447566101|FG002|Overall Study|Disease progression|6|||
124438424|NCT01491672|447566099|FG000|Overall Study|Protocol deviation|0|||
124438425|NCT01491672|447566100|FG001|Overall Study|Protocol deviation|1|||
124438426|NCT01491672|447566101|FG002|Overall Study|Protocol deviation|0|||
124438427|NCT01491672|447566099|FG000|Overall Study|Death|0|||
124438428|NCT01491672|447566100|FG001|Overall Study|Death|4|||
124438429|NCT01491672|447566101|FG002|Overall Study|Death|0|||
124438430|NCT02795429|447566102|FG000|Overall Study|Adverse Event|1|||
124438431|NCT02795429|447566103|FG001|Overall Study|Adverse Event|2|||
124438432|NCT02795429|447566104|FG002|Overall Study|Adverse Event|1|||
124438433|NCT02795429|447566105|FG003|Overall Study|Adverse Event|2|||
124438434|NCT02795429|447566106|FG004|Overall Study|Adverse Event|1|||
124438435|NCT02795429|447566102|FG000|Overall Study|Death|1|||
124438436|NCT02795429|447566103|FG001|Overall Study|Death|0|||
124438437|NCT02795429|447566104|FG002|Overall Study|Death|1|||
124438438|NCT02795429|447566105|FG003|Overall Study|Death|2|||
124438439|NCT02795429|447566106|FG004|Overall Study|Death|1|||
124438440|NCT02795429|447566102|FG000|Overall Study|Physician Decision|0|||
124438441|NCT02795429|447566103|FG001|Overall Study|Physician Decision|0|||
124438442|NCT02795429|447566104|FG002|Overall Study|Physician Decision|2|||
124438443|NCT02795429|447566105|FG003|Overall Study|Physician Decision|1|||
124438444|NCT02795429|447566106|FG004|Overall Study|Physician Decision|5|||
124438445|NCT02795429|447566102|FG000|Overall Study|Progressive disease|3|||
124438446|NCT02795429|447566103|FG001|Overall Study|Progressive disease|7|||
124438447|NCT02795429|447566104|FG002|Overall Study|Progressive disease|6|||
124438448|NCT02795429|447566105|FG003|Overall Study|Progressive disease|26|||
124438449|NCT02795429|447566106|FG004|Overall Study|Progressive disease|20|||
124438450|NCT02795429|447566102|FG000|Overall Study|Subject/guardian decision|1|||
124438451|NCT02795429|447566103|FG001|Overall Study|Subject/guardian decision|1|||
124438452|NCT02795429|447566104|FG002|Overall Study|Subject/guardian decision|1|||
124438453|NCT02795429|447566105|FG003|Overall Study|Subject/guardian decision|1|||
124438454|NCT02795429|447566106|FG004|Overall Study|Subject/guardian decision|3|||
124438455|NCT01640054|447566109|FG000|Overall Study|Study-specific disc criteria|1|||
124438456|NCT01640054|447566109|FG000|Overall Study|Lack of Efficacy|3|||
124438457|NCT01640054|447566109|FG000|Overall Study|Adverse Event|2|||
124438458|NCT02080221|447566110|FG000|Overall Study|Withdrawal by Subject|1|||
124438459|NCT02080221|447566110|FG000|Overall Study|Clinical Progression of Disease|1|||
124438460|NCT01386788|447566111|FG000|Overall Study|Lost to Follow-up|2|||
124438461|NCT03310268|447566112|FG000|Overall Study|(Not specified)|1|||
124438462|NCT03310268|447566113|FG001|Overall Study|(Not specified)|5|||
124438463|NCT03310268|447566114|FG002|Overall Study|(Not specified)|0|||
124438464|NCT00706433|447566117|FG000|Overall Study|Lost to Follow-up|3|||
124438465|NCT00706433|447566118|FG001|Overall Study|Lost to Follow-up|1|||
124438466|NCT00706433|447566119|FG002|Overall Study|Lost to Follow-up|6|||
124438467|NCT00706433|447566120|FG003|Overall Study|Lost to Follow-up|0|||
124438468|NCT00706433|447566117|FG000|Overall Study|Withdrawal by Subject|1|||
124681098|NCT04476043|448455671|FG000|Overall Study|Adverse Event|2|||
124681099|NCT04476043|448455672|FG001|Overall Study|Adverse Event|0|||
124438469|NCT00706433|447566118|FG001|Overall Study|Withdrawal by Subject|2|||
124438470|NCT00706433|447566119|FG002|Overall Study|Withdrawal by Subject|3|||
124681100|NCT04476043|448455673|FG002|Overall Study|Adverse Event|1|||
124438471|NCT00706433|447566120|FG003|Overall Study|Withdrawal by Subject|1|||
124438472|NCT00706433|447566117|FG000|Overall Study|Adverse Event|0|||
124438473|NCT00706433|447566118|FG001|Overall Study|Adverse Event|0|||
124438474|NCT00706433|447566119|FG002|Overall Study|Adverse Event|1|||
124438475|NCT00706433|447566120|FG003|Overall Study|Adverse Event|0|||
124438476|NCT00706433|447566117|FG000|Overall Study|Protocol Violation|1|||
124438477|NCT00706433|447566118|FG001|Overall Study|Protocol Violation|0|||
124438478|NCT00706433|447566119|FG002|Overall Study|Protocol Violation|0|||
124438479|NCT00706433|447566120|FG003|Overall Study|Protocol Violation|0|||
124438480|NCT00706433|447566117|FG000|Overall Study|new job|0|||
124438481|NCT00706433|447566118|FG001|Overall Study|new job|0|||
124438482|NCT00706433|447566119|FG002|Overall Study|new job|0|||
124438483|NCT00706433|447566120|FG003|Overall Study|new job|1|||
124438484|NCT00120406|447566123|FG000|Overall Study|Death|9|||
124438485|NCT00120406|447566124|FG001|Overall Study|Death|4|||
124438486|NCT00120406|447566123|FG000|Overall Study|Withdrawal by Subject|5|||
124438487|NCT00120406|447566124|FG001|Overall Study|Withdrawal by Subject|7|||
124438488|NCT00120406|447566123|FG000|Overall Study|Lost to Follow-up|5|||
124438489|NCT00120406|447566124|FG001|Overall Study|Lost to Follow-up|2|||
124438490|NCT00120406|447566123|FG000|Overall Study|received non-study stent|0|||
124438491|NCT00120406|447566124|FG001|Overall Study|received non-study stent|2|||
124438492|NCT00120406|447566123|FG000|Overall Study|patient moved but has not withdrawn|0|||
124438493|NCT00120406|447566124|FG001|Overall Study|patient moved but has not withdrawn|1|||
124438494|NCT02808143|447566125|FG000|Maintenance Phase|Disease recurrence|1|||
124438495|NCT02808143|447566126|FG001|Maintenance Phase|Disease recurrence|3|||
124438496|NCT02808143|447566125|FG000|Maintenance Phase|Disease progression|1|||
124438497|NCT02808143|447566126|FG001|Maintenance Phase|Disease progression|2|||
124438498|NCT02808143|447566125|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
124681101|NCT04476043|448455674|FG003|Overall Study|Adverse Event|0|||
124681102|NCT04476043|448455671|FG000|Overall Study|Protocol Violation|0|||
124681103|NCT04476043|448455672|FG001|Overall Study|Protocol Violation|1|||
124681104|NCT04476043|448455673|FG002|Overall Study|Protocol Violation|0|||
124681105|NCT04476043|448455674|FG003|Overall Study|Protocol Violation|0|||
124681106|NCT02194465|448455677|FG000|Overall Study|Adverse Event|6|||
124681107|NCT02194465|448455678|FG001|Overall Study|Adverse Event|1|||
124681108|NCT02194465|448455679|FG002|Overall Study|Adverse Event|4|||
124681109|NCT02194465|448455680|FG003|Overall Study|Adverse Event|4|||
124681110|NCT02194465|448455681|FG004|Overall Study|Adverse Event|4|||
124681111|NCT02194465|448455682|FG005|Overall Study|Adverse Event|2|||
124681112|NCT02194465|448455683|FG006|Overall Study|Adverse Event|0|||
124681113|NCT02194465|448455677|FG000|Overall Study|Lost to Follow-up|0|||
124681114|NCT02194465|448455678|FG001|Overall Study|Lost to Follow-up|0|||
124681115|NCT02194465|448455679|FG002|Overall Study|Lost to Follow-up|0|||
124681116|NCT02194465|448455680|FG003|Overall Study|Lost to Follow-up|1|||
124681117|NCT02194465|448455681|FG004|Overall Study|Lost to Follow-up|0|||
124681118|NCT02194465|448455682|FG005|Overall Study|Lost to Follow-up|1|||
124681119|NCT02194465|448455683|FG006|Overall Study|Lost to Follow-up|0|||
124681120|NCT02194465|448455677|FG000|Overall Study|Physician Decision|1|||
124681121|NCT02194465|448455678|FG001|Overall Study|Physician Decision|0|||
124681122|NCT02194465|448455679|FG002|Overall Study|Physician Decision|0|||
124681123|NCT02194465|448455680|FG003|Overall Study|Physician Decision|0|||
124681124|NCT02194465|448455681|FG004|Overall Study|Physician Decision|0|||
124681125|NCT02194465|448455682|FG005|Overall Study|Physician Decision|0|||
124681126|NCT02194465|448455683|FG006|Overall Study|Physician Decision|0|||
124681127|NCT02194465|448455677|FG000|Overall Study|Protocol Violation|1|||
124681128|NCT02194465|448455678|FG001|Overall Study|Protocol Violation|1|||
124681129|NCT02194465|448455679|FG002|Overall Study|Protocol Violation|2|||
124681130|NCT02194465|448455680|FG003|Overall Study|Protocol Violation|1|||
124681131|NCT02194465|448455681|FG004|Overall Study|Protocol Violation|1|||
124681132|NCT02194465|448455682|FG005|Overall Study|Protocol Violation|0|||
124681133|NCT02194465|448455683|FG006|Overall Study|Protocol Violation|0|||
124681134|NCT02194465|448455677|FG000|Overall Study|Withdrawal by Subject|1|||
124681135|NCT02194465|448455678|FG001|Overall Study|Withdrawal by Subject|3|||
124681136|NCT02194465|448455679|FG002|Overall Study|Withdrawal by Subject|1|||
124681137|NCT02194465|448455680|FG003|Overall Study|Withdrawal by Subject|2|||
124681138|NCT02194465|448455681|FG004|Overall Study|Withdrawal by Subject|2|||
124681139|NCT02194465|448455682|FG005|Overall Study|Withdrawal by Subject|1|||
124681140|NCT02194465|448455683|FG006|Overall Study|Withdrawal by Subject|2|||
124681141|NCT02194465|448455677|FG000|Overall Study|Discontinued follow-up period|0|||
124681142|NCT02194465|448455678|FG001|Overall Study|Discontinued follow-up period|2|||
124681143|NCT02194465|448455679|FG002|Overall Study|Discontinued follow-up period|1|||
124681144|NCT02194465|448455680|FG003|Overall Study|Discontinued follow-up period|0|||
124681145|NCT02194465|448455681|FG004|Overall Study|Discontinued follow-up period|2|||
124880298|NCT03285295|449185481|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
124880299|NCT03285295|449185482|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
124880300|NCT03285295|449185483|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
124880301|NCT03285295|449185484|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
124880302|NCT03285295|449185485|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
124880303|NCT03285295|449185481|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
124438499|NCT02808143|447566126|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
124438500|NCT02808143|447566125|FG000|Survival Follow-Up|Disease recurrence|0|||
124681146|NCT02194465|448455682|FG005|Overall Study|Discontinued follow-up period|0|||
124681147|NCT02194465|448455683|FG006|Overall Study|Discontinued follow-up period|0|||
124681148|NCT01408641|448455684|FG000|Overall Study|Physician Decision|1|||
124681149|NCT01408641|448455685|FG001|Overall Study|Physician Decision|0|||
124681150|NCT03183908|448455689|FG000|Overall Study|Missing Symptom Diary Data|0|||
124681151|NCT03183908|448455690|FG001|Overall Study|Missing Symptom Diary Data|2|||
124681152|NCT01240746|448455691|FG000|Overall Study|Adverse Event|2|||
124681153|NCT01240746|448455692|FG001|Overall Study|Adverse Event|0|||
124681154|NCT01240746|448455693|FG002|Overall Study|Adverse Event|10|||
124681155|NCT01240746|448455691|FG000|Overall Study|Lost to Follow-up|23|||
124438501|NCT02808143|447566126|FG001|Survival Follow-Up|Disease recurrence|2|||
124681156|NCT01240746|448455692|FG001|Overall Study|Lost to Follow-up|20|||
124681157|NCT01240746|448455693|FG002|Overall Study|Lost to Follow-up|102|||
124681158|NCT01240746|448455691|FG000|Overall Study|Protocol Violation|24|||
124681159|NCT01240746|448455692|FG001|Overall Study|Protocol Violation|15|||
124681160|NCT01240746|448455693|FG002|Overall Study|Protocol Violation|72|||
124681161|NCT01240746|448455691|FG000|Overall Study|Withdrawal by Subject|10|||
124681162|NCT01240746|448455692|FG001|Overall Study|Withdrawal by Subject|13|||
124681163|NCT01240746|448455693|FG002|Overall Study|Withdrawal by Subject|59|||
124681164|NCT03738696|448455694|FG000|Overall Study|Withdrawal by Subject|0|||
124880304|NCT03285295|449185482|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
124880305|NCT03285295|449185483|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
124880306|NCT03285295|449185484|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
124880307|NCT03285295|449185485|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
124880308|NCT03285295|449185481|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
124880309|NCT03285295|449185482|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
124880310|NCT03285295|449185483|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
124880311|NCT03285295|449185484|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
124438502|NCT02808143|447566125|FG000|Survival Follow-Up|Adverse Event|0|||
124681165|NCT03738696|448455695|FG001|Overall Study|Withdrawal by Subject|1|||
124880312|NCT03285295|449185485|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
124880313|NCT03285295|449185481|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
124438503|NCT02808143|447566126|FG001|Survival Follow-Up|Adverse Event|1|||
124438504|NCT02808143|447566125|FG000|Survival Follow-Up|Death|1|||
124438505|NCT02808143|447566126|FG001|Survival Follow-Up|Death|0|||
124438506|NCT04964388|447566127|FG000|Overall Study|Lost to Follow-up|3|||
124438507|NCT04964388|447566128|FG001|Overall Study|Lost to Follow-up|2|||
124438508|NCT00250679|447566129|FG000|Overall Study|Adverse Event|12|||
124438509|NCT00250679|447566130|FG001|Overall Study|Adverse Event|15|||
124438510|NCT00250679|447566131|FG002|Overall Study|Adverse Event|16|||
124438511|NCT00250679|447566129|FG000|Overall Study|Protocol Violation|2|||
124438512|NCT00250679|447566130|FG001|Overall Study|Protocol Violation|4|||
124438513|NCT00250679|447566131|FG002|Overall Study|Protocol Violation|3|||
124438514|NCT00250679|447566129|FG000|Overall Study|Withdrawal by Subject|15|||
124438515|NCT00250679|447566130|FG001|Overall Study|Withdrawal by Subject|18|||
124681166|NCT03738696|448455694|FG000|Overall Study|Lost to Follow-up|8|||
124681167|NCT03738696|448455695|FG001|Overall Study|Lost to Follow-up|14|||
124681168|NCT02566005|448455696|FG000|Overall Study|vaginal bleeding|0|||
124681169|NCT02566005|448455697|FG001|Overall Study|vaginal bleeding|1|||
124681170|NCT02566005|448455696|FG000|Overall Study|received foley|8|||
124681171|NCT02566005|448455697|FG001|Overall Study|received foley|0|||
124880314|NCT03285295|449185482|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
124438516|NCT00250679|447566131|FG002|Overall Study|Withdrawal by Subject|15|||
124438517|NCT00250679|447566129|FG000|Overall Study|Lost to Follow-up|3|||
124438518|NCT00250679|447566130|FG001|Overall Study|Lost to Follow-up|4|||
124438519|NCT00250679|447566131|FG002|Overall Study|Lost to Follow-up|2|||
124438520|NCT00250679|447566129|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
124438521|NCT00250679|447566130|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
124438522|NCT00250679|447566131|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
124438523|NCT00250679|447566129|FG000|Overall Study|Lack of Efficacy|0|||
124438524|NCT00250679|447566130|FG001|Overall Study|Lack of Efficacy|1|||
124438525|NCT00250679|447566131|FG002|Overall Study|Lack of Efficacy|3|||
124438526|NCT00250679|447566129|FG000|Overall Study|Technical Holter issues|1|||
124438527|NCT00250679|447566130|FG001|Overall Study|Technical Holter issues|0|||
124438528|NCT00250679|447566131|FG002|Overall Study|Technical Holter issues|2|||
124438529|NCT00250679|447566129|FG000|Overall Study|Moved|1|||
124438530|NCT00250679|447566130|FG001|Overall Study|Moved|1|||
124438531|NCT00250679|447566131|FG002|Overall Study|Moved|0|||
124438532|NCT00250679|447566129|FG000|Overall Study|Non-compliance|1|||
124438533|NCT00250679|447566130|FG001|Overall Study|Non-compliance|1|||
124438534|NCT00250679|447566131|FG002|Overall Study|Non-compliance|0|||
124438535|NCT00250679|447566129|FG000|Overall Study|various single events: hip surgery,diary|3|||
124438536|NCT00250679|447566130|FG001|Overall Study|various single events: hip surgery,diary|1|||
124438537|NCT00250679|447566131|FG002|Overall Study|various single events: hip surgery,diary|1|||
124438538|NCT03718533|447566133|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
124438539|NCT03718533|447566133|FG000|Overall Study|Protocol deviation|1|||
124438540|NCT03718533|447566133|FG000|Overall Study|Disease progression|1|||
124438541|NCT03718533|447566133|FG000|Overall Study|Relapse|1|||
124438542|NCT03718533|447566133|FG000|Overall Study|Physician Decision|2|||
124438543|NCT03718533|447566133|FG000|Overall Study|Physician Decision and Adverse Event|1|||
124438544|NCT05041101|447566134|FG000|Overall Study|Adverse Event|1|||
124438545|NCT05041101|447566135|FG001|Overall Study|Adverse Event|0|||
124438546|NCT05041101|447566136|FG002|Overall Study|Adverse Event|0|||
124438547|NCT05041101|447566134|FG000|Overall Study|Diease Progression|5|||
124438548|NCT05041101|447566135|FG001|Overall Study|Diease Progression|0|||
124438549|NCT05041101|447566136|FG002|Overall Study|Diease Progression|0|||
124438550|NCT04426851|447566137|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
124438551|NCT04426851|447566138|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
124438552|NCT04426851|447566137|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
124438553|NCT04426851|447566138|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
124438554|NCT01990560|447566139|FG000|Overall Study|Withdrawal by Subject|1|||
124438555|NCT01831856|447566141|FG000|Overall Study|Adverse Event|5|||
124438556|NCT01831856|447566142|FG001|Overall Study|Adverse Event|8|||
124438557|NCT01831856|447566141|FG000|Overall Study|Lack of Efficacy|13|||
124438558|NCT01831856|447566142|FG001|Overall Study|Lack of Efficacy|11|||
124438559|NCT01831856|447566141|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
124438560|NCT01831856|447566142|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
124438561|NCT01498653|447566143|FG000|Overall Study|Adverse Event|2|||
124438562|NCT01498653|447566144|FG001|Overall Study|Adverse Event|2|||
124438563|NCT01498653|447566143|FG000|Overall Study|Lack of Efficacy|12|||
124681172|NCT02566005|448455696|FG000|Overall Study|did not receive foley|0|||
124880315|NCT03285295|449185483|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
124438564|NCT01498653|447566144|FG001|Overall Study|Lack of Efficacy|26|||
124438565|NCT01498653|447566143|FG000|Overall Study|Protocol Violation|0|||
124438566|NCT01498653|447566144|FG001|Overall Study|Protocol Violation|4|||
124438567|NCT01498653|447566143|FG000|Overall Study|Lost to Follow-up|1|||
124438568|NCT01498653|447566144|FG001|Overall Study|Lost to Follow-up|0|||
124438569|NCT01498653|447566143|FG000|Overall Study|Physician Decision|2|||
124438570|NCT01498653|447566144|FG001|Overall Study|Physician Decision|0|||
124438571|NCT01498653|447566143|FG000|Overall Study|Withdrawal by Subject|2|||
124880316|NCT03285295|449185484|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
124438572|NCT01498653|447566144|FG001|Overall Study|Withdrawal by Subject|3|||
124438573|NCT02070588|447566145|FG000|Overall Study|Withdrawal by Subject|29|||
124438574|NCT02070588|447566146|FG001|Overall Study|Withdrawal by Subject|1|||
124438575|NCT02070588|447566147|FG002|Overall Study|Withdrawal by Subject|0|||
124681173|NCT02566005|448455697|FG001|Overall Study|did not receive foley|1|||
124681174|NCT02566005|448455696|FG000|Overall Study|labor after randomization|0|||
124681175|NCT02566005|448455697|FG001|Overall Study|labor after randomization|4|||
124681176|NCT03617588|448455698|FG000|Overall Study|Withdrawal by Subject|1|||
124681177|NCT03617588|448455699|FG001|Overall Study|Withdrawal by Subject|0|||
124681178|NCT01294514|448455700|FG000|Overall Study|Excluded due to Arrhythmia|1|||
124681179|NCT02690727|448455701|FG000|Overall Study|Adverse Event|2|||
124681180|NCT02690727|448455702|FG001|Overall Study|Adverse Event|2|||
124681181|NCT01461551|448455706|FG000|Overall Study|Physician Decision|2|||
124681182|NCT01461551|448455707|FG001|Overall Study|Physician Decision|1|||
124681183|NCT01461551|448455708|FG002|Overall Study|Physician Decision|2|||
124681184|NCT01155141|448455709|FG000|Overall Study|Withdrawal by Subject|1|||
124681185|NCT01155141|448455709|FG000|Overall Study|Screen Failure|1|||
124681186|NCT00303186|448455710|FG000|Overall Study|Other|52|||
124681187|NCT03473197|448455711|FG000|Overall Study|Adverse Event|4|||
124681188|NCT03473197|448455711|FG000|Overall Study|Lost to Follow-up|1|||
124681189|NCT03473197|448455711|FG000|Overall Study|Withdrawal by Subject|5|||
124681190|NCT00785629|448455712|FG000|Overall Study|Adverse Event|2|||
124681191|NCT00785629|448455713|FG001|Overall Study|Adverse Event|1|||
124681192|NCT00785629|448455714|FG002|Overall Study|Adverse Event|1|||
124681193|NCT00785629|448455715|FG003|Overall Study|Adverse Event|5|||
124681194|NCT00785629|448455712|FG000|Overall Study|Protocol Violation|1|||
124681195|NCT00785629|448455713|FG001|Overall Study|Protocol Violation|2|||
124681196|NCT00785629|448455714|FG002|Overall Study|Protocol Violation|4|||
124681197|NCT00785629|448455715|FG003|Overall Study|Protocol Violation|5|||
124681198|NCT00785629|448455712|FG000|Overall Study|administrative decision|5|||
124681199|NCT00785629|448455713|FG001|Overall Study|administrative decision|1|||
124681200|NCT00785629|448455714|FG002|Overall Study|administrative decision|3|||
124438576|NCT02070588|447566145|FG000|Overall Study|Writhdrawal due to early termination|9|||
124438577|NCT02070588|447566146|FG001|Overall Study|Writhdrawal due to early termination|0|||
124438578|NCT02070588|447566147|FG002|Overall Study|Writhdrawal due to early termination|0|||
124438579|NCT02070588|447566145|FG000|Overall Study|Adverse Event|1|||
124438580|NCT02070588|447566146|FG001|Overall Study|Adverse Event|0|||
124438581|NCT02070588|447566147|FG002|Overall Study|Adverse Event|0|||
124438582|NCT01718353|447566151|FG000|Overall Study|Lost to Follow-up|0|||
124438583|NCT01718353|447566152|FG001|Overall Study|Lost to Follow-up|1|||
124438584|NCT01718353|447566151|FG000|Overall Study|Principal Investigator's Decision|10|||
124438585|NCT01718353|447566152|FG001|Overall Study|Principal Investigator's Decision|4|||
124438586|NCT01718353|447566151|FG000|Overall Study|Randomized but not treated|2|||
124438587|NCT01718353|447566152|FG001|Overall Study|Randomized but not treated|0|||
124438588|NCT01078675|447566153|FG000|Overall Study|Withdrawal by Subject|7|||
124438589|NCT01078675|447566154|FG001|Overall Study|Withdrawal by Subject|3|||
124438590|NCT01078675|447566153|FG000|Overall Study|Protocol Violation|56|||
124438591|NCT01078675|447566154|FG001|Overall Study|Protocol Violation|0|||
124438592|NCT01078675|447566153|FG000|Overall Study|Provided in CRF for specific reasons|2|||
124438593|NCT01078675|447566154|FG001|Overall Study|Provided in CRF for specific reasons|3|||
124438594|NCT01078675|447566153|FG000|Overall Study|Adverse Event|3|||
124438595|NCT01078675|447566154|FG001|Overall Study|Adverse Event|0|||
124438596|NCT01959334|447566160|FG000|Second Dose|Adverse Event|1|||
124438597|NCT01959334|447566161|FG001|Second Dose|Adverse Event|0|||
124438598|NCT01959334|447566160|FG000|Third Dose|Adverse Event|0|||
124438599|NCT01959334|447566161|FG001|Third Dose|Adverse Event|1|||
124681201|NCT00785629|448455715|FG003|Overall Study|administrative decision|4|||
124438600|NCT00731120|447566164|FG000|Overall Study|Adverse Event|7|||
124681202|NCT00785629|448455712|FG000|Overall Study|Withdrawal by Subject|0|||
124681203|NCT00785629|448455713|FG001|Overall Study|Withdrawal by Subject|1|||
124681204|NCT00785629|448455714|FG002|Overall Study|Withdrawal by Subject|2|||
124681205|NCT00785629|448455715|FG003|Overall Study|Withdrawal by Subject|2|||
124681206|NCT00851591|448455718|FG000|Overall Study|Withdrawal by Subject|2|||
124438601|NCT00731120|447566165|FG001|Overall Study|Adverse Event|6|||
124438602|NCT00731120|447566166|FG002|Overall Study|Adverse Event|8|||
124438603|NCT00731120|447566164|FG000|Overall Study|Lack of Efficacy|4|||
124438604|NCT00731120|447566165|FG001|Overall Study|Lack of Efficacy|5|||
124681207|NCT00851591|448455719|FG001|Overall Study|Withdrawal by Subject|0|||
124681208|NCT02326883|448455721|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
124681209|NCT02326883|448455722|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
124681210|NCT02326883|448455723|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
124681211|NCT02736617|448455724|FG000|Treatment|Adverse Event|1|||
124681212|NCT02736617|448455724|FG000|Treatment|Lack of Efficacy|1|||
124438605|NCT00731120|447566166|FG002|Overall Study|Lack of Efficacy|4|||
124438606|NCT00731120|447566164|FG000|Overall Study|Noncompliance with Study Drug|3|||
124438607|NCT00731120|447566165|FG001|Overall Study|Noncompliance with Study Drug|3|||
124438608|NCT00731120|447566166|FG002|Overall Study|Noncompliance with Study Drug|1|||
124438609|NCT00731120|447566164|FG000|Overall Study|Protocol Deviations|1|||
124438610|NCT00731120|447566165|FG001|Overall Study|Protocol Deviations|6|||
124438611|NCT00731120|447566166|FG002|Overall Study|Protocol Deviations|1|||
124438612|NCT00731120|447566164|FG000|Overall Study|Withdrawal of Consent|13|||
124438613|NCT00731120|447566165|FG001|Overall Study|Withdrawal of Consent|8|||
124681213|NCT02736617|448455724|FG000|Treatment|Withdrawal by Subject|1|||
124681214|NCT02736617|448455724|FG000|Maintenance|Lack of Efficacy|4|||
124681215|NCT02736617|448455724|FG000|Maintenance|Physician Decision|1|||
124681216|NCT02911116|448455727|FG000|Overall Study|Insufficient Therapeutic Response|1|||
124681217|NCT02911116|448455728|FG001|Overall Study|Insufficient Therapeutic Response|0|||
124681218|NCT02911116|448455727|FG000|Overall Study|Lost to Follow-up|0|||
124681219|NCT02911116|448455728|FG001|Overall Study|Lost to Follow-up|1|||
124681220|NCT04796415|448455729|FG000|Overall Study|not interested|12|||
124681221|NCT04796415|448455729|FG000|Overall Study|health issue|8|||
124880317|NCT03285295|449185485|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
124438614|NCT00731120|447566166|FG002|Overall Study|Withdrawal of Consent|4|||
124438615|NCT00731120|447566164|FG000|Overall Study|Lost to Follow-up|10|||
124681222|NCT04796415|448455729|FG000|Overall Study|Other|4|||
124681223|NCT04796415|448455729|FG000|Overall Study|discharged from home health service|3|||
124681224|NCT04796415|448455729|FG000|Overall Study|re-hospitalization|2|||
124681225|NCT04796415|448455729|FG000|Overall Study|moving to nursing home|1|||
124681226|NCT04796415|448455729|FG000|Overall Study|lost contact|1|||
124681227|NCT02469857|448455730|FG000|Overall Study|Death|24|||
124681228|NCT02469857|448455731|FG001|Overall Study|Death|29|||
124438616|NCT00731120|447566165|FG001|Overall Study|Lost to Follow-up|15|||
124438617|NCT00731120|447566166|FG002|Overall Study|Lost to Follow-up|17|||
124438618|NCT00731120|447566164|FG000|Overall Study|Other|4|||
124438619|NCT00731120|447566165|FG001|Overall Study|Other|0|||
124438620|NCT00731120|447566166|FG002|Overall Study|Other|1|||
124438621|NCT01551212|447566167|FG000|Overall Study|Graft loss/Retransplantation|0|||
124438622|NCT01551212|447566168|FG001|Overall Study|Graft loss/Retransplantation|1|||
124438623|NCT01551212|447566167|FG000|Overall Study|Administrative problems|1|||
124438624|NCT01551212|447566168|FG001|Overall Study|Administrative problems|2|||
124438625|NCT01551212|447566167|FG000|Overall Study|Lost to Follow-up|0|||
124438626|NCT01551212|447566168|FG001|Overall Study|Lost to Follow-up|1|||
124438627|NCT01551212|447566167|FG000|Overall Study|Protocol Violation|0|||
124438628|NCT01551212|447566168|FG001|Overall Study|Protocol Violation|1|||
124438629|NCT01551212|447566167|FG000|Overall Study|Withdrawal by Subject|0|||
124438630|NCT01551212|447566168|FG001|Overall Study|Withdrawal by Subject|7|||
124438631|NCT01551212|447566167|FG000|Overall Study|Death|2|||
124438632|NCT01551212|447566168|FG001|Overall Study|Death|4|||
124438633|NCT01551212|447566167|FG000|Overall Study|Never Received Study Treatment|2|||
124681229|NCT02469857|448455730|FG000|Overall Study|Discontinuation|1|||
124681230|NCT02469857|448455731|FG001|Overall Study|Discontinuation|3|||
124681231|NCT02110693|448455732|FG000|Overall Study|Withdrawal by Subject|6|||
124681232|NCT02110693|448455733|FG001|Overall Study|Withdrawal by Subject|7|||
124681233|NCT02110693|448455732|FG000|Overall Study|skipped assessment|15|||
124681234|NCT02110693|448455733|FG001|Overall Study|skipped assessment|18|||
124681235|NCT02110693|448455732|FG000|Overall Study|technical difficulties|6|||
124681236|NCT02110693|448455733|FG001|Overall Study|technical difficulties|4|||
124681237|NCT02110693|448455732|FG000|Overall Study|Other|1|||
124681238|NCT02110693|448455733|FG001|Overall Study|Other|0|||
124681239|NCT00937950|448455734|FG000|Overall Study|Withdrawal by Subject|23|||
124681240|NCT00937950|448455734|FG000|Overall Study|Migrated/moved from study area|27|||
124681241|NCT00937950|448455734|FG000|Overall Study|Lost to Follow-up|144|||
124681242|NCT00937950|448455734|FG000|Overall Study|Missing confirmed|4|||
124681243|NCT00937950|448455734|FG000|Overall Study|Other|18|||
124681244|NCT00630292|448455735|FG000|Overall Study|Withdrawal by Subject|1|||
124438634|NCT01551212|447566168|FG001|Overall Study|Never Received Study Treatment|4|||
124438635|NCT00710021|447566169|FG000|Overall Study|Lost to Follow-up|1|||
124438636|NCT00710021|447566170|FG001|Overall Study|Lost to Follow-up|0|||
124438637|NCT00710021|447566171|FG002|Overall Study|Lost to Follow-up|0|||
124438638|NCT00710021|447566169|FG000|Overall Study|Subject's Decision|0|||
124438639|NCT00710021|447566170|FG001|Overall Study|Subject's Decision|1|||
124438640|NCT00710021|447566171|FG002|Overall Study|Subject's Decision|0|||
124681245|NCT00142415|448455736|FG000|Overall Study|Physician Decision|0|||
124681246|NCT00142415|448455737|FG001|Overall Study|Physician Decision|0|||
124681247|NCT00142415|448455738|FG002|Overall Study|Physician Decision|0|||
124681248|NCT00142415|448455739|FG003|Overall Study|Physician Decision|0|||
124681249|NCT00142415|448455740|FG004|Overall Study|Physician Decision|1|||
124681250|NCT00142415|448455741|FG005|Overall Study|Physician Decision|2|||
124681251|NCT00537277|448455742|FG000|Overall Study|Adverse Event|1|||
124681252|NCT00537277|448455742|FG000|Overall Study|Lack of Efficacy|2|||
124438641|NCT00710021|447566169|FG000|Overall Study|Subject misrandomized|0|||
124681253|NCT00537277|448455742|FG000|Overall Study|Lost to Follow-up|12|||
124681254|NCT00537277|448455742|FG000|Overall Study|Protocol Violation|11|||
124880318|NCT03285295|449185481|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
124880319|NCT03285295|449185482|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
124681255|NCT00537277|448455742|FG000|Overall Study|Unclassified|4|||
124681256|NCT00537277|448455742|FG000|Overall Study|Inability to tolerate trial medication|4|||
124681257|NCT00537277|448455742|FG000|Overall Study|Non-compliance with trial procedures|15|||
124681258|NCT03620162|448455743|FG000|Overall Study|Physician Decision|4|||
124681259|NCT03620162|448455744|FG001|Overall Study|Physician Decision|0|||
124681260|NCT03620162|448455745|FG002|Overall Study|Physician Decision|1|||
124681261|NCT03620162|448455746|FG003|Overall Study|Physician Decision|0|||
124681262|NCT03620162|448455747|FG004|Overall Study|Physician Decision|2|||
124681263|NCT03620162|448455743|FG000|Overall Study|Lost to Follow-up|2|||
124681264|NCT03620162|448455744|FG001|Overall Study|Lost to Follow-up|6|||
124681265|NCT03620162|448455745|FG002|Overall Study|Lost to Follow-up|7|||
124681266|NCT03620162|448455746|FG003|Overall Study|Lost to Follow-up|3|||
124681267|NCT03620162|448455747|FG004|Overall Study|Lost to Follow-up|2|||
124681268|NCT03620162|448455743|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
124681269|NCT03620162|448455744|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
124681270|NCT03620162|448455745|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
124681271|NCT03620162|448455746|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
124681272|NCT03620162|448455747|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
124681273|NCT01838876|448455750|FG000|Overall Study|Adverse Event|49|||
124681274|NCT01838876|448455750|FG000|Overall Study|Insufficient Therapeutic Response|10|||
124681275|NCT01838876|448455750|FG000|Overall Study|Protocol Violation|34|||
124681276|NCT01838876|448455750|FG000|Overall Study|Withdrawal of Consent|33|||
124681277|NCT01838876|448455750|FG000|Overall Study|Lost to Follow-up|21|||
124681278|NCT01838876|448455750|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
124681279|NCT01838876|448455750|FG000|Overall Study|Reason not Specified|7|||
124681280|NCT01838876|448455750|FG000|Overall Study|Did not meet eligibility criteria|78|||
124681281|NCT02101294|448455751|FG000|Overall Study|Withdrawal by Subject|5|||
124681282|NCT02101294|448455751|FG000|Overall Study|Lost to Follow-up|6|||
124681283|NCT03416179|448455752|FG000|Overall Study|Death|90|||
124681284|NCT03416179|448455753|FG001|Overall Study|Death|87|||
124681285|NCT03416179|448455754|FG002|Overall Study|Death|117|||
124681286|NCT03416179|448455755|FG003|Overall Study|Death|113|||
124681287|NCT03416179|448455752|FG000|Overall Study|Withdrawal by Subject|15|||
124681288|NCT03416179|448455753|FG001|Overall Study|Withdrawal by Subject|20|||
124681289|NCT03416179|448455754|FG002|Overall Study|Withdrawal by Subject|6|||
124681290|NCT03416179|448455755|FG003|Overall Study|Withdrawal by Subject|9|||
124681291|NCT03416179|448455752|FG000|Overall Study|Lost to Follow-up|1|||
124681292|NCT03416179|448455753|FG001|Overall Study|Lost to Follow-up|1|||
124681293|NCT03416179|448455754|FG002|Overall Study|Lost to Follow-up|0|||
124681294|NCT03416179|448455755|FG003|Overall Study|Lost to Follow-up|3|||
124681295|NCT03416179|448455752|FG000|Overall Study|Study participation terminated by Sponsor|93|||
124681296|NCT03416179|448455753|FG001|Overall Study|Study participation terminated by Sponsor|91|||
124681297|NCT03416179|448455754|FG002|Overall Study|Study participation terminated by Sponsor|26|||
124681298|NCT03416179|448455755|FG003|Overall Study|Study participation terminated by Sponsor|31|||
124681299|NCT03416179|448455752|FG000|Overall Study|Other|2|||
124681300|NCT03416179|448455753|FG001|Overall Study|Other|3|||
124681301|NCT03416179|448455754|FG002|Overall Study|Other|1|||
124681302|NCT03416179|448455755|FG003|Overall Study|Other|0|||
124681303|NCT01056536|448455762|FG000|Overall Study|Lost to Follow-up|202|||
124681304|NCT01056536|448455763|FG001|Overall Study|Lost to Follow-up|116|||
124681305|NCT01056536|448455764|FG002|Overall Study|Lost to Follow-up|248|||
124681306|NCT01933594|448455771|FG000|Overall Study|Lost to Follow-up|1|||
124681307|NCT01933594|448455772|FG001|Overall Study|Lost to Follow-up|0|||
124681308|NCT01933594|448455773|FG002|Overall Study|Lost to Follow-up|0|||
124681309|NCT01933594|448455774|FG003|Overall Study|Lost to Follow-up|0|||
124681310|NCT01933594|448455775|FG004|Overall Study|Lost to Follow-up|1|||
124681311|NCT01933594|448455776|FG005|Overall Study|Lost to Follow-up|0|||
124681312|NCT01933594|448455771|FG000|Overall Study|Ineligible for subsequent study step|0|||
124681313|NCT01933594|448455772|FG001|Overall Study|Ineligible for subsequent study step|0|||
124681314|NCT01933594|448455773|FG002|Overall Study|Ineligible for subsequent study step|0|||
124681315|NCT01933594|448455774|FG003|Overall Study|Ineligible for subsequent study step|0|||
124681316|NCT01933594|448455775|FG004|Overall Study|Ineligible for subsequent study step|1|||
124681317|NCT01933594|448455776|FG005|Overall Study|Ineligible for subsequent study step|0|||
124681318|NCT00315445|448455777|FG000|Overall Study|Adverse Event|7|||
124681319|NCT00315445|448455778|FG001|Overall Study|Adverse Event|12|||
124681320|NCT00315445|448455779|FG002|Overall Study|Adverse Event|15|||
124681321|NCT00315445|448455777|FG000|Overall Study|Lack of Efficacy|16|||
124681322|NCT00315445|448455778|FG001|Overall Study|Lack of Efficacy|1|||
124681323|NCT00315445|448455779|FG002|Overall Study|Lack of Efficacy|7|||
124681324|NCT00315445|448455777|FG000|Overall Study|Lost to Follow-up|1|||
124681325|NCT00315445|448455778|FG001|Overall Study|Lost to Follow-up|0|||
124681326|NCT00315445|448455779|FG002|Overall Study|Lost to Follow-up|1|||
124681327|NCT00315445|448455777|FG000|Overall Study|Protocol Violation|2|||
124438642|NCT00710021|447566170|FG001|Overall Study|Subject misrandomized|1|||
124438643|NCT00710021|447566171|FG002|Overall Study|Subject misrandomized|1|||
124438644|NCT00710021|447566169|FG000|Overall Study|Physician Decision|0|||
124438645|NCT00710021|447566170|FG001|Overall Study|Physician Decision|1|||
124438646|NCT00710021|447566171|FG002|Overall Study|Physician Decision|0|||
124438647|NCT00423930|447566177|FG000|Overall Study|Withdrawal by Subject|2|||
124438648|NCT04002401|447566178|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
124438649|NCT04002401|447566178|FG000|Overall Study|Death|10|||
124438650|NCT04002401|447566178|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
124438651|NCT04002401|447566178|FG000|Overall Study|Enrolled but Never Treated|1|||
124438652|NCT04002401|447566178|FG000|Overall Study|Lost to Follow-up|1|||
124438653|NCT01315353|447566182|FG000|Overall Study|Death|2|||
124681328|NCT00315445|448455778|FG001|Overall Study|Protocol Violation|0|||
124681329|NCT00315445|448455779|FG002|Overall Study|Protocol Violation|1|||
124681330|NCT00315445|448455777|FG000|Overall Study|Other|1|||
124681331|NCT00315445|448455778|FG001|Overall Study|Other|3|||
124681332|NCT00315445|448455779|FG002|Overall Study|Other|0|||
124681333|NCT01035138|448455780|FG000|Overall Study|Adverse Event|4|||
124681334|NCT01035138|448455781|FG001|Overall Study|Adverse Event|0|||
124681335|NCT01035138|448455782|FG002|Overall Study|Adverse Event|2|||
124681336|NCT01035138|448455780|FG000|Overall Study|Caregiver Decision|2|||
124681337|NCT01035138|448455781|FG001|Overall Study|Caregiver Decision|0|||
124681338|NCT01035138|448455782|FG002|Overall Study|Caregiver Decision|1|||
124681339|NCT01035138|448455780|FG000|Overall Study|Withdrawal by Subject|1|||
124681340|NCT01035138|448455781|FG001|Overall Study|Withdrawal by Subject|0|||
124681341|NCT01035138|448455782|FG002|Overall Study|Withdrawal by Subject|0|||
124681342|NCT01035138|448455780|FG000|Overall Study|Physician Decision|0|||
124681343|NCT01035138|448455781|FG001|Overall Study|Physician Decision|0|||
124681344|NCT01035138|448455782|FG002|Overall Study|Physician Decision|1|||
124681345|NCT01035138|448455780|FG000|Overall Study|Sponsor Decision|66|||
124681346|NCT01035138|448455781|FG001|Overall Study|Sponsor Decision|60|||
124681347|NCT01035138|448455782|FG002|Overall Study|Sponsor Decision|42|||
124681348|NCT01035138|448455780|FG000|Overall Study|Lost to Follow-up|0|||
124681349|NCT01035138|448455781|FG001|Overall Study|Lost to Follow-up|0|||
124681350|NCT01035138|448455782|FG002|Overall Study|Lost to Follow-up|1|||
124681351|NCT01811238|448455783|FG000|Overall Study|Withdrawal by Subject|42|||
124681352|NCT01811238|448455783|FG000|Overall Study|Adverse Event|25|||
124681353|NCT01811238|448455783|FG000|Overall Study|Protocol Violation|4|||
124681354|NCT01811238|448455783|FG000|Overall Study|Lack of Efficacy|4|||
124681355|NCT01811238|448455783|FG000|Overall Study|subject refused study medication|6|||
124681356|NCT02164916|448455786|FG000|Overall Study|Adverse Event|3|||
124681357|NCT02164916|448455787|FG001|Overall Study|Adverse Event|8|||
124681358|NCT02164916|448455786|FG000|Overall Study|Death|1|||
124681359|NCT02164916|448455787|FG001|Overall Study|Death|1|||
124681360|NCT02164916|448455786|FG000|Overall Study|Refusal unrelated to adverse event|3|||
124681361|NCT02164916|448455787|FG001|Overall Study|Refusal unrelated to adverse event|7|||
124681362|NCT02164916|448455786|FG000|Overall Study|Progression|37|||
124681363|NCT02164916|448455787|FG001|Overall Study|Progression|26|||
124681364|NCT02164916|448455786|FG000|Overall Study|Not protocol specified|5|||
124681365|NCT02164916|448455787|FG001|Overall Study|Not protocol specified|1|||
124681366|NCT02164916|448455786|FG000|Overall Study|Reason under review|1|||
124681367|NCT02164916|448455787|FG001|Overall Study|Reason under review|6|||
124681368|NCT02164916|448455786|FG000|Overall Study|Not eligible|2|||
124681369|NCT02164916|448455787|FG001|Overall Study|Not eligible|5|||
124681370|NCT02916927|448455790|FG000|Overall Study|Discharged prior to study drug receipt|0|||
124681371|NCT02916927|448455791|FG001|Overall Study|Discharged prior to study drug receipt|2|||
124681372|NCT02916927|448455790|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
124681373|NCT02916927|448455791|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
124681374|NCT02916927|448455790|FG000|Overall Study|Withdrawal before first time point|1|||
124681375|NCT02916927|448455791|FG001|Overall Study|Withdrawal before first time point|0|||
124681376|NCT00655889|448455796|FG000|Overall Study|Inadequate cell growth|1|||
124681377|NCT00655889|448455796|FG000|Overall Study|Protocol Violation|1|||
124681378|NCT02318940|448455797|FG000|Overall Study|lost the record|1|||
124681379|NCT02318940|448455798|FG001|Overall Study|lost the record|0|||
124681380|NCT03454555|448457796|FG000|Overall Study|Death|6|||
124681381|NCT03454555|448457797|FG001|Overall Study|Death|6|||
124438654|NCT01315353|447566183|FG001|Overall Study|Death|1|||
124438655|NCT01315353|447566184|FG002|Overall Study|Death|0|||
124681382|NCT03454555|448457796|FG000|Overall Study|Lost to Follow-up|31|||
124681383|NCT03454555|448457797|FG001|Overall Study|Lost to Follow-up|12|||
124681384|NCT03454555|448457796|FG000|Overall Study|Physician Decision|2|||
124681385|NCT03454555|448457797|FG001|Overall Study|Physician Decision|6|||
124681386|NCT03454555|448457796|FG000|Overall Study|Withdrawal by Subject|34|||
124681387|NCT03454555|448457797|FG001|Overall Study|Withdrawal by Subject|5|||
124438656|NCT01315353|447566182|FG000|Overall Study|Withdrawal by Subject|2|||
124681388|NCT03454555|448457796|FG000|Overall Study|Ineligible|1|||
124681389|NCT03454555|448457797|FG001|Overall Study|Ineligible|5|||
124681390|NCT05399680|448457798|FG000|Overall Study|Lost to Follow-up|1|||
124681391|NCT05399680|448457799|FG001|Overall Study|Lost to Follow-up|0|||
124681392|NCT05399680|448457798|FG000|Overall Study|Death|0|||
124681393|NCT05399680|448457799|FG001|Overall Study|Death|1|||
124681394|NCT04530630|448457800|FG000|Overall Study|Physician Decision|1|||
124681395|NCT03675308|448457803|FG000|Overall Study|Adverse Event|3|||
124681396|NCT03675308|448457804|FG001|Overall Study|Adverse Event|2|||
124681397|NCT03675308|448457803|FG000|Overall Study|Withdrawal by Subject|6|||
124681398|NCT03675308|448457804|FG001|Overall Study|Withdrawal by Subject|4|||
124681399|NCT03675308|448457803|FG000|Overall Study|Lost to Follow-up|3|||
124681400|NCT03675308|448457804|FG001|Overall Study|Lost to Follow-up|0|||
124681401|NCT03675308|448457803|FG000|Overall Study|Lack of Efficacy|1|||
124681402|NCT03675308|448457804|FG001|Overall Study|Lack of Efficacy|1|||
124681403|NCT03675308|448457803|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
124681404|NCT03675308|448457804|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
124681405|NCT03675308|448457803|FG000|Overall Study|Other|0|||
124681406|NCT03675308|448457804|FG001|Overall Study|Other|1|||
124681407|NCT01386385|448457807|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
124681408|NCT01386385|448457808|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
124681409|NCT01386385|448457809|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
124681410|NCT01386385|448457810|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
124681411|NCT01386385|448457811|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
124681412|NCT01386385|448457812|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
124681413|NCT01386385|448457813|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
124681414|NCT01386385|448457814|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
124681415|NCT01386385|448457807|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
124681416|NCT01386385|448457808|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
124681417|NCT01386385|448457809|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
124681418|NCT01386385|448457810|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
124681419|NCT01386385|448457811|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
124681420|NCT01386385|448457812|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
124681421|NCT01386385|448457813|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
124681422|NCT01386385|448457814|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
124681423|NCT01386385|448457807|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
124681424|NCT01386385|448457808|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
124681425|NCT01386385|448457809|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
124681426|NCT01386385|448457810|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
124681427|NCT01386385|448457811|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
124681428|NCT01386385|448457812|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
124681429|NCT01386385|448457813|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
124681430|NCT01386385|448457814|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
124681431|NCT01386385|448457807|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
124681432|NCT01386385|448457808|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
124681433|NCT01386385|448457809|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
124681434|NCT01386385|448457810|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
124681435|NCT01386385|448457811|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
124681436|NCT01386385|448457812|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
124681437|NCT01386385|448457813|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
124681438|NCT01386385|448457814|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
124681439|NCT01386385|448457807|FG000|Phase II Concurrent CRT|Adverse Event|0|||
124681440|NCT01386385|448457808|FG001|Phase II Concurrent CRT|Adverse Event|0|||
124681441|NCT01386385|448457809|FG002|Phase II Concurrent CRT|Adverse Event|0|||
124681442|NCT01386385|448457810|FG003|Phase II Concurrent CRT|Adverse Event|0|||
124681443|NCT01386385|448457811|FG004|Phase II Concurrent CRT|Adverse Event|0|||
124681444|NCT01386385|448457812|FG005|Phase II Concurrent CRT|Adverse Event|0|||
124681445|NCT01386385|448457813|FG006|Phase II Concurrent CRT|Adverse Event|3|||
124681446|NCT01386385|448457814|FG007|Phase II Concurrent CRT|Adverse Event|3|||
124681447|NCT01386385|448457807|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
124681448|NCT01386385|448457808|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
124681449|NCT01386385|448457809|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
124681450|NCT01386385|448457810|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
124681451|NCT01386385|448457811|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
124681452|NCT01386385|448457812|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
124681453|NCT01386385|448457813|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
124681454|NCT01386385|448457814|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
124681455|NCT01386385|448457807|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
124681456|NCT01386385|448457808|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
124681457|NCT01386385|448457809|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
124681458|NCT01386385|448457810|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
124681459|NCT01386385|448457811|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
124681460|NCT01386385|448457812|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
124681461|NCT01386385|448457813|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
124681462|NCT01386385|448457814|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
124681463|NCT01386385|448457807|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
124681464|NCT01386385|448457808|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
124681465|NCT01386385|448457809|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
124681466|NCT01386385|448457810|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
124681467|NCT01386385|448457811|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
124681468|NCT01386385|448457812|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
124681469|NCT01386385|448457813|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
124681470|NCT01386385|448457814|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
124681471|NCT01386385|448457807|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
124681472|NCT01386385|448457808|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
124681473|NCT01386385|448457809|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
124681474|NCT01386385|448457810|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
124681475|NCT01386385|448457811|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
124681476|NCT01386385|448457812|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
124681477|NCT01386385|448457813|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
124681478|NCT01386385|448457814|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
124681479|NCT03737994|448457816|FG000|Overall Study|Withdrawal by Subject|0|||
124681480|NCT03737994|448457817|FG001|Overall Study|Withdrawal by Subject|0|||
124681481|NCT03737994|448457818|FG002|Overall Study|Withdrawal by Subject|0|||
124681482|NCT03737994|448457819|FG003|Overall Study|Withdrawal by Subject|0|||
124681483|NCT03737994|448457820|FG004|Overall Study|Withdrawal by Subject|0|||
124681484|NCT03737994|448457821|FG005|Overall Study|Withdrawal by Subject|0|||
124681485|NCT03737994|448457822|FG006|Overall Study|Withdrawal by Subject|1|||
124681486|NCT02332707|448457823|FG000|Overall Study|Adverse Event|0|||
124681487|NCT02332707|448457824|FG001|Overall Study|Adverse Event|0|||
124681488|NCT02332707|448457825|FG002|Overall Study|Adverse Event|0|||
124681489|NCT02332707|448457826|FG003|Overall Study|Adverse Event|0|||
124681490|NCT02332707|448457827|FG004|Overall Study|Adverse Event|0|||
124681491|NCT02332707|448457828|FG005|Overall Study|Adverse Event|0|||
124681492|NCT02332707|448457829|FG006|Overall Study|Adverse Event|0|||
124681493|NCT02332707|448457830|FG007|Overall Study|Adverse Event|0|||
124681494|NCT02332707|448457831|FG008|Overall Study|Adverse Event|0|||
124681495|NCT02332707|448457832|FG009|Overall Study|Adverse Event|0|||
124681496|NCT02332707|448457833|FG010|Overall Study|Adverse Event|0|||
124681497|NCT02332707|448457834|FG011|Overall Study|Adverse Event|0|||
124681498|NCT02332707|448457835|FG012|Overall Study|Adverse Event|1|||
124681499|NCT02332707|448457836|FG013|Overall Study|Adverse Event|0|||
124681500|NCT02332707|448457837|FG014|Overall Study|Adverse Event|0|||
124681501|NCT02332707|448457838|FG015|Overall Study|Adverse Event|0|||
124681502|NCT02332707|448457839|FG016|Overall Study|Adverse Event|0|||
124681503|NCT02332707|448457840|FG017|Overall Study|Adverse Event|0|||
124681504|NCT02332707|448457823|FG000|Overall Study|Lost to Follow-up|0|||
124681505|NCT02332707|448457824|FG001|Overall Study|Lost to Follow-up|0|||
124681506|NCT02332707|448457825|FG002|Overall Study|Lost to Follow-up|0|||
124681507|NCT02332707|448457826|FG003|Overall Study|Lost to Follow-up|0|||
124681508|NCT02332707|448457827|FG004|Overall Study|Lost to Follow-up|0|||
124681509|NCT02332707|448457828|FG005|Overall Study|Lost to Follow-up|1|||
124681510|NCT02332707|448457829|FG006|Overall Study|Lost to Follow-up|0|||
124681511|NCT02332707|448457830|FG007|Overall Study|Lost to Follow-up|0|||
124681512|NCT02332707|448457831|FG008|Overall Study|Lost to Follow-up|0|||
124681513|NCT02332707|448457832|FG009|Overall Study|Lost to Follow-up|0|||
124681514|NCT02332707|448457833|FG010|Overall Study|Lost to Follow-up|2|||
124681515|NCT02332707|448457834|FG011|Overall Study|Lost to Follow-up|0|||
124681516|NCT02332707|448457835|FG012|Overall Study|Lost to Follow-up|3|||
124681517|NCT02332707|448457836|FG013|Overall Study|Lost to Follow-up|0|||
124681518|NCT02332707|448457837|FG014|Overall Study|Lost to Follow-up|0|||
124681519|NCT02332707|448457838|FG015|Overall Study|Lost to Follow-up|0|||
124681520|NCT02332707|448457839|FG016|Overall Study|Lost to Follow-up|0|||
124681521|NCT02332707|448457840|FG017|Overall Study|Lost to Follow-up|0|||
124681522|NCT02332707|448457823|FG000|Overall Study|Physician Decision|0|||
124681523|NCT02332707|448457824|FG001|Overall Study|Physician Decision|0|||
124681524|NCT02332707|448457825|FG002|Overall Study|Physician Decision|0|||
124681525|NCT02332707|448457826|FG003|Overall Study|Physician Decision|1|||
124681526|NCT02332707|448457827|FG004|Overall Study|Physician Decision|0|||
124681527|NCT02332707|448457828|FG005|Overall Study|Physician Decision|0|||
124681528|NCT02332707|448457829|FG006|Overall Study|Physician Decision|0|||
124681529|NCT02332707|448457830|FG007|Overall Study|Physician Decision|0|||
124681530|NCT02332707|448457831|FG008|Overall Study|Physician Decision|0|||
124681531|NCT02332707|448457832|FG009|Overall Study|Physician Decision|0|||
124681532|NCT02332707|448457833|FG010|Overall Study|Physician Decision|0|||
124681533|NCT02332707|448457834|FG011|Overall Study|Physician Decision|0|||
124681534|NCT02332707|448457835|FG012|Overall Study|Physician Decision|1|||
124681535|NCT02332707|448457836|FG013|Overall Study|Physician Decision|0|||
124681536|NCT02332707|448457837|FG014|Overall Study|Physician Decision|0|||
124681537|NCT02332707|448457838|FG015|Overall Study|Physician Decision|0|||
124681538|NCT02332707|448457839|FG016|Overall Study|Physician Decision|0|||
124681539|NCT02332707|448457840|FG017|Overall Study|Physician Decision|0|||
124681540|NCT02332707|448457823|FG000|Overall Study|Withdrawal by Subject|0|||
124681541|NCT02332707|448457824|FG001|Overall Study|Withdrawal by Subject|0|||
124681542|NCT02332707|448457825|FG002|Overall Study|Withdrawal by Subject|1|||
124681543|NCT02332707|448457826|FG003|Overall Study|Withdrawal by Subject|0|||
124681544|NCT02332707|448457827|FG004|Overall Study|Withdrawal by Subject|0|||
124681545|NCT02332707|448457828|FG005|Overall Study|Withdrawal by Subject|0|||
124681546|NCT02332707|448457829|FG006|Overall Study|Withdrawal by Subject|0|||
124681547|NCT02332707|448457830|FG007|Overall Study|Withdrawal by Subject|0|||
124681548|NCT02332707|448457831|FG008|Overall Study|Withdrawal by Subject|0|||
124681549|NCT02332707|448457832|FG009|Overall Study|Withdrawal by Subject|3|||
124681550|NCT02332707|448457833|FG010|Overall Study|Withdrawal by Subject|0|||
124681551|NCT02332707|448457834|FG011|Overall Study|Withdrawal by Subject|0|||
124681552|NCT02332707|448457835|FG012|Overall Study|Withdrawal by Subject|0|||
124681553|NCT02332707|448457836|FG013|Overall Study|Withdrawal by Subject|0|||
124681554|NCT02332707|448457837|FG014|Overall Study|Withdrawal by Subject|0|||
124681555|NCT02332707|448457838|FG015|Overall Study|Withdrawal by Subject|0|||
124681556|NCT02332707|448457839|FG016|Overall Study|Withdrawal by Subject|0|||
124681557|NCT02332707|448457840|FG017|Overall Study|Withdrawal by Subject|0|||
124681558|NCT01473134|448457841|FG000|Overall Study|Lost to Follow-up|21|||
124681559|NCT01473134|448457842|FG001|Overall Study|Lost to Follow-up|13|||
124681560|NCT01473134|448457841|FG000|Overall Study|Protocol Violation|32|||
124681561|NCT01473134|448457842|FG001|Overall Study|Protocol Violation|19|||
124681562|NCT01473134|448457841|FG000|Overall Study|Withdrawal by Subject|1|||
124681563|NCT01473134|448457842|FG001|Overall Study|Withdrawal by Subject|2|||
124681564|NCT01473134|448457841|FG000|Overall Study|Death|0|||
124681565|NCT01473134|448457842|FG001|Overall Study|Death|1|||
124681566|NCT01473134|448457841|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
124681567|NCT01473134|448457842|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
124681568|NCT04761822|448457843|FG000|Overall Study|Adverse Event|3|||
124681569|NCT04761822|448457844|FG001|Overall Study|Adverse Event|1|||
124681570|NCT04761822|448457845|FG002|Overall Study|Adverse Event|1|||
124681571|NCT04761822|448457846|FG003|Overall Study|Adverse Event|3|||
124681572|NCT04761822|448457843|FG000|Overall Study|Lost to Follow-up|1|||
124681573|NCT04761822|448457844|FG001|Overall Study|Lost to Follow-up|0|||
124681574|NCT04761822|448457845|FG002|Overall Study|Lost to Follow-up|2|||
124681575|NCT04761822|448457846|FG003|Overall Study|Lost to Follow-up|3|||
124681576|NCT04761822|448457843|FG000|Overall Study|Physician Decision|0|||
124681577|NCT04761822|448457844|FG001|Overall Study|Physician Decision|1|||
124681578|NCT04761822|448457845|FG002|Overall Study|Physician Decision|0|||
124681579|NCT04761822|448457846|FG003|Overall Study|Physician Decision|0|||
124681580|NCT04761822|448457843|FG000|Overall Study|Withdrawal by Subject|3|||
124681581|NCT04761822|448457844|FG001|Overall Study|Withdrawal by Subject|8|||
124681582|NCT04761822|448457845|FG002|Overall Study|Withdrawal by Subject|1|||
124681583|NCT04761822|448457846|FG003|Overall Study|Withdrawal by Subject|11|||
124681584|NCT04761822|448457843|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
124681585|NCT04761822|448457844|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
124681586|NCT04761822|448457845|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
124681587|NCT04761822|448457846|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
124681588|NCT04761822|448457843|FG000|Overall Study|Participant requested unblinding|0|||
124681589|NCT04761822|448457844|FG001|Overall Study|Participant requested unblinding|0|||
124681590|NCT04761822|448457845|FG002|Overall Study|Participant requested unblinding|0|||
124681591|NCT04761822|448457846|FG003|Overall Study|Participant requested unblinding|1|||
124681592|NCT04734652|448457847|FG000|Overall Study|Withdrawal by Subject|2|||
124681593|NCT04734652|448457848|FG001|Overall Study|Withdrawal by Subject|0|||
124681594|NCT04734652|448457847|FG000|Overall Study|Death|0|||
124681595|NCT04734652|448457848|FG001|Overall Study|Death|1|||
124681596|NCT02233413|448457849|FG000|Overall Study|Lost to Follow-up|7|||
124681597|NCT02233413|448457850|FG001|Overall Study|Lost to Follow-up|9|||
124681598|NCT02233413|448457849|FG000|Overall Study|Withdrawal by Subject|4|||
124681599|NCT02233413|448457850|FG001|Overall Study|Withdrawal by Subject|5|||
124681600|NCT02471183|448457859|FG000|Main Treatment Period|Adverse Event|1|||
124681601|NCT02471183|448457859|FG000|Main Treatment Period|Withdrawal by Subject|1|||
124681602|NCT02471183|448457859|FG000|Extended Treatment Period|Lack of Efficacy|1|||
124681603|NCT00827567|448457861|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
124681604|NCT04810962|448457862|FG000|Overall Study|Adverse Event|0|||
124681605|NCT04810962|448457863|FG001|Overall Study|Adverse Event|1|||
124681606|NCT04810962|448457862|FG000|Overall Study|Lost to Follow-up|2|||
124681607|NCT04810962|448457863|FG001|Overall Study|Lost to Follow-up|1|||
124681608|NCT04810962|448457862|FG000|Overall Study|Physician Decision|1|||
124681609|NCT04810962|448457863|FG001|Overall Study|Physician Decision|0|||
124681610|NCT04810962|448457862|FG000|Overall Study|Withdrawal by Subject|1|||
124681611|NCT04810962|448457863|FG001|Overall Study|Withdrawal by Subject|3|||
124681612|NCT04810962|448457862|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
124711990|NCT00690794|448570705|FG001|Overall Study|Withdrawal by Subject|9|||
124438657|NCT01315353|447566183|FG001|Overall Study|Withdrawal by Subject|6|||
124438658|NCT01315353|447566184|FG002|Overall Study|Withdrawal by Subject|1|||
124438659|NCT01315353|447566182|FG000|Overall Study|Lost to Follow-up|13|||
124438660|NCT01315353|447566183|FG001|Overall Study|Lost to Follow-up|6|||
124438661|NCT01315353|447566184|FG002|Overall Study|Lost to Follow-up|6|||
124438662|NCT01315353|447566182|FG000|Overall Study|Unwilling to adhere to requirements|5|||
124438663|NCT01315353|447566183|FG001|Overall Study|Unwilling to adhere to requirements|5|||
124438664|NCT01315353|447566184|FG002|Overall Study|Unwilling to adhere to requirements|4|||
124438665|NCT01315353|447566182|FG000|Overall Study|Site closing|7|||
124438666|NCT01315353|447566183|FG001|Overall Study|Site closing|4|||
124438667|NCT01315353|447566184|FG002|Overall Study|Site closing|0|||
124438668|NCT01315353|447566182|FG000|Overall Study|Taken off study by site in error|0|||
124438669|NCT01315353|447566183|FG001|Overall Study|Taken off study by site in error|1|||
124681613|NCT04810962|448457863|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
124681614|NCT02412657|448457867|FG000|Overall Study|Lost to Follow-up|1|||
124681615|NCT02412657|448457868|FG001|Overall Study|Lost to Follow-up|0|||
124681616|NCT02412657|448457869|FG002|Overall Study|Lost to Follow-up|0|||
124681617|NCT02412657|448457867|FG000|Overall Study|Protocol Violation|0|||
124681618|NCT02412657|448457868|FG001|Overall Study|Protocol Violation|2|||
124681619|NCT02412657|448457869|FG002|Overall Study|Protocol Violation|3|||
124681620|NCT00460798|448457870|FG000|Overall Study|Death|59|||
124681621|NCT00460798|448457870|FG000|Overall Study|Adverse Event|27|||
124681622|NCT00460798|448457870|FG000|Overall Study|Lost to Follow-up|19|||
124681623|NCT00460798|448457870|FG000|Overall Study|Progressive Disease|99|||
124681624|NCT00460798|448457870|FG000|Overall Study|Other|27|||
124681625|NCT00460798|448457870|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
124681626|NCT00460798|448457870|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
124681627|NCT01898130|448457871|FG000|Treatment|Withdrawal by Subject|2|||
124681628|NCT01898130|448457871|FG000|Treatment|Progressive Disease|4|||
124681629|NCT01898130|448457871|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
124681630|NCT01189266|448457872|FG000|Overall Study|Adverse Event|1|||
124681631|NCT01189266|448457873|FG001|Overall Study|Adverse Event|0|||
124681632|NCT01189266|448457874|FG002|Overall Study|Adverse Event|5|||
124681633|NCT01189266|448457872|FG000|Overall Study|Death|0|||
124681634|NCT01189266|448457873|FG001|Overall Study|Death|0|||
124681635|NCT01189266|448457874|FG002|Overall Study|Death|5|||
124681636|NCT01189266|448457872|FG000|Overall Study|Lack of Efficacy|4|||
124681637|NCT01189266|448457873|FG001|Overall Study|Lack of Efficacy|5|||
124681638|NCT01189266|448457874|FG002|Overall Study|Lack of Efficacy|44|||
124681639|NCT01189266|448457872|FG000|Overall Study|Physician Decision|0|||
124681640|NCT01189266|448457873|FG001|Overall Study|Physician Decision|0|||
124681641|NCT01189266|448457874|FG002|Overall Study|Physician Decision|1|||
124681642|NCT01189266|448457872|FG000|Overall Study|Protocol Violation|0|||
124681643|NCT01189266|448457873|FG001|Overall Study|Protocol Violation|1|||
124681644|NCT01189266|448457874|FG002|Overall Study|Protocol Violation|1|||
124681645|NCT01189266|448457872|FG000|Overall Study|Withdrawal by Subject|0|||
124681646|NCT01189266|448457873|FG001|Overall Study|Withdrawal by Subject|0|||
124681647|NCT01189266|448457874|FG002|Overall Study|Withdrawal by Subject|1|||
124681648|NCT01189266|448457872|FG000|Overall Study|Patient refuses further therapy|1|||
124681649|NCT01189266|448457873|FG001|Overall Study|Patient refuses further therapy|0|||
124681650|NCT01189266|448457874|FG002|Overall Study|Patient refuses further therapy|7|||
124681651|NCT01189266|448457872|FG000|Overall Study|No treatment|0|||
124681652|NCT01189266|448457873|FG001|Overall Study|No treatment|0|||
124681653|NCT01189266|448457874|FG002|Overall Study|No treatment|1|||
124681654|NCT01682031|448457875|FG000|Overall Study|Withdrawal by Subject|0|||
124681655|NCT01682031|448457876|FG001|Overall Study|Withdrawal by Subject|1|||
124681656|NCT01682031|448457875|FG000|Overall Study|Adverse Event|0|||
124681657|NCT01682031|448457876|FG001|Overall Study|Adverse Event|2|||
124681658|NCT01682031|448457875|FG000|Overall Study|MRI results indicate increased nodul|0|||
124681659|NCT01682031|448457876|FG001|Overall Study|MRI results indicate increased nodul|1|||
124681660|NCT01682031|448457875|FG000|Overall Study|Patient could not swallow tablets|1|||
124681661|NCT01682031|448457876|FG001|Overall Study|Patient could not swallow tablets|0|||
124681662|NCT01682031|448457875|FG000|Overall Study|Patient stopped selenium on his own|0|||
124681663|NCT01682031|448457876|FG001|Overall Study|Patient stopped selenium on his own|1|||
124681664|NCT00924898|448457879|FG000|Overall Study|Withdrawal by Subject|2|||
124681665|NCT01285518|448457880|FG000|Overall Study|Lost to Follow-up|0|||
124681666|NCT01285518|448457881|FG001|Overall Study|Lost to Follow-up|0|||
124681667|NCT01285518|448457882|FG002|Overall Study|Lost to Follow-up|0|||
124681668|NCT01285518|448457883|FG003|Overall Study|Lost to Follow-up|0|||
124681669|NCT01285518|448457884|FG004|Overall Study|Lost to Follow-up|0|||
124438670|NCT01315353|447566184|FG002|Overall Study|Taken off study by site in error|0|||
124438671|NCT01315353|447566182|FG000|Overall Study|Inadvertent randomization/assignment|0|||
124681670|NCT01285518|448457885|FG005|Overall Study|Lost to Follow-up|1|||
124681671|NCT01285518|448457886|FG006|Overall Study|Lost to Follow-up|0|||
124438672|NCT01315353|447566183|FG001|Overall Study|Inadvertent randomization/assignment|0|||
124681672|NCT01285518|448457887|FG007|Overall Study|Lost to Follow-up|0|||
124681673|NCT00294658|448457888|FG000|Overall Study|Death|0|||
124681674|NCT00294658|448457889|FG001|Overall Study|Death|1|||
124681675|NCT00294658|448457888|FG000|Overall Study|Lost to Follow-up|4|||
124681676|NCT00294658|448457889|FG001|Overall Study|Lost to Follow-up|0|||
124681677|NCT00294658|448457888|FG000|Overall Study|Physician Decision|1|||
124681678|NCT00294658|448457889|FG001|Overall Study|Physician Decision|2|||
124681679|NCT00294658|448457888|FG000|Overall Study|Pregnancy|0|||
124681680|NCT00294658|448457889|FG001|Overall Study|Pregnancy|1|||
124681681|NCT00294658|448457888|FG000|Overall Study|Withdrawal by Subject|0|||
124681682|NCT00294658|448457889|FG001|Overall Study|Withdrawal by Subject|4|||
124681683|NCT00294658|448457888|FG000|Overall Study|Found to have invasive thymoma|1|||
124681684|NCT00294658|448457889|FG001|Overall Study|Found to have invasive thymoma|0|||
124681685|NCT00294658|448457888|FG000|Overall Study|Patient and family were not satisfied|0|||
124681686|NCT00294658|448457889|FG001|Overall Study|Patient and family were not satisfied|1|||
124681687|NCT03805841|448457890|FG000|Overall Study|Clinical Progression|2|||
124681688|NCT03805841|448457891|FG001|Overall Study|Clinical Progression|0|||
124681689|NCT03805841|448457892|FG002|Overall Study|Clinical Progression|0|||
124681690|NCT03805841|448457890|FG000|Overall Study|Death|0|||
124681691|NCT03805841|448457891|FG001|Overall Study|Death|3|||
124681692|NCT03805841|448457892|FG002|Overall Study|Death|1|||
124681693|NCT03805841|448457890|FG000|Overall Study|Lost to Follow-up|0|||
124681694|NCT03805841|448457891|FG001|Overall Study|Lost to Follow-up|0|||
124681695|NCT03805841|448457892|FG002|Overall Study|Lost to Follow-up|1|||
124681696|NCT03805841|448457890|FG000|Overall Study|Withdrawal by Subject|2|||
124681697|NCT03805841|448457891|FG001|Overall Study|Withdrawal by Subject|3|||
124681698|NCT03805841|448457892|FG002|Overall Study|Withdrawal by Subject|0|||
124681699|NCT03805841|448457890|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
124681700|NCT03805841|448457891|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
124681701|NCT03805841|448457892|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
124681702|NCT01910441|448457898|FG000|Overall Study|Sponsor decision|0|||
124681703|NCT01910441|448457899|FG001|Overall Study|Sponsor decision|2|||
124681704|NCT01910441|448457898|FG000|Overall Study|Lost to Follow-up|6|||
124681705|NCT01910441|448457899|FG001|Overall Study|Lost to Follow-up|5|||
124681706|NCT01910441|448457898|FG000|Overall Study|Withdrawal by Subject|0|||
124681707|NCT01910441|448457899|FG001|Overall Study|Withdrawal by Subject|1|||
124681708|NCT01910441|448457898|FG000|Overall Study|Non-compliance|0|||
124681709|NCT01910441|448457899|FG001|Overall Study|Non-compliance|1|||
124681710|NCT01910441|448457898|FG000|Overall Study|Adverse Event|1|||
124681711|NCT01910441|448457899|FG001|Overall Study|Adverse Event|0|||
124681712|NCT01910441|448457898|FG000|Overall Study|Physician Decision|0|||
124681713|NCT01910441|448457899|FG001|Overall Study|Physician Decision|1|||
124681714|NCT02340949|448457900|FG000|Overall Study|Adverse Event|4|||
124681715|NCT02340949|448457901|FG001|Overall Study|Adverse Event|2|||
124681716|NCT02340949|448457900|FG000|Overall Study|Withdrawal by Subject|2|||
124681717|NCT02340949|448457901|FG001|Overall Study|Withdrawal by Subject|0|||
124681718|NCT02340949|448457900|FG000|Overall Study|Progression disease|6|||
124681719|NCT02340949|448457901|FG001|Overall Study|Progression disease|2|||
124681720|NCT02340949|448457900|FG000|Overall Study|Death|3|||
124681721|NCT02340949|448457901|FG001|Overall Study|Death|0|||
124681722|NCT02340949|448457900|FG000|Overall Study|Physician Decision|1|||
124681723|NCT02340949|448457901|FG001|Overall Study|Physician Decision|0|||
124681724|NCT01192178|448457902|FG000|Overall Study|Withdrawal by Subject|6|||
124681725|NCT01192178|448457903|FG001|Overall Study|Withdrawal by Subject|10|||
124681726|NCT01192178|448457902|FG000|Overall Study|Protocol Violation|10|||
124681727|NCT01192178|448457903|FG001|Overall Study|Protocol Violation|3|||
124438673|NCT01315353|447566184|FG002|Overall Study|Inadvertent randomization/assignment|2|||
124681728|NCT01192178|448457902|FG000|Overall Study|Physician Decision|2|||
124681729|NCT01192178|448457903|FG001|Overall Study|Physician Decision|4|||
124681730|NCT01192178|448457902|FG000|Overall Study|Lost to Follow-up|3|||
124681731|NCT01192178|448457903|FG001|Overall Study|Lost to Follow-up|3|||
124681732|NCT01192178|448457902|FG000|Overall Study|Adverse Event|2|||
124681733|NCT01192178|448457903|FG001|Overall Study|Adverse Event|1|||
124681734|NCT01192178|448457902|FG000|Overall Study|Lack of Efficacy|1|||
124681735|NCT01192178|448457903|FG001|Overall Study|Lack of Efficacy|2|||
124681736|NCT02460289|448457904|FG000|Overall Study|Adverse Event|1|||
124681737|NCT02460289|448457904|FG000|Overall Study|Withdrawal by Subject|8|||
124681738|NCT02460289|448457904|FG000|Overall Study|Lost to Follow-up|1|||
124681739|NCT01155570|448457905|FG000|Overall Study|Adverse Event|39|||
124681740|NCT01155570|448457905|FG000|Overall Study|Lack of Efficacy|46|||
124681741|NCT01155570|448457905|FG000|Overall Study|Participant's Economic Reasons|17|||
124681742|NCT01155570|448457905|FG000|Overall Study|No Hospital Visits|7|||
124681743|NCT01155570|448457905|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
124681744|NCT01155570|448457905|FG000|Overall Study|Adverse Event + Other Reasons|7|||
124681745|NCT01155570|448457905|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
124681746|NCT01155570|448457905|FG000|Overall Study|Other Reasons|23|||
124681747|NCT00296517|448457906|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
124681748|NCT00296517|448457907|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
124681749|NCT00296517|448457906|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
124681750|NCT00296517|448457907|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
124681751|NCT00296517|448457906|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
124681752|NCT00296517|448457907|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
124681753|NCT00296517|448457906|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
124681754|NCT00296517|448457907|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
124681755|NCT00296517|448457906|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
124681756|NCT00296517|448457907|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
124681757|NCT00296517|448457906|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
124681758|NCT00296517|448457907|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
124681759|NCT00296517|448457906|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
124681760|NCT00296517|448457907|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
124681761|NCT00296517|448457906|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
124681762|NCT00296517|448457907|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
124681763|NCT00296517|448457906|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
124681764|NCT00296517|448457907|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
124681765|NCT00964782|448457911|FG000|Overall Study|Lost to Follow-up|1|||
124681766|NCT00964782|448457912|FG001|Overall Study|Lost to Follow-up|0|||
124681767|NCT01143324|448457919|FG000|Overall Study|Lost to Follow-up|11|||
124681768|NCT01143324|448457919|FG000|Overall Study|Withdrawal by Subject|4|||
124681769|NCT01143324|448457919|FG000|Overall Study|Explant of the device|4|||
124681770|NCT00596635|448457920|FG000|Overall Study|Lost to Follow-up|0|||
124681771|NCT00596635|448457921|FG001|Overall Study|Lost to Follow-up|2|||
124681772|NCT00596635|448457922|FG002|Overall Study|Lost to Follow-up|0|||
124681773|NCT00596635|448457920|FG000|Overall Study|Treatment for symptomatic UTI|4|||
124681774|NCT00596635|448457921|FG001|Overall Study|Treatment for symptomatic UTI|6|||
124681775|NCT00596635|448457922|FG002|Overall Study|Treatment for symptomatic UTI|3|||
124681776|NCT00596635|448457920|FG000|Overall Study|Hip fracture|2|||
124681777|NCT00596635|448457921|FG001|Overall Study|Hip fracture|3|||
124681778|NCT00596635|448457922|FG002|Overall Study|Hip fracture|3|||
124681779|NCT00596635|448457920|FG000|Overall Study|Could not provide urine specimen|1|||
124681780|NCT00596635|448457921|FG001|Overall Study|Could not provide urine specimen|2|||
124681781|NCT00596635|448457922|FG002|Overall Study|Could not provide urine specimen|2|||
124681782|NCT01101178|448457925|FG000|Period 1|Withdrawal by Subject|1|||
124681783|NCT01101178|448457926|FG001|Period 1|Withdrawal by Subject|2|||
124681784|NCT01101178|448457925|FG000|Period 1|Positive drug screen|1|||
124681785|NCT01101178|448457926|FG001|Period 1|Positive drug screen|1|||
124681786|NCT01101178|448457925|FG000|Period 1|Adverse Event|2|||
124681787|NCT01101178|448457926|FG001|Period 1|Adverse Event|1|||
124681788|NCT01101178|448457925|FG000|Period 2|Withdrawal by Subject|0|||
124681789|NCT01101178|448457926|FG001|Period 2|Withdrawal by Subject|1|||
124681790|NCT01850641|448457927|FG000|Overall Study|Physician Decision|1|||
124681791|NCT01850641|448457927|FG000|Overall Study|Decrease in serum phosphorus|1|||
124681792|NCT01850641|448457927|FG000|Overall Study|Decrease in serum calcium|2|||
124681793|NCT01850641|448457927|FG000|Overall Study|Increase in serum ferritin|1|||
124681794|NCT00141817|448457928|FG000|Overall Study|Protocol Violation|0|||
124438674|NCT03567434|447566185|FG000|Overall Study|Lost to Follow-up|1|||
124681795|NCT00141817|448457929|FG001|Overall Study|Protocol Violation|0|||
124681796|NCT00141817|448457930|FG002|Overall Study|Protocol Violation|1|||
124681797|NCT00141817|448457931|FG003|Overall Study|Protocol Violation|0|||
124681798|NCT00141817|448457928|FG000|Overall Study|Parent request|1|||
124681799|NCT00141817|448457929|FG001|Overall Study|Parent request|0|||
124681800|NCT00141817|448457930|FG002|Overall Study|Parent request|0|||
124681801|NCT00141817|448457931|FG003|Overall Study|Parent request|0|||
124681802|NCT00127803|448457940|FG000|Overall Study|Adverse Event|2|||
124681803|NCT00127803|448457941|FG001|Overall Study|Adverse Event|0|||
124681804|NCT00127803|448457942|FG002|Overall Study|Adverse Event|0|||
124880320|NCT03285295|449185483|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
124880321|NCT03285295|449185484|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
124681805|NCT00127803|448457943|FG003|Overall Study|Adverse Event|0|||
124681806|NCT00127803|448457940|FG000|Overall Study|Withdrawal by Subject|1|||
124681807|NCT00127803|448457941|FG001|Overall Study|Withdrawal by Subject|0|||
124681808|NCT00127803|448457942|FG002|Overall Study|Withdrawal by Subject|0|||
124681809|NCT00127803|448457943|FG003|Overall Study|Withdrawal by Subject|0|||
124681810|NCT00127803|448457940|FG000|Overall Study|Lost to Follow-up|0|||
124681811|NCT00127803|448457941|FG001|Overall Study|Lost to Follow-up|0|||
124681812|NCT00127803|448457942|FG002|Overall Study|Lost to Follow-up|0|||
124681813|NCT00127803|448457943|FG003|Overall Study|Lost to Follow-up|1|||
124681814|NCT02774889|448457947|FG000|Overall Study|Lost to Follow-up|2|||
124681815|NCT02774889|448457948|FG001|Overall Study|Lost to Follow-up|1|||
124681816|NCT00858988|448457949|FG000|Analysis|Lactulose unable to be detected in urine|2|||
124681817|NCT00858988|448457950|FG001|Analysis|Lactulose unable to be detected in urine|1|||
124681818|NCT00846365|448457951|FG000|Overall Study|Adverse Event|20|||
124681819|NCT00846365|448457952|FG001|Overall Study|Adverse Event|30|||
124681820|NCT00846365|448457953|FG002|Overall Study|Adverse Event|11|||
124681821|NCT00846365|448457951|FG000|Overall Study|Protocol Violation|5|||
124681822|NCT00846365|448457952|FG001|Overall Study|Protocol Violation|4|||
124681823|NCT00846365|448457953|FG002|Overall Study|Protocol Violation|0|||
124681824|NCT00846365|448457951|FG000|Overall Study|Lost to Follow-up|8|||
124681825|NCT00846365|448457952|FG001|Overall Study|Lost to Follow-up|2|||
124880322|NCT03285295|449185485|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
124681826|NCT00846365|448457953|FG002|Overall Study|Lost to Follow-up|5|||
124681827|NCT00846365|448457951|FG000|Overall Study|Withdrawal by Subject|11|||
124681828|NCT00846365|448457952|FG001|Overall Study|Withdrawal by Subject|11|||
124681829|NCT00846365|448457953|FG002|Overall Study|Withdrawal by Subject|9|||
124681830|NCT00846365|448457951|FG000|Overall Study|Pregnancy|1|||
124681831|NCT00846365|448457952|FG001|Overall Study|Pregnancy|0|||
124681832|NCT00846365|448457953|FG002|Overall Study|Pregnancy|0|||
124681833|NCT00846365|448457951|FG000|Overall Study|Lack of Efficacy|1|||
124681834|NCT00846365|448457952|FG001|Overall Study|Lack of Efficacy|1|||
124880323|NCT03285295|449185481|FG000|Alinity s Anti-HBc|No Results Generated|70|||
124438675|NCT03567434|447566186|FG001|Overall Study|Lost to Follow-up|3|||
124438676|NCT01009580|447566188|FG000|Overall Study|Adverse Event|4|||
124438677|NCT01009580|447566189|FG001|Overall Study|Adverse Event|4|||
124438678|NCT01009580|447566188|FG000|Overall Study|Lack of Efficacy|0|||
124438679|NCT01009580|447566189|FG001|Overall Study|Lack of Efficacy|1|||
124438680|NCT01009580|447566188|FG000|Overall Study|Protocol Violation|2|||
124438681|NCT01009580|447566189|FG001|Overall Study|Protocol Violation|3|||
124438682|NCT01009580|447566188|FG000|Overall Study|Withdrawal Criteria|4|||
124438683|NCT01009580|447566189|FG001|Overall Study|Withdrawal Criteria|6|||
124438684|NCT01009580|447566188|FG000|Overall Study|Unclassified|17|||
124438685|NCT01009580|447566189|FG001|Overall Study|Unclassified|21|||
124438686|NCT02390245|447566191|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
124438687|NCT02390245|447566192|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
124438688|NCT02390245|447566193|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
124438689|NCT02390245|447566191|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
124438690|NCT02390245|447566192|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
124438691|NCT02390245|447566193|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
124438692|NCT03727438|447566194|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
124438693|NCT03727438|447566195|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
124438694|NCT03727438|447566194|FG000|Intervention Period|Excluded (health)|1|||
124438695|NCT03727438|447566195|FG001|Intervention Period|Excluded (health)|0|||
124438696|NCT03727438|447566194|FG000|Intervention Period|Withdrawal by Subject|3|||
124438697|NCT03727438|447566195|FG001|Intervention Period|Withdrawal by Subject|1|||
124438698|NCT03727438|447566194|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
124438699|NCT03727438|447566195|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
124438700|NCT03727438|447566194|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
124438701|NCT03727438|447566195|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
124438702|NCT03727438|447566194|FG000|8 Week Assessment|Withdrawal by Subject|6|||
124438703|NCT03727438|447566195|FG001|8 Week Assessment|Withdrawal by Subject|1|||
124438704|NCT03727438|447566194|FG000|6 mo Assessment|did not complete assessment|10|||
124438705|NCT03727438|447566195|FG001|6 mo Assessment|did not complete assessment|11|||
124438706|NCT05220254|447567683|FG000|Overall Study|Withdrawal by Subject|4|||
124438707|NCT05220254|447567683|FG000|Overall Study|Removed due to ineligibility|1|||
124438708|NCT05220254|447567683|FG000|Overall Study|Lost to Follow-up|7|||
124438709|NCT01557283|447567684|FG000|Overall Study|Lost to Follow-up|7|||
124438710|NCT01557283|447567684|FG000|Overall Study|Non-responder|19|||
124438711|NCT01557283|447567684|FG000|Overall Study|Adverse Event|7|||
124438712|NCT01557283|447567684|FG000|Overall Study|Lack of Efficacy|1|||
124438713|NCT01557283|447567684|FG000|Overall Study|Non-compliance|1|||
124438714|NCT01557283|447567684|FG000|Overall Study|Withdrawal by Subject|1|||
124438715|NCT01557283|447567684|FG000|Overall Study|Participant's weight too high for dose|1|||
124438716|NCT01557283|447567684|FG000|Overall Study|Worsening of psoriasis|1|||
124438717|NCT01557283|447567684|FG000|Overall Study|Other|6|||
124438718|NCT00448279|447567687|FG000|Overall Study|Lost to Follow-up|2|||
124438719|NCT00448279|447567688|FG001|Overall Study|Lost to Follow-up|2|||
124438720|NCT00448279|447567687|FG000|Overall Study|Adverse Event|1|||
124438721|NCT00448279|447567688|FG001|Overall Study|Adverse Event|1|||
124438722|NCT00448279|447567687|FG000|Overall Study|Disease progression|16|||
124681835|NCT00846365|448457953|FG002|Overall Study|Lack of Efficacy|2|||
124681836|NCT00846365|448457951|FG000|Overall Study|Other|9|||
124681837|NCT00846365|448457952|FG001|Overall Study|Other|1|||
124681838|NCT00846365|448457953|FG002|Overall Study|Other|6|||
124681839|NCT00862992|448457969|FG000|Overall Study|Adverse Event|2|||
124681840|NCT00862992|448457970|FG001|Overall Study|Adverse Event|1|||
124681841|NCT00862992|448457971|FG002|Overall Study|Adverse Event|1|||
124681842|NCT00862992|448457969|FG000|Overall Study|Physician Decision|1|||
124681843|NCT00862992|448457970|FG001|Overall Study|Physician Decision|0|||
124681844|NCT00862992|448457971|FG002|Overall Study|Physician Decision|0|||
124681845|NCT00862992|448457969|FG000|Overall Study|Withdrawal by Subject|0|||
124681846|NCT00862992|448457970|FG001|Overall Study|Withdrawal by Subject|0|||
124681847|NCT00862992|448457971|FG002|Overall Study|Withdrawal by Subject|2|||
124880324|NCT03285295|449185482|FG001|Alinity s Anti-HBc|No Results Generated|0|||
124880325|NCT03285295|449185483|FG002|Alinity s Anti-HBc|No Results Generated|0|||
124438723|NCT00448279|447567688|FG001|Overall Study|Disease progression|18|||
124438724|NCT00448279|447567687|FG000|Overall Study|Withdrawal by Subject|4|||
124438725|NCT00448279|447567688|FG001|Overall Study|Withdrawal by Subject|3|||
124438726|NCT00448279|447567687|FG000|Overall Study|Other|6|||
124438727|NCT00448279|447567688|FG001|Overall Study|Other|4|||
124438728|NCT00448279|447567687|FG000|Overall Study|Protocol Violation|0|||
124438729|NCT00448279|447567688|FG001|Overall Study|Protocol Violation|1|||
124438730|NCT03907410|447567689|FG000|Overall Study|Lost to Follow-up|4|||
124681848|NCT01277861|448457984|FG000|Overall Study|Physician Decision|2|||
124681849|NCT01277861|448457985|FG001|Overall Study|Physician Decision|2|||
124681850|NCT02696798|448457986|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
124681851|NCT02696798|448457987|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
124681852|NCT02696798|448457988|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
124681853|NCT02696798|448457986|FG000|Blinded Treatment Dosing Period|Death|0|||
124681854|NCT02696798|448457987|FG001|Blinded Treatment Dosing Period|Death|0|||
124681855|NCT02696798|448457988|FG002|Blinded Treatment Dosing Period|Death|1|||
124681856|NCT02696798|448457986|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
124681857|NCT02696798|448457987|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
124681858|NCT02696798|448457988|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
124681859|NCT02696798|448457986|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
124681860|NCT02696798|448457987|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
124681861|NCT02696798|448457988|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
124681862|NCT02696798|448457986|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
124681863|NCT02696798|448457987|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
124681864|NCT02696798|448457988|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
124681865|NCT02696798|448457986|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
124681866|NCT02696798|448457987|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
124681867|NCT02696798|448457988|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
124681868|NCT02696798|448457986|FG000|Extended Treatment Period|Adverse Event|1|||
124681869|NCT02696798|448457987|FG001|Extended Treatment Period|Adverse Event|4|||
124681870|NCT02696798|448457988|FG002|Extended Treatment Period|Adverse Event|5|||
124681871|NCT02696798|448457986|FG000|Extended Treatment Period|Lack of Efficacy|7|||
124681872|NCT02696798|448457987|FG001|Extended Treatment Period|Lack of Efficacy|2|||
124681873|NCT02696798|448457988|FG002|Extended Treatment Period|Lack of Efficacy|2|||
124681874|NCT02696798|448457986|FG000|Extended Treatment Period|Lost to Follow-up|1|||
124681875|NCT02696798|448457987|FG001|Extended Treatment Period|Lost to Follow-up|0|||
124681876|NCT02696798|448457988|FG002|Extended Treatment Period|Lost to Follow-up|0|||
124681877|NCT02696798|448457986|FG000|Extended Treatment Period|Physician Decision|0|||
124681878|NCT02696798|448457987|FG001|Extended Treatment Period|Physician Decision|1|||
124681879|NCT02696798|448457988|FG002|Extended Treatment Period|Physician Decision|0|||
124681880|NCT02696798|448457986|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
124681881|NCT02696798|448457987|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
124681882|NCT02696798|448457988|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
124681883|NCT02696798|448457986|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
124681884|NCT02696798|448457987|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
124681885|NCT02696798|448457988|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
124681886|NCT02696798|448457986|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
124681887|NCT02696798|448457987|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
124681888|NCT02696798|448457988|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
124681889|NCT02696798|448457986|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
124681890|NCT02696798|448457987|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
124681891|NCT02696798|448457988|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
124681892|NCT02696798|448457986|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
124681893|NCT02696798|448457987|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
124681894|NCT02696798|448457988|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
124681895|NCT02696798|448457986|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
124681896|NCT02696798|448457987|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
124681897|NCT02696798|448457988|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
124681898|NCT02696798|448457986|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
124681899|NCT02696798|448457987|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
124681900|NCT02696798|448457988|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
124681901|NCT00857389|448457989|FG000|Overall Study|Did not proceed to transplant|2|||
124681902|NCT01157845|448457990|FG000|Overall Study|Lost to Follow-up|5|||
124681903|NCT01157845|448457990|FG000|Overall Study|Withdrawal by Subject|12|||
124681904|NCT01157845|448457990|FG000|Overall Study|Physician Decision|3|||
124681905|NCT01157845|448457990|FG000|Overall Study|Protocol Violation|13|||
124681906|NCT01157845|448457990|FG000|Overall Study|Study was ended|1|||
124681907|NCT01157845|448457990|FG000|Overall Study|Device malfunction|1|||
124681908|NCT03311555|448457991|FG000|Overall Study|Adverse Event|1|||
124681909|NCT00788671|448459652|FG000|Overall Study|Death|2|||
124681910|NCT00788671|448459652|FG000|Overall Study|Unable to biopsy|1|||
124681911|NCT00788671|448459652|FG000|Overall Study|Withdrawal by Subject|4|||
124681912|NCT00788671|448459652|FG000|Overall Study|IUD expulsed|1|||
124681913|NCT00788671|448459652|FG000|Overall Study|Lost to follow up|2|||
124681914|NCT03405870|448459653|FG000|Overall Study|Withdrawal|1|||
124681915|NCT03405870|448459654|FG001|Overall Study|Withdrawal|0|||
124681916|NCT03405870|448459655|FG002|Overall Study|Withdrawal|1|||
124681917|NCT03405870|448459656|FG003|Overall Study|Withdrawal|0|||
124681918|NCT03405870|448459657|FG004|Overall Study|Withdrawal|0|||
124681919|NCT03405870|448459658|FG005|Overall Study|Withdrawal|0|||
124681920|NCT03405870|448459659|FG006|Overall Study|Withdrawal|1|||
124681921|NCT03405870|448459660|FG007|Overall Study|Withdrawal|0|||
124681922|NCT05172609|448459661|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
124681923|NCT05172609|448459662|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
124681924|NCT05172609|448459661|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
124681925|NCT05172609|448459662|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
124681926|NCT05172609|448459661|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
124681927|NCT05172609|448459662|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
124681928|NCT00549055|448459663|FG000|Overall Study|Adverse Event|4|||
124681929|NCT00549055|448459663|FG000|Overall Study|Lack of Efficacy|18|||
124681930|NCT00549055|448459663|FG000|Overall Study|Stabilization|5|||
124681931|NCT00549055|448459663|FG000|Overall Study|Progression to fibrosis|2|||
124681932|NCT00549055|448459663|FG000|Overall Study|Decrease of size|1|||
124681933|NCT00549055|448459663|FG000|Overall Study|Active choroidal neovascula increased|1|||
124681934|NCT00549055|448459663|FG000|Overall Study|Vitreous hemorrhage|1|||
124681935|NCT00549055|448459663|FG000|Overall Study|Growth choroidal neovascularisation|1|||
124681936|NCT00549055|448459663|FG000|Overall Study|Choroidal neovascularization|1|||
124681937|NCT00549055|448459663|FG000|Overall Study|Very low visual acuity (VA)|1|||
124681938|NCT03846479|448459664|FG000|Overall Study|Death|8|||
124681939|NCT03846479|448459664|FG000|Overall Study|Lost to Follow-up|1|||
124681940|NCT05020015|448459665|FG000|Overall Study|Ongoing on study|1|||
124681941|NCT05020015|448459666|FG001|Overall Study|Ongoing on study|3|||
124681942|NCT05020015|448459667|FG002|Overall Study|Ongoing on study|4|||
124681943|NCT05020015|448459668|FG003|Overall Study|Ongoing on study|7|||
124681944|NCT05020015|448459665|FG000|Overall Study|Death|2|||
124681945|NCT05020015|448459666|FG001|Overall Study|Death|3|||
124681946|NCT05020015|448459667|FG002|Overall Study|Death|4|||
124681947|NCT05020015|448459668|FG003|Overall Study|Death|0|||
124681948|NCT05020015|448459665|FG000|Overall Study|Withdrawal by Subject|0|||
124681949|NCT05020015|448459666|FG001|Overall Study|Withdrawal by Subject|0|||
124681950|NCT05020015|448459667|FG002|Overall Study|Withdrawal by Subject|1|||
124681951|NCT05020015|448459668|FG003|Overall Study|Withdrawal by Subject|0|||
124681952|NCT05020015|448459665|FG000|Overall Study|Reason Not Specified|0|||
124681953|NCT05020015|448459666|FG001|Overall Study|Reason Not Specified|0|||
124681954|NCT05020015|448459667|FG002|Overall Study|Reason Not Specified|2|||
124681955|NCT05020015|448459668|FG003|Overall Study|Reason Not Specified|0|||
124681956|NCT06217380|448459671|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
124681957|NCT06217380|448459671|FG000|Overall Study|Physician Decision|1|||
124681958|NCT06217380|448459671|FG000|Overall Study|Withdrawal by Subject|2|||
124681959|NCT06633965|448459672|FG000|Overall Study|Withdrawal by Subject|0|||
124681960|NCT06633965|448459673|FG001|Overall Study|Withdrawal by Subject|1|||
124681961|NCT00947544|448459676|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
124681962|NCT00947544|448459677|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
124681963|NCT01963611|448459682|FG000|Overall Study|Adverse Event|1|||
124681964|NCT01963611|448459683|FG001|Overall Study|Adverse Event|1|||
124681965|NCT01963611|448459684|FG002|Overall Study|Adverse Event|3|||
124681966|NCT01963611|448459685|FG003|Overall Study|Adverse Event|4|||
124681967|NCT01963611|448459686|FG004|Overall Study|Adverse Event|3|||
124681968|NCT01963611|448459682|FG000|Overall Study|Protocol Violation|0|||
124681969|NCT01963611|448459683|FG001|Overall Study|Protocol Violation|0|||
124681970|NCT01963611|448459684|FG002|Overall Study|Protocol Violation|0|||
124681971|NCT01963611|448459685|FG003|Overall Study|Protocol Violation|1|||
124681972|NCT01963611|448459686|FG004|Overall Study|Protocol Violation|0|||
124681973|NCT01963611|448459682|FG000|Overall Study|Lack of Efficacy|0|||
124681974|NCT01963611|448459683|FG001|Overall Study|Lack of Efficacy|0|||
124681975|NCT01963611|448459684|FG002|Overall Study|Lack of Efficacy|0|||
124681976|NCT01963611|448459685|FG003|Overall Study|Lack of Efficacy|1|||
124681977|NCT01963611|448459686|FG004|Overall Study|Lack of Efficacy|0|||
124681978|NCT01963611|448459682|FG000|Overall Study|Withdrawal by Subject|3|||
124681979|NCT01963611|448459683|FG001|Overall Study|Withdrawal by Subject|2|||
124681980|NCT01963611|448459684|FG002|Overall Study|Withdrawal by Subject|1|||
124681981|NCT01963611|448459685|FG003|Overall Study|Withdrawal by Subject|1|||
124681982|NCT01963611|448459686|FG004|Overall Study|Withdrawal by Subject|3|||
124681983|NCT01963611|448459682|FG000|Overall Study|Other|47|||
124681984|NCT01963611|448459683|FG001|Overall Study|Other|46|||
124681985|NCT01963611|448459684|FG002|Overall Study|Other|48|||
124681986|NCT01963611|448459685|FG003|Overall Study|Other|45|||
124681987|NCT01963611|448459686|FG004|Overall Study|Other|45|||
124681988|NCT01126424|448459687|FG000|Overall Study|Adverse Event|0|||
124681989|NCT01126424|448459688|FG001|Overall Study|Adverse Event|0|||
124681990|NCT01126424|448459689|FG002|Overall Study|Adverse Event|0|||
124681991|NCT01126424|448459690|FG003|Overall Study|Adverse Event|0|||
124681992|NCT01126424|448459691|FG004|Overall Study|Adverse Event|1|||
124681993|NCT01126424|448459692|FG005|Overall Study|Adverse Event|0|||
124681994|NCT01126424|448459687|FG000|Overall Study|Withdrawal by Subject|0|||
124681995|NCT01126424|448459688|FG001|Overall Study|Withdrawal by Subject|0|||
124681996|NCT01126424|448459689|FG002|Overall Study|Withdrawal by Subject|1|||
124681997|NCT01126424|448459690|FG003|Overall Study|Withdrawal by Subject|3|||
124681998|NCT01126424|448459691|FG004|Overall Study|Withdrawal by Subject|1|||
124681999|NCT01126424|448459692|FG005|Overall Study|Withdrawal by Subject|0|||
124682000|NCT03801252|448459693|FG000|Overall Study|Protocol Violation|1|||
124682001|NCT03801252|448459694|FG001|Overall Study|Protocol Violation|2|||
124682002|NCT01134042|448459695|FG000|Overall Study|Adverse Event|3|||
124682003|NCT01134042|448459696|FG001|Overall Study|Adverse Event|7|||
124682004|NCT01134042|448459697|FG002|Overall Study|Adverse Event|2|||
124682005|NCT01134042|448459695|FG000|Overall Study|Lack of Efficacy|21|||
124682006|NCT01134042|448459696|FG001|Overall Study|Lack of Efficacy|6|||
124682007|NCT01134042|448459697|FG002|Overall Study|Lack of Efficacy|18|||
124682008|NCT01134042|448459695|FG000|Overall Study|Protocol Violation|5|||
124682009|NCT01134042|448459696|FG001|Overall Study|Protocol Violation|3|||
124682010|NCT01134042|448459697|FG002|Overall Study|Protocol Violation|5|||
124682011|NCT01134042|448459695|FG000|Overall Study|Lost to Follow-up|2|||
124682012|NCT01134042|448459696|FG001|Overall Study|Lost to Follow-up|0|||
124682013|NCT01134042|448459697|FG002|Overall Study|Lost to Follow-up|1|||
124682014|NCT01134042|448459695|FG000|Overall Study|Physician Decision|4|||
124682015|NCT01134042|448459696|FG001|Overall Study|Physician Decision|8|||
124682016|NCT01134042|448459697|FG002|Overall Study|Physician Decision|1|||
124682017|NCT01134042|448459695|FG000|Overall Study|Withdrawal by Subject|13|||
124682018|NCT01134042|448459696|FG001|Overall Study|Withdrawal by Subject|4|||
124682019|NCT01134042|448459697|FG002|Overall Study|Withdrawal by Subject|7|||
124682020|NCT00393367|448459699|FG000|Overall Study|Protocol Violation|2|||
124682021|NCT00393367|448459700|FG001|Overall Study|Protocol Violation|5|||
124682022|NCT00393367|448459699|FG000|Overall Study|Withdrawal by Subject|0|||
124682023|NCT00393367|448459700|FG001|Overall Study|Withdrawal by Subject|2|||
124682024|NCT03286504|448459701|FG000|Overall Study|Lost to Follow-up|19|||
124682025|NCT03286504|448459702|FG001|Overall Study|Lost to Follow-up|16|||
124682026|NCT05350423|448459703|FG000|Overall Study|Lost to Follow-up|3|||
124682027|NCT05350423|448459704|FG001|Overall Study|Lost to Follow-up|3|||
124682028|NCT05350423|448459703|FG000|Overall Study|screen failure|5|||
124682029|NCT05350423|448459704|FG001|Overall Study|screen failure|6|||
124682030|NCT01432327|448459705|FG000|Posttest 3 Months|depression|3|||
124682031|NCT01432327|448459706|FG001|Posttest 3 Months|depression|0|||
124682032|NCT01432327|448459707|FG002|Posttest 3 Months|depression|0|||
124682033|NCT01432327|448459708|FG003|Posttest 3 Months|depression|0|||
124682034|NCT01432327|448459705|FG000|Posttest 3 Months|Lost to Follow-up|1|||
124682035|NCT01432327|448459706|FG001|Posttest 3 Months|Lost to Follow-up|0|||
124682036|NCT01432327|448459707|FG002|Posttest 3 Months|Lost to Follow-up|2|||
124682037|NCT01432327|448459708|FG003|Posttest 3 Months|Lost to Follow-up|1|||
124682038|NCT01432327|448459705|FG000|Posttest 3 Months|Allergic reaction|0|||
124682039|NCT01432327|448459706|FG001|Posttest 3 Months|Allergic reaction|2|||
124682040|NCT01432327|448459707|FG002|Posttest 3 Months|Allergic reaction|0|||
124682041|NCT01432327|448459708|FG003|Posttest 3 Months|Allergic reaction|0|||
124682042|NCT01432327|448459705|FG000|Posttest 6 Months|Lost to Follow-up|0|||
124682043|NCT01432327|448459706|FG001|Posttest 6 Months|Lost to Follow-up|0|||
124682044|NCT01432327|448459707|FG002|Posttest 6 Months|Lost to Follow-up|3|||
124438731|NCT03907410|447567690|FG001|Overall Study|Lost to Follow-up|1|||
124438732|NCT03907410|447567691|FG002|Overall Study|Lost to Follow-up|1|||
124438733|NCT03907410|447567689|FG000|Overall Study|Lost to follow-up and research burden|0|||
124438734|NCT03907410|447567690|FG001|Overall Study|Lost to follow-up and research burden|0|||
124438735|NCT03907410|447567691|FG002|Overall Study|Lost to follow-up and research burden|1|||
124438736|NCT01295034|447567692|FG000|Overall Study|Lost to Follow-up|5|||
124438737|NCT01295034|447567693|FG001|Overall Study|Lost to Follow-up|5|||
124438738|NCT01174160|447567696|FG000|Overall Study|Adverse Event|1|||
124438739|NCT01174160|447567697|FG001|Overall Study|Adverse Event|0|||
124438740|NCT01174160|447567696|FG000|Overall Study|Lost to Follow-up|1|||
124438741|NCT01174160|447567697|FG001|Overall Study|Lost to Follow-up|0|||
124438742|NCT01174160|447567696|FG000|Overall Study|Physician Decision|1|||
124438743|NCT01174160|447567697|FG001|Overall Study|Physician Decision|0|||
124438744|NCT01174160|447567696|FG000|Overall Study|Protocol Violation|4|||
124438745|NCT01174160|447567697|FG001|Overall Study|Protocol Violation|6|||
124438746|NCT01174160|447567696|FG000|Overall Study|Withdrawal by Subject|1|||
124438747|NCT01174160|447567697|FG001|Overall Study|Withdrawal by Subject|0|||
124438748|NCT04218084|447567698|FG000|Overall Study|Adverse Event|7|||
124438749|NCT04218084|447567699|FG001|Overall Study|Adverse Event|2|||
124438750|NCT04218084|447567698|FG000|Overall Study|Withdrawal of Consent|4|||
124682045|NCT01432327|448459708|FG003|Posttest 6 Months|Lost to Follow-up|2|||
124682046|NCT01432327|448459705|FG000|Posttest 6 Months|Allergic reaction|0|||
124682047|NCT01432327|448459706|FG001|Posttest 6 Months|Allergic reaction|0|||
124682048|NCT01432327|448459707|FG002|Posttest 6 Months|Allergic reaction|1|||
124682049|NCT01432327|448459708|FG003|Posttest 6 Months|Allergic reaction|0|||
124438751|NCT04218084|447567699|FG001|Overall Study|Withdrawal of Consent|5|||
124438752|NCT04218084|447567698|FG000|Overall Study|Physician Decision|1|||
124682050|NCT01432327|448459705|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
124682051|NCT01432327|448459706|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
124682052|NCT01432327|448459707|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
124682053|NCT01432327|448459708|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
124682054|NCT01432327|448459705|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
124682055|NCT01432327|448459706|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
124682056|NCT01432327|448459707|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
124682057|NCT01432327|448459708|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
124682058|NCT01432327|448459705|FG000|Posttest 1 Year|Lost to Follow-up|0|||
124682059|NCT01432327|448459706|FG001|Posttest 1 Year|Lost to Follow-up|0|||
124682060|NCT01432327|448459707|FG002|Posttest 1 Year|Lost to Follow-up|4|||
124682061|NCT01432327|448459708|FG003|Posttest 1 Year|Lost to Follow-up|2|||
124682062|NCT01432327|448459705|FG000|Posttest 1 Year|Allergic reaction|0|||
124682063|NCT01432327|448459706|FG001|Posttest 1 Year|Allergic reaction|0|||
124682064|NCT01432327|448459707|FG002|Posttest 1 Year|Allergic reaction|1|||
124682065|NCT01432327|448459708|FG003|Posttest 1 Year|Allergic reaction|1|||
124682066|NCT03320369|448459711|FG000|Overall Study|Adverse Event|1|||
124682067|NCT03320369|448459711|FG000|Overall Study|Withdrawal by Subject|2|||
124682068|NCT01732692|448459712|FG000|Overall Study|Adverse Event|0|||
124682069|NCT01732692|448459713|FG001|Overall Study|Adverse Event|1|||
124682070|NCT02030600|448459716|FG000|Treatment Period 1|Adverse Event|5|||
124682071|NCT02030600|448459717|FG001|Treatment Period 1|Adverse Event|7|||
124682072|NCT02030600|448459716|FG000|Treatment Period 1|Lack of Efficacy|0|||
124682073|NCT02030600|448459717|FG001|Treatment Period 1|Lack of Efficacy|1|||
124682074|NCT02030600|448459716|FG000|Treatment Period 1|Lost to Follow-up|11|||
124682075|NCT02030600|448459717|FG001|Treatment Period 1|Lost to Follow-up|3|||
124682076|NCT02030600|448459716|FG000|Treatment Period 1|Protocol Violation|22|||
124438753|NCT04218084|447567699|FG001|Overall Study|Physician Decision|1|||
124682077|NCT02030600|448459717|FG001|Treatment Period 1|Protocol Violation|17|||
124682078|NCT02030600|448459716|FG000|Treatment Period 1|Withdrawal by Subject|13|||
124682079|NCT02030600|448459717|FG001|Treatment Period 1|Withdrawal by Subject|17|||
124682080|NCT02030600|448459716|FG000|Treatment Period 1|Casebook Unsigned|1|||
124682081|NCT02030600|448459717|FG001|Treatment Period 1|Casebook Unsigned|0|||
124682082|NCT02030600|448459716|FG000|Treatment Period 1|Unclassified|1|||
124682083|NCT02030600|448459717|FG001|Treatment Period 1|Unclassified|0|||
124682084|NCT02030600|448459716|FG000|Treatment Period 2|Adverse Event|4|||
124682085|NCT02030600|448459717|FG001|Treatment Period 2|Adverse Event|4|||
124682086|NCT02030600|448459716|FG000|Treatment Period 2|Lack of Efficacy|2|||
124682087|NCT02030600|448459717|FG001|Treatment Period 2|Lack of Efficacy|1|||
124682088|NCT02030600|448459716|FG000|Treatment Period 2|Lost to Follow-up|4|||
124682089|NCT02030600|448459717|FG001|Treatment Period 2|Lost to Follow-up|2|||
124682090|NCT02030600|448459716|FG000|Treatment Period 2|Protocol Violation|1|||
124682091|NCT02030600|448459717|FG001|Treatment Period 2|Protocol Violation|2|||
124682092|NCT02030600|448459716|FG000|Treatment Period 2|Withdrawal by Subject|13|||
124682093|NCT02030600|448459717|FG001|Treatment Period 2|Withdrawal by Subject|9|||
124682094|NCT02030600|448459716|FG000|Treatment Period 2|Unclassified|1|||
124682095|NCT02030600|448459717|FG001|Treatment Period 2|Unclassified|0|||
124682096|NCT01155323|448459718|FG000|First Intervention|exclusion criteria|1|||
124682097|NCT01155323|448459719|FG001|First Intervention|exclusion criteria|1|||
124682098|NCT01155323|448459718|FG000|Second Intervention|Lost to Follow-up|1|||
124682099|NCT01155323|448459719|FG001|Second Intervention|Lost to Follow-up|1|||
124682100|NCT04154956|448459729|FG000|Overall Study|Death|109|||
124682101|NCT04154956|448459730|FG001|Overall Study|Death|110|||
124682102|NCT04154956|448459729|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
124682103|NCT04154956|448459730|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
124682104|NCT04154956|448459729|FG000|Overall Study|Withdrawal by Subject|1|||
124682105|NCT04154956|448459730|FG001|Overall Study|Withdrawal by Subject|7|||
124682106|NCT04154956|448459729|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
124682107|NCT04154956|448459730|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
124682108|NCT00805532|448459731|FG000|Overall Study|invalid data|0|||
124682109|NCT00805532|448459732|FG001|Overall Study|invalid data|1|||
124682110|NCT01859741|448459733|FG000|Overall Study|Death|3|||
124682111|NCT01859741|448459734|FG001|Overall Study|Death|2|||
124682112|NCT01859741|448459735|FG002|Overall Study|Death|4|||
124682113|NCT01859741|448459736|FG003|Overall Study|Death|3|||
124682114|NCT01859741|448459737|FG004|Overall Study|Death|5|||
124682115|NCT01859741|448459738|FG005|Overall Study|Death|4|||
124682116|NCT01859741|448459739|FG006|Overall Study|Death|51|||
124682117|NCT01859741|448459740|FG007|Overall Study|Death|51|||
124682118|NCT01859741|448459733|FG000|Overall Study|Lost to Follow-up|0|||
124682119|NCT01859741|448459734|FG001|Overall Study|Lost to Follow-up|0|||
124682120|NCT01859741|448459735|FG002|Overall Study|Lost to Follow-up|0|||
124682121|NCT01859741|448459736|FG003|Overall Study|Lost to Follow-up|0|||
124682122|NCT01859741|448459737|FG004|Overall Study|Lost to Follow-up|0|||
124682123|NCT01859741|448459738|FG005|Overall Study|Lost to Follow-up|1|||
124682124|NCT01859741|448459739|FG006|Overall Study|Lost to Follow-up|0|||
124682125|NCT01859741|448459740|FG007|Overall Study|Lost to Follow-up|4|||
124682126|NCT01859741|448459733|FG000|Overall Study|Withdrawal by Subject|0|||
124682127|NCT01859741|448459734|FG001|Overall Study|Withdrawal by Subject|1|||
124682128|NCT01859741|448459735|FG002|Overall Study|Withdrawal by Subject|2|||
124682129|NCT01859741|448459736|FG003|Overall Study|Withdrawal by Subject|0|||
124682130|NCT01859741|448459737|FG004|Overall Study|Withdrawal by Subject|0|||
124682131|NCT01859741|448459738|FG005|Overall Study|Withdrawal by Subject|1|||
124682132|NCT01859741|448459739|FG006|Overall Study|Withdrawal by Subject|1|||
124682133|NCT01859741|448459740|FG007|Overall Study|Withdrawal by Subject|1|||
124682134|NCT01859741|448459733|FG000|Overall Study|Study Terminated by Sponsor|0|||
124682135|NCT01859741|448459734|FG001|Overall Study|Study Terminated by Sponsor|0|||
124682136|NCT01859741|448459735|FG002|Overall Study|Study Terminated by Sponsor|0|||
124682137|NCT01859741|448459736|FG003|Overall Study|Study Terminated by Sponsor|0|||
124682138|NCT01859741|448459737|FG004|Overall Study|Study Terminated by Sponsor|1|||
124682139|NCT01859741|448459738|FG005|Overall Study|Study Terminated by Sponsor|0|||
124682140|NCT01859741|448459739|FG006|Overall Study|Study Terminated by Sponsor|16|||
124682141|NCT01859741|448459740|FG007|Overall Study|Study Terminated by Sponsor|14|||
124682142|NCT01859741|448459733|FG000|Overall Study|Other|0|||
124682143|NCT01859741|448459734|FG001|Overall Study|Other|0|||
124682144|NCT01859741|448459735|FG002|Overall Study|Other|0|||
124682145|NCT01859741|448459736|FG003|Overall Study|Other|0|||
124682146|NCT01859741|448459737|FG004|Overall Study|Other|0|||
124682147|NCT01859741|448459738|FG005|Overall Study|Other|0|||
124682148|NCT01859741|448459739|FG006|Overall Study|Other|2|||
124682149|NCT01859741|448459740|FG007|Overall Study|Other|0|||
124682150|NCT01281306|448459748|FG000|Overall Study|Lack of Efficacy|0|||
124682151|NCT01281306|448459749|FG001|Overall Study|Lack of Efficacy|1|||
124682152|NCT01281306|448459750|FG002|Overall Study|Lack of Efficacy|3|||
124682153|NCT01281306|448459751|FG003|Overall Study|Lack of Efficacy|0|||
124682154|NCT01281306|448459752|FG004|Overall Study|Lack of Efficacy|2|||
124682155|NCT01281306|448459753|FG005|Overall Study|Lack of Efficacy|0|||
124682156|NCT01281306|448459754|FG006|Overall Study|Lack of Efficacy|1|||
124682157|NCT01281306|448459748|FG000|Overall Study|Withdrawal by Subject|1|||
124682158|NCT01281306|448459749|FG001|Overall Study|Withdrawal by Subject|0|||
124682159|NCT01281306|448459750|FG002|Overall Study|Withdrawal by Subject|2|||
124682160|NCT01281306|448459751|FG003|Overall Study|Withdrawal by Subject|4|||
124682161|NCT01281306|448459752|FG004|Overall Study|Withdrawal by Subject|1|||
124682162|NCT01281306|448459753|FG005|Overall Study|Withdrawal by Subject|3|||
124682163|NCT01281306|448459754|FG006|Overall Study|Withdrawal by Subject|1|||
124682164|NCT01281306|448459748|FG000|Overall Study|Protocol deviation|0|||
124682165|NCT01281306|448459749|FG001|Overall Study|Protocol deviation|1|||
124682166|NCT01281306|448459750|FG002|Overall Study|Protocol deviation|1|||
124682167|NCT01281306|448459751|FG003|Overall Study|Protocol deviation|1|||
124682168|NCT01281306|448459752|FG004|Overall Study|Protocol deviation|1|||
124682169|NCT01281306|448459753|FG005|Overall Study|Protocol deviation|0|||
124682170|NCT01281306|448459754|FG006|Overall Study|Protocol deviation|0|||
124682171|NCT01281306|448459748|FG000|Overall Study|Condition no longer requires study drug|1|||
124682172|NCT01281306|448459749|FG001|Overall Study|Condition no longer requires study drug|0|||
124682173|NCT01281306|448459750|FG002|Overall Study|Condition no longer requires study drug|0|||
124682174|NCT01281306|448459751|FG003|Overall Study|Condition no longer requires study drug|0|||
124682175|NCT01281306|448459752|FG004|Overall Study|Condition no longer requires study drug|0|||
124682176|NCT01281306|448459753|FG005|Overall Study|Condition no longer requires study drug|1|||
124682177|NCT01281306|448459754|FG006|Overall Study|Condition no longer requires study drug|1|||
124682178|NCT01281306|448459748|FG000|Overall Study|Lost to Follow-up|1|||
124682179|NCT01281306|448459749|FG001|Overall Study|Lost to Follow-up|0|||
124682180|NCT01281306|448459750|FG002|Overall Study|Lost to Follow-up|0|||
124682181|NCT01281306|448459751|FG003|Overall Study|Lost to Follow-up|2|||
124682182|NCT01281306|448459752|FG004|Overall Study|Lost to Follow-up|0|||
124682183|NCT01281306|448459753|FG005|Overall Study|Lost to Follow-up|0|||
124682184|NCT01281306|448459754|FG006|Overall Study|Lost to Follow-up|1|||
124682185|NCT01281306|448459748|FG000|Overall Study|Death|1|||
124682186|NCT01281306|448459749|FG001|Overall Study|Death|0|||
124682187|NCT01281306|448459750|FG002|Overall Study|Death|0|||
124682188|NCT01281306|448459751|FG003|Overall Study|Death|0|||
124682189|NCT01281306|448459752|FG004|Overall Study|Death|0|||
124682190|NCT01281306|448459753|FG005|Overall Study|Death|0|||
124682191|NCT01281306|448459754|FG006|Overall Study|Death|0|||
124682192|NCT01281306|448459748|FG000|Overall Study|Adverse Event|3|||
124682193|NCT01281306|448459749|FG001|Overall Study|Adverse Event|2|||
124682194|NCT01281306|448459750|FG002|Overall Study|Adverse Event|2|||
124682195|NCT01281306|448459751|FG003|Overall Study|Adverse Event|3|||
124682196|NCT01281306|448459752|FG004|Overall Study|Adverse Event|5|||
124682197|NCT01281306|448459753|FG005|Overall Study|Adverse Event|3|||
124682198|NCT01281306|448459754|FG006|Overall Study|Adverse Event|3|||
124682199|NCT01281306|448459748|FG000|Overall Study|Randomized in error|1|||
124682200|NCT01281306|448459749|FG001|Overall Study|Randomized in error|0|||
124682201|NCT01281306|448459750|FG002|Overall Study|Randomized in error|0|||
124682202|NCT01281306|448459751|FG003|Overall Study|Randomized in error|1|||
124682203|NCT01281306|448459752|FG004|Overall Study|Randomized in error|0|||
124682204|NCT01281306|448459753|FG005|Overall Study|Randomized in error|0|||
124682205|NCT01281306|448459754|FG006|Overall Study|Randomized in error|0|||
124682206|NCT04491994|448459755|FG000|Overall Study|Withdrawal by Subject|10|||
124682207|NCT04491994|448459756|FG001|Overall Study|Withdrawal by Subject|5|||
124682208|NCT04491994|448459755|FG000|Overall Study|developed fever > 3 days|4|||
124682209|NCT04491994|448459756|FG001|Overall Study|developed fever > 3 days|1|||
124682210|NCT04491994|448459755|FG000|Overall Study|Protocol Violation|11|||
124438754|NCT04218084|447567698|FG000|Overall Study|Lost to Follow-up|1|||
124438755|NCT04218084|447567699|FG001|Overall Study|Lost to Follow-up|1|||
124438756|NCT04218084|447567698|FG000|Overall Study|Non-compliance with study drug|1|||
124438757|NCT04218084|447567699|FG001|Overall Study|Non-compliance with study drug|1|||
124438758|NCT04218084|447567698|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
124438759|NCT04218084|447567699|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
124438760|NCT04218084|447567698|FG000|Overall Study|Other|0|||
124438761|NCT04218084|447567699|FG001|Overall Study|Other|1|||
124438762|NCT04218084|447567698|FG000|Overall Study|Ongoing at data cut-off date|62|||
124438763|NCT04218084|447567699|FG001|Overall Study|Ongoing at data cut-off date|58|||
124438764|NCT05580588|447567700|FG000|Overall Study|Lack of Efficacy|12|||
124438765|NCT00211185|447567703|FG000|Overall Study|Death|2|||
124438766|NCT00211185|447567703|FG000|Overall Study|Disease progression|7|||
124438767|NCT00211185|447567703|FG000|Overall Study|Withdrawal by Subject|6|||
124438768|NCT00211185|447567703|FG000|Overall Study|Physician Decision|5|||
124438769|NCT00712673|447567704|FG000|Overall Study|Adverse Event|3|||
124438770|NCT00712673|447567705|FG001|Overall Study|Adverse Event|3|||
124438771|NCT00712673|447567706|FG002|Overall Study|Adverse Event|21|||
124438772|NCT00712673|447567707|FG003|Overall Study|Adverse Event|26|||
124438773|NCT00712673|447567704|FG000|Overall Study|Lack of Efficacy|2|||
124438774|NCT00712673|447567705|FG001|Overall Study|Lack of Efficacy|8|||
124438775|NCT00712673|447567706|FG002|Overall Study|Lack of Efficacy|8|||
124438776|NCT00712673|447567707|FG003|Overall Study|Lack of Efficacy|6|||
124438777|NCT00712673|447567704|FG000|Overall Study|Poor Compliance to Protocol|3|||
124682211|NCT04491994|448459756|FG001|Overall Study|Protocol Violation|2|||
124682212|NCT04491994|448459755|FG000|Overall Study|Lost to Follow-up|4|||
124682213|NCT04491994|448459756|FG001|Overall Study|Lost to Follow-up|3|||
124682214|NCT02320396|448459762|FG000|Overall Study|Adverse Event|2|||
124682215|NCT02320396|448459763|FG001|Overall Study|Adverse Event|2|||
124682216|NCT02320396|448459762|FG000|Overall Study|Pregnancy|0|||
124682217|NCT02320396|448459763|FG001|Overall Study|Pregnancy|1|||
124682218|NCT02320396|448459762|FG000|Overall Study|Protocol Violation|0|||
124682219|NCT02320396|448459763|FG001|Overall Study|Protocol Violation|1|||
124682220|NCT02320396|448459762|FG000|Overall Study|Withdrawal by Subject|2|||
124682221|NCT02320396|448459763|FG001|Overall Study|Withdrawal by Subject|0|||
124682222|NCT02606253|448459764|FG000|Overall Study|Adverse Event|2|||
124682223|NCT02606253|448459765|FG001|Overall Study|Adverse Event|0|||
124682224|NCT02606253|448459766|FG002|Overall Study|Adverse Event|0|||
124682225|NCT02606253|448459764|FG000|Overall Study|Protocol Violation|2|||
124682226|NCT02606253|448459765|FG001|Overall Study|Protocol Violation|1|||
124682227|NCT02606253|448459766|FG002|Overall Study|Protocol Violation|0|||
124682228|NCT02606253|448459764|FG000|Overall Study|Physician Decision|1|||
124682229|NCT02606253|448459765|FG001|Overall Study|Physician Decision|1|||
124682230|NCT02606253|448459766|FG002|Overall Study|Physician Decision|0|||
124682231|NCT03331562|448459769|FG000|Overall Study|Adverse Event|2|||
124682232|NCT03331562|448459770|FG001|Overall Study|Adverse Event|0|||
124682233|NCT03331562|448459769|FG000|Overall Study|Death|1|||
124682234|NCT03331562|448459770|FG001|Overall Study|Death|0|||
124682235|NCT03718000|448459771|FG000|Overall Study|Relocation|2|||
124682236|NCT03718000|448459772|FG001|Overall Study|Relocation|4|||
124682237|NCT03718000|448459771|FG000|Overall Study|Pregnancy|0|||
124682238|NCT03718000|448459772|FG001|Overall Study|Pregnancy|1|||
124682239|NCT02441283|448459775|FG000|Overall Study|Withdrew consent|15|||
124682240|NCT02441283|448459775|FG000|Overall Study|Lost to Follow-up|42|||
124682241|NCT02441283|448459775|FG000|Overall Study|Death|1|||
124682242|NCT02441283|448459775|FG000|Overall Study|Other, not specified|32|||
124682243|NCT05383209|448459776|FG000|Overall Study|Adverse Event: Non-ocular|0|||
124682244|NCT05383209|448459777|FG001|Overall Study|Adverse Event: Non-ocular|1|||
124682245|NCT05383209|448459778|FG002|Overall Study|Adverse Event: Non-ocular|0|||
124682246|NCT05383209|448459776|FG000|Overall Study|Lost to Follow-up|2|||
124682247|NCT05383209|448459777|FG001|Overall Study|Lost to Follow-up|1|||
124682248|NCT05383209|448459778|FG002|Overall Study|Lost to Follow-up|4|||
124682249|NCT05383209|448459776|FG000|Overall Study|Withdrawal by Subject|2|||
124438778|NCT00712673|447567705|FG001|Overall Study|Poor Compliance to Protocol|3|||
124438779|NCT00712673|447567706|FG002|Overall Study|Poor Compliance to Protocol|4|||
124438780|NCT00712673|447567707|FG003|Overall Study|Poor Compliance to Protocol|16|||
124438781|NCT00712673|447567704|FG000|Overall Study|Lost to Follow-up|1|||
124682250|NCT05383209|448459777|FG001|Overall Study|Withdrawal by Subject|0|||
124682251|NCT05383209|448459778|FG002|Overall Study|Withdrawal by Subject|1|||
124682252|NCT05383209|448459776|FG000|Overall Study|Death|1|||
124682253|NCT05383209|448459777|FG001|Overall Study|Death|0|||
124682254|NCT05383209|448459778|FG002|Overall Study|Death|0|||
124682255|NCT05383209|448459776|FG000|Overall Study|Other|0|||
124682256|NCT05383209|448459777|FG001|Overall Study|Other|1|||
124682257|NCT05383209|448459778|FG002|Overall Study|Other|0|||
124682258|NCT01582451|448459779|FG000|Overall Study|Adverse Event|1|||
124682259|NCT01582451|448459780|FG001|Overall Study|Adverse Event|3|||
124682260|NCT01582451|448459779|FG000|Overall Study|Death|3|||
124682261|NCT01582451|448459780|FG001|Overall Study|Death|3|||
124682262|NCT01582451|448459779|FG000|Overall Study|Lost to Follow-up|0|||
124682263|NCT01582451|448459780|FG001|Overall Study|Lost to Follow-up|2|||
124682264|NCT01582451|448459779|FG000|Overall Study|Protocol Violation|11|||
124682265|NCT01582451|448459780|FG001|Overall Study|Protocol Violation|3|||
124682266|NCT01582451|448459779|FG000|Overall Study|Withdrawal by Subject|13|||
124682267|NCT01582451|448459780|FG001|Overall Study|Withdrawal by Subject|9|||
124682268|NCT01582451|448459779|FG000|Overall Study|Physician Decision|3|||
124682269|NCT01582451|448459780|FG001|Overall Study|Physician Decision|0|||
124682270|NCT01582451|448459779|FG000|Overall Study|Sponsor Decision|1|||
124682271|NCT01582451|448459780|FG001|Overall Study|Sponsor Decision|0|||
124682272|NCT00487188|448459781|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
124682273|NCT00487188|448459782|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
124682274|NCT00487188|448459783|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
124682275|NCT00487188|448459781|FG000|Induction Phase|Adverse Event|5|||
124682276|NCT00487188|448459782|FG001|Induction Phase|Adverse Event|0|||
124682277|NCT00487188|448459783|FG002|Induction Phase|Adverse Event|0|||
124682278|NCT00487188|448459781|FG000|Induction Phase|Lack of Efficacy|0|||
124682279|NCT00487188|448459782|FG001|Induction Phase|Lack of Efficacy|1|||
124682280|NCT00487188|448459783|FG002|Induction Phase|Lack of Efficacy|0|||
124682281|NCT00487188|448459781|FG000|Induction Phase|Protocol Violation|1|||
124682282|NCT00487188|448459782|FG001|Induction Phase|Protocol Violation|0|||
124682283|NCT00487188|448459783|FG002|Induction Phase|Protocol Violation|0|||
124682284|NCT00487188|448459781|FG000|Induction Phase|Refused Treatment|1|||
124682285|NCT00487188|448459782|FG001|Induction Phase|Refused Treatment|2|||
124682286|NCT00487188|448459783|FG002|Induction Phase|Refused Treatment|0|||
124682287|NCT00487188|448459781|FG000|Induction Phase|Lost to Follow-up|2|||
124682288|NCT00487188|448459782|FG001|Induction Phase|Lost to Follow-up|2|||
124682289|NCT00487188|448459783|FG002|Induction Phase|Lost to Follow-up|0|||
124682290|NCT00487188|448459781|FG000|Induction Phase|Administrative|0|||
124682291|NCT00487188|448459782|FG001|Induction Phase|Administrative|1|||
124682292|NCT00487188|448459783|FG002|Induction Phase|Administrative|0|||
124682293|NCT00487188|448459781|FG000|Maintenance Phase|Adverse Event|1|||
124682294|NCT00487188|448459782|FG001|Maintenance Phase|Adverse Event|0|||
124682295|NCT00487188|448459783|FG002|Maintenance Phase|Adverse Event|0|||
124682296|NCT00487188|448459781|FG000|Maintenance Phase|Death|1|||
124682297|NCT00487188|448459782|FG001|Maintenance Phase|Death|0|||
124682298|NCT00487188|448459783|FG002|Maintenance Phase|Death|0|||
124682299|NCT00487188|448459781|FG000|Maintenance Phase|Lost to Follow-up|1|||
124682300|NCT00487188|448459782|FG001|Maintenance Phase|Lost to Follow-up|0|||
124682301|NCT00487188|448459783|FG002|Maintenance Phase|Lost to Follow-up|0|||
124682302|NCT00487188|448459781|FG000|Maintenance Phase|Administrative|0|||
124682303|NCT00487188|448459782|FG001|Maintenance Phase|Administrative|0|||
124682304|NCT00487188|448459783|FG002|Maintenance Phase|Administrative|1|||
124682305|NCT03822416|448459787|FG000|Overall Study|Lost to Follow-up|1|||
124682306|NCT03822416|448459788|FG001|Overall Study|Lost to Follow-up|0|||
124682307|NCT03822416|448459787|FG000|Overall Study|Withdrawal by Subject|0|||
124682308|NCT03822416|448459788|FG001|Overall Study|Withdrawal by Subject|1|||
124682309|NCT04666298|448459789|FG000|Overall Study|Subject decision|1|||
124682310|NCT04666298|448459790|FG001|Overall Study|Subject decision|0|||
124682311|NCT04666298|448459791|FG002|Overall Study|Subject decision|0|||
124682312|NCT04666298|448459792|FG003|Overall Study|Subject decision|2|||
124682313|NCT04666298|448459789|FG000|Overall Study|Death|1|||
124682314|NCT04666298|448459790|FG001|Overall Study|Death|0|||
124682315|NCT04666298|448459791|FG002|Overall Study|Death|0|||
124682316|NCT04666298|448459792|FG003|Overall Study|Death|0|||
124682317|NCT04666298|448459789|FG000|Overall Study|Lost to Follow-up|0|||
124682318|NCT04666298|448459790|FG001|Overall Study|Lost to Follow-up|0|||
124682319|NCT04666298|448459791|FG002|Overall Study|Lost to Follow-up|0|||
124682320|NCT04666298|448459792|FG003|Overall Study|Lost to Follow-up|1|||
124682321|NCT04666298|448459789|FG000|Overall Study|Physician Decision|0|||
124682322|NCT04666298|448459790|FG001|Overall Study|Physician Decision|0|||
124682323|NCT04666298|448459791|FG002|Overall Study|Physician Decision|0|||
124880326|NCT03285295|449185484|FG003|Alinity s Anti-HBc|No Results Generated|0|||
124682324|NCT04666298|448459792|FG003|Overall Study|Physician Decision|1|||
124682325|NCT04666298|448459789|FG000|Overall Study|Protocol deviation|0|||
124682326|NCT04666298|448459790|FG001|Overall Study|Protocol deviation|0|||
124682327|NCT04666298|448459791|FG002|Overall Study|Protocol deviation|1|||
124682328|NCT04666298|448459792|FG003|Overall Study|Protocol deviation|0|||
124682329|NCT00226655|448459793|FG000|Overall Study|Death|13|||
124682330|NCT00226655|448459793|FG000|Overall Study|Withdrawal by Subject|15|||
124682331|NCT00226655|448459793|FG000|Overall Study|Adverse Event|35|||
124682332|NCT00226655|448459793|FG000|Overall Study|Physician Decision|6|||
124682333|NCT00226655|448459793|FG000|Overall Study|Clinical deterioration|10|||
124682334|NCT01311661|448459796|FG000|Overall Study|Adverse Event|2|||
124682335|NCT01311661|448459796|FG000|Overall Study|Protocol Violation|3|||
124438782|NCT00712673|447567705|FG001|Overall Study|Lost to Follow-up|0|||
124438783|NCT00712673|447567706|FG002|Overall Study|Lost to Follow-up|2|||
124438784|NCT00712673|447567707|FG003|Overall Study|Lost to Follow-up|0|||
124438785|NCT00712673|447567704|FG000|Overall Study|Withdrawal by Subject|6|||
124438786|NCT00712673|447567705|FG001|Overall Study|Withdrawal by Subject|7|||
124438787|NCT00712673|447567706|FG002|Overall Study|Withdrawal by Subject|15|||
124438788|NCT00712673|447567707|FG003|Overall Study|Withdrawal by Subject|20|||
124438789|NCT00712673|447567704|FG000|Overall Study|Familial and Personal Reasons|5|||
124438790|NCT00712673|447567705|FG001|Overall Study|Familial and Personal Reasons|0|||
124438791|NCT00712673|447567706|FG002|Overall Study|Familial and Personal Reasons|5|||
124438792|NCT00712673|447567707|FG003|Overall Study|Familial and Personal Reasons|2|||
124438793|NCT00712673|447567704|FG000|Overall Study|Investigator's Decision|1|||
124438794|NCT00712673|447567705|FG001|Overall Study|Investigator's Decision|0|||
124438795|NCT00712673|447567706|FG002|Overall Study|Investigator's Decision|0|||
124438796|NCT00712673|447567707|FG003|Overall Study|Investigator's Decision|0|||
124438797|NCT00712673|447567704|FG000|Overall Study|Protocol Violation|0|||
124438798|NCT00712673|447567705|FG001|Overall Study|Protocol Violation|0|||
124438799|NCT00712673|447567706|FG002|Overall Study|Protocol Violation|2|||
124438800|NCT00712673|447567707|FG003|Overall Study|Protocol Violation|0|||
124438801|NCT03603028|447567708|FG000|Overall Study|Withdrawal by Subject|1|||
124438802|NCT00842985|447567713|FG000|Screening|Did not meet entrance requirements|27|||
124438803|NCT00842985|447567713|FG000|First Intervention|Withdrawal by Subject|3|||
124438804|NCT00842985|447567713|FG000|First Intervention|Protocol Violation|3|||
124438805|NCT00842985|447567713|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
124438806|NCT00842985|447567713|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
124438807|NCT01037244|447567714|FG000|Overall Study|Adverse Event|3|||
124438808|NCT01037244|447567715|FG001|Overall Study|Adverse Event|2|||
124438809|NCT01037244|447567716|FG002|Overall Study|Adverse Event|6|||
124438810|NCT01037244|447567717|FG003|Overall Study|Adverse Event|3|||
124438811|NCT01037244|447567714|FG000|Overall Study|Lack of Efficacy|1|||
124438812|NCT01037244|447567715|FG001|Overall Study|Lack of Efficacy|1|||
124438813|NCT01037244|447567716|FG002|Overall Study|Lack of Efficacy|0|||
124438814|NCT01037244|447567717|FG003|Overall Study|Lack of Efficacy|1|||
124438815|NCT01037244|447567714|FG000|Overall Study|Lost to Follow-up|3|||
124438816|NCT01037244|447567715|FG001|Overall Study|Lost to Follow-up|3|||
124438817|NCT01037244|447567716|FG002|Overall Study|Lost to Follow-up|4|||
124438818|NCT01037244|447567717|FG003|Overall Study|Lost to Follow-up|4|||
124438819|NCT01037244|447567714|FG000|Overall Study|Withdrawal by Subject|1|||
124438820|NCT01037244|447567715|FG001|Overall Study|Withdrawal by Subject|5|||
124438821|NCT01037244|447567716|FG002|Overall Study|Withdrawal by Subject|3|||
124438822|NCT01037244|447567717|FG003|Overall Study|Withdrawal by Subject|5|||
124438823|NCT01037244|447567714|FG000|Overall Study|Partner Withdrew Consent|2|||
124438824|NCT01037244|447567715|FG001|Overall Study|Partner Withdrew Consent|1|||
124438825|NCT01037244|447567716|FG002|Overall Study|Partner Withdrew Consent|0|||
124438826|NCT01037244|447567717|FG003|Overall Study|Partner Withdrew Consent|0|||
124438827|NCT01037244|447567714|FG000|Overall Study|Various|3|||
124438828|NCT01037244|447567715|FG001|Overall Study|Various|2|||
124438829|NCT01037244|447567716|FG002|Overall Study|Various|1|||
124438830|NCT01037244|447567717|FG003|Overall Study|Various|1|||
124438831|NCT00690820|447567718|FG000|Period 1|Withdrawal by Subject|0|||
124438832|NCT00690820|447567719|FG001|Period 1|Withdrawal by Subject|1|||
124438833|NCT01768117|447567721|FG000|Overall Study|Lost to Follow-up|1|||
124438834|NCT01768117|447567721|FG000|Overall Study|Withdrawal by Subject|2|||
124438835|NCT01768117|447567721|FG000|Overall Study|Protocol Violation|3|||
124438836|NCT03305731|447567724|FG000|Overall Study|Protocol Violation|1|||
124438837|NCT03658668|447567725|FG000|Overall Study|Time Commitment|1|||
124438838|NCT03658668|447567726|FG001|Overall Study|Time Commitment|1|||
124682336|NCT01311661|448459796|FG000|Overall Study|Withdrawal by Subject|2|||
124682337|NCT00207740|448459797|FG000|Overall Study|Adverse Event|4|||
124682338|NCT00207740|448459798|FG001|Overall Study|Adverse Event|14|||
124682339|NCT00207740|448459799|FG002|Overall Study|Adverse Event|14|||
124438839|NCT01952054|447567727|FG000|Overall Study|Physician Decision|1|||
124438840|NCT01127139|447567728|FG000|Overall Study|Adverse Event|40|||
124682340|NCT00207740|448459800|FG003|Overall Study|Adverse Event|11|||
124682341|NCT00207740|448459797|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124682342|NCT00207740|448459798|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124438841|NCT01127139|447567728|FG000|Overall Study|Incompliance|12|||
124438842|NCT01127139|447567728|FG000|Overall Study|Lack of Efficacy|4|||
124438843|NCT01127139|447567728|FG000|Overall Study|Reason not specified|1|||
124438844|NCT05208866|447567729|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
124438845|NCT02216357|447567730|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
124438846|NCT02216357|447567731|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
124438847|NCT00836095|447567732|FG000|Overall Study|Physician Decision|0|||
124438848|NCT00836095|447567733|FG001|Overall Study|Physician Decision|3|||
124438849|NCT04964414|447567735|FG000|Overall Study|Lost to Follow-up|10|||
124438850|NCT04964414|447567736|FG001|Overall Study|Lost to Follow-up|8|||
124438851|NCT04964414|447567735|FG000|Overall Study|Withdrawal by Subject|1|||
124711991|NCT00690794|448570704|FG000|Overall Study|Protocol Violation|6|||
124682343|NCT00207740|448459799|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
124682344|NCT00207740|448459800|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
124682345|NCT00207740|448459797|FG000|Overall Study|Lost to Follow-up|0|||
124682346|NCT00207740|448459798|FG001|Overall Study|Lost to Follow-up|2|||
124682347|NCT00207740|448459799|FG002|Overall Study|Lost to Follow-up|1|||
124682348|NCT00207740|448459800|FG003|Overall Study|Lost to Follow-up|1|||
124682349|NCT00207740|448459797|FG000|Overall Study|Death|0|||
124682350|NCT00207740|448459798|FG001|Overall Study|Death|0|||
124682351|NCT00207740|448459799|FG002|Overall Study|Death|0|||
124682352|NCT00207740|448459800|FG003|Overall Study|Death|1|||
124682353|NCT00207740|448459797|FG000|Overall Study|Sponsor Directive|22|||
124682354|NCT00207740|448459798|FG001|Overall Study|Sponsor Directive|15|||
124682355|NCT00207740|448459799|FG002|Overall Study|Sponsor Directive|16|||
124682356|NCT00207740|448459800|FG003|Overall Study|Sponsor Directive|21|||
124682357|NCT00207740|448459797|FG000|Overall Study|Other|2|||
124682358|NCT00207740|448459798|FG001|Overall Study|Other|10|||
124682359|NCT00207740|448459799|FG002|Overall Study|Other|7|||
124682360|NCT00207740|448459800|FG003|Overall Study|Other|5|||
124682361|NCT00390013|448459801|FG000|Phase 1|tired|0|||
124682362|NCT00390013|448459802|FG001|Phase 1|tired|0|||
124682363|NCT00390013|448459803|FG002|Phase 1|tired|0|||
124682364|NCT00390013|448459804|FG003|Phase 1|tired|1|||
124682365|NCT00390013|448459801|FG000|Phase 2 First Treatment|tired|1|||
124682366|NCT00390013|448459802|FG001|Phase 2 First Treatment|tired|0|||
124682367|NCT00390013|448459803|FG002|Phase 2 First Treatment|tired|0|||
124682368|NCT00390013|448459804|FG003|Phase 2 First Treatment|tired|0|||
124682369|NCT00390013|448459801|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
124682370|NCT00390013|448459802|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
124682371|NCT00390013|448459803|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
124682372|NCT00390013|448459804|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
124682373|NCT03188822|448459807|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
124682374|NCT03188822|448459807|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
124682375|NCT01977846|448459810|FG000|Total Study - Prospective|Death|0|||
124682376|NCT01977846|448459811|FG001|Total Study - Prospective|Death|1|||
124682377|NCT01977846|448459810|FG000|Total Study - Prospective|Lost to Follow-up|0|||
124682378|NCT01977846|448459811|FG001|Total Study - Prospective|Lost to Follow-up|8|||
124682379|NCT01977846|448459810|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
124682380|NCT01977846|448459811|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
124682381|NCT01977846|448459810|FG000|Total Study - Prospective|Not available at time of visit|0|||
124682382|NCT01977846|448459811|FG001|Total Study - Prospective|Not available at time of visit|5|||
124682383|NCT01977846|448459810|FG000|Total Study - Prospective|No show|0|||
124682384|NCT01977846|448459811|FG001|Total Study - Prospective|No show|1|||
124682385|NCT01977846|448459810|FG000|Total Study - Prospective|Protocol Violation|0|||
124682386|NCT01977846|448459811|FG001|Total Study - Prospective|Protocol Violation|1|||
124682387|NCT01349595|448459814|FG000|Overall Study|Lack of funding|2|||
124682388|NCT01349595|448459815|FG001|Overall Study|Lack of funding|2|||
124682389|NCT04584788|448459817|FG000|Overall Study|Physician Decision|8|||
124682390|NCT04584788|448459817|FG000|Overall Study|Withdrawal by Subject|1|||
124682391|NCT04584788|448459817|FG000|Overall Study|Adverse Event|3|||
124682392|NCT02328105|448461718|FG000|Overall Study|Death|6|||
124682393|NCT02328105|448461718|FG000|Overall Study|Withdrawal by Subject|1|||
124682394|NCT02328105|448461718|FG000|Overall Study|Still On Study in Follow-Up|4|||
124682395|NCT00614393|448461719|FG000|Overall Study|Adverse Event|20|||
124682396|NCT00614393|448461720|FG001|Overall Study|Adverse Event|2|||
124682397|NCT00614393|448461721|FG002|Overall Study|Adverse Event|3|||
124682398|NCT00614393|448461722|FG003|Overall Study|Adverse Event|13|||
124682399|NCT00614393|448461723|FG004|Overall Study|Adverse Event|21|||
124682400|NCT00614393|448461719|FG000|Overall Study|Lost to Follow-up|0|||
124682401|NCT00614393|448461720|FG001|Overall Study|Lost to Follow-up|0|||
124682402|NCT00614393|448461721|FG002|Overall Study|Lost to Follow-up|0|||
124682403|NCT00614393|448461722|FG003|Overall Study|Lost to Follow-up|1|||
124682404|NCT00614393|448461723|FG004|Overall Study|Lost to Follow-up|2|||
124682405|NCT00614393|448461719|FG000|Overall Study|Physician Decision|17|||
124682406|NCT00614393|448461720|FG001|Overall Study|Physician Decision|0|||
124682407|NCT00614393|448461721|FG002|Overall Study|Physician Decision|1|||
124682408|NCT00614393|448461722|FG003|Overall Study|Physician Decision|8|||
124682409|NCT00614393|448461723|FG004|Overall Study|Physician Decision|9|||
124682410|NCT00614393|448461719|FG000|Overall Study|Progressive Disease|118|||
124682411|NCT00614393|448461720|FG001|Overall Study|Progressive Disease|5|||
124682412|NCT00614393|448461721|FG002|Overall Study|Progressive Disease|5|||
124682413|NCT00614393|448461722|FG003|Overall Study|Progressive Disease|138|||
124682414|NCT00614393|448461723|FG004|Overall Study|Progressive Disease|130|||
124682415|NCT00614393|448461719|FG000|Overall Study|Protocol Violation|1|||
124682416|NCT00614393|448461720|FG001|Overall Study|Protocol Violation|0|||
124682417|NCT00614393|448461721|FG002|Overall Study|Protocol Violation|0|||
124682418|NCT00614393|448461722|FG003|Overall Study|Protocol Violation|0|||
124682419|NCT00614393|448461723|FG004|Overall Study|Protocol Violation|0|||
124682420|NCT00614393|448461719|FG000|Overall Study|Terminated by Sponsor|0|||
124682421|NCT00614393|448461720|FG001|Overall Study|Terminated by Sponsor|0|||
124880327|NCT03285295|449185485|FG004|Alinity s Anti-HBc|No Results Generated|0|||
124880328|NCT03285295|449185481|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
124682422|NCT00614393|448461721|FG002|Overall Study|Terminated by Sponsor|0|||
124682423|NCT00614393|448461722|FG003|Overall Study|Terminated by Sponsor|0|||
124682424|NCT00614393|448461723|FG004|Overall Study|Terminated by Sponsor|1|||
124682425|NCT00614393|448461719|FG000|Overall Study|Withdrawal by Subject|20|||
124682426|NCT00614393|448461720|FG001|Overall Study|Withdrawal by Subject|1|||
124682427|NCT00614393|448461721|FG002|Overall Study|Withdrawal by Subject|1|||
124682428|NCT00614393|448461722|FG003|Overall Study|Withdrawal by Subject|16|||
124682429|NCT00614393|448461723|FG004|Overall Study|Withdrawal by Subject|13|||
124682430|NCT00614393|448461719|FG000|Overall Study|Other|4|||
124682431|NCT00614393|448461720|FG001|Overall Study|Other|0|||
124682432|NCT00614393|448461721|FG002|Overall Study|Other|0|||
124682433|NCT00614393|448461722|FG003|Overall Study|Other|4|||
124682434|NCT00614393|448461723|FG004|Overall Study|Other|2|||
124682435|NCT00614393|448461719|FG000|Overall Study|Not Treated|0|||
124682436|NCT00614393|448461720|FG001|Overall Study|Not Treated|0|||
124682437|NCT00614393|448461721|FG002|Overall Study|Not Treated|0|||
124682438|NCT00614393|448461722|FG003|Overall Study|Not Treated|0|||
124682439|NCT00614393|448461723|FG004|Overall Study|Not Treated|2|||
124682440|NCT01588509|448461724|FG000|Overall Study|Lost to Follow-up|1|||
124682441|NCT01588509|448461725|FG001|Overall Study|Lost to Follow-up|0|||
124682442|NCT00855582|448461729|FG000|Overall Study|Adverse Event|2|||
124682443|NCT00855582|448461730|FG001|Overall Study|Adverse Event|6|||
124682444|NCT00855582|448461731|FG002|Overall Study|Adverse Event|3|||
124682445|NCT00855582|448461729|FG000|Overall Study|Death|1|||
124682446|NCT00855582|448461730|FG001|Overall Study|Death|0|||
124682447|NCT00855582|448461731|FG002|Overall Study|Death|0|||
124682448|NCT00855582|448461729|FG000|Overall Study|Lack of Efficacy|1|||
124682449|NCT00855582|448461730|FG001|Overall Study|Lack of Efficacy|3|||
124682450|NCT00855582|448461731|FG002|Overall Study|Lack of Efficacy|8|||
124682451|NCT00855582|448461729|FG000|Overall Study|Lost to Follow-up|1|||
124682452|NCT00855582|448461730|FG001|Overall Study|Lost to Follow-up|3|||
124682453|NCT00855582|448461731|FG002|Overall Study|Lost to Follow-up|1|||
124682454|NCT00855582|448461729|FG000|Overall Study|Physician Decision|0|||
124682455|NCT00855582|448461730|FG001|Overall Study|Physician Decision|0|||
124682456|NCT00855582|448461731|FG002|Overall Study|Physician Decision|1|||
124682457|NCT00855582|448461729|FG000|Overall Study|Protocol Violation|6|||
124682458|NCT00855582|448461730|FG001|Overall Study|Protocol Violation|2|||
124682459|NCT00855582|448461731|FG002|Overall Study|Protocol Violation|6|||
124682460|NCT00855582|448461729|FG000|Overall Study|Entry Criteria Not Met|8|||
124682461|NCT00855582|448461730|FG001|Overall Study|Entry Criteria Not Met|6|||
124682462|NCT00855582|448461731|FG002|Overall Study|Entry Criteria Not Met|3|||
124682463|NCT00855582|448461729|FG000|Overall Study|Withdrawal by Subject|7|||
124682464|NCT00855582|448461730|FG001|Overall Study|Withdrawal by Subject|4|||
124682465|NCT00855582|448461731|FG002|Overall Study|Withdrawal by Subject|8|||
124682466|NCT03345004|448461732|FG000|Overall Study|Physician Decision|1|||
124682467|NCT03345004|448461733|FG001|Overall Study|Physician Decision|0|||
124682468|NCT03345004|448461732|FG000|Overall Study|Withdrawal by Subject|0|||
124682469|NCT03345004|448461733|FG001|Overall Study|Withdrawal by Subject|1|||
124682470|NCT01013753|448461734|FG000|Overall Study|Adverse Event|8|||
124682471|NCT01013753|448461734|FG000|Overall Study|Protocol Violation|3|||
124682472|NCT01013753|448461734|FG000|Overall Study|Lost to Follow-up|1|||
124682473|NCT01013753|448461734|FG000|Overall Study|Withdrawal by Subject|2|||
124682474|NCT01013753|448461734|FG000|Overall Study|Other|2|||
124682475|NCT04757636|448461735|FG000|Overall Study|Adverse Event|25|||
124682476|NCT04757636|448461736|FG001|Overall Study|Adverse Event|8|||
124682477|NCT04757636|448461737|FG002|Overall Study|Adverse Event|11|||
124682478|NCT04757636|448461735|FG000|Overall Study|Death|9|||
124682479|NCT04757636|448461736|FG001|Overall Study|Death|12|||
124682480|NCT04757636|448461737|FG002|Overall Study|Death|6|||
124682481|NCT04757636|448461735|FG000|Overall Study|Lack of Efficacy|2|||
124682482|NCT04757636|448461736|FG001|Overall Study|Lack of Efficacy|0|||
124682483|NCT04757636|448461737|FG002|Overall Study|Lack of Efficacy|0|||
124682484|NCT04757636|448461735|FG000|Overall Study|Lost to Follow-up|1|||
124682485|NCT04757636|448461736|FG001|Overall Study|Lost to Follow-up|6|||
124682486|NCT04757636|448461737|FG002|Overall Study|Lost to Follow-up|7|||
124682487|NCT04757636|448461735|FG000|Overall Study|Physician Decision|1|||
124880329|NCT03285295|449185482|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
124880330|NCT03285295|449185483|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
124880331|NCT03285295|449185484|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
124880332|NCT03285295|449185485|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
124880333|NCT03285295|449185481|FG000|Alinity s Chagas|Protocol Violation|76|||
124880334|NCT03285295|449185482|FG001|Alinity s Chagas|Protocol Violation|0|||
124880335|NCT03285295|449185483|FG002|Alinity s Chagas|Protocol Violation|0|||
124880336|NCT03285295|449185484|FG003|Alinity s Chagas|Protocol Violation|0|||
124880337|NCT03285295|449185485|FG004|Alinity s Chagas|Protocol Violation|0|||
124880338|NCT03285295|449185481|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
124880339|NCT03285295|449185482|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
124880340|NCT03285295|449185483|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
124880341|NCT03285295|449185484|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
124880342|NCT03285295|449185485|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
124880343|NCT03285295|449185481|FG000|Alinity s Chagas|No Results Generated|105|||
124880344|NCT03285295|449185482|FG001|Alinity s Chagas|No Results Generated|0|||
124880345|NCT03285295|449185483|FG002|Alinity s Chagas|No Results Generated|0|||
124880346|NCT03285295|449185484|FG003|Alinity s Chagas|No Results Generated|0|||
124880347|NCT03285295|449185485|FG004|Alinity s Chagas|No Results Generated|0|||
124880348|NCT03285295|449185481|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
124880349|NCT03285295|449185482|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
124880350|NCT03285295|449185483|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
124880351|NCT03285295|449185484|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
124880352|NCT03285295|449185485|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
124880353|NCT02746575|449185486|FG000|Overall Study|Surgery cancelled or time chaned|13|||
124880354|NCT02746575|449185486|FG000|Overall Study|Received epidural|10|||
124682488|NCT04757636|448461736|FG001|Overall Study|Physician Decision|3|||
124682489|NCT04757636|448461737|FG002|Overall Study|Physician Decision|4|||
124682490|NCT04757636|448461735|FG000|Overall Study|Withdrawal by Subject|20|||
124682491|NCT04757636|448461736|FG001|Overall Study|Withdrawal by Subject|23|||
124682492|NCT04757636|448461737|FG002|Overall Study|Withdrawal by Subject|18|||
124880355|NCT02746575|449185486|FG000|Overall Study|Withdrawal by Subject|3|||
124880356|NCT02746575|449185486|FG000|Overall Study|Bradycardia/hypotension|9|||
124880357|NCT02746575|449185486|FG000|Overall Study|Study paused|8|||
124880358|NCT02746575|449185486|FG000|Overall Study|put on beta-blocker|3|||
124880359|NCT02746575|449185486|FG000|Overall Study|type of surgery|1|||
124880360|NCT02746575|449185486|FG000|Overall Study|typ of surgery|1|||
124880361|NCT02746575|449185486|FG000|Overall Study|PI unavailable|1|||
124880362|NCT02746575|449185486|FG000|Overall Study|Unknown history of CVA|1|||
124880363|NCT00957931|449185488|FG000|Overall Study|Death|4|||
124880364|NCT00857805|449185489|FG000|Overall Study|Withdrawal by Subject|1|||
124880365|NCT00857805|449185490|FG001|Overall Study|Withdrawal by Subject|1|||
124880366|NCT04867785|449185491|FG000|Overall Study|Adverse Event|1|||
124682493|NCT04757636|448461735|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
124880367|NCT04867785|449185492|FG001|Overall Study|Adverse Event|0|||
124880368|NCT04867785|449185493|FG002|Overall Study|Adverse Event|1|||
124880369|NCT04867785|449185494|FG003|Overall Study|Adverse Event|0|||
124880370|NCT04867785|449185495|FG004|Overall Study|Adverse Event|0|||
124880371|NCT04867785|449185496|FG005|Overall Study|Adverse Event|0|||
124880372|NCT04867785|449185497|FG006|Overall Study|Adverse Event|0|||
124880373|NCT04867785|449185498|FG007|Overall Study|Adverse Event|2|||
124880374|NCT04867785|449185491|FG000|Overall Study|Lost to Follow-up|4|||
124880375|NCT04867785|449185492|FG001|Overall Study|Lost to Follow-up|4|||
124880376|NCT04867785|449185493|FG002|Overall Study|Lost to Follow-up|3|||
124880377|NCT04867785|449185494|FG003|Overall Study|Lost to Follow-up|2|||
124880378|NCT04867785|449185495|FG004|Overall Study|Lost to Follow-up|0|||
124880379|NCT04867785|449185496|FG005|Overall Study|Lost to Follow-up|1|||
124880380|NCT04867785|449185497|FG006|Overall Study|Lost to Follow-up|0|||
124880381|NCT04867785|449185498|FG007|Overall Study|Lost to Follow-up|1|||
124880382|NCT04867785|449185491|FG000|Overall Study|Withdrawal by Subject|6|||
124880383|NCT04867785|449185492|FG001|Overall Study|Withdrawal by Subject|2|||
124880384|NCT04867785|449185493|FG002|Overall Study|Withdrawal by Subject|2|||
124880385|NCT04867785|449185494|FG003|Overall Study|Withdrawal by Subject|1|||
124880386|NCT04867785|449185495|FG004|Overall Study|Withdrawal by Subject|2|||
124880387|NCT04867785|449185496|FG005|Overall Study|Withdrawal by Subject|0|||
124880388|NCT04867785|449185497|FG006|Overall Study|Withdrawal by Subject|2|||
124880389|NCT04867785|449185498|FG007|Overall Study|Withdrawal by Subject|5|||
124880390|NCT04867785|449185491|FG000|Overall Study|Physician Decision|0|||
124880391|NCT04867785|449185492|FG001|Overall Study|Physician Decision|0|||
124880392|NCT04867785|449185493|FG002|Overall Study|Physician Decision|0|||
124880393|NCT04867785|449185494|FG003|Overall Study|Physician Decision|0|||
124880394|NCT04867785|449185495|FG004|Overall Study|Physician Decision|0|||
124880395|NCT04867785|449185496|FG005|Overall Study|Physician Decision|0|||
124880396|NCT04867785|449185497|FG006|Overall Study|Physician Decision|0|||
124880397|NCT04867785|449185498|FG007|Overall Study|Physician Decision|1|||
124880398|NCT04867785|449185491|FG000|Overall Study|Inadvertent Enrollment|0|||
124880399|NCT04867785|449185492|FG001|Overall Study|Inadvertent Enrollment|0|||
124880400|NCT04867785|449185493|FG002|Overall Study|Inadvertent Enrollment|0|||
124880401|NCT04867785|449185494|FG003|Overall Study|Inadvertent Enrollment|1|||
124880402|NCT04867785|449185495|FG004|Overall Study|Inadvertent Enrollment|1|||
124880403|NCT04867785|449185496|FG005|Overall Study|Inadvertent Enrollment|0|||
124880404|NCT04867785|449185497|FG006|Overall Study|Inadvertent Enrollment|0|||
124880405|NCT04867785|449185498|FG007|Overall Study|Inadvertent Enrollment|1|||
124880406|NCT04867785|449185491|FG000|Overall Study|Eligibility Criteria Not Met|0|||
124880407|NCT04867785|449185492|FG001|Overall Study|Eligibility Criteria Not Met|0|||
124880408|NCT04867785|449185493|FG002|Overall Study|Eligibility Criteria Not Met|0|||
124880409|NCT04867785|449185494|FG003|Overall Study|Eligibility Criteria Not Met|0|||
124880410|NCT04867785|449185495|FG004|Overall Study|Eligibility Criteria Not Met|0|||
124880411|NCT04867785|449185496|FG005|Overall Study|Eligibility Criteria Not Met|0|||
124880412|NCT04867785|449185497|FG006|Overall Study|Eligibility Criteria Not Met|0|||
124880413|NCT04867785|449185498|FG007|Overall Study|Eligibility Criteria Not Met|1|||
124880414|NCT01289041|449185499|FG000|Overall Study|Adverse Event|24|||
124880415|NCT01289041|449185499|FG000|Overall Study|Physician Decision|1|||
124880416|NCT01289041|449185499|FG000|Overall Study|Progressive Disease|41|||
124880417|NCT01289041|449185499|FG000|Overall Study|Withdrawal by Subject|3|||
124880418|NCT01289041|449185499|FG000|Overall Study|Death|1|||
124880419|NCT03239873|449185506|FG000|Overall Study|Lost to Follow-up|15|||
124880420|NCT03239873|449185507|FG001|Overall Study|Lost to Follow-up|16|||
124880421|NCT03239873|449185506|FG000|Overall Study|Physician Decision|1|||
124880422|NCT03239873|449185507|FG001|Overall Study|Physician Decision|0|||
124880423|NCT03239873|449185506|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
124880424|NCT03239873|449185507|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
124880425|NCT03239873|449185506|FG000|Overall Study|Withdrawal by Subject|2|||
124880426|NCT03239873|449185507|FG001|Overall Study|Withdrawal by Subject|0|||
124880427|NCT03239873|449185506|FG000|Overall Study|Contraindication to study medication|1|||
124880428|NCT03239873|449185507|FG001|Overall Study|Contraindication to study medication|0|||
124880429|NCT03239873|449185506|FG000|Overall Study|Protocol Violation|1|||
124880430|NCT03239873|449185507|FG001|Overall Study|Protocol Violation|0|||
124880431|NCT02670538|449185512|FG000|Overall Study|Withdrawal of Consent|8|||
124880432|NCT02670538|449185513|FG001|Overall Study|Withdrawal of Consent|6|||
124880433|NCT02670538|449185514|FG002|Overall Study|Withdrawal of Consent|5|||
124880434|NCT02670538|449185512|FG000|Overall Study|Lost to Follow-up|8|||
124880435|NCT02670538|449185513|FG001|Overall Study|Lost to Follow-up|12|||
124880436|NCT02670538|449185514|FG002|Overall Study|Lost to Follow-up|7|||
124880437|NCT02670538|449185512|FG000|Overall Study|Adverse Event|5|||
124880438|NCT02670538|449185513|FG001|Overall Study|Adverse Event|5|||
124880439|NCT02670538|449185514|FG002|Overall Study|Adverse Event|11|||
124880440|NCT02670538|449185512|FG000|Overall Study|Lack of Efficacy|7|||
124880441|NCT02670538|449185513|FG001|Overall Study|Lack of Efficacy|1|||
124880442|NCT02670538|449185514|FG002|Overall Study|Lack of Efficacy|2|||
124880443|NCT02670538|449185512|FG000|Overall Study|Protocol Violation|3|||
124880444|NCT02670538|449185513|FG001|Overall Study|Protocol Violation|4|||
124880445|NCT02670538|449185514|FG002|Overall Study|Protocol Violation|1|||
124880446|NCT02670538|449185512|FG000|Overall Study|Noncompliance with Study Drug|1|||
124880447|NCT02670538|449185513|FG001|Overall Study|Noncompliance with Study Drug|3|||
124880448|NCT02670538|449185514|FG002|Overall Study|Noncompliance with Study Drug|2|||
124880449|NCT02670538|449185512|FG000|Overall Study|Other Miscellaneous Reasons|0|||
124880450|NCT02670538|449185513|FG001|Overall Study|Other Miscellaneous Reasons|1|||
124682494|NCT04757636|448461736|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
124682495|NCT04757636|448461737|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
124682496|NCT04757636|448461735|FG000|Overall Study|Study Terminated by Sponsor|103|||
124682497|NCT04757636|448461736|FG001|Overall Study|Study Terminated by Sponsor|104|||
124682498|NCT04757636|448461737|FG002|Overall Study|Study Terminated by Sponsor|114|||
124682499|NCT04757636|448461735|FG000|Overall Study|Sponsor Decision|0|||
124880451|NCT02670538|449185514|FG002|Overall Study|Other Miscellaneous Reasons|2|||
124880452|NCT00674323|449185515|FG000|Overall Study|Adverse Event|0|||
124880453|NCT00674323|449185516|FG001|Overall Study|Adverse Event|1|||
124880454|NCT00674323|449185517|FG002|Overall Study|Adverse Event|0|||
124880455|NCT00674323|449185515|FG000|Overall Study|Protocol Violation|1|||
124880456|NCT00674323|449185516|FG001|Overall Study|Protocol Violation|0|||
124438852|NCT04964414|447567736|FG001|Overall Study|Withdrawal by Subject|1|||
124438853|NCT05116046|447567739|FG000|Overall Study|Withdrawal by parent/guardian|2|||
124438854|NCT05116046|447567740|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124438855|NCT05116046|447567741|FG002|Overall Study|Withdrawal by parent/guardian|1|||
124438856|NCT05116046|447567739|FG000|Overall Study|Study terminated by sponsor|14|||
124438857|NCT05116046|447567740|FG001|Overall Study|Study terminated by sponsor|16|||
124438858|NCT05116046|447567741|FG002|Overall Study|Study terminated by sponsor|1|||
124438859|NCT02745392|447567745|FG000|Overall Study|Lost to Follow-up|0|||
124438860|NCT02745392|447567746|FG001|Overall Study|Lost to Follow-up|1|||
124438861|NCT02745392|447567747|FG002|Overall Study|Lost to Follow-up|0|||
124438862|NCT02745392|447567748|FG003|Overall Study|Lost to Follow-up|0|||
124438863|NCT00899548|447567751|FG000|Overall Study|Physician Decision|3|||
124438864|NCT04781387|447567757|FG000|Overall Study|Withdrawal by Subject|1|||
124438865|NCT04781387|447567758|FG001|Overall Study|Withdrawal by Subject|0|||
124438866|NCT04781387|447567759|FG002|Overall Study|Withdrawal by Subject|1|||
124438867|NCT04781387|447567757|FG000|Overall Study|Lost to Follow-up|1|||
124438868|NCT04781387|447567758|FG001|Overall Study|Lost to Follow-up|0|||
124438869|NCT04781387|447567759|FG002|Overall Study|Lost to Follow-up|0|||
124438870|NCT01745848|447567760|FG000|Overall Study|Adverse Event|6|||
124682500|NCT04757636|448461736|FG001|Overall Study|Sponsor Decision|0|||
124682501|NCT04757636|448461737|FG002|Overall Study|Sponsor Decision|1|||
124682502|NCT04757636|448461735|FG000|Overall Study|Randomized in Error|0|||
124682503|NCT04757636|448461736|FG001|Overall Study|Randomized in Error|0|||
124682504|NCT04757636|448461737|FG002|Overall Study|Randomized in Error|2|||
124682505|NCT02097277|448461747|FG000|Overall Study|Subject no longer meets study criteria|0|||
124880457|NCT00674323|449185517|FG002|Overall Study|Protocol Violation|0|||
124880458|NCT02045433|449185522|FG000|Overall Study|Withdrawal by Subject|1|||
124880459|NCT01112514|449185523|FG000|Overall Study|Lost to Follow-up|1|||
124438871|NCT00679627|447567761|FG000|Overall Study|Death|41|||
124438872|NCT00679627|447567762|FG001|Overall Study|Death|29|||
124438873|NCT00679627|447567761|FG000|Overall Study|Adverse Event|43|||
124438874|NCT00679627|447567762|FG001|Overall Study|Adverse Event|53|||
124880460|NCT02176421|449185524|FG000|Overall Study|Lost to Follow-up|4|||
124880461|NCT02176421|449185524|FG000|Overall Study|Adverse Event|1|||
124880462|NCT02145078|449185527|FG000|Overall Study|Death|1|||
124880463|NCT02145078|449185527|FG000|Overall Study|Reason not given|3|||
124880464|NCT01077362|449185528|FG000|Overall Study|Lack of Efficacy|13|||
124880465|NCT01077362|449185529|FG001|Overall Study|Lack of Efficacy|8|||
124880466|NCT01077362|449185530|FG002|Overall Study|Lack of Efficacy|10|||
124880467|NCT01077362|449185528|FG000|Overall Study|Lost to Follow-up|1|||
124880468|NCT01077362|449185529|FG001|Overall Study|Lost to Follow-up|0|||
124880469|NCT01077362|449185530|FG002|Overall Study|Lost to Follow-up|3|||
124880470|NCT01077362|449185528|FG000|Overall Study|Adverse Event|12|||
124880471|NCT01077362|449185529|FG001|Overall Study|Adverse Event|7|||
124880472|NCT01077362|449185530|FG002|Overall Study|Adverse Event|4|||
124880473|NCT01077362|449185528|FG000|Overall Study|Withdrawal by Subject|5|||
124880474|NCT01077362|449185529|FG001|Overall Study|Withdrawal by Subject|3|||
124880475|NCT01077362|449185530|FG002|Overall Study|Withdrawal by Subject|5|||
124880476|NCT01077362|449185528|FG000|Overall Study|Other|0|||
124880477|NCT01077362|449185529|FG001|Overall Study|Other|1|||
124880478|NCT01077362|449185530|FG002|Overall Study|Other|2|||
124880479|NCT01872910|449185531|FG000|Overall Study|Lost to Follow-up|2|||
124880480|NCT01872910|449185532|FG001|Overall Study|Lost to Follow-up|0|||
124880481|NCT01872910|449185533|FG002|Overall Study|Lost to Follow-up|2|||
124880482|NCT01872910|449185534|FG003|Overall Study|Lost to Follow-up|0|||
124880483|NCT01872910|449185535|FG004|Overall Study|Lost to Follow-up|0|||
124880484|NCT01872910|449185536|FG005|Overall Study|Lost to Follow-up|0|||
124880485|NCT03101241|449185541|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
124880486|NCT03101241|449185542|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
124880487|NCT03101241|449185541|FG000|Overall Study|Participant withdrew consent|3|||
124880488|NCT03101241|449185542|FG001|Overall Study|Participant withdrew consent|1|||
124880489|NCT03101241|449185541|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
124880490|NCT03101241|449185542|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
124880491|NCT03101241|449185541|FG000|Overall Study|Lost to Follow-up|2|||
124880492|NCT03101241|449185542|FG001|Overall Study|Lost to Follow-up|0|||
124880493|NCT03101241|449185541|FG000|Overall Study|Lack of Efficacy|0|||
124880494|NCT03101241|449185542|FG001|Overall Study|Lack of Efficacy|1|||
124880495|NCT03101241|449185541|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
124880496|NCT03101241|449185542|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
124880497|NCT01678820|449185544|FG000|Overall Study|Study Terminated by Sponsor|45|||
124880498|NCT01678820|449185545|FG001|Overall Study|Study Terminated by Sponsor|43|||
124880499|NCT01678820|449185546|FG002|Overall Study|Study Terminated by Sponsor|43|||
124880500|NCT01678820|449185544|FG000|Overall Study|Withdrawal by Subject|2|||
124880501|NCT01678820|449185545|FG001|Overall Study|Withdrawal by Subject|5|||
124682506|NCT02097277|448461748|FG001|Overall Study|Subject no longer meets study criteria|1|||
124682507|NCT02097277|448461749|FG002|Overall Study|Subject no longer meets study criteria|0|||
124682508|NCT02097277|448461750|FG003|Overall Study|Subject no longer meets study criteria|1|||
124682509|NCT02097277|448461751|FG004|Overall Study|Subject no longer meets study criteria|0|||
124682510|NCT02097277|448461747|FG000|Overall Study|Subject request to discontinue treatment|0|||
124682511|NCT02097277|448461748|FG001|Overall Study|Subject request to discontinue treatment|0|||
124682512|NCT02097277|448461749|FG002|Overall Study|Subject request to discontinue treatment|0|||
124682513|NCT02097277|448461750|FG003|Overall Study|Subject request to discontinue treatment|0|||
124682514|NCT02097277|448461751|FG004|Overall Study|Subject request to discontinue treatment|1|||
124682515|NCT02097277|448461747|FG000|Overall Study|Lost to Follow-up|0|||
124880502|NCT01678820|449185546|FG002|Overall Study|Withdrawal by Subject|2|||
124880503|NCT01678820|449185544|FG000|Overall Study|Protocol Specified Criteria|2|||
124880504|NCT01678820|449185545|FG001|Overall Study|Protocol Specified Criteria|3|||
124880505|NCT01678820|449185546|FG002|Overall Study|Protocol Specified Criteria|1|||
124880506|NCT01678820|449185544|FG000|Overall Study|Adverse Event|2|||
124880507|NCT01678820|449185545|FG001|Overall Study|Adverse Event|2|||
124880508|NCT01678820|449185546|FG002|Overall Study|Adverse Event|2|||
124880509|NCT01678820|449185544|FG000|Overall Study|Lost to Follow-up|7|||
124438875|NCT00679627|447567761|FG000|Overall Study|Withdrawal by Subject|168|||
124438876|NCT00679627|447567762|FG001|Overall Study|Withdrawal by Subject|172|||
124438877|NCT00679627|447567761|FG000|Overall Study|Lost to Follow-up|22|||
124682516|NCT02097277|448461748|FG001|Overall Study|Lost to Follow-up|1|||
124682517|NCT02097277|448461749|FG002|Overall Study|Lost to Follow-up|1|||
124682518|NCT02097277|448461750|FG003|Overall Study|Lost to Follow-up|0|||
124682519|NCT02097277|448461751|FG004|Overall Study|Lost to Follow-up|0|||
124682520|NCT02097277|448461747|FG000|Overall Study|Withdrawal by Subject|2|||
124682521|NCT02097277|448461748|FG001|Overall Study|Withdrawal by Subject|1|||
124682522|NCT02097277|448461749|FG002|Overall Study|Withdrawal by Subject|0|||
124682523|NCT02097277|448461750|FG003|Overall Study|Withdrawal by Subject|1|||
124682524|NCT02097277|448461751|FG004|Overall Study|Withdrawal by Subject|0|||
124682525|NCT02097277|448461747|FG000|Overall Study|Adverse Event|0|||
124682526|NCT02097277|448461748|FG001|Overall Study|Adverse Event|0|||
124682527|NCT02097277|448461749|FG002|Overall Study|Adverse Event|1|||
124682528|NCT02097277|448461750|FG003|Overall Study|Adverse Event|2|||
124682529|NCT02097277|448461751|FG004|Overall Study|Adverse Event|0|||
124682530|NCT01091259|448461752|FG000|Overall Study|Adverse Event|3|||
124682531|NCT01091259|448461752|FG000|Overall Study|Lack of Efficacy|2|||
124682532|NCT03813654|448461753|FG000|Overall Study|Protocol Violation|0|||
124682533|NCT03813654|448461754|FG001|Overall Study|Protocol Violation|1|||
124682534|NCT03813654|448461755|FG002|Overall Study|Protocol Violation|2|||
124682535|NCT03813654|448461753|FG000|Overall Study|Withdrawal by Subject|1|||
124682536|NCT03813654|448461754|FG001|Overall Study|Withdrawal by Subject|0|||
124682537|NCT03813654|448461755|FG002|Overall Study|Withdrawal by Subject|0|||
124682538|NCT01208051|448461756|FG000|Total Enrollment|Withdrawal by Subject|0|||
124682539|NCT01208051|448461757|FG001|Total Enrollment|Withdrawal by Subject|1|||
124682540|NCT01208051|448461758|FG002|Total Enrollment|Withdrawal by Subject|0|||
124682541|NCT01208051|448461759|FG003|Total Enrollment|Withdrawal by Subject|0|||
124682542|NCT01208051|448461760|FG004|Total Enrollment|Withdrawal by Subject|2|||
124682543|NCT01208051|448461756|FG000|Total Enrollment|Brain metastases|0|||
124682544|NCT01208051|448461757|FG001|Total Enrollment|Brain metastases|0|||
124682545|NCT01208051|448461758|FG002|Total Enrollment|Brain metastases|1|||
124682546|NCT01208051|448461759|FG003|Total Enrollment|Brain metastases|0|||
124682547|NCT01208051|448461760|FG004|Total Enrollment|Brain metastases|0|||
124682548|NCT00973973|448461765|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
124682549|NCT00973973|448461766|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
124682550|NCT00973973|448461765|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
124682551|NCT00973973|448461766|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
124682552|NCT00973973|448461765|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
124682553|NCT00973973|448461766|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
124682554|NCT00973973|448461765|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
124682555|NCT00973973|448461766|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
124682556|NCT00973973|448461765|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
124682557|NCT00973973|448461766|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
124682558|NCT00973973|448461765|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
124682559|NCT00973973|448461766|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
124682560|NCT00973973|448461765|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
124682561|NCT00973973|448461766|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
124682562|NCT00973973|448461765|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
124682563|NCT00973973|448461766|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
124682564|NCT00973973|448461765|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
124682565|NCT00973973|448461766|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
124682566|NCT00973973|448461765|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
124682567|NCT00973973|448461766|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
124682568|NCT00973973|448461765|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
124682569|NCT00973973|448461766|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
124682570|NCT00973973|448461765|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
124682571|NCT00973973|448461766|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
124682572|NCT01541748|448461767|FG000|Overall Study|Lost to Follow-up|17|||
124682573|NCT01541748|448461767|FG000|Overall Study|Moved out of state|1|||
124682574|NCT01541748|448461767|FG000|Overall Study|Withdrawal by Subject|7|||
124682575|NCT01541748|448461767|FG000|Overall Study|Screen failure|5|||
124682576|NCT01541748|448461767|FG000|Overall Study|Did not receive study device|1|||
124682577|NCT06057064|448461768|FG000|Overall Study|Death|2|||
124682578|NCT06057064|448461769|FG001|Overall Study|Death|0|||
124682579|NCT06057064|448461768|FG000|Overall Study|Physician Decision|1|||
124682580|NCT06057064|448461769|FG001|Overall Study|Physician Decision|0|||
124682581|NCT06057064|448461768|FG000|Overall Study|Withdrawal by Subject|1|||
124682582|NCT06057064|448461769|FG001|Overall Study|Withdrawal by Subject|1|||
124438878|NCT00679627|447567762|FG001|Overall Study|Lost to Follow-up|26|||
124438879|NCT00679627|447567761|FG000|Overall Study|Early Study Closure|425|||
124880510|NCT01678820|449185545|FG001|Overall Study|Lost to Follow-up|2|||
124880511|NCT01678820|449185546|FG002|Overall Study|Lost to Follow-up|2|||
124880512|NCT01678820|449185544|FG000|Overall Study|Non-compliance with study drug|0|||
124880513|NCT01678820|449185545|FG001|Overall Study|Non-compliance with study drug|1|||
124880514|NCT01678820|449185546|FG002|Overall Study|Non-compliance with study drug|0|||
124880515|NCT01678820|449185544|FG000|Overall Study|Physician Decision|0|||
124880516|NCT01678820|449185545|FG001|Overall Study|Physician Decision|0|||
124880517|NCT01678820|449185546|FG002|Overall Study|Physician Decision|1|||
124880518|NCT01678820|449185544|FG000|Overall Study|Protocol Violation|4|||
124880519|NCT01678820|449185545|FG001|Overall Study|Protocol Violation|5|||
124880520|NCT01678820|449185546|FG002|Overall Study|Protocol Violation|4|||
124880521|NCT01678820|449185544|FG000|Overall Study|Not treated with double-blind study drug|0|||
124880522|NCT01678820|449185545|FG001|Overall Study|Not treated with double-blind study drug|2|||
124880523|NCT01678820|449185546|FG002|Overall Study|Not treated with double-blind study drug|2|||
124544386|NCT00948896|447946796|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
124880524|NCT05778526|449185551|FG000|Overall Study|Lost to Follow-up|0|||
124880525|NCT05778526|449185552|FG001|Overall Study|Lost to Follow-up|1|||
124880526|NCT05778526|449185553|FG002|Overall Study|Lost to Follow-up|3|||
124880527|NCT05778526|449185551|FG000|Overall Study|Protocol Violation|0|||
124880528|NCT05778526|449185552|FG001|Overall Study|Protocol Violation|0|||
124880529|NCT05778526|449185553|FG002|Overall Study|Protocol Violation|8|||
124880530|NCT00510458|449185568|FG000|Overall Study|5 year not evaluable/missed|21|||
124880531|NCT00510458|449185568|FG000|Overall Study|Death|1|||
124880532|NCT00510458|449185568|FG000|Overall Study|Terminated|14|||
124880533|NCT00510458|449185568|FG000|Overall Study|Lost to Follow-up|6|||
124880534|NCT00510458|449185568|FG000|Overall Study|Withdrawal by Subject|3|||
124880535|NCT00510458|449185568|FG000|Overall Study|Revision|2|||
124880536|NCT01861522|449185569|FG000|Overall Study|Adverse Event|1|||
124880537|NCT01861522|449185570|FG001|Overall Study|Adverse Event|0|||
124880538|NCT01861522|449185569|FG000|Overall Study|Withdrawal by Subject|2|||
124880539|NCT01861522|449185570|FG001|Overall Study|Withdrawal by Subject|0|||
124880540|NCT02716038|449185571|FG000|Overall Study|Not evaluable|1|||
124880541|NCT02716038|449185571|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
124880542|NCT02716038|449185571|FG000|Overall Study|Unresectable|3|||
124880543|NCT04006925|449185572|FG000|Overall Study|Side effects|2|||
124880544|NCT04006925|449185573|FG001|Overall Study|Side effects|0|||
124880545|NCT03757234|449185576|FG000|Overall Study|Adverse Event|0|||
124880546|NCT03757234|449185577|FG001|Overall Study|Adverse Event|0|||
124880547|NCT03757234|449185578|FG002|Overall Study|Adverse Event|0|||
124880548|NCT03757234|449185579|FG003|Overall Study|Adverse Event|0|||
124880549|NCT03757234|449185580|FG004|Overall Study|Adverse Event|1|||
124880550|NCT03757234|449185576|FG000|Overall Study|Lost to Follow-up|1|||
124880551|NCT03757234|449185577|FG001|Overall Study|Lost to Follow-up|0|||
124880552|NCT03757234|449185578|FG002|Overall Study|Lost to Follow-up|0|||
124880553|NCT03757234|449185579|FG003|Overall Study|Lost to Follow-up|0|||
124880554|NCT03757234|449185580|FG004|Overall Study|Lost to Follow-up|1|||
124880555|NCT03757234|449185576|FG000|Overall Study|Withdrawal by Subject|1|||
124880556|NCT03757234|449185577|FG001|Overall Study|Withdrawal by Subject|1|||
124880557|NCT03757234|449185578|FG002|Overall Study|Withdrawal by Subject|0|||
124880558|NCT03757234|449185579|FG003|Overall Study|Withdrawal by Subject|1|||
124880559|NCT03757234|449185580|FG004|Overall Study|Withdrawal by Subject|2|||
124880560|NCT03757234|449185576|FG000|Overall Study|Other|1|||
124438880|NCT00679627|447567762|FG001|Overall Study|Early Study Closure|405|||
124438881|NCT01886378|447567763|FG000|Overall Study|Adverse Event|1|||
124438882|NCT01886378|447567763|FG000|Overall Study|Withdrawal by Subject|4|||
124438883|NCT00446992|447567769|FG000|Overall Study|Adverse Event|11|||
124438884|NCT00446992|447567769|FG000|Overall Study|Lost to Follow-up|5|||
124438885|NCT01275131|447567770|FG000|Period 1|Withdrawal by Subject|1|||
124438886|NCT01275131|447567771|FG001|Period 1|Withdrawal by Subject|0|||
124438887|NCT01275131|447567772|FG002|Period 1|Withdrawal by Subject|3|||
124438888|NCT01275131|447567773|FG003|Period 1|Withdrawal by Subject|2|||
124438889|NCT01275131|447567770|FG000|Period 1|Physician Decision|1|||
124438890|NCT01275131|447567771|FG001|Period 1|Physician Decision|0|||
124438891|NCT01275131|447567772|FG002|Period 1|Physician Decision|0|||
124438892|NCT01275131|447567773|FG003|Period 1|Physician Decision|0|||
124438893|NCT01275131|447567770|FG000|Period 2 (Crossover)|Adverse Event|0|||
124438894|NCT01275131|447567771|FG001|Period 2 (Crossover)|Adverse Event|1|||
124438895|NCT01275131|447567772|FG002|Period 2 (Crossover)|Adverse Event|0|||
124438896|NCT01275131|447567773|FG003|Period 2 (Crossover)|Adverse Event|0|||
124438897|NCT01275131|447567770|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
124438898|NCT01275131|447567771|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
124438899|NCT01275131|447567772|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
124438900|NCT01275131|447567773|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
124438901|NCT02076178|447567774|FG000|Oral Phase|Adverse Event|0|||
124438902|NCT02076178|447567775|FG001|Oral Phase|Adverse Event|7|||
124438903|NCT02076178|447567774|FG000|Oral Phase|Withdrawal by Subject|0|||
124438904|NCT02076178|447567775|FG001|Oral Phase|Withdrawal by Subject|4|||
124438905|NCT02076178|447567774|FG000|Oral Phase|Physician Decision|0|||
124438906|NCT02076178|447567775|FG001|Oral Phase|Physician Decision|1|||
124438907|NCT02076178|447567774|FG000|Injection Phase|Protocol defined stopping criteria|1|||
124880561|NCT03757234|449185577|FG001|Overall Study|Other|1|||
124880562|NCT03757234|449185578|FG002|Overall Study|Other|0|||
124438908|NCT02076178|447567775|FG001|Injection Phase|Protocol defined stopping criteria|0|||
124438909|NCT02076178|447567774|FG000|Injection Phase|Withdrawal by Subject|0|||
124438910|NCT02076178|447567775|FG001|Injection Phase|Withdrawal by Subject|3|||
124438911|NCT02076178|447567774|FG000|Injection Phase|Physician Decision|0|||
124438912|NCT02076178|447567775|FG001|Injection Phase|Physician Decision|3|||
124438913|NCT02076178|447567774|FG000|Injection Phase|Lost to Follow-up|0|||
124438914|NCT02076178|447567775|FG001|Injection Phase|Lost to Follow-up|1|||
124438915|NCT00585195|447567791|FG000|Overall Study|Adverse Event|0|||
124880563|NCT03757234|449185579|FG003|Overall Study|Other|0|||
124880564|NCT03757234|449185580|FG004|Overall Study|Other|0|||
124880565|NCT01555164|449185582|FG000|Overall Study|Adverse Event|5|||
124880566|NCT01555164|449185583|FG001|Overall Study|Adverse Event|7|||
124880567|NCT01555164|449185582|FG000|Overall Study|Hyperglycemia|0|||
124880568|NCT01555164|449185583|FG001|Overall Study|Hyperglycemia|1|||
124880569|NCT01555164|449185582|FG000|Overall Study|Investigator's Discretion|2|||
124880570|NCT01555164|449185583|FG001|Overall Study|Investigator's Discretion|2|||
124880571|NCT01555164|449185582|FG000|Overall Study|Lost to Follow-up|4|||
124880572|NCT01555164|449185583|FG001|Overall Study|Lost to Follow-up|3|||
124880573|NCT01555164|449185582|FG000|Overall Study|Protocol Violation|9|||
124880574|NCT01555164|449185583|FG001|Overall Study|Protocol Violation|5|||
124682583|NCT02832037|448461770|FG000|Overall Study|Administrative reasons|0|||
124880575|NCT01555164|449185582|FG000|Overall Study|Subject Non-compliance|14|||
124880576|NCT01555164|449185583|FG001|Overall Study|Subject Non-compliance|6|||
124880577|NCT01555164|449185582|FG000|Overall Study|Subject Withdrew Consent|6|||
124880578|NCT01555164|449185583|FG001|Overall Study|Subject Withdrew Consent|11|||
124880579|NCT01396317|449185584|FG000|Overall Study|Adverse Event|1|||
124880580|NCT01396317|449185585|FG001|Overall Study|Adverse Event|0|||
124880581|NCT01709305|449185586|FG000|Phase 1|Clinical Adverse Event|80|||
124880582|NCT01709305|449185587|FG001|Phase 1|Clinical Adverse Event|0|||
124880583|NCT01709305|449185588|FG002|Phase 1|Clinical Adverse Event|0|||
124880584|NCT01709305|449185589|FG003|Phase 1|Clinical Adverse Event|0|||
124880585|NCT01709305|449185590|FG004|Phase 1|Clinical Adverse Event|0|||
124880586|NCT01709305|449185586|FG000|Phase 1|Death|2|||
124880587|NCT01709305|449185587|FG001|Phase 1|Death|0|||
124880588|NCT01709305|449185588|FG002|Phase 1|Death|0|||
124880589|NCT01709305|449185589|FG003|Phase 1|Death|0|||
124880590|NCT01709305|449185590|FG004|Phase 1|Death|0|||
124880591|NCT01709305|449185586|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
124880592|NCT01709305|449185587|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
124880593|NCT01709305|449185588|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
124880594|NCT01709305|449185589|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
124880595|NCT01709305|449185590|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
124880596|NCT01709305|449185586|FG000|Phase 1|Laboratory Adverse Event|16|||
124880597|NCT01709305|449185587|FG001|Phase 1|Laboratory Adverse Event|0|||
124880598|NCT01709305|449185588|FG002|Phase 1|Laboratory Adverse Event|0|||
124880599|NCT01709305|449185589|FG003|Phase 1|Laboratory Adverse Event|0|||
124880600|NCT01709305|449185590|FG004|Phase 1|Laboratory Adverse Event|0|||
124880601|NCT01709305|449185586|FG000|Phase 1|Lost to Follow-up|147|||
124880602|NCT01709305|449185587|FG001|Phase 1|Lost to Follow-up|0|||
124880603|NCT01709305|449185588|FG002|Phase 1|Lost to Follow-up|0|||
124880604|NCT01709305|449185589|FG003|Phase 1|Lost to Follow-up|0|||
124438916|NCT00585195|447567792|FG001|Overall Study|Adverse Event|0|||
124438917|NCT00585195|447567793|FG002|Overall Study|Adverse Event|0|||
124438918|NCT00585195|447567794|FG003|Overall Study|Adverse Event|0|||
124438919|NCT00585195|447567795|FG004|Overall Study|Adverse Event|2|||
124438920|NCT00585195|447567796|FG005|Overall Study|Adverse Event|1|||
124438921|NCT00585195|447567797|FG006|Overall Study|Adverse Event|0|||
124438922|NCT00585195|447567798|FG007|Overall Study|Adverse Event|1|||
124438923|NCT00585195|447567799|FG008|Overall Study|Adverse Event|0|||
124438924|NCT00585195|447567800|FG009|Overall Study|Adverse Event|0|||
124438925|NCT00585195|447567801|FG010|Overall Study|Adverse Event|3|||
124438926|NCT00585195|447567802|FG011|Overall Study|Adverse Event|0|||
124438927|NCT00585195|447567803|FG012|Overall Study|Adverse Event|8|||
124438928|NCT00585195|447567804|FG013|Overall Study|Adverse Event|6|||
124438929|NCT00585195|447567805|FG014|Overall Study|Adverse Event|4|||
124438930|NCT00585195|447567806|FG015|Overall Study|Adverse Event|1|||
124438931|NCT00585195|447567807|FG016|Overall Study|Adverse Event|14|||
124438932|NCT00585195|447567808|FG017|Overall Study|Adverse Event|9|||
124438933|NCT00585195|447567809|FG018|Overall Study|Adverse Event|2|||
124438934|NCT00585195|447567810|FG019|Overall Study|Adverse Event|3|||
124438935|NCT00585195|447567811|FG020|Overall Study|Adverse Event|1|||
124438936|NCT00585195|447567791|FG000|Overall Study|Progressive Disease|2|||
124438937|NCT00585195|447567792|FG001|Overall Study|Progressive Disease|2|||
124438938|NCT00585195|447567793|FG002|Overall Study|Progressive Disease|5|||
124438939|NCT00585195|447567794|FG003|Overall Study|Progressive Disease|4|||
124438940|NCT00585195|447567795|FG004|Overall Study|Progressive Disease|6|||
124438941|NCT00585195|447567796|FG005|Overall Study|Progressive Disease|4|||
124438942|NCT00585195|447567797|FG006|Overall Study|Progressive Disease|6|||
124438943|NCT00585195|447567798|FG007|Overall Study|Progressive Disease|3|||
124438944|NCT00585195|447567799|FG008|Overall Study|Progressive Disease|0|||
124438945|NCT00585195|447567800|FG009|Overall Study|Progressive Disease|5|||
124438946|NCT00585195|447567801|FG010|Overall Study|Progressive Disease|2|||
124682584|NCT02832037|448461771|FG001|Overall Study|Administrative reasons|0|||
124682585|NCT02832037|448461772|FG002|Overall Study|Administrative reasons|1|||
124682586|NCT02832037|448461773|FG003|Overall Study|Administrative reasons|0|||
124438947|NCT00585195|447567802|FG011|Overall Study|Progressive Disease|25|||
124880605|NCT01709305|449185590|FG004|Phase 1|Lost to Follow-up|0|||
124438948|NCT00585195|447567803|FG012|Overall Study|Progressive Disease|29|||
124438949|NCT00585195|447567804|FG013|Overall Study|Progressive Disease|26|||
124438950|NCT00585195|447567805|FG014|Overall Study|Progressive Disease|21|||
124438951|NCT00585195|447567806|FG015|Overall Study|Progressive Disease|12|||
124880606|NCT01709305|449185586|FG000|Phase 1|Travel, moving, etc.|30|||
124880607|NCT01709305|449185587|FG001|Phase 1|Travel, moving, etc.|0|||
124880608|NCT01709305|449185588|FG002|Phase 1|Travel, moving, etc.|0|||
124880609|NCT01709305|449185589|FG003|Phase 1|Travel, moving, etc.|0|||
124880610|NCT01709305|449185590|FG004|Phase 1|Travel, moving, etc.|0|||
124880611|NCT01709305|449185586|FG000|Phase 1|Physician Decision|13|||
124438952|NCT00585195|447567807|FG016|Overall Study|Progressive Disease|94|||
124438953|NCT00585195|447567808|FG017|Overall Study|Progressive Disease|42|||
124438954|NCT00585195|447567809|FG018|Overall Study|Progressive Disease|4|||
124438955|NCT00585195|447567810|FG019|Overall Study|Progressive Disease|9|||
124438956|NCT00585195|447567811|FG020|Overall Study|Progressive Disease|8|||
124438957|NCT00585195|447567791|FG000|Overall Study|Withdrawal by Subject|1|||
124438958|NCT00585195|447567792|FG001|Overall Study|Withdrawal by Subject|1|||
124438959|NCT00585195|447567793|FG002|Overall Study|Withdrawal by Subject|2|||
124438960|NCT00585195|447567794|FG003|Overall Study|Withdrawal by Subject|2|||
124438961|NCT00585195|447567795|FG004|Overall Study|Withdrawal by Subject|0|||
124438962|NCT00585195|447567796|FG005|Overall Study|Withdrawal by Subject|0|||
124438963|NCT00585195|447567797|FG006|Overall Study|Withdrawal by Subject|0|||
124438964|NCT00585195|447567798|FG007|Overall Study|Withdrawal by Subject|1|||
124438965|NCT00585195|447567799|FG008|Overall Study|Withdrawal by Subject|0|||
124438966|NCT00585195|447567800|FG009|Overall Study|Withdrawal by Subject|0|||
124438967|NCT00585195|447567801|FG010|Overall Study|Withdrawal by Subject|3|||
124438968|NCT00585195|447567802|FG011|Overall Study|Withdrawal by Subject|8|||
124682587|NCT02832037|448461774|FG004|Overall Study|Administrative reasons|0|||
124682588|NCT02832037|448461770|FG000|Overall Study|Protocol Violation|3|||
124682589|NCT02832037|448461771|FG001|Overall Study|Protocol Violation|0|||
124682590|NCT02832037|448461772|FG002|Overall Study|Protocol Violation|4|||
124682591|NCT02832037|448461773|FG003|Overall Study|Protocol Violation|1|||
124682592|NCT02832037|448461774|FG004|Overall Study|Protocol Violation|2|||
124682593|NCT02832037|448461770|FG000|Overall Study|Lost to Follow-up|2|||
124682594|NCT02832037|448461771|FG001|Overall Study|Lost to Follow-up|0|||
124682595|NCT02832037|448461772|FG002|Overall Study|Lost to Follow-up|3|||
124682596|NCT02832037|448461773|FG003|Overall Study|Lost to Follow-up|0|||
124682597|NCT02832037|448461774|FG004|Overall Study|Lost to Follow-up|5|||
124682598|NCT02832037|448461770|FG000|Overall Study|Withdrawal by Subject|9|||
124682599|NCT02832037|448461771|FG001|Overall Study|Withdrawal by Subject|8|||
124682600|NCT02832037|448461772|FG002|Overall Study|Withdrawal by Subject|0|||
124682601|NCT02832037|448461773|FG003|Overall Study|Withdrawal by Subject|4|||
124682602|NCT02832037|448461774|FG004|Overall Study|Withdrawal by Subject|8|||
124682603|NCT02832037|448461770|FG000|Overall Study|Adverse Event|5|||
124682604|NCT02832037|448461771|FG001|Overall Study|Adverse Event|4|||
124682605|NCT02832037|448461772|FG002|Overall Study|Adverse Event|0|||
124682606|NCT02832037|448461773|FG003|Overall Study|Adverse Event|2|||
124682607|NCT02832037|448461774|FG004|Overall Study|Adverse Event|4|||
124682608|NCT01137786|448461776|FG000|Overall Study|Lost to Follow-up|0|||
124682609|NCT01137786|448461777|FG001|Overall Study|Lost to Follow-up|2|||
124682610|NCT01137786|448461776|FG000|Overall Study|Withdrawal by Subject|1|||
124682611|NCT01137786|448461777|FG001|Overall Study|Withdrawal by Subject|1|||
124682612|NCT01531153|448461778|FG000|Overall Study|Withdrawal by Subject|10|||
124682613|NCT01531153|448461779|FG001|Overall Study|Withdrawal by Subject|9|||
124682614|NCT01531153|448461780|FG002|Overall Study|Withdrawal by Subject|15|||
124682615|NCT00770367|448461781|FG000|First Intervention|Withdrawal by Subject|0|||
124682616|NCT00770367|448461782|FG001|First Intervention|Withdrawal by Subject|2|||
124682617|NCT00770367|448461781|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
124682618|NCT00770367|448461782|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
124682619|NCT00770367|448461781|FG000|Second Intervention|Lost to Follow-up|2|||
124682620|NCT00770367|448461782|FG001|Second Intervention|Lost to Follow-up|0|||
124682621|NCT00435942|448461783|FG000|Overall Study|Death|17|||
124682622|NCT00435942|448461784|FG001|Overall Study|Death|10|||
124682623|NCT00435942|448461783|FG000|Overall Study|Withdrawal by Subject|2|||
124682624|NCT00435942|448461784|FG001|Overall Study|Withdrawal by Subject|0|||
124682625|NCT00435942|448461783|FG000|Overall Study|Lost to Follow-up|0|||
124682626|NCT00435942|448461784|FG001|Overall Study|Lost to Follow-up|16|||
124682627|NCT00435942|448461783|FG000|Overall Study|Conversion to Open Repair|1|||
124682628|NCT00435942|448461784|FG001|Overall Study|Conversion to Open Repair|0|||
124682629|NCT00435942|448461783|FG000|Overall Study|Technical Failure|3|||
124682630|NCT00435942|448461784|FG001|Overall Study|Technical Failure|0|||
124682631|NCT00435942|448461783|FG000|Overall Study|Other|0|||
124682632|NCT00435942|448461784|FG001|Overall Study|Other|1|||
124682633|NCT00920816|448461785|FG000|Overall Study|Death|116|||
124438969|NCT00585195|447567803|FG012|Overall Study|Withdrawal by Subject|15|||
124438970|NCT00585195|447567804|FG013|Overall Study|Withdrawal by Subject|0|||
124682634|NCT00920816|448461786|FG001|Overall Study|Death|63|||
124682635|NCT00920816|448461787|FG002|Overall Study|Death|8|||
124682636|NCT00920816|448461788|FG003|Overall Study|Death|3|||
124682637|NCT00920816|448461785|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
124682638|NCT00920816|448461786|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
124682639|NCT00920816|448461787|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
124438971|NCT00585195|447567805|FG014|Overall Study|Withdrawal by Subject|3|||
124682640|NCT00920816|448461788|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
124682641|NCT00920816|448461785|FG000|Overall Study|Global deterioration of health status|2|||
124682642|NCT00920816|448461786|FG001|Overall Study|Global deterioration of health status|0|||
124880612|NCT01709305|449185587|FG001|Phase 1|Physician Decision|0|||
124880613|NCT01709305|449185588|FG002|Phase 1|Physician Decision|0|||
124880614|NCT01709305|449185589|FG003|Phase 1|Physician Decision|0|||
124880615|NCT01709305|449185590|FG004|Phase 1|Physician Decision|0|||
124880616|NCT01709305|449185586|FG000|Phase 1|Protocol Violation|118|||
124880617|NCT01709305|449185587|FG001|Phase 1|Protocol Violation|0|||
124880618|NCT01709305|449185588|FG002|Phase 1|Protocol Violation|0|||
124880619|NCT01709305|449185589|FG003|Phase 1|Protocol Violation|0|||
124880620|NCT01709305|449185590|FG004|Phase 1|Protocol Violation|0|||
124880621|NCT01709305|449185586|FG000|Phase 1|Withdrawal by Subject|218|||
124880622|NCT01709305|449185587|FG001|Phase 1|Withdrawal by Subject|0|||
124880623|NCT01709305|449185588|FG002|Phase 1|Withdrawal by Subject|0|||
124880624|NCT01709305|449185589|FG003|Phase 1|Withdrawal by Subject|0|||
124682643|NCT00920816|448461787|FG002|Overall Study|Global deterioration of health status|0|||
124880625|NCT01709305|449185590|FG004|Phase 1|Withdrawal by Subject|0|||
124880626|NCT01709305|449185586|FG000|Phase 2|Clinical Adverse Event|0|||
124880627|NCT01709305|449185587|FG001|Phase 2|Clinical Adverse Event|10|||
124880628|NCT01709305|449185588|FG002|Phase 2|Clinical Adverse Event|10|||
124880629|NCT01709305|449185589|FG003|Phase 2|Clinical Adverse Event|6|||
124438972|NCT00585195|447567806|FG015|Overall Study|Withdrawal by Subject|0|||
124438973|NCT00585195|447567807|FG016|Overall Study|Withdrawal by Subject|7|||
124438974|NCT00585195|447567808|FG017|Overall Study|Withdrawal by Subject|1|||
124438975|NCT00585195|447567809|FG018|Overall Study|Withdrawal by Subject|2|||
124438976|NCT00585195|447567810|FG019|Overall Study|Withdrawal by Subject|2|||
124438977|NCT00585195|447567811|FG020|Overall Study|Withdrawal by Subject|0|||
124438978|NCT00585195|447567791|FG000|Overall Study|Other|0|||
124438979|NCT00585195|447567792|FG001|Overall Study|Other|1|||
124438980|NCT00585195|447567793|FG002|Overall Study|Other|1|||
124438981|NCT00585195|447567794|FG003|Overall Study|Other|1|||
124438982|NCT00585195|447567795|FG004|Overall Study|Other|0|||
124438983|NCT00585195|447567796|FG005|Overall Study|Other|1|||
124438984|NCT00585195|447567797|FG006|Overall Study|Other|0|||
124438985|NCT00585195|447567798|FG007|Overall Study|Other|0|||
124438986|NCT00585195|447567799|FG008|Overall Study|Other|2|||
124438987|NCT00585195|447567800|FG009|Overall Study|Other|1|||
124438988|NCT00585195|447567801|FG010|Overall Study|Other|0|||
124438989|NCT00585195|447567802|FG011|Overall Study|Other|19|||
124438990|NCT00585195|447567803|FG012|Overall Study|Other|24|||
124438991|NCT00585195|447567804|FG013|Overall Study|Other|7|||
124438992|NCT00585195|447567805|FG014|Overall Study|Other|11|||
124438993|NCT00585195|447567806|FG015|Overall Study|Other|3|||
124438994|NCT00585195|447567807|FG016|Overall Study|Other|28|||
124438995|NCT00585195|447567808|FG017|Overall Study|Other|12|||
124880630|NCT01709305|449185590|FG004|Phase 2|Clinical Adverse Event|11|||
124880631|NCT01709305|449185586|FG000|Phase 2|Death|0|||
124880632|NCT01709305|449185587|FG001|Phase 2|Death|0|||
124880633|NCT01709305|449185588|FG002|Phase 2|Death|1|||
124880634|NCT01709305|449185589|FG003|Phase 2|Death|0|||
124438996|NCT00585195|447567809|FG018|Overall Study|Other|10|||
124438997|NCT00585195|447567810|FG019|Overall Study|Other|4|||
124438998|NCT00585195|447567811|FG020|Overall Study|Other|2|||
124438999|NCT00585195|447567791|FG000|Overall Study|Randomized not treated|0|||
124880635|NCT01709305|449185590|FG004|Phase 2|Death|0|||
124880636|NCT01709305|449185586|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
124880637|NCT01709305|449185587|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
124439000|NCT00585195|447567792|FG001|Overall Study|Randomized not treated|0|||
124439001|NCT00585195|447567793|FG002|Overall Study|Randomized not treated|1|||
124439002|NCT00585195|447567794|FG003|Overall Study|Randomized not treated|0|||
124880638|NCT01709305|449185588|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
124880639|NCT01709305|449185589|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
124880640|NCT01709305|449185590|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
124880641|NCT01709305|449185586|FG000|Phase 2|Laboratory Adverse Event|0|||
124880642|NCT01709305|449185587|FG001|Phase 2|Laboratory Adverse Event|1|||
124880643|NCT01709305|449185588|FG002|Phase 2|Laboratory Adverse Event|0|||
124880644|NCT01709305|449185589|FG003|Phase 2|Laboratory Adverse Event|1|||
124880645|NCT01709305|449185590|FG004|Phase 2|Laboratory Adverse Event|1|||
124880646|NCT01709305|449185586|FG000|Phase 2|Lost to Follow-up|0|||
124880647|NCT01709305|449185587|FG001|Phase 2|Lost to Follow-up|10|||
124880648|NCT01709305|449185588|FG002|Phase 2|Lost to Follow-up|6|||
124880649|NCT01709305|449185589|FG003|Phase 2|Lost to Follow-up|9|||
124880650|NCT01709305|449185590|FG004|Phase 2|Lost to Follow-up|5|||
124880651|NCT01709305|449185586|FG000|Phase 2|Travel, moving, etc.|0|||
124880652|NCT01709305|449185587|FG001|Phase 2|Travel, moving, etc.|2|||
124880653|NCT01709305|449185588|FG002|Phase 2|Travel, moving, etc.|3|||
124880654|NCT01709305|449185589|FG003|Phase 2|Travel, moving, etc.|3|||
124880655|NCT01709305|449185590|FG004|Phase 2|Travel, moving, etc.|5|||
124880656|NCT01709305|449185586|FG000|Phase 2|Physician Decision|0|||
124880657|NCT01709305|449185587|FG001|Phase 2|Physician Decision|2|||
124880658|NCT01709305|449185588|FG002|Phase 2|Physician Decision|0|||
124880659|NCT01709305|449185589|FG003|Phase 2|Physician Decision|1|||
124880660|NCT01709305|449185590|FG004|Phase 2|Physician Decision|2|||
124880661|NCT01709305|449185586|FG000|Phase 2|Protocol Violation|0|||
124880662|NCT01709305|449185587|FG001|Phase 2|Protocol Violation|19|||
124880663|NCT01709305|449185588|FG002|Phase 2|Protocol Violation|19|||
124880664|NCT01709305|449185589|FG003|Phase 2|Protocol Violation|13|||
124880665|NCT01709305|449185590|FG004|Phase 2|Protocol Violation|9|||
124880666|NCT01709305|449185586|FG000|Phase 2|Withdrawal by Subject|0|||
124880667|NCT01709305|449185587|FG001|Phase 2|Withdrawal by Subject|8|||
124880668|NCT01709305|449185588|FG002|Phase 2|Withdrawal by Subject|6|||
124880669|NCT01709305|449185589|FG003|Phase 2|Withdrawal by Subject|15|||
124880670|NCT01709305|449185590|FG004|Phase 2|Withdrawal by Subject|12|||
124880671|NCT02294474|449185593|FG000|Overall Study|Adverse Event|7|||
124880672|NCT02294474|449185594|FG001|Overall Study|Adverse Event|7|||
124880673|NCT02294474|449185593|FG000|Overall Study|Lack of Efficacy|2|||
124880674|NCT02294474|449185594|FG001|Overall Study|Lack of Efficacy|1|||
124880675|NCT02294474|449185593|FG000|Overall Study|Protocol Violation|4|||
124880676|NCT02294474|449185594|FG001|Overall Study|Protocol Violation|2|||
124880677|NCT02294474|449185593|FG000|Overall Study|Other than specified above|12|||
124880678|NCT02294474|449185594|FG001|Overall Study|Other than specified above|12|||
124880679|NCT00171873|449185595|FG000|Overall Study|Withdrawal by Subject|4|||
124880680|NCT00171873|449185596|FG001|Overall Study|Withdrawal by Subject|2|||
124880681|NCT00171873|449185595|FG000|Overall Study|Adverse Event|5|||
124880682|NCT00171873|449185596|FG001|Overall Study|Adverse Event|0|||
124880683|NCT00171873|449185595|FG000|Overall Study|Switched to Octreotide|0|||
124880684|NCT00171873|449185596|FG001|Overall Study|Switched to Octreotide|1|||
124880685|NCT05200936|449185597|FG000|Overall Study|Withdrawal by Subject|2|||
124880686|NCT05200936|449185598|FG001|Overall Study|Withdrawal by Subject|2|||
124880687|NCT05200936|449185597|FG000|Overall Study|Lost to Follow-up|2|||
124439003|NCT00585195|447567795|FG004|Overall Study|Randomized not treated|1|||
124439004|NCT00585195|447567796|FG005|Overall Study|Randomized not treated|0|||
124439005|NCT00585195|447567797|FG006|Overall Study|Randomized not treated|1|||
124439006|NCT00585195|447567798|FG007|Overall Study|Randomized not treated|0|||
124439007|NCT00585195|447567799|FG008|Overall Study|Randomized not treated|0|||
124439008|NCT00585195|447567800|FG009|Overall Study|Randomized not treated|0|||
124439009|NCT00585195|447567801|FG010|Overall Study|Randomized not treated|2|||
124439010|NCT00585195|447567802|FG011|Overall Study|Randomized not treated|0|||
124682644|NCT00920816|448461788|FG003|Overall Study|Global deterioration of health status|0|||
124682645|NCT00920816|448461785|FG000|Overall Study|Objective progression or relapse|6|||
124682646|NCT00920816|448461786|FG001|Overall Study|Objective progression or relapse|2|||
124682647|NCT00920816|448461787|FG002|Overall Study|Objective progression or relapse|0|||
124682648|NCT00920816|448461788|FG003|Overall Study|Objective progression or relapse|0|||
124682649|NCT00920816|448461785|FG000|Overall Study|Other|26|||
124682650|NCT00920816|448461786|FG001|Overall Study|Other|15|||
124880688|NCT05200936|449185598|FG001|Overall Study|Lost to Follow-up|0|||
124880689|NCT05200936|449185597|FG000|Overall Study|Pregnancy|0|||
124880690|NCT05200936|449185598|FG001|Overall Study|Pregnancy|1|||
124880691|NCT00118898|449185600|FG000|Overall Study|Death|6|||
124880692|NCT00118898|449185601|FG001|Overall Study|Death|11|||
124880693|NCT00118898|449185602|FG002|Overall Study|Death|6|||
124880694|NCT00118898|449185603|FG003|Overall Study|Death|8|||
124880695|NCT00118898|449185600|FG000|Overall Study|Lost to Follow-up|26|||
124880696|NCT00118898|449185601|FG001|Overall Study|Lost to Follow-up|34|||
124439011|NCT00585195|447567803|FG012|Overall Study|Randomized not treated|0|||
124682651|NCT00920816|448461787|FG002|Overall Study|Other|1|||
124880697|NCT00118898|449185602|FG002|Overall Study|Lost to Follow-up|33|||
124439012|NCT00585195|447567804|FG013|Overall Study|Randomized not treated|0|||
124682652|NCT00920816|448461788|FG003|Overall Study|Other|2|||
124682653|NCT00920816|448461785|FG000|Overall Study|Lost to Follow-up|11|||
124880698|NCT00118898|449185603|FG003|Overall Study|Lost to Follow-up|33|||
124880699|NCT00118898|449185600|FG000|Overall Study|Withdrawal by Subject|10|||
124439013|NCT00585195|447567805|FG014|Overall Study|Randomized not treated|0|||
124439014|NCT00585195|447567806|FG015|Overall Study|Randomized not treated|1|||
124439015|NCT00585195|447567807|FG016|Overall Study|Randomized not treated|0|||
124439016|NCT00585195|447567808|FG017|Overall Study|Randomized not treated|1|||
124439017|NCT00585195|447567809|FG018|Overall Study|Randomized not treated|3|||
124439018|NCT00585195|447567810|FG019|Overall Study|Randomized not treated|0|||
124439019|NCT00585195|447567811|FG020|Overall Study|Randomized not treated|2|||
124439020|NCT00585195|447567791|FG000|Overall Study|Death|0|||
124439021|NCT00585195|447567792|FG001|Overall Study|Death|0|||
124439022|NCT00585195|447567793|FG002|Overall Study|Death|0|||
124439023|NCT00585195|447567794|FG003|Overall Study|Death|0|||
124439024|NCT00585195|447567795|FG004|Overall Study|Death|0|||
124682654|NCT00920816|448461786|FG001|Overall Study|Lost to Follow-up|2|||
124682655|NCT00920816|448461787|FG002|Overall Study|Lost to Follow-up|0|||
124682656|NCT00920816|448461788|FG003|Overall Study|Lost to Follow-up|0|||
124682657|NCT00920816|448461785|FG000|Overall Study|Adverse Event|1|||
124682658|NCT00920816|448461786|FG001|Overall Study|Adverse Event|1|||
124682659|NCT00920816|448461787|FG002|Overall Study|Adverse Event|1|||
124682660|NCT00920816|448461788|FG003|Overall Study|Adverse Event|0|||
124682661|NCT00920816|448461785|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
124682662|NCT00920816|448461786|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
124682663|NCT00920816|448461787|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
124682664|NCT00920816|448461788|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
124682665|NCT00920816|448461785|FG000|Overall Study|Randomized but not treated|3|||
124682666|NCT00920816|448461786|FG001|Overall Study|Randomized but not treated|0|||
124682667|NCT00920816|448461787|FG002|Overall Study|Randomized but not treated|0|||
124682668|NCT00920816|448461788|FG003|Overall Study|Randomized but not treated|0|||
124682669|NCT01180777|448461789|FG000|Overall Study|Protocol Violation|6|||
124682670|NCT01180777|448461789|FG000|Overall Study|Poor lens fit|4|||
124682671|NCT01180777|448461789|FG000|Overall Study|Lost to Follow-up|1|||
124682672|NCT01180777|448461789|FG000|Overall Study|Adverse Event|1|||
124682673|NCT04167462|448461794|FG000|Overall Study|Other reasons|3|||
124682674|NCT04167462|448461795|FG001|Overall Study|Other reasons|2|||
124682675|NCT04167462|448461794|FG000|Overall Study|Withdrawal by Subject|6|||
124682676|NCT04167462|448461795|FG001|Overall Study|Withdrawal by Subject|7|||
124682677|NCT04167462|448461794|FG000|Overall Study|Adverse Event|4|||
124682678|NCT04167462|448461795|FG001|Overall Study|Adverse Event|0|||
124682679|NCT04167462|448461794|FG000|Overall Study|Pregnancy|1|||
124682680|NCT04167462|448461795|FG001|Overall Study|Pregnancy|0|||
124682681|NCT04167462|448461794|FG000|Overall Study|Lack of Efficacy|0|||
124682682|NCT04167462|448461795|FG001|Overall Study|Lack of Efficacy|1|||
124682683|NCT05522751|448461796|FG000|Overall Study|Adverse Event|1|||
124682684|NCT02475213|448461797|FG000|Overall Study|Adverse Event|2|||
124682685|NCT02475213|448461798|FG001|Overall Study|Adverse Event|0|||
124682686|NCT02475213|448461799|FG002|Overall Study|Adverse Event|0|||
124682687|NCT02475213|448461800|FG003|Overall Study|Adverse Event|1|||
124682688|NCT02475213|448461801|FG004|Overall Study|Adverse Event|1|||
124682689|NCT02475213|448461802|FG005|Overall Study|Adverse Event|4|||
124682690|NCT02475213|448461803|FG006|Overall Study|Adverse Event|6|||
124682691|NCT02475213|448461804|FG007|Overall Study|Adverse Event|2|||
124682692|NCT02475213|448461797|FG000|Overall Study|Physician Decision|1|||
124682693|NCT02475213|448461798|FG001|Overall Study|Physician Decision|1|||
124682694|NCT02475213|448461799|FG002|Overall Study|Physician Decision|1|||
124682695|NCT02475213|448461800|FG003|Overall Study|Physician Decision|0|||
124682696|NCT02475213|448461801|FG004|Overall Study|Physician Decision|0|||
124682697|NCT02475213|448461802|FG005|Overall Study|Physician Decision|1|||
124682698|NCT02475213|448461803|FG006|Overall Study|Physician Decision|4|||
124682699|NCT02475213|448461804|FG007|Overall Study|Physician Decision|0|||
124682700|NCT02475213|448461797|FG000|Overall Study|Progressive Disease|3|||
124682701|NCT02475213|448461798|FG001|Overall Study|Progressive Disease|2|||
124682702|NCT02475213|448461799|FG002|Overall Study|Progressive Disease|2|||
124682703|NCT02475213|448461800|FG003|Overall Study|Progressive Disease|13|||
124682704|NCT02475213|448461801|FG004|Overall Study|Progressive Disease|15|||
124682705|NCT02475213|448461802|FG005|Overall Study|Progressive Disease|25|||
124682706|NCT02475213|448461803|FG006|Overall Study|Progressive Disease|30|||
124682707|NCT02475213|448461804|FG007|Overall Study|Progressive Disease|10|||
124682708|NCT02475213|448461797|FG000|Overall Study|Death|0|||
124682709|NCT02475213|448461798|FG001|Overall Study|Death|0|||
124439025|NCT00585195|447567796|FG005|Overall Study|Death|0|||
124682710|NCT02475213|448461799|FG002|Overall Study|Death|0|||
124682711|NCT02475213|448461800|FG003|Overall Study|Death|0|||
124682712|NCT02475213|448461801|FG004|Overall Study|Death|0|||
124682713|NCT02475213|448461802|FG005|Overall Study|Death|4|||
124682714|NCT02475213|448461803|FG006|Overall Study|Death|1|||
124682715|NCT02475213|448461804|FG007|Overall Study|Death|0|||
124682716|NCT02475213|448461797|FG000|Overall Study|Protocol Violation|0|||
124682717|NCT02475213|448461798|FG001|Overall Study|Protocol Violation|0|||
124682718|NCT02475213|448461799|FG002|Overall Study|Protocol Violation|0|||
124682719|NCT02475213|448461800|FG003|Overall Study|Protocol Violation|0|||
124682720|NCT02475213|448461801|FG004|Overall Study|Protocol Violation|1|||
124880700|NCT00118898|449185601|FG001|Overall Study|Withdrawal by Subject|5|||
124880701|NCT00118898|449185602|FG002|Overall Study|Withdrawal by Subject|8|||
124880702|NCT00118898|449185603|FG003|Overall Study|Withdrawal by Subject|8|||
124880703|NCT00118898|449185600|FG000|Overall Study|Site Closure|33|||
124880704|NCT00118898|449185601|FG001|Overall Study|Site Closure|31|||
124880705|NCT00118898|449185602|FG002|Overall Study|Site Closure|28|||
124880706|NCT00118898|449185603|FG003|Overall Study|Site Closure|37|||
124880707|NCT00118898|449185600|FG000|Overall Study|Severe debilitation|1|||
124880708|NCT00118898|449185601|FG001|Overall Study|Severe debilitation|4|||
124880709|NCT00118898|449185602|FG002|Overall Study|Severe debilitation|6|||
124880710|NCT00118898|449185603|FG003|Overall Study|Severe debilitation|4|||
124880711|NCT00118898|449185600|FG000|Overall Study|Not compliant with requirements|11|||
124880712|NCT00118898|449185601|FG001|Overall Study|Not compliant with requirements|13|||
124880713|NCT00118898|449185602|FG002|Overall Study|Not compliant with requirements|11|||
124880714|NCT00118898|449185603|FG003|Overall Study|Not compliant with requirements|11|||
124880715|NCT00118898|449185600|FG000|Overall Study|Not able to get to clinic|34|||
124880716|NCT00118898|449185601|FG001|Overall Study|Not able to get to clinic|43|||
124880717|NCT00118898|449185602|FG002|Overall Study|Not able to get to clinic|31|||
124880718|NCT00118898|449185603|FG003|Overall Study|Not able to get to clinic|40|||
124880719|NCT01338012|449185604|FG000|Overall Study|Death|4|||
124880720|NCT01338012|449185604|FG000|Overall Study|Study terminated|4|||
124880721|NCT05879198|449185605|FG000|Overall Study|Lost to Follow-up|1|||
124880722|NCT02073097|449185606|FG000|Overall Study|Adverse Event|0|||
124880723|NCT02073097|449185607|FG001|Overall Study|Adverse Event|0|||
124880724|NCT02073097|449185608|FG002|Overall Study|Adverse Event|0|||
124880725|NCT02073097|449185609|FG003|Overall Study|Adverse Event|0|||
124880726|NCT02073097|449185610|FG004|Overall Study|Adverse Event|0|||
124880727|NCT02073097|449185611|FG005|Overall Study|Adverse Event|0|||
124880728|NCT02073097|449185612|FG006|Overall Study|Adverse Event|0|||
124880729|NCT02073097|449185613|FG007|Overall Study|Adverse Event|2|||
124880730|NCT02073097|449185606|FG000|Overall Study|Withdrawal by Subject|0|||
124880731|NCT02073097|449185607|FG001|Overall Study|Withdrawal by Subject|0|||
124880732|NCT02073097|449185608|FG002|Overall Study|Withdrawal by Subject|0|||
124880733|NCT02073097|449185609|FG003|Overall Study|Withdrawal by Subject|0|||
124880734|NCT02073097|449185610|FG004|Overall Study|Withdrawal by Subject|0|||
124880735|NCT02073097|449185611|FG005|Overall Study|Withdrawal by Subject|0|||
124880736|NCT02073097|449185612|FG006|Overall Study|Withdrawal by Subject|0|||
124880737|NCT02073097|449185613|FG007|Overall Study|Withdrawal by Subject|2|||
124880738|NCT02073097|449185606|FG000|Overall Study|Death|0|||
124880739|NCT02073097|449185607|FG001|Overall Study|Death|0|||
124880740|NCT02073097|449185608|FG002|Overall Study|Death|0|||
124880741|NCT02073097|449185609|FG003|Overall Study|Death|0|||
124880742|NCT02073097|449185610|FG004|Overall Study|Death|0|||
124880743|NCT02073097|449185611|FG005|Overall Study|Death|0|||
124880744|NCT02073097|449185612|FG006|Overall Study|Death|0|||
124880745|NCT02073097|449185613|FG007|Overall Study|Death|1|||
124880746|NCT02073097|449185606|FG000|Overall Study|Physician Decision|0|||
124880747|NCT02073097|449185607|FG001|Overall Study|Physician Decision|0|||
124880748|NCT02073097|449185608|FG002|Overall Study|Physician Decision|0|||
124880749|NCT02073097|449185609|FG003|Overall Study|Physician Decision|0|||
124880750|NCT02073097|449185610|FG004|Overall Study|Physician Decision|0|||
124880751|NCT02073097|449185611|FG005|Overall Study|Physician Decision|0|||
124880752|NCT02073097|449185612|FG006|Overall Study|Physician Decision|0|||
124880753|NCT02073097|449185613|FG007|Overall Study|Physician Decision|1|||
124880754|NCT01693692|449185614|FG000|Overall Study|Withdrawal by Subject|12|||
124880755|NCT01693692|449185615|FG001|Overall Study|Withdrawal by Subject|10|||
124880756|NCT01693692|449185616|FG002|Overall Study|Withdrawal by Subject|11|||
124880757|NCT01693692|449185614|FG000|Overall Study|Adverse Event|7|||
124880758|NCT01693692|449185615|FG001|Overall Study|Adverse Event|14|||
124880759|NCT01693692|449185616|FG002|Overall Study|Adverse Event|9|||
124880760|NCT01693692|449185614|FG000|Overall Study|Physician Decision|0|||
124880761|NCT01693692|449185615|FG001|Overall Study|Physician Decision|0|||
124880762|NCT01693692|449185616|FG002|Overall Study|Physician Decision|1|||
124880763|NCT01693692|449185614|FG000|Overall Study|Protocol Violation|5|||
124880764|NCT01693692|449185615|FG001|Overall Study|Protocol Violation|4|||
124880765|NCT01693692|449185616|FG002|Overall Study|Protocol Violation|6|||
124880766|NCT01693692|449185614|FG000|Overall Study|Lost to Follow-up|2|||
124880767|NCT01693692|449185615|FG001|Overall Study|Lost to Follow-up|2|||
124880768|NCT01693692|449185616|FG002|Overall Study|Lost to Follow-up|3|||
124880769|NCT01693692|449185614|FG000|Overall Study|Other|4|||
124880770|NCT01693692|449185615|FG001|Overall Study|Other|4|||
124880771|NCT01693692|449185616|FG002|Overall Study|Other|6|||
124880772|NCT00663117|449186940|FG000|Overall Study|Lack of Efficacy|1|||
124880773|NCT00663117|449186941|FG001|Overall Study|Lack of Efficacy|0|||
124880774|NCT04022889|449186950|FG000|Stage 1: Period 1|Adverse Event|1|||
124880775|NCT04022889|449186951|FG001|Stage 1: Period 1|Adverse Event|0|||
124439026|NCT00585195|447567797|FG006|Overall Study|Death|0|||
124880776|NCT04022889|449186952|FG002|Stage 1: Period 1|Adverse Event|0|||
124880777|NCT04022889|449186950|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
124682721|NCT02475213|448461802|FG005|Overall Study|Protocol Violation|0|||
124682722|NCT02475213|448461803|FG006|Overall Study|Protocol Violation|0|||
124682723|NCT02475213|448461804|FG007|Overall Study|Protocol Violation|0|||
124682724|NCT02475213|448461797|FG000|Overall Study|Withdrawal by Subject|0|||
124682725|NCT02475213|448461798|FG001|Overall Study|Withdrawal by Subject|0|||
124682726|NCT02475213|448461799|FG002|Overall Study|Withdrawal by Subject|0|||
124682727|NCT02475213|448461800|FG003|Overall Study|Withdrawal by Subject|1|||
124682728|NCT02475213|448461801|FG004|Overall Study|Withdrawal by Subject|0|||
124682729|NCT02475213|448461802|FG005|Overall Study|Withdrawal by Subject|2|||
124682730|NCT02475213|448461803|FG006|Overall Study|Withdrawal by Subject|2|||
124682731|NCT02475213|448461804|FG007|Overall Study|Withdrawal by Subject|0|||
124682732|NCT02475213|448461797|FG000|Overall Study|Other|0|||
124682733|NCT02475213|448461798|FG001|Overall Study|Other|0|||
124682734|NCT02475213|448461799|FG002|Overall Study|Other|0|||
124682735|NCT02475213|448461800|FG003|Overall Study|Other|1|||
124682736|NCT02475213|448461801|FG004|Overall Study|Other|3|||
124682737|NCT02475213|448461802|FG005|Overall Study|Other|1|||
124682738|NCT02475213|448461803|FG006|Overall Study|Other|0|||
124682739|NCT02475213|448461804|FG007|Overall Study|Other|0|||
124682740|NCT00505921|448461805|FG000|Overall Study|Ineligible|1|||
124682741|NCT00505921|448461805|FG000|Overall Study|Failed to Mobilize|8|||
124682742|NCT02382939|448461811|FG000|Overall Study|Adverse Event|1|||
124682743|NCT02382939|448461812|FG001|Overall Study|Adverse Event|1|||
124682744|NCT02382939|448461811|FG000|Overall Study|Withdrawal by Subject|2|||
124682745|NCT02382939|448461812|FG001|Overall Study|Withdrawal by Subject|2|||
124682746|NCT00717886|448461817|FG000|Overall Study|Withdrawal by Subject|3|||
124682747|NCT00717886|448461817|FG000|Overall Study|Treatment Failure|1|||
124682748|NCT00716417|448461818|FG000|Overall Study|Adverse Event|0|||
124682749|NCT00716417|448461819|FG001|Overall Study|Adverse Event|0|||
124682750|NCT00716417|448461820|FG002|Overall Study|Adverse Event|2|||
124682751|NCT00716417|448461821|FG003|Overall Study|Adverse Event|1|||
124682752|NCT00716417|448461822|FG004|Overall Study|Adverse Event|0|||
124682753|NCT00716417|448461823|FG005|Overall Study|Adverse Event|0|||
124682754|NCT00716417|448461824|FG006|Overall Study|Adverse Event|3|||
124682755|NCT00716417|448461825|FG007|Overall Study|Adverse Event|1|||
124682756|NCT00716417|448461826|FG008|Overall Study|Adverse Event|0|||
124682757|NCT00716417|448461827|FG009|Overall Study|Adverse Event|3|||
124682758|NCT00716417|448461818|FG000|Overall Study|Withdrawal by Subject|0|||
124682759|NCT00716417|448461819|FG001|Overall Study|Withdrawal by Subject|1|||
124682760|NCT00716417|448461820|FG002|Overall Study|Withdrawal by Subject|0|||
124682761|NCT00716417|448461821|FG003|Overall Study|Withdrawal by Subject|2|||
124682762|NCT00716417|448461822|FG004|Overall Study|Withdrawal by Subject|0|||
124682763|NCT00716417|448461823|FG005|Overall Study|Withdrawal by Subject|0|||
124682764|NCT00716417|448461824|FG006|Overall Study|Withdrawal by Subject|1|||
124682765|NCT00716417|448461825|FG007|Overall Study|Withdrawal by Subject|0|||
124682766|NCT00716417|448461826|FG008|Overall Study|Withdrawal by Subject|0|||
124682767|NCT00716417|448461827|FG009|Overall Study|Withdrawal by Subject|0|||
124682768|NCT00716417|448461818|FG000|Overall Study|Progressive disease|3|||
124682769|NCT00716417|448461819|FG001|Overall Study|Progressive disease|5|||
124682770|NCT00716417|448461820|FG002|Overall Study|Progressive disease|3|||
124682771|NCT00716417|448461821|FG003|Overall Study|Progressive disease|8|||
124682772|NCT00716417|448461822|FG004|Overall Study|Progressive disease|0|||
124682773|NCT00716417|448461823|FG005|Overall Study|Progressive disease|3|||
124682774|NCT00716417|448461824|FG006|Overall Study|Progressive disease|3|||
124682775|NCT00716417|448461825|FG007|Overall Study|Progressive disease|1|||
124682776|NCT00716417|448461826|FG008|Overall Study|Progressive disease|5|||
124682777|NCT00716417|448461827|FG009|Overall Study|Progressive disease|0|||
124682778|NCT00716417|448461818|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
124682779|NCT00716417|448461819|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
124682780|NCT00716417|448461820|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
124682781|NCT00716417|448461821|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
124682782|NCT00716417|448461822|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
124682783|NCT00716417|448461823|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
124682784|NCT00716417|448461824|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
124682785|NCT00716417|448461825|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
124682786|NCT00716417|448461826|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
124682787|NCT00716417|448461827|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
124682788|NCT00716417|448461818|FG000|Overall Study|On patient request due to toxicities|0|||
124880778|NCT04022889|449186951|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
124880779|NCT04022889|449186952|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
124880780|NCT04022889|449186950|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
124880781|NCT04022889|449186951|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
124880782|NCT04022889|449186952|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
124880783|NCT04022889|449186950|FG000|Stage 2|Screen Failure|0|||
124880784|NCT04022889|449186951|FG001|Stage 2|Screen Failure|0|||
124880785|NCT04022889|449186952|FG002|Stage 2|Screen Failure|3|||
124880786|NCT04022889|449186950|FG000|Stage 2|Ineligible for apheresis donation|0|||
124880787|NCT04022889|449186951|FG001|Stage 2|Ineligible for apheresis donation|0|||
124880788|NCT04022889|449186952|FG002|Stage 2|Ineligible for apheresis donation|2|||
124880789|NCT04022889|449186950|FG000|Stage 2|Adverse Event|0|||
124880790|NCT04022889|449186951|FG001|Stage 2|Adverse Event|0|||
124880791|NCT04022889|449186952|FG002|Stage 2|Adverse Event|2|||
124880792|NCT04022889|449186950|FG000|Stage 2|Protocol Violation|0|||
124880793|NCT04022889|449186951|FG001|Stage 2|Protocol Violation|0|||
124880794|NCT04022889|449186952|FG002|Stage 2|Protocol Violation|1|||
124880795|NCT04022889|449186950|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
124880796|NCT04022889|449186951|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
124880797|NCT04022889|449186952|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
124880798|NCT00605319|449186954|FG000|Overall Study|Adverse Event|6|||
124880799|NCT01478113|449186955|FG000|Overall Study|Withdrawal by Subject|0|||
124880800|NCT01478113|449186956|FG001|Overall Study|Withdrawal by Subject|1|||
124880801|NCT01478113|449186955|FG000|Overall Study|Physician Decision|1|||
124880802|NCT01478113|449186956|FG001|Overall Study|Physician Decision|0|||
124880803|NCT03093428|449186959|FG000|Overall Study|Not eligible for treatment|2|||
124880804|NCT03093428|449186960|FG001|Overall Study|Not eligible for treatment|1|||
124880805|NCT03093428|449186959|FG000|Overall Study|Progression|14|||
124880806|NCT03093428|449186960|FG001|Overall Study|Progression|4|||
124880807|NCT03093428|449186959|FG000|Overall Study|Death|1|||
124880808|NCT03093428|449186960|FG001|Overall Study|Death|0|||
124880809|NCT03093428|449186959|FG000|Overall Study|Adverse Event|1|||
124880810|NCT03093428|449186960|FG001|Overall Study|Adverse Event|0|||
124880811|NCT03093428|449186959|FG000|Overall Study|Withdrawal by Subject|1|||
124880812|NCT03093428|449186960|FG001|Overall Study|Withdrawal by Subject|1|||
124880813|NCT03980184|449186961|FG000|Overall Study|Dropped out before treatment|2|||
124880814|NCT03980184|449186962|FG001|Overall Study|Dropped out before treatment|2|||
124880815|NCT03980184|449186961|FG000|Overall Study|Lost to Follow-up|11|||
124880816|NCT03980184|449186962|FG001|Overall Study|Lost to Follow-up|13|||
124880817|NCT01616771|449186963|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
124880818|NCT04041440|449186964|FG000|Overall Study|Withdrawal by Subject|0|||
124880819|NCT04041440|449186965|FG001|Overall Study|Withdrawal by Subject|1|||
124880820|NCT04041440|449186964|FG000|Overall Study|Lost to Follow-up|0|||
124880821|NCT04041440|449186965|FG001|Overall Study|Lost to Follow-up|1|||
124880822|NCT01381874|449186966|FG000|Overall Study|Lost to Follow-up|1|||
124880823|NCT01381874|449186967|FG001|Overall Study|Lost to Follow-up|1|||
124880824|NCT01381874|449186968|FG002|Overall Study|Lost to Follow-up|0|||
124880825|NCT01381874|449186966|FG000|Overall Study|Withdrawal by Subject|9|||
124880826|NCT01381874|449186967|FG001|Overall Study|Withdrawal by Subject|10|||
124880827|NCT01381874|449186968|FG002|Overall Study|Withdrawal by Subject|9|||
124880828|NCT01381874|449186966|FG000|Overall Study|Other|67|||
124880829|NCT01381874|449186967|FG001|Overall Study|Other|52|||
124880830|NCT01381874|449186968|FG002|Overall Study|Other|67|||
124880831|NCT02247804|449186969|FG000|Treatment Period 1|Adverse Event|9|||
124880832|NCT02247804|449186970|FG001|Treatment Period 1|Adverse Event|2|||
124880833|NCT02247804|449186971|FG002|Treatment Period 1|Adverse Event|0|||
124880834|NCT02247804|449186969|FG000|Treatment Period 1|Lack of Efficacy|0|||
124880835|NCT02247804|449186970|FG001|Treatment Period 1|Lack of Efficacy|0|||
124880836|NCT02247804|449186971|FG002|Treatment Period 1|Lack of Efficacy|2|||
124880837|NCT02247804|449186969|FG000|Treatment Period 1|Lost to Follow-up|1|||
124880838|NCT02247804|449186970|FG001|Treatment Period 1|Lost to Follow-up|0|||
124880839|NCT02247804|449186971|FG002|Treatment Period 1|Lost to Follow-up|2|||
124880840|NCT02247804|449186969|FG000|Treatment Period 1|Personal Reasons|7|||
124682789|NCT00716417|448461819|FG001|Overall Study|On patient request due to toxicities|0|||
124682790|NCT00716417|448461820|FG002|Overall Study|On patient request due to toxicities|0|||
124682791|NCT00716417|448461821|FG003|Overall Study|On patient request due to toxicities|0|||
124880841|NCT02247804|449186970|FG001|Treatment Period 1|Personal Reasons|1|||
124880842|NCT02247804|449186971|FG002|Treatment Period 1|Personal Reasons|2|||
124711992|NCT00690794|448570705|FG001|Overall Study|Protocol Violation|7|||
124880843|NCT02247804|449186969|FG000|Treatment Period 1|Protocol Deviation|0|||
124880844|NCT02247804|449186970|FG001|Treatment Period 1|Protocol Deviation|0|||
124880845|NCT02247804|449186971|FG002|Treatment Period 1|Protocol Deviation|1|||
124880846|NCT02247804|449186969|FG000|Treatment Period 1|Randomized but not Treated|5|||
124880847|NCT02247804|449186970|FG001|Treatment Period 1|Randomized but not Treated|1|||
124880848|NCT02247804|449186971|FG002|Treatment Period 1|Randomized but not Treated|1|||
124880849|NCT02247804|449186969|FG000|Treatment Period 2|Adverse Event|6|||
124880850|NCT02247804|449186970|FG001|Treatment Period 2|Adverse Event|3|||
124880851|NCT02247804|449186971|FG002|Treatment Period 2|Adverse Event|3|||
124880852|NCT02247804|449186969|FG000|Treatment Period 2|Lack of Efficacy|0|||
124880853|NCT02247804|449186970|FG001|Treatment Period 2|Lack of Efficacy|0|||
124880854|NCT02247804|449186971|FG002|Treatment Period 2|Lack of Efficacy|1|||
124880855|NCT02247804|449186969|FG000|Treatment Period 2|Lost to Follow-up|0|||
124880856|NCT02247804|449186970|FG001|Treatment Period 2|Lost to Follow-up|1|||
124880857|NCT02247804|449186971|FG002|Treatment Period 2|Lost to Follow-up|1|||
124880858|NCT02247804|449186969|FG000|Treatment Period 2|Personal Reasons|2|||
124880859|NCT02247804|449186970|FG001|Treatment Period 2|Personal Reasons|1|||
124880860|NCT02247804|449186971|FG002|Treatment Period 2|Personal Reasons|1|||
124880861|NCT02247804|449186969|FG000|Treatment Period 2|Reason not Specified|0|||
124880862|NCT02247804|449186970|FG001|Treatment Period 2|Reason not Specified|0|||
124880863|NCT02247804|449186971|FG002|Treatment Period 2|Reason not Specified|2|||
124880864|NCT02247804|449186969|FG000|Treatment Period 3|Adverse Event|4|||
124880865|NCT02247804|449186970|FG001|Treatment Period 3|Adverse Event|3|||
124880866|NCT02247804|449186971|FG002|Treatment Period 3|Adverse Event|3|||
124880867|NCT02247804|449186969|FG000|Treatment Period 3|Lack of Efficacy|0|||
124880868|NCT02247804|449186970|FG001|Treatment Period 3|Lack of Efficacy|1|||
124880869|NCT02247804|449186971|FG002|Treatment Period 3|Lack of Efficacy|0|||
124880870|NCT02247804|449186969|FG000|Treatment Period 3|Lost to Follow-up|1|||
124880871|NCT02247804|449186970|FG001|Treatment Period 3|Lost to Follow-up|2|||
124880872|NCT02247804|449186971|FG002|Treatment Period 3|Lost to Follow-up|2|||
124880873|NCT02247804|449186969|FG000|Treatment Period 3|Personal Reasons|4|||
124880874|NCT02247804|449186970|FG001|Treatment Period 3|Personal Reasons|3|||
124880875|NCT02247804|449186971|FG002|Treatment Period 3|Personal Reasons|2|||
124880876|NCT02247804|449186969|FG000|Treatment Period 3|Reason not Specified|2|||
124682792|NCT00716417|448461822|FG004|Overall Study|On patient request due to toxicities|0|||
124682793|NCT00716417|448461823|FG005|Overall Study|On patient request due to toxicities|0|||
124682794|NCT00716417|448461824|FG006|Overall Study|On patient request due to toxicities|0|||
124682795|NCT00716417|448461825|FG007|Overall Study|On patient request due to toxicities|1|||
124682796|NCT00716417|448461826|FG008|Overall Study|On patient request due to toxicities|0|||
124682797|NCT00716417|448461827|FG009|Overall Study|On patient request due to toxicities|0|||
124682798|NCT01369433|448461828|FG000|Overall Study|Adverse Event|31|||
124682799|NCT01369433|448461829|FG001|Overall Study|Adverse Event|1|||
124682800|NCT01369433|448461828|FG000|Overall Study|Required significant surgical procedure|1|||
124682801|NCT01369433|448461829|FG001|Overall Study|Required significant surgical procedure|0|||
124682802|NCT01369433|448461828|FG000|Overall Study|Non-compliance|1|||
124682803|NCT01369433|448461829|FG001|Overall Study|Non-compliance|0|||
124682804|NCT01369433|448461828|FG000|Overall Study|Withdrawal by Subject|5|||
124682805|NCT01369433|448461829|FG001|Overall Study|Withdrawal by Subject|2|||
124682806|NCT01369433|448461828|FG000|Overall Study|Study terminated by Sponsor|67|||
124682807|NCT01369433|448461829|FG001|Overall Study|Study terminated by Sponsor|0|||
124682808|NCT01369433|448461828|FG000|Overall Study|Lost to Follow-up|1|||
124682809|NCT01369433|448461829|FG001|Overall Study|Lost to Follow-up|0|||
124682810|NCT01369433|448461828|FG000|Overall Study|Death|5|||
124682811|NCT01369433|448461829|FG001|Overall Study|Death|0|||
124682812|NCT01369433|448461828|FG000|Overall Study|Investigator discretion|6|||
124682813|NCT01369433|448461829|FG001|Overall Study|Investigator discretion|1|||
124682814|NCT01369433|448461828|FG000|Overall Study|Progressive Disease|92|||
124682815|NCT01369433|448461829|FG001|Overall Study|Progressive Disease|12|||
124682816|NCT01553851|448461830|FG000|Overall Study|Adverse Event|2|||
124682817|NCT01553851|448461830|FG000|Overall Study|constipation|1|||
124682818|NCT00844519|448461846|FG000|Overall Study|Withdrawal by Subject|1|||
124682819|NCT00844519|448461847|FG001|Overall Study|Withdrawal by Subject|1|||
124682820|NCT00844519|448461846|FG000|Overall Study|Adverse Event|1|||
124682821|NCT00844519|448461847|FG001|Overall Study|Adverse Event|0|||
124682822|NCT06438601|448461848|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
124682823|NCT06438601|448461849|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
124682824|NCT06438601|448461848|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
124682825|NCT06438601|448461849|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
124880877|NCT02247804|449186970|FG001|Treatment Period 3|Reason not Specified|1|||
124880878|NCT02247804|449186971|FG002|Treatment Period 3|Reason not Specified|3|||
124880879|NCT02917265|449186978|FG000|Overall Study|Physician Decision|1|||
124682826|NCT03329001|448461850|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
124439027|NCT00585195|447567798|FG007|Overall Study|Death|0|||
124439028|NCT00585195|447567799|FG008|Overall Study|Death|1|||
124682827|NCT03329001|448461851|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
124682828|NCT03329001|448461852|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
124711993|NCT00690794|448570704|FG000|Overall Study|Noncompliance|1|||
124880880|NCT02917265|449186979|FG001|Overall Study|Physician Decision|0|||
124880881|NCT02917265|449186978|FG000|Overall Study|Withdrawal by Subject|1|||
124880882|NCT02917265|449186979|FG001|Overall Study|Withdrawal by Subject|0|||
124439029|NCT00585195|447567800|FG009|Overall Study|Death|0|||
124880883|NCT01737996|449186981|FG000|Overall Study|Adverse Event|0|||
124880884|NCT01737996|449186982|FG001|Overall Study|Adverse Event|1|||
124880885|NCT01737996|449186983|FG002|Overall Study|Adverse Event|1|||
124880886|NCT01737996|449186981|FG000|Overall Study|Withdrawal by Subject|0|||
124880887|NCT01737996|449186982|FG001|Overall Study|Withdrawal by Subject|0|||
124880888|NCT01737996|449186983|FG002|Overall Study|Withdrawal by Subject|1|||
124880889|NCT00452413|449186984|FG000|Overall Study|Progressive Disease|4|||
124880890|NCT00452413|449186985|FG001|Overall Study|Progressive Disease|11|||
124880891|NCT00452413|449186986|FG002|Overall Study|Progressive Disease|30|||
124880892|NCT00452413|449186984|FG000|Overall Study|Withdrawal by Subject|0|||
124880893|NCT00452413|449186985|FG001|Overall Study|Withdrawal by Subject|1|||
124880894|NCT00452413|449186986|FG002|Overall Study|Withdrawal by Subject|4|||
124880895|NCT00452413|449186984|FG000|Overall Study|Adverse Event|0|||
124880896|NCT00452413|449186985|FG001|Overall Study|Adverse Event|0|||
124880897|NCT00452413|449186986|FG002|Overall Study|Adverse Event|5|||
124880898|NCT00452413|449186984|FG000|Overall Study|Physician Decision|0|||
124880899|NCT00452413|449186985|FG001|Overall Study|Physician Decision|0|||
124880900|NCT00452413|449186986|FG002|Overall Study|Physician Decision|4|||
124880901|NCT00452413|449186984|FG000|Overall Study|Death due to study disease|0|||
124880902|NCT00452413|449186985|FG001|Overall Study|Death due to study disease|0|||
124880903|NCT00452413|449186986|FG002|Overall Study|Death due to study disease|2|||
124880904|NCT00452413|449186984|FG000|Overall Study|Death due to adverse event (AE)|0|||
124880905|NCT00452413|449186985|FG001|Overall Study|Death due to adverse event (AE)|0|||
124880906|NCT00452413|449186986|FG002|Overall Study|Death due to adverse event (AE)|1|||
124880907|NCT00452413|449186984|FG000|Overall Study|On treatment|0|||
124880908|NCT00452413|449186985|FG001|Overall Study|On treatment|0|||
124880909|NCT00452413|449186986|FG002|Overall Study|On treatment|3|||
124880910|NCT03119610|449186988|FG000|Overall Study|Adverse Event|1|||
124880911|NCT03119610|449186989|FG001|Overall Study|Adverse Event|0|||
124880912|NCT03119610|449186988|FG000|Overall Study|Lost to Follow-up|0|||
124880913|NCT03119610|449186989|FG001|Overall Study|Lost to Follow-up|1|||
124880914|NCT00114634|449186990|FG000|Overall Study|failure to return forms|3|||
124880915|NCT03283696|449186991|FG000|Overall Study|Physician Decision|5|||
124880916|NCT03283696|449186992|FG001|Overall Study|Physician Decision|6|||
124880917|NCT03283696|449186991|FG000|Overall Study|Withdrawal by Subject|2|||
124880918|NCT03283696|449186992|FG001|Overall Study|Withdrawal by Subject|0|||
124880919|NCT02765490|449186993|FG000|Overall Study|Lost to Follow-up|1|||
124880920|NCT02765490|449186994|FG001|Overall Study|Lost to Follow-up|1|||
124880921|NCT02765490|449186993|FG000|Overall Study|Other|0|||
124880922|NCT02765490|449186994|FG001|Overall Study|Other|1|||
124880923|NCT02765490|449186993|FG000|Overall Study|Death|0|||
124880924|NCT02765490|449186994|FG001|Overall Study|Death|1|||
124880925|NCT01350505|449186995|FG000|Overall Study|Lost to Follow-up|4|||
124880926|NCT00007475|449186996|FG000|Overall Study|Withdrawal by Subject|1|||
124880927|NCT00007475|449186997|FG001|Overall Study|Withdrawal by Subject|0|||
124880928|NCT00007475|449186998|FG002|Overall Study|Withdrawal by Subject|0|||
124880929|NCT00007475|449186999|FG003|Overall Study|Withdrawal by Subject|0|||
124880930|NCT00007475|449186996|FG000|Overall Study|Adverse Event|3|||
124880931|NCT00007475|449186997|FG001|Overall Study|Adverse Event|0|||
124880932|NCT00007475|449186998|FG002|Overall Study|Adverse Event|0|||
124880933|NCT00007475|449186999|FG003|Overall Study|Adverse Event|0|||
124880934|NCT01512745|449187000|FG000|Overall Study|Adverse Event|22|||
124880935|NCT01512745|449187001|FG001|Overall Study|Adverse Event|3|||
124880936|NCT01512745|449187000|FG000|Overall Study|Death|9|||
124880937|NCT01512745|449187001|FG001|Overall Study|Death|13|||
124880938|NCT01512745|449187000|FG000|Overall Study|Withdrawal by Subject|2|||
124880939|NCT01512745|449187001|FG001|Overall Study|Withdrawal by Subject|2|||
124880940|NCT01512745|449187000|FG000|Overall Study|Lost to Follow-up|4|||
124880941|NCT01512745|449187001|FG001|Overall Study|Lost to Follow-up|0|||
124880942|NCT01512745|449187000|FG000|Overall Study|Lack of Efficacy|2|||
124880943|NCT01512745|449187001|FG001|Overall Study|Lack of Efficacy|2|||
124439030|NCT00585195|447567801|FG010|Overall Study|Death|1|||
124439031|NCT00585195|447567802|FG011|Overall Study|Death|1|||
124439032|NCT00585195|447567803|FG012|Overall Study|Death|7|||
124439033|NCT00585195|447567804|FG013|Overall Study|Death|2|||
124439034|NCT00585195|447567805|FG014|Overall Study|Death|8|||
124439035|NCT00585195|447567806|FG015|Overall Study|Death|2|||
124439036|NCT00585195|447567807|FG016|Overall Study|Death|11|||
124439037|NCT00585195|447567808|FG017|Overall Study|Death|0|||
124439038|NCT00585195|447567809|FG018|Overall Study|Death|0|||
124439039|NCT00585195|447567810|FG019|Overall Study|Death|0|||
124439040|NCT00585195|447567811|FG020|Overall Study|Death|1|||
124439041|NCT00585195|447567791|FG000|Overall Study|Lost to Follow-up|0|||
124682829|NCT03329001|448461853|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
124682830|NCT03329001|448461854|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
124682831|NCT03329001|448461855|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
124682832|NCT03329001|448461856|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
124880944|NCT01512745|449187000|FG000|Overall Study|Protocol Violation|1|||
124880945|NCT01512745|449187001|FG001|Overall Study|Protocol Violation|0|||
124880946|NCT02357810|449187002|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
124880947|NCT02357810|449187002|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
124880948|NCT02357810|449187002|FG000|Reached 12 Weeks Response|Adverse Event|5|||
124880949|NCT02357810|449187002|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
124439042|NCT00585195|447567792|FG001|Overall Study|Lost to Follow-up|0|||
124682833|NCT03329001|448461857|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
124880950|NCT02357810|449187002|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
124880951|NCT02357810|449187002|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
124880952|NCT02357810|449187002|FG000|Reached 12 Weeks Response|Death|1|||
124880953|NCT02357810|449187002|FG000|Reached 12 Weeks Response|Physician Decision|1|||
124439043|NCT00585195|447567793|FG002|Overall Study|Lost to Follow-up|0|||
124439044|NCT00585195|447567794|FG003|Overall Study|Lost to Follow-up|0|||
124439045|NCT00585195|447567795|FG004|Overall Study|Lost to Follow-up|0|||
124439046|NCT00585195|447567796|FG005|Overall Study|Lost to Follow-up|0|||
124682834|NCT03329001|448461850|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
124682835|NCT03329001|448461851|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
124682836|NCT03329001|448461852|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
124682837|NCT03329001|448461853|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
124682838|NCT03329001|448461854|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
124682839|NCT03329001|448461855|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
124682840|NCT03329001|448461856|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
124682841|NCT03329001|448461857|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
124682842|NCT03329001|448461850|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
124682843|NCT03329001|448461851|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
124682844|NCT03329001|448461852|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
124682845|NCT03329001|448461853|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
124682846|NCT03329001|448461854|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
124439047|NCT00585195|447567797|FG006|Overall Study|Lost to Follow-up|0|||
124439048|NCT00585195|447567798|FG007|Overall Study|Lost to Follow-up|0|||
124439049|NCT00585195|447567799|FG008|Overall Study|Lost to Follow-up|0|||
124439050|NCT00585195|447567800|FG009|Overall Study|Lost to Follow-up|0|||
124880954|NCT02357810|449187002|FG000|Reached 12 Weeks Response|Other|1|||
124880955|NCT02357810|449187002|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
124880956|NCT02357810|449187002|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
124880957|NCT02357810|449187002|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
124880958|NCT02357810|449187002|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
124880959|NCT02357810|449187002|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
124880960|NCT02357810|449187002|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
124880961|NCT01617005|449187004|FG000|Overall Study|Pregnancy|1|||
124880962|NCT01617005|449187004|FG000|Overall Study|Lack of motivation for treatment|1|||
124880963|NCT01225822|449187014|FG000|Overall Study|Adverse Event|13|||
124880964|NCT01225822|449187015|FG001|Overall Study|Adverse Event|31|||
124880965|NCT01225822|449187016|FG002|Overall Study|Adverse Event|18|||
124880966|NCT01225822|449187017|FG003|Overall Study|Adverse Event|23|||
124880967|NCT01225822|449187018|FG004|Overall Study|Adverse Event|14|||
124880968|NCT01225822|449187014|FG000|Overall Study|Protocol Violation|6|||
124880969|NCT01225822|449187015|FG001|Overall Study|Protocol Violation|8|||
124880970|NCT01225822|449187016|FG002|Overall Study|Protocol Violation|6|||
124880971|NCT01225822|449187017|FG003|Overall Study|Protocol Violation|7|||
124880972|NCT01225822|449187018|FG004|Overall Study|Protocol Violation|4|||
124880973|NCT01225822|449187014|FG000|Overall Study|Lost to Follow-up|0|||
124880974|NCT01225822|449187015|FG001|Overall Study|Lost to Follow-up|0|||
124880975|NCT01225822|449187016|FG002|Overall Study|Lost to Follow-up|0|||
124880976|NCT01225822|449187017|FG003|Overall Study|Lost to Follow-up|1|||
124880977|NCT01225822|449187018|FG004|Overall Study|Lost to Follow-up|0|||
124880978|NCT01225822|449187014|FG000|Overall Study|Withdrawal by Subject|6|||
124880979|NCT01225822|449187015|FG001|Overall Study|Withdrawal by Subject|7|||
124880980|NCT01225822|449187016|FG002|Overall Study|Withdrawal by Subject|7|||
124880981|NCT01225822|449187017|FG003|Overall Study|Withdrawal by Subject|11|||
124880982|NCT01225822|449187018|FG004|Overall Study|Withdrawal by Subject|6|||
124880983|NCT01225822|449187014|FG000|Overall Study|Other|13|||
124880984|NCT01225822|449187015|FG001|Overall Study|Other|10|||
124880985|NCT01225822|449187016|FG002|Overall Study|Other|7|||
124880986|NCT01225822|449187017|FG003|Overall Study|Other|10|||
124880987|NCT01225822|449187018|FG004|Overall Study|Other|7|||
124880988|NCT05644353|449187019|FG000|Overall Study|Physician Decision|1|||
124880989|NCT05644353|449187020|FG001|Overall Study|Physician Decision|0|||
124880990|NCT05644353|449187021|FG002|Overall Study|Physician Decision|0|||
124880991|NCT05644353|449187022|FG003|Overall Study|Physician Decision|0|||
124880992|NCT05644353|449187023|FG004|Overall Study|Physician Decision|0|||
124880993|NCT05644353|449187024|FG005|Overall Study|Physician Decision|0|||
124880994|NCT05644353|449187019|FG000|Overall Study|Protocol Violation|1|||
124880995|NCT05644353|449187020|FG001|Overall Study|Protocol Violation|0|||
124880996|NCT05644353|449187021|FG002|Overall Study|Protocol Violation|0|||
124880997|NCT05644353|449187022|FG003|Overall Study|Protocol Violation|0|||
124880998|NCT05644353|449187023|FG004|Overall Study|Protocol Violation|0|||
124880999|NCT05644353|449187024|FG005|Overall Study|Protocol Violation|0|||
124881000|NCT05644353|449187019|FG000|Overall Study|Withdrawal by Subject|0|||
124881001|NCT05644353|449187020|FG001|Overall Study|Withdrawal by Subject|2|||
124881002|NCT05644353|449187021|FG002|Overall Study|Withdrawal by Subject|0|||
124881003|NCT05644353|449187022|FG003|Overall Study|Withdrawal by Subject|0|||
124881004|NCT05644353|449187023|FG004|Overall Study|Withdrawal by Subject|1|||
124881005|NCT05644353|449187024|FG005|Overall Study|Withdrawal by Subject|0|||
124881006|NCT05644353|449187019|FG000|Overall Study|Lost to Follow-up|0|||
124881007|NCT05644353|449187020|FG001|Overall Study|Lost to Follow-up|0|||
124881008|NCT05644353|449187021|FG002|Overall Study|Lost to Follow-up|1|||
124439051|NCT00585195|447567801|FG010|Overall Study|Lost to Follow-up|0|||
124439052|NCT00585195|447567802|FG011|Overall Study|Lost to Follow-up|0|||
124682847|NCT03329001|448461855|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
124682848|NCT03329001|448461856|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
124881009|NCT05644353|449187022|FG003|Overall Study|Lost to Follow-up|0|||
124881010|NCT05644353|449187023|FG004|Overall Study|Lost to Follow-up|0|||
124881011|NCT05644353|449187024|FG005|Overall Study|Lost to Follow-up|0|||
124881012|NCT01407354|449187025|FG000|First Intervention|Withdrawal by Subject|0|||
124881013|NCT01407354|449187026|FG001|First Intervention|Withdrawal by Subject|2|||
124881014|NCT01407354|449187025|FG000|First Intervention|Adverse Event|1|||
124881015|NCT01407354|449187026|FG001|First Intervention|Adverse Event|0|||
124881016|NCT01407354|449187025|FG000|First Intervention|Physician Decision|1|||
124881017|NCT01407354|449187026|FG001|First Intervention|Physician Decision|0|||
124881018|NCT02204579|449187028|FG000|Overall Study|Screen failures|2|||
124881019|NCT02778399|449187029|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
124439053|NCT00585195|447567803|FG012|Overall Study|Lost to Follow-up|1|||
124439054|NCT00585195|447567804|FG013|Overall Study|Lost to Follow-up|0|||
124881020|NCT02778399|449187030|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
124881021|NCT02778399|449187031|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
124881022|NCT02778399|449187032|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
124881023|NCT02778399|449187033|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
124881024|NCT02778399|449187034|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
124881025|NCT02778399|449187029|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
124881026|NCT02778399|449187030|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
124881027|NCT02778399|449187031|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
124881028|NCT02778399|449187032|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
124881029|NCT02778399|449187033|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
124881030|NCT02778399|449187034|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
124881031|NCT02778399|449187029|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
124881032|NCT02778399|449187030|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
124881033|NCT02778399|449187031|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
124881034|NCT02778399|449187032|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
124881035|NCT02778399|449187033|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
124881036|NCT02778399|449187034|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
124881037|NCT02778399|449187029|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
124881038|NCT02778399|449187030|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
124881039|NCT02778399|449187031|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
124881040|NCT02778399|449187032|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
124881041|NCT02778399|449187033|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
124881042|NCT02778399|449187034|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
124881043|NCT02778399|449187029|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
124881044|NCT02778399|449187030|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
124881045|NCT02778399|449187031|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
124881046|NCT02778399|449187032|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
124881047|NCT02778399|449187033|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
124881048|NCT02778399|449187034|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
124881049|NCT02778399|449187029|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
124881050|NCT02778399|449187030|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
124881051|NCT02778399|449187031|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
124881052|NCT02778399|449187032|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
124881053|NCT02778399|449187033|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
124881054|NCT02778399|449187034|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
124881055|NCT02778399|449187029|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
124881056|NCT02778399|449187030|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
124881057|NCT02778399|449187031|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
124881058|NCT02778399|449187032|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
124881059|NCT02778399|449187033|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
124881060|NCT02778399|449187034|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
124881061|NCT02778399|449187029|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
124881062|NCT02778399|449187030|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
124881063|NCT02778399|449187031|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
124881064|NCT02778399|449187032|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
124881065|NCT02778399|449187033|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
124881066|NCT02778399|449187034|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
124881067|NCT02778399|449187029|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
124881068|NCT02778399|449187030|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
124881069|NCT02778399|449187031|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
124881070|NCT02778399|449187032|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
124881071|NCT02778399|449187033|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
124881072|NCT02778399|449187034|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
124881073|NCT02778399|449187029|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
124881074|NCT02778399|449187030|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
124881075|NCT02778399|449187031|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
124881076|NCT02778399|449187032|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
124881077|NCT02778399|449187033|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
124881078|NCT02778399|449187034|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
124881079|NCT02778399|449187029|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
124881080|NCT02778399|449187030|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
124881081|NCT02778399|449187031|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
124881082|NCT02778399|449187032|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
124881083|NCT02778399|449187033|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
124881084|NCT02778399|449187034|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
124881085|NCT00612534|449187037|FG000|Overall Study|Adverse Event|0|||
124881086|NCT00612534|449187038|FG001|Overall Study|Adverse Event|4|||
124881087|NCT00612534|449187039|FG002|Overall Study|Adverse Event|2|||
124881088|NCT00612534|449187040|FG003|Overall Study|Adverse Event|1|||
124881089|NCT00612534|449187037|FG000|Overall Study|Lack of Efficacy|13|||
124881090|NCT00612534|449187038|FG001|Overall Study|Lack of Efficacy|12|||
124881091|NCT00612534|449187039|FG002|Overall Study|Lack of Efficacy|5|||
124881092|NCT00612534|449187040|FG003|Overall Study|Lack of Efficacy|16|||
124881093|NCT00612534|449187037|FG000|Overall Study|Other Reason|0|||
124881094|NCT00612534|449187038|FG001|Overall Study|Other Reason|1|||
124881095|NCT00612534|449187039|FG002|Overall Study|Other Reason|0|||
124881096|NCT00612534|449187040|FG003|Overall Study|Other Reason|0|||
124881097|NCT03916744|449187041|FG000|Overall Study|Withdrawal by Subject|0|||
124881098|NCT03916744|449187042|FG001|Overall Study|Withdrawal by Subject|1|||
124881099|NCT03916744|449187043|FG002|Overall Study|Withdrawal by Subject|2|||
124881100|NCT02223754|449187044|FG000|Period 1|Adverse Event|1|||
124881101|NCT02223754|449187045|FG001|Period 1|Adverse Event|0|||
124881102|NCT02223754|449187044|FG000|Period 1|Lost to Follow-up|0|||
124881103|NCT02223754|449187045|FG001|Period 1|Lost to Follow-up|1|||
124881104|NCT02223754|449187044|FG000|Period 1|Protocol Violation|2|||
124881105|NCT02223754|449187045|FG001|Period 1|Protocol Violation|4|||
124881106|NCT02223754|449187044|FG000|Period 1|Withdrawal by Subject|0|||
124881107|NCT02223754|449187045|FG001|Period 1|Withdrawal by Subject|4|||
124881108|NCT02223754|449187044|FG000|Period 1|Test Article No Longer Available|1|||
124881109|NCT02223754|449187045|FG001|Period 1|Test Article No Longer Available|5|||
124881110|NCT02223754|449187044|FG000|Period 1|Unsatisfactory Visual Response|0|||
124881111|NCT02223754|449187045|FG001|Period 1|Unsatisfactory Visual Response|1|||
124881112|NCT02223754|449187044|FG000|Period 2|Adverse Event|0|||
124439055|NCT00585195|447567805|FG014|Overall Study|Lost to Follow-up|0|||
124439056|NCT00585195|447567806|FG015|Overall Study|Lost to Follow-up|0|||
124439057|NCT00585195|447567807|FG016|Overall Study|Lost to Follow-up|0|||
124439058|NCT00585195|447567808|FG017|Overall Study|Lost to Follow-up|2|||
124439059|NCT00585195|447567809|FG018|Overall Study|Lost to Follow-up|0|||
124439060|NCT00585195|447567810|FG019|Overall Study|Lost to Follow-up|0|||
124439061|NCT00585195|447567811|FG020|Overall Study|Lost to Follow-up|0|||
124439062|NCT00585195|447567791|FG000|Overall Study|Site Terminated by Sponsor|0|||
124439063|NCT00585195|447567792|FG001|Overall Study|Site Terminated by Sponsor|0|||
124439064|NCT00585195|447567793|FG002|Overall Study|Site Terminated by Sponsor|0|||
124439065|NCT00585195|447567794|FG003|Overall Study|Site Terminated by Sponsor|0|||
124439066|NCT00585195|447567795|FG004|Overall Study|Site Terminated by Sponsor|0|||
124439067|NCT00585195|447567796|FG005|Overall Study|Site Terminated by Sponsor|0|||
124682849|NCT03329001|448461857|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
124682850|NCT03329001|448461850|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
124682851|NCT03329001|448461851|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
124682852|NCT03329001|448461852|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
124682853|NCT03329001|448461853|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
124682854|NCT03329001|448461854|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
124682855|NCT03329001|448461855|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
124682856|NCT03329001|448461856|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
124682857|NCT03329001|448461857|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
124682858|NCT03329001|448461850|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
124682859|NCT03329001|448461851|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
124682860|NCT03329001|448461852|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
124682861|NCT03329001|448461853|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
124682862|NCT03329001|448461854|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
124682863|NCT03329001|448461855|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
124682864|NCT03329001|448461856|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
124682865|NCT03329001|448461857|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
124881113|NCT02223754|449187045|FG001|Period 2|Adverse Event|1|||
124881114|NCT02223754|449187044|FG000|Period 2|Protocol Violation|1|||
124881115|NCT02223754|449187045|FG001|Period 2|Protocol Violation|0|||
124439068|NCT00585195|447567797|FG006|Overall Study|Site Terminated by Sponsor|0|||
124439069|NCT00585195|447567798|FG007|Overall Study|Site Terminated by Sponsor|0|||
124439070|NCT00585195|447567799|FG008|Overall Study|Site Terminated by Sponsor|0|||
124881116|NCT02223754|449187044|FG000|Period 2|Lens Discomfort|1|||
124881117|NCT02223754|449187045|FG001|Period 2|Lens Discomfort|1|||
124881118|NCT02223754|449187044|FG000|Period 2|Lost to Follow-up|1|||
124881119|NCT02223754|449187045|FG001|Period 2|Lost to Follow-up|0|||
124881120|NCT02223754|449187044|FG000|Period 2|Test Article No Longer Available|0|||
124881121|NCT02223754|449187045|FG001|Period 2|Test Article No Longer Available|1|||
124881122|NCT01008475|449187046|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
124881123|NCT01008475|449187047|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
124881124|NCT01008475|449187048|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
124881125|NCT01008475|449187049|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
124881126|NCT01008475|449187050|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
124881127|NCT01008475|449187051|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
124881128|NCT01008475|449187052|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
124881129|NCT03556358|449187054|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
124881130|NCT03556358|449187055|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
124881131|NCT03556358|449187054|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
124881132|NCT03556358|449187055|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
124881133|NCT03556358|449187054|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
124881134|NCT03556358|449187055|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
124881135|NCT03556358|449187054|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
124881136|NCT03556358|449187055|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
124881137|NCT03556358|449187054|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
124881138|NCT03556358|449187055|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
124881139|NCT03556358|449187054|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
124881140|NCT03556358|449187055|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
124881141|NCT03556358|449187054|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
124881142|NCT03556358|449187055|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
124881143|NCT02917941|449187058|FG000|Treatment Period|Adverse Event|11|||
124881144|NCT02917941|449187058|FG000|Treatment Period|Progressive Disease|11|||
124881145|NCT02917941|449187058|FG000|Treatment Period|Reason not Specified|2|||
124881146|NCT02917941|449187058|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
124881147|NCT02917941|449187058|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
124881148|NCT01351025|449187059|FG000|Week 0 - 20|Lost to Follow-up|2|||
124881149|NCT01351025|449187060|FG001|Week 0 - 20|Lost to Follow-up|1|||
124881150|NCT01351025|449187059|FG000|Week 0 - 20|Withdrawal by Subject|1|||
124881151|NCT01351025|449187060|FG001|Week 0 - 20|Withdrawal by Subject|0|||
124881152|NCT01351025|449187059|FG000|Week 24 - 44|Lost to Follow-up|0|||
124881153|NCT01351025|449187060|FG001|Week 24 - 44|Lost to Follow-up|2|||
124881154|NCT01351025|449187059|FG000|Week 24 - 44|Site closed|0|||
124881155|NCT01351025|449187060|FG001|Week 24 - 44|Site closed|1|||
124881156|NCT01351025|449187059|FG000|Week 24 - 44|unable to get to clinic|1|||
124881157|NCT01351025|449187060|FG001|Week 24 - 44|unable to get to clinic|1|||
124881158|NCT03573908|449187065|FG000|Treatment Period|Adverse Event|4|||
124881159|NCT03573908|449187066|FG001|Treatment Period|Adverse Event|9|||
124881160|NCT03573908|449187067|FG002|Treatment Period|Adverse Event|0|||
124881161|NCT03573908|449187068|FG003|Treatment Period|Adverse Event|0|||
124881162|NCT03573908|449187069|FG004|Treatment Period|Adverse Event|0|||
124881163|NCT03573908|449187065|FG000|Treatment Period|Protocol Violation|1|||
124881164|NCT03573908|449187066|FG001|Treatment Period|Protocol Violation|0|||
124881165|NCT03573908|449187067|FG002|Treatment Period|Protocol Violation|0|||
124881166|NCT03573908|449187068|FG003|Treatment Period|Protocol Violation|0|||
124881167|NCT03573908|449187069|FG004|Treatment Period|Protocol Violation|0|||
124881168|NCT03573908|449187065|FG000|Treatment Period|Withdrawal by Subject|7|||
124881169|NCT03573908|449187066|FG001|Treatment Period|Withdrawal by Subject|5|||
124881170|NCT03573908|449187067|FG002|Treatment Period|Withdrawal by Subject|0|||
124881171|NCT03573908|449187068|FG003|Treatment Period|Withdrawal by Subject|0|||
124881172|NCT03573908|449187069|FG004|Treatment Period|Withdrawal by Subject|0|||
124881173|NCT03573908|449187065|FG000|Treatment Period|Lost to Follow-up|7|||
124881174|NCT03573908|449187066|FG001|Treatment Period|Lost to Follow-up|6|||
124881175|NCT03573908|449187067|FG002|Treatment Period|Lost to Follow-up|0|||
124439071|NCT00585195|447567800|FG009|Overall Study|Site Terminated by Sponsor|0|||
124439072|NCT00585195|447567801|FG010|Overall Study|Site Terminated by Sponsor|0|||
124439073|NCT00585195|447567802|FG011|Overall Study|Site Terminated by Sponsor|0|||
124711994|NCT00690794|448570705|FG001|Overall Study|Noncompliance|2|||
124881176|NCT03573908|449187068|FG003|Treatment Period|Lost to Follow-up|0|||
124439074|NCT00585195|447567803|FG012|Overall Study|Site Terminated by Sponsor|1|||
124881177|NCT03573908|449187069|FG004|Treatment Period|Lost to Follow-up|0|||
124881178|NCT03573908|449187065|FG000|Treatment Period|Pregnancy|1|||
124881179|NCT03573908|449187066|FG001|Treatment Period|Pregnancy|0|||
124881180|NCT03573908|449187067|FG002|Treatment Period|Pregnancy|0|||
124439075|NCT00585195|447567804|FG013|Overall Study|Site Terminated by Sponsor|0|||
124881181|NCT03573908|449187068|FG003|Treatment Period|Pregnancy|0|||
124881182|NCT03573908|449187069|FG004|Treatment Period|Pregnancy|0|||
124881183|NCT03573908|449187065|FG000|Treatment Period|Other, Not Specified|4|||
124881184|NCT03573908|449187066|FG001|Treatment Period|Other, Not Specified|6|||
124881185|NCT03573908|449187067|FG002|Treatment Period|Other, Not Specified|0|||
124881186|NCT03573908|449187068|FG003|Treatment Period|Other, Not Specified|0|||
124881187|NCT03573908|449187069|FG004|Treatment Period|Other, Not Specified|0|||
124881188|NCT03573908|449187065|FG000|Randomized Withdrawal Period|Adverse Event|0|||
124881189|NCT03573908|449187066|FG001|Randomized Withdrawal Period|Adverse Event|0|||
124881190|NCT03573908|449187067|FG002|Randomized Withdrawal Period|Adverse Event|3|||
124881191|NCT03573908|449187068|FG003|Randomized Withdrawal Period|Adverse Event|0|||
124881192|NCT03573908|449187069|FG004|Randomized Withdrawal Period|Adverse Event|0|||
124881193|NCT03573908|449187065|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124881194|NCT03573908|449187066|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124881195|NCT03573908|449187067|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124881196|NCT03573908|449187068|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124881197|NCT03573908|449187069|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
124881198|NCT03573908|449187065|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
124881199|NCT03573908|449187066|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
124881200|NCT03573908|449187067|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
124881201|NCT03573908|449187068|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
124881202|NCT03573908|449187069|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
124881203|NCT03573908|449187065|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
124881204|NCT03573908|449187066|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
124881205|NCT03573908|449187067|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
124881206|NCT03573908|449187068|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
124881207|NCT03573908|449187069|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
124881208|NCT02669095|449187072|FG000|Overall Study|Adverse Event|1|||
124881209|NCT02669095|449187073|FG001|Overall Study|Adverse Event|0|||
124881210|NCT02669095|449187072|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
124881211|NCT02669095|449187073|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
124881212|NCT02669095|449187072|FG000|Overall Study|Torn Lens|0|||
124881213|NCT02669095|449187073|FG001|Overall Study|Torn Lens|1|||
124881214|NCT02669095|449187072|FG000|Overall Study|Visit 5 assessments not completed|0|||
124881215|NCT02669095|449187073|FG001|Overall Study|Visit 5 assessments not completed|1|||
124881216|NCT00926003|449187074|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
124881217|NCT00926003|449187075|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
124881218|NCT00926003|449187076|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
124881219|NCT00926003|449187074|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
124881220|NCT00926003|449187075|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
124881221|NCT00926003|449187076|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
124881222|NCT00539279|449187083|FG000|Treatment|Withdrawal by Subject|10|||
124881223|NCT00539279|449187084|FG001|Treatment|Withdrawal by Subject|8|||
124881224|NCT00539279|449187083|FG000|Treatment|Death|1|||
124881225|NCT00539279|449187084|FG001|Treatment|Death|0|||
124881226|NCT00539279|449187083|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
124881227|NCT00539279|449187084|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
124881228|NCT00539279|449187083|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
124881229|NCT00539279|449187084|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
124881230|NCT02769065|449189394|FG000|Overall Study|Voluntary Withdrawal|1|||
124881231|NCT02769065|449189395|FG001|Overall Study|Voluntary Withdrawal|0|||
124881232|NCT02769065|449189396|FG002|Overall Study|Voluntary Withdrawal|0|||
124881233|NCT02769065|449189397|FG003|Overall Study|Voluntary Withdrawal|0|||
124881234|NCT02769065|449189398|FG004|Overall Study|Voluntary Withdrawal|0|||
124881235|NCT02769065|449189399|FG005|Overall Study|Voluntary Withdrawal|0|||
124881236|NCT02769065|449189400|FG006|Overall Study|Voluntary Withdrawal|0|||
124881237|NCT02769065|449189401|FG007|Overall Study|Voluntary Withdrawal|0|||
124881238|NCT02769065|449189402|FG008|Overall Study|Voluntary Withdrawal|0|||
124881239|NCT02769065|449189403|FG009|Overall Study|Voluntary Withdrawal|0|||
124881240|NCT02769065|449189404|FG010|Overall Study|Voluntary Withdrawal|0|||
124881241|NCT02769065|449189405|FG011|Overall Study|Voluntary Withdrawal|0|||
124881242|NCT02769065|449189406|FG012|Overall Study|Voluntary Withdrawal|0|||
124881243|NCT02769065|449189407|FG013|Overall Study|Voluntary Withdrawal|0|||
124881244|NCT02769065|449189408|FG014|Overall Study|Voluntary Withdrawal|0|||
124881245|NCT02769065|449189409|FG015|Overall Study|Voluntary Withdrawal|0|||
124881246|NCT02769065|449189410|FG016|Overall Study|Voluntary Withdrawal|0|||
124881247|NCT02769065|449189411|FG017|Overall Study|Voluntary Withdrawal|0|||
124881248|NCT02769065|449189412|FG018|Overall Study|Voluntary Withdrawal|0|||
124881249|NCT02769065|449189413|FG019|Overall Study|Voluntary Withdrawal|0|||
124881250|NCT02769065|449189414|FG020|Overall Study|Voluntary Withdrawal|0|||
124881251|NCT02769065|449189415|FG021|Overall Study|Voluntary Withdrawal|0|||
124881252|NCT02769065|449189416|FG022|Overall Study|Voluntary Withdrawal|0|||
124881253|NCT02769065|449189417|FG023|Overall Study|Voluntary Withdrawal|0|||
124881254|NCT02769065|449189418|FG024|Overall Study|Voluntary Withdrawal|0|||
124881255|NCT02769065|449189419|FG025|Overall Study|Voluntary Withdrawal|0|||
124881256|NCT02769065|449189420|FG026|Overall Study|Voluntary Withdrawal|0|||
124881257|NCT02769065|449189421|FG027|Overall Study|Voluntary Withdrawal|0|||
124881258|NCT02769065|449189422|FG028|Overall Study|Voluntary Withdrawal|0|||
124881259|NCT02769065|449189423|FG029|Overall Study|Voluntary Withdrawal|0|||
124881260|NCT02769065|449189394|FG000|Overall Study|Reason Not Specified|0|||
124881261|NCT02769065|449189395|FG001|Overall Study|Reason Not Specified|0|||
124881262|NCT02769065|449189396|FG002|Overall Study|Reason Not Specified|0|||
124881263|NCT02769065|449189397|FG003|Overall Study|Reason Not Specified|0|||
124881264|NCT02769065|449189398|FG004|Overall Study|Reason Not Specified|0|||
124881265|NCT02769065|449189399|FG005|Overall Study|Reason Not Specified|0|||
124881266|NCT02769065|449189400|FG006|Overall Study|Reason Not Specified|1|||
124881267|NCT02769065|449189401|FG007|Overall Study|Reason Not Specified|0|||
124881268|NCT02769065|449189402|FG008|Overall Study|Reason Not Specified|0|||
124881269|NCT02769065|449189403|FG009|Overall Study|Reason Not Specified|0|||
124881270|NCT02769065|449189404|FG010|Overall Study|Reason Not Specified|0|||
124881271|NCT02769065|449189405|FG011|Overall Study|Reason Not Specified|0|||
124881272|NCT02769065|449189406|FG012|Overall Study|Reason Not Specified|0|||
124881273|NCT02769065|449189407|FG013|Overall Study|Reason Not Specified|0|||
124881274|NCT02769065|449189408|FG014|Overall Study|Reason Not Specified|0|||
124881275|NCT02769065|449189409|FG015|Overall Study|Reason Not Specified|0|||
124881276|NCT02769065|449189410|FG016|Overall Study|Reason Not Specified|0|||
124881277|NCT02769065|449189411|FG017|Overall Study|Reason Not Specified|0|||
124881278|NCT02769065|449189412|FG018|Overall Study|Reason Not Specified|0|||
124881279|NCT02769065|449189413|FG019|Overall Study|Reason Not Specified|0|||
124881280|NCT02769065|449189414|FG020|Overall Study|Reason Not Specified|0|||
124881281|NCT02769065|449189415|FG021|Overall Study|Reason Not Specified|0|||
124881282|NCT02769065|449189416|FG022|Overall Study|Reason Not Specified|0|||
124881283|NCT02769065|449189417|FG023|Overall Study|Reason Not Specified|0|||
124881284|NCT02769065|449189418|FG024|Overall Study|Reason Not Specified|0|||
124881285|NCT02769065|449189419|FG025|Overall Study|Reason Not Specified|0|||
124881286|NCT02769065|449189420|FG026|Overall Study|Reason Not Specified|0|||
124881287|NCT02769065|449189421|FG027|Overall Study|Reason Not Specified|0|||
124881288|NCT02769065|449189422|FG028|Overall Study|Reason Not Specified|0|||
124881289|NCT02769065|449189423|FG029|Overall Study|Reason Not Specified|0|||
124881290|NCT02769065|449189394|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881291|NCT02769065|449189395|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881292|NCT02769065|449189396|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881293|NCT02769065|449189397|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881294|NCT02769065|449189398|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881295|NCT02769065|449189399|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881296|NCT02769065|449189400|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881297|NCT02769065|449189401|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881298|NCT02769065|449189402|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881299|NCT02769065|449189403|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881300|NCT02769065|449189404|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
124881301|NCT02769065|449189405|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881302|NCT02769065|449189406|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881303|NCT02769065|449189407|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881304|NCT02769065|449189408|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881305|NCT02769065|449189409|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881306|NCT02769065|449189410|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881307|NCT02769065|449189411|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881308|NCT02769065|449189412|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881309|NCT02769065|449189413|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881310|NCT02769065|449189414|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881311|NCT02769065|449189415|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881312|NCT02769065|449189416|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881313|NCT02769065|449189417|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
124439076|NCT00585195|447567805|FG014|Overall Study|Site Terminated by Sponsor|0|||
124439077|NCT00585195|447567806|FG015|Overall Study|Site Terminated by Sponsor|0|||
124439078|NCT00585195|447567807|FG016|Overall Study|Site Terminated by Sponsor|0|||
124439079|NCT00585195|447567808|FG017|Overall Study|Site Terminated by Sponsor|0|||
124439080|NCT00585195|447567809|FG018|Overall Study|Site Terminated by Sponsor|0|||
124439081|NCT00585195|447567810|FG019|Overall Study|Site Terminated by Sponsor|0|||
124439082|NCT00585195|447567811|FG020|Overall Study|Site Terminated by Sponsor|0|||
124439083|NCT00585195|447567791|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
124439084|NCT00585195|447567792|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
124439085|NCT00585195|447567793|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
124881314|NCT02769065|449189418|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881315|NCT02769065|449189419|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881316|NCT02769065|449189420|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881317|NCT02769065|449189421|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881318|NCT02769065|449189422|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881319|NCT02769065|449189423|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
124881320|NCT02764775|449189426|FG000|Overall Study|Death|1|||
124881321|NCT02764775|449189426|FG000|Overall Study|Lost to Follow-up|2|||
124881322|NCT02764775|449189426|FG000|Overall Study|Withdrawal by Subject|3|||
124881323|NCT00767104|449189429|FG000|Overall Study|Lost to Follow-up|1|||
124881324|NCT00767104|449189430|FG001|Overall Study|Lost to Follow-up|2|||
124881325|NCT01186328|449189438|FG000|Overall Study|Death|1|||
124881326|NCT01186328|449189439|FG001|Overall Study|Death|0|||
124881327|NCT01186328|449189440|FG002|Overall Study|Death|0|||
124881328|NCT03015116|449189443|FG000|Overall Study|Lost to Follow-up|3|||
124881329|NCT03015116|449189444|FG001|Overall Study|Lost to Follow-up|0|||
124881330|NCT03015116|449189445|FG002|Overall Study|Lost to Follow-up|2|||
124881331|NCT03015116|449189443|FG000|Overall Study|Withdrawal by Subject|3|||
124881332|NCT03015116|449189444|FG001|Overall Study|Withdrawal by Subject|1|||
124881333|NCT03015116|449189445|FG002|Overall Study|Withdrawal by Subject|0|||
124881334|NCT03015116|449189443|FG000|Overall Study|Subject has New Medical Status|1|||
124881335|NCT03015116|449189444|FG001|Overall Study|Subject has New Medical Status|0|||
124881336|NCT03015116|449189445|FG002|Overall Study|Subject has New Medical Status|0|||
124881337|NCT03015116|449189443|FG000|Overall Study|Physician Decision|0|||
124881338|NCT03015116|449189444|FG001|Overall Study|Physician Decision|1|||
124881339|NCT03015116|449189445|FG002|Overall Study|Physician Decision|0|||
124881340|NCT02200939|449189450|FG000|Overall Study|Participant withdrew consent|0|||
124881341|NCT02200939|449189451|FG001|Overall Study|Participant withdrew consent|1|||
124881342|NCT02200939|449189450|FG000|Overall Study|Lost to Follow-up|2|||
124881343|NCT02200939|449189451|FG001|Overall Study|Lost to Follow-up|9|||
124881344|NCT02200939|449189450|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
124881345|NCT02200939|449189451|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
124881346|NCT02762981|449189452|FG000|Overall Study|Adverse Event|2|||
124881347|NCT02762981|449189453|FG001|Overall Study|Adverse Event|3|||
124881348|NCT02762981|449189454|FG002|Overall Study|Adverse Event|1|||
124881349|NCT02762981|449189455|FG003|Overall Study|Adverse Event|1|||
124881350|NCT02762981|449189456|FG004|Overall Study|Adverse Event|3|||
124881351|NCT02762981|449189452|FG000|Overall Study|Physician Decision|0|||
124881352|NCT02762981|449189453|FG001|Overall Study|Physician Decision|1|||
124881353|NCT02762981|449189454|FG002|Overall Study|Physician Decision|0|||
124881354|NCT02762981|449189455|FG003|Overall Study|Physician Decision|0|||
124881355|NCT02762981|449189456|FG004|Overall Study|Physician Decision|1|||
124881356|NCT02762981|449189452|FG000|Overall Study|Disease progression|11|||
124881357|NCT02762981|449189453|FG001|Overall Study|Disease progression|23|||
124881358|NCT02762981|449189454|FG002|Overall Study|Disease progression|4|||
124881359|NCT02762981|449189455|FG003|Overall Study|Disease progression|10|||
124881360|NCT02762981|449189456|FG004|Overall Study|Disease progression|1|||
124881361|NCT02762981|449189452|FG000|Overall Study|Enrolled not treated|1|||
124881362|NCT02762981|449189453|FG001|Overall Study|Enrolled not treated|5|||
124881363|NCT02762981|449189454|FG002|Overall Study|Enrolled not treated|0|||
124881364|NCT02762981|449189455|FG003|Overall Study|Enrolled not treated|2|||
124881365|NCT02762981|449189456|FG004|Overall Study|Enrolled not treated|0|||
124881366|NCT02762981|449189452|FG000|Overall Study|Other|2|||
124881367|NCT02762981|449189453|FG001|Overall Study|Other|3|||
124881368|NCT02762981|449189454|FG002|Overall Study|Other|1|||
124881369|NCT02762981|449189455|FG003|Overall Study|Other|0|||
124881370|NCT02762981|449189456|FG004|Overall Study|Other|0|||
124881371|NCT02762981|449189452|FG000|Overall Study|Missing|1|||
124881372|NCT02762981|449189453|FG001|Overall Study|Missing|0|||
124881373|NCT02762981|449189454|FG002|Overall Study|Missing|0|||
124881374|NCT02762981|449189455|FG003|Overall Study|Missing|0|||
124881375|NCT02762981|449189456|FG004|Overall Study|Missing|0|||
124881376|NCT02762981|449189452|FG000|Overall Study|Withdrawal by Subject|0|||
124881377|NCT02762981|449189453|FG001|Overall Study|Withdrawal by Subject|5|||
124881378|NCT02762981|449189454|FG002|Overall Study|Withdrawal by Subject|1|||
124881379|NCT02762981|449189455|FG003|Overall Study|Withdrawal by Subject|3|||
124881380|NCT02762981|449189456|FG004|Overall Study|Withdrawal by Subject|0|||
124881381|NCT01382940|449189457|FG000|Overall Study|Adverse Event|19|||
124881382|NCT01382940|449189457|FG000|Overall Study|Lost to Follow-up|4|||
124881383|NCT01382940|449189457|FG000|Overall Study|Physician Decision|7|||
124881384|NCT01382940|449189457|FG000|Overall Study|Withdrawal by Subject|23|||
124881385|NCT01382940|449189457|FG000|Overall Study|Protocol Violation|20|||
124881386|NCT00244374|449189460|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
124881387|NCT00244374|449189461|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
124881388|NCT00244374|449189462|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
124881389|NCT00244374|449189463|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
124881390|NCT00244374|449189464|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
124881391|NCT00244374|449189460|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
124881392|NCT00244374|449189461|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
124881393|NCT00244374|449189462|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
124881394|NCT00244374|449189463|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
124881395|NCT00244374|449189464|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
124881396|NCT00244374|449189460|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
124881397|NCT00244374|449189461|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
124881398|NCT00244374|449189462|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
124881399|NCT00244374|449189463|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
124881400|NCT00244374|449189464|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
124881401|NCT00244374|449189460|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
124881402|NCT00244374|449189461|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
124881403|NCT00244374|449189462|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
124881404|NCT00244374|449189463|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
124881405|NCT00244374|449189464|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
124881406|NCT00244374|449189460|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
124881407|NCT00244374|449189461|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
124881408|NCT00244374|449189462|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
124881409|NCT00244374|449189463|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
124881410|NCT00244374|449189464|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
124881411|NCT00244374|449189460|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
124881412|NCT00244374|449189461|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
124881413|NCT00244374|449189462|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
124881414|NCT00244374|449189463|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
124881415|NCT00244374|449189464|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
124881416|NCT00244374|449189460|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
124881417|NCT00244374|449189461|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
124881418|NCT00244374|449189462|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
124881419|NCT00244374|449189463|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
124881420|NCT00244374|449189464|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
124881421|NCT00244374|449189460|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
124881422|NCT00244374|449189461|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
124881423|NCT00244374|449189462|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
124881424|NCT00244374|449189463|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
124881425|NCT00244374|449189464|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
124881426|NCT00244374|449189460|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
124881427|NCT00244374|449189461|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
124881428|NCT00244374|449189462|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
124881429|NCT00244374|449189463|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
124881430|NCT00244374|449189464|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
124881431|NCT00976482|449189465|FG000|Overall Study|Death|208|||
124881432|NCT00976482|449189465|FG000|Overall Study|Withdrawal by Subject|45|||
124881433|NCT00976482|449189465|FG000|Overall Study|Center terminated|1|||
124881434|NCT00976482|449189465|FG000|Overall Study|Protocol Violation|5|||
124881435|NCT00720902|449189468|FG000|Overall Study|Withdrawal by Subject|1|||
124881436|NCT00720902|449189469|FG001|Overall Study|Withdrawal by Subject|0|||
124881437|NCT00720902|449189468|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
124881438|NCT00720902|449189469|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
124881439|NCT01486758|449189470|FG000|Overall Study|Lost to Follow-up|0|||
124881440|NCT01486758|449189471|FG001|Overall Study|Lost to Follow-up|1|||
124881441|NCT02254408|449189479|FG000|Overall Study|Randomized But Not Treated|1|||
124682866|NCT03329001|448461850|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
124682867|NCT03329001|448461851|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
124682868|NCT03329001|448461852|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
124682869|NCT03329001|448461853|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
124881442|NCT02254408|449189480|FG001|Overall Study|Randomized But Not Treated|3|||
124881443|NCT02254408|449189479|FG000|Overall Study|Adverse Event|1|||
124881444|NCT02254408|449189480|FG001|Overall Study|Adverse Event|0|||
124881445|NCT02254408|449189479|FG000|Overall Study|Death|2|||
124881446|NCT02254408|449189480|FG001|Overall Study|Death|3|||
124881447|NCT02254408|449189479|FG000|Overall Study|Investigator's Discretion|0|||
124881448|NCT02254408|449189480|FG001|Overall Study|Investigator's Discretion|1|||
124881449|NCT02254408|449189479|FG000|Overall Study|Withdrawal by Subject|3|||
124881450|NCT02254408|449189480|FG001|Overall Study|Withdrawal by Subject|3|||
124881451|NCT02254408|449189479|FG000|Overall Study|Lost to Follow-up|1|||
124881452|NCT02254408|449189480|FG001|Overall Study|Lost to Follow-up|0|||
124881453|NCT02914184|449189482|FG000|Overall Study|Lost to Follow-up|7|||
124881454|NCT02914184|449189483|FG001|Overall Study|Lost to Follow-up|10|||
124881455|NCT02914184|449189484|FG002|Overall Study|Lost to Follow-up|8|||
124881456|NCT02914184|449189485|FG003|Overall Study|Lost to Follow-up|7|||
124881457|NCT02914184|449189482|FG000|Overall Study|Withdrawal by Subject|4|||
124881458|NCT02914184|449189483|FG001|Overall Study|Withdrawal by Subject|2|||
124881459|NCT02914184|449189484|FG002|Overall Study|Withdrawal by Subject|7|||
124881460|NCT02914184|449189485|FG003|Overall Study|Withdrawal by Subject|3|||
124881461|NCT02914184|449189482|FG000|Overall Study|Other|1|||
124881462|NCT02914184|449189483|FG001|Overall Study|Other|0|||
124881463|NCT02914184|449189484|FG002|Overall Study|Other|0|||
124881464|NCT02914184|449189485|FG003|Overall Study|Other|0|||
124881465|NCT02914184|449189482|FG000|Overall Study|Migrated/moved from the study area|2|||
124881466|NCT02914184|449189483|FG001|Overall Study|Migrated/moved from the study area|1|||
124881467|NCT02914184|449189484|FG002|Overall Study|Migrated/moved from the study area|2|||
124881468|NCT02914184|449189485|FG003|Overall Study|Migrated/moved from the study area|1|||
124881469|NCT00798174|449189486|FG000|Overall Study|inability to implant azygos coil|3|||
124881470|NCT00798174|449189487|FG001|Overall Study|inability to implant azygos coil|3|||
124881471|NCT00798174|449189486|FG000|Overall Study|Inability to sedate for DFT testing|1|||
124881472|NCT00798174|449189487|FG001|Overall Study|Inability to sedate for DFT testing|0|||
124881473|NCT01642602|449189493|FG000|Overall Study|Adverse Event|2|||
124881474|NCT01460160|449189494|FG000|Treatment Phase|Lack of Efficacy|3|||
124881475|NCT01460160|449189494|FG000|Treatment Phase|Study Drug Toxicity|2|||
124881476|NCT01460160|449189494|FG000|Treatment Phase|Adverse Event|8|||
124881477|NCT01460160|449189494|FG000|Treatment Phase|Withdrawal by Subject|4|||
124881478|NCT01460160|449189494|FG000|Treatment Phase|Death|2|||
124881479|NCT01460160|449189494|FG000|Treatment Phase|Other reasons|9|||
124881480|NCT01460160|449189494|FG000|Follow-up Phase|Withdrawal by Subject|4|||
124881481|NCT01460160|449189494|FG000|Follow-up Phase|Death|14|||
124881482|NCT01460160|449189494|FG000|Follow-up Phase|Lost to Follow-up|7|||
124881483|NCT01460160|449189494|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
124881484|NCT01460160|449189494|FG000|Follow-up Phase|Other and not reported reasons|5|||
124881485|NCT00100932|449189495|FG000|Overall Study|Adverse Event|11|||
124881486|NCT00100932|449189496|FG001|Overall Study|Adverse Event|2|||
124881487|NCT00100932|449189495|FG000|Overall Study|Withdrawal by Subject|6|||
124881488|NCT00100932|449189496|FG001|Overall Study|Withdrawal by Subject|0|||
124881489|NCT00100932|449189495|FG000|Overall Study|Progressive Disease|44|||
124881490|NCT00100932|449189496|FG001|Overall Study|Progressive Disease|18|||
124881491|NCT00100932|449189495|FG000|Overall Study|Physician Decision|7|||
124881492|NCT00100932|449189496|FG001|Overall Study|Physician Decision|5|||
124881493|NCT00100932|449189495|FG000|Overall Study|Other|5|||
124881494|NCT00100932|449189496|FG001|Overall Study|Other|2|||
124881495|NCT00744328|449189497|FG000|Overall Study|Lost to Follow-up|2|||
124881496|NCT00744328|449189498|FG001|Overall Study|Lost to Follow-up|5|||
124881497|NCT00744328|449189499|FG002|Overall Study|Lost to Follow-up|3|||
124881498|NCT00744328|449189497|FG000|Overall Study|Withdrawal by Subject|5|||
124881499|NCT00744328|449189498|FG001|Overall Study|Withdrawal by Subject|3|||
124881500|NCT00744328|449189499|FG002|Overall Study|Withdrawal by Subject|4|||
124881501|NCT00744328|449189497|FG000|Overall Study|Found ineligible after randomization|0|||
124881502|NCT00744328|449189498|FG001|Overall Study|Found ineligible after randomization|0|||
124881503|NCT00744328|449189499|FG002|Overall Study|Found ineligible after randomization|1|||
124881504|NCT02387216|449189502|FG000|Overall Study|Progressive disease|2|||
124881505|NCT02387216|449189503|FG001|Overall Study|Progressive disease|0|||
124881506|NCT02387216|449189502|FG000|Overall Study|Withdrawal by Subject|3|||
124881507|NCT02387216|449189503|FG001|Overall Study|Withdrawal by Subject|5|||
124881508|NCT02387216|449189502|FG000|Overall Study|Physician Decision|2|||
124881509|NCT02387216|449189503|FG001|Overall Study|Physician Decision|0|||
124881510|NCT02387216|449189502|FG000|Overall Study|Sponsor Decision|28|||
124881511|NCT02387216|449189503|FG001|Overall Study|Sponsor Decision|12|||
124881512|NCT02387216|449189502|FG000|Overall Study|Death|60|||
124881513|NCT02387216|449189503|FG001|Overall Study|Death|23|||
124881514|NCT02387216|449189502|FG000|Overall Study|Other|5|||
124881515|NCT02387216|449189503|FG001|Overall Study|Other|4|||
124881516|NCT02387216|449189502|FG000|Overall Study|Lost to Follow-up|0|||
124881517|NCT02387216|449189503|FG001|Overall Study|Lost to Follow-up|3|||
124682870|NCT03329001|448461854|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
124682871|NCT03329001|448461855|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
124682872|NCT03329001|448461856|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
124682873|NCT03329001|448461857|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
124682874|NCT03329001|448461850|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
124682875|NCT03329001|448461851|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
124682876|NCT03329001|448461852|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
124682877|NCT03329001|448461853|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
124682878|NCT03329001|448461854|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
124682879|NCT03329001|448461855|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
124711995|NCT00690794|448570704|FG000|Overall Study|Other not specified|1|||
124881518|NCT00557622|449189507|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
124881519|NCT00557622|449189508|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
124881520|NCT00557622|449189507|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
124881521|NCT00557622|449189508|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
124881522|NCT00557622|449189507|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
124881523|NCT00557622|449189508|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
124881524|NCT01539863|449189509|FG000|Overall Study|Lost to Follow-up|5|||
124881525|NCT01539863|449189510|FG001|Overall Study|Lost to Follow-up|4|||
124881526|NCT01468922|449189513|FG000|Overall Study|Screening failure|0|||
124881527|NCT01468922|449189514|FG001|Overall Study|Screening failure|0|||
124881528|NCT01468922|449189515|FG002|Overall Study|Screening failure|0|||
124881529|NCT01468922|449189516|FG003|Overall Study|Screening failure|0|||
124881530|NCT01468922|449189517|FG004|Overall Study|Screening failure|0|||
124881531|NCT01468922|449189518|FG005|Overall Study|Screening failure|0|||
124881532|NCT01468922|449189519|FG006|Overall Study|Screening failure|0|||
124881533|NCT01468922|449189520|FG007|Overall Study|Screening failure|0|||
124881534|NCT01468922|449189521|FG008|Overall Study|Screening failure|1|||
124881535|NCT01468922|449189513|FG000|Overall Study|Per patient choice|1|||
124881536|NCT01468922|449189514|FG001|Overall Study|Per patient choice|0|||
124881537|NCT01468922|449189515|FG002|Overall Study|Per patient choice|0|||
124881538|NCT01468922|449189516|FG003|Overall Study|Per patient choice|0|||
124881539|NCT01468922|449189517|FG004|Overall Study|Per patient choice|0|||
124881540|NCT01468922|449189518|FG005|Overall Study|Per patient choice|0|||
124881541|NCT01468922|449189519|FG006|Overall Study|Per patient choice|0|||
124881542|NCT01468922|449189520|FG007|Overall Study|Per patient choice|0|||
124881543|NCT01468922|449189521|FG008|Overall Study|Per patient choice|0|||
124881544|NCT01468922|449189513|FG000|Overall Study|Switched to alternative treatment|1|||
124881545|NCT01468922|449189514|FG001|Overall Study|Switched to alternative treatment|0|||
124881546|NCT01468922|449189515|FG002|Overall Study|Switched to alternative treatment|0|||
124881547|NCT01468922|449189516|FG003|Overall Study|Switched to alternative treatment|0|||
124881548|NCT01468922|449189517|FG004|Overall Study|Switched to alternative treatment|1|||
124881549|NCT01468922|449189518|FG005|Overall Study|Switched to alternative treatment|0|||
124881550|NCT01468922|449189519|FG006|Overall Study|Switched to alternative treatment|0|||
124881551|NCT01468922|449189520|FG007|Overall Study|Switched to alternative treatment|0|||
124881552|NCT01468922|449189521|FG008|Overall Study|Switched to alternative treatment|0|||
124881553|NCT01468922|449189513|FG000|Overall Study|Enrolled on new protocol|0|||
124881554|NCT01468922|449189514|FG001|Overall Study|Enrolled on new protocol|0|||
124881555|NCT01468922|449189515|FG002|Overall Study|Enrolled on new protocol|0|||
124881556|NCT01468922|449189516|FG003|Overall Study|Enrolled on new protocol|0|||
124881557|NCT01468922|449189517|FG004|Overall Study|Enrolled on new protocol|1|||
124881558|NCT01468922|449189518|FG005|Overall Study|Enrolled on new protocol|0|||
124881559|NCT01468922|449189519|FG006|Overall Study|Enrolled on new protocol|0|||
124881560|NCT01468922|449189520|FG007|Overall Study|Enrolled on new protocol|0|||
124881561|NCT01468922|449189521|FG008|Overall Study|Enrolled on new protocol|0|||
124881562|NCT01468922|449189513|FG000|Overall Study|Adverse Event|0|||
124881563|NCT01468922|449189514|FG001|Overall Study|Adverse Event|0|||
124881564|NCT01468922|449189515|FG002|Overall Study|Adverse Event|0|||
124881565|NCT01468922|449189516|FG003|Overall Study|Adverse Event|0|||
124881566|NCT01468922|449189517|FG004|Overall Study|Adverse Event|0|||
124881567|NCT01468922|449189518|FG005|Overall Study|Adverse Event|0|||
124881568|NCT01468922|449189519|FG006|Overall Study|Adverse Event|0|||
124881569|NCT01468922|449189520|FG007|Overall Study|Adverse Event|1|||
124881570|NCT01468922|449189521|FG008|Overall Study|Adverse Event|0|||
124881571|NCT01468922|449189513|FG000|Overall Study|Infection of blood|0|||
124881572|NCT01468922|449189514|FG001|Overall Study|Infection of blood|0|||
124881573|NCT01468922|449189515|FG002|Overall Study|Infection of blood|0|||
124881574|NCT01468922|449189516|FG003|Overall Study|Infection of blood|0|||
124881575|NCT01468922|449189517|FG004|Overall Study|Infection of blood|0|||
124881576|NCT01468922|449189518|FG005|Overall Study|Infection of blood|0|||
124881577|NCT01468922|449189519|FG006|Overall Study|Infection of blood|0|||
124881578|NCT01468922|449189520|FG007|Overall Study|Infection of blood|1|||
124881579|NCT01468922|449189521|FG008|Overall Study|Infection of blood|0|||
124881580|NCT01468922|449189513|FG000|Overall Study|Patient choice - surgery|0|||
124881581|NCT01468922|449189514|FG001|Overall Study|Patient choice - surgery|0|||
124881582|NCT01468922|449189515|FG002|Overall Study|Patient choice - surgery|0|||
124881583|NCT01468922|449189516|FG003|Overall Study|Patient choice - surgery|0|||
124881584|NCT01468922|449189517|FG004|Overall Study|Patient choice - surgery|0|||
124881585|NCT01468922|449189518|FG005|Overall Study|Patient choice - surgery|0|||
124881586|NCT01468922|449189519|FG006|Overall Study|Patient choice - surgery|0|||
124881587|NCT01468922|449189520|FG007|Overall Study|Patient choice - surgery|1|||
124881588|NCT01468922|449189521|FG008|Overall Study|Patient choice - surgery|0|||
124881589|NCT01468922|449189513|FG000|Overall Study|Refused further treatment|0|||
124881590|NCT01468922|449189514|FG001|Overall Study|Refused further treatment|0|||
124881591|NCT01468922|449189515|FG002|Overall Study|Refused further treatment|0|||
124881592|NCT01468922|449189516|FG003|Overall Study|Refused further treatment|0|||
124881593|NCT01468922|449189517|FG004|Overall Study|Refused further treatment|0|||
124881594|NCT01468922|449189518|FG005|Overall Study|Refused further treatment|0|||
124881595|NCT01468922|449189519|FG006|Overall Study|Refused further treatment|0|||
124881596|NCT01468922|449189520|FG007|Overall Study|Refused further treatment|1|||
124881597|NCT01468922|449189521|FG008|Overall Study|Refused further treatment|0|||
124881598|NCT02563522|449189527|FG000|Overall Study|Adverse Event|2|||
124881599|NCT02563522|449189528|FG001|Overall Study|Adverse Event|3|||
124881600|NCT02563522|449189527|FG000|Overall Study|Lost to Follow-up|1|||
124881601|NCT02563522|449189528|FG001|Overall Study|Lost to Follow-up|0|||
124881602|NCT02563522|449189527|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
124881603|NCT02563522|449189528|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
124881604|NCT00675506|449189529|FG000|Overall Study|Lost to Follow-up|1|||
124881605|NCT00675506|449189530|FG001|Overall Study|Lost to Follow-up|5|||
124881606|NCT00675506|449189529|FG000|Overall Study|Lost interest|3|||
124881607|NCT00675506|449189530|FG001|Overall Study|Lost interest|5|||
124881608|NCT00675506|449189529|FG000|Overall Study|Elevated fasting glucose|2|||
124881609|NCT00675506|449189530|FG001|Overall Study|Elevated fasting glucose|1|||
124881610|NCT00675506|449189529|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
124881611|NCT00675506|449189530|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
124881612|NCT00675506|449189529|FG000|Overall Study|Elevated IGF-1|2|||
124881613|NCT00675506|449189530|FG001|Overall Study|Elevated IGF-1|0|||
124881614|NCT00675506|449189529|FG000|Overall Study|Hypersensitivity Reaction|1|||
124881615|NCT00675506|449189530|FG001|Overall Study|Hypersensitivity Reaction|0|||
124881616|NCT00675506|449189529|FG000|Overall Study|Disclosed history of cancer|1|||
124881617|NCT00675506|449189530|FG001|Overall Study|Disclosed history of cancer|0|||
124881618|NCT00675506|449189529|FG000|Overall Study|Declined participation|1|||
124881619|NCT00675506|449189530|FG001|Overall Study|Declined participation|0|||
124881620|NCT00675506|449189529|FG000|Overall Study|Schedule conflict|0|||
124881621|NCT00675506|449189530|FG001|Overall Study|Schedule conflict|1|||
124881622|NCT00936221|449189531|FG000|Overall Study|Withdrawal by Subject|1|||
124881623|NCT00936221|449189532|FG001|Overall Study|Withdrawal by Subject|1|||
124881624|NCT03820323|449189533|FG000|Overall Study|Lost to Follow-up|2|||
124881625|NCT03820323|449189534|FG001|Overall Study|Lost to Follow-up|1|||
124881626|NCT03820323|449189533|FG000|Overall Study|Missed 12-month visit|22|||
124881627|NCT03820323|449189534|FG001|Overall Study|Missed 12-month visit|14|||
124682880|NCT03329001|448461856|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
124881628|NCT03820323|449189533|FG000|Overall Study|Death|2|||
124881629|NCT03820323|449189534|FG001|Overall Study|Death|1|||
124881630|NCT03820323|449189533|FG000|Overall Study|Transferred out|13|||
124881631|NCT03820323|449189534|FG001|Overall Study|Transferred out|11|||
124881632|NCT03820323|449189533|FG000|Overall Study|Terminated|0|||
124881633|NCT03820323|449189534|FG001|Overall Study|Terminated|3|||
124881634|NCT03820323|449189533|FG000|Overall Study|Withdrawal by Subject|1|||
124881635|NCT03820323|449189534|FG001|Overall Study|Withdrawal by Subject|6|||
124881636|NCT03151395|449189535|FG000|Overall Study|Adverse Event|2|||
124881637|NCT03151395|449189535|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
124881638|NCT03151395|449189535|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
124881639|NCT03151395|449189535|FG000|Overall Study|Unspecified reason|4|||
124881640|NCT00879996|449189536|FG000|Overall Study|Lost to Follow-up|7|||
124881641|NCT00879996|449189537|FG001|Overall Study|Lost to Follow-up|6|||
124881642|NCT00879996|449189536|FG000|Overall Study|non-compliance|6|||
124881643|NCT00879996|449189537|FG001|Overall Study|non-compliance|4|||
124881644|NCT00879996|449189536|FG000|Overall Study|Physician Decision|1|||
124881645|NCT00879996|449189537|FG001|Overall Study|Physician Decision|2|||
124881646|NCT00879996|449189536|FG000|Overall Study|psychiatric problem|0|||
124881647|NCT00879996|449189537|FG001|Overall Study|psychiatric problem|1|||
124881648|NCT00879996|449189536|FG000|Overall Study|put on parole|1|||
124881649|NCT00879996|449189537|FG001|Overall Study|put on parole|0|||
124881650|NCT02597933|449189538|FG000|Overall Study|Withdrawal by Subject|7|||
124881651|NCT02597933|449189539|FG001|Overall Study|Withdrawal by Subject|5|||
124881652|NCT02597933|449189538|FG000|Overall Study|Protocol Violation|2|||
124881653|NCT02597933|449189539|FG001|Overall Study|Protocol Violation|2|||
124881654|NCT02597933|449189538|FG000|Overall Study|Adverse Event|20|||
124881655|NCT02597933|449189539|FG001|Overall Study|Adverse Event|28|||
124881656|NCT02597933|449189538|FG000|Overall Study|Not treated|2|||
124881657|NCT02597933|449189539|FG001|Overall Study|Not treated|2|||
124881658|NCT02597933|449189538|FG000|Overall Study|Other than stated above|7|||
124881659|NCT02597933|449189539|FG001|Overall Study|Other than stated above|14|||
124881660|NCT01107743|449189545|FG000|Overall Study|Protocol Violation|46|||
124881661|NCT00308737|449189546|FG000|Overall Study|Adverse Event|104|||
124881662|NCT00308737|449189547|FG001|Overall Study|Adverse Event|9|||
124881663|NCT00308737|449189548|FG002|Overall Study|Adverse Event|0|||
124881664|NCT00308737|449189546|FG000|Overall Study|Death|4|||
124881665|NCT00308737|449189547|FG001|Overall Study|Death|3|||
124881666|NCT00308737|449189548|FG002|Overall Study|Death|0|||
124881667|NCT00308737|449189546|FG000|Overall Study|Lost to Follow-up|56|||
124881668|NCT00308737|449189547|FG001|Overall Study|Lost to Follow-up|80|||
124881669|NCT00308737|449189548|FG002|Overall Study|Lost to Follow-up|5|||
124881670|NCT00308737|449189546|FG000|Overall Study|Physician Decision|15|||
124881671|NCT00308737|449189547|FG001|Overall Study|Physician Decision|2|||
124881672|NCT00308737|449189548|FG002|Overall Study|Physician Decision|1|||
124881673|NCT00308737|449189546|FG000|Overall Study|Protocol Violation|34|||
124881674|NCT00308737|449189547|FG001|Overall Study|Protocol Violation|9|||
124881675|NCT00308737|449189548|FG002|Overall Study|Protocol Violation|5|||
124881676|NCT00308737|449189546|FG000|Overall Study|Withdrawal by Subject|218|||
124881677|NCT00308737|449189547|FG001|Overall Study|Withdrawal by Subject|166|||
124881678|NCT00308737|449189548|FG002|Overall Study|Withdrawal by Subject|18|||
124881679|NCT00308737|449189546|FG000|Overall Study|Various|32|||
124881680|NCT00308737|449189547|FG001|Overall Study|Various|20|||
124881681|NCT00308737|449189548|FG002|Overall Study|Various|8|||
124881682|NCT04078035|449189551|FG000|Session 2|Lost to Follow-up|3|||
124881683|NCT04078035|449189552|FG001|Session 2|Lost to Follow-up|1|||
124881684|NCT04078035|449189551|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
124881685|NCT04078035|449189552|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
124881686|NCT02954458|449189555|FG000|Overall Study|Adverse Event|0|||
124881687|NCT02954458|449189556|FG001|Overall Study|Adverse Event|0|||
124881688|NCT02954458|449189557|FG002|Overall Study|Adverse Event|0|||
124881689|NCT02954458|449189558|FG003|Overall Study|Adverse Event|1|||
124881690|NCT02954458|449189555|FG000|Overall Study|Withdrawal by Subject|0|||
124881691|NCT02954458|449189556|FG001|Overall Study|Withdrawal by Subject|0|||
124881692|NCT02954458|449189557|FG002|Overall Study|Withdrawal by Subject|0|||
124881693|NCT02954458|449189558|FG003|Overall Study|Withdrawal by Subject|1|||
124881694|NCT02954458|449189555|FG000|Overall Study|Physician Decision|0|||
124881695|NCT02954458|449189556|FG001|Overall Study|Physician Decision|0|||
124881696|NCT02954458|449189557|FG002|Overall Study|Physician Decision|1|||
124881697|NCT02954458|449189558|FG003|Overall Study|Physician Decision|1|||
124881698|NCT02954458|449189555|FG000|Overall Study|Lost to Follow-up|1|||
124881699|NCT02954458|449189556|FG001|Overall Study|Lost to Follow-up|0|||
124439086|NCT00585195|447567794|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
124439087|NCT00585195|447567795|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
124881700|NCT02954458|449189557|FG002|Overall Study|Lost to Follow-up|0|||
124881701|NCT02954458|449189558|FG003|Overall Study|Lost to Follow-up|1|||
124881702|NCT02954458|449189555|FG000|Overall Study|Death|0|||
124881703|NCT02954458|449189556|FG001|Overall Study|Death|0|||
124881704|NCT02954458|449189557|FG002|Overall Study|Death|0|||
124439088|NCT00585195|447567796|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
124439089|NCT00585195|447567797|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
124881705|NCT02954458|449189558|FG003|Overall Study|Death|1|||
124881706|NCT02954458|449189555|FG000|Overall Study|Other|0|||
124881707|NCT02954458|449189556|FG001|Overall Study|Other|0|||
124881708|NCT02954458|449189557|FG002|Overall Study|Other|0|||
124881709|NCT02954458|449189558|FG003|Overall Study|Other|7|||
124881710|NCT01396395|449189564|FG000|Overall Study|Withdrawal by Subject|10|||
124881711|NCT01396395|449189565|FG001|Overall Study|Withdrawal by Subject|12|||
124881712|NCT01396395|449189564|FG000|Overall Study|Protocol Violation|3|||
124881713|NCT01396395|449189565|FG001|Overall Study|Protocol Violation|1|||
124881714|NCT01396395|449189564|FG000|Overall Study|Adverse Event|10|||
124881715|NCT01396395|449189565|FG001|Overall Study|Adverse Event|2|||
124881716|NCT01396395|449189564|FG000|Overall Study|Lost to Follow-up|17|||
124881717|NCT01396395|449189565|FG001|Overall Study|Lost to Follow-up|11|||
124881718|NCT01396395|449189564|FG000|Overall Study|Other|0|||
124881719|NCT01396395|449189565|FG001|Overall Study|Other|1|||
124881720|NCT02460263|449189567|FG000|Transition Period|Withdrawal by Subject|1|||
124881721|NCT02460263|449189567|FG000|Transition Period|Death|1|||
124881722|NCT03176238|449189570|FG000|Overall Study|Unacceptable AEs|15|||
124881723|NCT03176238|449189571|FG001|Overall Study|Unacceptable AEs|8|||
124881724|NCT03176238|449189570|FG000|Overall Study|Abnormal lab value(s)|2|||
124881725|NCT03176238|449189571|FG001|Overall Study|Abnormal lab value(s)|0|||
124881726|NCT03176238|449189570|FG000|Overall Study|Inter-current illness|0|||
124881727|NCT03176238|449189571|FG001|Overall Study|Inter-current illness|1|||
124881728|NCT03176238|449189570|FG000|Overall Study|Consent withdrawal|14|||
124881729|NCT03176238|449189571|FG001|Overall Study|Consent withdrawal|2|||
124881730|NCT03176238|449189570|FG000|Overall Study|Lost to Follow-up|3|||
124881731|NCT03176238|449189571|FG001|Overall Study|Lost to Follow-up|0|||
124881732|NCT03176238|449189570|FG000|Overall Study|Administrative problems|1|||
124881733|NCT03176238|449189571|FG001|Overall Study|Administrative problems|0|||
124881734|NCT03176238|449189570|FG000|Overall Study|Death|3|||
124881735|NCT03176238|449189571|FG001|Overall Study|Death|0|||
124881736|NCT03176238|449189570|FG000|Overall Study|Disease Progression|133|||
124881737|NCT03176238|449189571|FG001|Overall Study|Disease Progression|22|||
124881738|NCT03176238|449189570|FG000|Overall Study|Tx duration completed per EAP|0|||
124881739|NCT03176238|449189571|FG001|Overall Study|Tx duration completed per EAP|1|||
124881740|NCT03176238|449189570|FG000|Overall Study|Patient is switched to commercial drug|16|||
124881741|NCT03176238|449189571|FG001|Overall Study|Patient is switched to commercial drug|1|||
124881742|NCT03176238|449189570|FG000|Overall Study|Protocol Violation|1|||
124881743|NCT03176238|449189571|FG001|Overall Study|Protocol Violation|0|||
124881744|NCT03176238|449189570|FG000|Overall Study|Changes in the patient's condition|2|||
124881745|NCT03176238|449189571|FG001|Overall Study|Changes in the patient's condition|1|||
124881746|NCT03176238|449189570|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
124881747|NCT03176238|449189571|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
124881748|NCT04524598|449189572|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
124881749|NCT04524598|449189573|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
124881750|NCT04524598|449189574|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
124881751|NCT04524598|449189575|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
124881752|NCT04524598|449189576|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
124881753|NCT04524598|449189572|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
124881754|NCT04524598|449189573|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
124881755|NCT04524598|449189574|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881756|NCT04524598|449189575|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881757|NCT04524598|449189576|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881758|NCT04524598|449189572|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
124881759|NCT04524598|449189573|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
124881760|NCT04524598|449189574|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
124881761|NCT04524598|449189575|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
124881762|NCT04524598|449189576|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
124881763|NCT04524598|449189572|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
124881764|NCT04524598|449189573|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
124711996|NCT00690794|448570705|FG001|Overall Study|Other not specified|3|||
124881765|NCT04524598|449189574|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
124881766|NCT04524598|449189575|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
124881767|NCT04524598|449189576|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
124881768|NCT04524598|449189572|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881769|NCT04524598|449189573|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881770|NCT04524598|449189574|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
124881771|NCT04524598|449189575|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
124881772|NCT04524598|449189576|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881773|NCT04524598|449189572|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
124881774|NCT04524598|449189573|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
124881775|NCT04524598|449189574|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
124881776|NCT04524598|449189575|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
124881777|NCT04524598|449189576|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
124881778|NCT04524598|449189572|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881779|NCT04524598|449189573|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881780|NCT04524598|449189574|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881781|NCT04524598|449189575|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
124881782|NCT04524598|449189576|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
124881783|NCT04395183|449189577|FG000|Overall Study|Withdrawal by Subject|1|||
124881784|NCT04395183|449189578|FG001|Overall Study|Withdrawal by Subject|0|||
124881785|NCT04395183|449189579|FG002|Overall Study|Withdrawal by Subject|2|||
124881786|NCT04395183|449189580|FG003|Overall Study|Withdrawal by Subject|2|||
124881787|NCT02569710|449189582|FG000|Overall Study|Adverse Event|1|||
124881788|NCT02569710|449189583|FG001|Overall Study|Adverse Event|0|||
124881789|NCT02569710|449189584|FG002|Overall Study|Adverse Event|0|||
124881790|NCT02569710|449189585|FG003|Overall Study|Adverse Event|0|||
124881791|NCT02569710|449189586|FG004|Overall Study|Adverse Event|0|||
124881792|NCT02569710|449189587|FG005|Overall Study|Adverse Event|0|||
124881793|NCT02569710|449189588|FG006|Overall Study|Adverse Event|0|||
124439090|NCT00585195|447567798|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
124439091|NCT00585195|447567799|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
124439092|NCT00585195|447567800|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
124439093|NCT00585195|447567801|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
124439094|NCT00585195|447567802|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
124439095|NCT00585195|447567803|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
124439096|NCT00585195|447567804|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
124439097|NCT00585195|447567805|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
124439098|NCT00585195|447567806|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
124439099|NCT00585195|447567807|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
124439100|NCT00585195|447567808|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
124439101|NCT00585195|447567809|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
124439102|NCT00585195|447567810|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
124439103|NCT00585195|447567811|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
124439104|NCT02796560|447567812|FG000|Overall Study|Adverse Event|2|||
124439105|NCT02796560|447567813|FG001|Overall Study|Adverse Event|0|||
124439106|NCT02796560|447567812|FG000|Overall Study|Withdrawal by Subject|2|||
124439107|NCT02796560|447567813|FG001|Overall Study|Withdrawal by Subject|2|||
124439108|NCT00345293|447567814|FG000|Overall Study|Unable to access line for sample|1|||
124439109|NCT00345293|447567815|FG001|Overall Study|Unable to access line for sample|0|||
124439110|NCT00345293|447567814|FG000|Overall Study|Withdrawal by Subject|1|||
124439111|NCT00345293|447567815|FG001|Overall Study|Withdrawal by Subject|0|||
124439112|NCT01440374|447569063|FG000|Part 1: Open-label Phase|Adverse Event|5|||
124439113|NCT01440374|447569064|FG001|Part 1: Open-label Phase|Adverse Event|0|||
124439114|NCT01440374|447569065|FG002|Part 1: Open-label Phase|Adverse Event|0|||
124439115|NCT01440374|447569066|FG003|Part 1: Open-label Phase|Adverse Event|0|||
124439116|NCT01440374|447569063|FG000|Part 1: Open-label Phase|Physician Decision|1|||
124439117|NCT01440374|447569064|FG001|Part 1: Open-label Phase|Physician Decision|0|||
124439118|NCT01440374|447569065|FG002|Part 1: Open-label Phase|Physician Decision|0|||
124439119|NCT01440374|447569066|FG003|Part 1: Open-label Phase|Physician Decision|0|||
124439120|NCT01440374|447569063|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
124439121|NCT01440374|447569064|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
124439122|NCT01440374|447569065|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
124439123|NCT01440374|447569066|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
124439124|NCT01440374|447569063|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
124439125|NCT01440374|447569064|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
124439126|NCT01440374|447569065|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
124439127|NCT01440374|447569066|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
124682881|NCT03329001|448461857|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
124881794|NCT02569710|449189589|FG007|Overall Study|Adverse Event|0|||
124439128|NCT01440374|447569063|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
124439129|NCT01440374|447569064|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
124439130|NCT01440374|447569065|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
124439131|NCT01440374|447569066|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
124439132|NCT01440374|447569063|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
124881795|NCT02569710|449189590|FG008|Overall Study|Adverse Event|0|||
124881796|NCT02569710|449189591|FG009|Overall Study|Adverse Event|0|||
124881797|NCT02569710|449189582|FG000|Overall Study|Lost to Follow-up|0|||
124881798|NCT02569710|449189583|FG001|Overall Study|Lost to Follow-up|0|||
124881799|NCT02569710|449189584|FG002|Overall Study|Lost to Follow-up|0|||
124881800|NCT02569710|449189585|FG003|Overall Study|Lost to Follow-up|0|||
124881801|NCT02569710|449189586|FG004|Overall Study|Lost to Follow-up|0|||
124881802|NCT02569710|449189587|FG005|Overall Study|Lost to Follow-up|0|||
124881803|NCT02569710|449189588|FG006|Overall Study|Lost to Follow-up|1|||
124881804|NCT02569710|449189589|FG007|Overall Study|Lost to Follow-up|0|||
124881805|NCT02569710|449189590|FG008|Overall Study|Lost to Follow-up|1|||
124881806|NCT02569710|449189591|FG009|Overall Study|Lost to Follow-up|0|||
124881807|NCT02569710|449189582|FG000|Overall Study|Virologic failure|0|||
124881808|NCT02569710|449189583|FG001|Overall Study|Virologic failure|0|||
124881809|NCT02569710|449189584|FG002|Overall Study|Virologic failure|0|||
124881810|NCT02569710|449189585|FG003|Overall Study|Virologic failure|0|||
124881811|NCT02569710|449189586|FG004|Overall Study|Virologic failure|1|||
124881812|NCT02569710|449189587|FG005|Overall Study|Virologic failure|0|||
124881813|NCT02569710|449189588|FG006|Overall Study|Virologic failure|1|||
124881814|NCT02569710|449189589|FG007|Overall Study|Virologic failure|0|||
124881815|NCT02569710|449189590|FG008|Overall Study|Virologic failure|0|||
124881816|NCT02569710|449189591|FG009|Overall Study|Virologic failure|0|||
124881817|NCT02569710|449189582|FG000|Overall Study|Withdrawal by Subject|0|||
124881818|NCT02569710|449189583|FG001|Overall Study|Withdrawal by Subject|0|||
124881819|NCT02569710|449189584|FG002|Overall Study|Withdrawal by Subject|0|||
124881820|NCT02569710|449189585|FG003|Overall Study|Withdrawal by Subject|0|||
124881821|NCT02569710|449189586|FG004|Overall Study|Withdrawal by Subject|0|||
124881822|NCT02569710|449189587|FG005|Overall Study|Withdrawal by Subject|1|||
124881823|NCT02569710|449189588|FG006|Overall Study|Withdrawal by Subject|0|||
124881824|NCT02569710|449189589|FG007|Overall Study|Withdrawal by Subject|0|||
124881825|NCT02569710|449189590|FG008|Overall Study|Withdrawal by Subject|0|||
124881826|NCT02569710|449189591|FG009|Overall Study|Withdrawal by Subject|0|||
124881827|NCT04152343|449189592|FG000|Overall Study|Transplanted|5|||
124881828|NCT04152343|449189592|FG000|Overall Study|Death|20|||
124881829|NCT04152343|449189592|FG000|Overall Study|Lost to Follow-up|3|||
124881830|NCT00550550|449189593|FG000|Overall Study|Adverse Event|13|||
124881831|NCT00550550|449189594|FG001|Overall Study|Adverse Event|5|||
124881832|NCT00550550|449189593|FG000|Overall Study|Treatment Failure|0|||
124881833|NCT00550550|449189594|FG001|Overall Study|Treatment Failure|1|||
124881834|NCT00550550|449189593|FG000|Overall Study|Lost to Follow-up|4|||
124881835|NCT00550550|449189594|FG001|Overall Study|Lost to Follow-up|0|||
124881836|NCT00550550|449189593|FG000|Overall Study|Withdrawal by Subject|10|||
124881837|NCT00550550|449189594|FG001|Overall Study|Withdrawal by Subject|8|||
124881838|NCT00550550|449189593|FG000|Overall Study|Protocol Violation|5|||
124881839|NCT00550550|449189594|FG001|Overall Study|Protocol Violation|14|||
124881840|NCT00550550|449189593|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
124881841|NCT00550550|449189594|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
124881842|NCT00550550|449189593|FG000|Overall Study|Randomized But Not Treated|1|||
124881843|NCT00550550|449189594|FG001|Overall Study|Randomized But Not Treated|0|||
124881844|NCT01965938|449189599|FG000|Overall Study|Withdrawal by Subject|1|||
124881845|NCT01965938|449189600|FG001|Overall Study|Withdrawal by Subject|0|||
124881846|NCT02090634|449189601|FG000|Overall Study|Lost to Follow-up|0|||
124881847|NCT02090634|449189602|FG001|Overall Study|Lost to Follow-up|1|||
124881848|NCT02090634|449189601|FG000|Overall Study|Death|0|||
124881849|NCT02090634|449189602|FG001|Overall Study|Death|1|||
124881850|NCT02090634|449189601|FG000|Overall Study|Protocol Violation|3|||
124881851|NCT02090634|449189602|FG001|Overall Study|Protocol Violation|1|||
124881852|NCT02090634|449189601|FG000|Overall Study|Adverse Event|2|||
124881853|NCT02090634|449189602|FG001|Overall Study|Adverse Event|0|||
124881854|NCT01164228|449189603|FG000|Overall Study|Progression|24|||
124881855|NCT01164228|449189604|FG001|Overall Study|Progression|25|||
124881856|NCT01164228|449189603|FG000|Overall Study|Adverse Event|13|||
124881857|NCT01164228|449189604|FG001|Overall Study|Adverse Event|7|||
124881858|NCT01164228|449189603|FG000|Overall Study|Death|1|||
124881859|NCT01164228|449189604|FG001|Overall Study|Death|1|||
124881860|NCT01164228|449189603|FG000|Overall Study|Withdrawal by Subject|2|||
124881861|NCT01164228|449189604|FG001|Overall Study|Withdrawal by Subject|0|||
124881862|NCT01164228|449189603|FG000|Overall Study|Physician Decision|1|||
124881863|NCT01164228|449189604|FG001|Overall Study|Physician Decision|2|||
124881864|NCT01164228|449189603|FG000|Overall Study|Symptomatic deterioration|1|||
124881865|NCT01164228|449189604|FG001|Overall Study|Symptomatic deterioration|0|||
124881866|NCT01164228|449189603|FG000|Overall Study|Never started treatment|1|||
124881867|NCT01164228|449189604|FG001|Overall Study|Never started treatment|3|||
124881868|NCT01164228|449189603|FG000|Overall Study|Ineligible|1|||
124881869|NCT01164228|449189604|FG001|Overall Study|Ineligible|0|||
124881870|NCT02936037|449191050|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
124881871|NCT02936037|449191051|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
124881872|NCT02936037|449191050|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
124881873|NCT02936037|449191051|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
124682882|NCT03329001|448461850|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
124682883|NCT03329001|448461851|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
124682884|NCT03329001|448461852|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
124682885|NCT03329001|448461853|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
124682886|NCT03329001|448461854|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
124682887|NCT03329001|448461855|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
124682888|NCT03329001|448461856|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
124682889|NCT03329001|448461857|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
124682890|NCT03329001|448461850|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
124682891|NCT03329001|448461851|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
124682892|NCT03329001|448461852|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
124682893|NCT03329001|448461853|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
124682894|NCT03329001|448461854|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
124682895|NCT03329001|448461855|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
124682896|NCT03329001|448461856|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
124682897|NCT03329001|448461857|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
124682898|NCT03329001|448461850|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
124682899|NCT03329001|448461851|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
124682900|NCT03329001|448461852|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
124682901|NCT03329001|448461853|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
124682902|NCT03329001|448461854|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
124682903|NCT03329001|448461855|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
124682904|NCT03329001|448461856|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
124682905|NCT03329001|448461857|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
124682906|NCT03329001|448461850|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
124682907|NCT03329001|448461851|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
124682908|NCT03329001|448461852|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
124682909|NCT03329001|448461853|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
124682910|NCT03329001|448461854|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
124682911|NCT03329001|448461855|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
124682912|NCT03329001|448461856|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
124682913|NCT03329001|448461857|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
124682914|NCT03329001|448461850|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
124682915|NCT03329001|448461851|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
124682916|NCT03329001|448461852|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
124682917|NCT03329001|448461853|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
124682918|NCT03329001|448461854|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
124682919|NCT03329001|448461855|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
124682920|NCT03329001|448461856|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
124682921|NCT03329001|448461857|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
124682922|NCT03329001|448461850|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
124682923|NCT03329001|448461851|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
124682924|NCT03329001|448461852|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
124682925|NCT03329001|448461853|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
124682926|NCT03329001|448461854|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
124682927|NCT03329001|448461855|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
124682928|NCT03329001|448461856|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
124682929|NCT03329001|448461857|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
124682930|NCT03329001|448461850|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
124682931|NCT03329001|448461851|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
124682932|NCT03329001|448461852|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
124682933|NCT03329001|448461853|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
124682934|NCT03329001|448461854|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
124682935|NCT03329001|448461855|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
124682936|NCT03329001|448461856|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
124682937|NCT03329001|448461857|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
124682938|NCT03329001|448461850|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
124682939|NCT03329001|448461851|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
124682940|NCT03329001|448461852|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
124682941|NCT03329001|448461853|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
124682942|NCT03329001|448461854|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
124682943|NCT03329001|448461855|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
124682944|NCT03329001|448461856|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
124682945|NCT03329001|448461857|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
124682946|NCT03329001|448461850|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
124682947|NCT03329001|448461851|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
124682948|NCT03329001|448461852|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
124682949|NCT03329001|448461853|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
124682950|NCT03329001|448461854|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
124682951|NCT03329001|448461855|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
124682952|NCT03329001|448461856|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
124682953|NCT03329001|448461857|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
124682954|NCT03329001|448461850|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
124682955|NCT03329001|448461851|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
124682956|NCT03329001|448461852|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
124682957|NCT03329001|448461853|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
124682958|NCT03329001|448461854|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
124682959|NCT03329001|448461855|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
124682960|NCT03329001|448461856|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
124682961|NCT03329001|448461857|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
124682962|NCT03329001|448461850|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
124682963|NCT03329001|448461851|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
124682964|NCT03329001|448461852|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
124682965|NCT03329001|448461853|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
124682966|NCT03329001|448461854|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
124682967|NCT03329001|448461855|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
124682968|NCT03329001|448461856|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
124682969|NCT03329001|448461857|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
124682970|NCT03329001|448461850|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
124682971|NCT03329001|448461851|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
124682972|NCT03329001|448461852|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
124682973|NCT03329001|448461853|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
124682974|NCT03329001|448461854|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
124682975|NCT03329001|448461855|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
124682976|NCT03329001|448461856|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
124682977|NCT03329001|448461857|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
124682978|NCT03329001|448461850|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
124682979|NCT03329001|448461851|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
124682980|NCT03329001|448461852|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
124682981|NCT03329001|448461853|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
124682982|NCT03329001|448461854|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
124682983|NCT03329001|448461855|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
124682984|NCT03329001|448461856|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
124682985|NCT03329001|448461857|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
124682986|NCT03329001|448461850|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
124682987|NCT03329001|448461851|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
124682988|NCT03329001|448461852|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
124682989|NCT03329001|448461853|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
124682990|NCT03329001|448461854|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
124682991|NCT03329001|448461855|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
124881874|NCT02936037|449191050|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
124881875|NCT02936037|449191051|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
124881876|NCT02936037|449191050|FG000|Double-Blind Treatment Period|Death|0|||
124881877|NCT02936037|449191051|FG001|Double-Blind Treatment Period|Death|1|||
124881878|NCT02936037|449191050|FG000|Double-Blind Treatment Period|Adverse Event|11|||
124881879|NCT02936037|449191051|FG001|Double-Blind Treatment Period|Adverse Event|11|||
124881880|NCT02936037|449191050|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
124881881|NCT02936037|449191051|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
124881882|NCT02936037|449191050|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124881883|NCT02936037|449191051|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
124881884|NCT02936037|449191050|FG000|Open Label Extension|Adverse Event|0|||
124881885|NCT02936037|449191051|FG001|Open Label Extension|Adverse Event|3|||
124881886|NCT02936037|449191050|FG000|Open Label Extension|Other|0|||
124881887|NCT02936037|449191051|FG001|Open Label Extension|Other|3|||
124881888|NCT02936037|449191050|FG000|Open Label Extension|Withdrawal by Subject|0|||
124881889|NCT02936037|449191051|FG001|Open Label Extension|Withdrawal by Subject|4|||
124881890|NCT04567693|449191052|FG000|Overall Study|Death|0|||
124881891|NCT04567693|449191053|FG001|Overall Study|Death|0|||
124881892|NCT04567693|449191054|FG002|Overall Study|Death|2|||
124881893|NCT04567693|449191052|FG000|Overall Study|Lost to Follow-up|1|||
124881894|NCT04567693|449191053|FG001|Overall Study|Lost to Follow-up|0|||
124881895|NCT04567693|449191054|FG002|Overall Study|Lost to Follow-up|2|||
124881896|NCT04567693|449191052|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
124881897|NCT04567693|449191053|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
124881898|NCT04567693|449191054|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
124881899|NCT03462706|449191055|FG000|Overall Study|Polyp was pedunculated|1|||
124881900|NCT03462706|449191056|FG001|Overall Study|Polyp was pedunculated|0|||
124881901|NCT03462706|449191057|FG002|Overall Study|Polyp was pedunculated|1|||
124881902|NCT03462706|449191058|FG003|Overall Study|Polyp was pedunculated|0|||
124881903|NCT03462706|449191055|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
124881904|NCT03462706|449191056|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
124881905|NCT03462706|449191057|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
124881906|NCT03462706|449191058|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
124881907|NCT04105972|449191063|FG000|Overall Study|Adverse Event|2|||
124881908|NCT04105972|449191064|FG001|Overall Study|Adverse Event|1|||
124881909|NCT01161472|449191065|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
124881910|NCT01161472|449191066|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
124881911|NCT01161472|449191067|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
124881912|NCT01161472|449191068|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
124881913|NCT00067990|449191077|FG000|Overall Study|Death|5|||
124881914|NCT00067990|449191078|FG001|Overall Study|Death|7|||
124881915|NCT00067990|449191077|FG000|Overall Study|ESRD, Non IF/TA|1|||
124881916|NCT00067990|449191078|FG001|Overall Study|ESRD, Non IF/TA|3|||
124881917|NCT00067990|449191077|FG000|Overall Study|Withdrawal by Subject|4|||
124881918|NCT00067990|449191078|FG001|Overall Study|Withdrawal by Subject|12|||
124881919|NCT01118455|449191079|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
124881920|NCT01118455|449191080|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
124881921|NCT03327402|449191085|FG000|Overall Study|Withdrawal by Subject|1|||
124881922|NCT03327402|449191085|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
124881923|NCT03810313|449191086|FG000|Overall Study|Study terminated by sponsor|164|||
124881924|NCT03810313|449191087|FG001|Overall Study|Study terminated by sponsor|159|||
124881925|NCT03810313|449191086|FG000|Overall Study|Subject decision|10|||
124881926|NCT03810313|449191087|FG001|Overall Study|Subject decision|11|||
124881927|NCT03810313|449191086|FG000|Overall Study|Lost to Follow-up|3|||
124881928|NCT03810313|449191087|FG001|Overall Study|Lost to Follow-up|3|||
124881929|NCT03810313|449191086|FG000|Overall Study|Adverse Event|2|||
124881930|NCT03810313|449191087|FG001|Overall Study|Adverse Event|1|||
124881931|NCT03810313|449191086|FG000|Overall Study|Death|2|||
124881932|NCT03810313|449191087|FG001|Overall Study|Death|1|||
124881933|NCT03810313|449191086|FG000|Overall Study|Physician Decision|0|||
124881934|NCT03810313|449191087|FG001|Overall Study|Physician Decision|1|||
124881935|NCT00422799|449191090|FG000|Overall Study|Withdrawal by Subject|6|||
124881936|NCT00422799|449191090|FG000|Overall Study|Adverse Event|7|||
124881937|NCT03029780|449191092|FG000|Overall Study|Disease Progression|20|||
124881938|NCT03029780|449191093|FG001|Overall Study|Disease Progression|22|||
124881939|NCT03029780|449191092|FG000|Overall Study|Study Drug Toxicity|15|||
124881940|NCT03029780|449191093|FG001|Overall Study|Study Drug Toxicity|11|||
124881941|NCT03029780|449191092|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
124881942|NCT03029780|449191093|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
124682992|NCT03329001|448461856|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
124682993|NCT03329001|448461857|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
124881943|NCT03029780|449191092|FG000|Overall Study|Participant request to discontinue study treatment|4|||
124881944|NCT03029780|449191093|FG001|Overall Study|Participant request to discontinue study treatment|1|||
124881945|NCT03029780|449191092|FG000|Overall Study|Maximum clinical benefit|1|||
124881946|NCT03029780|449191093|FG001|Overall Study|Maximum clinical benefit|0|||
124881947|NCT03029780|449191092|FG000|Overall Study|Participant no longer meets study criteria|0|||
124881948|NCT03029780|449191093|FG001|Overall Study|Participant no longer meets study criteria|1|||
124881949|NCT03029780|449191092|FG000|Overall Study|Other reasons|6|||
124881950|NCT03029780|449191093|FG001|Overall Study|Other reasons|6|||
124881951|NCT03029780|449191092|FG000|Overall Study|Not reported|1|||
124881952|NCT03029780|449191093|FG001|Overall Study|Not reported|1|||
124881953|NCT03029780|449191092|FG000|Overall Study|Death|2|||
124881954|NCT03029780|449191093|FG001|Overall Study|Death|6|||
124881955|NCT03560258|449191094|FG000|Overall Study|Lost to Follow-up|3|||
124881956|NCT03560258|449191095|FG001|Overall Study|Lost to Follow-up|0|||
124881957|NCT03560258|449191096|FG002|Overall Study|Lost to Follow-up|0|||
124881958|NCT03560258|449191094|FG000|Overall Study|Protocol Violation|0|||
124881959|NCT03560258|449191095|FG001|Overall Study|Protocol Violation|1|||
124881960|NCT03560258|449191096|FG002|Overall Study|Protocol Violation|0|||
124881961|NCT03560258|449191094|FG000|Overall Study|Withdrawal by Subject|0|||
124881962|NCT03560258|449191095|FG001|Overall Study|Withdrawal by Subject|0|||
124881963|NCT03560258|449191096|FG002|Overall Study|Withdrawal by Subject|1|||
124881964|NCT04498247|449191099|FG000|Overall Study|Lost to Follow-up|0|||
124881965|NCT04498247|449191100|FG001|Overall Study|Lost to Follow-up|0|||
124881966|NCT04498247|449191101|FG002|Overall Study|Lost to Follow-up|0|||
124881967|NCT04498247|449191102|FG003|Overall Study|Lost to Follow-up|1|||
124881968|NCT04498247|449191103|FG004|Overall Study|Lost to Follow-up|0|||
124881969|NCT04498247|449191104|FG005|Overall Study|Lost to Follow-up|0|||
124881970|NCT04498247|449191105|FG006|Overall Study|Lost to Follow-up|0|||
124881971|NCT04498247|449191106|FG007|Overall Study|Lost to Follow-up|0|||
124881972|NCT04498247|449191099|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
124881973|NCT04498247|449191100|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
124881974|NCT04498247|449191101|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
124881975|NCT04498247|449191102|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
124881976|NCT04498247|449191103|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
124881977|NCT04498247|449191104|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
124881978|NCT04498247|449191105|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
124881979|NCT04498247|449191106|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
124881980|NCT04498247|449191099|FG000|Overall Study|Withdrawal by Subject|0|||
124881981|NCT04498247|449191100|FG001|Overall Study|Withdrawal by Subject|8|||
124881982|NCT04498247|449191101|FG002|Overall Study|Withdrawal by Subject|0|||
124881983|NCT04498247|449191102|FG003|Overall Study|Withdrawal by Subject|7|||
124881984|NCT04498247|449191103|FG004|Overall Study|Withdrawal by Subject|0|||
124881985|NCT04498247|449191104|FG005|Overall Study|Withdrawal by Subject|0|||
124881986|NCT04498247|449191105|FG006|Overall Study|Withdrawal by Subject|1|||
124881987|NCT04498247|449191106|FG007|Overall Study|Withdrawal by Subject|0|||
124881988|NCT04498247|449191099|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
124881989|NCT04498247|449191100|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
124881990|NCT04498247|449191101|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
124881991|NCT04498247|449191102|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
124881992|NCT04498247|449191103|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
124881993|NCT04498247|449191104|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
124881994|NCT04498247|449191105|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
124881995|NCT04498247|449191106|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
124881996|NCT02086162|449191107|FG000|Overall Study|Withdrawal by Subject|4|||
124881997|NCT02086162|449191108|FG001|Overall Study|Withdrawal by Subject|4|||
124881998|NCT02086162|449191107|FG000|Overall Study|moved|1|||
124881999|NCT02086162|449191108|FG001|Overall Study|moved|1|||
124882000|NCT02086162|449191107|FG000|Overall Study|Lost to Follow-up|4|||
124882001|NCT02086162|449191108|FG001|Overall Study|Lost to Follow-up|2|||
124882002|NCT02086162|449191107|FG000|Overall Study|Death|1|||
124882003|NCT02086162|449191108|FG001|Overall Study|Death|0|||
124882004|NCT01248962|449191109|FG000|Overall Study|Withdrawal by Subject|1|||
124882005|NCT01248962|449191110|FG001|Overall Study|Withdrawal by Subject|1|||
124882006|NCT01248962|449191109|FG000|Overall Study|Adverse Event|2|||
124882007|NCT01248962|449191110|FG001|Overall Study|Adverse Event|1|||
124882008|NCT01248962|449191109|FG000|Overall Study|Complete Response after 4 Cycles|1|||
124882009|NCT01248962|449191110|FG001|Overall Study|Complete Response after 4 Cycles|0|||
124882010|NCT01248962|449191109|FG000|Overall Study|Complete Response after 3 Cycles|0|||
124882011|NCT01248962|449191110|FG001|Overall Study|Complete Response after 3 Cycles|1|||
124882012|NCT01248962|449191109|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
124882013|NCT01248962|449191110|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
124882014|NCT01027364|449191111|FG000|Overall Study|Adverse Event|1|||
124882015|NCT01027364|449191112|FG001|Overall Study|Adverse Event|0|||
124882016|NCT01027364|449191113|FG002|Overall Study|Adverse Event|1|||
124882017|NCT01027364|449191114|FG003|Overall Study|Adverse Event|0|||
124882018|NCT01027364|449191111|FG000|Overall Study|Lost to Follow-up|1|||
124882019|NCT01027364|449191112|FG001|Overall Study|Lost to Follow-up|0|||
124882020|NCT01027364|449191113|FG002|Overall Study|Lost to Follow-up|0|||
124882021|NCT01027364|449191114|FG003|Overall Study|Lost to Follow-up|0|||
124882022|NCT01027364|449191111|FG000|Overall Study|Protocol Violation|1|||
124882023|NCT01027364|449191112|FG001|Overall Study|Protocol Violation|0|||
124882024|NCT01027364|449191113|FG002|Overall Study|Protocol Violation|0|||
124882025|NCT01027364|449191114|FG003|Overall Study|Protocol Violation|1|||
124882026|NCT01027364|449191111|FG000|Overall Study|Withdrawal by Subject|1|||
124439133|NCT01440374|447569064|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
124439134|NCT01440374|447569065|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
124439135|NCT01440374|447569066|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
124439136|NCT01440374|447569063|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
124439137|NCT01440374|447569064|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
124439138|NCT01440374|447569065|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
124439139|NCT01440374|447569066|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
124439140|NCT01440374|447569063|FG000|Part 2; Double-blind Phase|Not treated|0|||
124439141|NCT01440374|447569064|FG001|Part 2; Double-blind Phase|Not treated|0|||
124439142|NCT01440374|447569065|FG002|Part 2; Double-blind Phase|Not treated|1|||
124682994|NCT03329001|448461850|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
124682995|NCT03329001|448461851|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
124882027|NCT01027364|449191112|FG001|Overall Study|Withdrawal by Subject|2|||
124882028|NCT01027364|449191113|FG002|Overall Study|Withdrawal by Subject|0|||
124882029|NCT01027364|449191114|FG003|Overall Study|Withdrawal by Subject|0|||
124882030|NCT00245856|449191121|FG000|Period Two|Withdrawal by Subject|0|||
124882031|NCT00245856|449191122|FG001|Period Two|Withdrawal by Subject|1|||
124882032|NCT01003184|449191123|FG000|Overall Study|Adverse Event|12|||
124882033|NCT01003184|449191124|FG001|Overall Study|Adverse Event|5|||
124882034|NCT01003184|449191123|FG000|Overall Study|Lost to Follow-up|1|||
124882035|NCT01003184|449191124|FG001|Overall Study|Lost to Follow-up|0|||
124882036|NCT01003184|449191123|FG000|Overall Study|Loss of glucose control|1|||
124882037|NCT01003184|449191124|FG001|Overall Study|Loss of glucose control|1|||
124882038|NCT01003184|449191123|FG000|Overall Study|Protocol Violation|3|||
124882039|NCT01003184|449191124|FG001|Overall Study|Protocol Violation|0|||
124882040|NCT01003184|449191123|FG000|Overall Study|Withdrawal by Subject|1|||
124882041|NCT01003184|449191124|FG001|Overall Study|Withdrawal by Subject|6|||
124882042|NCT01003184|449191123|FG000|Overall Study|Physician Decision|1|||
124882043|NCT01003184|449191124|FG001|Overall Study|Physician Decision|0|||
124882044|NCT03662997|449191127|FG000|Overall Study|Adverse Event|0|||
124882045|NCT03662997|449191128|FG001|Overall Study|Adverse Event|2|||
124882046|NCT03662997|449191129|FG002|Overall Study|Adverse Event|0|||
124882047|NCT03662997|449191130|FG003|Overall Study|Adverse Event|0|||
124882048|NCT01719224|449191131|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
124882049|NCT01719224|449191132|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
124882050|NCT03853317|449191137|FG000|Overall Study|Progressive Disease|5|||
124882051|NCT03853317|449191137|FG000|Overall Study|Adverse Event|1|||
124882052|NCT03853317|449191137|FG000|Overall Study|Death|1|||
124882053|NCT03853317|449191137|FG000|Overall Study|other event|2|||
124882054|NCT00406419|449191140|FG000|Overall Study|Death|3|||
124882055|NCT00406419|449191141|FG001|Overall Study|Death|1|||
124882056|NCT00406419|449191142|FG002|Overall Study|Death|4|||
124882057|NCT00406419|449191140|FG000|Overall Study|Protocol Violation|6|||
124882058|NCT00406419|449191141|FG001|Overall Study|Protocol Violation|2|||
124882059|NCT00406419|449191142|FG002|Overall Study|Protocol Violation|5|||
124882060|NCT00406419|449191140|FG000|Overall Study|Study Terminated by Sponsor|260|||
124882061|NCT00406419|449191141|FG001|Overall Study|Study Terminated by Sponsor|288|||
124882062|NCT00406419|449191142|FG002|Overall Study|Study Terminated by Sponsor|282|||
124882063|NCT00406419|449191140|FG000|Overall Study|Withdrawal by Subject|17|||
124882064|NCT00406419|449191141|FG001|Overall Study|Withdrawal by Subject|24|||
124882065|NCT00406419|449191142|FG002|Overall Study|Withdrawal by Subject|26|||
124882066|NCT00406419|449191140|FG000|Overall Study|Lack of Efficacy|12|||
124882067|NCT00406419|449191141|FG001|Overall Study|Lack of Efficacy|1|||
124882068|NCT00406419|449191142|FG002|Overall Study|Lack of Efficacy|6|||
124882069|NCT00406419|449191140|FG000|Overall Study|Non-Compliance with Study Drug|5|||
124882070|NCT00406419|449191141|FG001|Overall Study|Non-Compliance with Study Drug|6|||
124882071|NCT00406419|449191142|FG002|Overall Study|Non-Compliance with Study Drug|3|||
124882072|NCT00406419|449191140|FG000|Overall Study|Adverse Event|10|||
124682996|NCT03329001|448461852|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
124682997|NCT03329001|448461853|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
124882073|NCT00406419|449191141|FG001|Overall Study|Adverse Event|12|||
124882074|NCT00406419|449191142|FG002|Overall Study|Adverse Event|16|||
124882075|NCT00406419|449191140|FG000|Overall Study|Lost to Follow-up|11|||
124882076|NCT00406419|449191141|FG001|Overall Study|Lost to Follow-up|10|||
124882077|NCT00406419|449191142|FG002|Overall Study|Lost to Follow-up|5|||
124882078|NCT01535274|449191143|FG000|Overall Study|Determined to be ineligible|0|||
124882079|NCT01535274|449191144|FG001|Overall Study|Determined to be ineligible|1|||
124882080|NCT01535274|449191143|FG000|Overall Study|Misallocated to propofol intervention|0|||
124882081|NCT01535274|449191144|FG001|Overall Study|Misallocated to propofol intervention|1|||
124882082|NCT03679767|449191145|FG000|Overall Study|Death|16|||
124882083|NCT03679767|449191146|FG001|Overall Study|Death|11|||
124439143|NCT01440374|447569066|FG003|Part 2; Double-blind Phase|Not treated|0|||
124882084|NCT03679767|449191147|FG002|Overall Study|Death|17|||
124439144|NCT01440374|447569063|FG000|Part 3: Extension|Withdrawal by Subject|0|||
124439145|NCT01440374|447569064|FG001|Part 3: Extension|Withdrawal by Subject|0|||
124682998|NCT03329001|448461854|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
124682999|NCT03329001|448461855|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
124683000|NCT03329001|448461856|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
124683001|NCT03329001|448461857|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
124683002|NCT03329001|448461850|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
124882085|NCT03679767|449191148|FG003|Overall Study|Death|10|||
124882086|NCT03679767|449191145|FG000|Overall Study|Lost to Follow-up|1|||
124882087|NCT03679767|449191146|FG001|Overall Study|Lost to Follow-up|1|||
124882088|NCT03679767|449191147|FG002|Overall Study|Lost to Follow-up|1|||
124882089|NCT03679767|449191148|FG003|Overall Study|Lost to Follow-up|1|||
124882090|NCT03679767|449191145|FG000|Overall Study|Withdrawal by Subject|0|||
124882091|NCT03679767|449191146|FG001|Overall Study|Withdrawal by Subject|0|||
124882092|NCT03679767|449191147|FG002|Overall Study|Withdrawal by Subject|0|||
124882093|NCT03679767|449191148|FG003|Overall Study|Withdrawal by Subject|1|||
124882094|NCT03679767|449191145|FG000|Overall Study|Follow-up Completed|18|||
124882095|NCT03679767|449191146|FG001|Overall Study|Follow-up Completed|11|||
124882096|NCT03679767|449191147|FG002|Overall Study|Follow-up Completed|11|||
124882097|NCT03679767|449191148|FG003|Overall Study|Follow-up Completed|20|||
124882098|NCT03679767|449191145|FG000|Overall Study|Entered Hospice Care|0|||
124882099|NCT03679767|449191146|FG001|Overall Study|Entered Hospice Care|0|||
124882100|NCT03679767|449191147|FG002|Overall Study|Entered Hospice Care|0|||
124882101|NCT03679767|449191148|FG003|Overall Study|Entered Hospice Care|1|||
124882102|NCT03679767|449191145|FG000|Overall Study|Progressive Disease|0|||
124882103|NCT03679767|449191146|FG001|Overall Study|Progressive Disease|0|||
124882104|NCT03679767|449191147|FG002|Overall Study|Progressive Disease|0|||
124882105|NCT03679767|449191148|FG003|Overall Study|Progressive Disease|1|||
124882106|NCT00882921|449191153|FG000|Overall Study|Death|2|||
124882107|NCT00882921|449191153|FG000|Overall Study|Other|3|||
124882108|NCT00882921|449191153|FG000|Overall Study|Lost to Follow-up|2|||
124882109|NCT00882921|449191153|FG000|Overall Study|Termination By Investigator|3|||
124882110|NCT00882921|449191153|FG000|Overall Study|Withdrawal Of Consent|1|||
124882111|NCT02009696|449191154|FG000|Overall Study|Withdrawal by Subject|2|||
124882112|NCT05490329|449191155|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
124882113|NCT05490329|449191156|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
124882114|NCT05490329|449191155|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
124882115|NCT05490329|449191156|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
124882116|NCT05490329|449191155|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
124882117|NCT05490329|449191156|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
124882118|NCT00447954|449191157|FG000|Overall Study|Adverse Event|0|||
124882119|NCT00447954|449191158|FG001|Overall Study|Adverse Event|2|||
124882120|NCT00447954|449191159|FG002|Overall Study|Adverse Event|0|||
124882121|NCT00447954|449191157|FG000|Overall Study|Withdrawal by Subject|0|||
124882122|NCT00447954|449191158|FG001|Overall Study|Withdrawal by Subject|1|||
124882123|NCT00447954|449191159|FG002|Overall Study|Withdrawal by Subject|1|||
124882124|NCT00447954|449191157|FG000|Overall Study|Lost to Follow-up|0|||
124439146|NCT01440374|447569065|FG002|Part 3: Extension|Withdrawal by Subject|0|||
124882125|NCT00447954|449191158|FG001|Overall Study|Lost to Follow-up|1|||
124882126|NCT00447954|449191159|FG002|Overall Study|Lost to Follow-up|0|||
124882127|NCT00447954|449191157|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
124882128|NCT00447954|449191158|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
124882129|NCT00447954|449191159|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
124882130|NCT00856661|449191160|FG000|Overall Study|Death|15|||
124882131|NCT00856661|449191161|FG001|Overall Study|Death|18|||
124882132|NCT00856661|449191160|FG000|Overall Study|Protocol Violation|2|||
124882133|NCT00856661|449191161|FG001|Overall Study|Protocol Violation|1|||
124882134|NCT00856661|449191160|FG000|Overall Study|Withdrawal by Subject|1|||
124882135|NCT00856661|449191161|FG001|Overall Study|Withdrawal by Subject|2|||
124882136|NCT00856661|449191160|FG000|Overall Study|Lost to Follow-up|1|||
124882137|NCT00856661|449191161|FG001|Overall Study|Lost to Follow-up|3|||
124439147|NCT01440374|447569066|FG003|Part 3: Extension|Withdrawal by Subject|5|||
124439148|NCT01440374|447569063|FG000|Part 3: Extension|Adverse Event|0|||
124439149|NCT01440374|447569064|FG001|Part 3: Extension|Adverse Event|0|||
124439150|NCT01440374|447569065|FG002|Part 3: Extension|Adverse Event|0|||
124439151|NCT01440374|447569066|FG003|Part 3: Extension|Adverse Event|13|||
124683003|NCT03329001|448461851|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
124683004|NCT03329001|448461852|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
124683005|NCT03329001|448461853|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
124882138|NCT00856661|449191160|FG000|Overall Study|Physician Judgement|8|||
124882139|NCT00856661|449191161|FG001|Overall Study|Physician Judgement|5|||
124882140|NCT02120664|449191162|FG000|Overall Study|Withdrawal by Subject|0|||
124882141|NCT02120664|449191163|FG001|Overall Study|Withdrawal by Subject|0|||
124882142|NCT02120664|449191164|FG002|Overall Study|Withdrawal by Subject|0|||
124882143|NCT02120664|449191165|FG003|Overall Study|Withdrawal by Subject|1|||
124882144|NCT02120664|449191166|FG004|Overall Study|Withdrawal by Subject|0|||
124882145|NCT00105586|449191167|FG000|Overall Study|Adverse Event|4|||
124882146|NCT00105586|449191168|FG001|Overall Study|Adverse Event|3|||
124882147|NCT00105586|449191167|FG000|Overall Study|Physician Decision|13|||
124439152|NCT01440374|447569063|FG000|Part 3: Extension|Physician Decision|0|||
124882148|NCT00105586|449191168|FG001|Overall Study|Physician Decision|13|||
124882149|NCT02306122|449191169|FG000|Initial Physician Randomization|Physician Decision|0|||
124882150|NCT02306122|449191170|FG001|Initial Physician Randomization|Physician Decision|0|||
124882151|NCT02306122|449191171|FG002|Initial Physician Randomization|Physician Decision|0|||
124882152|NCT02306122|449191172|FG003|Initial Physician Randomization|Physician Decision|0|||
124882153|NCT02306122|449191173|FG004|Initial Physician Randomization|Physician Decision|0|||
124882154|NCT02306122|449191174|FG005|Initial Physician Randomization|Physician Decision|0|||
124882155|NCT02306122|449191175|FG006|Initial Physician Randomization|Physician Decision|0|||
124882156|NCT02306122|449191176|FG007|Initial Physician Randomization|Physician Decision|0|||
124882157|NCT02306122|449191177|FG008|Initial Physician Randomization|Physician Decision|1|||
124882158|NCT02306122|449191178|FG009|Initial Physician Randomization|Physician Decision|0|||
124439153|NCT01440374|447569064|FG001|Part 3: Extension|Physician Decision|0|||
124439154|NCT01440374|447569065|FG002|Part 3: Extension|Physician Decision|0|||
124439155|NCT01440374|447569066|FG003|Part 3: Extension|Physician Decision|14|||
124439156|NCT01222507|447569073|FG000|Overall Study|Physician Decision|1|||
124439157|NCT01222507|447569073|FG000|Overall Study|Withdrawal by Subject|1|||
124439158|NCT02647320|447569074|FG000|Overall Study|Adverse Event|0|||
124439159|NCT02647320|447569075|FG001|Overall Study|Adverse Event|1|||
124439160|NCT02647320|447569076|FG002|Overall Study|Adverse Event|3|||
124439161|NCT02647320|447569077|FG003|Overall Study|Adverse Event|2|||
124439162|NCT02647320|447569078|FG004|Overall Study|Adverse Event|1|||
124439163|NCT02647320|447569074|FG000|Overall Study|Protocol Violation|0|||
124439164|NCT02647320|447569075|FG001|Overall Study|Protocol Violation|0|||
124439165|NCT02647320|447569076|FG002|Overall Study|Protocol Violation|3|||
124439166|NCT02647320|447569077|FG003|Overall Study|Protocol Violation|0|||
124439167|NCT02647320|447569078|FG004|Overall Study|Protocol Violation|0|||
124439168|NCT02647320|447569074|FG000|Overall Study|Withdrawal by Subject|7|||
124439169|NCT02647320|447569075|FG001|Overall Study|Withdrawal by Subject|4|||
124439170|NCT02647320|447569076|FG002|Overall Study|Withdrawal by Subject|2|||
124439171|NCT02647320|447569077|FG003|Overall Study|Withdrawal by Subject|2|||
124439172|NCT02647320|447569078|FG004|Overall Study|Withdrawal by Subject|7|||
124439173|NCT02647320|447569074|FG000|Overall Study|Persistent hyperglycemia|0|||
124439174|NCT02647320|447569075|FG001|Overall Study|Persistent hyperglycemia|1|||
124439175|NCT02647320|447569076|FG002|Overall Study|Persistent hyperglycemia|1|||
124439176|NCT02647320|447569077|FG003|Overall Study|Persistent hyperglycemia|1|||
124439177|NCT02647320|447569078|FG004|Overall Study|Persistent hyperglycemia|1|||
124439178|NCT02647320|447569074|FG000|Overall Study|Study terminated by sponsor|1|||
124439179|NCT02647320|447569075|FG001|Overall Study|Study terminated by sponsor|1|||
124439180|NCT02647320|447569076|FG002|Overall Study|Study terminated by sponsor|1|||
124439181|NCT02647320|447569077|FG003|Overall Study|Study terminated by sponsor|1|||
124439182|NCT02647320|447569078|FG004|Overall Study|Study terminated by sponsor|2|||
124439183|NCT02647320|447569074|FG000|Overall Study|Reason not provided|0|||
124439184|NCT02647320|447569075|FG001|Overall Study|Reason not provided|0|||
124439185|NCT02647320|447569076|FG002|Overall Study|Reason not provided|1|||
124439186|NCT02647320|447569077|FG003|Overall Study|Reason not provided|0|||
124439187|NCT02647320|447569078|FG004|Overall Study|Reason not provided|2|||
124439188|NCT02647320|447569074|FG000|Overall Study|Lost to Follow-up|1|||
124439189|NCT02647320|447569075|FG001|Overall Study|Lost to Follow-up|1|||
124439190|NCT02647320|447569076|FG002|Overall Study|Lost to Follow-up|0|||
124439191|NCT02647320|447569077|FG003|Overall Study|Lost to Follow-up|0|||
124439192|NCT02647320|447569078|FG004|Overall Study|Lost to Follow-up|0|||
124439193|NCT02647320|447569074|FG000|Overall Study|Develop anemia|1|||
124439194|NCT02647320|447569075|FG001|Overall Study|Develop anemia|0|||
124439195|NCT02647320|447569076|FG002|Overall Study|Develop anemia|0|||
124439196|NCT02647320|447569077|FG003|Overall Study|Develop anemia|0|||
124439197|NCT02647320|447569078|FG004|Overall Study|Develop anemia|0|||
124439198|NCT02647320|447569074|FG000|Overall Study|Lack of Efficacy|0|||
124439199|NCT02647320|447569075|FG001|Overall Study|Lack of Efficacy|0|||
124439200|NCT02647320|447569076|FG002|Overall Study|Lack of Efficacy|0|||
124439201|NCT02647320|447569077|FG003|Overall Study|Lack of Efficacy|1|||
124439202|NCT02647320|447569078|FG004|Overall Study|Lack of Efficacy|0|||
124439203|NCT02647320|447569074|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
124439204|NCT02647320|447569075|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
124439205|NCT02647320|447569076|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
124439206|NCT02647320|447569077|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
124439207|NCT02647320|447569078|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
124882159|NCT02306122|449191179|FG010|Initial Physician Randomization|Physician Decision|0|||
124439208|NCT01650246|447569081|FG000|Overall Study|Adverse Event|23|||
124439209|NCT01650246|447569081|FG000|Overall Study|Protocol Violation|5|||
124439210|NCT01650246|447569081|FG000|Overall Study|Sponsor terminated study|53|||
124439211|NCT01650246|447569081|FG000|Overall Study|Lost to Follow-up|5|||
124439212|NCT01650246|447569081|FG000|Overall Study|Withdrawal by Subject|26|||
124439213|NCT01650246|447569081|FG000|Overall Study|Death|1|||
124439214|NCT01650246|447569081|FG000|Overall Study|Lack of Efficacy|30|||
124439215|NCT00953407|447569082|FG000|Overall Study|Failed inclusion criteria|1|||
124439216|NCT00953407|447569083|FG001|Overall Study|Failed inclusion criteria|1|||
124439217|NCT00953407|447569084|FG002|Overall Study|Failed inclusion criteria|1|||
124439218|NCT00953407|447569085|FG003|Overall Study|Failed inclusion criteria|1|||
124439219|NCT00953407|447569086|FG004|Overall Study|Failed inclusion criteria|1|||
124882160|NCT00886639|449191180|FG000|Overall Study|acute exacerbation|14|||
124882161|NCT00886639|449191180|FG000|Overall Study|non-compliance|2|||
124882162|NCT03203694|449191181|FG000|Overall Study|Withdrawal by Subject|2|||
124882163|NCT03203694|449191182|FG001|Overall Study|Withdrawal by Subject|0|||
124882164|NCT03203694|449191183|FG002|Overall Study|Withdrawal by Subject|0|||
124882165|NCT03203694|449191184|FG003|Overall Study|Withdrawal by Subject|0|||
124882166|NCT03203694|449191185|FG004|Overall Study|Withdrawal by Subject|0|||
124882167|NCT03203694|449191186|FG005|Overall Study|Withdrawal by Subject|0|||
124882168|NCT00735644|449191189|FG000|Overall Study|Did not receive study vaccine|0|||
124882169|NCT00735644|449191190|FG001|Overall Study|Did not receive study vaccine|1|||
124882170|NCT00735644|449191191|FG002|Overall Study|Did not receive study vaccine|0|||
124882171|NCT00735644|449191192|FG003|Overall Study|Did not receive study vaccine|0|||
124882172|NCT00735644|449191193|FG004|Overall Study|Did not receive study vaccine|0|||
124882173|NCT00735644|449191189|FG000|Overall Study|Withdrawal by Subject|0|||
124882174|NCT00735644|449191190|FG001|Overall Study|Withdrawal by Subject|1|||
124882175|NCT00735644|449191191|FG002|Overall Study|Withdrawal by Subject|1|||
124882176|NCT00735644|449191192|FG003|Overall Study|Withdrawal by Subject|1|||
124882177|NCT00735644|449191193|FG004|Overall Study|Withdrawal by Subject|0|||
124882178|NCT02961374|449191194|FG000|Overall Study|Adverse Event|4|||
124882179|NCT01518946|449191201|FG000|Open-label Phase|Other|4|||
124882180|NCT01518946|449191202|FG001|Open-label Phase|Other|0|||
124882181|NCT01518946|449191203|FG002|Open-label Phase|Other|0|||
124882182|NCT01518946|449191201|FG000|Randomized Phase (First Intervention)|Other|0|||
124882183|NCT01518946|449191202|FG001|Randomized Phase (First Intervention)|Other|1|||
124882184|NCT01518946|449191203|FG002|Randomized Phase (First Intervention)|Other|0|||
124882185|NCT00384059|449191204|FG000|Infant Series|Not consented|2|||
124882186|NCT00384059|449191205|FG001|Infant Series|Not consented|6|||
124882187|NCT00384059|449191204|FG000|Infant Series|Withdrawal by Subject|2|||
124882188|NCT00384059|449191205|FG001|Infant Series|Withdrawal by Subject|2|||
124882189|NCT00384059|449191204|FG000|Infant Series|Adverse Event|1|||
124882190|NCT00384059|449191205|FG001|Infant Series|Adverse Event|2|||
124882191|NCT00384059|449191204|FG000|Infant Series|Protocol Violation|1|||
124882192|NCT00384059|449191205|FG001|Infant Series|Protocol Violation|2|||
124882193|NCT00384059|449191204|FG000|Infant Series|Lost to Follow-up|0|||
124882194|NCT00384059|449191205|FG001|Infant Series|Lost to Follow-up|1|||
124882195|NCT00384059|449191204|FG000|After Infant Series|Protocol Violation|2|||
124882196|NCT00384059|449191205|FG001|After Infant Series|Protocol Violation|3|||
124882197|NCT00384059|449191204|FG000|After Infant Series|Withdrawal by Subject|2|||
124882198|NCT00384059|449191205|FG001|After Infant Series|Withdrawal by Subject|2|||
124882199|NCT00384059|449191204|FG000|After Infant Series|Failed to Return|0|||
124882200|NCT00384059|449191205|FG001|After Infant Series|Failed to Return|2|||
124882201|NCT00384059|449191204|FG000|After Infant Series|Adverse Event|0|||
124882202|NCT00384059|449191205|FG001|After Infant Series|Adverse Event|1|||
124882203|NCT00384059|449191204|FG000|After Infant Series|Physician Decision|0|||
124882204|NCT00384059|449191205|FG001|After Infant Series|Physician Decision|1|||
124882205|NCT00384059|449191204|FG000|After Infant Series|Lost to Follow-up|0|||
124882206|NCT00384059|449191205|FG001|After Infant Series|Lost to Follow-up|1|||
124882207|NCT00384059|449191204|FG000|Toddler Dose|Lost to Follow-up|1|||
124882208|NCT00384059|449191205|FG001|Toddler Dose|Lost to Follow-up|1|||
124882209|NCT00384059|449191204|FG000|Toddler Dose|Failed to return|0|||
124882210|NCT00384059|449191205|FG001|Toddler Dose|Failed to return|1|||
124882211|NCT02714205|449191206|FG000|Overall Study|Cannot tolerate medication|1|||
124882212|NCT02714205|449191207|FG001|Overall Study|Cannot tolerate medication|0|||
124882213|NCT02714205|449191206|FG000|Overall Study|Adverse Event|2|||
124882214|NCT02714205|449191207|FG001|Overall Study|Adverse Event|0|||
124882215|NCT02714205|449191206|FG000|Overall Study|Too busy|1|||
124882216|NCT02714205|449191207|FG001|Overall Study|Too busy|0|||
124882217|NCT02714205|449191206|FG000|Overall Study|Incomplete outcome data|0|||
124882218|NCT02714205|449191207|FG001|Overall Study|Incomplete outcome data|1|||
124882219|NCT00381641|449191210|FG000|Overall Study|Withdrawal by Subject|0|||
124882220|NCT00381641|449191211|FG001|Overall Study|Withdrawal by Subject|2|||
124882221|NCT01598298|449191212|FG000|Overall Study|Not eligible|5|||
124882222|NCT01598298|449191213|FG001|Overall Study|Not eligible|5|||
124882223|NCT01598298|449191212|FG000|Overall Study|Adverse Event|21|||
124882224|NCT01598298|449191213|FG001|Overall Study|Adverse Event|19|||
124882225|NCT01598298|449191212|FG000|Overall Study|Progression/relapse|0|||
124882226|NCT01598298|449191213|FG001|Overall Study|Progression/relapse|2|||
124882227|NCT01598298|449191212|FG000|Overall Study|Withdrawal by Subject|10|||
124882228|NCT01598298|449191213|FG001|Overall Study|Withdrawal by Subject|15|||
124882229|NCT01598298|449191212|FG000|Overall Study|Other reason (not protocol specified)|4|||
124882230|NCT01598298|449191213|FG001|Overall Study|Other reason (not protocol specified)|0|||
124882231|NCT04287868|449191214|FG000|Overall Study|Screening fail|1|||
124882232|NCT04287868|449191215|FG001|Overall Study|Screening fail|0|||
124882233|NCT03813147|449191216|FG000|Overall Study|Lack of Efficacy|4|||
124882234|NCT03813147|449191217|FG001|Overall Study|Lack of Efficacy|4|||
124882235|NCT03813147|449191216|FG000|Overall Study|Physician Decision|2|||
124882236|NCT03813147|449191217|FG001|Overall Study|Physician Decision|1|||
124882237|NCT00553202|449193188|FG000|Overall Study|Death|16|||
124882238|NCT00553202|449193188|FG000|Overall Study|Lost to Follow-up|1|||
124882239|NCT00553202|449193188|FG000|Overall Study|Physician Decision|28|||
124882240|NCT00553202|449193188|FG000|Overall Study|Withdrawal by Subject|1|||
124882241|NCT00553202|449193188|FG000|Overall Study|No donor identified|16|||
124882242|NCT00553202|449193188|FG000|Overall Study|Fails to meet organ function|6|||
124882243|NCT04651114|449193189|FG000|Overall Study|Withdrawal by Subject|8|||
124882244|NCT01923896|449193194|FG000|Overall Study|Adverse Event|1|||
124882245|NCT01923896|449193195|FG001|Overall Study|Adverse Event|0|||
124882246|NCT00592319|449193198|FG000|Overall Study|Lost to Follow-up|0|||
124882247|NCT00592319|449193199|FG001|Overall Study|Lost to Follow-up|3|||
124882248|NCT00235443|449193202|FG000|Overall Study|Adverse Event|4|||
124882249|NCT00235443|449193203|FG001|Overall Study|Adverse Event|12|||
124882250|NCT00235443|449193204|FG002|Overall Study|Adverse Event|17|||
124882251|NCT00235443|449193205|FG003|Overall Study|Adverse Event|44|||
124882252|NCT00235443|449193206|FG004|Overall Study|Adverse Event|10|||
124882253|NCT00235443|449193207|FG005|Overall Study|Adverse Event|15|||
124882254|NCT00235443|449193202|FG000|Overall Study|Lack of Efficacy|0|||
124882255|NCT00235443|449193203|FG001|Overall Study|Lack of Efficacy|1|||
124882256|NCT00235443|449193204|FG002|Overall Study|Lack of Efficacy|5|||
124882257|NCT00235443|449193205|FG003|Overall Study|Lack of Efficacy|12|||
124882258|NCT00235443|449193206|FG004|Overall Study|Lack of Efficacy|2|||
124882259|NCT00235443|449193207|FG005|Overall Study|Lack of Efficacy|9|||
124882260|NCT00235443|449193202|FG000|Overall Study|Withdrawal by Subject|3|||
124882261|NCT00235443|449193203|FG001|Overall Study|Withdrawal by Subject|9|||
124882262|NCT00235443|449193204|FG002|Overall Study|Withdrawal by Subject|25|||
124882263|NCT00235443|449193205|FG003|Overall Study|Withdrawal by Subject|24|||
124882264|NCT00235443|449193206|FG004|Overall Study|Withdrawal by Subject|10|||
124882265|NCT00235443|449193207|FG005|Overall Study|Withdrawal by Subject|12|||
124882266|NCT00235443|449193202|FG000|Overall Study|Lost to Follow-up|0|||
124882267|NCT00235443|449193203|FG001|Overall Study|Lost to Follow-up|8|||
124882268|NCT00235443|449193204|FG002|Overall Study|Lost to Follow-up|6|||
124882269|NCT00235443|449193205|FG003|Overall Study|Lost to Follow-up|6|||
124882270|NCT00235443|449193206|FG004|Overall Study|Lost to Follow-up|4|||
124882271|NCT00235443|449193207|FG005|Overall Study|Lost to Follow-up|3|||
124882272|NCT00235443|449193202|FG000|Overall Study|Unsatisfactory compliance|0|||
124882273|NCT00235443|449193203|FG001|Overall Study|Unsatisfactory compliance|2|||
124882274|NCT00235443|449193204|FG002|Overall Study|Unsatisfactory compliance|3|||
124882275|NCT00235443|449193205|FG003|Overall Study|Unsatisfactory compliance|4|||
124882276|NCT00235443|449193206|FG004|Overall Study|Unsatisfactory compliance|1|||
124544387|NCT00948896|447946797|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
124544388|NCT00948896|447946798|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
124544389|NCT00948896|447946799|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
124683006|NCT03329001|448461854|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
124882277|NCT00235443|449193207|FG005|Overall Study|Unsatisfactory compliance|0|||
124882278|NCT00235443|449193202|FG000|Overall Study|Other reasons for premature termination|1|||
124882279|NCT00235443|449193203|FG001|Overall Study|Other reasons for premature termination|6|||
124882280|NCT00235443|449193204|FG002|Overall Study|Other reasons for premature termination|6|||
124882281|NCT00235443|449193205|FG003|Overall Study|Other reasons for premature termination|7|||
124882282|NCT00235443|449193206|FG004|Overall Study|Other reasons for premature termination|3|||
124882283|NCT00235443|449193207|FG005|Overall Study|Other reasons for premature termination|6|||
124882284|NCT00474929|449193211|FG000|Overall Study|Withdrawal by Subject|0|||
124882285|NCT00474929|449193212|FG001|Overall Study|Withdrawal by Subject|1|||
124882286|NCT00474929|449193213|FG002|Overall Study|Withdrawal by Subject|0|||
124882287|NCT00474929|449193214|FG003|Overall Study|Withdrawal by Subject|0|||
124882288|NCT00474929|449193215|FG004|Overall Study|Withdrawal by Subject|0|||
124882289|NCT00474929|449193211|FG000|Overall Study|Unrelated medical condition|0|||
124882290|NCT00474929|449193212|FG001|Overall Study|Unrelated medical condition|0|||
124882291|NCT00474929|449193213|FG002|Overall Study|Unrelated medical condition|1|||
124882292|NCT00474929|449193214|FG003|Overall Study|Unrelated medical condition|0|||
124882293|NCT00474929|449193215|FG004|Overall Study|Unrelated medical condition|0|||
124882294|NCT00474929|449193211|FG000|Overall Study|Physician Decision|0|||
124882295|NCT00474929|449193212|FG001|Overall Study|Physician Decision|0|||
124882296|NCT00474929|449193213|FG002|Overall Study|Physician Decision|1|||
124882297|NCT00474929|449193214|FG003|Overall Study|Physician Decision|2|||
124882298|NCT00474929|449193215|FG004|Overall Study|Physician Decision|0|||
124882299|NCT03029247|449193218|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
124882300|NCT03029247|449193219|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
124882301|NCT03029247|449193218|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
124882302|NCT03029247|449193219|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
124882303|NCT03029247|449193218|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
124882304|NCT03029247|449193219|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
124882305|NCT03029247|449193218|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
124882306|NCT03029247|449193219|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
124882307|NCT02593305|449193222|FG000|Post 1|Comparison only group. No intervention.|0|||
124882308|NCT02593305|449193223|FG001|Post 1|Comparison only group. No intervention.|0|||
124882309|NCT02593305|449193224|FG002|Post 1|Comparison only group. No intervention.|10|||
124882310|NCT01190215|449193225|FG000|Up to Month 6|Lost to Follow-up|2|||
124882311|NCT01190215|449193226|FG001|Up to Month 6|Lost to Follow-up|0|||
124882312|NCT00003511|449193228|FG000|Overall Study|Not evaluable|4|||
124882313|NCT00041756|449193247|FG000|Overall Study|Adverse Event|4|||
124882314|NCT00041756|449193248|FG001|Overall Study|Adverse Event|10|||
124882315|NCT00041756|449193249|FG002|Overall Study|Adverse Event|6|||
124882316|NCT00041756|449193250|FG003|Overall Study|Adverse Event|11|||
124882317|NCT00041756|449193251|FG004|Overall Study|Adverse Event|34|||
124882318|NCT00041756|449193247|FG000|Overall Study|Protocol Violation|1|||
124882319|NCT00041756|449193248|FG001|Overall Study|Protocol Violation|1|||
124882320|NCT00041756|449193249|FG002|Overall Study|Protocol Violation|2|||
124882321|NCT00041756|449193250|FG003|Overall Study|Protocol Violation|2|||
124882322|NCT00041756|449193251|FG004|Overall Study|Protocol Violation|1|||
124882323|NCT00041756|449193247|FG000|Overall Study|Withdrawal by Subject|3|||
124882324|NCT00041756|449193248|FG001|Overall Study|Withdrawal by Subject|3|||
124882325|NCT00041756|449193249|FG002|Overall Study|Withdrawal by Subject|4|||
124882326|NCT00041756|449193250|FG003|Overall Study|Withdrawal by Subject|2|||
124882327|NCT00041756|449193251|FG004|Overall Study|Withdrawal by Subject|3|||
124882328|NCT00041756|449193247|FG000|Overall Study|Lost to Follow-up|0|||
124882329|NCT00041756|449193248|FG001|Overall Study|Lost to Follow-up|1|||
124882330|NCT00041756|449193249|FG002|Overall Study|Lost to Follow-up|0|||
124882331|NCT00041756|449193250|FG003|Overall Study|Lost to Follow-up|1|||
124882332|NCT00041756|449193251|FG004|Overall Study|Lost to Follow-up|0|||
124882333|NCT00041756|449193247|FG000|Overall Study|Unable to meet protocol criteria|0|||
124882334|NCT00041756|449193248|FG001|Overall Study|Unable to meet protocol criteria|0|||
124882335|NCT00041756|449193249|FG002|Overall Study|Unable to meet protocol criteria|1|||
124882336|NCT00041756|449193250|FG003|Overall Study|Unable to meet protocol criteria|0|||
124882337|NCT00041756|449193251|FG004|Overall Study|Unable to meet protocol criteria|1|||
124882338|NCT00041756|449193247|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
124882339|NCT00041756|449193248|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
124882340|NCT00041756|449193249|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
124882341|NCT00041756|449193250|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
124882342|NCT00041756|449193251|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
124882343|NCT00603265|449193252|FG000|Overall Study|Adverse Event|2|||
124882344|NCT00603265|449193253|FG001|Overall Study|Adverse Event|11|||
124882345|NCT00603265|449193254|FG002|Overall Study|Adverse Event|1|||
124882346|NCT00603265|449193252|FG000|Overall Study|Withdrawal by Subject|1|||
124882347|NCT00603265|449193253|FG001|Overall Study|Withdrawal by Subject|2|||
124882348|NCT00603265|449193254|FG002|Overall Study|Withdrawal by Subject|1|||
124882349|NCT00603265|449193252|FG000|Overall Study|Lack of Efficacy|3|||
124882350|NCT00603265|449193253|FG001|Overall Study|Lack of Efficacy|0|||
124882351|NCT00603265|449193254|FG002|Overall Study|Lack of Efficacy|3|||
124882352|NCT00603265|449193252|FG000|Overall Study|Lost to Follow-up|0|||
124882353|NCT00603265|449193253|FG001|Overall Study|Lost to Follow-up|1|||
124683007|NCT03329001|448461855|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
124683008|NCT03329001|448461856|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
124882354|NCT00603265|449193254|FG002|Overall Study|Lost to Follow-up|0|||
124683009|NCT03329001|448461857|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
124882355|NCT00603265|449193252|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
124882356|NCT00603265|449193253|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
124882357|NCT00603265|449193254|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
124882358|NCT00603265|449193252|FG000|Overall Study|Participant Left Country, No Responses|0|||
124882359|NCT00603265|449193253|FG001|Overall Study|Participant Left Country, No Responses|1|||
124882360|NCT00603265|449193254|FG002|Overall Study|Participant Left Country, No Responses|0|||
124882361|NCT00603265|449193252|FG000|Overall Study|Protocol Violation|1|||
124882362|NCT00603265|449193253|FG001|Overall Study|Protocol Violation|0|||
124683010|NCT03329001|448461850|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
124683011|NCT03329001|448461851|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
124683012|NCT03329001|448461852|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
124683013|NCT03329001|448461853|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
124683014|NCT03329001|448461854|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
124683015|NCT03329001|448461855|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
124683016|NCT03329001|448461856|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
124683017|NCT03329001|448461857|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
124683018|NCT03329001|448461850|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
124683019|NCT03329001|448461851|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
124882363|NCT00603265|449193254|FG002|Overall Study|Protocol Violation|0|||
124882364|NCT02002884|449193255|FG000|Main Period (MP)|Other|0|||
124882365|NCT02002884|449193256|FG001|Main Period (MP)|Other|3|||
124882366|NCT02002884|449193257|FG002|Main Period (MP)|Other|3|||
124882367|NCT02002884|449193258|FG003|Main Period (MP)|Other|0|||
124882368|NCT02002884|449193255|FG000|Main Period (MP)|Adverse Event|0|||
124882369|NCT02002884|449193256|FG001|Main Period (MP)|Adverse Event|1|||
124882370|NCT02002884|449193257|FG002|Main Period (MP)|Adverse Event|1|||
124882371|NCT02002884|449193258|FG003|Main Period (MP)|Adverse Event|0|||
124882372|NCT02002884|449193255|FG000|Main Period (MP)|Withdrawal by Subject|6|||
124882373|NCT02002884|449193256|FG001|Main Period (MP)|Withdrawal by Subject|2|||
124882374|NCT02002884|449193257|FG002|Main Period (MP)|Withdrawal by Subject|2|||
124882375|NCT02002884|449193258|FG003|Main Period (MP)|Withdrawal by Subject|0|||
124882376|NCT02002884|449193255|FG000|Main Period (MP)|Lost to Follow-up|0|||
124683020|NCT03329001|448461852|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
124683021|NCT03329001|448461853|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
124683022|NCT03329001|448461854|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
124882377|NCT02002884|449193256|FG001|Main Period (MP)|Lost to Follow-up|0|||
124882378|NCT02002884|449193257|FG002|Main Period (MP)|Lost to Follow-up|2|||
124882379|NCT02002884|449193258|FG003|Main Period (MP)|Lost to Follow-up|0|||
124882380|NCT02002884|449193255|FG000|Open-Label Extension Period (OLEX)|Other|0|||
124882381|NCT02002884|449193256|FG001|Open-Label Extension Period (OLEX)|Other|0|||
124882382|NCT02002884|449193257|FG002|Open-Label Extension Period (OLEX)|Other|0|||
124882383|NCT02002884|449193258|FG003|Open-Label Extension Period (OLEX)|Other|24|||
124882384|NCT02002884|449193255|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
124882385|NCT02002884|449193256|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
124882386|NCT02002884|449193257|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
124882387|NCT02002884|449193258|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
124882388|NCT02002884|449193255|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
124882389|NCT02002884|449193256|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
124882390|NCT02002884|449193257|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
124882391|NCT02002884|449193258|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
124882392|NCT02002884|449193255|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
124882393|NCT02002884|449193256|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
124882394|NCT02002884|449193257|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
124882395|NCT02002884|449193258|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
124882396|NCT02002884|449193255|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
124882397|NCT02002884|449193256|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
124882398|NCT02002884|449193257|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
124882399|NCT02002884|449193258|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
124882400|NCT02966002|449193259|FG000|Overall Study|Withdrawal by Subject|2|||
124882401|NCT02966002|449193259|FG000|Overall Study|Adverse Event|1|||
124683023|NCT03329001|448461855|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
124683024|NCT03329001|448461856|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
124882402|NCT02966002|449193259|FG000|Overall Study|Lost to Follow-up|1|||
124882403|NCT02291432|449193265|FG000|Overall Study|Withdrawal by Subject|2|||
124882404|NCT03377790|449193266|FG000|Overall Study|Withdrawal by Subject|1|||
124882405|NCT03377790|449193267|FG001|Overall Study|Withdrawal by Subject|0|||
124882406|NCT03377790|449193266|FG000|Overall Study|Adverse Event|1|||
124882407|NCT03377790|449193267|FG001|Overall Study|Adverse Event|0|||
124882408|NCT03377790|449193266|FG000|Overall Study|Lost to Follow-up|0|||
124882409|NCT03377790|449193267|FG001|Overall Study|Lost to Follow-up|2|||
124882410|NCT03377790|449193266|FG000|Overall Study|Randomized but not treated|1|||
124882411|NCT03377790|449193267|FG001|Overall Study|Randomized but not treated|0|||
124882412|NCT03377790|449193266|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
124882413|NCT03377790|449193267|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
124882414|NCT02632786|449193271|FG000|Overall Study|Adverse Event|2|||
124882415|NCT02632786|449193272|FG001|Overall Study|Adverse Event|1|||
124882416|NCT02632786|449193271|FG000|Overall Study|Death|3|||
124882417|NCT02632786|449193272|FG001|Overall Study|Death|2|||
124882418|NCT02632786|449193271|FG000|Overall Study|Physician Decision|5|||
124882419|NCT02632786|449193272|FG001|Overall Study|Physician Decision|4|||
124882420|NCT02632786|449193271|FG000|Overall Study|Withdrawal by Subject|1|||
124882421|NCT02632786|449193272|FG001|Overall Study|Withdrawal by Subject|0|||
124882422|NCT01454830|449193276|FG000|Overall Study|Withdrawal by Subject|4|||
124882423|NCT01454830|449193277|FG001|Overall Study|Withdrawal by Subject|4|||
124882424|NCT01454830|449193276|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
124882425|NCT01454830|449193277|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
124882426|NCT01454830|449193276|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
124882427|NCT01454830|449193277|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
124882428|NCT01454830|449193276|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
124882429|NCT01454830|449193277|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
124882430|NCT01454830|449193276|FG000|Overall Study|Withdrawal - no polysomnography|3|||
124882431|NCT01454830|449193277|FG001|Overall Study|Withdrawal - no polysomnography|2|||
124882432|NCT00152763|449193278|FG000|Overall Study|Death|4|||
124711997|NCT01823107|448570706|FG000|Overall Study|Withdrawal by Subject|1|||
124882433|NCT00152763|449193279|FG001|Overall Study|Death|1|||
124882434|NCT00152763|449193280|FG002|Overall Study|Death|2|||
124882435|NCT00152763|449193281|FG003|Overall Study|Death|1|||
124882436|NCT00152763|449193278|FG000|Overall Study|Lost to Follow-up|6|||
124882437|NCT00152763|449193279|FG001|Overall Study|Lost to Follow-up|4|||
124882438|NCT00152763|449193280|FG002|Overall Study|Lost to Follow-up|2|||
124882439|NCT00152763|449193281|FG003|Overall Study|Lost to Follow-up|13|||
124882440|NCT00569803|449193282|FG000|Overall Study|Lost to Follow-up|1|||
124882441|NCT00569803|449193283|FG001|Overall Study|Lost to Follow-up|0|||
124882442|NCT00569803|449193284|FG002|Overall Study|Lost to Follow-up|0|||
124882443|NCT00569803|449193285|FG003|Overall Study|Lost to Follow-up|0|||
124882444|NCT00569803|449193286|FG004|Overall Study|Lost to Follow-up|0|||
124882445|NCT00569803|449193287|FG005|Overall Study|Lost to Follow-up|0|||
124882446|NCT00569803|449193288|FG006|Overall Study|Lost to Follow-up|0|||
124882447|NCT00569803|449193289|FG007|Overall Study|Lost to Follow-up|0|||
124882448|NCT00569803|449193282|FG000|Overall Study|injection syringe leaked during dosing|0|||
124882449|NCT00569803|449193283|FG001|Overall Study|injection syringe leaked during dosing|0|||
124882450|NCT00569803|449193284|FG002|Overall Study|injection syringe leaked during dosing|0|||
124882451|NCT00569803|449193285|FG003|Overall Study|injection syringe leaked during dosing|1|||
124882452|NCT00569803|449193286|FG004|Overall Study|injection syringe leaked during dosing|0|||
124882453|NCT00569803|449193287|FG005|Overall Study|injection syringe leaked during dosing|0|||
124882454|NCT00569803|449193288|FG006|Overall Study|injection syringe leaked during dosing|0|||
124882455|NCT00569803|449193289|FG007|Overall Study|injection syringe leaked during dosing|0|||
124882456|NCT00569803|449193282|FG000|Overall Study|Withdrawal by Subject|0|||
124882457|NCT00569803|449193283|FG001|Overall Study|Withdrawal by Subject|0|||
124882458|NCT00569803|449193284|FG002|Overall Study|Withdrawal by Subject|0|||
124882459|NCT00569803|449193285|FG003|Overall Study|Withdrawal by Subject|0|||
124882460|NCT00569803|449193286|FG004|Overall Study|Withdrawal by Subject|0|||
124882461|NCT00569803|449193287|FG005|Overall Study|Withdrawal by Subject|0|||
124882462|NCT00569803|449193288|FG006|Overall Study|Withdrawal by Subject|0|||
124882463|NCT00569803|449193289|FG007|Overall Study|Withdrawal by Subject|1|||
124882464|NCT01235975|449193290|FG000|Overall Study|Serious Adverse Event|0|||
124882465|NCT01235975|449193291|FG001|Overall Study|Serious Adverse Event|1|||
124882466|NCT01235975|449193290|FG000|Overall Study|Withdrawal by Subject|8|||
124882467|NCT01235975|449193291|FG001|Overall Study|Withdrawal by Subject|2|||
124882468|NCT01235975|449193290|FG000|Overall Study|Migrated/moved from study area|2|||
124882469|NCT01235975|449193291|FG001|Overall Study|Migrated/moved from study area|1|||
124882470|NCT01235975|449193290|FG000|Overall Study|Lost to Follow-up|7|||
124882471|NCT01235975|449193291|FG001|Overall Study|Lost to Follow-up|3|||
124882472|NCT00791921|449193294|FG000|Overall Study|Protocol planed|24|||
124882473|NCT00791921|449193295|FG001|Overall Study|Protocol planed|88|||
124882474|NCT00791921|449193294|FG000|Overall Study|Withdrawal by Subject|1|||
124882475|NCT00791921|449193295|FG001|Overall Study|Withdrawal by Subject|2|||
124882476|NCT00791921|449193294|FG000|Overall Study|Adverse Event|8|||
124882477|NCT00791921|449193295|FG001|Overall Study|Adverse Event|2|||
124882478|NCT00791921|449193294|FG000|Overall Study|Lack of Efficacy|0|||
124882479|NCT00791921|449193295|FG001|Overall Study|Lack of Efficacy|2|||
124882480|NCT00791921|449193294|FG000|Overall Study|Lack of study drug administration|1|||
124882481|NCT00791921|449193295|FG001|Overall Study|Lack of study drug administration|1|||
124882482|NCT00791921|449193294|FG000|Overall Study|Reason other than those above|0|||
124882483|NCT00791921|449193295|FG001|Overall Study|Reason other than those above|1|||
124882484|NCT01965158|449193297|FG000|Overall Study|Adverse Event|14|||
124882485|NCT01965158|449193298|FG001|Overall Study|Adverse Event|5|||
124882486|NCT01965158|449193297|FG000|Overall Study|Withdrawal by Subject|16|||
124882487|NCT01965158|449193298|FG001|Overall Study|Withdrawal by Subject|24|||
124882488|NCT01965158|449193297|FG000|Overall Study|Lost to Follow-up|7|||
124882489|NCT01965158|449193298|FG001|Overall Study|Lost to Follow-up|5|||
124882490|NCT01965158|449193297|FG000|Overall Study|Protocol Violation|1|||
124882491|NCT01965158|449193298|FG001|Overall Study|Protocol Violation|1|||
124882492|NCT01965158|449193297|FG000|Overall Study|Other - Miscellaneous|3|||
124882493|NCT01965158|449193298|FG001|Overall Study|Other - Miscellaneous|0|||
124882494|NCT00474175|449193299|FG000|Overall Study|Lack of Efficacy|0|||
124882495|NCT00474175|449193300|FG001|Overall Study|Lack of Efficacy|0|||
124882496|NCT00474175|449193301|FG002|Overall Study|Lack of Efficacy|1|||
124882497|NCT00474175|449193299|FG000|Overall Study|Withdrawal by Subject|0|||
124882498|NCT00474175|449193300|FG001|Overall Study|Withdrawal by Subject|1|||
124882499|NCT00474175|449193301|FG002|Overall Study|Withdrawal by Subject|1|||
124882500|NCT00474175|449193299|FG000|Overall Study|Ineligible|1|||
124882501|NCT00474175|449193300|FG001|Overall Study|Ineligible|3|||
124882502|NCT00474175|449193301|FG002|Overall Study|Ineligible|1|||
124882503|NCT00474175|449193299|FG000|Overall Study|Protocol Violation|0|||
124882504|NCT00474175|449193300|FG001|Overall Study|Protocol Violation|2|||
124882505|NCT00474175|449193301|FG002|Overall Study|Protocol Violation|1|||
124882506|NCT00474175|449193299|FG000|Overall Study|Administrative|0|||
124882507|NCT00474175|449193300|FG001|Overall Study|Administrative|1|||
124882508|NCT00474175|449193301|FG002|Overall Study|Administrative|0|||
124882509|NCT01619787|449193304|FG000|Overall Study|Lost to Follow-up|5|||
124882510|NCT01130883|449193305|FG000|Overall Study|Patient Noncompliance|6|||
124882511|NCT01130883|449193305|FG000|Overall Study|Reason Unknown|1|||
124882512|NCT01130883|449193305|FG000|Overall Study|Adverse Event|3|||
124882513|NCT02091739|449193313|FG000|MP: 16 Weeks|Adverse Event|1|||
124882514|NCT02091739|449193314|FG001|MP: 16 Weeks|Adverse Event|1|||
124882515|NCT02091739|449193315|FG002|MP: 16 Weeks|Adverse Event|1|||
124882516|NCT02091739|449193316|FG003|MP: 16 Weeks|Adverse Event|0|||
124882517|NCT02091739|449193317|FG004|MP: 16 Weeks|Adverse Event|0|||
124882518|NCT02091739|449193313|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
124882519|NCT02091739|449193314|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
124882520|NCT02091739|449193315|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
124882521|NCT02091739|449193316|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
124882522|NCT02091739|449193317|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
124882523|NCT02091739|449193313|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
124882524|NCT02091739|449193314|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
124882525|NCT02091739|449193315|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
124882526|NCT02091739|449193316|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
124882527|NCT02091739|449193317|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
124882528|NCT02091739|449193313|FG000|EP: 48 Weeks|Other|0|||
124882529|NCT02091739|449193314|FG001|EP: 48 Weeks|Other|0|||
124882530|NCT02091739|449193315|FG002|EP: 48 Weeks|Other|0|||
124882531|NCT02091739|449193316|FG003|EP: 48 Weeks|Other|1|||
124882532|NCT02091739|449193317|FG004|EP: 48 Weeks|Other|0|||
124882533|NCT02091739|449193313|FG000|EP: 48 Weeks|Death|0|||
124882534|NCT02091739|449193314|FG001|EP: 48 Weeks|Death|0|||
124882535|NCT02091739|449193315|FG002|EP: 48 Weeks|Death|0|||
124882536|NCT02091739|449193316|FG003|EP: 48 Weeks|Death|3|||
124882537|NCT02091739|449193317|FG004|EP: 48 Weeks|Death|2|||
124882538|NCT02091739|449193313|FG000|EP: 48 Weeks|Adverse Event|0|||
124882539|NCT02091739|449193314|FG001|EP: 48 Weeks|Adverse Event|0|||
124882540|NCT02091739|449193315|FG002|EP: 48 Weeks|Adverse Event|0|||
124882541|NCT02091739|449193316|FG003|EP: 48 Weeks|Adverse Event|2|||
124882542|NCT02091739|449193317|FG004|EP: 48 Weeks|Adverse Event|6|||
124882543|NCT02091739|449193313|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
124882544|NCT02091739|449193314|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
124882545|NCT02091739|449193315|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
124882546|NCT02091739|449193316|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
124882547|NCT02091739|449193317|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
124882548|NCT00192023|449193320|FG000|Period III - Double-Blind|Adverse Event|3|||
124882549|NCT00192023|449193321|FG001|Period III - Double-Blind|Adverse Event|0|||
124882550|NCT00192023|449193320|FG000|Period III - Double-Blind|Physician Decision|2|||
124882551|NCT00192023|449193321|FG001|Period III - Double-Blind|Physician Decision|0|||
124882552|NCT00192023|449193320|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
124882553|NCT00192023|449193321|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
124882554|NCT00192023|449193320|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
124882555|NCT00192023|449193321|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
124882556|NCT00192023|449193320|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
124882557|NCT00192023|449193321|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
124882558|NCT00192023|449193320|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
124882559|NCT00192023|449193321|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
124882560|NCT00192023|449193320|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
124882561|NCT00192023|449193321|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
124882562|NCT00192023|449193320|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
124882563|NCT00192023|449193321|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
124882564|NCT00192023|449193320|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
124882565|NCT00192023|449193321|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
124882566|NCT00192023|449193320|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
124882567|NCT00192023|449193321|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
124882568|NCT02912468|449193323|FG000|Overall Study|Adverse Event|3|||
124882569|NCT02912468|449193324|FG001|Overall Study|Adverse Event|2|||
124882570|NCT02912468|449193323|FG000|Overall Study|Withdrawal by Subject|6|||
124882571|NCT02912468|449193324|FG001|Overall Study|Withdrawal by Subject|2|||
124882572|NCT02912468|449193323|FG000|Overall Study|Randomized and not treated|0|||
124882573|NCT02912468|449193324|FG001|Overall Study|Randomized and not treated|1|||
124882574|NCT01320735|449193325|FG000|Overall Study|Adverse Event|3|||
124882575|NCT01320735|449193325|FG000|Overall Study|Withdrawal by Subject|3|||
124711998|NCT01343888|448570707|FG000|Overall Study|Adverse Event|12|||
124882576|NCT01320735|449193325|FG000|Overall Study|Lost to Follow-up|13|||
124882577|NCT01320735|449193325|FG000|Overall Study|Administrative Reason|6|||
124882578|NCT01320735|449193325|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
124882579|NCT01320735|449193325|FG000|Overall Study|Protocol Violation|1|||
124882580|NCT01320735|449193325|FG000|Overall Study|Other|1|||
124439220|NCT00953407|447569082|FG000|Overall Study|Lost to Follow-up|0|||
124439221|NCT00953407|447569083|FG001|Overall Study|Lost to Follow-up|0|||
124439222|NCT00953407|447569084|FG002|Overall Study|Lost to Follow-up|0|||
124439223|NCT00953407|447569085|FG003|Overall Study|Lost to Follow-up|1|||
124439224|NCT00953407|447569086|FG004|Overall Study|Lost to Follow-up|0|||
124439225|NCT03435497|447569088|FG000|Overall Study|Lost to Follow-up|1|||
124683025|NCT03329001|448461857|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
124683026|NCT03329001|448461850|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
124683027|NCT03329001|448461851|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
124683028|NCT03329001|448461852|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
124683029|NCT03329001|448461853|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
124683030|NCT03329001|448461854|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
124683031|NCT03329001|448461855|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
124683032|NCT03329001|448461856|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
124683033|NCT03329001|448461857|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
124683034|NCT03329001|448461850|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
124683035|NCT03329001|448461851|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
124683036|NCT03329001|448461852|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
124683037|NCT03329001|448461853|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
124683038|NCT03329001|448461854|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
124683039|NCT03329001|448461855|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
124683040|NCT03329001|448461856|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
124683041|NCT03329001|448461857|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
124683042|NCT03329001|448461850|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
124683043|NCT03329001|448461851|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
124683044|NCT03329001|448461852|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
124683045|NCT03329001|448461853|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
124683046|NCT03329001|448461854|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
124683047|NCT03329001|448461855|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
124683048|NCT03329001|448461856|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
124683049|NCT03329001|448461857|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
124683050|NCT03329001|448461850|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
124683051|NCT03329001|448461851|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
124683052|NCT03329001|448461852|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
124683053|NCT03329001|448461853|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
124683054|NCT03329001|448461854|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
124683055|NCT03329001|448461855|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
124683056|NCT03329001|448461856|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
124683057|NCT03329001|448461857|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
124683058|NCT02178956|448461858|FG000|Overall Study|Lost to Follow-up|4|||
124683059|NCT02178956|448461859|FG001|Overall Study|Lost to Follow-up|4|||
124683060|NCT02178956|448461858|FG000|Overall Study|Sponsor terminated study|49|||
124683061|NCT02178956|448461859|FG001|Overall Study|Sponsor terminated study|58|||
124683062|NCT02178956|448461858|FG000|Overall Study|Withdrawal by Subject|15|||
124683063|NCT02178956|448461859|FG001|Overall Study|Withdrawal by Subject|11|||
124683064|NCT02178956|448461858|FG000|Overall Study|Various Reasons|3|||
124683065|NCT02178956|448461859|FG001|Overall Study|Various Reasons|5|||
124683066|NCT01138046|448461860|FG000|Overall Study|Withdrawal due to death|6|||
124683067|NCT02709369|448461862|FG000|Overall Study|Lost to Follow-up|15|||
124683068|NCT02709369|448461862|FG000|Overall Study|Withdrawal by Subject|10|||
124683069|NCT02709369|448461862|FG000|Overall Study|Did not received intervention|2|||
124683070|NCT01900314|448461863|FG000|Overall Study|Lost to Follow-up|1|||
124683071|NCT01900314|448461864|FG001|Overall Study|Lost to Follow-up|0|||
124683072|NCT01900314|448461863|FG000|Overall Study|Protocol Violation|0|||
124683073|NCT01900314|448461864|FG001|Overall Study|Protocol Violation|1|||
124683074|NCT01900314|448461863|FG000|Overall Study|Withdrawal by Subject|3|||
124683075|NCT01900314|448461864|FG001|Overall Study|Withdrawal by Subject|3|||
124683076|NCT01104766|448461866|FG000|Overall Study|Did not meet inc/exc criteria|1|||
124683077|NCT01104766|448461867|FG001|Overall Study|Did not meet inc/exc criteria|0|||
124683078|NCT01104766|448461868|FG002|Overall Study|Did not meet inc/exc criteria|0|||
124683079|NCT01104766|448461869|FG003|Overall Study|Did not meet inc/exc criteria|0|||
124683080|NCT01104766|448461866|FG000|Overall Study|Adverse Event|17|||
124683081|NCT01104766|448461867|FG001|Overall Study|Adverse Event|15|||
124683082|NCT01104766|448461868|FG002|Overall Study|Adverse Event|20|||
124439226|NCT03435497|447569089|FG001|Overall Study|Lost to Follow-up|0|||
124439227|NCT03435497|447569088|FG000|Overall Study|Death|1|||
124439228|NCT03435497|447569089|FG001|Overall Study|Death|0|||
124439229|NCT03435497|447569088|FG000|Overall Study|Withdrawal by Subject|0|||
124683083|NCT01104766|448461869|FG003|Overall Study|Adverse Event|14|||
124683084|NCT01104766|448461866|FG000|Overall Study|Lack of Efficacy|20|||
124683085|NCT01104766|448461867|FG001|Overall Study|Lack of Efficacy|15|||
124882581|NCT01320735|449193325|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
124882582|NCT01320735|449193325|FG000|Overall Study|Investigator Unable to be Contacted|17|||
124882583|NCT01290822|449193326|FG000|Overall Study|Withdrawal by Subject|1|||
124882584|NCT01290822|449193326|FG000|Overall Study|Physician Decision|10|||
124882585|NCT00089895|449193329|FG000|Overall Study|Consent Withdrawn|11|||
124882586|NCT00089895|449193330|FG001|Overall Study|Consent Withdrawn|14|||
124882587|NCT00089895|449193329|FG000|Overall Study|Technical reason|7|||
124882588|NCT00089895|449193330|FG001|Overall Study|Technical reason|2|||
124882589|NCT00089895|449193329|FG000|Overall Study|Surgery|0|||
124882590|NCT00089895|449193330|FG001|Overall Study|Surgery|1|||
124882591|NCT00089895|449193329|FG000|Overall Study|Bleeding|0|||
124882592|NCT00089895|449193330|FG001|Overall Study|Bleeding|2|||
124882593|NCT00089895|449193329|FG000|Overall Study|Physician Decision|3|||
124882594|NCT00089895|449193330|FG001|Overall Study|Physician Decision|7|||
124882595|NCT00089895|449193329|FG000|Overall Study|Exclusion criteria met|6|||
124882596|NCT00089895|449193330|FG001|Overall Study|Exclusion criteria met|6|||
124882597|NCT00089895|449193329|FG000|Overall Study|Not otherwise specified|4|||
124882598|NCT00089895|449193330|FG001|Overall Study|Not otherwise specified|8|||
124882599|NCT00089895|449193329|FG000|Overall Study|Missing|4|||
124882600|NCT00089895|449193330|FG001|Overall Study|Missing|2|||
124882601|NCT02301156|449193331|FG000|Overall Study|Adverse Event|13|||
124882602|NCT02301156|449193332|FG001|Overall Study|Adverse Event|14|||
124882603|NCT02301156|449193331|FG000|Overall Study|Death|1|||
124882604|NCT02301156|449193332|FG001|Overall Study|Death|5|||
124882605|NCT02301156|449193331|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
124882606|NCT02301156|449193332|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
124882607|NCT02301156|449193331|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
124882608|NCT02301156|449193332|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
124882609|NCT02301156|449193331|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
124882610|NCT02301156|449193332|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
124882611|NCT02301156|449193331|FG000|Overall Study|Reason not Specified|6|||
124882612|NCT02301156|449193332|FG001|Overall Study|Reason not Specified|3|||
124882613|NCT03734991|449193336|FG000|Overall Study|Adverse Event|4|||
124882614|NCT03734991|449193337|FG001|Overall Study|Adverse Event|0|||
124882615|NCT03734991|449193336|FG000|Overall Study|Lost to Follow-up|4|||
124882616|NCT03734991|449193337|FG001|Overall Study|Lost to Follow-up|0|||
124882617|NCT03734991|449193336|FG000|Overall Study|Physician Decision|0|||
124882618|NCT03734991|449193337|FG001|Overall Study|Physician Decision|1|||
124882619|NCT03734991|449193336|FG000|Overall Study|Pregnancy|1|||
124882620|NCT03734991|449193337|FG001|Overall Study|Pregnancy|0|||
124882621|NCT03734991|449193336|FG000|Overall Study|Withdrawal by Subject|6|||
124882622|NCT03734991|449193337|FG001|Overall Study|Withdrawal by Subject|3|||
124882623|NCT03734991|449193336|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
124882624|NCT03734991|449193337|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
124882625|NCT03734991|449193336|FG000|Overall Study|Other|2|||
124882626|NCT03734991|449193337|FG001|Overall Study|Other|2|||
124882627|NCT02638623|449193338|FG000|Overall Study|Surgery timing|5|||
124882628|NCT02638623|449193339|FG001|Overall Study|Surgery timing|6|||
124882629|NCT02638623|449193338|FG000|Overall Study|Not given intervention|2|||
124882630|NCT02638623|449193339|FG001|Overall Study|Not given intervention|0|||
124882631|NCT01103960|449193348|FG000|Overall Study|Adverse Event|2|||
124882632|NCT01103960|449193349|FG001|Overall Study|Adverse Event|1|||
124882633|NCT01103960|449193348|FG000|Overall Study|Withdrawal by Subject|2|||
124882634|NCT01103960|449193349|FG001|Overall Study|Withdrawal by Subject|1|||
124882635|NCT01103960|449193348|FG000|Overall Study|Other|1|||
124882636|NCT01103960|449193349|FG001|Overall Study|Other|0|||
124882637|NCT00147225|449193350|FG000|Overall Study|Withdrawal by Subject|1|||
124882638|NCT00147225|449193351|FG001|Overall Study|Withdrawal by Subject|0|||
124882639|NCT00147225|449193352|FG002|Overall Study|Withdrawal by Subject|1|||
124882640|NCT00147225|449193353|FG003|Overall Study|Withdrawal by Subject|0|||
124439230|NCT03435497|447569089|FG001|Overall Study|Withdrawal by Subject|4|||
124439231|NCT03435497|447569088|FG000|Overall Study|Wrong survey administered|0|||
124439232|NCT03435497|447569089|FG001|Overall Study|Wrong survey administered|2|||
124439233|NCT04281004|447569092|FG000|Overall Study|Physician Decision|1|||
124882641|NCT00147225|449193354|FG004|Overall Study|Withdrawal by Subject|0|||
124882642|NCT00147225|449193355|FG005|Overall Study|Withdrawal by Subject|1|||
124882643|NCT00147225|449193350|FG000|Overall Study|Adverse Event|0|||
124882644|NCT00147225|449193351|FG001|Overall Study|Adverse Event|0|||
124882645|NCT00147225|449193352|FG002|Overall Study|Adverse Event|1|||
124439234|NCT04281004|447569093|FG001|Overall Study|Physician Decision|0|||
124882646|NCT00147225|449193353|FG003|Overall Study|Adverse Event|1|||
124882647|NCT00147225|449193354|FG004|Overall Study|Adverse Event|0|||
124439235|NCT00701779|447569094|FG000|Overall Study|Adverse Event|6|||
124882648|NCT00147225|449193355|FG005|Overall Study|Adverse Event|0|||
124882649|NCT00147225|449193350|FG000|Overall Study|Screen Failure|0|||
124882650|NCT00147225|449193351|FG001|Overall Study|Screen Failure|0|||
124882651|NCT00147225|449193352|FG002|Overall Study|Screen Failure|0|||
124882652|NCT00147225|449193353|FG003|Overall Study|Screen Failure|0|||
124882653|NCT00147225|449193354|FG004|Overall Study|Screen Failure|1|||
124882654|NCT00147225|449193355|FG005|Overall Study|Screen Failure|0|||
124882655|NCT00147225|449193350|FG000|Overall Study|Chemotherapy Changed|0|||
124882656|NCT00147225|449193351|FG001|Overall Study|Chemotherapy Changed|0|||
124882657|NCT00147225|449193352|FG002|Overall Study|Chemotherapy Changed|0|||
124882658|NCT00147225|449193353|FG003|Overall Study|Chemotherapy Changed|0|||
124882659|NCT00147225|449193354|FG004|Overall Study|Chemotherapy Changed|0|||
124882660|NCT00147225|449193355|FG005|Overall Study|Chemotherapy Changed|1|||
124882661|NCT01032044|449193358|FG000|Overall Study|Protocol Violation|14|||
124882662|NCT01032044|449193359|FG001|Overall Study|Protocol Violation|8|||
124882663|NCT01032044|449193358|FG000|Overall Study|Adverse Event|0|||
124882664|NCT01032044|449193359|FG001|Overall Study|Adverse Event|1|||
124882665|NCT01032044|449193358|FG000|Overall Study|Lost to Follow-up|11|||
124882666|NCT01032044|449193359|FG001|Overall Study|Lost to Follow-up|11|||
124882667|NCT02875834|449193360|FG000|Open-label Phase|Withdrawal by Subject|3|||
124882668|NCT02875834|449193361|FG001|Open-label Phase|Withdrawal by Subject|0|||
124882669|NCT02875834|449193362|FG002|Open-label Phase|Withdrawal by Subject|0|||
124882670|NCT02875834|449193363|FG003|Open-label Phase|Withdrawal by Subject|0|||
124882671|NCT02875834|449193360|FG000|Open-label Phase|(Not collected)|4|||
124882672|NCT02875834|449193361|FG001|Open-label Phase|(Not collected)|0|||
124882673|NCT02875834|449193362|FG002|Open-label Phase|(Not collected)|0|||
124882674|NCT02875834|449193363|FG003|Open-label Phase|(Not collected)|0|||
124882675|NCT02875834|449193360|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
124882676|NCT02875834|449193361|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
124882677|NCT02875834|449193362|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
124882678|NCT02875834|449193363|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
124882679|NCT02875834|449193360|FG000|Randomized Treatment Phase|Protocol Violation|0|||
124882680|NCT02875834|449193361|FG001|Randomized Treatment Phase|Protocol Violation|2|||
124439236|NCT00701779|447569094|FG000|Overall Study|Lost to Follow-up|1|||
124439237|NCT00701779|447569094|FG000|Overall Study|Withdrawal by Subject|2|||
124439238|NCT03628898|447569095|FG000|Overall Study|Device deficiency|1|||
124439239|NCT01217957|447569096|FG000|Phase 1|Withdrawal by Patient|1|||
124439240|NCT01217957|447569097|FG001|Phase 1|Withdrawal by Patient|0|||
124439241|NCT01217957|447569098|FG002|Phase 1|Withdrawal by Patient|1|||
124439242|NCT01217957|447569099|FG003|Phase 1|Withdrawal by Patient|1|||
124439243|NCT01217957|447569100|FG004|Phase 1|Withdrawal by Patient|0|||
124439244|NCT01217957|447569096|FG000|Phase 2|Withdrawal by Patient|0|||
124439245|NCT01217957|447569097|FG001|Phase 2|Withdrawal by Patient|0|||
124439246|NCT01217957|447569098|FG002|Phase 2|Withdrawal by Patient|0|||
124439247|NCT01217957|447569099|FG003|Phase 2|Withdrawal by Patient|0|||
124439248|NCT01217957|447569100|FG004|Phase 2|Withdrawal by Patient|1|||
124439249|NCT01873495|447569103|FG000|Overall Study|Withdrawal by Subject|1|||
124439250|NCT01873495|447569103|FG000|Overall Study|Physician Decision|3|||
124439251|NCT01873495|447569103|FG000|Overall Study|Adverse Event|1|||
124439252|NCT01873495|447569103|FG000|Overall Study|Removed for Transplantation|1|||
124439253|NCT01873495|447569103|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
124439254|NCT01206777|447569104|FG000|Overall Study|Death|1|||
124439255|NCT01206777|447569104|FG000|Overall Study|Adverse Event|1|||
124439256|NCT02986334|447569105|FG000|Overall Study|Withdrawal by Subject|0|||
124439257|NCT02986334|447569106|FG001|Overall Study|Withdrawal by Subject|1|||
124439258|NCT02986334|447569107|FG002|Overall Study|Withdrawal by Subject|2|||
124439259|NCT02986334|447569105|FG000|Overall Study|Lost to Follow-up|1|||
124439260|NCT02986334|447569106|FG001|Overall Study|Lost to Follow-up|2|||
124439261|NCT02986334|447569107|FG002|Overall Study|Lost to Follow-up|1|||
124439262|NCT02986334|447569105|FG000|Overall Study|Adverse Event|0|||
124439263|NCT02986334|447569106|FG001|Overall Study|Adverse Event|2|||
124439264|NCT02986334|447569107|FG002|Overall Study|Adverse Event|1|||
124882681|NCT02875834|449193362|FG002|Randomized Treatment Phase|Protocol Violation|0|||
124882682|NCT02875834|449193363|FG003|Randomized Treatment Phase|Protocol Violation|0|||
124439265|NCT02986334|447569105|FG000|Overall Study|non compliance in phone ratings|2|||
124439266|NCT02986334|447569106|FG001|Overall Study|non compliance in phone ratings|1|||
124439267|NCT02986334|447569107|FG002|Overall Study|non compliance in phone ratings|2|||
124439268|NCT02986334|447569105|FG000|Overall Study|undisclosed comorbidities|0|||
124439269|NCT02986334|447569106|FG001|Overall Study|undisclosed comorbidities|1|||
124439270|NCT02986334|447569107|FG002|Overall Study|undisclosed comorbidities|1|||
124882683|NCT02875834|449193360|FG000|Randomized Treatment Phase|(Not collected)|0|||
124882684|NCT02875834|449193361|FG001|Randomized Treatment Phase|(Not collected)|9|||
124439271|NCT00846391|447569111|FG000|Overall Study|Physician Decision|0|||
124439272|NCT00846391|447569112|FG001|Overall Study|Physician Decision|0|||
124439273|NCT00846391|447569113|FG002|Overall Study|Physician Decision|1|||
124439274|NCT00846391|447569111|FG000|Overall Study|Study Terminated by Sponsor|1|||
124439275|NCT00846391|447569112|FG001|Overall Study|Study Terminated by Sponsor|2|||
124882685|NCT02875834|449193362|FG002|Randomized Treatment Phase|(Not collected)|10|||
124439276|NCT00846391|447569113|FG002|Overall Study|Study Terminated by Sponsor|2|||
124439277|NCT01249274|447569115|FG000|Overall Study|Lost to Follow-up|3|||
124439278|NCT01249274|447569116|FG001|Overall Study|Lost to Follow-up|4|||
124882686|NCT02875834|449193363|FG003|Randomized Treatment Phase|(Not collected)|9|||
124882687|NCT03311230|449193364|FG000|Overall Study|Withdrawal by Subject|1|||
124882688|NCT03311230|449193365|FG001|Overall Study|Withdrawal by Subject|4|||
124882689|NCT03311230|449193366|FG002|Overall Study|Withdrawal by Subject|2|||
124882690|NCT03311230|449193367|FG003|Overall Study|Withdrawal by Subject|7|||
124882691|NCT03311230|449193364|FG000|Overall Study|Unrelated injury|0|||
124882692|NCT03311230|449193365|FG001|Overall Study|Unrelated injury|1|||
124882693|NCT03311230|449193366|FG002|Overall Study|Unrelated injury|0|||
124882694|NCT03311230|449193367|FG003|Overall Study|Unrelated injury|0|||
124882695|NCT02998021|449193368|FG000|Overall Study|Withdrawal by Subject|3|||
124882696|NCT02998021|449193369|FG001|Overall Study|Withdrawal by Subject|1|||
124882697|NCT02998021|449193368|FG000|Overall Study|unsafe home|0|||
124882698|NCT02998021|449193369|FG001|Overall Study|unsafe home|1|||
124882699|NCT01302938|449193370|FG000|Overall Study|Withdrawal by Subject|1|||
124882700|NCT01302938|449193371|FG001|Overall Study|Withdrawal by Subject|0|||
124882701|NCT01302938|449193370|FG000|Overall Study|Adverse Event|1|||
124882702|NCT01302938|449193371|FG001|Overall Study|Adverse Event|0|||
124882703|NCT03342053|449193372|FG000|Overall Study|Adverse Event|2|||
124882704|NCT03342053|449193373|FG001|Overall Study|Adverse Event|0|||
124882705|NCT03342053|449193372|FG000|Overall Study|Withdrawal by Subject|0|||
124882706|NCT03342053|449193373|FG001|Overall Study|Withdrawal by Subject|1|||
124882707|NCT01233609|449193374|FG000|Overall Study|Death|1|||
124882708|NCT01233609|449193375|FG001|Overall Study|Death|0|||
124882709|NCT01233609|449193374|FG000|Overall Study|Lost to Follow-up|3|||
124882710|NCT01233609|449193375|FG001|Overall Study|Lost to Follow-up|1|||
124882711|NCT01233609|449193374|FG000|Overall Study|Adverse Event|2|||
124882712|NCT01233609|449193375|FG001|Overall Study|Adverse Event|1|||
124882713|NCT01233609|449193374|FG000|Overall Study|Withdrawal by Subject|3|||
124882714|NCT01233609|449193375|FG001|Overall Study|Withdrawal by Subject|0|||
124882715|NCT01167179|449195002|FG000|Overall Study|disease recurrence|4|||
124882716|NCT01167179|449195003|FG001|Overall Study|disease recurrence|4|||
124882717|NCT01167179|449195002|FG000|Overall Study|Death|4|||
124882718|NCT01167179|449195003|FG001|Overall Study|Death|10|||
124882719|NCT01167179|449195002|FG000|Overall Study|Withdrawal by Subject|1|||
124882720|NCT01167179|449195003|FG001|Overall Study|Withdrawal by Subject|2|||
124882721|NCT01167179|449195002|FG000|Overall Study|diverse|6|||
124882722|NCT01167179|449195003|FG001|Overall Study|diverse|5|||
124882723|NCT03017235|449195004|FG000|Overall Study|Withdrawal by Subject|4|||
124882724|NCT03017235|449195005|FG001|Overall Study|Withdrawal by Subject|3|||
124882725|NCT03017235|449195004|FG000|Overall Study|Lost to Follow-up|2|||
124882726|NCT03017235|449195005|FG001|Overall Study|Lost to Follow-up|7|||
124882727|NCT03017235|449195004|FG000|Overall Study|Adverse Event|0|||
124882728|NCT03017235|449195005|FG001|Overall Study|Adverse Event|1|||
124882729|NCT03017235|449195004|FG000|Overall Study|Protocol Violation|2|||
124882730|NCT03017235|449195005|FG001|Overall Study|Protocol Violation|1|||
124882731|NCT03017235|449195004|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
124882732|NCT03017235|449195005|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
124882733|NCT02248961|449195009|FG000|Overall Study|Adverse Event|1|||
124882734|NCT02248961|449195010|FG001|Overall Study|Adverse Event|0|||
124882735|NCT02248961|449195009|FG000|Overall Study|Withdrawal by Subject|1|||
124882736|NCT02248961|449195010|FG001|Overall Study|Withdrawal by Subject|2|||
124882737|NCT02248961|449195009|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
124882738|NCT02248961|449195010|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
124882739|NCT00453310|449195013|FG000|Overall Study|Progression of Disease|10|||
124882740|NCT03321513|449195016|FG000|Overall Study|Death|11|||
124882741|NCT03321513|449195017|FG001|Overall Study|Death|5|||
124882742|NCT03321513|449195016|FG000|Overall Study|Withdrawal by Subject|5|||
124882743|NCT03321513|449195017|FG001|Overall Study|Withdrawal by Subject|10|||
124882744|NCT03321513|449195016|FG000|Overall Study|Lost to Follow-up|10|||
124882745|NCT03321513|449195017|FG001|Overall Study|Lost to Follow-up|11|||
124882746|NCT01976364|449195018|FG000|Main Study (36 Months)|Adverse Event|63|||
124882747|NCT01976364|449195019|FG001|Main Study (36 Months)|Adverse Event|0|||
124882748|NCT01976364|449195020|FG002|Main Study (36 Months)|Adverse Event|0|||
124882749|NCT01976364|449195018|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
124882750|NCT01976364|449195019|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
124882751|NCT01976364|449195020|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
124882752|NCT01976364|449195018|FG000|Main Study (36 Months)|Other|13|||
124882753|NCT01976364|449195019|FG001|Main Study (36 Months)|Other|0|||
124882754|NCT01976364|449195020|FG002|Main Study (36 Months)|Other|0|||
124882755|NCT01976364|449195018|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
124882756|NCT01976364|449195019|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
124882757|NCT01976364|449195020|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
124882758|NCT01976364|449195018|FG000|Main Study (36 Months)|Medication error|1|||
124882759|NCT01976364|449195019|FG001|Main Study (36 Months)|Medication error|0|||
124882760|NCT01976364|449195020|FG002|Main Study (36 Months)|Medication error|0|||
124882761|NCT01976364|449195018|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
124882762|NCT01976364|449195019|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
124882763|NCT01976364|449195020|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
124882764|NCT01976364|449195018|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
124882765|NCT01976364|449195019|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
124882766|NCT01976364|449195020|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
124882767|NCT01976364|449195018|FG000|Main Study (36 Months)|Protocol Violation|13|||
124882768|NCT01976364|449195019|FG001|Main Study (36 Months)|Protocol Violation|0|||
124882769|NCT01976364|449195020|FG002|Main Study (36 Months)|Protocol Violation|0|||
124882770|NCT01976364|449195018|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
124882771|NCT01976364|449195019|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
124882772|NCT01976364|449195020|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
124882773|NCT01976364|449195018|FG000|Main Study (36 Months)|Death|5|||
124882774|NCT01976364|449195019|FG001|Main Study (36 Months)|Death|0|||
124882775|NCT01976364|449195020|FG002|Main Study (36 Months)|Death|0|||
124882776|NCT01976364|449195018|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
124882777|NCT01976364|449195019|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
124882778|NCT01976364|449195020|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
124882779|NCT01976364|449195018|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
124882780|NCT01976364|449195019|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
124882781|NCT01976364|449195020|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
124882782|NCT01976364|449195018|FG000|Sub-study (12 Months)|Protocol Violation|0|||
124882783|NCT01976364|449195019|FG001|Sub-study (12 Months)|Protocol Violation|1|||
124882784|NCT01976364|449195020|FG002|Sub-study (12 Months)|Protocol Violation|1|||
124882785|NCT01976364|449195018|FG000|Sub-study (12 Months)|Adverse Event|0|||
124882786|NCT01976364|449195019|FG001|Sub-study (12 Months)|Adverse Event|4|||
124882787|NCT01976364|449195020|FG002|Sub-study (12 Months)|Adverse Event|3|||
124882788|NCT02757521|449195021|FG000|Overall Study|Adverse Event|1|||
124882789|NCT02757521|449195022|FG001|Overall Study|Adverse Event|0|||
124882790|NCT00768430|449195023|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
124882791|NCT00768430|449195024|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
124882792|NCT02318719|449195025|FG000|Double-blind Phase|Adverse Event|7|||
124882793|NCT02318719|449195026|FG001|Double-blind Phase|Adverse Event|6|||
124882794|NCT02318719|449195027|FG002|Double-blind Phase|Adverse Event|12|||
124882795|NCT02318719|449195028|FG003|Double-blind Phase|Adverse Event|4|||
124882796|NCT02318719|449195029|FG004|Double-blind Phase|Adverse Event|0|||
124882797|NCT02318719|449195025|FG000|Double-blind Phase|Lack of Efficacy|5|||
124882798|NCT02318719|449195026|FG001|Double-blind Phase|Lack of Efficacy|0|||
124882799|NCT02318719|449195027|FG002|Double-blind Phase|Lack of Efficacy|1|||
124882800|NCT02318719|449195028|FG003|Double-blind Phase|Lack of Efficacy|1|||
124882801|NCT02318719|449195029|FG004|Double-blind Phase|Lack of Efficacy|0|||
124882802|NCT02318719|449195025|FG000|Double-blind Phase|Protocol Violation|0|||
124882803|NCT02318719|449195026|FG001|Double-blind Phase|Protocol Violation|1|||
124882804|NCT02318719|449195027|FG002|Double-blind Phase|Protocol Violation|3|||
124882805|NCT02318719|449195028|FG003|Double-blind Phase|Protocol Violation|0|||
124882806|NCT02318719|449195029|FG004|Double-blind Phase|Protocol Violation|0|||
124882807|NCT02318719|449195025|FG000|Double-blind Phase|Withdrawal by Subject|25|||
124882808|NCT02318719|449195026|FG001|Double-blind Phase|Withdrawal by Subject|7|||
124882809|NCT02318719|449195027|FG002|Double-blind Phase|Withdrawal by Subject|9|||
124882810|NCT02318719|449195028|FG003|Double-blind Phase|Withdrawal by Subject|10|||
124882811|NCT02318719|449195029|FG004|Double-blind Phase|Withdrawal by Subject|0|||
124882812|NCT02318719|449195025|FG000|Double-blind Phase|Other|1|||
124882813|NCT02318719|449195026|FG001|Double-blind Phase|Other|2|||
124882814|NCT02318719|449195027|FG002|Double-blind Phase|Other|0|||
124882815|NCT02318719|449195028|FG003|Double-blind Phase|Other|0|||
124882816|NCT02318719|449195029|FG004|Double-blind Phase|Other|0|||
124882817|NCT02318719|449195025|FG000|Open-label Extension Phase|Adverse Event|0|||
124882818|NCT02318719|449195026|FG001|Open-label Extension Phase|Adverse Event|0|||
124882819|NCT02318719|449195027|FG002|Open-label Extension Phase|Adverse Event|0|||
124882820|NCT02318719|449195028|FG003|Open-label Extension Phase|Adverse Event|0|||
124882821|NCT02318719|449195029|FG004|Open-label Extension Phase|Adverse Event|15|||
124882822|NCT02318719|449195025|FG000|Open-label Extension Phase|Death|0|||
124882823|NCT02318719|449195026|FG001|Open-label Extension Phase|Death|0|||
124882824|NCT02318719|449195027|FG002|Open-label Extension Phase|Death|0|||
124882825|NCT02318719|449195028|FG003|Open-label Extension Phase|Death|0|||
124882826|NCT02318719|449195029|FG004|Open-label Extension Phase|Death|1|||
124882827|NCT02318719|449195025|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
124882828|NCT02318719|449195026|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
124882829|NCT02318719|449195027|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
124882830|NCT02318719|449195028|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
124882831|NCT02318719|449195029|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
124882832|NCT02318719|449195025|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
124882833|NCT02318719|449195026|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
124882834|NCT02318719|449195027|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
124882835|NCT02318719|449195028|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
124882836|NCT02318719|449195029|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
124882837|NCT02318719|449195025|FG000|Open-label Extension Phase|Other|0|||
124882838|NCT02318719|449195026|FG001|Open-label Extension Phase|Other|0|||
124882839|NCT02318719|449195027|FG002|Open-label Extension Phase|Other|0|||
124882840|NCT02318719|449195028|FG003|Open-label Extension Phase|Other|0|||
124882841|NCT02318719|449195029|FG004|Open-label Extension Phase|Other|7|||
124882842|NCT05340751|449195032|FG000|Overall Study|Physician Decision|3|||
124882843|NCT02961881|449195045|FG000|Overall Study|Adverse Event|1|||
124882844|NCT02961881|449195046|FG001|Overall Study|Adverse Event|2|||
124882845|NCT02961881|449195047|FG002|Overall Study|Adverse Event|2|||
124882846|NCT02961881|449195048|FG003|Overall Study|Adverse Event|0|||
124882847|NCT02961881|449195049|FG004|Overall Study|Adverse Event|1|||
124882848|NCT02961881|449195045|FG000|Overall Study|Participant request|0|||
124882849|NCT02961881|449195046|FG001|Overall Study|Participant request|2|||
124882850|NCT02961881|449195047|FG002|Overall Study|Participant request|0|||
124882851|NCT02961881|449195048|FG003|Overall Study|Participant request|0|||
124882852|NCT02961881|449195049|FG004|Overall Study|Participant request|0|||
124882853|NCT02961881|449195045|FG000|Overall Study|Disease progression|1|||
124882854|NCT02961881|449195046|FG001|Overall Study|Disease progression|0|||
124882855|NCT02961881|449195047|FG002|Overall Study|Disease progression|1|||
124882856|NCT02961881|449195048|FG003|Overall Study|Disease progression|0|||
124882857|NCT02961881|449195049|FG004|Overall Study|Disease progression|0|||
124882858|NCT01973491|449195050|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
124882859|NCT01973491|449195050|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
124882860|NCT01973491|449195050|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
124882861|NCT01928225|449195051|FG000|Overall Study|Pregnancy|1|||
124882862|NCT01928225|449195052|FG001|Overall Study|Pregnancy|0|||
124882863|NCT01928225|449195051|FG000|Overall Study|basaloid cervical cancer|1|||
124882864|NCT01928225|449195052|FG001|Overall Study|basaloid cervical cancer|0|||
124882865|NCT01928225|449195051|FG000|Overall Study|Lost to Follow-up|1|||
124882866|NCT01928225|449195052|FG001|Overall Study|Lost to Follow-up|3|||
124882867|NCT04250337|449195053|FG000|Overall Study|Adverse Event|0|||
124882868|NCT04250337|449195054|FG001|Overall Study|Adverse Event|3|||
124882869|NCT04250337|449195053|FG000|Overall Study|Lack of Efficacy|1|||
124882870|NCT04250337|449195054|FG001|Overall Study|Lack of Efficacy|3|||
124882871|NCT04250337|449195053|FG000|Overall Study|Physician Decision|1|||
124882872|NCT04250337|449195054|FG001|Overall Study|Physician Decision|0|||
124882873|NCT04250337|449195053|FG000|Overall Study|Protocol Deviation|2|||
124882874|NCT04250337|449195054|FG001|Overall Study|Protocol Deviation|2|||
124882875|NCT04250337|449195053|FG000|Overall Study|Withdrawal by Subject|4|||
124882876|NCT04250337|449195054|FG001|Overall Study|Withdrawal by Subject|3|||
124882877|NCT03321006|449195057|FG000|Overall Study|Death|1|||
124882878|NCT03321006|449195058|FG001|Overall Study|Death|0|||
124882879|NCT03321006|449195057|FG000|Overall Study|Lack of Efficacy|1|||
124882880|NCT03321006|449195058|FG001|Overall Study|Lack of Efficacy|0|||
124882881|NCT00365378|449195059|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
124882882|NCT00365378|449195060|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
124882883|NCT00365378|449195061|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
124882884|NCT00365378|449195059|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
124882885|NCT00365378|449195060|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
124882886|NCT00365378|449195061|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
124882887|NCT00365378|449195059|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
124882888|NCT00365378|449195060|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
124882889|NCT00365378|449195061|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
124882890|NCT00365378|449195059|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
124882891|NCT00365378|449195060|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
124882892|NCT00365378|449195061|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
124882893|NCT00365378|449195059|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
124882894|NCT00365378|449195060|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
124882895|NCT00365378|449195061|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
124882896|NCT00365378|449195059|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
124882897|NCT00365378|449195060|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
124882898|NCT00365378|449195061|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
124882899|NCT00365378|449195059|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
124882900|NCT00365378|449195060|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
124882901|NCT00365378|449195061|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
124882902|NCT00365378|449195059|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
124882903|NCT00365378|449195060|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
124882904|NCT00365378|449195061|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
124882905|NCT00365378|449195059|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
124882906|NCT00365378|449195060|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
124882907|NCT00365378|449195061|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
124882908|NCT00365378|449195059|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
124882909|NCT00365378|449195060|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
124882910|NCT00365378|449195061|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
124882911|NCT00365378|449195059|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
124882912|NCT00365378|449195060|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
124882913|NCT00365378|449195061|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
124882914|NCT00365378|449195059|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
124882915|NCT00365378|449195060|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
124882916|NCT00365378|449195061|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
124882917|NCT00365378|449195059|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
124882918|NCT00365378|449195060|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
124882919|NCT00365378|449195061|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
124439279|NCT01249274|447569115|FG000|Overall Study|Received inpatient substance treatment|1|||
124439280|NCT01249274|447569116|FG001|Overall Study|Received inpatient substance treatment|2|||
124439281|NCT01000636|447569117|FG000|Overall Study|Withdrawal by Subject|1|||
124439282|NCT01000636|447569117|FG000|Overall Study|Adverse Event|1|||
124439283|NCT03451162|447569118|FG000|Overall Study|Lost to Follow-up|1|||
124439284|NCT03451162|447569119|FG001|Overall Study|Lost to Follow-up|0|||
124439285|NCT03451162|447569120|FG002|Overall Study|Lost to Follow-up|0|||
124439286|NCT03451162|447569121|FG003|Overall Study|Lost to Follow-up|0|||
124439287|NCT03451162|447569122|FG004|Overall Study|Lost to Follow-up|0|||
124439288|NCT03451162|447569118|FG000|Overall Study|Physician Decision|0|||
124439289|NCT03451162|447569119|FG001|Overall Study|Physician Decision|1|||
124439290|NCT03451162|447569120|FG002|Overall Study|Physician Decision|0|||
124439291|NCT03451162|447569121|FG003|Overall Study|Physician Decision|0|||
124439292|NCT03451162|447569122|FG004|Overall Study|Physician Decision|0|||
124439293|NCT03451162|447569118|FG000|Overall Study|Withdrawal by Subject|1|||
124439294|NCT03451162|447569119|FG001|Overall Study|Withdrawal by Subject|1|||
124439295|NCT03451162|447569120|FG002|Overall Study|Withdrawal by Subject|0|||
124439296|NCT03451162|447569121|FG003|Overall Study|Withdrawal by Subject|0|||
124439297|NCT03451162|447569122|FG004|Overall Study|Withdrawal by Subject|0|||
124439298|NCT04634825|447569123|FG000|Overall Study|Death|10|||
124439299|NCT04634825|447569124|FG001|Overall Study|Death|3|||
124439300|NCT04634825|447569123|FG000|Overall Study|Lost to Follow-up|1|||
124439301|NCT04634825|447569124|FG001|Overall Study|Lost to Follow-up|0|||
124439302|NCT04634825|447569123|FG000|Overall Study|Study terminated by sponsor|35|||
124439303|NCT04634825|447569124|FG001|Overall Study|Study terminated by sponsor|11|||
124439304|NCT04634825|447569123|FG000|Overall Study|Withdrawal by Subject|2|||
124439305|NCT04634825|447569124|FG001|Overall Study|Withdrawal by Subject|0|||
124439306|NCT01079741|447569133|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
124439307|NCT01079741|447569134|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
124439308|NCT01079741|447569135|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
124439309|NCT01079741|447569136|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
124439310|NCT01079741|447569137|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
124882920|NCT00365378|449195059|FG000|Extension|Adverse Event|0|||
124439311|NCT01079741|447569133|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
124439312|NCT01079741|447569134|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
124882921|NCT00365378|449195060|FG001|Extension|Adverse Event|0|||
124439313|NCT01079741|447569135|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
124439314|NCT01079741|447569136|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
124439315|NCT01079741|447569137|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
124439316|NCT02434939|447569145|FG000|Overall Study|Lack of Efficacy|34|||
124439317|NCT02434939|447569146|FG001|Overall Study|Lack of Efficacy|48|||
124439318|NCT02434939|447569145|FG000|Overall Study|Withdrawal by Subject|3|||
124882922|NCT00365378|449195061|FG002|Extension|Adverse Event|1|||
124882923|NCT00365378|449195059|FG000|Extension|Moved|0|||
124439319|NCT02434939|447569146|FG001|Overall Study|Withdrawal by Subject|0|||
124882924|NCT00365378|449195060|FG001|Extension|Moved|0|||
124882925|NCT00365378|449195061|FG002|Extension|Moved|8|||
124439320|NCT02434939|447569145|FG000|Overall Study|Adverse Event|0|||
124439321|NCT02434939|447569146|FG001|Overall Study|Adverse Event|1|||
124439322|NCT01001832|447569149|FG000|Short-term Period|Adverse Event|2|||
124439323|NCT01001832|447569150|FG001|Short-term Period|Adverse Event|3|||
124439324|NCT01001832|447569149|FG000|Long-term Period|Adverse Event|2|||
124439325|NCT01001832|447569150|FG001|Long-term Period|Adverse Event|1|||
124439326|NCT01001832|447569149|FG000|Long-term Period|Withdrawal by Subject|1|||
124439327|NCT01001832|447569150|FG001|Long-term Period|Withdrawal by Subject|0|||
124439328|NCT01001832|447569149|FG000|Long-term Period|Lack of Efficacy|0|||
124439329|NCT01001832|447569150|FG001|Long-term Period|Lack of Efficacy|2|||
124439330|NCT01001832|447569149|FG000|Long-term Period|Other|1|||
124439331|NCT01001832|447569150|FG001|Long-term Period|Other|2|||
124439332|NCT01001832|447569149|FG000|Follow-up Period|Withdrawal by Subject|1|||
124439333|NCT01001832|447569150|FG001|Follow-up Period|Withdrawal by Subject|0|||
124439334|NCT01001832|447569149|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
124439335|NCT01001832|447569150|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
124439336|NCT01001832|447569149|FG000|Follow-up Period|Other|2|||
124439337|NCT01001832|447569150|FG001|Follow-up Period|Other|1|||
124439338|NCT01536015|447569153|FG000|Overall Study|Adverse Event|1|||
124439339|NCT01536015|447569154|FG001|Overall Study|Adverse Event|4|||
124439340|NCT01536015|447569153|FG000|Overall Study|Lost to Follow-up|0|||
124439341|NCT01536015|447569154|FG001|Overall Study|Lost to Follow-up|1|||
124439342|NCT01536015|447569153|FG000|Overall Study|Inclusion Criterion not met|2|||
124439343|NCT01536015|447569154|FG001|Overall Study|Inclusion Criterion not met|0|||
124439344|NCT01536015|447569153|FG000|Overall Study|Study closure|5|||
124439345|NCT01536015|447569154|FG001|Overall Study|Study closure|5|||
124439346|NCT00511901|447569156|FG000|Overall Study|Withdrawal by Subject|1|||
124439347|NCT00511901|447569157|FG001|Overall Study|Withdrawal by Subject|3|||
124439348|NCT00178126|447569158|FG000|Overall Study|Lost to Follow-up|21|||
124439349|NCT00178126|447569159|FG001|Overall Study|Lost to Follow-up|21|||
124439350|NCT00178126|447569158|FG000|Overall Study|did not receive intervention|4|||
124439351|NCT00178126|447569159|FG001|Overall Study|did not receive intervention|6|||
124439352|NCT02447172|447569160|FG000|Overall Study|Adverse Event|11|||
124439353|NCT02447172|447569161|FG001|Overall Study|Adverse Event|8|||
124439354|NCT02447172|447569162|FG002|Overall Study|Adverse Event|7|||
124439355|NCT02447172|447569160|FG000|Overall Study|Death|3|||
124439356|NCT02447172|447569161|FG001|Overall Study|Death|1|||
124439357|NCT02447172|447569162|FG002|Overall Study|Death|0|||
124439358|NCT02447172|447569160|FG000|Overall Study|Protocol Violation|2|||
124439359|NCT02447172|447569161|FG001|Overall Study|Protocol Violation|1|||
124439360|NCT02447172|447569162|FG002|Overall Study|Protocol Violation|2|||
124439361|NCT02447172|447569160|FG000|Overall Study|Lost to Follow-up|7|||
124439362|NCT02447172|447569161|FG001|Overall Study|Lost to Follow-up|4|||
124439363|NCT02447172|447569162|FG002|Overall Study|Lost to Follow-up|4|||
124439364|NCT02447172|447569160|FG000|Overall Study|Withdrawal by Subject|5|||
124439365|NCT02447172|447569161|FG001|Overall Study|Withdrawal by Subject|1|||
124439366|NCT02447172|447569162|FG002|Overall Study|Withdrawal by Subject|3|||
124439367|NCT02447172|447569160|FG000|Overall Study|protocol specific treatment unrelated|3|||
124439368|NCT02447172|447569161|FG001|Overall Study|protocol specific treatment unrelated|0|||
124439369|NCT02447172|447569162|FG002|Overall Study|protocol specific treatment unrelated|2|||
124439370|NCT03562247|447569163|FG000|Overall Study|Lost to Follow-up|3|||
124439371|NCT03562247|447569164|FG001|Overall Study|Lost to Follow-up|1|||
124439372|NCT03562247|447569165|FG002|Overall Study|Lost to Follow-up|1|||
124439373|NCT01013597|447569166|FG000|Overall Study|Withdrawal by Subject|1|||
124439374|NCT00960531|447569172|FG000|Overall Study|Lack of Efficacy|1|||
124439375|NCT00960531|447569173|FG001|Overall Study|Lack of Efficacy|0|||
124439376|NCT00960531|447569174|FG002|Overall Study|Lack of Efficacy|0|||
124439377|NCT00960531|447569175|FG003|Overall Study|Lack of Efficacy|0|||
124439378|NCT00960531|447569176|FG004|Overall Study|Lack of Efficacy|0|||
124439379|NCT00960531|447569177|FG005|Overall Study|Lack of Efficacy|0|||
124439380|NCT00960531|447569178|FG006|Overall Study|Lack of Efficacy|0|||
124439381|NCT00960531|447569179|FG007|Overall Study|Lack of Efficacy|0|||
124439382|NCT00960531|447569180|FG008|Overall Study|Lack of Efficacy|0|||
124439383|NCT00960531|447569181|FG009|Overall Study|Lack of Efficacy|0|||
124439384|NCT00960531|447569172|FG000|Overall Study|Withdrawal by Subject|1|||
124439385|NCT00960531|447569173|FG001|Overall Study|Withdrawal by Subject|0|||
124439386|NCT00960531|447569174|FG002|Overall Study|Withdrawal by Subject|5|||
124439387|NCT00960531|447569175|FG003|Overall Study|Withdrawal by Subject|2|||
124439388|NCT00960531|447569176|FG004|Overall Study|Withdrawal by Subject|0|||
124439389|NCT00960531|447569177|FG005|Overall Study|Withdrawal by Subject|0|||
124439390|NCT00960531|447569178|FG006|Overall Study|Withdrawal by Subject|2|||
124439391|NCT00960531|447569179|FG007|Overall Study|Withdrawal by Subject|0|||
124439392|NCT00960531|447569180|FG008|Overall Study|Withdrawal by Subject|1|||
124439393|NCT00960531|447569181|FG009|Overall Study|Withdrawal by Subject|0|||
124439394|NCT00960531|447569172|FG000|Overall Study|Caregiver Request|2|||
124439395|NCT00960531|447569173|FG001|Overall Study|Caregiver Request|0|||
124439396|NCT00960531|447569174|FG002|Overall Study|Caregiver Request|6|||
124439397|NCT00960531|447569175|FG003|Overall Study|Caregiver Request|5|||
124683086|NCT01104766|448461868|FG002|Overall Study|Lack of Efficacy|14|||
124683087|NCT01104766|448461869|FG003|Overall Study|Lack of Efficacy|8|||
124683088|NCT01104766|448461866|FG000|Overall Study|Protocol Violation|2|||
124683089|NCT01104766|448461867|FG001|Overall Study|Protocol Violation|0|||
124683090|NCT01104766|448461868|FG002|Overall Study|Protocol Violation|0|||
124683091|NCT01104766|448461869|FG003|Overall Study|Protocol Violation|0|||
124683092|NCT01104766|448461866|FG000|Overall Study|Withdrawal by Subject|17|||
124683093|NCT01104766|448461867|FG001|Overall Study|Withdrawal by Subject|19|||
124683094|NCT01104766|448461868|FG002|Overall Study|Withdrawal by Subject|25|||
124683095|NCT01104766|448461869|FG003|Overall Study|Withdrawal by Subject|15|||
124683096|NCT01104766|448461866|FG000|Overall Study|Lost to Follow-up|1|||
124683097|NCT01104766|448461867|FG001|Overall Study|Lost to Follow-up|2|||
124683098|NCT01104766|448461868|FG002|Overall Study|Lost to Follow-up|1|||
124683099|NCT01104766|448461869|FG003|Overall Study|Lost to Follow-up|1|||
124683100|NCT01341470|448461870|FG000|Overall Study|Sponsor decision|0|||
124683101|NCT01341470|448461871|FG001|Overall Study|Sponsor decision|0|||
124683102|NCT01341470|448461872|FG002|Overall Study|Sponsor decision|1|||
124683103|NCT01341470|448461873|FG003|Overall Study|Sponsor decision|1|||
124683104|NCT01341470|448461874|FG004|Overall Study|Sponsor decision|0|||
124683105|NCT01341470|448461875|FG005|Overall Study|Sponsor decision|1|||
124683106|NCT04225832|448461877|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
124683107|NCT04225832|448461878|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
124683108|NCT04225832|448461877|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
124683109|NCT04225832|448461878|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
124683110|NCT00311168|448461879|FG000|First Intervention|Withdrawal by Subject|2|||
124683111|NCT00311168|448461880|FG001|First Intervention|Withdrawal by Subject|2|||
124683112|NCT00311168|448461879|FG000|First Intervention|Lost to Follow-up|1|||
124683113|NCT00311168|448461880|FG001|First Intervention|Lost to Follow-up|1|||
124683114|NCT00311168|448461879|FG000|First Intervention|Protocol Violation|1|||
124683115|NCT00311168|448461880|FG001|First Intervention|Protocol Violation|1|||
124683116|NCT00311168|448461879|FG000|First Intervention|Adverse Event|1|||
124683117|NCT00311168|448461880|FG001|First Intervention|Adverse Event|0|||
124683118|NCT00311168|448461879|FG000|First Intervention|Other|2|||
124683119|NCT00311168|448461880|FG001|First Intervention|Other|2|||
124683120|NCT00311168|448461879|FG000|Second Intervention|Lost to Follow-up|9|||
124683121|NCT00311168|448461880|FG001|Second Intervention|Lost to Follow-up|2|||
124683122|NCT00311168|448461879|FG000|Second Intervention|Withdrawal by Subject|0|||
124683123|NCT00311168|448461880|FG001|Second Intervention|Withdrawal by Subject|1|||
124683124|NCT00311168|448461879|FG000|Second Intervention|Other|1|||
124683125|NCT00311168|448461880|FG001|Second Intervention|Other|1|||
124683126|NCT03965923|448461883|FG000|Overall Study|Withdrawal by Subject|1|||
124683127|NCT03965923|448461884|FG001|Overall Study|Withdrawal by Subject|2|||
124683128|NCT03965923|448461885|FG002|Overall Study|Withdrawal by Subject|3|||
124683129|NCT03965923|448461886|FG003|Overall Study|Withdrawal by Subject|1|||
124683130|NCT03965923|448461887|FG004|Overall Study|Withdrawal by Subject|2|||
124683131|NCT03965923|448461888|FG005|Overall Study|Withdrawal by Subject|0|||
124683132|NCT03965923|448461889|FG006|Overall Study|Withdrawal by Subject|4|||
124683133|NCT03965923|448461890|FG007|Overall Study|Withdrawal by Subject|3|||
124683134|NCT03965923|448461891|FG008|Overall Study|Withdrawal by Subject|4|||
124683135|NCT03965923|448461892|FG009|Overall Study|Withdrawal by Subject|0|||
124683136|NCT03965923|448461893|FG010|Overall Study|Withdrawal by Subject|2|||
124683137|NCT03965923|448461894|FG011|Overall Study|Withdrawal by Subject|0|||
124683138|NCT03965923|448461883|FG000|Overall Study|Lost to Follow-up|2|||
124683139|NCT03965923|448461884|FG001|Overall Study|Lost to Follow-up|1|||
124683140|NCT03965923|448461885|FG002|Overall Study|Lost to Follow-up|1|||
124683141|NCT03965923|448461886|FG003|Overall Study|Lost to Follow-up|0|||
124683142|NCT03965923|448461887|FG004|Overall Study|Lost to Follow-up|2|||
124683143|NCT03965923|448461888|FG005|Overall Study|Lost to Follow-up|1|||
124683144|NCT03965923|448461889|FG006|Overall Study|Lost to Follow-up|2|||
124683145|NCT03965923|448461890|FG007|Overall Study|Lost to Follow-up|1|||
124439398|NCT00960531|447569176|FG004|Overall Study|Caregiver Request|0|||
124683146|NCT03965923|448461891|FG008|Overall Study|Lost to Follow-up|0|||
124439399|NCT00960531|447569177|FG005|Overall Study|Caregiver Request|2|||
124683147|NCT03965923|448461892|FG009|Overall Study|Lost to Follow-up|2|||
124683148|NCT03965923|448461893|FG010|Overall Study|Lost to Follow-up|0|||
124683149|NCT03965923|448461894|FG011|Overall Study|Lost to Follow-up|0|||
124683150|NCT03965923|448461883|FG000|Overall Study|Death|0|||
124882926|NCT00365378|449195059|FG000|Extension|Lost to Follow-up|0|||
124882927|NCT00365378|449195060|FG001|Extension|Lost to Follow-up|0|||
124882928|NCT00365378|449195061|FG002|Extension|Lost to Follow-up|57|||
124882929|NCT00365378|449195059|FG000|Extension|Protocol Violation|0|||
124882930|NCT00365378|449195060|FG001|Extension|Protocol Violation|0|||
124882931|NCT00365378|449195061|FG002|Extension|Protocol Violation|2|||
124882932|NCT00365378|449195059|FG000|Extension|Withdrawal by Subject|0|||
124882933|NCT00365378|449195060|FG001|Extension|Withdrawal by Subject|0|||
124882934|NCT00365378|449195061|FG002|Extension|Withdrawal by Subject|98|||
124882935|NCT00365378|449195059|FG000|Extension|Other|0|||
124882936|NCT00365378|449195060|FG001|Extension|Other|0|||
124882937|NCT00365378|449195061|FG002|Extension|Other|31|||
124882938|NCT04161807|449195067|FG000|Overall Study|Withdrawal by Subject|2|||
124882939|NCT04161807|449195067|FG000|Overall Study|Performed only 1 treatment|2|||
124882940|NCT02006121|449195068|FG000|Double Blind Phase|Adverse Event|6|||
124882941|NCT02006121|449195069|FG001|Double Blind Phase|Adverse Event|0|||
124882942|NCT02006121|449195068|FG000|Double Blind Phase|Lack of Efficacy|1|||
124882943|NCT02006121|449195069|FG001|Double Blind Phase|Lack of Efficacy|16|||
124882944|NCT02006121|449195068|FG000|Double Blind Phase|Withdrawal by Subject|3|||
124882945|NCT02006121|449195069|FG001|Double Blind Phase|Withdrawal by Subject|4|||
124882946|NCT02006121|449195068|FG000|Double Blind Phase|Non-compliance with study drug|1|||
124882947|NCT02006121|449195069|FG001|Double Blind Phase|Non-compliance with study drug|3|||
124882948|NCT02006121|449195068|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
124882949|NCT02006121|449195069|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
124882950|NCT02006121|449195068|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
124882951|NCT02006121|449195069|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
124882952|NCT02006121|449195068|FG000|Open Label Phase|Adverse Event|15|||
124882953|NCT02006121|449195069|FG001|Open Label Phase|Adverse Event|0|||
124882954|NCT02006121|449195068|FG000|Open Label Phase|Lack of Efficacy|2|||
124882955|NCT02006121|449195069|FG001|Open Label Phase|Lack of Efficacy|0|||
124882956|NCT02006121|449195068|FG000|Open Label Phase|Protocol Violation|2|||
124882957|NCT02006121|449195069|FG001|Open Label Phase|Protocol Violation|0|||
124882958|NCT02006121|449195068|FG000|Open Label Phase|Withdrawal by Subject|3|||
124882959|NCT02006121|449195069|FG001|Open Label Phase|Withdrawal by Subject|0|||
124882960|NCT02006121|449195068|FG000|Open Label Phase|Non-compliance with study drug|3|||
124882961|NCT02006121|449195069|FG001|Open Label Phase|Non-compliance with study drug|0|||
124882962|NCT04789577|449195070|FG000|Overall Study|Withdrawal by Subject|1|||
124882963|NCT04789577|449195071|FG001|Overall Study|Withdrawal by Subject|1|||
124882964|NCT04789577|449195072|FG002|Overall Study|Withdrawal by Subject|1|||
124882965|NCT04789577|449195073|FG003|Overall Study|Withdrawal by Subject|3|||
124882966|NCT04789577|449195074|FG004|Overall Study|Withdrawal by Subject|1|||
124882967|NCT04789577|449195075|FG005|Overall Study|Withdrawal by Subject|7|||
124882968|NCT04789577|449195076|FG006|Overall Study|Withdrawal by Subject|1|||
124882969|NCT04789577|449195070|FG000|Overall Study|Lost to Follow-up|7|||
124882970|NCT04789577|449195071|FG001|Overall Study|Lost to Follow-up|12|||
124882971|NCT04789577|449195072|FG002|Overall Study|Lost to Follow-up|7|||
124882972|NCT04789577|449195073|FG003|Overall Study|Lost to Follow-up|10|||
124882973|NCT04789577|449195074|FG004|Overall Study|Lost to Follow-up|8|||
124882974|NCT04789577|449195075|FG005|Overall Study|Lost to Follow-up|6|||
124882975|NCT04789577|449195076|FG006|Overall Study|Lost to Follow-up|10|||
124882976|NCT04789577|449195070|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
124882977|NCT04789577|449195071|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
124882978|NCT04789577|449195072|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
124882979|NCT04789577|449195073|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
124882980|NCT04789577|449195074|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
124882981|NCT04789577|449195075|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
124882982|NCT04789577|449195076|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
124882983|NCT04789577|449195070|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
124882984|NCT04789577|449195071|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
124882985|NCT04789577|449195072|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
124882986|NCT04789577|449195073|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
124882987|NCT04789577|449195074|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
124882988|NCT04789577|449195075|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
124882989|NCT04789577|449195076|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
124882990|NCT02693834|449195085|FG000|Baseline Measurement|Withdrawal by Subject|1|||
124882991|NCT02693834|449195086|FG001|Baseline Measurement|Withdrawal by Subject|0|||
124882992|NCT02693834|449195085|FG000|Baseline Measurement|Adverse Event|1|||
124882993|NCT02693834|449195086|FG001|Baseline Measurement|Adverse Event|0|||
124882994|NCT02693834|449195085|FG000|Week 2 Practice|Adverse Event|0|||
124882995|NCT02693834|449195086|FG001|Week 2 Practice|Adverse Event|1|||
124882996|NCT04848662|449195089|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
124882997|NCT04848662|449195090|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
124882998|NCT03000673|449195091|FG000|Overall Study|Withdrawal by Subject|1|||
124882999|NCT03000673|449195092|FG001|Overall Study|Withdrawal by Subject|0|||
124883000|NCT03000673|449195093|FG002|Overall Study|Withdrawal by Subject|0|||
124883001|NCT03000673|449195094|FG003|Overall Study|Withdrawal by Subject|0|||
124883002|NCT01121484|449195095|FG000|Overall Study|Adverse Event|12|||
124883003|NCT01121484|449195096|FG001|Overall Study|Adverse Event|5|||
124883004|NCT01121484|449195095|FG000|Overall Study|Lack of Efficacy|3|||
124883005|NCT01121484|449195096|FG001|Overall Study|Lack of Efficacy|11|||
124883006|NCT01121484|449195095|FG000|Overall Study|Lost to Follow-up|5|||
124883007|NCT01121484|449195096|FG001|Overall Study|Lost to Follow-up|9|||
124883008|NCT01121484|449195095|FG000|Overall Study|Physician Decision|0|||
124883009|NCT01121484|449195096|FG001|Overall Study|Physician Decision|3|||
124883010|NCT01121484|449195095|FG000|Overall Study|Protocol Violation|1|||
124883011|NCT01121484|449195096|FG001|Overall Study|Protocol Violation|0|||
124883012|NCT01121484|449195095|FG000|Overall Study|Withdrawal by Subject|8|||
124883013|NCT01121484|449195096|FG001|Overall Study|Withdrawal by Subject|7|||
124883014|NCT01121484|449195095|FG000|Overall Study|Discontinuation of study by sponsor|0|||
124883015|NCT01121484|449195096|FG001|Overall Study|Discontinuation of study by sponsor|1|||
124883016|NCT01121484|449195095|FG000|Overall Study|Other|3|||
124883017|NCT01121484|449195096|FG001|Overall Study|Other|3|||
124883018|NCT01121484|449195095|FG000|Overall Study|Randomized, not treated|1|||
124883019|NCT01121484|449195096|FG001|Overall Study|Randomized, not treated|4|||
124883020|NCT00562978|449195097|FG000|Overall Study|Patient had imaging dose only|1|||
124883021|NCT00562978|449195098|FG001|Overall Study|Patient had imaging dose only|11|||
124883022|NCT01348776|449195104|FG000|Overall Study|Lost to Follow-up|3|||
124883023|NCT01463293|449195108|FG000|Overall Study|Lost to Follow-up|1|||
124883024|NCT01463293|449195109|FG001|Overall Study|Lost to Follow-up|4|||
124883025|NCT01463293|449195110|FG002|Overall Study|Lost to Follow-up|5|||
124883026|NCT01463293|449195108|FG000|Overall Study|Adverse Event|1|||
124883027|NCT01463293|449195109|FG001|Overall Study|Adverse Event|2|||
124883028|NCT01463293|449195110|FG002|Overall Study|Adverse Event|0|||
124883029|NCT01463293|449195108|FG000|Overall Study|Withdrawal by Subject|4|||
124883030|NCT01463293|449195109|FG001|Overall Study|Withdrawal by Subject|10|||
124883031|NCT01463293|449195110|FG002|Overall Study|Withdrawal by Subject|5|||
124883032|NCT01463293|449195108|FG000|Overall Study|Other|0|||
124883033|NCT01463293|449195109|FG001|Overall Study|Other|0|||
124883034|NCT01463293|449195110|FG002|Overall Study|Other|2|||
124883035|NCT00779584|449195119|FG000|Overall Study|Protocol Violation|0|||
124883036|NCT00779584|449195120|FG001|Overall Study|Protocol Violation|0|||
124883037|NCT00779584|449195121|FG002|Overall Study|Protocol Violation|0|||
124883038|NCT00779584|449195122|FG003|Overall Study|Protocol Violation|0|||
124883039|NCT00779584|449195123|FG004|Overall Study|Protocol Violation|0|||
124883040|NCT00779584|449195124|FG005|Overall Study|Protocol Violation|1|||
124883041|NCT00779584|449195125|FG006|Overall Study|Protocol Violation|0|||
124883042|NCT00779584|449195126|FG007|Overall Study|Protocol Violation|0|||
124883043|NCT00779584|449195127|FG008|Overall Study|Protocol Violation|0|||
124883044|NCT00779584|449195119|FG000|Overall Study|Withdrawal by Subject|1|||
124883045|NCT00779584|449195120|FG001|Overall Study|Withdrawal by Subject|1|||
124883046|NCT00779584|449195121|FG002|Overall Study|Withdrawal by Subject|2|||
124883047|NCT00779584|449195122|FG003|Overall Study|Withdrawal by Subject|0|||
124883048|NCT00779584|449195123|FG004|Overall Study|Withdrawal by Subject|0|||
124883049|NCT00779584|449195124|FG005|Overall Study|Withdrawal by Subject|2|||
124883050|NCT00779584|449195125|FG006|Overall Study|Withdrawal by Subject|1|||
124439400|NCT00960531|447569178|FG006|Overall Study|Caregiver Request|3|||
124439401|NCT00960531|447569179|FG007|Overall Study|Caregiver Request|1|||
124439402|NCT00960531|447569180|FG008|Overall Study|Caregiver Request|3|||
124439403|NCT00960531|447569181|FG009|Overall Study|Caregiver Request|0|||
124439404|NCT00960531|447569172|FG000|Overall Study|Investigator Request|0|||
124439405|NCT00960531|447569173|FG001|Overall Study|Investigator Request|0|||
124439406|NCT00960531|447569174|FG002|Overall Study|Investigator Request|1|||
124683151|NCT03965923|448461884|FG001|Overall Study|Death|0|||
124683152|NCT03965923|448461885|FG002|Overall Study|Death|0|||
124683153|NCT03965923|448461886|FG003|Overall Study|Death|0|||
124883051|NCT00779584|449195126|FG007|Overall Study|Withdrawal by Subject|0|||
124883052|NCT00779584|449195127|FG008|Overall Study|Withdrawal by Subject|0|||
124883053|NCT00779584|449195119|FG000|Overall Study|Lost to Follow-up|0|||
124883054|NCT00779584|449195120|FG001|Overall Study|Lost to Follow-up|0|||
124883055|NCT00779584|449195121|FG002|Overall Study|Lost to Follow-up|0|||
124883056|NCT00779584|449195122|FG003|Overall Study|Lost to Follow-up|0|||
124883057|NCT00779584|449195123|FG004|Overall Study|Lost to Follow-up|1|||
124883058|NCT00779584|449195124|FG005|Overall Study|Lost to Follow-up|0|||
124883059|NCT00779584|449195125|FG006|Overall Study|Lost to Follow-up|0|||
124883060|NCT00779584|449195126|FG007|Overall Study|Lost to Follow-up|0|||
124883061|NCT00779584|449195127|FG008|Overall Study|Lost to Follow-up|0|||
124883062|NCT00779584|449195119|FG000|Overall Study|Progression of Disease|0|||
124883063|NCT00779584|449195120|FG001|Overall Study|Progression of Disease|1|||
124883064|NCT00779584|449195121|FG002|Overall Study|Progression of Disease|2|||
124883065|NCT00779584|449195122|FG003|Overall Study|Progression of Disease|6|||
124883066|NCT00779584|449195123|FG004|Overall Study|Progression of Disease|5|||
124883067|NCT00779584|449195124|FG005|Overall Study|Progression of Disease|1|||
124883068|NCT00779584|449195125|FG006|Overall Study|Progression of Disease|4|||
124883069|NCT00779584|449195126|FG007|Overall Study|Progression of Disease|2|||
124883070|NCT00779584|449195127|FG008|Overall Study|Progression of Disease|1|||
124883071|NCT00779584|449195119|FG000|Overall Study|Adverse Event|1|||
124883072|NCT00779584|449195120|FG001|Overall Study|Adverse Event|0|||
124883073|NCT00779584|449195121|FG002|Overall Study|Adverse Event|2|||
124883074|NCT00779584|449195122|FG003|Overall Study|Adverse Event|0|||
124883075|NCT00779584|449195123|FG004|Overall Study|Adverse Event|0|||
124883076|NCT00779584|449195124|FG005|Overall Study|Adverse Event|0|||
124883077|NCT00779584|449195125|FG006|Overall Study|Adverse Event|2|||
124883078|NCT00779584|449195126|FG007|Overall Study|Adverse Event|1|||
124883079|NCT00779584|449195127|FG008|Overall Study|Adverse Event|1|||
124883080|NCT00779584|449195119|FG000|Overall Study|Symptomatic Deterioration|1|||
124883081|NCT00779584|449195120|FG001|Overall Study|Symptomatic Deterioration|1|||
124883082|NCT00779584|449195121|FG002|Overall Study|Symptomatic Deterioration|1|||
124883083|NCT00779584|449195122|FG003|Overall Study|Symptomatic Deterioration|0|||
124883084|NCT00779584|449195123|FG004|Overall Study|Symptomatic Deterioration|0|||
124883085|NCT00779584|449195124|FG005|Overall Study|Symptomatic Deterioration|1|||
124883086|NCT00779584|449195125|FG006|Overall Study|Symptomatic Deterioration|1|||
124883087|NCT00779584|449195126|FG007|Overall Study|Symptomatic Deterioration|0|||
124883088|NCT00779584|449195127|FG008|Overall Study|Symptomatic Deterioration|0|||
124883089|NCT00779584|449195119|FG000|Overall Study|Ongoing in Study|0|||
124883090|NCT00779584|449195120|FG001|Overall Study|Ongoing in Study|0|||
124883091|NCT00779584|449195121|FG002|Overall Study|Ongoing in Study|0|||
124883092|NCT00779584|449195122|FG003|Overall Study|Ongoing in Study|0|||
124883093|NCT00779584|449195123|FG004|Overall Study|Ongoing in Study|1|||
124883094|NCT00779584|449195124|FG005|Overall Study|Ongoing in Study|1|||
124883095|NCT00779584|449195125|FG006|Overall Study|Ongoing in Study|0|||
124883096|NCT00779584|449195126|FG007|Overall Study|Ongoing in Study|0|||
124883097|NCT00779584|449195127|FG008|Overall Study|Ongoing in Study|0|||
124883098|NCT02878213|449195132|FG000|Overall Study|Withdrawal by Subject|2|||
124883099|NCT02878213|449195132|FG000|Overall Study|Adverse Event|1|||
124883100|NCT01913639|449195133|FG000|Overall Study|Not Eligible|3|||
124883101|NCT04986982|449195138|FG000|Overall Study|Withdrawal by Subject|3|||
124883102|NCT04986982|449195139|FG001|Overall Study|Withdrawal by Subject|1|||
124883103|NCT04986982|449195138|FG000|Overall Study|Lack of Efficacy|0|||
124883104|NCT04986982|449195139|FG001|Overall Study|Lack of Efficacy|2|||
124883105|NCT04986982|449195138|FG000|Overall Study|Ineligibility|3|||
124883106|NCT04986982|449195139|FG001|Overall Study|Ineligibility|0|||
124883107|NCT04986982|449195138|FG000|Overall Study|Adverse Event|4|||
124883108|NCT04986982|449195139|FG001|Overall Study|Adverse Event|4|||
124883109|NCT04986982|449195138|FG000|Overall Study|Lost to Follow-up|0|||
124883110|NCT04986982|449195139|FG001|Overall Study|Lost to Follow-up|1|||
124883111|NCT04986982|449195138|FG000|Overall Study|Sponsor's discretion|1|||
124883112|NCT04986982|449195139|FG001|Overall Study|Sponsor's discretion|0|||
124883113|NCT01155661|449195140|FG000|Overall Study|Adverse Event|101|||
124883114|NCT01155661|449195140|FG000|Overall Study|Death|1|||
124883115|NCT01155661|449195140|FG000|Overall Study|Lack of Efficacy|32|||
124439407|NCT00960531|447569175|FG003|Overall Study|Investigator Request|0|||
124883116|NCT01155661|449195140|FG000|Overall Study|Lost to Follow-up|22|||
124883117|NCT01155661|449195140|FG000|Overall Study|Physician Decision|3|||
124883118|NCT01155661|449195140|FG000|Overall Study|Protocol Violation|35|||
124883119|NCT01155661|449195140|FG000|Overall Study|Withdrawal by Subject|73|||
124883120|NCT01155661|449195140|FG000|Overall Study|Sponsor Decision|13|||
124883121|NCT01370005|449195141|FG000|Overall Study|Not treated|1|||
124883122|NCT01370005|449195142|FG001|Overall Study|Not treated|0|||
124883123|NCT01370005|449195143|FG002|Overall Study|Not treated|0|||
124883124|NCT01370005|449195141|FG000|Overall Study|Adverse Event|5|||
124883125|NCT01370005|449195142|FG001|Overall Study|Adverse Event|5|||
124883126|NCT01370005|449195143|FG002|Overall Study|Adverse Event|6|||
124883127|NCT01370005|449195141|FG000|Overall Study|Lack of Efficacy|1|||
124883128|NCT01370005|449195142|FG001|Overall Study|Lack of Efficacy|0|||
124883129|NCT01370005|449195143|FG002|Overall Study|Lack of Efficacy|0|||
124883130|NCT01370005|449195141|FG000|Overall Study|Non compliant with protocol|0|||
124883131|NCT01370005|449195142|FG001|Overall Study|Non compliant with protocol|1|||
124883132|NCT01370005|449195143|FG002|Overall Study|Non compliant with protocol|2|||
124883133|NCT01370005|449195141|FG000|Overall Study|Lost to Follow-up|1|||
124883134|NCT01370005|449195142|FG001|Overall Study|Lost to Follow-up|1|||
124883135|NCT01370005|449195143|FG002|Overall Study|Lost to Follow-up|1|||
124883136|NCT01370005|449195141|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
124883137|NCT01370005|449195142|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
124883138|NCT01370005|449195143|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
124883139|NCT01370005|449195141|FG000|Overall Study|Other reason not defined above|3|||
124883140|NCT01370005|449195142|FG001|Overall Study|Other reason not defined above|0|||
124883141|NCT01370005|449195143|FG002|Overall Study|Other reason not defined above|2|||
124883142|NCT02302066|449195144|FG000|Overall Study|Adverse Event|1|||
124883143|NCT02302066|449195145|FG001|Overall Study|Adverse Event|1|||
124883144|NCT02302066|449195146|FG002|Overall Study|Adverse Event|3|||
124883145|NCT02302066|449195147|FG003|Overall Study|Adverse Event|0|||
124883146|NCT02302066|449195144|FG000|Overall Study|Lost to Follow-up|4|||
124883147|NCT02302066|449195145|FG001|Overall Study|Lost to Follow-up|5|||
124883148|NCT02302066|449195146|FG002|Overall Study|Lost to Follow-up|24|||
124883149|NCT02302066|449195147|FG003|Overall Study|Lost to Follow-up|7|||
124883150|NCT02302066|449195144|FG000|Overall Study|Withdrawal by Subject|25|||
124883151|NCT02302066|449195145|FG001|Overall Study|Withdrawal by Subject|58|||
124883152|NCT02302066|449195146|FG002|Overall Study|Withdrawal by Subject|124|||
124883153|NCT02302066|449195147|FG003|Overall Study|Withdrawal by Subject|33|||
124883154|NCT02302066|449195144|FG000|Overall Study|Pregnancy|2|||
124883155|NCT02302066|449195145|FG001|Overall Study|Pregnancy|10|||
124883156|NCT02302066|449195146|FG002|Overall Study|Pregnancy|12|||
124883157|NCT02302066|449195147|FG003|Overall Study|Pregnancy|0|||
124883158|NCT02302066|449195144|FG000|Overall Study|Reason Not Specified|1|||
124883159|NCT02302066|449195145|FG001|Overall Study|Reason Not Specified|1|||
124883160|NCT02302066|449195146|FG002|Overall Study|Reason Not Specified|9|||
124883161|NCT02302066|449195147|FG003|Overall Study|Reason Not Specified|1|||
124883162|NCT02049710|449195148|FG000|Overall Study|Lost to Follow-up|319|||
124883163|NCT02049710|449195149|FG001|Overall Study|Lost to Follow-up|324|||
124883164|NCT00874432|449195153|FG000|Overall Study|Withdrawal by Subject|1|||
124883165|NCT00874432|449195154|FG001|Overall Study|Withdrawal by Subject|0|||
124883166|NCT00874432|449195155|FG002|Overall Study|Withdrawal by Subject|0|||
124883167|NCT00874432|449195156|FG003|Overall Study|Withdrawal by Subject|0|||
124883168|NCT00874432|449195153|FG000|Overall Study|Physician Decision|1|||
124883169|NCT00874432|449195154|FG001|Overall Study|Physician Decision|0|||
124883170|NCT00874432|449195155|FG002|Overall Study|Physician Decision|0|||
124883171|NCT00874432|449195156|FG003|Overall Study|Physician Decision|0|||
124883172|NCT00874432|449195153|FG000|Overall Study|Other|1|||
124883173|NCT00874432|449195154|FG001|Overall Study|Other|2|||
124883174|NCT00874432|449195155|FG002|Overall Study|Other|8|||
124883175|NCT00874432|449195156|FG003|Overall Study|Other|3|||
124883176|NCT03713021|449195157|FG000|Overall Study|Did not have CT sim scan available|6|||
124544390|NCT00948896|447946800|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
124883177|NCT03713021|449195157|FG000|Overall Study|Not eligible|4|||
124883178|NCT03713021|449195157|FG000|Overall Study|Issues with TraceIT markers|5|||
124883179|NCT03391960|449195163|FG000|Overall Study|Protocol Violation|0|||
124883180|NCT03391960|449195164|FG001|Overall Study|Protocol Violation|0|||
124883181|NCT01158378|449197100|FG000|Overall Study|Death|4|||
124883182|NCT01158378|449197101|FG001|Overall Study|Death|5|||
124883183|NCT01158378|449197100|FG000|Overall Study|Lost to Follow-up|2|||
124883184|NCT01158378|449197101|FG001|Overall Study|Lost to Follow-up|4|||
124883185|NCT01158378|449197100|FG000|Overall Study|Withdrawal by Subject|4|||
124883186|NCT01158378|449197101|FG001|Overall Study|Withdrawal by Subject|0|||
124883187|NCT02593539|449197102|FG000|Overall Study|Adverse Event|1|||
124883188|NCT01282476|449197103|FG000|Overall Study|Death|11|||
124883189|NCT00437125|449197104|FG000|Overall Study|Adverse Event|12|||
124883190|NCT00437125|449197104|FG000|Overall Study|Death|1|||
124883191|NCT00437125|449197104|FG000|Overall Study|Clinical Relapse|1|||
124883192|NCT00437125|449197104|FG000|Overall Study|Lack of Efficacy|1|||
124883193|NCT00437125|449197104|FG000|Overall Study|Lost to Follow-up|1|||
124883194|NCT00437125|449197104|FG000|Overall Study|Withdrawal by Subject|13|||
124883195|NCT00437125|449197104|FG000|Overall Study|Withdrawal by Caregiver|2|||
124883196|NCT00437125|449197104|FG000|Overall Study|Physician Decision|1|||
124883197|NCT00649389|449197107|FG000|Overall Study|Adverse Event|22|||
124883198|NCT00649389|449197108|FG001|Overall Study|Adverse Event|46|||
124883199|NCT00649389|449197109|FG002|Overall Study|Adverse Event|38|||
124883200|NCT00649389|449197110|FG003|Overall Study|Adverse Event|48|||
124883201|NCT00649389|449197107|FG000|Overall Study|Lost to Follow-up|15|||
124883202|NCT00649389|449197108|FG001|Overall Study|Lost to Follow-up|17|||
124883203|NCT00649389|449197109|FG002|Overall Study|Lost to Follow-up|21|||
124883204|NCT00649389|449197110|FG003|Overall Study|Lost to Follow-up|26|||
124883205|NCT00649389|449197107|FG000|Overall Study|Protocol Violation|11|||
124883206|NCT00649389|449197108|FG001|Overall Study|Protocol Violation|13|||
124883207|NCT00649389|449197109|FG002|Overall Study|Protocol Violation|9|||
124883208|NCT00649389|449197110|FG003|Overall Study|Protocol Violation|8|||
124883209|NCT00649389|449197107|FG000|Overall Study|Withdrawal by Subject|20|||
124883210|NCT00649389|449197108|FG001|Overall Study|Withdrawal by Subject|21|||
124883211|NCT00649389|449197109|FG002|Overall Study|Withdrawal by Subject|19|||
124883212|NCT00649389|449197110|FG003|Overall Study|Withdrawal by Subject|23|||
124883213|NCT00649389|449197107|FG000|Overall Study|Other|3|||
124883214|NCT00649389|449197108|FG001|Overall Study|Other|9|||
124883215|NCT00649389|449197109|FG002|Overall Study|Other|1|||
124883216|NCT00649389|449197110|FG003|Overall Study|Other|6|||
124883217|NCT01267825|449197113|FG000|Overall Study|study terminated. no data collected.|1|||
124883218|NCT01267825|449197114|FG001|Overall Study|study terminated. no data collected.|0|||
124883219|NCT01806740|449197115|FG000|Overall Study|Withdrawal by Subject|4|||
124883220|NCT01806740|449197115|FG000|Overall Study|Physician Decision|1|||
124883221|NCT01806740|449197115|FG000|Overall Study|Patient's refusal of treatment|1|||
124883222|NCT04666922|449197116|FG000|Overall Study|Withdrawal by Subject|1|||
124883223|NCT04666922|449197117|FG001|Overall Study|Withdrawal by Subject|0|||
124883224|NCT04666922|449197118|FG002|Overall Study|Withdrawal by Subject|0|||
124883225|NCT04666922|449197119|FG003|Overall Study|Withdrawal by Subject|0|||
124883226|NCT04666922|449197120|FG004|Overall Study|Withdrawal by Subject|0|||
124883227|NCT04666922|449197121|FG005|Overall Study|Withdrawal by Subject|0|||
124883228|NCT04666922|449197122|FG006|Overall Study|Withdrawal by Subject|0|||
124883229|NCT03722264|449197128|FG000|Overall Study|Physician Decision|3|||
124883230|NCT00871351|449197129|FG000|Overall Study|Withdrawal by Subject|1|||
124883231|NCT00871351|449197130|FG001|Overall Study|Withdrawal by Subject|0|||
124683154|NCT03965923|448461887|FG004|Overall Study|Death|0|||
124683155|NCT03965923|448461888|FG005|Overall Study|Death|0|||
124683156|NCT03965923|448461889|FG006|Overall Study|Death|0|||
124683157|NCT03965923|448461890|FG007|Overall Study|Death|1|||
124683158|NCT03965923|448461891|FG008|Overall Study|Death|4|||
124683159|NCT03965923|448461892|FG009|Overall Study|Death|0|||
124683160|NCT03965923|448461893|FG010|Overall Study|Death|4|||
124683161|NCT03965923|448461894|FG011|Overall Study|Death|0|||
124683162|NCT03965923|448461883|FG000|Overall Study|Other reason|0|||
124683163|NCT03965923|448461884|FG001|Overall Study|Other reason|0|||
124883232|NCT00871351|449197131|FG002|Overall Study|Withdrawal by Subject|0|||
124883233|NCT00871351|449197129|FG000|Overall Study|Adverse Event|3|||
124883234|NCT00871351|449197130|FG001|Overall Study|Adverse Event|1|||
124683164|NCT03965923|448461885|FG002|Overall Study|Other reason|0|||
124683165|NCT03965923|448461886|FG003|Overall Study|Other reason|1|||
124883235|NCT00871351|449197131|FG002|Overall Study|Adverse Event|0|||
124883236|NCT02959671|449197133|FG000|Overall Study|Adverse Event|2|||
124683166|NCT03965923|448461887|FG004|Overall Study|Other reason|0|||
124883237|NCT02959671|449197133|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
124883238|NCT02791490|449197134|FG000|Overall Study|Lost to Follow-up|1|||
124883239|NCT02791490|449197135|FG001|Overall Study|Lost to Follow-up|2|||
124883240|NCT02791490|449197134|FG000|Overall Study|Withdrawal by Subject|2|||
124883241|NCT02791490|449197135|FG001|Overall Study|Withdrawal by Subject|6|||
124883242|NCT01984424|449197136|FG000|Overall Study|Withdrawal by Subject|3|||
124883243|NCT01984424|449197137|FG001|Overall Study|Withdrawal by Subject|5|||
124883244|NCT01984424|449197136|FG000|Overall Study|Sponsor Decision|0|||
124883245|NCT01984424|449197137|FG001|Overall Study|Sponsor Decision|1|||
124883246|NCT01984424|449197136|FG000|Overall Study|Lost to Follow-up|0|||
124883247|NCT01984424|449197137|FG001|Overall Study|Lost to Follow-up|1|||
124883248|NCT00077636|449197138|FG000|Overall Study|Refused Treatment|9|||
124883249|NCT00077636|449197139|FG001|Overall Study|Refused Treatment|31|||
124883250|NCT00077636|449197138|FG000|Overall Study|Admin|3|||
124883251|NCT00077636|449197139|FG001|Overall Study|Admin|3|||
124883252|NCT00077636|449197138|FG000|Overall Study|Withdrawal by Subject|2|||
124883253|NCT00077636|449197139|FG001|Overall Study|Withdrawal by Subject|2|||
124883254|NCT00077636|449197138|FG000|Overall Study|Adverse Event|17|||
124883255|NCT00077636|449197139|FG001|Overall Study|Adverse Event|34|||
124883256|NCT00077636|449197138|FG000|Overall Study|Protocol Violation|0|||
124883257|NCT00077636|449197139|FG001|Overall Study|Protocol Violation|2|||
124883258|NCT00077636|449197138|FG000|Overall Study|Lost to Follow-up|10|||
124883259|NCT00077636|449197139|FG001|Overall Study|Lost to Follow-up|18|||
124883260|NCT00077636|449197138|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
124883261|NCT00077636|449197139|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
124883262|NCT02032173|449197140|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
124883263|NCT03661996|449197143|FG000|Overall Study|Adverse Event|0|||
124883264|NCT03661996|449197144|FG001|Overall Study|Adverse Event|0|||
124883265|NCT03661996|449197145|FG002|Overall Study|Adverse Event|1|||
124883266|NCT03661996|449197146|FG003|Overall Study|Adverse Event|1|||
124883267|NCT03661996|449197147|FG004|Overall Study|Adverse Event|0|||
124883268|NCT03661996|449197143|FG000|Overall Study|Lost to Follow-up|5|||
124883269|NCT03661996|449197144|FG001|Overall Study|Lost to Follow-up|1|||
124883270|NCT03661996|449197145|FG002|Overall Study|Lost to Follow-up|2|||
124883271|NCT03661996|449197146|FG003|Overall Study|Lost to Follow-up|2|||
124883272|NCT03661996|449197147|FG004|Overall Study|Lost to Follow-up|6|||
124883273|NCT03661996|449197143|FG000|Overall Study|Physician Decision|1|||
124883274|NCT03661996|449197144|FG001|Overall Study|Physician Decision|1|||
124883275|NCT03661996|449197145|FG002|Overall Study|Physician Decision|1|||
124883276|NCT03661996|449197146|FG003|Overall Study|Physician Decision|2|||
124883277|NCT03661996|449197147|FG004|Overall Study|Physician Decision|0|||
124883278|NCT03661996|449197143|FG000|Overall Study|Protocol Violation|0|||
124883279|NCT03661996|449197144|FG001|Overall Study|Protocol Violation|0|||
124883280|NCT03661996|449197145|FG002|Overall Study|Protocol Violation|0|||
124883281|NCT03661996|449197146|FG003|Overall Study|Protocol Violation|0|||
124883282|NCT03661996|449197147|FG004|Overall Study|Protocol Violation|1|||
124883283|NCT03661996|449197143|FG000|Overall Study|Withdrawal by Subject|3|||
124883284|NCT03661996|449197144|FG001|Overall Study|Withdrawal by Subject|5|||
124883285|NCT03661996|449197145|FG002|Overall Study|Withdrawal by Subject|1|||
124883286|NCT03661996|449197146|FG003|Overall Study|Withdrawal by Subject|7|||
124883287|NCT03661996|449197147|FG004|Overall Study|Withdrawal by Subject|7|||
124883288|NCT03661996|449197143|FG000|Overall Study|Sponsors Decision|2|||
124883289|NCT03661996|449197144|FG001|Overall Study|Sponsors Decision|0|||
124883290|NCT03661996|449197145|FG002|Overall Study|Sponsors Decision|0|||
124883291|NCT03661996|449197146|FG003|Overall Study|Sponsors Decision|0|||
124883292|NCT03661996|449197147|FG004|Overall Study|Sponsors Decision|0|||
124883293|NCT03661996|449197143|FG000|Overall Study|Other|1|||
124683167|NCT03965923|448461888|FG005|Overall Study|Other reason|0|||
124683168|NCT03965923|448461889|FG006|Overall Study|Other reason|0|||
124683169|NCT03965923|448461890|FG007|Overall Study|Other reason|0|||
124683170|NCT03965923|448461891|FG008|Overall Study|Other reason|0|||
124683171|NCT03965923|448461892|FG009|Overall Study|Other reason|0|||
124683172|NCT03965923|448461893|FG010|Overall Study|Other reason|2|||
124683173|NCT03965923|448461894|FG011|Overall Study|Other reason|0|||
124883294|NCT03661996|449197144|FG001|Overall Study|Other|1|||
124883295|NCT03661996|449197145|FG002|Overall Study|Other|1|||
124883296|NCT03661996|449197146|FG003|Overall Study|Other|1|||
124439408|NCT00960531|447569176|FG004|Overall Study|Investigator Request|0|||
124883297|NCT03661996|449197147|FG004|Overall Study|Other|0|||
124439409|NCT00960531|447569177|FG005|Overall Study|Investigator Request|0|||
124439410|NCT00960531|447569178|FG006|Overall Study|Investigator Request|0|||
124683174|NCT02755090|448461896|FG000|Overall Study|equipment malfunction|1|||
124883298|NCT01993017|449197148|FG000|Overall Study|Death|23|||
124883299|NCT01993017|449197149|FG001|Overall Study|Death|26|||
124883300|NCT01993017|449197150|FG002|Overall Study|Death|18|||
124883301|NCT01993017|449197148|FG000|Overall Study|Could not be contacted|43|||
124883302|NCT01993017|449197149|FG001|Overall Study|Could not be contacted|42|||
124883303|NCT01993017|449197150|FG002|Overall Study|Could not be contacted|38|||
124883304|NCT01993017|449197148|FG000|Overall Study|Dropped out|19|||
124883305|NCT01993017|449197149|FG001|Overall Study|Dropped out|6|||
124883306|NCT01993017|449197150|FG002|Overall Study|Dropped out|11|||
124883307|NCT01993017|449197148|FG000|Overall Study|Other reasons|17|||
124883308|NCT01993017|449197149|FG001|Overall Study|Other reasons|11|||
124883309|NCT01993017|449197150|FG002|Overall Study|Other reasons|7|||
124883310|NCT01993017|449197148|FG000|Overall Study|Ineligible after randomization|4|||
124883311|NCT01993017|449197149|FG001|Overall Study|Ineligible after randomization|5|||
124883312|NCT01993017|449197150|FG002|Overall Study|Ineligible after randomization|5|||
124883313|NCT00068380|449197151|FG000|Overall Study|Withdrawal by Subject|3|||
124883314|NCT00068380|449197151|FG000|Overall Study|Adverse Event|2|||
124883315|NCT00917267|449197159|FG000|Overall Study|Adverse Event|15|||
124883316|NCT00917267|449197160|FG001|Overall Study|Adverse Event|36|||
124883317|NCT00917267|449197159|FG000|Overall Study|Physician Decision|2|||
124883318|NCT00917267|449197160|FG001|Overall Study|Physician Decision|4|||
124883319|NCT00917267|449197159|FG000|Overall Study|Protocol Violation|9|||
124883320|NCT00917267|449197160|FG001|Overall Study|Protocol Violation|18|||
124883321|NCT00917267|449197159|FG000|Overall Study|Withdrawal by Subject|5|||
124883322|NCT00917267|449197160|FG001|Overall Study|Withdrawal by Subject|12|||
124883323|NCT00917267|449197159|FG000|Overall Study|Lost to follow up|0|||
124883324|NCT00917267|449197160|FG001|Overall Study|Lost to follow up|2|||
124883325|NCT00917267|449197159|FG000|Overall Study|Entry Criteria Not Met|1|||
124883326|NCT00917267|449197160|FG001|Overall Study|Entry Criteria Not Met|0|||
124883327|NCT00917267|449197159|FG000|Overall Study|Sponsor Decision|5|||
124883328|NCT00917267|449197160|FG001|Overall Study|Sponsor Decision|5|||
124883329|NCT00917267|449197159|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
124883330|NCT00917267|449197160|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
124883331|NCT02960763|449197161|FG000|Step 1|Withdrawal by Subject|10|||
124883332|NCT02960763|449197162|FG001|Step 1|Withdrawal by Subject|8|||
124883333|NCT02960763|449197163|FG002|Step 1|Withdrawal by Subject|13|||
124883334|NCT02960763|449197164|FG003|Step 1|Withdrawal by Subject|0|||
124883335|NCT02960763|449197165|FG004|Step 1|Withdrawal by Subject|0|||
124883336|NCT02960763|449197161|FG000|Step 1|Lost to Follow-up|7|||
124883337|NCT02960763|449197162|FG001|Step 1|Lost to Follow-up|9|||
124883338|NCT02960763|449197163|FG002|Step 1|Lost to Follow-up|12|||
124883339|NCT02960763|449197164|FG003|Step 1|Lost to Follow-up|0|||
124883340|NCT02960763|449197165|FG004|Step 1|Lost to Follow-up|0|||
124883341|NCT02960763|449197161|FG000|Step 1|Death|1|||
124883342|NCT02960763|449197162|FG001|Step 1|Death|1|||
124883343|NCT02960763|449197163|FG002|Step 1|Death|1|||
124883344|NCT02960763|449197164|FG003|Step 1|Death|0|||
124883345|NCT02960763|449197165|FG004|Step 1|Death|0|||
124883346|NCT02960763|449197161|FG000|Step 1|Investigator discretion|1|||
124883347|NCT02960763|449197162|FG001|Step 1|Investigator discretion|0|||
124683175|NCT02755090|448461897|FG001|Overall Study|equipment malfunction|0|||
124683176|NCT03839641|448461899|FG000|Overall Study|Withdrawal by Subject|1|||
124683177|NCT03839641|448461900|FG001|Overall Study|Withdrawal by Subject|1|||
124683178|NCT00770809|448463780|FG000|Overall Study|Adverse Event|9|||
124683179|NCT00770809|448463781|FG001|Overall Study|Adverse Event|1|||
124683180|NCT00770809|448463782|FG002|Overall Study|Adverse Event|12|||
124683181|NCT00770809|448463780|FG000|Overall Study|Death|1|||
124683182|NCT00770809|448463781|FG001|Overall Study|Death|0|||
124683183|NCT00770809|448463782|FG002|Overall Study|Death|0|||
124683184|NCT00770809|448463780|FG000|Overall Study|Withdrawal by Subject|3|||
124683185|NCT00770809|448463781|FG001|Overall Study|Withdrawal by Subject|3|||
124883348|NCT02960763|449197163|FG002|Step 1|Investigator discretion|1|||
124683186|NCT00770809|448463782|FG002|Overall Study|Withdrawal by Subject|7|||
124683187|NCT00770809|448463780|FG000|Overall Study|Progression|2|||
124683188|NCT00770809|448463781|FG001|Overall Study|Progression|2|||
124883349|NCT02960763|449197164|FG003|Step 1|Investigator discretion|0|||
124883350|NCT02960763|449197165|FG004|Step 1|Investigator discretion|0|||
124883351|NCT02960763|449197161|FG000|Step 1|Other|0|||
124683189|NCT00770809|448463782|FG002|Overall Study|Progression|0|||
124683190|NCT00770809|448463780|FG000|Overall Study|Complicating illness|0|||
124683191|NCT00770809|448463781|FG001|Overall Study|Complicating illness|0|||
124883352|NCT02960763|449197162|FG001|Step 1|Other|0|||
124883353|NCT02960763|449197163|FG002|Step 1|Other|1|||
124883354|NCT02960763|449197164|FG003|Step 1|Other|0|||
124883355|NCT02960763|449197165|FG004|Step 1|Other|0|||
124883356|NCT02960763|449197161|FG000|Step 2|Withdrawal by Subject|0|||
124883357|NCT02960763|449197162|FG001|Step 2|Withdrawal by Subject|0|||
124883358|NCT02960763|449197163|FG002|Step 2|Withdrawal by Subject|0|||
124883359|NCT02960763|449197164|FG003|Step 2|Withdrawal by Subject|7|||
124883360|NCT02960763|449197165|FG004|Step 2|Withdrawal by Subject|3|||
124883361|NCT02960763|449197161|FG000|Step 2|Lost to Follow-up|0|||
124883362|NCT02960763|449197162|FG001|Step 2|Lost to Follow-up|0|||
124883363|NCT02960763|449197163|FG002|Step 2|Lost to Follow-up|0|||
124883364|NCT02960763|449197164|FG003|Step 2|Lost to Follow-up|4|||
124883365|NCT02960763|449197165|FG004|Step 2|Lost to Follow-up|1|||
124883366|NCT02960763|449197161|FG000|Step 2|Investigator discretion|0|||
124883367|NCT02960763|449197162|FG001|Step 2|Investigator discretion|0|||
124883368|NCT02960763|449197163|FG002|Step 2|Investigator discretion|0|||
124883369|NCT02960763|449197164|FG003|Step 2|Investigator discretion|0|||
124883370|NCT02960763|449197165|FG004|Step 2|Investigator discretion|1|||
124883371|NCT00312858|449197169|FG000|Overall Study|Adverse Event|0|||
124883372|NCT00312858|449197170|FG001|Overall Study|Adverse Event|1|||
124883373|NCT00312858|449197169|FG000|Overall Study|Lost to Follow-up|25|||
124883374|NCT00312858|449197170|FG001|Overall Study|Lost to Follow-up|42|||
124883375|NCT00312858|449197169|FG000|Overall Study|Protocol Violation|3|||
124883376|NCT00312858|449197170|FG001|Overall Study|Protocol Violation|8|||
124883377|NCT00312858|449197169|FG000|Overall Study|Withdraw by Participant|20|||
124883378|NCT00312858|449197170|FG001|Overall Study|Withdraw by Participant|20|||
124883379|NCT00312858|449197169|FG000|Overall Study|Participant Moved|11|||
124883380|NCT00312858|449197170|FG001|Overall Study|Participant Moved|10|||
124883381|NCT00312858|449197169|FG000|Overall Study|Other|9|||
124883382|NCT00312858|449197170|FG001|Overall Study|Other|12|||
124883383|NCT01868035|449197171|FG000|Overall Study|Lost to Follow-up|3|||
124883384|NCT01868035|449197171|FG000|Overall Study|Withdrawal by Subject|1|||
124883385|NCT01868035|449197171|FG000|Overall Study|Progressive Disease|2|||
124883386|NCT01868035|449197171|FG000|Overall Study|Non-compliance|1|||
124883387|NCT00432835|449197172|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
124883388|NCT00432835|449197173|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
124883389|NCT00423293|449197174|FG000|Overall Study|Ineligible / No protocol treatment|11|||
124883390|NCT01912222|449197175|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
124883391|NCT01912222|449197176|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
124883392|NCT01912222|449197177|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
124883393|NCT01912222|449197175|FG000|Part B: Treatment Period|Progressive disease|10|||
124883394|NCT01912222|449197176|FG001|Part B: Treatment Period|Progressive disease|12|||
124883395|NCT01912222|449197177|FG002|Part B: Treatment Period|Progressive disease|15|||
124883396|NCT01912222|449197175|FG000|Part B: Treatment Period|Adverse Event|1|||
124883397|NCT01912222|449197176|FG001|Part B: Treatment Period|Adverse Event|2|||
124883398|NCT01912222|449197177|FG002|Part B: Treatment Period|Adverse Event|3|||
124883399|NCT01912222|449197175|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
124883400|NCT01912222|449197176|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
124883401|NCT01912222|449197177|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
124883402|NCT04399551|449197178|FG000|Overall Study|Adverse Event|15|||
124883403|NCT04399551|449197178|FG000|Overall Study|Withdrawal by Subject|6|||
124883404|NCT04399551|449197178|FG000|Overall Study|Physician Decision|3|||
124883405|NCT04399551|449197178|FG000|Overall Study|Lost to Follow-up|2|||
124883406|NCT04399551|449197178|FG000|Overall Study|Protocol Deviation|2|||
124883407|NCT01014975|449197179|FG000|Overall Study|Withdrawal by Subject|1|||
124883408|NCT01014975|449197180|FG001|Overall Study|Withdrawal by Subject|0|||
124883409|NCT01014975|449197181|FG002|Overall Study|Withdrawal by Subject|1|||
124883410|NCT01014975|449197179|FG000|Overall Study|Death|3|||
124883411|NCT01014975|449197180|FG001|Overall Study|Death|3|||
124883412|NCT01014975|449197181|FG002|Overall Study|Death|4|||
124883413|NCT01014975|449197179|FG000|Overall Study|Lost to Follow-up|0|||
124883414|NCT01014975|449197180|FG001|Overall Study|Lost to Follow-up|0|||
124883415|NCT01014975|449197181|FG002|Overall Study|Lost to Follow-up|1|||
124883416|NCT01336634|449197184|FG000|Overall Study|Study closed/terminated|5|||
124883417|NCT01336634|449197185|FG001|Overall Study|Study closed/terminated|6|||
124883418|NCT01336634|449197186|FG002|Overall Study|Study closed/terminated|6|||
124883419|NCT01336634|449197184|FG000|Overall Study|Lost to Follow-up|2|||
124883420|NCT01336634|449197185|FG001|Overall Study|Lost to Follow-up|1|||
124883421|NCT01336634|449197186|FG002|Overall Study|Lost to Follow-up|1|||
124758661|NCT02679287|448739823|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
124883422|NCT01336634|449197184|FG000|Overall Study|Physician Decision|1|||
124883423|NCT01336634|449197185|FG001|Overall Study|Physician Decision|1|||
124883424|NCT01336634|449197186|FG002|Overall Study|Physician Decision|0|||
124883425|NCT01336634|449197184|FG000|Overall Study|Withdrawal by Subject|6|||
124883426|NCT01336634|449197185|FG001|Overall Study|Withdrawal by Subject|0|||
124883427|NCT01336634|449197186|FG002|Overall Study|Withdrawal by Subject|2|||
124883428|NCT01863043|449197187|FG000|Overall Study|Death|6|||
124883429|NCT01863043|449197188|FG001|Overall Study|Death|1|||
124883430|NCT01863043|449197187|FG000|Overall Study|Withdrawal by Subject|0|||
124883431|NCT01863043|449197188|FG001|Overall Study|Withdrawal by Subject|2|||
124883432|NCT01863043|449197187|FG000|Overall Study|Adverse Event|7|||
124883433|NCT01863043|449197188|FG001|Overall Study|Adverse Event|8|||
124883434|NCT01863043|449197187|FG000|Overall Study|exclusion criteria found after enrollment|0|||
124883435|NCT01863043|449197188|FG001|Overall Study|exclusion criteria found after enrollment|1|||
124883436|NCT00854295|449197191|FG000|Overall Study|Death|7|||
124883437|NCT00854295|449197192|FG001|Overall Study|Death|0|||
124883438|NCT00854295|449197193|FG002|Overall Study|Death|1|||
124883439|NCT00854295|449197194|FG003|Overall Study|Death|1|||
124883440|NCT00854295|449197191|FG000|Overall Study|Adverse Event|6|||
124883441|NCT00854295|449197192|FG001|Overall Study|Adverse Event|1|||
124883442|NCT00854295|449197193|FG002|Overall Study|Adverse Event|1|||
124883443|NCT00854295|449197194|FG003|Overall Study|Adverse Event|3|||
124883444|NCT00854295|449197191|FG000|Overall Study|Lost to Follow-up|18|||
124883445|NCT00854295|449197192|FG001|Overall Study|Lost to Follow-up|5|||
124883446|NCT00854295|449197193|FG002|Overall Study|Lost to Follow-up|21|||
124883447|NCT00854295|449197194|FG003|Overall Study|Lost to Follow-up|21|||
124883448|NCT00854295|449197191|FG000|Overall Study|Physician Decision|10|||
124883449|NCT00854295|449197192|FG001|Overall Study|Physician Decision|0|||
124883450|NCT00854295|449197193|FG002|Overall Study|Physician Decision|0|||
124883451|NCT00854295|449197194|FG003|Overall Study|Physician Decision|0|||
124883452|NCT03154359|449197195|FG000|Overall Study|Adverse Event|1|||
124883453|NCT03154359|449197195|FG000|Overall Study|Lack of Efficacy|2|||
124883454|NCT03154359|449197195|FG000|Overall Study|Lost to Follow-up|3|||
124883455|NCT03154359|449197195|FG000|Overall Study|Physician Decision|3|||
124883456|NCT03154359|449197195|FG000|Overall Study|Protocol Violation|4|||
124883457|NCT03154359|449197195|FG000|Overall Study|Withdrawal by Subject|5|||
124883458|NCT03154359|449197195|FG000|Overall Study|Disruption of study due to COVID-19|4|||
124883459|NCT05033743|449197196|FG000|Overall Study|Lost to Follow-up|1|||
124883460|NCT05033743|449197196|FG000|Overall Study|Protocol Violation|2|||
124883461|NCT05033743|449197196|FG000|Overall Study|Withdrawal by Subject|1|||
124883462|NCT00885352|449197199|FG000|Overall Study|Adverse Event|2|||
124883463|NCT00885352|449197200|FG001|Overall Study|Adverse Event|3|||
124883464|NCT00885352|449197199|FG000|Overall Study|Lost to Follow-up|2|||
124883465|NCT00885352|449197200|FG001|Overall Study|Lost to Follow-up|2|||
124883466|NCT00885352|449197199|FG000|Overall Study|Physician Decision|0|||
124883467|NCT00885352|449197200|FG001|Overall Study|Physician Decision|3|||
124883468|NCT00885352|449197199|FG000|Overall Study|Protocol Violation|0|||
124883469|NCT00885352|449197200|FG001|Overall Study|Protocol Violation|2|||
124883470|NCT00885352|449197199|FG000|Overall Study|Withdrawal by Subject|1|||
124883471|NCT00885352|449197200|FG001|Overall Study|Withdrawal by Subject|5|||
124439411|NCT00960531|447569179|FG007|Overall Study|Investigator Request|0|||
124439412|NCT00960531|447569180|FG008|Overall Study|Investigator Request|0|||
124439413|NCT00960531|447569181|FG009|Overall Study|Investigator Request|0|||
124439414|NCT00960531|447569172|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
124439415|NCT00960531|447569173|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
124439416|NCT00960531|447569174|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
124439417|NCT00960531|447569175|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
124439418|NCT00960531|447569176|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
124439419|NCT00960531|447569177|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
124439420|NCT00960531|447569178|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
124439421|NCT00960531|447569179|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
124439422|NCT00960531|447569180|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
124439423|NCT00960531|447569181|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
124439424|NCT00960531|447569172|FG000|Overall Study|Lost to Follow-up|0|||
124439425|NCT00960531|447569173|FG001|Overall Study|Lost to Follow-up|0|||
124439426|NCT00960531|447569174|FG002|Overall Study|Lost to Follow-up|1|||
124439427|NCT00960531|447569175|FG003|Overall Study|Lost to Follow-up|0|||
124439428|NCT00960531|447569176|FG004|Overall Study|Lost to Follow-up|0|||
124439429|NCT00960531|447569177|FG005|Overall Study|Lost to Follow-up|0|||
124439430|NCT00960531|447569178|FG006|Overall Study|Lost to Follow-up|1|||
124439431|NCT00960531|447569179|FG007|Overall Study|Lost to Follow-up|0|||
124439432|NCT00960531|447569180|FG008|Overall Study|Lost to Follow-up|0|||
124439433|NCT00960531|447569181|FG009|Overall Study|Lost to Follow-up|0|||
124439434|NCT00960531|447569172|FG000|Overall Study|Failed to Return|2|||
124439435|NCT00960531|447569173|FG001|Overall Study|Failed to Return|0|||
124758662|NCT02679287|448739824|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
124758663|NCT02679287|448739823|FG000|Period 2|Work/Scheduling Conflict|1|||
124883472|NCT00885352|449197199|FG000|Overall Study|Contradiction to study medication|0|||
124883473|NCT00885352|449197200|FG001|Overall Study|Contradiction to study medication|2|||
124883474|NCT00885352|449197199|FG000|Overall Study|Excluded medication|2|||
124883475|NCT00885352|449197200|FG001|Overall Study|Excluded medication|2|||
124883476|NCT00885352|449197199|FG000|Overall Study|Lab abnormalities|1|||
124883477|NCT00885352|449197200|FG001|Overall Study|Lab abnormalities|1|||
124883478|NCT00152971|449197206|FG000|Overall Study|Adverse Event|12|||
124883479|NCT00152971|449197207|FG001|Overall Study|Adverse Event|10|||
124883480|NCT00152971|449197208|FG002|Overall Study|Adverse Event|9|||
124439436|NCT00960531|447569174|FG002|Overall Study|Failed to Return|0|||
124439437|NCT00960531|447569175|FG003|Overall Study|Failed to Return|0|||
124439438|NCT00960531|447569176|FG004|Overall Study|Failed to Return|0|||
124439439|NCT00960531|447569177|FG005|Overall Study|Failed to Return|0|||
124439440|NCT00960531|447569178|FG006|Overall Study|Failed to Return|0|||
124883481|NCT00152971|449197206|FG000|Overall Study|Protocol Violation|10|||
124883482|NCT00152971|449197207|FG001|Overall Study|Protocol Violation|11|||
124883483|NCT00152971|449197208|FG002|Overall Study|Protocol Violation|8|||
124883484|NCT00152971|449197206|FG000|Overall Study|Lost to Follow-up|17|||
124883485|NCT00152971|449197207|FG001|Overall Study|Lost to Follow-up|14|||
124883486|NCT00152971|449197208|FG002|Overall Study|Lost to Follow-up|13|||
124883487|NCT00152971|449197206|FG000|Overall Study|Withdrawal by Subject|9|||
124883488|NCT00152971|449197207|FG001|Overall Study|Withdrawal by Subject|8|||
124883489|NCT00152971|449197208|FG002|Overall Study|Withdrawal by Subject|14|||
124883490|NCT00152971|449197206|FG000|Overall Study|Other|3|||
124883491|NCT00152971|449197207|FG001|Overall Study|Other|5|||
124883492|NCT00152971|449197208|FG002|Overall Study|Other|5|||
124883493|NCT00152971|449197206|FG000|Treatment|Adverse Event|49|||
124883494|NCT00152971|449197207|FG001|Treatment|Adverse Event|40|||
124883495|NCT00152971|449197208|FG002|Treatment|Adverse Event|54|||
124883496|NCT00152971|449197206|FG000|Treatment|Protocol Violation|8|||
124883497|NCT00152971|449197207|FG001|Treatment|Protocol Violation|6|||
124883498|NCT00152971|449197208|FG002|Treatment|Protocol Violation|10|||
124883499|NCT00152971|449197206|FG000|Treatment|Lost to Follow-up|1|||
124883500|NCT00152971|449197207|FG001|Treatment|Lost to Follow-up|2|||
124883501|NCT00152971|449197208|FG002|Treatment|Lost to Follow-up|1|||
124883502|NCT00152971|449197206|FG000|Treatment|Withdrawal by Subject|4|||
124883503|NCT00152971|449197207|FG001|Treatment|Withdrawal by Subject|4|||
124883504|NCT00152971|449197208|FG002|Treatment|Withdrawal by Subject|5|||
124883505|NCT00152971|449197206|FG000|Treatment|Other|9|||
124883506|NCT00152971|449197207|FG001|Treatment|Other|11|||
124883507|NCT00152971|449197208|FG002|Treatment|Other|10|||
124883508|NCT03292146|449197209|FG000|Baseline to 12 Months|Relocation|1|||
124883509|NCT03292146|449197210|FG001|Baseline to 12 Months|Relocation|0|||
124883510|NCT03292146|449197209|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
124883511|NCT03292146|449197210|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
124883512|NCT03292146|449197209|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
124883513|NCT03292146|449197210|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
124883514|NCT03292146|449197209|FG000|12 Months to 24 Months|Planning pregnancy|2|||
124883515|NCT03292146|449197210|FG001|12 Months to 24 Months|Planning pregnancy|2|||
124883516|NCT03292146|449197209|FG000|12 Months to 24 Months|Personal reasons|1|||
124883517|NCT03292146|449197210|FG001|12 Months to 24 Months|Personal reasons|0|||
124883518|NCT03292146|449197209|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
124883519|NCT03292146|449197210|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
124883520|NCT00366301|449197213|FG000|Overall Study|Lost to Follow-up|4|||
124883521|NCT00366301|449197214|FG001|Overall Study|Lost to Follow-up|4|||
124883522|NCT00366301|449197215|FG002|Overall Study|Lost to Follow-up|3|||
124883523|NCT00366301|449197216|FG003|Overall Study|Lost to Follow-up|7|||
124883524|NCT00366301|449197213|FG000|Overall Study|Withdrawal by Subject|4|||
124883525|NCT00366301|449197214|FG001|Overall Study|Withdrawal by Subject|2|||
124883526|NCT00366301|449197215|FG002|Overall Study|Withdrawal by Subject|1|||
124883527|NCT00366301|449197216|FG003|Overall Study|Withdrawal by Subject|1|||
124883528|NCT01076088|449197223|FG000|Overall Study|Adverse Event|1|||
124883529|NCT01076088|449197224|FG001|Overall Study|Adverse Event|6|||
124883530|NCT01076088|449197225|FG002|Overall Study|Adverse Event|3|||
124883531|NCT01076088|449197226|FG003|Overall Study|Adverse Event|2|||
124883532|NCT01076088|449197227|FG004|Overall Study|Adverse Event|3|||
124883533|NCT01076088|449197228|FG005|Overall Study|Adverse Event|3|||
124883534|NCT01076088|449197223|FG000|Overall Study|Lost to Follow-up|1|||
124883535|NCT01076088|449197224|FG001|Overall Study|Lost to Follow-up|1|||
124883536|NCT01076088|449197225|FG002|Overall Study|Lost to Follow-up|0|||
124883537|NCT01076088|449197226|FG003|Overall Study|Lost to Follow-up|1|||
124883538|NCT01076088|449197227|FG004|Overall Study|Lost to Follow-up|1|||
124883539|NCT01076088|449197228|FG005|Overall Study|Lost to Follow-up|2|||
124883540|NCT01076088|449197223|FG000|Overall Study|Non-compliance with study drug|0|||
124883541|NCT01076088|449197224|FG001|Overall Study|Non-compliance with study drug|0|||
124883542|NCT01076088|449197225|FG002|Overall Study|Non-compliance with study drug|0|||
124883543|NCT01076088|449197226|FG003|Overall Study|Non-compliance with study drug|1|||
124683192|NCT00770809|448463782|FG002|Overall Study|Complicating illness|1|||
124683193|NCT00770809|448463780|FG000|Overall Study|Other Medical Reasons|2|||
124683194|NCT00770809|448463781|FG001|Overall Study|Other Medical Reasons|4|||
124683195|NCT00770809|448463782|FG002|Overall Study|Other Medical Reasons|3|||
124883544|NCT01076088|449197227|FG004|Overall Study|Non-compliance with study drug|0|||
124883545|NCT01076088|449197228|FG005|Overall Study|Non-compliance with study drug|0|||
124883546|NCT01076088|449197223|FG000|Overall Study|Physician Decision|1|||
124883547|NCT01076088|449197224|FG001|Overall Study|Physician Decision|3|||
124883548|NCT01076088|449197225|FG002|Overall Study|Physician Decision|0|||
124883549|NCT01076088|449197226|FG003|Overall Study|Physician Decision|1|||
124683196|NCT02469233|448463787|FG000|Overall Study|Death|1|||
124883550|NCT01076088|449197227|FG004|Overall Study|Physician Decision|1|||
124883551|NCT01076088|449197228|FG005|Overall Study|Physician Decision|0|||
124883552|NCT01076088|449197223|FG000|Overall Study|Withdrawal by Subject|8|||
124883553|NCT01076088|449197224|FG001|Overall Study|Withdrawal by Subject|8|||
124883554|NCT01076088|449197225|FG002|Overall Study|Withdrawal by Subject|14|||
124683197|NCT02469233|448463788|FG001|Overall Study|Death|1|||
124683198|NCT02469233|448463787|FG000|Overall Study|Lost to post or 6 month follow up|7|||
124683199|NCT02469233|448463788|FG001|Overall Study|Lost to post or 6 month follow up|2|||
124683200|NCT03474107|448463789|FG000|Overall Study|Adverse Event|42|||
124683201|NCT03474107|448463790|FG001|Overall Study|Adverse Event|46|||
124683202|NCT03474107|448463789|FG000|Overall Study|Death|2|||
124683203|NCT03474107|448463790|FG001|Overall Study|Death|2|||
124683204|NCT03474107|448463789|FG000|Overall Study|Lost to Follow-up|0|||
124683205|NCT03474107|448463790|FG001|Overall Study|Lost to Follow-up|1|||
124683206|NCT03474107|448463789|FG000|Overall Study|Progressive Disease|177|||
124683207|NCT03474107|448463790|FG001|Overall Study|Progressive Disease|180|||
124683208|NCT03474107|448463789|FG000|Overall Study|Protocol Violation|1|||
124683209|NCT03474107|448463790|FG001|Overall Study|Protocol Violation|1|||
124683210|NCT03474107|448463789|FG000|Overall Study|Withdrawal by Subject|15|||
124683211|NCT03474107|448463790|FG001|Overall Study|Withdrawal by Subject|27|||
124683212|NCT03474107|448463789|FG000|Overall Study|Physician Decision|7|||
124683213|NCT03474107|448463790|FG001|Overall Study|Physician Decision|22|||
124683214|NCT03474107|448463789|FG000|Overall Study|Miscellaneous|1|||
124683215|NCT03474107|448463790|FG001|Overall Study|Miscellaneous|6|||
124683216|NCT03095287|448463791|FG000|Overall Study|Treatment Failure|1|||
124683217|NCT03095287|448463791|FG000|Overall Study|Adverse Event|1|||
124683218|NCT01431976|448463792|FG000|Overall Study|Adverse Event|6|||
124683219|NCT01431976|448463792|FG000|Overall Study|Lack of Efficacy|2|||
124683220|NCT01431976|448463792|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
124683221|NCT01431976|448463792|FG000|Overall Study|Physician Decision|1|||
124683222|NCT01431976|448463792|FG000|Overall Study|Withdrawal by Subject|1|||
124683223|NCT02127671|448463800|FG000|Overall Study|Death|2|||
124683224|NCT02127671|448463801|FG001|Overall Study|Death|2|||
124683225|NCT02127671|448463800|FG000|Overall Study|Lost to Follow-up|4|||
124683226|NCT02127671|448463801|FG001|Overall Study|Lost to Follow-up|2|||
124683227|NCT02127671|448463800|FG000|Overall Study|Physician Decision|1|||
124683228|NCT02127671|448463801|FG001|Overall Study|Physician Decision|0|||
124683229|NCT02127671|448463800|FG000|Overall Study|incarceration|0|||
124683230|NCT02127671|448463801|FG001|Overall Study|incarceration|1|||
124683231|NCT02127671|448463800|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
124683232|NCT02127671|448463801|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
124439441|NCT00960531|447569179|FG007|Overall Study|Failed to Return|2|||
124439442|NCT00960531|447569180|FG008|Overall Study|Failed to Return|0|||
124683233|NCT01136954|448463802|FG000|Overall Study|Adverse Event|3|||
124683234|NCT01136954|448463803|FG001|Overall Study|Adverse Event|2|||
124683235|NCT01136954|448463802|FG000|Overall Study|Withdrawal by Subject|6|||
124683236|NCT01136954|448463803|FG001|Overall Study|Withdrawal by Subject|2|||
124683237|NCT01136954|448463802|FG000|Overall Study|Lack of Efficacy|14|||
124683238|NCT01136954|448463803|FG001|Overall Study|Lack of Efficacy|13|||
124439443|NCT00960531|447569181|FG009|Overall Study|Failed to Return|0|||
124883555|NCT01076088|449197226|FG003|Overall Study|Withdrawal by Subject|10|||
124883556|NCT01076088|449197227|FG004|Overall Study|Withdrawal by Subject|11|||
124883557|NCT01076088|449197228|FG005|Overall Study|Withdrawal by Subject|17|||
124883558|NCT01076088|449197223|FG000|Overall Study|Other protocol specified criteria|0|||
124883559|NCT01076088|449197224|FG001|Overall Study|Other protocol specified criteria|0|||
124883560|NCT01076088|449197225|FG002|Overall Study|Other protocol specified criteria|0|||
124883561|NCT01076088|449197226|FG003|Overall Study|Other protocol specified criteria|0|||
124883562|NCT01076088|449197227|FG004|Overall Study|Other protocol specified criteria|0|||
124883563|NCT01076088|449197228|FG005|Overall Study|Other protocol specified criteria|1|||
124883564|NCT03306043|449197232|FG000|Overall Study|Adverse Event|1|||
124883565|NCT03306043|449197232|FG000|Overall Study|Lost to Follow-up|1|||
124883566|NCT03306043|449197232|FG000|Overall Study|Withdrawal by Subject|2|||
124883567|NCT00785538|449197246|FG000|Treatment Period|Adverse Event|1|||
124883568|NCT00785538|449197247|FG001|Treatment Period|Adverse Event|2|||
124883569|NCT00785538|449197248|FG002|Treatment Period|Adverse Event|2|||
124883570|NCT00785538|449197249|FG003|Treatment Period|Adverse Event|0|||
124883571|NCT00785538|449197246|FG000|Treatment Period|Withdrawal by Subject|0|||
124883572|NCT00785538|449197247|FG001|Treatment Period|Withdrawal by Subject|0|||
124883573|NCT00785538|449197248|FG002|Treatment Period|Withdrawal by Subject|0|||
124883574|NCT00785538|449197249|FG003|Treatment Period|Withdrawal by Subject|1|||
124883575|NCT02494206|449197250|FG000|Overall Study|Adverse Event|1|||
124883576|NCT02494206|449197250|FG000|Overall Study|Disease Progression|1|||
124883577|NCT04276090|449197251|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
124883578|NCT04276090|449197252|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
124883579|NCT01799720|449197253|FG000|Overall Study|Withdrawal by Subject|3|||
124883580|NCT01799720|449197254|FG001|Overall Study|Withdrawal by Subject|0|||
124883581|NCT01799720|449197255|FG002|Overall Study|Withdrawal by Subject|0|||
124883582|NCT01799720|449197253|FG000|Overall Study|Protocol Violation|0|||
124883583|NCT01799720|449197254|FG001|Overall Study|Protocol Violation|1|||
124883584|NCT01799720|449197255|FG002|Overall Study|Protocol Violation|0|||
124883585|NCT01799720|449197253|FG000|Overall Study|Pregnancy|0|||
124883586|NCT01799720|449197254|FG001|Overall Study|Pregnancy|0|||
124883587|NCT01799720|449197255|FG002|Overall Study|Pregnancy|1|||
124883588|NCT01234649|449197256|FG000|Overall Study|Withdrawal by Subject|32|||
124883589|NCT01234649|449197257|FG001|Overall Study|Withdrawal by Subject|26|||
124883590|NCT01234649|449197256|FG000|Overall Study|Pregnancy|6|||
124883591|NCT01234649|449197257|FG001|Overall Study|Pregnancy|6|||
124883592|NCT01234649|449197256|FG000|Overall Study|intolerant to side effects|4|||
124883593|NCT01234649|449197257|FG001|Overall Study|intolerant to side effects|3|||
124883594|NCT01234649|449197256|FG000|Overall Study|Allergic reaction|1|||
124883595|NCT01234649|449197257|FG001|Overall Study|Allergic reaction|0|||
124883596|NCT01234649|449197256|FG000|Overall Study|Lack of Efficacy|0|||
124883597|NCT01234649|449197257|FG001|Overall Study|Lack of Efficacy|3|||
124883598|NCT00318149|449197258|FG000|Overall Study|Adverse Event|0|||
124883599|NCT00318149|449197259|FG001|Overall Study|Adverse Event|0|||
124883600|NCT00318149|449197260|FG002|Overall Study|Adverse Event|0|||
124883601|NCT00318149|449197261|FG003|Overall Study|Adverse Event|0|||
124883602|NCT00318149|449197262|FG004|Overall Study|Adverse Event|0|||
124883603|NCT00318149|449197263|FG005|Overall Study|Adverse Event|2|||
124883604|NCT00785707|449197265|FG000|Overall Study|Lost to Follow-up|7|||
124883605|NCT02322814|449197266|FG000|Overall Study|Death|7|||
124883606|NCT02322814|449197267|FG001|Overall Study|Death|29|||
124883607|NCT02322814|449197268|FG002|Overall Study|Death|32|||
124883608|NCT02322814|449197269|FG003|Overall Study|Death|23|||
124883609|NCT02322814|449197270|FG004|Overall Study|Death|14|||
124883610|NCT02322814|449197266|FG000|Overall Study|Lost to Follow-up|1|||
124883611|NCT02322814|449197267|FG001|Overall Study|Lost to Follow-up|3|||
124883612|NCT02322814|449197268|FG002|Overall Study|Lost to Follow-up|3|||
124883613|NCT02322814|449197269|FG003|Overall Study|Lost to Follow-up|1|||
124883614|NCT02322814|449197270|FG004|Overall Study|Lost to Follow-up|0|||
124883615|NCT02322814|449197266|FG000|Overall Study|Various Reasons|2|||
124883616|NCT02322814|449197267|FG001|Overall Study|Various Reasons|0|||
124883617|NCT02322814|449197268|FG002|Overall Study|Various Reasons|1|||
124883618|NCT02322814|449197269|FG003|Overall Study|Various Reasons|1|||
124883619|NCT02322814|449197270|FG004|Overall Study|Various Reasons|0|||
124883620|NCT02322814|449197266|FG000|Overall Study|Progressive Disease|0|||
124883621|NCT02322814|449197267|FG001|Overall Study|Progressive Disease|0|||
124883622|NCT02322814|449197268|FG002|Overall Study|Progressive Disease|0|||
124883623|NCT02322814|449197269|FG003|Overall Study|Progressive Disease|1|||
124883624|NCT02322814|449197270|FG004|Overall Study|Progressive Disease|1|||
124883625|NCT02322814|449197266|FG000|Overall Study|Protocol Violation|1|||
124883626|NCT02322814|449197267|FG001|Overall Study|Protocol Violation|0|||
124883627|NCT02322814|449197268|FG002|Overall Study|Protocol Violation|0|||
124883628|NCT02322814|449197269|FG003|Overall Study|Protocol Violation|0|||
124883629|NCT02322814|449197270|FG004|Overall Study|Protocol Violation|0|||
124883630|NCT02322814|449197266|FG000|Overall Study|Study Terminated by Sponsor|0|||
124883631|NCT02322814|449197267|FG001|Overall Study|Study Terminated by Sponsor|7|||
124883632|NCT02322814|449197268|FG002|Overall Study|Study Terminated by Sponsor|9|||
124883633|NCT02322814|449197269|FG003|Overall Study|Study Terminated by Sponsor|5|||
124883634|NCT02322814|449197270|FG004|Overall Study|Study Terminated by Sponsor|13|||
124883635|NCT02322814|449197266|FG000|Overall Study|Withdrawal by Subject|5|||
124883636|NCT02322814|449197267|FG001|Overall Study|Withdrawal by Subject|4|||
124883637|NCT02322814|449197268|FG002|Overall Study|Withdrawal by Subject|2|||
124883638|NCT02322814|449197269|FG003|Overall Study|Withdrawal by Subject|1|||
124883639|NCT02322814|449197270|FG004|Overall Study|Withdrawal by Subject|3|||
124883640|NCT00118092|449197271|FG000|Overall Study|Withdrawal by Subject|1|||
124883641|NCT00118092|449197271|FG000|Overall Study|Protocol Violation|1|||
124883642|NCT02459093|449197272|FG000|Overall Study|Protocol Violation|6|||
124883643|NCT02459093|449197273|FG001|Overall Study|Protocol Violation|11|||
124883644|NCT02459093|449197272|FG000|Overall Study|Lost to Follow-up|6|||
124883645|NCT02459093|449197273|FG001|Overall Study|Lost to Follow-up|7|||
124883646|NCT00591864|449197274|FG000|Overall Study|Incomplete Imaging|5|||
124883647|NCT01871558|449197275|FG000|Overall Study|Other reason|0|||
124883648|NCT01871558|449197276|FG001|Overall Study|Other reason|1|||
124883649|NCT01871558|449197275|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
124883650|NCT01871558|449197276|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
124883651|NCT01871558|449197275|FG000|Overall Study|Withdrawal by Subject|2|||
124883652|NCT01871558|449197276|FG001|Overall Study|Withdrawal by Subject|0|||
124883653|NCT02401308|449197279|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
124883654|NCT02401308|449197280|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
124883655|NCT02736968|449197281|FG000|Overall Study|Lost to Follow-up|0|||
124883656|NCT02736968|449197282|FG001|Overall Study|Lost to Follow-up|0|||
124683239|NCT01136954|448463802|FG000|Overall Study|Physician Decision|0|||
124683240|NCT01136954|448463803|FG001|Overall Study|Physician Decision|1|||
124883657|NCT02736968|449197283|FG002|Overall Study|Lost to Follow-up|0|||
124883658|NCT02736968|449197284|FG003|Overall Study|Lost to Follow-up|0|||
124883659|NCT02736968|449197285|FG004|Overall Study|Lost to Follow-up|0|||
124883660|NCT02736968|449197286|FG005|Overall Study|Lost to Follow-up|0|||
124883661|NCT02736968|449197287|FG006|Overall Study|Lost to Follow-up|5|||
124883662|NCT02736968|449197288|FG007|Overall Study|Lost to Follow-up|2|||
124883663|NCT02736968|449197281|FG000|Overall Study|COVID-19 Pandemic|0|||
124883664|NCT02736968|449197282|FG001|Overall Study|COVID-19 Pandemic|0|||
124883665|NCT02736968|449197283|FG002|Overall Study|COVID-19 Pandemic|0|||
124883666|NCT02736968|449197284|FG003|Overall Study|COVID-19 Pandemic|0|||
124883667|NCT02736968|449197285|FG004|Overall Study|COVID-19 Pandemic|0|||
124883668|NCT02736968|449197286|FG005|Overall Study|COVID-19 Pandemic|0|||
124883669|NCT02736968|449197287|FG006|Overall Study|COVID-19 Pandemic|2|||
124883670|NCT02736968|449197288|FG007|Overall Study|COVID-19 Pandemic|0|||
124883671|NCT02736968|449197281|FG000|Overall Study|Withdrawal by Subject|0|||
124883672|NCT02736968|449197282|FG001|Overall Study|Withdrawal by Subject|0|||
124883673|NCT02736968|449197283|FG002|Overall Study|Withdrawal by Subject|0|||
124883674|NCT02736968|449197284|FG003|Overall Study|Withdrawal by Subject|0|||
124883675|NCT02736968|449197285|FG004|Overall Study|Withdrawal by Subject|0|||
124883676|NCT02736968|449197286|FG005|Overall Study|Withdrawal by Subject|0|||
124883677|NCT02736968|449197287|FG006|Overall Study|Withdrawal by Subject|1|||
124883678|NCT02736968|449197288|FG007|Overall Study|Withdrawal by Subject|0|||
124883679|NCT02041923|449197291|FG000|Overall Study|Lost to Follow-up|26|||
124883680|NCT02041923|449197292|FG001|Overall Study|Lost to Follow-up|30|||
124883681|NCT01734434|449197293|FG000|Overall Study|Death Infant|3|||
124883682|NCT01734434|449197294|FG001|Overall Study|Death Infant|1|||
124883683|NCT01734434|449197295|FG002|Overall Study|Death Infant|17|||
124883684|NCT01734434|449197296|FG003|Overall Study|Death Infant|5|||
124883685|NCT01734434|449197293|FG000|Overall Study|Lost to Follow-up|2|||
124883686|NCT01734434|449197294|FG001|Overall Study|Lost to Follow-up|9|||
124883687|NCT01734434|449197295|FG002|Overall Study|Lost to Follow-up|67|||
124883688|NCT01734434|449197296|FG003|Overall Study|Lost to Follow-up|11|||
124883689|NCT01734434|449197293|FG000|Overall Study|No Live Birth|1|||
124883690|NCT01734434|449197294|FG001|Overall Study|No Live Birth|2|||
124883691|NCT01734434|449197295|FG002|Overall Study|No Live Birth|32|||
124683241|NCT01136954|448463802|FG000|Overall Study|Other|1|||
124683242|NCT01136954|448463803|FG001|Overall Study|Other|3|||
124883692|NCT01734434|449197296|FG003|Overall Study|No Live Birth|6|||
124883693|NCT01734434|449197293|FG000|Overall Study|Withdrawal by Subject|4|||
124883694|NCT01734434|449197294|FG001|Overall Study|Withdrawal by Subject|0|||
124883695|NCT01734434|449197295|FG002|Overall Study|Withdrawal by Subject|8|||
124883696|NCT01734434|449197296|FG003|Overall Study|Withdrawal by Subject|1|||
124883697|NCT01734434|449197293|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
124883698|NCT01734434|449197294|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
124883699|NCT01734434|449197295|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
124883700|NCT01734434|449197296|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
124883701|NCT01734434|449197293|FG000|Overall Study|Subject Not Reachable|0|||
124439444|NCT00960531|447569172|FG000|Overall Study|Adverse Event (AE)|2|||
124883702|NCT01734434|449197294|FG001|Overall Study|Subject Not Reachable|0|||
124883703|NCT01734434|449197295|FG002|Overall Study|Subject Not Reachable|1|||
124883704|NCT01734434|449197296|FG003|Overall Study|Subject Not Reachable|0|||
124883705|NCT01734434|449197293|FG000|Overall Study|Treatment Defaulter|0|||
124883706|NCT01734434|449197294|FG001|Overall Study|Treatment Defaulter|0|||
124883707|NCT01734434|449197295|FG002|Overall Study|Treatment Defaulter|1|||
124883708|NCT01734434|449197296|FG003|Overall Study|Treatment Defaulter|0|||
124883709|NCT01734434|449197293|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
124883710|NCT01734434|449197294|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
124883711|NCT01734434|449197295|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
124883712|NCT01734434|449197296|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
124883713|NCT01734434|449197293|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
124883714|NCT01734434|449197294|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
124883715|NCT01734434|449197295|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
124883716|NCT01734434|449197296|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
124883717|NCT04921969|449197297|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
124883718|NCT04921969|449197298|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
124883719|NCT04921969|449197299|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
124883720|NCT04921969|449197300|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
124883721|NCT04921969|449197301|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
124883722|NCT04921969|449197302|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
124883723|NCT04921969|449197303|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
124883724|NCT04921969|449197297|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
124883725|NCT04921969|449197298|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124883726|NCT04921969|449197299|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124883727|NCT04921969|449197300|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124883728|NCT04921969|449197301|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124883729|NCT04921969|449197302|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124883730|NCT04921969|449197303|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124883731|NCT04921969|449197297|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
124883732|NCT04921969|449197298|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
124883733|NCT04921969|449197299|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
124883734|NCT04921969|449197300|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124883735|NCT04921969|449197301|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124883736|NCT04921969|449197302|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124883737|NCT04921969|449197303|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124883738|NCT04921969|449197297|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
124883739|NCT04921969|449197298|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
124883740|NCT04921969|449197299|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
124883741|NCT04921969|449197300|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
124883742|NCT04921969|449197301|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
124883743|NCT04921969|449197302|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
124883744|NCT04921969|449197303|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
124883745|NCT04921969|449197297|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
124883746|NCT04921969|449197298|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
124883747|NCT04921969|449197299|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
124883748|NCT04921969|449197300|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
124883749|NCT04921969|449197301|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
124883750|NCT04921969|449197302|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
124883751|NCT04921969|449197303|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
124883752|NCT04921969|449197297|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
124883753|NCT04921969|449197298|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
124883754|NCT04921969|449197299|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
124883755|NCT04921969|449197300|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124883756|NCT04921969|449197301|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124883757|NCT04921969|449197302|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124883758|NCT04921969|449197303|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124883759|NCT04921969|449197297|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
124883760|NCT04921969|449197298|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
124883761|NCT04921969|449197299|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
124883762|NCT04921969|449197300|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
124683243|NCT02394275|448463804|FG000|Overall Study|Adverse Event|22|||
124883763|NCT04921969|449197301|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
124883764|NCT04921969|449197302|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
124439445|NCT00960531|447569173|FG001|Overall Study|Adverse Event (AE)|0|||
124439446|NCT00960531|447569174|FG002|Overall Study|Adverse Event (AE)|0|||
124439447|NCT00960531|447569175|FG003|Overall Study|Adverse Event (AE)|0|||
124439448|NCT00960531|447569176|FG004|Overall Study|Adverse Event (AE)|0|||
124439449|NCT00960531|447569177|FG005|Overall Study|Adverse Event (AE)|1|||
124439450|NCT00960531|447569178|FG006|Overall Study|Adverse Event (AE)|2|||
124439451|NCT00960531|447569179|FG007|Overall Study|Adverse Event (AE)|0|||
124439452|NCT00960531|447569180|FG008|Overall Study|Adverse Event (AE)|2|||
124439453|NCT00960531|447569181|FG009|Overall Study|Adverse Event (AE)|0|||
124439454|NCT00960531|447569172|FG000|Overall Study|Reason not Specified|2|||
124439455|NCT00960531|447569173|FG001|Overall Study|Reason not Specified|1|||
124439456|NCT00960531|447569174|FG002|Overall Study|Reason not Specified|13|||
124439457|NCT00960531|447569175|FG003|Overall Study|Reason not Specified|1|||
124439458|NCT00960531|447569176|FG004|Overall Study|Reason not Specified|2|||
124439459|NCT00960531|447569177|FG005|Overall Study|Reason not Specified|0|||
124439460|NCT00960531|447569178|FG006|Overall Study|Reason not Specified|16|||
124439461|NCT00960531|447569179|FG007|Overall Study|Reason not Specified|0|||
124439462|NCT00960531|447569180|FG008|Overall Study|Reason not Specified|8|||
124439463|NCT00960531|447569181|FG009|Overall Study|Reason not Specified|1|||
124439464|NCT02533570|447569182|FG000|Overall Study|Adverse Event|0|||
124439465|NCT02533570|447569183|FG001|Overall Study|Adverse Event|1|||
124439466|NCT02533570|447569184|FG002|Overall Study|Adverse Event|1|||
124439467|NCT02656823|447569190|FG000|Overall Study|Adverse Event|3|||
124439468|NCT02656823|447569190|FG000|Overall Study|Lost to Follow-up|2|||
124439469|NCT02881957|447569196|FG000|Overall Study|Comfort care|0|||
124439470|NCT02881957|447569197|FG001|Overall Study|Comfort care|1|||
124439471|NCT02881957|447569196|FG000|Overall Study|Concurrent trial enrollment|0|||
124439472|NCT02881957|447569197|FG001|Overall Study|Concurrent trial enrollment|1|||
124439473|NCT02881957|447569196|FG000|Overall Study|Discharged within 48 hours|0|||
124439474|NCT02881957|447569197|FG001|Overall Study|Discharged within 48 hours|1|||
124439475|NCT02881957|447569196|FG000|Overall Study|Withdrawal by Subject|2|||
124439476|NCT02881957|447569197|FG001|Overall Study|Withdrawal by Subject|1|||
124439477|NCT02881957|447569196|FG000|Overall Study|Protocol Violation|1|||
124439478|NCT02881957|447569197|FG001|Overall Study|Protocol Violation|0|||
124439479|NCT05269355|447569198|FG000|Overall Study|Progressive Disease|104|||
124439480|NCT05269355|447569199|FG001|Overall Study|Progressive Disease|68|||
124439481|NCT05269355|447569198|FG000|Overall Study|Study Terminated by Sponsor|87|||
124439482|NCT05269355|447569199|FG001|Overall Study|Study Terminated by Sponsor|29|||
124439483|NCT05269355|447569198|FG000|Overall Study|Adverse Event|15|||
124439484|NCT05269355|447569199|FG001|Overall Study|Adverse Event|8|||
124439485|NCT05269355|447569198|FG000|Overall Study|Withdrawal by Subject|18|||
124439486|NCT05269355|447569199|FG001|Overall Study|Withdrawal by Subject|5|||
124439487|NCT05269355|447569198|FG000|Overall Study|Physician Decision|6|||
124439488|NCT05269355|447569199|FG001|Overall Study|Physician Decision|4|||
124439489|NCT05269355|447569198|FG000|Overall Study|Death|3|||
124439490|NCT05269355|447569199|FG001|Overall Study|Death|5|||
124439491|NCT05269355|447569198|FG000|Overall Study|Other Than Specified|5|||
124439492|NCT05269355|447569199|FG001|Overall Study|Other Than Specified|1|||
124439493|NCT05269355|447569198|FG000|Overall Study|Randomized But Not Treated|1|||
124439494|NCT05269355|447569199|FG001|Overall Study|Randomized But Not Treated|0|||
124439495|NCT00081497|447569200|FG000|Overall Study|Adverse Event|2|||
124439496|NCT00081497|447569201|FG001|Overall Study|Adverse Event|0|||
124439497|NCT00081497|447569200|FG000|Overall Study|Death|0|||
124439498|NCT00081497|447569201|FG001|Overall Study|Death|1|||
124439499|NCT00081497|447569200|FG000|Overall Study|Withdrawal by Subject|1|||
124439500|NCT00081497|447569201|FG001|Overall Study|Withdrawal by Subject|0|||
124439501|NCT00081497|447569200|FG000|Overall Study|Non-compliance|0|||
124439502|NCT00081497|447569201|FG001|Overall Study|Non-compliance|1|||
124439503|NCT00959647|447569202|FG000|Overall Study|Adverse Event|2|||
124439504|NCT00959647|447569202|FG000|Overall Study|Progressive disease|6|||
124439505|NCT00959647|447569202|FG000|Overall Study|Study terminated by sponsor|4|||
124439506|NCT00959647|447569202|FG000|Overall Study|Withdrawal by Subject|7|||
124439507|NCT01786174|447570783|FG000|Overall Study|Discontinued Study Drug|2|||
124439508|NCT01786174|447570784|FG001|Overall Study|Discontinued Study Drug|0|||
124439509|NCT03442985|447570793|FG000|Overall Study|Sponsor Request|55|||
124439510|NCT03442985|447570794|FG001|Overall Study|Sponsor Request|60|||
124439511|NCT03442985|447570795|FG002|Overall Study|Sponsor Request|54|||
124439512|NCT03442985|447570793|FG000|Overall Study|Lost to Follow-up|5|||
124439513|NCT03442985|447570794|FG001|Overall Study|Lost to Follow-up|2|||
124439514|NCT03442985|447570795|FG002|Overall Study|Lost to Follow-up|7|||
124439515|NCT03442985|447570793|FG000|Overall Study|Withdrawal by Subject|2|||
124439516|NCT03442985|447570794|FG001|Overall Study|Withdrawal by Subject|3|||
124439517|NCT03442985|447570795|FG002|Overall Study|Withdrawal by Subject|4|||
124439518|NCT03442985|447570793|FG000|Overall Study|Adverse Event|0|||
124439519|NCT03442985|447570794|FG001|Overall Study|Adverse Event|1|||
124439520|NCT03442985|447570795|FG002|Overall Study|Adverse Event|0|||
124439521|NCT01716117|447570799|FG000|Overall Study|Death|5|||
124439522|NCT01716117|447570800|FG001|Overall Study|Death|2|||
124439523|NCT01716117|447570799|FG000|Overall Study|Withdrawal by Subject|2|||
124883765|NCT04921969|449197303|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
124883766|NCT04921969|449197297|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
124883767|NCT04921969|449197298|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
124883768|NCT04921969|449197299|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
124883769|NCT04921969|449197300|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
124883770|NCT04921969|449197301|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
124883771|NCT04921969|449197302|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
124883772|NCT04921969|449197303|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
124883773|NCT04921969|449197297|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124883774|NCT04921969|449197298|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124883775|NCT04921969|449197299|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124883776|NCT04921969|449197300|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
124883777|NCT04921969|449197301|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124883778|NCT04921969|449197302|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
124883779|NCT04921969|449197303|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
124883780|NCT04921969|449197297|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
124883781|NCT04921969|449197298|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
124883782|NCT04921969|449197299|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
124883783|NCT04921969|449197300|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
124883784|NCT04921969|449197301|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
124883785|NCT04921969|449197302|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
124883786|NCT04921969|449197303|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
124883787|NCT04921969|449197297|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
124883788|NCT04921969|449197298|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
124883789|NCT04921969|449197299|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
124883790|NCT04921969|449197300|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
124883791|NCT04921969|449197301|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
124883792|NCT04921969|449197302|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
124883793|NCT04921969|449197303|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
124883794|NCT04921969|449197297|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
124883795|NCT04921969|449197298|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
124883796|NCT04921969|449197299|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
124883797|NCT04921969|449197300|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
124883798|NCT04921969|449197301|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
124883799|NCT04921969|449197302|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
124883800|NCT04921969|449197303|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
124883801|NCT04921969|449197297|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
124883802|NCT04921969|449197298|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
124883803|NCT04921969|449197299|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
124883804|NCT04921969|449197300|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
124883805|NCT04921969|449197301|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
124883806|NCT04921969|449197302|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
124883807|NCT04921969|449197303|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
124883808|NCT04921969|449197297|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
124883809|NCT04921969|449197298|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
124883810|NCT04921969|449197299|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
124883811|NCT04921969|449197300|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
124883812|NCT04921969|449197301|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
124883813|NCT04921969|449197302|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
124883814|NCT04921969|449197303|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
124883815|NCT04921969|449197297|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
124883816|NCT04921969|449197298|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
124883817|NCT04921969|449197299|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
124883818|NCT04921969|449197300|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
124883819|NCT04921969|449197301|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
124883820|NCT04921969|449197302|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
124883821|NCT04921969|449197303|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
124883822|NCT01340482|449198617|FG000|Overall Study|Adverse Event|2|||
124883823|NCT01340482|449198618|FG001|Overall Study|Adverse Event|0|||
124439524|NCT01716117|447570800|FG001|Overall Study|Withdrawal by Subject|0|||
124439525|NCT03645057|447570801|FG000|Randomization to Baseline|Lost to Follow-up|1|||
124439526|NCT03645057|447570802|FG001|Randomization to Baseline|Lost to Follow-up|0|||
124883824|NCT01340482|449198619|FG002|Overall Study|Adverse Event|0|||
124883825|NCT03518658|449198620|FG000|Overall Study|Other|51|||
124883826|NCT03518658|449198621|FG001|Overall Study|Other|0|||
124883827|NCT02105636|449198625|FG000|Pre-Treatment|Disease Progression|1|||
124883828|NCT02105636|449198626|FG001|Pre-Treatment|Disease Progression|0|||
124439527|NCT03645057|447570803|FG002|Randomization to Baseline|Lost to Follow-up|1|||
124883829|NCT02105636|449198625|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
124439528|NCT03645057|447570804|FG003|Randomization to Baseline|Lost to Follow-up|0|||
124439529|NCT03645057|447570801|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
124439530|NCT03645057|447570802|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
124439531|NCT03645057|447570803|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
124439532|NCT03645057|447570804|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
124439533|NCT03645057|447570801|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
124439534|NCT03645057|447570802|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
124439535|NCT03645057|447570803|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
124439536|NCT03645057|447570804|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
124439537|NCT03645057|447570801|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
124439538|NCT03645057|447570802|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
124439539|NCT03645057|447570803|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
124439540|NCT03645057|447570804|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
124439541|NCT00288509|447570805|FG000|Treatment Cycle 1|Adverse Event|1|||
124439542|NCT00288509|447570805|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
124439543|NCT00288509|447570805|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
124439544|NCT00288509|447570805|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
124439545|NCT00288509|447570805|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
124439546|NCT00288509|447570805|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
124439547|NCT00288509|447570805|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
124439548|NCT00288509|447570805|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
124439549|NCT00288509|447570805|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
124439550|NCT00288509|447570805|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
124439551|NCT00288509|447570805|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
124439552|NCT00288509|447570805|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
124439553|NCT00288509|447570805|FG000|Treatment Cycle 4|Physician Decision|4|||
124439554|NCT00288509|447570805|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
124439555|NCT00762970|447570812|FG000|Overall Study|Withdrawal by Subject|7|||
124439556|NCT00762970|447570813|FG001|Overall Study|Withdrawal by Subject|4|||
124439557|NCT00762970|447570814|FG002|Overall Study|Withdrawal by Subject|0|||
124439558|NCT00762970|447570812|FG000|Overall Study|Protocol Violation|3|||
124439559|NCT00762970|447570813|FG001|Overall Study|Protocol Violation|1|||
124439560|NCT00762970|447570814|FG002|Overall Study|Protocol Violation|1|||
124439561|NCT00762970|447570812|FG000|Overall Study|Lost to Follow-up|1|||
124439562|NCT00762970|447570813|FG001|Overall Study|Lost to Follow-up|2|||
124439563|NCT00762970|447570814|FG002|Overall Study|Lost to Follow-up|0|||
124439564|NCT00762970|447570812|FG000|Overall Study|Difficulty of handling lens|1|||
124439565|NCT00762970|447570813|FG001|Overall Study|Difficulty of handling lens|2|||
124439566|NCT00762970|447570814|FG002|Overall Study|Difficulty of handling lens|0|||
124439567|NCT01480674|447570815|FG000|Overall Study|Death|23|||
124439568|NCT01480674|447570815|FG000|Overall Study|Lost to Follow-up|2|||
124439569|NCT01480674|447570815|FG000|Overall Study|visit not done|10|||
124439570|NCT03818204|447570816|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124439571|NCT03818204|447570817|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124439572|NCT03818204|447570818|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124439573|NCT03818204|447570819|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124439574|NCT03818204|447570820|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
124439575|NCT03818204|447570821|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124439576|NCT03818204|447570822|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124439577|NCT03818204|447570823|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124439578|NCT03818204|447570824|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124439579|NCT03818204|447570825|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124439580|NCT03818204|447570826|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124439581|NCT03818204|447570827|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124439582|NCT03818204|447570828|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124439583|NCT03818204|447570829|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
124439584|NCT03818204|447570830|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124683244|NCT02394275|448463804|FG000|Overall Study|Lost to Follow-up|7|||
124683245|NCT00782067|448463807|FG000|Overall Study|Adverse Event|35|||
124883830|NCT02105636|449198626|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
124883831|NCT02105636|449198625|FG000|Pre-Treatment|Participant withdrew consent|0|||
124883832|NCT02105636|449198626|FG001|Pre-Treatment|Participant withdrew consent|6|||
124439585|NCT03818204|447570831|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124439586|NCT03818204|447570832|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124439587|NCT03818204|447570833|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124439588|NCT03818204|447570834|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
124439589|NCT03818204|447570816|FG000|Overall Study|Physician Decision|0|||
124439590|NCT03818204|447570817|FG001|Overall Study|Physician Decision|0|||
124683246|NCT00782067|448463807|FG000|Overall Study|Subject withdrew consent|11|||
124883833|NCT02105636|449198625|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
124883834|NCT02105636|449198626|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
124883835|NCT02105636|449198625|FG000|Treatment|Study Drug Toxicity|14|||
124883836|NCT02105636|449198626|FG001|Treatment|Study Drug Toxicity|10|||
124883837|NCT02105636|449198625|FG000|Treatment|Adverse event unrelated to study drug|19|||
124883838|NCT02105636|449198626|FG001|Treatment|Adverse event unrelated to study drug|3|||
124883839|NCT02105636|449198625|FG000|Treatment|Participant request to discontinue study treatment|8|||
124883840|NCT02105636|449198626|FG001|Treatment|Participant request to discontinue study treatment|6|||
124883841|NCT02105636|449198625|FG000|Treatment|Participant withdrew consent|5|||
124883842|NCT02105636|449198626|FG001|Treatment|Participant withdrew consent|1|||
124883843|NCT02105636|449198625|FG000|Treatment|Lost to Follow-up|1|||
124883844|NCT02105636|449198626|FG001|Treatment|Lost to Follow-up|0|||
124883845|NCT02105636|449198625|FG000|Treatment|Maximum Clinical Benefit|1|||
124883846|NCT02105636|449198626|FG001|Treatment|Maximum Clinical Benefit|3|||
124883847|NCT02105636|449198625|FG000|Treatment|Poor/Non-compliance|0|||
124883848|NCT02105636|449198626|FG001|Treatment|Poor/Non-compliance|1|||
124883849|NCT02105636|449198625|FG000|Treatment|Participant no longer meets study criteria|1|||
124883850|NCT02105636|449198626|FG001|Treatment|Participant no longer meets study criteria|0|||
124883851|NCT02105636|449198625|FG000|Treatment|Other reasons|1|||
124883852|NCT02105636|449198626|FG001|Treatment|Other reasons|0|||
124883853|NCT02105636|449198625|FG000|Treatment|Disease Progression|185|||
124883854|NCT02105636|449198626|FG001|Treatment|Disease Progression|87|||
124883855|NCT00744237|449198627|FG000|Overall Study|Lack of Efficacy|1|||
124883856|NCT00744237|449198628|FG001|Overall Study|Lack of Efficacy|1|||
124883857|NCT00744237|449198629|FG002|Overall Study|Lack of Efficacy|0|||
124883858|NCT00744237|449198627|FG000|Overall Study|Withdrawal by Subject|9|||
124883859|NCT00744237|449198628|FG001|Overall Study|Withdrawal by Subject|5|||
124883860|NCT00744237|449198629|FG002|Overall Study|Withdrawal by Subject|3|||
124883861|NCT00744237|449198627|FG000|Overall Study|Lost to Follow-up|1|||
124883862|NCT00744237|449198628|FG001|Overall Study|Lost to Follow-up|1|||
124883863|NCT00744237|449198629|FG002|Overall Study|Lost to Follow-up|1|||
124883864|NCT00744237|449198627|FG000|Overall Study|Protocol Violation|3|||
124883865|NCT00744237|449198628|FG001|Overall Study|Protocol Violation|4|||
124883866|NCT00744237|449198629|FG002|Overall Study|Protocol Violation|3|||
124883867|NCT00744237|449198627|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
124883868|NCT00744237|449198628|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
124883869|NCT00744237|449198629|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
124883870|NCT00744237|449198627|FG000|Overall Study|Dosing Error|1|||
124883871|NCT00744237|449198628|FG001|Overall Study|Dosing Error|0|||
124883872|NCT00744237|449198629|FG002|Overall Study|Dosing Error|1|||
124883873|NCT00744237|449198627|FG000|Overall Study|Study Drug Error|1|||
124883874|NCT00744237|449198628|FG001|Overall Study|Study Drug Error|0|||
124883875|NCT00744237|449198629|FG002|Overall Study|Study Drug Error|0|||
124883876|NCT00744237|449198627|FG000|Overall Study|Prohibited Concomitant Medication|0|||
124883877|NCT00744237|449198628|FG001|Overall Study|Prohibited Concomitant Medication|0|||
124883878|NCT00744237|449198629|FG002|Overall Study|Prohibited Concomitant Medication|1|||
124883879|NCT00744237|449198627|FG000|Overall Study|Poor Compliance|0|||
124883880|NCT00744237|449198628|FG001|Overall Study|Poor Compliance|2|||
124883881|NCT00744237|449198629|FG002|Overall Study|Poor Compliance|0|||
124883882|NCT00744237|449198627|FG000|Overall Study|Administrative. Site Closed|1|||
124883883|NCT00744237|449198628|FG001|Overall Study|Administrative. Site Closed|1|||
124883884|NCT00744237|449198629|FG002|Overall Study|Administrative. Site Closed|1|||
124883885|NCT00744237|449198627|FG000|Overall Study|Adverse Event|9|||
124883886|NCT00744237|449198628|FG001|Overall Study|Adverse Event|13|||
124883887|NCT00744237|449198629|FG002|Overall Study|Adverse Event|5|||
124883888|NCT00802659|449198631|FG000|Overall Study|Physician Decision|0|||
124883889|NCT00802659|449198632|FG001|Overall Study|Physician Decision|1|||
124883890|NCT00802659|449198633|FG002|Overall Study|Physician Decision|0|||
124883891|NCT00802659|449198634|FG003|Overall Study|Physician Decision|0|||
124883892|NCT01912781|449198636|FG000|Overall Study|Withdrawal by Subject|2|||
124883893|NCT01912781|449198637|FG001|Overall Study|Withdrawal by Subject|0|||
124883894|NCT04537897|449198643|FG000|Overall Study|Other than listed|0|||
124883895|NCT04537897|449198644|FG001|Overall Study|Other than listed|0|||
124758664|NCT02679287|448739824|FG001|Period 2|Work/Scheduling Conflict|0|||
124883896|NCT04537897|449198645|FG002|Overall Study|Other than listed|0|||
124883897|NCT04537897|449198646|FG003|Overall Study|Other than listed|0|||
124883898|NCT04537897|449198647|FG004|Overall Study|Other than listed|0|||
124883899|NCT04537897|449198648|FG005|Overall Study|Other than listed|0|||
124883900|NCT04537897|449198649|FG006|Overall Study|Other than listed|1|||
124883901|NCT04537897|449198650|FG007|Overall Study|Other than listed|0|||
124883902|NCT04537897|449198651|FG008|Overall Study|Other than listed|0|||
124883903|NCT04537897|449198643|FG000|Overall Study|Adverse Event|0|||
124883904|NCT04537897|449198644|FG001|Overall Study|Adverse Event|0|||
124883905|NCT04537897|449198645|FG002|Overall Study|Adverse Event|0|||
124439591|NCT03818204|447570818|FG002|Overall Study|Physician Decision|0|||
124439592|NCT03818204|447570819|FG003|Overall Study|Physician Decision|0|||
124439593|NCT03818204|447570820|FG004|Overall Study|Physician Decision|0|||
124439594|NCT03818204|447570821|FG005|Overall Study|Physician Decision|0|||
124439595|NCT03818204|447570822|FG006|Overall Study|Physician Decision|0|||
124439596|NCT03818204|447570823|FG007|Overall Study|Physician Decision|0|||
124439597|NCT03818204|447570824|FG008|Overall Study|Physician Decision|0|||
124439598|NCT03818204|447570825|FG009|Overall Study|Physician Decision|0|||
124439599|NCT03818204|447570826|FG010|Overall Study|Physician Decision|0|||
124439600|NCT03818204|447570827|FG011|Overall Study|Physician Decision|0|||
124439601|NCT03818204|447570828|FG012|Overall Study|Physician Decision|0|||
124439602|NCT03818204|447570829|FG013|Overall Study|Physician Decision|0|||
124439603|NCT03818204|447570830|FG014|Overall Study|Physician Decision|1|||
124439604|NCT03818204|447570831|FG015|Overall Study|Physician Decision|0|||
124439605|NCT03818204|447570832|FG016|Overall Study|Physician Decision|0|||
124439606|NCT03818204|447570833|FG017|Overall Study|Physician Decision|0|||
124439607|NCT03818204|447570834|FG018|Overall Study|Physician Decision|0|||
124439608|NCT03864146|447570835|FG000|Overall Study|Lost to Follow-up|14|||
124439609|NCT03864146|447570836|FG001|Overall Study|Lost to Follow-up|23|||
124439610|NCT03864146|447570835|FG000|Overall Study|Withdrawal by Subject|3|||
124439611|NCT03864146|447570836|FG001|Overall Study|Withdrawal by Subject|2|||
124439612|NCT01313637|447570840|FG000|Overall Study|Adverse Event|17|||
124439613|NCT01313637|447570841|FG001|Overall Study|Adverse Event|24|||
124439614|NCT01313637|447570842|FG002|Overall Study|Adverse Event|25|||
124439615|NCT01313637|447570843|FG003|Overall Study|Adverse Event|18|||
124439616|NCT01313637|447570840|FG000|Overall Study|Lack of Efficacy|44|||
124439617|NCT01313637|447570841|FG001|Overall Study|Lack of Efficacy|38|||
124439618|NCT01313637|447570842|FG002|Overall Study|Lack of Efficacy|37|||
124439619|NCT01313637|447570843|FG003|Overall Study|Lack of Efficacy|24|||
124439620|NCT01313637|447570840|FG000|Overall Study|Protocol Violation|4|||
124439621|NCT01313637|447570841|FG001|Overall Study|Protocol Violation|3|||
124439622|NCT01313637|447570842|FG002|Overall Study|Protocol Violation|11|||
124439623|NCT01313637|447570843|FG003|Overall Study|Protocol Violation|5|||
124439624|NCT01313637|447570840|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
124439625|NCT01313637|447570841|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
124439626|NCT01313637|447570842|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
124439627|NCT01313637|447570843|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
124439628|NCT01313637|447570840|FG000|Overall Study|Lost to Follow-up|0|||
124439629|NCT01313637|447570841|FG001|Overall Study|Lost to Follow-up|2|||
124439630|NCT01313637|447570842|FG002|Overall Study|Lost to Follow-up|1|||
124439631|NCT01313637|447570843|FG003|Overall Study|Lost to Follow-up|3|||
124439632|NCT01313637|447570840|FG000|Overall Study|Withdrawal by Subject|11|||
124439633|NCT01313637|447570841|FG001|Overall Study|Withdrawal by Subject|13|||
124439634|NCT01313637|447570842|FG002|Overall Study|Withdrawal by Subject|18|||
124439635|NCT01313637|447570843|FG003|Overall Study|Withdrawal by Subject|15|||
124439636|NCT01009203|447570844|FG000|Overall Study|Withdrawal by Subject|1|||
124439637|NCT01009203|447570844|FG000|Overall Study|Adverse Event|5|||
124439638|NCT01009203|447570844|FG000|Overall Study|Treatment-unrelated death|1|||
124439639|NCT00892723|447570845|FG000|Overall Study|Lost to Follow-up|1|||
124439640|NCT00892723|447570846|FG001|Overall Study|Lost to Follow-up|3|||
124439641|NCT00892723|447570847|FG002|Overall Study|Lost to Follow-up|1|||
124439642|NCT00892723|447570845|FG000|Overall Study|Withdrawal by Subject|1|||
124439643|NCT00892723|447570846|FG001|Overall Study|Withdrawal by Subject|1|||
124439644|NCT00892723|447570847|FG002|Overall Study|Withdrawal by Subject|1|||
124439645|NCT00615836|447570848|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
124439646|NCT00615836|447570849|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
124439647|NCT00615836|447570850|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
124439648|NCT00615836|447570851|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
124683247|NCT00782067|448463807|FG000|Overall Study|Lost to Follow-up|2|||
124683248|NCT00782067|448463807|FG000|Overall Study|Administrative problems|14|||
124683249|NCT00782067|448463807|FG000|Overall Study|Death|9|||
124683250|NCT00782067|448463807|FG000|Overall Study|Disease progression|43|||
124683251|NCT00782067|448463807|FG000|Overall Study|Protocol deviation|2|||
124683252|NCT00764517|448463811|FG000|Overall Study|Adverse Event|9|||
124683253|NCT00764517|448463812|FG001|Overall Study|Adverse Event|3|||
124683254|NCT00764517|448463811|FG000|Overall Study|Death|3|||
124683255|NCT00764517|448463812|FG001|Overall Study|Death|11|||
124683256|NCT00764517|448463811|FG000|Overall Study|Physician Decision|3|||
124439649|NCT00615836|447570852|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
124439650|NCT00615836|447570848|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
124439651|NCT00615836|447570849|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
124439652|NCT00615836|447570850|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
124439653|NCT00615836|447570851|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
124439654|NCT00615836|447570852|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
124439655|NCT00615836|447570848|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
124544391|NCT00948896|447946793|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
124683257|NCT00764517|448463812|FG001|Overall Study|Physician Decision|0|||
124683258|NCT00671060|448463820|FG000|Overall Study|Protocol Violation|1|||
124683259|NCT00671060|448463821|FG001|Overall Study|Protocol Violation|0|||
124683260|NCT00671060|448463820|FG000|Overall Study|Physician Decision|0|||
124683261|NCT00671060|448463821|FG001|Overall Study|Physician Decision|1|||
124683262|NCT02239328|448463822|FG000|Overall Study|Benign disease noted at time of surgery|6|||
124683263|NCT02239328|448463822|FG000|Overall Study|Equipment or website malfunction|2|||
124683264|NCT03483103|448463823|FG000|Pre-Treatment Phase|Other reasons|1|||
124683265|NCT03483103|448463823|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
124683266|NCT03483103|448463823|FG000|Pre-Treatment Phase|Disease-related complications|1|||
124683267|NCT03483103|448463823|FG000|Pre-Treatment Phase|Death|5|||
124683268|NCT03483103|448463823|FG000|Treatment Phase|Withdrawal by Subject|7|||
124683269|NCT03483103|448463823|FG000|Treatment Phase|Other reasons|1|||
124683270|NCT03483103|448463823|FG000|Treatment Phase|Death|23|||
124683271|NCT03483103|448463823|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
124683272|NCT03483103|448463823|FG000|Treatment Phase|Received nonconforming product|1|||
124683273|NCT03881371|448463824|FG000|Overall Study|Adverse Event|8|||
124683274|NCT03881371|448463825|FG001|Overall Study|Adverse Event|9|||
124683275|NCT03881371|448463824|FG000|Overall Study|Death|1|||
124683276|NCT03881371|448463825|FG001|Overall Study|Death|0|||
124683277|NCT03881371|448463824|FG000|Overall Study|Lost to Follow-up|1|||
124683278|NCT03881371|448463825|FG001|Overall Study|Lost to Follow-up|0|||
124683279|NCT03881371|448463824|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124683280|NCT03881371|448463825|FG001|Overall Study|Non-Compliance with Study Drug|2|||
124683281|NCT03881371|448463824|FG000|Overall Study|Physician Decision|3|||
124683282|NCT03881371|448463825|FG001|Overall Study|Physician Decision|3|||
124683283|NCT03881371|448463824|FG000|Overall Study|Withdrawal by Subject|2|||
124683284|NCT03881371|448463825|FG001|Overall Study|Withdrawal by Subject|10|||
124683285|NCT03881371|448463824|FG000|Overall Study|Discontinuation from Study|1|||
124683286|NCT03881371|448463825|FG001|Overall Study|Discontinuation from Study|0|||
124683287|NCT00933933|448463826|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
124683288|NCT00933933|448463827|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
124683289|NCT00933933|448463828|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
124683290|NCT00933933|448463826|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
124683291|NCT00933933|448463827|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
124683292|NCT00933933|448463828|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
124683293|NCT03282097|448463829|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
124683294|NCT03282097|448463830|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
124683295|NCT03282097|448463829|FG000|Intervention Visit Complete|Patient Death|13|||
124683296|NCT03282097|448463830|FG001|Intervention Visit Complete|Patient Death|15|||
124683297|NCT03282097|448463829|FG000|Intervention Visit Complete|Caregiver Death|0|||
124683298|NCT03282097|448463830|FG001|Intervention Visit Complete|Caregiver Death|3|||
124683299|NCT03282097|448463829|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
124683300|NCT03282097|448463830|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
124683301|NCT03282097|448463829|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
124683302|NCT03282097|448463830|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
124683303|NCT03282097|448463829|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
124683304|NCT03282097|448463830|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
124683305|NCT03282097|448463829|FG000|Primary Outcome Data Collection Complete|Missing|2|||
124683306|NCT03282097|448463830|FG001|Primary Outcome Data Collection Complete|Missing|3|||
124683307|NCT03282097|448463829|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
124683308|NCT03282097|448463830|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
124544392|NCT00948896|447946794|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
124683309|NCT03282097|448463829|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
124883906|NCT04537897|449198646|FG003|Overall Study|Adverse Event|1|||
124883907|NCT04537897|449198647|FG004|Overall Study|Adverse Event|0|||
124883908|NCT04537897|449198648|FG005|Overall Study|Adverse Event|0|||
124883909|NCT04537897|449198649|FG006|Overall Study|Adverse Event|0|||
124883910|NCT04537897|449198650|FG007|Overall Study|Adverse Event|0|||
124883911|NCT04537897|449198651|FG008|Overall Study|Adverse Event|0|||
124883912|NCT04537897|449198643|FG000|Overall Study|Withdrawal by Subject|0|||
124883913|NCT04537897|449198644|FG001|Overall Study|Withdrawal by Subject|1|||
124883914|NCT04537897|449198645|FG002|Overall Study|Withdrawal by Subject|0|||
124883915|NCT04537897|449198646|FG003|Overall Study|Withdrawal by Subject|0|||
124883916|NCT04537897|449198647|FG004|Overall Study|Withdrawal by Subject|0|||
124883917|NCT04537897|449198648|FG005|Overall Study|Withdrawal by Subject|0|||
124883918|NCT04537897|449198649|FG006|Overall Study|Withdrawal by Subject|0|||
124883919|NCT04537897|449198650|FG007|Overall Study|Withdrawal by Subject|0|||
124883920|NCT04537897|449198651|FG008|Overall Study|Withdrawal by Subject|0|||
124883921|NCT00197028|449198655|FG000|Overall Study|Adverse Event|2|||
124883922|NCT00197028|449198656|FG001|Overall Study|Adverse Event|2|||
124883923|NCT00197028|449198655|FG000|Overall Study|Protocol Violation|2|||
124883924|NCT00197028|449198656|FG001|Overall Study|Protocol Violation|1|||
124883925|NCT00197028|449198655|FG000|Overall Study|Withdrawal by Subject|8|||
124883926|NCT00197028|449198656|FG001|Overall Study|Withdrawal by Subject|12|||
124883927|NCT00197028|449198655|FG000|Overall Study|Lost to Follow-up|1|||
124883928|NCT00197028|449198656|FG001|Overall Study|Lost to Follow-up|0|||
124883929|NCT00197028|449198655|FG000|Overall Study|Other|3|||
124883930|NCT00197028|449198656|FG001|Overall Study|Other|6|||
124883931|NCT00669903|449198661|FG000|Overall Study|Adverse Event|0|||
124883932|NCT00669903|449198662|FG001|Overall Study|Adverse Event|1|||
124883933|NCT00669903|449198663|FG002|Overall Study|Adverse Event|3|||
124883934|NCT00669903|449198664|FG003|Overall Study|Adverse Event|1|||
124883935|NCT00669903|449198661|FG000|Overall Study|Withdrawal by Subject|0|||
124883936|NCT00669903|449198662|FG001|Overall Study|Withdrawal by Subject|2|||
124883937|NCT00669903|449198663|FG002|Overall Study|Withdrawal by Subject|2|||
124683310|NCT03282097|448463830|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
124683311|NCT03282097|448463829|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
124883938|NCT00669903|449198664|FG003|Overall Study|Withdrawal by Subject|2|||
124883939|NCT00669903|449198661|FG000|Overall Study|Lost to Follow-up|1|||
124883940|NCT00669903|449198662|FG001|Overall Study|Lost to Follow-up|1|||
124883941|NCT00669903|449198663|FG002|Overall Study|Lost to Follow-up|0|||
124883942|NCT00669903|449198664|FG003|Overall Study|Lost to Follow-up|1|||
124439656|NCT00615836|447570849|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
124439657|NCT00615836|447570850|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
124439658|NCT00615836|447570851|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
124439659|NCT00615836|447570852|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
124439660|NCT00615836|447570848|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
124439661|NCT00615836|447570849|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
124439662|NCT00615836|447570850|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
124439663|NCT00615836|447570851|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
124439664|NCT00615836|447570852|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
124439665|NCT00615836|447570848|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
124439666|NCT00615836|447570849|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
124439667|NCT00615836|447570850|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
124439668|NCT00615836|447570851|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
124439669|NCT00615836|447570852|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
124439670|NCT00615836|447570848|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
124439671|NCT00615836|447570849|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
124439672|NCT00615836|447570850|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
124439673|NCT00615836|447570851|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
124439674|NCT00615836|447570852|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
124439675|NCT00615836|447570848|FG000|Extension Study (FE992026 CS31)|Other|10|||
124439676|NCT00615836|447570849|FG001|Extension Study (FE992026 CS31)|Other|7|||
124439677|NCT00615836|447570850|FG002|Extension Study (FE992026 CS31)|Other|8|||
124439678|NCT00615836|447570851|FG003|Extension Study (FE992026 CS31)|Other|8|||
124439679|NCT00615836|447570852|FG004|Extension Study (FE992026 CS31)|Other|0|||
124439680|NCT00615836|447570848|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
124439681|NCT00615836|447570849|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
124439682|NCT00615836|447570850|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
124439683|NCT00615836|447570851|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
124439684|NCT00615836|447570852|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
124439685|NCT00615836|447570848|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
124439686|NCT00615836|447570849|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
124439687|NCT00615836|447570850|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
124439688|NCT00615836|447570851|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
124439689|NCT00615836|447570852|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
124439690|NCT01313689|447570853|FG000|24-Week Randomization 1|Adverse Event|10|||
124439691|NCT01313689|447570854|FG001|24-Week Randomization 1|Adverse Event|5|||
124439692|NCT01313689|447570855|FG002|24-Week Randomization 1|Adverse Event|0|||
124439693|NCT01313689|447570856|FG003|24-Week Randomization 1|Adverse Event|0|||
124439694|NCT01313689|447570857|FG004|24-Week Randomization 1|Adverse Event|0|||
124439695|NCT01313689|447570853|FG000|24-Week Randomization 1|Physician Decision|4|||
124439696|NCT01313689|447570854|FG001|24-Week Randomization 1|Physician Decision|5|||
124439697|NCT01313689|447570855|FG002|24-Week Randomization 1|Physician Decision|0|||
124439698|NCT01313689|447570856|FG003|24-Week Randomization 1|Physician Decision|0|||
124439699|NCT01313689|447570857|FG004|24-Week Randomization 1|Physician Decision|0|||
124439700|NCT01313689|447570853|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
124439701|NCT01313689|447570854|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
124439702|NCT01313689|447570855|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
124439703|NCT01313689|447570856|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
124439704|NCT01313689|447570857|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
124439705|NCT01313689|447570853|FG000|24-Week Randomization 2|Adverse Event|0|||
124439706|NCT01313689|447570854|FG001|24-Week Randomization 2|Adverse Event|0|||
124439707|NCT01313689|447570855|FG002|24-Week Randomization 2|Adverse Event|2|||
124683312|NCT03282097|448463830|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
124683313|NCT06001021|448463833|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
124683314|NCT06001021|448463834|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
124683315|NCT06001021|448463835|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
124683316|NCT06001021|448463836|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
124683317|NCT06001021|448463837|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
124683318|NCT06001021|448463838|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
124711999|NCT01343888|448570708|FG001|Overall Study|Adverse Event|22|||
124439708|NCT01313689|447570856|FG003|24-Week Randomization 2|Adverse Event|0|||
124439709|NCT01313689|447570857|FG004|24-Week Randomization 2|Adverse Event|8|||
124439710|NCT01313689|447570853|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
124439711|NCT01313689|447570854|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
124439712|NCT01313689|447570855|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
124439713|NCT01313689|447570856|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
124439714|NCT01313689|447570857|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
124439715|NCT01313689|447570853|FG000|24-Week Randomization 2|Physician Decision|0|||
124439716|NCT01313689|447570854|FG001|24-Week Randomization 2|Physician Decision|0|||
124439717|NCT01313689|447570855|FG002|24-Week Randomization 2|Physician Decision|0|||
124439718|NCT01313689|447570856|FG003|24-Week Randomization 2|Physician Decision|0|||
124439719|NCT01313689|447570857|FG004|24-Week Randomization 2|Physician Decision|4|||
124439720|NCT01007448|447570859|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
124439721|NCT01007448|447570860|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
124439722|NCT01007448|447570859|FG000|Overall Study|Staph Skin Infection Flare|1|||
124439723|NCT01007448|447570860|FG001|Overall Study|Staph Skin Infection Flare|0|||
124439724|NCT01007448|447570859|FG000|Overall Study|Participant Leaving the Country|1|||
124439725|NCT01007448|447570860|FG001|Overall Study|Participant Leaving the Country|0|||
124439726|NCT01007448|447570859|FG000|Overall Study|Participant Given Prohibited Medication|1|||
124439727|NCT01007448|447570860|FG001|Overall Study|Participant Given Prohibited Medication|0|||
124439728|NCT01007448|447570859|FG000|Overall Study|Progressive Disease|1|||
124439729|NCT01007448|447570860|FG001|Overall Study|Progressive Disease|2|||
124439730|NCT01007448|447570859|FG000|Overall Study|Lack of Efficacy|2|||
124439731|NCT01007448|447570860|FG001|Overall Study|Lack of Efficacy|0|||
124439732|NCT01007448|447570859|FG000|Overall Study|Withdrawal by Subject|2|||
124439733|NCT01007448|447570860|FG001|Overall Study|Withdrawal by Subject|3|||
124439734|NCT01007448|447570859|FG000|Overall Study|Adverse Event|1|||
124439735|NCT01007448|447570860|FG001|Overall Study|Adverse Event|4|||
124439736|NCT00406653|447570863|FG000|Induction Period|Adverse Event|1|||
124439737|NCT00406653|447570864|FG001|Induction Period|Adverse Event|10|||
124439738|NCT00406653|447570865|FG002|Induction Period|Adverse Event|4|||
124439739|NCT00406653|447570866|FG003|Induction Period|Adverse Event|11|||
124439740|NCT00406653|447570867|FG004|Induction Period|Adverse Event|0|||
124439741|NCT00406653|447570868|FG005|Induction Period|Adverse Event|0|||
124439742|NCT00406653|447570869|FG006|Induction Period|Adverse Event|0|||
124439743|NCT00406653|447570863|FG000|Induction Period|Lack of Efficacy|11|||
124439744|NCT00406653|447570864|FG001|Induction Period|Lack of Efficacy|14|||
124439745|NCT00406653|447570865|FG002|Induction Period|Lack of Efficacy|8|||
124883943|NCT00669903|449198661|FG000|Overall Study|Protocol Violation|0|||
124439746|NCT00406653|447570866|FG003|Induction Period|Lack of Efficacy|10|||
124439747|NCT00406653|447570867|FG004|Induction Period|Lack of Efficacy|0|||
124439748|NCT00406653|447570868|FG005|Induction Period|Lack of Efficacy|0|||
124439749|NCT00406653|447570869|FG006|Induction Period|Lack of Efficacy|0|||
124439750|NCT00406653|447570863|FG000|Induction Period|Lost to Follow-up|0|||
124439751|NCT00406653|447570864|FG001|Induction Period|Lost to Follow-up|2|||
124439752|NCT00406653|447570865|FG002|Induction Period|Lost to Follow-up|0|||
124439753|NCT00406653|447570866|FG003|Induction Period|Lost to Follow-up|0|||
124439754|NCT00406653|447570867|FG004|Induction Period|Lost to Follow-up|0|||
124439755|NCT00406653|447570868|FG005|Induction Period|Lost to Follow-up|0|||
124683319|NCT06001021|448463839|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
124683320|NCT06001021|448463833|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
124883944|NCT00669903|449198662|FG001|Overall Study|Protocol Violation|1|||
124883945|NCT00669903|449198663|FG002|Overall Study|Protocol Violation|0|||
124883946|NCT00669903|449198664|FG003|Overall Study|Protocol Violation|0|||
124883947|NCT01827254|449198667|FG000|Overall Study|Death|10|||
124883948|NCT01827254|449198667|FG000|Overall Study|Case report form not completed|4|||
124683321|NCT06001021|448463834|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
124683322|NCT06001021|448463835|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
124883949|NCT01827254|449198667|FG000|Overall Study|Invalidated centre|3|||
124883950|NCT01827254|449198667|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
124883951|NCT01827254|449198667|FG000|Overall Study|Did not complete re-challenge|1|||
124883952|NCT01827254|449198667|FG000|Overall Study|Disease progression|36|||
124883953|NCT01827254|449198667|FG000|Overall Study|Intolerance to treatment|4|||
124883954|NCT01923389|449198668|FG000|Overall Study|Protocol Violation|1|||
124883955|NCT01923389|449198669|FG001|Overall Study|Protocol Violation|0|||
124883956|NCT01613027|449198675|FG000|Overall Study|Lost to Follow-up|5|||
124883957|NCT01613027|449198675|FG000|Overall Study|Switched Physician|1|||
124439756|NCT00406653|447570869|FG006|Induction Period|Lost to Follow-up|0|||
124439757|NCT00406653|447570863|FG000|Induction Period|Withdrawal of Consent|2|||
124439758|NCT00406653|447570864|FG001|Induction Period|Withdrawal of Consent|5|||
124439759|NCT00406653|447570865|FG002|Induction Period|Withdrawal of Consent|1|||
124439760|NCT00406653|447570866|FG003|Induction Period|Withdrawal of Consent|2|||
124439761|NCT00406653|447570867|FG004|Induction Period|Withdrawal of Consent|0|||
124439762|NCT00406653|447570868|FG005|Induction Period|Withdrawal of Consent|0|||
124439763|NCT00406653|447570869|FG006|Induction Period|Withdrawal of Consent|0|||
124439764|NCT00406653|447570863|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
124683323|NCT06001021|448463836|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
124683324|NCT06001021|448463837|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
124683325|NCT06001021|448463838|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
124683326|NCT06001021|448463839|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
124439765|NCT00406653|447570864|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
124683327|NCT04797169|448463840|FG000|Overall Study|Lost to Follow-up|84|||
124683328|NCT04797169|448463841|FG001|Overall Study|Lost to Follow-up|67|||
124883958|NCT01613027|449198675|FG000|Overall Study|Lack of Efficacy|1|||
124758665|NCT02679287|448739823|FG000|Period 2|Disliked Mobile System|2|||
124758666|NCT02679287|448739824|FG001|Period 2|Disliked Mobile System|0|||
124758667|NCT02679287|448739823|FG000|Period 3|Work/Scheduling Conflict|0|||
124758668|NCT02679287|448739824|FG001|Period 3|Work/Scheduling Conflict|1|||
124758669|NCT00992459|448739833|FG000|Overall Study|Withdrawal by Subject|0|||
124758670|NCT00992459|448739834|FG001|Overall Study|Withdrawal by Subject|1|||
124758671|NCT00992459|448739833|FG000|Overall Study|Adverse Event|1|||
124683329|NCT04797169|448463840|FG000|Overall Study|Pregnancy|1|||
124683330|NCT04797169|448463841|FG001|Overall Study|Pregnancy|3|||
124683331|NCT04797169|448463840|FG000|Overall Study|Withdrawal by Subject|27|||
124683332|NCT04797169|448463841|FG001|Overall Study|Withdrawal by Subject|35|||
124683333|NCT04221490|448463850|FG000|At 30 Days Follow-up|Death|7|||
124683334|NCT04221490|448463850|FG000|At 30 Days Follow-up|Missed Visit|4|||
124683335|NCT04221490|448463850|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
124683336|NCT04221490|448463850|FG000|At 6 Months Follow-up|Death|9|||
124683337|NCT04221490|448463850|FG000|At 6 Months Follow-up|Physician Decision|1|||
124683338|NCT04221490|448463850|FG000|At 6 Months Follow-up|Missed Visit|8|||
124683339|NCT04221490|448463850|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
124683340|NCT03034967|448463851|FG000|Overall Study|Withdrawal by Subject|9|||
124683341|NCT03034967|448463852|FG001|Overall Study|Withdrawal by Subject|2|||
124683342|NCT03034967|448463853|FG002|Overall Study|Withdrawal by Subject|6|||
124683343|NCT03034967|448463854|FG003|Overall Study|Withdrawal by Subject|6|||
124683344|NCT03034967|448463855|FG004|Overall Study|Withdrawal by Subject|9|||
124683345|NCT03034967|448463856|FG005|Overall Study|Withdrawal by Subject|2|||
124683346|NCT03034967|448463851|FG000|Overall Study|Physician Decision|1|||
124683347|NCT03034967|448463852|FG001|Overall Study|Physician Decision|0|||
124683348|NCT03034967|448463853|FG002|Overall Study|Physician Decision|1|||
124683349|NCT03034967|448463854|FG003|Overall Study|Physician Decision|1|||
124683350|NCT03034967|448463855|FG004|Overall Study|Physician Decision|1|||
124683351|NCT03034967|448463856|FG005|Overall Study|Physician Decision|0|||
124683352|NCT03034967|448463851|FG000|Overall Study|Lost to Follow-up|0|||
124683353|NCT03034967|448463852|FG001|Overall Study|Lost to Follow-up|0|||
124683354|NCT03034967|448463853|FG002|Overall Study|Lost to Follow-up|0|||
124683355|NCT03034967|448463854|FG003|Overall Study|Lost to Follow-up|1|||
124683356|NCT03034967|448463855|FG004|Overall Study|Lost to Follow-up|0|||
124683357|NCT03034967|448463856|FG005|Overall Study|Lost to Follow-up|2|||
124683358|NCT03034967|448463851|FG000|Overall Study|Liver function test abnormality|0|||
124683359|NCT03034967|448463852|FG001|Overall Study|Liver function test abnormality|0|||
124683360|NCT03034967|448463853|FG002|Overall Study|Liver function test abnormality|1|||
124683361|NCT03034967|448463854|FG003|Overall Study|Liver function test abnormality|0|||
124683362|NCT03034967|448463855|FG004|Overall Study|Liver function test abnormality|0|||
124683363|NCT03034967|448463856|FG005|Overall Study|Liver function test abnormality|0|||
124683364|NCT03034967|448463851|FG000|Overall Study|Protocol Violation|1|||
124683365|NCT03034967|448463852|FG001|Overall Study|Protocol Violation|0|||
124683366|NCT03034967|448463853|FG002|Overall Study|Protocol Violation|0|||
124683367|NCT03034967|448463854|FG003|Overall Study|Protocol Violation|0|||
124683368|NCT03034967|448463855|FG004|Overall Study|Protocol Violation|0|||
124683369|NCT03034967|448463856|FG005|Overall Study|Protocol Violation|2|||
124683370|NCT03034967|448463851|FG000|Overall Study|Lack of Efficacy|0|||
124683371|NCT03034967|448463852|FG001|Overall Study|Lack of Efficacy|1|||
124683372|NCT03034967|448463853|FG002|Overall Study|Lack of Efficacy|2|||
124683373|NCT03034967|448463854|FG003|Overall Study|Lack of Efficacy|1|||
124683374|NCT03034967|448463855|FG004|Overall Study|Lack of Efficacy|1|||
124683375|NCT03034967|448463856|FG005|Overall Study|Lack of Efficacy|0|||
124683376|NCT03034967|448463851|FG000|Overall Study|Adverse Event, non-fatal|3|||
124683377|NCT03034967|448463852|FG001|Overall Study|Adverse Event, non-fatal|1|||
124683378|NCT03034967|448463853|FG002|Overall Study|Adverse Event, non-fatal|2|||
124683379|NCT03034967|448463854|FG003|Overall Study|Adverse Event, non-fatal|0|||
124683380|NCT03034967|448463855|FG004|Overall Study|Adverse Event, non-fatal|2|||
124683381|NCT03034967|448463856|FG005|Overall Study|Adverse Event, non-fatal|8|||
124683382|NCT03034967|448463851|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
124683383|NCT03034967|448463852|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
124683384|NCT03034967|448463853|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
124683385|NCT03034967|448463854|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
124683386|NCT03034967|448463855|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
124683387|NCT03034967|448463856|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
124683388|NCT02550795|448463865|FG000|Overall Study|Physician Decision|0|||
124683389|NCT02550795|448463866|FG001|Overall Study|Physician Decision|1|||
124683390|NCT02550795|448463867|FG002|Overall Study|Physician Decision|0|||
124683391|NCT00879658|448463871|FG000|Overall Study|Abnormal laboratory value(s)|3|||
124683392|NCT00879658|448463872|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124683393|NCT00879658|448463873|FG002|Overall Study|Abnormal laboratory value(s)|0|||
124683394|NCT00879658|448463874|FG003|Overall Study|Abnormal laboratory value(s)|1|||
124683395|NCT00879658|448463875|FG004|Overall Study|Abnormal laboratory value(s)|0|||
124683396|NCT00879658|448463876|FG005|Overall Study|Abnormal laboratory value(s)|0|||
124683397|NCT00879658|448463877|FG006|Overall Study|Abnormal laboratory value(s)|0|||
124683398|NCT00879658|448463871|FG000|Overall Study|Administrative problems|2|||
124683399|NCT00879658|448463872|FG001|Overall Study|Administrative problems|1|||
124683400|NCT00879658|448463873|FG002|Overall Study|Administrative problems|0|||
124683401|NCT00879658|448463874|FG003|Overall Study|Administrative problems|1|||
124683402|NCT00879658|448463875|FG004|Overall Study|Administrative problems|0|||
124683403|NCT00879658|448463876|FG005|Overall Study|Administrative problems|0|||
124683404|NCT00879658|448463877|FG006|Overall Study|Administrative problems|0|||
124683405|NCT00879658|448463871|FG000|Overall Study|Adverse Event|6|||
124683406|NCT00879658|448463872|FG001|Overall Study|Adverse Event|4|||
124683407|NCT00879658|448463873|FG002|Overall Study|Adverse Event|3|||
124683408|NCT00879658|448463874|FG003|Overall Study|Adverse Event|1|||
124683409|NCT00879658|448463875|FG004|Overall Study|Adverse Event|2|||
124683410|NCT00879658|448463876|FG005|Overall Study|Adverse Event|0|||
124683411|NCT00879658|448463877|FG006|Overall Study|Adverse Event|0|||
124683412|NCT00879658|448463871|FG000|Overall Study|Protocol Violation|1|||
124683413|NCT00879658|448463872|FG001|Overall Study|Protocol Violation|0|||
124683414|NCT00879658|448463873|FG002|Overall Study|Protocol Violation|0|||
124883959|NCT01613027|449198675|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
124883960|NCT00545363|449198676|FG000|Overall Study|Adverse Event|6|||
124883961|NCT00545363|449198677|FG001|Overall Study|Adverse Event|7|||
124883962|NCT00545363|449198676|FG000|Overall Study|Withdrawal by Subject|6|||
124883963|NCT00545363|449198677|FG001|Overall Study|Withdrawal by Subject|5|||
124883964|NCT00545363|449198676|FG000|Overall Study|Non-compliance|3|||
124883965|NCT00545363|449198677|FG001|Overall Study|Non-compliance|1|||
124883966|NCT00545363|449198676|FG000|Overall Study|Did not meet entry criteria|1|||
124883967|NCT00545363|449198677|FG001|Overall Study|Did not meet entry criteria|1|||
124883968|NCT00545363|449198676|FG000|Overall Study|Lost to Follow-up|2|||
124883969|NCT00545363|449198677|FG001|Overall Study|Lost to Follow-up|0|||
124883970|NCT00545363|449198676|FG000|Overall Study|Other|1|||
124883971|NCT00545363|449198677|FG001|Overall Study|Other|1|||
124883972|NCT00951509|449198678|FG000|Overall Study|Withdrawal by Subject|2|||
124883973|NCT03125941|449198680|FG000|Overall Study|did not receive intervention|1|||
124883974|NCT03125941|449198681|FG001|Overall Study|did not receive intervention|2|||
124883975|NCT00582491|449198682|FG000|Overall Study|Withdrawal by Subject|1|||
124883976|NCT00582491|449198683|FG001|Overall Study|Withdrawal by Subject|0|||
124883977|NCT04192630|449198684|FG000|Overall Study|Discontinued before surgery|2|||
124883978|NCT04192630|449198685|FG001|Overall Study|Discontinued before surgery|0|||
124883979|NCT04192630|449198684|FG000|Overall Study|Discontinued after surgery|5|||
124883980|NCT04192630|449198685|FG001|Overall Study|Discontinued after surgery|3|||
124883981|NCT01193582|449198686|FG000|Vaccination Series|Withdrawal by Subject|11|||
124883982|NCT01193582|449198687|FG001|Vaccination Series|Withdrawal by Subject|13|||
124883983|NCT01193582|449198688|FG002|Vaccination Series|Withdrawal by Subject|8|||
124883984|NCT01193582|449198689|FG003|Vaccination Series|Withdrawal by Subject|3|||
124883985|NCT01193582|449198686|FG000|12 Month Follow-up|Death|0|||
124883986|NCT01193582|449198687|FG001|12 Month Follow-up|Death|0|||
124883987|NCT01193582|449198688|FG002|12 Month Follow-up|Death|1|||
124883988|NCT01193582|449198689|FG003|12 Month Follow-up|Death|0|||
124883989|NCT01193582|449198686|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
124883990|NCT01193582|449198687|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
124883991|NCT01193582|449198688|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
124883992|NCT01193582|449198689|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
124883993|NCT01425632|449198690|FG000|Overall Study|Adverse Event|0|||
124883994|NCT01425632|449198691|FG001|Overall Study|Adverse Event|1|||
124883995|NCT01425632|449198692|FG002|Overall Study|Adverse Event|1|||
124883996|NCT01425632|449198690|FG000|Overall Study|Physician Decision|1|||
124883997|NCT01425632|449198691|FG001|Overall Study|Physician Decision|0|||
124883998|NCT01425632|449198692|FG002|Overall Study|Physician Decision|0|||
124883999|NCT01425632|449198690|FG000|Overall Study|Protocol Violation|0|||
124884000|NCT01425632|449198691|FG001|Overall Study|Protocol Violation|0|||
124884001|NCT01425632|449198692|FG002|Overall Study|Protocol Violation|2|||
124884002|NCT01425632|449198690|FG000|Overall Study|Withdrawal by Subject|0|||
124884003|NCT01425632|449198691|FG001|Overall Study|Withdrawal by Subject|0|||
124884004|NCT01425632|449198692|FG002|Overall Study|Withdrawal by Subject|1|||
124884005|NCT03632434|449198698|FG000|Overall Study|Withdrawal by Subject|2|||
124884006|NCT01751113|449198699|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
124884007|NCT01751113|449198700|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
124884008|NCT01751113|449198701|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
124884009|NCT01751113|449198702|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
124884010|NCT01751113|449198703|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
124884011|NCT01751113|449198704|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
124884012|NCT01751113|449198699|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
124884013|NCT01751113|449198700|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
124884014|NCT01751113|449198701|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
124884015|NCT01751113|449198702|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
124884016|NCT01751113|449198703|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
124884017|NCT01751113|449198704|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
124884018|NCT01551303|449198705|FG000|Overall Study|failed awareness check on vision test|4|||
124884019|NCT01551303|449198706|FG001|Overall Study|failed awareness check on vision test|7|||
124884020|NCT01208415|449198709|FG000|Overall Study|Death|1|||
124884021|NCT01208415|449198709|FG000|Overall Study|Lost to Follow-up|2|||
124884022|NCT01208415|449198709|FG000|Overall Study|Withdrawal by Subject|3|||
124884023|NCT01208415|449198709|FG000|Overall Study|Device not placed|1|||
124884024|NCT01208415|449198709|FG000|Overall Study|Still be eligible for follow-up|33|||
124884025|NCT01115491|449198710|FG000|Overall Study|Death|22|||
124884026|NCT01115491|449198710|FG000|Overall Study|Adverse Event|3|||
124884027|NCT01115491|449198710|FG000|Overall Study|Lost to Follow-up|3|||
124884028|NCT01115491|449198710|FG000|Overall Study|Withdrawal by Subject|1|||
124884029|NCT01115491|449198710|FG000|Overall Study|Physician Decision|1|||
124884030|NCT04297241|449198711|FG000|Overall Study|Withdrawal by Subject|1|||
124884031|NCT04297241|449198711|FG000|Overall Study|Adverse Event|1|||
124884032|NCT04297241|449198711|FG000|Overall Study|Physician Decision|3|||
124884033|NCT03856996|449198712|FG000|Overall Study|Withdrawal by Subject|1|||
124884034|NCT03856996|449198713|FG001|Overall Study|Withdrawal by Subject|0|||
124884035|NCT03856996|449198712|FG000|Overall Study|Lost to Follow-up|0|||
124884036|NCT03856996|449198713|FG001|Overall Study|Lost to Follow-up|1|||
124884037|NCT03856996|449198712|FG000|Overall Study|Adverse Event|1|||
124884038|NCT03856996|449198713|FG001|Overall Study|Adverse Event|1|||
124884039|NCT03856996|449198712|FG000|Overall Study|Other|1|||
124884040|NCT03856996|449198713|FG001|Overall Study|Other|0|||
124884041|NCT01003639|449198714|FG000|Overall Study|Lost to Follow-up|6|||
124884042|NCT01003639|449198715|FG001|Overall Study|Lost to Follow-up|9|||
124884043|NCT01003639|449198714|FG000|Overall Study|Withdrawal by Subject|9|||
124884044|NCT01003639|449198715|FG001|Overall Study|Withdrawal by Subject|5|||
124884045|NCT01003639|449198714|FG000|Overall Study|Lack of Efficacy|1|||
124884046|NCT01003639|449198715|FG001|Overall Study|Lack of Efficacy|6|||
124884047|NCT01003639|449198714|FG000|Overall Study|Adverse Event|0|||
124884048|NCT01003639|449198715|FG001|Overall Study|Adverse Event|1|||
124884049|NCT01003639|449198714|FG000|Overall Study|Protocol Violation|0|||
124884050|NCT01003639|449198715|FG001|Overall Study|Protocol Violation|1|||
124884051|NCT01003639|449198714|FG000|Overall Study|Physician Decision|1|||
124884052|NCT01003639|449198715|FG001|Overall Study|Physician Decision|0|||
124884053|NCT04362137|449198717|FG000|Overall Study|Death|9|||
124884054|NCT04362137|449198718|FG001|Overall Study|Death|3|||
124884055|NCT04362137|449198717|FG000|Overall Study|Patient decision|6|||
124884056|NCT04362137|449198718|FG001|Overall Study|Patient decision|3|||
124884057|NCT04362137|449198717|FG000|Overall Study|Adverse Event|1|||
124884058|NCT04362137|449198718|FG001|Overall Study|Adverse Event|0|||
124884059|NCT04362137|449198717|FG000|Overall Study|Lost to Follow-up|1|||
124884060|NCT04362137|449198718|FG001|Overall Study|Lost to Follow-up|0|||
124884061|NCT04362137|449198717|FG000|Overall Study|Protocol deviation|1|||
124884062|NCT04362137|449198718|FG001|Overall Study|Protocol deviation|0|||
124884063|NCT02262260|449198726|FG000|Overall Study|Adverse Event|4|||
124884064|NCT02262260|449198727|FG001|Overall Study|Adverse Event|1|||
124884065|NCT02262260|449198726|FG000|Overall Study|Withdrawal of consent|4|||
124884066|NCT02262260|449198727|FG001|Overall Study|Withdrawal of consent|2|||
124884067|NCT02262260|449198726|FG000|Overall Study|Lost to Follow-up|1|||
124884068|NCT02262260|449198727|FG001|Overall Study|Lost to Follow-up|2|||
124884069|NCT02262260|449198726|FG000|Overall Study|Protocol deviation|2|||
124884070|NCT02262260|449198727|FG001|Overall Study|Protocol deviation|5|||
124884071|NCT01794117|449198729|FG000|Overall Study|Adverse Event|1|||
124884072|NCT01794117|449198730|FG001|Overall Study|Adverse Event|0|||
124884073|NCT01794117|449198731|FG002|Overall Study|Adverse Event|0|||
124884074|NCT01794117|449198732|FG003|Overall Study|Adverse Event|0|||
124884075|NCT01794117|449198729|FG000|Overall Study|Participant noncompliance|0|||
124884076|NCT01794117|449198730|FG001|Overall Study|Participant noncompliance|1|||
124884077|NCT01794117|449198731|FG002|Overall Study|Participant noncompliance|0|||
124884078|NCT01794117|449198732|FG003|Overall Study|Participant noncompliance|0|||
124884079|NCT01794117|449198729|FG000|Overall Study|Refused further treatment|0|||
124884080|NCT01794117|449198730|FG001|Overall Study|Refused further treatment|2|||
124884081|NCT01794117|449198731|FG002|Overall Study|Refused further treatment|0|||
124884082|NCT01794117|449198732|FG003|Overall Study|Refused further treatment|0|||
124884083|NCT00514046|449198738|FG000|Overall Study|transferred to another protocol|2|||
124884084|NCT00514046|449198739|FG001|Overall Study|transferred to another protocol|1|||
124884085|NCT00514046|449198740|FG002|Overall Study|transferred to another protocol|3|||
124884086|NCT00514046|449198741|FG003|Overall Study|transferred to another protocol|0|||
124884087|NCT00514046|449198742|FG004|Overall Study|transferred to another protocol|1|||
124884088|NCT00514046|449198743|FG005|Overall Study|transferred to another protocol|0|||
124884089|NCT00514046|449198744|FG006|Overall Study|transferred to another protocol|0|||
124884090|NCT00514046|449198745|FG007|Overall Study|transferred to another protocol|0|||
124884091|NCT00514046|449198746|FG008|Overall Study|transferred to another protocol|0|||
124884092|NCT00514046|449198738|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
124439766|NCT00406653|447570865|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
124439767|NCT00406653|447570866|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
124884093|NCT00514046|449198739|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
124884094|NCT00514046|449198740|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
124439768|NCT00406653|447570867|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
124884095|NCT00514046|449198741|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
124884096|NCT00514046|449198742|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
124884097|NCT00514046|449198743|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
124884098|NCT00514046|449198744|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
124884099|NCT00514046|449198745|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
124884100|NCT00514046|449198746|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
124884101|NCT00514046|449198738|FG000|Overall Study|Disease progression on study|0|||
124884102|NCT00514046|449198739|FG001|Overall Study|Disease progression on study|0|||
124884103|NCT00514046|449198740|FG002|Overall Study|Disease progression on study|2|||
124884104|NCT00514046|449198741|FG003|Overall Study|Disease progression on study|0|||
124884105|NCT00514046|449198742|FG004|Overall Study|Disease progression on study|0|||
124884106|NCT00514046|449198743|FG005|Overall Study|Disease progression on study|1|||
124884107|NCT00514046|449198744|FG006|Overall Study|Disease progression on study|0|||
124884108|NCT00514046|449198745|FG007|Overall Study|Disease progression on study|0|||
124884109|NCT00514046|449198746|FG008|Overall Study|Disease progression on study|0|||
124884110|NCT00655551|449198747|FG000|All Periods Combined|Adverse Event|0|||
124884111|NCT00655551|449198748|FG001|All Periods Combined|Adverse Event|3|||
124884112|NCT00655551|449198749|FG002|All Periods Combined|Adverse Event|4|||
124884113|NCT00655551|449198747|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
124884114|NCT00655551|449198748|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
124884115|NCT00655551|449198749|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
124884116|NCT00655551|449198747|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
124884117|NCT00655551|449198748|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
124884118|NCT00655551|449198749|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
124884119|NCT00655551|449198747|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
124884120|NCT00655551|449198748|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
124884121|NCT00655551|449198749|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
124884122|NCT00876460|449198750|FG000|Combination Therapy Phase|Progressive disease|2|||
124884123|NCT00876460|449198751|FG001|Combination Therapy Phase|Progressive disease|3|||
124884124|NCT00876460|449198752|FG002|Combination Therapy Phase|Progressive disease|3|||
124884125|NCT00876460|449198753|FG003|Combination Therapy Phase|Progressive disease|3|||
124884126|NCT00876460|449198754|FG004|Combination Therapy Phase|Progressive disease|3|||
124884127|NCT00876460|449198755|FG005|Combination Therapy Phase|Progressive disease|1|||
124884128|NCT00876460|449198756|FG006|Combination Therapy Phase|Progressive disease|1|||
124884129|NCT00876460|449198757|FG007|Combination Therapy Phase|Progressive disease|1|||
124884130|NCT00876460|449198750|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
124884131|NCT00876460|449198751|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
124884132|NCT00876460|449198752|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
124884133|NCT00876460|449198753|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
124884134|NCT00876460|449198754|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
124884135|NCT00876460|449198755|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
124884136|NCT00876460|449198756|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
124884137|NCT00876460|449198757|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
124884138|NCT00876460|449198750|FG000|Combination Therapy Phase|Adverse Event|0|||
124884139|NCT00876460|449198751|FG001|Combination Therapy Phase|Adverse Event|2|||
124884140|NCT00876460|449198752|FG002|Combination Therapy Phase|Adverse Event|0|||
124884141|NCT00876460|449198753|FG003|Combination Therapy Phase|Adverse Event|2|||
124884142|NCT00876460|449198754|FG004|Combination Therapy Phase|Adverse Event|2|||
124884143|NCT00876460|449198755|FG005|Combination Therapy Phase|Adverse Event|0|||
124884144|NCT00876460|449198756|FG006|Combination Therapy Phase|Adverse Event|3|||
124884145|NCT00876460|449198757|FG007|Combination Therapy Phase|Adverse Event|2|||
124884146|NCT00876460|449198750|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
124884147|NCT00876460|449198751|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
124884148|NCT00876460|449198752|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
124884149|NCT00876460|449198753|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
124683415|NCT00879658|448463874|FG003|Overall Study|Protocol Violation|0|||
124683416|NCT00879658|448463875|FG004|Overall Study|Protocol Violation|0|||
124683417|NCT00879658|448463876|FG005|Overall Study|Protocol Violation|0|||
124683418|NCT00879658|448463877|FG006|Overall Study|Protocol Violation|0|||
124683419|NCT00879658|448463871|FG000|Overall Study|Withdrawal by Subject|3|||
124683420|NCT00879658|448463872|FG001|Overall Study|Withdrawal by Subject|0|||
124683421|NCT00879658|448463873|FG002|Overall Study|Withdrawal by Subject|2|||
124683422|NCT00879658|448463874|FG003|Overall Study|Withdrawal by Subject|0|||
124683423|NCT00879658|448463875|FG004|Overall Study|Withdrawal by Subject|0|||
124884150|NCT00876460|449198754|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
124884151|NCT00876460|449198755|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
124884152|NCT00876460|449198756|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
124884153|NCT00876460|449198757|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
124884154|NCT00876460|449198750|FG000|Combination Therapy Phase|Other reason not defined above|0|||
124884155|NCT00876460|449198751|FG001|Combination Therapy Phase|Other reason not defined above|0|||
124884156|NCT00876460|449198752|FG002|Combination Therapy Phase|Other reason not defined above|0|||
124884157|NCT00876460|449198753|FG003|Combination Therapy Phase|Other reason not defined above|0|||
124884158|NCT00876460|449198754|FG004|Combination Therapy Phase|Other reason not defined above|0|||
124884159|NCT00876460|449198755|FG005|Combination Therapy Phase|Other reason not defined above|0|||
124884160|NCT00876460|449198756|FG006|Combination Therapy Phase|Other reason not defined above|1|||
124884161|NCT00876460|449198757|FG007|Combination Therapy Phase|Other reason not defined above|2|||
124884162|NCT00876460|449198750|FG000|Combination Therapy Phase|Not treated|0|||
124884163|NCT00876460|449198751|FG001|Combination Therapy Phase|Not treated|0|||
124884164|NCT00876460|449198752|FG002|Combination Therapy Phase|Not treated|0|||
124884165|NCT00876460|449198753|FG003|Combination Therapy Phase|Not treated|0|||
124884166|NCT00876460|449198754|FG004|Combination Therapy Phase|Not treated|0|||
124884167|NCT00876460|449198755|FG005|Combination Therapy Phase|Not treated|0|||
124884168|NCT00876460|449198756|FG006|Combination Therapy Phase|Not treated|1|||
124884169|NCT00876460|449198757|FG007|Combination Therapy Phase|Not treated|0|||
124884170|NCT00876460|449198750|FG000|Mono Therapy Phase|Progressive disease|0|||
124884171|NCT00876460|449198751|FG001|Mono Therapy Phase|Progressive disease|0|||
124884172|NCT00876460|449198752|FG002|Mono Therapy Phase|Progressive disease|0|||
124884173|NCT00876460|449198753|FG003|Mono Therapy Phase|Progressive disease|0|||
124884174|NCT00876460|449198754|FG004|Mono Therapy Phase|Progressive disease|2|||
124884175|NCT00876460|449198755|FG005|Mono Therapy Phase|Progressive disease|0|||
124884176|NCT00876460|449198756|FG006|Mono Therapy Phase|Progressive disease|1|||
124884177|NCT00876460|449198757|FG007|Mono Therapy Phase|Progressive disease|3|||
124884178|NCT00876460|449198750|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
124884179|NCT00876460|449198751|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
124884180|NCT00876460|449198752|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
124884181|NCT00876460|449198753|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
124884182|NCT00876460|449198754|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
124884183|NCT00876460|449198755|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
124884184|NCT00876460|449198756|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
124884185|NCT00876460|449198757|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
124884186|NCT00876460|449198750|FG000|Mono Therapy Phase|Adverse Event|0|||
124884187|NCT00876460|449198751|FG001|Mono Therapy Phase|Adverse Event|0|||
124884188|NCT00876460|449198752|FG002|Mono Therapy Phase|Adverse Event|0|||
124884189|NCT00876460|449198753|FG003|Mono Therapy Phase|Adverse Event|1|||
124884190|NCT00876460|449198754|FG004|Mono Therapy Phase|Adverse Event|0|||
124884191|NCT00876460|449198755|FG005|Mono Therapy Phase|Adverse Event|0|||
124884192|NCT00876460|449198756|FG006|Mono Therapy Phase|Adverse Event|0|||
124884193|NCT00876460|449198757|FG007|Mono Therapy Phase|Adverse Event|0|||
124884194|NCT01567865|449198762|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
124884195|NCT01567865|449198763|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
124884196|NCT01567865|449198764|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
124884197|NCT01567865|449198765|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
124884198|NCT01567865|449198762|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
124884199|NCT01567865|449198763|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
124758672|NCT00992459|448739834|FG001|Overall Study|Adverse Event|0|||
124758673|NCT00543387|448739835|FG000|Panel 1 + Panel 2|Adverse Event|0|||
124758674|NCT00543387|448739836|FG001|Panel 1 + Panel 2|Adverse Event|1|||
124758675|NCT00543387|448739837|FG002|Panel 1 + Panel 2|Adverse Event|0|||
124758676|NCT00543387|448739838|FG003|Panel 1 + Panel 2|Adverse Event|0|||
124758677|NCT00543387|448739839|FG004|Panel 1 + Panel 2|Adverse Event|0|||
124758678|NCT00543387|448739840|FG005|Panel 1 + Panel 2|Adverse Event|0|||
124758679|NCT00543387|448739841|FG006|Panel 1 + Panel 2|Adverse Event|0|||
124758680|NCT00543387|448739842|FG007|Panel 1 + Panel 2|Adverse Event|1|||
124758681|NCT00543387|448739843|FG008|Panel 1 + Panel 2|Adverse Event|1|||
124884200|NCT01567865|449198764|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
124884201|NCT01567865|449198765|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
124884202|NCT00309608|449198766|FG000|Overall Study|Adverse Event|1|||
124884203|NCT00309608|449198767|FG001|Overall Study|Adverse Event|5|||
124884204|NCT00309608|449198768|FG002|Overall Study|Adverse Event|3|||
124884205|NCT00309608|449198769|FG003|Overall Study|Adverse Event|2|||
124884206|NCT00309608|449198770|FG004|Overall Study|Adverse Event|3|||
124884207|NCT00309608|449198766|FG000|Overall Study|Protocol Violation|2|||
124758682|NCT00543387|448739844|FG009|Panel 1 + Panel 2|Adverse Event|0|||
124758683|NCT00543387|448739845|FG010|Panel 1 + Panel 2|Adverse Event|0|||
124758684|NCT00543387|448739835|FG000|Panel 1 + Panel 2|Physician Decision|0|||
124884208|NCT00309608|449198767|FG001|Overall Study|Protocol Violation|0|||
124884209|NCT00309608|449198768|FG002|Overall Study|Protocol Violation|0|||
124884210|NCT00309608|449198769|FG003|Overall Study|Protocol Violation|0|||
124884211|NCT00309608|449198770|FG004|Overall Study|Protocol Violation|0|||
124884212|NCT00309608|449198766|FG000|Overall Study|Lost to Follow-up|0|||
124884213|NCT00309608|449198767|FG001|Overall Study|Lost to Follow-up|0|||
124758685|NCT00543387|448739836|FG001|Panel 1 + Panel 2|Physician Decision|0|||
124884214|NCT00309608|449198768|FG002|Overall Study|Lost to Follow-up|2|||
124884215|NCT00309608|449198769|FG003|Overall Study|Lost to Follow-up|0|||
124884216|NCT00309608|449198770|FG004|Overall Study|Lost to Follow-up|1|||
124884217|NCT00309608|449198766|FG000|Overall Study|Withdrawal by Subject|1|||
124884218|NCT00309608|449198767|FG001|Overall Study|Withdrawal by Subject|4|||
124884219|NCT00309608|449198768|FG002|Overall Study|Withdrawal by Subject|2|||
124884220|NCT00309608|449198769|FG003|Overall Study|Withdrawal by Subject|0|||
124884221|NCT00309608|449198770|FG004|Overall Study|Withdrawal by Subject|0|||
124884222|NCT00309608|449198766|FG000|Overall Study|Other incl. Lack of efficacy|10|||
124884223|NCT00309608|449198767|FG001|Overall Study|Other incl. Lack of efficacy|4|||
124884224|NCT00309608|449198768|FG002|Overall Study|Other incl. Lack of efficacy|3|||
124884225|NCT00309608|449198769|FG003|Overall Study|Other incl. Lack of efficacy|4|||
124884226|NCT00309608|449198770|FG004|Overall Study|Other incl. Lack of efficacy|0|||
124884227|NCT00621296|449198777|FG000|Overall Study|Adverse Event|2|||
124884228|NCT00621296|449198777|FG000|Overall Study|Lack of Efficacy|1|||
124884229|NCT00621296|449198777|FG000|Overall Study|Physician Decision|7|||
124884230|NCT00621296|449198777|FG000|Overall Study|Unmatch Criteria|1|||
124884231|NCT00621296|449198777|FG000|Overall Study|Stopping Criteria|3|||
124884232|NCT01051063|449198778|FG000|Overall Study|Death|2|||
124884233|NCT01051063|449198779|FG001|Overall Study|Death|2|||
124884234|NCT01051063|449198778|FG000|Overall Study|Withdrawal by Subject|1|||
124884235|NCT01051063|449198779|FG001|Overall Study|Withdrawal by Subject|1|||
124884236|NCT01051063|449198778|FG000|Overall Study|Termination of the study|5|||
124884237|NCT01051063|449198779|FG001|Overall Study|Termination of the study|0|||
124884238|NCT01051063|449198778|FG000|Overall Study|Moved from the study site area|1|||
124884239|NCT01051063|449198779|FG001|Overall Study|Moved from the study site area|0|||
124884240|NCT01051063|449198778|FG000|Overall Study|Other|1|||
124884241|NCT01051063|449198779|FG001|Overall Study|Other|0|||
124884242|NCT01051063|449198778|FG000|Overall Study|Lost to Follow-up|0|||
124884243|NCT01051063|449198779|FG001|Overall Study|Lost to Follow-up|1|||
124884244|NCT03857841|449198783|FG000|Overall Study|Death|1|||
124884245|NCT03857841|449198784|FG001|Overall Study|Death|0|||
124884246|NCT03857841|449198785|FG002|Overall Study|Death|0|||
124884247|NCT03857841|449198786|FG003|Overall Study|Death|0|||
124884248|NCT03857841|449198783|FG000|Overall Study|Study Terminated by Sponsor|1|||
124884249|NCT03857841|449198784|FG001|Overall Study|Study Terminated by Sponsor|0|||
124884250|NCT03857841|449198785|FG002|Overall Study|Study Terminated by Sponsor|0|||
124884251|NCT03857841|449198786|FG003|Overall Study|Study Terminated by Sponsor|0|||
124884252|NCT00386308|449200485|FG000|Overall Study|Adverse Event|3|||
124884253|NCT00386308|449200486|FG001|Overall Study|Adverse Event|3|||
124884254|NCT00386308|449200485|FG000|Overall Study|Protocol Violation|2|||
124884255|NCT00386308|449200486|FG001|Overall Study|Protocol Violation|5|||
124884256|NCT00386308|449200485|FG000|Overall Study|Lack of Efficacy|0|||
124884257|NCT00386308|449200486|FG001|Overall Study|Lack of Efficacy|2|||
124884258|NCT00386308|449200485|FG000|Overall Study|Lost to Follow-up|10|||
124884259|NCT00386308|449200486|FG001|Overall Study|Lost to Follow-up|6|||
124884260|NCT00386308|449200485|FG000|Overall Study|Withdrawal by Subject|6|||
124884261|NCT00386308|449200486|FG001|Overall Study|Withdrawal by Subject|2|||
124884262|NCT00386308|449200485|FG000|Overall Study|Other Event|8|||
124884263|NCT00386308|449200486|FG001|Overall Study|Other Event|1|||
124884264|NCT02906683|449200487|FG000|Overall Study|Adverse Event|0|||
124884265|NCT02906683|449200488|FG001|Overall Study|Adverse Event|1|||
124884266|NCT02906683|449200489|FG002|Overall Study|Adverse Event|0|||
124884267|NCT02906683|449200487|FG000|Overall Study|Physician Decision|0|||
124884268|NCT02906683|449200488|FG001|Overall Study|Physician Decision|1|||
124884269|NCT02906683|449200489|FG002|Overall Study|Physician Decision|1|||
124884270|NCT02906683|449200487|FG000|Overall Study|Withdrawal by Subject|0|||
124884271|NCT02906683|449200488|FG001|Overall Study|Withdrawal by Subject|2|||
124884272|NCT02906683|449200489|FG002|Overall Study|Withdrawal by Subject|1|||
124884273|NCT02906683|449200487|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
124884274|NCT02906683|449200488|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
124683424|NCT00879658|448463876|FG005|Overall Study|Withdrawal by Subject|1|||
124683425|NCT00879658|448463877|FG006|Overall Study|Withdrawal by Subject|0|||
124884275|NCT02906683|449200489|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
124884276|NCT02906683|449200487|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
124884277|NCT02906683|449200488|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
124884278|NCT02906683|449200489|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
124884279|NCT02781506|449200490|FG000|Overall Study|Adverse Event|5|||
124884280|NCT01242176|449200491|FG000|Washout Period of 7 Days|Adverse Event|0|||
124884281|NCT01242176|449200492|FG001|Washout Period of 7 Days|Adverse Event|2|||
124884282|NCT01242176|449200491|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
124884283|NCT01242176|449200492|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
124884284|NCT02802319|449200495|FG000|Overall Study|Physician Decision|2|||
124884285|NCT02802319|449200496|FG001|Overall Study|Physician Decision|1|||
124884286|NCT02802319|449200495|FG000|Overall Study|Lost to Follow-up|0|||
124884287|NCT02802319|449200496|FG001|Overall Study|Lost to Follow-up|4|||
124884288|NCT03545113|449200497|FG000|Overall Study|Surgery Cancelled|1|||
124884289|NCT03545113|449200498|FG001|Overall Study|Surgery Cancelled|0|||
124884290|NCT03545113|449200497|FG000|Overall Study|Death|1|||
124884291|NCT03545113|449200498|FG001|Overall Study|Death|0|||
124884292|NCT03545113|449200497|FG000|Overall Study|Adverse Event|2|||
124884293|NCT03545113|449200498|FG001|Overall Study|Adverse Event|0|||
124884294|NCT03545113|449200497|FG000|Overall Study|Received different surgery|1|||
124884295|NCT03545113|449200498|FG001|Overall Study|Received different surgery|0|||
124884296|NCT01683994|449200501|FG000|Overall Study|Withdrawal by Subject|1|||
124884297|NCT01683994|449200502|FG001|Overall Study|Withdrawal by Subject|0|||
124884298|NCT01683994|449200503|FG002|Overall Study|Withdrawal by Subject|0|||
124884299|NCT01683994|449200504|FG003|Overall Study|Withdrawal by Subject|1|||
124884300|NCT01683994|449200505|FG004|Overall Study|Withdrawal by Subject|0|||
124884301|NCT01683994|449200501|FG000|Overall Study|Intercurrent illness|0|||
124884302|NCT01683994|449200502|FG001|Overall Study|Intercurrent illness|0|||
124884303|NCT01683994|449200503|FG002|Overall Study|Intercurrent illness|0|||
124884304|NCT01683994|449200504|FG003|Overall Study|Intercurrent illness|2|||
124884305|NCT01683994|449200505|FG004|Overall Study|Intercurrent illness|1|||
124884306|NCT00999661|449200506|FG000|Overall Study|Lost to Follow-up|59|||
124884307|NCT00999661|449200506|FG000|Overall Study|Adverse Event|1|||
124884308|NCT00999661|449200506|FG000|Overall Study|Withdrawal by Subject|1|||
124884309|NCT00999661|449200506|FG000|Overall Study|Not meeting eligibility criteria|9|||
124884310|NCT03638635|449200508|FG000|Initial Hospitalization|Study terminated prematurely|0|||
124884311|NCT03638635|449200509|FG001|Initial Hospitalization|Study terminated prematurely|1|||
124884312|NCT03638635|449200508|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
124884313|NCT03638635|449200509|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
124884314|NCT03638635|449200508|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
124884315|NCT03638635|449200509|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
124884316|NCT00313911|449200512|FG000|Overall Study|Serious adverse event|6|||
124884317|NCT00313911|449200513|FG001|Overall Study|Serious adverse event|1|||
124884318|NCT00313911|449200512|FG000|Overall Study|Adverse Event|2|||
124884319|NCT00313911|449200513|FG001|Overall Study|Adverse Event|3|||
124884320|NCT00313911|449200512|FG000|Overall Study|Protocol Violation|19|||
124884321|NCT00313911|449200513|FG001|Overall Study|Protocol Violation|10|||
124884322|NCT00313911|449200512|FG000|Overall Study|Lost to Follow-up|27|||
124884323|NCT00313911|449200513|FG001|Overall Study|Lost to Follow-up|14|||
124884324|NCT00313911|449200512|FG000|Overall Study|Withdrawal by Subject|39|||
124884325|NCT00313911|449200513|FG001|Overall Study|Withdrawal by Subject|12|||
124884326|NCT00313911|449200512|FG000|Overall Study|Did not meet age criteria|1|||
124884327|NCT00313911|449200513|FG001|Overall Study|Did not meet age criteria|1|||
124884328|NCT01987596|449200516|FG000|Overall Study|Physician Decision|1|||
124884329|NCT01987596|449200517|FG001|Overall Study|Physician Decision|0|||
124884330|NCT01987596|449200516|FG000|Overall Study|Progressive Disease; missing all period|0|||
124884331|NCT01987596|449200517|FG001|Overall Study|Progressive Disease; missing all period|1|||
124884332|NCT01533714|449200519|FG000|Overall Study|Adverse Event|0|||
124884333|NCT01533714|449200520|FG001|Overall Study|Adverse Event|1|||
124884334|NCT01533714|449200521|FG002|Overall Study|Adverse Event|2|||
124884335|NCT01533714|449200522|FG003|Overall Study|Adverse Event|2|||
124884336|NCT01533714|449200523|FG004|Overall Study|Adverse Event|2|||
124884337|NCT01533714|449200524|FG005|Overall Study|Adverse Event|1|||
124884338|NCT01533714|449200519|FG000|Overall Study|Lack of Efficacy|0|||
124884339|NCT01533714|449200520|FG001|Overall Study|Lack of Efficacy|0|||
124884340|NCT01533714|449200521|FG002|Overall Study|Lack of Efficacy|0|||
124884341|NCT01533714|449200522|FG003|Overall Study|Lack of Efficacy|0|||
124884342|NCT01533714|449200523|FG004|Overall Study|Lack of Efficacy|0|||
124884343|NCT01533714|449200524|FG005|Overall Study|Lack of Efficacy|1|||
124884344|NCT01533714|449200519|FG000|Overall Study|Withdrawal by Subject|0|||
124884345|NCT01533714|449200520|FG001|Overall Study|Withdrawal by Subject|1|||
124884346|NCT01533714|449200521|FG002|Overall Study|Withdrawal by Subject|0|||
124884347|NCT01533714|449200522|FG003|Overall Study|Withdrawal by Subject|1|||
124884348|NCT01533714|449200523|FG004|Overall Study|Withdrawal by Subject|1|||
124884349|NCT01533714|449200524|FG005|Overall Study|Withdrawal by Subject|0|||
124884350|NCT01533714|449200519|FG000|Overall Study|Exclusion criteria|0|||
124884351|NCT01533714|449200520|FG001|Overall Study|Exclusion criteria|1|||
124884352|NCT01533714|449200521|FG002|Overall Study|Exclusion criteria|0|||
124884353|NCT01533714|449200522|FG003|Overall Study|Exclusion criteria|0|||
124884354|NCT01533714|449200523|FG004|Overall Study|Exclusion criteria|0|||
124884355|NCT01533714|449200524|FG005|Overall Study|Exclusion criteria|0|||
124884356|NCT01533714|449200519|FG000|Overall Study|Positive for purified protein derivative|0|||
124884357|NCT01533714|449200520|FG001|Overall Study|Positive for purified protein derivative|0|||
124884358|NCT01533714|449200521|FG002|Overall Study|Positive for purified protein derivative|1|||
124884359|NCT01533714|449200522|FG003|Overall Study|Positive for purified protein derivative|0|||
124884360|NCT01533714|449200523|FG004|Overall Study|Positive for purified protein derivative|1|||
124884361|NCT01533714|449200524|FG005|Overall Study|Positive for purified protein derivative|0|||
124884362|NCT01533714|449200519|FG000|Overall Study|Withdrawal criteria|0|||
124884363|NCT01533714|449200520|FG001|Overall Study|Withdrawal criteria|0|||
124884364|NCT01533714|449200521|FG002|Overall Study|Withdrawal criteria|1|||
124884365|NCT01533714|449200522|FG003|Overall Study|Withdrawal criteria|0|||
124884366|NCT01533714|449200523|FG004|Overall Study|Withdrawal criteria|3|||
124884367|NCT01533714|449200524|FG005|Overall Study|Withdrawal criteria|1|||
124884368|NCT01533714|449200519|FG000|Overall Study|Ineligibility reason|0|||
124884369|NCT01533714|449200520|FG001|Overall Study|Ineligibility reason|0|||
124884370|NCT01533714|449200521|FG002|Overall Study|Ineligibility reason|0|||
124884371|NCT01533714|449200522|FG003|Overall Study|Ineligibility reason|1|||
124884372|NCT01533714|449200523|FG004|Overall Study|Ineligibility reason|0|||
124884373|NCT01533714|449200524|FG005|Overall Study|Ineligibility reason|0|||
124884374|NCT00251927|449200529|FG000|Overall Study|Adverse Event|3|||
124884375|NCT00251927|449200530|FG001|Overall Study|Adverse Event|15|||
124884376|NCT00251927|449200529|FG000|Overall Study|Lack of Efficacy|22|||
124439769|NCT00406653|447570868|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
124439770|NCT00406653|447570869|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
124439771|NCT00406653|447570863|FG000|Induction Period|Pregnancy|1|||
124439772|NCT00406653|447570864|FG001|Induction Period|Pregnancy|0|||
124439773|NCT00406653|447570865|FG002|Induction Period|Pregnancy|0|||
124439774|NCT00406653|447570866|FG003|Induction Period|Pregnancy|0|||
124439775|NCT00406653|447570867|FG004|Induction Period|Pregnancy|0|||
124439776|NCT00406653|447570868|FG005|Induction Period|Pregnancy|0|||
124439777|NCT00406653|447570869|FG006|Induction Period|Pregnancy|0|||
124439778|NCT00406653|447570863|FG000|Induction Period|Declined participation but followup done|0|||
124439779|NCT00406653|447570864|FG001|Induction Period|Declined participation but followup done|2|||
124439780|NCT00406653|447570865|FG002|Induction Period|Declined participation but followup done|1|||
124439781|NCT00406653|447570866|FG003|Induction Period|Declined participation but followup done|1|||
124439782|NCT00406653|447570867|FG004|Induction Period|Declined participation but followup done|0|||
124439783|NCT00406653|447570868|FG005|Induction Period|Declined participation but followup done|0|||
124439784|NCT00406653|447570869|FG006|Induction Period|Declined participation but followup done|0|||
124439785|NCT00406653|447570863|FG000|Induction Period|Given prohibited drug|0|||
124439786|NCT00406653|447570864|FG001|Induction Period|Given prohibited drug|1|||
124439787|NCT00406653|447570865|FG002|Induction Period|Given prohibited drug|2|||
124439788|NCT00406653|447570866|FG003|Induction Period|Given prohibited drug|0|||
124439789|NCT00406653|447570867|FG004|Induction Period|Given prohibited drug|0|||
124683426|NCT00879658|448463871|FG000|Overall Study|Lack of Efficacy|0|||
124683427|NCT00879658|448463872|FG001|Overall Study|Lack of Efficacy|0|||
124683428|NCT00879658|448463873|FG002|Overall Study|Lack of Efficacy|2|||
124683429|NCT00879658|448463874|FG003|Overall Study|Lack of Efficacy|0|||
124683430|NCT00879658|448463875|FG004|Overall Study|Lack of Efficacy|0|||
124683431|NCT00879658|448463876|FG005|Overall Study|Lack of Efficacy|0|||
124683432|NCT00879658|448463877|FG006|Overall Study|Lack of Efficacy|0|||
124683433|NCT00879658|448463871|FG000|Overall Study|misrandomized (never received study med)|0|||
124683434|NCT00879658|448463872|FG001|Overall Study|misrandomized (never received study med)|0|||
124683435|NCT00879658|448463873|FG002|Overall Study|misrandomized (never received study med)|0|||
124683436|NCT00879658|448463874|FG003|Overall Study|misrandomized (never received study med)|1|||
124683437|NCT00879658|448463875|FG004|Overall Study|misrandomized (never received study med)|0|||
124683438|NCT00879658|448463876|FG005|Overall Study|misrandomized (never received study med)|0|||
124683439|NCT00879658|448463877|FG006|Overall Study|misrandomized (never received study med)|0|||
124683440|NCT00314145|448463878|FG000|Overall Study|Withdrawal by Subject|8|||
124683441|NCT00314145|448463879|FG001|Overall Study|Withdrawal by Subject|10|||
124683442|NCT00314145|448463878|FG000|Overall Study|Lost to Follow-up|5|||
124683443|NCT00314145|448463879|FG001|Overall Study|Lost to Follow-up|12|||
124683444|NCT00314145|448463878|FG000|Overall Study|Physician Decision|3|||
124683445|NCT00314145|448463879|FG001|Overall Study|Physician Decision|4|||
124683446|NCT00314145|448463878|FG000|Overall Study|Adverse Event|0|||
124683447|NCT00314145|448463879|FG001|Overall Study|Adverse Event|3|||
124683448|NCT00314145|448463878|FG000|Overall Study|Protocol Violation|3|||
124683449|NCT00314145|448463879|FG001|Overall Study|Protocol Violation|0|||
124683450|NCT00314145|448463878|FG000|Overall Study|Sponsor Decision|2|||
124683451|NCT00314145|448463879|FG001|Overall Study|Sponsor Decision|0|||
124683452|NCT00580840|448463880|FG000|Run-in|Adverse Event|17|||
124683453|NCT00580840|448463881|FG001|Run-in|Adverse Event|0|||
124683454|NCT00580840|448463882|FG002|Run-in|Adverse Event|0|||
124683455|NCT00580840|448463883|FG003|Run-in|Adverse Event|0|||
124758686|NCT00543387|448739837|FG002|Panel 1 + Panel 2|Physician Decision|1|||
124884377|NCT00251927|449200530|FG001|Overall Study|Lack of Efficacy|16|||
124439790|NCT00406653|447570868|FG005|Induction Period|Given prohibited drug|0|||
124439791|NCT00406653|447570869|FG006|Induction Period|Given prohibited drug|0|||
124683456|NCT00580840|448463880|FG000|Run-in|Lack of Efficacy|93|||
124683457|NCT00580840|448463881|FG001|Run-in|Lack of Efficacy|0|||
124683458|NCT00580840|448463882|FG002|Run-in|Lack of Efficacy|0|||
124683459|NCT00580840|448463883|FG003|Run-in|Lack of Efficacy|0|||
124683460|NCT00580840|448463880|FG000|Run-in|Loss of Efficacy|1|||
124884378|NCT00251927|449200529|FG000|Overall Study|Lost to Follow-up|22|||
124884379|NCT00251927|449200530|FG001|Overall Study|Lost to Follow-up|8|||
124884380|NCT00251927|449200529|FG000|Overall Study|Protocol Violation|1|||
124683461|NCT00580840|448463881|FG001|Run-in|Loss of Efficacy|0|||
124884381|NCT00251927|449200530|FG001|Overall Study|Protocol Violation|2|||
124884382|NCT00251927|449200529|FG000|Overall Study|Pregnancy|2|||
124884383|NCT00251927|449200530|FG001|Overall Study|Pregnancy|0|||
124884384|NCT00251927|449200529|FG000|Overall Study|Withdrawal by Subject|40|||
124884385|NCT00251927|449200530|FG001|Overall Study|Withdrawal by Subject|25|||
124884386|NCT00251927|449200529|FG000|Overall Study|Study-specific discont. achieved|13|||
124884387|NCT00251927|449200530|FG001|Overall Study|Study-specific discont. achieved|2|||
124884388|NCT00251927|449200529|FG000|Overall Study|Study procedure non-compliance|5|||
124884389|NCT00251927|449200530|FG001|Overall Study|Study procedure non-compliance|6|||
124884390|NCT02406261|449200535|FG000|Period 1|Lost to Follow-up|2|||
124884391|NCT02406261|449200536|FG001|Period 1|Lost to Follow-up|0|||
124884392|NCT02406261|449200535|FG000|Period 1|Adverse Event|1|||
124884393|NCT02406261|449200536|FG001|Period 1|Adverse Event|0|||
124884394|NCT02406261|449200535|FG000|Period 2|Physician Decision|0|||
124884395|NCT02406261|449200536|FG001|Period 2|Physician Decision|1|||
124884396|NCT02406261|449200535|FG000|Period 2|Protocol Violation|0|||
124884397|NCT02406261|449200536|FG001|Period 2|Protocol Violation|1|||
124884398|NCT02406261|449200535|FG000|Period 2|Withdrawal by Subject|0|||
124884399|NCT02406261|449200536|FG001|Period 2|Withdrawal by Subject|1|||
124884400|NCT02222896|449200539|FG000|Abdomen|Did not qualify|34|||
124884401|NCT02222896|449200540|FG001|Abdomen|Did not qualify|10|||
124884402|NCT02222896|449200541|FG002|Abdomen|Did not qualify|32|||
124884403|NCT02222896|449200539|FG000|Groin|Did not qualify|43|||
124884404|NCT02222896|449200540|FG001|Groin|Did not qualify|9|||
124884405|NCT02222896|449200541|FG002|Groin|Did not qualify|40|||
124884406|NCT02441946|449200542|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
124884407|NCT02441946|449200543|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
124884408|NCT02441946|449200544|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
124884409|NCT02441946|449200542|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
124884410|NCT02441946|449200543|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
124884411|NCT02441946|449200544|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
124884412|NCT02441946|449200542|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
124884413|NCT02441946|449200543|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
124884414|NCT02441946|449200544|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
124439792|NCT00406653|447570863|FG000|Induction Period|Incarcerated|0|||
124439793|NCT00406653|447570864|FG001|Induction Period|Incarcerated|0|||
124439794|NCT00406653|447570865|FG002|Induction Period|Incarcerated|1|||
124439795|NCT00406653|447570866|FG003|Induction Period|Incarcerated|0|||
124439796|NCT00406653|447570867|FG004|Induction Period|Incarcerated|0|||
124439797|NCT00406653|447570868|FG005|Induction Period|Incarcerated|0|||
124439798|NCT00406653|447570869|FG006|Induction Period|Incarcerated|0|||
124439799|NCT00406653|447570863|FG000|Induction Period|Patient relocated|0|||
124439800|NCT00406653|447570864|FG001|Induction Period|Patient relocated|0|||
124439801|NCT00406653|447570865|FG002|Induction Period|Patient relocated|1|||
124439802|NCT00406653|447570866|FG003|Induction Period|Patient relocated|0|||
124439803|NCT00406653|447570867|FG004|Induction Period|Patient relocated|0|||
124439804|NCT00406653|447570868|FG005|Induction Period|Patient relocated|0|||
124439805|NCT00406653|447570869|FG006|Induction Period|Patient relocated|0|||
124439806|NCT00406653|447570863|FG000|Maintenance Period|Adverse Event|0|||
124439807|NCT00406653|447570864|FG001|Maintenance Period|Adverse Event|0|||
124439808|NCT00406653|447570865|FG002|Maintenance Period|Adverse Event|0|||
124439809|NCT00406653|447570866|FG003|Maintenance Period|Adverse Event|0|||
124439810|NCT00406653|447570867|FG004|Maintenance Period|Adverse Event|1|||
124439811|NCT00406653|447570868|FG005|Maintenance Period|Adverse Event|1|||
124439812|NCT00406653|447570869|FG006|Maintenance Period|Adverse Event|0|||
124439813|NCT00406653|447570863|FG000|Maintenance Period|Lack of Efficacy|0|||
124439814|NCT00406653|447570864|FG001|Maintenance Period|Lack of Efficacy|0|||
124439815|NCT00406653|447570865|FG002|Maintenance Period|Lack of Efficacy|0|||
124439816|NCT00406653|447570866|FG003|Maintenance Period|Lack of Efficacy|0|||
124439817|NCT00406653|447570867|FG004|Maintenance Period|Lack of Efficacy|20|||
124439818|NCT00406653|447570868|FG005|Maintenance Period|Lack of Efficacy|26|||
124439819|NCT00406653|447570869|FG006|Maintenance Period|Lack of Efficacy|0|||
124439820|NCT00406653|447570863|FG000|Maintenance Period|Lost to Follow-up|0|||
124439821|NCT00406653|447570864|FG001|Maintenance Period|Lost to Follow-up|0|||
124439822|NCT00406653|447570865|FG002|Maintenance Period|Lost to Follow-up|0|||
124439823|NCT00406653|447570866|FG003|Maintenance Period|Lost to Follow-up|0|||
124439824|NCT00406653|447570867|FG004|Maintenance Period|Lost to Follow-up|2|||
124439825|NCT00406653|447570868|FG005|Maintenance Period|Lost to Follow-up|1|||
124439826|NCT00406653|447570869|FG006|Maintenance Period|Lost to Follow-up|0|||
124439827|NCT00406653|447570863|FG000|Maintenance Period|Withdrawal of Consent|0|||
124439828|NCT00406653|447570864|FG001|Maintenance Period|Withdrawal of Consent|0|||
124439829|NCT00406653|447570865|FG002|Maintenance Period|Withdrawal of Consent|0|||
124884415|NCT02441946|449200542|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
124884416|NCT02441946|449200543|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
124884417|NCT02441946|449200544|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
124884418|NCT02441946|449200542|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
124884419|NCT02441946|449200543|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
124884420|NCT02441946|449200544|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
124884421|NCT02441946|449200542|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
124884422|NCT02441946|449200543|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
124884423|NCT02441946|449200544|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
124884424|NCT02441946|449200542|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
124884425|NCT02441946|449200543|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
124884426|NCT02441946|449200544|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
124884427|NCT02441946|449200542|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
124884428|NCT02441946|449200543|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
124884429|NCT02441946|449200544|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
124884430|NCT02441946|449200542|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
124884431|NCT02441946|449200543|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
124884432|NCT02441946|449200544|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
124884433|NCT02441946|449200542|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
124884434|NCT02441946|449200543|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
124884435|NCT02441946|449200544|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
124884436|NCT02441946|449200542|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
124884437|NCT02441946|449200543|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
124884438|NCT02441946|449200544|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
124884439|NCT02111213|449200545|FG000|Overall Study|Withdrawal by Subject|3|||
124884440|NCT02111213|449200546|FG001|Overall Study|Withdrawal by Subject|2|||
124884441|NCT02111213|449200545|FG000|Overall Study|Lost to Follow-up|3|||
124884442|NCT02111213|449200546|FG001|Overall Study|Lost to Follow-up|4|||
124884443|NCT02226172|449200553|FG000|Overall Study|Participant refused further follow-up|4|||
124884444|NCT02226172|449200553|FG000|Overall Study|Other|5|||
124884445|NCT02226172|449200553|FG000|Overall Study|Death|1|||
124884446|NCT02226172|449200553|FG000|Overall Study|Study terminated by sponsor|1|||
124884447|NCT02226172|449200553|FG000|Overall Study|Adverse Event|6|||
124884448|NCT01865617|449200554|FG000|Overall Study|Death|27|||
124884449|NCT01865617|449200555|FG001|Overall Study|Death|3|||
124884450|NCT01865617|449200556|FG002|Overall Study|Death|1|||
124884451|NCT01865617|449200557|FG003|Overall Study|Death|1|||
124884452|NCT01865617|449200558|FG004|Overall Study|Death|5|||
124884453|NCT01865617|449200559|FG005|Overall Study|Death|1|||
124884454|NCT01865617|449200560|FG006|Overall Study|Death|11|||
124884455|NCT01865617|449200561|FG007|Overall Study|Death|1|||
124884456|NCT01865617|449200562|FG008|Overall Study|Death|11|||
124884457|NCT01865617|449200563|FG009|Overall Study|Death|3|||
124884458|NCT01865617|449200564|FG010|Overall Study|Death|32|||
124884459|NCT01865617|449200565|FG011|Overall Study|Death|6|||
124884460|NCT01865617|449200566|FG012|Overall Study|Death|13|||
124884461|NCT01865617|449200554|FG000|Overall Study|Lost to Follow-up|2|||
124884462|NCT01865617|449200555|FG001|Overall Study|Lost to Follow-up|0|||
124884463|NCT01865617|449200556|FG002|Overall Study|Lost to Follow-up|0|||
124884464|NCT01865617|449200557|FG003|Overall Study|Lost to Follow-up|0|||
124884465|NCT01865617|449200558|FG004|Overall Study|Lost to Follow-up|0|||
124884466|NCT01865617|449200559|FG005|Overall Study|Lost to Follow-up|0|||
124884467|NCT01865617|449200560|FG006|Overall Study|Lost to Follow-up|0|||
124884468|NCT01865617|449200561|FG007|Overall Study|Lost to Follow-up|0|||
124884469|NCT01865617|449200562|FG008|Overall Study|Lost to Follow-up|0|||
124884470|NCT01865617|449200563|FG009|Overall Study|Lost to Follow-up|0|||
124884471|NCT01865617|449200564|FG010|Overall Study|Lost to Follow-up|0|||
124884472|NCT01865617|449200565|FG011|Overall Study|Lost to Follow-up|0|||
124884473|NCT01865617|449200566|FG012|Overall Study|Lost to Follow-up|0|||
124884474|NCT01865617|449200554|FG000|Overall Study|Withdrawal by Subject|1|||
124884475|NCT01865617|449200555|FG001|Overall Study|Withdrawal by Subject|0|||
124884476|NCT01865617|449200556|FG002|Overall Study|Withdrawal by Subject|0|||
124884477|NCT01865617|449200557|FG003|Overall Study|Withdrawal by Subject|0|||
124884478|NCT01865617|449200558|FG004|Overall Study|Withdrawal by Subject|0|||
124884479|NCT01865617|449200559|FG005|Overall Study|Withdrawal by Subject|0|||
124884480|NCT01865617|449200560|FG006|Overall Study|Withdrawal by Subject|0|||
124884481|NCT01865617|449200561|FG007|Overall Study|Withdrawal by Subject|0|||
124884482|NCT01865617|449200562|FG008|Overall Study|Withdrawal by Subject|0|||
124884483|NCT01865617|449200563|FG009|Overall Study|Withdrawal by Subject|0|||
124884484|NCT01865617|449200564|FG010|Overall Study|Withdrawal by Subject|0|||
124884485|NCT01865617|449200565|FG011|Overall Study|Withdrawal by Subject|0|||
124884486|NCT01865617|449200566|FG012|Overall Study|Withdrawal by Subject|0|||
124884487|NCT01865617|449200554|FG000|Overall Study|Patient proceeded to new therapy|0|||
124884488|NCT01865617|449200555|FG001|Overall Study|Patient proceeded to new therapy|0|||
124884489|NCT01865617|449200556|FG002|Overall Study|Patient proceeded to new therapy|0|||
124884490|NCT01865617|449200557|FG003|Overall Study|Patient proceeded to new therapy|0|||
124884491|NCT01865617|449200558|FG004|Overall Study|Patient proceeded to new therapy|2|||
124884492|NCT01865617|449200559|FG005|Overall Study|Patient proceeded to new therapy|0|||
124884493|NCT01865617|449200560|FG006|Overall Study|Patient proceeded to new therapy|0|||
124884494|NCT01865617|449200561|FG007|Overall Study|Patient proceeded to new therapy|0|||
124884495|NCT01865617|449200562|FG008|Overall Study|Patient proceeded to new therapy|0|||
124884496|NCT01865617|449200563|FG009|Overall Study|Patient proceeded to new therapy|0|||
124884497|NCT01865617|449200564|FG010|Overall Study|Patient proceeded to new therapy|0|||
124884498|NCT01865617|449200565|FG011|Overall Study|Patient proceeded to new therapy|0|||
124884499|NCT01865617|449200566|FG012|Overall Study|Patient proceeded to new therapy|0|||
124884500|NCT01865617|449200554|FG000|Overall Study|Other|0|||
124884501|NCT01865617|449200555|FG001|Overall Study|Other|0|||
124884502|NCT01865617|449200556|FG002|Overall Study|Other|0|||
124884503|NCT01865617|449200557|FG003|Overall Study|Other|0|||
124884504|NCT01865617|449200558|FG004|Overall Study|Other|0|||
124884505|NCT01865617|449200559|FG005|Overall Study|Other|0|||
124884506|NCT01865617|449200560|FG006|Overall Study|Other|1|||
124884507|NCT01865617|449200561|FG007|Overall Study|Other|0|||
124884508|NCT01865617|449200562|FG008|Overall Study|Other|0|||
124884509|NCT01865617|449200563|FG009|Overall Study|Other|0|||
124884510|NCT01865617|449200564|FG010|Overall Study|Other|0|||
124884511|NCT01865617|449200565|FG011|Overall Study|Other|0|||
124884512|NCT01865617|449200566|FG012|Overall Study|Other|0|||
124884513|NCT00258440|449200571|FG000|Overall Study|Withdrawal by Subject|0|||
124884514|NCT00258440|449200572|FG001|Overall Study|Withdrawal by Subject|0|||
124884515|NCT00258440|449200573|FG002|Overall Study|Withdrawal by Subject|1|||
124884516|NCT00737061|449200574|FG000|Waiting Period|Lost to Follow-up|6|||
124884517|NCT00737061|449200574|FG000|Waiting Period|Withdrawal by Subject|1|||
124884518|NCT00737061|449200574|FG000|Waiting Period|Bilateral placement failure|34|||
124884519|NCT00737061|449200574|FG000|Waiting Period|Deemed patent following HSG|26|||
124884520|NCT00737061|449200574|FG000|Waiting Period|Alternative contraception failure|3|||
124884521|NCT00737061|449200574|FG000|Waiting Period|Elected surgical tubal ligation|5|||
124884522|NCT00737061|449200574|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
124884523|NCT00737061|449200574|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
124884524|NCT00737061|449200574|FG000|1 Year Wearing Period|Discontinued reilance|3|||
124884525|NCT00737061|449200574|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
124884526|NCT00439179|449200575|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
124884527|NCT00439179|449200576|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
124884528|NCT00439179|449200577|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
124884529|NCT00439179|449200578|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
124884530|NCT01844115|449200579|FG000|Overall Study|Adverse Event|4|||
124884531|NCT01844115|449200580|FG001|Overall Study|Adverse Event|22|||
124884532|NCT01844115|449200579|FG000|Overall Study|Lack of Efficacy|1|||
124884533|NCT01844115|449200580|FG001|Overall Study|Lack of Efficacy|4|||
124884534|NCT01844115|449200579|FG000|Overall Study|Protocol Violation|12|||
124884535|NCT01844115|449200580|FG001|Overall Study|Protocol Violation|10|||
124884536|NCT01844115|449200579|FG000|Overall Study|Withdrawal by Subject|11|||
124884537|NCT01844115|449200580|FG001|Overall Study|Withdrawal by Subject|11|||
124884538|NCT01844115|449200579|FG000|Overall Study|Lost to Follow-up|11|||
124884539|NCT01844115|449200580|FG001|Overall Study|Lost to Follow-up|10|||
124884540|NCT01844115|449200579|FG000|Overall Study|Pregnancy|0|||
124884541|NCT01844115|449200580|FG001|Overall Study|Pregnancy|1|||
124884542|NCT00758160|449200581|FG000|Overall Study|No Longer Requires Study Medication|4|||
124884543|NCT00758160|449200581|FG000|Overall Study|Administration Problems|3|||
124884544|NCT00758160|449200581|FG000|Overall Study|Adverse Event|15|||
124884545|NCT00758160|449200581|FG000|Overall Study|Lack of Efficacy|10|||
124884546|NCT00758160|449200581|FG000|Overall Study|Lost to Follow-up|14|||
124884547|NCT00758160|449200581|FG000|Overall Study|Protocol Violation|12|||
124884548|NCT00758160|449200581|FG000|Overall Study|Withdrawal by Subject|8|||
124884549|NCT00993317|449200582|FG000|Overall Study|Adverse Event|2|||
124884550|NCT00993317|449200583|FG001|Overall Study|Adverse Event|4|||
124884551|NCT00993317|449200582|FG000|Overall Study|Lack of Efficacy|18|||
124884552|NCT00993317|449200583|FG001|Overall Study|Lack of Efficacy|18|||
124884553|NCT00993317|449200582|FG000|Overall Study|Withdrawal by Subject|0|||
124884554|NCT00993317|449200583|FG001|Overall Study|Withdrawal by Subject|2|||
124884555|NCT00993317|449200582|FG000|Overall Study|Investigator's opinion|0|||
124884556|NCT00993317|449200583|FG001|Overall Study|Investigator's opinion|1|||
124884557|NCT00993317|449200582|FG000|Overall Study|Early study termination at the site|1|||
124884558|NCT00993317|449200583|FG001|Overall Study|Early study termination at the site|0|||
124884559|NCT02153359|449200584|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
124884560|NCT02153359|449200585|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
124884561|NCT04422639|449200586|FG000|Overall Study|Death|1|||
124884562|NCT04422639|449200587|FG001|Overall Study|Death|0|||
124884563|NCT04422639|449200586|FG000|Overall Study|study closed prior to completion of FU visits|0|||
124884564|NCT04422639|449200587|FG001|Overall Study|study closed prior to completion of FU visits|2|||
124683462|NCT00580840|448463882|FG002|Run-in|Loss of Efficacy|0|||
124683463|NCT00580840|448463883|FG003|Run-in|Loss of Efficacy|0|||
124683464|NCT00580840|448463880|FG000|Run-in|Lost to Follow-up|4|||
124884565|NCT01964521|449200588|FG000|Overall Study|Lost to Follow-up|4|||
124884566|NCT01372605|449200589|FG000|Overall Study|Death|1|||
124884567|NCT01372605|449200590|FG001|Overall Study|Death|2|||
124884568|NCT01372605|449200589|FG000|Overall Study|Lost to Follow-up|2|||
124884569|NCT01372605|449200590|FG001|Overall Study|Lost to Follow-up|1|||
124884570|NCT01372605|449200589|FG000|Overall Study|Withdrawal by Subject|4|||
124884571|NCT01372605|449200590|FG001|Overall Study|Withdrawal by Subject|7|||
124884572|NCT01372605|449200589|FG000|Overall Study|Moved|3|||
124884573|NCT01372605|449200590|FG001|Overall Study|Moved|0|||
124884574|NCT01372605|449200589|FG000|Overall Study|Changed medical home|2|||
124884575|NCT01372605|449200590|FG001|Overall Study|Changed medical home|0|||
124884576|NCT01108510|449200591|FG000|Overall Study|Randomized but Not Treated|5|||
124884577|NCT01108510|449200592|FG001|Overall Study|Randomized but Not Treated|1|||
124884578|NCT01108510|449200591|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
124884579|NCT01108510|449200592|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
124884580|NCT01108510|449200591|FG000|Overall Study|Adverse Event|26|||
124884581|NCT01108510|449200592|FG001|Overall Study|Adverse Event|19|||
124884582|NCT01108510|449200591|FG000|Overall Study|Lost to Follow-up|20|||
124884583|NCT01108510|449200592|FG001|Overall Study|Lost to Follow-up|17|||
124884584|NCT01108510|449200591|FG000|Overall Study|Withdrew Consent|21|||
124884585|NCT01108510|449200592|FG001|Overall Study|Withdrew Consent|15|||
124884586|NCT01108510|449200591|FG000|Overall Study|Investigator's Discretion|12|||
124884587|NCT01108510|449200592|FG001|Overall Study|Investigator's Discretion|10|||
124884588|NCT01108510|449200591|FG000|Overall Study|Participant Noncompliance|5|||
124884589|NCT01108510|449200592|FG001|Overall Study|Participant Noncompliance|7|||
124884590|NCT01108510|449200591|FG000|Overall Study|Lack of Efficacy|3|||
124884591|NCT01108510|449200592|FG001|Overall Study|Lack of Efficacy|0|||
124884592|NCT01108510|449200591|FG000|Overall Study|Pregnancy|0|||
124884593|NCT01108510|449200592|FG001|Overall Study|Pregnancy|3|||
124884594|NCT01108510|449200591|FG000|Overall Study|Death|1|||
124884595|NCT01108510|449200592|FG001|Overall Study|Death|1|||
124884596|NCT02796963|449200593|FG000|Overall Study|Lost to Follow-up|89|||
124884597|NCT02796963|449200594|FG001|Overall Study|Lost to Follow-up|76|||
124884598|NCT02796963|449200595|FG002|Overall Study|Lost to Follow-up|69|||
124884599|NCT02796963|449200596|FG003|Overall Study|Lost to Follow-up|72|||
124884600|NCT01258660|449200597|FG000|Overall Study|Adverse Event|2|||
124884601|NCT01258660|449200598|FG001|Overall Study|Adverse Event|4|||
124884602|NCT01258660|449200597|FG000|Overall Study|Withdrawal by Subject|3|||
124884603|NCT01258660|449200598|FG001|Overall Study|Withdrawal by Subject|0|||
124884604|NCT01258660|449200597|FG000|Overall Study|due to relocation|2|||
124683465|NCT00580840|448463881|FG001|Run-in|Lost to Follow-up|0|||
124884605|NCT01258660|449200598|FG001|Overall Study|due to relocation|0|||
124884606|NCT01258660|449200597|FG000|Overall Study|Protocol Violation|0|||
124884607|NCT01258660|449200598|FG001|Overall Study|Protocol Violation|1|||
124884608|NCT01258660|449200597|FG000|Overall Study|Invalid for primary analysis data set|4|||
124884609|NCT01258660|449200598|FG001|Overall Study|Invalid for primary analysis data set|6|||
124683466|NCT00580840|448463882|FG002|Run-in|Lost to Follow-up|0|||
124884610|NCT01775930|449200606|FG000|Overall Study|Futility stopping boundary met|1|||
124884611|NCT00363896|449200608|FG000|Overall Study|Withdrawal by Subject|29|||
124683467|NCT00580840|448463883|FG003|Run-in|Lost to Follow-up|0|||
124884612|NCT00363896|449200609|FG001|Overall Study|Withdrawal by Subject|16|||
124683468|NCT00580840|448463880|FG000|Run-in|Withdrawal by Subject|5|||
124683469|NCT00580840|448463881|FG001|Run-in|Withdrawal by Subject|0|||
124683470|NCT00580840|448463882|FG002|Run-in|Withdrawal by Subject|0|||
124683471|NCT00580840|448463883|FG003|Run-in|Withdrawal by Subject|0|||
124683472|NCT00580840|448463880|FG000|Run-in|Other: Per Sponsor Request|2|||
124683473|NCT00580840|448463881|FG001|Run-in|Other: Per Sponsor Request|0|||
124683474|NCT00580840|448463882|FG002|Run-in|Other: Per Sponsor Request|0|||
124683475|NCT00580840|448463883|FG003|Run-in|Other: Per Sponsor Request|0|||
124683476|NCT00580840|448463880|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
124683477|NCT00580840|448463881|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
124683478|NCT00580840|448463882|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
124683479|NCT00580840|448463883|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
124683480|NCT00580840|448463880|FG000|Run-in|Other: Exclusionary Lab Value|1|||
124683481|NCT00580840|448463881|FG001|Run-in|Other: Exclusionary Lab Value|0|||
124683482|NCT00580840|448463882|FG002|Run-in|Other: Exclusionary Lab Value|0|||
124683483|NCT00580840|448463883|FG003|Run-in|Other: Exclusionary Lab Value|0|||
124683484|NCT00580840|448463880|FG000|Double-Blind|Adverse Event|0|||
124683485|NCT00580840|448463881|FG001|Double-Blind|Adverse Event|3|||
124683486|NCT00580840|448463882|FG002|Double-Blind|Adverse Event|4|||
124683487|NCT00580840|448463883|FG003|Double-Blind|Adverse Event|1|||
124683488|NCT00580840|448463880|FG000|Double-Blind|Loss of Efficacy|0|||
124683489|NCT00580840|448463881|FG001|Double-Blind|Loss of Efficacy|1|||
124683490|NCT00580840|448463882|FG002|Double-Blind|Loss of Efficacy|2|||
124683491|NCT00580840|448463883|FG003|Double-Blind|Loss of Efficacy|10|||
124683492|NCT00580840|448463880|FG000|Double-Blind|Lost to Follow-up|0|||
124683493|NCT00580840|448463881|FG001|Double-Blind|Lost to Follow-up|1|||
124683494|NCT00580840|448463882|FG002|Double-Blind|Lost to Follow-up|0|||
124683495|NCT00580840|448463883|FG003|Double-Blind|Lost to Follow-up|2|||
124683496|NCT00580840|448463880|FG000|Double-Blind|Withdrawal by Subject|0|||
124683497|NCT00580840|448463881|FG001|Double-Blind|Withdrawal by Subject|1|||
124683498|NCT00580840|448463882|FG002|Double-Blind|Withdrawal by Subject|2|||
124683499|NCT00580840|448463883|FG003|Double-Blind|Withdrawal by Subject|2|||
124683500|NCT00580840|448463880|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
124683501|NCT00580840|448463881|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
124683502|NCT00580840|448463882|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
124683503|NCT00580840|448463883|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
124683504|NCT00580840|448463880|FG000|Double-Blind|Other: Forbidden Medication|0|||
124683505|NCT00580840|448463881|FG001|Double-Blind|Other: Forbidden Medication|0|||
124683506|NCT00580840|448463882|FG002|Double-Blind|Other: Forbidden Medication|1|||
124683507|NCT00580840|448463883|FG003|Double-Blind|Other: Forbidden Medication|0|||
124683508|NCT01551173|448463884|FG000|Overall Study|Withdrawal by Subject|11|||
124683509|NCT01551173|448463885|FG001|Overall Study|Withdrawal by Subject|16|||
124683510|NCT01551173|448463884|FG000|Overall Study|Adverse Event|7|||
124683511|NCT01551173|448463885|FG001|Overall Study|Adverse Event|6|||
124683512|NCT01551173|448463884|FG000|Overall Study|Lost to Follow-up|5|||
124683513|NCT01551173|448463885|FG001|Overall Study|Lost to Follow-up|7|||
124683514|NCT01551173|448463884|FG000|Overall Study|Other|5|||
124683515|NCT01551173|448463885|FG001|Overall Study|Other|3|||
124683516|NCT04530344|448463886|FG000|Overall Study|Lost to Follow-up|3|||
124683517|NCT04530344|448463887|FG001|Overall Study|Lost to Follow-up|3|||
124683518|NCT04530344|448463888|FG002|Overall Study|Lost to Follow-up|3|||
124683519|NCT04530344|448463889|FG003|Overall Study|Lost to Follow-up|10|||
124683520|NCT04530344|448463886|FG000|Overall Study|Withdrawal by Subject|14|||
124683521|NCT04530344|448463887|FG001|Overall Study|Withdrawal by Subject|5|||
124683522|NCT04530344|448463888|FG002|Overall Study|Withdrawal by Subject|18|||
124683523|NCT04530344|448463889|FG003|Overall Study|Withdrawal by Subject|33|||
124683524|NCT04530344|448463886|FG000|Overall Study|Adverse Event|0|||
124683525|NCT04530344|448463887|FG001|Overall Study|Adverse Event|0|||
124683526|NCT04530344|448463888|FG002|Overall Study|Adverse Event|0|||
124683527|NCT04530344|448463889|FG003|Overall Study|Adverse Event|1|||
124758687|NCT00543387|448739838|FG003|Panel 1 + Panel 2|Physician Decision|0|||
124758688|NCT00543387|448739839|FG004|Panel 1 + Panel 2|Physician Decision|0|||
124884613|NCT00363896|449200608|FG000|Overall Study|Adverse Event|24|||
124884614|NCT00363896|449200609|FG001|Overall Study|Adverse Event|13|||
124884615|NCT00363896|449200608|FG000|Overall Study|COPD exacerbation|13|||
124683528|NCT04530344|448463886|FG000|Overall Study|Lack of Efficacy|0|||
124758689|NCT00543387|448739840|FG005|Panel 1 + Panel 2|Physician Decision|0|||
124884616|NCT00363896|449200609|FG001|Overall Study|COPD exacerbation|7|||
124683529|NCT04530344|448463887|FG001|Overall Study|Lack of Efficacy|0|||
124683530|NCT04530344|448463888|FG002|Overall Study|Lack of Efficacy|0|||
124683531|NCT04530344|448463889|FG003|Overall Study|Lack of Efficacy|1|||
124683532|NCT04530344|448463886|FG000|Overall Study|Physician Decision|0|||
124683533|NCT04530344|448463887|FG001|Overall Study|Physician Decision|0|||
124683534|NCT04530344|448463888|FG002|Overall Study|Physician Decision|1|||
124683535|NCT04530344|448463889|FG003|Overall Study|Physician Decision|1|||
124683536|NCT04530344|448463886|FG000|Overall Study|Pregnancy|0|||
124683537|NCT04530344|448463887|FG001|Overall Study|Pregnancy|0|||
124683538|NCT04530344|448463888|FG002|Overall Study|Pregnancy|2|||
124758690|NCT00543387|448739841|FG006|Panel 1 + Panel 2|Physician Decision|0|||
124683539|NCT04530344|448463889|FG003|Overall Study|Pregnancy|1|||
124683540|NCT04530344|448463886|FG000|Overall Study|Protocol Violation|0|||
124683541|NCT04530344|448463887|FG001|Overall Study|Protocol Violation|0|||
124683542|NCT04530344|448463888|FG002|Overall Study|Protocol Violation|0|||
124683543|NCT04530344|448463889|FG003|Overall Study|Protocol Violation|1|||
124683544|NCT04530344|448463886|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
124683545|NCT04530344|448463887|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
124683546|NCT04530344|448463888|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
124683547|NCT04530344|448463889|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
124683548|NCT04530344|448463886|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
124683549|NCT04530344|448463887|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
124683550|NCT04530344|448463888|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
124683551|NCT04530344|448463889|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
124683552|NCT04530344|448463886|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
124683553|NCT04530344|448463887|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
124683554|NCT04530344|448463888|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
124683555|NCT04530344|448463889|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
124683556|NCT04530344|448463886|FG000|Overall Study|Personal Reasons|0|||
124683557|NCT04530344|448463887|FG001|Overall Study|Personal Reasons|0|||
124683558|NCT04530344|448463888|FG002|Overall Study|Personal Reasons|0|||
124683559|NCT04530344|448463889|FG003|Overall Study|Personal Reasons|1|||
124683560|NCT04530344|448463886|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
124683561|NCT04530344|448463887|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
124683562|NCT04530344|448463888|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
124683563|NCT04530344|448463889|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
124683564|NCT01402700|448463890|FG000|Overall Study|Death|3|||
124683565|NCT01402700|448463890|FG000|Overall Study|Withdrawal by Subject|3|||
124683566|NCT01402700|448463890|FG000|Overall Study|Missed Visit|1|||
124683567|NCT05523297|448463896|FG000|Overall Study|Death|7|||
124683568|NCT05523297|448463897|FG001|Overall Study|Death|8|||
124683569|NCT05523297|448463896|FG000|Overall Study|Lost to Follow-up|2|||
124683570|NCT05523297|448463897|FG001|Overall Study|Lost to Follow-up|1|||
124683571|NCT03462680|448463898|FG000|Overall Study|Withdrawal by Subject|3|||
124683572|NCT03462680|448463899|FG001|Overall Study|Withdrawal by Subject|5|||
124683573|NCT02246777|448463900|FG000|Overall Study|Adverse Event|2|||
124683574|NCT02246777|448463900|FG000|Overall Study|Change of residence|1|||
124683575|NCT02401230|448463901|FG000|Overall Study|Adverse Event|3|||
124683576|NCT02401230|448463902|FG001|Overall Study|Adverse Event|2|||
124683577|NCT02401230|448463903|FG002|Overall Study|Adverse Event|0|||
124683578|NCT02401230|448463901|FG000|Overall Study|Withdrawal by Subject|2|||
124683579|NCT02401230|448463902|FG001|Overall Study|Withdrawal by Subject|1|||
124683580|NCT02401230|448463903|FG002|Overall Study|Withdrawal by Subject|1|||
124683581|NCT02401230|448463901|FG000|Overall Study|Lost to Follow-up|1|||
124683582|NCT02401230|448463902|FG001|Overall Study|Lost to Follow-up|3|||
124683583|NCT02401230|448463903|FG002|Overall Study|Lost to Follow-up|3|||
124683584|NCT04133909|448463904|FG000|Overall Study|Death|11|||
124683585|NCT04133909|448463905|FG001|Overall Study|Death|11|||
124683586|NCT04133909|448463904|FG000|Overall Study|Adverse Event|4|||
124683587|NCT04133909|448463905|FG001|Overall Study|Adverse Event|5|||
124683588|NCT04133909|448463904|FG000|Overall Study|Lost to Follow-up|3|||
124683589|NCT04133909|448463905|FG001|Overall Study|Lost to Follow-up|5|||
124683590|NCT04133909|448463904|FG000|Overall Study|Physician Decision|4|||
124683591|NCT04133909|448463905|FG001|Overall Study|Physician Decision|7|||
124683592|NCT04133909|448463904|FG000|Overall Study|Withdrawal by Subject|40|||
124683593|NCT04133909|448463905|FG001|Overall Study|Withdrawal by Subject|35|||
124683594|NCT04133909|448463904|FG000|Overall Study|Lack of Efficacy|2|||
124683595|NCT04133909|448463905|FG001|Overall Study|Lack of Efficacy|7|||
124683596|NCT04133909|448463904|FG000|Overall Study|Randomized in error|1|||
124683597|NCT04133909|448463905|FG001|Overall Study|Randomized in error|1|||
124683598|NCT00830765|448463906|FG000|Overall Study|Protocol Violation|3|||
124683599|NCT00830765|448463907|FG001|Overall Study|Protocol Violation|2|||
124683600|NCT01299909|448463908|FG000|Overall Study|Lost to Follow-up|22|||
124683601|NCT01299909|448463909|FG001|Overall Study|Lost to Follow-up|18|||
124683602|NCT01299909|448463910|FG002|Overall Study|Lost to Follow-up|17|||
124683603|NCT03069989|448463914|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
124683604|NCT03069989|448463915|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
124683605|NCT03595748|448466004|FG000|Overall Study|Death|11|||
124683606|NCT03595748|448466005|FG001|Overall Study|Death|12|||
124884617|NCT00363896|449200608|FG000|Overall Study|Lack of Efficacy|12|||
124884618|NCT00363896|449200609|FG001|Overall Study|Lack of Efficacy|8|||
124884619|NCT00363896|449200608|FG000|Overall Study|Protocol Violation|6|||
124884620|NCT00363896|449200609|FG001|Overall Study|Protocol Violation|1|||
124884621|NCT00363896|449200608|FG000|Overall Study|Lost to Follow-up|3|||
124884622|NCT00363896|449200609|FG001|Overall Study|Lost to Follow-up|0|||
124884623|NCT00363896|449200608|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
124884624|NCT00363896|449200609|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
124884625|NCT00363896|449200608|FG000|Overall Study|Other|1|||
124884626|NCT00363896|449200609|FG001|Overall Study|Other|2|||
124884627|NCT00924469|449200615|FG000|Overall Study|Adverse Event|2|||
124884628|NCT00924469|449200616|FG001|Overall Study|Adverse Event|0|||
124884629|NCT00924469|449200615|FG000|Overall Study|Withdrawal by Subject|0|||
124884630|NCT00924469|449200616|FG001|Overall Study|Withdrawal by Subject|1|||
124884631|NCT00924469|449200615|FG000|Overall Study|Lost to Follow-up|0|||
124884632|NCT00924469|449200616|FG001|Overall Study|Lost to Follow-up|1|||
124884633|NCT03044353|449200617|FG000|Overall Study|Adverse Event|0|||
124884634|NCT03044353|449200618|FG001|Overall Study|Adverse Event|1|||
124884635|NCT03044353|449200619|FG002|Overall Study|Adverse Event|0|||
124884636|NCT01464255|449200631|FG000|Overall Study|unresolve corneal staining|0|||
124884637|NCT01464255|449200632|FG001|Overall Study|unresolve corneal staining|1|||
124884638|NCT03051659|449200633|FG000|Treatment Period|Withdrawal by Subject|0|||
124884639|NCT03051659|449200634|FG001|Treatment Period|Withdrawal by Subject|2|||
124884640|NCT03051659|449200633|FG000|Survival Follow-up|Lost to Follow-up|23|||
124884641|NCT03051659|449200634|FG001|Survival Follow-up|Lost to Follow-up|22|||
124884642|NCT00786474|449200635|FG000|Overall Study|Death|5|||
124884643|NCT00786474|449200636|FG001|Overall Study|Death|4|||
124884644|NCT00786474|449200635|FG000|Overall Study|Withdrawal by Subject|23|||
124884645|NCT00786474|449200636|FG001|Overall Study|Withdrawal by Subject|31|||
124884646|NCT00786474|449200635|FG000|Overall Study|Lost to Follow-up|3|||
124884647|NCT00786474|449200636|FG001|Overall Study|Lost to Follow-up|3|||
124884648|NCT00786474|449200635|FG000|Overall Study|Physician Decision|2|||
124884649|NCT00786474|449200636|FG001|Overall Study|Physician Decision|1|||
124884650|NCT00786474|449200635|FG000|Overall Study|Other|4|||
124884651|NCT00786474|449200636|FG001|Overall Study|Other|4|||
124884652|NCT02733042|449200637|FG000|Overall Study|Adverse Event|1|||
124884653|NCT02733042|449200638|FG001|Overall Study|Adverse Event|0|||
124884654|NCT02733042|449200639|FG002|Overall Study|Adverse Event|1|||
124884655|NCT02733042|449200640|FG003|Overall Study|Adverse Event|1|||
124884656|NCT02733042|449200641|FG004|Overall Study|Adverse Event|0|||
124884657|NCT02733042|449200642|FG005|Overall Study|Adverse Event|0|||
124884658|NCT02733042|449200643|FG006|Overall Study|Adverse Event|0|||
124884659|NCT02733042|449200644|FG007|Overall Study|Adverse Event|0|||
124884660|NCT02733042|449200645|FG008|Overall Study|Adverse Event|0|||
124884661|NCT02733042|449200646|FG009|Overall Study|Adverse Event|0|||
124884662|NCT02733042|449200647|FG010|Overall Study|Adverse Event|2|||
124884663|NCT02733042|449200648|FG011|Overall Study|Adverse Event|2|||
124884664|NCT02733042|449200649|FG012|Overall Study|Adverse Event|0|||
124884665|NCT02733042|449200650|FG013|Overall Study|Adverse Event|2|||
124884666|NCT02733042|449200651|FG014|Overall Study|Adverse Event|0|||
124884667|NCT02733042|449200652|FG015|Overall Study|Adverse Event|0|||
124884668|NCT02733042|449200653|FG016|Overall Study|Adverse Event|0|||
124884669|NCT02733042|449200654|FG017|Overall Study|Adverse Event|1|||
124884670|NCT02733042|449200655|FG018|Overall Study|Adverse Event|0|||
124884671|NCT02733042|449200637|FG000|Overall Study|Progressive Disease|2|||
124884672|NCT02733042|449200638|FG001|Overall Study|Progressive Disease|1|||
124884673|NCT02733042|449200639|FG002|Overall Study|Progressive Disease|3|||
124884674|NCT02733042|449200640|FG003|Overall Study|Progressive Disease|1|||
124884675|NCT02733042|449200641|FG004|Overall Study|Progressive Disease|2|||
124884676|NCT02733042|449200642|FG005|Overall Study|Progressive Disease|3|||
124884677|NCT02733042|449200643|FG006|Overall Study|Progressive Disease|0|||
124884678|NCT02733042|449200644|FG007|Overall Study|Progressive Disease|3|||
124884679|NCT02733042|449200645|FG008|Overall Study|Progressive Disease|3|||
124884680|NCT02733042|449200646|FG009|Overall Study|Progressive Disease|2|||
124884681|NCT02733042|449200647|FG010|Overall Study|Progressive Disease|2|||
124884682|NCT02733042|449200648|FG011|Overall Study|Progressive Disease|2|||
124884683|NCT02733042|449200649|FG012|Overall Study|Progressive Disease|8|||
124884684|NCT02733042|449200650|FG013|Overall Study|Progressive Disease|1|||
124884685|NCT02733042|449200651|FG014|Overall Study|Progressive Disease|4|||
124884686|NCT02733042|449200652|FG015|Overall Study|Progressive Disease|7|||
124683607|NCT03595748|448466004|FG000|Overall Study|Withdrawal by Subject|28|||
124884687|NCT02733042|449200653|FG016|Overall Study|Progressive Disease|2|||
124683608|NCT03595748|448466005|FG001|Overall Study|Withdrawal by Subject|29|||
124683609|NCT03595748|448466004|FG000|Overall Study|Protocol Violation|0|||
124884688|NCT02733042|449200654|FG017|Overall Study|Progressive Disease|3|||
124884689|NCT02733042|449200655|FG018|Overall Study|Progressive Disease|4|||
124884690|NCT02733042|449200637|FG000|Overall Study|Withdrawal by Subject|0|||
124884691|NCT02733042|449200638|FG001|Overall Study|Withdrawal by Subject|1|||
124884692|NCT02733042|449200639|FG002|Overall Study|Withdrawal by Subject|2|||
124884693|NCT02733042|449200640|FG003|Overall Study|Withdrawal by Subject|1|||
124683610|NCT03595748|448466005|FG001|Overall Study|Protocol Violation|1|||
124683611|NCT04809974|448466007|FG000|Lead-in Phase|Withdrawal by Subject|3|||
124683612|NCT04809974|448466008|FG001|Lead-in Phase|Withdrawal by Subject|0|||
124683613|NCT04809974|448466009|FG002|Lead-in Phase|Withdrawal by Subject|0|||
124683614|NCT04809974|448466007|FG000|Lead-in Phase|No longer eligible|11|||
124683615|NCT04809974|448466008|FG001|Lead-in Phase|No longer eligible|0|||
124683616|NCT04809974|448466009|FG002|Lead-in Phase|No longer eligible|0|||
124683617|NCT04809974|448466007|FG000|Randomized Phase|Lost to Follow-up|0|||
124683618|NCT04809974|448466008|FG001|Randomized Phase|Lost to Follow-up|1|||
124683619|NCT04809974|448466009|FG002|Randomized Phase|Lost to Follow-up|5|||
124683620|NCT04809974|448466007|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
124683621|NCT04809974|448466008|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
124683622|NCT04809974|448466009|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
124683623|NCT04809974|448466007|FG000|Randomized Phase|Adverse Event|0|||
124683624|NCT04809974|448466008|FG001|Randomized Phase|Adverse Event|1|||
124683625|NCT04809974|448466009|FG002|Randomized Phase|Adverse Event|4|||
124683626|NCT04809974|448466007|FG000|Randomized Phase|Withdrawal by Subject|0|||
124683627|NCT04809974|448466008|FG001|Randomized Phase|Withdrawal by Subject|0|||
124683628|NCT04809974|448466009|FG002|Randomized Phase|Withdrawal by Subject|5|||
124683629|NCT05493111|448466011|FG000|Overall Study|Adverse Event|3|||
124683630|NCT05493111|448466012|FG001|Overall Study|Adverse Event|4|||
124683631|NCT05493111|448466011|FG000|Overall Study|Withdrawal of Consent|19|||
124683632|NCT05493111|448466012|FG001|Overall Study|Withdrawal of Consent|10|||
124683633|NCT05493111|448466011|FG000|Overall Study|Non-compliance|1|||
124683634|NCT05493111|448466012|FG001|Overall Study|Non-compliance|1|||
124683635|NCT05493111|448466011|FG000|Overall Study|Lost to Follow-up|8|||
124683636|NCT05493111|448466012|FG001|Overall Study|Lost to Follow-up|1|||
124683637|NCT05493111|448466011|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
124683638|NCT05493111|448466012|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
124683639|NCT05493111|448466011|FG000|Overall Study|Withdrawal by Subject|1|||
124683640|NCT05493111|448466012|FG001|Overall Study|Withdrawal by Subject|1|||
124683641|NCT05399485|448466013|FG000|DBT Phase|Other|6|||
124683642|NCT05399485|448466014|FG001|DBT Phase|Other|5|||
124683643|NCT05399485|448466013|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
124683644|NCT05399485|448466014|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
124683645|NCT05399485|448466013|FG000|DBT Phase|Withdrawal by Subject|3|||
124683646|NCT05399485|448466014|FG001|DBT Phase|Withdrawal by Subject|2|||
124683647|NCT05399485|448466013|FG000|DBT Phase|Protocol Violation|2|||
124683648|NCT05399485|448466014|FG001|DBT Phase|Protocol Violation|1|||
124683649|NCT05399485|448466013|FG000|DBT Phase|Physician Decision|0|||
124683650|NCT05399485|448466014|FG001|DBT Phase|Physician Decision|1|||
124683651|NCT05399485|448466013|FG000|DBT Phase|Adverse Event|2|||
124683652|NCT05399485|448466014|FG001|DBT Phase|Adverse Event|1|||
124683653|NCT05399485|448466013|FG000|OLE Phase|Not reported|0|||
124683654|NCT05399485|448466014|FG001|OLE Phase|Not reported|1|||
124683655|NCT05399485|448466013|FG000|OLE Phase|Other|3|||
124683656|NCT05399485|448466014|FG001|OLE Phase|Other|3|||
124683657|NCT05399485|448466013|FG000|OLE Phase|Withdrawal by Subject|8|||
124683658|NCT05399485|448466014|FG001|OLE Phase|Withdrawal by Subject|5|||
124683659|NCT05399485|448466013|FG000|OLE Phase|Pregnancy|0|||
124683660|NCT05399485|448466014|FG001|OLE Phase|Pregnancy|1|||
124683661|NCT05399485|448466013|FG000|OLE Phase|Physician Decision|2|||
124683662|NCT05399485|448466014|FG001|OLE Phase|Physician Decision|0|||
124683663|NCT05399485|448466013|FG000|OLE Phase|Adverse Event|0|||
124683664|NCT05399485|448466014|FG001|OLE Phase|Adverse Event|1|||
124683665|NCT05399485|448466013|FG000|OLE Phase|Ongoing in the OLE Phase|141|||
124683666|NCT05399485|448466014|FG001|OLE Phase|Ongoing in the OLE Phase|140|||
124683667|NCT06125964|448466015|FG000|Overall Study|Lost to Follow-up|0|||
124683668|NCT06125964|448466016|FG001|Overall Study|Lost to Follow-up|1|||
124683669|NCT06125964|448466017|FG002|Overall Study|Lost to Follow-up|0|||
124683670|NCT06125964|448466018|FG003|Overall Study|Lost to Follow-up|0|||
124884694|NCT02733042|449200641|FG004|Overall Study|Withdrawal by Subject|1|||
124683671|NCT01787838|448466019|FG000|Overall Study|refused|1413|||
124683672|NCT02020941|448466020|FG000|Overall Study|Adverse Event|1|||
124683673|NCT02020941|448466020|FG000|Overall Study|Physician Decision|2|||
124683674|NCT02020941|448466020|FG000|Overall Study|Withdrawal by Subject|1|||
124683675|NCT02020941|448466020|FG000|Overall Study|Disease Progression|4|||
124884695|NCT02733042|449200642|FG005|Overall Study|Withdrawal by Subject|0|||
124884696|NCT02733042|449200643|FG006|Overall Study|Withdrawal by Subject|0|||
124884697|NCT02733042|449200644|FG007|Overall Study|Withdrawal by Subject|0|||
124884698|NCT02733042|449200645|FG008|Overall Study|Withdrawal by Subject|1|||
124884699|NCT02733042|449200646|FG009|Overall Study|Withdrawal by Subject|1|||
124884700|NCT02733042|449200647|FG010|Overall Study|Withdrawal by Subject|0|||
124884701|NCT02733042|449200648|FG011|Overall Study|Withdrawal by Subject|2|||
124884702|NCT02733042|449200649|FG012|Overall Study|Withdrawal by Subject|1|||
124884703|NCT02733042|449200650|FG013|Overall Study|Withdrawal by Subject|1|||
124884704|NCT02733042|449200651|FG014|Overall Study|Withdrawal by Subject|0|||
124884705|NCT02733042|449200652|FG015|Overall Study|Withdrawal by Subject|0|||
124884706|NCT02733042|449200653|FG016|Overall Study|Withdrawal by Subject|0|||
124884707|NCT02733042|449200654|FG017|Overall Study|Withdrawal by Subject|0|||
124884708|NCT02733042|449200655|FG018|Overall Study|Withdrawal by Subject|0|||
124884709|NCT02733042|449200637|FG000|Overall Study|Other Reasons|0|||
124884710|NCT02733042|449200638|FG001|Overall Study|Other Reasons|0|||
124884711|NCT02733042|449200639|FG002|Overall Study|Other Reasons|1|||
124884712|NCT02733042|449200640|FG003|Overall Study|Other Reasons|0|||
124884713|NCT02733042|449200641|FG004|Overall Study|Other Reasons|0|||
124884714|NCT02733042|449200642|FG005|Overall Study|Other Reasons|0|||
124884715|NCT02733042|449200643|FG006|Overall Study|Other Reasons|0|||
124884716|NCT02733042|449200644|FG007|Overall Study|Other Reasons|0|||
124884717|NCT02733042|449200645|FG008|Overall Study|Other Reasons|0|||
124884718|NCT02733042|449200646|FG009|Overall Study|Other Reasons|1|||
124884719|NCT02733042|449200647|FG010|Overall Study|Other Reasons|1|||
124884720|NCT02733042|449200648|FG011|Overall Study|Other Reasons|0|||
124884721|NCT02733042|449200649|FG012|Overall Study|Other Reasons|0|||
124884722|NCT02733042|449200650|FG013|Overall Study|Other Reasons|0|||
124884723|NCT02733042|449200651|FG014|Overall Study|Other Reasons|0|||
124884724|NCT02733042|449200652|FG015|Overall Study|Other Reasons|1|||
124884725|NCT02733042|449200653|FG016|Overall Study|Other Reasons|0|||
124884726|NCT02733042|449200654|FG017|Overall Study|Other Reasons|1|||
124884727|NCT02733042|449200655|FG018|Overall Study|Other Reasons|0|||
124884728|NCT02733042|449200637|FG000|Overall Study|Death|0|||
124884729|NCT02733042|449200638|FG001|Overall Study|Death|0|||
124884730|NCT02733042|449200639|FG002|Overall Study|Death|0|||
124884731|NCT02733042|449200640|FG003|Overall Study|Death|0|||
124884732|NCT02733042|449200641|FG004|Overall Study|Death|0|||
124884733|NCT02733042|449200642|FG005|Overall Study|Death|0|||
124884734|NCT02733042|449200643|FG006|Overall Study|Death|1|||
124884735|NCT02733042|449200644|FG007|Overall Study|Death|0|||
124884736|NCT02733042|449200645|FG008|Overall Study|Death|1|||
124884737|NCT02733042|449200646|FG009|Overall Study|Death|0|||
124884738|NCT02733042|449200647|FG010|Overall Study|Death|1|||
124884739|NCT02733042|449200648|FG011|Overall Study|Death|0|||
124884740|NCT02733042|449200649|FG012|Overall Study|Death|0|||
124884741|NCT02733042|449200650|FG013|Overall Study|Death|0|||
124884742|NCT02733042|449200651|FG014|Overall Study|Death|1|||
124884743|NCT02733042|449200652|FG015|Overall Study|Death|2|||
124884744|NCT02733042|449200653|FG016|Overall Study|Death|0|||
124884745|NCT02733042|449200654|FG017|Overall Study|Death|0|||
124884746|NCT02733042|449200655|FG018|Overall Study|Death|0|||
124884747|NCT00960752|449200656|FG000|Overall Study|Adverse Event|0|||
124884748|NCT00960752|449200657|FG001|Overall Study|Adverse Event|0|||
124884749|NCT00960752|449200658|FG002|Overall Study|Adverse Event|1|||
124884750|NCT00960752|449200656|FG000|Overall Study|Progression|0|||
124884751|NCT00960752|449200657|FG001|Overall Study|Progression|0|||
124884752|NCT00960752|449200658|FG002|Overall Study|Progression|1|||
124884753|NCT02180438|449200664|FG000|Overall Study|Lost to Follow-up|1|||
124884754|NCT00180713|449200667|FG000|Overall Study|Withdrawal by Subject|2|||
124884755|NCT00180713|449200668|FG001|Overall Study|Withdrawal by Subject|0|||
124884756|NCT00180713|449200667|FG000|Overall Study|Adverse Event|3|||
124884757|NCT00180713|449200668|FG001|Overall Study|Adverse Event|3|||
124884758|NCT01091428|449202469|FG000|Phase 1|Progressive Disease|24|||
124884759|NCT01091428|449202470|FG001|Phase 1|Progressive Disease|8|||
124884760|NCT01091428|449202471|FG002|Phase 1|Progressive Disease|0|||
124884761|NCT01091428|449202472|FG003|Phase 1|Progressive Disease|0|||
124884762|NCT01091428|449202469|FG000|Phase 1|Symptomatic Deterioration|3|||
124884763|NCT01091428|449202470|FG001|Phase 1|Symptomatic Deterioration|2|||
124884764|NCT01091428|449202471|FG002|Phase 1|Symptomatic Deterioration|0|||
124884765|NCT01091428|449202472|FG003|Phase 1|Symptomatic Deterioration|0|||
124884766|NCT01091428|449202469|FG000|Phase 1|Adverse Event|2|||
124884767|NCT01091428|449202470|FG001|Phase 1|Adverse Event|0|||
124884768|NCT01091428|449202471|FG002|Phase 1|Adverse Event|0|||
124884769|NCT01091428|449202472|FG003|Phase 1|Adverse Event|0|||
124884770|NCT01091428|449202469|FG000|Phase 1|Withdrawal by Subject|7|||
124884771|NCT01091428|449202470|FG001|Phase 1|Withdrawal by Subject|0|||
124884772|NCT01091428|449202471|FG002|Phase 1|Withdrawal by Subject|0|||
124884773|NCT01091428|449202472|FG003|Phase 1|Withdrawal by Subject|0|||
124884774|NCT01091428|449202469|FG000|Phase 1|Reason not specified|0|||
124884775|NCT01091428|449202470|FG001|Phase 1|Reason not specified|1|||
124884776|NCT01091428|449202471|FG002|Phase 1|Reason not specified|0|||
124884777|NCT01091428|449202472|FG003|Phase 1|Reason not specified|0|||
124884778|NCT01091428|449202469|FG000|Phase 1|Single-Patient IND|2|||
124884779|NCT01091428|449202470|FG001|Phase 1|Single-Patient IND|0|||
124884780|NCT01091428|449202471|FG002|Phase 1|Single-Patient IND|0|||
124884781|NCT01091428|449202472|FG003|Phase 1|Single-Patient IND|0|||
124884782|NCT01091428|449202469|FG000|Phase 2|Progressive Disease|0|||
124884783|NCT01091428|449202470|FG001|Phase 2|Progressive Disease|0|||
124884784|NCT01091428|449202471|FG002|Phase 2|Progressive Disease|44|||
124884785|NCT01091428|449202472|FG003|Phase 2|Progressive Disease|46|||
124884786|NCT01091428|449202469|FG000|Phase 2|Symptomatic Deterioration|0|||
124884787|NCT01091428|449202470|FG001|Phase 2|Symptomatic Deterioration|0|||
124884788|NCT01091428|449202471|FG002|Phase 2|Symptomatic Deterioration|1|||
124884789|NCT01091428|449202472|FG003|Phase 2|Symptomatic Deterioration|6|||
124884790|NCT01091428|449202469|FG000|Phase 2|Adverse Event|0|||
124884791|NCT01091428|449202470|FG001|Phase 2|Adverse Event|0|||
124884792|NCT01091428|449202471|FG002|Phase 2|Adverse Event|12|||
124884793|NCT01091428|449202472|FG003|Phase 2|Adverse Event|5|||
124884794|NCT01091428|449202469|FG000|Phase 2|Withdrawal by Subject|0|||
124884795|NCT01091428|449202470|FG001|Phase 2|Withdrawal by Subject|0|||
124884796|NCT01091428|449202471|FG002|Phase 2|Withdrawal by Subject|9|||
124884797|NCT01091428|449202472|FG003|Phase 2|Withdrawal by Subject|8|||
124884798|NCT01091428|449202469|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
124884799|NCT01091428|449202470|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
124884800|NCT01091428|449202471|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
124884801|NCT01091428|449202472|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
124884802|NCT01091428|449202469|FG000|Phase 2|Reason not specified|0|||
124884803|NCT01091428|449202470|FG001|Phase 2|Reason not specified|0|||
124884804|NCT01091428|449202471|FG002|Phase 2|Reason not specified|4|||
124884805|NCT01091428|449202472|FG003|Phase 2|Reason not specified|3|||
124884806|NCT01091428|449202469|FG000|Phase 2|Physician Decision|0|||
124884807|NCT01091428|449202470|FG001|Phase 2|Physician Decision|0|||
124884808|NCT01091428|449202471|FG002|Phase 2|Physician Decision|2|||
124884809|NCT01091428|449202472|FG003|Phase 2|Physician Decision|0|||
124884810|NCT02531295|449202473|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
124884811|NCT02531295|449202474|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
124884812|NCT02531295|449202475|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
124884813|NCT02531295|449202476|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
124884814|NCT02531295|449202477|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
124884815|NCT02531295|449202478|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
124884816|NCT04424290|449202480|FG000|Overall Study|Not treated|0|||
124884817|NCT04424290|449202481|FG001|Overall Study|Not treated|0|||
124884818|NCT04424290|449202482|FG002|Overall Study|Not treated|1|||
124884819|NCT04424290|449202483|FG003|Overall Study|Not treated|0|||
124884820|NCT04424290|449202484|FG004|Overall Study|Not treated|1|||
124884821|NCT04424290|449202480|FG000|Overall Study|Adverse Event|0|||
124884822|NCT04424290|449202481|FG001|Overall Study|Adverse Event|0|||
124884823|NCT04424290|449202482|FG002|Overall Study|Adverse Event|0|||
124884824|NCT04424290|449202483|FG003|Overall Study|Adverse Event|2|||
124884825|NCT04424290|449202484|FG004|Overall Study|Adverse Event|0|||
124884826|NCT04424290|449202480|FG000|Overall Study|Withdrawal by Subject|0|||
124884827|NCT04424290|449202481|FG001|Overall Study|Withdrawal by Subject|0|||
124884828|NCT04424290|449202482|FG002|Overall Study|Withdrawal by Subject|0|||
124884829|NCT04424290|449202483|FG003|Overall Study|Withdrawal by Subject|0|||
124884830|NCT04424290|449202484|FG004|Overall Study|Withdrawal by Subject|1|||
124884831|NCT04424290|449202480|FG000|Overall Study|Other than listed|0|||
124884832|NCT04424290|449202481|FG001|Overall Study|Other than listed|0|||
124884833|NCT04424290|449202482|FG002|Overall Study|Other than listed|0|||
124884834|NCT04424290|449202483|FG003|Overall Study|Other than listed|1|||
124884835|NCT04424290|449202484|FG004|Overall Study|Other than listed|0|||
124884836|NCT00806624|449202491|FG000|Overall Study|Adverse Event|2|||
124884837|NCT00806624|449202492|FG001|Overall Study|Adverse Event|8|||
124884838|NCT00806624|449202493|FG002|Overall Study|Adverse Event|0|||
124884839|NCT00806624|449202491|FG000|Overall Study|Death|0|||
124884840|NCT00806624|449202492|FG001|Overall Study|Death|1|||
124884841|NCT00806624|449202493|FG002|Overall Study|Death|1|||
124884842|NCT00806624|449202491|FG000|Overall Study|Lost to Follow-up|1|||
124884843|NCT00806624|449202492|FG001|Overall Study|Lost to Follow-up|0|||
124884844|NCT00806624|449202493|FG002|Overall Study|Lost to Follow-up|1|||
124884845|NCT00806624|449202491|FG000|Overall Study|Withdrawal by Subject|6|||
124884846|NCT00806624|449202492|FG001|Overall Study|Withdrawal by Subject|3|||
124884847|NCT00806624|449202493|FG002|Overall Study|Withdrawal by Subject|3|||
124884848|NCT00806624|449202491|FG000|Overall Study|discontinued before start of treatment|0|||
124884849|NCT00806624|449202492|FG001|Overall Study|discontinued before start of treatment|0|||
124884850|NCT00806624|449202493|FG002|Overall Study|discontinued before start of treatment|1|||
124884851|NCT00467142|449202498|FG000|Overall Study|Withdrawal by Subject|1|||
124884852|NCT00467142|449202498|FG000|Overall Study|Adverse Event|1|||
124884853|NCT00467142|449202498|FG000|Overall Study|Protocol Violation|1|||
124884854|NCT02771210|449202499|FG000|Period 1|Adverse Event|5|||
124884855|NCT02771210|449202500|FG001|Period 1|Adverse Event|3|||
124884856|NCT02771210|449202499|FG000|Period 1|Lack of Efficacy|3|||
124884857|NCT02771210|449202500|FG001|Period 1|Lack of Efficacy|6|||
124884858|NCT02771210|449202499|FG000|Period 1|Lost to Follow-up|2|||
124884859|NCT02771210|449202500|FG001|Period 1|Lost to Follow-up|0|||
124884860|NCT02771210|449202499|FG000|Period 1|Physician Decision|0|||
124884861|NCT02771210|449202500|FG001|Period 1|Physician Decision|1|||
124884862|NCT02771210|449202499|FG000|Period 1|Withdrawal by Subject|0|||
124884863|NCT02771210|449202500|FG001|Period 1|Withdrawal by Subject|3|||
124884864|NCT02771210|449202499|FG000|Period 1|Withdrawal of informed consent|1|||
124884865|NCT02771210|449202500|FG001|Period 1|Withdrawal of informed consent|5|||
124884866|NCT02771210|449202499|FG000|Period 2|Adverse Event|1|||
124884867|NCT02771210|449202500|FG001|Period 2|Adverse Event|0|||
124884868|NCT02771210|449202499|FG000|Period 2|Lack of Efficacy|0|||
124884869|NCT02771210|449202500|FG001|Period 2|Lack of Efficacy|1|||
124884870|NCT02771210|449202499|FG000|Period 2|Withdrawal by Subject|1|||
124884871|NCT02771210|449202500|FG001|Period 2|Withdrawal by Subject|0|||
124884872|NCT02771210|449202499|FG000|Period 2|Withdrawal of informed consent|0|||
124884873|NCT02771210|449202500|FG001|Period 2|Withdrawal of informed consent|2|||
124884874|NCT00684762|449202507|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
124884875|NCT00684762|449202508|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
124884876|NCT02572817|449202509|FG000|Overall Study|Death|6|||
124884877|NCT02572817|449202510|FG001|Overall Study|Death|3|||
124884878|NCT02572817|449202509|FG000|Overall Study|Lost to Follow-up|3|||
124884879|NCT02572817|449202510|FG001|Overall Study|Lost to Follow-up|3|||
124884880|NCT00119262|449202513|FG000|Overall Study|Lack of Efficacy|0|||
124884881|NCT00119262|449202514|FG001|Overall Study|Lack of Efficacy|3|||
124884882|NCT00119262|449202513|FG000|Overall Study|Withdrawal by Subject|12|||
124884883|NCT00119262|449202514|FG001|Overall Study|Withdrawal by Subject|11|||
124884884|NCT00119262|449202513|FG000|Overall Study|Adverse Event|33|||
124884885|NCT00119262|449202514|FG001|Overall Study|Adverse Event|35|||
124884886|NCT00119262|449202513|FG000|Overall Study|other disease|0|||
124884887|NCT00119262|449202514|FG001|Overall Study|other disease|2|||
124884888|NCT00119262|449202513|FG000|Overall Study|ineligble|1|||
124884889|NCT00119262|449202514|FG001|Overall Study|ineligble|2|||
124884890|NCT00119262|449202513|FG000|Overall Study|others|0|||
124884891|NCT00119262|449202514|FG001|Overall Study|others|5|||
124884892|NCT00734214|449202515|FG000|Overall Study|Withdrawal by Subject|3|||
124884893|NCT00734214|449202516|FG001|Overall Study|Withdrawal by Subject|4|||
124884894|NCT00734214|449202515|FG000|Overall Study|MD withdrawal|1|||
124884895|NCT00734214|449202516|FG001|Overall Study|MD withdrawal|0|||
124884896|NCT00630058|449202522|FG000|Overall Study|Adverse Event|1|||
124884897|NCT00630058|449202523|FG001|Overall Study|Adverse Event|1|||
124884898|NCT00630058|449202522|FG000|Overall Study|Withdrawal by Subject|0|||
124884899|NCT00630058|449202523|FG001|Overall Study|Withdrawal by Subject|1|||
124884900|NCT00630058|449202522|FG000|Overall Study|stopping criteria|3|||
124884901|NCT00630058|449202523|FG001|Overall Study|stopping criteria|2|||
124884902|NCT01651936|449202524|FG000|Base Study|Adverse Event|3|||
124884903|NCT01651936|449202525|FG001|Base Study|Adverse Event|0|||
124884904|NCT01651936|449202526|FG002|Base Study|Adverse Event|0|||
124884905|NCT01651936|449202524|FG000|Base Study|Withdrawal by Subject|1|||
124884906|NCT01651936|449202525|FG001|Base Study|Withdrawal by Subject|1|||
124884907|NCT01651936|449202526|FG002|Base Study|Withdrawal by Subject|0|||
124884908|NCT01651936|449202524|FG000|Base Study|Early Escape|2|||
124884909|NCT01651936|449202525|FG001|Base Study|Early Escape|8|||
124884910|NCT01651936|449202526|FG002|Base Study|Early Escape|0|||
124884911|NCT01651936|449202524|FG000|Base Study|Study terminated by sponsor|21|||
124884912|NCT01651936|449202525|FG001|Base Study|Study terminated by sponsor|16|||
124884913|NCT01651936|449202526|FG002|Base Study|Study terminated by sponsor|0|||
124884914|NCT01651936|449202524|FG000|Extension Study|Lack of Efficacy|0|||
124884915|NCT01651936|449202525|FG001|Extension Study|Lack of Efficacy|0|||
124884916|NCT01651936|449202526|FG002|Extension Study|Lack of Efficacy|1|||
124884917|NCT01651936|449202524|FG000|Extension Study|Study terminated by sponsor|0|||
124884918|NCT01651936|449202525|FG001|Extension Study|Study terminated by sponsor|0|||
124884919|NCT01651936|449202526|FG002|Extension Study|Study terminated by sponsor|13|||
124884920|NCT02141659|449202530|FG000|Overall Study|Major Protocol Deviation|0|||
124884921|NCT02141659|449202531|FG001|Overall Study|Major Protocol Deviation|1|||
124884922|NCT02141659|449202532|FG002|Overall Study|Major Protocol Deviation|0|||
124884923|NCT02141659|449202533|FG003|Overall Study|Major Protocol Deviation|0|||
124884924|NCT02141659|449202534|FG004|Overall Study|Major Protocol Deviation|0|||
124884925|NCT02141659|449202535|FG005|Overall Study|Major Protocol Deviation|0|||
124884926|NCT02141659|449202530|FG000|Overall Study|Lack of Efficacy|0|||
124884927|NCT02141659|449202531|FG001|Overall Study|Lack of Efficacy|0|||
124884928|NCT02141659|449202532|FG002|Overall Study|Lack of Efficacy|0|||
124884929|NCT02141659|449202533|FG003|Overall Study|Lack of Efficacy|0|||
124884930|NCT02141659|449202534|FG004|Overall Study|Lack of Efficacy|0|||
124884931|NCT02141659|449202535|FG005|Overall Study|Lack of Efficacy|1|||
124884932|NCT02141659|449202530|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
124884933|NCT02141659|449202531|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
124884934|NCT02141659|449202532|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
124884935|NCT02141659|449202533|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
124884936|NCT02141659|449202534|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
124884937|NCT02141659|449202535|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
124884938|NCT02340520|449202536|FG000|Overall Study|Lost to Follow-up|1|||
124884939|NCT02340520|449202536|FG000|Overall Study|Patient did not take drug as specified|1|||
124884940|NCT02340520|449202536|FG000|Overall Study|Withdrawal by Subject|1|||
124884941|NCT01231503|449202537|FG000|Overall Study|Adverse Event|0|||
124884942|NCT01231503|449202538|FG001|Overall Study|Adverse Event|0|||
124884943|NCT01231503|449202539|FG002|Overall Study|Adverse Event|0|||
124884944|NCT01231503|449202540|FG003|Overall Study|Adverse Event|0|||
124884945|NCT01231503|449202541|FG004|Overall Study|Adverse Event|0|||
124884946|NCT01231503|449202542|FG005|Overall Study|Adverse Event|1|||
124884947|NCT01231503|449202543|FG006|Overall Study|Adverse Event|0|||
124884948|NCT01231503|449202544|FG007|Overall Study|Adverse Event|0|||
124884949|NCT01231503|449202537|FG000|Overall Study|Adverse event, serious fatal|0|||
124884950|NCT01231503|449202538|FG001|Overall Study|Adverse event, serious fatal|0|||
124884951|NCT01231503|449202539|FG002|Overall Study|Adverse event, serious fatal|1|||
124884952|NCT01231503|449202540|FG003|Overall Study|Adverse event, serious fatal|1|||
124884953|NCT01231503|449202541|FG004|Overall Study|Adverse event, serious fatal|0|||
124884954|NCT01231503|449202542|FG005|Overall Study|Adverse event, serious fatal|1|||
124884955|NCT01231503|449202543|FG006|Overall Study|Adverse event, serious fatal|0|||
124884956|NCT01231503|449202544|FG007|Overall Study|Adverse event, serious fatal|0|||
124884957|NCT01231503|449202537|FG000|Overall Study|Withdrawal by Subject|6|||
124884958|NCT01231503|449202538|FG001|Overall Study|Withdrawal by Subject|3|||
124884959|NCT01231503|449202539|FG002|Overall Study|Withdrawal by Subject|3|||
124884960|NCT01231503|449202540|FG003|Overall Study|Withdrawal by Subject|1|||
124884961|NCT01231503|449202541|FG004|Overall Study|Withdrawal by Subject|3|||
124884962|NCT01231503|449202542|FG005|Overall Study|Withdrawal by Subject|5|||
124884963|NCT01231503|449202543|FG006|Overall Study|Withdrawal by Subject|1|||
124884964|NCT01231503|449202544|FG007|Overall Study|Withdrawal by Subject|2|||
124884965|NCT01231503|449202537|FG000|Overall Study|Lost to Follow-up|8|||
124884966|NCT01231503|449202538|FG001|Overall Study|Lost to Follow-up|10|||
124884967|NCT01231503|449202539|FG002|Overall Study|Lost to Follow-up|8|||
124884968|NCT01231503|449202540|FG003|Overall Study|Lost to Follow-up|5|||
124884969|NCT01231503|449202541|FG004|Overall Study|Lost to Follow-up|7|||
124884970|NCT01231503|449202542|FG005|Overall Study|Lost to Follow-up|9|||
124884971|NCT01231503|449202543|FG006|Overall Study|Lost to Follow-up|6|||
124884972|NCT01231503|449202544|FG007|Overall Study|Lost to Follow-up|6|||
124884973|NCT01231503|449202537|FG000|Overall Study|Protocol Violation|0|||
124884974|NCT01231503|449202538|FG001|Overall Study|Protocol Violation|0|||
124884975|NCT01231503|449202539|FG002|Overall Study|Protocol Violation|0|||
124884976|NCT01231503|449202540|FG003|Overall Study|Protocol Violation|1|||
124884977|NCT01231503|449202541|FG004|Overall Study|Protocol Violation|0|||
124884978|NCT01231503|449202542|FG005|Overall Study|Protocol Violation|0|||
124884979|NCT01231503|449202543|FG006|Overall Study|Protocol Violation|0|||
124884980|NCT01231503|449202544|FG007|Overall Study|Protocol Violation|0|||
124884981|NCT01586338|449202545|FG000|Overall Study|Adverse Event|3|||
124884982|NCT01586338|449202545|FG000|Overall Study|Lost to Follow-up|1|||
124884983|NCT01586338|449202545|FG000|Overall Study|Withdrawal by participant|3|||
124884984|NCT01586338|449202545|FG000|Overall Study|Other|1|||
124884985|NCT00284089|449202546|FG000|Multiple Dose Phase|Adverse Event|1|||
124884986|NCT00284089|449202547|FG001|Multiple Dose Phase|Adverse Event|0|||
124884987|NCT00284089|449202548|FG002|Multiple Dose Phase|Adverse Event|1|||
124884988|NCT00284089|449202549|FG003|Multiple Dose Phase|Adverse Event|1|||
124884989|NCT00284089|449202546|FG000|Multiple Dose Phase|Protocol Violation|0|||
124884990|NCT00284089|449202547|FG001|Multiple Dose Phase|Protocol Violation|0|||
124884991|NCT00284089|449202548|FG002|Multiple Dose Phase|Protocol Violation|1|||
124884992|NCT00284089|449202549|FG003|Multiple Dose Phase|Protocol Violation|0|||
124884993|NCT00284089|449202546|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
124884994|NCT00284089|449202547|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
124884995|NCT00284089|449202548|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
124884996|NCT00284089|449202549|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
124884997|NCT00284089|449202546|FG000|Multiple Dose Phase|Death|0|||
124884998|NCT00284089|449202547|FG001|Multiple Dose Phase|Death|0|||
124884999|NCT00284089|449202548|FG002|Multiple Dose Phase|Death|1|||
124885000|NCT00284089|449202549|FG003|Multiple Dose Phase|Death|1|||
124885001|NCT00284089|449202546|FG000|Extension Phase|Adverse Event|0|||
124885002|NCT00284089|449202547|FG001|Extension Phase|Adverse Event|0|||
124885003|NCT00284089|449202548|FG002|Extension Phase|Adverse Event|2|||
124885004|NCT00284089|449202549|FG003|Extension Phase|Adverse Event|2|||
124885005|NCT00284089|449202546|FG000|Extension Phase|condition no longer requires study drug|2|||
124885006|NCT00284089|449202547|FG001|Extension Phase|condition no longer requires study drug|0|||
124885007|NCT00284089|449202548|FG002|Extension Phase|condition no longer requires study drug|2|||
124885008|NCT00284089|449202549|FG003|Extension Phase|condition no longer requires study drug|7|||
124885009|NCT00284089|449202546|FG000|Extension Phase|Protocol Violation|0|||
124885010|NCT00284089|449202547|FG001|Extension Phase|Protocol Violation|0|||
124885011|NCT00284089|449202548|FG002|Extension Phase|Protocol Violation|1|||
124885012|NCT00284089|449202549|FG003|Extension Phase|Protocol Violation|0|||
124885013|NCT00284089|449202546|FG000|Extension Phase|Withdrawal by Subject|0|||
124885014|NCT00284089|449202547|FG001|Extension Phase|Withdrawal by Subject|0|||
124885015|NCT00284089|449202548|FG002|Extension Phase|Withdrawal by Subject|1|||
124885016|NCT00284089|449202549|FG003|Extension Phase|Withdrawal by Subject|3|||
124885017|NCT01146574|449202552|FG000|Overall Study|Death|0|||
124885018|NCT01146574|449202553|FG001|Overall Study|Death|1|||
124885019|NCT01146574|449202554|FG002|Overall Study|Death|1|||
124885020|NCT01146574|449202555|FG003|Overall Study|Death|0|||
124885021|NCT01146574|449202556|FG004|Overall Study|Death|0|||
124885022|NCT01146574|449202557|FG005|Overall Study|Death|0|||
124885023|NCT01146574|449202558|FG006|Overall Study|Death|0|||
124885024|NCT01146574|449202552|FG000|Overall Study|Other reasons|0|||
124885025|NCT01146574|449202553|FG001|Overall Study|Other reasons|0|||
124885026|NCT01146574|449202554|FG002|Overall Study|Other reasons|3|||
124885027|NCT01146574|449202555|FG003|Overall Study|Other reasons|0|||
124885028|NCT01146574|449202556|FG004|Overall Study|Other reasons|0|||
124885029|NCT01146574|449202557|FG005|Overall Study|Other reasons|0|||
124885030|NCT01146574|449202558|FG006|Overall Study|Other reasons|0|||
124885031|NCT01146574|449202552|FG000|Overall Study|Kidney transplant|0|||
124885032|NCT01146574|449202553|FG001|Overall Study|Kidney transplant|0|||
124885033|NCT01146574|449202554|FG002|Overall Study|Kidney transplant|1|||
124885034|NCT01146574|449202555|FG003|Overall Study|Kidney transplant|1|||
124885035|NCT01146574|449202556|FG004|Overall Study|Kidney transplant|0|||
124885036|NCT01146574|449202557|FG005|Overall Study|Kidney transplant|0|||
124885037|NCT01146574|449202558|FG006|Overall Study|Kidney transplant|0|||
124885038|NCT01146574|449202552|FG000|Overall Study|Withdrew consent|0|||
124885039|NCT01146574|449202553|FG001|Overall Study|Withdrew consent|0|||
124885040|NCT01146574|449202554|FG002|Overall Study|Withdrew consent|1|||
124885041|NCT01146574|449202555|FG003|Overall Study|Withdrew consent|1|||
124885042|NCT01146574|449202556|FG004|Overall Study|Withdrew consent|2|||
124885043|NCT01146574|449202557|FG005|Overall Study|Withdrew consent|1|||
124885044|NCT01146574|449202558|FG006|Overall Study|Withdrew consent|1|||
124885045|NCT03053492|449202559|FG000|Overall Study|Adverse Event|1|||
124885046|NCT03053492|449202560|FG001|Overall Study|Adverse Event|1|||
124885047|NCT03053492|449202559|FG000|Overall Study|Withdrawal by Subject|7|||
124885048|NCT03053492|449202560|FG001|Overall Study|Withdrawal by Subject|5|||
124885049|NCT01868074|449202561|FG000|Overall Study|Lost to Follow-up|3|||
124885050|NCT01868074|449202562|FG001|Overall Study|Lost to Follow-up|2|||
124885051|NCT01868074|449202561|FG000|Overall Study|Withdrawal by Subject|4|||
124885052|NCT01868074|449202562|FG001|Overall Study|Withdrawal by Subject|2|||
124885053|NCT01544491|449202563|FG000|Overall Study|Withdrawal by Subject|3|||
124885054|NCT01544491|449202564|FG001|Overall Study|Withdrawal by Subject|2|||
124885055|NCT01544491|449202563|FG000|Overall Study|Lost to Follow-up|0|||
124885056|NCT01544491|449202564|FG001|Overall Study|Lost to Follow-up|1|||
124885057|NCT01544491|449202563|FG000|Overall Study|administrative problems|2|||
124885058|NCT01544491|449202564|FG001|Overall Study|administrative problems|0|||
124885059|NCT00967018|449202565|FG000|Overall Study|Adverse Event|2|||
124885060|NCT00967018|449202565|FG000|Overall Study|Physician Decision|7|||
124885061|NCT00967018|449202565|FG000|Overall Study|Lost to Follow-up|2|||
124885062|NCT00967018|449202565|FG000|Overall Study|Withdrawal by Subject|1|||
124885063|NCT00967018|449202565|FG000|Overall Study|Miscellaneous Reasons|9|||
124885064|NCT04642469|449202571|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
124885065|NCT04642469|449202572|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
124885066|NCT04642469|449202571|FG000|Overall Study|Death|1|||
124885067|NCT04642469|449202572|FG001|Overall Study|Death|2|||
124885068|NCT04642469|449202571|FG000|Overall Study|Study/site closed following amendment 1|11|||
124885069|NCT04642469|449202572|FG001|Overall Study|Study/site closed following amendment 1|11|||
124885070|NCT04642469|449202571|FG000|Overall Study|Other|1|||
124885071|NCT04642469|449202572|FG001|Overall Study|Other|1|||
124885072|NCT04642469|449202571|FG000|Overall Study|Withdrawal by Subject|1|||
124885073|NCT04642469|449202572|FG001|Overall Study|Withdrawal by Subject|0|||
124885074|NCT00680056|449202574|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
124885075|NCT00680056|449202575|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
124885076|NCT00680056|449202574|FG000|Second Intervention|Protocol Violation|3|||
124439830|NCT00406653|447570866|FG003|Maintenance Period|Withdrawal of Consent|0|||
124439831|NCT00406653|447570867|FG004|Maintenance Period|Withdrawal of Consent|2|||
124439832|NCT00406653|447570868|FG005|Maintenance Period|Withdrawal of Consent|0|||
124439833|NCT00406653|447570869|FG006|Maintenance Period|Withdrawal of Consent|0|||
124439834|NCT00406653|447570863|FG000|Maintenance Period|Pregnancy|0|||
124439835|NCT00406653|447570864|FG001|Maintenance Period|Pregnancy|0|||
124439836|NCT00406653|447570865|FG002|Maintenance Period|Pregnancy|0|||
124439837|NCT00406653|447570866|FG003|Maintenance Period|Pregnancy|0|||
124439838|NCT00406653|447570867|FG004|Maintenance Period|Pregnancy|0|||
124439839|NCT00406653|447570868|FG005|Maintenance Period|Pregnancy|1|||
124439840|NCT00406653|447570869|FG006|Maintenance Period|Pregnancy|0|||
124439841|NCT00406653|447570863|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
124439842|NCT00406653|447570864|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
124439843|NCT00406653|447570865|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
124439844|NCT00406653|447570866|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
124439845|NCT00406653|447570867|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
124439846|NCT00406653|447570868|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
124439847|NCT00406653|447570869|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
124439848|NCT00406653|447570863|FG000|Maintenance Period|Error in disease score evaluation|0|||
124439849|NCT00406653|447570864|FG001|Maintenance Period|Error in disease score evaluation|0|||
124885077|NCT00680056|449202575|FG001|Second Intervention|Protocol Violation|1|||
124885078|NCT01088529|449202576|FG000|Overall Study|Did not receive study treatment|0|||
124439850|NCT00406653|447570865|FG002|Maintenance Period|Error in disease score evaluation|0|||
124439851|NCT00406653|447570866|FG003|Maintenance Period|Error in disease score evaluation|0|||
124885079|NCT01088529|449202577|FG001|Overall Study|Did not receive study treatment|1|||
124885080|NCT01821898|449202578|FG000|Overall Study|Withdrawal by Subject|2|||
124885081|NCT01821898|449202579|FG001|Overall Study|Withdrawal by Subject|1|||
124885082|NCT00337662|449202582|FG000|Study Period II|Lost to Follow-up|0|||
124885083|NCT00337662|449202583|FG001|Study Period II|Lost to Follow-up|0|||
124885084|NCT00337662|449202584|FG002|Study Period II|Lost to Follow-up|0|||
124885085|NCT00337662|449202585|FG003|Study Period II|Lost to Follow-up|35|||
124885086|NCT00337662|449202582|FG000|Study Period II|Withdrawal by Subject|0|||
124885087|NCT00337662|449202583|FG001|Study Period II|Withdrawal by Subject|0|||
124885088|NCT00337662|449202584|FG002|Study Period II|Withdrawal by Subject|0|||
124885089|NCT00337662|449202585|FG003|Study Period II|Withdrawal by Subject|20|||
124885090|NCT00337662|449202582|FG000|Study Period II|Adverse Event|0|||
124885091|NCT00337662|449202583|FG001|Study Period II|Adverse Event|0|||
124885092|NCT00337662|449202584|FG002|Study Period II|Adverse Event|0|||
124885093|NCT00337662|449202585|FG003|Study Period II|Adverse Event|16|||
124885094|NCT00337662|449202582|FG000|Study Period II|Physician Decision|0|||
124885095|NCT00337662|449202583|FG001|Study Period II|Physician Decision|0|||
124885096|NCT00337662|449202584|FG002|Study Period II|Physician Decision|0|||
124885097|NCT00337662|449202585|FG003|Study Period II|Physician Decision|13|||
124885098|NCT00337662|449202582|FG000|Study Period II|Entry Criteria Not Met|0|||
124885099|NCT00337662|449202583|FG001|Study Period II|Entry Criteria Not Met|0|||
124885100|NCT00337662|449202584|FG002|Study Period II|Entry Criteria Not Met|0|||
124885101|NCT00337662|449202585|FG003|Study Period II|Entry Criteria Not Met|6|||
124885102|NCT00337662|449202582|FG000|Study Period II|Protocol Violation|0|||
124885103|NCT00337662|449202583|FG001|Study Period II|Protocol Violation|0|||
124885104|NCT00337662|449202584|FG002|Study Period II|Protocol Violation|0|||
124885105|NCT00337662|449202585|FG003|Study Period II|Protocol Violation|6|||
124885106|NCT00337662|449202582|FG000|Study Period II|Lack of Efficacy|0|||
124885107|NCT00337662|449202583|FG001|Study Period II|Lack of Efficacy|0|||
124885108|NCT00337662|449202584|FG002|Study Period II|Lack of Efficacy|0|||
124885109|NCT00337662|449202585|FG003|Study Period II|Lack of Efficacy|7|||
124885110|NCT00337662|449202582|FG000|Study Period II|Sponsor Decision|0|||
124885111|NCT00337662|449202583|FG001|Study Period II|Sponsor Decision|0|||
124885112|NCT00337662|449202584|FG002|Study Period II|Sponsor Decision|0|||
124885113|NCT00337662|449202585|FG003|Study Period II|Sponsor Decision|2|||
124885114|NCT00337662|449202582|FG000|Study Period II|Parent/Caregiver Decision|0|||
124885115|NCT00337662|449202583|FG001|Study Period II|Parent/Caregiver Decision|0|||
124885116|NCT00337662|449202584|FG002|Study Period II|Parent/Caregiver Decision|0|||
124885117|NCT00337662|449202585|FG003|Study Period II|Parent/Caregiver Decision|1|||
124885118|NCT00337662|449202582|FG000|Study Period III|Lost to Follow-up|14|||
124885119|NCT00337662|449202583|FG001|Study Period III|Lost to Follow-up|16|||
124885120|NCT00337662|449202584|FG002|Study Period III|Lost to Follow-up|14|||
124885121|NCT00337662|449202585|FG003|Study Period III|Lost to Follow-up|0|||
124885122|NCT00337662|449202582|FG000|Study Period III|Withdrawal by Subject|18|||
124885123|NCT00337662|449202583|FG001|Study Period III|Withdrawal by Subject|14|||
124885124|NCT00337662|449202584|FG002|Study Period III|Withdrawal by Subject|12|||
124885125|NCT00337662|449202585|FG003|Study Period III|Withdrawal by Subject|0|||
124885126|NCT00337662|449202582|FG000|Study Period III|Adverse Event|9|||
124885127|NCT00337662|449202583|FG001|Study Period III|Adverse Event|10|||
124885128|NCT00337662|449202584|FG002|Study Period III|Adverse Event|8|||
124885129|NCT00337662|449202585|FG003|Study Period III|Adverse Event|0|||
124885130|NCT00337662|449202582|FG000|Study Period III|Protocol Violation|3|||
124885131|NCT00337662|449202583|FG001|Study Period III|Protocol Violation|8|||
124885132|NCT00337662|449202584|FG002|Study Period III|Protocol Violation|2|||
124885133|NCT00337662|449202585|FG003|Study Period III|Protocol Violation|0|||
124885134|NCT00337662|449202582|FG000|Study Period III|Physician Decision|6|||
124885135|NCT00337662|449202583|FG001|Study Period III|Physician Decision|5|||
124885136|NCT00337662|449202584|FG002|Study Period III|Physician Decision|0|||
124885137|NCT00337662|449202585|FG003|Study Period III|Physician Decision|0|||
124885138|NCT00337662|449202582|FG000|Study Period III|Entry Criteria Not Met|4|||
124885139|NCT00337662|449202583|FG001|Study Period III|Entry Criteria Not Met|1|||
124885140|NCT00337662|449202584|FG002|Study Period III|Entry Criteria Not Met|3|||
124885141|NCT00337662|449202585|FG003|Study Period III|Entry Criteria Not Met|0|||
124885142|NCT00337662|449202582|FG000|Study Period III|Lack of Efficacy|4|||
124885143|NCT00337662|449202583|FG001|Study Period III|Lack of Efficacy|4|||
124885144|NCT00337662|449202584|FG002|Study Period III|Lack of Efficacy|2|||
124885145|NCT00337662|449202585|FG003|Study Period III|Lack of Efficacy|0|||
124885146|NCT00337662|449202582|FG000|Study Period III|Parent/Caregiver Decision|0|||
124885147|NCT00337662|449202583|FG001|Study Period III|Parent/Caregiver Decision|0|||
124885148|NCT00337662|449202584|FG002|Study Period III|Parent/Caregiver Decision|2|||
124885149|NCT00337662|449202585|FG003|Study Period III|Parent/Caregiver Decision|0|||
124885150|NCT00337662|449202582|FG000|Study Period III|Sponsor Decision|1|||
124885151|NCT00337662|449202583|FG001|Study Period III|Sponsor Decision|0|||
124885152|NCT00337662|449202584|FG002|Study Period III|Sponsor Decision|1|||
124885153|NCT00337662|449202585|FG003|Study Period III|Sponsor Decision|0|||
124885154|NCT00337662|449202582|FG000|Study Period III|Clinical Relapse|1|||
124885155|NCT00337662|449202583|FG001|Study Period III|Clinical Relapse|0|||
124885156|NCT00337662|449202584|FG002|Study Period III|Clinical Relapse|0|||
124885157|NCT00337662|449202585|FG003|Study Period III|Clinical Relapse|0|||
124885158|NCT03691948|449202587|FG000|Overall Study|Lost to Follow-up|1|||
124885159|NCT03691948|449202588|FG001|Overall Study|Lost to Follow-up|3|||
124885160|NCT02344537|449202589|FG000|Overall Study|Protocol Violation|1|||
124885161|NCT02344537|449202590|FG001|Overall Study|Protocol Violation|1|||
124885162|NCT02344537|449202589|FG000|Overall Study|Subject started another treatment after wk 6|1|||
124885163|NCT02344537|449202590|FG001|Overall Study|Subject started another treatment after wk 6|0|||
124885164|NCT02344537|449202589|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
124885165|NCT02344537|449202590|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
124885166|NCT02611830|449202592|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
124885167|NCT02611830|449202593|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
124885168|NCT02611830|449202594|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
124885169|NCT02611830|449202595|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
124885170|NCT02611830|449202592|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
124885171|NCT02611830|449202593|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
124885172|NCT02611830|449202594|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
124885173|NCT02611830|449202595|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
124885174|NCT02611830|449202592|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
124885175|NCT02611830|449202593|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
124885176|NCT02611830|449202594|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
124885177|NCT02611830|449202595|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
124885178|NCT02611830|449202592|FG000|OL Induction Phase|Lack of Efficacy|9|||
124885179|NCT02611830|449202593|FG001|OL Induction Phase|Lack of Efficacy|0|||
124885180|NCT02611830|449202594|FG002|OL Induction Phase|Lack of Efficacy|0|||
124885181|NCT02611830|449202595|FG003|OL Induction Phase|Lack of Efficacy|0|||
124885182|NCT02611830|449202592|FG000|OL Induction Phase|Reason not specified|3|||
124885183|NCT02611830|449202593|FG001|OL Induction Phase|Reason not specified|0|||
124885184|NCT02611830|449202594|FG002|OL Induction Phase|Reason not specified|0|||
124885185|NCT02611830|449202595|FG003|OL Induction Phase|Reason not specified|0|||
124885186|NCT02611830|449202592|FG000|Maintenance Phase|Lack of Efficacy|0|||
124885187|NCT02611830|449202593|FG001|Maintenance Phase|Lack of Efficacy|29|||
124885188|NCT02611830|449202594|FG002|Maintenance Phase|Lack of Efficacy|18|||
124885189|NCT02611830|449202595|FG003|Maintenance Phase|Lack of Efficacy|6|||
124885190|NCT02611830|449202592|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
124885191|NCT02611830|449202593|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
124885192|NCT02611830|449202594|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
124885193|NCT02611830|449202595|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
124885194|NCT02611830|449202592|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
124885195|NCT02611830|449202593|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
124885196|NCT02611830|449202594|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
124885197|NCT02611830|449202595|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
124885198|NCT02611830|449202592|FG000|Maintenance Phase|Lost to Follow-up|0|||
124885199|NCT02611830|449202593|FG001|Maintenance Phase|Lost to Follow-up|0|||
124885200|NCT02611830|449202594|FG002|Maintenance Phase|Lost to Follow-up|0|||
124885201|NCT02611830|449202595|FG003|Maintenance Phase|Lost to Follow-up|1|||
124885202|NCT02611830|449202592|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
124885203|NCT02611830|449202593|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
124885204|NCT02611830|449202594|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
124885205|NCT02611830|449202595|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
124885206|NCT02611830|449202592|FG000|Maintenance Phase|Pregnancy|0|||
124885207|NCT02611830|449202593|FG001|Maintenance Phase|Pregnancy|0|||
124885208|NCT02611830|449202594|FG002|Maintenance Phase|Pregnancy|1|||
124885209|NCT02611830|449202595|FG003|Maintenance Phase|Pregnancy|0|||
124885210|NCT02611830|449202592|FG000|Maintenance Phase|Reason not specified|0|||
124885211|NCT02611830|449202593|FG001|Maintenance Phase|Reason not specified|1|||
124885212|NCT02611830|449202594|FG002|Maintenance Phase|Reason not specified|4|||
124885213|NCT02611830|449202595|FG003|Maintenance Phase|Reason not specified|0|||
124439852|NCT00406653|447570867|FG004|Maintenance Period|Error in disease score evaluation|1|||
124683676|NCT02107898|448466023|FG000|Overall Study|Adverse Event|4|||
124683677|NCT02107898|448466024|FG001|Overall Study|Adverse Event|7|||
124683678|NCT02107898|448466023|FG000|Overall Study|Poor compliance to protocol|0|||
124885214|NCT02058290|449202599|FG000|Overall Study|Protocol Violation|2|||
124683679|NCT02107898|448466024|FG001|Overall Study|Poor compliance to protocol|1|||
124885215|NCT02058290|449202600|FG001|Overall Study|Protocol Violation|1|||
124885216|NCT02058290|449202599|FG000|Overall Study|Physician Decision|1|||
124885217|NCT02058290|449202600|FG001|Overall Study|Physician Decision|0|||
124885218|NCT02058290|449202599|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
124885219|NCT02058290|449202600|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
124885220|NCT02058290|449202599|FG000|Overall Study|Withdrawal by Subject|0|||
124885221|NCT02058290|449202600|FG001|Overall Study|Withdrawal by Subject|1|||
124885222|NCT03012061|449202603|FG000|Overall Study|Withdrawal by Subject|1|||
124885223|NCT03012061|449202604|FG001|Overall Study|Withdrawal by Subject|5|||
124885224|NCT03012061|449202605|FG002|Overall Study|Withdrawal by Subject|4|||
124885225|NCT03012061|449202603|FG000|Overall Study|Investigator Site Closed|1|||
124885226|NCT03012061|449202604|FG001|Overall Study|Investigator Site Closed|2|||
124885227|NCT03012061|449202605|FG002|Overall Study|Investigator Site Closed|0|||
124885228|NCT03012061|449202603|FG000|Overall Study|Lost to Follow-up|2|||
124885229|NCT03012061|449202604|FG001|Overall Study|Lost to Follow-up|1|||
124885230|NCT03012061|449202605|FG002|Overall Study|Lost to Follow-up|0|||
124885231|NCT03012061|449202603|FG000|Overall Study|Study closed/ Terminated|0|||
124885232|NCT03012061|449202604|FG001|Overall Study|Study closed/ Terminated|0|||
124885233|NCT03012061|449202605|FG002|Overall Study|Study closed/ Terminated|1|||
124885234|NCT03012061|449202603|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
124885235|NCT03012061|449202604|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
124885236|NCT03012061|449202605|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
124885237|NCT03012061|449202603|FG000|Overall Study|Protocol Violation|0|||
124885238|NCT03012061|449202604|FG001|Overall Study|Protocol Violation|0|||
124885239|NCT03012061|449202605|FG002|Overall Study|Protocol Violation|2|||
124885240|NCT03012061|449202603|FG000|Overall Study|Lack of Efficacy|0|||
124885241|NCT03012061|449202604|FG001|Overall Study|Lack of Efficacy|1|||
124885242|NCT03012061|449202605|FG002|Overall Study|Lack of Efficacy|0|||
124885243|NCT03012061|449202603|FG000|Overall Study|Adverse Event|2|||
124885244|NCT03012061|449202604|FG001|Overall Study|Adverse Event|0|||
124885245|NCT03012061|449202605|FG002|Overall Study|Adverse Event|0|||
124885246|NCT02696902|449202606|FG000|Overall Study|Lost to Follow-up|0|||
124885247|NCT02696902|449202607|FG001|Overall Study|Lost to Follow-up|1|||
124885248|NCT02696902|449202608|FG002|Overall Study|Lost to Follow-up|1|||
124885249|NCT02696902|449202606|FG000|Overall Study|Withdrawal by Subject|0|||
124885250|NCT02696902|449202607|FG001|Overall Study|Withdrawal by Subject|0|||
124885251|NCT02696902|449202608|FG002|Overall Study|Withdrawal by Subject|1|||
124885252|NCT02696902|449202606|FG000|Overall Study|Death|19|||
124885253|NCT02696902|449202607|FG001|Overall Study|Death|3|||
124885254|NCT02696902|449202608|FG002|Overall Study|Death|24|||
124885255|NCT02696902|449202606|FG000|Overall Study|Participant not fit post-randomization|0|||
124885256|NCT02696902|449202607|FG001|Overall Study|Participant not fit post-randomization|0|||
124885257|NCT02696902|449202608|FG002|Overall Study|Participant not fit post-randomization|1|||
124885258|NCT02696902|449202606|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
124885259|NCT02696902|449202607|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
124885260|NCT02696902|449202608|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
124885261|NCT02696902|449202606|FG000|Overall Study|Principal investigator's decision|1|||
124885262|NCT02696902|449202607|FG001|Overall Study|Principal investigator's decision|0|||
124885263|NCT02696902|449202608|FG002|Overall Study|Principal investigator's decision|0|||
124885264|NCT02696902|449202606|FG000|Overall Study|Sponsor's decision|1|||
124885265|NCT02696902|449202607|FG001|Overall Study|Sponsor's decision|0|||
124885266|NCT02696902|449202608|FG002|Overall Study|Sponsor's decision|0|||
124885267|NCT02696902|449202606|FG000|Overall Study|Transferred to other hospital|1|||
124885268|NCT02696902|449202607|FG001|Overall Study|Transferred to other hospital|0|||
124885269|NCT02696902|449202608|FG002|Overall Study|Transferred to other hospital|0|||
124885270|NCT01291225|449202610|FG000|Overall Study|Lost to Follow-up|85|||
124885271|NCT01291225|449202611|FG001|Overall Study|Lost to Follow-up|39|||
124885272|NCT01267253|449202612|FG000|Overall Study|Ineligible - required test not done|1|||
124885273|NCT01267253|449202612|FG000|Overall Study|Inevaluable-never received study treatme|2|||
124885274|NCT02855164|449202615|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
124885275|NCT02855164|449202616|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
124885276|NCT02855164|449202617|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
124885277|NCT02855164|449202618|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
124885278|NCT02855164|449202619|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
124885279|NCT02855164|449202620|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
124885280|NCT02855164|449202621|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
124885281|NCT02855164|449202622|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
124885282|NCT02855164|449202615|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
124885283|NCT02855164|449202616|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
124885284|NCT02855164|449202617|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
124885285|NCT02855164|449202618|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
124885286|NCT02855164|449202619|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
124885287|NCT02855164|449202620|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
124885288|NCT02855164|449202621|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
124885289|NCT02855164|449202622|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
124885290|NCT02855164|449202615|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
124885291|NCT02855164|449202616|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
124885292|NCT02855164|449202617|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
124885293|NCT02855164|449202618|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
124885294|NCT02855164|449202619|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
124885295|NCT02855164|449202620|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
124885296|NCT02855164|449202621|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
124885297|NCT02855164|449202622|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
124885298|NCT02855164|449202615|FG000|Part C (Randomized Set)|Adverse Event|0|||
124885299|NCT02855164|449202616|FG001|Part C (Randomized Set)|Adverse Event|0|||
124885300|NCT02855164|449202617|FG002|Part C (Randomized Set)|Adverse Event|0|||
124885301|NCT02855164|449202618|FG003|Part C (Randomized Set)|Adverse Event|0|||
124885302|NCT02855164|449202619|FG004|Part C (Randomized Set)|Adverse Event|0|||
124885303|NCT02855164|449202620|FG005|Part C (Randomized Set)|Adverse Event|5|||
124885304|NCT02855164|449202621|FG006|Part C (Randomized Set)|Adverse Event|9|||
124885305|NCT02855164|449202622|FG007|Part C (Randomized Set)|Adverse Event|2|||
124885306|NCT02855164|449202615|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
124885307|NCT02855164|449202616|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
124885308|NCT02855164|449202617|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
124885309|NCT02855164|449202618|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
124885310|NCT02855164|449202619|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
124885311|NCT02855164|449202620|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
124885312|NCT02855164|449202621|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
124885313|NCT02855164|449202622|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
124885314|NCT02855164|449202615|FG000|Part C (Randomized Set)|Physician Decision|0|||
124885315|NCT02855164|449202616|FG001|Part C (Randomized Set)|Physician Decision|0|||
124885316|NCT02855164|449202617|FG002|Part C (Randomized Set)|Physician Decision|0|||
124885317|NCT02855164|449202618|FG003|Part C (Randomized Set)|Physician Decision|0|||
124885318|NCT02855164|449202619|FG004|Part C (Randomized Set)|Physician Decision|0|||
124885319|NCT02855164|449202620|FG005|Part C (Randomized Set)|Physician Decision|1|||
124885320|NCT02855164|449202621|FG006|Part C (Randomized Set)|Physician Decision|0|||
124885321|NCT02855164|449202622|FG007|Part C (Randomized Set)|Physician Decision|1|||
124885322|NCT02855164|449202615|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
124885323|NCT02855164|449202616|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
124885324|NCT02855164|449202617|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
124885325|NCT02855164|449202618|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
124885326|NCT02855164|449202619|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
124885327|NCT02855164|449202620|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
124885328|NCT02855164|449202621|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
124885329|NCT02855164|449202622|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
124885330|NCT00383240|449202623|FG000|Overall Study|Adverse Event|4|||
124885331|NCT00383240|449202624|FG001|Overall Study|Adverse Event|6|||
124885332|NCT00383240|449202625|FG002|Overall Study|Adverse Event|9|||
124885333|NCT00383240|449202626|FG003|Overall Study|Adverse Event|7|||
124885334|NCT00383240|449202623|FG000|Overall Study|Treatment Failure|8|||
124885335|NCT00383240|449202624|FG001|Overall Study|Treatment Failure|13|||
124885336|NCT00383240|449202625|FG002|Overall Study|Treatment Failure|47|||
124885337|NCT00383240|449202626|FG003|Overall Study|Treatment Failure|46|||
124885338|NCT00383240|449202623|FG000|Overall Study|Lost to Follow-up|3|||
124885339|NCT00383240|449202624|FG001|Overall Study|Lost to Follow-up|0|||
124885340|NCT00383240|449202625|FG002|Overall Study|Lost to Follow-up|0|||
124885341|NCT00383240|449202626|FG003|Overall Study|Lost to Follow-up|2|||
124885342|NCT00383240|449202623|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
124885343|NCT00383240|449202624|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
124885344|NCT00383240|449202625|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
124885345|NCT00383240|449202626|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
124885346|NCT00383240|449202623|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
124885347|NCT00383240|449202624|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
124885348|NCT00383240|449202625|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
124885349|NCT00383240|449202626|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
124885350|NCT00383240|449202623|FG000|Overall Study|Protocol Violation|4|||
124885351|NCT00383240|449202624|FG001|Overall Study|Protocol Violation|5|||
124885352|NCT00383240|449202625|FG002|Overall Study|Protocol Violation|9|||
124885353|NCT00383240|449202626|FG003|Overall Study|Protocol Violation|6|||
124885354|NCT00383240|449202623|FG000|Overall Study|Did not meet protocol eligibility|9|||
124885355|NCT00383240|449202624|FG001|Overall Study|Did not meet protocol eligibility|4|||
124885356|NCT00383240|449202625|FG002|Overall Study|Did not meet protocol eligibility|9|||
124885357|NCT00383240|449202626|FG003|Overall Study|Did not meet protocol eligibility|3|||
124885358|NCT00383240|449202623|FG000|Overall Study|Administrative|1|||
124885359|NCT00383240|449202624|FG001|Overall Study|Administrative|1|||
124885360|NCT00383240|449202625|FG002|Overall Study|Administrative|0|||
124885361|NCT00383240|449202626|FG003|Overall Study|Administrative|0|||
124885362|NCT02601937|449202627|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885363|NCT02601937|449202628|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885364|NCT02601937|449202629|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885365|NCT02601937|449202630|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885366|NCT02601937|449202631|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885367|NCT02601937|449202632|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
124885368|NCT02601937|449202633|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885369|NCT02601937|449202634|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885370|NCT02601937|449202635|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885371|NCT02601937|449202636|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885372|NCT02601937|449202637|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
124885373|NCT02601937|449202627|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
124885374|NCT02601937|449202628|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885375|NCT02601937|449202629|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885376|NCT02601937|449202630|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885377|NCT02601937|449202631|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885378|NCT02601937|449202632|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885379|NCT02601937|449202633|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
124885380|NCT02601937|449202634|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885381|NCT02601937|449202635|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885382|NCT02601937|449202636|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885383|NCT02601937|449202637|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
124885384|NCT02601937|449202627|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885385|NCT02601937|449202628|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885386|NCT02601937|449202629|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
124885387|NCT02601937|449202630|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885388|NCT02601937|449202631|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885389|NCT02601937|449202632|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885390|NCT02601937|449202633|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885391|NCT02601937|449202634|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885392|NCT02601937|449202635|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885393|NCT02601937|449202636|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885394|NCT02601937|449202637|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
124885395|NCT02601937|449202627|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
124885396|NCT02601937|449202628|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
124885397|NCT02601937|449202629|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
124885398|NCT02601937|449202630|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
124885399|NCT02601937|449202631|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
124885400|NCT02601937|449202632|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
124885401|NCT02601937|449202633|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
124885402|NCT02601937|449202634|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
124885403|NCT02601937|449202635|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
124885404|NCT02601937|449202636|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
124885405|NCT02601937|449202637|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
124885406|NCT02601937|449202627|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124885407|NCT02601937|449202628|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124885408|NCT02601937|449202629|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124885409|NCT02601937|449202630|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124885410|NCT02601937|449202631|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124885411|NCT02601937|449202632|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124885412|NCT02601937|449202633|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124885413|NCT02601937|449202634|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124683680|NCT02107898|448466023|FG000|Overall Study|Participant moved|0|||
124683681|NCT02107898|448466024|FG001|Overall Study|Participant moved|2|||
124885414|NCT02601937|449202635|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124885415|NCT02601937|449202636|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
124885416|NCT02601937|449202637|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
124885417|NCT02601937|449202627|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124885418|NCT02601937|449202628|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124885419|NCT02601937|449202629|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124683682|NCT02107898|448466023|FG000|Overall Study|Consent withdrawn by participant|2|||
124683683|NCT02107898|448466024|FG001|Overall Study|Consent withdrawn by participant|1|||
124683684|NCT02107898|448466023|FG000|Overall Study|Randomized but not treated|0|||
124683685|NCT02107898|448466024|FG001|Overall Study|Randomized but not treated|1|||
124683686|NCT03329989|448466025|FG000|Overall Study|Withdrawal by Subject|9|||
124683687|NCT03329989|448466025|FG000|Overall Study|Lost to Follow-up|8|||
124683688|NCT03329989|448466025|FG000|Overall Study|Adverse Event|5|||
124683689|NCT03329989|448466025|FG000|Overall Study|Protocol Violation|1|||
124683690|NCT00620542|448466026|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
124683691|NCT00620542|448466027|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
124683692|NCT00620542|448466028|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
124683693|NCT00620542|448466029|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
124683694|NCT00620542|448466026|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
124683695|NCT00620542|448466027|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
124683696|NCT00620542|448466028|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
124683697|NCT00620542|448466029|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
124885420|NCT02601937|449202630|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124885421|NCT02601937|449202631|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124683698|NCT00620542|448466026|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
124683699|NCT00620542|448466027|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
124683700|NCT00620542|448466028|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
124683701|NCT00620542|448466029|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
124683702|NCT00620542|448466026|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
124683703|NCT00620542|448466027|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
124683704|NCT00620542|448466028|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
124683705|NCT00620542|448466029|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
124683706|NCT00620542|448466026|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
124683707|NCT00620542|448466027|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
124885422|NCT02601937|449202632|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124885423|NCT02601937|449202633|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124885424|NCT02601937|449202634|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
124885425|NCT02601937|449202635|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124885426|NCT02601937|449202636|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124885427|NCT02601937|449202637|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
124683708|NCT00620542|448466028|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
124683709|NCT00620542|448466029|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
124885428|NCT02601937|449202627|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124885429|NCT02601937|449202628|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124885430|NCT02601937|449202629|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124885431|NCT02601937|449202630|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124885432|NCT02601937|449202631|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124885433|NCT02601937|449202632|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124683710|NCT00620542|448466026|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
124885434|NCT02601937|449202633|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124885435|NCT02601937|449202634|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124683711|NCT00620542|448466027|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
124683712|NCT00620542|448466028|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
124683713|NCT00620542|448466029|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
124885436|NCT02601937|449202635|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
124885437|NCT02601937|449202636|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
124885438|NCT02601937|449202637|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
124885439|NCT02601937|449202627|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
124885440|NCT02601937|449202628|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
124683714|NCT00620542|448466026|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
124885441|NCT02601937|449202629|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
124683715|NCT00620542|448466027|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
124683716|NCT00620542|448466028|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
124683717|NCT00620542|448466029|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
124683718|NCT00620542|448466026|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
124683719|NCT00620542|448466027|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
124683720|NCT00620542|448466028|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
124885442|NCT02601937|449202630|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
124885443|NCT02601937|449202631|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
124885444|NCT02601937|449202632|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
124885445|NCT02601937|449202633|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
124885446|NCT02601937|449202634|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
124885447|NCT02601937|449202635|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
124885448|NCT02601937|449202636|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
124885449|NCT02601937|449202637|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
124885450|NCT02601937|449202627|FG000|Period 2: Dose Expansion Cohort|Other|0|||
124885451|NCT02601937|449202628|FG001|Period 2: Dose Expansion Cohort|Other|0|||
124885452|NCT02601937|449202629|FG002|Period 2: Dose Expansion Cohort|Other|0|||
124885453|NCT02601937|449202630|FG003|Period 2: Dose Expansion Cohort|Other|0|||
124885454|NCT02601937|449202631|FG004|Period 2: Dose Expansion Cohort|Other|0|||
124885455|NCT02601937|449202632|FG005|Period 2: Dose Expansion Cohort|Other|0|||
124885456|NCT02601937|449202633|FG006|Period 2: Dose Expansion Cohort|Other|0|||
124885457|NCT02601937|449202634|FG007|Period 2: Dose Expansion Cohort|Other|0|||
124885458|NCT02601937|449202635|FG008|Period 2: Dose Expansion Cohort|Other|2|||
124885459|NCT02601937|449202636|FG009|Period 2: Dose Expansion Cohort|Other|2|||
124885460|NCT02601937|449202637|FG010|Period 2: Dose Expansion Cohort|Other|0|||
124885461|NCT02601937|449202627|FG000|Period 2: Dose Expansion Cohort|Death|0|||
124885462|NCT02601937|449202628|FG001|Period 2: Dose Expansion Cohort|Death|0|||
124885463|NCT02601937|449202629|FG002|Period 2: Dose Expansion Cohort|Death|0|||
124885464|NCT02601937|449202630|FG003|Period 2: Dose Expansion Cohort|Death|0|||
124885465|NCT02601937|449202631|FG004|Period 2: Dose Expansion Cohort|Death|0|||
124885466|NCT02601937|449202632|FG005|Period 2: Dose Expansion Cohort|Death|0|||
124885467|NCT02601937|449202633|FG006|Period 2: Dose Expansion Cohort|Death|0|||
124885468|NCT02601937|449202634|FG007|Period 2: Dose Expansion Cohort|Death|0|||
124885469|NCT02601937|449202635|FG008|Period 2: Dose Expansion Cohort|Death|1|||
124885470|NCT02601937|449202636|FG009|Period 2: Dose Expansion Cohort|Death|0|||
124885471|NCT02601937|449202637|FG010|Period 2: Dose Expansion Cohort|Death|0|||
124885472|NCT02924389|449202638|FG000|Overall Study|Lost to Follow-up|1|||
124885473|NCT02924389|449202639|FG001|Overall Study|Lost to Follow-up|0|||
124885474|NCT02924389|449202638|FG000|Overall Study|Physician Decision|2|||
124885475|NCT02924389|449202639|FG001|Overall Study|Physician Decision|0|||
124885476|NCT02924389|449202638|FG000|Overall Study|Withdrawal by Subject|3|||
124885477|NCT02924389|449202639|FG001|Overall Study|Withdrawal by Subject|0|||
124885478|NCT02924389|449202638|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
124885479|NCT02924389|449202639|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
124885480|NCT03918239|449204346|FG000|Overall Study|Lost to Follow-up|3|||
124885481|NCT03918239|449204347|FG001|Overall Study|Lost to Follow-up|1|||
124885482|NCT03918239|449204346|FG000|Overall Study|Pregnancy|0|||
124885483|NCT03918239|449204347|FG001|Overall Study|Pregnancy|2|||
124885484|NCT03918239|449204346|FG000|Overall Study|Withdrawal by Subject|3|||
124885485|NCT03918239|449204347|FG001|Overall Study|Withdrawal by Subject|3|||
124885486|NCT03918239|449204346|FG000|Overall Study|positive urine drug screening results|4|||
124885487|NCT03918239|449204347|FG001|Overall Study|positive urine drug screening results|1|||
124885488|NCT04249336|449204350|FG000|Overall Study|Lost to Follow-up|3|||
124885489|NCT04249336|449204351|FG001|Overall Study|Lost to Follow-up|3|||
124885490|NCT04249336|449204352|FG002|Overall Study|Lost to Follow-up|3|||
124885491|NCT04249336|449204353|FG003|Overall Study|Lost to Follow-up|3|||
124885492|NCT02930122|449204354|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
124885493|NCT02930122|449204355|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
124885494|NCT03390036|449204356|FG000|Overall Study|Lost to Follow-up|1|||
124885495|NCT03390036|449204357|FG001|Overall Study|Lost to Follow-up|0|||
124885496|NCT03390036|449204358|FG002|Overall Study|Lost to Follow-up|0|||
124885497|NCT03390036|449204356|FG000|Overall Study|Lack of Efficacy|1|||
124885498|NCT03390036|449204357|FG001|Overall Study|Lack of Efficacy|0|||
124885499|NCT03390036|449204358|FG002|Overall Study|Lack of Efficacy|0|||
124885500|NCT00358215|449204359|FG000|Overall Study|Ineligibility determined|4|||
124885501|NCT00358215|449204360|FG001|Overall Study|Ineligibility determined|3|||
124885502|NCT00358215|449204359|FG000|Overall Study|Adverse Event|83|||
124885503|NCT00358215|449204360|FG001|Overall Study|Adverse Event|65|||
124885504|NCT00358215|449204359|FG000|Overall Study|Withdrawal by Subject|111|||
124885505|NCT00358215|449204360|FG001|Overall Study|Withdrawal by Subject|102|||
124885506|NCT00358215|449204359|FG000|Overall Study|Participant request|65|||
124885507|NCT00358215|449204360|FG001|Overall Study|Participant request|64|||
124885508|NCT00358215|449204359|FG000|Overall Study|Physician Decision|47|||
124885509|NCT00358215|449204360|FG001|Overall Study|Physician Decision|39|||
124885510|NCT00358215|449204359|FG000|Overall Study|Lost to Follow-up|16|||
124885511|NCT00358215|449204360|FG001|Overall Study|Lost to Follow-up|22|||
124885512|NCT00358215|449204359|FG000|Overall Study|Death|265|||
124885513|NCT00358215|449204360|FG001|Overall Study|Death|281|||
124885514|NCT00358215|449204359|FG000|Overall Study|Protocol Violation|64|||
124885515|NCT00358215|449204360|FG001|Overall Study|Protocol Violation|59|||
124885516|NCT00358215|449204359|FG000|Overall Study|Pregnancy|1|||
124885517|NCT00358215|449204360|FG001|Overall Study|Pregnancy|0|||
124885518|NCT00358215|449204359|FG000|Overall Study|Other|21|||
124885519|NCT00358215|449204360|FG001|Overall Study|Other|14|||
124885520|NCT00358215|449204359|FG000|Overall Study|Did not receive investigational product|2|||
124885521|NCT00358215|449204360|FG001|Overall Study|Did not receive investigational product|3|||
124885522|NCT04329104|449204361|FG000|Efficacy Study|Withdrawal by Subject|0|||
124885523|NCT04329104|449204362|FG001|Efficacy Study|Withdrawal by Subject|0|||
124885524|NCT04329104|449204363|FG002|Efficacy Study|Withdrawal by Subject|0|||
124885525|NCT04329104|449204364|FG003|Efficacy Study|Withdrawal by Subject|5|||
124885526|NCT04329104|449204365|FG004|Efficacy Study|Withdrawal by Subject|6|||
124885527|NCT04329104|449204366|FG005|Efficacy Study|Withdrawal by Subject|8|||
124885528|NCT03884231|449204367|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
124885529|NCT03884231|449204367|FG000|Overall Study|Subject Withdrew Consent|1|||
124885530|NCT03884231|449204367|FG000|Overall Study|MRI Scan Not Performed|1|||
124885531|NCT01853254|449204368|FG000|Overall Study|Abnormal Laboratory Test|1|||
124885532|NCT01853254|449204368|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
124885533|NCT01853254|449204368|FG000|Overall Study|Death|1|||
124885534|NCT01853254|449204368|FG000|Overall Study|Failure to Return|43|||
124885535|NCT01853254|449204368|FG000|Overall Study|Insufficient Therapeutic Response|22|||
124885536|NCT01853254|449204368|FG000|Overall Study|Refusal of Treatment|1|||
124885537|NCT01853254|449204368|FG000|Overall Study|Other Protocol Violation|1|||
124885538|NCT01853254|449204368|FG000|Overall Study|Withdrawal of Consent|16|||
124885539|NCT01853254|449204368|FG000|Overall Study|Administrative/Other|16|||
124885540|NCT01017120|449204378|FG000|Overall Study|Adverse Event|9|||
124885541|NCT01017120|449204379|FG001|Overall Study|Adverse Event|0|||
124885542|NCT01017120|449204378|FG000|Overall Study|Lost to Follow-up|13|||
124885543|NCT01017120|449204379|FG001|Overall Study|Lost to Follow-up|11|||
124885544|NCT01017120|449204378|FG000|Overall Study|Lack of Efficacy|1|||
124885545|NCT01017120|449204379|FG001|Overall Study|Lack of Efficacy|0|||
124885546|NCT01017120|449204378|FG000|Overall Study|Withdrawal by Subject|39|||
124885547|NCT01017120|449204379|FG001|Overall Study|Withdrawal by Subject|21|||
124885548|NCT01017120|449204378|FG000|Overall Study|Pregnancy|1|||
124885549|NCT01017120|449204379|FG001|Overall Study|Pregnancy|1|||
124885550|NCT01017120|449204378|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
124885551|NCT01017120|449204379|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
124885552|NCT01017120|449204378|FG000|Overall Study|Relocated Out of Town|0|||
124885553|NCT01017120|449204379|FG001|Overall Study|Relocated Out of Town|2|||
124885554|NCT01017120|449204378|FG000|Overall Study|Protocol Violation|1|||
124885555|NCT01017120|449204379|FG001|Overall Study|Protocol Violation|0|||
124885556|NCT01017120|449204378|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
124885557|NCT01017120|449204379|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
124885558|NCT01087723|449204381|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
124885559|NCT01087723|449204382|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
124885560|NCT01087723|449204381|FG000|Overall Study|Withdrawal by Subject|10|||
124885561|NCT01087723|449204382|FG001|Overall Study|Withdrawal by Subject|13|||
124885562|NCT01087723|449204381|FG000|Overall Study|Physician Decision|2|||
124885563|NCT01087723|449204382|FG001|Overall Study|Physician Decision|0|||
124885564|NCT01087723|449204381|FG000|Overall Study|Lost to Follow-up|1|||
124885565|NCT01087723|449204382|FG001|Overall Study|Lost to Follow-up|4|||
124885566|NCT01087723|449204381|FG000|Overall Study|Reason Not Specified|1|||
124439853|NCT00406653|447570868|FG005|Maintenance Period|Error in disease score evaluation|0|||
124439854|NCT00406653|447570869|FG006|Maintenance Period|Error in disease score evaluation|0|||
124439855|NCT00406653|447570863|FG000|Open-Label Period|Death|0|||
124439856|NCT00406653|447570864|FG001|Open-Label Period|Death|0|||
124439857|NCT00406653|447570865|FG002|Open-Label Period|Death|0|||
124439858|NCT00406653|447570866|FG003|Open-Label Period|Death|0|||
124439859|NCT00406653|447570867|FG004|Open-Label Period|Death|0|||
124885567|NCT01087723|449204382|FG001|Overall Study|Reason Not Specified|2|||
124885568|NCT00289770|449204386|FG000|Year 15|Withdrawal by Subject|1|||
124885569|NCT01702428|449204387|FG000|Overall Study|Adverse Event|2|||
124885570|NCT01702428|449204388|FG001|Overall Study|Adverse Event|0|||
124885571|NCT01702428|449204389|FG002|Overall Study|Adverse Event|0|||
124885572|NCT01702428|449204390|FG003|Overall Study|Adverse Event|0|||
124885573|NCT01702428|449204387|FG000|Overall Study|Lost to Follow-up|33|||
124885574|NCT01702428|449204388|FG001|Overall Study|Lost to Follow-up|41|||
124885575|NCT01702428|449204389|FG002|Overall Study|Lost to Follow-up|37|||
124885576|NCT01702428|449204390|FG003|Overall Study|Lost to Follow-up|44|||
124885577|NCT01702428|449204387|FG000|Overall Study|Parents cannot assist to site|1|||
124885578|NCT01702428|449204388|FG001|Overall Study|Parents cannot assist to site|0|||
124885579|NCT01702428|449204389|FG002|Overall Study|Parents cannot assist to site|1|||
124885580|NCT01702428|449204390|FG003|Overall Study|Parents cannot assist to site|0|||
124885581|NCT01702428|449204387|FG000|Overall Study|Lost Coverage|0|||
124885582|NCT01702428|449204388|FG001|Overall Study|Lost Coverage|0|||
124885583|NCT01702428|449204389|FG002|Overall Study|Lost Coverage|0|||
124885584|NCT01702428|449204390|FG003|Overall Study|Lost Coverage|1|||
124885585|NCT01702428|449204387|FG000|Overall Study|Lost Health Plan|3|||
124885586|NCT01702428|449204388|FG001|Overall Study|Lost Health Plan|5|||
124885587|NCT01702428|449204389|FG002|Overall Study|Lost Health Plan|0|||
124885588|NCT01702428|449204390|FG003|Overall Study|Lost Health Plan|2|||
124885589|NCT01702428|449204387|FG000|Overall Study|Mother transferred care|0|||
124885590|NCT01702428|449204388|FG001|Overall Study|Mother transferred care|1|||
124885591|NCT01702428|449204389|FG002|Overall Study|Mother transferred care|0|||
124885592|NCT01702428|449204390|FG003|Overall Study|Mother transferred care|0|||
124885593|NCT01702428|449204387|FG000|Overall Study|Parents too busy|1|||
124885594|NCT01702428|449204388|FG001|Overall Study|Parents too busy|0|||
124885595|NCT01702428|449204389|FG002|Overall Study|Parents too busy|0|||
124885596|NCT01702428|449204390|FG003|Overall Study|Parents too busy|0|||
124885597|NCT01702428|449204387|FG000|Overall Study|Protocol Violation|3|||
124885598|NCT01702428|449204388|FG001|Overall Study|Protocol Violation|0|||
124885599|NCT01702428|449204389|FG002|Overall Study|Protocol Violation|1|||
124885600|NCT01702428|449204390|FG003|Overall Study|Protocol Violation|0|||
124885601|NCT01702428|449204387|FG000|Overall Study|Withdrawal by Subject|21|||
124885602|NCT01702428|449204388|FG001|Overall Study|Withdrawal by Subject|23|||
124885603|NCT01702428|449204389|FG002|Overall Study|Withdrawal by Subject|14|||
124885604|NCT01702428|449204390|FG003|Overall Study|Withdrawal by Subject|10|||
124885605|NCT00154063|449204393|FG000|Overall Study|Adverse Event|4|||
124885606|NCT00154063|449204394|FG001|Overall Study|Adverse Event|8|||
124885607|NCT00154063|449204393|FG000|Overall Study|Protocol Violation|1|||
124885608|NCT00154063|449204394|FG001|Overall Study|Protocol Violation|1|||
124885609|NCT00154063|449204393|FG000|Overall Study|Investigator or Sponsor Request|0|||
124885610|NCT00154063|449204394|FG001|Overall Study|Investigator or Sponsor Request|1|||
124439860|NCT00406653|447570868|FG005|Open-Label Period|Death|0|||
124439861|NCT00406653|447570869|FG006|Open-Label Period|Death|1|||
124885611|NCT00154063|449204393|FG000|Overall Study|Withdrawal by Subject|4|||
124885612|NCT00154063|449204394|FG001|Overall Study|Withdrawal by Subject|9|||
124885613|NCT00154063|449204393|FG000|Overall Study|Other|3|||
124885614|NCT00154063|449204394|FG001|Overall Study|Other|3|||
124885615|NCT02091869|449204395|FG000|Overall Study|Withdrawal by Subject|0|||
124885616|NCT02091869|449204396|FG001|Overall Study|Withdrawal by Subject|3|||
124885617|NCT01804673|449204397|FG000|Overall Study|Adverse Event|4|||
124439862|NCT00406653|447570863|FG000|Open-Label Period|Adverse Event|0|||
124439863|NCT00406653|447570864|FG001|Open-Label Period|Adverse Event|0|||
124885618|NCT01804673|449204397|FG000|Overall Study|Withdrawal by Subject|1|||
124885619|NCT01804673|449204397|FG000|Overall Study|Lack of Efficacy|9|||
124885620|NCT01804673|449204397|FG000|Overall Study|Change to Oral Therapy|37|||
124885621|NCT01804673|449204397|FG000|Overall Study|No Further Therapy Required|84|||
124885622|NCT01804673|449204397|FG000|Overall Study|Use of Prohibited Medication|1|||
124885623|NCT01804673|449204397|FG000|Overall Study|Other|4|||
124885624|NCT00451217|449204407|FG000|Overall Study|Lost to Follow-up|0|||
124885625|NCT00451217|449204408|FG001|Overall Study|Lost to Follow-up|1|||
124885626|NCT00451217|449204409|FG002|Overall Study|Lost to Follow-up|1|||
124885627|NCT00451217|449204410|FG003|Overall Study|Lost to Follow-up|1|||
124885628|NCT00451217|449204407|FG000|Overall Study|Withdrawal by Subject|1|||
124885629|NCT00451217|449204408|FG001|Overall Study|Withdrawal by Subject|0|||
124885630|NCT00451217|449204409|FG002|Overall Study|Withdrawal by Subject|0|||
124885631|NCT00451217|449204410|FG003|Overall Study|Withdrawal by Subject|0|||
124885632|NCT00451217|449204407|FG000|Overall Study|Not Treated|1|||
124885633|NCT00451217|449204408|FG001|Overall Study|Not Treated|1|||
124885634|NCT00451217|449204409|FG002|Overall Study|Not Treated|3|||
124885635|NCT00451217|449204410|FG003|Overall Study|Not Treated|4|||
124885636|NCT00358150|449204411|FG000|Overall Study|Adverse Event|3|||
124885637|NCT00358150|449204411|FG000|Overall Study|Withdrawal by Subject|1|||
124885638|NCT00358150|449204411|FG000|Overall Study|Undefined|3|||
124885639|NCT04668989|449204412|FG000|First Intervention|Covid-19 related self-isolation|0|||
124885640|NCT04668989|449204413|FG001|First Intervention|Covid-19 related self-isolation|1|||
124885641|NCT04668989|449204412|FG000|Second Intervention|Adverse Event|0|||
124885642|NCT04668989|449204413|FG001|Second Intervention|Adverse Event|1|||
124885643|NCT01622348|449204418|FG000|Overall Study|Withdrawal by Subject|1|||
124885644|NCT01622348|449204419|FG001|Overall Study|Withdrawal by Subject|0|||
124885645|NCT01622348|449204420|FG002|Overall Study|Withdrawal by Subject|1|||
124885646|NCT00179010|449204421|FG000|Overall Study|Muscle probe defective|1|||
124885647|NCT00179010|449204422|FG001|Overall Study|Muscle probe defective|1|||
124885648|NCT00179010|449204421|FG000|Overall Study|Failure to place arterial line|0|||
124885649|NCT00179010|449204422|FG001|Overall Study|Failure to place arterial line|1|||
124885650|NCT01592695|449204431|FG000|Overall Study|Lost to Follow-up|8|||
124885651|NCT01592695|449204432|FG001|Overall Study|Lost to Follow-up|4|||
124885652|NCT01763788|449204444|FG000|Overall Study|Lost to Follow-up|0|||
124885653|NCT01763788|449204445|FG001|Overall Study|Lost to Follow-up|0|||
124885654|NCT01763788|449204446|FG002|Overall Study|Lost to Follow-up|1|||
124885655|NCT01763788|449204447|FG003|Overall Study|Lost to Follow-up|0|||
124885656|NCT03893825|449204448|FG000|Overall Study|Death|2|||
124885657|NCT03893825|449204449|FG001|Overall Study|Death|1|||
124885658|NCT03893825|449204448|FG000|Overall Study|Adverse Event|0|||
124885659|NCT03893825|449204449|FG001|Overall Study|Adverse Event|2|||
124885660|NCT03893825|449204448|FG000|Overall Study|Withdrawal by Subject|19|||
124885661|NCT03893825|449204449|FG001|Overall Study|Withdrawal by Subject|21|||
124885662|NCT03893825|449204448|FG000|Overall Study|Protocol deviation|1|||
124885663|NCT03893825|449204449|FG001|Overall Study|Protocol deviation|0|||
124885664|NCT03893825|449204448|FG000|Overall Study|Lost to Follow-up|10|||
124885665|NCT03893825|449204449|FG001|Overall Study|Lost to Follow-up|10|||
124885666|NCT03893825|449204448|FG000|Overall Study|Other than specified|7|||
124885667|NCT03893825|449204449|FG001|Overall Study|Other than specified|6|||
124885668|NCT02086552|449204452|FG000|Overall Study|Withdrawal by Subject|1|||
124885669|NCT00708305|449204453|FG000|Period 1|Protocol Violation|1|||
124885670|NCT00708305|449204454|FG001|Period 1|Protocol Violation|0|||
124885671|NCT00708305|449204455|FG002|Period 1|Protocol Violation|1|||
124885672|NCT00708305|449204456|FG003|Period 1|Protocol Violation|0|||
124885673|NCT00708305|449204453|FG000|Period 1|Other Reason|0|||
124885674|NCT00708305|449204454|FG001|Period 1|Other Reason|0|||
124885675|NCT00708305|449204455|FG002|Period 1|Other Reason|0|||
124885676|NCT00708305|449204456|FG003|Period 1|Other Reason|2|||
124885677|NCT00708305|449204453|FG000|Period 2|Lost to Follow-up|0|||
124885678|NCT00708305|449204454|FG001|Period 2|Lost to Follow-up|1|||
124885679|NCT00708305|449204455|FG002|Period 2|Lost to Follow-up|0|||
124885680|NCT00708305|449204456|FG003|Period 2|Lost to Follow-up|0|||
124885681|NCT00708305|449204453|FG000|Period 2|Protocol Violation|0|||
124885682|NCT00708305|449204454|FG001|Period 2|Protocol Violation|1|||
124885683|NCT00708305|449204455|FG002|Period 2|Protocol Violation|0|||
124885684|NCT00708305|449204456|FG003|Period 2|Protocol Violation|0|||
124885685|NCT00708305|449204453|FG000|Period 2|Other Reason|1|||
124885686|NCT00708305|449204454|FG001|Period 2|Other Reason|0|||
124885687|NCT00708305|449204455|FG002|Period 2|Other Reason|0|||
124885688|NCT00708305|449204456|FG003|Period 2|Other Reason|1|||
124885689|NCT00708305|449204453|FG000|Period 3|Protocol Violation|0|||
124885690|NCT00708305|449204454|FG001|Period 3|Protocol Violation|2|||
124885691|NCT00708305|449204455|FG002|Period 3|Protocol Violation|0|||
124885692|NCT00708305|449204456|FG003|Period 3|Protocol Violation|0|||
124885693|NCT00708305|449204453|FG000|Period 3|Other Reason|1|||
124885694|NCT00708305|449204454|FG001|Period 3|Other Reason|0|||
124885695|NCT00708305|449204455|FG002|Period 3|Other Reason|0|||
124885696|NCT00708305|449204456|FG003|Period 3|Other Reason|0|||
124885697|NCT02823964|449204461|FG000|Overall Study|Adverse Event|2|||
124885698|NCT02823964|449204461|FG000|Overall Study|Physician Decision|1|||
124885699|NCT02823964|449204461|FG000|Overall Study|Lack of Efficacy|1|||
124885700|NCT02823964|449204461|FG000|Overall Study|Withdrawal by Subject|1|||
124885701|NCT04012814|449204464|FG000|Overall Study|Lost to Follow-up|4|||
124885702|NCT04012814|449204464|FG000|Overall Study|Withdrawal by Subject|2|||
124885703|NCT04012814|449204464|FG000|Overall Study|Protocol Violation|1|||
124885704|NCT04012814|449204464|FG000|Overall Study|Adverse Event|1|||
124885705|NCT00390455|449204465|FG000|Overall Study|Adverse Event|17|||
124885706|NCT00390455|449204466|FG001|Overall Study|Adverse Event|3|||
124885707|NCT00390455|449204465|FG000|Overall Study|Withdrawal by Subject|8|||
124885708|NCT00390455|449204466|FG001|Overall Study|Withdrawal by Subject|8|||
124885709|NCT00390455|449204465|FG000|Overall Study|Alternate Treatment|0|||
124885710|NCT00390455|449204466|FG001|Overall Study|Alternate Treatment|1|||
124885711|NCT00390455|449204465|FG000|Overall Study|Other Medical Reasons|7|||
124885712|NCT00390455|449204466|FG001|Overall Study|Other Medical Reasons|11|||
124885713|NCT04397523|449204467|FG000|Overall Study|Lost to Follow-up|3|||
124885714|NCT04397523|449204467|FG000|Overall Study|Transfer from/to other hospital|8|||
124885715|NCT01275196|449204468|FG000|Overall Study|Adverse Event|3|||
124885716|NCT01275196|449204469|FG001|Overall Study|Adverse Event|5|||
124885717|NCT01275196|449204468|FG000|Overall Study|Withdrawal by Subject|4|||
124885718|NCT01275196|449204469|FG001|Overall Study|Withdrawal by Subject|5|||
124885719|NCT01275196|449204468|FG000|Overall Study|Lost to Follow-up|1|||
124885720|NCT01275196|449204469|FG001|Overall Study|Lost to Follow-up|0|||
124885721|NCT01275196|449204468|FG000|Overall Study|Disease Progression|6|||
124885722|NCT01275196|449204469|FG001|Overall Study|Disease Progression|5|||
124885723|NCT01275196|449204468|FG000|Overall Study|Protocol Violation|1|||
124885724|NCT01275196|449204469|FG001|Overall Study|Protocol Violation|0|||
124885725|NCT01275196|449204468|FG000|Overall Study|Suboptimal response/treatment failure|5|||
124885726|NCT01275196|449204469|FG001|Overall Study|Suboptimal response/treatment failure|6|||
124885727|NCT02838628|449204500|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
124885728|NCT02838628|449204501|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
124885729|NCT02838628|449204500|FG000|Recurrence Follow-up Period|Adverse Event|1|||
124885730|NCT02838628|449204501|FG001|Recurrence Follow-up Period|Adverse Event|0|||
124885731|NCT02838628|449204500|FG000|Recurrence Follow-up Period|Non-compliance|0|||
124885732|NCT02838628|449204501|FG001|Recurrence Follow-up Period|Non-compliance|1|||
124885733|NCT02838628|449204500|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
124885734|NCT02838628|449204501|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
124885735|NCT02838628|449204500|FG000|Recurrence Follow-up Period|Other un-specified|1|||
124885736|NCT02838628|449204501|FG001|Recurrence Follow-up Period|Other un-specified|1|||
124885737|NCT05033080|449204504|FG000|Overall Study|Adverse Event|4|||
124885738|NCT05033080|449204505|FG001|Overall Study|Adverse Event|4|||
124885739|NCT05033080|449204504|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
124885740|NCT05033080|449204505|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
124885741|NCT05033080|449204504|FG000|Overall Study|Lost to Follow-up|1|||
124885742|NCT05033080|449204505|FG001|Overall Study|Lost to Follow-up|0|||
124885743|NCT05033080|449204504|FG000|Overall Study|Other non-compliance|0|||
124885744|NCT05033080|449204505|FG001|Overall Study|Other non-compliance|1|||
124885745|NCT05033080|449204504|FG000|Overall Study|Physician Decision|0|||
124885746|NCT05033080|449204505|FG001|Overall Study|Physician Decision|1|||
124885747|NCT05033080|449204504|FG000|Overall Study|Other|1|||
124885748|NCT05033080|449204505|FG001|Overall Study|Other|1|||
124885749|NCT03560245|449204506|FG000|Overall Study|Withdrawal by Subject|3|||
124885750|NCT03560245|449204507|FG001|Overall Study|Withdrawal by Subject|2|||
124885751|NCT03560245|449204506|FG000|Overall Study|Adverse Event|1|||
124885752|NCT03560245|449204507|FG001|Overall Study|Adverse Event|1|||
124885753|NCT03560245|449204506|FG000|Overall Study|Protocol Violation|1|||
124885754|NCT03560245|449204507|FG001|Overall Study|Protocol Violation|0|||
124885755|NCT03560245|449204506|FG000|Overall Study|Death|0|||
124885756|NCT03560245|449204507|FG001|Overall Study|Death|1|||
124885757|NCT03560245|449204506|FG000|Overall Study|Lost to Follow-up|0|||
124885758|NCT03560245|449204507|FG001|Overall Study|Lost to Follow-up|1|||
124885759|NCT03560245|449204506|FG000|Overall Study|Physician Decision|0|||
124885760|NCT03560245|449204507|FG001|Overall Study|Physician Decision|1|||
124885761|NCT03560245|449204506|FG000|Overall Study|Other|0|||
124885762|NCT03560245|449204507|FG001|Overall Study|Other|1|||
124885763|NCT01265823|449204508|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
124885764|NCT01265823|449204508|FG000|Overall Study|Failure to Return|4|||
124885765|NCT01265823|449204508|FG000|Overall Study|Protocol Violation|1|||
124885766|NCT01265823|449204508|FG000|Overall Study|Participant Request|1|||
124885767|NCT01018563|449204519|FG000|Overall Study|Termination of the study by Sponsor|2|||
124885768|NCT01018563|449204520|FG001|Overall Study|Termination of the study by Sponsor|1|||
124885769|NCT00903786|449204523|FG000|Overall Study|Physician Decision|6|||
124885770|NCT00903786|449204523|FG000|Overall Study|Lack of Efficacy|5|||
124885771|NCT00903786|449204523|FG000|Overall Study|Reason other than lack of efficacy|4|||
124885772|NCT05822921|449204530|FG000|Overall Study|Lost to Follow-up|1|||
124885773|NCT05822921|449204531|FG001|Overall Study|Lost to Follow-up|1|||
124885774|NCT03406702|449204532|FG000|Overall Study|Missed Day 27 Dosing|1|||
124885775|NCT01857622|449204533|FG000|Overall Study|Adverse Event|5|||
124885776|NCT01857622|449204534|FG001|Overall Study|Adverse Event|0|||
124885777|NCT01857622|449204535|FG002|Overall Study|Adverse Event|2|||
124885778|NCT01857622|449204533|FG000|Overall Study|Physician Decision|1|||
124885779|NCT01857622|449204534|FG001|Overall Study|Physician Decision|0|||
124885780|NCT01857622|449204535|FG002|Overall Study|Physician Decision|0|||
124885781|NCT01857622|449204533|FG000|Overall Study|Protocol Violation|4|||
124885782|NCT01857622|449204534|FG001|Overall Study|Protocol Violation|1|||
124885783|NCT01857622|449204535|FG002|Overall Study|Protocol Violation|0|||
124885784|NCT01857622|449204533|FG000|Overall Study|Withdrawal by Subject|1|||
124885785|NCT01857622|449204534|FG001|Overall Study|Withdrawal by Subject|0|||
124885786|NCT01857622|449204535|FG002|Overall Study|Withdrawal by Subject|0|||
124885787|NCT04213989|449206455|FG000|Overall Study|Withdrawal by Subject|3|||
124885788|NCT04213989|449206456|FG001|Overall Study|Withdrawal by Subject|2|||
124885789|NCT04213989|449206455|FG000|Overall Study|Physician Decision|1|||
124885790|NCT04213989|449206456|FG001|Overall Study|Physician Decision|0|||
124885791|NCT04213989|449206455|FG000|Overall Study|Lost to Follow-up|0|||
124885792|NCT04213989|449206456|FG001|Overall Study|Lost to Follow-up|4|||
124885793|NCT01024959|449206460|FG000|Overall Study|ineligible|12|||
124885794|NCT01024959|449206460|FG000|Overall Study|results not evaluable|12|||
124885795|NCT01024959|449206460|FG000|Overall Study|missing results required for analysis|17|||
124885796|NCT00636792|449206461|FG000|Overall Study|Adverse Event|16|||
124885797|NCT00636792|449206461|FG000|Overall Study|Physician Decision|7|||
124885798|NCT00636792|449206461|FG000|Overall Study|Progressive Disease|4|||
124885799|NCT00636792|449206461|FG000|Overall Study|Withdrawal by Subject|3|||
124885800|NCT00636792|449206461|FG000|Overall Study|Other|3|||
124885801|NCT00709592|449206464|FG000|Overall Study|Unable to proceed to transplant|0|||
124885802|NCT00709592|449206465|FG001|Overall Study|Unable to proceed to transplant|1|||
124885803|NCT01950273|449206466|FG000|Overall Study|Protocol Violation|1|||
124885804|NCT01950273|449206467|FG001|Overall Study|Protocol Violation|0|||
124885805|NCT01950273|449206466|FG000|Overall Study|Withdrawal by Subject|2|||
124885806|NCT01950273|449206467|FG001|Overall Study|Withdrawal by Subject|0|||
124885807|NCT01950273|449206466|FG000|Overall Study|Other not defined above|1|||
124885808|NCT01950273|449206467|FG001|Overall Study|Other not defined above|0|||
124885809|NCT00472186|449206468|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
124885810|NCT00472186|449206469|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
124885811|NCT01254565|449206470|FG000|Overall Study|Non-compliance to Study Procedures|0|||
124885812|NCT01254565|449206471|FG001|Overall Study|Non-compliance to Study Procedures|0|||
124885813|NCT01254565|449206472|FG002|Overall Study|Non-compliance to Study Procedures|0|||
124885814|NCT01254565|449206473|FG003|Overall Study|Non-compliance to Study Procedures|0|||
124885815|NCT01254565|449206474|FG004|Overall Study|Non-compliance to Study Procedures|1|||
124885816|NCT01254565|449206475|FG005|Overall Study|Non-compliance to Study Procedures|0|||
124885817|NCT01254565|449206470|FG000|Overall Study|Did not Receive Treatment|1|||
124885818|NCT01254565|449206471|FG001|Overall Study|Did not Receive Treatment|1|||
124885819|NCT01254565|449206472|FG002|Overall Study|Did not Receive Treatment|0|||
124885820|NCT01254565|449206473|FG003|Overall Study|Did not Receive Treatment|0|||
124885821|NCT01254565|449206474|FG004|Overall Study|Did not Receive Treatment|3|||
124885822|NCT01254565|449206475|FG005|Overall Study|Did not Receive Treatment|4|||
124885823|NCT01254565|449206470|FG000|Overall Study|Other|0|||
124885824|NCT01254565|449206471|FG001|Overall Study|Other|0|||
124885825|NCT01254565|449206472|FG002|Overall Study|Other|0|||
124885826|NCT01254565|449206473|FG003|Overall Study|Other|1|||
124885827|NCT01254565|449206474|FG004|Overall Study|Other|0|||
124885828|NCT01254565|449206475|FG005|Overall Study|Other|0|||
124885829|NCT00178256|449206476|FG000|Overall Study|Adverse Event|2|||
124885830|NCT00178256|449206477|FG001|Overall Study|Adverse Event|0|||
124885831|NCT00178256|449206478|FG002|Overall Study|Adverse Event|0|||
124885832|NCT00178256|449206479|FG003|Overall Study|Adverse Event|0|||
124885833|NCT00178256|449206476|FG000|Overall Study|Death|0|||
124885834|NCT00178256|449206477|FG001|Overall Study|Death|1|||
124885835|NCT00178256|449206478|FG002|Overall Study|Death|0|||
124885836|NCT00178256|449206479|FG003|Overall Study|Death|1|||
124885837|NCT00178256|449206476|FG000|Overall Study|Cancer progression|2|||
124885838|NCT00178256|449206477|FG001|Overall Study|Cancer progression|0|||
124885839|NCT00178256|449206478|FG002|Overall Study|Cancer progression|0|||
124885840|NCT00178256|449206479|FG003|Overall Study|Cancer progression|1|||
124885841|NCT04076020|449206483|FG000|Overall Study|Death|4|||
124885842|NCT04076020|449206484|FG001|Overall Study|Death|6|||
124885843|NCT04076020|449206483|FG000|Overall Study|Withdrawal by Subject|12|||
124885844|NCT04076020|449206484|FG001|Overall Study|Withdrawal by Subject|8|||
124885845|NCT02310126|449206486|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
124885846|NCT02310126|449206487|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
124885847|NCT02310126|449206486|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
124885848|NCT02310126|449206487|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
124885849|NCT02761629|449206494|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
124885850|NCT02761629|449206495|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
124885851|NCT02761629|449206494|FG000|Overall Study|Insufficient Therapeutic Response|2|||
124885852|NCT02761629|449206495|FG001|Overall Study|Insufficient Therapeutic Response|7|||
124885853|NCT02761629|449206494|FG000|Overall Study|Failure to Return|2|||
124885854|NCT02761629|449206495|FG001|Overall Study|Failure to Return|4|||
124885855|NCT02761629|449206494|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
124885856|NCT02761629|449206495|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
124885857|NCT02761629|449206494|FG000|Overall Study|Protocol Violation|2|||
124885858|NCT02761629|449206495|FG001|Overall Study|Protocol Violation|2|||
124885859|NCT02761629|449206494|FG000|Overall Study|Withdrawal by Subject|0|||
124885860|NCT02761629|449206495|FG001|Overall Study|Withdrawal by Subject|3|||
124885861|NCT02761629|449206494|FG000|Overall Study|Other|0|||
124885862|NCT02761629|449206495|FG001|Overall Study|Other|2|||
124885863|NCT02761629|449206494|FG000|Overall Study|Lost to Follow-up|4|||
124885864|NCT02761629|449206495|FG001|Overall Study|Lost to Follow-up|1|||
124885865|NCT02761629|449206494|FG000|Overall Study|Randomized But Not Treated|8|||
124885866|NCT02761629|449206495|FG001|Overall Study|Randomized But Not Treated|4|||
124683721|NCT00620542|448466029|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
124683722|NCT00620542|448466026|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
124683723|NCT00620542|448466027|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
124683724|NCT00620542|448466028|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
124683725|NCT00620542|448466029|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
124683726|NCT00620542|448466026|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
124683727|NCT00620542|448466027|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
124683728|NCT00620542|448466028|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
124683729|NCT00620542|448466029|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
124683730|NCT00620542|448466026|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
124683731|NCT00620542|448466027|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
124683732|NCT00620542|448466028|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
124683733|NCT00620542|448466029|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
124683734|NCT00620542|448466026|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
124683735|NCT00620542|448466027|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
124683736|NCT00620542|448466028|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
124683737|NCT00620542|448466029|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
124683738|NCT00620542|448466026|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
124683739|NCT00620542|448466027|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
124683740|NCT00620542|448466028|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
124683741|NCT00620542|448466029|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
124683742|NCT00620542|448466026|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
124683743|NCT00620542|448466027|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
124683744|NCT00620542|448466028|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
124683745|NCT00620542|448466029|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
124683746|NCT00620542|448466026|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
124683747|NCT00620542|448466027|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
124683748|NCT00620542|448466028|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
124683749|NCT00620542|448466029|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
124683750|NCT01283386|448466036|FG000|Overall Study|Death|2|||
124683751|NCT01283386|448466037|FG001|Overall Study|Death|0|||
124683752|NCT01283386|448466036|FG000|Overall Study|Withdrawal by Subject|2|||
124683753|NCT01283386|448466037|FG001|Overall Study|Withdrawal by Subject|1|||
124683754|NCT01283386|448466036|FG000|Overall Study|Relapse of underlying disease|1|||
124683755|NCT01283386|448466037|FG001|Overall Study|Relapse of underlying disease|3|||
124683756|NCT01283386|448466036|FG000|Overall Study|Progression of underlying disease|2|||
124683757|NCT01283386|448466037|FG001|Overall Study|Progression of underlying disease|7|||
124683758|NCT01283386|448466036|FG000|Overall Study|Reason not specified|1|||
124683759|NCT01283386|448466037|FG001|Overall Study|Reason not specified|0|||
124683760|NCT01283386|448466036|FG000|Overall Study|Protocol Violation|0|||
124683761|NCT01283386|448466037|FG001|Overall Study|Protocol Violation|1|||
124683762|NCT04115059|448466041|FG000|Overall Study|Withdrawal by Subject|1|||
124683763|NCT04115059|448466041|FG000|Overall Study|Lack of Efficacy|2|||
124683764|NCT06420232|448466042|FG000|Overall Study|Withdrawal by Subject|3|||
124683765|NCT00963235|448466043|FG000|Overall Study|Withdrawal by Subject|22|||
124683766|NCT00963235|448466043|FG000|Overall Study|Lost to Follow-up|14|||
124683767|NCT00963235|448466043|FG000|Overall Study|Failed to return|9|||
124683768|NCT00963235|448466043|FG000|Overall Study|Protocol Violation|7|||
124683769|NCT00963235|448466043|FG000|Overall Study|Adverse Event|5|||
124683770|NCT00963235|448466043|FG000|Overall Study|Physician Decision|2|||
124683771|NCT00963235|448466043|FG000|Overall Study|Other|1|||
124683772|NCT01136915|448466044|FG000|Overall Study|Lost to Follow-up|2|||
124683773|NCT01136915|448466045|FG001|Overall Study|Lost to Follow-up|0|||
124683774|NCT01136915|448466044|FG000|Overall Study|Exclusion criterion met|0|||
124683775|NCT01136915|448466045|FG001|Overall Study|Exclusion criterion met|1|||
124683776|NCT01756235|448466046|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
124683777|NCT02213926|448466049|FG000|Overall Study|Death|59|||
124683778|NCT02213926|448466049|FG000|Overall Study|Withdrawal by Subject|10|||
124683779|NCT02213926|448466049|FG000|Overall Study|study terminated by sponsor|51|||
124683780|NCT02213926|448466049|FG000|Overall Study|Lost to Follow-up|3|||
124683781|NCT02213926|448466049|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
124683782|NCT01697579|448466052|FG000|Base Study-Cycle 1|Adverse Event|1|||
124683783|NCT01697579|448466053|FG001|Base Study-Cycle 1|Adverse Event|0|||
124683784|NCT01697579|448466054|FG002|Base Study-Cycle 1|Adverse Event|0|||
124683785|NCT01697579|448466055|FG003|Base Study-Cycle 1|Adverse Event|0|||
124683786|NCT01697579|448466056|FG004|Base Study-Cycle 1|Adverse Event|0|||
124683787|NCT01697579|448466057|FG005|Base Study-Cycle 1|Adverse Event|0|||
124683788|NCT01697579|448466058|FG006|Base Study-Cycle 1|Adverse Event|0|||
124683789|NCT01697579|448466052|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
124683790|NCT01697579|448466053|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
124683791|NCT01697579|448466054|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
124683792|NCT01697579|448466055|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
124683793|NCT01697579|448466056|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
124712000|NCT01343888|448570709|FG002|Overall Study|Adverse Event|5|||
124885867|NCT02001974|449206498|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
124885868|NCT02001974|449206499|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
124885869|NCT02001974|449206500|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
124885870|NCT02001974|449206498|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
124885871|NCT02001974|449206499|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
124885872|NCT02001974|449206500|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
124885873|NCT02001974|449206498|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
124885874|NCT02001974|449206499|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
124885875|NCT02001974|449206500|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
124885876|NCT02001974|449206498|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
124885877|NCT02001974|449206499|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
124885878|NCT02001974|449206500|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
124885879|NCT00672958|449206501|FG000|Overall Study|Adverse Event|11|||
124885880|NCT00672958|449206502|FG001|Overall Study|Adverse Event|9|||
124885881|NCT00672958|449206501|FG000|Overall Study|Lack of Efficacy|6|||
124885882|NCT00672958|449206502|FG001|Overall Study|Lack of Efficacy|11|||
124885883|NCT00672958|449206501|FG000|Overall Study|Non-compliance with study drug|2|||
124885884|NCT00672958|449206502|FG001|Overall Study|Non-compliance with study drug|3|||
124885885|NCT00672958|449206501|FG000|Overall Study|Protocol deviations|11|||
124885886|NCT00672958|449206502|FG001|Overall Study|Protocol deviations|5|||
124885887|NCT00672958|449206501|FG000|Overall Study|Voluntary withdrawal|12|||
124885888|NCT00672958|449206502|FG001|Overall Study|Voluntary withdrawal|8|||
124885889|NCT00672958|449206501|FG000|Overall Study|Lost to Follow-up|22|||
124885890|NCT00672958|449206502|FG001|Overall Study|Lost to Follow-up|17|||
124885891|NCT00672958|449206501|FG000|Overall Study|Reason not specified|0|||
124885892|NCT00672958|449206502|FG001|Overall Study|Reason not specified|3|||
124885893|NCT01380990|449206503|FG000|Overall Study|Treatment Failure|1|||
124885894|NCT01380990|449206504|FG001|Overall Study|Treatment Failure|0|||
124885895|NCT01380990|449206503|FG000|Overall Study|Death|0|||
124885896|NCT01380990|449206504|FG001|Overall Study|Death|1|||
124885897|NCT02374593|449206506|FG000|Overall Study|non-compliant|2|||
124885898|NCT02374593|449206507|FG001|Overall Study|non-compliant|0|||
124885899|NCT04267614|449206508|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
124885900|NCT04267614|449206508|FG000|Overall Study|Lost to Follow-up|115|||
124885901|NCT00210119|449206509|FG000|Overall Study|Protocol Violation|1|||
124885902|NCT00210119|449206509|FG000|Overall Study|Withdrawal by Subject|1|||
124885903|NCT04827134|449206510|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
124885904|NCT04827134|449206511|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
124885905|NCT04827134|449206512|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
124885906|NCT04827134|449206513|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
124885907|NCT01830881|449206514|FG000|Overall Study|Changed decision to have an abortion|0|||
124885908|NCT01830881|449206515|FG001|Overall Study|Changed decision to have an abortion|1|||
124885909|NCT00988351|449206516|FG000|Overall Study|Withdrawal by Subject|8|||
124885910|NCT00988351|449206517|FG001|Overall Study|Withdrawal by Subject|0|||
124885911|NCT00988351|449206516|FG000|Overall Study|Lost to Follow-up|6|||
124885912|NCT00988351|449206517|FG001|Overall Study|Lost to Follow-up|9|||
124885913|NCT00988351|449206516|FG000|Overall Study|not using CPAP|5|||
124885914|NCT00988351|449206517|FG001|Overall Study|not using CPAP|3|||
124885915|NCT02038764|449206518|FG000|Overall Study|Adverse Event|0|||
124885916|NCT02038764|449206519|FG001|Overall Study|Adverse Event|0|||
124885917|NCT02038764|449206520|FG002|Overall Study|Adverse Event|1|||
124885918|NCT02038764|449206521|FG003|Overall Study|Adverse Event|0|||
124885919|NCT02038764|449206522|FG004|Overall Study|Adverse Event|0|||
124885920|NCT02038764|449206518|FG000|Overall Study|Lost to Follow-up|0|||
124885921|NCT02038764|449206519|FG001|Overall Study|Lost to Follow-up|1|||
124885922|NCT02038764|449206520|FG002|Overall Study|Lost to Follow-up|0|||
124885923|NCT02038764|449206521|FG003|Overall Study|Lost to Follow-up|0|||
124885924|NCT02038764|449206522|FG004|Overall Study|Lost to Follow-up|0|||
124683794|NCT01697579|448466057|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
124683795|NCT01697579|448466058|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
124683796|NCT01697579|448466052|FG000|Base Study-Cycle 1|Protocol Violation|0|||
124683797|NCT01697579|448466053|FG001|Base Study-Cycle 1|Protocol Violation|0|||
124683798|NCT01697579|448466054|FG002|Base Study-Cycle 1|Protocol Violation|0|||
124683799|NCT01697579|448466055|FG003|Base Study-Cycle 1|Protocol Violation|0|||
124885925|NCT02038764|449206518|FG000|Overall Study|Withdrawal by Subject|0|||
124885926|NCT02038764|449206519|FG001|Overall Study|Withdrawal by Subject|0|||
124885927|NCT02038764|449206520|FG002|Overall Study|Withdrawal by Subject|0|||
124885928|NCT02038764|449206521|FG003|Overall Study|Withdrawal by Subject|0|||
124885929|NCT02038764|449206522|FG004|Overall Study|Withdrawal by Subject|1|||
124885930|NCT02038764|449206518|FG000|Overall Study|Other|1|||
124885931|NCT02038764|449206519|FG001|Overall Study|Other|0|||
124885932|NCT02038764|449206520|FG002|Overall Study|Other|1|||
124885933|NCT02038764|449206521|FG003|Overall Study|Other|0|||
124885934|NCT02038764|449206522|FG004|Overall Study|Other|0|||
124885935|NCT04844918|449206526|FG000|Overall Study|Adverse Event|7|||
124885936|NCT04844918|449206527|FG001|Overall Study|Adverse Event|8|||
124885937|NCT04844918|449206528|FG002|Overall Study|Adverse Event|5|||
124885938|NCT04844918|449206526|FG000|Overall Study|Physician Decision|0|||
124885939|NCT04844918|449206527|FG001|Overall Study|Physician Decision|1|||
124885940|NCT04844918|449206528|FG002|Overall Study|Physician Decision|0|||
124885941|NCT04844918|449206526|FG000|Overall Study|Withdrawal by Subject|6|||
124885942|NCT04844918|449206527|FG001|Overall Study|Withdrawal by Subject|3|||
124885943|NCT04844918|449206528|FG002|Overall Study|Withdrawal by Subject|3|||
124885944|NCT04844918|449206526|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
124885945|NCT04844918|449206527|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
124885946|NCT04844918|449206528|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
124885947|NCT01927731|449206543|FG000|Overall Study|Graft Failure|1|||
124885948|NCT01927731|449206544|FG001|Overall Study|Graft Failure|2|||
124885949|NCT01927731|449206543|FG000|Overall Study|Physician Decision|2|||
124885950|NCT01927731|449206544|FG001|Overall Study|Physician Decision|3|||
124885951|NCT01927731|449206543|FG000|Overall Study|Withdrawal by Subject|0|||
124885952|NCT01927731|449206544|FG001|Overall Study|Withdrawal by Subject|2|||
124885953|NCT01927731|449206543|FG000|Overall Study|Death|0|||
124885954|NCT01927731|449206544|FG001|Overall Study|Death|3|||
124885955|NCT01388530|449206545|FG000|Overall Study|Lost to Follow-up|5|||
124885956|NCT02743793|449206548|FG000|Overall Study|Death|1|||
124885957|NCT02743793|449206549|FG001|Overall Study|Death|1|||
124885958|NCT02743793|449206548|FG000|Overall Study|Withdrawal by Subject|0|||
124885959|NCT02743793|449206549|FG001|Overall Study|Withdrawal by Subject|1|||
124885960|NCT02743793|449206548|FG000|Overall Study|Screen Failure|4|||
124885961|NCT02743793|449206549|FG001|Overall Study|Screen Failure|0|||
124885962|NCT02743793|449206548|FG000|Overall Study|No Primary Care Physician|0|||
124885963|NCT02743793|449206549|FG001|Overall Study|No Primary Care Physician|1|||
124885964|NCT02743793|449206548|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
124885965|NCT02743793|449206549|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
124885966|NCT02743793|449206548|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
124885967|NCT02743793|449206549|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
124885968|NCT02065570|449206550|FG000|Induction Study|Adverse Event|5|||
124885969|NCT02065570|449206551|FG001|Induction Study|Adverse Event|12|||
124885970|NCT02065570|449206552|FG002|Induction Study|Adverse Event|0|||
124885971|NCT02065570|449206553|FG003|Induction Study|Adverse Event|0|||
124885972|NCT02065570|449206550|FG000|Induction Study|Withdrawal by Subject|2|||
124885973|NCT02065570|449206551|FG001|Induction Study|Withdrawal by Subject|3|||
124885974|NCT02065570|449206552|FG002|Induction Study|Withdrawal by Subject|0|||
124885975|NCT02065570|449206553|FG003|Induction Study|Withdrawal by Subject|0|||
124885976|NCT02065570|449206550|FG000|Induction Study|Lost to Follow-up|1|||
124885977|NCT02065570|449206551|FG001|Induction Study|Lost to Follow-up|1|||
124885978|NCT02065570|449206552|FG002|Induction Study|Lost to Follow-up|0|||
124885979|NCT02065570|449206553|FG003|Induction Study|Lost to Follow-up|0|||
124885980|NCT02065570|449206550|FG000|Induction Study|Other, Not Specified|6|||
124885981|NCT02065570|449206551|FG001|Induction Study|Other, Not Specified|5|||
124885982|NCT02065570|449206552|FG002|Induction Study|Other, Not Specified|0|||
124885983|NCT02065570|449206553|FG003|Induction Study|Other, Not Specified|0|||
124885984|NCT02065570|449206550|FG000|Maintenance Study|Adverse Event|0|||
124885985|NCT02065570|449206551|FG001|Maintenance Study|Adverse Event|0|||
124885986|NCT02065570|449206552|FG002|Maintenance Study|Adverse Event|8|||
124885987|NCT02065570|449206553|FG003|Maintenance Study|Adverse Event|8|||
124885988|NCT02065570|449206550|FG000|Maintenance Study|Withdrawal by Subject|0|||
124885989|NCT02065570|449206551|FG001|Maintenance Study|Withdrawal by Subject|0|||
124885990|NCT02065570|449206552|FG002|Maintenance Study|Withdrawal by Subject|1|||
124885991|NCT02065570|449206553|FG003|Maintenance Study|Withdrawal by Subject|4|||
124683800|NCT01697579|448466056|FG004|Base Study-Cycle 1|Protocol Violation|3|||
124885992|NCT02065570|449206550|FG000|Maintenance Study|Lost to Follow-up|0|||
124885993|NCT02065570|449206551|FG001|Maintenance Study|Lost to Follow-up|0|||
124885994|NCT02065570|449206552|FG002|Maintenance Study|Lost to Follow-up|2|||
124885995|NCT02065570|449206553|FG003|Maintenance Study|Lost to Follow-up|2|||
124885996|NCT02065570|449206550|FG000|Maintenance Study|Other, Not Specified|0|||
124885997|NCT02065570|449206551|FG001|Maintenance Study|Other, Not Specified|0|||
124885998|NCT02065570|449206552|FG002|Maintenance Study|Other, Not Specified|11|||
124885999|NCT02065570|449206553|FG003|Maintenance Study|Other, Not Specified|5|||
124886000|NCT02293837|449206556|FG000|Overall Study|Lost to Follow-up|0|||
124886001|NCT02293837|449206557|FG001|Overall Study|Lost to Follow-up|2|||
124886002|NCT02293837|449206558|FG002|Overall Study|Lost to Follow-up|1|||
124439864|NCT00406653|447570865|FG002|Open-Label Period|Adverse Event|0|||
124439865|NCT00406653|447570866|FG003|Open-Label Period|Adverse Event|0|||
124439866|NCT00406653|447570867|FG004|Open-Label Period|Adverse Event|0|||
124439867|NCT00406653|447570868|FG005|Open-Label Period|Adverse Event|0|||
124439868|NCT00406653|447570869|FG006|Open-Label Period|Adverse Event|18|||
124439869|NCT00406653|447570863|FG000|Open-Label Period|Lack of Efficacy|0|||
124439870|NCT00406653|447570864|FG001|Open-Label Period|Lack of Efficacy|0|||
124439871|NCT00406653|447570865|FG002|Open-Label Period|Lack of Efficacy|0|||
124439872|NCT00406653|447570866|FG003|Open-Label Period|Lack of Efficacy|0|||
124439873|NCT00406653|447570867|FG004|Open-Label Period|Lack of Efficacy|0|||
124439874|NCT00406653|447570868|FG005|Open-Label Period|Lack of Efficacy|0|||
124439875|NCT00406653|447570869|FG006|Open-Label Period|Lack of Efficacy|160|||
124439876|NCT00406653|447570863|FG000|Open-Label Period|Lost to Follow-up|0|||
124439877|NCT00406653|447570864|FG001|Open-Label Period|Lost to Follow-up|0|||
124439878|NCT00406653|447570865|FG002|Open-Label Period|Lost to Follow-up|0|||
124439879|NCT00406653|447570866|FG003|Open-Label Period|Lost to Follow-up|0|||
124439880|NCT00406653|447570867|FG004|Open-Label Period|Lost to Follow-up|0|||
124439881|NCT00406653|447570868|FG005|Open-Label Period|Lost to Follow-up|0|||
124683801|NCT01697579|448466057|FG005|Base Study-Cycle 1|Protocol Violation|0|||
124683802|NCT01697579|448466058|FG006|Base Study-Cycle 1|Protocol Violation|0|||
124683803|NCT01697579|448466052|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
124683804|NCT01697579|448466053|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
124683805|NCT01697579|448466054|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
124683806|NCT01697579|448466055|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
124683807|NCT01697579|448466056|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
124683808|NCT01697579|448466057|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
124683809|NCT01697579|448466058|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
124683810|NCT01697579|448466052|FG000|Base Study-Cycle 1|Technical Problems|0|||
124683811|NCT01697579|448466053|FG001|Base Study-Cycle 1|Technical Problems|0|||
124683812|NCT01697579|448466054|FG002|Base Study-Cycle 1|Technical Problems|1|||
124683813|NCT01697579|448466055|FG003|Base Study-Cycle 1|Technical Problems|1|||
124683814|NCT01697579|448466056|FG004|Base Study-Cycle 1|Technical Problems|0|||
124683815|NCT01697579|448466057|FG005|Base Study-Cycle 1|Technical Problems|0|||
124683816|NCT01697579|448466058|FG006|Base Study-Cycle 1|Technical Problems|0|||
124683817|NCT01697579|448466052|FG000|Optional Extension-Cycles 2-6|Death|0|||
124683818|NCT01697579|448466053|FG001|Optional Extension-Cycles 2-6|Death|0|||
124683819|NCT01697579|448466054|FG002|Optional Extension-Cycles 2-6|Death|0|||
124683820|NCT01697579|448466055|FG003|Optional Extension-Cycles 2-6|Death|0|||
124683821|NCT01697579|448466056|FG004|Optional Extension-Cycles 2-6|Death|0|||
124683822|NCT01697579|448466057|FG005|Optional Extension-Cycles 2-6|Death|0|||
124683823|NCT01697579|448466058|FG006|Optional Extension-Cycles 2-6|Death|2|||
124683824|NCT01697579|448466052|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
124683825|NCT01697579|448466053|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
124683826|NCT01697579|448466054|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
124683827|NCT01697579|448466055|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
124683828|NCT01697579|448466056|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
124683829|NCT01697579|448466057|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
124683830|NCT01697579|448466058|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
124683831|NCT01697579|448466052|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
124683832|NCT01697579|448466053|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
124683833|NCT01697579|448466054|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
124683834|NCT01697579|448466055|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
124683835|NCT01697579|448466056|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
124439882|NCT00406653|447570869|FG006|Open-Label Period|Lost to Follow-up|6|||
124439883|NCT00406653|447570863|FG000|Open-Label Period|Withdrawal of Consent|0|||
124439884|NCT00406653|447570864|FG001|Open-Label Period|Withdrawal of Consent|0|||
124439885|NCT00406653|447570865|FG002|Open-Label Period|Withdrawal of Consent|0|||
124439886|NCT00406653|447570866|FG003|Open-Label Period|Withdrawal of Consent|0|||
124683836|NCT01697579|448466057|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
124683837|NCT01697579|448466058|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
124683838|NCT01697579|448466052|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
124683839|NCT01697579|448466053|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
124683840|NCT01697579|448466054|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
124683841|NCT01697579|448466055|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
124683842|NCT01697579|448466056|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
124683843|NCT01697579|448466057|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
124683844|NCT01697579|448466058|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
124683845|NCT01697579|448466052|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
124683846|NCT01697579|448466053|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
124683847|NCT01697579|448466054|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
124683848|NCT01697579|448466055|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
124683849|NCT01697579|448466056|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
124886003|NCT02293837|449206559|FG003|Overall Study|Lost to Follow-up|0|||
124886004|NCT02293837|449206556|FG000|Overall Study|Withdrawal by Subject|2|||
124886005|NCT02293837|449206557|FG001|Overall Study|Withdrawal by Subject|1|||
124886006|NCT02293837|449206558|FG002|Overall Study|Withdrawal by Subject|2|||
124886007|NCT02293837|449206559|FG003|Overall Study|Withdrawal by Subject|1|||
124886008|NCT02293837|449206556|FG000|Overall Study|COVID-19 Related|1|||
124886009|NCT02293837|449206557|FG001|Overall Study|COVID-19 Related|1|||
124886010|NCT02293837|449206558|FG002|Overall Study|COVID-19 Related|0|||
124886011|NCT02293837|449206559|FG003|Overall Study|COVID-19 Related|0|||
124886012|NCT02293837|449206556|FG000|Overall Study|Participant ill and could not be infused|0|||
124886013|NCT02293837|449206557|FG001|Overall Study|Participant ill and could not be infused|0|||
124886014|NCT02293837|449206558|FG002|Overall Study|Participant ill and could not be infused|1|||
124886015|NCT02293837|449206559|FG003|Overall Study|Participant ill and could not be infused|0|||
124886016|NCT04779242|449206560|FG000|Overall Study|Adverse Event|1|||
124886017|NCT04779242|449206561|FG001|Overall Study|Adverse Event|1|||
124886018|NCT04779242|449206560|FG000|Overall Study|Lost to Follow-up|2|||
124886019|NCT04779242|449206561|FG001|Overall Study|Lost to Follow-up|4|||
124886020|NCT04779242|449206560|FG000|Overall Study|Withdrawal by Subject|7|||
124886021|NCT04779242|449206561|FG001|Overall Study|Withdrawal by Subject|9|||
124886022|NCT04779242|449206560|FG000|Overall Study|Death|6|||
124886023|NCT04779242|449206561|FG001|Overall Study|Death|6|||
124886024|NCT04779242|449206560|FG000|Overall Study|COVID-19 related reasons|2|||
124886025|NCT04779242|449206561|FG001|Overall Study|COVID-19 related reasons|1|||
124886026|NCT04779242|449206560|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
124886027|NCT04779242|449206561|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
124886028|NCT04779242|449206560|FG000|Overall Study|Martial Law in Ukraine|2|||
124886029|NCT04779242|449206561|FG001|Overall Study|Martial Law in Ukraine|3|||
124886030|NCT03285113|449206564|FG000|Overall Study|Unable to implant leads|2|||
124886031|NCT00849680|449206567|FG000|Overall Study|Adverse Event|0|||
124886032|NCT00849680|449206568|FG001|Overall Study|Adverse Event|0|||
124886033|NCT00849680|449206569|FG002|Overall Study|Adverse Event|0|||
124886034|NCT00849680|449206570|FG003|Overall Study|Adverse Event|0|||
124886035|NCT00849680|449206571|FG004|Overall Study|Adverse Event|0|||
124886036|NCT00849680|449206572|FG005|Overall Study|Adverse Event|0|||
124886037|NCT00849680|449206573|FG006|Overall Study|Adverse Event|2|||
124886038|NCT00849680|449206574|FG007|Overall Study|Adverse Event|0|||
124886039|NCT00849680|449206567|FG000|Overall Study|Lost to Follow-up|7|||
124886040|NCT00849680|449206568|FG001|Overall Study|Lost to Follow-up|3|||
124886041|NCT00849680|449206569|FG002|Overall Study|Lost to Follow-up|12|||
124886042|NCT00849680|449206570|FG003|Overall Study|Lost to Follow-up|11|||
124886043|NCT00849680|449206571|FG004|Overall Study|Lost to Follow-up|8|||
124886044|NCT00849680|449206572|FG005|Overall Study|Lost to Follow-up|11|||
124886045|NCT00849680|449206573|FG006|Overall Study|Lost to Follow-up|12|||
124886046|NCT00849680|449206574|FG007|Overall Study|Lost to Follow-up|5|||
124439887|NCT00406653|447570867|FG004|Open-Label Period|Withdrawal of Consent|0|||
124439888|NCT00406653|447570868|FG005|Open-Label Period|Withdrawal of Consent|0|||
124439889|NCT00406653|447570869|FG006|Open-Label Period|Withdrawal of Consent|11|||
124439890|NCT00406653|447570863|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
124886047|NCT00849680|449206567|FG000|Overall Study|Subject moved|1|||
124886048|NCT00849680|449206568|FG001|Overall Study|Subject moved|0|||
124886049|NCT00849680|449206569|FG002|Overall Study|Subject moved|3|||
124886050|NCT00849680|449206570|FG003|Overall Study|Subject moved|1|||
124886051|NCT00849680|449206571|FG004|Overall Study|Subject moved|0|||
124439891|NCT00406653|447570864|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
124712001|NCT01343888|448570707|FG000|Overall Study|Lack of Efficacy|9|||
124886052|NCT00849680|449206572|FG005|Overall Study|Subject moved|2|||
124886053|NCT00849680|449206573|FG006|Overall Study|Subject moved|2|||
124886054|NCT00849680|449206574|FG007|Overall Study|Subject moved|2|||
124886055|NCT00849680|449206567|FG000|Overall Study|Withdrawal by Subject|2|||
124886056|NCT00849680|449206568|FG001|Overall Study|Withdrawal by Subject|0|||
124886057|NCT00849680|449206569|FG002|Overall Study|Withdrawal by Subject|0|||
124886058|NCT00849680|449206570|FG003|Overall Study|Withdrawal by Subject|2|||
124886059|NCT00849680|449206571|FG004|Overall Study|Withdrawal by Subject|2|||
124886060|NCT00849680|449206572|FG005|Overall Study|Withdrawal by Subject|2|||
124886061|NCT00849680|449206573|FG006|Overall Study|Withdrawal by Subject|1|||
124886062|NCT00849680|449206574|FG007|Overall Study|Withdrawal by Subject|1|||
124886063|NCT00849680|449206567|FG000|Overall Study|Subject unable to comply with protocol|1|||
124886064|NCT00849680|449206568|FG001|Overall Study|Subject unable to comply with protocol|0|||
124886065|NCT00849680|449206569|FG002|Overall Study|Subject unable to comply with protocol|0|||
124886066|NCT00849680|449206570|FG003|Overall Study|Subject unable to comply with protocol|0|||
124886067|NCT00849680|449206571|FG004|Overall Study|Subject unable to comply with protocol|0|||
124886068|NCT00849680|449206572|FG005|Overall Study|Subject unable to comply with protocol|0|||
124886069|NCT00849680|449206573|FG006|Overall Study|Subject unable to comply with protocol|0|||
124886070|NCT00849680|449206574|FG007|Overall Study|Subject unable to comply with protocol|0|||
124886071|NCT01461993|449206576|FG000|Overall Study|Withdrawal by Subject|60|||
124886072|NCT01461993|449206577|FG001|Overall Study|Withdrawal by Subject|53|||
124886073|NCT01461993|449206578|FG002|Overall Study|Withdrawal by Subject|16|||
124886074|NCT01461993|449206576|FG000|Overall Study|Lost to Follow-up|44|||
124886075|NCT01461993|449206577|FG001|Overall Study|Lost to Follow-up|48|||
124886076|NCT01461993|449206578|FG002|Overall Study|Lost to Follow-up|22|||
124886077|NCT01461993|449206576|FG000|Overall Study|Protocol Violation|10|||
124886078|NCT01461993|449206577|FG001|Overall Study|Protocol Violation|9|||
124886079|NCT01461993|449206578|FG002|Overall Study|Protocol Violation|7|||
124886080|NCT01461993|449206576|FG000|Overall Study|Adverse Event|9|||
124886081|NCT01461993|449206577|FG001|Overall Study|Adverse Event|11|||
124886082|NCT01461993|449206578|FG002|Overall Study|Adverse Event|3|||
124886083|NCT01461993|449206576|FG000|Overall Study|No longer met eligibility criteria|13|||
124886084|NCT01461993|449206577|FG001|Overall Study|No longer met eligibility criteria|18|||
124886085|NCT01461993|449206578|FG002|Overall Study|No longer met eligibility criteria|10|||
124886086|NCT01461993|449206576|FG000|Overall Study|Did not meet entrance criteria|2|||
124886087|NCT01461993|449206577|FG001|Overall Study|Did not meet entrance criteria|3|||
124886088|NCT01461993|449206578|FG002|Overall Study|Did not meet entrance criteria|0|||
124886089|NCT01461993|449206576|FG000|Overall Study|Other|13|||
124886090|NCT01461993|449206577|FG001|Overall Study|Other|15|||
124886091|NCT01461993|449206578|FG002|Overall Study|Other|6|||
124886092|NCT00219141|449206580|FG000|Overall Study|Adverse Event|4|||
124886093|NCT00219141|449206581|FG001|Overall Study|Adverse Event|10|||
124886094|NCT00219141|449206582|FG002|Overall Study|Adverse Event|5|||
124886095|NCT00219141|449206580|FG000|Overall Study|Lack of Efficacy|3|||
124886096|NCT00219141|449206581|FG001|Overall Study|Lack of Efficacy|2|||
124886097|NCT00219141|449206582|FG002|Overall Study|Lack of Efficacy|0|||
124886098|NCT00219141|449206580|FG000|Overall Study|Administrative problems|0|||
124886099|NCT00219141|449206581|FG001|Overall Study|Administrative problems|1|||
124886100|NCT00219141|449206582|FG002|Overall Study|Administrative problems|0|||
124886101|NCT00219141|449206580|FG000|Overall Study|Lost to Follow-up|2|||
124886102|NCT00219141|449206581|FG001|Overall Study|Lost to Follow-up|4|||
124886103|NCT00219141|449206582|FG002|Overall Study|Lost to Follow-up|1|||
124886104|NCT00219141|449206580|FG000|Overall Study|Protocol Violation|3|||
124886105|NCT00219141|449206581|FG001|Overall Study|Protocol Violation|1|||
124886106|NCT00219141|449206582|FG002|Overall Study|Protocol Violation|1|||
124886107|NCT00219141|449206580|FG000|Overall Study|Withdrawal by Subject|1|||
124886108|NCT00219141|449206581|FG001|Overall Study|Withdrawal by Subject|3|||
124886109|NCT00219141|449206582|FG002|Overall Study|Withdrawal by Subject|5|||
124886110|NCT00219141|449206580|FG000|Overall Study|Condition no longer requires study drug|1|||
124886111|NCT00219141|449206581|FG001|Overall Study|Condition no longer requires study drug|0|||
124886112|NCT00219141|449206582|FG002|Overall Study|Condition no longer requires study drug|0|||
124886113|NCT02066532|449206585|FG000|Phase II|Withdrawal by Subject|1|||
124886114|NCT02066532|449206586|FG001|Phase II|Withdrawal by Subject|0|||
124886115|NCT02066532|449206587|FG002|Phase II|Withdrawal by Subject|0|||
124886116|NCT02066532|449206588|FG003|Phase II|Withdrawal by Subject|0|||
124886117|NCT01263106|449206595|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
124886118|NCT01263106|449206596|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
124886119|NCT01680458|449206602|FG000|Overall Study|Protocol Violation|3|||
124886120|NCT00544544|449206609|FG000|Overall Study|Withdrawal by Subject|1|||
124886121|NCT00544544|449206609|FG000|Overall Study|Adverse Event|1|||
124886122|NCT00544544|449206609|FG000|Overall Study|Lost to Follow-up|1|||
124886123|NCT04318093|449206614|FG000|Overall Study|Adverse Event|2|||
124886124|NCT04318093|449206615|FG001|Overall Study|Adverse Event|2|||
124886125|NCT04318093|449206614|FG000|Overall Study|Participant withdrew consent|1|||
124886126|NCT04318093|449206615|FG001|Overall Study|Participant withdrew consent|0|||
124886127|NCT04318093|449206614|FG000|Overall Study|Other reasons|0|||
124886128|NCT04318093|449206615|FG001|Overall Study|Other reasons|1|||
124886129|NCT00127413|449206619|FG000|Overall Study|Lost to Follow-up|6|||
124886130|NCT00127413|449206620|FG001|Overall Study|Lost to Follow-up|4|||
124886131|NCT00127413|449206621|FG002|Overall Study|Lost to Follow-up|8|||
124886132|NCT00127413|449206622|FG003|Overall Study|Lost to Follow-up|2|||
124886133|NCT00547911|449206625|FG000|Overall Study|Adverse Event|0|||
124886134|NCT00547911|449206626|FG001|Overall Study|Adverse Event|0|||
124886135|NCT00547911|449206627|FG002|Overall Study|Adverse Event|0|||
124886136|NCT00547911|449206628|FG003|Overall Study|Adverse Event|1|||
124886137|NCT00547911|449206629|FG004|Overall Study|Adverse Event|0|||
124886138|NCT00547911|449206630|FG005|Overall Study|Adverse Event|0|||
124886139|NCT01644474|449206632|FG000|Overall Study|Poor compliance to protocol|1|||
124886140|NCT01644474|449206633|FG001|Overall Study|Poor compliance to protocol|0|||
124886141|NCT01644474|449206632|FG000|Overall Study|Consent withdrawn by participant|0|||
124886142|NCT01644474|449206633|FG001|Overall Study|Consent withdrawn by participant|1|||
124886143|NCT01644474|449206632|FG000|Overall Study|Participant moved|0|||
124886144|NCT01644474|449206633|FG001|Overall Study|Participant moved|1|||
124886145|NCT01644474|449206632|FG000|Overall Study|Adverse Event|4|||
124886146|NCT01644474|449206633|FG001|Overall Study|Adverse Event|5|||
124886147|NCT01644474|449206632|FG000|Overall Study|Site scheduling error|1|||
124886148|NCT01644474|449206633|FG001|Overall Study|Site scheduling error|1|||
124886149|NCT01644474|449206632|FG000|Overall Study|Protocol Violation|1|||
124886150|NCT01644474|449206633|FG001|Overall Study|Protocol Violation|0|||
124886151|NCT02023879|449206634|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
124886152|NCT02023879|449206635|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
124886153|NCT02023879|449206636|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
124886154|NCT02023879|449206634|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
124886155|NCT02023879|449206635|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
124886156|NCT02023879|449206636|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
124886157|NCT02023879|449206634|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
124886158|NCT02023879|449206635|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
124886159|NCT02023879|449206636|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
124886160|NCT02023879|449206634|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
124886161|NCT02023879|449206635|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
124886162|NCT02023879|449206636|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
124886163|NCT02023879|449206634|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
124886164|NCT02023879|449206635|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
124886165|NCT02023879|449206636|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
124886166|NCT02023879|449206634|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
124886167|NCT02023879|449206635|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
124886168|NCT02023879|449206636|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
124886169|NCT02023879|449206634|FG000|Extension Open Label Treatment|Adverse Event|1|||
124886170|NCT02023879|449206635|FG001|Extension Open Label Treatment|Adverse Event|7|||
124683850|NCT01697579|448466057|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
124683851|NCT01697579|448466058|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
124683852|NCT01697579|448466052|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
124683853|NCT01697579|448466053|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
124683854|NCT01697579|448466054|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
124683855|NCT01697579|448466055|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
124683856|NCT01697579|448466056|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
124683857|NCT01697579|448466057|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
124683858|NCT01697579|448466058|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
124683859|NCT01697579|448466052|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
124683860|NCT01697579|448466053|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
124712002|NCT01343888|448570708|FG001|Overall Study|Lack of Efficacy|9|||
124886171|NCT02023879|449206636|FG002|Extension Open Label Treatment|Adverse Event|3|||
124886172|NCT02023879|449206634|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
124886173|NCT02023879|449206635|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
124886174|NCT02023879|449206636|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
124886175|NCT02023879|449206634|FG000|Extension Open Label Treatment|Participant moved|1|||
124886176|NCT02023879|449206635|FG001|Extension Open Label Treatment|Participant moved|2|||
124886177|NCT02023879|449206636|FG002|Extension Open Label Treatment|Participant moved|0|||
124886178|NCT02023879|449206634|FG000|Extension Open Label Treatment|Other than specified above|2|||
124886179|NCT02023879|449206635|FG001|Extension Open Label Treatment|Other than specified above|7|||
124886180|NCT02023879|449206636|FG002|Extension Open Label Treatment|Other than specified above|2|||
124886181|NCT02044458|449206640|FG000|Overall Study|Protocol Violation|3|||
124886182|NCT02044458|449206641|FG001|Overall Study|Protocol Violation|8|||
124886183|NCT03363659|449206642|FG000|Overall Study|Adverse Event|1|||
124886184|NCT03363659|449206642|FG000|Overall Study|Screen fail|1|||
124886185|NCT03363659|449206642|FG000|Overall Study|Withdrawal by Subject|1|||
124886186|NCT03872388|449206643|FG000|Overall Study|Disease Progression|0|||
124886187|NCT03872388|449206644|FG001|Overall Study|Disease Progression|0|||
124886188|NCT03872388|449206645|FG002|Overall Study|Disease Progression|0|||
124886189|NCT03872388|449206646|FG003|Overall Study|Disease Progression|0|||
124886190|NCT03872388|449206647|FG004|Overall Study|Disease Progression|0|||
124886191|NCT03872388|449206648|FG005|Overall Study|Disease Progression|0|||
124886192|NCT03872388|449206649|FG006|Overall Study|Disease Progression|1|||
124886193|NCT03872388|449206650|FG007|Overall Study|Disease Progression|1|||
124886194|NCT01040780|449209495|FG000|Overall Study|Protocol Violation|1|||
124886195|NCT01040780|449209496|FG001|Overall Study|Protocol Violation|3|||
124886196|NCT00802737|449209497|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
124886197|NCT00802737|449209498|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
124886198|NCT00802737|449209499|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
124886199|NCT00802737|449209497|FG000|Overall Study|Death|6|||
124886200|NCT00802737|449209498|FG001|Overall Study|Death|5|||
124886201|NCT00802737|449209499|FG002|Overall Study|Death|1|||
124886202|NCT00802737|449209497|FG000|Overall Study|Adverse Event|1|||
124886203|NCT00802737|449209498|FG001|Overall Study|Adverse Event|0|||
124886204|NCT00802737|449209499|FG002|Overall Study|Adverse Event|0|||
124886205|NCT00802737|449209497|FG000|Overall Study|Received Prohibited Therapy|1|||
124886206|NCT00802737|449209498|FG001|Overall Study|Received Prohibited Therapy|0|||
124886207|NCT00802737|449209499|FG002|Overall Study|Received Prohibited Therapy|0|||
124886208|NCT00802737|449209497|FG000|Overall Study|Ongoing CLL-Treatment|0|||
124886209|NCT00802737|449209498|FG001|Overall Study|Ongoing CLL-Treatment|1|||
124886210|NCT00802737|449209499|FG002|Overall Study|Ongoing CLL-Treatment|0|||
124886211|NCT00802737|449209497|FG000|Overall Study|Participant too Unwell|0|||
124886212|NCT00802737|449209498|FG001|Overall Study|Participant too Unwell|2|||
124886213|NCT00802737|449209499|FG002|Overall Study|Participant too Unwell|0|||
124886214|NCT03864926|449209507|FG000|Overall Study|Death|0|||
124886215|NCT03864926|449209508|FG001|Overall Study|Death|2|||
124886216|NCT00445601|449209509|FG000|Overall Study|Withdrawal by Subject|11|||
124886217|NCT00445601|449209510|FG001|Overall Study|Withdrawal by Subject|11|||
124886218|NCT00445601|449209509|FG000|Overall Study|TURBT Complication|12|||
124886219|NCT00445601|449209510|FG001|Overall Study|TURBT Complication|8|||
124886220|NCT00445601|449209509|FG000|Overall Study|Incorrect Disease Status|6|||
124886221|NCT00445601|449209510|FG001|Overall Study|Incorrect Disease Status|6|||
124886222|NCT00445601|449209509|FG000|Overall Study|Drug Delivery Issue|2|||
124886223|NCT00445601|449209510|FG001|Overall Study|Drug Delivery Issue|2|||
124886224|NCT00445601|449209509|FG000|Overall Study|Adverse Event|2|||
124886225|NCT00445601|449209510|FG001|Overall Study|Adverse Event|0|||
124886226|NCT00445601|449209509|FG000|Overall Study|Death prior to TURBT|0|||
124886227|NCT00445601|449209510|FG001|Overall Study|Death prior to TURBT|1|||
124886228|NCT01625910|449209517|FG000|Overall Study|Lost to Follow-up|3|||
124886229|NCT01625910|449209518|FG001|Overall Study|Lost to Follow-up|4|||
124886230|NCT02959138|449209519|FG000|Overall Study|Enrolled but Never Treated|0|||
124886231|NCT02959138|449209520|FG001|Overall Study|Enrolled but Never Treated|1|||
124886232|NCT02959138|449209521|FG002|Overall Study|Enrolled but Never Treated|0|||
124886233|NCT02391038|449209522|FG000|Overall Study|Progressive disease|3|||
124886234|NCT02391038|449209523|FG001|Overall Study|Progressive disease|3|||
124886235|NCT02391038|449209524|FG002|Overall Study|Progressive disease|6|||
124886236|NCT01681368|449209533|FG000|Overall Study|Refused further treatment|1|||
124886237|NCT01681368|449209533|FG000|Overall Study|Refused further follow up|1|||
124886238|NCT01189890|449209534|FG000|Overall Study|Adverse Event|3|||
124886239|NCT01189890|449209535|FG001|Overall Study|Adverse Event|4|||
124439892|NCT00406653|447570865|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
124439893|NCT00406653|447570866|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
124439894|NCT00406653|447570867|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
124439895|NCT00406653|447570868|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
124439896|NCT00406653|447570869|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
124439897|NCT00406653|447570863|FG000|Open-Label Period|Pregnancy|0|||
124758691|NCT00543387|448739842|FG007|Panel 1 + Panel 2|Physician Decision|1|||
124439898|NCT00406653|447570864|FG001|Open-Label Period|Pregnancy|0|||
124439899|NCT00406653|447570865|FG002|Open-Label Period|Pregnancy|0|||
124886240|NCT01189890|449209534|FG000|Overall Study|Lack of Efficacy|7|||
124886241|NCT01189890|449209535|FG001|Overall Study|Lack of Efficacy|2|||
124886242|NCT01189890|449209534|FG000|Overall Study|Lost to Follow-up|1|||
124886243|NCT01189890|449209535|FG001|Overall Study|Lost to Follow-up|7|||
124886244|NCT01189890|449209534|FG000|Overall Study|Protocol Violation|1|||
124886245|NCT01189890|449209535|FG001|Overall Study|Protocol Violation|5|||
124439900|NCT00406653|447570866|FG003|Open-Label Period|Pregnancy|0|||
124439901|NCT00406653|447570867|FG004|Open-Label Period|Pregnancy|0|||
124886246|NCT01189890|449209534|FG000|Overall Study|Withdrawal by Subject|15|||
124886247|NCT01189890|449209535|FG001|Overall Study|Withdrawal by Subject|11|||
124886248|NCT01189890|449209534|FG000|Overall Study|Non Compliance|0|||
124886249|NCT01189890|449209535|FG001|Overall Study|Non Compliance|1|||
124886250|NCT01189890|449209534|FG000|Overall Study|Physician Decision|5|||
124886251|NCT01189890|449209535|FG001|Overall Study|Physician Decision|4|||
124886252|NCT01189890|449209534|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
124886253|NCT01189890|449209535|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
124886254|NCT00593554|449209536|FG000|Overall Study|Death|1|||
124886255|NCT00593554|449209537|FG001|Overall Study|Death|2|||
124886256|NCT00593554|449209536|FG000|Overall Study|Physician Decision|0|||
124886257|NCT00593554|449209537|FG001|Overall Study|Physician Decision|1|||
124886258|NCT00593554|449209536|FG000|Overall Study|Withdrawal by Subject|1|||
124886259|NCT00593554|449209537|FG001|Overall Study|Withdrawal by Subject|0|||
124886260|NCT00593554|449209536|FG000|Overall Study|Disease Progression|1|||
124886261|NCT00593554|449209537|FG001|Overall Study|Disease Progression|2|||
124886262|NCT02254421|449209540|FG000|Overall Study|Randomized but Not Treated|1|||
124886263|NCT02254421|449209541|FG001|Overall Study|Randomized but Not Treated|0|||
124886264|NCT02254421|449209540|FG000|Overall Study|Death|0|||
124886265|NCT02254421|449209541|FG001|Overall Study|Death|2|||
124886266|NCT02254421|449209540|FG000|Overall Study|Withdrew Consent|1|||
124886267|NCT02254421|449209541|FG001|Overall Study|Withdrew Consent|1|||
124886268|NCT00839917|449209544|FG000|Overall Study|Lost to Follow-up|1|||
124886269|NCT00839917|449209545|FG001|Overall Study|Lost to Follow-up|0|||
124886270|NCT00839917|449209544|FG000|Overall Study|Did not receive vaccine|0|||
124886271|NCT00839917|449209545|FG001|Overall Study|Did not receive vaccine|1|||
124886272|NCT01129336|449209546|FG000|Overall Study|Protocol Violation|1|||
124886273|NCT01129336|449209547|FG001|Overall Study|Protocol Violation|0|||
124886274|NCT01129336|449209546|FG000|Overall Study|Disease Progression|1|||
124886275|NCT01129336|449209547|FG001|Overall Study|Disease Progression|4|||
124886276|NCT01129336|449209546|FG000|Overall Study|Lost to Follow-up|1|||
124886277|NCT01129336|449209547|FG001|Overall Study|Lost to Follow-up|0|||
124886278|NCT01129336|449209546|FG000|Overall Study|Withdrawal by Subject|7|||
124886279|NCT01129336|449209547|FG001|Overall Study|Withdrawal by Subject|4|||
124886280|NCT01129336|449209546|FG000|Overall Study|Adverse Event|0|||
124886281|NCT01129336|449209547|FG001|Overall Study|Adverse Event|1|||
124886282|NCT01129336|449209546|FG000|Overall Study|Missing Study Completion Status|2|||
124886283|NCT01129336|449209547|FG001|Overall Study|Missing Study Completion Status|3|||
124886284|NCT01129336|449209546|FG000|Overall Study|Death|0|||
124886285|NCT01129336|449209547|FG001|Overall Study|Death|4|||
124886286|NCT00867490|449209548|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
124886287|NCT00867490|449209548|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
124886288|NCT00867490|449209548|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
124886289|NCT00867490|449209548|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
124886290|NCT00867490|449209548|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
124886291|NCT03354637|449209553|FG000|Double-blind Period|Protocol Violation|2|||
124886292|NCT03354637|449209554|FG001|Double-blind Period|Protocol Violation|0|||
124886293|NCT03354637|449209555|FG002|Double-blind Period|Protocol Violation|0|||
124886294|NCT03354637|449209553|FG000|Double-blind Period|Adverse Event|1|||
124886295|NCT03354637|449209554|FG001|Double-blind Period|Adverse Event|2|||
124439902|NCT00406653|447570868|FG005|Open-Label Period|Pregnancy|0|||
124439903|NCT00406653|447570869|FG006|Open-Label Period|Pregnancy|2|||
124683861|NCT01697579|448466054|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
124683862|NCT01697579|448466055|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
124683863|NCT01697579|448466056|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
124683864|NCT01697579|448466057|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
124683865|NCT01697579|448466058|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
124683866|NCT01697579|448466052|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
124683867|NCT01697579|448466053|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
124683868|NCT01697579|448466054|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
124683869|NCT01697579|448466055|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
124886296|NCT03354637|449209555|FG002|Double-blind Period|Adverse Event|0|||
124439904|NCT00406653|447570863|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
124439905|NCT00406653|447570864|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
124683870|NCT01697579|448466056|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
124683871|NCT01697579|448466057|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
124683872|NCT01697579|448466058|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
124886297|NCT03354637|449209553|FG000|Double-blind Period|Lost to Follow-up|3|||
124886298|NCT03354637|449209554|FG001|Double-blind Period|Lost to Follow-up|4|||
124886299|NCT03354637|449209555|FG002|Double-blind Period|Lost to Follow-up|3|||
124886300|NCT03354637|449209553|FG000|Double-blind Period|Withdrawal by Subject|10|||
124886301|NCT03354637|449209554|FG001|Double-blind Period|Withdrawal by Subject|6|||
124886302|NCT03354637|449209555|FG002|Double-blind Period|Withdrawal by Subject|4|||
124886303|NCT03354637|449209553|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
124886304|NCT03354637|449209554|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
124886305|NCT03354637|449209555|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
124886306|NCT03354637|449209553|FG000|Open Label Extension|Adverse Event|0|||
124886307|NCT03354637|449209554|FG001|Open Label Extension|Adverse Event|0|||
124886308|NCT03354637|449209555|FG002|Open Label Extension|Adverse Event|1|||
124886309|NCT03354637|449209553|FG000|Open Label Extension|Lost to Follow-up|0|||
124683873|NCT01697579|448466052|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
124683874|NCT01697579|448466053|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
124683875|NCT01697579|448466054|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
124683876|NCT01697579|448466055|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
124683877|NCT01697579|448466056|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
124683878|NCT01697579|448466057|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
124683879|NCT01697579|448466058|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
124683880|NCT01697579|448466052|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
124683881|NCT01697579|448466053|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
124683882|NCT01697579|448466054|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
124683883|NCT01697579|448466055|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
124683884|NCT01697579|448466056|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
124683885|NCT01697579|448466057|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
124683886|NCT01697579|448466058|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
124683887|NCT01697579|448466052|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
124886310|NCT03354637|449209554|FG001|Open Label Extension|Lost to Follow-up|0|||
124886311|NCT03354637|449209555|FG002|Open Label Extension|Lost to Follow-up|2|||
124886312|NCT03354637|449209553|FG000|Open Label Extension|Withdrawal by Subject|0|||
124886313|NCT03354637|449209554|FG001|Open Label Extension|Withdrawal by Subject|0|||
124886314|NCT03354637|449209555|FG002|Open Label Extension|Withdrawal by Subject|5|||
124886315|NCT03354637|449209553|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
124683888|NCT01697579|448466053|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
124683889|NCT01697579|448466054|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
124683890|NCT01697579|448466055|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
124683891|NCT01697579|448466056|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
124683892|NCT01697579|448466057|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
124683893|NCT01697579|448466058|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
124683894|NCT01697579|448466052|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
124683895|NCT01697579|448466053|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
124683896|NCT01697579|448466054|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
124886316|NCT03354637|449209554|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
124886317|NCT03354637|449209555|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
124683897|NCT01697579|448466055|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
124683898|NCT01697579|448466056|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
124683899|NCT01697579|448466057|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
124683900|NCT01697579|448466058|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
124683901|NCT01697579|448466052|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
124683902|NCT01697579|448466053|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
124683903|NCT01697579|448466054|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
124683904|NCT01697579|448466055|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
124683905|NCT01697579|448466056|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
124683906|NCT01697579|448466057|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
124683907|NCT01697579|448466058|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
124683908|NCT01044498|448466061|FG000|Overall Study|Withdrew consent|1|||
124683909|NCT01044498|448466062|FG001|Overall Study|Withdrew consent|1|||
124683910|NCT01044498|448466061|FG000|Overall Study|Adverse Event|1|||
124683911|NCT01044498|448466062|FG001|Overall Study|Adverse Event|1|||
124683912|NCT01044498|448466061|FG000|Overall Study|Other|1|||
124683913|NCT01044498|448466062|FG001|Overall Study|Other|0|||
124683914|NCT06001866|448466063|FG000|Overall Study|Withdrawal by Subject|0|||
124683915|NCT06001866|448466064|FG001|Overall Study|Withdrawal by Subject|2|||
124683916|NCT06001866|448466063|FG000|Overall Study|Protocol Violation|0|||
124683917|NCT06001866|448466064|FG001|Overall Study|Protocol Violation|2|||
124683918|NCT02903914|448466065|FG000|Overall Study|Adverse Event|0|||
124683919|NCT02903914|448466066|FG001|Overall Study|Adverse Event|0|||
124886318|NCT03354637|449209553|FG000|Open Label Extension|Subject Noncompliance|0|||
124683920|NCT02903914|448466067|FG002|Overall Study|Adverse Event|1|||
124683921|NCT02903914|448466068|FG003|Overall Study|Adverse Event|0|||
124683922|NCT02903914|448466069|FG004|Overall Study|Adverse Event|0|||
124683923|NCT02903914|448466070|FG005|Overall Study|Adverse Event|0|||
124683924|NCT02903914|448466071|FG006|Overall Study|Adverse Event|2|||
124683925|NCT02903914|448466072|FG007|Overall Study|Adverse Event|0|||
124683926|NCT02903914|448466065|FG000|Overall Study|Withdrawal by Subject|3|||
124683927|NCT02903914|448466066|FG001|Overall Study|Withdrawal by Subject|1|||
124683928|NCT02903914|448466067|FG002|Overall Study|Withdrawal by Subject|28|||
124683929|NCT02903914|448466068|FG003|Overall Study|Withdrawal by Subject|0|||
124683930|NCT02903914|448466069|FG004|Overall Study|Withdrawal by Subject|1|||
124683931|NCT02903914|448466070|FG005|Overall Study|Withdrawal by Subject|2|||
124683932|NCT02903914|448466071|FG006|Overall Study|Withdrawal by Subject|12|||
124683933|NCT02903914|448466072|FG007|Overall Study|Withdrawal by Subject|0|||
124683934|NCT02903914|448466065|FG000|Overall Study|Progressive Disease|1|||
124683935|NCT02903914|448466066|FG001|Overall Study|Progressive Disease|0|||
124683936|NCT02903914|448466067|FG002|Overall Study|Progressive Disease|4|||
124683937|NCT02903914|448466068|FG003|Overall Study|Progressive Disease|0|||
124683938|NCT02903914|448466069|FG004|Overall Study|Progressive Disease|0|||
124683939|NCT02903914|448466070|FG005|Overall Study|Progressive Disease|0|||
124683940|NCT02903914|448466071|FG006|Overall Study|Progressive Disease|2|||
124683941|NCT02903914|448466072|FG007|Overall Study|Progressive Disease|0|||
124683942|NCT02903914|448466065|FG000|Overall Study|Death|0|||
124683943|NCT02903914|448466066|FG001|Overall Study|Death|0|||
124683944|NCT02903914|448466067|FG002|Overall Study|Death|9|||
124683945|NCT02903914|448466068|FG003|Overall Study|Death|0|||
124683946|NCT02903914|448466069|FG004|Overall Study|Death|1|||
124683947|NCT02903914|448466070|FG005|Overall Study|Death|3|||
124683948|NCT02903914|448466071|FG006|Overall Study|Death|24|||
124886319|NCT03354637|449209554|FG001|Open Label Extension|Subject Noncompliance|0|||
124886320|NCT03354637|449209555|FG002|Open Label Extension|Subject Noncompliance|1|||
124886321|NCT03354637|449209553|FG000|Open Label Extension|Lack of Efficacy|0|||
124886322|NCT03354637|449209554|FG001|Open Label Extension|Lack of Efficacy|0|||
124886323|NCT03354637|449209555|FG002|Open Label Extension|Lack of Efficacy|1|||
124886324|NCT03354637|449209553|FG000|Open Label Extension|Physician Decision|0|||
124886325|NCT03354637|449209554|FG001|Open Label Extension|Physician Decision|0|||
124886326|NCT03354637|449209555|FG002|Open Label Extension|Physician Decision|1|||
124886327|NCT02726399|449209556|FG000|Overall Study|Participant Non-Compliance|1|||
124886328|NCT02726399|449209556|FG000|Overall Study|Adverse Event|2|||
124886329|NCT02726399|449209556|FG000|Overall Study|Progression of disease|4|||
124886330|NCT02564055|449209557|FG000|Overall Study|Adverse Event|1|||
124886331|NCT02564055|449209558|FG001|Overall Study|Adverse Event|0|||
124886332|NCT02564055|449209559|FG002|Overall Study|Adverse Event|4|||
124886333|NCT02564055|449209560|FG003|Overall Study|Adverse Event|1|||
124886334|NCT02564055|449209561|FG004|Overall Study|Adverse Event|4|||
124886335|NCT02564055|449209562|FG005|Overall Study|Adverse Event|1|||
124886336|NCT02564055|449209557|FG000|Overall Study|Protocol Violation|1|||
124683949|NCT02903914|448466072|FG007|Overall Study|Death|2|||
124683950|NCT02903914|448466065|FG000|Overall Study|Lost to Follow-up|0|||
124683951|NCT02903914|448466066|FG001|Overall Study|Lost to Follow-up|1|||
124683952|NCT02903914|448466067|FG002|Overall Study|Lost to Follow-up|0|||
124683953|NCT02903914|448466068|FG003|Overall Study|Lost to Follow-up|0|||
124683954|NCT02903914|448466069|FG004|Overall Study|Lost to Follow-up|2|||
124683955|NCT02903914|448466070|FG005|Overall Study|Lost to Follow-up|0|||
124886337|NCT02564055|449209558|FG001|Overall Study|Protocol Violation|0|||
124886338|NCT02564055|449209559|FG002|Overall Study|Protocol Violation|0|||
124886339|NCT02564055|449209560|FG003|Overall Study|Protocol Violation|0|||
124683956|NCT02903914|448466071|FG006|Overall Study|Lost to Follow-up|1|||
124683957|NCT02903914|448466072|FG007|Overall Study|Lost to Follow-up|0|||
124886340|NCT02564055|449209561|FG004|Overall Study|Protocol Violation|0|||
124886341|NCT02564055|449209562|FG005|Overall Study|Protocol Violation|0|||
124886342|NCT02564055|449209557|FG000|Overall Study|Reached stopping criteria|0|||
124886343|NCT02564055|449209558|FG001|Overall Study|Reached stopping criteria|0|||
124886344|NCT02564055|449209559|FG002|Overall Study|Reached stopping criteria|0|||
124886345|NCT02564055|449209560|FG003|Overall Study|Reached stopping criteria|0|||
124886346|NCT02564055|449209561|FG004|Overall Study|Reached stopping criteria|0|||
124886347|NCT02564055|449209562|FG005|Overall Study|Reached stopping criteria|1|||
124886348|NCT02564055|449209557|FG000|Overall Study|Lost to Follow-up|0|||
124886349|NCT02564055|449209558|FG001|Overall Study|Lost to Follow-up|1|||
124886350|NCT02564055|449209559|FG002|Overall Study|Lost to Follow-up|4|||
124886351|NCT02564055|449209560|FG003|Overall Study|Lost to Follow-up|2|||
124886352|NCT02564055|449209561|FG004|Overall Study|Lost to Follow-up|1|||
124886353|NCT02564055|449209562|FG005|Overall Study|Lost to Follow-up|0|||
124886354|NCT02564055|449209557|FG000|Overall Study|Physician Decision|0|||
124886355|NCT02564055|449209558|FG001|Overall Study|Physician Decision|0|||
124886356|NCT02564055|449209559|FG002|Overall Study|Physician Decision|1|||
124886357|NCT02564055|449209560|FG003|Overall Study|Physician Decision|0|||
124886358|NCT02564055|449209561|FG004|Overall Study|Physician Decision|0|||
124886359|NCT02564055|449209562|FG005|Overall Study|Physician Decision|0|||
124886360|NCT02564055|449209557|FG000|Overall Study|Withdrawal by Subject|4|||
124886361|NCT02564055|449209558|FG001|Overall Study|Withdrawal by Subject|4|||
124886362|NCT02564055|449209559|FG002|Overall Study|Withdrawal by Subject|3|||
124886363|NCT02564055|449209560|FG003|Overall Study|Withdrawal by Subject|3|||
124886364|NCT02564055|449209561|FG004|Overall Study|Withdrawal by Subject|10|||
124886365|NCT02564055|449209562|FG005|Overall Study|Withdrawal by Subject|10|||
124886366|NCT04747275|449209563|FG000|Overall Study|Study terminated|0|||
124886367|NCT04747275|449209564|FG001|Overall Study|Study terminated|1|||
124886368|NCT00531011|449209566|FG000|Overall Study|Withdrawal by Subject|2|||
124886369|NCT00531011|449209567|FG001|Overall Study|Withdrawal by Subject|4|||
124886370|NCT00531011|449209566|FG000|Overall Study|Death|1|||
124886371|NCT00531011|449209567|FG001|Overall Study|Death|0|||
124683958|NCT02903914|448466065|FG000|Overall Study|Physician Decision|0|||
124683959|NCT02903914|448466066|FG001|Overall Study|Physician Decision|0|||
124683960|NCT02903914|448466067|FG002|Overall Study|Physician Decision|1|||
124683961|NCT02903914|448466068|FG003|Overall Study|Physician Decision|0|||
124683962|NCT02903914|448466069|FG004|Overall Study|Physician Decision|0|||
124683963|NCT02903914|448466070|FG005|Overall Study|Physician Decision|0|||
124683964|NCT02903914|448466071|FG006|Overall Study|Physician Decision|1|||
124683965|NCT02903914|448466072|FG007|Overall Study|Physician Decision|0|||
124439906|NCT00406653|447570865|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
124439907|NCT00406653|447570866|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
124683966|NCT02903914|448466065|FG000|Overall Study|Symptomatic Deterioration|0|||
124683967|NCT02903914|448466066|FG001|Overall Study|Symptomatic Deterioration|0|||
124683968|NCT02903914|448466067|FG002|Overall Study|Symptomatic Deterioration|1|||
124683969|NCT02903914|448466068|FG003|Overall Study|Symptomatic Deterioration|0|||
124683970|NCT02903914|448466069|FG004|Overall Study|Symptomatic Deterioration|0|||
124683971|NCT02903914|448466070|FG005|Overall Study|Symptomatic Deterioration|0|||
124683972|NCT02903914|448466071|FG006|Overall Study|Symptomatic Deterioration|0|||
124683973|NCT02903914|448466072|FG007|Overall Study|Symptomatic Deterioration|0|||
124683974|NCT02903914|448466065|FG000|Overall Study|New Cancer Therapy|2|||
124683975|NCT02903914|448466066|FG001|Overall Study|New Cancer Therapy|2|||
124886372|NCT00531011|449209566|FG000|Overall Study|Lost to Follow-up|1|||
124886373|NCT00531011|449209567|FG001|Overall Study|Lost to Follow-up|0|||
124886374|NCT00531011|449209566|FG000|Overall Study|Physician Decision|0|||
124886375|NCT00531011|449209567|FG001|Overall Study|Physician Decision|3|||
124886376|NCT03268590|449209568|FG000|Overall Study|Previously unknown exclusion criteria|1|||
124886377|NCT00919893|449209575|FG000|Overall Study|Protocol Violation|19|||
124886378|NCT00919893|449209576|FG001|Overall Study|Protocol Violation|9|||
124886379|NCT01375959|449209577|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
124886380|NCT01375959|449209578|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
124886381|NCT01375959|449209577|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
124439908|NCT00406653|447570867|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
124439909|NCT00406653|447570868|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
124439910|NCT00406653|447570869|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
124439911|NCT00406653|447570863|FG000|Open-Label Period|Declined participation but followup done|0|||
124439912|NCT00406653|447570864|FG001|Open-Label Period|Declined participation but followup done|0|||
124439913|NCT00406653|447570865|FG002|Open-Label Period|Declined participation but followup done|0|||
124683976|NCT02903914|448466067|FG002|Overall Study|New Cancer Therapy|21|||
124683977|NCT02903914|448466068|FG003|Overall Study|New Cancer Therapy|4|||
124683978|NCT02903914|448466069|FG004|Overall Study|New Cancer Therapy|3|||
124683979|NCT02903914|448466070|FG005|Overall Study|New Cancer Therapy|6|||
124683980|NCT02903914|448466071|FG006|Overall Study|New Cancer Therapy|56|||
124683981|NCT02903914|448466072|FG007|Overall Study|New Cancer Therapy|3|||
124683982|NCT02903914|448466065|FG000|Overall Study|Didn't Return to Site|1|||
124683983|NCT02903914|448466066|FG001|Overall Study|Didn't Return to Site|0|||
124683984|NCT02903914|448466067|FG002|Overall Study|Didn't Return to Site|1|||
124683985|NCT02903914|448466068|FG003|Overall Study|Didn't Return to Site|1|||
124683986|NCT02903914|448466069|FG004|Overall Study|Didn't Return to Site|0|||
124683987|NCT02903914|448466070|FG005|Overall Study|Didn't Return to Site|0|||
124683988|NCT02903914|448466071|FG006|Overall Study|Didn't Return to Site|2|||
124683989|NCT02903914|448466072|FG007|Overall Study|Didn't Return to Site|0|||
124683990|NCT02903914|448466065|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
124683991|NCT02903914|448466066|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
124683992|NCT02903914|448466067|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
124683993|NCT02903914|448466068|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
124683994|NCT02903914|448466069|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
124886382|NCT01375959|449209578|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
124886383|NCT01375959|449209577|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
124886384|NCT01375959|449209578|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
124439914|NCT00406653|447570866|FG003|Open-Label Period|Declined participation but followup done|0|||
124886385|NCT04254679|449209579|FG000|Overall Study|Protocol Violation|1|||
124886386|NCT04254679|449209580|FG001|Overall Study|Protocol Violation|1|||
124439915|NCT00406653|447570867|FG004|Open-Label Period|Declined participation but followup done|0|||
124439916|NCT00406653|447570868|FG005|Open-Label Period|Declined participation but followup done|0|||
124683995|NCT02903914|448466070|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
124683996|NCT02903914|448466071|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
124683997|NCT02903914|448466072|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
124683998|NCT02903914|448466065|FG000|Overall Study|Follow-up Did Not Occur|0|||
124683999|NCT02903914|448466066|FG001|Overall Study|Follow-up Did Not Occur|1|||
124684000|NCT02903914|448466067|FG002|Overall Study|Follow-up Did Not Occur|1|||
124684001|NCT02903914|448466068|FG003|Overall Study|Follow-up Did Not Occur|0|||
124684002|NCT02903914|448466069|FG004|Overall Study|Follow-up Did Not Occur|2|||
124684003|NCT02903914|448466070|FG005|Overall Study|Follow-up Did Not Occur|0|||
124684004|NCT02903914|448466071|FG006|Overall Study|Follow-up Did Not Occur|8|||
124886387|NCT04254679|449209579|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
124886388|NCT04254679|449209580|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
124886389|NCT00794820|449209581|FG000|Overall Study|Adverse Event|11|||
124886390|NCT00794820|449209581|FG000|Overall Study|Secondary Malignancies|2|||
124886391|NCT00794820|449209581|FG000|Overall Study|Resistant Disease|2|||
124886392|NCT00794820|449209581|FG000|Overall Study|Ineligible/Screen Failure|1|||
124886393|NCT03537261|449209585|FG000|Overall Study|Lost to Follow-up|4|||
124886394|NCT03537261|449209586|FG001|Overall Study|Lost to Follow-up|5|||
124886395|NCT03537261|449209585|FG000|Overall Study|Withdrawal by Subject|4|||
124886396|NCT03537261|449209586|FG001|Overall Study|Withdrawal by Subject|6|||
124886397|NCT03537261|449209585|FG000|Overall Study|Did not return study questionnaires|0|||
124886398|NCT03537261|449209586|FG001|Overall Study|Did not return study questionnaires|1|||
124886399|NCT03237013|449209587|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
124886400|NCT03237013|449209588|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
124886401|NCT03237013|449209589|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
124886402|NCT00502996|449209592|FG000|Overall Study|Lost to Follow-up|9|||
124886403|NCT00502996|449209592|FG000|Overall Study|Protocol Violation|2|||
124886404|NCT00502996|449209592|FG000|Overall Study|Treatment failure|25|||
124886405|NCT00502996|449209592|FG000|Overall Study|Withdrawal Informed Consent|6|||
124439917|NCT00406653|447570869|FG006|Open-Label Period|Declined participation but followup done|8|||
124439918|NCT00406653|447570863|FG000|Open-Label Period|Discontinued by Sponsor|0|||
124439919|NCT00406653|447570864|FG001|Open-Label Period|Discontinued by Sponsor|0|||
124439920|NCT00406653|447570865|FG002|Open-Label Period|Discontinued by Sponsor|0|||
124439921|NCT00406653|447570866|FG003|Open-Label Period|Discontinued by Sponsor|0|||
124439922|NCT00406653|447570867|FG004|Open-Label Period|Discontinued by Sponsor|0|||
124439923|NCT00406653|447570868|FG005|Open-Label Period|Discontinued by Sponsor|0|||
124439924|NCT00406653|447570869|FG006|Open-Label Period|Discontinued by Sponsor|1|||
124439925|NCT00406653|447570863|FG000|Open-Label Period|Refused followup|0|||
124439926|NCT00406653|447570864|FG001|Open-Label Period|Refused followup|0|||
124684005|NCT02903914|448466072|FG007|Overall Study|Follow-up Did Not Occur|0|||
124439927|NCT00406653|447570865|FG002|Open-Label Period|Refused followup|0|||
124439928|NCT00406653|447570866|FG003|Open-Label Period|Refused followup|0|||
124439929|NCT00406653|447570867|FG004|Open-Label Period|Refused followup|0|||
124439930|NCT00406653|447570868|FG005|Open-Label Period|Refused followup|0|||
124439931|NCT00406653|447570869|FG006|Open-Label Period|Refused followup|1|||
124439932|NCT00818649|447570870|FG000|Overall Study|Declining performance status|2|||
124439933|NCT00818649|447570870|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
124439934|NCT00818649|447570870|FG000|Overall Study|Adverse Event|1|||
124439935|NCT03513588|447570871|FG000|Overall Study|Lost to Follow-up|0|||
124439936|NCT03513588|447570872|FG001|Overall Study|Lost to Follow-up|1|||
124439937|NCT03513588|447570873|FG002|Overall Study|Lost to Follow-up|1|||
124439938|NCT03513588|447570871|FG000|Overall Study|Study dosing paused by sponsor|1|||
124439939|NCT03513588|447570872|FG001|Overall Study|Study dosing paused by sponsor|1|||
124439940|NCT03513588|447570873|FG002|Overall Study|Study dosing paused by sponsor|0|||
124439941|NCT03513588|447570871|FG000|Overall Study|Death|0|||
124439942|NCT03513588|447570872|FG001|Overall Study|Death|0|||
124439943|NCT03513588|447570873|FG002|Overall Study|Death|1|||
124439944|NCT00940108|447570874|FG000|Overall Study|Adverse Event|2|||
124439945|NCT00940108|447570875|FG001|Overall Study|Adverse Event|4|||
124439946|NCT00940108|447570876|FG002|Overall Study|Adverse Event|0|||
124439947|NCT00940108|447570877|FG003|Overall Study|Adverse Event|2|||
124439948|NCT00940108|447570874|FG000|Overall Study|Withdrew Consent|2|||
124439949|NCT00940108|447570875|FG001|Overall Study|Withdrew Consent|1|||
124439950|NCT00940108|447570876|FG002|Overall Study|Withdrew Consent|0|||
124439951|NCT00940108|447570877|FG003|Overall Study|Withdrew Consent|1|||
124684006|NCT02903914|448466065|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
124684007|NCT02903914|448466066|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
124684008|NCT02903914|448466067|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
124684009|NCT02903914|448466068|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
124886406|NCT00502996|449209592|FG000|Overall Study|Adverse Event|2|||
124886407|NCT01729728|449209593|FG000|Overall Study|Adverse Event|0|||
124886408|NCT01729728|449209594|FG001|Overall Study|Adverse Event|6|||
124886409|NCT01729728|449209595|FG002|Overall Study|Adverse Event|0|||
124886410|NCT01729728|449209593|FG000|Overall Study|Protocol Violation|1|||
124886411|NCT01729728|449209594|FG001|Overall Study|Protocol Violation|0|||
124886412|NCT01729728|449209595|FG002|Overall Study|Protocol Violation|1|||
124886413|NCT02500979|449209596|FG000|Period 1|Hyperglycemia|1|||
124439952|NCT00940108|447570874|FG000|Overall Study|Dose 2 contraindicated|1|||
124439953|NCT00940108|447570875|FG001|Overall Study|Dose 2 contraindicated|1|||
124439954|NCT00940108|447570876|FG002|Overall Study|Dose 2 contraindicated|0|||
124439955|NCT00940108|447570877|FG003|Overall Study|Dose 2 contraindicated|1|||
124886414|NCT02500979|449209597|FG001|Period 1|Hyperglycemia|0|||
124886415|NCT02500979|449209596|FG000|Period 1|Severe non-compliance to protocol|0|||
124439956|NCT00940108|447570874|FG000|Overall Study|Declined further vaccination|0|||
124439957|NCT00940108|447570875|FG001|Overall Study|Declined further vaccination|1|||
124886416|NCT02500979|449209597|FG001|Period 1|Severe non-compliance to protocol|1|||
124886417|NCT02500979|449209596|FG000|Period 1|Adverse Event|1|||
124886418|NCT02500979|449209597|FG001|Period 1|Adverse Event|0|||
124886419|NCT02500979|449209596|FG000|Period 1|Subject decision|2|||
124886420|NCT02500979|449209597|FG001|Period 1|Subject decision|0|||
124886421|NCT02500979|449209596|FG000|Period 2|Change in risk|1|||
124684010|NCT02903914|448466069|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
124684011|NCT02903914|448466070|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
124684012|NCT02903914|448466071|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
124684013|NCT02903914|448466072|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
124684014|NCT02903914|448466065|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
124684015|NCT02903914|448466066|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
124684016|NCT02903914|448466067|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
124684017|NCT02903914|448466068|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
124684018|NCT02903914|448466069|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
124886422|NCT02500979|449209597|FG001|Period 2|Change in risk|0|||
124886423|NCT00610675|449209598|FG000|Overall Study|Untreated|4|||
124886424|NCT00610675|449209598|FG000|Overall Study|Adverse Event|67|||
124886425|NCT00610675|449209598|FG000|Overall Study|Insufficient Effect|31|||
124439958|NCT00940108|447570876|FG002|Overall Study|Declined further vaccination|3|||
124439959|NCT00940108|447570877|FG003|Overall Study|Declined further vaccination|0|||
124439960|NCT00940108|447570874|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
124439961|NCT00940108|447570875|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
124439962|NCT00940108|447570876|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
124439963|NCT00940108|447570877|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
124439964|NCT00940108|447570874|FG000|Overall Study|Viral illness after Dose 1|0|||
124439965|NCT00940108|447570875|FG001|Overall Study|Viral illness after Dose 1|1|||
124439966|NCT00940108|447570876|FG002|Overall Study|Viral illness after Dose 1|0|||
124439967|NCT00940108|447570877|FG003|Overall Study|Viral illness after Dose 1|0|||
124439968|NCT00940108|447570874|FG000|Overall Study|Diagnosed with H1N1|0|||
124439969|NCT00940108|447570875|FG001|Overall Study|Diagnosed with H1N1|0|||
124439970|NCT00940108|447570876|FG002|Overall Study|Diagnosed with H1N1|0|||
124439971|NCT00940108|447570877|FG003|Overall Study|Diagnosed with H1N1|1|||
124439972|NCT02075541|447570878|FG000|Overall Study|Serious Adverse Event|1|||
124439973|NCT02075541|447570879|FG001|Overall Study|Serious Adverse Event|4|||
124439974|NCT02075541|447570878|FG000|Overall Study|Protocol Violation|1|||
124439975|NCT02075541|447570879|FG001|Overall Study|Protocol Violation|0|||
124439976|NCT02075541|447570878|FG000|Overall Study|Withdrawal by Subject|1|||
124439977|NCT02075541|447570879|FG001|Overall Study|Withdrawal by Subject|3|||
124439978|NCT02075541|447570878|FG000|Overall Study|Sponsor study termination|0|||
124439979|NCT02075541|447570879|FG001|Overall Study|Sponsor study termination|1|||
124439980|NCT02075541|447570878|FG000|Overall Study|Other- unable to perform study procedure|1|||
124439981|NCT02075541|447570879|FG001|Overall Study|Other- unable to perform study procedure|0|||
124439982|NCT01142596|447570881|FG000|Overall Study|Withdrawal by Subject|9|||
124439983|NCT01142596|447570882|FG001|Overall Study|Withdrawal by Subject|35|||
124439984|NCT01142596|447570881|FG000|Overall Study|Adverse Event|8|||
124439985|NCT01142596|447570882|FG001|Overall Study|Adverse Event|35|||
124439986|NCT01142596|447570881|FG000|Overall Study|Lack of Efficacy|5|||
124439987|NCT01142596|447570882|FG001|Overall Study|Lack of Efficacy|9|||
124439988|NCT01142596|447570881|FG000|Overall Study|Lost to Follow-up|2|||
124439989|NCT01142596|447570882|FG001|Overall Study|Lost to Follow-up|3|||
124439990|NCT01142596|447570881|FG000|Overall Study|Other reason (not specified)|5|||
124439991|NCT01142596|447570882|FG001|Overall Study|Other reason (not specified)|4|||
124439992|NCT01054846|447570883|FG000|Overall Study|Lost to Follow-up|76|||
124439993|NCT01054846|447570884|FG001|Overall Study|Lost to Follow-up|17|||
124439994|NCT02446886|447570885|FG000|Overall Study|Adverse Event|1|||
124439995|NCT02446886|447570886|FG001|Overall Study|Adverse Event|3|||
124439996|NCT02446886|447570885|FG000|Overall Study|Withdrawal by Subject|1|||
124439997|NCT02446886|447570886|FG001|Overall Study|Withdrawal by Subject|1|||
124439998|NCT00928447|447570887|FG000|Overall Study|Withdrawal by Subject|1|||
124439999|NCT00928447|447570887|FG000|Overall Study|Investigator's decision|1|||
124440000|NCT01259284|447570888|FG000|Overall Study|Study Termination|2|||
124440001|NCT01259284|447570889|FG001|Overall Study|Study Termination|0|||
124684019|NCT02903914|448466070|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
124886426|NCT00610675|449209598|FG000|Overall Study|Withdrawal by Subject|28|||
124886427|NCT00610675|449209598|FG000|Overall Study|Reasons unrelated to trial|27|||
124886428|NCT00610675|449209598|FG000|Overall Study|Lack of Compliance|7|||
124440002|NCT01259284|447570890|FG002|Overall Study|Study Termination|0|||
124886429|NCT00610675|449209598|FG000|Overall Study|Lost to Follow-up|31|||
124886430|NCT00610675|449209598|FG000|Overall Study|Other reason (not specified)|25|||
124440003|NCT03021954|447570891|FG000|Overall Study|Lost to Follow-up|10|||
124440004|NCT03021954|447570892|FG001|Overall Study|Lost to Follow-up|43|||
124440005|NCT03021954|447570891|FG000|Overall Study|Subjects had avulsion trauma|4|||
124440006|NCT03021954|447570892|FG001|Overall Study|Subjects had avulsion trauma|1|||
124886431|NCT01316692|449209601|FG000|Overall Study|Adverse Event|5|||
124758692|NCT00543387|448739843|FG008|Panel 1 + Panel 2|Physician Decision|0|||
124758693|NCT00543387|448739844|FG009|Panel 1 + Panel 2|Physician Decision|0|||
124758694|NCT00543387|448739845|FG010|Panel 1 + Panel 2|Physician Decision|0|||
124758695|NCT00543387|448739835|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
124758696|NCT00543387|448739836|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
124758697|NCT00543387|448739837|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
124758698|NCT00543387|448739838|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
124758699|NCT00543387|448739839|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
124758700|NCT00543387|448739840|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
124758701|NCT00543387|448739841|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
124758702|NCT00543387|448739842|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
124758703|NCT00543387|448739843|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
124758704|NCT00543387|448739844|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
124758705|NCT00543387|448739845|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
124758706|NCT00543387|448739835|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
124758707|NCT00543387|448739836|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
124758708|NCT00543387|448739837|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
124758709|NCT00543387|448739838|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
124758710|NCT00543387|448739839|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
124758711|NCT00543387|448739840|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
124758712|NCT00543387|448739841|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
124758713|NCT00543387|448739842|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
124758714|NCT00543387|448739843|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
124758715|NCT00543387|448739844|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
124758716|NCT00543387|448739845|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
124758717|NCT00543387|448739835|FG000|Crossover Participants|Progressive Disease|0|||
124758718|NCT00543387|448739836|FG001|Crossover Participants|Progressive Disease|0|||
124758719|NCT00543387|448739837|FG002|Crossover Participants|Progressive Disease|0|||
124758720|NCT00543387|448739838|FG003|Crossover Participants|Progressive Disease|0|||
124758721|NCT00543387|448739839|FG004|Crossover Participants|Progressive Disease|0|||
124758722|NCT00543387|448739840|FG005|Crossover Participants|Progressive Disease|0|||
124758723|NCT00543387|448739841|FG006|Crossover Participants|Progressive Disease|0|||
124758724|NCT00543387|448739842|FG007|Crossover Participants|Progressive Disease|0|||
124758725|NCT00543387|448739843|FG008|Crossover Participants|Progressive Disease|0|||
124758726|NCT00543387|448739844|FG009|Crossover Participants|Progressive Disease|1|||
124758727|NCT00543387|448739845|FG010|Crossover Participants|Progressive Disease|2|||
124758728|NCT00543387|448739835|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
124758729|NCT00543387|448739836|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
124758730|NCT00543387|448739837|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
124758731|NCT00543387|448739838|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
124758732|NCT00543387|448739839|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
124758733|NCT00543387|448739840|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
124758734|NCT00543387|448739841|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
124758735|NCT00543387|448739842|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
124758736|NCT00543387|448739843|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
124758737|NCT00543387|448739844|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
124758738|NCT00543387|448739845|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
124886432|NCT01316692|449209601|FG000|Overall Study|Disease Progression|7|||
124886433|NCT01536145|449209608|FG000|Overall Study|Progressive disease|3|||
124886434|NCT01536145|449209609|FG001|Overall Study|Progressive disease|4|||
124886435|NCT01536145|449209610|FG002|Overall Study|Progressive disease|1|||
124886436|NCT01536145|449209611|FG003|Overall Study|Progressive disease|2|||
124886437|NCT01536145|449209612|FG004|Overall Study|Progressive disease|1|||
124886438|NCT01536145|449209613|FG005|Overall Study|Progressive disease|2|||
124886439|NCT01536145|449209614|FG006|Overall Study|Progressive disease|1|||
124886440|NCT01536145|449209615|FG007|Overall Study|Progressive disease|2|||
124886441|NCT01536145|449209616|FG008|Overall Study|Progressive disease|1|||
124886442|NCT01536145|449209617|FG009|Overall Study|Progressive disease|3|||
124886443|NCT01536145|449209618|FG010|Overall Study|Progressive disease|3|||
124886444|NCT01536145|449209608|FG000|Overall Study|Withdrawal by Subject|0|||
124886445|NCT01536145|449209609|FG001|Overall Study|Withdrawal by Subject|0|||
124886446|NCT01536145|449209610|FG002|Overall Study|Withdrawal by Subject|1|||
124886447|NCT01536145|449209611|FG003|Overall Study|Withdrawal by Subject|0|||
124886448|NCT01536145|449209612|FG004|Overall Study|Withdrawal by Subject|0|||
124886449|NCT01536145|449209613|FG005|Overall Study|Withdrawal by Subject|1|||
124886450|NCT01536145|449209614|FG006|Overall Study|Withdrawal by Subject|0|||
124758739|NCT00940498|448739846|FG000|Overall Study|Death|2|||
124758740|NCT00940498|448739847|FG001|Overall Study|Death|0|||
124758741|NCT00940498|448739848|FG002|Overall Study|Death|0|||
124758742|NCT00940498|448739849|FG003|Overall Study|Death|1|||
124886451|NCT01536145|449209615|FG007|Overall Study|Withdrawal by Subject|0|||
124684020|NCT02903914|448466071|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
124684021|NCT02903914|448466072|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
124684022|NCT02903914|448466065|FG000|Overall Study|Clinical Disease Progression|0|||
124684023|NCT02903914|448466066|FG001|Overall Study|Clinical Disease Progression|0|||
124684024|NCT02903914|448466067|FG002|Overall Study|Clinical Disease Progression|2|||
124684025|NCT02903914|448466068|FG003|Overall Study|Clinical Disease Progression|0|||
124684026|NCT02903914|448466069|FG004|Overall Study|Clinical Disease Progression|0|||
124684027|NCT02903914|448466070|FG005|Overall Study|Clinical Disease Progression|0|||
124684028|NCT02903914|448466071|FG006|Overall Study|Clinical Disease Progression|0|||
124684029|NCT02903914|448466072|FG007|Overall Study|Clinical Disease Progression|0|||
124684030|NCT02903914|448466065|FG000|Overall Study|Completed Follow-up Period|0|||
124684031|NCT02903914|448466066|FG001|Overall Study|Completed Follow-up Period|0|||
124684032|NCT02903914|448466067|FG002|Overall Study|Completed Follow-up Period|6|||
124684033|NCT02903914|448466068|FG003|Overall Study|Completed Follow-up Period|2|||
124684034|NCT02903914|448466069|FG004|Overall Study|Completed Follow-up Period|1|||
124684035|NCT02903914|448466070|FG005|Overall Study|Completed Follow-up Period|0|||
124684036|NCT02903914|448466071|FG006|Overall Study|Completed Follow-up Period|9|||
124684037|NCT02903914|448466072|FG007|Overall Study|Completed Follow-up Period|1|||
124684038|NCT02903914|448466065|FG000|Overall Study|Taken off Treatment per Protocol|0|||
124684039|NCT02903914|448466066|FG001|Overall Study|Taken off Treatment per Protocol|0|||
124684040|NCT02903914|448466067|FG002|Overall Study|Taken off Treatment per Protocol|0|||
124684041|NCT02903914|448466068|FG003|Overall Study|Taken off Treatment per Protocol|0|||
124684042|NCT02903914|448466069|FG004|Overall Study|Taken off Treatment per Protocol|0|||
124684043|NCT02903914|448466070|FG005|Overall Study|Taken off Treatment per Protocol|1|||
124886452|NCT01536145|449209616|FG008|Overall Study|Withdrawal by Subject|2|||
124886453|NCT01536145|449209617|FG009|Overall Study|Withdrawal by Subject|0|||
124886454|NCT01536145|449209618|FG010|Overall Study|Withdrawal by Subject|2|||
124886455|NCT01536145|449209608|FG000|Overall Study|Other|0|||
124886456|NCT01536145|449209609|FG001|Overall Study|Other|0|||
124886457|NCT01536145|449209610|FG002|Overall Study|Other|0|||
124886458|NCT01536145|449209611|FG003|Overall Study|Other|0|||
124886459|NCT01536145|449209612|FG004|Overall Study|Other|1|||
124886460|NCT01536145|449209613|FG005|Overall Study|Other|0|||
124886461|NCT01536145|449209614|FG006|Overall Study|Other|0|||
124684044|NCT02903914|448466071|FG006|Overall Study|Taken off Treatment per Protocol|0|||
124684045|NCT02903914|448466072|FG007|Overall Study|Taken off Treatment per Protocol|0|||
124684046|NCT02903914|448466065|FG000|Overall Study|Refused Further Treatment/Contact|0|||
124684047|NCT02903914|448466066|FG001|Overall Study|Refused Further Treatment/Contact|0|||
124684048|NCT02903914|448466067|FG002|Overall Study|Refused Further Treatment/Contact|0|||
124758743|NCT00940498|448739850|FG004|Overall Study|Death|5|||
124758744|NCT00940498|448739851|FG005|Overall Study|Death|0|||
124886462|NCT01536145|449209615|FG007|Overall Study|Other|0|||
124886463|NCT01536145|449209616|FG008|Overall Study|Other|0|||
124886464|NCT01536145|449209617|FG009|Overall Study|Other|3|||
124886465|NCT01536145|449209618|FG010|Overall Study|Other|2|||
124886466|NCT01536145|449209608|FG000|Overall Study|Death|0|||
124886467|NCT01536145|449209609|FG001|Overall Study|Death|0|||
124886468|NCT01536145|449209610|FG002|Overall Study|Death|0|||
124886469|NCT01536145|449209611|FG003|Overall Study|Death|0|||
124886470|NCT01536145|449209612|FG004|Overall Study|Death|0|||
124886471|NCT01536145|449209613|FG005|Overall Study|Death|0|||
124886472|NCT01536145|449209614|FG006|Overall Study|Death|1|||
124886473|NCT01536145|449209615|FG007|Overall Study|Death|0|||
124886474|NCT01536145|449209616|FG008|Overall Study|Death|0|||
124440007|NCT00069238|447570893|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
124440008|NCT00069238|447570894|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
124684049|NCT02903914|448466068|FG003|Overall Study|Refused Further Treatment/Contact|0|||
124758745|NCT00940498|448739852|FG006|Overall Study|Death|1|||
124758746|NCT00940498|448739853|FG007|Overall Study|Death|0|||
124758747|NCT00940498|448739846|FG000|Overall Study|Lost to Follow-up|1|||
124758748|NCT00940498|448739847|FG001|Overall Study|Lost to Follow-up|1|||
124758749|NCT00940498|448739848|FG002|Overall Study|Lost to Follow-up|2|||
124886475|NCT01536145|449209617|FG009|Overall Study|Death|0|||
124886476|NCT01536145|449209618|FG010|Overall Study|Death|0|||
124684050|NCT02903914|448466069|FG004|Overall Study|Refused Further Treatment/Contact|0|||
124684051|NCT02903914|448466070|FG005|Overall Study|Refused Further Treatment/Contact|0|||
124684052|NCT02903914|448466071|FG006|Overall Study|Refused Further Treatment/Contact|1|||
124758750|NCT00940498|448739849|FG003|Overall Study|Lost to Follow-up|0|||
124684053|NCT02903914|448466072|FG007|Overall Study|Refused Further Treatment/Contact|0|||
124684054|NCT02903914|448466065|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
124758751|NCT00940498|448739850|FG004|Overall Study|Lost to Follow-up|1|||
124758752|NCT00940498|448739851|FG005|Overall Study|Lost to Follow-up|0|||
124886477|NCT01536145|449209608|FG000|Overall Study|Adverse Event|0|||
124886478|NCT01536145|449209609|FG001|Overall Study|Adverse Event|0|||
124886479|NCT01536145|449209610|FG002|Overall Study|Adverse Event|0|||
124886480|NCT01536145|449209611|FG003|Overall Study|Adverse Event|0|||
124684055|NCT02903914|448466066|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
124684056|NCT02903914|448466067|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
124684057|NCT02903914|448466068|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
124684058|NCT02903914|448466069|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
124684059|NCT02903914|448466070|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
124684060|NCT02903914|448466071|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
124684061|NCT02903914|448466072|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
124684062|NCT04725188|448466075|FG000|Overall Study|Death|72|||
124684063|NCT04725188|448466076|FG001|Overall Study|Death|69|||
124684064|NCT04725188|448466077|FG002|Overall Study|Death|76|||
124684065|NCT04725188|448466075|FG000|Overall Study|Lost to Follow-up|1|||
124684066|NCT04725188|448466076|FG001|Overall Study|Lost to Follow-up|0|||
124684067|NCT04725188|448466077|FG002|Overall Study|Lost to Follow-up|1|||
124684068|NCT04725188|448466075|FG000|Overall Study|Withdrawal by Subject|2|||
124684069|NCT04725188|448466076|FG001|Overall Study|Withdrawal by Subject|2|||
124684070|NCT04725188|448466077|FG002|Overall Study|Withdrawal by Subject|1|||
124684071|NCT04725188|448466075|FG000|Overall Study|Sponsor Decision|12|||
124684072|NCT04725188|448466076|FG001|Overall Study|Sponsor Decision|12|||
124684073|NCT04725188|448466077|FG002|Overall Study|Sponsor Decision|7|||
124684074|NCT02337829|448466078|FG000|Overall Study|Death|0|||
124684075|NCT02337829|448466079|FG001|Overall Study|Death|1|||
124684076|NCT02337829|448466080|FG002|Overall Study|Death|0|||
124684077|NCT02337829|448466081|FG003|Overall Study|Death|0|||
124684078|NCT02337829|448466078|FG000|Overall Study|Study terminated by sponsor|12|||
124684079|NCT02337829|448466079|FG001|Overall Study|Study terminated by sponsor|10|||
124684080|NCT02337829|448466080|FG002|Overall Study|Study terminated by sponsor|5|||
124684081|NCT02337829|448466081|FG003|Overall Study|Study terminated by sponsor|6|||
124684082|NCT02337829|448466078|FG000|Overall Study|discontinued for other reasons|6|||
124684083|NCT02337829|448466079|FG001|Overall Study|discontinued for other reasons|3|||
124684084|NCT02337829|448466080|FG002|Overall Study|discontinued for other reasons|1|||
124684085|NCT02337829|448466081|FG003|Overall Study|discontinued for other reasons|4|||
124684086|NCT03765073|448466082|FG000|Stage 1|Lost to Follow-up|1|||
124684087|NCT03765073|448466083|FG001|Stage 1|Lost to Follow-up|0|||
124684088|NCT03765073|448466084|FG002|Stage 1|Lost to Follow-up|0|||
124684089|NCT03765073|448466085|FG003|Stage 1|Lost to Follow-up|0|||
124684090|NCT03765073|448466086|FG004|Stage 1|Lost to Follow-up|0|||
124684091|NCT03765073|448466087|FG005|Stage 1|Lost to Follow-up|0|||
124684092|NCT03765073|448466088|FG006|Stage 1|Lost to Follow-up|0|||
124684093|NCT03765073|448466089|FG007|Stage 1|Lost to Follow-up|0|||
124684094|NCT03765073|448466090|FG008|Stage 1|Lost to Follow-up|0|||
124684095|NCT03765073|448466091|FG009|Stage 1|Lost to Follow-up|0|||
124684096|NCT03765073|448466092|FG010|Stage 1|Lost to Follow-up|0|||
124684097|NCT03765073|448466093|FG011|Stage 1|Lost to Follow-up|0|||
124684098|NCT03765073|448466094|FG012|Stage 1|Lost to Follow-up|0|||
124684099|NCT03765073|448466095|FG013|Stage 1|Lost to Follow-up|0|||
124684100|NCT03765073|448466096|FG014|Stage 1|Lost to Follow-up|0|||
124684101|NCT03765073|448466097|FG015|Stage 1|Lost to Follow-up|0|||
124684102|NCT03765073|448466098|FG016|Stage 1|Lost to Follow-up|0|||
124684103|NCT03765073|448466099|FG017|Stage 1|Lost to Follow-up|0|||
124684104|NCT03765073|448466100|FG018|Stage 1|Lost to Follow-up|0|||
124684105|NCT03765073|448466101|FG019|Stage 1|Lost to Follow-up|0|||
124684106|NCT03765073|448466102|FG020|Stage 1|Lost to Follow-up|0|||
124684107|NCT03765073|448466082|FG000|Stage 1|Withdrawal by participant|0|||
124684108|NCT03765073|448466083|FG001|Stage 1|Withdrawal by participant|1|||
124684109|NCT03765073|448466084|FG002|Stage 1|Withdrawal by participant|0|||
124684110|NCT03765073|448466085|FG003|Stage 1|Withdrawal by participant|0|||
124684111|NCT03765073|448466086|FG004|Stage 1|Withdrawal by participant|0|||
124684112|NCT03765073|448466087|FG005|Stage 1|Withdrawal by participant|0|||
124684113|NCT03765073|448466088|FG006|Stage 1|Withdrawal by participant|0|||
124684114|NCT03765073|448466089|FG007|Stage 1|Withdrawal by participant|0|||
124684115|NCT03765073|448466090|FG008|Stage 1|Withdrawal by participant|0|||
124684116|NCT03765073|448466091|FG009|Stage 1|Withdrawal by participant|0|||
124684117|NCT03765073|448466092|FG010|Stage 1|Withdrawal by participant|0|||
124684118|NCT03765073|448466093|FG011|Stage 1|Withdrawal by participant|0|||
124684119|NCT03765073|448466094|FG012|Stage 1|Withdrawal by participant|0|||
124684120|NCT03765073|448466095|FG013|Stage 1|Withdrawal by participant|0|||
124684121|NCT03765073|448466096|FG014|Stage 1|Withdrawal by participant|0|||
124758753|NCT00940498|448739852|FG006|Overall Study|Lost to Follow-up|0|||
124684122|NCT03765073|448466097|FG015|Stage 1|Withdrawal by participant|0|||
124684123|NCT03765073|448466098|FG016|Stage 1|Withdrawal by participant|0|||
124684124|NCT03765073|448466099|FG017|Stage 1|Withdrawal by participant|0|||
124684125|NCT03765073|448466100|FG018|Stage 1|Withdrawal by participant|0|||
124684126|NCT03765073|448466101|FG019|Stage 1|Withdrawal by participant|0|||
124684127|NCT03765073|448466102|FG020|Stage 1|Withdrawal by participant|0|||
124684128|NCT03765073|448466082|FG000|Stage 2|Death|0|||
124684129|NCT03765073|448466083|FG001|Stage 2|Death|0|||
124684130|NCT03765073|448466084|FG002|Stage 2|Death|0|||
124684131|NCT03765073|448466085|FG003|Stage 2|Death|0|||
124684132|NCT03765073|448466086|FG004|Stage 2|Death|0|||
124684133|NCT03765073|448466087|FG005|Stage 2|Death|0|||
124684134|NCT03765073|448466088|FG006|Stage 2|Death|0|||
124684135|NCT03765073|448466089|FG007|Stage 2|Death|0|||
124684136|NCT03765073|448466090|FG008|Stage 2|Death|0|||
124684137|NCT03765073|448466091|FG009|Stage 2|Death|1|||
124684138|NCT03765073|448466092|FG010|Stage 2|Death|0|||
124684139|NCT03765073|448466093|FG011|Stage 2|Death|1|||
124684140|NCT03765073|448466094|FG012|Stage 2|Death|0|||
124684141|NCT03765073|448466095|FG013|Stage 2|Death|0|||
124684142|NCT03765073|448466096|FG014|Stage 2|Death|0|||
124684143|NCT03765073|448466097|FG015|Stage 2|Death|0|||
124684144|NCT03765073|448466098|FG016|Stage 2|Death|2|||
124684145|NCT03765073|448466099|FG017|Stage 2|Death|0|||
124684146|NCT03765073|448466100|FG018|Stage 2|Death|0|||
124684147|NCT03765073|448466101|FG019|Stage 2|Death|0|||
124684148|NCT03765073|448466102|FG020|Stage 2|Death|0|||
124684149|NCT03765073|448466082|FG000|Stage 2|Lost to Follow-up|0|||
124684150|NCT03765073|448466083|FG001|Stage 2|Lost to Follow-up|0|||
124684151|NCT03765073|448466084|FG002|Stage 2|Lost to Follow-up|0|||
124684152|NCT03765073|448466085|FG003|Stage 2|Lost to Follow-up|5|||
124684153|NCT03765073|448466086|FG004|Stage 2|Lost to Follow-up|1|||
124684154|NCT03765073|448466087|FG005|Stage 2|Lost to Follow-up|0|||
124684155|NCT03765073|448466088|FG006|Stage 2|Lost to Follow-up|3|||
124684156|NCT03765073|448466089|FG007|Stage 2|Lost to Follow-up|3|||
124684157|NCT03765073|448466090|FG008|Stage 2|Lost to Follow-up|1|||
124684158|NCT03765073|448466091|FG009|Stage 2|Lost to Follow-up|6|||
124684159|NCT03765073|448466092|FG010|Stage 2|Lost to Follow-up|5|||
124684160|NCT03765073|448466093|FG011|Stage 2|Lost to Follow-up|1|||
124684161|NCT03765073|448466094|FG012|Stage 2|Lost to Follow-up|1|||
124684162|NCT03765073|448466095|FG013|Stage 2|Lost to Follow-up|3|||
124684163|NCT03765073|448466096|FG014|Stage 2|Lost to Follow-up|3|||
124684164|NCT03765073|448466097|FG015|Stage 2|Lost to Follow-up|1|||
124684165|NCT03765073|448466098|FG016|Stage 2|Lost to Follow-up|6|||
124684166|NCT03765073|448466099|FG017|Stage 2|Lost to Follow-up|0|||
124684167|NCT03765073|448466100|FG018|Stage 2|Lost to Follow-up|0|||
124684168|NCT03765073|448466101|FG019|Stage 2|Lost to Follow-up|0|||
124684169|NCT03765073|448466102|FG020|Stage 2|Lost to Follow-up|0|||
124684170|NCT03765073|448466082|FG000|Stage 2|Other|0|||
124684171|NCT03765073|448466083|FG001|Stage 2|Other|0|||
124684172|NCT03765073|448466084|FG002|Stage 2|Other|0|||
124684173|NCT03765073|448466085|FG003|Stage 2|Other|0|||
124684174|NCT03765073|448466086|FG004|Stage 2|Other|0|||
124684175|NCT03765073|448466087|FG005|Stage 2|Other|0|||
124684176|NCT03765073|448466088|FG006|Stage 2|Other|0|||
124684177|NCT03765073|448466089|FG007|Stage 2|Other|1|||
124684178|NCT03765073|448466090|FG008|Stage 2|Other|1|||
124684179|NCT03765073|448466091|FG009|Stage 2|Other|3|||
124684180|NCT03765073|448466092|FG010|Stage 2|Other|0|||
124684181|NCT03765073|448466093|FG011|Stage 2|Other|0|||
124684182|NCT03765073|448466094|FG012|Stage 2|Other|0|||
124684183|NCT03765073|448466095|FG013|Stage 2|Other|0|||
124684184|NCT03765073|448466096|FG014|Stage 2|Other|0|||
124684185|NCT03765073|448466097|FG015|Stage 2|Other|1|||
124684186|NCT03765073|448466098|FG016|Stage 2|Other|2|||
124684187|NCT03765073|448466099|FG017|Stage 2|Other|0|||
124684188|NCT03765073|448466100|FG018|Stage 2|Other|0|||
124684189|NCT03765073|448466101|FG019|Stage 2|Other|0|||
124684190|NCT03765073|448466102|FG020|Stage 2|Other|0|||
124684191|NCT03765073|448466082|FG000|Stage 2|Withdrawal by parent/guardian|0|||
124684192|NCT03765073|448466083|FG001|Stage 2|Withdrawal by parent/guardian|0|||
124684193|NCT03765073|448466084|FG002|Stage 2|Withdrawal by parent/guardian|0|||
124684194|NCT03765073|448466085|FG003|Stage 2|Withdrawal by parent/guardian|0|||
124684195|NCT03765073|448466086|FG004|Stage 2|Withdrawal by parent/guardian|0|||
124684196|NCT03765073|448466087|FG005|Stage 2|Withdrawal by parent/guardian|0|||
124684197|NCT03765073|448466088|FG006|Stage 2|Withdrawal by parent/guardian|0|||
124684198|NCT03765073|448466089|FG007|Stage 2|Withdrawal by parent/guardian|0|||
124684199|NCT03765073|448466090|FG008|Stage 2|Withdrawal by parent/guardian|0|||
124684200|NCT03765073|448466091|FG009|Stage 2|Withdrawal by parent/guardian|0|||
124886481|NCT01536145|449209612|FG004|Overall Study|Adverse Event|0|||
124684201|NCT03765073|448466092|FG010|Stage 2|Withdrawal by parent/guardian|3|||
124684202|NCT03765073|448466093|FG011|Stage 2|Withdrawal by parent/guardian|3|||
124684203|NCT03765073|448466094|FG012|Stage 2|Withdrawal by parent/guardian|3|||
124684204|NCT03765073|448466095|FG013|Stage 2|Withdrawal by parent/guardian|1|||
124684205|NCT03765073|448466096|FG014|Stage 2|Withdrawal by parent/guardian|1|||
124684206|NCT03765073|448466097|FG015|Stage 2|Withdrawal by parent/guardian|0|||
124684207|NCT03765073|448466098|FG016|Stage 2|Withdrawal by parent/guardian|3|||
124684208|NCT03765073|448466099|FG017|Stage 2|Withdrawal by parent/guardian|0|||
124684209|NCT03765073|448466100|FG018|Stage 2|Withdrawal by parent/guardian|0|||
124684210|NCT03765073|448466101|FG019|Stage 2|Withdrawal by parent/guardian|0|||
124886482|NCT01536145|449209613|FG005|Overall Study|Adverse Event|0|||
124684211|NCT03765073|448466102|FG020|Stage 2|Withdrawal by parent/guardian|0|||
124684212|NCT03765073|448466082|FG000|Stage 2|Withdrawal by Subject|0|||
124684213|NCT03765073|448466083|FG001|Stage 2|Withdrawal by Subject|0|||
124684214|NCT03765073|448466084|FG002|Stage 2|Withdrawal by Subject|0|||
124684215|NCT03765073|448466085|FG003|Stage 2|Withdrawal by Subject|3|||
124684216|NCT03765073|448466086|FG004|Stage 2|Withdrawal by Subject|3|||
124684217|NCT03765073|448466087|FG005|Stage 2|Withdrawal by Subject|3|||
124684218|NCT03765073|448466088|FG006|Stage 2|Withdrawal by Subject|0|||
124684219|NCT03765073|448466089|FG007|Stage 2|Withdrawal by Subject|1|||
124758754|NCT00940498|448739853|FG007|Overall Study|Lost to Follow-up|1|||
124758755|NCT00940498|448739846|FG000|Overall Study|Disease Progression|0|||
124758756|NCT00940498|448739847|FG001|Overall Study|Disease Progression|0|||
124758757|NCT00940498|448739848|FG002|Overall Study|Disease Progression|1|||
124758758|NCT00940498|448739849|FG003|Overall Study|Disease Progression|1|||
124758759|NCT00940498|448739850|FG004|Overall Study|Disease Progression|0|||
124758760|NCT00940498|448739851|FG005|Overall Study|Disease Progression|1|||
124758761|NCT00940498|448739852|FG006|Overall Study|Disease Progression|0|||
124684220|NCT03765073|448466090|FG008|Stage 2|Withdrawal by Subject|0|||
124758762|NCT00940498|448739853|FG007|Overall Study|Disease Progression|0|||
124758763|NCT00940498|448739846|FG000|Overall Study|Physician Decision|0|||
124758764|NCT00940498|448739847|FG001|Overall Study|Physician Decision|0|||
124758765|NCT00940498|448739848|FG002|Overall Study|Physician Decision|0|||
124758766|NCT00940498|448739849|FG003|Overall Study|Physician Decision|0|||
124758767|NCT00940498|448739850|FG004|Overall Study|Physician Decision|2|||
124758768|NCT00940498|448739851|FG005|Overall Study|Physician Decision|0|||
124758769|NCT00940498|448739852|FG006|Overall Study|Physician Decision|0|||
124758770|NCT00940498|448739853|FG007|Overall Study|Physician Decision|0|||
124758771|NCT00940498|448739846|FG000|Overall Study|Not treated due to disease related pain|0|||
124758772|NCT00940498|448739847|FG001|Overall Study|Not treated due to disease related pain|0|||
124758773|NCT00940498|448739848|FG002|Overall Study|Not treated due to disease related pain|0|||
124758774|NCT00940498|448739849|FG003|Overall Study|Not treated due to disease related pain|0|||
124758775|NCT00940498|448739850|FG004|Overall Study|Not treated due to disease related pain|1|||
124758776|NCT00940498|448739851|FG005|Overall Study|Not treated due to disease related pain|0|||
124758777|NCT00940498|448739852|FG006|Overall Study|Not treated due to disease related pain|0|||
124758778|NCT00940498|448739853|FG007|Overall Study|Not treated due to disease related pain|0|||
124758779|NCT01943591|448739854|FG000|Overall Study|Lost to Follow-up|3|||
124758780|NCT01943591|448739855|FG001|Overall Study|Lost to Follow-up|4|||
124758781|NCT01943591|448739854|FG000|Overall Study|Death|2|||
124758782|NCT01943591|448739855|FG001|Overall Study|Death|7|||
124758783|NCT00227721|448741122|FG000|Overall Study|On study, but never treated.|1|||
124758784|NCT01389882|448741131|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
124758785|NCT01389882|448741132|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
124758786|NCT01389882|448741131|FG000|Overall Study|Withdrawal by Subject|0|||
124758787|NCT01389882|448741132|FG001|Overall Study|Withdrawal by Subject|1|||
124758788|NCT00859547|448741142|FG000|Overall Study|Lost to Follow-up|1|||
124758789|NCT00859547|448741142|FG000|Overall Study|Parent withdrew consent|1|||
124758790|NCT01276639|448741153|FG000|Week 0 to 16|Death|1|||
124758791|NCT01276639|448741154|FG001|Week 0 to 16|Death|0|||
124886483|NCT01536145|449209614|FG006|Overall Study|Adverse Event|0|||
124886484|NCT01536145|449209615|FG007|Overall Study|Adverse Event|2|||
124886485|NCT01536145|449209616|FG008|Overall Study|Adverse Event|0|||
124684221|NCT03765073|448466091|FG009|Stage 2|Withdrawal by Subject|5|||
124684222|NCT03765073|448466092|FG010|Stage 2|Withdrawal by Subject|0|||
124684223|NCT03765073|448466093|FG011|Stage 2|Withdrawal by Subject|0|||
124684224|NCT03765073|448466094|FG012|Stage 2|Withdrawal by Subject|0|||
124684225|NCT03765073|448466095|FG013|Stage 2|Withdrawal by Subject|0|||
124684226|NCT03765073|448466096|FG014|Stage 2|Withdrawal by Subject|0|||
124684227|NCT03765073|448466097|FG015|Stage 2|Withdrawal by Subject|0|||
124684228|NCT03765073|448466098|FG016|Stage 2|Withdrawal by Subject|0|||
124684229|NCT03765073|448466099|FG017|Stage 2|Withdrawal by Subject|0|||
124684230|NCT03765073|448466100|FG018|Stage 2|Withdrawal by Subject|0|||
124684231|NCT03765073|448466101|FG019|Stage 2|Withdrawal by Subject|0|||
124684232|NCT03765073|448466102|FG020|Stage 2|Withdrawal by Subject|0|||
124684233|NCT03765073|448466082|FG000|Stage 3|Adverse Event|0|||
124684234|NCT03765073|448466083|FG001|Stage 3|Adverse Event|0|||
124684235|NCT03765073|448466084|FG002|Stage 3|Adverse Event|0|||
124684236|NCT03765073|448466085|FG003|Stage 3|Adverse Event|0|||
124684237|NCT03765073|448466086|FG004|Stage 3|Adverse Event|0|||
124684238|NCT03765073|448466087|FG005|Stage 3|Adverse Event|0|||
124684239|NCT03765073|448466088|FG006|Stage 3|Adverse Event|0|||
124886486|NCT01536145|449209617|FG009|Overall Study|Adverse Event|0|||
124886487|NCT01536145|449209618|FG010|Overall Study|Adverse Event|3|||
124886488|NCT00579982|449209619|FG000|Overall Study|Adverse Event|4|||
124886489|NCT00579982|449209619|FG000|Overall Study|Protocol Violation|4|||
124886490|NCT05199233|449209620|FG000|Overall Study|Lack of Efficacy|1|||
124684240|NCT03765073|448466089|FG007|Stage 3|Adverse Event|0|||
124684241|NCT03765073|448466090|FG008|Stage 3|Adverse Event|0|||
124758792|NCT01276639|448741155|FG002|Week 0 to 16|Death|0|||
124758793|NCT01276639|448741156|FG003|Week 0 to 16|Death|0|||
124684242|NCT03765073|448466091|FG009|Stage 3|Adverse Event|0|||
124758794|NCT01276639|448741157|FG004|Week 0 to 16|Death|0|||
124684243|NCT03765073|448466092|FG010|Stage 3|Adverse Event|0|||
124684244|NCT03765073|448466093|FG011|Stage 3|Adverse Event|0|||
124758795|NCT01276639|448741153|FG000|Week 0 to 16|Adverse Event|11|||
124758796|NCT01276639|448741154|FG001|Week 0 to 16|Adverse Event|8|||
124886491|NCT02443103|449209623|FG000|Overall Study|Adverse Event|2|||
124684245|NCT03765073|448466094|FG012|Stage 3|Adverse Event|0|||
124684246|NCT03765073|448466095|FG013|Stage 3|Adverse Event|0|||
124684247|NCT03765073|448466096|FG014|Stage 3|Adverse Event|0|||
124684248|NCT03765073|448466097|FG015|Stage 3|Adverse Event|0|||
124684249|NCT03765073|448466098|FG016|Stage 3|Adverse Event|0|||
124684250|NCT03765073|448466099|FG017|Stage 3|Adverse Event|0|||
124684251|NCT03765073|448466100|FG018|Stage 3|Adverse Event|1|||
124684252|NCT03765073|448466101|FG019|Stage 3|Adverse Event|0|||
124684253|NCT03765073|448466102|FG020|Stage 3|Adverse Event|0|||
124684254|NCT03765073|448466082|FG000|Stage 3|Death|0|||
124684255|NCT03765073|448466083|FG001|Stage 3|Death|0|||
124684256|NCT03765073|448466084|FG002|Stage 3|Death|0|||
124684257|NCT03765073|448466085|FG003|Stage 3|Death|0|||
124684258|NCT03765073|448466086|FG004|Stage 3|Death|0|||
124684259|NCT03765073|448466087|FG005|Stage 3|Death|0|||
124684260|NCT03765073|448466088|FG006|Stage 3|Death|0|||
124684261|NCT03765073|448466089|FG007|Stage 3|Death|0|||
124684262|NCT03765073|448466090|FG008|Stage 3|Death|0|||
124684263|NCT03765073|448466091|FG009|Stage 3|Death|0|||
124684264|NCT03765073|448466092|FG010|Stage 3|Death|0|||
124684265|NCT03765073|448466093|FG011|Stage 3|Death|0|||
124684266|NCT03765073|448466094|FG012|Stage 3|Death|0|||
124684267|NCT03765073|448466095|FG013|Stage 3|Death|0|||
124684268|NCT03765073|448466096|FG014|Stage 3|Death|0|||
124684269|NCT03765073|448466097|FG015|Stage 3|Death|0|||
124684270|NCT03765073|448466098|FG016|Stage 3|Death|0|||
124684271|NCT03765073|448466099|FG017|Stage 3|Death|0|||
124684272|NCT03765073|448466100|FG018|Stage 3|Death|0|||
124684273|NCT03765073|448466101|FG019|Stage 3|Death|3|||
124684274|NCT03765073|448466102|FG020|Stage 3|Death|2|||
124684275|NCT03765073|448466082|FG000|Stage 3|Lost to Follow-up|0|||
124684276|NCT03765073|448466083|FG001|Stage 3|Lost to Follow-up|0|||
124684277|NCT03765073|448466084|FG002|Stage 3|Lost to Follow-up|0|||
124684278|NCT03765073|448466085|FG003|Stage 3|Lost to Follow-up|0|||
124684279|NCT03765073|448466086|FG004|Stage 3|Lost to Follow-up|0|||
124684280|NCT03765073|448466087|FG005|Stage 3|Lost to Follow-up|0|||
124684281|NCT03765073|448466088|FG006|Stage 3|Lost to Follow-up|0|||
124684282|NCT03765073|448466089|FG007|Stage 3|Lost to Follow-up|0|||
124684283|NCT03765073|448466090|FG008|Stage 3|Lost to Follow-up|0|||
124684284|NCT03765073|448466091|FG009|Stage 3|Lost to Follow-up|0|||
124684285|NCT03765073|448466092|FG010|Stage 3|Lost to Follow-up|0|||
124684286|NCT03765073|448466093|FG011|Stage 3|Lost to Follow-up|0|||
124684287|NCT03765073|448466094|FG012|Stage 3|Lost to Follow-up|0|||
124684288|NCT03765073|448466095|FG013|Stage 3|Lost to Follow-up|0|||
124684289|NCT03765073|448466096|FG014|Stage 3|Lost to Follow-up|0|||
124684290|NCT03765073|448466097|FG015|Stage 3|Lost to Follow-up|0|||
124684291|NCT03765073|448466098|FG016|Stage 3|Lost to Follow-up|0|||
124684292|NCT03765073|448466099|FG017|Stage 3|Lost to Follow-up|8|||
124684293|NCT03765073|448466100|FG018|Stage 3|Lost to Follow-up|5|||
124684294|NCT03765073|448466101|FG019|Stage 3|Lost to Follow-up|7|||
124684295|NCT03765073|448466102|FG020|Stage 3|Lost to Follow-up|4|||
124684296|NCT03765073|448466082|FG000|Stage 3|No longer meets eligibility criteria|0|||
124684297|NCT03765073|448466083|FG001|Stage 3|No longer meets eligibility criteria|0|||
124684298|NCT03765073|448466084|FG002|Stage 3|No longer meets eligibility criteria|0|||
124684299|NCT03765073|448466085|FG003|Stage 3|No longer meets eligibility criteria|0|||
124684300|NCT03765073|448466086|FG004|Stage 3|No longer meets eligibility criteria|0|||
124684301|NCT03765073|448466087|FG005|Stage 3|No longer meets eligibility criteria|0|||
124684302|NCT03765073|448466088|FG006|Stage 3|No longer meets eligibility criteria|0|||
124684303|NCT03765073|448466089|FG007|Stage 3|No longer meets eligibility criteria|0|||
124758797|NCT01276639|448741155|FG002|Week 0 to 16|Adverse Event|11|||
124886492|NCT02443103|449209623|FG000|Overall Study|Noncompliance|1|||
124886493|NCT01630590|449209624|FG000|Overall Study|Adverse Event|9|||
124886494|NCT01630590|449209624|FG000|Overall Study|Lack of Efficacy|37|||
124886495|NCT01630590|449209624|FG000|Overall Study|Withdrawal by Subject|4|||
124886496|NCT01630590|449209624|FG000|Overall Study|2nd primary tumor|2|||
124684304|NCT03765073|448466090|FG008|Stage 3|No longer meets eligibility criteria|0|||
124758798|NCT01276639|448741156|FG003|Week 0 to 16|Adverse Event|0|||
124684305|NCT03765073|448466091|FG009|Stage 3|No longer meets eligibility criteria|0|||
124758799|NCT01276639|448741157|FG004|Week 0 to 16|Adverse Event|0|||
124684306|NCT03765073|448466092|FG010|Stage 3|No longer meets eligibility criteria|0|||
124684307|NCT03765073|448466093|FG011|Stage 3|No longer meets eligibility criteria|0|||
124684308|NCT03765073|448466094|FG012|Stage 3|No longer meets eligibility criteria|0|||
124684309|NCT03765073|448466095|FG013|Stage 3|No longer meets eligibility criteria|0|||
124684310|NCT03765073|448466096|FG014|Stage 3|No longer meets eligibility criteria|0|||
124684311|NCT03765073|448466097|FG015|Stage 3|No longer meets eligibility criteria|0|||
124684312|NCT03765073|448466098|FG016|Stage 3|No longer meets eligibility criteria|0|||
124684313|NCT03765073|448466099|FG017|Stage 3|No longer meets eligibility criteria|0|||
124684314|NCT03765073|448466100|FG018|Stage 3|No longer meets eligibility criteria|1|||
124684315|NCT03765073|448466101|FG019|Stage 3|No longer meets eligibility criteria|0|||
124684316|NCT03765073|448466102|FG020|Stage 3|No longer meets eligibility criteria|1|||
124758800|NCT01276639|448741153|FG000|Week 0 to 16|Lack of Efficacy|20|||
124886497|NCT01630590|449209624|FG000|Overall Study|Automobile accident|1|||
124758801|NCT01276639|448741154|FG001|Week 0 to 16|Lack of Efficacy|15|||
124758802|NCT01276639|448741155|FG002|Week 0 to 16|Lack of Efficacy|25|||
124758803|NCT01276639|448741156|FG003|Week 0 to 16|Lack of Efficacy|0|||
124758804|NCT01276639|448741157|FG004|Week 0 to 16|Lack of Efficacy|0|||
124758805|NCT01276639|448741153|FG000|Week 0 to 16|Lost to Follow-up|3|||
124758806|NCT01276639|448741154|FG001|Week 0 to 16|Lost to Follow-up|5|||
124758807|NCT01276639|448741155|FG002|Week 0 to 16|Lost to Follow-up|3|||
124684317|NCT03765073|448466082|FG000|Stage 3|Other|0|||
124684318|NCT03765073|448466083|FG001|Stage 3|Other|0|||
124684319|NCT03765073|448466084|FG002|Stage 3|Other|0|||
124684320|NCT03765073|448466085|FG003|Stage 3|Other|0|||
124684321|NCT03765073|448466086|FG004|Stage 3|Other|0|||
124684322|NCT03765073|448466087|FG005|Stage 3|Other|0|||
124684323|NCT03765073|448466088|FG006|Stage 3|Other|0|||
124684324|NCT03765073|448466089|FG007|Stage 3|Other|0|||
124684325|NCT03765073|448466090|FG008|Stage 3|Other|0|||
124684326|NCT03765073|448466091|FG009|Stage 3|Other|0|||
124684327|NCT03765073|448466092|FG010|Stage 3|Other|0|||
124684328|NCT03765073|448466093|FG011|Stage 3|Other|0|||
124684329|NCT03765073|448466094|FG012|Stage 3|Other|0|||
124684330|NCT03765073|448466095|FG013|Stage 3|Other|0|||
124758808|NCT01276639|448741156|FG003|Week 0 to 16|Lost to Follow-up|0|||
124758809|NCT01276639|448741157|FG004|Week 0 to 16|Lost to Follow-up|0|||
124758810|NCT01276639|448741153|FG000|Week 0 to 16|Withdrawal by Subject|8|||
124758811|NCT01276639|448741154|FG001|Week 0 to 16|Withdrawal by Subject|5|||
124758812|NCT01276639|448741155|FG002|Week 0 to 16|Withdrawal by Subject|4|||
124684331|NCT03765073|448466096|FG014|Stage 3|Other|0|||
124684332|NCT03765073|448466097|FG015|Stage 3|Other|0|||
124758813|NCT01276639|448741156|FG003|Week 0 to 16|Withdrawal by Subject|0|||
124758814|NCT01276639|448741157|FG004|Week 0 to 16|Withdrawal by Subject|0|||
124758815|NCT01276639|448741153|FG000|Week 0 to 16|Other|7|||
124758816|NCT01276639|448741154|FG001|Week 0 to 16|Other|7|||
124758817|NCT01276639|448741155|FG002|Week 0 to 16|Other|2|||
124758818|NCT01276639|448741156|FG003|Week 0 to 16|Other|0|||
124758819|NCT01276639|448741157|FG004|Week 0 to 16|Other|0|||
124758820|NCT01276639|448741153|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
124758821|NCT01276639|448741154|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
124758822|NCT01276639|448741155|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
124758823|NCT01276639|448741156|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
124758824|NCT01276639|448741157|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
124758825|NCT01276639|448741153|FG000|Week 16 to 52|Death|1|||
124758826|NCT01276639|448741154|FG001|Week 16 to 52|Death|0|||
124758827|NCT01276639|448741155|FG002|Week 16 to 52|Death|0|||
124758828|NCT01276639|448741156|FG003|Week 16 to 52|Death|0|||
124758829|NCT01276639|448741157|FG004|Week 16 to 52|Death|0|||
124758830|NCT01276639|448741153|FG000|Week 16 to 52|Adverse Event|10|||
124758831|NCT01276639|448741154|FG001|Week 16 to 52|Adverse Event|13|||
124758832|NCT01276639|448741155|FG002|Week 16 to 52|Adverse Event|0|||
124758833|NCT01276639|448741156|FG003|Week 16 to 52|Adverse Event|1|||
124758834|NCT01276639|448741157|FG004|Week 16 to 52|Adverse Event|3|||
124758835|NCT01276639|448741153|FG000|Week 16 to 52|Lack of Efficacy|99|||
124758836|NCT01276639|448741154|FG001|Week 16 to 52|Lack of Efficacy|71|||
124544393|NCT00948896|447946795|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
124544394|NCT00948896|447946796|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
124684333|NCT03765073|448466098|FG016|Stage 3|Other|0|||
124684334|NCT03765073|448466099|FG017|Stage 3|Other|1|||
124758837|NCT01276639|448741155|FG002|Week 16 to 52|Lack of Efficacy|0|||
124758838|NCT01276639|448741156|FG003|Week 16 to 52|Lack of Efficacy|14|||
124758839|NCT01276639|448741157|FG004|Week 16 to 52|Lack of Efficacy|13|||
124758840|NCT01276639|448741153|FG000|Week 16 to 52|Lost to Follow-up|3|||
124758841|NCT01276639|448741154|FG001|Week 16 to 52|Lost to Follow-up|1|||
124758842|NCT01276639|448741155|FG002|Week 16 to 52|Lost to Follow-up|0|||
124758843|NCT01276639|448741156|FG003|Week 16 to 52|Lost to Follow-up|0|||
124758844|NCT01276639|448741157|FG004|Week 16 to 52|Lost to Follow-up|1|||
124758845|NCT01276639|448741153|FG000|Week 16 to 52|Withdrawal by Subject|4|||
124758846|NCT01276639|448741154|FG001|Week 16 to 52|Withdrawal by Subject|4|||
124758847|NCT01276639|448741155|FG002|Week 16 to 52|Withdrawal by Subject|0|||
124886498|NCT01630590|449209624|FG000|Overall Study|Maximum benefit|4|||
124758848|NCT01276639|448741156|FG003|Week 16 to 52|Withdrawal by Subject|0|||
124758849|NCT01276639|448741157|FG004|Week 16 to 52|Withdrawal by Subject|1|||
124684335|NCT03765073|448466100|FG018|Stage 3|Other|2|||
124684336|NCT03765073|448466101|FG019|Stage 3|Other|2|||
124684337|NCT03765073|448466102|FG020|Stage 3|Other|2|||
124684338|NCT03765073|448466082|FG000|Stage 3|Withdrawal by parent/guardian|0|||
124758850|NCT01276639|448741153|FG000|Week 16 to 52|Other|10|||
124886499|NCT02366936|449209625|FG000|Overall Study|Withdrawal by Subject|2|||
124758851|NCT01276639|448741154|FG001|Week 16 to 52|Other|12|||
124758852|NCT01276639|448741155|FG002|Week 16 to 52|Other|0|||
124684339|NCT03765073|448466083|FG001|Stage 3|Withdrawal by parent/guardian|0|||
124684340|NCT03765073|448466084|FG002|Stage 3|Withdrawal by parent/guardian|0|||
124684341|NCT03765073|448466085|FG003|Stage 3|Withdrawal by parent/guardian|0|||
124684342|NCT03765073|448466086|FG004|Stage 3|Withdrawal by parent/guardian|0|||
124758853|NCT01276639|448741156|FG003|Week 16 to 52|Other|1|||
124886500|NCT02366936|449209625|FG000|Overall Study|Lost to Follow-up|4|||
124684343|NCT03765073|448466087|FG005|Stage 3|Withdrawal by parent/guardian|0|||
124684344|NCT03765073|448466088|FG006|Stage 3|Withdrawal by parent/guardian|0|||
124684345|NCT03765073|448466089|FG007|Stage 3|Withdrawal by parent/guardian|0|||
124684346|NCT03765073|448466090|FG008|Stage 3|Withdrawal by parent/guardian|0|||
124684347|NCT03765073|448466091|FG009|Stage 3|Withdrawal by parent/guardian|0|||
124684348|NCT03765073|448466092|FG010|Stage 3|Withdrawal by parent/guardian|0|||
124684349|NCT03765073|448466093|FG011|Stage 3|Withdrawal by parent/guardian|0|||
124684350|NCT03765073|448466094|FG012|Stage 3|Withdrawal by parent/guardian|0|||
124684351|NCT03765073|448466095|FG013|Stage 3|Withdrawal by parent/guardian|0|||
124684352|NCT03765073|448466096|FG014|Stage 3|Withdrawal by parent/guardian|0|||
124684353|NCT03765073|448466097|FG015|Stage 3|Withdrawal by parent/guardian|0|||
124684354|NCT03765073|448466098|FG016|Stage 3|Withdrawal by parent/guardian|0|||
124684355|NCT03765073|448466099|FG017|Stage 3|Withdrawal by parent/guardian|0|||
124684356|NCT03765073|448466100|FG018|Stage 3|Withdrawal by parent/guardian|0|||
124684357|NCT03765073|448466101|FG019|Stage 3|Withdrawal by parent/guardian|6|||
124684358|NCT03765073|448466102|FG020|Stage 3|Withdrawal by parent/guardian|9|||
124684359|NCT03765073|448466082|FG000|Stage 3|Withdrawal by Subject|0|||
124684360|NCT03765073|448466083|FG001|Stage 3|Withdrawal by Subject|0|||
124684361|NCT03765073|448466084|FG002|Stage 3|Withdrawal by Subject|0|||
124684362|NCT03765073|448466085|FG003|Stage 3|Withdrawal by Subject|0|||
124684363|NCT03765073|448466086|FG004|Stage 3|Withdrawal by Subject|0|||
124684364|NCT03765073|448466087|FG005|Stage 3|Withdrawal by Subject|0|||
124684365|NCT03765073|448466088|FG006|Stage 3|Withdrawal by Subject|0|||
124684366|NCT03765073|448466089|FG007|Stage 3|Withdrawal by Subject|0|||
124684367|NCT03765073|448466090|FG008|Stage 3|Withdrawal by Subject|0|||
124684368|NCT03765073|448466091|FG009|Stage 3|Withdrawal by Subject|0|||
124684369|NCT03765073|448466092|FG010|Stage 3|Withdrawal by Subject|0|||
124684370|NCT03765073|448466093|FG011|Stage 3|Withdrawal by Subject|0|||
124684371|NCT03765073|448466094|FG012|Stage 3|Withdrawal by Subject|0|||
124684372|NCT03765073|448466095|FG013|Stage 3|Withdrawal by Subject|0|||
124684373|NCT03765073|448466096|FG014|Stage 3|Withdrawal by Subject|0|||
124684374|NCT03765073|448466097|FG015|Stage 3|Withdrawal by Subject|0|||
124684375|NCT03765073|448466098|FG016|Stage 3|Withdrawal by Subject|0|||
124684376|NCT03765073|448466099|FG017|Stage 3|Withdrawal by Subject|8|||
124684377|NCT03765073|448466100|FG018|Stage 3|Withdrawal by Subject|11|||
124684378|NCT03765073|448466101|FG019|Stage 3|Withdrawal by Subject|0|||
124684379|NCT03765073|448466102|FG020|Stage 3|Withdrawal by Subject|0|||
124684380|NCT02802228|448466117|FG000|Overall Study|Withdrawal by Subject|2|||
124684381|NCT02802228|448466118|FG001|Overall Study|Withdrawal by Subject|0|||
124684382|NCT02802228|448466117|FG000|Overall Study|Lost to Follow-up|1|||
124684383|NCT02802228|448466118|FG001|Overall Study|Lost to Follow-up|0|||
124684384|NCT02802228|448466117|FG000|Overall Study|Adverse Event|1|||
124684385|NCT02802228|448466118|FG001|Overall Study|Adverse Event|0|||
124684386|NCT02802228|448466117|FG000|Overall Study|Physician Decision|1|||
124684387|NCT02802228|448466118|FG001|Overall Study|Physician Decision|0|||
124684388|NCT00695019|448466119|FG000|Overall Study|Withdrawal by Subject|8|||
124684389|NCT00695019|448466120|FG001|Overall Study|Withdrawal by Subject|6|||
124684390|NCT00695019|448466121|FG002|Overall Study|Withdrawal by Subject|4|||
124684391|NCT00695019|448466119|FG000|Overall Study|Protocol Violation|1|||
124684392|NCT00695019|448466120|FG001|Overall Study|Protocol Violation|3|||
124684393|NCT00695019|448466121|FG002|Overall Study|Protocol Violation|1|||
124684394|NCT00695019|448466119|FG000|Overall Study|Lack of Efficacy|0|||
124684395|NCT00695019|448466120|FG001|Overall Study|Lack of Efficacy|0|||
124684396|NCT00695019|448466121|FG002|Overall Study|Lack of Efficacy|1|||
124684397|NCT00695019|448466119|FG000|Overall Study|Various|4|||
124684398|NCT00695019|448466120|FG001|Overall Study|Various|5|||
124684399|NCT00695019|448466121|FG002|Overall Study|Various|4|||
124684400|NCT03197129|448466128|FG000|Overall Study|did not answer the VPT: shyness|4|||
124684401|NCT03197129|448466129|FG001|Overall Study|did not answer the VPT: shyness|5|||
124684402|NCT02879695|448466132|FG000|Overall Study|Did not start study treatment|2|||
124684403|NCT02879695|448466133|FG001|Overall Study|Did not start study treatment|0|||
124684404|NCT02879695|448466134|FG002|Overall Study|Did not start study treatment|3|||
124684405|NCT02879695|448466135|FG003|Overall Study|Did not start study treatment|0|||
124684406|NCT02442349|448466136|FG000|Overall Study|Death|95|||
124684407|NCT02442349|448466136|FG000|Overall Study|Withdrawal by Subject|27|||
124684408|NCT02442349|448466136|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
124684409|NCT02442349|448466136|FG000|Overall Study|Lost to Follow-up|1|||
124684410|NCT03507790|448466137|FG000|Overall Study|Adverse Event|0|||
124684411|NCT03507790|448466138|FG001|Overall Study|Adverse Event|11|||
124684412|NCT03507790|448466139|FG002|Overall Study|Adverse Event|3|||
124684413|NCT03507790|448466137|FG000|Overall Study|Withdrawal by Subject|2|||
124758854|NCT01276639|448741157|FG004|Week 16 to 52|Other|3|||
124758855|NCT00330759|448741163|FG000|Overall Study|Death|316|||
124758856|NCT00330759|448741164|FG001|Overall Study|Death|310|||
124758857|NCT00330759|448741163|FG000|Overall Study|Disease progression|104|||
124758858|NCT00330759|448741164|FG001|Overall Study|Disease progression|126|||
124758859|NCT00330759|448741163|FG000|Overall Study|Withdrawal by Subject|143|||
124758860|NCT00330759|448741164|FG001|Overall Study|Withdrawal by Subject|124|||
124758861|NCT00330759|448741163|FG000|Overall Study|Adverse Event|48|||
124758862|NCT00330759|448741164|FG001|Overall Study|Adverse Event|36|||
124758863|NCT00330759|448741163|FG000|Overall Study|Participant request|31|||
124758864|NCT00330759|448741164|FG001|Overall Study|Participant request|22|||
124758865|NCT00330759|448741163|FG000|Overall Study|Lost to Follow-up|16|||
124758866|NCT00330759|448741164|FG001|Overall Study|Lost to Follow-up|22|||
124758867|NCT00330759|448741163|FG000|Overall Study|Noncompliance|15|||
124758868|NCT00330759|448741164|FG001|Overall Study|Noncompliance|17|||
124758869|NCT00330759|448741163|FG000|Overall Study|Physician Decision|1|||
124758870|NCT00330759|448741164|FG001|Overall Study|Physician Decision|2|||
124758871|NCT00330759|448741163|FG000|Overall Study|Protocol deviation|0|||
124758872|NCT00330759|448741164|FG001|Overall Study|Protocol deviation|2|||
124758873|NCT00330759|448741163|FG000|Overall Study|Ineligibility determined|2|||
124758874|NCT00330759|448741164|FG001|Overall Study|Ineligibility determined|1|||
124758875|NCT00330759|448741163|FG000|Overall Study|Other|36|||
124758876|NCT00330759|448741164|FG001|Overall Study|Other|44|||
124758877|NCT03654690|448741169|FG000|Overall Study|Withdrawal by Subject|1|||
124758878|NCT03654690|448741170|FG001|Overall Study|Withdrawal by Subject|0|||
124758879|NCT03654690|448741171|FG002|Overall Study|Withdrawal by Subject|0|||
124758880|NCT00742183|448741174|FG000|Overall Study|Adverse Event|2|||
124758881|NCT00742183|448741175|FG001|Overall Study|Adverse Event|2|||
124758882|NCT00742183|448741174|FG000|Overall Study|Death|1|||
124758883|NCT00742183|448741175|FG001|Overall Study|Death|0|||
124758884|NCT00742183|448741174|FG000|Overall Study|Physician Decision|0|||
124758885|NCT00742183|448741175|FG001|Overall Study|Physician Decision|2|||
124758886|NCT00742183|448741174|FG000|Overall Study|Lost to Follow-up|4|||
124758887|NCT00742183|448741175|FG001|Overall Study|Lost to Follow-up|4|||
124758888|NCT00742183|448741174|FG000|Overall Study|Required skin-graft|1|||
124758889|NCT00742183|448741175|FG001|Overall Study|Required skin-graft|1|||
124758890|NCT00742183|448741174|FG000|Overall Study|Withdrawal by Subject|1|||
124758891|NCT00742183|448741175|FG001|Overall Study|Withdrawal by Subject|0|||
124758892|NCT00742183|448741174|FG000|Overall Study|Lack of Efficacy|0|||
124758893|NCT00742183|448741175|FG001|Overall Study|Lack of Efficacy|3|||
124758894|NCT00786799|448741178|FG000|Overall Study|Lost to Follow-up|1|||
124758895|NCT00786799|448741179|FG001|Overall Study|Lost to Follow-up|1|||
124758896|NCT02544503|448741180|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
124758897|NCT02544503|448741181|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
124758898|NCT02544503|448741180|FG000|Overall Study|Lost to Follow-up|9|||
124758899|NCT02544503|448741181|FG001|Overall Study|Lost to Follow-up|0|||
124758900|NCT02544503|448741180|FG000|Overall Study|Withdrawal by Subject|1|||
124758901|NCT02544503|448741181|FG001|Overall Study|Withdrawal by Subject|0|||
124758902|NCT01080807|448741185|FG000|Overall Study|Adverse Event|9|||
124758903|NCT01080807|448741186|FG001|Overall Study|Adverse Event|1|||
124758904|NCT01080807|448741185|FG000|Overall Study|Lack of Efficacy|0|||
124758905|NCT01080807|448741186|FG001|Overall Study|Lack of Efficacy|1|||
124758906|NCT01080807|448741185|FG000|Overall Study|Withdrawal by Subject|7|||
124758907|NCT01080807|448741186|FG001|Overall Study|Withdrawal by Subject|2|||
124758908|NCT01080807|448741185|FG000|Overall Study|Protocol Violation|7|||
124758909|NCT01080807|448741186|FG001|Overall Study|Protocol Violation|6|||
124758910|NCT01080807|448741185|FG000|Overall Study|Lost to Follow-up|6|||
124758911|NCT01080807|448741186|FG001|Overall Study|Lost to Follow-up|4|||
124758912|NCT01080807|448741185|FG000|Overall Study|Noncompliance with drug administration|1|||
124758913|NCT01080807|448741186|FG001|Overall Study|Noncompliance with drug administration|1|||
124758914|NCT01080807|448741185|FG000|Overall Study|Noncompliance to study procedures|1|||
124758915|NCT01080807|448741186|FG001|Overall Study|Noncompliance to study procedures|1|||
124758916|NCT01080807|448741185|FG000|Overall Study|Began working day shift|0|||
124758917|NCT01080807|448741186|FG001|Overall Study|Began working day shift|2|||
124758918|NCT01080807|448741185|FG000|Overall Study|Laid off or terminated from job|1|||
124758919|NCT01080807|448741186|FG001|Overall Study|Laid off or terminated from job|2|||
124684414|NCT03507790|448466138|FG001|Overall Study|Withdrawal by Subject|0|||
124684415|NCT03507790|448466139|FG002|Overall Study|Withdrawal by Subject|0|||
124684416|NCT03507790|448466137|FG000|Overall Study|Subject moved to another location|1|||
124684417|NCT03507790|448466138|FG001|Overall Study|Subject moved to another location|2|||
124684418|NCT03507790|448466139|FG002|Overall Study|Subject moved to another location|0|||
124684419|NCT03507790|448466137|FG000|Overall Study|Non-compliance with study drug|0|||
124684420|NCT03507790|448466138|FG001|Overall Study|Non-compliance with study drug|0|||
124684421|NCT03507790|448466139|FG002|Overall Study|Non-compliance with study drug|1|||
124684422|NCT03507790|448466137|FG000|Overall Study|COVID 19 Pandemic|0|||
124684423|NCT03507790|448466138|FG001|Overall Study|COVID 19 Pandemic|1|||
124684424|NCT03507790|448466139|FG002|Overall Study|COVID 19 Pandemic|0|||
124684425|NCT03507790|448466137|FG000|Overall Study|Lost to Follow-up|0|||
124684426|NCT03507790|448466138|FG001|Overall Study|Lost to Follow-up|1|||
124684427|NCT03507790|448466139|FG002|Overall Study|Lost to Follow-up|0|||
124684428|NCT03507790|448466137|FG000|Overall Study|Discontinuation of the trial at the site|1|||
124684429|NCT03507790|448466138|FG001|Overall Study|Discontinuation of the trial at the site|1|||
124684430|NCT03507790|448466139|FG002|Overall Study|Discontinuation of the trial at the site|0|||
124684431|NCT03507790|448466137|FG000|Overall Study|Randomized in error|0|||
124886501|NCT02366936|449209625|FG000|Overall Study|Physician Decision|2|||
124886502|NCT03358329|449209628|FG000|Overall Study|Lost to Follow-up|2|||
124886503|NCT03358329|449209628|FG000|Overall Study|Withdrawal by Subject|2|||
124886504|NCT01313923|449209629|FG000|Overall Study|Physician Decision|3|||
124886505|NCT02471404|449209630|FG000|Overall Study|Adverse Event|7|||
124886506|NCT02471404|449209631|FG001|Overall Study|Adverse Event|1|||
124886507|NCT02471404|449209632|FG002|Overall Study|Adverse Event|2|||
124886508|NCT02471404|449209630|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
124886509|NCT02471404|449209631|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
124886510|NCT02471404|449209632|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
124886511|NCT02471404|449209630|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
124886512|NCT02471404|449209631|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
124886513|NCT02471404|449209632|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
124886514|NCT02471404|449209630|FG000|Overall Study|Lost to Follow-up|1|||
124886515|NCT02471404|449209631|FG001|Overall Study|Lost to Follow-up|1|||
124886516|NCT02471404|449209632|FG002|Overall Study|Lost to Follow-up|3|||
124886517|NCT02471404|449209630|FG000|Overall Study|Protocol Violation|1|||
124684432|NCT03507790|448466138|FG001|Overall Study|Randomized in error|0|||
124684433|NCT03507790|448466139|FG002|Overall Study|Randomized in error|1|||
124684434|NCT01160614|448466142|FG000|Overall Study|Withdrawal by Subject|0|||
124684435|NCT01160614|448466143|FG001|Overall Study|Withdrawal by Subject|2|||
124684436|NCT05845619|448466144|FG000|Overall Study|duplicate enrollment|2|||
124684437|NCT05845619|448466145|FG001|Overall Study|duplicate enrollment|2|||
124684438|NCT05845619|448466146|FG002|Overall Study|duplicate enrollment|1|||
124684439|NCT03636477|448466147|FG000|Overall Study|Adverse Event|0|||
124684440|NCT03636477|448466148|FG001|Overall Study|Adverse Event|0|||
124684441|NCT03636477|448466149|FG002|Overall Study|Adverse Event|1|||
124684442|NCT03621592|448466150|FG000|Overall Study|Lost to Follow-up|1|||
124684443|NCT03621592|448466151|FG001|Overall Study|Lost to Follow-up|0|||
124684444|NCT03621592|448466150|FG000|Overall Study|Lack of Improvement|1|||
124684445|NCT03621592|448466151|FG001|Overall Study|Lack of Improvement|0|||
124684446|NCT03621592|448466150|FG000|Overall Study|Preference to receive wound care closer to home|1|||
124684447|NCT03621592|448466151|FG001|Overall Study|Preference to receive wound care closer to home|0|||
124684448|NCT03621592|448466150|FG000|Overall Study|Lack of healing|0|||
124886518|NCT02471404|449209631|FG001|Overall Study|Protocol Violation|0|||
124684449|NCT03621592|448466151|FG001|Overall Study|Lack of healing|2|||
124684450|NCT02382380|448466152|FG000|Overall Study|Withdrawal by Subject|2|||
124684451|NCT02382380|448466153|FG001|Overall Study|Withdrawal by Subject|2|||
124684452|NCT02382380|448466152|FG000|Overall Study|Lost to Follow-up|0|||
124684453|NCT02382380|448466153|FG001|Overall Study|Lost to Follow-up|1|||
124684454|NCT04153864|448466161|FG000|Overall Study|Withdrawal by Subject|21|||
124684455|NCT04153864|448466162|FG001|Overall Study|Withdrawal by Subject|7|||
124684456|NCT04153864|448466163|FG002|Overall Study|Withdrawal by Subject|23|||
124684457|NCT04153864|448466164|FG003|Overall Study|Withdrawal by Subject|2|||
124684458|NCT04153864|448466161|FG000|Overall Study|Lost to Follow-up|4|||
124684459|NCT04153864|448466162|FG001|Overall Study|Lost to Follow-up|0|||
124684460|NCT04153864|448466163|FG002|Overall Study|Lost to Follow-up|3|||
124684461|NCT04153864|448466164|FG003|Overall Study|Lost to Follow-up|0|||
124684462|NCT04153864|448466161|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
124684463|NCT04153864|448466162|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
124684464|NCT04153864|448466163|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
124886519|NCT02471404|449209632|FG002|Overall Study|Protocol Violation|0|||
124886520|NCT02471404|449209630|FG000|Overall Study|Withdrawal by Subject|8|||
124684465|NCT04153864|448466164|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
124684466|NCT00569127|448466165|FG000|Overall Study|Adverse Event|57|||
124684467|NCT00569127|448466166|FG001|Overall Study|Adverse Event|47|||
124684468|NCT00569127|448466165|FG000|Overall Study|Withdrawal by Subject|13|||
124684469|NCT00569127|448466166|FG001|Overall Study|Withdrawal by Subject|27|||
124684470|NCT00569127|448466165|FG000|Overall Study|Progression|99|||
124684471|NCT00569127|448466166|FG001|Overall Study|Progression|100|||
124684472|NCT00569127|448466165|FG000|Overall Study|Death|4|||
124684473|NCT00569127|448466166|FG001|Overall Study|Death|3|||
124684474|NCT00569127|448466165|FG000|Overall Study|Other|20|||
124684475|NCT00569127|448466166|FG001|Overall Study|Other|19|||
124684476|NCT00569127|448466165|FG000|Overall Study|Lost to Follow-up|0|||
124684477|NCT00569127|448466166|FG001|Overall Study|Lost to Follow-up|3|||
124684478|NCT00569127|448466165|FG000|Overall Study|Not Eligible|14|||
124684479|NCT00569127|448466166|FG001|Overall Study|Not Eligible|11|||
124684480|NCT00569127|448466165|FG000|Overall Study|Still on Treatment|7|||
124684481|NCT00569127|448466166|FG001|Overall Study|Still on Treatment|3|||
124684482|NCT04279522|448466168|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
124684483|NCT04279522|448466169|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
124684484|NCT04279522|448466168|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
124684485|NCT04279522|448466169|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
124684486|NCT04279522|448466168|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
124684487|NCT04279522|448466169|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
124684488|NCT04279522|448466168|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
124684489|NCT04279522|448466169|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
124684490|NCT04279522|448466168|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
124684491|NCT04279522|448466169|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
124684492|NCT04279522|448466168|FG000|Period 2: Open Label Phase|Physician Decision|0|||
124684493|NCT04279522|448466169|FG001|Period 2: Open Label Phase|Physician Decision|3|||
124684494|NCT04279522|448466168|FG000|Period 2: Open Label Phase|Adverse Event|0|||
124684495|NCT04279522|448466169|FG001|Period 2: Open Label Phase|Adverse Event|1|||
124684496|NCT04279522|448466168|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
124684497|NCT04279522|448466169|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
124684498|NCT00724945|448466170|FG000|Period 1|non-compliance|1|||
124684499|NCT00724945|448466171|FG001|Period 1|non-compliance|0|||
124684500|NCT00724945|448466170|FG000|Period 1|Adverse Event|1|||
124684501|NCT00724945|448466171|FG001|Period 1|Adverse Event|1|||
124684502|NCT00724945|448466170|FG000|Period 1|Lost to Follow-up|1|||
124684503|NCT00724945|448466171|FG001|Period 1|Lost to Follow-up|0|||
124684504|NCT00724945|448466170|FG000|Period 2|lens comfort issue|3|||
124684505|NCT00724945|448466171|FG001|Period 2|lens comfort issue|0|||
124684506|NCT00724945|448466170|FG000|Period 2|lens physiology issue|1|||
124684507|NCT00724945|448466171|FG001|Period 2|lens physiology issue|0|||
124684508|NCT04817410|448468069|FG000|Overall Study|Withdrawal by Subject|5|||
124684509|NCT04817410|448468069|FG000|Overall Study|Physician Decision|3|||
124684510|NCT01970371|448468070|FG000|Overall Study|Death|8|||
124684511|NCT01970371|448468071|FG001|Overall Study|Death|13|||
124684512|NCT01970371|448468072|FG002|Overall Study|Death|12|||
124684513|NCT01970371|448468070|FG000|Overall Study|Lost to Follow-up|0|||
124684514|NCT01970371|448468071|FG001|Overall Study|Lost to Follow-up|0|||
124684515|NCT01970371|448468072|FG002|Overall Study|Lost to Follow-up|1|||
124684516|NCT01348269|448468073|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
124684517|NCT01348269|448468074|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
124684518|NCT01348269|448468073|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
124684519|NCT01348269|448468074|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
124684520|NCT01348269|448468073|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
124684521|NCT01348269|448468074|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
124684522|NCT04727749|448468075|FG000|Overall Study|Lost to Follow-up|10|||
124684523|NCT04727749|448468076|FG001|Overall Study|Lost to Follow-up|3|||
124684524|NCT01481779|448468077|FG000|Overall Study|Adverse Event|23|||
124684525|NCT01481779|448468078|FG001|Overall Study|Adverse Event|5|||
124684526|NCT01481779|448468077|FG000|Overall Study|Lost to Follow-up|3|||
124684527|NCT01481779|448468078|FG001|Overall Study|Lost to Follow-up|2|||
124684528|NCT01481779|448468077|FG000|Overall Study|Protocol Violation|2|||
124684529|NCT01481779|448468078|FG001|Overall Study|Protocol Violation|3|||
124684530|NCT01481779|448468077|FG000|Overall Study|Withdrawal by Subject|26|||
124684531|NCT01481779|448468078|FG001|Overall Study|Withdrawal by Subject|13|||
124684532|NCT01481779|448468077|FG000|Overall Study|Physician Decision|13|||
124684533|NCT01481779|448468078|FG001|Overall Study|Physician Decision|4|||
124684534|NCT01481779|448468077|FG000|Overall Study|Sponsor Decision|3|||
124684535|NCT01481779|448468078|FG001|Overall Study|Sponsor Decision|1|||
124684536|NCT02378181|448468079|FG000|Overall Study|Lost to Follow-up|2|||
124684537|NCT02378181|448468080|FG001|Overall Study|Lost to Follow-up|5|||
124684538|NCT02378181|448468079|FG000|Overall Study|Withdrawal by Subject|1|||
124684539|NCT02378181|448468080|FG001|Overall Study|Withdrawal by Subject|1|||
124684540|NCT02378181|448468079|FG000|Overall Study|Incarcerated|0|||
124684541|NCT02378181|448468080|FG001|Overall Study|Incarcerated|1|||
124684542|NCT03517137|448468091|FG000|Overall Study|Lack of Efficacy|1|||
124684543|NCT03517137|448468091|FG000|Overall Study|Adverse Event|2|||
124684544|NCT03517137|448468091|FG000|Overall Study|Withdrawal by Subject|2|||
124684545|NCT03517137|448468091|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
124684546|NCT02313155|448468093|FG000|Overall Study|Lost to Follow-up|0|||
124684547|NCT02313155|448468094|FG001|Overall Study|Lost to Follow-up|1|||
124684548|NCT00689936|448468095|FG000|Active Treatment Phase|Adverse Event|68|||
124684549|NCT00689936|448468096|FG001|Active Treatment Phase|Adverse Event|71|||
124684550|NCT00689936|448468097|FG002|Active Treatment Phase|Adverse Event|76|||
124684551|NCT00689936|448468095|FG000|Active Treatment Phase|Disease Progression|273|||
124684552|NCT00689936|448468096|FG001|Active Treatment Phase|Disease Progression|362|||
124684553|NCT00689936|448468097|FG002|Active Treatment Phase|Disease Progression|339|||
124684554|NCT00689936|448468095|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
124684555|NCT00689936|448468096|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
124684556|NCT00689936|448468097|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
124684557|NCT00689936|448468095|FG000|Active Treatment Phase|Death|60|||
124684558|NCT00689936|448468096|FG001|Active Treatment Phase|Death|28|||
124684559|NCT00689936|448468097|FG002|Active Treatment Phase|Death|37|||
124684560|NCT00689936|448468095|FG000|Active Treatment Phase|Lost to Follow-up|0|||
124758920|NCT01080807|448741185|FG000|Overall Study|Stopped working consistent night shifts|0|||
124758921|NCT01080807|448741186|FG001|Overall Study|Stopped working consistent night shifts|1|||
124758922|NCT01080807|448741185|FG000|Overall Study|Work schedule changing|1|||
124758923|NCT01080807|448741186|FG001|Overall Study|Work schedule changing|1|||
124758924|NCT01080807|448741185|FG000|Overall Study|Work schedule and travel|0|||
124886521|NCT02471404|449209631|FG001|Overall Study|Withdrawal by Subject|4|||
124886522|NCT02471404|449209632|FG002|Overall Study|Withdrawal by Subject|5|||
124886523|NCT02471404|449209630|FG000|Overall Study|Other reasons not specified|10|||
124886524|NCT02471404|449209631|FG001|Overall Study|Other reasons not specified|7|||
124886525|NCT02471404|449209632|FG002|Overall Study|Other reasons not specified|12|||
124886526|NCT02982720|449209633|FG000|Overall Study|Adverse Event|3|||
124886527|NCT02982720|449209633|FG000|Overall Study|Death|1|||
124886528|NCT00305864|449209636|FG000|Overall Study|Ineligible / No protocol treatment|0|||
124886529|NCT00305864|449209637|FG001|Overall Study|Ineligible / No protocol treatment|1|||
124886530|NCT00305864|449209638|FG002|Overall Study|Ineligible / No protocol treatment|1|||
124886531|NCT00305864|449209639|FG003|Overall Study|Ineligible / No protocol treatment|13|||
124886532|NCT02836613|449209642|FG000|Overall Study|Accidental drowning|1|||
124886533|NCT02836613|449209643|FG001|Overall Study|Accidental drowning|0|||
124886534|NCT02836613|449209642|FG000|Overall Study|Lost to Follow-up|0|||
124886535|NCT02836613|449209643|FG001|Overall Study|Lost to Follow-up|1|||
124886536|NCT02836613|449209642|FG000|Overall Study|Withdrawal by Subject|0|||
124886537|NCT02836613|449209643|FG001|Overall Study|Withdrawal by Subject|2|||
124886538|NCT03881059|449209644|FG000|Treatment Period - Part A|Adverse Event|1|||
124886539|NCT03881059|449209645|FG001|Treatment Period - Part A|Adverse Event|3|||
124886540|NCT03881059|449209646|FG002|Treatment Period - Part A|Adverse Event|4|||
124886541|NCT03881059|449209644|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
124886542|NCT03881059|449209645|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
124886543|NCT03881059|449209646|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
124886544|NCT03881059|449209644|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
124886545|NCT03881059|449209645|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
124886546|NCT03881059|449209646|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
124886547|NCT03881059|449209644|FG000|Treatment Period - Part A|Other reasons|2|||
124886548|NCT03881059|449209645|FG001|Treatment Period - Part A|Other reasons|1|||
124886549|NCT03881059|449209646|FG002|Treatment Period - Part A|Other reasons|0|||
124886550|NCT03881059|449209644|FG000|Treatment Period - Part B|Adverse Event|0|||
124886551|NCT03881059|449209645|FG001|Treatment Period - Part B|Adverse Event|0|||
124886552|NCT03881059|449209646|FG002|Treatment Period - Part B|Adverse Event|3|||
124886553|NCT03881059|449209644|FG000|Treatment Period - Part B|Death|0|||
124886554|NCT03881059|449209645|FG001|Treatment Period - Part B|Death|1|||
124886555|NCT03881059|449209646|FG002|Treatment Period - Part B|Death|1|||
124886556|NCT03881059|449209644|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
124886557|NCT03881059|449209645|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
124684561|NCT00689936|448468096|FG001|Active Treatment Phase|Lost to Follow-up|2|||
124684562|NCT00689936|448468097|FG002|Active Treatment Phase|Lost to Follow-up|2|||
124684563|NCT00689936|448468095|FG000|Active Treatment Phase|Protocol Violation|2|||
124684564|NCT00689936|448468096|FG001|Active Treatment Phase|Protocol Violation|2|||
124684565|NCT00689936|448468097|FG002|Active Treatment Phase|Protocol Violation|4|||
124684566|NCT00689936|448468095|FG000|Active Treatment Phase|Study Close Out|64|||
124684567|NCT00689936|448468096|FG001|Active Treatment Phase|Study Close Out|26|||
124684568|NCT00689936|448468097|FG002|Active Treatment Phase|Study Close Out|21|||
124684569|NCT00689936|448468095|FG000|Active Treatment Phase|Miscellaneous|52|||
124758925|NCT01080807|448741186|FG001|Overall Study|Work schedule and travel|1|||
124886558|NCT03881059|449209646|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
124886559|NCT03881059|449209644|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
124684570|NCT00689936|448468096|FG001|Active Treatment Phase|Miscellaneous|34|||
124684571|NCT00689936|448468097|FG002|Active Treatment Phase|Miscellaneous|47|||
124684572|NCT00689936|448468095|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
124684573|NCT00689936|448468096|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
124684574|NCT00689936|448468097|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
124684575|NCT01303419|448468100|FG000|Overall Study|Discontinuation of study|60|||
124684576|NCT01303419|448468100|FG000|Overall Study|Did not complete both imaging methods|5|||
124684577|NCT01303419|448468100|FG000|Overall Study|Did not meet all I/E after screening|31|||
124684578|NCT01995201|448468101|FG000|From Baseline Until Week 24|Adverse Event|4|||
124684579|NCT01995201|448468102|FG001|From Baseline Until Week 24|Adverse Event|15|||
124684580|NCT01995201|448468103|FG002|From Baseline Until Week 24|Adverse Event|0|||
124684581|NCT01995201|448468104|FG003|From Baseline Until Week 24|Adverse Event|0|||
124684582|NCT01995201|448468105|FG004|From Baseline Until Week 24|Adverse Event|0|||
124684583|NCT01995201|448468106|FG005|From Baseline Until Week 24|Adverse Event|0|||
124684584|NCT01995201|448468107|FG006|From Baseline Until Week 24|Adverse Event|0|||
124684585|NCT01995201|448468101|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
124684586|NCT01995201|448468102|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
124684587|NCT01995201|448468103|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
124684588|NCT01995201|448468104|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
124684589|NCT01995201|448468105|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
124684590|NCT01995201|448468106|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
124684591|NCT01995201|448468107|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
124684592|NCT01995201|448468101|FG000|From Baseline Until Week 24|Death|0|||
124684593|NCT01995201|448468102|FG001|From Baseline Until Week 24|Death|1|||
124684594|NCT01995201|448468103|FG002|From Baseline Until Week 24|Death|0|||
124684595|NCT01995201|448468104|FG003|From Baseline Until Week 24|Death|0|||
124684596|NCT01995201|448468105|FG004|From Baseline Until Week 24|Death|0|||
124684597|NCT01995201|448468106|FG005|From Baseline Until Week 24|Death|0|||
124684598|NCT01995201|448468107|FG006|From Baseline Until Week 24|Death|0|||
124684599|NCT01995201|448468101|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
124684600|NCT01995201|448468102|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
124684601|NCT01995201|448468103|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
124684602|NCT01995201|448468104|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
124684603|NCT01995201|448468105|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
124684604|NCT01995201|448468106|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
124684605|NCT01995201|448468107|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
124684606|NCT01995201|448468101|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
124684607|NCT01995201|448468102|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
124684608|NCT01995201|448468103|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
124684609|NCT01995201|448468104|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
124684610|NCT01995201|448468105|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
124684611|NCT01995201|448468106|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
124684612|NCT01995201|448468107|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
124684613|NCT01995201|448468101|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
124684614|NCT01995201|448468102|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
124684615|NCT01995201|448468103|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
124684616|NCT01995201|448468104|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
124684617|NCT01995201|448468105|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
124684618|NCT01995201|448468106|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
124684619|NCT01995201|448468107|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
124684620|NCT01995201|448468101|FG000|From Baseline Until Week 24|Physician Decision|0|||
124684621|NCT01995201|448468102|FG001|From Baseline Until Week 24|Physician Decision|2|||
124684622|NCT01995201|448468103|FG002|From Baseline Until Week 24|Physician Decision|0|||
124684623|NCT01995201|448468104|FG003|From Baseline Until Week 24|Physician Decision|0|||
124684624|NCT01995201|448468105|FG004|From Baseline Until Week 24|Physician Decision|0|||
124684625|NCT01995201|448468106|FG005|From Baseline Until Week 24|Physician Decision|0|||
124684626|NCT01995201|448468107|FG006|From Baseline Until Week 24|Physician Decision|0|||
124684627|NCT01995201|448468101|FG000|From Baseline Until Week 24|Protocol Violation|0|||
124684628|NCT01995201|448468102|FG001|From Baseline Until Week 24|Protocol Violation|9|||
124684629|NCT01995201|448468103|FG002|From Baseline Until Week 24|Protocol Violation|0|||
124684630|NCT01995201|448468104|FG003|From Baseline Until Week 24|Protocol Violation|0|||
124684631|NCT01995201|448468105|FG004|From Baseline Until Week 24|Protocol Violation|0|||
124684632|NCT01995201|448468106|FG005|From Baseline Until Week 24|Protocol Violation|0|||
124684633|NCT01995201|448468107|FG006|From Baseline Until Week 24|Protocol Violation|0|||
124684634|NCT01995201|448468101|FG000|From Week 24 Until Week 48|Adverse Event|0|||
124684635|NCT01995201|448468102|FG001|From Week 24 Until Week 48|Adverse Event|0|||
124684636|NCT01995201|448468103|FG002|From Week 24 Until Week 48|Adverse Event|2|||
124684637|NCT01995201|448468104|FG003|From Week 24 Until Week 48|Adverse Event|1|||
124684638|NCT01995201|448468105|FG004|From Week 24 Until Week 48|Adverse Event|1|||
124684639|NCT01995201|448468106|FG005|From Week 24 Until Week 48|Adverse Event|3|||
124886560|NCT03881059|449209645|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
124886561|NCT03881059|449209646|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
124684640|NCT01995201|448468107|FG006|From Week 24 Until Week 48|Adverse Event|1|||
124684641|NCT01995201|448468101|FG000|From Week 24 Until Week 48|Death|0|||
124886562|NCT03881059|449209644|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
124886563|NCT03881059|449209645|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
124886564|NCT03881059|449209646|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
124684642|NCT01995201|448468102|FG001|From Week 24 Until Week 48|Death|0|||
124684643|NCT01995201|448468103|FG002|From Week 24 Until Week 48|Death|0|||
124684644|NCT01995201|448468104|FG003|From Week 24 Until Week 48|Death|0|||
124684645|NCT01995201|448468105|FG004|From Week 24 Until Week 48|Death|0|||
124684646|NCT01995201|448468106|FG005|From Week 24 Until Week 48|Death|2|||
124684647|NCT01995201|448468107|FG006|From Week 24 Until Week 48|Death|0|||
124684648|NCT01995201|448468101|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
124684649|NCT01995201|448468102|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
124684650|NCT01995201|448468103|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
124684651|NCT01995201|448468104|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
124684652|NCT01995201|448468105|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
124684653|NCT01995201|448468106|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
124684654|NCT01995201|448468107|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
124684655|NCT01995201|448468101|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
124684656|NCT01995201|448468102|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
124684657|NCT01995201|448468103|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
124684658|NCT01995201|448468104|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
124684659|NCT01995201|448468105|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
124684660|NCT01995201|448468106|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
124684661|NCT01995201|448468107|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
124684662|NCT01995201|448468101|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
124684663|NCT01995201|448468102|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
124684664|NCT01995201|448468103|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
124684665|NCT01995201|448468104|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
124684666|NCT01995201|448468105|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
124684667|NCT01995201|448468106|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
124684668|NCT01995201|448468107|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
124684669|NCT01995201|448468101|FG000|From Week 24 Until Week 48|Physician Decision|0|||
124684670|NCT01995201|448468102|FG001|From Week 24 Until Week 48|Physician Decision|0|||
124684671|NCT01995201|448468103|FG002|From Week 24 Until Week 48|Physician Decision|0|||
124684672|NCT01995201|448468104|FG003|From Week 24 Until Week 48|Physician Decision|0|||
124684673|NCT01995201|448468105|FG004|From Week 24 Until Week 48|Physician Decision|1|||
124684674|NCT01995201|448468106|FG005|From Week 24 Until Week 48|Physician Decision|0|||
124684675|NCT01995201|448468107|FG006|From Week 24 Until Week 48|Physician Decision|0|||
124684676|NCT01995201|448468101|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
124684677|NCT01995201|448468102|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
124684678|NCT01995201|448468103|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
124684679|NCT01995201|448468104|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
124886565|NCT03881059|449209644|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
124886566|NCT03881059|449209645|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
124886567|NCT03881059|449209646|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
124886568|NCT03881059|449209644|FG000|Treatment Period - Part B|Other reasons|4|||
124886569|NCT03881059|449209645|FG001|Treatment Period - Part B|Other reasons|3|||
124886570|NCT03881059|449209646|FG002|Treatment Period - Part B|Other reasons|3|||
124886571|NCT05284019|449209647|FG000|Overall Study|Study terminated|2|||
124886572|NCT05284019|449209648|FG001|Overall Study|Study terminated|2|||
124886573|NCT05284019|449209649|FG002|Overall Study|Study terminated|2|||
124886574|NCT05284019|449209650|FG003|Overall Study|Study terminated|5|||
124886575|NCT05284019|449209651|FG004|Overall Study|Study terminated|15|||
124886576|NCT05284019|449209647|FG000|Overall Study|Withdrawal by Subject|0|||
124886577|NCT05284019|449209648|FG001|Overall Study|Withdrawal by Subject|0|||
124886578|NCT05284019|449209649|FG002|Overall Study|Withdrawal by Subject|0|||
124886579|NCT05284019|449209650|FG003|Overall Study|Withdrawal by Subject|1|||
124684680|NCT01995201|448468105|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
124684681|NCT01995201|448468106|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
124886580|NCT05284019|449209651|FG004|Overall Study|Withdrawal by Subject|1|||
124684682|NCT01995201|448468107|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
124684683|NCT05376358|448468111|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
124684684|NCT05376358|448468112|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
124886581|NCT05284019|449209647|FG000|Overall Study|Lost to Follow-up|1|||
124886582|NCT05284019|449209648|FG001|Overall Study|Lost to Follow-up|0|||
124886583|NCT05284019|449209649|FG002|Overall Study|Lost to Follow-up|0|||
124886584|NCT05284019|449209650|FG003|Overall Study|Lost to Follow-up|2|||
124440009|NCT00069238|447570895|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
124684685|NCT05376358|448468111|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
124684686|NCT05376358|448468112|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
124684687|NCT05376358|448468111|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
124684688|NCT05376358|448468112|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
124684689|NCT05376358|448468111|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
124684690|NCT05376358|448468112|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
124684691|NCT05376358|448468111|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
124684692|NCT05376358|448468112|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
124684693|NCT05376358|448468111|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
124684694|NCT05376358|448468112|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
124684695|NCT02452190|448468113|FG000|Overall Study|Withdrawal by Sponsor|1|||
124684696|NCT02452190|448468114|FG001|Overall Study|Withdrawal by Sponsor|3|||
124684697|NCT02452190|448468113|FG000|Overall Study|Pregnancy|1|||
124684698|NCT02452190|448468114|FG001|Overall Study|Pregnancy|0|||
124684699|NCT02452190|448468113|FG000|Overall Study|Investigator's Decision|2|||
124684700|NCT02452190|448468114|FG001|Overall Study|Investigator's Decision|0|||
124684701|NCT02452190|448468113|FG000|Overall Study|Lack of Efficacy|3|||
124684702|NCT02452190|448468114|FG001|Overall Study|Lack of Efficacy|1|||
124684703|NCT02452190|448468113|FG000|Overall Study|Lost to Follow-up|4|||
124684704|NCT02452190|448468114|FG001|Overall Study|Lost to Follow-up|3|||
124684705|NCT02452190|448468113|FG000|Overall Study|Adverse Event|2|||
124684706|NCT02452190|448468114|FG001|Overall Study|Adverse Event|5|||
124684707|NCT02452190|448468113|FG000|Overall Study|Withdrawal by Subject|20|||
124684708|NCT02452190|448468114|FG001|Overall Study|Withdrawal by Subject|11|||
124684709|NCT02452190|448468113|FG000|Overall Study|Noncompliance with study drug|1|||
124684710|NCT02452190|448468114|FG001|Overall Study|Noncompliance with study drug|0|||
124684711|NCT02452190|448468113|FG000|Overall Study|Participant traveled abroad|1|||
124684712|NCT02452190|448468114|FG001|Overall Study|Participant traveled abroad|0|||
124684713|NCT02452190|448468113|FG000|Overall Study|Death|0|||
124684714|NCT02452190|448468114|FG001|Overall Study|Death|1|||
124684715|NCT02327078|448468119|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
124886585|NCT05284019|449209651|FG004|Overall Study|Lost to Follow-up|1|||
124886586|NCT00287469|449209652|FG000|Overall Study|serious adverse event|1|||
124886587|NCT00287469|449209653|FG001|Overall Study|serious adverse event|6|||
124886588|NCT00287469|449209652|FG000|Overall Study|Adverse Event|1|||
124886589|NCT00287469|449209653|FG001|Overall Study|Adverse Event|1|||
124886590|NCT00287469|449209652|FG000|Overall Study|moved from area|144|||
124886591|NCT00287469|449209653|FG001|Overall Study|moved from area|138|||
124886592|NCT00287469|449209652|FG000|Overall Study|Lost to Follow-up|74|||
124886593|NCT00287469|449209653|FG001|Overall Study|Lost to Follow-up|69|||
124886594|NCT01266993|449209656|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
124886595|NCT01266993|449209657|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
124886596|NCT01266993|449209656|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
124886597|NCT01266993|449209657|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
124886598|NCT02942004|449209658|FG000|Overall Study|Withdrawal by Subject|0|||
124886599|NCT02942004|449209659|FG001|Overall Study|Withdrawal by Subject|2|||
124886600|NCT02942004|449209660|FG002|Overall Study|Withdrawal by Subject|3|||
124886601|NCT02942004|449209658|FG000|Overall Study|Lost to Follow-up|1|||
124886602|NCT02942004|449209659|FG001|Overall Study|Lost to Follow-up|1|||
124886603|NCT02942004|449209660|FG002|Overall Study|Lost to Follow-up|2|||
124886604|NCT02942004|449209658|FG000|Overall Study|Randomized but not dosed|3|||
124886605|NCT02942004|449209659|FG001|Overall Study|Randomized but not dosed|9|||
124886606|NCT02942004|449209660|FG002|Overall Study|Randomized but not dosed|4|||
124886607|NCT03382600|449209661|FG000|Overall Study|Adverse Event|3|||
124886608|NCT03382600|449209662|FG001|Overall Study|Adverse Event|3|||
124886609|NCT03382600|449209661|FG000|Overall Study|Clinical Disease Progression|2|||
124886610|NCT03382600|449209662|FG001|Overall Study|Clinical Disease Progression|4|||
124886611|NCT03382600|449209661|FG000|Overall Study|Radiological Progression|40|||
124886612|NCT03382600|449209662|FG001|Overall Study|Radiological Progression|31|||
124886613|NCT03382600|449209661|FG000|Overall Study|Withdrawal by Subject|0|||
124684716|NCT02327078|448468120|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
124886614|NCT03382600|449209662|FG001|Overall Study|Withdrawal by Subject|1|||
124886615|NCT03382600|449209661|FG000|Overall Study|Other|9|||
124684717|NCT02327078|448468121|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
124684718|NCT02327078|448468122|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
124886616|NCT03382600|449209662|FG001|Overall Study|Other|7|||
124886617|NCT01448044|449209663|FG000|Treatment Period|Adverse Event|4|||
124886618|NCT01448044|449209664|FG001|Treatment Period|Adverse Event|3|||
124886619|NCT01448044|449209663|FG000|Treatment Period|Lack of Efficacy|5|||
124886620|NCT01448044|449209664|FG001|Treatment Period|Lack of Efficacy|12|||
124886621|NCT01448044|449209663|FG000|Treatment Period|Subject requested discontinue study drug|1|||
124886622|NCT01448044|449209664|FG001|Treatment Period|Subject requested discontinue study drug|0|||
124886623|NCT01448044|449209663|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
124886624|NCT01448044|449209664|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
124886625|NCT01448044|449209663|FG000|Treatment Period|Participant does not meet study criteria|1|||
124886626|NCT01448044|449209664|FG001|Treatment Period|Participant does not meet study criteria|0|||
124886627|NCT01448044|449209663|FG000|Treatment Period|Lost to Follow-up|2|||
124886628|NCT01448044|449209664|FG001|Treatment Period|Lost to Follow-up|1|||
124886629|NCT01448044|449209663|FG000|Treatment Period|Other reason|2|||
124886630|NCT01448044|449209664|FG001|Treatment Period|Other reason|0|||
124886631|NCT01448044|449209663|FG000|Follow Up Period|Withdrawal by Subject|1|||
124440010|NCT00069238|447570893|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
124440011|NCT00069238|447570894|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
124440012|NCT00069238|447570895|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
124440013|NCT00069238|447570893|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
124684719|NCT02327078|448468123|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
124684720|NCT02327078|448468124|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
124684721|NCT02327078|448468125|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
124684722|NCT02327078|448468126|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
124684723|NCT02327078|448468127|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
124684724|NCT02327078|448468119|FG000|Overall Study|Death|2|||
124684725|NCT02327078|448468120|FG001|Overall Study|Death|4|||
124684726|NCT02327078|448468121|FG002|Overall Study|Death|10|||
124684727|NCT02327078|448468122|FG003|Overall Study|Death|6|||
124684728|NCT02327078|448468123|FG004|Overall Study|Death|4|||
124684729|NCT02327078|448468124|FG005|Overall Study|Death|3|||
124684730|NCT02327078|448468125|FG006|Overall Study|Death|2|||
124684731|NCT02327078|448468126|FG007|Overall Study|Death|51|||
124440014|NCT00069238|447570894|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
124440015|NCT00069238|447570895|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
124440016|NCT00807235|447570900|FG000|Overall Study|Adverse Event|1|||
124440017|NCT00807235|447570901|FG001|Overall Study|Adverse Event|0|||
124440018|NCT01765179|447570902|FG000|Overall Study|Adverse Event|3|||
124440019|NCT01765179|447570902|FG000|Overall Study|Lost to Follow-up|5|||
124440020|NCT01765179|447570902|FG000|Overall Study|Non-compliance with study drug|2|||
124684732|NCT02327078|448468127|FG008|Overall Study|Death|97|||
124684733|NCT02327078|448468119|FG000|Overall Study|Lost to Follow-up|0|||
124684734|NCT02327078|448468120|FG001|Overall Study|Lost to Follow-up|1|||
124684735|NCT02327078|448468121|FG002|Overall Study|Lost to Follow-up|1|||
124684736|NCT02327078|448468122|FG003|Overall Study|Lost to Follow-up|0|||
124684737|NCT02327078|448468123|FG004|Overall Study|Lost to Follow-up|0|||
124684738|NCT02327078|448468124|FG005|Overall Study|Lost to Follow-up|0|||
124684739|NCT02327078|448468125|FG006|Overall Study|Lost to Follow-up|0|||
124684740|NCT02327078|448468126|FG007|Overall Study|Lost to Follow-up|2|||
124684741|NCT02327078|448468127|FG008|Overall Study|Lost to Follow-up|5|||
124684742|NCT02327078|448468119|FG000|Overall Study|Site Terminated by Sponsor|1|||
124440021|NCT01765179|447570902|FG000|Overall Study|Protocol Violation|1|||
124440022|NCT01765179|447570902|FG000|Overall Study|Withdrawal by Subject|8|||
124440023|NCT01765179|447570902|FG000|Overall Study|Hematocrit >54%|3|||
124440024|NCT01765179|447570902|FG000|Overall Study|prohibited med|1|||
124440025|NCT01765179|447570902|FG000|Overall Study|Out of country unable to finish study|1|||
124684743|NCT02327078|448468120|FG001|Overall Study|Site Terminated by Sponsor|0|||
124684744|NCT02327078|448468121|FG002|Overall Study|Site Terminated by Sponsor|1|||
124684745|NCT02327078|448468122|FG003|Overall Study|Site Terminated by Sponsor|4|||
124684746|NCT02327078|448468123|FG004|Overall Study|Site Terminated by Sponsor|0|||
124684747|NCT02327078|448468124|FG005|Overall Study|Site Terminated by Sponsor|0|||
124684748|NCT02327078|448468125|FG006|Overall Study|Site Terminated by Sponsor|0|||
124684749|NCT02327078|448468126|FG007|Overall Study|Site Terminated by Sponsor|11|||
124886632|NCT01448044|449209664|FG001|Follow Up Period|Withdrawal by Subject|1|||
124886633|NCT01448044|449209663|FG000|Follow Up Period|Lost to Follow-up|6|||
124440026|NCT01765179|447570902|FG000|Overall Study|lack of venous access|1|||
124440027|NCT01765179|447570902|FG000|Overall Study|work conflict|1|||
124440028|NCT01765179|447570902|FG000|Overall Study|Ca elevated 10.6|1|||
124440029|NCT03581825|447570903|FG000|Period 1|Lens Discomfort|1|||
124440030|NCT03581825|447570904|FG001|Period 1|Lens Discomfort|0|||
124684750|NCT02327078|448468127|FG008|Overall Study|Site Terminated by Sponsor|25|||
124684751|NCT02327078|448468119|FG000|Overall Study|Physician Decision|0|||
124684752|NCT02327078|448468120|FG001|Overall Study|Physician Decision|0|||
124886634|NCT01448044|449209664|FG001|Follow Up Period|Lost to Follow-up|2|||
124886635|NCT01448044|449209663|FG000|Follow Up Period|Other|5|||
124440031|NCT03581825|447570903|FG000|Period 2|Unsatisfactory Vision to Test|0|||
124440032|NCT03581825|447570904|FG001|Period 2|Unsatisfactory Vision to Test|1|||
124440033|NCT01668667|447570905|FG000|Overall Study|Adverse Event|3|||
124440034|NCT01668667|447570906|FG001|Overall Study|Adverse Event|6|||
124684753|NCT02327078|448468121|FG002|Overall Study|Physician Decision|0|||
124886636|NCT01448044|449209664|FG001|Follow Up Period|Other|11|||
124684754|NCT02327078|448468122|FG003|Overall Study|Physician Decision|1|||
124684755|NCT02327078|448468123|FG004|Overall Study|Physician Decision|0|||
124684756|NCT02327078|448468124|FG005|Overall Study|Physician Decision|0|||
124684757|NCT02327078|448468125|FG006|Overall Study|Physician Decision|0|||
124684758|NCT02327078|448468126|FG007|Overall Study|Physician Decision|0|||
124684759|NCT02327078|448468127|FG008|Overall Study|Physician Decision|1|||
124684760|NCT02327078|448468119|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
124684761|NCT02327078|448468120|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
124684762|NCT02327078|448468121|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
124684763|NCT02327078|448468122|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
124684764|NCT02327078|448468123|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
124684765|NCT02327078|448468124|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
124684766|NCT02327078|448468125|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
124684767|NCT02327078|448468126|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
124684768|NCT02327078|448468127|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
124684769|NCT02327078|448468119|FG000|Overall Study|Reason not Specified|0|||
124684770|NCT02327078|448468120|FG001|Overall Study|Reason not Specified|0|||
124684771|NCT02327078|448468121|FG002|Overall Study|Reason not Specified|0|||
124684772|NCT02327078|448468122|FG003|Overall Study|Reason not Specified|0|||
124684773|NCT02327078|448468123|FG004|Overall Study|Reason not Specified|0|||
124684774|NCT02327078|448468124|FG005|Overall Study|Reason not Specified|0|||
124684775|NCT02327078|448468125|FG006|Overall Study|Reason not Specified|0|||
124684776|NCT02327078|448468126|FG007|Overall Study|Reason not Specified|5|||
124684777|NCT02327078|448468127|FG008|Overall Study|Reason not Specified|12|||
124684778|NCT05513950|448468128|FG000|Overall Study|Not treated due to technical reasons|0|||
124684779|NCT05513950|448468129|FG001|Overall Study|Not treated due to technical reasons|0|||
124684780|NCT05513950|448468130|FG002|Overall Study|Not treated due to technical reasons|1|||
124684781|NCT05513950|448468131|FG003|Overall Study|Not treated due to technical reasons|0|||
124684782|NCT03112603|448468133|FG000|End of Randomization Period|Lost to Follow-up|3|||
124684783|NCT03112603|448468134|FG001|End of Randomization Period|Lost to Follow-up|0|||
124684784|NCT03112603|448468135|FG002|End of Randomization Period|Lost to Follow-up|0|||
124684785|NCT03112603|448468133|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
124684786|NCT03112603|448468134|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
124684787|NCT03112603|448468135|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
124684788|NCT03112603|448468133|FG000|End of Randomization Period|Physician Decision|43|||
124684789|NCT03112603|448468134|FG001|End of Randomization Period|Physician Decision|18|||
124684790|NCT03112603|448468135|FG002|End of Randomization Period|Physician Decision|0|||
124684791|NCT03112603|448468133|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
124684792|NCT03112603|448468134|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
124684793|NCT03112603|448468135|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
124684794|NCT03112603|448468133|FG000|End of Randomization Period|Death|10|||
124684795|NCT03112603|448468134|FG001|End of Randomization Period|Death|7|||
124684796|NCT03112603|448468135|FG002|End of Randomization Period|Death|0|||
124684797|NCT03112603|448468133|FG000|End of Randomization Period|Disease Relapse|12|||
124684798|NCT03112603|448468134|FG001|End of Randomization Period|Disease Relapse|7|||
124684799|NCT03112603|448468135|FG002|End of Randomization Period|Disease Relapse|0|||
124684800|NCT03112603|448468133|FG000|End of Randomization Period|Lack of Efficacy|25|||
124684801|NCT03112603|448468134|FG001|End of Randomization Period|Lack of Efficacy|77|||
124684802|NCT03112603|448468135|FG002|End of Randomization Period|Lack of Efficacy|0|||
124684803|NCT03112603|448468133|FG000|End of Randomization Period|Adverse Event|32|||
124684804|NCT03112603|448468134|FG001|End of Randomization Period|Adverse Event|12|||
124684805|NCT03112603|448468135|FG002|End of Randomization Period|Adverse Event|0|||
124684806|NCT03112603|448468133|FG000|End of Cross Over Period|Death|0|||
124684807|NCT03112603|448468134|FG001|End of Cross Over Period|Death|0|||
124684808|NCT03112603|448468135|FG002|End of Cross Over Period|Death|2|||
124684809|NCT03112603|448468133|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
124684810|NCT03112603|448468134|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
124684811|NCT03112603|448468135|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
124684812|NCT03112603|448468133|FG000|End of Cross Over Period|Physician Decision|0|||
124440035|NCT01668667|447570907|FG002|Overall Study|Adverse Event|4|||
124684813|NCT03112603|448468134|FG001|End of Cross Over Period|Physician Decision|0|||
124684814|NCT03112603|448468135|FG002|End of Cross Over Period|Physician Decision|29|||
124684815|NCT03112603|448468133|FG000|End of Cross Over Period|Lack of Efficacy|0|||
124684816|NCT03112603|448468134|FG001|End of Cross Over Period|Lack of Efficacy|0|||
124684817|NCT03112603|448468135|FG002|End of Cross Over Period|Lack of Efficacy|8|||
124684818|NCT03112603|448468133|FG000|End of Cross Over Period|Adverse Event|0|||
124684819|NCT03112603|448468134|FG001|End of Cross Over Period|Adverse Event|0|||
124684820|NCT03112603|448468135|FG002|End of Cross Over Period|Adverse Event|6|||
124684821|NCT03112603|448468133|FG000|End of Cross Over Period|Disease Relapse|0|||
124684822|NCT03112603|448468134|FG001|End of Cross Over Period|Disease Relapse|0|||
124684823|NCT03112603|448468135|FG002|End of Cross Over Period|Disease Relapse|2|||
124684824|NCT04225039|448468136|FG000|Overall Study|Withdrawal by Subject|1|||
124684825|NCT04225039|448468137|FG001|Overall Study|Withdrawal by Subject|0|||
124684826|NCT04225039|448468138|FG002|Overall Study|Withdrawal by Subject|0|||
124684827|NCT04225039|448468139|FG003|Overall Study|Withdrawal by Subject|1|||
124684828|NCT04225039|448468136|FG000|Overall Study|Currently active on study treatment|0|||
124684829|NCT04225039|448468137|FG001|Overall Study|Currently active on study treatment|1|||
124684830|NCT04225039|448468138|FG002|Overall Study|Currently active on study treatment|0|||
124684831|NCT04225039|448468139|FG003|Overall Study|Currently active on study treatment|0|||
124684832|NCT04225039|448468136|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
124684833|NCT04225039|448468137|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
124684834|NCT04225039|448468138|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
124684835|NCT04225039|448468139|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
124684836|NCT04225039|448468136|FG000|Overall Study|Ineligible for treatment|0|||
124684837|NCT04225039|448468137|FG001|Overall Study|Ineligible for treatment|0|||
124684838|NCT04225039|448468138|FG002|Overall Study|Ineligible for treatment|0|||
124684839|NCT04225039|448468139|FG003|Overall Study|Ineligible for treatment|4|||
124684840|NCT02225587|448468148|FG000|Overall Study|Adverse Event|5|||
124684841|NCT02225587|448468149|FG001|Overall Study|Adverse Event|5|||
124684842|NCT02225587|448468148|FG000|Overall Study|Lost to Follow-up|5|||
124684843|NCT02225587|448468149|FG001|Overall Study|Lost to Follow-up|5|||
124684844|NCT02225587|448468148|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124684845|NCT02225587|448468149|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124684846|NCT02225587|448468148|FG000|Overall Study|Physician Decision|2|||
124684847|NCT02225587|448468149|FG001|Overall Study|Physician Decision|0|||
124684848|NCT02225587|448468148|FG000|Overall Study|Protocol Violation|1|||
124684849|NCT02225587|448468149|FG001|Overall Study|Protocol Violation|0|||
124684850|NCT02225587|448468148|FG000|Overall Study|Participant Moved|1|||
124684851|NCT02225587|448468149|FG001|Overall Study|Participant Moved|0|||
124684852|NCT02225587|448468148|FG000|Overall Study|Withdrawal by Subject|13|||
124684853|NCT02225587|448468149|FG001|Overall Study|Withdrawal by Subject|28|||
124684854|NCT01933932|448468152|FG000|Overall Study|Death|173|||
124684855|NCT01933932|448468153|FG001|Overall Study|Death|163|||
124684856|NCT01933932|448468152|FG000|Overall Study|Withdrawal by Subject|11|||
124684857|NCT01933932|448468153|FG001|Overall Study|Withdrawal by Subject|14|||
124684858|NCT01933932|448468152|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124684859|NCT01933932|448468153|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
124684860|NCT04896385|448468154|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
124684861|NCT04896385|448468155|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
124684862|NCT04896385|448468156|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
124684863|NCT04896385|448468157|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
124684864|NCT04896385|448468154|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
124684865|NCT04896385|448468155|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
124684866|NCT04896385|448468156|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
124684867|NCT04896385|448468157|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
124684868|NCT04896385|448468154|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
124684869|NCT04896385|448468155|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
124684870|NCT04896385|448468156|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
124684871|NCT04896385|448468157|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
124684872|NCT04896385|448468154|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
124684873|NCT04896385|448468155|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
124684874|NCT04896385|448468156|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
124684875|NCT04896385|448468157|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
124684876|NCT04896385|448468154|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
124684877|NCT04896385|448468155|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
124684878|NCT04896385|448468156|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
124684879|NCT04896385|448468157|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
124684880|NCT04896385|448468154|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
124684881|NCT04896385|448468155|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
124684882|NCT04896385|448468156|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
124684883|NCT04896385|448468157|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
124684884|NCT01931098|448468161|FG000|Overall Study|Withdrawal by Subject|0|||
124684885|NCT01931098|448468162|FG001|Overall Study|Withdrawal by Subject|1|||
124684886|NCT01931098|448468161|FG000|Overall Study|Enrolled in different protocol|0|||
124684887|NCT01931098|448468162|FG001|Overall Study|Enrolled in different protocol|1|||
124684888|NCT01931098|448468161|FG000|Overall Study|Unable to begin trmt:active infection|0|||
124684889|NCT01931098|448468162|FG001|Overall Study|Unable to begin trmt:active infection|1|||
124684890|NCT01931098|448468161|FG000|Overall Study|Refused further treatment|0|||
124684891|NCT01931098|448468162|FG001|Overall Study|Refused further treatment|1|||
124684892|NCT01564407|448468165|FG000|Overall Study|Lost to Follow-up|0|||
124684893|NCT01564407|448468166|FG001|Overall Study|Lost to Follow-up|1|||
124684894|NCT01564407|448468167|FG002|Overall Study|Lost to Follow-up|0|||
124684895|NCT01564407|448468168|FG003|Overall Study|Lost to Follow-up|0|||
124684896|NCT01564407|448468169|FG004|Overall Study|Lost to Follow-up|0|||
124684897|NCT01564407|448468165|FG000|Overall Study|Withdrawal by Subject|0|||
124684898|NCT01564407|448468166|FG001|Overall Study|Withdrawal by Subject|1|||
124684899|NCT01564407|448468167|FG002|Overall Study|Withdrawal by Subject|0|||
124684900|NCT01564407|448468168|FG003|Overall Study|Withdrawal by Subject|0|||
124684901|NCT01564407|448468169|FG004|Overall Study|Withdrawal by Subject|0|||
124684902|NCT01564407|448468165|FG000|Overall Study|funding lost, study ended|0|||
124684903|NCT01564407|448468166|FG001|Overall Study|funding lost, study ended|0|||
124684904|NCT01564407|448468167|FG002|Overall Study|funding lost, study ended|0|||
124684905|NCT01564407|448468168|FG003|Overall Study|funding lost, study ended|1|||
124684906|NCT01564407|448468169|FG004|Overall Study|funding lost, study ended|0|||
124684907|NCT03126110|448468170|FG000|Phase 1|Death|2|||
124684908|NCT03126110|448468171|FG001|Phase 1|Death|2|||
124684909|NCT03126110|448468172|FG002|Phase 1|Death|4|||
124684910|NCT03126110|448468173|FG003|Phase 1|Death|3|||
124684911|NCT03126110|448468174|FG004|Phase 1|Death|4|||
124684912|NCT03126110|448468175|FG005|Phase 1|Death|4|||
124684913|NCT03126110|448468176|FG006|Phase 1|Death|3|||
124684914|NCT03126110|448468177|FG007|Phase 1|Death|4|||
124684915|NCT03126110|448468178|FG008|Phase 1|Death|5|||
124684916|NCT03126110|448468179|FG009|Phase 1|Death|2|||
124684917|NCT03126110|448468180|FG010|Phase 1|Death|6|||
124684918|NCT03126110|448468181|FG011|Phase 1|Death|0|||
124684919|NCT03126110|448468182|FG012|Phase 1|Death|0|||
124684920|NCT03126110|448468183|FG013|Phase 1|Death|0|||
124684921|NCT03126110|448468184|FG014|Phase 1|Death|0|||
124684922|NCT03126110|448468185|FG015|Phase 1|Death|0|||
124684923|NCT03126110|448468186|FG016|Phase 1|Death|0|||
124684924|NCT03126110|448468170|FG000|Phase 1|Lost to Follow-up|0|||
124684925|NCT03126110|448468171|FG001|Phase 1|Lost to Follow-up|1|||
124684926|NCT03126110|448468172|FG002|Phase 1|Lost to Follow-up|0|||
124684927|NCT03126110|448468173|FG003|Phase 1|Lost to Follow-up|0|||
124684928|NCT03126110|448468174|FG004|Phase 1|Lost to Follow-up|0|||
124684929|NCT03126110|448468175|FG005|Phase 1|Lost to Follow-up|0|||
124684930|NCT03126110|448468176|FG006|Phase 1|Lost to Follow-up|0|||
124684931|NCT03126110|448468177|FG007|Phase 1|Lost to Follow-up|0|||
124684932|NCT03126110|448468178|FG008|Phase 1|Lost to Follow-up|1|||
124684933|NCT03126110|448468179|FG009|Phase 1|Lost to Follow-up|0|||
124684934|NCT03126110|448468180|FG010|Phase 1|Lost to Follow-up|0|||
124684935|NCT03126110|448468181|FG011|Phase 1|Lost to Follow-up|0|||
124684936|NCT03126110|448468182|FG012|Phase 1|Lost to Follow-up|0|||
124684937|NCT03126110|448468183|FG013|Phase 1|Lost to Follow-up|0|||
124684938|NCT03126110|448468184|FG014|Phase 1|Lost to Follow-up|0|||
124684939|NCT03126110|448468185|FG015|Phase 1|Lost to Follow-up|0|||
124684940|NCT03126110|448468186|FG016|Phase 1|Lost to Follow-up|0|||
124684941|NCT03126110|448468170|FG000|Phase 1|Withdrawal by Subject|1|||
124684942|NCT03126110|448468171|FG001|Phase 1|Withdrawal by Subject|0|||
124684943|NCT03126110|448468172|FG002|Phase 1|Withdrawal by Subject|0|||
124684944|NCT03126110|448468173|FG003|Phase 1|Withdrawal by Subject|1|||
124684945|NCT03126110|448468174|FG004|Phase 1|Withdrawal by Subject|1|||
124684946|NCT03126110|448468175|FG005|Phase 1|Withdrawal by Subject|0|||
124684947|NCT03126110|448468176|FG006|Phase 1|Withdrawal by Subject|0|||
124684948|NCT03126110|448468177|FG007|Phase 1|Withdrawal by Subject|0|||
124758926|NCT01080807|448741185|FG000|Overall Study|Switched to first shift|1|||
124758927|NCT01080807|448741186|FG001|Overall Study|Switched to first shift|0|||
124684949|NCT03126110|448468178|FG008|Phase 1|Withdrawal by Subject|2|||
124684950|NCT03126110|448468179|FG009|Phase 1|Withdrawal by Subject|1|||
124684951|NCT03126110|448468180|FG010|Phase 1|Withdrawal by Subject|0|||
124684952|NCT03126110|448468181|FG011|Phase 1|Withdrawal by Subject|0|||
124684953|NCT03126110|448468182|FG012|Phase 1|Withdrawal by Subject|0|||
124684954|NCT03126110|448468183|FG013|Phase 1|Withdrawal by Subject|0|||
124684955|NCT03126110|448468184|FG014|Phase 1|Withdrawal by Subject|0|||
124684956|NCT03126110|448468185|FG015|Phase 1|Withdrawal by Subject|0|||
124684957|NCT03126110|448468186|FG016|Phase 1|Withdrawal by Subject|0|||
124684958|NCT03126110|448468170|FG000|Phase 1|Safety follow-up no longer necessary|1|||
124684959|NCT03126110|448468171|FG001|Phase 1|Safety follow-up no longer necessary|0|||
124684960|NCT03126110|448468172|FG002|Phase 1|Safety follow-up no longer necessary|0|||
124684961|NCT03126110|448468173|FG003|Phase 1|Safety follow-up no longer necessary|0|||
124684962|NCT03126110|448468174|FG004|Phase 1|Safety follow-up no longer necessary|0|||
124684963|NCT03126110|448468175|FG005|Phase 1|Safety follow-up no longer necessary|0|||
124684964|NCT03126110|448468176|FG006|Phase 1|Safety follow-up no longer necessary|0|||
124684965|NCT03126110|448468177|FG007|Phase 1|Safety follow-up no longer necessary|0|||
124684966|NCT03126110|448468178|FG008|Phase 1|Safety follow-up no longer necessary|0|||
124684967|NCT03126110|448468179|FG009|Phase 1|Safety follow-up no longer necessary|0|||
124684968|NCT03126110|448468180|FG010|Phase 1|Safety follow-up no longer necessary|0|||
124886637|NCT01000376|449209667|FG000|Cycle 1 Day 1|Adverse Event|1|||
124684969|NCT03126110|448468181|FG011|Phase 1|Safety follow-up no longer necessary|0|||
124684970|NCT03126110|448468182|FG012|Phase 1|Safety follow-up no longer necessary|0|||
124684971|NCT03126110|448468183|FG013|Phase 1|Safety follow-up no longer necessary|0|||
124684972|NCT03126110|448468184|FG014|Phase 1|Safety follow-up no longer necessary|0|||
124684973|NCT03126110|448468185|FG015|Phase 1|Safety follow-up no longer necessary|0|||
124684974|NCT03126110|448468186|FG016|Phase 1|Safety follow-up no longer necessary|0|||
124684975|NCT03126110|448468170|FG000|Phase 1|Survival follow-up no longer necessary|0|||
124684976|NCT03126110|448468171|FG001|Phase 1|Survival follow-up no longer necessary|0|||
124684977|NCT03126110|448468172|FG002|Phase 1|Survival follow-up no longer necessary|1|||
124684978|NCT03126110|448468173|FG003|Phase 1|Survival follow-up no longer necessary|0|||
124684979|NCT03126110|448468174|FG004|Phase 1|Survival follow-up no longer necessary|0|||
124684980|NCT03126110|448468175|FG005|Phase 1|Survival follow-up no longer necessary|0|||
124684981|NCT03126110|448468176|FG006|Phase 1|Survival follow-up no longer necessary|0|||
124684982|NCT03126110|448468177|FG007|Phase 1|Survival follow-up no longer necessary|0|||
124684983|NCT03126110|448468178|FG008|Phase 1|Survival follow-up no longer necessary|0|||
124684984|NCT03126110|448468179|FG009|Phase 1|Survival follow-up no longer necessary|0|||
124684985|NCT03126110|448468180|FG010|Phase 1|Survival follow-up no longer necessary|0|||
124684986|NCT03126110|448468181|FG011|Phase 1|Survival follow-up no longer necessary|0|||
124684987|NCT03126110|448468182|FG012|Phase 1|Survival follow-up no longer necessary|0|||
124684988|NCT03126110|448468183|FG013|Phase 1|Survival follow-up no longer necessary|0|||
124684989|NCT03126110|448468184|FG014|Phase 1|Survival follow-up no longer necessary|0|||
124684990|NCT03126110|448468185|FG015|Phase 1|Survival follow-up no longer necessary|0|||
124684991|NCT03126110|448468186|FG016|Phase 1|Survival follow-up no longer necessary|0|||
124684992|NCT03126110|448468170|FG000|Phase 2|Study terminated by the sponsor|0|||
124684993|NCT03126110|448468171|FG001|Phase 2|Study terminated by the sponsor|0|||
124684994|NCT03126110|448468172|FG002|Phase 2|Study terminated by the sponsor|0|||
124684995|NCT03126110|448468173|FG003|Phase 2|Study terminated by the sponsor|0|||
124684996|NCT03126110|448468174|FG004|Phase 2|Study terminated by the sponsor|0|||
124684997|NCT03126110|448468175|FG005|Phase 2|Study terminated by the sponsor|0|||
124684998|NCT03126110|448468176|FG006|Phase 2|Study terminated by the sponsor|0|||
124684999|NCT03126110|448468177|FG007|Phase 2|Study terminated by the sponsor|0|||
124685000|NCT03126110|448468178|FG008|Phase 2|Study terminated by the sponsor|0|||
124685001|NCT03126110|448468179|FG009|Phase 2|Study terminated by the sponsor|0|||
124685002|NCT03126110|448468180|FG010|Phase 2|Study terminated by the sponsor|0|||
124685003|NCT03126110|448468181|FG011|Phase 2|Study terminated by the sponsor|0|||
124685004|NCT03126110|448468182|FG012|Phase 2|Study terminated by the sponsor|0|||
124685005|NCT03126110|448468183|FG013|Phase 2|Study terminated by the sponsor|4|||
124685006|NCT03126110|448468184|FG014|Phase 2|Study terminated by the sponsor|0|||
124685007|NCT03126110|448468185|FG015|Phase 2|Study terminated by the sponsor|0|||
124685008|NCT03126110|448468186|FG016|Phase 2|Study terminated by the sponsor|0|||
124685009|NCT03126110|448468170|FG000|Phase 2|Withdrawal by Subject|0|||
124685010|NCT03126110|448468171|FG001|Phase 2|Withdrawal by Subject|0|||
124685011|NCT03126110|448468172|FG002|Phase 2|Withdrawal by Subject|0|||
124685012|NCT03126110|448468173|FG003|Phase 2|Withdrawal by Subject|0|||
124685013|NCT03126110|448468174|FG004|Phase 2|Withdrawal by Subject|0|||
124685014|NCT03126110|448468175|FG005|Phase 2|Withdrawal by Subject|0|||
124685015|NCT03126110|448468176|FG006|Phase 2|Withdrawal by Subject|0|||
124685016|NCT03126110|448468177|FG007|Phase 2|Withdrawal by Subject|0|||
124685017|NCT03126110|448468178|FG008|Phase 2|Withdrawal by Subject|0|||
124685018|NCT03126110|448468179|FG009|Phase 2|Withdrawal by Subject|0|||
124685019|NCT03126110|448468180|FG010|Phase 2|Withdrawal by Subject|0|||
124685020|NCT03126110|448468181|FG011|Phase 2|Withdrawal by Subject|1|||
124685021|NCT03126110|448468182|FG012|Phase 2|Withdrawal by Subject|3|||
124685022|NCT03126110|448468183|FG013|Phase 2|Withdrawal by Subject|3|||
124685023|NCT03126110|448468184|FG014|Phase 2|Withdrawal by Subject|2|||
124685024|NCT03126110|448468185|FG015|Phase 2|Withdrawal by Subject|1|||
124685025|NCT03126110|448468186|FG016|Phase 2|Withdrawal by Subject|0|||
124685026|NCT03126110|448468170|FG000|Phase 2|Lost to Follow-up|0|||
124685027|NCT03126110|448468171|FG001|Phase 2|Lost to Follow-up|0|||
124685028|NCT03126110|448468172|FG002|Phase 2|Lost to Follow-up|0|||
124685029|NCT03126110|448468173|FG003|Phase 2|Lost to Follow-up|0|||
124685030|NCT03126110|448468174|FG004|Phase 2|Lost to Follow-up|0|||
124685031|NCT03126110|448468175|FG005|Phase 2|Lost to Follow-up|0|||
124685032|NCT03126110|448468176|FG006|Phase 2|Lost to Follow-up|0|||
124685033|NCT03126110|448468177|FG007|Phase 2|Lost to Follow-up|0|||
124685034|NCT03126110|448468178|FG008|Phase 2|Lost to Follow-up|0|||
124685035|NCT03126110|448468179|FG009|Phase 2|Lost to Follow-up|0|||
124685036|NCT03126110|448468180|FG010|Phase 2|Lost to Follow-up|0|||
124685037|NCT03126110|448468181|FG011|Phase 2|Lost to Follow-up|1|||
124685038|NCT03126110|448468182|FG012|Phase 2|Lost to Follow-up|1|||
124685039|NCT03126110|448468183|FG013|Phase 2|Lost to Follow-up|1|||
124685040|NCT03126110|448468184|FG014|Phase 2|Lost to Follow-up|2|||
124685041|NCT03126110|448468185|FG015|Phase 2|Lost to Follow-up|0|||
124685042|NCT03126110|448468186|FG016|Phase 2|Lost to Follow-up|0|||
124685043|NCT03126110|448468170|FG000|Phase 2|Death|0|||
124685044|NCT03126110|448468171|FG001|Phase 2|Death|0|||
124685045|NCT03126110|448468172|FG002|Phase 2|Death|0|||
124685046|NCT03126110|448468173|FG003|Phase 2|Death|0|||
124685047|NCT03126110|448468174|FG004|Phase 2|Death|0|||
124685048|NCT03126110|448468175|FG005|Phase 2|Death|0|||
124685049|NCT03126110|448468176|FG006|Phase 2|Death|0|||
124685050|NCT03126110|448468177|FG007|Phase 2|Death|0|||
124685051|NCT03126110|448468178|FG008|Phase 2|Death|0|||
124685052|NCT03126110|448468179|FG009|Phase 2|Death|0|||
124685053|NCT03126110|448468180|FG010|Phase 2|Death|0|||
124685054|NCT03126110|448468181|FG011|Phase 2|Death|6|||
124685055|NCT03126110|448468182|FG012|Phase 2|Death|12|||
124685056|NCT03126110|448468183|FG013|Phase 2|Death|25|||
124685057|NCT03126110|448468184|FG014|Phase 2|Death|11|||
124685058|NCT03126110|448468185|FG015|Phase 2|Death|3|||
124685059|NCT03126110|448468186|FG016|Phase 2|Death|2|||
124685060|NCT03126110|448468170|FG000|Phase 2|Progressive Disease|0|||
124685061|NCT03126110|448468171|FG001|Phase 2|Progressive Disease|0|||
124685062|NCT03126110|448468172|FG002|Phase 2|Progressive Disease|0|||
124685063|NCT03126110|448468173|FG003|Phase 2|Progressive Disease|0|||
124685064|NCT03126110|448468174|FG004|Phase 2|Progressive Disease|0|||
124685065|NCT03126110|448468175|FG005|Phase 2|Progressive Disease|0|||
124685066|NCT03126110|448468176|FG006|Phase 2|Progressive Disease|0|||
124685067|NCT03126110|448468177|FG007|Phase 2|Progressive Disease|0|||
124685068|NCT03126110|448468178|FG008|Phase 2|Progressive Disease|0|||
124685069|NCT03126110|448468179|FG009|Phase 2|Progressive Disease|0|||
124685070|NCT03126110|448468180|FG010|Phase 2|Progressive Disease|0|||
124685071|NCT03126110|448468181|FG011|Phase 2|Progressive Disease|0|||
124685072|NCT03126110|448468182|FG012|Phase 2|Progressive Disease|0|||
124685073|NCT03126110|448468183|FG013|Phase 2|Progressive Disease|1|||
124685074|NCT03126110|448468184|FG014|Phase 2|Progressive Disease|0|||
124685075|NCT03126110|448468185|FG015|Phase 2|Progressive Disease|0|||
124685076|NCT03126110|448468186|FG016|Phase 2|Progressive Disease|0|||
124685077|NCT03126110|448468170|FG000|Phase 2|Started new treatment|0|||
124685078|NCT03126110|448468171|FG001|Phase 2|Started new treatment|0|||
124685079|NCT03126110|448468172|FG002|Phase 2|Started new treatment|0|||
124685080|NCT03126110|448468173|FG003|Phase 2|Started new treatment|0|||
124685081|NCT03126110|448468174|FG004|Phase 2|Started new treatment|0|||
124685082|NCT03126110|448468175|FG005|Phase 2|Started new treatment|0|||
124685083|NCT03126110|448468176|FG006|Phase 2|Started new treatment|0|||
124685084|NCT03126110|448468177|FG007|Phase 2|Started new treatment|0|||
124685085|NCT03126110|448468178|FG008|Phase 2|Started new treatment|0|||
124685086|NCT03126110|448468179|FG009|Phase 2|Started new treatment|0|||
124685087|NCT03126110|448468180|FG010|Phase 2|Started new treatment|0|||
124685088|NCT03126110|448468181|FG011|Phase 2|Started new treatment|0|||
124685089|NCT03126110|448468182|FG012|Phase 2|Started new treatment|0|||
124685090|NCT03126110|448468183|FG013|Phase 2|Started new treatment|0|||
124685091|NCT03126110|448468184|FG014|Phase 2|Started new treatment|1|||
124685092|NCT03126110|448468185|FG015|Phase 2|Started new treatment|0|||
124685093|NCT03126110|448468186|FG016|Phase 2|Started new treatment|0|||
124685094|NCT04235374|448468187|FG000|Overall Study|Death|91|||
124685095|NCT04235374|448468188|FG001|Overall Study|Death|91|||
124685096|NCT04235374|448468187|FG000|Overall Study|Refused|2|||
124685097|NCT04235374|448468188|FG001|Overall Study|Refused|2|||
124685098|NCT04235374|448468187|FG000|Overall Study|Unavailable|12|||
124685099|NCT04235374|448468188|FG001|Overall Study|Unavailable|3|||
124685100|NCT04235374|448468187|FG000|Overall Study|Withdrawal by Subject|0|||
124685101|NCT04235374|448468188|FG001|Overall Study|Withdrawal by Subject|1|||
124685102|NCT04235374|448468187|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
124685103|NCT04235374|448468188|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
124685104|NCT02572167|448468189|FG000|Overall Study|Withdrawal by Subject|0|||
124685105|NCT02572167|448468190|FG001|Overall Study|Withdrawal by Subject|3|||
124685106|NCT02572167|448468191|FG002|Overall Study|Withdrawal by Subject|0|||
124685107|NCT02572167|448468189|FG000|Overall Study|Lost to Follow-up|2|||
124685108|NCT02572167|448468190|FG001|Overall Study|Lost to Follow-up|5|||
124685109|NCT02572167|448468191|FG002|Overall Study|Lost to Follow-up|3|||
124685110|NCT02572167|448468189|FG000|Overall Study|Death|0|||
124685111|NCT02572167|448468190|FG001|Overall Study|Death|8|||
124685112|NCT02572167|448468191|FG002|Overall Study|Death|3|||
124685113|NCT02572167|448468189|FG000|Overall Study|Did not meet inclusion criteria|0|||
124685114|NCT02572167|448468190|FG001|Overall Study|Did not meet inclusion criteria|0|||
124685115|NCT02572167|448468191|FG002|Overall Study|Did not meet inclusion criteria|1|||
124685116|NCT02572167|448468189|FG000|Overall Study|Study closure by Sponsor|4|||
124685117|NCT02572167|448468190|FG001|Overall Study|Study closure by Sponsor|40|||
124685118|NCT02572167|448468191|FG002|Overall Study|Study closure by Sponsor|24|||
124685119|NCT00005047|448468194|FG000|Overall Study|Withdrawal by Subject|12|||
124685120|NCT00005047|448468195|FG001|Overall Study|Withdrawal by Subject|0|||
124685121|NCT00005047|448468196|FG002|Overall Study|Withdrawal by Subject|0|||
124685122|NCT00005047|448468197|FG003|Overall Study|Withdrawal by Subject|0|||
124685123|NCT00005047|448468194|FG000|Overall Study|Adverse Event|5|||
124685124|NCT00005047|448468195|FG001|Overall Study|Adverse Event|0|||
124685125|NCT00005047|448468196|FG002|Overall Study|Adverse Event|0|||
124685126|NCT00005047|448468197|FG003|Overall Study|Adverse Event|0|||
124685127|NCT00005047|448468194|FG000|Overall Study|Lost to Follow-up|1|||
124685128|NCT00005047|448468195|FG001|Overall Study|Lost to Follow-up|0|||
124685129|NCT00005047|448468196|FG002|Overall Study|Lost to Follow-up|0|||
124685130|NCT00005047|448468197|FG003|Overall Study|Lost to Follow-up|0|||
124685131|NCT00005047|448468194|FG000|Overall Study|Lack of Efficacy|1|||
124685132|NCT00005047|448468195|FG001|Overall Study|Lack of Efficacy|0|||
124685133|NCT00005047|448468196|FG002|Overall Study|Lack of Efficacy|0|||
124685134|NCT00005047|448468197|FG003|Overall Study|Lack of Efficacy|0|||
124685135|NCT00088153|448468198|FG000|Overall Study|Physician Decision|3|||
124685136|NCT00088153|448468199|FG001|Overall Study|Physician Decision|3|||
124685137|NCT00088153|448468198|FG000|Overall Study|Withdrawal by Subject|10|||
124685138|NCT00088153|448468199|FG001|Overall Study|Withdrawal by Subject|10|||
124685139|NCT00088153|448468198|FG000|Overall Study|Lost to Follow-up|11|||
124685140|NCT00088153|448468199|FG001|Overall Study|Lost to Follow-up|12|||
124685141|NCT00976027|448468201|FG000|Overall Study|Serious Adverse Event|36|||
124685142|NCT00976027|448468202|FG001|Overall Study|Serious Adverse Event|17|||
124685143|NCT00976027|448468201|FG000|Overall Study|Adverse Event|0|||
124685144|NCT00976027|448468202|FG001|Overall Study|Adverse Event|2|||
124685145|NCT00976027|448468201|FG000|Overall Study|Protocol Violation|60|||
124685146|NCT00976027|448468202|FG001|Overall Study|Protocol Violation|27|||
124685147|NCT00976027|448468201|FG000|Overall Study|Lost to Follow-up|208|||
124685148|NCT00976027|448468202|FG001|Overall Study|Lost to Follow-up|103|||
124685149|NCT00976027|448468201|FG000|Overall Study|Withdrawal by Subject|107|||
124685150|NCT00976027|448468202|FG001|Overall Study|Withdrawal by Subject|66|||
124685151|NCT01771107|448468209|FG000|Overall Study|Adverse Event|1|||
124685152|NCT01771107|448468210|FG001|Overall Study|Adverse Event|3|||
124685153|NCT01771107|448468209|FG000|Overall Study|Withdrawal by Subject|0|||
124685154|NCT01771107|448468210|FG001|Overall Study|Withdrawal by Subject|2|||
124685155|NCT01771107|448468209|FG000|Overall Study|Lost to Follow-up|0|||
124886638|NCT01000376|449209668|FG001|Cycle 1 Day 1|Adverse Event|0|||
124685156|NCT01771107|448468210|FG001|Overall Study|Lost to Follow-up|1|||
124685157|NCT01771107|448468209|FG000|Overall Study|participant moved|0|||
124685158|NCT01771107|448468210|FG001|Overall Study|participant moved|1|||
124685159|NCT01771107|448468209|FG000|Overall Study|Other|0|||
124685160|NCT01771107|448468210|FG001|Overall Study|Other|1|||
124685161|NCT02296125|448468215|FG000|Overall Study|Withdrawal by Subject|18|||
124685162|NCT02296125|448468216|FG001|Overall Study|Withdrawal by Subject|8|||
124685163|NCT02296125|448468217|FG002|Overall Study|Withdrawal by Subject|6|||
124685164|NCT02296125|448468218|FG003|Overall Study|Withdrawal by Subject|2|||
124685165|NCT02296125|448468215|FG000|Overall Study|Adverse Event|41|||
124685166|NCT02296125|448468216|FG001|Overall Study|Adverse Event|52|||
124685167|NCT02296125|448468217|FG002|Overall Study|Adverse Event|9|||
124685168|NCT02296125|448468218|FG003|Overall Study|Adverse Event|4|||
124886639|NCT01000376|449209667|FG000|Cycle 1 Day 1|Progressive Disease|1|||
124886640|NCT01000376|449209668|FG001|Cycle 1 Day 1|Progressive Disease|0|||
124886641|NCT00507026|449209669|FG000|Overall Study|Lack of Efficacy|6|||
124886642|NCT00507026|449209670|FG001|Overall Study|Lack of Efficacy|4|||
124886643|NCT00507026|449209671|FG002|Overall Study|Lack of Efficacy|21|||
124886644|NCT00507026|449209669|FG000|Overall Study|Withdrawal by Subject|2|||
124685169|NCT02296125|448468215|FG000|Overall Study|Severe non-compliance to protocol|0|||
124685170|NCT02296125|448468216|FG001|Overall Study|Severe non-compliance to protocol|1|||
124685171|NCT02296125|448468217|FG002|Overall Study|Severe non-compliance to protocol|0|||
124685172|NCT02296125|448468218|FG003|Overall Study|Severe non-compliance to protocol|0|||
124685173|NCT02296125|448468215|FG000|Overall Study|Condition under investigation worsened|153|||
124685174|NCT02296125|448468216|FG001|Overall Study|Condition under investigation worsened|199|||
124685175|NCT02296125|448468217|FG002|Overall Study|Condition under investigation worsened|39|||
124685176|NCT02296125|448468218|FG003|Overall Study|Condition under investigation worsened|56|||
124685177|NCT02296125|448468215|FG000|Overall Study|Any reason not specifically recorded|6|||
124685178|NCT02296125|448468216|FG001|Overall Study|Any reason not specifically recorded|4|||
124712003|NCT01343888|448570709|FG002|Overall Study|Lack of Efficacy|13|||
124712004|NCT01343888|448570707|FG000|Overall Study|Lost to Follow-up|0|||
124712005|NCT01343888|448570708|FG001|Overall Study|Lost to Follow-up|2|||
124712006|NCT01343888|448570709|FG002|Overall Study|Lost to Follow-up|1|||
124685179|NCT02296125|448468217|FG002|Overall Study|Any reason not specifically recorded|2|||
124685180|NCT02296125|448468218|FG003|Overall Study|Any reason not specifically recorded|0|||
124685181|NCT00157755|448468219|FG000|Overall Study|Death|2|||
124685182|NCT00157755|448468220|FG001|Overall Study|Death|3|||
124685183|NCT00157755|448468221|FG002|Overall Study|Death|3|||
124685184|NCT00157755|448468222|FG003|Overall Study|Death|2|||
124685185|NCT00157755|448468223|FG004|Overall Study|Death|0|||
124685186|NCT00157755|448468224|FG005|Overall Study|Death|0|||
124685187|NCT00157755|448468219|FG000|Overall Study|Lost to Follow-up|0|||
124685188|NCT00157755|448468220|FG001|Overall Study|Lost to Follow-up|0|||
124685189|NCT00157755|448468221|FG002|Overall Study|Lost to Follow-up|1|||
124685190|NCT00157755|448468222|FG003|Overall Study|Lost to Follow-up|0|||
124685191|NCT00157755|448468223|FG004|Overall Study|Lost to Follow-up|0|||
124685192|NCT00157755|448468224|FG005|Overall Study|Lost to Follow-up|0|||
124685193|NCT00157755|448468219|FG000|Overall Study|Withdrawal by Subject|0|||
124685194|NCT00157755|448468220|FG001|Overall Study|Withdrawal by Subject|0|||
124685195|NCT00157755|448468221|FG002|Overall Study|Withdrawal by Subject|1|||
124685196|NCT00157755|448468222|FG003|Overall Study|Withdrawal by Subject|1|||
124685197|NCT00157755|448468223|FG004|Overall Study|Withdrawal by Subject|1|||
124685198|NCT00157755|448468224|FG005|Overall Study|Withdrawal by Subject|2|||
124685199|NCT00157755|448468219|FG000|Overall Study|Explant due to infection|0|||
124685200|NCT00157755|448468220|FG001|Overall Study|Explant due to infection|0|||
124685201|NCT00157755|448468221|FG002|Overall Study|Explant due to infection|1|||
124685202|NCT00157755|448468222|FG003|Overall Study|Explant due to infection|0|||
124685203|NCT00157755|448468223|FG004|Overall Study|Explant due to infection|0|||
124685204|NCT00157755|448468224|FG005|Overall Study|Explant due to infection|0|||
124685205|NCT00157755|448468219|FG000|Overall Study|Medical reason|0|||
124685206|NCT00157755|448468220|FG001|Overall Study|Medical reason|0|||
124685207|NCT00157755|448468221|FG002|Overall Study|Medical reason|1|||
124685208|NCT00157755|448468222|FG003|Overall Study|Medical reason|1|||
124685209|NCT00157755|448468223|FG004|Overall Study|Medical reason|0|||
124685210|NCT00157755|448468224|FG005|Overall Study|Medical reason|0|||
124685211|NCT00157755|448468219|FG000|Overall Study|Study site closure|0|||
124685212|NCT00157755|448468220|FG001|Overall Study|Study site closure|1|||
124685213|NCT00157755|448468221|FG002|Overall Study|Study site closure|0|||
124685214|NCT00157755|448468222|FG003|Overall Study|Study site closure|0|||
124685215|NCT00157755|448468223|FG004|Overall Study|Study site closure|0|||
124685216|NCT00157755|448468224|FG005|Overall Study|Study site closure|0|||
124685217|NCT00157755|448468219|FG000|Overall Study|Subject non-compliance|0|||
124685218|NCT00157755|448468220|FG001|Overall Study|Subject non-compliance|0|||
124685219|NCT00157755|448468221|FG002|Overall Study|Subject non-compliance|0|||
124685220|NCT00157755|448468222|FG003|Overall Study|Subject non-compliance|0|||
124685221|NCT00157755|448468223|FG004|Overall Study|Subject non-compliance|0|||
124685222|NCT00157755|448468224|FG005|Overall Study|Subject non-compliance|1|||
124685223|NCT00157755|448468219|FG000|Overall Study|Study completion|0|||
124685224|NCT00157755|448468220|FG001|Overall Study|Study completion|0|||
124685225|NCT00157755|448468221|FG002|Overall Study|Study completion|0|||
124685226|NCT00157755|448468222|FG003|Overall Study|Study completion|0|||
124685227|NCT00157755|448468223|FG004|Overall Study|Study completion|1|||
124685228|NCT00157755|448468224|FG005|Overall Study|Study completion|2|||
124685229|NCT03314935|448468227|FG000|Phase 1|Death|4|||
124685230|NCT03314935|448468228|FG001|Phase 1|Death|2|||
124685231|NCT03314935|448468229|FG002|Phase 1|Death|5|||
124685232|NCT03314935|448468230|FG003|Phase 1|Death|4|||
124685233|NCT03314935|448468231|FG004|Phase 1|Death|3|||
124685234|NCT03314935|448468232|FG005|Phase 1|Death|4|||
124685235|NCT03314935|448468233|FG006|Phase 1|Death|5|||
124685236|NCT03314935|448468234|FG007|Phase 1|Death|4|||
124685237|NCT03314935|448468235|FG008|Phase 1|Death|3|||
124685238|NCT03314935|448468236|FG009|Phase 1|Death|0|||
124685239|NCT03314935|448468237|FG010|Phase 1|Death|0|||
124685240|NCT03314935|448468238|FG011|Phase 1|Death|0|||
124685241|NCT03314935|448468239|FG012|Phase 1|Death|0|||
124685242|NCT03314935|448468240|FG013|Phase 1|Death|0|||
124685243|NCT03314935|448468241|FG014|Phase 1|Death|0|||
124685244|NCT03314935|448468227|FG000|Phase 1|Withdrawal by Subject|2|||
124685245|NCT03314935|448468228|FG001|Phase 1|Withdrawal by Subject|1|||
124685246|NCT03314935|448468229|FG002|Phase 1|Withdrawal by Subject|1|||
124685247|NCT03314935|448468230|FG003|Phase 1|Withdrawal by Subject|2|||
124685248|NCT03314935|448468231|FG004|Phase 1|Withdrawal by Subject|1|||
124685249|NCT03314935|448468232|FG005|Phase 1|Withdrawal by Subject|0|||
124685250|NCT03314935|448468233|FG006|Phase 1|Withdrawal by Subject|1|||
124685251|NCT03314935|448468234|FG007|Phase 1|Withdrawal by Subject|0|||
124685252|NCT03314935|448468235|FG008|Phase 1|Withdrawal by Subject|1|||
124685253|NCT03314935|448468236|FG009|Phase 1|Withdrawal by Subject|0|||
124685254|NCT03314935|448468237|FG010|Phase 1|Withdrawal by Subject|0|||
124685255|NCT03314935|448468238|FG011|Phase 1|Withdrawal by Subject|0|||
124685256|NCT03314935|448468239|FG012|Phase 1|Withdrawal by Subject|0|||
124685257|NCT03314935|448468240|FG013|Phase 1|Withdrawal by Subject|0|||
124685258|NCT03314935|448468241|FG014|Phase 1|Withdrawal by Subject|0|||
124685259|NCT03314935|448468227|FG000|Phase 1|Progressive Disease|2|||
124685260|NCT03314935|448468228|FG001|Phase 1|Progressive Disease|0|||
124685261|NCT03314935|448468229|FG002|Phase 1|Progressive Disease|0|||
124886645|NCT00507026|449209670|FG001|Overall Study|Withdrawal by Subject|0|||
124886646|NCT00507026|449209671|FG002|Overall Study|Withdrawal by Subject|0|||
124886647|NCT00507026|449209669|FG000|Overall Study|Investigator Decision|1|||
124886648|NCT00507026|449209670|FG001|Overall Study|Investigator Decision|0|||
124886649|NCT00507026|449209671|FG002|Overall Study|Investigator Decision|0|||
124886650|NCT00507026|449209669|FG000|Overall Study|Adverse Event|2|||
124886651|NCT00507026|449209670|FG001|Overall Study|Adverse Event|0|||
124886652|NCT00507026|449209671|FG002|Overall Study|Adverse Event|0|||
124886653|NCT00507026|449209669|FG000|Overall Study|Protocol Violation|1|||
124886654|NCT00507026|449209670|FG001|Overall Study|Protocol Violation|0|||
124886655|NCT00507026|449209671|FG002|Overall Study|Protocol Violation|0|||
124886656|NCT00507026|449209669|FG000|Overall Study|Other|1|||
124886657|NCT00507026|449209670|FG001|Overall Study|Other|0|||
124886658|NCT00507026|449209671|FG002|Overall Study|Other|0|||
124886659|NCT00896454|449209672|FG000|Overall Study|Death|10|||
124886660|NCT00896454|449209672|FG000|Overall Study|Adverse Event|8|||
124886661|NCT00896454|449209672|FG000|Overall Study|Disease Progression|5|||
124886662|NCT00896454|449209672|FG000|Overall Study|Other|4|||
124886663|NCT00896454|449209672|FG000|Overall Study|Requirement for alternative therapy|3|||
124886664|NCT00896454|449209672|FG000|Overall Study|Ongoing in study|2|||
124886665|NCT00896454|449209672|FG000|Overall Study|Withdrawal by Subject|1|||
124886666|NCT03688711|449209675|FG000|Overall Study|Withdrawal by Subject|0|||
124886667|NCT03688711|449209676|FG001|Overall Study|Withdrawal by Subject|1|||
124886668|NCT02500316|449209686|FG000|Overall Study|Adverse Event|3|||
124685262|NCT03314935|448468230|FG003|Phase 1|Progressive Disease|1|||
124685263|NCT03314935|448468231|FG004|Phase 1|Progressive Disease|0|||
124685264|NCT03314935|448468232|FG005|Phase 1|Progressive Disease|0|||
124685265|NCT03314935|448468233|FG006|Phase 1|Progressive Disease|0|||
124685266|NCT03314935|448468234|FG007|Phase 1|Progressive Disease|0|||
124685267|NCT03314935|448468235|FG008|Phase 1|Progressive Disease|0|||
124685268|NCT03314935|448468236|FG009|Phase 1|Progressive Disease|0|||
124685269|NCT03314935|448468237|FG010|Phase 1|Progressive Disease|0|||
124685270|NCT03314935|448468238|FG011|Phase 1|Progressive Disease|0|||
124685271|NCT03314935|448468239|FG012|Phase 1|Progressive Disease|0|||
124685272|NCT03314935|448468240|FG013|Phase 1|Progressive Disease|0|||
124685273|NCT03314935|448468241|FG014|Phase 1|Progressive Disease|0|||
124685274|NCT03314935|448468227|FG000|Phase 1|Study Terminated by Sponsor|0|||
124685275|NCT03314935|448468228|FG001|Phase 1|Study Terminated by Sponsor|1|||
124685276|NCT03314935|448468229|FG002|Phase 1|Study Terminated by Sponsor|0|||
124685277|NCT03314935|448468230|FG003|Phase 1|Study Terminated by Sponsor|0|||
124685278|NCT03314935|448468231|FG004|Phase 1|Study Terminated by Sponsor|0|||
124685279|NCT03314935|448468232|FG005|Phase 1|Study Terminated by Sponsor|0|||
124685280|NCT03314935|448468233|FG006|Phase 1|Study Terminated by Sponsor|0|||
124685281|NCT03314935|448468234|FG007|Phase 1|Study Terminated by Sponsor|0|||
124685282|NCT03314935|448468235|FG008|Phase 1|Study Terminated by Sponsor|1|||
124685283|NCT03314935|448468236|FG009|Phase 1|Study Terminated by Sponsor|0|||
124685284|NCT03314935|448468237|FG010|Phase 1|Study Terminated by Sponsor|0|||
124685285|NCT03314935|448468238|FG011|Phase 1|Study Terminated by Sponsor|0|||
124685286|NCT03314935|448468239|FG012|Phase 1|Study Terminated by Sponsor|0|||
124685287|NCT03314935|448468240|FG013|Phase 1|Study Terminated by Sponsor|0|||
124685288|NCT03314935|448468241|FG014|Phase 1|Study Terminated by Sponsor|0|||
124685289|NCT03314935|448468227|FG000|Phase 1|"Captured as Other in Database"|0|||
124886669|NCT02500316|449209686|FG000|Overall Study|Lost to Follow-up|2|||
124685290|NCT03314935|448468228|FG001|Phase 1|"Captured as Other in Database"|2|||
124685291|NCT03314935|448468229|FG002|Phase 1|"Captured as Other in Database"|0|||
124685292|NCT03314935|448468230|FG003|Phase 1|"Captured as Other in Database"|0|||
124685293|NCT03314935|448468231|FG004|Phase 1|"Captured as Other in Database"|0|||
124685294|NCT03314935|448468232|FG005|Phase 1|"Captured as Other in Database"|0|||
124685295|NCT03314935|448468233|FG006|Phase 1|"Captured as Other in Database"|1|||
124685296|NCT03314935|448468234|FG007|Phase 1|"Captured as Other in Database"|1|||
124685297|NCT03314935|448468235|FG008|Phase 1|"Captured as Other in Database"|1|||
124886670|NCT02500316|449209686|FG000|Overall Study|Protocol Violation|1|||
124886671|NCT02500316|449209686|FG000|Overall Study|Withdrawal by Subject|15|||
124886672|NCT02500316|449209686|FG000|Overall Study|Final height achieved|5|||
124886673|NCT02500316|449209686|FG000|Overall Study|Due to war activity|1|||
124886674|NCT01406717|449209687|FG000|Overall Study|Subject non-compliance|4|||
124886675|NCT01406717|449209688|FG001|Overall Study|Subject non-compliance|3|||
124886676|NCT01406717|449209687|FG000|Overall Study|Protocol Violation|5|||
124886677|NCT01406717|449209688|FG001|Overall Study|Protocol Violation|1|||
124886678|NCT01406717|449209687|FG000|Overall Study|Lost to Follow-up|14|||
124886679|NCT01406717|449209688|FG001|Overall Study|Lost to Follow-up|8|||
124886680|NCT01406717|449209687|FG000|Overall Study|Withdrawal by Subject|19|||
124886681|NCT01406717|449209688|FG001|Overall Study|Withdrawal by Subject|15|||
124886682|NCT01406717|449209687|FG000|Overall Study|Adverse Event|1|||
124886683|NCT01406717|449209688|FG001|Overall Study|Adverse Event|2|||
124886684|NCT01406717|449209687|FG000|Overall Study|Lack of Efficacy|0|||
124886685|NCT01406717|449209688|FG001|Overall Study|Lack of Efficacy|1|||
124886686|NCT01406717|449209687|FG000|Overall Study|Non-completion of visit activity|0|||
124886687|NCT01406717|449209688|FG001|Overall Study|Non-completion of visit activity|1|||
124886688|NCT03257995|449209689|FG000|Overall Study|Adverse Event|0|||
124886689|NCT03257995|449209690|FG001|Overall Study|Adverse Event|1|||
124886690|NCT03257995|449209691|FG002|Overall Study|Adverse Event|0|||
124886691|NCT03257995|449209692|FG003|Overall Study|Adverse Event|0|||
124886692|NCT03257995|449209693|FG004|Overall Study|Adverse Event|0|||
124886693|NCT03257995|449209694|FG005|Overall Study|Adverse Event|0|||
124886694|NCT03257995|449209689|FG000|Overall Study|Protocol deviation|0|||
124886695|NCT03257995|449209690|FG001|Overall Study|Protocol deviation|0|||
124886696|NCT03257995|449209691|FG002|Overall Study|Protocol deviation|0|||
124886697|NCT03257995|449209692|FG003|Overall Study|Protocol deviation|0|||
124886698|NCT03257995|449209693|FG004|Overall Study|Protocol deviation|0|||
124886699|NCT03257995|449209694|FG005|Overall Study|Protocol deviation|2|||
124886700|NCT01556763|449209699|FG000|Overall Study|Withdrawal by Subject|0|||
124886701|NCT01556763|449209700|FG001|Overall Study|Withdrawal by Subject|1|||
124886702|NCT01556763|449209701|FG002|Overall Study|Withdrawal by Subject|0|||
124886703|NCT04170296|449209702|FG000|Overall Study|Adverse Event|1|||
124886704|NCT04170296|449209703|FG001|Overall Study|Adverse Event|0|||
124886705|NCT04170296|449209702|FG000|Overall Study|Withdrawal by Subject|3|||
124886706|NCT04170296|449209703|FG001|Overall Study|Withdrawal by Subject|2|||
124886707|NCT04170296|449209702|FG000|Overall Study|Lost to Follow-up|4|||
124886708|NCT04170296|449209703|FG001|Overall Study|Lost to Follow-up|2|||
124886709|NCT00195715|449209704|FG000|Overall Study|Adverse Event|122|||
124886710|NCT00195715|449209704|FG000|Overall Study|Withdrawal by Subject|58|||
124886711|NCT00195715|449209704|FG000|Overall Study|Lost to Follow-up|27|||
124886712|NCT00195715|449209704|FG000|Overall Study|Protocol Violation|13|||
124886713|NCT00195715|449209704|FG000|Overall Study|Lack of Efficacy|93|||
124886714|NCT00195715|449209704|FG000|Overall Study|Pregnancy|14|||
124886715|NCT00195715|449209704|FG000|Overall Study|Investigative site closure|8|||
124886716|NCT00195715|449209704|FG000|Overall Study|Subject moved/relocated|7|||
124886717|NCT00195715|449209704|FG000|Overall Study|Subject non-compliance|6|||
124886718|NCT00195715|449209704|FG000|Overall Study|Subject started commercial Humira|5|||
124886719|NCT00195715|449209704|FG000|Overall Study|Subject choice|3|||
124886720|NCT00195715|449209704|FG000|Overall Study|Loss of response/no improvement|3|||
124886721|NCT00195715|449209704|FG000|Overall Study|Sponsor stopped study|1|||
124440036|NCT01668667|447570908|FG003|Overall Study|Adverse Event|4|||
124440037|NCT01668667|447570905|FG000|Overall Study|Lack of Efficacy|3|||
124440038|NCT01668667|447570906|FG001|Overall Study|Lack of Efficacy|2|||
124440039|NCT01668667|447570907|FG002|Overall Study|Lack of Efficacy|2|||
124440040|NCT01668667|447570908|FG003|Overall Study|Lack of Efficacy|3|||
124440041|NCT01668667|447570905|FG000|Overall Study|Protocol Violation|6|||
124440042|NCT01668667|447570906|FG001|Overall Study|Protocol Violation|10|||
124440043|NCT01668667|447570907|FG002|Overall Study|Protocol Violation|12|||
124440044|NCT01668667|447570908|FG003|Overall Study|Protocol Violation|5|||
124440045|NCT01668667|447570905|FG000|Overall Study|Lost to Follow-up|9|||
124440046|NCT01668667|447570906|FG001|Overall Study|Lost to Follow-up|4|||
124440047|NCT01668667|447570907|FG002|Overall Study|Lost to Follow-up|7|||
124440048|NCT01668667|447570908|FG003|Overall Study|Lost to Follow-up|6|||
124440049|NCT01668667|447570905|FG000|Overall Study|Physician Decision|3|||
124685298|NCT03314935|448468236|FG009|Phase 1|"Captured as Other in Database"|0|||
124440050|NCT01668667|447570906|FG001|Overall Study|Physician Decision|0|||
124440051|NCT01668667|447570907|FG002|Overall Study|Physician Decision|1|||
124440052|NCT01668667|447570908|FG003|Overall Study|Physician Decision|0|||
124440053|NCT01668667|447570905|FG000|Overall Study|Withdrawal by Subject|7|||
124685299|NCT03314935|448468237|FG010|Phase 1|"Captured as Other in Database"|0|||
124685300|NCT03314935|448468238|FG011|Phase 1|"Captured as Other in Database"|0|||
124440054|NCT01668667|447570906|FG001|Overall Study|Withdrawal by Subject|4|||
124440055|NCT01668667|447570907|FG002|Overall Study|Withdrawal by Subject|5|||
124886722|NCT00195715|449209704|FG000|Overall Study|Administrative reasons|2|||
124886723|NCT00195715|449209704|FG000|Overall Study|Investigator's decision|2|||
124886724|NCT00195715|449209704|FG000|Overall Study|Subject wants to get pregnant|4|||
124886725|NCT00195715|449209704|FG000|Overall Study|Use of prohibited medication|2|||
124886726|NCT00195715|449209704|FG000|Overall Study|Planned surgery|2|||
124886727|NCT00195715|449209704|FG000|Overall Study|Increased infection rate|1|||
124886728|NCT00195715|449209704|FG000|Overall Study|Ineligible|1|||
124886729|NCT00195715|449209704|FG000|Overall Study|Colonic stricture|1|||
124886730|NCT00195715|449209704|FG000|Overall Study|Sponsor discontinued trial|1|||
124886731|NCT00195715|449209704|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
124886732|NCT00845871|449209705|FG000|Assessment Period|Adverse Event|2|||
124886733|NCT00845871|449209705|FG000|Assessment Period|Abnormal laboratory values|1|||
124886734|NCT00845871|449209705|FG000|Assessment Period|Abnormal test procedure results|1|||
124886735|NCT00845871|449209705|FG000|Assessment Period|Patient withdrew consent|3|||
124886736|NCT01370603|449209707|FG000|Period 1|Adverse Event|5|||
124886737|NCT01370603|449209708|FG001|Period 1|Adverse Event|3|||
124886738|NCT01370603|449209707|FG000|Period 1|Lost to Follow-up|2|||
124886739|NCT01370603|449209708|FG001|Period 1|Lost to Follow-up|0|||
124886740|NCT01370603|449209707|FG000|Period 1|Protocol Violation|2|||
124886741|NCT01370603|449209708|FG001|Period 1|Protocol Violation|2|||
124886742|NCT01370603|449209707|FG000|Period 1|Withdrawal by Subject|5|||
124886743|NCT01370603|449209708|FG001|Period 1|Withdrawal by Subject|5|||
124886744|NCT01370603|449209707|FG000|Crossover Washout|Adverse Event|2|||
124886745|NCT01370603|449209708|FG001|Crossover Washout|Adverse Event|1|||
124886746|NCT01370603|449209707|FG000|Crossover Washout|Lost to Follow-up|2|||
124886747|NCT01370603|449209708|FG001|Crossover Washout|Lost to Follow-up|0|||
124886748|NCT01370603|449209707|FG000|Crossover Washout|Protocol Violation|1|||
124886749|NCT01370603|449209708|FG001|Crossover Washout|Protocol Violation|0|||
124886750|NCT01370603|449209707|FG000|Crossover Washout|Withdrawal by Subject|4|||
124886751|NCT01370603|449209708|FG001|Crossover Washout|Withdrawal by Subject|1|||
124886752|NCT01370603|449209707|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
124886753|NCT01370603|449209708|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
124886754|NCT01370603|449209707|FG000|Period 2|Adverse Event|1|||
124886755|NCT01370603|449209708|FG001|Period 2|Adverse Event|4|||
124886756|NCT01370603|449209707|FG000|Period 2|Lost to Follow-up|1|||
124886757|NCT01370603|449209708|FG001|Period 2|Lost to Follow-up|0|||
124886758|NCT01370603|449209707|FG000|Period 2|Withdrawal by Subject|1|||
124886759|NCT01370603|449209708|FG001|Period 2|Withdrawal by Subject|0|||
124886760|NCT04039503|449209710|FG000|Overall Study|Adverse Event|3|||
124886761|NCT04039503|449209711|FG001|Overall Study|Adverse Event|0|||
124886762|NCT04039503|449209712|FG002|Overall Study|Adverse Event|2|||
124685301|NCT03314935|448468239|FG012|Phase 1|"Captured as Other in Database"|0|||
124685302|NCT03314935|448468240|FG013|Phase 1|"Captured as Other in Database"|0|||
124685303|NCT03314935|448468241|FG014|Phase 1|"Captured as Other in Database"|0|||
124685304|NCT03314935|448468227|FG000|Phase 1|Lost to Follow-up|0|||
124685305|NCT03314935|448468228|FG001|Phase 1|Lost to Follow-up|0|||
124685306|NCT03314935|448468229|FG002|Phase 1|Lost to Follow-up|0|||
124685307|NCT03314935|448468230|FG003|Phase 1|Lost to Follow-up|0|||
124685308|NCT03314935|448468231|FG004|Phase 1|Lost to Follow-up|0|||
124685309|NCT03314935|448468232|FG005|Phase 1|Lost to Follow-up|0|||
124685310|NCT03314935|448468233|FG006|Phase 1|Lost to Follow-up|0|||
124685311|NCT03314935|448468234|FG007|Phase 1|Lost to Follow-up|0|||
124685312|NCT03314935|448468235|FG008|Phase 1|Lost to Follow-up|1|||
124685313|NCT03314935|448468236|FG009|Phase 1|Lost to Follow-up|0|||
124685314|NCT03314935|448468237|FG010|Phase 1|Lost to Follow-up|0|||
124685315|NCT03314935|448468238|FG011|Phase 1|Lost to Follow-up|0|||
124685316|NCT03314935|448468239|FG012|Phase 1|Lost to Follow-up|0|||
124685317|NCT03314935|448468240|FG013|Phase 1|Lost to Follow-up|0|||
124685318|NCT03314935|448468241|FG014|Phase 1|Lost to Follow-up|0|||
124685319|NCT03314935|448468227|FG000|Phase 2|Death|0|||
124685320|NCT03314935|448468228|FG001|Phase 2|Death|0|||
124685321|NCT03314935|448468229|FG002|Phase 2|Death|0|||
124685322|NCT03314935|448468230|FG003|Phase 2|Death|0|||
124685323|NCT03314935|448468231|FG004|Phase 2|Death|0|||
124685324|NCT03314935|448468232|FG005|Phase 2|Death|0|||
124685325|NCT03314935|448468233|FG006|Phase 2|Death|0|||
124685326|NCT03314935|448468234|FG007|Phase 2|Death|0|||
124685327|NCT03314935|448468235|FG008|Phase 2|Death|0|||
124685328|NCT03314935|448468236|FG009|Phase 2|Death|5|||
124685329|NCT03314935|448468237|FG010|Phase 2|Death|20|||
124685330|NCT03314935|448468238|FG011|Phase 2|Death|6|||
124685331|NCT03314935|448468239|FG012|Phase 2|Death|7|||
124886763|NCT04039503|449209713|FG003|Overall Study|Adverse Event|0|||
124886764|NCT04039503|449209710|FG000|Overall Study|Lost to Follow-up|0|||
124685332|NCT03314935|448468240|FG013|Phase 2|Death|6|||
124685333|NCT03314935|448468241|FG014|Phase 2|Death|17|||
124886765|NCT04039503|449209711|FG001|Overall Study|Lost to Follow-up|0|||
124886766|NCT04039503|449209712|FG002|Overall Study|Lost to Follow-up|1|||
124886767|NCT04039503|449209713|FG003|Overall Study|Lost to Follow-up|0|||
124886768|NCT04039503|449209710|FG000|Overall Study|Protocol Violation|0|||
124886769|NCT04039503|449209711|FG001|Overall Study|Protocol Violation|1|||
124886770|NCT04039503|449209712|FG002|Overall Study|Protocol Violation|2|||
124685334|NCT03314935|448468227|FG000|Phase 2|Withdrawal by Subject|0|||
124685335|NCT03314935|448468228|FG001|Phase 2|Withdrawal by Subject|0|||
124685336|NCT03314935|448468229|FG002|Phase 2|Withdrawal by Subject|0|||
124685337|NCT03314935|448468230|FG003|Phase 2|Withdrawal by Subject|0|||
124886771|NCT04039503|449209713|FG003|Overall Study|Protocol Violation|1|||
124886772|NCT04039503|449209710|FG000|Overall Study|Withdrawal by Subject|4|||
124886773|NCT04039503|449209711|FG001|Overall Study|Withdrawal by Subject|3|||
124886774|NCT04039503|449209712|FG002|Overall Study|Withdrawal by Subject|5|||
124886775|NCT04039503|449209713|FG003|Overall Study|Withdrawal by Subject|2|||
124886776|NCT01163747|449209714|FG000|Overall Study|Adverse Event|0|||
124886777|NCT01163747|449209715|FG001|Overall Study|Adverse Event|5|||
124886778|NCT01163747|449209714|FG000|Overall Study|Insufficient Therapeutic Response|0|||
124886779|NCT01163747|449209715|FG001|Overall Study|Insufficient Therapeutic Response|1|||
124886780|NCT01163747|449209714|FG000|Overall Study|Protocol Violation|0|||
124886781|NCT01163747|449209715|FG001|Overall Study|Protocol Violation|1|||
124886782|NCT01163747|449209714|FG000|Overall Study|Refused Treatment|6|||
124886783|NCT01163747|449209715|FG001|Overall Study|Refused Treatment|4|||
124886784|NCT03681639|449211619|FG000|Overall Study|Death|4|||
124886785|NCT03681639|449211619|FG000|Overall Study|Lost to Follow-up|2|||
124886786|NCT03681639|449211619|FG000|Overall Study|Withdrawal by Subject|1|||
124886787|NCT03681639|449211619|FG000|Overall Study|Adverse Event|2|||
124886788|NCT00654940|449211620|FG000|Period 1|Adverse Event|0|||
124886789|NCT00654940|449211621|FG001|Period 1|Adverse Event|1|||
124886790|NCT00654940|449211620|FG000|Period 1|Intolerable Pain Level|1|||
124886791|NCT00654940|449211621|FG001|Period 1|Intolerable Pain Level|0|||
124886792|NCT00581113|449211622|FG000|Overall Study|Withdrawal by Subject|0|||
124886793|NCT00581113|449211623|FG001|Overall Study|Withdrawal by Subject|1|||
124886794|NCT01818141|449211624|FG000|Overall Study|Withdrawal by Subject|2|||
124886795|NCT01818141|449211625|FG001|Overall Study|Withdrawal by Subject|0|||
124886796|NCT01818141|449211624|FG000|Overall Study|No baseline C.diff colonies|1|||
124886797|NCT01818141|449211625|FG001|Overall Study|No baseline C.diff colonies|1|||
124886798|NCT01818141|449211624|FG000|Overall Study|Lost to Follow-up|0|||
124886799|NCT01818141|449211625|FG001|Overall Study|Lost to Follow-up|2|||
124886800|NCT00619476|449211626|FG000|Overall Study|Adverse Event|12|||
124886801|NCT00619476|449211627|FG001|Overall Study|Adverse Event|6|||
124886802|NCT00619476|449211628|FG002|Overall Study|Adverse Event|12|||
124886803|NCT00619476|449211629|FG003|Overall Study|Adverse Event|16|||
124886804|NCT00619476|449211626|FG000|Overall Study|Lack of Efficacy|6|||
124886805|NCT00619476|449211627|FG001|Overall Study|Lack of Efficacy|1|||
124886806|NCT00619476|449211628|FG002|Overall Study|Lack of Efficacy|1|||
124886807|NCT00619476|449211629|FG003|Overall Study|Lack of Efficacy|4|||
124886808|NCT00619476|449211626|FG000|Overall Study|Protocol Violation|5|||
124886809|NCT00619476|449211627|FG001|Overall Study|Protocol Violation|4|||
124886810|NCT00619476|449211628|FG002|Overall Study|Protocol Violation|4|||
124886811|NCT00619476|449211629|FG003|Overall Study|Protocol Violation|9|||
124886812|NCT00619476|449211626|FG000|Overall Study|Lost to Follow-up|1|||
124886813|NCT00619476|449211627|FG001|Overall Study|Lost to Follow-up|2|||
124886814|NCT00619476|449211628|FG002|Overall Study|Lost to Follow-up|0|||
124886815|NCT00619476|449211629|FG003|Overall Study|Lost to Follow-up|1|||
124886816|NCT00619476|449211626|FG000|Overall Study|Investigator Discretion|2|||
124886817|NCT00619476|449211627|FG001|Overall Study|Investigator Discretion|2|||
124886818|NCT00619476|449211628|FG002|Overall Study|Investigator Discretion|2|||
124886819|NCT00619476|449211629|FG003|Overall Study|Investigator Discretion|0|||
124886820|NCT00619476|449211626|FG000|Overall Study|Withdrawal by Subject|5|||
124886821|NCT00619476|449211627|FG001|Overall Study|Withdrawal by Subject|7|||
124886822|NCT00619476|449211628|FG002|Overall Study|Withdrawal by Subject|5|||
124886823|NCT00619476|449211629|FG003|Overall Study|Withdrawal by Subject|4|||
124886824|NCT03204695|449211633|FG000|Overall Study|Death|1|||
124886825|NCT03204695|449211633|FG000|Overall Study|Participant was treated with another device|1|||
124886826|NCT03204695|449211633|FG000|Overall Study|Physician Decision|2|||
124886827|NCT04834362|449211634|FG000|Overall Study|Death|1|||
124886828|NCT04834362|449211635|FG001|Overall Study|Death|2|||
124886829|NCT01349829|449211638|FG000|Overall Study|Lost to Follow-up|4|||
124886830|NCT01349829|449211639|FG001|Overall Study|Lost to Follow-up|8|||
124886831|NCT01349829|449211638|FG000|Overall Study|Consent withdrawal|3|||
124886832|NCT01349829|449211639|FG001|Overall Study|Consent withdrawal|8|||
124886833|NCT01349829|449211638|FG000|Overall Study|Migrated/moved|2|||
124886834|NCT01349829|449211639|FG001|Overall Study|Migrated/moved|7|||
124886835|NCT03095599|449211640|FG000|Overall Study|Withdrawal by Subject|1|||
124886836|NCT03095599|449211641|FG001|Overall Study|Withdrawal by Subject|0|||
124886837|NCT03095599|449211640|FG000|Overall Study|Lost to Follow-up|1|||
124886838|NCT03095599|449211641|FG001|Overall Study|Lost to Follow-up|0|||
124886839|NCT03095599|449211640|FG000|Overall Study|Withdrawal prior to vaccination|1|||
124886840|NCT03095599|449211641|FG001|Overall Study|Withdrawal prior to vaccination|0|||
124758928|NCT01080807|448741185|FG000|Overall Study|Moved away without notifying center|1|||
124886841|NCT00742885|449211643|FG000|Overall Study|Lost to Follow-up|1|||
124886842|NCT00742885|449211644|FG001|Overall Study|Lost to Follow-up|0|||
124886843|NCT04781647|449211645|FG000|Overall Study|Study terminated by Sponsor|11|||
124886844|NCT04781647|449211646|FG001|Overall Study|Study terminated by Sponsor|9|||
124886845|NCT04781647|449211647|FG002|Overall Study|Study terminated by Sponsor|9|||
124886846|NCT04781647|449211645|FG000|Overall Study|Withdrawal by Subject|1|||
124886847|NCT04781647|449211646|FG001|Overall Study|Withdrawal by Subject|2|||
124886848|NCT04781647|449211647|FG002|Overall Study|Withdrawal by Subject|0|||
124886849|NCT04781647|449211645|FG000|Overall Study|Adverse Event|0|||
124886850|NCT04781647|449211646|FG001|Overall Study|Adverse Event|1|||
124886851|NCT04781647|449211647|FG002|Overall Study|Adverse Event|1|||
124886852|NCT04781647|449211645|FG000|Overall Study|Protocol Violation|1|||
124886853|NCT04781647|449211646|FG001|Overall Study|Protocol Violation|0|||
124886854|NCT04781647|449211647|FG002|Overall Study|Protocol Violation|0|||
124886855|NCT04781647|449211645|FG000|Overall Study|Pregnancy|0|||
124886856|NCT04781647|449211646|FG001|Overall Study|Pregnancy|0|||
124886857|NCT04781647|449211647|FG002|Overall Study|Pregnancy|1|||
124886858|NCT04781647|449211645|FG000|Overall Study|Virology rebounded|1|||
124886859|NCT04781647|449211646|FG001|Overall Study|Virology rebounded|0|||
124886860|NCT04781647|449211647|FG002|Overall Study|Virology rebounded|0|||
124886861|NCT01811563|449211648|FG000|Overall Study|Lost to Follow-up|5|||
124886862|NCT01811563|449211649|FG001|Overall Study|Lost to Follow-up|2|||
124886863|NCT01811563|449211648|FG000|Overall Study|Incorrect Randomization procedure|0|||
124886864|NCT01811563|449211649|FG001|Overall Study|Incorrect Randomization procedure|1|||
124886865|NCT00329719|449211650|FG000|Overall Study|Lost to Follow-up|0|||
124886866|NCT00329719|449211651|FG001|Overall Study|Lost to Follow-up|0|||
124886867|NCT00329719|449211652|FG002|Overall Study|Lost to Follow-up|0|||
124886868|NCT00329719|449211653|FG003|Overall Study|Lost to Follow-up|1|||
124886869|NCT01995357|449211656|FG000|Period 5|Lack of Efficacy|1|||
124886870|NCT01995357|449211657|FG001|Period 5|Lack of Efficacy|0|||
124886871|NCT01995357|449211658|FG002|Period 5|Lack of Efficacy|0|||
124886872|NCT01995357|449211659|FG003|Period 5|Lack of Efficacy|0|||
124886873|NCT01995357|449211660|FG004|Period 5|Lack of Efficacy|0|||
124886874|NCT01995357|449211661|FG005|Period 5|Lack of Efficacy|0|||
124886875|NCT01995357|449211656|FG000|Period 5|Adverse Event|1|||
124886876|NCT01995357|449211657|FG001|Period 5|Adverse Event|0|||
124886877|NCT01995357|449211658|FG002|Period 5|Adverse Event|1|||
124886878|NCT01995357|449211659|FG003|Period 5|Adverse Event|0|||
124886879|NCT01995357|449211660|FG004|Period 5|Adverse Event|0|||
124886880|NCT01995357|449211661|FG005|Period 5|Adverse Event|0|||
124886881|NCT01807221|449211664|FG000|Overall Study|Progressive disease|1|||
124886882|NCT01807221|449211665|FG001|Overall Study|Progressive disease|0|||
124886883|NCT01807221|449211666|FG002|Overall Study|Progressive disease|1|||
124886884|NCT01807221|449211667|FG003|Overall Study|Progressive disease|0|||
124886885|NCT01807221|449211668|FG004|Overall Study|Progressive disease|0|||
124886886|NCT01807221|449211669|FG005|Overall Study|Progressive disease|0|||
124886887|NCT01807221|449211664|FG000|Overall Study|Death|7|||
124886888|NCT01807221|449211665|FG001|Overall Study|Death|9|||
124886889|NCT01807221|449211666|FG002|Overall Study|Death|4|||
124886890|NCT01807221|449211667|FG003|Overall Study|Death|2|||
124886891|NCT01807221|449211668|FG004|Overall Study|Death|1|||
124886892|NCT01807221|449211669|FG005|Overall Study|Death|6|||
124886893|NCT01807221|449211664|FG000|Overall Study|Physician Decision|2|||
124886894|NCT01807221|449211665|FG001|Overall Study|Physician Decision|1|||
124886895|NCT01807221|449211666|FG002|Overall Study|Physician Decision|0|||
124886896|NCT01807221|449211667|FG003|Overall Study|Physician Decision|0|||
124886897|NCT01807221|449211668|FG004|Overall Study|Physician Decision|0|||
124886898|NCT01807221|449211669|FG005|Overall Study|Physician Decision|0|||
124886899|NCT01807221|449211664|FG000|Overall Study|Adverse Event|33|||
124886900|NCT01807221|449211665|FG001|Overall Study|Adverse Event|22|||
124886901|NCT01807221|449211666|FG002|Overall Study|Adverse Event|26|||
124886902|NCT01807221|449211667|FG003|Overall Study|Adverse Event|25|||
124886903|NCT01807221|449211668|FG004|Overall Study|Adverse Event|18|||
124886904|NCT01807221|449211669|FG005|Overall Study|Adverse Event|21|||
124886905|NCT01807221|449211664|FG000|Overall Study|Protocol Violation|0|||
124886906|NCT01807221|449211665|FG001|Overall Study|Protocol Violation|2|||
124886907|NCT01807221|449211666|FG002|Overall Study|Protocol Violation|1|||
124886908|NCT01807221|449211667|FG003|Overall Study|Protocol Violation|2|||
124685338|NCT03314935|448468231|FG004|Phase 2|Withdrawal by Subject|0|||
124685339|NCT03314935|448468232|FG005|Phase 2|Withdrawal by Subject|0|||
124886909|NCT01807221|449211668|FG004|Overall Study|Protocol Violation|0|||
124886910|NCT01807221|449211669|FG005|Overall Study|Protocol Violation|1|||
124886911|NCT01807221|449211664|FG000|Overall Study|Non-compliance|1|||
124886912|NCT01807221|449211665|FG001|Overall Study|Non-compliance|2|||
124685340|NCT03314935|448468233|FG006|Phase 2|Withdrawal by Subject|0|||
124685341|NCT03314935|448468234|FG007|Phase 2|Withdrawal by Subject|0|||
124685342|NCT03314935|448468235|FG008|Phase 2|Withdrawal by Subject|0|||
124886913|NCT01807221|449211666|FG002|Overall Study|Non-compliance|0|||
124886914|NCT01807221|449211667|FG003|Overall Study|Non-compliance|1|||
124886915|NCT01807221|449211668|FG004|Overall Study|Non-compliance|0|||
124685343|NCT03314935|448468236|FG009|Phase 2|Withdrawal by Subject|1|||
124886916|NCT01807221|449211669|FG005|Overall Study|Non-compliance|0|||
124886917|NCT01807221|449211664|FG000|Overall Study|Logistical difficulties|0|||
124886918|NCT01807221|449211665|FG001|Overall Study|Logistical difficulties|1|||
124886919|NCT01807221|449211666|FG002|Overall Study|Logistical difficulties|0|||
124886920|NCT01807221|449211667|FG003|Overall Study|Logistical difficulties|0|||
124886921|NCT01807221|449211668|FG004|Overall Study|Logistical difficulties|1|||
124886922|NCT01807221|449211669|FG005|Overall Study|Logistical difficulties|0|||
124886923|NCT01807221|449211664|FG000|Overall Study|Withdrawal by Subject|33|||
124886924|NCT01807221|449211665|FG001|Overall Study|Withdrawal by Subject|15|||
124886925|NCT01807221|449211666|FG002|Overall Study|Withdrawal by Subject|8|||
124886926|NCT01807221|449211667|FG003|Overall Study|Withdrawal by Subject|14|||
124886927|NCT01807221|449211668|FG004|Overall Study|Withdrawal by Subject|16|||
124886928|NCT01807221|449211669|FG005|Overall Study|Withdrawal by Subject|13|||
124886929|NCT01807221|449211664|FG000|Overall Study|Sponsor decision|2|||
124886930|NCT01807221|449211665|FG001|Overall Study|Sponsor decision|0|||
124886931|NCT01807221|449211666|FG002|Overall Study|Sponsor decision|1|||
124886932|NCT01807221|449211667|FG003|Overall Study|Sponsor decision|1|||
124886933|NCT01807221|449211668|FG004|Overall Study|Sponsor decision|0|||
124886934|NCT01807221|449211669|FG005|Overall Study|Sponsor decision|0|||
124886935|NCT01807221|449211664|FG000|Overall Study|Lost to Follow-up|1|||
124886936|NCT01807221|449211665|FG001|Overall Study|Lost to Follow-up|0|||
124886937|NCT01807221|449211666|FG002|Overall Study|Lost to Follow-up|2|||
124886938|NCT01807221|449211667|FG003|Overall Study|Lost to Follow-up|1|||
124886939|NCT01807221|449211668|FG004|Overall Study|Lost to Follow-up|0|||
124886940|NCT01807221|449211669|FG005|Overall Study|Lost to Follow-up|0|||
124886941|NCT02609659|449211670|FG000|Overall Study|Adverse Event|1|||
124886942|NCT02609659|449211670|FG000|Overall Study|Lost to Follow-up|6|||
124886943|NCT02609659|449211670|FG000|Overall Study|Other|1|||
124886944|NCT01155388|449211671|FG000|Overall Study|Adverse Event|1|||
124886945|NCT01155388|449211672|FG001|Overall Study|Adverse Event|0|||
124886946|NCT01004250|449211673|FG000|Induction Therapy Period|Adverse Event|10|||
124886947|NCT01004250|449211673|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
124886948|NCT01004250|449211673|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
124886949|NCT01004250|449211673|FG000|Induction Therapy Period|Physician Decision|2|||
124886950|NCT01004250|449211673|FG000|Maintenance Therapy Period|Adverse Event|15|||
124886951|NCT01004250|449211673|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
124886952|NCT01004250|449211673|FG000|Maintenance Therapy Period|Protocol Violation|1|||
124886953|NCT01004250|449211673|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
124886954|NCT01004250|449211673|FG000|Maintenance Therapy Period|Physician Decision|4|||
124886955|NCT01004250|449211673|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
124886956|NCT03943589|449211674|FG000|Overall Study|Death|1|||
124886957|NCT03943589|449211674|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
124886958|NCT00900627|449211675|FG000|Overall Study|Condition under investigation worsened|4|||
124886959|NCT00900627|449211676|FG001|Overall Study|Condition under investigation worsened|0|||
124886960|NCT00900627|449211677|FG002|Overall Study|Condition under investigation worsened|5|||
124886961|NCT00900627|449211678|FG003|Overall Study|Condition under investigation worsened|3|||
124886962|NCT00900627|449211679|FG004|Overall Study|Condition under investigation worsened|0|||
124886963|NCT00900627|449211680|FG005|Overall Study|Condition under investigation worsened|0|||
124886964|NCT00900627|449211675|FG000|Overall Study|Withdrawal by Subject|1|||
124886965|NCT00900627|449211676|FG001|Overall Study|Withdrawal by Subject|0|||
124886966|NCT00900627|449211677|FG002|Overall Study|Withdrawal by Subject|1|||
124886967|NCT00900627|449211678|FG003|Overall Study|Withdrawal by Subject|0|||
124440056|NCT01668667|447570908|FG003|Overall Study|Withdrawal by Subject|5|||
124440057|NCT00421707|447570909|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
124440058|NCT00421707|447570910|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
124440059|NCT00421707|447570909|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
124685344|NCT03314935|448468237|FG010|Phase 2|Withdrawal by Subject|4|||
124440060|NCT00421707|447570910|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
124440061|NCT00421707|447570909|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
124440062|NCT00421707|447570910|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
124440063|NCT00421707|447570909|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
124440064|NCT00421707|447570910|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
124440065|NCT00421707|447570909|FG000|Period 2: Washout|Adverse Event|1|||
124440066|NCT00421707|447570910|FG001|Period 2: Washout|Adverse Event|1|||
124440067|NCT00421707|447570909|FG000|Period 2: Washout|Withdrawal by Subject|0|||
124440068|NCT00421707|447570910|FG001|Period 2: Washout|Withdrawal by Subject|1|||
124440069|NCT00421707|447570909|FG000|Period 2: Washout|Lost to Follow-up|0|||
124886968|NCT00900627|449211679|FG004|Overall Study|Withdrawal by Subject|1|||
124886969|NCT00900627|449211680|FG005|Overall Study|Withdrawal by Subject|2|||
124886970|NCT00900627|449211675|FG000|Overall Study|Adverse Event|1|||
124886971|NCT00900627|449211676|FG001|Overall Study|Adverse Event|2|||
124886972|NCT00900627|449211677|FG002|Overall Study|Adverse Event|0|||
124886973|NCT00900627|449211678|FG003|Overall Study|Adverse Event|3|||
124886974|NCT00900627|449211679|FG004|Overall Study|Adverse Event|0|||
124886975|NCT00900627|449211680|FG005|Overall Study|Adverse Event|0|||
124886976|NCT00900627|449211675|FG000|Overall Study|Death|0|||
124886977|NCT00900627|449211676|FG001|Overall Study|Death|0|||
124440070|NCT00421707|447570910|FG001|Period 2: Washout|Lost to Follow-up|1|||
124440071|NCT00421707|447570909|FG000|Period 2: Washout|Other: Pregnancy|0|||
124886978|NCT00900627|449211677|FG002|Overall Study|Death|0|||
124886979|NCT00900627|449211678|FG003|Overall Study|Death|0|||
124886980|NCT00900627|449211679|FG004|Overall Study|Death|28|||
124886981|NCT00900627|449211680|FG005|Overall Study|Death|24|||
124886982|NCT00373295|449211681|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
124886983|NCT00373295|449211682|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
124886984|NCT00373295|449211683|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
124886985|NCT00373295|449211684|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
124886986|NCT00373295|449211685|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
124886987|NCT00373295|449211686|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
124886988|NCT00830947|449211687|FG000|Overall Study|Lost to Follow-up|4|||
124886989|NCT00830947|449211688|FG001|Overall Study|Lost to Follow-up|4|||
124886990|NCT02291289|449211689|FG000|Induction Treatment|Withdrawal by Subject|0|||
124886991|NCT02291289|449211690|FG001|Induction Treatment|Withdrawal by Subject|0|||
124886992|NCT02291289|449211691|FG002|Induction Treatment|Withdrawal by Subject|0|||
124886993|NCT02291289|449211692|FG003|Induction Treatment|Withdrawal by Subject|24|||
124886994|NCT02291289|449211693|FG004|Induction Treatment|Withdrawal by Subject|0|||
124886995|NCT02291289|449211694|FG005|Induction Treatment|Withdrawal by Subject|0|||
124886996|NCT02291289|449211695|FG006|Induction Treatment|Withdrawal by Subject|0|||
124886997|NCT02291289|449211696|FG007|Induction Treatment|Withdrawal by Subject|0|||
124886998|NCT02291289|449211697|FG008|Induction Treatment|Withdrawal by Subject|0|||
124886999|NCT02291289|449211698|FG009|Induction Treatment|Withdrawal by Subject|18|||
124887000|NCT02291289|449211699|FG010|Induction Treatment|Withdrawal by Subject|0|||
124887001|NCT02291289|449211700|FG011|Induction Treatment|Withdrawal by Subject|0|||
124887002|NCT02291289|449211701|FG012|Induction Treatment|Withdrawal by Subject|0|||
124887003|NCT02291289|449211689|FG000|Induction Treatment|Adverse Event|0|||
124887004|NCT02291289|449211690|FG001|Induction Treatment|Adverse Event|0|||
124887005|NCT02291289|449211691|FG002|Induction Treatment|Adverse Event|0|||
124887006|NCT02291289|449211692|FG003|Induction Treatment|Adverse Event|3|||
124887007|NCT02291289|449211693|FG004|Induction Treatment|Adverse Event|0|||
124887008|NCT02291289|449211694|FG005|Induction Treatment|Adverse Event|0|||
124887009|NCT02291289|449211695|FG006|Induction Treatment|Adverse Event|0|||
124887010|NCT02291289|449211696|FG007|Induction Treatment|Adverse Event|0|||
124887011|NCT02291289|449211697|FG008|Induction Treatment|Adverse Event|0|||
124887012|NCT02291289|449211698|FG009|Induction Treatment|Adverse Event|1|||
124887013|NCT02291289|449211699|FG010|Induction Treatment|Adverse Event|0|||
124887014|NCT02291289|449211700|FG011|Induction Treatment|Adverse Event|0|||
124887015|NCT02291289|449211701|FG012|Induction Treatment|Adverse Event|0|||
124887016|NCT02291289|449211689|FG000|Induction Treatment|Death|25|||
124887017|NCT02291289|449211690|FG001|Induction Treatment|Death|0|||
124887018|NCT02291289|449211691|FG002|Induction Treatment|Death|0|||
124887019|NCT02291289|449211692|FG003|Induction Treatment|Death|111|||
124887020|NCT02291289|449211693|FG004|Induction Treatment|Death|0|||
124887021|NCT02291289|449211694|FG005|Induction Treatment|Death|0|||
124887022|NCT02291289|449211695|FG006|Induction Treatment|Death|1|||
124887023|NCT02291289|449211696|FG007|Induction Treatment|Death|0|||
124887024|NCT02291289|449211697|FG008|Induction Treatment|Death|0|||
124887025|NCT02291289|449211698|FG009|Induction Treatment|Death|82|||
124887026|NCT02291289|449211699|FG010|Induction Treatment|Death|0|||
124887027|NCT02291289|449211700|FG011|Induction Treatment|Death|0|||
124887028|NCT02291289|449211701|FG012|Induction Treatment|Death|0|||
124887029|NCT02291289|449211689|FG000|Induction Treatment|Lost to Follow-up|1|||
124887030|NCT02291289|449211690|FG001|Induction Treatment|Lost to Follow-up|0|||
124887031|NCT02291289|449211691|FG002|Induction Treatment|Lost to Follow-up|0|||
124887032|NCT02291289|449211692|FG003|Induction Treatment|Lost to Follow-up|12|||
124887033|NCT02291289|449211693|FG004|Induction Treatment|Lost to Follow-up|0|||
124887034|NCT02291289|449211694|FG005|Induction Treatment|Lost to Follow-up|0|||
124440072|NCT00421707|447570910|FG001|Period 2: Washout|Other: Pregnancy|1|||
124440073|NCT00421707|447570909|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
124440074|NCT00421707|447570910|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
124440075|NCT00421707|447570909|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
124440076|NCT00421707|447570910|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
124440077|NCT00421707|447570909|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
124887035|NCT02291289|449211695|FG006|Induction Treatment|Lost to Follow-up|0|||
124887036|NCT02291289|449211696|FG007|Induction Treatment|Lost to Follow-up|0|||
124887037|NCT02291289|449211697|FG008|Induction Treatment|Lost to Follow-up|0|||
124887038|NCT02291289|449211698|FG009|Induction Treatment|Lost to Follow-up|9|||
124887039|NCT02291289|449211699|FG010|Induction Treatment|Lost to Follow-up|0|||
124440078|NCT00421707|447570910|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
124887040|NCT02291289|449211700|FG011|Induction Treatment|Lost to Follow-up|0|||
124887041|NCT02291289|449211701|FG012|Induction Treatment|Lost to Follow-up|0|||
124887042|NCT02291289|449211689|FG000|Induction Treatment|Non-Compliance|0|||
124887043|NCT02291289|449211690|FG001|Induction Treatment|Non-Compliance|0|||
124887044|NCT02291289|449211691|FG002|Induction Treatment|Non-Compliance|0|||
124887045|NCT02291289|449211692|FG003|Induction Treatment|Non-Compliance|1|||
124887046|NCT02291289|449211693|FG004|Induction Treatment|Non-Compliance|0|||
124887047|NCT02291289|449211694|FG005|Induction Treatment|Non-Compliance|0|||
124440079|NCT03261700|447570914|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
124440080|NCT03261700|447570915|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
124440081|NCT01204398|447570916|FG000|Overall Study|Adverse Event|1|||
124440082|NCT00983931|447570917|FG000|14 Day Washout Period|Physician Decision|1|||
124440083|NCT01281969|447570920|FG000|Overall Study|not randomized didn't meet criteria|0|||
124440084|NCT01281969|447570921|FG001|Overall Study|not randomized didn't meet criteria|0|||
124440085|NCT01281969|447570922|FG002|Overall Study|not randomized didn't meet criteria|7|||
124440086|NCT01281969|447570920|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
124440087|NCT01281969|447570921|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
124440088|NCT01281969|447570922|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
124440089|NCT01281969|447570920|FG000|Overall Study|not randomized, child consent not given|0|||
124440090|NCT01281969|447570921|FG001|Overall Study|not randomized, child consent not given|0|||
124440091|NCT01281969|447570922|FG002|Overall Study|not randomized, child consent not given|2|||
124440092|NCT01723254|447570923|FG000|Overall Study|Conflict with work schedule|0|||
124440093|NCT01723254|447570924|FG001|Overall Study|Conflict with work schedule|0|||
124440094|NCT01723254|447570925|FG002|Overall Study|Conflict with work schedule|0|||
124440095|NCT01723254|447570926|FG003|Overall Study|Conflict with work schedule|0|||
124887048|NCT02291289|449211695|FG006|Induction Treatment|Non-Compliance|0|||
124440096|NCT01723254|447570927|FG004|Overall Study|Conflict with work schedule|0|||
124440097|NCT01723254|447570928|FG005|Overall Study|Conflict with work schedule|0|||
124440098|NCT01723254|447570929|FG006|Overall Study|Conflict with work schedule|0|||
124440099|NCT01723254|447570930|FG007|Overall Study|Conflict with work schedule|1|||
124440100|NCT01723254|447570923|FG000|Overall Study|Personal issues|0|||
124440101|NCT01723254|447570924|FG001|Overall Study|Personal issues|0|||
124440102|NCT01723254|447570925|FG002|Overall Study|Personal issues|0|||
124440103|NCT01723254|447570926|FG003|Overall Study|Personal issues|0|||
124440104|NCT01723254|447570927|FG004|Overall Study|Personal issues|0|||
124440105|NCT01723254|447570928|FG005|Overall Study|Personal issues|1|||
124440106|NCT01723254|447570929|FG006|Overall Study|Personal issues|0|||
124440107|NCT01723254|447570930|FG007|Overall Study|Personal issues|0|||
124440108|NCT01723254|447570923|FG000|Overall Study|No longer have time to participate|0|||
124440109|NCT01723254|447570924|FG001|Overall Study|No longer have time to participate|0|||
124440110|NCT01723254|447570925|FG002|Overall Study|No longer have time to participate|0|||
124440111|NCT01723254|447570926|FG003|Overall Study|No longer have time to participate|1|||
124440112|NCT01723254|447570927|FG004|Overall Study|No longer have time to participate|0|||
124440113|NCT01723254|447570928|FG005|Overall Study|No longer have time to participate|0|||
124440114|NCT01723254|447570929|FG006|Overall Study|No longer have time to participate|0|||
124440115|NCT01723254|447570930|FG007|Overall Study|No longer have time to participate|0|||
124440116|NCT01723254|447570923|FG000|Overall Study|Move/Left to another country/city|0|||
124440117|NCT01723254|447570924|FG001|Overall Study|Move/Left to another country/city|0|||
124440118|NCT01723254|447570925|FG002|Overall Study|Move/Left to another country/city|2|||
124440119|NCT01723254|447570926|FG003|Overall Study|Move/Left to another country/city|1|||
124887049|NCT02291289|449211696|FG007|Induction Treatment|Non-Compliance|0|||
124887050|NCT02291289|449211697|FG008|Induction Treatment|Non-Compliance|0|||
124887051|NCT02291289|449211698|FG009|Induction Treatment|Non-Compliance|1|||
124887052|NCT02291289|449211699|FG010|Induction Treatment|Non-Compliance|0|||
124887053|NCT02291289|449211700|FG011|Induction Treatment|Non-Compliance|0|||
124887054|NCT02291289|449211701|FG012|Induction Treatment|Non-Compliance|0|||
124887055|NCT02291289|449211689|FG000|Induction Treatment|Reason Not Specified|0|||
124887056|NCT02291289|449211690|FG001|Induction Treatment|Reason Not Specified|0|||
124887057|NCT02291289|449211691|FG002|Induction Treatment|Reason Not Specified|0|||
124887058|NCT02291289|449211692|FG003|Induction Treatment|Reason Not Specified|4|||
124887059|NCT02291289|449211693|FG004|Induction Treatment|Reason Not Specified|0|||
124887060|NCT02291289|449211694|FG005|Induction Treatment|Reason Not Specified|0|||
124887061|NCT02291289|449211695|FG006|Induction Treatment|Reason Not Specified|0|||
124887062|NCT02291289|449211696|FG007|Induction Treatment|Reason Not Specified|0|||
124887063|NCT02291289|449211697|FG008|Induction Treatment|Reason Not Specified|0|||
124887064|NCT02291289|449211698|FG009|Induction Treatment|Reason Not Specified|7|||
124887065|NCT02291289|449211699|FG010|Induction Treatment|Reason Not Specified|0|||
124887066|NCT02291289|449211700|FG011|Induction Treatment|Reason Not Specified|0|||
124887067|NCT02291289|449211701|FG012|Induction Treatment|Reason Not Specified|0|||
124887068|NCT02291289|449211689|FG000|Induction Treatment|Physician Decision|0|||
124887069|NCT02291289|449211690|FG001|Induction Treatment|Physician Decision|0|||
124887070|NCT02291289|449211691|FG002|Induction Treatment|Physician Decision|0|||
124887071|NCT02291289|449211692|FG003|Induction Treatment|Physician Decision|3|||
124887072|NCT02291289|449211693|FG004|Induction Treatment|Physician Decision|0|||
124887073|NCT02291289|449211694|FG005|Induction Treatment|Physician Decision|0|||
124887074|NCT02291289|449211695|FG006|Induction Treatment|Physician Decision|0|||
124887075|NCT02291289|449211696|FG007|Induction Treatment|Physician Decision|0|||
124440120|NCT01723254|447570927|FG004|Overall Study|Move/Left to another country/city|1|||
124440121|NCT01723254|447570928|FG005|Overall Study|Move/Left to another country/city|0|||
124440122|NCT01723254|447570929|FG006|Overall Study|Move/Left to another country/city|0|||
124685345|NCT03314935|448468238|FG011|Phase 2|Withdrawal by Subject|0|||
124685346|NCT03314935|448468239|FG012|Phase 2|Withdrawal by Subject|1|||
124887076|NCT02291289|449211697|FG008|Induction Treatment|Physician Decision|0|||
124887077|NCT02291289|449211698|FG009|Induction Treatment|Physician Decision|1|||
124887078|NCT02291289|449211699|FG010|Induction Treatment|Physician Decision|0|||
124887079|NCT02291289|449211700|FG011|Induction Treatment|Physician Decision|0|||
124887080|NCT02291289|449211701|FG012|Induction Treatment|Physician Decision|0|||
124887081|NCT02291289|449211689|FG000|Induction Treatment|Protocol Violation|0|||
124887082|NCT02291289|449211690|FG001|Induction Treatment|Protocol Violation|0|||
124887083|NCT02291289|449211691|FG002|Induction Treatment|Protocol Violation|0|||
124887084|NCT02291289|449211692|FG003|Induction Treatment|Protocol Violation|3|||
124887085|NCT02291289|449211693|FG004|Induction Treatment|Protocol Violation|0|||
124887086|NCT02291289|449211694|FG005|Induction Treatment|Protocol Violation|0|||
124887087|NCT02291289|449211695|FG006|Induction Treatment|Protocol Violation|0|||
124887088|NCT02291289|449211696|FG007|Induction Treatment|Protocol Violation|0|||
124887089|NCT02291289|449211697|FG008|Induction Treatment|Protocol Violation|0|||
124887090|NCT02291289|449211698|FG009|Induction Treatment|Protocol Violation|2|||
124887091|NCT02291289|449211699|FG010|Induction Treatment|Protocol Violation|0|||
124887092|NCT02291289|449211700|FG011|Induction Treatment|Protocol Violation|0|||
124887093|NCT02291289|449211701|FG012|Induction Treatment|Protocol Violation|0|||
124887094|NCT02291289|449211689|FG000|Induction Treatment|Missing|4|||
124887095|NCT02291289|449211690|FG001|Induction Treatment|Missing|0|||
124887096|NCT02291289|449211691|FG002|Induction Treatment|Missing|0|||
124887097|NCT02291289|449211692|FG003|Induction Treatment|Missing|14|||
124887098|NCT02291289|449211693|FG004|Induction Treatment|Missing|0|||
124887099|NCT02291289|449211694|FG005|Induction Treatment|Missing|0|||
124887100|NCT02291289|449211695|FG006|Induction Treatment|Missing|0|||
124887101|NCT02291289|449211696|FG007|Induction Treatment|Missing|0|||
124887102|NCT02291289|449211697|FG008|Induction Treatment|Missing|0|||
124887103|NCT02291289|449211698|FG009|Induction Treatment|Missing|54|||
124887104|NCT02291289|449211699|FG010|Induction Treatment|Missing|0|||
124887105|NCT02291289|449211700|FG011|Induction Treatment|Missing|0|||
124887106|NCT02291289|449211701|FG012|Induction Treatment|Missing|0|||
124887107|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887108|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887109|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887110|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887111|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
124685347|NCT03314935|448468240|FG013|Phase 2|Withdrawal by Subject|0|||
124887112|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
124887113|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887114|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887115|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887116|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887117|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
124887118|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
124887119|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124887120|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Death|0|||
124685348|NCT03314935|448468241|FG014|Phase 2|Withdrawal by Subject|1|||
124887121|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Death|29|||
124440123|NCT01723254|447570930|FG007|Overall Study|Move/Left to another country/city|0|||
124440124|NCT01723254|447570923|FG000|Overall Study|Protocol Violation|0|||
124440125|NCT01723254|447570924|FG001|Overall Study|Protocol Violation|1|||
124685349|NCT03314935|448468227|FG000|Phase 2|Progressive Disease|0|||
124685350|NCT03314935|448468228|FG001|Phase 2|Progressive Disease|0|||
124685351|NCT03314935|448468229|FG002|Phase 2|Progressive Disease|0|||
124685352|NCT03314935|448468230|FG003|Phase 2|Progressive Disease|0|||
124685353|NCT03314935|448468231|FG004|Phase 2|Progressive Disease|0|||
124685354|NCT03314935|448468232|FG005|Phase 2|Progressive Disease|0|||
124685355|NCT03314935|448468233|FG006|Phase 2|Progressive Disease|0|||
124685356|NCT03314935|448468234|FG007|Phase 2|Progressive Disease|0|||
124685357|NCT03314935|448468235|FG008|Phase 2|Progressive Disease|0|||
124685358|NCT03314935|448468236|FG009|Phase 2|Progressive Disease|1|||
124685359|NCT03314935|448468237|FG010|Phase 2|Progressive Disease|1|||
124685360|NCT03314935|448468238|FG011|Phase 2|Progressive Disease|1|||
124685361|NCT03314935|448468239|FG012|Phase 2|Progressive Disease|2|||
124685362|NCT03314935|448468240|FG013|Phase 2|Progressive Disease|0|||
124685363|NCT03314935|448468241|FG014|Phase 2|Progressive Disease|1|||
124685364|NCT03314935|448468227|FG000|Phase 2|Study Terminated by Sponsor|0|||
124685365|NCT03314935|448468228|FG001|Phase 2|Study Terminated by Sponsor|0|||
124685366|NCT03314935|448468229|FG002|Phase 2|Study Terminated by Sponsor|0|||
124685367|NCT03314935|448468230|FG003|Phase 2|Study Terminated by Sponsor|0|||
124685368|NCT03314935|448468231|FG004|Phase 2|Study Terminated by Sponsor|0|||
124685369|NCT03314935|448468232|FG005|Phase 2|Study Terminated by Sponsor|0|||
124685370|NCT03314935|448468233|FG006|Phase 2|Study Terminated by Sponsor|0|||
124685371|NCT03314935|448468234|FG007|Phase 2|Study Terminated by Sponsor|0|||
124685372|NCT03314935|448468235|FG008|Phase 2|Study Terminated by Sponsor|0|||
124685373|NCT03314935|448468236|FG009|Phase 2|Study Terminated by Sponsor|0|||
124685374|NCT03314935|448468237|FG010|Phase 2|Study Terminated by Sponsor|7|||
124685375|NCT03314935|448468238|FG011|Phase 2|Study Terminated by Sponsor|2|||
124685376|NCT03314935|448468239|FG012|Phase 2|Study Terminated by Sponsor|1|||
124685377|NCT03314935|448468240|FG013|Phase 2|Study Terminated by Sponsor|4|||
124685378|NCT03314935|448468241|FG014|Phase 2|Study Terminated by Sponsor|4|||
124685379|NCT03314935|448468227|FG000|Phase 2|Lost to Follow-up|0|||
124685380|NCT03314935|448468228|FG001|Phase 2|Lost to Follow-up|0|||
124685381|NCT03314935|448468229|FG002|Phase 2|Lost to Follow-up|0|||
124685382|NCT03314935|448468230|FG003|Phase 2|Lost to Follow-up|0|||
124685383|NCT03314935|448468231|FG004|Phase 2|Lost to Follow-up|0|||
124685384|NCT03314935|448468232|FG005|Phase 2|Lost to Follow-up|0|||
124685385|NCT03314935|448468233|FG006|Phase 2|Lost to Follow-up|0|||
124685386|NCT03314935|448468234|FG007|Phase 2|Lost to Follow-up|0|||
124685387|NCT03314935|448468235|FG008|Phase 2|Lost to Follow-up|0|||
124685388|NCT03314935|448468236|FG009|Phase 2|Lost to Follow-up|1|||
124685389|NCT03314935|448468237|FG010|Phase 2|Lost to Follow-up|0|||
124685390|NCT03314935|448468238|FG011|Phase 2|Lost to Follow-up|0|||
124685391|NCT03314935|448468239|FG012|Phase 2|Lost to Follow-up|0|||
124685392|NCT03314935|448468240|FG013|Phase 2|Lost to Follow-up|0|||
124685393|NCT03314935|448468241|FG014|Phase 2|Lost to Follow-up|1|||
124685394|NCT03314935|448468227|FG000|Phase 2|Physician Decision|0|||
124685395|NCT03314935|448468228|FG001|Phase 2|Physician Decision|0|||
124685396|NCT03314935|448468229|FG002|Phase 2|Physician Decision|0|||
124685397|NCT03314935|448468230|FG003|Phase 2|Physician Decision|0|||
124685398|NCT03314935|448468231|FG004|Phase 2|Physician Decision|0|||
124685399|NCT03314935|448468232|FG005|Phase 2|Physician Decision|0|||
124685400|NCT03314935|448468233|FG006|Phase 2|Physician Decision|0|||
124685401|NCT03314935|448468234|FG007|Phase 2|Physician Decision|0|||
124685402|NCT03314935|448468235|FG008|Phase 2|Physician Decision|0|||
124685403|NCT03314935|448468236|FG009|Phase 2|Physician Decision|0|||
124685404|NCT03314935|448468237|FG010|Phase 2|Physician Decision|1|||
124685405|NCT03314935|448468238|FG011|Phase 2|Physician Decision|0|||
124685406|NCT03314935|448468239|FG012|Phase 2|Physician Decision|0|||
124685407|NCT03314935|448468240|FG013|Phase 2|Physician Decision|0|||
124685408|NCT03314935|448468241|FG014|Phase 2|Physician Decision|0|||
124685409|NCT04967222|448468246|FG000|Randomized|Lost to Follow-up|0|||
124685410|NCT04967222|448468247|FG001|Randomized|Lost to Follow-up|1|||
124685411|NCT04967222|448468248|FG002|Randomized|Lost to Follow-up|1|||
124685412|NCT04967222|448468246|FG000|Randomized|Physician Decision|0|||
124685413|NCT04967222|448468247|FG001|Randomized|Physician Decision|0|||
124685414|NCT04967222|448468248|FG002|Randomized|Physician Decision|1|||
124685415|NCT04967222|448468246|FG000|Randomized|Withdrawal by Subject|0|||
124685416|NCT04967222|448468247|FG001|Randomized|Withdrawal by Subject|0|||
124685417|NCT04967222|448468248|FG002|Randomized|Withdrawal by Subject|2|||
124685418|NCT04967222|448468246|FG000|Randomized|abnormal finding in MRI|0|||
124685419|NCT04967222|448468247|FG001|Randomized|abnormal finding in MRI|2|||
124685420|NCT04967222|448468248|FG002|Randomized|abnormal finding in MRI|0|||
124758929|NCT01080807|448741186|FG001|Overall Study|Moved away without notifying center|0|||
124685421|NCT03785366|448468249|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
124685422|NCT03785366|448468250|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
124685423|NCT03785366|448468249|FG000|Overall Study|Lost to Follow-up|1|||
124685424|NCT03785366|448468250|FG001|Overall Study|Lost to Follow-up|0|||
124887122|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Death|16|||
124887123|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Death|0|||
124887124|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Death|188|||
124887125|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Death|107|||
124887126|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Death|0|||
124887127|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Death|1|||
124887128|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Death|1|||
124887129|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Death|0|||
124887130|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Death|46|||
124887131|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Death|19|||
124887132|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Death|0|||
124887133|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Adverse Event|0|||
124887134|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Adverse Event|0|||
124887135|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Adverse Event|0|||
124887136|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Adverse Event|0|||
124887137|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Adverse Event|1|||
124887138|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Adverse Event|1|||
124887139|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Adverse Event|0|||
124887140|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Adverse Event|0|||
124887141|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Adverse Event|0|||
124887142|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Adverse Event|0|||
124887143|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Adverse Event|0|||
124887144|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Adverse Event|0|||
124887145|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Adverse Event|0|||
124887146|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
124887147|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
124887148|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
124887149|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
124887150|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
124887151|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
124887152|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
124887153|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
124887154|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
124887155|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
124887156|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
124887157|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
124887158|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
124887159|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
124887160|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
124887161|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
124887162|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
124887163|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
124887164|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
124887165|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
124887166|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
124887167|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
124887168|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
124887169|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
124887170|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
124887171|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
124887172|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Physician Decision|0|||
124887173|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Physician Decision|2|||
124887174|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Physician Decision|0|||
124887175|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Physician Decision|0|||
124887176|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Physician Decision|3|||
124887177|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Physician Decision|0|||
124887178|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Physician Decision|0|||
124887179|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Physician Decision|0|||
124887180|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Physician Decision|0|||
124887181|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Physician Decision|0|||
124887182|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Physician Decision|1|||
124887183|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Physician Decision|3|||
124887184|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Physician Decision|0|||
124887185|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Not Treated|0|||
124887186|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Not Treated|0|||
124887187|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Not Treated|2|||
124887188|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Not Treated|0|||
124887189|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Not Treated|0|||
124887190|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Not Treated|0|||
124887191|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Not Treated|0|||
124887192|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Not Treated|0|||
124887193|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Not Treated|0|||
124887194|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Not Treated|0|||
124440126|NCT01723254|447570925|FG002|Overall Study|Protocol Violation|0|||
124685425|NCT03785366|448468249|FG000|Overall Study|Partial IUD Expulsion|0|||
124685426|NCT03785366|448468250|FG001|Overall Study|Partial IUD Expulsion|2|||
124685427|NCT03785366|448468249|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
124685428|NCT03785366|448468250|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
124685429|NCT03916926|448469796|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
124685430|NCT03916926|448469797|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
124685431|NCT03916926|448469796|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
124685432|NCT03916926|448469797|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
124685433|NCT03916926|448469796|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
124685434|NCT03916926|448469797|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
124685435|NCT03916926|448469796|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
124685436|NCT03916926|448469797|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
124685437|NCT03330197|448469798|FG000|Overall Study|Adverse Event|0|||
124685438|NCT03330197|448469799|FG001|Overall Study|Adverse Event|1|||
124685439|NCT03330197|448469798|FG000|Overall Study|Withdrawal by Subject|0|||
124685440|NCT03330197|448469799|FG001|Overall Study|Withdrawal by Subject|1|||
124685441|NCT04537299|448469800|FG000|Overall Study|Withdrawal by Subject|2|||
124685442|NCT04537299|448469801|FG001|Overall Study|Withdrawal by Subject|0|||
124685443|NCT04537299|448469800|FG000|Overall Study|Protocol Violation|1|||
124685444|NCT04537299|448469801|FG001|Overall Study|Protocol Violation|1|||
124685445|NCT03806296|448469802|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
124685446|NCT03806296|448469803|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
124685447|NCT03806296|448469804|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
124685448|NCT03806296|448469802|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
124685449|NCT03806296|448469803|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
124685450|NCT03806296|448469804|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
124685451|NCT03806296|448469802|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
124685452|NCT03806296|448469803|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
124685453|NCT03806296|448469804|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
124685454|NCT00876343|448469805|FG000|Overall Study|Adverse Event|7|||
124685455|NCT00876343|448469806|FG001|Overall Study|Adverse Event|8|||
124685456|NCT00876343|448469807|FG002|Overall Study|Adverse Event|2|||
124685457|NCT00876343|448469805|FG000|Overall Study|Withdrawal by Subject|4|||
124685458|NCT00876343|448469806|FG001|Overall Study|Withdrawal by Subject|4|||
124685459|NCT00876343|448469807|FG002|Overall Study|Withdrawal by Subject|3|||
124685460|NCT00876343|448469805|FG000|Overall Study|Lack of Efficacy|0|||
124685461|NCT00876343|448469806|FG001|Overall Study|Lack of Efficacy|0|||
124685462|NCT00876343|448469807|FG002|Overall Study|Lack of Efficacy|1|||
124685463|NCT00876343|448469805|FG000|Overall Study|Protocol Violation|4|||
124685464|NCT00876343|448469806|FG001|Overall Study|Protocol Violation|1|||
124685465|NCT00876343|448469807|FG002|Overall Study|Protocol Violation|1|||
124685466|NCT00876343|448469805|FG000|Overall Study|Physician Decision|0|||
124685467|NCT00876343|448469806|FG001|Overall Study|Physician Decision|1|||
124685468|NCT00876343|448469807|FG002|Overall Study|Physician Decision|1|||
124685469|NCT00876343|448469805|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
124685470|NCT00876343|448469806|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
124685471|NCT00876343|448469807|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
124685472|NCT00876343|448469805|FG000|Overall Study|Change of residence or other commitments|2|||
124685473|NCT00876343|448469806|FG001|Overall Study|Change of residence or other commitments|2|||
124685474|NCT00876343|448469807|FG002|Overall Study|Change of residence or other commitments|3|||
124685475|NCT01925794|448469814|FG000|180 Days|Death|2|||
124685476|NCT01925794|448469814|FG000|180 Days|Withdrawal by Subject|2|||
124685477|NCT01925794|448469814|FG000|270 Days|Death|2|||
124685478|NCT01925794|448469814|FG000|270 Days|Protocol Violation|3|||
124685479|NCT00790036|448469815|FG000|Overall Study|Abnormal lab values|3|||
124685480|NCT00790036|448469816|FG001|Overall Study|Abnormal lab values|2|||
124887195|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Not Treated|0|||
124887196|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Not Treated|0|||
124440127|NCT01723254|447570926|FG003|Overall Study|Protocol Violation|0|||
124685481|NCT00790036|448469815|FG000|Overall Study|Administrative problems|5|||
124685482|NCT00790036|448469816|FG001|Overall Study|Administrative problems|9|||
124440128|NCT01723254|447570927|FG004|Overall Study|Protocol Violation|0|||
124685483|NCT00790036|448469815|FG000|Overall Study|Adverse Event|113|||
124685484|NCT00790036|448469816|FG001|Overall Study|Adverse Event|44|||
124685485|NCT00790036|448469815|FG000|Overall Study|Death|1|||
124685486|NCT00790036|448469816|FG001|Overall Study|Death|0|||
124685487|NCT00790036|448469815|FG000|Overall Study|Disease progression|24|||
124685488|NCT00790036|448469816|FG001|Overall Study|Disease progression|48|||
124685489|NCT00790036|448469815|FG000|Overall Study|Lost to Follow-up|1|||
124887197|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Not Treated|0|||
124887198|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887199|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
124887200|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887201|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887202|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887203|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887204|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887205|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887206|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887207|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887208|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887209|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887210|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
124887211|NCT02291289|449211689|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
124887212|NCT02291289|449211690|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
124887213|NCT02291289|449211691|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
124887214|NCT02291289|449211692|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
124887215|NCT02291289|449211693|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
124887216|NCT02291289|449211694|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
124887217|NCT02291289|449211695|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
124887218|NCT02291289|449211696|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
124887219|NCT02291289|449211697|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
124887220|NCT02291289|449211698|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
124887221|NCT02291289|449211699|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
124887222|NCT02291289|449211700|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
124887223|NCT02291289|449211701|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
124887224|NCT02291289|449211689|FG000|Early Disease Progression|Death|0|||
124887225|NCT02291289|449211690|FG001|Early Disease Progression|Death|0|||
124887226|NCT02291289|449211691|FG002|Early Disease Progression|Death|0|||
124887227|NCT02291289|449211692|FG003|Early Disease Progression|Death|0|||
124887228|NCT02291289|449211693|FG004|Early Disease Progression|Death|0|||
124887229|NCT02291289|449211694|FG005|Early Disease Progression|Death|0|||
124887230|NCT02291289|449211695|FG006|Early Disease Progression|Death|0|||
124887231|NCT02291289|449211696|FG007|Early Disease Progression|Death|0|||
124887232|NCT02291289|449211697|FG008|Early Disease Progression|Death|0|||
124887233|NCT02291289|449211698|FG009|Early Disease Progression|Death|0|||
124887234|NCT02291289|449211699|FG010|Early Disease Progression|Death|0|||
124887235|NCT02291289|449211700|FG011|Early Disease Progression|Death|0|||
124887236|NCT02291289|449211701|FG012|Early Disease Progression|Death|10|||
124887237|NCT02291289|449211689|FG000|Early Disease Progression|Lost to Follow-up|0|||
124887238|NCT02291289|449211690|FG001|Early Disease Progression|Lost to Follow-up|0|||
124887239|NCT02291289|449211691|FG002|Early Disease Progression|Lost to Follow-up|0|||
124887240|NCT02291289|449211692|FG003|Early Disease Progression|Lost to Follow-up|0|||
124887241|NCT02291289|449211693|FG004|Early Disease Progression|Lost to Follow-up|0|||
124887242|NCT02291289|449211694|FG005|Early Disease Progression|Lost to Follow-up|0|||
124887243|NCT02291289|449211695|FG006|Early Disease Progression|Lost to Follow-up|0|||
124887244|NCT02291289|449211696|FG007|Early Disease Progression|Lost to Follow-up|0|||
124887245|NCT02291289|449211697|FG008|Early Disease Progression|Lost to Follow-up|0|||
124887246|NCT02291289|449211698|FG009|Early Disease Progression|Lost to Follow-up|0|||
124887247|NCT02291289|449211699|FG010|Early Disease Progression|Lost to Follow-up|0|||
124887248|NCT02291289|449211700|FG011|Early Disease Progression|Lost to Follow-up|0|||
124887249|NCT02291289|449211701|FG012|Early Disease Progression|Lost to Follow-up|1|||
124887250|NCT00962585|449211706|FG000|Overall Study|Adverse Event|0|||
124887251|NCT00962585|449211707|FG001|Overall Study|Adverse Event|2|||
124887252|NCT00962585|449211708|FG002|Overall Study|Adverse Event|1|||
124887253|NCT00962585|449211709|FG003|Overall Study|Adverse Event|0|||
124887254|NCT00962585|449211706|FG000|Overall Study|Lost to Follow-up|3|||
124887255|NCT00962585|449211707|FG001|Overall Study|Lost to Follow-up|0|||
124887256|NCT00962585|449211708|FG002|Overall Study|Lost to Follow-up|1|||
124887257|NCT00962585|449211709|FG003|Overall Study|Lost to Follow-up|0|||
124887258|NCT00962585|449211706|FG000|Overall Study|Protocol Violation|0|||
124887259|NCT00962585|449211707|FG001|Overall Study|Protocol Violation|0|||
124440129|NCT01723254|447570928|FG005|Overall Study|Protocol Violation|0|||
124887260|NCT00962585|449211708|FG002|Overall Study|Protocol Violation|1|||
124887261|NCT00962585|449211709|FG003|Overall Study|Protocol Violation|0|||
124887262|NCT00962585|449211706|FG000|Overall Study|Withdrawal by Subject|1|||
124887263|NCT00962585|449211707|FG001|Overall Study|Withdrawal by Subject|0|||
124887264|NCT00962585|449211708|FG002|Overall Study|Withdrawal by Subject|0|||
124887265|NCT00962585|449211709|FG003|Overall Study|Withdrawal by Subject|0|||
124887266|NCT00962585|449211706|FG000|Overall Study|Withdrew Consent|2|||
124887267|NCT00962585|449211707|FG001|Overall Study|Withdrew Consent|0|||
124887268|NCT00962585|449211708|FG002|Overall Study|Withdrew Consent|0|||
124887269|NCT00962585|449211709|FG003|Overall Study|Withdrew Consent|0|||
124887270|NCT00594906|449211714|FG000|Overall Study|Physician Decision|1|||
124685490|NCT00790036|448469816|FG001|Overall Study|Lost to Follow-up|2|||
124887271|NCT00594906|449211715|FG001|Overall Study|Physician Decision|0|||
124887272|NCT00594906|449211714|FG000|Overall Study|Physician Decision|0|||
124887273|NCT00594906|449211715|FG001|Overall Study|Physician Decision|1|||
124887274|NCT00594906|449211714|FG000|Overall Study|Death|0|||
124887275|NCT00594906|449211715|FG001|Overall Study|Death|1|||
124887276|NCT04430335|449211718|FG000|Overall Study|Withdrawal by Subject|1|||
124887277|NCT02139982|449211721|FG000|Overall Study|Lack of Efficacy|0|||
124887278|NCT02139982|449211722|FG001|Overall Study|Lack of Efficacy|1|||
124887279|NCT02139982|449211723|FG002|Overall Study|Lack of Efficacy|0|||
124887280|NCT02139982|449211724|FG003|Overall Study|Lack of Efficacy|1|||
124887281|NCT02139982|449211725|FG004|Overall Study|Lack of Efficacy|0|||
124887282|NCT02139982|449211726|FG005|Overall Study|Lack of Efficacy|0|||
124887283|NCT02139982|449211727|FG006|Overall Study|Lack of Efficacy|0|||
124887284|NCT02139982|449211728|FG007|Overall Study|Lack of Efficacy|0|||
124887285|NCT02139982|449211729|FG008|Overall Study|Lack of Efficacy|0|||
124887286|NCT02139982|449211730|FG009|Overall Study|Lack of Efficacy|0|||
124887287|NCT02206152|449211763|FG000|Pre-Randomization|Withdrawal by Subject|2|||
124887288|NCT00478608|449211764|FG000|Overall Study|Adverse Event|1|||
124887289|NCT00478608|449211764|FG000|Overall Study|Serious Adverse Event|14|||
124887290|NCT00478608|449211764|FG000|Overall Study|Withdrawal by Subject|2|||
124887291|NCT00478608|449211764|FG000|Overall Study|Protocol Violation|3|||
124887292|NCT02080520|449211766|FG000|Overall Study|Self-reported symptoms|5|||
124887293|NCT02080520|449211767|FG001|Overall Study|Self-reported symptoms|6|||
124887294|NCT02080520|449211766|FG000|Overall Study|Unable to contact|2|||
124887295|NCT02080520|449211767|FG001|Overall Study|Unable to contact|1|||
124887296|NCT02080520|449211766|FG000|Overall Study|Initiated aspirin|2|||
124887297|NCT02080520|449211767|FG001|Overall Study|Initiated aspirin|0|||
124887298|NCT02080520|449211766|FG000|Overall Study|Atrial fibrillation|1|||
124887299|NCT02080520|449211767|FG001|Overall Study|Atrial fibrillation|1|||
124887300|NCT02080520|449211766|FG000|Overall Study|Cancer|1|||
124887301|NCT02080520|449211767|FG001|Overall Study|Cancer|2|||
124887302|NCT02080520|449211766|FG000|Overall Study|Not interested in study|1|||
124887303|NCT02080520|449211767|FG001|Overall Study|Not interested in study|3|||
124887304|NCT02080520|449211766|FG000|Overall Study|Too busy|1|||
124887305|NCT02080520|449211767|FG001|Overall Study|Too busy|1|||
124685491|NCT00790036|448469815|FG000|Overall Study|Protocol Violation|10|||
124685492|NCT00790036|448469816|FG001|Overall Study|Protocol Violation|2|||
124685493|NCT00790036|448469815|FG000|Overall Study|Withdrawal by Subject|18|||
124685494|NCT00790036|448469816|FG001|Overall Study|Withdrawal by Subject|7|||
124685495|NCT00790036|448469815|FG000|Overall Study|Subject/guardian decision|20|||
124685496|NCT00790036|448469816|FG001|Overall Study|Subject/guardian decision|7|||
124685497|NCT05248386|448469818|FG000|Overall Study|Technical problems|0|||
124685498|NCT05248386|448469819|FG001|Overall Study|Technical problems|1|||
124685499|NCT05248386|448469818|FG000|Overall Study|Withdrawal by Subject|15|||
124685500|NCT05248386|448469819|FG001|Overall Study|Withdrawal by Subject|10|||
124685501|NCT05248386|448469818|FG000|Overall Study|Physician Decision|0|||
124685502|NCT05248386|448469819|FG001|Overall Study|Physician Decision|1|||
124887306|NCT02080520|449211766|FG000|Overall Study|Work-related injury|1|||
124887307|NCT02080520|449211767|FG001|Overall Study|Work-related injury|0|||
124887308|NCT02080520|449211766|FG000|Overall Study|Personal reasons|0|||
124440130|NCT01723254|447570929|FG006|Overall Study|Protocol Violation|0|||
124685503|NCT05248386|448469818|FG000|Overall Study|Adverse Event|2|||
124887309|NCT02080520|449211767|FG001|Overall Study|Personal reasons|3|||
124440131|NCT01723254|447570930|FG007|Overall Study|Protocol Violation|0|||
124440132|NCT01723254|447570923|FG000|Overall Study|Withdrawal by Subject|1|||
124685504|NCT05248386|448469819|FG001|Overall Study|Adverse Event|4|||
124685505|NCT05248386|448469818|FG000|Overall Study|Other|1|||
124685506|NCT05248386|448469819|FG001|Overall Study|Other|0|||
124887310|NCT01394250|449211773|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
124887311|NCT01394250|449211774|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
124685507|NCT05248386|448469818|FG000|Overall Study|Lack of Efficacy|14|||
124887312|NCT01394250|449211773|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
124887313|NCT01394250|449211774|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
124887314|NCT03230864|449211778|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
124887315|NCT03230864|449211779|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
124887316|NCT03230864|449211780|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
124887317|NCT03230864|449211781|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
124887318|NCT03230864|449211778|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
124887319|NCT03230864|449211779|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
124887320|NCT03230864|449211780|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
124887321|NCT03230864|449211781|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
124887322|NCT03230864|449211778|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
124887323|NCT03230864|449211779|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
124887324|NCT03230864|449211780|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
124887325|NCT03230864|449211781|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
124887326|NCT03230864|449211778|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
124887327|NCT03230864|449211779|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
124887328|NCT03230864|449211780|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
124887329|NCT03230864|449211781|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
124887330|NCT03230864|449211778|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
124887331|NCT03230864|449211779|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
124887332|NCT03230864|449211780|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
124887333|NCT03230864|449211781|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
124887334|NCT03230864|449211778|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
124887335|NCT03230864|449211779|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
124887336|NCT03230864|449211780|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
124887337|NCT03230864|449211781|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
124887338|NCT03230864|449211778|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
124887339|NCT03230864|449211779|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
124887340|NCT03230864|449211780|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
124887341|NCT03230864|449211781|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
124887342|NCT03230864|449211778|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
124887343|NCT03230864|449211779|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
124887344|NCT03230864|449211780|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
124887345|NCT03230864|449211781|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
124887346|NCT03230864|449211778|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
124887347|NCT03230864|449211779|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
124887348|NCT03230864|449211780|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
124440133|NCT01723254|447570924|FG001|Overall Study|Withdrawal by Subject|2|||
124440134|NCT01723254|447570925|FG002|Overall Study|Withdrawal by Subject|1|||
124440135|NCT01723254|447570926|FG003|Overall Study|Withdrawal by Subject|0|||
124440136|NCT01723254|447570927|FG004|Overall Study|Withdrawal by Subject|1|||
124440137|NCT01723254|447570928|FG005|Overall Study|Withdrawal by Subject|1|||
124440138|NCT01723254|447570929|FG006|Overall Study|Withdrawal by Subject|1|||
124440139|NCT01723254|447570930|FG007|Overall Study|Withdrawal by Subject|2|||
124440140|NCT01201265|447570934|FG000|Overall Study|Death|14|||
124440141|NCT01201265|447570934|FG000|Overall Study|Insufficient Therapeutic Response|3|||
124440142|NCT01201265|447570934|FG000|Overall Study|Lost to Follow-up|10|||
124440143|NCT01201265|447570934|FG000|Overall Study|Withdrawal by Subject|7|||
124440144|NCT01201265|447570934|FG000|Overall Study|Disease Progression|4|||
124440145|NCT04640077|447570935|FG000|Period 1|Withdrawal by Subject|4|||
124440146|NCT04640077|447570936|FG001|Period 1|Withdrawal by Subject|5|||
124440147|NCT04640077|447570937|FG002|Period 1|Withdrawal by Subject|0|||
124440148|NCT04640077|447570935|FG000|Period 1|Adverse Event|1|||
124440149|NCT04640077|447570936|FG001|Period 1|Adverse Event|1|||
124440150|NCT04640077|447570937|FG002|Period 1|Adverse Event|0|||
124440151|NCT04640077|447570935|FG000|Period 1|Screen Failure|2|||
124440152|NCT04640077|447570936|FG001|Period 1|Screen Failure|0|||
124440153|NCT04640077|447570937|FG002|Period 1|Screen Failure|0|||
124440154|NCT04640077|447570935|FG000|Period 2|Withdrawal by Subject|0|||
124440155|NCT04640077|447570936|FG001|Period 2|Withdrawal by Subject|0|||
124440156|NCT04640077|447570937|FG002|Period 2|Withdrawal by Subject|18|||
124440157|NCT04640077|447570935|FG000|Period 2|Adverse Event|0|||
124440158|NCT04640077|447570936|FG001|Period 2|Adverse Event|0|||
124440159|NCT04640077|447570937|FG002|Period 2|Adverse Event|6|||
124440160|NCT04640077|447570935|FG000|Period 2|Lost to Follow-up|0|||
124440161|NCT04640077|447570936|FG001|Period 2|Lost to Follow-up|0|||
124440162|NCT04640077|447570937|FG002|Period 2|Lost to Follow-up|2|||
124685508|NCT05248386|448469819|FG001|Overall Study|Lack of Efficacy|12|||
124685509|NCT02864992|448469821|FG000|Overall Study|still on treatment|15|||
124440163|NCT04640077|447570935|FG000|Period 2|Death|0|||
124440164|NCT04640077|447570936|FG001|Period 2|Death|0|||
124440165|NCT04640077|447570937|FG002|Period 2|Death|2|||
124440166|NCT04640077|447570935|FG000|Period 2|Progressive Disease|0|||
124440167|NCT04640077|447570936|FG001|Period 2|Progressive Disease|0|||
124440168|NCT04640077|447570937|FG002|Period 2|Progressive Disease|1|||
124440169|NCT04640077|447570935|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
124440170|NCT04640077|447570936|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
124887349|NCT03230864|449211781|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
124887350|NCT03230864|449211778|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
124887351|NCT03230864|449211779|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
124887352|NCT03230864|449211780|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
124887353|NCT03230864|449211781|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
124887354|NCT00432679|449211786|FG000|Overall Study|Adverse Event|2|||
124887355|NCT00432679|449211787|FG001|Overall Study|Adverse Event|1|||
124887356|NCT00432679|449211786|FG000|Overall Study|Withdrawal by Subject|3|||
124887357|NCT00432679|449211787|FG001|Overall Study|Withdrawal by Subject|2|||
124887358|NCT01177813|449211793|FG000|Overall Study|Adverse Event|8|||
124887359|NCT01177813|449211794|FG001|Overall Study|Adverse Event|2|||
124887360|NCT01177813|449211795|FG002|Overall Study|Adverse Event|4|||
124887361|NCT01177813|449211796|FG003|Overall Study|Adverse Event|6|||
124887362|NCT01177813|449211797|FG004|Overall Study|Adverse Event|3|||
124887363|NCT01177813|449211793|FG000|Overall Study|Lack of Efficacy|1|||
124887364|NCT01177813|449211794|FG001|Overall Study|Lack of Efficacy|0|||
124887365|NCT01177813|449211795|FG002|Overall Study|Lack of Efficacy|0|||
124887366|NCT01177813|449211796|FG003|Overall Study|Lack of Efficacy|0|||
124887367|NCT01177813|449211797|FG004|Overall Study|Lack of Efficacy|0|||
124887368|NCT01177813|449211793|FG000|Overall Study|Protocol Violation|3|||
124887369|NCT01177813|449211794|FG001|Overall Study|Protocol Violation|2|||
124887370|NCT01177813|449211795|FG002|Overall Study|Protocol Violation|2|||
124887371|NCT01177813|449211796|FG003|Overall Study|Protocol Violation|0|||
124887372|NCT01177813|449211797|FG004|Overall Study|Protocol Violation|1|||
124887373|NCT01177813|449211793|FG000|Overall Study|Lost to Follow-up|12|||
124887374|NCT01177813|449211794|FG001|Overall Study|Lost to Follow-up|5|||
124887375|NCT01177813|449211795|FG002|Overall Study|Lost to Follow-up|6|||
124887376|NCT01177813|449211796|FG003|Overall Study|Lost to Follow-up|3|||
124887377|NCT01177813|449211797|FG004|Overall Study|Lost to Follow-up|0|||
124887378|NCT01177813|449211793|FG000|Overall Study|Withdrawal by Subject|12|||
124887379|NCT01177813|449211794|FG001|Overall Study|Withdrawal by Subject|7|||
124887380|NCT01177813|449211795|FG002|Overall Study|Withdrawal by Subject|6|||
124887381|NCT01177813|449211796|FG003|Overall Study|Withdrawal by Subject|5|||
124887382|NCT01177813|449211797|FG004|Overall Study|Withdrawal by Subject|3|||
124887383|NCT01177813|449211793|FG000|Overall Study|Other reason not defined above|5|||
124887384|NCT01177813|449211794|FG001|Overall Study|Other reason not defined above|2|||
124887385|NCT01177813|449211795|FG002|Overall Study|Other reason not defined above|2|||
124887386|NCT01177813|449211796|FG003|Overall Study|Other reason not defined above|3|||
124887387|NCT01177813|449211797|FG004|Overall Study|Other reason not defined above|2|||
124887388|NCT00109928|449211800|FG000|Overall Study|Adverse Event|2|||
124887389|NCT00109928|449211800|FG000|Overall Study|Progression|6|||
124887390|NCT00109928|449211800|FG000|Overall Study|Death|2|||
124887391|NCT00109928|449211800|FG000|Overall Study|not protocol specified|2|||
124887392|NCT00109928|449211800|FG000|Overall Study|not eligible|1|||
124887393|NCT01196104|449211801|FG000|Overall Study|Lost to Follow-up|1|||
124887394|NCT01196104|449211802|FG001|Overall Study|Lost to Follow-up|0|||
124887395|NCT01196104|449211801|FG000|Overall Study|Physician Decision|0|||
124887396|NCT01196104|449211802|FG001|Overall Study|Physician Decision|1|||
124887397|NCT01196104|449211801|FG000|Overall Study|Withdrawal by Subject|3|||
124887398|NCT01196104|449211802|FG001|Overall Study|Withdrawal by Subject|3|||
124887399|NCT01196104|449211801|FG000|Overall Study|Various|0|||
124887400|NCT01196104|449211802|FG001|Overall Study|Various|1|||
124887401|NCT00983619|449211803|FG000|Overall Study|Lost to Follow-up|0|||
124887402|NCT00983619|449211804|FG001|Overall Study|Lost to Follow-up|1|||
124887403|NCT00983619|449211805|FG002|Overall Study|Lost to Follow-up|0|||
124887404|NCT00983619|449211806|FG003|Overall Study|Lost to Follow-up|0|||
124887405|NCT00983619|449211807|FG004|Overall Study|Lost to Follow-up|0|||
124887406|NCT00983619|449211808|FG005|Overall Study|Lost to Follow-up|2|||
124887407|NCT00983619|449211809|FG006|Overall Study|Lost to Follow-up|0|||
124887408|NCT00983619|449211810|FG007|Overall Study|Lost to Follow-up|0|||
124887409|NCT00983619|449211811|FG008|Overall Study|Lost to Follow-up|0|||
124887410|NCT00983619|449211812|FG009|Overall Study|Lost to Follow-up|0|||
124887411|NCT00983619|449211813|FG010|Overall Study|Lost to Follow-up|0|||
124887412|NCT00983619|449211814|FG011|Overall Study|Lost to Follow-up|2|||
124887413|NCT00983619|449211803|FG000|Overall Study|Withdrawal by Subject|2|||
124887414|NCT00983619|449211804|FG001|Overall Study|Withdrawal by Subject|1|||
124887415|NCT00983619|449211805|FG002|Overall Study|Withdrawal by Subject|1|||
124887416|NCT00983619|449211806|FG003|Overall Study|Withdrawal by Subject|3|||
124887417|NCT00983619|449211807|FG004|Overall Study|Withdrawal by Subject|1|||
124887418|NCT00983619|449211808|FG005|Overall Study|Withdrawal by Subject|23|||
124887419|NCT00983619|449211809|FG006|Overall Study|Withdrawal by Subject|0|||
124887420|NCT00983619|449211810|FG007|Overall Study|Withdrawal by Subject|0|||
124887421|NCT00983619|449211811|FG008|Overall Study|Withdrawal by Subject|0|||
124887422|NCT00983619|449211812|FG009|Overall Study|Withdrawal by Subject|0|||
124887423|NCT00983619|449211813|FG010|Overall Study|Withdrawal by Subject|1|||
124887424|NCT00983619|449211814|FG011|Overall Study|Withdrawal by Subject|1|||
124887425|NCT00983619|449211803|FG000|Overall Study|Death|0|||
124887426|NCT00983619|449211804|FG001|Overall Study|Death|2|||
124887427|NCT00983619|449211805|FG002|Overall Study|Death|2|||
124887428|NCT00983619|449211806|FG003|Overall Study|Death|1|||
124887429|NCT00983619|449211807|FG004|Overall Study|Death|2|||
124887430|NCT00983619|449211808|FG005|Overall Study|Death|30|||
124887431|NCT00983619|449211809|FG006|Overall Study|Death|1|||
124887432|NCT00983619|449211810|FG007|Overall Study|Death|0|||
124887433|NCT00983619|449211811|FG008|Overall Study|Death|1|||
124887434|NCT00983619|449211812|FG009|Overall Study|Death|2|||
124887435|NCT00983619|449211813|FG010|Overall Study|Death|9|||
124887436|NCT00983619|449211814|FG011|Overall Study|Death|8|||
124887437|NCT00983619|449211803|FG000|Overall Study|Other|1|||
124887438|NCT00983619|449211804|FG001|Overall Study|Other|0|||
124887439|NCT00983619|449211805|FG002|Overall Study|Other|0|||
124887440|NCT00983619|449211806|FG003|Overall Study|Other|1|||
124887441|NCT00983619|449211807|FG004|Overall Study|Other|0|||
124887442|NCT00983619|449211808|FG005|Overall Study|Other|12|||
124887443|NCT00983619|449211809|FG006|Overall Study|Other|2|||
124887444|NCT00983619|449211810|FG007|Overall Study|Other|2|||
124887445|NCT00983619|449211811|FG008|Overall Study|Other|0|||
124887446|NCT00983619|449211812|FG009|Overall Study|Other|1|||
124887447|NCT00983619|449211813|FG010|Overall Study|Other|1|||
124887448|NCT00983619|449211814|FG011|Overall Study|Other|0|||
124887449|NCT03772314|449211815|FG000|Overall Study|Adverse Event|7|||
124887450|NCT03772314|449211816|FG001|Overall Study|Adverse Event|2|||
124887451|NCT01284140|449211821|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
124887452|NCT01284140|449211822|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
124887453|NCT01284140|449211821|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
124887454|NCT01284140|449211822|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
124887455|NCT00088205|449211823|FG000|Overall Study|Adverse Event|4|||
124887456|NCT00088205|449211823|FG000|Overall Study|Progressive Disease|51|||
124887457|NCT00088205|449211823|FG000|Overall Study|Physician Decision|1|||
124887458|NCT00088205|449211823|FG000|Overall Study|Death Due to Study Disease|4|||
124887459|NCT03192215|449211824|FG000|Overall Study|Death|28|||
124887460|NCT03192215|449211825|FG001|Overall Study|Death|23|||
124887461|NCT03192215|449211824|FG000|Overall Study|Lost to Follow-up|10|||
124887462|NCT03192215|449211825|FG001|Overall Study|Lost to Follow-up|15|||
124887463|NCT03192215|449211824|FG000|Overall Study|Withdrawal by Subject|49|||
124887464|NCT03192215|449211825|FG001|Overall Study|Withdrawal by Subject|48|||
124887465|NCT03192215|449211824|FG000|Overall Study|Other as reported in analysis|4|||
124887466|NCT03192215|449211825|FG001|Overall Study|Other as reported in analysis|1|||
124887467|NCT02061761|449211829|FG000|Overall Study|Disease progression|2|||
124887468|NCT02061761|449211830|FG001|Overall Study|Disease progression|8|||
124887469|NCT02061761|449211831|FG002|Overall Study|Disease progression|4|||
124887470|NCT02061761|449211832|FG003|Overall Study|Disease progression|5|||
124887471|NCT02061761|449211833|FG004|Overall Study|Disease progression|9|||
124887472|NCT02061761|449211834|FG005|Overall Study|Disease progression|3|||
124887473|NCT02061761|449211835|FG006|Overall Study|Disease progression|1|||
124887474|NCT02061761|449211836|FG007|Overall Study|Disease progression|2|||
124887475|NCT02061761|449211837|FG008|Overall Study|Disease progression|28|||
124887476|NCT02061761|449211829|FG000|Overall Study|Study Drug toxicity|0|||
124887477|NCT02061761|449211830|FG001|Overall Study|Study Drug toxicity|0|||
124887478|NCT02061761|449211831|FG002|Overall Study|Study Drug toxicity|0|||
124887479|NCT02061761|449211832|FG003|Overall Study|Study Drug toxicity|0|||
124758930|NCT03922581|448741192|FG000|Overall Study|Lost to Follow-up|20|||
124758931|NCT03922581|448741193|FG001|Overall Study|Lost to Follow-up|9|||
124758932|NCT03922581|448741192|FG000|Overall Study|Physician Decision|1|||
124758933|NCT03922581|448741193|FG001|Overall Study|Physician Decision|1|||
124887480|NCT02061761|449211833|FG004|Overall Study|Study Drug toxicity|0|||
124887481|NCT02061761|449211834|FG005|Overall Study|Study Drug toxicity|1|||
124887482|NCT02061761|449211835|FG006|Overall Study|Study Drug toxicity|0|||
124887483|NCT02061761|449211836|FG007|Overall Study|Study Drug toxicity|2|||
124887484|NCT02061761|449211837|FG008|Overall Study|Study Drug toxicity|6|||
124887485|NCT02061761|449211829|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
124887486|NCT02061761|449211830|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
124887487|NCT02061761|449211831|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
124887488|NCT02061761|449211832|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
124887489|NCT02061761|449211833|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
124887490|NCT02061761|449211834|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
124758934|NCT03922581|448741192|FG000|Overall Study|Withdrawal by Subject|1|||
124887491|NCT02061761|449211835|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
124887492|NCT02061761|449211836|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
124887493|NCT02061761|449211837|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
124758935|NCT03922581|448741193|FG001|Overall Study|Withdrawal by Subject|0|||
124758936|NCT04685798|448741196|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
124758937|NCT02223715|448741197|FG000|Overall Study|Death|31|||
124758938|NCT02223715|448741197|FG000|Overall Study|Lost to Follow-up|73|||
124758939|NCT03956550|448741198|FG000|Overall Study|Sponsor decision|65|||
124758940|NCT03956550|448741199|FG001|Overall Study|Sponsor decision|66|||
124758941|NCT03956550|448741200|FG002|Overall Study|Sponsor decision|64|||
124758942|NCT03956550|448741198|FG000|Overall Study|Adverse Event|0|||
124758943|NCT03956550|448741199|FG001|Overall Study|Adverse Event|1|||
124758944|NCT03956550|448741200|FG002|Overall Study|Adverse Event|0|||
124758945|NCT03956550|448741198|FG000|Overall Study|Withdrawal by Subject|5|||
124758946|NCT03956550|448741199|FG001|Overall Study|Withdrawal by Subject|5|||
124758947|NCT03956550|448741200|FG002|Overall Study|Withdrawal by Subject|6|||
124758948|NCT01745367|448741203|FG000|Overall Study|Death|1|||
124758949|NCT01745367|448741204|FG001|Overall Study|Death|0|||
124758950|NCT01745367|448741203|FG000|Overall Study|Withdrawal by Subject|1|||
124758951|NCT01745367|448741204|FG001|Overall Study|Withdrawal by Subject|2|||
124758952|NCT01745367|448741203|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
124758953|NCT01745367|448741204|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
124758954|NCT01745367|448741203|FG000|Overall Study|Other Reasons Unspecified|0|||
124758955|NCT01745367|448741204|FG001|Overall Study|Other Reasons Unspecified|2|||
124758956|NCT00824473|448741208|FG000|Overall Study|Adverse Event|4|||
124758957|NCT00824473|448741209|FG001|Overall Study|Adverse Event|5|||
124758958|NCT00824473|448741208|FG000|Overall Study|Lack of Efficacy|2|||
124758959|NCT00824473|448741209|FG001|Overall Study|Lack of Efficacy|2|||
124758960|NCT00824473|448741208|FG000|Overall Study|Protocol Violation|2|||
124758961|NCT00824473|448741209|FG001|Overall Study|Protocol Violation|0|||
124758962|NCT00824473|448741208|FG000|Overall Study|Non-Compliance|4|||
124887494|NCT02061761|449211829|FG000|Overall Study|Participant request to discontinue study treatment|0|||
124887495|NCT02061761|449211830|FG001|Overall Study|Participant request to discontinue study treatment|0|||
124887496|NCT02061761|449211831|FG002|Overall Study|Participant request to discontinue study treatment|2|||
124887497|NCT02061761|449211832|FG003|Overall Study|Participant request to discontinue study treatment|2|||
124887498|NCT02061761|449211833|FG004|Overall Study|Participant request to discontinue study treatment|0|||
124758963|NCT00824473|448741209|FG001|Overall Study|Non-Compliance|2|||
124758964|NCT00824473|448741208|FG000|Overall Study|Withdrawal by Subject|2|||
124758965|NCT00824473|448741209|FG001|Overall Study|Withdrawal by Subject|3|||
124758966|NCT00824473|448741208|FG000|Overall Study|Other|1|||
124758967|NCT00824473|448741209|FG001|Overall Study|Other|1|||
124758968|NCT01359904|448741210|FG000|Overall Study|Withdrawal by Subject|1|||
124758969|NCT01359904|448741211|FG001|Overall Study|Withdrawal by Subject|0|||
124758970|NCT02525588|448741213|FG000|Overall Study|Death|3|||
124758971|NCT02525588|448741214|FG001|Overall Study|Death|1|||
124758972|NCT02525588|448741213|FG000|Overall Study|Lost to Follow-up|2|||
124758973|NCT02525588|448741214|FG001|Overall Study|Lost to Follow-up|0|||
124758974|NCT02525588|448741213|FG000|Overall Study|Withdrawal by Subject|1|||
124758975|NCT02525588|448741214|FG001|Overall Study|Withdrawal by Subject|1|||
124758976|NCT02525588|448741213|FG000|Overall Study|Adverse Event|0|||
124758977|NCT02525588|448741214|FG001|Overall Study|Adverse Event|1|||
124758978|NCT03018691|448741217|FG000|Overall Study|Adverse Event|1|||
124758979|NCT03018691|448741218|FG001|Overall Study|Adverse Event|1|||
124758980|NCT03018691|448741219|FG002|Overall Study|Adverse Event|4|||
124758981|NCT03018691|448741217|FG000|Overall Study|Lack of Efficacy|0|||
124758982|NCT03018691|448741218|FG001|Overall Study|Lack of Efficacy|0|||
124758983|NCT03018691|448741219|FG002|Overall Study|Lack of Efficacy|1|||
124758984|NCT03018691|448741217|FG000|Overall Study|Withdrawal by Subject|0|||
124758985|NCT03018691|448741218|FG001|Overall Study|Withdrawal by Subject|0|||
124758986|NCT03018691|448741219|FG002|Overall Study|Withdrawal by Subject|1|||
124758987|NCT03018691|448741217|FG000|Overall Study|Withdrawal by parent/guardian|1|||
124758988|NCT03018691|448741218|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124758989|NCT03018691|448741219|FG002|Overall Study|Withdrawal by parent/guardian|1|||
124758990|NCT03369418|448741221|FG000|Overall Study|Withdrawal by Subject|3|||
124887499|NCT02061761|449211834|FG005|Overall Study|Participant request to discontinue study treatment|1|||
124887500|NCT02061761|449211835|FG006|Overall Study|Participant request to discontinue study treatment|0|||
124887501|NCT02061761|449211836|FG007|Overall Study|Participant request to discontinue study treatment|0|||
124758991|NCT03369418|448741222|FG001|Overall Study|Withdrawal by Subject|3|||
124758992|NCT00796666|448741224|FG000|Overall Study|Death|2|||
124758993|NCT00796666|448741225|FG001|Overall Study|Death|4|||
124758994|NCT00796666|448741224|FG000|Overall Study|Withdrawal by Subject|2|||
124758995|NCT00796666|448741225|FG001|Overall Study|Withdrawal by Subject|0|||
124758996|NCT00796666|448741224|FG000|Overall Study|Adverse Event|7|||
124758997|NCT00796666|448741225|FG001|Overall Study|Adverse Event|5|||
124758998|NCT00796666|448741224|FG000|Overall Study|Protocol Violation|1|||
124758999|NCT00796666|448741225|FG001|Overall Study|Protocol Violation|0|||
124759000|NCT00796666|448741224|FG000|Overall Study|Other|1|||
124759001|NCT00796666|448741225|FG001|Overall Study|Other|0|||
124759002|NCT00796666|448741224|FG000|Overall Study|Terminated by sponsor|53|||
124685510|NCT02864992|448469822|FG001|Overall Study|still on treatment|1|||
124685511|NCT02864992|448469823|FG002|Overall Study|still on treatment|33|||
124685512|NCT01295944|448469824|FG000|Overall Study|Switched to alternative treatment|1|||
124685513|NCT01295944|448469824|FG000|Overall Study|Ineligible|9|||
124685514|NCT01295944|448469824|FG000|Overall Study|Withdrawal by Subject|1|||
124685515|NCT01295944|448469824|FG000|Overall Study|Participant chose to be treated in Peru|1|||
124685516|NCT01295944|448469824|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
124685517|NCT01295944|448469824|FG000|Overall Study|Physician Decision|1|||
124685518|NCT01295944|448469824|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
124685519|NCT01295944|448469824|FG000|Overall Study|Disease progression|4|||
124685520|NCT01295944|448469824|FG000|Overall Study|Transferred care before starting new treatment|1|||
124685521|NCT05168800|448469825|FG000|Time 1 Survey|Did not start T1 survey|182|||
124685522|NCT05168800|448469826|FG001|Time 1 Survey|Did not start T1 survey|150|||
124685523|NCT05168800|448469827|FG002|Time 1 Survey|Did not start T1 survey|140|||
124685524|NCT05168800|448469825|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
124685525|NCT05168800|448469826|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
124685526|NCT05168800|448469827|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
124685527|NCT05168800|448469825|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
124685528|NCT05168800|448469826|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
124685529|NCT05168800|448469827|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
124685530|NCT05168800|448469825|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
124685531|NCT05168800|448469826|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
124685532|NCT05168800|448469827|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
124685533|NCT05168800|448469825|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
124685534|NCT05168800|448469826|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
124685535|NCT05168800|448469827|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
124685536|NCT05168800|448469825|FG000|Time 1 Survey|Withdrawal by Subject|6|||
124685537|NCT05168800|448469826|FG001|Time 1 Survey|Withdrawal by Subject|3|||
124685538|NCT05168800|448469827|FG002|Time 1 Survey|Withdrawal by Subject|2|||
124685539|NCT05168800|448469825|FG000|Time 2 Survey|Already excluded at Time 1|228|||
124685540|NCT05168800|448469826|FG001|Time 2 Survey|Already excluded at Time 1|202|||
124685541|NCT05168800|448469827|FG002|Time 2 Survey|Already excluded at Time 1|173|||
124685542|NCT05168800|448469825|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
124685543|NCT05168800|448469826|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
124685544|NCT05168800|448469827|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
124685545|NCT05168800|448469825|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
124685546|NCT05168800|448469826|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
124685547|NCT05168800|448469827|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
124685548|NCT05168800|448469825|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
124685549|NCT05168800|448469826|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
124685550|NCT05168800|448469827|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
124685551|NCT05168800|448469825|FG000|Time 2 Survey|Withdrawal by Subject|1|||
124685552|NCT05168800|448469826|FG001|Time 2 Survey|Withdrawal by Subject|0|||
124685553|NCT05168800|448469827|FG002|Time 2 Survey|Withdrawal by Subject|1|||
124685554|NCT05168800|448469825|FG000|Time 3 Survey|Already excluded at Time 1|228|||
124685555|NCT05168800|448469826|FG001|Time 3 Survey|Already excluded at Time 1|200|||
124685556|NCT05168800|448469827|FG002|Time 3 Survey|Already excluded at Time 1|173|||
124685557|NCT05168800|448469825|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
124685558|NCT05168800|448469826|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
124685559|NCT05168800|448469827|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
124685560|NCT05168800|448469825|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
124685561|NCT05168800|448469826|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
124685562|NCT05168800|448469827|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
124685563|NCT05168800|448469825|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
124685564|NCT05168800|448469826|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
124685565|NCT05168800|448469827|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
124685566|NCT03240874|448469828|FG000|Overall Study|Lost to Follow-up|0|||
124685567|NCT03240874|448469829|FG001|Overall Study|Lost to Follow-up|2|||
124685568|NCT03240874|448469830|FG002|Overall Study|Lost to Follow-up|4|||
124685569|NCT03240874|448469831|FG003|Overall Study|Lost to Follow-up|1|||
124685570|NCT05252702|448469832|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
124685571|NCT05252702|448469832|FG000|Overall Study|Death|16|||
124685572|NCT05252702|448469832|FG000|Overall Study|System explant|5|||
124685573|NCT05252702|448469832|FG000|Overall Study|Lost to Follow-up|1|||
124685574|NCT05252702|448469832|FG000|Overall Study|Withdrawn by investigator|1|||
124685575|NCT05252702|448469832|FG000|Overall Study|Visit not due|306|||
124685576|NCT05252702|448469832|FG000|Overall Study|Visit within window but not completed|92|||
124685577|NCT05252702|448469832|FG000|Overall Study|Unsuccessful implant|1|||
124685578|NCT04958707|448469833|FG000|Post Intervention|Withdrawal by Subject|1|||
124685579|NCT04958707|448469834|FG001|Post Intervention|Withdrawal by Subject|0|||
124685580|NCT04958707|448469835|FG002|Post Intervention|Withdrawal by Subject|0|||
124887502|NCT02061761|449211837|FG008|Overall Study|Participant request to discontinue study treatment|2|||
124887503|NCT02061761|449211829|FG000|Overall Study|Withdrawal by Subject|0|||
124887504|NCT02061761|449211830|FG001|Overall Study|Withdrawal by Subject|0|||
124887505|NCT02061761|449211831|FG002|Overall Study|Withdrawal by Subject|0|||
124887506|NCT02061761|449211832|FG003|Overall Study|Withdrawal by Subject|0|||
124887507|NCT02061761|449211833|FG004|Overall Study|Withdrawal by Subject|0|||
124887508|NCT02061761|449211834|FG005|Overall Study|Withdrawal by Subject|0|||
124887509|NCT02061761|449211835|FG006|Overall Study|Withdrawal by Subject|0|||
124887510|NCT02061761|449211836|FG007|Overall Study|Withdrawal by Subject|0|||
124887511|NCT02061761|449211837|FG008|Overall Study|Withdrawal by Subject|2|||
124887512|NCT02061761|449211829|FG000|Overall Study|Maximum clinical benefit|0|||
124887513|NCT02061761|449211830|FG001|Overall Study|Maximum clinical benefit|0|||
124887514|NCT02061761|449211831|FG002|Overall Study|Maximum clinical benefit|0|||
124887515|NCT02061761|449211832|FG003|Overall Study|Maximum clinical benefit|1|||
124887516|NCT02061761|449211833|FG004|Overall Study|Maximum clinical benefit|0|||
124887517|NCT02061761|449211834|FG005|Overall Study|Maximum clinical benefit|0|||
124887518|NCT02061761|449211835|FG006|Overall Study|Maximum clinical benefit|0|||
124887519|NCT02061761|449211836|FG007|Overall Study|Maximum clinical benefit|0|||
124887520|NCT02061761|449211837|FG008|Overall Study|Maximum clinical benefit|6|||
124887521|NCT02061761|449211829|FG000|Overall Study|Participant no longer meets study criteria|0|||
124887522|NCT02061761|449211830|FG001|Overall Study|Participant no longer meets study criteria|0|||
124887523|NCT02061761|449211831|FG002|Overall Study|Participant no longer meets study criteria|0|||
124887524|NCT02061761|449211832|FG003|Overall Study|Participant no longer meets study criteria|0|||
124887525|NCT02061761|449211833|FG004|Overall Study|Participant no longer meets study criteria|0|||
124887526|NCT02061761|449211834|FG005|Overall Study|Participant no longer meets study criteria|0|||
124887527|NCT02061761|449211835|FG006|Overall Study|Participant no longer meets study criteria|0|||
124887528|NCT02061761|449211836|FG007|Overall Study|Participant no longer meets study criteria|0|||
124887529|NCT02061761|449211837|FG008|Overall Study|Participant no longer meets study criteria|1|||
124887530|NCT02061761|449211829|FG000|Overall Study|Other reasons|0|||
124887531|NCT02061761|449211830|FG001|Overall Study|Other reasons|0|||
124887532|NCT02061761|449211831|FG002|Overall Study|Other reasons|0|||
124887533|NCT02061761|449211832|FG003|Overall Study|Other reasons|0|||
124887534|NCT02061761|449211833|FG004|Overall Study|Other reasons|2|||
124887535|NCT02061761|449211834|FG005|Overall Study|Other reasons|0|||
124887536|NCT02061761|449211835|FG006|Overall Study|Other reasons|0|||
124887537|NCT02061761|449211836|FG007|Overall Study|Other reasons|0|||
124887538|NCT02061761|449211837|FG008|Overall Study|Other reasons|6|||
124887539|NCT02337478|449211838|FG000|Overall Study|Lack of Efficacy|5|||
124887540|NCT02258464|449211839|FG000|Overall Study|Progressive disease (PD)|9|||
124887541|NCT02258464|449211840|FG001|Overall Study|Progressive disease (PD)|17|||
124887542|NCT02258464|449211839|FG000|Overall Study|Study drug never administered|1|||
124887543|NCT02258464|449211840|FG001|Overall Study|Study drug never administered|1|||
124887544|NCT02258464|449211839|FG000|Overall Study|AE not related to clinical PD|1|||
124887545|NCT02258464|449211840|FG001|Overall Study|AE not related to clinical PD|3|||
124887546|NCT02258464|449211839|FG000|Overall Study|Withdrawal by Subject|5|||
124887547|NCT02258464|449211840|FG001|Overall Study|Withdrawal by Subject|4|||
124887548|NCT02258464|449211839|FG000|Overall Study|AE related to clinical PD|1|||
124887549|NCT02258464|449211840|FG001|Overall Study|AE related to clinical PD|0|||
124887550|NCT04714216|449213609|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
124887551|NCT04714216|449213609|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
124887552|NCT01755689|449213614|FG000|Overall Study|Withdrawal by Subject|1|||
124887553|NCT01755689|449213615|FG001|Overall Study|Withdrawal by Subject|3|||
124887554|NCT01755689|449213616|FG002|Overall Study|Withdrawal by Subject|2|||
124887555|NCT01755689|449213617|FG003|Overall Study|Withdrawal by Subject|1|||
124887556|NCT01755689|449213618|FG004|Overall Study|Withdrawal by Subject|1|||
124685581|NCT04958707|448469833|FG000|3 Months Follow- up|Lost to Follow-up|0|||
124685582|NCT04958707|448469834|FG001|3 Months Follow- up|Lost to Follow-up|3|||
124887557|NCT01755689|449213614|FG000|Overall Study|Migrated/moved from study area|0|||
124887558|NCT01755689|449213615|FG001|Overall Study|Migrated/moved from study area|1|||
124887559|NCT01755689|449213616|FG002|Overall Study|Migrated/moved from study area|1|||
124887560|NCT01755689|449213617|FG003|Overall Study|Migrated/moved from study area|1|||
124887561|NCT01755689|449213618|FG004|Overall Study|Migrated/moved from study area|1|||
124887562|NCT01755689|449213614|FG000|Overall Study|Lost to Follow-up|1|||
124887563|NCT01755689|449213615|FG001|Overall Study|Lost to Follow-up|0|||
124887564|NCT01755689|449213616|FG002|Overall Study|Lost to Follow-up|1|||
124887565|NCT01755689|449213617|FG003|Overall Study|Lost to Follow-up|0|||
124887566|NCT01755689|449213618|FG004|Overall Study|Lost to Follow-up|2|||
124887567|NCT01755689|449213614|FG000|Overall Study|Pregnancy|1|||
124887568|NCT01755689|449213615|FG001|Overall Study|Pregnancy|1|||
124887569|NCT01755689|449213616|FG002|Overall Study|Pregnancy|2|||
124887570|NCT01755689|449213617|FG003|Overall Study|Pregnancy|4|||
124887571|NCT01755689|449213618|FG004|Overall Study|Pregnancy|2|||
124887572|NCT01327547|449213619|FG000|Overall Study|Adverse Event|4|||
124887573|NCT01327547|449213620|FG001|Overall Study|Adverse Event|1|||
124887574|NCT01327547|449213619|FG000|Overall Study|Death|1|||
124887575|NCT01327547|449213620|FG001|Overall Study|Death|2|||
124887576|NCT01327547|449213619|FG000|Overall Study|Lost to Follow-up|6|||
124887577|NCT01327547|449213620|FG001|Overall Study|Lost to Follow-up|6|||
124887578|NCT01327547|449213619|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
124887579|NCT01327547|449213620|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
124887580|NCT01327547|449213619|FG000|Overall Study|Withdrawal by Subject|3|||
124887581|NCT01327547|449213620|FG001|Overall Study|Withdrawal by Subject|7|||
124887582|NCT01327547|449213619|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
124887583|NCT01327547|449213620|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
124887584|NCT01327547|449213619|FG000|Overall Study|Protocol Violation|1|||
124887585|NCT01327547|449213620|FG001|Overall Study|Protocol Violation|0|||
124887586|NCT01327547|449213619|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
124887587|NCT01327547|449213620|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
124887588|NCT01327547|449213619|FG000|Overall Study|Required prohibited medication|2|||
124887589|NCT01327547|449213620|FG001|Overall Study|Required prohibited medication|0|||
124887590|NCT01327547|449213619|FG000|Overall Study|Non-compliance with study procedures|1|||
124887591|NCT01327547|449213620|FG001|Overall Study|Non-compliance with study procedures|0|||
124887592|NCT01327547|449213619|FG000|Overall Study|By investigator in subject's interest|0|||
124887593|NCT01327547|449213620|FG001|Overall Study|By investigator in subject's interest|1|||
124887594|NCT02462083|449213621|FG000|Overall Study|Sponsor request|39|||
124887595|NCT02462083|449213621|FG000|Overall Study|Withdrawal by Subject|87|||
124887596|NCT02462083|449213621|FG000|Overall Study|Lost to Follow-up|41|||
124887597|NCT02462083|449213621|FG000|Overall Study|Lack of Efficacy|151|||
124887598|NCT02462083|449213621|FG000|Overall Study|Pregnancy|1|||
124887599|NCT02462083|449213621|FG000|Overall Study|Protocol Violation|6|||
124887600|NCT02462083|449213621|FG000|Overall Study|Adverse Event|33|||
124887601|NCT02462083|449213621|FG000|Overall Study|Worsening condition|16|||
124887602|NCT02462083|449213621|FG000|Overall Study|Other than specified|45|||
124887603|NCT01642186|449213624|FG000|Overall Study|Death|0|||
124887604|NCT01642186|449213625|FG001|Overall Study|Death|2|||
124887605|NCT01642186|449213626|FG002|Overall Study|Death|2|||
124887606|NCT01642186|449213624|FG000|Overall Study|Lost to Follow-up|0|||
124887607|NCT01642186|449213625|FG001|Overall Study|Lost to Follow-up|0|||
124887608|NCT01642186|449213626|FG002|Overall Study|Lost to Follow-up|1|||
124887609|NCT01668147|449213627|FG000|Overall Study|Withdrawal by Subject|6|||
124887610|NCT00590980|449213633|FG000|Overall Study|Did not meet all inclusion criteria|10|||
124887611|NCT03699124|449213634|FG000|Overall Study|Adverse Event|6|||
124887612|NCT03699124|449213635|FG001|Overall Study|Adverse Event|5|||
124887613|NCT03699124|449213636|FG002|Overall Study|Adverse Event|2|||
124887614|NCT03699124|449213634|FG000|Overall Study|Death|0|||
124887615|NCT03699124|449213635|FG001|Overall Study|Death|2|||
124887616|NCT03699124|449213636|FG002|Overall Study|Death|0|||
124887617|NCT03699124|449213634|FG000|Overall Study|Lost to Follow-up|20|||
124887618|NCT03699124|449213635|FG001|Overall Study|Lost to Follow-up|16|||
124887619|NCT03699124|449213636|FG002|Overall Study|Lost to Follow-up|15|||
124887620|NCT03699124|449213634|FG000|Overall Study|Protocol Violation|1|||
124887621|NCT03699124|449213635|FG001|Overall Study|Protocol Violation|0|||
124887622|NCT03699124|449213636|FG002|Overall Study|Protocol Violation|0|||
124887623|NCT03699124|449213634|FG000|Overall Study|Withdrawal by Subject|13|||
124887624|NCT03699124|449213635|FG001|Overall Study|Withdrawal by Subject|14|||
124887625|NCT03699124|449213636|FG002|Overall Study|Withdrawal by Subject|13|||
124887626|NCT03699124|449213634|FG000|Overall Study|Other reasons|5|||
124887627|NCT03699124|449213635|FG001|Overall Study|Other reasons|3|||
124887628|NCT03699124|449213636|FG002|Overall Study|Other reasons|10|||
124887629|NCT00506285|449213637|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
124887630|NCT00506285|449213638|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
124887631|NCT00506285|449213637|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
124887632|NCT00506285|449213638|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
124887633|NCT00506285|449213637|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
124887634|NCT00506285|449213638|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
124887635|NCT00506285|449213637|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
124887636|NCT00506285|449213638|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
124887637|NCT00506285|449213637|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
124887638|NCT00506285|449213638|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
124887639|NCT01089556|449213639|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
124887640|NCT01089556|449213640|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
124887641|NCT01089556|449213641|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
124887642|NCT01089556|449213642|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
124887643|NCT01089556|449213643|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
124887644|NCT01089556|449213644|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
124887645|NCT01089556|449213639|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
124887646|NCT01089556|449213640|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
124887647|NCT01089556|449213641|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
124887648|NCT01089556|449213642|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
124887649|NCT01089556|449213643|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
124887650|NCT01089556|449213644|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
124887651|NCT01089556|449213639|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
124887652|NCT01089556|449213640|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
124887653|NCT01089556|449213641|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
124887654|NCT01089556|449213642|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
124887655|NCT01089556|449213643|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
124887656|NCT01089556|449213644|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
124887657|NCT01089556|449213639|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
124887658|NCT01089556|449213640|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
124887659|NCT01089556|449213641|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
124887660|NCT01089556|449213642|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
124887661|NCT01089556|449213643|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
124887662|NCT01089556|449213644|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
124887663|NCT01089556|449213639|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
124887664|NCT01089556|449213640|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
124887665|NCT01089556|449213641|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
124887666|NCT01089556|449213642|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
124887667|NCT01089556|449213643|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
124887668|NCT01089556|449213644|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
124887669|NCT01089556|449213639|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
124887670|NCT01089556|449213640|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
124887671|NCT01089556|449213641|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
124887672|NCT01089556|449213642|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
124887673|NCT01089556|449213643|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
124887674|NCT01089556|449213644|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
124887675|NCT01089556|449213639|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
124887676|NCT01089556|449213640|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
124887677|NCT01089556|449213641|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
124887678|NCT01089556|449213642|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
124887679|NCT01089556|449213643|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
124887680|NCT01089556|449213644|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
124887681|NCT01089556|449213639|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
124887682|NCT01089556|449213640|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
124887683|NCT01089556|449213641|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
124887684|NCT01089556|449213642|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
124887685|NCT01089556|449213643|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
124887686|NCT01089556|449213644|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
124887687|NCT01089556|449213639|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
124887688|NCT01089556|449213640|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
124887689|NCT01089556|449213641|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
124887690|NCT01089556|449213642|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
124887691|NCT01089556|449213643|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
124887692|NCT01089556|449213644|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
124887693|NCT01089556|449213639|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
124887694|NCT01089556|449213640|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
124887695|NCT01089556|449213641|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
124887696|NCT01089556|449213642|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
124887697|NCT01089556|449213643|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
124887698|NCT01089556|449213644|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
124887699|NCT01089556|449213639|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
124887700|NCT01089556|449213640|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
124887701|NCT01089556|449213641|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
124887702|NCT01089556|449213642|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
124887703|NCT01089556|449213643|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
124887704|NCT01089556|449213644|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
124887705|NCT01089556|449213639|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
124440171|NCT04640077|447570937|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
124685583|NCT04958707|448469835|FG002|3 Months Follow- up|Lost to Follow-up|0|||
124685584|NCT04958707|448469833|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
124685585|NCT04958707|448469834|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
124887706|NCT01089556|449213640|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
124887707|NCT01089556|449213641|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
124440172|NCT01257425|447570938|FG000|Overall Study|Lack of Efficacy|3|||
124685586|NCT04958707|448469835|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
124887708|NCT01089556|449213642|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
124887709|NCT01089556|449213643|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
124887710|NCT01089556|449213644|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
124887711|NCT01089556|449213639|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
124887712|NCT01089556|449213640|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
124887713|NCT01089556|449213641|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
124887714|NCT01089556|449213642|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
124887715|NCT01089556|449213643|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
124887716|NCT01089556|449213644|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
124887717|NCT01089556|449213639|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
124887718|NCT01089556|449213640|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
124887719|NCT01089556|449213641|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
124887720|NCT01089556|449213642|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
124887721|NCT01089556|449213643|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
124887722|NCT01089556|449213644|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
124887723|NCT01089556|449213639|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
124887724|NCT01089556|449213640|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
124887725|NCT01089556|449213641|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
124887726|NCT01089556|449213642|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
124887727|NCT01089556|449213643|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
124887728|NCT01089556|449213644|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
124887729|NCT01238575|449213645|FG000|Overall Study|Lack of Efficacy|2|||
124887730|NCT01238575|449213646|FG001|Overall Study|Lack of Efficacy|4|||
124887731|NCT01238575|449213645|FG000|Overall Study|Adverse Event|2|||
124887732|NCT01238575|449213646|FG001|Overall Study|Adverse Event|0|||
124887733|NCT03405662|449213647|FG000|Overall Study|COVID-19 restriction|1|||
124887734|NCT03405662|449213648|FG001|Overall Study|COVID-19 restriction|0|||
124887735|NCT03405662|449213647|FG000|Overall Study|unblinding|0|||
124887736|NCT03405662|449213648|FG001|Overall Study|unblinding|1|||
124887737|NCT03405662|449213647|FG000|Overall Study|placement in memory care facility|0|||
124887738|NCT03405662|449213648|FG001|Overall Study|placement in memory care facility|2|||
124887739|NCT01555021|449213651|FG000|Overall Study|Lost to Follow-up|1|||
124887740|NCT01555021|449213652|FG001|Overall Study|Lost to Follow-up|2|||
124887741|NCT03875911|449213655|FG000|Overall Study|Lost to Follow-up|3|||
124887742|NCT03875911|449213656|FG001|Overall Study|Lost to Follow-up|6|||
124887743|NCT03875911|449213657|FG002|Overall Study|Lost to Follow-up|2|||
124887744|NCT03875911|449213655|FG000|Overall Study|Surgery cancelled|1|||
124887745|NCT03875911|449213656|FG001|Overall Study|Surgery cancelled|0|||
124887746|NCT03875911|449213657|FG002|Overall Study|Surgery cancelled|1|||
124887747|NCT03875911|449213655|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
124887748|NCT03875911|449213656|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
124887749|NCT03875911|449213657|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
124887750|NCT00750893|449213660|FG000|Overall Study|Adverse Event|5|||
124887751|NCT00750893|449213660|FG000|Overall Study|Withdrawal by Subject|10|||
124887752|NCT00750893|449213660|FG000|Overall Study|Lost to Follow-up|510|||
124887753|NCT00750893|449213660|FG000|Overall Study|Other|17|||
124887754|NCT03824938|449213661|FG000|Overall Study|Withdrawal by Subject|2|||
124887755|NCT03824938|449213662|FG001|Overall Study|Withdrawal by Subject|1|||
124887756|NCT03824938|449213663|FG002|Overall Study|Withdrawal by Subject|0|||
124887757|NCT03824938|449213664|FG003|Overall Study|Withdrawal by Subject|2|||
124887758|NCT03824938|449213665|FG004|Overall Study|Withdrawal by Subject|0|||
124887759|NCT03824938|449213666|FG005|Overall Study|Withdrawal by Subject|1|||
124887760|NCT03824938|449213661|FG000|Overall Study|Lost to Follow-up|0|||
124887761|NCT03824938|449213662|FG001|Overall Study|Lost to Follow-up|1|||
124887762|NCT03824938|449213663|FG002|Overall Study|Lost to Follow-up|0|||
124887763|NCT03824938|449213664|FG003|Overall Study|Lost to Follow-up|0|||
124887764|NCT03824938|449213665|FG004|Overall Study|Lost to Follow-up|1|||
124887765|NCT03824938|449213666|FG005|Overall Study|Lost to Follow-up|0|||
124887766|NCT02420327|449213670|FG000|Overall Study|Adverse Event|7|||
124887767|NCT02420327|449213670|FG000|Overall Study|Pregnancy|1|||
124887768|NCT02420327|449213670|FG000|Overall Study|Withdrawal by Subject|6|||
124887769|NCT02420327|449213670|FG000|Overall Study|Lost to Follow-up|1|||
124887770|NCT02420327|449213670|FG000|Overall Study|Protocol Violation|1|||
124887771|NCT00065468|449213673|FG000|Overall Study|Death|172|||
124887772|NCT00065468|449213674|FG001|Overall Study|Death|169|||
124887773|NCT00065468|449213675|FG002|Overall Study|Death|171|||
124887774|NCT00065468|449213673|FG000|Overall Study|Withdrawal by Subject|3|||
124887775|NCT00065468|449213674|FG001|Overall Study|Withdrawal by Subject|4|||
124887776|NCT00065468|449213675|FG002|Overall Study|Withdrawal by Subject|5|||
124887777|NCT00065468|449213673|FG000|Overall Study|Lost to Follow-up|5|||
124887778|NCT00065468|449213674|FG001|Overall Study|Lost to Follow-up|3|||
124440173|NCT01257425|447570939|FG001|Overall Study|Lack of Efficacy|3|||
124685587|NCT02629159|448469839|FG000|Overall Study|Adverse Event|17|||
124685588|NCT02629159|448469840|FG001|Overall Study|Adverse Event|20|||
124887779|NCT00065468|449213675|FG002|Overall Study|Lost to Follow-up|2|||
124887780|NCT00065468|449213673|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
124887781|NCT00065468|449213674|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
124887782|NCT00065468|449213675|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
124685589|NCT02629159|448469841|FG002|Overall Study|Adverse Event|22|||
124685590|NCT02629159|448469839|FG000|Overall Study|Withdrawal by Subject|22|||
124887783|NCT00065468|449213673|FG000|Overall Study|Disease progression|0|||
124887784|NCT00065468|449213674|FG001|Overall Study|Disease progression|0|||
124685591|NCT02629159|448469840|FG001|Overall Study|Withdrawal by Subject|11|||
124685592|NCT02629159|448469841|FG002|Overall Study|Withdrawal by Subject|15|||
124685593|NCT02629159|448469839|FG000|Overall Study|Lost to Follow-up|7|||
124685594|NCT02629159|448469840|FG001|Overall Study|Lost to Follow-up|4|||
124685595|NCT02629159|448469841|FG002|Overall Study|Lost to Follow-up|5|||
124685596|NCT02629159|448469839|FG000|Overall Study|Lack of Efficacy|4|||
124685597|NCT02629159|448469840|FG001|Overall Study|Lack of Efficacy|0|||
124685598|NCT02629159|448469841|FG002|Overall Study|Lack of Efficacy|1|||
124685599|NCT02629159|448469839|FG000|Overall Study|Other|6|||
124685600|NCT02629159|448469840|FG001|Overall Study|Other|4|||
124685601|NCT02629159|448469841|FG002|Overall Study|Other|8|||
124685602|NCT03036254|448469846|FG000|Overall Study|Adverse Event|6|||
124685603|NCT03036254|448469847|FG001|Overall Study|Adverse Event|4|||
124685604|NCT03036254|448469846|FG000|Overall Study|Death|3|||
124685605|NCT03036254|448469847|FG001|Overall Study|Death|1|||
124685606|NCT03036254|448469846|FG000|Overall Study|Lack of Efficacy|5|||
124685607|NCT03036254|448469847|FG001|Overall Study|Lack of Efficacy|1|||
124685608|NCT03036254|448469846|FG000|Overall Study|Withdrawal by Subject|3|||
124685609|NCT03036254|448469847|FG001|Overall Study|Withdrawal by Subject|5|||
124685610|NCT02783274|448469856|FG000|Overall Study|Withdrawal by Subject|16|||
124685611|NCT02783274|448469856|FG000|Overall Study|Physician Decision|6|||
124685612|NCT02783274|448469856|FG000|Overall Study|Death|9|||
124887785|NCT00065468|449213675|FG002|Overall Study|Disease progression|1|||
124887786|NCT00065468|449213673|FG000|Overall Study|Other|14|||
124887787|NCT00065468|449213674|FG001|Overall Study|Other|24|||
124887788|NCT00065468|449213675|FG002|Overall Study|Other|18|||
124887789|NCT01225835|449213676|FG000|Overall Study|Completed protocol|2|||
124685613|NCT02783274|448469856|FG000|Overall Study|Lost to Follow-up|22|||
124685614|NCT02783274|448469856|FG000|Overall Study|Other|22|||
124887790|NCT01225835|449213677|FG001|Overall Study|Completed protocol|1|||
124887791|NCT01225835|449213676|FG000|Overall Study|Did not meet hCG criterion|2|||
124685615|NCT04717557|448469861|FG000|Overall Study|Withdrawal by Subject|2|||
124685616|NCT04717557|448469862|FG001|Overall Study|Withdrawal by Subject|0|||
124685617|NCT04717557|448469861|FG000|Overall Study|Death|1|||
124685618|NCT04717557|448469862|FG001|Overall Study|Death|0|||
124685619|NCT00098475|448469866|FG000|Step 1|Progressive disease|33|||
124685620|NCT00098475|448469867|FG001|Step 1|Progressive disease|35|||
124759003|NCT00796666|448741225|FG001|Overall Study|Terminated by sponsor|55|||
124887792|NCT01225835|449213677|FG001|Overall Study|Did not meet hCG criterion|0|||
124887793|NCT01225835|449213676|FG000|Overall Study|Adverse Event|2|||
124887794|NCT01225835|449213677|FG001|Overall Study|Adverse Event|1|||
124887795|NCT01225835|449213676|FG000|Overall Study|Other|1|||
124887796|NCT01225835|449213677|FG001|Overall Study|Other|1|||
124887797|NCT02589392|449213678|FG000|Overall Study|Adverse Event|1|||
124887798|NCT02589392|449213679|FG001|Overall Study|Adverse Event|1|||
124887799|NCT02589392|449213678|FG000|Overall Study|Withdrawal by Subject|1|||
124887800|NCT02589392|449213679|FG001|Overall Study|Withdrawal by Subject|2|||
124887801|NCT02589392|449213678|FG000|Overall Study|Protocol Violation|1|||
124887802|NCT02589392|449213679|FG001|Overall Study|Protocol Violation|1|||
124887803|NCT02589392|449213678|FG000|Overall Study|Lost to Follow-up|2|||
124887804|NCT02589392|449213679|FG001|Overall Study|Lost to Follow-up|2|||
124887805|NCT02589392|449213678|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
124887806|NCT02589392|449213679|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
124887807|NCT02207374|449213686|FG000|Overall Study|Withdrawal by Subject|5|||
124887808|NCT02207374|449213687|FG001|Overall Study|Withdrawal by Subject|9|||
124685621|NCT00098475|448469868|FG002|Step 1|Progressive disease|2|||
124759004|NCT00796666|448741224|FG000|Overall Study|Randomized and not treated|1|||
124759005|NCT00796666|448741225|FG001|Overall Study|Randomized and not treated|0|||
124887809|NCT02207374|449213688|FG002|Overall Study|Withdrawal by Subject|4|||
124887810|NCT02207374|449213686|FG000|Overall Study|Death|1|||
124685622|NCT00098475|448469869|FG003|Step 1|Progressive disease|1|||
124685623|NCT00098475|448469866|FG000|Step 1|Adverse Event|56|||
124685624|NCT00098475|448469867|FG001|Step 1|Adverse Event|37|||
124685625|NCT00098475|448469868|FG002|Step 1|Adverse Event|0|||
124685626|NCT00098475|448469869|FG003|Step 1|Adverse Event|1|||
124685627|NCT00098475|448469866|FG000|Step 1|Death|8|||
124685628|NCT00098475|448469867|FG001|Step 1|Death|5|||
124685629|NCT00098475|448469868|FG002|Step 1|Death|0|||
124685630|NCT00098475|448469869|FG003|Step 1|Death|1|||
124685631|NCT00098475|448469866|FG000|Step 1|Withdrawal by Subject|14|||
124685632|NCT00098475|448469867|FG001|Step 1|Withdrawal by Subject|11|||
124887811|NCT02207374|449213687|FG001|Overall Study|Death|0|||
124887812|NCT02207374|449213688|FG002|Overall Study|Death|1|||
124887813|NCT02207374|449213686|FG000|Overall Study|Missing follow-up information|0|||
124887814|NCT02207374|449213687|FG001|Overall Study|Missing follow-up information|1|||
124887815|NCT02207374|449213688|FG002|Overall Study|Missing follow-up information|1|||
124887816|NCT02087150|449213689|FG000|Overall Study|Death|0|||
124887817|NCT02087150|449213690|FG001|Overall Study|Death|1|||
124887818|NCT02087150|449213691|FG002|Overall Study|Death|0|||
124887819|NCT02087150|449213689|FG000|Overall Study|Lost to Follow-up|6|||
124887820|NCT02087150|449213690|FG001|Overall Study|Lost to Follow-up|13|||
124887821|NCT02087150|449213691|FG002|Overall Study|Lost to Follow-up|7|||
124685633|NCT00098475|448469868|FG002|Step 1|Withdrawal by Subject|0|||
124685634|NCT00098475|448469869|FG003|Step 1|Withdrawal by Subject|0|||
124685635|NCT00098475|448469866|FG000|Step 1|Physician Decision|5|||
124685636|NCT00098475|448469867|FG001|Step 1|Physician Decision|2|||
124685637|NCT00098475|448469868|FG002|Step 1|Physician Decision|0|||
124685638|NCT00098475|448469869|FG003|Step 1|Physician Decision|0|||
124685639|NCT00098475|448469866|FG000|Step 1|Alternative therapy|31|||
124887822|NCT02087150|449213689|FG000|Overall Study|Withdrawal by Subject|2|||
124887823|NCT02087150|449213690|FG001|Overall Study|Withdrawal by Subject|5|||
124887824|NCT02087150|449213691|FG002|Overall Study|Withdrawal by Subject|3|||
124887825|NCT02087150|449213689|FG000|Overall Study|Physician Decision|0|||
124887826|NCT02087150|449213690|FG001|Overall Study|Physician Decision|1|||
124887827|NCT02087150|449213691|FG002|Overall Study|Physician Decision|0|||
124887828|NCT02087150|449213689|FG000|Overall Study|Procedure not done|1|||
124887829|NCT02087150|449213690|FG001|Overall Study|Procedure not done|13|||
124887830|NCT02087150|449213691|FG002|Overall Study|Procedure not done|0|||
124887831|NCT02087150|449213689|FG000|Overall Study|F/U not completed w/in study window|0|||
124887832|NCT02087150|449213690|FG001|Overall Study|F/U not completed w/in study window|0|||
124887833|NCT02087150|449213691|FG002|Overall Study|F/U not completed w/in study window|1|||
124887834|NCT02087150|449213689|FG000|Overall Study|Other|1|||
124887835|NCT02087150|449213690|FG001|Overall Study|Other|0|||
124887836|NCT02087150|449213691|FG002|Overall Study|Other|0|||
124887837|NCT02087150|449213689|FG000|Overall Study|Pt moved out of town|0|||
124887838|NCT02087150|449213690|FG001|Overall Study|Pt moved out of town|1|||
124685640|NCT00098475|448469867|FG001|Step 1|Alternative therapy|43|||
124685641|NCT00098475|448469868|FG002|Step 1|Alternative therapy|1|||
124685642|NCT00098475|448469869|FG003|Step 1|Alternative therapy|0|||
124685643|NCT00098475|448469866|FG000|Step 1|Other disease|2|||
124685644|NCT00098475|448469867|FG001|Step 1|Other disease|1|||
124685645|NCT00098475|448469868|FG002|Step 1|Other disease|1|||
124887839|NCT02087150|449213691|FG002|Overall Study|Pt moved out of town|0|||
124887840|NCT02372058|449213693|FG000|Overall Study|Withdrawal by Subject|3|||
124887841|NCT00972179|449213695|FG000|Overall Study|Noncompliance|1|||
124887842|NCT00972179|449213696|FG001|Overall Study|Noncompliance|0|||
124887843|NCT00972179|449213697|FG002|Overall Study|Noncompliance|0|||
124887844|NCT00972179|449213698|FG003|Overall Study|Noncompliance|0|||
124887845|NCT00972179|449213699|FG004|Overall Study|Noncompliance|1|||
124887846|NCT00972179|449213700|FG005|Overall Study|Noncompliance|0|||
124887847|NCT00972179|449213701|FG006|Overall Study|Noncompliance|1|||
124887848|NCT00972179|449213695|FG000|Overall Study|Withdrawal by Subject|0|||
124685646|NCT00098475|448469869|FG003|Step 1|Other disease|0|||
124685647|NCT00098475|448469866|FG000|Step 1|Never started treatment|0|||
124685648|NCT00098475|448469867|FG001|Step 1|Never started treatment|2|||
124685649|NCT00098475|448469868|FG002|Step 1|Never started treatment|0|||
124887849|NCT00972179|449213696|FG001|Overall Study|Withdrawal by Subject|3|||
124685650|NCT00098475|448469869|FG003|Step 1|Never started treatment|0|||
124685651|NCT00098475|448469866|FG000|Step 1|Still on treatment as of this analysis|14|||
124887850|NCT00972179|449213697|FG002|Overall Study|Withdrawal by Subject|0|||
124887851|NCT00972179|449213698|FG003|Overall Study|Withdrawal by Subject|1|||
124685652|NCT00098475|448469867|FG001|Step 1|Still on treatment as of this analysis|27|||
124685653|NCT00098475|448469868|FG002|Step 1|Still on treatment as of this analysis|0|||
124712007|NCT01343888|448570707|FG000|Overall Study|Protocol Violation|0|||
124712008|NCT01343888|448570708|FG001|Overall Study|Protocol Violation|2|||
124712009|NCT01343888|448570709|FG002|Overall Study|Protocol Violation|0|||
124887852|NCT00972179|449213699|FG004|Overall Study|Withdrawal by Subject|0|||
124887853|NCT00972179|449213700|FG005|Overall Study|Withdrawal by Subject|0|||
124887854|NCT00972179|449213701|FG006|Overall Study|Withdrawal by Subject|2|||
124887855|NCT00972179|449213695|FG000|Overall Study|Administrative Decision|0|||
124887856|NCT00972179|449213696|FG001|Overall Study|Administrative Decision|0|||
124887857|NCT00972179|449213697|FG002|Overall Study|Administrative Decision|0|||
124887858|NCT00972179|449213698|FG003|Overall Study|Administrative Decision|0|||
124887859|NCT00972179|449213699|FG004|Overall Study|Administrative Decision|1|||
124887860|NCT00972179|449213700|FG005|Overall Study|Administrative Decision|0|||
124887861|NCT00972179|449213701|FG006|Overall Study|Administrative Decision|0|||
124887862|NCT00972179|449213695|FG000|Overall Study|Lost to Follow-up|0|||
124887863|NCT00972179|449213696|FG001|Overall Study|Lost to Follow-up|0|||
124887864|NCT00972179|449213697|FG002|Overall Study|Lost to Follow-up|1|||
124887865|NCT00972179|449213698|FG003|Overall Study|Lost to Follow-up|0|||
124887866|NCT00972179|449213699|FG004|Overall Study|Lost to Follow-up|0|||
124887867|NCT00972179|449213700|FG005|Overall Study|Lost to Follow-up|3|||
124887868|NCT00972179|449213701|FG006|Overall Study|Lost to Follow-up|1|||
124887869|NCT02584855|449213705|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
124887870|NCT02584855|449213706|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
124887871|NCT02584855|449213707|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
124887872|NCT02584855|449213708|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
124887873|NCT02584855|449213709|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
124887874|NCT02584855|449213710|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
124887875|NCT02584855|449213705|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
124887876|NCT02584855|449213706|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
124887877|NCT02584855|449213707|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
124887878|NCT02584855|449213708|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
124887879|NCT02584855|449213709|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
124887880|NCT02584855|449213710|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
124887881|NCT02584855|449213705|FG000|Open-Label Treatment Period|Adverse Event|14|||
124887882|NCT02584855|449213706|FG001|Open-Label Treatment Period|Adverse Event|0|||
124887883|NCT02584855|449213707|FG002|Open-Label Treatment Period|Adverse Event|0|||
124887884|NCT02584855|449213708|FG003|Open-Label Treatment Period|Adverse Event|0|||
124887885|NCT02584855|449213709|FG004|Open-Label Treatment Period|Adverse Event|0|||
124887886|NCT02584855|449213710|FG005|Open-Label Treatment Period|Adverse Event|0|||
124887887|NCT02584855|449213705|FG000|Open-Label Treatment Period|Death|2|||
124887888|NCT02584855|449213706|FG001|Open-Label Treatment Period|Death|0|||
124887889|NCT02584855|449213707|FG002|Open-Label Treatment Period|Death|0|||
124887890|NCT02584855|449213708|FG003|Open-Label Treatment Period|Death|0|||
124887891|NCT02584855|449213709|FG004|Open-Label Treatment Period|Death|0|||
124887892|NCT02584855|449213710|FG005|Open-Label Treatment Period|Death|0|||
124887893|NCT02584855|449213705|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
124685654|NCT00098475|448469869|FG003|Step 1|Still on treatment as of this analysis|0|||
124685655|NCT00098475|448469866|FG000|Step 1|Knee surgery|1|||
124685656|NCT00098475|448469867|FG001|Step 1|Knee surgery|0|||
124685657|NCT00098475|448469868|FG002|Step 1|Knee surgery|0|||
124685658|NCT00098475|448469869|FG003|Step 1|Knee surgery|0|||
124685659|NCT00098475|448469866|FG000|Step 1|Complications|1|||
124685660|NCT00098475|448469867|FG001|Step 1|Complications|0|||
124887894|NCT02584855|449213706|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
124887895|NCT02584855|449213707|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
124887896|NCT02584855|449213708|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
124887897|NCT02584855|449213709|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
124887898|NCT02584855|449213710|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
124887899|NCT02584855|449213705|FG000|Open-Label Treatment Period|Protocol Violation|1|||
124887900|NCT02584855|449213706|FG001|Open-Label Treatment Period|Protocol Violation|0|||
124887901|NCT02584855|449213707|FG002|Open-Label Treatment Period|Protocol Violation|0|||
124887902|NCT02584855|449213708|FG003|Open-Label Treatment Period|Protocol Violation|0|||
124887903|NCT02584855|449213709|FG004|Open-Label Treatment Period|Protocol Violation|0|||
124685661|NCT00098475|448469868|FG002|Step 1|Complications|0|||
124685662|NCT00098475|448469869|FG003|Step 1|Complications|0|||
124685663|NCT00098475|448469866|FG000|Step 1|Cannot comply due to other tx|0|||
124685664|NCT00098475|448469867|FG001|Step 1|Cannot comply due to other tx|1|||
124685665|NCT00098475|448469868|FG002|Step 1|Cannot comply due to other tx|0|||
124887904|NCT02584855|449213710|FG005|Open-Label Treatment Period|Protocol Violation|0|||
124685666|NCT00098475|448469869|FG003|Step 1|Cannot comply due to other tx|0|||
124887905|NCT02584855|449213705|FG000|Open-Label Treatment Period|No PI Available|2|||
124887906|NCT02584855|449213706|FG001|Open-Label Treatment Period|No PI Available|0|||
124887907|NCT02584855|449213707|FG002|Open-Label Treatment Period|No PI Available|0|||
124887908|NCT02584855|449213708|FG003|Open-Label Treatment Period|No PI Available|0|||
124887909|NCT02584855|449213709|FG004|Open-Label Treatment Period|No PI Available|0|||
124887910|NCT02584855|449213710|FG005|Open-Label Treatment Period|No PI Available|0|||
124887911|NCT02584855|449213705|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
124887912|NCT02584855|449213706|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
124887913|NCT02584855|449213707|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
124887914|NCT02584855|449213708|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
124887915|NCT02584855|449213709|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
124887916|NCT02584855|449213710|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
124887917|NCT02584855|449213705|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
124887918|NCT02584855|449213706|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
124887919|NCT02584855|449213707|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
124887920|NCT02584855|449213708|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
124887921|NCT02584855|449213709|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
124887922|NCT02584855|449213710|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
124887923|NCT02584855|449213705|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
124887924|NCT02584855|449213706|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
124887925|NCT02584855|449213707|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
124887926|NCT02584855|449213708|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
124887927|NCT02584855|449213709|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
124887928|NCT02584855|449213710|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
124887929|NCT02584855|449213705|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
124887930|NCT02584855|449213706|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
124887931|NCT02584855|449213707|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
124887932|NCT02584855|449213708|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
124887933|NCT02584855|449213709|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
124887934|NCT02584855|449213710|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
124887935|NCT02584855|449213705|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
124887936|NCT02584855|449213706|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
124887937|NCT02584855|449213707|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
124887938|NCT02584855|449213708|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
124887939|NCT02584855|449213709|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
124887940|NCT02584855|449213710|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
124887941|NCT02584855|449213705|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
124887942|NCT02584855|449213706|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
124887943|NCT02584855|449213707|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
124887944|NCT02584855|449213708|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
124887945|NCT02584855|449213709|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
124887946|NCT02584855|449213710|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
124887947|NCT02584855|449213705|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
124887948|NCT02584855|449213706|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
124887949|NCT02584855|449213707|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
124887950|NCT02584855|449213708|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
124887951|NCT02584855|449213709|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
124887952|NCT02584855|449213710|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
124887953|NCT02138747|449213711|FG000|Treatment Period 1|Adverse Event|10|||
124887954|NCT02138747|449213712|FG001|Treatment Period 1|Adverse Event|14|||
124759006|NCT00057863|448741227|FG000|Overall Study|Death|1|||
124759007|NCT00057863|448741227|FG000|Overall Study|Withdrawal by Subject|2|||
124759008|NCT01521507|448741228|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
124759009|NCT01521507|448741229|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
124759010|NCT01521507|448741228|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
124759011|NCT01521507|448741229|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
124759012|NCT01521507|448741228|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
124887955|NCT02138747|449213713|FG002|Treatment Period 1|Adverse Event|2|||
124887956|NCT02138747|449213714|FG003|Treatment Period 1|Adverse Event|1|||
124887957|NCT02138747|449213711|FG000|Treatment Period 1|Lost to Follow-up|0|||
124440174|NCT01257425|447570938|FG000|Overall Study|Adverse Event|1|||
124887958|NCT02138747|449213712|FG001|Treatment Period 1|Lost to Follow-up|1|||
124887959|NCT02138747|449213713|FG002|Treatment Period 1|Lost to Follow-up|1|||
124887960|NCT02138747|449213714|FG003|Treatment Period 1|Lost to Follow-up|0|||
124887961|NCT02138747|449213711|FG000|Treatment Period 1|Protocol Violation|0|||
124887962|NCT02138747|449213712|FG001|Treatment Period 1|Protocol Violation|2|||
124887963|NCT02138747|449213713|FG002|Treatment Period 1|Protocol Violation|0|||
124887964|NCT02138747|449213714|FG003|Treatment Period 1|Protocol Violation|0|||
124887965|NCT02138747|449213711|FG000|Treatment Period 1|Withdrawal by Subject|8|||
124887966|NCT02138747|449213712|FG001|Treatment Period 1|Withdrawal by Subject|4|||
124887967|NCT02138747|449213713|FG002|Treatment Period 1|Withdrawal by Subject|1|||
124887968|NCT02138747|449213714|FG003|Treatment Period 1|Withdrawal by Subject|3|||
124887969|NCT02138747|449213711|FG000|Treatment Period 1|Other - Miscellaneous|2|||
124887970|NCT02138747|449213712|FG001|Treatment Period 1|Other - Miscellaneous|4|||
124887971|NCT02138747|449213713|FG002|Treatment Period 1|Other - Miscellaneous|0|||
124887972|NCT02138747|449213714|FG003|Treatment Period 1|Other - Miscellaneous|0|||
124887973|NCT02138747|449213711|FG000|Treatment Period 2|Adverse Event|6|||
124887974|NCT02138747|449213712|FG001|Treatment Period 2|Adverse Event|3|||
124887975|NCT02138747|449213713|FG002|Treatment Period 2|Adverse Event|1|||
124887976|NCT02138747|449213714|FG003|Treatment Period 2|Adverse Event|1|||
124887977|NCT02138747|449213711|FG000|Treatment Period 2|Lost to Follow-up|2|||
124887978|NCT02138747|449213712|FG001|Treatment Period 2|Lost to Follow-up|0|||
124887979|NCT02138747|449213713|FG002|Treatment Period 2|Lost to Follow-up|0|||
124887980|NCT02138747|449213714|FG003|Treatment Period 2|Lost to Follow-up|0|||
124887981|NCT02138747|449213711|FG000|Treatment Period 2|Protocol Violation|1|||
124887982|NCT02138747|449213712|FG001|Treatment Period 2|Protocol Violation|0|||
124887983|NCT02138747|449213713|FG002|Treatment Period 2|Protocol Violation|0|||
124887984|NCT02138747|449213714|FG003|Treatment Period 2|Protocol Violation|0|||
124887985|NCT02138747|449213711|FG000|Treatment Period 2|Withdrawal by Subject|5|||
124887986|NCT02138747|449213712|FG001|Treatment Period 2|Withdrawal by Subject|4|||
124887987|NCT02138747|449213713|FG002|Treatment Period 2|Withdrawal by Subject|1|||
124887988|NCT02138747|449213714|FG003|Treatment Period 2|Withdrawal by Subject|2|||
124887989|NCT02138747|449213711|FG000|Treatment Period 2|Other - Miscellaneous|3|||
124887990|NCT02138747|449213712|FG001|Treatment Period 2|Other - Miscellaneous|0|||
124887991|NCT02138747|449213713|FG002|Treatment Period 2|Other - Miscellaneous|0|||
124887992|NCT02138747|449213714|FG003|Treatment Period 2|Other - Miscellaneous|0|||
124887993|NCT00932646|449213715|FG000|Overall Study|Adverse Event|2|||
124887994|NCT00932646|449213716|FG001|Overall Study|Adverse Event|1|||
124887995|NCT00932646|449213717|FG002|Overall Study|Adverse Event|1|||
124887996|NCT00932646|449213718|FG003|Overall Study|Adverse Event|1|||
124887997|NCT00932646|449213715|FG000|Overall Study|Lost to Follow-up|2|||
124887998|NCT00932646|449213716|FG001|Overall Study|Lost to Follow-up|1|||
124887999|NCT00932646|449213717|FG002|Overall Study|Lost to Follow-up|0|||
124888000|NCT00932646|449213718|FG003|Overall Study|Lost to Follow-up|0|||
124888001|NCT00932646|449213715|FG000|Overall Study|Withdrawal by Subject|1|||
124888002|NCT00932646|449213716|FG001|Overall Study|Withdrawal by Subject|1|||
124888003|NCT00932646|449213717|FG002|Overall Study|Withdrawal by Subject|3|||
124888004|NCT00932646|449213718|FG003|Overall Study|Withdrawal by Subject|0|||
124888005|NCT00653263|449213719|FG000|Overall Study|Withdrawal by Subject|1|||
124888006|NCT00653263|449213719|FG000|Overall Study|Physician Decision|1|||
124888007|NCT02285595|449213723|FG000|Overall Study|Lost to Follow-up|14|||
124888008|NCT02285595|449213723|FG000|Overall Study|Withdrawal by Subject|1|||
124888009|NCT00064025|449213734|FG000|Overall Study|Ineligible|4|||
124888010|NCT00064025|449213734|FG000|Overall Study|Inevaluable|3|||
124888011|NCT02468934|449213737|FG000|Overall Study|Withdrawal by Subject|4|||
124888012|NCT02468934|449213737|FG000|Overall Study|Screen Failure|3|||
124888013|NCT00641186|449213742|FG000|Overall Study|Adverse Event|3|||
124888014|NCT02218489|449213745|FG000|Overall Study|Withdrawal by Subject|4|||
124888015|NCT02218489|449213746|FG001|Overall Study|Withdrawal by Subject|3|||
124888016|NCT02218489|449213745|FG000|Overall Study|Lost to Follow-up|1|||
124888017|NCT02218489|449213746|FG001|Overall Study|Lost to Follow-up|0|||
124888018|NCT02404493|449213747|FG000|Overall Study|Adverse Event|1|||
124888019|NCT02404493|449213748|FG001|Overall Study|Adverse Event|1|||
124888020|NCT02388074|449213749|FG000|Overall Study|Lost in Transit|2|||
124888021|NCT02388074|449213749|FG000|Overall Study|Sample Not Returned|1|||
124440175|NCT01257425|447570939|FG001|Overall Study|Adverse Event|1|||
124888022|NCT00003458|449213750|FG000|Overall Study|Not evaluable|4|||
124888023|NCT02133924|449213751|FG000|Overall Study|Death|38|||
124888024|NCT02133924|449213751|FG000|Overall Study|Physician Decision|1|||
124888025|NCT02133924|449213751|FG000|Overall Study|Withdrawal by Subject|3|||
124888026|NCT01254890|449213752|FG000|Overall Study|Ineligible|0|||
124888027|NCT01254890|449213753|FG001|Overall Study|Ineligible|3|||
124888028|NCT01254890|449213752|FG000|Overall Study|Withdrawal by Subject|1|||
124888029|NCT01254890|449213753|FG001|Overall Study|Withdrawal by Subject|2|||
124888030|NCT01254890|449213752|FG000|Overall Study|Disease Progression|0|||
124888031|NCT01254890|449213753|FG001|Overall Study|Disease Progression|5|||
124888032|NCT04157686|449213754|FG000|Overall Study|Adverse Event|1|||
124888033|NCT04157686|449213755|FG001|Overall Study|Adverse Event|0|||
124888034|NCT04157686|449213756|FG002|Overall Study|Adverse Event|1|||
124888035|NCT04157686|449213757|FG003|Overall Study|Adverse Event|0|||
124888036|NCT04157686|449213758|FG004|Overall Study|Adverse Event|1|||
124888037|NCT04157686|449213759|FG005|Overall Study|Adverse Event|0|||
124888038|NCT04157686|449213760|FG006|Overall Study|Adverse Event|0|||
124888039|NCT04157686|449213761|FG007|Overall Study|Adverse Event|0|||
124888040|NCT04157686|449213754|FG000|Overall Study|Pregnancy|0|||
124888041|NCT04157686|449213755|FG001|Overall Study|Pregnancy|1|||
124888042|NCT04157686|449213756|FG002|Overall Study|Pregnancy|3|||
124888043|NCT04157686|449213757|FG003|Overall Study|Pregnancy|0|||
124888044|NCT04157686|449213758|FG004|Overall Study|Pregnancy|0|||
124888045|NCT04157686|449213759|FG005|Overall Study|Pregnancy|0|||
124888046|NCT04157686|449213760|FG006|Overall Study|Pregnancy|3|||
124888047|NCT04157686|449213761|FG007|Overall Study|Pregnancy|0|||
124888048|NCT04157686|449213754|FG000|Overall Study|Lost to Follow-up|1|||
124888049|NCT04157686|449213755|FG001|Overall Study|Lost to Follow-up|2|||
124888050|NCT04157686|449213756|FG002|Overall Study|Lost to Follow-up|8|||
124888051|NCT04157686|449213757|FG003|Overall Study|Lost to Follow-up|6|||
124888052|NCT04157686|449213758|FG004|Overall Study|Lost to Follow-up|6|||
124888053|NCT04157686|449213759|FG005|Overall Study|Lost to Follow-up|3|||
124888054|NCT04157686|449213760|FG006|Overall Study|Lost to Follow-up|7|||
124888055|NCT04157686|449213761|FG007|Overall Study|Lost to Follow-up|9|||
124888056|NCT04157686|449213754|FG000|Overall Study|Lack of Efficacy|0|||
124888057|NCT04157686|449213755|FG001|Overall Study|Lack of Efficacy|0|||
124888058|NCT04157686|449213756|FG002|Overall Study|Lack of Efficacy|0|||
124888059|NCT04157686|449213757|FG003|Overall Study|Lack of Efficacy|0|||
124888060|NCT04157686|449213758|FG004|Overall Study|Lack of Efficacy|0|||
124888061|NCT04157686|449213759|FG005|Overall Study|Lack of Efficacy|2|||
124888062|NCT04157686|449213760|FG006|Overall Study|Lack of Efficacy|0|||
124888063|NCT04157686|449213761|FG007|Overall Study|Lack of Efficacy|1|||
124888064|NCT04157686|449213754|FG000|Overall Study|Withdrawal by Subject|10|||
124888065|NCT04157686|449213755|FG001|Overall Study|Withdrawal by Subject|10|||
124888066|NCT04157686|449213756|FG002|Overall Study|Withdrawal by Subject|12|||
124888067|NCT04157686|449213757|FG003|Overall Study|Withdrawal by Subject|20|||
124888068|NCT04157686|449213758|FG004|Overall Study|Withdrawal by Subject|12|||
124888069|NCT04157686|449213759|FG005|Overall Study|Withdrawal by Subject|11|||
124888070|NCT04157686|449213760|FG006|Overall Study|Withdrawal by Subject|18|||
124888071|NCT04157686|449213761|FG007|Overall Study|Withdrawal by Subject|24|||
124888072|NCT04157686|449213754|FG000|Overall Study|Physician Decision|0|||
124888073|NCT04157686|449213755|FG001|Overall Study|Physician Decision|0|||
124888074|NCT04157686|449213756|FG002|Overall Study|Physician Decision|1|||
124888075|NCT04157686|449213757|FG003|Overall Study|Physician Decision|0|||
124888076|NCT04157686|449213758|FG004|Overall Study|Physician Decision|1|||
124888077|NCT04157686|449213759|FG005|Overall Study|Physician Decision|0|||
124888078|NCT04157686|449213760|FG006|Overall Study|Physician Decision|3|||
124888079|NCT04157686|449213761|FG007|Overall Study|Physician Decision|0|||
124888080|NCT04157686|449213754|FG000|Overall Study|Death|0|||
124888081|NCT04157686|449213755|FG001|Overall Study|Death|0|||
124888082|NCT04157686|449213756|FG002|Overall Study|Death|0|||
124888083|NCT04157686|449213757|FG003|Overall Study|Death|2|||
124888084|NCT04157686|449213758|FG004|Overall Study|Death|0|||
124888085|NCT04157686|449213759|FG005|Overall Study|Death|0|||
124888086|NCT04157686|449213760|FG006|Overall Study|Death|0|||
124440176|NCT01257425|447570938|FG000|Overall Study|Protocol Violation|1|||
124440177|NCT01257425|447570939|FG001|Overall Study|Protocol Violation|1|||
124440178|NCT01257425|447570938|FG000|Overall Study|Withdrawal by Subject|0|||
124440179|NCT01257425|447570939|FG001|Overall Study|Withdrawal by Subject|1|||
124440180|NCT01257425|447570938|FG000|Overall Study|Death|1|||
124440181|NCT01257425|447570939|FG001|Overall Study|Death|0|||
124440182|NCT01182194|447570941|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
124888087|NCT04157686|449213761|FG007|Overall Study|Death|0|||
124888088|NCT04157686|449213754|FG000|Overall Study|Protocol Violation|0|||
124888089|NCT04157686|449213755|FG001|Overall Study|Protocol Violation|0|||
124440183|NCT01182194|447570942|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
124888090|NCT04157686|449213756|FG002|Overall Study|Protocol Violation|0|||
124888091|NCT04157686|449213757|FG003|Overall Study|Protocol Violation|0|||
124888092|NCT04157686|449213758|FG004|Overall Study|Protocol Violation|1|||
124888093|NCT04157686|449213759|FG005|Overall Study|Protocol Violation|0|||
124888094|NCT04157686|449213760|FG006|Overall Study|Protocol Violation|0|||
124888095|NCT04157686|449213761|FG007|Overall Study|Protocol Violation|0|||
124888096|NCT04157686|449213754|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
124888097|NCT04157686|449213755|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
124888098|NCT04157686|449213756|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
124888099|NCT04157686|449213757|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
124888100|NCT04157686|449213758|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
124888101|NCT04157686|449213759|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
124888102|NCT04157686|449213760|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
124888103|NCT04157686|449213761|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
124440184|NCT03343301|447570943|FG000|Overall Study|Withdrawal by Subject|1|||
124440185|NCT03343301|447570944|FG001|Overall Study|Withdrawal by Subject|1|||
124888104|NCT01216293|449213762|FG000|Main Study|Adverse Event|1|||
124685667|NCT00098475|448469866|FG000|Step 1|Both patient and physician's decision|2|||
124685668|NCT00098475|448469867|FG001|Step 1|Both patient and physician's decision|1|||
124685669|NCT00098475|448469868|FG002|Step 1|Both patient and physician's decision|0|||
124888105|NCT01216293|449213763|FG001|Main Study|Adverse Event|4|||
124888106|NCT01216293|449213764|FG002|Main Study|Adverse Event|2|||
124888107|NCT01216293|449213762|FG000|Main Study|Major Protocol Deviation|1|||
124888108|NCT01216293|449213763|FG001|Main Study|Major Protocol Deviation|0|||
124888109|NCT01216293|449213764|FG002|Main Study|Major Protocol Deviation|1|||
124888110|NCT01216293|449213762|FG000|Main Study|Lost to Follow-up|3|||
124888111|NCT01216293|449213763|FG001|Main Study|Lost to Follow-up|1|||
124888112|NCT01216293|449213764|FG002|Main Study|Lost to Follow-up|0|||
124888113|NCT01216293|449213762|FG000|Main Study|Voluntary Withdrawal|2|||
124888114|NCT01216293|449213763|FG001|Main Study|Voluntary Withdrawal|2|||
124888115|NCT01216293|449213764|FG002|Main Study|Voluntary Withdrawal|2|||
124888116|NCT01216293|449213762|FG000|Main Study|Other Reason Not Specified|0|||
124888117|NCT01216293|449213763|FG001|Main Study|Other Reason Not Specified|1|||
124888118|NCT01216293|449213764|FG002|Main Study|Other Reason Not Specified|1|||
124888119|NCT01216293|449213762|FG000|Main Study|Randomized, Not Treated|1|||
124888120|NCT01216293|449213763|FG001|Main Study|Randomized, Not Treated|0|||
124888121|NCT01216293|449213764|FG002|Main Study|Randomized, Not Treated|0|||
124888122|NCT01216293|449213762|FG000|Calcium Absorption Substudy|Adverse Event|0|||
124888123|NCT01216293|449213763|FG001|Calcium Absorption Substudy|Adverse Event|2|||
124888124|NCT01216293|449213764|FG002|Calcium Absorption Substudy|Adverse Event|0|||
124888125|NCT01216293|449213762|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
124888126|NCT01216293|449213763|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
124888127|NCT01216293|449213764|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
124888128|NCT01216293|449213762|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
124888129|NCT01216293|449213763|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
124888130|NCT01216293|449213764|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
124888131|NCT01023308|449215389|FG000|Overall Study|Abnormal test proceedure results|3|||
124888132|NCT01023308|449215390|FG001|Overall Study|Abnormal test proceedure results|8|||
124888133|NCT01023308|449215389|FG000|Overall Study|Administrative problems|2|||
124888134|NCT01023308|449215390|FG001|Overall Study|Administrative problems|1|||
124685670|NCT00098475|448469869|FG003|Step 1|Both patient and physician's decision|0|||
124685671|NCT00098475|448469866|FG000|Step 1|Incorrect disease assessment|2|||
124888135|NCT01023308|449215389|FG000|Overall Study|Adverse Event|130|||
124888136|NCT01023308|449215390|FG001|Overall Study|Adverse Event|66|||
124888137|NCT01023308|449215389|FG000|Overall Study|Death|21|||
124888138|NCT01023308|449215390|FG001|Overall Study|Death|17|||
124888139|NCT01023308|449215389|FG000|Overall Study|Disease progression|82|||
124888140|NCT01023308|449215390|FG001|Overall Study|Disease progression|153|||
124888141|NCT01023308|449215389|FG000|Overall Study|New Cancer therapy|4|||
124888142|NCT01023308|449215390|FG001|Overall Study|New Cancer therapy|7|||
124888143|NCT01023308|449215389|FG000|Overall Study|Protocol Violation|3|||
124888144|NCT01023308|449215390|FG001|Overall Study|Protocol Violation|4|||
124888145|NCT01023308|449215389|FG000|Overall Study|Untreated|5|||
124888146|NCT01023308|449215390|FG001|Overall Study|Untreated|5|||
124888147|NCT01023308|449215389|FG000|Overall Study|Lost to Follow-up|1|||
124888148|NCT01023308|449215390|FG001|Overall Study|Lost to Follow-up|0|||
124888149|NCT01023308|449215389|FG000|Overall Study|Withdrawal by Subject|34|||
124888150|NCT01023308|449215390|FG001|Overall Study|Withdrawal by Subject|18|||
124888151|NCT00551213|449215391|FG000|Overall Study|Adverse Event|6|||
124888152|NCT00551213|449215392|FG001|Overall Study|Adverse Event|3|||
124888153|NCT00551213|449215391|FG000|Overall Study|Progressive Disease|41|||
124888154|NCT00551213|449215392|FG001|Overall Study|Progressive Disease|12|||
124888155|NCT00551213|449215391|FG000|Overall Study|Withdrawal by Subject|2|||
124888156|NCT00551213|449215392|FG001|Overall Study|Withdrawal by Subject|0|||
124888157|NCT00551213|449215391|FG000|Overall Study|Not Treated|1|||
124888158|NCT00551213|449215392|FG001|Overall Study|Not Treated|2|||
124888159|NCT01383993|449215393|FG000|Overall Study|Adverse Event|1|||
124888160|NCT01383993|449215394|FG001|Overall Study|Adverse Event|1|||
124888161|NCT01383993|449215395|FG002|Overall Study|Adverse Event|0|||
124888162|NCT01383993|449215393|FG000|Overall Study|Withdrawal by Subject|0|||
124888163|NCT01383993|449215394|FG001|Overall Study|Withdrawal by Subject|0|||
124888164|NCT01383993|449215395|FG002|Overall Study|Withdrawal by Subject|1|||
124888165|NCT01383993|449215393|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
124888166|NCT01383993|449215394|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
124888167|NCT01383993|449215395|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
124888168|NCT02561455|449215398|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
124888169|NCT02561455|449215399|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
124888170|NCT02561455|449215400|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
124888171|NCT02561455|449215401|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
124888172|NCT02561455|449215398|FG000|Overall Study|Withdrawal by Subject|1|||
124888173|NCT02561455|449215399|FG001|Overall Study|Withdrawal by Subject|0|||
124888174|NCT02561455|449215400|FG002|Overall Study|Withdrawal by Subject|1|||
124888175|NCT02561455|449215401|FG003|Overall Study|Withdrawal by Subject|0|||
124888176|NCT02561455|449215398|FG000|Overall Study|Disease Progression|0|||
124888177|NCT02561455|449215399|FG001|Overall Study|Disease Progression|1|||
124888178|NCT02561455|449215400|FG002|Overall Study|Disease Progression|0|||
124888179|NCT02561455|449215401|FG003|Overall Study|Disease Progression|0|||
124888180|NCT00262743|449215402|FG000|Overall Study|Adverse Event|0|||
124888181|NCT00262743|449215403|FG001|Overall Study|Adverse Event|9|||
124888182|NCT00262743|449215402|FG000|Overall Study|Disease progression|0|||
124888183|NCT00262743|449215403|FG001|Overall Study|Disease progression|3|||
124888186|NCT03249376|449215429|FG000|Overall Study|Adverse Event|11|||
124888187|NCT03249376|449215430|FG001|Overall Study|Adverse Event|5|||
124888188|NCT03249376|449215429|FG000|Overall Study|Lack of Efficacy|2|||
124888189|NCT03249376|449215430|FG001|Overall Study|Lack of Efficacy|4|||
124888190|NCT03249376|449215429|FG000|Overall Study|Protocol Violation|3|||
124888191|NCT03249376|449215430|FG001|Overall Study|Protocol Violation|2|||
124888192|NCT03249376|449215429|FG000|Overall Study|Physician Decision|0|||
124888193|NCT03249376|449215430|FG001|Overall Study|Physician Decision|2|||
124888194|NCT03249376|449215429|FG000|Overall Study|Withdrawal by Subject|3|||
124888195|NCT03249376|449215430|FG001|Overall Study|Withdrawal by Subject|9|||
124888196|NCT03249376|449215429|FG000|Overall Study|LTFU|2|||
124888197|NCT03249376|449215430|FG001|Overall Study|LTFU|1|||
124888198|NCT01154036|449215431|FG000|Phase I|Physician Decision|0|||
124888199|NCT01154036|449215432|FG001|Phase I|Physician Decision|1|||
124685672|NCT00098475|448469867|FG001|Step 1|Incorrect disease assessment|0|||
124685673|NCT00098475|448469868|FG002|Step 1|Incorrect disease assessment|0|||
124685674|NCT00098475|448469869|FG003|Step 1|Incorrect disease assessment|0|||
124685675|NCT00098475|448469866|FG000|Step 1|Off treatment for > specified timeframe|1|||
124685676|NCT00098475|448469867|FG001|Step 1|Off treatment for > specified timeframe|1|||
124888200|NCT01154036|449215433|FG002|Phase I|Physician Decision|0|||
124888201|NCT01154036|449215434|FG003|Phase I|Physician Decision|0|||
124888202|NCT01154036|449215435|FG004|Phase I|Physician Decision|0|||
124888203|NCT01154036|449215436|FG005|Phase I|Physician Decision|0|||
124685677|NCT00098475|448469868|FG002|Step 1|Off treatment for > specified timeframe|0|||
124888204|NCT01154036|449215437|FG006|Phase I|Physician Decision|0|||
124685678|NCT00098475|448469869|FG003|Step 1|Off treatment for > specified timeframe|0|||
124888205|NCT01154036|449215438|FG007|Phase I|Physician Decision|0|||
124888206|NCT01154036|449215431|FG000|Phase I|Lost to Follow-up|0|||
124888207|NCT01154036|449215432|FG001|Phase I|Lost to Follow-up|3|||
124888208|NCT01154036|449215433|FG002|Phase I|Lost to Follow-up|6|||
124888209|NCT01154036|449215434|FG003|Phase I|Lost to Follow-up|0|||
124888210|NCT01154036|449215435|FG004|Phase I|Lost to Follow-up|0|||
124685679|NCT00098475|448469866|FG000|Step 1|Declining performance status|0|||
124685680|NCT00098475|448469867|FG001|Step 1|Declining performance status|1|||
124685681|NCT00098475|448469868|FG002|Step 1|Declining performance status|0|||
124685682|NCT00098475|448469869|FG003|Step 1|Declining performance status|0|||
124685683|NCT00098475|448469866|FG000|Step 1|Insurance issue|0|||
124685684|NCT00098475|448469867|FG001|Step 1|Insurance issue|1|||
124685685|NCT00098475|448469868|FG002|Step 1|Insurance issue|0|||
124685686|NCT00098475|448469869|FG003|Step 1|Insurance issue|0|||
124759013|NCT01521507|448741229|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
124759014|NCT01521507|448741228|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
124759015|NCT01521507|448741229|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
124759016|NCT01521507|448741228|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
124888211|NCT01154036|449215436|FG005|Phase I|Lost to Follow-up|0|||
124888212|NCT01154036|449215437|FG006|Phase I|Lost to Follow-up|0|||
124888213|NCT01154036|449215438|FG007|Phase I|Lost to Follow-up|0|||
124888214|NCT01154036|449215431|FG000|Phase I|Protocol Violation|0|||
124888215|NCT01154036|449215432|FG001|Phase I|Protocol Violation|3|||
124888216|NCT01154036|449215433|FG002|Phase I|Protocol Violation|9|||
124888217|NCT01154036|449215434|FG003|Phase I|Protocol Violation|0|||
124888218|NCT01154036|449215435|FG004|Phase I|Protocol Violation|0|||
124888219|NCT01154036|449215436|FG005|Phase I|Protocol Violation|0|||
124888220|NCT01154036|449215437|FG006|Phase I|Protocol Violation|0|||
124888221|NCT01154036|449215438|FG007|Phase I|Protocol Violation|0|||
124888222|NCT01154036|449215431|FG000|Phase I|Withdrawal by Subject|2|||
124888223|NCT01154036|449215432|FG001|Phase I|Withdrawal by Subject|10|||
124888224|NCT01154036|449215433|FG002|Phase I|Withdrawal by Subject|29|||
124888225|NCT01154036|449215434|FG003|Phase I|Withdrawal by Subject|0|||
124888226|NCT01154036|449215435|FG004|Phase I|Withdrawal by Subject|0|||
124888227|NCT01154036|449215436|FG005|Phase I|Withdrawal by Subject|0|||
124888228|NCT01154036|449215437|FG006|Phase I|Withdrawal by Subject|0|||
124888229|NCT01154036|449215438|FG007|Phase I|Withdrawal by Subject|0|||
124888230|NCT01154036|449215431|FG000|Phase I|Adverse Event|1|||
124888231|NCT01154036|449215432|FG001|Phase I|Adverse Event|11|||
124888232|NCT01154036|449215433|FG002|Phase I|Adverse Event|12|||
124888233|NCT01154036|449215434|FG003|Phase I|Adverse Event|0|||
124888234|NCT01154036|449215435|FG004|Phase I|Adverse Event|0|||
124888235|NCT01154036|449215436|FG005|Phase I|Adverse Event|0|||
124888236|NCT01154036|449215437|FG006|Phase I|Adverse Event|0|||
124888237|NCT01154036|449215438|FG007|Phase I|Adverse Event|0|||
124888238|NCT01154036|449215431|FG000|Phase II|Adverse Event|0|||
124888239|NCT01154036|449215432|FG001|Phase II|Adverse Event|0|||
124888240|NCT01154036|449215433|FG002|Phase II|Adverse Event|0|||
124888241|NCT01154036|449215434|FG003|Phase II|Adverse Event|0|||
124888242|NCT01154036|449215435|FG004|Phase II|Adverse Event|1|||
124888243|NCT01154036|449215436|FG005|Phase II|Adverse Event|1|||
124888244|NCT01154036|449215437|FG006|Phase II|Adverse Event|1|||
124888245|NCT01154036|449215438|FG007|Phase II|Adverse Event|1|||
124888246|NCT01154036|449215431|FG000|Phase II|Physician Decision|0|||
124888247|NCT01154036|449215432|FG001|Phase II|Physician Decision|0|||
124888248|NCT01154036|449215433|FG002|Phase II|Physician Decision|0|||
124888249|NCT01154036|449215434|FG003|Phase II|Physician Decision|0|||
124888250|NCT01154036|449215435|FG004|Phase II|Physician Decision|0|||
124888251|NCT01154036|449215436|FG005|Phase II|Physician Decision|0|||
124888252|NCT01154036|449215437|FG006|Phase II|Physician Decision|1|||
124888253|NCT01154036|449215438|FG007|Phase II|Physician Decision|0|||
124888254|NCT01154036|449215431|FG000|Phase II|Lost to Follow-up|0|||
124888255|NCT01154036|449215432|FG001|Phase II|Lost to Follow-up|0|||
124888256|NCT01154036|449215433|FG002|Phase II|Lost to Follow-up|0|||
124888257|NCT01154036|449215434|FG003|Phase II|Lost to Follow-up|1|||
124888258|NCT01154036|449215435|FG004|Phase II|Lost to Follow-up|2|||
124888259|NCT01154036|449215436|FG005|Phase II|Lost to Follow-up|0|||
124888260|NCT01154036|449215437|FG006|Phase II|Lost to Follow-up|2|||
124440186|NCT03343301|447570943|FG000|Overall Study|Death|0|||
124440187|NCT03343301|447570944|FG001|Overall Study|Death|2|||
124685687|NCT00098475|448469866|FG000|Step 1|Rising paraprotein|0|||
124685688|NCT00098475|448469867|FG001|Step 1|Rising paraprotein|1|||
124888261|NCT01154036|449215438|FG007|Phase II|Lost to Follow-up|1|||
124888262|NCT01154036|449215431|FG000|Phase II|Protocol Violation|0|||
124888263|NCT01154036|449215432|FG001|Phase II|Protocol Violation|0|||
124888264|NCT01154036|449215433|FG002|Phase II|Protocol Violation|0|||
124888265|NCT01154036|449215434|FG003|Phase II|Protocol Violation|0|||
124888266|NCT01154036|449215435|FG004|Phase II|Protocol Violation|1|||
124888267|NCT01154036|449215436|FG005|Phase II|Protocol Violation|2|||
124888268|NCT01154036|449215437|FG006|Phase II|Protocol Violation|0|||
124888269|NCT01154036|449215438|FG007|Phase II|Protocol Violation|0|||
124685689|NCT00098475|448469868|FG002|Step 1|Rising paraprotein|0|||
124888270|NCT01154036|449215431|FG000|Phase II|Withdrawal by Subject|0|||
124888271|NCT01154036|449215432|FG001|Phase II|Withdrawal by Subject|0|||
124888272|NCT01154036|449215433|FG002|Phase II|Withdrawal by Subject|0|||
124888273|NCT01154036|449215434|FG003|Phase II|Withdrawal by Subject|0|||
124888274|NCT01154036|449215435|FG004|Phase II|Withdrawal by Subject|4|||
124888275|NCT01154036|449215436|FG005|Phase II|Withdrawal by Subject|2|||
124888276|NCT01154036|449215437|FG006|Phase II|Withdrawal by Subject|5|||
124888277|NCT01154036|449215438|FG007|Phase II|Withdrawal by Subject|4|||
124685690|NCT00098475|448469869|FG003|Step 1|Rising paraprotein|0|||
124685691|NCT00098475|448469866|FG000|Step 1|Referred to other physicians|0|||
124685692|NCT00098475|448469867|FG001|Step 1|Referred to other physicians|1|||
124685693|NCT00098475|448469868|FG002|Step 1|Referred to other physicians|0|||
124685694|NCT00098475|448469869|FG003|Step 1|Referred to other physicians|0|||
124685695|NCT00098475|448469866|FG000|Step 1|Criteria to continue treatment not met|0|||
124888278|NCT01349907|449215439|FG000|Overall Study|Adverse Event|37|||
124888279|NCT01349907|449215440|FG001|Overall Study|Adverse Event|11|||
124888280|NCT01349907|449215439|FG000|Overall Study|Treatment failure|13|||
124888281|NCT01349907|449215440|FG001|Overall Study|Treatment failure|4|||
124888282|NCT01349907|449215439|FG000|Overall Study|Lost to Follow-up|25|||
124888283|NCT01349907|449215440|FG001|Overall Study|Lost to Follow-up|6|||
124888284|NCT01349907|449215439|FG000|Overall Study|Withdrawal by Subject|30|||
124888285|NCT01349907|449215440|FG001|Overall Study|Withdrawal by Subject|8|||
124888286|NCT01349907|449215439|FG000|Overall Study|Protocol Violation|33|||
124888287|NCT01349907|449215440|FG001|Overall Study|Protocol Violation|13|||
124888288|NCT01349907|449215439|FG000|Overall Study|Administrative|1|||
124888289|NCT01349907|449215440|FG001|Overall Study|Administrative|1|||
124888290|NCT01591460|449215443|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
124888291|NCT01591460|449215443|FG000|Overall Study|Futility Rule (Week 12)|7|||
124888292|NCT01591460|449215443|FG000|Overall Study|Futility Rule (Week 24)|3|||
124888293|NCT01591460|449215443|FG000|Overall Study|Rebound or Breakthrough|3|||
124888294|NCT01591460|449215443|FG000|Overall Study|Treatment Discontinued by Error|1|||
124888295|NCT01591460|449215443|FG000|Overall Study|Lost to Follow-up|1|||
124888296|NCT01591460|449215443|FG000|Overall Study|Noncompliance|1|||
124685696|NCT00098475|448469867|FG001|Step 1|Criteria to continue treatment not met|1|||
124685697|NCT00098475|448469868|FG002|Step 1|Criteria to continue treatment not met|0|||
124685698|NCT00098475|448469869|FG003|Step 1|Criteria to continue treatment not met|0|||
124685699|NCT00098475|448469866|FG000|Step 1|Misinterpretation of lab data|0|||
124685700|NCT00098475|448469867|FG001|Step 1|Misinterpretation of lab data|1|||
124685701|NCT00098475|448469868|FG002|Step 1|Misinterpretation of lab data|0|||
124685702|NCT00098475|448469869|FG003|Step 1|Misinterpretation of lab data|0|||
124685703|NCT00098475|448469866|FG000|Step 1|Patient fell with fracture|1|||
124685704|NCT00098475|448469867|FG001|Step 1|Patient fell with fracture|0|||
124685705|NCT00098475|448469868|FG002|Step 1|Patient fell with fracture|0|||
124888297|NCT01591460|449215443|FG000|Overall Study|Participant Refusal|3|||
124685706|NCT00098475|448469869|FG003|Step 1|Patient fell with fracture|0|||
124888298|NCT01591460|449215443|FG000|Overall Study|Withdrawal by Subject|1|||
124888299|NCT01591460|449215443|FG000|Overall Study|Protocol Violation|1|||
124888300|NCT04102540|449215446|FG000|Overall Study|Withdrawn by PI|2|||
124888301|NCT04102540|449215446|FG000|Overall Study|Lost to Follow-up|6|||
124888302|NCT01744496|449215447|FG000|Titration Period|Adverse Event|2|||
124440188|NCT03343301|447570943|FG000|Overall Study|Other|0|||
124685707|NCT00098475|448469866|FG000|Step 1|Not documented|0|||
124685708|NCT00098475|448469867|FG001|Step 1|Not documented|1|||
124685709|NCT00098475|448469868|FG002|Step 1|Not documented|0|||
124685710|NCT00098475|448469869|FG003|Step 1|Not documented|0|||
124685711|NCT00098475|448469866|FG000|Step 2|Disease progression|1|||
124685712|NCT00098475|448469867|FG001|Step 2|Disease progression|4|||
124685713|NCT00098475|448469868|FG002|Step 2|Disease progression|0|||
124685714|NCT00098475|448469869|FG003|Step 2|Disease progression|0|||
124685715|NCT00098475|448469866|FG000|Step 2|Adverse Event|2|||
124685716|NCT00098475|448469867|FG001|Step 2|Adverse Event|0|||
124685717|NCT00098475|448469868|FG002|Step 2|Adverse Event|0|||
124685718|NCT00098475|448469869|FG003|Step 2|Adverse Event|0|||
124685719|NCT00098475|448469866|FG000|Step 2|Withdrawal by Subject|0|||
124685720|NCT00098475|448469867|FG001|Step 2|Withdrawal by Subject|2|||
124685721|NCT00098475|448469868|FG002|Step 2|Withdrawal by Subject|0|||
124685722|NCT00098475|448469869|FG003|Step 2|Withdrawal by Subject|0|||
124685723|NCT00098475|448469866|FG000|Step 2|Physician Decision|0|||
124685724|NCT00098475|448469867|FG001|Step 2|Physician Decision|1|||
124888303|NCT01744496|449215448|FG001|Titration Period|Adverse Event|1|||
124888304|NCT01744496|449215447|FG000|Titration Period|Personal reasons|0|||
124888305|NCT01744496|449215448|FG001|Titration Period|Personal reasons|1|||
124888306|NCT01744496|449215447|FG000|Maintenance Period|Adverse Event|1|||
124888307|NCT01744496|449215448|FG001|Maintenance Period|Adverse Event|3|||
124685725|NCT00098475|448469868|FG002|Step 2|Physician Decision|0|||
124888308|NCT01744496|449215447|FG000|Maintenance Period|Protocol Violation|1|||
124888309|NCT01744496|449215448|FG001|Maintenance Period|Protocol Violation|0|||
124888310|NCT01744496|449215447|FG000|Maintenance Period|Withdrawal by Subject|1|||
124888311|NCT01744496|449215448|FG001|Maintenance Period|Withdrawal by Subject|1|||
124888312|NCT01744496|449215447|FG000|Maintenance Period|Subject left town|1|||
124888313|NCT01744496|449215448|FG001|Maintenance Period|Subject left town|0|||
124888314|NCT01567163|449215449|FG000|Overall Study|Progressive Disease|2|||
124888315|NCT01567163|449215449|FG000|Overall Study|Lost to Follow-up|2|||
124888316|NCT01364727|449215457|FG000|Overall Study|Not Eligible|2|||
124888317|NCT01009047|449215459|FG000|Overall Study|Adverse Event|5|||
124888318|NCT01009047|449215460|FG001|Overall Study|Adverse Event|0|||
124888319|NCT01009047|449215459|FG000|Overall Study|Lost to Follow-up|0|||
124888320|NCT01009047|449215460|FG001|Overall Study|Lost to Follow-up|2|||
124888321|NCT01009047|449215459|FG000|Overall Study|Lack of Efficacy|4|||
124888322|NCT01009047|449215460|FG001|Overall Study|Lack of Efficacy|11|||
124888323|NCT01009047|449215459|FG000|Overall Study|Withdrawal by consent|16|||
124888324|NCT01009047|449215460|FG001|Overall Study|Withdrawal by consent|11|||
124440189|NCT03343301|447570944|FG001|Overall Study|Other|6|||
124440190|NCT03343301|447570943|FG000|Overall Study|Missing|2|||
124440191|NCT03343301|447570944|FG001|Overall Study|Missing|0|||
124440192|NCT00368992|447570945|FG000|Overall Study|Ineligible|5|||
124440193|NCT00368992|447570945|FG000|Overall Study|Refused treatment|3|||
124440194|NCT00368992|447570945|FG000|Overall Study|Lack of Efficacy|63|||
124440195|NCT00368992|447570945|FG000|Overall Study|Adverse Event|26|||
124440196|NCT00368992|447570945|FG000|Overall Study|Death|4|||
124440197|NCT00368992|447570945|FG000|Overall Study|Other|9|||
124440198|NCT02668185|447570946|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
124440199|NCT02668185|447570947|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
124440200|NCT02668185|447570946|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
124440201|NCT02668185|447570947|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
124440202|NCT02668185|447570946|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
124440203|NCT02668185|447570947|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
124440204|NCT02668185|447570946|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
124440205|NCT02668185|447570947|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
124440206|NCT00427895|447570950|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
124440207|NCT00427895|447570951|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
124440208|NCT00427895|447570952|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
124440209|NCT00427895|447570953|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
124440210|NCT00427895|447570954|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
124440211|NCT00427895|447570955|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
124440212|NCT00427895|447570956|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
124440213|NCT00427895|447570957|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
124440214|NCT00427895|447570950|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
124440215|NCT00427895|447570951|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
124440216|NCT00427895|447570952|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
124440217|NCT00427895|447570953|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
124440218|NCT00427895|447570954|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
124440219|NCT00427895|447570955|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
124440220|NCT00427895|447570956|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
124440221|NCT00427895|447570957|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
124440222|NCT00427895|447570950|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
124440223|NCT00427895|447570951|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
124440224|NCT00427895|447570952|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
124440225|NCT00427895|447570953|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
124440226|NCT00427895|447570954|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
124440227|NCT00427895|447570955|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
124440228|NCT00427895|447570956|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
124440229|NCT00427895|447570957|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
124440230|NCT00427895|447570950|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
124440231|NCT00427895|447570951|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
124440232|NCT00427895|447570952|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
124440233|NCT00427895|447570953|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
124440234|NCT00427895|447570954|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
124440235|NCT00427895|447570955|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
124888325|NCT01009047|449215459|FG000|Overall Study|Other|3|||
124888326|NCT01009047|449215460|FG001|Overall Study|Other|2|||
124440236|NCT00427895|447570956|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
124440237|NCT00427895|447570957|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
124685726|NCT00098475|448469869|FG003|Step 2|Physician Decision|0|||
124685727|NCT00098475|448469866|FG000|Step 2|Alternative therapy|1|||
124888327|NCT04716881|449215461|FG000|Overall Study|Adverse Event|1|||
124888328|NCT04716881|449215461|FG000|Overall Study|Lost to Follow-up|1|||
124888329|NCT01558674|449215464|FG000|Part 1|Study Terminated by Sponsor|10|||
124888330|NCT01558674|449215465|FG001|Part 1|Study Terminated by Sponsor|0|||
124888331|NCT01558674|449215464|FG000|Part 1|Withdrawal by Subject|1|||
124685728|NCT00098475|448469867|FG001|Step 2|Alternative therapy|2|||
124888332|NCT01558674|449215465|FG001|Part 1|Withdrawal by Subject|0|||
124888333|NCT04147260|449215466|FG000|Overall Study|Adverse Event|1|||
124888334|NCT04147260|449215467|FG001|Overall Study|Adverse Event|0|||
124888335|NCT04147260|449215468|FG002|Overall Study|Adverse Event|1|||
124888336|NCT04147260|449215469|FG003|Overall Study|Adverse Event|2|||
124888337|NCT04147260|449215470|FG004|Overall Study|Adverse Event|0|||
124888338|NCT04147260|449215466|FG000|Overall Study|Withdrawal by Subject|0|||
124888339|NCT04147260|449215467|FG001|Overall Study|Withdrawal by Subject|0|||
124888340|NCT04147260|449215468|FG002|Overall Study|Withdrawal by Subject|1|||
124888341|NCT04147260|449215469|FG003|Overall Study|Withdrawal by Subject|1|||
124888342|NCT04147260|449215470|FG004|Overall Study|Withdrawal by Subject|0|||
124888343|NCT01734850|449215473|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
124888344|NCT01734850|449215474|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
124888345|NCT01734850|449215475|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
124888346|NCT01734850|449215473|FG000|Overall Study|Not infused due to manufacturing failure|0|||
124440238|NCT00427895|447570950|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
124440239|NCT00427895|447570951|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
124440240|NCT00427895|447570952|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
124440241|NCT00427895|447570953|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
124440242|NCT00427895|447570954|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
124440243|NCT00427895|447570955|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
124440244|NCT00427895|447570956|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
124440245|NCT00427895|447570957|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
124440246|NCT00427895|447570950|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
124440247|NCT00427895|447570951|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
124440248|NCT00427895|447570952|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
124440249|NCT00427895|447570953|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
124685729|NCT00098475|448469868|FG002|Step 2|Alternative therapy|0|||
124685730|NCT00098475|448469869|FG003|Step 2|Alternative therapy|0|||
124685731|NCT00098475|448469866|FG000|Step 2|Never started treatment|1|||
124685732|NCT00098475|448469867|FG001|Step 2|Never started treatment|1|||
124685733|NCT00098475|448469868|FG002|Step 2|Never started treatment|0|||
124685734|NCT00098475|448469869|FG003|Step 2|Never started treatment|0|||
124685735|NCT05352399|448469871|FG000|Overall Study|Discontinued intervention|6|||
124685736|NCT01802281|448469874|FG000|Overall Study|Death|1|||
124685737|NCT01802281|448469875|FG001|Overall Study|Death|2|||
124685738|NCT01802281|448469874|FG000|Overall Study|Withdrawal by Subject|2|||
124685739|NCT01802281|448469875|FG001|Overall Study|Withdrawal by Subject|1|||
124685740|NCT01802281|448469874|FG000|Overall Study|Ineligible|5|||
124685741|NCT01802281|448469875|FG001|Overall Study|Ineligible|3|||
124685742|NCT02685735|448469876|FG000|Overall Study|Surgery Cancelled|4|||
124685743|NCT02685735|448469877|FG001|Overall Study|Surgery Cancelled|9|||
124685744|NCT02685735|448469876|FG000|Overall Study|Adverse Event|10|||
124685745|NCT02685735|448469877|FG001|Overall Study|Adverse Event|3|||
124685746|NCT02685735|448469876|FG000|Overall Study|Preop testing found to be incomplete|2|||
124685747|NCT02685735|448469877|FG001|Overall Study|Preop testing found to be incomplete|2|||
124685748|NCT02685735|448469876|FG000|Overall Study|Withdrawal by Subject|1|||
124685749|NCT02685735|448469877|FG001|Overall Study|Withdrawal by Subject|2|||
124685750|NCT02685735|448469876|FG000|Overall Study|Death|1|||
124685751|NCT02685735|448469877|FG001|Overall Study|Death|0|||
124685752|NCT00927472|448469887|FG000|Overall Study|Withdrawal by Subject|10|||
124685753|NCT00927472|448469888|FG001|Overall Study|Withdrawal by Subject|11|||
124685754|NCT00927472|448469887|FG000|Overall Study|Lost to Follow-up|1|||
124685755|NCT00927472|448469888|FG001|Overall Study|Lost to Follow-up|6|||
124685756|NCT00927472|448469887|FG000|Overall Study|Protocol Violation|0|||
124685757|NCT00927472|448469888|FG001|Overall Study|Protocol Violation|1|||
124685758|NCT00927472|448469887|FG000|Overall Study|Post treatment Assessment out of window|0|||
124685759|NCT00927472|448469888|FG001|Overall Study|Post treatment Assessment out of window|4|||
124685760|NCT04556097|448469889|FG000|Overall Study|Death|0|||
124685761|NCT04556097|448469890|FG001|Overall Study|Death|5|||
124685762|NCT04556097|448469891|FG002|Overall Study|Death|0|||
124685763|NCT04556097|448469892|FG003|Overall Study|Death|0|||
124685764|NCT04556097|448469889|FG000|Overall Study|No caregiver|43|||
124685765|NCT04556097|448469890|FG001|Overall Study|No caregiver|53|||
124685766|NCT04556097|448469891|FG002|Overall Study|No caregiver|0|||
124685767|NCT04556097|448469892|FG003|Overall Study|No caregiver|0|||
124685768|NCT04556097|448469889|FG000|Overall Study|Ineligible, SNF|2|||
124685769|NCT04556097|448469890|FG001|Overall Study|Ineligible, SNF|2|||
124685770|NCT04556097|448469891|FG002|Overall Study|Ineligible, SNF|0|||
124685771|NCT04556097|448469892|FG003|Overall Study|Ineligible, SNF|0|||
124685772|NCT04556097|448469889|FG000|Overall Study|Ineligible, health|3|||
124685773|NCT04556097|448469890|FG001|Overall Study|Ineligible, health|4|||
124685774|NCT04556097|448469891|FG002|Overall Study|Ineligible, health|0|||
124685775|NCT04556097|448469892|FG003|Overall Study|Ineligible, health|0|||
124685776|NCT04556097|448469889|FG000|Overall Study|Ineligible, language|0|||
124888347|NCT01734850|449215474|FG001|Overall Study|Not infused due to manufacturing failure|0|||
124888348|NCT01734850|449215475|FG002|Overall Study|Not infused due to manufacturing failure|1|||
124888349|NCT02204293|449215476|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
124888350|NCT02204293|449215477|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
124888351|NCT02204293|449215478|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
124888352|NCT02204293|449215479|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
124888353|NCT02204293|449215480|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
124888354|NCT02204293|449215481|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
124888355|NCT02204293|449215476|FG000|Core Study Part I|Adverse Event|1|||
124888356|NCT02204293|449215477|FG001|Core Study Part I|Adverse Event|0|||
124888357|NCT02204293|449215478|FG002|Core Study Part I|Adverse Event|0|||
124888358|NCT02204293|449215479|FG003|Core Study Part I|Adverse Event|0|||
124685777|NCT04556097|448469890|FG001|Overall Study|Ineligible, language|1|||
124685778|NCT04556097|448469891|FG002|Overall Study|Ineligible, language|0|||
124685779|NCT04556097|448469892|FG003|Overall Study|Ineligible, language|0|||
124685780|NCT04556097|448469889|FG000|Overall Study|Ineligible, no longer in care management|0|||
124685781|NCT04556097|448469890|FG001|Overall Study|Ineligible, no longer in care management|2|||
124685782|NCT04556097|448469891|FG002|Overall Study|Ineligible, no longer in care management|1|||
124685783|NCT04556097|448469892|FG003|Overall Study|Ineligible, no longer in care management|0|||
124685784|NCT04556097|448469889|FG000|Overall Study|No dementia|13|||
124685785|NCT04556097|448469890|FG001|Overall Study|No dementia|3|||
124685786|NCT04556097|448469891|FG002|Overall Study|No dementia|0|||
124685787|NCT04556097|448469892|FG003|Overall Study|No dementia|0|||
124685788|NCT04556097|448469889|FG000|Overall Study|Missing identifier|2|||
124685789|NCT04556097|448469890|FG001|Overall Study|Missing identifier|4|||
124685790|NCT04556097|448469891|FG002|Overall Study|Missing identifier|0|||
124888359|NCT02204293|449215480|FG004|Core Study Part I|Adverse Event|0|||
124888360|NCT02204293|449215481|FG005|Core Study Part I|Adverse Event|0|||
124888361|NCT02204293|449215476|FG000|Core Study Part I|Physician Decision|0|||
124888362|NCT02204293|449215477|FG001|Core Study Part I|Physician Decision|3|||
124888363|NCT02204293|449215478|FG002|Core Study Part I|Physician Decision|0|||
124888364|NCT02204293|449215479|FG003|Core Study Part I|Physician Decision|0|||
124685791|NCT04556097|448469892|FG003|Overall Study|Missing identifier|0|||
124712010|NCT01343888|448570707|FG000|Overall Study|Withdrawal by Subject|4|||
124888365|NCT02204293|449215480|FG004|Core Study Part I|Physician Decision|0|||
124888366|NCT02204293|449215481|FG005|Core Study Part I|Physician Decision|0|||
124888367|NCT02204293|449215476|FG000|LTE Phase|Study Suspended|0|||
124685792|NCT04556097|448469889|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
124685793|NCT04556097|448469890|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
124685794|NCT04556097|448469891|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
124685795|NCT04556097|448469892|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
124685796|NCT02516241|448469898|FG000|Overall Study|Death|255|||
124685797|NCT02516241|448469899|FG001|Overall Study|Death|262|||
124685798|NCT02516241|448469900|FG002|Overall Study|Death|270|||
124685799|NCT02516241|448469898|FG000|Overall Study|Lost to Follow-up|1|||
124685800|NCT02516241|448469899|FG001|Overall Study|Lost to Follow-up|1|||
124685801|NCT02516241|448469900|FG002|Overall Study|Lost to Follow-up|3|||
124685802|NCT02516241|448469898|FG000|Overall Study|Withdrawal by Subject|2|||
124685803|NCT02516241|448469899|FG001|Overall Study|Withdrawal by Subject|7|||
124685804|NCT02516241|448469900|FG002|Overall Study|Withdrawal by Subject|12|||
124685805|NCT02516241|448469898|FG000|Overall Study|participants ongoing at data cut-off|84|||
124685806|NCT02516241|448469899|FG001|Overall Study|participants ongoing at data cut-off|76|||
124685807|NCT02516241|448469900|FG002|Overall Study|participants ongoing at data cut-off|59|||
124685808|NCT03370276|448469901|FG000|Overall Study|Death|0|||
124685809|NCT03370276|448469902|FG001|Overall Study|Death|2|||
124685810|NCT03370276|448469903|FG002|Overall Study|Death|5|||
124685811|NCT04057365|448469904|FG000|Overall Study|Withdrawal by Subject|2|||
124685812|NCT04057365|448469905|FG001|Overall Study|Withdrawal by Subject|0|||
124685813|NCT03976375|448469906|FG000|Overall Study|Death|158|||
124685814|NCT03976375|448469907|FG001|Overall Study|Death|160|||
124685815|NCT03976375|448469908|FG002|Overall Study|Death|42|||
124685816|NCT03976375|448469906|FG000|Overall Study|Lost to Follow-up|2|||
124685817|NCT03976375|448469907|FG001|Overall Study|Lost to Follow-up|1|||
124685818|NCT03976375|448469908|FG002|Overall Study|Lost to Follow-up|1|||
124685819|NCT03976375|448469906|FG000|Overall Study|Withdrawal by Subject|5|||
124685820|NCT03976375|448469907|FG001|Overall Study|Withdrawal by Subject|9|||
124685821|NCT03976375|448469908|FG002|Overall Study|Withdrawal by Subject|4|||
124685822|NCT03976375|448469906|FG000|Overall Study|Sponsor decision|20|||
124685823|NCT03976375|448469907|FG001|Overall Study|Sponsor decision|19|||
124685824|NCT03976375|448469908|FG002|Overall Study|Sponsor decision|1|||
124685825|NCT04635423|448469909|FG000|Overall Study|Ongoing|493|||
124685826|NCT04635423|448469910|FG001|Overall Study|Ongoing|501|||
124685827|NCT04635423|448469909|FG000|Overall Study|Withdrawal by Subject|36|||
124685828|NCT04635423|448469910|FG001|Overall Study|Withdrawal by Subject|29|||
124685829|NCT03228537|448469911|FG000|Neoadjuvant|Adverse Event|2|||
124685830|NCT03228537|448469911|FG000|Neoadjuvant|Progression/Relapse|4|||
124685831|NCT03228537|448469911|FG000|Neoadjuvant|Death|1|||
124685832|NCT03228537|448469911|FG000|Surgery|Death|1|||
124685833|NCT03228537|448469911|FG000|Surgery|Other - Not Protocol Specified|2|||
124685834|NCT03228537|448469911|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
124685835|NCT03228537|448469911|FG000|Maintenance|Progression/Relapse|10|||
124685836|NCT00385840|448469912|FG000|Overall Study|Adverse Event|1|||
124685837|NCT00385840|448469913|FG001|Overall Study|Adverse Event|1|||
124685838|NCT00385840|448469912|FG000|Overall Study|Lost to Follow-up|3|||
124685839|NCT00385840|448469913|FG001|Overall Study|Lost to Follow-up|13|||
124685840|NCT00832975|448469915|FG000|Overall Study|Lost to Follow-up|7|||
124685841|NCT00832975|448469915|FG000|Overall Study|Protocol Violation|6|||
124685842|NCT00832975|448469915|FG000|Overall Study|Death|5|||
124685843|NCT00832975|448469915|FG000|Overall Study|Physician Decision|4|||
124685844|NCT00832975|448469915|FG000|Overall Study|Withdrawal by Subject|3|||
124685845|NCT00832975|448469915|FG000|Overall Study|Other reasons|14|||
124685846|NCT02112916|448469916|FG000|Overall Study|Adverse Event|6|||
124685847|NCT02112916|448469917|FG001|Overall Study|Adverse Event|9|||
124685848|NCT02112916|448469918|FG002|Overall Study|Adverse Event|3|||
124888368|NCT02204293|449215477|FG001|LTE Phase|Study Suspended|0|||
124888369|NCT02204293|449215478|FG002|LTE Phase|Study Suspended|0|||
124888370|NCT02204293|449215479|FG003|LTE Phase|Study Suspended|0|||
124888371|NCT02204293|449215480|FG004|LTE Phase|Study Suspended|0|||
124888372|NCT02204293|449215481|FG005|LTE Phase|Study Suspended|7|||
124888373|NCT01990300|449215482|FG000|Overall Study|Case Report Forms Uncollected|89|||
124888374|NCT01990300|449215482|FG000|Overall Study|Protocol Deviation|53|||
124888375|NCT02019602|449215484|FG000|Screening Period|Ineligibility|4|||
124888376|NCT02019602|449215485|FG001|Screening Period|Ineligibility|0|||
124888377|NCT02019602|449215484|FG000|Screening Period|Adverse Event|1|||
124888378|NCT02019602|449215485|FG001|Screening Period|Adverse Event|0|||
124685849|NCT02112916|448469919|FG003|Overall Study|Adverse Event|2|||
124685850|NCT02112916|448469916|FG000|Overall Study|Death|9|||
124685851|NCT02112916|448469917|FG001|Overall Study|Death|9|||
124685852|NCT02112916|448469918|FG002|Overall Study|Death|3|||
124685853|NCT02112916|448469919|FG003|Overall Study|Death|4|||
124685854|NCT02112916|448469916|FG000|Overall Study|Lost to Follow-up|1|||
124685855|NCT02112916|448469917|FG001|Overall Study|Lost to Follow-up|0|||
124685856|NCT02112916|448469918|FG002|Overall Study|Lost to Follow-up|0|||
124685857|NCT02112916|448469919|FG003|Overall Study|Lost to Follow-up|0|||
124888379|NCT00322374|449215486|FG000|Starting Dose|Physician Decision|2|||
124888380|NCT00322374|449215487|FG001|Starting Dose|Physician Decision|0|||
124888381|NCT00322374|449215488|FG002|Starting Dose|Physician Decision|0|||
124888382|NCT00322374|449215489|FG003|Starting Dose|Physician Decision|0|||
124888383|NCT00322374|449215486|FG000|Starting Dose|Study Drug Toxicity|4|||
124888384|NCT00322374|449215487|FG001|Starting Dose|Study Drug Toxicity|0|||
124888385|NCT00322374|449215488|FG002|Starting Dose|Study Drug Toxicity|0|||
124888386|NCT00322374|449215489|FG003|Starting Dose|Study Drug Toxicity|0|||
124888387|NCT00322374|449215486|FG000|First Escalation|Documented Disease Progression|0|||
124888388|NCT00322374|449215487|FG001|First Escalation|Documented Disease Progression|6|||
124888389|NCT00322374|449215488|FG002|First Escalation|Documented Disease Progression|0|||
124888390|NCT00322374|449215489|FG003|First Escalation|Documented Disease Progression|0|||
124888391|NCT00322374|449215486|FG000|First Escalation|Physician Decision|0|||
124888392|NCT00322374|449215487|FG001|First Escalation|Physician Decision|12|||
124888393|NCT00322374|449215488|FG002|First Escalation|Physician Decision|0|||
124888394|NCT00322374|449215489|FG003|First Escalation|Physician Decision|0|||
124888395|NCT00322374|449215486|FG000|First Escalation|Study Drug Toxicity|0|||
124888396|NCT00322374|449215487|FG001|First Escalation|Study Drug Toxicity|11|||
124440250|NCT00427895|447570954|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
124759017|NCT01521507|448741229|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
124759018|NCT01521507|448741228|FG000|Stage 2: Observational Design|Physician Decision|1|||
124759019|NCT01521507|448741229|FG001|Stage 2: Observational Design|Physician Decision|0|||
124685858|NCT02112916|448469916|FG000|Overall Study|Physician Decision|94|||
124685859|NCT02112916|448469917|FG001|Overall Study|Physician Decision|72|||
124685860|NCT02112916|448469918|FG002|Overall Study|Physician Decision|24|||
124685861|NCT02112916|448469919|FG003|Overall Study|Physician Decision|15|||
124685862|NCT02112916|448469916|FG000|Overall Study|Withdrawal by Subject|5|||
124685863|NCT02112916|448469917|FG001|Overall Study|Withdrawal by Subject|3|||
124685864|NCT02112916|448469918|FG002|Overall Study|Withdrawal by Subject|1|||
124685865|NCT02112916|448469919|FG003|Overall Study|Withdrawal by Subject|1|||
124685866|NCT02112916|448469916|FG000|Overall Study|Ineligible|4|||
124685867|NCT02112916|448469917|FG001|Overall Study|Ineligible|8|||
124685868|NCT02112916|448469918|FG002|Overall Study|Ineligible|3|||
124685869|NCT02112916|448469919|FG003|Overall Study|Ineligible|8|||
124685870|NCT02112916|448469916|FG000|Overall Study|Inevaluable|6|||
124685871|NCT02112916|448469917|FG001|Overall Study|Inevaluable|4|||
124685872|NCT02112916|448469918|FG002|Overall Study|Inevaluable|5|||
124685873|NCT02112916|448469919|FG003|Overall Study|Inevaluable|5|||
124888397|NCT00322374|449215488|FG002|First Escalation|Study Drug Toxicity|0|||
124888398|NCT00322374|449215489|FG003|First Escalation|Study Drug Toxicity|0|||
124888399|NCT00322374|449215486|FG000|First Escalation|Participant Request|0|||
124888400|NCT00322374|449215487|FG001|First Escalation|Participant Request|1|||
124685874|NCT02112916|448469916|FG000|Overall Study|Refusal of further protocol therapy|19|||
124685875|NCT02112916|448469917|FG001|Overall Study|Refusal of further protocol therapy|16|||
124685876|NCT02112916|448469918|FG002|Overall Study|Refusal of further protocol therapy|1|||
124685877|NCT02112916|448469919|FG003|Overall Study|Refusal of further protocol therapy|7|||
124685878|NCT02112916|448469916|FG000|Overall Study|Development of SMN|1|||
124685879|NCT02112916|448469917|FG001|Overall Study|Development of SMN|0|||
124685880|NCT02112916|448469918|FG002|Overall Study|Development of SMN|0|||
124685881|NCT02112916|448469919|FG003|Overall Study|Development of SMN|1|||
124685882|NCT02112916|448469916|FG000|Overall Study|Relapse/Progression|10|||
124685883|NCT02112916|448469917|FG001|Overall Study|Relapse/Progression|18|||
124685884|NCT02112916|448469918|FG002|Overall Study|Relapse/Progression|15|||
124685885|NCT02112916|448469919|FG003|Overall Study|Relapse/Progression|2|||
124685886|NCT02112916|448469916|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
124685887|NCT02112916|448469917|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
124685888|NCT02112916|448469918|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
124685889|NCT02112916|448469919|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
124685890|NCT02112916|448469916|FG000|Overall Study|Still on Therapy|44|||
124685891|NCT02112916|448469917|FG001|Overall Study|Still on Therapy|47|||
124685892|NCT02112916|448469918|FG002|Overall Study|Still on Therapy|3|||
124685893|NCT02112916|448469919|FG003|Overall Study|Still on Therapy|2|||
124685894|NCT02112916|448469916|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
124685895|NCT02112916|448469917|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
124685896|NCT02112916|448469918|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
124685897|NCT02112916|448469919|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
124685898|NCT02112916|448469916|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
124685899|NCT02112916|448469917|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
124685900|NCT02112916|448469918|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
124685901|NCT02112916|448469919|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
124685902|NCT05032196|448469920|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
124685903|NCT05032196|448469921|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
124685904|NCT05032196|448469922|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
124685905|NCT05032196|448469923|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
124685906|NCT05032196|448469924|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
124685907|NCT05032196|448469925|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
124685908|NCT05032196|448469920|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
124685909|NCT05032196|448469921|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
124685910|NCT05032196|448469922|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
124685911|NCT05032196|448469923|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
124685912|NCT05032196|448469924|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
124685913|NCT05032196|448469925|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
124888401|NCT00322374|449215488|FG002|First Escalation|Participant Request|0|||
124888402|NCT00322374|449215489|FG003|First Escalation|Participant Request|0|||
124685914|NCT05032196|448469920|FG000|Period 2 (Multidose)|Physician Decision|0|||
124685915|NCT05032196|448469921|FG001|Period 2 (Multidose)|Physician Decision|0|||
124685916|NCT05032196|448469922|FG002|Period 2 (Multidose)|Physician Decision|0|||
124685917|NCT05032196|448469923|FG003|Period 2 (Multidose)|Physician Decision|0|||
124685918|NCT05032196|448469924|FG004|Period 2 (Multidose)|Physician Decision|1|||
124685919|NCT05032196|448469925|FG005|Period 2 (Multidose)|Physician Decision|0|||
124685920|NCT05260008|448469926|FG000|Overall Study|Physician Decision|0|||
124685921|NCT05260008|448469927|FG001|Overall Study|Physician Decision|1|||
124888403|NCT00322374|449215486|FG000|Second Escalation|Physician Decision|0|||
124685922|NCT05260008|448469928|FG002|Overall Study|Physician Decision|0|||
124888404|NCT00322374|449215487|FG001|Second Escalation|Physician Decision|0|||
124888405|NCT00322374|449215488|FG002|Second Escalation|Physician Decision|5|||
124888406|NCT00322374|449215489|FG003|Second Escalation|Physician Decision|0|||
124888407|NCT00322374|449215486|FG000|Second Escalation|Study Drug Toxicity|0|||
124888408|NCT00322374|449215487|FG001|Second Escalation|Study Drug Toxicity|0|||
124888409|NCT00322374|449215488|FG002|Second Escalation|Study Drug Toxicity|1|||
124888410|NCT00322374|449215489|FG003|Second Escalation|Study Drug Toxicity|0|||
124888411|NCT02397460|449215492|FG000|Treatment Period 2|Adverse Event|0|||
124685923|NCT05260008|448469929|FG003|Overall Study|Physician Decision|0|||
124685924|NCT05977868|448471141|FG000|Overall Study|Withdrawal by Subject|1|||
124685925|NCT05977868|448471142|FG001|Overall Study|Withdrawal by Subject|2|||
124685926|NCT05977868|448471141|FG000|Overall Study|Transitioned to comfort care|1|||
124685927|NCT05977868|448471142|FG001|Overall Study|Transitioned to comfort care|0|||
124685928|NCT03575364|448471149|FG000|Overall Study|Death|45|||
124685929|NCT03575364|448471149|FG000|Overall Study|Lost to Follow-up|114|||
124685930|NCT03575364|448471149|FG000|Overall Study|Withdrawal by Subject|21|||
124685931|NCT03575364|448471149|FG000|Overall Study|Physician Decision|11|||
124685932|NCT03575364|448471149|FG000|Overall Study|Subject Refused Follow-up|13|||
124685933|NCT03575364|448471149|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
124685934|NCT03575364|448471149|FG000|Overall Study|Patient moved out of the state|1|||
124685935|NCT03575364|448471149|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
124685936|NCT03575364|448471149|FG000|Overall Study|Patient is lost to follow up|1|||
124685937|NCT03575364|448471149|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
124685938|NCT05696847|448471154|FG000|Overall Study|Withdrawal by Subject|1|||
124685939|NCT05696847|448471155|FG001|Overall Study|Withdrawal by Subject|0|||
124685940|NCT05696847|448471156|FG002|Overall Study|Withdrawal by Subject|0|||
124685941|NCT05696847|448471157|FG003|Overall Study|Withdrawal by Subject|0|||
124685942|NCT05696847|448471158|FG004|Overall Study|Withdrawal by Subject|0|||
124685943|NCT05696847|448471159|FG005|Overall Study|Withdrawal by Subject|0|||
124685944|NCT05696847|448471154|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124685945|NCT05696847|448471155|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
124685946|NCT05696847|448471156|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
124685947|NCT05696847|448471157|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
124440251|NCT00427895|447570955|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
124685948|NCT05696847|448471158|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
124685949|NCT05696847|448471159|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
124685950|NCT05696847|448471154|FG000|Overall Study|Adverse Event|0|||
124685951|NCT05696847|448471155|FG001|Overall Study|Adverse Event|0|||
124685952|NCT05696847|448471156|FG002|Overall Study|Adverse Event|0|||
124685953|NCT05696847|448471157|FG003|Overall Study|Adverse Event|0|||
124685954|NCT05696847|448471158|FG004|Overall Study|Adverse Event|0|||
124759020|NCT01479868|448741230|FG000|Overall Study|Adverse Event|1|||
124440252|NCT00427895|447570956|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
124440253|NCT00427895|447570957|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
124440254|NCT00427895|447570950|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
124440255|NCT00427895|447570951|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
124440256|NCT00427895|447570952|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
124440257|NCT00427895|447570953|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
124440258|NCT00427895|447570954|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
124440259|NCT00427895|447570955|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
124440260|NCT00427895|447570956|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
124440261|NCT00427895|447570957|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
124440262|NCT00427895|447570950|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
124440263|NCT00427895|447570951|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
124440264|NCT00427895|447570952|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
124440265|NCT00427895|447570953|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
124440266|NCT00427895|447570954|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
124440267|NCT00427895|447570955|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
124440268|NCT00427895|447570956|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
124440269|NCT00427895|447570957|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
124440270|NCT00427895|447570950|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
124440271|NCT00427895|447570951|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
124440272|NCT00427895|447570952|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
124440273|NCT00427895|447570953|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
124440274|NCT00427895|447570954|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
124440275|NCT00427895|447570955|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
124440276|NCT00427895|447570956|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
124440277|NCT00427895|447570957|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
124440278|NCT00427895|447570950|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
124440279|NCT00427895|447570951|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
124440280|NCT00427895|447570952|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
124440281|NCT00427895|447570953|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
124440282|NCT00427895|447570954|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
124440283|NCT00427895|447570955|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
124440284|NCT00427895|447570956|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
124440285|NCT00427895|447570957|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
124440286|NCT00427895|447570950|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
124440287|NCT00427895|447570951|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
124440288|NCT00427895|447570952|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
124440289|NCT00427895|447570953|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
124440290|NCT00427895|447570954|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
124440291|NCT00427895|447570955|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
124440292|NCT00427895|447570956|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
124440293|NCT00427895|447570957|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
124440294|NCT00427895|447570950|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
124440295|NCT00427895|447570951|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
124440296|NCT00427895|447570952|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
124440297|NCT00427895|447570953|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
124440298|NCT00427895|447570954|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
124440299|NCT00427895|447570955|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
124440300|NCT00427895|447570956|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
124440301|NCT00427895|447570957|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
124440302|NCT00427895|447570950|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
124440303|NCT00427895|447570951|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
124440304|NCT00427895|447570952|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
124440305|NCT00427895|447570953|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
124440306|NCT00427895|447570954|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
124440307|NCT00427895|447570955|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
124440308|NCT00427895|447570956|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
124440309|NCT00427895|447570957|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
124440310|NCT00427895|447570950|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
124440311|NCT00427895|447570951|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
124440312|NCT00427895|447570952|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
124440313|NCT00427895|447570953|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
124440314|NCT00427895|447570954|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
124440315|NCT00427895|447570955|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
124440316|NCT00427895|447570956|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
124440317|NCT00427895|447570957|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
124440318|NCT00427895|447570950|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
124440319|NCT00427895|447570951|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
124440320|NCT00427895|447570952|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
124440321|NCT00427895|447570953|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
124888412|NCT02397460|449215493|FG001|Treatment Period 2|Adverse Event|0|||
124888413|NCT02397460|449215494|FG002|Treatment Period 2|Adverse Event|0|||
124888414|NCT02397460|449215495|FG003|Treatment Period 2|Adverse Event|0|||
124888415|NCT02397460|449215496|FG004|Treatment Period 2|Adverse Event|0|||
124440322|NCT00427895|447570954|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
124440323|NCT00427895|447570955|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
124440324|NCT00427895|447570956|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
124440325|NCT00427895|447570957|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
124440326|NCT00427895|447570950|FG000|Vax 1/Year 1 Follow-up|Death|1|||
124440327|NCT00427895|447570951|FG001|Vax 1/Year 1 Follow-up|Death|0|||
124440328|NCT00427895|447570952|FG002|Vax 1/Year 1 Follow-up|Death|0|||
124440329|NCT00427895|447570953|FG003|Vax 1/Year 1 Follow-up|Death|0|||
124440330|NCT00427895|447570954|FG004|Vax 1/Year 1 Follow-up|Death|0|||
124440331|NCT00427895|447570955|FG005|Vax 1/Year 1 Follow-up|Death|0|||
124440332|NCT00427895|447570956|FG006|Vax 1/Year 1 Follow-up|Death|0|||
124440333|NCT00427895|447570957|FG007|Vax 1/Year 1 Follow-up|Death|0|||
124440334|NCT00427895|447570950|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
124440335|NCT00427895|447570951|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
124440336|NCT00427895|447570952|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
124440337|NCT00427895|447570953|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
124440338|NCT00427895|447570954|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
124440339|NCT00427895|447570955|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
124440340|NCT00427895|447570956|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
124440341|NCT00427895|447570957|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
124440342|NCT00427895|447570950|FG000|Vax 1/Year 1 Follow-up|Other|0|||
124440343|NCT00427895|447570951|FG001|Vax 1/Year 1 Follow-up|Other|0|||
124440344|NCT00427895|447570952|FG002|Vax 1/Year 1 Follow-up|Other|0|||
124440345|NCT00427895|447570953|FG003|Vax 1/Year 1 Follow-up|Other|2|||
124440346|NCT00427895|447570954|FG004|Vax 1/Year 1 Follow-up|Other|0|||
124440347|NCT00427895|447570955|FG005|Vax 1/Year 1 Follow-up|Other|0|||
124440348|NCT00427895|447570956|FG006|Vax 1/Year 1 Follow-up|Other|0|||
124440349|NCT00427895|447570957|FG007|Vax 1/Year 1 Follow-up|Other|0|||
124440350|NCT00427895|447570950|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
124440351|NCT00427895|447570951|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
124440352|NCT00427895|447570952|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
124440353|NCT00427895|447570953|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
124440354|NCT00427895|447570954|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
124440355|NCT00427895|447570955|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
124440356|NCT00427895|447570956|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
124440357|NCT00427895|447570957|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
124440358|NCT00723021|447570960|FG000|Intervention Period 4|Adverse Event|0|||
124440359|NCT00723021|447570961|FG001|Intervention Period 4|Adverse Event|0|||
124440360|NCT00723021|447570962|FG002|Intervention Period 4|Adverse Event|0|||
124440361|NCT00723021|447570963|FG003|Intervention Period 4|Adverse Event|0|||
124440362|NCT00723021|447570964|FG004|Intervention Period 4|Adverse Event|1|||
124440363|NCT00770341|447570965|FG000|Overall Study|Did not meet eligibility criteria|1|||
124440364|NCT00770341|447570966|FG001|Overall Study|Did not meet eligibility criteria|0|||
124440365|NCT00770341|447570967|FG002|Overall Study|Did not meet eligibility criteria|0|||
124440366|NCT00770341|447570965|FG000|Overall Study|Withdrawal by Subject|0|||
124440367|NCT00770341|447570966|FG001|Overall Study|Withdrawal by Subject|1|||
124440368|NCT00770341|447570967|FG002|Overall Study|Withdrawal by Subject|0|||
124440369|NCT00770341|447570965|FG000|Overall Study|Clinical Adverse Event|3|||
124440370|NCT00770341|447570966|FG001|Overall Study|Clinical Adverse Event|1|||
124440371|NCT00770341|447570967|FG002|Overall Study|Clinical Adverse Event|2|||
124440372|NCT00770341|447570965|FG000|Overall Study|Laboratory adverse event|3|||
124440373|NCT00770341|447570966|FG001|Overall Study|Laboratory adverse event|3|||
124440374|NCT00770341|447570967|FG002|Overall Study|Laboratory adverse event|0|||
124440375|NCT00770341|447570965|FG000|Overall Study|Lack of Efficacy|3|||
124440376|NCT00770341|447570966|FG001|Overall Study|Lack of Efficacy|0|||
124440377|NCT00770341|447570967|FG002|Overall Study|Lack of Efficacy|1|||
124440378|NCT00770341|447570965|FG000|Overall Study|Other|1|||
124440379|NCT00770341|447570966|FG001|Overall Study|Other|0|||
124440380|NCT00770341|447570967|FG002|Overall Study|Other|0|||
124440381|NCT00770341|447570965|FG000|Overall Study|Not treated|1|||
124440382|NCT00770341|447570966|FG001|Overall Study|Not treated|0|||
124440383|NCT00770341|447570967|FG002|Overall Study|Not treated|0|||
124440384|NCT01163916|447570968|FG000|Overall Study|Withdrawal by Subject|2|||
124440385|NCT01163916|447570969|FG001|Overall Study|Withdrawal by Subject|0|||
124888416|NCT02397460|449215497|FG005|Treatment Period 2|Adverse Event|0|||
124440386|NCT01163916|447570970|FG002|Overall Study|Withdrawal by Subject|2|||
124888417|NCT02397460|449215498|FG006|Treatment Period 2|Adverse Event|0|||
124440387|NCT01163916|447570968|FG000|Overall Study|Adverse Event|2|||
124440388|NCT01163916|447570969|FG001|Overall Study|Adverse Event|0|||
124440389|NCT01163916|447570970|FG002|Overall Study|Adverse Event|1|||
124888418|NCT02397460|449215499|FG007|Treatment Period 2|Adverse Event|1|||
124888419|NCT02397460|449215492|FG000|Treatment Period 4|Adverse Event|0|||
124888420|NCT02397460|449215493|FG001|Treatment Period 4|Adverse Event|1|||
124685955|NCT05696847|448471159|FG005|Overall Study|Adverse Event|1|||
124685956|NCT05696847|448471154|FG000|Overall Study|Sponsor Decision|0|||
124685957|NCT05696847|448471155|FG001|Overall Study|Sponsor Decision|0|||
124685958|NCT05696847|448471156|FG002|Overall Study|Sponsor Decision|0|||
124685959|NCT05696847|448471157|FG003|Overall Study|Sponsor Decision|1|||
124888421|NCT02397460|449215494|FG002|Treatment Period 4|Adverse Event|0|||
124888422|NCT02397460|449215495|FG003|Treatment Period 4|Adverse Event|0|||
124888423|NCT02397460|449215496|FG004|Treatment Period 4|Adverse Event|0|||
124888424|NCT02397460|449215497|FG005|Treatment Period 4|Adverse Event|0|||
124888425|NCT02397460|449215498|FG006|Treatment Period 4|Adverse Event|0|||
124888426|NCT02397460|449215499|FG007|Treatment Period 4|Adverse Event|0|||
124888427|NCT02397460|449215492|FG000|Treatment Period 4|Physician Decision|0|||
124888428|NCT02397460|449215493|FG001|Treatment Period 4|Physician Decision|0|||
124888429|NCT02397460|449215494|FG002|Treatment Period 4|Physician Decision|0|||
124888430|NCT02397460|449215495|FG003|Treatment Period 4|Physician Decision|0|||
124888431|NCT02397460|449215496|FG004|Treatment Period 4|Physician Decision|1|||
124888432|NCT02397460|449215497|FG005|Treatment Period 4|Physician Decision|0|||
124888433|NCT02397460|449215498|FG006|Treatment Period 4|Physician Decision|0|||
124888434|NCT02397460|449215499|FG007|Treatment Period 4|Physician Decision|0|||
124888435|NCT02213055|449215500|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
124685960|NCT05696847|448471158|FG004|Overall Study|Sponsor Decision|0|||
124685961|NCT05696847|448471159|FG005|Overall Study|Sponsor Decision|0|||
124685962|NCT03323502|448471160|FG000|Overall Study|Resident could not be linked to CMS data|594|||
124685963|NCT03323502|448471161|FG001|Overall Study|Resident could not be linked to CMS data|435|||
124685964|NCT03323502|448471160|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
124685965|NCT03323502|448471161|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
124685966|NCT03323502|448471160|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
124685967|NCT03323502|448471161|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
124685968|NCT03323502|448471160|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
124685969|NCT03323502|448471161|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
124685970|NCT03323502|448471160|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
124685971|NCT03323502|448471161|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
124685972|NCT04092777|448471162|FG000|Overall Study|Lost to Follow-up|28|||
124685973|NCT04092777|448471163|FG001|Overall Study|Lost to Follow-up|46|||
124759021|NCT01479868|448741230|FG000|Overall Study|Lost to Follow-up|4|||
124759022|NCT01479868|448741230|FG000|Overall Study|Protocol Violation|1|||
124888436|NCT02213055|449215501|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
124888437|NCT02213055|449215500|FG000|Overall Study|Protocol was not Followed during Study|1|||
124888438|NCT02213055|449215501|FG001|Overall Study|Protocol was not Followed during Study|0|||
124888439|NCT02213055|449215500|FG000|Overall Study|Documentation Issue at Enrollment|1|||
124888440|NCT02213055|449215501|FG001|Overall Study|Documentation Issue at Enrollment|0|||
124888441|NCT02213055|449215500|FG000|Overall Study|Documentation Issue during Study|10|||
124888442|NCT02213055|449215501|FG001|Overall Study|Documentation Issue during Study|0|||
124685974|NCT04092777|448471162|FG000|Overall Study|Withdrawal by Subject|8|||
124759023|NCT01479868|448741230|FG000|Overall Study|Withdrawal by Subject|1|||
124440390|NCT01163916|447570968|FG000|Overall Study|Lack of Efficacy|2|||
124759024|NCT01479868|448741230|FG000|Overall Study|Sponsor's Decision|1|||
124759025|NCT01479868|448741230|FG000|Overall Study|Initiation of new HCV Therapy|1|||
124759026|NCT01292187|448741231|FG000|Overall Study|Adverse Event|10|||
124759027|NCT01292187|448741232|FG001|Overall Study|Adverse Event|5|||
124759028|NCT01292187|448741231|FG000|Overall Study|Withdrawal by Subject|6|||
124759029|NCT01292187|448741232|FG001|Overall Study|Withdrawal by Subject|5|||
124759030|NCT01292187|448741231|FG000|Overall Study|All other reasons|1|||
124759031|NCT01292187|448741232|FG001|Overall Study|All other reasons|3|||
124888443|NCT02213055|449215500|FG000|Overall Study|Did not have Live Lice|8|||
124888444|NCT02213055|449215501|FG001|Overall Study|Did not have Live Lice|0|||
124759032|NCT00113841|448741234|FG000|Overall Study|Disease progression|0|||
124888445|NCT02213055|449215500|FG000|Overall Study|Had another Treatment during the Study|3|||
124888446|NCT02213055|449215501|FG001|Overall Study|Had another Treatment during the Study|0|||
124888447|NCT02213055|449215500|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
124888448|NCT02213055|449215501|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
124888449|NCT02213055|449215500|FG000|Overall Study|Did not Return to School|5|||
124888450|NCT02213055|449215501|FG001|Overall Study|Did not Return to School|0|||
124888451|NCT01024751|449215502|FG000|Enrolled Participants|Ineligible at baseline|3|||
124888452|NCT01024751|449215503|FG001|Enrolled Participants|Ineligible at baseline|4|||
124888453|NCT01024751|449215502|FG000|Eligible Participants|Withdrawal by Subject|0|||
124888454|NCT01024751|449215503|FG001|Eligible Participants|Withdrawal by Subject|1|||
124888455|NCT01024751|449215502|FG000|Eligible Participants|Lost to Follow-up|0|||
124888456|NCT01024751|449215503|FG001|Eligible Participants|Lost to Follow-up|1|||
124888457|NCT01024751|449215502|FG000|Eligible Participants|Ineligible|0|||
124888458|NCT01024751|449215503|FG001|Eligible Participants|Ineligible|1|||
124888459|NCT01141660|449215504|FG000|Overall Study|Physician Decision|0|||
124888460|NCT01141660|449215505|FG001|Overall Study|Physician Decision|12|||
124888461|NCT01848834|449215506|FG000|Overall Study|Adverse Event|3|||
124888462|NCT01848834|449215507|FG001|Overall Study|Adverse Event|11|||
124888463|NCT01848834|449215508|FG002|Overall Study|Adverse Event|3|||
124888464|NCT01848834|449215509|FG003|Overall Study|Adverse Event|5|||
124888465|NCT01848834|449215510|FG004|Overall Study|Adverse Event|9|||
124888466|NCT01848834|449215506|FG000|Overall Study|Death|2|||
124888467|NCT01848834|449215507|FG001|Overall Study|Death|11|||
124888468|NCT01848834|449215508|FG002|Overall Study|Death|1|||
124888469|NCT01848834|449215509|FG003|Overall Study|Death|8|||
124888470|NCT01848834|449215510|FG004|Overall Study|Death|27|||
124888471|NCT01848834|449215506|FG000|Overall Study|Excluded Medication|5|||
124888472|NCT01848834|449215507|FG001|Overall Study|Excluded Medication|4|||
124888473|NCT01848834|449215508|FG002|Overall Study|Excluded Medication|3|||
124888474|NCT01848834|449215509|FG003|Overall Study|Excluded Medication|6|||
124759033|NCT00113841|448741235|FG001|Overall Study|Disease progression|2|||
124888475|NCT01848834|449215510|FG004|Overall Study|Excluded Medication|6|||
124888476|NCT01848834|449215506|FG000|Overall Study|Lost to Follow-up|5|||
124759034|NCT00113841|448741234|FG000|Overall Study|Non-compliant|1|||
124888477|NCT01848834|449215507|FG001|Overall Study|Lost to Follow-up|5|||
124888478|NCT01848834|449215508|FG002|Overall Study|Lost to Follow-up|3|||
124888479|NCT01848834|449215509|FG003|Overall Study|Lost to Follow-up|0|||
124888480|NCT01848834|449215510|FG004|Overall Study|Lost to Follow-up|3|||
124888481|NCT01848834|449215506|FG000|Overall Study|Physician Decision|1|||
124888482|NCT01848834|449215507|FG001|Overall Study|Physician Decision|3|||
124888483|NCT01848834|449215508|FG002|Overall Study|Physician Decision|4|||
124888484|NCT01848834|449215509|FG003|Overall Study|Physician Decision|0|||
124759035|NCT00113841|448741235|FG001|Overall Study|Non-compliant|0|||
124888485|NCT01848834|449215510|FG004|Overall Study|Physician Decision|11|||
124888486|NCT01848834|449215506|FG000|Overall Study|Protocol Violation|0|||
124888487|NCT01848834|449215507|FG001|Overall Study|Protocol Violation|0|||
124888488|NCT01848834|449215508|FG002|Overall Study|Protocol Violation|0|||
124888489|NCT01848834|449215509|FG003|Overall Study|Protocol Violation|0|||
124888490|NCT01848834|449215510|FG004|Overall Study|Protocol Violation|1|||
124440391|NCT01163916|447570969|FG001|Overall Study|Lack of Efficacy|0|||
124440392|NCT01163916|447570970|FG002|Overall Study|Lack of Efficacy|1|||
124440393|NCT01163916|447570968|FG000|Overall Study|Other|24|||
124440394|NCT01163916|447570969|FG001|Overall Study|Other|4|||
124440395|NCT01163916|447570970|FG002|Overall Study|Other|16|||
124440396|NCT00883051|447570971|FG000|Overall Study|Lost to Follow-up|0|||
124440397|NCT00883051|447570972|FG001|Overall Study|Lost to Follow-up|0|||
124440398|NCT00883051|447570973|FG002|Overall Study|Lost to Follow-up|0|||
124440399|NCT00883051|447570974|FG003|Overall Study|Lost to Follow-up|0|||
124440400|NCT00883051|447570975|FG004|Overall Study|Lost to Follow-up|1|||
124440401|NCT00883051|447570971|FG000|Overall Study|Did not use study medication|24|||
124440402|NCT00883051|447570972|FG001|Overall Study|Did not use study medication|22|||
124440403|NCT00883051|447570973|FG002|Overall Study|Did not use study medication|29|||
124440404|NCT00883051|447570974|FG003|Overall Study|Did not use study medication|29|||
124440405|NCT00883051|447570975|FG004|Overall Study|Did not use study medication|17|||
124440406|NCT02337751|447570976|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
124440407|NCT02337751|447570977|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
124440408|NCT02337751|447570976|FG000|Overall Study|Voluntary Withdrawal|6|||
124440409|NCT02337751|447570977|FG001|Overall Study|Voluntary Withdrawal|8|||
124440410|NCT02337751|447570976|FG000|Overall Study|Lack of Efficacy|2|||
124440411|NCT02337751|447570977|FG001|Overall Study|Lack of Efficacy|5|||
124440412|NCT02337751|447570976|FG000|Overall Study|Investigator's Judgement|1|||
124440413|NCT02337751|447570977|FG001|Overall Study|Investigator's Judgement|0|||
124440414|NCT01328717|447573101|FG000|Overall Study|Adverse Event|1|||
124440415|NCT03440320|447573102|FG000|Overall Study|Withdrawal by Subject|0|||
124440416|NCT03440320|447573103|FG001|Overall Study|Withdrawal by Subject|1|||
124440417|NCT01620255|447573106|FG000|Overall Study|Withdrawal by Subject|4|||
124440418|NCT01620255|447573107|FG001|Overall Study|Withdrawal by Subject|1|||
124440419|NCT01620255|447573108|FG002|Overall Study|Withdrawal by Subject|1|||
124440420|NCT01620255|447573109|FG003|Overall Study|Withdrawal by Subject|2|||
124440421|NCT01620255|447573110|FG004|Overall Study|Withdrawal by Subject|4|||
124440422|NCT01620255|447573106|FG000|Overall Study|Participant underwent fecal transplant|0|||
124440423|NCT01620255|447573107|FG001|Overall Study|Participant underwent fecal transplant|0|||
124440424|NCT01620255|447573108|FG002|Overall Study|Participant underwent fecal transplant|1|||
124440425|NCT01620255|447573109|FG003|Overall Study|Participant underwent fecal transplant|0|||
124440426|NCT01620255|447573110|FG004|Overall Study|Participant underwent fecal transplant|0|||
124440427|NCT01620255|447573106|FG000|Overall Study|Non-compliance|0|||
124440428|NCT01620255|447573107|FG001|Overall Study|Non-compliance|1|||
124685975|NCT04092777|448471163|FG001|Overall Study|Withdrawal by Subject|5|||
124685976|NCT02306161|448471164|FG000|Overall Study|Death|1|||
124685977|NCT02306161|448471165|FG001|Overall Study|Death|3|||
124685978|NCT02306161|448471164|FG000|Overall Study|Lack of Efficacy|20|||
124685979|NCT02306161|448471165|FG001|Overall Study|Lack of Efficacy|43|||
124685980|NCT02306161|448471164|FG000|Overall Study|Physician Decision|30|||
124685981|NCT02306161|448471165|FG001|Overall Study|Physician Decision|18|||
124685982|NCT02306161|448471164|FG000|Overall Study|Withdrawal by Subject|4|||
124685983|NCT02306161|448471165|FG001|Overall Study|Withdrawal by Subject|0|||
124685984|NCT02306161|448471164|FG000|Overall Study|Ineligible|9|||
124685985|NCT02306161|448471165|FG001|Overall Study|Ineligible|5|||
124685986|NCT01081951|448471166|FG000|Overall Study|Death|54|||
124685987|NCT01081951|448471167|FG001|Overall Study|Death|47|||
124685988|NCT01081951|448471166|FG000|Overall Study|Withdrawal by Subject|2|||
124685989|NCT01081951|448471167|FG001|Overall Study|Withdrawal by Subject|6|||
124685990|NCT01081951|448471166|FG000|Overall Study|Allocated treatment but did not take it|0|||
124685991|NCT01081951|448471167|FG001|Overall Study|Allocated treatment but did not take it|1|||
124685992|NCT01081951|448471166|FG000|Overall Study|Lost to Follow-up|0|||
124685993|NCT01081951|448471167|FG001|Overall Study|Lost to Follow-up|1|||
124685994|NCT00975923|448471173|FG000|Overall Study|Withdrawal by Subject|0|||
124440429|NCT01620255|447573108|FG002|Overall Study|Non-compliance|0|||
124440430|NCT01620255|447573109|FG003|Overall Study|Non-compliance|0|||
124685995|NCT00975923|448471174|FG001|Overall Study|Withdrawal by Subject|1|||
124685996|NCT05291689|448471177|FG000|Overall Study|Adverse Event|3|||
124685997|NCT05291689|448471177|FG000|Overall Study|Lack of Efficacy|10|||
124685998|NCT05291689|448471177|FG000|Overall Study|Withdrawal by Subject|4|||
124685999|NCT02278354|448471178|FG000|Overall Study|Lost to Follow-up|2|||
124686000|NCT02278354|448471179|FG001|Overall Study|Lost to Follow-up|2|||
124686001|NCT02278354|448471178|FG000|Overall Study|Withdrawal by Subject|0|||
124686002|NCT02278354|448471179|FG001|Overall Study|Withdrawal by Subject|1|||
124686003|NCT02278354|448471178|FG000|Overall Study|<10 professional fights|2|||
124686004|NCT02278354|448471179|FG001|Overall Study|<10 professional fights|0|||
124888491|NCT01848834|449215506|FG000|Overall Study|Sponsor Decision|1|||
124686005|NCT01901562|448471181|FG000|Overall Study|Protocol Violation|5|||
124440431|NCT01620255|447573110|FG004|Overall Study|Non-compliance|0|||
124440432|NCT01620255|447573106|FG000|Overall Study|Adverse Event|0|||
124440433|NCT01620255|447573107|FG001|Overall Study|Adverse Event|4|||
124440434|NCT01620255|447573108|FG002|Overall Study|Adverse Event|0|||
124440435|NCT01620255|447573109|FG003|Overall Study|Adverse Event|1|||
124440436|NCT01620255|447573110|FG004|Overall Study|Adverse Event|1|||
124440437|NCT01620255|447573106|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
124440438|NCT01620255|447573107|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
124440439|NCT01620255|447573108|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
124440440|NCT01620255|447573109|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
124440441|NCT01620255|447573110|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
124440442|NCT01155375|447573118|FG000|Overall Study|Adverse Event|1|||
124440443|NCT01155375|447573119|FG001|Overall Study|Adverse Event|0|||
124440444|NCT01933113|447573120|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
124440445|NCT04981366|447573121|FG000|Overall Study|Withdrawal by Subject|5|||
124440446|NCT04981366|447573122|FG001|Overall Study|Withdrawal by Subject|4|||
124440447|NCT04981366|447573123|FG002|Overall Study|Withdrawal by Subject|8|||
124440448|NCT04981366|447573121|FG000|Overall Study|Health issues unrelated to the trial|1|||
124440449|NCT04981366|447573122|FG001|Overall Study|Health issues unrelated to the trial|2|||
124440450|NCT04981366|447573123|FG002|Overall Study|Health issues unrelated to the trial|0|||
124440451|NCT00795951|447573124|FG000|Overall Study|Lost to Follow-up|1|||
124440452|NCT00795951|447573124|FG000|Overall Study|Withdrawal by Subject|1|||
124440453|NCT01122862|447573136|FG000|Period 1|Protocol Violation|0|||
124440454|NCT01122862|447573137|FG001|Period 1|Protocol Violation|1|||
124440455|NCT01122862|447573138|FG002|Period 1|Protocol Violation|0|||
124440456|NCT01122862|447573136|FG000|Period 2|Adverse Event|0|||
124440457|NCT01122862|447573137|FG001|Period 2|Adverse Event|0|||
124440458|NCT01122862|447573138|FG002|Period 2|Adverse Event|1|||
124440459|NCT02699983|447573141|FG000|Overall Study|Withdrawal by Subject|1|||
124440460|NCT02699983|447573142|FG001|Overall Study|Withdrawal by Subject|0|||
124440461|NCT01790126|447573143|FG000|Overall Study|PSA Progression|12|||
124440462|NCT01790126|447573144|FG001|Overall Study|PSA Progression|16|||
124440463|NCT01790126|447573145|FG002|Overall Study|PSA Progression|16|||
124440464|NCT01790126|447573143|FG000|Overall Study|Other|5|||
124440465|NCT01790126|447573144|FG001|Overall Study|Other|4|||
124440466|NCT01790126|447573145|FG002|Overall Study|Other|8|||
124440467|NCT01790126|447573143|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
124440468|NCT01790126|447573144|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
124440469|NCT01790126|447573145|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
124440470|NCT01790126|447573143|FG000|Overall Study|Withdrawal by Physician|1|||
124440471|NCT01790126|447573144|FG001|Overall Study|Withdrawal by Physician|1|||
124440472|NCT01790126|447573145|FG002|Overall Study|Withdrawal by Physician|2|||
124440473|NCT01790126|447573143|FG000|Overall Study|Withdrawal by Subject|3|||
124440474|NCT01790126|447573144|FG001|Overall Study|Withdrawal by Subject|1|||
124440475|NCT01790126|447573145|FG002|Overall Study|Withdrawal by Subject|2|||
124440476|NCT01790126|447573143|FG000|Overall Study|Lost to Follow-up|1|||
124686006|NCT01901562|448471181|FG000|Overall Study|Excluded intraoperatively|4|||
124686007|NCT02612155|448471182|FG000|Overall Study|Death|1|||
124686008|NCT02612155|448471183|FG001|Overall Study|Death|1|||
124686009|NCT02612155|448471182|FG000|Overall Study|Lost to Follow-up|2|||
124888492|NCT01848834|449215507|FG001|Overall Study|Sponsor Decision|1|||
124888493|NCT01848834|449215508|FG002|Overall Study|Sponsor Decision|0|||
124888494|NCT01848834|449215509|FG003|Overall Study|Sponsor Decision|1|||
124888495|NCT01848834|449215510|FG004|Overall Study|Sponsor Decision|1|||
124888496|NCT01848834|449215506|FG000|Overall Study|Withdrawal by Subject|2|||
124440477|NCT01790126|447573144|FG001|Overall Study|Lost to Follow-up|0|||
124440478|NCT01790126|447573145|FG002|Overall Study|Lost to Follow-up|1|||
124440479|NCT01790126|447573143|FG000|Overall Study|Adverse Event|0|||
124440480|NCT01790126|447573144|FG001|Overall Study|Adverse Event|2|||
124440481|NCT01790126|447573145|FG002|Overall Study|Adverse Event|0|||
124440482|NCT01790126|447573143|FG000|Overall Study|Death|2|||
124440483|NCT01790126|447573144|FG001|Overall Study|Death|0|||
124440484|NCT01790126|447573145|FG002|Overall Study|Death|0|||
124440485|NCT01790126|447573143|FG000|Overall Study|Radiographic Progression|3|||
124440486|NCT01790126|447573144|FG001|Overall Study|Radiographic Progression|1|||
124440487|NCT01790126|447573145|FG002|Overall Study|Radiographic Progression|0|||
124440488|NCT01211197|447573146|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124440489|NCT01211197|447573147|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124440490|NCT01211197|447573148|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
124888497|NCT01848834|449215507|FG001|Overall Study|Withdrawal by Subject|13|||
124440491|NCT01211197|447573149|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124440492|NCT01211197|447573150|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124440493|NCT01211197|447573151|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124888498|NCT01848834|449215508|FG002|Overall Study|Withdrawal by Subject|10|||
124440494|NCT01211197|447573146|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
124686010|NCT02612155|448471183|FG001|Overall Study|Lost to Follow-up|2|||
124888499|NCT01848834|449215509|FG003|Overall Study|Withdrawal by Subject|6|||
124686011|NCT04435626|448471186|FG000|Overall Study|Lost to Follow-up|1|||
124686012|NCT04435626|448471187|FG001|Overall Study|Lost to Follow-up|5|||
124686013|NCT04435626|448471186|FG000|Overall Study|Withdrawal by Subject|6|||
124686014|NCT04435626|448471187|FG001|Overall Study|Withdrawal by Subject|7|||
124686015|NCT04435626|448471186|FG000|Overall Study|major GCP violations|8|||
124686016|NCT04435626|448471187|FG001|Overall Study|major GCP violations|7|||
124686017|NCT06354257|448471193|FG000|Treatment Period 1|Withdrawal by Subject|1|||
124686018|NCT06354257|448471193|FG000|Treatment Period 2|Adverse Event|1|||
124686019|NCT00433537|448471194|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
124686020|NCT00433537|448471195|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
124686021|NCT00433537|448471196|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
124686022|NCT00433537|448471194|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
124686023|NCT00433537|448471195|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
124686024|NCT00433537|448471196|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
124686025|NCT00433537|448471194|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
124686026|NCT00433537|448471195|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
124686027|NCT00433537|448471196|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
124686028|NCT00433537|448471194|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
124686029|NCT00433537|448471195|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
124686030|NCT00433537|448471196|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
124686031|NCT00433537|448471194|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
124686032|NCT00433537|448471195|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
124888500|NCT01848834|449215510|FG004|Overall Study|Withdrawal by Subject|36|||
124888501|NCT02040090|449215513|FG000|Overall Study|Adverse Event|2|||
124888502|NCT02040090|449215514|FG001|Overall Study|Adverse Event|0|||
124686033|NCT00433537|448471196|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
124686034|NCT00433537|448471194|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
124686035|NCT00433537|448471195|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
124686036|NCT00433537|448471196|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
124686037|NCT00433537|448471194|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
124686038|NCT00433537|448471195|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
124686039|NCT00433537|448471196|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
124686040|NCT00433537|448471194|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
124686041|NCT00433537|448471195|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
124686042|NCT00433537|448471196|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
124686043|NCT00433537|448471194|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
124686044|NCT00433537|448471195|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
124686045|NCT00433537|448471196|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
124686046|NCT01757847|448471197|FG000|Overall Study|Withdrawal by Subject|3|||
124686047|NCT01757847|448471198|FG001|Overall Study|Withdrawal by Subject|4|||
124686048|NCT00831844|448471201|FG000|Overall Study|Adverse Event|2|||
124686049|NCT00831844|448471202|FG001|Overall Study|Adverse Event|0|||
124686050|NCT00831844|448471203|FG002|Overall Study|Adverse Event|0|||
124686051|NCT00831844|448471204|FG003|Overall Study|Adverse Event|0|||
124686052|NCT00831844|448471205|FG004|Overall Study|Adverse Event|1|||
124686053|NCT00831844|448471206|FG005|Overall Study|Adverse Event|1|||
124686054|NCT00831844|448471207|FG006|Overall Study|Adverse Event|2|||
124686055|NCT00831844|448471208|FG007|Overall Study|Adverse Event|0|||
124686056|NCT00831844|448471209|FG008|Overall Study|Adverse Event|0|||
124686057|NCT00831844|448471210|FG009|Overall Study|Adverse Event|0|||
124686058|NCT00831844|448471201|FG000|Overall Study|Death|0|||
124686059|NCT00831844|448471202|FG001|Overall Study|Death|0|||
124888503|NCT02040090|449215513|FG000|Overall Study|Physician Decision|1|||
124888504|NCT02040090|449215514|FG001|Overall Study|Physician Decision|0|||
124686060|NCT00831844|448471203|FG002|Overall Study|Death|0|||
124686061|NCT00831844|448471204|FG003|Overall Study|Death|1|||
124440495|NCT01211197|447573147|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
124440496|NCT01211197|447573148|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
124440497|NCT01211197|447573149|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
124440498|NCT01211197|447573150|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
124440499|NCT01211197|447573151|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
124440500|NCT00261846|447573152|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
124440501|NCT00261846|447573153|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
124440502|NCT00261846|447573154|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
124440503|NCT00261846|447573155|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124440504|NCT00261846|447573156|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124440505|NCT00261846|447573157|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124440506|NCT00261846|447573158|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124440507|NCT00261846|447573159|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124440508|NCT00261846|447573160|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124440509|NCT00261846|447573161|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124440510|NCT00261846|447573162|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124440511|NCT00261846|447573163|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
124440512|NCT00261846|447573152|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124440513|NCT00261846|447573153|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124440514|NCT00261846|447573154|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124440515|NCT00261846|447573155|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
124440516|NCT00261846|447573156|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124440517|NCT00261846|447573157|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124440518|NCT00261846|447573158|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124440519|NCT00261846|447573159|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124440520|NCT00261846|447573160|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
124440521|NCT00261846|447573161|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124440522|NCT00261846|447573162|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124440523|NCT00261846|447573163|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
124440524|NCT00261846|447573152|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
124440525|NCT00261846|447573153|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
124440526|NCT00261846|447573154|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
124440527|NCT00261846|447573155|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
124440528|NCT00261846|447573156|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
124440529|NCT00261846|447573157|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
124440530|NCT00261846|447573158|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
124440531|NCT00261846|447573159|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
124440532|NCT00261846|447573160|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
124686062|NCT00831844|448471205|FG004|Overall Study|Death|0|||
124686063|NCT00831844|448471206|FG005|Overall Study|Death|0|||
124686064|NCT00831844|448471207|FG006|Overall Study|Death|0|||
124686065|NCT00831844|448471208|FG007|Overall Study|Death|0|||
124686066|NCT00831844|448471209|FG008|Overall Study|Death|0|||
124686067|NCT00831844|448471210|FG009|Overall Study|Death|0|||
124686068|NCT00831844|448471201|FG000|Overall Study|Lack of Efficacy|8|||
124686069|NCT00831844|448471202|FG001|Overall Study|Lack of Efficacy|10|||
124686070|NCT00831844|448471203|FG002|Overall Study|Lack of Efficacy|15|||
124686071|NCT00831844|448471204|FG003|Overall Study|Lack of Efficacy|8|||
124686072|NCT00831844|448471205|FG004|Overall Study|Lack of Efficacy|11|||
124686073|NCT00831844|448471206|FG005|Overall Study|Lack of Efficacy|17|||
124686074|NCT00831844|448471207|FG006|Overall Study|Lack of Efficacy|8|||
124686075|NCT00831844|448471208|FG007|Overall Study|Lack of Efficacy|9|||
124686076|NCT00831844|448471209|FG008|Overall Study|Lack of Efficacy|7|||
124686077|NCT00831844|448471210|FG009|Overall Study|Lack of Efficacy|0|||
124686078|NCT00831844|448471201|FG000|Overall Study|Physician Decision|0|||
124686079|NCT00831844|448471202|FG001|Overall Study|Physician Decision|1|||
124686080|NCT00831844|448471203|FG002|Overall Study|Physician Decision|3|||
124686081|NCT00831844|448471204|FG003|Overall Study|Physician Decision|1|||
124686082|NCT00831844|448471205|FG004|Overall Study|Physician Decision|1|||
124686083|NCT00831844|448471206|FG005|Overall Study|Physician Decision|1|||
124888505|NCT02040090|449215513|FG000|Overall Study|Withdrawal by Subject|0|||
124686084|NCT00831844|448471207|FG006|Overall Study|Physician Decision|0|||
124686085|NCT00831844|448471208|FG007|Overall Study|Physician Decision|0|||
124686086|NCT00831844|448471209|FG008|Overall Study|Physician Decision|1|||
124686087|NCT00831844|448471210|FG009|Overall Study|Physician Decision|0|||
124686088|NCT00831844|448471201|FG000|Overall Study|Withdrawal by Subject|0|||
124686089|NCT00831844|448471202|FG001|Overall Study|Withdrawal by Subject|0|||
124888506|NCT02040090|449215514|FG001|Overall Study|Withdrawal by Subject|1|||
124888507|NCT02040090|449215513|FG000|Overall Study|Lost to Follow-up|0|||
124888508|NCT02040090|449215514|FG001|Overall Study|Lost to Follow-up|1|||
124888509|NCT04894903|449215515|FG000|Overall Study|Death|1|||
124888510|NCT04894903|449215516|FG001|Overall Study|Death|0|||
124888511|NCT04894903|449215515|FG000|Overall Study|Pregnancy|1|||
124888512|NCT04894903|449215516|FG001|Overall Study|Pregnancy|0|||
124888513|NCT04894903|449215515|FG000|Overall Study|Withdrawal by Subject|1|||
124888514|NCT04894903|449215516|FG001|Overall Study|Withdrawal by Subject|1|||
124888515|NCT04894903|449215515|FG000|Overall Study|moved or exited health system|1|||
124888516|NCT04894903|449215516|FG001|Overall Study|moved or exited health system|3|||
124888517|NCT00776100|449215524|FG000|Overall Study|Disease Progression|1|||
124888518|NCT00776100|449215525|FG001|Overall Study|Disease Progression|0|||
124888519|NCT03567993|449215528|FG000|Overall Study|Lost to Follow-up|4|||
124888520|NCT03567993|449215529|FG001|Overall Study|Lost to Follow-up|2|||
124888521|NCT03567993|449215528|FG000|Overall Study|Death|1|||
124888522|NCT03567993|449215529|FG001|Overall Study|Death|1|||
124888523|NCT03567993|449215528|FG000|Overall Study|Withdrawal by Subject|1|||
124888524|NCT03567993|449215529|FG001|Overall Study|Withdrawal by Subject|0|||
124888525|NCT04793464|449215530|FG000|Overall Study|Lost to Follow-up|458|||
124888526|NCT04793464|449215531|FG001|Overall Study|Lost to Follow-up|168|||
124686090|NCT00831844|448471203|FG002|Overall Study|Withdrawal by Subject|1|||
124686091|NCT00831844|448471204|FG003|Overall Study|Withdrawal by Subject|0|||
124686092|NCT00831844|448471205|FG004|Overall Study|Withdrawal by Subject|0|||
124888527|NCT04793464|449215532|FG002|Overall Study|Lost to Follow-up|5|||
124888528|NCT04793464|449215530|FG000|Overall Study|Withdrawal by Subject|43|||
124888529|NCT04793464|449215531|FG001|Overall Study|Withdrawal by Subject|15|||
124888530|NCT04793464|449215532|FG002|Overall Study|Withdrawal by Subject|0|||
124888531|NCT05221749|449215535|FG000|Overall Study|Lost to Follow-up|2|||
124888532|NCT05221749|449215536|FG001|Overall Study|Lost to Follow-up|3|||
124888533|NCT00519636|449215537|FG000|Treatment Period 1|Adverse Event|1|||
124440533|NCT00261846|447573161|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
124440534|NCT00261846|447573162|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
124440535|NCT00261846|447573163|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
124440536|NCT00261846|447573152|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
124440537|NCT00261846|447573153|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
124440538|NCT00261846|447573154|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
124440539|NCT00261846|447573155|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
124440540|NCT00261846|447573156|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
124440541|NCT00261846|447573157|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
124440542|NCT00261846|447573158|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
124440543|NCT00261846|447573159|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
124440544|NCT00261846|447573160|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
124440545|NCT00261846|447573161|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
124440546|NCT00261846|447573162|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
124440547|NCT00261846|447573163|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
124440548|NCT00261846|447573152|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
124440549|NCT00261846|447573153|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
124440550|NCT00261846|447573154|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
124440551|NCT00261846|447573155|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
124440552|NCT00261846|447573156|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
124440553|NCT00261846|447573157|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
124440554|NCT00261846|447573158|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
124440555|NCT00261846|447573159|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
124440556|NCT00261846|447573160|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
124440557|NCT00261846|447573161|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
124440558|NCT00261846|447573162|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
124440559|NCT00261846|447573163|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
124440560|NCT00261846|447573152|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
124440561|NCT00261846|447573153|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
124440562|NCT00261846|447573154|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
124440563|NCT00261846|447573155|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
124440564|NCT00261846|447573156|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
124440565|NCT00261846|447573157|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
124440566|NCT00261846|447573158|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
124440567|NCT00261846|447573159|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
124440568|NCT00261846|447573160|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
124440569|NCT00261846|447573161|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
124440570|NCT00261846|447573162|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
124440571|NCT00261846|447573163|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
124440572|NCT00261846|447573152|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
124440573|NCT00261846|447573153|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
124440574|NCT00261846|447573154|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
124686093|NCT00831844|448471206|FG005|Overall Study|Withdrawal by Subject|0|||
124686094|NCT00831844|448471207|FG006|Overall Study|Withdrawal by Subject|0|||
124686095|NCT00831844|448471208|FG007|Overall Study|Withdrawal by Subject|1|||
124686096|NCT00831844|448471209|FG008|Overall Study|Withdrawal by Subject|1|||
124686097|NCT00831844|448471210|FG009|Overall Study|Withdrawal by Subject|0|||
124686098|NCT00831844|448471201|FG000|Overall Study|Ineligible|0|||
124686099|NCT00831844|448471202|FG001|Overall Study|Ineligible|1|||
124686100|NCT00831844|448471203|FG002|Overall Study|Ineligible|1|||
124686101|NCT00831844|448471204|FG003|Overall Study|Ineligible|0|||
124686102|NCT00831844|448471205|FG004|Overall Study|Ineligible|1|||
124686103|NCT00831844|448471206|FG005|Overall Study|Ineligible|0|||
124686104|NCT00831844|448471207|FG006|Overall Study|Ineligible|0|||
124686105|NCT00831844|448471208|FG007|Overall Study|Ineligible|0|||
124686106|NCT00831844|448471209|FG008|Overall Study|Ineligible|0|||
124686107|NCT00831844|448471210|FG009|Overall Study|Ineligible|0|||
124686108|NCT05119569|448471223|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
124888534|NCT00519636|449215538|FG001|Treatment Period 1|Adverse Event|0|||
124888535|NCT00519636|449215539|FG002|Treatment Period 1|Adverse Event|1|||
124888536|NCT00519636|449215540|FG003|Treatment Period 1|Adverse Event|0|||
124888537|NCT00519636|449215537|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
124888538|NCT00519636|449215538|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
124888539|NCT00519636|449215539|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
124888540|NCT00519636|449215540|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
124888541|NCT00519636|449215537|FG000|Washout Period|Adverse Event|2|||
124888542|NCT00519636|449215538|FG001|Washout Period|Adverse Event|1|||
124888543|NCT00519636|449215539|FG002|Washout Period|Adverse Event|1|||
124686109|NCT05119569|448471224|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
124686110|NCT05119569|448471225|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
124686111|NCT05119569|448471226|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
124686112|NCT05119569|448471223|FG000|Double Blind Treatment Phase|Adverse Event|6|||
124686113|NCT05119569|448471224|FG001|Double Blind Treatment Phase|Adverse Event|0|||
124686114|NCT05119569|448471225|FG002|Double Blind Treatment Phase|Adverse Event|0|||
124686115|NCT05119569|448471226|FG003|Double Blind Treatment Phase|Adverse Event|0|||
124686116|NCT05119569|448471223|FG000|Open Label Extension Phase|Ongoing in the study|0|||
124686117|NCT05119569|448471224|FG001|Open Label Extension Phase|Ongoing in the study|0|||
124686118|NCT05119569|448471225|FG002|Open Label Extension Phase|Ongoing in the study|65|||
124686119|NCT05119569|448471226|FG003|Open Label Extension Phase|Ongoing in the study|34|||
124686120|NCT03683030|448471227|FG000|Overall Study|Enrolled but screen failures|12|||
124686121|NCT03683030|448471228|FG001|Overall Study|Enrolled but screen failures|7|||
124686122|NCT03683030|448471227|FG000|Overall Study|Enrolled but no catheter inserted|11|||
124686123|NCT03683030|448471228|FG001|Overall Study|Enrolled but no catheter inserted|13|||
124686124|NCT03683030|448471227|FG000|Overall Study|Withdrawal by Subject|0|||
124686125|NCT03683030|448471228|FG001|Overall Study|Withdrawal by Subject|2|||
124686126|NCT03683030|448471227|FG000|Overall Study|Early termination by subject|1|||
124686127|NCT03683030|448471228|FG001|Overall Study|Early termination by subject|0|||
124686128|NCT03683030|448471227|FG000|Overall Study|Lost to Follow-up|0|||
124686129|NCT03683030|448471228|FG001|Overall Study|Lost to Follow-up|6|||
124686130|NCT03683030|448471227|FG000|Overall Study|Death|0|||
124759036|NCT02721875|448741237|FG000|Overall Study|Progressive disease/relapse|1|||
124759037|NCT02721875|448741238|FG001|Overall Study|Progressive disease/relapse|0|||
124759038|NCT00430716|448741239|FG000|Double Blind Phase|Death|1|||
124759039|NCT00430716|448741240|FG001|Double Blind Phase|Death|0|||
124888544|NCT00519636|449215540|FG003|Washout Period|Adverse Event|0|||
124888545|NCT00519636|449215537|FG000|Washout Period|Lost to Follow-up|1|||
124686131|NCT03683030|448471228|FG001|Overall Study|Death|2|||
124686132|NCT03683030|448471227|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
124686133|NCT03683030|448471228|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
124759040|NCT00430716|448741241|FG002|Double Blind Phase|Death|0|||
124759041|NCT00430716|448741239|FG000|Double Blind Phase|No longer willing to participate|2|||
124759042|NCT00430716|448741240|FG001|Double Blind Phase|No longer willing to participate|1|||
124759043|NCT00430716|448741241|FG002|Double Blind Phase|No longer willing to participate|1|||
124759044|NCT00430716|448741239|FG000|Double Blind Phase|Other|0|||
124759045|NCT00430716|448741240|FG001|Double Blind Phase|Other|2|||
124759046|NCT00430716|448741241|FG002|Double Blind Phase|Other|0|||
124759047|NCT00430716|448741239|FG000|Double Blind Phase|Study terminated by sponsor|1|||
124759048|NCT00430716|448741240|FG001|Double Blind Phase|Study terminated by sponsor|1|||
124759049|NCT00430716|448741241|FG002|Double Blind Phase|Study terminated by sponsor|2|||
124759050|NCT00430716|448741239|FG000|Double Blind Phase|Adverse Event|1|||
124440575|NCT00261846|447573155|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
124440576|NCT00261846|447573156|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
124440577|NCT00261846|447573157|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
124440578|NCT00261846|447573158|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
124440579|NCT00261846|447573159|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
124440580|NCT00261846|447573160|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
124440581|NCT00261846|447573161|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
124440582|NCT00261846|447573162|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
124440583|NCT00261846|447573163|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
124440584|NCT00150969|447573164|FG000|24 Month Main Study|Adverse Event|3|||
124440585|NCT00150969|447573165|FG001|24 Month Main Study|Adverse Event|4|||
124440586|NCT00150969|447573164|FG000|24 Month Main Study|Death|1|||
124440587|NCT00150969|447573165|FG001|24 Month Main Study|Death|1|||
124440588|NCT00150969|447573164|FG000|24 Month Main Study|Lack of Efficacy|1|||
124440589|NCT00150969|447573165|FG001|24 Month Main Study|Lack of Efficacy|8|||
124440590|NCT00150969|447573164|FG000|24 Month Main Study|Lost to Follow-up|3|||
124440591|NCT00150969|447573165|FG001|24 Month Main Study|Lost to Follow-up|2|||
124440592|NCT00150969|447573164|FG000|24 Month Main Study|Protocol Violation|4|||
124440593|NCT00150969|447573165|FG001|24 Month Main Study|Protocol Violation|2|||
124440594|NCT00150969|447573164|FG000|24 Month Main Study|Withdrawal by Subject|7|||
124759051|NCT00430716|448741240|FG001|Double Blind Phase|Adverse Event|1|||
124759052|NCT00430716|448741241|FG002|Double Blind Phase|Adverse Event|3|||
124759053|NCT00430716|448741239|FG000|Double Blind Phase|Not treated|1|||
124759054|NCT00430716|448741240|FG001|Double Blind Phase|Not treated|0|||
124759055|NCT00430716|448741241|FG002|Double Blind Phase|Not treated|0|||
124440595|NCT00150969|447573165|FG001|24 Month Main Study|Withdrawal by Subject|4|||
124440596|NCT00150969|447573164|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
124440597|NCT00150969|447573165|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
124440598|NCT00150969|447573164|FG000|24-48 Month Extension|Lack of Efficacy|0|||
124440599|NCT00150969|447573165|FG001|24-48 Month Extension|Lack of Efficacy|1|||
124440600|NCT00150969|447573164|FG000|24-48 Month Extension|Adverse Event|1|||
124440601|NCT00150969|447573165|FG001|24-48 Month Extension|Adverse Event|3|||
124440602|NCT00150969|447573164|FG000|24-48 Month Extension|Other Reason|81|||
124440603|NCT00150969|447573165|FG001|24-48 Month Extension|Other Reason|91|||
124440604|NCT02121834|447573167|FG000|Overall Study|Protocol Violation|0|||
124440605|NCT02121834|447573168|FG001|Overall Study|Protocol Violation|1|||
124440606|NCT02121834|447573169|FG002|Overall Study|Protocol Violation|0|||
124440607|NCT02121834|447573170|FG003|Overall Study|Protocol Violation|0|||
124440608|NCT02121834|447573171|FG004|Overall Study|Protocol Violation|0|||
124440609|NCT02121834|447573172|FG005|Overall Study|Protocol Violation|0|||
124440610|NCT02121834|447573173|FG006|Overall Study|Protocol Violation|0|||
124759056|NCT00430716|448741239|FG000|Open Label Phase|Lost to Follow-up|1|||
124759057|NCT00430716|448741240|FG001|Open Label Phase|Lost to Follow-up|0|||
124759058|NCT00430716|448741241|FG002|Open Label Phase|Lost to Follow-up|1|||
124759059|NCT00430716|448741239|FG000|Open Label Phase|No longer willing to participate|0|||
124440611|NCT02121834|447573167|FG000|Overall Study|Withdrawal by Subject|0|||
124440612|NCT02121834|447573168|FG001|Overall Study|Withdrawal by Subject|1|||
124440613|NCT02121834|447573169|FG002|Overall Study|Withdrawal by Subject|1|||
124440614|NCT02121834|447573170|FG003|Overall Study|Withdrawal by Subject|0|||
124440615|NCT02121834|447573171|FG004|Overall Study|Withdrawal by Subject|0|||
124440616|NCT02121834|447573172|FG005|Overall Study|Withdrawal by Subject|0|||
124440617|NCT02121834|447573173|FG006|Overall Study|Withdrawal by Subject|0|||
124440618|NCT02121834|447573167|FG000|Overall Study|Lost to Follow-up|0|||
124440619|NCT02121834|447573168|FG001|Overall Study|Lost to Follow-up|0|||
124440620|NCT02121834|447573169|FG002|Overall Study|Lost to Follow-up|1|||
124440621|NCT02121834|447573170|FG003|Overall Study|Lost to Follow-up|0|||
124440622|NCT02121834|447573171|FG004|Overall Study|Lost to Follow-up|0|||
124440623|NCT02121834|447573172|FG005|Overall Study|Lost to Follow-up|0|||
124440624|NCT02121834|447573173|FG006|Overall Study|Lost to Follow-up|0|||
124440625|NCT01337115|447573174|FG000|Overall Study|Protocol Violation|2|||
124440626|NCT01337115|447573175|FG001|Overall Study|Protocol Violation|0|||
124440627|NCT00551460|447573176|FG000|Overall Study|Adverse Event|1|||
124440628|NCT00551460|447573176|FG000|Overall Study|Withdrawal by Subject|1|||
124440629|NCT00551460|447573176|FG000|Overall Study|Physician Decision|1|||
124440630|NCT00551460|447573176|FG000|Overall Study|Death|7|||
124440631|NCT00551460|447573176|FG000|Overall Study|Ineligible|4|||
124440632|NCT00551460|447573176|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
124440633|NCT00448123|447573177|FG000|Overall Study|Lost to Follow-up|9|||
124440634|NCT00448123|447573178|FG001|Overall Study|Lost to Follow-up|6|||
124440635|NCT00448123|447573177|FG000|Overall Study|Physician Decision|6|||
124440636|NCT00448123|447573178|FG001|Overall Study|Physician Decision|6|||
124440637|NCT02027623|447573180|FG000|Overall Study|Lost to Follow-up|3|||
124440638|NCT02027623|447573181|FG001|Overall Study|Lost to Follow-up|3|||
124440639|NCT02027623|447573180|FG000|Overall Study|Withdrawal by Subject|6|||
124440640|NCT02027623|447573181|FG001|Overall Study|Withdrawal by Subject|9|||
124440641|NCT01971203|447573186|FG000|Overall Study|Protocol Violation|3|||
124440642|NCT01971203|447573187|FG001|Overall Study|Protocol Violation|2|||
124440643|NCT01971203|447573186|FG000|Overall Study|Withdrawal by Subject|5|||
124440644|NCT01971203|447573187|FG001|Overall Study|Withdrawal by Subject|6|||
124440645|NCT01971203|447573186|FG000|Overall Study|Adverse Event|1|||
124440646|NCT01971203|447573187|FG001|Overall Study|Adverse Event|0|||
124440647|NCT03353350|447573188|FG000|30-week Core Treatment Period|Protocol Violation|1|||
124440648|NCT03353350|447573189|FG001|30-week Core Treatment Period|Protocol Violation|1|||
124440649|NCT03353350|447573190|FG002|30-week Core Treatment Period|Protocol Violation|1|||
124440650|NCT03353350|447573191|FG003|30-week Core Treatment Period|Protocol Violation|0|||
124440651|NCT03353350|447573188|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
124440652|NCT03353350|447573189|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
124440653|NCT03353350|447573190|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
124440654|NCT03353350|447573191|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
124440655|NCT03353350|447573188|FG000|30-week Core Treatment Period|Adverse Event|0|||
124440656|NCT03353350|447573189|FG001|30-week Core Treatment Period|Adverse Event|4|||
124440657|NCT03353350|447573190|FG002|30-week Core Treatment Period|Adverse Event|2|||
124440658|NCT03353350|447573191|FG003|30-week Core Treatment Period|Adverse Event|3|||
124440659|NCT03353350|447573188|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
124440660|NCT03353350|447573189|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
124440661|NCT03353350|447573190|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
124440662|NCT03353350|447573191|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
124440663|NCT03353350|447573188|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
124440664|NCT03353350|447573189|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
124440665|NCT03353350|447573190|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
124440666|NCT03353350|447573191|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
124440667|NCT03353350|447573188|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
124440668|NCT03353350|447573189|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
124440669|NCT03353350|447573190|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
124440670|NCT03353350|447573191|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
124686134|NCT03980223|448471229|FG000|Overall Study|Lost to Follow-up|3|||
124686135|NCT03980223|448471230|FG001|Overall Study|Lost to Follow-up|7|||
124440671|NCT03353350|447573188|FG000|26-week Treatment Extension Period|Adverse Event|1|||
124440672|NCT03353350|447573189|FG001|26-week Treatment Extension Period|Adverse Event|0|||
124440673|NCT03353350|447573190|FG002|26-week Treatment Extension Period|Adverse Event|0|||
124686136|NCT03980223|448471231|FG002|Overall Study|Lost to Follow-up|10|||
124440674|NCT03353350|447573191|FG003|26-week Treatment Extension Period|Adverse Event|1|||
124440675|NCT03353350|447573188|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
124440676|NCT03353350|447573189|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
124440677|NCT03353350|447573190|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
124440678|NCT03353350|447573191|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
124440679|NCT00147823|447573197|FG000|Overall Study|Lost to Follow-up|6|||
124440680|NCT00147823|447573198|FG001|Overall Study|Lost to Follow-up|12|||
124686137|NCT03980223|448471232|FG003|Overall Study|Lost to Follow-up|8|||
124686138|NCT03980223|448471229|FG000|Overall Study|Withdrawal by Subject|0|||
124686139|NCT03980223|448471230|FG001|Overall Study|Withdrawal by Subject|0|||
124686140|NCT03980223|448471231|FG002|Overall Study|Withdrawal by Subject|1|||
124888546|NCT00519636|449215538|FG001|Washout Period|Lost to Follow-up|0|||
124888547|NCT00519636|449215539|FG002|Washout Period|Lost to Follow-up|0|||
124686141|NCT03980223|448471232|FG003|Overall Study|Withdrawal by Subject|2|||
124686142|NCT03980223|448471229|FG000|Overall Study|Physician Decision|0|||
124888548|NCT00519636|449215540|FG003|Washout Period|Lost to Follow-up|0|||
124686143|NCT03980223|448471230|FG001|Overall Study|Physician Decision|0|||
124686144|NCT03980223|448471231|FG002|Overall Study|Physician Decision|1|||
124440681|NCT00147823|447573197|FG000|Overall Study|Physician Decision|1|||
124686145|NCT03980223|448471232|FG003|Overall Study|Physician Decision|0|||
124888549|NCT00519636|449215537|FG000|Washout Period|Protocol Violation|0|||
124686146|NCT03980223|448471229|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
124686147|NCT03980223|448471230|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
124686148|NCT03980223|448471231|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
124686149|NCT03980223|448471232|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
124686150|NCT06239610|448471233|FG000|Overall Study|no usable migration data for minimum of one day|11|||
124686151|NCT01922934|448471237|FG000|Eligible Patients|Death|0|||
124686152|NCT01922934|448471238|FG001|Eligible Patients|Death|7|||
124686153|NCT01922934|448471237|FG000|Eligible Patients|Physician Decision|17|||
124686154|NCT01922934|448471238|FG001|Eligible Patients|Physician Decision|0|||
124686155|NCT01922934|448471237|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
124686156|NCT01922934|448471238|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
124686157|NCT01922934|448471237|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
124686158|NCT01922934|448471238|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
124440682|NCT00147823|447573198|FG001|Overall Study|Physician Decision|0|||
124440683|NCT00147823|447573197|FG000|Overall Study|Withdrawal by Subject|0|||
124440684|NCT00147823|447573198|FG001|Overall Study|Withdrawal by Subject|1|||
124440685|NCT00147823|447573197|FG000|Overall Study|Did not receive vitoss due to infection|6|||
124440686|NCT00147823|447573198|FG001|Overall Study|Did not receive vitoss due to infection|2|||
124440687|NCT01012713|447573199|FG000|Overall Study|Lack of Efficacy|3|||
124440688|NCT02571049|447573200|FG000|Screening|Did not meet entry criteria|2|||
124440689|NCT02571049|447573201|FG001|Screening|Did not meet entry criteria|2|||
124440690|NCT02571049|447573200|FG000|Randomization|No migraine attack|0|||
124440691|NCT02571049|447573201|FG001|Randomization|No migraine attack|1|||
124440692|NCT02571049|447573200|FG000|Randomization|Adverse Event|0|||
124440693|NCT02571049|447573201|FG001|Randomization|Adverse Event|1|||
124440694|NCT01055262|447573202|FG000|Overall Study|Adverse Event|5|||
124440695|NCT01055262|447573202|FG000|Overall Study|Protocol Violation|3|||
124888550|NCT00519636|449215538|FG001|Washout Period|Protocol Violation|0|||
124888551|NCT00519636|449215539|FG002|Washout Period|Protocol Violation|1|||
124888552|NCT00519636|449215540|FG003|Washout Period|Protocol Violation|2|||
124888553|NCT00519636|449215537|FG000|Washout Period|Withdrawal by Subject|1|||
124888554|NCT00519636|449215538|FG001|Washout Period|Withdrawal by Subject|0|||
124440696|NCT01055262|447573202|FG000|Overall Study|Uncooperativeness|1|||
124440697|NCT03370471|447573203|FG000|Overall Study|Withdrawal by Subject|6|||
124440698|NCT03370471|447573204|FG001|Overall Study|Withdrawal by Subject|1|||
124440699|NCT03370471|447573203|FG000|Overall Study|Unable to access veins for blood draw|0|||
124440700|NCT03370471|447573204|FG001|Overall Study|Unable to access veins for blood draw|1|||
124440701|NCT03370471|447573203|FG000|Overall Study|Screen fail|1|||
124440702|NCT03370471|447573204|FG001|Overall Study|Screen fail|0|||
124440703|NCT00561951|447573205|FG000|Overall Study|Adverse Event|11|||
124440704|NCT00561951|447573206|FG001|Overall Study|Adverse Event|14|||
124440705|NCT00561951|447573207|FG002|Overall Study|Adverse Event|14|||
124440706|NCT00561951|447573205|FG000|Overall Study|Lack of Efficacy|5|||
124440707|NCT00561951|447573206|FG001|Overall Study|Lack of Efficacy|3|||
124440708|NCT00561951|447573207|FG002|Overall Study|Lack of Efficacy|2|||
124440709|NCT00561951|447573205|FG000|Overall Study|Lost to Follow-up|1|||
124440710|NCT00561951|447573206|FG001|Overall Study|Lost to Follow-up|1|||
124440711|NCT00561951|447573207|FG002|Overall Study|Lost to Follow-up|0|||
124440712|NCT00561951|447573205|FG000|Overall Study|Withdrawal by Subject|10|||
124440713|NCT00561951|447573206|FG001|Overall Study|Withdrawal by Subject|9|||
124440714|NCT00561951|447573207|FG002|Overall Study|Withdrawal by Subject|10|||
124440715|NCT00561951|447573205|FG000|Overall Study|Protocol Violation|4|||
124440716|NCT00561951|447573206|FG001|Overall Study|Protocol Violation|3|||
124440717|NCT00561951|447573207|FG002|Overall Study|Protocol Violation|4|||
124440718|NCT00561951|447573205|FG000|Overall Study|Physician Decision|1|||
124440719|NCT00561951|447573206|FG001|Overall Study|Physician Decision|0|||
124440720|NCT00561951|447573207|FG002|Overall Study|Physician Decision|0|||
124440721|NCT00561951|447573205|FG000|Overall Study|Pregnancy|0|||
124440722|NCT00561951|447573206|FG001|Overall Study|Pregnancy|1|||
124440723|NCT00561951|447573207|FG002|Overall Study|Pregnancy|0|||
124440724|NCT00561951|447573205|FG000|Overall Study|Meet Withdrawal Criterion|0|||
124440725|NCT00561951|447573206|FG001|Overall Study|Meet Withdrawal Criterion|1|||
124888555|NCT00519636|449215539|FG002|Washout Period|Withdrawal by Subject|1|||
124440726|NCT00561951|447573207|FG002|Overall Study|Meet Withdrawal Criterion|1|||
124440727|NCT00561951|447573205|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
124440728|NCT00561951|447573206|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
124440729|NCT00561951|447573207|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
124686159|NCT01922934|448471237|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
124686160|NCT01922934|448471238|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
124440730|NCT00392327|447573219|FG000|Overall Study|Death|1|||
124440731|NCT00392327|447573220|FG001|Overall Study|Death|0|||
124440732|NCT00392327|447573221|FG002|Overall Study|Death|1|||
124440733|NCT00392327|447573222|FG003|Overall Study|Death|0|||
124440734|NCT00392327|447573223|FG004|Overall Study|Death|0|||
124686161|NCT01922934|448471237|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
124686162|NCT01922934|448471238|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
124888556|NCT00519636|449215540|FG003|Washout Period|Withdrawal by Subject|0|||
124440735|NCT00392327|447573224|FG005|Overall Study|Death|0|||
124440736|NCT00392327|447573225|FG006|Overall Study|Death|0|||
124440737|NCT00392327|447573226|FG007|Overall Study|Death|0|||
124440738|NCT00392327|447573219|FG000|Overall Study|Lack of Efficacy|8|||
124440739|NCT00392327|447573220|FG001|Overall Study|Lack of Efficacy|8|||
124440740|NCT00392327|447573221|FG002|Overall Study|Lack of Efficacy|9|||
124440741|NCT00392327|447573222|FG003|Overall Study|Lack of Efficacy|6|||
124440742|NCT00392327|447573223|FG004|Overall Study|Lack of Efficacy|3|||
124440743|NCT00392327|447573224|FG005|Overall Study|Lack of Efficacy|3|||
124440744|NCT00392327|447573225|FG006|Overall Study|Lack of Efficacy|3|||
124440745|NCT00392327|447573226|FG007|Overall Study|Lack of Efficacy|3|||
124440746|NCT00392327|447573219|FG000|Overall Study|Physician Decision|3|||
124440747|NCT00392327|447573220|FG001|Overall Study|Physician Decision|5|||
124440748|NCT00392327|447573221|FG002|Overall Study|Physician Decision|2|||
124440749|NCT00392327|447573222|FG003|Overall Study|Physician Decision|2|||
124440750|NCT00392327|447573223|FG004|Overall Study|Physician Decision|0|||
124440751|NCT00392327|447573224|FG005|Overall Study|Physician Decision|1|||
124440752|NCT00392327|447573225|FG006|Overall Study|Physician Decision|5|||
124440753|NCT00392327|447573226|FG007|Overall Study|Physician Decision|3|||
124440754|NCT00392327|447573219|FG000|Overall Study|Protocol Violation|0|||
124440755|NCT00392327|447573220|FG001|Overall Study|Protocol Violation|0|||
124440756|NCT00392327|447573221|FG002|Overall Study|Protocol Violation|1|||
124440757|NCT00392327|447573222|FG003|Overall Study|Protocol Violation|0|||
124440758|NCT00392327|447573223|FG004|Overall Study|Protocol Violation|0|||
124440759|NCT00392327|447573224|FG005|Overall Study|Protocol Violation|0|||
124440760|NCT00392327|447573225|FG006|Overall Study|Protocol Violation|0|||
124440761|NCT00392327|447573226|FG007|Overall Study|Protocol Violation|0|||
124440762|NCT00392327|447573219|FG000|Overall Study|Withdrawal by Subject|3|||
124440763|NCT00392327|447573220|FG001|Overall Study|Withdrawal by Subject|2|||
124440764|NCT00392327|447573221|FG002|Overall Study|Withdrawal by Subject|4|||
124440765|NCT00392327|447573222|FG003|Overall Study|Withdrawal by Subject|6|||
124440766|NCT00392327|447573223|FG004|Overall Study|Withdrawal by Subject|0|||
124440767|NCT00392327|447573224|FG005|Overall Study|Withdrawal by Subject|1|||
124440768|NCT00392327|447573225|FG006|Overall Study|Withdrawal by Subject|1|||
124440769|NCT00392327|447573226|FG007|Overall Study|Withdrawal by Subject|5|||
124440770|NCT00392327|447573219|FG000|Overall Study|Ineligible|0|||
124440771|NCT00392327|447573220|FG001|Overall Study|Ineligible|4|||
124440772|NCT00392327|447573221|FG002|Overall Study|Ineligible|3|||
124440773|NCT00392327|447573222|FG003|Overall Study|Ineligible|2|||
124440774|NCT00392327|447573223|FG004|Overall Study|Ineligible|0|||
124440775|NCT00392327|447573224|FG005|Overall Study|Ineligible|0|||
124440776|NCT00392327|447573225|FG006|Overall Study|Ineligible|0|||
124440777|NCT00392327|447573226|FG007|Overall Study|Ineligible|0|||
124440778|NCT04508023|447573227|FG000|Overall Study|Withdrawal by Subject|1|||
124440779|NCT04508023|447573228|FG001|Overall Study|Withdrawal by Subject|2|||
124440780|NCT02988622|447573235|FG000|Overall Study|Lost to Follow-up|17|||
124440781|NCT01074216|447573237|FG000|Overall Study|Physician Decision|1|||
124440782|NCT01074216|447573237|FG000|Overall Study|Not Treated|12|||
124440783|NCT01323634|447573238|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
124440784|NCT01323634|447573239|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
124440785|NCT01323634|447573240|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
124440786|NCT01323634|447573238|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
124440787|NCT01323634|447573239|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
124440788|NCT01323634|447573240|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
124440789|NCT01323634|447573238|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
124440790|NCT01323634|447573239|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
124440791|NCT01323634|447573240|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
124440792|NCT01323634|447573238|FG000|2-week Run-in Period|Physician Decision|5|||
124440793|NCT01323634|447573239|FG001|2-week Run-in Period|Physician Decision|0|||
124440794|NCT01323634|447573240|FG002|2-week Run-in Period|Physician Decision|0|||
124440795|NCT01323634|447573238|FG000|2-week Run-in Period|Protocol Violation|1|||
124440796|NCT01323634|447573239|FG001|2-week Run-in Period|Protocol Violation|0|||
124440797|NCT01323634|447573240|FG002|2-week Run-in Period|Protocol Violation|0|||
124440798|NCT01323634|447573238|FG000|2-week Run-in Period|Adverse Event|1|||
124440799|NCT01323634|447573239|FG001|2-week Run-in Period|Adverse Event|0|||
124440800|NCT01323634|447573240|FG002|2-week Run-in Period|Adverse Event|0|||
124440801|NCT01323634|447573238|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
124440802|NCT01323634|447573239|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
124686163|NCT01069939|448471243|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
124440803|NCT01323634|447573240|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
124440804|NCT01323634|447573238|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
124440805|NCT01323634|447573239|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
124440806|NCT01323634|447573240|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
124440807|NCT01323634|447573238|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
124440808|NCT01323634|447573239|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
124440809|NCT01323634|447573240|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
124440810|NCT01323634|447573238|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
124440811|NCT01323634|447573239|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
124440812|NCT01323634|447573240|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
124440813|NCT01323634|447573238|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
124440814|NCT01323634|447573239|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
124440815|NCT01323634|447573240|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
124440816|NCT01323634|447573238|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
124440817|NCT01323634|447573239|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
124440818|NCT01323634|447573240|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
124440819|NCT01323634|447573238|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
124440820|NCT01323634|447573239|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
124440821|NCT01323634|447573240|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
124440822|NCT05056987|447573241|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
124440823|NCT05056987|447573242|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
124440824|NCT05056987|447573241|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
124440825|NCT05056987|447573242|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
124440826|NCT00753272|447573244|FG000|Overall Study|Adverse Event|878|||
124440827|NCT00753272|447573245|FG001|Overall Study|Adverse Event|869|||
124440828|NCT00753272|447573244|FG000|Overall Study|Protocol Violation|28|||
124440829|NCT00753272|447573245|FG001|Overall Study|Protocol Violation|46|||
124440830|NCT00753272|447573244|FG000|Overall Study|Withdrawal by Subject|2481|||
124440831|NCT00753272|447573245|FG001|Overall Study|Withdrawal by Subject|2407|||
124440832|NCT00753272|447573244|FG000|Overall Study|Lost to Follow-up|491|||
124440833|NCT00753272|447573245|FG001|Overall Study|Lost to Follow-up|497|||
124440834|NCT00753272|447573244|FG000|Overall Study|Other|1104|||
124440835|NCT00753272|447573245|FG001|Overall Study|Other|1088|||
124440836|NCT03604523|447573246|FG000|Overall Study|Physician Decision|1|||
124440837|NCT03604523|447573247|FG001|Overall Study|Physician Decision|0|||
124440838|NCT01675479|447573255|FG000|Overall Study|Lost to Follow-up|11|||
124440839|NCT01910181|447573256|FG000|Overall Study|Death|37|||
124440840|NCT01910181|447573256|FG000|Overall Study|Lost to Follow-up|3|||
124440841|NCT01910181|447573256|FG000|Overall Study|Study Terminated by Sponsor|6|||
124440842|NCT00655486|447575037|FG000|Overall Study|Adverse Event|10|||
124440843|NCT00655486|447575037|FG000|Overall Study|Lack of Efficacy|8|||
124440844|NCT00655486|447575037|FG000|Overall Study|Withdrawal by Subject|4|||
124440845|NCT00655486|447575037|FG000|Overall Study|Protocol Violation|1|||
124440846|NCT00655486|447575037|FG000|Overall Study|Unsatisfactory compliance|2|||
124440847|NCT00655486|447575037|FG000|Overall Study|Other: Pregnancy|1|||
124440848|NCT00655486|447575037|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
124440849|NCT00655486|447575037|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
124440850|NCT03840486|447575038|FG000|Overall Study|Withdrawal by Subject|0|||
124686164|NCT01069939|448471244|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
124686165|NCT01069939|448471243|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
124686166|NCT01069939|448471244|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
124686167|NCT01069939|448471243|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
124686168|NCT01069939|448471244|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
124686169|NCT01069939|448471243|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
124686170|NCT01069939|448471244|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
124686171|NCT01069939|448471243|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
124686172|NCT01069939|448471244|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
124686173|NCT01069939|448471243|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
124686174|NCT01069939|448471244|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
124686175|NCT01069939|448471243|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
124440851|NCT03840486|447575039|FG001|Overall Study|Withdrawal by Subject|1|||
124440852|NCT03840486|447575040|FG002|Overall Study|Withdrawal by Subject|0|||
124712011|NCT01343888|448570708|FG001|Overall Study|Withdrawal by Subject|4|||
124712012|NCT01343888|448570709|FG002|Overall Study|Withdrawal by Subject|2|||
124686176|NCT01069939|448471244|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
124686177|NCT01069939|448471243|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
124686178|NCT01069939|448471244|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
124686179|NCT01069939|448471243|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
124888557|NCT00519636|449215537|FG000|Washout Period|Failed to meet continuation criteria|14|||
124888558|NCT00519636|449215538|FG001|Washout Period|Failed to meet continuation criteria|11|||
124888559|NCT00519636|449215539|FG002|Washout Period|Failed to meet continuation criteria|9|||
124888560|NCT00519636|449215540|FG003|Washout Period|Failed to meet continuation criteria|3|||
124888561|NCT00519636|449215537|FG000|Washout Period|Out of pollen area > 48 hours|1|||
124888562|NCT00519636|449215538|FG001|Washout Period|Out of pollen area > 48 hours|0|||
124888563|NCT00519636|449215539|FG002|Washout Period|Out of pollen area > 48 hours|0|||
124888564|NCT00519636|449215540|FG003|Washout Period|Out of pollen area > 48 hours|0|||
124440853|NCT03840486|447575041|FG003|Overall Study|Withdrawal by Subject|0|||
124440854|NCT03840486|447575042|FG004|Overall Study|Withdrawal by Subject|0|||
124440855|NCT03840486|447575043|FG005|Overall Study|Withdrawal by Subject|0|||
124440856|NCT03840486|447575044|FG006|Overall Study|Withdrawal by Subject|0|||
124440857|NCT03840486|447575045|FG007|Overall Study|Withdrawal by Subject|0|||
124440858|NCT03840486|447575046|FG008|Overall Study|Withdrawal by Subject|0|||
124440859|NCT03840486|447575047|FG009|Overall Study|Withdrawal by Subject|0|||
124440860|NCT03840486|447575048|FG010|Overall Study|Withdrawal by Subject|0|||
124440861|NCT03840486|447575049|FG011|Overall Study|Withdrawal by Subject|0|||
124440862|NCT02768870|447575050|FG000|Overall Study|Death|1|||
124440863|NCT02768870|447575050|FG000|Overall Study|Reoperation|6|||
124440864|NCT02768870|447575050|FG000|Overall Study|Lost to Follow-up|1|||
124440865|NCT02768870|447575050|FG000|Overall Study|Exit|4|||
124440866|NCT01774110|447575051|FG000|Overall Study|Lost to Follow-up|7|||
124440867|NCT00640016|447575052|FG000|Overall Study|Withdrawal by Subject|0|||
124440868|NCT00640016|447575053|FG001|Overall Study|Withdrawal by Subject|1|||
124440869|NCT00640016|447575054|FG002|Overall Study|Withdrawal by Subject|0|||
124440870|NCT00640016|447575055|FG003|Overall Study|Withdrawal by Subject|0|||
124440871|NCT00640016|447575052|FG000|Overall Study|Study termination|2|||
124440872|NCT00640016|447575053|FG001|Overall Study|Study termination|1|||
124440873|NCT00640016|447575054|FG002|Overall Study|Study termination|3|||
124440874|NCT00640016|447575055|FG003|Overall Study|Study termination|2|||
124440875|NCT00640016|447575052|FG000|Overall Study|Adverse Event|0|||
124440876|NCT00640016|447575053|FG001|Overall Study|Adverse Event|0|||
124440877|NCT00640016|447575054|FG002|Overall Study|Adverse Event|0|||
124440878|NCT00640016|447575055|FG003|Overall Study|Adverse Event|1|||
124440879|NCT01287065|447575056|FG000|Treatment Period 1|Adverse Event|0|||
124440880|NCT01287065|447575057|FG001|Treatment Period 1|Adverse Event|0|||
124440881|NCT01287065|447575058|FG002|Treatment Period 1|Adverse Event|0|||
124440882|NCT01287065|447575059|FG003|Treatment Period 1|Adverse Event|0|||
124440883|NCT01287065|447575060|FG004|Treatment Period 1|Adverse Event|1|||
124440884|NCT01287065|447575061|FG005|Treatment Period 1|Adverse Event|0|||
124440885|NCT01287065|447575056|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124440886|NCT01287065|447575057|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124440887|NCT01287065|447575058|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124440888|NCT01287065|447575059|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124440889|NCT01287065|447575060|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124440890|NCT01287065|447575061|FG005|Treatment Period 1|Withdrawal by Subject|1|||
124440891|NCT02875977|447575062|FG000|Overall Study|Lost to Follow-up|42|||
124440892|NCT02875977|447575063|FG001|Overall Study|Lost to Follow-up|29|||
124440893|NCT01259726|447575064|FG000|Overall Study|Death|1|||
124440894|NCT01259726|447575065|FG001|Overall Study|Death|0|||
124440895|NCT01259726|447575066|FG002|Overall Study|Death|0|||
124440896|NCT01259726|447575067|FG003|Overall Study|Death|0|||
124440897|NCT01259726|447575064|FG000|Overall Study|Physician Decision|2|||
124440898|NCT01259726|447575065|FG001|Overall Study|Physician Decision|0|||
124440899|NCT01259726|447575066|FG002|Overall Study|Physician Decision|1|||
124686180|NCT01069939|448471244|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
124686181|NCT01069939|448471243|FG000|Randomised and Included in the Analyses|Removal|1|||
124686182|NCT01069939|448471244|FG001|Randomised and Included in the Analyses|Removal|0|||
124888565|NCT00519636|449215537|FG000|Washout Period|Participating in study at another site|1|||
124888566|NCT00519636|449215538|FG001|Washout Period|Participating in study at another site|0|||
124888567|NCT00519636|449215539|FG002|Washout Period|Participating in study at another site|0|||
124888568|NCT00519636|449215540|FG003|Washout Period|Participating in study at another site|0|||
124440900|NCT01259726|447575067|FG003|Overall Study|Physician Decision|1|||
124440901|NCT01259726|447575064|FG000|Overall Study|Withdrawal by Subject|1|||
124440902|NCT01259726|447575065|FG001|Overall Study|Withdrawal by Subject|3|||
124440903|NCT01259726|447575066|FG002|Overall Study|Withdrawal by Subject|2|||
124440904|NCT01259726|447575067|FG003|Overall Study|Withdrawal by Subject|1|||
124440905|NCT01259726|447575064|FG000|Overall Study|Lost to Follow-up|1|||
124440906|NCT01259726|447575065|FG001|Overall Study|Lost to Follow-up|1|||
124440907|NCT01259726|447575066|FG002|Overall Study|Lost to Follow-up|1|||
124440908|NCT01259726|447575067|FG003|Overall Study|Lost to Follow-up|3|||
124440909|NCT01978262|447575068|FG000|Overall Study|Withdrawal by Subject|9|||
124440910|NCT01978262|447575068|FG000|Overall Study|Lost to Follow-up|2|||
124440911|NCT03421431|447575076|FG000|Overall Study|Adverse Event|2|||
124440912|NCT03421431|447575077|FG001|Overall Study|Adverse Event|1|||
124440913|NCT03421431|447575078|FG002|Overall Study|Adverse Event|12|||
124440914|NCT03421431|447575076|FG000|Overall Study|Lost to Follow-up|1|||
124440915|NCT03421431|447575077|FG001|Overall Study|Lost to Follow-up|1|||
124440916|NCT03421431|447575078|FG002|Overall Study|Lost to Follow-up|1|||
124440917|NCT03421431|447575076|FG000|Overall Study|Withdrawal by Subject|3|||
124440918|NCT03421431|447575077|FG001|Overall Study|Withdrawal by Subject|2|||
124440919|NCT03421431|447575078|FG002|Overall Study|Withdrawal by Subject|1|||
124440920|NCT03421431|447575076|FG000|Overall Study|Protocol Violation|0|||
124440921|NCT03421431|447575077|FG001|Overall Study|Protocol Violation|1|||
124440922|NCT03421431|447575078|FG002|Overall Study|Protocol Violation|0|||
124440923|NCT03421431|447575076|FG000|Overall Study|Participant met Stopping Rules|0|||
124440924|NCT03421431|447575077|FG001|Overall Study|Participant met Stopping Rules|1|||
124440925|NCT03421431|447575078|FG002|Overall Study|Participant met Stopping Rules|0|||
124440926|NCT00141726|447575082|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
124440927|NCT00235326|447575087|FG000|Overall Study|Lost to Follow-up|746|||
124440928|NCT00235326|447575088|FG001|Overall Study|Lost to Follow-up|1400|||
124440929|NCT01128738|447575089|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
124440930|NCT01128738|447575090|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
124440931|NCT01128738|447575089|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
124440932|NCT01128738|447575090|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
124440933|NCT01128738|447575089|FG000|Second TP|Lost to Follow-up|0|||
124440934|NCT01128738|447575090|FG001|Second TP|Lost to Follow-up|1|||
124440935|NCT01128738|447575089|FG000|Second TP|Withdrawal by Subject|0|||
124440936|NCT01128738|447575090|FG001|Second TP|Withdrawal by Subject|2|||
124440937|NCT01178671|447575091|FG000|Overall Study|Adverse Event|4|||
124440938|NCT01178671|447575092|FG001|Overall Study|Adverse Event|6|||
124440939|NCT01178671|447575091|FG000|Overall Study|Protocol Violation|1|||
124440940|NCT01178671|447575092|FG001|Overall Study|Protocol Violation|1|||
124440941|NCT01178671|447575091|FG000|Overall Study|Lack of Efficacy|0|||
124440942|NCT01178671|447575092|FG001|Overall Study|Lack of Efficacy|1|||
124440943|NCT01178671|447575091|FG000|Overall Study|Lost to Follow-up|3|||
124440944|NCT01178671|447575092|FG001|Overall Study|Lost to Follow-up|1|||
124440945|NCT01178671|447575091|FG000|Overall Study|Physician Decision|4|||
124440946|NCT01178671|447575092|FG001|Overall Study|Physician Decision|6|||
124440947|NCT02349451|447575096|FG000|Overall Study|Withdrawal by Subject|0|||
124440948|NCT02349451|447575097|FG001|Overall Study|Withdrawal by Subject|1|||
124440949|NCT02349451|447575098|FG002|Overall Study|Withdrawal by Subject|2|||
124440950|NCT02349451|447575099|FG003|Overall Study|Withdrawal by Subject|1|||
124440951|NCT02683941|447575100|FG000|Double-blind Phase|Adverse Event|0|||
124440952|NCT02683941|447575101|FG001|Double-blind Phase|Adverse Event|1|||
124440953|NCT02683941|447575100|FG000|Double-blind Phase|Withdrawal by Subject|4|||
124440954|NCT02683941|447575101|FG001|Double-blind Phase|Withdrawal by Subject|2|||
124440955|NCT02683941|447575100|FG000|Double-blind Phase|Lost to Follow-up|1|||
124440956|NCT02683941|447575101|FG001|Double-blind Phase|Lost to Follow-up|0|||
124440957|NCT02683941|447575100|FG000|Double-blind Phase|Disease Progression|5|||
124440958|NCT02683941|447575101|FG001|Double-blind Phase|Disease Progression|2|||
124686183|NCT05166876|448471245|FG000|Overall Study|Withdrawal by Subject|1|||
124686184|NCT05166876|448471246|FG001|Overall Study|Withdrawal by Subject|0|||
124686185|NCT05166876|448471247|FG002|Overall Study|Withdrawal by Subject|0|||
124440959|NCT02683941|447575100|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
124440960|NCT02683941|447575101|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
124440961|NCT02683941|447575100|FG000|Open-label Treatment Phase|Disease Progression|1|||
124440962|NCT02683941|447575101|FG001|Open-label Treatment Phase|Disease Progression|2|||
124440963|NCT02683941|447575100|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
124440964|NCT02683941|447575101|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
124759060|NCT00430716|448741240|FG001|Open Label Phase|No longer willing to participate|1|||
124759061|NCT00430716|448741241|FG002|Open Label Phase|No longer willing to participate|1|||
124759062|NCT00430716|448741239|FG000|Open Label Phase|Other|3|||
124759063|NCT00430716|448741240|FG001|Open Label Phase|Other|1|||
124759064|NCT00430716|448741241|FG002|Open Label Phase|Other|1|||
124759065|NCT00430716|448741239|FG000|Open Label Phase|Protocol Violation|1|||
124759066|NCT00430716|448741240|FG001|Open Label Phase|Protocol Violation|0|||
124759067|NCT00430716|448741241|FG002|Open Label Phase|Protocol Violation|0|||
124759068|NCT00430716|448741239|FG000|Open Label Phase|Study terminated by sponsor|4|||
124759069|NCT00430716|448741240|FG001|Open Label Phase|Study terminated by sponsor|5|||
124759070|NCT00430716|448741241|FG002|Open Label Phase|Study terminated by sponsor|4|||
124759071|NCT01433172|448741242|FG000|Overall Study|Withdrawal by Subject|0|||
124759072|NCT01433172|448741243|FG001|Overall Study|Withdrawal by Subject|1|||
124759073|NCT01433172|448741244|FG002|Overall Study|Withdrawal by Subject|0|||
124759074|NCT01433172|448741242|FG000|Overall Study|Disease Progression|0|||
124759075|NCT01433172|448741243|FG001|Overall Study|Disease Progression|0|||
124759076|NCT01433172|448741244|FG002|Overall Study|Disease Progression|1|||
124686186|NCT00658528|448471248|FG000|Overall Study|Adverse Event|5|||
124686187|NCT00658528|448471249|FG001|Overall Study|Adverse Event|7|||
124686188|NCT00658528|448471248|FG000|Overall Study|Lost to Follow-up|14|||
124759077|NCT01433172|448741242|FG000|Overall Study|Death|0|||
124759078|NCT01433172|448741243|FG001|Overall Study|Death|2|||
124888569|NCT00519636|449215537|FG000|Washout Period|Non-compliant|0|||
124440965|NCT02683941|447575100|FG000|Open-label Treatment Phase|Other|1|||
124440966|NCT02683941|447575101|FG001|Open-label Treatment Phase|Other|0|||
124440967|NCT02683941|447575100|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
124686189|NCT00658528|448471249|FG001|Overall Study|Lost to Follow-up|22|||
124686190|NCT00658528|448471248|FG000|Overall Study|Withdrawal by Subject|8|||
124686191|NCT00658528|448471249|FG001|Overall Study|Withdrawal by Subject|6|||
124686192|NCT00658528|448471248|FG000|Overall Study|Withdrawal of consent|5|||
124686193|NCT00658528|448471249|FG001|Overall Study|Withdrawal of consent|6|||
124686194|NCT00658528|448471248|FG000|Overall Study|Other|8|||
124686195|NCT00658528|448471249|FG001|Overall Study|Other|4|||
124686196|NCT01937299|448471251|FG000|Overall Study|Adverse Event|13|||
124686197|NCT01937299|448471252|FG001|Overall Study|Adverse Event|0|||
124686198|NCT01937299|448471251|FG000|Overall Study|Lack of Efficacy|0|||
124686199|NCT01937299|448471252|FG001|Overall Study|Lack of Efficacy|4|||
124686200|NCT01937299|448471251|FG000|Overall Study|Withdrawal by Subject|1|||
124686201|NCT01937299|448471252|FG001|Overall Study|Withdrawal by Subject|0|||
124686202|NCT04017962|448471253|FG000|Overall Study|Death|2|||
124686203|NCT04017962|448471254|FG001|Overall Study|Death|0|||
124686204|NCT04017962|448471253|FG000|Overall Study|Lost to Follow-up|2|||
124686205|NCT04017962|448471254|FG001|Overall Study|Lost to Follow-up|0|||
124440968|NCT02683941|447575101|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
124440969|NCT02683941|447575100|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
124440970|NCT02683941|447575101|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
124440971|NCT02683941|447575100|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
124440972|NCT02683941|447575101|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
124440973|NCT02683941|447575100|FG000|Open-label Follow-up Phase|Other|8|||
124440974|NCT02683941|447575101|FG001|Open-label Follow-up Phase|Other|1|||
124440975|NCT02168842|447575103|FG000|Overall Study|Withdrawal by Subject|5|||
124440976|NCT02168842|447575104|FG001|Overall Study|Withdrawal by Subject|3|||
124440977|NCT02168842|447575103|FG000|Overall Study|Lost to Follow-up|0|||
124440978|NCT02168842|447575104|FG001|Overall Study|Lost to Follow-up|2|||
124440979|NCT02168842|447575103|FG000|Overall Study|Death|2|||
124440980|NCT02168842|447575104|FG001|Overall Study|Death|1|||
124440981|NCT02168842|447575103|FG000|Overall Study|Physician Decision|1|||
124440982|NCT02168842|447575104|FG001|Overall Study|Physician Decision|2|||
124440983|NCT00325039|447575105|FG000|Overall Study|Lost to Follow-up|18|||
124440984|NCT00325039|447575106|FG001|Overall Study|Lost to Follow-up|14|||
124440985|NCT02974088|447575107|FG000|Overall Study|Lost to Follow-up|0|||
124686206|NCT04017962|448471253|FG000|Overall Study|Physician Decision|1|||
124686207|NCT04017962|448471254|FG001|Overall Study|Physician Decision|0|||
124759079|NCT01433172|448741244|FG002|Overall Study|Death|0|||
124759080|NCT03116685|448741249|FG000|Overall Study|Physician Decision|0|||
124440986|NCT02974088|447575108|FG001|Overall Study|Lost to Follow-up|2|||
124440987|NCT02974088|447575107|FG000|Overall Study|Adverse Event|0|||
124686208|NCT04017962|448471253|FG000|Overall Study|Discontinued LTV|5|||
124759081|NCT03116685|448741250|FG001|Overall Study|Physician Decision|1|||
124440988|NCT02974088|447575108|FG001|Overall Study|Adverse Event|1|||
124440989|NCT00687973|447575114|FG000|Overall Study|Adverse Event|18|||
124686209|NCT04017962|448471254|FG001|Overall Study|Discontinued LTV|0|||
124686210|NCT01260948|448471255|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
124686211|NCT01260948|448471256|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
124686212|NCT01260948|448471255|FG000|Second Intervention|Emesis|0|||
124686213|NCT01260948|448471256|FG001|Second Intervention|Emesis|1|||
124686214|NCT01163617|448471257|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
124759082|NCT01045694|448741251|FG000|Overall Study|Withdrawal by Subject|2|||
124759083|NCT01150097|448741252|FG000|Months 24 to 36 Post-transplantation|Death|2|||
124759084|NCT01150097|448741253|FG001|Months 24 to 36 Post-transplantation|Death|0|||
124759085|NCT01150097|448741254|FG002|Months 24 to 36 Post-transplantation|Death|0|||
124759086|NCT01150097|448741252|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
124759087|NCT01150097|448741253|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
124759088|NCT01150097|448741254|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
124759089|NCT01150097|448741252|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
124759090|NCT01150097|448741253|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
124759091|NCT01150097|448741254|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
124759092|NCT01150097|448741252|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
124759093|NCT01150097|448741253|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
124759094|NCT01150097|448741254|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
124759095|NCT01150097|448741252|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
124759096|NCT01150097|448741253|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
124759097|NCT01150097|448741254|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
124759098|NCT01150097|448741252|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
124759099|NCT01150097|448741253|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
124759100|NCT01150097|448741254|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
124759101|NCT01150097|448741252|FG000|Months 24 to 48 Post-transplantation|Death|2|||
124759102|NCT01150097|448741253|FG001|Months 24 to 48 Post-transplantation|Death|0|||
124759103|NCT01150097|448741254|FG002|Months 24 to 48 Post-transplantation|Death|0|||
124759104|NCT02719171|448742512|FG000|Overall Study|Adverse Event|1|||
124759105|NCT02719171|448742513|FG001|Overall Study|Adverse Event|2|||
124759106|NCT02719171|448742514|FG002|Overall Study|Adverse Event|0|||
124759107|NCT02719171|448742515|FG003|Overall Study|Adverse Event|0|||
124759108|NCT02719171|448742516|FG004|Overall Study|Adverse Event|2|||
124759109|NCT02719171|448742512|FG000|Overall Study|Lost to Follow-up|0|||
124759110|NCT02719171|448742513|FG001|Overall Study|Lost to Follow-up|0|||
124759111|NCT02719171|448742514|FG002|Overall Study|Lost to Follow-up|1|||
124759112|NCT02719171|448742515|FG003|Overall Study|Lost to Follow-up|0|||
124759113|NCT02719171|448742516|FG004|Overall Study|Lost to Follow-up|0|||
124759114|NCT02719171|448742512|FG000|Overall Study|Subject Withdrawal|0|||
124888570|NCT00519636|449215538|FG001|Washout Period|Non-compliant|1|||
124888571|NCT00519636|449215539|FG002|Washout Period|Non-compliant|0|||
124888572|NCT00519636|449215540|FG003|Washout Period|Non-compliant|0|||
124888573|NCT00519636|449215537|FG000|Washout Period|Per doctors request|0|||
124888574|NCT00519636|449215538|FG001|Washout Period|Per doctors request|1|||
124888575|NCT00519636|449215539|FG002|Washout Period|Per doctors request|0|||
124888576|NCT00519636|449215540|FG003|Washout Period|Per doctors request|0|||
124888577|NCT00519636|449215537|FG000|Washout Period|Subject randomized in error|0|||
124888578|NCT00519636|449215538|FG001|Washout Period|Subject randomized in error|0|||
124888579|NCT00519636|449215539|FG002|Washout Period|Subject randomized in error|1|||
124888580|NCT00519636|449215540|FG003|Washout Period|Subject randomized in error|0|||
124888581|NCT00519636|449215537|FG000|Washout Period|Prohibited medications|0|||
124888582|NCT00519636|449215538|FG001|Washout Period|Prohibited medications|0|||
124888583|NCT00519636|449215539|FG002|Washout Period|Prohibited medications|1|||
124888584|NCT00519636|449215540|FG003|Washout Period|Prohibited medications|0|||
124888585|NCT00519636|449215537|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
124888586|NCT00519636|449215538|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
124888587|NCT00519636|449215539|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
124888588|NCT00519636|449215540|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
124888589|NCT00519636|449215537|FG000|Treatment Period 2|Subject randomized in error|0|||
124888590|NCT00519636|449215538|FG001|Treatment Period 2|Subject randomized in error|1|||
124888591|NCT00519636|449215539|FG002|Treatment Period 2|Subject randomized in error|0|||
124888592|NCT00519636|449215540|FG003|Treatment Period 2|Subject randomized in error|0|||
124888593|NCT00519636|449215537|FG000|Treatment Period 2|Per doctors request|0|||
124888594|NCT00519636|449215538|FG001|Treatment Period 2|Per doctors request|0|||
124888595|NCT00519636|449215539|FG002|Treatment Period 2|Per doctors request|1|||
124888596|NCT00519636|449215540|FG003|Treatment Period 2|Per doctors request|0|||
124888597|NCT00519636|449215537|FG000|Treatment Period 2|Subject misrandomized|0|||
124888598|NCT00519636|449215538|FG001|Treatment Period 2|Subject misrandomized|0|||
124888599|NCT00519636|449215539|FG002|Treatment Period 2|Subject misrandomized|0|||
124888600|NCT00519636|449215540|FG003|Treatment Period 2|Subject misrandomized|1|||
124759115|NCT02719171|448742513|FG001|Overall Study|Subject Withdrawal|2|||
124888601|NCT00519636|449215537|FG000|Post Study Period|Subject randomized in error|0|||
124888602|NCT00519636|449215538|FG001|Post Study Period|Subject randomized in error|0|||
124888603|NCT00519636|449215539|FG002|Post Study Period|Subject randomized in error|0|||
124888604|NCT00519636|449215540|FG003|Post Study Period|Subject randomized in error|1|||
124759116|NCT02719171|448742514|FG002|Overall Study|Subject Withdrawal|2|||
124759117|NCT02719171|448742515|FG003|Overall Study|Subject Withdrawal|1|||
124759118|NCT02719171|448742516|FG004|Overall Study|Subject Withdrawal|0|||
124759119|NCT02719171|448742512|FG000|Overall Study|Other|0|||
124888605|NCT01671748|449215547|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
124440990|NCT00687973|447575115|FG001|Overall Study|Adverse Event|28|||
124888606|NCT01671748|449215548|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
124888607|NCT01671748|449215547|FG000|4 Week run-in Phase|Adverse Event|1|||
124888608|NCT01671748|449215548|FG001|4 Week run-in Phase|Adverse Event|0|||
124888609|NCT01671748|449215547|FG000|4 Week run-in Phase|Not eligible|9|||
124888610|NCT01671748|449215548|FG001|4 Week run-in Phase|Not eligible|0|||
124440991|NCT00687973|447575114|FG000|Overall Study|Lack of Efficacy|2|||
124440992|NCT00687973|447575115|FG001|Overall Study|Lack of Efficacy|3|||
124440993|NCT00687973|447575114|FG000|Overall Study|Protocol Violation|1|||
124440994|NCT00687973|447575115|FG001|Overall Study|Protocol Violation|2|||
124440995|NCT00687973|447575114|FG000|Overall Study|Administrative Reasons|0|||
124440996|NCT00687973|447575115|FG001|Overall Study|Administrative Reasons|2|||
124440997|NCT00687973|447575114|FG000|Overall Study|Withdrawal by Subject|3|||
124440998|NCT00687973|447575115|FG001|Overall Study|Withdrawal by Subject|3|||
124686215|NCT01163617|448471258|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
124686216|NCT01163617|448471259|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
124686217|NCT01163617|448471260|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
124686218|NCT01163617|448471261|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
124686219|NCT01163617|448471262|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
124686220|NCT01163617|448471263|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
124888611|NCT02169830|449216773|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
124888612|NCT02169830|449216774|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
124888613|NCT02169830|449216775|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
124888614|NCT02169830|449216773|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
124888615|NCT02169830|449216774|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
124888616|NCT02169830|449216775|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
124888617|NCT02169830|449216773|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
124888618|NCT02169830|449216774|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
124888619|NCT02169830|449216775|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
124888620|NCT02169830|449216773|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
124888621|NCT02169830|449216774|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
124888622|NCT02169830|449216775|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
124888623|NCT02169830|449216773|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
124888624|NCT02169830|449216774|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
124888625|NCT02169830|449216775|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
124888626|NCT02555371|449216776|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
124888627|NCT02555371|449216777|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
124888628|NCT02555371|449216778|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
124888629|NCT02555371|449216779|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
124686221|NCT01163617|448471264|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
124686222|NCT01163617|448471257|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
124686223|NCT01163617|448471258|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
124686224|NCT01163617|448471259|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
124686225|NCT01163617|448471260|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
124686226|NCT01163617|448471261|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
124686227|NCT01163617|448471262|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
124686228|NCT01163617|448471263|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
124686229|NCT01163617|448471264|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
124686230|NCT01163617|448471257|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
124686231|NCT01163617|448471258|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
124686232|NCT01163617|448471259|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
124686233|NCT01163617|448471260|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
124686234|NCT01163617|448471261|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
124686235|NCT01163617|448471262|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
124686236|NCT01163617|448471263|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
124686237|NCT01163617|448471264|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
124686238|NCT02394756|448471265|FG000|Period 1|Lens Discomfort|0|||
124686239|NCT02394756|448471266|FG001|Period 1|Lens Discomfort|0|||
124686240|NCT02394756|448471267|FG002|Period 1|Lens Discomfort|0|||
124888630|NCT02555371|449216780|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
124888631|NCT02555371|449216776|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
124888632|NCT02555371|449216777|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
124888633|NCT02555371|449216778|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
124888634|NCT02555371|449216779|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
124440999|NCT00343252|447575116|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
124441000|NCT00343252|447575117|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
124441001|NCT00343252|447575116|FG000|6 Months (All Treated Participants)|Death|0|||
124441002|NCT00343252|447575117|FG001|6 Months (All Treated Participants)|Death|2|||
124441003|NCT00343252|447575116|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
124441004|NCT00343252|447575117|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
124441005|NCT00343252|447575116|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
124441006|NCT00343252|447575117|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
124441007|NCT00343252|447575116|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
124441008|NCT00343252|447575117|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
124441009|NCT00343252|447575116|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
124441010|NCT00343252|447575117|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
124441011|NCT00343252|447575116|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
124441012|NCT00343252|447575117|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
124441013|NCT00343252|447575116|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
124441014|NCT00343252|447575117|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
124441015|NCT00343252|447575116|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
124441016|NCT00343252|447575117|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
124441017|NCT00343252|447575116|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
124441018|NCT00343252|447575117|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
124441019|NCT00343252|447575116|FG000|12 Months (All Treated Participants)|Death|3|||
124441020|NCT00343252|447575117|FG001|12 Months (All Treated Participants)|Death|3|||
124441021|NCT00343252|447575116|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
124441022|NCT00343252|447575117|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
124441023|NCT00343252|447575116|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
124441024|NCT00343252|447575117|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
124441025|NCT00343252|447575116|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
124441026|NCT00343252|447575117|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
124441027|NCT00343252|447575116|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
124441028|NCT00343252|447575117|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
124441029|NCT00343252|447575116|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
124441030|NCT00343252|447575117|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
124441031|NCT00343252|447575116|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
124441032|NCT00343252|447575117|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
124441033|NCT00343252|447575116|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
124441034|NCT00343252|447575117|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
124441035|NCT00343252|447575116|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
124441036|NCT00343252|447575117|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
124888635|NCT02555371|449216780|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
124888636|NCT02555371|449216776|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
124888637|NCT02555371|449216777|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
124888638|NCT02555371|449216778|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
124888639|NCT02555371|449216779|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
124888640|NCT02555371|449216780|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
124888641|NCT02555371|449216776|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
124888642|NCT02555371|449216777|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
124888643|NCT02555371|449216778|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
124888644|NCT02555371|449216779|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
124888645|NCT02555371|449216780|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
124888646|NCT02555371|449216776|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
124888647|NCT02555371|449216777|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
124888648|NCT02555371|449216778|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
124888649|NCT02555371|449216779|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
124888650|NCT02555371|449216780|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
124888651|NCT02555371|449216776|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
124888652|NCT02555371|449216777|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
124888653|NCT02555371|449216778|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
124888654|NCT02555371|449216779|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
124888655|NCT02555371|449216780|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
124888656|NCT02555371|449216776|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
124888657|NCT02555371|449216777|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
124888658|NCT02555371|449216778|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
124888659|NCT02555371|449216779|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
124888660|NCT02555371|449216780|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
124888661|NCT02555371|449216776|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
124441037|NCT00343252|447575116|FG000|18 Months (All Treated Participants)|Death|4|||
124441038|NCT00343252|447575117|FG001|18 Months (All Treated Participants)|Death|5|||
124441039|NCT00343252|447575116|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
124441040|NCT00343252|447575117|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
124441041|NCT00343252|447575116|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
124441042|NCT00343252|447575117|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
124441043|NCT00343252|447575116|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
124441044|NCT00343252|447575117|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
124441045|NCT00343252|447575116|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
124441046|NCT00343252|447575117|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
124441047|NCT00343252|447575116|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
124441048|NCT00343252|447575117|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
124441049|NCT00343252|447575116|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
124441050|NCT00343252|447575117|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
124441051|NCT00343252|447575116|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
124441052|NCT00343252|447575117|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
124441053|NCT01740323|447575118|FG000|Overall Study|Adverse Event|1|||
124441054|NCT01740323|447575119|FG001|Overall Study|Adverse Event|0|||
124441055|NCT01740323|447575118|FG000|Overall Study|Randomized but did not take study drug|1|||
124441056|NCT01740323|447575119|FG001|Overall Study|Randomized but did not take study drug|0|||
124441057|NCT03945825|447575124|FG000|Overall Study|Enrolled but treatment not administered|0|||
124441058|NCT03945825|447575125|FG001|Overall Study|Enrolled but treatment not administered|0|||
124441059|NCT03945825|447575126|FG002|Overall Study|Enrolled but treatment not administered|0|||
124441060|NCT03945825|447575127|FG003|Overall Study|Enrolled but treatment not administered|0|||
124441061|NCT03945825|447575128|FG004|Overall Study|Enrolled but treatment not administered|1|||
124441062|NCT03945825|447575129|FG005|Overall Study|Enrolled but treatment not administered|0|||
124441063|NCT03945825|447575124|FG000|Overall Study|Lost to Follow-up|1|||
124441064|NCT03945825|447575125|FG001|Overall Study|Lost to Follow-up|5|||
124441065|NCT03945825|447575126|FG002|Overall Study|Lost to Follow-up|0|||
124441066|NCT03945825|447575127|FG003|Overall Study|Lost to Follow-up|1|||
124441067|NCT03945825|447575128|FG004|Overall Study|Lost to Follow-up|2|||
124441068|NCT03945825|447575129|FG005|Overall Study|Lost to Follow-up|2|||
124441069|NCT03945825|447575124|FG000|Overall Study|Withdrawal by Subject|1|||
124441070|NCT03945825|447575125|FG001|Overall Study|Withdrawal by Subject|0|||
124441071|NCT03945825|447575126|FG002|Overall Study|Withdrawal by Subject|1|||
124441072|NCT03945825|447575127|FG003|Overall Study|Withdrawal by Subject|1|||
124441073|NCT03945825|447575128|FG004|Overall Study|Withdrawal by Subject|0|||
124441074|NCT03945825|447575129|FG005|Overall Study|Withdrawal by Subject|1|||
124441075|NCT01423253|447575137|FG000|Overall Study|Adverse Event|2|||
124441076|NCT01423253|447575137|FG000|Overall Study|Lack of Efficacy|2|||
124441077|NCT01423253|447575137|FG000|Overall Study|Lost to Follow-up|1|||
124441078|NCT01423253|447575137|FG000|Overall Study|Protocol Violation|2|||
124441079|NCT01423253|447575137|FG000|Overall Study|Withdrawal by Subject|2|||
124441080|NCT00307125|447575138|FG000|Screening Phase|Adverse Event|1|||
124441081|NCT00307125|447575139|FG001|Screening Phase|Adverse Event|0|||
124441082|NCT00307125|447575140|FG002|Screening Phase|Adverse Event|0|||
124686241|NCT02394756|448471268|FG003|Period 1|Lens Discomfort|0|||
124686242|NCT02394756|448471269|FG004|Period 1|Lens Discomfort|0|||
124686243|NCT02394756|448471270|FG005|Period 1|Lens Discomfort|1|||
124686244|NCT02394756|448471265|FG000|Period 1|Withdrawal by Subject|0|||
124686245|NCT02394756|448471266|FG001|Period 1|Withdrawal by Subject|1|||
124686246|NCT02394756|448471267|FG002|Period 1|Withdrawal by Subject|1|||
124441083|NCT00307125|447575138|FG000|Screening Phase|Protocol Violation|27|||
124441084|NCT00307125|447575139|FG001|Screening Phase|Protocol Violation|0|||
124441085|NCT00307125|447575140|FG002|Screening Phase|Protocol Violation|0|||
124441086|NCT00307125|447575138|FG000|Screening Phase|Lost to Follow-up|87|||
124441087|NCT00307125|447575139|FG001|Screening Phase|Lost to Follow-up|0|||
124441088|NCT00307125|447575140|FG002|Screening Phase|Lost to Follow-up|0|||
124441089|NCT00307125|447575138|FG000|Screening Phase|Death|10|||
124441090|NCT00307125|447575139|FG001|Screening Phase|Death|0|||
124441091|NCT00307125|447575140|FG002|Screening Phase|Death|0|||
124441092|NCT00307125|447575138|FG000|Screening Phase|Withdrawal by Subject|77|||
124441093|NCT00307125|447575139|FG001|Screening Phase|Withdrawal by Subject|0|||
124441094|NCT00307125|447575140|FG002|Screening Phase|Withdrawal by Subject|0|||
124441095|NCT00307125|447575138|FG000|Screening Phase|Physician Decision|26|||
124441096|NCT00307125|447575139|FG001|Screening Phase|Physician Decision|0|||
124441097|NCT00307125|447575140|FG002|Screening Phase|Physician Decision|0|||
124441098|NCT00307125|447575138|FG000|Screening Phase|Sponsor Decision|4|||
124441099|NCT00307125|447575139|FG001|Screening Phase|Sponsor Decision|0|||
124441100|NCT00307125|447575140|FG002|Screening Phase|Sponsor Decision|0|||
124441101|NCT00307125|447575138|FG000|Screening Phase|Study Terminated|17|||
124441102|NCT00307125|447575139|FG001|Screening Phase|Study Terminated|0|||
124441103|NCT00307125|447575140|FG002|Screening Phase|Study Terminated|0|||
124441104|NCT00307125|447575138|FG000|Screening Phase|Graft Loss|3|||
124686247|NCT02394756|448471268|FG003|Period 1|Withdrawal by Subject|1|||
124686248|NCT02394756|448471269|FG004|Period 1|Withdrawal by Subject|0|||
124759120|NCT02719171|448742513|FG001|Overall Study|Other|0|||
124441105|NCT00307125|447575139|FG001|Screening Phase|Graft Loss|0|||
124441106|NCT00307125|447575140|FG002|Screening Phase|Graft Loss|0|||
124441107|NCT00307125|447575138|FG000|Screening Phase|Graft Failure|8|||
124441108|NCT00307125|447575139|FG001|Screening Phase|Graft Failure|0|||
124441109|NCT00307125|447575140|FG002|Screening Phase|Graft Failure|0|||
124441110|NCT00307125|447575138|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
124441111|NCT00307125|447575139|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
124441112|NCT00307125|447575140|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
124441113|NCT00307125|447575138|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
124441114|NCT00307125|447575139|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
124441115|NCT00307125|447575140|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
124441116|NCT00307125|447575138|FG000|Screening Phase|Moved or transferred facilities|34|||
124441117|NCT00307125|447575139|FG001|Screening Phase|Moved or transferred facilities|0|||
124441118|NCT00307125|447575140|FG002|Screening Phase|Moved or transferred facilities|0|||
124441119|NCT00307125|447575138|FG000|Screening Phase|Received Pancreas Transplant|8|||
124441120|NCT00307125|447575139|FG001|Screening Phase|Received Pancreas Transplant|0|||
124441121|NCT00307125|447575140|FG002|Screening Phase|Received Pancreas Transplant|0|||
124441122|NCT00307125|447575138|FG000|Screening Phase|Ineligible for pilot|4|||
124441123|NCT00307125|447575139|FG001|Screening Phase|Ineligible for pilot|0|||
124441124|NCT00307125|447575140|FG002|Screening Phase|Ineligible for pilot|0|||
124441125|NCT00307125|447575138|FG000|Screening Phase|Try to get pregnant|1|||
124441126|NCT00307125|447575139|FG001|Screening Phase|Try to get pregnant|0|||
124441127|NCT00307125|447575140|FG002|Screening Phase|Try to get pregnant|0|||
124441128|NCT00307125|447575138|FG000|Screening Phase|Developed acute leukemia|1|||
124759121|NCT02719171|448742514|FG002|Overall Study|Other|0|||
124759122|NCT02719171|448742515|FG003|Overall Study|Other|1|||
124441129|NCT00307125|447575139|FG001|Screening Phase|Developed acute leukemia|0|||
124441130|NCT00307125|447575140|FG002|Screening Phase|Developed acute leukemia|0|||
124441131|NCT00307125|447575138|FG000|Screening Phase|Metastatic colon cancer|1|||
124441132|NCT00307125|447575139|FG001|Screening Phase|Metastatic colon cancer|0|||
124759123|NCT02719171|448742516|FG004|Overall Study|Other|0|||
124759124|NCT02796677|448742517|FG000|Overall Study|Adverse Event|11|||
124759125|NCT02796677|448742518|FG001|Overall Study|Adverse Event|22|||
124759126|NCT02796677|448742519|FG002|Overall Study|Adverse Event|14|||
124759127|NCT02796677|448742520|FG003|Overall Study|Adverse Event|14|||
124759128|NCT02796677|448742517|FG000|Overall Study|Protocol Violation|7|||
124759129|NCT02796677|448742518|FG001|Overall Study|Protocol Violation|5|||
124759130|NCT02796677|448742519|FG002|Overall Study|Protocol Violation|4|||
124759131|NCT02796677|448742520|FG003|Overall Study|Protocol Violation|8|||
124759132|NCT02796677|448742517|FG000|Overall Study|Lost to Follow-up|1|||
124759133|NCT02796677|448742518|FG001|Overall Study|Lost to Follow-up|5|||
124759134|NCT02796677|448742519|FG002|Overall Study|Lost to Follow-up|2|||
124888662|NCT02555371|449216777|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
124888663|NCT02555371|449216778|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
124686249|NCT02394756|448471270|FG005|Period 1|Withdrawal by Subject|0|||
124686250|NCT02394756|448471265|FG000|Period 2|Unsatisfactory Visual Response|0|||
124686251|NCT02394756|448471266|FG001|Period 2|Unsatisfactory Visual Response|0|||
124686252|NCT02394756|448471267|FG002|Period 2|Unsatisfactory Visual Response|0|||
124686253|NCT02394756|448471268|FG003|Period 2|Unsatisfactory Visual Response|0|||
124686254|NCT02394756|448471269|FG004|Period 2|Unsatisfactory Visual Response|1|||
124686255|NCT02394756|448471270|FG005|Period 2|Unsatisfactory Visual Response|0|||
124686256|NCT02335944|448471271|FG000|Treatment Phase|Progressive Disease|2|||
124759135|NCT02796677|448742520|FG003|Overall Study|Lost to Follow-up|2|||
124888664|NCT02555371|449216779|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
124888665|NCT02555371|449216780|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
124888666|NCT02555371|449216776|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
124888667|NCT02555371|449216777|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
124888668|NCT02555371|449216778|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
124888669|NCT02555371|449216779|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
124686257|NCT02335944|448471272|FG001|Treatment Phase|Progressive Disease|5|||
124686258|NCT02335944|448471273|FG002|Treatment Phase|Progressive Disease|2|||
124888670|NCT02555371|449216780|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
124441133|NCT00307125|447575140|FG002|Screening Phase|Metastatic colon cancer|0|||
124441134|NCT00307125|447575138|FG000|Screening Phase|Malignancy|1|||
124441135|NCT00307125|447575139|FG001|Screening Phase|Malignancy|0|||
124441136|NCT00307125|447575140|FG002|Screening Phase|Malignancy|0|||
124441137|NCT00307125|447575138|FG000|Screening Phase|PAK|1|||
124441138|NCT00307125|447575139|FG001|Screening Phase|PAK|0|||
124441139|NCT00307125|447575140|FG002|Screening Phase|PAK|0|||
124441140|NCT00307125|447575138|FG000|Screening Phase|Ineligible|1|||
124441141|NCT00307125|447575139|FG001|Screening Phase|Ineligible|0|||
124441142|NCT00307125|447575140|FG002|Screening Phase|Ineligible|0|||
124441143|NCT00307125|447575138|FG000|Screening Phase|Screen Error|1|||
124441144|NCT00307125|447575139|FG001|Screening Phase|Screen Error|0|||
124441145|NCT00307125|447575140|FG002|Screening Phase|Screen Error|0|||
124441146|NCT00307125|447575138|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
124441147|NCT00307125|447575139|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
124441148|NCT00307125|447575140|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
124441149|NCT00307125|447575138|FG000|Screening Phase|AMR and treated with rituximab|1|||
124441150|NCT00307125|447575139|FG001|Screening Phase|AMR and treated with rituximab|0|||
124441151|NCT00307125|447575140|FG002|Screening Phase|AMR and treated with rituximab|0|||
124441152|NCT00307125|447575138|FG000|Screening Phase|Coronary artery bypass|1|||
124441153|NCT00307125|447575139|FG001|Screening Phase|Coronary artery bypass|0|||
124441154|NCT00307125|447575140|FG002|Screening Phase|Coronary artery bypass|0|||
124441155|NCT00307125|447575138|FG000|Pilot Phase|Lost to Follow-up|0|||
124441156|NCT00307125|447575139|FG001|Pilot Phase|Lost to Follow-up|1|||
124441157|NCT00307125|447575140|FG002|Pilot Phase|Lost to Follow-up|0|||
124441158|NCT00307125|447575138|FG000|Pilot Phase|Withdrawal by Subject|0|||
124441159|NCT00307125|447575139|FG001|Pilot Phase|Withdrawal by Subject|1|||
124441160|NCT00307125|447575140|FG002|Pilot Phase|Withdrawal by Subject|1|||
124441161|NCT00051363|447575141|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
124441162|NCT00051363|447575142|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
124441163|NCT00051363|447575141|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
124441164|NCT00051363|447575142|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
124441165|NCT00051363|447575141|FG000|Overall Study|Death|2|||
124441166|NCT00051363|447575142|FG001|Overall Study|Death|2|||
124441167|NCT00051363|447575141|FG000|Overall Study|Excluded Pre-Randomization|2|||
124441168|NCT00051363|447575142|FG001|Overall Study|Excluded Pre-Randomization|5|||
124441169|NCT00985153|447575143|FG000|Overall Study|Lost to Follow-up|16|||
124441170|NCT00985153|447575144|FG001|Overall Study|Lost to Follow-up|19|||
124441171|NCT00985153|447575145|FG002|Overall Study|Lost to Follow-up|17|||
124441172|NCT00985153|447575146|FG003|Overall Study|Lost to Follow-up|20|||
124441173|NCT00985153|447575143|FG000|Overall Study|Protocol Violation|3|||
124441174|NCT00985153|447575144|FG001|Overall Study|Protocol Violation|2|||
124441175|NCT00985153|447575145|FG002|Overall Study|Protocol Violation|4|||
124441176|NCT00985153|447575146|FG003|Overall Study|Protocol Violation|3|||
124441177|NCT00985153|447575143|FG000|Overall Study|Withdrawal by Subject|6|||
124441178|NCT00985153|447575144|FG001|Overall Study|Withdrawal by Subject|11|||
124441179|NCT00985153|447575145|FG002|Overall Study|Withdrawal by Subject|11|||
124441180|NCT00985153|447575146|FG003|Overall Study|Withdrawal by Subject|10|||
124441181|NCT00985153|447575143|FG000|Overall Study|Missed One or More Bleeds|7|||
124441182|NCT00985153|447575144|FG001|Overall Study|Missed One or More Bleeds|7|||
124441183|NCT00985153|447575145|FG002|Overall Study|Missed One or More Bleeds|8|||
124441184|NCT00985153|447575146|FG003|Overall Study|Missed One or More Bleeds|10|||
124441185|NCT00985153|447575143|FG000|Overall Study|Incomplete Safety Follow-up|3|||
124759136|NCT02796677|448742517|FG000|Overall Study|Lack of Efficacy|7|||
124759137|NCT02796677|448742518|FG001|Overall Study|Lack of Efficacy|9|||
124759138|NCT02796677|448742519|FG002|Overall Study|Lack of Efficacy|14|||
124759139|NCT02796677|448742520|FG003|Overall Study|Lack of Efficacy|20|||
124759140|NCT02796677|448742517|FG000|Overall Study|Withdrawal by Subject|4|||
124759141|NCT02796677|448742518|FG001|Overall Study|Withdrawal by Subject|14|||
124759142|NCT02796677|448742519|FG002|Overall Study|Withdrawal by Subject|6|||
124759143|NCT02796677|448742520|FG003|Overall Study|Withdrawal by Subject|7|||
124759144|NCT02796677|448742517|FG000|Overall Study|Progressive disease|6|||
124759145|NCT02796677|448742518|FG001|Overall Study|Progressive disease|15|||
124759146|NCT02796677|448742519|FG002|Overall Study|Progressive disease|13|||
124759147|NCT02796677|448742520|FG003|Overall Study|Progressive disease|18|||
124441186|NCT00985153|447575144|FG001|Overall Study|Incomplete Safety Follow-up|5|||
124441187|NCT00985153|447575145|FG002|Overall Study|Incomplete Safety Follow-up|4|||
124441188|NCT00985153|447575146|FG003|Overall Study|Incomplete Safety Follow-up|4|||
124441189|NCT01596621|447575148|FG000|Overall Study|Death|4|||
124441190|NCT01596621|447575148|FG000|Overall Study|Withdrawal by Subject|9|||
124759148|NCT02796677|448742517|FG000|Overall Study|Reason not mentioned|2|||
124441191|NCT01596621|447575148|FG000|Overall Study|Disease Progression|49|||
124441192|NCT01596621|447575148|FG000|Overall Study|Lost to Follow-up|3|||
124441193|NCT01596621|447575148|FG000|Overall Study|Other than specified|13|||
124441194|NCT02678247|447575153|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
124441195|NCT02678247|447575154|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
124759149|NCT02796677|448742518|FG001|Overall Study|Reason not mentioned|3|||
124441196|NCT02678247|447575153|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
124441197|NCT02678247|447575154|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
124888671|NCT02555371|449216776|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
124888672|NCT02555371|449216777|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
124441198|NCT02678247|447575153|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
124441199|NCT02678247|447575154|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
124441200|NCT02678247|447575153|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
124441201|NCT02678247|447575154|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
124441202|NCT02678247|447575153|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
124441203|NCT02678247|447575154|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
124441204|NCT02678247|447575153|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
124441205|NCT02678247|447575154|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
124441206|NCT00971243|447575157|FG000|Double Blind Period|Adverse Event|2|||
124441207|NCT00971243|447575158|FG001|Double Blind Period|Adverse Event|3|||
124441208|NCT00971243|447575159|FG002|Double Blind Period|Adverse Event|2|||
124441209|NCT00971243|447575160|FG003|Double Blind Period|Adverse Event|2|||
124441210|NCT00971243|447575161|FG004|Double Blind Period|Adverse Event|3|||
124441211|NCT00971243|447575157|FG000|Double Blind Period|Lost to Follow-up|0|||
124441212|NCT00971243|447575158|FG001|Double Blind Period|Lost to Follow-up|1|||
124441213|NCT00971243|447575159|FG002|Double Blind Period|Lost to Follow-up|1|||
124441214|NCT00971243|447575160|FG003|Double Blind Period|Lost to Follow-up|0|||
124441215|NCT00971243|447575161|FG004|Double Blind Period|Lost to Follow-up|1|||
124441216|NCT00971243|447575157|FG000|Double Blind Period|Physician Decision|10|||
124441217|NCT00971243|447575158|FG001|Double Blind Period|Physician Decision|6|||
124441218|NCT00971243|447575159|FG002|Double Blind Period|Physician Decision|7|||
124441219|NCT00971243|447575160|FG003|Double Blind Period|Physician Decision|6|||
124441220|NCT00971243|447575161|FG004|Double Blind Period|Physician Decision|7|||
124441221|NCT00971243|447575157|FG000|Double Blind Period|Protocol Violation|2|||
124441222|NCT00971243|447575158|FG001|Double Blind Period|Protocol Violation|0|||
124441223|NCT00971243|447575159|FG002|Double Blind Period|Protocol Violation|3|||
124441224|NCT00971243|447575160|FG003|Double Blind Period|Protocol Violation|2|||
124441225|NCT00971243|447575161|FG004|Double Blind Period|Protocol Violation|2|||
124441226|NCT00971243|447575157|FG000|Double Blind Period|Withdrawal by Subject|4|||
124441227|NCT00971243|447575158|FG001|Double Blind Period|Withdrawal by Subject|1|||
124441228|NCT00971243|447575159|FG002|Double Blind Period|Withdrawal by Subject|4|||
124441229|NCT00971243|447575160|FG003|Double Blind Period|Withdrawal by Subject|4|||
124441230|NCT00971243|447575161|FG004|Double Blind Period|Withdrawal by Subject|4|||
124441231|NCT00971243|447575157|FG000|Double Blind Period|Other reasons|1|||
124441232|NCT00971243|447575158|FG001|Double Blind Period|Other reasons|0|||
124441233|NCT00971243|447575159|FG002|Double Blind Period|Other reasons|2|||
124441234|NCT00971243|447575160|FG003|Double Blind Period|Other reasons|0|||
124441235|NCT00971243|447575161|FG004|Double Blind Period|Other reasons|1|||
124441236|NCT00971243|447575157|FG000|Open-label Period|Adverse Event|1|||
124441237|NCT00971243|447575158|FG001|Open-label Period|Adverse Event|0|||
124441238|NCT00971243|447575159|FG002|Open-label Period|Adverse Event|1|||
124441239|NCT00971243|447575160|FG003|Open-label Period|Adverse Event|1|||
124441240|NCT00971243|447575161|FG004|Open-label Period|Adverse Event|0|||
124441241|NCT00971243|447575157|FG000|Open-label Period|Physician Decision|5|||
124441242|NCT00971243|447575158|FG001|Open-label Period|Physician Decision|9|||
124441243|NCT00971243|447575159|FG002|Open-label Period|Physician Decision|3|||
124441244|NCT00971243|447575160|FG003|Open-label Period|Physician Decision|7|||
124441245|NCT00971243|447575161|FG004|Open-label Period|Physician Decision|2|||
124441246|NCT00971243|447575157|FG000|Open-label Period|Protocol Violation|1|||
124441247|NCT00971243|447575158|FG001|Open-label Period|Protocol Violation|1|||
124441248|NCT00971243|447575159|FG002|Open-label Period|Protocol Violation|1|||
124441249|NCT00971243|447575160|FG003|Open-label Period|Protocol Violation|0|||
124441250|NCT00971243|447575161|FG004|Open-label Period|Protocol Violation|1|||
124441251|NCT00971243|447575157|FG000|Open-label Period|Withdrawal by Subject|1|||
124441252|NCT00971243|447575158|FG001|Open-label Period|Withdrawal by Subject|0|||
124441253|NCT00971243|447575159|FG002|Open-label Period|Withdrawal by Subject|0|||
124441254|NCT00971243|447575160|FG003|Open-label Period|Withdrawal by Subject|2|||
124441255|NCT00971243|447575161|FG004|Open-label Period|Withdrawal by Subject|1|||
124441256|NCT00971243|447575157|FG000|Open-label Period|Other reason|0|||
124441257|NCT00971243|447575158|FG001|Open-label Period|Other reason|0|||
124441258|NCT00971243|447575159|FG002|Open-label Period|Other reason|0|||
124441259|NCT00971243|447575160|FG003|Open-label Period|Other reason|0|||
124441260|NCT00971243|447575161|FG004|Open-label Period|Other reason|2|||
124441261|NCT02730598|447575162|FG000|Overall Study|Withdrawal by Subject|3|||
124441262|NCT02730598|447575163|FG001|Overall Study|Withdrawal by Subject|3|||
124441263|NCT02730598|447575162|FG000|Overall Study|Protocol Violation|0|||
124441264|NCT02730598|447575163|FG001|Overall Study|Protocol Violation|1|||
124441265|NCT02730598|447575162|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
124441266|NCT02730598|447575163|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
124441267|NCT02910739|447575164|FG000|Overall Study|Adverse Event|1|||
124441268|NCT02910739|447575165|FG001|Overall Study|Adverse Event|0|||
124441269|NCT02910739|447575166|FG002|Overall Study|Adverse Event|0|||
124441270|NCT02910739|447575167|FG003|Overall Study|Adverse Event|0|||
124441271|NCT01696942|447575170|FG000|Overall Study|Withdrawal by Subject|1|||
124441272|NCT01696942|447575171|FG001|Overall Study|Withdrawal by Subject|0|||
124441273|NCT01696942|447575170|FG000|Overall Study|Protocol Violation|1|||
124686259|NCT02335944|448471274|FG003|Treatment Phase|Progressive Disease|11|||
124441274|NCT01696942|447575171|FG001|Overall Study|Protocol Violation|2|||
124441275|NCT01696942|447575170|FG000|Overall Study|screen failure|0|||
124441276|NCT01696942|447575171|FG001|Overall Study|screen failure|1|||
124441277|NCT01313117|447575176|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
124441278|NCT01313117|447575176|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
124441279|NCT04223856|447575179|FG000|Overall Study|Progressive disease|153|||
124441280|NCT04223856|447575180|FG001|Overall Study|Progressive disease|73|||
124441281|NCT04223856|447575179|FG000|Overall Study|Adverse Event|97|||
124441282|NCT04223856|447575180|FG001|Overall Study|Adverse Event|62|||
124441283|NCT04223856|447575179|FG000|Overall Study|Physician Decision|9|||
124441284|NCT04223856|447575180|FG001|Overall Study|Physician Decision|28|||
124441285|NCT04223856|447575179|FG000|Overall Study|Withdrawal by Subject|22|||
124441286|NCT04223856|447575180|FG001|Overall Study|Withdrawal by Subject|24|||
124441287|NCT04223856|447575179|FG000|Overall Study|Other|7|||
124441288|NCT04223856|447575180|FG001|Overall Study|Other|2|||
124441289|NCT04223856|447575179|FG000|Overall Study|Randomized but not treated|2|||
124441290|NCT04223856|447575180|FG001|Overall Study|Randomized but not treated|11|||
124441291|NCT04223856|447575179|FG000|Overall Study|On-treatment|144|||
124441292|NCT04223856|447575180|FG001|Overall Study|On-treatment|0|||
124441293|NCT03226275|447575181|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
124441294|NCT03226275|447575182|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
124441295|NCT03226275|447575183|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
124441296|NCT03226275|447575184|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
124441297|NCT03226275|447575181|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
124441298|NCT03226275|447575182|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
124441299|NCT03226275|447575183|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
124441300|NCT03226275|447575184|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
124441301|NCT03442114|447575187|FG000|Overall Study|Lost to Follow-up|13|||
124441302|NCT03442114|447575188|FG001|Overall Study|Lost to Follow-up|13|||
124441303|NCT03442114|447575187|FG000|Overall Study|Physician Decision|2|||
124441304|NCT03442114|447575188|FG001|Overall Study|Physician Decision|2|||
124441305|NCT03442114|447575187|FG000|Overall Study|Protocol Violation|0|||
124441306|NCT03442114|447575188|FG001|Overall Study|Protocol Violation|2|||
124441307|NCT03442114|447575187|FG000|Overall Study|Withdrawal by Subject|1|||
124441308|NCT03442114|447575188|FG001|Overall Study|Withdrawal by Subject|3|||
124441309|NCT03442114|447575187|FG000|Overall Study|Guardianship Change|0|||
124441310|NCT03442114|447575188|FG001|Overall Study|Guardianship Change|1|||
124441311|NCT02903368|447575189|FG000|Part 1|Adverse Event|3|||
124441312|NCT02903368|447575190|FG001|Part 1|Adverse Event|0|||
124441313|NCT02903368|447575191|FG002|Part 1|Adverse Event|0|||
124441314|NCT02903368|447575192|FG003|Part 1|Adverse Event|0|||
124441315|NCT02903368|447575189|FG000|Part 1|Withdrawal by Subject|1|||
124441316|NCT02903368|447575190|FG001|Part 1|Withdrawal by Subject|0|||
124441317|NCT02903368|447575191|FG002|Part 1|Withdrawal by Subject|0|||
124441318|NCT02903368|447575192|FG003|Part 1|Withdrawal by Subject|0|||
124441319|NCT02903368|447575189|FG000|Part 2|Adverse Event|0|||
124441320|NCT02903368|447575190|FG001|Part 2|Adverse Event|0|||
124441321|NCT02903368|447575191|FG002|Part 2|Adverse Event|5|||
124441322|NCT02903368|447575192|FG003|Part 2|Adverse Event|0|||
124441323|NCT02903368|447575189|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
124441324|NCT02903368|447575190|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
124441325|NCT02903368|447575191|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
124441326|NCT02903368|447575192|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
124441327|NCT02903368|447575189|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
124441328|NCT02903368|447575190|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
124441329|NCT02903368|447575191|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
124441330|NCT02903368|447575192|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
124441331|NCT02903368|447575189|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
124441332|NCT02903368|447575190|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
124441333|NCT02903368|447575191|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
124441334|NCT02903368|447575192|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
124441335|NCT01340196|447577657|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
124441336|NCT00081770|447577660|FG000|Overall Study|Adverse Event|130|||
124888673|NCT02555371|449216778|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
124888674|NCT02555371|449216779|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
124441337|NCT00081770|447577661|FG001|Overall Study|Adverse Event|98|||
124441338|NCT00081770|447577662|FG002|Overall Study|Adverse Event|136|||
124441339|NCT00081770|447577660|FG000|Overall Study|Lack of Efficacy|262|||
124441340|NCT00081770|447577661|FG001|Overall Study|Lack of Efficacy|357|||
124888675|NCT02555371|449216780|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
124888676|NCT02555371|449216776|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
124441341|NCT00081770|447577662|FG002|Overall Study|Lack of Efficacy|211|||
124441342|NCT00081770|447577660|FG000|Overall Study|Lost to Follow-up|45|||
124441343|NCT00081770|447577661|FG001|Overall Study|Lost to Follow-up|34|||
124441344|NCT00081770|447577662|FG002|Overall Study|Lost to Follow-up|45|||
124441345|NCT00081770|447577660|FG000|Overall Study|Protocol Violation|15|||
124441346|NCT00081770|447577661|FG001|Overall Study|Protocol Violation|10|||
124441347|NCT00081770|447577662|FG002|Overall Study|Protocol Violation|10|||
124441348|NCT00081770|447577660|FG000|Overall Study|Withdrawal by Subject|45|||
124441349|NCT00081770|447577661|FG001|Overall Study|Withdrawal by Subject|40|||
124441350|NCT00081770|447577662|FG002|Overall Study|Withdrawal by Subject|42|||
124441351|NCT00081770|447577660|FG000|Overall Study|Did not meet protocol eligibility|2|||
124441352|NCT00081770|447577661|FG001|Overall Study|Did not meet protocol eligibility|0|||
124441353|NCT00081770|447577662|FG002|Overall Study|Did not meet protocol eligibility|3|||
124441354|NCT00081770|447577660|FG000|Overall Study|Administrative|1|||
124441355|NCT00081770|447577661|FG001|Overall Study|Administrative|0|||
124441356|NCT00081770|447577662|FG002|Overall Study|Administrative|1|||
124441357|NCT00081770|447577660|FG000|Overall Study|Other|2|||
124441358|NCT00081770|447577661|FG001|Overall Study|Other|7|||
124441359|NCT00081770|447577662|FG002|Overall Study|Other|8|||
124441360|NCT02245672|447577663|FG000|Overall Study|Adverse Event|4|||
124441361|NCT02245672|447577664|FG001|Overall Study|Adverse Event|4|||
124441362|NCT02245672|447577665|FG002|Overall Study|Adverse Event|4|||
124441363|NCT02245672|447577663|FG000|Overall Study|Lost to Follow-up|3|||
124441364|NCT02245672|447577664|FG001|Overall Study|Lost to Follow-up|5|||
124441365|NCT02245672|447577665|FG002|Overall Study|Lost to Follow-up|1|||
124441366|NCT02245672|447577663|FG000|Overall Study|Withdrawal by Subject|6|||
124441367|NCT02245672|447577664|FG001|Overall Study|Withdrawal by Subject|3|||
124441368|NCT02245672|447577665|FG002|Overall Study|Withdrawal by Subject|0|||
124441369|NCT02245672|447577663|FG000|Overall Study|Randomized in error (not treated)|0|||
124441370|NCT02245672|447577664|FG001|Overall Study|Randomized in error (not treated)|1|||
124441371|NCT02245672|447577665|FG002|Overall Study|Randomized in error (not treated)|0|||
124441372|NCT00971932|447577666|FG000|Overall Study|Withdrawal by Subject|1|||
124441373|NCT00971932|447577666|FG000|Overall Study|Investigator's decision|2|||
124441374|NCT00971932|447577666|FG000|Overall Study|Ongoing|4|||
124441375|NCT01765192|447577667|FG000|Treatment Period 1|Adverse Event|0|||
124441376|NCT01765192|447577668|FG001|Treatment Period 1|Adverse Event|1|||
124441377|NCT01765192|447577667|FG000|Washout Period|Voluntary Withdrawal|1|||
124441378|NCT01765192|447577668|FG001|Washout Period|Voluntary Withdrawal|1|||
124441379|NCT01765192|447577667|FG000|Washout Period|Reason not specified|1|||
124441380|NCT01765192|447577668|FG001|Washout Period|Reason not specified|0|||
124441381|NCT01765192|447577667|FG000|Treatment Period 2|Reason not specified|0|||
124441382|NCT01765192|447577668|FG001|Treatment Period 2|Reason not specified|2|||
124441383|NCT01765192|447577667|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
124441384|NCT01765192|447577668|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
124441385|NCT00876694|447577673|FG000|Overall Study|Adverse Event|10|||
124441386|NCT00876694|447577674|FG001|Overall Study|Adverse Event|7|||
124441387|NCT00876694|447577673|FG000|Overall Study|Subject withdrew consent|6|||
124441388|NCT00876694|447577674|FG001|Overall Study|Subject withdrew consent|4|||
124441389|NCT00876694|447577673|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124441390|NCT00876694|447577674|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124441391|NCT00876694|447577673|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124441392|NCT00876694|447577674|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124441393|NCT00876694|447577673|FG000|Overall Study|Administrative problems|1|||
124441394|NCT00876694|447577674|FG001|Overall Study|Administrative problems|1|||
124441395|NCT00876694|447577673|FG000|Overall Study|Death|1|||
124441396|NCT00876694|447577674|FG001|Overall Study|Death|0|||
124441397|NCT01215422|447577679|FG000|Overall Study|Relocation|1|||
124441398|NCT01215422|447577680|FG001|Overall Study|Relocation|0|||
124441399|NCT01215422|447577681|FG002|Overall Study|Relocation|0|||
124441400|NCT01215422|447577682|FG003|Overall Study|Relocation|0|||
124441401|NCT01215422|447577679|FG000|Overall Study|Failed intubations|0|||
124441402|NCT01215422|447577680|FG001|Overall Study|Failed intubations|0|||
124441403|NCT01215422|447577681|FG002|Overall Study|Failed intubations|3|||
124441404|NCT01215422|447577682|FG003|Overall Study|Failed intubations|8|||
124441405|NCT01215422|447577679|FG000|Overall Study|Did not complete all intubations|7|||
124441406|NCT01215422|447577680|FG001|Overall Study|Did not complete all intubations|0|||
124441407|NCT01215422|447577681|FG002|Overall Study|Did not complete all intubations|0|||
124441408|NCT01215422|447577682|FG003|Overall Study|Did not complete all intubations|0|||
124888677|NCT02555371|449216777|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
124441409|NCT00294554|447577685|FG000|Overall Study|Lack of Efficacy|0|||
124441410|NCT00294554|447577686|FG001|Overall Study|Lack of Efficacy|1|||
124441411|NCT00294554|447577685|FG000|Overall Study|Physician Decision|0|||
124441412|NCT00294554|447577686|FG001|Overall Study|Physician Decision|1|||
124441413|NCT00462865|447577687|FG000|Overall Study|Adverse Event|1|||
124441414|NCT02864381|447577688|FG000|Overall Study|Death|58|||
124441415|NCT02864381|447577689|FG001|Overall Study|Death|61|||
124441416|NCT02864381|447577688|FG000|Overall Study|Withdrew Consent|5|||
124759150|NCT02796677|448742519|FG002|Overall Study|Reason not mentioned|0|||
124441417|NCT02864381|447577689|FG001|Overall Study|Withdrew Consent|6|||
124441418|NCT02864381|447577688|FG000|Overall Study|Reason Unknown|7|||
124441419|NCT02864381|447577689|FG001|Overall Study|Reason Unknown|3|||
124441420|NCT02864381|447577688|FG000|Overall Study|Lost to Follow-up|1|||
124441421|NCT02864381|447577689|FG001|Overall Study|Lost to Follow-up|1|||
124441422|NCT02864381|447577688|FG000|Overall Study|Investigator's Discretion|1|||
124441423|NCT02864381|447577689|FG001|Overall Study|Investigator's Discretion|0|||
124441424|NCT02864381|447577688|FG000|Overall Study|Protocol Violation|0|||
124441425|NCT02864381|447577689|FG001|Overall Study|Protocol Violation|1|||
124441426|NCT02544217|447577690|FG000|Overall Study|Withdrawal by Subject|1|||
124441427|NCT02544217|447577691|FG001|Overall Study|Withdrawal by Subject|1|||
124441428|NCT02544217|447577692|FG002|Overall Study|Withdrawal by Subject|0|||
124441429|NCT02544217|447577693|FG003|Overall Study|Withdrawal by Subject|0|||
124441430|NCT02544217|447577694|FG004|Overall Study|Withdrawal by Subject|0|||
124441431|NCT02544217|447577695|FG005|Overall Study|Withdrawal by Subject|0|||
124441432|NCT01146054|447577698|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
124441433|NCT01146054|447577698|FG000|Overall Study|Rapid tumor progression|2|||
124441434|NCT01146054|447577698|FG000|Overall Study|Other illness precluded treatment|2|||
124441435|NCT01146054|447577698|FG000|Overall Study|Lost to Follow-up|1|||
124441436|NCT04335812|447577699|FG000|Overall Study|Withdrawal by Subject|1|||
124441437|NCT04335812|447577700|FG001|Overall Study|Withdrawal by Subject|3|||
124441438|NCT04335812|447577699|FG000|Overall Study|Lost to Follow-up|12|||
124441439|NCT04335812|447577700|FG001|Overall Study|Lost to Follow-up|12|||
124441440|NCT04335812|447577699|FG000|Overall Study|Did not engage in the intervention|22|||
124441441|NCT04335812|447577700|FG001|Overall Study|Did not engage in the intervention|18|||
124441442|NCT02901041|447577711|FG000|Overall Study|Withdrawal by PI|4|||
124441443|NCT02901041|447577712|FG001|Overall Study|Withdrawal by PI|8|||
124441444|NCT02901041|447577711|FG000|Overall Study|Withdrawal by Subject|7|||
124441445|NCT02901041|447577712|FG001|Overall Study|Withdrawal by Subject|3|||
124441446|NCT00975507|447577713|FG000|Overall Study|Adverse Event|1|||
124441447|NCT00975507|447577714|FG001|Overall Study|Adverse Event|0|||
124441448|NCT00975507|447577713|FG000|Overall Study|Lost to Follow-up|7|||
124441449|NCT00975507|447577714|FG001|Overall Study|Lost to Follow-up|1|||
124441450|NCT00975507|447577713|FG000|Overall Study|Protocol Violation|2|||
124441451|NCT00975507|447577714|FG001|Overall Study|Protocol Violation|0|||
124441452|NCT00975507|447577713|FG000|Overall Study|Withdrawal by Subject|10|||
124441453|NCT00975507|447577714|FG001|Overall Study|Withdrawal by Subject|3|||
124441454|NCT00887250|447577715|FG000|Overall Study|Adverse Event|3|||
124441455|NCT00887250|447577716|FG001|Overall Study|Adverse Event|0|||
124441456|NCT00887250|447577717|FG002|Overall Study|Adverse Event|7|||
124441457|NCT00887250|447577715|FG000|Overall Study|Lack of Efficacy|9|||
124441458|NCT00887250|447577716|FG001|Overall Study|Lack of Efficacy|6|||
124441459|NCT00887250|447577717|FG002|Overall Study|Lack of Efficacy|1|||
124441460|NCT00887250|447577715|FG000|Overall Study|Lost to Follow-up|2|||
124441461|NCT00887250|447577716|FG001|Overall Study|Lost to Follow-up|3|||
124441462|NCT00887250|447577717|FG002|Overall Study|Lost to Follow-up|1|||
124441463|NCT00887250|447577715|FG000|Overall Study|Protocol Violation|2|||
124441464|NCT00887250|447577716|FG001|Overall Study|Protocol Violation|2|||
124441465|NCT00887250|447577717|FG002|Overall Study|Protocol Violation|1|||
124441466|NCT00887250|447577715|FG000|Overall Study|Withdrawal by Subject|2|||
124441467|NCT00887250|447577716|FG001|Overall Study|Withdrawal by Subject|1|||
124441468|NCT00887250|447577717|FG002|Overall Study|Withdrawal by Subject|2|||
124441469|NCT00887250|447577715|FG000|Overall Study|Patient uncooperative|0|||
124441470|NCT00887250|447577716|FG001|Overall Study|Patient uncooperative|0|||
124441471|NCT00887250|447577717|FG002|Overall Study|Patient uncooperative|1|||
124441472|NCT00879762|447577723|FG000|Overall Study|Lost to Follow-up|3|||
124441473|NCT00879762|447577724|FG001|Overall Study|Lost to Follow-up|1|||
124441474|NCT00881608|447577725|FG000|Overall Study|Study prematurely terminated|11|||
124441475|NCT03214094|447577726|FG000|Overall Study|Case Report Forms Uncollected|14|||
124441476|NCT03214094|447577726|FG000|Overall Study|Protocol Deviation|46|||
124441477|NCT03401229|447577727|FG000|Overall Study|Lost to Follow-up|2|||
124441478|NCT03401229|447577728|FG001|Overall Study|Lost to Follow-up|1|||
124441479|NCT03401229|447577727|FG000|Overall Study|Other|1|||
124441480|NCT03401229|447577728|FG001|Overall Study|Other|3|||
124441481|NCT03401229|447577727|FG000|Overall Study|Adverse Event|8|||
124441482|NCT03401229|447577728|FG001|Overall Study|Adverse Event|6|||
124441483|NCT03401229|447577727|FG000|Overall Study|Withdrawal by Subject|29|||
124441484|NCT03401229|447577728|FG001|Overall Study|Withdrawal by Subject|26|||
124441485|NCT03401229|447577727|FG000|Overall Study|COVID-19|0|||
124441486|NCT03401229|447577728|FG001|Overall Study|COVID-19|1|||
124441487|NCT03575143|447577729|FG000|Overall Study|Lost to Follow-up|0|||
124441488|NCT03575143|447577730|FG001|Overall Study|Lost to Follow-up|0|||
124441489|NCT03575143|447577731|FG002|Overall Study|Lost to Follow-up|4|||
124441490|NCT03575143|447577729|FG000|Overall Study|Withdrawal by Subject|0|||
124441491|NCT03575143|447577730|FG001|Overall Study|Withdrawal by Subject|0|||
124441492|NCT03575143|447577731|FG002|Overall Study|Withdrawal by Subject|5|||
124441493|NCT03575143|447577729|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
124441494|NCT03575143|447577730|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
124441495|NCT03575143|447577731|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
124441496|NCT02027701|447577734|FG000|Overall Study|Adverse Event|3|||
124441497|NCT02027701|447577734|FG000|Overall Study|Lack of Efficacy|8|||
124441498|NCT02027701|447577734|FG000|Overall Study|Physician Decision|2|||
124441499|NCT02027701|447577734|FG000|Overall Study|Withdrawal by Subject|3|||
124441500|NCT02435966|447577735|FG000|Overall Study|Withdrawal by Subject|0|||
124441501|NCT02435966|447577736|FG001|Overall Study|Withdrawal by Subject|1|||
124441502|NCT02435966|447577737|FG002|Overall Study|Withdrawal by Subject|0|||
124441503|NCT02893930|447577740|FG000|Overall Study|Adverse Event|3|||
124441504|NCT02893930|447577740|FG000|Overall Study|Death|1|||
124441505|NCT02893930|447577740|FG000|Overall Study|Disease progression|5|||
124441506|NCT02893930|447577740|FG000|Overall Study|Withdrawal by Subject|2|||
124441507|NCT02893930|447577740|FG000|Overall Study|Physician Decision|1|||
124441508|NCT02893930|447577740|FG000|Overall Study|Ineligible|1|||
124441509|NCT02349360|447577741|FG000|Overall Study|Withdrawal by Subject|0|||
124441510|NCT02349360|447577742|FG001|Overall Study|Withdrawal by Subject|1|||
124441511|NCT02019927|447577743|FG000|Overall Study|Lost to Follow-up|2|||
124441512|NCT02019927|447577744|FG001|Overall Study|Lost to Follow-up|4|||
124441513|NCT02019927|447577745|FG002|Overall Study|Lost to Follow-up|1|||
124441514|NCT02019927|447577746|FG003|Overall Study|Lost to Follow-up|2|||
124441515|NCT02019927|447577747|FG004|Overall Study|Lost to Follow-up|3|||
124441516|NCT02019927|447577748|FG005|Overall Study|Lost to Follow-up|1|||
124441517|NCT00394953|447577749|FG000|First Treatment Period|Adverse Event|1|||
124441518|NCT00394953|447577750|FG001|First Treatment Period|Adverse Event|2|||
124441519|NCT00394953|447577749|FG000|First Treatment Period|Death|6|||
124441520|NCT00394953|447577750|FG001|First Treatment Period|Death|7|||
124441521|NCT00394953|447577749|FG000|First Treatment Period|Lack of Efficacy|1|||
124441522|NCT00394953|447577750|FG001|First Treatment Period|Lack of Efficacy|1|||
124441523|NCT00394953|447577749|FG000|First Treatment Period|Withdrawal by Subject|6|||
124441524|NCT00394953|447577750|FG001|First Treatment Period|Withdrawal by Subject|3|||
124441525|NCT00394953|447577749|FG000|First Treatment Period|Lost to Follow-up|0|||
124441526|NCT00394953|447577750|FG001|First Treatment Period|Lost to Follow-up|1|||
124441527|NCT00394953|447577749|FG000|First Treatment Period|Renal transplant|11|||
124441528|NCT00394953|447577750|FG001|First Treatment Period|Renal transplant|7|||
124441529|NCT00394953|447577749|FG000|First Treatment Period|Not defined|4|||
124441530|NCT00394953|447577750|FG001|First Treatment Period|Not defined|1|||
124441531|NCT00394953|447577749|FG000|Second Treatment Period|Adverse Event|2|||
124441532|NCT00394953|447577750|FG001|Second Treatment Period|Adverse Event|5|||
124441533|NCT00394953|447577749|FG000|Second Treatment Period|Death|8|||
124441534|NCT00394953|447577750|FG001|Second Treatment Period|Death|4|||
124441535|NCT00394953|447577749|FG000|Second Treatment Period|Lack of Efficacy|9|||
124441536|NCT00394953|447577750|FG001|Second Treatment Period|Lack of Efficacy|47|||
124441537|NCT00394953|447577749|FG000|Second Treatment Period|Withdrawal by Subject|3|||
124441538|NCT00394953|447577750|FG001|Second Treatment Period|Withdrawal by Subject|3|||
124441539|NCT00394953|447577749|FG000|Second Treatment Period|Lost to Follow-up|0|||
124441540|NCT00394953|447577750|FG001|Second Treatment Period|Lost to Follow-up|1|||
124441541|NCT00394953|447577749|FG000|Second Treatment Period|Renal transplant|4|||
124441542|NCT00394953|447577750|FG001|Second Treatment Period|Renal transplant|6|||
124441543|NCT00394953|447577749|FG000|Second Treatment Period|Not defined|3|||
124441544|NCT00394953|447577750|FG001|Second Treatment Period|Not defined|8|||
124441545|NCT04079803|447577756|FG000|Overall Study|Withdrawal by Subject|0|||
124441546|NCT04079803|447577757|FG001|Overall Study|Withdrawal by Subject|0|||
124441547|NCT04079803|447577758|FG002|Overall Study|Withdrawal by Subject|1|||
124441548|NCT01294683|447577761|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
124441549|NCT01294683|447577762|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
124441550|NCT01294683|447577761|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
124441551|NCT01294683|447577762|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
124441552|NCT01294683|447577761|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
124686260|NCT02335944|448471275|FG004|Treatment Phase|Progressive Disease|4|||
124686261|NCT02335944|448471276|FG005|Treatment Phase|Progressive Disease|25|||
124686262|NCT02335944|448471277|FG006|Treatment Phase|Progressive Disease|2|||
124686263|NCT02335944|448471278|FG007|Treatment Phase|Progressive Disease|30|||
124441553|NCT01294683|447577762|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
124441554|NCT01294683|447577761|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
124441555|NCT01294683|447577762|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
124441556|NCT01294683|447577761|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
124441557|NCT01294683|447577762|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
124441558|NCT01294683|447577761|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
124441559|NCT01294683|447577762|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
124441560|NCT01294683|447577761|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
124686264|NCT02335944|448471279|FG008|Treatment Phase|Progressive Disease|27|||
124441561|NCT01294683|447577762|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
124441562|NCT01294683|447577761|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
124441563|NCT01294683|447577762|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
124441564|NCT01294683|447577761|FG000|Post Crossover (Period III)|Adverse Event|6|||
124441565|NCT01294683|447577762|FG001|Post Crossover (Period III)|Adverse Event|6|||
124441566|NCT01294683|447577761|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
124441567|NCT01294683|447577762|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
124441568|NCT01294683|447577761|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
124441569|NCT01294683|447577762|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
124441570|NCT01294683|447577761|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
124441571|NCT01294683|447577762|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
124441572|NCT01032382|447577764|FG000|Overall Study|Disease dissemination|1|||
124441573|NCT01032382|447577765|FG001|Overall Study|Disease dissemination|1|||
124441574|NCT01032382|447577764|FG000|Overall Study|Treatment failure|3|||
124441575|NCT01032382|447577765|FG001|Overall Study|Treatment failure|1|||
124441576|NCT01032382|447577764|FG000|Overall Study|Index lesion relapse|1|||
124441577|NCT01032382|447577765|FG001|Overall Study|Index lesion relapse|3|||
124441578|NCT00412971|447577766|FG000|Overall Study|Lost to Follow-up|17|||
124441579|NCT00412971|447577767|FG001|Overall Study|Lost to Follow-up|9|||
124441580|NCT00412971|447577766|FG000|Overall Study|Protocol Violation|13|||
124686265|NCT02335944|448471280|FG009|Treatment Phase|Progressive Disease|0|||
124686266|NCT02335944|448471271|FG000|Treatment Phase|Adverse Event|2|||
124441581|NCT00412971|447577767|FG001|Overall Study|Protocol Violation|1|||
124441582|NCT02409368|447577768|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
124888678|NCT02555371|449216778|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
124888679|NCT02555371|449216779|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
124888680|NCT02555371|449216780|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
124888681|NCT02555371|449216776|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
124888682|NCT02555371|449216777|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
124888683|NCT02555371|449216778|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
124888684|NCT02555371|449216779|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
124888685|NCT02555371|449216780|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
124888686|NCT02555371|449216776|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
124888687|NCT02555371|449216777|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
124888688|NCT02555371|449216778|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
124441583|NCT02409368|447577769|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
124686267|NCT02335944|448471272|FG001|Treatment Phase|Adverse Event|0|||
124888689|NCT02555371|449216779|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
124888690|NCT02555371|449216780|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
124888691|NCT02555371|449216776|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
124441584|NCT02409368|447577770|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
124441585|NCT02409368|447577771|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
124441586|NCT02409368|447577768|FG000|ECOG Reclassification|Death|1|||
124441587|NCT02409368|447577769|FG001|ECOG Reclassification|Death|5|||
124441588|NCT02409368|447577770|FG002|ECOG Reclassification|Death|0|||
124441589|NCT02409368|447577771|FG003|ECOG Reclassification|Death|0|||
124441590|NCT02409368|447577768|FG000|ECOG Reclassification|Disease Progression|113|||
124441591|NCT02409368|447577769|FG001|ECOG Reclassification|Disease Progression|382|||
124441592|NCT02409368|447577770|FG002|ECOG Reclassification|Disease Progression|70|||
124441593|NCT02409368|447577771|FG003|ECOG Reclassification|Disease Progression|1|||
124441594|NCT02409368|447577768|FG000|ECOG Reclassification|Lost to Follow-up|1|||
124441595|NCT02409368|447577769|FG001|ECOG Reclassification|Lost to Follow-up|5|||
124441596|NCT02409368|447577770|FG002|ECOG Reclassification|Lost to Follow-up|0|||
124441597|NCT02409368|447577771|FG003|ECOG Reclassification|Lost to Follow-up|0|||
124441598|NCT02409368|447577768|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
124441599|NCT02409368|447577769|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
124441600|NCT02409368|447577770|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
124441601|NCT02409368|447577771|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
124441602|NCT02409368|447577768|FG000|ECOG Reclassification|Poor/non-compliance|0|||
124441603|NCT02409368|447577769|FG001|ECOG Reclassification|Poor/non-compliance|3|||
124441604|NCT02409368|447577770|FG002|ECOG Reclassification|Poor/non-compliance|2|||
124441605|NCT02409368|447577771|FG003|ECOG Reclassification|Poor/non-compliance|0|||
124441606|NCT02409368|447577768|FG000|ECOG Reclassification|Study drug toxicity|17|||
124441607|NCT02409368|447577769|FG001|ECOG Reclassification|Study drug toxicity|42|||
124441608|NCT02409368|447577770|FG002|ECOG Reclassification|Study drug toxicity|7|||
124441609|NCT02409368|447577771|FG003|ECOG Reclassification|Study drug toxicity|0|||
124441610|NCT02409368|447577768|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
124686268|NCT02335944|448471273|FG002|Treatment Phase|Adverse Event|0|||
124686269|NCT02335944|448471274|FG003|Treatment Phase|Adverse Event|2|||
124686270|NCT02335944|448471275|FG004|Treatment Phase|Adverse Event|1|||
124441611|NCT02409368|447577769|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
124686271|NCT02335944|448471276|FG005|Treatment Phase|Adverse Event|15|||
124686272|NCT02335944|448471277|FG006|Treatment Phase|Adverse Event|0|||
124888692|NCT02555371|449216777|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
124441612|NCT02409368|447577770|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
124686273|NCT02335944|448471278|FG007|Treatment Phase|Adverse Event|5|||
124686274|NCT02335944|448471279|FG008|Treatment Phase|Adverse Event|7|||
124441613|NCT02409368|447577771|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
124441614|NCT02409368|447577768|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
124686275|NCT02335944|448471280|FG009|Treatment Phase|Adverse Event|0|||
124759151|NCT02796677|448742520|FG003|Overall Study|Reason not mentioned|5|||
124759152|NCT00961181|448742521|FG000|Overall Study|Death|2|||
124759153|NCT00961181|448742521|FG000|Overall Study|Withdrawal by Subject|2|||
124759154|NCT00961181|448742521|FG000|Overall Study|Lost to Follow-up|1|||
124759155|NCT03811340|448742522|FG000|Overall Study|subjects did not complete the survey.|90|||
124759156|NCT01045967|448742523|FG000|Second Intervention|Protocol Violation|0|||
124759157|NCT01045967|448742524|FG001|Second Intervention|Protocol Violation|1|||
124759158|NCT01485094|448742534|FG000|Overall Study|Adverse Event|1|||
124759159|NCT01485094|448742535|FG001|Overall Study|Adverse Event|1|||
124759160|NCT01485094|448742536|FG002|Overall Study|Adverse Event|1|||
124759161|NCT01485094|448742534|FG000|Overall Study|Lost to Follow-up|1|||
124759162|NCT01485094|448742535|FG001|Overall Study|Lost to Follow-up|0|||
124759163|NCT01485094|448742536|FG002|Overall Study|Lost to Follow-up|0|||
124759164|NCT01485094|448742534|FG000|Overall Study|Withdrawal by Subject|1|||
124759165|NCT01485094|448742535|FG001|Overall Study|Withdrawal by Subject|1|||
124759166|NCT01485094|448742536|FG002|Overall Study|Withdrawal by Subject|0|||
124759167|NCT02576639|448742537|FG000|Overall Study|Withdrawal by Subject|1|||
124759168|NCT02576639|448742538|FG001|Overall Study|Withdrawal by Subject|2|||
124759169|NCT02576639|448742539|FG002|Overall Study|Withdrawal by Subject|1|||
124759170|NCT02576639|448742540|FG003|Overall Study|Withdrawal by Subject|0|||
124759171|NCT02576639|448742541|FG004|Overall Study|Withdrawal by Subject|1|||
124759172|NCT02576639|448742537|FG000|Overall Study|Adverse Event|1|||
124759173|NCT02576639|448742538|FG001|Overall Study|Adverse Event|0|||
124759174|NCT02576639|448742539|FG002|Overall Study|Adverse Event|1|||
124759175|NCT02576639|448742540|FG003|Overall Study|Adverse Event|1|||
124759176|NCT02576639|448742541|FG004|Overall Study|Adverse Event|2|||
124759177|NCT02576639|448742537|FG000|Overall Study|Physician Decision|0|||
124759178|NCT02576639|448742538|FG001|Overall Study|Physician Decision|0|||
124759179|NCT02576639|448742539|FG002|Overall Study|Physician Decision|0|||
124759180|NCT02576639|448742540|FG003|Overall Study|Physician Decision|0|||
124759181|NCT02576639|448742541|FG004|Overall Study|Physician Decision|1|||
124759182|NCT02079038|448742542|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
124759183|NCT02079038|448742543|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
124759184|NCT02079038|448742542|FG000|Modified Intent to Treat Population|Death|1|||
124759185|NCT02079038|448742543|FG001|Modified Intent to Treat Population|Death|0|||
124759186|NCT02079038|448742542|FG000|Completed 6 Months|Lost to Follow-up|2|||
124759187|NCT02079038|448742543|FG001|Completed 6 Months|Lost to Follow-up|1|||
124759188|NCT02478463|448742544|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
124759189|NCT02478463|448742544|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
124759190|NCT02478463|448742544|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
124686276|NCT02335944|448471271|FG000|Treatment Phase|Physician Decision|0|||
124686277|NCT02335944|448471272|FG001|Treatment Phase|Physician Decision|0|||
124686278|NCT02335944|448471273|FG002|Treatment Phase|Physician Decision|0|||
124686279|NCT02335944|448471274|FG003|Treatment Phase|Physician Decision|1|||
124686280|NCT02335944|448471275|FG004|Treatment Phase|Physician Decision|0|||
124686281|NCT02335944|448471276|FG005|Treatment Phase|Physician Decision|6|||
124686282|NCT02335944|448471277|FG006|Treatment Phase|Physician Decision|1|||
124686283|NCT02335944|448471278|FG007|Treatment Phase|Physician Decision|2|||
124686284|NCT02335944|448471279|FG008|Treatment Phase|Physician Decision|1|||
124686285|NCT02335944|448471280|FG009|Treatment Phase|Physician Decision|0|||
124686286|NCT02335944|448471271|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
124686287|NCT02335944|448471272|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
124686288|NCT02335944|448471273|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
124686289|NCT02335944|448471274|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
124759191|NCT01358825|448742547|FG000|Overall Study|Blood sample not drawn|0|||
124759192|NCT01358825|448742548|FG001|Overall Study|Blood sample not drawn|1|||
124759193|NCT01508169|448742552|FG000|Overall Study|Adverse Event|1|||
124759194|NCT01508169|448742553|FG001|Overall Study|Adverse Event|0|||
124759195|NCT01508169|448742552|FG000|Overall Study|Withdrawal by Subject|1|||
124759196|NCT01508169|448742553|FG001|Overall Study|Withdrawal by Subject|0|||
124759197|NCT01508169|448742552|FG000|Overall Study|Lost to Follow-up|1|||
124759198|NCT01508169|448742553|FG001|Overall Study|Lost to Follow-up|2|||
124759199|NCT03600740|448742554|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
124759200|NCT01814527|448742555|FG000|Overall Study|RTP greater than 30 days|6|||
124759201|NCT01814527|448742556|FG001|Overall Study|RTP greater than 30 days|1|||
124759202|NCT04524858|448742557|FG000|Overall Study|Adverse Event|1|||
124759203|NCT03571204|448742558|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
124686290|NCT02335944|448471275|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
124686291|NCT02335944|448471276|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
124686292|NCT02335944|448471277|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
124759204|NCT03571204|448742559|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
124759205|NCT03571204|448742560|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
124759206|NCT03571204|448742558|FG000|Overall Study|Physician Decision|0|||
124759207|NCT03571204|448742559|FG001|Overall Study|Physician Decision|1|||
124888693|NCT02555371|449216778|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
124888694|NCT02555371|449216779|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
124888695|NCT02555371|449216780|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
124888696|NCT00513019|449216781|FG000|Overall Study|Adverse Event|1|||
124888697|NCT00513019|449216782|FG001|Overall Study|Adverse Event|0|||
124888698|NCT00513019|449216781|FG000|Overall Study|Withdrawal by Subject|4|||
124888699|NCT00513019|449216782|FG001|Overall Study|Withdrawal by Subject|5|||
124888700|NCT03615482|449216783|FG000|Overall Study|Death|1|||
124888701|NCT03615482|449216784|FG001|Overall Study|Death|0|||
124888702|NCT03615482|449216783|FG000|Overall Study|Lost to Follow-up|7|||
124888703|NCT03615482|449216784|FG001|Overall Study|Lost to Follow-up|7|||
124888704|NCT03615482|449216783|FG000|Overall Study|Physician Decision|2|||
124888705|NCT03615482|449216784|FG001|Overall Study|Physician Decision|3|||
124888706|NCT03615482|449216783|FG000|Overall Study|Withdrawal by Subject|7|||
124888707|NCT03615482|449216784|FG001|Overall Study|Withdrawal by Subject|7|||
124888708|NCT01500226|449216785|FG000|Overall Study|Adverse Event|31|||
124888709|NCT01500226|449216786|FG001|Overall Study|Adverse Event|38|||
124888710|NCT01500226|449216785|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
124888711|NCT01500226|449216786|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
124888712|NCT01500226|449216785|FG000|Overall Study|Withdrawal by Subject|93|||
124888713|NCT01500226|449216786|FG001|Overall Study|Withdrawal by Subject|96|||
124888714|NCT01500226|449216785|FG000|Overall Study|Death|12|||
124441615|NCT02409368|447577769|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
124441616|NCT02409368|447577770|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
124441617|NCT02409368|447577771|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
124441618|NCT02409368|447577768|FG000|ECOG Reclassification|Participant withdrew consent|2|||
124441619|NCT02409368|447577769|FG001|ECOG Reclassification|Participant withdrew consent|3|||
124441620|NCT02409368|447577770|FG002|ECOG Reclassification|Participant withdrew consent|4|||
124441621|NCT02409368|447577771|FG003|ECOG Reclassification|Participant withdrew consent|0|||
124441622|NCT02409368|447577768|FG000|ECOG Reclassification|Other Reasons|5|||
124441623|NCT02409368|447577769|FG001|ECOG Reclassification|Other Reasons|26|||
124441624|NCT02409368|447577770|FG002|ECOG Reclassification|Other Reasons|2|||
124441625|NCT02409368|447577771|FG003|ECOG Reclassification|Other Reasons|0|||
124441626|NCT02409368|447577768|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
124441627|NCT02409368|447577769|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
124441628|NCT02409368|447577770|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
124441629|NCT02409368|447577771|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
124441630|NCT01296347|447577772|FG000|Allocation|Withdrawal by Subject|1|||
124441631|NCT01296347|447577773|FG001|Allocation|Withdrawal by Subject|2|||
124441632|NCT01296347|447577772|FG000|Allocation|Lack of Efficacy|1|||
124441633|NCT01296347|447577773|FG001|Allocation|Lack of Efficacy|2|||
124441634|NCT01296347|447577772|FG000|Allocation|not received infusion|1|||
124441635|NCT01296347|447577773|FG001|Allocation|not received infusion|0|||
124441636|NCT01296347|447577772|FG000|6 Week Follow up|Death|0|||
124441637|NCT01296347|447577773|FG001|6 Week Follow up|Death|1|||
124441638|NCT01296347|447577772|FG000|3 Month Follow up|Death|1|||
124441639|NCT01296347|447577773|FG001|3 Month Follow up|Death|0|||
124441640|NCT01296347|447577772|FG000|3 Month Follow up|Lost to Follow-up|0|||
124441641|NCT01296347|447577773|FG001|3 Month Follow up|Lost to Follow-up|1|||
124441642|NCT01296347|447577772|FG000|6 Month Follow up|Death|2|||
124441643|NCT01296347|447577773|FG001|6 Month Follow up|Death|1|||
124441644|NCT01296347|447577772|FG000|6 Month Follow up|Lost to Follow-up|0|||
124441645|NCT01296347|447577773|FG001|6 Month Follow up|Lost to Follow-up|1|||
124441646|NCT01296347|447577772|FG000|12 Month Follow up|Lost to Follow-up|3|||
124441647|NCT01296347|447577773|FG001|12 Month Follow up|Lost to Follow-up|1|||
124441648|NCT01296347|447577772|FG000|12 Month Follow up|Death|1|||
124441649|NCT01296347|447577773|FG001|12 Month Follow up|Death|1|||
124441650|NCT01296347|447577772|FG000|12 Month Follow up|Withdrawal by Subject|0|||
124441651|NCT01296347|447577773|FG001|12 Month Follow up|Withdrawal by Subject|1|||
124441652|NCT01585987|447577774|FG000|Randomized|Withdrawal by Subject|0|||
124441653|NCT01585987|447577775|FG001|Randomized|Withdrawal by Subject|4|||
124441654|NCT01585987|447577774|FG000|Randomized|No longer met criteria|0|||
124441655|NCT01585987|447577775|FG001|Randomized|No longer met criteria|2|||
124441656|NCT01585987|447577774|FG000|Treated|Disease Progression|39|||
124441657|NCT01585987|447577775|FG001|Treated|Disease Progression|36|||
124441658|NCT01585987|447577774|FG000|Treated|Study Drug Toxicity|9|||
124759208|NCT03571204|448742560|FG002|Overall Study|Physician Decision|0|||
124759209|NCT02396212|448742561|FG000|Overall Study|Adverse Event|1|||
124888715|NCT01500226|449216786|FG001|Overall Study|Death|4|||
124888716|NCT01500226|449216785|FG000|Overall Study|Disease Progression|16|||
124888717|NCT01500226|449216786|FG001|Overall Study|Disease Progression|14|||
124888718|NCT01500226|449216785|FG000|Overall Study|Protocol Violation|53|||
124441659|NCT01585987|447577775|FG001|Treated|Study Drug Toxicity|5|||
124759210|NCT02396212|448742561|FG000|Overall Study|Lack of Efficacy|2|||
124888719|NCT01500226|449216786|FG001|Overall Study|Protocol Violation|39|||
124441660|NCT01585987|447577774|FG000|Treated|Adverse Event|3|||
124888720|NCT01500226|449216785|FG000|Overall Study|Physician Decision|17|||
124888721|NCT01500226|449216786|FG001|Overall Study|Physician Decision|15|||
124888722|NCT01500226|449216785|FG000|Overall Study|Lack of Efficacy|14|||
124888723|NCT01500226|449216786|FG001|Overall Study|Lack of Efficacy|30|||
124888724|NCT01500226|449216785|FG000|Overall Study|Lost to Follow-up|9|||
124686293|NCT02335944|448471278|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
124686294|NCT02335944|448471279|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
124888725|NCT01500226|449216786|FG001|Overall Study|Lost to Follow-up|5|||
124888726|NCT01500226|449216785|FG000|Overall Study|Other Reasons|19|||
124888727|NCT01500226|449216786|FG001|Overall Study|Other Reasons|16|||
124888728|NCT02955277|449216787|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
124888729|NCT02955277|449216788|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
124888730|NCT02955277|449216787|FG000|Post to Follow-up|Lost to Follow-up|8|||
124888731|NCT02955277|449216788|FG001|Post to Follow-up|Lost to Follow-up|11|||
124888732|NCT01809210|449216794|FG000|Overall Study|Withdrawal by Subject|0|||
124888733|NCT01809210|449216795|FG001|Overall Study|Withdrawal by Subject|0|||
124888734|NCT01809210|449216796|FG002|Overall Study|Withdrawal by Subject|1|||
124888735|NCT01809210|449216797|FG003|Overall Study|Withdrawal by Subject|1|||
124888736|NCT01809210|449216798|FG004|Overall Study|Withdrawal by Subject|1|||
124686295|NCT02335944|448471280|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
124686296|NCT02335944|448471271|FG000|Treatment Phase|Subject/Guardian Decision|0|||
124686297|NCT02335944|448471272|FG001|Treatment Phase|Subject/Guardian Decision|0|||
124686298|NCT02335944|448471273|FG002|Treatment Phase|Subject/Guardian Decision|1|||
124686299|NCT02335944|448471274|FG003|Treatment Phase|Subject/Guardian Decision|0|||
124686300|NCT02335944|448471275|FG004|Treatment Phase|Subject/Guardian Decision|0|||
124686301|NCT02335944|448471276|FG005|Treatment Phase|Subject/Guardian Decision|1|||
124686302|NCT02335944|448471277|FG006|Treatment Phase|Subject/Guardian Decision|0|||
124686303|NCT02335944|448471278|FG007|Treatment Phase|Subject/Guardian Decision|4|||
124686304|NCT02335944|448471279|FG008|Treatment Phase|Subject/Guardian Decision|0|||
124686305|NCT02335944|448471280|FG009|Treatment Phase|Subject/Guardian Decision|0|||
124686306|NCT02335944|448471271|FG000|Post-treatment Follow-up|Progressive Disease|0|||
124686307|NCT02335944|448471272|FG001|Post-treatment Follow-up|Progressive Disease|0|||
124686308|NCT02335944|448471273|FG002|Post-treatment Follow-up|Progressive Disease|0|||
124686309|NCT02335944|448471274|FG003|Post-treatment Follow-up|Progressive Disease|1|||
124686310|NCT02335944|448471275|FG004|Post-treatment Follow-up|Progressive Disease|0|||
124686311|NCT02335944|448471276|FG005|Post-treatment Follow-up|Progressive Disease|9|||
124686312|NCT02335944|448471277|FG006|Post-treatment Follow-up|Progressive Disease|0|||
124686313|NCT02335944|448471278|FG007|Post-treatment Follow-up|Progressive Disease|2|||
124686314|NCT02335944|448471279|FG008|Post-treatment Follow-up|Progressive Disease|3|||
124686315|NCT02335944|448471280|FG009|Post-treatment Follow-up|Progressive Disease|0|||
124686316|NCT02335944|448471271|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
124686317|NCT02335944|448471272|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
124686318|NCT02335944|448471273|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
124686319|NCT02335944|448471274|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
124686320|NCT02335944|448471275|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
124686321|NCT02335944|448471276|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
124686322|NCT02335944|448471277|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
124686323|NCT02335944|448471278|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
124686324|NCT02335944|448471279|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
124686325|NCT02335944|448471280|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
124686326|NCT02335944|448471271|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
124888737|NCT01809210|449216799|FG005|Overall Study|Withdrawal by Subject|0|||
124888738|NCT01809210|449216800|FG006|Overall Study|Withdrawal by Subject|4|||
124888739|NCT01809210|449216794|FG000|Overall Study|Death|1|||
124888740|NCT01809210|449216795|FG001|Overall Study|Death|1|||
124888741|NCT01809210|449216796|FG002|Overall Study|Death|2|||
124888742|NCT01809210|449216797|FG003|Overall Study|Death|0|||
124888743|NCT01809210|449216798|FG004|Overall Study|Death|1|||
124888744|NCT01809210|449216799|FG005|Overall Study|Death|3|||
124888745|NCT01809210|449216800|FG006|Overall Study|Death|1|||
124888746|NCT00504348|449216801|FG000|Overall Study|Adverse Event|3|||
124888747|NCT00504348|449216801|FG000|Overall Study|Lack of Efficacy|4|||
124686327|NCT02335944|448471272|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
124686328|NCT02335944|448471273|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
124686329|NCT02335944|448471274|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
124686330|NCT02335944|448471275|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
124686331|NCT02335944|448471276|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
124888748|NCT00504348|449216801|FG000|Overall Study|Physician Decision|1|||
124888749|NCT01118962|449216802|FG000|Overall Study|Adverse Event|2|||
124888750|NCT01118962|449216802|FG000|Overall Study|Lack of Efficacy|1|||
124888751|NCT01118962|449216802|FG000|Overall Study|Protocol Violation|1|||
124686332|NCT02335944|448471277|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
124686333|NCT02335944|448471278|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
124686334|NCT02335944|448471279|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
124888752|NCT01118962|449216802|FG000|Overall Study|Withdrawal by Subject|4|||
124888753|NCT01118962|449216802|FG000|Overall Study|Pregnancy|1|||
124888754|NCT01118962|449216802|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
124888755|NCT03685708|449216807|FG000|Overall Study|Withdrawal by Subject|0|||
124888756|NCT03685708|449216808|FG001|Overall Study|Withdrawal by Subject|0|||
124686335|NCT02335944|448471280|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
124686336|NCT02335944|448471271|FG000|Post-treatment Follow-up|Adverse Event|0|||
124888757|NCT03685708|449216809|FG002|Overall Study|Withdrawal by Subject|1|||
124888758|NCT03685708|449216807|FG000|Overall Study|Screen Fail|0|||
124888759|NCT03685708|449216808|FG001|Overall Study|Screen Fail|1|||
124888760|NCT03685708|449216809|FG002|Overall Study|Screen Fail|1|||
124888761|NCT03685708|449216807|FG000|Overall Study|COVID 19 Pandemic|1|||
124888762|NCT03685708|449216808|FG001|Overall Study|COVID 19 Pandemic|1|||
124888763|NCT03685708|449216809|FG002|Overall Study|COVID 19 Pandemic|6|||
124888764|NCT03685708|449216807|FG000|Overall Study|Disease Progression|0|||
124888765|NCT03685708|449216808|FG001|Overall Study|Disease Progression|0|||
124888766|NCT03685708|449216809|FG002|Overall Study|Disease Progression|1|||
124888767|NCT00627042|449216813|FG000|Overall Study|Withdrawal by Subject|2|||
124888768|NCT03583541|449216819|FG000|Overall Study|Lost to Follow-up|31|||
124686337|NCT02335944|448471272|FG001|Post-treatment Follow-up|Adverse Event|0|||
124686338|NCT02335944|448471273|FG002|Post-treatment Follow-up|Adverse Event|0|||
124686339|NCT02335944|448471274|FG003|Post-treatment Follow-up|Adverse Event|0|||
124686340|NCT02335944|448471275|FG004|Post-treatment Follow-up|Adverse Event|0|||
124686341|NCT02335944|448471276|FG005|Post-treatment Follow-up|Adverse Event|1|||
124686342|NCT02335944|448471277|FG006|Post-treatment Follow-up|Adverse Event|0|||
124686343|NCT02335944|448471278|FG007|Post-treatment Follow-up|Adverse Event|0|||
124686344|NCT02335944|448471279|FG008|Post-treatment Follow-up|Adverse Event|0|||
124686345|NCT02335944|448471280|FG009|Post-treatment Follow-up|Adverse Event|0|||
124686346|NCT02335944|448471271|FG000|Post-treatment Follow-up|Death|0|||
124888769|NCT03583541|449216820|FG001|Overall Study|Lost to Follow-up|65|||
124888770|NCT01686932|449216824|FG000|Period 1|Adverse Event|1|||
124888771|NCT01686932|449216825|FG001|Period 1|Adverse Event|1|||
124888772|NCT00393094|449216828|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
124888773|NCT00393094|449216828|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
124888774|NCT01058863|449216829|FG000|Overall Study|Lost to Follow-up|1|||
124888775|NCT01058863|449216829|FG000|Overall Study|Withdrawal by Subject|1|||
124888776|NCT01058863|449216829|FG000|Overall Study|Sponsor requested withdrawal|1|||
124888777|NCT01058863|449216829|FG000|Overall Study|Randomized in error|1|||
124888778|NCT00681187|449216830|FG000|Overall Study|Withdrawal by Subject|1|||
124888779|NCT00681187|449216831|FG001|Overall Study|Withdrawal by Subject|0|||
124888780|NCT00681187|449216830|FG000|Overall Study|Death|0|||
124888781|NCT00681187|449216831|FG001|Overall Study|Death|1|||
124888782|NCT00681187|449216830|FG000|Overall Study|Adverse Event|0|||
124888783|NCT00681187|449216831|FG001|Overall Study|Adverse Event|1|||
124888784|NCT03653416|449216832|FG000|Overall Study|Protocol Violation|6|||
124888785|NCT03653416|449216833|FG001|Overall Study|Protocol Violation|1|||
124888786|NCT04230980|449216834|FG000|Overall Study|Lost to Follow-up|1|||
124888787|NCT04230980|449216835|FG001|Overall Study|Lost to Follow-up|2|||
124888788|NCT04230980|449216834|FG000|Overall Study|Adverse Event|0|||
124888789|NCT04230980|449216835|FG001|Overall Study|Adverse Event|1|||
124888790|NCT02788006|449216837|FG000|Overall Study|Patient not treated|1|||
124888791|NCT03050398|449216840|FG000|Overall Study|Study terminated by sponsor|8|||
124888792|NCT00598481|449216841|FG000|Treatment|Physician Decision|1|||
124888793|NCT03523871|449216842|FG000|Overall Study|Death|1|||
124888794|NCT01994720|449216843|FG000|Overall Study|Withdrawal by Subject|46|||
124888795|NCT01994720|449216844|FG001|Overall Study|Withdrawal by Subject|56|||
124888796|NCT01991197|449216845|FG000|Overall Study|Lost to Follow-up|1|||
124888797|NCT01991197|449216846|FG001|Overall Study|Lost to Follow-up|1|||
124888798|NCT01991197|449216845|FG000|Overall Study|Physician Decision|0|||
124888799|NCT01991197|449216846|FG001|Overall Study|Physician Decision|2|||
124888800|NCT01991197|449216845|FG000|Overall Study|Withdrawal by Subject|2|||
124888801|NCT01991197|449216846|FG001|Overall Study|Withdrawal by Subject|0|||
124888802|NCT04285229|449216850|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
124888803|NCT04285229|449216851|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124888804|NCT04285229|449216852|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124888805|NCT04285229|449216853|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124888806|NCT04285229|449216854|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124888807|NCT04285229|449216855|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124686347|NCT02335944|448471272|FG001|Post-treatment Follow-up|Death|0|||
124888808|NCT04285229|449216850|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
124888809|NCT04285229|449216851|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
124888810|NCT04285229|449216852|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
124888811|NCT04285229|449216853|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
124441661|NCT01585987|447577775|FG001|Treated|Adverse Event|0|||
124441662|NCT01585987|447577774|FG000|Treated|Withdrawal by Subject|1|||
124441663|NCT01585987|447577775|FG001|Treated|Withdrawal by Subject|2|||
124441664|NCT01585987|447577774|FG000|Treated|Death|1|||
124441665|NCT01585987|447577775|FG001|Treated|Death|0|||
124441666|NCT01585987|447577774|FG000|Treated|Lost to Follow-up|0|||
124441667|NCT01585987|447577775|FG001|Treated|Lost to Follow-up|1|||
124441668|NCT01585987|447577774|FG000|Treated|Maximum Clinical Benefit|0|||
124441669|NCT01585987|447577775|FG001|Treated|Maximum Clinical Benefit|1|||
124441670|NCT01585987|447577774|FG000|Treated|Non-Specified|1|||
124441671|NCT01585987|447577775|FG001|Treated|Non-Specified|2|||
124441672|NCT01585987|447577774|FG000|Treated|Subject Request|0|||
124441673|NCT01585987|447577775|FG001|Treated|Subject Request|1|||
124686348|NCT02335944|448471273|FG002|Post-treatment Follow-up|Death|0|||
124686349|NCT02335944|448471274|FG003|Post-treatment Follow-up|Death|1|||
124686350|NCT02335944|448471275|FG004|Post-treatment Follow-up|Death|0|||
124686351|NCT02335944|448471276|FG005|Post-treatment Follow-up|Death|1|||
124686352|NCT02335944|448471277|FG006|Post-treatment Follow-up|Death|0|||
124686353|NCT02335944|448471278|FG007|Post-treatment Follow-up|Death|0|||
124686354|NCT02335944|448471279|FG008|Post-treatment Follow-up|Death|0|||
124686355|NCT02335944|448471280|FG009|Post-treatment Follow-up|Death|0|||
124686356|NCT02335944|448471271|FG000|Post-treatment Follow-up|Physician Decision|1|||
124686357|NCT02335944|448471272|FG001|Post-treatment Follow-up|Physician Decision|0|||
124686358|NCT02335944|448471273|FG002|Post-treatment Follow-up|Physician Decision|0|||
124686359|NCT02335944|448471274|FG003|Post-treatment Follow-up|Physician Decision|0|||
124686360|NCT02335944|448471275|FG004|Post-treatment Follow-up|Physician Decision|0|||
124686361|NCT02335944|448471276|FG005|Post-treatment Follow-up|Physician Decision|0|||
124686362|NCT02335944|448471277|FG006|Post-treatment Follow-up|Physician Decision|0|||
124686363|NCT02335944|448471278|FG007|Post-treatment Follow-up|Physician Decision|1|||
124686364|NCT02335944|448471279|FG008|Post-treatment Follow-up|Physician Decision|0|||
124686365|NCT02335944|448471280|FG009|Post-treatment Follow-up|Physician Decision|0|||
124686366|NCT01706328|448471281|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
124686367|NCT01706328|448471282|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
124686368|NCT01706328|448471283|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
124686369|NCT01706328|448471281|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
124686370|NCT01706328|448471282|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
124686371|NCT01706328|448471283|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
124686372|NCT01706328|448471281|FG000|2-week Run-in Period|Physician Decision|4|||
124686373|NCT01706328|448471282|FG001|2-week Run-in Period|Physician Decision|0|||
124686374|NCT01706328|448471283|FG002|2-week Run-in Period|Physician Decision|0|||
124686375|NCT01706328|448471281|FG000|2-week Run-in Period|Adverse Event|4|||
124686376|NCT01706328|448471282|FG001|2-week Run-in Period|Adverse Event|0|||
124686377|NCT01706328|448471283|FG002|2-week Run-in Period|Adverse Event|0|||
124686378|NCT01706328|448471281|FG000|2-week Run-in Period|Lost to Follow-up|2|||
124686379|NCT01706328|448471282|FG001|2-week Run-in Period|Lost to Follow-up|0|||
124686380|NCT01706328|448471283|FG002|2-week Run-in Period|Lost to Follow-up|0|||
124686381|NCT01706328|448471281|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
124686382|NCT01706328|448471282|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
124686383|NCT01706328|448471283|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
124686384|NCT01706328|448471281|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
124686385|NCT01706328|448471282|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
124686386|NCT01706328|448471283|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
124686387|NCT01706328|448471281|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
124686388|NCT01706328|448471282|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
124686389|NCT01706328|448471283|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
124686390|NCT01706328|448471281|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
124686391|NCT01706328|448471282|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
124686392|NCT01706328|448471283|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
124686393|NCT01706328|448471281|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
124686394|NCT01706328|448471282|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
124686395|NCT01706328|448471283|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
124686396|NCT01706328|448471281|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
124686397|NCT01706328|448471282|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
124686398|NCT01706328|448471283|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
124686399|NCT01706328|448471281|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
124441674|NCT01585987|447577774|FG000|Treated|Poor/Non-Compliance|0|||
124686400|NCT01706328|448471282|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
124686401|NCT01706328|448471283|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
124441675|NCT01585987|447577775|FG001|Treated|Poor/Non-Compliance|1|||
124441676|NCT02041520|447577776|FG000|Overall Study|Adverse Event|2|||
124441677|NCT02041520|447577777|FG001|Overall Study|Adverse Event|1|||
124441678|NCT02041520|447577776|FG000|Overall Study|Withdrawal by Subject|3|||
124759211|NCT01363700|448742562|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
124759212|NCT01363700|448742563|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
124759213|NCT01363700|448742564|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
124759214|NCT01363700|448742565|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
124759215|NCT01363700|448742566|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
124759216|NCT05202418|448742574|FG000|Overall Study|Withdrawal by Subject|2|||
124759217|NCT05202418|448742575|FG001|Overall Study|Withdrawal by Subject|1|||
124686402|NCT01525589|448471284|FG000|Overall Study|Non-treatment-related AE|1|||
124686403|NCT01525589|448471285|FG001|Overall Study|Non-treatment-related AE|0|||
124686404|NCT01525589|448471286|FG002|Overall Study|Non-treatment-related AE|0|||
124686405|NCT01525589|448471284|FG000|Overall Study|Progressive disease|48|||
124686406|NCT01525589|448471285|FG001|Overall Study|Progressive disease|15|||
124686407|NCT01525589|448471286|FG002|Overall Study|Progressive disease|29|||
124686408|NCT01525589|448471284|FG000|Overall Study|Never treated|2|||
124686409|NCT01525589|448471285|FG001|Overall Study|Never treated|0|||
124686410|NCT01525589|448471286|FG002|Overall Study|Never treated|0|||
124686411|NCT01525589|448471284|FG000|Overall Study|Physician Decision|4|||
124686412|NCT01525589|448471285|FG001|Overall Study|Physician Decision|2|||
124759218|NCT05202418|448742574|FG000|Overall Study|Lost to Follow-up|1|||
124759219|NCT05202418|448742575|FG001|Overall Study|Lost to Follow-up|1|||
124759220|NCT01329978|448742579|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
124759221|NCT01329978|448742580|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
124759222|NCT01329978|448742581|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
124759223|NCT01329978|448742582|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
124759224|NCT01329978|448742583|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
124759225|NCT01329978|448742579|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
124888812|NCT04285229|449216854|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
124888813|NCT04285229|449216855|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
124888814|NCT04285229|449216850|FG000|Extended Treatment Period|Adverse Event|0|||
124888815|NCT04285229|449216851|FG001|Extended Treatment Period|Adverse Event|0|||
124888816|NCT04285229|449216852|FG002|Extended Treatment Period|Adverse Event|0|||
124888817|NCT04285229|449216853|FG003|Extended Treatment Period|Adverse Event|1|||
124888818|NCT04285229|449216854|FG004|Extended Treatment Period|Adverse Event|0|||
124888819|NCT04285229|449216855|FG005|Extended Treatment Period|Adverse Event|0|||
124888820|NCT04285229|449216850|FG000|Extended Treatment Period|Physician Decision|0|||
124888821|NCT04285229|449216851|FG001|Extended Treatment Period|Physician Decision|0|||
124888822|NCT04285229|449216852|FG002|Extended Treatment Period|Physician Decision|1|||
124888823|NCT04285229|449216853|FG003|Extended Treatment Period|Physician Decision|0|||
124759226|NCT01329978|448742580|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
124759227|NCT01329978|448742581|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
124759228|NCT01329978|448742582|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
124888824|NCT04285229|449216854|FG004|Extended Treatment Period|Physician Decision|0|||
124888825|NCT04285229|449216855|FG005|Extended Treatment Period|Physician Decision|0|||
124888826|NCT04285229|449216850|FG000|Follow-up Period|Adverse Event|0|||
124888827|NCT04285229|449216851|FG001|Follow-up Period|Adverse Event|0|||
124888828|NCT04285229|449216852|FG002|Follow-up Period|Adverse Event|0|||
124888829|NCT04285229|449216853|FG003|Follow-up Period|Adverse Event|0|||
124888830|NCT04285229|449216854|FG004|Follow-up Period|Adverse Event|1|||
124888831|NCT04285229|449216855|FG005|Follow-up Period|Adverse Event|4|||
124888832|NCT04285229|449216850|FG000|Follow-up Period|Withdrawal by Subject|0|||
124888833|NCT04285229|449216851|FG001|Follow-up Period|Withdrawal by Subject|0|||
124888834|NCT04285229|449216852|FG002|Follow-up Period|Withdrawal by Subject|0|||
124686413|NCT01525589|448471286|FG002|Overall Study|Physician Decision|2|||
124686414|NCT01525589|448471284|FG000|Overall Study|Death|0|||
124686415|NCT01525589|448471285|FG001|Overall Study|Death|0|||
124686416|NCT01525589|448471286|FG002|Overall Study|Death|2|||
124759229|NCT01329978|448742583|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
124759230|NCT01329978|448742579|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
124888835|NCT04285229|449216853|FG003|Follow-up Period|Withdrawal by Subject|0|||
124888836|NCT04285229|449216854|FG004|Follow-up Period|Withdrawal by Subject|0|||
124888837|NCT04285229|449216855|FG005|Follow-up Period|Withdrawal by Subject|5|||
124686417|NCT01525589|448471284|FG000|Overall Study|Treatment-related AE|1|||
124686418|NCT01525589|448471285|FG001|Overall Study|Treatment-related AE|1|||
124686419|NCT01525589|448471286|FG002|Overall Study|Treatment-related AE|2|||
124686420|NCT01525589|448471284|FG000|Overall Study|Other reasons|0|||
124686421|NCT01525589|448471285|FG001|Overall Study|Other reasons|1|||
124686422|NCT01525589|448471286|FG002|Overall Study|Other reasons|0|||
124888838|NCT04285229|449216850|FG000|Follow-up Period|Covid-19|0|||
124888839|NCT04285229|449216851|FG001|Follow-up Period|Covid-19|0|||
124888840|NCT04285229|449216852|FG002|Follow-up Period|Covid-19|0|||
124888841|NCT04285229|449216853|FG003|Follow-up Period|Covid-19|0|||
124888842|NCT04285229|449216854|FG004|Follow-up Period|Covid-19|0|||
124888843|NCT04285229|449216855|FG005|Follow-up Period|Covid-19|2|||
124888844|NCT04285229|449216850|FG000|Follow-up Period|Physician Decision|0|||
124888845|NCT04285229|449216851|FG001|Follow-up Period|Physician Decision|0|||
124888846|NCT04285229|449216852|FG002|Follow-up Period|Physician Decision|0|||
124888847|NCT04285229|449216853|FG003|Follow-up Period|Physician Decision|0|||
124888848|NCT04285229|449216854|FG004|Follow-up Period|Physician Decision|0|||
124888849|NCT04285229|449216855|FG005|Follow-up Period|Physician Decision|1|||
124888850|NCT00231894|449216856|FG000|Overall Study|Withdrawal by Subject|1|||
124888851|NCT00231894|449216857|FG001|Overall Study|Withdrawal by Subject|1|||
124888852|NCT02025205|449216858|FG000|Overall Study|Withdrawal by Subject|1|||
124759231|NCT01329978|448742580|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
124759232|NCT01329978|448742581|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
124759233|NCT01329978|448742582|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
124888853|NCT02025205|449216859|FG001|Overall Study|Withdrawal by Subject|1|||
124888854|NCT02025205|449216858|FG000|Overall Study|Protocol Violation|2|||
124888855|NCT02025205|449216859|FG001|Overall Study|Protocol Violation|1|||
124888856|NCT02025205|449216858|FG000|Overall Study|Death|0|||
124888857|NCT02025205|449216859|FG001|Overall Study|Death|1|||
124888858|NCT01767129|449216860|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
124888859|NCT01767129|449216861|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
124888860|NCT03389893|449216862|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
124888861|NCT03389893|449216863|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
124888862|NCT03389893|449216864|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
124888863|NCT03389893|449216865|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
124888864|NCT03389893|449216862|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
124888865|NCT03389893|449216863|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
124888866|NCT03389893|449216864|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
124888867|NCT03389893|449216865|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
124888868|NCT03389893|449216862|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
124888869|NCT03389893|449216863|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
124888870|NCT03389893|449216864|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
124888871|NCT03389893|449216865|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
124888872|NCT03389893|449216862|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
124888873|NCT03389893|449216863|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
124888874|NCT03389893|449216864|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
124888875|NCT03389893|449216865|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
124888876|NCT01232556|449216869|FG000|Overall Study|Withdrawal by Subject|21|||
124888877|NCT01232556|449216870|FG001|Overall Study|Withdrawal by Subject|17|||
124888878|NCT01232556|449216869|FG000|Overall Study|Death|97|||
124888879|NCT01232556|449216870|FG001|Overall Study|Death|97|||
124888880|NCT01232556|449216869|FG000|Overall Study|Lost to Follow-up|0|||
124888881|NCT01232556|449216870|FG001|Overall Study|Lost to Follow-up|2|||
124888882|NCT01232556|449216869|FG000|Overall Study|Terminated by Sponsor|35|||
124888883|NCT01232556|449216870|FG001|Overall Study|Terminated by Sponsor|51|||
124441679|NCT02041520|447577777|FG001|Overall Study|Withdrawal by Subject|4|||
124441680|NCT02041520|447577776|FG000|Overall Study|Protocol Violation|1|||
124441681|NCT02041520|447577777|FG001|Overall Study|Protocol Violation|0|||
124441682|NCT02041520|447577776|FG000|Overall Study|Lost to Follow-up|0|||
124441683|NCT02041520|447577777|FG001|Overall Study|Lost to Follow-up|1|||
124441684|NCT02041520|447577776|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
124441685|NCT02041520|447577777|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
124441686|NCT01759407|447577778|FG000|Overall Study|Protocol Violation|0|||
124441687|NCT01759407|447577779|FG001|Overall Study|Protocol Violation|2|||
124759234|NCT01329978|448742583|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
124888884|NCT01232556|449216869|FG000|Overall Study|Other|6|||
124888885|NCT01232556|449216870|FG001|Overall Study|Other|4|||
124888886|NCT01473420|449216872|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
124888887|NCT01473420|449216873|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
124888888|NCT01473420|449216872|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
124888889|NCT01473420|449216873|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
124759235|NCT01329978|448742579|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
124759236|NCT01329978|448742580|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
124888890|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
124888891|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
124888892|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
124888893|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
124441688|NCT03737474|447577780|FG000|Overall Study|Adverse Event|18|||
124441689|NCT03737474|447577781|FG001|Overall Study|Adverse Event|48|||
124888894|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
124888895|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
124888896|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
124888897|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
124888898|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
124888899|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
124888900|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
124888901|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
124888902|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
124888903|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
124888904|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
124888905|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
124888906|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
124888907|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
124888908|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
124888909|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
124888910|NCT01473420|449216872|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
124888911|NCT01473420|449216873|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
124888912|NCT00388362|449216883|FG000|Enrolled|Ineligible|1|||
124888913|NCT00388362|449216883|FG000|Enrolled|Adverse Event|9|||
124888914|NCT00388362|449216883|FG000|Enrolled|Death|1|||
124888915|NCT00388362|449216883|FG000|Enrolled|Loss insurance|1|||
124888916|NCT00388362|449216883|FG000|Enrolled|Withdrawal by Subject|1|||
124888917|NCT00388362|449216883|FG000|Remained on Study Median of 514 Days|Death|2|||
124888918|NCT03259373|449216890|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
124888919|NCT03259373|449216891|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
124888920|NCT03259373|449216890|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
124888921|NCT03259373|449216891|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
124888922|NCT03259373|449216890|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
124888923|NCT03259373|449216891|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
124888924|NCT03259373|449216890|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
124888925|NCT03259373|449216891|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
124888926|NCT03259373|449216890|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
124888927|NCT03259373|449216891|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
124888928|NCT03259373|449216890|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
124888929|NCT03259373|449216891|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
124888930|NCT04963062|449216899|FG000|Overall Study|withdrew by the study team|4|||
124888931|NCT04963062|449216900|FG001|Overall Study|withdrew by the study team|2|||
124888932|NCT01857323|449216901|FG000|Overall Study|Adverse Event|1|||
124888933|NCT01857323|449216901|FG000|Overall Study|Withdrawal by Subject|3|||
124888934|NCT01857323|449216901|FG000|Overall Study|Non-compliance|1|||
124888935|NCT01857323|449216901|FG000|Overall Study|Protocol Violation|6|||
124888936|NCT01857323|449216901|FG000|Overall Study|Lost to Follow-up|1|||
124888937|NCT01857323|449216901|FG000|Overall Study|Other|4|||
124888938|NCT01857323|449216901|FG000|Overall Study|Did not complete 180 doses|48|||
124888939|NCT03873246|449216902|FG000|Overall Study|Adverse Event|1|||
124888940|NCT03873246|449216903|FG001|Overall Study|Adverse Event|3|||
124888941|NCT03873246|449216904|FG002|Overall Study|Adverse Event|3|||
124888942|NCT03873246|449216902|FG000|Overall Study|Lost to Follow-up|4|||
124888943|NCT03873246|449216903|FG001|Overall Study|Lost to Follow-up|4|||
124888944|NCT03873246|449216904|FG002|Overall Study|Lost to Follow-up|5|||
124888945|NCT03873246|449216902|FG000|Overall Study|Protocol Violation|0|||
124888946|NCT03873246|449216903|FG001|Overall Study|Protocol Violation|1|||
124888947|NCT03873246|449216904|FG002|Overall Study|Protocol Violation|0|||
124888948|NCT03873246|449216902|FG000|Overall Study|Withdrawal by Subject|0|||
124888949|NCT03873246|449216903|FG001|Overall Study|Withdrawal by Subject|4|||
124888950|NCT03873246|449216904|FG002|Overall Study|Withdrawal by Subject|1|||
124888951|NCT01368211|449216908|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
124888952|NCT01368211|449216909|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
124888953|NCT01987830|449216911|FG000|Overall Study|Never received baseline scan|1|||
124888954|NCT01349660|449216915|FG000|Overall Study|Still Receiving Study Treatment|0|||
124888955|NCT01349660|449216916|FG001|Overall Study|Still Receiving Study Treatment|0|||
124888956|NCT01349660|449216917|FG002|Overall Study|Still Receiving Study Treatment|1|||
124888957|NCT01349660|449216915|FG000|Overall Study|Disease Progression|2|||
124888958|NCT01349660|449216916|FG001|Overall Study|Disease Progression|4|||
124888959|NCT01349660|449216917|FG002|Overall Study|Disease Progression|50|||
124888960|NCT01349660|449216915|FG000|Overall Study|Adverse Event|1|||
124888961|NCT01349660|449216916|FG001|Overall Study|Adverse Event|1|||
124888962|NCT01349660|449216917|FG002|Overall Study|Adverse Event|12|||
124888963|NCT01349660|449216915|FG000|Overall Study|Withdrawal by Subject|2|||
124888964|NCT01349660|449216916|FG001|Overall Study|Withdrawal by Subject|0|||
124888965|NCT01349660|449216917|FG002|Overall Study|Withdrawal by Subject|9|||
124888966|NCT01349660|449216915|FG000|Overall Study|Death|1|||
124888967|NCT01349660|449216916|FG001|Overall Study|Death|1|||
124888968|NCT01349660|449216917|FG002|Overall Study|Death|0|||
124888969|NCT01349660|449216915|FG000|Overall Study|Non-Permitted Interventions|0|||
124888970|NCT01349660|449216916|FG001|Overall Study|Non-Permitted Interventions|0|||
124888971|NCT01349660|449216917|FG002|Overall Study|Non-Permitted Interventions|2|||
124888972|NCT01349660|449216915|FG000|Overall Study|Study Compliance|0|||
124888973|NCT01349660|449216916|FG001|Overall Study|Study Compliance|0|||
124888974|NCT01349660|449216917|FG002|Overall Study|Study Compliance|1|||
124888975|NCT01349660|449216915|FG000|Overall Study|Declining Performance Status|0|||
124888976|NCT01349660|449216916|FG001|Overall Study|Declining Performance Status|0|||
124888977|NCT01349660|449216917|FG002|Overall Study|Declining Performance Status|1|||
124888978|NCT05764239|449216918|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
124888979|NCT05764239|449216918|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
124888980|NCT05764239|449216918|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
124888981|NCT05764239|449216918|FG000|DEP (Part 1)|Adverse Event|1|||
124888982|NCT05764239|449216918|FG000|DEP (Part 1)|Lost to Follow-up|1|||
124888983|NCT05764239|449216918|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
124888984|NCT05764239|449216918|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
124441690|NCT03737474|447577780|FG000|Overall Study|Lack of Efficacy|1|||
124441691|NCT03737474|447577781|FG001|Overall Study|Lack of Efficacy|3|||
124441692|NCT03737474|447577780|FG000|Overall Study|Protocol Violation|0|||
124441693|NCT03737474|447577781|FG001|Overall Study|Protocol Violation|8|||
124441694|NCT03737474|447577780|FG000|Overall Study|Withdrawal by Subject|5|||
124441695|NCT03737474|447577781|FG001|Overall Study|Withdrawal by Subject|20|||
124441696|NCT03737474|447577780|FG000|Overall Study|Non-compliance With Study Drug|0|||
124441697|NCT03737474|447577781|FG001|Overall Study|Non-compliance With Study Drug|1|||
124441698|NCT03737474|447577780|FG000|Overall Study|Physician Decision|1|||
124441699|NCT03737474|447577781|FG001|Overall Study|Physician Decision|4|||
124441700|NCT02513745|447577782|FG000|Overall Study|Criteria at time of surgery not met.|3|||
124441701|NCT02513745|447577783|FG001|Overall Study|Criteria at time of surgery not met.|3|||
124441702|NCT01209143|447577784|FG000|Overall Study|Adverse Event|2|||
124441703|NCT01209143|447577785|FG001|Overall Study|Adverse Event|1|||
124441704|NCT01209143|447577784|FG000|Overall Study|Death|0|||
124441705|NCT01209143|447577785|FG001|Overall Study|Death|1|||
124441706|NCT01209143|447577784|FG000|Overall Study|Physician Decision|3|||
124441707|NCT01209143|447577785|FG001|Overall Study|Physician Decision|1|||
124441708|NCT01209143|447577784|FG000|Overall Study|Lost to Follow-up|1|||
124441709|NCT01209143|447577785|FG001|Overall Study|Lost to Follow-up|0|||
124441710|NCT01209143|447577784|FG000|Overall Study|Withdrawal by Subject|2|||
124441711|NCT01209143|447577785|FG001|Overall Study|Withdrawal by Subject|1|||
124441712|NCT01209143|447577784|FG000|Overall Study|Disease progression|11|||
124441713|NCT01209143|447577785|FG001|Overall Study|Disease progression|16|||
124441714|NCT01145755|447577786|FG000|Overall Study|Adverse Event|2|||
124888985|NCT05764239|449216918|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
124888986|NCT05764239|449216918|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
124888987|NCT00057811|449216919|FG000|Overall Study|Lack of Efficacy|1|||
124888988|NCT00057811|449216920|FG001|Overall Study|Lack of Efficacy|4|||
124888989|NCT00057811|449216919|FG000|Overall Study|Physician Decision|1|||
124888990|NCT00057811|449216920|FG001|Overall Study|Physician Decision|0|||
124888991|NCT00057811|449216919|FG000|Overall Study|Withdrawal by Subject|3|||
124888992|NCT00057811|449216920|FG001|Overall Study|Withdrawal by Subject|4|||
124888993|NCT00057811|449216919|FG000|Overall Study|Ineligible|4|||
124759237|NCT01329978|448742581|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
124759238|NCT01329978|448742582|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
124888994|NCT00057811|449216920|FG001|Overall Study|Ineligible|2|||
124888995|NCT00057811|449216919|FG000|Overall Study|Inevaluable|1|||
124441715|NCT01145755|447577787|FG001|Overall Study|Adverse Event|4|||
124441716|NCT01145755|447577788|FG002|Overall Study|Adverse Event|2|||
124441717|NCT01145755|447577786|FG000|Overall Study|Withdrawal by Subject|2|||
124888996|NCT00057811|449216920|FG001|Overall Study|Inevaluable|2|||
124888997|NCT01475786|449216923|FG000|Overall Study|Adverse Event|0|||
124888998|NCT01475786|449216924|FG001|Overall Study|Adverse Event|1|||
124888999|NCT01475786|449216925|FG002|Overall Study|Adverse Event|0|||
124889000|NCT01475786|449216923|FG000|Overall Study|Lost to Follow-up|1|||
124889001|NCT01475786|449216924|FG001|Overall Study|Lost to Follow-up|2|||
124889002|NCT01475786|449216925|FG002|Overall Study|Lost to Follow-up|1|||
124889003|NCT01475786|449216923|FG000|Overall Study|Withdrawal by Subject|0|||
124889004|NCT01475786|449216924|FG001|Overall Study|Withdrawal by Subject|1|||
124889005|NCT01475786|449216925|FG002|Overall Study|Withdrawal by Subject|1|||
124889006|NCT01475786|449216923|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
124889007|NCT01475786|449216924|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
124889008|NCT01475786|449216925|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
124889009|NCT04129580|449218603|FG000|Overall Study|Lost to Follow-up|14|||
124889010|NCT04129580|449218604|FG001|Overall Study|Lost to Follow-up|25|||
124889011|NCT02018861|449218607|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
124889012|NCT02018861|449218608|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
124889013|NCT02018861|449218609|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
124889014|NCT02018861|449218610|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
124889015|NCT02018861|449218611|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
124889016|NCT02018861|449218612|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
124889017|NCT02018861|449218613|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
124889018|NCT02018861|449218614|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
124889019|NCT02018861|449218615|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
124889020|NCT02018861|449218616|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
124889021|NCT02018861|449218607|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
124889022|NCT02018861|449218608|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
124889023|NCT02018861|449218609|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
124889024|NCT02018861|449218610|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
124889025|NCT02018861|449218611|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
124889026|NCT02018861|449218612|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
124889027|NCT02018861|449218613|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
124889028|NCT02018861|449218614|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
124889029|NCT02018861|449218615|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
124889030|NCT02018861|449218616|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
124889031|NCT02018861|449218607|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
124889032|NCT02018861|449218608|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
124889033|NCT02018861|449218609|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
124889034|NCT02018861|449218610|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
124889035|NCT02018861|449218611|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
124889036|NCT02018861|449218612|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
124889037|NCT02018861|449218613|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
124889038|NCT02018861|449218614|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
124889039|NCT02018861|449218615|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
124889040|NCT02018861|449218616|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
124889041|NCT02018861|449218607|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
124889042|NCT02018861|449218608|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
124889043|NCT02018861|449218609|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
124889044|NCT02018861|449218610|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
124889045|NCT02018861|449218611|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
124889046|NCT02018861|449218612|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
124889047|NCT02018861|449218613|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
124889048|NCT02018861|449218614|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
124889049|NCT02018861|449218615|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
124889050|NCT02018861|449218616|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
124889051|NCT02018861|449218607|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
124889052|NCT02018861|449218608|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
124889053|NCT02018861|449218609|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
124889054|NCT02018861|449218610|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
124889055|NCT02018861|449218611|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
124889056|NCT02018861|449218612|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
124889057|NCT02018861|449218613|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
124889058|NCT02018861|449218614|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
124889059|NCT02018861|449218615|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
124889060|NCT02018861|449218616|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
124889061|NCT02018861|449218607|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889062|NCT02018861|449218608|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889063|NCT02018861|449218609|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889064|NCT02018861|449218610|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889065|NCT02018861|449218611|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
124889066|NCT02018861|449218612|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889067|NCT02018861|449218613|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889068|NCT02018861|449218614|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889069|NCT02018861|449218615|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889070|NCT02018861|449218616|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
124889071|NCT02018861|449218607|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
124889072|NCT02018861|449218608|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
124889073|NCT02018861|449218609|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
124889074|NCT02018861|449218610|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
124889075|NCT02018861|449218611|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
124889076|NCT02018861|449218612|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
124889077|NCT02018861|449218613|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
124889078|NCT02018861|449218614|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
124889079|NCT02018861|449218615|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
124889080|NCT02018861|449218616|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
124889081|NCT02018861|449218607|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
124889082|NCT02018861|449218608|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
124889083|NCT02018861|449218609|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
124889084|NCT02018861|449218610|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
124889085|NCT02018861|449218611|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
124889086|NCT02018861|449218612|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
124889087|NCT02018861|449218613|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
124889088|NCT02018861|449218614|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
124889089|NCT02018861|449218615|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
124889090|NCT02018861|449218616|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
124889091|NCT02018861|449218607|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
124889092|NCT02018861|449218608|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
124889093|NCT02018861|449218609|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
124889094|NCT02018861|449218610|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
124889095|NCT02018861|449218611|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
124889096|NCT02018861|449218612|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
124889097|NCT02018861|449218613|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
124889098|NCT02018861|449218614|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
124889099|NCT02018861|449218615|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
124889100|NCT02018861|449218616|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
124889101|NCT02018861|449218607|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
124889102|NCT02018861|449218608|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
124889103|NCT02018861|449218609|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
124889104|NCT02018861|449218610|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
124889105|NCT02018861|449218611|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
124889106|NCT02018861|449218612|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
124889107|NCT02018861|449218613|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
124889108|NCT02018861|449218614|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
124889109|NCT02018861|449218615|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
124889110|NCT02018861|449218616|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
124889111|NCT02018861|449218607|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889112|NCT02018861|449218608|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889113|NCT02018861|449218609|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889114|NCT02018861|449218610|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889115|NCT02018861|449218611|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889116|NCT02018861|449218612|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889117|NCT02018861|449218613|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889118|NCT02018861|449218614|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889119|NCT02018861|449218615|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
124889120|NCT02018861|449218616|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
124889121|NCT02018861|449218607|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124889122|NCT02018861|449218608|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124889123|NCT02018861|449218609|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124889124|NCT02018861|449218610|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124759239|NCT01329978|448742583|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
124759240|NCT01329978|448742579|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
124889125|NCT02018861|449218611|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124889126|NCT02018861|449218612|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124889127|NCT02018861|449218613|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124889128|NCT02018861|449218614|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124889129|NCT02018861|449218615|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
124889130|NCT02018861|449218616|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
124889131|NCT02018861|449218607|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889132|NCT02018861|449218608|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889133|NCT02018861|449218609|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889134|NCT02018861|449218610|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889135|NCT02018861|449218611|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889136|NCT02018861|449218612|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889137|NCT02018861|449218613|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889138|NCT02018861|449218614|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889139|NCT02018861|449218615|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
124889140|NCT02018861|449218616|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
124889141|NCT01474512|449218621|FG000|Induction Period|Adverse Event|6|||
124889142|NCT01474512|449218622|FG001|Induction Period|Adverse Event|10|||
124889143|NCT01474512|449218623|FG002|Induction Period|Adverse Event|10|||
124889144|NCT01474512|449218624|FG003|Induction Period|Adverse Event|0|||
124889145|NCT01474512|449218625|FG004|Induction Period|Adverse Event|0|||
124686423|NCT01525589|448471284|FG000|Overall Study|Withdrawal by Subject|0|||
124686424|NCT01525589|448471285|FG001|Overall Study|Withdrawal by Subject|1|||
124686425|NCT01525589|448471286|FG002|Overall Study|Withdrawal by Subject|0|||
124686426|NCT02101853|448471290|FG000|Block 1 Induction|Adverse Event|11|||
124686427|NCT02101853|448471291|FG001|Block 1 Induction|Adverse Event|0|||
124686428|NCT02101853|448471292|FG002|Block 1 Induction|Adverse Event|0|||
124686429|NCT02101853|448471293|FG003|Block 1 Induction|Adverse Event|0|||
124686430|NCT02101853|448471294|FG004|Block 1 Induction|Adverse Event|0|||
124686431|NCT02101853|448471295|FG005|Block 1 Induction|Adverse Event|0|||
124686432|NCT02101853|448471290|FG000|Block 1 Induction|Death|20|||
124686433|NCT02101853|448471291|FG001|Block 1 Induction|Death|0|||
124686434|NCT02101853|448471292|FG002|Block 1 Induction|Death|0|||
124686435|NCT02101853|448471293|FG003|Block 1 Induction|Death|0|||
124686436|NCT02101853|448471294|FG004|Block 1 Induction|Death|0|||
124686437|NCT02101853|448471295|FG005|Block 1 Induction|Death|0|||
124686438|NCT02101853|448471290|FG000|Block 1 Induction|Lack of Efficacy|6|||
124686439|NCT02101853|448471291|FG001|Block 1 Induction|Lack of Efficacy|0|||
124686440|NCT02101853|448471292|FG002|Block 1 Induction|Lack of Efficacy|0|||
124686441|NCT02101853|448471293|FG003|Block 1 Induction|Lack of Efficacy|0|||
124686442|NCT02101853|448471294|FG004|Block 1 Induction|Lack of Efficacy|0|||
124686443|NCT02101853|448471295|FG005|Block 1 Induction|Lack of Efficacy|0|||
124686444|NCT02101853|448471290|FG000|Block 1 Induction|Physician Decision|61|||
124686445|NCT02101853|448471291|FG001|Block 1 Induction|Physician Decision|0|||
124686446|NCT02101853|448471292|FG002|Block 1 Induction|Physician Decision|0|||
124686447|NCT02101853|448471293|FG003|Block 1 Induction|Physician Decision|0|||
124686448|NCT02101853|448471294|FG004|Block 1 Induction|Physician Decision|0|||
124686449|NCT02101853|448471295|FG005|Block 1 Induction|Physician Decision|0|||
124686450|NCT02101853|448471290|FG000|Block 1 Induction|Protocol Violation|2|||
124686451|NCT02101853|448471291|FG001|Block 1 Induction|Protocol Violation|0|||
124686452|NCT02101853|448471292|FG002|Block 1 Induction|Protocol Violation|0|||
124686453|NCT02101853|448471293|FG003|Block 1 Induction|Protocol Violation|0|||
124686454|NCT02101853|448471294|FG004|Block 1 Induction|Protocol Violation|0|||
124686455|NCT02101853|448471295|FG005|Block 1 Induction|Protocol Violation|0|||
124686456|NCT02101853|448471290|FG000|Block 1 Induction|Withdrawal by Subject|65|||
124686457|NCT02101853|448471291|FG001|Block 1 Induction|Withdrawal by Subject|0|||
124686458|NCT02101853|448471292|FG002|Block 1 Induction|Withdrawal by Subject|0|||
124686459|NCT02101853|448471293|FG003|Block 1 Induction|Withdrawal by Subject|0|||
124686460|NCT02101853|448471294|FG004|Block 1 Induction|Withdrawal by Subject|0|||
124686461|NCT02101853|448471295|FG005|Block 1 Induction|Withdrawal by Subject|0|||
124686462|NCT02101853|448471290|FG000|Block 1 Induction|Ineligible|8|||
124686463|NCT02101853|448471291|FG001|Block 1 Induction|Ineligible|0|||
124686464|NCT02101853|448471292|FG002|Block 1 Induction|Ineligible|0|||
124686465|NCT02101853|448471293|FG003|Block 1 Induction|Ineligible|0|||
124686466|NCT02101853|448471294|FG004|Block 1 Induction|Ineligible|0|||
124686467|NCT02101853|448471295|FG005|Block 1 Induction|Ineligible|0|||
124686468|NCT02101853|448471290|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
124686469|NCT02101853|448471291|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
124686470|NCT02101853|448471292|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
124686471|NCT02101853|448471293|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
124686472|NCT02101853|448471294|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
124686473|NCT02101853|448471295|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
124712013|NCT01343888|448570707|FG000|Overall Study|other than stated above|0|||
124889146|NCT01474512|449218626|FG005|Induction Period|Adverse Event|0|||
124889147|NCT01474512|449218627|FG006|Induction Period|Adverse Event|0|||
124889148|NCT01474512|449218628|FG007|Induction Period|Adverse Event|0|||
124889149|NCT01474512|449218629|FG008|Induction Period|Adverse Event|0|||
124889150|NCT01474512|449218630|FG009|Induction Period|Adverse Event|0|||
124889151|NCT01474512|449218631|FG010|Induction Period|Adverse Event|0|||
124889152|NCT01474512|449218632|FG011|Induction Period|Adverse Event|0|||
124889153|NCT01474512|449218633|FG012|Induction Period|Adverse Event|0|||
124889154|NCT01474512|449218634|FG013|Induction Period|Adverse Event|0|||
124889155|NCT01474512|449218635|FG014|Induction Period|Adverse Event|0|||
124889156|NCT01474512|449218636|FG015|Induction Period|Adverse Event|0|||
124889157|NCT01474512|449218637|FG016|Induction Period|Adverse Event|0|||
124889158|NCT01474512|449218638|FG017|Induction Period|Adverse Event|0|||
124889159|NCT01474512|449218621|FG000|Induction Period|Lack of Efficacy|7|||
124889160|NCT01474512|449218622|FG001|Induction Period|Lack of Efficacy|1|||
124889161|NCT01474512|449218623|FG002|Induction Period|Lack of Efficacy|0|||
124889162|NCT01474512|449218624|FG003|Induction Period|Lack of Efficacy|0|||
124889163|NCT01474512|449218625|FG004|Induction Period|Lack of Efficacy|0|||
124889164|NCT01474512|449218626|FG005|Induction Period|Lack of Efficacy|0|||
124889165|NCT01474512|449218627|FG006|Induction Period|Lack of Efficacy|0|||
124889166|NCT01474512|449218628|FG007|Induction Period|Lack of Efficacy|0|||
124889167|NCT01474512|449218629|FG008|Induction Period|Lack of Efficacy|0|||
124889168|NCT01474512|449218630|FG009|Induction Period|Lack of Efficacy|0|||
124889169|NCT01474512|449218631|FG010|Induction Period|Lack of Efficacy|0|||
124889170|NCT01474512|449218632|FG011|Induction Period|Lack of Efficacy|0|||
124889171|NCT01474512|449218633|FG012|Induction Period|Lack of Efficacy|0|||
124889172|NCT01474512|449218634|FG013|Induction Period|Lack of Efficacy|0|||
124889173|NCT01474512|449218635|FG014|Induction Period|Lack of Efficacy|0|||
124889174|NCT01474512|449218636|FG015|Induction Period|Lack of Efficacy|0|||
124889175|NCT01474512|449218637|FG016|Induction Period|Lack of Efficacy|0|||
124889176|NCT01474512|449218638|FG017|Induction Period|Lack of Efficacy|0|||
124889177|NCT01474512|449218621|FG000|Induction Period|Withdrawal by Subject|6|||
124889178|NCT01474512|449218622|FG001|Induction Period|Withdrawal by Subject|6|||
124889179|NCT01474512|449218623|FG002|Induction Period|Withdrawal by Subject|5|||
124889180|NCT01474512|449218624|FG003|Induction Period|Withdrawal by Subject|0|||
124889181|NCT01474512|449218625|FG004|Induction Period|Withdrawal by Subject|0|||
124889182|NCT01474512|449218626|FG005|Induction Period|Withdrawal by Subject|0|||
124889183|NCT01474512|449218627|FG006|Induction Period|Withdrawal by Subject|0|||
124889184|NCT01474512|449218628|FG007|Induction Period|Withdrawal by Subject|0|||
124889185|NCT01474512|449218629|FG008|Induction Period|Withdrawal by Subject|0|||
124889186|NCT01474512|449218630|FG009|Induction Period|Withdrawal by Subject|0|||
124889187|NCT01474512|449218631|FG010|Induction Period|Withdrawal by Subject|0|||
124889188|NCT01474512|449218632|FG011|Induction Period|Withdrawal by Subject|0|||
124889189|NCT01474512|449218633|FG012|Induction Period|Withdrawal by Subject|0|||
124889190|NCT01474512|449218634|FG013|Induction Period|Withdrawal by Subject|0|||
124889191|NCT01474512|449218635|FG014|Induction Period|Withdrawal by Subject|0|||
124889192|NCT01474512|449218636|FG015|Induction Period|Withdrawal by Subject|0|||
124889193|NCT01474512|449218637|FG016|Induction Period|Withdrawal by Subject|0|||
124889194|NCT01474512|449218638|FG017|Induction Period|Withdrawal by Subject|0|||
124889195|NCT01474512|449218621|FG000|Induction Period|Protocol Violation|3|||
124889196|NCT01474512|449218622|FG001|Induction Period|Protocol Violation|6|||
124889197|NCT01474512|449218623|FG002|Induction Period|Protocol Violation|0|||
124889198|NCT01474512|449218624|FG003|Induction Period|Protocol Violation|0|||
124889199|NCT01474512|449218625|FG004|Induction Period|Protocol Violation|0|||
124889200|NCT01474512|449218626|FG005|Induction Period|Protocol Violation|0|||
124889201|NCT01474512|449218627|FG006|Induction Period|Protocol Violation|0|||
124889202|NCT01474512|449218628|FG007|Induction Period|Protocol Violation|0|||
124889203|NCT01474512|449218629|FG008|Induction Period|Protocol Violation|0|||
124889204|NCT01474512|449218630|FG009|Induction Period|Protocol Violation|0|||
124889205|NCT01474512|449218631|FG010|Induction Period|Protocol Violation|0|||
124889206|NCT01474512|449218632|FG011|Induction Period|Protocol Violation|0|||
124889207|NCT01474512|449218633|FG012|Induction Period|Protocol Violation|0|||
124889208|NCT01474512|449218634|FG013|Induction Period|Protocol Violation|0|||
124889209|NCT01474512|449218635|FG014|Induction Period|Protocol Violation|0|||
124889210|NCT01474512|449218636|FG015|Induction Period|Protocol Violation|0|||
124889211|NCT01474512|449218637|FG016|Induction Period|Protocol Violation|0|||
124889212|NCT01474512|449218638|FG017|Induction Period|Protocol Violation|0|||
124889213|NCT01474512|449218621|FG000|Induction Period|Sponsor Decision|1|||
124889214|NCT01474512|449218622|FG001|Induction Period|Sponsor Decision|1|||
124889215|NCT01474512|449218623|FG002|Induction Period|Sponsor Decision|1|||
124889216|NCT01474512|449218624|FG003|Induction Period|Sponsor Decision|0|||
124889217|NCT01474512|449218625|FG004|Induction Period|Sponsor Decision|0|||
124889218|NCT01474512|449218626|FG005|Induction Period|Sponsor Decision|0|||
124889219|NCT01474512|449218627|FG006|Induction Period|Sponsor Decision|0|||
124889220|NCT01474512|449218628|FG007|Induction Period|Sponsor Decision|0|||
124889221|NCT01474512|449218629|FG008|Induction Period|Sponsor Decision|0|||
124889222|NCT01474512|449218630|FG009|Induction Period|Sponsor Decision|0|||
124686474|NCT02101853|448471290|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
124686475|NCT02101853|448471291|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
124686476|NCT02101853|448471292|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
124686477|NCT02101853|448471293|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
124686478|NCT02101853|448471294|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
124686479|NCT02101853|448471295|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
124686480|NCT02101853|448471290|FG000|Post Induction Randomization|Adverse Event|0|||
124686481|NCT02101853|448471291|FG001|Post Induction Randomization|Adverse Event|3|||
124686482|NCT02101853|448471292|FG002|Post Induction Randomization|Adverse Event|8|||
124889223|NCT01474512|449218631|FG010|Induction Period|Sponsor Decision|0|||
124889224|NCT01474512|449218632|FG011|Induction Period|Sponsor Decision|0|||
124889225|NCT01474512|449218633|FG012|Induction Period|Sponsor Decision|0|||
124889226|NCT01474512|449218634|FG013|Induction Period|Sponsor Decision|0|||
124889227|NCT01474512|449218635|FG014|Induction Period|Sponsor Decision|0|||
124889228|NCT01474512|449218636|FG015|Induction Period|Sponsor Decision|0|||
124889229|NCT01474512|449218637|FG016|Induction Period|Sponsor Decision|0|||
124889230|NCT01474512|449218638|FG017|Induction Period|Sponsor Decision|0|||
124889231|NCT01474512|449218621|FG000|Induction Period|Lost to Follow-up|1|||
124889232|NCT01474512|449218622|FG001|Induction Period|Lost to Follow-up|0|||
124889233|NCT01474512|449218623|FG002|Induction Period|Lost to Follow-up|2|||
124889234|NCT01474512|449218624|FG003|Induction Period|Lost to Follow-up|0|||
124889235|NCT01474512|449218625|FG004|Induction Period|Lost to Follow-up|0|||
124889236|NCT01474512|449218626|FG005|Induction Period|Lost to Follow-up|0|||
124889237|NCT01474512|449218627|FG006|Induction Period|Lost to Follow-up|0|||
124889238|NCT01474512|449218628|FG007|Induction Period|Lost to Follow-up|0|||
124889239|NCT01474512|449218629|FG008|Induction Period|Lost to Follow-up|0|||
124889240|NCT01474512|449218630|FG009|Induction Period|Lost to Follow-up|0|||
124889241|NCT01474512|449218631|FG010|Induction Period|Lost to Follow-up|0|||
124889242|NCT01474512|449218632|FG011|Induction Period|Lost to Follow-up|0|||
124889243|NCT01474512|449218633|FG012|Induction Period|Lost to Follow-up|0|||
124889244|NCT01474512|449218634|FG013|Induction Period|Lost to Follow-up|0|||
124889245|NCT01474512|449218635|FG014|Induction Period|Lost to Follow-up|0|||
124889246|NCT01474512|449218636|FG015|Induction Period|Lost to Follow-up|0|||
124889247|NCT01474512|449218637|FG016|Induction Period|Lost to Follow-up|0|||
124889248|NCT01474512|449218638|FG017|Induction Period|Lost to Follow-up|0|||
124889249|NCT01474512|449218621|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889250|NCT01474512|449218622|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889251|NCT01474512|449218623|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889252|NCT01474512|449218624|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
124889253|NCT01474512|449218625|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
124889254|NCT01474512|449218626|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
124889255|NCT01474512|449218627|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
124889256|NCT01474512|449218628|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889257|NCT01474512|449218629|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889258|NCT01474512|449218630|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889259|NCT01474512|449218631|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889260|NCT01474512|449218632|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889261|NCT01474512|449218633|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889262|NCT01474512|449218634|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889263|NCT01474512|449218635|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889264|NCT01474512|449218636|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889265|NCT01474512|449218637|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889266|NCT01474512|449218638|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
124889267|NCT01474512|449218621|FG000|Maintenance Period|Adverse Event|0|||
124889268|NCT01474512|449218622|FG001|Maintenance Period|Adverse Event|0|||
124889269|NCT01474512|449218623|FG002|Maintenance Period|Adverse Event|0|||
124889270|NCT01474512|449218624|FG003|Maintenance Period|Adverse Event|4|||
124889271|NCT01474512|449218625|FG004|Maintenance Period|Adverse Event|2|||
124889272|NCT01474512|449218626|FG005|Maintenance Period|Adverse Event|7|||
124889273|NCT01474512|449218627|FG006|Maintenance Period|Adverse Event|0|||
124889274|NCT01474512|449218628|FG007|Maintenance Period|Adverse Event|19|||
124889275|NCT01474512|449218629|FG008|Maintenance Period|Adverse Event|1|||
124889276|NCT01474512|449218630|FG009|Maintenance Period|Adverse Event|3|||
124889277|NCT01474512|449218631|FG010|Maintenance Period|Adverse Event|0|||
124889278|NCT01474512|449218632|FG011|Maintenance Period|Adverse Event|0|||
124889279|NCT01474512|449218633|FG012|Maintenance Period|Adverse Event|0|||
124889280|NCT01474512|449218634|FG013|Maintenance Period|Adverse Event|0|||
124889281|NCT01474512|449218635|FG014|Maintenance Period|Adverse Event|0|||
124889282|NCT01474512|449218636|FG015|Maintenance Period|Adverse Event|0|||
124889283|NCT01474512|449218637|FG016|Maintenance Period|Adverse Event|0|||
124889284|NCT01474512|449218638|FG017|Maintenance Period|Adverse Event|0|||
124889285|NCT01474512|449218621|FG000|Maintenance Period|Withdrawal by Subject|0|||
124889286|NCT01474512|449218622|FG001|Maintenance Period|Withdrawal by Subject|0|||
124889287|NCT01474512|449218623|FG002|Maintenance Period|Withdrawal by Subject|0|||
124889288|NCT01474512|449218624|FG003|Maintenance Period|Withdrawal by Subject|6|||
124889289|NCT01474512|449218625|FG004|Maintenance Period|Withdrawal by Subject|2|||
124889290|NCT01474512|449218626|FG005|Maintenance Period|Withdrawal by Subject|3|||
124889291|NCT01474512|449218627|FG006|Maintenance Period|Withdrawal by Subject|1|||
124889292|NCT01474512|449218628|FG007|Maintenance Period|Withdrawal by Subject|6|||
124889293|NCT01474512|449218629|FG008|Maintenance Period|Withdrawal by Subject|3|||
124889294|NCT01474512|449218630|FG009|Maintenance Period|Withdrawal by Subject|1|||
124889295|NCT01474512|449218631|FG010|Maintenance Period|Withdrawal by Subject|0|||
124889296|NCT01474512|449218632|FG011|Maintenance Period|Withdrawal by Subject|0|||
124889297|NCT01474512|449218633|FG012|Maintenance Period|Withdrawal by Subject|0|||
124889298|NCT01474512|449218634|FG013|Maintenance Period|Withdrawal by Subject|0|||
124889299|NCT01474512|449218635|FG014|Maintenance Period|Withdrawal by Subject|0|||
124889300|NCT01474512|449218636|FG015|Maintenance Period|Withdrawal by Subject|0|||
124889301|NCT01474512|449218637|FG016|Maintenance Period|Withdrawal by Subject|0|||
124889302|NCT01474512|449218638|FG017|Maintenance Period|Withdrawal by Subject|0|||
124889303|NCT01474512|449218621|FG000|Maintenance Period|Lost to Follow-up|0|||
124889304|NCT01474512|449218622|FG001|Maintenance Period|Lost to Follow-up|0|||
124889305|NCT01474512|449218623|FG002|Maintenance Period|Lost to Follow-up|0|||
124889306|NCT01474512|449218624|FG003|Maintenance Period|Lost to Follow-up|3|||
124889307|NCT01474512|449218625|FG004|Maintenance Period|Lost to Follow-up|3|||
124889308|NCT01474512|449218626|FG005|Maintenance Period|Lost to Follow-up|0|||
124889309|NCT01474512|449218627|FG006|Maintenance Period|Lost to Follow-up|0|||
124889310|NCT01474512|449218628|FG007|Maintenance Period|Lost to Follow-up|2|||
124889311|NCT01474512|449218629|FG008|Maintenance Period|Lost to Follow-up|1|||
124889312|NCT01474512|449218630|FG009|Maintenance Period|Lost to Follow-up|1|||
124889313|NCT01474512|449218631|FG010|Maintenance Period|Lost to Follow-up|0|||
124889314|NCT01474512|449218632|FG011|Maintenance Period|Lost to Follow-up|0|||
124889315|NCT01474512|449218633|FG012|Maintenance Period|Lost to Follow-up|0|||
124889316|NCT01474512|449218634|FG013|Maintenance Period|Lost to Follow-up|0|||
124889317|NCT01474512|449218635|FG014|Maintenance Period|Lost to Follow-up|0|||
124889318|NCT01474512|449218636|FG015|Maintenance Period|Lost to Follow-up|0|||
124889319|NCT01474512|449218637|FG016|Maintenance Period|Lost to Follow-up|0|||
124889320|NCT01474512|449218638|FG017|Maintenance Period|Lost to Follow-up|0|||
124889321|NCT01474512|449218621|FG000|Maintenance Period|Death|0|||
124889322|NCT01474512|449218622|FG001|Maintenance Period|Death|0|||
124889323|NCT01474512|449218623|FG002|Maintenance Period|Death|0|||
124889324|NCT01474512|449218624|FG003|Maintenance Period|Death|0|||
124889325|NCT01474512|449218625|FG004|Maintenance Period|Death|0|||
124889326|NCT01474512|449218626|FG005|Maintenance Period|Death|2|||
124889327|NCT01474512|449218627|FG006|Maintenance Period|Death|0|||
124889328|NCT01474512|449218628|FG007|Maintenance Period|Death|0|||
124889329|NCT01474512|449218629|FG008|Maintenance Period|Death|0|||
124889330|NCT01474512|449218630|FG009|Maintenance Period|Death|0|||
124889331|NCT01474512|449218631|FG010|Maintenance Period|Death|0|||
124889332|NCT01474512|449218632|FG011|Maintenance Period|Death|0|||
124889333|NCT01474512|449218633|FG012|Maintenance Period|Death|0|||
124889334|NCT01474512|449218634|FG013|Maintenance Period|Death|0|||
124889335|NCT01474512|449218635|FG014|Maintenance Period|Death|0|||
124889336|NCT01474512|449218636|FG015|Maintenance Period|Death|0|||
124889337|NCT01474512|449218637|FG016|Maintenance Period|Death|0|||
124889338|NCT01474512|449218638|FG017|Maintenance Period|Death|0|||
124889339|NCT01474512|449218621|FG000|Maintenance Period|Physician Decision|0|||
124889340|NCT01474512|449218622|FG001|Maintenance Period|Physician Decision|0|||
124889341|NCT01474512|449218623|FG002|Maintenance Period|Physician Decision|0|||
124889342|NCT01474512|449218624|FG003|Maintenance Period|Physician Decision|0|||
124889343|NCT01474512|449218625|FG004|Maintenance Period|Physician Decision|0|||
124889344|NCT01474512|449218626|FG005|Maintenance Period|Physician Decision|1|||
124889345|NCT01474512|449218627|FG006|Maintenance Period|Physician Decision|0|||
124889346|NCT01474512|449218628|FG007|Maintenance Period|Physician Decision|2|||
124889347|NCT01474512|449218629|FG008|Maintenance Period|Physician Decision|0|||
124889348|NCT01474512|449218630|FG009|Maintenance Period|Physician Decision|0|||
124889349|NCT01474512|449218631|FG010|Maintenance Period|Physician Decision|0|||
124889350|NCT01474512|449218632|FG011|Maintenance Period|Physician Decision|0|||
124889351|NCT01474512|449218633|FG012|Maintenance Period|Physician Decision|0|||
124441718|NCT01145755|447577787|FG001|Overall Study|Withdrawal by Subject|2|||
124441719|NCT01145755|447577788|FG002|Overall Study|Withdrawal by Subject|2|||
124441720|NCT01145755|447577786|FG000|Overall Study|Lost to Follow-up|2|||
124441721|NCT01145755|447577787|FG001|Overall Study|Lost to Follow-up|3|||
124441722|NCT01145755|447577788|FG002|Overall Study|Lost to Follow-up|1|||
124441723|NCT01145755|447577786|FG000|Overall Study|Protocol Violation|0|||
124441724|NCT01145755|447577787|FG001|Overall Study|Protocol Violation|3|||
124441725|NCT01145755|447577788|FG002|Overall Study|Protocol Violation|1|||
124441726|NCT01145755|447577786|FG000|Overall Study|Study Closure|14|||
124441727|NCT01145755|447577787|FG001|Overall Study|Study Closure|14|||
124441728|NCT01145755|447577788|FG002|Overall Study|Study Closure|17|||
124441729|NCT01145755|447577786|FG000|Overall Study|Lack of Efficacy|0|||
124441730|NCT01145755|447577787|FG001|Overall Study|Lack of Efficacy|1|||
124441731|NCT01145755|447577788|FG002|Overall Study|Lack of Efficacy|0|||
124441732|NCT01145755|447577786|FG000|Overall Study|Patient could not swollow medication|0|||
124441733|NCT01145755|447577787|FG001|Overall Study|Patient could not swollow medication|0|||
124441734|NCT01145755|447577788|FG002|Overall Study|Patient could not swollow medication|1|||
124441735|NCT01145755|447577786|FG000|Overall Study|Withdrawal by Subject|0|||
124441736|NCT01145755|447577787|FG001|Overall Study|Withdrawal by Subject|0|||
124441737|NCT01145755|447577788|FG002|Overall Study|Withdrawal by Subject|1|||
124441738|NCT01145755|447577786|FG000|Overall Study|Positive urine ethanol|0|||
124441739|NCT01145755|447577787|FG001|Overall Study|Positive urine ethanol|1|||
124441740|NCT01145755|447577788|FG002|Overall Study|Positive urine ethanol|0|||
124441741|NCT02092220|447577796|FG000|Period 1|Unrelated Illness|0|||
124441742|NCT02092220|447577797|FG001|Period 1|Unrelated Illness|2|||
124441743|NCT02092220|447577796|FG000|Period 2|Severe Hypoglycaemia|1|||
124441744|NCT02092220|447577797|FG001|Period 2|Severe Hypoglycaemia|0|||
124441745|NCT02092220|447577796|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
124441746|NCT02092220|447577797|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
124441747|NCT02739360|447577798|FG000|Overall Study|Adverse Event|1|||
124441748|NCT02739360|447577798|FG000|Overall Study|Study terminated by Sponsor|2|||
124441749|NCT01193920|447577799|FG000|Overall Study|Withdrawal by Subject|1|||
124441750|NCT01193920|447577800|FG001|Overall Study|Withdrawal by Subject|0|||
124441751|NCT01193920|447577801|FG002|Overall Study|Withdrawal by Subject|5|||
124441752|NCT01193920|447577802|FG003|Overall Study|Withdrawal by Subject|1|||
124441753|NCT01193920|447577803|FG004|Overall Study|Withdrawal by Subject|3|||
124441754|NCT01193920|447577804|FG005|Overall Study|Withdrawal by Subject|1|||
124441755|NCT01193920|447577805|FG006|Overall Study|Withdrawal by Subject|3|||
124441756|NCT01193920|447577806|FG007|Overall Study|Withdrawal by Subject|0|||
124441757|NCT01193920|447577807|FG008|Overall Study|Withdrawal by Subject|1|||
124441758|NCT01193920|447577808|FG009|Overall Study|Withdrawal by Subject|0|||
124441759|NCT01193920|447577799|FG000|Overall Study|Lost to Follow-up|1|||
124441760|NCT01193920|447577800|FG001|Overall Study|Lost to Follow-up|0|||
124441761|NCT01193920|447577801|FG002|Overall Study|Lost to Follow-up|1|||
124441762|NCT01193920|447577802|FG003|Overall Study|Lost to Follow-up|1|||
124889352|NCT01474512|449218634|FG013|Maintenance Period|Physician Decision|0|||
124889353|NCT01474512|449218635|FG014|Maintenance Period|Physician Decision|0|||
124889354|NCT01474512|449218636|FG015|Maintenance Period|Physician Decision|0|||
124441763|NCT01193920|447577803|FG004|Overall Study|Lost to Follow-up|3|||
124441764|NCT01193920|447577804|FG005|Overall Study|Lost to Follow-up|3|||
124441765|NCT01193920|447577805|FG006|Overall Study|Lost to Follow-up|1|||
124441766|NCT01193920|447577806|FG007|Overall Study|Lost to Follow-up|0|||
124441767|NCT01193920|447577807|FG008|Overall Study|Lost to Follow-up|2|||
124889355|NCT01474512|449218637|FG016|Maintenance Period|Physician Decision|0|||
124889356|NCT01474512|449218638|FG017|Maintenance Period|Physician Decision|0|||
124441768|NCT01193920|447577808|FG009|Overall Study|Lost to Follow-up|3|||
124889357|NCT01474512|449218621|FG000|Maintenance Period|Clinical Relapse|0|||
124889358|NCT01474512|449218622|FG001|Maintenance Period|Clinical Relapse|0|||
124889359|NCT01474512|449218623|FG002|Maintenance Period|Clinical Relapse|0|||
124889360|NCT01474512|449218624|FG003|Maintenance Period|Clinical Relapse|1|||
124889361|NCT01474512|449218625|FG004|Maintenance Period|Clinical Relapse|0|||
124889362|NCT01474512|449218626|FG005|Maintenance Period|Clinical Relapse|0|||
124889363|NCT01474512|449218627|FG006|Maintenance Period|Clinical Relapse|0|||
124889364|NCT01474512|449218628|FG007|Maintenance Period|Clinical Relapse|0|||
124889365|NCT01474512|449218629|FG008|Maintenance Period|Clinical Relapse|0|||
124889366|NCT01474512|449218630|FG009|Maintenance Period|Clinical Relapse|0|||
124889367|NCT01474512|449218631|FG010|Maintenance Period|Clinical Relapse|0|||
124889368|NCT01474512|449218632|FG011|Maintenance Period|Clinical Relapse|0|||
124889369|NCT01474512|449218633|FG012|Maintenance Period|Clinical Relapse|0|||
124889370|NCT01474512|449218634|FG013|Maintenance Period|Clinical Relapse|0|||
124889371|NCT01474512|449218635|FG014|Maintenance Period|Clinical Relapse|0|||
124889372|NCT01474512|449218636|FG015|Maintenance Period|Clinical Relapse|0|||
124889373|NCT01474512|449218637|FG016|Maintenance Period|Clinical Relapse|0|||
124889374|NCT01474512|449218638|FG017|Maintenance Period|Clinical Relapse|0|||
124889375|NCT01474512|449218621|FG000|Maintenance Period|Lack of Efficacy|0|||
124889376|NCT01474512|449218622|FG001|Maintenance Period|Lack of Efficacy|0|||
124889377|NCT01474512|449218623|FG002|Maintenance Period|Lack of Efficacy|0|||
124889378|NCT01474512|449218624|FG003|Maintenance Period|Lack of Efficacy|1|||
124889379|NCT01474512|449218625|FG004|Maintenance Period|Lack of Efficacy|0|||
124889380|NCT01474512|449218626|FG005|Maintenance Period|Lack of Efficacy|0|||
124889381|NCT01474512|449218627|FG006|Maintenance Period|Lack of Efficacy|0|||
124889382|NCT01474512|449218628|FG007|Maintenance Period|Lack of Efficacy|11|||
124889383|NCT01474512|449218629|FG008|Maintenance Period|Lack of Efficacy|11|||
124889384|NCT01474512|449218630|FG009|Maintenance Period|Lack of Efficacy|12|||
124889385|NCT01474512|449218631|FG010|Maintenance Period|Lack of Efficacy|0|||
124889386|NCT01474512|449218632|FG011|Maintenance Period|Lack of Efficacy|0|||
124889387|NCT01474512|449218633|FG012|Maintenance Period|Lack of Efficacy|0|||
124889388|NCT01474512|449218634|FG013|Maintenance Period|Lack of Efficacy|0|||
124889389|NCT01474512|449218635|FG014|Maintenance Period|Lack of Efficacy|0|||
124889390|NCT01474512|449218636|FG015|Maintenance Period|Lack of Efficacy|0|||
124889391|NCT01474512|449218637|FG016|Maintenance Period|Lack of Efficacy|0|||
124889392|NCT01474512|449218638|FG017|Maintenance Period|Lack of Efficacy|0|||
124889393|NCT01474512|449218621|FG000|Maintenance Period|Protocol Violation|0|||
124889394|NCT01474512|449218622|FG001|Maintenance Period|Protocol Violation|0|||
124889395|NCT01474512|449218623|FG002|Maintenance Period|Protocol Violation|0|||
124889396|NCT01474512|449218624|FG003|Maintenance Period|Protocol Violation|1|||
124889397|NCT01474512|449218625|FG004|Maintenance Period|Protocol Violation|0|||
124889398|NCT01474512|449218626|FG005|Maintenance Period|Protocol Violation|0|||
124889399|NCT01474512|449218627|FG006|Maintenance Period|Protocol Violation|0|||
124889400|NCT01474512|449218628|FG007|Maintenance Period|Protocol Violation|1|||
124889401|NCT01474512|449218629|FG008|Maintenance Period|Protocol Violation|0|||
124889402|NCT01474512|449218630|FG009|Maintenance Period|Protocol Violation|1|||
124889403|NCT01474512|449218631|FG010|Maintenance Period|Protocol Violation|0|||
124889404|NCT01474512|449218632|FG011|Maintenance Period|Protocol Violation|0|||
124889405|NCT01474512|449218633|FG012|Maintenance Period|Protocol Violation|0|||
124889406|NCT01474512|449218634|FG013|Maintenance Period|Protocol Violation|0|||
124889407|NCT01474512|449218635|FG014|Maintenance Period|Protocol Violation|0|||
124889408|NCT01474512|449218636|FG015|Maintenance Period|Protocol Violation|0|||
124889409|NCT01474512|449218637|FG016|Maintenance Period|Protocol Violation|0|||
124889410|NCT01474512|449218638|FG017|Maintenance Period|Protocol Violation|0|||
124889411|NCT01474512|449218621|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
124889412|NCT01474512|449218622|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
124889413|NCT01474512|449218623|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
124889414|NCT01474512|449218624|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
124889415|NCT01474512|449218625|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
124686483|NCT02101853|448471293|FG003|Post Induction Randomization|Adverse Event|4|||
124889416|NCT01474512|449218626|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
124889417|NCT01474512|449218627|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
124889418|NCT01474512|449218628|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
124889419|NCT01474512|449218629|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
124889420|NCT01474512|449218630|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
124889421|NCT01474512|449218631|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
124889422|NCT01474512|449218632|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
124889423|NCT01474512|449218633|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
124889424|NCT01474512|449218634|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
124889425|NCT01474512|449218635|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
124889426|NCT01474512|449218636|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
124889427|NCT01474512|449218637|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
124889428|NCT01474512|449218638|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
124889429|NCT01474512|449218621|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
124889430|NCT01474512|449218622|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
124889431|NCT01474512|449218623|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
124889432|NCT01474512|449218624|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
124889433|NCT01474512|449218625|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
124889434|NCT01474512|449218626|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
124889435|NCT01474512|449218627|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
124889436|NCT01474512|449218628|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
124889437|NCT01474512|449218629|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
124889438|NCT01474512|449218630|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
124889439|NCT01474512|449218631|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
124889440|NCT01474512|449218632|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
124889441|NCT01474512|449218633|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
124889442|NCT01474512|449218634|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
124889443|NCT01474512|449218635|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
124889444|NCT01474512|449218636|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
124889445|NCT01474512|449218637|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
124889446|NCT01474512|449218638|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
124889447|NCT01474512|449218621|FG000|Long-Term Extension Period|Adverse Event|0|||
124889448|NCT01474512|449218622|FG001|Long-Term Extension Period|Adverse Event|0|||
124889449|NCT01474512|449218623|FG002|Long-Term Extension Period|Adverse Event|0|||
124889450|NCT01474512|449218624|FG003|Long-Term Extension Period|Adverse Event|0|||
124889451|NCT01474512|449218625|FG004|Long-Term Extension Period|Adverse Event|0|||
124889452|NCT01474512|449218626|FG005|Long-Term Extension Period|Adverse Event|0|||
124889453|NCT01474512|449218627|FG006|Long-Term Extension Period|Adverse Event|0|||
124889454|NCT01474512|449218628|FG007|Long-Term Extension Period|Adverse Event|0|||
124889455|NCT01474512|449218629|FG008|Long-Term Extension Period|Adverse Event|0|||
124889456|NCT01474512|449218630|FG009|Long-Term Extension Period|Adverse Event|0|||
124889457|NCT01474512|449218631|FG010|Long-Term Extension Period|Adverse Event|0|||
124889458|NCT01474512|449218632|FG011|Long-Term Extension Period|Adverse Event|1|||
124889459|NCT01474512|449218633|FG012|Long-Term Extension Period|Adverse Event|57|||
124889460|NCT01474512|449218634|FG013|Long-Term Extension Period|Adverse Event|58|||
124889461|NCT01474512|449218635|FG014|Long-Term Extension Period|Adverse Event|0|||
124889462|NCT01474512|449218636|FG015|Long-Term Extension Period|Adverse Event|0|||
124889463|NCT01474512|449218637|FG016|Long-Term Extension Period|Adverse Event|0|||
124889464|NCT01474512|449218638|FG017|Long-Term Extension Period|Adverse Event|0|||
124889465|NCT01474512|449218621|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
124889466|NCT01474512|449218622|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
124889467|NCT01474512|449218623|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
124889468|NCT01474512|449218624|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
124889469|NCT01474512|449218625|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
124889470|NCT01474512|449218626|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
124889471|NCT01474512|449218627|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
124889472|NCT01474512|449218628|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
124889473|NCT01474512|449218629|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
124889474|NCT01474512|449218630|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
124889475|NCT01474512|449218631|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
124889476|NCT01474512|449218632|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
124889477|NCT01474512|449218633|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
124889478|NCT01474512|449218634|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
124889479|NCT01474512|449218635|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
124889480|NCT01474512|449218636|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
124889481|NCT01474512|449218637|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
124889482|NCT01474512|449218638|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
124889483|NCT01474512|449218621|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
124889484|NCT01474512|449218622|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
124889485|NCT01474512|449218623|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
124889486|NCT01474512|449218624|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
124889487|NCT01474512|449218625|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
124889488|NCT01474512|449218626|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
124889489|NCT01474512|449218627|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
124889490|NCT01474512|449218628|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
124889491|NCT01474512|449218629|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
124889492|NCT01474512|449218630|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
124686484|NCT02101853|448471294|FG004|Post Induction Randomization|Adverse Event|4|||
124889493|NCT01474512|449218631|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
124889494|NCT01474512|449218632|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
124889495|NCT01474512|449218633|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
124889496|NCT01474512|449218634|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
124889497|NCT01474512|449218635|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
124889498|NCT01474512|449218636|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
124889499|NCT01474512|449218637|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
124889500|NCT01474512|449218638|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
124889501|NCT01474512|449218621|FG000|Long-Term Extension Period|Physician Decision|0|||
124889502|NCT01474512|449218622|FG001|Long-Term Extension Period|Physician Decision|0|||
124889503|NCT01474512|449218623|FG002|Long-Term Extension Period|Physician Decision|0|||
124889504|NCT01474512|449218624|FG003|Long-Term Extension Period|Physician Decision|0|||
124889505|NCT01474512|449218625|FG004|Long-Term Extension Period|Physician Decision|0|||
124889506|NCT01474512|449218626|FG005|Long-Term Extension Period|Physician Decision|0|||
124889507|NCT01474512|449218627|FG006|Long-Term Extension Period|Physician Decision|0|||
124889508|NCT01474512|449218628|FG007|Long-Term Extension Period|Physician Decision|0|||
124889509|NCT01474512|449218629|FG008|Long-Term Extension Period|Physician Decision|0|||
124889510|NCT01474512|449218630|FG009|Long-Term Extension Period|Physician Decision|0|||
124889511|NCT01474512|449218631|FG010|Long-Term Extension Period|Physician Decision|0|||
124889512|NCT01474512|449218632|FG011|Long-Term Extension Period|Physician Decision|0|||
124889513|NCT01474512|449218633|FG012|Long-Term Extension Period|Physician Decision|21|||
124889514|NCT01474512|449218634|FG013|Long-Term Extension Period|Physician Decision|21|||
124889515|NCT01474512|449218635|FG014|Long-Term Extension Period|Physician Decision|0|||
124889516|NCT01474512|449218636|FG015|Long-Term Extension Period|Physician Decision|0|||
124889517|NCT01474512|449218637|FG016|Long-Term Extension Period|Physician Decision|0|||
124889518|NCT01474512|449218638|FG017|Long-Term Extension Period|Physician Decision|0|||
124889519|NCT01474512|449218621|FG000|Long-Term Extension Period|Clinical Relapse|0|||
124889520|NCT01474512|449218622|FG001|Long-Term Extension Period|Clinical Relapse|0|||
124889521|NCT01474512|449218623|FG002|Long-Term Extension Period|Clinical Relapse|0|||
124889522|NCT01474512|449218624|FG003|Long-Term Extension Period|Clinical Relapse|0|||
124889523|NCT01474512|449218625|FG004|Long-Term Extension Period|Clinical Relapse|0|||
124889524|NCT01474512|449218626|FG005|Long-Term Extension Period|Clinical Relapse|0|||
124889525|NCT01474512|449218627|FG006|Long-Term Extension Period|Clinical Relapse|0|||
124889526|NCT01474512|449218628|FG007|Long-Term Extension Period|Clinical Relapse|0|||
124889527|NCT01474512|449218629|FG008|Long-Term Extension Period|Clinical Relapse|0|||
124889528|NCT01474512|449218630|FG009|Long-Term Extension Period|Clinical Relapse|0|||
124889529|NCT01474512|449218631|FG010|Long-Term Extension Period|Clinical Relapse|0|||
124889530|NCT01474512|449218632|FG011|Long-Term Extension Period|Clinical Relapse|0|||
124889531|NCT01474512|449218633|FG012|Long-Term Extension Period|Clinical Relapse|9|||
124889532|NCT01474512|449218634|FG013|Long-Term Extension Period|Clinical Relapse|9|||
124889533|NCT01474512|449218635|FG014|Long-Term Extension Period|Clinical Relapse|0|||
124686485|NCT02101853|448471295|FG005|Post Induction Randomization|Adverse Event|0|||
124686486|NCT02101853|448471290|FG000|Post Induction Randomization|Death|0|||
124686487|NCT02101853|448471291|FG001|Post Induction Randomization|Death|9|||
124686488|NCT02101853|448471292|FG002|Post Induction Randomization|Death|2|||
124686489|NCT02101853|448471293|FG003|Post Induction Randomization|Death|2|||
124889534|NCT01474512|449218636|FG015|Long-Term Extension Period|Clinical Relapse|0|||
124889535|NCT01474512|449218637|FG016|Long-Term Extension Period|Clinical Relapse|0|||
124686490|NCT02101853|448471294|FG004|Post Induction Randomization|Death|0|||
124686491|NCT02101853|448471295|FG005|Post Induction Randomization|Death|0|||
124686492|NCT02101853|448471290|FG000|Post Induction Randomization|Lack of Efficacy|0|||
124889536|NCT01474512|449218638|FG017|Long-Term Extension Period|Clinical Relapse|0|||
124889537|NCT01474512|449218621|FG000|Long-Term Extension Period|Death|0|||
124889538|NCT01474512|449218622|FG001|Long-Term Extension Period|Death|0|||
124889539|NCT01474512|449218623|FG002|Long-Term Extension Period|Death|0|||
124889540|NCT01474512|449218624|FG003|Long-Term Extension Period|Death|0|||
124889541|NCT01474512|449218625|FG004|Long-Term Extension Period|Death|0|||
124889542|NCT01474512|449218626|FG005|Long-Term Extension Period|Death|0|||
124889543|NCT01474512|449218627|FG006|Long-Term Extension Period|Death|0|||
124889544|NCT01474512|449218628|FG007|Long-Term Extension Period|Death|0|||
124889545|NCT01474512|449218629|FG008|Long-Term Extension Period|Death|0|||
124441769|NCT01193920|447577799|FG000|Overall Study|Protocol Violation|1|||
124441770|NCT01193920|447577800|FG001|Overall Study|Protocol Violation|0|||
124441771|NCT01193920|447577801|FG002|Overall Study|Protocol Violation|0|||
124441772|NCT01193920|447577802|FG003|Overall Study|Protocol Violation|0|||
124441773|NCT01193920|447577803|FG004|Overall Study|Protocol Violation|0|||
124441774|NCT01193920|447577804|FG005|Overall Study|Protocol Violation|0|||
124441775|NCT01193920|447577805|FG006|Overall Study|Protocol Violation|0|||
124441776|NCT01193920|447577806|FG007|Overall Study|Protocol Violation|0|||
124441777|NCT01193920|447577807|FG008|Overall Study|Protocol Violation|0|||
124441778|NCT01193920|447577808|FG009|Overall Study|Protocol Violation|0|||
124441779|NCT01193920|447577799|FG000|Overall Study|Death|0|||
124441780|NCT01193920|447577800|FG001|Overall Study|Death|0|||
124441781|NCT01193920|447577801|FG002|Overall Study|Death|0|||
124441782|NCT01193920|447577802|FG003|Overall Study|Death|1|||
124441783|NCT01193920|447577803|FG004|Overall Study|Death|0|||
124441784|NCT01193920|447577804|FG005|Overall Study|Death|0|||
124441785|NCT01193920|447577805|FG006|Overall Study|Death|2|||
124441786|NCT01193920|447577806|FG007|Overall Study|Death|3|||
124441787|NCT01193920|447577807|FG008|Overall Study|Death|2|||
124441788|NCT01193920|447577808|FG009|Overall Study|Death|4|||
124441789|NCT01193920|447577799|FG000|Overall Study|Unable to classify|0|||
124441790|NCT01193920|447577800|FG001|Overall Study|Unable to classify|0|||
124441791|NCT01193920|447577801|FG002|Overall Study|Unable to classify|0|||
124441792|NCT01193920|447577802|FG003|Overall Study|Unable to classify|1|||
124441793|NCT01193920|447577803|FG004|Overall Study|Unable to classify|0|||
124441794|NCT01193920|447577804|FG005|Overall Study|Unable to classify|0|||
124441795|NCT01193920|447577805|FG006|Overall Study|Unable to classify|0|||
124441796|NCT01193920|447577806|FG007|Overall Study|Unable to classify|1|||
124441797|NCT01193920|447577807|FG008|Overall Study|Unable to classify|0|||
124441798|NCT01193920|447577808|FG009|Overall Study|Unable to classify|0|||
124441799|NCT01231516|447577811|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
124441800|NCT01231516|447577812|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
124441801|NCT01231516|447577811|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
124441802|NCT01231516|447577812|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
124441803|NCT01231516|447577811|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
124441804|NCT01231516|447577812|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
124441805|NCT01231516|447577811|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
124441806|NCT01231516|447577812|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
124441807|NCT01231516|447577811|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
124441808|NCT01231516|447577812|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
124441809|NCT01231516|447577811|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
124686493|NCT02101853|448471291|FG001|Post Induction Randomization|Lack of Efficacy|14|||
124889546|NCT01474512|449218630|FG009|Long-Term Extension Period|Death|0|||
124889547|NCT01474512|449218631|FG010|Long-Term Extension Period|Death|0|||
124889548|NCT01474512|449218632|FG011|Long-Term Extension Period|Death|0|||
124441810|NCT01231516|447577812|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
124441811|NCT01231516|447577811|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
124441812|NCT01231516|447577812|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
124889549|NCT01474512|449218633|FG012|Long-Term Extension Period|Death|9|||
124441813|NCT01231516|447577811|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
124441814|NCT01231516|447577812|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
124441815|NCT01231516|447577811|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
124466429|NCT01414257|447666398|FG000|Overall Study|No Visit After First Day of Treatment|12|||
124889550|NCT01474512|449218634|FG013|Long-Term Extension Period|Death|9|||
124889551|NCT01474512|449218635|FG014|Long-Term Extension Period|Death|0|||
124889552|NCT01474512|449218636|FG015|Long-Term Extension Period|Death|0|||
124889553|NCT01474512|449218637|FG016|Long-Term Extension Period|Death|0|||
124889554|NCT01474512|449218638|FG017|Long-Term Extension Period|Death|0|||
124889555|NCT01474512|449218621|FG000|Long-Term Extension Period|Sponsor Decision|0|||
124889556|NCT01474512|449218622|FG001|Long-Term Extension Period|Sponsor Decision|0|||
124889557|NCT01474512|449218623|FG002|Long-Term Extension Period|Sponsor Decision|0|||
124889558|NCT01474512|449218624|FG003|Long-Term Extension Period|Sponsor Decision|0|||
124889559|NCT01474512|449218625|FG004|Long-Term Extension Period|Sponsor Decision|0|||
124889560|NCT01474512|449218626|FG005|Long-Term Extension Period|Sponsor Decision|0|||
124889561|NCT01474512|449218627|FG006|Long-Term Extension Period|Sponsor Decision|0|||
124889562|NCT01474512|449218628|FG007|Long-Term Extension Period|Sponsor Decision|0|||
124889563|NCT01474512|449218629|FG008|Long-Term Extension Period|Sponsor Decision|0|||
124889564|NCT01474512|449218630|FG009|Long-Term Extension Period|Sponsor Decision|0|||
124889565|NCT01474512|449218631|FG010|Long-Term Extension Period|Sponsor Decision|0|||
124889566|NCT01474512|449218632|FG011|Long-Term Extension Period|Sponsor Decision|0|||
124889567|NCT01474512|449218633|FG012|Long-Term Extension Period|Sponsor Decision|6|||
124889568|NCT01474512|449218634|FG013|Long-Term Extension Period|Sponsor Decision|6|||
124889569|NCT01474512|449218635|FG014|Long-Term Extension Period|Sponsor Decision|0|||
124889570|NCT01474512|449218636|FG015|Long-Term Extension Period|Sponsor Decision|0|||
124889571|NCT01474512|449218637|FG016|Long-Term Extension Period|Sponsor Decision|0|||
124889572|NCT01474512|449218638|FG017|Long-Term Extension Period|Sponsor Decision|0|||
124889573|NCT01474512|449218621|FG000|Long-Term Extension Period|Protocol Violation|0|||
124889574|NCT01474512|449218622|FG001|Long-Term Extension Period|Protocol Violation|0|||
124889575|NCT01474512|449218623|FG002|Long-Term Extension Period|Protocol Violation|0|||
124889576|NCT01474512|449218624|FG003|Long-Term Extension Period|Protocol Violation|0|||
124889577|NCT01474512|449218625|FG004|Long-Term Extension Period|Protocol Violation|0|||
124889578|NCT01474512|449218626|FG005|Long-Term Extension Period|Protocol Violation|0|||
124889579|NCT01474512|449218627|FG006|Long-Term Extension Period|Protocol Violation|0|||
124889580|NCT01474512|449218628|FG007|Long-Term Extension Period|Protocol Violation|0|||
124889581|NCT01474512|449218629|FG008|Long-Term Extension Period|Protocol Violation|0|||
124889582|NCT01474512|449218630|FG009|Long-Term Extension Period|Protocol Violation|0|||
124889583|NCT01474512|449218631|FG010|Long-Term Extension Period|Protocol Violation|0|||
124889584|NCT01474512|449218632|FG011|Long-Term Extension Period|Protocol Violation|0|||
124889585|NCT01474512|449218633|FG012|Long-Term Extension Period|Protocol Violation|5|||
124889586|NCT01474512|449218634|FG013|Long-Term Extension Period|Protocol Violation|5|||
124889587|NCT01474512|449218635|FG014|Long-Term Extension Period|Protocol Violation|0|||
124889588|NCT01474512|449218636|FG015|Long-Term Extension Period|Protocol Violation|0|||
124889589|NCT01474512|449218637|FG016|Long-Term Extension Period|Protocol Violation|0|||
124889590|NCT01474512|449218638|FG017|Long-Term Extension Period|Protocol Violation|0|||
124889591|NCT01474512|449218621|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889592|NCT01474512|449218622|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889593|NCT01474512|449218623|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889594|NCT01474512|449218624|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889595|NCT01474512|449218625|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889596|NCT01474512|449218626|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889597|NCT01474512|449218627|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889598|NCT01474512|449218628|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889599|NCT01474512|449218629|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889600|NCT01474512|449218630|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889601|NCT01474512|449218631|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889602|NCT01474512|449218632|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889603|NCT01474512|449218633|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
124889604|NCT01474512|449218634|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
124889605|NCT01474512|449218635|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889606|NCT01474512|449218636|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889607|NCT01474512|449218637|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889608|NCT01474512|449218638|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
124889609|NCT01474512|449218621|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889610|NCT01474512|449218622|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889611|NCT01474512|449218623|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889612|NCT01474512|449218624|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889613|NCT01474512|449218625|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889614|NCT01474512|449218626|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889615|NCT01474512|449218627|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889616|NCT01474512|449218628|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124686494|NCT02101853|448471292|FG002|Post Induction Randomization|Lack of Efficacy|23|||
124686495|NCT02101853|448471293|FG003|Post Induction Randomization|Lack of Efficacy|18|||
124889617|NCT01474512|449218629|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889618|NCT01474512|449218630|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889619|NCT01474512|449218631|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889620|NCT01474512|449218632|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
124889621|NCT01474512|449218633|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889622|NCT01474512|449218634|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889623|NCT01474512|449218635|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889624|NCT01474512|449218636|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889625|NCT01474512|449218637|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889626|NCT01474512|449218638|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
124889627|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
124889628|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
124889629|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
124889630|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
124889631|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
124889632|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
124889633|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
124889634|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
124889635|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
124889636|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
124889637|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
124889638|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
124889639|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
124889640|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
124889641|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
124889642|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
124889643|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
124889644|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
124889645|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889646|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889647|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889648|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889649|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889650|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889651|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889652|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889653|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889654|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889655|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889656|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889657|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124889658|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
124441816|NCT01231516|447577812|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
124441817|NCT01231516|447577811|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
124441818|NCT01231516|447577812|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
124441819|NCT01231516|447577811|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
124441820|NCT01231516|447577812|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
124441821|NCT01231516|447577811|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
124441822|NCT01231516|447577812|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
124441823|NCT01231516|447577811|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
124441824|NCT01231516|447577812|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
124441825|NCT01231516|447577811|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
124441826|NCT01231516|447577812|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
124441827|NCT01231516|447577811|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
124441828|NCT01231516|447577812|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
124441829|NCT01231516|447577811|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
124441830|NCT01231516|447577812|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
124441831|NCT00026208|447577813|FG000|Overall Study|Complications of auto accident|1|||
124441832|NCT00026208|447577814|FG001|Overall Study|Complications of auto accident|0|||
124441833|NCT03170154|447577815|FG000|Overall Study|Lost to Follow-up|4|||
124441834|NCT03170154|447577815|FG000|Overall Study|Death|2|||
124686496|NCT02101853|448471294|FG004|Post Induction Randomization|Lack of Efficacy|21|||
124686497|NCT02101853|448471295|FG005|Post Induction Randomization|Lack of Efficacy|0|||
124889659|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
124889660|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
124889661|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
124889662|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
124441835|NCT03170154|447577815|FG000|Overall Study|Withdrawal by Subject|2|||
124441836|NCT05266586|447577816|FG000|Overall Study|Adverse Event|2|||
124441837|NCT05266586|447577817|FG001|Overall Study|Adverse Event|2|||
124889663|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889664|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889665|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889666|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889667|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889668|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889669|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889670|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889671|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889672|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889673|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889674|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889675|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889676|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
124889677|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
124889678|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
124889679|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
124889680|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
124889681|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889682|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889683|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889684|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889685|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889686|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889687|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889688|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889689|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889690|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889691|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889692|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889693|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889694|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889695|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889696|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
124889697|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
124889698|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
124889699|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
124889700|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
124889701|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
124889702|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
124889703|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
124889704|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
124889705|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
124889706|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
124889707|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
124889708|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
124889709|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
124889710|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
124889711|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
124889712|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
124889713|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
124889714|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
124889715|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
124889716|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
124889717|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889718|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889719|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889720|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889721|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889722|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889723|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889724|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889725|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889726|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889727|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889728|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
124441838|NCT05266586|447577818|FG002|Overall Study|Adverse Event|1|||
124889729|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889730|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889731|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889732|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
124889733|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
124889734|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
124889735|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
124889736|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
124889737|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
124889738|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
124889739|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
124889740|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
124889741|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
124889742|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
124889743|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
124889744|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
124889745|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
124889746|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
124889747|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
124889748|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
124889749|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
124889750|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
124889751|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
124889752|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
124889753|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889754|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889755|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889756|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889757|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889758|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889759|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889760|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889761|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889762|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889763|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889764|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889765|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889766|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889767|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
124889768|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889769|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
124889770|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
124889771|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889772|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889773|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889774|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889775|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889776|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889777|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889778|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889779|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889780|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889781|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889782|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889783|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889784|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889785|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
124889786|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124441839|NCT05266586|447577816|FG000|Overall Study|Withdrawal by Subject|1|||
124441840|NCT05266586|447577817|FG001|Overall Study|Withdrawal by Subject|0|||
124441841|NCT05266586|447577818|FG002|Overall Study|Withdrawal by Subject|1|||
124686498|NCT02101853|448471290|FG000|Post Induction Randomization|Physician Decision|0|||
124889787|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
124889788|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
124686499|NCT02101853|448471291|FG001|Post Induction Randomization|Physician Decision|43|||
124686500|NCT02101853|448471292|FG002|Post Induction Randomization|Physician Decision|23|||
124889789|NCT01474512|449218621|FG000|Post-Treatment Follow-Up|Death|0|||
124889790|NCT01474512|449218622|FG001|Post-Treatment Follow-Up|Death|0|||
124889791|NCT01474512|449218623|FG002|Post-Treatment Follow-Up|Death|0|||
124889792|NCT01474512|449218624|FG003|Post-Treatment Follow-Up|Death|0|||
124889793|NCT01474512|449218625|FG004|Post-Treatment Follow-Up|Death|0|||
124889794|NCT01474512|449218626|FG005|Post-Treatment Follow-Up|Death|0|||
124889795|NCT01474512|449218627|FG006|Post-Treatment Follow-Up|Death|0|||
124889796|NCT01474512|449218628|FG007|Post-Treatment Follow-Up|Death|0|||
124889797|NCT01474512|449218629|FG008|Post-Treatment Follow-Up|Death|0|||
124889798|NCT01474512|449218630|FG009|Post-Treatment Follow-Up|Death|0|||
124889799|NCT01474512|449218631|FG010|Post-Treatment Follow-Up|Death|0|||
124889800|NCT01474512|449218632|FG011|Post-Treatment Follow-Up|Death|0|||
124889801|NCT01474512|449218633|FG012|Post-Treatment Follow-Up|Death|0|||
124889802|NCT01474512|449218634|FG013|Post-Treatment Follow-Up|Death|0|||
124889803|NCT01474512|449218635|FG014|Post-Treatment Follow-Up|Death|0|||
124889804|NCT01474512|449218636|FG015|Post-Treatment Follow-Up|Death|0|||
124889805|NCT01474512|449218637|FG016|Post-Treatment Follow-Up|Death|1|||
124889806|NCT01474512|449218638|FG017|Post-Treatment Follow-Up|Death|0|||
124889807|NCT01890967|449218641|FG000|Overall Study|Adverse Event|3|||
124889808|NCT01890967|449218642|FG001|Overall Study|Adverse Event|3|||
124889809|NCT01890967|449218643|FG002|Overall Study|Adverse Event|3|||
124889810|NCT01890967|449218644|FG003|Overall Study|Adverse Event|2|||
124889811|NCT01890967|449218645|FG004|Overall Study|Adverse Event|1|||
124889812|NCT01890967|449218646|FG005|Overall Study|Adverse Event|7|||
124889813|NCT01890967|449218641|FG000|Overall Study|Death|1|||
124889814|NCT01890967|449218642|FG001|Overall Study|Death|0|||
124889815|NCT01890967|449218643|FG002|Overall Study|Death|0|||
124889816|NCT01890967|449218644|FG003|Overall Study|Death|0|||
124889817|NCT01890967|449218645|FG004|Overall Study|Death|0|||
124889818|NCT01890967|449218646|FG005|Overall Study|Death|0|||
124889819|NCT01890967|449218641|FG000|Overall Study|Lost to Follow-up|1|||
124889820|NCT01890967|449218642|FG001|Overall Study|Lost to Follow-up|1|||
124889821|NCT01890967|449218643|FG002|Overall Study|Lost to Follow-up|1|||
124889822|NCT01890967|449218644|FG003|Overall Study|Lost to Follow-up|1|||
124889823|NCT01890967|449218645|FG004|Overall Study|Lost to Follow-up|0|||
124889824|NCT01890967|449218646|FG005|Overall Study|Lost to Follow-up|1|||
124889825|NCT01890967|449218641|FG000|Overall Study|Protocol Violation|0|||
124889826|NCT01890967|449218642|FG001|Overall Study|Protocol Violation|3|||
124889827|NCT01890967|449218643|FG002|Overall Study|Protocol Violation|3|||
124889828|NCT01890967|449218644|FG003|Overall Study|Protocol Violation|2|||
124889829|NCT01890967|449218645|FG004|Overall Study|Protocol Violation|4|||
124889830|NCT01890967|449218646|FG005|Overall Study|Protocol Violation|1|||
124889831|NCT01890967|449218641|FG000|Overall Study|Sponsor Decision|2|||
124889832|NCT01890967|449218642|FG001|Overall Study|Sponsor Decision|0|||
124889833|NCT01890967|449218643|FG002|Overall Study|Sponsor Decision|1|||
124889834|NCT01890967|449218644|FG003|Overall Study|Sponsor Decision|3|||
124889835|NCT01890967|449218645|FG004|Overall Study|Sponsor Decision|2|||
124889836|NCT01890967|449218646|FG005|Overall Study|Sponsor Decision|3|||
124889837|NCT01890967|449218641|FG000|Overall Study|Withdrawal by Subject|3|||
124889838|NCT01890967|449218642|FG001|Overall Study|Withdrawal by Subject|4|||
124889839|NCT01890967|449218643|FG002|Overall Study|Withdrawal by Subject|2|||
124889840|NCT01890967|449218644|FG003|Overall Study|Withdrawal by Subject|3|||
124889841|NCT01890967|449218645|FG004|Overall Study|Withdrawal by Subject|3|||
124889842|NCT01890967|449218646|FG005|Overall Study|Withdrawal by Subject|1|||
124889843|NCT04006366|449218650|FG000|Overall Study|Withdrawal by Subject|1|||
124889844|NCT01440049|449218654|FG000|Overall Study|Adverse Event|5|||
124889845|NCT00997243|449218655|FG000|Overall Study|Early termination of study by sponsor|7|||
124889846|NCT00280293|449218663|FG000|Overall Study|Protocol Violation|3|||
124889847|NCT00280293|449218664|FG001|Overall Study|Protocol Violation|0|||
124889848|NCT00280293|449218663|FG000|Overall Study|Physician Decision|5|||
124889849|NCT00280293|449218664|FG001|Overall Study|Physician Decision|4|||
124889850|NCT00280293|449218663|FG000|Overall Study|Lost to Follow-up|14|||
124889851|NCT00280293|449218664|FG001|Overall Study|Lost to Follow-up|12|||
124889852|NCT00280293|449218663|FG000|Overall Study|Withdrawal by Subject|3|||
124889853|NCT00280293|449218664|FG001|Overall Study|Withdrawal by Subject|5|||
124889854|NCT00280293|449218663|FG000|Overall Study|Incarceration/Legal Reasons|1|||
124889855|NCT00280293|449218664|FG001|Overall Study|Incarceration/Legal Reasons|1|||
124889856|NCT00280293|449218663|FG000|Overall Study|Adverse Event|0|||
124889857|NCT00280293|449218664|FG001|Overall Study|Adverse Event|1|||
124889858|NCT01458249|449218669|FG000|Overall Study|Not treated|1|||
124889859|NCT01458249|449218669|FG000|Overall Study|Adverse Event|4|||
124889860|NCT01458249|449218669|FG000|Overall Study|Other|2|||
124889861|NCT01458249|449218669|FG000|Overall Study|Ongoing|1|||
124889862|NCT02056119|449218672|FG000|Overall Study|Death|1|||
124889863|NCT02056119|449218673|FG001|Overall Study|Death|2|||
124889864|NCT02056119|449218672|FG000|Overall Study|Intubated for less than 24 hrs|2|||
124889865|NCT02056119|449218673|FG001|Overall Study|Intubated for less than 24 hrs|7|||
124889866|NCT02056119|449218672|FG000|Overall Study|No aerosol treatments were given.|3|||
124889867|NCT02056119|449218673|FG001|Overall Study|No aerosol treatments were given.|2|||
124889868|NCT02056119|449218672|FG000|Overall Study|Received Metaneb treatment|0|||
124889869|NCT02056119|449218673|FG001|Overall Study|Received Metaneb treatment|2|||
124889870|NCT02056119|449218672|FG000|Overall Study|Protocol Violation|4|||
124889871|NCT02056119|449218673|FG001|Overall Study|Protocol Violation|7|||
124889872|NCT01348854|449218674|FG000|Overall Study|Lost to Follow-up|2|||
124889873|NCT01348854|449218675|FG001|Overall Study|Lost to Follow-up|1|||
124889874|NCT01348854|449218674|FG000|Overall Study|Withdrawal by Subject|1|||
124889875|NCT01348854|449218675|FG001|Overall Study|Withdrawal by Subject|0|||
124889876|NCT03220737|449218676|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
124889877|NCT03220737|449218677|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
124889878|NCT03220737|449218678|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
124889879|NCT03220737|449218679|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
124889880|NCT03220737|449218680|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
124889881|NCT03220737|449218681|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
124889882|NCT03220737|449218682|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
124889883|NCT03220737|449218676|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
124889884|NCT03220737|449218677|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
124889885|NCT03220737|449218678|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
124889886|NCT03220737|449218679|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
124889887|NCT03220737|449218680|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
124889888|NCT03220737|449218681|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
124889889|NCT03220737|449218682|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
124889890|NCT03220737|449218676|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
124889891|NCT03220737|449218677|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
124889892|NCT03220737|449218678|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
124889893|NCT03220737|449218679|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
124889894|NCT03220737|449218680|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
124889895|NCT03220737|449218681|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
124889896|NCT03220737|449218682|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
124889897|NCT03220737|449218676|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
124889898|NCT03220737|449218677|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
124889899|NCT03220737|449218678|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
124889900|NCT03220737|449218679|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
124889901|NCT03220737|449218680|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
124889902|NCT03220737|449218681|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
124889903|NCT03220737|449218682|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
124889904|NCT03220737|449218676|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
124889905|NCT03220737|449218677|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
124889906|NCT03220737|449218678|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
124889907|NCT03220737|449218679|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
124889908|NCT03220737|449218680|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
124889909|NCT03220737|449218681|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
124441842|NCT05266586|447577816|FG000|Overall Study|Non-compliance with study drug|0|||
124441843|NCT05266586|447577817|FG001|Overall Study|Non-compliance with study drug|1|||
124889910|NCT03220737|449218682|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
124889911|NCT03220737|449218676|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
124889912|NCT03220737|449218677|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
124889913|NCT03220737|449218678|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
124889914|NCT03220737|449218679|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
124889915|NCT03220737|449218680|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
124889916|NCT03220737|449218681|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
124889917|NCT03220737|449218682|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
124889918|NCT03220737|449218676|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
124889919|NCT03220737|449218677|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
124889920|NCT03220737|449218678|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
124889921|NCT03220737|449218679|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
124889922|NCT03220737|449218680|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
124889923|NCT03220737|449218681|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
124889924|NCT03220737|449218682|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
124889925|NCT03220737|449218676|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
124889926|NCT03220737|449218677|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
124889927|NCT03220737|449218678|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
124889928|NCT03220737|449218679|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
124889929|NCT03220737|449218680|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
124889930|NCT03220737|449218681|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
124889931|NCT03220737|449218682|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
124889932|NCT01720797|449218683|FG000|Overall Study|Withdrawal by Subject|3|||
124889933|NCT01720797|449218684|FG001|Overall Study|Withdrawal by Subject|0|||
124889934|NCT04011384|449218691|FG000|Overall Study|Withdrawal by Subject|2|||
124889935|NCT04011384|449218692|FG001|Overall Study|Withdrawal by Subject|0|||
124889936|NCT01094171|449218693|FG000|Overall Study|Lost to Follow-up|2|||
124889937|NCT01094171|449218693|FG000|Overall Study|Informed consent withdrawal|4|||
124889938|NCT01094171|449218693|FG000|Overall Study|Migration from the study area|3|||
124889939|NCT01094171|449218693|FG000|Overall Study|Other|1|||
124889940|NCT00594932|449218694|FG000|First 3 Months|Withdrawal by Subject|1|||
124889941|NCT00594932|449218695|FG001|First 3 Months|Withdrawal by Subject|3|||
124889942|NCT00594932|449218694|FG000|Final 3 Months|Withdrawal by Subject|4|||
124889943|NCT00594932|449218695|FG001|Final 3 Months|Withdrawal by Subject|3|||
124889944|NCT01083160|449218696|FG000|Overall Study|Adverse Event|1|||
124889945|NCT00918749|449218697|FG000|Overall Study|Adverse Event|1|||
124889946|NCT00918749|449218698|FG001|Overall Study|Adverse Event|0|||
124889947|NCT00918749|449218699|FG002|Overall Study|Adverse Event|1|||
124889948|NCT00918749|449218697|FG000|Overall Study|Lost to Follow-up|0|||
124889949|NCT00918749|449218698|FG001|Overall Study|Lost to Follow-up|0|||
124889950|NCT00918749|449218699|FG002|Overall Study|Lost to Follow-up|1|||
124889951|NCT00918749|449218697|FG000|Overall Study|Withdrawal by Subject|5|||
124889952|NCT00918749|449218698|FG001|Overall Study|Withdrawal by Subject|3|||
124889953|NCT00918749|449218699|FG002|Overall Study|Withdrawal by Subject|5|||
124889954|NCT00918749|449218697|FG000|Overall Study|No Study Medication Taken|1|||
124889955|NCT00918749|449218698|FG001|Overall Study|No Study Medication Taken|0|||
124889956|NCT00918749|449218699|FG002|Overall Study|No Study Medication Taken|0|||
124889957|NCT01951092|449218700|FG000|Overall Study|Lost to Follow-up|10|||
124889958|NCT01951092|449218700|FG000|Overall Study|Incarceration|1|||
124889959|NCT01951092|449218700|FG000|Overall Study|Transfer of Care|1|||
124889960|NCT01712789|449218701|FG000|Overall Study|Lack of Efficacy|2|||
124889961|NCT01712789|449218701|FG000|Overall Study|Lost to Follow-up|1|||
124889962|NCT01712789|449218701|FG000|Overall Study|Progressive Disease|504|||
124889963|NCT01712789|449218701|FG000|Overall Study|Death|57|||
124889964|NCT01712789|449218701|FG000|Overall Study|Adverse Event|52|||
124889965|NCT01712789|449218701|FG000|Overall Study|Miscellaneous|31|||
124889966|NCT01712789|449218701|FG000|Overall Study|Withdrawal by Subject|21|||
124889967|NCT01712789|449218701|FG000|Overall Study|Transition to Commercial Treatment|8|||
124889968|NCT01712789|449218701|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
124889969|NCT01708187|449218702|FG000|Overall Study|Lost to Follow-up|0|||
124889970|NCT01708187|449218703|FG001|Overall Study|Lost to Follow-up|1|||
124889971|NCT03055832|449218705|FG000|Week 2|Withdrawal by Subject|1|||
124889972|NCT03055832|449218706|FG001|Week 2|Withdrawal by Subject|0|||
124889973|NCT01152554|449218707|FG000|Overall Study|Withdrawal by Subject|73|||
124889974|NCT01152554|449218708|FG001|Overall Study|Withdrawal by Subject|28|||
124889975|NCT01152554|449218707|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
124889976|NCT01152554|449218708|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
124889977|NCT01152554|449218707|FG000|Overall Study|Adverse Event|67|||
124889978|NCT01152554|449218708|FG001|Overall Study|Adverse Event|14|||
124889979|NCT01152554|449218707|FG000|Overall Study|Severe non-compliance to protocol|36|||
124889980|NCT01152554|449218708|FG001|Overall Study|Severe non-compliance to protocol|14|||
124889981|NCT01152554|449218707|FG000|Overall Study|Condition under investigation worsened|5|||
124889982|NCT01152554|449218708|FG001|Overall Study|Condition under investigation worsened|2|||
124889983|NCT01152554|449218707|FG000|Overall Study|Lack of Efficacy|20|||
124889984|NCT01152554|449218708|FG001|Overall Study|Lack of Efficacy|3|||
124889985|NCT01152554|449218707|FG000|Overall Study|Study-specific withdrawal criteria|17|||
124889986|NCT01152554|449218708|FG001|Overall Study|Study-specific withdrawal criteria|8|||
124889987|NCT01152554|449218707|FG000|Overall Study|Lost to Follow-up|87|||
124889988|NCT01152554|449218708|FG001|Overall Study|Lost to Follow-up|32|||
124889989|NCT01152554|449218707|FG000|Overall Study|Other|28|||
124889990|NCT01152554|449218708|FG001|Overall Study|Other|8|||
124889991|NCT01152554|449218707|FG000|Overall Study|Death|1|||
124889992|NCT01152554|449218708|FG001|Overall Study|Death|1|||
124889993|NCT02117544|449218709|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
124889994|NCT02117544|449218710|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
124889995|NCT01439711|449218711|FG000|Overall Study|Ineligible|13|||
124889996|NCT01439711|449218711|FG000|Overall Study|Cancel|3|||
124889997|NCT01439711|449218711|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
124889998|NCT01439711|449218711|FG000|Overall Study|Adverse Event|5|||
124889999|NCT01439711|449218711|FG000|Overall Study|Withdrawal by Subject|3|||
124890000|NCT01439711|449218711|FG000|Overall Study|Progression During Active Tx|3|||
124890001|NCT01439711|449218711|FG000|Overall Study|Noncompliance|3|||
124890002|NCT01439711|449218711|FG000|Overall Study|No MRI|9|||
124890003|NCT01012973|449218712|FG000|Overall Study|Adverse Event|5|||
124890004|NCT01012973|449218713|FG001|Overall Study|Adverse Event|5|||
124890005|NCT01012973|449218712|FG000|Overall Study|Lack of Efficacy|0|||
124890006|NCT01012973|449218713|FG001|Overall Study|Lack of Efficacy|5|||
124890007|NCT01012973|449218712|FG000|Overall Study|Lost to Follow-up|1|||
124890008|NCT01012973|449218713|FG001|Overall Study|Lost to Follow-up|0|||
124890009|NCT01012973|449218712|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
124890010|NCT01012973|449218713|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
124890011|NCT01012973|449218712|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
124890012|NCT01012973|449218713|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
124890013|NCT01012973|449218712|FG000|Overall Study|Protocol Violation|5|||
124890014|NCT01012973|449218713|FG001|Overall Study|Protocol Violation|2|||
124890015|NCT01012973|449218712|FG000|Overall Study|Withdrawal by Subject|4|||
124890016|NCT01012973|449218713|FG001|Overall Study|Withdrawal by Subject|6|||
124890017|NCT02448719|449218715|FG000|Overall Study|Withdrawal by Subject|0|||
124890018|NCT02448719|449218716|FG001|Overall Study|Withdrawal by Subject|0|||
124890019|NCT02448719|449218717|FG002|Overall Study|Withdrawal by Subject|0|||
124890020|NCT02448719|449218718|FG003|Overall Study|Withdrawal by Subject|0|||
124890021|NCT02448719|449218719|FG004|Overall Study|Withdrawal by Subject|1|||
124890022|NCT02448719|449218720|FG005|Overall Study|Withdrawal by Subject|0|||
124890023|NCT02448719|449218721|FG006|Overall Study|Withdrawal by Subject|0|||
124890024|NCT02448719|449218722|FG007|Overall Study|Withdrawal by Subject|0|||
124890025|NCT02448719|449218723|FG008|Overall Study|Withdrawal by Subject|0|||
124890026|NCT02448719|449218724|FG009|Overall Study|Withdrawal by Subject|0|||
124890027|NCT02448719|449218725|FG010|Overall Study|Withdrawal by Subject|0|||
124890028|NCT00209027|449218726|FG000|Overall Study|study terminated|10|||
124890029|NCT00209027|449218727|FG001|Overall Study|study terminated|0|||
124890030|NCT01932996|449218728|FG000|Overall Study|Protocol Violation|2|||
124890031|NCT01932996|449218729|FG001|Overall Study|Protocol Violation|0|||
124890032|NCT02806336|449218730|FG000|Overall Study|Physician Decision|1|||
124890033|NCT02806336|449218731|FG001|Overall Study|Physician Decision|0|||
124890034|NCT02806336|449218730|FG000|Overall Study|Withdrawal by Subject|2|||
124890035|NCT02806336|449218731|FG001|Overall Study|Withdrawal by Subject|4|||
124890036|NCT02806336|449218730|FG000|Overall Study|COVID-19 research shut down|3|||
124890037|NCT02806336|449218731|FG001|Overall Study|COVID-19 research shut down|4|||
124890038|NCT02806336|449218730|FG000|Overall Study|Lack of Efficacy|0|||
124890039|NCT02806336|449218731|FG001|Overall Study|Lack of Efficacy|1|||
124890040|NCT00895843|449218732|FG000|Overall Study|Protocol Violation|12|||
124890041|NCT00895843|449218733|FG001|Overall Study|Protocol Violation|12|||
124890042|NCT03658811|449218734|FG000|Overall Study|Lost to Follow-up|3|||
124890043|NCT00946647|449218735|FG000|Phase 1 Part|Adverse Event|2|||
124890044|NCT00946647|449218736|FG001|Phase 1 Part|Adverse Event|5|||
124686501|NCT02101853|448471293|FG003|Post Induction Randomization|Physician Decision|14|||
124686502|NCT02101853|448471294|FG004|Post Induction Randomization|Physician Decision|14|||
124890045|NCT00946647|449218737|FG002|Phase 1 Part|Adverse Event|3|||
124890046|NCT00946647|449218738|FG003|Phase 1 Part|Adverse Event|0|||
124890047|NCT00946647|449218739|FG004|Phase 1 Part|Adverse Event|0|||
124890048|NCT00946647|449218735|FG000|Phase 1 Part|Disease progression|3|||
124890049|NCT00946647|449218736|FG001|Phase 1 Part|Disease progression|6|||
124890050|NCT00946647|449218737|FG002|Phase 1 Part|Disease progression|1|||
124890051|NCT00946647|449218738|FG003|Phase 1 Part|Disease progression|0|||
124890052|NCT00946647|449218739|FG004|Phase 1 Part|Disease progression|0|||
124890053|NCT00946647|449218735|FG000|Phase 1 Part|Withdrawal by Subject|1|||
124890054|NCT00946647|449218736|FG001|Phase 1 Part|Withdrawal by Subject|4|||
124890055|NCT00946647|449218737|FG002|Phase 1 Part|Withdrawal by Subject|3|||
124890056|NCT00946647|449218738|FG003|Phase 1 Part|Withdrawal by Subject|0|||
124890057|NCT00946647|449218739|FG004|Phase 1 Part|Withdrawal by Subject|0|||
124890058|NCT00946647|449218735|FG000|Phase 1 Part|Abnormal values|0|||
124890059|NCT00946647|449218736|FG001|Phase 1 Part|Abnormal values|2|||
124890060|NCT00946647|449218737|FG002|Phase 1 Part|Abnormal values|0|||
124890061|NCT00946647|449218738|FG003|Phase 1 Part|Abnormal values|0|||
124890062|NCT00946647|449218739|FG004|Phase 1 Part|Abnormal values|0|||
124890063|NCT00946647|449218735|FG000|Phase 1 Part|Reason missing|0|||
124890064|NCT00946647|449218736|FG001|Phase 1 Part|Reason missing|1|||
124890065|NCT00946647|449218737|FG002|Phase 1 Part|Reason missing|0|||
124890066|NCT00946647|449218738|FG003|Phase 1 Part|Reason missing|0|||
124890067|NCT00946647|449218739|FG004|Phase 1 Part|Reason missing|0|||
124890068|NCT00946647|449218735|FG000|Phase ll Part|Untreated|0|||
124890069|NCT00946647|449218736|FG001|Phase ll Part|Untreated|0|||
124890070|NCT00946647|449218737|FG002|Phase ll Part|Untreated|0|||
124890071|NCT00946647|449218738|FG003|Phase ll Part|Untreated|0|||
124890072|NCT00946647|449218739|FG004|Phase ll Part|Untreated|2|||
124890073|NCT00946647|449218735|FG000|Phase ll Part|Adverse Event|0|||
124890074|NCT00946647|449218736|FG001|Phase ll Part|Adverse Event|0|||
124890075|NCT00946647|449218737|FG002|Phase ll Part|Adverse Event|0|||
124890076|NCT00946647|449218738|FG003|Phase ll Part|Adverse Event|10|||
124890077|NCT00946647|449218739|FG004|Phase ll Part|Adverse Event|6|||
124890078|NCT00946647|449218735|FG000|Phase ll Part|Withdrawal by Subject|0|||
124441844|NCT05266586|447577818|FG002|Overall Study|Non-compliance with study drug|0|||
124890079|NCT00946647|449218736|FG001|Phase ll Part|Withdrawal by Subject|0|||
124890080|NCT00946647|449218737|FG002|Phase ll Part|Withdrawal by Subject|0|||
124890081|NCT00946647|449218738|FG003|Phase ll Part|Withdrawal by Subject|8|||
124890082|NCT00946647|449218739|FG004|Phase ll Part|Withdrawal by Subject|6|||
124890083|NCT00946647|449218735|FG000|Phase ll Part|Administrative problems|0|||
124890084|NCT00946647|449218736|FG001|Phase ll Part|Administrative problems|0|||
124890085|NCT00946647|449218737|FG002|Phase ll Part|Administrative problems|0|||
124890086|NCT00946647|449218738|FG003|Phase ll Part|Administrative problems|3|||
124890087|NCT00946647|449218739|FG004|Phase ll Part|Administrative problems|8|||
124890088|NCT00946647|449218735|FG000|Phase ll Part|Death|0|||
124686503|NCT02101853|448471295|FG005|Post Induction Randomization|Physician Decision|0|||
124890089|NCT00946647|449218736|FG001|Phase ll Part|Death|0|||
124890090|NCT00946647|449218737|FG002|Phase ll Part|Death|0|||
124890091|NCT00946647|449218738|FG003|Phase ll Part|Death|7|||
124890092|NCT00946647|449218739|FG004|Phase ll Part|Death|4|||
124890093|NCT00946647|449218735|FG000|Phase ll Part|Disease progression|0|||
124890094|NCT00946647|449218736|FG001|Phase ll Part|Disease progression|0|||
124890095|NCT00946647|449218737|FG002|Phase ll Part|Disease progression|0|||
124890096|NCT00946647|449218738|FG003|Phase ll Part|Disease progression|6|||
124890097|NCT00946647|449218739|FG004|Phase ll Part|Disease progression|14|||
124890098|NCT00946647|449218735|FG000|Phase ll Part|Protocol Violation|0|||
124890099|NCT00946647|449218736|FG001|Phase ll Part|Protocol Violation|0|||
124890100|NCT00946647|449218737|FG002|Phase ll Part|Protocol Violation|0|||
124890101|NCT00946647|449218738|FG003|Phase ll Part|Protocol Violation|4|||
124890102|NCT00946647|449218739|FG004|Phase ll Part|Protocol Violation|2|||
124890103|NCT00946647|449218735|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
124890104|NCT00946647|449218736|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
124890105|NCT00946647|449218737|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
124890106|NCT00946647|449218738|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
124890107|NCT00946647|449218739|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
124890108|NCT03990363|449218740|FG000|Overall Study|Withdrawal by Subject|10|||
124890109|NCT03990363|449218741|FG001|Overall Study|Withdrawal by Subject|9|||
124890110|NCT03990363|449218742|FG002|Overall Study|Withdrawal by Subject|18|||
124890111|NCT03990363|449218743|FG003|Overall Study|Withdrawal by Subject|11|||
124890112|NCT03990363|449218744|FG004|Overall Study|Withdrawal by Subject|9|||
124890113|NCT03990363|449218740|FG000|Overall Study|Physician Decision|1|||
124890114|NCT03990363|449218741|FG001|Overall Study|Physician Decision|0|||
124890115|NCT03990363|449218742|FG002|Overall Study|Physician Decision|0|||
124686504|NCT02101853|448471290|FG000|Post Induction Randomization|Protocol Violation|0|||
124890116|NCT03990363|449218743|FG003|Overall Study|Physician Decision|0|||
124890117|NCT03990363|449218744|FG004|Overall Study|Physician Decision|0|||
124890118|NCT03990363|449218740|FG000|Overall Study|Adverse Event|1|||
124890119|NCT03990363|449218741|FG001|Overall Study|Adverse Event|3|||
124890120|NCT03990363|449218742|FG002|Overall Study|Adverse Event|2|||
124890121|NCT03990363|449218743|FG003|Overall Study|Adverse Event|2|||
124890122|NCT03990363|449218744|FG004|Overall Study|Adverse Event|0|||
124890123|NCT03990363|449218740|FG000|Overall Study|Death|14|||
124890124|NCT03990363|449218741|FG001|Overall Study|Death|8|||
124890125|NCT03990363|449218742|FG002|Overall Study|Death|14|||
124890126|NCT03990363|449218743|FG003|Overall Study|Death|10|||
124890127|NCT03990363|449218744|FG004|Overall Study|Death|11|||
124890128|NCT03990363|449218740|FG000|Overall Study|Failure to meet randomization criteria|0|||
124890129|NCT03990363|449218741|FG001|Overall Study|Failure to meet randomization criteria|1|||
124890130|NCT03990363|449218742|FG002|Overall Study|Failure to meet randomization criteria|1|||
124890131|NCT03990363|449218743|FG003|Overall Study|Failure to meet randomization criteria|0|||
124890132|NCT03990363|449218744|FG004|Overall Study|Failure to meet randomization criteria|0|||
124890133|NCT03990363|449218740|FG000|Overall Study|Lost to Follow-up|0|||
124890134|NCT03990363|449218741|FG001|Overall Study|Lost to Follow-up|0|||
124890135|NCT03990363|449218742|FG002|Overall Study|Lost to Follow-up|0|||
124890136|NCT03990363|449218743|FG003|Overall Study|Lost to Follow-up|1|||
124890137|NCT03990363|449218744|FG004|Overall Study|Lost to Follow-up|2|||
124890138|NCT03990363|449218740|FG000|Overall Study|Non-compliance with study drug|2|||
124890139|NCT03990363|449218741|FG001|Overall Study|Non-compliance with study drug|1|||
124890140|NCT03990363|449218742|FG002|Overall Study|Non-compliance with study drug|2|||
124890141|NCT03990363|449218743|FG003|Overall Study|Non-compliance with study drug|0|||
124890142|NCT03990363|449218744|FG004|Overall Study|Non-compliance with study drug|0|||
124890143|NCT03990363|449218740|FG000|Overall Study|Study terminated by sponsor|0|||
124890144|NCT03990363|449218741|FG001|Overall Study|Study terminated by sponsor|1|||
124890145|NCT03990363|449218742|FG002|Overall Study|Study terminated by sponsor|0|||
124890146|NCT03990363|449218743|FG003|Overall Study|Study terminated by sponsor|0|||
124890147|NCT03990363|449218744|FG004|Overall Study|Study terminated by sponsor|0|||
124890148|NCT03990363|449218740|FG000|Overall Study|Site terminated by sponsor|2|||
124890149|NCT03990363|449218741|FG001|Overall Study|Site terminated by sponsor|1|||
124890150|NCT03990363|449218742|FG002|Overall Study|Site terminated by sponsor|2|||
124890151|NCT03990363|449218743|FG003|Overall Study|Site terminated by sponsor|0|||
124890152|NCT03990363|449218744|FG004|Overall Study|Site terminated by sponsor|2|||
124890153|NCT03990363|449218740|FG000|Overall Study|Not categorized|5|||
124890154|NCT03990363|449218741|FG001|Overall Study|Not categorized|5|||
124890155|NCT03990363|449218742|FG002|Overall Study|Not categorized|3|||
124890156|NCT03990363|449218743|FG003|Overall Study|Not categorized|2|||
124890157|NCT03990363|449218744|FG004|Overall Study|Not categorized|2|||
124890158|NCT00556374|449218746|FG000|Overall Study|Withdrawal by Subject|235|||
124890159|NCT00556374|449218747|FG001|Overall Study|Withdrawal by Subject|205|||
124890160|NCT00556374|449218746|FG000|Overall Study|Death|158|||
124890161|NCT00556374|449218747|FG001|Overall Study|Death|127|||
124890162|NCT00556374|449218746|FG000|Overall Study|Lost to Follow-up|24|||
124890163|NCT00556374|449218747|FG001|Overall Study|Lost to Follow-up|17|||
124890164|NCT00556374|449218746|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
124890165|NCT00556374|449218747|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
124890166|NCT00663962|449218748|FG000|Overall Study|somnolence|1|||
124890167|NCT00663962|449218749|FG001|Overall Study|somnolence|0|||
124890168|NCT02846558|449218754|FG000|Overall Study|Adverse Event|1|||
124890169|NCT02846558|449218755|FG001|Overall Study|Adverse Event|0|||
124890170|NCT02846558|449218756|FG002|Overall Study|Adverse Event|0|||
124890171|NCT02846558|449218757|FG003|Overall Study|Adverse Event|0|||
124890172|NCT02846558|449218754|FG000|Overall Study|Withdrawal by Subject|5|||
124890173|NCT02846558|449218755|FG001|Overall Study|Withdrawal by Subject|4|||
124890174|NCT02846558|449218756|FG002|Overall Study|Withdrawal by Subject|2|||
124890175|NCT02846558|449218757|FG003|Overall Study|Withdrawal by Subject|2|||
124890176|NCT02846558|449218754|FG000|Overall Study|Lost to Follow-up|2|||
124890177|NCT02846558|449218755|FG001|Overall Study|Lost to Follow-up|0|||
124890178|NCT02846558|449218756|FG002|Overall Study|Lost to Follow-up|0|||
124890179|NCT02846558|449218757|FG003|Overall Study|Lost to Follow-up|0|||
124890180|NCT00810641|449218761|FG000|Overall Study|Withdrawal by Subject|0|||
124890181|NCT00810641|449218762|FG001|Overall Study|Withdrawal by Subject|1|||
124890182|NCT00810641|449218763|FG002|Overall Study|Withdrawal by Subject|2|||
124890183|NCT02684903|449218772|FG000|Overall Study|COVID-19 shutdown of lab|4|||
124890184|NCT02684903|449218773|FG001|Overall Study|COVID-19 shutdown of lab|6|||
124890185|NCT02684903|449218772|FG000|Overall Study|Lost to Follow-up|31|||
124890186|NCT02684903|449218773|FG001|Overall Study|Lost to Follow-up|41|||
124890187|NCT00904150|449218774|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
124890188|NCT00904150|449218775|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
124890189|NCT00904150|449218774|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
124890190|NCT00904150|449218775|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
124890191|NCT04212169|449220408|FG000|Overall Study|Adverse Event|0|||
124890192|NCT04212169|449220409|FG001|Overall Study|Adverse Event|0|||
124890193|NCT04212169|449220410|FG002|Overall Study|Adverse Event|0|||
124890194|NCT04212169|449220411|FG003|Overall Study|Adverse Event|2|||
124890195|NCT04212169|449220408|FG000|Overall Study|Lost to Follow-up|1|||
124890196|NCT04212169|449220409|FG001|Overall Study|Lost to Follow-up|0|||
124890197|NCT04212169|449220410|FG002|Overall Study|Lost to Follow-up|0|||
124890198|NCT04212169|449220411|FG003|Overall Study|Lost to Follow-up|2|||
124890199|NCT04212169|449220408|FG000|Overall Study|Withdrawal by Subject|10|||
124890200|NCT04212169|449220409|FG001|Overall Study|Withdrawal by Subject|2|||
124890201|NCT04212169|449220410|FG002|Overall Study|Withdrawal by Subject|5|||
124890202|NCT04212169|449220411|FG003|Overall Study|Withdrawal by Subject|7|||
124890203|NCT04212169|449220408|FG000|Overall Study|Other reason, unspecified|3|||
124890204|NCT04212169|449220409|FG001|Overall Study|Other reason, unspecified|1|||
124890205|NCT04212169|449220410|FG002|Overall Study|Other reason, unspecified|0|||
124890206|NCT04212169|449220411|FG003|Overall Study|Other reason, unspecified|2|||
124890207|NCT02176928|449220412|FG000|Overall Study|Lost to Follow-up|2|||
124890208|NCT02176928|449220413|FG001|Overall Study|Lost to Follow-up|4|||
124890209|NCT00224133|449220414|FG000|Overall Study|Adverse Event|93|||
124890210|NCT00224133|449220414|FG000|Overall Study|Protocol Violation|6|||
124890211|NCT00224133|449220414|FG000|Overall Study|Withdrawal by Subject|33|||
124890212|NCT00224133|449220414|FG000|Overall Study|Lack of Efficacy|58|||
124890213|NCT00224133|449220414|FG000|Overall Study|Lost to Follow-up|21|||
124890214|NCT00224133|449220414|FG000|Overall Study|Physician Decision|1|||
124890215|NCT00224133|449220414|FG000|Overall Study|Other|14|||
124890216|NCT02718417|449220415|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
124890217|NCT02718417|449220416|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
124890218|NCT02718417|449220417|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
124890219|NCT02718417|449220415|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
124890220|NCT02718417|449220416|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
124890221|NCT02718417|449220417|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
124890222|NCT02718417|449220415|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
124890223|NCT02718417|449220416|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
124890224|NCT02718417|449220417|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
124890225|NCT02718417|449220415|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
124890226|NCT02718417|449220416|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
124890227|NCT02718417|449220417|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
124890228|NCT02718417|449220415|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
124890229|NCT02718417|449220416|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
124890230|NCT02718417|449220417|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
124890231|NCT02718417|449220415|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
124890232|NCT02718417|449220416|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
124890233|NCT02718417|449220417|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
124890234|NCT02718417|449220415|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
124890235|NCT02718417|449220416|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
124890236|NCT02718417|449220417|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
124890237|NCT02718417|449220415|FG000|Chemotherapy Phase (CP)|Other|2|||
124890238|NCT02718417|449220416|FG001|Chemotherapy Phase (CP)|Other|0|||
124890239|NCT02718417|449220417|FG002|Chemotherapy Phase (CP)|Other|1|||
124890240|NCT02718417|449220415|FG000|Maintenance Phase (MP)|Adverse Event|21|||
124890241|NCT02718417|449220416|FG001|Maintenance Phase (MP)|Adverse Event|26|||
124890242|NCT02718417|449220417|FG002|Maintenance Phase (MP)|Adverse Event|0|||
124890243|NCT02718417|449220415|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
124890244|NCT02718417|449220416|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
124890245|NCT02718417|449220417|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
124890246|NCT02718417|449220415|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
124890247|NCT02718417|449220416|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
124890248|NCT02718417|449220417|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
124890249|NCT02718417|449220415|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
124890250|NCT02718417|449220416|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
124890251|NCT02718417|449220417|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
124890252|NCT02718417|449220415|FG000|Maintenance Phase (MP)|Physician's decision|6|||
124890253|NCT02718417|449220416|FG001|Maintenance Phase (MP)|Physician's decision|7|||
124890254|NCT02718417|449220417|FG002|Maintenance Phase (MP)|Physician's decision|0|||
124890255|NCT02718417|449220415|FG000|Maintenance Phase (MP)|Progressive disease|100|||
124890256|NCT02718417|449220416|FG001|Maintenance Phase (MP)|Progressive disease|88|||
124890257|NCT02718417|449220417|FG002|Maintenance Phase (MP)|Progressive disease|0|||
124890258|NCT02718417|449220415|FG000|Maintenance Phase (MP)|Other|2|||
124890259|NCT02718417|449220416|FG001|Maintenance Phase (MP)|Other|1|||
124890260|NCT02718417|449220417|FG002|Maintenance Phase (MP)|Other|0|||
124890261|NCT02718417|449220415|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
124890262|NCT02718417|449220416|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
124890263|NCT02718417|449220417|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
124890264|NCT02718417|449220415|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
124890265|NCT02718417|449220416|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
124890266|NCT02718417|449220417|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
124890267|NCT02718417|449220415|FG000|Observation Phase (OP)|Adverse Event|0|||
124890268|NCT02718417|449220416|FG001|Observation Phase (OP)|Adverse Event|0|||
124890269|NCT02718417|449220417|FG002|Observation Phase (OP)|Adverse Event|1|||
124890270|NCT02718417|449220415|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
124890271|NCT02718417|449220416|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
124890272|NCT02718417|449220417|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
124890273|NCT02718417|449220415|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
124890274|NCT02718417|449220416|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
124890275|NCT02718417|449220417|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
124890276|NCT02718417|449220415|FG000|Observation Phase (OP)|Physician Decision|0|||
124890277|NCT02718417|449220416|FG001|Observation Phase (OP)|Physician Decision|0|||
124890278|NCT02718417|449220417|FG002|Observation Phase (OP)|Physician Decision|9|||
124890279|NCT02718417|449220415|FG000|Observation Phase (OP)|Progressive disease|0|||
124890280|NCT02718417|449220416|FG001|Observation Phase (OP)|Progressive disease|0|||
124890281|NCT02718417|449220417|FG002|Observation Phase (OP)|Progressive disease|92|||
124890282|NCT02718417|449220415|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
124890283|NCT02718417|449220416|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
124890284|NCT02718417|449220417|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
124890285|NCT02718417|449220415|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
124890286|NCT02718417|449220416|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
124890287|NCT02718417|449220417|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
124890288|NCT02718417|449220415|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
124890289|NCT02718417|449220416|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
124890290|NCT02718417|449220417|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
124890291|NCT02718417|449220415|FG000|Observation Phase (OP)|Other|0|||
124890292|NCT02718417|449220416|FG001|Observation Phase (OP)|Other|0|||
124890293|NCT02718417|449220417|FG002|Observation Phase (OP)|Other|7|||
124890294|NCT02718417|449220415|FG000|Follow-up Phase|Adverse Event|3|||
124890295|NCT02718417|449220416|FG001|Follow-up Phase|Adverse Event|1|||
124890296|NCT02718417|449220417|FG002|Follow-up Phase|Adverse Event|1|||
124890297|NCT02718417|449220415|FG000|Follow-up Phase|Other|4|||
124890298|NCT02718417|449220416|FG001|Follow-up Phase|Other|6|||
124890299|NCT02718417|449220417|FG002|Follow-up Phase|Other|4|||
124441845|NCT05266586|447577816|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
124441846|NCT05266586|447577817|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
124441847|NCT05266586|447577818|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
124441848|NCT02225353|447577819|FG000|Overall Study|Lost to Follow-up|0|||
124441849|NCT02225353|447577820|FG001|Overall Study|Lost to Follow-up|1|||
124441850|NCT02225353|447577821|FG002|Overall Study|Lost to Follow-up|3|||
124441851|NCT02225353|447577819|FG000|Overall Study|Protocol Violation|4|||
124441852|NCT02225353|447577820|FG001|Overall Study|Protocol Violation|5|||
124441853|NCT02225353|447577821|FG002|Overall Study|Protocol Violation|12|||
124441854|NCT01117857|447577822|FG000|Overall Study|Lost to Follow-up|4|||
124441855|NCT01117857|447577822|FG000|Overall Study|Withdrawal by Subject|4|||
124441856|NCT01117857|447577822|FG000|Overall Study|Physician Decision|1|||
124441857|NCT03282240|447577823|FG000|Overall Study|Adverse Event|2|||
124441858|NCT03282240|447577824|FG001|Overall Study|Adverse Event|2|||
124441859|NCT03282240|447577825|FG002|Overall Study|Adverse Event|0|||
124441860|NCT03282240|447577823|FG000|Overall Study|Lost to Follow-up|3|||
124441861|NCT03282240|447577824|FG001|Overall Study|Lost to Follow-up|0|||
124441862|NCT03282240|447577825|FG002|Overall Study|Lost to Follow-up|0|||
124441863|NCT03282240|447577823|FG000|Overall Study|Protocol Deviation|4|||
124441864|NCT03282240|447577824|FG001|Overall Study|Protocol Deviation|1|||
124441865|NCT03282240|447577825|FG002|Overall Study|Protocol Deviation|2|||
124441866|NCT03282240|447577823|FG000|Overall Study|Withdrawal by Subject|1|||
124441867|NCT03282240|447577824|FG001|Overall Study|Withdrawal by Subject|0|||
124441868|NCT03282240|447577825|FG002|Overall Study|Withdrawal by Subject|1|||
124441869|NCT02146326|447577826|FG000|Overall Study|Lost to Follow-up|3|||
124441870|NCT02146326|447577827|FG001|Overall Study|Lost to Follow-up|3|||
124441871|NCT02146326|447577828|FG002|Overall Study|Lost to Follow-up|11|||
124441872|NCT02146326|447577829|FG003|Overall Study|Lost to Follow-up|19|||
124441873|NCT02146326|447577826|FG000|Overall Study|Withdrawal by Subject|2|||
124441874|NCT02146326|447577827|FG001|Overall Study|Withdrawal by Subject|1|||
124441875|NCT02146326|447577828|FG002|Overall Study|Withdrawal by Subject|15|||
124441876|NCT02146326|447577829|FG003|Overall Study|Withdrawal by Subject|11|||
124441877|NCT02146326|447577826|FG000|Overall Study|Separated from mental health center|23|||
124441878|NCT02146326|447577827|FG001|Overall Study|Separated from mental health center|33|||
124441879|NCT02146326|447577828|FG002|Overall Study|Separated from mental health center|0|||
124441880|NCT02146326|447577829|FG003|Overall Study|Separated from mental health center|0|||
124890300|NCT02718417|449220415|FG000|Follow-up Phase|Withdrawal by Subject|19|||
124890301|NCT02718417|449220416|FG001|Follow-up Phase|Withdrawal by Subject|17|||
124890302|NCT02718417|449220417|FG002|Follow-up Phase|Withdrawal by Subject|5|||
124890303|NCT02718417|449220415|FG000|Follow-up Phase|Study terminated by sponsor|100|||
124890304|NCT02718417|449220416|FG001|Follow-up Phase|Study terminated by sponsor|138|||
124441881|NCT02146326|447577826|FG000|Overall Study|Incarcerated|0|||
124441882|NCT02146326|447577827|FG001|Overall Study|Incarcerated|0|||
124890305|NCT02718417|449220417|FG002|Follow-up Phase|Study terminated by sponsor|6|||
124890306|NCT02718417|449220415|FG000|Follow-up Phase|Lost to Follow-up|2|||
124890307|NCT02718417|449220416|FG001|Follow-up Phase|Lost to Follow-up|3|||
124890308|NCT02718417|449220417|FG002|Follow-up Phase|Lost to Follow-up|0|||
124890309|NCT02718417|449220415|FG000|Follow-up Phase|Death leading to discontinuation|7|||
124890310|NCT02718417|449220416|FG001|Follow-up Phase|Death leading to discontinuation|7|||
124890311|NCT02718417|449220417|FG002|Follow-up Phase|Death leading to discontinuation|3|||
124890312|NCT02718417|449220415|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
124890313|NCT02718417|449220416|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
124890314|NCT02718417|449220417|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
124890315|NCT02718417|449220415|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
124890316|NCT02718417|449220416|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
124890317|NCT02718417|449220417|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
124890318|NCT02718417|449220415|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
124890319|NCT02718417|449220416|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
124890320|NCT02718417|449220417|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
124890321|NCT02718417|449220415|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
124890322|NCT02718417|449220416|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
124890323|NCT02718417|449220417|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
124890324|NCT02718417|449220415|FG000|Long-term Follow-up Phase|Other|0|||
124890325|NCT02718417|449220416|FG001|Long-term Follow-up Phase|Other|2|||
124890326|NCT02718417|449220417|FG002|Long-term Follow-up Phase|Other|0|||
124890327|NCT02451930|449220418|FG000|Overall Study|Death|0|||
124890328|NCT02451930|449220419|FG001|Overall Study|Death|15|||
124890329|NCT02451930|449220418|FG000|Overall Study|Lost to Follow-up|0|||
124890330|NCT02451930|449220419|FG001|Overall Study|Lost to Follow-up|3|||
124890331|NCT02451930|449220418|FG000|Overall Study|Sponsor Decision|2|||
124890332|NCT02451930|449220419|FG001|Overall Study|Sponsor Decision|10|||
124890333|NCT02451930|449220418|FG000|Overall Study|Withdrawal by Subject|0|||
124890334|NCT02451930|449220419|FG001|Overall Study|Withdrawal by Subject|1|||
124890335|NCT02451930|449220418|FG000|Overall Study|Other|0|||
124890336|NCT02451930|449220419|FG001|Overall Study|Other|1|||
124890337|NCT02268552|449220420|FG000|Part 1|Death|1|||
124890338|NCT02268552|449220421|FG001|Part 1|Death|1|||
124890339|NCT02268552|449220422|FG002|Part 1|Death|1|||
124890340|NCT02268552|449220423|FG003|Part 1|Death|2|||
124890341|NCT02268552|449220424|FG004|Part 1|Death|0|||
124890342|NCT02268552|449220425|FG005|Part 1|Death|0|||
124890343|NCT02268552|449220426|FG006|Part 1|Death|0|||
124890344|NCT02268552|449220420|FG000|Part 1|Subject/guardian decision|0|||
124890345|NCT02268552|449220421|FG001|Part 1|Subject/guardian decision|0|||
124890346|NCT02268552|449220422|FG002|Part 1|Subject/guardian decision|0|||
124890347|NCT02268552|449220423|FG003|Part 1|Subject/guardian decision|1|||
124890348|NCT02268552|449220424|FG004|Part 1|Subject/guardian decision|0|||
124890349|NCT02268552|449220425|FG005|Part 1|Subject/guardian decision|0|||
124890350|NCT02268552|449220426|FG006|Part 1|Subject/guardian decision|0|||
124890351|NCT02268552|449220420|FG000|Part 2|Death|0|||
124890352|NCT02268552|449220421|FG001|Part 2|Death|0|||
124890353|NCT02268552|449220422|FG002|Part 2|Death|0|||
124890354|NCT02268552|449220423|FG003|Part 2|Death|0|||
124890355|NCT02268552|449220424|FG004|Part 2|Death|0|||
124890356|NCT02268552|449220425|FG005|Part 2|Death|0|||
124890357|NCT02268552|449220426|FG006|Part 2|Death|2|||
124890358|NCT02268552|449220420|FG000|Part 2|Subject/guardian decision|0|||
124890359|NCT02268552|449220421|FG001|Part 2|Subject/guardian decision|0|||
124890360|NCT02268552|449220422|FG002|Part 2|Subject/guardian decision|0|||
124890361|NCT02268552|449220423|FG003|Part 2|Subject/guardian decision|0|||
124890362|NCT02268552|449220424|FG004|Part 2|Subject/guardian decision|0|||
124890363|NCT02268552|449220425|FG005|Part 2|Subject/guardian decision|0|||
124890364|NCT02268552|449220426|FG006|Part 2|Subject/guardian decision|1|||
124890365|NCT02268552|449220420|FG000|Part 3 Extension|Death|0|||
124890366|NCT02268552|449220421|FG001|Part 3 Extension|Death|1|||
124890367|NCT02268552|449220422|FG002|Part 3 Extension|Death|1|||
124890368|NCT02268552|449220423|FG003|Part 3 Extension|Death|1|||
124759241|NCT01329978|448742580|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
124890369|NCT02268552|449220424|FG004|Part 3 Extension|Death|1|||
124890370|NCT02268552|449220425|FG005|Part 3 Extension|Death|1|||
124890371|NCT02268552|449220426|FG006|Part 3 Extension|Death|0|||
124890372|NCT02268552|449220420|FG000|Part 3 Extension|Early termination of trial|1|||
124890373|NCT02268552|449220421|FG001|Part 3 Extension|Early termination of trial|0|||
124890374|NCT02268552|449220422|FG002|Part 3 Extension|Early termination of trial|0|||
124890375|NCT02268552|449220423|FG003|Part 3 Extension|Early termination of trial|0|||
124686505|NCT02101853|448471291|FG001|Post Induction Randomization|Protocol Violation|3|||
124686506|NCT02101853|448471292|FG002|Post Induction Randomization|Protocol Violation|0|||
124686507|NCT02101853|448471293|FG003|Post Induction Randomization|Protocol Violation|0|||
124686508|NCT02101853|448471294|FG004|Post Induction Randomization|Protocol Violation|0|||
124686509|NCT02101853|448471295|FG005|Post Induction Randomization|Protocol Violation|0|||
124686510|NCT02101853|448471290|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
124686511|NCT02101853|448471291|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
124686512|NCT02101853|448471292|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
124686513|NCT02101853|448471293|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
124686514|NCT02101853|448471294|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
124686515|NCT02101853|448471295|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
124686516|NCT02101853|448471290|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
124686517|NCT02101853|448471291|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
124686518|NCT02101853|448471292|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
124686519|NCT02101853|448471293|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
124686520|NCT02101853|448471294|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
124686521|NCT02101853|448471295|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
124686522|NCT02101853|448471290|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
124686523|NCT02101853|448471291|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
124686524|NCT02101853|448471292|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
124686525|NCT02101853|448471293|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
124686526|NCT02101853|448471294|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
124686527|NCT02101853|448471295|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
124686528|NCT02101853|448471290|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
124686529|NCT02101853|448471291|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
124686530|NCT02101853|448471292|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
124686531|NCT02101853|448471293|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
124686532|NCT02101853|448471294|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
124686533|NCT02101853|448471295|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
124686534|NCT02101853|448471290|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
124686535|NCT02101853|448471291|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
124686536|NCT02101853|448471292|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
124686537|NCT02101853|448471293|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
124686538|NCT02101853|448471294|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
124686539|NCT02101853|448471295|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
124686540|NCT02101853|448471290|FG000|Blinatumomab Salvage Therapy|Death|0|||
124686541|NCT02101853|448471291|FG001|Blinatumomab Salvage Therapy|Death|0|||
124686542|NCT02101853|448471292|FG002|Blinatumomab Salvage Therapy|Death|0|||
124686543|NCT02101853|448471293|FG003|Blinatumomab Salvage Therapy|Death|0|||
124686544|NCT02101853|448471294|FG004|Blinatumomab Salvage Therapy|Death|0|||
124686545|NCT02101853|448471295|FG005|Blinatumomab Salvage Therapy|Death|2|||
124686546|NCT02101853|448471290|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
124686547|NCT02101853|448471291|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
124686548|NCT02101853|448471292|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
124686549|NCT02101853|448471293|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
124686550|NCT02101853|448471294|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
124686551|NCT02101853|448471295|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
124686552|NCT02101853|448471290|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
124686553|NCT02101853|448471291|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
124686554|NCT02101853|448471292|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
124686555|NCT02101853|448471293|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
124686556|NCT02101853|448471294|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
124686557|NCT02101853|448471295|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
124686558|NCT02101853|448471290|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
124686559|NCT02101853|448471291|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
124686560|NCT02101853|448471292|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
124686561|NCT02101853|448471293|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
124441883|NCT02146326|447577828|FG002|Overall Study|Incarcerated|3|||
124686562|NCT02101853|448471294|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
124686563|NCT02101853|448471295|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
124686564|NCT04409002|448471296|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
124686565|NCT04835441|448471297|FG000|Overall Study|Physician Decision|4|||
124686566|NCT04835441|448471298|FG001|Overall Study|Physician Decision|4|||
124686567|NCT04835441|448471297|FG000|Overall Study|Other|1|||
124686568|NCT04835441|448471298|FG001|Overall Study|Other|1|||
124686569|NCT04835441|448471297|FG000|Overall Study|Lost to Follow-up|0|||
124686570|NCT04835441|448471298|FG001|Overall Study|Lost to Follow-up|1|||
124686571|NCT04132050|448472112|FG000|Period I (Double-blind Period)|Adverse Event|3|||
124686572|NCT04132050|448472113|FG001|Period I (Double-blind Period)|Adverse Event|0|||
124686573|NCT04132050|448472112|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
124686574|NCT04132050|448472113|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
124686575|NCT04132050|448472112|FG000|R788 Treatment Period|Adverse Event|5|||
124686576|NCT04132050|448472113|FG001|R788 Treatment Period|Adverse Event|0|||
124686577|NCT04132050|448472112|FG000|R788 Treatment Period|Lack of Efficacy|5|||
124686578|NCT04132050|448472113|FG001|R788 Treatment Period|Lack of Efficacy|0|||
124686579|NCT04132050|448472112|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
124686580|NCT04132050|448472113|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
124686581|NCT03168672|448472114|FG000|Overall Study|Withdrawal by Subject|13|||
124890376|NCT02268552|449220424|FG004|Part 3 Extension|Early termination of trial|2|||
124890377|NCT02268552|449220425|FG005|Part 3 Extension|Early termination of trial|9|||
124890378|NCT02268552|449220426|FG006|Part 3 Extension|Early termination of trial|11|||
124890379|NCT02268552|449220420|FG000|Part 3 Extension|Subject/guardian decision|0|||
124890380|NCT02268552|449220421|FG001|Part 3 Extension|Subject/guardian decision|0|||
124890381|NCT02268552|449220422|FG002|Part 3 Extension|Subject/guardian decision|0|||
124890382|NCT02268552|449220423|FG003|Part 3 Extension|Subject/guardian decision|0|||
124890383|NCT02268552|449220424|FG004|Part 3 Extension|Subject/guardian decision|0|||
124890384|NCT02268552|449220425|FG005|Part 3 Extension|Subject/guardian decision|0|||
124890385|NCT02268552|449220426|FG006|Part 3 Extension|Subject/guardian decision|1|||
124890386|NCT03415022|449220429|FG000|Overall Study|Withdrawal by Subject|1|||
124890387|NCT03415022|449220430|FG001|Overall Study|Withdrawal by Subject|2|||
124890388|NCT03415022|449220429|FG000|Overall Study|COVID-19 Suspension|2|||
124890389|NCT03415022|449220430|FG001|Overall Study|COVID-19 Suspension|3|||
124890390|NCT03415022|449220429|FG000|Overall Study|Lost to Follow-up|2|||
124890391|NCT03415022|449220430|FG001|Overall Study|Lost to Follow-up|0|||
124890392|NCT04466618|449220431|FG000|Overall Study|Withdrawal by Subject|0|||
124890393|NCT04466618|449220432|FG001|Overall Study|Withdrawal by Subject|1|||
124890394|NCT01676220|449220434|FG000|Overall Study|Randomized But Not Treated|4|||
124890395|NCT01676220|449220435|FG001|Overall Study|Randomized But Not Treated|1|||
124890396|NCT01676220|449220434|FG000|Overall Study|Adverse Event|10|||
124890397|NCT01676220|449220435|FG001|Overall Study|Adverse Event|8|||
124890398|NCT01676220|449220434|FG000|Overall Study|Lack of Efficacy|2|||
124890399|NCT01676220|449220435|FG001|Overall Study|Lack of Efficacy|5|||
124890400|NCT01676220|449220434|FG000|Overall Study|Protocol Violation|11|||
124890401|NCT01676220|449220435|FG001|Overall Study|Protocol Violation|12|||
124890402|NCT01676220|449220434|FG000|Overall Study|Received Rescue Therapy|14|||
124890403|NCT01676220|449220435|FG001|Overall Study|Received Rescue Therapy|22|||
124890404|NCT01676220|449220434|FG000|Overall Study|Personal Reason|34|||
124890405|NCT01676220|449220435|FG001|Overall Study|Personal Reason|45|||
124890406|NCT01676220|449220434|FG000|Overall Study|Lost to Follow-up|11|||
124890407|NCT01676220|449220435|FG001|Overall Study|Lost to Follow-up|18|||
124890408|NCT01676220|449220434|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
124890409|NCT01676220|449220435|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
124890410|NCT01676220|449220434|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
124890411|NCT01676220|449220435|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
124890412|NCT01676220|449220434|FG000|Overall Study|Perceived Lack of Efficacy|3|||
124890413|NCT01676220|449220435|FG001|Overall Study|Perceived Lack of Efficacy|1|||
124890414|NCT01676220|449220434|FG000|Overall Study|Non Serious Hypoglycemia|2|||
124890415|NCT01676220|449220435|FG001|Overall Study|Non Serious Hypoglycemia|0|||
124890416|NCT01676220|449220434|FG000|Overall Study|No More Need of Insulin|1|||
124890417|NCT01676220|449220435|FG001|Overall Study|No More Need of Insulin|0|||
124890418|NCT04496167|449220436|FG000|Overall Study|Adverse Event|6|||
124890419|NCT04496167|449220437|FG001|Overall Study|Adverse Event|2|||
124890420|NCT04496167|449220436|FG000|Overall Study|Withdrawal by Subject|7|||
124890421|NCT04496167|449220437|FG001|Overall Study|Withdrawal by Subject|6|||
124890422|NCT04496167|449220436|FG000|Overall Study|Lost to Follow-up|3|||
124890423|NCT04496167|449220437|FG001|Overall Study|Lost to Follow-up|5|||
124890424|NCT04496167|449220436|FG000|Overall Study|Not Treated|1|||
124890425|NCT04496167|449220437|FG001|Overall Study|Not Treated|2|||
124441884|NCT02146326|447577829|FG003|Overall Study|Incarcerated|8|||
124890426|NCT04496167|449220436|FG000|Overall Study|Other Than Specified|1|||
124890427|NCT04496167|449220437|FG001|Overall Study|Other Than Specified|1|||
124890428|NCT02269943|449220438|FG000|Treatment Period|Death|0|||
124890429|NCT02269943|449220439|FG001|Treatment Period|Death|1|||
124890430|NCT02269943|449220438|FG000|Treatment Period|Adverse Event|1|||
124890431|NCT02269943|449220439|FG001|Treatment Period|Adverse Event|10|||
124890432|NCT02269943|449220438|FG000|Treatment Period|Progressive Disease|5|||
124890433|NCT02269943|449220439|FG001|Treatment Period|Progressive Disease|17|||
124890434|NCT02269943|449220438|FG000|Treatment Period|Symptomatic Deterioration|0|||
124890435|NCT02269943|449220439|FG001|Treatment Period|Symptomatic Deterioration|2|||
124890436|NCT02269943|449220438|FG000|Follow-Up Survival Period|Death|3|||
124890437|NCT02269943|449220439|FG001|Follow-Up Survival Period|Death|16|||
124890438|NCT02269943|449220438|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
124890439|NCT02269943|449220439|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
124890440|NCT02269943|449220438|FG000|Follow-Up Survival Period|Alive|2|||
124890441|NCT02269943|449220439|FG001|Follow-Up Survival Period|Alive|8|||
124890442|NCT03541642|449220440|FG000|Overall Study|Withdrawal by Subject|1|||
124890443|NCT03541642|449220441|FG001|Overall Study|Withdrawal by Subject|2|||
124890444|NCT03541642|449220440|FG000|Overall Study|Lost to Follow-up|16|||
124890445|NCT03541642|449220441|FG001|Overall Study|Lost to Follow-up|12|||
124890446|NCT03541642|449220440|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
124890447|NCT03541642|449220441|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
124890448|NCT00873093|449220448|FG000|Overall Study|Adverse Event|0|||
124890449|NCT00873093|449220449|FG001|Overall Study|Adverse Event|2|||
124890450|NCT00873093|449220450|FG002|Overall Study|Adverse Event|0|||
124890451|NCT00873093|449220451|FG003|Overall Study|Adverse Event|0|||
124890452|NCT00873093|449220452|FG004|Overall Study|Adverse Event|0|||
124890453|NCT00873093|449220448|FG000|Overall Study|Death|0|||
124890454|NCT00873093|449220449|FG001|Overall Study|Death|3|||
124890455|NCT00873093|449220450|FG002|Overall Study|Death|2|||
124890456|NCT00873093|449220451|FG003|Overall Study|Death|0|||
124890457|NCT00873093|449220452|FG004|Overall Study|Death|0|||
124890458|NCT00873093|449220448|FG000|Overall Study|Physician Decision|0|||
124890459|NCT00873093|449220449|FG001|Overall Study|Physician Decision|17|||
124890460|NCT00873093|449220450|FG002|Overall Study|Physician Decision|10|||
124890461|NCT00873093|449220451|FG003|Overall Study|Physician Decision|10|||
124890462|NCT00873093|449220452|FG004|Overall Study|Physician Decision|2|||
124890463|NCT00873093|449220448|FG000|Overall Study|Withdrawal by Subject|1|||
124890464|NCT00873093|449220449|FG001|Overall Study|Withdrawal by Subject|4|||
124890465|NCT00873093|449220450|FG002|Overall Study|Withdrawal by Subject|4|||
124890466|NCT00873093|449220451|FG003|Overall Study|Withdrawal by Subject|0|||
124890467|NCT00873093|449220452|FG004|Overall Study|Withdrawal by Subject|0|||
124890468|NCT00873093|449220448|FG000|Overall Study|Ineligible|0|||
124890469|NCT00873093|449220449|FG001|Overall Study|Ineligible|1|||
124890470|NCT00873093|449220450|FG002|Overall Study|Ineligible|0|||
124890471|NCT00873093|449220451|FG003|Overall Study|Ineligible|1|||
124890472|NCT00873093|449220452|FG004|Overall Study|Ineligible|0|||
124890473|NCT00136916|449220453|FG000|Overall Study|Never received study treatment|3|||
124890474|NCT00136916|449220454|FG001|Overall Study|Never received study treatment|5|||
124890475|NCT00136916|449220453|FG000|Overall Study|Death|1|||
124890476|NCT00136916|449220454|FG001|Overall Study|Death|3|||
124890477|NCT00136916|449220453|FG000|Overall Study|Adverse Event|27|||
124890478|NCT00136916|449220454|FG001|Overall Study|Adverse Event|8|||
124890479|NCT00136916|449220453|FG000|Overall Study|Laboratory abnormality|0|||
124890480|NCT00136916|449220454|FG001|Overall Study|Laboratory abnormality|1|||
124890481|NCT00136916|449220453|FG000|Overall Study|Lack of Efficacy|13|||
124890482|NCT00136916|449220454|FG001|Overall Study|Lack of Efficacy|3|||
124890483|NCT00136916|449220453|FG000|Overall Study|Lost to Follow-up|12|||
124890484|NCT00136916|449220454|FG001|Overall Study|Lost to Follow-up|14|||
124890485|NCT00136916|449220453|FG000|Overall Study|Withdrawal by Subject|44|||
124441885|NCT02146326|447577826|FG000|Overall Study|Death|0|||
124441886|NCT02146326|447577827|FG001|Overall Study|Death|0|||
124441887|NCT02146326|447577828|FG002|Overall Study|Death|4|||
124441888|NCT02146326|447577829|FG003|Overall Study|Death|4|||
124441889|NCT02146326|447577826|FG000|Overall Study|Unable to complete interview|0|||
124890486|NCT00136916|449220454|FG001|Overall Study|Withdrawal by Subject|46|||
124890487|NCT00136916|449220453|FG000|Overall Study|Other|22|||
124890488|NCT00136916|449220454|FG001|Overall Study|Other|24|||
124890489|NCT00136916|449220453|FG000|Overall Study|Discontinued in follow up period|3|||
124890490|NCT00136916|449220454|FG001|Overall Study|Discontinued in follow up period|0|||
124890491|NCT04242875|449220457|FG000|Overall Study|Adverse Event|2|||
124890492|NCT04172987|449220458|FG000|Lead In Period|Adverse Event|1|||
124890493|NCT04172987|449220458|FG000|Lead In Period|Protocol Violation|1|||
124890494|NCT04172987|449220458|FG000|Period 1|Physician Decision|1|||
124890495|NCT04172987|449220458|FG000|Period 2|Adverse Event|5|||
124890496|NCT04172987|449220458|FG000|Period 2|Dosing Termination by Sponsor|4|||
124890497|NCT04179461|449220459|FG000|Overall Study|Lost to Follow-up|4|||
124441890|NCT02146326|447577827|FG001|Overall Study|Unable to complete interview|0|||
124890498|NCT03285711|449220460|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
124890499|NCT03285711|449220461|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
124890500|NCT03285711|449220462|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
124890501|NCT03285711|449220463|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
124890502|NCT03285711|449220460|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
124890503|NCT03285711|449220461|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
124890504|NCT03285711|449220462|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
124890505|NCT03285711|449220463|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
124890506|NCT03285711|449220460|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
124890507|NCT03285711|449220461|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
124890508|NCT03285711|449220462|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
124890509|NCT03285711|449220463|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
124890510|NCT03285711|449220460|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
124890511|NCT03285711|449220461|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
124890512|NCT03285711|449220462|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
124890513|NCT03285711|449220463|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
124890514|NCT02431533|449220468|FG000|Overall Study|Withdrawal by Subject|1|||
124890515|NCT02431533|449220469|FG001|Overall Study|Withdrawal by Subject|3|||
124890516|NCT02431533|449220468|FG000|Overall Study|Developed Exclusionary criteria|1|||
124890517|NCT02431533|449220469|FG001|Overall Study|Developed Exclusionary criteria|0|||
124890518|NCT02107443|449220470|FG000|Overall Study|Death|42|||
124890519|NCT02107443|449220471|FG001|Overall Study|Death|30|||
124890520|NCT02107443|449220470|FG000|Overall Study|Study Protocol Violation|3|||
124890521|NCT02107443|449220471|FG001|Overall Study|Study Protocol Violation|1|||
124890522|NCT02107443|449220470|FG000|Overall Study|Registered but Not Eligible|0|||
124890523|NCT02107443|449220471|FG001|Overall Study|Registered but Not Eligible|1|||
124890524|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
124890525|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
124890526|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
124890527|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
124890528|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Changed Mind|2|||
124890529|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Changed Mind|0|||
124890530|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
124890531|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
124890532|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
124890533|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
124890534|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
124890535|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
124890536|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
124890537|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
124890538|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Other Medical|9|||
124890539|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Other Medical|5|||
124890540|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Disease Progression|4|||
124890541|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Disease Progression|2|||
124890542|NCT02107443|449220470|FG000|Overall Study|Withdrawal: Personal Issues|0|||
124890543|NCT02107443|449220471|FG001|Overall Study|Withdrawal: Personal Issues|3|||
124890544|NCT01513967|449220473|FG000|Overall Study|Pregnancy|0|||
124890545|NCT01513967|449220474|FG001|Overall Study|Pregnancy|0|||
124890546|NCT01513967|449220475|FG002|Overall Study|Pregnancy|0|||
124890547|NCT01513967|449220476|FG003|Overall Study|Pregnancy|0|||
124890548|NCT01513967|449220477|FG004|Overall Study|Pregnancy|0|||
124890549|NCT01513967|449220478|FG005|Overall Study|Pregnancy|0|||
124441891|NCT02146326|447577828|FG002|Overall Study|Unable to complete interview|10|||
124441892|NCT02146326|447577829|FG003|Overall Study|Unable to complete interview|6|||
124441893|NCT01340651|447577830|FG000|Overall Study|Adverse Event|3|||
124441894|NCT01340651|447577830|FG000|Overall Study|Consent Withdrawn|2|||
124441895|NCT01340651|447577830|FG000|Overall Study|Commercial Supply per Sponsor|12|||
124441896|NCT00171704|447579961|FG000|Overall Study|Adverse Event|24|||
124890550|NCT01513967|449220479|FG006|Overall Study|Pregnancy|1|||
124890551|NCT01513967|449220480|FG007|Overall Study|Pregnancy|0|||
124890552|NCT01513967|449220473|FG000|Overall Study|missed a study visit|0|||
124890553|NCT01513967|449220474|FG001|Overall Study|missed a study visit|0|||
124890554|NCT01513967|449220475|FG002|Overall Study|missed a study visit|0|||
124890555|NCT01513967|449220476|FG003|Overall Study|missed a study visit|0|||
124890556|NCT01513967|449220477|FG004|Overall Study|missed a study visit|0|||
124890557|NCT01513967|449220478|FG005|Overall Study|missed a study visit|0|||
124890558|NCT01513967|449220479|FG006|Overall Study|missed a study visit|1|||
124890559|NCT01513967|449220480|FG007|Overall Study|missed a study visit|0|||
124890560|NCT01513967|449220473|FG000|Overall Study|excluded due to positive drug screen|0|||
124890561|NCT01513967|449220474|FG001|Overall Study|excluded due to positive drug screen|0|||
124890562|NCT01513967|449220475|FG002|Overall Study|excluded due to positive drug screen|0|||
124890563|NCT01513967|449220476|FG003|Overall Study|excluded due to positive drug screen|0|||
124890564|NCT01513967|449220477|FG004|Overall Study|excluded due to positive drug screen|0|||
124890565|NCT01513967|449220478|FG005|Overall Study|excluded due to positive drug screen|0|||
124890566|NCT01513967|449220479|FG006|Overall Study|excluded due to positive drug screen|0|||
124890567|NCT01513967|449220480|FG007|Overall Study|excluded due to positive drug screen|2|||
124890568|NCT01513967|449220473|FG000|Overall Study|Physician Decision|0|||
124890569|NCT01513967|449220474|FG001|Overall Study|Physician Decision|0|||
124890570|NCT01513967|449220475|FG002|Overall Study|Physician Decision|0|||
124890571|NCT01513967|449220476|FG003|Overall Study|Physician Decision|0|||
124890572|NCT01513967|449220477|FG004|Overall Study|Physician Decision|0|||
124890573|NCT01513967|449220478|FG005|Overall Study|Physician Decision|1|||
124890574|NCT01513967|449220479|FG006|Overall Study|Physician Decision|0|||
124890575|NCT01513967|449220480|FG007|Overall Study|Physician Decision|0|||
124890576|NCT02906202|449220481|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
124890577|NCT01563978|449220485|FG000|Overall Study|Physician Decision|1|||
124890578|NCT01563978|449220486|FG001|Overall Study|Physician Decision|0|||
124890579|NCT01563978|449220485|FG000|Overall Study|Lost to Follow-up|1|||
124890580|NCT01563978|449220486|FG001|Overall Study|Lost to Follow-up|0|||
124890581|NCT01563978|449220485|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
124890582|NCT01563978|449220486|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
124890583|NCT01563978|449220485|FG000|Overall Study|Adverse Event|1|||
124890584|NCT01563978|449220486|FG001|Overall Study|Adverse Event|2|||
124890585|NCT00729690|449220487|FG000|Overall Study|IT Catheter Malfunction|0|||
124441897|NCT00171704|447579962|FG001|Overall Study|Adverse Event|33|||
124441898|NCT00171704|447579961|FG000|Overall Study|Disease Progression|14|||
124441899|NCT00171704|447579962|FG001|Overall Study|Disease Progression|9|||
124441900|NCT00171704|447579961|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
124890586|NCT00729690|449220488|FG001|Overall Study|IT Catheter Malfunction|2|||
124890587|NCT00729690|449220489|FG002|Overall Study|IT Catheter Malfunction|2|||
124441901|NCT00171704|447579962|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
124441902|NCT00171704|447579961|FG000|Overall Study|Administrative Problems|2|||
124441903|NCT00171704|447579962|FG001|Overall Study|Administrative Problems|1|||
124441904|NCT00171704|447579961|FG000|Overall Study|Death|2|||
124441905|NCT00171704|447579962|FG001|Overall Study|Death|2|||
124441906|NCT00171704|447579961|FG000|Overall Study|Withdrawal by Subject|1|||
124441907|NCT00171704|447579962|FG001|Overall Study|Withdrawal by Subject|3|||
124441908|NCT00171704|447579961|FG000|Overall Study|Protocol Violation|0|||
124441909|NCT00171704|447579962|FG001|Overall Study|Protocol Violation|1|||
124441910|NCT01101477|447579963|FG000|Overall Study|Protocol Violation|5|||
124441911|NCT01101477|447579964|FG001|Overall Study|Protocol Violation|3|||
124441912|NCT01101477|447579965|FG002|Overall Study|Protocol Violation|1|||
124441913|NCT02141984|447579966|FG000|Overall Study|Lack of Efficacy|2|||
124441914|NCT00816400|447579970|FG000|Overall Study|Death|2|||
124441915|NCT00816400|447579971|FG001|Overall Study|Death|3|||
124441916|NCT00816400|447579972|FG002|Overall Study|Death|3|||
124441917|NCT00816400|447579973|FG003|Overall Study|Death|3|||
124441918|NCT00816400|447579974|FG004|Overall Study|Death|2|||
124441919|NCT00816400|447579975|FG005|Overall Study|Death|3|||
124441920|NCT00816400|447579976|FG006|Overall Study|Death|2|||
124441921|NCT00816400|447579977|FG007|Overall Study|Death|5|||
124441922|NCT00816400|447579978|FG008|Overall Study|Death|6|||
124441923|NCT00816400|447579970|FG000|Overall Study|In hospice care at the end of the study|0|||
124441924|NCT00816400|447579971|FG001|Overall Study|In hospice care at the end of the study|0|||
124441925|NCT00816400|447579972|FG002|Overall Study|In hospice care at the end of the study|2|||
124441926|NCT00816400|447579973|FG003|Overall Study|In hospice care at the end of the study|0|||
124441927|NCT00816400|447579974|FG004|Overall Study|In hospice care at the end of the study|0|||
124890588|NCT04562779|449220492|FG000|Overall Study|Lost to Follow-up|7|||
124890589|NCT04562779|449220493|FG001|Overall Study|Lost to Follow-up|5|||
124890590|NCT04562779|449220494|FG002|Overall Study|Lost to Follow-up|10|||
124890591|NCT04562779|449220492|FG000|Overall Study|Protocol Violation|2|||
124890592|NCT04562779|449220493|FG001|Overall Study|Protocol Violation|2|||
124441928|NCT00816400|447579975|FG005|Overall Study|In hospice care at the end of the study|0|||
124441929|NCT00816400|447579976|FG006|Overall Study|In hospice care at the end of the study|0|||
124441930|NCT00816400|447579977|FG007|Overall Study|In hospice care at the end of the study|0|||
124441931|NCT00816400|447579978|FG008|Overall Study|In hospice care at the end of the study|0|||
124441932|NCT00601419|447579979|FG000|Overall Study|Lost to Follow-up|3|||
124441933|NCT00601419|447579979|FG000|Overall Study|Missed Visits|1|||
124441934|NCT01614197|447579980|FG000|Overall Study|Withdrawal by Subject|0|||
124441935|NCT01614197|447579981|FG001|Overall Study|Withdrawal by Subject|1|||
124466430|NCT01414257|447666398|FG000|Overall Study|Protocol Violation|10|||
124890593|NCT04562779|449220494|FG002|Overall Study|Protocol Violation|0|||
124890594|NCT00333138|449220495|FG000|Core Study (6 Months)|Adverse Event|4|||
124890595|NCT00333138|449220496|FG001|Core Study (6 Months)|Adverse Event|5|||
124890596|NCT00333138|449220497|FG002|Core Study (6 Months)|Adverse Event|8|||
124890597|NCT00333138|449220495|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
124890598|NCT00333138|449220496|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
124890599|NCT00333138|449220497|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
124890600|NCT00333138|449220495|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
124890601|NCT00333138|449220496|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
124890602|NCT00333138|449220497|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
124890603|NCT00333138|449220495|FG000|Core Study (6 Months)|Protocol Violation|1|||
124890604|NCT00333138|449220496|FG001|Core Study (6 Months)|Protocol Violation|0|||
124890605|NCT00333138|449220497|FG002|Core Study (6 Months)|Protocol Violation|1|||
124890606|NCT00333138|449220495|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
124890607|NCT00333138|449220496|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
124890608|NCT00333138|449220497|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
124890609|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
124890610|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
124890611|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
124890612|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
124890613|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
124890614|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
124890615|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
124890616|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
124890617|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
124890618|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
124890619|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
124890620|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
124890621|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
124890622|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
124890623|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
124890624|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
124890625|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
124890626|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
124890627|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
124890628|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
124890629|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
124890630|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
124890631|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
124890632|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
124890633|NCT00333138|449220495|FG000|Extension Study (Month6 to End of Study)|Death|0|||
124890634|NCT00333138|449220496|FG001|Extension Study (Month6 to End of Study)|Death|1|||
124890635|NCT00333138|449220497|FG002|Extension Study (Month6 to End of Study)|Death|0|||
124890636|NCT05593211|449220498|FG000|Overall Study|Withdrawal by Subject|1|||
124890637|NCT03077620|449220502|FG000|Overall Study|Unable to place lumbar catheter|1|||
124890638|NCT03077620|449220503|FG001|Overall Study|Unable to place lumbar catheter|0|||
124890639|NCT03077620|449220504|FG002|Overall Study|Unable to place lumbar catheter|1|||
124890640|NCT03077620|449220505|FG003|Overall Study|Unable to place lumbar catheter|0|||
124686582|NCT03168672|448472114|FG000|Overall Study|Death|3|||
124686583|NCT03168672|448472114|FG000|Overall Study|Investigator's Decision|137|||
124686584|NCT03168672|448472114|FG000|Overall Study|Adverse Event|1|||
124686585|NCT03168672|448472114|FG000|Overall Study|Other|2|||
124686586|NCT03168672|448472114|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
124890641|NCT03077620|449220502|FG000|Overall Study|Withdrawal by Subject|0|||
124890642|NCT03077620|449220503|FG001|Overall Study|Withdrawal by Subject|1|||
124890643|NCT03077620|449220504|FG002|Overall Study|Withdrawal by Subject|0|||
124890644|NCT03077620|449220505|FG003|Overall Study|Withdrawal by Subject|0|||
124890645|NCT03077620|449220502|FG000|Overall Study|Physician Decision|0|||
124890646|NCT03077620|449220503|FG001|Overall Study|Physician Decision|0|||
124686587|NCT03506477|448472115|FG000|Overall Study|Withdrawal by Subject|1|||
124686588|NCT03506477|448472116|FG001|Overall Study|Withdrawal by Subject|0|||
124890647|NCT03077620|449220504|FG002|Overall Study|Physician Decision|1|||
124890648|NCT03077620|449220505|FG003|Overall Study|Physician Decision|0|||
124890649|NCT03225846|449220506|FG000|Overall Study|Adverse Event|0|||
124890650|NCT03225846|449220507|FG001|Overall Study|Adverse Event|0|||
124890651|NCT03225846|449220508|FG002|Overall Study|Adverse Event|0|||
124890652|NCT03225846|449220509|FG003|Overall Study|Adverse Event|0|||
124890653|NCT03225846|449220510|FG004|Overall Study|Adverse Event|0|||
124890654|NCT03225846|449220511|FG005|Overall Study|Adverse Event|0|||
124890655|NCT03225846|449220512|FG006|Overall Study|Adverse Event|6|||
124890656|NCT03225846|449220506|FG000|Overall Study|Withdrawal by Subject|0|||
124890657|NCT03225846|449220507|FG001|Overall Study|Withdrawal by Subject|1|||
124890658|NCT03225846|449220508|FG002|Overall Study|Withdrawal by Subject|0|||
124890659|NCT03225846|449220509|FG003|Overall Study|Withdrawal by Subject|0|||
124890660|NCT03225846|449220510|FG004|Overall Study|Withdrawal by Subject|0|||
124890661|NCT03225846|449220511|FG005|Overall Study|Withdrawal by Subject|0|||
124890662|NCT03225846|449220512|FG006|Overall Study|Withdrawal by Subject|0|||
124890663|NCT03225846|449220506|FG000|Overall Study|Death|0|||
124890664|NCT03225846|449220507|FG001|Overall Study|Death|1|||
124890665|NCT03225846|449220508|FG002|Overall Study|Death|0|||
124890666|NCT03225846|449220509|FG003|Overall Study|Death|0|||
124890667|NCT03225846|449220510|FG004|Overall Study|Death|0|||
124890668|NCT03225846|449220511|FG005|Overall Study|Death|0|||
124890669|NCT03225846|449220512|FG006|Overall Study|Death|0|||
124890670|NCT03225846|449220506|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
124890671|NCT03225846|449220507|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
124890672|NCT03225846|449220508|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
124890673|NCT03225846|449220509|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
124890674|NCT03225846|449220510|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
124890675|NCT03225846|449220511|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
124890676|NCT03225846|449220512|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
124890677|NCT03225846|449220506|FG000|Overall Study|Patient decision|0|||
124890678|NCT03225846|449220507|FG001|Overall Study|Patient decision|0|||
124890679|NCT03225846|449220508|FG002|Overall Study|Patient decision|0|||
124890680|NCT03225846|449220509|FG003|Overall Study|Patient decision|0|||
124890681|NCT03225846|449220510|FG004|Overall Study|Patient decision|0|||
124441936|NCT01614197|447579982|FG002|Overall Study|Withdrawal by Subject|0|||
124441937|NCT01614197|447579983|FG003|Overall Study|Withdrawal by Subject|0|||
124441938|NCT01729156|447579986|FG000|Overall Study|Withdrawal by Subject|1|||
124441939|NCT01729156|447579987|FG001|Overall Study|Withdrawal by Subject|0|||
124441940|NCT01729156|447579988|FG002|Overall Study|Withdrawal by Subject|0|||
124441941|NCT04142450|447579989|FG000|Overall Study|Screen Failure|1|||
124441942|NCT04142450|447579989|FG000|Overall Study|Lost to Follow-up|1|||
124686589|NCT05436613|448472117|FG000|Overall Study|Lost to Follow-up|9|||
124686590|NCT05436613|448472117|FG000|Overall Study|Withdrawal by Subject|3|||
124686591|NCT00843882|448472118|FG000|Step 1|Lack of Efficacy|14|||
124686592|NCT00843882|448472119|FG001|Step 1|Lack of Efficacy|10|||
124686593|NCT00843882|448472120|FG002|Step 1|Lack of Efficacy|21|||
124441943|NCT03249714|447579990|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
124441944|NCT03249714|447579991|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
124441945|NCT03249714|447579990|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
124441946|NCT03249714|447579991|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
124441947|NCT03249714|447579990|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
124441948|NCT03249714|447579991|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
124441949|NCT03249714|447579990|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
124441950|NCT03249714|447579991|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
124441951|NCT01112306|447579992|FG000|Overall Study|Death|175|||
124441952|NCT01112306|447579992|FG000|Overall Study|Lost to Follow-up|9|||
124441953|NCT01112306|447579992|FG000|Overall Study|Withdrawal by Subject|31|||
124441954|NCT01112306|447579992|FG000|Overall Study|Other|70|||
124441955|NCT01607554|447579996|FG000|Overall Study|Disease progression|2|||
124441956|NCT03952806|447579997|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
124441957|NCT03952806|447579998|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
124441958|NCT03952806|447579997|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
124686594|NCT00843882|448472118|FG000|Step 1|Adverse Event|8|||
124441959|NCT03952806|447579998|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
124686595|NCT00843882|448472119|FG001|Step 1|Adverse Event|17|||
124466431|NCT01882907|447666400|FG000|Overall Study|Adverse Event|3|||
124890682|NCT03225846|449220511|FG005|Overall Study|Patient decision|0|||
124890683|NCT03225846|449220512|FG006|Overall Study|Patient decision|1|||
124890684|NCT00238420|449220513|FG000|Overall Study|Protocol Violation|1|||
124686596|NCT00843882|448472120|FG002|Step 1|Adverse Event|20|||
124686597|NCT00843882|448472118|FG000|Step 1|Death|1|||
124890685|NCT00238420|449220514|FG001|Overall Study|Protocol Violation|1|||
124890686|NCT02102464|449220517|FG000|Randomized Study|Withdrawal by Subject|0|||
124890687|NCT02102464|449220518|FG001|Randomized Study|Withdrawal by Subject|1|||
124890688|NCT02102464|449220519|FG002|Randomized Study|Withdrawal by Subject|0|||
124890689|NCT04140890|449220520|FG000|Overall Study|Withdrawal by Subject|0|||
124890690|NCT04140890|449220521|FG001|Overall Study|Withdrawal by Subject|1|||
124890691|NCT03958630|449220522|FG000|Overall Study|Withdrawal by Subject|0|||
124890692|NCT03958630|449220523|FG001|Overall Study|Withdrawal by Subject|0|||
124890693|NCT03958630|449220524|FG002|Overall Study|Withdrawal by Subject|1|||
124890694|NCT03958630|449220522|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
124890695|NCT03958630|449220523|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
124890696|NCT03958630|449220524|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
124890697|NCT00245011|449220527|FG000|Overall Study|Lack of Efficacy|1|||
124890698|NCT03040687|449220528|FG000|Overall Study|Withdrawal by Subject|1|||
124890699|NCT03040687|449220529|FG001|Overall Study|Withdrawal by Subject|0|||
124890700|NCT03040687|449220530|FG002|Overall Study|Withdrawal by Subject|0|||
124890701|NCT02325713|449220537|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890702|NCT02325713|449220538|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890703|NCT02325713|449220539|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890704|NCT02325713|449220540|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890705|NCT02325713|449220541|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890706|NCT02325713|449220542|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890707|NCT02325713|449220543|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890708|NCT02325713|449220544|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890709|NCT02325713|449220545|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890710|NCT02325713|449220546|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890711|NCT02325713|449220547|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
124890712|NCT02325713|449220548|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890713|NCT02325713|449220549|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890714|NCT02325713|449220550|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890715|NCT02325713|449220551|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890716|NCT02325713|449220552|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
124890717|NCT02325713|449220537|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
124890718|NCT02325713|449220538|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890719|NCT02325713|449220539|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890720|NCT02325713|449220540|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890721|NCT02325713|449220541|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890722|NCT02325713|449220542|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890723|NCT02325713|449220543|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890724|NCT02325713|449220544|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890725|NCT02325713|449220545|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890726|NCT02325713|449220546|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890727|NCT02325713|449220547|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890728|NCT02325713|449220548|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890729|NCT02325713|449220549|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890730|NCT02325713|449220550|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890731|NCT02325713|449220551|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890732|NCT02325713|449220552|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
124890733|NCT02325713|449220537|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890734|NCT02325713|449220538|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890735|NCT02325713|449220539|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890736|NCT02325713|449220540|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890737|NCT02325713|449220541|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890738|NCT02325713|449220542|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890739|NCT02325713|449220543|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890740|NCT02325713|449220544|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890741|NCT02325713|449220545|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890742|NCT02325713|449220546|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
124890743|NCT02325713|449220547|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124441960|NCT03952806|447579997|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
124466432|NCT01882907|447666401|FG001|Overall Study|Adverse Event|1|||
124890744|NCT02325713|449220548|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890745|NCT02325713|449220549|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890746|NCT02325713|449220550|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890747|NCT02325713|449220551|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890748|NCT02325713|449220552|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
124890749|NCT02353832|449220553|FG000|Overall Study|Ineligible after enrollment|1|||
124890750|NCT02353832|449220553|FG000|Overall Study|Lost to Follow-up|1|||
124890751|NCT00322868|449222545|FG000|Overall Study|disease progression|1|||
124890752|NCT00795132|449222555|FG000|Overall Study|Death|1|||
124890753|NCT00795132|449222555|FG000|Overall Study|Relapse|2|||
124890754|NCT01536262|449222556|FG000|Overall Study|Adverse Event|6|||
124890755|NCT01536262|449222557|FG001|Overall Study|Adverse Event|1|||
124890756|NCT01536262|449222558|FG002|Overall Study|Adverse Event|2|||
124890757|NCT01536262|449222556|FG000|Overall Study|Withdrawal by Subject|1|||
124890758|NCT01536262|449222557|FG001|Overall Study|Withdrawal by Subject|1|||
124890759|NCT01536262|449222558|FG002|Overall Study|Withdrawal by Subject|0|||
124890760|NCT01536262|449222556|FG000|Overall Study|Other than stated above|1|||
124890761|NCT01536262|449222557|FG001|Overall Study|Other than stated above|0|||
124890762|NCT01536262|449222558|FG002|Overall Study|Other than stated above|0|||
124890763|NCT01781611|449222562|FG000|Overall Study|Adverse Event|4|||
124890764|NCT01781611|449222563|FG001|Overall Study|Adverse Event|0|||
124890765|NCT03639675|449222564|FG000|Overall Study|Withdrawal by Subject|1|||
124890766|NCT02459587|449222565|FG000|3-Month Follow-up Assessment|Death|0|||
124890767|NCT02459587|449222566|FG001|3-Month Follow-up Assessment|Death|2|||
124890768|NCT02459587|449222565|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
124890769|NCT02459587|449222566|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
124890770|NCT02459587|449222565|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
124890771|NCT02459587|449222566|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
124890772|NCT02459587|449222565|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
124890773|NCT02459587|449222566|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
124890774|NCT02459587|449222565|FG000|6-month Follow-up Assessment|Death|2|||
124890775|NCT02459587|449222566|FG001|6-month Follow-up Assessment|Death|1|||
124890776|NCT02459587|449222565|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
124890777|NCT02459587|449222566|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
124890778|NCT02459587|449222565|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
124890779|NCT02459587|449222566|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
124890780|NCT02459587|449222565|FG000|12-month Follow-up Assessment|Death|2|||
124890781|NCT02459587|449222566|FG001|12-month Follow-up Assessment|Death|0|||
124890782|NCT02459587|449222565|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
124890783|NCT02459587|449222566|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
124890784|NCT02459587|449222565|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
124890785|NCT02459587|449222566|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
124890786|NCT02459587|449222565|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
124890787|NCT02459587|449222566|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
124890788|NCT02264574|449222567|FG000|Overall Study|Death|21|||
124890789|NCT02264574|449222568|FG001|Overall Study|Death|21|||
124890790|NCT02264574|449222567|FG000|Overall Study|Withdrawal by Subject|8|||
124890791|NCT02264574|449222568|FG001|Overall Study|Withdrawal by Subject|6|||
124890792|NCT02264574|449222567|FG000|Overall Study|Other, Not Specified|0|||
124890793|NCT02264574|449222568|FG001|Overall Study|Other, Not Specified|3|||
124890794|NCT01477749|449222570|FG000|Overall Study|Physician Decision|4|||
124890795|NCT02886728|449222573|FG000|Overall Study|Withdrew Consent|31|||
124890796|NCT02886728|449222574|FG001|Overall Study|Withdrew Consent|13|||
124890797|NCT02886728|449222575|FG002|Overall Study|Withdrew Consent|11|||
124890798|NCT02886728|449222576|FG003|Overall Study|Withdrew Consent|47|||
124890799|NCT02886728|449222573|FG000|Overall Study|Lost to Follow-up|12|||
124890800|NCT02886728|449222574|FG001|Overall Study|Lost to Follow-up|6|||
124441961|NCT03952806|447579998|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
124441962|NCT03952806|447579997|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
124441963|NCT03952806|447579998|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
124441964|NCT03952806|447579997|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
124441965|NCT03952806|447579998|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
124441966|NCT03952806|447579997|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
124441967|NCT03952806|447579998|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
124441968|NCT03952806|447579997|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
124441969|NCT03952806|447579998|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
124890801|NCT02886728|449222575|FG002|Overall Study|Lost to Follow-up|13|||
124890802|NCT02886728|449222576|FG003|Overall Study|Lost to Follow-up|12|||
124890803|NCT02886728|449222573|FG000|Overall Study|Adverse Event|13|||
124890804|NCT02886728|449222574|FG001|Overall Study|Adverse Event|5|||
124890805|NCT02886728|449222575|FG002|Overall Study|Adverse Event|5|||
124890806|NCT02886728|449222576|FG003|Overall Study|Adverse Event|11|||
124890807|NCT02886728|449222573|FG000|Overall Study|Investigator's Discretion|11|||
124890808|NCT02886728|449222574|FG001|Overall Study|Investigator's Discretion|7|||
124890809|NCT02886728|449222575|FG002|Overall Study|Investigator's Discretion|5|||
124890810|NCT02886728|449222576|FG003|Overall Study|Investigator's Discretion|11|||
124890811|NCT02886728|449222573|FG000|Overall Study|Death|3|||
124890812|NCT02886728|449222574|FG001|Overall Study|Death|1|||
124890813|NCT02886728|449222575|FG002|Overall Study|Death|0|||
124890814|NCT02886728|449222576|FG003|Overall Study|Death|0|||
124890815|NCT02886728|449222573|FG000|Overall Study|Protocol Violation|0|||
124890816|NCT02886728|449222574|FG001|Overall Study|Protocol Violation|0|||
124890817|NCT02886728|449222575|FG002|Overall Study|Protocol Violation|0|||
124890818|NCT02886728|449222576|FG003|Overall Study|Protocol Violation|4|||
124890819|NCT02886728|449222573|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124890820|NCT02886728|449222574|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124890821|NCT02886728|449222575|FG002|Overall Study|Non-Compliance with Study Drug|1|||
124890822|NCT02886728|449222576|FG003|Overall Study|Non-Compliance with Study Drug|0|||
124890823|NCT02886728|449222573|FG000|Overall Study|Pregnancy|0|||
124890824|NCT02886728|449222574|FG001|Overall Study|Pregnancy|0|||
124890825|NCT02886728|449222575|FG002|Overall Study|Pregnancy|1|||
124890826|NCT02886728|449222576|FG003|Overall Study|Pregnancy|0|||
124890827|NCT02886728|449222573|FG000|Overall Study|Randomized but Not Dosed|1|||
124890828|NCT02886728|449222574|FG001|Overall Study|Randomized but Not Dosed|0|||
124890829|NCT02886728|449222575|FG002|Overall Study|Randomized but Not Dosed|0|||
124890830|NCT02886728|449222576|FG003|Overall Study|Randomized but Not Dosed|2|||
124890831|NCT00884286|449222577|FG000|Overall Study|Progressive disease|21|||
124890832|NCT00884286|449222578|FG001|Overall Study|Progressive disease|28|||
124890833|NCT00884286|449222577|FG000|Overall Study|Toxicity|4|||
124890834|NCT00884286|449222578|FG001|Overall Study|Toxicity|1|||
124890835|NCT00884286|449222577|FG000|Overall Study|Death|2|||
124890836|NCT00884286|449222578|FG001|Overall Study|Death|2|||
124890837|NCT00884286|449222577|FG000|Overall Study|Physician Decision|1|||
124890838|NCT00884286|449222578|FG001|Overall Study|Physician Decision|0|||
124890839|NCT00884286|449222577|FG000|Overall Study|Septic shock|1|||
124890840|NCT00884286|449222578|FG001|Overall Study|Septic shock|0|||
124890841|NCT00884286|449222577|FG000|Overall Study|Thrombus in right auricle|1|||
124890842|NCT00884286|449222578|FG001|Overall Study|Thrombus in right auricle|0|||
124890843|NCT00884286|449222577|FG000|Overall Study|Not treated|2|||
124890844|NCT00884286|449222578|FG001|Overall Study|Not treated|1|||
124890845|NCT00884286|449222577|FG000|Overall Study|Comprised lung carcinoma|0|||
124890846|NCT00884286|449222578|FG001|Overall Study|Comprised lung carcinoma|1|||
124890847|NCT02118714|449222582|FG000|Overall Study|Lost to Follow-up|2|||
124890848|NCT02118714|449222582|FG000|Overall Study|Protocol Violation|1|||
124890849|NCT01310868|449222583|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
124890850|NCT02411591|449222584|FG000|Overall Study|Adverse Event|0|||
124890851|NCT02411591|449222585|FG001|Overall Study|Adverse Event|4|||
124890852|NCT02411591|449222586|FG002|Overall Study|Adverse Event|2|||
124890853|NCT02411591|449222584|FG000|Overall Study|Withdrawal by Subject|0|||
124890854|NCT02411591|449222585|FG001|Overall Study|Withdrawal by Subject|3|||
124890855|NCT02411591|449222586|FG002|Overall Study|Withdrawal by Subject|0|||
124890856|NCT02411591|449222584|FG000|Overall Study|Physician Decision|0|||
124890857|NCT02411591|449222585|FG001|Overall Study|Physician Decision|3|||
124890858|NCT02411591|449222586|FG002|Overall Study|Physician Decision|1|||
124890859|NCT04227340|449222587|FG000|Overall Study|Withdrawal by Subject|3|||
124890860|NCT01628874|449222588|FG000|Overall Study|Physician Decision|1|||
124890861|NCT01628874|449222589|FG001|Overall Study|Physician Decision|1|||
124890862|NCT01628874|449222588|FG000|Overall Study|Age >4 months|4|||
124890863|NCT01628874|449222589|FG001|Overall Study|Age >4 months|2|||
124890864|NCT03018106|449222590|FG000|Overall Study|Lost to Follow-up|0|||
124890865|NCT03018106|449222591|FG001|Overall Study|Lost to Follow-up|1|||
124890866|NCT03619174|449222592|FG000|Overall Study|Lost to Follow-up|3|||
124890867|NCT03619174|449222593|FG001|Overall Study|Lost to Follow-up|0|||
124890868|NCT03619174|449222592|FG000|Overall Study|Withdrawal by Subject|4|||
124890869|NCT03619174|449222593|FG001|Overall Study|Withdrawal by Subject|3|||
124890870|NCT03619174|449222592|FG000|Overall Study|Pregnancy|1|||
124890871|NCT03619174|449222593|FG001|Overall Study|Pregnancy|1|||
124890872|NCT03619174|449222592|FG000|Overall Study|Discomfort during treatment|1|||
124890873|NCT03619174|449222593|FG001|Overall Study|Discomfort during treatment|0|||
124890874|NCT03486899|449222594|FG000|Overall Study|Lost to Follow-up|4|||
124890875|NCT03486899|449222595|FG001|Overall Study|Lost to Follow-up|1|||
124890876|NCT03486899|449222596|FG002|Overall Study|Lost to Follow-up|4|||
124890877|NCT03486899|449222597|FG003|Overall Study|Lost to Follow-up|3|||
124890878|NCT03486899|449222594|FG000|Overall Study|Death|1|||
124890879|NCT03486899|449222595|FG001|Overall Study|Death|0|||
124890880|NCT03486899|449222596|FG002|Overall Study|Death|0|||
124890881|NCT03486899|449222597|FG003|Overall Study|Death|1|||
124890882|NCT03486899|449222594|FG000|Overall Study|Adverse Event|0|||
124890883|NCT03486899|449222595|FG001|Overall Study|Adverse Event|2|||
124890884|NCT03486899|449222596|FG002|Overall Study|Adverse Event|0|||
124890885|NCT03486899|449222597|FG003|Overall Study|Adverse Event|2|||
124890886|NCT03486899|449222594|FG000|Overall Study|Withdrawal by Subject|3|||
124890887|NCT03486899|449222595|FG001|Overall Study|Withdrawal by Subject|7|||
124890888|NCT03486899|449222596|FG002|Overall Study|Withdrawal by Subject|4|||
124890889|NCT03486899|449222597|FG003|Overall Study|Withdrawal by Subject|3|||
124890890|NCT03486899|449222594|FG000|Overall Study|Other Reasons|0|||
124890891|NCT03486899|449222595|FG001|Overall Study|Other Reasons|1|||
124890892|NCT03486899|449222596|FG002|Overall Study|Other Reasons|0|||
124890893|NCT03486899|449222597|FG003|Overall Study|Other Reasons|1|||
124890894|NCT01010217|449222598|FG000|Overall Study|Lost to Follow-up|4|||
124890895|NCT01010217|449222599|FG001|Overall Study|Lost to Follow-up|5|||
124890896|NCT01010217|449222600|FG002|Overall Study|Lost to Follow-up|1|||
124890897|NCT01010217|449222601|FG003|Overall Study|Lost to Follow-up|0|||
124890898|NCT01010217|449222602|FG004|Overall Study|Lost to Follow-up|0|||
124890899|NCT01010217|449222598|FG000|Overall Study|Withdrawal by Subject|1|||
124890900|NCT01010217|449222599|FG001|Overall Study|Withdrawal by Subject|0|||
124890901|NCT01010217|449222600|FG002|Overall Study|Withdrawal by Subject|0|||
124890902|NCT01010217|449222601|FG003|Overall Study|Withdrawal by Subject|0|||
124890903|NCT01010217|449222602|FG004|Overall Study|Withdrawal by Subject|0|||
124890904|NCT01010217|449222598|FG000|Overall Study|Physician Decision|0|||
124890905|NCT01010217|449222599|FG001|Overall Study|Physician Decision|0|||
124890906|NCT01010217|449222600|FG002|Overall Study|Physician Decision|0|||
124890907|NCT01010217|449222601|FG003|Overall Study|Physician Decision|6|||
124890908|NCT01010217|449222602|FG004|Overall Study|Physician Decision|3|||
124890909|NCT01782326|449222604|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
124890910|NCT01782326|449222605|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
124890911|NCT01782326|449222604|FG000|Planned Treatment Epoch|Death|29|||
124890912|NCT01782326|449222605|FG001|Planned Treatment Epoch|Death|30|||
124890913|NCT01782326|449222604|FG000|Planned Treatment Epoch|Physician Decision|18|||
124890914|NCT01782326|449222605|FG001|Planned Treatment Epoch|Physician Decision|16|||
124890915|NCT01782326|449222604|FG000|Planned Treatment Epoch|Protocol deviation|2|||
124890916|NCT01782326|449222605|FG001|Planned Treatment Epoch|Protocol deviation|3|||
124890917|NCT01782326|449222604|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
124890918|NCT01782326|449222605|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
124890919|NCT01782326|449222604|FG000|Planned Treatment Epoch|Technical problems|0|||
124890920|NCT01782326|449222605|FG001|Planned Treatment Epoch|Technical problems|4|||
124890921|NCT01782326|449222604|FG000|Double-blind Treatment|Adverse Event|129|||
124890922|NCT01782326|449222605|FG001|Double-blind Treatment|Adverse Event|145|||
124890923|NCT01782326|449222604|FG000|Double-blind Treatment|Subject/guardian decision|111|||
124890924|NCT01782326|449222605|FG001|Double-blind Treatment|Subject/guardian decision|125|||
124890925|NCT01782326|449222604|FG000|Double-blind Treatment|Lack of Efficacy|17|||
124890926|NCT01782326|449222605|FG001|Double-blind Treatment|Lack of Efficacy|22|||
124890927|NCT01782326|449222604|FG000|Double-blind Treatment|Physician Decision|13|||
124890928|NCT01782326|449222605|FG001|Double-blind Treatment|Physician Decision|16|||
124890929|NCT01782326|449222604|FG000|Double-blind Treatment|Protocol deviation|8|||
124890930|NCT01782326|449222605|FG001|Double-blind Treatment|Protocol deviation|7|||
124890931|NCT01782326|449222604|FG000|Double-blind Treatment|Technical problems|0|||
124890932|NCT01782326|449222605|FG001|Double-blind Treatment|Technical problems|5|||
124890933|NCT00738530|449222618|FG000|Overall Study|Death|220|||
124890934|NCT00738530|449222619|FG001|Overall Study|Death|224|||
124890935|NCT00738530|449222618|FG000|Overall Study|Lost to Follow-up|8|||
124890936|NCT00738530|449222619|FG001|Overall Study|Lost to Follow-up|6|||
124890937|NCT00738530|449222618|FG000|Overall Study|Withdrawal by Subject|6|||
124890938|NCT00738530|449222619|FG001|Overall Study|Withdrawal by Subject|8|||
124890939|NCT01628510|449222620|FG000|Overall Study|Withdrawal by Subject|0|||
124890940|NCT01628510|449222621|FG001|Overall Study|Withdrawal by Subject|4|||
124890941|NCT01628510|449222620|FG000|Overall Study|Death|3|||
124890942|NCT01628510|449222621|FG001|Overall Study|Death|1|||
124890943|NCT01653847|449222622|FG000|Overall Study|Withdrawal by Subject|1|||
124890944|NCT01653847|449222623|FG001|Overall Study|Withdrawal by Subject|0|||
124890945|NCT04707391|449222624|FG000|Overall Study|Adverse Event|5|||
124890946|NCT04707391|449222625|FG001|Overall Study|Adverse Event|8|||
124890947|NCT04707391|449222624|FG000|Overall Study|Lost to Follow-up|44|||
124890948|NCT04707391|449222625|FG001|Overall Study|Lost to Follow-up|31|||
124890949|NCT04707391|449222624|FG000|Overall Study|Protocol Violation|1|||
124890950|NCT04707391|449222625|FG001|Overall Study|Protocol Violation|5|||
124890951|NCT04707391|449222624|FG000|Overall Study|Withdrawal by Subject|27|||
124890952|NCT04707391|449222625|FG001|Overall Study|Withdrawal by Subject|25|||
124890953|NCT04707391|449222624|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
124890954|NCT04707391|449222625|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
124890955|NCT04707391|449222624|FG000|Overall Study|Other|0|||
124890956|NCT04707391|449222625|FG001|Overall Study|Other|2|||
124890957|NCT03246672|449222626|FG000|Overall Study|Lost to Follow-up|2|||
124890958|NCT01347645|449222627|FG000|Overall Study|Death|1|||
124890959|NCT01347645|449222628|FG001|Overall Study|Death|5|||
124890960|NCT01347645|449222629|FG002|Overall Study|Death|2|||
124890961|NCT01347645|449222630|FG003|Overall Study|Death|7|||
124890962|NCT01347645|449222631|FG004|Overall Study|Death|7|||
124890963|NCT01347645|449222627|FG000|Overall Study|Lost to Follow-up|1|||
124890964|NCT01347645|449222628|FG001|Overall Study|Lost to Follow-up|1|||
124890965|NCT01347645|449222629|FG002|Overall Study|Lost to Follow-up|0|||
124890966|NCT01347645|449222630|FG003|Overall Study|Lost to Follow-up|1|||
124890967|NCT01347645|449222631|FG004|Overall Study|Lost to Follow-up|1|||
124890968|NCT01347645|449222627|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
124890969|NCT01347645|449222628|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
124890970|NCT01347645|449222629|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
124890971|NCT01347645|449222630|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
124890972|NCT01347645|449222631|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
124890973|NCT01347645|449222627|FG000|Overall Study|Other|1|||
124890974|NCT01347645|449222628|FG001|Overall Study|Other|0|||
124890975|NCT01347645|449222629|FG002|Overall Study|Other|0|||
124890976|NCT01347645|449222630|FG003|Overall Study|Other|0|||
124890977|NCT01347645|449222631|FG004|Overall Study|Other|1|||
124890978|NCT01347645|449222627|FG000|Overall Study|Withdrawal by Subject|0|||
124890979|NCT01347645|449222628|FG001|Overall Study|Withdrawal by Subject|0|||
124890980|NCT01347645|449222629|FG002|Overall Study|Withdrawal by Subject|0|||
124890981|NCT01347645|449222630|FG003|Overall Study|Withdrawal by Subject|3|||
124890982|NCT01347645|449222631|FG004|Overall Study|Withdrawal by Subject|3|||
124890983|NCT01347645|449222627|FG000|Overall Study|Physician Decision|0|||
124890984|NCT01347645|449222628|FG001|Overall Study|Physician Decision|0|||
124890985|NCT01347645|449222629|FG002|Overall Study|Physician Decision|0|||
124890986|NCT01347645|449222630|FG003|Overall Study|Physician Decision|0|||
124890987|NCT01347645|449222631|FG004|Overall Study|Physician Decision|1|||
124890988|NCT01347645|449222627|FG000|Overall Study|Adverse Event|0|||
124890989|NCT01347645|449222628|FG001|Overall Study|Adverse Event|0|||
124890990|NCT01347645|449222629|FG002|Overall Study|Adverse Event|0|||
124890991|NCT01347645|449222630|FG003|Overall Study|Adverse Event|1|||
124890992|NCT01347645|449222631|FG004|Overall Study|Adverse Event|1|||
124890993|NCT01163149|449222633|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
124890994|NCT01163149|449222634|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
124890995|NCT01163149|449222635|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
124890996|NCT01163149|449222633|FG000|Extension Treatment Period|Adverse Event|0|||
124890997|NCT01163149|449222634|FG001|Extension Treatment Period|Adverse Event|1|||
124890998|NCT01163149|449222635|FG002|Extension Treatment Period|Adverse Event|0|||
124890999|NCT01163149|449222633|FG000|Extension Treatment Period|Noncompliance|0|||
124891000|NCT01163149|449222634|FG001|Extension Treatment Period|Noncompliance|0|||
124891001|NCT01163149|449222635|FG002|Extension Treatment Period|Noncompliance|1|||
124891002|NCT01923428|449222644|FG000|Overall Study|Adverse Event|8|||
124891003|NCT01923428|449222645|FG001|Overall Study|Adverse Event|6|||
124891004|NCT01923428|449222646|FG002|Overall Study|Adverse Event|3|||
124891005|NCT01923428|449222647|FG003|Overall Study|Adverse Event|3|||
124891006|NCT01923428|449222644|FG000|Overall Study|Withdrawal by Subject|5|||
124891007|NCT01923428|449222645|FG001|Overall Study|Withdrawal by Subject|3|||
124891008|NCT01923428|449222646|FG002|Overall Study|Withdrawal by Subject|0|||
124441970|NCT03952806|447579997|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
124441971|NCT03952806|447579998|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
124441972|NCT03952806|447579997|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
124441973|NCT03952806|447579998|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
124686598|NCT00843882|448472119|FG001|Step 1|Death|2|||
124686599|NCT00843882|448472120|FG002|Step 1|Death|4|||
124686600|NCT00843882|448472118|FG000|Step 1|Withdrawal by Subject|6|||
124686601|NCT00843882|448472119|FG001|Step 1|Withdrawal by Subject|12|||
124891009|NCT01923428|449222647|FG003|Overall Study|Withdrawal by Subject|4|||
124891010|NCT01923428|449222644|FG000|Overall Study|Lost to Follow-up|2|||
124891011|NCT01923428|449222645|FG001|Overall Study|Lost to Follow-up|1|||
124891012|NCT01923428|449222646|FG002|Overall Study|Lost to Follow-up|5|||
124441974|NCT03952806|447579997|FG000|OLE Phase (48 Weeks)|Other|16|||
124686602|NCT00843882|448472120|FG002|Step 1|Withdrawal by Subject|9|||
124891013|NCT01923428|449222647|FG003|Overall Study|Lost to Follow-up|0|||
124891014|NCT01923428|449222644|FG000|Overall Study|Protocol Violation|3|||
124686603|NCT00843882|448472118|FG000|Step 1|Physician Decision|0|||
124891015|NCT01923428|449222645|FG001|Overall Study|Protocol Violation|0|||
124686604|NCT00843882|448472119|FG001|Step 1|Physician Decision|5|||
124891016|NCT01923428|449222646|FG002|Overall Study|Protocol Violation|2|||
124891017|NCT01923428|449222647|FG003|Overall Study|Protocol Violation|1|||
124891018|NCT01923428|449222644|FG000|Overall Study|Non Compliance to treatment|1|||
124891019|NCT01923428|449222645|FG001|Overall Study|Non Compliance to treatment|2|||
124891020|NCT01923428|449222646|FG002|Overall Study|Non Compliance to treatment|0|||
124891021|NCT01923428|449222647|FG003|Overall Study|Non Compliance to treatment|1|||
124891022|NCT01923428|449222644|FG000|Overall Study|Lack of Efficacy|0|||
124891023|NCT01923428|449222645|FG001|Overall Study|Lack of Efficacy|0|||
124891024|NCT01923428|449222646|FG002|Overall Study|Lack of Efficacy|1|||
124891025|NCT01923428|449222647|FG003|Overall Study|Lack of Efficacy|1|||
124891026|NCT02550873|449222648|FG000|Randomized Double Blind|Adverse Event|3|||
124891027|NCT02550873|449222649|FG001|Randomized Double Blind|Adverse Event|1|||
124891028|NCT02550873|449222650|FG002|Randomized Double Blind|Adverse Event|0|||
124891029|NCT02550873|449222648|FG000|Randomized Double Blind|Disease progression|1|||
124891030|NCT02550873|449222649|FG001|Randomized Double Blind|Disease progression|1|||
124891031|NCT02550873|449222650|FG002|Randomized Double Blind|Disease progression|0|||
124891032|NCT02550873|449222648|FG000|Open Label Extension|Study ongoing|0|||
124891033|NCT02550873|449222649|FG001|Open Label Extension|Study ongoing|0|||
124891034|NCT02550873|449222650|FG002|Open Label Extension|Study ongoing|111|||
124891035|NCT01822353|449222651|FG000|Overall Study|Adverse Event|1|||
124891036|NCT01822353|449222652|FG001|Overall Study|Adverse Event|3|||
124891037|NCT01822353|449222653|FG002|Overall Study|Adverse Event|1|||
124891038|NCT01822353|449222651|FG000|Overall Study|Pregnancy|0|||
124891039|NCT01822353|449222652|FG001|Overall Study|Pregnancy|1|||
124891040|NCT01822353|449222653|FG002|Overall Study|Pregnancy|0|||
124891041|NCT01822353|449222651|FG000|Overall Study|Withdrawal by Subject|3|||
124891042|NCT01822353|449222652|FG001|Overall Study|Withdrawal by Subject|1|||
124891043|NCT01822353|449222653|FG002|Overall Study|Withdrawal by Subject|0|||
124891044|NCT04320615|449222654|FG000|Overall Study|Withdrawal by Subject|4|||
124891045|NCT04320615|449222655|FG001|Overall Study|Withdrawal by Subject|10|||
124891046|NCT04320615|449222654|FG000|Overall Study|Physician Decision|2|||
124891047|NCT04320615|449222655|FG001|Overall Study|Physician Decision|0|||
124891048|NCT04320615|449222654|FG000|Overall Study|Other|2|||
124891049|NCT04320615|449222655|FG001|Overall Study|Other|0|||
124891050|NCT04320615|449222654|FG000|Overall Study|Lost to Follow-up|5|||
124891051|NCT04320615|449222655|FG001|Overall Study|Lost to Follow-up|23|||
124891052|NCT04320615|449222654|FG000|Overall Study|Death|35|||
124891053|NCT04320615|449222655|FG001|Overall Study|Death|71|||
124891054|NCT01449721|449222656|FG000|Overall Study|Physician Decision|0|||
124891055|NCT01449721|449222657|FG001|Overall Study|Physician Decision|1|||
124891056|NCT01449721|449222656|FG000|Overall Study|Physician Decision|0|||
124891057|NCT01449721|449222657|FG001|Overall Study|Physician Decision|1|||
124891058|NCT00885495|449222658|FG000|Overall Study|Adverse Event|1|||
124891059|NCT00885495|449222659|FG001|Overall Study|Adverse Event|2|||
124891060|NCT00885495|449222658|FG000|Overall Study|Protocol Violation|0|||
124891061|NCT00885495|449222659|FG001|Overall Study|Protocol Violation|1|||
124891062|NCT00885495|449222658|FG000|Overall Study|Withdrawal by Subject|1|||
124891063|NCT00885495|449222659|FG001|Overall Study|Withdrawal by Subject|0|||
124891064|NCT01400893|449222660|FG000|Overall Study|Death|27|||
124891065|NCT01400893|449222661|FG001|Overall Study|Death|21|||
124891066|NCT01400893|449222660|FG000|Overall Study|Lost to Follow-up|0|||
124891067|NCT01400893|449222661|FG001|Overall Study|Lost to Follow-up|6|||
124891068|NCT02320721|449222670|FG000|Overall Study|Adverse Event|6|||
124891069|NCT02320721|449222671|FG001|Overall Study|Adverse Event|6|||
124891070|NCT02320721|449222670|FG000|Overall Study|Lack of Efficacy|2|||
124891071|NCT02320721|449222671|FG001|Overall Study|Lack of Efficacy|0|||
124891072|NCT02320721|449222670|FG000|Overall Study|Poor compliance to protocol|3|||
124891073|NCT02320721|449222671|FG001|Overall Study|Poor compliance to protocol|7|||
124891074|NCT02320721|449222670|FG000|Overall Study|Randomized but not treated|0|||
124891075|NCT02320721|449222671|FG001|Overall Study|Randomized but not treated|1|||
124891076|NCT02320721|449222670|FG000|Overall Study|Hypoglycemia|1|||
124891077|NCT02320721|449222671|FG001|Overall Study|Hypoglycemia|0|||
124891078|NCT02320721|449222670|FG000|Overall Study|Other than specified above|15|||
124891079|NCT02320721|449222671|FG001|Overall Study|Other than specified above|20|||
124891080|NCT04630756|449222672|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
124891081|NCT04630756|449222673|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
124891082|NCT04630756|449222674|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
124891083|NCT00847301|449222675|FG000|Overall Study|Adverse Event|35|||
124891084|NCT00847301|449222675|FG000|Overall Study|Switch to other anticoagulants|16|||
124891085|NCT00847301|449222675|FG000|Overall Study|Lost to Follow-up|1|||
124891086|NCT00847301|449222675|FG000|Overall Study|No prescription after hospital discharge|1|||
124891087|NCT00847301|449222675|FG000|Overall Study|Other reason not defined above|1|||
124891088|NCT00996580|449222676|FG000|Overall Study|Adverse Event|466|||
124891089|NCT00996580|449222676|FG000|Overall Study|Lost to Follow-up|480|||
124891090|NCT00996580|449222676|FG000|Overall Study|Noncompliance with the protocol|137|||
124891091|NCT00996580|449222676|FG000|Overall Study|Physician Decision|5|||
124891092|NCT00996580|449222676|FG000|Overall Study|Pregnancy|68|||
124891093|NCT00996580|449222676|FG000|Overall Study|Protocol Violation|16|||
124891094|NCT00996580|449222676|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
124891095|NCT00996580|449222676|FG000|Overall Study|Withdrawal by Subject|217|||
124891096|NCT00996580|449222676|FG000|Overall Study|Other|29|||
124891097|NCT02036515|449222677|FG000|Overall Study|Adverse Event|1|||
124891098|NCT02036515|449222678|FG001|Overall Study|Adverse Event|1|||
124891099|NCT02036515|449222679|FG002|Overall Study|Adverse Event|2|||
124891100|NCT02036515|449222677|FG000|Overall Study|Lost to Follow-up|0|||
124891101|NCT02036515|449222678|FG001|Overall Study|Lost to Follow-up|2|||
124891102|NCT02036515|449222679|FG002|Overall Study|Lost to Follow-up|0|||
124891103|NCT02036515|449222677|FG000|Overall Study|Non-compliance with study drug|0|||
124891104|NCT02036515|449222678|FG001|Overall Study|Non-compliance with study drug|0|||
124891105|NCT02036515|449222679|FG002|Overall Study|Non-compliance with study drug|2|||
124891106|NCT02036515|449222677|FG000|Overall Study|Screen failure|0|||
124891107|NCT02036515|449222678|FG001|Overall Study|Screen failure|2|||
124891108|NCT02036515|449222679|FG002|Overall Study|Screen failure|0|||
124891109|NCT02036515|449222677|FG000|Overall Study|Withdrawal by Subject|4|||
124891110|NCT02036515|449222678|FG001|Overall Study|Withdrawal by Subject|7|||
124891111|NCT02036515|449222679|FG002|Overall Study|Withdrawal by Subject|9|||
124891112|NCT02036515|449222677|FG000|Overall Study|Hyperglycemia|0|||
124891113|NCT02036515|449222678|FG001|Overall Study|Hyperglycemia|0|||
124891114|NCT02036515|449222679|FG002|Overall Study|Hyperglycemia|1|||
124891115|NCT03621982|449222680|FG000|Overall Study|Withdrawal by Subject|1|||
124891116|NCT03621982|449222681|FG001|Overall Study|Withdrawal by Subject|0|||
124891117|NCT03621982|449222682|FG002|Overall Study|Withdrawal by Subject|0|||
124891118|NCT03621982|449222683|FG003|Overall Study|Withdrawal by Subject|1|||
124891119|NCT03621982|449222684|FG004|Overall Study|Withdrawal by Subject|0|||
124891120|NCT03621982|449222685|FG005|Overall Study|Withdrawal by Subject|1|||
124891121|NCT03621982|449222686|FG006|Overall Study|Withdrawal by Subject|1|||
124891122|NCT03621982|449222687|FG007|Overall Study|Withdrawal by Subject|0|||
124891123|NCT03621982|449222688|FG008|Overall Study|Withdrawal by Subject|1|||
124891124|NCT03621982|449222689|FG009|Overall Study|Withdrawal by Subject|0|||
124891125|NCT03621982|449222690|FG010|Overall Study|Withdrawal by Subject|2|||
124891126|NCT03621982|449222691|FG011|Overall Study|Withdrawal by Subject|1|||
124891127|NCT03621982|449222692|FG012|Overall Study|Withdrawal by Subject|2|||
124891128|NCT03621982|449222693|FG013|Overall Study|Withdrawal by Subject|2|||
124891129|NCT03621982|449222680|FG000|Overall Study|Investigator/Sponsor decision|0|||
124891130|NCT03621982|449222681|FG001|Overall Study|Investigator/Sponsor decision|0|||
124891131|NCT03621982|449222682|FG002|Overall Study|Investigator/Sponsor decision|0|||
124891132|NCT03621982|449222683|FG003|Overall Study|Investigator/Sponsor decision|0|||
124891133|NCT03621982|449222684|FG004|Overall Study|Investigator/Sponsor decision|0|||
124891134|NCT03621982|449222685|FG005|Overall Study|Investigator/Sponsor decision|0|||
124891135|NCT03621982|449222686|FG006|Overall Study|Investigator/Sponsor decision|0|||
124891136|NCT03621982|449222687|FG007|Overall Study|Investigator/Sponsor decision|0|||
124891137|NCT03621982|449222688|FG008|Overall Study|Investigator/Sponsor decision|0|||
124891138|NCT03621982|449222689|FG009|Overall Study|Investigator/Sponsor decision|0|||
124891139|NCT03621982|449222690|FG010|Overall Study|Investigator/Sponsor decision|0|||
124891140|NCT03621982|449222691|FG011|Overall Study|Investigator/Sponsor decision|4|||
124891141|NCT03621982|449222692|FG012|Overall Study|Investigator/Sponsor decision|0|||
124891142|NCT03621982|449222693|FG013|Overall Study|Investigator/Sponsor decision|2|||
124891143|NCT03621982|449222680|FG000|Overall Study|Death|2|||
124891144|NCT03621982|449222681|FG001|Overall Study|Death|4|||
124891145|NCT03621982|449222682|FG002|Overall Study|Death|4|||
124891146|NCT03621982|449222683|FG003|Overall Study|Death|3|||
124891147|NCT03621982|449222684|FG004|Overall Study|Death|8|||
124891148|NCT03621982|449222685|FG005|Overall Study|Death|4|||
124891149|NCT03621982|449222686|FG006|Overall Study|Death|6|||
124891150|NCT03621982|449222687|FG007|Overall Study|Death|3|||
124891151|NCT03621982|449222688|FG008|Overall Study|Death|0|||
124891152|NCT03621982|449222689|FG009|Overall Study|Death|3|||
124891153|NCT03621982|449222690|FG010|Overall Study|Death|8|||
124891154|NCT03621982|449222691|FG011|Overall Study|Death|4|||
124891155|NCT03621982|449222692|FG012|Overall Study|Death|2|||
124891156|NCT03621982|449222693|FG013|Overall Study|Death|2|||
124891157|NCT03621982|449222680|FG000|Overall Study|Lost to Follow-up|0|||
124891158|NCT03621982|449222681|FG001|Overall Study|Lost to Follow-up|0|||
124891159|NCT03621982|449222682|FG002|Overall Study|Lost to Follow-up|1|||
124891160|NCT03621982|449222683|FG003|Overall Study|Lost to Follow-up|0|||
124891161|NCT03621982|449222684|FG004|Overall Study|Lost to Follow-up|0|||
124686605|NCT00843882|448472120|FG002|Step 1|Physician Decision|1|||
124686606|NCT00843882|448472118|FG000|Step 1|Patient and physician's decision|0|||
124891162|NCT03621982|449222685|FG005|Overall Study|Lost to Follow-up|0|||
124891163|NCT03621982|449222686|FG006|Overall Study|Lost to Follow-up|1|||
124891164|NCT03621982|449222687|FG007|Overall Study|Lost to Follow-up|0|||
124891165|NCT03621982|449222688|FG008|Overall Study|Lost to Follow-up|0|||
124891166|NCT03621982|449222689|FG009|Overall Study|Lost to Follow-up|1|||
124891167|NCT03621982|449222690|FG010|Overall Study|Lost to Follow-up|0|||
124891168|NCT03621982|449222691|FG011|Overall Study|Lost to Follow-up|0|||
124891169|NCT03621982|449222692|FG012|Overall Study|Lost to Follow-up|0|||
124891170|NCT03621982|449222693|FG013|Overall Study|Lost to Follow-up|0|||
124891171|NCT01544582|449222696|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
124891172|NCT01544582|449222697|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
124891173|NCT01544582|449222698|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
124891174|NCT01544582|449222699|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
124891175|NCT01544582|449222696|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
124891176|NCT01544582|449222697|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
124891177|NCT01544582|449222698|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
124891178|NCT01544582|449222699|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
124891179|NCT01544582|449222696|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
124891180|NCT01544582|449222697|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
124891181|NCT01544582|449222698|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
124891182|NCT01544582|449222699|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
124891183|NCT01544582|449222696|FG000|Analysis Population|Physician Decision|0|||
124891184|NCT01544582|449222697|FG001|Analysis Population|Physician Decision|13|||
124891185|NCT01544582|449222698|FG002|Analysis Population|Physician Decision|10|||
124891186|NCT01544582|449222699|FG003|Analysis Population|Physician Decision|9|||
124891187|NCT01544582|449222696|FG000|Analysis Population|Safety Reason|0|||
124891188|NCT01544582|449222697|FG001|Analysis Population|Safety Reason|33|||
124891189|NCT01544582|449222698|FG002|Analysis Population|Safety Reason|31|||
124891190|NCT01544582|449222699|FG003|Analysis Population|Safety Reason|8|||
124891191|NCT01544582|449222696|FG000|Analysis Population|Effectiveness Reason|0|||
124891192|NCT01544582|449222697|FG001|Analysis Population|Effectiveness Reason|48|||
124891193|NCT01544582|449222698|FG002|Analysis Population|Effectiveness Reason|29|||
124891194|NCT01544582|449222699|FG003|Analysis Population|Effectiveness Reason|12|||
124891195|NCT01544582|449222696|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
124891196|NCT01544582|449222697|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
124891197|NCT01544582|449222698|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
124891198|NCT01544582|449222699|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
124891199|NCT01544582|449222696|FG000|Analysis Population|Lost to Follow-up|0|||
124891200|NCT01544582|449222697|FG001|Analysis Population|Lost to Follow-up|6|||
124891201|NCT01544582|449222698|FG002|Analysis Population|Lost to Follow-up|6|||
124891202|NCT01544582|449222699|FG003|Analysis Population|Lost to Follow-up|5|||
124891203|NCT01544582|449222696|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
124891204|NCT01544582|449222697|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
124891205|NCT01544582|449222698|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
124891206|NCT01544582|449222699|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
124891207|NCT01544582|449222696|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
124891208|NCT01544582|449222697|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
124891209|NCT01544582|449222698|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
124891210|NCT01544582|449222699|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
124891211|NCT01544582|449222696|FG000|Analysis Population|Intolerance|0|||
124891212|NCT01544582|449222697|FG001|Analysis Population|Intolerance|1|||
124891213|NCT01544582|449222698|FG002|Analysis Population|Intolerance|0|||
124891214|NCT01544582|449222699|FG003|Analysis Population|Intolerance|0|||
124891215|NCT01544582|449222696|FG000|Analysis Population|Liver Transplantation|0|||
124891216|NCT01544582|449222697|FG001|Analysis Population|Liver Transplantation|0|||
124891217|NCT01544582|449222698|FG002|Analysis Population|Liver Transplantation|1|||
124891218|NCT01544582|449222699|FG003|Analysis Population|Liver Transplantation|0|||
124891219|NCT01544582|449222696|FG000|Analysis Population|No Social Insurance|0|||
124891220|NCT01544582|449222697|FG001|Analysis Population|No Social Insurance|0|||
124891221|NCT01544582|449222698|FG002|Analysis Population|No Social Insurance|1|||
124891222|NCT01544582|449222699|FG003|Analysis Population|No Social Insurance|0|||
124891223|NCT01544582|449222696|FG000|Analysis Population|Poor Adherence|0|||
124891224|NCT01544582|449222697|FG001|Analysis Population|Poor Adherence|0|||
124891225|NCT01544582|449222698|FG002|Analysis Population|Poor Adherence|1|||
124891226|NCT01544582|449222699|FG003|Analysis Population|Poor Adherence|0|||
124686607|NCT00843882|448472119|FG001|Step 1|Patient and physician's decision|0|||
124686608|NCT00843882|448472120|FG002|Step 1|Patient and physician's decision|1|||
124891227|NCT01544582|449222696|FG000|Analysis Population|Poor Participant Compliance|0|||
124891228|NCT01544582|449222697|FG001|Analysis Population|Poor Participant Compliance|1|||
124891229|NCT01544582|449222698|FG002|Analysis Population|Poor Participant Compliance|0|||
124891230|NCT01544582|449222699|FG003|Analysis Population|Poor Participant Compliance|0|||
124891231|NCT01544582|449222696|FG000|Analysis Population|Programmed Surgery|0|||
124891232|NCT01544582|449222697|FG001|Analysis Population|Programmed Surgery|1|||
124891233|NCT01544582|449222698|FG002|Analysis Population|Programmed Surgery|0|||
124686609|NCT00843882|448472118|FG000|Step 1|Other complicating disease|1|||
124891234|NCT01544582|449222699|FG003|Analysis Population|Programmed Surgery|0|||
124891235|NCT01544582|449222696|FG000|Analysis Population|Participant in Jail|0|||
124891236|NCT01544582|449222697|FG001|Analysis Population|Participant in Jail|0|||
124891237|NCT01544582|449222698|FG002|Analysis Population|Participant in Jail|1|||
124891238|NCT01544582|449222699|FG003|Analysis Population|Participant in Jail|0|||
124891239|NCT03317379|449222704|FG000|Overall Study|Lost to Follow-up|0|||
124891240|NCT03317379|449222705|FG001|Overall Study|Lost to Follow-up|3|||
124891241|NCT03317379|449222706|FG002|Overall Study|Lost to Follow-up|2|||
124891242|NCT04445155|449222707|FG000|Overall Study|Lost to Follow-up|11|||
124891243|NCT04445155|449222708|FG001|Overall Study|Lost to Follow-up|2|||
124891244|NCT04445155|449222709|FG002|Overall Study|Lost to Follow-up|3|||
124891245|NCT04445155|449222710|FG003|Overall Study|Lost to Follow-up|0|||
124891246|NCT04445155|449222707|FG000|Overall Study|Withdrawal by Subject|8|||
124891247|NCT04445155|449222708|FG001|Overall Study|Withdrawal by Subject|0|||
124891248|NCT04445155|449222709|FG002|Overall Study|Withdrawal by Subject|0|||
124891249|NCT04445155|449222710|FG003|Overall Study|Withdrawal by Subject|0|||
124891250|NCT04445155|449222707|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
124891251|NCT04445155|449222708|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
124891252|NCT04445155|449222709|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
124891253|NCT04445155|449222710|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
124891254|NCT04445155|449222707|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
124891255|NCT04445155|449222708|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
124891256|NCT04445155|449222709|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
124891257|NCT04445155|449222710|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
124891258|NCT00550173|449222711|FG000|Overall Study|Death|45|||
124891259|NCT00550173|449222712|FG001|Overall Study|Death|38|||
124891260|NCT00550173|449222713|FG002|Overall Study|Death|50|||
124891261|NCT00550173|449222711|FG000|Overall Study|Physician Decision|1|||
124891262|NCT00550173|449222712|FG001|Overall Study|Physician Decision|2|||
124891263|NCT00550173|449222713|FG002|Overall Study|Physician Decision|2|||
124891264|NCT00550173|449222711|FG000|Overall Study|Withdrawal by Subject|9|||
124891265|NCT00550173|449222712|FG001|Overall Study|Withdrawal by Subject|12|||
124891266|NCT00550173|449222713|FG002|Overall Study|Withdrawal by Subject|17|||
124441975|NCT03952806|447579998|FG001|OLE Phase (48 Weeks)|Other|13|||
124441976|NCT00655863|447579999|FG000|Overall Study|Lost to Follow-up|0|||
124441977|NCT00655863|447580000|FG001|Overall Study|Lost to Follow-up|0|||
124441978|NCT00655863|447580001|FG002|Overall Study|Lost to Follow-up|1|||
124441979|NCT01138007|447580002|FG000|Overall Study|Adverse Event|4|||
124891267|NCT00550173|449222711|FG000|Overall Study|Sponsor Decision|13|||
124441980|NCT01138007|447580003|FG001|Overall Study|Adverse Event|12|||
124441981|NCT01138007|447580004|FG002|Overall Study|Adverse Event|9|||
124441982|NCT01138007|447580002|FG000|Overall Study|Lack of Efficacy|2|||
124441983|NCT01138007|447580003|FG001|Overall Study|Lack of Efficacy|0|||
124441984|NCT01138007|447580004|FG002|Overall Study|Lack of Efficacy|6|||
124441985|NCT01138007|447580002|FG000|Overall Study|Protocol Violation|2|||
124441986|NCT01138007|447580003|FG001|Overall Study|Protocol Violation|3|||
124441987|NCT01138007|447580004|FG002|Overall Study|Protocol Violation|2|||
124441988|NCT01138007|447580002|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
124441989|NCT01138007|447580003|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
124441990|NCT01138007|447580004|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
124441991|NCT01138007|447580002|FG000|Overall Study|Lost to Follow-up|3|||
124441992|NCT01138007|447580003|FG001|Overall Study|Lost to Follow-up|3|||
124441993|NCT01138007|447580004|FG002|Overall Study|Lost to Follow-up|5|||
124441994|NCT01138007|447580002|FG000|Overall Study|Physician Decision|0|||
124441995|NCT01138007|447580003|FG001|Overall Study|Physician Decision|5|||
124441996|NCT01138007|447580004|FG002|Overall Study|Physician Decision|3|||
124441997|NCT01138007|447580002|FG000|Overall Study|Withdrawal by Subject|5|||
124441998|NCT01138007|447580003|FG001|Overall Study|Withdrawal by Subject|6|||
124686610|NCT00843882|448472119|FG001|Step 1|Other complicating disease|3|||
124686611|NCT00843882|448472120|FG002|Step 1|Other complicating disease|4|||
124891268|NCT00550173|449222712|FG001|Overall Study|Sponsor Decision|7|||
124891269|NCT00550173|449222713|FG002|Overall Study|Sponsor Decision|1|||
124441999|NCT01138007|447580004|FG002|Overall Study|Withdrawal by Subject|15|||
124442000|NCT04661878|447580005|FG000|Overall Study|Lost to Follow-up|6|||
124442001|NCT04661878|447580006|FG001|Overall Study|Lost to Follow-up|5|||
124442002|NCT04442737|447580011|FG000|Overall Study|Lost to Follow-up|1|||
124891270|NCT00550173|449222711|FG000|Overall Study|Lost to Follow-up|4|||
124891271|NCT00550173|449222712|FG001|Overall Study|Lost to Follow-up|4|||
124891272|NCT00550173|449222713|FG002|Overall Study|Lost to Follow-up|3|||
124442003|NCT04442737|447580012|FG001|Overall Study|Lost to Follow-up|3|||
124442004|NCT04442737|447580011|FG000|Overall Study|Withdrawal by Subject|3|||
124442005|NCT04442737|447580012|FG001|Overall Study|Withdrawal by Subject|2|||
124442006|NCT04442737|447580011|FG000|Overall Study|Adverse Event|3|||
124442007|NCT04442737|447580012|FG001|Overall Study|Adverse Event|2|||
124442008|NCT04442737|447580011|FG000|Overall Study|Death|0|||
124891273|NCT01556243|449222714|FG000|Overall Study|Ineligible|34|||
124891274|NCT01556243|449222714|FG000|Overall Study|Converted to mastectomy|14|||
124891275|NCT01556243|449222714|FG000|Overall Study|Unable to achieve negative margins|2|||
124891276|NCT01556243|449222714|FG000|Overall Study|Withdrawal by Subject|16|||
124891277|NCT01388543|449222715|FG000|Day 14|Adverse Event|1|||
124891278|NCT01388543|449222716|FG001|Day 14|Adverse Event|4|||
124891279|NCT01213173|449222718|FG000|Overall Study|Protocol Violation|2|||
124891280|NCT01213173|449222719|FG001|Overall Study|Protocol Violation|0|||
124891281|NCT01213173|449222718|FG000|Overall Study|Adverse Event|4|||
124891282|NCT01213173|449222719|FG001|Overall Study|Adverse Event|8|||
124891283|NCT01213173|449222718|FG000|Overall Study|Withdrawal by Subject|5|||
124891284|NCT01213173|449222719|FG001|Overall Study|Withdrawal by Subject|5|||
124891285|NCT01213173|449222718|FG000|Overall Study|Incorrect Enrollment|1|||
124891286|NCT01213173|449222719|FG001|Overall Study|Incorrect Enrollment|3|||
124891287|NCT04880161|449222722|FG000|Overall Study|Withdrawal by Subject|1|||
124891288|NCT04880161|449222723|FG001|Overall Study|Withdrawal by Subject|0|||
124891289|NCT04880161|449222722|FG000|Overall Study|Lack of Compliance|1|||
124891290|NCT04880161|449222723|FG001|Overall Study|Lack of Compliance|1|||
124891291|NCT04880161|449222722|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
124891292|NCT04880161|449222723|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
124891293|NCT04880161|449222722|FG000|Overall Study|Screen Failure|0|||
124891294|NCT04880161|449222723|FG001|Overall Study|Screen Failure|1|||
124891295|NCT01354106|449222724|FG000|Overall Study|Withdrawal by Subject|2|||
124891296|NCT00731042|449224316|FG000|Second Intervention|Did not meet inclusion criteria|0|||
124891297|NCT00731042|449224317|FG001|Second Intervention|Did not meet inclusion criteria|2|||
124891298|NCT02692235|449224318|FG000|Overall Study|Withdrawal by Subject|2|||
124891299|NCT02692235|449224319|FG001|Overall Study|Withdrawal by Subject|1|||
124891300|NCT02692235|449224318|FG000|Overall Study|Adverse Event|1|||
124891301|NCT02692235|449224319|FG001|Overall Study|Adverse Event|2|||
124891302|NCT00802841|449224320|FG000|Overall Study|Administrative problems|1|||
124891303|NCT00802841|449224321|FG001|Overall Study|Administrative problems|0|||
124891304|NCT00802841|449224320|FG000|Overall Study|Lost to Follow-up|2|||
124891305|NCT00802841|449224321|FG001|Overall Study|Lost to Follow-up|1|||
124891306|NCT00802841|449224320|FG000|Overall Study|Death|1|||
124891307|NCT00802841|449224321|FG001|Overall Study|Death|2|||
124891308|NCT00802841|449224320|FG000|Overall Study|Adverse Event|8|||
124891309|NCT00802841|449224321|FG001|Overall Study|Adverse Event|2|||
124891310|NCT00802841|449224320|FG000|Overall Study|Disease progression|7|||
124891311|NCT00802841|449224321|FG001|Overall Study|Disease progression|3|||
124891312|NCT00802841|449224320|FG000|Overall Study|Withdrawal by Subject|9|||
124891313|NCT00802841|449224321|FG001|Overall Study|Withdrawal by Subject|5|||
124891314|NCT00802841|449224320|FG000|Overall Study|Protocol deviation|2|||
124891315|NCT00802841|449224321|FG001|Overall Study|Protocol deviation|6|||
124891316|NCT00802841|449224320|FG000|Overall Study|Treatment duration completed|66|||
124891317|NCT00802841|449224321|FG001|Overall Study|Treatment duration completed|76|||
124891318|NCT02711995|449224324|FG000|Washout (90 Days)|Conflicting medication|1|||
124891319|NCT00107380|449224328|FG000|Overall Study|Adverse Event|7|||
124891320|NCT00107380|449224328|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
124891321|NCT00107380|449224328|FG000|Overall Study|Progression/relapse|4|||
124891322|NCT00107380|449224328|FG000|Overall Study|Death|3|||
124891323|NCT00107380|449224328|FG000|Overall Study|Other - not protocol specified|7|||
124891324|NCT00107380|449224328|FG000|Overall Study|Ineligible|2|||
124891325|NCT03673098|449224329|FG000|Overall Study|Lost to Follow-up|2|||
124891326|NCT03673098|449224330|FG001|Overall Study|Lost to Follow-up|3|||
124442009|NCT04442737|447580012|FG001|Overall Study|Death|1|||
124442010|NCT04442737|447580011|FG000|Overall Study|Protocol Violation|0|||
124442011|NCT04442737|447580012|FG001|Overall Study|Protocol Violation|2|||
124442012|NCT04442737|447580011|FG000|Overall Study|Other|1|||
124442013|NCT04442737|447580012|FG001|Overall Study|Other|1|||
124442014|NCT00744523|447580013|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
124442015|NCT00744523|447580014|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
124442016|NCT01139021|447580017|FG000|Overall Study|Adverse Event|0|||
124442017|NCT01139021|447580018|FG001|Overall Study|Adverse Event|0|||
124891327|NCT03673098|449224329|FG000|Overall Study|Withdrawal by Subject|6|||
124891328|NCT03673098|449224330|FG001|Overall Study|Withdrawal by Subject|1|||
124442018|NCT01139021|447580019|FG002|Overall Study|Adverse Event|0|||
124442019|NCT01139021|447580020|FG003|Overall Study|Adverse Event|0|||
124891329|NCT03673098|449224329|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
124891330|NCT03673098|449224330|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
124891331|NCT03531905|449224335|FG000|Overall Study|Withdrawal by Subject|3|||
124891332|NCT03531905|449224336|FG001|Overall Study|Withdrawal by Subject|3|||
124891333|NCT03531905|449224337|FG002|Overall Study|Withdrawal by Subject|2|||
124442020|NCT01139021|447580021|FG004|Overall Study|Adverse Event|1|||
124442021|NCT01139021|447580022|FG005|Overall Study|Adverse Event|0|||
124442022|NCT01139021|447580017|FG000|Overall Study|Lost to Follow-up|0|||
124442023|NCT01139021|447580018|FG001|Overall Study|Lost to Follow-up|0|||
124891334|NCT03531905|449224335|FG000|Overall Study|Lost to Follow-up|2|||
124891335|NCT03531905|449224336|FG001|Overall Study|Lost to Follow-up|2|||
124891336|NCT03531905|449224337|FG002|Overall Study|Lost to Follow-up|1|||
124891337|NCT03531905|449224335|FG000|Overall Study|Participant was out of town|1|||
124891338|NCT03531905|449224336|FG001|Overall Study|Participant was out of town|0|||
124891339|NCT03531905|449224337|FG002|Overall Study|Participant was out of town|0|||
124891340|NCT03531905|449224335|FG000|Overall Study|Could not speak with the participant|1|||
124891341|NCT03531905|449224336|FG001|Overall Study|Could not speak with the participant|0|||
124891342|NCT03531905|449224337|FG002|Overall Study|Could not speak with the participant|0|||
124891343|NCT01155726|449224338|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
124891344|NCT01155726|449224339|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
124891345|NCT01155726|449224340|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
124891346|NCT01155726|449224341|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
124891347|NCT02724020|449224346|FG000|Overall Study|Death|16|||
124891348|NCT02724020|449224347|FG001|Overall Study|Death|18|||
124891349|NCT02724020|449224348|FG002|Overall Study|Death|19|||
124891350|NCT02724020|449224346|FG000|Overall Study|Lost to Follow-up|0|||
124891351|NCT02724020|449224347|FG001|Overall Study|Lost to Follow-up|3|||
124891352|NCT02724020|449224348|FG002|Overall Study|Lost to Follow-up|0|||
124891353|NCT02724020|449224346|FG000|Overall Study|Site Terminated by Sponsor|15|||
124891354|NCT02724020|449224347|FG001|Overall Study|Site Terminated by Sponsor|8|||
124891355|NCT02724020|449224348|FG002|Overall Study|Site Terminated by Sponsor|8|||
124891356|NCT02724020|449224346|FG000|Overall Study|Withdrawal by Subject|1|||
124891357|NCT02724020|449224347|FG001|Overall Study|Withdrawal by Subject|3|||
124891358|NCT02724020|449224348|FG002|Overall Study|Withdrawal by Subject|5|||
124891359|NCT00425503|449224349|FG000|Overall Study|Adverse Event|2|||
124891360|NCT00425503|449224349|FG000|Overall Study|Protocol Violation|1|||
124891361|NCT00688259|449224350|FG000|Overall Study|Lost to Follow-up|2|||
124891362|NCT00688259|449224351|FG001|Overall Study|Lost to Follow-up|4|||
124891363|NCT00688259|449224350|FG000|Overall Study|Physician Decision|1|||
124891364|NCT00688259|449224351|FG001|Overall Study|Physician Decision|0|||
124891365|NCT00688259|449224350|FG000|Overall Study|Withdrawal by Subject|2|||
124891366|NCT00688259|449224351|FG001|Overall Study|Withdrawal by Subject|0|||
124891367|NCT00688259|449224350|FG000|Overall Study|Declined Interview|2|||
124891368|NCT00688259|449224351|FG001|Overall Study|Declined Interview|3|||
124891369|NCT00688259|449224350|FG000|Overall Study|Hospitalized at Follow-up|0|||
124891370|NCT00688259|449224351|FG001|Overall Study|Hospitalized at Follow-up|1|||
124891371|NCT02954575|449224352|FG000|Overall Study|Withdrawal by Subject|2|||
124891372|NCT02954575|449224352|FG000|Overall Study|Adverse Event|1|||
124891373|NCT02491892|449224354|FG000|Overall Study|Adverse Event|1|||
124891374|NCT02491892|449224355|FG001|Overall Study|Adverse Event|1|||
124891375|NCT02491892|449224354|FG000|Overall Study|Death|1|||
124891376|NCT02491892|449224355|FG001|Overall Study|Death|1|||
124891377|NCT02491892|449224354|FG000|Overall Study|Lack of Efficacy|37|||
124891378|NCT02491892|449224355|FG001|Overall Study|Lack of Efficacy|36|||
124891379|NCT02491892|449224354|FG000|Overall Study|Refused Treatment|1|||
124891380|NCT02491892|449224355|FG001|Overall Study|Refused Treatment|0|||
124891381|NCT02491892|449224354|FG000|Overall Study|Lost to Follow-up|1|||
124891382|NCT02491892|449224355|FG001|Overall Study|Lost to Follow-up|0|||
124891383|NCT01066156|449224356|FG000|Overall Study|ineligible|2|||
124891384|NCT01066156|449224356|FG000|Overall Study|Lost to Follow-up|7|||
124891385|NCT01066156|449224356|FG000|Overall Study|Withdrawal by Subject|1|||
124891386|NCT01734382|449224360|FG000|Part 1|Adverse Event|2|||
124891387|NCT01734382|449224361|FG001|Part 1|Adverse Event|0|||
124891388|NCT01734382|449224362|FG002|Part 1|Adverse Event|0|||
124891389|NCT01734382|449224360|FG000|Part 2|Adverse Event|0|||
124891390|NCT01734382|449224361|FG001|Part 2|Adverse Event|0|||
124891391|NCT01734382|449224362|FG002|Part 2|Adverse Event|1|||
124891392|NCT01734382|449224360|FG000|Part 2|Lack of Efficacy|0|||
124891393|NCT01734382|449224361|FG001|Part 2|Lack of Efficacy|1|||
124891394|NCT01734382|449224362|FG002|Part 2|Lack of Efficacy|1|||
124891395|NCT01734382|449224360|FG000|Part 2|Other|0|||
124891396|NCT01734382|449224361|FG001|Part 2|Other|0|||
124891397|NCT01734382|449224362|FG002|Part 2|Other|1|||
124759242|NCT01329978|448742581|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
124891398|NCT01734382|449224360|FG000|Part 2|Physician Decision|0|||
124891399|NCT01734382|449224361|FG001|Part 2|Physician Decision|0|||
124891400|NCT01734382|449224362|FG002|Part 2|Physician Decision|3|||
124891401|NCT01734382|449224360|FG000|Part 2|Protocol Violation|0|||
124891402|NCT01734382|449224361|FG001|Part 2|Protocol Violation|1|||
124891403|NCT01734382|449224362|FG002|Part 2|Protocol Violation|0|||
124891404|NCT01734382|449224360|FG000|Part 2|Withdrawal by Subject|0|||
124891405|NCT01734382|449224361|FG001|Part 2|Withdrawal by Subject|0|||
124891406|NCT01734382|449224362|FG002|Part 2|Withdrawal by Subject|1|||
124891407|NCT00661258|449224370|FG000|Overall Study|Death|1|||
124891408|NCT00661258|449224371|FG001|Overall Study|Death|0|||
124891409|NCT00661258|449224370|FG000|Overall Study|caught by police and in detox center|2|||
124891410|NCT00661258|449224371|FG001|Overall Study|caught by police and in detox center|1|||
124891411|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
124891412|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
124891413|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
124891414|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
124891415|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
124891416|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
124891417|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
124891418|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
124891419|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
124891420|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
124891421|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
124891422|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
124891423|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
124891424|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
124891425|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
124891426|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
124891427|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
124891428|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
124891429|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
124891430|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
124891431|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
124891432|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
124891433|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
124891434|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
124891435|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
124891436|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
124891437|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
124891438|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
124891439|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
124891440|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
124891441|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
124891442|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
124891443|NCT03890120|449224372|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
124891444|NCT03890120|449224373|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
124891445|NCT03890120|449224374|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
124891446|NCT03890120|449224375|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
124891447|NCT03890120|449224372|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
124891448|NCT03890120|449224373|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
124891449|NCT03890120|449224374|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
124891450|NCT03890120|449224375|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
124891451|NCT03890120|449224372|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
124891452|NCT03890120|449224373|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
124891453|NCT03890120|449224374|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
124891454|NCT03890120|449224375|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
124891455|NCT03890120|449224372|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
124891456|NCT03890120|449224373|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
124442024|NCT01139021|447580019|FG002|Overall Study|Lost to Follow-up|0|||
124759243|NCT01329978|448742582|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
124759244|NCT01329978|448742583|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
124759245|NCT01329978|448742579|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
124759246|NCT01329978|448742580|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
124759247|NCT01329978|448742581|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
124759248|NCT01329978|448742582|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
124759249|NCT01329978|448742583|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
124759250|NCT01329978|448742579|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
124759251|NCT01329978|448742580|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
124759252|NCT01329978|448742581|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
124759253|NCT01329978|448742582|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
124759254|NCT01329978|448742583|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
124442025|NCT01139021|447580020|FG003|Overall Study|Lost to Follow-up|0|||
124442026|NCT01139021|447580021|FG004|Overall Study|Lost to Follow-up|2|||
124759255|NCT04170543|448742593|FG000|Overall Study|Death|1|||
124759256|NCT04170543|448742594|FG001|Overall Study|Death|1|||
124759257|NCT04170543|448742595|FG002|Overall Study|Death|1|||
124442027|NCT01139021|447580022|FG005|Overall Study|Lost to Follow-up|0|||
124442028|NCT01139021|447580017|FG000|Overall Study|Protocol Violation|1|||
124442029|NCT01139021|447580018|FG001|Overall Study|Protocol Violation|0|||
124442030|NCT01139021|447580019|FG002|Overall Study|Protocol Violation|0|||
124442031|NCT01139021|447580020|FG003|Overall Study|Protocol Violation|0|||
124891457|NCT03890120|449224374|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
124891458|NCT03890120|449224375|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
124891459|NCT03890120|449224372|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
124891460|NCT03890120|449224373|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
124891461|NCT03890120|449224374|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
124891462|NCT03890120|449224375|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
124891463|NCT00683449|449224376|FG000|Overall Study|Lost to Follow-up|0|||
124891464|NCT00683449|449224377|FG001|Overall Study|Lost to Follow-up|1|||
124891465|NCT00683449|449224378|FG002|Overall Study|Lost to Follow-up|0|||
124891466|NCT00683449|449224379|FG003|Overall Study|Lost to Follow-up|0|||
124891467|NCT00683449|449224380|FG004|Overall Study|Lost to Follow-up|0|||
124891468|NCT00479674|449224385|FG000|Overall Study|Adverse Event|18|||
124891469|NCT00479674|449224385|FG000|Overall Study|Withdrawal by Subject|6|||
124891470|NCT00479674|449224385|FG000|Overall Study|Physician Decision|14|||
124891471|NCT00479674|449224385|FG000|Overall Study|none provided|3|||
124891472|NCT00146640|449224388|FG000|Overall Study|Adverse Event|12|||
124891473|NCT00146640|449224389|FG001|Overall Study|Adverse Event|10|||
124891474|NCT00146640|449224388|FG000|Overall Study|Medical Reasons|3|||
124891475|NCT00146640|449224389|FG001|Overall Study|Medical Reasons|0|||
124891476|NCT00146640|449224388|FG000|Overall Study|Non-Medical Reasons|8|||
124891477|NCT00146640|449224389|FG001|Overall Study|Non-Medical Reasons|4|||
124891478|NCT02059161|449224392|FG000|Overall Study|Pregnancy|0|||
124891479|NCT02059161|449224393|FG001|Overall Study|Pregnancy|2|||
124891480|NCT02059161|449224392|FG000|Overall Study|Adverse Event|2|||
124891481|NCT02059161|449224393|FG001|Overall Study|Adverse Event|6|||
124891482|NCT02059161|449224392|FG000|Overall Study|Lost to Follow-up|20|||
124891483|NCT02059161|449224393|FG001|Overall Study|Lost to Follow-up|12|||
124891484|NCT02059161|449224392|FG000|Overall Study|Physician Decision|4|||
124891485|NCT02059161|449224393|FG001|Overall Study|Physician Decision|4|||
124891486|NCT02059161|449224392|FG000|Overall Study|Protocol Violation|1|||
124891487|NCT02059161|449224393|FG001|Overall Study|Protocol Violation|1|||
124891488|NCT02059161|449224392|FG000|Overall Study|Withdrawal by Subject|16|||
124891489|NCT02059161|449224393|FG001|Overall Study|Withdrawal by Subject|13|||
124891490|NCT02059161|449224392|FG000|Overall Study|Randomized in error, no study drug|0|||
124891491|NCT02059161|449224393|FG001|Overall Study|Randomized in error, no study drug|1|||
124891492|NCT02059161|449224392|FG000|Overall Study|Non-compliance with study drug|6|||
124891493|NCT02059161|449224393|FG001|Overall Study|Non-compliance with study drug|2|||
124891494|NCT03023332|449224398|FG000|Overall Study|Withdrawal by Subject|10|||
124891495|NCT03023332|449224399|FG001|Overall Study|Withdrawal by Subject|5|||
124891496|NCT03023332|449224400|FG002|Overall Study|Withdrawal by Subject|4|||
124891497|NCT03023332|449224401|FG003|Overall Study|Withdrawal by Subject|7|||
124891498|NCT03023332|449224398|FG000|Overall Study|Lost to Follow-up|13|||
124891499|NCT03023332|449224399|FG001|Overall Study|Lost to Follow-up|16|||
124891500|NCT03023332|449224400|FG002|Overall Study|Lost to Follow-up|8|||
124891501|NCT03023332|449224401|FG003|Overall Study|Lost to Follow-up|13|||
124891502|NCT03023332|449224398|FG000|Overall Study|Death|1|||
124891503|NCT03023332|449224399|FG001|Overall Study|Death|0|||
124891504|NCT03023332|449224400|FG002|Overall Study|Death|0|||
124891505|NCT03023332|449224401|FG003|Overall Study|Death|0|||
124891506|NCT01818700|449224402|FG000|Overall Study|Adverse Event|67|||
124891507|NCT01818700|449224402|FG000|Overall Study|Lack of Efficacy|2|||
124891508|NCT01818700|449224402|FG000|Overall Study|Lost to Follow-up|5|||
124891509|NCT01818700|449224402|FG000|Overall Study|Withdrawal by Subject|27|||
124891510|NCT01818700|449224402|FG000|Overall Study|Protocol Violation|2|||
124891511|NCT01818700|449224402|FG000|Overall Study|Other|1|||
124891512|NCT02408549|449224405|FG000|Overall Study|Adverse Event|15|||
124891513|NCT02408549|449224405|FG000|Overall Study|Death|4|||
124891514|NCT02408549|449224405|FG000|Overall Study|Lack of Efficacy|17|||
124891515|NCT02408549|449224405|FG000|Overall Study|Protocol Violation|4|||
124442032|NCT01139021|447580021|FG004|Overall Study|Protocol Violation|2|||
124442033|NCT01139021|447580022|FG005|Overall Study|Protocol Violation|0|||
124442034|NCT01139021|447580017|FG000|Overall Study|Withdrawal by Subject|0|||
124442035|NCT01139021|447580018|FG001|Overall Study|Withdrawal by Subject|0|||
124442036|NCT01139021|447580019|FG002|Overall Study|Withdrawal by Subject|0|||
124442037|NCT01139021|447580020|FG003|Overall Study|Withdrawal by Subject|1|||
124891516|NCT02408549|449224405|FG000|Overall Study|Lost to Follow-up|6|||
124891517|NCT02408549|449224405|FG000|Overall Study|Consent withdrawn|30|||
124442038|NCT01139021|447580021|FG004|Overall Study|Withdrawal by Subject|4|||
124686612|NCT00843882|448472118|FG000|Step 1|Alternative therapy|0|||
124442039|NCT01139021|447580022|FG005|Overall Study|Withdrawal by Subject|0|||
124891518|NCT02408549|449224405|FG000|Overall Study|Neurology research program closing at site|1|||
124891519|NCT02408549|449224405|FG000|Overall Study|Site closure|1|||
124891520|NCT02408549|449224405|FG000|Overall Study|Pregnancy|1|||
124891521|NCT02408549|449224405|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
124891522|NCT02408549|449224405|FG000|Overall Study|Subject moved to another place, far from site|1|||
124891523|NCT02408549|449224405|FG000|Overall Study|Study terminated at site|1|||
124466433|NCT01882907|447666400|FG000|Overall Study|Lack of Efficacy|0|||
124891524|NCT01656759|449224406|FG000|Overall Study|Protocol Violation|2|||
124891525|NCT01656759|449224407|FG001|Overall Study|Protocol Violation|3|||
124891526|NCT02687919|449224408|FG000|Overall Study|Withdrawal by Subject|6|||
124891527|NCT02687919|449224409|FG001|Overall Study|Withdrawal by Subject|6|||
124891528|NCT02687919|449224408|FG000|Overall Study|Protocol Violation|2|||
124891529|NCT02687919|449224409|FG001|Overall Study|Protocol Violation|0|||
124891530|NCT01192295|449224410|FG000|Overall Study|Adverse Event|3|||
124891531|NCT01192295|449224411|FG001|Overall Study|Adverse Event|7|||
124891532|NCT01192295|449224410|FG000|Overall Study|Withdrawal by Subject|3|||
124891533|NCT01192295|449224411|FG001|Overall Study|Withdrawal by Subject|4|||
124891534|NCT01192295|449224410|FG000|Overall Study|Lost to Follow-up|0|||
124891535|NCT01192295|449224411|FG001|Overall Study|Lost to Follow-up|1|||
124891536|NCT01192295|449224410|FG000|Overall Study|Lack of Efficacy|0|||
124891537|NCT01192295|449224411|FG001|Overall Study|Lack of Efficacy|5|||
124891538|NCT01192295|449224410|FG000|Overall Study|Administrative|4|||
124891539|NCT01192295|449224411|FG001|Overall Study|Administrative|6|||
124891540|NCT01670500|449224421|FG000|Overall Study|Withdrawal by Subject|1|||
124891541|NCT01670500|449224422|FG001|Overall Study|Withdrawal by Subject|0|||
124891542|NCT03473756|449224423|FG000|Overall Study|Withdrawal by Subject|1|||
124891543|NCT03473756|449224424|FG001|Overall Study|Withdrawal by Subject|4|||
124891544|NCT03473756|449224423|FG000|Overall Study|Adverse Event|6|||
124891545|NCT03473756|449224424|FG001|Overall Study|Adverse Event|7|||
124891546|NCT03473756|449224423|FG000|Overall Study|Lack of Efficacy|3|||
124891547|NCT03473756|449224424|FG001|Overall Study|Lack of Efficacy|10|||
124891548|NCT03473756|449224423|FG000|Overall Study|Physician Decision|0|||
124891549|NCT03473756|449224424|FG001|Overall Study|Physician Decision|2|||
124891550|NCT03473756|449224423|FG000|Overall Study|End of study treatment|0|||
124891551|NCT03473756|449224424|FG001|Overall Study|End of study treatment|2|||
124891552|NCT03473756|449224423|FG000|Overall Study|Lost to Follow-up|0|||
124891553|NCT03473756|449224424|FG001|Overall Study|Lost to Follow-up|1|||
124891554|NCT02148718|449224425|FG000|Overall Study|Protocol Violation|26|||
124891555|NCT02148718|449224425|FG000|Overall Study|Discontinued Study Prematurely|5|||
124891556|NCT00003509|449224426|FG000|Overall Study|Not evaluable|5|||
124891557|NCT02711826|449224427|FG000|Overall Study|Physician Decision|0|||
124891558|NCT02711826|449224428|FG001|Overall Study|Physician Decision|0|||
124891559|NCT02711826|449224429|FG002|Overall Study|Physician Decision|0|||
124891560|NCT02711826|449224430|FG003|Overall Study|Physician Decision|1|||
124891561|NCT02711826|449224431|FG004|Overall Study|Physician Decision|0|||
124891562|NCT02711826|449224427|FG000|Overall Study|Withdrawal by Subject|0|||
124891563|NCT02711826|449224428|FG001|Overall Study|Withdrawal by Subject|1|||
124891564|NCT02711826|449224429|FG002|Overall Study|Withdrawal by Subject|0|||
124891565|NCT02711826|449224430|FG003|Overall Study|Withdrawal by Subject|4|||
124891566|NCT02711826|449224431|FG004|Overall Study|Withdrawal by Subject|0|||
124891567|NCT02711826|449224427|FG000|Overall Study|Failure to manufacture cellular product|0|||
124891568|NCT02711826|449224428|FG001|Overall Study|Failure to manufacture cellular product|0|||
124891569|NCT02711826|449224429|FG002|Overall Study|Failure to manufacture cellular product|5|||
124891570|NCT02711826|449224430|FG003|Overall Study|Failure to manufacture cellular product|0|||
124891571|NCT02711826|449224431|FG004|Overall Study|Failure to manufacture cellular product|0|||
124891572|NCT02711826|449224427|FG000|Overall Study|Infusion canceled for active infection|0|||
124891573|NCT02711826|449224428|FG001|Overall Study|Infusion canceled for active infection|1|||
124891574|NCT02711826|449224429|FG002|Overall Study|Infusion canceled for active infection|0|||
124891575|NCT02711826|449224430|FG003|Overall Study|Infusion canceled for active infection|0|||
124891576|NCT02711826|449224431|FG004|Overall Study|Infusion canceled for active infection|0|||
124891577|NCT02711826|449224427|FG000|Overall Study|Screen failures|0|||
124891578|NCT02711826|449224428|FG001|Overall Study|Screen failures|0|||
124891579|NCT02711826|449224429|FG002|Overall Study|Screen failures|0|||
124891580|NCT02711826|449224430|FG003|Overall Study|Screen failures|4|||
124891581|NCT02711826|449224431|FG004|Overall Study|Screen failures|0|||
124891582|NCT01960790|449224432|FG000|Overall Study|Survey forms could not be recovered|3|||
124891583|NCT01960790|449224432|FG000|Overall Study|Treat with Humira outside survey period|3|||
124891584|NCT01960790|449224432|FG000|Overall Study|Transferred to another hospital|4|||
124891585|NCT01960790|449224432|FG000|Overall Study|Unevaluable for safety|1|||
124891586|NCT02169219|449224435|FG000|Overall Study|Lack of Efficacy|6|||
124891587|NCT02886936|449224442|FG000|Overall Study|Lost to Follow-up|4|||
124891588|NCT02886936|449224443|FG001|Overall Study|Lost to Follow-up|3|||
124891589|NCT02886936|449224444|FG002|Overall Study|Lost to Follow-up|0|||
124891590|NCT04131907|449224446|FG000|Overall Study|Adverse Event|2|||
124891591|NCT04131907|449224447|FG001|Overall Study|Adverse Event|0|||
124891592|NCT04131907|449224448|FG002|Overall Study|Adverse Event|0|||
124891593|NCT04131907|449224446|FG000|Overall Study|Physician Decision|4|||
124891594|NCT04131907|449224447|FG001|Overall Study|Physician Decision|22|||
124891595|NCT04131907|449224448|FG002|Overall Study|Physician Decision|0|||
124891596|NCT04131907|449224446|FG000|Overall Study|Withdrawal by Subject|2|||
124891597|NCT04131907|449224447|FG001|Overall Study|Withdrawal by Subject|0|||
124891598|NCT04131907|449224448|FG002|Overall Study|Withdrawal by Subject|1|||
124891599|NCT04131907|449224446|FG000|Overall Study|Treatment failure|2|||
124891600|NCT04131907|449224447|FG001|Overall Study|Treatment failure|0|||
124891601|NCT04131907|449224448|FG002|Overall Study|Treatment failure|1|||
124891602|NCT04248465|449224449|FG000|Randomized-Controlled Period|Death|12|||
124891603|NCT04248465|449224450|FG001|Randomized-Controlled Period|Death|5|||
124891604|NCT04248465|449224449|FG000|Randomized-Controlled Period|Adverse Event|2|||
124891605|NCT04248465|449224450|FG001|Randomized-Controlled Period|Adverse Event|0|||
124891606|NCT04248465|449224449|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
124891607|NCT04248465|449224450|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
124891608|NCT04248465|449224449|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
124891609|NCT04248465|449224450|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
124891610|NCT04248465|449224449|FG000|Randomized-Controlled Period|Physician Decision|1|||
124891611|NCT04248465|449224450|FG001|Randomized-Controlled Period|Physician Decision|1|||
124891612|NCT04248465|449224449|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
124891613|NCT04248465|449224450|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
124891614|NCT04248465|449224449|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
124891615|NCT04248465|449224450|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
124891616|NCT04248465|449224449|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
124891617|NCT04248465|449224450|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
124891618|NCT05708846|449224451|FG000|Overall Study|Death|5|||
124891619|NCT05708846|449224451|FG000|Overall Study|Withdrawal by Subject|20|||
124891620|NCT00442286|449224452|FG000|Overall Study|Death|2|||
124891621|NCT00442286|449224453|FG001|Overall Study|Death|2|||
124891622|NCT00442286|449224452|FG000|Overall Study|Lost to Follow-up|1|||
124891623|NCT00442286|449224453|FG001|Overall Study|Lost to Follow-up|0|||
124891624|NCT00442286|449224452|FG000|Overall Study|Withdrawal by Subject|2|||
124891625|NCT00442286|449224453|FG001|Overall Study|Withdrawal by Subject|0|||
124891626|NCT00442286|449224452|FG000|Overall Study|System explanted|1|||
124891627|NCT00442286|449224453|FG001|Overall Study|System explanted|0|||
124891628|NCT00442286|449224452|FG000|Overall Study|Patient Injury|1|||
124891629|NCT00442286|449224453|FG001|Overall Study|Patient Injury|0|||
124891630|NCT03428815|449224454|FG000|Overall Study|Lost to Follow-up|2|||
124891631|NCT03428815|449224455|FG001|Overall Study|Lost to Follow-up|2|||
124891632|NCT03428815|449224454|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
124891633|NCT03428815|449224455|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
124891634|NCT03428815|449224454|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
124891635|NCT03428815|449224455|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
124891636|NCT01700348|449224456|FG000|Overall Study|Withdrawal by Subject|22|||
124891637|NCT01700348|449224456|FG000|Overall Study|Lost to Follow-up|1|||
124891638|NCT01778062|449224457|FG000|Overall Study|Adverse Event|1|||
124442040|NCT02963610|447580024|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
124442041|NCT05333224|447580025|FG000|Overall Study - Infants|Lost to Follow-up|1|||
124442042|NCT05333224|447580026|FG001|Overall Study - Infants|Lost to Follow-up|1|||
124442043|NCT00063154|447580027|FG000|Overall Study|Disease progression|27|||
124442044|NCT00063154|447580027|FG000|Overall Study|Adverse Event|2|||
124442045|NCT00063154|447580027|FG000|Overall Study|Physician Decision|10|||
124442046|NCT00063154|447580027|FG000|Overall Study|Death|3|||
124442047|NCT00063154|447580027|FG000|Overall Study|Reason unspecified|1|||
124442048|NCT00063154|447580027|FG000|Overall Study|Did not receive treatment|8|||
124891639|NCT01778062|449224458|FG001|Overall Study|Adverse Event|3|||
124891640|NCT01778062|449224457|FG000|Overall Study|Consent Withdrawal|1|||
124891641|NCT01778062|449224458|FG001|Overall Study|Consent Withdrawal|5|||
124442049|NCT03588728|447580028|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
124442050|NCT03588728|447580029|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
124442051|NCT03588728|447580030|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
124442052|NCT03588728|447580031|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
124891642|NCT01778062|449224457|FG000|Overall Study|major protocol deviation|4|||
124891643|NCT01778062|449224458|FG001|Overall Study|major protocol deviation|3|||
124891644|NCT01824472|449224459|FG000|Overall Study|Lost to Follow-up|0|||
124891645|NCT01824472|449224460|FG001|Overall Study|Lost to Follow-up|0|||
124891646|NCT01824472|449224461|FG002|Overall Study|Lost to Follow-up|1|||
124891647|NCT01824472|449224459|FG000|Overall Study|Withdrawal by Subject|1|||
124891648|NCT01824472|449224460|FG001|Overall Study|Withdrawal by Subject|5|||
124891649|NCT01824472|449224461|FG002|Overall Study|Withdrawal by Subject|3|||
124891650|NCT01824472|449224459|FG000|Overall Study|Ineligible post randomization&screening|0|||
124442053|NCT03588728|447580028|FG000|Overall Study|Lab shut down due to COVID-19|0|||
124891651|NCT01824472|449224460|FG001|Overall Study|Ineligible post randomization&screening|2|||
124891652|NCT01824472|449224461|FG002|Overall Study|Ineligible post randomization&screening|0|||
124891653|NCT01815736|449224464|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
124891654|NCT01815736|449224465|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
124891655|NCT01815736|449224464|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
124442054|NCT03588728|447580029|FG001|Overall Study|Lab shut down due to COVID-19|0|||
124442055|NCT03588728|447580030|FG002|Overall Study|Lab shut down due to COVID-19|0|||
124442056|NCT03588728|447580031|FG003|Overall Study|Lab shut down due to COVID-19|1|||
124442057|NCT03588728|447580028|FG000|Overall Study|multiple technical issues|1|||
124891656|NCT01815736|449224465|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
124891657|NCT01815736|449224464|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
124891658|NCT01815736|449224465|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
124891659|NCT01815736|449224464|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
124891660|NCT01815736|449224465|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
124891661|NCT01815736|449224464|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
124891662|NCT01815736|449224465|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
124891663|NCT01815736|449224464|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
124891664|NCT01815736|449224465|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
124891665|NCT01815736|449224464|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
124891666|NCT01815736|449224465|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
124891667|NCT01815736|449224464|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
124891668|NCT01815736|449224465|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
124891669|NCT01815736|449224464|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
124891670|NCT01815736|449224465|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
124891671|NCT01815736|449224464|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
124891672|NCT01815736|449224465|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
124891673|NCT01815736|449224464|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
124891674|NCT01815736|449224465|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
124891675|NCT01815736|449224464|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
124891676|NCT01815736|449224465|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
124891677|NCT01815736|449224464|FG000|Extension Treatment Phase- After Week 96|Death|1|||
124891678|NCT01815736|449224465|FG001|Extension Treatment Phase- After Week 96|Death|0|||
124891679|NCT03387514|449224467|FG000|Overall Study|Withdrawal by Subject|2|||
124891680|NCT03387514|449224467|FG000|Overall Study|Physician Decision|1|||
124891681|NCT03387514|449224467|FG000|Overall Study|Lost to Follow-up|2|||
124891682|NCT00394095|449225854|FG000|Screening|Withdrawal by Subject|1|||
124891683|NCT00394095|449225855|FG001|Screening|Withdrawal by Subject|0|||
124891684|NCT00394095|449225854|FG000|Randomized|Withdrawal by Subject|5|||
124891685|NCT00394095|449225855|FG001|Randomized|Withdrawal by Subject|1|||
124891686|NCT00394095|449225854|FG000|Randomized|Adverse Event|1|||
124891687|NCT00394095|449225855|FG001|Randomized|Adverse Event|1|||
124891688|NCT00394095|449225854|FG000|Randomized|Overdose|1|||
124891689|NCT00394095|449225855|FG001|Randomized|Overdose|0|||
124891690|NCT00394095|449225854|FG000|Randomized|Lost to Follow-up|1|||
124891691|NCT00394095|449225855|FG001|Randomized|Lost to Follow-up|2|||
124891692|NCT01646320|449225863|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
124891693|NCT01646320|449225864|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
124891694|NCT01646320|449225863|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
124891695|NCT01646320|449225864|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
124891696|NCT01646320|449225863|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
124891697|NCT01646320|449225864|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
124891698|NCT01646320|449225863|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
124891699|NCT01646320|449225864|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
124891700|NCT01646320|449225863|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
124891701|NCT01646320|449225864|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
124891702|NCT01646320|449225863|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
124891703|NCT01646320|449225864|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
124891704|NCT01646320|449225863|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
124891705|NCT01646320|449225864|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
124891706|NCT01646320|449225863|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
124891707|NCT01646320|449225864|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
124891708|NCT01646320|449225863|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
124891709|NCT01646320|449225864|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
124891710|NCT01646320|449225863|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
124891711|NCT01646320|449225864|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
124891712|NCT01646320|449225863|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
124891713|NCT01646320|449225864|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
124891714|NCT01489020|449225865|FG000|Overall Study|Withdrawal by Subject|1|||
124891715|NCT01489020|449225866|FG001|Overall Study|Withdrawal by Subject|0|||
124891716|NCT01489020|449225867|FG002|Overall Study|Withdrawal by Subject|0|||
124891717|NCT01489020|449225868|FG003|Overall Study|Withdrawal by Subject|0|||
124891718|NCT01489020|449225869|FG004|Overall Study|Withdrawal by Subject|0|||
124891719|NCT01489020|449225870|FG005|Overall Study|Withdrawal by Subject|0|||
124891720|NCT01489020|449225865|FG000|Overall Study|Adverse Event|0|||
124891721|NCT01489020|449225866|FG001|Overall Study|Adverse Event|0|||
124891722|NCT01489020|449225867|FG002|Overall Study|Adverse Event|3|||
124466434|NCT01882907|447666401|FG001|Overall Study|Lack of Efficacy|3|||
124891723|NCT01489020|449225868|FG003|Overall Study|Adverse Event|0|||
124891724|NCT01489020|449225869|FG004|Overall Study|Adverse Event|3|||
124891725|NCT01489020|449225870|FG005|Overall Study|Adverse Event|0|||
124891726|NCT01489020|449225865|FG000|Overall Study|Concomitant disease|0|||
124891727|NCT01489020|449225866|FG001|Overall Study|Concomitant disease|0|||
124891728|NCT01489020|449225867|FG002|Overall Study|Concomitant disease|0|||
124891729|NCT01489020|449225868|FG003|Overall Study|Concomitant disease|0|||
124891730|NCT01489020|449225869|FG004|Overall Study|Concomitant disease|3|||
124891731|NCT01489020|449225870|FG005|Overall Study|Concomitant disease|0|||
124891732|NCT02424344|449225871|FG000|Overall Study|Lack of Efficacy|0|||
124891733|NCT02424344|449225872|FG001|Overall Study|Lack of Efficacy|1|||
124891734|NCT02424344|449225871|FG000|Overall Study|Withdrawal by Subject|2|||
124891735|NCT02424344|449225872|FG001|Overall Study|Withdrawal by Subject|1|||
124891736|NCT02424344|449225871|FG000|Overall Study|Lost to Follow-up|1|||
124891737|NCT02424344|449225872|FG001|Overall Study|Lost to Follow-up|0|||
124891738|NCT02424344|449225871|FG000|Overall Study|Adverse Event|4|||
124891739|NCT02424344|449225872|FG001|Overall Study|Adverse Event|8|||
124891740|NCT01174550|449225873|FG000|Overall Study|Death|75|||
124891741|NCT01174550|449225874|FG001|Overall Study|Death|74|||
124891742|NCT01174550|449225873|FG000|Overall Study|Lost to Follow-up|652|||
124891743|NCT01174550|449225874|FG001|Overall Study|Lost to Follow-up|510|||
124891744|NCT01174550|449225873|FG000|Overall Study|Withdrawal by Subject|543|||
124891745|NCT01174550|449225874|FG001|Overall Study|Withdrawal by Subject|289|||
124891746|NCT05257837|449225875|FG000|Overall Study|Excluded (did not find the guns)|4|||
124891747|NCT05257837|449225876|FG001|Overall Study|Excluded (did not find the guns)|2|||
124891748|NCT05257837|449225877|FG002|Overall Study|Excluded (did not find the guns)|4|||
124891749|NCT05257837|449225878|FG003|Overall Study|Excluded (did not find the guns)|0|||
124891750|NCT01625338|449225879|FG000|Overall Study|Enrolled but not Treated|0|||
124891751|NCT01625338|449225880|FG001|Overall Study|Enrolled but not Treated|0|||
124891752|NCT01625338|449225881|FG002|Overall Study|Enrolled but not Treated|1|||
124891753|NCT01625338|449225879|FG000|Overall Study|Efficacy Failure|27|||
124891754|NCT01625338|449225880|FG001|Overall Study|Efficacy Failure|39|||
124891755|NCT01625338|449225881|FG002|Overall Study|Efficacy Failure|31|||
124891756|NCT01625338|449225879|FG000|Overall Study|Lost to Follow-up|3|||
124891757|NCT01625338|449225880|FG001|Overall Study|Lost to Follow-up|3|||
124442058|NCT03588728|447580029|FG001|Overall Study|multiple technical issues|0|||
124442059|NCT03588728|447580030|FG002|Overall Study|multiple technical issues|0|||
124442060|NCT03588728|447580031|FG003|Overall Study|multiple technical issues|0|||
124442061|NCT03588728|447580028|FG000|Overall Study|Hospitalized for COVID|1|||
124442062|NCT03588728|447580029|FG001|Overall Study|Hospitalized for COVID|0|||
124442063|NCT03588728|447580030|FG002|Overall Study|Hospitalized for COVID|0|||
124442064|NCT03588728|447580031|FG003|Overall Study|Hospitalized for COVID|0|||
124442065|NCT03588728|447580028|FG000|Overall Study|Schedule change unable to attend sessions|1|||
124442066|NCT03588728|447580029|FG001|Overall Study|Schedule change unable to attend sessions|0|||
124442067|NCT03588728|447580030|FG002|Overall Study|Schedule change unable to attend sessions|0|||
124442068|NCT03588728|447580031|FG003|Overall Study|Schedule change unable to attend sessions|0|||
124442069|NCT03285178|447580032|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
124442070|NCT03285178|447580033|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
124442071|NCT03285178|447580034|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
124442072|NCT03285178|447580035|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
124442073|NCT03285178|447580036|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
124442074|NCT03285178|447580037|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
124442075|NCT03285178|447580038|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
124466435|NCT01882907|447666400|FG000|Overall Study|Lost to Follow-up|1|||
124686613|NCT00843882|448472119|FG001|Step 1|Alternative therapy|1|||
124686614|NCT00843882|448472120|FG002|Step 1|Alternative therapy|1|||
124686615|NCT00843882|448472118|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
124686616|NCT00843882|448472119|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
124686617|NCT00843882|448472120|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
124686618|NCT00843882|448472118|FG000|Step 1|Off treatment reason unknown|0|||
124891758|NCT01625338|449225881|FG002|Overall Study|Lost to Follow-up|2|||
124891759|NCT01625338|449225879|FG000|Overall Study|Investigator Decision|0|||
124891760|NCT01625338|449225880|FG001|Overall Study|Investigator Decision|2|||
124891761|NCT01625338|449225881|FG002|Overall Study|Investigator Decision|1|||
124891762|NCT01625338|449225879|FG000|Overall Study|Subject Withdrew Consent|1|||
124891763|NCT01625338|449225880|FG001|Overall Study|Subject Withdrew Consent|0|||
124891764|NCT01625338|449225881|FG002|Overall Study|Subject Withdrew Consent|2|||
124891765|NCT01625338|449225879|FG000|Overall Study|Adverse Event|1|||
124891766|NCT01625338|449225880|FG001|Overall Study|Adverse Event|0|||
124891767|NCT01625338|449225881|FG002|Overall Study|Adverse Event|1|||
124891768|NCT01625338|449225879|FG000|Overall Study|Study Discontinued by Sponsor|0|||
124891769|NCT01625338|449225880|FG001|Overall Study|Study Discontinued by Sponsor|0|||
124891770|NCT01625338|449225881|FG002|Overall Study|Study Discontinued by Sponsor|1|||
124891771|NCT02485353|449225882|FG000|Overall Study|Death|1|||
124891772|NCT02485353|449225882|FG000|Overall Study|Disease Progression|1|||
124891773|NCT03930186|449225883|FG000|Weeks 0 to 16|Adverse Event|6|||
124891774|NCT03930186|449225883|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
124891775|NCT03930186|449225883|FG000|Weeks 16 to 32|Adverse Event|1|||
124891776|NCT03930186|449225883|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
124891777|NCT00557505|449225886|FG000|Overall Study|Death|0|||
124891778|NCT00557505|449225887|FG001|Overall Study|Death|0|||
124891779|NCT00557505|449225888|FG002|Overall Study|Death|0|||
124891780|NCT00557505|449225889|FG003|Overall Study|Death|0|||
124891781|NCT00557505|449225890|FG004|Overall Study|Death|0|||
124891782|NCT00557505|449225891|FG005|Overall Study|Death|0|||
124891783|NCT00557505|449225892|FG006|Overall Study|Death|0|||
124891784|NCT00557505|449225893|FG007|Overall Study|Death|0|||
124891785|NCT00557505|449225894|FG008|Overall Study|Death|1|||
124891786|NCT00557505|449225886|FG000|Overall Study|Adverse Event|0|||
124891787|NCT00557505|449225887|FG001|Overall Study|Adverse Event|0|||
124891788|NCT00557505|449225888|FG002|Overall Study|Adverse Event|1|||
124891789|NCT00557505|449225889|FG003|Overall Study|Adverse Event|0|||
124891790|NCT00557505|449225890|FG004|Overall Study|Adverse Event|0|||
124891791|NCT00557505|449225891|FG005|Overall Study|Adverse Event|0|||
124442076|NCT03285178|447580032|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
124891792|NCT00557505|449225892|FG006|Overall Study|Adverse Event|1|||
124891793|NCT00557505|449225893|FG007|Overall Study|Adverse Event|0|||
124891794|NCT00557505|449225894|FG008|Overall Study|Adverse Event|0|||
124891795|NCT00557505|449225886|FG000|Overall Study|Global deterioration of health|1|||
124891796|NCT00557505|449225887|FG001|Overall Study|Global deterioration of health|0|||
124891797|NCT00557505|449225888|FG002|Overall Study|Global deterioration of health|0|||
124891798|NCT00557505|449225889|FG003|Overall Study|Global deterioration of health|0|||
124891799|NCT00557505|449225890|FG004|Overall Study|Global deterioration of health|0|||
124891800|NCT00557505|449225891|FG005|Overall Study|Global deterioration of health|0|||
124891801|NCT00557505|449225892|FG006|Overall Study|Global deterioration of health|0|||
124891802|NCT00557505|449225893|FG007|Overall Study|Global deterioration of health|0|||
124891803|NCT00557505|449225894|FG008|Overall Study|Global deterioration of health|0|||
124891804|NCT00557505|449225886|FG000|Overall Study|Objective progression or relapse|2|||
124891805|NCT00557505|449225887|FG001|Overall Study|Objective progression or relapse|3|||
124891806|NCT00557505|449225888|FG002|Overall Study|Objective progression or relapse|3|||
124891807|NCT00557505|449225889|FG003|Overall Study|Objective progression or relapse|2|||
124891808|NCT00557505|449225890|FG004|Overall Study|Objective progression or relapse|2|||
124891809|NCT00557505|449225891|FG005|Overall Study|Objective progression or relapse|3|||
124891810|NCT00557505|449225892|FG006|Overall Study|Objective progression or relapse|2|||
124891811|NCT00557505|449225893|FG007|Overall Study|Objective progression or relapse|5|||
124442077|NCT03285178|447580033|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
124442078|NCT03285178|447580034|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
124442079|NCT03285178|447580035|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
124759258|NCT04170543|448742596|FG003|Overall Study|Death|1|||
124891812|NCT00557505|449225894|FG008|Overall Study|Objective progression or relapse|15|||
124891813|NCT00557505|449225886|FG000|Overall Study|Withdrawal by Subject|0|||
124891814|NCT00557505|449225887|FG001|Overall Study|Withdrawal by Subject|0|||
124891815|NCT00557505|449225888|FG002|Overall Study|Withdrawal by Subject|0|||
124891816|NCT00557505|449225889|FG003|Overall Study|Withdrawal by Subject|1|||
124759259|NCT04170543|448742597|FG004|Overall Study|Death|1|||
124891817|NCT00557505|449225890|FG004|Overall Study|Withdrawal by Subject|0|||
124891818|NCT00557505|449225891|FG005|Overall Study|Withdrawal by Subject|0|||
124891819|NCT00557505|449225892|FG006|Overall Study|Withdrawal by Subject|0|||
124891820|NCT00557505|449225893|FG007|Overall Study|Withdrawal by Subject|0|||
124891821|NCT00557505|449225894|FG008|Overall Study|Withdrawal by Subject|1|||
124891822|NCT04990440|449225905|FG000|Overall Study|Sponsor's Decision|0|||
124891823|NCT04990440|449225906|FG001|Overall Study|Sponsor's Decision|0|||
124891824|NCT04990440|449225907|FG002|Overall Study|Sponsor's Decision|1|||
124891825|NCT03712098|449225908|FG000|Overall Study|Lost to Follow-up|3|||
124891826|NCT03712098|449225909|FG001|Overall Study|Lost to Follow-up|7|||
124891827|NCT03712098|449225908|FG000|Overall Study|Withdrawal by Subject|9|||
124891828|NCT03712098|449225909|FG001|Overall Study|Withdrawal by Subject|4|||
124891829|NCT03712098|449225908|FG000|Overall Study|Protocol Violation|2|||
124891830|NCT03712098|449225909|FG001|Overall Study|Protocol Violation|1|||
124891831|NCT00724061|449225912|FG000|Dose Escalation Phase|Adverse Event|2|||
124891832|NCT00724061|449225912|FG000|Dose Escalation Phase|Disease Progression|3|||
124891833|NCT01237678|449225917|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
124891834|NCT01237678|449225918|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
124891835|NCT01237678|449225919|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
124891836|NCT01237678|449225917|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
124891837|NCT01237678|449225918|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
124891838|NCT01237678|449225919|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
124891839|NCT01237678|449225917|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
124891840|NCT01237678|449225918|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
124891841|NCT01237678|449225919|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
124891842|NCT01237678|449225917|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
124891843|NCT01237678|449225918|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
124891844|NCT01237678|449225919|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
124891845|NCT01237678|449225917|FG000|Phase II|Adverse Event|0|||
124891846|NCT01237678|449225918|FG001|Phase II|Adverse Event|39|||
124891847|NCT01237678|449225919|FG002|Phase II|Adverse Event|9|||
124891848|NCT01237678|449225917|FG000|Phase II|Death|0|||
124891849|NCT01237678|449225918|FG001|Phase II|Death|0|||
124891850|NCT01237678|449225919|FG002|Phase II|Death|2|||
124891851|NCT01237678|449225917|FG000|Phase II|Lack of Efficacy|0|||
124891852|NCT01237678|449225918|FG001|Phase II|Lack of Efficacy|25|||
124891853|NCT01237678|449225919|FG002|Phase II|Lack of Efficacy|3|||
124891854|NCT01237678|449225917|FG000|Phase II|Withdrawal by Subject|0|||
124891855|NCT01237678|449225918|FG001|Phase II|Withdrawal by Subject|1|||
124891856|NCT01237678|449225919|FG002|Phase II|Withdrawal by Subject|5|||
124891857|NCT01237678|449225917|FG000|Phase II|Completed Cycles 4-6|0|||
124891858|NCT01237678|449225918|FG001|Phase II|Completed Cycles 4-6|11|||
124891859|NCT01237678|449225919|FG002|Phase II|Completed Cycles 4-6|21|||
124891860|NCT01237678|449225917|FG000|Phase II|Sponsor Decision/Study Closed|0|||
124891861|NCT01237678|449225918|FG001|Phase II|Sponsor Decision/Study Closed|18|||
124891862|NCT01237678|449225919|FG002|Phase II|Sponsor Decision/Study Closed|7|||
124891863|NCT01237678|449225917|FG000|Phase II|Randomized but were not treated|0|||
124891864|NCT01237678|449225918|FG001|Phase II|Randomized but were not treated|4|||
124891865|NCT01237678|449225919|FG002|Phase II|Randomized but were not treated|3|||
124891866|NCT01723826|449225920|FG000|Overall Study|Adverse Event|4|||
124891867|NCT01723826|449225921|FG001|Overall Study|Adverse Event|1|||
124891868|NCT01723826|449225922|FG002|Overall Study|Adverse Event|4|||
124891869|NCT01723826|449225923|FG003|Overall Study|Adverse Event|5|||
124891870|NCT01723826|449225920|FG000|Overall Study|Death according to AE eCRF|2|||
124891871|NCT01723826|449225921|FG001|Overall Study|Death according to AE eCRF|3|||
124891872|NCT01723826|449225922|FG002|Overall Study|Death according to AE eCRF|3|||
124891873|NCT01723826|449225923|FG003|Overall Study|Death according to AE eCRF|7|||
124891874|NCT01723826|449225920|FG000|Overall Study|Lost to Follow-up|1|||
124891875|NCT01723826|449225921|FG001|Overall Study|Lost to Follow-up|3|||
124891876|NCT01723826|449225922|FG002|Overall Study|Lost to Follow-up|1|||
124891877|NCT01723826|449225923|FG003|Overall Study|Lost to Follow-up|1|||
124891878|NCT01723826|449225920|FG000|Overall Study|Non-compliance|0|||
124891879|NCT01723826|449225921|FG001|Overall Study|Non-compliance|1|||
124891880|NCT01723826|449225922|FG002|Overall Study|Non-compliance|3|||
124891881|NCT01723826|449225923|FG003|Overall Study|Non-compliance|3|||
124891882|NCT01723826|449225920|FG000|Overall Study|Non-compliance With Study Drug|0|||
124891883|NCT01723826|449225921|FG001|Overall Study|Non-compliance With Study Drug|1|||
124891884|NCT01723826|449225922|FG002|Overall Study|Non-compliance With Study Drug|0|||
124891885|NCT01723826|449225923|FG003|Overall Study|Non-compliance With Study Drug|0|||
124891886|NCT01723826|449225920|FG000|Overall Study|Other Reason|8|||
124891887|NCT01723826|449225921|FG001|Overall Study|Other Reason|6|||
124891888|NCT01723826|449225922|FG002|Overall Study|Other Reason|12|||
124891889|NCT01723826|449225923|FG003|Overall Study|Other Reason|14|||
124891890|NCT01723826|449225920|FG000|Overall Study|Physician Decision|1|||
124891891|NCT01723826|449225921|FG001|Overall Study|Physician Decision|3|||
124891892|NCT01723826|449225922|FG002|Overall Study|Physician Decision|4|||
124891893|NCT01723826|449225923|FG003|Overall Study|Physician Decision|11|||
124891894|NCT01723826|449225920|FG000|Overall Study|Protocol Violation|1|||
124891895|NCT01723826|449225921|FG001|Overall Study|Protocol Violation|1|||
124891896|NCT01723826|449225922|FG002|Overall Study|Protocol Violation|3|||
124891897|NCT01723826|449225923|FG003|Overall Study|Protocol Violation|1|||
124891898|NCT01723826|449225920|FG000|Overall Study|Withdrawal by Subject|10|||
124891899|NCT01723826|449225921|FG001|Overall Study|Withdrawal by Subject|17|||
124891900|NCT01723826|449225922|FG002|Overall Study|Withdrawal by Subject|27|||
124891901|NCT01723826|449225923|FG003|Overall Study|Withdrawal by Subject|48|||
124891902|NCT01272011|449225924|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
124891903|NCT01272011|449225925|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
124891904|NCT01272011|449225926|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
124891905|NCT01627340|449225927|FG000|Overall Study|Adverse Event|1|||
124891906|NCT01627340|449225928|FG001|Overall Study|Adverse Event|0|||
124891907|NCT01627340|449225927|FG000|Overall Study|Lost to Follow-up|8|||
124891908|NCT01627340|449225928|FG001|Overall Study|Lost to Follow-up|4|||
124891909|NCT01627340|449225927|FG000|Overall Study|Pregnancy|1|||
124891910|NCT01627340|449225928|FG001|Overall Study|Pregnancy|0|||
124891911|NCT01627340|449225927|FG000|Overall Study|Withdrawal by Subject|2|||
124891912|NCT01627340|449225928|FG001|Overall Study|Withdrawal by Subject|0|||
124891913|NCT02013687|449225929|FG000|Overall Study|Lost to Follow-up|0|||
124891914|NCT02013687|449225930|FG001|Overall Study|Lost to Follow-up|0|||
124891915|NCT02013687|449225931|FG002|Overall Study|Lost to Follow-up|1|||
124891916|NCT02013687|449225932|FG003|Overall Study|Lost to Follow-up|0|||
124891917|NCT02013687|449225929|FG000|Overall Study|Protocol Violation|0|||
124891918|NCT02013687|449225930|FG001|Overall Study|Protocol Violation|0|||
124891919|NCT02013687|449225931|FG002|Overall Study|Protocol Violation|0|||
124891920|NCT02013687|449225932|FG003|Overall Study|Protocol Violation|1|||
124891921|NCT02013687|449225929|FG000|Overall Study|Withdrawal by Subject|0|||
124891922|NCT02013687|449225930|FG001|Overall Study|Withdrawal by Subject|0|||
124891923|NCT02013687|449225931|FG002|Overall Study|Withdrawal by Subject|0|||
124891924|NCT02013687|449225932|FG003|Overall Study|Withdrawal by Subject|1|||
124891925|NCT02013687|449225929|FG000|Overall Study|Missed visits due to patient travel|0|||
124891926|NCT02013687|449225930|FG001|Overall Study|Missed visits due to patient travel|0|||
124891927|NCT02013687|449225931|FG002|Overall Study|Missed visits due to patient travel|1|||
124891928|NCT02013687|449225932|FG003|Overall Study|Missed visits due to patient travel|0|||
124891929|NCT01657032|449225933|FG000|Overall Study|Lost to Follow-up|0|||
124891930|NCT01657032|449225934|FG001|Overall Study|Lost to Follow-up|7|||
124891931|NCT03633903|449225935|FG000|Overall Study|Withdrawal by Subject|1|||
124891932|NCT03633903|449225936|FG001|Overall Study|Withdrawal by Subject|2|||
124891933|NCT03633903|449225935|FG000|Overall Study|Lost to Follow-up|5|||
124891934|NCT03633903|449225936|FG001|Overall Study|Lost to Follow-up|5|||
124891935|NCT05968482|449225937|FG000|First Crossover Period|Withdrawal by Subject|0|||
124891936|NCT05968482|449225938|FG001|First Crossover Period|Withdrawal by Subject|0|||
124891937|NCT05968482|449225939|FG002|First Crossover Period|Withdrawal by Subject|1|||
124891938|NCT05968482|449225940|FG003|First Crossover Period|Withdrawal by Subject|0|||
124891939|NCT05968482|449225941|FG004|First Crossover Period|Withdrawal by Subject|0|||
124891940|NCT05968482|449225942|FG005|First Crossover Period|Withdrawal by Subject|0|||
124891941|NCT05968482|449225937|FG000|First Crossover Period|Adverse Event|0|||
124891942|NCT05968482|449225938|FG001|First Crossover Period|Adverse Event|0|||
124891943|NCT05968482|449225939|FG002|First Crossover Period|Adverse Event|0|||
124891944|NCT05968482|449225940|FG003|First Crossover Period|Adverse Event|0|||
124891945|NCT05968482|449225941|FG004|First Crossover Period|Adverse Event|0|||
124891946|NCT05968482|449225942|FG005|First Crossover Period|Adverse Event|1|||
124891947|NCT05968482|449225937|FG000|Second Crossover Period|Withdrawal by Subject|0|||
124891948|NCT05968482|449225938|FG001|Second Crossover Period|Withdrawal by Subject|0|||
124891949|NCT05968482|449225939|FG002|Second Crossover Period|Withdrawal by Subject|0|||
124891950|NCT05968482|449225940|FG003|Second Crossover Period|Withdrawal by Subject|0|||
124891951|NCT05968482|449225941|FG004|Second Crossover Period|Withdrawal by Subject|1|||
124891952|NCT05968482|449225942|FG005|Second Crossover Period|Withdrawal by Subject|0|||
124891953|NCT05968482|449225937|FG000|Third Crossover Period|Adverse Event|0|||
124891954|NCT05968482|449225938|FG001|Third Crossover Period|Adverse Event|0|||
124891955|NCT05968482|449225939|FG002|Third Crossover Period|Adverse Event|0|||
124686619|NCT00843882|448472119|FG001|Step 1|Off treatment reason unknown|1|||
124686620|NCT00843882|448472120|FG002|Step 1|Off treatment reason unknown|4|||
124686621|NCT00843882|448472118|FG000|Step 1|Never started treatment|2|||
124891956|NCT05968482|449225940|FG003|Third Crossover Period|Adverse Event|0|||
124891957|NCT05968482|449225941|FG004|Third Crossover Period|Adverse Event|1|||
124891958|NCT05968482|449225942|FG005|Third Crossover Period|Adverse Event|0|||
124891959|NCT05968482|449225937|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
124891960|NCT05968482|449225938|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
124891961|NCT05968482|449225939|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
124891962|NCT05968482|449225940|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
124891963|NCT05968482|449225941|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
124891964|NCT05968482|449225942|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
124891965|NCT02559817|449225943|FG000|Treatment Period|Adverse Event|1|||
124891966|NCT02559817|449225944|FG001|Treatment Period|Adverse Event|0|||
124891967|NCT02559817|449225945|FG002|Treatment Period|Adverse Event|1|||
124891968|NCT02559817|449225946|FG003|Treatment Period|Adverse Event|0|||
124891969|NCT02559817|449225947|FG004|Treatment Period|Adverse Event|0|||
124891970|NCT02559817|449225943|FG000|Treatment Period|Lack of Efficacy|0|||
124891971|NCT02559817|449225944|FG001|Treatment Period|Lack of Efficacy|1|||
124891972|NCT02559817|449225945|FG002|Treatment Period|Lack of Efficacy|0|||
124891973|NCT02559817|449225946|FG003|Treatment Period|Lack of Efficacy|0|||
124891974|NCT02559817|449225947|FG004|Treatment Period|Lack of Efficacy|0|||
124891975|NCT02559817|449225943|FG000|Treatment Period|Lost to Follow-up|0|||
124891976|NCT02559817|449225944|FG001|Treatment Period|Lost to Follow-up|1|||
124891977|NCT02559817|449225945|FG002|Treatment Period|Lost to Follow-up|0|||
124891978|NCT02559817|449225946|FG003|Treatment Period|Lost to Follow-up|1|||
124891979|NCT02559817|449225947|FG004|Treatment Period|Lost to Follow-up|0|||
124891980|NCT02559817|449225943|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
124891981|NCT02559817|449225944|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
124891982|NCT02559817|449225945|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
124891983|NCT02559817|449225946|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
124891984|NCT02559817|449225947|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
124891985|NCT02559817|449225943|FG000|Treatment Period|Protocol Violation|0|||
124891986|NCT02559817|449225944|FG001|Treatment Period|Protocol Violation|0|||
124891987|NCT02559817|449225945|FG002|Treatment Period|Protocol Violation|0|||
124891988|NCT02559817|449225946|FG003|Treatment Period|Protocol Violation|1|||
124891989|NCT02559817|449225947|FG004|Treatment Period|Protocol Violation|0|||
124891990|NCT00761774|449225952|FG000|Overall Study|Adverse Event|17|||
124891991|NCT00761774|449225952|FG000|Overall Study|Lack of Efficacy|37|||
124891992|NCT00761774|449225952|FG000|Overall Study|Lost to Follow-up|2|||
124891993|NCT00761774|449225952|FG000|Overall Study|Withdrawal by Subject|9|||
124891994|NCT00761774|449225952|FG000|Overall Study|Non-compliance|4|||
124891995|NCT00761774|449225952|FG000|Overall Study|End of study|2|||
124891996|NCT00761774|449225952|FG000|Overall Study|Reclassification of seizures|1|||
124891997|NCT00761774|449225952|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
124891998|NCT00761774|449225952|FG000|Overall Study|Sponsor decision|1|||
124891999|NCT00761774|449225952|FG000|Overall Study|Investigator clinical judgement|1|||
124892000|NCT00761774|449225952|FG000|Overall Study|Patient moved out of study area|1|||
124892001|NCT00761774|449225952|FG000|Overall Study|Coordinator leaving site|1|||
124892002|NCT00761774|449225952|FG000|Overall Study|Subject IP non-compliance|1|||
124892003|NCT00761774|449225952|FG000|Overall Study|IP stopped by hospital physician|1|||
124892004|NCT01925170|449225953|FG000|Overall Study|Unverified cancer status|53|||
124892005|NCT01077024|449225954|FG000|Overall Study|Lost to Follow-up|20|||
124892006|NCT01077024|449225955|FG001|Overall Study|Lost to Follow-up|14|||
124892007|NCT01077024|449225954|FG000|Overall Study|Withdrawal by Subject|0|||
124892008|NCT01077024|449225955|FG001|Overall Study|Withdrawal by Subject|2|||
124892009|NCT01077024|449225954|FG000|Overall Study|Incarcerated|7|||
124892010|NCT01077024|449225955|FG001|Overall Study|Incarcerated|8|||
124892011|NCT01077024|449225954|FG000|Overall Study|Other|4|||
124892012|NCT01077024|449225955|FG001|Overall Study|Other|4|||
124892013|NCT01603121|449225956|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
124892014|NCT01603121|449225957|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
124892015|NCT00577720|449225958|FG000|Overall Study|Adverse Event|2|||
124892016|NCT00577720|449225959|FG001|Overall Study|Adverse Event|1|||
124892017|NCT00577720|449225960|FG002|Overall Study|Adverse Event|0|||
124892018|NCT00577720|449225961|FG003|Overall Study|Adverse Event|4|||
124892019|NCT00577720|449225958|FG000|Overall Study|Lost to Follow-up|0|||
124892020|NCT00577720|449225959|FG001|Overall Study|Lost to Follow-up|0|||
124892021|NCT00577720|449225960|FG002|Overall Study|Lost to Follow-up|1|||
124892022|NCT00577720|449225961|FG003|Overall Study|Lost to Follow-up|0|||
124892023|NCT00577720|449225958|FG000|Overall Study|Protocol Violation|0|||
124892024|NCT00577720|449225959|FG001|Overall Study|Protocol Violation|0|||
124892025|NCT00577720|449225960|FG002|Overall Study|Protocol Violation|0|||
124892026|NCT00577720|449225961|FG003|Overall Study|Protocol Violation|1|||
124892027|NCT00577720|449225958|FG000|Overall Study|Withdrawal by Subject|2|||
124892028|NCT00577720|449225959|FG001|Overall Study|Withdrawal by Subject|0|||
124892029|NCT00577720|449225960|FG002|Overall Study|Withdrawal by Subject|0|||
124892030|NCT00577720|449225961|FG003|Overall Study|Withdrawal by Subject|2|||
124892031|NCT02839681|449225964|FG000|Overall Study|Death|2|||
124892032|NCT00419003|449225965|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
124892033|NCT00419003|449225966|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
124892034|NCT00419003|449225965|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
124892035|NCT00419003|449225966|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
124892036|NCT02531438|449225967|FG000|Overall Study|Adverse Event|7|||
124892037|NCT02531438|449225968|FG001|Overall Study|Adverse Event|9|||
124892038|NCT02531438|449225967|FG000|Overall Study|Lost to Follow-up|0|||
124892039|NCT02531438|449225968|FG001|Overall Study|Lost to Follow-up|3|||
124892040|NCT02531438|449225967|FG000|Overall Study|Withdrawal by Subject|7|||
124892041|NCT02531438|449225968|FG001|Overall Study|Withdrawal by Subject|8|||
124892042|NCT02531438|449225967|FG000|Overall Study|Physician Decision|0|||
124892043|NCT02531438|449225968|FG001|Overall Study|Physician Decision|1|||
124892044|NCT02531438|449225967|FG000|Overall Study|Death|6|||
124892045|NCT02531438|449225968|FG001|Overall Study|Death|3|||
124892046|NCT02531438|449225967|FG000|Overall Study|Randomized, but Not Treated|4|||
124892047|NCT02531438|449225968|FG001|Overall Study|Randomized, but Not Treated|0|||
124892048|NCT02531438|449225967|FG000|Overall Study|Missed EOT/PTE Visit|5|||
124892049|NCT02531438|449225968|FG001|Overall Study|Missed EOT/PTE Visit|2|||
124892050|NCT02531438|449225967|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
124892051|NCT02531438|449225968|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
124892052|NCT00772928|449225969|FG000|Overall Study|Lost to Follow-up|9|||
124892053|NCT00772928|449225970|FG001|Overall Study|Lost to Follow-up|6|||
124892054|NCT00772928|449225969|FG000|Overall Study|Protocol Violation|10|||
124892055|NCT00772928|449225970|FG001|Overall Study|Protocol Violation|12|||
124892056|NCT00772928|449225969|FG000|Overall Study|Withdrawal by Subject|25|||
124892057|NCT00772928|449225970|FG001|Overall Study|Withdrawal by Subject|22|||
124892058|NCT00772928|449225969|FG000|Overall Study|Did not receive vaccine|0|||
124892059|NCT00772928|449225970|FG001|Overall Study|Did not receive vaccine|1|||
124892060|NCT03100838|449225972|FG000|Overall Study|Adverse Event|1|||
124892061|NCT03100838|449225973|FG001|Overall Study|Adverse Event|0|||
124892062|NCT03100838|449225974|FG002|Overall Study|Adverse Event|0|||
124892063|NCT03100838|449225975|FG003|Overall Study|Adverse Event|0|||
124892064|NCT03100838|449225972|FG000|Overall Study|Physician Decision|1|||
124892065|NCT03100838|449225973|FG001|Overall Study|Physician Decision|1|||
124892066|NCT03100838|449225974|FG002|Overall Study|Physician Decision|1|||
124892067|NCT03100838|449225975|FG003|Overall Study|Physician Decision|1|||
124892068|NCT03100838|449225972|FG000|Overall Study|Pregnancy|0|||
124892069|NCT03100838|449225973|FG001|Overall Study|Pregnancy|1|||
124892070|NCT03100838|449225974|FG002|Overall Study|Pregnancy|0|||
124892071|NCT03100838|449225975|FG003|Overall Study|Pregnancy|0|||
124892072|NCT03100838|449225972|FG000|Overall Study|Lost to Follow-up|0|||
124892073|NCT03100838|449225973|FG001|Overall Study|Lost to Follow-up|0|||
124892074|NCT03100838|449225974|FG002|Overall Study|Lost to Follow-up|1|||
124892075|NCT03100838|449225975|FG003|Overall Study|Lost to Follow-up|0|||
124892076|NCT00801242|449225976|FG000|Overall Study|Adverse Event|10|||
124892077|NCT00801242|449225976|FG000|Overall Study|Withdrawal by Subject|13|||
124892078|NCT00801242|449225976|FG000|Overall Study|Protocol Violation|5|||
124892079|NCT00801242|449225976|FG000|Overall Study|Physician Decision|3|||
124892080|NCT00801242|449225976|FG000|Overall Study|Lost to Follow-up|1|||
124892081|NCT00801242|449225976|FG000|Overall Study|Miscellaneous reasons|20|||
124892082|NCT02554513|449225978|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
124892083|NCT02554513|449225979|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
124892084|NCT00184028|449225982|FG000|Overall Study|Death|1|||
124892085|NCT00184028|449225982|FG000|Overall Study|Lack of Efficacy|4|||
124892086|NCT00184028|449225982|FG000|Overall Study|Adverse Event|2|||
124892087|NCT00184028|449225982|FG000|Overall Study|Withdrawal by Subject|1|||
124892088|NCT00184028|449225982|FG000|Overall Study|Non-compliance|2|||
124892089|NCT00162942|449225985|FG000|Overall Study|Adverse Event|10|||
124892090|NCT00162942|449225986|FG001|Overall Study|Adverse Event|6|||
124892091|NCT00162942|449225985|FG000|Overall Study|Death|1|||
124892092|NCT00162942|449225986|FG001|Overall Study|Death|0|||
124892093|NCT00162942|449225985|FG000|Overall Study|Withdrawal by Subject|3|||
124892094|NCT00162942|449225986|FG001|Overall Study|Withdrawal by Subject|6|||
124892095|NCT00162942|449225985|FG000|Overall Study|Physician Decision|1|||
124892096|NCT00162942|449225986|FG001|Overall Study|Physician Decision|0|||
124892097|NCT00162942|449225985|FG000|Overall Study|Enter Open-Label Study|76|||
124892098|NCT00162942|449225986|FG001|Overall Study|Enter Open-Label Study|35|||
124892099|NCT00162942|449225985|FG000|Overall Study|Alternate Therapy|6|||
124892100|NCT00162942|449225986|FG001|Overall Study|Alternate Therapy|2|||
124892101|NCT00162942|449225985|FG000|Overall Study|Lack of Efficacy|1|||
124892102|NCT00162942|449225986|FG001|Overall Study|Lack of Efficacy|0|||
124892103|NCT00162942|449225985|FG000|Overall Study|Flare During Active Treatment|7|||
124892104|NCT00162942|449225986|FG001|Overall Study|Flare During Active Treatment|3|||
124892105|NCT00162942|449225985|FG000|Overall Study|2 or more consecutive treatments missed|1|||
124892106|NCT00162942|449225986|FG001|Overall Study|2 or more consecutive treatments missed|0|||
124892107|NCT01354938|449225987|FG000|Overall Study|Lost to Follow-up|1|||
124892108|NCT01253200|449225988|FG000|Overall Study|Death|1|||
124892109|NCT01253200|449225989|FG001|Overall Study|Death|0|||
124892110|NCT01253200|449225990|FG002|Overall Study|Death|0|||
124892111|NCT01253200|449225991|FG003|Overall Study|Death|0|||
124892112|NCT01253200|449225992|FG004|Overall Study|Death|0|||
124892113|NCT01253200|449225988|FG000|Overall Study|Lost to Follow-up|1|||
124892114|NCT01253200|449225989|FG001|Overall Study|Lost to Follow-up|1|||
124892115|NCT01253200|449225990|FG002|Overall Study|Lost to Follow-up|0|||
124892116|NCT01253200|449225991|FG003|Overall Study|Lost to Follow-up|0|||
124892117|NCT01253200|449225992|FG004|Overall Study|Lost to Follow-up|0|||
124892118|NCT01253200|449225988|FG000|Overall Study|Withdrawal by Subject|2|||
124892119|NCT01253200|449225989|FG001|Overall Study|Withdrawal by Subject|0|||
124892120|NCT01253200|449225990|FG002|Overall Study|Withdrawal by Subject|0|||
124892121|NCT01253200|449225991|FG003|Overall Study|Withdrawal by Subject|0|||
124892122|NCT01253200|449225992|FG004|Overall Study|Withdrawal by Subject|0|||
124892123|NCT01253200|449225988|FG000|Overall Study|Protocol Violation|1|||
124892124|NCT01253200|449225989|FG001|Overall Study|Protocol Violation|4|||
124892125|NCT01253200|449225990|FG002|Overall Study|Protocol Violation|0|||
124892126|NCT01253200|449225991|FG003|Overall Study|Protocol Violation|0|||
124892127|NCT01253200|449225992|FG004|Overall Study|Protocol Violation|5|||
124892128|NCT01253200|449225988|FG000|Overall Study|intents|10|||
124892129|NCT01253200|449225989|FG001|Overall Study|intents|10|||
124892130|NCT01253200|449225990|FG002|Overall Study|intents|1|||
124892131|NCT01253200|449225991|FG003|Overall Study|intents|3|||
124892132|NCT01253200|449225992|FG004|Overall Study|intents|0|||
124892133|NCT01253200|449225988|FG000|Overall Study|Attempts|6|||
124892134|NCT01253200|449225989|FG001|Overall Study|Attempts|4|||
124892135|NCT01253200|449225990|FG002|Overall Study|Attempts|1|||
124892136|NCT01253200|449225991|FG003|Overall Study|Attempts|2|||
124892137|NCT01253200|449225992|FG004|Overall Study|Attempts|0|||
124892138|NCT02335268|449225993|FG000|Overall Study|Physician Decision|5|||
124892139|NCT02335268|449225994|FG001|Overall Study|Physician Decision|1|||
124892140|NCT02335268|449225993|FG000|Overall Study|Lack of Efficacy|2|||
124892141|NCT02335268|449225994|FG001|Overall Study|Lack of Efficacy|1|||
124892142|NCT02335268|449225993|FG000|Overall Study|Adverse Event|5|||
124892143|NCT02335268|449225994|FG001|Overall Study|Adverse Event|2|||
124892144|NCT02335268|449225993|FG000|Overall Study|increase blasts|2|||
124892145|NCT02335268|449225994|FG001|Overall Study|increase blasts|0|||
124892146|NCT02335268|449225993|FG000|Overall Study|Withdrawal by Subject|3|||
124892147|NCT02335268|449225994|FG001|Overall Study|Withdrawal by Subject|2|||
124892148|NCT03785340|449225998|FG000|Overall Study|Lost to Follow-up|2|||
124892149|NCT03785340|449225999|FG001|Overall Study|Lost to Follow-up|0|||
124892150|NCT03785340|449225998|FG000|Overall Study|Adverse Event|1|||
124892151|NCT03785340|449225999|FG001|Overall Study|Adverse Event|0|||
124892152|NCT01700530|449226002|FG000|Overall Study|Withdrawal by Subject|0|||
124892153|NCT01700530|449226003|FG001|Overall Study|Withdrawal by Subject|3|||
124892154|NCT01700530|449226004|FG002|Overall Study|Withdrawal by Subject|1|||
124892155|NCT03289455|449226009|FG000|Overall Study|Death|1|||
124892156|NCT03289455|449226010|FG001|Overall Study|Death|0|||
124892157|NCT03289455|449226011|FG002|Overall Study|Death|0|||
124892158|NCT03289455|449226009|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
124892159|NCT03289455|449226010|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
124892160|NCT03289455|449226011|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
124892161|NCT03289455|449226009|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
124892162|NCT03289455|449226010|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
124892163|NCT03289455|449226011|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
124892164|NCT03289455|449226009|FG000|Overall Study|Progressive disease|3|||
124892165|NCT03289455|449226010|FG001|Overall Study|Progressive disease|4|||
124892166|NCT03289455|449226011|FG002|Overall Study|Progressive disease|5|||
124892167|NCT00333788|449226012|FG000|Overall Study|Adverse Event|44|||
124892168|NCT00333788|449226012|FG000|Overall Study|Lack of Efficacy|80|||
124892169|NCT00333788|449226012|FG000|Overall Study|Lost to Follow-up|2|||
124892170|NCT00333788|449226012|FG000|Overall Study|Withdrawal by Subject|24|||
124892171|NCT00333788|449226012|FG000|Overall Study|Other: Non-compliance|2|||
124892172|NCT00333788|449226012|FG000|Overall Study|Other: Moved|2|||
124892173|NCT00333788|449226012|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
124892174|NCT00333788|449226012|FG000|Overall Study|Other: Investigator decision|1|||
124892175|NCT00333788|449226012|FG000|Overall Study|Other: Quality of life concern|1|||
124892176|NCT00333788|449226012|FG000|Overall Study|Other: Sponsor decision|1|||
124892177|NCT00333788|449226012|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
124892178|NCT00333788|449226012|FG000|Overall Study|Other: Medical monitor decision|1|||
124892179|NCT00333788|449226012|FG000|Overall Study|Other: Physician decision|1|||
124892180|NCT00333788|449226012|FG000|Overall Study|Other: Signed consent for another study|1|||
124892181|NCT04951479|449226013|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
124892182|NCT01268059|449227775|FG000|Overall Study|Lost to Follow-up|0|||
124892183|NCT01268059|449227776|FG001|Overall Study|Lost to Follow-up|1|||
124892184|NCT01268059|449227777|FG002|Overall Study|Lost to Follow-up|0|||
124892185|NCT01268059|449227778|FG003|Overall Study|Lost to Follow-up|0|||
124892186|NCT01268059|449227775|FG000|Overall Study|Withdrawal by Subject|7|||
124892187|NCT01268059|449227776|FG001|Overall Study|Withdrawal by Subject|4|||
124892188|NCT01268059|449227777|FG002|Overall Study|Withdrawal by Subject|0|||
124892189|NCT01268059|449227778|FG003|Overall Study|Withdrawal by Subject|0|||
124892190|NCT01268059|449227775|FG000|Overall Study|Death|20|||
124892191|NCT01268059|449227776|FG001|Overall Study|Death|30|||
124892192|NCT01268059|449227777|FG002|Overall Study|Death|3|||
124892193|NCT01268059|449227778|FG003|Overall Study|Death|5|||
124892194|NCT01268059|449227775|FG000|Overall Study|Progression of disease|1|||
124892195|NCT01268059|449227776|FG001|Overall Study|Progression of disease|0|||
124892196|NCT01268059|449227777|FG002|Overall Study|Progression of disease|0|||
124892197|NCT01268059|449227778|FG003|Overall Study|Progression of disease|0|||
124892198|NCT02819479|449227779|FG000|Overall Study|Adverse Event|2|||
124892199|NCT05310084|449227780|FG000|Overall Study|Withdrawal by Subject|2|||
124892200|NCT05310084|449227781|FG001|Overall Study|Withdrawal by Subject|3|||
124892201|NCT05310084|449227780|FG000|Overall Study|Participant availability|0|||
124892202|NCT05310084|449227781|FG001|Overall Study|Participant availability|4|||
124892203|NCT05310084|449227780|FG000|Overall Study|Lost to Follow-up|1|||
124892204|NCT05310084|449227781|FG001|Overall Study|Lost to Follow-up|1|||
124892205|NCT05310084|449227780|FG000|Overall Study|Adverse Event|1|||
124892206|NCT05310084|449227781|FG001|Overall Study|Adverse Event|1|||
124892207|NCT05310084|449227780|FG000|Overall Study|Randomized but not vaccinated|4|||
124892208|NCT05310084|449227781|FG001|Overall Study|Randomized but not vaccinated|2|||
124892209|NCT01021332|449227783|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
124892210|NCT01021332|449227783|FG000|Overall Study|Adverse Event|43|||
124892211|NCT01021332|449227783|FG000|Overall Study|Lack of Efficacy|19|||
124892212|NCT01021332|449227783|FG000|Overall Study|Withdrawal of Consent|23|||
124892213|NCT01021332|449227783|FG000|Overall Study|Lost to Follow-up|4|||
124892214|NCT01021332|449227783|FG000|Overall Study|Protocol Violation|9|||
124892215|NCT01021332|449227783|FG000|Overall Study|Miscellaneous|3|||
124892216|NCT03487666|449227786|FG000|Overall Study|Disease progression|4|||
124892217|NCT03487666|449227787|FG001|Overall Study|Disease progression|2|||
124892218|NCT03487666|449227788|FG002|Overall Study|Disease progression|0|||
124892219|NCT03487666|449227786|FG000|Overall Study|Adverse Event|0|||
124892220|NCT03487666|449227787|FG001|Overall Study|Adverse Event|0|||
124892221|NCT03487666|449227788|FG002|Overall Study|Adverse Event|1|||
124892222|NCT05343455|449227791|FG000|Overall Study|Withdrawal by Subject|4|||
124892223|NCT05343455|449227792|FG001|Overall Study|Withdrawal by Subject|9|||
124892224|NCT05343455|449227793|FG002|Overall Study|Withdrawal by Subject|7|||
124892225|NCT05343455|449227791|FG000|Overall Study|Adverse Event|2|||
124892226|NCT05343455|449227792|FG001|Overall Study|Adverse Event|1|||
124892227|NCT05343455|449227793|FG002|Overall Study|Adverse Event|2|||
124892228|NCT05343455|449227791|FG000|Overall Study|Lost to Follow-up|1|||
124892229|NCT05343455|449227792|FG001|Overall Study|Lost to Follow-up|1|||
124892230|NCT05343455|449227793|FG002|Overall Study|Lost to Follow-up|3|||
124892231|NCT05343455|449227791|FG000|Overall Study|Pregnancy|1|||
124892232|NCT05343455|449227792|FG001|Overall Study|Pregnancy|0|||
124892233|NCT05343455|449227793|FG002|Overall Study|Pregnancy|0|||
124892234|NCT05343455|449227791|FG000|Overall Study|Physician Decision|0|||
124892235|NCT05343455|449227792|FG001|Overall Study|Physician Decision|0|||
124892236|NCT05343455|449227793|FG002|Overall Study|Physician Decision|1|||
124892237|NCT05343455|449227791|FG000|Overall Study|Protocol Violation|0|||
124892238|NCT05343455|449227792|FG001|Overall Study|Protocol Violation|1|||
124892239|NCT05343455|449227793|FG002|Overall Study|Protocol Violation|1|||
124892240|NCT02748512|449227798|FG000|Overall Study|Lost to Follow-up|1|||
124892241|NCT02748512|449227799|FG001|Overall Study|Lost to Follow-up|1|||
124892242|NCT00765362|449227801|FG000|Overall Study|Death|9|||
124892243|NCT00765362|449227801|FG000|Overall Study|Adverse Event|2|||
124892244|NCT00765362|449227801|FG000|Overall Study|Protocol Violation|18|||
124892245|NCT00765362|449227801|FG000|Overall Study|Withdrawal by Subject|13|||
124892246|NCT00765362|449227801|FG000|Overall Study|Lost to Follow-up|95|||
124892247|NCT03019458|449227802|FG000|Overall Study|Death|0|||
124892248|NCT03019458|449227803|FG001|Overall Study|Death|1|||
124892249|NCT00031447|449227804|FG000|Overall Study|Lost to Follow-up|0|||
124892250|NCT00031447|449227805|FG001|Overall Study|Lost to Follow-up|1|||
124892251|NCT00031447|449227804|FG000|Overall Study|Non-compliant|1|||
124892252|NCT00031447|449227805|FG001|Overall Study|Non-compliant|1|||
124892253|NCT00031447|449227804|FG000|Overall Study|Re-activation of Disease|2|||
124892254|NCT00031447|449227805|FG001|Overall Study|Re-activation of Disease|1|||
124892255|NCT00031447|449227804|FG000|Overall Study|Disruption of blinded study drug supply|7|||
124892256|NCT00031447|449227805|FG001|Overall Study|Disruption of blinded study drug supply|4|||
124892257|NCT01636362|449227806|FG000|Overall Study|Physician Decision|6|||
124892258|NCT01636362|449227806|FG000|Overall Study|Subject healed, not returning|1|||
124892259|NCT01636362|449227806|FG000|Overall Study|Withdrawal by Subject|1|||
124892260|NCT01244763|449227807|FG000|Overall Study|Adverse Event|1|||
124892261|NCT01244763|449227808|FG001|Overall Study|Adverse Event|0|||
124892262|NCT01244763|449227809|FG002|Overall Study|Adverse Event|0|||
124892263|NCT01244763|449227810|FG003|Overall Study|Adverse Event|0|||
124892264|NCT01244763|449227811|FG004|Overall Study|Adverse Event|0|||
124892265|NCT01244763|449227812|FG005|Overall Study|Adverse Event|1|||
124892266|NCT01244763|449227807|FG000|Overall Study|Death|1|||
124892267|NCT01244763|449227808|FG001|Overall Study|Death|0|||
124892268|NCT01244763|449227809|FG002|Overall Study|Death|1|||
124892269|NCT01244763|449227810|FG003|Overall Study|Death|0|||
124892270|NCT01244763|449227811|FG004|Overall Study|Death|2|||
124892271|NCT01244763|449227812|FG005|Overall Study|Death|0|||
124892272|NCT01244763|449227807|FG000|Overall Study|Physician Decision|0|||
124892273|NCT01244763|449227808|FG001|Overall Study|Physician Decision|0|||
124892274|NCT01244763|449227809|FG002|Overall Study|Physician Decision|1|||
124892275|NCT01244763|449227810|FG003|Overall Study|Physician Decision|0|||
124892276|NCT01244763|449227811|FG004|Overall Study|Physician Decision|0|||
124892277|NCT01244763|449227812|FG005|Overall Study|Physician Decision|0|||
124892278|NCT01244763|449227807|FG000|Overall Study|Withdrawal by Subject|1|||
124892279|NCT01244763|449227808|FG001|Overall Study|Withdrawal by Subject|2|||
124892280|NCT01244763|449227809|FG002|Overall Study|Withdrawal by Subject|0|||
124892281|NCT01244763|449227810|FG003|Overall Study|Withdrawal by Subject|1|||
124892282|NCT01244763|449227811|FG004|Overall Study|Withdrawal by Subject|1|||
124892283|NCT01244763|449227812|FG005|Overall Study|Withdrawal by Subject|2|||
124892284|NCT01244763|449227807|FG000|Overall Study|Lost to Follow-up|0|||
124892285|NCT01244763|449227808|FG001|Overall Study|Lost to Follow-up|1|||
124892286|NCT01244763|449227809|FG002|Overall Study|Lost to Follow-up|0|||
124892287|NCT01244763|449227810|FG003|Overall Study|Lost to Follow-up|0|||
124892288|NCT01244763|449227811|FG004|Overall Study|Lost to Follow-up|0|||
124892289|NCT01244763|449227812|FG005|Overall Study|Lost to Follow-up|0|||
124892290|NCT01244763|449227807|FG000|Overall Study|Enrolled into the Extension Study|0|||
124892291|NCT01244763|449227808|FG001|Overall Study|Enrolled into the Extension Study|0|||
124892292|NCT01244763|449227809|FG002|Overall Study|Enrolled into the Extension Study|0|||
124892293|NCT01244763|449227810|FG003|Overall Study|Enrolled into the Extension Study|0|||
124892294|NCT01244763|449227811|FG004|Overall Study|Enrolled into the Extension Study|0|||
124892295|NCT01244763|449227812|FG005|Overall Study|Enrolled into the Extension Study|1|||
124892296|NCT01561079|449227816|FG000|Overall Study|Physician Decision|17|||
124892297|NCT01561079|449227816|FG000|Overall Study|Withdrawal by Subject|59|||
124892298|NCT01561079|449227816|FG000|Overall Study|Protocol Violation|2|||
124892299|NCT00664521|449227822|FG000|Overall Study|Adverse Event|4|||
124892300|NCT00664521|449227823|FG001|Overall Study|Adverse Event|1|||
124892301|NCT00664521|449227822|FG000|Overall Study|Lost to Follow-up|1|||
124892302|NCT00664521|449227823|FG001|Overall Study|Lost to Follow-up|0|||
124892303|NCT00664521|449227822|FG000|Overall Study|Other|1|||
124892304|NCT00664521|449227823|FG001|Overall Study|Other|0|||
124892305|NCT02459964|449227824|FG000|Overall Study|Withdrawal by Subject|0|||
124892306|NCT02459964|449227825|FG001|Overall Study|Withdrawal by Subject|0|||
124892307|NCT02459964|449227826|FG002|Overall Study|Withdrawal by Subject|1|||
124892308|NCT02459964|449227824|FG000|Overall Study|Abnormal EKG changes|0|||
124892309|NCT02459964|449227825|FG001|Overall Study|Abnormal EKG changes|0|||
124892310|NCT02459964|449227826|FG002|Overall Study|Abnormal EKG changes|1|||
124892311|NCT00367237|449227827|FG000|Overall Study|Adverse Event|7|||
124442080|NCT03285178|447580036|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
124442081|NCT03285178|447580037|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
124442082|NCT03285178|447580038|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
124686622|NCT00843882|448472119|FG001|Step 1|Never started treatment|0|||
124686623|NCT00843882|448472120|FG002|Step 1|Never started treatment|0|||
124686624|NCT00843882|448472118|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
124686625|NCT00843882|448472119|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
124686626|NCT00843882|448472120|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
124686627|NCT00843882|448472118|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
124686628|NCT00843882|448472119|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
124892312|NCT00367237|449227828|FG001|Overall Study|Adverse Event|2|||
124892313|NCT00367237|449227827|FG000|Overall Study|Lost to Follow-up|1|||
124892314|NCT00367237|449227828|FG001|Overall Study|Lost to Follow-up|0|||
124892315|NCT00367237|449227827|FG000|Overall Study|Withdrawal by Subject|0|||
124892316|NCT00367237|449227828|FG001|Overall Study|Withdrawal by Subject|4|||
124892317|NCT00367237|449227827|FG000|Overall Study|Protocol Violation|2|||
124892318|NCT00367237|449227828|FG001|Overall Study|Protocol Violation|5|||
124892319|NCT02800928|449227831|FG000|Overall Study|Withdrawal by Subject|1|||
124892320|NCT02800928|449227832|FG001|Overall Study|Withdrawal by Subject|1|||
124892321|NCT02800928|449227831|FG000|Overall Study|Protocol Violation|1|||
124892322|NCT02800928|449227832|FG001|Overall Study|Protocol Violation|1|||
124892323|NCT00953160|449227845|FG000|Overall Study|Lost to Follow-up|23|||
124892324|NCT00953160|449227845|FG000|Overall Study|Withdrawal by Subject|4|||
124892325|NCT00570661|449227852|FG000|Overall Study|Disease worsening|5|||
124892326|NCT00570661|449227852|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
124892327|NCT00570661|449227852|FG000|Overall Study|Adverse Event|1|||
124892328|NCT01052662|449227855|FG000|Overall Study|Lost to Follow-up|15|||
124892329|NCT01052662|449227856|FG001|Overall Study|Lost to Follow-up|13|||
124892330|NCT01052662|449227857|FG002|Overall Study|Lost to Follow-up|18|||
124892331|NCT01052662|449227855|FG000|Overall Study|Withdrawal by Subject|3|||
124892332|NCT01052662|449227856|FG001|Overall Study|Withdrawal by Subject|2|||
124892333|NCT01052662|449227857|FG002|Overall Study|Withdrawal by Subject|1|||
124892334|NCT01052662|449227855|FG000|Overall Study|Pharmacy issue|1|||
124892335|NCT01052662|449227856|FG001|Overall Study|Pharmacy issue|3|||
124892336|NCT01052662|449227857|FG002|Overall Study|Pharmacy issue|3|||
124892337|NCT01052662|449227855|FG000|Overall Study|Adverse Event|1|||
124892338|NCT01052662|449227856|FG001|Overall Study|Adverse Event|1|||
124892339|NCT01052662|449227857|FG002|Overall Study|Adverse Event|0|||
124892340|NCT01052662|449227855|FG000|Overall Study|Legal Problem|2|||
124892341|NCT01052662|449227856|FG001|Overall Study|Legal Problem|0|||
124892342|NCT01052662|449227857|FG002|Overall Study|Legal Problem|0|||
124892343|NCT01052662|449227855|FG000|Overall Study|Administrative|0|||
124892344|NCT01052662|449227856|FG001|Overall Study|Administrative|3|||
124892345|NCT01052662|449227857|FG002|Overall Study|Administrative|0|||
124892346|NCT02015663|449227859|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
124892347|NCT02015663|449227860|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
124892348|NCT02015663|449227859|FG000|Overall Study|Withdrawal by Subject|1|||
124892349|NCT02015663|449227860|FG001|Overall Study|Withdrawal by Subject|0|||
124892350|NCT02015663|449227859|FG000|Overall Study|Protocol Violation|0|||
124892351|NCT02015663|449227860|FG001|Overall Study|Protocol Violation|1|||
124892352|NCT02015663|449227859|FG000|Overall Study|Adverse Event|3|||
124892353|NCT02015663|449227860|FG001|Overall Study|Adverse Event|0|||
124892354|NCT02015663|449227859|FG000|Overall Study|Administrative problems|10|||
124892355|NCT02015663|449227860|FG001|Overall Study|Administrative problems|11|||
124892356|NCT01113463|449227861|FG000|Overall Study|Physician Decision|5|||
124892357|NCT03293485|449227863|FG000|Overall Study|Death|1|||
124892358|NCT03293485|449227863|FG000|Overall Study|Screen Failure|2|||
124892359|NCT03293485|449227863|FG000|Overall Study|Withdrawal by Subject|2|||
124892360|NCT00087490|449227864|FG000|Overall Study|Death|6|||
124892361|NCT00087490|449227865|FG001|Overall Study|Death|4|||
124892362|NCT00087490|449227864|FG000|Overall Study|Adverse Event|3|||
124892363|NCT00087490|449227865|FG001|Overall Study|Adverse Event|8|||
124892364|NCT00087490|449227864|FG000|Overall Study|Lack of Efficacy|0|||
124892365|NCT00087490|449227865|FG001|Overall Study|Lack of Efficacy|2|||
124892366|NCT00087490|449227864|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
124892367|NCT00087490|449227865|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
124892368|NCT00087490|449227864|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
124892369|NCT00087490|449227865|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
124892370|NCT00087490|449227864|FG000|Overall Study|Randomized but not treated|7|||
124892371|NCT00087490|449227865|FG001|Overall Study|Randomized but not treated|18|||
124892372|NCT02034435|449227866|FG000|Overall Study|Withdrawal by Subject|1|||
124892373|NCT02034435|449227867|FG001|Overall Study|Withdrawal by Subject|0|||
124892374|NCT02034435|449227868|FG002|Overall Study|Withdrawal by Subject|0|||
124892375|NCT02034435|449227869|FG003|Overall Study|Withdrawal by Subject|0|||
124892376|NCT02034435|449227866|FG000|Overall Study|Illness|0|||
124892377|NCT02034435|449227867|FG001|Overall Study|Illness|2|||
124892378|NCT02034435|449227868|FG002|Overall Study|Illness|0|||
124892379|NCT02034435|449227869|FG003|Overall Study|Illness|0|||
124892380|NCT02034435|449227866|FG000|Overall Study|Inadequate IV access|1|||
124892381|NCT02034435|449227867|FG001|Overall Study|Inadequate IV access|0|||
124892382|NCT02034435|449227868|FG002|Overall Study|Inadequate IV access|0|||
124892383|NCT02034435|449227869|FG003|Overall Study|Inadequate IV access|1|||
124892384|NCT03379233|449227870|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
124892385|NCT03379233|449227871|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
124892386|NCT02300311|449227872|FG000|Overall Study|Other than the reason specified|1|||
124892387|NCT02300311|449227873|FG001|Overall Study|Other than the reason specified|0|||
124892388|NCT02300311|449227872|FG000|Overall Study|Refused to continue taking medication|18|||
124892389|NCT02300311|449227873|FG001|Overall Study|Refused to continue taking medication|0|||
124892390|NCT02015195|449227879|FG000|Overall Study|Adverse Event|0|||
124892391|NCT02015195|449227880|FG001|Overall Study|Adverse Event|0|||
124892392|NCT02015195|449227881|FG002|Overall Study|Adverse Event|0|||
124892393|NCT02015195|449227882|FG003|Overall Study|Adverse Event|1|||
124892394|NCT02015195|449227883|FG004|Overall Study|Adverse Event|0|||
124892395|NCT02015195|449227884|FG005|Overall Study|Adverse Event|0|||
124892396|NCT02015195|449227885|FG006|Overall Study|Adverse Event|0|||
124892397|NCT01318811|449227886|FG000|Overall Study|Physician Decision|1|||
124892398|NCT01318811|449227887|FG001|Overall Study|Physician Decision|1|||
124892399|NCT01318811|449227886|FG000|Overall Study|CRRT stopped for head CT|0|||
124892400|NCT01318811|449227887|FG001|Overall Study|CRRT stopped for head CT|1|||
124892401|NCT01318811|449227886|FG000|Overall Study|Death|0|||
124892402|NCT01318811|449227887|FG001|Overall Study|Death|1|||
124892403|NCT01318811|449227886|FG000|Overall Study|CRRT stopped for head MRI|0|||
124892404|NCT01318811|449227887|FG001|Overall Study|CRRT stopped for head MRI|1|||
124892405|NCT00811187|449227888|FG000|Overall Study|Unable to place device / procedure abort|3|||
124892406|NCT00811187|449227889|FG001|Overall Study|Unable to place device / procedure abort|3|||
124892407|NCT00131911|449227890|FG000|Overall Study|Withdrawal by Subject|1|||
124892408|NCT00131911|449227891|FG001|Overall Study|Withdrawal by Subject|0|||
124892409|NCT00329303|449227892|FG000|Overall Study|Lack of Efficacy|1|||
124892410|NCT00329303|449227893|FG001|Overall Study|Lack of Efficacy|0|||
124892411|NCT00329303|449227892|FG000|Overall Study|Decision of the sponsor|0|||
124892412|NCT00329303|449227893|FG001|Overall Study|Decision of the sponsor|1|||
124892413|NCT00329303|449227892|FG000|Overall Study|Patient no longer available|1|||
124892414|NCT00329303|449227893|FG001|Overall Study|Patient no longer available|0|||
124892415|NCT00329303|449227892|FG000|Overall Study|Patient relocated|0|||
124892416|NCT00329303|449227893|FG001|Overall Study|Patient relocated|1|||
124892417|NCT00994279|449227898|FG000|Overall Study|Withdrawal by Subject|2|||
124892418|NCT00994279|449227899|FG001|Overall Study|Withdrawal by Subject|2|||
124892419|NCT00994279|449227898|FG000|Overall Study|Toxicity|1|||
124892420|NCT00994279|449227899|FG001|Overall Study|Toxicity|0|||
124892421|NCT00994279|449227898|FG000|Overall Study|Multiple reasons|1|||
124892422|NCT00994279|449227899|FG001|Overall Study|Multiple reasons|3|||
124892423|NCT04833855|449227900|FG000|Overall Study|Decision by sponsor|0|||
124892424|NCT04833855|449227901|FG001|Overall Study|Decision by sponsor|1|||
124892425|NCT04833855|449227902|FG002|Overall Study|Decision by sponsor|0|||
124892426|NCT04833855|449227903|FG003|Overall Study|Decision by sponsor|0|||
124892427|NCT04833855|449227900|FG000|Overall Study|Withdrawal by Subject|4|||
124892428|NCT04833855|449227901|FG001|Overall Study|Withdrawal by Subject|1|||
124892429|NCT04833855|449227902|FG002|Overall Study|Withdrawal by Subject|3|||
124892430|NCT04833855|449227903|FG003|Overall Study|Withdrawal by Subject|1|||
124892431|NCT04833855|449227900|FG000|Overall Study|Lost to Follow-up|1|||
124892432|NCT04833855|449227901|FG001|Overall Study|Lost to Follow-up|0|||
124892433|NCT04833855|449227902|FG002|Overall Study|Lost to Follow-up|2|||
124892434|NCT04833855|449227903|FG003|Overall Study|Lost to Follow-up|2|||
124892435|NCT04833855|449227900|FG000|Overall Study|Protocol specified criteria|0|||
124892436|NCT04833855|449227901|FG001|Overall Study|Protocol specified criteria|0|||
124892437|NCT04833855|449227902|FG002|Overall Study|Protocol specified criteria|2|||
124892438|NCT04833855|449227903|FG003|Overall Study|Protocol specified criteria|1|||
124892439|NCT03008122|449227904|FG000|Overall Study|Physician Decision|3|||
124892440|NCT03008122|449227905|FG001|Overall Study|Physician Decision|2|||
124892441|NCT03008122|449227906|FG002|Overall Study|Physician Decision|0|||
124892442|NCT03008122|449227904|FG000|Overall Study|Withdrawal by Subject|1|||
124892443|NCT03008122|449227905|FG001|Overall Study|Withdrawal by Subject|3|||
124892444|NCT03008122|449227906|FG002|Overall Study|Withdrawal by Subject|0|||
124892445|NCT03008122|449227904|FG000|Overall Study|Lost to Follow-up|4|||
124892446|NCT03008122|449227905|FG001|Overall Study|Lost to Follow-up|8|||
124892447|NCT03008122|449227906|FG002|Overall Study|Lost to Follow-up|3|||
124892448|NCT03008122|449227904|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
124892449|NCT03008122|449227905|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
124892450|NCT03008122|449227906|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
124892451|NCT03008122|449227904|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
124892452|NCT03008122|449227905|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
124892453|NCT03008122|449227906|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
124892454|NCT03008122|449227904|FG000|Overall Study|Death|0|||
124892455|NCT03008122|449227905|FG001|Overall Study|Death|0|||
124892456|NCT03008122|449227906|FG002|Overall Study|Death|1|||
124892457|NCT04529538|449227908|FG000|Overall Study|Lost to Follow-up|3|||
124892458|NCT04529538|449227909|FG001|Overall Study|Lost to Follow-up|2|||
124892459|NCT04529538|449227910|FG002|Overall Study|Lost to Follow-up|1|||
124892460|NCT04529538|449227911|FG003|Overall Study|Lost to Follow-up|0|||
124892461|NCT04529538|449227912|FG004|Overall Study|Lost to Follow-up|1|||
124892462|NCT04529538|449227913|FG005|Overall Study|Lost to Follow-up|1|||
124892463|NCT04529538|449227914|FG006|Overall Study|Lost to Follow-up|2|||
124892464|NCT04529538|449227915|FG007|Overall Study|Lost to Follow-up|0|||
124892465|NCT04529538|449227908|FG000|Overall Study|Not eligible at enrollment|0|||
124892466|NCT04529538|449227909|FG001|Overall Study|Not eligible at enrollment|1|||
124892467|NCT04529538|449227910|FG002|Overall Study|Not eligible at enrollment|2|||
124892468|NCT04529538|449227911|FG003|Overall Study|Not eligible at enrollment|1|||
124892469|NCT04529538|449227912|FG004|Overall Study|Not eligible at enrollment|0|||
124892470|NCT04529538|449227913|FG005|Overall Study|Not eligible at enrollment|0|||
124892471|NCT04529538|449227914|FG006|Overall Study|Not eligible at enrollment|0|||
124892472|NCT04529538|449227915|FG007|Overall Study|Not eligible at enrollment|1|||
124892473|NCT04529538|449227908|FG000|Overall Study|Withdrawal by Subject|0|||
124892474|NCT04529538|449227909|FG001|Overall Study|Withdrawal by Subject|1|||
124892475|NCT04529538|449227910|FG002|Overall Study|Withdrawal by Subject|1|||
124892476|NCT04529538|449227911|FG003|Overall Study|Withdrawal by Subject|2|||
124892477|NCT04529538|449227912|FG004|Overall Study|Withdrawal by Subject|0|||
124892478|NCT04529538|449227913|FG005|Overall Study|Withdrawal by Subject|2|||
124892479|NCT04529538|449227914|FG006|Overall Study|Withdrawal by Subject|3|||
124892480|NCT04529538|449227915|FG007|Overall Study|Withdrawal by Subject|0|||
124892481|NCT04529538|449227908|FG000|Overall Study|Other|0|||
124892482|NCT04529538|449227909|FG001|Overall Study|Other|1|||
124892483|NCT04529538|449227910|FG002|Overall Study|Other|0|||
124892484|NCT04529538|449227911|FG003|Overall Study|Other|0|||
124892485|NCT04529538|449227912|FG004|Overall Study|Other|0|||
124892486|NCT04529538|449227913|FG005|Overall Study|Other|0|||
124892487|NCT04529538|449227914|FG006|Overall Study|Other|0|||
124892488|NCT04529538|449227915|FG007|Overall Study|Other|0|||
124892489|NCT04529538|449227908|FG000|Overall Study|Adverse Event|0|||
124892490|NCT04529538|449227909|FG001|Overall Study|Adverse Event|0|||
124892491|NCT04529538|449227910|FG002|Overall Study|Adverse Event|0|||
124892492|NCT04529538|449227911|FG003|Overall Study|Adverse Event|1|||
124892493|NCT04529538|449227912|FG004|Overall Study|Adverse Event|0|||
124892494|NCT04529538|449227913|FG005|Overall Study|Adverse Event|0|||
124892495|NCT04529538|449227914|FG006|Overall Study|Adverse Event|0|||
124892496|NCT04529538|449227915|FG007|Overall Study|Adverse Event|0|||
124892497|NCT04529538|449227908|FG000|Overall Study|Protocol Deviation|0|||
124892498|NCT04529538|449227909|FG001|Overall Study|Protocol Deviation|0|||
124892499|NCT04529538|449227910|FG002|Overall Study|Protocol Deviation|0|||
124892500|NCT04529538|449227911|FG003|Overall Study|Protocol Deviation|1|||
124892501|NCT04529538|449227912|FG004|Overall Study|Protocol Deviation|0|||
124892502|NCT04529538|449227913|FG005|Overall Study|Protocol Deviation|0|||
124892503|NCT04529538|449227914|FG006|Overall Study|Protocol Deviation|0|||
124892504|NCT04529538|449227915|FG007|Overall Study|Protocol Deviation|0|||
124892505|NCT04529538|449227908|FG000|Overall Study|Physician Decision|0|||
124892506|NCT04529538|449227909|FG001|Overall Study|Physician Decision|0|||
124892507|NCT04529538|449227910|FG002|Overall Study|Physician Decision|0|||
124892508|NCT04529538|449227911|FG003|Overall Study|Physician Decision|0|||
124892509|NCT04529538|449227912|FG004|Overall Study|Physician Decision|0|||
124892510|NCT04529538|449227913|FG005|Overall Study|Physician Decision|1|||
124892511|NCT04529538|449227914|FG006|Overall Study|Physician Decision|0|||
124892512|NCT04529538|449227915|FG007|Overall Study|Physician Decision|1|||
124892513|NCT02322775|449227916|FG000|Overall Study|Adverse Event|1|||
124892514|NCT02322775|449227917|FG001|Overall Study|Adverse Event|0|||
124892515|NCT02322775|449227916|FG000|Overall Study|Lost to Follow-up|0|||
124892516|NCT02322775|449227917|FG001|Overall Study|Lost to Follow-up|1|||
124892517|NCT02322775|449227916|FG000|Overall Study|Protocol Violation|1|||
124892518|NCT02322775|449227917|FG001|Overall Study|Protocol Violation|0|||
124892519|NCT02322775|449227916|FG000|Overall Study|Withdrawal by Subject|3|||
124892520|NCT02322775|449227917|FG001|Overall Study|Withdrawal by Subject|4|||
124892521|NCT02322775|449227916|FG000|Overall Study|Not willing to perform all FU visits|0|||
124892522|NCT02322775|449227917|FG001|Overall Study|Not willing to perform all FU visits|1|||
124892523|NCT01641861|449227918|FG000|Overall Study|Lost to Follow-up|21|||
124892524|NCT01641861|449227919|FG001|Overall Study|Lost to Follow-up|16|||
124892525|NCT01641861|449227918|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
124892526|NCT01641861|449227919|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
124892527|NCT01641861|449227918|FG000|Overall Study|Died due to drowning|0|||
124892528|NCT01641861|449227919|FG001|Overall Study|Died due to drowning|1|||
124892529|NCT05567952|449229886|FG000|Overall Study|Lost to Follow-up|3|||
124892530|NCT05567952|449229887|FG001|Overall Study|Lost to Follow-up|2|||
124892531|NCT05567952|449229886|FG000|Overall Study|Withdrawal by Subject|6|||
124892532|NCT05567952|449229887|FG001|Overall Study|Withdrawal by Subject|3|||
124892533|NCT05567952|449229886|FG000|Overall Study|Other|3|||
124892534|NCT05567952|449229887|FG001|Overall Study|Other|1|||
124892535|NCT00777803|449229888|FG000|Overall Study|Lost to Follow-up|12|||
124892536|NCT00777803|449229889|FG001|Overall Study|Lost to Follow-up|5|||
124892537|NCT00777803|449229888|FG000|Overall Study|Adverse Event|1|||
124892538|NCT00777803|449229889|FG001|Overall Study|Adverse Event|0|||
124892539|NCT00777803|449229888|FG000|Overall Study|Non-compliance|2|||
124892540|NCT00777803|449229889|FG001|Overall Study|Non-compliance|2|||
124892541|NCT04213846|449229890|FG000|Overall Study|Withdrawal by Subject|7|||
124892542|NCT04213846|449229891|FG001|Overall Study|Withdrawal by Subject|6|||
124892543|NCT04213846|449229890|FG000|Overall Study|Lost to Follow-up|15|||
124892544|NCT04213846|449229891|FG001|Overall Study|Lost to Follow-up|21|||
124892545|NCT04423393|449229892|FG000|Overall Study|Withdrawal by Subject|0|||
124892546|NCT04423393|449229893|FG001|Overall Study|Withdrawal by Subject|0|||
124892547|NCT04423393|449229894|FG002|Overall Study|Withdrawal by Subject|0|||
124892548|NCT04423393|449229895|FG003|Overall Study|Withdrawal by Subject|0|||
124892549|NCT04423393|449229896|FG004|Overall Study|Withdrawal by Subject|0|||
124892550|NCT04423393|449229897|FG005|Overall Study|Withdrawal by Subject|1|||
124892551|NCT04423393|449229898|FG006|Overall Study|Withdrawal by Subject|0|||
124892552|NCT04423393|449229899|FG007|Overall Study|Withdrawal by Subject|0|||
124892553|NCT04423393|449229900|FG008|Overall Study|Withdrawal by Subject|0|||
124892554|NCT04423393|449229901|FG009|Overall Study|Withdrawal by Subject|0|||
124892555|NCT04423393|449229902|FG010|Overall Study|Withdrawal by Subject|0|||
124892556|NCT04423393|449229903|FG011|Overall Study|Withdrawal by Subject|0|||
124892557|NCT04423393|449229904|FG012|Overall Study|Withdrawal by Subject|0|||
124892558|NCT04423393|449229905|FG013|Overall Study|Withdrawal by Subject|1|||
124892559|NCT04423393|449229906|FG014|Overall Study|Withdrawal by Subject|0|||
124892560|NCT04423393|449229907|FG015|Overall Study|Withdrawal by Subject|0|||
124892561|NCT04423393|449229908|FG016|Overall Study|Withdrawal by Subject|0|||
124892562|NCT04423393|449229909|FG017|Overall Study|Withdrawal by Subject|0|||
124892563|NCT04423393|449229892|FG000|Overall Study|Sponsor Decision|0|||
124892564|NCT04423393|449229893|FG001|Overall Study|Sponsor Decision|0|||
124892565|NCT04423393|449229894|FG002|Overall Study|Sponsor Decision|0|||
124892566|NCT04423393|449229895|FG003|Overall Study|Sponsor Decision|0|||
124892567|NCT04423393|449229896|FG004|Overall Study|Sponsor Decision|0|||
124892568|NCT04423393|449229897|FG005|Overall Study|Sponsor Decision|0|||
124892569|NCT04423393|449229898|FG006|Overall Study|Sponsor Decision|0|||
124892570|NCT04423393|449229899|FG007|Overall Study|Sponsor Decision|0|||
124892571|NCT04423393|449229900|FG008|Overall Study|Sponsor Decision|0|||
124892572|NCT04423393|449229901|FG009|Overall Study|Sponsor Decision|0|||
124892573|NCT04423393|449229902|FG010|Overall Study|Sponsor Decision|0|||
124892574|NCT04423393|449229903|FG011|Overall Study|Sponsor Decision|0|||
124892575|NCT04423393|449229904|FG012|Overall Study|Sponsor Decision|0|||
124892576|NCT04423393|449229905|FG013|Overall Study|Sponsor Decision|1|||
124892577|NCT04423393|449229906|FG014|Overall Study|Sponsor Decision|0|||
124892578|NCT04423393|449229907|FG015|Overall Study|Sponsor Decision|0|||
124892579|NCT04423393|449229908|FG016|Overall Study|Sponsor Decision|0|||
124892580|NCT04423393|449229909|FG017|Overall Study|Sponsor Decision|0|||
124442083|NCT03285178|447580032|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
124442084|NCT03285178|447580033|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
124442085|NCT03285178|447580034|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
124442086|NCT03285178|447580035|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
124442087|NCT03285178|447580036|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
124686629|NCT00843882|448472120|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
124686630|NCT00843882|448472118|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
124686631|NCT00843882|448472119|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
124686632|NCT00843882|448472120|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
124686633|NCT00843882|448472118|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
124892581|NCT00432159|449229912|FG000|Overall Study|Death|0|||
124892582|NCT00432159|449229913|FG001|Overall Study|Death|1|||
124892583|NCT00432159|449229914|FG002|Overall Study|Death|0|||
124892584|NCT00432159|449229915|FG003|Overall Study|Death|0|||
124892585|NCT00432159|449229916|FG004|Overall Study|Death|0|||
124892586|NCT00432159|449229912|FG000|Overall Study|Failure|9|||
124892587|NCT00432159|449229913|FG001|Overall Study|Failure|5|||
124892588|NCT00432159|449229914|FG002|Overall Study|Failure|3|||
124892589|NCT00432159|449229915|FG003|Overall Study|Failure|2|||
124892590|NCT00432159|449229916|FG004|Overall Study|Failure|3|||
124892591|NCT00432159|449229912|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
124892592|NCT00432159|449229913|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
124892593|NCT00432159|449229914|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
124892594|NCT00432159|449229915|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
124892595|NCT00432159|449229916|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
124892596|NCT01115998|449229919|FG000|Overall Study|Lost to Follow-up|6|||
124892597|NCT01115998|449229920|FG001|Overall Study|Lost to Follow-up|6|||
124892598|NCT03850444|449229921|FG000|Overall Study|Adverse Event|16|||
124892599|NCT03850444|449229922|FG001|Overall Study|Adverse Event|10|||
124892600|NCT03850444|449229921|FG000|Overall Study|Death|87|||
124892601|NCT03850444|449229922|FG001|Overall Study|Death|107|||
124892602|NCT03850444|449229921|FG000|Overall Study|Lost to Follow-up|1|||
124892603|NCT03850444|449229922|FG001|Overall Study|Lost to Follow-up|1|||
124892604|NCT03850444|449229921|FG000|Overall Study|Withdrawal by Subject|1|||
124892605|NCT03850444|449229922|FG001|Overall Study|Withdrawal by Subject|5|||
124892606|NCT03850444|449229921|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
124892607|NCT03850444|449229922|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
124892608|NCT04096365|449229923|FG000|Overall Study|Adverse Event|1|||
124892609|NCT01598987|449229925|FG000|Baseline to Month 12|Administrative problems|2|||
124892610|NCT01598987|449229925|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
124892611|NCT01598987|449229925|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
124892612|NCT01598987|449229925|FG000|Baseline to 24 Month|Administrative problems|2|||
124892613|NCT01598987|449229925|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
124892614|NCT02107274|449229926|FG000|Treatment vs. Placebo|Adverse Event|3|||
124892615|NCT02107274|449229927|FG001|Treatment vs. Placebo|Adverse Event|0|||
124892616|NCT02107274|449229926|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
124892617|NCT02107274|449229927|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
124892618|NCT02107274|449229926|FG000|Control Phase|Lost to Follow-up|1|||
124892619|NCT02107274|449229927|FG001|Control Phase|Lost to Follow-up|1|||
124892620|NCT02107274|449229926|FG000|Control Phase|Death|2|||
124892621|NCT02107274|449229927|FG001|Control Phase|Death|0|||
124892622|NCT02107274|449229926|FG000|Control Phase|Adverse Event|0|||
124892623|NCT02107274|449229927|FG001|Control Phase|Adverse Event|1|||
124892624|NCT01036087|449229928|FG000|Overall Study|Adverse Event|2|||
124892625|NCT01036087|449229928|FG000|Overall Study|Lack of Efficacy|1|||
124892626|NCT01021878|449229932|FG000|Overall Study|Lost to Follow-up|4|||
124892627|NCT01021878|449229933|FG001|Overall Study|Lost to Follow-up|3|||
124892628|NCT01021878|449229932|FG000|Overall Study|Death|0|||
124892629|NCT01021878|449229933|FG001|Overall Study|Death|1|||
124892630|NCT01021878|449229932|FG000|Overall Study|Adverse Event|6|||
124892631|NCT01021878|449229933|FG001|Overall Study|Adverse Event|5|||
124892632|NCT01021878|449229932|FG000|Overall Study|Transplantation|6|||
124892633|NCT01021878|449229933|FG001|Overall Study|Transplantation|1|||
124892634|NCT05305040|449229937|FG000|Overall Study|Not Dosed|37|||
124892635|NCT05305040|449229938|FG001|Overall Study|Not Dosed|37|||
124892636|NCT05305040|449229937|FG000|Overall Study|Study Closure|34|||
124892637|NCT05305040|449229938|FG001|Overall Study|Study Closure|46|||
124892638|NCT05305040|449229937|FG000|Overall Study|Death|14|||
124892639|NCT05305040|449229938|FG001|Overall Study|Death|13|||
124892640|NCT05305040|449229937|FG000|Overall Study|Withdrawal by Subject|15|||
124892641|NCT05305040|449229938|FG001|Overall Study|Withdrawal by Subject|10|||
124892642|NCT05305040|449229937|FG000|Overall Study|Other|13|||
124892643|NCT05305040|449229938|FG001|Overall Study|Other|10|||
124892644|NCT05305040|449229937|FG000|Overall Study|Primary Malignancy Relapse|3|||
124892645|NCT05305040|449229938|FG001|Overall Study|Primary Malignancy Relapse|4|||
124892646|NCT05305040|449229937|FG000|Overall Study|Adverse Event|3|||
124892647|NCT05305040|449229938|FG001|Overall Study|Adverse Event|3|||
124892648|NCT05305040|449229937|FG000|Overall Study|Lost to Follow-up|2|||
124892649|NCT05305040|449229938|FG001|Overall Study|Lost to Follow-up|1|||
124892650|NCT05305040|449229937|FG000|Overall Study|Graft versus host disease|2|||
124892651|NCT05305040|449229938|FG001|Overall Study|Graft versus host disease|0|||
124892652|NCT05305040|449229937|FG000|Overall Study|Investigator's Decision|1|||
124892653|NCT05305040|449229938|FG001|Overall Study|Investigator's Decision|1|||
124892654|NCT05305040|449229937|FG000|Overall Study|COVID-19 Reasons|1|||
124892655|NCT05305040|449229938|FG001|Overall Study|COVID-19 Reasons|0|||
124892656|NCT05406791|449229939|FG000|Overall Study|Lost to Follow-up|13|||
124892657|NCT05406791|449229940|FG001|Overall Study|Lost to Follow-up|10|||
124892658|NCT02297503|449229943|FG000|Overall Study|Withdrawal by Subject|1|||
124892659|NCT02297503|449229944|FG001|Overall Study|Withdrawal by Subject|1|||
124892660|NCT02297503|449229943|FG000|Overall Study|Protocol Violation|1|||
124892661|NCT02297503|449229944|FG001|Overall Study|Protocol Violation|0|||
124892662|NCT02297503|449229943|FG000|Overall Study|Pregnancy|0|||
124892663|NCT02297503|449229944|FG001|Overall Study|Pregnancy|1|||
124892664|NCT02297503|449229943|FG000|Overall Study|Lost to Follow-up|0|||
124892665|NCT02297503|449229944|FG001|Overall Study|Lost to Follow-up|1|||
124892666|NCT02297503|449229943|FG000|Overall Study|Medical reason|0|||
124892667|NCT02297503|449229944|FG001|Overall Study|Medical reason|1|||
124892668|NCT00519779|449229947|FG000|Overall Study|Withdrawal by Subject|0|||
124892669|NCT00519779|449229948|FG001|Overall Study|Withdrawal by Subject|1|||
124892670|NCT03330119|449229949|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
124892671|NCT03330119|449229950|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
124892672|NCT00550732|449229959|FG000|Overall Study|Death|4|||
124892673|NCT00550732|449229959|FG000|Overall Study|Withdrawal by Subject|2|||
124892674|NCT00550732|449229959|FG000|Overall Study|Physician Decision|2|||
124892675|NCT00550732|449229959|FG000|Overall Study|Lost to Follow-up|1|||
124892676|NCT00550732|449229959|FG000|Overall Study|Palliative care|1|||
124892677|NCT00550732|449229959|FG000|Overall Study|Adverse Event|1|||
124892678|NCT03302910|449229965|FG000|Overall Study|Protocol Violation|1|||
124892679|NCT03302910|449229966|FG001|Overall Study|Protocol Violation|0|||
124892680|NCT04004208|449229967|FG000|Overall Study|Withdrawal by parent/guardian|1|||
124892681|NCT04004208|449229968|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124892682|NCT04004208|449229967|FG000|Overall Study|Death|3|||
124892683|NCT04004208|449229968|FG001|Overall Study|Death|0|||
124892684|NCT04004208|449229967|FG000|Overall Study|COVID-19 pandemic|1|||
124892685|NCT04004208|449229968|FG001|Overall Study|COVID-19 pandemic|0|||
124892686|NCT04004208|449229967|FG000|Overall Study|Physician Decision|1|||
124892687|NCT04004208|449229968|FG001|Overall Study|Physician Decision|0|||
124892688|NCT04004208|449229967|FG000|Overall Study|Adverse Event|1|||
124892689|NCT04004208|449229968|FG001|Overall Study|Adverse Event|1|||
124892690|NCT02400307|449229970|FG000|Overall Study|Enrolled and Never Dosed|1|||
124892691|NCT02400307|449229971|FG001|Overall Study|Enrolled and Never Dosed|0|||
124892692|NCT03582137|449229977|FG000|Overall Study|Adverse Event|1|||
124892693|NCT03582137|449229978|FG001|Overall Study|Adverse Event|0|||
124892694|NCT02303574|449229979|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
124892695|NCT02303574|449229980|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
124892696|NCT02303574|449229981|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
124892697|NCT02303574|449229982|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
124466436|NCT01882907|447666401|FG001|Overall Study|Lost to Follow-up|4|||
124892698|NCT02303574|449229983|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
124892699|NCT02303574|449229984|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
124892700|NCT02303574|449229985|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
124892701|NCT02303574|449229986|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
124892702|NCT02303574|449229987|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
124892703|NCT02303574|449229988|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
124892704|NCT02303574|449229979|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
124892705|NCT02303574|449229980|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
124892706|NCT02303574|449229981|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
124892707|NCT02303574|449229982|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
124892708|NCT02303574|449229983|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
124442088|NCT03285178|447580037|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
124892709|NCT02303574|449229984|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
124892710|NCT02303574|449229985|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
124442089|NCT03285178|447580038|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
124442090|NCT03285178|447580032|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
124442091|NCT03285178|447580033|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
124442092|NCT03285178|447580034|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
124442093|NCT03285178|447580035|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
124442094|NCT03285178|447580036|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
124442095|NCT03285178|447580037|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
124442096|NCT03285178|447580038|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
124442097|NCT03285178|447580032|FG000|Single-Blind Run-In Period|Physician Decision|2|||
124442098|NCT03285178|447580033|FG001|Single-Blind Run-In Period|Physician Decision|0|||
124442099|NCT03285178|447580034|FG002|Single-Blind Run-In Period|Physician Decision|0|||
124442100|NCT03285178|447580035|FG003|Single-Blind Run-In Period|Physician Decision|0|||
124442101|NCT03285178|447580036|FG004|Single-Blind Run-In Period|Physician Decision|0|||
124442102|NCT03285178|447580037|FG005|Single-Blind Run-In Period|Physician Decision|0|||
124442103|NCT03285178|447580038|FG006|Single-Blind Run-In Period|Physician Decision|0|||
124442104|NCT03285178|447580032|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
124442105|NCT03285178|447580033|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
124442106|NCT03285178|447580034|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
124442107|NCT03285178|447580035|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
124442108|NCT03285178|447580036|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
124442109|NCT03285178|447580037|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
124442110|NCT03285178|447580038|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
124442111|NCT03285178|447580032|FG000|Double-Blind Treatment Period|Adverse Event|0|||
124442112|NCT03285178|447580033|FG001|Double-Blind Treatment Period|Adverse Event|0|||
124442113|NCT03285178|447580034|FG002|Double-Blind Treatment Period|Adverse Event|0|||
124442114|NCT03285178|447580035|FG003|Double-Blind Treatment Period|Adverse Event|0|||
124442115|NCT03285178|447580036|FG004|Double-Blind Treatment Period|Adverse Event|0|||
124442116|NCT03285178|447580037|FG005|Double-Blind Treatment Period|Adverse Event|0|||
124442117|NCT03285178|447580038|FG006|Double-Blind Treatment Period|Adverse Event|2|||
124442118|NCT03285178|447580032|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124442119|NCT03285178|447580033|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
124442120|NCT03285178|447580034|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
124442121|NCT03285178|447580035|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
124442122|NCT03285178|447580036|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
124442123|NCT03285178|447580037|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
124442124|NCT03285178|447580038|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
124442125|NCT03285178|447580032|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124442126|NCT03285178|447580033|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124442127|NCT03285178|447580034|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
124442128|NCT03285178|447580035|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
124442129|NCT03285178|447580036|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124442130|NCT03285178|447580037|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
124442131|NCT03285178|447580038|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
124442132|NCT03285178|447580032|FG000|Double-Blind Treatment Period|COVID-19|0|||
124442133|NCT03285178|447580033|FG001|Double-Blind Treatment Period|COVID-19|0|||
124442134|NCT03285178|447580034|FG002|Double-Blind Treatment Period|COVID-19|1|||
124442135|NCT03285178|447580035|FG003|Double-Blind Treatment Period|COVID-19|0|||
124442136|NCT03285178|447580036|FG004|Double-Blind Treatment Period|COVID-19|0|||
124892711|NCT02303574|449229986|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
124892712|NCT02303574|449229987|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
124892713|NCT02303574|449229988|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
124892714|NCT01606189|449229989|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
124442137|NCT03285178|447580037|FG005|Double-Blind Treatment Period|COVID-19|0|||
124442138|NCT03285178|447580038|FG006|Double-Blind Treatment Period|COVID-19|0|||
124442139|NCT01388790|447580039|FG000|Overall Study|Ongoing at data cut-off date|8|||
124442140|NCT01128894|447580040|FG000|Overall Study|Adverse Event|31|||
124442141|NCT01128894|447580041|FG001|Overall Study|Adverse Event|41|||
124892715|NCT01606189|449229990|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
124892716|NCT01606189|449229991|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
124892717|NCT01606189|449229992|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
124892718|NCT01606189|449229993|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
124892719|NCT01606189|449229994|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
124892720|NCT01606189|449229989|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
124892721|NCT01606189|449229990|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
124892722|NCT01606189|449229991|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
124892723|NCT01606189|449229992|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
124892724|NCT01606189|449229993|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
124892725|NCT01606189|449229994|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
124892726|NCT02162732|449229995|FG000|Overall Study|Biopsy not performed.|18|||
124892727|NCT01167023|449229996|FG000|Overall Study|Lost to Follow-up|0|||
124892728|NCT01167023|449229997|FG001|Overall Study|Lost to Follow-up|1|||
124892729|NCT01167023|449229998|FG002|Overall Study|Lost to Follow-up|1|||
124892730|NCT01167023|449229996|FG000|Overall Study|Screen Failure|0|||
124892731|NCT01167023|449229997|FG001|Overall Study|Screen Failure|1|||
124892732|NCT01167023|449229998|FG002|Overall Study|Screen Failure|0|||
124892733|NCT01167023|449229996|FG000|Overall Study|Sponsor Decision|0|||
124892734|NCT01167023|449229997|FG001|Overall Study|Sponsor Decision|1|||
124892735|NCT01167023|449229998|FG002|Overall Study|Sponsor Decision|0|||
124442142|NCT01128894|447580040|FG000|Overall Study|Protocol Violation|2|||
124442143|NCT01128894|447580041|FG001|Overall Study|Protocol Violation|1|||
124442144|NCT01128894|447580040|FG000|Overall Study|Noncompliance|4|||
124442145|NCT01128894|447580041|FG001|Overall Study|Noncompliance|5|||
124442146|NCT01128894|447580040|FG000|Overall Study|Lost to Follow-up|8|||
124442147|NCT01128894|447580041|FG001|Overall Study|Lost to Follow-up|8|||
124442148|NCT01128894|447580040|FG000|Overall Study|Withdrawal by Subject|10|||
124442149|NCT01128894|447580041|FG001|Overall Study|Withdrawal by Subject|12|||
124759260|NCT04170543|448742593|FG000|Overall Study|Lost to Follow-up|3|||
124892736|NCT01167023|449229996|FG000|Overall Study|Withdrawal by Subject|0|||
124442150|NCT01128894|447580040|FG000|Overall Study|Physician Decision|2|||
124892737|NCT01167023|449229997|FG001|Overall Study|Withdrawal by Subject|0|||
124892738|NCT01167023|449229998|FG002|Overall Study|Withdrawal by Subject|1|||
124442151|NCT01128894|447580041|FG001|Overall Study|Physician Decision|1|||
124686634|NCT00843882|448472119|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
124686635|NCT00843882|448472120|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
124686636|NCT00843882|448472118|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
124686637|NCT00843882|448472119|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
124686638|NCT00843882|448472120|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
124892739|NCT00410384|449229999|FG000|Overall Study|Withdrawal by Subject|28|||
124892740|NCT00410384|449230000|FG001|Overall Study|Withdrawal by Subject|17|||
124892741|NCT00410384|449230001|FG002|Overall Study|Withdrawal by Subject|20|||
124892742|NCT00410384|449229999|FG000|Overall Study|Adverse Event|23|||
124892743|NCT00410384|449230000|FG001|Overall Study|Adverse Event|18|||
124892744|NCT00410384|449230001|FG002|Overall Study|Adverse Event|23|||
124892745|NCT00410384|449229999|FG000|Overall Study|Lack of Efficacy|20|||
124892746|NCT00410384|449230000|FG001|Overall Study|Lack of Efficacy|12|||
124892747|NCT00410384|449230001|FG002|Overall Study|Lack of Efficacy|17|||
124892748|NCT00410384|449229999|FG000|Overall Study|Lack of Compliance|2|||
124892749|NCT00410384|449230000|FG001|Overall Study|Lack of Compliance|2|||
124892750|NCT00410384|449230001|FG002|Overall Study|Lack of Compliance|2|||
124892751|NCT00410384|449229999|FG000|Overall Study|Lost to Follow-up|4|||
124892752|NCT00410384|449230000|FG001|Overall Study|Lost to Follow-up|6|||
124892753|NCT00410384|449230001|FG002|Overall Study|Lost to Follow-up|6|||
124892754|NCT00410384|449229999|FG000|Overall Study|Protocol Violation|6|||
124892755|NCT00410384|449230000|FG001|Overall Study|Protocol Violation|6|||
124892756|NCT00410384|449230001|FG002|Overall Study|Protocol Violation|6|||
124892757|NCT00410384|449229999|FG000|Overall Study|Physician Decision|3|||
124892758|NCT00410384|449230000|FG001|Overall Study|Physician Decision|3|||
124892759|NCT00410384|449230001|FG002|Overall Study|Physician Decision|4|||
124892760|NCT00410384|449229999|FG000|Overall Study|Other|3|||
124892761|NCT00410384|449230000|FG001|Overall Study|Other|8|||
124892762|NCT00410384|449230001|FG002|Overall Study|Other|4|||
124892763|NCT02049437|449230004|FG000|Period 1|Adverse Event|1|||
124892764|NCT02049437|449230005|FG001|Period 1|Adverse Event|1|||
124892765|NCT02049437|449230004|FG000|Period 1|Adverse Event|1|||
124892766|NCT02049437|449230005|FG001|Period 1|Adverse Event|0|||
124892767|NCT00630539|449230006|FG000|Overall Study|Adverse Event|1|||
124892768|NCT00630539|449230007|FG001|Overall Study|Adverse Event|3|||
124892769|NCT00630539|449230008|FG002|Overall Study|Adverse Event|1|||
124892770|NCT00630539|449230009|FG003|Overall Study|Adverse Event|2|||
124892771|NCT00630539|449230006|FG000|Overall Study|Withdrawal by Subject|0|||
124892772|NCT00630539|449230007|FG001|Overall Study|Withdrawal by Subject|1|||
124892773|NCT00630539|449230008|FG002|Overall Study|Withdrawal by Subject|0|||
124892774|NCT00630539|449230009|FG003|Overall Study|Withdrawal by Subject|1|||
124892775|NCT03682536|449230019|FG000|Randomization|Withdrawal by Subject|0|||
124892776|NCT03682536|449230020|FG001|Randomization|Withdrawal by Subject|2|||
124892777|NCT03682536|449230019|FG000|Treatment|Other Reasons|8|||
124892778|NCT03682536|449230020|FG001|Treatment|Other Reasons|7|||
124892779|NCT03682536|449230019|FG000|Treatment|Physician Decision|5|||
124892780|NCT03682536|449230020|FG001|Treatment|Physician Decision|5|||
124892781|NCT03682536|449230019|FG000|Treatment|Protocol Violation|1|||
124892782|NCT03682536|449230020|FG001|Treatment|Protocol Violation|0|||
124892783|NCT03682536|449230019|FG000|Treatment|Study Terminated by Sponsor|1|||
124892784|NCT03682536|449230020|FG001|Treatment|Study Terminated by Sponsor|2|||
124892785|NCT03682536|449230019|FG000|Treatment|Lost to Follow-up|0|||
124892786|NCT03682536|449230020|FG001|Treatment|Lost to Follow-up|1|||
124892787|NCT03682536|449230019|FG000|Treatment|Withdrawal by Subject|16|||
124892788|NCT03682536|449230020|FG001|Treatment|Withdrawal by Subject|18|||
124892789|NCT03682536|449230019|FG000|Treatment|Lack of Efficacy|41|||
124892790|NCT03682536|449230020|FG001|Treatment|Lack of Efficacy|68|||
124892791|NCT03682536|449230019|FG000|Treatment|Disease Progression|9|||
124892792|NCT03682536|449230020|FG001|Treatment|Disease Progression|7|||
124892793|NCT03682536|449230019|FG000|Treatment|Adverse Event|9|||
124892794|NCT03682536|449230020|FG001|Treatment|Adverse Event|5|||
124892795|NCT03682536|449230019|FG000|Treatment|Death|14|||
124892796|NCT03682536|449230020|FG001|Treatment|Death|13|||
124686639|NCT00843882|448472118|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
124892797|NCT02507219|449230031|FG000|Overall Study|Physician Decision|1|||
124892798|NCT02507219|449230032|FG001|Overall Study|Physician Decision|0|||
124892799|NCT02507219|449230033|FG002|Overall Study|Physician Decision|0|||
124892800|NCT02507219|449230034|FG003|Overall Study|Physician Decision|0|||
124892801|NCT02507219|449230035|FG004|Overall Study|Physician Decision|0|||
124892802|NCT02507219|449230036|FG005|Overall Study|Physician Decision|0|||
124892803|NCT02507219|449230031|FG000|Overall Study|Withdrawal by Subject|0|||
124892804|NCT02507219|449230032|FG001|Overall Study|Withdrawal by Subject|0|||
124892805|NCT02507219|449230033|FG002|Overall Study|Withdrawal by Subject|0|||
124892806|NCT02507219|449230034|FG003|Overall Study|Withdrawal by Subject|0|||
124892807|NCT02507219|449230035|FG004|Overall Study|Withdrawal by Subject|1|||
124892808|NCT02507219|449230036|FG005|Overall Study|Withdrawal by Subject|0|||
124892809|NCT01342887|449230043|FG000|Overall Study|Death|2|||
124892810|NCT00209274|449230044|FG000|Overall Study|Missed visit|3|||
124892811|NCT00209274|449230045|FG001|Overall Study|Missed visit|2|||
124892812|NCT00209274|449230044|FG000|Overall Study|Death|32|||
124892813|NCT00209274|449230045|FG001|Overall Study|Death|15|||
124892814|NCT00209274|449230044|FG000|Overall Study|Withdrawal by Subject|30|||
124892815|NCT00209274|449230045|FG001|Overall Study|Withdrawal by Subject|15|||
124892816|NCT00209274|449230044|FG000|Overall Study|Randomized not treated (RNT)|6|||
124892817|NCT00209274|449230045|FG001|Overall Study|Randomized not treated (RNT)|15|||
124892818|NCT02753530|449230046|FG000|Overall Study|Adverse Event|7|||
124892819|NCT02753530|449230047|FG001|Overall Study|Adverse Event|1|||
124892820|NCT02753530|449230046|FG000|Overall Study|Death|0|||
124892821|NCT02753530|449230047|FG001|Overall Study|Death|1|||
124892822|NCT02753530|449230046|FG000|Overall Study|Physician Decision|0|||
124892823|NCT02753530|449230047|FG001|Overall Study|Physician Decision|1|||
124892824|NCT02753530|449230046|FG000|Overall Study|Protocol Violation|1|||
124892825|NCT02753530|449230047|FG001|Overall Study|Protocol Violation|0|||
124892826|NCT02753530|449230046|FG000|Overall Study|Withdrawal by Subject|4|||
124892827|NCT02753530|449230047|FG001|Overall Study|Withdrawal by Subject|3|||
124892828|NCT00465361|449231914|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
124442152|NCT01128894|447580040|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
124442153|NCT01128894|447580041|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
124442154|NCT00195507|447580042|FG000|Overall Study|Adverse Event|24|||
124442155|NCT00195507|447580043|FG001|Overall Study|Adverse Event|13|||
124442156|NCT00195507|447580042|FG000|Overall Study|Death|0|||
124442157|NCT00195507|447580043|FG001|Overall Study|Death|1|||
124442158|NCT00195507|447580042|FG000|Overall Study|Failed to Return|4|||
124442159|NCT00195507|447580043|FG001|Overall Study|Failed to Return|3|||
124442160|NCT00195507|447580042|FG000|Overall Study|Physician Decision|1|||
124442161|NCT00195507|447580043|FG001|Overall Study|Physician Decision|2|||
124442162|NCT00195507|447580042|FG000|Overall Study|Lost to Follow-up|3|||
124442163|NCT00195507|447580043|FG001|Overall Study|Lost to Follow-up|2|||
124442164|NCT00195507|447580042|FG000|Overall Study|Protocol Violation|5|||
124442165|NCT00195507|447580043|FG001|Overall Study|Protocol Violation|4|||
124442166|NCT00195507|447580042|FG000|Overall Study|Lack of Efficacy|40|||
124442167|NCT00195507|447580043|FG001|Overall Study|Lack of Efficacy|67|||
124442168|NCT00195507|447580042|FG000|Overall Study|Withdrawal by Subject|16|||
124442169|NCT00195507|447580043|FG001|Overall Study|Withdrawal by Subject|23|||
124442170|NCT00195507|447580042|FG000|Overall Study|Protocol Deviation|6|||
124442171|NCT00195507|447580043|FG001|Overall Study|Protocol Deviation|3|||
124442172|NCT00973362|447580044|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
124442173|NCT00973362|447580045|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
124442174|NCT00973362|447580044|FG000|Baseline Evaluation|No colposcopy visit|62|||
124442175|NCT00973362|447580045|FG001|Baseline Evaluation|No colposcopy visit|0|||
124442176|NCT00973362|447580044|FG000|Baseline Evaluation|Inevaluable|686|||
124442177|NCT00973362|447580045|FG001|Baseline Evaluation|Inevaluable|223|||
124442178|NCT00973362|447580044|FG000|3-Year Follow-up|Lost to Follow-up|17|||
124442179|NCT00973362|447580045|FG001|3-Year Follow-up|Lost to Follow-up|0|||
124442180|NCT00887679|447580046|FG000|Overall Study|Withdrawal by Subject|1|||
124442181|NCT00887679|447580046|FG000|Overall Study|Lost to Follow-up|4|||
124442182|NCT00887679|447580046|FG000|Overall Study|Physician Decision|5|||
124442183|NCT01630434|447580053|FG000|Overall Study|Donor lungs turned down|1|||
124442184|NCT01630434|447580054|FG001|Overall Study|Donor lungs turned down|0|||
124442185|NCT01630434|447580053|FG000|Overall Study|Protocol Violation|9|||
124442186|NCT01630434|447580054|FG001|Overall Study|Protocol Violation|4|||
124442187|NCT01630434|447580053|FG000|Overall Study|Death|20|||
124442188|NCT01630434|447580054|FG001|Overall Study|Death|26|||
124442189|NCT02578862|447580055|FG000|Overall Study|Withdrawal by Subject|0|||
124892829|NCT01333943|449231918|FG000|Overall Study|Known neuropathy|1|||
124892830|NCT01333943|449231919|FG001|Overall Study|Known neuropathy|0|||
124892831|NCT02652130|449231926|FG000|Overall Study|Death|1|||
124442190|NCT02578862|447580056|FG001|Overall Study|Withdrawal by Subject|1|||
124442191|NCT02578862|447580055|FG000|Overall Study|Unplanned unilateral procedure|0|||
124759261|NCT04170543|448742594|FG001|Overall Study|Lost to Follow-up|3|||
124892832|NCT02028884|449231927|FG000|Double-blind Period|Adverse Event|5|||
124892833|NCT02028884|449231928|FG001|Double-blind Period|Adverse Event|3|||
124892834|NCT02028884|449231929|FG002|Double-blind Period|Adverse Event|0|||
124892835|NCT02028884|449231927|FG000|Double-blind Period|Eligibility Violation|1|||
124892836|NCT02028884|449231928|FG001|Double-blind Period|Eligibility Violation|0|||
124892837|NCT02028884|449231929|FG002|Double-blind Period|Eligibility Violation|0|||
124442192|NCT02578862|447580056|FG001|Overall Study|Unplanned unilateral procedure|1|||
124442193|NCT01026454|447580057|FG000|Second Intervention|Pregnancy|1|||
124442194|NCT01026454|447580058|FG001|Second Intervention|Pregnancy|1|||
124442195|NCT01176773|447580059|FG000|Overall Study|Screen Failure|2|||
124442196|NCT01176773|447580059|FG000|Overall Study|Withdrew consent|1|||
124759262|NCT04170543|448742595|FG002|Overall Study|Lost to Follow-up|0|||
124686640|NCT00843882|448472119|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
124686641|NCT00843882|448472120|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
124686642|NCT00843882|448472118|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
124686643|NCT00843882|448472119|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
124686644|NCT00843882|448472120|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
124686645|NCT05317546|448472121|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
124686646|NCT05317546|448472122|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
124686647|NCT03331250|448472123|FG000|Overall Study|Withdrawal by Subject|1|||
124686648|NCT04590963|448472124|FG000|Overall Study|Death|118|||
124686649|NCT04590963|448472125|FG001|Overall Study|Death|59|||
124686650|NCT04590963|448472124|FG000|Overall Study|Lost to Follow-up|1|||
124686651|NCT04590963|448472125|FG001|Overall Study|Lost to Follow-up|1|||
124686652|NCT04590963|448472124|FG000|Overall Study|Progressive disease|0|||
124686653|NCT04590963|448472125|FG001|Overall Study|Progressive disease|1|||
124686654|NCT04590963|448472124|FG000|Overall Study|Study terminated by sponsor|103|||
124686655|NCT04590963|448472125|FG001|Overall Study|Study terminated by sponsor|50|||
124686656|NCT04590963|448472124|FG000|Overall Study|Withdrawal by Subject|15|||
124686657|NCT04590963|448472125|FG001|Overall Study|Withdrawal by Subject|8|||
124686658|NCT04590963|448472124|FG000|Overall Study|Ongoing at data cut-off|9|||
124686659|NCT04590963|448472125|FG001|Overall Study|Ongoing at data cut-off|4|||
124686660|NCT04590963|448472124|FG000|Overall Study|Screen failure|1|||
124686661|NCT04590963|448472125|FG001|Overall Study|Screen failure|0|||
124686662|NCT04738487|448472126|FG000|Overall Study|Participant Ongoing in Study|298|||
124686663|NCT04738487|448472127|FG001|Overall Study|Participant Ongoing in Study|297|||
124686664|NCT04738487|448472126|FG000|Overall Study|Withdrawal by Subject|7|||
124686665|NCT04738487|448472127|FG001|Overall Study|Withdrawal by Subject|9|||
124686666|NCT04738487|448472126|FG000|Overall Study|Lost to Follow-up|2|||
124686667|NCT04738487|448472127|FG001|Overall Study|Lost to Follow-up|0|||
124686668|NCT04738487|448472126|FG000|Overall Study|Death|287|||
124686669|NCT04738487|448472127|FG001|Overall Study|Death|306|||
124686670|NCT05350202|448472128|FG000|Visit 1 - Baseline|Not-treated|18|||
124686671|NCT05350202|448472129|FG001|Visit 1 - Baseline|Not-treated|0|||
124686672|NCT05350202|448472128|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
124686673|NCT05350202|448472129|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
124686674|NCT05350202|448472128|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
124686675|NCT05350202|448472129|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
124686676|NCT05350202|448472128|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
124686677|NCT05350202|448472129|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
124686678|NCT05350202|448472128|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
124686679|NCT05350202|448472129|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
124686680|NCT05350202|448472128|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
124686681|NCT05350202|448472129|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
124686682|NCT05350202|448472128|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
124686683|NCT05350202|448472129|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
124686684|NCT01063114|448472130|FG000|Overall Study|Lost to Follow-up|1|||
124686685|NCT02717611|448472143|FG000|Overall Study|Death|13|||
124686686|NCT02717611|448472143|FG000|Overall Study|Withdrawal by Subject|6|||
124686687|NCT02717611|448472143|FG000|Overall Study|Active, not recruiting|40|||
124686688|NCT02717611|448472143|FG000|Overall Study|Complicating disease|1|||
124686689|NCT05556057|448472144|FG000|Overall Study|Lost to Follow-up|5|||
124686690|NCT05556057|448472145|FG001|Overall Study|Lost to Follow-up|4|||
124759263|NCT04170543|448742596|FG003|Overall Study|Lost to Follow-up|3|||
124759264|NCT04170543|448742597|FG004|Overall Study|Lost to Follow-up|1|||
124759265|NCT04170543|448742593|FG000|Overall Study|Withdrawal by Subject|13|||
124759266|NCT04170543|448742594|FG001|Overall Study|Withdrawal by Subject|6|||
124759267|NCT04170543|448742595|FG002|Overall Study|Withdrawal by Subject|5|||
124759268|NCT04170543|448742596|FG003|Overall Study|Withdrawal by Subject|4|||
124759269|NCT04170543|448742597|FG004|Overall Study|Withdrawal by Subject|9|||
124759270|NCT04170543|448742593|FG000|Overall Study|Not able to transition to phase 2b|8|||
124759271|NCT04170543|448742594|FG001|Overall Study|Not able to transition to phase 2b|0|||
124759272|NCT04170543|448742595|FG002|Overall Study|Not able to transition to phase 2b|10|||
124442197|NCT02196714|447580063|FG000|Overall Study|Protocol Violation|0|||
124759273|NCT04170543|448742596|FG003|Overall Study|Not able to transition to phase 2b|0|||
124759274|NCT04170543|448742597|FG004|Overall Study|Not able to transition to phase 2b|6|||
124759275|NCT04170543|448742593|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
124759276|NCT04170543|448742594|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
124759277|NCT04170543|448742595|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
124759278|NCT04170543|448742596|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
124442198|NCT02196714|447580064|FG001|Overall Study|Protocol Violation|0|||
124686691|NCT05556057|448472144|FG000|Overall Study|Withdrawal by Subject|0|||
124686692|NCT05556057|448472145|FG001|Overall Study|Withdrawal by Subject|2|||
124686693|NCT02466971|448472149|FG000|Overall Study|eligible and never treated|14|||
124686694|NCT02466971|448472150|FG001|Overall Study|eligible and never treated|20|||
124892838|NCT02028884|449231927|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
124892839|NCT02028884|449231928|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
124892840|NCT02028884|449231929|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
124892841|NCT02028884|449231927|FG000|Double-blind Period|Withdrawal by Subject|2|||
124892842|NCT02028884|449231928|FG001|Double-blind Period|Withdrawal by Subject|0|||
124892843|NCT02028884|449231929|FG002|Double-blind Period|Withdrawal by Subject|0|||
124442199|NCT02196714|447580065|FG002|Overall Study|Protocol Violation|1|||
124442200|NCT02196714|447580066|FG003|Overall Study|Protocol Violation|0|||
124442201|NCT01592864|447580068|FG000|Overall Study|Withdrawal by Subject|0|||
124442202|NCT01592864|447580069|FG001|Overall Study|Withdrawal by Subject|1|||
124442203|NCT02804178|447580077|FG000|Overall Study|Adverse Event|1|||
124442204|NCT01106404|447580078|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
124442205|NCT01106404|447580079|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
124442206|NCT01106404|447580078|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
124442207|NCT01106404|447580079|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
124442208|NCT01106404|447580078|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
124442209|NCT01106404|447580079|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
124442210|NCT01106404|447580078|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
124442211|NCT01106404|447580079|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
124442212|NCT01290601|447580080|FG000|Overall Study|Adverse Event|0|||
124442213|NCT01290601|447580081|FG001|Overall Study|Adverse Event|2|||
124442214|NCT01290601|447580082|FG002|Overall Study|Adverse Event|0|||
124442215|NCT01290601|447580083|FG003|Overall Study|Adverse Event|0|||
124442216|NCT01290601|447580080|FG000|Overall Study|Lack of Efficacy|2|||
124442217|NCT01290601|447580081|FG001|Overall Study|Lack of Efficacy|1|||
124442218|NCT01290601|447580082|FG002|Overall Study|Lack of Efficacy|0|||
124442219|NCT01290601|447580083|FG003|Overall Study|Lack of Efficacy|0|||
124442220|NCT01290601|447580080|FG000|Overall Study|Lost to Follow-up|7|||
124442221|NCT01290601|447580081|FG001|Overall Study|Lost to Follow-up|2|||
124442222|NCT01290601|447580082|FG002|Overall Study|Lost to Follow-up|0|||
124442223|NCT01290601|447580083|FG003|Overall Study|Lost to Follow-up|0|||
124442224|NCT01290601|447580080|FG000|Overall Study|Other|1|||
124442225|NCT01290601|447580081|FG001|Overall Study|Other|0|||
124442226|NCT01290601|447580082|FG002|Overall Study|Other|0|||
124442227|NCT01290601|447580083|FG003|Overall Study|Other|0|||
124442228|NCT01290601|447580080|FG000|Overall Study|Protocol Violation|1|||
124442229|NCT01290601|447580081|FG001|Overall Study|Protocol Violation|0|||
124442230|NCT01290601|447580082|FG002|Overall Study|Protocol Violation|0|||
124442231|NCT01290601|447580083|FG003|Overall Study|Protocol Violation|0|||
124442232|NCT00775450|447580084|FG000|Overall Study|Serious Adverse Event|2|||
124442233|NCT00775450|447580085|FG001|Overall Study|Serious Adverse Event|0|||
124442234|NCT00775450|447580086|FG002|Overall Study|Serious Adverse Event|0|||
124442235|NCT00775450|447580087|FG003|Overall Study|Serious Adverse Event|0|||
124442236|NCT00775450|447580088|FG004|Overall Study|Serious Adverse Event|0|||
124442237|NCT00775450|447580084|FG000|Overall Study|Protocol Violation|0|||
124442238|NCT00775450|447580085|FG001|Overall Study|Protocol Violation|0|||
124442239|NCT00775450|447580086|FG002|Overall Study|Protocol Violation|0|||
124442240|NCT00775450|447580087|FG003|Overall Study|Protocol Violation|0|||
124442241|NCT00775450|447580088|FG004|Overall Study|Protocol Violation|1|||
124442242|NCT00775450|447580084|FG000|Overall Study|Withdrawal by Subject|1|||
124442243|NCT00775450|447580085|FG001|Overall Study|Withdrawal by Subject|0|||
124442244|NCT00775450|447580086|FG002|Overall Study|Withdrawal by Subject|0|||
124442245|NCT00775450|447580087|FG003|Overall Study|Withdrawal by Subject|0|||
124442246|NCT00775450|447580088|FG004|Overall Study|Withdrawal by Subject|1|||
124442247|NCT01749540|447580095|FG000|Overall Study|Protocol Violation|0|||
124442248|NCT01749540|447580096|FG001|Overall Study|Protocol Violation|0|||
124442249|NCT01749540|447580097|FG002|Overall Study|Protocol Violation|0|||
124442250|NCT01749540|447580098|FG003|Overall Study|Protocol Violation|0|||
124442251|NCT01749540|447580099|FG004|Overall Study|Protocol Violation|0|||
124442252|NCT01749540|447580100|FG005|Overall Study|Protocol Violation|1|||
124442253|NCT01749540|447580101|FG006|Overall Study|Protocol Violation|1|||
124442254|NCT01749540|447580095|FG000|Overall Study|Withdrawal by Subject|0|||
124686695|NCT02466971|448472149|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
124686696|NCT02466971|448472150|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
124686697|NCT02466971|448472149|FG000|Overall Study|ineligible and treated|1|||
124686698|NCT02466971|448472150|FG001|Overall Study|ineligible and treated|0|||
124442255|NCT01749540|447580096|FG001|Overall Study|Withdrawal by Subject|0|||
124442256|NCT01749540|447580097|FG002|Overall Study|Withdrawal by Subject|0|||
124442257|NCT01749540|447580098|FG003|Overall Study|Withdrawal by Subject|1|||
124442258|NCT01749540|447580099|FG004|Overall Study|Withdrawal by Subject|0|||
124442259|NCT01749540|447580100|FG005|Overall Study|Withdrawal by Subject|0|||
124442260|NCT01749540|447580101|FG006|Overall Study|Withdrawal by Subject|0|||
124442261|NCT01749540|447580095|FG000|Overall Study|Initiated into extension study A536-06|0|||
124442262|NCT01749540|447580096|FG001|Overall Study|Initiated into extension study A536-06|0|||
124442263|NCT01749540|447580097|FG002|Overall Study|Initiated into extension study A536-06|0|||
124686699|NCT02466971|448472149|FG000|Overall Study|ineligible and never treated|0|||
124686700|NCT02466971|448472150|FG001|Overall Study|ineligible and never treated|1|||
124686701|NCT04818112|448472156|FG000|Overall Study|Withdrawal by Subject|54|||
124686702|NCT04818112|448472157|FG001|Overall Study|Withdrawal by Subject|12|||
124686703|NCT04818112|448472156|FG000|Overall Study|Lost to Follow-up|38|||
124686704|NCT04818112|448472157|FG001|Overall Study|Lost to Follow-up|10|||
124686705|NCT02390284|448472163|FG000|Overall Study|Physician Decision|0|||
124686706|NCT02390284|448472164|FG001|Overall Study|Physician Decision|0|||
124686707|NCT02390284|448472165|FG002|Overall Study|Physician Decision|9|||
124686708|NCT00462462|448472175|FG000|Overall Study|Physician Decision|0|||
124686709|NCT00462462|448472176|FG001|Overall Study|Physician Decision|1|||
124686710|NCT03018938|448472184|FG000|Overall Study|Death|0|||
124686711|NCT03018938|448472185|FG001|Overall Study|Death|1|||
124686712|NCT03018938|448472184|FG000|Overall Study|Lost to Follow-up|21|||
124686713|NCT03018938|448472185|FG001|Overall Study|Lost to Follow-up|32|||
124686714|NCT03018938|448472184|FG000|Overall Study|Withdrawal by Subject|38|||
124686715|NCT03018938|448472185|FG001|Overall Study|Withdrawal by Subject|45|||
124686716|NCT03018938|448472184|FG000|Overall Study|Physician Decision|3|||
124686717|NCT03018938|448472185|FG001|Overall Study|Physician Decision|2|||
124686718|NCT03018938|448472184|FG000|Overall Study|Sponsor Decision|0|||
124686719|NCT03018938|448472185|FG001|Overall Study|Sponsor Decision|1|||
124686720|NCT03018938|448472184|FG000|Overall Study|Screen failure-After randomization|4|||
124686721|NCT03018938|448472185|FG001|Overall Study|Screen failure-After randomization|2|||
124686722|NCT03018938|448472184|FG000|Overall Study|Not recorded|0|||
124686723|NCT03018938|448472185|FG001|Overall Study|Not recorded|2|||
124686724|NCT00191100|448472188|FG000|Overall Study|Adverse Event|18|||
124686725|NCT00191100|448472189|FG001|Overall Study|Adverse Event|1|||
124686726|NCT00191100|448472188|FG000|Overall Study|Lost to Follow-up|2|||
124686727|NCT00191100|448472189|FG001|Overall Study|Lost to Follow-up|0|||
124686728|NCT00191100|448472188|FG000|Overall Study|Patient Moved|0|||
124686729|NCT00191100|448472189|FG001|Overall Study|Patient Moved|1|||
124686730|NCT00191100|448472188|FG000|Overall Study|Withdrawal by Subject|9|||
124686731|NCT00191100|448472189|FG001|Overall Study|Withdrawal by Subject|3|||
124686732|NCT00191100|448472188|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
124686733|NCT00191100|448472189|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
124686734|NCT00191100|448472188|FG000|Overall Study|Clinical Relapse|2|||
124686735|NCT00191100|448472189|FG001|Overall Study|Clinical Relapse|1|||
124686736|NCT00191100|448472188|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
124686737|NCT00191100|448472189|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
124686738|NCT00191100|448472188|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
124686739|NCT00191100|448472189|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
124686740|NCT00191100|448472188|FG000|Overall Study|Physician Decision|3|||
124686741|NCT00191100|448472189|FG001|Overall Study|Physician Decision|1|||
124686742|NCT00191100|448472188|FG000|Overall Study|Death from Study Drug Toxicity|2|||
124686743|NCT00191100|448472189|FG001|Overall Study|Death from Study Drug Toxicity|0|||
124686744|NCT00191100|448472188|FG000|Overall Study|Protocol Violation|1|||
124686745|NCT00191100|448472189|FG001|Overall Study|Protocol Violation|1|||
124686746|NCT00191100|448472188|FG000|Overall Study|Death from Other Cause|1|||
124686747|NCT00191100|448472189|FG001|Overall Study|Death from Other Cause|0|||
124686748|NCT00191100|448472188|FG000|Overall Study|Reason Not Specified|0|||
124686749|NCT00191100|448472189|FG001|Overall Study|Reason Not Specified|1|||
124686750|NCT02811159|448472190|FG000|Treatment Course 1|Lost to Follow-up|1|||
124686751|NCT02406612|448472191|FG000|Overall Study|Screening Failure|3|||
124686752|NCT02406612|448472192|FG001|Overall Study|Screening Failure|0|||
124686753|NCT02406612|448472191|FG000|Overall Study|Intra-procedural Exclusion|1|||
124686754|NCT02406612|448472192|FG001|Overall Study|Intra-procedural Exclusion|3|||
124686755|NCT02406612|448472191|FG000|Overall Study|Guidewire Failure|0|||
124686756|NCT02406612|448472192|FG001|Overall Study|Guidewire Failure|1|||
124686757|NCT02916771|448472197|FG000|Overall Study|Withdrawal by Subject|9|||
124686758|NCT02916771|448472197|FG000|Overall Study|Physician Decision|1|||
124686759|NCT02916771|448472197|FG000|Overall Study|Began treatment for another active malignancy|1|||
124686760|NCT02924376|448472198|FG000|Overall Study|Progressive Disease|4|||
124686761|NCT02924376|448472199|FG001|Overall Study|Progressive Disease|0|||
124686762|NCT02924376|448472200|FG002|Overall Study|Progressive Disease|1|||
124686763|NCT02924376|448472201|FG003|Overall Study|Progressive Disease|0|||
124686764|NCT02924376|448472198|FG000|Overall Study|Death|73|||
124686765|NCT02924376|448472199|FG001|Overall Study|Death|18|||
124686766|NCT02924376|448472200|FG002|Overall Study|Death|15|||
124686767|NCT02924376|448472201|FG003|Overall Study|Death|2|||
124686768|NCT02924376|448472198|FG000|Overall Study|Lost to Follow-up|3|||
124686769|NCT02924376|448472199|FG001|Overall Study|Lost to Follow-up|0|||
124686770|NCT02924376|448472200|FG002|Overall Study|Lost to Follow-up|0|||
124686771|NCT02924376|448472201|FG003|Overall Study|Lost to Follow-up|0|||
124686772|NCT02924376|448472198|FG000|Overall Study|Study Terminated by Sponsor|19|||
124686773|NCT02924376|448472199|FG001|Overall Study|Study Terminated by Sponsor|0|||
124686774|NCT02924376|448472200|FG002|Overall Study|Study Terminated by Sponsor|0|||
124686775|NCT02924376|448472201|FG003|Overall Study|Study Terminated by Sponsor|0|||
124686776|NCT02924376|448472198|FG000|Overall Study|Physician Decision|1|||
124686777|NCT02924376|448472199|FG001|Overall Study|Physician Decision|0|||
124686778|NCT02924376|448472200|FG002|Overall Study|Physician Decision|0|||
124686779|NCT02924376|448472201|FG003|Overall Study|Physician Decision|0|||
124686780|NCT02924376|448472198|FG000|Overall Study|Withdrawal by Subject|7|||
124686781|NCT02924376|448472199|FG001|Overall Study|Withdrawal by Subject|2|||
124686782|NCT02924376|448472200|FG002|Overall Study|Withdrawal by Subject|1|||
124686783|NCT02924376|448472201|FG003|Overall Study|Withdrawal by Subject|0|||
124686784|NCT02924376|448472198|FG000|Overall Study|Rolled Over to Another Study|1|||
124686785|NCT02924376|448472199|FG001|Overall Study|Rolled Over to Another Study|0|||
124686786|NCT02924376|448472200|FG002|Overall Study|Rolled Over to Another Study|0|||
124686787|NCT02924376|448472201|FG003|Overall Study|Rolled Over to Another Study|0|||
124686788|NCT05763875|448472207|FG000|Overall Study|Subject decision|5|||
124686789|NCT05763875|448472208|FG001|Overall Study|Subject decision|2|||
124686790|NCT05763875|448472209|FG002|Overall Study|Subject decision|1|||
124686791|NCT05763875|448472207|FG000|Overall Study|Lost to Follow-up|4|||
124686792|NCT05763875|448472208|FG001|Overall Study|Lost to Follow-up|1|||
124686793|NCT05763875|448472209|FG002|Overall Study|Lost to Follow-up|2|||
124686794|NCT05763875|448472207|FG000|Overall Study|Adverse Event|1|||
124686795|NCT05763875|448472208|FG001|Overall Study|Adverse Event|0|||
124686796|NCT05763875|448472209|FG002|Overall Study|Adverse Event|0|||
124686797|NCT00217737|448472210|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
124686798|NCT00217737|448472211|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
124686799|NCT00217737|448472212|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
124686800|NCT00217737|448472213|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
124686801|NCT00217737|448472210|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
124686802|NCT00217737|448472211|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
124686803|NCT00217737|448472212|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
124686804|NCT00217737|448472213|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
124686805|NCT00217737|448472210|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
124686806|NCT00217737|448472211|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
124686807|NCT00217737|448472212|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
124686808|NCT00217737|448472213|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
124686809|NCT00217737|448472210|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
124686810|NCT00217737|448472211|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
124686811|NCT00217737|448472212|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
124686812|NCT00217737|448472213|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
124686813|NCT00217737|448472210|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
124686814|NCT00217737|448472211|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
124686815|NCT00217737|448472212|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
124686816|NCT00217737|448472213|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
124686817|NCT00217737|448472210|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
124686818|NCT00217737|448472211|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
124686819|NCT00217737|448472212|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
124686820|NCT00217737|448472213|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
124686821|NCT00217737|448472210|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
124686822|NCT00217737|448472211|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
124686823|NCT00217737|448472212|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
124686824|NCT00217737|448472213|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
124686825|NCT00217737|448472210|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
124686826|NCT00217737|448472211|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
124686827|NCT00217737|448472212|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
124686828|NCT00217737|448472213|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
124686829|NCT00217737|448472210|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
124686830|NCT00217737|448472211|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
124686831|NCT00217737|448472212|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
124686832|NCT00217737|448472213|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
124686833|NCT00217737|448472210|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
124686834|NCT00217737|448472211|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
124686835|NCT00217737|448472212|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
124759279|NCT04170543|448742597|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
124892844|NCT02028884|449231927|FG000|Open-label Extension Period|Adverse Event|3|||
124892845|NCT02028884|449231928|FG001|Open-label Extension Period|Adverse Event|1|||
124892846|NCT02028884|449231929|FG002|Open-label Extension Period|Adverse Event|0|||
124892847|NCT02028884|449231927|FG000|Open-label Extension Period|Lack of Efficacy|3|||
124892848|NCT02028884|449231928|FG001|Open-label Extension Period|Lack of Efficacy|0|||
124892849|NCT02028884|449231929|FG002|Open-label Extension Period|Lack of Efficacy|0|||
124759280|NCT04170543|448742593|FG000|Overall Study|Not Treated|0|||
124759281|NCT04170543|448742594|FG001|Overall Study|Not Treated|0|||
124892850|NCT02028884|449231927|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
124442264|NCT01749540|447580098|FG003|Overall Study|Initiated into extension study A536-06|0|||
124442265|NCT01749540|447580099|FG004|Overall Study|Initiated into extension study A536-06|0|||
124442266|NCT01749540|447580100|FG005|Overall Study|Initiated into extension study A536-06|2|||
124442267|NCT01749540|447580101|FG006|Overall Study|Initiated into extension study A536-06|24|||
124442268|NCT00954421|447580102|FG000|Screening|screen failures|3|||
124442269|NCT00954421|447580102|FG000|6 Months of DBS|Withdrawal by Subject|1|||
124442270|NCT00954421|447580102|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
124442271|NCT00633061|447580103|FG000|Overall Study|Study closed|86|||
124442272|NCT00633061|447580104|FG001|Overall Study|Study closed|0|||
124442273|NCT05245097|447580105|FG000|Overall Study|Adverse Event|13|||
124442274|NCT05245097|447580106|FG001|Overall Study|Adverse Event|2|||
124442275|NCT05245097|447580105|FG000|Overall Study|Protocol Violation|8|||
124442276|NCT05245097|447580106|FG001|Overall Study|Protocol Violation|6|||
124442277|NCT05245097|447580105|FG000|Overall Study|Withdrawal by Subject|18|||
124442278|NCT05245097|447580106|FG001|Overall Study|Withdrawal by Subject|0|||
124442279|NCT05245097|447580105|FG000|Overall Study|Death|6|||
124442280|NCT05245097|447580106|FG001|Overall Study|Death|7|||
124442281|NCT05245097|447580105|FG000|Overall Study|Physician Decision|6|||
124442282|NCT05245097|447580106|FG001|Overall Study|Physician Decision|0|||
124442283|NCT05245097|447580105|FG000|Overall Study|Relocation|4|||
124442284|NCT05245097|447580106|FG001|Overall Study|Relocation|3|||
124442285|NCT04675151|447580112|FG000|Overall Study|Protocol Violation|1|||
124442286|NCT04675151|447580113|FG001|Overall Study|Protocol Violation|0|||
124442287|NCT04675151|447580114|FG002|Overall Study|Protocol Violation|0|||
124442288|NCT04675151|447580115|FG003|Overall Study|Protocol Violation|1|||
124442289|NCT00777946|447580116|FG000|Overall Study|Adverse Event|11|||
124892851|NCT02028884|449231928|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
124892852|NCT02028884|449231929|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
124892853|NCT02028884|449231927|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
124892854|NCT02028884|449231928|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
124892855|NCT02028884|449231929|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
124892856|NCT02028884|449231927|FG000|Open-label Extension Period|Switched to another treatment option|3|||
124892857|NCT02028884|449231928|FG001|Open-label Extension Period|Switched to another treatment option|0|||
124892858|NCT02028884|449231929|FG002|Open-label Extension Period|Switched to another treatment option|0|||
124892859|NCT00354029|449231930|FG000|Overall Study|Protocol Violation|4|||
124892860|NCT00354029|449231931|FG001|Overall Study|Protocol Violation|2|||
124892861|NCT00723294|449231932|FG000|Overall Study|Lobular histology|2|||
124892862|NCT00723294|449231932|FG000|Overall Study|>25% intraductal component|1|||
124892863|NCT00723294|449231932|FG000|Overall Study|No MRI tumor enhancement|1|||
124892864|NCT00723294|449231932|FG000|Overall Study|1.0-Tesla MRI|1|||
124892865|NCT00723294|449231932|FG000|Overall Study|No cryoabalation|2|||
124892866|NCT00723294|449231932|FG000|Overall Study|Did not undergo surgery|1|||
124892867|NCT00723294|449231932|FG000|Overall Study|Treated prior to registration|1|||
124442290|NCT00777946|447580117|FG001|Overall Study|Adverse Event|1|||
124442291|NCT00777946|447580118|FG002|Overall Study|Adverse Event|3|||
124442292|NCT00777946|447580116|FG000|Overall Study|Lack of Efficacy|0|||
124442293|NCT00777946|447580117|FG001|Overall Study|Lack of Efficacy|0|||
124442294|NCT00777946|447580118|FG002|Overall Study|Lack of Efficacy|9|||
124892868|NCT00723294|449231932|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
124892869|NCT00723294|449231932|FG000|Overall Study|Benign lesion|1|||
124442295|NCT00777946|447580116|FG000|Overall Study|Condition no longer required study drug|1|||
124442296|NCT00777946|447580117|FG001|Overall Study|Condition no longer required study drug|0|||
124442297|NCT00777946|447580118|FG002|Overall Study|Condition no longer required study drug|0|||
124442298|NCT00777946|447580116|FG000|Overall Study|Patient withdrew consent|3|||
124442299|NCT00777946|447580117|FG001|Overall Study|Patient withdrew consent|2|||
124442300|NCT00777946|447580118|FG002|Overall Study|Patient withdrew consent|3|||
124442301|NCT00777946|447580116|FG000|Overall Study|Lost to Follow-up|3|||
124442302|NCT00777946|447580117|FG001|Overall Study|Lost to Follow-up|1|||
124442303|NCT00777946|447580118|FG002|Overall Study|Lost to Follow-up|0|||
124442304|NCT00777946|447580116|FG000|Overall Study|Protocol deviation|2|||
124442305|NCT00777946|447580117|FG001|Overall Study|Protocol deviation|1|||
124442306|NCT00777946|447580118|FG002|Overall Study|Protocol deviation|1|||
124442307|NCT00777946|447580116|FG000|Overall Study|Randomized in error|1|||
124442308|NCT00777946|447580117|FG001|Overall Study|Randomized in error|1|||
124442309|NCT00777946|447580118|FG002|Overall Study|Randomized in error|0|||
124442310|NCT01658826|447580121|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
124442311|NCT01658826|447580122|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
124442312|NCT01658826|447580121|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
124442313|NCT01658826|447580122|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
124442314|NCT01658826|447580121|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
124442315|NCT01658826|447580122|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
124442316|NCT01658826|447580121|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
124442317|NCT01658826|447580122|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
124442318|NCT01658826|447580121|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
124442319|NCT01658826|447580122|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
124442320|NCT01658826|447580121|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
124442321|NCT01658826|447580122|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
124442322|NCT01658826|447580121|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
124442323|NCT01658826|447580122|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
124442324|NCT01658826|447580121|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
124442325|NCT01658826|447580122|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
124442326|NCT01658826|447580121|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
124442327|NCT01658826|447580122|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
124442328|NCT05677893|447581422|FG000|Overall Study|Withdrawal by Subject|0|||
124442329|NCT05677893|447581423|FG001|Overall Study|Withdrawal by Subject|0|||
124442330|NCT05677893|447581424|FG002|Overall Study|Withdrawal by Subject|0|||
124442331|NCT05677893|447581425|FG003|Overall Study|Withdrawal by Subject|0|||
124442332|NCT05677893|447581426|FG004|Overall Study|Withdrawal by Subject|1|||
124442333|NCT05677893|447581427|FG005|Overall Study|Withdrawal by Subject|1|||
124442334|NCT05677893|447581428|FG006|Overall Study|Withdrawal by Subject|0|||
124442335|NCT05677893|447581422|FG000|Overall Study|Others|1|||
124442336|NCT05677893|447581423|FG001|Overall Study|Others|0|||
124442337|NCT05677893|447581424|FG002|Overall Study|Others|0|||
124442338|NCT05677893|447581425|FG003|Overall Study|Others|0|||
124442339|NCT05677893|447581426|FG004|Overall Study|Others|0|||
124442340|NCT05677893|447581427|FG005|Overall Study|Others|0|||
124442341|NCT05677893|447581428|FG006|Overall Study|Others|0|||
124442342|NCT01485354|447581429|FG000|Overall Study|Withdrawal by Subject|5|||
124442343|NCT02101034|447581430|FG000|Overall Study|Enrolled but did not start treatment|0|||
124442344|NCT02101034|447581431|FG001|Overall Study|Enrolled but did not start treatment|0|||
124442345|NCT02101034|447581432|FG002|Overall Study|Enrolled but did not start treatment|1|||
124442346|NCT02101034|447581433|FG003|Overall Study|Enrolled but did not start treatment|0|||
124442347|NCT02101034|447581434|FG004|Overall Study|Enrolled but did not start treatment|0|||
124442348|NCT02382016|447581444|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
124442349|NCT02382016|447581445|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
124442350|NCT02382016|447581444|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
124442351|NCT02382016|447581445|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
124442352|NCT02382016|447581444|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
124442353|NCT02382016|447581445|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
124442354|NCT02382016|447581444|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
124442355|NCT02382016|447581445|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
124442356|NCT02382016|447581444|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
124442357|NCT02382016|447581445|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
124442358|NCT02382016|447581444|FG000|Open-label (OL) Treatment Period|Death|4|||
124892870|NCT00723294|449231932|FG000|Overall Study|Withdrawal by Subject|1|||
124442359|NCT02382016|447581445|FG001|Open-label (OL) Treatment Period|Death|0|||
124759282|NCT04170543|448742595|FG002|Overall Study|Not Treated|0|||
124892871|NCT00723294|449231932|FG000|Overall Study|No treatment due to probe failure|1|||
124892872|NCT02403674|449231933|FG000|Base Study|Death|1|||
124686836|NCT00217737|448472213|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
124686837|NCT00217737|448472210|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
124686838|NCT00217737|448472211|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
124686839|NCT00217737|448472212|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
124686840|NCT00217737|448472213|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
124686841|NCT00217737|448472210|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
124686842|NCT00217737|448472211|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
124686843|NCT00217737|448472212|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
124686844|NCT00217737|448472213|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
124686845|NCT00217737|448472210|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
124686846|NCT00217737|448472211|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
124686847|NCT00217737|448472212|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
124686848|NCT00217737|448472213|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
124686849|NCT00217737|448472210|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
124686850|NCT00217737|448472211|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
124686851|NCT00217737|448472212|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
124686852|NCT00217737|448472213|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
124686853|NCT00217737|448472210|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
124686854|NCT00217737|448472211|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
124892873|NCT02403674|449231934|FG001|Base Study|Death|4|||
124892874|NCT02403674|449231933|FG000|Base Study|Adverse Event|11|||
124892875|NCT02403674|449231934|FG001|Base Study|Adverse Event|26|||
124892876|NCT02403674|449231933|FG000|Base Study|Lack of Efficacy|31|||
124892877|NCT02403674|449231934|FG001|Base Study|Lack of Efficacy|23|||
124686855|NCT00217737|448472212|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
124686856|NCT00217737|448472213|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
124686857|NCT00217737|448472210|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
124686858|NCT00217737|448472211|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
124686859|NCT00217737|448472212|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
124686860|NCT00217737|448472213|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
124686861|NCT00217737|448472210|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
124686862|NCT00217737|448472211|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
124686863|NCT00217737|448472212|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
124686864|NCT00217737|448472213|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
124686865|NCT00217737|448472210|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
124686866|NCT00217737|448472211|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
124686867|NCT00217737|448472212|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
124686868|NCT00217737|448472213|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
124686869|NCT00217737|448472210|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
124686870|NCT00217737|448472211|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
124686871|NCT00217737|448472212|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
124686872|NCT00217737|448472213|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
124686873|NCT00217737|448472210|FG000|Step 2 Randomization/Registration|Study suspension|0|||
124686874|NCT00217737|448472211|FG001|Step 2 Randomization/Registration|Study suspension|45|||
124686875|NCT00217737|448472212|FG002|Step 2 Randomization/Registration|Study suspension|0|||
124686876|NCT00217737|448472213|FG003|Step 2 Randomization/Registration|Study suspension|0|||
124686877|NCT00217737|448472210|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
124686878|NCT00217737|448472211|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
124686879|NCT00217737|448472212|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
124686880|NCT00217737|448472213|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
124686881|NCT00217737|448472210|FG000|Step 2 Randomization/Registration|Death|2|||
124686882|NCT00217737|448472211|FG001|Step 2 Randomization/Registration|Death|3|||
124686883|NCT00217737|448472212|FG002|Step 2 Randomization/Registration|Death|0|||
124686884|NCT00217737|448472213|FG003|Step 2 Randomization/Registration|Death|0|||
124686885|NCT00217737|448472210|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
124686886|NCT00217737|448472211|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
124686887|NCT00217737|448472212|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
124686888|NCT00217737|448472213|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
124686889|NCT00217737|448472210|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
124686890|NCT00217737|448472211|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
124686891|NCT00217737|448472212|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
124892878|NCT02403674|449231933|FG000|Base Study|Lost to Follow-up|6|||
124892879|NCT02403674|449231934|FG001|Base Study|Lost to Follow-up|8|||
124892880|NCT02403674|449231933|FG000|Base Study|Withdrawal by Subject|10|||
124892881|NCT02403674|449231934|FG001|Base Study|Withdrawal by Subject|17|||
124892882|NCT02403674|449231933|FG000|Base Study|Physician Decision|2|||
124892883|NCT02403674|449231934|FG001|Base Study|Physician Decision|2|||
124892884|NCT02403674|449231933|FG000|Base Study|Pregnancy|2|||
124892885|NCT02403674|449231934|FG001|Base Study|Pregnancy|2|||
124892886|NCT02403674|449231933|FG000|Base Study|Protocol Violation|8|||
124892887|NCT02403674|449231934|FG001|Base Study|Protocol Violation|4|||
124892888|NCT02403674|449231933|FG000|Base Study|Non-Compliance with study drug|1|||
124892889|NCT02403674|449231934|FG001|Base Study|Non-Compliance with study drug|4|||
124442360|NCT02382016|447581444|FG000|OL Extension Period|Physician Decision|3|||
124442361|NCT02382016|447581445|FG001|OL Extension Period|Physician Decision|0|||
124892890|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
124442362|NCT02382016|447581444|FG000|OL Extension Period|Death|2|||
124892891|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
124442363|NCT02382016|447581445|FG001|OL Extension Period|Death|0|||
124442364|NCT02382016|447581444|FG000|OL Extension Period|Withdrawal by Subject|1|||
124442365|NCT02382016|447581445|FG001|OL Extension Period|Withdrawal by Subject|0|||
124442366|NCT00084266|447581446|FG000|Overall Study|Death|42|||
124442367|NCT00084266|447581447|FG001|Overall Study|Death|39|||
124442368|NCT00084266|447581446|FG000|Overall Study|Adverse Event|8|||
124442369|NCT00084266|447581447|FG001|Overall Study|Adverse Event|5|||
124442370|NCT00084266|447581446|FG000|Overall Study|Lack of Efficacy|2|||
124442371|NCT00084266|447581447|FG001|Overall Study|Lack of Efficacy|4|||
124442372|NCT00084266|447581446|FG000|Overall Study|Lost to Follow-up|5|||
124442373|NCT00084266|447581447|FG001|Overall Study|Lost to Follow-up|3|||
124442374|NCT00084266|447581446|FG000|Overall Study|Participant not willing to participate|3|||
124442375|NCT00084266|447581447|FG001|Overall Study|Participant not willing to participate|8|||
124442376|NCT00084266|447581446|FG000|Overall Study|Other|360|||
124442377|NCT00084266|447581447|FG001|Overall Study|Other|344|||
124442378|NCT00084266|447581446|FG000|Overall Study|Randomized not treated|21|||
124442379|NCT00084266|447581447|FG001|Overall Study|Randomized not treated|20|||
124442380|NCT00730171|447581448|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
124442381|NCT00730171|447581448|FG000|Overall Study|Adverse Event|193|||
124442382|NCT00730171|447581448|FG000|Overall Study|Protocol Violation|48|||
124442383|NCT00730171|447581448|FG000|Overall Study|Withdrawal by Subject|202|||
124442384|NCT00730171|447581448|FG000|Overall Study|Lost to Follow-up|121|||
124442385|NCT00730171|447581448|FG000|Overall Study|Insufficient Therapeutic Response|141|||
124442386|NCT00730171|447581448|FG000|Overall Study|Other|61|||
124442387|NCT01326533|447581461|FG000|Overall Study|Lost to Follow-up|2|||
124442388|NCT01326533|447581462|FG001|Overall Study|Lost to Follow-up|0|||
124442389|NCT01326533|447581461|FG000|Overall Study|Withdrawal by Subject|1|||
124442390|NCT01326533|447581462|FG001|Overall Study|Withdrawal by Subject|0|||
124442391|NCT01326533|447581461|FG000|Overall Study|Adverse Event|1|||
124442392|NCT01326533|447581462|FG001|Overall Study|Adverse Event|0|||
124442393|NCT01881750|447581463|FG000|Overall Study|Changes in concomitant therapies|2|||
124442394|NCT01881750|447581464|FG001|Overall Study|Changes in concomitant therapies|3|||
124442395|NCT01881750|447581463|FG000|Overall Study|Lost to Follow-up|0|||
124442396|NCT01881750|447581464|FG001|Overall Study|Lost to Follow-up|1|||
124442397|NCT00926211|447581465|FG000|Overall Study|Lost to Follow-up|1|||
124442398|NCT00894686|447581469|FG000|Overall Study|Withdrawal by Subject|50|||
124442399|NCT00894686|447581469|FG000|Overall Study|Physician Decision|1|||
124442400|NCT00894686|447581469|FG000|Overall Study|Other|5|||
124442401|NCT00564018|447581470|FG000|Overall Study|Withdrawal by Subject|2|||
124442402|NCT00564018|447581471|FG001|Overall Study|Withdrawal by Subject|3|||
124442403|NCT00564018|447581472|FG002|Overall Study|Withdrawal by Subject|1|||
124442404|NCT03267940|447581475|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
124442405|NCT03267940|447581476|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
124442406|NCT03267940|447581477|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
124442407|NCT03267940|447581478|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
124442408|NCT03267940|447581479|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
124442409|NCT03267940|447581480|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
124442410|NCT03267940|447581475|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
124442411|NCT03267940|447581476|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
124442412|NCT03267940|447581477|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
124442413|NCT03267940|447581478|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
124442414|NCT03267940|447581479|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
124442415|NCT03267940|447581480|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
124442416|NCT03267940|447581475|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
124442417|NCT03267940|447581476|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
124442418|NCT03267940|447581477|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
124442419|NCT03267940|447581478|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
124442420|NCT03267940|447581479|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
124442421|NCT03267940|447581480|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
124442422|NCT03267940|447581475|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
124442423|NCT03267940|447581476|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
124442424|NCT03267940|447581477|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
124442425|NCT03267940|447581478|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
124442426|NCT03267940|447581479|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
124442427|NCT03267940|447581480|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
124442428|NCT03267940|447581475|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
124442429|NCT03267940|447581476|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
124442430|NCT03267940|447581477|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
124442431|NCT03267940|447581478|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
124442432|NCT03267940|447581479|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
124686892|NCT00217737|448472213|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
124686893|NCT00217737|448472210|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
124686894|NCT00217737|448472211|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
124686895|NCT00217737|448472212|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
124686896|NCT00217737|448472213|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
124686897|NCT00217737|448472210|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
124686898|NCT00217737|448472211|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
124686899|NCT00217737|448472212|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
124686900|NCT00217737|448472213|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
124686901|NCT00217737|448472210|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
124686902|NCT00217737|448472211|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
124686903|NCT00217737|448472212|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
124686904|NCT00217737|448472213|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
124686905|NCT00217737|448472210|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
124686906|NCT00217737|448472211|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
124686907|NCT00217737|448472212|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
124686908|NCT00217737|448472213|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
124686909|NCT00217737|448472210|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
124686910|NCT00217737|448472211|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
124686911|NCT00217737|448472212|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
124686912|NCT00217737|448472213|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
124686913|NCT00217737|448472210|FG000|Step 2 Randomization/Registration|Other|1|||
124686914|NCT00217737|448472211|FG001|Step 2 Randomization/Registration|Other|2|||
124686915|NCT00217737|448472212|FG002|Step 2 Randomization/Registration|Other|0|||
124686916|NCT00217737|448472213|FG003|Step 2 Randomization/Registration|Other|0|||
124686917|NCT04589650|448472656|FG000|Overall Study|Subject decision|6|||
124686918|NCT04589650|448472657|FG001|Overall Study|Subject decision|2|||
124686919|NCT04589650|448472658|FG002|Overall Study|Subject decision|2|||
124686920|NCT04589650|448472659|FG003|Overall Study|Subject decision|0|||
124686921|NCT04589650|448472660|FG004|Overall Study|Subject decision|0|||
124686922|NCT04589650|448472661|FG005|Overall Study|Subject decision|0|||
124686923|NCT04589650|448472656|FG000|Overall Study|Adverse Event|3|||
124686924|NCT04589650|448472657|FG001|Overall Study|Adverse Event|1|||
124686925|NCT04589650|448472658|FG002|Overall Study|Adverse Event|1|||
124686926|NCT04589650|448472659|FG003|Overall Study|Adverse Event|1|||
124892892|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
124892893|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
124892894|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
124892895|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
124892896|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
124892897|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
124892898|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
124892899|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
124892900|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
124892901|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
124892902|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Death|1|||
124892903|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Death|0|||
124892904|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
124892905|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
124892906|NCT02403674|449231933|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
124892907|NCT02403674|449231934|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
124892908|NCT02403674|449231933|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
124892909|NCT02403674|449231934|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
124892910|NCT02403674|449231933|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
124892911|NCT02403674|449231934|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
124892912|NCT02403674|449231933|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
124892913|NCT02403674|449231934|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
124892914|NCT02403674|449231933|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
124892915|NCT02403674|449231934|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
124892916|NCT02403674|449231933|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
124892917|NCT02403674|449231934|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
124892918|NCT02403674|449231933|FG000|Study Extension 2 (Open-Label)|Death|2|||
124892919|NCT02403674|449231934|FG001|Study Extension 2 (Open-Label)|Death|2|||
124686927|NCT04589650|448472660|FG004|Overall Study|Adverse Event|0|||
124686928|NCT04589650|448472661|FG005|Overall Study|Adverse Event|1|||
124892920|NCT02403674|449231933|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
124686929|NCT04589650|448472656|FG000|Overall Study|Physician Decision|1|||
124686930|NCT04589650|448472657|FG001|Overall Study|Physician Decision|1|||
124466437|NCT01882907|447666400|FG000|Overall Study|Protocol Violation|10|||
124686931|NCT04589650|448472658|FG002|Overall Study|Physician Decision|0|||
124686932|NCT04589650|448472659|FG003|Overall Study|Physician Decision|0|||
124686933|NCT04589650|448472660|FG004|Overall Study|Physician Decision|0|||
124686934|NCT04589650|448472661|FG005|Overall Study|Physician Decision|0|||
124686935|NCT04589650|448472656|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124686936|NCT04589650|448472657|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124686937|NCT04589650|448472658|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
124686938|NCT04589650|448472659|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
124686939|NCT04589650|448472660|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
124686940|NCT04589650|448472661|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
124686941|NCT04589650|448472656|FG000|Overall Study|Death|0|||
124686942|NCT04589650|448472657|FG001|Overall Study|Death|0|||
124686943|NCT04589650|448472658|FG002|Overall Study|Death|0|||
124686944|NCT04589650|448472659|FG003|Overall Study|Death|1|||
124686945|NCT04589650|448472660|FG004|Overall Study|Death|0|||
124686946|NCT04589650|448472661|FG005|Overall Study|Death|0|||
124686947|NCT04589650|448472656|FG000|Overall Study|Guardian Decision|0|||
124686948|NCT04589650|448472657|FG001|Overall Study|Guardian Decision|0|||
124686949|NCT04589650|448472658|FG002|Overall Study|Guardian Decision|0|||
124686950|NCT04589650|448472659|FG003|Overall Study|Guardian Decision|1|||
124686951|NCT04589650|448472660|FG004|Overall Study|Guardian Decision|0|||
124686952|NCT04589650|448472661|FG005|Overall Study|Guardian Decision|0|||
124686953|NCT04937387|448472663|FG000|Overall Study|Adverse Event|1|||
124686954|NCT04937387|448472664|FG001|Overall Study|Adverse Event|0|||
124686955|NCT04937387|448472665|FG002|Overall Study|Adverse Event|2|||
124686956|NCT04937387|448472666|FG003|Overall Study|Adverse Event|0|||
124686957|NCT04937387|448472663|FG000|Overall Study|Lack of Efficacy|1|||
124686958|NCT04937387|448472664|FG001|Overall Study|Lack of Efficacy|0|||
124686959|NCT04937387|448472665|FG002|Overall Study|Lack of Efficacy|0|||
124686960|NCT04937387|448472666|FG003|Overall Study|Lack of Efficacy|1|||
124686961|NCT04937387|448472663|FG000|Overall Study|Withdrawal by Subject|1|||
124686962|NCT04937387|448472664|FG001|Overall Study|Withdrawal by Subject|0|||
124686963|NCT04937387|448472665|FG002|Overall Study|Withdrawal by Subject|1|||
124686964|NCT04937387|448472666|FG003|Overall Study|Withdrawal by Subject|1|||
124686965|NCT04937387|448472663|FG000|Overall Study|Randomized in error|0|||
124686966|NCT04937387|448472664|FG001|Overall Study|Randomized in error|0|||
124686967|NCT04937387|448472665|FG002|Overall Study|Randomized in error|0|||
124686968|NCT04937387|448472666|FG003|Overall Study|Randomized in error|1|||
124686969|NCT04134845|448472667|FG000|Overall Study|withdrawl by PI|12|||
124686970|NCT04134845|448472668|FG001|Overall Study|withdrawl by PI|5|||
124686971|NCT01371981|448472669|FG000|Overall Study|Adverse Event|12|||
124686972|NCT01371981|448472670|FG001|Overall Study|Adverse Event|17|||
124686973|NCT01371981|448472671|FG002|Overall Study|Adverse Event|0|||
124686974|NCT01371981|448472672|FG003|Overall Study|Adverse Event|4|||
124686975|NCT01371981|448472673|FG004|Overall Study|Adverse Event|1|||
124686976|NCT01371981|448472674|FG005|Overall Study|Adverse Event|0|||
124686977|NCT01371981|448472669|FG000|Overall Study|Death|22|||
124686978|NCT01371981|448472670|FG001|Overall Study|Death|16|||
124686979|NCT01371981|448472671|FG002|Overall Study|Death|0|||
124686980|NCT01371981|448472672|FG003|Overall Study|Death|0|||
124686981|NCT01371981|448472673|FG004|Overall Study|Death|2|||
124686982|NCT01371981|448472674|FG005|Overall Study|Death|2|||
124686983|NCT01371981|448472669|FG000|Overall Study|Lack of Efficacy|69|||
124686984|NCT01371981|448472670|FG001|Overall Study|Lack of Efficacy|61|||
124686985|NCT01371981|448472671|FG002|Overall Study|Lack of Efficacy|4|||
124686986|NCT01371981|448472672|FG003|Overall Study|Lack of Efficacy|8|||
124686987|NCT01371981|448472673|FG004|Overall Study|Lack of Efficacy|5|||
124686988|NCT01371981|448472674|FG005|Overall Study|Lack of Efficacy|0|||
124686989|NCT01371981|448472669|FG000|Overall Study|Physician Decision|48|||
124686990|NCT01371981|448472670|FG001|Overall Study|Physician Decision|63|||
124686991|NCT01371981|448472671|FG002|Overall Study|Physician Decision|1|||
124686992|NCT01371981|448472672|FG003|Overall Study|Physician Decision|7|||
124892921|NCT02403674|449231934|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
124442433|NCT03267940|447581480|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
124442434|NCT03267940|447581475|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
124442435|NCT03267940|447581476|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
124686993|NCT01371981|448472673|FG004|Overall Study|Physician Decision|14|||
124686994|NCT01371981|448472674|FG005|Overall Study|Physician Decision|3|||
124686995|NCT01371981|448472669|FG000|Overall Study|Withdrawal by Subject|12|||
124442436|NCT03267940|447581477|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
124686996|NCT01371981|448472670|FG001|Overall Study|Withdrawal by Subject|19|||
124686997|NCT01371981|448472671|FG002|Overall Study|Withdrawal by Subject|1|||
124686998|NCT01371981|448472672|FG003|Overall Study|Withdrawal by Subject|2|||
124686999|NCT01371981|448472673|FG004|Overall Study|Withdrawal by Subject|10|||
124687000|NCT01371981|448472674|FG005|Overall Study|Withdrawal by Subject|3|||
124687001|NCT01371981|448472669|FG000|Overall Study|Ineligible|19|||
124687002|NCT01371981|448472670|FG001|Overall Study|Ineligible|13|||
124687003|NCT01371981|448472671|FG002|Overall Study|Ineligible|0|||
124687004|NCT01371981|448472672|FG003|Overall Study|Ineligible|0|||
124687005|NCT01371981|448472673|FG004|Overall Study|Ineligible|0|||
124687006|NCT01371981|448472674|FG005|Overall Study|Ineligible|4|||
124687007|NCT01371981|448472669|FG000|Overall Study|Did not start treatment|2|||
124687008|NCT01371981|448472670|FG001|Overall Study|Did not start treatment|3|||
124687009|NCT01371981|448472671|FG002|Overall Study|Did not start treatment|0|||
124687010|NCT01371981|448472672|FG003|Overall Study|Did not start treatment|0|||
124687011|NCT01371981|448472673|FG004|Overall Study|Did not start treatment|0|||
124687012|NCT01371981|448472674|FG005|Overall Study|Did not start treatment|2|||
124687013|NCT05759338|448472675|FG000|Overall Study|Withdrawal by Subject|3|||
124687014|NCT03244189|448472676|FG000|Overall Study|Death|0|||
124687015|NCT03244189|448472677|FG001|Overall Study|Death|2|||
124687016|NCT03244189|448472676|FG000|Overall Study|Lost to Follow-up|92|||
124687017|NCT03244189|448472677|FG001|Overall Study|Lost to Follow-up|107|||
124687018|NCT03244189|448472676|FG000|Overall Study|Physician Decision|4|||
124687019|NCT03244189|448472677|FG001|Overall Study|Physician Decision|2|||
124687020|NCT03244189|448472676|FG000|Overall Study|Pregnancy|7|||
124687021|NCT03244189|448472677|FG001|Overall Study|Pregnancy|5|||
124687022|NCT03244189|448472676|FG000|Overall Study|Protocol Violation|0|||
124687023|NCT03244189|448472677|FG001|Overall Study|Protocol Violation|2|||
124687024|NCT03244189|448472676|FG000|Overall Study|Withdrawal by Subject|45|||
124687025|NCT03244189|448472677|FG001|Overall Study|Withdrawal by Subject|23|||
124687026|NCT03244189|448472676|FG000|Overall Study|Technical Problems|2|||
124687027|NCT03244189|448472677|FG001|Overall Study|Technical Problems|0|||
124687028|NCT06481579|448472678|FG000|Overall Study|Death|1|||
124687029|NCT06481579|448472679|FG001|Overall Study|Death|0|||
124687030|NCT06481579|448472678|FG000|Overall Study|Withdrawal by Subject|3|||
124687031|NCT06481579|448472679|FG001|Overall Study|Withdrawal by Subject|0|||
124687032|NCT06481579|448472678|FG000|Overall Study|Other|1|||
124687033|NCT06481579|448472679|FG001|Overall Study|Other|1|||
124687034|NCT06170827|448472680|FG000|Overall Study|Withdrawal by Subject|1|||
124687035|NCT06170827|448472681|FG001|Overall Study|Withdrawal by Subject|1|||
124687036|NCT05253807|448472682|FG000|Overall Study|Death|1|||
124687037|NCT05253807|448472683|FG001|Overall Study|Death|4|||
124687038|NCT05253807|448472682|FG000|Overall Study|Withdrawal by Subject|1|||
124687039|NCT05253807|448472683|FG001|Overall Study|Withdrawal by Subject|0|||
124687040|NCT05253807|448472682|FG000|Overall Study|Study Terminated by Sponsor|1|||
124687041|NCT05253807|448472683|FG001|Overall Study|Study Terminated by Sponsor|1|||
124687042|NCT04611126|448472684|FG000|Overall Study|TIL expansion unsuccessful|1|||
124687043|NCT04611126|448472685|FG001|Overall Study|TIL expansion unsuccessful|0|||
124687044|NCT03459846|448472690|FG000|Overall Study|Death|52|||
124687045|NCT03459846|448472691|FG001|Overall Study|Death|46|||
124687046|NCT03459846|448472690|FG000|Overall Study|Study terminated by sponsor|24|||
124687047|NCT03459846|448472691|FG001|Overall Study|Study terminated by sponsor|28|||
124687048|NCT03459846|448472690|FG000|Overall Study|Withdrawal by Subject|2|||
124687049|NCT03459846|448472691|FG001|Overall Study|Withdrawal by Subject|2|||
124687050|NCT06455111|448472697|FG000|Overall Study|Withdrawal by Subject|11|||
124687051|NCT06455111|448472698|FG001|Overall Study|Withdrawal by Subject|4|||
124687052|NCT05578872|448472706|FG000|Overall Study|Withdrawal by Subject|2|||
124687053|NCT05578872|448472707|FG001|Overall Study|Withdrawal by Subject|1|||
124687054|NCT05578872|448472706|FG000|Overall Study|Adverse Event|1|||
124687055|NCT05578872|448472707|FG001|Overall Study|Adverse Event|1|||
124687056|NCT05578872|448472706|FG000|Overall Study|Physician Decision|1|||
124687057|NCT05578872|448472707|FG001|Overall Study|Physician Decision|2|||
124442437|NCT03267940|447581478|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
124442438|NCT03267940|447581479|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
124442439|NCT03267940|447581480|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
124442440|NCT03267940|447581475|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
124442441|NCT03267940|447581476|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
124687058|NCT05578872|448472706|FG000|Overall Study|Progressive disease|10|||
124892922|NCT02403674|449231933|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
124892923|NCT02403674|449231934|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
124892924|NCT02403674|449231933|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
124892925|NCT02403674|449231934|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
124442442|NCT03267940|447581477|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
124442443|NCT03267940|447581478|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
124687059|NCT05578872|448472707|FG001|Overall Study|Progressive disease|9|||
124687060|NCT05578872|448472706|FG000|Overall Study|Sponsor decision|0|||
124687061|NCT05578872|448472707|FG001|Overall Study|Sponsor decision|1|||
124687062|NCT05578872|448472706|FG000|Overall Study|Toxicity and Patient's decision|0|||
124687063|NCT05578872|448472707|FG001|Overall Study|Toxicity and Patient's decision|1|||
124687064|NCT01732783|448473513|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
124687065|NCT01732783|448473514|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
124687066|NCT01732783|448473515|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
124687067|NCT01732783|448473513|FG000|Overall Study|Death|13|||
124687068|NCT01732783|448473514|FG001|Overall Study|Death|4|||
124687069|NCT01732783|448473515|FG002|Overall Study|Death|1|||
124687070|NCT01732783|448473513|FG000|Overall Study|Lost to Follow-up|7|||
124892926|NCT02403674|449231933|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
124892927|NCT02403674|449231934|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
124892928|NCT02403674|449231933|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
124892929|NCT02403674|449231934|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
124892930|NCT02403674|449231933|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
124892931|NCT02403674|449231934|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
124892932|NCT02403674|449231933|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
124892933|NCT02403674|449231934|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
124892934|NCT00826280|449231936|FG000|Overall Study|Randomized but drug not received|1|||
124892935|NCT00826280|449231937|FG001|Overall Study|Randomized but drug not received|0|||
124892936|NCT00826280|449231938|FG002|Overall Study|Randomized but drug not received|1|||
124892937|NCT00826280|449231936|FG000|Overall Study|Adverse Event|1|||
124892938|NCT00826280|449231937|FG001|Overall Study|Adverse Event|3|||
124892939|NCT00826280|449231938|FG002|Overall Study|Adverse Event|0|||
124892940|NCT00826280|449231936|FG000|Overall Study|Lost to Follow-up|0|||
124892941|NCT00826280|449231937|FG001|Overall Study|Lost to Follow-up|1|||
124892942|NCT00826280|449231938|FG002|Overall Study|Lost to Follow-up|0|||
124892943|NCT00826280|449231936|FG000|Overall Study|Sponsor discontinued subject or study|1|||
124892944|NCT00826280|449231937|FG001|Overall Study|Sponsor discontinued subject or study|0|||
124892945|NCT00826280|449231938|FG002|Overall Study|Sponsor discontinued subject or study|0|||
124892946|NCT00826280|449231936|FG000|Overall Study|Reversible ischemic defect not present|43|||
124892947|NCT00826280|449231937|FG001|Overall Study|Reversible ischemic defect not present|40|||
124892948|NCT00826280|449231938|FG002|Overall Study|Reversible ischemic defect not present|44|||
124892949|NCT00826280|449231936|FG000|Overall Study|Interpretation Failure|1|||
124892950|NCT00826280|449231937|FG001|Overall Study|Interpretation Failure|0|||
124892951|NCT00826280|449231938|FG002|Overall Study|Interpretation Failure|0|||
124892952|NCT00826280|449231936|FG000|Overall Study|Machine Failure|1|||
124892953|NCT00826280|449231937|FG001|Overall Study|Machine Failure|1|||
124892954|NCT00826280|449231938|FG002|Overall Study|Machine Failure|0|||
124442444|NCT03267940|447581479|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
124442445|NCT03267940|447581480|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
124892955|NCT00826280|449231936|FG000|Overall Study|One or more non-interpretable scan|0|||
124892956|NCT00826280|449231937|FG001|Overall Study|One or more non-interpretable scan|1|||
124892957|NCT00826280|449231938|FG002|Overall Study|One or more non-interpretable scan|1|||
124892958|NCT03201757|449231939|FG000|Overall Study|Withdrawal by Subject|133|||
124892959|NCT03201757|449231939|FG000|Overall Study|Adverse Event|44|||
124442446|NCT03267940|447581475|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
124892960|NCT03201757|449231939|FG000|Overall Study|Lost to Follow-up|37|||
124892961|NCT03201757|449231939|FG000|Overall Study|Pregnancy|2|||
124892962|NCT03201757|449231939|FG000|Overall Study|Lack of Efficacy|1|||
124892963|NCT03201757|449231939|FG000|Overall Study|Protocol Violation|20|||
124892964|NCT03201757|449231939|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
124892965|NCT03201757|449231939|FG000|Overall Study|Not Yet Determined|5|||
124892966|NCT03201757|449231939|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
124892967|NCT03201757|449231939|FG000|Overall Study|Other|20|||
124892968|NCT01254305|449231940|FG000|Overall Study|Adverse Event|6|||
124892969|NCT01254305|449231941|FG001|Overall Study|Adverse Event|3|||
124892970|NCT01254305|449231942|FG002|Overall Study|Adverse Event|2|||
124892971|NCT01254305|449231940|FG000|Overall Study|Lack of Efficacy|1|||
124892972|NCT01254305|449231941|FG001|Overall Study|Lack of Efficacy|0|||
124892973|NCT01254305|449231942|FG002|Overall Study|Lack of Efficacy|1|||
124892974|NCT01254305|449231940|FG000|Overall Study|Protocol Violation|1|||
124892975|NCT01254305|449231941|FG001|Overall Study|Protocol Violation|7|||
124892976|NCT01254305|449231942|FG002|Overall Study|Protocol Violation|3|||
124892977|NCT01254305|449231940|FG000|Overall Study|Withdrawal by Subject|4|||
124892978|NCT01254305|449231941|FG001|Overall Study|Withdrawal by Subject|2|||
124892979|NCT01254305|449231942|FG002|Overall Study|Withdrawal by Subject|4|||
124892980|NCT01254305|449231940|FG000|Overall Study|Lost to Follow-up|10|||
124892981|NCT01254305|449231941|FG001|Overall Study|Lost to Follow-up|6|||
124892982|NCT01254305|449231942|FG002|Overall Study|Lost to Follow-up|5|||
124892983|NCT01254305|449231940|FG000|Overall Study|Other Reasons|0|||
124892984|NCT01254305|449231941|FG001|Overall Study|Other Reasons|0|||
124892985|NCT01254305|449231942|FG002|Overall Study|Other Reasons|2|||
124892986|NCT01511536|449231943|FG000|Phase 1|Other|0|||
124892987|NCT01511536|449231944|FG001|Phase 1|Other|1|||
124892988|NCT01511536|449231945|FG002|Phase 1|Other|0|||
124892989|NCT01511536|449231943|FG000|Phase 2|Other|0|||
124892990|NCT01511536|449231944|FG001|Phase 2|Other|0|||
124892991|NCT01511536|449231945|FG002|Phase 2|Other|9|||
124892992|NCT02703532|449231949|FG000|Overall Study|Withdrawal by Subject|0|||
124892993|NCT02703532|449231950|FG001|Overall Study|Withdrawal by Subject|1|||
124892994|NCT02703532|449231951|FG002|Overall Study|Withdrawal by Subject|0|||
124892995|NCT02703532|449231952|FG003|Overall Study|Withdrawal by Subject|1|||
124892996|NCT02703532|449231949|FG000|Overall Study|Lost to Follow-up|2|||
124442447|NCT03267940|447581476|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
124892997|NCT02703532|449231950|FG001|Overall Study|Lost to Follow-up|0|||
124892998|NCT02703532|449231951|FG002|Overall Study|Lost to Follow-up|2|||
124892999|NCT02703532|449231952|FG003|Overall Study|Lost to Follow-up|0|||
124893000|NCT03239210|449231953|FG000|Overall Study|Lost to Follow-up|2|||
124893001|NCT03239210|449231954|FG001|Overall Study|Lost to Follow-up|2|||
124893002|NCT03239210|449231953|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
124893003|NCT03239210|449231954|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
124893004|NCT03239210|449231953|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
124893005|NCT03239210|449231954|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
124893006|NCT01403987|449231957|FG000|Overall Study|Residents forgot their secret PIN|18|||
124893007|NCT01403987|449231958|FG001|Overall Study|Residents forgot their secret PIN|17|||
124893008|NCT01403987|449231959|FG002|Overall Study|Residents forgot their secret PIN|18|||
124893009|NCT00751790|449231960|FG000|Overall Study|Lost to Follow-up|1|||
124893010|NCT00751790|449231960|FG000|Overall Study|Death|3|||
124893011|NCT00751790|449231960|FG000|Overall Study|Withdrawal by Subject|1|||
124893012|NCT02179918|449231964|FG000|Overall Study|Death|0|||
124893013|NCT02179918|449231965|FG001|Overall Study|Death|0|||
124893014|NCT02179918|449231966|FG002|Overall Study|Death|0|||
124893015|NCT02179918|449231967|FG003|Overall Study|Death|1|||
124893016|NCT02179918|449231968|FG004|Overall Study|Death|0|||
124893017|NCT02179918|449231964|FG000|Overall Study|Lost to Follow-up|0|||
124893018|NCT02179918|449231965|FG001|Overall Study|Lost to Follow-up|0|||
124893019|NCT02179918|449231966|FG002|Overall Study|Lost to Follow-up|1|||
124893020|NCT02179918|449231967|FG003|Overall Study|Lost to Follow-up|0|||
124893021|NCT02179918|449231968|FG004|Overall Study|Lost to Follow-up|0|||
124893022|NCT02179918|449231964|FG000|Overall Study|Progressive Disease|4|||
124893023|NCT02179918|449231965|FG001|Overall Study|Progressive Disease|1|||
124893024|NCT02179918|449231966|FG002|Overall Study|Progressive Disease|1|||
124893025|NCT02179918|449231967|FG003|Overall Study|Progressive Disease|2|||
124893026|NCT02179918|449231968|FG004|Overall Study|Progressive Disease|6|||
124893027|NCT02179918|449231964|FG000|Overall Study|Other|0|||
124893028|NCT02179918|449231965|FG001|Overall Study|Other|1|||
124893029|NCT02179918|449231966|FG002|Overall Study|Other|0|||
124893030|NCT02179918|449231967|FG003|Overall Study|Other|0|||
124893031|NCT02179918|449231968|FG004|Overall Study|Other|1|||
124893032|NCT02179918|449231964|FG000|Overall Study|Subject refused further follow-up|0|||
124893033|NCT02179918|449231965|FG001|Overall Study|Subject refused further follow-up|1|||
124893034|NCT02179918|449231966|FG002|Overall Study|Subject refused further follow-up|0|||
124893035|NCT02179918|449231967|FG003|Overall Study|Subject refused further follow-up|0|||
124893036|NCT02179918|449231968|FG004|Overall Study|Subject refused further follow-up|1|||
124893037|NCT04337489|449231973|FG000|Overall Study|Withdrawal by Subject|1|||
124893038|NCT00972543|449231974|FG000|Overall Study|Adverse Event|1|||
124893039|NCT00972543|449231975|FG001|Overall Study|Adverse Event|0|||
124893040|NCT00972543|449231974|FG000|Overall Study|Early study termination by sponsor|4|||
124893041|NCT00972543|449231975|FG001|Overall Study|Early study termination by sponsor|1|||
124893042|NCT04537949|449231978|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
124893043|NCT04537949|449231979|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
124893044|NCT04537949|449231980|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
124893045|NCT04537949|449231981|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
124893046|NCT04537949|449231982|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
124893047|NCT04537949|449231983|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
124893048|NCT04537949|449231984|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
124893049|NCT04537949|449231985|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
124893050|NCT04537949|449231978|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
124893051|NCT04537949|449231979|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
124893052|NCT04537949|449231980|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
124893053|NCT04537949|449231981|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
124893054|NCT04537949|449231982|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
124893055|NCT04537949|449231983|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
124893056|NCT04537949|449231984|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
124893057|NCT04537949|449231985|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
124893058|NCT04537949|449231978|FG000|Follow-up Phase|Lost to Follow-up|0|||
124893059|NCT04537949|449231979|FG001|Follow-up Phase|Lost to Follow-up|3|||
124893060|NCT04537949|449231980|FG002|Follow-up Phase|Lost to Follow-up|0|||
124893061|NCT04537949|449231981|FG003|Follow-up Phase|Lost to Follow-up|0|||
124893062|NCT04537949|449231982|FG004|Follow-up Phase|Lost to Follow-up|0|||
124893063|NCT04537949|449231983|FG005|Follow-up Phase|Lost to Follow-up|0|||
124893064|NCT04537949|449231984|FG006|Follow-up Phase|Lost to Follow-up|0|||
124759283|NCT04170543|448742596|FG003|Overall Study|Not Treated|0|||
124893065|NCT04537949|449231985|FG007|Follow-up Phase|Lost to Follow-up|0|||
124893066|NCT04537949|449231978|FG000|Follow-up Phase|personal reasons|0|||
124893067|NCT04537949|449231979|FG001|Follow-up Phase|personal reasons|0|||
124893068|NCT04537949|449231980|FG002|Follow-up Phase|personal reasons|0|||
124893069|NCT04537949|449231981|FG003|Follow-up Phase|personal reasons|1|||
124893070|NCT04537949|449231982|FG004|Follow-up Phase|personal reasons|1|||
124893071|NCT04537949|449231983|FG005|Follow-up Phase|personal reasons|0|||
124893072|NCT04537949|449231984|FG006|Follow-up Phase|personal reasons|0|||
124893073|NCT04537949|449231985|FG007|Follow-up Phase|personal reasons|0|||
124893074|NCT04537949|449231978|FG000|Follow-up Phase|Withdrawal by Subject|0|||
124759284|NCT04170543|448742597|FG004|Overall Study|Not Treated|2|||
124759285|NCT04170543|448742593|FG000|Overall Study|(CRF)|16|||
124442448|NCT03267940|447581477|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
124442449|NCT03267940|447581478|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
124442450|NCT03267940|447581479|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
124442451|NCT03267940|447581480|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
124442452|NCT03267940|447581475|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
124442453|NCT03267940|447581476|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
124442454|NCT03267940|447581477|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
124442455|NCT03267940|447581478|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
124442456|NCT03267940|447581479|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
124442457|NCT03267940|447581480|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
124442458|NCT00388154|447581487|FG000|Overall Study|Withdrawal by Subject|1|||
124442459|NCT02240693|447581490|FG000|Overall Study|Adverse Event|0|||
124442460|NCT02240693|447581491|FG001|Overall Study|Adverse Event|0|||
124442461|NCT02240693|447581492|FG002|Overall Study|Adverse Event|0|||
124442462|NCT02240693|447581493|FG003|Overall Study|Adverse Event|0|||
124442463|NCT02240693|447581494|FG004|Overall Study|Adverse Event|1|||
124442464|NCT02240693|447581490|FG000|Overall Study|Withdrawal by Subject|0|||
124442465|NCT02240693|447581491|FG001|Overall Study|Withdrawal by Subject|0|||
124442466|NCT02240693|447581492|FG002|Overall Study|Withdrawal by Subject|2|||
124442467|NCT02240693|447581493|FG003|Overall Study|Withdrawal by Subject|1|||
124442468|NCT02240693|447581494|FG004|Overall Study|Withdrawal by Subject|0|||
124442469|NCT02240693|447581490|FG000|Overall Study|Other than specified|0|||
124442470|NCT02240693|447581491|FG001|Overall Study|Other than specified|0|||
124442471|NCT02240693|447581492|FG002|Overall Study|Other than specified|2|||
124442472|NCT02240693|447581493|FG003|Overall Study|Other than specified|0|||
124442473|NCT02240693|447581494|FG004|Overall Study|Other than specified|0|||
124442474|NCT01948908|447581495|FG000|Overall Study|Protocol Violation|1|||
124442475|NCT01948908|447581496|FG001|Overall Study|Protocol Violation|0|||
124442476|NCT01948908|447581497|FG002|Overall Study|Protocol Violation|2|||
124442477|NCT03291587|447581498|FG000|Overall Study|Lost to Follow-up|62|||
124442478|NCT03291587|447581499|FG001|Overall Study|Lost to Follow-up|43|||
124442479|NCT03291587|447581498|FG000|Overall Study|Refused to Answer|5|||
124442480|NCT03291587|447581499|FG001|Overall Study|Refused to Answer|2|||
124442481|NCT03291587|447581498|FG000|Overall Study|Death|2|||
124442482|NCT03291587|447581499|FG001|Overall Study|Death|4|||
124442483|NCT03291587|447581498|FG000|Overall Study|Not interested in participating|8|||
124442484|NCT03291587|447581499|FG001|Overall Study|Not interested in participating|6|||
124442485|NCT03291587|447581498|FG000|Overall Study|Too busy to participate|4|||
124442486|NCT03291587|447581499|FG001|Overall Study|Too busy to participate|2|||
124442487|NCT00796120|447581500|FG000|Overall Study|Death|3|||
124442488|NCT00796120|447581501|FG001|Overall Study|Death|0|||
124442489|NCT00796120|447581500|FG000|Overall Study|Adverse Event|11|||
124442490|NCT00796120|447581501|FG001|Overall Study|Adverse Event|6|||
124442491|NCT00796120|447581500|FG000|Overall Study|Progressive disease|22|||
124759286|NCT04170543|448742594|FG001|Overall Study|(CRF)|15|||
124759287|NCT04170543|448742595|FG002|Overall Study|(CRF)|12|||
124893075|NCT04537949|449231979|FG001|Follow-up Phase|Withdrawal by Subject|0|||
124893076|NCT04537949|449231980|FG002|Follow-up Phase|Withdrawal by Subject|0|||
124759288|NCT04170543|448742596|FG003|Overall Study|(CRF)|17|||
124893077|NCT04537949|449231981|FG003|Follow-up Phase|Withdrawal by Subject|0|||
124893078|NCT04537949|449231982|FG004|Follow-up Phase|Withdrawal by Subject|1|||
124442492|NCT00796120|447581501|FG001|Overall Study|Progressive disease|13|||
124759289|NCT04170543|448742597|FG004|Overall Study|(CRF)|17|||
124759290|NCT04170543|448742593|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
124759291|NCT04170543|448742594|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
124442493|NCT00796120|447581500|FG000|Overall Study|Participant refusal|3|||
124442494|NCT00796120|447581501|FG001|Overall Study|Participant refusal|4|||
124442495|NCT00796120|447581500|FG000|Overall Study|Other|6|||
124442496|NCT00796120|447581501|FG001|Overall Study|Other|17|||
124442497|NCT00796120|447581500|FG000|Overall Study|Physician Decision|16|||
124442498|NCT00796120|447581501|FG001|Overall Study|Physician Decision|17|||
124442499|NCT00796120|447581500|FG000|Overall Study|Randomized but not treated|0|||
124442500|NCT00796120|447581501|FG001|Overall Study|Randomized but not treated|3|||
124893079|NCT04537949|449231983|FG005|Follow-up Phase|Withdrawal by Subject|0|||
124893080|NCT04537949|449231984|FG006|Follow-up Phase|Withdrawal by Subject|0|||
124687071|NCT01732783|448473514|FG001|Overall Study|Lost to Follow-up|1|||
124687072|NCT01732783|448473515|FG002|Overall Study|Lost to Follow-up|1|||
124687073|NCT01732783|448473513|FG000|Overall Study|Administrative Decision|8|||
124687074|NCT01732783|448473514|FG001|Overall Study|Administrative Decision|2|||
124687075|NCT01732783|448473515|FG002|Overall Study|Administrative Decision|1|||
124687076|NCT01732783|448473513|FG000|Overall Study|Withdrawal by Subject|1|||
124687077|NCT01732783|448473514|FG001|Overall Study|Withdrawal by Subject|0|||
124687078|NCT01732783|448473515|FG002|Overall Study|Withdrawal by Subject|0|||
124687079|NCT04615507|448473516|FG000|Period 1|Covid-19 exposure|2|||
124687080|NCT04615507|448473517|FG001|Period 1|Covid-19 exposure|1|||
124687081|NCT04615507|448473516|FG000|Period 2|Covid-19 exposure|0|||
124687082|NCT04615507|448473517|FG001|Period 2|Covid-19 exposure|1|||
124687083|NCT04615507|448473516|FG000|Period 2|Protocol Violation|1|||
124687084|NCT04615507|448473517|FG001|Period 2|Protocol Violation|0|||
124687085|NCT04615507|448473516|FG000|Period 2|Withdrawal by Subject|1|||
124687086|NCT04615507|448473517|FG001|Period 2|Withdrawal by Subject|0|||
124687087|NCT04615507|448473516|FG000|Period 2|Adverse Event|0|||
124687088|NCT04615507|448473517|FG001|Period 2|Adverse Event|1|||
124687089|NCT04615507|448473516|FG000|Period 3|Covid-19 exposure|0|||
124687090|NCT04615507|448473517|FG001|Period 3|Covid-19 exposure|1|||
124687091|NCT04598828|448473518|FG000|Overall Study|Physician Decision|1|||
124687092|NCT04598828|448473519|FG001|Overall Study|Physician Decision|0|||
124687093|NCT04598828|448473518|FG000|Overall Study|Withdrawal by Subject|0|||
124687094|NCT04598828|448473519|FG001|Overall Study|Withdrawal by Subject|1|||
124687095|NCT04598828|448473518|FG000|Overall Study|Withdrawal by Subject|0|||
124687096|NCT04598828|448473519|FG001|Overall Study|Withdrawal by Subject|1|||
124687097|NCT06187909|448473520|FG000|Overall Study|Withdrawal by Subject|2|||
124687098|NCT06187909|448473521|FG001|Overall Study|Withdrawal by Subject|2|||
124687099|NCT02676973|448473522|FG000|Overall Study|Withdrawal by Subject|9|||
124687100|NCT02676973|448473523|FG001|Overall Study|Withdrawal by Subject|8|||
124687101|NCT02676973|448473524|FG002|Overall Study|Withdrawal by Subject|11|||
124687102|NCT02676973|448473522|FG000|Overall Study|Lost to Follow-up|8|||
124687103|NCT02676973|448473523|FG001|Overall Study|Lost to Follow-up|12|||
124687104|NCT02676973|448473524|FG002|Overall Study|Lost to Follow-up|8|||
124687105|NCT02676973|448473522|FG000|Overall Study|Death|2|||
124687106|NCT02676973|448473523|FG001|Overall Study|Death|1|||
124687107|NCT02676973|448473524|FG002|Overall Study|Death|5|||
124687108|NCT05020743|448473526|FG000|Overall Study|Enrollment in Interventional Study|2|||
124893081|NCT04537949|449231985|FG007|Follow-up Phase|Withdrawal by Subject|0|||
124893082|NCT04296942|449231987|FG000|Overall Study|Study closure by sponsor|1|||
124893083|NCT04296942|449231988|FG001|Overall Study|Study closure by sponsor|0|||
124893084|NCT04296942|449231989|FG002|Overall Study|Study closure by sponsor|0|||
124893085|NCT02478359|449231992|FG000|Overall Study|Disenrolled from health plan|106|||
124893086|NCT02478359|449231993|FG001|Overall Study|Disenrolled from health plan|65|||
124893087|NCT00562965|449231994|FG000|Overall Study|Withdrawal by Subject|0|||
124893088|NCT00562965|449231995|FG001|Overall Study|Withdrawal by Subject|1|||
124893089|NCT00562965|449231994|FG000|Overall Study|Death|2|||
124687109|NCT05020743|448473527|FG001|Overall Study|Enrollment in Interventional Study|9|||
124687110|NCT05020743|448473528|FG002|Overall Study|Enrollment in Interventional Study|0|||
124687111|NCT05020743|448473526|FG000|Overall Study|Withdrawal by Subject|0|||
124687112|NCT05020743|448473527|FG001|Overall Study|Withdrawal by Subject|3|||
124687113|NCT05020743|448473528|FG002|Overall Study|Withdrawal by Subject|1|||
124687114|NCT05020743|448473526|FG000|Overall Study|Lost to Follow-up|1|||
124687115|NCT05020743|448473527|FG001|Overall Study|Lost to Follow-up|0|||
124687116|NCT05020743|448473528|FG002|Overall Study|Lost to Follow-up|0|||
124687117|NCT05020743|448473526|FG000|Overall Study|Study Termination by Sponsor|10|||
124687118|NCT05020743|448473527|FG001|Overall Study|Study Termination by Sponsor|11|||
124687119|NCT05020743|448473528|FG002|Overall Study|Study Termination by Sponsor|10|||
124687120|NCT03488524|448473529|FG000|Overall Study|Withdrawal by Subject|51|||
124442501|NCT00413972|447581506|FG000|Overall Study|Adverse Event|2|||
124442502|NCT00413972|447581507|FG001|Overall Study|Adverse Event|1|||
124442503|NCT00413972|447581508|FG002|Overall Study|Adverse Event|0|||
124687121|NCT03488524|448473529|FG000|Overall Study|Death|19|||
124687122|NCT03488524|448473529|FG000|Overall Study|Study Sponsor|11|||
124687123|NCT03488524|448473529|FG000|Overall Study|Physician Decision|4|||
124687124|NCT03488524|448473529|FG000|Overall Study|Lost to Follow-up|3|||
124687125|NCT01078662|448473530|FG000|Overall Study|Death|41|||
124687126|NCT01078662|448473531|FG001|Overall Study|Death|103|||
124687127|NCT01078662|448473532|FG002|Overall Study|Death|18|||
124687128|NCT01078662|448473533|FG003|Overall Study|Death|5|||
124687129|NCT01078662|448473534|FG004|Overall Study|Death|8|||
124687130|NCT01078662|448473530|FG000|Overall Study|Patients reached data cut-off|12|||
124687131|NCT01078662|448473531|FG001|Overall Study|Patients reached data cut-off|53|||
124687132|NCT01078662|448473532|FG002|Overall Study|Patients reached data cut-off|2|||
124687133|NCT01078662|448473533|FG003|Overall Study|Patients reached data cut-off|2|||
124687134|NCT01078662|448473534|FG004|Overall Study|Patients reached data cut-off|3|||
124893090|NCT00562965|449231995|FG001|Overall Study|Death|4|||
124893091|NCT00562965|449231994|FG000|Overall Study|Lost to Follow-up|1|||
124687135|NCT01078662|448473530|FG000|Overall Study|Withdrawal by Subject|4|||
124687136|NCT01078662|448473531|FG001|Overall Study|Withdrawal by Subject|11|||
124687137|NCT01078662|448473532|FG002|Overall Study|Withdrawal by Subject|1|||
124687138|NCT01078662|448473533|FG003|Overall Study|Withdrawal by Subject|0|||
124687139|NCT01078662|448473534|FG004|Overall Study|Withdrawal by Subject|0|||
124687140|NCT01078662|448473530|FG000|Overall Study|Protocol Violation|0|||
124687141|NCT01078662|448473531|FG001|Overall Study|Protocol Violation|1|||
124687142|NCT01078662|448473532|FG002|Overall Study|Protocol Violation|0|||
124687143|NCT01078662|448473533|FG003|Overall Study|Protocol Violation|0|||
124687144|NCT01078662|448473534|FG004|Overall Study|Protocol Violation|0|||
124687145|NCT01078662|448473530|FG000|Overall Study|Lost to Follow-up|1|||
124687146|NCT01078662|448473531|FG001|Overall Study|Lost to Follow-up|0|||
124687147|NCT01078662|448473532|FG002|Overall Study|Lost to Follow-up|0|||
124687148|NCT01078662|448473533|FG003|Overall Study|Lost to Follow-up|0|||
124687149|NCT01078662|448473534|FG004|Overall Study|Lost to Follow-up|0|||
124687150|NCT00325416|448473535|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
124687151|NCT00325416|448473536|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
124687152|NCT00325416|448473535|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
124893092|NCT00562965|449231995|FG001|Overall Study|Lost to Follow-up|0|||
124893093|NCT00562965|449231994|FG000|Overall Study|Other|0|||
124893094|NCT00562965|449231995|FG001|Overall Study|Other|1|||
124893095|NCT00965484|449231999|FG000|Overall Study|Protocol Violation|1|||
124893096|NCT00965484|449231999|FG000|Overall Study|Withdrawal by Subject|1|||
124893097|NCT00848211|449232000|FG000|Overall Study|Protocol Violation|0|||
124893098|NCT00848211|449232001|FG001|Overall Study|Protocol Violation|1|||
124893099|NCT00848211|449232002|FG002|Overall Study|Protocol Violation|1|||
124893100|NCT00848211|449232003|FG003|Overall Study|Protocol Violation|0|||
124893101|NCT00848211|449232000|FG000|Overall Study|Adverse Event|0|||
124893102|NCT00848211|449232001|FG001|Overall Study|Adverse Event|0|||
124893103|NCT00848211|449232002|FG002|Overall Study|Adverse Event|0|||
124893104|NCT00848211|449232003|FG003|Overall Study|Adverse Event|0|||
124893105|NCT01124617|449232004|FG000|Overall Study|Adverse Event|5|||
124893106|NCT01124617|449232005|FG001|Overall Study|Adverse Event|2|||
124893107|NCT01124617|449232004|FG000|Overall Study|Lack of Efficacy|2|||
124893108|NCT01124617|449232005|FG001|Overall Study|Lack of Efficacy|1|||
124893109|NCT01124617|449232004|FG000|Overall Study|Protocol Violation|1|||
124893110|NCT01124617|449232005|FG001|Overall Study|Protocol Violation|1|||
124893111|NCT01124617|449232004|FG000|Overall Study|Withdrawal by Subject|9|||
124893112|NCT01124617|449232005|FG001|Overall Study|Withdrawal by Subject|1|||
124687153|NCT00325416|448473536|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
124687154|NCT00325416|448473535|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
124893113|NCT01124617|449232004|FG000|Overall Study|Other|2|||
124893114|NCT01124617|449232005|FG001|Overall Study|Other|1|||
124893115|NCT00945477|449232006|FG000|Overall Study|Adverse Event|3|||
124893116|NCT00945477|449232006|FG000|Overall Study|Lack of Efficacy|2|||
124893117|NCT00945477|449232006|FG000|Overall Study|Withdrawal by Subject|1|||
124687155|NCT00325416|448473536|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
124687156|NCT00325416|448473535|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
124687157|NCT00325416|448473536|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
124687158|NCT00325416|448473535|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
124687159|NCT00325416|448473536|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
124687160|NCT00325416|448473535|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
124687161|NCT00325416|448473536|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
124687162|NCT02324153|448473537|FG000|Overall Study|Withdrawal by Subject|4|||
124687163|NCT02324153|448473538|FG001|Overall Study|Withdrawal by Subject|1|||
124687164|NCT02324153|448473537|FG000|Overall Study|Surgery postponed after randomization|3|||
124687165|NCT02324153|448473538|FG001|Overall Study|Surgery postponed after randomization|0|||
124687166|NCT02324153|448473537|FG000|Overall Study|Developed delirium preoperatively|1|||
124687167|NCT02324153|448473538|FG001|Overall Study|Developed delirium preoperatively|0|||
124759292|NCT04170543|448742595|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
124759293|NCT04170543|448742596|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
124759294|NCT04170543|448742597|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
124759295|NCT04303559|448742598|FG000|Overall Study|Study closed due to poor enrollment.|1|||
124759296|NCT01987102|448742599|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
124759297|NCT01987102|448742600|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
124759298|NCT01987102|448742599|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
124759299|NCT01987102|448742600|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
124759300|NCT01987102|448742599|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
124759301|NCT01987102|448742600|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
124759302|NCT01987102|448742599|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
124759303|NCT01987102|448742600|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
124759304|NCT01987102|448742599|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
124759305|NCT01987102|448742600|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
124759306|NCT01987102|448742599|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
124759307|NCT01987102|448742600|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
124759308|NCT04037891|448742603|FG000|Open-label Period|Withdrawal by Subject|1|||
124759309|NCT04037891|448742604|FG001|Open-label Period|Withdrawal by Subject|0|||
124759310|NCT04037891|448742605|FG002|Open-label Period|Withdrawal by Subject|0|||
124759311|NCT04037891|448742603|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
124759312|NCT04037891|448742604|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
124759313|NCT04037891|448742605|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
124759314|NCT03446313|448742606|FG000|Overall Study|Lost to Follow-up|1|||
124759315|NCT03446313|448742607|FG001|Overall Study|Lost to Follow-up|2|||
124759316|NCT03446313|448742606|FG000|Overall Study|Failed primary screening|3|||
124759317|NCT03446313|448742607|FG001|Overall Study|Failed primary screening|0|||
124759318|NCT03446313|448742606|FG000|Overall Study|Diagnosed with terminal cancer|1|||
124759319|NCT03446313|448742607|FG001|Overall Study|Diagnosed with terminal cancer|0|||
124442504|NCT00413972|447581509|FG003|Overall Study|Adverse Event|0|||
124442505|NCT00413972|447581506|FG000|Overall Study|Lost to Follow-up|1|||
124442506|NCT00413972|447581507|FG001|Overall Study|Lost to Follow-up|2|||
124442507|NCT00413972|447581508|FG002|Overall Study|Lost to Follow-up|1|||
124442508|NCT00413972|447581509|FG003|Overall Study|Lost to Follow-up|0|||
124442509|NCT00413972|447581506|FG000|Overall Study|Withdrawal by Subject|4|||
124442510|NCT00413972|447581507|FG001|Overall Study|Withdrawal by Subject|5|||
124442511|NCT00413972|447581508|FG002|Overall Study|Withdrawal by Subject|7|||
124442512|NCT00413972|447581509|FG003|Overall Study|Withdrawal by Subject|2|||
124442513|NCT00413972|447581506|FG000|Overall Study|Protocol Violation|0|||
124442514|NCT00413972|447581507|FG001|Overall Study|Protocol Violation|0|||
124442515|NCT00413972|447581508|FG002|Overall Study|Protocol Violation|2|||
124442516|NCT00413972|447581509|FG003|Overall Study|Protocol Violation|0|||
124442517|NCT00413972|447581506|FG000|Overall Study|Other|0|||
124442518|NCT00413972|447581507|FG001|Overall Study|Other|0|||
124442519|NCT00413972|447581508|FG002|Overall Study|Other|0|||
124442520|NCT00413972|447581509|FG003|Overall Study|Other|1|||
124442521|NCT01898923|447581510|FG000|Overall Study|Lack of Efficacy|5|||
124442522|NCT01898923|447581511|FG001|Overall Study|Lack of Efficacy|6|||
124442523|NCT01898923|447581510|FG000|Overall Study|Adverse Event|3|||
124442524|NCT01898923|447581511|FG001|Overall Study|Adverse Event|1|||
124442525|NCT01898923|447581510|FG000|Overall Study|Lost to Follow-up|0|||
124442526|NCT01898923|447581511|FG001|Overall Study|Lost to Follow-up|1|||
124442527|NCT01898923|447581510|FG000|Overall Study|Withdrawal by Subject|4|||
124442528|NCT01898923|447581511|FG001|Overall Study|Withdrawal by Subject|7|||
124442529|NCT01898923|447581510|FG000|Overall Study|Physician Decision|3|||
124442530|NCT01898923|447581511|FG001|Overall Study|Physician Decision|4|||
124759320|NCT03446313|448742606|FG000|Overall Study|Excluded from analysis|1|||
124759321|NCT03446313|448742607|FG001|Overall Study|Excluded from analysis|1|||
124442531|NCT01898923|447581510|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
124466438|NCT01882907|447666401|FG001|Overall Study|Protocol Violation|14|||
124687168|NCT03122106|448473541|FG000|Overall Study|Not enough tissue|1|||
124687169|NCT03122106|448473541|FG000|Overall Study|Disease progression during screening|2|||
124893118|NCT00619151|449232007|FG000|Overall Study|Study terminated prior to followup|1|||
124893119|NCT00619151|449232008|FG001|Overall Study|Study terminated prior to followup|0|||
124893120|NCT02825043|449232009|FG000|Overall Study|Lost to Follow-up|4|||
124893121|NCT01982760|449232013|FG000|Overall Study|Physician Decision|1|||
124893122|NCT01982760|449232014|FG001|Overall Study|Physician Decision|0|||
124893123|NCT00859014|449232015|FG000|Overall Study|Death|4|||
124893124|NCT00859014|449232015|FG000|Overall Study|Lost to Follow-up|1|||
124893125|NCT04796935|449232016|FG000|Overall Study|Withdrawal by Subject|0|||
124893126|NCT04796935|449232017|FG001|Overall Study|Withdrawal by Subject|1|||
124893127|NCT04796935|449232016|FG000|Overall Study|Physician Decision|0|||
124893128|NCT04796935|449232017|FG001|Overall Study|Physician Decision|1|||
124893129|NCT04796935|449232016|FG000|Overall Study|Device not available|1|||
124893130|NCT04796935|449232017|FG001|Overall Study|Device not available|0|||
124893131|NCT04796935|449232016|FG000|Overall Study|Trained provider not available|1|||
124893132|NCT04796935|449232017|FG001|Overall Study|Trained provider not available|0|||
124893133|NCT00783718|449232018|FG000|Induction Phase|Adverse Event|4|||
124893134|NCT00783718|449232019|FG001|Induction Phase|Adverse Event|0|||
124893135|NCT00783718|449232020|FG002|Induction Phase|Adverse Event|7|||
124893136|NCT00783718|449232021|FG003|Induction Phase|Adverse Event|0|||
124893137|NCT00783718|449232022|FG004|Induction Phase|Adverse Event|0|||
124893138|NCT00783718|449232023|FG005|Induction Phase|Adverse Event|0|||
124893139|NCT00783718|449232024|FG006|Induction Phase|Adverse Event|0|||
124893140|NCT00783718|449232018|FG000|Induction Phase|Protocol Violation|1|||
124893141|NCT00783718|449232019|FG001|Induction Phase|Protocol Violation|1|||
124893142|NCT00783718|449232020|FG002|Induction Phase|Protocol Violation|6|||
124893143|NCT00783718|449232021|FG003|Induction Phase|Protocol Violation|0|||
124893144|NCT00783718|449232022|FG004|Induction Phase|Protocol Violation|0|||
124893145|NCT00783718|449232023|FG005|Induction Phase|Protocol Violation|0|||
124893146|NCT00783718|449232024|FG006|Induction Phase|Protocol Violation|0|||
124893147|NCT00783718|449232018|FG000|Induction Phase|Lack of Efficacy|5|||
124893148|NCT00783718|449232019|FG001|Induction Phase|Lack of Efficacy|2|||
124893149|NCT00783718|449232020|FG002|Induction Phase|Lack of Efficacy|14|||
124893150|NCT00783718|449232021|FG003|Induction Phase|Lack of Efficacy|0|||
124893151|NCT00783718|449232022|FG004|Induction Phase|Lack of Efficacy|0|||
124893152|NCT00783718|449232023|FG005|Induction Phase|Lack of Efficacy|0|||
124893153|NCT00783718|449232024|FG006|Induction Phase|Lack of Efficacy|0|||
124893154|NCT00783718|449232018|FG000|Induction Phase|Withdrawal by Subject|3|||
124893155|NCT00783718|449232019|FG001|Induction Phase|Withdrawal by Subject|4|||
124893156|NCT00783718|449232020|FG002|Induction Phase|Withdrawal by Subject|8|||
124893157|NCT00783718|449232021|FG003|Induction Phase|Withdrawal by Subject|0|||
124893158|NCT00783718|449232022|FG004|Induction Phase|Withdrawal by Subject|0|||
124893159|NCT00783718|449232023|FG005|Induction Phase|Withdrawal by Subject|0|||
124893160|NCT00783718|449232024|FG006|Induction Phase|Withdrawal by Subject|0|||
124893161|NCT00783718|449232018|FG000|Induction Phase|Lost to Follow-up|1|||
124893162|NCT00783718|449232019|FG001|Induction Phase|Lost to Follow-up|0|||
124893163|NCT00783718|449232020|FG002|Induction Phase|Lost to Follow-up|1|||
124893164|NCT00783718|449232021|FG003|Induction Phase|Lost to Follow-up|0|||
124893165|NCT00783718|449232022|FG004|Induction Phase|Lost to Follow-up|0|||
124893166|NCT00783718|449232023|FG005|Induction Phase|Lost to Follow-up|0|||
124893167|NCT00783718|449232024|FG006|Induction Phase|Lost to Follow-up|0|||
124893168|NCT00783718|449232018|FG000|Maintenance Phase|Adverse Event|12|||
124442532|NCT01898923|447581511|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
124442533|NCT00381303|447581514|FG000|Overall Study|Lost to Follow-up|25|||
124442534|NCT00381303|447581515|FG001|Overall Study|Lost to Follow-up|9|||
124442535|NCT00381303|447581514|FG000|Overall Study|AE/HIV-related event|22|||
124442536|NCT00381303|447581515|FG001|Overall Study|AE/HIV-related event|6|||
124442537|NCT00381303|447581514|FG000|Overall Study|Non-Adherence|13|||
124442538|NCT00381303|447581515|FG001|Overall Study|Non-Adherence|6|||
124442539|NCT00381303|447581514|FG000|Overall Study|Withdrawal by Subject|13|||
124442540|NCT00381303|447581515|FG001|Overall Study|Withdrawal by Subject|6|||
124442541|NCT00381303|447581514|FG000|Overall Study|Virologic failure|6|||
124687170|NCT03122106|448473541|FG000|Overall Study|Poor RNA quality for vaccine|1|||
124687171|NCT01913353|448473543|FG000|Overall Study|Adverse Event|2|||
124893169|NCT00783718|449232019|FG001|Maintenance Phase|Adverse Event|0|||
124893170|NCT00783718|449232020|FG002|Maintenance Phase|Adverse Event|0|||
124893171|NCT00783718|449232021|FG003|Maintenance Phase|Adverse Event|15|||
124687172|NCT01913353|448473544|FG001|Overall Study|Adverse Event|0|||
124893172|NCT00783718|449232022|FG004|Maintenance Phase|Adverse Event|7|||
124893173|NCT00783718|449232023|FG005|Maintenance Phase|Adverse Event|6|||
124893174|NCT00783718|449232024|FG006|Maintenance Phase|Adverse Event|16|||
124893175|NCT00783718|449232018|FG000|Maintenance Phase|Protocol Violation|1|||
124893176|NCT00783718|449232019|FG001|Maintenance Phase|Protocol Violation|0|||
124893177|NCT00783718|449232020|FG002|Maintenance Phase|Protocol Violation|0|||
124893178|NCT00783718|449232021|FG003|Maintenance Phase|Protocol Violation|0|||
124893179|NCT00783718|449232022|FG004|Maintenance Phase|Protocol Violation|0|||
124893180|NCT00783718|449232023|FG005|Maintenance Phase|Protocol Violation|0|||
124893181|NCT00783718|449232024|FG006|Maintenance Phase|Protocol Violation|2|||
124893182|NCT00783718|449232018|FG000|Maintenance Phase|Lack of Efficacy|83|||
124893183|NCT00783718|449232019|FG001|Maintenance Phase|Lack of Efficacy|0|||
124893184|NCT00783718|449232020|FG002|Maintenance Phase|Lack of Efficacy|0|||
124893185|NCT00783718|449232021|FG003|Maintenance Phase|Lack of Efficacy|61|||
124893186|NCT00783718|449232022|FG004|Maintenance Phase|Lack of Efficacy|31|||
124893187|NCT00783718|449232023|FG005|Maintenance Phase|Lack of Efficacy|33|||
124442542|NCT00381303|447581515|FG001|Overall Study|Virologic failure|4|||
124442543|NCT00381303|447581514|FG000|Overall Study|Ineligible to continue the trial|2|||
124442544|NCT00381303|447581515|FG001|Overall Study|Ineligible to continue the trial|1|||
124442545|NCT00381303|447581514|FG000|Overall Study|Pregnancy|2|||
124442546|NCT00381303|447581515|FG001|Overall Study|Pregnancy|0|||
124442547|NCT00381303|447581514|FG000|Overall Study|Physician Decision|1|||
124442548|NCT00381303|447581515|FG001|Overall Study|Physician Decision|0|||
124442549|NCT00381303|447581514|FG000|Overall Study|Physician's decision to close the site|3|||
124442550|NCT00381303|447581515|FG001|Overall Study|Physician's decision to close the site|1|||
124442551|NCT00381303|447581514|FG000|Overall Study|Subject moved out of state|2|||
124442552|NCT00381303|447581515|FG001|Overall Study|Subject moved out of state|0|||
124442553|NCT00381303|447581514|FG000|Overall Study|Subject taking too many different meds|1|||
124442554|NCT00381303|447581515|FG001|Overall Study|Subject taking too many different meds|0|||
124442555|NCT00381303|447581514|FG000|Overall Study|No virologic response by week 12|1|||
124442556|NCT00381303|447581515|FG001|Overall Study|No virologic response by week 12|0|||
124442557|NCT00381303|447581514|FG000|Overall Study|Subject was too busy for appointments|1|||
124442558|NCT00381303|447581515|FG001|Overall Study|Subject was too busy for appointments|0|||
124442559|NCT00381303|447581514|FG000|Overall Study|Subject did not continue visits|1|||
124442560|NCT00381303|447581515|FG001|Overall Study|Subject did not continue visits|0|||
124442561|NCT00381303|447581514|FG000|Overall Study|Subject primary physician's decision|1|||
124442562|NCT00381303|447581515|FG001|Overall Study|Subject primary physician's decision|0|||
124442563|NCT01966471|447581518|FG000|Overall Study|Death|44|||
124442564|NCT01966471|447581519|FG001|Overall Study|Death|56|||
124442565|NCT01966471|447581518|FG000|Overall Study|Lost to Follow-up|46|||
124442566|NCT01966471|447581519|FG001|Overall Study|Lost to Follow-up|39|||
124442567|NCT01966471|447581518|FG000|Overall Study|Various reasons|4|||
124442568|NCT01966471|447581519|FG001|Overall Study|Various reasons|4|||
124442569|NCT01966471|447581518|FG000|Overall Study|Physician Decision|7|||
124442570|NCT01966471|447581519|FG001|Overall Study|Physician Decision|5|||
124442571|NCT01966471|447581518|FG000|Overall Study|Study Terminated By Sponsor|758|||
124442572|NCT01966471|447581519|FG001|Overall Study|Study Terminated By Sponsor|773|||
124442573|NCT01966471|447581518|FG000|Overall Study|Withdrawal by Subject|59|||
124442574|NCT01966471|447581519|FG001|Overall Study|Withdrawal by Subject|51|||
124442575|NCT00494481|447581520|FG000|Overall Study|Condition under investigation worsened|11|||
124442576|NCT00494481|447581521|FG001|Overall Study|Condition under investigation worsened|13|||
124442577|NCT00494481|447581520|FG000|Overall Study|Adverse Event|15|||
124442578|NCT00494481|447581521|FG001|Overall Study|Adverse Event|11|||
124442579|NCT00494481|447581520|FG000|Overall Study|Other|1|||
124442580|NCT00494481|447581521|FG001|Overall Study|Other|0|||
124442581|NCT00494481|447581520|FG000|Overall Study|Never received IP|2|||
124442582|NCT00494481|447581521|FG001|Overall Study|Never received IP|0|||
124442583|NCT01030198|447581522|FG000|Overall Study|Could not measure efficacy accurately|0|||
124442584|NCT01030198|447581523|FG001|Overall Study|Could not measure efficacy accurately|7|||
124442585|NCT00332189|447581524|FG000|Overall Study|Adverse Event|3|||
124442586|NCT00332189|447581524|FG000|Overall Study|Uncooperative/Noncompliant|3|||
124442587|NCT00332189|447581524|FG000|Overall Study|Withdrawal by Subject|9|||
124442588|NCT00332189|447581524|FG000|Overall Study|Lack of Efficacy|4|||
124442589|NCT00332189|447581524|FG000|Overall Study|Moved out of country|2|||
124442590|NCT02370043|447581525|FG000|Overall Study|Withdrawal by Subject|0|||
124442591|NCT02370043|447581526|FG001|Overall Study|Withdrawal by Subject|0|||
124442592|NCT02370043|447581527|FG002|Overall Study|Withdrawal by Subject|0|||
124442593|NCT02370043|447581528|FG003|Overall Study|Withdrawal by Subject|0|||
124442594|NCT02370043|447581529|FG004|Overall Study|Withdrawal by Subject|1|||
124442595|NCT02370043|447581530|FG005|Overall Study|Withdrawal by Subject|1|||
124687173|NCT01913353|448473543|FG000|Overall Study|Physician Decision|0|||
124687174|NCT01913353|448473544|FG001|Overall Study|Physician Decision|2|||
124442596|NCT02279862|447581531|FG000|Overall Study|Study drug toxicity|3|||
124442597|NCT02279862|447581532|FG001|Overall Study|Study drug toxicity|6|||
124442598|NCT02279862|447581531|FG000|Overall Study|No longer meets criteria|0|||
124442599|NCT02279862|447581532|FG001|Overall Study|No longer meets criteria|1|||
124442600|NCT02279862|447581531|FG000|Overall Study|Administrative reason by sponsor|0|||
124442601|NCT02279862|447581532|FG001|Overall Study|Administrative reason by sponsor|1|||
124442602|NCT02279862|447581531|FG000|Overall Study|Disease progression|5|||
124442603|NCT02279862|447581532|FG001|Overall Study|Disease progression|2|||
124687175|NCT01913353|448473543|FG000|Overall Study|Withdrawal by Subject|20|||
124893188|NCT00783718|449232024|FG006|Maintenance Phase|Lack of Efficacy|155|||
124893189|NCT00783718|449232018|FG000|Maintenance Phase|Withdrawal by Subject|6|||
124442604|NCT02279862|447581531|FG000|Overall Study|Study closed by sponsor|16|||
124442605|NCT02279862|447581532|FG001|Overall Study|Study closed by sponsor|13|||
124442606|NCT02279862|447581531|FG000|Overall Study|Other|1|||
124442607|NCT02279862|447581532|FG001|Overall Study|Other|2|||
124442608|NCT02279862|447581531|FG000|Overall Study|Withdrawal by Subject|1|||
124442609|NCT02279862|447581532|FG001|Overall Study|Withdrawal by Subject|0|||
124442610|NCT01163721|447581533|FG000|Overall Study|Adverse Event|5|||
124442611|NCT01163721|447581534|FG001|Overall Study|Adverse Event|6|||
124442612|NCT01163721|447581533|FG000|Overall Study|Withdrawal by Subject|3|||
124442613|NCT01163721|447581534|FG001|Overall Study|Withdrawal by Subject|4|||
124442614|NCT01163721|447581533|FG000|Overall Study|Lost to Follow-up|0|||
124893190|NCT00783718|449232019|FG001|Maintenance Phase|Withdrawal by Subject|0|||
124893191|NCT00783718|449232020|FG002|Maintenance Phase|Withdrawal by Subject|0|||
124893192|NCT00783718|449232021|FG003|Maintenance Phase|Withdrawal by Subject|2|||
124893193|NCT00783718|449232022|FG004|Maintenance Phase|Withdrawal by Subject|5|||
124893194|NCT00783718|449232023|FG005|Maintenance Phase|Withdrawal by Subject|2|||
124893195|NCT00783718|449232024|FG006|Maintenance Phase|Withdrawal by Subject|20|||
124893196|NCT00783718|449232018|FG000|Maintenance Phase|Lost to Follow-up|3|||
124893197|NCT00783718|449232019|FG001|Maintenance Phase|Lost to Follow-up|0|||
124442615|NCT01163721|447581534|FG001|Overall Study|Lost to Follow-up|1|||
124442616|NCT01163721|447581533|FG000|Overall Study|Physician Decision|0|||
124442617|NCT01163721|447581534|FG001|Overall Study|Physician Decision|1|||
124442618|NCT00688181|447581535|FG000|Overall Study|Lost to Follow-up|17|||
124442619|NCT00688181|447581535|FG000|Overall Study|Unknown Reason|4|||
124442620|NCT00688181|447581535|FG000|Overall Study|Non-clinical Reason|2|||
124442621|NCT01050205|447581536|FG000|Overall Study|Lost to Follow-up|7|||
124442622|NCT01050205|447581537|FG001|Overall Study|Lost to Follow-up|1|||
124442623|NCT01050205|447581536|FG000|Overall Study|Withdrawal by Subject|1|||
124442624|NCT01050205|447581537|FG001|Overall Study|Withdrawal by Subject|1|||
124442625|NCT01050205|447581536|FG000|Overall Study|Relocated from area|1|||
124442626|NCT01050205|447581537|FG001|Overall Study|Relocated from area|2|||
124442627|NCT01050205|447581536|FG000|Overall Study|Discontinued Intervention|2|||
124442628|NCT01050205|447581537|FG001|Overall Study|Discontinued Intervention|0|||
124442629|NCT01119001|447581538|FG000|Overall Study|Withdrawal by Subject|2|||
124442630|NCT00607022|447581543|FG000|Overall Study|Withdrawal by Subject|1|||
124442631|NCT00607022|447581544|FG001|Overall Study|Withdrawal by Subject|0|||
124442632|NCT00607022|447581545|FG002|Overall Study|Withdrawal by Subject|0|||
124442633|NCT00810394|447581546|FG000|Overall Study|Withdrawal by Subject|3|||
124442634|NCT03254485|447581547|FG000|Overall Study|Adverse Event|3|||
124442635|NCT03254485|447581548|FG001|Overall Study|Adverse Event|0|||
124442636|NCT03254485|447581549|FG002|Overall Study|Adverse Event|0|||
124442637|NCT03254485|447581550|FG003|Overall Study|Adverse Event|6|||
124442638|NCT03254485|447581547|FG000|Overall Study|Protocol Violation|6|||
124442639|NCT03254485|447581548|FG001|Overall Study|Protocol Violation|0|||
124442640|NCT03254485|447581549|FG002|Overall Study|Protocol Violation|0|||
124442641|NCT03254485|447581550|FG003|Overall Study|Protocol Violation|2|||
124442642|NCT03254485|447581547|FG000|Overall Study|Withdrawal by Subject|1|||
124442643|NCT03254485|447581548|FG001|Overall Study|Withdrawal by Subject|0|||
124442644|NCT03254485|447581549|FG002|Overall Study|Withdrawal by Subject|0|||
124442645|NCT03254485|447581550|FG003|Overall Study|Withdrawal by Subject|4|||
124442646|NCT03254485|447581547|FG000|Overall Study|Death|0|||
124442647|NCT03254485|447581548|FG001|Overall Study|Death|0|||
124442648|NCT03254485|447581549|FG002|Overall Study|Death|0|||
124442649|NCT03254485|447581550|FG003|Overall Study|Death|1|||
124442650|NCT03254485|447581547|FG000|Overall Study|Lost to Follow-up|1|||
124442651|NCT03254485|447581548|FG001|Overall Study|Lost to Follow-up|0|||
124442652|NCT03254485|447581549|FG002|Overall Study|Lost to Follow-up|0|||
124442653|NCT03254485|447581550|FG003|Overall Study|Lost to Follow-up|0|||
124442654|NCT03254485|447581547|FG000|Overall Study|Other|1|||
124442655|NCT03254485|447581548|FG001|Overall Study|Other|0|||
124442656|NCT03254485|447581549|FG002|Overall Study|Other|0|||
124687176|NCT01913353|448473544|FG001|Overall Study|Withdrawal by Subject|6|||
124687177|NCT01913353|448473543|FG000|Overall Study|multiple reasons|10|||
124442657|NCT03254485|447581550|FG003|Overall Study|Other|2|||
124442658|NCT00467285|447581551|FG000|Overall Study|Lost to Follow-up|4|||
124442659|NCT00467285|447581552|FG001|Overall Study|Lost to Follow-up|4|||
124442660|NCT01598311|447581566|FG000|Overall Study|Physician Decision|4|||
124442661|NCT01598311|447581567|FG001|Overall Study|Physician Decision|5|||
124687178|NCT01913353|448473544|FG001|Overall Study|multiple reasons|7|||
124442662|NCT01598311|447581566|FG000|Overall Study|Adverse Event|9|||
124687179|NCT01147458|448473545|FG000|First Intervention|Study terminated by sponsor|8|||
124442663|NCT01598311|447581567|FG001|Overall Study|Adverse Event|13|||
124442664|NCT01598311|447581566|FG000|Overall Study|Lost to Follow-up|7|||
124442665|NCT01598311|447581567|FG001|Overall Study|Lost to Follow-up|12|||
124687180|NCT01147458|448473546|FG001|First Intervention|Study terminated by sponsor|8|||
124893198|NCT00783718|449232020|FG002|Maintenance Phase|Lost to Follow-up|0|||
124442666|NCT01598311|447581566|FG000|Overall Study|Withdrawal by Subject|9|||
124442667|NCT01598311|447581567|FG001|Overall Study|Withdrawal by Subject|13|||
124442668|NCT01598311|447581566|FG000|Overall Study|No reason provided.|0|||
124687181|NCT01147458|448473547|FG002|First Intervention|Study terminated by sponsor|7|||
124687182|NCT01147458|448473548|FG003|First Intervention|Study terminated by sponsor|8|||
124687183|NCT01147458|448473545|FG000|First Intervention|Protocol Violation|2|||
124687184|NCT01147458|448473546|FG001|First Intervention|Protocol Violation|3|||
124687185|NCT01147458|448473547|FG002|First Intervention|Protocol Violation|2|||
124687186|NCT01147458|448473548|FG003|First Intervention|Protocol Violation|3|||
124687187|NCT01147458|448473545|FG000|First Intervention|Withdrawal by Subject|3|||
124687188|NCT01147458|448473546|FG001|First Intervention|Withdrawal by Subject|0|||
124687189|NCT01147458|448473547|FG002|First Intervention|Withdrawal by Subject|1|||
124687190|NCT01147458|448473548|FG003|First Intervention|Withdrawal by Subject|0|||
124687191|NCT01147458|448473545|FG000|First Intervention|Adverse Event|0|||
124687192|NCT01147458|448473546|FG001|First Intervention|Adverse Event|3|||
124687193|NCT01147458|448473547|FG002|First Intervention|Adverse Event|2|||
124687194|NCT01147458|448473548|FG003|First Intervention|Adverse Event|3|||
124687195|NCT01147458|448473545|FG000|First Intervention|Other|1|||
124687196|NCT01147458|448473546|FG001|First Intervention|Other|2|||
124687197|NCT01147458|448473547|FG002|First Intervention|Other|0|||
124687198|NCT01147458|448473548|FG003|First Intervention|Other|0|||
124687199|NCT01147458|448473545|FG000|Second Intervention|Study terminated by sponsor|7|||
124687200|NCT01147458|448473546|FG001|Second Intervention|Study terminated by sponsor|5|||
124687201|NCT01147458|448473547|FG002|Second Intervention|Study terminated by sponsor|5|||
124687202|NCT01147458|448473548|FG003|Second Intervention|Study terminated by sponsor|3|||
124687203|NCT01147458|448473545|FG000|Second Intervention|Protocol Violation|0|||
124687204|NCT01147458|448473546|FG001|Second Intervention|Protocol Violation|1|||
124687205|NCT01147458|448473547|FG002|Second Intervention|Protocol Violation|1|||
124687206|NCT01147458|448473548|FG003|Second Intervention|Protocol Violation|0|||
124687207|NCT01147458|448473545|FG000|Second Intervention|Withdrawal by Subject|0|||
124687208|NCT01147458|448473546|FG001|Second Intervention|Withdrawal by Subject|1|||
124687209|NCT01147458|448473547|FG002|Second Intervention|Withdrawal by Subject|0|||
124687210|NCT01147458|448473548|FG003|Second Intervention|Withdrawal by Subject|0|||
124687211|NCT01147458|448473545|FG000|Second Intervention|Adverse Event|2|||
124687212|NCT01147458|448473546|FG001|Second Intervention|Adverse Event|0|||
124687213|NCT01147458|448473547|FG002|Second Intervention|Adverse Event|1|||
124687214|NCT01147458|448473548|FG003|Second Intervention|Adverse Event|1|||
124687215|NCT01147458|448473545|FG000|Second Intervention|Other|0|||
124687216|NCT01147458|448473546|FG001|Second Intervention|Other|0|||
124687217|NCT01147458|448473547|FG002|Second Intervention|Other|1|||
124687218|NCT01147458|448473548|FG003|Second Intervention|Other|0|||
124687219|NCT03550209|448473549|FG000|Overall Study|Lost to Follow-up|1|||
124687220|NCT03550209|448473550|FG001|Overall Study|Lost to Follow-up|0|||
124687221|NCT03550209|448473551|FG002|Overall Study|Lost to Follow-up|1|||
124687222|NCT03550209|448473552|FG003|Overall Study|Lost to Follow-up|0|||
124687223|NCT03550209|448473549|FG000|Overall Study|Withdrawal by Subject|0|||
124687224|NCT03550209|448473550|FG001|Overall Study|Withdrawal by Subject|3|||
124687225|NCT03550209|448473551|FG002|Overall Study|Withdrawal by Subject|1|||
124687226|NCT03550209|448473552|FG003|Overall Study|Withdrawal by Subject|2|||
124687227|NCT03550209|448473549|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
124687228|NCT03550209|448473550|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
124687229|NCT03550209|448473551|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
124687230|NCT03550209|448473552|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
124687231|NCT02555878|448473553|FG000|Overall Study|Lost to Follow-up|2|||
124687232|NCT02555878|448473554|FG001|Overall Study|Lost to Follow-up|3|||
124687233|NCT02555878|448473553|FG000|Overall Study|Withdrawal by Subject|48|||
124687234|NCT02555878|448473554|FG001|Overall Study|Withdrawal by Subject|48|||
124759322|NCT05274958|448742608|FG000|Overall Study|Only completed 1 set of PROMs|22|||
124759323|NCT05274958|448742609|FG001|Overall Study|Only completed 1 set of PROMs|35|||
124759324|NCT05481359|448742610|FG000|Overall Study|Lost to Follow-up|3|||
124759325|NCT05481359|448742610|FG000|Overall Study|Withdrawal by Subject|1|||
124759326|NCT04491136|448742615|FG000|Overall Study|Patient withdraw informed consent|9|||
124759327|NCT04491136|448742615|FG000|Overall Study|Adverse Event|2|||
124893199|NCT00783718|449232021|FG003|Maintenance Phase|Lost to Follow-up|0|||
124687235|NCT02555878|448473553|FG000|Overall Study|Adverse Event|12|||
124687236|NCT02555878|448473554|FG001|Overall Study|Adverse Event|8|||
124687237|NCT02555878|448473553|FG000|Overall Study|Death|74|||
124687238|NCT02555878|448473554|FG001|Overall Study|Death|59|||
124687239|NCT02555878|448473553|FG000|Overall Study|Protocol Violation|1|||
124687240|NCT02555878|448473554|FG001|Overall Study|Protocol Violation|2|||
124687241|NCT02555878|448473553|FG000|Overall Study|Physician Decision|12|||
124687242|NCT02555878|448473554|FG001|Overall Study|Physician Decision|13|||
124687243|NCT02555878|448473553|FG000|Overall Study|Other|17|||
124687244|NCT02555878|448473554|FG001|Overall Study|Other|17|||
124687245|NCT00765076|448473555|FG000|Overall Study|Adverse Event|1|||
124759328|NCT04491136|448742615|FG000|Overall Study|Death|3|||
124759329|NCT04491136|448742615|FG000|Overall Study|Lost to Follow-up|3|||
124687246|NCT00765076|448473556|FG001|Overall Study|Adverse Event|0|||
124687247|NCT00765076|448473557|FG002|Overall Study|Adverse Event|0|||
124687248|NCT00765076|448473555|FG000|Overall Study|Withdrawal by Subject|0|||
124442669|NCT01598311|447581567|FG001|Overall Study|No reason provided.|5|||
124442670|NCT01598311|447581566|FG000|Overall Study|Randomized but never treated|8|||
124442671|NCT01598311|447581567|FG001|Overall Study|Randomized but never treated|5|||
124442672|NCT01598311|447581566|FG000|Overall Study|Treated but no confirmed CDAD|9|||
124442673|NCT01598311|447581567|FG001|Overall Study|Treated but no confirmed CDAD|8|||
124442674|NCT01598311|447581566|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
124442675|NCT01598311|447581567|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
124442676|NCT00658684|447581568|FG000|Overall Study|Adverse Event|10|||
124442677|NCT00658684|447581569|FG001|Overall Study|Adverse Event|8|||
124442678|NCT00658684|447581570|FG002|Overall Study|Adverse Event|2|||
124442679|NCT00658684|447581571|FG003|Overall Study|Adverse Event|0|||
124442680|NCT00658684|447581568|FG000|Overall Study|Withdrawal by Subject|6|||
124442681|NCT00658684|447581569|FG001|Overall Study|Withdrawal by Subject|4|||
124442682|NCT00658684|447581570|FG002|Overall Study|Withdrawal by Subject|1|||
124442683|NCT00658684|447581571|FG003|Overall Study|Withdrawal by Subject|1|||
124442684|NCT00658684|447581568|FG000|Overall Study|Lack of Efficacy|1|||
124442685|NCT00658684|447581569|FG001|Overall Study|Lack of Efficacy|1|||
124442686|NCT00658684|447581570|FG002|Overall Study|Lack of Efficacy|0|||
124442687|NCT00658684|447581571|FG003|Overall Study|Lack of Efficacy|0|||
124442688|NCT00658684|447581568|FG000|Overall Study|Protocol Violation|1|||
124442689|NCT00658684|447581569|FG001|Overall Study|Protocol Violation|1|||
124442690|NCT00658684|447581570|FG002|Overall Study|Protocol Violation|0|||
124442691|NCT00658684|447581571|FG003|Overall Study|Protocol Violation|0|||
124442692|NCT00658684|447581568|FG000|Overall Study|Pregnancy|1|||
124442693|NCT00658684|447581569|FG001|Overall Study|Pregnancy|1|||
124442694|NCT00658684|447581570|FG002|Overall Study|Pregnancy|0|||
124442695|NCT00658684|447581571|FG003|Overall Study|Pregnancy|0|||
124442696|NCT00688103|447581572|FG000|Overall Study|Adverse Event|4|||
124442697|NCT00688103|447581573|FG001|Overall Study|Adverse Event|1|||
124442698|NCT00688103|447581572|FG000|Overall Study|Lack of Efficacy|11|||
124442699|NCT00688103|447581573|FG001|Overall Study|Lack of Efficacy|1|||
124442700|NCT00688103|447581572|FG000|Overall Study|Withdrawal by Subject|4|||
124442701|NCT00688103|447581573|FG001|Overall Study|Withdrawal by Subject|2|||
124442702|NCT00688103|447581572|FG000|Overall Study|complex reasons|11|||
124442703|NCT00688103|447581573|FG001|Overall Study|complex reasons|9|||
124442704|NCT03602261|447581576|FG000|Overall Study|Adverse Event|5|||
124442705|NCT03602261|447581577|FG001|Overall Study|Adverse Event|1|||
124442706|NCT03602261|447581576|FG000|Overall Study|Physician Decision|1|||
124442707|NCT03602261|447581577|FG001|Overall Study|Physician Decision|0|||
124442708|NCT03602261|447581576|FG000|Overall Study|Withdrawal by Subject|1|||
124442709|NCT03602261|447581577|FG001|Overall Study|Withdrawal by Subject|1|||
124442710|NCT03602261|447581576|FG000|Overall Study|Lack of Efficacy|0|||
124442711|NCT03602261|447581577|FG001|Overall Study|Lack of Efficacy|1|||
124442712|NCT03602261|447581576|FG000|Overall Study|Subject moving out of state|1|||
124442713|NCT03602261|447581577|FG001|Overall Study|Subject moving out of state|0|||
124442714|NCT06515483|447581578|FG000|Overall Study|Subject withdraw due to family issues|1|||
124442715|NCT06515483|447581579|FG001|Overall Study|Subject withdraw due to family issues|0|||
124442716|NCT00604279|447582935|FG000|Overall Study|Lack of Efficacy|22|||
124442717|NCT00604279|447582936|FG001|Overall Study|Lack of Efficacy|9|||
124442718|NCT00604279|447582935|FG000|Overall Study|Lost to Follow-up|9|||
124442719|NCT00604279|447582936|FG001|Overall Study|Lost to Follow-up|14|||
124442720|NCT00604279|447582935|FG000|Overall Study|Pregnancy|2|||
124442721|NCT00604279|447582936|FG001|Overall Study|Pregnancy|0|||
124442722|NCT00604279|447582935|FG000|Overall Study|Protocol Violation|3|||
124442723|NCT00604279|447582936|FG001|Overall Study|Protocol Violation|1|||
124442724|NCT00604279|447582935|FG000|Overall Study|Withdrawal by Subject|16|||
124442725|NCT00604279|447582936|FG001|Overall Study|Withdrawal by Subject|5|||
124442726|NCT00604279|447582935|FG000|Overall Study|Adverse Event|4|||
124442727|NCT00604279|447582936|FG001|Overall Study|Adverse Event|5|||
124442728|NCT00604279|447582935|FG000|Overall Study|Other|8|||
124442729|NCT00604279|447582936|FG001|Overall Study|Other|4|||
124442730|NCT00995020|447582940|FG000|Overall Study|margin analysis not performed|2|||
124442731|NCT00995020|447582941|FG001|Overall Study|margin analysis not performed|5|||
124442732|NCT00995020|447582940|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
124442733|NCT00995020|447582941|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
124442734|NCT00719563|447582947|FG000|Overall Study|Adverse Event|16|||
124442735|NCT00719563|447582948|FG001|Overall Study|Adverse Event|13|||
124442736|NCT00719563|447582947|FG000|Overall Study|Medical condition changed|3|||
124442737|NCT00719563|447582948|FG001|Overall Study|Medical condition changed|5|||
124442738|NCT00719563|447582947|FG000|Overall Study|Lack of Efficacy|3|||
124442739|NCT00719563|447582948|FG001|Overall Study|Lack of Efficacy|7|||
124442740|NCT00719563|447582947|FG000|Overall Study|Personal reasons|6|||
124442741|NCT00719563|447582948|FG001|Overall Study|Personal reasons|7|||
124442742|NCT00719563|447582947|FG000|Overall Study|Unknown reasons|4|||
124442743|NCT00719563|447582948|FG001|Overall Study|Unknown reasons|6|||
124442744|NCT00719563|447582947|FG000|Overall Study|Noncompliant|1|||
124442745|NCT00719563|447582948|FG001|Overall Study|Noncompliant|1|||
124442746|NCT00719563|447582947|FG000|Overall Study|Lost to Follow-up|5|||
124893200|NCT00783718|449232022|FG004|Maintenance Phase|Lost to Follow-up|2|||
124893201|NCT00783718|449232023|FG005|Maintenance Phase|Lost to Follow-up|0|||
124893202|NCT00783718|449232024|FG006|Maintenance Phase|Lost to Follow-up|2|||
124893203|NCT04159896|449232028|FG000|Overall Study|Lack of Efficacy|7|||
124893204|NCT04159896|449232028|FG000|Overall Study|Withdrawal by Subject|1|||
124893205|NCT04159896|449232028|FG000|Overall Study|Adverse Event|1|||
124893206|NCT04159896|449232028|FG000|Overall Study|A transient ischaemic attack|1|||
124893207|NCT02338609|449232029|FG000|Overall Study|Physician Decision|1|||
124893208|NCT02338609|449232029|FG000|Overall Study|Death|1|||
124893209|NCT02223182|449232032|FG000|Double-Blind Period|Adverse Event|0|||
124893210|NCT02223182|449232033|FG001|Double-Blind Period|Adverse Event|2|||
124893211|NCT02223182|449232034|FG002|Double-Blind Period|Adverse Event|1|||
124893212|NCT02223182|449232035|FG003|Double-Blind Period|Adverse Event|0|||
124893213|NCT02223182|449232032|FG000|Double-Blind Period|Withdrawal by Subject|1|||
124893214|NCT02223182|449232033|FG001|Double-Blind Period|Withdrawal by Subject|1|||
124893215|NCT02223182|449232034|FG002|Double-Blind Period|Withdrawal by Subject|1|||
124893216|NCT02223182|449232035|FG003|Double-Blind Period|Withdrawal by Subject|0|||
124893217|NCT02223182|449232032|FG000|Double-Blind Period|Lost to Follow-up|0|||
124893218|NCT02223182|449232033|FG001|Double-Blind Period|Lost to Follow-up|1|||
124687249|NCT00765076|448473556|FG001|Overall Study|Withdrawal by Subject|0|||
124687250|NCT00765076|448473557|FG002|Overall Study|Withdrawal by Subject|1|||
124687251|NCT02875080|448473558|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
124687252|NCT02875080|448473559|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
124893219|NCT02223182|449232034|FG002|Double-Blind Period|Lost to Follow-up|0|||
124893220|NCT02223182|449232035|FG003|Double-Blind Period|Lost to Follow-up|0|||
124893221|NCT02223182|449232032|FG000|Double-Blind Period|Non Compliance|0|||
124893222|NCT02223182|449232033|FG001|Double-Blind Period|Non Compliance|0|||
124893223|NCT02223182|449232034|FG002|Double-Blind Period|Non Compliance|0|||
124893224|NCT02223182|449232035|FG003|Double-Blind Period|Non Compliance|1|||
124893225|NCT02223182|449232032|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
124893226|NCT02223182|449232033|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
124893227|NCT02223182|449232034|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
124893228|NCT02223182|449232035|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
124893229|NCT02223182|449232032|FG000|Open-Label 500 Period|Adverse Event|1|||
124893230|NCT02223182|449232033|FG001|Open-Label 500 Period|Adverse Event|0|||
124893231|NCT02223182|449232034|FG002|Open-Label 500 Period|Adverse Event|2|||
124893232|NCT02223182|449232035|FG003|Open-Label 500 Period|Adverse Event|1|||
124893233|NCT02223182|449232032|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
124893234|NCT02223182|449232033|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
124893235|NCT02223182|449232034|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
124893236|NCT02223182|449232035|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
124893237|NCT02223182|449232032|FG000|Open-Label 500 Period|Physician Decision|0|||
124893238|NCT02223182|449232033|FG001|Open-Label 500 Period|Physician Decision|0|||
124893239|NCT02223182|449232034|FG002|Open-Label 500 Period|Physician Decision|0|||
124893240|NCT02223182|449232035|FG003|Open-Label 500 Period|Physician Decision|1|||
124893241|NCT02223182|449232032|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
124893242|NCT02223182|449232033|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
124893243|NCT02223182|449232034|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
124893244|NCT02223182|449232035|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
124893245|NCT02223182|449232032|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
124893246|NCT02223182|449232033|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
124893247|NCT02223182|449232034|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
124893248|NCT02223182|449232035|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
124893249|NCT02223182|449232032|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
124893250|NCT02223182|449232033|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
124893251|NCT02223182|449232034|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
124893252|NCT02223182|449232035|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
124893253|NCT02223182|449232032|FG000|Open-Label 300 Period|Non Compliance|0|||
124893254|NCT02223182|449232033|FG001|Open-Label 300 Period|Non Compliance|2|||
124893255|NCT02223182|449232034|FG002|Open-Label 300 Period|Non Compliance|1|||
124893256|NCT02223182|449232035|FG003|Open-Label 300 Period|Non Compliance|0|||
124893257|NCT03714022|449232036|FG000|Overall Study|Adverse Event|1|||
124893258|NCT03714022|449232037|FG001|Overall Study|Adverse Event|0|||
124893259|NCT03714022|449232036|FG000|Overall Study|Consent withdrawal|0|||
124893260|NCT03714022|449232037|FG001|Overall Study|Consent withdrawal|1|||
124442747|NCT00719563|447582948|FG001|Overall Study|Lost to Follow-up|3|||
124442748|NCT00567268|447582949|FG000|Overall Study|Protocol Violation|7|||
124893261|NCT03714022|449232036|FG000|Overall Study|Lost to Follow-up|3|||
124893262|NCT03714022|449232037|FG001|Overall Study|Lost to Follow-up|2|||
124893263|NCT02234310|449232048|FG000|Overall Study|Physician Decision|1|||
124893264|NCT02234310|449232048|FG000|Overall Study|Adverse Event|1|||
124893265|NCT02234310|449232048|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
124893266|NCT02234310|449232048|FG000|Overall Study|Withdrawal by Subject|2|||
124893267|NCT00235495|449232049|FG000|Overall Study|Death|52|||
124893268|NCT00235495|449232050|FG001|Overall Study|Death|42|||
124893269|NCT00235495|449232049|FG000|Overall Study|Withdrawal by Subject|5|||
124893270|NCT00235495|449232050|FG001|Overall Study|Withdrawal by Subject|3|||
124893271|NCT00235495|449232049|FG000|Overall Study|Lost to Follow-up|11|||
124893272|NCT00235495|449232050|FG001|Overall Study|Lost to Follow-up|13|||
124893273|NCT00235495|449232049|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
124687253|NCT02875080|448473560|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
124687254|NCT00768053|448473561|FG000|Overall Study|Adverse Event|10|||
124687255|NCT00768053|448473561|FG000|Overall Study|Lost to Follow-up|1|||
124893274|NCT00235495|449232050|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
124442749|NCT00567268|447582949|FG000|Overall Study|Lost to Follow-up|36|||
124687256|NCT01164475|448473562|FG000|Overall Study|Lack of Efficacy|1|||
124687257|NCT01164475|448473563|FG001|Overall Study|Lack of Efficacy|0|||
124687258|NCT01164475|448473562|FG000|Overall Study|Other|0|||
124687259|NCT01164475|448473563|FG001|Overall Study|Other|1|||
124893275|NCT02192359|449232051|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
124893276|NCT02192359|449232052|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
124893277|NCT02192359|449232053|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
124893278|NCT02192359|449232054|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
124893279|NCT02192359|449232051|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
124893280|NCT02192359|449232052|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
124893281|NCT02192359|449232053|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
124893282|NCT02192359|449232054|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
124893283|NCT02192359|449232051|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
124893284|NCT02192359|449232052|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
124893285|NCT02192359|449232053|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
124893286|NCT02192359|449232054|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
124893287|NCT00114959|449232055|FG000|Overall Study|Lack of Efficacy|6|||
124893288|NCT00114959|449232055|FG000|Overall Study|Physician Decision|1|||
124893289|NCT00114959|449232055|FG000|Overall Study|Death|1|||
124893290|NCT03251378|449232056|FG000|Overall Study|Death|3|||
124893291|NCT03251378|449232057|FG001|Overall Study|Death|2|||
124893292|NCT03251378|449232058|FG002|Overall Study|Death|3|||
124893293|NCT03251378|449232059|FG003|Overall Study|Death|30|||
124893294|NCT03251378|449232060|FG004|Overall Study|Death|24|||
124893295|NCT03251378|449232061|FG005|Overall Study|Death|12|||
124893296|NCT03251378|449232062|FG006|Overall Study|Death|12|||
124893297|NCT03251378|449232056|FG000|Overall Study|Lost to Follow-up|0|||
124893298|NCT03251378|449232057|FG001|Overall Study|Lost to Follow-up|0|||
124893299|NCT03251378|449232058|FG002|Overall Study|Lost to Follow-up|1|||
124893300|NCT03251378|449232059|FG003|Overall Study|Lost to Follow-up|3|||
124893301|NCT03251378|449232060|FG004|Overall Study|Lost to Follow-up|0|||
124893302|NCT03251378|449232061|FG005|Overall Study|Lost to Follow-up|0|||
124893303|NCT03251378|449232062|FG006|Overall Study|Lost to Follow-up|0|||
124893304|NCT03251378|449232056|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
124893305|NCT03251378|449232057|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
124893306|NCT03251378|449232058|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
124893307|NCT03251378|449232059|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
124893308|NCT03251378|449232060|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
124893309|NCT03251378|449232061|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
124893310|NCT03251378|449232062|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
124893311|NCT03251378|449232056|FG000|Overall Study|Progressive disease|2|||
124893312|NCT03251378|449232057|FG001|Overall Study|Progressive disease|0|||
124893313|NCT03251378|449232058|FG002|Overall Study|Progressive disease|0|||
124893314|NCT03251378|449232059|FG003|Overall Study|Progressive disease|1|||
124893315|NCT03251378|449232060|FG004|Overall Study|Progressive disease|0|||
124893316|NCT03251378|449232061|FG005|Overall Study|Progressive disease|0|||
124893317|NCT03251378|449232062|FG006|Overall Study|Progressive disease|0|||
124893318|NCT03251378|449232056|FG000|Overall Study|Physician Decision|0|||
124893319|NCT03251378|449232057|FG001|Overall Study|Physician Decision|2|||
124893320|NCT03251378|449232058|FG002|Overall Study|Physician Decision|0|||
124893321|NCT03251378|449232059|FG003|Overall Study|Physician Decision|0|||
124893322|NCT03251378|449232060|FG004|Overall Study|Physician Decision|0|||
124893323|NCT03251378|449232061|FG005|Overall Study|Physician Decision|0|||
124893324|NCT03251378|449232062|FG006|Overall Study|Physician Decision|0|||
124893325|NCT03251378|449232056|FG000|Overall Study|Other|2|||
124893326|NCT03251378|449232057|FG001|Overall Study|Other|3|||
124893327|NCT03251378|449232058|FG002|Overall Study|Other|2|||
124893328|NCT03251378|449232059|FG003|Overall Study|Other|0|||
124893329|NCT03251378|449232060|FG004|Overall Study|Other|1|||
124893330|NCT03251378|449232061|FG005|Overall Study|Other|1|||
124893331|NCT03251378|449232062|FG006|Overall Study|Other|1|||
124893332|NCT03251378|449232056|FG000|Overall Study|Other|0|||
124893333|NCT03251378|449232057|FG001|Overall Study|Other|0|||
124893334|NCT03251378|449232058|FG002|Overall Study|Other|0|||
124893335|NCT03251378|449232059|FG003|Overall Study|Other|4|||
124893336|NCT03251378|449232060|FG004|Overall Study|Other|13|||
124893337|NCT03251378|449232061|FG005|Overall Study|Other|0|||
124893338|NCT03251378|449232062|FG006|Overall Study|Other|0|||
124893339|NCT04060680|449232065|FG000|Overall Study|Unsuccessful implant|17|||
124893340|NCT04060680|449232066|FG001|Overall Study|Unsuccessful implant|2|||
124687260|NCT01164475|448473562|FG000|Overall Study|Progressive disease|0|||
124687261|NCT01164475|448473563|FG001|Overall Study|Progressive disease|1|||
124893341|NCT04060680|449232065|FG000|Overall Study|Adverse Event|3|||
124893342|NCT04060680|449232066|FG001|Overall Study|Adverse Event|0|||
124893343|NCT04060680|449232065|FG000|Overall Study|Death|2|||
124893344|NCT04060680|449232066|FG001|Overall Study|Death|0|||
124893345|NCT04060680|449232065|FG000|Overall Study|Study product no longer in use|1|||
124893346|NCT04060680|449232066|FG001|Overall Study|Study product no longer in use|0|||
124893347|NCT04060680|449232065|FG000|Overall Study|Withdrawal by Subject|1|||
124893348|NCT04060680|449232066|FG001|Overall Study|Withdrawal by Subject|0|||
124442750|NCT00567268|447582949|FG000|Overall Study|No Visit After First Day of Treatment|2|||
124442751|NCT00567268|447582949|FG000|Overall Study|No Drug Administration|4|||
124442752|NCT00567268|447582949|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
124442753|NCT01717989|447582952|FG000|Overall Study|Ineligibility determined|6|||
124442754|NCT01717989|447582952|FG000|Overall Study|Protocol deviation|6|||
124442755|NCT01717989|447582952|FG000|Overall Study|Withdrawal by Subject|11|||
124442756|NCT01717989|447582952|FG000|Overall Study|Physician Decision|2|||
124442757|NCT01717989|447582952|FG000|Overall Study|Lost to Follow-up|11|||
124442758|NCT01717989|447582952|FG000|Overall Study|Death|439|||
124442759|NCT01717989|447582952|FG000|Overall Study|Protocol-specified criteria|551|||
124442760|NCT01717989|447582952|FG000|Overall Study|Other|40|||
124442761|NCT00792805|447582953|FG000|Overall Study|Adverse Event|12|||
124893349|NCT04739423|449232070|FG000|Overall Study|Protocol Violation|0|||
124442762|NCT00792805|447582954|FG001|Overall Study|Adverse Event|10|||
124442763|NCT00792805|447582955|FG002|Overall Study|Adverse Event|10|||
124442764|NCT00792805|447582953|FG000|Overall Study|Subject withdrew consent|5|||
124442765|NCT00792805|447582954|FG001|Overall Study|Subject withdrew consent|6|||
124442766|NCT00792805|447582955|FG002|Overall Study|Subject withdrew consent|5|||
124442767|NCT00792805|447582953|FG000|Overall Study|Administrative problems|2|||
124442768|NCT00792805|447582954|FG001|Overall Study|Administrative problems|0|||
124442769|NCT00792805|447582955|FG002|Overall Study|Administrative problems|4|||
124442770|NCT00792805|447582953|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124442771|NCT00792805|447582954|FG001|Overall Study|Abnormal test procedure result(s)|2|||
124442772|NCT00792805|447582955|FG002|Overall Study|Abnormal test procedure result(s)|0|||
124442773|NCT00792805|447582953|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124442774|NCT00792805|447582954|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
124442775|NCT00792805|447582955|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
124442776|NCT00792805|447582953|FG000|Overall Study|Lost to Follow-up|1|||
124442777|NCT00792805|447582954|FG001|Overall Study|Lost to Follow-up|1|||
124442778|NCT00792805|447582955|FG002|Overall Study|Lost to Follow-up|6|||
124442779|NCT00792805|447582953|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124442780|NCT00792805|447582954|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124442781|NCT00792805|447582955|FG002|Overall Study|Abnormal laboratory value(s)|1|||
124442782|NCT00792805|447582953|FG000|Overall Study|Protocol deviation|0|||
124442783|NCT00792805|447582954|FG001|Overall Study|Protocol deviation|1|||
124442784|NCT00792805|447582955|FG002|Overall Study|Protocol deviation|1|||
124442785|NCT03224325|447582956|FG000|Overall Study|Adverse Event|1|||
124442786|NCT03224325|447582957|FG001|Overall Study|Adverse Event|0|||
124442787|NCT03224325|447582958|FG002|Overall Study|Adverse Event|0|||
124442788|NCT03224325|447582959|FG003|Overall Study|Adverse Event|0|||
124442789|NCT03224325|447582960|FG004|Overall Study|Adverse Event|0|||
124442790|NCT03224325|447582961|FG005|Overall Study|Adverse Event|0|||
124442791|NCT03224325|447582962|FG006|Overall Study|Adverse Event|1|||
124442792|NCT03224325|447582956|FG000|Overall Study|Withdrawal by Subject|0|||
124442793|NCT03224325|447582957|FG001|Overall Study|Withdrawal by Subject|0|||
124442794|NCT03224325|447582958|FG002|Overall Study|Withdrawal by Subject|0|||
124442795|NCT03224325|447582959|FG003|Overall Study|Withdrawal by Subject|1|||
124442796|NCT03224325|447582960|FG004|Overall Study|Withdrawal by Subject|0|||
124442797|NCT03224325|447582961|FG005|Overall Study|Withdrawal by Subject|0|||
124442798|NCT03224325|447582962|FG006|Overall Study|Withdrawal by Subject|0|||
124442799|NCT02952001|447582963|FG000|Overall Study|Adverse Event|3|||
124442800|NCT02952001|447582964|FG001|Overall Study|Adverse Event|0|||
124442801|NCT02952001|447582963|FG000|Overall Study|Prohibited therapy|10|||
124442802|NCT02952001|447582964|FG001|Overall Study|Prohibited therapy|3|||
124442803|NCT02952001|447582963|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
124442804|NCT02952001|447582964|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
124442805|NCT03278106|447582974|FG000|Overall Study|No protocol treatment|1|||
124442806|NCT02982187|447582975|FG000|Overall Study|Withdrawal by Subject|0|||
124442807|NCT02982187|447582976|FG001|Overall Study|Withdrawal by Subject|0|||
124442808|NCT02982187|447582977|FG002|Overall Study|Withdrawal by Subject|0|||
124442809|NCT02982187|447582978|FG003|Overall Study|Withdrawal by Subject|0|||
124442810|NCT02982187|447582979|FG004|Overall Study|Withdrawal by Subject|0|||
124442811|NCT02982187|447582980|FG005|Overall Study|Withdrawal by Subject|0|||
124442812|NCT02982187|447582981|FG006|Overall Study|Withdrawal by Subject|1|||
124759330|NCT04491136|448742615|FG000|Overall Study|Physician Decision|45|||
124442813|NCT02982187|447582982|FG007|Overall Study|Withdrawal by Subject|0|||
124893350|NCT04739423|449232071|FG001|Overall Study|Protocol Violation|1|||
124893351|NCT04739423|449232072|FG002|Overall Study|Protocol Violation|0|||
124893352|NCT04739423|449232073|FG003|Overall Study|Protocol Violation|0|||
124442814|NCT02604433|447582983|FG000|Overall Study|Withdrawal by Subject|37|||
124442815|NCT02604433|447582984|FG001|Overall Study|Withdrawal by Subject|16|||
124442816|NCT02604433|447582983|FG000|Overall Study|Adverse Event|4|||
124442817|NCT02604433|447582984|FG001|Overall Study|Adverse Event|0|||
124442818|NCT02604433|447582983|FG000|Overall Study|Other reasons|3|||
124442819|NCT02604433|447582984|FG001|Overall Study|Other reasons|5|||
124442820|NCT02604433|447582983|FG000|Overall Study|Death|4|||
124442821|NCT02604433|447582984|FG001|Overall Study|Death|1|||
124442822|NCT02604433|447582983|FG000|Overall Study|Transition to Rollover Protocol|169|||
124442823|NCT02604433|447582984|FG001|Overall Study|Transition to Rollover Protocol|82|||
124442824|NCT02604433|447582983|FG000|Overall Study|Physician Decision|1|||
124442825|NCT02604433|447582984|FG001|Overall Study|Physician Decision|1|||
124442826|NCT02604433|447582983|FG000|Overall Study|Lack of Efficacy|0|||
124442827|NCT02604433|447582984|FG001|Overall Study|Lack of Efficacy|1|||
124442828|NCT03437278|447582985|FG000|Overall Study|Adverse Event|0|||
124442829|NCT03437278|447582986|FG001|Overall Study|Adverse Event|0|||
124442830|NCT03437278|447582987|FG002|Overall Study|Adverse Event|1|||
124442831|NCT03437278|447582985|FG000|Overall Study|Progressive disease|1|||
124893353|NCT04739423|449232074|FG004|Overall Study|Protocol Violation|0|||
124893354|NCT04739423|449232075|FG005|Overall Study|Protocol Violation|0|||
124893355|NCT04739423|449232070|FG000|Overall Study|Adverse Event|0|||
124893356|NCT04739423|449232071|FG001|Overall Study|Adverse Event|0|||
124893357|NCT04739423|449232072|FG002|Overall Study|Adverse Event|1|||
124893358|NCT04739423|449232073|FG003|Overall Study|Adverse Event|0|||
124442832|NCT03437278|447582986|FG001|Overall Study|Progressive disease|0|||
124442833|NCT03437278|447582987|FG002|Overall Study|Progressive disease|0|||
124442834|NCT03437278|447582985|FG000|Overall Study|Physician Decision|1|||
124442835|NCT03437278|447582986|FG001|Overall Study|Physician Decision|0|||
124893359|NCT04739423|449232074|FG004|Overall Study|Adverse Event|1|||
124893360|NCT04739423|449232075|FG005|Overall Study|Adverse Event|0|||
124893361|NCT04739423|449232070|FG000|Overall Study|Withdrawal by Subject|0|||
124893362|NCT04739423|449232071|FG001|Overall Study|Withdrawal by Subject|0|||
124893363|NCT04739423|449232072|FG002|Overall Study|Withdrawal by Subject|0|||
124893364|NCT04739423|449232073|FG003|Overall Study|Withdrawal by Subject|0|||
124893365|NCT04739423|449232074|FG004|Overall Study|Withdrawal by Subject|0|||
124893366|NCT04739423|449232075|FG005|Overall Study|Withdrawal by Subject|1|||
124893367|NCT01007552|449232076|FG000|Overall Study|Withdrawal by Subject|1|||
124893368|NCT00901485|449232082|FG000|Overall Study|Lack of Efficacy|0|||
124893369|NCT00901485|449232083|FG001|Overall Study|Lack of Efficacy|2|||
124893370|NCT00901485|449232082|FG000|Overall Study|Withdrawal by Subject|1|||
124893371|NCT00901485|449232083|FG001|Overall Study|Withdrawal by Subject|2|||
124893372|NCT01929993|449233671|FG000|Overall Study|Protocol Violation|4|||
124893373|NCT01929993|449233672|FG001|Overall Study|Protocol Violation|6|||
124893374|NCT01929993|449233671|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
124893375|NCT01929993|449233672|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
124893376|NCT01852162|449233673|FG000|Overall Study|Adverse Event|1|||
124893377|NCT01852162|449233674|FG001|Overall Study|Adverse Event|0|||
124893378|NCT01852162|449233673|FG000|Overall Study|Withdrawal by Subject|3|||
124893379|NCT01852162|449233674|FG001|Overall Study|Withdrawal by Subject|1|||
124893380|NCT01256476|449233675|FG000|Overall Study|Adverse Event|2|||
124893381|NCT01256476|449233676|FG001|Overall Study|Adverse Event|1|||
124893382|NCT01256476|449233675|FG000|Overall Study|Withdrawal by Subject|2|||
124893383|NCT01256476|449233676|FG001|Overall Study|Withdrawal by Subject|1|||
124893384|NCT01256476|449233675|FG000|Overall Study|Lost to Follow-up|1|||
124893385|NCT01256476|449233676|FG001|Overall Study|Lost to Follow-up|2|||
124893386|NCT01256476|449233675|FG000|Overall Study|Persistent ALT or AST elevation|1|||
124893387|NCT01256476|449233676|FG001|Overall Study|Persistent ALT or AST elevation|0|||
124893388|NCT01256476|449233675|FG000|Overall Study|Physician Decision|0|||
124893389|NCT01256476|449233676|FG001|Overall Study|Physician Decision|1|||
124893390|NCT01256476|449233675|FG000|Overall Study|Subject non-compliance|0|||
124893391|NCT01256476|449233676|FG001|Overall Study|Subject non-compliance|1|||
124893392|NCT01256476|449233675|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
124893393|NCT01256476|449233676|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
124893394|NCT00163215|449233681|FG000|Overall Study|Lack of Efficacy|3|||
124893395|NCT00163215|449233681|FG000|Overall Study|Withdrawal by Subject|5|||
124893396|NCT00163215|449233681|FG000|Overall Study|Other|7|||
124893397|NCT00231179|449233682|FG000|Overall Study|Lost to Follow-up|21|||
124442836|NCT03437278|447582987|FG002|Overall Study|Physician Decision|1|||
124442837|NCT02202551|447582988|FG000|Overall Study|Adverse Event|8|||
124893398|NCT00231179|449233683|FG001|Overall Study|Lost to Follow-up|21|||
124893399|NCT00231179|449233682|FG000|Overall Study|Withdrawal by Subject|3|||
124442838|NCT02202551|447582989|FG001|Overall Study|Adverse Event|19|||
124893400|NCT00231179|449233683|FG001|Overall Study|Withdrawal by Subject|3|||
124893401|NCT02892409|449233684|FG000|Overall Study|Adverse Event|1|||
124893402|NCT02892409|449233685|FG001|Overall Study|Adverse Event|0|||
124893403|NCT02892409|449233684|FG000|Overall Study|Withdrawal by Subject|2|||
124893404|NCT02892409|449233685|FG001|Overall Study|Withdrawal by Subject|1|||
124893405|NCT02123966|449233688|FG000|Overall Study|Intercurrent Illness|1|||
124687262|NCT01164475|448473562|FG000|Overall Study|Protocol Violation|1|||
124687263|NCT01164475|448473563|FG001|Overall Study|Protocol Violation|0|||
124687264|NCT04603066|448473565|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
124687265|NCT04603066|448473566|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
124687266|NCT00632359|448473570|FG000|Overall Study|Withdrawal by Subject|2|||
124893406|NCT01460381|449233689|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
124893407|NCT01460381|449233690|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
124893408|NCT04822298|449233692|FG000|Overall Study|Death|3|||
124893409|NCT00852475|449233699|FG000|Overall Study|Lost to Follow-up|3|||
124893410|NCT00852475|449233700|FG001|Overall Study|Lost to Follow-up|4|||
124893411|NCT00515086|449233701|FG000|Overall Study|Adverse Event|1|||
124893412|NCT00515086|449233702|FG001|Overall Study|Adverse Event|1|||
124893413|NCT00515086|449233703|FG002|Overall Study|Adverse Event|2|||
124893414|NCT00515086|449233704|FG003|Overall Study|Adverse Event|3|||
124893415|NCT00515086|449233701|FG000|Overall Study|Administrative|1|||
124687267|NCT02872714|448473571|FG000|Overall Study|Progressive Disease|1|||
124687268|NCT02872714|448473572|FG001|Overall Study|Progressive Disease|2|||
124687269|NCT02872714|448473573|FG002|Overall Study|Progressive Disease|0|||
124687270|NCT02872714|448473574|FG003|Overall Study|Progressive Disease|0|||
124687271|NCT02872714|448473575|FG004|Overall Study|Progressive Disease|0|||
124687272|NCT02872714|448473571|FG000|Overall Study|Death|87|||
124687273|NCT02872714|448473572|FG001|Overall Study|Death|36|||
124687274|NCT02872714|448473573|FG002|Overall Study|Death|8|||
124687275|NCT02872714|448473574|FG003|Overall Study|Death|81|||
124687276|NCT02872714|448473575|FG004|Overall Study|Death|2|||
124687277|NCT02872714|448473571|FG000|Overall Study|Lost to Follow-up|2|||
124687278|NCT02872714|448473572|FG001|Overall Study|Lost to Follow-up|1|||
124687279|NCT02872714|448473573|FG002|Overall Study|Lost to Follow-up|0|||
124687280|NCT02872714|448473574|FG003|Overall Study|Lost to Follow-up|3|||
124687281|NCT02872714|448473575|FG004|Overall Study|Lost to Follow-up|0|||
124687282|NCT02872714|448473571|FG000|Overall Study|Physician Decision|0|||
124687283|NCT02872714|448473572|FG001|Overall Study|Physician Decision|0|||
124687284|NCT02872714|448473573|FG002|Overall Study|Physician Decision|0|||
124687285|NCT02872714|448473574|FG003|Overall Study|Physician Decision|1|||
124687286|NCT02872714|448473575|FG004|Overall Study|Physician Decision|0|||
124687287|NCT02872714|448473571|FG000|Overall Study|Withdrawal by Subject|1|||
124687288|NCT02872714|448473572|FG001|Overall Study|Withdrawal by Subject|3|||
124687289|NCT02872714|448473573|FG002|Overall Study|Withdrawal by Subject|0|||
124687290|NCT02872714|448473574|FG003|Overall Study|Withdrawal by Subject|2|||
124687291|NCT02872714|448473575|FG004|Overall Study|Withdrawal by Subject|0|||
124687292|NCT02872714|448473571|FG000|Overall Study|Captured as Other|2|||
124687293|NCT02872714|448473572|FG001|Overall Study|Captured as Other|0|||
124687294|NCT02872714|448473573|FG002|Overall Study|Captured as Other|0|||
124687295|NCT02872714|448473574|FG003|Overall Study|Captured as Other|1|||
124687296|NCT02872714|448473575|FG004|Overall Study|Captured as Other|0|||
124687297|NCT02145390|448473576|FG000|Overall Study|Withdrawal by Subject|1|||
124687298|NCT02737618|448474354|FG000|Overall Study|Withdrawal by Subject|9|||
124687299|NCT00817063|448474357|FG000|Overall Study|Adverse Event|32|||
124687300|NCT00817063|448474358|FG001|Overall Study|Adverse Event|13|||
124687301|NCT00817063|448474357|FG000|Overall Study|Death|1|||
124687302|NCT00817063|448474358|FG001|Overall Study|Death|1|||
124687303|NCT00817063|448474357|FG000|Overall Study|Lack of Efficacy|33|||
124687304|NCT00817063|448474358|FG001|Overall Study|Lack of Efficacy|86|||
124687305|NCT00817063|448474357|FG000|Overall Study|Failure to Return|13|||
124687306|NCT00817063|448474358|FG001|Overall Study|Failure to Return|12|||
124687307|NCT00817063|448474357|FG000|Overall Study|Violation of Selection at Entry|7|||
124893416|NCT00515086|449233702|FG001|Overall Study|Administrative|1|||
124687308|NCT00817063|448474358|FG001|Overall Study|Violation of Selection at Entry|4|||
124687309|NCT00817063|448474357|FG000|Overall Study|Protocol Violation|3|||
124687310|NCT00817063|448474358|FG001|Overall Study|Protocol Violation|8|||
124687311|NCT00817063|448474357|FG000|Overall Study|Withdrawal by Subject|17|||
124687312|NCT00817063|448474358|FG001|Overall Study|Withdrawal by Subject|37|||
124687313|NCT00817063|448474357|FG000|Overall Study|Early Improvement|19|||
124687314|NCT00817063|448474358|FG001|Overall Study|Early Improvement|4|||
124687315|NCT00817063|448474357|FG000|Overall Study|Administrative|10|||
124687316|NCT00817063|448474358|FG001|Overall Study|Administrative|4|||
124687317|NCT00817063|448474357|FG000|Overall Study|Abnormality of Laboratory Test|2|||
124893417|NCT00515086|449233703|FG002|Overall Study|Administrative|0|||
124893418|NCT00515086|449233704|FG003|Overall Study|Administrative|0|||
124687318|NCT00817063|448474358|FG001|Overall Study|Abnormality of Laboratory Test|1|||
124687319|NCT02362451|448474360|FG000|Overall Study|Withdrawal by Subject|0|||
124687320|NCT02362451|448474361|FG001|Overall Study|Withdrawal by Subject|1|||
124687321|NCT02362451|448474360|FG000|Overall Study|Lack of Efficacy|2|||
124687322|NCT02362451|448474361|FG001|Overall Study|Lack of Efficacy|0|||
124687323|NCT02362451|448474360|FG000|Overall Study|Progression|1|||
124687324|NCT02362451|448474361|FG001|Overall Study|Progression|0|||
124893419|NCT00515086|449233701|FG000|Overall Study|Withdrawal by Subject|1|||
124442839|NCT02202551|447582990|FG002|Overall Study|Adverse Event|5|||
124442840|NCT02202551|447582991|FG003|Overall Study|Adverse Event|9|||
124442841|NCT02202551|447582988|FG000|Overall Study|Death|3|||
124893420|NCT00515086|449233702|FG001|Overall Study|Withdrawal by Subject|0|||
124893421|NCT00515086|449233703|FG002|Overall Study|Withdrawal by Subject|0|||
124893422|NCT00515086|449233704|FG003|Overall Study|Withdrawal by Subject|1|||
124893423|NCT00515086|449233701|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
124893424|NCT00515086|449233702|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
124893425|NCT00515086|449233703|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
124893426|NCT00515086|449233704|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
124893427|NCT00515086|449233701|FG000|Overall Study|Lost to Follow-up|1|||
124893428|NCT00515086|449233702|FG001|Overall Study|Lost to Follow-up|0|||
124893429|NCT00515086|449233703|FG002|Overall Study|Lost to Follow-up|0|||
124893430|NCT00515086|449233704|FG003|Overall Study|Lost to Follow-up|0|||
124893431|NCT00515086|449233701|FG000|Overall Study|Study drug no longer required|0|||
124893432|NCT00515086|449233702|FG001|Overall Study|Study drug no longer required|1|||
124893433|NCT00515086|449233703|FG002|Overall Study|Study drug no longer required|0|||
124893434|NCT00515086|449233704|FG003|Overall Study|Study drug no longer required|0|||
124893435|NCT00515086|449233701|FG000|Overall Study|Death|2|||
124893436|NCT00515086|449233702|FG001|Overall Study|Death|0|||
124893437|NCT00515086|449233703|FG002|Overall Study|Death|0|||
124893438|NCT00515086|449233704|FG003|Overall Study|Death|0|||
124893439|NCT02373813|449233705|FG000|Run-In Period|Other, Not Specified|5|||
124893440|NCT02373813|449233706|FG001|Run-In Period|Other, Not Specified|0|||
124893441|NCT02373813|449233707|FG002|Run-In Period|Other, Not Specified|0|||
124893442|NCT02373813|449233708|FG003|Run-In Period|Other, Not Specified|0|||
124893443|NCT02373813|449233705|FG000|Run-In Period|Withdrawal by Subject|16|||
124893444|NCT02373813|449233706|FG001|Run-In Period|Withdrawal by Subject|0|||
124893445|NCT02373813|449233707|FG002|Run-In Period|Withdrawal by Subject|0|||
124893446|NCT02373813|449233708|FG003|Run-In Period|Withdrawal by Subject|0|||
124893447|NCT02373813|449233705|FG000|Run-In Period|Decision by Sponsor|11|||
124893448|NCT02373813|449233706|FG001|Run-In Period|Decision by Sponsor|0|||
124893449|NCT02373813|449233707|FG002|Run-In Period|Decision by Sponsor|0|||
124687325|NCT02362451|448474360|FG000|Overall Study|Participant chose other therapy.|1|||
124687326|NCT02362451|448474361|FG001|Overall Study|Participant chose other therapy.|0|||
124687327|NCT00700635|448474362|FG000|Overall Study|Adverse Event|1|||
124893450|NCT02373813|449233708|FG003|Run-In Period|Decision by Sponsor|0|||
124893451|NCT02373813|449233705|FG000|Run-In Period|Protocol Violation|75|||
124442842|NCT02202551|447582989|FG001|Overall Study|Death|2|||
124893452|NCT02373813|449233706|FG001|Run-In Period|Protocol Violation|0|||
124893453|NCT02373813|449233707|FG002|Run-In Period|Protocol Violation|0|||
124893454|NCT02373813|449233708|FG003|Run-In Period|Protocol Violation|0|||
124893455|NCT02373813|449233705|FG000|Run-In Period|Lost to Follow-up|2|||
124893456|NCT02373813|449233706|FG001|Run-In Period|Lost to Follow-up|0|||
124442843|NCT02202551|447582990|FG002|Overall Study|Death|1|||
124687328|NCT00700635|448474363|FG001|Overall Study|Adverse Event|0|||
124893457|NCT02373813|449233707|FG002|Run-In Period|Lost to Follow-up|0|||
124687329|NCT00700635|448474364|FG002|Overall Study|Adverse Event|0|||
124687330|NCT00700635|448474362|FG000|Overall Study|Lost to Follow-up|1|||
124687331|NCT00700635|448474363|FG001|Overall Study|Lost to Follow-up|3|||
124893458|NCT02373813|449233708|FG003|Run-In Period|Lost to Follow-up|0|||
124893459|NCT02373813|449233705|FG000|Run-In Period|Adverse Event|3|||
124893460|NCT02373813|449233706|FG001|Run-In Period|Adverse Event|0|||
124893461|NCT02373813|449233707|FG002|Run-In Period|Adverse Event|0|||
124893462|NCT02373813|449233708|FG003|Run-In Period|Adverse Event|0|||
124893463|NCT02373813|449233705|FG000|Run-In Period|Noncompliance|1|||
124893464|NCT02373813|449233706|FG001|Run-In Period|Noncompliance|0|||
124893465|NCT02373813|449233707|FG002|Run-In Period|Noncompliance|0|||
124893466|NCT02373813|449233708|FG003|Run-In Period|Noncompliance|0|||
124893467|NCT02373813|449233705|FG000|Run-In Period|Ineligibility Determined|3|||
124893468|NCT02373813|449233706|FG001|Run-In Period|Ineligibility Determined|0|||
124893469|NCT02373813|449233707|FG002|Run-In Period|Ineligibility Determined|0|||
124893470|NCT02373813|449233708|FG003|Run-In Period|Ineligibility Determined|0|||
124893471|NCT02373813|449233705|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
124893472|NCT02373813|449233706|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
124893473|NCT02373813|449233707|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
124893474|NCT02373813|449233708|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
124893475|NCT02373813|449233705|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
124893476|NCT02373813|449233706|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
124893477|NCT02373813|449233707|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
124893478|NCT02373813|449233708|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
124893479|NCT02373813|449233705|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124893480|NCT02373813|449233706|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
124893481|NCT02373813|449233707|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
124893482|NCT02373813|449233708|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
124893483|NCT02373813|449233705|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124893484|NCT02373813|449233706|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
124893485|NCT02373813|449233707|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
124893486|NCT02373813|449233708|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
124893487|NCT03738241|449233709|FG000|Overall Study|Withdrawal by Subject|0|||
124893488|NCT03738241|449233710|FG001|Overall Study|Withdrawal by Subject|0|||
124893489|NCT03738241|449233711|FG002|Overall Study|Withdrawal by Subject|0|||
124893490|NCT03738241|449233712|FG003|Overall Study|Withdrawal by Subject|0|||
124893491|NCT03738241|449233713|FG004|Overall Study|Withdrawal by Subject|0|||
124893492|NCT03738241|449233714|FG005|Overall Study|Withdrawal by Subject|0|||
124893493|NCT03738241|449233715|FG006|Overall Study|Withdrawal by Subject|0|||
124893494|NCT03738241|449233716|FG007|Overall Study|Withdrawal by Subject|0|||
124893495|NCT03738241|449233717|FG008|Overall Study|Withdrawal by Subject|0|||
124893496|NCT03738241|449233718|FG009|Overall Study|Withdrawal by Subject|1|||
124893497|NCT03738241|449233709|FG000|Overall Study|Physician Decision|0|||
124893498|NCT03738241|449233710|FG001|Overall Study|Physician Decision|0|||
124893499|NCT03738241|449233711|FG002|Overall Study|Physician Decision|0|||
124893500|NCT03738241|449233712|FG003|Overall Study|Physician Decision|0|||
124893501|NCT03738241|449233713|FG004|Overall Study|Physician Decision|0|||
124893502|NCT03738241|449233714|FG005|Overall Study|Physician Decision|0|||
124893503|NCT03738241|449233715|FG006|Overall Study|Physician Decision|0|||
124893504|NCT03738241|449233716|FG007|Overall Study|Physician Decision|0|||
124893505|NCT03738241|449233717|FG008|Overall Study|Physician Decision|1|||
124893506|NCT03738241|449233718|FG009|Overall Study|Physician Decision|0|||
124893507|NCT03738241|449233709|FG000|Overall Study|Adverse Event|1|||
124893508|NCT03738241|449233710|FG001|Overall Study|Adverse Event|0|||
124893509|NCT03738241|449233711|FG002|Overall Study|Adverse Event|0|||
124893510|NCT03738241|449233712|FG003|Overall Study|Adverse Event|0|||
124893511|NCT03738241|449233713|FG004|Overall Study|Adverse Event|0|||
124893512|NCT03738241|449233714|FG005|Overall Study|Adverse Event|0|||
124893513|NCT03738241|449233715|FG006|Overall Study|Adverse Event|0|||
124893514|NCT03738241|449233716|FG007|Overall Study|Adverse Event|0|||
124893515|NCT03738241|449233717|FG008|Overall Study|Adverse Event|0|||
124893516|NCT03738241|449233718|FG009|Overall Study|Adverse Event|0|||
124893517|NCT02788656|449233719|FG000|Overall Study|Withdrawal by Subject|1|||
124893518|NCT02788656|449233720|FG001|Overall Study|Withdrawal by Subject|0|||
124893519|NCT03169361|449233721|FG000|Overall Study|Protocol Violation|32|||
124893520|NCT02263885|449233722|FG000|Overall Study|Withdrawal by Subject|7|||
124893521|NCT02263885|449233722|FG000|Overall Study|Alternative Treatment|3|||
124893522|NCT00088465|449233723|FG000|Overall Study|Withdrawal by Subject|290|||
124893523|NCT00088465|449233723|FG000|Overall Study|Adverse Event|77|||
124893524|NCT00088465|449233723|FG000|Overall Study|Lost to Follow-up|57|||
124893525|NCT00088465|449233723|FG000|Overall Study|Physician Decision|45|||
124893526|NCT00088465|449233723|FG000|Overall Study|Sponsor Decision|37|||
124893527|NCT00088465|449233723|FG000|Overall Study|Lack of Efficacy|27|||
124893528|NCT00088465|449233723|FG000|Overall Study|Protocol Violation|17|||
124893529|NCT00088465|449233723|FG000|Overall Study|Death|11|||
124893530|NCT02688621|449233724|FG000|Overall Study|Pregnancy|1|||
124893531|NCT02688621|449233725|FG001|Overall Study|Pregnancy|3|||
124687332|NCT00700635|448474364|FG002|Overall Study|Lost to Follow-up|0|||
124687333|NCT00700635|448474362|FG000|Overall Study|Protocol Violation|2|||
124687334|NCT00700635|448474363|FG001|Overall Study|Protocol Violation|2|||
124687335|NCT00700635|448474364|FG002|Overall Study|Protocol Violation|0|||
124687336|NCT00700635|448474362|FG000|Overall Study|Withdrawal by Subject|7|||
124687337|NCT00700635|448474363|FG001|Overall Study|Withdrawal by Subject|3|||
124687338|NCT00700635|448474364|FG002|Overall Study|Withdrawal by Subject|1|||
124687339|NCT05172570|448474365|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
124687340|NCT05172570|448474366|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
124687341|NCT05172570|448474367|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
124687342|NCT05172570|448474365|FG000|Overall Study|PI Decision due to equipment shortages|0|||
124687343|NCT05172570|448474366|FG001|Overall Study|PI Decision due to equipment shortages|0|||
124687344|NCT05172570|448474367|FG002|Overall Study|PI Decision due to equipment shortages|1|||
124687345|NCT03421808|448474373|FG000|Overall Study|COVID related problems|2|||
124687346|NCT03421808|448474374|FG001|Overall Study|COVID related problems|0|||
124687347|NCT03421808|448474373|FG000|Overall Study|Withdrawal by Subject|1|||
124687348|NCT03421808|448474374|FG001|Overall Study|Withdrawal by Subject|0|||
124687349|NCT03421808|448474373|FG000|Overall Study|Protocol Violation|0|||
124687350|NCT03421808|448474374|FG001|Overall Study|Protocol Violation|1|||
124687351|NCT06717399|448474375|FG000|Overall Study|Death|1|||
124687352|NCT02180867|448474378|FG000|Overall Study|Adverse Event|3|||
124687353|NCT02180867|448474379|FG001|Overall Study|Adverse Event|4|||
124687354|NCT02180867|448474380|FG002|Overall Study|Adverse Event|1|||
124687355|NCT02180867|448474381|FG003|Overall Study|Adverse Event|5|||
124687356|NCT02180867|448474382|FG004|Overall Study|Adverse Event|0|||
124687357|NCT02180867|448474383|FG005|Overall Study|Adverse Event|0|||
124687358|NCT02180867|448474384|FG006|Overall Study|Adverse Event|0|||
124687359|NCT02180867|448474378|FG000|Overall Study|Death|0|||
124687360|NCT02180867|448474379|FG001|Overall Study|Death|0|||
124687361|NCT02180867|448474380|FG002|Overall Study|Death|0|||
124687362|NCT02180867|448474381|FG003|Overall Study|Death|0|||
124687363|NCT02180867|448474382|FG004|Overall Study|Death|1|||
124687364|NCT02180867|448474383|FG005|Overall Study|Death|0|||
124442844|NCT02202551|447582991|FG003|Overall Study|Death|1|||
124442845|NCT02202551|447582988|FG000|Overall Study|Lost to Follow-up|0|||
124442846|NCT02202551|447582989|FG001|Overall Study|Lost to Follow-up|1|||
124442847|NCT02202551|447582990|FG002|Overall Study|Lost to Follow-up|0|||
124442848|NCT02202551|447582991|FG003|Overall Study|Lost to Follow-up|1|||
124442849|NCT02202551|447582988|FG000|Overall Study|Needed to take excluded medication|0|||
124442850|NCT02202551|447582989|FG001|Overall Study|Needed to take excluded medication|2|||
124442851|NCT02202551|447582990|FG002|Overall Study|Needed to take excluded medication|0|||
124442852|NCT02202551|447582991|FG003|Overall Study|Needed to take excluded medication|1|||
124442853|NCT02202551|447582988|FG000|Overall Study|Subject moved away|0|||
124442854|NCT02202551|447582989|FG001|Overall Study|Subject moved away|1|||
124442855|NCT02202551|447582990|FG002|Overall Study|Subject moved away|0|||
124442856|NCT02202551|447582991|FG003|Overall Study|Subject moved away|0|||
124442857|NCT02202551|447582988|FG000|Overall Study|DBS surgery|3|||
124442858|NCT02202551|447582989|FG001|Overall Study|DBS surgery|0|||
124442859|NCT02202551|447582990|FG002|Overall Study|DBS surgery|0|||
124442860|NCT02202551|447582991|FG003|Overall Study|DBS surgery|0|||
124442861|NCT02202551|447582988|FG000|Overall Study|Dyskinesia upon taper|1|||
124442862|NCT02202551|447582989|FG001|Overall Study|Dyskinesia upon taper|0|||
124442863|NCT02202551|447582990|FG002|Overall Study|Dyskinesia upon taper|0|||
124442864|NCT02202551|447582991|FG003|Overall Study|Dyskinesia upon taper|0|||
124442865|NCT02202551|447582988|FG000|Overall Study|Lack of Efficacy|0|||
124442866|NCT02202551|447582989|FG001|Overall Study|Lack of Efficacy|1|||
124442867|NCT02202551|447582990|FG002|Overall Study|Lack of Efficacy|0|||
124442868|NCT02202551|447582991|FG003|Overall Study|Lack of Efficacy|0|||
124442869|NCT02202551|447582988|FG000|Overall Study|Physician Decision|1|||
124442870|NCT02202551|447582989|FG001|Overall Study|Physician Decision|0|||
124442871|NCT02202551|447582990|FG002|Overall Study|Physician Decision|0|||
124442872|NCT02202551|447582991|FG003|Overall Study|Physician Decision|0|||
124442873|NCT02202551|447582988|FG000|Overall Study|Site closure|3|||
124442874|NCT02202551|447582989|FG001|Overall Study|Site closure|0|||
124442875|NCT02202551|447582990|FG002|Overall Study|Site closure|0|||
124687365|NCT02180867|448474384|FG006|Overall Study|Death|0|||
124687366|NCT02180867|448474378|FG000|Overall Study|Lack of Efficacy|0|||
124442876|NCT02202551|447582991|FG003|Overall Study|Site closure|1|||
124442877|NCT02202551|447582988|FG000|Overall Study|Unable to complete visits per protocol|1|||
124442878|NCT02202551|447582989|FG001|Overall Study|Unable to complete visits per protocol|0|||
124687367|NCT02180867|448474379|FG001|Overall Study|Lack of Efficacy|2|||
124687368|NCT02180867|448474380|FG002|Overall Study|Lack of Efficacy|0|||
124442879|NCT02202551|447582990|FG002|Overall Study|Unable to complete visits per protocol|0|||
124442880|NCT02202551|447582991|FG003|Overall Study|Unable to complete visits per protocol|0|||
124687369|NCT02180867|448474381|FG003|Overall Study|Lack of Efficacy|1|||
124687370|NCT02180867|448474382|FG004|Overall Study|Lack of Efficacy|6|||
124442881|NCT02202551|447582988|FG000|Overall Study|Worsening Dyskinesia|0|||
124687371|NCT02180867|448474383|FG005|Overall Study|Lack of Efficacy|0|||
124687372|NCT02180867|448474384|FG006|Overall Study|Lack of Efficacy|1|||
124687373|NCT02180867|448474378|FG000|Overall Study|Physician Decision|1|||
124687374|NCT02180867|448474379|FG001|Overall Study|Physician Decision|3|||
124687375|NCT02180867|448474380|FG002|Overall Study|Physician Decision|1|||
124687376|NCT02180867|448474381|FG003|Overall Study|Physician Decision|10|||
124687377|NCT02180867|448474382|FG004|Overall Study|Physician Decision|9|||
124687378|NCT02180867|448474383|FG005|Overall Study|Physician Decision|3|||
124687379|NCT02180867|448474384|FG006|Overall Study|Physician Decision|4|||
124687380|NCT02180867|448474378|FG000|Overall Study|Withdrawal by Subject|0|||
124687381|NCT02180867|448474379|FG001|Overall Study|Withdrawal by Subject|0|||
124687382|NCT02180867|448474380|FG002|Overall Study|Withdrawal by Subject|0|||
124687383|NCT02180867|448474381|FG003|Overall Study|Withdrawal by Subject|1|||
124687384|NCT02180867|448474382|FG004|Overall Study|Withdrawal by Subject|1|||
124687385|NCT02180867|448474383|FG005|Overall Study|Withdrawal by Subject|0|||
124687386|NCT02180867|448474384|FG006|Overall Study|Withdrawal by Subject|0|||
124687387|NCT02180867|448474378|FG000|Overall Study|Ineligible|1|||
124687388|NCT02180867|448474379|FG001|Overall Study|Ineligible|2|||
124687389|NCT02180867|448474380|FG002|Overall Study|Ineligible|0|||
124687390|NCT02180867|448474381|FG003|Overall Study|Ineligible|3|||
124687391|NCT02180867|448474382|FG004|Overall Study|Ineligible|5|||
124687392|NCT02180867|448474383|FG005|Overall Study|Ineligible|0|||
124687393|NCT02180867|448474384|FG006|Overall Study|Ineligible|0|||
124687394|NCT02180867|448474378|FG000|Overall Study|Repeat Eligibility Studies|0|||
124687395|NCT02180867|448474379|FG001|Overall Study|Repeat Eligibility Studies|0|||
124687396|NCT02180867|448474380|FG002|Overall Study|Repeat Eligibility Studies|0|||
124687397|NCT02180867|448474381|FG003|Overall Study|Repeat Eligibility Studies|0|||
124687398|NCT02180867|448474382|FG004|Overall Study|Repeat Eligibility Studies|1|||
124687399|NCT02180867|448474383|FG005|Overall Study|Repeat Eligibility Studies|0|||
124687400|NCT02180867|448474384|FG006|Overall Study|Repeat Eligibility Studies|0|||
124687401|NCT02180867|448474378|FG000|Overall Study|Refusal of further protocol therapy|1|||
124687402|NCT02180867|448474379|FG001|Overall Study|Refusal of further protocol therapy|0|||
124687403|NCT02180867|448474380|FG002|Overall Study|Refusal of further protocol therapy|2|||
124687404|NCT02180867|448474381|FG003|Overall Study|Refusal of further protocol therapy|6|||
124687405|NCT02180867|448474382|FG004|Overall Study|Refusal of further protocol therapy|4|||
124687406|NCT02180867|448474383|FG005|Overall Study|Refusal of further protocol therapy|0|||
124687407|NCT02180867|448474384|FG006|Overall Study|Refusal of further protocol therapy|0|||
124687408|NCT02337686|448474385|FG000|Overall Study|Adverse Event|1|||
124687409|NCT00177671|448475110|FG000|Overall Study|Withdrawal by Subject|5|||
124687410|NCT00177671|448475111|FG001|Overall Study|Withdrawal by Subject|6|||
124687411|NCT00177671|448475110|FG000|Overall Study|medical complications|2|||
124687412|NCT00177671|448475111|FG001|Overall Study|medical complications|0|||
124687413|NCT00177671|448475110|FG000|Overall Study|Adverse Event|6|||
124687414|NCT00177671|448475111|FG001|Overall Study|Adverse Event|0|||
124687415|NCT00177671|448475110|FG000|Overall Study|Physician Decision|12|||
124687416|NCT00177671|448475111|FG001|Overall Study|Physician Decision|8|||
124893532|NCT02688621|449233724|FG000|Overall Study|Lost to Follow-up|38|||
124893533|NCT02688621|449233725|FG001|Overall Study|Lost to Follow-up|15|||
124893534|NCT02688621|449233724|FG000|Overall Study|Withdrawal by Subject|1|||
124893535|NCT02688621|449233725|FG001|Overall Study|Withdrawal by Subject|0|||
124893536|NCT00180674|449233728|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
124893537|NCT00180674|449233728|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
124893538|NCT01106976|449233729|FG000|Overall Study|Lost to Follow-up|8|||
124893539|NCT00278564|449233731|FG000|Overall Study|Lack of Efficacy|4|||
124893540|NCT01094743|449233732|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
124893541|NCT02851511|449233733|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
124893542|NCT02851511|449233734|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
124893543|NCT02851511|449233735|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
124893544|NCT02851511|449233736|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
124893545|NCT02851511|449233733|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
124893546|NCT02851511|449233734|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
124893547|NCT02851511|449233735|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
124893548|NCT02851511|449233736|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
124893549|NCT02851511|449233733|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
124687417|NCT02293499|448475112|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
124687418|NCT02293499|448475113|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
124687419|NCT02293499|448475114|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
124687420|NCT02293499|448475112|FG000|Intervention - Camp|Withdrawal by Subject|3|||
124687421|NCT02293499|448475113|FG001|Intervention - Camp|Withdrawal by Subject|6|||
124687422|NCT02293499|448475114|FG002|Intervention - Camp|Withdrawal by Subject|2|||
124687423|NCT02293499|448475112|FG000|Intervention - Camp|these are those not showing up at camp|24|||
124687424|NCT02293499|448475113|FG001|Intervention - Camp|these are those not showing up at camp|28|||
124687425|NCT02293499|448475114|FG002|Intervention - Camp|these are those not showing up at camp|4|||
124687426|NCT02293499|448475112|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
124687427|NCT02293499|448475113|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
124687428|NCT02293499|448475114|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
124687429|NCT02293499|448475112|FG000|3 Month Follow Up|Lost to Follow-up|14|||
124687430|NCT02293499|448475113|FG001|3 Month Follow Up|Lost to Follow-up|15|||
124687431|NCT02293499|448475114|FG002|3 Month Follow Up|Lost to Follow-up|6|||
124687432|NCT02293499|448475112|FG000|6 Month Follow Up|Lost to Follow-up|17|||
124687433|NCT02293499|448475113|FG001|6 Month Follow Up|Lost to Follow-up|27|||
124687434|NCT02293499|448475114|FG002|6 Month Follow Up|Lost to Follow-up|6|||
124687435|NCT02293499|448475112|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
124687436|NCT02293499|448475113|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
124687437|NCT02293499|448475114|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
124687438|NCT02293499|448475112|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
124687439|NCT02293499|448475113|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
124687440|NCT02293499|448475114|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
124687441|NCT02293499|448475112|FG000|9 Month Follow Up|Lost to Follow-up|24|||
124687442|NCT02293499|448475113|FG001|9 Month Follow Up|Lost to Follow-up|28|||
124687443|NCT02293499|448475114|FG002|9 Month Follow Up|Lost to Follow-up|4|||
124687444|NCT02293499|448475112|FG000|12 Month Follow Up|Lost to Follow-up|26|||
124687445|NCT02293499|448475113|FG001|12 Month Follow Up|Lost to Follow-up|25|||
124687446|NCT02293499|448475114|FG002|12 Month Follow Up|Lost to Follow-up|6|||
124687447|NCT02293499|448475112|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
124687448|NCT02293499|448475113|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
124759331|NCT04491136|448742615|FG000|Overall Study|sponsor terminated the study early|16|||
124893550|NCT02851511|449233734|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
124893551|NCT02851511|449233735|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
124893552|NCT02851511|449233736|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
124893553|NCT02851511|449233733|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
124893554|NCT02851511|449233734|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
124893555|NCT02851511|449233735|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
124893556|NCT02851511|449233736|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
124893557|NCT02851511|449233733|FG000|Phase I|Physician Decision|0|||
124893558|NCT02851511|449233734|FG001|Phase I|Physician Decision|0|||
124893559|NCT02851511|449233735|FG002|Phase I|Physician Decision|0|||
124893560|NCT02851511|449233736|FG003|Phase I|Physician Decision|1|||
124893561|NCT02851511|449233733|FG000|Phase I|Withdrawal by Subject|2|||
124893562|NCT02851511|449233734|FG001|Phase I|Withdrawal by Subject|1|||
124687449|NCT02293499|448475114|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
124687450|NCT02293499|448475112|FG000|15 Month Follow Up|Lost to Follow-up|22|||
124687451|NCT02293499|448475113|FG001|15 Month Follow Up|Lost to Follow-up|22|||
124687452|NCT02293499|448475114|FG002|15 Month Follow Up|Lost to Follow-up|7|||
124893563|NCT02851511|449233735|FG002|Phase I|Withdrawal by Subject|0|||
124893564|NCT02851511|449233736|FG003|Phase I|Withdrawal by Subject|3|||
124893565|NCT02851511|449233733|FG000|Phase II|Physician Decision|18|||
124893566|NCT02851511|449233734|FG001|Phase II|Physician Decision|16|||
124893567|NCT02851511|449233735|FG002|Phase II|Physician Decision|0|||
124893568|NCT02851511|449233736|FG003|Phase II|Physician Decision|0|||
124893569|NCT02851511|449233733|FG000|Phase II|Withdrawal by Subject|18|||
124893570|NCT02851511|449233734|FG001|Phase II|Withdrawal by Subject|16|||
124893571|NCT02851511|449233735|FG002|Phase II|Withdrawal by Subject|0|||
124893572|NCT02851511|449233736|FG003|Phase II|Withdrawal by Subject|0|||
124893573|NCT02851511|449233733|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
124893574|NCT02851511|449233734|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
124893575|NCT02851511|449233735|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
124893576|NCT02851511|449233736|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
124893577|NCT02851511|449233733|FG000|Phase II|Lost to Follow-up|0|||
124893578|NCT02851511|449233734|FG001|Phase II|Lost to Follow-up|1|||
124893579|NCT02851511|449233735|FG002|Phase II|Lost to Follow-up|0|||
124893580|NCT02851511|449233736|FG003|Phase II|Lost to Follow-up|0|||
124893581|NCT03836664|449233737|FG000|Overall Study|Didn't complete forms and lost drug|3|||
124893582|NCT03836664|449233738|FG001|Overall Study|Didn't complete forms and lost drug|3|||
124893583|NCT01427907|449233739|FG000|Overall Study|Withdrawal by Subject|3|||
124893584|NCT01427907|449233740|FG001|Overall Study|Withdrawal by Subject|4|||
124893585|NCT04003974|449233741|FG000|Overall Study|Missing|1|||
124893586|NCT04003974|449233742|FG001|Overall Study|Missing|0|||
124893587|NCT04003974|449233741|FG000|Overall Study|Withdrawal by Subject|0|||
124893588|NCT04003974|449233742|FG001|Overall Study|Withdrawal by Subject|2|||
124893589|NCT00335153|449233743|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
124893590|NCT00335153|449233743|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
124893591|NCT00335153|449233743|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
124893592|NCT00335153|449233743|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
124893593|NCT00335153|449233743|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
124893594|NCT00335153|449233743|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
124893595|NCT00335153|449233743|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
124893596|NCT00335153|449233743|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
124687453|NCT00690898|448475115|FG000|SCREENING|Screen failure|18|||
124687454|NCT00690898|448475115|FG000|TREATMENT|Adverse Event|3|||
124687455|NCT00690898|448475115|FG000|TREATMENT|Lack of Efficacy|18|||
124687456|NCT00690898|448475115|FG000|TREATMENT|Withdrawal by Subject|4|||
124687457|NCT00690898|448475115|FG000|TREATMENT|Other (not otherwise specified)|1|||
124687458|NCT01847209|448475118|FG000|Overall Study|Withdrawal by Subject|1|||
124687459|NCT01847209|448475118|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
124687460|NCT02008370|448475134|FG000|Overall Study|Lost to Follow-up|7|||
124893597|NCT00335153|449233743|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
124893598|NCT00335153|449233743|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
124893599|NCT00372528|449233744|FG000|Overall Study|Lack of Efficacy|1|||
124893600|NCT00372528|449233744|FG000|Overall Study|Adverse Event|1|||
124893601|NCT00372528|449233744|FG000|Overall Study|Study Terminated by Sponsor|18|||
124893602|NCT00372528|449233744|FG000|Overall Study|Other|1|||
124893603|NCT02412761|449233745|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124893604|NCT02412761|449233746|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
124893605|NCT02412761|449233747|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
124893606|NCT02412761|449233748|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124893607|NCT02412761|449233749|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124893608|NCT02412761|449233750|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
124893609|NCT02240680|449233751|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
124893610|NCT02240680|449233752|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
124893611|NCT02240680|449233753|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
124893612|NCT02240680|449233754|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
124893613|NCT02240680|449233751|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
124893614|NCT02240680|449233752|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
124893615|NCT02240680|449233753|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
124893616|NCT02240680|449233754|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
124893617|NCT02240680|449233751|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
124893618|NCT02240680|449233752|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
124893619|NCT02240680|449233753|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
124893620|NCT02240680|449233754|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
124893621|NCT02240680|449233751|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
124893622|NCT02240680|449233752|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
124893623|NCT02240680|449233753|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
124893624|NCT02240680|449233754|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
124893625|NCT02240680|449233751|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
124893626|NCT02240680|449233752|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
124893627|NCT02240680|449233753|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
124893628|NCT02240680|449233754|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
124893629|NCT02240680|449233751|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
124893630|NCT02240680|449233752|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
124893631|NCT02240680|449233753|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
124893632|NCT02240680|449233754|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
124893633|NCT02240680|449233751|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
124893634|NCT02240680|449233752|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
124893635|NCT02240680|449233753|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
124893636|NCT02240680|449233754|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
124893637|NCT02240680|449233751|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
124893638|NCT02240680|449233752|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
124893639|NCT02240680|449233753|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
124893640|NCT02240680|449233754|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
124893641|NCT01657682|449233755|FG000|Overall Study|Lost to Follow-up|1|||
124893642|NCT01657682|449233756|FG001|Overall Study|Lost to Follow-up|0|||
124893643|NCT01657682|449233757|FG002|Overall Study|Lost to Follow-up|0|||
124893644|NCT01657682|449233755|FG000|Overall Study|Withdrawal by Subject|0|||
124893645|NCT01657682|449233756|FG001|Overall Study|Withdrawal by Subject|1|||
124893646|NCT01657682|449233757|FG002|Overall Study|Withdrawal by Subject|1|||
124893647|NCT01657682|449233755|FG000|Overall Study|Adverse Event|0|||
124687461|NCT03317496|448475136|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
124687462|NCT03317496|448475137|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
124687463|NCT03317496|448475138|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
124759332|NCT04491136|448742615|FG000|Overall Study|Patient/guardian's decision|1|||
124893648|NCT01657682|449233756|FG001|Overall Study|Adverse Event|1|||
124893649|NCT01657682|449233757|FG002|Overall Study|Adverse Event|0|||
124893650|NCT01719861|449233758|FG000|Cycle 1|Death|4|||
124687464|NCT03317496|448475139|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
124893651|NCT01719861|449233758|FG000|Cycle 2|Death|1|||
124893652|NCT03704298|449233759|FG000|Overall Study|Death|3|||
124893653|NCT03704298|449233760|FG001|Overall Study|Death|1|||
124893654|NCT03704298|449233761|FG002|Overall Study|Death|1|||
124893655|NCT03704298|449233762|FG003|Overall Study|Death|0|||
124893656|NCT03704298|449233759|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
124893657|NCT03704298|449233760|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
124893658|NCT03704298|449233761|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
124893659|NCT03704298|449233762|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
124893660|NCT03704298|449233759|FG000|Overall Study|Withdrawal by Subject|1|||
124893661|NCT03704298|449233760|FG001|Overall Study|Withdrawal by Subject|0|||
124893662|NCT03704298|449233761|FG002|Overall Study|Withdrawal by Subject|0|||
124893663|NCT03704298|449233762|FG003|Overall Study|Withdrawal by Subject|0|||
124893664|NCT03704298|449233759|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
124893665|NCT03704298|449233760|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
124893666|NCT03704298|449233761|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
124893667|NCT03704298|449233762|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
124893668|NCT04482855|449233765|FG000|Overall Study|Lost to Follow-up|1|||
124893669|NCT04482855|449233766|FG001|Overall Study|Lost to Follow-up|0|||
124893670|NCT04482855|449233765|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
124893671|NCT04482855|449233766|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
124893672|NCT04482855|449233765|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
124893673|NCT04482855|449233766|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
124893674|NCT03212365|449233767|FG000|Overall Study|Discharged prior to Xa level|12|||
124893675|NCT03212365|449233768|FG001|Overall Study|Discharged prior to Xa level|8|||
124893676|NCT03212365|449233767|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
124893677|NCT03212365|449233768|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
124893678|NCT03212365|449233767|FG000|Overall Study|Refused study medication|3|||
124893679|NCT03212365|449233768|FG001|Overall Study|Refused study medication|0|||
124893680|NCT03212365|449233767|FG000|Overall Study|Initiated heparin infusion on floor|1|||
124893681|NCT03212365|449233768|FG001|Overall Study|Initiated heparin infusion on floor|1|||
124893682|NCT03212365|449233767|FG000|Overall Study|Unexpected return to OR|1|||
124893683|NCT03212365|449233768|FG001|Overall Study|Unexpected return to OR|1|||
124893684|NCT03212365|449233767|FG000|Overall Study|Medication distribution error|1|||
124893685|NCT03212365|449233768|FG001|Overall Study|Medication distribution error|0|||
124893686|NCT03212365|449233767|FG000|Overall Study|Required epidural placement|1|||
124893687|NCT03212365|449233768|FG001|Overall Study|Required epidural placement|0|||
124893688|NCT03212365|449233767|FG000|Overall Study|Withdrawal by Subject|0|||
124893689|NCT03212365|449233768|FG001|Overall Study|Withdrawal by Subject|1|||
124893690|NCT03212365|449233767|FG000|Overall Study|developed acute renal failure|0|||
124893691|NCT03212365|449233768|FG001|Overall Study|developed acute renal failure|1|||
124893692|NCT00819234|449233769|FG000|Overall Study|Withdrawal by Subject|8|||
124893693|NCT00819234|449233770|FG001|Overall Study|Withdrawal by Subject|13|||
124893694|NCT00819234|449233771|FG002|Overall Study|Withdrawal by Subject|6|||
124893695|NCT00819234|449233772|FG003|Overall Study|Withdrawal by Subject|3|||
124893696|NCT00819234|449233773|FG004|Overall Study|Withdrawal by Subject|0|||
124893697|NCT00819234|449233774|FG005|Overall Study|Withdrawal by Subject|4|||
124893698|NCT00819234|449233775|FG006|Overall Study|Withdrawal by Subject|4|||
124893699|NCT00819234|449233776|FG007|Overall Study|Withdrawal by Subject|8|||
124893700|NCT00819234|449233777|FG008|Overall Study|Withdrawal by Subject|5|||
124893701|NCT00819234|449233778|FG009|Overall Study|Withdrawal by Subject|3|||
124893702|NCT00819234|449233769|FG000|Overall Study|Adverse Event|0|||
124893703|NCT00819234|449233770|FG001|Overall Study|Adverse Event|0|||
124893704|NCT00819234|449233771|FG002|Overall Study|Adverse Event|1|||
124893705|NCT00819234|449233772|FG003|Overall Study|Adverse Event|0|||
124893706|NCT00819234|449233773|FG004|Overall Study|Adverse Event|0|||
124893707|NCT00819234|449233774|FG005|Overall Study|Adverse Event|2|||
124893708|NCT00819234|449233775|FG006|Overall Study|Adverse Event|0|||
124893709|NCT00819234|449233776|FG007|Overall Study|Adverse Event|0|||
124759333|NCT01611194|448742616|FG000|Overall Study|Lost to Follow-up|0|||
124759334|NCT01611194|448742617|FG001|Overall Study|Lost to Follow-up|1|||
124893710|NCT00819234|449233777|FG008|Overall Study|Adverse Event|0|||
124893711|NCT00819234|449233778|FG009|Overall Study|Adverse Event|0|||
124893712|NCT00819234|449233769|FG000|Overall Study|Physician Decision|0|||
124893713|NCT00819234|449233770|FG001|Overall Study|Physician Decision|0|||
124893714|NCT00819234|449233771|FG002|Overall Study|Physician Decision|0|||
124893715|NCT00819234|449233772|FG003|Overall Study|Physician Decision|1|||
124893716|NCT00819234|449233773|FG004|Overall Study|Physician Decision|0|||
124893717|NCT00819234|449233774|FG005|Overall Study|Physician Decision|0|||
124893718|NCT00819234|449233775|FG006|Overall Study|Physician Decision|0|||
124893719|NCT00819234|449233776|FG007|Overall Study|Physician Decision|0|||
124442882|NCT02202551|447582989|FG001|Overall Study|Worsening Dyskinesia|0|||
124442883|NCT02202551|447582990|FG002|Overall Study|Worsening Dyskinesia|0|||
124442884|NCT02202551|447582991|FG003|Overall Study|Worsening Dyskinesia|1|||
124442885|NCT02202551|447582988|FG000|Overall Study|Protocol Violation|0|||
124442886|NCT02202551|447582989|FG001|Overall Study|Protocol Violation|1|||
124442887|NCT02202551|447582990|FG002|Overall Study|Protocol Violation|0|||
124687465|NCT03317496|448475140|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
124442888|NCT02202551|447582991|FG003|Overall Study|Protocol Violation|0|||
124442889|NCT02202551|447582988|FG000|Overall Study|Sponsor's decision|2|||
124442890|NCT02202551|447582989|FG001|Overall Study|Sponsor's decision|0|||
124442891|NCT02202551|447582990|FG002|Overall Study|Sponsor's decision|0|||
124442892|NCT02202551|447582991|FG003|Overall Study|Sponsor's decision|0|||
124442893|NCT02202551|447582988|FG000|Overall Study|Subject unwilling to proceed|1|||
124442894|NCT02202551|447582989|FG001|Overall Study|Subject unwilling to proceed|5|||
124442895|NCT02202551|447582990|FG002|Overall Study|Subject unwilling to proceed|3|||
124442896|NCT02202551|447582991|FG003|Overall Study|Subject unwilling to proceed|5|||
124442897|NCT02202551|447582988|FG000|Overall Study|Subject consent withdrawn|0|||
124442898|NCT02202551|447582989|FG001|Overall Study|Subject consent withdrawn|3|||
124442899|NCT02202551|447582990|FG002|Overall Study|Subject consent withdrawn|1|||
124442900|NCT02202551|447582991|FG003|Overall Study|Subject consent withdrawn|2|||
124442901|NCT02202551|447582988|FG000|Overall Study|eGFR<50mL/min/m2|2|||
124442902|NCT02202551|447582989|FG001|Overall Study|eGFR<50mL/min/m2|2|||
124442903|NCT02202551|447582990|FG002|Overall Study|eGFR<50mL/min/m2|0|||
124442904|NCT02202551|447582991|FG003|Overall Study|eGFR<50mL/min/m2|1|||
124442905|NCT02147353|447582992|FG000|Overall Study|Lost to Follow-up|2|||
124442906|NCT02147353|447582993|FG001|Overall Study|Lost to Follow-up|0|||
124442907|NCT02147353|447582992|FG000|Overall Study|unable to make visits|4|||
124442908|NCT02147353|447582993|FG001|Overall Study|unable to make visits|0|||
124442909|NCT02147353|447582992|FG000|Overall Study|medication noncompliance|3|||
124442910|NCT02147353|447582993|FG001|Overall Study|medication noncompliance|0|||
124442911|NCT04744285|447583001|FG000|Overall Study|Withdrawal by Subject|1|||
124442912|NCT04744285|447583002|FG001|Overall Study|Withdrawal by Subject|1|||
124442913|NCT04744285|447583003|FG002|Overall Study|Withdrawal by Subject|2|||
124442914|NCT04744285|447583004|FG003|Overall Study|Withdrawal by Subject|1|||
124687466|NCT03317496|448475136|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
124687467|NCT03317496|448475137|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
124687468|NCT03317496|448475138|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
124687469|NCT03317496|448475139|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
124687470|NCT03317496|448475140|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
124687471|NCT03317496|448475136|FG000|Phase 1b Lead-in: Treatment|Death|0|||
124687472|NCT03317496|448475137|FG001|Phase 1b Lead-in: Treatment|Death|0|||
124687473|NCT03317496|448475138|FG002|Phase 1b Lead-in: Treatment|Death|1|||
124687474|NCT03317496|448475139|FG003|Phase 1b Lead-in: Treatment|Death|0|||
124687475|NCT03317496|448475140|FG004|Phase 1b Lead-in: Treatment|Death|0|||
124687476|NCT03317496|448475136|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
124687477|NCT03317496|448475137|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
124687478|NCT03317496|448475138|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
124687479|NCT03317496|448475139|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
124687480|NCT03317496|448475140|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
124687481|NCT03317496|448475136|FG000|Phase 1b Lead-in: Treatment|Other|2|||
124442915|NCT00752622|447583012|FG000|Induction Phase|Adverse Event|3|||
124687482|NCT03317496|448475137|FG001|Phase 1b Lead-in: Treatment|Other|1|||
124687483|NCT03317496|448475138|FG002|Phase 1b Lead-in: Treatment|Other|0|||
124687484|NCT03317496|448475139|FG003|Phase 1b Lead-in: Treatment|Other|0|||
124687485|NCT03317496|448475140|FG004|Phase 1b Lead-in: Treatment|Other|0|||
124893720|NCT00819234|449233777|FG008|Overall Study|Physician Decision|0|||
124893721|NCT00819234|449233778|FG009|Overall Study|Physician Decision|2|||
124893722|NCT00819234|449233769|FG000|Overall Study|Protocol Violation|0|||
124442916|NCT00752622|447583012|FG000|Induction Phase|Other|3|||
124442917|NCT00752622|447583012|FG000|Induction Phase|Non-responder|14|||
124442918|NCT00752622|447583012|FG000|Induction Phase|Withdrawal by Subject|1|||
124442919|NCT00752622|447583012|FG000|Induction Phase|Premature study termination|14|||
124442920|NCT00752622|447583012|FG000|Observational Phase|Premature Study Termination|36|||
124442921|NCT00752622|447583012|FG000|Observational Phase|Non-responder|2|||
124442922|NCT00752622|447583012|FG000|Observational Phase|Withdrawal by Subject|2|||
124893723|NCT00819234|449233770|FG001|Overall Study|Protocol Violation|0|||
124893724|NCT00819234|449233771|FG002|Overall Study|Protocol Violation|1|||
124893725|NCT00819234|449233772|FG003|Overall Study|Protocol Violation|0|||
124893726|NCT00819234|449233773|FG004|Overall Study|Protocol Violation|0|||
124893727|NCT00819234|449233774|FG005|Overall Study|Protocol Violation|0|||
124893728|NCT00819234|449233775|FG006|Overall Study|Protocol Violation|0|||
124893729|NCT00819234|449233776|FG007|Overall Study|Protocol Violation|0|||
124893730|NCT00819234|449233777|FG008|Overall Study|Protocol Violation|0|||
124893731|NCT00819234|449233778|FG009|Overall Study|Protocol Violation|0|||
124893732|NCT00819234|449233769|FG000|Overall Study|Lost to Follow-up|2|||
124893733|NCT00819234|449233770|FG001|Overall Study|Lost to Follow-up|2|||
124893734|NCT00819234|449233771|FG002|Overall Study|Lost to Follow-up|0|||
124893735|NCT00819234|449233772|FG003|Overall Study|Lost to Follow-up|2|||
124893736|NCT00819234|449233773|FG004|Overall Study|Lost to Follow-up|1|||
124893737|NCT00819234|449233774|FG005|Overall Study|Lost to Follow-up|1|||
124893738|NCT00819234|449233775|FG006|Overall Study|Lost to Follow-up|1|||
124893739|NCT00819234|449233776|FG007|Overall Study|Lost to Follow-up|1|||
124893740|NCT00819234|449233777|FG008|Overall Study|Lost to Follow-up|1|||
124893741|NCT00819234|449233778|FG009|Overall Study|Lost to Follow-up|2|||
124893742|NCT05174065|449233779|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
124893743|NCT05174065|449233780|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
124893744|NCT05174065|449233781|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
124893745|NCT05174065|449233779|FG000|Placebo-controlled Period|Other|0|||
124893746|NCT05174065|449233780|FG001|Placebo-controlled Period|Other|1|||
124893747|NCT05174065|449233781|FG002|Placebo-controlled Period|Other|0|||
124893748|NCT05174065|449233779|FG000|Placebo-controlled Period|Adverse Event|1|||
124893749|NCT05174065|449233780|FG001|Placebo-controlled Period|Adverse Event|1|||
124893750|NCT05174065|449233781|FG002|Placebo-controlled Period|Adverse Event|0|||
124893751|NCT05174065|449233779|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
124893752|NCT05174065|449233780|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
124893753|NCT05174065|449233781|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
124893754|NCT05174065|449233779|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
124893755|NCT05174065|449233780|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
124893756|NCT05174065|449233781|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
124893757|NCT05174065|449233779|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
124893758|NCT05174065|449233780|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
124893759|NCT05174065|449233781|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
124893760|NCT00924560|449233785|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
124893761|NCT00924560|449233786|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
124893762|NCT00924560|449233787|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
124893763|NCT00924560|449233785|FG000|Overall Study|Non Compliance with the Protocol|20|||
124893764|NCT00924560|449233786|FG001|Overall Study|Non Compliance with the Protocol|15|||
124893765|NCT00924560|449233787|FG002|Overall Study|Non Compliance with the Protocol|4|||
124893766|NCT00924560|449233785|FG000|Overall Study|Physician Decision|2|||
124893767|NCT00924560|449233786|FG001|Overall Study|Physician Decision|3|||
124893768|NCT00924560|449233787|FG002|Overall Study|Physician Decision|4|||
124893769|NCT00924560|449233785|FG000|Overall Study|Withdrawal by Subject|50|||
124893770|NCT00924560|449233786|FG001|Overall Study|Withdrawal by Subject|44|||
124893771|NCT00924560|449233787|FG002|Overall Study|Withdrawal by Subject|18|||
124893772|NCT00924560|449233785|FG000|Overall Study|Adverse Event|39|||
124893773|NCT00924560|449233786|FG001|Overall Study|Adverse Event|33|||
124893774|NCT00924560|449233787|FG002|Overall Study|Adverse Event|0|||
124893775|NCT00924560|449233785|FG000|Overall Study|Pregnancy|5|||
124893776|NCT00924560|449233786|FG001|Overall Study|Pregnancy|7|||
124893777|NCT00924560|449233787|FG002|Overall Study|Pregnancy|1|||
124893778|NCT00924560|449233785|FG000|Overall Study|Lost to Follow-up|78|||
124893779|NCT00924560|449233786|FG001|Overall Study|Lost to Follow-up|94|||
124893780|NCT00924560|449233787|FG002|Overall Study|Lost to Follow-up|45|||
124893781|NCT00924560|449233785|FG000|Overall Study|Miscellaneous Reasons|13|||
124893782|NCT00924560|449233786|FG001|Overall Study|Miscellaneous Reasons|10|||
124893783|NCT00924560|449233787|FG002|Overall Study|Miscellaneous Reasons|10|||
124893784|NCT02696226|449233789|FG000|Overall Study|Study terminated - lack of enrollment|1|||
124893785|NCT02696226|449233790|FG001|Overall Study|Study terminated - lack of enrollment|0|||
124893786|NCT02696226|449233791|FG002|Overall Study|Study terminated - lack of enrollment|2|||
124893787|NCT02696226|449233792|FG003|Overall Study|Study terminated - lack of enrollment|0|||
124893788|NCT02909101|449233800|FG000|Overall Study|Lost to Follow-up|1|||
124893789|NCT02909101|449233801|FG001|Overall Study|Lost to Follow-up|1|||
124893790|NCT01221181|449233806|FG000|Overall Study|Lost to Follow-up|1|||
124893791|NCT00429793|449233811|FG000|Overall Study|Improper pre-protocol treatment|3|||
124893792|NCT00429793|449233811|FG000|Overall Study|Required test not done|1|||
124893793|NCT00429793|449233811|FG000|Overall Study|Never treated|1|||
124893794|NCT00429793|449233811|FG000|Overall Study|Non-measurable|1|||
124893795|NCT00097370|449233812|FG000|Stage 1|Adverse Event|3|||
124893796|NCT00097370|449233812|FG000|Stage 1|Withdrawal by Subject|1|||
124893797|NCT00097370|449233812|FG000|Stage 1|Lack of Efficacy|2|||
124893798|NCT00097370|449233812|FG000|Stage 2|Adverse Event|5|||
124893799|NCT00097370|449233812|FG000|Stage 2|Withdrawal by Subject|1|||
124893800|NCT00097370|449233812|FG000|Stage 2|Lack of Efficacy|3|||
124893801|NCT00097370|449233812|FG000|Stage 2|Pregnancy|1|||
124893802|NCT00097370|449233812|FG000|Stage 2|Sponsor Terminated Study|2|||
124893803|NCT00097370|449233812|FG000|Stage 2|Lost to Follow-up|1|||
124893804|NCT00097370|449233812|FG000|Stage 3|Adverse Event|2|||
124893805|NCT00097370|449233812|FG000|Stage 3|Withdrawal by Subject|3|||
124893806|NCT00097370|449233812|FG000|Stage 3|Lack of Efficacy|1|||
124893807|NCT00097370|449233812|FG000|Stage 3|Sponsor Terminated Study|52|||
124893808|NCT00097370|449233812|FG000|Stage 3|Lost to Follow-up|1|||
124442923|NCT00752622|447583012|FG000|Observational Phase|Adverse Event|1|||
124442924|NCT00752622|447583012|FG000|Observational Phase|Other|2|||
124442925|NCT00752622|447583012|FG000|Interventional Phase|Non-responder|2|||
124442926|NCT00752622|447583012|FG000|Interventional Phase|Physician Decision|1|||
124442927|NCT00752622|447583012|FG000|Interventional Phase|Premature Study Termination|5|||
124442928|NCT00576836|447583013|FG000|Overall Study|Death|0|||
124442929|NCT00576836|447583014|FG001|Overall Study|Death|1|||
124442930|NCT00576836|447583013|FG000|Overall Study|Physician Decision|0|||
124442931|NCT00576836|447583014|FG001|Overall Study|Physician Decision|1|||
124442932|NCT02520284|447583015|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
124442933|NCT02520284|447583016|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
124442934|NCT02520284|447583017|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
124442935|NCT02520284|447583015|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
124442936|NCT02520284|447583016|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
124442937|NCT02520284|447583017|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
124442938|NCT02520284|447583015|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
124442939|NCT02520284|447583016|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
124442940|NCT02520284|447583017|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
124442941|NCT02520284|447583015|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
124442942|NCT02520284|447583016|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
124442943|NCT02520284|447583017|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
124442944|NCT02520284|447583015|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
124442945|NCT02520284|447583016|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
124442946|NCT02520284|447583017|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
124442947|NCT02520284|447583015|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
124442948|NCT02520284|447583016|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
124442949|NCT02520284|447583017|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
124442950|NCT02520284|447583015|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
124442951|NCT02520284|447583016|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
124442952|NCT02520284|447583017|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
124442953|NCT02520284|447583015|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
124442954|NCT02520284|447583016|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
124442955|NCT02520284|447583017|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
124442956|NCT02520284|447583015|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
124442957|NCT02520284|447583016|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
124442958|NCT02520284|447583017|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
124442959|NCT02520284|447583015|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
124442960|NCT02520284|447583016|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
124442961|NCT02520284|447583017|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
124442962|NCT02520284|447583015|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
124442963|NCT02520284|447583016|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
124442964|NCT02520284|447583017|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
124442965|NCT01211522|447583021|FG000|Overall Study|Withdrawal by Subject|3|||
124442966|NCT01211522|447583022|FG001|Overall Study|Withdrawal by Subject|7|||
124893809|NCT02337361|449233814|FG000|3-month Follow-up|Lost to Follow-up|19|||
124893810|NCT02337361|449233815|FG001|3-month Follow-up|Lost to Follow-up|14|||
124893811|NCT02337361|449233814|FG000|6-month Follow-up|Lost to Follow-up|2|||
124893812|NCT02337361|449233815|FG001|6-month Follow-up|Lost to Follow-up|4|||
124893813|NCT02419755|449233816|FG000|Overall Study|Death|1|||
124893814|NCT02419755|449233817|FG001|Overall Study|Death|3|||
124893815|NCT02419755|449233816|FG000|Overall Study|Relapse|0|||
124893816|NCT02419755|449233817|FG001|Overall Study|Relapse|1|||
124893817|NCT02419755|449233816|FG000|Overall Study|Ineligible|1|||
124893818|NCT02419755|449233817|FG001|Overall Study|Ineligible|0|||
124893819|NCT02419755|449233816|FG000|Overall Study|Withdrawal by Subject|1|||
124442967|NCT01211522|447583023|FG002|Overall Study|Withdrawal by Subject|5|||
124442968|NCT01116882|447583029|FG000|30-day|Lost to Follow-up|50|||
124442969|NCT01116882|447583030|FG001|30-day|Lost to Follow-up|21|||
124442970|NCT01116882|447583029|FG000|30-day|Withdrawal by Subject|2|||
124442971|NCT01116882|447583030|FG001|30-day|Withdrawal by Subject|4|||
124442972|NCT01116882|447583029|FG000|30-day|Other Reasons|16|||
124442973|NCT01116882|447583030|FG001|30-day|Other Reasons|6|||
124442974|NCT01116882|447583029|FG000|12-month|Lost to Follow-up|111|||
124442975|NCT01116882|447583030|FG001|12-month|Lost to Follow-up|42|||
124442976|NCT01116882|447583029|FG000|12-month|Other Reasons|151|||
124442977|NCT01116882|447583030|FG001|12-month|Other Reasons|49|||
124442978|NCT01116882|447583029|FG000|12-month|Withdrawal by Subject|5|||
124442979|NCT01116882|447583030|FG001|12-month|Withdrawal by Subject|8|||
124893820|NCT02419755|449233817|FG001|Overall Study|Withdrawal by Subject|0|||
124893821|NCT02427646|449233818|FG000|Overall Study|Lack of Efficacy|2|||
124893822|NCT02427646|449233819|FG001|Overall Study|Lack of Efficacy|3|||
124893823|NCT02427646|449233818|FG000|Overall Study|Physician Decision|1|||
124893824|NCT02427646|449233819|FG001|Overall Study|Physician Decision|4|||
124893825|NCT02427646|449233818|FG000|Overall Study|Protocol Violation|3|||
124893826|NCT02427646|449233819|FG001|Overall Study|Protocol Violation|3|||
124893827|NCT02427646|449233818|FG000|Overall Study|Bothersome hand weakness|2|||
124893828|NCT02427646|449233819|FG001|Overall Study|Bothersome hand weakness|4|||
124893829|NCT01101542|449233820|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
124893830|NCT01101542|449233820|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
124893831|NCT01101542|449233820|FG000|Year 4 Surveillance Period|Other|287|||
124893832|NCT01101542|449233820|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
124893833|NCT01101542|449233820|FG000|Year 5 Surveillance Period|Pregnancy|1|||
124893834|NCT01101542|449233820|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
124893835|NCT01101542|449233820|FG000|Year 6 Surveillance Period|Pregnancy|1|||
124893836|NCT01101542|449233820|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
124893837|NCT02268396|449235669|FG000|Overall Study|Adverse Event|3|||
124893838|NCT02268396|449235669|FG000|Overall Study|Administrative|2|||
124893839|NCT02268396|449235669|FG000|Overall Study|Withdrawal by Subject|1|||
124893840|NCT02268396|449235669|FG000|Overall Study|Lost to Follow-up|2|||
124893841|NCT02268396|449235669|FG000|Overall Study|Protocol-Specified Criteria|2|||
124893842|NCT02268396|449235669|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
124893843|NCT03660943|449235670|FG000|Overall Study|Adverse Event|5|||
124893844|NCT03660943|449235671|FG001|Overall Study|Adverse Event|3|||
124893845|NCT03660943|449235670|FG000|Overall Study|Death|0|||
124893846|NCT03660943|449235671|FG001|Overall Study|Death|2|||
124893847|NCT03660943|449235670|FG000|Overall Study|Lost to Follow-up|7|||
124893848|NCT03660943|449235671|FG001|Overall Study|Lost to Follow-up|3|||
124893849|NCT03660943|449235670|FG000|Overall Study|Protocol Violation|3|||
124893850|NCT03660943|449235671|FG001|Overall Study|Protocol Violation|5|||
124893851|NCT03660943|449235670|FG000|Overall Study|Withdrawal by Subject|8|||
124893852|NCT03660943|449235671|FG001|Overall Study|Withdrawal by Subject|15|||
124893853|NCT03660943|449235670|FG000|Overall Study|Lack of Efficacy|9|||
124893854|NCT03660943|449235671|FG001|Overall Study|Lack of Efficacy|12|||
124893855|NCT03660943|449235670|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
124893856|NCT03660943|449235671|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
124893857|NCT02491411|449235674|FG000|Overall Study|Physician Decision|4|||
124893858|NCT04034238|449235675|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
124893859|NCT04034238|449235676|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
124893860|NCT04034238|449235677|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
124893861|NCT04034238|449235678|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
124893862|NCT04034238|449235675|FG000|Dose Escalation Phase|Screen failures|0|||
124893863|NCT04034238|449235676|FG001|Dose Escalation Phase|Screen failures|0|||
124893864|NCT04034238|449235677|FG002|Dose Escalation Phase|Screen failures|0|||
124893865|NCT04034238|449235678|FG003|Dose Escalation Phase|Screen failures|2|||
124893866|NCT04034238|449235675|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
124442980|NCT00547365|447583031|FG000|Overall Study|Physician Decision|1|||
124442981|NCT00547365|447583031|FG000|Overall Study|Lost to Follow-up|1|||
124893867|NCT04034238|449235676|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
124893868|NCT04034238|449235677|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
124893869|NCT04034238|449235678|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
124893870|NCT04034238|449235675|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
124893871|NCT04034238|449235676|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
124893872|NCT04034238|449235677|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
124442982|NCT00547365|447583031|FG000|Overall Study|Protocol Violation|2|||
124442983|NCT00547365|447583031|FG000|Overall Study|death (not related to study)|4|||
124442984|NCT01139658|447583032|FG000|Overall Study|Adverse Event|10|||
124893873|NCT04034238|449235678|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
124893874|NCT01939158|449235679|FG000|Overall Study|Adverse Event|1|||
124893875|NCT01939158|449235680|FG001|Overall Study|Adverse Event|0|||
124442985|NCT01139658|447583033|FG001|Overall Study|Adverse Event|27|||
124893876|NCT01939158|449235681|FG002|Overall Study|Adverse Event|0|||
124893877|NCT01939158|449235682|FG003|Overall Study|Adverse Event|0|||
124893878|NCT01939158|449235679|FG000|Overall Study|Withdrawal by Subject|22|||
124893879|NCT01939158|449235680|FG001|Overall Study|Withdrawal by Subject|25|||
124893880|NCT01939158|449235681|FG002|Overall Study|Withdrawal by Subject|15|||
124893881|NCT01939158|449235682|FG003|Overall Study|Withdrawal by Subject|17|||
124893882|NCT01939158|449235679|FG000|Overall Study|Migrated/moved from study area|5|||
124893883|NCT01939158|449235680|FG001|Overall Study|Migrated/moved from study area|7|||
124893884|NCT01939158|449235681|FG002|Overall Study|Migrated/moved from study area|3|||
124893885|NCT01939158|449235682|FG003|Overall Study|Migrated/moved from study area|6|||
124893886|NCT01939158|449235679|FG000|Overall Study|Lost to Follow-up|18|||
124893887|NCT01939158|449235680|FG001|Overall Study|Lost to Follow-up|17|||
124442986|NCT01139658|447583032|FG000|Overall Study|Lack of Efficacy|15|||
124442987|NCT01139658|447583033|FG001|Overall Study|Lack of Efficacy|7|||
124442988|NCT01139658|447583032|FG000|Overall Study|Withdrawal by Subject|2|||
124442989|NCT01139658|447583033|FG001|Overall Study|Withdrawal by Subject|4|||
124442990|NCT01139658|447583032|FG000|Overall Study|No documentation of treatment|1|||
124442991|NCT01139658|447583033|FG001|Overall Study|No documentation of treatment|0|||
124442992|NCT01139658|447583032|FG000|Overall Study|Other|28|||
124442993|NCT01139658|447583033|FG001|Overall Study|Other|75|||
124442994|NCT00504881|447583034|FG000|Overall Study|Lack of Efficacy|1|||
124442995|NCT00504881|447583035|FG001|Overall Study|Lack of Efficacy|5|||
124442996|NCT00504881|447583034|FG000|Overall Study|Lost to Follow-up|0|||
124442997|NCT00504881|447583035|FG001|Overall Study|Lost to Follow-up|2|||
124442998|NCT00504881|447583034|FG000|Overall Study|Withdrawal by Subject|1|||
124442999|NCT00504881|447583035|FG001|Overall Study|Withdrawal by Subject|4|||
124443000|NCT00504881|447583034|FG000|Overall Study|Non-Compliance|1|||
124443001|NCT00504881|447583035|FG001|Overall Study|Non-Compliance|0|||
124443002|NCT00504881|447583034|FG000|Overall Study|No Birth Control|0|||
124443003|NCT00504881|447583035|FG001|Overall Study|No Birth Control|1|||
124443004|NCT00504881|447583034|FG000|Overall Study|Safety Visit not performed|0|||
124443005|NCT00504881|447583035|FG001|Overall Study|Safety Visit not performed|1|||
124443006|NCT00504881|447583034|FG000|Overall Study|AE, serious fatal|0|||
124443007|NCT00504881|447583035|FG001|Overall Study|AE, serious fatal|1|||
124443008|NCT00504881|447583034|FG000|Overall Study|SAE, non-fatal|2|||
124443009|NCT00504881|447583035|FG001|Overall Study|SAE, non-fatal|6|||
124443010|NCT00504881|447583034|FG000|Overall Study|AE, non-serious non-fatal|4|||
124443011|NCT00504881|447583035|FG001|Overall Study|AE, non-serious non-fatal|14|||
124443012|NCT00504881|447583034|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
124443013|NCT00504881|447583035|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
124443014|NCT00504881|447583034|FG000|Overall Study|AE of unknown type|1|||
124443015|NCT00504881|447583035|FG001|Overall Study|AE of unknown type|0|||
124443016|NCT01777269|447583036|FG000|Overall Study|Adverse Event|24|||
124443017|NCT01777269|447583037|FG001|Overall Study|Adverse Event|33|||
124443018|NCT01777269|447583036|FG000|Overall Study|Lack of Efficacy|8|||
124443019|NCT01777269|447583037|FG001|Overall Study|Lack of Efficacy|10|||
124443020|NCT01777269|447583036|FG000|Overall Study|Protocol Violation|4|||
124443021|NCT01777269|447583037|FG001|Overall Study|Protocol Violation|4|||
124443022|NCT01777269|447583036|FG000|Overall Study|Participants reached stopping criteria|1|||
124443023|NCT01777269|447583037|FG001|Overall Study|Participants reached stopping criteria|1|||
124443024|NCT01777269|447583036|FG000|Overall Study|Lost to Follow-up|4|||
124443025|NCT01777269|447583037|FG001|Overall Study|Lost to Follow-up|0|||
124443026|NCT01777269|447583036|FG000|Overall Study|Physician Decision|5|||
124443027|NCT01777269|447583037|FG001|Overall Study|Physician Decision|2|||
124443028|NCT01777269|447583036|FG000|Overall Study|Withdrawal by Subject|9|||
124443029|NCT01777269|447583037|FG001|Overall Study|Withdrawal by Subject|9|||
124443030|NCT00803270|447583039|FG000|Overall Study|Lost to Follow-up|1|||
124443031|NCT00803270|447583040|FG001|Overall Study|Lost to Follow-up|2|||
124443032|NCT00593957|447583044|FG000|Overall Study|Physician Decision|0|||
124443033|NCT00593957|447583045|FG001|Overall Study|Physician Decision|1|||
124443034|NCT00593957|447583046|FG002|Overall Study|Physician Decision|2|||
124443035|NCT03707925|447583049|FG000|Overall Study|Inevaluable|1|||
124443036|NCT02511678|447583052|FG000|Overall Study|Withdrawal by Subject|2|||
124443037|NCT02511678|447583052|FG000|Overall Study|Lost to Follow-up|4|||
124893888|NCT01939158|449235681|FG002|Overall Study|Lost to Follow-up|17|||
124443038|NCT02511678|447583052|FG000|Overall Study|Death|19|||
124893889|NCT01939158|449235682|FG003|Overall Study|Lost to Follow-up|17|||
124893890|NCT01939158|449235679|FG000|Overall Study|Death|0|||
124893891|NCT01939158|449235680|FG001|Overall Study|Death|0|||
124759335|NCT01611194|448742616|FG000|Overall Study|Withdrawal by Subject|0|||
124893892|NCT01939158|449235681|FG002|Overall Study|Death|1|||
124893893|NCT01939158|449235682|FG003|Overall Study|Death|1|||
124443039|NCT02511678|447583052|FG000|Overall Study|Adverse Event|1|||
124443040|NCT02511678|447583052|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
124443041|NCT02511678|447583052|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
124443042|NCT02511678|447583052|FG000|Overall Study|Required Radiofrequency Ablation|1|||
124443043|NCT02511678|447583052|FG000|Overall Study|Biopsy was Negative|1|||
124893894|NCT01939158|449235679|FG000|Overall Study|No longer meets eligibility criteria|0|||
124893895|NCT01939158|449235680|FG001|Overall Study|No longer meets eligibility criteria|0|||
124893896|NCT01939158|449235681|FG002|Overall Study|No longer meets eligibility criteria|1|||
124893897|NCT01939158|449235682|FG003|Overall Study|No longer meets eligibility criteria|0|||
124893898|NCT01939158|449235679|FG000|Overall Study|Other|1|||
124893899|NCT01939158|449235680|FG001|Overall Study|Other|3|||
124893900|NCT01939158|449235681|FG002|Overall Study|Other|4|||
124893901|NCT01939158|449235682|FG003|Overall Study|Other|3|||
124893902|NCT02065245|449235683|FG000|Infusion 1|Lost to Follow-up|0|||
124893903|NCT02065245|449235684|FG001|Infusion 1|Lost to Follow-up|0|||
124893904|NCT02065245|449235685|FG002|Infusion 1|Lost to Follow-up|0|||
124893905|NCT02065245|449235686|FG003|Infusion 1|Lost to Follow-up|0|||
124893906|NCT02065245|449235687|FG004|Infusion 1|Lost to Follow-up|0|||
124893907|NCT02065245|449235688|FG005|Infusion 1|Lost to Follow-up|0|||
124893908|NCT02065245|449235689|FG006|Infusion 1|Lost to Follow-up|1|||
124893909|NCT02065245|449235683|FG000|Infusion 1|Death|0|||
124893910|NCT02065245|449235684|FG001|Infusion 1|Death|0|||
124893911|NCT02065245|449235685|FG002|Infusion 1|Death|1|||
124893912|NCT02065245|449235686|FG003|Infusion 1|Death|0|||
124893913|NCT02065245|449235687|FG004|Infusion 1|Death|1|||
124893914|NCT02065245|449235688|FG005|Infusion 1|Death|0|||
124893915|NCT02065245|449235689|FG006|Infusion 1|Death|0|||
124893916|NCT02065245|449235683|FG000|Infusion 2|Death|0|||
124893917|NCT02065245|449235684|FG001|Infusion 2|Death|0|||
124893918|NCT02065245|449235685|FG002|Infusion 2|Death|0|||
124893919|NCT02065245|449235686|FG003|Infusion 2|Death|0|||
124893920|NCT02065245|449235687|FG004|Infusion 2|Death|0|||
124893921|NCT02065245|449235688|FG005|Infusion 2|Death|0|||
124893922|NCT02065245|449235689|FG006|Infusion 2|Death|1|||
124893923|NCT02065245|449235683|FG000|Infusion 3|Lost to Follow-up|1|||
124893924|NCT02065245|449235684|FG001|Infusion 3|Lost to Follow-up|1|||
124893925|NCT02065245|449235685|FG002|Infusion 3|Lost to Follow-up|0|||
124893926|NCT02065245|449235686|FG003|Infusion 3|Lost to Follow-up|0|||
124893927|NCT02065245|449235687|FG004|Infusion 3|Lost to Follow-up|0|||
124893928|NCT02065245|449235688|FG005|Infusion 3|Lost to Follow-up|0|||
124893929|NCT02065245|449235689|FG006|Infusion 3|Lost to Follow-up|0|||
124893930|NCT01304706|449235690|FG000|Overall Study|Adverse Event|2|||
124893931|NCT01304706|449235690|FG000|Overall Study|Lack of Efficacy|1|||
124893932|NCT01304706|449235690|FG000|Overall Study|Death|3|||
124893933|NCT01304706|449235690|FG000|Overall Study|Withdrawal by Subject|3|||
124893934|NCT01304706|449235690|FG000|Overall Study|Lost to Follow-up|7|||
124893935|NCT01304706|449235690|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
124893936|NCT01345292|449235693|FG000|Overall Study|Withdrawal by Subject|2|||
124893937|NCT01345292|449235694|FG001|Overall Study|Withdrawal by Subject|0|||
124893938|NCT01345292|449235695|FG002|Overall Study|Withdrawal by Subject|1|||
124893939|NCT01033643|449235698|FG000|Overall Study|Withdrew Consent|0|||
124893940|NCT01033643|449235699|FG001|Overall Study|Withdrew Consent|3|||
124893941|NCT01033643|449235700|FG002|Overall Study|Withdrew Consent|0|||
124893942|NCT01033643|449235701|FG003|Overall Study|Withdrew Consent|0|||
124893943|NCT01033643|449235702|FG004|Overall Study|Withdrew Consent|0|||
124893944|NCT01033643|449235703|FG005|Overall Study|Withdrew Consent|1|||
124893945|NCT02271594|449235713|FG000|Overall Study|Study closed; recruiting failure|19|||
124893946|NCT02271594|449235714|FG001|Overall Study|Study closed; recruiting failure|12|||
124893947|NCT00495469|449235715|FG000|Overall Study|Adverse Event|0|||
124893948|NCT00495469|449235716|FG001|Overall Study|Adverse Event|1|||
124893949|NCT00495469|449235717|FG002|Overall Study|Adverse Event|3|||
124893950|NCT00495469|449235718|FG003|Overall Study|Adverse Event|0|||
124893951|NCT00495469|449235719|FG004|Overall Study|Adverse Event|1|||
124893952|NCT00495469|449235720|FG005|Overall Study|Adverse Event|1|||
124893953|NCT00495469|449235721|FG006|Overall Study|Adverse Event|1|||
124893954|NCT00495469|449235715|FG000|Overall Study|Lost to Follow-up|1|||
124893955|NCT00495469|449235716|FG001|Overall Study|Lost to Follow-up|1|||
124893956|NCT00495469|449235717|FG002|Overall Study|Lost to Follow-up|3|||
124893957|NCT00495469|449235718|FG003|Overall Study|Lost to Follow-up|1|||
124893958|NCT00495469|449235719|FG004|Overall Study|Lost to Follow-up|0|||
124893959|NCT00495469|449235720|FG005|Overall Study|Lost to Follow-up|0|||
124893960|NCT00495469|449235721|FG006|Overall Study|Lost to Follow-up|0|||
124893961|NCT00495469|449235715|FG000|Overall Study|Protocol Violation|0|||
124893962|NCT00495469|449235716|FG001|Overall Study|Protocol Violation|0|||
124893963|NCT00495469|449235717|FG002|Overall Study|Protocol Violation|0|||
124893964|NCT00495469|449235718|FG003|Overall Study|Protocol Violation|0|||
124893965|NCT00495469|449235719|FG004|Overall Study|Protocol Violation|1|||
124893966|NCT00495469|449235720|FG005|Overall Study|Protocol Violation|2|||
124893967|NCT00495469|449235721|FG006|Overall Study|Protocol Violation|0|||
124893968|NCT00495469|449235715|FG000|Overall Study|Withdrawal by Subject|5|||
124893969|NCT00495469|449235716|FG001|Overall Study|Withdrawal by Subject|3|||
124893970|NCT00495469|449235717|FG002|Overall Study|Withdrawal by Subject|1|||
124893971|NCT00495469|449235718|FG003|Overall Study|Withdrawal by Subject|3|||
124893972|NCT00495469|449235719|FG004|Overall Study|Withdrawal by Subject|3|||
124893973|NCT00495469|449235720|FG005|Overall Study|Withdrawal by Subject|2|||
124893974|NCT00495469|449235721|FG006|Overall Study|Withdrawal by Subject|3|||
124893975|NCT00495469|449235715|FG000|Overall Study|Lack of Efficacy|0|||
124893976|NCT00495469|449235716|FG001|Overall Study|Lack of Efficacy|0|||
124893977|NCT00495469|449235717|FG002|Overall Study|Lack of Efficacy|0|||
124893978|NCT00495469|449235718|FG003|Overall Study|Lack of Efficacy|0|||
124443044|NCT02511678|447583052|FG000|Overall Study|Protocol Violation|1|||
124893979|NCT00495469|449235719|FG004|Overall Study|Lack of Efficacy|0|||
124893980|NCT00495469|449235720|FG005|Overall Study|Lack of Efficacy|0|||
124893981|NCT00495469|449235721|FG006|Overall Study|Lack of Efficacy|1|||
124893982|NCT00495469|449235715|FG000|Overall Study|Liver function test abnormality|0|||
124893983|NCT00495469|449235716|FG001|Overall Study|Liver function test abnormality|1|||
124893984|NCT00495469|449235717|FG002|Overall Study|Liver function test abnormality|0|||
124893985|NCT00495469|449235718|FG003|Overall Study|Liver function test abnormality|0|||
124893986|NCT00495469|449235719|FG004|Overall Study|Liver function test abnormality|0|||
124893987|NCT00495469|449235720|FG005|Overall Study|Liver function test abnormality|0|||
124893988|NCT00495469|449235721|FG006|Overall Study|Liver function test abnormality|0|||
124893989|NCT00495469|449235715|FG000|Overall Study|ST depression at randomisation in ECG|0|||
124893990|NCT00495469|449235716|FG001|Overall Study|ST depression at randomisation in ECG|1|||
124893991|NCT00495469|449235717|FG002|Overall Study|ST depression at randomisation in ECG|0|||
124893992|NCT00495469|449235718|FG003|Overall Study|ST depression at randomisation in ECG|0|||
124893993|NCT00495469|449235719|FG004|Overall Study|ST depression at randomisation in ECG|0|||
124893994|NCT00495469|449235720|FG005|Overall Study|ST depression at randomisation in ECG|0|||
124893995|NCT00495469|449235721|FG006|Overall Study|ST depression at randomisation in ECG|0|||
124893996|NCT00448864|449235724|FG000|Overall Study|Death|1|||
124893997|NCT00448864|449235725|FG001|Overall Study|Death|0|||
124893998|NCT00448864|449235726|FG002|Overall Study|Death|0|||
124893999|NCT00448864|449235724|FG000|Overall Study|Lost to Follow-up|3|||
124894000|NCT00448864|449235725|FG001|Overall Study|Lost to Follow-up|1|||
124894001|NCT00448864|449235726|FG002|Overall Study|Lost to Follow-up|0|||
124894002|NCT00448864|449235724|FG000|Overall Study|Physician Decision|1|||
124894003|NCT00448864|449235725|FG001|Overall Study|Physician Decision|0|||
124894004|NCT00448864|449235726|FG002|Overall Study|Physician Decision|1|||
124894005|NCT00448864|449235724|FG000|Overall Study|Withdrawal by Subject|0|||
124894006|NCT00448864|449235725|FG001|Overall Study|Withdrawal by Subject|2|||
124894007|NCT00448864|449235726|FG002|Overall Study|Withdrawal by Subject|0|||
124894008|NCT00448864|449235724|FG000|Overall Study|Protocol Violation|0|||
124894009|NCT00448864|449235725|FG001|Overall Study|Protocol Violation|2|||
124894010|NCT00448864|449235726|FG002|Overall Study|Protocol Violation|0|||
124894011|NCT01323660|449235727|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
124894012|NCT01323660|449235728|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
124894013|NCT01323660|449235729|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
124894014|NCT01323660|449235730|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
124894015|NCT01323660|449235731|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
124894016|NCT01323660|449235732|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
124894017|NCT01323660|449235727|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
124894018|NCT01323660|449235728|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
124894019|NCT01323660|449235729|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
124894020|NCT01323660|449235730|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
124894021|NCT01323660|449235731|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
124894022|NCT01323660|449235732|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
124894023|NCT01323660|449235727|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
124894024|NCT01323660|449235728|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
124894025|NCT01323660|449235729|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
124894026|NCT01323660|449235730|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
124894027|NCT01323660|449235731|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
124894028|NCT01323660|449235732|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
124894029|NCT01323660|449235727|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
124894030|NCT01323660|449235728|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
124894031|NCT01323660|449235729|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
124894032|NCT01323660|449235730|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
124894033|NCT01323660|449235731|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
124894034|NCT01323660|449235732|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
124894035|NCT01323660|449235727|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124894036|NCT01323660|449235728|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124894037|NCT01323660|449235729|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124894038|NCT01323660|449235730|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124894039|NCT01323660|449235731|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
124894040|NCT01323660|449235732|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124894041|NCT01323660|449235727|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
124894042|NCT01323660|449235728|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
124894043|NCT01323660|449235729|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
124894044|NCT01323660|449235730|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
124894045|NCT01323660|449235731|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
124894046|NCT01323660|449235732|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
124894047|NCT01323660|449235727|FG000|Washout Period (14 Days)|Adverse Event|0|||
124894048|NCT01323660|449235728|FG001|Washout Period (14 Days)|Adverse Event|0|||
124894049|NCT01323660|449235729|FG002|Washout Period (14 Days)|Adverse Event|0|||
124894050|NCT01323660|449235730|FG003|Washout Period (14 Days)|Adverse Event|0|||
124894051|NCT01323660|449235731|FG004|Washout Period (14 Days)|Adverse Event|1|||
124894052|NCT01323660|449235732|FG005|Washout Period (14 Days)|Adverse Event|0|||
124894053|NCT01323660|449235727|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
124894054|NCT01323660|449235728|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
124894055|NCT01323660|449235729|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
124894056|NCT01323660|449235730|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
124894057|NCT01323660|449235731|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
124894058|NCT01323660|449235732|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
124894059|NCT01323660|449235727|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
124894060|NCT01323660|449235728|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
124894061|NCT01323660|449235729|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
124894062|NCT01323660|449235730|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
124894063|NCT01323660|449235731|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
124894064|NCT01323660|449235732|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
124894065|NCT01323660|449235727|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
124894066|NCT01323660|449235728|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
124894067|NCT01323660|449235729|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
124894068|NCT01323660|449235730|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
124894069|NCT01323660|449235731|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
124894070|NCT01323660|449235732|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
124894071|NCT01323660|449235727|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
124894072|NCT01323660|449235728|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
124894073|NCT01323660|449235729|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
124894074|NCT01323660|449235730|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
124894075|NCT01323660|449235731|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
124894076|NCT01323660|449235732|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
124894077|NCT01323660|449235727|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
124894078|NCT01323660|449235728|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
124894079|NCT01323660|449235729|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
124894080|NCT01323660|449235730|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
124894081|NCT01323660|449235731|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
124894082|NCT01323660|449235732|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
124894083|NCT01323660|449235727|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
124894084|NCT01323660|449235728|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
124894085|NCT01323660|449235729|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
124894086|NCT01323660|449235730|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124894087|NCT01323660|449235731|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
124894088|NCT01323660|449235732|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124894089|NCT04531540|449235735|FG000|Overall Study|Adverse Event|1|||
124894090|NCT04531540|449235735|FG000|Overall Study|Protocol Violation|3|||
124894091|NCT04531540|449235735|FG000|Overall Study|Withdrawal by Subject|4|||
124894092|NCT04531540|449235735|FG000|Overall Study|Found to be Ineligible|1|||
124894093|NCT01575860|449235738|FG000|Overall Study|Withdrawal by Subject|1|||
124894094|NCT01575860|449235738|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
124894095|NCT03606460|449235739|FG000|Overall Study|Lost to Follow-up|1|||
124687486|NCT03317496|448475136|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
124687487|NCT03317496|448475137|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
124687488|NCT03317496|448475138|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
124687489|NCT03317496|448475139|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
124687490|NCT03317496|448475140|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
124894096|NCT03606460|449235740|FG001|Overall Study|Lost to Follow-up|8|||
124894097|NCT04170023|449235741|FG000|LTE Period|Withdrawal by Subject|1|||
124894098|NCT04170023|449235742|FG001|LTE Period|Withdrawal by Subject|0|||
124894099|NCT04170023|449235743|FG002|LTE Period|Withdrawal by Subject|0|||
124894100|NCT04170023|449235741|FG000|LTE Period|Study Termination|11|||
124894101|NCT04170023|449235742|FG001|LTE Period|Study Termination|11|||
124894102|NCT04170023|449235743|FG002|LTE Period|Study Termination|5|||
124443045|NCT02511678|447583052|FG000|Overall Study|Received Radiation Treatment|1|||
124443046|NCT01295281|447583053|FG000|First Intervention (7 Days)|Death|0|||
124443047|NCT01295281|447583054|FG001|First Intervention (7 Days)|Death|1|||
124443048|NCT01411839|447583056|FG000|Overall Study|Lost to Follow-up|4|||
124443049|NCT01411839|447583057|FG001|Overall Study|Lost to Follow-up|3|||
124443050|NCT05461794|447583060|FG000|Overall Study|Withdrawal by Subject|1|||
124443051|NCT05461794|447583061|FG001|Overall Study|Withdrawal by Subject|1|||
124443052|NCT05461794|447583062|FG002|Overall Study|Withdrawal by Subject|3|||
124443053|NCT05461794|447583060|FG000|Overall Study|Study Terminated By Sponsor|18|||
124443054|NCT05461794|447583061|FG001|Overall Study|Study Terminated By Sponsor|13|||
124443055|NCT05461794|447583062|FG002|Overall Study|Study Terminated By Sponsor|16|||
124443056|NCT05461794|447583060|FG000|Overall Study|Death|20|||
124443057|NCT05461794|447583061|FG001|Overall Study|Death|5|||
124443058|NCT05461794|447583062|FG002|Overall Study|Death|19|||
124443059|NCT02684357|447583063|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
124443060|NCT02684357|447583064|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
124443061|NCT02684357|447583065|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
124443062|NCT02684357|447583066|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
124443063|NCT02684357|447583067|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
124443064|NCT02684357|447583068|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
124443065|NCT02684357|447583063|FG000|Part A|Lost to Follow-up|0|||
124443066|NCT02684357|447583064|FG001|Part A|Lost to Follow-up|2|||
124443067|NCT02684357|447583065|FG002|Part A|Lost to Follow-up|2|||
124443068|NCT02684357|447583066|FG003|Part A|Lost to Follow-up|0|||
124443069|NCT02684357|447583067|FG004|Part A|Lost to Follow-up|0|||
124443070|NCT02684357|447583068|FG005|Part A|Lost to Follow-up|0|||
124443071|NCT02684357|447583063|FG000|Part A|Withdrawal by Subject|3|||
124443072|NCT02684357|447583064|FG001|Part A|Withdrawal by Subject|0|||
124687491|NCT03317496|448475136|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
124687492|NCT03317496|448475137|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
124687493|NCT03317496|448475138|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
124687494|NCT03317496|448475139|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
124443073|NCT02684357|447583065|FG002|Part A|Withdrawal by Subject|0|||
124443074|NCT02684357|447583066|FG003|Part A|Withdrawal by Subject|0|||
124443075|NCT02684357|447583067|FG004|Part A|Withdrawal by Subject|0|||
124443076|NCT02684357|447583068|FG005|Part A|Withdrawal by Subject|0|||
124443077|NCT02684357|447583063|FG000|Part A|Other|0|||
124894103|NCT00372567|449235753|FG000|Phase 3 Study|Adverse Event|5|||
124443078|NCT02684357|447583064|FG001|Part A|Other|1|||
124443079|NCT02684357|447583065|FG002|Part A|Other|0|||
124759336|NCT01611194|448742617|FG001|Overall Study|Withdrawal by Subject|1|||
124894104|NCT00372567|449235754|FG001|Phase 3 Study|Adverse Event|1|||
124894105|NCT00372567|449235755|FG002|Phase 3 Study|Adverse Event|1|||
124894106|NCT00372567|449235753|FG000|Phase 3 Study|Death|1|||
124894107|NCT00372567|449235754|FG001|Phase 3 Study|Death|1|||
124894108|NCT00372567|449235755|FG002|Phase 3 Study|Death|0|||
124894109|NCT00372567|449235753|FG000|Phase 3 Study|Protocol Violation|0|||
124894110|NCT00372567|449235754|FG001|Phase 3 Study|Protocol Violation|0|||
124894111|NCT00372567|449235755|FG002|Phase 3 Study|Protocol Violation|1|||
124894112|NCT00372567|449235753|FG000|Phase 3 Study|Objective progression or relapse|10|||
124894113|NCT00372567|449235754|FG001|Phase 3 Study|Objective progression or relapse|13|||
124687495|NCT03317496|448475140|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
124687496|NCT03317496|448475136|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
124687497|NCT03317496|448475137|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
124687498|NCT03317496|448475138|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
124687499|NCT03317496|448475139|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
124687500|NCT03317496|448475140|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
124687501|NCT03317496|448475136|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
124687502|NCT03317496|448475137|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
124687503|NCT03317496|448475138|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
124687504|NCT03317496|448475139|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
124687505|NCT03317496|448475140|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
124687506|NCT03317496|448475136|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
124687507|NCT03317496|448475137|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
124687508|NCT03317496|448475138|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
124443080|NCT02684357|447583066|FG003|Part A|Other|0|||
124443081|NCT02684357|447583067|FG004|Part A|Other|0|||
124443082|NCT02684357|447583068|FG005|Part A|Other|0|||
124443083|NCT02684357|447583063|FG000|Part B|Adverse Event (Other)|0|||
124443084|NCT02684357|447583064|FG001|Part B|Adverse Event (Other)|0|||
124443085|NCT02684357|447583065|FG002|Part B|Adverse Event (Other)|0|||
124443086|NCT02684357|447583066|FG003|Part B|Adverse Event (Other)|1|||
124443087|NCT02684357|447583067|FG004|Part B|Adverse Event (Other)|1|||
124443088|NCT02684357|447583068|FG005|Part B|Adverse Event (Other)|1|||
124443089|NCT02684357|447583063|FG000|Part B|Lost to Follow-up|0|||
124687509|NCT03317496|448475139|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
124687510|NCT03317496|448475140|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
124687511|NCT03317496|448475136|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
124687512|NCT03317496|448475137|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
124443090|NCT02684357|447583064|FG001|Part B|Lost to Follow-up|0|||
124687513|NCT03317496|448475138|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
124443091|NCT02684357|447583065|FG002|Part B|Lost to Follow-up|0|||
124687514|NCT03317496|448475139|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
124687515|NCT03317496|448475140|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
124687516|NCT03317496|448475136|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
124443092|NCT02684357|447583066|FG003|Part B|Lost to Follow-up|1|||
124443093|NCT02684357|447583067|FG004|Part B|Lost to Follow-up|1|||
124443094|NCT02684357|447583068|FG005|Part B|Lost to Follow-up|7|||
124443095|NCT02684357|447583063|FG000|Part B|Withdrawal by Subject|0|||
124443096|NCT02684357|447583064|FG001|Part B|Withdrawal by Subject|0|||
124443097|NCT02684357|447583065|FG002|Part B|Withdrawal by Subject|0|||
124443098|NCT02684357|447583066|FG003|Part B|Withdrawal by Subject|0|||
124443099|NCT02684357|447583067|FG004|Part B|Withdrawal by Subject|2|||
124443100|NCT02684357|447583068|FG005|Part B|Withdrawal by Subject|4|||
124443101|NCT02684357|447583063|FG000|Part B|Other|0|||
124443102|NCT02684357|447583064|FG001|Part B|Other|0|||
124443103|NCT02684357|447583065|FG002|Part B|Other|0|||
124443104|NCT02684357|447583066|FG003|Part B|Other|1|||
124443105|NCT02684357|447583067|FG004|Part B|Other|0|||
124443106|NCT02684357|447583068|FG005|Part B|Other|1|||
124443107|NCT01079130|447583069|FG000|Overall Study|Adverse Event|1|||
124443108|NCT01079130|447583070|FG001|Overall Study|Adverse Event|1|||
124443109|NCT01079130|447583071|FG002|Overall Study|Adverse Event|0|||
124443110|NCT01079130|447583072|FG003|Overall Study|Adverse Event|1|||
124443111|NCT01079130|447583073|FG004|Overall Study|Adverse Event|5|||
124443112|NCT01079130|447583074|FG005|Overall Study|Adverse Event|1|||
124443113|NCT01079130|447583069|FG000|Overall Study|Administrative problems|1|||
124443114|NCT01079130|447583070|FG001|Overall Study|Administrative problems|3|||
124443115|NCT01079130|447583071|FG002|Overall Study|Administrative problems|0|||
124443116|NCT01079130|447583072|FG003|Overall Study|Administrative problems|0|||
124894114|NCT00372567|449235755|FG002|Phase 3 Study|Objective progression or relapse|4|||
124894115|NCT00372567|449235753|FG000|Phase 3 Study|Global deterioration of health status|0|||
124894116|NCT00372567|449235754|FG001|Phase 3 Study|Global deterioration of health status|1|||
124894117|NCT00372567|449235755|FG002|Phase 3 Study|Global deterioration of health status|0|||
124894118|NCT00372567|449235753|FG000|Phase 3 Study|Other|2|||
124894119|NCT00372567|449235754|FG001|Phase 3 Study|Other|2|||
124894120|NCT00372567|449235755|FG002|Phase 3 Study|Other|1|||
124894121|NCT00372567|449235753|FG000|Phase 3 Study|study terminated by sponsor|13|||
124894122|NCT00372567|449235754|FG001|Phase 3 Study|study terminated by sponsor|8|||
124894123|NCT00372567|449235755|FG002|Phase 3 Study|study terminated by sponsor|5|||
124894124|NCT00303303|449235757|FG000|Overall Study|Withdrawal by Subject|0|||
124894125|NCT00303303|449235758|FG001|Overall Study|Withdrawal by Subject|0|||
124894126|NCT00303303|449235759|FG002|Overall Study|Withdrawal by Subject|1|||
124894127|NCT00582790|449235762|FG000|Overall Study|Rapid progression of disease|1|||
124894128|NCT00480441|449235763|FG000|Screening|Not Eligible|37|||
124894129|NCT00480441|449235764|FG001|Screening|Not Eligible|0|||
124894130|NCT00480441|449235765|FG002|Screening|Not Eligible|0|||
124894131|NCT00480441|449235763|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
124894132|NCT00480441|449235764|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
124894133|NCT00480441|449235765|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
124443117|NCT01079130|447583073|FG004|Overall Study|Administrative problems|0|||
124894134|NCT00480441|449235763|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
124443118|NCT01079130|447583074|FG005|Overall Study|Administrative problems|1|||
124443119|NCT01079130|447583069|FG000|Overall Study|Withdrawal by Subject|0|||
124443120|NCT01079130|447583070|FG001|Overall Study|Withdrawal by Subject|1|||
124443121|NCT01079130|447583071|FG002|Overall Study|Withdrawal by Subject|0|||
124443122|NCT01079130|447583072|FG003|Overall Study|Withdrawal by Subject|0|||
124443123|NCT01079130|447583073|FG004|Overall Study|Withdrawal by Subject|1|||
124443124|NCT01079130|447583074|FG005|Overall Study|Withdrawal by Subject|3|||
124443125|NCT01079130|447583069|FG000|Overall Study|Protocol deviation|0|||
124443126|NCT01079130|447583070|FG001|Overall Study|Protocol deviation|2|||
124443127|NCT01079130|447583071|FG002|Overall Study|Protocol deviation|1|||
124443128|NCT01079130|447583072|FG003|Overall Study|Protocol deviation|2|||
124443129|NCT01079130|447583073|FG004|Overall Study|Protocol deviation|0|||
124443130|NCT01079130|447583074|FG005|Overall Study|Protocol deviation|0|||
124443131|NCT01079130|447583069|FG000|Overall Study|Abnormal test procedure result(s)|0|||
124443132|NCT01079130|447583070|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124443133|NCT01079130|447583071|FG002|Overall Study|Abnormal test procedure result(s)|0|||
124443134|NCT01079130|447583072|FG003|Overall Study|Abnormal test procedure result(s)|0|||
124443135|NCT01079130|447583073|FG004|Overall Study|Abnormal test procedure result(s)|1|||
124443136|NCT01079130|447583074|FG005|Overall Study|Abnormal test procedure result(s)|0|||
124443137|NCT01079130|447583069|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124443138|NCT01079130|447583070|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124443139|NCT01079130|447583071|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
124443140|NCT01079130|447583072|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
124443141|NCT01079130|447583073|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
124443142|NCT01079130|447583074|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
124443143|NCT01079130|447583069|FG000|Overall Study|Lost to Follow-up|0|||
124443144|NCT01079130|447583070|FG001|Overall Study|Lost to Follow-up|0|||
124443145|NCT01079130|447583071|FG002|Overall Study|Lost to Follow-up|0|||
124443146|NCT01079130|447583072|FG003|Overall Study|Lost to Follow-up|0|||
124443147|NCT01079130|447583073|FG004|Overall Study|Lost to Follow-up|1|||
124443148|NCT01079130|447583074|FG005|Overall Study|Lost to Follow-up|0|||
124443149|NCT04821869|447583080|FG000|Overall Study|Adverse Event|4|||
124443150|NCT04821869|447583080|FG000|Overall Study|Withdrawal by Subject|2|||
124443151|NCT04821869|447583080|FG000|Overall Study|Did not meet FEV1 criteria|1|||
124443152|NCT03444324|447583081|FG000|Overall Study|Withdrawal by Subject|0|||
124443153|NCT03444324|447583082|FG001|Overall Study|Withdrawal by Subject|1|||
124443154|NCT03444324|447583081|FG000|Overall Study|Lost to Follow-up|4|||
124443155|NCT03444324|447583082|FG001|Overall Study|Lost to Follow-up|2|||
124443156|NCT03444324|447583081|FG000|Overall Study|Protocol Violation|0|||
124443157|NCT03444324|447583082|FG001|Overall Study|Protocol Violation|1|||
124443158|NCT03444324|447583081|FG000|Overall Study|Lack of Trial Compliance|1|||
124443159|NCT03444324|447583082|FG001|Overall Study|Lack of Trial Compliance|1|||
124443160|NCT03444324|447583081|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
124443161|NCT03444324|447583082|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
124443162|NCT01390181|447584792|FG000|Overall Study|Lost to Follow-up|1|||
124443163|NCT01390181|447584792|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
124443164|NCT01103245|447584793|FG000|Overall Study|Withdrawal by Subject|1|||
124443165|NCT01103245|447584794|FG001|Overall Study|Withdrawal by Subject|0|||
124443166|NCT01103245|447584795|FG002|Overall Study|Withdrawal by Subject|3|||
124443167|NCT01103245|447584796|FG003|Overall Study|Withdrawal by Subject|0|||
124443168|NCT01103245|447584793|FG000|Overall Study|Inadequate IV access|1|||
124687517|NCT03317496|448475137|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
124894135|NCT00480441|449235764|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
124894136|NCT00480441|449235765|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
124894137|NCT00480441|449235763|FG000|Baseline Functional MRI|physical contraindication|4|||
124894138|NCT00480441|449235764|FG001|Baseline Functional MRI|physical contraindication|0|||
124894139|NCT00480441|449235765|FG002|Baseline Functional MRI|physical contraindication|0|||
124894140|NCT00480441|449235763|FG000|Randomization|Lost to Follow-up|0|||
124894141|NCT00480441|449235764|FG001|Randomization|Lost to Follow-up|7|||
124894142|NCT00480441|449235765|FG002|Randomization|Lost to Follow-up|2|||
124894143|NCT01004263|449235777|FG000|Overall Study|Adverse Event|15|||
124894144|NCT01004263|449235777|FG000|Overall Study|Withdrawal by Subject|58|||
124894145|NCT01004263|449235777|FG000|Overall Study|Protocol Violation|10|||
124687518|NCT03317496|448475138|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
124687519|NCT03317496|448475139|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
124894146|NCT01004263|449235777|FG000|Overall Study|Lost to Follow-up|64|||
124894147|NCT01004263|449235777|FG000|Overall Study|Lack of Efficacy|13|||
124443169|NCT01103245|447584794|FG001|Overall Study|Inadequate IV access|0|||
124443170|NCT01103245|447584795|FG002|Overall Study|Inadequate IV access|0|||
124443171|NCT01103245|447584796|FG003|Overall Study|Inadequate IV access|0|||
124443172|NCT01103245|447584793|FG000|Overall Study|Adverse Event|0|||
124443173|NCT01103245|447584794|FG001|Overall Study|Adverse Event|2|||
124443174|NCT01103245|447584795|FG002|Overall Study|Adverse Event|1|||
124443175|NCT01103245|447584796|FG003|Overall Study|Adverse Event|0|||
124443176|NCT01103245|447584793|FG000|Overall Study|Physician Decision|1|||
124443177|NCT01103245|447584794|FG001|Overall Study|Physician Decision|0|||
124443178|NCT01103245|447584795|FG002|Overall Study|Physician Decision|0|||
124687520|NCT03317496|448475140|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
124443179|NCT01103245|447584796|FG003|Overall Study|Physician Decision|0|||
124443180|NCT00720941|447584797|FG000|Overall Study|Protocol Violation|1|||
124443181|NCT00720941|447584798|FG001|Overall Study|Protocol Violation|2|||
124443182|NCT00720941|447584797|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
124443183|NCT00720941|447584798|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
124443184|NCT00720941|447584797|FG000|Overall Study|Lost to Follow-up|20|||
124443185|NCT00720941|447584798|FG001|Overall Study|Lost to Follow-up|15|||
124443186|NCT00720941|447584797|FG000|Overall Study|Physician Decision|14|||
124443187|NCT00720941|447584798|FG001|Overall Study|Physician Decision|12|||
124443188|NCT00720941|447584797|FG000|Overall Study|Withdrawal by Subject|29|||
124443189|NCT00720941|447584798|FG001|Overall Study|Withdrawal by Subject|36|||
124443190|NCT00355056|447584799|FG000|Randomization Period|Early Termination|4|||
124443191|NCT00355056|447584800|FG001|Randomization Period|Early Termination|6|||
124443192|NCT02805725|447584801|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
124443193|NCT02805725|447584802|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
124443194|NCT02805725|447584803|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
124443195|NCT02805725|447584804|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
124443196|NCT02805725|447584805|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
124443197|NCT02805725|447584801|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
124443198|NCT02805725|447584802|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
124443199|NCT02805725|447584803|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
124443200|NCT02805725|447584804|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
124443201|NCT02805725|447584805|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
124443202|NCT02805725|447584801|FG000|Phase II|Protocol Violation|0|||
124443203|NCT02805725|447584802|FG001|Phase II|Protocol Violation|0|||
124443204|NCT02805725|447584803|FG002|Phase II|Protocol Violation|0|||
124443205|NCT02805725|447584804|FG003|Phase II|Protocol Violation|0|||
124443206|NCT02805725|447584805|FG004|Phase II|Protocol Violation|6|||
124443207|NCT01195545|447584806|FG000|Overall Study|Protocol Violation|4|||
124443208|NCT02425644|447584807|FG000|Overall Study|Lost to Follow-up|2|||
124443209|NCT02425644|447584808|FG001|Overall Study|Lost to Follow-up|3|||
124443210|NCT02425644|447584807|FG000|Overall Study|Withdrawal by Subject|41|||
124443211|NCT02425644|447584808|FG001|Overall Study|Withdrawal by Subject|36|||
124443212|NCT02425644|447584807|FG000|Overall Study|Lack of Efficacy|3|||
124443213|NCT02425644|447584808|FG001|Overall Study|Lack of Efficacy|10|||
124443214|NCT02425644|447584807|FG000|Overall Study|Adverse Event|13|||
124443215|NCT02425644|447584808|FG001|Overall Study|Adverse Event|3|||
124443216|NCT02425644|447584807|FG000|Overall Study|Death|0|||
124443217|NCT02425644|447584808|FG001|Overall Study|Death|2|||
124443218|NCT02425644|447584807|FG000|Overall Study|Other|18|||
124443219|NCT02425644|447584808|FG001|Overall Study|Other|17|||
124443220|NCT01072877|447584809|FG000|Overall Study|Lost to Follow-up|1|||
124443221|NCT01072877|447584810|FG001|Overall Study|Lost to Follow-up|1|||
124443222|NCT01072877|447584811|FG002|Overall Study|Lost to Follow-up|0|||
124443223|NCT01072877|447584812|FG003|Overall Study|Lost to Follow-up|2|||
124443224|NCT01072877|447584813|FG004|Overall Study|Lost to Follow-up|0|||
124443225|NCT02720536|447584814|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
124894148|NCT01004263|449235777|FG000|Overall Study|Pregnancy|2|||
124894149|NCT01004263|449235777|FG000|Overall Study|Physician Decision|15|||
124443226|NCT02720536|447584814|FG000|Overall Study|PR - pregnancy|2|||
124443227|NCT02720536|447584814|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
124443228|NCT02720536|447584814|FG000|Overall Study|PR - death|1|||
124894150|NCT01004263|449235777|FG000|Overall Study|Lack of Qualifying Event|2|||
124894151|NCT00958009|449235778|FG000|Overall Study|Adverse Event|1|||
124443229|NCT02720536|447584814|FG000|Overall Study|PR - adverse event|1|||
124443230|NCT02720536|447584814|FG000|Overall Study|PR - abnormal lab value(s)|1|||
124443231|NCT02720536|447584814|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
124687521|NCT03317496|448475136|FG000|Phase 2: Treatment|Adverse Event|0|||
124894152|NCT00958009|449235778|FG000|Overall Study|Subject found device difficult to use|1|||
124894153|NCT00558753|449235782|FG000|Overall Study|Lost to Follow-up|5|||
124894154|NCT00558753|449235783|FG001|Overall Study|Lost to Follow-up|7|||
124894155|NCT04668144|449235784|FG000|Overall Study|Protocol Violation|0|||
124894156|NCT04668144|449235785|FG001|Overall Study|Protocol Violation|1|||
124894157|NCT04668144|449235786|FG002|Overall Study|Protocol Violation|2|||
124894158|NCT02929108|449235787|FG000|Overall Study|Hospice patient death|100|||
124894159|NCT02929108|449235788|FG001|Overall Study|Hospice patient death|64|||
124894160|NCT02929108|449235789|FG002|Overall Study|Hospice patient death|28|||
124894161|NCT02929108|449235790|FG003|Overall Study|Hospice patient death|46|||
124894162|NCT02929108|449235791|FG004|Overall Study|Hospice patient death|55|||
124894163|NCT02929108|449235792|FG005|Overall Study|Hospice patient death|28|||
124894164|NCT02929108|449235793|FG006|Overall Study|Hospice patient death|78|||
124894165|NCT01027871|449235794|FG000|Overall Study|Physician Decision|1|||
124894166|NCT01027871|449235795|FG001|Overall Study|Physician Decision|5|||
124894167|NCT01027871|449235796|FG002|Overall Study|Physician Decision|0|||
124894168|NCT01027871|449235794|FG000|Overall Study|Protocol Violation|0|||
124894169|NCT01027871|449235795|FG001|Overall Study|Protocol Violation|2|||
124894170|NCT01027871|449235796|FG002|Overall Study|Protocol Violation|2|||
124894171|NCT01027871|449235794|FG000|Overall Study|Withdrawal by Subject|1|||
124894172|NCT01027871|449235795|FG001|Overall Study|Withdrawal by Subject|2|||
124894173|NCT01027871|449235796|FG002|Overall Study|Withdrawal by Subject|2|||
124894174|NCT01027871|449235794|FG000|Overall Study|Adverse Event|0|||
124894175|NCT01027871|449235795|FG001|Overall Study|Adverse Event|2|||
124894176|NCT01027871|449235796|FG002|Overall Study|Adverse Event|2|||
124894177|NCT01027871|449235794|FG000|Overall Study|Sponsor Decision|0|||
124894178|NCT01027871|449235795|FG001|Overall Study|Sponsor Decision|2|||
124894179|NCT01027871|449235796|FG002|Overall Study|Sponsor Decision|0|||
124894180|NCT01027871|449235794|FG000|Overall Study|Discontinued Prior to Treatment|0|||
124894181|NCT01027871|449235795|FG001|Overall Study|Discontinued Prior to Treatment|0|||
124894182|NCT01027871|449235796|FG002|Overall Study|Discontinued Prior to Treatment|1|||
124894183|NCT01414166|449235797|FG000|Overall Study|Adverse Event|10|||
124894184|NCT01414166|449235798|FG001|Overall Study|Adverse Event|2|||
124894185|NCT01414166|449235797|FG000|Overall Study|Lost to Follow-up|4|||
124894186|NCT01414166|449235798|FG001|Overall Study|Lost to Follow-up|1|||
124894187|NCT01414166|449235797|FG000|Overall Study|Non-compliance with study drug|2|||
124894188|NCT01414166|449235798|FG001|Overall Study|Non-compliance with study drug|0|||
124894189|NCT01414166|449235797|FG000|Overall Study|Physician Decision|2|||
124894190|NCT01414166|449235798|FG001|Overall Study|Physician Decision|0|||
124894191|NCT01414166|449235797|FG000|Overall Study|Protocol Violation|2|||
124894192|NCT01414166|449235798|FG001|Overall Study|Protocol Violation|0|||
124894193|NCT01414166|449235797|FG000|Overall Study|Study terminated by Sponsor|68|||
124894194|NCT01414166|449235798|FG001|Overall Study|Study terminated by Sponsor|75|||
124894195|NCT01414166|449235797|FG000|Overall Study|Withdrawal by Subject|3|||
124894196|NCT01414166|449235798|FG001|Overall Study|Withdrawal by Subject|5|||
124894197|NCT03782727|449235799|FG000|Overall Study|Lost to Follow-up|32|||
124894198|NCT02084082|449235802|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
124894199|NCT02084082|449235803|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
124894200|NCT02084082|449235804|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
124894201|NCT02084082|449235805|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
124894202|NCT02084082|449235802|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
124894203|NCT02084082|449235803|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
124894204|NCT02084082|449235804|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
124894205|NCT02084082|449235805|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
124894206|NCT05705167|449235806|FG000|Overall Study|Randomised but not Treated|0|||
124894207|NCT05705167|449235807|FG001|Overall Study|Randomised but not Treated|2|||
124894208|NCT05705167|449235808|FG002|Overall Study|Randomised but not Treated|0|||
124894209|NCT05705167|449235809|FG003|Overall Study|Randomised but not Treated|7|||
124687522|NCT03317496|448475137|FG001|Phase 2: Treatment|Adverse Event|0|||
124687523|NCT03317496|448475138|FG002|Phase 2: Treatment|Adverse Event|0|||
124894210|NCT05705167|449235810|FG004|Overall Study|Randomised but not Treated|0|||
124894211|NCT05705167|449235811|FG005|Overall Study|Randomised but not Treated|0|||
124894212|NCT05705167|449235812|FG006|Overall Study|Randomised but not Treated|0|||
124894213|NCT05705167|449235806|FG000|Overall Study|Death|0|||
124894214|NCT05705167|449235807|FG001|Overall Study|Death|0|||
124894215|NCT05705167|449235808|FG002|Overall Study|Death|3|||
124687524|NCT03317496|448475139|FG003|Phase 2: Treatment|Adverse Event|0|||
124687525|NCT03317496|448475140|FG004|Phase 2: Treatment|Adverse Event|6|||
124687526|NCT03317496|448475136|FG000|Phase 2: Treatment|Progressive disease|0|||
124687527|NCT03317496|448475137|FG001|Phase 2: Treatment|Progressive disease|0|||
124894216|NCT05705167|449235809|FG003|Overall Study|Death|0|||
124894217|NCT05705167|449235810|FG004|Overall Study|Death|1|||
124894218|NCT05705167|449235811|FG005|Overall Study|Death|1|||
124894219|NCT05705167|449235812|FG006|Overall Study|Death|1|||
124894220|NCT05705167|449235806|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
124894221|NCT05705167|449235807|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
124687528|NCT03317496|448475138|FG002|Phase 2: Treatment|Progressive disease|0|||
124687529|NCT03317496|448475139|FG003|Phase 2: Treatment|Progressive disease|0|||
124687530|NCT03317496|448475140|FG004|Phase 2: Treatment|Progressive disease|22|||
124687531|NCT03317496|448475136|FG000|Phase 2: Treatment|Other|0|||
124687532|NCT03317496|448475137|FG001|Phase 2: Treatment|Other|0|||
124687533|NCT03317496|448475138|FG002|Phase 2: Treatment|Other|0|||
124687534|NCT03317496|448475139|FG003|Phase 2: Treatment|Other|0|||
124687535|NCT03317496|448475140|FG004|Phase 2: Treatment|Other|4|||
124687536|NCT03317496|448475136|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
124687537|NCT03317496|448475137|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
124687538|NCT03317496|448475138|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
124687539|NCT03317496|448475139|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
124687540|NCT03317496|448475140|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
124687541|NCT03317496|448475136|FG000|Phase 2: Treatment|Physician Decision|0|||
124894222|NCT05705167|449235808|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
124894223|NCT05705167|449235809|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
124687542|NCT03317496|448475137|FG001|Phase 2: Treatment|Physician Decision|0|||
124687543|NCT03317496|448475138|FG002|Phase 2: Treatment|Physician Decision|0|||
124687544|NCT03317496|448475139|FG003|Phase 2: Treatment|Physician Decision|0|||
124687545|NCT03317496|448475140|FG004|Phase 2: Treatment|Physician Decision|1|||
124687546|NCT03317496|448475136|FG000|Phase 2: Treatment|Death|0|||
124687547|NCT03317496|448475137|FG001|Phase 2: Treatment|Death|0|||
124687548|NCT03317496|448475138|FG002|Phase 2: Treatment|Death|0|||
124687549|NCT03317496|448475139|FG003|Phase 2: Treatment|Death|0|||
124687550|NCT03317496|448475140|FG004|Phase 2: Treatment|Death|1|||
124894224|NCT05705167|449235810|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
124894225|NCT05705167|449235811|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
124894226|NCT05705167|449235812|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
124894227|NCT04736056|449235813|FG000|Overall Study|Death|0|||
124894228|NCT04736056|449235814|FG001|Overall Study|Death|0|||
124894229|NCT04736056|449235815|FG002|Overall Study|Death|0|||
124894230|NCT04736056|449235816|FG003|Overall Study|Death|1|||
124894231|NCT04736056|449235813|FG000|Overall Study|Lost to Follow-up|1|||
124894232|NCT04736056|449235814|FG001|Overall Study|Lost to Follow-up|0|||
124894233|NCT04736056|449235815|FG002|Overall Study|Lost to Follow-up|1|||
124894234|NCT04736056|449235816|FG003|Overall Study|Lost to Follow-up|1|||
124894235|NCT04736056|449235813|FG000|Overall Study|Withdrawal by Subject|2|||
124894236|NCT04736056|449235814|FG001|Overall Study|Withdrawal by Subject|0|||
124894237|NCT04736056|449235815|FG002|Overall Study|Withdrawal by Subject|0|||
124894238|NCT04736056|449235816|FG003|Overall Study|Withdrawal by Subject|0|||
124894239|NCT04736056|449235813|FG000|Overall Study|Physician Decision|1|||
124894240|NCT04736056|449235814|FG001|Overall Study|Physician Decision|0|||
124894241|NCT04736056|449235815|FG002|Overall Study|Physician Decision|1|||
124894242|NCT04736056|449235816|FG003|Overall Study|Physician Decision|0|||
124894243|NCT02099539|449235823|FG000|Overall Study|Progressive Disease|3|||
124894244|NCT02099539|449235824|FG001|Overall Study|Progressive Disease|2|||
124894245|NCT02099539|449235825|FG002|Overall Study|Progressive Disease|2|||
124894246|NCT02099539|449235826|FG003|Overall Study|Progressive Disease|1|||
124894247|NCT02099539|449235827|FG004|Overall Study|Progressive Disease|4|||
124894248|NCT02099539|449235828|FG005|Overall Study|Progressive Disease|2|||
124894249|NCT02099539|449235829|FG006|Overall Study|Progressive Disease|0|||
124894250|NCT02099539|449235823|FG000|Overall Study|Adverse Event|0|||
124894251|NCT02099539|449235824|FG001|Overall Study|Adverse Event|0|||
124894252|NCT02099539|449235825|FG002|Overall Study|Adverse Event|1|||
124894253|NCT02099539|449235826|FG003|Overall Study|Adverse Event|1|||
124894254|NCT02099539|449235827|FG004|Overall Study|Adverse Event|0|||
124894255|NCT02099539|449235828|FG005|Overall Study|Adverse Event|0|||
124894256|NCT02099539|449235829|FG006|Overall Study|Adverse Event|0|||
124894257|NCT02099539|449235823|FG000|Overall Study|Physician Decision|0|||
124894258|NCT02099539|449235824|FG001|Overall Study|Physician Decision|0|||
124894259|NCT02099539|449235825|FG002|Overall Study|Physician Decision|0|||
124894260|NCT02099539|449235826|FG003|Overall Study|Physician Decision|0|||
124894261|NCT02099539|449235827|FG004|Overall Study|Physician Decision|0|||
124443232|NCT00909792|447584815|FG000|Period 1|Did not meet inclusion criteria|0|||
124687551|NCT03317496|448475136|FG000|Phase 2: Follow-up|Death|0|||
124687552|NCT03317496|448475137|FG001|Phase 2: Follow-up|Death|0|||
124687553|NCT03317496|448475138|FG002|Phase 2: Follow-up|Death|0|||
124759337|NCT01611194|448742616|FG000|Overall Study|drug use|0|||
124759338|NCT01611194|448742617|FG001|Overall Study|drug use|1|||
124894262|NCT02099539|449235828|FG005|Overall Study|Physician Decision|1|||
124894263|NCT02099539|449235829|FG006|Overall Study|Physician Decision|0|||
124894264|NCT02956967|449235831|FG000|Overall Study|Adverse Event|3|||
124894265|NCT02956967|449235831|FG000|Overall Study|Reason non-related to neutropenia|10|||
124894266|NCT02956967|449235831|FG000|Overall Study|Lost to Follow-up|5|||
124894267|NCT02956967|449235831|FG000|Overall Study|Missing|1|||
124894268|NCT02956967|449235831|FG000|Overall Study|Termination of Nivestim administration|29|||
124894269|NCT01823341|449235840|FG000|Overall Study|Failed run-in|7|||
124894270|NCT01823341|449235840|FG000|Overall Study|Withdrawal by Subject|7|||
124687554|NCT03317496|448475139|FG003|Phase 2: Follow-up|Death|0|||
124687555|NCT03317496|448475140|FG004|Phase 2: Follow-up|Death|24|||
124894271|NCT01823341|449235840|FG000|Overall Study|Adverse Event|1|||
124894272|NCT02027935|449235841|FG000|Overall Study|Death|1|||
124894273|NCT02027935|449235841|FG000|Overall Study|Lack of Efficacy|5|||
124894274|NCT02027935|449235841|FG000|Overall Study|Study Closure|1|||
124894275|NCT03590743|449235842|FG000|Overall Study|Withdrawal by Subject|0|||
124894276|NCT03590743|449235843|FG001|Overall Study|Withdrawal by Subject|1|||
124894277|NCT00604786|449235844|FG000|Overall Study|Lost to Follow-up|2|||
124894278|NCT00604786|449235845|FG001|Overall Study|Lost to Follow-up|0|||
124894279|NCT02698436|449235846|FG000|Overall Study|Adverse Event|1|||
124894280|NCT02698436|449235847|FG001|Overall Study|Adverse Event|0|||
124894281|NCT02698436|449235846|FG000|Overall Study|Withdrawal by Subject|3|||
124894282|NCT02698436|449235847|FG001|Overall Study|Withdrawal by Subject|3|||
124894283|NCT02698436|449235846|FG000|Overall Study|Lost to Follow-up|2|||
124894284|NCT02698436|449235847|FG001|Overall Study|Lost to Follow-up|4|||
124894285|NCT02698436|449235846|FG000|Overall Study|Non-compliance with study regimen|1|||
124894286|NCT02698436|449235847|FG001|Overall Study|Non-compliance with study regimen|0|||
124894287|NCT01394991|449235848|FG000|Overall Study|Adverse Event|0|||
124894288|NCT01394991|449235849|FG001|Overall Study|Adverse Event|4|||
124894289|NCT01394991|449235848|FG000|Overall Study|Lack of Efficacy|5|||
124894290|NCT01394991|449235849|FG001|Overall Study|Lack of Efficacy|7|||
124894291|NCT01394991|449235848|FG000|Overall Study|Lost to Follow-up|6|||
124894292|NCT01394991|449235849|FG001|Overall Study|Lost to Follow-up|8|||
124894293|NCT01394991|449235848|FG000|Overall Study|Physician Decision|1|||
124894294|NCT01394991|449235849|FG001|Overall Study|Physician Decision|3|||
124894295|NCT01394991|449235848|FG000|Overall Study|Protocol Violation|1|||
124894296|NCT01394991|449235849|FG001|Overall Study|Protocol Violation|1|||
124894297|NCT01394991|449235848|FG000|Overall Study|Withdrawal by Subject|20|||
124894298|NCT01394991|449235849|FG001|Overall Study|Withdrawal by Subject|17|||
124894299|NCT01394991|449235848|FG000|Overall Study|Chemotherapy Termination|10|||
124894300|NCT01394991|449235849|FG001|Overall Study|Chemotherapy Termination|15|||
124894301|NCT01394991|449235848|FG000|Overall Study|Disease Progression|7|||
124894302|NCT01394991|449235849|FG001|Overall Study|Disease Progression|7|||
124894303|NCT01394991|449235848|FG000|Overall Study|Prematurely Termination of Trial|9|||
124894304|NCT01394991|449235849|FG001|Overall Study|Prematurely Termination of Trial|10|||
124894305|NCT03073005|449235850|FG000|Overall Study|Death|6|||
124894306|NCT03073005|449235851|FG001|Overall Study|Death|0|||
124894307|NCT03073005|449235852|FG002|Overall Study|Death|7|||
124894308|NCT03073005|449235853|FG003|Overall Study|Death|0|||
124894309|NCT03073005|449235850|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
124894310|NCT03073005|449235851|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
124894311|NCT03073005|449235852|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
124894312|NCT03073005|449235853|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
124894313|NCT03073005|449235850|FG000|Overall Study|Lost to Follow-up|2|||
124894314|NCT03073005|449235851|FG001|Overall Study|Lost to Follow-up|2|||
124894315|NCT03073005|449235852|FG002|Overall Study|Lost to Follow-up|1|||
124894316|NCT03073005|449235853|FG003|Overall Study|Lost to Follow-up|2|||
124894317|NCT03073005|449235850|FG000|Overall Study|Withdrawal by Subject|0|||
124894318|NCT03073005|449235851|FG001|Overall Study|Withdrawal by Subject|4|||
124894319|NCT03073005|449235852|FG002|Overall Study|Withdrawal by Subject|4|||
124894320|NCT03073005|449235853|FG003|Overall Study|Withdrawal by Subject|4|||
124687556|NCT03317496|448475136|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
124687557|NCT03317496|448475137|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
124687558|NCT03317496|448475138|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
124687559|NCT03317496|448475139|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
124687560|NCT03317496|448475140|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
124687561|NCT03317496|448475136|FG000|Phase 2: Follow-up|Other|0|||
124687562|NCT03317496|448475137|FG001|Phase 2: Follow-up|Other|0|||
124687563|NCT03317496|448475138|FG002|Phase 2: Follow-up|Other|0|||
124687564|NCT03317496|448475139|FG003|Phase 2: Follow-up|Other|0|||
124687565|NCT03317496|448475140|FG004|Phase 2: Follow-up|Other|1|||
124687566|NCT03317496|448475136|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
124894321|NCT00725010|449235863|FG000|Overall Study|Toxicity|9|||
124687567|NCT03317496|448475137|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
124687568|NCT03317496|448475138|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
124894322|NCT00725010|449235863|FG000|Overall Study|Tumor Progression|7|||
124894323|NCT00725010|449235863|FG000|Overall Study|Withdrawal by Subject|2|||
124894324|NCT00725010|449235863|FG000|Overall Study|Death|1|||
124894325|NCT00725010|449235863|FG000|Overall Study|Lost to Follow-up|1|||
124894326|NCT00725010|449235863|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
124894327|NCT00725010|449235863|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
124687569|NCT03317496|448475139|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
124687570|NCT03317496|448475140|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
124687571|NCT01879852|448475141|FG000|Overall Study|Withdrawal by Subject|2|||
124687572|NCT01879852|448475142|FG001|Overall Study|Withdrawal by Subject|0|||
124687573|NCT02696616|448475144|FG000|Overall Study|Adverse Event|0|||
124687574|NCT02696616|448475145|FG001|Overall Study|Adverse Event|1|||
124687575|NCT02696616|448475146|FG002|Overall Study|Adverse Event|0|||
124687576|NCT02696616|448475147|FG003|Overall Study|Adverse Event|0|||
124687577|NCT02696616|448475148|FG004|Overall Study|Adverse Event|0|||
124687578|NCT02696616|448475149|FG005|Overall Study|Adverse Event|0|||
124687579|NCT02696616|448475150|FG006|Overall Study|Adverse Event|0|||
124687580|NCT01500083|448475151|FG000|Overall Study|Adverse Event|4|||
124687581|NCT01500083|448475152|FG001|Overall Study|Adverse Event|17|||
124687582|NCT01500083|448475151|FG000|Overall Study|Death|0|||
124687583|NCT01500083|448475152|FG001|Overall Study|Death|2|||
124687584|NCT01500083|448475151|FG000|Overall Study|Lost to Follow-up|1|||
124687585|NCT01500083|448475152|FG001|Overall Study|Lost to Follow-up|0|||
124687586|NCT01500083|448475151|FG000|Overall Study|Withdrawal of Consent|0|||
124687587|NCT01500083|448475152|FG001|Overall Study|Withdrawal of Consent|1|||
124687588|NCT01500083|448475151|FG000|Overall Study|Disease Progression|2|||
124687589|NCT01500083|448475152|FG001|Overall Study|Disease Progression|10|||
124687590|NCT01500083|448475151|FG000|Overall Study|Investigator Discretion|3|||
124687591|NCT01500083|448475152|FG001|Overall Study|Investigator Discretion|8|||
124687592|NCT01500083|448475151|FG000|Overall Study|Other Reasons|2|||
124687593|NCT01500083|448475152|FG001|Overall Study|Other Reasons|5|||
124687594|NCT01555931|448475153|FG000|Overall Study|Lost to Follow-up|2|||
124687595|NCT01555931|448475154|FG001|Overall Study|Lost to Follow-up|5|||
124687596|NCT01922011|448475155|FG000|Overall Study|Protocol Violation|0|||
124687597|NCT01922011|448475156|FG001|Overall Study|Protocol Violation|1|||
124687598|NCT01922011|448475155|FG000|Overall Study|Physician Decision|0|||
124687599|NCT01922011|448475156|FG001|Overall Study|Physician Decision|1|||
124687600|NCT01922011|448475155|FG000|Overall Study|Parent/Guardian Decision|3|||
124687601|NCT01922011|448475156|FG001|Overall Study|Parent/Guardian Decision|0|||
124687602|NCT01922011|448475155|FG000|Overall Study|Lost to Follow-up|0|||
124687603|NCT01922011|448475156|FG001|Overall Study|Lost to Follow-up|1|||
124687604|NCT01922011|448475155|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
124687605|NCT01922011|448475156|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
124687606|NCT01922011|448475155|FG000|Overall Study|Not Treated|1|||
124687607|NCT01922011|448475156|FG001|Overall Study|Not Treated|0|||
124687608|NCT01922011|448475155|FG000|Overall Study|Lack of willing home health agency|1|||
124687609|NCT01922011|448475156|FG001|Overall Study|Lack of willing home health agency|0|||
124687610|NCT01922011|448475155|FG000|Overall Study|Randomized in error|1|||
124687611|NCT01922011|448475156|FG001|Overall Study|Randomized in error|0|||
124687612|NCT02299167|448475159|FG000|Overall Study|patients were excluded from the study|11|||
124687613|NCT01695746|448475160|FG000|Overall Study|Adverse Event|1|||
124687614|NCT01695746|448475160|FG000|Overall Study|Non-compliance by the participant|3|||
124687615|NCT01695746|448475160|FG000|Overall Study|Protocol Violation|5|||
124687616|NCT01695746|448475160|FG000|Overall Study|Participant not willing to participate|3|||
124687617|NCT03010501|448475162|FG000|Study Week 1|Withdrawal by Subject|2|||
124687618|NCT03010501|448475163|FG001|Study Week 1|Withdrawal by Subject|1|||
124687619|NCT03010501|448475164|FG002|Study Week 1|Withdrawal by Subject|0|||
124687620|NCT03010501|448475165|FG003|Study Week 1|Withdrawal by Subject|2|||
124687621|NCT03010501|448475166|FG004|Study Week 1|Withdrawal by Subject|0|||
124687622|NCT03010501|448475167|FG005|Study Week 1|Withdrawal by Subject|0|||
124687623|NCT03010501|448475162|FG000|Study Week 3|Withdrawal by Subject|0|||
124687624|NCT03010501|448475163|FG001|Study Week 3|Withdrawal by Subject|0|||
124687625|NCT03010501|448475164|FG002|Study Week 3|Withdrawal by Subject|0|||
124687626|NCT03010501|448475165|FG003|Study Week 3|Withdrawal by Subject|1|||
124687627|NCT03010501|448475166|FG004|Study Week 3|Withdrawal by Subject|0|||
124687628|NCT03010501|448475167|FG005|Study Week 3|Withdrawal by Subject|0|||
124687629|NCT00640289|448475168|FG000|Overall Study|Death|3|||
124687630|NCT00640289|448475168|FG000|Overall Study|Withdrawal by Subject|1|||
124894328|NCT00725010|449235863|FG000|Overall Study|No further documentation|1|||
124894329|NCT00725010|449235863|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
124894330|NCT01290094|449235864|FG000|Overall Study|Withdrawal by Subject|1|||
124687631|NCT00640289|448475168|FG000|Overall Study|Lost to Follow-up|1|||
124687632|NCT00640289|448475168|FG000|Overall Study|Data collected under different amendment|2|||
124687633|NCT00640289|448475168|FG000|Overall Study|Transferred to another center|1|||
124894331|NCT01290094|449235864|FG000|Overall Study|Lost to Follow-up|5|||
124894332|NCT02414828|449235865|FG000|Overall Study|Lost to Follow-up|0|||
124894333|NCT02414828|449235866|FG001|Overall Study|Lost to Follow-up|1|||
124894334|NCT02414828|449235867|FG002|Overall Study|Lost to Follow-up|1|||
124687634|NCT00640289|448475168|FG000|Overall Study|Missing status|5|||
124687635|NCT01202591|448475169|FG000|Overall Study|Adverse Event|2|||
124687636|NCT01202591|448475170|FG001|Overall Study|Adverse Event|1|||
124687637|NCT01202591|448475171|FG002|Overall Study|Adverse Event|4|||
124687638|NCT01202591|448475172|FG003|Overall Study|Adverse Event|4|||
124894335|NCT02414828|449235868|FG003|Overall Study|Lost to Follow-up|2|||
124894336|NCT04949399|449235869|FG000|Overall Study|Lost to Follow-up|11|||
124894337|NCT04949399|449235870|FG001|Overall Study|Lost to Follow-up|6|||
124894338|NCT04949399|449235869|FG000|Overall Study|Withdrawal by Subject|2|||
124894339|NCT04949399|449235870|FG001|Overall Study|Withdrawal by Subject|3|||
124894340|NCT04091672|449237620|FG000|Overall Study|Death|6|||
124894341|NCT04091672|449237621|FG001|Overall Study|Death|6|||
124443233|NCT00909792|447584816|FG001|Period 1|Did not meet inclusion criteria|1|||
124443234|NCT00909792|447584815|FG000|Period 2|Biomicroscopy|1|||
124443235|NCT00909792|447584816|FG001|Period 2|Biomicroscopy|0|||
124443236|NCT00909792|447584815|FG000|Period 2|Lost to Follow-up|0|||
124443237|NCT00909792|447584816|FG001|Period 2|Lost to Follow-up|1|||
124443238|NCT02120625|447584818|FG000|Overall Study|Physician Decision|2|||
124443239|NCT01177787|447584819|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
124443240|NCT01177787|447584819|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
124443241|NCT01177787|447584819|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
124443242|NCT00402363|447584822|FG000|Overall Study|Adverse Event|9|||
124443243|NCT00402363|447584823|FG001|Overall Study|Adverse Event|14|||
124443244|NCT00402363|447584824|FG002|Overall Study|Adverse Event|2|||
124443245|NCT00402363|447584825|FG003|Overall Study|Adverse Event|2|||
124443246|NCT00402363|447584822|FG000|Overall Study|Withdrew Consent|10|||
124443247|NCT00402363|447584823|FG001|Overall Study|Withdrew Consent|5|||
124443248|NCT00402363|447584824|FG002|Overall Study|Withdrew Consent|2|||
124443249|NCT00402363|447584825|FG003|Overall Study|Withdrew Consent|1|||
124443250|NCT00402363|447584822|FG000|Overall Study|Protocol Violation|3|||
124443251|NCT00402363|447584823|FG001|Overall Study|Protocol Violation|5|||
124443252|NCT00402363|447584824|FG002|Overall Study|Protocol Violation|0|||
124443253|NCT00402363|447584825|FG003|Overall Study|Protocol Violation|3|||
124443254|NCT00402363|447584822|FG000|Overall Study|Lost to Follow-up|5|||
124443255|NCT00402363|447584823|FG001|Overall Study|Lost to Follow-up|4|||
124443256|NCT00402363|447584824|FG002|Overall Study|Lost to Follow-up|0|||
124443257|NCT00402363|447584825|FG003|Overall Study|Lost to Follow-up|2|||
124443258|NCT00402363|447584822|FG000|Overall Study|"Captured as Other"|6|||
124443259|NCT00402363|447584823|FG001|Overall Study|"Captured as Other"|2|||
124443260|NCT00402363|447584824|FG002|Overall Study|"Captured as Other"|2|||
124443261|NCT00402363|447584825|FG003|Overall Study|"Captured as Other"|2|||
124443262|NCT00293722|447584826|FG000|Overall Study|Other|427|||
124443263|NCT02634346|447584828|FG000|Overall Study|Withdrawal by Subject|8|||
124443264|NCT02634346|447584829|FG001|Overall Study|Withdrawal by Subject|9|||
124443265|NCT02634346|447584830|FG002|Overall Study|Withdrawal by Subject|8|||
124443266|NCT02634346|447584828|FG000|Overall Study|Adverse Event|2|||
124443267|NCT02634346|447584829|FG001|Overall Study|Adverse Event|2|||
124443268|NCT02634346|447584830|FG002|Overall Study|Adverse Event|7|||
124443269|NCT02634346|447584828|FG000|Overall Study|Lack of Efficacy|1|||
124443270|NCT02634346|447584829|FG001|Overall Study|Lack of Efficacy|2|||
124443271|NCT02634346|447584830|FG002|Overall Study|Lack of Efficacy|8|||
124443272|NCT02634346|447584828|FG000|Overall Study|Lost to Follow-up|1|||
124443273|NCT02634346|447584829|FG001|Overall Study|Lost to Follow-up|0|||
124443274|NCT02634346|447584830|FG002|Overall Study|Lost to Follow-up|0|||
124443275|NCT02634346|447584828|FG000|Overall Study|Protocol Violation|0|||
124443276|NCT02634346|447584829|FG001|Overall Study|Protocol Violation|1|||
124443277|NCT02634346|447584830|FG002|Overall Study|Protocol Violation|0|||
124443278|NCT02824263|447584832|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
124443279|NCT02824263|447584833|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
124443280|NCT02824263|447584832|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
124443281|NCT02824263|447584833|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
124443282|NCT01008696|447584834|FG000|Overall Study|Participant's evasion of hospital visit|5|||
124443283|NCT01008696|447584835|FG001|Overall Study|Participant's evasion of hospital visit|4|||
124443284|NCT01008696|447584834|FG000|Overall Study|Withdrawal by Subject|2|||
124443285|NCT01008696|447584835|FG001|Overall Study|Withdrawal by Subject|4|||
124443286|NCT01008696|447584834|FG000|Overall Study|Physician Decision|5|||
124443287|NCT01008696|447584835|FG001|Overall Study|Physician Decision|1|||
124443288|NCT01008696|447584834|FG000|Overall Study|Adverse Event|1|||
124894342|NCT04091672|449237620|FG000|Overall Study|Lost to Follow-up|7|||
124894343|NCT04091672|449237621|FG001|Overall Study|Lost to Follow-up|7|||
124894344|NCT04091672|449237620|FG000|Overall Study|Withdrawal by Subject|3|||
124443289|NCT01008696|447584835|FG001|Overall Study|Adverse Event|0|||
124443290|NCT01008696|447584834|FG000|Overall Study|Participants' non-cooperation|2|||
124443291|NCT01008696|447584835|FG001|Overall Study|Participants' non-cooperation|3|||
124443292|NCT01008696|447584834|FG000|Overall Study|Other|2|||
124443293|NCT01008696|447584835|FG001|Overall Study|Other|3|||
124443294|NCT01008696|447584834|FG000|Overall Study|Other|0|||
124443295|NCT01008696|447584835|FG001|Overall Study|Other|2|||
124443296|NCT00568321|447584836|FG000|Overall Study|Adverse Event|1|||
124443297|NCT00568321|447584837|FG001|Overall Study|Adverse Event|0|||
124443298|NCT00568321|447584838|FG002|Overall Study|Adverse Event|0|||
124894345|NCT04091672|449237621|FG001|Overall Study|Withdrawal by Subject|3|||
124443299|NCT00568321|447584836|FG000|Overall Study|Lack of Efficacy|8|||
124894346|NCT04091672|449237620|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
124894347|NCT04091672|449237621|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
124894348|NCT05296629|449237622|FG000|Overall Study|Withdrawal by Subject|3|||
124894349|NCT05296629|449237623|FG001|Overall Study|Withdrawal by Subject|10|||
124894350|NCT05296629|449237624|FG002|Overall Study|Withdrawal by Subject|4|||
124894351|NCT05296629|449237622|FG000|Overall Study|Lost to Follow-up|2|||
124894352|NCT05296629|449237623|FG001|Overall Study|Lost to Follow-up|7|||
124894353|NCT05296629|449237624|FG002|Overall Study|Lost to Follow-up|1|||
124894354|NCT05296629|449237622|FG000|Overall Study|Adverse Event|0|||
124894355|NCT05296629|449237623|FG001|Overall Study|Adverse Event|4|||
124894356|NCT05296629|449237624|FG002|Overall Study|Adverse Event|2|||
124894357|NCT05296629|449237622|FG000|Overall Study|Protocol Violation|0|||
124894358|NCT05296629|449237623|FG001|Overall Study|Protocol Violation|2|||
124894359|NCT05296629|449237624|FG002|Overall Study|Protocol Violation|0|||
124894360|NCT02401529|449237627|FG000|Overall Study|Lost to Follow-up|2|||
124894361|NCT02401529|449237628|FG001|Overall Study|Lost to Follow-up|1|||
124894362|NCT02401529|449237627|FG000|Overall Study|Physician Decision|2|||
124894363|NCT02401529|449237628|FG001|Overall Study|Physician Decision|6|||
124894364|NCT02401529|449237627|FG000|Overall Study|Protocol Violation|5|||
124894365|NCT02401529|449237628|FG001|Overall Study|Protocol Violation|0|||
124894366|NCT02949271|449237633|FG000|Overall Study|Lack of Efficacy|5|||
124894367|NCT02949271|449237634|FG001|Overall Study|Lack of Efficacy|4|||
124894368|NCT02949271|449237633|FG000|Overall Study|Lost to Follow-up|3|||
124894369|NCT02949271|449237634|FG001|Overall Study|Lost to Follow-up|6|||
124894370|NCT02949271|449237633|FG000|Overall Study|Physician Decision|5|||
124894371|NCT02949271|449237634|FG001|Overall Study|Physician Decision|5|||
124894372|NCT02949271|449237633|FG000|Overall Study|Protocol Violation|6|||
124894373|NCT02949271|449237634|FG001|Overall Study|Protocol Violation|3|||
124894374|NCT02949271|449237633|FG000|Overall Study|Withdrawal by Subject|1|||
124894375|NCT02949271|449237634|FG001|Overall Study|Withdrawal by Subject|0|||
124894376|NCT02949271|449237633|FG000|Overall Study|Delivered prior to intervention|7|||
124894377|NCT02949271|449237634|FG001|Overall Study|Delivered prior to intervention|9|||
124894378|NCT02949271|449237633|FG000|Overall Study|Outside the window for cervical dilation|2|||
124894379|NCT02949271|449237634|FG001|Overall Study|Outside the window for cervical dilation|3|||
124894380|NCT01684046|449237635|FG000|Period 1, First 30 Days|Adverse Event|0|||
124894381|NCT01684046|449237636|FG001|Period 1, First 30 Days|Adverse Event|2|||
124894382|NCT01097655|449237637|FG000|Overall Study|Withdrawal by Subject|1|||
124894383|NCT01097655|449237637|FG000|Overall Study|Subject Documented Twice|1|||
124894384|NCT01097655|449237637|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
124894385|NCT05458102|449237638|FG000|Overall Study|Withdrew consent|2|||
124894386|NCT05458102|449237639|FG001|Overall Study|Withdrew consent|0|||
124894387|NCT05458102|449237638|FG000|Overall Study|Adverse Event|1|||
124894388|NCT05458102|449237639|FG001|Overall Study|Adverse Event|0|||
124894389|NCT05458102|449237638|FG000|Overall Study|Enrolled but never treated|1|||
124894390|NCT05458102|449237639|FG001|Overall Study|Enrolled but never treated|0|||
124894391|NCT05458102|449237638|FG000|Overall Study|Protocol Violation|1|||
124894392|NCT05458102|449237639|FG001|Overall Study|Protocol Violation|0|||
124443300|NCT00568321|447584837|FG001|Overall Study|Lack of Efficacy|5|||
124894393|NCT03303105|449237640|FG000|Overall Study|Adverse Event|0|||
124894394|NCT03303105|449237641|FG001|Overall Study|Adverse Event|2|||
124894395|NCT03303105|449237640|FG000|Overall Study|Lack of Efficacy|1|||
124894396|NCT03303105|449237641|FG001|Overall Study|Lack of Efficacy|0|||
124894397|NCT03303105|449237640|FG000|Overall Study|Protocol Violation|1|||
124894398|NCT03303105|449237641|FG001|Overall Study|Protocol Violation|0|||
124894399|NCT03303105|449237640|FG000|Overall Study|Withdrawal by Subject|0|||
124894400|NCT03303105|449237641|FG001|Overall Study|Withdrawal by Subject|2|||
124894401|NCT02790606|449237650|FG000|Overall Study|Death|27|||
124894402|NCT02790606|449237650|FG000|Overall Study|Lost to Follow-up|4|||
124894403|NCT02790606|449237650|FG000|Overall Study|Physician Decision|3|||
124894404|NCT02790606|449237650|FG000|Overall Study|Withdrawal by Subject|1|||
124894405|NCT02735915|449237651|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
124894406|NCT02735915|449237651|FG000|Overall Study|Withdrawal following SAE|2|||
124894407|NCT02735915|449237651|FG000|Overall Study|Withdrawal by Subject|1|||
124894408|NCT01789203|449237652|FG000|Overall Study|Adverse Event|2|||
124894409|NCT01789203|449237653|FG001|Overall Study|Adverse Event|2|||
124894410|NCT01789203|449237652|FG000|Overall Study|Withdrawal by Subject|1|||
124894411|NCT01789203|449237653|FG001|Overall Study|Withdrawal by Subject|0|||
124894412|NCT01789203|449237652|FG000|Overall Study|Death|1|||
124894413|NCT01789203|449237653|FG001|Overall Study|Death|0|||
124894414|NCT01789203|449237652|FG000|Overall Study|Protocol Violation|2|||
124894415|NCT01789203|449237653|FG001|Overall Study|Protocol Violation|1|||
124894416|NCT01789203|449237652|FG000|Overall Study|Other|1|||
124894417|NCT01789203|449237653|FG001|Overall Study|Other|1|||
124894418|NCT01789203|449237652|FG000|Overall Study|patient non-adherent|2|||
124894419|NCT01789203|449237653|FG001|Overall Study|patient non-adherent|0|||
124894420|NCT03929302|449237659|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
124894421|NCT03929302|449237660|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
124894422|NCT03929302|449237661|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
124894423|NCT03929302|449237659|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
124894424|NCT03929302|449237660|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
124894425|NCT03929302|449237661|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
124894426|NCT03929302|449237659|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
124894427|NCT03929302|449237660|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
124894428|NCT03929302|449237661|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
124894429|NCT01123161|449237665|FG000|Overall Study|Lost to Follow-up|1|||
124894430|NCT01123161|449237666|FG001|Overall Study|Lost to Follow-up|0|||
124894431|NCT01123161|449237665|FG000|Overall Study|Withdrawal by Subject|1|||
124894432|NCT01123161|449237666|FG001|Overall Study|Withdrawal by Subject|0|||
124894433|NCT00051311|449237669|FG000|Overall Study|Starting new study|0|||
124894434|NCT00051311|449237670|FG001|Overall Study|Starting new study|1|||
124894435|NCT00051311|449237669|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
124894436|NCT00051311|449237670|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
124894437|NCT00051311|449237669|FG000|Overall Study|Death of recipient|8|||
124894438|NCT00051311|449237670|FG001|Overall Study|Death of recipient|8|||
124894439|NCT00051311|449237669|FG000|Overall Study|Recipient taken off study|4|||
124894440|NCT00051311|449237670|FG001|Overall Study|Recipient taken off study|4|||
124894441|NCT00821236|449237674|FG000|Overall Study|Lost to Follow-up|3|||
124894442|NCT00578227|449237677|FG000|Overall Study|Lost to Follow-up|0|||
124894443|NCT00578227|449237678|FG001|Overall Study|Lost to Follow-up|1|||
124894444|NCT00578227|449237679|FG002|Overall Study|Lost to Follow-up|1|||
124443301|NCT00568321|447584838|FG002|Overall Study|Lack of Efficacy|6|||
124687639|NCT01202591|448475173|FG004|Overall Study|Adverse Event|0|||
124894445|NCT00578227|449237677|FG000|Overall Study|Withdrawal by Subject|5|||
124894446|NCT00578227|449237678|FG001|Overall Study|Withdrawal by Subject|1|||
124894447|NCT00578227|449237679|FG002|Overall Study|Withdrawal by Subject|3|||
124894448|NCT00577629|449237680|FG000|Treatment Period|Death|1|||
124894449|NCT00577629|449237680|FG000|Long Term Follow-Up|Death|15|||
124894450|NCT00577629|449237680|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
124894451|NCT00577629|449237680|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
124894452|NCT00577629|449237680|FG000|Long Term Follow-Up|Physician Decision|1|||
124894453|NCT01605136|449237683|FG000|Study Period|Withdrawal by Subject|2|||
124894454|NCT01605136|449237684|FG001|Study Period|Withdrawal by Subject|0|||
124894455|NCT01605136|449237683|FG000|Study Period|Physician Decision|1|||
124894456|NCT01605136|449237684|FG001|Study Period|Physician Decision|1|||
124894457|NCT01605136|449237683|FG000|Study Period|Lost to Follow-up|0|||
124687640|NCT01202591|448475174|FG005|Overall Study|Adverse Event|0|||
124687641|NCT01202591|448475169|FG000|Overall Study|Other reason as per investigator|3|||
124687642|NCT01202591|448475170|FG001|Overall Study|Other reason as per investigator|4|||
124687643|NCT01202591|448475171|FG002|Overall Study|Other reason as per investigator|7|||
124687644|NCT01202591|448475172|FG003|Overall Study|Other reason as per investigator|3|||
124687645|NCT01202591|448475173|FG004|Overall Study|Other reason as per investigator|1|||
124687646|NCT01202591|448475174|FG005|Overall Study|Other reason as per investigator|3|||
124687647|NCT01202591|448475169|FG000|Overall Study|Withdrawal by Subject|0|||
124687648|NCT01202591|448475170|FG001|Overall Study|Withdrawal by Subject|0|||
124687649|NCT01202591|448475171|FG002|Overall Study|Withdrawal by Subject|0|||
124687650|NCT01202591|448475172|FG003|Overall Study|Withdrawal by Subject|0|||
124687651|NCT01202591|448475173|FG004|Overall Study|Withdrawal by Subject|2|||
124687652|NCT01202591|448475174|FG005|Overall Study|Withdrawal by Subject|1|||
124687653|NCT01202591|448475169|FG000|Overall Study|Objective Disease Progression|0|||
124687654|NCT01202591|448475170|FG001|Overall Study|Objective Disease Progression|0|||
124687655|NCT01202591|448475171|FG002|Overall Study|Objective Disease Progression|0|||
124687656|NCT01202591|448475172|FG003|Overall Study|Objective Disease Progression|0|||
124687657|NCT01202591|448475173|FG004|Overall Study|Objective Disease Progression|2|||
124687658|NCT01202591|448475174|FG005|Overall Study|Objective Disease Progression|0|||
124687659|NCT02207608|448475181|FG000|Overall Study|Adverse Event|1|||
124687660|NCT02207608|448475182|FG001|Overall Study|Adverse Event|0|||
124687661|NCT00980460|448475183|FG000|Overall Study|Death|0|||
124687662|NCT00980460|448475184|FG001|Overall Study|Death|0|||
124687663|NCT00980460|448475185|FG002|Overall Study|Death|1|||
124687664|NCT00980460|448475186|FG003|Overall Study|Death|2|||
124687665|NCT00980460|448475187|FG004|Overall Study|Death|1|||
124687666|NCT00980460|448475183|FG000|Overall Study|Lack of Efficacy|0|||
124687667|NCT00980460|448475184|FG001|Overall Study|Lack of Efficacy|0|||
124894458|NCT01605136|449237684|FG001|Study Period|Lost to Follow-up|2|||
124894459|NCT01605136|449237683|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
124894460|NCT01605136|449237684|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
124894461|NCT01072929|449237685|FG000|Overall Study|Adverse Event|8|||
124894462|NCT01072929|449237686|FG001|Overall Study|Adverse Event|11|||
124894463|NCT01072929|449237687|FG002|Overall Study|Adverse Event|2|||
124894464|NCT01072929|449237685|FG000|Overall Study|Lack of Efficacy|7|||
124894465|NCT01072929|449237686|FG001|Overall Study|Lack of Efficacy|4|||
124894466|NCT01072929|449237687|FG002|Overall Study|Lack of Efficacy|0|||
124687668|NCT00980460|448475185|FG002|Overall Study|Lack of Efficacy|10|||
124687669|NCT00980460|448475186|FG003|Overall Study|Lack of Efficacy|6|||
124687670|NCT00980460|448475187|FG004|Overall Study|Lack of Efficacy|8|||
124687671|NCT00980460|448475183|FG000|Overall Study|Lost to Follow-up|0|||
124894467|NCT01072929|449237685|FG000|Overall Study|Withdrawal by Subject|7|||
124894468|NCT01072929|449237686|FG001|Overall Study|Withdrawal by Subject|15|||
124894469|NCT01072929|449237687|FG002|Overall Study|Withdrawal by Subject|3|||
124894470|NCT01072929|449237685|FG000|Overall Study|Protocol Violation|13|||
124894471|NCT01072929|449237686|FG001|Overall Study|Protocol Violation|11|||
124894472|NCT01072929|449237687|FG002|Overall Study|Protocol Violation|2|||
124894473|NCT01072929|449237685|FG000|Overall Study|Lost to Follow-up|8|||
124894474|NCT01072929|449237686|FG001|Overall Study|Lost to Follow-up|4|||
124443302|NCT00568321|447584836|FG000|Overall Study|Lost to Follow-up|0|||
124443303|NCT00568321|447584837|FG001|Overall Study|Lost to Follow-up|0|||
124443304|NCT00568321|447584838|FG002|Overall Study|Lost to Follow-up|1|||
124687672|NCT00980460|448475184|FG001|Overall Study|Lost to Follow-up|0|||
124687673|NCT00980460|448475185|FG002|Overall Study|Lost to Follow-up|0|||
124687674|NCT00980460|448475186|FG003|Overall Study|Lost to Follow-up|1|||
124687675|NCT00980460|448475187|FG004|Overall Study|Lost to Follow-up|0|||
124687676|NCT00980460|448475183|FG000|Overall Study|Physician Decision|0|||
124687677|NCT00980460|448475184|FG001|Overall Study|Physician Decision|0|||
124894475|NCT01072929|449237687|FG002|Overall Study|Lost to Follow-up|1|||
124894476|NCT01072929|449237685|FG000|Overall Study|Noncompliance with study medication|0|||
124687678|NCT00980460|448475185|FG002|Overall Study|Physician Decision|11|||
124894477|NCT01072929|449237686|FG001|Overall Study|Noncompliance with study medication|3|||
124894478|NCT01072929|449237687|FG002|Overall Study|Noncompliance with study medication|0|||
124894479|NCT01072929|449237685|FG000|Overall Study|Noncompliance with study procedures|1|||
124894480|NCT01072929|449237686|FG001|Overall Study|Noncompliance with study procedures|0|||
124894481|NCT01072929|449237687|FG002|Overall Study|Noncompliance with study procedures|1|||
124894482|NCT01072929|449237685|FG000|Overall Study|Other|0|||
124894483|NCT01072929|449237686|FG001|Overall Study|Other|3|||
124894484|NCT01072929|449237687|FG002|Overall Study|Other|0|||
124894485|NCT00052962|449237690|FG000|Overall Study|Not evaluable|0|||
124894486|NCT00052962|449237691|FG001|Overall Study|Not evaluable|2|||
124894487|NCT00052962|449237690|FG000|Overall Study|Not randomized/not evaluable|1|||
124894488|NCT00052962|449237691|FG001|Overall Study|Not randomized/not evaluable|0|||
124894489|NCT01723774|449237700|FG000|Neoadjuvant|Ki67 > 10%|4|||
124894490|NCT01723774|449237701|FG001|Neoadjuvant|Ki67 > 10%|0|||
124894491|NCT01723774|449237702|FG002|Neoadjuvant|Ki67 > 10%|10|||
124894492|NCT01723774|449237703|FG003|Neoadjuvant|Ki67 > 10%|0|||
124894493|NCT01723774|449237700|FG000|Neoadjuvant|Withdrawal by Subject|3|||
124894494|NCT01723774|449237701|FG001|Neoadjuvant|Withdrawal by Subject|1|||
124894495|NCT01723774|449237702|FG002|Neoadjuvant|Withdrawal by Subject|0|||
124894496|NCT01723774|449237703|FG003|Neoadjuvant|Withdrawal by Subject|0|||
124894497|NCT01723774|449237700|FG000|Neoadjuvant|Disease progression|0|||
124894498|NCT01723774|449237701|FG001|Neoadjuvant|Disease progression|1|||
124894499|NCT01723774|449237702|FG002|Neoadjuvant|Disease progression|1|||
124894500|NCT01723774|449237703|FG003|Neoadjuvant|Disease progression|0|||
124894501|NCT01723774|449237700|FG000|Neoadjuvant|Adverse Event|0|||
124894502|NCT01723774|449237701|FG001|Neoadjuvant|Adverse Event|1|||
124894503|NCT01723774|449237702|FG002|Neoadjuvant|Adverse Event|2|||
124894504|NCT01723774|449237703|FG003|Neoadjuvant|Adverse Event|0|||
124894505|NCT01723774|449237700|FG000|Neoadjuvant|High estradiol|0|||
124894506|NCT01723774|449237701|FG001|Neoadjuvant|High estradiol|1|||
124894507|NCT01723774|449237702|FG002|Neoadjuvant|High estradiol|0|||
124894508|NCT01723774|449237703|FG003|Neoadjuvant|High estradiol|0|||
124894509|NCT02487446|449237707|FG000|Period 1|Physician Decision|0|||
124894510|NCT02487446|449237708|FG001|Period 1|Physician Decision|1|||
124894511|NCT02487446|449237707|FG000|Period 1|Lack of Efficacy|1|||
124894512|NCT02487446|449237708|FG001|Period 1|Lack of Efficacy|0|||
124894513|NCT02487446|449237707|FG000|Period 1|Protocol deviation|3|||
124894514|NCT02487446|449237708|FG001|Period 1|Protocol deviation|2|||
124894515|NCT02487446|449237707|FG000|Period 1|Lost to Follow-up|2|||
124894516|NCT02487446|449237708|FG001|Period 1|Lost to Follow-up|0|||
124894517|NCT02487446|449237707|FG000|Period 1|Withdrawal by Subject|2|||
124894518|NCT02487446|449237708|FG001|Period 1|Withdrawal by Subject|0|||
124894519|NCT02487446|449237707|FG000|Period 1|Adverse Event|5|||
124894520|NCT02487446|449237708|FG001|Period 1|Adverse Event|5|||
124894521|NCT02487446|449237707|FG000|Washout|Lost to Follow-up|0|||
124894522|NCT02487446|449237708|FG001|Washout|Lost to Follow-up|2|||
124894523|NCT02487446|449237707|FG000|Washout|Withdrawal by Subject|1|||
124894524|NCT02487446|449237708|FG001|Washout|Withdrawal by Subject|4|||
124894525|NCT02487446|449237707|FG000|Washout|Adverse Event|2|||
124894526|NCT02487446|449237708|FG001|Washout|Adverse Event|2|||
124894527|NCT02487446|449237707|FG000|Period 2|Protocol deviation|0|||
124894528|NCT02487446|449237708|FG001|Period 2|Protocol deviation|1|||
124894529|NCT02487446|449237707|FG000|Period 2|Lost to Follow-up|1|||
124894530|NCT02487446|449237708|FG001|Period 2|Lost to Follow-up|1|||
124894531|NCT02487446|449237707|FG000|Period 2|Withdrawal by Subject|1|||
124894532|NCT02487446|449237708|FG001|Period 2|Withdrawal by Subject|1|||
124894533|NCT02487446|449237707|FG000|Period 2|Adverse Event|6|||
124894534|NCT02487446|449237708|FG001|Period 2|Adverse Event|2|||
124894535|NCT04438785|449237709|FG000|Overall Study|change of weight, give up intervention|2|||
124894536|NCT04438785|449237710|FG001|Overall Study|change of weight, give up intervention|10|||
124894537|NCT04011033|449237711|FG000|Overall Study|Physician Decision|2|||
124894538|NCT04011033|449237712|FG001|Overall Study|Physician Decision|3|||
124894539|NCT04011033|449237711|FG000|Overall Study|Withdrawal by Subject|1|||
124894540|NCT04011033|449237712|FG001|Overall Study|Withdrawal by Subject|0|||
124894541|NCT00689104|449237713|FG000|Overall Study|Eligibility criterion not met|5|||
124894542|NCT00689104|449237714|FG001|Overall Study|Eligibility criterion not met|8|||
124894543|NCT00689104|449237715|FG002|Overall Study|Eligibility criterion not met|0|||
124894544|NCT00689104|449237716|FG003|Overall Study|Eligibility criterion not met|4|||
124894545|NCT00689104|449237713|FG000|Overall Study|Adverse Event|13|||
124894546|NCT00689104|449237714|FG001|Overall Study|Adverse Event|25|||
124894547|NCT00689104|449237715|FG002|Overall Study|Adverse Event|16|||
124894548|NCT00689104|449237716|FG003|Overall Study|Adverse Event|24|||
124894549|NCT00689104|449237713|FG000|Overall Study|Lack of Efficacy|5|||
124894550|NCT00689104|449237714|FG001|Overall Study|Lack of Efficacy|6|||
124894551|NCT00689104|449237715|FG002|Overall Study|Lack of Efficacy|2|||
124894552|NCT00689104|449237716|FG003|Overall Study|Lack of Efficacy|3|||
124894553|NCT00689104|449237713|FG000|Overall Study|Withdrawal by Subject|12|||
124894554|NCT00689104|449237714|FG001|Overall Study|Withdrawal by Subject|11|||
124894555|NCT00689104|449237715|FG002|Overall Study|Withdrawal by Subject|18|||
124894556|NCT00689104|449237716|FG003|Overall Study|Withdrawal by Subject|11|||
124894557|NCT00689104|449237713|FG000|Overall Study|Lost to Follow-up|4|||
124894558|NCT00689104|449237714|FG001|Overall Study|Lost to Follow-up|3|||
124894559|NCT00689104|449237715|FG002|Overall Study|Lost to Follow-up|2|||
124894560|NCT00689104|449237716|FG003|Overall Study|Lost to Follow-up|5|||
124894561|NCT00689104|449237713|FG000|Overall Study|Protocol Violation|2|||
124894562|NCT00689104|449237714|FG001|Overall Study|Protocol Violation|3|||
124894563|NCT00689104|449237715|FG002|Overall Study|Protocol Violation|5|||
124894564|NCT00689104|449237716|FG003|Overall Study|Protocol Violation|3|||
124894565|NCT00689104|449237713|FG000|Overall Study|Randomized but never received study drug|2|||
124894566|NCT00689104|449237714|FG001|Overall Study|Randomized but never received study drug|1|||
124894567|NCT00689104|449237715|FG002|Overall Study|Randomized but never received study drug|1|||
124894568|NCT00689104|449237716|FG003|Overall Study|Randomized but never received study drug|0|||
124894569|NCT00689104|449237713|FG000|Overall Study|Physician Decision|1|||
124894570|NCT00689104|449237714|FG001|Overall Study|Physician Decision|0|||
124894571|NCT00689104|449237715|FG002|Overall Study|Physician Decision|0|||
124894572|NCT00689104|449237716|FG003|Overall Study|Physician Decision|0|||
124894573|NCT00689104|449237713|FG000|Overall Study|Non-compliance with study procedures|0|||
124894574|NCT00689104|449237714|FG001|Overall Study|Non-compliance with study procedures|0|||
124894575|NCT00689104|449237715|FG002|Overall Study|Non-compliance with study procedures|1|||
124894576|NCT00689104|449237716|FG003|Overall Study|Non-compliance with study procedures|0|||
124894577|NCT00814489|449237744|FG000|Overall Study|Other|2|||
124894578|NCT00814489|449237745|FG001|Overall Study|Other|0|||
124894579|NCT00814489|449237746|FG002|Overall Study|Other|1|||
124894580|NCT01712685|449237747|FG000|Overall Study|pt declined to participate before trmt|1|||
124894581|NCT03253653|449237751|FG000|Overall Study|Withdrawal by Subject|4|||
124894582|NCT03253653|449237752|FG001|Overall Study|Withdrawal by Subject|1|||
124894583|NCT03253653|449237751|FG000|Overall Study|Protocol Violation|0|||
124894584|NCT03253653|449237752|FG001|Overall Study|Protocol Violation|5|||
124894585|NCT00662909|449237754|FG000|Overall Study|Adverse Event|17|||
124894586|NCT00662909|449237755|FG001|Overall Study|Adverse Event|18|||
124894587|NCT00662909|449237756|FG002|Overall Study|Adverse Event|19|||
124894588|NCT00662909|449237754|FG000|Overall Study|Lack of Efficacy|9|||
124894589|NCT00662909|449237755|FG001|Overall Study|Lack of Efficacy|1|||
124894590|NCT00662909|449237756|FG002|Overall Study|Lack of Efficacy|5|||
124894591|NCT00662909|449237754|FG000|Overall Study|Withdrawal by Subject|29|||
124894592|NCT00662909|449237755|FG001|Overall Study|Withdrawal by Subject|22|||
124894593|NCT00662909|449237756|FG002|Overall Study|Withdrawal by Subject|16|||
124894594|NCT00662909|449237754|FG000|Overall Study|Lost to Follow-up|2|||
124894595|NCT00662909|449237755|FG001|Overall Study|Lost to Follow-up|9|||
124894596|NCT00662909|449237756|FG002|Overall Study|Lost to Follow-up|3|||
124894597|NCT00662909|449237754|FG000|Overall Study|Protocol Violation|7|||
124894598|NCT00662909|449237755|FG001|Overall Study|Protocol Violation|4|||
124894599|NCT00662909|449237756|FG002|Overall Study|Protocol Violation|5|||
124894600|NCT00662909|449237754|FG000|Overall Study|Randomized- never received study drug|1|||
124894601|NCT00662909|449237755|FG001|Overall Study|Randomized- never received study drug|0|||
124894602|NCT00662909|449237756|FG002|Overall Study|Randomized- never received study drug|0|||
124894603|NCT00662909|449237754|FG000|Overall Study|Non-compliance with study procedures|3|||
124894604|NCT00662909|449237755|FG001|Overall Study|Non-compliance with study procedures|3|||
124894605|NCT00662909|449237756|FG002|Overall Study|Non-compliance with study procedures|2|||
124894606|NCT00662909|449237754|FG000|Overall Study|Physician Decision|1|||
124894607|NCT00662909|449237755|FG001|Overall Study|Physician Decision|1|||
124894608|NCT00662909|449237756|FG002|Overall Study|Physician Decision|2|||
124894609|NCT00662909|449237754|FG000|Overall Study|Eligibility criterion not met|0|||
124894610|NCT00662909|449237755|FG001|Overall Study|Eligibility criterion not met|1|||
124894611|NCT00662909|449237756|FG002|Overall Study|Eligibility criterion not met|1|||
124969498|NCT03520075|449517411|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969499|NCT03520075|449517412|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
124969500|NCT03520075|449517413|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
124969501|NCT03520075|449517414|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
124969502|NCT03520075|449517415|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969503|NCT03520075|449517416|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
124969504|NCT03520075|449517417|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969505|NCT03520075|449517418|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
124969506|NCT03520075|449517419|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969507|NCT03520075|449517420|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969508|NCT03520075|449517421|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
124969509|NCT03520075|449517422|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969510|NCT03520075|449517423|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969511|NCT03520075|449517424|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969512|NCT03520075|449517425|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969513|NCT03520075|449517426|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124969514|NCT03520075|449517427|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
124687679|NCT00980460|448475186|FG003|Overall Study|Physician Decision|5|||
124687680|NCT00980460|448475187|FG004|Overall Study|Physician Decision|3|||
124687681|NCT00980460|448475183|FG000|Overall Study|Withdrawal by Subject|0|||
124687682|NCT00980460|448475184|FG001|Overall Study|Withdrawal by Subject|0|||
124894612|NCT01518257|449239446|FG000|Overall Study|Lost to Follow-up|1|||
124894613|NCT01518257|449239447|FG001|Overall Study|Lost to Follow-up|0|||
124894614|NCT01518257|449239446|FG000|Overall Study|Other Miscellaneous Reason|1|||
124894615|NCT01518257|449239447|FG001|Overall Study|Other Miscellaneous Reason|0|||
124894616|NCT00924664|449239448|FG000|Overall Study|Adverse Event|23|||
124894617|NCT00924664|449239449|FG001|Overall Study|Adverse Event|39|||
124894618|NCT00924664|449239448|FG000|Overall Study|Lack of Efficacy|10|||
124894619|NCT00924664|449239449|FG001|Overall Study|Lack of Efficacy|15|||
124894620|NCT00924664|449239448|FG000|Overall Study|Lost to Follow-up|10|||
124894621|NCT00924664|449239449|FG001|Overall Study|Lost to Follow-up|12|||
124894622|NCT00924664|449239448|FG000|Overall Study|Withdrawal by Subject|47|||
124894623|NCT00924664|449239449|FG001|Overall Study|Withdrawal by Subject|71|||
124894624|NCT00924664|449239448|FG000|Overall Study|Protocol Violation|2|||
124443305|NCT00568321|447584836|FG000|Overall Study|Withdrawal by Subject|2|||
124443306|NCT00568321|447584837|FG001|Overall Study|Withdrawal by Subject|0|||
124443307|NCT00568321|447584838|FG002|Overall Study|Withdrawal by Subject|0|||
124443308|NCT00568321|447584836|FG000|Overall Study|Protocol Violation|0|||
124443309|NCT00568321|447584837|FG001|Overall Study|Protocol Violation|0|||
124443310|NCT00568321|447584838|FG002|Overall Study|Protocol Violation|1|||
124443311|NCT00568321|447584836|FG000|Overall Study|Randomized, not treated|2|||
124443312|NCT00568321|447584837|FG001|Overall Study|Randomized, not treated|0|||
124443313|NCT00568321|447584838|FG002|Overall Study|Randomized, not treated|1|||
124443314|NCT00937833|447584839|FG000|Overall Study|Protocol Violation|1|||
124443315|NCT00937833|447584840|FG001|Overall Study|Protocol Violation|2|||
124443316|NCT00937833|447584839|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
124894625|NCT00924664|449239449|FG001|Overall Study|Protocol Violation|5|||
124894626|NCT00924664|449239448|FG000|Overall Study|Pregnancy|1|||
124894627|NCT00924664|449239449|FG001|Overall Study|Pregnancy|1|||
124894628|NCT00924664|449239448|FG000|Overall Study|Death|0|||
124894629|NCT00924664|449239449|FG001|Overall Study|Death|2|||
124894630|NCT00924664|449239448|FG000|Overall Study|Study terminated by sponsor|199|||
124894631|NCT00924664|449239449|FG001|Overall Study|Study terminated by sponsor|330|||
124894632|NCT00924664|449239448|FG000|Overall Study|Other|29|||
124894633|NCT00924664|449239449|FG001|Overall Study|Other|52|||
124894634|NCT00924664|449239448|FG000|Overall Study|Randomized but not Treated|1|||
124894635|NCT00924664|449239449|FG001|Overall Study|Randomized but not Treated|0|||
124894636|NCT03158948|449239451|FG000|Overall Study|Death|1|||
124894637|NCT03158948|449239452|FG001|Overall Study|Death|1|||
124894638|NCT03158948|449239453|FG002|Overall Study|Death|3|||
124894639|NCT03158948|449239454|FG003|Overall Study|Death|2|||
124894640|NCT03158948|449239451|FG000|Overall Study|Physician Decision|0|||
124443317|NCT00937833|447584840|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
124443318|NCT00937833|447584839|FG000|Overall Study|Lost to Follow-up|10|||
124443319|NCT00937833|447584840|FG001|Overall Study|Lost to Follow-up|8|||
124443320|NCT00937833|447584839|FG000|Overall Study|Withdrawal by Subject|4|||
124443321|NCT00937833|447584840|FG001|Overall Study|Withdrawal by Subject|6|||
124687683|NCT00980460|448475185|FG002|Overall Study|Withdrawal by Subject|1|||
124687684|NCT00980460|448475186|FG003|Overall Study|Withdrawal by Subject|0|||
124687685|NCT00980460|448475187|FG004|Overall Study|Withdrawal by Subject|0|||
124687686|NCT00980460|448475183|FG000|Overall Study|Ineligible|0|||
124687687|NCT00980460|448475184|FG001|Overall Study|Ineligible|2|||
124687688|NCT00980460|448475185|FG002|Overall Study|Ineligible|3|||
124687689|NCT00980460|448475186|FG003|Overall Study|Ineligible|1|||
124687690|NCT00980460|448475187|FG004|Overall Study|Ineligible|4|||
124687691|NCT00980460|448475183|FG000|Overall Study|Refusal of further therapy|0|||
124687692|NCT00980460|448475184|FG001|Overall Study|Refusal of further therapy|2|||
124687693|NCT00980460|448475185|FG002|Overall Study|Refusal of further therapy|3|||
124687694|NCT00980460|448475186|FG003|Overall Study|Refusal of further therapy|2|||
124687695|NCT00980460|448475187|FG004|Overall Study|Refusal of further therapy|0|||
124687696|NCT00980460|448475183|FG000|Overall Study|No therapy within 42 days of resection|0|||
124443322|NCT01676909|447584841|FG000|Overall Study|Withdrawal by Subject|3|||
124443323|NCT01676909|447584842|FG001|Overall Study|Withdrawal by Subject|5|||
124443324|NCT01676909|447584841|FG000|Overall Study|Lost to Follow-up|15|||
124443325|NCT01676909|447584842|FG001|Overall Study|Lost to Follow-up|9|||
124443326|NCT00221195|447584847|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
124443327|NCT00221195|447584848|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
124687697|NCT00980460|448475184|FG001|Overall Study|No therapy within 42 days of resection|0|||
124687698|NCT00980460|448475185|FG002|Overall Study|No therapy within 42 days of resection|3|||
124894641|NCT03158948|449239452|FG001|Overall Study|Physician Decision|0|||
124894642|NCT03158948|449239453|FG002|Overall Study|Physician Decision|0|||
124894643|NCT03158948|449239454|FG003|Overall Study|Physician Decision|1|||
124894644|NCT02153788|449239455|FG000|Overall Study|Physician Decision|2|||
124894645|NCT02153788|449239456|FG001|Overall Study|Physician Decision|1|||
124894646|NCT04672460|449239457|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
124894647|NCT04672460|449239458|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
124894648|NCT04672460|449239457|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
124894649|NCT04672460|449239458|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
124894650|NCT04672460|449239457|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
124894651|NCT04672460|449239458|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
124894652|NCT04672460|449239457|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
124894653|NCT04672460|449239458|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
124894654|NCT04672460|449239457|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
124894655|NCT04672460|449239458|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
124894656|NCT04672460|449239457|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
124443328|NCT00221195|447584847|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
124443329|NCT00221195|447584848|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
124894657|NCT04672460|449239458|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
124894658|NCT04672460|449239457|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
124894659|NCT04672460|449239458|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
124894660|NCT04672460|449239457|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
124894661|NCT04672460|449239458|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
124894662|NCT04672460|449239457|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
124443330|NCT00221195|447584847|FG000|Washout Period (Months 7-9)|Death|0|||
124443331|NCT00221195|447584848|FG001|Washout Period (Months 7-9)|Death|1|||
124443332|NCT00221195|447584847|FG000|Therapy 2 (Months 10-15)|Death|1|||
124443333|NCT00221195|447584848|FG001|Therapy 2 (Months 10-15)|Death|0|||
124443334|NCT00221195|447584847|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
124443335|NCT00221195|447584848|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
124443336|NCT00162032|447584850|FG000|Overall Study|Lost to Follow-up|4|||
124443337|NCT00162032|447584851|FG001|Overall Study|Lost to Follow-up|2|||
124443338|NCT00162032|447584850|FG000|Overall Study|Reason not specified|1|||
124443339|NCT00162032|447584851|FG001|Overall Study|Reason not specified|0|||
124443340|NCT00833911|447584852|FG000|Titration|Adverse Event|18|||
124443341|NCT00833911|447584852|FG000|Titration|Withdrawal by Subject|3|||
124443342|NCT00833911|447584852|FG000|Maintenance Phase I|Adverse Event|73|||
124443343|NCT00833911|447584852|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
124443344|NCT00833911|447584852|FG000|Maintenance Phase I|Physician Decision|10|||
124443345|NCT00833911|447584852|FG000|Maintenance Phase I|Lack of Efficacy|4|||
124443346|NCT00833911|447584852|FG000|Maintenance Phase II|Adverse Event|6|||
124443347|NCT00833911|447584852|FG000|Maintenance Phase II|Physician Decision|2|||
124443348|NCT00833911|447584852|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
124443349|NCT00833911|447584852|FG000|Maintenance Phase II|Lack of Efficacy|1|||
124443350|NCT00718640|447584853|FG000|Overall Study|Adverse Event|4|||
124443351|NCT00718640|447584853|FG000|Overall Study|Death|1|||
124443352|NCT00718640|447584853|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
124443353|NCT00818389|447584856|FG000|Overall Study|Death|1|||
124443354|NCT00818389|447584857|FG001|Overall Study|Death|3|||
124443355|NCT00818389|447584856|FG000|Overall Study|ALS Disease Progression|1|||
124443356|NCT00818389|447584857|FG001|Overall Study|ALS Disease Progression|0|||
124443357|NCT00818389|447584856|FG000|Overall Study|Withdrawal by Subject|2|||
124443358|NCT00818389|447584857|FG001|Overall Study|Withdrawal by Subject|2|||
124443359|NCT00818389|447584856|FG000|Overall Study|Adverse Event|0|||
124443360|NCT00818389|447584857|FG001|Overall Study|Adverse Event|1|||
124443361|NCT01207596|447584858|FG000|Overall Study|Physician Decision|4|||
124443362|NCT01207596|447584858|FG000|Overall Study|Lack of Efficacy|1|||
124443363|NCT01207596|447584858|FG000|Overall Study|Adverse Event|3|||
124687699|NCT00980460|448475186|FG003|Overall Study|No therapy within 42 days of resection|1|||
124687700|NCT00980460|448475187|FG004|Overall Study|No therapy within 42 days of resection|0|||
124687701|NCT00980460|448475183|FG000|Overall Study|No transplant by protocol timepoints|0|||
124687702|NCT00980460|448475184|FG001|Overall Study|No transplant by protocol timepoints|0|||
124687703|NCT00980460|448475185|FG002|Overall Study|No transplant by protocol timepoints|3|||
124687704|NCT00980460|448475186|FG003|Overall Study|No transplant by protocol timepoints|0|||
124687705|NCT00980460|448475187|FG004|Overall Study|No transplant by protocol timepoints|0|||
124687706|NCT03580928|448475188|FG000|Overall Study|Death|0|||
124687707|NCT03580928|448475189|FG001|Overall Study|Death|3|||
124687708|NCT03580928|448475188|FG000|Overall Study|Withdrawal by Subject|2|||
124687709|NCT03580928|448475189|FG001|Overall Study|Withdrawal by Subject|1|||
124687710|NCT03580928|448475188|FG000|Overall Study|Lost to Follow-up|2|||
124687711|NCT03580928|448475189|FG001|Overall Study|Lost to Follow-up|0|||
124687712|NCT03580928|448475188|FG000|Overall Study|Progressive Disease|0|||
124443364|NCT01207596|447584858|FG000|Overall Study|Withdrawal by Subject|1|||
124443365|NCT03548987|447584859|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
124443366|NCT03548987|447584860|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
124443367|NCT03548987|447584859|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
124443368|NCT03548987|447584860|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
124687713|NCT03580928|448475189|FG001|Overall Study|Progressive Disease|1|||
124443369|NCT03548987|447584859|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
124443370|NCT03548987|447584860|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
124443371|NCT03548987|447584859|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
124443372|NCT03548987|447584860|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
124443373|NCT03548987|447584859|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
124443374|NCT03548987|447584860|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
124443375|NCT03548987|447584859|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
124443376|NCT03548987|447584860|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
124443377|NCT03548987|447584859|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
124443378|NCT03548987|447584860|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
124443379|NCT03548987|447584859|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
124443380|NCT03548987|447584860|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
124443381|NCT03548987|447584859|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
124443382|NCT03548987|447584860|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
124443383|NCT03548987|447584859|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
124687714|NCT01001104|448475916|FG000|Overall Study|Adverse Event|2|||
124687715|NCT01001104|448475917|FG001|Overall Study|Adverse Event|1|||
124894663|NCT04672460|449239458|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
124894664|NCT04672460|449239457|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
124894665|NCT04672460|449239458|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
124894666|NCT04672460|449239457|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
124894667|NCT04672460|449239458|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
124894668|NCT04672460|449239457|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
124894669|NCT04672460|449239458|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
124894670|NCT04672460|449239457|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
124894671|NCT04672460|449239458|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
124894672|NCT04672460|449239457|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
124894673|NCT04672460|449239458|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
124894674|NCT04672460|449239457|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
124894675|NCT04672460|449239458|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
124894676|NCT04672460|449239457|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
124894677|NCT04672460|449239458|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
124894678|NCT04672460|449239457|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
124894679|NCT04672460|449239458|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
124894680|NCT01876043|449239461|FG000|Overall Study|Death|1|||
124894681|NCT01876043|449239461|FG000|Overall Study|Withdrawal by Subject|1|||
124894682|NCT00079937|449239463|FG000|Overall Study|Adverse Event|2|||
124894683|NCT00079937|449239464|FG001|Overall Study|Adverse Event|1|||
124894684|NCT00079937|449239463|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124894685|NCT00079937|449239464|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124894686|NCT00079937|449239463|FG000|Overall Study|Subject no longer requires study drug|3|||
124894687|NCT00079937|449239464|FG001|Overall Study|Subject no longer requires study drug|0|||
124894688|NCT00079937|449239463|FG000|Overall Study|Protocol Violation|8|||
124894689|NCT00079937|449239464|FG001|Overall Study|Protocol Violation|6|||
124894690|NCT00079937|449239463|FG000|Overall Study|Withdrawal by Subject|21|||
124894691|NCT00079937|449239464|FG001|Overall Study|Withdrawal by Subject|7|||
124894692|NCT00079937|449239463|FG000|Overall Study|Lost to Follow-up|12|||
124894693|NCT00079937|449239464|FG001|Overall Study|Lost to Follow-up|5|||
124894694|NCT00079937|449239463|FG000|Overall Study|Administrative problems|22|||
124894695|NCT00079937|449239464|FG001|Overall Study|Administrative problems|11|||
124894696|NCT01616563|449239465|FG000|Overall Study|Lost to Follow-up|40|||
124894697|NCT02206685|449239466|FG000|Overall Study|Surgery cancelled/changed|2|||
124894698|NCT02206685|449239467|FG001|Overall Study|Surgery cancelled/changed|3|||
124894699|NCT02206685|449239466|FG000|Overall Study|Withdrawal by Subject|1|||
124894700|NCT02206685|449239467|FG001|Overall Study|Withdrawal by Subject|2|||
124894701|NCT02206685|449239466|FG000|Overall Study|Protocol Violation|2|||
124894702|NCT02206685|449239467|FG001|Overall Study|Protocol Violation|2|||
124894703|NCT00093795|449239471|FG000|Overall Study|No follow up data|20|||
124894704|NCT00093795|449239472|FG001|Overall Study|No follow up data|16|||
124443384|NCT03548987|447584860|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
124443385|NCT03548987|447584859|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
124443386|NCT03548987|447584860|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
124687716|NCT01001104|448475918|FG002|Overall Study|Adverse Event|0|||
124687717|NCT01001104|448475919|FG003|Overall Study|Adverse Event|0|||
124894705|NCT00093795|449239473|FG002|Overall Study|No follow up data|17|||
124894706|NCT01195675|449239474|FG000|Overall Study|Adverse Event|1|||
124894707|NCT01195675|449239474|FG000|Overall Study|Withdrawal by Subject|2|||
124894708|NCT01106287|449239475|FG000|Overall Study|Adverse Event|1|||
124894709|NCT01106287|449239476|FG001|Overall Study|Adverse Event|0|||
124894710|NCT01106287|449239477|FG002|Overall Study|Adverse Event|0|||
124894711|NCT01106287|449239478|FG003|Overall Study|Adverse Event|0|||
124687718|NCT01001104|448475916|FG000|Overall Study|Lost to Follow-up|0|||
124687719|NCT01001104|448475917|FG001|Overall Study|Lost to Follow-up|0|||
124687720|NCT01001104|448475918|FG002|Overall Study|Lost to Follow-up|1|||
124687721|NCT01001104|448475919|FG003|Overall Study|Lost to Follow-up|0|||
124687722|NCT01001104|448475916|FG000|Overall Study|Entry Criteria Not Met|0|||
124687723|NCT01001104|448475917|FG001|Overall Study|Entry Criteria Not Met|0|||
124687724|NCT01001104|448475918|FG002|Overall Study|Entry Criteria Not Met|0|||
124687725|NCT01001104|448475919|FG003|Overall Study|Entry Criteria Not Met|1|||
124687726|NCT01001104|448475916|FG000|Overall Study|Withdrawal by Subject|0|||
124687727|NCT01001104|448475917|FG001|Overall Study|Withdrawal by Subject|0|||
124687728|NCT01001104|448475918|FG002|Overall Study|Withdrawal by Subject|0|||
124687729|NCT01001104|448475919|FG003|Overall Study|Withdrawal by Subject|2|||
124687730|NCT02397837|448475921|FG000|Overall Study|Withdrawal by Subject|6|||
124687731|NCT02397837|448475922|FG001|Overall Study|Withdrawal by Subject|5|||
124687732|NCT02397837|448475921|FG000|Overall Study|Physician Decision|1|||
124687733|NCT02397837|448475922|FG001|Overall Study|Physician Decision|1|||
124687734|NCT00599313|448475923|FG000|Overall Study|Adverse Event|19|||
124687735|NCT00599313|448475923|FG000|Overall Study|Disease Progression|12|||
124687736|NCT00599313|448475923|FG000|Overall Study|Patient Request|4|||
124687737|NCT00599313|448475923|FG000|Overall Study|Ineligible|1|||
124687738|NCT02536794|448475924|FG000|Reached 1st Response Assessment|Adverse Event|2|||
124687739|NCT02536794|448475924|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
124687740|NCT02536794|448475924|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
124687741|NCT02536794|448475924|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
124687742|NCT02536794|448475924|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
124687743|NCT02536794|448475924|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
124894712|NCT00072475|449239479|FG000|Overall Study|Adverse Event|44|||
124894713|NCT00072475|449239479|FG000|Overall Study|Death|3|||
124894714|NCT00072475|449239479|FG000|Overall Study|Withdrawal by Subject|46|||
124894715|NCT00072475|449239479|FG000|Overall Study|Patient/Investigator Decision|4|||
124894716|NCT04730947|449239480|FG000|Overall Study|Withdrawal by Subject|0|||
124894717|NCT04730947|449239481|FG001|Overall Study|Withdrawal by Subject|1|||
124894718|NCT00940017|449239482|FG000|Overall Study|did not meet entrance criteria|3|||
124894719|NCT00940017|449239482|FG000|Overall Study|Adverse Event|1|||
124894720|NCT01450943|449239483|FG000|Overall Study|Screen failure, loss to follow-up|2|||
124894721|NCT01450943|449239484|FG001|Overall Study|Screen failure, loss to follow-up|7|||
124894722|NCT01450943|449239485|FG002|Overall Study|Screen failure, loss to follow-up|6|||
124894723|NCT05328973|449239491|FG000|Overall Study|Withdrawal by Subject|0|||
124687744|NCT01496456|448475935|FG000|Overall Study|Protocol Violation|1|||
124687745|NCT01496456|448475935|FG000|Overall Study|Lost to Follow-up|7|||
124687746|NCT04919161|448475936|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
124687747|NCT04919161|448475937|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
124687748|NCT04919161|448475936|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
124687749|NCT04919161|448475937|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
124894724|NCT05328973|449239492|FG001|Overall Study|Withdrawal by Subject|1|||
124894725|NCT00946114|449239493|FG000|Overall Study|Death|5|||
124687750|NCT04919161|448475936|FG000|Overall Study|Acute ankle sprain after session 1|0|||
124687751|NCT04919161|448475937|FG001|Overall Study|Acute ankle sprain after session 1|1|||
124687752|NCT00712920|448475938|FG000|Overall Study|Adverse Event|3|||
124687753|NCT00712920|448475939|FG001|Overall Study|Adverse Event|4|||
124687754|NCT00712920|448475940|FG002|Overall Study|Adverse Event|7|||
124687755|NCT00712920|448475938|FG000|Overall Study|Withdrawal by Subject|4|||
124687756|NCT00712920|448475939|FG001|Overall Study|Withdrawal by Subject|2|||
124687757|NCT00712920|448475940|FG002|Overall Study|Withdrawal by Subject|1|||
124687758|NCT00712920|448475938|FG000|Overall Study|Lost to Follow-up|1|||
124687759|NCT00712920|448475939|FG001|Overall Study|Lost to Follow-up|4|||
124687760|NCT00712920|448475940|FG002|Overall Study|Lost to Follow-up|0|||
124687761|NCT00712920|448475938|FG000|Overall Study|Lack of Efficacy|1|||
124687762|NCT00712920|448475939|FG001|Overall Study|Lack of Efficacy|0|||
124687763|NCT00712920|448475940|FG002|Overall Study|Lack of Efficacy|1|||
124687764|NCT00712920|448475938|FG000|Overall Study|Other|5|||
124687765|NCT00712920|448475939|FG001|Overall Study|Other|7|||
124687766|NCT00712920|448475940|FG002|Overall Study|Other|3|||
124687767|NCT00712920|448475938|FG000|Overall Study|Non-compliance|3|||
124687768|NCT00712920|448475939|FG001|Overall Study|Non-compliance|0|||
124687769|NCT00712920|448475940|FG002|Overall Study|Non-compliance|0|||
124687770|NCT03086343|448475945|FG000|Period 1|Adverse Event|7|||
124687771|NCT03086343|448475946|FG001|Period 1|Adverse Event|7|||
124687772|NCT03086343|448475947|FG002|Period 1|Adverse Event|0|||
124687773|NCT03086343|448475948|FG003|Period 1|Adverse Event|1|||
124687774|NCT03086343|448475945|FG000|Period 1|Withdrawal by Subject|6|||
124687775|NCT03086343|448475946|FG001|Period 1|Withdrawal by Subject|10|||
124687776|NCT03086343|448475947|FG002|Period 1|Withdrawal by Subject|0|||
124687777|NCT03086343|448475948|FG003|Period 1|Withdrawal by Subject|0|||
124687778|NCT03086343|448475945|FG000|Period 1|Lost to Follow-up|1|||
124687779|NCT03086343|448475946|FG001|Period 1|Lost to Follow-up|3|||
124687780|NCT03086343|448475947|FG002|Period 1|Lost to Follow-up|1|||
124687781|NCT03086343|448475948|FG003|Period 1|Lost to Follow-up|0|||
124687782|NCT03086343|448475945|FG000|Period 1|Other, Not Specified|10|||
124687783|NCT03086343|448475946|FG001|Period 1|Other, Not Specified|12|||
124687784|NCT03086343|448475947|FG002|Period 1|Other, Not Specified|2|||
124687785|NCT03086343|448475948|FG003|Period 1|Other, Not Specified|1|||
124687786|NCT03086343|448475945|FG000|Period 1|Missing|1|||
124687787|NCT03086343|448475946|FG001|Period 1|Missing|0|||
124687788|NCT03086343|448475947|FG002|Period 1|Missing|0|||
124687789|NCT03086343|448475948|FG003|Period 1|Missing|0|||
124687790|NCT03086343|448475945|FG000|Period 2|Adverse Event|20|||
124687791|NCT03086343|448475946|FG001|Period 2|Adverse Event|11|||
124687792|NCT03086343|448475947|FG002|Period 2|Adverse Event|1|||
124687793|NCT03086343|448475948|FG003|Period 2|Adverse Event|2|||
124687794|NCT03086343|448475945|FG000|Period 2|Withdrawal by Subject|15|||
124687795|NCT03086343|448475946|FG001|Period 2|Withdrawal by Subject|25|||
124687796|NCT03086343|448475947|FG002|Period 2|Withdrawal by Subject|2|||
124687797|NCT03086343|448475948|FG003|Period 2|Withdrawal by Subject|2|||
124687798|NCT03086343|448475945|FG000|Period 2|Lost to Follow-up|6|||
124687799|NCT03086343|448475946|FG001|Period 2|Lost to Follow-up|11|||
124687800|NCT03086343|448475947|FG002|Period 2|Lost to Follow-up|1|||
124687801|NCT03086343|448475948|FG003|Period 2|Lost to Follow-up|0|||
124687802|NCT03086343|448475945|FG000|Period 2|COVID-19 Infection|5|||
124687803|NCT03086343|448475946|FG001|Period 2|COVID-19 Infection|0|||
124687804|NCT03086343|448475947|FG002|Period 2|COVID-19 Infection|0|||
124687805|NCT03086343|448475948|FG003|Period 2|COVID-19 Infection|0|||
124759339|NCT00452790|448742620|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
124759340|NCT00452790|448742621|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
124759341|NCT00452790|448742620|FG000|Infant Series|Parent/legal guardian request|8|||
124759342|NCT00452790|448742621|FG001|Infant Series|Parent/legal guardian request|6|||
124687806|NCT03086343|448475945|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
124687807|NCT03086343|448475946|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
124687808|NCT03086343|448475947|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
124687809|NCT03086343|448475948|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
124687810|NCT03086343|448475945|FG000|Period 2|Other, Not Specified|23|||
124687811|NCT03086343|448475946|FG001|Period 2|Other, Not Specified|22|||
124687812|NCT03086343|448475947|FG002|Period 2|Other, Not Specified|2|||
124687813|NCT03086343|448475948|FG003|Period 2|Other, Not Specified|4|||
124687814|NCT02830087|448475953|FG000|Overall Study|No study staff to follow-up patients|4|||
124687815|NCT02830087|448475954|FG001|Overall Study|No study staff to follow-up patients|4|||
124687816|NCT02830087|448475955|FG002|Overall Study|No study staff to follow-up patients|4|||
124687817|NCT02830087|448475956|FG003|Overall Study|No study staff to follow-up patients|3|||
124687818|NCT02830087|448475957|FG004|Overall Study|No study staff to follow-up patients|3|||
124687819|NCT02830087|448475958|FG005|Overall Study|No study staff to follow-up patients|3|||
124687820|NCT02583269|448475959|FG000|Overall Study|Patient hospitalized prior to start|1|||
124687821|NCT02583269|448475960|FG001|Overall Study|Patient hospitalized prior to start|0|||
124687822|NCT02583269|448475961|FG002|Overall Study|Patient hospitalized prior to start|0|||
124687823|NCT02583269|448475962|FG003|Overall Study|Patient hospitalized prior to start|0|||
124687824|NCT02583269|448475963|FG004|Overall Study|Patient hospitalized prior to start|0|||
124687825|NCT03611946|448475964|FG000|Overall Study|Withdrawal by Subject|0|||
124687826|NCT03611946|448475965|FG001|Overall Study|Withdrawal by Subject|0|||
124687827|NCT03611946|448475966|FG002|Overall Study|Withdrawal by Subject|1|||
124687828|NCT03611946|448475967|FG003|Overall Study|Withdrawal by Subject|0|||
124687829|NCT03043573|448475968|FG000|Overall Study|Lost to Follow-up|3|||
124687830|NCT03043573|448475969|FG001|Overall Study|Lost to Follow-up|3|||
124687831|NCT03043573|448475968|FG000|Overall Study|Physician Decision|0|||
124687832|NCT03043573|448475969|FG001|Overall Study|Physician Decision|5|||
124687833|NCT03043573|448475968|FG000|Overall Study|Withdrawal by Subject|0|||
124687834|NCT03043573|448475969|FG001|Overall Study|Withdrawal by Subject|4|||
124687835|NCT01251861|448475972|FG000|Overall Study|Disease progression|6|||
124687836|NCT01251861|448475973|FG001|Overall Study|Disease progression|6|||
124687837|NCT01251861|448475972|FG000|Overall Study|Adverse Event|2|||
124687838|NCT01251861|448475973|FG001|Overall Study|Adverse Event|17|||
124687839|NCT01251861|448475972|FG000|Overall Study|Withdrawal by Subject|2|||
124687840|NCT01251861|448475973|FG001|Overall Study|Withdrawal by Subject|2|||
124687841|NCT01251861|448475972|FG000|Overall Study|Alternative therapy|1|||
124687842|NCT01251861|448475973|FG001|Overall Study|Alternative therapy|0|||
124687843|NCT01251861|448475972|FG000|Overall Study|Other complicating disease|0|||
124687844|NCT01251861|448475973|FG001|Overall Study|Other complicating disease|1|||
124687845|NCT01251861|448475972|FG000|Overall Study|Physician Decision|1|||
124687846|NCT01251861|448475973|FG001|Overall Study|Physician Decision|0|||
124687847|NCT01251861|448475972|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
124687848|NCT01251861|448475973|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
124687849|NCT01251861|448475972|FG000|Overall Study|Other|1|||
124894726|NCT00946114|449239494|FG001|Overall Study|Death|2|||
124894727|NCT00946114|449239493|FG000|Overall Study|Other|1|||
124894728|NCT00946114|449239494|FG001|Overall Study|Other|0|||
124894729|NCT00946114|449239493|FG000|Overall Study|Withdrawal by Subject|2|||
124894730|NCT00946114|449239494|FG001|Overall Study|Withdrawal by Subject|0|||
124894731|NCT01764386|449239498|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
124894732|NCT01764386|449239499|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
124687850|NCT01251861|448475973|FG001|Overall Study|Other|0|||
124687851|NCT01251861|448475972|FG000|Overall Study|Never started therapy|4|||
124687852|NCT01251861|448475973|FG001|Overall Study|Never started therapy|1|||
124687853|NCT01251861|448475972|FG000|Overall Study|Potential interaction of drugs|0|||
124687854|NCT01251861|448475973|FG001|Overall Study|Potential interaction of drugs|1|||
124687855|NCT05800145|448475979|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
124894733|NCT01764386|449239498|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
124687856|NCT05800145|448475980|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
124894734|NCT01764386|449239499|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
124687857|NCT05800145|448475981|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
124687858|NCT05800145|448475982|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
124687859|NCT05800145|448475983|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
124687860|NCT05800145|448475984|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
124687861|NCT05800145|448475979|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
124687862|NCT05800145|448475980|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
124894735|NCT01764386|449239498|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
124894736|NCT01764386|449239499|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
124894737|NCT01764386|449239498|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
124894738|NCT01764386|449239499|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
124894739|NCT01764386|449239498|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
124894740|NCT01764386|449239499|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
124894741|NCT01764386|449239498|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
124894742|NCT01764386|449239499|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
124894743|NCT01764386|449239498|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
124894744|NCT01764386|449239499|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
124894745|NCT01764386|449239498|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
124894746|NCT01764386|449239499|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
124894747|NCT04454567|449239500|FG000|Overall Study|Study Terminated by Sponsor|1|||
124894748|NCT04454567|449239501|FG001|Overall Study|Study Terminated by Sponsor|1|||
124894749|NCT02757885|449239502|FG000|Overall Study|Screen Failures|4|||
124894750|NCT01175707|449239503|FG000|Overall Study|Adverse Event|4|||
124894751|NCT01175707|449239504|FG001|Overall Study|Adverse Event|6|||
124894752|NCT00003377|449239507|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
124894753|NCT00003377|449239508|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
124894754|NCT00003377|449239509|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
124894755|NCT00003377|449239510|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
124894756|NCT00003377|449239511|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
124894757|NCT00003377|449239507|FG000|Period II|Ureteral stent complications|0|||
124894758|NCT00003377|449239508|FG001|Period II|Ureteral stent complications|0|||
124894759|NCT00003377|449239509|FG002|Period II|Ureteral stent complications|0|||
124894760|NCT00003377|449239510|FG003|Period II|Ureteral stent complications|0|||
124894761|NCT00003377|449239511|FG004|Period II|Ureteral stent complications|1|||
124894762|NCT00463151|449239513|FG000|Overall Study|Adverse Event|0|||
124894763|NCT00463151|449239514|FG001|Overall Study|Adverse Event|0|||
124894764|NCT00463151|449239515|FG002|Overall Study|Adverse Event|1|||
124894765|NCT00463151|449239516|FG003|Overall Study|Adverse Event|0|||
124894766|NCT00463151|449239513|FG000|Overall Study|Lack of Efficacy|2|||
124894767|NCT00463151|449239514|FG001|Overall Study|Lack of Efficacy|5|||
124894768|NCT00463151|449239515|FG002|Overall Study|Lack of Efficacy|2|||
124894769|NCT00463151|449239516|FG003|Overall Study|Lack of Efficacy|5|||
124894770|NCT00463151|449239513|FG000|Overall Study|Protocol Violation|0|||
124894771|NCT00463151|449239514|FG001|Overall Study|Protocol Violation|0|||
124894772|NCT00463151|449239515|FG002|Overall Study|Protocol Violation|0|||
124894773|NCT00463151|449239516|FG003|Overall Study|Protocol Violation|1|||
124894774|NCT00463151|449239513|FG000|Overall Study|Withdrawal by Subject|0|||
124894775|NCT00463151|449239514|FG001|Overall Study|Withdrawal by Subject|0|||
124894776|NCT00463151|449239515|FG002|Overall Study|Withdrawal by Subject|0|||
124894777|NCT00463151|449239516|FG003|Overall Study|Withdrawal by Subject|1|||
124894778|NCT05349084|449239517|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
124894779|NCT00688688|449239518|FG000|Overall Study|Eligibility criterion not met|7|||
124894780|NCT00688688|449239519|FG001|Overall Study|Eligibility criterion not met|7|||
124894781|NCT00688688|449239520|FG002|Overall Study|Eligibility criterion not met|10|||
124687863|NCT05800145|448475981|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
124894782|NCT00688688|449239518|FG000|Overall Study|Adverse Event|52|||
124894783|NCT00688688|449239519|FG001|Overall Study|Adverse Event|51|||
124443387|NCT03548987|447584859|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
124443388|NCT03548987|447584860|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
124443389|NCT03548987|447584859|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
124443390|NCT03548987|447584860|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
124443391|NCT03548987|447584859|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
124443392|NCT03548987|447584860|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
124443393|NCT01106014|447584863|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
124443394|NCT01106014|447584864|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
124443395|NCT01106014|447584863|FG000|Overall Study|Adverse Event|78|||
124443396|NCT01106014|447584864|FG001|Overall Study|Adverse Event|42|||
124443397|NCT01106014|447584863|FG000|Overall Study|Withdrawal by Subject|43|||
124443398|NCT01106014|447584864|FG001|Overall Study|Withdrawal by Subject|37|||
124443399|NCT01106014|447584863|FG000|Overall Study|Administrative reason|7|||
124443400|NCT01106014|447584864|FG001|Overall Study|Administrative reason|6|||
124443401|NCT01106014|447584863|FG000|Overall Study|Lost to Follow-up|2|||
124443402|NCT01106014|447584864|FG001|Overall Study|Lost to Follow-up|3|||
124443403|NCT00784693|447584865|FG000|Overall Study|Lost to Follow-up|0|||
124443404|NCT00784693|447584866|FG001|Overall Study|Lost to Follow-up|1|||
124443405|NCT00784693|447584865|FG000|Overall Study|Lack of Efficacy|1|||
124443406|NCT00784693|447584866|FG001|Overall Study|Lack of Efficacy|1|||
124443407|NCT00784693|447584865|FG000|Overall Study|Withdrawal by Subject|0|||
124443408|NCT00784693|447584866|FG001|Overall Study|Withdrawal by Subject|4|||
124443409|NCT00784693|447584865|FG000|Overall Study|Randomized but not Treated|1|||
124443410|NCT00784693|447584866|FG001|Overall Study|Randomized but not Treated|0|||
124443411|NCT00784693|447584865|FG000|Overall Study|Other|1|||
124443412|NCT00784693|447584866|FG001|Overall Study|Other|0|||
124443413|NCT00756470|447584869|FG000|Overall Study|Withdrawal by Subject|1|||
124443414|NCT00756470|447584869|FG000|Overall Study|Adverse Event|4|||
124443415|NCT00820027|447584870|FG000|Overall Study|Adverse Event|15|||
124443416|NCT00820027|447584871|FG001|Overall Study|Adverse Event|8|||
124443417|NCT00820027|447584872|FG002|Overall Study|Adverse Event|10|||
124443418|NCT00820027|447584873|FG003|Overall Study|Adverse Event|5|||
124443419|NCT00820027|447584870|FG000|Overall Study|Lack of Efficacy|2|||
124443420|NCT00820027|447584871|FG001|Overall Study|Lack of Efficacy|1|||
124443421|NCT00820027|447584872|FG002|Overall Study|Lack of Efficacy|2|||
124443422|NCT00820027|447584873|FG003|Overall Study|Lack of Efficacy|2|||
124443423|NCT00820027|447584870|FG000|Overall Study|Physician Decision|0|||
124443424|NCT00820027|447584871|FG001|Overall Study|Physician Decision|1|||
124443425|NCT00820027|447584872|FG002|Overall Study|Physician Decision|1|||
124443426|NCT00820027|447584873|FG003|Overall Study|Physician Decision|0|||
124443427|NCT00820027|447584870|FG000|Overall Study|Protocol Violation|3|||
124443428|NCT00820027|447584871|FG001|Overall Study|Protocol Violation|0|||
124443429|NCT00820027|447584872|FG002|Overall Study|Protocol Violation|4|||
124443430|NCT00820027|447584873|FG003|Overall Study|Protocol Violation|0|||
124443431|NCT00820027|447584870|FG000|Overall Study|Withdrawal by Subject|6|||
124443432|NCT00820027|447584871|FG001|Overall Study|Withdrawal by Subject|4|||
124443433|NCT00820027|447584872|FG002|Overall Study|Withdrawal by Subject|4|||
124687864|NCT05800145|448475982|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
124687865|NCT05800145|448475983|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
124687866|NCT05800145|448475984|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
124443434|NCT00820027|447584873|FG003|Overall Study|Withdrawal by Subject|6|||
124443435|NCT00908232|447584874|FG000|Cycle 1 to 4|Death|5|||
124443436|NCT00908232|447584875|FG001|Cycle 1 to 4|Death|0|||
124443437|NCT00908232|447584876|FG002|Cycle 1 to 4|Death|0|||
124443438|NCT00908232|447584877|FG003|Cycle 1 to 4|Death|0|||
124443439|NCT00908232|447584874|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
124443440|NCT00908232|447584875|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
124759343|NCT00452790|448742620|FG000|Infant Series|Failed to return|4|||
124759344|NCT00452790|448742621|FG001|Infant Series|Failed to return|1|||
124759345|NCT00452790|448742620|FG000|Infant Series|Protocol Violation|1|||
124443441|NCT00908232|447584876|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
124687867|NCT05800145|448475979|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
124687868|NCT05800145|448475980|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
124687869|NCT05800145|448475981|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
124687870|NCT05800145|448475982|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
124687871|NCT05800145|448475983|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
124687872|NCT05800145|448475984|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
124687873|NCT02850406|448475985|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
124687874|NCT02850406|448475986|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
124687875|NCT02850406|448475987|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
124687876|NCT02850406|448475988|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
124687877|NCT02850406|448475989|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
124687878|NCT02850406|448475990|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
124687879|NCT02850406|448475991|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
124687880|NCT02850406|448475992|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
124687881|NCT02850406|448475985|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
124687882|NCT02850406|448475986|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
124687883|NCT02850406|448475987|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
124687884|NCT02850406|448475988|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
124687885|NCT02850406|448475989|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
124687886|NCT02850406|448475990|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
124687887|NCT02850406|448475991|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
124687888|NCT02850406|448475992|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
124687889|NCT02850406|448475985|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
124687890|NCT02850406|448475986|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
124687891|NCT02850406|448475987|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
124687892|NCT02850406|448475988|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
124687893|NCT02850406|448475989|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
124687894|NCT02850406|448475990|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
124687895|NCT02850406|448475991|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
124687896|NCT02850406|448475992|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
124687897|NCT02850406|448475985|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
124687898|NCT02850406|448475986|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
124687899|NCT02850406|448475987|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
124687900|NCT02850406|448475988|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
124687901|NCT02850406|448475989|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
124687902|NCT02850406|448475990|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
124894784|NCT00688688|449239520|FG002|Overall Study|Adverse Event|50|||
124894785|NCT00688688|449239518|FG000|Overall Study|Lack of Efficacy|34|||
124443442|NCT00908232|447584877|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
124443443|NCT00908232|447584874|FG000|Cycle 1 to 4|Progressive Disease|6|||
124443444|NCT00908232|447584875|FG001|Cycle 1 to 4|Progressive Disease|0|||
124443445|NCT00908232|447584876|FG002|Cycle 1 to 4|Progressive Disease|0|||
124687903|NCT02850406|448475991|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
124687904|NCT02850406|448475992|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
124687905|NCT02850406|448475985|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
124894786|NCT00688688|449239519|FG001|Overall Study|Lack of Efficacy|25|||
124687906|NCT02850406|448475986|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
124687907|NCT02850406|448475987|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
124687908|NCT02850406|448475988|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
124687909|NCT02850406|448475989|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
124687910|NCT02850406|448475990|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
124687911|NCT02850406|448475991|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
124894787|NCT00688688|449239520|FG002|Overall Study|Lack of Efficacy|45|||
124894788|NCT00688688|449239518|FG000|Overall Study|Withdrawal by Subject|66|||
124687912|NCT02850406|448475992|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
124687913|NCT02850406|448475985|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
124687914|NCT02850406|448475986|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
124687915|NCT02850406|448475987|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
124687916|NCT02850406|448475988|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
124687917|NCT02850406|448475989|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
124687918|NCT02850406|448475990|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
124687919|NCT02850406|448475991|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
124687920|NCT02850406|448475992|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
124687921|NCT02850406|448475985|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
124687922|NCT02850406|448475986|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
124687923|NCT02850406|448475987|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
124687924|NCT02850406|448475988|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
124687925|NCT02850406|448475989|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
124687926|NCT02850406|448475990|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
124687927|NCT02850406|448475991|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
124687928|NCT02850406|448475992|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
124687929|NCT02850406|448475985|FG000|Part C (Up to 52 Weeks)|Other|0|||
124687930|NCT02850406|448475986|FG001|Part C (Up to 52 Weeks)|Other|0|||
124687931|NCT02850406|448475987|FG002|Part C (Up to 52 Weeks)|Other|0|||
124687932|NCT02850406|448475988|FG003|Part C (Up to 52 Weeks)|Other|0|||
124687933|NCT02850406|448475989|FG004|Part C (Up to 52 Weeks)|Other|1|||
124687934|NCT02850406|448475990|FG005|Part C (Up to 52 Weeks)|Other|3|||
124687935|NCT02850406|448475991|FG006|Part C (Up to 52 Weeks)|Other|0|||
124687936|NCT02850406|448475992|FG007|Part C (Up to 52 Weeks)|Other|0|||
124687937|NCT02850406|448475985|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
124687938|NCT02850406|448475986|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
124687939|NCT02850406|448475987|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
124687940|NCT02850406|448475988|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
124687941|NCT02850406|448475989|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
124687942|NCT02850406|448475990|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
124687943|NCT02850406|448475991|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
124687944|NCT02850406|448475992|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
124687945|NCT02850406|448475985|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
124687946|NCT02850406|448475986|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
124687947|NCT02850406|448475987|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
124687948|NCT02850406|448475988|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
124687949|NCT02850406|448475989|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
124687950|NCT02850406|448475990|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
124687951|NCT02850406|448475991|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
124687952|NCT02850406|448475992|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
124687953|NCT02850406|448475985|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
124687954|NCT02850406|448475986|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
124687955|NCT02850406|448475987|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
124687956|NCT02850406|448475988|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
124687957|NCT02850406|448475989|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
124687958|NCT02850406|448475990|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
124687959|NCT02850406|448475991|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
124687960|NCT02850406|448475992|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
124687961|NCT02850406|448475985|FG000|Part D (Up to 52 Weeks)|Other|0|||
124687962|NCT02850406|448475986|FG001|Part D (Up to 52 Weeks)|Other|0|||
124687963|NCT02850406|448475987|FG002|Part D (Up to 52 Weeks)|Other|0|||
124687964|NCT02850406|448475988|FG003|Part D (Up to 52 Weeks)|Other|0|||
124687965|NCT02850406|448475989|FG004|Part D (Up to 52 Weeks)|Other|0|||
124687966|NCT02850406|448475990|FG005|Part D (Up to 52 Weeks)|Other|0|||
124687967|NCT02850406|448475991|FG006|Part D (Up to 52 Weeks)|Other|0|||
124687968|NCT02850406|448475992|FG007|Part D (Up to 52 Weeks)|Other|1|||
124687969|NCT04167670|448477384|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
124687970|NCT04167670|448477385|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
124687971|NCT04167670|448477386|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
124687972|NCT04167670|448477384|FG000|Overall Study|Significant protocol deviation|3|||
124687973|NCT04167670|448477385|FG001|Overall Study|Significant protocol deviation|1|||
124687974|NCT04167670|448477386|FG002|Overall Study|Significant protocol deviation|0|||
124687975|NCT04167670|448477384|FG000|Overall Study|Lost to Follow-up|0|||
124687976|NCT04167670|448477385|FG001|Overall Study|Lost to Follow-up|3|||
124687977|NCT04167670|448477386|FG002|Overall Study|Lost to Follow-up|3|||
124687978|NCT04167670|448477384|FG000|Overall Study|Voluntary Withdrawal|0|||
124687979|NCT04167670|448477385|FG001|Overall Study|Voluntary Withdrawal|1|||
124687980|NCT04167670|448477386|FG002|Overall Study|Voluntary Withdrawal|1|||
124687981|NCT04167670|448477384|FG000|Overall Study|Withdrawal of Consent|4|||
124687982|NCT04167670|448477385|FG001|Overall Study|Withdrawal of Consent|1|||
124687983|NCT04167670|448477386|FG002|Overall Study|Withdrawal of Consent|3|||
124687984|NCT04167670|448477384|FG000|Overall Study|Miscellaneous|7|||
124894789|NCT00688688|449239519|FG001|Overall Study|Withdrawal by Subject|75|||
124894790|NCT00688688|449239520|FG002|Overall Study|Withdrawal by Subject|65|||
124894791|NCT00688688|449239518|FG000|Overall Study|Lost to Follow-up|14|||
124894792|NCT00688688|449239519|FG001|Overall Study|Lost to Follow-up|7|||
124894793|NCT00688688|449239520|FG002|Overall Study|Lost to Follow-up|7|||
124894794|NCT00688688|449239518|FG000|Overall Study|Protocol Violation|6|||
124894795|NCT00688688|449239519|FG001|Overall Study|Protocol Violation|9|||
124894796|NCT00688688|449239520|FG002|Overall Study|Protocol Violation|11|||
124894797|NCT00688688|449239518|FG000|Overall Study|Randomized but never received study drug|1|||
124894798|NCT00688688|449239519|FG001|Overall Study|Randomized but never received study drug|0|||
124894799|NCT00688688|449239520|FG002|Overall Study|Randomized but never received study drug|0|||
124894800|NCT00688688|449239518|FG000|Overall Study|Non-compliance with study procedures|5|||
124894801|NCT00688688|449239519|FG001|Overall Study|Non-compliance with study procedures|3|||
124894802|NCT00688688|449239520|FG002|Overall Study|Non-compliance with study procedures|4|||
124894803|NCT00688688|449239518|FG000|Overall Study|Taking exclusionary medications|1|||
124894804|NCT00688688|449239519|FG001|Overall Study|Taking exclusionary medications|0|||
124894805|NCT00688688|449239520|FG002|Overall Study|Taking exclusionary medications|0|||
124894806|NCT00688688|449239518|FG000|Overall Study|Site closure|0|||
124894807|NCT00688688|449239519|FG001|Overall Study|Site closure|1|||
124894808|NCT00688688|449239520|FG002|Overall Study|Site closure|0|||
124894809|NCT00688688|449239518|FG000|Overall Study|Violation of exclusion criterion|0|||
124894810|NCT00688688|449239519|FG001|Overall Study|Violation of exclusion criterion|1|||
124894811|NCT00688688|449239520|FG002|Overall Study|Violation of exclusion criterion|0|||
124894812|NCT03283553|449239523|FG000|Patient Participant Flow|Death|5|||
124894813|NCT03283553|449239524|FG001|Patient Participant Flow|Death|10|||
124894814|NCT03283553|449239523|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
124894815|NCT03283553|449239524|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
124894816|NCT03283553|449239523|FG000|Patient Participant Flow|Lost to Follow-up|1|||
124894817|NCT03283553|449239524|FG001|Patient Participant Flow|Lost to Follow-up|1|||
124894818|NCT03283553|449239523|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
124894819|NCT03283553|449239524|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
124894820|NCT03283553|449239523|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
124894821|NCT03283553|449239524|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
124894822|NCT03283553|449239523|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
124894823|NCT03283553|449239524|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
124894824|NCT03686683|449239525|FG000|Overall Study|Withdrawal by Subject|52|||
124894825|NCT03686683|449239526|FG001|Overall Study|Withdrawal by Subject|32|||
124894826|NCT03686683|449239525|FG000|Overall Study|Lost to Follow-up|23|||
124894827|NCT03686683|449239526|FG001|Overall Study|Lost to Follow-up|19|||
124894828|NCT03686683|449239525|FG000|Overall Study|Adverse Event|1|||
124894829|NCT03686683|449239526|FG001|Overall Study|Adverse Event|0|||
124894830|NCT03686683|449239525|FG000|Overall Study|Death|10|||
124894831|NCT03686683|449239526|FG001|Overall Study|Death|5|||
124894832|NCT03686683|449239525|FG000|Overall Study|Progressive Disease|1|||
124894833|NCT03686683|449239526|FG001|Overall Study|Progressive Disease|1|||
124894834|NCT03686683|449239525|FG000|Overall Study|Noncompliance|1|||
124759346|NCT00452790|448742621|FG001|Infant Series|Protocol Violation|3|||
124894835|NCT03686683|449239526|FG001|Overall Study|Noncompliance|0|||
124443446|NCT00908232|447584877|FG003|Cycle 1 to 4|Progressive Disease|0|||
124894836|NCT03686683|449239525|FG000|Overall Study|Physician Decision|1|||
124894837|NCT03686683|449239526|FG001|Overall Study|Physician Decision|1|||
124894838|NCT03686683|449239525|FG000|Overall Study|Screen fail post-randomization|1|||
124894839|NCT03686683|449239526|FG001|Overall Study|Screen fail post-randomization|0|||
124894840|NCT03686683|449239525|FG000|Overall Study|Protocol Violation|3|||
124894841|NCT03686683|449239526|FG001|Overall Study|Protocol Violation|0|||
124894842|NCT03686683|449239525|FG000|Overall Study|No data available|1|||
124894843|NCT03686683|449239526|FG001|Overall Study|No data available|0|||
124894844|NCT03255941|449239527|FG000|Overall Study|Not eligible or refused injection|37|||
124894845|NCT03255941|449239528|FG001|Overall Study|Not eligible or refused injection|44|||
124894846|NCT03255941|449239529|FG002|Overall Study|Not eligible or refused injection|5|||
124894847|NCT03255941|449239530|FG003|Overall Study|Not eligible or refused injection|6|||
124894848|NCT03255941|449239527|FG000|Overall Study|Did not complete exit interview|1|||
124894849|NCT03255941|449239528|FG001|Overall Study|Did not complete exit interview|2|||
124894850|NCT03255941|449239529|FG002|Overall Study|Did not complete exit interview|0|||
124894851|NCT03255941|449239530|FG003|Overall Study|Did not complete exit interview|0|||
124894852|NCT00372060|449239531|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
124894853|NCT00372060|449239532|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
124894854|NCT00372060|449239531|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
124443447|NCT00908232|447584874|FG000|Cycle 1 to 4|Adverse Event|12|||
124687985|NCT04167670|448477385|FG001|Overall Study|Miscellaneous|5|||
124687986|NCT04167670|448477386|FG002|Overall Study|Miscellaneous|3|||
124687987|NCT00587457|448477391|FG000|Overall Study|Adverse Event|1|||
124687988|NCT00587457|448477392|FG001|Overall Study|Adverse Event|2|||
124687989|NCT00587457|448477393|FG002|Overall Study|Adverse Event|1|||
124687990|NCT00587457|448477391|FG000|Overall Study|Disease progression|2|||
124687991|NCT00587457|448477392|FG001|Overall Study|Disease progression|0|||
124687992|NCT00587457|448477393|FG002|Overall Study|Disease progression|2|||
124687993|NCT00587457|448477391|FG000|Overall Study|Initiation of alternative therapy|0|||
124687994|NCT00587457|448477392|FG001|Overall Study|Initiation of alternative therapy|1|||
124687995|NCT00587457|448477393|FG002|Overall Study|Initiation of alternative therapy|0|||
124687996|NCT00587457|448477391|FG000|Overall Study|Undefined|0|||
124687997|NCT00587457|448477392|FG001|Overall Study|Undefined|0|||
124687998|NCT00587457|448477393|FG002|Overall Study|Undefined|1|||
124687999|NCT00587457|448477391|FG000|Overall Study|Development of neutralizing Abs|0|||
124443448|NCT00908232|447584875|FG001|Cycle 1 to 4|Adverse Event|0|||
124894855|NCT00372060|449239532|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
124688000|NCT00587457|448477392|FG001|Overall Study|Development of neutralizing Abs|0|||
124688001|NCT00587457|448477393|FG002|Overall Study|Development of neutralizing Abs|1|||
124688002|NCT00876395|448477394|FG000|Overall Study|Untreated|8|||
124688003|NCT00876395|448477395|FG001|Overall Study|Untreated|1|||
124688004|NCT00876395|448477394|FG000|Overall Study|Adverse Event|63|||
124688005|NCT00876395|448477395|FG001|Overall Study|Adverse Event|11|||
124688006|NCT00876395|448477394|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124688007|NCT00876395|448477395|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124688008|NCT00876395|448477394|FG000|Overall Study|Disease progression|259|||
124688009|NCT00876395|448477395|FG001|Overall Study|Disease progression|162|||
124688010|NCT00876395|448477394|FG000|Overall Study|New cancer therapy|25|||
124688011|NCT00876395|448477395|FG001|Overall Study|New cancer therapy|7|||
124688012|NCT00876395|448477394|FG000|Overall Study|Protocol Violation|5|||
124688013|NCT00876395|448477395|FG001|Overall Study|Protocol Violation|2|||
124688014|NCT00876395|448477394|FG000|Overall Study|Withdrawal by Subject|66|||
124688015|NCT00876395|448477395|FG001|Overall Study|Withdrawal by Subject|33|||
124688016|NCT00876395|448477394|FG000|Overall Study|Lost to Follow-up|2|||
124688017|NCT00876395|448477395|FG001|Overall Study|Lost to Follow-up|0|||
124688018|NCT00876395|448477394|FG000|Overall Study|Administrative problems|39|||
124688019|NCT00876395|448477395|FG001|Overall Study|Administrative problems|23|||
124688020|NCT00876395|448477394|FG000|Overall Study|Death|12|||
124688021|NCT00876395|448477395|FG001|Overall Study|Death|0|||
124688022|NCT03807843|448477396|FG000|Overall Study|Lost to Follow-up|1|||
124688023|NCT03807843|448477397|FG001|Overall Study|Lost to Follow-up|0|||
124688024|NCT01312129|448477398|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
124688025|NCT01312129|448477399|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
124688026|NCT00924651|448477402|FG000|Overall Study|Chemo started too soon|2|||
124688027|NCT00924651|448477403|FG001|Overall Study|Chemo started too soon|3|||
124688028|NCT00924651|448477402|FG000|Overall Study|No Reason|3|||
124688029|NCT00924651|448477403|FG001|Overall Study|No Reason|7|||
124688030|NCT00924651|448477402|FG000|Overall Study|Overwhelmed|6|||
124688031|NCT00924651|448477403|FG001|Overall Study|Overwhelmed|6|||
124688032|NCT00924651|448477402|FG000|Overall Study|Noncompliant|1|||
124688033|NCT00924651|448477403|FG001|Overall Study|Noncompliant|4|||
124688034|NCT00924651|448477402|FG000|Overall Study|Medical|1|||
124688035|NCT00924651|448477403|FG001|Overall Study|Medical|3|||
124688036|NCT00924651|448477402|FG000|Overall Study|Changed Mind|10|||
124688037|NCT00924651|448477403|FG001|Overall Study|Changed Mind|1|||
124688038|NCT00924651|448477402|FG000|Overall Study|Incomplete Form|2|||
124688039|NCT00924651|448477403|FG001|Overall Study|Incomplete Form|1|||
124688040|NCT00729586|448477404|FG000|Overall Study|Ineligible|0|||
124443449|NCT00908232|447584876|FG002|Cycle 1 to 4|Adverse Event|0|||
124688041|NCT00729586|448477405|FG001|Overall Study|Ineligible|1|||
124688042|NCT00729586|448477404|FG000|Overall Study|never treated|1|||
124688043|NCT00729586|448477405|FG001|Overall Study|never treated|0|||
124688044|NCT00970944|448477407|FG000|Overall Study|Death|1|||
124688045|NCT00970944|448477408|FG001|Overall Study|Death|0|||
124688046|NCT00970944|448477407|FG000|Overall Study|Physician Decision|0|||
124688047|NCT00970944|448477408|FG001|Overall Study|Physician Decision|2|||
124688048|NCT00662259|448477409|FG000|Overall Study|Adverse Event|2|||
124443450|NCT00908232|447584877|FG003|Cycle 1 to 4|Adverse Event|0|||
124443451|NCT00908232|447584874|FG000|Cycle 1 to 4|Other|1|||
124443452|NCT00908232|447584875|FG001|Cycle 1 to 4|Other|0|||
124443453|NCT00908232|447584876|FG002|Cycle 1 to 4|Other|0|||
124443454|NCT00908232|447584877|FG003|Cycle 1 to 4|Other|0|||
124443455|NCT00908232|447584874|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
124894856|NCT00372060|449239531|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
124894857|NCT00372060|449239532|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
124894858|NCT00372060|449239531|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
124894859|NCT00372060|449239532|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
124894860|NCT00372060|449239531|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
124894861|NCT00372060|449239532|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
124894862|NCT00372060|449239531|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
124894863|NCT00372060|449239532|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
124894864|NCT05124899|449239534|FG000|Overall Study|Lost to Follow-up|3|||
124894865|NCT00647348|449239536|FG000|Overall Study|Lost to Follow-up|3|||
124894866|NCT00647348|449239537|FG001|Overall Study|Lost to Follow-up|6|||
124894867|NCT01417000|449239544|FG000|Overall Study|Death|59|||
124894868|NCT01417000|449239545|FG001|Overall Study|Death|28|||
124894869|NCT01417000|449239544|FG000|Overall Study|Lost to Follow-up|1|||
124894870|NCT01417000|449239545|FG001|Overall Study|Lost to Follow-up|0|||
124894871|NCT01417000|449239544|FG000|Overall Study|Study Terminated by Sponsor|1|||
124894872|NCT01417000|449239545|FG001|Overall Study|Study Terminated by Sponsor|1|||
124894873|NCT00797225|449239546|FG000|Weeks 1 to 12|Adverse Event|0|||
124894874|NCT00797225|449239547|FG001|Weeks 1 to 12|Adverse Event|0|||
124894875|NCT00797225|449239548|FG002|Weeks 1 to 12|Adverse Event|1|||
124894876|NCT00797225|449239549|FG003|Weeks 1 to 12|Adverse Event|0|||
124894877|NCT00797225|449239550|FG004|Weeks 1 to 12|Adverse Event|0|||
124894878|NCT00797225|449239551|FG005|Weeks 1 to 12|Adverse Event|0|||
124894879|NCT00797225|449239552|FG006|Weeks 1 to 12|Adverse Event|0|||
124894880|NCT00797225|449239553|FG007|Weeks 1 to 12|Adverse Event|0|||
124894881|NCT00797225|449239546|FG000|Weeks 1 to 12|Non-compliance|0|||
124894882|NCT00797225|449239547|FG001|Weeks 1 to 12|Non-compliance|1|||
124443456|NCT00908232|447584875|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
124443457|NCT00908232|447584876|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
124443458|NCT00908232|447584877|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
124443459|NCT00908232|447584874|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
124443460|NCT00908232|447584875|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
124443461|NCT00908232|447584876|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
124443462|NCT00908232|447584877|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
124443463|NCT00908232|447584874|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
124443464|NCT00908232|447584875|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
124688049|NCT00662259|448477410|FG001|Overall Study|Adverse Event|0|||
124443465|NCT00908232|447584876|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
124443466|NCT00908232|447584877|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
124443467|NCT00908232|447584874|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
124688050|NCT00972738|448477411|FG000|Overall Study|Adverse Event|7|||
124894883|NCT00797225|449239548|FG002|Weeks 1 to 12|Non-compliance|0|||
124894884|NCT00797225|449239549|FG003|Weeks 1 to 12|Non-compliance|0|||
124894885|NCT00797225|449239550|FG004|Weeks 1 to 12|Non-compliance|0|||
124894886|NCT00797225|449239551|FG005|Weeks 1 to 12|Non-compliance|0|||
124894887|NCT00797225|449239552|FG006|Weeks 1 to 12|Non-compliance|0|||
124894888|NCT00797225|449239553|FG007|Weeks 1 to 12|Non-compliance|0|||
124894889|NCT00797225|449239546|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
124894890|NCT00797225|449239547|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
124894891|NCT00797225|449239548|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
124894892|NCT00797225|449239549|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
124894893|NCT00797225|449239550|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
124894894|NCT00797225|449239551|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
124894895|NCT00797225|449239552|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
124894896|NCT00797225|449239553|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
124894897|NCT00797225|449239546|FG000|Weeks 1 to 12|Sponsor Decision|1|||
124894898|NCT00797225|449239547|FG001|Weeks 1 to 12|Sponsor Decision|0|||
124894899|NCT00797225|449239548|FG002|Weeks 1 to 12|Sponsor Decision|0|||
124894900|NCT00797225|449239549|FG003|Weeks 1 to 12|Sponsor Decision|0|||
124894901|NCT00797225|449239550|FG004|Weeks 1 to 12|Sponsor Decision|0|||
124894902|NCT00797225|449239551|FG005|Weeks 1 to 12|Sponsor Decision|0|||
124894903|NCT00797225|449239552|FG006|Weeks 1 to 12|Sponsor Decision|0|||
124443468|NCT00908232|447584875|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
124443469|NCT00908232|447584876|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
124443470|NCT00908232|447584877|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
124894904|NCT00797225|449239553|FG007|Weeks 1 to 12|Sponsor Decision|0|||
124894905|NCT00797225|449239546|FG000|Weeks 13 to 24|Non-compliance|0|||
124894906|NCT00797225|449239547|FG001|Weeks 13 to 24|Non-compliance|2|||
124894907|NCT00797225|449239548|FG002|Weeks 13 to 24|Non-compliance|0|||
124894908|NCT00797225|449239549|FG003|Weeks 13 to 24|Non-compliance|0|||
124894909|NCT00797225|449239550|FG004|Weeks 13 to 24|Non-compliance|0|||
124894910|NCT00797225|449239551|FG005|Weeks 13 to 24|Non-compliance|0|||
124894911|NCT00797225|449239552|FG006|Weeks 13 to 24|Non-compliance|0|||
124894912|NCT00797225|449239553|FG007|Weeks 13 to 24|Non-compliance|0|||
124894913|NCT00797225|449239546|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
124894914|NCT00797225|449239547|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
124894915|NCT00797225|449239548|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
124894916|NCT00797225|449239549|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
124894917|NCT00797225|449239550|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
124894918|NCT00797225|449239551|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
124894919|NCT00797225|449239552|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
124894920|NCT00797225|449239553|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
124894921|NCT00797225|449239546|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
124894922|NCT00797225|449239547|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
124894923|NCT00797225|449239548|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
124894924|NCT00797225|449239549|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
124894925|NCT00797225|449239550|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
124894926|NCT00797225|449239551|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
124894927|NCT00797225|449239552|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
124894928|NCT00797225|449239553|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
124894929|NCT00797225|449239546|FG000|Weeks 13 to 24|Adverse Event|0|||
124894930|NCT00797225|449239547|FG001|Weeks 13 to 24|Adverse Event|1|||
124894931|NCT00797225|449239548|FG002|Weeks 13 to 24|Adverse Event|0|||
124894932|NCT00797225|449239549|FG003|Weeks 13 to 24|Adverse Event|0|||
124894933|NCT00797225|449239550|FG004|Weeks 13 to 24|Adverse Event|0|||
124894934|NCT00797225|449239551|FG005|Weeks 13 to 24|Adverse Event|0|||
124894935|NCT00797225|449239552|FG006|Weeks 13 to 24|Adverse Event|1|||
124894936|NCT00797225|449239553|FG007|Weeks 13 to 24|Adverse Event|0|||
124894937|NCT00797225|449239546|FG000|Weeks 13 to 24|Sponsor Decision|0|||
124894938|NCT00797225|449239547|FG001|Weeks 13 to 24|Sponsor Decision|0|||
124894939|NCT00797225|449239548|FG002|Weeks 13 to 24|Sponsor Decision|0|||
124894940|NCT00797225|449239549|FG003|Weeks 13 to 24|Sponsor Decision|0|||
124894941|NCT00797225|449239550|FG004|Weeks 13 to 24|Sponsor Decision|0|||
124894942|NCT00797225|449239551|FG005|Weeks 13 to 24|Sponsor Decision|0|||
124894943|NCT00797225|449239552|FG006|Weeks 13 to 24|Sponsor Decision|1|||
124894944|NCT00797225|449239553|FG007|Weeks 13 to 24|Sponsor Decision|0|||
124894945|NCT02954055|449239554|FG000|Overall Study|Did not initiate therapy|6|||
124894946|NCT02954055|449239555|FG001|Overall Study|Did not initiate therapy|1|||
124894947|NCT05489224|449239558|FG000|Treatment Period I|Withdrawal by Subject|6|||
124894948|NCT05489224|449239559|FG001|Treatment Period I|Withdrawal by Subject|5|||
124894949|NCT05489224|449239560|FG002|Treatment Period I|Withdrawal by Subject|0|||
124894950|NCT05489224|449239558|FG000|Treatment Period I|Adverse Event|3|||
124894951|NCT05489224|449239559|FG001|Treatment Period I|Adverse Event|11|||
124894952|NCT05489224|449239560|FG002|Treatment Period I|Adverse Event|0|||
124894953|NCT05489224|449239558|FG000|Treatment Period I|Lost to Follow-up|0|||
124894954|NCT05489224|449239559|FG001|Treatment Period I|Lost to Follow-up|1|||
124894955|NCT05489224|449239560|FG002|Treatment Period I|Lost to Follow-up|0|||
124894956|NCT05489224|449239558|FG000|Treatment Period I|Physician Decision|0|||
124894957|NCT05489224|449239559|FG001|Treatment Period I|Physician Decision|1|||
124894958|NCT05489224|449239560|FG002|Treatment Period I|Physician Decision|0|||
124894959|NCT05489224|449239558|FG000|Treatment Period II up to Week 32|Ongoing|222|||
124894960|NCT05489224|449239559|FG001|Treatment Period II up to Week 32|Ongoing|107|||
124894961|NCT05489224|449239560|FG002|Treatment Period II up to Week 32|Ongoing|107|||
124894962|NCT05489224|449239558|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
124894963|NCT05489224|449239559|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
124894964|NCT05489224|449239560|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
124894965|NCT05489224|449239558|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
124894966|NCT05489224|449239559|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
124894967|NCT05489224|449239560|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
124894968|NCT04640571|449239561|FG000|Overall Study|Withdrawal by Subject|0|||
124894969|NCT04640571|449239562|FG001|Overall Study|Withdrawal by Subject|0|||
124894970|NCT04640571|449239563|FG002|Overall Study|Withdrawal by Subject|0|||
124894971|NCT04640571|449239564|FG003|Overall Study|Withdrawal by Subject|0|||
124894972|NCT04640571|449239565|FG004|Overall Study|Withdrawal by Subject|0|||
124894973|NCT04640571|449239566|FG005|Overall Study|Withdrawal by Subject|2|||
124894974|NCT00832780|449239568|FG000|Overall Study|Death|16|||
124894975|NCT00832780|449239568|FG000|Overall Study|Lost to Follow-up|4|||
124894976|NCT00832780|449239568|FG000|Overall Study|no reason given|2|||
124894977|NCT00832780|449239568|FG000|Overall Study|other complicating condition|2|||
124894978|NCT00832780|449239568|FG000|Overall Study|Physician Decision|1|||
124894979|NCT01767909|449239571|FG000|Overall Study|Withdrawal by Subject|4|||
124894980|NCT01767909|449239572|FG001|Overall Study|Withdrawal by Subject|7|||
124894981|NCT01767909|449239571|FG000|Overall Study|Adverse Event|3|||
124894982|NCT01767909|449239572|FG001|Overall Study|Adverse Event|1|||
124894983|NCT01767909|449239571|FG000|Overall Study|Withdrawal by Study Partner|3|||
124894984|NCT01767909|449239572|FG001|Overall Study|Withdrawal by Study Partner|1|||
124688051|NCT00972738|448477412|FG001|Overall Study|Adverse Event|1|||
124688052|NCT00972738|448477413|FG002|Overall Study|Adverse Event|8|||
124688053|NCT00972738|448477411|FG000|Overall Study|Protocol Violation|2|||
124688054|NCT00972738|448477412|FG001|Overall Study|Protocol Violation|1|||
124688055|NCT00972738|448477413|FG002|Overall Study|Protocol Violation|3|||
124688056|NCT00972738|448477411|FG000|Overall Study|Lost to Follow-up|1|||
124688057|NCT00972738|448477412|FG001|Overall Study|Lost to Follow-up|0|||
124688058|NCT00972738|448477413|FG002|Overall Study|Lost to Follow-up|1|||
124688059|NCT00972738|448477411|FG000|Overall Study|Lack of Efficacy|5|||
124688060|NCT00972738|448477412|FG001|Overall Study|Lack of Efficacy|1|||
124688061|NCT00972738|448477413|FG002|Overall Study|Lack of Efficacy|11|||
124688062|NCT00972738|448477411|FG000|Overall Study|Withdrawal by Subject|5|||
124688063|NCT00972738|448477412|FG001|Overall Study|Withdrawal by Subject|1|||
124688064|NCT00972738|448477413|FG002|Overall Study|Withdrawal by Subject|4|||
124688065|NCT00972738|448477411|FG000|Overall Study|Moved|0|||
124688066|NCT00972738|448477412|FG001|Overall Study|Moved|0|||
124688067|NCT00972738|448477413|FG002|Overall Study|Moved|1|||
124688068|NCT00972738|448477411|FG000|Overall Study|Other|1|||
124688069|NCT00972738|448477412|FG001|Overall Study|Other|2|||
124894985|NCT01767909|449239571|FG000|Overall Study|Non-Compliance|2|||
124688070|NCT00972738|448477413|FG002|Overall Study|Other|1|||
124688071|NCT03915067|448477414|FG000|Overall Study|Adverse Event|0|||
124688072|NCT03915067|448477415|FG001|Overall Study|Adverse Event|0|||
124688073|NCT03915067|448477416|FG002|Overall Study|Adverse Event|1|||
124688074|NCT03915067|448477414|FG000|Overall Study|Withdrawal by Subject|4|||
124688075|NCT03915067|448477415|FG001|Overall Study|Withdrawal by Subject|3|||
124688076|NCT03915067|448477416|FG002|Overall Study|Withdrawal by Subject|0|||
124688077|NCT03915067|448477414|FG000|Overall Study|Lost to Follow-up|3|||
124688078|NCT03915067|448477415|FG001|Overall Study|Lost to Follow-up|2|||
124688079|NCT03915067|448477416|FG002|Overall Study|Lost to Follow-up|0|||
124688080|NCT03915067|448477414|FG000|Overall Study|Protocol Deviation|0|||
124688081|NCT03915067|448477415|FG001|Overall Study|Protocol Deviation|0|||
124688082|NCT03915067|448477416|FG002|Overall Study|Protocol Deviation|1|||
124688083|NCT03915067|448477414|FG000|Overall Study|Covid-19 Related Issues|2|||
124688084|NCT03915067|448477415|FG001|Overall Study|Covid-19 Related Issues|4|||
124688085|NCT03915067|448477416|FG002|Overall Study|Covid-19 Related Issues|4|||
124688086|NCT03915067|448477414|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
124688087|NCT03915067|448477415|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
124688088|NCT03915067|448477416|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
124688089|NCT02693418|448477417|FG000|Overall Study|Lost to Follow-up|1|||
124688090|NCT02693418|448477418|FG001|Overall Study|Lost to Follow-up|2|||
124688091|NCT02693418|448477419|FG002|Overall Study|Lost to Follow-up|0|||
124688092|NCT02693418|448477420|FG003|Overall Study|Lost to Follow-up|0|||
124688093|NCT02693418|448477421|FG004|Overall Study|Lost to Follow-up|0|||
124688094|NCT02693418|448477417|FG000|Overall Study|Menses during study period|0|||
124894986|NCT01767909|449239572|FG001|Overall Study|Non-Compliance|0|||
124894987|NCT01767909|449239571|FG000|Overall Study|Perceived Lack of Efficacy|1|||
124894988|NCT01767909|449239572|FG001|Overall Study|Perceived Lack of Efficacy|0|||
124894989|NCT01767909|449239571|FG000|Overall Study|Investigator Recommendation|0|||
124894990|NCT01767909|449239572|FG001|Overall Study|Investigator Recommendation|1|||
124894991|NCT01767909|449239571|FG000|Overall Study|Lost to Follow-up|0|||
124894992|NCT01767909|449239572|FG001|Overall Study|Lost to Follow-up|1|||
124894993|NCT01767909|449239571|FG000|Overall Study|LP uncessessful|0|||
124894994|NCT01767909|449239572|FG001|Overall Study|LP uncessessful|1|||
124894995|NCT04319094|449239574|FG000|Baseline|Lost to Follow-up|4|||
124894996|NCT04319094|449239575|FG001|Baseline|Lost to Follow-up|5|||
124894997|NCT04319094|449239574|FG000|Baseline|Protocol Violation|0|||
124894998|NCT04319094|449239575|FG001|Baseline|Protocol Violation|3|||
124894999|NCT04319094|449239574|FG000|Baseline|Withdrawal by Subject|2|||
124895000|NCT04319094|449239575|FG001|Baseline|Withdrawal by Subject|1|||
124895001|NCT04319094|449239574|FG000|Post-Intervention|Death|0|||
124895002|NCT04319094|449239575|FG001|Post-Intervention|Death|1|||
124895003|NCT04319094|449239574|FG000|Post-Intervention|Lost to Follow-up|4|||
124895004|NCT04319094|449239575|FG001|Post-Intervention|Lost to Follow-up|4|||
124895005|NCT04319094|449239574|FG000|Post-Intervention|Withdrawal by Subject|8|||
124443471|NCT00908232|447584874|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
124688095|NCT02693418|448477418|FG001|Overall Study|Menses during study period|0|||
124688096|NCT02693418|448477419|FG002|Overall Study|Menses during study period|2|||
124688097|NCT02693418|448477420|FG003|Overall Study|Menses during study period|0|||
124895006|NCT04319094|449239575|FG001|Post-Intervention|Withdrawal by Subject|5|||
124895007|NCT04319094|449239574|FG000|Post-Intervention|Incomplete Data Collection|1|||
124688098|NCT02693418|448477421|FG004|Overall Study|Menses during study period|0|||
124688099|NCT01750346|448477422|FG000|Overall Study|Adverse Event|1|||
124688100|NCT01750346|448477423|FG001|Overall Study|Adverse Event|0|||
124688101|NCT01750346|448477424|FG002|Overall Study|Adverse Event|0|||
124895008|NCT04319094|449239575|FG001|Post-Intervention|Incomplete Data Collection|3|||
124895009|NCT04319094|449239574|FG000|3-month|Death|1|||
124895010|NCT04319094|449239575|FG001|3-month|Death|0|||
124895011|NCT04319094|449239574|FG000|3-month|Lost to Follow-up|2|||
124895012|NCT04319094|449239575|FG001|3-month|Lost to Follow-up|2|||
124895013|NCT04319094|449239574|FG000|3-month|Withdrawal by Subject|0|||
124895014|NCT04319094|449239575|FG001|3-month|Withdrawal by Subject|3|||
124895015|NCT04319094|449239574|FG000|3-month|Incomplete data collection|9|||
124895016|NCT04319094|449239575|FG001|3-month|Incomplete data collection|7|||
124895017|NCT04319094|449239574|FG000|6-month|Lost to Follow-up|1|||
124895018|NCT04319094|449239575|FG001|6-month|Lost to Follow-up|1|||
124895019|NCT04319094|449239574|FG000|6-month|Withdrawal by Subject|0|||
124895020|NCT04319094|449239575|FG001|6-month|Withdrawal by Subject|3|||
124895021|NCT04319094|449239574|FG000|6-month|Incomplete data collection|14|||
124895022|NCT04319094|449239575|FG001|6-month|Incomplete data collection|9|||
124895023|NCT04319094|449239574|FG000|9-month|Lost to Follow-up|8|||
124895024|NCT04319094|449239575|FG001|9-month|Lost to Follow-up|4|||
124895025|NCT04319094|449239574|FG000|9-month|Withdrawal by Subject|0|||
124895026|NCT04319094|449239575|FG001|9-month|Withdrawal by Subject|1|||
124895027|NCT04319094|449239574|FG000|9-month|Incomplete data collection|8|||
124895028|NCT04319094|449239575|FG001|9-month|Incomplete data collection|5|||
124895029|NCT04319094|449239574|FG000|12-month|Lost to Follow-up|11|||
124895030|NCT04319094|449239575|FG001|12-month|Lost to Follow-up|8|||
124895031|NCT04956692|449239576|FG000|Overall Study|Death|115|||
124895032|NCT04956692|449239577|FG001|Overall Study|Death|47|||
124895033|NCT04956692|449239576|FG000|Overall Study|Lost to Follow-up|0|||
124895034|NCT04956692|449239577|FG001|Overall Study|Lost to Follow-up|1|||
124895035|NCT04956692|449239576|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
124895036|NCT04956692|449239577|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124895037|NCT04956692|449239576|FG000|Overall Study|Withdrawal by Subject|5|||
124895038|NCT04956692|449239577|FG001|Overall Study|Withdrawal by Subject|2|||
124895039|NCT04956692|449239576|FG000|Overall Study|Ongoing in Study|236|||
124895040|NCT04956692|449239577|FG001|Overall Study|Ongoing in Study|123|||
124895041|NCT05780047|449239581|FG000|Overall Study|Did not submit baseline urine test kit|226|||
124895042|NCT05780047|449239581|FG000|Overall Study|Lost to Follow-up|34|||
124895043|NCT05780047|449239581|FG000|Overall Study|Did not submit second urine test kit|124|||
124895044|NCT04873817|449239582|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
124895045|NCT04873817|449239582|FG000|Overall Study|Lost to Follow-up|4|||
124895046|NCT04873817|449239582|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
124895047|NCT04873817|449239582|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
124895048|NCT04873817|449239582|FG000|Overall Study|Other Reasons|3|||
124895049|NCT00665561|449239583|FG000|Overall Study|Death recorded on subject summary pages|75|||
124895050|NCT00665561|449239584|FG001|Overall Study|Death recorded on subject summary pages|75|||
124895051|NCT00665561|449239583|FG000|Overall Study|Does not meet entrance criteria|19|||
124895052|NCT00665561|449239584|FG001|Overall Study|Does not meet entrance criteria|21|||
124895053|NCT00665561|449239583|FG000|Overall Study|Lost to Follow-up|203|||
124895054|NCT00665561|449239584|FG001|Overall Study|Lost to Follow-up|264|||
124895055|NCT00665561|449239583|FG000|Overall Study|Withdrawal by Subject|74|||
124895056|NCT00665561|449239584|FG001|Overall Study|Withdrawal by Subject|65|||
124895057|NCT00665561|449239583|FG000|Overall Study|Other|123|||
124895058|NCT00665561|449239584|FG001|Overall Study|Other|108|||
124895059|NCT00665561|449239583|FG000|Overall Study|Site closed|8|||
124895060|NCT00665561|449239584|FG001|Overall Study|Site closed|0|||
124895061|NCT00665561|449239583|FG000|Overall Study|Withdrawn due to pregnancy|0|||
124895062|NCT00665561|449239584|FG001|Overall Study|Withdrawn due to pregnancy|1|||
124895063|NCT01734811|449239587|FG000|Overall Study|Lost to Follow-up|2|||
124895064|NCT01734811|449239588|FG001|Overall Study|Lost to Follow-up|3|||
124895065|NCT01734811|449239587|FG000|Overall Study|Withdrawal by Subject|2|||
124895066|NCT01734811|449239588|FG001|Overall Study|Withdrawal by Subject|0|||
124895067|NCT00062868|449239589|FG000|Dose Level 1|Death|2|||
124895068|NCT00062868|449239590|FG001|Dose Level 1|Death|0|||
124895069|NCT00062868|449239591|FG002|Dose Level 1|Death|0|||
124895070|NCT00062868|449239592|FG003|Dose Level 1|Death|2|||
124895071|NCT00062868|449239593|FG004|Dose Level 1|Death|0|||
124895072|NCT00062868|449239594|FG005|Dose Level 1|Death|0|||
124895073|NCT00062868|449239595|FG006|Dose Level 1|Death|3|||
124895074|NCT00062868|449239596|FG007|Dose Level 1|Death|0|||
124895075|NCT00062868|449239597|FG008|Dose Level 1|Death|0|||
124895076|NCT00062868|449239598|FG009|Dose Level 1|Death|0|||
124895077|NCT00062868|449239599|FG010|Dose Level 1|Death|0|||
124895078|NCT00062868|449239600|FG011|Dose Level 1|Death|0|||
124895079|NCT00062868|449239601|FG012|Dose Level 1|Death|0|||
124895080|NCT00062868|449239602|FG013|Dose Level 1|Death|0|||
124895081|NCT00062868|449239603|FG014|Dose Level 1|Death|0|||
124895082|NCT00062868|449239604|FG015|Dose Level 1|Death|0|||
124895083|NCT00062868|449239605|FG016|Dose Level 1|Death|0|||
124895084|NCT00062868|449239606|FG017|Dose Level 1|Death|0|||
124895085|NCT00062868|449239607|FG018|Dose Level 1|Death|7|||
124895086|NCT00062868|449239608|FG019|Dose Level 1|Death|0|||
124895087|NCT00062868|449239609|FG020|Dose Level 1|Death|1|||
124895088|NCT00062868|449239589|FG000|Dose Level 1|Lost to Follow-up|0|||
124895089|NCT00062868|449239590|FG001|Dose Level 1|Lost to Follow-up|0|||
124895090|NCT00062868|449239591|FG002|Dose Level 1|Lost to Follow-up|0|||
124895091|NCT00062868|449239592|FG003|Dose Level 1|Lost to Follow-up|0|||
124895092|NCT00062868|449239593|FG004|Dose Level 1|Lost to Follow-up|0|||
124895093|NCT00062868|449239594|FG005|Dose Level 1|Lost to Follow-up|0|||
124895094|NCT00062868|449239595|FG006|Dose Level 1|Lost to Follow-up|0|||
124895095|NCT00062868|449239596|FG007|Dose Level 1|Lost to Follow-up|0|||
124895096|NCT00062868|449239597|FG008|Dose Level 1|Lost to Follow-up|0|||
124895097|NCT00062868|449239598|FG009|Dose Level 1|Lost to Follow-up|0|||
124895098|NCT00062868|449239599|FG010|Dose Level 1|Lost to Follow-up|0|||
124895099|NCT00062868|449239600|FG011|Dose Level 1|Lost to Follow-up|0|||
124895100|NCT00062868|449239601|FG012|Dose Level 1|Lost to Follow-up|1|||
124895101|NCT00062868|449239602|FG013|Dose Level 1|Lost to Follow-up|0|||
124895102|NCT00062868|449239603|FG014|Dose Level 1|Lost to Follow-up|0|||
124895103|NCT00062868|449239604|FG015|Dose Level 1|Lost to Follow-up|0|||
124895104|NCT00062868|449239605|FG016|Dose Level 1|Lost to Follow-up|0|||
124895105|NCT00062868|449239606|FG017|Dose Level 1|Lost to Follow-up|0|||
124895106|NCT00062868|449239607|FG018|Dose Level 1|Lost to Follow-up|2|||
124895107|NCT00062868|449239608|FG019|Dose Level 1|Lost to Follow-up|0|||
124895108|NCT00062868|449239609|FG020|Dose Level 1|Lost to Follow-up|1|||
124895109|NCT00062868|449239589|FG000|Dose Level 2|Death|0|||
124895110|NCT00062868|449239590|FG001|Dose Level 2|Death|3|||
124895111|NCT00062868|449239591|FG002|Dose Level 2|Death|0|||
124895112|NCT00062868|449239592|FG003|Dose Level 2|Death|0|||
124895113|NCT00062868|449239593|FG004|Dose Level 2|Death|2|||
124895114|NCT00062868|449239594|FG005|Dose Level 2|Death|0|||
124895115|NCT00062868|449239595|FG006|Dose Level 2|Death|0|||
124895116|NCT00062868|449239596|FG007|Dose Level 2|Death|0|||
124895117|NCT00062868|449239597|FG008|Dose Level 2|Death|0|||
124895118|NCT00062868|449239598|FG009|Dose Level 2|Death|0|||
124895119|NCT00062868|449239599|FG010|Dose Level 2|Death|1|||
124895120|NCT00062868|449239600|FG011|Dose Level 2|Death|0|||
124895121|NCT00062868|449239601|FG012|Dose Level 2|Death|0|||
124895122|NCT00062868|449239602|FG013|Dose Level 2|Death|0|||
124895123|NCT00062868|449239603|FG014|Dose Level 2|Death|0|||
124895124|NCT00062868|449239604|FG015|Dose Level 2|Death|0|||
124895125|NCT00062868|449239605|FG016|Dose Level 2|Death|2|||
124895126|NCT00062868|449239606|FG017|Dose Level 2|Death|0|||
124895127|NCT00062868|449239607|FG018|Dose Level 2|Death|0|||
124895128|NCT00062868|449239608|FG019|Dose Level 2|Death|0|||
124895129|NCT00062868|449239609|FG020|Dose Level 2|Death|0|||
124895130|NCT00062868|449239589|FG000|Dose Level 2|Lost to Follow-up|0|||
124895131|NCT00062868|449239590|FG001|Dose Level 2|Lost to Follow-up|0|||
124895132|NCT00062868|449239591|FG002|Dose Level 2|Lost to Follow-up|0|||
124895133|NCT00062868|449239592|FG003|Dose Level 2|Lost to Follow-up|0|||
124895134|NCT00062868|449239593|FG004|Dose Level 2|Lost to Follow-up|0|||
124895135|NCT00062868|449239594|FG005|Dose Level 2|Lost to Follow-up|0|||
124895136|NCT00062868|449239595|FG006|Dose Level 2|Lost to Follow-up|0|||
124895137|NCT00062868|449239596|FG007|Dose Level 2|Lost to Follow-up|0|||
124895138|NCT00062868|449239597|FG008|Dose Level 2|Lost to Follow-up|0|||
124895139|NCT00062868|449239598|FG009|Dose Level 2|Lost to Follow-up|0|||
124895140|NCT00062868|449239599|FG010|Dose Level 2|Lost to Follow-up|0|||
124895141|NCT00062868|449239600|FG011|Dose Level 2|Lost to Follow-up|0|||
124895142|NCT00062868|449239601|FG012|Dose Level 2|Lost to Follow-up|0|||
124895143|NCT00062868|449239602|FG013|Dose Level 2|Lost to Follow-up|1|||
124895144|NCT00062868|449239603|FG014|Dose Level 2|Lost to Follow-up|0|||
124895145|NCT00062868|449239604|FG015|Dose Level 2|Lost to Follow-up|0|||
124895146|NCT00062868|449239605|FG016|Dose Level 2|Lost to Follow-up|1|||
124895147|NCT00062868|449239606|FG017|Dose Level 2|Lost to Follow-up|0|||
124895148|NCT00062868|449239607|FG018|Dose Level 2|Lost to Follow-up|0|||
124895149|NCT00062868|449239608|FG019|Dose Level 2|Lost to Follow-up|0|||
124895150|NCT00062868|449239609|FG020|Dose Level 2|Lost to Follow-up|0|||
124895151|NCT00062868|449239589|FG000|Dose Level 3|Death|0|||
124895152|NCT00062868|449239590|FG001|Dose Level 3|Death|0|||
124895153|NCT00062868|449239591|FG002|Dose Level 3|Death|0|||
124895154|NCT00062868|449239592|FG003|Dose Level 3|Death|0|||
124895155|NCT00062868|449239593|FG004|Dose Level 3|Death|0|||
124895156|NCT00062868|449239594|FG005|Dose Level 3|Death|0|||
124895157|NCT00062868|449239595|FG006|Dose Level 3|Death|0|||
124895158|NCT00062868|449239596|FG007|Dose Level 3|Death|0|||
124895159|NCT00062868|449239597|FG008|Dose Level 3|Death|0|||
124895160|NCT00062868|449239598|FG009|Dose Level 3|Death|0|||
124895161|NCT00062868|449239599|FG010|Dose Level 3|Death|0|||
124895162|NCT00062868|449239600|FG011|Dose Level 3|Death|1|||
124895163|NCT00062868|449239601|FG012|Dose Level 3|Death|0|||
124895164|NCT00062868|449239602|FG013|Dose Level 3|Death|0|||
124895165|NCT00062868|449239603|FG014|Dose Level 3|Death|0|||
124895166|NCT00062868|449239604|FG015|Dose Level 3|Death|0|||
124895167|NCT00062868|449239605|FG016|Dose Level 3|Death|0|||
124895168|NCT00062868|449239606|FG017|Dose Level 3|Death|1|||
124895169|NCT00062868|449239607|FG018|Dose Level 3|Death|0|||
124895170|NCT00062868|449239608|FG019|Dose Level 3|Death|0|||
124895171|NCT00062868|449239609|FG020|Dose Level 3|Death|0|||
124895172|NCT00062868|449239589|FG000|Dose Level 3|Lost to Follow-up|0|||
124895173|NCT00062868|449239590|FG001|Dose Level 3|Lost to Follow-up|0|||
124895174|NCT00062868|449239591|FG002|Dose Level 3|Lost to Follow-up|0|||
124688102|NCT02260986|448477428|FG000|Overall Study|Adverse Event|24|||
124688103|NCT02260986|448477429|FG001|Overall Study|Adverse Event|0|||
124688104|NCT02260986|448477430|FG002|Overall Study|Adverse Event|11|||
124688105|NCT02260986|448477428|FG000|Overall Study|Lack of Efficacy|27|||
124688106|NCT02260986|448477429|FG001|Overall Study|Lack of Efficacy|3|||
124688107|NCT02260986|448477430|FG002|Overall Study|Lack of Efficacy|0|||
124688108|NCT02260986|448477428|FG000|Overall Study|Protocol Violation|14|||
124688109|NCT02260986|448477429|FG001|Overall Study|Protocol Violation|5|||
124688110|NCT02260986|448477430|FG002|Overall Study|Protocol Violation|16|||
124688111|NCT02260986|448477428|FG000|Overall Study|Car accident|0|||
124688112|NCT02260986|448477429|FG001|Overall Study|Car accident|0|||
124688113|NCT02260986|448477430|FG002|Overall Study|Car accident|1|||
124688114|NCT02260986|448477428|FG000|Overall Study|Withdrawal by Subject|17|||
124688115|NCT02260986|448477429|FG001|Overall Study|Withdrawal by Subject|4|||
124688116|NCT02260986|448477430|FG002|Overall Study|Withdrawal by Subject|9|||
124688117|NCT02260986|448477428|FG000|Overall Study|Incorrect randomization|0|||
124688118|NCT02260986|448477429|FG001|Overall Study|Incorrect randomization|1|||
124688119|NCT02260986|448477430|FG002|Overall Study|Incorrect randomization|0|||
124688120|NCT02260986|448477428|FG000|Overall Study|Lack of investigation product supply|2|||
124688121|NCT02260986|448477429|FG001|Overall Study|Lack of investigation product supply|0|||
124895175|NCT00062868|449239592|FG003|Dose Level 3|Lost to Follow-up|0|||
124895176|NCT00062868|449239593|FG004|Dose Level 3|Lost to Follow-up|0|||
124895177|NCT00062868|449239594|FG005|Dose Level 3|Lost to Follow-up|0|||
124895178|NCT00062868|449239595|FG006|Dose Level 3|Lost to Follow-up|0|||
124895179|NCT00062868|449239596|FG007|Dose Level 3|Lost to Follow-up|0|||
124895180|NCT00062868|449239597|FG008|Dose Level 3|Lost to Follow-up|0|||
124895181|NCT00062868|449239598|FG009|Dose Level 3|Lost to Follow-up|0|||
124895182|NCT00062868|449239599|FG010|Dose Level 3|Lost to Follow-up|0|||
124895183|NCT00062868|449239600|FG011|Dose Level 3|Lost to Follow-up|0|||
124895184|NCT00062868|449239601|FG012|Dose Level 3|Lost to Follow-up|0|||
124895185|NCT00062868|449239602|FG013|Dose Level 3|Lost to Follow-up|0|||
124895186|NCT00062868|449239603|FG014|Dose Level 3|Lost to Follow-up|1|||
124895187|NCT00062868|449239604|FG015|Dose Level 3|Lost to Follow-up|0|||
124895188|NCT00062868|449239605|FG016|Dose Level 3|Lost to Follow-up|0|||
124895189|NCT00062868|449239606|FG017|Dose Level 3|Lost to Follow-up|0|||
124895190|NCT00062868|449239607|FG018|Dose Level 3|Lost to Follow-up|0|||
124895191|NCT00062868|449239608|FG019|Dose Level 3|Lost to Follow-up|0|||
124895192|NCT00062868|449239609|FG020|Dose Level 3|Lost to Follow-up|0|||
124895193|NCT00062868|449239589|FG000|Dose Level 3|Withdrew|0|||
124895194|NCT00062868|449239590|FG001|Dose Level 3|Withdrew|0|||
124895195|NCT00062868|449239591|FG002|Dose Level 3|Withdrew|2|||
124895196|NCT00062868|449239592|FG003|Dose Level 3|Withdrew|0|||
124895197|NCT00062868|449239593|FG004|Dose Level 3|Withdrew|0|||
124895198|NCT00062868|449239594|FG005|Dose Level 3|Withdrew|0|||
124895199|NCT00062868|449239595|FG006|Dose Level 3|Withdrew|0|||
124688122|NCT02260986|448477430|FG002|Overall Study|Lack of investigation product supply|1|||
124688123|NCT02260986|448477428|FG000|Overall Study|Lost to Follow-up|4|||
124688124|NCT02260986|448477429|FG001|Overall Study|Lost to Follow-up|0|||
124688125|NCT02260986|448477430|FG002|Overall Study|Lost to Follow-up|3|||
124688126|NCT02260986|448477428|FG000|Overall Study|Pregnancy|2|||
124688127|NCT02260986|448477429|FG001|Overall Study|Pregnancy|0|||
124688128|NCT02260986|448477430|FG002|Overall Study|Pregnancy|0|||
124688129|NCT02034591|448477433|FG000|Overall Study|Withdrawal by Subject|0|||
124688130|NCT02034591|448477434|FG001|Overall Study|Withdrawal by Subject|0|||
124759347|NCT00452790|448742620|FG000|Infant Series|Lost to Follow-up|2|||
124895200|NCT00062868|449239596|FG007|Dose Level 3|Withdrew|0|||
124895201|NCT00062868|449239597|FG008|Dose Level 3|Withdrew|0|||
124895202|NCT00062868|449239598|FG009|Dose Level 3|Withdrew|0|||
124759348|NCT00452790|448742621|FG001|Infant Series|Lost to Follow-up|2|||
124759349|NCT00452790|448742620|FG000|Infant Series|Adverse Event|1|||
124759350|NCT00452790|448742621|FG001|Infant Series|Adverse Event|2|||
124759351|NCT00452790|448742620|FG000|Infant Series|Other reasons|1|||
124895203|NCT00062868|449239599|FG010|Dose Level 3|Withdrew|0|||
124895204|NCT00062868|449239600|FG011|Dose Level 3|Withdrew|0|||
124895205|NCT00062868|449239601|FG012|Dose Level 3|Withdrew|0|||
124895206|NCT00062868|449239602|FG013|Dose Level 3|Withdrew|0|||
124895207|NCT00062868|449239603|FG014|Dose Level 3|Withdrew|0|||
124895208|NCT00062868|449239604|FG015|Dose Level 3|Withdrew|0|||
124895209|NCT00062868|449239605|FG016|Dose Level 3|Withdrew|0|||
124895210|NCT00062868|449239606|FG017|Dose Level 3|Withdrew|0|||
124895211|NCT00062868|449239607|FG018|Dose Level 3|Withdrew|0|||
124895212|NCT00062868|449239608|FG019|Dose Level 3|Withdrew|0|||
124895213|NCT00062868|449239609|FG020|Dose Level 3|Withdrew|0|||
124895214|NCT00670540|449239614|FG000|Overall Study|ineligible|17|||
124895215|NCT00670540|449239614|FG000|Overall Study|not living in France|348|||
124895216|NCT00670540|449239614|FG000|Overall Study|refused to participate|189|||
124895217|NCT00670540|449239614|FG000|Overall Study|controls randomised for no follow up|2770|||
124895218|NCT00670540|449239614|FG000|Overall Study|missing information inclusion criteria|1|||
124895219|NCT01866917|449239615|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
124895220|NCT01866917|449239616|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
124895221|NCT01515319|449239620|FG000|Overall Study|Withdrawal by Subject|0|||
124895222|NCT01515319|449239621|FG001|Overall Study|Withdrawal by Subject|0|||
124895223|NCT01515319|449239622|FG002|Overall Study|Withdrawal by Subject|0|||
124895224|NCT01515319|449239623|FG003|Overall Study|Withdrawal by Subject|0|||
124895225|NCT01515319|449239624|FG004|Overall Study|Withdrawal by Subject|0|||
124895226|NCT01515319|449239625|FG005|Overall Study|Withdrawal by Subject|0|||
124895227|NCT01515319|449239626|FG006|Overall Study|Withdrawal by Subject|1|||
124895228|NCT01515319|449239627|FG007|Overall Study|Withdrawal by Subject|0|||
124443472|NCT00908232|447584875|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
124443473|NCT00908232|447584876|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
124443474|NCT00908232|447584877|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
124443475|NCT00908232|447584874|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
124443476|NCT00908232|447584875|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
124443477|NCT00908232|447584876|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
124443478|NCT00908232|447584877|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
124443479|NCT00908232|447584874|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
124443480|NCT00908232|447584875|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
124443481|NCT00908232|447584876|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
124443482|NCT00908232|447584877|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
124443483|NCT00908232|447584874|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
124443484|NCT00908232|447584875|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
124443485|NCT00908232|447584876|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
124443486|NCT00908232|447584877|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
124443487|NCT02260882|447584878|FG000|Overall Study|Protocol Violation|0|||
124443488|NCT02260882|447584879|FG001|Overall Study|Protocol Violation|1|||
124443489|NCT02119325|447584880|FG000|Washout Period 1|Adverse Event|0|||
124895229|NCT01515319|449239628|FG008|Overall Study|Withdrawal by Subject|0|||
124895230|NCT01515319|449239629|FG009|Overall Study|Withdrawal by Subject|0|||
124895231|NCT01515319|449239620|FG000|Overall Study|Adverse Event|0|||
124895232|NCT01515319|449239621|FG001|Overall Study|Adverse Event|0|||
124895233|NCT01515319|449239622|FG002|Overall Study|Adverse Event|0|||
124895234|NCT01515319|449239623|FG003|Overall Study|Adverse Event|0|||
124895235|NCT01515319|449239624|FG004|Overall Study|Adverse Event|0|||
124895236|NCT01515319|449239625|FG005|Overall Study|Adverse Event|0|||
124895237|NCT01515319|449239626|FG006|Overall Study|Adverse Event|0|||
124895238|NCT01515319|449239627|FG007|Overall Study|Adverse Event|0|||
124895239|NCT01515319|449239628|FG008|Overall Study|Adverse Event|3|||
124895240|NCT01515319|449239629|FG009|Overall Study|Adverse Event|0|||
124895241|NCT01515319|449239620|FG000|Overall Study|Protocol Violation|0|||
124895242|NCT01515319|449239621|FG001|Overall Study|Protocol Violation|0|||
124895243|NCT01515319|449239622|FG002|Overall Study|Protocol Violation|0|||
124895244|NCT01515319|449239623|FG003|Overall Study|Protocol Violation|0|||
124895245|NCT01515319|449239624|FG004|Overall Study|Protocol Violation|0|||
124895246|NCT01515319|449239625|FG005|Overall Study|Protocol Violation|0|||
124895247|NCT01515319|449239626|FG006|Overall Study|Protocol Violation|0|||
124895248|NCT01515319|449239627|FG007|Overall Study|Protocol Violation|0|||
124895249|NCT01515319|449239628|FG008|Overall Study|Protocol Violation|2|||
124895250|NCT01515319|449239629|FG009|Overall Study|Protocol Violation|0|||
124895251|NCT01449929|449239631|FG000|Randomization Phase 96 Week|Adverse Event|5|||
124895252|NCT01449929|449239632|FG001|Randomization Phase 96 Week|Adverse Event|13|||
124895253|NCT01449929|449239633|FG002|Randomization Phase 96 Week|Adverse Event|0|||
124895254|NCT01449929|449239631|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
124895255|NCT01449929|449239632|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
124895256|NCT01449929|449239633|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
124895257|NCT01449929|449239631|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
124895258|NCT01449929|449239632|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
124895259|NCT01449929|449239633|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
124895260|NCT01449929|449239631|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
124443490|NCT02119325|447584881|FG001|Washout Period 1|Adverse Event|1|||
124443491|NCT00954174|447584882|FG000|Overall Study|Adverse Event|28|||
124443492|NCT00954174|447584883|FG001|Overall Study|Adverse Event|23|||
124443493|NCT00954174|447584884|FG002|Overall Study|Adverse Event|4|||
124443494|NCT00954174|447584885|FG003|Overall Study|Adverse Event|9|||
124443495|NCT00954174|447584882|FG000|Overall Study|Death|4|||
124443496|NCT00954174|447584883|FG001|Overall Study|Death|2|||
124895261|NCT01449929|449239632|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
124895262|NCT01449929|449239633|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
124895263|NCT01449929|449239631|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
124895264|NCT01449929|449239632|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
124895265|NCT01449929|449239633|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
124895266|NCT01449929|449239631|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
124895267|NCT01449929|449239632|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
124895268|NCT01449929|449239633|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
124895269|NCT01449929|449239631|FG000|Randomization Phase 96 Week|Physician Decision|2|||
124895270|NCT01449929|449239632|FG001|Randomization Phase 96 Week|Physician Decision|3|||
124895271|NCT01449929|449239633|FG002|Randomization Phase 96 Week|Physician Decision|0|||
124895272|NCT01449929|449239631|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
124895273|NCT01449929|449239632|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
124443497|NCT00954174|447584884|FG002|Overall Study|Death|0|||
124443498|NCT00954174|447584885|FG003|Overall Study|Death|0|||
124443499|NCT00954174|447584882|FG000|Overall Study|Lack of Efficacy|32|||
124443500|NCT00954174|447584883|FG001|Overall Study|Lack of Efficacy|22|||
124443501|NCT00954174|447584884|FG002|Overall Study|Lack of Efficacy|8|||
124443502|NCT00954174|447584885|FG003|Overall Study|Lack of Efficacy|6|||
124443503|NCT00954174|447584882|FG000|Overall Study|Withdrawal by Subject|14|||
124443504|NCT00954174|447584883|FG001|Overall Study|Withdrawal by Subject|10|||
124443505|NCT00954174|447584884|FG002|Overall Study|Withdrawal by Subject|4|||
124443506|NCT00954174|447584885|FG003|Overall Study|Withdrawal by Subject|3|||
124443507|NCT00954174|447584882|FG000|Overall Study|Medical Reason|4|||
124443508|NCT00954174|447584883|FG001|Overall Study|Medical Reason|2|||
124443509|NCT00954174|447584884|FG002|Overall Study|Medical Reason|1|||
124443510|NCT00954174|447584885|FG003|Overall Study|Medical Reason|0|||
124443511|NCT00954174|447584882|FG000|Overall Study|Ineligible|40|||
124443512|NCT00954174|447584883|FG001|Overall Study|Ineligible|47|||
124443513|NCT00954174|447584884|FG002|Overall Study|Ineligible|7|||
124443514|NCT00954174|447584885|FG003|Overall Study|Ineligible|4|||
124443515|NCT00954174|447584882|FG000|Overall Study|Never Treated|4|||
124443516|NCT00954174|447584883|FG001|Overall Study|Never Treated|17|||
124443517|NCT00954174|447584884|FG002|Overall Study|Never Treated|0|||
124443518|NCT00954174|447584885|FG003|Overall Study|Never Treated|3|||
124443519|NCT01776424|447584887|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
124443520|NCT01776424|447584888|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
124443521|NCT01776424|447584889|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
124443522|NCT01776424|447584887|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
124443523|NCT01776424|447584888|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
124443524|NCT01776424|447584889|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
124443525|NCT01776424|447584887|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
124443526|NCT01776424|447584888|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
124443527|NCT01776424|447584889|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
124443528|NCT01776424|447584887|FG000|LTOLE Part (Open Label)|Refused|5|||
124443529|NCT01776424|447584888|FG001|LTOLE Part (Open Label)|Refused|2|||
124443530|NCT01776424|447584889|FG002|LTOLE Part (Open Label)|Refused|11|||
124443531|NCT01776424|447584887|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
124443532|NCT01776424|447584888|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
124443533|NCT01776424|447584889|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
124443534|NCT00146757|447584890|FG000|Overall Study|Death|1|||
124443535|NCT00146757|447584891|FG001|Overall Study|Death|0|||
124443536|NCT00146757|447584890|FG000|Overall Study|Adverse Event|1|||
124443537|NCT00146757|447584891|FG001|Overall Study|Adverse Event|0|||
124443538|NCT03181451|447584898|FG000|Overall Study|Adverse Event|0|||
124443539|NCT03181451|447584899|FG001|Overall Study|Adverse Event|1|||
124443540|NCT03181451|447584900|FG002|Overall Study|Adverse Event|0|||
124443541|NCT03181451|447584898|FG000|Overall Study|Withdrawal by Subject|0|||
124443542|NCT03181451|447584899|FG001|Overall Study|Withdrawal by Subject|1|||
124688131|NCT02034591|448477435|FG002|Overall Study|Withdrawal by Subject|0|||
124688132|NCT02034591|448477436|FG003|Overall Study|Withdrawal by Subject|0|||
124443543|NCT03181451|447584900|FG002|Overall Study|Withdrawal by Subject|0|||
124443544|NCT03037619|447584910|FG000|Overall Study|Lost to Follow-up|0|||
124443545|NCT03037619|447584911|FG001|Overall Study|Lost to Follow-up|1|||
124688133|NCT02034591|448477437|FG004|Overall Study|Withdrawal by Subject|1|||
124443546|NCT03294109|447584912|FG000|Overall Study|Withdrawal by Subject|6|||
124443547|NCT03294109|447584913|FG001|Overall Study|Withdrawal by Subject|5|||
124443548|NCT01794923|447584914|FG000|Overall Study|Adverse Event|0|||
124688134|NCT02034591|448477438|FG005|Overall Study|Withdrawal by Subject|0|||
124895274|NCT01449929|449239633|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
124895275|NCT01449929|449239631|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
124443549|NCT01794923|447584915|FG001|Overall Study|Adverse Event|0|||
124443550|NCT01794923|447584916|FG002|Overall Study|Adverse Event|1|||
124443551|NCT02030405|447584929|FG000|Overall Study|Withdrawal by Subject|1|||
124443552|NCT02030405|447584929|FG000|Overall Study|Lost to Follow-up|1|||
124895276|NCT01449929|449239632|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
124895277|NCT01449929|449239633|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
124895278|NCT01449929|449239631|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
124895279|NCT01449929|449239632|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
124895280|NCT01449929|449239633|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
124895281|NCT01449929|449239631|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
124895282|NCT01449929|449239632|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
124895283|NCT01449929|449239633|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
124895284|NCT01871285|449239634|FG000|First Intervention (1 Day)|Adverse Event|1|||
124443553|NCT00986440|447584930|FG000|Overall Study|Progressive disease|27|||
124443554|NCT00986440|447584931|FG001|Overall Study|Progressive disease|37|||
124895285|NCT01871285|449239635|FG001|First Intervention (1 Day)|Adverse Event|0|||
124895286|NCT01871285|449239636|FG002|First Intervention (1 Day)|Adverse Event|0|||
124895287|NCT01871285|449239637|FG003|First Intervention (1 Day)|Adverse Event|0|||
124895288|NCT01871285|449239634|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
124895289|NCT01871285|449239635|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
124895290|NCT01871285|449239636|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
124895291|NCT01871285|449239637|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
124895292|NCT01959880|449239638|FG000|Overall Study|Withdrawal by Subject|11|||
124895293|NCT01959880|449239639|FG001|Overall Study|Withdrawal by Subject|13|||
124895294|NCT01959880|449239640|FG002|Overall Study|Withdrawal by Subject|8|||
124443555|NCT00986440|447584930|FG000|Overall Study|Serious adverse event or adverse event|9|||
124443556|NCT00986440|447584931|FG001|Overall Study|Serious adverse event or adverse event|2|||
124443557|NCT00986440|447584930|FG000|Overall Study|Withdrawal by Subject|1|||
124895295|NCT01959880|449239641|FG003|Overall Study|Withdrawal by Subject|7|||
124895296|NCT01959880|449239638|FG000|Overall Study|Death|1|||
124443558|NCT00986440|447584931|FG001|Overall Study|Withdrawal by Subject|2|||
124443559|NCT00986440|447584930|FG000|Overall Study|Screen failure (not dosed)|4|||
124443560|NCT00986440|447584931|FG001|Overall Study|Screen failure (not dosed)|2|||
124443561|NCT02973048|447584932|FG000|Overall Study|Epidural catheter insertion failure|1|||
124443562|NCT02973048|447584933|FG001|Overall Study|Epidural catheter insertion failure|0|||
124443563|NCT02973048|447584932|FG000|Overall Study|Withdrawal by Subject|0|||
124443564|NCT02973048|447584933|FG001|Overall Study|Withdrawal by Subject|3|||
124443565|NCT00651157|447584935|FG000|Overall Study|Death|1|||
124443566|NCT00651157|447584935|FG000|Overall Study|Protocol Violation|1|||
124443567|NCT00364156|447584937|FG000|Overall Study|Withdrawal by Subject|73|||
124443568|NCT00364156|447584938|FG001|Overall Study|Withdrawal by Subject|80|||
124443569|NCT00364156|447584937|FG000|Overall Study|Protocol Violation|6|||
124443570|NCT00364156|447584938|FG001|Overall Study|Protocol Violation|1|||
124443571|NCT00292461|447584939|FG000|Overall Study|Adverse Event|4|||
124443572|NCT00292461|447584940|FG001|Overall Study|Adverse Event|2|||
124443573|NCT00292461|447584939|FG000|Overall Study|Lack of Efficacy|1|||
124443574|NCT00292461|447584940|FG001|Overall Study|Lack of Efficacy|0|||
124443575|NCT00292461|447584939|FG000|Overall Study|Withdrawal by Subject|0|||
124443576|NCT00292461|447584940|FG001|Overall Study|Withdrawal by Subject|1|||
124443577|NCT00292461|447584939|FG000|Overall Study|Protocol Violation|4|||
124443578|NCT00292461|447584940|FG001|Overall Study|Protocol Violation|3|||
124443579|NCT00292461|447584939|FG000|Overall Study|Lost to Follow-up|1|||
124443580|NCT00292461|447584940|FG001|Overall Study|Lost to Follow-up|0|||
124443581|NCT04356183|447586155|FG000|Overall Study|Lost to Follow-up|1|||
124443582|NCT04356183|447586156|FG001|Overall Study|Lost to Follow-up|0|||
124443583|NCT04356183|447586155|FG000|Overall Study|Withdrawal by Subject|1|||
124443584|NCT04356183|447586156|FG001|Overall Study|Withdrawal by Subject|1|||
124443585|NCT00667355|447586159|FG000|Overall Study|Adverse Event|5|||
124443586|NCT00667355|447586159|FG000|Overall Study|Lost to Follow-up|1|||
124443587|NCT00667355|447586159|FG000|Overall Study|Other reason was not specified|5|||
124443588|NCT00823901|447586160|FG000|Overall Study|Adverse Event|1|||
124443589|NCT00823901|447586161|FG001|Overall Study|Adverse Event|1|||
124443590|NCT00823901|447586160|FG000|Overall Study|Lack of Efficacy|1|||
124443591|NCT00823901|447586161|FG001|Overall Study|Lack of Efficacy|0|||
124443592|NCT00823901|447586160|FG000|Overall Study|Lost to Follow-up|2|||
124443593|NCT00823901|447586161|FG001|Overall Study|Lost to Follow-up|1|||
124443594|NCT01369511|447586163|FG000|Overall Study|Adverse Event|1|||
124443595|NCT01369511|447586164|FG001|Overall Study|Adverse Event|1|||
124443596|NCT01369511|447586165|FG002|Overall Study|Adverse Event|5|||
124443597|NCT01369511|447586166|FG003|Overall Study|Adverse Event|0|||
124443598|NCT01369511|447586163|FG000|Overall Study|Entry criteria not met|2|||
124443599|NCT01369511|447586164|FG001|Overall Study|Entry criteria not met|0|||
124443600|NCT01369511|447586165|FG002|Overall Study|Entry criteria not met|0|||
124443601|NCT01369511|447586166|FG003|Overall Study|Entry criteria not met|1|||
124443602|NCT01369511|447586163|FG000|Overall Study|Lost to Follow-up|0|||
124443603|NCT01369511|447586164|FG001|Overall Study|Lost to Follow-up|1|||
124443604|NCT01369511|447586165|FG002|Overall Study|Lost to Follow-up|1|||
124443605|NCT01369511|447586166|FG003|Overall Study|Lost to Follow-up|2|||
124443606|NCT01369511|447586163|FG000|Overall Study|Protocol Violation|0|||
124443607|NCT01369511|447586164|FG001|Overall Study|Protocol Violation|1|||
124443608|NCT01369511|447586165|FG002|Overall Study|Protocol Violation|0|||
124443609|NCT01369511|447586166|FG003|Overall Study|Protocol Violation|2|||
124443610|NCT01369511|447586163|FG000|Overall Study|Physician Decision|3|||
124443611|NCT01369511|447586164|FG001|Overall Study|Physician Decision|4|||
124443612|NCT01369511|447586165|FG002|Overall Study|Physician Decision|0|||
124443613|NCT01369511|447586166|FG003|Overall Study|Physician Decision|0|||
124443614|NCT01369511|447586163|FG000|Overall Study|Sponsor decision|2|||
124443615|NCT01369511|447586164|FG001|Overall Study|Sponsor decision|0|||
124443616|NCT01369511|447586165|FG002|Overall Study|Sponsor decision|1|||
124443617|NCT01369511|447586166|FG003|Overall Study|Sponsor decision|0|||
124443618|NCT01369511|447586163|FG000|Overall Study|Withdrawal by Subject|5|||
124895297|NCT01959880|449239639|FG001|Overall Study|Death|10|||
124895298|NCT01959880|449239640|FG002|Overall Study|Death|1|||
124443619|NCT01369511|447586164|FG001|Overall Study|Withdrawal by Subject|6|||
124443620|NCT01369511|447586165|FG002|Overall Study|Withdrawal by Subject|4|||
124443621|NCT01369511|447586166|FG003|Overall Study|Withdrawal by Subject|6|||
124443622|NCT01180998|447586167|FG000|Overall Study|Poor Vision|0|||
124443623|NCT01180998|447586168|FG001|Overall Study|Poor Vision|2|||
124443624|NCT01180998|447586169|FG002|Overall Study|Poor Vision|2|||
124895299|NCT01959880|449239641|FG003|Overall Study|Death|2|||
124443625|NCT01180998|447586167|FG000|Overall Study|Lost to Follow-up|0|||
124443626|NCT01180998|447586168|FG001|Overall Study|Lost to Follow-up|0|||
124443627|NCT01180998|447586169|FG002|Overall Study|Lost to Follow-up|1|||
124443628|NCT01180998|447586167|FG000|Overall Study|Protocol Violation|1|||
124443629|NCT01180998|447586168|FG001|Overall Study|Protocol Violation|2|||
124443630|NCT01180998|447586169|FG002|Overall Study|Protocol Violation|0|||
124443631|NCT01180998|447586167|FG000|Overall Study|Withdrawal by Subject|0|||
124443632|NCT01180998|447586168|FG001|Overall Study|Withdrawal by Subject|0|||
124443633|NCT01180998|447586169|FG002|Overall Study|Withdrawal by Subject|1|||
124895300|NCT01959880|449239638|FG000|Overall Study|Lost to Follow-up|95|||
124443634|NCT01180998|447586167|FG000|Overall Study|Poor comfort|3|||
124443635|NCT01180998|447586168|FG001|Overall Study|Poor comfort|0|||
124443636|NCT01180998|447586169|FG002|Overall Study|Poor comfort|4|||
124443637|NCT01180998|447586167|FG000|Overall Study|Poor lens handling|0|||
124443638|NCT01180998|447586168|FG001|Overall Study|Poor lens handling|0|||
124443639|NCT01180998|447586169|FG002|Overall Study|Poor lens handling|2|||
124443640|NCT01376349|447586170|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
124443641|NCT01376349|447586171|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
124443642|NCT01376349|447586172|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
124443643|NCT01376349|447586170|FG000|Raondomized Treatment|Adverse Event|13|||
124443644|NCT01376349|447586171|FG001|Raondomized Treatment|Adverse Event|17|||
124443645|NCT01376349|447586172|FG002|Raondomized Treatment|Adverse Event|14|||
124443646|NCT01376349|447586170|FG000|Raondomized Treatment|Unkown|1|||
124443647|NCT01376349|447586171|FG001|Raondomized Treatment|Unkown|2|||
124443648|NCT01376349|447586172|FG002|Raondomized Treatment|Unkown|1|||
124443649|NCT01376349|447586170|FG000|Raondomized Treatment|Alternative Treatment|0|||
124443650|NCT01376349|447586171|FG001|Raondomized Treatment|Alternative Treatment|0|||
124688135|NCT01771913|448477442|FG000|Overall Study|Withdrawal by Subject|1|||
124688136|NCT01771913|448477443|FG001|Overall Study|Withdrawal by Subject|0|||
124688137|NCT04307394|448477444|FG000|Overall Study|Lost to Follow-up|3|||
124895301|NCT01959880|449239639|FG001|Overall Study|Lost to Follow-up|18|||
124895302|NCT01959880|449239640|FG002|Overall Study|Lost to Follow-up|15|||
124895303|NCT01959880|449239641|FG003|Overall Study|Lost to Follow-up|8|||
124895304|NCT01959880|449239638|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
124895305|NCT01959880|449239639|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
124895306|NCT01959880|449239640|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
124895307|NCT01959880|449239641|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
124895308|NCT01959880|449239638|FG000|Overall Study|Study completed early-FDA approved|1003|||
124895309|NCT01959880|449239639|FG001|Overall Study|Study completed early-FDA approved|311|||
124895310|NCT01959880|449239640|FG002|Overall Study|Study completed early-FDA approved|179|||
124443651|NCT01376349|447586172|FG002|Raondomized Treatment|Alternative Treatment|1|||
124443652|NCT01137955|447586173|FG000|Overall Study|Withdrawal by Subject|5|||
124443653|NCT01137955|447586174|FG001|Overall Study|Withdrawal by Subject|4|||
124443654|NCT00068588|447586175|FG000|Overall Study|Adverse Event|0|||
124443655|NCT00068588|447586176|FG001|Overall Study|Adverse Event|0|||
124443656|NCT00068588|447586177|FG002|Overall Study|Adverse Event|2|||
124443657|NCT00068588|447586175|FG000|Overall Study|Withdrawal by Subject|0|||
124443658|NCT00068588|447586176|FG001|Overall Study|Withdrawal by Subject|0|||
124443659|NCT00068588|447586177|FG002|Overall Study|Withdrawal by Subject|1|||
124443660|NCT00068588|447586175|FG000|Overall Study|Poor KPS|0|||
124688138|NCT04307394|448477444|FG000|Overall Study|Withdrawal by Subject|2|||
124688139|NCT01121926|448477445|FG000|First Intervention Period|Adverse Event|1|||
124688140|NCT01121926|448477446|FG001|First Intervention Period|Adverse Event|0|||
124688141|NCT01121926|448477445|FG000|Washout Period|Adverse Event|0|||
124688142|NCT01121926|448477446|FG001|Washout Period|Adverse Event|1|||
124688143|NCT01121926|448477445|FG000|Washout Period|Positive pregnancy test|0|||
124688144|NCT01121926|448477446|FG001|Washout Period|Positive pregnancy test|1|||
124688145|NCT00416949|448477448|FG000|Overall Study|Patients refused to participate|5|||
124688146|NCT02782468|448477449|FG000|Overall Study|Progressive Disease|2|||
124688147|NCT02782468|448477450|FG001|Overall Study|Progressive Disease|5|||
124688148|NCT02782468|448477451|FG002|Overall Study|Progressive Disease|0|||
124688149|NCT02782468|448477452|FG003|Overall Study|Progressive Disease|4|||
124688150|NCT02782468|448477449|FG000|Overall Study|Adverse Event|0|||
124688151|NCT02782468|448477450|FG001|Overall Study|Adverse Event|2|||
124688152|NCT02782468|448477451|FG002|Overall Study|Adverse Event|2|||
124688153|NCT02782468|448477452|FG003|Overall Study|Adverse Event|3|||
124688154|NCT02782468|448477449|FG000|Overall Study|Other|0|||
124443661|NCT00068588|447586176|FG001|Overall Study|Poor KPS|0|||
124443662|NCT00068588|447586177|FG002|Overall Study|Poor KPS|1|||
124443663|NCT05193500|447586178|FG000|Overall Study|Withdrawal by Subject|7|||
124443664|NCT05193500|447586179|FG001|Overall Study|Withdrawal by Subject|4|||
124443665|NCT05193500|447586180|FG002|Overall Study|Withdrawal by Subject|3|||
124443666|NCT05193500|447586181|FG003|Overall Study|Withdrawal by Subject|5|||
124443667|NCT04098068|447586182|FG000|Overall Study|Disease Progression|7|||
124443668|NCT04098068|447586182|FG000|Overall Study|Withdrawal by Subject|2|||
124443669|NCT04098068|447586182|FG000|Overall Study|New Cancer Diagnosis|1|||
124688155|NCT02782468|448477450|FG001|Overall Study|Other|0|||
124688156|NCT02782468|448477451|FG002|Overall Study|Other|1|||
124895311|NCT01959880|449239641|FG003|Overall Study|Study completed early-FDA approved|152|||
124443670|NCT03871829|447586183|FG000|Overall Study|Lost to Follow-up|0|||
124443671|NCT03871829|447586184|FG001|Overall Study|Lost to Follow-up|1|||
124688157|NCT02782468|448477452|FG003|Overall Study|Other|1|||
124443672|NCT03871829|447586183|FG000|Overall Study|Withdrawal by Subject|1|||
124688158|NCT02782468|448477449|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
124688159|NCT02782468|448477450|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
124688160|NCT02782468|448477451|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
124688161|NCT02782468|448477452|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
124688162|NCT02782468|448477449|FG000|Overall Study|Symptomatic Deterioration|0|||
124688163|NCT02782468|448477450|FG001|Overall Study|Symptomatic Deterioration|0|||
124688164|NCT02782468|448477451|FG002|Overall Study|Symptomatic Deterioration|0|||
124688165|NCT02782468|448477452|FG003|Overall Study|Symptomatic Deterioration|1|||
124688166|NCT02782468|448477449|FG000|Overall Study|Withdrawal by Subject|1|||
124688167|NCT02782468|448477450|FG001|Overall Study|Withdrawal by Subject|0|||
124688168|NCT02782468|448477451|FG002|Overall Study|Withdrawal by Subject|0|||
124688169|NCT02782468|448477452|FG003|Overall Study|Withdrawal by Subject|0|||
124688170|NCT00313170|448477453|FG000|Overall Study|Death|2|||
124688171|NCT00313170|448477454|FG001|Overall Study|Death|4|||
124688172|NCT00313170|448477455|FG002|Overall Study|Death|2|||
124688173|NCT00313170|448477453|FG000|Overall Study|Adverse Event|1|||
124688174|NCT00313170|448477454|FG001|Overall Study|Adverse Event|2|||
124688175|NCT00313170|448477455|FG002|Overall Study|Adverse Event|0|||
124688176|NCT00313170|448477453|FG000|Overall Study|Disease progression|31|||
124688177|NCT00313170|448477454|FG001|Overall Study|Disease progression|26|||
124688178|NCT00313170|448477455|FG002|Overall Study|Disease progression|27|||
124688179|NCT00313170|448477453|FG000|Overall Study|Withdrawal by Subject|1|||
124688180|NCT00313170|448477454|FG001|Overall Study|Withdrawal by Subject|0|||
124688181|NCT00313170|448477455|FG002|Overall Study|Withdrawal by Subject|1|||
124688182|NCT00313170|448477453|FG000|Overall Study|Incorrect enrollment|0|||
124688183|NCT00313170|448477454|FG001|Overall Study|Incorrect enrollment|2|||
124688184|NCT00313170|448477455|FG002|Overall Study|Incorrect enrollment|1|||
124688185|NCT00313170|448477453|FG000|Overall Study|Lost to Follow-up|0|||
124688186|NCT00313170|448477454|FG001|Overall Study|Lost to Follow-up|0|||
124688187|NCT00313170|448477455|FG002|Overall Study|Lost to Follow-up|1|||
124688188|NCT00313170|448477453|FG000|Overall Study|Progression (investigators opinion)|1|||
124688189|NCT00313170|448477454|FG001|Overall Study|Progression (investigators opinion)|0|||
124688190|NCT00313170|448477455|FG002|Overall Study|Progression (investigators opinion)|0|||
124688191|NCT01410604|448477457|FG000|Overall Study|Adverse Event|2|||
124688192|NCT01410604|448477458|FG001|Overall Study|Adverse Event|1|||
124688193|NCT01410604|448477457|FG000|Overall Study|Lost to Follow-up|1|||
124688194|NCT01410604|448477458|FG001|Overall Study|Lost to Follow-up|0|||
124688195|NCT01410604|448477457|FG000|Overall Study|Physician Decision|0|||
124688196|NCT01410604|448477458|FG001|Overall Study|Physician Decision|1|||
124688197|NCT00356590|448477459|FG000|Overall Study|Adverse Event|54|||
124688198|NCT00356590|448477459|FG000|Overall Study|Death|10|||
124688199|NCT00356590|448477459|FG000|Overall Study|Lost to Follow-up|35|||
124443673|NCT03871829|447586184|FG001|Overall Study|Withdrawal by Subject|1|||
124443674|NCT03871829|447586183|FG000|Overall Study|Death|12|||
124443675|NCT03871829|447586184|FG001|Overall Study|Death|8|||
124443676|NCT03871829|447586183|FG000|Overall Study|Study terminated by sponsor|31|||
124443677|NCT03871829|447586184|FG001|Overall Study|Study terminated by sponsor|34|||
124443678|NCT05458479|447586190|FG000|Overall Study|Lost to Follow-up|1|||
124443679|NCT01324323|447586191|FG000|Overall Study|Withdrawal by Subject|1|||
124443680|NCT00993915|447586198|FG000|Overall Study|Insufficient clinical response|3|||
124443681|NCT00993915|447586198|FG000|Overall Study|Withdrawal by Subject|2|||
124443682|NCT00993915|447586198|FG000|Overall Study|Other|1|||
124443683|NCT00993915|447586198|FG000|Overall Study|Ongoing|3|||
124443684|NCT01386658|447586199|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
124443685|NCT01386658|447586200|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
124443686|NCT01386658|447586199|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
124443687|NCT01386658|447586200|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
124443688|NCT02465463|447586208|FG000|Overall Study|Lost to Follow-up|2|||
124443689|NCT02465463|447586209|FG001|Overall Study|Lost to Follow-up|1|||
124443690|NCT02465463|447586208|FG000|Overall Study|Death|1|||
124443691|NCT02465463|447586209|FG001|Overall Study|Death|0|||
124443692|NCT02465463|447586208|FG000|Overall Study|Protocol Violation|1|||
124443693|NCT02465463|447586209|FG001|Overall Study|Protocol Violation|0|||
124443694|NCT00821431|447586210|FG000|Overall Study|Adverse Event|6|||
124443695|NCT00821431|447586211|FG001|Overall Study|Adverse Event|3|||
124443696|NCT00821431|447586210|FG000|Overall Study|Withdrawal by Subject|5|||
124443697|NCT00821431|447586211|FG001|Overall Study|Withdrawal by Subject|0|||
124443698|NCT00821431|447586210|FG000|Overall Study|Lost to Follow-up|1|||
124443699|NCT00821431|447586211|FG001|Overall Study|Lost to Follow-up|0|||
124443700|NCT00821431|447586210|FG000|Overall Study|Protocol Violation|3|||
124443701|NCT00821431|447586211|FG001|Overall Study|Protocol Violation|1|||
124688200|NCT00356590|448477459|FG000|Overall Study|Physician Decision|46|||
124688201|NCT00356590|448477459|FG000|Overall Study|Withdrawal by Subject|41|||
124688202|NCT00356590|448477459|FG000|Overall Study|Completed month 12 only|2|||
124688203|NCT00356590|448477459|FG000|Overall Study|Protocol issues|6|||
124688204|NCT00356590|448477459|FG000|Overall Study|Response status|28|||
124688205|NCT00356590|448477459|FG000|Overall Study|Other|52|||
124688206|NCT00898807|448477463|FG000|Overall Study|Withdrawal by Subject|5|||
124688207|NCT00898807|448477464|FG001|Overall Study|Withdrawal by Subject|3|||
124688208|NCT00898807|448477463|FG000|Overall Study|Family pressure to discontinue|2|||
124688209|NCT00898807|448477464|FG001|Overall Study|Family pressure to discontinue|2|||
124895312|NCT01919619|449239642|FG000|Overall Study|Physician Decision|1|||
124895313|NCT01919619|449239643|FG001|Overall Study|Physician Decision|1|||
124895314|NCT04610684|449241246|FG000|Study Treatment|Withdrawal by Subject|1|||
124895315|NCT04610684|449241246|FG000|Study Treatment|Disease Progression|2|||
124895316|NCT04610684|449241246|FG000|Follow up|Death|2|||
124895317|NCT04610684|449241246|FG000|Follow up|Withdrawal by Subject|1|||
124895318|NCT04978363|449241252|FG000|Overall Study|Other medical issues unrelated to the study|0|||
124895319|NCT04978363|449241253|FG001|Overall Study|Other medical issues unrelated to the study|0|||
124895320|NCT04978363|449241254|FG002|Overall Study|Other medical issues unrelated to the study|0|||
124895321|NCT04978363|449241255|FG003|Overall Study|Other medical issues unrelated to the study|0|||
124895322|NCT04978363|449241256|FG004|Overall Study|Other medical issues unrelated to the study|1|||
124443702|NCT00821431|447586210|FG000|Overall Study|Physician Decision|0|||
124443703|NCT00821431|447586211|FG001|Overall Study|Physician Decision|1|||
124443704|NCT00372385|447586212|FG000|Overall Study|Adverse Event|6|||
124443705|NCT00372385|447586213|FG001|Overall Study|Adverse Event|11|||
124443706|NCT00372385|447586214|FG002|Overall Study|Adverse Event|9|||
124688210|NCT00898807|448477463|FG000|Overall Study|Lost to Follow-up|1|||
124443707|NCT00372385|447586215|FG003|Overall Study|Adverse Event|7|||
124443708|NCT00372385|447586212|FG000|Overall Study|Noncompliance|0|||
124443709|NCT00372385|447586213|FG001|Overall Study|Noncompliance|1|||
124443710|NCT00372385|447586214|FG002|Overall Study|Noncompliance|1|||
124443711|NCT00372385|447586215|FG003|Overall Study|Noncompliance|1|||
124443712|NCT00372385|447586212|FG000|Overall Study|Physician Decision|1|||
124443713|NCT00372385|447586213|FG001|Overall Study|Physician Decision|0|||
124443714|NCT00372385|447586214|FG002|Overall Study|Physician Decision|0|||
124443715|NCT00372385|447586215|FG003|Overall Study|Physician Decision|0|||
124443716|NCT00372385|447586212|FG000|Overall Study|Lost to Follow-up|2|||
124443717|NCT00372385|447586213|FG001|Overall Study|Lost to Follow-up|0|||
124443718|NCT00372385|447586214|FG002|Overall Study|Lost to Follow-up|0|||
124443719|NCT00372385|447586215|FG003|Overall Study|Lost to Follow-up|0|||
124443720|NCT00372385|447586212|FG000|Overall Study|Withdrawal by Subject|2|||
124443721|NCT00372385|447586213|FG001|Overall Study|Withdrawal by Subject|1|||
124443722|NCT00372385|447586214|FG002|Overall Study|Withdrawal by Subject|0|||
124443723|NCT00372385|447586215|FG003|Overall Study|Withdrawal by Subject|0|||
124443724|NCT00372385|447586212|FG000|Overall Study|Refusal of Treatment|3|||
124443725|NCT00372385|447586213|FG001|Overall Study|Refusal of Treatment|6|||
124443726|NCT00372385|447586214|FG002|Overall Study|Refusal of Treatment|0|||
124443727|NCT00372385|447586215|FG003|Overall Study|Refusal of Treatment|0|||
124443728|NCT00372385|447586212|FG000|Overall Study|No Response|1|||
124443729|NCT00372385|447586213|FG001|Overall Study|No Response|1|||
124443730|NCT00372385|447586214|FG002|Overall Study|No Response|0|||
124443731|NCT00372385|447586215|FG003|Overall Study|No Response|0|||
124443732|NCT00372385|447586212|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
124443733|NCT00372385|447586213|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
124443734|NCT00372385|447586214|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
124443735|NCT00372385|447586215|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
124443736|NCT00372385|447586212|FG000|Overall Study|Virologic Stopping Rule|17|||
124443737|NCT00372385|447586213|FG001|Overall Study|Virologic Stopping Rule|0|||
124443738|NCT00372385|447586214|FG002|Overall Study|Virologic Stopping Rule|0|||
124443739|NCT00372385|447586215|FG003|Overall Study|Virologic Stopping Rule|0|||
124443740|NCT01699789|447586216|FG000|Overall Study|Withdrawal by Subject|18|||
124443741|NCT01699789|447586217|FG001|Overall Study|Withdrawal by Subject|23|||
124443742|NCT01699789|447586216|FG000|Overall Study|Death|1|||
124443743|NCT01699789|447586217|FG001|Overall Study|Death|2|||
124443744|NCT01699789|447586216|FG000|Overall Study|Lost to Follow-up|83|||
124443745|NCT01699789|447586217|FG001|Overall Study|Lost to Follow-up|101|||
124688211|NCT00898807|448477464|FG001|Overall Study|Lost to Follow-up|3|||
124688212|NCT00898807|448477463|FG000|Overall Study|Death|0|||
124688213|NCT00898807|448477464|FG001|Overall Study|Death|1|||
124688214|NCT02489773|448477465|FG000|Overall Study|Lost to Follow-up|4|||
124895323|NCT04978363|449241257|FG005|Overall Study|Other medical issues unrelated to the study|0|||
124443746|NCT02411578|447586220|FG000|Crossover Trial Phase|Pregnancy|0|||
124443747|NCT02411578|447586221|FG001|Crossover Trial Phase|Pregnancy|1|||
124443748|NCT03431857|447586226|FG000|Overall Study|Death|6|||
124443749|NCT03431857|447586226|FG000|Overall Study|Lost to Follow-up|41|||
124443750|NCT03431857|447586226|FG000|Overall Study|Adverse Event|6|||
124443751|NCT03431857|447586226|FG000|Overall Study|Withdrawal by Subject|1|||
124443752|NCT01323621|447586228|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
124443753|NCT01323621|447586229|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
124443754|NCT01323621|447586230|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
124443755|NCT01323621|447586228|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
124443756|NCT01323621|447586229|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
124443757|NCT01323621|447586230|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
124443758|NCT01323621|447586228|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
124688215|NCT02489773|448477466|FG001|Overall Study|Lost to Follow-up|1|||
124895324|NCT04978363|449241258|FG006|Overall Study|Other medical issues unrelated to the study|0|||
124443759|NCT01323621|447586229|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
124443760|NCT01323621|447586230|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
124443761|NCT01323621|447586228|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
124443762|NCT01323621|447586229|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
124443763|NCT01323621|447586230|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
124443764|NCT01323621|447586228|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
124443765|NCT01323621|447586229|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
124443766|NCT01323621|447586230|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
124443767|NCT01323621|447586228|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
124443768|NCT01323621|447586229|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
124443769|NCT01323621|447586230|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
124443770|NCT01323621|447586228|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
124443771|NCT01323621|447586229|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
124443772|NCT01323621|447586230|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
124443773|NCT01323621|447586228|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
124443774|NCT01323621|447586229|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
124443775|NCT01323621|447586230|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
124443776|NCT01323621|447586228|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
124443777|NCT01323621|447586229|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
124443778|NCT01323621|447586230|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
124443779|NCT01323621|447586228|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
124443780|NCT01323621|447586229|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
124443781|NCT01323621|447586230|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
124443782|NCT01323621|447586228|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
124443783|NCT01323621|447586229|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
124443784|NCT01323621|447586230|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
124443785|NCT01323621|447586228|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
124443786|NCT01323621|447586229|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
124443787|NCT01323621|447586230|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
124443788|NCT01472380|447586231|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
124443789|NCT01472380|447586231|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
124443790|NCT01891721|447586232|FG000|Overall Study|Lost to Follow-up|10|||
124443791|NCT01891721|447586233|FG001|Overall Study|Lost to Follow-up|5|||
124443792|NCT01891721|447586234|FG002|Overall Study|Lost to Follow-up|1|||
124443793|NCT05125679|447586241|FG000|Overall Study|Study Terminated by Sponsor|2|||
124443794|NCT05125679|447586242|FG001|Overall Study|Study Terminated by Sponsor|5|||
124443795|NCT04908189|447586259|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
124443796|NCT04908189|447586260|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
124443797|NCT04908189|447586261|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
124443798|NCT04908189|447586259|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
124443799|NCT04908189|447586260|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
124443800|NCT04908189|447586261|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
124443801|NCT04908189|447586259|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
124443802|NCT04908189|447586260|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
124443803|NCT04908189|447586261|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
124443804|NCT04908189|447586259|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
124443805|NCT04908189|447586260|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
124443806|NCT04908189|447586261|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
124443807|NCT04908189|447586259|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
124443808|NCT04908189|447586260|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
124443809|NCT04908189|447586261|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
124443810|NCT04908189|447586259|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
124443811|NCT04908189|447586260|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
124443812|NCT04908189|447586261|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
124443813|NCT04908189|447586259|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
124443814|NCT04908189|447586260|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
124443815|NCT04908189|447586261|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
124443816|NCT04908189|447586259|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
124443817|NCT04908189|447586260|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
124443818|NCT04908189|447586261|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
124443819|NCT04908189|447586259|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
124443820|NCT04908189|447586260|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
124443821|NCT04908189|447586261|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
124443822|NCT04908189|447586259|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
124895325|NCT04978363|449241259|FG007|Overall Study|Other medical issues unrelated to the study|0|||
124895326|NCT04978363|449241260|FG008|Overall Study|Other medical issues unrelated to the study|0|||
124895327|NCT04978363|449241261|FG009|Overall Study|Other medical issues unrelated to the study|0|||
124895328|NCT04978363|449241262|FG010|Overall Study|Other medical issues unrelated to the study|0|||
124895329|NCT04978363|449241252|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
124895330|NCT04978363|449241253|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
124895331|NCT04978363|449241254|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
124895332|NCT04978363|449241255|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
124895333|NCT04978363|449241256|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
124895334|NCT04978363|449241257|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
124895335|NCT04978363|449241258|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
124895336|NCT04978363|449241259|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
124895337|NCT04978363|449241260|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
124895338|NCT04978363|449241261|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
124895339|NCT04978363|449241262|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
124895340|NCT04978363|449241252|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895341|NCT04978363|449241253|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
124895342|NCT04978363|449241254|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895343|NCT04978363|449241255|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895344|NCT04978363|449241256|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895345|NCT04978363|449241257|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895346|NCT04978363|449241258|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895347|NCT04978363|449241259|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895348|NCT04978363|449241260|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895349|NCT04978363|449241261|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895350|NCT04978363|449241262|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
124895351|NCT01251614|449241263|FG000|Overall Study|Adverse Event|1|||
124895352|NCT01251614|449241264|FG001|Overall Study|Adverse Event|0|||
124895353|NCT01251614|449241265|FG002|Overall Study|Adverse Event|1|||
124895354|NCT01251614|449241263|FG000|Overall Study|Lack of Efficacy|1|||
124895355|NCT01251614|449241264|FG001|Overall Study|Lack of Efficacy|9|||
124443823|NCT04908189|447586260|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
124443824|NCT04908189|447586261|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
124443825|NCT04908189|447586259|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
124443826|NCT04908189|447586260|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
124443827|NCT04908189|447586261|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
124895356|NCT01251614|449241265|FG002|Overall Study|Lack of Efficacy|4|||
124895357|NCT01251614|449241263|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
124443828|NCT04908189|447586259|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
124895358|NCT01251614|449241264|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
124895359|NCT01251614|449241265|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
124895360|NCT01251614|449241263|FG000|Overall Study|Pregnancy|0|||
124895361|NCT01251614|449241264|FG001|Overall Study|Pregnancy|0|||
124895362|NCT01251614|449241265|FG002|Overall Study|Pregnancy|2|||
124895363|NCT01251614|449241263|FG000|Overall Study|Loss of Disease Control|0|||
124895364|NCT01251614|449241264|FG001|Overall Study|Loss of Disease Control|1|||
124895365|NCT01251614|449241265|FG002|Overall Study|Loss of Disease Control|0|||
124895366|NCT01251614|449241263|FG000|Overall Study|Withdrawal by Subject|0|||
124895367|NCT01251614|449241264|FG001|Overall Study|Withdrawal by Subject|2|||
124895368|NCT01251614|449241265|FG002|Overall Study|Withdrawal by Subject|1|||
124895369|NCT01251614|449241263|FG000|Overall Study|Lost to Follow-up|0|||
124895370|NCT01251614|449241264|FG001|Overall Study|Lost to Follow-up|1|||
124895371|NCT01251614|449241265|FG002|Overall Study|Lost to Follow-up|0|||
124895372|NCT00049517|449241266|FG000|Induction|Disease progression|0|||
124895373|NCT00049517|449241267|FG001|Induction|Disease progression|0|||
124895374|NCT00049517|449241268|FG002|Induction|Disease progression|0|||
124895375|NCT00049517|449241269|FG003|Induction|Disease progression|0|||
124895376|NCT00049517|449241270|FG004|Induction|Disease progression|18|||
124895377|NCT00049517|449241271|FG005|Induction|Disease progression|11|||
124895378|NCT00049517|449241266|FG000|Induction|Adverse Event|0|||
124895379|NCT00049517|449241267|FG001|Induction|Adverse Event|0|||
124895380|NCT00049517|449241268|FG002|Induction|Adverse Event|0|||
124895381|NCT00049517|449241269|FG003|Induction|Adverse Event|0|||
124895382|NCT00049517|449241270|FG004|Induction|Adverse Event|5|||
124895383|NCT00049517|449241271|FG005|Induction|Adverse Event|7|||
124895384|NCT00049517|449241266|FG000|Induction|Death|0|||
124895385|NCT00049517|449241267|FG001|Induction|Death|0|||
124895386|NCT00049517|449241268|FG002|Induction|Death|0|||
124895387|NCT00049517|449241269|FG003|Induction|Death|0|||
124895388|NCT00049517|449241270|FG004|Induction|Death|9|||
124895389|NCT00049517|449241271|FG005|Induction|Death|6|||
124895390|NCT00049517|449241266|FG000|Induction|Withdrawal by Subject|0|||
124895391|NCT00049517|449241267|FG001|Induction|Withdrawal by Subject|0|||
124895392|NCT00049517|449241268|FG002|Induction|Withdrawal by Subject|0|||
124895393|NCT00049517|449241269|FG003|Induction|Withdrawal by Subject|0|||
124895394|NCT00049517|449241270|FG004|Induction|Withdrawal by Subject|1|||
124895395|NCT00049517|449241271|FG005|Induction|Withdrawal by Subject|3|||
124895396|NCT00049517|449241266|FG000|Induction|Alternative therapy|0|||
124895397|NCT00049517|449241267|FG001|Induction|Alternative therapy|0|||
124895398|NCT00049517|449241268|FG002|Induction|Alternative therapy|0|||
124895399|NCT00049517|449241269|FG003|Induction|Alternative therapy|0|||
124895400|NCT00049517|449241270|FG004|Induction|Alternative therapy|2|||
124895401|NCT00049517|449241271|FG005|Induction|Alternative therapy|2|||
124895402|NCT00049517|449241266|FG000|Induction|Other complicating disease|0|||
124895403|NCT00049517|449241267|FG001|Induction|Other complicating disease|0|||
124895404|NCT00049517|449241268|FG002|Induction|Other complicating disease|0|||
124895405|NCT00049517|449241269|FG003|Induction|Other complicating disease|0|||
124895406|NCT00049517|449241270|FG004|Induction|Other complicating disease|3|||
124895407|NCT00049517|449241271|FG005|Induction|Other complicating disease|0|||
124895408|NCT00049517|449241266|FG000|Induction|Reasons not reported|0|||
124895409|NCT00049517|449241267|FG001|Induction|Reasons not reported|0|||
124895410|NCT00049517|449241268|FG002|Induction|Reasons not reported|0|||
124895411|NCT00049517|449241269|FG003|Induction|Reasons not reported|0|||
124895412|NCT00049517|449241270|FG004|Induction|Reasons not reported|22|||
124895413|NCT00049517|449241271|FG005|Induction|Reasons not reported|25|||
124895414|NCT00049517|449241266|FG000|Conditioning/Transplant|Disease progression|14|||
124895415|NCT00049517|449241267|FG001|Conditioning/Transplant|Disease progression|6|||
124895416|NCT00049517|449241268|FG002|Conditioning/Transplant|Disease progression|10|||
124895417|NCT00049517|449241269|FG003|Conditioning/Transplant|Disease progression|6|||
124895418|NCT00049517|449241270|FG004|Conditioning/Transplant|Disease progression|0|||
124895419|NCT00049517|449241271|FG005|Conditioning/Transplant|Disease progression|0|||
124895420|NCT00049517|449241266|FG000|Conditioning/Transplant|Adverse Event|2|||
124895421|NCT00049517|449241267|FG001|Conditioning/Transplant|Adverse Event|1|||
124688216|NCT02489773|448477465|FG000|Overall Study|Physician Decision|1|||
124895422|NCT00049517|449241268|FG002|Conditioning/Transplant|Adverse Event|4|||
124895423|NCT00049517|449241269|FG003|Conditioning/Transplant|Adverse Event|8|||
124895424|NCT00049517|449241270|FG004|Conditioning/Transplant|Adverse Event|0|||
124895425|NCT00049517|449241271|FG005|Conditioning/Transplant|Adverse Event|0|||
124895426|NCT00049517|449241266|FG000|Conditioning/Transplant|Death|1|||
124895427|NCT00049517|449241267|FG001|Conditioning/Transplant|Death|0|||
124895428|NCT00049517|449241268|FG002|Conditioning/Transplant|Death|0|||
124895429|NCT00049517|449241269|FG003|Conditioning/Transplant|Death|2|||
124895430|NCT00049517|449241270|FG004|Conditioning/Transplant|Death|0|||
124895431|NCT00049517|449241271|FG005|Conditioning/Transplant|Death|0|||
124895432|NCT00049517|449241266|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
124895433|NCT00049517|449241267|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
124895434|NCT00049517|449241268|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
124895435|NCT00049517|449241269|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
124895436|NCT00049517|449241270|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
124688217|NCT02489773|448477466|FG001|Overall Study|Physician Decision|0|||
124688218|NCT02489773|448477465|FG000|Overall Study|Withdrawal by Subject|1|||
124688219|NCT02489773|448477466|FG001|Overall Study|Withdrawal by Subject|0|||
124895437|NCT00049517|449241271|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
124443829|NCT04908189|447586260|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
124443830|NCT04908189|447586261|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
124443831|NCT04683731|447586262|FG000|Overall Study|Withdrawal by Subject|1|||
124443832|NCT04683731|447586263|FG001|Overall Study|Withdrawal by Subject|0|||
124443833|NCT04683731|447586264|FG002|Overall Study|Withdrawal by Subject|3|||
124443834|NCT04683731|447586265|FG003|Overall Study|Withdrawal by Subject|2|||
124443835|NCT04683731|447586262|FG000|Overall Study|Determined patient was not eligible|3|||
124443836|NCT04683731|447586263|FG001|Overall Study|Determined patient was not eligible|3|||
124443837|NCT04683731|447586264|FG002|Overall Study|Determined patient was not eligible|12|||
124443838|NCT04683731|447586265|FG003|Overall Study|Determined patient was not eligible|3|||
124443839|NCT01210118|447586270|FG000|Overall Study|Lost to Follow-up|1|||
124443840|NCT01210118|447586271|FG001|Overall Study|Lost to Follow-up|1|||
124443841|NCT01210118|447586270|FG000|Overall Study|Protocol Violation|1|||
124443842|NCT01210118|447586271|FG001|Overall Study|Protocol Violation|1|||
124688220|NCT02489773|448477465|FG000|Overall Study|Leave the country or the state|1|||
124895438|NCT00049517|449241266|FG000|Conditioning/Transplant|Alternative therapy|4|||
124443843|NCT01210118|447586270|FG000|Overall Study|Spontaneous abortion|1|||
124895439|NCT00049517|449241267|FG001|Conditioning/Transplant|Alternative therapy|4|||
124895440|NCT00049517|449241268|FG002|Conditioning/Transplant|Alternative therapy|2|||
124895441|NCT00049517|449241269|FG003|Conditioning/Transplant|Alternative therapy|1|||
124443844|NCT01210118|447586271|FG001|Overall Study|Spontaneous abortion|3|||
124688221|NCT02489773|448477466|FG001|Overall Study|Leave the country or the state|1|||
124688222|NCT02115386|448477467|FG000|Overall Study|Protocol Violation|1|||
124895442|NCT00049517|449241270|FG004|Conditioning/Transplant|Alternative therapy|1|||
124895443|NCT00049517|449241271|FG005|Conditioning/Transplant|Alternative therapy|0|||
124895444|NCT00049517|449241266|FG000|Conditioning/Transplant|Other complicating disease|2|||
124895445|NCT00049517|449241267|FG001|Conditioning/Transplant|Other complicating disease|0|||
124895446|NCT00049517|449241268|FG002|Conditioning/Transplant|Other complicating disease|0|||
124895447|NCT00049517|449241269|FG003|Conditioning/Transplant|Other complicating disease|4|||
124895448|NCT00049517|449241270|FG004|Conditioning/Transplant|Other complicating disease|0|||
124895449|NCT00049517|449241271|FG005|Conditioning/Transplant|Other complicating disease|1|||
124895450|NCT00049517|449241266|FG000|Conditioning/Transplant|Reasons not reported|25|||
124895451|NCT00049517|449241267|FG001|Conditioning/Transplant|Reasons not reported|31|||
124895452|NCT00049517|449241268|FG002|Conditioning/Transplant|Reasons not reported|18|||
124895453|NCT00049517|449241269|FG003|Conditioning/Transplant|Reasons not reported|15|||
124895454|NCT00049517|449241270|FG004|Conditioning/Transplant|Reasons not reported|5|||
124895455|NCT00049517|449241271|FG005|Conditioning/Transplant|Reasons not reported|5|||
124895456|NCT00256308|449241272|FG000|Overall Study|Death|2|||
124895457|NCT00886613|449241278|FG000|Overall Study|Protocol deviation (Part B)|1|||
124895458|NCT00886613|449241279|FG001|Overall Study|Protocol deviation (Part B)|0|||
124895459|NCT00886613|449241280|FG002|Overall Study|Protocol deviation (Part B)|0|||
124895460|NCT00886613|449241278|FG000|Overall Study|Lost to follow-up (Part B)|1|||
124895461|NCT00886613|449241279|FG001|Overall Study|Lost to follow-up (Part B)|0|||
124895462|NCT00886613|449241280|FG002|Overall Study|Lost to follow-up (Part B)|1|||
124895463|NCT00886613|449241278|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
124895464|NCT00886613|449241279|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
124895465|NCT00886613|449241280|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
124895466|NCT02256969|449241285|FG000|Overall Study|Screenfailed or withdrew|2|||
124895467|NCT02256969|449241286|FG001|Overall Study|Screenfailed or withdrew|1|||
124895468|NCT02256969|449241287|FG002|Overall Study|Screenfailed or withdrew|1|||
124895469|NCT02347943|449241288|FG000|Overall Study|Study was cancelled|140|||
124895470|NCT02347943|449241289|FG001|Overall Study|Study was cancelled|67|||
124895471|NCT02347943|449241290|FG002|Overall Study|Study was cancelled|45|||
124895472|NCT03566680|449241294|FG000|Overall Study|Pregnancy|1|||
124895473|NCT03566680|449241294|FG000|Overall Study|Lost to Follow-up|13|||
124895474|NCT03566680|449241294|FG000|Overall Study|Withdrawal by Subject|3|||
124895475|NCT02374957|449241301|FG000|Overall Study|Patient did not complete forms correctly|1|||
124895476|NCT02374957|449241302|FG001|Overall Study|Patient did not complete forms correctly|0|||
124895477|NCT00748969|449241303|FG000|Overall Study|Withdrawal by Subject|1|||
124895478|NCT00748969|449241304|FG001|Overall Study|Withdrawal by Subject|0|||
124895479|NCT00748969|449241303|FG000|Overall Study|Withdrawal by Subject|0|||
124895480|NCT00748969|449241304|FG001|Overall Study|Withdrawal by Subject|1|||
124895481|NCT02334306|449241305|FG000|Double-blind Period|Adverse Event|0|||
124895482|NCT02334306|449241306|FG001|Double-blind Period|Adverse Event|1|||
124895483|NCT02334306|449241305|FG000|Double-blind Period|Withdrawal by Subject|1|||
124895484|NCT02334306|449241306|FG001|Double-blind Period|Withdrawal by Subject|1|||
124895485|NCT01687270|449241307|FG000|Overall Study|Lack of Efficacy|11|||
124895486|NCT01687270|449241307|FG000|Overall Study|Lost to Follow-up|1|||
124895487|NCT00465985|449241308|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
124895488|NCT00465985|449241309|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
124895489|NCT00465985|449241308|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
124895490|NCT00465985|449241309|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
124895491|NCT00465985|449241308|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
124895492|NCT00465985|449241309|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
124895493|NCT00465985|449241308|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
124895494|NCT00465985|449241309|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
124895495|NCT03302156|449241310|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
124895496|NCT03302156|449241311|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
124895497|NCT03302156|449241312|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
124895498|NCT03532178|449241313|FG000|First Period|Withdrawal by Subject|1|||
124895499|NCT03532178|449241314|FG001|First Period|Withdrawal by Subject|3|||
124895500|NCT03532178|449241313|FG000|First Period|technical issues in data collection Technical issues|0|||
124443845|NCT02958267|447586272|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
124443846|NCT02958267|447586273|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
124443847|NCT02958267|447586272|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
124443848|NCT02958267|447586273|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
124443849|NCT02958267|447586272|FG000|Follow-up Visits|Additional treatment pursued|2|||
124443850|NCT02958267|447586273|FG001|Follow-up Visits|Additional treatment pursued|1|||
124895501|NCT03532178|449241314|FG001|First Period|technical issues in data collection Technical issues|1|||
124895502|NCT03532178|449241313|FG000|Second Period|Withdrawal by Subject|1|||
124443851|NCT01853982|447586276|FG000|Overall Study|Withdrawal by Subject|1|||
124443852|NCT01853982|447586277|FG001|Overall Study|Withdrawal by Subject|0|||
124443853|NCT01853982|447586276|FG000|Overall Study|Death|1|||
124443854|NCT01853982|447586277|FG001|Overall Study|Death|0|||
124443855|NCT01853982|447586276|FG000|Overall Study|Lost to Follow-up|0|||
124443856|NCT01853982|447586277|FG001|Overall Study|Lost to Follow-up|1|||
124443857|NCT01839487|447586278|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
124443858|NCT01839487|447586279|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
124443859|NCT01839487|447586280|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
124443860|NCT01839487|447586281|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
124443861|NCT01839487|447586282|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
124443862|NCT01839487|447586283|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
124443863|NCT01839487|447586278|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
124443864|NCT01839487|447586279|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
124443865|NCT01839487|447586280|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
124443866|NCT01839487|447586281|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
124443867|NCT01839487|447586282|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
124443868|NCT01839487|447586283|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
124443869|NCT01839487|447586278|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
124443870|NCT01839487|447586279|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
124443871|NCT01839487|447586280|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
124443872|NCT01839487|447586281|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
124443873|NCT01839487|447586282|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
124443874|NCT01839487|447586283|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
124443875|NCT01839487|447586278|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
124443876|NCT01839487|447586279|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
124443877|NCT01839487|447586280|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
124443878|NCT01839487|447586281|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
124443879|NCT01839487|447586282|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
124443880|NCT01839487|447586283|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
124443881|NCT01839487|447586278|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
124443882|NCT01839487|447586279|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
124443883|NCT01839487|447586280|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
124443884|NCT01839487|447586281|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
124688223|NCT02115386|448477467|FG000|Overall Study|Administrative - trial was terminated|6|||
124688224|NCT02493855|448477468|FG000|Overall Study|Non-compliance|1|||
124688225|NCT02493855|448477469|FG001|Overall Study|Non-compliance|0|||
124895503|NCT03532178|449241314|FG001|Second Period|Withdrawal by Subject|1|||
124895504|NCT03532178|449241313|FG000|Second Period|Technical issues|0|||
124895505|NCT03532178|449241314|FG001|Second Period|Technical issues|1|||
124895506|NCT02390557|449241315|FG000|Wave 2|Survey non-respondent|72|||
124895507|NCT02390557|449241316|FG001|Wave 2|Survey non-respondent|41|||
124895508|NCT02390557|449241317|FG002|Wave 2|Survey non-respondent|23|||
124895509|NCT03278028|449241321|FG000|Overall Study|Lost to Follow-up|1|||
124895510|NCT03278028|449241322|FG001|Overall Study|Lost to Follow-up|0|||
124895511|NCT03278028|449241321|FG000|Overall Study|Withdrawal by Subject|3|||
124895512|NCT03278028|449241322|FG001|Overall Study|Withdrawal by Subject|1|||
124895513|NCT03278028|449241321|FG000|Overall Study|Pregnancy|0|||
124895514|NCT03278028|449241322|FG001|Overall Study|Pregnancy|1|||
124895515|NCT01360840|449241323|FG000|Overall Study|Ongoing at data cut-off|10|||
124895516|NCT01360840|449241324|FG001|Overall Study|Ongoing at data cut-off|10|||
124895517|NCT01360840|449241325|FG002|Overall Study|Ongoing at data cut-off|9|||
124895518|NCT00293462|449241326|FG000|Overall Study|Withdrawal by Subject|4|||
124895519|NCT00293462|449241327|FG001|Overall Study|Withdrawal by Subject|3|||
124895520|NCT00293462|449241328|FG002|Overall Study|Withdrawal by Subject|8|||
124895521|NCT00293462|449241326|FG000|Overall Study|Death|1|||
124895522|NCT00293462|449241327|FG001|Overall Study|Death|0|||
124895523|NCT00293462|449241328|FG002|Overall Study|Death|0|||
124895524|NCT00293462|449241326|FG000|Overall Study|Lost to Follow-up|0|||
124895525|NCT00293462|449241327|FG001|Overall Study|Lost to Follow-up|1|||
124895526|NCT00293462|449241328|FG002|Overall Study|Lost to Follow-up|0|||
124895527|NCT00293462|449241326|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
124895528|NCT00293462|449241327|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
124895529|NCT00293462|449241328|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
124443885|NCT01839487|447586282|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
124443886|NCT01839487|447586283|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
124443887|NCT01839487|447586278|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
124443888|NCT01839487|447586279|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
124688226|NCT02493855|448477470|FG002|Overall Study|Non-compliance|0|||
124688227|NCT02493855|448477468|FG000|Overall Study|Adverse Event|0|||
124895530|NCT00293462|449241326|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
124895531|NCT00293462|449241327|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
124895532|NCT00293462|449241328|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
124895533|NCT00293462|449241326|FG000|Overall Study|Refuse Radiation Treatment|1|||
124895534|NCT00293462|449241327|FG001|Overall Study|Refuse Radiation Treatment|0|||
124895535|NCT00293462|449241328|FG002|Overall Study|Refuse Radiation Treatment|0|||
124895536|NCT00293462|449241326|FG000|Overall Study|No Show|0|||
124895537|NCT00293462|449241327|FG001|Overall Study|No Show|0|||
124895538|NCT00293462|449241328|FG002|Overall Study|No Show|1|||
124895539|NCT00293462|449241326|FG000|Overall Study|Went back to his home country|0|||
124895540|NCT00293462|449241327|FG001|Overall Study|Went back to his home country|0|||
124895541|NCT00293462|449241328|FG002|Overall Study|Went back to his home country|1|||
124443889|NCT01839487|447586280|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
124895542|NCT00293462|449241326|FG000|Overall Study|Blood clot after chemotherapy|0|||
124895543|NCT00293462|449241327|FG001|Overall Study|Blood clot after chemotherapy|0|||
124895544|NCT00293462|449241328|FG002|Overall Study|Blood clot after chemotherapy|1|||
124895545|NCT00293462|449241326|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
124895546|NCT00293462|449241327|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
124895547|NCT00293462|449241328|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
124895548|NCT00293462|449241326|FG000|Overall Study|Possible Tracheostomy leakage|0|||
124895549|NCT00293462|449241327|FG001|Overall Study|Possible Tracheostomy leakage|1|||
124895550|NCT00293462|449241328|FG002|Overall Study|Possible Tracheostomy leakage|0|||
124895551|NCT00293462|449241326|FG000|Overall Study|Low radiation dose in oral cavity|0|||
124895552|NCT00293462|449241327|FG001|Overall Study|Low radiation dose in oral cavity|1|||
124895553|NCT00293462|449241328|FG002|Overall Study|Low radiation dose in oral cavity|0|||
124895554|NCT00293462|449241326|FG000|Overall Study|Physician Decision|0|||
124895555|NCT00293462|449241327|FG001|Overall Study|Physician Decision|1|||
124895556|NCT00293462|449241328|FG002|Overall Study|Physician Decision|0|||
124895557|NCT01579578|449241329|FG000|Overall Study|Death|4|||
124895558|NCT01579578|449241330|FG001|Overall Study|Death|1|||
124895559|NCT01579578|449241329|FG000|Overall Study|Lost to Follow-up|1|||
124895560|NCT01579578|449241330|FG001|Overall Study|Lost to Follow-up|1|||
124895561|NCT01579578|449241329|FG000|Overall Study|Withdrawal by Subject|2|||
124895562|NCT01579578|449241330|FG001|Overall Study|Withdrawal by Subject|1|||
124895563|NCT01579578|449241329|FG000|Overall Study|Eligibility criteria|3|||
124895564|NCT01579578|449241330|FG001|Overall Study|Eligibility criteria|9|||
124895565|NCT01579578|449241329|FG000|Overall Study|Ongoing|3|||
124895566|NCT01579578|449241330|FG001|Overall Study|Ongoing|0|||
124895567|NCT01528709|449241331|FG000|Overall Study|Death|2|||
124895568|NCT01528709|449241332|FG001|Overall Study|Death|0|||
124895569|NCT01528709|449241331|FG000|Overall Study|Withdrawal by Subject|10|||
124895570|NCT01528709|449241332|FG001|Overall Study|Withdrawal by Subject|15|||
124895571|NCT01528709|449241331|FG000|Overall Study|allergy|1|||
124443890|NCT01839487|447586281|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
124443891|NCT01839487|447586282|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
124443892|NCT01839487|447586283|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
124443893|NCT01839487|447586278|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
124443894|NCT01839487|447586279|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
124443895|NCT01839487|447586280|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
124443896|NCT01839487|447586281|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
124443897|NCT01839487|447586282|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
124443898|NCT01839487|447586283|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
124443899|NCT01839487|447586278|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
124443900|NCT01839487|447586279|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
124443901|NCT01839487|447586280|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
124443902|NCT01839487|447586281|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
124443903|NCT01839487|447586282|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
124443904|NCT01839487|447586283|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
124443905|NCT01839487|447586278|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
124443906|NCT01839487|447586279|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
124443907|NCT01839487|447586280|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
124443908|NCT01839487|447586281|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
124895572|NCT01528709|449241332|FG001|Overall Study|allergy|0|||
124895573|NCT01813422|449241342|FG000|Overall Study|Withdrawal by Subject|14|||
124895574|NCT01813422|449241343|FG001|Overall Study|Withdrawal by Subject|8|||
124895575|NCT01813422|449241342|FG000|Overall Study|Death|2|||
124895576|NCT01813422|449241343|FG001|Overall Study|Death|3|||
124895577|NCT01813422|449241342|FG000|Overall Study|Sponsor Decision|2|||
124895578|NCT01813422|449241343|FG001|Overall Study|Sponsor Decision|1|||
124895579|NCT01813422|449241342|FG000|Overall Study|Lost to Follow-up|2|||
124895580|NCT01813422|449241343|FG001|Overall Study|Lost to Follow-up|4|||
124895581|NCT01653743|449241344|FG000|Overall Study|Withdrawal by Subject|1|||
124443909|NCT01839487|447586282|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
124443910|NCT01839487|447586283|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
124443911|NCT05066724|447586284|FG000|Overall Study|Adverse Event|1|||
124443912|NCT05066724|447586284|FG000|Overall Study|Non-Compliance With Study Drug|5|||
124895582|NCT01653743|449241345|FG001|Overall Study|Withdrawal by Subject|0|||
124895583|NCT01653743|449241344|FG000|Overall Study|Investigator discretion|3|||
124895584|NCT01653743|449241345|FG001|Overall Study|Investigator discretion|0|||
124895585|NCT04889118|449241347|FG000|Overall Study|Death|33|||
124895586|NCT04889118|449241348|FG001|Overall Study|Death|37|||
124895587|NCT04889118|449241347|FG000|Overall Study|Ongoing in Study|31|||
124895588|NCT04889118|449241348|FG001|Overall Study|Ongoing in Study|30|||
124895589|NCT02397889|449241349|FG000|Overall Study|Physician Decision|1|||
124443913|NCT05066724|447586284|FG000|Overall Study|Withdrawal by Subject|6|||
124443914|NCT05066724|447586284|FG000|Overall Study|Physician Decision|2|||
124443915|NCT00475033|447586285|FG000|Infant Series|Failed to return|3|||
124895590|NCT02397889|449241350|FG001|Overall Study|Physician Decision|0|||
124895591|NCT01928940|449241352|FG000|Overall Study|Adverse Event|0|||
124895592|NCT01928940|449241353|FG001|Overall Study|Adverse Event|1|||
124895593|NCT01352507|449241356|FG000|Treatment Period 1|Adverse Event|3|||
124895594|NCT01352507|449241357|FG001|Treatment Period 1|Adverse Event|0|||
124895595|NCT01352507|449241356|FG000|Treatment Period 1|Lost to Follow-up|3|||
124895596|NCT01352507|449241357|FG001|Treatment Period 1|Lost to Follow-up|4|||
124895597|NCT01352507|449241356|FG000|Treatment Period 1|Withdrawal by Subject|7|||
124895598|NCT01352507|449241357|FG001|Treatment Period 1|Withdrawal by Subject|5|||
124895599|NCT01352507|449241356|FG000|Treatment Period 1|Physician Decision|1|||
124895600|NCT01352507|449241357|FG001|Treatment Period 1|Physician Decision|0|||
124895601|NCT01352507|449241356|FG000|Washout Period|Withdrawal by Subject|0|||
124895602|NCT01352507|449241357|FG001|Washout Period|Withdrawal by Subject|1|||
124895603|NCT01352507|449241356|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
124895604|NCT01352507|449241357|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
124895605|NCT01352507|449241356|FG000|Treatment Period 2|Withdrawal by Subject|4|||
124443916|NCT00475033|447586286|FG001|Infant Series|Failed to return|4|||
124443917|NCT00475033|447586285|FG000|Infant Series|Parent or legal guardian request|1|||
124895606|NCT01352507|449241357|FG001|Treatment Period 2|Withdrawal by Subject|3|||
124895607|NCT01352507|449241356|FG000|Treatment Period 2|Lack of Efficacy|1|||
124895608|NCT01352507|449241357|FG001|Treatment Period 2|Lack of Efficacy|0|||
124895609|NCT01511250|449241358|FG000|Overall Study|Withdrawal of Consent|1|||
124895610|NCT01511250|449241359|FG001|Overall Study|Withdrawal of Consent|0|||
124895611|NCT01511250|449241360|FG002|Overall Study|Withdrawal of Consent|0|||
124895612|NCT01511250|449241361|FG003|Overall Study|Withdrawal of Consent|0|||
124895613|NCT01511250|449241362|FG004|Overall Study|Withdrawal of Consent|0|||
124895614|NCT01511250|449241363|FG005|Overall Study|Withdrawal of Consent|0|||
124895615|NCT01511250|449241364|FG006|Overall Study|Withdrawal of Consent|0|||
124895616|NCT01511250|449241365|FG007|Overall Study|Withdrawal of Consent|1|||
124895617|NCT01511250|449241366|FG008|Overall Study|Withdrawal of Consent|1|||
124895618|NCT01511250|449241367|FG009|Overall Study|Withdrawal of Consent|0|||
124895619|NCT01511250|449241358|FG000|Overall Study|Sponsor/Investigator Decision|1|||
124443918|NCT00475033|447586286|FG001|Infant Series|Parent or legal guardian request|5|||
124443919|NCT00475033|447586285|FG000|Infant Series|Protocol Violation|1|||
124443920|NCT00475033|447586286|FG001|Infant Series|Protocol Violation|2|||
124443921|NCT00475033|447586285|FG000|Infant Series|Lost to Follow-up|2|||
124443922|NCT00475033|447586286|FG001|Infant Series|Lost to Follow-up|0|||
124895620|NCT01511250|449241359|FG001|Overall Study|Sponsor/Investigator Decision|0|||
124895621|NCT01511250|449241360|FG002|Overall Study|Sponsor/Investigator Decision|0|||
124895622|NCT01511250|449241361|FG003|Overall Study|Sponsor/Investigator Decision|0|||
124895623|NCT01511250|449241362|FG004|Overall Study|Sponsor/Investigator Decision|0|||
124895624|NCT01511250|449241363|FG005|Overall Study|Sponsor/Investigator Decision|0|||
124895625|NCT01511250|449241364|FG006|Overall Study|Sponsor/Investigator Decision|0|||
124895626|NCT01511250|449241365|FG007|Overall Study|Sponsor/Investigator Decision|0|||
124895627|NCT01511250|449241366|FG008|Overall Study|Sponsor/Investigator Decision|0|||
124895628|NCT01511250|449241367|FG009|Overall Study|Sponsor/Investigator Decision|0|||
124895629|NCT01511250|449241358|FG000|Overall Study|Lost to Follow-up|7|||
124895630|NCT01511250|449241359|FG001|Overall Study|Lost to Follow-up|3|||
124895631|NCT01511250|449241360|FG002|Overall Study|Lost to Follow-up|3|||
124443923|NCT00475033|447586285|FG000|Infant Series|Adverse Event|0|||
124443924|NCT00475033|447586286|FG001|Infant Series|Adverse Event|2|||
124895632|NCT01511250|449241361|FG003|Overall Study|Lost to Follow-up|3|||
124895633|NCT01511250|449241362|FG004|Overall Study|Lost to Follow-up|0|||
124895634|NCT01511250|449241363|FG005|Overall Study|Lost to Follow-up|0|||
124895635|NCT01511250|449241364|FG006|Overall Study|Lost to Follow-up|2|||
124895636|NCT01511250|449241365|FG007|Overall Study|Lost to Follow-up|3|||
124895637|NCT01511250|449241366|FG008|Overall Study|Lost to Follow-up|13|||
124895638|NCT01511250|449241367|FG009|Overall Study|Lost to Follow-up|5|||
124895639|NCT01511250|449241358|FG000|Overall Study|Protocol Violation|0|||
124895640|NCT01511250|449241359|FG001|Overall Study|Protocol Violation|2|||
124895641|NCT01511250|449241360|FG002|Overall Study|Protocol Violation|1|||
124895642|NCT01511250|449241361|FG003|Overall Study|Protocol Violation|0|||
124895643|NCT01511250|449241362|FG004|Overall Study|Protocol Violation|0|||
124895644|NCT01511250|449241363|FG005|Overall Study|Protocol Violation|0|||
124443925|NCT00475033|447586285|FG000|After the Infant Series|Adverse Event|0|||
124443926|NCT00475033|447586286|FG001|After the Infant Series|Adverse Event|4|||
124895645|NCT01511250|449241364|FG006|Overall Study|Protocol Violation|0|||
124895646|NCT01511250|449241365|FG007|Overall Study|Protocol Violation|0|||
124895647|NCT01511250|449241366|FG008|Overall Study|Protocol Violation|0|||
124895648|NCT01511250|449241367|FG009|Overall Study|Protocol Violation|0|||
124895649|NCT05487703|449241371|FG000|Overall Study|Other|19|||
124895650|NCT05487703|449241371|FG000|Overall Study|Participant not well|5|||
124895651|NCT05487703|449241371|FG000|Overall Study|Insurance Reasons|6|||
124895652|NCT05487703|449241371|FG000|Overall Study|Physician Decision|19|||
124895653|NCT05487703|449241371|FG000|Overall Study|Lack of Efficacy|60|||
124895654|NCT04824131|449241372|FG000|CAB LA Oral Phase|Adverse Event|1|||
124895655|NCT04824131|449241372|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
124895656|NCT04824131|449241372|FG000|Step 3|Withdrawal by Subject|2|||
124895657|NCT04887285|449241373|FG000|Overall Study|Lost to Follow-up|0|||
124895658|NCT04887285|449241374|FG001|Overall Study|Lost to Follow-up|2|||
124895659|NCT04887285|449241375|FG002|Overall Study|Lost to Follow-up|3|||
124895660|NCT04939428|449241376|FG000|Overall Study|Death|0|||
124895661|NCT04939428|449241377|FG001|Overall Study|Death|1|||
124895662|NCT04939428|449241378|FG002|Overall Study|Death|0|||
124895663|NCT04939428|449241376|FG000|Overall Study|Lost to Follow-up|0|||
124895664|NCT04939428|449241377|FG001|Overall Study|Lost to Follow-up|5|||
124895665|NCT04939428|449241378|FG002|Overall Study|Lost to Follow-up|0|||
124895666|NCT04939428|449241376|FG000|Overall Study|Physician Decision|1|||
124895667|NCT04939428|449241377|FG001|Overall Study|Physician Decision|0|||
124895668|NCT04939428|449241378|FG002|Overall Study|Physician Decision|0|||
124895669|NCT04939428|449241376|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
124895670|NCT04939428|449241377|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124895671|NCT04939428|449241378|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124895672|NCT04939428|449241376|FG000|Overall Study|Withdrawal by Subject|10|||
124895673|NCT04939428|449241377|FG001|Overall Study|Withdrawal by Subject|11|||
124895674|NCT04939428|449241378|FG002|Overall Study|Withdrawal by Subject|0|||
124688228|NCT02493855|448477469|FG001|Overall Study|Adverse Event|1|||
124895675|NCT04939428|449241376|FG000|Overall Study|Unkown|6|||
124895676|NCT04939428|449241377|FG001|Overall Study|Unkown|3|||
124895677|NCT04939428|449241378|FG002|Overall Study|Unkown|0|||
124895678|NCT04939428|449241376|FG000|Overall Study|Discotinued per protocol|0|||
124895679|NCT04939428|449241377|FG001|Overall Study|Discotinued per protocol|0|||
124895680|NCT04939428|449241378|FG002|Overall Study|Discotinued per protocol|902|||
124895681|NCT02696785|449241379|FG000|Blinded Treatment Period|Adverse Event|0|||
124895682|NCT02696785|449241380|FG001|Blinded Treatment Period|Adverse Event|1|||
124895683|NCT02696785|449241381|FG002|Blinded Treatment Period|Adverse Event|3|||
124895684|NCT02696785|449241382|FG003|Blinded Treatment Period|Adverse Event|0|||
124895685|NCT02696785|449241379|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
124895686|NCT02696785|449241380|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
124895687|NCT02696785|449241381|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
124895688|NCT02696785|449241382|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
124895689|NCT02696785|449241379|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
124895690|NCT02696785|449241380|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
124895691|NCT02696785|449241381|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
124895692|NCT02696785|449241382|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
124688229|NCT02493855|448477470|FG002|Overall Study|Adverse Event|0|||
124895693|NCT02696785|449241379|FG000|Blinded Treatment Period|Screen Failure|1|||
124895694|NCT02696785|449241380|FG001|Blinded Treatment Period|Screen Failure|0|||
124895695|NCT02696785|449241381|FG002|Blinded Treatment Period|Screen Failure|0|||
124895696|NCT02696785|449241382|FG003|Blinded Treatment Period|Screen Failure|0|||
124895697|NCT02696785|449241379|FG000|Washout Period|Withdrawal by Subject|0|||
124895698|NCT02696785|449241380|FG001|Washout Period|Withdrawal by Subject|1|||
124895699|NCT02696785|449241381|FG002|Washout Period|Withdrawal by Subject|0|||
124895700|NCT02696785|449241382|FG003|Washout Period|Withdrawal by Subject|0|||
124895701|NCT02696785|449241379|FG000|Washout Period|Lack of Efficacy|0|||
124895702|NCT02696785|449241380|FG001|Washout Period|Lack of Efficacy|1|||
124759352|NCT00452790|448742621|FG001|Infant Series|Other reasons|2|||
124443927|NCT00475033|447586285|FG000|After the Infant Series|Parent or legal guardian request|2|||
124443928|NCT00475033|447586286|FG001|After the Infant Series|Parent or legal guardian request|2|||
124443929|NCT00475033|447586285|FG000|After the Infant Series|Failed to return|2|||
124443930|NCT00475033|447586286|FG001|After the Infant Series|Failed to return|1|||
124443931|NCT00475033|447586285|FG000|After the Infant Series|Protocol Violation|1|||
124443932|NCT00475033|447586286|FG001|After the Infant Series|Protocol Violation|0|||
124443933|NCT00475033|447586285|FG000|After the Infant Series|Lost to Follow-up|1|||
124443934|NCT00475033|447586286|FG001|After the Infant Series|Lost to Follow-up|0|||
124443935|NCT00475033|447586285|FG000|After the Infant Series|Other|0|||
124443936|NCT00475033|447586286|FG001|After the Infant Series|Other|1|||
124443937|NCT00475033|447586285|FG000|Toddler Dose|Parent or legal guardian request|2|||
124443938|NCT00475033|447586286|FG001|Toddler Dose|Parent or legal guardian request|0|||
124443939|NCT00475033|447586285|FG000|Toddler Dose|Failed to return|1|||
124443940|NCT00475033|447586286|FG001|Toddler Dose|Failed to return|0|||
124443941|NCT00475033|447586285|FG000|Toddler Dose|Lost to Follow-up|1|||
124443942|NCT00475033|447586286|FG001|Toddler Dose|Lost to Follow-up|0|||
124443943|NCT01422850|447586290|FG000|Overall Study|Physician Decision|3|||
124443944|NCT04484831|447586291|FG000|Overall Study|Withdrawal by Subject|1|||
124443945|NCT04484831|447586292|FG001|Overall Study|Withdrawal by Subject|0|||
124443946|NCT02244996|447586293|FG000|Overall Study|Lack of Efficacy|2|||
124443947|NCT02244996|447586294|FG001|Overall Study|Lack of Efficacy|6|||
124443948|NCT01335009|447586295|FG000|Overall Study|Too ill to travel to study sites|1|||
124443949|NCT01335009|447586296|FG001|Overall Study|Too ill to travel to study sites|0|||
124443950|NCT01335009|447586295|FG000|Overall Study|Death|28|||
124443951|NCT01335009|447586296|FG001|Overall Study|Death|32|||
124443952|NCT01335009|447586295|FG000|Overall Study|Withdrawal by Subject|1|||
124443953|NCT01335009|447586296|FG001|Overall Study|Withdrawal by Subject|1|||
124443954|NCT01335009|447586295|FG000|Overall Study|Lost to Follow-up|1|||
124443955|NCT01335009|447586296|FG001|Overall Study|Lost to Follow-up|0|||
124443956|NCT04751656|447587717|FG000|Overall Study|Lost to Follow-up|1|||
124443957|NCT00146328|447587726|FG000|Overall Study|Adverse Event|39|||
124443958|NCT00146328|447587727|FG001|Overall Study|Adverse Event|48|||
124443959|NCT00146328|447587728|FG002|Overall Study|Adverse Event|79|||
124443960|NCT00146328|447587726|FG000|Overall Study|Protocol Violation|11|||
124443961|NCT00146328|447587727|FG001|Overall Study|Protocol Violation|6|||
124443962|NCT00146328|447587728|FG002|Overall Study|Protocol Violation|12|||
124443963|NCT00146328|447587726|FG000|Overall Study|Lost to Follow-up|7|||
124443964|NCT00146328|447587727|FG001|Overall Study|Lost to Follow-up|4|||
124443965|NCT00146328|447587728|FG002|Overall Study|Lost to Follow-up|7|||
124443966|NCT00146328|447587726|FG000|Overall Study|Withdrawal by Subject|16|||
124443967|NCT00146328|447587727|FG001|Overall Study|Withdrawal by Subject|16|||
124443968|NCT00146328|447587728|FG002|Overall Study|Withdrawal by Subject|22|||
124443969|NCT00146328|447587726|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
124443970|NCT00146328|447587727|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
124443971|NCT00146328|447587728|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
124443972|NCT00146328|447587726|FG000|Overall Study|Trial ended/site closed|8|||
124443973|NCT00146328|447587727|FG001|Overall Study|Trial ended/site closed|2|||
124443974|NCT00146328|447587728|FG002|Overall Study|Trial ended/site closed|19|||
124443975|NCT00146328|447587726|FG000|Overall Study|Patient decision to end|0|||
124443976|NCT00146328|447587727|FG001|Overall Study|Patient decision to end|1|||
124443977|NCT00146328|447587728|FG002|Overall Study|Patient decision to end|6|||
124443978|NCT00146328|447587726|FG000|Overall Study|Enroll into other trial|2|||
124443979|NCT00146328|447587727|FG001|Overall Study|Enroll into other trial|4|||
124443980|NCT00146328|447587728|FG002|Overall Study|Enroll into other trial|2|||
124443981|NCT00146328|447587726|FG000|Overall Study|Death|0|||
124443982|NCT00146328|447587727|FG001|Overall Study|Death|1|||
124443983|NCT00146328|447587728|FG002|Overall Study|Death|1|||
124443984|NCT00146328|447587726|FG000|Overall Study|Moved|2|||
124443985|NCT00146328|447587727|FG001|Overall Study|Moved|0|||
124443986|NCT00146328|447587728|FG002|Overall Study|Moved|0|||
124443987|NCT00146328|447587726|FG000|Overall Study|Interaction with other medication|2|||
124443988|NCT00146328|447587727|FG001|Overall Study|Interaction with other medication|0|||
124443989|NCT00146328|447587728|FG002|Overall Study|Interaction with other medication|1|||
124443990|NCT00300781|447587729|FG000|Overall Study|Disease Progression|55|||
124443991|NCT00300781|447587730|FG001|Overall Study|Disease Progression|52|||
124443992|NCT00300781|447587729|FG000|Overall Study|Adverse Event|5|||
124443993|NCT00300781|447587730|FG001|Overall Study|Adverse Event|6|||
124443994|NCT00300781|447587729|FG000|Overall Study|Withdrawal by Subject|1|||
124443995|NCT00300781|447587730|FG001|Overall Study|Withdrawal by Subject|2|||
124443996|NCT00300781|447587729|FG000|Overall Study|Physician Decision|1|||
124443997|NCT00300781|447587730|FG001|Overall Study|Physician Decision|0|||
124443998|NCT00300781|447587729|FG000|Overall Study|Not Recorded|0|||
124443999|NCT00300781|447587730|FG001|Overall Study|Not Recorded|1|||
124444000|NCT00300781|447587729|FG000|Overall Study|Symptomatic Deterioration|1|||
124444001|NCT00300781|447587730|FG001|Overall Study|Symptomatic Deterioration|0|||
124444002|NCT00300781|447587729|FG000|Overall Study|Lost to Follow-up|0|||
124444003|NCT00300781|447587730|FG001|Overall Study|Lost to Follow-up|1|||
124444004|NCT01256658|447587731|FG000|Period 1|Lost to Follow-up|837|||
124895703|NCT02696785|449241381|FG002|Washout Period|Lack of Efficacy|0|||
124444005|NCT01256658|447587732|FG001|Period 1|Lost to Follow-up|661|||
124444006|NCT01256658|447587731|FG000|Period 1|Withdrawal by Subject|35|||
124444007|NCT01256658|447587732|FG001|Period 1|Withdrawal by Subject|43|||
124444008|NCT01256658|447587731|FG000|Period 1|Death|48|||
124444009|NCT01256658|447587732|FG001|Period 1|Death|44|||
124444010|NCT02072434|447587736|FG000|Overall Study|Protocol Violation|10|||
124444011|NCT02072434|447587737|FG001|Overall Study|Protocol Violation|9|||
124444012|NCT02072434|447587736|FG000|Overall Study|Physician Decision|5|||
124444013|NCT02072434|447587737|FG001|Overall Study|Physician Decision|10|||
124444014|NCT02072434|447587736|FG000|Overall Study|Adverse event, serious fatal|1|||
124444015|NCT02072434|447587737|FG001|Overall Study|Adverse event, serious fatal|6|||
124444016|NCT02072434|447587736|FG000|Overall Study|Adverse Event|7|||
124444017|NCT02072434|447587737|FG001|Overall Study|Adverse Event|6|||
124895704|NCT02696785|449241382|FG003|Washout Period|Lack of Efficacy|0|||
124895705|NCT02696785|449241379|FG000|Extended Treatment Period|Adverse Event|2|||
124895706|NCT02696785|449241380|FG001|Extended Treatment Period|Adverse Event|3|||
124895707|NCT02696785|449241381|FG002|Extended Treatment Period|Adverse Event|2|||
124895708|NCT02696785|449241382|FG003|Extended Treatment Period|Adverse Event|1|||
124895709|NCT02696785|449241379|FG000|Extended Treatment Period|Lack of Efficacy|0|||
124895710|NCT02696785|449241380|FG001|Extended Treatment Period|Lack of Efficacy|1|||
124895711|NCT02696785|449241381|FG002|Extended Treatment Period|Lack of Efficacy|0|||
124895712|NCT02696785|449241382|FG003|Extended Treatment Period|Lack of Efficacy|0|||
124895713|NCT02696785|449241379|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
124895714|NCT02696785|449241380|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
124895715|NCT02696785|449241381|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
124895716|NCT02696785|449241382|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
124895717|NCT02696785|449241379|FG000|Follow-up Period|Adverse Event|0|||
124895718|NCT02696785|449241380|FG001|Follow-up Period|Adverse Event|0|||
124895719|NCT02696785|449241381|FG002|Follow-up Period|Adverse Event|8|||
124895720|NCT02696785|449241382|FG003|Follow-up Period|Adverse Event|2|||
124895721|NCT02696785|449241379|FG000|Follow-up Period|Lost to Follow-up|0|||
124895722|NCT02696785|449241380|FG001|Follow-up Period|Lost to Follow-up|0|||
124895723|NCT02696785|449241381|FG002|Follow-up Period|Lost to Follow-up|0|||
124895724|NCT02696785|449241382|FG003|Follow-up Period|Lost to Follow-up|1|||
124895725|NCT02696785|449241379|FG000|Follow-up Period|Lack of Efficacy|0|||
124895726|NCT02696785|449241380|FG001|Follow-up Period|Lack of Efficacy|0|||
124895727|NCT02696785|449241381|FG002|Follow-up Period|Lack of Efficacy|0|||
124895728|NCT02696785|449241382|FG003|Follow-up Period|Lack of Efficacy|1|||
124895729|NCT02696785|449241379|FG000|Follow-up Period|Withdrawal by Subject|1|||
124895730|NCT02696785|449241380|FG001|Follow-up Period|Withdrawal by Subject|0|||
124895731|NCT02696785|449241381|FG002|Follow-up Period|Withdrawal by Subject|5|||
124895732|NCT02696785|449241382|FG003|Follow-up Period|Withdrawal by Subject|4|||
124895733|NCT04863898|449241383|FG000|Overall Study|Away from study clinic during intervention training period|2|||
124895734|NCT04863898|449241383|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
124895735|NCT04863898|449241383|FG000|Overall Study|Lost to Follow-up|3|||
124895736|NCT04863898|449241383|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
124895737|NCT04863898|449241383|FG000|Overall Study|No longer employed at clinic|3|||
124895738|NCT00770211|449241384|FG000|Overall Study|Lost to Follow-up|1|||
124895739|NCT00770211|449241385|FG001|Overall Study|Lost to Follow-up|0|||
124895740|NCT00770211|449241384|FG000|Overall Study|Withdrawal by Subject|0|||
124895741|NCT00770211|449241385|FG001|Overall Study|Withdrawal by Subject|2|||
124895742|NCT01822821|449241387|FG000|Overall Study|Eligible surgery cancelled|1|||
124895743|NCT01822821|449241388|FG001|Overall Study|Eligible surgery cancelled|1|||
124895744|NCT01822821|449241387|FG000|Overall Study|Other reasons|1|||
124895745|NCT01822821|449241388|FG001|Overall Study|Other reasons|0|||
124895746|NCT00764868|449241390|FG000|Overall Study|Adverse Event|18|||
124895747|NCT00764868|449241390|FG000|Overall Study|Withdrawal by Subject|31|||
124895748|NCT00764868|449241390|FG000|Overall Study|Non-compliance|16|||
124895749|NCT00764868|449241390|FG000|Overall Study|Lost to Follow-up|25|||
124895750|NCT00764868|449241390|FG000|Overall Study|Lack of Efficacy|5|||
124895751|NCT00764868|449241390|FG000|Overall Study|Subject moved|7|||
124444018|NCT02072434|447587736|FG000|Overall Study|Withdrawal by Subject|17|||
124444019|NCT02072434|447587737|FG001|Overall Study|Withdrawal by Subject|29|||
124895752|NCT00764868|449241390|FG000|Overall Study|Pregnancy|3|||
124895753|NCT00764868|449241390|FG000|Overall Study|Prohibited medication|1|||
124895754|NCT00764868|449241390|FG000|Overall Study|Out of town|1|||
124895755|NCT00764868|449241390|FG000|Overall Study|Misuse and compliance of study drug|1|||
124895756|NCT00764868|449241390|FG000|Overall Study|Subject sent to boarding school|1|||
124895757|NCT00764868|449241390|FG000|Overall Study|Met an exclusion criteria|1|||
124895758|NCT00764868|449241390|FG000|Overall Study|Positive drug screen|2|||
124444020|NCT02072434|447587736|FG000|Overall Study|Other|14|||
124444021|NCT02072434|447587737|FG001|Overall Study|Other|29|||
124444022|NCT02072434|447587736|FG000|Overall Study|Lost to Follow-up|0|||
124444023|NCT02072434|447587737|FG001|Overall Study|Lost to Follow-up|1|||
124444024|NCT02525861|447587740|FG000|Overall Study|Adverse Event|1|||
124688230|NCT02493855|448477468|FG000|Overall Study|Withdrawal by Subject|1|||
124895759|NCT00764868|449241390|FG000|Overall Study|Sponsor requested withdrawal|1|||
124895760|NCT03005288|449241393|FG000|Overall Study|Withdrawal by Subject|7|||
124895761|NCT03005288|449241394|FG001|Overall Study|Withdrawal by Subject|5|||
124895762|NCT03005288|449241393|FG000|Overall Study|Lost to Follow-up|0|||
124895763|NCT03005288|449241394|FG001|Overall Study|Lost to Follow-up|1|||
124895764|NCT03005288|449241393|FG000|Overall Study|Adverse Event|5|||
124895765|NCT03005288|449241394|FG001|Overall Study|Adverse Event|0|||
124895766|NCT03005288|449241393|FG000|Overall Study|Protocol deviation|0|||
124895767|NCT03005288|449241394|FG001|Overall Study|Protocol deviation|1|||
124895768|NCT03005288|449241393|FG000|Overall Study|Physician Decision|0|||
124895769|NCT03005288|449241394|FG001|Overall Study|Physician Decision|1|||
124895770|NCT03824236|449241395|FG000|Overall Study|Lost to Follow-up|0|||
124895771|NCT03824236|449241396|FG001|Overall Study|Lost to Follow-up|0|||
124895772|NCT03824236|449241397|FG002|Overall Study|Lost to Follow-up|1|||
124895773|NCT00701311|449241398|FG000|Overall Study|Lack of Efficacy|3|||
124895774|NCT00701311|449241398|FG000|Overall Study|Adverse Event|3|||
124895775|NCT00701311|449241398|FG000|Overall Study|Withdrawal by Subject|2|||
124895776|NCT00359619|449242829|FG000|Overall Study|Adverse Event|0|||
124895777|NCT00359619|449242830|FG001|Overall Study|Adverse Event|0|||
124895778|NCT00359619|449242831|FG002|Overall Study|Adverse Event|1|||
124895779|NCT00359619|449242832|FG003|Overall Study|Adverse Event|0|||
124895780|NCT00359619|449242833|FG004|Overall Study|Adverse Event|0|||
124895781|NCT00359619|449242834|FG005|Overall Study|Adverse Event|0|||
124895782|NCT00359619|449242835|FG006|Overall Study|Adverse Event|1|||
124895783|NCT00359619|449242829|FG000|Overall Study|Withdrawal by Subject|3|||
124895784|NCT00359619|449242830|FG001|Overall Study|Withdrawal by Subject|1|||
124895785|NCT00359619|449242831|FG002|Overall Study|Withdrawal by Subject|4|||
124895786|NCT00359619|449242832|FG003|Overall Study|Withdrawal by Subject|2|||
124895787|NCT00359619|449242833|FG004|Overall Study|Withdrawal by Subject|2|||
124895788|NCT00359619|449242834|FG005|Overall Study|Withdrawal by Subject|0|||
124895789|NCT00359619|449242835|FG006|Overall Study|Withdrawal by Subject|3|||
124895790|NCT00359619|449242829|FG000|Overall Study|Other|1|||
124688231|NCT02493855|448477469|FG001|Overall Study|Withdrawal by Subject|0|||
124895791|NCT00359619|449242830|FG001|Overall Study|Other|0|||
124895792|NCT00359619|449242831|FG002|Overall Study|Other|0|||
124444025|NCT02525861|447587741|FG001|Overall Study|Adverse Event|0|||
124444026|NCT02525861|447587740|FG000|Overall Study|Withdrawal by Subject|0|||
124444027|NCT02525861|447587741|FG001|Overall Study|Withdrawal by Subject|1|||
124895793|NCT00359619|449242832|FG003|Overall Study|Other|0|||
124895794|NCT00359619|449242833|FG004|Overall Study|Other|0|||
124895795|NCT00359619|449242834|FG005|Overall Study|Other|0|||
124895796|NCT00359619|449242835|FG006|Overall Study|Other|0|||
124895797|NCT00359619|449242829|FG000|Overall Study|Lost to Follow-up|4|||
124895798|NCT00359619|449242830|FG001|Overall Study|Lost to Follow-up|4|||
124895799|NCT00359619|449242831|FG002|Overall Study|Lost to Follow-up|2|||
124895800|NCT00359619|449242832|FG003|Overall Study|Lost to Follow-up|1|||
124895801|NCT00359619|449242833|FG004|Overall Study|Lost to Follow-up|1|||
124895802|NCT00359619|449242834|FG005|Overall Study|Lost to Follow-up|5|||
124895803|NCT00359619|449242835|FG006|Overall Study|Lost to Follow-up|0|||
124895804|NCT01419717|449242836|FG000|Overall Study|Protocol-specified Criteria|62|||
124895805|NCT01419717|449242836|FG000|Overall Study|Adverse Event|19|||
124895806|NCT01419717|449242836|FG000|Overall Study|Death|17|||
124895807|NCT01419717|449242836|FG000|Overall Study|Withdrawal by Subject|10|||
124895808|NCT01419717|449242836|FG000|Overall Study|Disease Progression|9|||
124895809|NCT01419717|449242836|FG000|Overall Study|Other|4|||
124895810|NCT01419717|449242836|FG000|Overall Study|Lost to Follow-up|2|||
124895811|NCT01419717|449242836|FG000|Overall Study|Administrative Decision|1|||
124895812|NCT01419717|449242836|FG000|Overall Study|Noncompliance|1|||
124895813|NCT02857283|449242837|FG000|First Exposure|Withdrawal by Subject|1|||
124895814|NCT02857283|449242838|FG001|First Exposure|Withdrawal by Subject|0|||
124895815|NCT05074498|449242843|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
124895816|NCT05074498|449242844|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
124895817|NCT05074498|449242845|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
124895818|NCT05074498|449242846|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
124895819|NCT05074498|449242847|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
124895820|NCT05074498|449242848|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
124895821|NCT05074498|449242843|FG000|Part 1 (Upto Day 104)|Other|1|||
124895822|NCT05074498|449242844|FG001|Part 1 (Upto Day 104)|Other|0|||
124895823|NCT05074498|449242845|FG002|Part 1 (Upto Day 104)|Other|0|||
124895824|NCT05074498|449242846|FG003|Part 1 (Upto Day 104)|Other|0|||
124895825|NCT05074498|449242847|FG004|Part 1 (Upto Day 104)|Other|0|||
124895826|NCT05074498|449242848|FG005|Part 1 (Upto Day 104)|Other|0|||
124444028|NCT02525861|447587740|FG000|Overall Study|Physician Decision|0|||
124444029|NCT02525861|447587741|FG001|Overall Study|Physician Decision|1|||
124444030|NCT01117454|447587744|FG000|Overall Study|Pregnancy|0|||
124444031|NCT01117454|447587745|FG001|Overall Study|Pregnancy|1|||
124444032|NCT00888433|447587746|FG000|Overall Study|Withdrawal by Subject|1|||
124444033|NCT00888433|447587747|FG001|Overall Study|Withdrawal by Subject|2|||
124444034|NCT00888433|447587746|FG000|Overall Study|Missed Visit|2|||
124444035|NCT00888433|447587747|FG001|Overall Study|Missed Visit|1|||
124444036|NCT01681628|447587748|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
124444037|NCT01681628|447587749|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
124444038|NCT01681628|447587748|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
124444039|NCT01681628|447587749|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
124444040|NCT01681628|447587748|FG000|19 Months Follow-up|Death|1|||
124444041|NCT01681628|447587749|FG001|19 Months Follow-up|Death|0|||
124444042|NCT01681628|447587748|FG000|19 Months Follow-up|Lost to Follow-up|61|||
124688232|NCT02493855|448477470|FG002|Overall Study|Withdrawal by Subject|0|||
124688233|NCT02453048|448477471|FG000|Overall Study|Only part of initial 6 mo. study|0|||
124688234|NCT02453048|448477472|FG001|Overall Study|Only part of initial 6 mo. study|0|||
124688235|NCT02453048|448477473|FG002|Overall Study|Only part of initial 6 mo. study|0|||
124444043|NCT01681628|447587749|FG001|19 Months Follow-up|Lost to Follow-up|43|||
124444044|NCT01794520|447587750|FG000|Overall Study|Adverse events- related to progression|0|||
124444045|NCT01794520|447587751|FG001|Overall Study|Adverse events- related to progression|0|||
124444046|NCT01794520|447587752|FG002|Overall Study|Adverse events- related to progression|1|||
124688236|NCT02453048|448477474|FG003|Overall Study|Only part of initial 6 mo. study|0|||
124444047|NCT01794520|447587753|FG003|Overall Study|Adverse events- related to progression|2|||
124444048|NCT01794520|447587754|FG004|Overall Study|Adverse events- related to progression|0|||
124444049|NCT01794520|447587755|FG005|Overall Study|Adverse events- related to progression|1|||
124444050|NCT01794520|447587756|FG006|Overall Study|Adverse events- related to progression|0|||
124444051|NCT01794520|447587750|FG000|Overall Study|Adverse event- not related to progression|1|||
124444052|NCT01794520|447587751|FG001|Overall Study|Adverse event- not related to progression|1|||
124444053|NCT01794520|447587752|FG002|Overall Study|Adverse event- not related to progression|0|||
124444054|NCT01794520|447587753|FG003|Overall Study|Adverse event- not related to progression|0|||
124444055|NCT01794520|447587754|FG004|Overall Study|Adverse event- not related to progression|2|||
124444056|NCT01794520|447587755|FG005|Overall Study|Adverse event- not related to progression|0|||
124444057|NCT01794520|447587756|FG006|Overall Study|Adverse event- not related to progression|0|||
124444058|NCT01794520|447587750|FG000|Overall Study|Progressive disease|5|||
124444059|NCT01794520|447587751|FG001|Overall Study|Progressive disease|6|||
124444060|NCT01794520|447587752|FG002|Overall Study|Progressive disease|2|||
124444061|NCT01794520|447587753|FG003|Overall Study|Progressive disease|5|||
124444062|NCT01794520|447587754|FG004|Overall Study|Progressive disease|27|||
124444063|NCT01794520|447587755|FG005|Overall Study|Progressive disease|18|||
124895827|NCT05074498|449242843|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
124895828|NCT05074498|449242844|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
124895829|NCT05074498|449242845|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
124895830|NCT05074498|449242846|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
124444064|NCT01794520|447587756|FG006|Overall Study|Progressive disease|0|||
124444065|NCT01794520|447587750|FG000|Overall Study|Withdrew consent|0|||
124895831|NCT05074498|449242847|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
124895832|NCT05074498|449242848|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
124688237|NCT02453048|448477475|FG004|Overall Study|Only part of initial 6 mo. study|6|||
124688238|NCT02453048|448477471|FG000|Overall Study|Lost to Follow-up|0|||
124444066|NCT01794520|447587751|FG001|Overall Study|Withdrew consent|0|||
124688239|NCT02453048|448477472|FG001|Overall Study|Lost to Follow-up|1|||
124688240|NCT02453048|448477473|FG002|Overall Study|Lost to Follow-up|2|||
124688241|NCT02453048|448477474|FG003|Overall Study|Lost to Follow-up|0|||
124688242|NCT02453048|448477475|FG004|Overall Study|Lost to Follow-up|0|||
124688243|NCT01482221|448477476|FG000|Overall Study|Lack of Efficacy|1|||
124688244|NCT01482221|448477477|FG001|Overall Study|Lack of Efficacy|0|||
124688245|NCT01482221|448477478|FG002|Overall Study|Lack of Efficacy|1|||
124688246|NCT01482221|448477476|FG000|Overall Study|Lost to Follow-up|3|||
124688247|NCT01482221|448477477|FG001|Overall Study|Lost to Follow-up|2|||
124895833|NCT05074498|449242843|FG000|Part 2 (Upto Day 104)|Death|0|||
124895834|NCT05074498|449242844|FG001|Part 2 (Upto Day 104)|Death|0|||
124688248|NCT01482221|448477478|FG002|Overall Study|Lost to Follow-up|1|||
124688249|NCT01482221|448477476|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
124444067|NCT01794520|447587752|FG002|Overall Study|Withdrew consent|1|||
124444068|NCT01794520|447587753|FG003|Overall Study|Withdrew consent|1|||
124444069|NCT01794520|447587754|FG004|Overall Study|Withdrew consent|0|||
124444070|NCT01794520|447587755|FG005|Overall Study|Withdrew consent|0|||
124444071|NCT01794520|447587756|FG006|Overall Study|Withdrew consent|0|||
124444072|NCT01794520|447587750|FG000|Overall Study|Lost to Follow-up|0|||
124444073|NCT01794520|447587751|FG001|Overall Study|Lost to Follow-up|0|||
124444074|NCT01794520|447587752|FG002|Overall Study|Lost to Follow-up|0|||
124444075|NCT01794520|447587753|FG003|Overall Study|Lost to Follow-up|0|||
124444076|NCT01794520|447587754|FG004|Overall Study|Lost to Follow-up|1|||
124444077|NCT01794520|447587755|FG005|Overall Study|Lost to Follow-up|0|||
124444078|NCT01794520|447587756|FG006|Overall Study|Lost to Follow-up|0|||
124444079|NCT01794520|447587750|FG000|Overall Study|Toxicity|0|||
124444080|NCT01794520|447587751|FG001|Overall Study|Toxicity|2|||
124444081|NCT01794520|447587752|FG002|Overall Study|Toxicity|0|||
124444082|NCT01794520|447587753|FG003|Overall Study|Toxicity|0|||
124444083|NCT01794520|447587754|FG004|Overall Study|Toxicity|0|||
124444084|NCT01794520|447587755|FG005|Overall Study|Toxicity|0|||
124444085|NCT01794520|447587756|FG006|Overall Study|Toxicity|0|||
124444086|NCT01794520|447587750|FG000|Overall Study|Study terminated by sponsor|0|||
124444087|NCT01794520|447587751|FG001|Overall Study|Study terminated by sponsor|0|||
124444088|NCT01794520|447587752|FG002|Overall Study|Study terminated by sponsor|1|||
124444089|NCT01794520|447587753|FG003|Overall Study|Study terminated by sponsor|0|||
124444090|NCT01794520|447587754|FG004|Overall Study|Study terminated by sponsor|1|||
124444091|NCT01794520|447587755|FG005|Overall Study|Study terminated by sponsor|0|||
124444092|NCT01794520|447587756|FG006|Overall Study|Study terminated by sponsor|7|||
124444093|NCT01794520|447587750|FG000|Overall Study|Death|0|||
124444094|NCT01794520|447587751|FG001|Overall Study|Death|0|||
124444095|NCT01794520|447587752|FG002|Overall Study|Death|0|||
124444096|NCT01794520|447587753|FG003|Overall Study|Death|0|||
124444097|NCT01794520|447587754|FG004|Overall Study|Death|1|||
124444098|NCT01794520|447587755|FG005|Overall Study|Death|0|||
124444099|NCT01794520|447587756|FG006|Overall Study|Death|22|||
124444100|NCT01794520|447587750|FG000|Overall Study|Other, not specified|0|||
124444101|NCT01794520|447587751|FG001|Overall Study|Other, not specified|0|||
124444102|NCT01794520|447587752|FG002|Overall Study|Other, not specified|1|||
124444103|NCT01794520|447587753|FG003|Overall Study|Other, not specified|1|||
124444104|NCT01794520|447587754|FG004|Overall Study|Other, not specified|4|||
124444105|NCT01794520|447587755|FG005|Overall Study|Other, not specified|1|||
124444106|NCT01794520|447587756|FG006|Overall Study|Other, not specified|2|||
124444107|NCT04796896|447587760|FG000|Overall Study|Adverse Event|1|||
124444108|NCT04796896|447587761|FG001|Overall Study|Adverse Event|0|||
124444109|NCT04796896|447587762|FG002|Overall Study|Adverse Event|0|||
124444110|NCT04796896|447587763|FG003|Overall Study|Adverse Event|0|||
124444111|NCT04796896|447587764|FG004|Overall Study|Adverse Event|0|||
124444112|NCT04796896|447587765|FG005|Overall Study|Adverse Event|1|||
124444113|NCT04796896|447587766|FG006|Overall Study|Adverse Event|1|||
124444114|NCT04796896|447587767|FG007|Overall Study|Adverse Event|0|||
124444115|NCT04796896|447587768|FG008|Overall Study|Adverse Event|1|||
124444116|NCT04796896|447587769|FG009|Overall Study|Adverse Event|1|||
124444117|NCT04796896|447587770|FG010|Overall Study|Adverse Event|1|||
124444118|NCT04796896|447587771|FG011|Overall Study|Adverse Event|0|||
124444119|NCT04796896|447587760|FG000|Overall Study|Lost to Follow-up|24|||
124444120|NCT04796896|447587761|FG001|Overall Study|Lost to Follow-up|15|||
124688250|NCT01482221|448477477|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
124688251|NCT01482221|448477478|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
124688252|NCT01482221|448477476|FG000|Overall Study|Condition under Investigation Worsened|3|||
124688253|NCT01482221|448477477|FG001|Overall Study|Condition under Investigation Worsened|2|||
124895835|NCT05074498|449242845|FG002|Part 2 (Upto Day 104)|Death|0|||
124895836|NCT05074498|449242846|FG003|Part 2 (Upto Day 104)|Death|0|||
124444121|NCT04796896|447587762|FG002|Overall Study|Lost to Follow-up|6|||
124444122|NCT04796896|447587763|FG003|Overall Study|Lost to Follow-up|4|||
124444123|NCT04796896|447587764|FG004|Overall Study|Lost to Follow-up|21|||
124444124|NCT04796896|447587765|FG005|Overall Study|Lost to Follow-up|55|||
124444125|NCT04796896|447587766|FG006|Overall Study|Lost to Follow-up|237|||
124444126|NCT04796896|447587767|FG007|Overall Study|Lost to Follow-up|52|||
124444127|NCT04796896|447587768|FG008|Overall Study|Lost to Follow-up|221|||
124444128|NCT04796896|447587769|FG009|Overall Study|Lost to Follow-up|43|||
124444129|NCT04796896|447587770|FG010|Overall Study|Lost to Follow-up|142|||
124444130|NCT04796896|447587771|FG011|Overall Study|Lost to Follow-up|18|||
124895837|NCT05074498|449242847|FG004|Part 2 (Upto Day 104)|Death|1|||
124444131|NCT04796896|447587760|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
124444132|NCT04796896|447587761|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
124444133|NCT04796896|447587762|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
124444134|NCT04796896|447587763|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
124444135|NCT04796896|447587764|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
124444136|NCT04796896|447587765|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
124444137|NCT04796896|447587766|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
124444138|NCT04796896|447587767|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
124444139|NCT04796896|447587768|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
124444140|NCT04796896|447587769|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
124444141|NCT04796896|447587770|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
124444142|NCT04796896|447587771|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
124444143|NCT04796896|447587760|FG000|Overall Study|Physician Decision|1|||
124444144|NCT04796896|447587761|FG001|Overall Study|Physician Decision|0|||
124444145|NCT04796896|447587762|FG002|Overall Study|Physician Decision|0|||
124444146|NCT04796896|447587763|FG003|Overall Study|Physician Decision|0|||
124444147|NCT04796896|447587764|FG004|Overall Study|Physician Decision|0|||
124444148|NCT04796896|447587765|FG005|Overall Study|Physician Decision|3|||
124444149|NCT04796896|447587766|FG006|Overall Study|Physician Decision|18|||
124444150|NCT04796896|447587767|FG007|Overall Study|Physician Decision|1|||
124444151|NCT04796896|447587768|FG008|Overall Study|Physician Decision|7|||
124444152|NCT04796896|447587769|FG009|Overall Study|Physician Decision|0|||
124444153|NCT04796896|447587770|FG010|Overall Study|Physician Decision|5|||
124444154|NCT04796896|447587771|FG011|Overall Study|Physician Decision|0|||
124444155|NCT04796896|447587760|FG000|Overall Study|Withdrawal by Subject|36|||
124444156|NCT04796896|447587761|FG001|Overall Study|Withdrawal by Subject|31|||
124444157|NCT04796896|447587762|FG002|Overall Study|Withdrawal by Subject|11|||
124444158|NCT04796896|447587763|FG003|Overall Study|Withdrawal by Subject|8|||
124444159|NCT04796896|447587764|FG004|Overall Study|Withdrawal by Subject|16|||
124444160|NCT04796896|447587765|FG005|Overall Study|Withdrawal by Subject|162|||
124444161|NCT04796896|447587766|FG006|Overall Study|Withdrawal by Subject|299|||
124444162|NCT04796896|447587767|FG007|Overall Study|Withdrawal by Subject|149|||
124444163|NCT04796896|447587768|FG008|Overall Study|Withdrawal by Subject|303|||
124444164|NCT04796896|447587769|FG009|Overall Study|Withdrawal by Subject|94|||
124444165|NCT04796896|447587770|FG010|Overall Study|Withdrawal by Subject|192|||
124444166|NCT04796896|447587771|FG011|Overall Study|Withdrawal by Subject|16|||
124444167|NCT04796896|447587760|FG000|Overall Study|Other Than Specified|6|||
124444168|NCT04796896|447587761|FG001|Overall Study|Other Than Specified|5|||
124444169|NCT04796896|447587762|FG002|Overall Study|Other Than Specified|3|||
124444170|NCT04796896|447587763|FG003|Overall Study|Other Than Specified|2|||
124444171|NCT04796896|447587764|FG004|Overall Study|Other Than Specified|6|||
124444172|NCT04796896|447587765|FG005|Overall Study|Other Than Specified|31|||
124444173|NCT04796896|447587766|FG006|Overall Study|Other Than Specified|86|||
124444174|NCT04796896|447587767|FG007|Overall Study|Other Than Specified|66|||
124444175|NCT04796896|447587768|FG008|Overall Study|Other Than Specified|388|||
124444176|NCT04796896|447587769|FG009|Overall Study|Other Than Specified|48|||
124444177|NCT04796896|447587770|FG010|Overall Study|Other Than Specified|258|||
124444178|NCT04796896|447587771|FG011|Overall Study|Other Than Specified|4|||
124444179|NCT04796896|447587760|FG000|Overall Study|Protocol Deviation|0|||
124688254|NCT01482221|448477478|FG002|Overall Study|Condition under Investigation Worsened|4|||
124688255|NCT01482221|448477476|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
124688256|NCT01482221|448477477|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
124688257|NCT01482221|448477478|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
124895838|NCT05074498|449242848|FG005|Part 2 (Upto Day 104)|Death|0|||
124895839|NCT05074498|449242843|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
124444180|NCT04796896|447587761|FG001|Overall Study|Protocol Deviation|0|||
124444181|NCT04796896|447587762|FG002|Overall Study|Protocol Deviation|0|||
124444182|NCT04796896|447587763|FG003|Overall Study|Protocol Deviation|1|||
124444183|NCT04796896|447587764|FG004|Overall Study|Protocol Deviation|1|||
124444184|NCT04796896|447587765|FG005|Overall Study|Protocol Deviation|2|||
124444185|NCT04796896|447587766|FG006|Overall Study|Protocol Deviation|2|||
124444186|NCT04796896|447587767|FG007|Overall Study|Protocol Deviation|2|||
124444187|NCT04796896|447587768|FG008|Overall Study|Protocol Deviation|2|||
124444188|NCT04796896|447587769|FG009|Overall Study|Protocol Deviation|1|||
124444189|NCT04796896|447587770|FG010|Overall Study|Protocol Deviation|0|||
124444190|NCT04796896|447587771|FG011|Overall Study|Protocol Deviation|0|||
124444191|NCT04796896|447587760|FG000|Overall Study|Missing|0|||
124444192|NCT04796896|447587761|FG001|Overall Study|Missing|0|||
124444193|NCT04796896|447587762|FG002|Overall Study|Missing|0|||
124444194|NCT04796896|447587763|FG003|Overall Study|Missing|0|||
124444195|NCT04796896|447587764|FG004|Overall Study|Missing|0|||
124444196|NCT04796896|447587765|FG005|Overall Study|Missing|0|||
124444197|NCT04796896|447587766|FG006|Overall Study|Missing|2|||
124444198|NCT04796896|447587767|FG007|Overall Study|Missing|1|||
124444199|NCT04796896|447587768|FG008|Overall Study|Missing|2|||
124444200|NCT04796896|447587769|FG009|Overall Study|Missing|1|||
124444201|NCT04796896|447587770|FG010|Overall Study|Missing|1|||
124444202|NCT04796896|447587771|FG011|Overall Study|Missing|0|||
124444203|NCT04796896|447587760|FG000|Overall Study|Death|0|||
124444204|NCT04796896|447587761|FG001|Overall Study|Death|0|||
124444205|NCT04796896|447587762|FG002|Overall Study|Death|0|||
124444206|NCT04796896|447587763|FG003|Overall Study|Death|0|||
124444207|NCT04796896|447587764|FG004|Overall Study|Death|0|||
124444208|NCT04796896|447587765|FG005|Overall Study|Death|0|||
124444209|NCT04796896|447587766|FG006|Overall Study|Death|0|||
124444210|NCT04796896|447587767|FG007|Overall Study|Death|0|||
124444211|NCT04796896|447587768|FG008|Overall Study|Death|1|||
124444212|NCT04796896|447587769|FG009|Overall Study|Death|0|||
124444213|NCT04796896|447587770|FG010|Overall Study|Death|0|||
124444214|NCT04796896|447587771|FG011|Overall Study|Death|0|||
124444215|NCT02170389|447587776|FG000|Overall Study|Study terminated prior to start of treat|1|||
124444216|NCT02175004|447587778|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
124444217|NCT02175004|447587779|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
124444218|NCT02175004|447587778|FG000|Overall Study|Investigator Judgment|1|||
124444219|NCT02175004|447587779|FG001|Overall Study|Investigator Judgment|4|||
124444220|NCT02175004|447587778|FG000|Overall Study|Voluntary Withdrawal|6|||
124444221|NCT02175004|447587779|FG001|Overall Study|Voluntary Withdrawal|19|||
124444222|NCT02175004|447587778|FG000|Overall Study|Liver Transplant|1|||
124444223|NCT02175004|447587779|FG001|Overall Study|Liver Transplant|0|||
124444224|NCT02175004|447587778|FG000|Overall Study|Disease Progression|1|||
124444225|NCT02175004|447587779|FG001|Overall Study|Disease Progression|0|||
124444226|NCT02175004|447587778|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
124444227|NCT02175004|447587779|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
124444228|NCT02960854|447587780|FG000|Overall Study|Not Disclosed|2|||
124444229|NCT02960854|447587781|FG001|Overall Study|Not Disclosed|2|||
124444230|NCT02960854|447587780|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
124444231|NCT02960854|447587781|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
124444232|NCT02960854|447587780|FG000|Overall Study|Subject Withdrew Consent|0|||
124444233|NCT02960854|447587781|FG001|Overall Study|Subject Withdrew Consent|1|||
124444234|NCT02960854|447587780|FG000|Overall Study|Death|4|||
124444235|NCT02960854|447587781|FG001|Overall Study|Death|6|||
124444236|NCT01176968|447587782|FG000|Overall Study|Adverse Event|10|||
124444237|NCT01176968|447587783|FG001|Overall Study|Adverse Event|11|||
124444238|NCT01176968|447587782|FG000|Overall Study|Death|2|||
124444239|NCT01176968|447587783|FG001|Overall Study|Death|3|||
124444240|NCT01176968|447587782|FG000|Overall Study|Lack of Efficacy|0|||
124444241|NCT01176968|447587783|FG001|Overall Study|Lack of Efficacy|1|||
124444242|NCT01176968|447587782|FG000|Overall Study|Lost to Follow-up|16|||
124444243|NCT01176968|447587783|FG001|Overall Study|Lost to Follow-up|14|||
124444244|NCT01176968|447587782|FG000|Overall Study|Withdrawal by Subject|48|||
124444245|NCT01176968|447587783|FG001|Overall Study|Withdrawal by Subject|48|||
124444246|NCT01176968|447587782|FG000|Overall Study|Protocol Violation|2|||
124444247|NCT01176968|447587783|FG001|Overall Study|Protocol Violation|1|||
124444248|NCT01176968|447587782|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
124444249|NCT01176968|447587783|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
124444250|NCT01176968|447587782|FG000|Overall Study|Study terminated by sponsor|0|||
124444251|NCT01176968|447587783|FG001|Overall Study|Study terminated by sponsor|1|||
124444252|NCT01176968|447587782|FG000|Overall Study|Reason not defined|5|||
124444253|NCT01176968|447587783|FG001|Overall Study|Reason not defined|3|||
124444254|NCT01383161|447587784|FG000|Overall Study|Adverse Event|5|||
124444255|NCT01383161|447587785|FG001|Overall Study|Adverse Event|1|||
124444256|NCT01383161|447587784|FG000|Overall Study|Withdrawal by Subject|0|||
124688258|NCT01482221|448477476|FG000|Overall Study|Adverse Event|1|||
124688259|NCT01482221|448477477|FG001|Overall Study|Adverse Event|7|||
124688260|NCT01482221|448477478|FG002|Overall Study|Adverse Event|3|||
124688261|NCT01482221|448477476|FG000|Overall Study|Withdrawal by Subject|10|||
124688262|NCT01482221|448477477|FG001|Overall Study|Withdrawal by Subject|7|||
124688263|NCT01482221|448477478|FG002|Overall Study|Withdrawal by Subject|12|||
124688264|NCT01482221|448477476|FG000|Overall Study|Incorrect randomization|0|||
124688265|NCT01482221|448477477|FG001|Overall Study|Incorrect randomization|1|||
124688266|NCT01482221|448477478|FG002|Overall Study|Incorrect randomization|0|||
124688267|NCT01482221|448477476|FG000|Overall Study|Physician Decision|0|||
124688268|NCT01482221|448477477|FG001|Overall Study|Physician Decision|1|||
124688269|NCT01482221|448477478|FG002|Overall Study|Physician Decision|0|||
124688270|NCT01047501|448477479|FG000|Overall Study|Adverse Event|7|||
124688271|NCT01047501|448477480|FG001|Overall Study|Adverse Event|8|||
124688272|NCT01047501|448477481|FG002|Overall Study|Adverse Event|5|||
124444257|NCT01383161|447587785|FG001|Overall Study|Withdrawal by Subject|2|||
124444258|NCT01383161|447587784|FG000|Overall Study|Lack of Efficacy|0|||
124688273|NCT01047501|448477479|FG000|Overall Study|Withdrew Consent|6|||
124688274|NCT01047501|448477480|FG001|Overall Study|Withdrew Consent|2|||
124444259|NCT01383161|447587785|FG001|Overall Study|Lack of Efficacy|1|||
124444260|NCT03942406|447587792|FG000|Overall Study|Lost to Follow-up|4|||
124444261|NCT03942406|447587793|FG001|Overall Study|Lost to Follow-up|5|||
124444262|NCT03942406|447587794|FG002|Overall Study|Lost to Follow-up|3|||
124444263|NCT03942406|447587795|FG003|Overall Study|Lost to Follow-up|7|||
124444264|NCT03942406|447587796|FG004|Overall Study|Lost to Follow-up|1|||
124444265|NCT03942406|447587797|FG005|Overall Study|Lost to Follow-up|0|||
124688275|NCT01047501|448477481|FG002|Overall Study|Withdrew Consent|4|||
124688276|NCT01047501|448477479|FG000|Overall Study|Lost to Follow-up|0|||
124688277|NCT01047501|448477480|FG001|Overall Study|Lost to Follow-up|1|||
124688278|NCT01047501|448477481|FG002|Overall Study|Lost to Follow-up|1|||
124895840|NCT05074498|449242844|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
124444266|NCT03942406|447587798|FG006|Overall Study|Lost to Follow-up|0|||
124444267|NCT03942406|447587792|FG000|Overall Study|Withdrawal by Subject|3|||
124444268|NCT03942406|447587793|FG001|Overall Study|Withdrawal by Subject|1|||
124444269|NCT03942406|447587794|FG002|Overall Study|Withdrawal by Subject|1|||
124444270|NCT03942406|447587795|FG003|Overall Study|Withdrawal by Subject|3|||
124444271|NCT03942406|447587796|FG004|Overall Study|Withdrawal by Subject|0|||
124444272|NCT03942406|447587797|FG005|Overall Study|Withdrawal by Subject|0|||
124444273|NCT03942406|447587798|FG006|Overall Study|Withdrawal by Subject|0|||
124444274|NCT03942406|447587792|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
124444275|NCT03942406|447587793|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
124444276|NCT03942406|447587794|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
124444277|NCT03942406|447587795|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
124444278|NCT03942406|447587796|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
124895841|NCT05074498|449242845|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
124895842|NCT05074498|449242846|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
124895843|NCT05074498|449242847|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
124895844|NCT05074498|449242848|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
124895845|NCT05074498|449242843|FG000|Part 2 (Upto Day 104)|Other|0|||
124895846|NCT05074498|449242844|FG001|Part 2 (Upto Day 104)|Other|0|||
124895847|NCT05074498|449242845|FG002|Part 2 (Upto Day 104)|Other|0|||
124895848|NCT05074498|449242846|FG003|Part 2 (Upto Day 104)|Other|0|||
124895849|NCT05074498|449242847|FG004|Part 2 (Upto Day 104)|Other|1|||
124895850|NCT05074498|449242848|FG005|Part 2 (Upto Day 104)|Other|0|||
124895851|NCT01240356|449242849|FG000|Overall Study|Withdrawal by Subject|2|||
124895852|NCT01240356|449242850|FG001|Overall Study|Withdrawal by Subject|0|||
124444279|NCT03942406|447587797|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
124444280|NCT03942406|447587798|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
124444281|NCT00216203|447587801|FG000|Overall Study|Withdrawal by Subject|2|||
124444282|NCT04263909|447587802|FG000|Overall Study|Physician Decision|1|||
124444283|NCT04263909|447587803|FG001|Overall Study|Physician Decision|0|||
124444284|NCT04263909|447587804|FG002|Overall Study|Physician Decision|0|||
124444285|NCT04263909|447587802|FG000|Overall Study|Adverse Event|3|||
124444286|NCT04263909|447587803|FG001|Overall Study|Adverse Event|0|||
124444287|NCT04263909|447587804|FG002|Overall Study|Adverse Event|0|||
124444288|NCT04263909|447587802|FG000|Overall Study|Protocol Violation|5|||
124444289|NCT04263909|447587803|FG001|Overall Study|Protocol Violation|0|||
124444290|NCT04263909|447587804|FG002|Overall Study|Protocol Violation|0|||
124444291|NCT02310672|447587805|FG000|Overall Study|Death|1|||
124444292|NCT02310672|447587805|FG000|Overall Study|Lost to Follow-up|1|||
124444293|NCT02310672|447587805|FG000|Overall Study|Withdrawal by Subject|1|||
124444294|NCT02310672|447587805|FG000|Overall Study|Sponsor's decision|12|||
124444295|NCT04288778|447587806|FG000|Overall Study|Withdrawal by Subject|2|||
124444296|NCT04288778|447587806|FG000|Overall Study|Adverse Event|5|||
124444297|NCT04288778|447587806|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124444298|NCT04288778|447587806|FG000|Overall Study|Other|1|||
124444299|NCT04288778|447587806|FG000|Overall Study|Started but not treated|2|||
124444300|NCT03118674|447587811|FG000|Overall Study|Lost to Follow-up|2|||
124444301|NCT03118674|447587811|FG000|Overall Study|Screen Faliure|8|||
124444302|NCT03118674|447587811|FG000|Overall Study|Withdrawal by Subject|5|||
124444303|NCT03153137|447587812|FG000|Overall Study|Lost to Follow-up|1|||
124444304|NCT03153137|447587813|FG001|Overall Study|Lost to Follow-up|0|||
124444305|NCT03153137|447587812|FG000|Overall Study|Withdrawal by Subject|2|||
124444306|NCT03153137|447587813|FG001|Overall Study|Withdrawal by Subject|1|||
124444307|NCT03153137|447587812|FG000|Overall Study|Physician Decision|0|||
124444308|NCT03153137|447587813|FG001|Overall Study|Physician Decision|3|||
124444309|NCT04209621|447587814|FG000|Overall Study|Death|1|||
124444310|NCT04209621|447587814|FG000|Overall Study|Study Terminated Early|2|||
124444311|NCT02249767|447587815|FG000|Overall Study|Did not use medication|8|||
124444312|NCT02249767|447587816|FG001|Overall Study|Did not use medication|9|||
124444313|NCT02249767|447587817|FG002|Overall Study|Did not use medication|8|||
124444314|NCT01372410|447587818|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
124444315|NCT01372410|447587819|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
124444316|NCT01372410|447587820|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
124895853|NCT01240356|449242849|FG000|Overall Study|MRI contraindication|1|||
124444317|NCT01372410|447587821|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
124895854|NCT01240356|449242850|FG001|Overall Study|MRI contraindication|0|||
124895855|NCT01211665|449242853|FG000|Overall Study|Withdrawal by Subject|1|||
124895856|NCT01211665|449242854|FG001|Overall Study|Withdrawal by Subject|0|||
124444318|NCT01372410|447587822|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
124444319|NCT01372410|447587823|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
124444320|NCT01372410|447587824|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
124444321|NCT01372410|447587825|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
124444322|NCT01372410|447587818|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
124444323|NCT01372410|447587819|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
124895857|NCT01211665|449242853|FG000|Overall Study|Death|1|||
124444324|NCT01372410|447587820|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
124444325|NCT01372410|447587821|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
124444326|NCT01372410|447587822|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
124444327|NCT01372410|447587823|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
124444328|NCT01372410|447587824|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
124444329|NCT01372410|447587825|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
124444330|NCT01372410|447587818|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124444331|NCT01372410|447587819|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124444332|NCT01372410|447587820|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124444333|NCT01372410|447587821|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124444334|NCT01372410|447587822|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
124444335|NCT01372410|447587823|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124444336|NCT01372410|447587824|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124444337|NCT01372410|447587825|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124444338|NCT01372410|447587818|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
124444339|NCT01372410|447587819|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
124444340|NCT01372410|447587820|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
124444341|NCT01372410|447587821|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
124444342|NCT01372410|447587822|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
124444343|NCT01372410|447587823|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
124444344|NCT01372410|447587824|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
124444345|NCT01372410|447587825|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
124444346|NCT01372410|447587818|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
124444347|NCT01372410|447587819|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
124444348|NCT01372410|447587820|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
124444349|NCT01372410|447587821|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
124444350|NCT01372410|447587822|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
124444351|NCT01372410|447587823|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
124444352|NCT01372410|447587824|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
124444353|NCT01372410|447587825|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
124444354|NCT01372410|447587818|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
124444355|NCT01372410|447587819|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
124444356|NCT01372410|447587820|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
124444357|NCT01372410|447587821|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
124444358|NCT01372410|447587822|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
124444359|NCT01372410|447587823|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
124444360|NCT01372410|447587824|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
124444361|NCT01372410|447587825|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
124444362|NCT01372410|447587818|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
124444363|NCT01372410|447587819|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
124444364|NCT01372410|447587820|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
124444365|NCT01372410|447587821|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
124444366|NCT01372410|447587822|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
124444367|NCT01372410|447587823|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
124444368|NCT01372410|447587824|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
124444369|NCT01372410|447587825|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
124444370|NCT01372410|447587818|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
124444371|NCT01372410|447587819|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
124444372|NCT01372410|447587820|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
124444373|NCT01372410|447587821|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
124444374|NCT01372410|447587822|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
124444375|NCT01372410|447587823|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
124444376|NCT01372410|447587824|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
124444377|NCT01372410|447587825|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
124444378|NCT01372410|447587818|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
124895858|NCT01211665|449242854|FG001|Overall Study|Death|0|||
124895859|NCT00498186|449242857|FG000|Overall Study|Protocol Violation|10|||
124895860|NCT00498186|449242857|FG000|Overall Study|Lack of Efficacy|31|||
124895861|NCT00498186|449242857|FG000|Overall Study|Adverse Event|89|||
124895862|NCT00498186|449242857|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
124895863|NCT00498186|449242857|FG000|Overall Study|Withdrawal by Subject|18|||
124444379|NCT01372410|447587819|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
124444380|NCT01372410|447587820|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
124444381|NCT01372410|447587821|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
124895864|NCT00498186|449242857|FG000|Overall Study|Lost to Follow-up|3|||
124895865|NCT00498186|449242857|FG000|Overall Study|Other|10|||
124895866|NCT01390857|449242858|FG000|Overall Study|Protocol Violation|2|||
124895867|NCT01390857|449242858|FG000|Overall Study|Lost to Follow-up|1|||
124444382|NCT01372410|447587822|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
124444383|NCT01372410|447587823|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
124444384|NCT01372410|447587824|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
124444385|NCT01372410|447587825|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
124444386|NCT01372410|447587818|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
124444387|NCT01372410|447587819|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
124444388|NCT01372410|447587820|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
124444389|NCT01372410|447587821|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
124444390|NCT01372410|447587822|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
124444391|NCT01372410|447587823|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
124444392|NCT01372410|447587824|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
124444393|NCT01372410|447587825|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
124444394|NCT04585646|447587826|FG000|First Intervention|Physician Decision|1|||
124444395|NCT04585646|447587827|FG001|First Intervention|Physician Decision|0|||
124444396|NCT04585646|447587826|FG000|First Intervention|Lost to Follow-up|0|||
124444397|NCT04585646|447587827|FG001|First Intervention|Lost to Follow-up|3|||
124444398|NCT04585646|447587826|FG000|First Intervention|Withdrawal by Subject|0|||
124444399|NCT04585646|447587827|FG001|First Intervention|Withdrawal by Subject|1|||
124444400|NCT01067326|447587834|FG000|Overall Study|Adverse Event|0|||
124444401|NCT01067326|447587835|FG001|Overall Study|Adverse Event|2|||
124444402|NCT01067326|447587834|FG000|Overall Study|Withdrawal by Subject|1|||
124444403|NCT01067326|447587835|FG001|Overall Study|Withdrawal by Subject|0|||
124444404|NCT01067326|447587834|FG000|Overall Study|Early Study Termination|1|||
124444405|NCT01067326|447587835|FG001|Overall Study|Early Study Termination|1|||
124444406|NCT01230788|447587842|FG000|Overall Study|Prescribed exclusion drug|1|||
124444407|NCT00769860|447587843|FG000|Overall Study|Withdrawal by Subject|2|||
124444408|NCT00769860|447587844|FG001|Overall Study|Withdrawal by Subject|0|||
124444409|NCT01603082|447587845|FG000|Overall Study|Adverse Event|0|||
124444410|NCT01603082|447587846|FG001|Overall Study|Adverse Event|1|||
124444411|NCT01603082|447587845|FG000|Overall Study|Withdrawal by Subject|1|||
124444412|NCT01603082|447587846|FG001|Overall Study|Withdrawal by Subject|0|||
124444413|NCT01603082|447587845|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
124444414|NCT01603082|447587846|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
124444415|NCT01019317|447587850|FG000|Overall Study|Not Eligible|4|||
124444416|NCT01498289|447587852|FG000|Overall Study|Adverse Event|16|||
124444417|NCT01498289|447587853|FG001|Overall Study|Adverse Event|18|||
124444418|NCT01498289|447587852|FG000|Overall Study|Death|6|||
124444419|NCT01498289|447587853|FG001|Overall Study|Death|8|||
124444420|NCT01498289|447587852|FG000|Overall Study|Withdrawal unrelated to AE|16|||
124444421|NCT01498289|447587853|FG001|Overall Study|Withdrawal unrelated to AE|16|||
124444422|NCT01498289|447587852|FG000|Overall Study|Progression/relapse|53|||
124444423|NCT01498289|447587853|FG001|Overall Study|Progression/relapse|59|||
124444424|NCT01498289|447587852|FG000|Overall Study|Not protocol specified|7|||
124444425|NCT01498289|447587853|FG001|Overall Study|Not protocol specified|2|||
124444426|NCT01498289|447587852|FG000|Overall Study|Reason under review|0|||
124444427|NCT01498289|447587853|FG001|Overall Study|Reason under review|1|||
124444428|NCT01774084|447587854|FG000|Overall Study|Personal reasons|1|||
124444429|NCT01774084|447587855|FG001|Overall Study|Personal reasons|0|||
124444430|NCT04526197|447587857|FG000|Period 1|Adverse Event|0|||
124444431|NCT04526197|447587858|FG001|Period 1|Adverse Event|1|||
124444432|NCT04526197|447587857|FG000|Period 1|Withdrawal by Subject|1|||
124444433|NCT04526197|447587858|FG001|Period 1|Withdrawal by Subject|0|||
124444434|NCT04526197|447587857|FG000|Period 2|Adverse Event|0|||
124444435|NCT04526197|447587858|FG001|Period 2|Adverse Event|1|||
124444436|NCT04526197|447587857|FG000|Period 2|Withdrawal by Subject|0|||
124444437|NCT04526197|447587858|FG001|Period 2|Withdrawal by Subject|1|||
124444438|NCT01557348|447587859|FG000|Overall Study|Adverse Event|6|||
124444439|NCT01557348|447587860|FG001|Overall Study|Adverse Event|16|||
124444440|NCT01557348|447587859|FG000|Overall Study|Infusion reaction event|5|||
124444441|NCT01557348|447587860|FG001|Overall Study|Infusion reaction event|5|||
124444442|NCT01557348|447587859|FG000|Overall Study|Death|7|||
124444443|NCT01557348|447587860|FG001|Overall Study|Death|4|||
124444444|NCT01557348|447587859|FG000|Overall Study|Insufficient Therapeutic Response|13|||
124444445|NCT01557348|447587860|FG001|Overall Study|Insufficient Therapeutic Response|28|||
124444446|NCT01557348|447587859|FG000|Overall Study|Withdrawal by Subject|5|||
124444447|NCT01557348|447587860|FG001|Overall Study|Withdrawal by Subject|4|||
124444448|NCT01557348|447587859|FG000|Overall Study|Lost to Follow-up|26|||
124444449|NCT01557348|447587860|FG001|Overall Study|Lost to Follow-up|22|||
124444450|NCT01557348|447587859|FG000|Overall Study|Administrative|18|||
124444451|NCT01557348|447587860|FG001|Overall Study|Administrative|11|||
124444452|NCT02000427|447587861|FG000|Overall Study|Death|22|||
124444453|NCT04343248|447587862|FG000|Overall Study|Withdrawal by Subject|5|||
124444454|NCT04343248|447587863|FG001|Overall Study|Withdrawal by Subject|6|||
124444455|NCT04343248|447587862|FG000|Overall Study|Death|1|||
124444456|NCT04343248|447587863|FG001|Overall Study|Death|2|||
124444457|NCT04343248|447587862|FG000|Overall Study|Lost to Follow-up|9|||
124444458|NCT04343248|447587863|FG001|Overall Study|Lost to Follow-up|6|||
124444459|NCT04343248|447587862|FG000|Overall Study|Physician Decision|0|||
124444460|NCT04343248|447587863|FG001|Overall Study|Physician Decision|1|||
124444461|NCT04343248|447587862|FG000|Overall Study|Adverse Event|1|||
124444462|NCT04343248|447587863|FG001|Overall Study|Adverse Event|0|||
124444463|NCT04484259|447587864|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
124444464|NCT04484259|447587865|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
124444465|NCT04484259|447587866|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
124444466|NCT04484259|447587867|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
124444467|NCT04484259|447587868|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
124444468|NCT04484259|447587864|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
124444469|NCT04484259|447587865|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
124444470|NCT04484259|447587866|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
124444471|NCT04484259|447587867|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
124444472|NCT04484259|447587868|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
124444473|NCT04484259|447587864|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
124444474|NCT04484259|447587865|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
124444475|NCT04484259|447587866|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
124444476|NCT04484259|447587867|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
124444477|NCT04484259|447587868|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
124444478|NCT04484259|447587864|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
124444479|NCT04484259|447587865|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
124444480|NCT04484259|447587866|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
124444481|NCT04484259|447587867|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
124444482|NCT04484259|447587868|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
124444483|NCT04484259|447587864|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
124444484|NCT04484259|447587865|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
124444485|NCT04484259|447587866|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
124444486|NCT04484259|447587867|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
124444487|NCT04484259|447587868|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
124444488|NCT04484259|447587864|FG000|Randomized Treatment|Withdrawal by Subject|1|||
124444489|NCT04484259|447587865|FG001|Randomized Treatment|Withdrawal by Subject|0|||
124444490|NCT04484259|447587866|FG002|Randomized Treatment|Withdrawal by Subject|0|||
124444491|NCT04484259|447587867|FG003|Randomized Treatment|Withdrawal by Subject|0|||
124444492|NCT04484259|447587868|FG004|Randomized Treatment|Withdrawal by Subject|0|||
124444493|NCT03566810|447590198|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
124444494|NCT03566810|447590199|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
124444495|NCT03566810|447590200|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
124444496|NCT03566810|447590201|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
124444497|NCT03078907|447590205|FG000|Overall Study|Adverse Event|2|||
124444498|NCT03078907|447590206|FG001|Overall Study|Adverse Event|0|||
124444499|NCT03078907|447590205|FG000|Overall Study|Other|1|||
124444500|NCT03078907|447590206|FG001|Overall Study|Other|0|||
124444501|NCT03078907|447590205|FG000|Overall Study|Protocol Violation|0|||
124444502|NCT03078907|447590206|FG001|Overall Study|Protocol Violation|1|||
124444503|NCT01955122|447590207|FG000|Overall Study|Physician Decision|5|||
124444504|NCT01955122|447590208|FG001|Overall Study|Physician Decision|5|||
124444505|NCT00826111|447590209|FG000|Overall Study|Lost to Follow-up|0|||
124444506|NCT00826111|447590210|FG001|Overall Study|Lost to Follow-up|1|||
124444507|NCT00826111|447590209|FG000|Overall Study|Protocol Violation|1|||
124444508|NCT00826111|447590210|FG001|Overall Study|Protocol Violation|0|||
124444509|NCT00826111|447590209|FG000|Overall Study|Withdrawal by Subject|5|||
124444510|NCT00826111|447590210|FG001|Overall Study|Withdrawal by Subject|0|||
124444511|NCT00826111|447590209|FG000|Overall Study|Physician Decision|1|||
124444512|NCT00826111|447590210|FG001|Overall Study|Physician Decision|1|||
124444513|NCT01672788|447590211|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
124444514|NCT01672788|447590212|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
124444515|NCT01672788|447590213|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
124444516|NCT01672788|447590214|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
124444517|NCT03511053|447590220|FG000|Overall Study|Withdrawal by Subject|1|||
124444518|NCT01128361|447590221|FG000|Overall Study|Lost to Follow-up|0|||
124444519|NCT01128361|447590222|FG001|Overall Study|Lost to Follow-up|1|||
124444520|NCT01128361|447590221|FG000|Overall Study|Withdrawal by Subject|5|||
124444521|NCT01128361|447590222|FG001|Overall Study|Withdrawal by Subject|2|||
124444522|NCT01929980|447590223|FG000|Overall Study|Physician Decision|1|||
124444523|NCT01028222|447590224|FG000|Overall Study|Protocol deviation|1|||
124444524|NCT01028222|447590225|FG001|Overall Study|Protocol deviation|0|||
124444525|NCT01028222|447590224|FG000|Overall Study|Disease progression|33|||
124444526|NCT01028222|447590225|FG001|Overall Study|Disease progression|9|||
124444527|NCT01028222|447590224|FG000|Overall Study|Administrative problems|1|||
124444528|NCT01028222|447590225|FG001|Overall Study|Administrative problems|1|||
124444529|NCT01028222|447590224|FG000|Overall Study|Lost to Follow-up|0|||
124444530|NCT01028222|447590225|FG001|Overall Study|Lost to Follow-up|1|||
124895868|NCT01390857|449242858|FG000|Overall Study|No Visit after the First Visit|7|||
124895869|NCT04541186|449242860|FG000|Main Study|Adverse Event|0|||
124895870|NCT04541186|449242861|FG001|Main Study|Adverse Event|0|||
124444531|NCT01028222|447590224|FG000|Overall Study|Withdrawal by Subject|1|||
124444532|NCT01028222|447590225|FG001|Overall Study|Withdrawal by Subject|0|||
124444533|NCT01028222|447590224|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
124444534|NCT01028222|447590225|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
124444535|NCT01028222|447590224|FG000|Overall Study|Adverse Event|2|||
124444536|NCT01028222|447590225|FG001|Overall Study|Adverse Event|0|||
124444537|NCT03236246|447590228|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
124444538|NCT03236246|447590229|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
124444539|NCT03236246|447590228|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
124444540|NCT03236246|447590229|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
124444541|NCT03236246|447590228|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
124444542|NCT03236246|447590229|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
124444543|NCT03236246|447590228|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
124444544|NCT03236246|447590229|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
124444545|NCT03236246|447590228|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
124444546|NCT03236246|447590229|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
124444547|NCT03236246|447590228|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
124444548|NCT03236246|447590229|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
124444549|NCT03236246|447590228|FG000|24-Week Dose Titration Period|Death|3|||
124444550|NCT03236246|447590229|FG001|24-Week Dose Titration Period|Death|1|||
124444551|NCT03236246|447590228|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
124444552|NCT03236246|447590229|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
124444553|NCT03236246|447590228|FG000|24-Week Dose Titration Period|Adverse Event|7|||
124444554|NCT03236246|447590229|FG001|24-Week Dose Titration Period|Adverse Event|8|||
124444555|NCT03236246|447590228|FG000|24-Week Dose Titration Period|Captured as Other|1|||
124444556|NCT03236246|447590229|FG001|24-Week Dose Titration Period|Captured as Other|2|||
124444557|NCT03236246|447590228|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
124444558|NCT03236246|447590229|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
124444559|NCT03236246|447590228|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
124444560|NCT03236246|447590229|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
124444561|NCT03236246|447590228|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
124444562|NCT03236246|447590229|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
124444563|NCT03236246|447590228|FG000|24-Week Dose Maintenance Period|Death|0|||
124444564|NCT03236246|447590229|FG001|24-Week Dose Maintenance Period|Death|1|||
124444565|NCT03236246|447590228|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
124444566|NCT03236246|447590229|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
124444567|NCT02598557|447590230|FG000|Overall Study|Withdrawal by Subject|1|||
124444568|NCT02598557|447590231|FG001|Overall Study|Withdrawal by Subject|0|||
124444569|NCT02598557|447590232|FG002|Overall Study|Withdrawal by Subject|1|||
124444570|NCT02598557|447590230|FG000|Overall Study|Participant did not start treatment|2|||
124444571|NCT02598557|447590231|FG001|Overall Study|Participant did not start treatment|1|||
124444572|NCT02598557|447590232|FG002|Overall Study|Participant did not start treatment|1|||
124444573|NCT02598557|447590230|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
124444574|NCT02598557|447590231|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
124444575|NCT02598557|447590232|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
124444576|NCT02598557|447590230|FG000|Overall Study|Adverse Event|1|||
124444577|NCT02598557|447590231|FG001|Overall Study|Adverse Event|1|||
124444578|NCT02598557|447590232|FG002|Overall Study|Adverse Event|0|||
124444579|NCT01637623|447590235|FG000|Overall Study|Lost to Follow-up|0|||
124444580|NCT01637623|447590236|FG001|Overall Study|Lost to Follow-up|0|||
124444581|NCT01637623|447590237|FG002|Overall Study|Lost to Follow-up|2|||
124444582|NCT01637623|447590235|FG000|Overall Study|Physician Decision|1|||
124444583|NCT01637623|447590236|FG001|Overall Study|Physician Decision|0|||
124444584|NCT01637623|447590237|FG002|Overall Study|Physician Decision|1|||
124444585|NCT04615247|447590238|FG000|Overall Study|Adverse Event|0|||
124444586|NCT04615247|447590239|FG001|Overall Study|Adverse Event|2|||
124444587|NCT04615247|447590238|FG000|Overall Study|Withdrawal by Subject|1|||
124444588|NCT04615247|447590239|FG001|Overall Study|Withdrawal by Subject|1|||
124444589|NCT02076113|447590244|FG000|Overall Study|Lost to Follow-up|4|||
124444590|NCT02076113|447590245|FG001|Overall Study|Lost to Follow-up|1|||
124444591|NCT02076113|447590244|FG000|Overall Study|Withdrawal by Subject|2|||
124444592|NCT02076113|447590245|FG001|Overall Study|Withdrawal by Subject|3|||
124444593|NCT02076113|447590244|FG000|Overall Study|Death|1|||
124444594|NCT02076113|447590245|FG001|Overall Study|Death|3|||
124444595|NCT02596620|447590250|FG000|Overall Study|Lost to Follow-up|1|||
124444596|NCT02596620|447590251|FG001|Overall Study|Lost to Follow-up|1|||
124444597|NCT01054144|447590252|FG000|Overall Study|Death|2|||
124444598|NCT05628285|447590253|FG000|Overall Study|Lost to Follow-up|1|||
124444599|NCT01284062|447590256|FG000|Overall Study|Adverse Event|4|||
124444600|NCT01284062|447590257|FG001|Overall Study|Adverse Event|5|||
124444601|NCT01284062|447590258|FG002|Overall Study|Adverse Event|0|||
124444602|NCT01284062|447590259|FG003|Overall Study|Adverse Event|5|||
124444603|NCT01284062|447590256|FG000|Overall Study|Lack of Efficacy|3|||
124688279|NCT01047501|448477479|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
124688280|NCT01047501|448477480|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
124688281|NCT01047501|448477481|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
124688282|NCT01047501|448477479|FG000|Overall Study|Death|1|||
124688283|NCT01047501|448477480|FG001|Overall Study|Death|0|||
124688284|NCT01047501|448477481|FG002|Overall Study|Death|0|||
124688285|NCT01047501|448477479|FG000|Overall Study|Other discontinuation|1|||
124688286|NCT01047501|448477480|FG001|Overall Study|Other discontinuation|0|||
124688287|NCT01047501|448477481|FG002|Overall Study|Other discontinuation|1|||
124688288|NCT01047501|448477479|FG000|Overall Study|Investigator judgement|0|||
124688289|NCT01047501|448477480|FG001|Overall Study|Investigator judgement|0|||
124688290|NCT01047501|448477481|FG002|Overall Study|Investigator judgement|1|||
124688291|NCT00741611|448477482|FG000|Overall Study|Death|0|||
124688292|NCT00741611|448477483|FG001|Overall Study|Death|0|||
124688293|NCT00741611|448477484|FG002|Overall Study|Death|1|||
124688294|NCT00741611|448477482|FG000|Overall Study|Withdrawal by Subject|0|||
124688295|NCT00741611|448477483|FG001|Overall Study|Withdrawal by Subject|2|||
124688296|NCT00741611|448477484|FG002|Overall Study|Withdrawal by Subject|2|||
124688297|NCT00429299|448477489|FG000|Overall Study|Disease Progression|1|||
124688298|NCT00429299|448477490|FG001|Overall Study|Disease Progression|1|||
124688299|NCT00429299|448477491|FG002|Overall Study|Disease Progression|0|||
124688300|NCT00429299|448477489|FG000|Overall Study|Adverse Event|2|||
124688301|NCT00429299|448477490|FG001|Overall Study|Adverse Event|5|||
124688302|NCT00429299|448477491|FG002|Overall Study|Adverse Event|1|||
124688303|NCT00429299|448477489|FG000|Overall Study|Protocol Violation|1|||
124688304|NCT00429299|448477490|FG001|Overall Study|Protocol Violation|0|||
124688305|NCT00429299|448477491|FG002|Overall Study|Protocol Violation|0|||
124688306|NCT00429299|448477489|FG000|Overall Study|Withdrawal by Subject|0|||
124688307|NCT00429299|448477490|FG001|Overall Study|Withdrawal by Subject|1|||
124688308|NCT00429299|448477491|FG002|Overall Study|Withdrawal by Subject|3|||
124688309|NCT01510756|448477492|FG000|Overall Study|Death|1|||
124688310|NCT01510756|448477492|FG000|Overall Study|Lack of Efficacy|2|||
124688311|NCT01510756|448477492|FG000|Overall Study|Physician Decision|1|||
124895871|NCT04541186|449242862|FG002|Main Study|Adverse Event|4|||
124688312|NCT04871113|448477493|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
124688313|NCT04871113|448477494|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
124688314|NCT04871113|448477495|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
124688315|NCT04871113|448477496|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
124688316|NCT04871113|448477497|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
124688317|NCT04871113|448477498|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
124688318|NCT04871113|448477499|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
124895872|NCT04541186|449242863|FG003|Main Study|Adverse Event|0|||
124895873|NCT04541186|449242864|FG004|Main Study|Adverse Event|0|||
124895874|NCT04541186|449242860|FG000|Main Study|Investigator Decision|0|||
124895875|NCT04541186|449242861|FG001|Main Study|Investigator Decision|0|||
124895876|NCT04541186|449242862|FG002|Main Study|Investigator Decision|1|||
124895877|NCT04541186|449242863|FG003|Main Study|Investigator Decision|1|||
124688319|NCT04871113|448477500|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
124688320|NCT04871113|448477501|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
124688321|NCT04871113|448477502|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
124688322|NCT04871113|448477493|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
124688323|NCT04871113|448477494|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
124688324|NCT04871113|448477495|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
124895878|NCT04541186|449242864|FG004|Main Study|Investigator Decision|0|||
124688325|NCT04871113|448477496|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
124895879|NCT04541186|449242860|FG000|Main Study|Withdrawal by Subject|1|||
124895880|NCT04541186|449242861|FG001|Main Study|Withdrawal by Subject|1|||
124688326|NCT04871113|448477497|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
124688327|NCT04871113|448477498|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
124688328|NCT04871113|448477499|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
124688329|NCT04871113|448477500|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
124688330|NCT04871113|448477501|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
124688331|NCT04871113|448477502|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
124688332|NCT01257542|448477505|FG000|Overall Study|Protocol Violation|3|||
124688333|NCT01257542|448477506|FG001|Overall Study|Protocol Violation|5|||
124688334|NCT01257542|448477505|FG000|Overall Study|Withdrawal by Subject|0|||
124688335|NCT01257542|448477506|FG001|Overall Study|Withdrawal by Subject|2|||
124688336|NCT03600428|448477512|FG000|Overall Study|Not eligible|0|||
124688337|NCT03600428|448477513|FG001|Overall Study|Not eligible|1|||
124688338|NCT03600428|448477512|FG000|Overall Study|Lost to Follow-up|5|||
124688339|NCT03600428|448477513|FG001|Overall Study|Lost to Follow-up|4|||
124688340|NCT04398134|448477514|FG000|Overall Study|Adverse Event|0|||
124688341|NCT04398134|448477515|FG001|Overall Study|Adverse Event|0|||
124688342|NCT04398134|448477516|FG002|Overall Study|Adverse Event|1|||
124688343|NCT04398134|448477517|FG003|Overall Study|Adverse Event|0|||
124688344|NCT04398134|448477514|FG000|Overall Study|Withdrawal by Subject|2|||
124688345|NCT04398134|448477515|FG001|Overall Study|Withdrawal by Subject|0|||
124688346|NCT04398134|448477516|FG002|Overall Study|Withdrawal by Subject|0|||
124688347|NCT04398134|448477517|FG003|Overall Study|Withdrawal by Subject|1|||
124688348|NCT04398134|448477514|FG000|Overall Study|Study Terminated by Sponsor|30|||
124688349|NCT04398134|448477515|FG001|Overall Study|Study Terminated by Sponsor|11|||
124688350|NCT04398134|448477516|FG002|Overall Study|Study Terminated by Sponsor|32|||
124688351|NCT04398134|448477517|FG003|Overall Study|Study Terminated by Sponsor|11|||
124688352|NCT00153920|448477519|FG000|Overall Study|Adverse Event|9|||
124688353|NCT00153920|448477519|FG000|Overall Study|Progressive Disease|9|||
124688354|NCT00153920|448477519|FG000|Overall Study|Physician Decision|3|||
124688355|NCT00153920|448477519|FG000|Overall Study|Lack of Response|3|||
124688356|NCT00153920|448477519|FG000|Overall Study|Death|2|||
124688357|NCT00153920|448477519|FG000|Overall Study|Withdrawal by Subject|1|||
124688358|NCT00153920|448477519|FG000|Overall Study|Non-Protocol Therapy|1|||
124688359|NCT00153920|448477519|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
124688360|NCT00153920|448477519|FG000|Overall Study|Progressive Disease before Trt|1|||
124688361|NCT01666652|448477525|FG000|Overall Study|Serious Adverse Event|0|||
124688362|NCT01666652|448477526|FG001|Overall Study|Serious Adverse Event|0|||
124688363|NCT01666652|448477527|FG002|Overall Study|Serious Adverse Event|0|||
124688364|NCT01666652|448477528|FG003|Overall Study|Serious Adverse Event|1|||
124688365|NCT01666652|448477529|FG004|Overall Study|Serious Adverse Event|0|||
124895881|NCT04541186|449242862|FG002|Main Study|Withdrawal by Subject|0|||
124895882|NCT04541186|449242863|FG003|Main Study|Withdrawal by Subject|0|||
124444604|NCT01284062|447590257|FG001|Overall Study|Lack of Efficacy|2|||
124444605|NCT01284062|447590258|FG002|Overall Study|Lack of Efficacy|2|||
124444606|NCT01284062|447590259|FG003|Overall Study|Lack of Efficacy|1|||
124444607|NCT01284062|447590256|FG000|Overall Study|Medication error without adverse event|0|||
124444608|NCT01284062|447590257|FG001|Overall Study|Medication error without adverse event|0|||
124444609|NCT01284062|447590258|FG002|Overall Study|Medication error without adverse event|1|||
124444610|NCT01284062|447590259|FG003|Overall Study|Medication error without adverse event|0|||
124444611|NCT01284062|447590256|FG000|Overall Study|Protocol Violation|1|||
124444612|NCT01284062|447590257|FG001|Overall Study|Protocol Violation|0|||
124444613|NCT01284062|447590258|FG002|Overall Study|Protocol Violation|0|||
124688366|NCT01666652|448477525|FG000|Overall Study|Withdrawal by Subject|0|||
124688367|NCT01666652|448477526|FG001|Overall Study|Withdrawal by Subject|0|||
124688368|NCT01666652|448477527|FG002|Overall Study|Withdrawal by Subject|0|||
124688369|NCT01666652|448477528|FG003|Overall Study|Withdrawal by Subject|0|||
124688370|NCT01666652|448477529|FG004|Overall Study|Withdrawal by Subject|1|||
124688371|NCT01666652|448477525|FG000|Overall Study|Moved from study area|1|||
124688372|NCT01666652|448477526|FG001|Overall Study|Moved from study area|0|||
124688373|NCT01666652|448477527|FG002|Overall Study|Moved from study area|0|||
124688374|NCT01666652|448477528|FG003|Overall Study|Moved from study area|2|||
124688375|NCT01666652|448477529|FG004|Overall Study|Moved from study area|0|||
124688376|NCT01666652|448477525|FG000|Overall Study|Lost to Follow-up|1|||
124688377|NCT01666652|448477526|FG001|Overall Study|Lost to Follow-up|1|||
124688378|NCT01666652|448477527|FG002|Overall Study|Lost to Follow-up|1|||
124688379|NCT01666652|448477528|FG003|Overall Study|Lost to Follow-up|1|||
124688380|NCT01666652|448477529|FG004|Overall Study|Lost to Follow-up|0|||
124688381|NCT01018979|448477530|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
124688382|NCT01018979|448477531|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
124688383|NCT01018979|448477530|FG000|Overall Study|Not received at least one dose|0|||
124688384|NCT01018979|448477531|FG001|Overall Study|Not received at least one dose|1|||
124688385|NCT03301714|448477532|FG000|Overall Study|Lost to Follow-up|10|||
124688386|NCT03301714|448477533|FG001|Overall Study|Lost to Follow-up|4|||
124688387|NCT03301714|448477534|FG002|Overall Study|Lost to Follow-up|4|||
124444614|NCT01284062|447590259|FG003|Overall Study|Protocol Violation|2|||
124895883|NCT04541186|449242864|FG004|Main Study|Withdrawal by Subject|0|||
124895884|NCT04541186|449242860|FG000|Main Study|COVID-19-related Dose Interruption|0|||
124895885|NCT04541186|449242861|FG001|Main Study|COVID-19-related Dose Interruption|0|||
124895886|NCT04541186|449242862|FG002|Main Study|COVID-19-related Dose Interruption|0|||
124895887|NCT04541186|449242863|FG003|Main Study|COVID-19-related Dose Interruption|0|||
124895888|NCT04541186|449242864|FG004|Main Study|COVID-19-related Dose Interruption|1|||
124895889|NCT04541186|449242860|FG000|Main Study|Randomized in Error Not Treated|0|||
124895890|NCT04541186|449242861|FG001|Main Study|Randomized in Error Not Treated|0|||
124895891|NCT04541186|449242862|FG002|Main Study|Randomized in Error Not Treated|1|||
124895892|NCT04541186|449242863|FG003|Main Study|Randomized in Error Not Treated|0|||
124895893|NCT04541186|449242864|FG004|Main Study|Randomized in Error Not Treated|0|||
124895894|NCT04541186|449242860|FG000|Fibrate Expansion Study|Other than Specified|0|||
124895895|NCT04541186|449242861|FG001|Fibrate Expansion Study|Other than Specified|0|||
124895896|NCT04541186|449242862|FG002|Fibrate Expansion Study|Other than Specified|0|||
124895897|NCT04541186|449242863|FG003|Fibrate Expansion Study|Other than Specified|0|||
124895898|NCT04541186|449242864|FG004|Fibrate Expansion Study|Other than Specified|1|||
124895899|NCT00691028|449242865|FG000|Open-label Period|Adverse Event|0|||
124895900|NCT00691028|449242866|FG001|Open-label Period|Adverse Event|0|||
124895901|NCT00691028|449242867|FG002|Open-label Period|Adverse Event|0|||
124895902|NCT00691028|449242868|FG003|Open-label Period|Adverse Event|16|||
124895903|NCT00691028|449242865|FG000|Open-label Period|Withdrawal by Subject|0|||
124895904|NCT00691028|449242866|FG001|Open-label Period|Withdrawal by Subject|0|||
124895905|NCT00691028|449242867|FG002|Open-label Period|Withdrawal by Subject|0|||
124895906|NCT00691028|449242868|FG003|Open-label Period|Withdrawal by Subject|3|||
124895907|NCT00691028|449242865|FG000|Open-label Period|not come to a hospital|0|||
124895908|NCT00691028|449242866|FG001|Open-label Period|not come to a hospital|0|||
124895909|NCT00691028|449242867|FG002|Open-label Period|not come to a hospital|0|||
124895910|NCT00691028|449242868|FG003|Open-label Period|not come to a hospital|1|||
124895911|NCT00691028|449242865|FG000|Double-blind Period|Adverse Event|8|||
124895912|NCT00691028|449242866|FG001|Double-blind Period|Adverse Event|9|||
124895913|NCT00691028|449242867|FG002|Double-blind Period|Adverse Event|6|||
124895914|NCT00691028|449242868|FG003|Double-blind Period|Adverse Event|0|||
124895915|NCT00691028|449242865|FG000|Double-blind Period|Lack of Efficacy|4|||
124895916|NCT00691028|449242866|FG001|Double-blind Period|Lack of Efficacy|3|||
124895917|NCT00691028|449242867|FG002|Double-blind Period|Lack of Efficacy|2|||
124895918|NCT00691028|449242868|FG003|Double-blind Period|Lack of Efficacy|0|||
124895919|NCT00691028|449242865|FG000|Double-blind Period|Withdrawal by Subject|1|||
124895920|NCT00691028|449242866|FG001|Double-blind Period|Withdrawal by Subject|0|||
124895921|NCT00691028|449242867|FG002|Double-blind Period|Withdrawal by Subject|1|||
124895922|NCT00691028|449242868|FG003|Double-blind Period|Withdrawal by Subject|0|||
124895923|NCT00691028|449242865|FG000|Double-blind Period|not come to a hospital.|0|||
124895924|NCT00691028|449242866|FG001|Double-blind Period|not come to a hospital.|1|||
124895925|NCT00691028|449242867|FG002|Double-blind Period|not come to a hospital.|0|||
124895926|NCT00691028|449242868|FG003|Double-blind Period|not come to a hospital.|0|||
124895927|NCT03085017|449242869|FG000|Overall Study|Death|0|||
124895928|NCT03085017|449242870|FG001|Overall Study|Death|3|||
124895929|NCT00058058|449242871|FG000|Overall Study|Withdrawal by Subject|4|||
124895930|NCT00058058|449242871|FG000|Overall Study|Ineligible|20|||
124895931|NCT00058058|449242871|FG000|Overall Study|Claustrophobic|5|||
124895932|NCT00058058|449242871|FG000|Overall Study|technical issues|6|||
124895933|NCT00058058|449242871|FG000|Overall Study|Poor positioning, illness,pain|3|||
124895934|NCT03255018|449242882|FG000|Overall Study|Death on study|0|||
124895935|NCT03255018|449242883|FG001|Overall Study|Death on study|5|||
124895936|NCT03255018|449242882|FG000|Overall Study|Withdrawal by Subject|0|||
124895937|NCT03255018|449242883|FG001|Overall Study|Withdrawal by Subject|2|||
124895938|NCT03681691|449242887|FG000|Overall Study|COVID|1|||
124895939|NCT03681691|449242888|FG001|Overall Study|COVID|0|||
124895940|NCT03681691|449242887|FG000|Overall Study|prolonged bleeding|1|||
124895941|NCT03681691|449242888|FG001|Overall Study|prolonged bleeding|0|||
124895942|NCT03681691|449242887|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
124688388|NCT03301714|448477532|FG000|Overall Study|Did not receive allocated intervention|0|||
124895943|NCT03681691|449242888|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
124895944|NCT03432533|449242889|FG000|Overall Study|Lost to Follow-up|1|||
124895945|NCT03432533|449242890|FG001|Overall Study|Lost to Follow-up|2|||
124895946|NCT03432533|449242889|FG000|Overall Study|Withdrawal by Subject|14|||
124895947|NCT03432533|449242890|FG001|Overall Study|Withdrawal by Subject|9|||
124895948|NCT01582243|449242899|FG000|Overall Study|Withdrawal by Subject|1|||
124895949|NCT01582243|449242899|FG000|Overall Study|Adverse Event|1|||
124895950|NCT01582243|449242899|FG000|Overall Study|Lost to Follow-up|1|||
124895951|NCT01674569|449242905|FG000|Overall Study|Adverse Event|0|||
124895952|NCT01674569|449242906|FG001|Overall Study|Adverse Event|2|||
124895953|NCT01674569|449242907|FG002|Overall Study|Adverse Event|0|||
124895954|NCT01674569|449242908|FG003|Overall Study|Adverse Event|1|||
124895955|NCT01674569|449242909|FG004|Overall Study|Adverse Event|2|||
124895956|NCT01674569|449242910|FG005|Overall Study|Adverse Event|2|||
124895957|NCT01674569|449242905|FG000|Overall Study|Protocol Violation|0|||
124895958|NCT01674569|449242906|FG001|Overall Study|Protocol Violation|1|||
124895959|NCT01674569|449242907|FG002|Overall Study|Protocol Violation|1|||
124895960|NCT01674569|449242908|FG003|Overall Study|Protocol Violation|0|||
124895961|NCT01674569|449242909|FG004|Overall Study|Protocol Violation|0|||
124895962|NCT01674569|449242910|FG005|Overall Study|Protocol Violation|0|||
124895963|NCT01674569|449242905|FG000|Overall Study|Withdrawal by Subject|0|||
124895964|NCT01674569|449242906|FG001|Overall Study|Withdrawal by Subject|0|||
124895965|NCT01674569|449242907|FG002|Overall Study|Withdrawal by Subject|1|||
124895966|NCT01674569|449242908|FG003|Overall Study|Withdrawal by Subject|0|||
124895967|NCT01674569|449242909|FG004|Overall Study|Withdrawal by Subject|0|||
124895968|NCT01674569|449242910|FG005|Overall Study|Withdrawal by Subject|0|||
124895969|NCT01119703|449242914|FG000|Overall Study|Adverse Event|0|||
124895970|NCT01119703|449242915|FG001|Overall Study|Adverse Event|1|||
124895971|NCT02096003|449242916|FG000|Overall Study|Protocol Violation|0|||
124895972|NCT02096003|449242917|FG001|Overall Study|Protocol Violation|2|||
124895973|NCT02096003|449242916|FG000|Overall Study|additional surgery|2|||
124895974|NCT02096003|449242917|FG001|Overall Study|additional surgery|1|||
124895975|NCT01763047|449242920|FG000|Period 1|Test Article Not Available|4|||
124895976|NCT01763047|449242921|FG001|Period 1|Test Article Not Available|1|||
124895977|NCT01763047|449242920|FG000|Period 1|Protocol Violation|4|||
124895978|NCT01763047|449242921|FG001|Period 1|Protocol Violation|4|||
124895979|NCT01763047|449242920|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
124895980|NCT01763047|449242921|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
124444615|NCT01284062|447590256|FG000|Overall Study|Withdrawal by Subject|3|||
124444616|NCT01284062|447590257|FG001|Overall Study|Withdrawal by Subject|1|||
124444617|NCT01284062|447590258|FG002|Overall Study|Withdrawal by Subject|2|||
124444618|NCT01284062|447590259|FG003|Overall Study|Withdrawal by Subject|5|||
124444619|NCT01284062|447590256|FG000|Overall Study|Other|0|||
124444620|NCT01284062|447590257|FG001|Overall Study|Other|0|||
124444621|NCT01284062|447590258|FG002|Overall Study|Other|0|||
124444622|NCT01284062|447590259|FG003|Overall Study|Other|1|||
124444623|NCT01284062|447590256|FG000|Overall Study|Site Closed|0|||
124444624|NCT01284062|447590257|FG001|Overall Study|Site Closed|0|||
124444625|NCT01284062|447590258|FG002|Overall Study|Site Closed|1|||
124444626|NCT01284062|447590259|FG003|Overall Study|Site Closed|0|||
124444627|NCT00559585|447590260|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
124444628|NCT00559585|447590261|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
124444629|NCT00559585|447590260|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
124444630|NCT00559585|447590261|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
124444631|NCT00559585|447590260|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
124444632|NCT00559585|447590261|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
124444633|NCT00559585|447590260|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
124444634|NCT00559585|447590261|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
124444635|NCT00559585|447590260|FG000|Double Blind ST Period Main Study|Death|1|||
124444636|NCT00559585|447590261|FG001|Double Blind ST Period Main Study|Death|1|||
124444637|NCT00559585|447590260|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
124895981|NCT01763047|449242920|FG000|Period 1|Adverse Event|0|||
124895982|NCT01763047|449242921|FG001|Period 1|Adverse Event|1|||
124895983|NCT01763047|449242920|FG000|Period 1|Unsatisfactory Visual Response|0|||
124895984|NCT01763047|449242921|FG001|Period 1|Unsatisfactory Visual Response|3|||
124895985|NCT01763047|449242920|FG000|Period 1|Lens Power Not Available|0|||
124895986|NCT01763047|449242921|FG001|Period 1|Lens Power Not Available|1|||
124895987|NCT01763047|449242920|FG000|Period 1|Study Site office Closed|0|||
124895988|NCT01763047|449242921|FG001|Period 1|Study Site office Closed|1|||
124895989|NCT01763047|449242920|FG000|Period 2|Lens Discomfort|1|||
124895990|NCT01763047|449242921|FG001|Period 2|Lens Discomfort|0|||
124895991|NCT01763047|449242920|FG000|Period 2|No longer meets Eligibility Criteria|1|||
124895992|NCT01763047|449242921|FG001|Period 2|No longer meets Eligibility Criteria|0|||
124895993|NCT01763047|449242920|FG000|Period 2|Study Site office Closed|1|||
124895994|NCT01763047|449242921|FG001|Period 2|Study Site office Closed|1|||
124895995|NCT01763047|449242920|FG000|Period 2|Unsatisfactory Visual Response|1|||
124895996|NCT01763047|449242921|FG001|Period 2|Unsatisfactory Visual Response|1|||
124444638|NCT00559585|447590261|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
124444639|NCT00559585|447590260|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
124444640|NCT00559585|447590261|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
124444641|NCT00559585|447590260|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
124444642|NCT00559585|447590261|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
124444643|NCT00559585|447590260|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
124444644|NCT00559585|447590261|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
124444645|NCT00559585|447590260|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
124444646|NCT00559585|447590261|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
124759353|NCT00452790|448742620|FG000|Infant Series|Investigator request|0|||
124444647|NCT00559585|447590260|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
124444648|NCT00559585|447590261|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
124444649|NCT00559585|447590260|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
124444650|NCT00559585|447590261|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
124444651|NCT00559585|447590260|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
124444652|NCT00559585|447590261|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
124444653|NCT00559585|447590260|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
124759354|NCT00452790|448742621|FG001|Infant Series|Investigator request|1|||
124895997|NCT01763047|449242920|FG000|Period 2|Protocol Violation|0|||
124895998|NCT01763047|449242921|FG001|Period 2|Protocol Violation|2|||
124444654|NCT00559585|447590261|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
124759355|NCT00452790|448742620|FG000|Infant Series|Death|0|||
124759356|NCT00452790|448742621|FG001|Infant Series|Death|1|||
124759357|NCT00452790|448742620|FG000|After Infant Series|Investigator request|10|||
124759358|NCT00452790|448742621|FG001|After Infant Series|Investigator request|10|||
124895999|NCT01763047|449242920|FG000|Period 2|Unsatisfactory lens Fitting|0|||
124896000|NCT01763047|449242921|FG001|Period 2|Unsatisfactory lens Fitting|1|||
124896001|NCT00916006|449242924|FG000|Overall Study|Adverse Event|1|||
124896002|NCT00916006|449242925|FG001|Overall Study|Adverse Event|1|||
124896003|NCT00916006|449242924|FG000|Overall Study|Withdrawal by Subject|2|||
124896004|NCT00916006|449242925|FG001|Overall Study|Withdrawal by Subject|5|||
124896005|NCT00916006|449242924|FG000|Overall Study|Protocol Violation|0|||
124896006|NCT00916006|449242925|FG001|Overall Study|Protocol Violation|1|||
124896007|NCT01222247|449242931|FG000|Overall Study|Lost to Follow-up|2|||
124896008|NCT01222247|449242932|FG001|Overall Study|Lost to Follow-up|2|||
124896009|NCT04639947|449242933|FG000|Overall Study|Screen fail|1|||
124896010|NCT00877851|449242935|FG000|Overall Study|Lost to Follow-up|5|||
124896011|NCT00877851|449242936|FG001|Overall Study|Lost to Follow-up|5|||
124896012|NCT00877851|449242935|FG000|Overall Study|computer problem|3|||
124896013|NCT00877851|449242936|FG001|Overall Study|computer problem|0|||
124896014|NCT00877851|449242935|FG000|Overall Study|no longer interested in participating|1|||
124896015|NCT00877851|449242936|FG001|Overall Study|no longer interested in participating|0|||
124896016|NCT03424239|449242937|FG000|Overall Study|Withdrawal by Subject|2|||
124896017|NCT02042443|449242945|FG000|Overall Study|Adverse Event|2|||
124896018|NCT02042443|449242946|FG001|Overall Study|Adverse Event|1|||
124896019|NCT02042443|449242945|FG000|Overall Study|Withdrawal by Subject|0|||
124896020|NCT02042443|449242946|FG001|Overall Study|Withdrawal by Subject|1|||
124896021|NCT02042443|449242945|FG000|Overall Study|Progression|21|||
124896022|NCT02042443|449242946|FG001|Overall Study|Progression|17|||
124896023|NCT02042443|449242945|FG000|Overall Study|not protocol specified|1|||
124896024|NCT02042443|449242946|FG001|Overall Study|not protocol specified|1|||
124896025|NCT02042443|449242945|FG000|Overall Study|Not eligible/not analyzable|3|||
124896026|NCT02042443|449242946|FG001|Overall Study|Not eligible/not analyzable|6|||
124896027|NCT02320253|449242947|FG000|Overall Study|Withdrawal by Subject|3|||
124896028|NCT02320253|449242948|FG001|Overall Study|Withdrawal by Subject|0|||
124896029|NCT02320253|449242949|FG002|Overall Study|Withdrawal by Subject|0|||
124896030|NCT02320253|449242947|FG000|Overall Study|Lost to Follow-up|2|||
124896031|NCT02320253|449242948|FG001|Overall Study|Lost to Follow-up|2|||
124896032|NCT02320253|449242949|FG002|Overall Study|Lost to Follow-up|1|||
124896033|NCT02320253|449242947|FG000|Overall Study|Death|1|||
124896034|NCT02320253|449242948|FG001|Overall Study|Death|0|||
124896035|NCT02320253|449242949|FG002|Overall Study|Death|1|||
124896036|NCT04794179|449242950|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
124896037|NCT04794179|449242951|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
124896038|NCT05550337|449242954|FG000|Overall Study|Lack of Efficacy|0|||
124896039|NCT05550337|449242955|FG001|Overall Study|Lack of Efficacy|0|||
124896040|NCT05550337|449242956|FG002|Overall Study|Lack of Efficacy|1|||
124896041|NCT05550337|449242954|FG000|Overall Study|Adverse Event|1|||
124896042|NCT05550337|449242955|FG001|Overall Study|Adverse Event|5|||
124444655|NCT00559585|447590260|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
124444656|NCT00559585|447590261|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
124444657|NCT00559585|447590260|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
124444658|NCT00559585|447590261|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
124444659|NCT00559585|447590260|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
124444660|NCT00559585|447590261|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
124444661|NCT00559585|447590260|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
124444662|NCT00559585|447590261|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
124444663|NCT00559585|447590260|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
124444664|NCT00559585|447590261|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
124444665|NCT00559585|447590260|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
124444666|NCT00559585|447590261|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
124444667|NCT00559585|447590260|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
124444668|NCT00559585|447590261|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
124444669|NCT00559585|447590260|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
124444670|NCT00559585|447590261|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
124444671|NCT00559585|447590260|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
124444672|NCT00559585|447590261|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
124444673|NCT00559585|447590260|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
124444674|NCT00559585|447590261|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
124444675|NCT00559585|447590260|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
124444676|NCT00559585|447590261|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
124444677|NCT00559585|447590260|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
124688389|NCT03301714|448477533|FG001|Overall Study|Did not receive allocated intervention|2|||
124688390|NCT03301714|448477534|FG002|Overall Study|Did not receive allocated intervention|3|||
124688391|NCT00544882|448477548|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
124896043|NCT05550337|449242956|FG002|Overall Study|Adverse Event|0|||
124896044|NCT05550337|449242954|FG000|Overall Study|Withdrawal by Subject|8|||
124896045|NCT05550337|449242955|FG001|Overall Study|Withdrawal by Subject|14|||
124896046|NCT05550337|449242956|FG002|Overall Study|Withdrawal by Subject|10|||
124896047|NCT05550337|449242954|FG000|Overall Study|Pregnancy|0|||
124896048|NCT05550337|449242955|FG001|Overall Study|Pregnancy|0|||
124896049|NCT05550337|449242956|FG002|Overall Study|Pregnancy|1|||
124896050|NCT05550337|449242954|FG000|Overall Study|Protocol Violation|1|||
124688392|NCT00544882|448477549|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
124688393|NCT00544882|448477550|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
124688394|NCT00544882|448477548|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
124688395|NCT00544882|448477549|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
124688396|NCT00544882|448477550|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
124688397|NCT00544882|448477548|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
124688398|NCT00544882|448477549|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
124688399|NCT00544882|448477550|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
124688400|NCT00544882|448477548|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
124688401|NCT00544882|448477549|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
124688402|NCT00544882|448477550|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
124688403|NCT00544882|448477548|FG000|Cycle 3: Follow-up|Noncompliance|0|||
124688404|NCT00544882|448477549|FG001|Cycle 3: Follow-up|Noncompliance|1|||
124688405|NCT00544882|448477550|FG002|Cycle 3: Follow-up|Noncompliance|0|||
124688406|NCT00544882|448477548|FG000|Cycle 3: Follow-up|Pregnancy|0|||
124688407|NCT00544882|448477549|FG001|Cycle 3: Follow-up|Pregnancy|1|||
124688408|NCT00544882|448477550|FG002|Cycle 3: Follow-up|Pregnancy|0|||
124688409|NCT01127061|448478707|FG000|Overall Study|Lost to Follow-up|7|||
124896051|NCT05550337|449242955|FG001|Overall Study|Protocol Violation|3|||
124896052|NCT05550337|449242956|FG002|Overall Study|Protocol Violation|4|||
124896053|NCT05550337|449242954|FG000|Overall Study|Physician Decision|2|||
124688410|NCT01127061|448478708|FG001|Overall Study|Lost to Follow-up|10|||
124688411|NCT01127061|448478707|FG000|Overall Study|Physician Decision|3|||
124688412|NCT01127061|448478708|FG001|Overall Study|Physician Decision|3|||
124688413|NCT00003456|448478709|FG000|Overall Study|Not evaluable|8|||
124688414|NCT00479232|448478710|FG000|Overall Study|Adverse Event|0|||
124688415|NCT00479232|448478711|FG001|Overall Study|Adverse Event|0|||
124688416|NCT00479232|448478712|FG002|Overall Study|Adverse Event|5|||
124688417|NCT00479232|448478713|FG003|Overall Study|Adverse Event|0|||
124688418|NCT00479232|448478714|FG004|Overall Study|Adverse Event|0|||
124688419|NCT00479232|448478715|FG005|Overall Study|Adverse Event|10|||
124688420|NCT00479232|448478710|FG000|Overall Study|Deviation from Protocol|0|||
124688421|NCT00479232|448478711|FG001|Overall Study|Deviation from Protocol|0|||
124688422|NCT00479232|448478712|FG002|Overall Study|Deviation from Protocol|1|||
124688423|NCT00479232|448478713|FG003|Overall Study|Deviation from Protocol|0|||
124688424|NCT00479232|448478714|FG004|Overall Study|Deviation from Protocol|0|||
124688425|NCT00479232|448478715|FG005|Overall Study|Deviation from Protocol|0|||
124688426|NCT00479232|448478710|FG000|Overall Study|Lack of Efficacy|0|||
124688427|NCT00479232|448478711|FG001|Overall Study|Lack of Efficacy|0|||
124688428|NCT00479232|448478712|FG002|Overall Study|Lack of Efficacy|2|||
124688429|NCT00479232|448478713|FG003|Overall Study|Lack of Efficacy|0|||
124688430|NCT00479232|448478714|FG004|Overall Study|Lack of Efficacy|0|||
124688431|NCT00479232|448478715|FG005|Overall Study|Lack of Efficacy|4|||
124688432|NCT00479232|448478710|FG000|Overall Study|Physician Decision|0|||
124688433|NCT00479232|448478711|FG001|Overall Study|Physician Decision|0|||
124896054|NCT05550337|449242955|FG001|Overall Study|Physician Decision|1|||
124896055|NCT05550337|449242956|FG002|Overall Study|Physician Decision|1|||
124896056|NCT05550337|449242954|FG000|Overall Study|Lost to Follow-up|16|||
124896057|NCT05550337|449242955|FG001|Overall Study|Lost to Follow-up|11|||
124896058|NCT05550337|449242956|FG002|Overall Study|Lost to Follow-up|11|||
124896059|NCT03115346|449242958|FG000|Overall Study|Did not have AAA surgery|28|||
124896060|NCT03115346|449242959|FG001|Overall Study|Did not have AAA surgery|15|||
124896061|NCT03115346|449242958|FG000|Overall Study|Death|3|||
124896062|NCT03115346|449242959|FG001|Overall Study|Death|1|||
124896063|NCT03115346|449242958|FG000|Overall Study|Withdrawal by Subject|0|||
124896064|NCT03115346|449242959|FG001|Overall Study|Withdrawal by Subject|3|||
124896065|NCT03115346|449242958|FG000|Overall Study|Lost to Follow-up|0|||
124896066|NCT03115346|449242959|FG001|Overall Study|Lost to Follow-up|3|||
124896067|NCT01140347|449242961|FG000|Overall Study|Lost to Follow-up|5|||
124896068|NCT01140347|449242962|FG001|Overall Study|Lost to Follow-up|6|||
124896069|NCT01140347|449242961|FG000|Overall Study|Withdrawal by Subject|13|||
124896070|NCT01140347|449242962|FG001|Overall Study|Withdrawal by Subject|8|||
124896071|NCT00828919|449242963|FG000|Overall Study|Death|0|||
124896072|NCT00828919|449242964|FG001|Overall Study|Death|1|||
124896073|NCT00828919|449242965|FG002|Overall Study|Death|2|||
124688434|NCT00479232|448478712|FG002|Overall Study|Physician Decision|2|||
124688435|NCT00479232|448478713|FG003|Overall Study|Physician Decision|0|||
124896074|NCT00828919|449242966|FG003|Overall Study|Death|0|||
124896075|NCT00828919|449242967|FG004|Overall Study|Death|0|||
124896076|NCT00828919|449242963|FG000|Overall Study|Adverse Event|2|||
124896077|NCT00828919|449242964|FG001|Overall Study|Adverse Event|2|||
124688436|NCT00479232|448478714|FG004|Overall Study|Physician Decision|0|||
124688437|NCT00479232|448478715|FG005|Overall Study|Physician Decision|1|||
124688438|NCT00479232|448478710|FG000|Overall Study|Progressive Disease|3|||
124688439|NCT00479232|448478711|FG001|Overall Study|Progressive Disease|1|||
124688440|NCT00479232|448478712|FG002|Overall Study|Progressive Disease|12|||
124688441|NCT00479232|448478713|FG003|Overall Study|Progressive Disease|3|||
124688442|NCT00479232|448478714|FG004|Overall Study|Progressive Disease|3|||
124688443|NCT00479232|448478715|FG005|Overall Study|Progressive Disease|12|||
124688444|NCT00479232|448478710|FG000|Overall Study|Withdrew Consent|0|||
124688445|NCT00479232|448478711|FG001|Overall Study|Withdrew Consent|2|||
124688446|NCT00479232|448478712|FG002|Overall Study|Withdrew Consent|6|||
124688447|NCT00479232|448478713|FG003|Overall Study|Withdrew Consent|0|||
124688448|NCT00479232|448478714|FG004|Overall Study|Withdrew Consent|1|||
124688449|NCT00479232|448478715|FG005|Overall Study|Withdrew Consent|3|||
124688450|NCT01373229|448478716|FG000|Overall Study|Death|3|||
124688451|NCT01373229|448478716|FG000|Overall Study|Physician Decision|3|||
124688452|NCT00143507|448478718|FG000|Overall Study|Death|572|||
124688453|NCT00143507|448478719|FG001|Overall Study|Death|547|||
124688454|NCT00143507|448478718|FG000|Overall Study|Withdrawal by Subject|114|||
124688455|NCT00143507|448478719|FG001|Overall Study|Withdrawal by Subject|102|||
124688456|NCT00143507|448478718|FG000|Overall Study|Lost to Follow-up|1|||
124688457|NCT00143507|448478719|FG001|Overall Study|Lost to Follow-up|0|||
124688458|NCT00143507|448478718|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
124688459|NCT00143507|448478719|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
124688460|NCT01991314|448478720|FG000|Overall Study|Adverse Event|5|||
124688461|NCT01991314|448478721|FG001|Overall Study|Adverse Event|1|||
124688462|NCT01991314|448478720|FG000|Overall Study|Lost to Follow-up|6|||
124688463|NCT01991314|448478721|FG001|Overall Study|Lost to Follow-up|10|||
124688464|NCT01033942|448478722|FG000|Overall Study|Withdrawal by Subject|1|||
124688465|NCT01033942|448478723|FG001|Overall Study|Withdrawal by Subject|1|||
124688466|NCT01033942|448478724|FG002|Overall Study|Withdrawal by Subject|1|||
124688467|NCT01033942|448478722|FG000|Overall Study|Lost to Follow-up|1|||
124688468|NCT01033942|448478723|FG001|Overall Study|Lost to Follow-up|0|||
124688469|NCT01033942|448478724|FG002|Overall Study|Lost to Follow-up|0|||
124688470|NCT01033942|448478722|FG000|Overall Study|Enrolled in Extension Study|0|||
124688471|NCT01033942|448478723|FG001|Overall Study|Enrolled in Extension Study|3|||
124688472|NCT01033942|448478724|FG002|Overall Study|Enrolled in Extension Study|0|||
124688473|NCT01793935|448478727|FG000|Overall Study|Pregnancy|1|||
124688474|NCT01793935|448478728|FG001|Overall Study|Pregnancy|0|||
124688475|NCT01793935|448478727|FG000|Overall Study|Protocol Violation|2|||
124688476|NCT01793935|448478728|FG001|Overall Study|Protocol Violation|1|||
124688477|NCT01793935|448478727|FG000|Overall Study|Adverse Event|2|||
124688478|NCT01793935|448478728|FG001|Overall Study|Adverse Event|0|||
124688479|NCT01793935|448478727|FG000|Overall Study|Patient did not take study medication|1|||
124688480|NCT01793935|448478728|FG001|Overall Study|Patient did not take study medication|1|||
124688481|NCT01793935|448478727|FG000|Overall Study|Lost to Follow-up|0|||
124688482|NCT01793935|448478728|FG001|Overall Study|Lost to Follow-up|1|||
124688483|NCT04900272|448478729|FG000|Overall Study|Lost to Follow-up|2|||
124688484|NCT04900272|448478729|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
124688485|NCT04900272|448478729|FG000|Overall Study|Withdrawal by Subject|1|||
124688486|NCT05059080|448478731|FG000|Overall Study|Withdrawal by Subject|3|||
124688487|NCT05059080|448478731|FG000|Overall Study|Study Terminated by Sponsor|64|||
124688488|NCT05607043|448478732|FG000|Overall Study|Lost to Follow-up|2|||
124688489|NCT00800540|448478736|FG000|Period One: 6 Weeks|Noncompliance|1|||
124688490|NCT00800540|448478737|FG001|Period One: 6 Weeks|Noncompliance|0|||
124688491|NCT00800540|448478736|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
124688492|NCT00800540|448478737|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
124688493|NCT00800540|448478736|FG000|Period 2: 6 Weeks|Adverse Event|0|||
124688494|NCT00800540|448478737|FG001|Period 2: 6 Weeks|Adverse Event|1|||
124688495|NCT02447029|448478740|FG000|Overall Study|Withdrawal by Subject|3|||
124688496|NCT02447029|448478741|FG001|Overall Study|Withdrawal by Subject|2|||
124688497|NCT00549328|448478742|FG000|Overall Study|Adverse Event|2|||
124688498|NCT00549328|448478742|FG000|Overall Study|Disease Progression|10|||
124688499|NCT00549328|448478742|FG000|Overall Study|Death|1|||
124688500|NCT00549328|448478742|FG000|Overall Study|Use of Prohibited Medication|1|||
124688501|NCT00770484|448478743|FG000|Overall Study|Withdrawal by Subject|1|||
124688502|NCT00770484|448478744|FG001|Overall Study|Withdrawal by Subject|0|||
124688503|NCT03097315|448478749|FG000|Overall Study|Withdrawal by Subject|1|||
124688504|NCT01946802|448478750|FG000|Overall Study|Death|1|||
124688505|NCT01946802|448478750|FG000|Overall Study|Withdrawal by Subject|2|||
124688506|NCT01946802|448478750|FG000|Overall Study|Combined septic shock|1|||
124688507|NCT01946802|448478750|FG000|Overall Study|Protocol Violation|1|||
124688508|NCT04327271|448478751|FG000|Overall Study|Death|1|||
124688509|NCT04327271|448478752|FG001|Overall Study|Death|0|||
124688510|NCT04327271|448478751|FG000|Overall Study|Withdrawal by Subject|1|||
124688511|NCT04327271|448478752|FG001|Overall Study|Withdrawal by Subject|0|||
124688512|NCT04327271|448478751|FG000|Overall Study|randomization error (data capture)|4|||
124688513|NCT04327271|448478752|FG001|Overall Study|randomization error (data capture)|3|||
124688514|NCT03637374|448478753|FG000|Overall Study|Death|2|||
124688515|NCT03637374|448478754|FG001|Overall Study|Death|0|||
124688516|NCT01479530|448478756|FG000|Overall Study|Adverse Event|5|||
124688517|NCT01479530|448478757|FG001|Overall Study|Adverse Event|6|||
124688518|NCT01479530|448478756|FG000|Overall Study|Lack of Efficacy|0|||
124688519|NCT01479530|448478757|FG001|Overall Study|Lack of Efficacy|1|||
124688520|NCT01479530|448478756|FG000|Overall Study|Protocol Violation|2|||
124688521|NCT01479530|448478757|FG001|Overall Study|Protocol Violation|3|||
124688522|NCT01479530|448478756|FG000|Overall Study|Withdrawal of Consent|3|||
124688523|NCT01479530|448478757|FG001|Overall Study|Withdrawal of Consent|2|||
124688524|NCT00303628|448478758|FG000|Overall Study|Disease progression|0|||
124688525|NCT00303628|448478759|FG001|Overall Study|Disease progression|1|||
124688526|NCT00303628|448478758|FG000|Overall Study|Adverse Event|26|||
124688527|NCT00303628|448478759|FG001|Overall Study|Adverse Event|36|||
124688528|NCT00303628|448478758|FG000|Overall Study|Death|0|||
124444678|NCT00559585|447590261|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
124444679|NCT00559585|447590260|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
124444680|NCT00559585|447590261|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
124444681|NCT00559585|447590260|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
124444682|NCT00559585|447590261|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
124444683|NCT01717768|447590263|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124444684|NCT01717768|447590264|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
124444685|NCT01717768|447590265|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124444686|NCT01717768|447590266|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124444687|NCT01717768|447590267|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124444688|NCT01717768|447590268|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124444689|NCT01717768|447590269|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124444690|NCT01717768|447590270|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124444691|NCT01717768|447590271|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124444692|NCT01717768|447590272|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124444693|NCT01717768|447590273|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124444694|NCT01717768|447590274|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
124444695|NCT01717768|447590263|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124444696|NCT01717768|447590264|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124444697|NCT01717768|447590265|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124444698|NCT01717768|447590266|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124444699|NCT01717768|447590267|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124444700|NCT01717768|447590268|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124688529|NCT00303628|448478759|FG001|Overall Study|Death|1|||
124688530|NCT00303628|448478758|FG000|Overall Study|Withdrawal by Subject|11|||
124688531|NCT00303628|448478759|FG001|Overall Study|Withdrawal by Subject|20|||
124688532|NCT00303628|448478758|FG000|Overall Study|Alternative therapy|2|||
124688533|NCT00303628|448478759|FG001|Overall Study|Alternative therapy|0|||
124688534|NCT00303628|448478758|FG000|Overall Study|Other complicating disease|0|||
124688535|NCT00303628|448478759|FG001|Overall Study|Other complicating disease|1|||
124688536|NCT00303628|448478758|FG000|Overall Study|Not start protocol therapy|3|||
124688537|NCT00303628|448478759|FG001|Overall Study|Not start protocol therapy|5|||
124688538|NCT00303628|448478758|FG000|Overall Study|Other|8|||
124688539|NCT00303628|448478759|FG001|Overall Study|Other|9|||
124688540|NCT00376506|448478760|FG000|Overall Study|Death|0|||
124688541|NCT00376506|448478761|FG001|Overall Study|Death|2|||
124688542|NCT00776997|448478763|FG000|Overall Study|Adverse Event|2|||
124688543|NCT02948400|448478764|FG000|Overall Study|Withdrawal by Subject|17|||
124688544|NCT02948400|448478765|FG001|Overall Study|Withdrawal by Subject|10|||
124688545|NCT02948400|448478764|FG000|Overall Study|failed to attend appointments|47|||
124688546|NCT02948400|448478765|FG001|Overall Study|failed to attend appointments|34|||
124688547|NCT02948400|448478764|FG000|Overall Study|COVID-related closure|6|||
124688548|NCT02948400|448478765|FG001|Overall Study|COVID-related closure|2|||
124688549|NCT02948400|448478764|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
124688550|NCT02948400|448478765|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
124688551|NCT02948400|448478764|FG000|Overall Study|motion sickness in virtual reality|2|||
124688552|NCT02948400|448478765|FG001|Overall Study|motion sickness in virtual reality|0|||
124688553|NCT02403271|448478766|FG000|Period 1|Other varied reasons|1|||
124688554|NCT02403271|448478767|FG001|Period 1|Other varied reasons|0|||
124688555|NCT02403271|448478766|FG000|Period 2|Withdrawal by Subject|0|||
124688556|NCT02403271|448478767|FG001|Period 2|Withdrawal by Subject|14|||
124688557|NCT02403271|448478766|FG000|Period 2|Death|0|||
124688558|NCT02403271|448478767|FG001|Period 2|Death|84|||
124688559|NCT02403271|448478766|FG000|Period 2|Lost to Follow-up|0|||
124688560|NCT02403271|448478767|FG001|Period 2|Lost to Follow-up|2|||
124688561|NCT02403271|448478766|FG000|Period 2|Study Terminated by Sponsor|0|||
124688562|NCT02403271|448478767|FG001|Period 2|Study Terminated by Sponsor|14|||
124688563|NCT02403271|448478766|FG000|Period 2|Other varied reasons|0|||
124688564|NCT02403271|448478767|FG001|Period 2|Other varied reasons|10|||
124896078|NCT00828919|449242965|FG002|Overall Study|Adverse Event|2|||
124896079|NCT00828919|449242966|FG003|Overall Study|Adverse Event|1|||
124896080|NCT00828919|449242967|FG004|Overall Study|Adverse Event|3|||
124896081|NCT00828919|449242963|FG000|Overall Study|Objective progression or relapse|4|||
124896082|NCT00828919|449242964|FG001|Overall Study|Objective progression or relapse|4|||
124896083|NCT00828919|449242965|FG002|Overall Study|Objective progression or relapse|11|||
124896084|NCT00828919|449242966|FG003|Overall Study|Objective progression or relapse|0|||
124896085|NCT00828919|449242967|FG004|Overall Study|Objective progression or relapse|5|||
124896086|NCT00828919|449242963|FG000|Overall Study|No longer willing to participate in study|0|||
124896087|NCT00828919|449242964|FG001|Overall Study|No longer willing to participate in study|0|||
124896088|NCT00828919|449242965|FG002|Overall Study|No longer willing to participate in study|2|||
124896089|NCT00828919|449242966|FG003|Overall Study|No longer willing to participate in study|0|||
124896090|NCT00828919|449242967|FG004|Overall Study|No longer willing to participate in study|0|||
124896091|NCT00828919|449242963|FG000|Overall Study|Insufficient Clinical Response|0|||
124896092|NCT00828919|449242964|FG001|Overall Study|Insufficient Clinical Response|1|||
124896093|NCT00828919|449242965|FG002|Overall Study|Insufficient Clinical Response|2|||
124896094|NCT00828919|449242966|FG003|Overall Study|Insufficient Clinical Response|0|||
124896095|NCT00828919|449242967|FG004|Overall Study|Insufficient Clinical Response|0|||
124896096|NCT00828919|449242963|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
124896097|NCT00828919|449242964|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
124896098|NCT00828919|449242965|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
124896099|NCT00828919|449242966|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
124896100|NCT00828919|449242967|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
124896101|NCT00828919|449242963|FG000|Overall Study|Other|1|||
124896102|NCT00828919|449242964|FG001|Overall Study|Other|0|||
124896103|NCT00828919|449242965|FG002|Overall Study|Other|1|||
124896104|NCT00828919|449242966|FG003|Overall Study|Other|1|||
124896105|NCT00828919|449242967|FG004|Overall Study|Other|0|||
124896106|NCT00828919|449242963|FG000|Overall Study|Lost to Follow-up|0|||
124896107|NCT00828919|449242964|FG001|Overall Study|Lost to Follow-up|1|||
124896108|NCT00828919|449242965|FG002|Overall Study|Lost to Follow-up|0|||
124896109|NCT00828919|449242966|FG003|Overall Study|Lost to Follow-up|0|||
124896110|NCT00828919|449242967|FG004|Overall Study|Lost to Follow-up|0|||
124896111|NCT02501811|449242969|FG000|Overall Study|Death|1|||
124896112|NCT02501811|449242970|FG001|Overall Study|Death|3|||
124896113|NCT02501811|449242971|FG002|Overall Study|Death|2|||
124896114|NCT02501811|449242972|FG003|Overall Study|Death|3|||
124896115|NCT02501811|449242969|FG000|Overall Study|Withdrawal by Subject|3|||
124896116|NCT02501811|449242970|FG001|Overall Study|Withdrawal by Subject|3|||
124444701|NCT01717768|447590269|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124444702|NCT01717768|447590270|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124444703|NCT01717768|447590271|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124444704|NCT01717768|447590272|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124444705|NCT01717768|447590273|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
124444706|NCT01717768|447590274|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
124444707|NCT01717768|447590263|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124444708|NCT01717768|447590264|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124444709|NCT01717768|447590265|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124444710|NCT01717768|447590266|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124444711|NCT01717768|447590267|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124444712|NCT01717768|447590268|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124444713|NCT01717768|447590269|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124444714|NCT01717768|447590270|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
124444715|NCT01717768|447590271|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124444716|NCT01717768|447590272|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124444717|NCT01717768|447590273|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124444718|NCT01717768|447590274|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
124444719|NCT01717768|447590263|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124444720|NCT01717768|447590264|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124444721|NCT01717768|447590265|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124688565|NCT03487445|448478768|FG000|Randomization|Not treated for administrative reasons|1|||
124896117|NCT02501811|449242971|FG002|Overall Study|Withdrawal by Subject|2|||
124896118|NCT02501811|449242972|FG003|Overall Study|Withdrawal by Subject|3|||
124896119|NCT02501811|449242969|FG000|Overall Study|Lost to Follow-up|0|||
124896120|NCT02501811|449242970|FG001|Overall Study|Lost to Follow-up|0|||
124896121|NCT02501811|449242971|FG002|Overall Study|Lost to Follow-up|2|||
124896122|NCT02501811|449242972|FG003|Overall Study|Lost to Follow-up|1|||
124896123|NCT01124162|449244652|FG000|First Intervention|Adverse Event|2|||
124896124|NCT01124162|449244653|FG001|First Intervention|Adverse Event|0|||
124896125|NCT01124162|449244652|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
124896126|NCT01124162|449244653|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
124896127|NCT02680756|449244654|FG000|Overall Study|Adverse Event|10|||
124896128|NCT02680756|449244655|FG001|Overall Study|Adverse Event|2|||
124896129|NCT02680756|449244654|FG000|Overall Study|Lost to Follow-up|7|||
124896130|NCT02680756|449244655|FG001|Overall Study|Lost to Follow-up|6|||
124896131|NCT02680756|449244654|FG000|Overall Study|Withdrawal by Subject|5|||
124896132|NCT02680756|449244655|FG001|Overall Study|Withdrawal by Subject|5|||
124896133|NCT02680756|449244654|FG000|Overall Study|Physician Decision|4|||
124896134|NCT02680756|449244655|FG001|Overall Study|Physician Decision|1|||
124896135|NCT02680756|449244654|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
124896136|NCT02680756|449244655|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
124896137|NCT02680756|449244654|FG000|Overall Study|Blood transfusion for any reason|0|||
124896138|NCT02680756|449244655|FG001|Overall Study|Blood transfusion for any reason|1|||
124896139|NCT02680756|449244654|FG000|Overall Study|Death|1|||
124896140|NCT02680756|449244655|FG001|Overall Study|Death|0|||
124896141|NCT02680756|449244654|FG000|Overall Study|Protocol Violation|1|||
124896142|NCT02680756|449244655|FG001|Overall Study|Protocol Violation|0|||
124896143|NCT02680756|449244654|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
124896144|NCT02680756|449244655|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
124896145|NCT02680756|449244654|FG000|Overall Study|None of above or not recorded|3|||
124896146|NCT02680756|449244655|FG001|Overall Study|None of above or not recorded|2|||
124896147|NCT03613129|449244656|FG000|Pre-treatment Assessment|Protocol Violation|2|||
124896148|NCT03613129|449244657|FG001|Pre-treatment Assessment|Protocol Violation|0|||
124896149|NCT03613129|449244658|FG002|Pre-treatment Assessment|Protocol Violation|0|||
124444722|NCT01717768|447590266|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124444723|NCT01717768|447590267|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124444724|NCT01717768|447590268|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124444725|NCT01717768|447590269|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124444726|NCT01717768|447590270|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124444727|NCT01717768|447590271|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124444728|NCT01717768|447590272|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
124444729|NCT01717768|447590273|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124444730|NCT01717768|447590274|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
124444731|NCT04195581|447590277|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
124444732|NCT04195581|447590277|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
124444733|NCT04195581|447590277|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
124444734|NCT04195581|447590277|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
124444735|NCT04195581|447590277|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
124444736|NCT04195581|447590277|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
124444737|NCT01237340|447590282|FG000|Overall Study|Adverse Event|3|||
124444738|NCT01237340|447590282|FG000|Overall Study|Withdrawal by Subject|1|||
124444739|NCT01237340|447590282|FG000|Overall Study|Early termination of the trial|36|||
124444740|NCT01906346|447590283|FG000|Overall Study|AEs|1|||
124444741|NCT04226833|447590284|FG000|Overall Study|Death|0|||
124896150|NCT03613129|449244659|FG003|Pre-treatment Assessment|Protocol Violation|0|||
124444742|NCT04226833|447590285|FG001|Overall Study|Death|0|||
124444743|NCT04226833|447590286|FG002|Overall Study|Death|1|||
124444744|NCT04226833|447590287|FG003|Overall Study|Death|0|||
124444745|NCT02876835|447590290|FG000|Treatment Period (51.1 Month)|Other|1|||
124444746|NCT02876835|447590291|FG001|Treatment Period (51.1 Month)|Other|0|||
124444747|NCT02876835|447590290|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
124444748|NCT02876835|447590291|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
124444749|NCT02876835|447590290|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
124444750|NCT02876835|447590291|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
124444751|NCT02876835|447590290|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
124444752|NCT02876835|447590291|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
124444753|NCT02540538|447590292|FG000|Overall Study|Pregnancy|0|||
124444754|NCT02540538|447590293|FG001|Overall Study|Pregnancy|1|||
124444755|NCT02540538|447590294|FG002|Overall Study|Pregnancy|0|||
124444756|NCT00403754|447590295|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
124444757|NCT00403754|447590296|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
124896151|NCT03613129|449244660|FG004|Pre-treatment Assessment|Protocol Violation|0|||
124896152|NCT03613129|449244656|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
124444758|NCT00403754|447590297|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
124444759|NCT00403754|447590298|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
124444760|NCT00403754|447590295|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
124896153|NCT03613129|449244657|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
124896154|NCT03613129|449244658|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
124896155|NCT03613129|449244659|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
124896156|NCT03613129|449244660|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
124896157|NCT00938340|449244661|FG000|Overall Study|Withdrawal by Subject|3|||
124896158|NCT00938340|449244661|FG000|Overall Study|Protocol Violation|1|||
124896159|NCT00938340|449244661|FG000|Overall Study|Adverse Event|1|||
124444761|NCT00403754|447590296|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
124444762|NCT00403754|447590297|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
124444763|NCT00403754|447590298|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
124444764|NCT02708095|447590301|FG000|Overall Study|Adverse Event|4|||
124444765|NCT02708095|447590302|FG001|Overall Study|Adverse Event|10|||
124444766|NCT02708095|447590303|FG002|Overall Study|Adverse Event|11|||
124444767|NCT02708095|447590301|FG000|Overall Study|Lack of Efficacy|9|||
124444768|NCT02708095|447590302|FG001|Overall Study|Lack of Efficacy|3|||
124444769|NCT02708095|447590303|FG002|Overall Study|Lack of Efficacy|0|||
124444770|NCT02708095|447590301|FG000|Overall Study|Lost to Follow-up|2|||
124444771|NCT02708095|447590302|FG001|Overall Study|Lost to Follow-up|0|||
124444772|NCT02708095|447590303|FG002|Overall Study|Lost to Follow-up|0|||
124444773|NCT02708095|447590301|FG000|Overall Study|Physician Decision|2|||
124444774|NCT02708095|447590302|FG001|Overall Study|Physician Decision|3|||
124444775|NCT02708095|447590303|FG002|Overall Study|Physician Decision|2|||
124444776|NCT02708095|447590301|FG000|Overall Study|Protocol Violation|0|||
124444777|NCT02708095|447590302|FG001|Overall Study|Protocol Violation|0|||
124444778|NCT02708095|447590303|FG002|Overall Study|Protocol Violation|1|||
124444779|NCT02708095|447590301|FG000|Overall Study|Withdrawal by Subject|5|||
124444780|NCT02708095|447590302|FG001|Overall Study|Withdrawal by Subject|3|||
124444781|NCT02708095|447590303|FG002|Overall Study|Withdrawal by Subject|4|||
124444782|NCT01313650|447590304|FG000|Overall Study|Adverse Event|9|||
124444783|NCT01313650|447590305|FG001|Overall Study|Adverse Event|34|||
124896160|NCT04353037|449244662|FG000|Overall Study|Lost to Follow-up|0|||
124896161|NCT04353037|449244663|FG001|Overall Study|Lost to Follow-up|1|||
124896162|NCT04353037|449244664|FG002|Overall Study|Lost to Follow-up|2|||
124444784|NCT01313650|447590306|FG002|Overall Study|Adverse Event|24|||
124444785|NCT01313650|447590307|FG003|Overall Study|Adverse Event|23|||
124444786|NCT01313650|447590304|FG000|Overall Study|Lack of Efficacy|37|||
124444787|NCT01313650|447590305|FG001|Overall Study|Lack of Efficacy|20|||
124444788|NCT01313650|447590306|FG002|Overall Study|Lack of Efficacy|32|||
124444789|NCT01313650|447590307|FG003|Overall Study|Lack of Efficacy|20|||
124444790|NCT01313650|447590304|FG000|Overall Study|Lost to Follow-up|1|||
124444791|NCT01313650|447590305|FG001|Overall Study|Lost to Follow-up|0|||
124444792|NCT01313650|447590306|FG002|Overall Study|Lost to Follow-up|3|||
124444793|NCT01313650|447590307|FG003|Overall Study|Lost to Follow-up|2|||
124444794|NCT01313650|447590304|FG000|Overall Study|Withdrawal by Subject|16|||
124444795|NCT01313650|447590305|FG001|Overall Study|Withdrawal by Subject|20|||
124444796|NCT01313650|447590306|FG002|Overall Study|Withdrawal by Subject|15|||
124444797|NCT01313650|447590307|FG003|Overall Study|Withdrawal by Subject|15|||
124444798|NCT01313650|447590304|FG000|Overall Study|Protocol Violation|4|||
124444799|NCT01313650|447590305|FG001|Overall Study|Protocol Violation|7|||
124444800|NCT01313650|447590306|FG002|Overall Study|Protocol Violation|5|||
124444801|NCT01313650|447590307|FG003|Overall Study|Protocol Violation|6|||
124444802|NCT01313650|447590304|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
124444803|NCT01313650|447590305|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
124444804|NCT01313650|447590306|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
124444805|NCT01313650|447590307|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
124444806|NCT05393037|447590308|FG000|Part A|Death|1|||
124444807|NCT05393037|447590309|FG001|Part A|Death|0|||
124444808|NCT05393037|447590308|FG000|Part A|Lost to Follow-up|1|||
124444809|NCT05393037|447590309|FG001|Part A|Lost to Follow-up|1|||
124444810|NCT05393037|447590308|FG000|Part A|Withdrawal by Subject|2|||
124444811|NCT05393037|447590309|FG001|Part A|Withdrawal by Subject|4|||
124444812|NCT05393037|447590308|FG000|Part B|Lost to Follow-up|1|||
124444813|NCT05393037|447590309|FG001|Part B|Lost to Follow-up|0|||
124444814|NCT01012739|447590310|FG000|Treatment Period 1|Adverse Event|0|||
124444815|NCT01012739|447590311|FG001|Treatment Period 1|Adverse Event|0|||
124444816|NCT01012739|447590312|FG002|Treatment Period 1|Adverse Event|0|||
124444817|NCT01012739|447590313|FG003|Treatment Period 1|Adverse Event|1|||
124444818|NCT01012739|447590310|FG000|Treatment Period 2|Abnormal test procedure results|0|||
124444819|NCT01012739|447590311|FG001|Treatment Period 2|Abnormal test procedure results|0|||
124444820|NCT01012739|447590312|FG002|Treatment Period 2|Abnormal test procedure results|0|||
124896163|NCT04353037|449244665|FG003|Overall Study|Lost to Follow-up|3|||
124444821|NCT01012739|447590313|FG003|Treatment Period 2|Abnormal test procedure results|1|||
124444822|NCT00458341|447590314|FG000|Cycle 1|Adverse Event|1|||
124444823|NCT00458341|447590315|FG001|Cycle 1|Adverse Event|0|||
124444824|NCT04540133|447590316|FG000|Overall Study|Lost to Follow-up|1|||
124444825|NCT04540133|447590317|FG001|Overall Study|Lost to Follow-up|0|||
124444826|NCT03049735|447590322|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
124444827|NCT03049735|447590323|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
124444828|NCT03049735|447590324|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
124444829|NCT03049735|447590322|FG000|Overall Study|Other|5|||
124444830|NCT03049735|447590323|FG001|Overall Study|Other|3|||
124444831|NCT03049735|447590324|FG002|Overall Study|Other|1|||
124444832|NCT03049735|447590322|FG000|Overall Study|Lack of Efficacy|4|||
124444833|NCT03049735|447590323|FG001|Overall Study|Lack of Efficacy|0|||
124444834|NCT03049735|447590324|FG002|Overall Study|Lack of Efficacy|3|||
124444835|NCT03049735|447590322|FG000|Overall Study|Protocol deviation|1|||
124896164|NCT04353037|449244662|FG000|Overall Study|Withdrawal by Subject|0|||
124896165|NCT04353037|449244663|FG001|Overall Study|Withdrawal by Subject|2|||
124896166|NCT04353037|449244664|FG002|Overall Study|Withdrawal by Subject|3|||
124896167|NCT04353037|449244665|FG003|Overall Study|Withdrawal by Subject|5|||
124896168|NCT04353037|449244662|FG000|Overall Study|Adverse Event|0|||
124896169|NCT04353037|449244663|FG001|Overall Study|Adverse Event|0|||
124896170|NCT04353037|449244664|FG002|Overall Study|Adverse Event|2|||
124896171|NCT04353037|449244665|FG003|Overall Study|Adverse Event|0|||
124896172|NCT04353037|449244662|FG000|Overall Study|Exposure Change|0|||
124896173|NCT04353037|449244663|FG001|Overall Study|Exposure Change|0|||
124896174|NCT04353037|449244664|FG002|Overall Study|Exposure Change|0|||
124896175|NCT04353037|449244665|FG003|Overall Study|Exposure Change|2|||
124896176|NCT02950545|449244670|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
124896177|NCT02950545|449244671|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
124896178|NCT02950545|449244672|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
124896179|NCT02950545|449244673|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
124896180|NCT02950545|449244674|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
124896181|NCT02950545|449244675|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
124896182|NCT02950545|449244670|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
124896183|NCT02950545|449244671|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
124896184|NCT02950545|449244672|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
124896185|NCT02950545|449244673|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
124896186|NCT02950545|449244674|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
124896187|NCT02950545|449244675|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
124896188|NCT02950545|449244670|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
124896189|NCT02950545|449244671|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
124896190|NCT02950545|449244672|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
124896191|NCT02950545|449244673|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
124896192|NCT02950545|449244674|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
124896193|NCT02950545|449244675|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
124896194|NCT02950545|449244670|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
124896195|NCT02950545|449244671|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
124896196|NCT02950545|449244672|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
124896197|NCT02950545|449244673|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
124896198|NCT02950545|449244674|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
124896199|NCT02950545|449244675|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
124896200|NCT02950545|449244670|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
124896201|NCT02950545|449244671|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
124896202|NCT02950545|449244672|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
124896203|NCT02950545|449244673|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
124896204|NCT02950545|449244674|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
124896205|NCT02950545|449244675|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
124896206|NCT03398356|449244676|FG000|Before Treatment|Lost to Follow-up|1|||
124896207|NCT03398356|449244677|FG001|Before Treatment|Lost to Follow-up|2|||
124444836|NCT03049735|447590323|FG001|Overall Study|Protocol deviation|0|||
124896208|NCT03398356|449244678|FG002|Before Treatment|Lost to Follow-up|0|||
124896209|NCT03398356|449244676|FG000|Before Treatment|drug intolerance|2|||
124444837|NCT03049735|447590324|FG002|Overall Study|Protocol deviation|0|||
124444838|NCT03049735|447590322|FG000|Overall Study|Pregnancy|0|||
124444839|NCT03049735|447590323|FG001|Overall Study|Pregnancy|0|||
124444840|NCT03049735|447590324|FG002|Overall Study|Pregnancy|1|||
124444841|NCT03049735|447590322|FG000|Overall Study|Adverse Event|7|||
124444842|NCT03049735|447590323|FG001|Overall Study|Adverse Event|18|||
124444843|NCT03049735|447590324|FG002|Overall Study|Adverse Event|5|||
124444844|NCT03049735|447590322|FG000|Overall Study|Withdrawal by Subject|10|||
124444845|NCT03049735|447590323|FG001|Overall Study|Withdrawal by Subject|3|||
124444846|NCT03049735|447590324|FG002|Overall Study|Withdrawal by Subject|7|||
124444847|NCT03049735|447590322|FG000|Overall Study|Lost to Follow-up|1|||
124444848|NCT03049735|447590323|FG001|Overall Study|Lost to Follow-up|5|||
124444849|NCT03049735|447590324|FG002|Overall Study|Lost to Follow-up|5|||
124444850|NCT03153111|447590325|FG000|Overall Study|Death|2|||
124444851|NCT03153111|447590326|FG001|Overall Study|Death|5|||
124444852|NCT03153111|447590325|FG000|Overall Study|Lost to Follow-up|1|||
124444853|NCT03153111|447590326|FG001|Overall Study|Lost to Follow-up|0|||
124444854|NCT03153111|447590325|FG000|Overall Study|Physician Decision|5|||
124444855|NCT03153111|447590326|FG001|Overall Study|Physician Decision|1|||
124444856|NCT03153111|447590325|FG000|Overall Study|Withdrawal by Subject|3|||
124444857|NCT03153111|447590326|FG001|Overall Study|Withdrawal by Subject|3|||
124444858|NCT03891524|447590327|FG000|Overall Study|Death|0|||
124444859|NCT03891524|447590328|FG001|Overall Study|Death|0|||
124444860|NCT03891524|447590329|FG002|Overall Study|Death|0|||
124444861|NCT03891524|447590330|FG003|Overall Study|Death|0|||
124444862|NCT03891524|447590331|FG004|Overall Study|Death|0|||
124444863|NCT03891524|447590332|FG005|Overall Study|Death|0|||
124444864|NCT03891524|447590333|FG006|Overall Study|Death|0|||
124444865|NCT03891524|447590334|FG007|Overall Study|Death|1|||
124444866|NCT03891524|447590327|FG000|Overall Study|Withdrawal by Subject|0|||
124444867|NCT03891524|447590328|FG001|Overall Study|Withdrawal by Subject|1|||
124444868|NCT03891524|447590329|FG002|Overall Study|Withdrawal by Subject|2|||
124444869|NCT03891524|447590330|FG003|Overall Study|Withdrawal by Subject|1|||
124444870|NCT03891524|447590331|FG004|Overall Study|Withdrawal by Subject|2|||
124444871|NCT03891524|447590332|FG005|Overall Study|Withdrawal by Subject|2|||
124444872|NCT03891524|447590333|FG006|Overall Study|Withdrawal by Subject|2|||
124896210|NCT03398356|449244677|FG001|Before Treatment|drug intolerance|1|||
124896211|NCT03398356|449244678|FG002|Before Treatment|drug intolerance|0|||
124896212|NCT03398356|449244676|FG000|Before Treatment|Withdrawal by Subject|0|||
124896213|NCT03398356|449244677|FG001|Before Treatment|Withdrawal by Subject|5|||
124896214|NCT03398356|449244678|FG002|Before Treatment|Withdrawal by Subject|0|||
124896215|NCT03398356|449244676|FG000|Before Treatment|Physician Decision|0|||
124896216|NCT03398356|449244677|FG001|Before Treatment|Physician Decision|0|||
124896217|NCT03398356|449244678|FG002|Before Treatment|Physician Decision|11|||
124444873|NCT03891524|447590334|FG007|Overall Study|Withdrawal by Subject|1|||
124444874|NCT00390910|447590335|FG000|Overall Study|Adverse Event|1|||
124444875|NCT00390910|447590336|FG001|Overall Study|Adverse Event|0|||
124444876|NCT00390910|447590337|FG002|Overall Study|Adverse Event|0|||
124444877|NCT00390910|447590335|FG000|Overall Study|Lost to Follow-up|0|||
124444878|NCT00390910|447590336|FG001|Overall Study|Lost to Follow-up|1|||
124444879|NCT00390910|447590337|FG002|Overall Study|Lost to Follow-up|5|||
124444880|NCT00390910|447590335|FG000|Overall Study|Withdrawal by Subject|1|||
124444881|NCT00390910|447590336|FG001|Overall Study|Withdrawal by Subject|3|||
124444882|NCT00390910|447590337|FG002|Overall Study|Withdrawal by Subject|2|||
124444883|NCT00390910|447590335|FG000|Overall Study|Migrated/moved from study area|0|||
124444884|NCT00390910|447590336|FG001|Overall Study|Migrated/moved from study area|0|||
124444885|NCT00390910|447590337|FG002|Overall Study|Migrated/moved from study area|3|||
124444886|NCT00174265|447590342|FG000|Overall Study|Adverse Event|7|||
124444887|NCT00174265|447590343|FG001|Overall Study|Adverse Event|4|||
124896218|NCT03398356|449244676|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
124896219|NCT03398356|449244677|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
124444888|NCT00174265|447590342|FG000|Overall Study|Lack of Efficacy|2|||
124444889|NCT00174265|447590343|FG001|Overall Study|Lack of Efficacy|2|||
124444890|NCT00174265|447590342|FG000|Overall Study|Withdrawal by Subject|3|||
124896220|NCT03398356|449244678|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
124896221|NCT01648283|449244680|FG000|Overall Study|Withdrawal by Subject|14|||
124444891|NCT00174265|447590343|FG001|Overall Study|Withdrawal by Subject|5|||
124444892|NCT00174265|447590342|FG000|Overall Study|Lost to Follow-up|1|||
124444893|NCT00174265|447590343|FG001|Overall Study|Lost to Follow-up|0|||
124444894|NCT00174265|447590342|FG000|Overall Study|Other (Not specified)|16|||
124444895|NCT00174265|447590343|FG001|Overall Study|Other (Not specified)|10|||
124444896|NCT03471871|447590345|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
124444897|NCT03471871|447590346|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
124444898|NCT03471871|447590347|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
124444899|NCT03471871|447590348|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
124444900|NCT03471871|447590349|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
124444901|NCT03471871|447590345|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
124759359|NCT00452790|448742620|FG000|After Infant Series|Adverse Event|4|||
124896222|NCT00530777|449244686|FG000|Overall Study|Lost to Follow-up|0|||
124896223|NCT00530777|449244687|FG001|Overall Study|Lost to Follow-up|1|||
124896224|NCT00530777|449244686|FG000|Overall Study|Death|1|||
124896225|NCT00530777|449244687|FG001|Overall Study|Death|2|||
124896226|NCT00530777|449244686|FG000|Overall Study|Physician Decision|1|||
124896227|NCT00530777|449244687|FG001|Overall Study|Physician Decision|0|||
124896228|NCT00530777|449244686|FG000|Overall Study|Withdrawal by Subject|0|||
124896229|NCT00530777|449244687|FG001|Overall Study|Withdrawal by Subject|1|||
124896230|NCT00530777|449244686|FG000|Overall Study|Unable to adhere to visit schedule|5|||
124896231|NCT00530777|449244687|FG001|Overall Study|Unable to adhere to visit schedule|1|||
124896232|NCT03382821|449244694|FG000|Overall Study|Did not receive allocated intervention.|0|||
124896233|NCT03382821|449244695|FG001|Overall Study|Did not receive allocated intervention.|3|||
124896234|NCT00282438|449244697|FG000|Overall Study|Lack of Efficacy|1|||
124896235|NCT00282438|449244698|FG001|Overall Study|Lack of Efficacy|0|||
124896236|NCT00282438|449244697|FG000|Overall Study|Death|0|||
124896237|NCT00282438|449244698|FG001|Overall Study|Death|1|||
124896238|NCT03178201|449244706|FG000|Overall Study|Off study|5|||
124896239|NCT02095158|449244707|FG000|Overall Study|Adverse Event|14|||
124896240|NCT02095158|449244707|FG000|Overall Study|Lack of Efficacy|3|||
124896241|NCT02095158|449244707|FG000|Overall Study|Pregnancy|1|||
124896242|NCT02095158|449244707|FG000|Overall Study|Lost to Follow-up|20|||
124896243|NCT02095158|449244707|FG000|Overall Study|Personal Reasons|35|||
124896244|NCT02095158|449244707|FG000|Overall Study|Protocol Violation|1|||
124896245|NCT02095158|449244707|FG000|Overall Study|Other Miscellaneous Reasons|1|||
124896246|NCT01008748|449244708|FG000|Overall Study|Lost to Follow-up|80|||
124896247|NCT01008748|449244708|FG000|Overall Study|Other|1|||
124896248|NCT02775435|449244709|FG000|Overall Study|Adverse Event|32|||
124896249|NCT02775435|449244710|FG001|Overall Study|Adverse Event|27|||
124896250|NCT02775435|449244709|FG000|Overall Study|Lost to Follow-up|2|||
124896251|NCT02775435|449244710|FG001|Overall Study|Lost to Follow-up|2|||
124896252|NCT02775435|449244709|FG000|Overall Study|Sponsor decision|44|||
124896253|NCT02775435|449244710|FG001|Overall Study|Sponsor decision|19|||
124444902|NCT03471871|447590346|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
124896254|NCT02775435|449244709|FG000|Overall Study|Withdrawal by Subject|4|||
124896255|NCT02775435|449244710|FG001|Overall Study|Withdrawal by Subject|9|||
124896256|NCT02775435|449244709|FG000|Overall Study|Death|196|||
124896257|NCT02775435|449244710|FG001|Overall Study|Death|224|||
124896258|NCT02282527|449244711|FG000|Overall Study|Lost to Follow-up|0|||
124896259|NCT02282527|449244712|FG001|Overall Study|Lost to Follow-up|1|||
124896260|NCT02282527|449244711|FG000|Overall Study|Lack of home health aid|1|||
124896261|NCT02282527|449244712|FG001|Overall Study|Lack of home health aid|0|||
124896262|NCT00941031|449244713|FG000|Induction Period|Lack of Efficacy|2|||
124896263|NCT00941031|449244714|FG001|Induction Period|Lack of Efficacy|1|||
124896264|NCT00941031|449244715|FG002|Induction Period|Lack of Efficacy|0|||
124896265|NCT00941031|449244716|FG003|Induction Period|Lack of Efficacy|5|||
124896266|NCT00941031|449244717|FG004|Induction Period|Lack of Efficacy|0|||
124896267|NCT00941031|449244718|FG005|Induction Period|Lack of Efficacy|0|||
124896268|NCT00941031|449244719|FG006|Induction Period|Lack of Efficacy|0|||
124896269|NCT00941031|449244713|FG000|Induction Period|Withdrawal by Subject|1|||
124896270|NCT00941031|449244714|FG001|Induction Period|Withdrawal by Subject|2|||
124896271|NCT00941031|449244715|FG002|Induction Period|Withdrawal by Subject|2|||
124896272|NCT00941031|449244716|FG003|Induction Period|Withdrawal by Subject|2|||
124896273|NCT00941031|449244717|FG004|Induction Period|Withdrawal by Subject|0|||
124896274|NCT00941031|449244718|FG005|Induction Period|Withdrawal by Subject|0|||
124896275|NCT00941031|449244719|FG006|Induction Period|Withdrawal by Subject|0|||
124896276|NCT00941031|449244713|FG000|Induction Period|Adminstative Problems|1|||
124896277|NCT00941031|449244714|FG001|Induction Period|Adminstative Problems|1|||
124896278|NCT00941031|449244715|FG002|Induction Period|Adminstative Problems|1|||
124896279|NCT00941031|449244716|FG003|Induction Period|Adminstative Problems|0|||
124896280|NCT00941031|449244717|FG004|Induction Period|Adminstative Problems|0|||
124896281|NCT00941031|449244718|FG005|Induction Period|Adminstative Problems|0|||
124896282|NCT00941031|449244719|FG006|Induction Period|Adminstative Problems|0|||
124896283|NCT00941031|449244713|FG000|Induction Period|Adverse Event|1|||
124896284|NCT00941031|449244714|FG001|Induction Period|Adverse Event|0|||
124896285|NCT00941031|449244715|FG002|Induction Period|Adverse Event|3|||
124896286|NCT00941031|449244716|FG003|Induction Period|Adverse Event|2|||
124896287|NCT00941031|449244717|FG004|Induction Period|Adverse Event|0|||
124896288|NCT00941031|449244718|FG005|Induction Period|Adverse Event|0|||
124896289|NCT00941031|449244719|FG006|Induction Period|Adverse Event|0|||
124896290|NCT00941031|449244713|FG000|Maintenance Period|Withdrawal by Subject|0|||
124896291|NCT00941031|449244714|FG001|Maintenance Period|Withdrawal by Subject|0|||
124896292|NCT00941031|449244715|FG002|Maintenance Period|Withdrawal by Subject|0|||
124896293|NCT00941031|449244716|FG003|Maintenance Period|Withdrawal by Subject|0|||
124896294|NCT00941031|449244717|FG004|Maintenance Period|Withdrawal by Subject|6|||
124896295|NCT00941031|449244718|FG005|Maintenance Period|Withdrawal by Subject|2|||
124896296|NCT00941031|449244719|FG006|Maintenance Period|Withdrawal by Subject|13|||
124896297|NCT00941031|449244713|FG000|Maintenance Period|Administrative Problems|0|||
124896298|NCT00941031|449244714|FG001|Maintenance Period|Administrative Problems|0|||
124896299|NCT00941031|449244715|FG002|Maintenance Period|Administrative Problems|0|||
124896300|NCT00941031|449244716|FG003|Maintenance Period|Administrative Problems|0|||
124896301|NCT00941031|449244717|FG004|Maintenance Period|Administrative Problems|1|||
124896302|NCT00941031|449244718|FG005|Maintenance Period|Administrative Problems|0|||
124896303|NCT00941031|449244719|FG006|Maintenance Period|Administrative Problems|1|||
124896304|NCT00941031|449244713|FG000|Maintenance Period|Protocol Violation|0|||
124896305|NCT00941031|449244714|FG001|Maintenance Period|Protocol Violation|0|||
124759360|NCT00452790|448742621|FG001|After Infant Series|Adverse Event|1|||
124759361|NCT00452790|448742620|FG000|After Infant Series|Parent/legal guardian request|1|||
124759362|NCT00452790|448742621|FG001|After Infant Series|Parent/legal guardian request|3|||
124759363|NCT00452790|448742620|FG000|After Infant Series|Lost to Follow-up|4|||
124759364|NCT00452790|448742621|FG001|After Infant Series|Lost to Follow-up|0|||
124759365|NCT00452790|448742620|FG000|After Infant Series|Failed to return|1|||
124759366|NCT00452790|448742621|FG001|After Infant Series|Failed to return|0|||
124896306|NCT00941031|449244715|FG002|Maintenance Period|Protocol Violation|0|||
124896307|NCT00941031|449244716|FG003|Maintenance Period|Protocol Violation|0|||
124896308|NCT00941031|449244717|FG004|Maintenance Period|Protocol Violation|0|||
124896309|NCT00941031|449244718|FG005|Maintenance Period|Protocol Violation|0|||
124896310|NCT00941031|449244719|FG006|Maintenance Period|Protocol Violation|1|||
124896311|NCT00941031|449244713|FG000|Maintenance Period|Adverse Event|0|||
124896312|NCT00941031|449244714|FG001|Maintenance Period|Adverse Event|0|||
124896313|NCT00941031|449244715|FG002|Maintenance Period|Adverse Event|0|||
124896314|NCT00941031|449244716|FG003|Maintenance Period|Adverse Event|0|||
124896315|NCT00941031|449244717|FG004|Maintenance Period|Adverse Event|0|||
124896316|NCT00941031|449244718|FG005|Maintenance Period|Adverse Event|2|||
124896317|NCT00941031|449244719|FG006|Maintenance Period|Adverse Event|8|||
124759367|NCT00452790|448742620|FG000|After Infant Series|Other reasons|1|||
124896318|NCT00941031|449244713|FG000|Maintenance Period|Lost to Follow-up|0|||
124444903|NCT03471871|447590347|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
124444904|NCT03471871|447590348|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
124444905|NCT03471871|447590349|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
124444906|NCT03471871|447590345|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
124444907|NCT03471871|447590346|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
124444908|NCT03471871|447590347|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
124444909|NCT03471871|447590348|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
124444910|NCT03471871|447590349|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
124444911|NCT03471871|447590345|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
124444912|NCT03471871|447590346|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
124444913|NCT03471871|447590347|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
124444914|NCT03471871|447590348|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
124444915|NCT03471871|447590349|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
124444916|NCT03471871|447590345|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
124444917|NCT03471871|447590346|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
124444918|NCT03471871|447590347|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
124444919|NCT03471871|447590348|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
124444920|NCT03471871|447590349|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
124444921|NCT01572922|447590351|FG000|Overall Study|Adverse Event|1|||
124444922|NCT01572922|447590351|FG000|Overall Study|Protocol Violation|1|||
124444923|NCT01572922|447590351|FG000|Overall Study|Death|1|||
124444924|NCT03040622|447590352|FG000|Overall Study|unable to implant device|3|||
124444925|NCT00445068|447590353|FG000|Overall Study|Disease progression|26|||
124444926|NCT00445068|447590353|FG000|Overall Study|Adverse Event|5|||
124444927|NCT00445068|447590353|FG000|Overall Study|Abnormal laboratory value|2|||
124444928|NCT00445068|447590353|FG000|Overall Study|Withdrawal by Subject|2|||
124444929|NCT00445068|447590353|FG000|Overall Study|Death|1|||
124444930|NCT00447382|447590354|FG000|Overall Study|Adverse Event|1|||
124444931|NCT00447382|447590355|FG001|Overall Study|Adverse Event|1|||
124444932|NCT00447382|447590354|FG000|Overall Study|Lack of Efficacy|1|||
124444933|NCT00447382|447590355|FG001|Overall Study|Lack of Efficacy|0|||
124444934|NCT00447382|447590354|FG000|Overall Study|Protocol Violation|2|||
124444935|NCT00447382|447590355|FG001|Overall Study|Protocol Violation|0|||
124444936|NCT00447382|447590354|FG000|Overall Study|Unclassified|2|||
124444937|NCT00447382|447590355|FG001|Overall Study|Unclassified|5|||
124444938|NCT04600336|447590356|FG000|Initial Treatment|Withdrawal by Subject|1|||
124444939|NCT04600336|447590357|FG001|Initial Treatment|Withdrawal by Subject|2|||
124444940|NCT04600336|447590358|FG002|Initial Treatment|Withdrawal by Subject|0|||
124444941|NCT04600336|447590359|FG003|Initial Treatment|Withdrawal by Subject|0|||
124444942|NCT04600336|447590356|FG000|Initial Treatment|Adverse Event|0|||
124444943|NCT04600336|447590357|FG001|Initial Treatment|Adverse Event|2|||
124444944|NCT04600336|447590358|FG002|Initial Treatment|Adverse Event|0|||
124444945|NCT04600336|447590359|FG003|Initial Treatment|Adverse Event|0|||
124444946|NCT04600336|447590356|FG000|Initial Treatment|Other complicating disease|0|||
124444947|NCT04600336|447590357|FG001|Initial Treatment|Other complicating disease|0|||
124444948|NCT04600336|447590358|FG002|Initial Treatment|Other complicating disease|1|||
124444949|NCT04600336|447590359|FG003|Initial Treatment|Other complicating disease|0|||
124444950|NCT04600336|447590356|FG000|Crossover Treatment|Withdrawal by Subject|0|||
124444951|NCT04600336|447590357|FG001|Crossover Treatment|Withdrawal by Subject|0|||
124444952|NCT04600336|447590358|FG002|Crossover Treatment|Withdrawal by Subject|2|||
124444953|NCT04600336|447590359|FG003|Crossover Treatment|Withdrawal by Subject|1|||
124444954|NCT04600336|447590356|FG000|Crossover Treatment|Adverse Event|0|||
124444955|NCT04600336|447590357|FG001|Crossover Treatment|Adverse Event|0|||
124444956|NCT04600336|447590358|FG002|Crossover Treatment|Adverse Event|1|||
124896319|NCT00941031|449244714|FG001|Maintenance Period|Lost to Follow-up|0|||
124444957|NCT04600336|447590359|FG003|Crossover Treatment|Adverse Event|1|||
124444958|NCT03144804|447590361|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
124444959|NCT04091451|447590364|FG000|Overall Study|Adverse Event|15|||
124444960|NCT04091451|447590365|FG001|Overall Study|Adverse Event|10|||
124444961|NCT04091451|447590364|FG000|Overall Study|Lost to Follow-up|8|||
124688566|NCT03487445|448478769|FG001|Randomization|Not treated for administrative reasons|0|||
124688567|NCT00221104|448478770|FG000|Overall Study|Adverse Event|1|||
124688568|NCT00221104|448478771|FG001|Overall Study|Adverse Event|0|||
124688569|NCT00221104|448478770|FG000|Overall Study|Physician Decision|1|||
124896320|NCT00941031|449244715|FG002|Maintenance Period|Lost to Follow-up|0|||
124444962|NCT04091451|447590365|FG001|Overall Study|Lost to Follow-up|8|||
124444963|NCT04091451|447590364|FG000|Overall Study|Protocol Violation|5|||
124444964|NCT04091451|447590365|FG001|Overall Study|Protocol Violation|4|||
124444965|NCT04091451|447590364|FG000|Overall Study|Withdrawal by Subject|21|||
124444966|NCT04091451|447590365|FG001|Overall Study|Withdrawal by Subject|27|||
124444967|NCT04091451|447590364|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
124688570|NCT00221104|448478771|FG001|Overall Study|Physician Decision|0|||
124444968|NCT04091451|447590365|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
124896321|NCT00941031|449244716|FG003|Maintenance Period|Lost to Follow-up|0|||
124896322|NCT00941031|449244717|FG004|Maintenance Period|Lost to Follow-up|2|||
124896323|NCT00941031|449244718|FG005|Maintenance Period|Lost to Follow-up|2|||
124896324|NCT00941031|449244719|FG006|Maintenance Period|Lost to Follow-up|7|||
124896325|NCT00941031|449244713|FG000|Maintenance Period|Lack of Efficacy|0|||
124896326|NCT00941031|449244714|FG001|Maintenance Period|Lack of Efficacy|0|||
124896327|NCT00941031|449244715|FG002|Maintenance Period|Lack of Efficacy|0|||
124896328|NCT00941031|449244716|FG003|Maintenance Period|Lack of Efficacy|0|||
124896329|NCT00941031|449244717|FG004|Maintenance Period|Lack of Efficacy|0|||
124896330|NCT00941031|449244718|FG005|Maintenance Period|Lack of Efficacy|0|||
124896331|NCT00941031|449244719|FG006|Maintenance Period|Lack of Efficacy|13|||
124896332|NCT03124108|449244721|FG000|Overall Study|Adverse Event|0|||
124896333|NCT03124108|449244722|FG001|Overall Study|Adverse Event|1|||
124896334|NCT03124108|449244723|FG002|Overall Study|Adverse Event|0|||
124896335|NCT00631917|449244724|FG000|Overall Study|Adverse Event|34|||
124896336|NCT00631917|449244725|FG001|Overall Study|Adverse Event|45|||
124896337|NCT00631917|449244724|FG000|Overall Study|Abnormal laboratory value(s)|2|||
124896338|NCT00631917|449244725|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124896339|NCT00631917|449244724|FG000|Overall Study|Abnormal test procedure result(s)|3|||
124896340|NCT00631917|449244725|FG001|Overall Study|Abnormal test procedure result(s)|2|||
124896341|NCT00631917|449244724|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
124896342|NCT00631917|449244725|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
124896343|NCT00631917|449244724|FG000|Overall Study|No longer required study drug|0|||
124896344|NCT00631917|449244725|FG001|Overall Study|No longer required study drug|1|||
124896345|NCT00631917|449244724|FG000|Overall Study|Protocol deviation|6|||
124896346|NCT00631917|449244725|FG001|Overall Study|Protocol deviation|5|||
124896347|NCT00631917|449244724|FG000|Overall Study|Subject withdrew consent|25|||
124896348|NCT00631917|449244725|FG001|Overall Study|Subject withdrew consent|33|||
124896349|NCT00631917|449244724|FG000|Overall Study|Lost to Follow-up|7|||
124896350|NCT00631917|449244725|FG001|Overall Study|Lost to Follow-up|7|||
124896351|NCT00631917|449244724|FG000|Overall Study|Administrative problems|2|||
124896352|NCT00631917|449244725|FG001|Overall Study|Administrative problems|0|||
124896353|NCT00631917|449244724|FG000|Overall Study|Death|1|||
124896354|NCT00631917|449244725|FG001|Overall Study|Death|0|||
124896355|NCT05650333|449244731|FG000|Treatment Period (7 Days)|Adverse Event|1|||
124896356|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
124896357|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
124896358|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
124896359|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Death|3|||
124896360|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Death|0|||
124896361|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Death|0|||
124896362|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
124896363|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
124896364|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
124896365|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
124896366|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
124896367|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
124896368|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
124896369|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
124688571|NCT00221104|448478770|FG000|Overall Study|Protocol Violation|2|||
124688572|NCT00221104|448478771|FG001|Overall Study|Protocol Violation|0|||
124688573|NCT00221104|448478770|FG000|Overall Study|Withdrawal by Subject|42|||
124688574|NCT00221104|448478771|FG001|Overall Study|Withdrawal by Subject|29|||
124688575|NCT00221104|448478770|FG000|Overall Study|Others|37|||
124688576|NCT00221104|448478771|FG001|Overall Study|Others|47|||
124688577|NCT02989389|448478772|FG000|Period 1|Lost to Follow-up|0|||
124896370|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
124896371|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
124896372|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
124896373|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
124896374|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
124688578|NCT02989389|448478773|FG001|Period 1|Lost to Follow-up|1|||
124896375|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
124896376|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
124896377|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Other|1|||
124896378|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Other|0|||
124444969|NCT04091451|447590364|FG000|Overall Study|Migrated/moved from the study area|3|||
124444970|NCT04091451|447590365|FG001|Overall Study|Migrated/moved from the study area|5|||
124444971|NCT04091451|447590364|FG000|Overall Study|Suspected HZ episode|1|||
124444972|NCT04091451|447590365|FG001|Overall Study|Suspected HZ episode|0|||
124444973|NCT04124614|447590366|FG000|Placebo Run-in Period|Not Randomized|34|||
124444974|NCT04124614|447590367|FG001|Placebo Run-in Period|Not Randomized|0|||
124444975|NCT04124614|447590368|FG002|Placebo Run-in Period|Not Randomized|0|||
124444976|NCT04124614|447590366|FG000|Double Blind Treatment Period|Adverse Event|0|||
124444977|NCT04124614|447590367|FG001|Double Blind Treatment Period|Adverse Event|7|||
124444978|NCT04124614|447590368|FG002|Double Blind Treatment Period|Adverse Event|22|||
124444979|NCT04124614|447590366|FG000|Double Blind Treatment Period|Death|0|||
124444980|NCT04124614|447590367|FG001|Double Blind Treatment Period|Death|0|||
124444981|NCT04124614|447590368|FG002|Double Blind Treatment Period|Death|1|||
124444982|NCT04124614|447590366|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
124444983|NCT04124614|447590367|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
124444984|NCT04124614|447590368|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
124444985|NCT04124614|447590366|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
124444986|NCT04124614|447590367|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
124444987|NCT04124614|447590368|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
124444988|NCT04124614|447590366|FG000|Double Blind Treatment Period|Physician Decision|0|||
124444989|NCT04124614|447590367|FG001|Double Blind Treatment Period|Physician Decision|0|||
124444990|NCT04124614|447590368|FG002|Double Blind Treatment Period|Physician Decision|3|||
124444991|NCT04124614|447590366|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
124444992|NCT04124614|447590367|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
124444993|NCT04124614|447590368|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
124896379|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Other|0|||
124896380|NCT02403323|449244734|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
124896381|NCT02403323|449244735|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
124896382|NCT02403323|449244736|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
124896383|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
124896384|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
124896385|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
124896386|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
124896387|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
124896388|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
124444994|NCT04124614|447590366|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
124444995|NCT04124614|447590367|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
124444996|NCT04124614|447590368|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
124444997|NCT04124614|447590366|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
124444998|NCT04124614|447590367|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
124444999|NCT04124614|447590368|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
124445000|NCT03769181|447591744|FG000|Overall Study|Adverse Event|1|||
124445001|NCT03769181|447591745|FG001|Overall Study|Adverse Event|0|||
124445002|NCT03769181|447591746|FG002|Overall Study|Adverse Event|2|||
124445003|NCT03769181|447591747|FG003|Overall Study|Adverse Event|4|||
124445004|NCT03769181|447591744|FG000|Overall Study|Withdrawal by Subject|1|||
124688579|NCT02989389|448478774|FG002|Period 1|Lost to Follow-up|0|||
124896389|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
124896390|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
124896391|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
124896392|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
124896393|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
124896394|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
124896395|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
124896396|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
124896397|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
124896398|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
124445005|NCT03769181|447591745|FG001|Overall Study|Withdrawal by Subject|0|||
124688580|NCT02989389|448478775|FG003|Period 1|Lost to Follow-up|0|||
124896399|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
124896400|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
124445006|NCT03769181|447591746|FG002|Overall Study|Withdrawal by Subject|2|||
124445007|NCT03769181|447591747|FG003|Overall Study|Withdrawal by Subject|1|||
124445008|NCT03769181|447591744|FG000|Overall Study|Progressive disease|9|||
124445009|NCT03769181|447591745|FG001|Overall Study|Progressive disease|7|||
124896401|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
124896402|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
124896403|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
124896404|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
124896405|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
124896406|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
124896407|NCT02403323|449244734|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
124896408|NCT02403323|449244735|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
124896409|NCT02403323|449244736|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
124896410|NCT03885596|449244737|FG000|Overall Study|Withdrawal by Subject|2|||
124896411|NCT03885596|449244738|FG001|Overall Study|Withdrawal by Subject|1|||
124896412|NCT03885596|449244739|FG002|Overall Study|Withdrawal by Subject|0|||
124896413|NCT03885596|449244740|FG003|Overall Study|Withdrawal by Subject|0|||
124896414|NCT03852433|449244741|FG000|Overall Study|Withdrawal of consent|5|||
124896415|NCT03852433|449244742|FG001|Overall Study|Withdrawal of consent|8|||
124896416|NCT03852433|449244743|FG002|Overall Study|Withdrawal of consent|1|||
124896417|NCT03852433|449244744|FG003|Overall Study|Withdrawal of consent|1|||
124896418|NCT03852433|449244741|FG000|Overall Study|Adverse Event|1|||
124896419|NCT03852433|449244742|FG001|Overall Study|Adverse Event|1|||
124896420|NCT03852433|449244743|FG002|Overall Study|Adverse Event|1|||
124896421|NCT03852433|449244744|FG003|Overall Study|Adverse Event|1|||
124896422|NCT03852433|449244741|FG000|Overall Study|Lost to Follow-up|0|||
124896423|NCT03852433|449244742|FG001|Overall Study|Lost to Follow-up|1|||
124896424|NCT03852433|449244743|FG002|Overall Study|Lost to Follow-up|0|||
124896425|NCT03852433|449244744|FG003|Overall Study|Lost to Follow-up|1|||
124896426|NCT03852433|449244741|FG000|Overall Study|Pregnancy|0|||
124896427|NCT03852433|449244742|FG001|Overall Study|Pregnancy|1|||
124445010|NCT03769181|447591746|FG002|Overall Study|Progressive disease|13|||
124445011|NCT03769181|447591747|FG003|Overall Study|Progressive disease|6|||
124445012|NCT03769181|447591744|FG000|Overall Study|Other - Unspecified|2|||
124445013|NCT03769181|447591745|FG001|Overall Study|Other - Unspecified|1|||
124896428|NCT03852433|449244743|FG002|Overall Study|Pregnancy|1|||
124896429|NCT03852433|449244744|FG003|Overall Study|Pregnancy|0|||
124896430|NCT03852433|449244741|FG000|Overall Study|Protocol Violation|0|||
124896431|NCT03852433|449244742|FG001|Overall Study|Protocol Violation|0|||
124896432|NCT03852433|449244743|FG002|Overall Study|Protocol Violation|1|||
124896433|NCT03852433|449244744|FG003|Overall Study|Protocol Violation|1|||
124896434|NCT03852433|449244741|FG000|Overall Study|Death|0|||
124896435|NCT03852433|449244742|FG001|Overall Study|Death|0|||
124896436|NCT03852433|449244743|FG002|Overall Study|Death|1|||
124896437|NCT03852433|449244744|FG003|Overall Study|Death|0|||
124896438|NCT03852433|449244741|FG000|Overall Study|Lack of Efficacy|0|||
124896439|NCT03852433|449244742|FG001|Overall Study|Lack of Efficacy|1|||
124896440|NCT03852433|449244743|FG002|Overall Study|Lack of Efficacy|0|||
124896441|NCT03852433|449244744|FG003|Overall Study|Lack of Efficacy|0|||
124896442|NCT03852433|449244741|FG000|Overall Study|Non-compliance with study drug|0|||
124896443|NCT03852433|449244742|FG001|Overall Study|Non-compliance with study drug|0|||
124445014|NCT03769181|447591746|FG002|Overall Study|Other - Unspecified|0|||
124445015|NCT03769181|447591747|FG003|Overall Study|Other - Unspecified|0|||
124445016|NCT03971422|447591748|FG000|Overall Study|Lost to Follow-up|0|||
124445017|NCT03971422|447591749|FG001|Overall Study|Lost to Follow-up|1|||
124896444|NCT03852433|449244743|FG002|Overall Study|Non-compliance with study drug|0|||
124896445|NCT03852433|449244744|FG003|Overall Study|Non-compliance with study drug|1|||
124896446|NCT03852433|449244741|FG000|Overall Study|Physician Decision|1|||
124896447|NCT03852433|449244742|FG001|Overall Study|Physician Decision|0|||
124896448|NCT03852433|449244743|FG002|Overall Study|Physician Decision|0|||
124896449|NCT03852433|449244744|FG003|Overall Study|Physician Decision|0|||
124896450|NCT03852433|449244741|FG000|Overall Study|Randomized but never treated|1|||
124445018|NCT03971422|447591750|FG002|Overall Study|Lost to Follow-up|0|||
124445019|NCT03971422|447591748|FG000|Overall Study|Lack of Efficacy|5|||
124445020|NCT03971422|447591749|FG001|Overall Study|Lack of Efficacy|1|||
124896451|NCT03852433|449244742|FG001|Overall Study|Randomized but never treated|0|||
124896452|NCT03852433|449244743|FG002|Overall Study|Randomized but never treated|0|||
124896453|NCT03852433|449244744|FG003|Overall Study|Randomized but never treated|0|||
124896454|NCT01076335|449244745|FG000|Overall Study|Withdrawal by Subject|3|||
124896455|NCT01076335|449244745|FG000|Overall Study|Withdrawal without treatment|1|||
124896456|NCT02616263|449244746|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
124445021|NCT03971422|447591750|FG002|Overall Study|Lack of Efficacy|1|||
124445022|NCT03971422|447591748|FG000|Overall Study|Adverse event, not fatal|2|||
124759368|NCT00452790|448742621|FG001|After Infant Series|Other reasons|0|||
124445023|NCT03971422|447591749|FG001|Overall Study|Adverse event, not fatal|2|||
124445024|NCT03971422|447591750|FG002|Overall Study|Adverse event, not fatal|5|||
124445025|NCT03971422|447591748|FG000|Overall Study|Worsening of MG Symptoms|1|||
124896457|NCT02616263|449244747|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
124896458|NCT02616263|449244746|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
124896459|NCT02616263|449244747|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
124445026|NCT03971422|447591749|FG001|Overall Study|Worsening of MG Symptoms|4|||
124896460|NCT02616263|449244746|FG000|6 Month to 1.5 Year|Death|1|||
124896461|NCT02616263|449244747|FG001|6 Month to 1.5 Year|Death|0|||
124896462|NCT02616263|449244746|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
124896463|NCT02616263|449244747|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
124896464|NCT02616263|449244746|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
124896465|NCT02616263|449244747|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
124896466|NCT02616263|449244746|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
124896467|NCT02616263|449244747|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
124896468|NCT03686384|449244748|FG000|Overall Study|Lack of Efficacy|4|||
124896469|NCT03686384|449244749|FG001|Overall Study|Lack of Efficacy|13|||
124896470|NCT03686384|449244748|FG000|Overall Study|Lost to Follow-up|3|||
124896471|NCT03686384|449244749|FG001|Overall Study|Lost to Follow-up|0|||
124896472|NCT03686384|449244748|FG000|Overall Study|Physician Decision|0|||
124896473|NCT03686384|449244749|FG001|Overall Study|Physician Decision|1|||
124896474|NCT03686384|449244748|FG000|Overall Study|Took prohibited medication|0|||
124896475|NCT03686384|449244749|FG001|Overall Study|Took prohibited medication|1|||
124896476|NCT02820051|449244752|FG000|Overall Study|Lost to Follow-up|7|||
124896477|NCT02820051|449244753|FG001|Overall Study|Lost to Follow-up|4|||
124896478|NCT00614744|449244759|FG000|Overall Study|Lost to Follow-up|5|||
124896479|NCT00614744|449244760|FG001|Overall Study|Lost to Follow-up|4|||
124896480|NCT00614744|449244759|FG000|Overall Study|Incomplete for Behavior Issues|0|||
124896481|NCT00614744|449244760|FG001|Overall Study|Incomplete for Behavior Issues|2|||
124896482|NCT00768066|449244761|FG000|Overall Study|Did not receive study product injection.|3|||
124896483|NCT00768066|449244762|FG001|Overall Study|Did not receive study product injection.|3|||
124896484|NCT00768066|449244763|FG002|Overall Study|Did not receive study product injection.|0|||
124896485|NCT04831775|449244764|FG000|Overall Study|Lost to Follow-up|11|||
124896486|NCT04831775|449244765|FG001|Overall Study|Lost to Follow-up|13|||
124896487|NCT01737268|449244768|FG000|Overall Study|Adverse Event|6|||
124896488|NCT01737268|449244768|FG000|Overall Study|Worsening of Target Disease|2|||
124896489|NCT01737268|449244768|FG000|Overall Study|In consideration of the patient's safety|1|||
124896490|NCT01458275|449244769|FG000|Overall Study|Adverse Event|3|||
124896491|NCT01458275|449244770|FG001|Overall Study|Adverse Event|4|||
124896492|NCT01458275|449244771|FG002|Overall Study|Adverse Event|1|||
124896493|NCT01458275|449244769|FG000|Overall Study|Lost to Follow-up|3|||
124896494|NCT01458275|449244770|FG001|Overall Study|Lost to Follow-up|2|||
124896495|NCT01458275|449244771|FG002|Overall Study|Lost to Follow-up|5|||
124896496|NCT01458275|449244769|FG000|Overall Study|Protocol Violation|5|||
124896497|NCT01458275|449244770|FG001|Overall Study|Protocol Violation|5|||
124896498|NCT01458275|449244771|FG002|Overall Study|Protocol Violation|2|||
124896499|NCT01458275|449244769|FG000|Overall Study|Withdrawal by Subject|3|||
124896500|NCT01458275|449244770|FG001|Overall Study|Withdrawal by Subject|2|||
124896501|NCT01458275|449244771|FG002|Overall Study|Withdrawal by Subject|1|||
124896502|NCT03697460|449244772|FG000|Overall Study|Withdrawal by Subject|3|||
124896503|NCT03499600|449244779|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
124896504|NCT03499600|449244780|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
124896505|NCT00445692|449244781|FG000|Overall Study|Adverse Event|11|||
124896506|NCT00445692|449244781|FG000|Overall Study|Lack of Efficacy|5|||
124896507|NCT03425539|449244782|FG000|Overall Study|Randomized but not treated|0|||
124896508|NCT03425539|449244783|FG001|Overall Study|Randomized but not treated|1|||
124896509|NCT03425539|449244782|FG000|Overall Study|Adverse Event|2|||
124896510|NCT03425539|449244783|FG001|Overall Study|Adverse Event|2|||
124896511|NCT03425539|449244782|FG000|Overall Study|Withdrawal by Subject|3|||
124896512|NCT03425539|449244783|FG001|Overall Study|Withdrawal by Subject|0|||
124896513|NCT03425539|449244782|FG000|Overall Study|Lost to Follow-up|0|||
124896514|NCT03425539|449244783|FG001|Overall Study|Lost to Follow-up|1|||
124896515|NCT01137292|449244784|FG000|Overall Study|Death|30|||
124896516|NCT01137292|449244784|FG000|Overall Study|Adverse Event|3|||
124896517|NCT01137292|449244784|FG000|Overall Study|Lack of Efficacy|13|||
124896518|NCT01137292|449244784|FG000|Overall Study|Lost to Follow-up|1|||
124445027|NCT03971422|447591750|FG002|Overall Study|Worsening of MG Symptoms|2|||
124445028|NCT03971422|447591748|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
124896519|NCT01137292|449244784|FG000|Overall Study|Other|7|||
124896520|NCT02014558|449244785|FG000|Overall Study|Never Received Study Drug|0|||
124896521|NCT02014558|449244786|FG001|Overall Study|Never Received Study Drug|0|||
124896522|NCT02014558|449244787|FG002|Overall Study|Never Received Study Drug|0|||
124896523|NCT02014558|449244788|FG003|Overall Study|Never Received Study Drug|0|||
124896524|NCT02014558|449244789|FG004|Overall Study|Never Received Study Drug|1|||
124896525|NCT02014558|449244790|FG005|Overall Study|Never Received Study Drug|0|||
124896526|NCT02014558|449244791|FG006|Overall Study|Never Received Study Drug|1|||
124896527|NCT02014558|449244792|FG007|Overall Study|Never Received Study Drug|0|||
124896528|NCT02014558|449244793|FG008|Overall Study|Never Received Study Drug|2|||
124896529|NCT02014558|449244794|FG009|Overall Study|Never Received Study Drug|0|||
124445029|NCT03971422|447591749|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
124896530|NCT02014558|449244795|FG010|Overall Study|Never Received Study Drug|2|||
124896531|NCT02014558|449244796|FG011|Overall Study|Never Received Study Drug|2|||
124896532|NCT02014558|449244797|FG012|Overall Study|Never Received Study Drug|0|||
124445030|NCT03971422|447591750|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
124445031|NCT03971422|447591748|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
124445032|NCT03971422|447591749|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
124445033|NCT03971422|447591750|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
124445034|NCT03971422|447591748|FG000|Overall Study|Due to COVID-19 pandemic|0|||
124445035|NCT03971422|447591749|FG001|Overall Study|Due to COVID-19 pandemic|1|||
124445036|NCT03971422|447591750|FG002|Overall Study|Due to COVID-19 pandemic|1|||
124445037|NCT03217266|447591751|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
124445038|NCT03217266|447591752|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
124445039|NCT03217266|447591753|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
124445040|NCT03217266|447591754|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
124759369|NCT00452790|448742620|FG000|Toddler Dose|Failed to return|0|||
124759370|NCT00452790|448742621|FG001|Toddler Dose|Failed to return|1|||
124759371|NCT00452790|448742620|FG000|Toddler Dose|Parent/legal guardian request|0|||
124759372|NCT00452790|448742621|FG001|Toddler Dose|Parent/legal guardian request|1|||
124759373|NCT00348673|448742623|FG000|Stage 1|Randomized but not Treated|0|||
124759374|NCT00348673|448742624|FG001|Stage 1|Randomized but not Treated|0|||
124759375|NCT00348673|448742625|FG002|Stage 1|Randomized but not Treated|1|||
124759376|NCT00348673|448742626|FG003|Stage 1|Randomized but not Treated|0|||
124759377|NCT00348673|448742627|FG004|Stage 1|Randomized but not Treated|0|||
124759378|NCT00348673|448742628|FG005|Stage 1|Randomized but not Treated|0|||
124759379|NCT00348673|448742629|FG006|Stage 1|Randomized but not Treated|0|||
124759380|NCT00348673|448742630|FG007|Stage 1|Randomized but not Treated|0|||
124759381|NCT00348673|448742631|FG008|Stage 1|Randomized but not Treated|0|||
124759382|NCT01712204|448742632|FG000|Overall Study|Adverse Event|3|||
124759383|NCT01712204|448742633|FG001|Overall Study|Adverse Event|1|||
124759384|NCT01712204|448742632|FG000|Overall Study|Withdrawal by Subject|3|||
124759385|NCT01712204|448742633|FG001|Overall Study|Withdrawal by Subject|3|||
124759386|NCT01712204|448742632|FG000|Overall Study|Lost to Follow-up|1|||
124759387|NCT01712204|448742633|FG001|Overall Study|Lost to Follow-up|0|||
124759388|NCT01712204|448742632|FG000|Overall Study|Protocol Violation|1|||
124759389|NCT01712204|448742633|FG001|Overall Study|Protocol Violation|1|||
124759390|NCT01114828|448742641|FG000|Overall Study|Adverse Event|1|||
124759391|NCT01114828|448742642|FG001|Overall Study|Adverse Event|1|||
124759392|NCT01114828|448742641|FG000|Overall Study|Lack of Efficacy|0|||
124759393|NCT01114828|448742642|FG001|Overall Study|Lack of Efficacy|2|||
124759394|NCT01114828|448742641|FG000|Overall Study|Protocol Violation|2|||
124759395|NCT01114828|448742642|FG001|Overall Study|Protocol Violation|0|||
124759396|NCT01114828|448742641|FG000|Overall Study|Withdrawal by Subject|0|||
124759397|NCT01114828|448742642|FG001|Overall Study|Withdrawal by Subject|1|||
124759398|NCT00549445|448742643|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
124759399|NCT00549445|448742644|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
124759400|NCT03790111|448744683|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
124759401|NCT03798717|448744688|FG000|Overall Study|Failed Screening|0|||
124759402|NCT03798717|448744689|FG001|Overall Study|Failed Screening|0|||
124759403|NCT03798717|448744690|FG002|Overall Study|Failed Screening|0|||
124759404|NCT03798717|448744691|FG003|Overall Study|Failed Screening|0|||
124759405|NCT03798717|448744692|FG004|Overall Study|Failed Screening|0|||
124759406|NCT03798717|448744693|FG005|Overall Study|Failed Screening|1|||
124759407|NCT03798717|448744688|FG000|Overall Study|Physician Decision|1|||
124759408|NCT03798717|448744689|FG001|Overall Study|Physician Decision|0|||
124759409|NCT03798717|448744690|FG002|Overall Study|Physician Decision|1|||
124759410|NCT03798717|448744691|FG003|Overall Study|Physician Decision|0|||
124759411|NCT03798717|448744692|FG004|Overall Study|Physician Decision|0|||
124759412|NCT03798717|448744693|FG005|Overall Study|Physician Decision|0|||
124759413|NCT03798717|448744688|FG000|Overall Study|Withdrawal by Subject|0|||
124759414|NCT03798717|448744689|FG001|Overall Study|Withdrawal by Subject|0|||
124759415|NCT03798717|448744690|FG002|Overall Study|Withdrawal by Subject|0|||
124759416|NCT03798717|448744691|FG003|Overall Study|Withdrawal by Subject|1|||
124759417|NCT03798717|448744692|FG004|Overall Study|Withdrawal by Subject|0|||
124445041|NCT03217266|447591751|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
124759418|NCT03798717|448744693|FG005|Overall Study|Withdrawal by Subject|0|||
124759419|NCT03798717|448744688|FG000|Overall Study|Lost to Follow-up|1|||
124759420|NCT03798717|448744689|FG001|Overall Study|Lost to Follow-up|0|||
124759421|NCT03798717|448744690|FG002|Overall Study|Lost to Follow-up|0|||
124759422|NCT03798717|448744691|FG003|Overall Study|Lost to Follow-up|1|||
124759423|NCT03798717|448744692|FG004|Overall Study|Lost to Follow-up|0|||
124759424|NCT03798717|448744693|FG005|Overall Study|Lost to Follow-up|0|||
124544395|NCT00948896|447946797|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
124759425|NCT03798717|448744688|FG000|Overall Study|Adverse Event|0|||
124759426|NCT03798717|448744689|FG001|Overall Study|Adverse Event|1|||
124445042|NCT03217266|447591752|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
124759427|NCT03798717|448744690|FG002|Overall Study|Adverse Event|0|||
124759428|NCT03798717|448744691|FG003|Overall Study|Adverse Event|0|||
124759429|NCT03798717|448744692|FG004|Overall Study|Adverse Event|0|||
124759430|NCT03798717|448744693|FG005|Overall Study|Adverse Event|0|||
124445043|NCT03217266|447591753|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
124445044|NCT03217266|447591754|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
124445045|NCT03217266|447591751|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
124445046|NCT03217266|447591752|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
124445047|NCT03217266|447591753|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
124445048|NCT03217266|447591754|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
124445049|NCT00985166|447591755|FG000|Overall Study|Lost to Follow-up|3|||
124445050|NCT00985166|447591756|FG001|Overall Study|Lost to Follow-up|2|||
124445051|NCT00985166|447591757|FG002|Overall Study|Lost to Follow-up|2|||
124445052|NCT00985166|447591755|FG000|Overall Study|Withdrawal by Subject|3|||
124445053|NCT00985166|447591756|FG001|Overall Study|Withdrawal by Subject|2|||
124445054|NCT00985166|447591757|FG002|Overall Study|Withdrawal by Subject|0|||
124445055|NCT00985166|447591755|FG000|Overall Study|Test not done|2|||
124445056|NCT00985166|447591756|FG001|Overall Study|Test not done|0|||
124445057|NCT00985166|447591757|FG002|Overall Study|Test not done|4|||
124445058|NCT00985166|447591755|FG000|Overall Study|Other|1|||
124445059|NCT00985166|447591756|FG001|Overall Study|Other|0|||
124445060|NCT00985166|447591757|FG002|Overall Study|Other|1|||
124445061|NCT01831544|447591760|FG000|Overall Study|Death|1|||
124445062|NCT01831544|447591760|FG000|Overall Study|Still on original MVAD device|2|||
124445063|NCT04175808|447591761|FG000|Part A|Miscellaneous|2|||
124445064|NCT04175808|447591762|FG001|Part A|Miscellaneous|0|||
124445065|NCT04175808|447591763|FG002|Part A|Miscellaneous|0|||
124445066|NCT04175808|447591764|FG003|Part A|Miscellaneous|0|||
124896533|NCT02014558|449244785|FG000|Overall Study|Adverse Event|0|||
124896534|NCT02014558|449244786|FG001|Overall Study|Adverse Event|0|||
124896535|NCT02014558|449244787|FG002|Overall Study|Adverse Event|0|||
124896536|NCT02014558|449244788|FG003|Overall Study|Adverse Event|0|||
124896537|NCT02014558|449244789|FG004|Overall Study|Adverse Event|1|||
124445067|NCT04175808|447591765|FG004|Part A|Miscellaneous|0|||
124445068|NCT04175808|447591766|FG005|Part A|Miscellaneous|0|||
124445069|NCT04175808|447591767|FG006|Part A|Miscellaneous|0|||
124445070|NCT03801902|447591771|FG000|Overall Study|Did not receive protocol treatment.|1|||
124445071|NCT03801902|447591772|FG001|Overall Study|Did not receive protocol treatment.|0|||
124445072|NCT03801902|447591773|FG002|Overall Study|Did not receive protocol treatment.|0|||
124445073|NCT03801902|447591774|FG003|Overall Study|Did not receive protocol treatment.|0|||
124445074|NCT00528866|447591778|FG000|Overall Study|Protocol Violation|6|||
124445075|NCT01601847|447591779|FG000|Overall Study|Death|1|||
124445076|NCT01601847|447591780|FG001|Overall Study|Death|0|||
124445077|NCT01601847|447591779|FG000|Overall Study|Withdrawal by Subject|11|||
124445078|NCT01601847|447591780|FG001|Overall Study|Withdrawal by Subject|7|||
124445079|NCT01601847|447591779|FG000|Overall Study|Lost to Follow-up|1|||
124445080|NCT01601847|447591780|FG001|Overall Study|Lost to Follow-up|3|||
124445081|NCT02234323|447591781|FG000|All Enrolled|Not Treated: Completed study in database|2|||
124445082|NCT02234323|447591781|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
124445083|NCT02234323|447591781|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
124445084|NCT02234323|447591781|FG000|All Treated|Death|1|||
124445085|NCT02234323|447591781|FG000|All Treated|Physician Decision|5|||
124445086|NCT02234323|447591781|FG000|All Treated|Lack of Efficacy|3|||
124445087|NCT02234323|447591781|FG000|All Treated|Exceeded lab value limit|2|||
124445088|NCT02234323|447591781|FG000|All Treated|Other|7|||
124445089|NCT02644941|447591782|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
124445090|NCT02644941|447591783|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
124445091|NCT04614662|447591784|FG000|Overall Study|Withdrawal by Subject|0|||
124896538|NCT02014558|449244790|FG005|Overall Study|Adverse Event|0|||
124896539|NCT02014558|449244791|FG006|Overall Study|Adverse Event|0|||
124896540|NCT02014558|449244792|FG007|Overall Study|Adverse Event|0|||
124896541|NCT02014558|449244793|FG008|Overall Study|Adverse Event|2|||
124896542|NCT02014558|449244794|FG009|Overall Study|Adverse Event|2|||
124445092|NCT04614662|447591785|FG001|Overall Study|Withdrawal by Subject|1|||
124445093|NCT01136811|447591788|FG000|Overall Study|Physician Decision|11|||
124896543|NCT02014558|449244795|FG010|Overall Study|Adverse Event|5|||
124445094|NCT01009554|447591789|FG000|Overall Study|Adverse Event|1|||
124445095|NCT01009554|447591790|FG001|Overall Study|Adverse Event|1|||
124445096|NCT01009554|447591789|FG000|Overall Study|Withdrawal by Subject|1|||
124445097|NCT01009554|447591790|FG001|Overall Study|Withdrawal by Subject|3|||
124445098|NCT01009554|447591789|FG000|Overall Study|Noncompliant with Study Product|0|||
124445099|NCT01009554|447591790|FG001|Overall Study|Noncompliant with Study Product|3|||
124445100|NCT01605253|447591791|FG000|Overall Study|Physician Decision|3|||
124445101|NCT01605253|447591792|FG001|Overall Study|Physician Decision|2|||
124445102|NCT01605253|447591791|FG000|Overall Study|Lost to Follow-up|3|||
124445103|NCT01605253|447591792|FG001|Overall Study|Lost to Follow-up|1|||
124445104|NCT03231943|447591806|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124445105|NCT03231943|447591807|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
124445106|NCT03231943|447591808|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
124896544|NCT02014558|449244796|FG011|Overall Study|Adverse Event|21|||
124896545|NCT02014558|449244797|FG012|Overall Study|Adverse Event|3|||
124896546|NCT02014558|449244785|FG000|Overall Study|Death|1|||
124445107|NCT03231943|447591809|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124445108|NCT03231943|447591810|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124445109|NCT03231943|447591811|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124445110|NCT03231943|447591812|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124445111|NCT03231943|447591813|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124445112|NCT03231943|447591814|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124445113|NCT03231943|447591815|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124896547|NCT02014558|449244786|FG001|Overall Study|Death|0|||
124896548|NCT02014558|449244787|FG002|Overall Study|Death|0|||
124896549|NCT02014558|449244788|FG003|Overall Study|Death|0|||
124896550|NCT02014558|449244789|FG004|Overall Study|Death|0|||
124896551|NCT02014558|449244790|FG005|Overall Study|Death|0|||
124896552|NCT02014558|449244791|FG006|Overall Study|Death|1|||
124896553|NCT02014558|449244792|FG007|Overall Study|Death|1|||
124896554|NCT02014558|449244793|FG008|Overall Study|Death|2|||
124896555|NCT02014558|449244794|FG009|Overall Study|Death|5|||
124896556|NCT02014558|449244795|FG010|Overall Study|Death|5|||
124896557|NCT02014558|449244796|FG011|Overall Study|Death|19|||
124896558|NCT02014558|449244797|FG012|Overall Study|Death|2|||
124896559|NCT02014558|449244785|FG000|Overall Study|Lack of Efficacy|1|||
124896560|NCT02014558|449244786|FG001|Overall Study|Lack of Efficacy|2|||
124896561|NCT02014558|449244787|FG002|Overall Study|Lack of Efficacy|1|||
124896562|NCT02014558|449244788|FG003|Overall Study|Lack of Efficacy|1|||
124896563|NCT02014558|449244789|FG004|Overall Study|Lack of Efficacy|0|||
124896564|NCT02014558|449244790|FG005|Overall Study|Lack of Efficacy|0|||
124896565|NCT02014558|449244791|FG006|Overall Study|Lack of Efficacy|1|||
124896566|NCT02014558|449244792|FG007|Overall Study|Lack of Efficacy|3|||
124896567|NCT02014558|449244793|FG008|Overall Study|Lack of Efficacy|3|||
124896568|NCT02014558|449244794|FG009|Overall Study|Lack of Efficacy|3|||
124896569|NCT02014558|449244795|FG010|Overall Study|Lack of Efficacy|16|||
124896570|NCT02014558|449244796|FG011|Overall Study|Lack of Efficacy|8|||
124896571|NCT02014558|449244797|FG012|Overall Study|Lack of Efficacy|5|||
124896572|NCT02014558|449244785|FG000|Overall Study|Lost to Follow-up|0|||
124896573|NCT02014558|449244786|FG001|Overall Study|Lost to Follow-up|0|||
124896574|NCT02014558|449244787|FG002|Overall Study|Lost to Follow-up|0|||
124896575|NCT02014558|449244788|FG003|Overall Study|Lost to Follow-up|0|||
124896576|NCT02014558|449244789|FG004|Overall Study|Lost to Follow-up|0|||
124896577|NCT02014558|449244790|FG005|Overall Study|Lost to Follow-up|0|||
124896578|NCT02014558|449244791|FG006|Overall Study|Lost to Follow-up|0|||
124896579|NCT02014558|449244792|FG007|Overall Study|Lost to Follow-up|0|||
124896580|NCT02014558|449244793|FG008|Overall Study|Lost to Follow-up|0|||
124896581|NCT02014558|449244794|FG009|Overall Study|Lost to Follow-up|0|||
124896582|NCT02014558|449244795|FG010|Overall Study|Lost to Follow-up|1|||
124896583|NCT02014558|449244796|FG011|Overall Study|Lost to Follow-up|0|||
124896584|NCT02014558|449244797|FG012|Overall Study|Lost to Follow-up|0|||
124896585|NCT02014558|449244785|FG000|Overall Study|Progressive Disease|1|||
124896586|NCT02014558|449244786|FG001|Overall Study|Progressive Disease|0|||
124896587|NCT02014558|449244787|FG002|Overall Study|Progressive Disease|1|||
124896588|NCT02014558|449244788|FG003|Overall Study|Progressive Disease|1|||
124896589|NCT02014558|449244789|FG004|Overall Study|Progressive Disease|1|||
124896590|NCT02014558|449244790|FG005|Overall Study|Progressive Disease|2|||
124896591|NCT02014558|449244791|FG006|Overall Study|Progressive Disease|1|||
124896592|NCT02014558|449244792|FG007|Overall Study|Progressive Disease|6|||
124896593|NCT02014558|449244793|FG008|Overall Study|Progressive Disease|5|||
124896594|NCT02014558|449244794|FG009|Overall Study|Progressive Disease|6|||
124896595|NCT02014558|449244795|FG010|Overall Study|Progressive Disease|22|||
124896596|NCT02014558|449244796|FG011|Overall Study|Progressive Disease|31|||
124896597|NCT02014558|449244797|FG012|Overall Study|Progressive Disease|6|||
124896598|NCT02014558|449244785|FG000|Overall Study|Withdrawal by Subject|0|||
124896599|NCT02014558|449244786|FG001|Overall Study|Withdrawal by Subject|0|||
124896600|NCT02014558|449244787|FG002|Overall Study|Withdrawal by Subject|0|||
124896601|NCT02014558|449244788|FG003|Overall Study|Withdrawal by Subject|0|||
124896602|NCT02014558|449244789|FG004|Overall Study|Withdrawal by Subject|1|||
124896603|NCT02014558|449244790|FG005|Overall Study|Withdrawal by Subject|0|||
124896604|NCT02014558|449244791|FG006|Overall Study|Withdrawal by Subject|0|||
124896605|NCT02014558|449244792|FG007|Overall Study|Withdrawal by Subject|0|||
124896606|NCT02014558|449244793|FG008|Overall Study|Withdrawal by Subject|0|||
124896607|NCT02014558|449244794|FG009|Overall Study|Withdrawal by Subject|2|||
124896608|NCT02014558|449244795|FG010|Overall Study|Withdrawal by Subject|6|||
124896609|NCT02014558|449244796|FG011|Overall Study|Withdrawal by Subject|10|||
124896610|NCT02014558|449244797|FG012|Overall Study|Withdrawal by Subject|0|||
124896611|NCT02014558|449244785|FG000|Overall Study|Miscellaneous|2|||
124896612|NCT02014558|449244786|FG001|Overall Study|Miscellaneous|1|||
124896613|NCT02014558|449244787|FG002|Overall Study|Miscellaneous|1|||
124896614|NCT02014558|449244788|FG003|Overall Study|Miscellaneous|1|||
124896615|NCT02014558|449244789|FG004|Overall Study|Miscellaneous|0|||
124896616|NCT02014558|449244790|FG005|Overall Study|Miscellaneous|1|||
124896617|NCT02014558|449244791|FG006|Overall Study|Miscellaneous|0|||
124896618|NCT02014558|449244792|FG007|Overall Study|Miscellaneous|1|||
124896619|NCT02014558|449244793|FG008|Overall Study|Miscellaneous|1|||
124896620|NCT02014558|449244794|FG009|Overall Study|Miscellaneous|3|||
124896621|NCT02014558|449244795|FG010|Overall Study|Miscellaneous|12|||
124896622|NCT02014558|449244796|FG011|Overall Study|Miscellaneous|11|||
124896623|NCT02014558|449244797|FG012|Overall Study|Miscellaneous|1|||
124445114|NCT03231943|447591816|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124688581|NCT02989389|448478776|FG004|Period 1|Lost to Follow-up|0|||
124896624|NCT04580407|449244798|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
124896625|NCT05567159|449244803|FG000|Overall Study|Adverse Event|4|||
124688582|NCT02989389|448478777|FG005|Period 1|Lost to Follow-up|0|||
124896626|NCT05567159|449244803|FG000|Overall Study|Physician Decision|3|||
124896627|NCT05567159|449244803|FG000|Overall Study|Protocol deviation|1|||
124896628|NCT00672256|449246855|FG000|Overall Study|PI dropped, bad data|44|||
124896629|NCT02072226|449246856|FG000|Overall Study|Lost to Follow-up|11|||
124896630|NCT02072226|449246857|FG001|Overall Study|Lost to Follow-up|7|||
124896631|NCT02072226|449246856|FG000|Overall Study|Patient Non-compliance|2|||
124896632|NCT02072226|449246857|FG001|Overall Study|Patient Non-compliance|3|||
124896633|NCT02072226|449246856|FG000|Overall Study|Death|1|||
124896634|NCT02072226|449246857|FG001|Overall Study|Death|0|||
124896635|NCT02072226|449246856|FG000|Overall Study|Patient Withdrawal of Consent|1|||
124896636|NCT02072226|449246857|FG001|Overall Study|Patient Withdrawal of Consent|0|||
124896637|NCT03635112|449246861|FG000|Overall Study|Adverse Event|5|||
124896638|NCT03635112|449246862|FG001|Overall Study|Adverse Event|9|||
124896639|NCT03635112|449246863|FG002|Overall Study|Adverse Event|14|||
124896640|NCT03635112|449246861|FG000|Overall Study|Lost to Follow-up|1|||
124896641|NCT03635112|449246862|FG001|Overall Study|Lost to Follow-up|0|||
124896642|NCT03635112|449246863|FG002|Overall Study|Lost to Follow-up|1|||
124896643|NCT03635112|449246861|FG000|Overall Study|Physician Decision|5|||
124896644|NCT03635112|449246862|FG001|Overall Study|Physician Decision|7|||
124896645|NCT03635112|449246863|FG002|Overall Study|Physician Decision|5|||
124896646|NCT03635112|449246861|FG000|Overall Study|Protocol Violation|0|||
124896647|NCT03635112|449246862|FG001|Overall Study|Protocol Violation|0|||
124896648|NCT03635112|449246863|FG002|Overall Study|Protocol Violation|1|||
124896649|NCT03635112|449246861|FG000|Overall Study|Study Terminated by Sponsor|11|||
124896650|NCT03635112|449246862|FG001|Overall Study|Study Terminated by Sponsor|17|||
124896651|NCT03635112|449246863|FG002|Overall Study|Study Terminated by Sponsor|21|||
124896652|NCT03635112|449246861|FG000|Overall Study|Withdrawal by Subject|4|||
124896653|NCT03635112|449246862|FG001|Overall Study|Withdrawal by Subject|9|||
124896654|NCT03635112|449246863|FG002|Overall Study|Withdrawal by Subject|7|||
124896655|NCT03635112|449246861|FG000|Overall Study|Miscellaneous|0|||
124896656|NCT03635112|449246862|FG001|Overall Study|Miscellaneous|0|||
124896657|NCT03635112|449246863|FG002|Overall Study|Miscellaneous|1|||
124896658|NCT03006341|449246865|FG000|Overall Study|Not linked in the EMR|25069|||
124896659|NCT03006341|449246866|FG001|Overall Study|Not linked in the EMR|67505|||
124896660|NCT03006341|449246867|FG002|Overall Study|Not linked in the EMR|30993|||
124896661|NCT03006341|449246868|FG003|Overall Study|Not linked in the EMR|10685|||
124896662|NCT03101592|449246869|FG000|Overall Study|participant files could not be located|111|||
124896663|NCT03101592|449246870|FG001|Overall Study|participant files could not be located|170|||
124896664|NCT03101592|449246871|FG002|Overall Study|participant files could not be located|118|||
124896665|NCT01770860|449246872|FG000|Overall Study|Withdrawal by Subject|4|||
124896666|NCT01770860|449246872|FG000|Overall Study|Lost to Follow-up|1|||
124896667|NCT01770860|449246872|FG000|Overall Study|Administrative decision made by the PI|1|||
124896668|NCT00601640|449246876|FG000|Overall Study|Withdrawal by Subject|3|||
124896669|NCT00601640|449246877|FG001|Overall Study|Withdrawal by Subject|0|||
124896670|NCT00601640|449246878|FG002|Overall Study|Withdrawal by Subject|7|||
124896671|NCT00601640|449246876|FG000|Overall Study|Death|1|||
124896672|NCT00601640|449246877|FG001|Overall Study|Death|0|||
124896673|NCT00601640|449246878|FG002|Overall Study|Death|0|||
124896674|NCT00601640|449246876|FG000|Overall Study|Adverse Event|0|||
124896675|NCT00601640|449246877|FG001|Overall Study|Adverse Event|4|||
124896676|NCT00601640|449246878|FG002|Overall Study|Adverse Event|2|||
124896677|NCT00601640|449246876|FG000|Overall Study|intercurrent illness|1|||
124896678|NCT00601640|449246877|FG001|Overall Study|intercurrent illness|0|||
124896679|NCT00601640|449246878|FG002|Overall Study|intercurrent illness|0|||
124896680|NCT00601640|449246876|FG000|Overall Study|change in eligibility status|0|||
124896681|NCT00601640|449246877|FG001|Overall Study|change in eligibility status|1|||
124896682|NCT00601640|449246878|FG002|Overall Study|change in eligibility status|1|||
124896683|NCT01872611|449246883|FG000|Overall Study|Adverse Event|3|||
124896684|NCT01872611|449246884|FG001|Overall Study|Adverse Event|1|||
124896685|NCT01872611|449246883|FG000|Overall Study|Adverse Event, prior to treatment|0|||
124688583|NCT02989389|448478778|FG006|Period 1|Lost to Follow-up|0|||
124688584|NCT02989389|448478779|FG007|Period 1|Lost to Follow-up|0|||
124896686|NCT01872611|449246884|FG001|Overall Study|Adverse Event, prior to treatment|1|||
124896687|NCT01872611|449246883|FG000|Overall Study|Death|0|||
124896688|NCT01872611|449246884|FG001|Overall Study|Death|1|||
124896689|NCT01872611|449246883|FG000|Overall Study|Death, prior to treatment|0|||
124896690|NCT01872611|449246884|FG001|Overall Study|Death, prior to treatment|1|||
124896691|NCT01872611|449246883|FG000|Overall Study|Lost to Follow-up|8|||
124896692|NCT01872611|449246884|FG001|Overall Study|Lost to Follow-up|1|||
124896693|NCT01872611|449246883|FG000|Overall Study|Physician Decision|1|||
124896694|NCT01872611|449246884|FG001|Overall Study|Physician Decision|0|||
124896695|NCT01872611|449246883|FG000|Overall Study|Withdrawal by Subject|6|||
124896696|NCT01872611|449246884|FG001|Overall Study|Withdrawal by Subject|1|||
124896697|NCT01872611|449246883|FG000|Overall Study|Reason not provided|6|||
124896698|NCT01872611|449246884|FG001|Overall Study|Reason not provided|6|||
124896699|NCT03537651|449246885|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
124896700|NCT03537651|449246885|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
124896701|NCT03537651|449246885|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
124896702|NCT03537651|449246885|FG000|Part A (Up to 96 Weeks)|Other|1|||
124688585|NCT02989389|448478780|FG008|Period 1|Lost to Follow-up|0|||
124896703|NCT03537651|449246885|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
124896704|NCT03537651|449246885|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
124896705|NCT03537651|449246885|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
124896706|NCT03537651|449246885|FG000|Part B (Up to 192 Weeks)|Other|1|||
124896707|NCT02939183|449246888|FG000|Overall Study|Death|0|||
124896708|NCT02939183|449246889|FG001|Overall Study|Death|0|||
124896709|NCT02939183|449246890|FG002|Overall Study|Death|1|||
124896710|NCT02939183|449246891|FG003|Overall Study|Death|0|||
124896711|NCT02939183|449246892|FG004|Overall Study|Death|0|||
124896712|NCT02939183|449246893|FG005|Overall Study|Death|2|||
124896713|NCT02939183|449246894|FG006|Overall Study|Death|1|||
124896714|NCT02939183|449246895|FG007|Overall Study|Death|0|||
124896715|NCT02939183|449246896|FG008|Overall Study|Death|0|||
124896716|NCT02939183|449246888|FG000|Overall Study|Sponsor decision|0|||
124896717|NCT02939183|449246889|FG001|Overall Study|Sponsor decision|1|||
124896718|NCT02939183|449246890|FG002|Overall Study|Sponsor decision|0|||
124896719|NCT02939183|449246891|FG003|Overall Study|Sponsor decision|1|||
124896720|NCT02939183|449246892|FG004|Overall Study|Sponsor decision|2|||
124896721|NCT02939183|449246893|FG005|Overall Study|Sponsor decision|0|||
124896722|NCT02939183|449246894|FG006|Overall Study|Sponsor decision|3|||
124896723|NCT02939183|449246895|FG007|Overall Study|Sponsor decision|1|||
124896724|NCT02939183|449246896|FG008|Overall Study|Sponsor decision|4|||
124896725|NCT02939183|449246888|FG000|Overall Study|Withdrawal by Subject|0|||
124896726|NCT02939183|449246889|FG001|Overall Study|Withdrawal by Subject|2|||
124896727|NCT02939183|449246890|FG002|Overall Study|Withdrawal by Subject|0|||
124896728|NCT02939183|449246891|FG003|Overall Study|Withdrawal by Subject|1|||
124896729|NCT02939183|449246892|FG004|Overall Study|Withdrawal by Subject|0|||
124896730|NCT02939183|449246893|FG005|Overall Study|Withdrawal by Subject|0|||
124896731|NCT02939183|449246894|FG006|Overall Study|Withdrawal by Subject|2|||
124896732|NCT02939183|449246895|FG007|Overall Study|Withdrawal by Subject|2|||
124896733|NCT02939183|449246896|FG008|Overall Study|Withdrawal by Subject|2|||
124896734|NCT02939183|449246888|FG000|Overall Study|Not treated due to adverse event|0|||
124688586|NCT02989389|448478781|FG009|Period 1|Lost to Follow-up|0|||
124688587|NCT02989389|448478772|FG000|Period 1|Physician Decision|0|||
124688588|NCT02989389|448478773|FG001|Period 1|Physician Decision|0|||
124896735|NCT02939183|449246889|FG001|Overall Study|Not treated due to adverse event|0|||
124896736|NCT02939183|449246890|FG002|Overall Study|Not treated due to adverse event|0|||
124896737|NCT02939183|449246891|FG003|Overall Study|Not treated due to adverse event|1|||
124896738|NCT02939183|449246892|FG004|Overall Study|Not treated due to adverse event|0|||
124896739|NCT02939183|449246893|FG005|Overall Study|Not treated due to adverse event|0|||
124896740|NCT02939183|449246894|FG006|Overall Study|Not treated due to adverse event|1|||
124896741|NCT02939183|449246895|FG007|Overall Study|Not treated due to adverse event|0|||
124896742|NCT02939183|449246896|FG008|Overall Study|Not treated due to adverse event|0|||
124896743|NCT00654238|449246901|FG000|Overall Study|Screen Failures|4|||
124896744|NCT01446003|449246902|FG000|Period 1|Protocol Violation|2|||
124896745|NCT01446003|449246903|FG001|Period 1|Protocol Violation|0|||
124896746|NCT01446003|449246902|FG000|Period 2|Adverse Event|1|||
124896747|NCT01446003|449246903|FG001|Period 2|Adverse Event|0|||
124896748|NCT00318656|449246904|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
124896749|NCT00318656|449246905|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
124896750|NCT00318656|449246904|FG000|Overall Study|Did not receive any treatment|0|||
124896751|NCT00318656|449246905|FG001|Overall Study|Did not receive any treatment|1|||
124896752|NCT03905135|449246906|FG000|Dose Escalation|Adverse Event|1|||
124896753|NCT03905135|449246907|FG001|Dose Escalation|Adverse Event|1|||
124896754|NCT03905135|449246906|FG000|Dose Escalation|Progressive disease|3|||
124896755|NCT03905135|449246907|FG001|Dose Escalation|Progressive disease|1|||
124896756|NCT03905135|449246906|FG000|Dose Escalation|Intercurrent illness|1|||
124896757|NCT03905135|449246907|FG001|Dose Escalation|Intercurrent illness|0|||
124896758|NCT01740557|449246908|FG000|Overall Study|Ineligible|1|||
124896759|NCT01740557|449246908|FG000|Overall Study|Screen failure|1|||
124896760|NCT00490555|449246913|FG000|Overall Study|noncompliant with drug administration|0|||
124896761|NCT00490555|449246914|FG001|Overall Study|noncompliant with drug administration|0|||
124896762|NCT00490555|449246915|FG002|Overall Study|noncompliant with drug administration|2|||
124896763|NCT00490555|449246916|FG003|Overall Study|noncompliant with drug administration|0|||
124896764|NCT01268566|449246917|FG000|Overall Study|Lost to Follow-up|1|||
124896765|NCT01268566|449246917|FG000|Overall Study|Withdrawal by Subject|12|||
124896766|NCT01268566|449246917|FG000|Overall Study|Death|30|||
124896767|NCT01348087|449246927|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
124896768|NCT01348087|449246927|FG000|Overall Study|Administrative problems|79|||
124896769|NCT01348087|449246927|FG000|Overall Study|protocol deviation|1|||
124896770|NCT01348087|449246927|FG000|Overall Study|Lost to Follow-up|1|||
124896771|NCT01348087|449246927|FG000|Overall Study|Subject withdrew consent|7|||
124896772|NCT01348087|449246927|FG000|Overall Study|Adverse Event|25|||
124896773|NCT01007149|449246928|FG000|Overall Study|Administrative problems|0|||
124896774|NCT01007149|449246929|FG001|Overall Study|Administrative problems|1|||
124896775|NCT01913340|449246930|FG000|Overall Study|Death|2|||
124896776|NCT01913340|449246931|FG001|Overall Study|Death|5|||
124896777|NCT01913340|449246930|FG000|Overall Study|Lost to Follow-up|1|||
124896778|NCT01913340|449246931|FG001|Overall Study|Lost to Follow-up|1|||
124896779|NCT02784704|449246932|FG000|Overall Study|Adverse Event|4|||
124896780|NCT02784704|449246933|FG001|Overall Study|Adverse Event|2|||
124896781|NCT02784704|449246932|FG000|Overall Study|Lost to Follow-up|6|||
124896782|NCT02784704|449246933|FG001|Overall Study|Lost to Follow-up|4|||
124896783|NCT02784704|449246932|FG000|Overall Study|Withdrawal by Subject|1|||
124896784|NCT02784704|449246933|FG001|Overall Study|Withdrawal by Subject|3|||
124688589|NCT02989389|448478774|FG002|Period 1|Physician Decision|0|||
124896785|NCT02784704|449246932|FG000|Overall Study|Subject Non Compliance|2|||
124896786|NCT02784704|449246933|FG001|Overall Study|Subject Non Compliance|0|||
124896787|NCT00603538|449246934|FG000|Overall Study|Adverse Event|0|||
124688590|NCT02989389|448478775|FG003|Period 1|Physician Decision|0|||
124896788|NCT00603538|449246935|FG001|Overall Study|Adverse Event|4|||
124896789|NCT00603538|449246936|FG002|Overall Study|Adverse Event|2|||
124896790|NCT00603538|449246934|FG000|Overall Study|Objective progression or relapse|3|||
124445115|NCT03231943|447591817|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124445116|NCT03231943|447591818|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
124445117|NCT03231943|447591806|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124445118|NCT03231943|447591807|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
124445119|NCT03231943|447591808|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124445120|NCT03231943|447591809|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124445121|NCT03231943|447591810|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124445122|NCT03231943|447591811|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124445123|NCT03231943|447591812|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124445124|NCT03231943|447591813|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124445125|NCT03231943|447591814|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124445126|NCT03231943|447591815|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124445127|NCT03231943|447591816|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124445128|NCT03231943|447591817|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124445129|NCT03231943|447591818|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
124445130|NCT03231943|447591806|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
124445131|NCT03231943|447591807|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124445132|NCT03231943|447591808|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124445133|NCT03231943|447591809|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124445134|NCT03231943|447591810|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124445135|NCT03231943|447591811|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124445136|NCT03231943|447591812|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124445137|NCT03231943|447591813|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124445138|NCT03231943|447591814|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124445139|NCT03231943|447591815|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124445140|NCT03231943|447591816|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124445141|NCT03231943|447591817|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124445142|NCT03231943|447591818|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
124445143|NCT03231943|447591806|FG000|Part 2|Adverse Event|0|||
124445144|NCT03231943|447591807|FG001|Part 2|Adverse Event|0|||
124445145|NCT03231943|447591808|FG002|Part 2|Adverse Event|0|||
124445146|NCT03231943|447591809|FG003|Part 2|Adverse Event|0|||
124445147|NCT03231943|447591810|FG004|Part 2|Adverse Event|0|||
124445148|NCT03231943|447591811|FG005|Part 2|Adverse Event|0|||
124445149|NCT03231943|447591812|FG006|Part 2|Adverse Event|0|||
124445150|NCT03231943|447591813|FG007|Part 2|Adverse Event|0|||
124445151|NCT03231943|447591814|FG008|Part 2|Adverse Event|0|||
124445152|NCT03231943|447591815|FG009|Part 2|Adverse Event|0|||
124445153|NCT03231943|447591816|FG010|Part 2|Adverse Event|1|||
124445154|NCT03231943|447591817|FG011|Part 2|Adverse Event|0|||
124445155|NCT03231943|447591818|FG012|Part 2|Adverse Event|0|||
124445156|NCT03231943|447591806|FG000|Part 2|Withdrawal by Subject|0|||
124445157|NCT03231943|447591807|FG001|Part 2|Withdrawal by Subject|0|||
124445158|NCT03231943|447591808|FG002|Part 2|Withdrawal by Subject|0|||
124445159|NCT03231943|447591809|FG003|Part 2|Withdrawal by Subject|0|||
124445160|NCT03231943|447591810|FG004|Part 2|Withdrawal by Subject|0|||
124445161|NCT03231943|447591811|FG005|Part 2|Withdrawal by Subject|0|||
124445162|NCT03231943|447591812|FG006|Part 2|Withdrawal by Subject|0|||
124445163|NCT03231943|447591813|FG007|Part 2|Withdrawal by Subject|0|||
124445164|NCT03231943|447591814|FG008|Part 2|Withdrawal by Subject|0|||
124445165|NCT03231943|447591815|FG009|Part 2|Withdrawal by Subject|0|||
124445166|NCT03231943|447591816|FG010|Part 2|Withdrawal by Subject|0|||
124445167|NCT03231943|447591817|FG011|Part 2|Withdrawal by Subject|1|||
124445168|NCT03231943|447591818|FG012|Part 2|Withdrawal by Subject|0|||
124445169|NCT04824521|447591821|FG000|Overall Study|Lost to Follow-up|1|||
124445170|NCT01843218|447592102|FG000|Overall Study|Withdrawal by Subject|5|||
124445171|NCT03829319|447592103|FG000|Overall Study|Sponsor's Decision|4|||
124445172|NCT03829319|447592104|FG001|Overall Study|Sponsor's Decision|90|||
124445173|NCT03829319|447592105|FG002|Overall Study|Sponsor's Decision|102|||
124445174|NCT03829319|447592103|FG000|Overall Study|Withdrawal by Subject|1|||
124445175|NCT03829319|447592104|FG001|Overall Study|Withdrawal by Subject|5|||
124445176|NCT03829319|447592105|FG002|Overall Study|Withdrawal by Subject|4|||
124445177|NCT03829319|447592103|FG000|Overall Study|Physician Decision|0|||
124445178|NCT03829319|447592104|FG001|Overall Study|Physician Decision|3|||
124445179|NCT03829319|447592105|FG002|Overall Study|Physician Decision|0|||
124445180|NCT03829319|447592103|FG000|Overall Study|Lost to Follow-up|0|||
124445181|NCT03829319|447592104|FG001|Overall Study|Lost to Follow-up|0|||
124445182|NCT03829319|447592105|FG002|Overall Study|Lost to Follow-up|1|||
124445183|NCT03829319|447592103|FG000|Overall Study|Death|8|||
124445184|NCT03829319|447592104|FG001|Overall Study|Death|277|||
124445185|NCT03829319|447592105|FG002|Overall Study|Death|266|||
124445186|NCT04498832|447592106|FG000|Overall Study|Adverse Event|1|||
124445187|NCT04498832|447592107|FG001|Overall Study|Adverse Event|3|||
124445188|NCT04498832|447592106|FG000|Overall Study|Withdrawal by Subject|0|||
124445189|NCT04498832|447592107|FG001|Overall Study|Withdrawal by Subject|1|||
124445190|NCT05579990|447592113|FG000|Overall Study|Lost to Follow-up|3|||
124445191|NCT05560763|447592114|FG000|Overall Study|Withdrawal by Subject|4|||
124445192|NCT02408861|447592117|FG000|Overall Study|Death|0|||
124445193|NCT02408861|447592118|FG001|Overall Study|Death|3|||
124445194|NCT02408861|447592119|FG002|Overall Study|Death|1|||
124445195|NCT02408861|447592120|FG003|Overall Study|Death|2|||
124445196|NCT02408861|447592121|FG004|Overall Study|Death|4|||
124688591|NCT02989389|448478776|FG004|Period 1|Physician Decision|0|||
124688592|NCT02989389|448478777|FG005|Period 1|Physician Decision|0|||
124896791|NCT00603538|449246935|FG001|Overall Study|Objective progression or relapse|0|||
124896792|NCT00603538|449246936|FG002|Overall Study|Objective progression or relapse|0|||
124896793|NCT05750745|449246938|FG000|Overall Study|Adverse Event|1|||
124896794|NCT05750745|449246939|FG001|Overall Study|Adverse Event|0|||
124896795|NCT05750745|449246940|FG002|Overall Study|Adverse Event|0|||
124896796|NCT05750745|449246938|FG000|Overall Study|Protocol Violation|1|||
124896797|NCT05750745|449246939|FG001|Overall Study|Protocol Violation|0|||
124896798|NCT05750745|449246940|FG002|Overall Study|Protocol Violation|0|||
124896799|NCT05750745|449246938|FG000|Overall Study|Withdrawal by Subject|0|||
124896800|NCT05750745|449246939|FG001|Overall Study|Withdrawal by Subject|1|||
124896801|NCT05750745|449246940|FG002|Overall Study|Withdrawal by Subject|0|||
124896802|NCT00783692|449246946|FG000|Induction Phase|Adverse Event|7|||
124896803|NCT00783692|449246947|FG001|Induction Phase|Adverse Event|9|||
124896804|NCT00783692|449246948|FG002|Induction Phase|Adverse Event|24|||
124896805|NCT00783692|449246949|FG003|Induction Phase|Adverse Event|0|||
124896806|NCT00783692|449246950|FG004|Induction Phase|Adverse Event|0|||
124896807|NCT00783692|449246951|FG005|Induction Phase|Adverse Event|0|||
124896808|NCT00783692|449246952|FG006|Induction Phase|Adverse Event|0|||
124896809|NCT00783692|449246946|FG000|Induction Phase|Protocol Violation|0|||
124896810|NCT00783692|449246947|FG001|Induction Phase|Protocol Violation|0|||
124896811|NCT00783692|449246948|FG002|Induction Phase|Protocol Violation|1|||
124896812|NCT00783692|449246949|FG003|Induction Phase|Protocol Violation|0|||
124896813|NCT00783692|449246950|FG004|Induction Phase|Protocol Violation|0|||
124896814|NCT00783692|449246951|FG005|Induction Phase|Protocol Violation|0|||
124896815|NCT00783692|449246952|FG006|Induction Phase|Protocol Violation|0|||
124896816|NCT00783692|449246946|FG000|Induction Phase|Lack of Efficacy|1|||
124896817|NCT00783692|449246947|FG001|Induction Phase|Lack of Efficacy|3|||
124896818|NCT00783692|449246948|FG002|Induction Phase|Lack of Efficacy|28|||
124896819|NCT00783692|449246949|FG003|Induction Phase|Lack of Efficacy|0|||
124896820|NCT00783692|449246950|FG004|Induction Phase|Lack of Efficacy|0|||
124896821|NCT00783692|449246951|FG005|Induction Phase|Lack of Efficacy|0|||
124445197|NCT02408861|447592122|FG005|Overall Study|Death|1|||
124445198|NCT02408861|447592123|FG006|Overall Study|Death|0|||
124688593|NCT02989389|448478778|FG006|Period 1|Physician Decision|0|||
124688594|NCT02989389|448478779|FG007|Period 1|Physician Decision|0|||
124688595|NCT02989389|448478780|FG008|Period 1|Physician Decision|1|||
124688596|NCT02989389|448478781|FG009|Period 1|Physician Decision|0|||
124896822|NCT00783692|449246952|FG006|Induction Phase|Lack of Efficacy|0|||
124896823|NCT00783692|449246946|FG000|Induction Phase|Withdrawal by Subject|3|||
124445199|NCT02408861|447592117|FG000|Overall Study|Lost to Follow-up|0|||
124896824|NCT00783692|449246947|FG001|Induction Phase|Withdrawal by Subject|9|||
124896825|NCT00783692|449246948|FG002|Induction Phase|Withdrawal by Subject|16|||
124896826|NCT00783692|449246949|FG003|Induction Phase|Withdrawal by Subject|0|||
124896827|NCT00783692|449246950|FG004|Induction Phase|Withdrawal by Subject|0|||
124896828|NCT00783692|449246951|FG005|Induction Phase|Withdrawal by Subject|0|||
124896829|NCT00783692|449246952|FG006|Induction Phase|Withdrawal by Subject|0|||
124896830|NCT00783692|449246946|FG000|Induction Phase|Lost to Follow-up|0|||
124896831|NCT00783692|449246947|FG001|Induction Phase|Lost to Follow-up|0|||
124896832|NCT00783692|449246948|FG002|Induction Phase|Lost to Follow-up|3|||
124896833|NCT00783692|449246949|FG003|Induction Phase|Lost to Follow-up|0|||
124896834|NCT00783692|449246950|FG004|Induction Phase|Lost to Follow-up|0|||
124896835|NCT00783692|449246951|FG005|Induction Phase|Lost to Follow-up|0|||
124896836|NCT00783692|449246952|FG006|Induction Phase|Lost to Follow-up|0|||
124896837|NCT00783692|449246946|FG000|Induction Phase|Other|0|||
124896838|NCT00783692|449246947|FG001|Induction Phase|Other|0|||
124896839|NCT00783692|449246948|FG002|Induction Phase|Other|2|||
124896840|NCT00783692|449246949|FG003|Induction Phase|Other|0|||
124896841|NCT00783692|449246950|FG004|Induction Phase|Other|0|||
124896842|NCT00783692|449246951|FG005|Induction Phase|Other|0|||
124896843|NCT00783692|449246952|FG006|Induction Phase|Other|0|||
124896844|NCT00783692|449246946|FG000|Maintenance Phase|Adverse Event|7|||
124896845|NCT00783692|449246947|FG001|Maintenance Phase|Adverse Event|0|||
124896846|NCT00783692|449246948|FG002|Maintenance Phase|Adverse Event|0|||
124896847|NCT00783692|449246949|FG003|Maintenance Phase|Adverse Event|15|||
124896848|NCT00783692|449246950|FG004|Maintenance Phase|Adverse Event|12|||
124896849|NCT00783692|449246951|FG005|Maintenance Phase|Adverse Event|9|||
124896850|NCT00783692|449246952|FG006|Maintenance Phase|Adverse Event|38|||
124896851|NCT00783692|449246946|FG000|Maintenance Phase|Protocol Violation|0|||
124896852|NCT00783692|449246947|FG001|Maintenance Phase|Protocol Violation|0|||
124896853|NCT00783692|449246948|FG002|Maintenance Phase|Protocol Violation|0|||
124896854|NCT00783692|449246949|FG003|Maintenance Phase|Protocol Violation|1|||
124896855|NCT00783692|449246950|FG004|Maintenance Phase|Protocol Violation|2|||
124896856|NCT00783692|449246951|FG005|Maintenance Phase|Protocol Violation|3|||
124896857|NCT00783692|449246952|FG006|Maintenance Phase|Protocol Violation|4|||
124896858|NCT00783692|449246946|FG000|Maintenance Phase|Lack of Efficacy|79|||
124896859|NCT00783692|449246947|FG001|Maintenance Phase|Lack of Efficacy|0|||
124896860|NCT00783692|449246948|FG002|Maintenance Phase|Lack of Efficacy|0|||
124896861|NCT00783692|449246949|FG003|Maintenance Phase|Lack of Efficacy|64|||
124896862|NCT00783692|449246950|FG004|Maintenance Phase|Lack of Efficacy|58|||
124896863|NCT00783692|449246951|FG005|Maintenance Phase|Lack of Efficacy|48|||
124896864|NCT00783692|449246952|FG006|Maintenance Phase|Lack of Efficacy|177|||
124896865|NCT00783692|449246946|FG000|Maintenance Phase|Withdrawal by Subject|7|||
124896866|NCT00783692|449246947|FG001|Maintenance Phase|Withdrawal by Subject|0|||
124896867|NCT00783692|449246948|FG002|Maintenance Phase|Withdrawal by Subject|0|||
124896868|NCT00783692|449246949|FG003|Maintenance Phase|Withdrawal by Subject|7|||
124896869|NCT00783692|449246950|FG004|Maintenance Phase|Withdrawal by Subject|6|||
124896870|NCT00783692|449246951|FG005|Maintenance Phase|Withdrawal by Subject|9|||
124445200|NCT02408861|447592118|FG001|Overall Study|Lost to Follow-up|0|||
124445201|NCT02408861|447592119|FG002|Overall Study|Lost to Follow-up|1|||
124445202|NCT02408861|447592120|FG003|Overall Study|Lost to Follow-up|1|||
124445203|NCT02408861|447592121|FG004|Overall Study|Lost to Follow-up|4|||
124445204|NCT02408861|447592122|FG005|Overall Study|Lost to Follow-up|2|||
124445205|NCT02408861|447592123|FG006|Overall Study|Lost to Follow-up|1|||
124445206|NCT02408861|447592117|FG000|Overall Study|Disease Progression|0|||
124445207|NCT02408861|447592118|FG001|Overall Study|Disease Progression|0|||
124445208|NCT02408861|447592119|FG002|Overall Study|Disease Progression|1|||
124445209|NCT02408861|447592120|FG003|Overall Study|Disease Progression|0|||
124445210|NCT02408861|447592121|FG004|Overall Study|Disease Progression|3|||
124445211|NCT02408861|447592122|FG005|Overall Study|Disease Progression|1|||
124896871|NCT00783692|449246952|FG006|Maintenance Phase|Withdrawal by Subject|24|||
124896872|NCT00783692|449246946|FG000|Maintenance Phase|Lost to Follow-up|2|||
124896873|NCT00783692|449246947|FG001|Maintenance Phase|Lost to Follow-up|0|||
124445212|NCT02408861|447592123|FG006|Overall Study|Disease Progression|1|||
124445213|NCT02408861|447592117|FG000|Overall Study|Adverse Event|1|||
124688597|NCT00374868|448478782|FG000|Overall Study|Adverse Event|12|||
124688598|NCT00374868|448478782|FG000|Overall Study|Progressive Disease|7|||
124688599|NCT00374868|448478782|FG000|Overall Study|Physician Decision|13|||
124688600|NCT00374868|448478782|FG000|Overall Study|Lost to Follow-up|1|||
124688601|NCT00374868|448478782|FG000|Overall Study|Death|2|||
124896874|NCT00783692|449246948|FG002|Maintenance Phase|Lost to Follow-up|0|||
124896875|NCT00783692|449246949|FG003|Maintenance Phase|Lost to Follow-up|1|||
124896876|NCT00783692|449246950|FG004|Maintenance Phase|Lost to Follow-up|3|||
124896877|NCT00783692|449246951|FG005|Maintenance Phase|Lost to Follow-up|2|||
124896878|NCT00783692|449246952|FG006|Maintenance Phase|Lost to Follow-up|5|||
124896879|NCT00783692|449246946|FG000|Maintenance Phase|Other|0|||
124896880|NCT00783692|449246947|FG001|Maintenance Phase|Other|0|||
124896881|NCT00783692|449246948|FG002|Maintenance Phase|Other|0|||
124445214|NCT02408861|447592118|FG001|Overall Study|Adverse Event|0|||
124445215|NCT02408861|447592119|FG002|Overall Study|Adverse Event|1|||
124896882|NCT00783692|449246949|FG003|Maintenance Phase|Other|1|||
124445216|NCT02408861|447592120|FG003|Overall Study|Adverse Event|0|||
124896883|NCT00783692|449246950|FG004|Maintenance Phase|Other|0|||
124445217|NCT02408861|447592121|FG004|Overall Study|Adverse Event|2|||
124445218|NCT02408861|447592122|FG005|Overall Study|Adverse Event|0|||
124445219|NCT02408861|447592123|FG006|Overall Study|Adverse Event|0|||
124896884|NCT00783692|449246951|FG005|Maintenance Phase|Other|1|||
124896885|NCT00783692|449246952|FG006|Maintenance Phase|Other|1|||
124896886|NCT01096056|449246955|FG000|Overall Study|Lost to Follow-up|0|||
124896887|NCT01096056|449246956|FG001|Overall Study|Lost to Follow-up|1|||
124896888|NCT03568162|449246960|FG000|Overall Study|Adverse Event|0|||
124896889|NCT03568162|449246961|FG001|Overall Study|Adverse Event|1|||
124896890|NCT03568162|449246962|FG002|Overall Study|Adverse Event|2|||
124896891|NCT03568162|449246963|FG003|Overall Study|Adverse Event|0|||
124896892|NCT03568162|449246964|FG004|Overall Study|Adverse Event|0|||
124896893|NCT03568162|449246965|FG005|Overall Study|Adverse Event|1|||
124896894|NCT03568162|449246960|FG000|Overall Study|Death|0|||
124896895|NCT03568162|449246961|FG001|Overall Study|Death|0|||
124896896|NCT03568162|449246962|FG002|Overall Study|Death|0|||
124896897|NCT03568162|449246963|FG003|Overall Study|Death|0|||
124896898|NCT03568162|449246964|FG004|Overall Study|Death|1|||
124896899|NCT03568162|449246965|FG005|Overall Study|Death|0|||
124896900|NCT03568162|449246960|FG000|Overall Study|Lost to Follow-up|3|||
124896901|NCT03568162|449246961|FG001|Overall Study|Lost to Follow-up|2|||
124896902|NCT03568162|449246962|FG002|Overall Study|Lost to Follow-up|4|||
124896903|NCT03568162|449246963|FG003|Overall Study|Lost to Follow-up|2|||
124896904|NCT03568162|449246964|FG004|Overall Study|Lost to Follow-up|3|||
124896905|NCT03568162|449246965|FG005|Overall Study|Lost to Follow-up|2|||
124896906|NCT03568162|449246960|FG000|Overall Study|Physician Decision|0|||
124896907|NCT03568162|449246961|FG001|Overall Study|Physician Decision|1|||
124896908|NCT03568162|449246962|FG002|Overall Study|Physician Decision|1|||
124896909|NCT03568162|449246963|FG003|Overall Study|Physician Decision|0|||
124896910|NCT03568162|449246964|FG004|Overall Study|Physician Decision|1|||
124896911|NCT03568162|449246965|FG005|Overall Study|Physician Decision|0|||
124896912|NCT03568162|449246960|FG000|Overall Study|Pregnancy|0|||
124896913|NCT03568162|449246961|FG001|Overall Study|Pregnancy|0|||
124896914|NCT03568162|449246962|FG002|Overall Study|Pregnancy|0|||
124896915|NCT03568162|449246963|FG003|Overall Study|Pregnancy|1|||
124896916|NCT03568162|449246964|FG004|Overall Study|Pregnancy|0|||
124896917|NCT03568162|449246965|FG005|Overall Study|Pregnancy|0|||
124896918|NCT03568162|449246960|FG000|Overall Study|Protocol Violation|1|||
124896919|NCT03568162|449246961|FG001|Overall Study|Protocol Violation|0|||
124896920|NCT03568162|449246962|FG002|Overall Study|Protocol Violation|1|||
124896921|NCT03568162|449246963|FG003|Overall Study|Protocol Violation|1|||
124896922|NCT03568162|449246964|FG004|Overall Study|Protocol Violation|1|||
124896923|NCT03568162|449246965|FG005|Overall Study|Protocol Violation|1|||
124896924|NCT03568162|449246960|FG000|Overall Study|Withdrawal by Subject|15|||
124896925|NCT03568162|449246961|FG001|Overall Study|Withdrawal by Subject|15|||
124896926|NCT03568162|449246962|FG002|Overall Study|Withdrawal by Subject|26|||
124896927|NCT03568162|449246963|FG003|Overall Study|Withdrawal by Subject|22|||
124896928|NCT03568162|449246964|FG004|Overall Study|Withdrawal by Subject|6|||
124896929|NCT03568162|449246965|FG005|Overall Study|Withdrawal by Subject|9|||
124896930|NCT03568162|449246960|FG000|Overall Study|Others|3|||
124896931|NCT03568162|449246961|FG001|Overall Study|Others|4|||
124896932|NCT03568162|449246962|FG002|Overall Study|Others|1|||
124896933|NCT03568162|449246963|FG003|Overall Study|Others|4|||
124896934|NCT03568162|449246964|FG004|Overall Study|Others|2|||
124896935|NCT03568162|449246965|FG005|Overall Study|Others|1|||
124896936|NCT03717194|449246967|FG000|Overall Study|Withdrawal by Subject|2|||
124896937|NCT03717194|449246968|FG001|Overall Study|Withdrawal by Subject|4|||
124896938|NCT03717194|449246967|FG000|Overall Study|Adverse Event|1|||
124896939|NCT03717194|449246968|FG001|Overall Study|Adverse Event|1|||
124445220|NCT02408861|447592117|FG000|Overall Study|Physician Decision|1|||
124445221|NCT02408861|447592118|FG001|Overall Study|Physician Decision|1|||
124445222|NCT02408861|447592119|FG002|Overall Study|Physician Decision|1|||
124896940|NCT01190176|449246972|FG000|Overall Study|Withdrawal by Subject|1|||
124896941|NCT01190176|449246972|FG000|Overall Study|Lost to Follow-up|1|||
124896942|NCT01836458|449246973|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
124896943|NCT01836458|449246974|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124896944|NCT01836458|449246975|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
124896945|NCT01836458|449246976|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
124896946|NCT02081391|449246977|FG000|12-hour Treatment|Withdrawal by Subject|3|||
124896947|NCT02081391|449246978|FG001|12-hour Treatment|Withdrawal by Subject|2|||
124896948|NCT02081391|449246979|FG002|12-hour Treatment|Withdrawal by Subject|0|||
124445223|NCT02408861|447592120|FG003|Overall Study|Physician Decision|0|||
124445224|NCT02408861|447592121|FG004|Overall Study|Physician Decision|0|||
124896949|NCT02081391|449246980|FG003|12-hour Treatment|Withdrawal by Subject|0|||
124896950|NCT02081391|449246977|FG000|12-hour Treatment|Physician Decision|4|||
124896951|NCT02081391|449246978|FG001|12-hour Treatment|Physician Decision|1|||
124445225|NCT02408861|447592122|FG005|Overall Study|Physician Decision|1|||
124445226|NCT02408861|447592123|FG006|Overall Study|Physician Decision|0|||
124896952|NCT02081391|449246979|FG002|12-hour Treatment|Physician Decision|0|||
124896953|NCT02081391|449246980|FG003|12-hour Treatment|Physician Decision|0|||
124896954|NCT02081391|449246977|FG000|12-hour Treatment|Lack of Efficacy|3|||
124688602|NCT00374868|448478782|FG000|Overall Study|Other - Not Specified|1|||
124688603|NCT04470427|448478783|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
124688604|NCT04470427|448478784|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
124688605|NCT04470427|448478785|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
124688606|NCT04470427|448478786|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
124688607|NCT04470427|448478787|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
124688608|NCT04470427|448478788|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
124688609|NCT04470427|448478783|FG000|Part B :Open-label|Other than specified|0|||
124688610|NCT04470427|448478784|FG001|Part B :Open-label|Other than specified|0|||
124688611|NCT04470427|448478785|FG002|Part B :Open-label|Other than specified|788|||
124688612|NCT04470427|448478786|FG003|Part B :Open-label|Other than specified|0|||
124688613|NCT04470427|448478787|FG004|Part B :Open-label|Other than specified|523|||
124688614|NCT04470427|448478788|FG005|Part B :Open-label|Other than specified|0|||
124688615|NCT04470427|448478783|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
124688616|NCT04470427|448478784|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
124688617|NCT04470427|448478785|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
124688618|NCT04470427|448478786|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
124688619|NCT04470427|448478787|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
124688620|NCT04470427|448478788|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
124688621|NCT04470427|448478783|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
124688622|NCT04470427|448478784|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
124688623|NCT04470427|448478785|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
124688624|NCT04470427|448478786|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
124688625|NCT04470427|448478787|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
124688626|NCT04470427|448478788|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
124688627|NCT01179516|448478789|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
124688628|NCT01179516|448478790|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
124688629|NCT01179516|448478791|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
124688630|NCT01179516|448478789|FG000|Overall Study|Lack of Efficacy|4|||
124688631|NCT01179516|448478790|FG001|Overall Study|Lack of Efficacy|2|||
124688632|NCT01179516|448478791|FG002|Overall Study|Lack of Efficacy|0|||
124688633|NCT01179516|448478789|FG000|Overall Study|Noncompliance with Study Drug|2|||
124688634|NCT01179516|448478790|FG001|Overall Study|Noncompliance with Study Drug|0|||
124688635|NCT01179516|448478791|FG002|Overall Study|Noncompliance with Study Drug|1|||
124688636|NCT01179516|448478789|FG000|Overall Study|Protocol Deviations|4|||
124688637|NCT01179516|448478790|FG001|Overall Study|Protocol Deviations|3|||
124688638|NCT01179516|448478791|FG002|Overall Study|Protocol Deviations|3|||
124688639|NCT01179516|448478789|FG000|Overall Study|Withdrawal of Consent|2|||
124688640|NCT01179516|448478790|FG001|Overall Study|Withdrawal of Consent|6|||
124688641|NCT01179516|448478791|FG002|Overall Study|Withdrawal of Consent|10|||
124688642|NCT01179516|448478789|FG000|Overall Study|Lost to Follow-up|7|||
124688643|NCT01179516|448478790|FG001|Overall Study|Lost to Follow-up|7|||
124688644|NCT01179516|448478791|FG002|Overall Study|Lost to Follow-up|3|||
124688645|NCT01179516|448478789|FG000|Overall Study|Other|2|||
124688646|NCT01179516|448478790|FG001|Overall Study|Other|0|||
124688647|NCT01179516|448478791|FG002|Overall Study|Other|2|||
124688648|NCT03349515|448478792|FG000|Overall Study|Lack of Efficacy|2|||
124688649|NCT03349515|448478793|FG001|Overall Study|Lack of Efficacy|0|||
124688650|NCT03349515|448478792|FG000|Overall Study|Physician Decision|3|||
124688651|NCT03349515|448478793|FG001|Overall Study|Physician Decision|1|||
124688652|NCT03412890|448478794|FG000|Overall Study|Adverse Event|5|||
124688653|NCT03412890|448478795|FG001|Overall Study|Adverse Event|5|||
124688654|NCT03412890|448478796|FG002|Overall Study|Adverse Event|9|||
124688655|NCT03412890|448478794|FG000|Overall Study|Protocol deviation|2|||
124688656|NCT03412890|448478795|FG001|Overall Study|Protocol deviation|1|||
124688657|NCT03412890|448478796|FG002|Overall Study|Protocol deviation|2|||
124688658|NCT03412890|448478794|FG000|Overall Study|Lost to Follow-up|7|||
124688659|NCT03412890|448478795|FG001|Overall Study|Lost to Follow-up|10|||
124688660|NCT03412890|448478796|FG002|Overall Study|Lost to Follow-up|10|||
124688661|NCT03412890|448478794|FG000|Overall Study|Withdrawal by Subject|9|||
124688662|NCT03412890|448478795|FG001|Overall Study|Withdrawal by Subject|12|||
124688663|NCT03412890|448478796|FG002|Overall Study|Withdrawal by Subject|11|||
124688664|NCT03412890|448478794|FG000|Overall Study|Lack of Efficacy|2|||
124688665|NCT03412890|448478795|FG001|Overall Study|Lack of Efficacy|7|||
124688666|NCT03412890|448478796|FG002|Overall Study|Lack of Efficacy|5|||
124896955|NCT02081391|449246978|FG001|12-hour Treatment|Lack of Efficacy|0|||
124896956|NCT02081391|449246979|FG002|12-hour Treatment|Lack of Efficacy|0|||
124896957|NCT02081391|449246980|FG003|12-hour Treatment|Lack of Efficacy|0|||
124896958|NCT02081391|449246977|FG000|12-hour Treatment|Adverse Event|4|||
124896959|NCT02081391|449246978|FG001|12-hour Treatment|Adverse Event|2|||
124896960|NCT02081391|449246979|FG002|12-hour Treatment|Adverse Event|0|||
124896961|NCT02081391|449246980|FG003|12-hour Treatment|Adverse Event|0|||
124896962|NCT02081391|449246977|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
124896963|NCT02081391|449246978|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
124896964|NCT02081391|449246979|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
124896965|NCT02081391|449246980|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
124896966|NCT02081391|449246977|FG000|12-hour Treatment|Further reasons|2|||
124896967|NCT02081391|449246978|FG001|12-hour Treatment|Further reasons|1|||
124896968|NCT02081391|449246979|FG002|12-hour Treatment|Further reasons|0|||
124896969|NCT02081391|449246980|FG003|12-hour Treatment|Further reasons|0|||
124896970|NCT02081391|449246977|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
124896971|NCT02081391|449246978|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
124896972|NCT02081391|449246979|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
124896973|NCT02081391|449246980|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
124896974|NCT02081391|449246977|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
124896975|NCT02081391|449246978|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
124896976|NCT02081391|449246979|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
124896977|NCT02081391|449246980|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
124896978|NCT02081391|449246977|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
124896979|NCT02081391|449246978|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
124445227|NCT02408861|447592117|FG000|Overall Study|Protocol Violation|1|||
124445228|NCT02408861|447592118|FG001|Overall Study|Protocol Violation|0|||
124896980|NCT02081391|449246979|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
124896981|NCT02081391|449246980|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
124896982|NCT02081391|449246977|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
124896983|NCT02081391|449246978|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
124896984|NCT02081391|449246979|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
124445229|NCT02408861|447592119|FG002|Overall Study|Protocol Violation|0|||
124445230|NCT02408861|447592120|FG003|Overall Study|Protocol Violation|0|||
124445231|NCT02408861|447592121|FG004|Overall Study|Protocol Violation|0|||
124445232|NCT02408861|447592122|FG005|Overall Study|Protocol Violation|0|||
124445233|NCT02408861|447592123|FG006|Overall Study|Protocol Violation|0|||
124445234|NCT02408861|447592117|FG000|Overall Study|Withdrawal by Subject|0|||
124445235|NCT02408861|447592118|FG001|Overall Study|Withdrawal by Subject|0|||
124445236|NCT02408861|447592119|FG002|Overall Study|Withdrawal by Subject|0|||
124445237|NCT02408861|447592120|FG003|Overall Study|Withdrawal by Subject|0|||
124896985|NCT02081391|449246980|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
124896986|NCT02081391|449246977|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
124896987|NCT02081391|449246978|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
124896988|NCT02081391|449246979|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
124896989|NCT02081391|449246980|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
124445238|NCT02408861|447592121|FG004|Overall Study|Withdrawal by Subject|1|||
124445239|NCT02408861|447592122|FG005|Overall Study|Withdrawal by Subject|1|||
124445240|NCT02408861|447592123|FG006|Overall Study|Withdrawal by Subject|0|||
124445241|NCT02408861|447592117|FG000|Overall Study|Other Treatment|0|||
124445242|NCT02408861|447592118|FG001|Overall Study|Other Treatment|0|||
124445243|NCT02408861|447592119|FG002|Overall Study|Other Treatment|0|||
124445244|NCT02408861|447592120|FG003|Overall Study|Other Treatment|0|||
124896990|NCT02081391|449246977|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
124896991|NCT02081391|449246978|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
124445245|NCT02408861|447592121|FG004|Overall Study|Other Treatment|0|||
124896992|NCT02081391|449246979|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
124896993|NCT02081391|449246980|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
124445246|NCT02408861|447592122|FG005|Overall Study|Other Treatment|1|||
124445247|NCT02408861|447592123|FG006|Overall Study|Other Treatment|1|||
124445248|NCT03338192|447593634|FG000|Year One to Year Two|High Blood Pressure|7|||
124445249|NCT03338192|447593635|FG001|Year One to Year Two|High Blood Pressure|1|||
124688667|NCT03412890|448478794|FG000|Overall Study|Other|5|||
124688668|NCT03412890|448478795|FG001|Overall Study|Other|6|||
124445250|NCT03338192|447593634|FG000|Year One to Year Two|HIV +|1|||
124445251|NCT03338192|447593635|FG001|Year One to Year Two|HIV +|0|||
124445252|NCT03338192|447593634|FG000|Year Two to Year Four|High Blood Pressure|1|||
124445253|NCT03338192|447593635|FG001|Year Two to Year Four|High Blood Pressure|0|||
124445254|NCT03338192|447593634|FG000|Year Two to Year Four|HIV +|2|||
124688669|NCT03412890|448478796|FG002|Overall Study|Other|5|||
124688670|NCT03412890|448478794|FG000|Overall Study|Participants who did not receive any study drug|0|||
124688671|NCT03412890|448478795|FG001|Overall Study|Participants who did not receive any study drug|1|||
124688672|NCT03412890|448478796|FG002|Overall Study|Participants who did not receive any study drug|0|||
124688673|NCT02315625|448478797|FG000|First Intervention|Disease Progression|1|||
124688674|NCT02315625|448478798|FG001|First Intervention|Disease Progression|0|||
124688675|NCT02315625|448478797|FG000|Second Intervention|Physician Decision|2|||
124688676|NCT02315625|448478798|FG001|Second Intervention|Physician Decision|1|||
124688677|NCT02315625|448478797|FG000|Second Intervention|Study closure|1|||
124688678|NCT02315625|448478798|FG001|Second Intervention|Study closure|0|||
124688679|NCT02315625|448478797|FG000|Second Intervention|Disease Progression|1|||
124688680|NCT02315625|448478798|FG001|Second Intervention|Disease Progression|0|||
124896994|NCT02189863|449246981|FG000|First 2 Weeks|Motion Sickness|4|||
124896995|NCT02189863|449246982|FG001|First 2 Weeks|Motion Sickness|2|||
124896996|NCT01559090|449246983|FG000|Stage I|Withdrawal by Subject|2|||
124896997|NCT01559090|449246984|FG001|Stage I|Withdrawal by Subject|2|||
124896998|NCT01559090|449246985|FG002|Stage I|Withdrawal by Subject|3|||
124896999|NCT01559090|449246983|FG000|Stage II|Withdrawal by Subject|1|||
124897000|NCT01559090|449246984|FG001|Stage II|Withdrawal by Subject|0|||
124897001|NCT01559090|449246985|FG002|Stage II|Withdrawal by Subject|0|||
124897002|NCT03677375|449246986|FG000|Overall Study|Incomplete procedure|8|||
124897003|NCT03677375|449246986|FG000|Overall Study|Adverse Event|3|||
124897004|NCT03677375|449246986|FG000|Overall Study|Physician Decision|1|||
124897005|NCT03971357|449246992|FG000|Overall Study|Lack of Efficacy|0|||
124897006|NCT03971357|449246993|FG001|Overall Study|Lack of Efficacy|1|||
124897007|NCT00430677|449246997|FG000|Short-term Period|Death|1|||
124897008|NCT00430677|449246998|FG001|Short-term Period|Death|1|||
124897009|NCT00430677|449246999|FG002|Short-term Period|Death|5|||
124897010|NCT00430677|449246997|FG000|Short-term Period|Adverse Event|15|||
124897011|NCT00430677|449246998|FG001|Short-term Period|Adverse Event|13|||
124897012|NCT00430677|449246999|FG002|Short-term Period|Adverse Event|9|||
124445255|NCT03338192|447593635|FG001|Year Two to Year Four|HIV +|0|||
124445256|NCT03338192|447593634|FG000|Year Four to Year Six|High Blood Pressure|2|||
124445257|NCT03338192|447593635|FG001|Year Four to Year Six|High Blood Pressure|1|||
124445258|NCT03808688|447593636|FG000|Overall Study|Adverse Event|13|||
124445259|NCT03808688|447593637|FG001|Overall Study|Adverse Event|17|||
124445260|NCT03808688|447593636|FG000|Overall Study|Lack of Efficacy|2|||
124445261|NCT03808688|447593637|FG001|Overall Study|Lack of Efficacy|0|||
124445262|NCT03808688|447593636|FG000|Overall Study|Lost to Follow-up|0|||
124445263|NCT03808688|447593637|FG001|Overall Study|Lost to Follow-up|2|||
124688681|NCT00021255|448478799|FG000|Overall Study|Death|1|||
124688682|NCT00021255|448478800|FG001|Overall Study|Death|0|||
124688683|NCT00021255|448478801|FG002|Overall Study|Death|2|||
124688684|NCT00021255|448478799|FG000|Overall Study|Breast cancer relapse|5|||
124688685|NCT00021255|448478800|FG001|Overall Study|Breast cancer relapse|18|||
124688686|NCT00021255|448478801|FG002|Overall Study|Breast cancer relapse|11|||
124897013|NCT00430677|449246997|FG000|Short-term Period|Lack of Efficacy|5|||
124897014|NCT00430677|449246998|FG001|Short-term Period|Lack of Efficacy|6|||
124688687|NCT00021255|448478799|FG000|Overall Study|Second primary malignancy|0|||
124688688|NCT00021255|448478800|FG001|Overall Study|Second primary malignancy|4|||
124897015|NCT00430677|449246999|FG002|Short-term Period|Lack of Efficacy|4|||
124897016|NCT00430677|449246997|FG000|Short-term Period|Withdrawal by Subject|1|||
124897017|NCT00430677|449246998|FG001|Short-term Period|Withdrawal by Subject|1|||
124897018|NCT00430677|449246999|FG002|Short-term Period|Withdrawal by Subject|2|||
124897019|NCT00430677|449246997|FG000|Short-term Period|Participant no longer met study criteria|1|||
124897020|NCT00430677|449246998|FG001|Short-term Period|Participant no longer met study criteria|1|||
124445264|NCT03808688|447593636|FG000|Overall Study|Withdrawal by Subject|1|||
124688689|NCT00021255|448478801|FG002|Overall Study|Second primary malignancy|1|||
124688690|NCT00021255|448478799|FG000|Overall Study|Withdrawal by Subject|41|||
124688691|NCT00021255|448478800|FG001|Overall Study|Withdrawal by Subject|64|||
124445265|NCT03808688|447593637|FG001|Overall Study|Withdrawal by Subject|0|||
124688692|NCT00021255|448478801|FG002|Overall Study|Withdrawal by Subject|26|||
124688693|NCT00021255|448478799|FG000|Overall Study|Lost to Follow-up|0|||
124688694|NCT00021255|448478800|FG001|Overall Study|Lost to Follow-up|2|||
124688695|NCT00021255|448478801|FG002|Overall Study|Lost to Follow-up|3|||
124688696|NCT00021255|448478799|FG000|Overall Study|Cardiac toxicity|0|||
124688697|NCT00021255|448478800|FG001|Overall Study|Cardiac toxicity|61|||
124688698|NCT00021255|448478801|FG002|Overall Study|Cardiac toxicity|32|||
124688699|NCT00021255|448478799|FG000|Overall Study|Herceptin toxicity|0|||
124688700|NCT00021255|448478800|FG001|Overall Study|Herceptin toxicity|22|||
124445266|NCT03808688|447593636|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
124688701|NCT00021255|448478801|FG002|Overall Study|Herceptin toxicity|6|||
124688702|NCT00021255|448478799|FG000|Overall Study|Adverse Event|46|||
124688703|NCT00021255|448478800|FG001|Overall Study|Adverse Event|30|||
124688704|NCT00021255|448478801|FG002|Overall Study|Adverse Event|18|||
124688705|NCT00021255|448478799|FG000|Overall Study|Protocol Violation|0|||
124688706|NCT00021255|448478800|FG001|Overall Study|Protocol Violation|2|||
124445267|NCT03808688|447593637|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
124445268|NCT03808688|447593636|FG000|Overall Study|IOP Too High|1|||
124445269|NCT03808688|447593637|FG001|Overall Study|IOP Too High|1|||
124445270|NCT03808688|447593636|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
124445271|NCT03808688|447593637|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
124445272|NCT03808688|447593636|FG000|Overall Study|Visit Out of Window|0|||
124445273|NCT03808688|447593637|FG001|Overall Study|Visit Out of Window|1|||
124445274|NCT03808688|447593636|FG000|Overall Study|Medication Non-Compliance|0|||
124445275|NCT03808688|447593637|FG001|Overall Study|Medication Non-Compliance|1|||
124445276|NCT03329196|447593638|FG000|Overall Study|Adverse Event|10|||
124445277|NCT03329196|447593639|FG001|Overall Study|Adverse Event|5|||
124445278|NCT03329196|447593638|FG000|Overall Study|Physician Decision|2|||
124445279|NCT03329196|447593639|FG001|Overall Study|Physician Decision|2|||
124445280|NCT03329196|447593638|FG000|Overall Study|Withdrawal by Subject|11|||
124445281|NCT03329196|447593639|FG001|Overall Study|Withdrawal by Subject|3|||
124445282|NCT03329196|447593638|FG000|Overall Study|Hepatic function abnormalities|0|||
124445283|NCT03329196|447593639|FG001|Overall Study|Hepatic function abnormalities|1|||
124445284|NCT03329196|447593638|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
124445285|NCT03329196|447593639|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
124445286|NCT03329196|447593638|FG000|Overall Study|Difficult to control Hb|2|||
124688707|NCT00021255|448478801|FG002|Overall Study|Protocol Violation|0|||
124688708|NCT00021255|448478799|FG000|Overall Study|Other than specified above|0|||
124688709|NCT00021255|448478800|FG001|Overall Study|Other than specified above|38|||
124759431|NCT03798717|448744688|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
124759432|NCT03798717|448744689|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
124445287|NCT03329196|447593639|FG001|Overall Study|Difficult to control Hb|3|||
124445288|NCT03329196|447593638|FG000|Overall Study|Dialysis or renal transplant|13|||
124445289|NCT03329196|447593639|FG001|Overall Study|Dialysis or renal transplant|15|||
124445290|NCT01096342|447593644|FG000|Overall Study|Protocol Violation|1|||
124445291|NCT00234494|447593645|FG000|Overall Study|Protocol Violation|2|||
124445292|NCT02021292|447593657|FG000|Overall Study|Physician Decision|0|||
124445293|NCT02021292|447593658|FG001|Overall Study|Physician Decision|1|||
124445294|NCT02021292|447593657|FG000|Overall Study|Lost to Follow-up|0|||
124445295|NCT02021292|447593658|FG001|Overall Study|Lost to Follow-up|1|||
124445296|NCT02021292|447593657|FG000|Overall Study|Death|0|||
124445297|NCT02021292|447593658|FG001|Overall Study|Death|1|||
124445298|NCT04147234|447593659|FG000|Overall Study|Clinical deterioration|0|||
124445299|NCT04147234|447593660|FG001|Overall Study|Clinical deterioration|0|||
124445300|NCT04147234|447593661|FG002|Overall Study|Clinical deterioration|1|||
124445301|NCT04147234|447593662|FG003|Overall Study|Clinical deterioration|0|||
124445302|NCT04147234|447593663|FG004|Overall Study|Clinical deterioration|0|||
124445303|NCT04147234|447593664|FG005|Overall Study|Clinical deterioration|0|||
124445304|NCT04147234|447593665|FG006|Overall Study|Clinical deterioration|0|||
124445305|NCT04147234|447593659|FG000|Overall Study|Withdrawal by Subject|0|||
124445306|NCT04147234|447593660|FG001|Overall Study|Withdrawal by Subject|1|||
124445307|NCT04147234|447593661|FG002|Overall Study|Withdrawal by Subject|1|||
124445308|NCT04147234|447593662|FG003|Overall Study|Withdrawal by Subject|0|||
124445309|NCT04147234|447593663|FG004|Overall Study|Withdrawal by Subject|0|||
124445310|NCT04147234|447593664|FG005|Overall Study|Withdrawal by Subject|0|||
124445311|NCT04147234|447593665|FG006|Overall Study|Withdrawal by Subject|0|||
124445312|NCT04147234|447593659|FG000|Overall Study|Clinical disease progression|1|||
124445313|NCT04147234|447593660|FG001|Overall Study|Clinical disease progression|3|||
124445314|NCT04147234|447593661|FG002|Overall Study|Clinical disease progression|1|||
124445315|NCT04147234|447593662|FG003|Overall Study|Clinical disease progression|1|||
124445316|NCT04147234|447593663|FG004|Overall Study|Clinical disease progression|0|||
124445317|NCT04147234|447593664|FG005|Overall Study|Clinical disease progression|1|||
124445318|NCT04147234|447593665|FG006|Overall Study|Clinical disease progression|0|||
124688710|NCT00021255|448478801|FG002|Overall Study|Other than specified above|19|||
124759433|NCT03798717|448744690|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
124445319|NCT04147234|447593659|FG000|Overall Study|Objective disease progression|6|||
124688711|NCT00021255|448478799|FG000|Overall Study|Missing|0|||
124688712|NCT00021255|448478800|FG001|Overall Study|Missing|27|||
124688713|NCT00021255|448478801|FG002|Overall Study|Missing|13|||
124759434|NCT03798717|448744691|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
124445320|NCT04147234|447593660|FG001|Overall Study|Objective disease progression|4|||
124445321|NCT04147234|447593661|FG002|Overall Study|Objective disease progression|3|||
124445322|NCT04147234|447593662|FG003|Overall Study|Objective disease progression|3|||
124445323|NCT04147234|447593663|FG004|Overall Study|Objective disease progression|5|||
124445324|NCT04147234|447593664|FG005|Overall Study|Objective disease progression|2|||
124445325|NCT04147234|447593665|FG006|Overall Study|Objective disease progression|3|||
124445326|NCT04147234|447593659|FG000|Overall Study|Adverse Event|0|||
124445327|NCT04147234|447593660|FG001|Overall Study|Adverse Event|0|||
124445328|NCT04147234|447593661|FG002|Overall Study|Adverse Event|0|||
124445329|NCT04147234|447593662|FG003|Overall Study|Adverse Event|0|||
124445330|NCT04147234|447593663|FG004|Overall Study|Adverse Event|1|||
124445331|NCT04147234|447593664|FG005|Overall Study|Adverse Event|0|||
124445332|NCT04147234|447593665|FG006|Overall Study|Adverse Event|0|||
124445333|NCT05972733|447593667|FG000|Overall Study|Lost to Follow-up|2|||
124445334|NCT05972733|447593667|FG000|Overall Study|Withdrawal by Subject|1|||
124445335|NCT04982588|447593670|FG000|Overall Study|Withdrawal by Subject|2|||
124445336|NCT02366728|447593671|FG000|Overall Study|Death|0|||
124445337|NCT02366728|447593672|FG001|Overall Study|Death|0|||
124445338|NCT02366728|447593673|FG002|Overall Study|Death|1|||
124445339|NCT02366728|447593671|FG000|Overall Study|Adverse Event|1|||
124445340|NCT02366728|447593672|FG001|Overall Study|Adverse Event|0|||
124445341|NCT02366728|447593673|FG002|Overall Study|Adverse Event|0|||
124445342|NCT02366728|447593671|FG000|Overall Study|Screen Failure|2|||
124445343|NCT02366728|447593672|FG001|Overall Study|Screen Failure|1|||
124445344|NCT02366728|447593673|FG002|Overall Study|Screen Failure|0|||
124445345|NCT02366728|447593671|FG000|Overall Study|Only yielded 2 vaccines|1|||
124445346|NCT02366728|447593672|FG001|Overall Study|Only yielded 2 vaccines|0|||
124445347|NCT02366728|447593673|FG002|Overall Study|Only yielded 2 vaccines|0|||
124445348|NCT00992511|447593675|FG000|Overall Study|Migrated/moved from study area|1|||
124445349|NCT00992511|447593676|FG001|Overall Study|Migrated/moved from study area|0|||
124445350|NCT00992511|447593677|FG002|Overall Study|Migrated/moved from study area|1|||
124445351|NCT00992511|447593678|FG003|Overall Study|Migrated/moved from study area|2|||
124445352|NCT00992511|447593675|FG000|Overall Study|Lost to Follow-up|1|||
124445353|NCT00992511|447593676|FG001|Overall Study|Lost to Follow-up|0|||
124445354|NCT00992511|447593677|FG002|Overall Study|Lost to Follow-up|0|||
124445355|NCT00992511|447593678|FG003|Overall Study|Lost to Follow-up|2|||
124445356|NCT00992511|447593675|FG000|Overall Study|Withdrawal by Subject|0|||
124445357|NCT00992511|447593676|FG001|Overall Study|Withdrawal by Subject|0|||
124445358|NCT00992511|447593677|FG002|Overall Study|Withdrawal by Subject|1|||
124445359|NCT00992511|447593678|FG003|Overall Study|Withdrawal by Subject|1|||
124445360|NCT04498169|447593679|FG000|Study Completion|Adverse Event|1|||
124445361|NCT04498169|447593680|FG001|Study Completion|Adverse Event|1|||
124445362|NCT02993523|447593681|FG000|Overall Study|Withdrew Consent|0|||
124445363|NCT02993523|447593682|FG001|Overall Study|Withdrew Consent|0|||
124445364|NCT02993523|447593683|FG002|Overall Study|Withdrew Consent|2|||
124445365|NCT02993523|447593684|FG003|Overall Study|Withdrew Consent|9|||
124445366|NCT02993523|447593685|FG004|Overall Study|Withdrew Consent|0|||
124445367|NCT02993523|447593681|FG000|Overall Study|Lost to Follow-up|0|||
124445368|NCT02993523|447593682|FG001|Overall Study|Lost to Follow-up|0|||
124445369|NCT02993523|447593683|FG002|Overall Study|Lost to Follow-up|3|||
124445370|NCT02993523|447593684|FG003|Overall Study|Lost to Follow-up|6|||
124445371|NCT02993523|447593685|FG004|Overall Study|Lost to Follow-up|0|||
124445372|NCT02993523|447593681|FG000|Overall Study|Death|1|||
124445373|NCT02993523|447593682|FG001|Overall Study|Death|1|||
124445374|NCT02993523|447593683|FG002|Overall Study|Death|138|||
124445375|NCT02993523|447593684|FG003|Overall Study|Death|222|||
124445376|NCT02993523|447593685|FG004|Overall Study|Death|6|||
124445377|NCT02993523|447593681|FG000|Overall Study|Reason not Specified|0|||
124445378|NCT02993523|447593682|FG001|Overall Study|Reason not Specified|0|||
124445379|NCT02993523|447593683|FG002|Overall Study|Reason not Specified|1|||
124445380|NCT02993523|447593684|FG003|Overall Study|Reason not Specified|1|||
124445381|NCT02993523|447593685|FG004|Overall Study|Reason not Specified|0|||
124445382|NCT03694418|447593686|FG000|Overall Study|Lost to Follow-up|115|||
124445383|NCT03694418|447593687|FG001|Overall Study|Lost to Follow-up|23|||
124445384|NCT03694418|447593688|FG002|Overall Study|Lost to Follow-up|12|||
124445385|NCT03694418|447593689|FG003|Overall Study|Lost to Follow-up|12|||
124445386|NCT03694418|447593690|FG004|Overall Study|Lost to Follow-up|13|||
124445387|NCT00867113|447593691|FG000|Treatment Period|Adverse Event|15|||
124445388|NCT00867113|447593691|FG000|Treatment Period|Death|2|||
124688714|NCT00021255|448478799|FG000|Overall Study|Randomized but not treated|28|||
124688715|NCT00021255|448478800|FG001|Overall Study|Randomized but not treated|2|||
124445389|NCT00867113|447593691|FG000|Treatment Period|Withdrawal by Subject|19|||
124445390|NCT00867113|447593691|FG000|Treatment Period|Lost to Follow-up|3|||
124445391|NCT00867113|447593691|FG000|Treatment Period|Administrative problems|1|||
124445392|NCT00867113|447593691|FG000|Treatment Period|Disease progression/relapse|1|||
124445393|NCT00867113|447593691|FG000|Treatment Period|Protocol Violation|4|||
124445394|NCT00867113|447593691|FG000|Post Treatment After Survival Follow-up|Death|1|||
124688716|NCT00021255|448478801|FG002|Overall Study|Randomized but not treated|18|||
124688717|NCT02337946|448478804|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
124688718|NCT02337946|448478805|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
124445395|NCT00867113|447593691|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
124445396|NCT00867113|447593691|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
124445397|NCT00867113|447593691|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
124445398|NCT01387230|447593692|FG000|Overall Study|Adverse Event|0|||
124897021|NCT00430677|449246999|FG002|Short-term Period|Participant no longer met study criteria|2|||
124897022|NCT00430677|449246997|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
124897023|NCT00430677|449246998|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
124897024|NCT00430677|449246999|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
124897025|NCT00430677|449246997|FG000|Short-term Period|Pregnancy|0|||
124897026|NCT00430677|449246998|FG001|Short-term Period|Pregnancy|2|||
124897027|NCT00430677|449246999|FG002|Short-term Period|Pregnancy|0|||
124897028|NCT00430677|449246997|FG000|Long-term Extension Period|Death|1|||
124897029|NCT00430677|449246998|FG001|Long-term Extension Period|Death|0|||
124897030|NCT00430677|449246999|FG002|Long-term Extension Period|Death|0|||
124897031|NCT00430677|449246997|FG000|Long-term Extension Period|Adverse Event|3|||
124897032|NCT00430677|449246998|FG001|Long-term Extension Period|Adverse Event|2|||
124897033|NCT00430677|449246999|FG002|Long-term Extension Period|Adverse Event|5|||
124897034|NCT00430677|449246997|FG000|Long-term Extension Period|Lack of Efficacy|5|||
124897035|NCT00430677|449246998|FG001|Long-term Extension Period|Lack of Efficacy|3|||
124897036|NCT00430677|449246999|FG002|Long-term Extension Period|Lack of Efficacy|8|||
124897037|NCT00430677|449246997|FG000|Long-term Extension Period|Lost to Follow-up|1|||
124897038|NCT00430677|449246998|FG001|Long-term Extension Period|Lost to Follow-up|1|||
124897039|NCT00430677|449246999|FG002|Long-term Extension Period|Lost to Follow-up|1|||
124897040|NCT00430677|449246997|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
124897041|NCT00430677|449246998|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
124897042|NCT00430677|449246999|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
124897043|NCT00430677|449246997|FG000|Long-term Extension Period|Pregnancy|1|||
124897044|NCT00430677|449246998|FG001|Long-term Extension Period|Pregnancy|1|||
124897045|NCT00430677|449246999|FG002|Long-term Extension Period|Pregnancy|0|||
124897046|NCT00430677|449246997|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
124897047|NCT00430677|449246998|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
124897048|NCT00430677|449246999|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
124897049|NCT00430677|449246997|FG000|Long-term Extension Period|Other|2|||
124897050|NCT00430677|449246998|FG001|Long-term Extension Period|Other|1|||
124897051|NCT00430677|449246999|FG002|Long-term Extension Period|Other|1|||
124897052|NCT00430677|449246997|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
124897053|NCT00430677|449246998|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
124897054|NCT00430677|449246999|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
124688719|NCT02337946|448478806|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
124897055|NCT01555762|449247000|FG000|Overall Study|No information on Bevacizumab intake|11|||
124897056|NCT01555762|449247000|FG000|Overall Study|Missing start date of infusion|8|||
124897057|NCT01555762|449247000|FG000|Overall Study|75 years old or more ticked No|1|||
124897058|NCT01555762|449247000|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
124897059|NCT01555762|449247000|FG000|Overall Study|Death linked to progression of disease|165|||
124897060|NCT01555762|449247000|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
124688720|NCT02337946|448478804|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
124688721|NCT02337946|448478805|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
124688722|NCT02337946|448478806|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
124688723|NCT02337946|448478804|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
124688724|NCT02337946|448478805|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
124688725|NCT02337946|448478806|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
124688726|NCT02337946|448478804|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
124445399|NCT01387230|447593693|FG001|Overall Study|Adverse Event|1|||
124445400|NCT01387230|447593694|FG002|Overall Study|Adverse Event|3|||
124445401|NCT01387230|447593692|FG000|Overall Study|Lack of Efficacy|8|||
124445402|NCT01387230|447593693|FG001|Overall Study|Lack of Efficacy|5|||
124445403|NCT01387230|447593694|FG002|Overall Study|Lack of Efficacy|4|||
124445404|NCT01387230|447593692|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
124445405|NCT01387230|447593693|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
124445406|NCT01387230|447593694|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
124445407|NCT01387230|447593692|FG000|Overall Study|Lost to Follow-up|0|||
124445408|NCT01387230|447593693|FG001|Overall Study|Lost to Follow-up|0|||
124445409|NCT01387230|447593694|FG002|Overall Study|Lost to Follow-up|1|||
124445410|NCT01387230|447593692|FG000|Overall Study|Withdrawal by Subject|4|||
124445411|NCT01387230|447593693|FG001|Overall Study|Withdrawal by Subject|1|||
124445412|NCT01387230|447593694|FG002|Overall Study|Withdrawal by Subject|0|||
124445413|NCT02066051|447593697|FG000|Overall Study|Subject developed active GVHD|1|||
124445414|NCT03027557|447593701|FG000|Overall Study|Adverse Event|1|||
124445415|NCT03027557|447593702|FG001|Overall Study|Adverse Event|0|||
124445416|NCT03027557|447593703|FG002|Overall Study|Adverse Event|0|||
124445417|NCT01610687|447593704|FG000|Overall Study|Lack of Efficacy|26|||
124445418|NCT01610687|447593704|FG000|Overall Study|Adverse Event|18|||
124445419|NCT01610687|447593704|FG000|Overall Study|Moved out of area|6|||
124445420|NCT01610687|447593704|FG000|Overall Study|Withdrawal by Subject|7|||
124445421|NCT01610687|447593704|FG000|Overall Study|Lost to Follow-up|4|||
124445422|NCT01610687|447593704|FG000|Overall Study|Symptom control without study medication|2|||
124445423|NCT01610687|447593704|FG000|Overall Study|Unable to make journey|1|||
124445424|NCT01610687|447593704|FG000|Overall Study|Death|1|||
124445425|NCT01610687|447593704|FG000|Overall Study|Cannabis affecting job|1|||
124445426|NCT01610687|447593704|FG000|Overall Study|Felt more alter without study medication|1|||
124445427|NCT03836807|447593705|FG000|Overall Study|Physician Decision|1|||
124445428|NCT03836807|447593706|FG001|Overall Study|Physician Decision|0|||
124445429|NCT02430051|447593707|FG000|Overall Study|Withdrawal by Subject|6|||
124445430|NCT02430051|447593708|FG001|Overall Study|Withdrawal by Subject|3|||
124445431|NCT02430051|447593707|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
124445432|NCT02430051|447593708|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
124445433|NCT02430051|447593707|FG000|Overall Study|Protocol Violation|1|||
124445434|NCT02430051|447593708|FG001|Overall Study|Protocol Violation|0|||
124445435|NCT02019420|447593710|FG000|Overall Study|Did not receive study drug|2|||
124445436|NCT02019420|447593711|FG001|Overall Study|Did not receive study drug|2|||
124445437|NCT02019420|447593710|FG000|Overall Study|Withdrawal by Subject|1|||
124445438|NCT02019420|447593711|FG001|Overall Study|Withdrawal by Subject|3|||
124445439|NCT02019420|447593710|FG000|Overall Study|At request of sponsor or investigator|0|||
124445440|NCT02019420|447593711|FG001|Overall Study|At request of sponsor or investigator|1|||
124445441|NCT02019420|447593710|FG000|Overall Study|Death|104|||
124445442|NCT02019420|447593711|FG001|Overall Study|Death|99|||
124445443|NCT02019420|447593710|FG000|Overall Study|Transferred to other care facility|1|||
124445444|NCT02019420|447593711|FG001|Overall Study|Transferred to other care facility|1|||
124445445|NCT02554903|447593714|FG000|Overall Study|Death|1|||
124445446|NCT02554903|447593715|FG001|Overall Study|Death|1|||
124445447|NCT02554903|447593714|FG000|Overall Study|Physician Decision|2|||
124445448|NCT02554903|447593715|FG001|Overall Study|Physician Decision|2|||
124445449|NCT02554903|447593714|FG000|Overall Study|Heart Transplant|1|||
124445450|NCT02554903|447593715|FG001|Overall Study|Heart Transplant|2|||
124445451|NCT02742766|447593716|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445452|NCT02742766|447593717|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445453|NCT02742766|447593718|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445454|NCT02742766|447593719|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445455|NCT02742766|447593720|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445456|NCT02742766|447593721|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445457|NCT02742766|447593722|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445458|NCT02742766|447593723|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445459|NCT02742766|447593724|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445460|NCT02742766|447593725|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445461|NCT02742766|447593726|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445462|NCT02742766|447593727|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445463|NCT02742766|447593728|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445464|NCT02742766|447593729|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
124445465|NCT02742766|447593730|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445466|NCT02742766|447593731|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445467|NCT02742766|447593732|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445468|NCT02742766|447593733|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445469|NCT02742766|447593734|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
124445470|NCT02742766|447593716|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
124445471|NCT02742766|447593717|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
124445472|NCT02742766|447593718|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
124445473|NCT02742766|447593719|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
124445474|NCT02742766|447593720|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
124445475|NCT02742766|447593721|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
124445476|NCT02742766|447593722|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
124445477|NCT02742766|447593723|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
124445478|NCT02742766|447593724|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
124445479|NCT02742766|447593725|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
124445480|NCT02742766|447593726|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
124445481|NCT02742766|447593727|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
124445482|NCT02742766|447593728|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
124445483|NCT02742766|447593729|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
124445484|NCT02742766|447593730|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
124445485|NCT02742766|447593731|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
124445486|NCT02742766|447593732|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
124445487|NCT02742766|447593733|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
124445488|NCT02742766|447593734|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
124445489|NCT00999713|447593735|FG000|Overall Study|Physician Decision|2|||
124445490|NCT00999713|447593736|FG001|Overall Study|Physician Decision|0|||
124445491|NCT03739437|447593740|FG000|Overall Study|Lost to Follow-up|2|||
124445492|NCT03739437|447593741|FG001|Overall Study|Lost to Follow-up|5|||
124445493|NCT01395316|447593744|FG000|Overall Study|Lost to Follow-up|2|||
124445494|NCT01395316|447593744|FG000|Overall Study|poor MRI quality|1|||
124445495|NCT03359590|447593746|FG000|First Intervention|Withdrawal by Subject|1|||
124445496|NCT03359590|447593747|FG001|First Intervention|Withdrawal by Subject|1|||
124445497|NCT03359590|447593746|FG000|First Intervention|Protocol Violation|0|||
124445498|NCT03359590|447593747|FG001|First Intervention|Protocol Violation|1|||
124445499|NCT02846532|447593748|FG000|Overall Study|Lost to Follow-up|0|||
124445500|NCT02846532|447593749|FG001|Overall Study|Lost to Follow-up|1|||
124445501|NCT02846532|447593750|FG002|Overall Study|Lost to Follow-up|1|||
124445502|NCT02846532|447593748|FG000|Overall Study|Withdrawal by Subject|1|||
124445503|NCT02846532|447593749|FG001|Overall Study|Withdrawal by Subject|2|||
124445504|NCT02846532|447593750|FG002|Overall Study|Withdrawal by Subject|0|||
124445505|NCT03951220|447593751|FG000|Overall Study|Withdrawal by Subject|9|||
124445506|NCT03951220|447593752|FG001|Overall Study|Withdrawal by Subject|2|||
124445507|NCT03951220|447593753|FG002|Overall Study|Withdrawal by Subject|0|||
124445508|NCT06132425|447593754|FG000|Overall Study|Withdrawal by Subject|3|||
124445509|NCT06132425|447593755|FG001|Overall Study|Withdrawal by Subject|0|||
124445510|NCT06132425|447593754|FG000|Overall Study|Did not follow study instructions|0|||
124445511|NCT06132425|447593755|FG001|Overall Study|Did not follow study instructions|2|||
124445512|NCT06132425|447593754|FG000|Overall Study|Lost to Follow-up|3|||
124445513|NCT06132425|447593755|FG001|Overall Study|Lost to Follow-up|5|||
124445514|NCT04598477|447593757|FG000|Overall Study|Adverse Event|2|||
124445515|NCT04598477|447593758|FG001|Overall Study|Adverse Event|0|||
124445516|NCT04598477|447593757|FG000|Overall Study|Death|0|||
124445517|NCT04598477|447593758|FG001|Overall Study|Death|1|||
124445518|NCT04598477|447593757|FG000|Overall Study|Lost to Follow-up|1|||
124445519|NCT04598477|447593758|FG001|Overall Study|Lost to Follow-up|0|||
124445520|NCT04598477|447593757|FG000|Overall Study|Physician Decision|7|||
124445521|NCT04598477|447593758|FG001|Overall Study|Physician Decision|2|||
124445522|NCT04598477|447593757|FG000|Overall Study|Pregnancy|0|||
124445523|NCT04598477|447593758|FG001|Overall Study|Pregnancy|1|||
124445524|NCT04598477|447593757|FG000|Overall Study|Requires Prohibited Medication|0|||
124445525|NCT04598477|447593758|FG001|Overall Study|Requires Prohibited Medication|1|||
124897061|NCT01555762|449247000|FG000|Overall Study|Investigator's decision|10|||
124897062|NCT01555762|449247000|FG000|Overall Study|Participant not wishing to continue|5|||
124897063|NCT01555762|449247000|FG000|Overall Study|Missing data|1|||
124897064|NCT01555762|449247000|FG000|Overall Study|Death linked to an adverse event|14|||
124897065|NCT01333514|449247001|FG000|Overall Study|Withdrawal by Subject|1|||
124897066|NCT01333514|449247002|FG001|Overall Study|Withdrawal by Subject|0|||
124897067|NCT00836810|449247003|FG000|Overall Study|New diagnosis|1|||
124897068|NCT00836810|449247004|FG001|Overall Study|New diagnosis|0|||
124445526|NCT04598477|447593757|FG000|Overall Study|Study Terminated by Sponsor|18|||
124445527|NCT04598477|447593758|FG001|Overall Study|Study Terminated by Sponsor|12|||
124445528|NCT04598477|447593757|FG000|Overall Study|Withdrawal by Subject|16|||
124897069|NCT00389519|449247007|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
124897070|NCT00389519|449247008|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
124897071|NCT00389519|449247009|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
124897072|NCT00389519|449247010|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
124445529|NCT04598477|447593758|FG001|Overall Study|Withdrawal by Subject|12|||
124445530|NCT04598477|447593757|FG000|Overall Study|Other|15|||
124445531|NCT04598477|447593758|FG001|Overall Study|Other|8|||
124445532|NCT02673619|447593762|FG000|Overall Study|Lost to Follow-up|1|||
124445533|NCT02673619|447593763|FG001|Overall Study|Lost to Follow-up|0|||
124445534|NCT02673619|447593764|FG002|Overall Study|Lost to Follow-up|0|||
124445535|NCT02673619|447593765|FG003|Overall Study|Lost to Follow-up|0|||
124445536|NCT02673619|447593762|FG000|Overall Study|Withdrawal by Subject|1|||
124897073|NCT00389519|449247007|FG000|Placebo Run-In|Withdrawal by Subject|19|||
124897074|NCT00389519|449247008|FG001|Placebo Run-In|Withdrawal by Subject|0|||
124897075|NCT00389519|449247009|FG002|Placebo Run-In|Withdrawal by Subject|0|||
124897076|NCT00389519|449247010|FG003|Placebo Run-In|Withdrawal by Subject|0|||
124897077|NCT00389519|449247007|FG000|Placebo Run-In|Reason not specified|40|||
124897078|NCT00389519|449247008|FG001|Placebo Run-In|Reason not specified|0|||
124897079|NCT00389519|449247009|FG002|Placebo Run-In|Reason not specified|0|||
124897080|NCT00389519|449247010|FG003|Placebo Run-In|Reason not specified|0|||
124897081|NCT00389519|449247007|FG000|Randomized|Did not receive study drug|2|||
124897082|NCT00389519|449247008|FG001|Randomized|Did not receive study drug|0|||
124897083|NCT00389519|449247009|FG002|Randomized|Did not receive study drug|0|||
124897084|NCT00389519|449247010|FG003|Randomized|Did not receive study drug|0|||
124897085|NCT00389519|449247007|FG000|Treated|Adverse Event|1|||
124897086|NCT00389519|449247008|FG001|Treated|Adverse Event|0|||
124897087|NCT00389519|449247009|FG002|Treated|Adverse Event|0|||
124897088|NCT00389519|449247010|FG003|Treated|Adverse Event|2|||
124897089|NCT00389519|449247007|FG000|Treated|Reason not specified|1|||
124897090|NCT00389519|449247008|FG001|Treated|Reason not specified|1|||
124897091|NCT00389519|449247009|FG002|Treated|Reason not specified|0|||
124897092|NCT00389519|449247010|FG003|Treated|Reason not specified|2|||
124897093|NCT02040844|449247011|FG000|Overall Study|Adverse Event|0|||
124897094|NCT02040844|449247012|FG001|Overall Study|Adverse Event|0|||
124897095|NCT02040844|449247013|FG002|Overall Study|Adverse Event|1|||
124897096|NCT02040844|449247011|FG000|Overall Study|Withdrawal by Subject|16|||
124897097|NCT02040844|449247012|FG001|Overall Study|Withdrawal by Subject|22|||
124897098|NCT02040844|449247013|FG002|Overall Study|Withdrawal by Subject|25|||
124897099|NCT02040844|449247011|FG000|Overall Study|Lost to Follow-up|12|||
124897100|NCT02040844|449247012|FG001|Overall Study|Lost to Follow-up|9|||
124897101|NCT02040844|449247013|FG002|Overall Study|Lost to Follow-up|13|||
124897102|NCT02040844|449247011|FG000|Overall Study|Missing|13|||
124897103|NCT02040844|449247012|FG001|Overall Study|Missing|3|||
124897104|NCT02040844|449247013|FG002|Overall Study|Missing|2|||
124897105|NCT02040844|449247011|FG000|Overall Study|Non-specified|8|||
124897106|NCT02040844|449247012|FG001|Overall Study|Non-specified|2|||
124897107|NCT02040844|449247013|FG002|Overall Study|Non-specified|5|||
124897108|NCT02040844|449247011|FG000|Overall Study|Concomitant medication|1|||
124897109|NCT02040844|449247012|FG001|Overall Study|Concomitant medication|3|||
124897110|NCT02040844|449247013|FG002|Overall Study|Concomitant medication|1|||
124897111|NCT01560949|449247020|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
124897112|NCT01560949|449247020|FG000|Surgery Phase|Physician Decision|3|||
124897113|NCT02068885|449247025|FG000|Overall Study|Withdrew|3|||
124897114|NCT02068885|449247026|FG001|Overall Study|Withdrew|5|||
124897115|NCT02068885|449247027|FG002|Overall Study|Withdrew|8|||
124897116|NCT00681811|449247028|FG000|Overall Study|Adverse Event|1|||
124897117|NCT00681811|449247029|FG001|Overall Study|Adverse Event|1|||
124897118|NCT00681811|449247028|FG000|Overall Study|Withdrawal by Subject|2|||
124897119|NCT00681811|449247029|FG001|Overall Study|Withdrawal by Subject|2|||
124897120|NCT00681811|449247028|FG000|Overall Study|Non-compliance|0|||
124897121|NCT00681811|449247029|FG001|Overall Study|Non-compliance|1|||
124897122|NCT01562743|449247035|FG000|Overall Study|Adverse Event|29|||
124897123|NCT01562743|449247035|FG000|Overall Study|Lack of Efficacy|3|||
124897124|NCT01562743|449247035|FG000|Overall Study|Withdrawal by Subject|13|||
124897125|NCT01562743|449247035|FG000|Overall Study|Protocol Violation|1|||
124897126|NCT01562743|449247035|FG000|Overall Study|Discontinuation criteria|2|||
124897127|NCT01562743|449247035|FG000|Overall Study|Lost to Follow-up|2|||
124897128|NCT01562743|449247035|FG000|Overall Study|Physician Decision|2|||
124897129|NCT04159506|449247036|FG000|Overall Study|Lost to Follow-up|2|||
124897130|NCT04159506|449247037|FG001|Overall Study|Lost to Follow-up|5|||
124897131|NCT02449044|449247038|FG000|Overall Study|Lost to Follow-up|2|||
124897132|NCT02449044|449247038|FG000|Overall Study|Withdrawal by Subject|13|||
124897133|NCT02449044|449247038|FG000|Overall Study|Adverse Event|30|||
124897134|NCT02449044|449247038|FG000|Overall Study|Met Withdrawal Criteria|7|||
124897135|NCT02449044|449247038|FG000|Overall Study|Physician Decision|9|||
124897136|NCT02449044|449247038|FG000|Overall Study|Sponsor Discontinued Trial|3|||
124897137|NCT02624778|449249447|FG000|Overall Study|Lost to Follow-up|0|||
124897138|NCT02624778|449249448|FG001|Overall Study|Lost to Follow-up|0|||
124897139|NCT02624778|449249449|FG002|Overall Study|Lost to Follow-up|1|||
124897140|NCT02624778|449249450|FG003|Overall Study|Lost to Follow-up|0|||
124897141|NCT02624778|449249451|FG004|Overall Study|Lost to Follow-up|0|||
124688727|NCT02337946|448478805|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
124897142|NCT02624778|449249452|FG005|Overall Study|Lost to Follow-up|0|||
124897143|NCT02624778|449249453|FG006|Overall Study|Lost to Follow-up|0|||
124897144|NCT02624778|449249454|FG007|Overall Study|Lost to Follow-up|0|||
124897145|NCT02624778|449249455|FG008|Overall Study|Lost to Follow-up|0|||
124897146|NCT02624778|449249447|FG000|Overall Study|Withdrawal by Subject|0|||
124897147|NCT02624778|449249448|FG001|Overall Study|Withdrawal by Subject|1|||
124897148|NCT02624778|449249449|FG002|Overall Study|Withdrawal by Subject|0|||
124897149|NCT02624778|449249450|FG003|Overall Study|Withdrawal by Subject|0|||
124897150|NCT02624778|449249451|FG004|Overall Study|Withdrawal by Subject|0|||
124897151|NCT02624778|449249452|FG005|Overall Study|Withdrawal by Subject|1|||
124897152|NCT02624778|449249453|FG006|Overall Study|Withdrawal by Subject|1|||
124897153|NCT02624778|449249454|FG007|Overall Study|Withdrawal by Subject|1|||
124897154|NCT02624778|449249455|FG008|Overall Study|Withdrawal by Subject|1|||
124897155|NCT02624778|449249447|FG000|Overall Study|Adverse Event|0|||
124897156|NCT02624778|449249448|FG001|Overall Study|Adverse Event|0|||
124897157|NCT02624778|449249449|FG002|Overall Study|Adverse Event|0|||
124897158|NCT02624778|449249450|FG003|Overall Study|Adverse Event|0|||
124897159|NCT02624778|449249451|FG004|Overall Study|Adverse Event|0|||
124897160|NCT02624778|449249452|FG005|Overall Study|Adverse Event|0|||
124897161|NCT02624778|449249453|FG006|Overall Study|Adverse Event|0|||
124897162|NCT02624778|449249454|FG007|Overall Study|Adverse Event|0|||
124897163|NCT02624778|449249455|FG008|Overall Study|Adverse Event|2|||
124897164|NCT02624778|449249447|FG000|Overall Study|Death|0|||
124897165|NCT02624778|449249448|FG001|Overall Study|Death|0|||
124897166|NCT02624778|449249449|FG002|Overall Study|Death|0|||
124897167|NCT02624778|449249450|FG003|Overall Study|Death|0|||
124897168|NCT02624778|449249451|FG004|Overall Study|Death|0|||
124897169|NCT02624778|449249452|FG005|Overall Study|Death|0|||
124897170|NCT02624778|449249453|FG006|Overall Study|Death|1|||
124897171|NCT02624778|449249454|FG007|Overall Study|Death|0|||
124897172|NCT02624778|449249455|FG008|Overall Study|Death|0|||
124897173|NCT02624778|449249447|FG000|Overall Study|Physician Decision|0|||
124759435|NCT03798717|448744692|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
124897174|NCT02624778|449249448|FG001|Overall Study|Physician Decision|0|||
124897175|NCT02624778|449249449|FG002|Overall Study|Physician Decision|0|||
124897176|NCT02624778|449249450|FG003|Overall Study|Physician Decision|0|||
124897177|NCT02624778|449249451|FG004|Overall Study|Physician Decision|0|||
124897178|NCT02624778|449249452|FG005|Overall Study|Physician Decision|0|||
124897179|NCT02624778|449249453|FG006|Overall Study|Physician Decision|0|||
124897180|NCT02624778|449249454|FG007|Overall Study|Physician Decision|3|||
124897181|NCT02624778|449249455|FG008|Overall Study|Physician Decision|3|||
124897182|NCT01537133|449249458|FG000|Overall Study|Withdrawal by Subject|2|||
124897183|NCT01537133|449249459|FG001|Overall Study|Withdrawal by Subject|0|||
124897184|NCT01537133|449249460|FG002|Overall Study|Withdrawal by Subject|0|||
124897185|NCT01537133|449249461|FG003|Overall Study|Withdrawal by Subject|0|||
124897186|NCT01537133|449249458|FG000|Overall Study|Lost to Follow-up|1|||
124897187|NCT01537133|449249459|FG001|Overall Study|Lost to Follow-up|0|||
124897188|NCT01537133|449249460|FG002|Overall Study|Lost to Follow-up|0|||
124897189|NCT01537133|449249461|FG003|Overall Study|Lost to Follow-up|0|||
124897190|NCT01244984|449249466|FG000|Overall Study|Adverse Event|2|||
124897191|NCT01244984|449249467|FG001|Overall Study|Adverse Event|11|||
124897192|NCT01244984|449249468|FG002|Overall Study|Adverse Event|2|||
124897193|NCT01244984|449249466|FG000|Overall Study|Protocol Violation|1|||
124897194|NCT01244984|449249467|FG001|Overall Study|Protocol Violation|0|||
124897195|NCT01244984|449249468|FG002|Overall Study|Protocol Violation|0|||
124897196|NCT01244984|449249466|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
124897197|NCT01244984|449249467|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
124897198|NCT01244984|449249468|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
124897199|NCT01244984|449249466|FG000|Overall Study|Withdrawal by Subject|1|||
124897200|NCT01244984|449249467|FG001|Overall Study|Withdrawal by Subject|2|||
124897201|NCT01244984|449249468|FG002|Overall Study|Withdrawal by Subject|2|||
124759436|NCT03798717|448744693|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
124759437|NCT01777308|448744697|FG000|Overall Study|Withdrawal by Subject|5|||
124897202|NCT01168401|449249469|FG000|Overall Study|Lost to Follow-up|1|||
124897203|NCT01168401|449249470|FG001|Overall Study|Lost to Follow-up|1|||
124897204|NCT01168401|449249471|FG002|Overall Study|Lost to Follow-up|2|||
124897205|NCT01168401|449249472|FG003|Overall Study|Lost to Follow-up|1|||
124897206|NCT01168401|449249473|FG004|Overall Study|Lost to Follow-up|0|||
124897207|NCT01168401|449249474|FG005|Overall Study|Lost to Follow-up|0|||
124897208|NCT01168401|449249475|FG006|Overall Study|Lost to Follow-up|0|||
124897209|NCT01168401|449249476|FG007|Overall Study|Lost to Follow-up|0|||
124897210|NCT01168401|449249477|FG008|Overall Study|Lost to Follow-up|0|||
124897211|NCT01168401|449249478|FG009|Overall Study|Lost to Follow-up|0|||
124897212|NCT01168401|449249479|FG010|Overall Study|Lost to Follow-up|0|||
124445537|NCT02673619|447593763|FG001|Overall Study|Withdrawal by Subject|1|||
124897213|NCT01168401|449249469|FG000|Overall Study|Withdrawal by Subject|0|||
124897214|NCT01168401|449249470|FG001|Overall Study|Withdrawal by Subject|0|||
124897215|NCT01168401|449249471|FG002|Overall Study|Withdrawal by Subject|0|||
124897216|NCT01168401|449249472|FG003|Overall Study|Withdrawal by Subject|1|||
124897217|NCT01168401|449249473|FG004|Overall Study|Withdrawal by Subject|0|||
124897218|NCT01168401|449249474|FG005|Overall Study|Withdrawal by Subject|0|||
124897219|NCT01168401|449249475|FG006|Overall Study|Withdrawal by Subject|0|||
124897220|NCT01168401|449249476|FG007|Overall Study|Withdrawal by Subject|0|||
124897221|NCT01168401|449249477|FG008|Overall Study|Withdrawal by Subject|0|||
124897222|NCT01168401|449249478|FG009|Overall Study|Withdrawal by Subject|0|||
124897223|NCT01168401|449249479|FG010|Overall Study|Withdrawal by Subject|0|||
124897224|NCT01149681|449249484|FG000|Overall Study|Withdrawal by Subject|7|||
124897225|NCT01149681|449249484|FG000|Overall Study|Progressive disease|1|||
124897226|NCT01149681|449249484|FG000|Overall Study|Physician Decision|2|||
124897227|NCT01149681|449249484|FG000|Overall Study|adverse events nonrelated study drug|2|||
124897228|NCT03710564|449249485|FG000|Overall Study|Study Terminated by Sponsor|104|||
124897229|NCT03710564|449249486|FG001|Overall Study|Study Terminated by Sponsor|55|||
124897230|NCT03710564|449249485|FG000|Overall Study|Withdrawal by Subject|57|||
124897231|NCT03710564|449249486|FG001|Overall Study|Withdrawal by Subject|25|||
124897232|NCT03710564|449249485|FG000|Overall Study|Death|10|||
124897233|NCT03710564|449249486|FG001|Overall Study|Death|4|||
124897234|NCT03710564|449249485|FG000|Overall Study|Lost to Follow-up|5|||
124897235|NCT03710564|449249486|FG001|Overall Study|Lost to Follow-up|4|||
124897236|NCT03710564|449249485|FG000|Overall Study|Protocol Violation|3|||
124897237|NCT03710564|449249486|FG001|Overall Study|Protocol Violation|2|||
124897238|NCT03710564|449249485|FG000|Overall Study|Adverse Event|3|||
124897239|NCT03710564|449249486|FG001|Overall Study|Adverse Event|0|||
124897240|NCT03710564|449249485|FG000|Overall Study|Physician Decision|2|||
124688728|NCT02337946|448478806|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
124688729|NCT02337946|448478804|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
124688730|NCT02337946|448478805|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
124688731|NCT02337946|448478806|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
124688732|NCT02337946|448478804|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
124688733|NCT02337946|448478805|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
124688734|NCT02337946|448478806|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
124688735|NCT02337946|448478804|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
124688736|NCT02337946|448478805|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
124688737|NCT02337946|448478806|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
124688738|NCT02337946|448478804|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
124688739|NCT02337946|448478805|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
124688740|NCT02337946|448478806|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
124688741|NCT02337946|448478804|FG000|In-between Period|Without Informed Consent|1|||
124688742|NCT02337946|448478805|FG001|In-between Period|Without Informed Consent|0|||
124688743|NCT02337946|448478806|FG002|In-between Period|Without Informed Consent|0|||
124688744|NCT02337946|448478804|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
124688745|NCT02337946|448478805|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
124688746|NCT02337946|448478806|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
124688747|NCT02337946|448478804|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
124688748|NCT02337946|448478805|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
124688749|NCT02337946|448478806|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
124688750|NCT02337946|448478804|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
124688751|NCT02337946|448478805|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
124688752|NCT02337946|448478806|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
124688753|NCT02337946|448478804|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
124688754|NCT02337946|448478805|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
124688755|NCT02337946|448478806|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
124688756|NCT02337946|448478804|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
124688757|NCT02337946|448478805|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
124688758|NCT02337946|448478806|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
124688759|NCT02337946|448478804|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
124688760|NCT02337946|448478805|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
124688761|NCT02337946|448478806|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
124688762|NCT05324371|448478808|FG000|Overall Study|Withdrawal by Subject|1|||
124688763|NCT05324371|448478808|FG000|Overall Study|Death|1|||
124688764|NCT03599713|448478809|FG000|Overall Study|Death|38|||
124688765|NCT03599713|448478810|FG001|Overall Study|Death|3|||
124688766|NCT03599713|448478809|FG000|Overall Study|Withdrawal by Subject|17|||
124688767|NCT03599713|448478810|FG001|Overall Study|Withdrawal by Subject|0|||
124688768|NCT03599713|448478809|FG000|Overall Study|Lost to Follow-up|4|||
124688769|NCT03599713|448478810|FG001|Overall Study|Lost to Follow-up|0|||
124688770|NCT03599713|448478809|FG000|Overall Study|Discontinued Due to End of Study|42|||
124688771|NCT03599713|448478810|FG001|Overall Study|Discontinued Due to End of Study|3|||
124688772|NCT04827446|448479838|FG000|Overall Study|Lost to Follow-up|1|||
124897241|NCT03710564|449249486|FG001|Overall Study|Physician Decision|3|||
124897242|NCT02993471|449249487|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
124897243|NCT02993471|449249487|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
124897244|NCT00930813|449249488|FG000|Overall Study|Death|4|||
124688773|NCT04827446|448479839|FG001|Overall Study|Lost to Follow-up|1|||
124897245|NCT00930813|449249489|FG001|Overall Study|Death|5|||
124688774|NCT04827446|448479838|FG000|Overall Study|Death|2|||
124688775|NCT04827446|448479839|FG001|Overall Study|Death|0|||
124897246|NCT00930813|449249488|FG000|Overall Study|Withdrawal by Subject|2|||
124897247|NCT00930813|449249489|FG001|Overall Study|Withdrawal by Subject|5|||
124897248|NCT00930813|449249488|FG000|Overall Study|Lost to Follow-up|2|||
124897249|NCT00930813|449249489|FG001|Overall Study|Lost to Follow-up|4|||
124897250|NCT03999554|449249496|FG000|Overall Study|Lost to Follow-up|4|||
124897251|NCT03999554|449249497|FG001|Overall Study|Lost to Follow-up|5|||
124897252|NCT03999554|449249498|FG002|Overall Study|Lost to Follow-up|4|||
124897253|NCT03999554|449249499|FG003|Overall Study|Lost to Follow-up|5|||
124897254|NCT03999554|449249500|FG004|Overall Study|Lost to Follow-up|8|||
124897255|NCT03999554|449249496|FG000|Overall Study|Protocol Violation|0|||
124897256|NCT03999554|449249497|FG001|Overall Study|Protocol Violation|0|||
124897257|NCT03999554|449249498|FG002|Overall Study|Protocol Violation|5|||
124897258|NCT03999554|449249499|FG003|Overall Study|Protocol Violation|0|||
124897259|NCT03999554|449249500|FG004|Overall Study|Protocol Violation|0|||
124897260|NCT03999554|449249496|FG000|Overall Study|Pregnancy|0|||
124897261|NCT03999554|449249497|FG001|Overall Study|Pregnancy|0|||
124897262|NCT03999554|449249498|FG002|Overall Study|Pregnancy|1|||
124897263|NCT03999554|449249499|FG003|Overall Study|Pregnancy|0|||
124897264|NCT03999554|449249500|FG004|Overall Study|Pregnancy|0|||
124897265|NCT03999554|449249496|FG000|Overall Study|Withdrawal by Subject|2|||
124897266|NCT03999554|449249497|FG001|Overall Study|Withdrawal by Subject|2|||
124897267|NCT03999554|449249498|FG002|Overall Study|Withdrawal by Subject|2|||
124897268|NCT03999554|449249499|FG003|Overall Study|Withdrawal by Subject|1|||
124897269|NCT03999554|449249500|FG004|Overall Study|Withdrawal by Subject|1|||
124897270|NCT03999554|449249496|FG000|Overall Study|failure to comply with protocol requirements|0|||
124897271|NCT03999554|449249497|FG001|Overall Study|failure to comply with protocol requirements|0|||
124897272|NCT03999554|449249498|FG002|Overall Study|failure to comply with protocol requirements|0|||
124897273|NCT03999554|449249499|FG003|Overall Study|failure to comply with protocol requirements|1|||
124897274|NCT03999554|449249500|FG004|Overall Study|failure to comply with protocol requirements|0|||
124897275|NCT04582877|449249501|FG000|Overall Study|Did not use device measurement|5|||
124897276|NCT04582877|449249501|FG000|Overall Study|No fractional flow reserve test results|2|||
124897277|NCT04582877|449249501|FG000|Overall Study|Protocol Violation|1|||
124897278|NCT00003656|449249502|FG000|Overall Study|Adverse Event|0|||
124897279|NCT00003656|449249503|FG001|Overall Study|Adverse Event|1|||
124897280|NCT03055767|449249504|FG000|Open-Label Period|Lost to Follow-up|0|||
124897281|NCT03055767|449249505|FG001|Open-Label Period|Lost to Follow-up|0|||
124897282|NCT03055767|449249506|FG002|Open-Label Period|Lost to Follow-up|2|||
124897283|NCT03055767|449249507|FG003|Open-Label Period|Lost to Follow-up|0|||
124897284|NCT03055767|449249504|FG000|Open-Label Period|Withdrawal by Subject|0|||
124897285|NCT03055767|449249505|FG001|Open-Label Period|Withdrawal by Subject|0|||
124897286|NCT03055767|449249506|FG002|Open-Label Period|Withdrawal by Subject|0|||
124897287|NCT03055767|449249507|FG003|Open-Label Period|Withdrawal by Subject|1|||
124897288|NCT00763282|449249510|FG000|Overall Study|Withdrawal by Subject|6|||
124897289|NCT00763282|449249511|FG001|Overall Study|Withdrawal by Subject|5|||
124897290|NCT00763282|449249510|FG000|Overall Study|Death|4|||
124897291|NCT00763282|449249511|FG001|Overall Study|Death|3|||
124897292|NCT00763282|449249510|FG000|Overall Study|Lost to Follow-up|22|||
124897293|NCT00763282|449249511|FG001|Overall Study|Lost to Follow-up|26|||
124897294|NCT00742274|449249512|FG000|Overall Study|Death|1|||
124897295|NCT00742274|449249513|FG001|Overall Study|Death|0|||
124897296|NCT00742274|449249512|FG000|Overall Study|Withdrawal by Subject|1|||
124897297|NCT00742274|449249513|FG001|Overall Study|Withdrawal by Subject|2|||
124897298|NCT00742274|449249512|FG000|Overall Study|Removed for medical reasons|1|||
124897299|NCT00742274|449249513|FG001|Overall Study|Removed for medical reasons|1|||
124897300|NCT02974010|449249518|FG000|Overall Study|Lost to Follow-up|3|||
124897301|NCT02974010|449249519|FG001|Overall Study|Lost to Follow-up|1|||
124897302|NCT02974010|449249520|FG002|Overall Study|Lost to Follow-up|0|||
124897303|NCT02974010|449249521|FG003|Overall Study|Lost to Follow-up|0|||
124897304|NCT02974010|449249518|FG000|Overall Study|Withdrawal by Subject|2|||
124897305|NCT02974010|449249519|FG001|Overall Study|Withdrawal by Subject|1|||
124897306|NCT02974010|449249520|FG002|Overall Study|Withdrawal by Subject|0|||
124897307|NCT02974010|449249521|FG003|Overall Study|Withdrawal by Subject|0|||
124897308|NCT02974010|449249518|FG000|Overall Study|Adverse Event|0|||
124897309|NCT02974010|449249519|FG001|Overall Study|Adverse Event|1|||
124897310|NCT02974010|449249520|FG002|Overall Study|Adverse Event|0|||
124897311|NCT02974010|449249521|FG003|Overall Study|Adverse Event|0|||
124897312|NCT02974010|449249518|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
124897313|NCT02974010|449249519|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
124897314|NCT02974010|449249520|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
124897315|NCT02974010|449249521|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
124897316|NCT02974010|449249518|FG000|Overall Study|Lack of Efficacy|0|||
124897317|NCT02974010|449249519|FG001|Overall Study|Lack of Efficacy|0|||
124897318|NCT02974010|449249520|FG002|Overall Study|Lack of Efficacy|1|||
124897319|NCT02974010|449249521|FG003|Overall Study|Lack of Efficacy|0|||
124897320|NCT01941316|449249522|FG000|Overall Study|Adverse Event|0|||
124897321|NCT01941316|449249523|FG001|Overall Study|Adverse Event|1|||
124897322|NCT01941316|449249524|FG002|Overall Study|Adverse Event|0|||
124897323|NCT01941316|449249525|FG003|Overall Study|Adverse Event|7|||
124897324|NCT01941316|449249522|FG000|Overall Study|Progressive Disease|3|||
124897325|NCT01941316|449249523|FG001|Overall Study|Progressive Disease|6|||
124897326|NCT01941316|449249524|FG002|Overall Study|Progressive Disease|2|||
124897327|NCT01941316|449249525|FG003|Overall Study|Progressive Disease|29|||
124897328|NCT01941316|449249522|FG000|Overall Study|Withdrawal by Subject|0|||
124897329|NCT01941316|449249523|FG001|Overall Study|Withdrawal by Subject|2|||
124897330|NCT01941316|449249524|FG002|Overall Study|Withdrawal by Subject|1|||
124897331|NCT01941316|449249525|FG003|Overall Study|Withdrawal by Subject|8|||
124897332|NCT01941316|449249522|FG000|Overall Study|Death|0|||
124897333|NCT01941316|449249523|FG001|Overall Study|Death|0|||
124897334|NCT01941316|449249524|FG002|Overall Study|Death|0|||
124897335|NCT01941316|449249525|FG003|Overall Study|Death|3|||
124897336|NCT01941316|449249522|FG000|Overall Study|Physician Decision|0|||
124897337|NCT01941316|449249523|FG001|Overall Study|Physician Decision|0|||
124897338|NCT01941316|449249524|FG002|Overall Study|Physician Decision|0|||
124897339|NCT01941316|449249525|FG003|Overall Study|Physician Decision|3|||
124897340|NCT01941316|449249522|FG000|Overall Study|Protocol Violation|0|||
124897341|NCT01941316|449249523|FG001|Overall Study|Protocol Violation|0|||
124897342|NCT01941316|449249524|FG002|Overall Study|Protocol Violation|0|||
124897343|NCT01941316|449249525|FG003|Overall Study|Protocol Violation|3|||
124897344|NCT01941316|449249522|FG000|Overall Study|Intercurrent illness|0|||
124897345|NCT01941316|449249523|FG001|Overall Study|Intercurrent illness|0|||
124897346|NCT01941316|449249524|FG002|Overall Study|Intercurrent illness|0|||
124897347|NCT01941316|449249525|FG003|Overall Study|Intercurrent illness|1|||
124897348|NCT01941316|449249522|FG000|Overall Study|Other, not specified|0|||
124897349|NCT01941316|449249523|FG001|Overall Study|Other, not specified|0|||
124897350|NCT01941316|449249524|FG002|Overall Study|Other, not specified|0|||
124897351|NCT01941316|449249525|FG003|Overall Study|Other, not specified|1|||
124897352|NCT00320489|449249526|FG000|Overall Study|Adverse Event|26|||
124897353|NCT00320489|449249527|FG001|Overall Study|Adverse Event|25|||
124897354|NCT00320489|449249526|FG000|Overall Study|Clinical Relapse|26|||
124897355|NCT00320489|449249527|FG001|Overall Study|Clinical Relapse|20|||
124897356|NCT00320489|449249526|FG000|Overall Study|Death|0|||
124897357|NCT00320489|449249527|FG001|Overall Study|Death|2|||
124897358|NCT00320489|449249526|FG000|Overall Study|Entry Criteria Exclusion|2|||
124897359|NCT00320489|449249527|FG001|Overall Study|Entry Criteria Exclusion|4|||
124897360|NCT00320489|449249526|FG000|Overall Study|Lack of Efficacy|16|||
124897361|NCT00320489|449249527|FG001|Overall Study|Lack of Efficacy|7|||
124897362|NCT00320489|449249526|FG000|Overall Study|Lost to Follow-up|21|||
124897363|NCT00320489|449249527|FG001|Overall Study|Lost to Follow-up|22|||
124897364|NCT00320489|449249526|FG000|Overall Study|Physician Decision|8|||
124897365|NCT00320489|449249527|FG001|Overall Study|Physician Decision|8|||
124897366|NCT00320489|449249526|FG000|Overall Study|Protocol Violation|4|||
124897367|NCT00320489|449249527|FG001|Overall Study|Protocol Violation|4|||
124897368|NCT00320489|449249526|FG000|Overall Study|Sponsor Decision|3|||
124897369|NCT00320489|449249527|FG001|Overall Study|Sponsor Decision|3|||
124897370|NCT00320489|449249526|FG000|Overall Study|Withdrawal by Subject|39|||
124897371|NCT00320489|449249527|FG001|Overall Study|Withdrawal by Subject|41|||
124897372|NCT03441984|449249528|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897373|NCT03441984|449249529|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897374|NCT03441984|449249530|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
124897375|NCT03441984|449249531|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897376|NCT03441984|449249532|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897377|NCT03441984|449249533|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897378|NCT03441984|449249534|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897379|NCT03441984|449249535|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897380|NCT03441984|449249536|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897381|NCT03441984|449249537|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897382|NCT03441984|449249538|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897383|NCT03441984|449249539|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
124897384|NCT04088188|449249544|FG000|Overall Study|Withdrawal by Subject|2|||
124897385|NCT04088188|449249545|FG001|Overall Study|Withdrawal by Subject|0|||
124897386|NCT04088188|449249544|FG000|Overall Study|Adverse Event|2|||
124897387|NCT04088188|449249545|FG001|Overall Study|Adverse Event|0|||
124897388|NCT01670019|449249547|FG000|Overall Study|Adverse Event|3|||
124897389|NCT01670019|449249548|FG001|Overall Study|Adverse Event|0|||
124897390|NCT01670019|449249547|FG000|Overall Study|Withdrawal by Subject|6|||
124897391|NCT01670019|449249548|FG001|Overall Study|Withdrawal by Subject|0|||
124897392|NCT00580801|449249549|FG000|Overall Study|Physician Decision|1|||
124897393|NCT00580801|449249550|FG001|Overall Study|Physician Decision|0|||
124897394|NCT00580801|449249551|FG002|Overall Study|Physician Decision|0|||
124897395|NCT00580801|449249549|FG000|Overall Study|Adverse Event|2|||
124897396|NCT00580801|449249550|FG001|Overall Study|Adverse Event|0|||
124897397|NCT00580801|449249551|FG002|Overall Study|Adverse Event|0|||
124897398|NCT00580801|449249549|FG000|Overall Study|Lost to Follow-up|2|||
124897399|NCT00580801|449249550|FG001|Overall Study|Lost to Follow-up|0|||
124897400|NCT00580801|449249551|FG002|Overall Study|Lost to Follow-up|0|||
124897401|NCT00580801|449249549|FG000|Overall Study|Reached a virologic endpoint|0|||
124897402|NCT00580801|449249550|FG001|Overall Study|Reached a virologic endpoint|1|||
124897403|NCT00580801|449249551|FG002|Overall Study|Reached a virologic endpoint|2|||
124897404|NCT00580801|449249549|FG000|Overall Study|Participant non-compliant|0|||
124897405|NCT00580801|449249550|FG001|Overall Study|Participant non-compliant|0|||
124897406|NCT00580801|449249551|FG002|Overall Study|Participant non-compliant|1|||
124897407|NCT00580801|449249549|FG000|Overall Study|Travel|1|||
124897408|NCT00580801|449249550|FG001|Overall Study|Travel|0|||
124897409|NCT00580801|449249551|FG002|Overall Study|Travel|0|||
124897410|NCT03601507|449249552|FG000|Overall Study|Adverse Event|1|||
124897411|NCT02107014|449249555|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
124897412|NCT01981850|449249558|FG000|Main Phase Stage 1|Death|2|||
124897413|NCT01981850|449249559|FG001|Main Phase Stage 1|Death|0|||
124897414|NCT01981850|449249560|FG002|Main Phase Stage 1|Death|0|||
124897415|NCT01981850|449249561|FG003|Main Phase Stage 1|Death|0|||
124897416|NCT01981850|449249562|FG004|Main Phase Stage 1|Death|0|||
124897417|NCT01981850|449249563|FG005|Main Phase Stage 1|Death|0|||
124897418|NCT01981850|449249564|FG006|Main Phase Stage 1|Death|0|||
124897419|NCT01981850|449249565|FG007|Main Phase Stage 1|Death|0|||
124897420|NCT01981850|449249566|FG008|Main Phase Stage 1|Death|0|||
124897421|NCT01981850|449249567|FG009|Main Phase Stage 1|Death|0|||
124897422|NCT01981850|449249558|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
124897423|NCT01981850|449249559|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897424|NCT01981850|449249560|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897425|NCT01981850|449249561|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897426|NCT01981850|449249562|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897427|NCT01981850|449249563|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897428|NCT01981850|449249564|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897429|NCT01981850|449249565|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897430|NCT01981850|449249566|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897431|NCT01981850|449249567|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
124897432|NCT01981850|449249558|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
124897433|NCT01981850|449249559|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
124897434|NCT01981850|449249560|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
124897435|NCT01981850|449249561|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
124897436|NCT01981850|449249562|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
124897437|NCT01981850|449249563|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
124897438|NCT01981850|449249564|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
124897439|NCT01981850|449249565|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
124897440|NCT01981850|449249566|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
124897441|NCT01981850|449249567|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
124897442|NCT01981850|449249558|FG000|Main Phase Stage 1|Various reasons|0|||
124897443|NCT01981850|449249559|FG001|Main Phase Stage 1|Various reasons|0|||
124897444|NCT01981850|449249560|FG002|Main Phase Stage 1|Various reasons|2|||
124897445|NCT01981850|449249561|FG003|Main Phase Stage 1|Various reasons|0|||
124897446|NCT01981850|449249562|FG004|Main Phase Stage 1|Various reasons|0|||
124897447|NCT01981850|449249563|FG005|Main Phase Stage 1|Various reasons|0|||
124897448|NCT01981850|449249564|FG006|Main Phase Stage 1|Various reasons|0|||
124897449|NCT01981850|449249565|FG007|Main Phase Stage 1|Various reasons|0|||
124897450|NCT01981850|449249566|FG008|Main Phase Stage 1|Various reasons|0|||
124897451|NCT01981850|449249567|FG009|Main Phase Stage 1|Various reasons|0|||
124897452|NCT01981850|449249558|FG000|Main Phase Stage 2|Adverse Event|0|||
124897453|NCT01981850|449249559|FG001|Main Phase Stage 2|Adverse Event|0|||
124897454|NCT01981850|449249560|FG002|Main Phase Stage 2|Adverse Event|0|||
124897455|NCT01981850|449249561|FG003|Main Phase Stage 2|Adverse Event|0|||
124897456|NCT01981850|449249562|FG004|Main Phase Stage 2|Adverse Event|6|||
124897457|NCT01981850|449249563|FG005|Main Phase Stage 2|Adverse Event|5|||
124897458|NCT01981850|449249564|FG006|Main Phase Stage 2|Adverse Event|7|||
124897459|NCT01981850|449249565|FG007|Main Phase Stage 2|Adverse Event|0|||
124897460|NCT01981850|449249566|FG008|Main Phase Stage 2|Adverse Event|0|||
124897461|NCT01981850|449249567|FG009|Main Phase Stage 2|Adverse Event|0|||
124897462|NCT01981850|449249558|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
124897463|NCT01981850|449249559|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
124897464|NCT01981850|449249560|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
124897465|NCT01981850|449249561|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
124897466|NCT01981850|449249562|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
124897467|NCT01981850|449249563|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
124897468|NCT01981850|449249564|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
124897469|NCT01981850|449249565|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
124897470|NCT01981850|449249566|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
124897471|NCT01981850|449249567|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
124897472|NCT01981850|449249558|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
124897473|NCT01981850|449249559|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
124897474|NCT01981850|449249560|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
124897475|NCT01981850|449249561|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
124897476|NCT01981850|449249562|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
124897477|NCT01981850|449249563|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
124897478|NCT01981850|449249564|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
124897479|NCT01981850|449249565|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
124897480|NCT01981850|449249566|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
124897481|NCT01981850|449249567|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
124897482|NCT01981850|449249558|FG000|Main Phase Stage 2|Various reasons|0|||
124897483|NCT01981850|449249559|FG001|Main Phase Stage 2|Various reasons|0|||
124897484|NCT01981850|449249560|FG002|Main Phase Stage 2|Various reasons|0|||
124897485|NCT01981850|449249561|FG003|Main Phase Stage 2|Various reasons|0|||
124897486|NCT01981850|449249562|FG004|Main Phase Stage 2|Various reasons|2|||
124897487|NCT01981850|449249563|FG005|Main Phase Stage 2|Various reasons|0|||
124897488|NCT01981850|449249564|FG006|Main Phase Stage 2|Various reasons|1|||
124897489|NCT01981850|449249565|FG007|Main Phase Stage 2|Various reasons|0|||
124897490|NCT01981850|449249566|FG008|Main Phase Stage 2|Various reasons|0|||
124897491|NCT01981850|449249567|FG009|Main Phase Stage 2|Various reasons|0|||
124897492|NCT01981850|449249558|FG000|Main Phase Stage 2|Progressive Disease|0|||
124897493|NCT01981850|449249559|FG001|Main Phase Stage 2|Progressive Disease|0|||
124897494|NCT01981850|449249560|FG002|Main Phase Stage 2|Progressive Disease|0|||
124897495|NCT01981850|449249561|FG003|Main Phase Stage 2|Progressive Disease|0|||
124897496|NCT01981850|449249562|FG004|Main Phase Stage 2|Progressive Disease|0|||
124897497|NCT01981850|449249563|FG005|Main Phase Stage 2|Progressive Disease|6|||
124897498|NCT01981850|449249564|FG006|Main Phase Stage 2|Progressive Disease|6|||
124897499|NCT01981850|449249565|FG007|Main Phase Stage 2|Progressive Disease|0|||
124897500|NCT01981850|449249566|FG008|Main Phase Stage 2|Progressive Disease|0|||
124897501|NCT01981850|449249567|FG009|Main Phase Stage 2|Progressive Disease|0|||
124897502|NCT01981850|449249558|FG000|Open Label Extension (OLE)|Adverse Event|0|||
124897503|NCT01981850|449249559|FG001|Open Label Extension (OLE)|Adverse Event|0|||
124897504|NCT01981850|449249560|FG002|Open Label Extension (OLE)|Adverse Event|0|||
124897505|NCT01981850|449249561|FG003|Open Label Extension (OLE)|Adverse Event|0|||
124897506|NCT01981850|449249562|FG004|Open Label Extension (OLE)|Adverse Event|0|||
124897507|NCT01981850|449249563|FG005|Open Label Extension (OLE)|Adverse Event|0|||
124897508|NCT01981850|449249564|FG006|Open Label Extension (OLE)|Adverse Event|0|||
124897509|NCT01981850|449249565|FG007|Open Label Extension (OLE)|Adverse Event|2|||
124897510|NCT01981850|449249566|FG008|Open Label Extension (OLE)|Adverse Event|1|||
124897511|NCT01981850|449249567|FG009|Open Label Extension (OLE)|Adverse Event|8|||
124897512|NCT01981850|449249558|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
124897513|NCT01981850|449249559|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
124897514|NCT01981850|449249560|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
124897515|NCT01981850|449249561|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
124897516|NCT01981850|449249562|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
124897517|NCT01981850|449249563|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
124897518|NCT01981850|449249564|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
124897519|NCT01981850|449249565|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
124897520|NCT01981850|449249566|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
124897521|NCT01981850|449249567|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
124897522|NCT01981850|449249558|FG000|Open Label Extension (OLE)|Various reasons|0|||
124897523|NCT01981850|449249559|FG001|Open Label Extension (OLE)|Various reasons|0|||
124897524|NCT01981850|449249560|FG002|Open Label Extension (OLE)|Various reasons|0|||
124897525|NCT01981850|449249561|FG003|Open Label Extension (OLE)|Various reasons|0|||
124897526|NCT01981850|449249562|FG004|Open Label Extension (OLE)|Various reasons|0|||
124897527|NCT01981850|449249563|FG005|Open Label Extension (OLE)|Various reasons|0|||
124897528|NCT01981850|449249564|FG006|Open Label Extension (OLE)|Various reasons|0|||
124897529|NCT01981850|449249565|FG007|Open Label Extension (OLE)|Various reasons|3|||
124897530|NCT01981850|449249566|FG008|Open Label Extension (OLE)|Various reasons|1|||
124897531|NCT01981850|449249567|FG009|Open Label Extension (OLE)|Various reasons|3|||
124897532|NCT01981850|449249558|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
124897533|NCT01981850|449249559|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
124897534|NCT01981850|449249560|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
124897535|NCT01981850|449249561|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
124897536|NCT01981850|449249562|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
124897537|NCT01981850|449249563|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
124897538|NCT01981850|449249564|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
124897539|NCT01981850|449249565|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
124897540|NCT01981850|449249566|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
124897541|NCT01981850|449249567|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
124897542|NCT01981850|449249558|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897543|NCT01981850|449249559|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897544|NCT01981850|449249560|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897545|NCT01981850|449249561|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897546|NCT01981850|449249562|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897547|NCT01981850|449249563|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897548|NCT01981850|449249564|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897549|NCT01981850|449249565|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897550|NCT01981850|449249566|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
124897551|NCT01981850|449249567|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
124897552|NCT01981850|449249558|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897553|NCT01981850|449249559|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897554|NCT01981850|449249560|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897555|NCT01981850|449249561|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897556|NCT01981850|449249562|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897557|NCT01981850|449249563|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897558|NCT01981850|449249564|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897559|NCT01981850|449249565|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897560|NCT01981850|449249566|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
124897561|NCT01981850|449249567|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
124897562|NCT03168438|449249568|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
124897563|NCT03168438|449249569|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
124897564|NCT05015478|449249572|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
124897565|NCT05015478|449249573|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
124897566|NCT05015478|449249574|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
124897567|NCT05015478|449249575|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
124897568|NCT01649427|449249579|FG000|Overall Study|Adverse Event|1|||
124897569|NCT01649427|449249580|FG001|Overall Study|Adverse Event|1|||
124897570|NCT01649427|449249579|FG000|Overall Study|Withdrawal by Subject|8|||
124897571|NCT01649427|449249580|FG001|Overall Study|Withdrawal by Subject|7|||
124897572|NCT01649427|449249579|FG000|Overall Study|Lost to Follow-up|0|||
124897573|NCT01649427|449249580|FG001|Overall Study|Lost to Follow-up|1|||
124897574|NCT01649427|449249579|FG000|Overall Study|Graft loss|0|||
124897575|NCT01649427|449249580|FG001|Overall Study|Graft loss|1|||
124897576|NCT01649427|449249579|FG000|Overall Study|Surgical problems during nephrectomy|2|||
124897577|NCT01649427|449249580|FG001|Overall Study|Surgical problems during nephrectomy|2|||
124897578|NCT02138916|449249581|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
124897579|NCT02138916|449249582|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
124897580|NCT02138916|449249583|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
124897581|NCT02138916|449249581|FG000|Overall Study|Death|14|||
124897582|NCT02138916|449249582|FG001|Overall Study|Death|11|||
124897583|NCT02138916|449249583|FG002|Overall Study|Death|12|||
124897584|NCT02138916|449249581|FG000|Overall Study|Withdrawal by Subject|27|||
124897585|NCT02138916|449249582|FG001|Overall Study|Withdrawal by Subject|31|||
124897586|NCT02138916|449249583|FG002|Overall Study|Withdrawal by Subject|32|||
124897587|NCT02138916|449249581|FG000|Overall Study|Study specific withdrawal criteria|0|||
124897588|NCT02138916|449249582|FG001|Overall Study|Study specific withdrawal criteria|0|||
124897589|NCT02138916|449249583|FG002|Overall Study|Study specific withdrawal criteria|1|||
124897590|NCT02138916|449249581|FG000|Overall Study|incorrect enrolment|1|||
124897591|NCT02138916|449249582|FG001|Overall Study|incorrect enrolment|1|||
124897592|NCT02138916|449249583|FG002|Overall Study|incorrect enrolment|0|||
124897593|NCT02138916|449249581|FG000|Overall Study|Severe non-compliance|1|||
124897594|NCT02138916|449249582|FG001|Overall Study|Severe non-compliance|2|||
124897595|NCT02138916|449249583|FG002|Overall Study|Severe non-compliance|1|||
124897596|NCT02138916|449249581|FG000|Overall Study|Lost to Follow-up|4|||
124897597|NCT02138916|449249582|FG001|Overall Study|Lost to Follow-up|2|||
124897598|NCT02138916|449249583|FG002|Overall Study|Lost to Follow-up|3|||
124897599|NCT02138916|449249581|FG000|Overall Study|Adverse Event|4|||
124897600|NCT02138916|449249582|FG001|Overall Study|Adverse Event|4|||
124897601|NCT02138916|449249583|FG002|Overall Study|Adverse Event|3|||
124897602|NCT00117988|449249588|FG000|Overall Study|Death|3|||
124897603|NCT00117988|449249588|FG000|Overall Study|Adverse Event|1|||
124897604|NCT05196737|449249590|FG000|Non-intervention Week|Lost to Follow-up|2|||
124897605|NCT05196737|449249590|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
124897606|NCT05096884|449249591|FG000|Overall Study|Excluded based on negative tilt table test|4|||
124897607|NCT04927975|449249592|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
124897608|NCT04927975|449249593|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
124897609|NCT04927975|449249594|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
124897610|NCT04927975|449249595|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
124897611|NCT04927975|449249596|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
124897612|NCT04927975|449249597|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
124897613|NCT04927975|449249592|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
124897614|NCT04927975|449249593|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
124897615|NCT04927975|449249594|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
124897616|NCT04927975|449249595|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
124897617|NCT04927975|449249596|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
124897618|NCT04927975|449249597|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
124897619|NCT04927975|449249592|FG000|Period 1 (Baseline-Week 24)|Death|0|||
124897620|NCT04927975|449249593|FG001|Period 1 (Baseline-Week 24)|Death|0|||
124897621|NCT04927975|449249594|FG002|Period 1 (Baseline-Week 24)|Death|0|||
124897622|NCT04927975|449249595|FG003|Period 1 (Baseline-Week 24)|Death|0|||
124897623|NCT04927975|449249596|FG004|Period 1 (Baseline-Week 24)|Death|0|||
124897624|NCT04927975|449249597|FG005|Period 1 (Baseline-Week 24)|Death|1|||
124897625|NCT04927975|449249592|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
124897626|NCT04927975|449249593|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
124897627|NCT04927975|449249594|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
124897628|NCT04927975|449249595|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
124897629|NCT04927975|449249596|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
124897630|NCT04927975|449249597|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
124897631|NCT04927975|449249592|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
124897632|NCT04927975|449249593|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
124897633|NCT04927975|449249594|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
124897634|NCT04927975|449249595|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
124897635|NCT04927975|449249596|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
124897636|NCT04927975|449249597|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
124897637|NCT03781804|449249598|FG000|Overall Study|Adverse Event|2|||
124897638|NCT03781804|449249599|FG001|Overall Study|Adverse Event|2|||
124897639|NCT03781804|449249600|FG002|Overall Study|Adverse Event|3|||
124897640|NCT03781804|449249598|FG000|Overall Study|Lost to Follow-up|1|||
124897641|NCT03781804|449249599|FG001|Overall Study|Lost to Follow-up|1|||
124897642|NCT03781804|449249600|FG002|Overall Study|Lost to Follow-up|2|||
124897643|NCT03781804|449249598|FG000|Overall Study|Lack of Efficacy|4|||
124897644|NCT03781804|449249599|FG001|Overall Study|Lack of Efficacy|2|||
124897645|NCT03781804|449249600|FG002|Overall Study|Lack of Efficacy|9|||
124897646|NCT03781804|449249598|FG000|Overall Study|Protocol Violation|0|||
124897647|NCT03781804|449249599|FG001|Overall Study|Protocol Violation|0|||
124897648|NCT03781804|449249600|FG002|Overall Study|Protocol Violation|1|||
124897649|NCT03781804|449249598|FG000|Overall Study|Withdrawal by Subject|0|||
124897650|NCT03781804|449249599|FG001|Overall Study|Withdrawal by Subject|1|||
124897651|NCT03781804|449249600|FG002|Overall Study|Withdrawal by Subject|1|||
124897652|NCT03781804|449249598|FG000|Overall Study|Reason not provided|2|||
124897653|NCT03781804|449249599|FG001|Overall Study|Reason not provided|2|||
124897654|NCT03781804|449249600|FG002|Overall Study|Reason not provided|0|||
124897655|NCT00337818|449249601|FG000|Overall Study|Lost to Follow-up|289|||
124897656|NCT00337818|449249602|FG001|Overall Study|Lost to Follow-up|91|||
124897657|NCT00337818|449249603|FG002|Overall Study|Lost to Follow-up|107|||
124897658|NCT04678830|449249604|FG000|Overall Study|Lack of Efficacy|2|||
124897659|NCT04678830|449249605|FG001|Overall Study|Lack of Efficacy|0|||
124897660|NCT04678830|449249604|FG000|Overall Study|Withdrawal by Subject|0|||
124897661|NCT04678830|449249605|FG001|Overall Study|Withdrawal by Subject|1|||
124897662|NCT03563053|449249609|FG000|Overall Study|Withdrawal by Subject|17|||
124897663|NCT03563053|449249609|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
124897664|NCT03563053|449249609|FG000|Overall Study|Adverse Event|3|||
124897665|NCT03563053|449249609|FG000|Overall Study|Physician Decision|1|||
124897666|NCT03563053|449249609|FG000|Overall Study|study terminated by sponsor|71|||
124897667|NCT03369951|449249611|FG000|Overall Study|Withdrawal by Subject|3|||
124897668|NCT03369951|449249611|FG000|Overall Study|Death|1|||
124897669|NCT03369951|449249611|FG000|Overall Study|Lost to Follow-up|1|||
124897670|NCT03369951|449249611|FG000|Overall Study|Protocol Violation|1|||
124897671|NCT02926937|449249612|FG000|Overall Study|Adverse Event|0|||
124897672|NCT02926937|449249613|FG001|Overall Study|Adverse Event|1|||
124897673|NCT02926937|449249614|FG002|Overall Study|Adverse Event|1|||
124897674|NCT02926937|449249612|FG000|Overall Study|Poor Compliance to Protocol|1|||
124897675|NCT02926937|449249613|FG001|Overall Study|Poor Compliance to Protocol|0|||
124897676|NCT02926937|449249614|FG002|Overall Study|Poor Compliance to Protocol|0|||
124897677|NCT02926937|449249612|FG000|Overall Study|Lost to Follow-up|4|||
124897678|NCT02926937|449249613|FG001|Overall Study|Lost to Follow-up|5|||
124897679|NCT02926937|449249614|FG002|Overall Study|Lost to Follow-up|0|||
124897680|NCT02926937|449249612|FG000|Overall Study|At the Participant's own Request|11|||
124445538|NCT02673619|447593764|FG002|Overall Study|Withdrawal by Subject|1|||
124897681|NCT02926937|449249613|FG001|Overall Study|At the Participant's own Request|5|||
124445539|NCT02673619|447593765|FG003|Overall Study|Withdrawal by Subject|0|||
124897682|NCT02926937|449249614|FG002|Overall Study|At the Participant's own Request|8|||
124897683|NCT02926937|449249612|FG000|Overall Study|Reason not Specified|3|||
124897684|NCT02926937|449249613|FG001|Overall Study|Reason not Specified|4|||
124897685|NCT02926937|449249614|FG002|Overall Study|Reason not Specified|2|||
124445540|NCT02673619|447593762|FG000|Overall Study|Adverse Event|0|||
124897686|NCT00561574|449249615|FG000|Overall Study|Adverse Event|21|||
124897687|NCT00561574|449249616|FG001|Overall Study|Adverse Event|24|||
124897688|NCT00561574|449249615|FG000|Overall Study|Lack of Efficacy|11|||
124897689|NCT00561574|449249616|FG001|Overall Study|Lack of Efficacy|21|||
124897690|NCT00561574|449249615|FG000|Overall Study|Withdrawal by Subject|4|||
124897691|NCT00561574|449249616|FG001|Overall Study|Withdrawal by Subject|4|||
124897692|NCT00561574|449249615|FG000|Overall Study|Reason Unrelated to Trial|6|||
124897693|NCT00561574|449249616|FG001|Overall Study|Reason Unrelated to Trial|2|||
124897694|NCT00561574|449249615|FG000|Overall Study|Lost to Follow-up|1|||
124897695|NCT00561574|449249616|FG001|Overall Study|Lost to Follow-up|0|||
124897696|NCT00561574|449249615|FG000|Overall Study|Other|5|||
124897697|NCT00561574|449249616|FG001|Overall Study|Other|7|||
124897698|NCT00630864|449249621|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
124897699|NCT00630864|449249621|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
124897700|NCT00124982|449249622|FG000|Short-term Period|Death|1|||
124897701|NCT00124982|449249623|FG001|Short-term Period|Death|1|||
124897702|NCT00124982|449249624|FG002|Short-term Period|Death|0|||
124897703|NCT00124982|449249622|FG000|Short-term Period|Adverse Event|17|||
124897704|NCT00124982|449249623|FG001|Short-term Period|Adverse Event|22|||
124897705|NCT00124982|449249624|FG002|Short-term Period|Adverse Event|0|||
124897706|NCT00124982|449249622|FG000|Short-term Period|Lack of Efficacy|32|||
124897707|NCT00124982|449249623|FG001|Short-term Period|Lack of Efficacy|73|||
124897708|NCT00124982|449249624|FG002|Short-term Period|Lack of Efficacy|0|||
124897709|NCT00124982|449249622|FG000|Short-term Period|Lost to Follow-up|8|||
124897710|NCT00124982|449249623|FG001|Short-term Period|Lost to Follow-up|5|||
124897711|NCT00124982|449249624|FG002|Short-term Period|Lost to Follow-up|0|||
124897712|NCT00124982|449249622|FG000|Short-term Period|Withdrawal of Consent|7|||
124897713|NCT00124982|449249623|FG001|Short-term Period|Withdrawal of Consent|9|||
124897714|NCT00124982|449249624|FG002|Short-term Period|Withdrawal of Consent|0|||
124897715|NCT00124982|449249622|FG000|Short-term Period|Poor/Non-compliance|3|||
124897716|NCT00124982|449249623|FG001|Short-term Period|Poor/Non-compliance|1|||
124897717|NCT00124982|449249624|FG002|Short-term Period|Poor/Non-compliance|0|||
124897718|NCT00124982|449249622|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
124897719|NCT00124982|449249623|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
124897720|NCT00124982|449249624|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
124897721|NCT00124982|449249622|FG000|Short-term Period|Participant Decision|1|||
124897722|NCT00124982|449249623|FG001|Short-term Period|Participant Decision|0|||
124897723|NCT00124982|449249624|FG002|Short-term Period|Participant Decision|0|||
124897724|NCT00124982|449249622|FG000|Short-term Period|Participant Chose Own Doctor|0|||
124897725|NCT00124982|449249623|FG001|Short-term Period|Participant Chose Own Doctor|1|||
124897726|NCT00124982|449249624|FG002|Short-term Period|Participant Chose Own Doctor|0|||
124897727|NCT00124982|449249622|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
124897728|NCT00124982|449249623|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
124897729|NCT00124982|449249624|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
124897730|NCT00124982|449249622|FG000|Short-term Period|Participant Had Lymphopenia|1|||
124897731|NCT00124982|449249623|FG001|Short-term Period|Participant Had Lymphopenia|0|||
124897732|NCT00124982|449249624|FG002|Short-term Period|Participant Had Lymphopenia|0|||
124897733|NCT00124982|449249622|FG000|Long-term Period|Death|0|||
124897734|NCT00124982|449249623|FG001|Long-term Period|Death|0|||
124897735|NCT00124982|449249624|FG002|Long-term Period|Death|1|||
124897736|NCT00124982|449249622|FG000|Long-term Period|Adverse Event|0|||
124897737|NCT00124982|449249623|FG001|Long-term Period|Adverse Event|0|||
124897738|NCT00124982|449249624|FG002|Long-term Period|Adverse Event|17|||
124897739|NCT00124982|449249622|FG000|Long-term Period|Lack of Efficacy|0|||
124897740|NCT00124982|449249623|FG001|Long-term Period|Lack of Efficacy|0|||
124897741|NCT00124982|449249624|FG002|Long-term Period|Lack of Efficacy|46|||
124897742|NCT00124982|449249622|FG000|Long-term Period|Lost to Follow-up|0|||
124897743|NCT00124982|449249623|FG001|Long-term Period|Lost to Follow-up|0|||
124897744|NCT00124982|449249624|FG002|Long-term Period|Lost to Follow-up|4|||
124897745|NCT00124982|449249622|FG000|Long-term Period|Withdrawal by Subject|0|||
124897746|NCT00124982|449249623|FG001|Long-term Period|Withdrawal by Subject|0|||
124897747|NCT00124982|449249624|FG002|Long-term Period|Withdrawal by Subject|16|||
124897748|NCT00124982|449249622|FG000|Long-term Period|Pregnancy|0|||
124897749|NCT00124982|449249623|FG001|Long-term Period|Pregnancy|0|||
124897750|NCT00124982|449249624|FG002|Long-term Period|Pregnancy|1|||
124897751|NCT00124982|449249622|FG000|Long-term Period|Poor/Non-compliance|0|||
124688776|NCT04827446|448479838|FG000|Overall Study|Withdrawal by Subject|2|||
124897752|NCT00124982|449249623|FG001|Long-term Period|Poor/Non-compliance|0|||
124688777|NCT04827446|448479839|FG001|Overall Study|Withdrawal by Subject|2|||
124897753|NCT00124982|449249624|FG002|Long-term Period|Poor/Non-compliance|2|||
124897754|NCT00124982|449249622|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
124897755|NCT00124982|449249623|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
124688778|NCT05399771|448479842|FG000|Overall Study|Physician Decision|3|||
124897756|NCT00124982|449249624|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
124897757|NCT00124982|449249622|FG000|Long-term Period|Neurologist Recommendation|0|||
124897758|NCT00124982|449249623|FG001|Long-term Period|Neurologist Recommendation|0|||
124897759|NCT00124982|449249624|FG002|Long-term Period|Neurologist Recommendation|1|||
124897760|NCT04155424|449249625|FG000|Overall Study|Other than specified|3|||
124897761|NCT04155424|449249625|FG000|Overall Study|Withdrawal by Subject|1|||
124897762|NCT04155424|449249625|FG000|Overall Study|Adverse Event|1|||
124897763|NCT03015740|449249626|FG000|Overall Study|Adverse Event|1|||
124897764|NCT03015740|449249627|FG001|Overall Study|Adverse Event|0|||
124897765|NCT03015740|449249628|FG002|Overall Study|Adverse Event|0|||
124897766|NCT03015740|449249626|FG000|Overall Study|Death|3|||
124897767|NCT03015740|449249627|FG001|Overall Study|Death|5|||
124897768|NCT03015740|449249628|FG002|Overall Study|Death|0|||
124897769|NCT03015740|449249626|FG000|Overall Study|Withdrawal by Subject|2|||
124897770|NCT03015740|449249627|FG001|Overall Study|Withdrawal by Subject|0|||
124897771|NCT03015740|449249628|FG002|Overall Study|Withdrawal by Subject|0|||
124897772|NCT00587288|449251082|FG000|Overall Study|Adverse Event|0|||
124897773|NCT00587288|449251083|FG001|Overall Study|Adverse Event|1|||
124897774|NCT00587288|449251082|FG000|Overall Study|Lack of Efficacy|2|||
124897775|NCT00587288|449251083|FG001|Overall Study|Lack of Efficacy|8|||
124897776|NCT00587288|449251082|FG000|Overall Study|Protocol Violation|1|||
124897777|NCT00587288|449251083|FG001|Overall Study|Protocol Violation|0|||
124897778|NCT00797862|449251084|FG000|Overall Study|Adverse Event|86|||
124897779|NCT00797862|449251085|FG001|Overall Study|Adverse Event|44|||
124897780|NCT00797862|449251086|FG002|Overall Study|Adverse Event|58|||
124897781|NCT00797862|449251084|FG000|Overall Study|Abnormal Test Procedure Result|0|||
124897782|NCT00797862|449251085|FG001|Overall Study|Abnormal Test Procedure Result|1|||
124897783|NCT00797862|449251086|FG002|Overall Study|Abnormal Test Procedure Result|1|||
124897784|NCT00797862|449251084|FG000|Overall Study|Lack of Efficacy|1|||
124897785|NCT00797862|449251085|FG001|Overall Study|Lack of Efficacy|7|||
124897786|NCT00797862|449251086|FG002|Overall Study|Lack of Efficacy|6|||
124897787|NCT00797862|449251084|FG000|Overall Study|No longer required study medication|1|||
124897788|NCT00797862|449251085|FG001|Overall Study|No longer required study medication|0|||
124897789|NCT00797862|449251086|FG002|Overall Study|No longer required study medication|0|||
124897790|NCT00797862|449251084|FG000|Overall Study|Withdrawal by Subject|14|||
124897791|NCT00797862|449251085|FG001|Overall Study|Withdrawal by Subject|7|||
124897792|NCT00797862|449251086|FG002|Overall Study|Withdrawal by Subject|7|||
124897793|NCT00797862|449251084|FG000|Overall Study|Lost to Follow-up|11|||
124897794|NCT00797862|449251085|FG001|Overall Study|Lost to Follow-up|0|||
124897795|NCT00797862|449251086|FG002|Overall Study|Lost to Follow-up|5|||
124897796|NCT00797862|449251084|FG000|Overall Study|Administrative Problem|4|||
124897797|NCT00797862|449251085|FG001|Overall Study|Administrative Problem|0|||
124897798|NCT00797862|449251086|FG002|Overall Study|Administrative Problem|0|||
124897799|NCT00797862|449251084|FG000|Overall Study|Protocol Violation|4|||
124897800|NCT00797862|449251085|FG001|Overall Study|Protocol Violation|6|||
124897801|NCT00797862|449251086|FG002|Overall Study|Protocol Violation|8|||
124897802|NCT00797862|449251084|FG000|Overall Study|Mis-randomized|3|||
124897803|NCT00797862|449251085|FG001|Overall Study|Mis-randomized|3|||
124897804|NCT00797862|449251086|FG002|Overall Study|Mis-randomized|1|||
124897805|NCT00531479|449251087|FG000|Overall Study|Death|68|||
124897806|NCT00531479|449251088|FG001|Overall Study|Death|71|||
124897807|NCT00531479|449251087|FG000|Overall Study|Lost to Follow-up|0|||
124897808|NCT00531479|449251088|FG001|Overall Study|Lost to Follow-up|2|||
124759438|NCT01777308|448744698|FG001|Overall Study|Withdrawal by Subject|1|||
124897809|NCT00531479|449251087|FG000|Overall Study|Other|0|||
124897810|NCT00531479|449251088|FG001|Overall Study|Other|1|||
124897811|NCT00531479|449251087|FG000|Overall Study|Withdrawal by Subject|6|||
124897812|NCT00531479|449251088|FG001|Overall Study|Withdrawal by Subject|6|||
124897813|NCT00531479|449251087|FG000|Overall Study|Did not receive treatment|2|||
124897814|NCT00531479|449251088|FG001|Overall Study|Did not receive treatment|3|||
124897815|NCT00409708|449251100|FG000|Treatment|Abnormal test procedure result(s)|1|||
124897816|NCT00409708|449251101|FG001|Treatment|Abnormal test procedure result(s)|0|||
124897817|NCT00409708|449251100|FG000|Treatment|Lack of Efficacy|0|||
124897818|NCT00409708|449251101|FG001|Treatment|Lack of Efficacy|1|||
124897819|NCT00409708|449251100|FG000|Treatment|Protocol Violation|6|||
124897820|NCT00409708|449251101|FG001|Treatment|Protocol Violation|2|||
124897821|NCT00409708|449251100|FG000|Treatment|Withdrawal by Subject|3|||
124445541|NCT02673619|447593763|FG001|Overall Study|Adverse Event|0|||
124897822|NCT00409708|449251101|FG001|Treatment|Withdrawal by Subject|8|||
124897823|NCT00409708|449251100|FG000|Treatment|Lost to Follow-up|0|||
124897824|NCT00409708|449251101|FG001|Treatment|Lost to Follow-up|6|||
124897825|NCT00409708|449251100|FG000|Treatment|Administrative problems|5|||
124897826|NCT00409708|449251101|FG001|Treatment|Administrative problems|0|||
124897827|NCT00409708|449251100|FG000|Washout|Lack of Efficacy|9|||
124897828|NCT00409708|449251101|FG001|Washout|Lack of Efficacy|1|||
124897829|NCT00409708|449251100|FG000|Washout|Protocol Violation|0|||
124897830|NCT00409708|449251101|FG001|Washout|Protocol Violation|1|||
124897831|NCT00409708|449251100|FG000|Washout|Withdrawal by Subject|11|||
124897832|NCT00409708|449251101|FG001|Washout|Withdrawal by Subject|5|||
124897833|NCT00409708|449251100|FG000|Washout|Lost to Follow-up|1|||
124897834|NCT00409708|449251101|FG001|Washout|Lost to Follow-up|3|||
124897835|NCT01474538|449251108|FG000|Treatment Period 1|Death|1|||
124897836|NCT01474538|449251109|FG001|Treatment Period 1|Death|0|||
124897837|NCT01474538|449251108|FG000|Treatment Period 1|Physician Decision|1|||
124897838|NCT01474538|449251109|FG001|Treatment Period 1|Physician Decision|0|||
124897839|NCT01474538|449251108|FG000|Treatment Period 1|Withdrawal by Subject|1|||
124897840|NCT01474538|449251109|FG001|Treatment Period 1|Withdrawal by Subject|3|||
124897841|NCT01474538|449251108|FG000|Treatment Period 1|Protocol Violation|0|||
124897842|NCT01474538|449251109|FG001|Treatment Period 1|Protocol Violation|1|||
124897843|NCT01474538|449251108|FG000|Treatment Period 2|Death|1|||
124897844|NCT01474538|449251109|FG001|Treatment Period 2|Death|0|||
124897845|NCT01474538|449251108|FG000|Treatment Period 2|Adverse Event|1|||
124897846|NCT01474538|449251109|FG001|Treatment Period 2|Adverse Event|1|||
124759439|NCT01777308|448744697|FG000|Overall Study|Migrated/moved from study area|1|||
124759440|NCT01777308|448744698|FG001|Overall Study|Migrated/moved from study area|0|||
124759441|NCT01777308|448744697|FG000|Overall Study|Lost to Follow-up|7|||
124759442|NCT01777308|448744698|FG001|Overall Study|Lost to Follow-up|2|||
124759443|NCT01777308|448744697|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
124759444|NCT01777308|448744698|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
124759445|NCT03212326|448744700|FG000|Overall Study|Physician Decision|4|||
124759446|NCT00985673|448744712|FG000|Overall Study|Lost to Follow-up|6|||
124759447|NCT00985673|448744713|FG001|Overall Study|Lost to Follow-up|7|||
124759448|NCT00985673|448744714|FG002|Overall Study|Lost to Follow-up|6|||
124759449|NCT00985673|448744715|FG003|Overall Study|Lost to Follow-up|10|||
124759450|NCT00985673|448744716|FG004|Overall Study|Lost to Follow-up|5|||
124759451|NCT00985673|448744717|FG005|Overall Study|Lost to Follow-up|3|||
124759452|NCT00985673|448744712|FG000|Overall Study|Withdrawal by Subject|0|||
124759453|NCT00985673|448744713|FG001|Overall Study|Withdrawal by Subject|4|||
124759454|NCT00985673|448744714|FG002|Overall Study|Withdrawal by Subject|5|||
124897847|NCT01474538|449251108|FG000|Treatment Period 2|Withdrawal by Subject|2|||
124897848|NCT01474538|449251109|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124897849|NCT01474538|449251108|FG000|Treatment Period 2|Sponsor decision|1|||
124897850|NCT01474538|449251109|FG001|Treatment Period 2|Sponsor decision|0|||
124897851|NCT01474538|449251108|FG000|Treatment Period 2|Physician Decision|0|||
124897852|NCT01474538|449251109|FG001|Treatment Period 2|Physician Decision|1|||
124897853|NCT01474538|449251108|FG000|Treatment Period 2|Protocol Violation|1|||
124897854|NCT01474538|449251109|FG001|Treatment Period 2|Protocol Violation|0|||
124897855|NCT01456780|449251110|FG000|Overall Study|Lost to Follow-up|3|||
124897856|NCT01456780|449251111|FG001|Overall Study|Lost to Follow-up|3|||
124897857|NCT01456780|449251112|FG002|Overall Study|Lost to Follow-up|0|||
124897858|NCT02501629|449251116|FG000|Overall Study|Death|0|||
124897859|NCT02501629|449251117|FG001|Overall Study|Death|1|||
124897860|NCT02501629|449251116|FG000|Overall Study|Withdrawn from study by sponsor|1|||
124897861|NCT02501629|449251117|FG001|Overall Study|Withdrawn from study by sponsor|0|||
124759455|NCT00985673|448744715|FG003|Overall Study|Withdrawal by Subject|2|||
124759456|NCT00985673|448744716|FG004|Overall Study|Withdrawal by Subject|2|||
124759457|NCT00985673|448744717|FG005|Overall Study|Withdrawal by Subject|3|||
124759458|NCT00985673|448744712|FG000|Overall Study|Other|1|||
124759459|NCT00985673|448744713|FG001|Overall Study|Other|0|||
124759460|NCT00985673|448744714|FG002|Overall Study|Other|1|||
124759461|NCT00985673|448744715|FG003|Overall Study|Other|0|||
124759462|NCT00985673|448744716|FG004|Overall Study|Other|1|||
124897862|NCT02501629|449251116|FG000|Overall Study|Early termination by sponsor|1|||
124445542|NCT02673619|447593764|FG002|Overall Study|Adverse Event|1|||
124759463|NCT00985673|448744717|FG005|Overall Study|Other|0|||
124759464|NCT00984256|448744720|FG000|Overall Study|Withdrawal by Subject|0|||
124759465|NCT00984256|448744721|FG001|Overall Study|Withdrawal by Subject|1|||
124759466|NCT03057496|448744722|FG000|Overall Study|Withdrawal by Subject|8|||
124759467|NCT03057496|448744722|FG000|Overall Study|Lost to Follow-up|5|||
124759468|NCT03057496|448744722|FG000|Overall Study|Did not use device during home trial|3|||
124759469|NCT03057496|448744722|FG000|Overall Study|Device failure|2|||
124759470|NCT00280917|448744723|FG000|Overall Study|Adverse Event|1|||
124759471|NCT00280917|448744724|FG001|Overall Study|Adverse Event|1|||
124759472|NCT00280917|448744725|FG002|Overall Study|Adverse Event|4|||
124759473|NCT00280917|448744726|FG003|Overall Study|Adverse Event|1|||
124759474|NCT00280917|448744723|FG000|Overall Study|Change Therapy|1|||
124759475|NCT00280917|448744724|FG001|Overall Study|Change Therapy|2|||
124759476|NCT00280917|448744725|FG002|Overall Study|Change Therapy|0|||
124759477|NCT00280917|448744726|FG003|Overall Study|Change Therapy|0|||
124759478|NCT00280917|448744723|FG000|Overall Study|Withdrawal by Subject|0|||
124759479|NCT00280917|448744724|FG001|Overall Study|Withdrawal by Subject|2|||
124759480|NCT00280917|448744725|FG002|Overall Study|Withdrawal by Subject|0|||
124759481|NCT00280917|448744726|FG003|Overall Study|Withdrawal by Subject|1|||
124759482|NCT00280917|448744723|FG000|Overall Study|Noncompliance|0|||
124759483|NCT00280917|448744724|FG001|Overall Study|Noncompliance|1|||
124759484|NCT00280917|448744725|FG002|Overall Study|Noncompliance|2|||
124759485|NCT00280917|448744726|FG003|Overall Study|Noncompliance|0|||
124759486|NCT01307319|448744727|FG000|Overall Study|Adverse Event|2|||
124897863|NCT02501629|449251117|FG001|Overall Study|Early termination by sponsor|0|||
124445543|NCT02673619|447593765|FG003|Overall Study|Adverse Event|0|||
124445544|NCT02673619|447593762|FG000|Overall Study|Lack of Efficacy|0|||
124445545|NCT02673619|447593763|FG001|Overall Study|Lack of Efficacy|0|||
124445546|NCT02673619|447593764|FG002|Overall Study|Lack of Efficacy|1|||
124445547|NCT02673619|447593765|FG003|Overall Study|Lack of Efficacy|0|||
124688779|NCT05399771|448479842|FG000|Overall Study|Adverse Event|1|||
124688780|NCT00484159|448479844|FG000|Overall Study|Lost to Follow-up|1|||
124688781|NCT00484159|448479845|FG001|Overall Study|Lost to Follow-up|1|||
124688782|NCT00484159|448479846|FG002|Overall Study|Lost to Follow-up|0|||
124688783|NCT03234881|448479847|FG000|Overall Study|Lost to Follow-up|9|||
124688784|NCT03234881|448479848|FG001|Overall Study|Lost to Follow-up|3|||
124688785|NCT03720847|448479849|FG000|Washout|Physician Decision|1|||
124688786|NCT03720847|448479850|FG001|Washout|Physician Decision|2|||
124688787|NCT01239680|448479851|FG000|Overall Study|Withdrawal by Subject|2|||
124688788|NCT01239680|448479852|FG001|Overall Study|Withdrawal by Subject|0|||
124688789|NCT03033901|448479853|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
124688790|NCT03033901|448479853|FG000|Overall Study|Refused PSG|23|||
124688791|NCT03033901|448479853|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
124688792|NCT03033901|448479853|FG000|Overall Study|Missing Oximetry Data|3|||
124688793|NCT05177094|448479860|FG000|Overall Study|Adverse Event|5|||
124688794|NCT05177094|448479861|FG001|Overall Study|Adverse Event|5|||
124688795|NCT05177094|448479860|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
124759487|NCT01307319|448744728|FG001|Overall Study|Adverse Event|2|||
124759488|NCT01307319|448744729|FG002|Overall Study|Adverse Event|1|||
124759489|NCT01307319|448744727|FG000|Overall Study|Lost to Follow-up|1|||
124759490|NCT01307319|448744728|FG001|Overall Study|Lost to Follow-up|0|||
124759491|NCT01307319|448744729|FG002|Overall Study|Lost to Follow-up|1|||
124897864|NCT02501629|449251116|FG000|Overall Study|Withdrawal by Subject|3|||
124445548|NCT04225806|447593766|FG000|Overall Study|Trial termination|15|||
124688796|NCT05177094|448479861|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
124759492|NCT01307319|448744727|FG000|Overall Study|Protocol Violation|1|||
124759493|NCT01307319|448744728|FG001|Overall Study|Protocol Violation|1|||
124897865|NCT02501629|449251117|FG001|Overall Study|Withdrawal by Subject|5|||
124897866|NCT02501629|449251116|FG000|Overall Study|Subject did not return to site|0|||
124897867|NCT02501629|449251117|FG001|Overall Study|Subject did not return to site|1|||
124897868|NCT00868231|449251122|FG000|Treatment Period 1|Adverse Event|0|||
124897869|NCT00868231|449251123|FG001|Treatment Period 1|Adverse Event|0|||
124897870|NCT00868231|449251124|FG002|Treatment Period 1|Adverse Event|0|||
124897871|NCT00868231|449251125|FG003|Treatment Period 1|Adverse Event|0|||
124897872|NCT00868231|449251126|FG004|Treatment Period 1|Adverse Event|1|||
124897873|NCT00868231|449251127|FG005|Treatment Period 1|Adverse Event|0|||
124897874|NCT00868231|449251122|FG000|Treatment Period 2|Adverse Event|1|||
124897875|NCT00868231|449251123|FG001|Treatment Period 2|Adverse Event|0|||
124897876|NCT00868231|449251124|FG002|Treatment Period 2|Adverse Event|0|||
124897877|NCT00868231|449251125|FG003|Treatment Period 2|Adverse Event|0|||
124897878|NCT00868231|449251126|FG004|Treatment Period 2|Adverse Event|0|||
124688797|NCT05177094|448479860|FG000|Overall Study|Protocol Deviation|3|||
124897879|NCT00868231|449251127|FG005|Treatment Period 2|Adverse Event|0|||
124897880|NCT00868231|449251122|FG000|Treatment Period 3|Adverse Event|0|||
124897881|NCT00868231|449251123|FG001|Treatment Period 3|Adverse Event|0|||
124897882|NCT00868231|449251124|FG002|Treatment Period 3|Adverse Event|1|||
124897883|NCT00868231|449251125|FG003|Treatment Period 3|Adverse Event|0|||
124897884|NCT00868231|449251126|FG004|Treatment Period 3|Adverse Event|0|||
124897885|NCT00868231|449251127|FG005|Treatment Period 3|Adverse Event|0|||
124897886|NCT00349908|449251130|FG000|Overall Study|Withdrawal by Subject|0|||
124897887|NCT00349908|449251131|FG001|Overall Study|Withdrawal by Subject|4|||
124897888|NCT04565249|449251132|FG000|Overall Study|Death|0|||
124897889|NCT04565249|449251133|FG001|Overall Study|Death|0|||
124897890|NCT04565249|449251134|FG002|Overall Study|Death|0|||
124897891|NCT04565249|449251135|FG003|Overall Study|Death|1|||
124897892|NCT03120676|449251136|FG000|Overall Study|Not treated|1|||
124897893|NCT00926393|449251137|FG000|Overall Study|Withdrawal by Subject|1|||
124897894|NCT00926393|449251138|FG001|Overall Study|Withdrawal by Subject|2|||
124897895|NCT00926393|449251137|FG000|Overall Study|Adverse Event|1|||
124897896|NCT00926393|449251138|FG001|Overall Study|Adverse Event|1|||
124897897|NCT02333630|449251139|FG000|Overall Study|Lost to Follow-up|5|||
124897898|NCT02333630|449251140|FG001|Overall Study|Lost to Follow-up|2|||
124897899|NCT05349864|449251141|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
124897900|NCT05349864|449251142|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
124897901|NCT00984282|449251143|FG000|Double Blind Treatment|Adverse Event|40|||
124897902|NCT00984282|449251144|FG001|Double Blind Treatment|Adverse Event|6|||
124897903|NCT00984282|449251143|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
124897904|NCT00984282|449251144|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
124897905|NCT00984282|449251143|FG000|Double Blind Treatment|Physician Decision|1|||
124897906|NCT00984282|449251144|FG001|Double Blind Treatment|Physician Decision|2|||
124897907|NCT00984282|449251143|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
124897908|NCT00984282|449251144|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
124897909|NCT00984282|449251143|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
124897910|NCT00984282|449251144|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
124897911|NCT00984282|449251143|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
124897912|NCT00984282|449251144|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
124897913|NCT00984282|449251143|FG000|Double Blind Treatment|Lost to Follow-up|3|||
124897914|NCT00984282|449251144|FG001|Double Blind Treatment|Lost to Follow-up|0|||
124897915|NCT00984282|449251143|FG000|Double Blind Treatment|Death|8|||
124897916|NCT00984282|449251144|FG001|Double Blind Treatment|Death|4|||
124897917|NCT00984282|449251143|FG000|Double Blind Treatment|Not treated|0|||
124897918|NCT00984282|449251144|FG001|Double Blind Treatment|Not treated|1|||
124897919|NCT00984282|449251143|FG000|Double Blind Treatment|Switched to commercial drug|6|||
124897920|NCT00984282|449251144|FG001|Double Blind Treatment|Switched to commercial drug|1|||
124897921|NCT00984282|449251143|FG000|Double Blind Treatment|protocol driven decision point|1|||
124897922|NCT00984282|449251144|FG001|Double Blind Treatment|protocol driven decision point|1|||
124897923|NCT00984282|449251143|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
124445549|NCT07052682|447593767|FG000|Overall Study|Withdrawal by Subject|4|||
124445550|NCT01940354|447595497|FG000|Overall Study|Withdrawal by Subject|4|||
124445551|NCT01940354|447595498|FG001|Overall Study|Withdrawal by Subject|2|||
124897924|NCT00984282|449251144|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
124897925|NCT00984282|449251143|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
124897926|NCT00984282|449251144|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
124897927|NCT00984282|449251143|FG000|Open-label Treatment|Adverse Event|20|||
124897928|NCT00984282|449251144|FG001|Open-label Treatment|Adverse Event|30|||
124897929|NCT00984282|449251143|FG000|Open-label Treatment|Withdrawal by Subject|6|||
124897930|NCT00984282|449251144|FG001|Open-label Treatment|Withdrawal by Subject|21|||
124897931|NCT00984282|449251143|FG000|Open-label Treatment|Death|7|||
124897932|NCT00984282|449251144|FG001|Open-label Treatment|Death|15|||
124897933|NCT00984282|449251143|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
124897934|NCT00984282|449251144|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
124897935|NCT00984282|449251143|FG000|Open-label Treatment|Lost to Follow-up|1|||
124897936|NCT00984282|449251144|FG001|Open-label Treatment|Lost to Follow-up|1|||
124897937|NCT00984282|449251143|FG000|Open-label Treatment|Patient convenience|1|||
124897938|NCT00984282|449251144|FG001|Open-label Treatment|Patient convenience|0|||
124897939|NCT00984282|449251143|FG000|Open-label Treatment|Non-compliant with study medication|1|||
124688798|NCT05177094|448479861|FG001|Overall Study|Protocol Deviation|0|||
124688799|NCT05177094|448479860|FG000|Overall Study|Withdrawal by Subject|6|||
124897940|NCT00984282|449251144|FG001|Open-label Treatment|Non-compliant with study medication|0|||
124897941|NCT00984282|449251143|FG000|Open-label Treatment|Target lesion removed|0|||
124897942|NCT00984282|449251144|FG001|Open-label Treatment|Target lesion removed|1|||
124897943|NCT00984282|449251143|FG000|Open-label Treatment|Protocol driven decision point|1|||
124897944|NCT00984282|449251144|FG001|Open-label Treatment|Protocol driven decision point|1|||
124897945|NCT00984282|449251143|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
124897946|NCT00984282|449251144|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
124897947|NCT00984282|449251143|FG000|Open-label Treatment|Switched to commercial drug|6|||
124897948|NCT00984282|449251144|FG001|Open-label Treatment|Switched to commercial drug|7|||
124897949|NCT00984282|449251143|FG000|Open-label Treatment|Physician Decision|1|||
124897950|NCT00984282|449251144|FG001|Open-label Treatment|Physician Decision|0|||
124897951|NCT00984282|449251143|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
124897952|NCT00984282|449251144|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
124897953|NCT00984282|449251143|FG000|Long Term Follow-up|Death|27|||
124897954|NCT00984282|449251144|FG001|Long Term Follow-up|Death|68|||
124897955|NCT00984282|449251143|FG000|Long Term Follow-up|Lost to Follow-up|3|||
124897956|NCT00984282|449251144|FG001|Long Term Follow-up|Lost to Follow-up|6|||
124897957|NCT00984282|449251143|FG000|Long Term Follow-up|Protocol driven decision point|25|||
124897958|NCT00984282|449251144|FG001|Long Term Follow-up|Protocol driven decision point|26|||
124897959|NCT00984282|449251143|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
124897960|NCT00984282|449251144|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
124897961|NCT00984282|449251143|FG000|Long Term Follow-up|Switched to commercial drug|4|||
124897962|NCT00984282|449251144|FG001|Long Term Follow-up|Switched to commercial drug|2|||
124897963|NCT00984282|449251143|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
124897964|NCT00984282|449251144|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
124897965|NCT02223793|449251145|FG000|Overall Study|Lost to Follow-up|10|||
124897966|NCT02223793|449251146|FG001|Overall Study|Lost to Follow-up|1|||
124897967|NCT02223793|449251147|FG002|Overall Study|Lost to Follow-up|2|||
124897968|NCT02223793|449251145|FG000|Overall Study|Withdrawal by Subject|3|||
124897969|NCT02223793|449251146|FG001|Overall Study|Withdrawal by Subject|2|||
124897970|NCT02223793|449251147|FG002|Overall Study|Withdrawal by Subject|3|||
124897971|NCT02223793|449251145|FG000|Overall Study|Moved/studycenter unable to participate|4|||
124897972|NCT02223793|449251146|FG001|Overall Study|Moved/studycenter unable to participate|6|||
124897973|NCT02223793|449251147|FG002|Overall Study|Moved/studycenter unable to participate|8|||
124897974|NCT02359435|449251149|FG000|Overall Study|Lost to Follow-up|4|||
124897975|NCT02359435|449251150|FG001|Overall Study|Lost to Follow-up|4|||
124897976|NCT00315055|449251151|FG000|Overall Study|Protocol Violation|2|||
124897977|NCT00315055|449251152|FG001|Overall Study|Protocol Violation|4|||
124897978|NCT00315055|449251151|FG000|Overall Study|Lost to Follow-up|1|||
124897979|NCT00315055|449251152|FG001|Overall Study|Lost to Follow-up|1|||
124897980|NCT01289119|449251157|FG000|Overall Study|Adverse Event|2|||
124688800|NCT05177094|448479861|FG001|Overall Study|Withdrawal by Subject|3|||
124897981|NCT01289119|449251158|FG001|Overall Study|Adverse Event|1|||
124897982|NCT01289119|449251159|FG002|Overall Study|Adverse Event|0|||
124897983|NCT01289119|449251160|FG003|Overall Study|Adverse Event|2|||
124897984|NCT01289119|449251161|FG004|Overall Study|Adverse Event|1|||
124897985|NCT01289119|449251162|FG005|Overall Study|Adverse Event|0|||
124897986|NCT01289119|449251157|FG000|Overall Study|Major Protocol Deviation|2|||
124897987|NCT01289119|449251158|FG001|Overall Study|Major Protocol Deviation|1|||
124897988|NCT01289119|449251159|FG002|Overall Study|Major Protocol Deviation|3|||
124897989|NCT01289119|449251160|FG003|Overall Study|Major Protocol Deviation|0|||
124897990|NCT01289119|449251161|FG004|Overall Study|Major Protocol Deviation|2|||
124897991|NCT01289119|449251162|FG005|Overall Study|Major Protocol Deviation|1|||
124897992|NCT01289119|449251157|FG000|Overall Study|Lost to Follow-up|0|||
124897993|NCT01289119|449251158|FG001|Overall Study|Lost to Follow-up|3|||
124897994|NCT01289119|449251159|FG002|Overall Study|Lost to Follow-up|0|||
124897995|NCT01289119|449251160|FG003|Overall Study|Lost to Follow-up|0|||
124897996|NCT01289119|449251161|FG004|Overall Study|Lost to Follow-up|0|||
124897997|NCT01289119|449251162|FG005|Overall Study|Lost to Follow-up|1|||
124897998|NCT01289119|449251157|FG000|Overall Study|Withdrawal by Subject|4|||
124897999|NCT01289119|449251158|FG001|Overall Study|Withdrawal by Subject|2|||
124898000|NCT01289119|449251159|FG002|Overall Study|Withdrawal by Subject|4|||
124898001|NCT01289119|449251160|FG003|Overall Study|Withdrawal by Subject|3|||
124898002|NCT01289119|449251161|FG004|Overall Study|Withdrawal by Subject|1|||
124898003|NCT01289119|449251162|FG005|Overall Study|Withdrawal by Subject|1|||
124898004|NCT01289119|449251157|FG000|Overall Study|Pregnancy|0|||
124898005|NCT01289119|449251158|FG001|Overall Study|Pregnancy|1|||
124898006|NCT01289119|449251159|FG002|Overall Study|Pregnancy|0|||
124898007|NCT01289119|449251160|FG003|Overall Study|Pregnancy|0|||
124898008|NCT01289119|449251161|FG004|Overall Study|Pregnancy|0|||
124898009|NCT01289119|449251162|FG005|Overall Study|Pregnancy|0|||
124898010|NCT01289119|449251157|FG000|Overall Study|Lack of Efficacy|0|||
124898011|NCT01289119|449251158|FG001|Overall Study|Lack of Efficacy|1|||
124898012|NCT01289119|449251159|FG002|Overall Study|Lack of Efficacy|1|||
124898013|NCT01289119|449251160|FG003|Overall Study|Lack of Efficacy|1|||
124898014|NCT01289119|449251161|FG004|Overall Study|Lack of Efficacy|1|||
124898015|NCT01289119|449251162|FG005|Overall Study|Lack of Efficacy|1|||
124898016|NCT01289119|449251157|FG000|Overall Study|Other|1|||
124898017|NCT01289119|449251158|FG001|Overall Study|Other|0|||
124898018|NCT01289119|449251159|FG002|Overall Study|Other|1|||
124898019|NCT01289119|449251160|FG003|Overall Study|Other|0|||
124898020|NCT01289119|449251161|FG004|Overall Study|Other|0|||
124898021|NCT01289119|449251162|FG005|Overall Study|Other|0|||
124898022|NCT01704846|449251163|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124898023|NCT01704846|449251164|FG001|Treatment Period 2|Withdrawal by Subject|1|||
124898024|NCT00530335|449251165|FG000|Overall Study|Adverse Event|3|||
124898025|NCT00530335|449251165|FG000|Overall Study|Protocol Violation|1|||
124898026|NCT00530335|449251165|FG000|Overall Study|Withdrawal by Subject|1|||
124898027|NCT00530335|449251165|FG000|Overall Study|Physician Decision|1|||
124898028|NCT02321540|449251166|FG000|Overall Study|Death|0|||
124898029|NCT02321540|449251167|FG001|Overall Study|Death|1|||
124898030|NCT02321540|449251166|FG000|Overall Study|Progression|3|||
124898031|NCT02321540|449251167|FG001|Overall Study|Progression|9|||
124898032|NCT01649791|449251168|FG000|Overall Study|Disease Progression|2|||
124898033|NCT01649791|449251168|FG000|Overall Study|Adverse Event|1|||
124898034|NCT04577183|449251169|FG000|Overall Study|Death|1|||
124898035|NCT04577183|449251169|FG000|Overall Study|Withdrawal by Subject|3|||
124898036|NCT04577183|449251169|FG000|Overall Study|Early termination|2|||
124898037|NCT01268891|449251175|FG000|Overall Study|Adverse Event|3|||
124898038|NCT01268891|449251176|FG001|Overall Study|Adverse Event|7|||
124898039|NCT01268891|449251175|FG000|Overall Study|Lack of Efficacy|1|||
124898040|NCT01268891|449251176|FG001|Overall Study|Lack of Efficacy|0|||
124898041|NCT01268891|449251175|FG000|Overall Study|Withdrawal of Consent|3|||
124898042|NCT01268891|449251176|FG001|Overall Study|Withdrawal of Consent|1|||
124898043|NCT01268891|449251175|FG000|Overall Study|Administrative or other reason(s)|1|||
124898044|NCT01268891|449251176|FG001|Overall Study|Administrative or other reason(s)|0|||
124898045|NCT00991276|449251177|FG000|First Intervention Period|Adverse Event|0|||
124898046|NCT00991276|449251178|FG001|First Intervention Period|Adverse Event|1|||
124898047|NCT00991276|449251179|FG002|First Intervention Period|Adverse Event|0|||
124898048|NCT00991276|449251180|FG003|First Intervention Period|Adverse Event|1|||
124898049|NCT00991276|449251181|FG004|First Intervention Period|Adverse Event|0|||
124898050|NCT00991276|449251182|FG005|First Intervention Period|Adverse Event|0|||
124898051|NCT00991276|449251177|FG000|First Intervention Period|Protocol Violation|0|||
124898052|NCT00991276|449251178|FG001|First Intervention Period|Protocol Violation|0|||
124898053|NCT00991276|449251179|FG002|First Intervention Period|Protocol Violation|0|||
124898054|NCT00991276|449251180|FG003|First Intervention Period|Protocol Violation|0|||
124898055|NCT00991276|449251181|FG004|First Intervention Period|Protocol Violation|2|||
124898056|NCT00991276|449251182|FG005|First Intervention Period|Protocol Violation|0|||
124898057|NCT00991276|449251177|FG000|First Intervention Period|Insufficient clinical response|0|||
124898058|NCT00991276|449251178|FG001|First Intervention Period|Insufficient clinical response|0|||
124898059|NCT00991276|449251179|FG002|First Intervention Period|Insufficient clinical response|0|||
124898060|NCT00991276|449251180|FG003|First Intervention Period|Insufficient clinical response|0|||
124898061|NCT00991276|449251181|FG004|First Intervention Period|Insufficient clinical response|1|||
124898062|NCT00991276|449251182|FG005|First Intervention Period|Insufficient clinical response|0|||
124898063|NCT00991276|449251177|FG000|First Intervention Period|Other|0|||
124898064|NCT00991276|449251178|FG001|First Intervention Period|Other|0|||
124898065|NCT00991276|449251179|FG002|First Intervention Period|Other|0|||
124898066|NCT00991276|449251180|FG003|First Intervention Period|Other|1|||
124898067|NCT00991276|449251181|FG004|First Intervention Period|Other|1|||
124898068|NCT00991276|449251182|FG005|First Intervention Period|Other|0|||
124898069|NCT00991276|449251177|FG000|First Intervention Period|Withdrawal by Subject|0|||
124898070|NCT00991276|449251178|FG001|First Intervention Period|Withdrawal by Subject|1|||
124898071|NCT00991276|449251179|FG002|First Intervention Period|Withdrawal by Subject|0|||
124898072|NCT00991276|449251180|FG003|First Intervention Period|Withdrawal by Subject|1|||
124898073|NCT00991276|449251181|FG004|First Intervention Period|Withdrawal by Subject|0|||
124898074|NCT00991276|449251182|FG005|First Intervention Period|Withdrawal by Subject|1|||
124898075|NCT00991276|449251177|FG000|First Intervention Period|Lost to Follow-up|0|||
124898076|NCT00991276|449251178|FG001|First Intervention Period|Lost to Follow-up|1|||
124898077|NCT00991276|449251179|FG002|First Intervention Period|Lost to Follow-up|0|||
124898078|NCT00991276|449251180|FG003|First Intervention Period|Lost to Follow-up|1|||
124898079|NCT00991276|449251181|FG004|First Intervention Period|Lost to Follow-up|0|||
124898080|NCT00991276|449251182|FG005|First Intervention Period|Lost to Follow-up|0|||
124898081|NCT00991276|449251177|FG000|Second Intervention Period|Adverse Event|0|||
124898082|NCT00991276|449251178|FG001|Second Intervention Period|Adverse Event|2|||
124898083|NCT00991276|449251179|FG002|Second Intervention Period|Adverse Event|0|||
124898084|NCT00991276|449251180|FG003|Second Intervention Period|Adverse Event|1|||
124898085|NCT00991276|449251181|FG004|Second Intervention Period|Adverse Event|1|||
124898086|NCT00991276|449251182|FG005|Second Intervention Period|Adverse Event|0|||
124898087|NCT00991276|449251177|FG000|Second Intervention Period|Protocol Violation|1|||
124898088|NCT00991276|449251178|FG001|Second Intervention Period|Protocol Violation|0|||
124898089|NCT00991276|449251179|FG002|Second Intervention Period|Protocol Violation|0|||
124898090|NCT00991276|449251180|FG003|Second Intervention Period|Protocol Violation|0|||
124445552|NCT03872453|447595499|FG000|Overall Study|Adverse Event|1|||
124445553|NCT03872453|447595500|FG001|Overall Study|Adverse Event|1|||
124445554|NCT03872453|447595501|FG002|Overall Study|Adverse Event|0|||
124445555|NCT03872453|447595502|FG003|Overall Study|Adverse Event|0|||
124445556|NCT03872453|447595499|FG000|Overall Study|Lost to Follow-up|8|||
124445557|NCT03872453|447595500|FG001|Overall Study|Lost to Follow-up|7|||
124445558|NCT03872453|447595501|FG002|Overall Study|Lost to Follow-up|4|||
124445559|NCT03872453|447595502|FG003|Overall Study|Lost to Follow-up|4|||
124445560|NCT03872453|447595499|FG000|Overall Study|Never Treated Migraine|19|||
124445561|NCT03872453|447595500|FG001|Overall Study|Never Treated Migraine|17|||
124445562|NCT03872453|447595501|FG002|Overall Study|Never Treated Migraine|13|||
124445563|NCT03872453|447595502|FG003|Overall Study|Never Treated Migraine|12|||
124445564|NCT03872453|447595499|FG000|Overall Study|Pregnancy|1|||
124445565|NCT03872453|447595500|FG001|Overall Study|Pregnancy|0|||
124445566|NCT03872453|447595501|FG002|Overall Study|Pregnancy|0|||
124445567|NCT03872453|447595502|FG003|Overall Study|Pregnancy|0|||
124445568|NCT03872453|447595499|FG000|Overall Study|Protocol Deviation|2|||
124445569|NCT03872453|447595500|FG001|Overall Study|Protocol Deviation|0|||
124445570|NCT03872453|447595501|FG002|Overall Study|Protocol Deviation|0|||
124445571|NCT03872453|447595502|FG003|Overall Study|Protocol Deviation|2|||
124445572|NCT03872453|447595499|FG000|Overall Study|Withdrawal by Subject|0|||
124445573|NCT03872453|447595500|FG001|Overall Study|Withdrawal by Subject|1|||
124445574|NCT03872453|447595501|FG002|Overall Study|Withdrawal by Subject|2|||
124445575|NCT03872453|447595502|FG003|Overall Study|Withdrawal by Subject|0|||
124445576|NCT03872453|447595499|FG000|Overall Study|Other Than Specified|1|||
124445577|NCT03872453|447595500|FG001|Overall Study|Other Than Specified|0|||
124445578|NCT03872453|447595501|FG002|Overall Study|Other Than Specified|0|||
124445579|NCT03872453|447595502|FG003|Overall Study|Other Than Specified|0|||
124445580|NCT00352885|447595503|FG000|Overall Study|Withdrawal by Subject|0|||
124445581|NCT00352885|447595504|FG001|Overall Study|Withdrawal by Subject|3|||
124445582|NCT00352885|447595503|FG000|Overall Study|Development of major depression|0|||
124445583|NCT00352885|447595504|FG001|Overall Study|Development of major depression|1|||
124445584|NCT00352885|447595503|FG000|Overall Study|Progression of metastatic melanoma|5|||
124445585|NCT00352885|447595504|FG001|Overall Study|Progression of metastatic melanoma|3|||
124445586|NCT00352885|447595503|FG000|Overall Study|Side effects of IL-2 administration|1|||
124445587|NCT00352885|447595504|FG001|Overall Study|Side effects of IL-2 administration|0|||
124445588|NCT03873493|447595505|FG000|Overall Study|Withdrawal by Subject|1|||
124445589|NCT03873493|447595505|FG000|Overall Study|Death|9|||
124445590|NCT03873493|447595505|FG000|Overall Study|Lost to Follow-up|1|||
124445591|NCT03873493|447595505|FG000|Overall Study|Study Terminated by Sponsor|1|||
124445592|NCT03873493|447595505|FG000|Overall Study|Other|2|||
124445593|NCT03756350|447595510|FG000|Overall Study|Lost to Follow-up|1|||
124445594|NCT00440700|447595513|FG000|Overall Study|Withdrawal by Subject|8|||
124898091|NCT00991276|449251181|FG004|Second Intervention Period|Protocol Violation|0|||
124898092|NCT00991276|449251182|FG005|Second Intervention Period|Protocol Violation|0|||
124898093|NCT00991276|449251177|FG000|Second Intervention Period|Other|0|||
124898094|NCT00991276|449251178|FG001|Second Intervention Period|Other|0|||
124445595|NCT00440700|447595514|FG001|Overall Study|Withdrawal by Subject|8|||
124445596|NCT00440700|447595515|FG002|Overall Study|Withdrawal by Subject|4|||
124445597|NCT03434353|447595516|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
124445598|NCT03434353|447595517|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
124445599|NCT03434353|447595518|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
124445600|NCT03434353|447595519|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
124445601|NCT03434353|447595520|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
124898095|NCT00991276|449251179|FG002|Second Intervention Period|Other|0|||
124898096|NCT00991276|449251180|FG003|Second Intervention Period|Other|1|||
124898097|NCT00991276|449251181|FG004|Second Intervention Period|Other|0|||
124898098|NCT00991276|449251182|FG005|Second Intervention Period|Other|1|||
124898099|NCT00991276|449251177|FG000|Third Intervention Period|Protocol Violation|1|||
124898100|NCT00991276|449251178|FG001|Third Intervention Period|Protocol Violation|0|||
124898101|NCT00991276|449251179|FG002|Third Intervention Period|Protocol Violation|0|||
124898102|NCT00991276|449251180|FG003|Third Intervention Period|Protocol Violation|0|||
124898103|NCT00991276|449251181|FG004|Third Intervention Period|Protocol Violation|0|||
124898104|NCT00991276|449251182|FG005|Third Intervention Period|Protocol Violation|0|||
124898105|NCT00991276|449251177|FG000|Third Intervention Period|Other|0|||
124898106|NCT00991276|449251178|FG001|Third Intervention Period|Other|0|||
124898107|NCT00991276|449251179|FG002|Third Intervention Period|Other|0|||
124898108|NCT00991276|449251180|FG003|Third Intervention Period|Other|0|||
124898109|NCT00991276|449251181|FG004|Third Intervention Period|Other|0|||
124898110|NCT00991276|449251182|FG005|Third Intervention Period|Other|1|||
124898111|NCT00991276|449251177|FG000|Third Intervention Period|Adverse Event|0|||
124898112|NCT00991276|449251178|FG001|Third Intervention Period|Adverse Event|0|||
124898113|NCT00991276|449251179|FG002|Third Intervention Period|Adverse Event|1|||
124898114|NCT00991276|449251180|FG003|Third Intervention Period|Adverse Event|0|||
124898115|NCT00991276|449251181|FG004|Third Intervention Period|Adverse Event|0|||
124898116|NCT00991276|449251182|FG005|Third Intervention Period|Adverse Event|0|||
124898117|NCT00991276|449251177|FG000|Third Intervention Period|Withdrawal by Subject|0|||
124898118|NCT00991276|449251178|FG001|Third Intervention Period|Withdrawal by Subject|0|||
124898119|NCT00991276|449251179|FG002|Third Intervention Period|Withdrawal by Subject|0|||
124898120|NCT00991276|449251180|FG003|Third Intervention Period|Withdrawal by Subject|1|||
124898121|NCT00991276|449251181|FG004|Third Intervention Period|Withdrawal by Subject|0|||
124898122|NCT00991276|449251182|FG005|Third Intervention Period|Withdrawal by Subject|0|||
124898123|NCT01720043|449251184|FG000|Overall Study|Withdrawal by Subject|1|||
124898124|NCT01688973|449251185|FG000|Overall Study|Ineligible|2|||
124898125|NCT01688973|449251186|FG001|Overall Study|Ineligible|3|||
124898126|NCT01516892|449251190|FG000|Overall Study|Adverse Event|25|||
124898127|NCT01516892|449251190|FG000|Overall Study|Lack of Efficacy|35|||
124898128|NCT01516892|449251190|FG000|Overall Study|Pregnancy|5|||
124898129|NCT01516892|449251190|FG000|Overall Study|Lost to Follow-up|82|||
124898130|NCT01516892|449251190|FG000|Overall Study|Subject Withdrew Consent|92|||
124898131|NCT01516892|449251190|FG000|Overall Study|Protocol Violation|60|||
124898132|NCT01516892|449251190|FG000|Overall Study|Other Miscellaneous Reasons|43|||
124898133|NCT01516892|449251190|FG000|Overall Study|Missing|1|||
124898134|NCT02534896|449251195|FG000|Overall Study|Adverse Event|2|||
124898135|NCT02534896|449251196|FG001|Overall Study|Adverse Event|1|||
124898136|NCT02534896|449251197|FG002|Overall Study|Adverse Event|1|||
124898137|NCT02534896|449251195|FG000|Overall Study|Insufficient therapeutic response|2|||
124898138|NCT02534896|449251196|FG001|Overall Study|Insufficient therapeutic response|0|||
124898139|NCT02534896|449251197|FG002|Overall Study|Insufficient therapeutic response|0|||
124898140|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
124898141|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
124898142|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
124898143|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
124898144|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Adverse Event|198|||
124898145|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Adverse Event|0|||
124898146|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Adverse Event|0|||
124445602|NCT03434353|447595516|FG000|Overall Study|Withdrew consent|1|||
124445603|NCT03434353|447595517|FG001|Overall Study|Withdrew consent|0|||
124445604|NCT03434353|447595518|FG002|Overall Study|Withdrew consent|3|||
124445605|NCT03434353|447595519|FG003|Overall Study|Withdrew consent|0|||
124445606|NCT03434353|447595520|FG004|Overall Study|Withdrew consent|0|||
124445607|NCT03434353|447595516|FG000|Overall Study|Adverse Event|1|||
124445608|NCT03434353|447595517|FG001|Overall Study|Adverse Event|0|||
124445609|NCT03434353|447595518|FG002|Overall Study|Adverse Event|0|||
124445610|NCT03434353|447595519|FG003|Overall Study|Adverse Event|0|||
124445611|NCT03434353|447595520|FG004|Overall Study|Adverse Event|1|||
124898147|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Adverse Event|0|||
124898148|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Death|62|||
124898149|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Death|0|||
124898150|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Death|0|||
124898151|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Death|0|||
124898152|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
124898153|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
124898154|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
124445612|NCT03434353|447595516|FG000|Overall Study|Lost to Follow-up|2|||
124445613|NCT03434353|447595517|FG001|Overall Study|Lost to Follow-up|0|||
124445614|NCT03434353|447595518|FG002|Overall Study|Lost to Follow-up|0|||
124445615|NCT03434353|447595519|FG003|Overall Study|Lost to Follow-up|0|||
124445616|NCT03434353|447595520|FG004|Overall Study|Lost to Follow-up|0|||
124898155|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
124898156|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Complicating disease|13|||
124898157|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Complicating disease|0|||
124898158|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Complicating disease|0|||
124898159|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Complicating disease|0|||
124898160|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
124898161|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
124898162|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
124898163|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
124898164|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
124898165|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
124898166|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
124898167|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
124898168|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Non-compliance|4|||
124898169|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Non-compliance|0|||
124898170|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Non-compliance|0|||
124898171|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Non-compliance|0|||
124898172|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Pain|4|||
124898173|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Pain|0|||
124898174|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Pain|0|||
124898175|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Pain|0|||
124898176|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
124898177|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
124898178|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
124898179|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
124898180|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Hospice care|1|||
124898181|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Hospice care|0|||
124898182|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Hospice care|0|||
124898183|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Hospice care|0|||
124898184|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Physician Decision|1|||
124898185|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Physician Decision|0|||
124898186|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Physician Decision|0|||
124898187|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Physician Decision|0|||
124898188|NCT01107626|449251198|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
124898189|NCT01107626|449251199|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
124898190|NCT01107626|449251200|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
124898191|NCT01107626|449251201|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
124898192|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
124898193|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
124898194|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
124898195|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
124898196|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
124898197|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
124898198|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
124898199|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
124898200|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Death|0|||
124898201|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Death|8|||
124898202|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Death|2|||
124898203|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Death|13|||
124898204|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
124898205|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
124898206|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
124898207|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
124898208|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
124898209|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
124898210|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
124898211|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
124898212|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
124898213|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
124898214|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
124898215|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
124898216|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
124898217|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
124898218|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
124898219|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
124898220|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
124898221|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
124898222|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
124898223|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
124445617|NCT04906616|447595521|FG000|Overall Study|Divorce|3|||
124445618|NCT04906616|447595522|FG001|Overall Study|Divorce|2|||
124759494|NCT01307319|448744729|FG002|Overall Study|Protocol Violation|0|||
124898224|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
124898225|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
124898226|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
124898227|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
124898228|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
124898229|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
124898230|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
124898231|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
124898232|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
124898233|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
124898234|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
124898235|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
124898236|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
124898237|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
124898238|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
124898239|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
124898240|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
124898241|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
124898242|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
124898243|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
124898244|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Pain|0|||
124898245|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Pain|0|||
124898246|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Pain|0|||
124898247|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Pain|1|||
124898248|NCT01107626|449251198|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
124898249|NCT01107626|449251199|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
124898250|NCT01107626|449251200|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
124898251|NCT01107626|449251201|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
124898252|NCT00711646|449251202|FG000|Overall Study|Adverse Event|6|||
124898253|NCT00711646|449251203|FG001|Overall Study|Adverse Event|1|||
124898254|NCT00711646|449251202|FG000|Overall Study|Withdrawal by Subject|4|||
124898255|NCT00711646|449251203|FG001|Overall Study|Withdrawal by Subject|0|||
124898256|NCT00711646|449251202|FG000|Overall Study|Protocol Violation|0|||
124898257|NCT00711646|449251203|FG001|Overall Study|Protocol Violation|1|||
124898258|NCT00711646|449251202|FG000|Overall Study|Lost to Follow-up|1|||
124898259|NCT00711646|449251203|FG001|Overall Study|Lost to Follow-up|0|||
124898260|NCT00711646|449251202|FG000|Overall Study|administrative decision|0|||
124898261|NCT00711646|449251203|FG001|Overall Study|administrative decision|1|||
124898262|NCT00711646|449251202|FG000|Overall Study|patient non-compliance|1|||
124898263|NCT00711646|449251203|FG001|Overall Study|patient non-compliance|0|||
124898264|NCT04381494|449251204|FG000|Overall Study|Early termination of trial|19|||
124898265|NCT04381494|449251204|FG000|Overall Study|Investigator's discretion|1|||
124898266|NCT04381494|449251204|FG000|Overall Study|Withdrawal by Subject|9|||
124898267|NCT04381494|449251204|FG000|Overall Study|NSCLC disease progression|4|||
124898268|NCT04381494|449251204|FG000|Overall Study|Device-Related Adverse Event|2|||
124898269|NCT04310579|449251205|FG000|Overall Study|Adverse Event|0|||
124898270|NCT04310579|449251206|FG001|Overall Study|Adverse Event|0|||
124898271|NCT04310579|449251207|FG002|Overall Study|Adverse Event|0|||
124898272|NCT04310579|449251208|FG003|Overall Study|Adverse Event|0|||
124898273|NCT04310579|449251209|FG004|Overall Study|Adverse Event|0|||
124898274|NCT04310579|449251210|FG005|Overall Study|Adverse Event|0|||
124898275|NCT04310579|449251211|FG006|Overall Study|Adverse Event|2|||
124898276|NCT04310579|449251212|FG007|Overall Study|Adverse Event|0|||
124898277|NCT04310579|449251213|FG008|Overall Study|Adverse Event|1|||
124898278|NCT04310579|449251214|FG009|Overall Study|Adverse Event|1|||
124898279|NCT04310579|449251215|FG010|Overall Study|Adverse Event|0|||
124898280|NCT04310579|449251205|FG000|Overall Study|Withdrawal by Subject|0|||
124898281|NCT04310579|449251206|FG001|Overall Study|Withdrawal by Subject|0|||
124898282|NCT04310579|449251207|FG002|Overall Study|Withdrawal by Subject|0|||
124898283|NCT04310579|449251208|FG003|Overall Study|Withdrawal by Subject|0|||
124688801|NCT05177094|448479860|FG000|Overall Study|Participant could not tolerate long study visits|1|||
124898284|NCT04310579|449251209|FG004|Overall Study|Withdrawal by Subject|0|||
124898285|NCT04310579|449251210|FG005|Overall Study|Withdrawal by Subject|1|||
124688802|NCT05177094|448479861|FG001|Overall Study|Participant could not tolerate long study visits|0|||
124898286|NCT04310579|449251211|FG006|Overall Study|Withdrawal by Subject|0|||
124898287|NCT04310579|449251212|FG007|Overall Study|Withdrawal by Subject|0|||
124898288|NCT04310579|449251213|FG008|Overall Study|Withdrawal by Subject|0|||
124898289|NCT04310579|449251214|FG009|Overall Study|Withdrawal by Subject|0|||
124898290|NCT04310579|449251215|FG010|Overall Study|Withdrawal by Subject|0|||
124688803|NCT02513199|448479864|FG000|Treatment|Death|1|||
124898291|NCT04310579|449251205|FG000|Overall Study|Positive COVID-19 test|0|||
124898292|NCT04310579|449251206|FG001|Overall Study|Positive COVID-19 test|0|||
124898293|NCT04310579|449251207|FG002|Overall Study|Positive COVID-19 test|0|||
124898294|NCT04310579|449251208|FG003|Overall Study|Positive COVID-19 test|0|||
124898295|NCT04310579|449251209|FG004|Overall Study|Positive COVID-19 test|0|||
124898296|NCT04310579|449251210|FG005|Overall Study|Positive COVID-19 test|0|||
124898297|NCT04310579|449251211|FG006|Overall Study|Positive COVID-19 test|0|||
124898298|NCT04310579|449251212|FG007|Overall Study|Positive COVID-19 test|0|||
124898299|NCT04310579|449251213|FG008|Overall Study|Positive COVID-19 test|0|||
124898300|NCT04310579|449251214|FG009|Overall Study|Positive COVID-19 test|0|||
124898301|NCT04310579|449251215|FG010|Overall Study|Positive COVID-19 test|1|||
124898302|NCT02365298|449251216|FG000|Period 2|incorrect Rx dispensed|1|||
124898303|NCT02365298|449251217|FG001|Period 2|incorrect Rx dispensed|0|||
124898304|NCT02365298|449251216|FG000|Period 2|Discontinued at request of Sponsor|1|||
124898305|NCT02365298|449251217|FG001|Period 2|Discontinued at request of Sponsor|0|||
124898306|NCT02365298|449251216|FG000|Period 2|Test Article longer available|0|||
124898307|NCT02365298|449251217|FG001|Period 2|Test Article longer available|1|||
124898308|NCT02365298|449251216|FG000|Period 2|Protocol Violation|0|||
124898309|NCT02365298|449251217|FG001|Period 2|Protocol Violation|1|||
124898310|NCT04555044|449251226|FG000|Overall Study|Adverse Event|0|||
124898311|NCT04555044|449251227|FG001|Overall Study|Adverse Event|1|||
124898312|NCT03722446|449251228|FG000|Overall Study|Protocol Violation|15|||
124898313|NCT03722446|449251229|FG001|Overall Study|Protocol Violation|2|||
124898314|NCT00819910|449251232|FG000|Overall Study|Adverse Event|0|||
124898315|NCT00819910|449251233|FG001|Overall Study|Adverse Event|0|||
124898316|NCT00819910|449251234|FG002|Overall Study|Adverse Event|2|||
124898317|NCT00819910|449251235|FG003|Overall Study|Adverse Event|1|||
124898318|NCT00819910|449251232|FG000|Overall Study|Withdrawal by Subject|1|||
124898319|NCT00819910|449251233|FG001|Overall Study|Withdrawal by Subject|1|||
124898320|NCT00819910|449251234|FG002|Overall Study|Withdrawal by Subject|1|||
124898321|NCT00819910|449251235|FG003|Overall Study|Withdrawal by Subject|0|||
124898322|NCT00819910|449251232|FG000|Overall Study|Lost to Follow-up|1|||
124898323|NCT00819910|449251233|FG001|Overall Study|Lost to Follow-up|0|||
124898324|NCT00819910|449251234|FG002|Overall Study|Lost to Follow-up|0|||
124898325|NCT00819910|449251235|FG003|Overall Study|Lost to Follow-up|0|||
124898326|NCT03102242|449251236|FG000|Overall Study|Adverse Event|2|||
124898327|NCT00946192|449251239|FG000|Overall Study|Lost to Follow-up|6|||
124898328|NCT00946192|449251240|FG001|Overall Study|Lost to Follow-up|11|||
124898329|NCT00946192|449251241|FG002|Overall Study|Lost to Follow-up|9|||
124898330|NCT00946192|449251239|FG000|Overall Study|Withdrawal by Subject|10|||
124898331|NCT00946192|449251240|FG001|Overall Study|Withdrawal by Subject|7|||
124898332|NCT00946192|449251241|FG002|Overall Study|Withdrawal by Subject|3|||
124898333|NCT00946192|449251239|FG000|Overall Study|Did not start medication|2|||
124898334|NCT00946192|449251240|FG001|Overall Study|Did not start medication|0|||
124898335|NCT00946192|449251241|FG002|Overall Study|Did not start medication|0|||
124898336|NCT01080131|449251242|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
124898337|NCT01080131|449251243|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
124898338|NCT01080131|449251242|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
124898339|NCT01080131|449251243|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
124898340|NCT01080131|449251242|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
124898341|NCT01080131|449251243|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
124898342|NCT01080131|449251242|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
124898343|NCT01080131|449251243|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
124898344|NCT01080131|449251242|FG000|Core Study (0- 12 Weeks)|Death|1|||
124898345|NCT01080131|449251243|FG001|Core Study (0- 12 Weeks)|Death|0|||
124898346|NCT01080131|449251242|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
124898347|NCT01080131|449251243|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
124898348|NCT01080131|449251242|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
124898349|NCT01080131|449251243|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
124898350|NCT01080131|449251242|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
124898351|NCT01080131|449251243|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
124898352|NCT01080131|449251242|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
124898353|NCT01080131|449251243|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
124445619|NCT02464228|447595523|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
124898354|NCT01080131|449251242|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
124898355|NCT01080131|449251243|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
124898356|NCT01080131|449251242|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
124898357|NCT01080131|449251243|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
124898358|NCT01080131|449251242|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
124898359|NCT01080131|449251243|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
124898360|NCT01080131|449251242|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
124898361|NCT01080131|449251243|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
124898362|NCT03646669|449253282|FG000|Overall Study|Withdrawal by Subject|5|||
124898363|NCT03646669|449253283|FG001|Overall Study|Withdrawal by Subject|0|||
124898364|NCT03441360|449253286|FG000|Overall Study|Radiological disease progression|5|||
124898365|NCT03441360|449253287|FG001|Overall Study|Radiological disease progression|6|||
124898366|NCT03441360|449253288|FG002|Overall Study|Radiological disease progression|4|||
124898367|NCT03441360|449253286|FG000|Overall Study|Clinical disease progression|2|||
124898368|NCT03441360|449253287|FG001|Overall Study|Clinical disease progression|2|||
124898369|NCT03441360|449253288|FG002|Overall Study|Clinical disease progression|0|||
124898370|NCT03441360|449253286|FG000|Overall Study|Adverse Event|1|||
124898371|NCT03441360|449253287|FG001|Overall Study|Adverse Event|0|||
124898372|NCT03441360|449253288|FG002|Overall Study|Adverse Event|1|||
124898373|NCT00269399|449253289|FG000|Overall Study|Lack of Efficacy|27|||
124898374|NCT00269399|449253290|FG001|Overall Study|Lack of Efficacy|10|||
124898375|NCT00269399|449253289|FG000|Overall Study|Adverse Event|10|||
124898376|NCT00269399|449253290|FG001|Overall Study|Adverse Event|4|||
124898377|NCT00269399|449253289|FG000|Overall Study|Withdrawal by Subject|2|||
124898378|NCT00269399|449253290|FG001|Overall Study|Withdrawal by Subject|5|||
124898379|NCT00269399|449253289|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
124898380|NCT00269399|449253290|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
124898381|NCT00269399|449253289|FG000|Overall Study|Other|0|||
124898382|NCT00269399|449253290|FG001|Overall Study|Other|4|||
124898383|NCT00269399|449253289|FG000|Overall Study|Development of exclusion criteria|0|||
124898384|NCT00269399|449253290|FG001|Overall Study|Development of exclusion criteria|1|||
124898385|NCT03467724|449253292|FG000|Overall Study|Lost to Follow-up|5|||
124898386|NCT03467724|449253292|FG000|Overall Study|Withdrawal by Subject|1|||
124898387|NCT03467724|449253292|FG000|Overall Study|Protocol Violation|1|||
124898388|NCT03467724|449253292|FG000|Overall Study|Adverse Event|1|||
124898389|NCT02049866|449253296|FG000|Overall Study|Withdrawal by Subject|1|||
124898390|NCT02955069|449253298|FG000|Overall Study|Adverse Event|7|||
124898391|NCT02955069|449253299|FG001|Overall Study|Adverse Event|2|||
124898392|NCT02955069|449253298|FG000|Overall Study|Death|7|||
124898393|NCT02955069|449253299|FG001|Overall Study|Death|3|||
124898394|NCT02955069|449253298|FG000|Overall Study|Physician Decision|10|||
124898395|NCT02955069|449253299|FG001|Overall Study|Physician Decision|2|||
124898396|NCT02955069|449253298|FG000|Overall Study|Progressive disease|64|||
124898397|NCT02955069|449253299|FG001|Overall Study|Progressive disease|13|||
124898398|NCT02955069|449253298|FG000|Overall Study|Study terminated by sponsor|4|||
124898399|NCT02955069|449253299|FG001|Overall Study|Study terminated by sponsor|0|||
124898400|NCT02955069|449253298|FG000|Overall Study|Subject/Guardian decision|3|||
124898401|NCT02955069|449253299|FG001|Overall Study|Subject/Guardian decision|1|||
124898402|NCT04148937|449253301|FG000|Overall Study|Withdrawal by Subject|0|||
124898403|NCT04148937|449253302|FG001|Overall Study|Withdrawal by Subject|0|||
124898404|NCT04148937|449253303|FG002|Overall Study|Withdrawal by Subject|0|||
124898405|NCT04148937|449253304|FG003|Overall Study|Withdrawal by Subject|1|||
124898406|NCT04148937|449253305|FG004|Overall Study|Withdrawal by Subject|0|||
124898407|NCT04148937|449253306|FG005|Overall Study|Withdrawal by Subject|1|||
124898408|NCT04148937|449253307|FG006|Overall Study|Withdrawal by Subject|1|||
124898409|NCT04148937|449253308|FG007|Overall Study|Withdrawal by Subject|0|||
124898410|NCT04148937|449253301|FG000|Overall Study|Lost to Follow-up|0|||
124898411|NCT04148937|449253302|FG001|Overall Study|Lost to Follow-up|0|||
124898412|NCT04148937|449253303|FG002|Overall Study|Lost to Follow-up|1|||
124898413|NCT04148937|449253304|FG003|Overall Study|Lost to Follow-up|0|||
124898414|NCT04148937|449253305|FG004|Overall Study|Lost to Follow-up|0|||
124898415|NCT04148937|449253306|FG005|Overall Study|Lost to Follow-up|2|||
124898416|NCT04148937|449253307|FG006|Overall Study|Lost to Follow-up|0|||
124898417|NCT04148937|449253308|FG007|Overall Study|Lost to Follow-up|0|||
124898418|NCT03107611|449253313|FG000|Overall Study|Adverse Event|1|||
124688804|NCT02513199|448479864|FG000|Treatment|Lost to Follow-up|1|||
124688805|NCT02513199|448479864|FG000|Follow-Up|Death|11|||
124688806|NCT00407511|448479877|FG000|Overall Study|Adverse Event|9|||
124688807|NCT00407511|448479877|FG000|Overall Study|Lost to Follow-up|4|||
124688808|NCT00407511|448479877|FG000|Overall Study|Other|5|||
124688809|NCT00407511|448479877|FG000|Overall Study|Withdrawal by Subject|4|||
124688810|NCT00529035|448479878|FG000|Overall Study|Withdrawal by Subject|1|||
124688811|NCT03439514|448479879|FG000|Double-Blind Treatment Period|Other|4|||
124898419|NCT03107611|449253314|FG001|Overall Study|Adverse Event|0|||
124898420|NCT03107611|449253315|FG002|Overall Study|Adverse Event|2|||
124898421|NCT03107611|449253313|FG000|Overall Study|Lost to Follow-up|3|||
124898422|NCT03107611|449253314|FG001|Overall Study|Lost to Follow-up|3|||
124898423|NCT03107611|449253315|FG002|Overall Study|Lost to Follow-up|3|||
124898424|NCT03107611|449253313|FG000|Overall Study|Protocol Violation|0|||
124898425|NCT03107611|449253314|FG001|Overall Study|Protocol Violation|0|||
124898426|NCT03107611|449253315|FG002|Overall Study|Protocol Violation|1|||
124898427|NCT03107611|449253313|FG000|Overall Study|Withdrawal by Subject|1|||
124898428|NCT03107611|449253314|FG001|Overall Study|Withdrawal by Subject|0|||
124898429|NCT03107611|449253315|FG002|Overall Study|Withdrawal by Subject|1|||
124898430|NCT03107611|449253313|FG000|Overall Study|Worsening signs/symptoms|2|||
124898431|NCT03107611|449253314|FG001|Overall Study|Worsening signs/symptoms|1|||
124898432|NCT03107611|449253315|FG002|Overall Study|Worsening signs/symptoms|2|||
124898433|NCT02145182|449253316|FG000|Overall Study|Adverse Event|4|||
124898434|NCT02145182|449253317|FG001|Overall Study|Adverse Event|1|||
124688812|NCT03439514|448479880|FG001|Double-Blind Treatment Period|Other|1|||
124898435|NCT02145182|449253316|FG000|Overall Study|Death|7|||
124898436|NCT02145182|449253317|FG001|Overall Study|Death|7|||
124898437|NCT02145182|449253316|FG000|Overall Study|Lost to Follow-up|2|||
124898438|NCT02145182|449253317|FG001|Overall Study|Lost to Follow-up|2|||
124898439|NCT02145182|449253316|FG000|Overall Study|Pre-transplant Withdrawal|0|||
124898440|NCT02145182|449253317|FG001|Overall Study|Pre-transplant Withdrawal|2|||
124898441|NCT02145182|449253316|FG000|Overall Study|Withdrawal by Subject|5|||
124898442|NCT02145182|449253317|FG001|Overall Study|Withdrawal by Subject|4|||
124898443|NCT00588666|449253319|FG000|Overall Study|Adverse Event|4|||
124898444|NCT02274493|449253320|FG000|Overall Study|Withdrawal by Subject|1|||
124898445|NCT03102710|449253321|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
124898446|NCT03102710|449253322|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
124898447|NCT03102710|449253323|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
124898448|NCT03102710|449253321|FG000|Overall Study|Technical issues during final MRI scan|0|||
124898449|NCT03102710|449253322|FG001|Overall Study|Technical issues during final MRI scan|1|||
124898450|NCT03102710|449253323|FG002|Overall Study|Technical issues during final MRI scan|0|||
124898451|NCT03102710|449253321|FG000|Overall Study|Nausea during MRI scan|0|||
124898452|NCT03102710|449253322|FG001|Overall Study|Nausea during MRI scan|1|||
124898453|NCT03102710|449253323|FG002|Overall Study|Nausea during MRI scan|0|||
124898454|NCT03102710|449253321|FG000|Overall Study|Subject unable to attend final session|0|||
124898455|NCT03102710|449253322|FG001|Overall Study|Subject unable to attend final session|1|||
124898456|NCT03102710|449253323|FG002|Overall Study|Subject unable to attend final session|0|||
124898457|NCT02759731|449253324|FG000|Overall Study|Did not complete treatment.|8|||
124898458|NCT01101165|449253325|FG000|Period 1|Adverse Event|1|||
124898459|NCT01101165|449253326|FG001|Period 1|Adverse Event|2|||
124898460|NCT01101165|449253325|FG000|Period 1|Withdrawal by Subject|0|||
124898461|NCT01101165|449253326|FG001|Period 1|Withdrawal by Subject|2|||
124898462|NCT01101165|449253325|FG000|Period 1|Positive Drug Screen|0|||
124898463|NCT01101165|449253326|FG001|Period 1|Positive Drug Screen|1|||
124898464|NCT01101165|449253325|FG000|Period 1|Lost to Follow-up|1|||
124898465|NCT01101165|449253326|FG001|Period 1|Lost to Follow-up|0|||
124898466|NCT01101165|449253325|FG000|Period 2|Withdrawal by Subject|3|||
124898467|NCT01101165|449253326|FG001|Period 2|Withdrawal by Subject|1|||
124898468|NCT01101165|449253325|FG000|Period 2|Adverse Event|1|||
124898469|NCT01101165|449253326|FG001|Period 2|Adverse Event|0|||
124898470|NCT00335556|449253327|FG000|Overall Study|Death|0|||
124898471|NCT00335556|449253328|FG001|Overall Study|Death|5|||
124898472|NCT00335556|449253329|FG002|Overall Study|Death|0|||
124898473|NCT00335556|449253330|FG003|Overall Study|Death|0|||
124445620|NCT02464228|447595524|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
124445621|NCT02464228|447595525|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
124445622|NCT02464228|447595526|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
124445623|NCT02464228|447595523|FG000|Overall Study|Physician Decision|2|||
124445624|NCT02464228|447595524|FG001|Overall Study|Physician Decision|0|||
124445625|NCT02464228|447595525|FG002|Overall Study|Physician Decision|1|||
124445626|NCT02464228|447595526|FG003|Overall Study|Physician Decision|0|||
124445627|NCT02464228|447595523|FG000|Overall Study|Miscellaneous|1|||
124445628|NCT02464228|447595524|FG001|Overall Study|Miscellaneous|0|||
124445629|NCT02464228|447595525|FG002|Overall Study|Miscellaneous|1|||
124445630|NCT02464228|447595526|FG003|Overall Study|Miscellaneous|0|||
124445631|NCT02464228|447595523|FG000|Overall Study|Adverse Event|9|||
124445632|NCT02464228|447595524|FG001|Overall Study|Adverse Event|0|||
124445633|NCT02464228|447595525|FG002|Overall Study|Adverse Event|3|||
124445634|NCT02464228|447595526|FG003|Overall Study|Adverse Event|0|||
124445635|NCT02464228|447595523|FG000|Overall Study|Withdrawal by Subject|1|||
124445636|NCT02464228|447595524|FG001|Overall Study|Withdrawal by Subject|1|||
124445637|NCT02464228|447595525|FG002|Overall Study|Withdrawal by Subject|1|||
124445638|NCT02464228|447595526|FG003|Overall Study|Withdrawal by Subject|0|||
124445639|NCT02464228|447595523|FG000|Overall Study|Disease Progression|22|||
124445640|NCT02464228|447595524|FG001|Overall Study|Disease Progression|12|||
124445641|NCT02464228|447595525|FG002|Overall Study|Disease Progression|5|||
124445642|NCT02464228|447595526|FG003|Overall Study|Disease Progression|2|||
124445643|NCT01990534|447595527|FG000|Overall Study|Death|22|||
124445644|NCT01990534|447595527|FG000|Overall Study|Progressive disease|3|||
124445645|NCT01990534|447595527|FG000|Overall Study|Protocol Violation|1|||
124898474|NCT00335556|449253331|FG004|Overall Study|Death|1|||
124898475|NCT00335556|449253332|FG005|Overall Study|Death|0|||
124898476|NCT00335556|449253327|FG000|Overall Study|Lack of Efficacy|0|||
124898477|NCT00335556|449253328|FG001|Overall Study|Lack of Efficacy|19|||
124898478|NCT00335556|449253329|FG002|Overall Study|Lack of Efficacy|3|||
124898479|NCT00335556|449253330|FG003|Overall Study|Lack of Efficacy|3|||
124898480|NCT00335556|449253331|FG004|Overall Study|Lack of Efficacy|0|||
124898481|NCT00335556|449253332|FG005|Overall Study|Lack of Efficacy|1|||
124898482|NCT00335556|449253327|FG000|Overall Study|Physician Decision|0|||
124898483|NCT00335556|449253328|FG001|Overall Study|Physician Decision|6|||
124898484|NCT00335556|449253329|FG002|Overall Study|Physician Decision|2|||
124445646|NCT01990534|447595527|FG000|Overall Study|Withdrawal of Informed Consent|2|||
124445647|NCT01990534|447595527|FG000|Overall Study|Symptomatic Deterioration|1|||
124898485|NCT00335556|449253330|FG003|Overall Study|Physician Decision|1|||
124898486|NCT00335556|449253331|FG004|Overall Study|Physician Decision|0|||
124898487|NCT00335556|449253332|FG005|Overall Study|Physician Decision|0|||
124898488|NCT00335556|449253327|FG000|Overall Study|Ineligible|2|||
124898489|NCT00335556|449253328|FG001|Overall Study|Ineligible|0|||
124898490|NCT00335556|449253329|FG002|Overall Study|Ineligible|0|||
124898491|NCT00335556|449253330|FG003|Overall Study|Ineligible|0|||
124898492|NCT00335556|449253331|FG004|Overall Study|Ineligible|0|||
124898493|NCT00335556|449253332|FG005|Overall Study|Ineligible|0|||
124898494|NCT00335556|449253327|FG000|Overall Study|Refusal of further protocol therapy|0|||
124898495|NCT00335556|449253328|FG001|Overall Study|Refusal of further protocol therapy|4|||
124898496|NCT00335556|449253329|FG002|Overall Study|Refusal of further protocol therapy|0|||
124898497|NCT00335556|449253330|FG003|Overall Study|Refusal of further protocol therapy|1|||
124898498|NCT00335556|449253331|FG004|Overall Study|Refusal of further protocol therapy|0|||
124898499|NCT00335556|449253332|FG005|Overall Study|Refusal of further protocol therapy|0|||
124898500|NCT01878890|449253333|FG000|Overall Study|Protocol Violation|0|||
124898501|NCT01878890|449253334|FG001|Overall Study|Protocol Violation|1|||
124898502|NCT01878890|449253335|FG002|Overall Study|Protocol Violation|0|||
124898503|NCT01878890|449253336|FG003|Overall Study|Protocol Violation|0|||
124898504|NCT03404843|449253338|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
124898505|NCT03404843|449253339|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
124898506|NCT00567164|449253340|FG000|Overall Study|Withdrawal by Subject|171|||
124898507|NCT00567164|449253341|FG001|Overall Study|Withdrawal by Subject|21|||
124898508|NCT00567164|449253342|FG002|Overall Study|Withdrawal by Subject|17|||
124898509|NCT00567164|449253340|FG000|Overall Study|Protocol Violation|23|||
124898510|NCT00567164|449253341|FG001|Overall Study|Protocol Violation|4|||
124898511|NCT00567164|449253342|FG002|Overall Study|Protocol Violation|2|||
124898512|NCT00567164|449253340|FG000|Overall Study|Adverse Event|92|||
124898513|NCT00567164|449253341|FG001|Overall Study|Adverse Event|13|||
124898514|NCT00567164|449253342|FG002|Overall Study|Adverse Event|9|||
124898515|NCT00567164|449253340|FG000|Overall Study|Death|0|||
124898516|NCT00567164|449253341|FG001|Overall Study|Death|0|||
124898517|NCT00567164|449253342|FG002|Overall Study|Death|1|||
124898518|NCT00567164|449253340|FG000|Overall Study|Lost to Follow-up|202|||
124898519|NCT00567164|449253341|FG001|Overall Study|Lost to Follow-up|23|||
124898520|NCT00567164|449253342|FG002|Overall Study|Lost to Follow-up|21|||
124898521|NCT00567164|449253340|FG000|Overall Study|Pregnancy|20|||
124898522|NCT00567164|449253341|FG001|Overall Study|Pregnancy|4|||
124898523|NCT00567164|449253342|FG002|Overall Study|Pregnancy|6|||
124898524|NCT00567164|449253340|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
124898525|NCT00567164|449253341|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
124898526|NCT00567164|449253342|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
124898527|NCT00567164|449253340|FG000|Overall Study|Missing|1|||
124898528|NCT00567164|449253341|FG001|Overall Study|Missing|0|||
124898529|NCT00567164|449253342|FG002|Overall Study|Missing|0|||
124898530|NCT00502593|449253347|FG000|Overall Study|Withdrawn unspecified reason|1|||
124898531|NCT00502593|449253348|FG001|Overall Study|Withdrawn unspecified reason|1|||
124898532|NCT00502593|449253349|FG002|Overall Study|Withdrawn unspecified reason|3|||
124898533|NCT00502593|449253350|FG003|Overall Study|Withdrawn unspecified reason|1|||
124898534|NCT00502593|449253351|FG004|Overall Study|Withdrawn unspecified reason|2|||
124898535|NCT00502593|449253352|FG005|Overall Study|Withdrawn unspecified reason|0|||
124898536|NCT00502593|449253353|FG006|Overall Study|Withdrawn unspecified reason|2|||
124445648|NCT01990534|447595527|FG000|Overall Study|Withdrawal by Subject|3|||
124445649|NCT01990534|447595527|FG000|Overall Study|Reason not Specified|2|||
124445650|NCT01990534|447595527|FG000|Overall Study|Lost to Follow-up|1|||
124445651|NCT01521897|447595532|FG000|Overall Study|Protocol Violation|18|||
124445652|NCT01521897|447595532|FG000|Overall Study|Lost to Follow-up|5|||
124445653|NCT03308942|447595533|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
124445654|NCT03308942|447595534|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
124445655|NCT03308942|447595535|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
124445656|NCT03308942|447595536|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
124445657|NCT03308942|447595537|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
124445658|NCT03308942|447595533|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
124445659|NCT03308942|447595534|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
124759495|NCT01307319|448744727|FG000|Overall Study|Withdrawal by Subject|0|||
124759496|NCT01307319|448744728|FG001|Overall Study|Withdrawal by Subject|1|||
124898537|NCT00502593|449253354|FG007|Overall Study|Withdrawn unspecified reason|0|||
124898538|NCT00502593|449253355|FG008|Overall Study|Withdrawn unspecified reason|0|||
124898539|NCT00502593|449253356|FG009|Overall Study|Withdrawn unspecified reason|0|||
124898540|NCT00502593|449253357|FG010|Overall Study|Withdrawn unspecified reason|0|||
124898541|NCT00502593|449253358|FG011|Overall Study|Withdrawn unspecified reason|0|||
124898542|NCT00502593|449253347|FG000|Overall Study|Withdrawal by Subject|0|||
124898543|NCT00502593|449253348|FG001|Overall Study|Withdrawal by Subject|0|||
124898544|NCT00502593|449253349|FG002|Overall Study|Withdrawal by Subject|6|||
124898545|NCT00502593|449253350|FG003|Overall Study|Withdrawal by Subject|2|||
124898546|NCT00502593|449253351|FG004|Overall Study|Withdrawal by Subject|2|||
124898547|NCT00502593|449253352|FG005|Overall Study|Withdrawal by Subject|0|||
124898548|NCT00502593|449253353|FG006|Overall Study|Withdrawal by Subject|3|||
124898549|NCT00502593|449253354|FG007|Overall Study|Withdrawal by Subject|0|||
124898550|NCT00502593|449253355|FG008|Overall Study|Withdrawal by Subject|3|||
124898551|NCT00502593|449253356|FG009|Overall Study|Withdrawal by Subject|0|||
124898552|NCT00502593|449253357|FG010|Overall Study|Withdrawal by Subject|1|||
124898553|NCT00502593|449253358|FG011|Overall Study|Withdrawal by Subject|0|||
124898554|NCT00502593|449253347|FG000|Overall Study|Lost to Follow-up|2|||
124898555|NCT00502593|449253348|FG001|Overall Study|Lost to Follow-up|1|||
124898556|NCT00502593|449253349|FG002|Overall Study|Lost to Follow-up|1|||
124898557|NCT00502593|449253350|FG003|Overall Study|Lost to Follow-up|1|||
124898558|NCT00502593|449253351|FG004|Overall Study|Lost to Follow-up|0|||
124898559|NCT00502593|449253352|FG005|Overall Study|Lost to Follow-up|0|||
124898560|NCT00502593|449253353|FG006|Overall Study|Lost to Follow-up|0|||
124898561|NCT00502593|449253354|FG007|Overall Study|Lost to Follow-up|0|||
124898562|NCT00502593|449253355|FG008|Overall Study|Lost to Follow-up|3|||
124898563|NCT00502593|449253356|FG009|Overall Study|Lost to Follow-up|0|||
124898564|NCT00502593|449253357|FG010|Overall Study|Lost to Follow-up|1|||
124898565|NCT00502593|449253358|FG011|Overall Study|Lost to Follow-up|0|||
124898566|NCT01664104|449253359|FG000|Overall Study|Adverse Event|6|||
124898567|NCT01664104|449253359|FG000|Overall Study|Lack of Efficacy|2|||
124898568|NCT01664104|449253359|FG000|Overall Study|Withdrawal by Subject|1|||
124898569|NCT01664104|449253359|FG000|Overall Study|Lost to Follow-up|4|||
124898570|NCT01664104|449253359|FG000|Overall Study|Other|1|||
124898571|NCT01664104|449253359|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
124898572|NCT03761784|449253360|FG000|Overall Study|Adverse Event|4|||
124898573|NCT03761784|449253361|FG001|Overall Study|Adverse Event|0|||
124898574|NCT03761784|449253360|FG000|Overall Study|Lost to Follow-up|10|||
124898575|NCT03761784|449253361|FG001|Overall Study|Lost to Follow-up|7|||
124898576|NCT03761784|449253360|FG000|Overall Study|Pregnancy|1|||
124898577|NCT03761784|449253361|FG001|Overall Study|Pregnancy|0|||
124898578|NCT03761784|449253360|FG000|Overall Study|Protocol Violation|2|||
124898579|NCT03761784|449253361|FG001|Overall Study|Protocol Violation|0|||
124898580|NCT03761784|449253360|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
124688813|NCT03439514|448479879|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
124898581|NCT03761784|449253361|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
124898582|NCT03761784|449253360|FG000|Overall Study|Withdrawal by Subject|9|||
124898583|NCT03761784|449253361|FG001|Overall Study|Withdrawal by Subject|4|||
124898584|NCT03761784|449253360|FG000|Overall Study|Physician Decision|1|||
124898585|NCT03761784|449253361|FG001|Overall Study|Physician Decision|0|||
124898586|NCT03761784|449253360|FG000|Overall Study|Other Than Specified|1|||
124898587|NCT03761784|449253361|FG001|Overall Study|Other Than Specified|0|||
124898588|NCT00586339|449253362|FG000|Overall Study|Withdrawal by Subject|1|||
124898589|NCT00586339|449253363|FG001|Overall Study|Withdrawal by Subject|3|||
124898590|NCT00586339|449253364|FG002|Overall Study|Withdrawal by Subject|1|||
124898591|NCT00586339|449253362|FG000|Overall Study|Migrated/moved from study area|3|||
124898592|NCT00586339|449253363|FG001|Overall Study|Migrated/moved from study area|2|||
124898593|NCT00586339|449253364|FG002|Overall Study|Migrated/moved from study area|4|||
124898594|NCT00586339|449253362|FG000|Overall Study|Lost to Follow-up|3|||
124898595|NCT00586339|449253363|FG001|Overall Study|Lost to Follow-up|2|||
124898596|NCT00586339|449253364|FG002|Overall Study|Lost to Follow-up|1|||
124898597|NCT00197236|449253368|FG000|Overall Study|Adverse Event|1|||
124898598|NCT00197236|449253369|FG001|Overall Study|Adverse Event|0|||
124898599|NCT00197236|449253370|FG002|Overall Study|Adverse Event|1|||
124898600|NCT00197236|449253368|FG000|Overall Study|Lost to Follow-up|5|||
124898601|NCT00197236|449253369|FG001|Overall Study|Lost to Follow-up|14|||
124688814|NCT03439514|448479880|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
124688815|NCT03439514|448479879|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
124898602|NCT00197236|449253370|FG002|Overall Study|Lost to Follow-up|6|||
124898603|NCT00197236|449253368|FG000|Overall Study|Protocol Violation|0|||
124898604|NCT00197236|449253369|FG001|Overall Study|Protocol Violation|0|||
124898605|NCT00197236|449253370|FG002|Overall Study|Protocol Violation|1|||
124898606|NCT00197236|449253368|FG000|Overall Study|Withdrawal by Subject|7|||
124898607|NCT00197236|449253369|FG001|Overall Study|Withdrawal by Subject|3|||
124898608|NCT00197236|449253370|FG002|Overall Study|Withdrawal by Subject|11|||
124898609|NCT00197236|449253368|FG000|Overall Study|Study drug/medication expiration|1|||
124898610|NCT00197236|449253369|FG001|Overall Study|Study drug/medication expiration|0|||
124898611|NCT00197236|449253370|FG002|Overall Study|Study drug/medication expiration|3|||
124898612|NCT00197236|449253368|FG000|Overall Study|Returned out of specified time window|0|||
124898613|NCT00197236|449253369|FG001|Overall Study|Returned out of specified time window|0|||
124898614|NCT00197236|449253370|FG002|Overall Study|Returned out of specified time window|1|||
124898615|NCT00746330|449253371|FG000|Period 1|Abnormal test procedure result|0|||
124898616|NCT00746330|449253372|FG001|Period 1|Abnormal test procedure result|0|||
124898617|NCT00746330|449253373|FG002|Period 1|Abnormal test procedure result|1|||
124898618|NCT00746330|449253374|FG003|Period 1|Abnormal test procedure result|0|||
124898619|NCT02524288|449253375|FG000|Overall Study|Adverse Event|115|||
124898620|NCT02524288|449253375|FG000|Overall Study|Lost to Follow-up|216|||
124898621|NCT02524288|449253375|FG000|Overall Study|Non-Compliance With Protocol|32|||
124898622|NCT02524288|449253375|FG000|Overall Study|Non-Compliance With Study Drug|14|||
124898623|NCT02524288|449253375|FG000|Overall Study|Pregnancy Wish|6|||
124898624|NCT02524288|449253375|FG000|Overall Study|Protocol Violation|6|||
124898625|NCT02524288|449253375|FG000|Overall Study|Screen Failure|2|||
124898626|NCT02524288|449253375|FG000|Overall Study|Site Discontinued Study Participation|1|||
124898627|NCT02524288|449253375|FG000|Overall Study|Study Terminated By Sponsor|1417|||
124898628|NCT02524288|449253375|FG000|Overall Study|Subject Moved|32|||
124898629|NCT02524288|449253375|FG000|Overall Study|Withdrawal by Subject|76|||
124445660|NCT03308942|447595535|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
124898630|NCT02524288|449253375|FG000|Overall Study|Pregnancy|22|||
124898631|NCT02524288|449253375|FG000|Overall Study|Physician Decision|2|||
124898632|NCT00517933|449253376|FG000|Period 1|Death|2|||
124898633|NCT00517933|449253377|FG001|Period 1|Death|1|||
124445661|NCT03308942|447595536|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
124445662|NCT03308942|447595537|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
124445663|NCT03308942|447595533|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
124445664|NCT03308942|447595534|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
124445665|NCT03308942|447595535|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
124445666|NCT03308942|447595536|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
124445667|NCT03308942|447595537|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
124445668|NCT03308942|447595533|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
124688816|NCT03439514|448479880|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
124898634|NCT00517933|449253376|FG000|Period 1|Adverse Event|4|||
124898635|NCT00517933|449253377|FG001|Period 1|Adverse Event|4|||
124898636|NCT00517933|449253376|FG000|Period 1|Lost to Follow-up|2|||
124898637|NCT00517933|449253377|FG001|Period 1|Lost to Follow-up|0|||
124898638|NCT00517933|449253376|FG000|Period 1|Underwent lung transplant|0|||
124898639|NCT00517933|449253377|FG001|Period 1|Underwent lung transplant|1|||
124898640|NCT00517933|449253376|FG000|Period 2|Death|2|||
124898641|NCT00517933|449253377|FG001|Period 2|Death|4|||
124898642|NCT00517933|449253376|FG000|Period 2|Adverse Event|2|||
124898643|NCT00517933|449253377|FG001|Period 2|Adverse Event|4|||
124898644|NCT00517933|449253376|FG000|Period 2|Physician Decision|1|||
124898645|NCT00517933|449253377|FG001|Period 2|Physician Decision|0|||
124898646|NCT00517933|449253376|FG000|Period 2|Withdrawal by Subject|1|||
124898647|NCT00517933|449253377|FG001|Period 2|Withdrawal by Subject|3|||
124898648|NCT00517933|449253376|FG000|Period 2|Underwent lung transplant|0|||
124898649|NCT00517933|449253377|FG001|Period 2|Underwent lung transplant|2|||
124898650|NCT01835899|449253379|FG000|Overall Study|Adverse Event|0|||
124898651|NCT01835899|449253380|FG001|Overall Study|Adverse Event|0|||
124898652|NCT01835899|449253381|FG002|Overall Study|Adverse Event|1|||
124898653|NCT01835899|449253379|FG000|Overall Study|Other than stated above|0|||
124898654|NCT01835899|449253380|FG001|Overall Study|Other than stated above|1|||
124898655|NCT01835899|449253381|FG002|Overall Study|Other than stated above|0|||
124898656|NCT00121199|449253384|FG000|Overall Study|Adverse Event|11|||
124898657|NCT00121199|449253384|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
124898658|NCT00121199|449253384|FG000|Overall Study|Progression/Relapse|1|||
124898659|NCT00121199|449253384|FG000|Overall Study|Death|3|||
124898660|NCT00121199|449253384|FG000|Overall Study|Other - Not Protocol Specified|3|||
124688817|NCT03439514|448479879|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
124898661|NCT00121199|449253384|FG000|Overall Study|Ineligible|9|||
124898662|NCT01018511|449253386|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
124898663|NCT01018511|449253387|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
124445669|NCT03308942|447595534|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
124898664|NCT01018511|449253388|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
124445670|NCT03308942|447595535|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
124898665|NCT01018511|449253389|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
124898666|NCT01018511|449253386|FG000|Overall Study|Adverse Event|5|||
124898667|NCT01018511|449253387|FG001|Overall Study|Adverse Event|9|||
124898668|NCT01018511|449253388|FG002|Overall Study|Adverse Event|13|||
124898669|NCT01018511|449253389|FG003|Overall Study|Adverse Event|10|||
124898670|NCT01018511|449253386|FG000|Overall Study|Lack of Efficacy|4|||
124898671|NCT01018511|449253387|FG001|Overall Study|Lack of Efficacy|1|||
124898672|NCT01018511|449253388|FG002|Overall Study|Lack of Efficacy|1|||
124898673|NCT01018511|449253389|FG003|Overall Study|Lack of Efficacy|2|||
124898674|NCT01018511|449253386|FG000|Overall Study|Withdrawal by Subject|6|||
124898675|NCT01018511|449253387|FG001|Overall Study|Withdrawal by Subject|5|||
124898676|NCT01018511|449253388|FG002|Overall Study|Withdrawal by Subject|11|||
124898677|NCT01018511|449253389|FG003|Overall Study|Withdrawal by Subject|9|||
124898678|NCT01018511|449253386|FG000|Overall Study|Lost to Follow-up|0|||
124898679|NCT01018511|449253387|FG001|Overall Study|Lost to Follow-up|0|||
124898680|NCT01018511|449253388|FG002|Overall Study|Lost to Follow-up|1|||
124898681|NCT01018511|449253389|FG003|Overall Study|Lost to Follow-up|0|||
124898682|NCT01018511|449253386|FG000|Overall Study|Protocol Violation|5|||
124898683|NCT01018511|449253387|FG001|Overall Study|Protocol Violation|8|||
124898684|NCT01018511|449253388|FG002|Overall Study|Protocol Violation|7|||
124898685|NCT01018511|449253389|FG003|Overall Study|Protocol Violation|9|||
124898686|NCT01018511|449253386|FG000|Overall Study|Miscellaneous|0|||
124898687|NCT01018511|449253387|FG001|Overall Study|Miscellaneous|2|||
124898688|NCT01018511|449253388|FG002|Overall Study|Miscellaneous|0|||
124898689|NCT01018511|449253389|FG003|Overall Study|Miscellaneous|0|||
124898690|NCT04305912|449253391|FG000|First Intervention|COVID-19 Suspension|2|||
124898691|NCT04305912|449253392|FG001|First Intervention|COVID-19 Suspension|0|||
124898692|NCT04305912|449253391|FG000|First Intervention|Withdrawal by Subject|0|||
124898693|NCT04305912|449253392|FG001|First Intervention|Withdrawal by Subject|1|||
124898694|NCT04305912|449253391|FG000|Second Intervention|Adverse Event|0|||
124898695|NCT04305912|449253392|FG001|Second Intervention|Adverse Event|1|||
124898696|NCT04550039|449253393|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
124898697|NCT04550039|449253394|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
124898698|NCT04550039|449253393|FG000|Overall Study|patient self-withdrew from study|0|||
124898699|NCT04550039|449253394|FG001|Overall Study|patient self-withdrew from study|1|||
124898700|NCT04888585|449253395|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
124898701|NCT04888585|449253396|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
124898702|NCT04888585|449253397|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
124898703|NCT04888585|449253398|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
124898704|NCT04888585|449253399|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
124898705|NCT04888585|449253400|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
124898706|NCT04888585|449253401|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
124898707|NCT04888585|449253402|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
124898708|NCT04888585|449253403|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
124898709|NCT04888585|449253404|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
124898710|NCT04888585|449253405|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
124898711|NCT04888585|449253395|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
124898712|NCT04888585|449253396|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
124898713|NCT04888585|449253397|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
124898714|NCT04888585|449253398|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
124898715|NCT04888585|449253399|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
124898716|NCT04888585|449253400|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
124898717|NCT04888585|449253401|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
124898718|NCT04888585|449253402|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
124898719|NCT04888585|449253403|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
124898720|NCT04888585|449253404|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
124898721|NCT04888585|449253405|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
124898722|NCT04888585|449253395|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898723|NCT04888585|449253396|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898724|NCT04888585|449253397|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
124898725|NCT04888585|449253398|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898726|NCT04888585|449253399|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
124898727|NCT04888585|449253400|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898728|NCT04888585|449253401|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898729|NCT04888585|449253402|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898730|NCT04888585|449253403|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898731|NCT04888585|449253404|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898732|NCT04888585|449253405|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
124898733|NCT04888585|449253395|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
124898734|NCT04888585|449253396|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
124898735|NCT04888585|449253397|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
124445671|NCT03308942|447595536|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
124445672|NCT03308942|447595537|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
124898736|NCT04888585|449253398|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
124898737|NCT04888585|449253399|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
124898738|NCT04888585|449253400|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
124898739|NCT04888585|449253401|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
124898740|NCT04888585|449253402|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
124898741|NCT04888585|449253403|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
124898742|NCT04888585|449253404|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
124898743|NCT04888585|449253405|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
124898744|NCT04888585|449253395|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
124898745|NCT04888585|449253396|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
124898746|NCT04888585|449253397|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
124898747|NCT04888585|449253398|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
124898748|NCT04888585|449253399|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
124898749|NCT04888585|449253400|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
124898750|NCT04888585|449253401|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
124898751|NCT04888585|449253402|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
124898752|NCT04888585|449253403|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
124898753|NCT04888585|449253404|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
124898754|NCT04888585|449253405|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
124898755|NCT04888585|449253395|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
124898756|NCT04888585|449253396|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
124898757|NCT04888585|449253397|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
124898758|NCT04888585|449253398|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
124898759|NCT04888585|449253399|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
124898760|NCT04888585|449253400|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
124898761|NCT04888585|449253401|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
124898762|NCT04888585|449253402|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
124898763|NCT04888585|449253403|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
124898764|NCT04888585|449253404|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
124898765|NCT04888585|449253405|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
124898766|NCT04888585|449253395|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
124898767|NCT04888585|449253396|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
124898768|NCT04888585|449253397|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
124898769|NCT04888585|449253398|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
124898770|NCT04888585|449253399|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
124898771|NCT04888585|449253400|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
124898772|NCT04888585|449253401|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
124898773|NCT04888585|449253402|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
124898774|NCT04888585|449253403|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
124898775|NCT04888585|449253404|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
124898776|NCT04888585|449253405|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
124898777|NCT04888585|449253395|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
124898778|NCT04888585|449253396|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
124898779|NCT04888585|449253397|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
124898780|NCT04888585|449253398|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
124898781|NCT04888585|449253399|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
124898782|NCT04888585|449253400|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
124898783|NCT04888585|449253401|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
124898784|NCT04888585|449253402|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
124898785|NCT04888585|449253403|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
124898786|NCT04888585|449253404|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
124898787|NCT04888585|449253405|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
124898788|NCT02908464|449253407|FG000|Overall Study|Withdrawal by Subject|2|||
124898789|NCT02908464|449253408|FG001|Overall Study|Withdrawal by Subject|1|||
124898790|NCT02908464|449253407|FG000|Overall Study|Found ineligible after randomization|0|||
124898791|NCT02908464|449253408|FG001|Overall Study|Found ineligible after randomization|2|||
124898792|NCT01772719|449253409|FG000|Overall Study|Withdrawal by Subject|3|||
124898793|NCT01772719|449253409|FG000|Overall Study|Adverse Event|2|||
124898794|NCT01772719|449253409|FG000|Overall Study|Protocol Violation|1|||
124898795|NCT01772719|449253409|FG000|Overall Study|Lost to Follow-up|1|||
124898796|NCT01311713|449253410|FG000|Overall Study|Death|0|||
124898797|NCT01311713|449253411|FG001|Overall Study|Death|0|||
124898798|NCT01311713|449253412|FG002|Overall Study|Death|1|||
124898799|NCT01311713|449253413|FG003|Overall Study|Death|1|||
124898800|NCT01311713|449253414|FG004|Overall Study|Death|0|||
124898801|NCT01311713|449253415|FG005|Overall Study|Death|1|||
124898802|NCT01311713|449253416|FG006|Overall Study|Death|0|||
124898803|NCT01311713|449253410|FG000|Overall Study|Adverse Event|0|||
124898804|NCT01311713|449253411|FG001|Overall Study|Adverse Event|1|||
124898805|NCT01311713|449253412|FG002|Overall Study|Adverse Event|0|||
124898806|NCT01311713|449253413|FG003|Overall Study|Adverse Event|2|||
124898807|NCT01311713|449253414|FG004|Overall Study|Adverse Event|0|||
124898808|NCT01311713|449253415|FG005|Overall Study|Adverse Event|0|||
124898809|NCT01311713|449253416|FG006|Overall Study|Adverse Event|2|||
124898810|NCT01311713|449253410|FG000|Overall Study|Withdrawal by Subject|0|||
124898811|NCT01311713|449253411|FG001|Overall Study|Withdrawal by Subject|1|||
124898812|NCT01311713|449253412|FG002|Overall Study|Withdrawal by Subject|1|||
124898813|NCT01311713|449253413|FG003|Overall Study|Withdrawal by Subject|0|||
124898814|NCT01311713|449253414|FG004|Overall Study|Withdrawal by Subject|0|||
124898815|NCT01311713|449253415|FG005|Overall Study|Withdrawal by Subject|1|||
124898816|NCT01311713|449253416|FG006|Overall Study|Withdrawal by Subject|2|||
124898817|NCT01311713|449253410|FG000|Overall Study|Disease progression|3|||
124898818|NCT01311713|449253411|FG001|Overall Study|Disease progression|4|||
124898819|NCT01311713|449253412|FG002|Overall Study|Disease progression|3|||
124898820|NCT01311713|449253413|FG003|Overall Study|Disease progression|2|||
124898821|NCT01311713|449253414|FG004|Overall Study|Disease progression|4|||
124898822|NCT01311713|449253415|FG005|Overall Study|Disease progression|4|||
124898823|NCT01311713|449253416|FG006|Overall Study|Disease progression|5|||
124898824|NCT01311713|449253410|FG000|Overall Study|Lost to Follow-up|0|||
124898825|NCT01311713|449253411|FG001|Overall Study|Lost to Follow-up|0|||
124898826|NCT01311713|449253412|FG002|Overall Study|Lost to Follow-up|1|||
124898827|NCT01311713|449253413|FG003|Overall Study|Lost to Follow-up|0|||
124898828|NCT01311713|449253414|FG004|Overall Study|Lost to Follow-up|0|||
124898829|NCT01311713|449253415|FG005|Overall Study|Lost to Follow-up|0|||
124898830|NCT01311713|449253416|FG006|Overall Study|Lost to Follow-up|0|||
124898831|NCT01311713|449253410|FG000|Overall Study|Stopped taking study medication|0|||
124898832|NCT01311713|449253411|FG001|Overall Study|Stopped taking study medication|0|||
124898833|NCT01311713|449253412|FG002|Overall Study|Stopped taking study medication|0|||
124898834|NCT01311713|449253413|FG003|Overall Study|Stopped taking study medication|1|||
124898835|NCT01311713|449253414|FG004|Overall Study|Stopped taking study medication|1|||
124898836|NCT01311713|449253415|FG005|Overall Study|Stopped taking study medication|0|||
124898837|NCT01311713|449253416|FG006|Overall Study|Stopped taking study medication|0|||
124898838|NCT01311713|449253410|FG000|Overall Study|Enrolled but not treated|0|||
124688818|NCT03439514|448479880|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
124688819|NCT03439514|448479879|FG000|Double-Blind Treatment Period|Death|1|||
124688820|NCT03439514|448479880|FG001|Double-Blind Treatment Period|Death|2|||
124688821|NCT01521364|448479881|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
124688822|NCT01521364|448479881|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
124688823|NCT02175758|448479882|FG000|Treatment Phase|Lost to Follow-up|0|||
124688824|NCT02175758|448479883|FG001|Treatment Phase|Lost to Follow-up|1|||
124688825|NCT02175758|448479884|FG002|Treatment Phase|Lost to Follow-up|0|||
124688826|NCT02175758|448479885|FG003|Treatment Phase|Lost to Follow-up|0|||
124688827|NCT02175758|448479886|FG004|Treatment Phase|Lost to Follow-up|0|||
124688828|NCT02175758|448479887|FG005|Treatment Phase|Lost to Follow-up|0|||
124898839|NCT01311713|449253411|FG001|Overall Study|Enrolled but not treated|0|||
124898840|NCT01311713|449253412|FG002|Overall Study|Enrolled but not treated|1|||
124898841|NCT01311713|449253413|FG003|Overall Study|Enrolled but not treated|0|||
124898842|NCT01311713|449253414|FG004|Overall Study|Enrolled but not treated|0|||
124898843|NCT01311713|449253415|FG005|Overall Study|Enrolled but not treated|0|||
124898844|NCT01311713|449253416|FG006|Overall Study|Enrolled but not treated|0|||
124898845|NCT01311713|449253410|FG000|Overall Study|Other than specified|0|||
124898846|NCT01311713|449253411|FG001|Overall Study|Other than specified|1|||
124898847|NCT01311713|449253412|FG002|Overall Study|Other than specified|2|||
124898848|NCT01311713|449253413|FG003|Overall Study|Other than specified|0|||
124898849|NCT01311713|449253414|FG004|Overall Study|Other than specified|0|||
124898850|NCT01311713|449253415|FG005|Overall Study|Other than specified|0|||
124898851|NCT01311713|449253416|FG006|Overall Study|Other than specified|0|||
124898852|NCT00299702|449253420|FG000|Overall Study|Death|1|||
124898853|NCT00299702|449253421|FG001|Overall Study|Death|0|||
124898854|NCT00299702|449253420|FG000|Overall Study|Adverse Event|0|||
124898855|NCT00299702|449253421|FG001|Overall Study|Adverse Event|4|||
124898856|NCT00299702|449253420|FG000|Overall Study|Lost to Follow-up|18|||
124898857|NCT00299702|449253421|FG001|Overall Study|Lost to Follow-up|10|||
124898858|NCT00299702|449253420|FG000|Overall Study|Withdrawal by Subject|25|||
124898859|NCT00299702|449253421|FG001|Overall Study|Withdrawal by Subject|23|||
124898860|NCT00299702|449253420|FG000|Overall Study|Pregnancy|0|||
124898861|NCT00299702|449253421|FG001|Overall Study|Pregnancy|1|||
124898862|NCT00299702|449253420|FG000|Overall Study|Insufficient Response|4|||
124898863|NCT00299702|449253421|FG001|Overall Study|Insufficient Response|3|||
124898864|NCT00299702|449253420|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
124898865|NCT00299702|449253421|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
124898866|NCT00751036|449253422|FG000|Overall Study|Disease Progression|28|||
124898867|NCT00751036|449253423|FG001|Overall Study|Disease Progression|29|||
124898868|NCT00751036|449253422|FG000|Overall Study|Adverse Event|6|||
124898869|NCT00751036|449253423|FG001|Overall Study|Adverse Event|4|||
124898870|NCT00751036|449253422|FG000|Overall Study|Administrative Problems|3|||
124898871|NCT00751036|449253423|FG001|Overall Study|Administrative Problems|4|||
124898872|NCT00751036|449253422|FG000|Overall Study|Withdrawal by Subject|5|||
124898873|NCT00751036|449253423|FG001|Overall Study|Withdrawal by Subject|2|||
124898874|NCT00751036|449253422|FG000|Overall Study|Death|3|||
124898875|NCT00751036|449253423|FG001|Overall Study|Death|3|||
124898876|NCT00751036|449253422|FG000|Overall Study|Lost to Follow-up|0|||
124898877|NCT00751036|449253423|FG001|Overall Study|Lost to Follow-up|1|||
124898878|NCT00751036|449253422|FG000|Overall Study|Protocol Violation|1|||
124898879|NCT00751036|449253423|FG001|Overall Study|Protocol Violation|0|||
124898880|NCT00751036|449253422|FG000|Overall Study|Missing end of Treatment Page|2|||
124898881|NCT00751036|449253423|FG001|Overall Study|Missing end of Treatment Page|3|||
124898882|NCT05460663|449253424|FG000|Overall Study|Withdrawal by Subject|2|||
124898883|NCT05460663|449253425|FG001|Overall Study|Withdrawal by Subject|5|||
124898884|NCT05273801|449253426|FG000|Overall Study|Physician Decision|1|||
124898885|NCT03820986|449253427|FG000|Overall Study|Death|177|||
124898886|NCT03820986|449253428|FG001|Overall Study|Death|156|||
124898887|NCT03820986|449253427|FG000|Overall Study|Lost to Follow-up|0|||
124898888|NCT03820986|449253428|FG001|Overall Study|Lost to Follow-up|1|||
124898889|NCT03820986|449253427|FG000|Overall Study|Withdrawal by Subject|8|||
124898890|NCT03820986|449253428|FG001|Overall Study|Withdrawal by Subject|3|||
124898891|NCT03820986|449253427|FG000|Overall Study|Ongoing|149|||
124898892|NCT03820986|449253428|FG001|Overall Study|Ongoing|180|||
124898893|NCT01729819|449254693|FG000|Overall Study|Adverse Event|2|||
124898894|NCT01729819|449254694|FG001|Overall Study|Adverse Event|4|||
124898895|NCT01729819|449254693|FG000|Overall Study|Lack of Efficacy|1|||
124898896|NCT01729819|449254694|FG001|Overall Study|Lack of Efficacy|0|||
124898897|NCT01729819|449254693|FG000|Overall Study|Lost to Follow-up|2|||
124898898|NCT01729819|449254694|FG001|Overall Study|Lost to Follow-up|0|||
124898899|NCT01729819|449254693|FG000|Overall Study|Other reason|1|||
124898900|NCT01729819|449254694|FG001|Overall Study|Other reason|0|||
124898901|NCT01729819|449254693|FG000|Overall Study|Protocol Violation|0|||
124898902|NCT01729819|449254694|FG001|Overall Study|Protocol Violation|1|||
124898903|NCT01729819|449254693|FG000|Overall Study|Withdrawal by Subject|0|||
124898904|NCT01729819|449254694|FG001|Overall Study|Withdrawal by Subject|2|||
124898905|NCT04464421|449254699|FG000|Overall Study|Lost to Follow-up|2|||
124898906|NCT04464421|449254700|FG001|Overall Study|Lost to Follow-up|2|||
124898907|NCT01020838|449254702|FG000|Overall Study|Death|90|||
124898908|NCT01020838|449254702|FG000|Overall Study|Adverse Event|1|||
124898909|NCT01020838|449254702|FG000|Overall Study|Withdrawal by Subject|9|||
124898910|NCT01020838|449254702|FG000|Overall Study|Lost to Follow-up|6|||
124898911|NCT01020838|449254702|FG000|Overall Study|Most common: Study ended by sponsor|77|||
124898912|NCT01167426|449254703|FG000|Overall Study|Lost to Follow-up|6|||
124898913|NCT01167426|449254703|FG000|Overall Study|Protocol Violation|1|||
124898914|NCT01167426|449254703|FG000|Overall Study|Withdrawal by Subject|2|||
124898915|NCT01167426|449254703|FG000|Overall Study|Sponsor Decision|1|||
124898916|NCT01908634|449254705|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
124898917|NCT01908634|449254705|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
124898918|NCT04176458|449254706|FG000|Overall Study|Covid 19|4|||
124898919|NCT01570751|449254707|FG000|Period A (16 Weeks)|Protocol Violation|1|||
124898920|NCT01570751|449254708|FG001|Period A (16 Weeks)|Protocol Violation|1|||
124898921|NCT01570751|449254707|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
124898922|NCT01570751|449254708|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
124898923|NCT01570751|449254707|FG000|Period A (16 Weeks)|Unclassified|2|||
124898924|NCT01570751|449254708|FG001|Period A (16 Weeks)|Unclassified|3|||
124898925|NCT01570751|449254707|FG000|Period B (16 Weeks)|Adverse Event|1|||
124898926|NCT01570751|449254708|FG001|Period B (16 Weeks)|Adverse Event|0|||
124898927|NCT01570751|449254707|FG000|Period B (16 Weeks)|Protocol Violation|0|||
124898928|NCT01570751|449254708|FG001|Period B (16 Weeks)|Protocol Violation|1|||
124898929|NCT05790408|449254709|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
124898930|NCT00558363|449254713|FG000|Overall Study|Physician Decision|18|||
124898931|NCT00558363|449254714|FG001|Overall Study|Physician Decision|4|||
124898932|NCT00558363|449254713|FG000|Overall Study|Withdrawal by Subject|11|||
124898933|NCT00558363|449254714|FG001|Overall Study|Withdrawal by Subject|4|||
124898934|NCT00558363|449254713|FG000|Overall Study|Adverse Event|5|||
124898935|NCT00558363|449254714|FG001|Overall Study|Adverse Event|5|||
124898936|NCT00558363|449254713|FG000|Overall Study|Lack of Efficacy|2|||
124898937|NCT00558363|449254714|FG001|Overall Study|Lack of Efficacy|2|||
124898938|NCT00558363|449254713|FG000|Overall Study|Protocol Violation|2|||
124898939|NCT00558363|449254714|FG001|Overall Study|Protocol Violation|1|||
124898940|NCT00558363|449254713|FG000|Overall Study|Lost to Follow-up|0|||
124898941|NCT00558363|449254714|FG001|Overall Study|Lost to Follow-up|1|||
124898942|NCT00558363|449254713|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
124898943|NCT00558363|449254714|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
124898944|NCT00558363|449254713|FG000|Overall Study|Randomized in Error|1|||
124898945|NCT00558363|449254714|FG001|Overall Study|Randomized in Error|2|||
124898946|NCT00558363|449254713|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
124898947|NCT00558363|449254714|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
124898948|NCT04012853|449254715|FG000|Overall Study|Withdrawal by Subject|1|||
124898949|NCT04012853|449254716|FG001|Overall Study|Withdrawal by Subject|1|||
124898950|NCT04012853|449254715|FG000|Overall Study|Protocol Violation|1|||
124898951|NCT04012853|449254716|FG001|Overall Study|Protocol Violation|0|||
124898952|NCT04012853|449254715|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
124898953|NCT04012853|449254716|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
124445673|NCT03308942|447595533|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
124445674|NCT03308942|447595534|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
124445675|NCT03308942|447595535|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
124445676|NCT03308942|447595536|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
124445677|NCT03308942|447595537|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
124445678|NCT03308942|447595533|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
124445679|NCT03308942|447595534|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
124445680|NCT03308942|447595535|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
124445681|NCT03308942|447595536|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
124445682|NCT03308942|447595537|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
124445683|NCT03308942|447595533|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
124445684|NCT03308942|447595534|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
124445685|NCT03308942|447595535|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
124445686|NCT03308942|447595536|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
124445687|NCT03308942|447595537|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
124445688|NCT02194062|447595538|FG000|Overall Study|Lost to Follow-up|2|||
124445689|NCT02194062|447595539|FG001|Overall Study|Lost to Follow-up|2|||
124445690|NCT02194062|447595540|FG002|Overall Study|Lost to Follow-up|5|||
124445691|NCT02276872|447595541|FG000|Overall Study|Adverse Event|1|||
124445692|NCT02276872|447595542|FG001|Overall Study|Adverse Event|0|||
124445693|NCT02276872|447595543|FG002|Overall Study|Adverse Event|0|||
124445694|NCT01423812|447595546|FG000|Overall Study|Lost to Follow-up|2|||
124445695|NCT01423812|447595547|FG001|Overall Study|Lost to Follow-up|2|||
124445696|NCT01423812|447595546|FG000|Overall Study|Withdrawal by Subject|1|||
124445697|NCT01423812|447595547|FG001|Overall Study|Withdrawal by Subject|2|||
124445698|NCT01179672|447595548|FG000|Overall Study|Adverse Event|17|||
124445699|NCT01179672|447595549|FG001|Overall Study|Adverse Event|8|||
124445700|NCT01179672|447595548|FG000|Overall Study|Withdrawal by Subject|10|||
124445701|NCT01179672|447595549|FG001|Overall Study|Withdrawal by Subject|12|||
124445702|NCT01179672|447595548|FG000|Overall Study|Entry Criteria Not Met|0|||
124445703|NCT01179672|447595549|FG001|Overall Study|Entry Criteria Not Met|2|||
124445704|NCT01179672|447595548|FG000|Overall Study|Lost to Follow-up|0|||
124445705|NCT01179672|447595549|FG001|Overall Study|Lost to Follow-up|1|||
124445706|NCT01179672|447595548|FG000|Overall Study|Protocol Violation|2|||
124445707|NCT01179672|447595549|FG001|Overall Study|Protocol Violation|2|||
124445708|NCT01179672|447595548|FG000|Overall Study|Physician Decision|1|||
124445709|NCT01179672|447595549|FG001|Overall Study|Physician Decision|1|||
124445710|NCT00578786|447595559|FG000|Overall Study|Adverse Event|27|||
124445711|NCT00578786|447595560|FG001|Overall Study|Adverse Event|37|||
124445712|NCT00578786|447595561|FG002|Overall Study|Adverse Event|17|||
124445713|NCT00578786|447595559|FG000|Overall Study|Lack of Efficacy|2|||
124445714|NCT00578786|447595560|FG001|Overall Study|Lack of Efficacy|5|||
124445715|NCT00578786|447595561|FG002|Overall Study|Lack of Efficacy|2|||
124445716|NCT00578786|447595559|FG000|Overall Study|Early Escape from Prior Study|2|||
124445717|NCT00578786|447595560|FG001|Overall Study|Early Escape from Prior Study|1|||
124445718|NCT00578786|447595561|FG002|Overall Study|Early Escape from Prior Study|2|||
124445719|NCT00578786|447595559|FG000|Overall Study|Withdrawal by Subject|7|||
124445720|NCT00578786|447595560|FG001|Overall Study|Withdrawal by Subject|8|||
124445721|NCT00578786|447595561|FG002|Overall Study|Withdrawal by Subject|5|||
124445722|NCT00578786|447595559|FG000|Overall Study|Protocol Violation|0|||
124445723|NCT00578786|447595560|FG001|Overall Study|Protocol Violation|3|||
124898954|NCT00015457|449254719|FG000|First Intervention|Adverse Event|0|||
124898955|NCT00015457|449254720|FG001|First Intervention|Adverse Event|2|||
124898956|NCT00015457|449254719|FG000|First Intervention|Lack of Efficacy|0|||
124898957|NCT00015457|449254720|FG001|First Intervention|Lack of Efficacy|1|||
124898958|NCT00015457|449254719|FG000|Second Intervention|Withdrawal by Subject|1|||
124898959|NCT00015457|449254720|FG001|Second Intervention|Withdrawal by Subject|0|||
124898960|NCT02317705|449254721|FG000|Overall Study|Withdrawal by Subject|3|||
124898961|NCT02317705|449254721|FG000|Overall Study|Physician Decision|1|||
124898962|NCT02317705|449254721|FG000|Overall Study|Drug not usable|1|||
124898963|NCT02219490|449254722|FG000|Overall Study|Adverse Event|24|||
124898964|NCT02219490|449254722|FG000|Overall Study|Withdrew consent|96|||
124898965|NCT02219490|449254722|FG000|Overall Study|Lost to Follow-up|126|||
124898966|NCT02219490|449254722|FG000|Overall Study|COVID-19 infection|2|||
124898967|NCT02219490|449254722|FG000|Overall Study|COVID-19 logistical restrictions|33|||
124898968|NCT02219490|449254722|FG000|Overall Study|Other, not specified|57|||
124898969|NCT01599325|449254723|FG000|Primary Parent Phase|Adverse Event|5|||
124898970|NCT01599325|449254723|FG000|Primary Parent Phase|Disease Progression|7|||
124898971|NCT01599325|449254723|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
124898972|NCT01599325|449254723|FG000|Primary Parent Phase|Death|13|||
124898973|NCT01599325|449254723|FG000|Primary Parent Phase|Protocol Violation|1|||
124898974|NCT01599325|449254723|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
124898975|NCT01599325|449254723|FG000|Primary Parent Phase|Other|2|||
124898976|NCT01599325|449254723|FG000|Extension Phase|Study Closure|1|||
124898977|NCT01599325|449254723|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
124898978|NCT01599325|449254723|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
124898979|NCT01599325|449254723|FG000|Extension Phase|Disease Progression|1|||
124898980|NCT01599325|449254723|FG000|Extension Phase|Withdrawal by Subject|8|||
124898981|NCT02430532|449254726|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
124898982|NCT02430532|449254727|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
124898983|NCT02430532|449254726|FG000|Overall Study|Consent Withdrawn|0|||
124898984|NCT02430532|449254727|FG001|Overall Study|Consent Withdrawn|2|||
124898985|NCT02430532|449254726|FG000|Overall Study|Adverse Event|0|||
124898986|NCT02430532|449254727|FG001|Overall Study|Adverse Event|1|||
124898987|NCT04109118|449254742|FG000|Overall Study|Lost to Follow-up|3|||
124898988|NCT03235349|449254745|FG000|Overall Study|Adverse Event|1|||
124898989|NCT03235349|449254745|FG000|Overall Study|Other|1|||
124898990|NCT04523181|449254750|FG000|Overall Study|Withdrawal by Subject|4|||
124898991|NCT04523181|449254751|FG001|Overall Study|Withdrawal by Subject|5|||
124898992|NCT04523181|449254750|FG000|Overall Study|Lost to Follow-up|2|||
124898993|NCT04523181|449254751|FG001|Overall Study|Lost to Follow-up|3|||
124898994|NCT04523181|449254750|FG000|Overall Study|Physician Decision|1|||
124898995|NCT04523181|449254751|FG001|Overall Study|Physician Decision|0|||
124898996|NCT04523181|449254750|FG000|Overall Study|Transferred to external facility.|1|||
124898997|NCT04523181|449254751|FG001|Overall Study|Transferred to external facility.|1|||
124898998|NCT04391309|449254752|FG000|Overall Study|Death|1|||
124898999|NCT04391309|449254753|FG001|Overall Study|Death|1|||
124899000|NCT04391309|449254752|FG000|Overall Study|Lost to Follow-up|3|||
124899001|NCT04391309|449254753|FG001|Overall Study|Lost to Follow-up|2|||
124899002|NCT04391309|449254752|FG000|Overall Study|Withdrawal by Subject|2|||
124899003|NCT04391309|449254753|FG001|Overall Study|Withdrawal by Subject|2|||
124899004|NCT01155869|449254754|FG000|Overall Study|Lost to Follow-up|3|||
124899005|NCT01155869|449254755|FG001|Overall Study|Lost to Follow-up|1|||
124899006|NCT03396913|449254757|FG000|Overall Study|Lost to Follow-up|0|||
124899007|NCT03396913|449254758|FG001|Overall Study|Lost to Follow-up|6|||
124899008|NCT05824351|449254759|FG000|Overall Study|Adverse Event|6|||
124899009|NCT00828945|449254760|FG000|Overall Study|Death|4|||
124899010|NCT00828945|449254760|FG000|Overall Study|Participant was missing|1|||
124899011|NCT00828945|449254760|FG000|Overall Study|Other|36|||
124688829|NCT02175758|448479882|FG000|Treatment Phase|Adverse Event|0|||
124899012|NCT02482233|449254765|FG000|Overall Study|Lost to Follow-up|1|||
124899013|NCT02482233|449254766|FG001|Overall Study|Lost to Follow-up|1|||
124899014|NCT03822351|449254767|FG000|Overall Study|Death|27|||
124899015|NCT03822351|449254768|FG001|Overall Study|Death|23|||
124899016|NCT03822351|449254769|FG002|Overall Study|Death|24|||
124899017|NCT03822351|449254767|FG000|Overall Study|Lost to Follow-up|6|||
124899018|NCT03822351|449254768|FG001|Overall Study|Lost to Follow-up|2|||
124899019|NCT03822351|449254769|FG002|Overall Study|Lost to Follow-up|1|||
124899020|NCT03822351|449254767|FG000|Overall Study|Withdrawal by Subject|10|||
124899021|NCT03822351|449254768|FG001|Overall Study|Withdrawal by Subject|4|||
124899022|NCT03822351|449254769|FG002|Overall Study|Withdrawal by Subject|6|||
124899023|NCT03822351|449254767|FG000|Overall Study|Progressive Disease|2|||
124899024|NCT03822351|449254768|FG001|Overall Study|Progressive Disease|1|||
124899025|NCT03822351|449254769|FG002|Overall Study|Progressive Disease|0|||
124445724|NCT00578786|447595561|FG002|Overall Study|Protocol Violation|1|||
124899026|NCT03822351|449254767|FG000|Overall Study|Not Treated|1|||
124899027|NCT03822351|449254768|FG001|Overall Study|Not Treated|1|||
124899028|NCT03822351|449254769|FG002|Overall Study|Not Treated|1|||
124899029|NCT00462943|449254770|FG000|Overall Study|Failure to achieve a response|5|||
124899030|NCT00462943|449254771|FG001|Overall Study|Failure to achieve a response|5|||
124899031|NCT00462943|449254772|FG002|Overall Study|Failure to achieve a response|1|||
124899032|NCT00462943|449254770|FG000|Overall Study|Adverse Event|6|||
124899033|NCT00462943|449254771|FG001|Overall Study|Adverse Event|4|||
124899034|NCT00462943|449254772|FG002|Overall Study|Adverse Event|1|||
124899035|NCT00462943|449254770|FG000|Overall Study|Protocol Violation|1|||
124899036|NCT00462943|449254771|FG001|Overall Study|Protocol Violation|0|||
124899037|NCT00462943|449254772|FG002|Overall Study|Protocol Violation|0|||
124899038|NCT00462943|449254770|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
124899039|NCT00462943|449254771|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
124899040|NCT00462943|449254772|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
124899041|NCT00462943|449254770|FG000|Overall Study|Disease Progression|15|||
124899042|NCT00462943|449254771|FG001|Overall Study|Disease Progression|15|||
124899043|NCT00462943|449254772|FG002|Overall Study|Disease Progression|9|||
124899044|NCT00462943|449254770|FG000|Overall Study|Death|5|||
124899045|NCT00462943|449254771|FG001|Overall Study|Death|2|||
124899046|NCT00462943|449254772|FG002|Overall Study|Death|7|||
124899047|NCT00462943|449254770|FG000|Overall Study|Stem Cell Transplant|1|||
124899048|NCT00462943|449254771|FG001|Overall Study|Stem Cell Transplant|1|||
124899049|NCT00462943|449254772|FG002|Overall Study|Stem Cell Transplant|0|||
124899050|NCT00462943|449254770|FG000|Overall Study|Bone Marrow Transplant|1|||
124899051|NCT00462943|449254771|FG001|Overall Study|Bone Marrow Transplant|0|||
124899052|NCT00462943|449254772|FG002|Overall Study|Bone Marrow Transplant|0|||
124899053|NCT00462943|449254770|FG000|Overall Study|Required Lymphocyte Infusion|1|||
124899054|NCT00462943|449254771|FG001|Overall Study|Required Lymphocyte Infusion|0|||
124899055|NCT00462943|449254772|FG002|Overall Study|Required Lymphocyte Infusion|0|||
124899056|NCT00462943|449254770|FG000|Overall Study|Transplant - not specified|1|||
124899057|NCT00462943|449254771|FG001|Overall Study|Transplant - not specified|0|||
124899058|NCT00462943|449254772|FG002|Overall Study|Transplant - not specified|1|||
124899059|NCT00462943|449254770|FG000|Overall Study|Physician Decision|1|||
124445725|NCT00578786|447595559|FG000|Overall Study|Physician Decision|1|||
124445726|NCT00578786|447595560|FG001|Overall Study|Physician Decision|0|||
124445727|NCT00578786|447595561|FG002|Overall Study|Physician Decision|1|||
124445728|NCT00578786|447595559|FG000|Overall Study|Sponsor Decision|0|||
124445729|NCT00578786|447595560|FG001|Overall Study|Sponsor Decision|0|||
124445730|NCT00578786|447595561|FG002|Overall Study|Sponsor Decision|1|||
124445731|NCT00578786|447595559|FG000|Overall Study|Lost to Follow-up|0|||
124445732|NCT00578786|447595560|FG001|Overall Study|Lost to Follow-up|4|||
124445733|NCT00578786|447595561|FG002|Overall Study|Lost to Follow-up|0|||
124445734|NCT00578786|447595559|FG000|Overall Study|Pregnancy|0|||
124445735|NCT00578786|447595560|FG001|Overall Study|Pregnancy|1|||
124445736|NCT00578786|447595561|FG002|Overall Study|Pregnancy|0|||
124445737|NCT00578786|447595559|FG000|Overall Study|Not Otherwise Specified|0|||
124445738|NCT00578786|447595560|FG001|Overall Study|Not Otherwise Specified|4|||
124445739|NCT00578786|447595561|FG002|Overall Study|Not Otherwise Specified|1|||
124445740|NCT00578786|447595559|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
124445741|NCT00578786|447595560|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
124445742|NCT00578786|447595561|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
124445743|NCT05105789|447595562|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
124445744|NCT00323297|447595565|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
124445745|NCT00323297|447595566|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
124445746|NCT00323297|447595565|FG000|Part A (Double Blind Randomized)|Death|0|||
124445747|NCT00323297|447595566|FG001|Part A (Double Blind Randomized)|Death|1|||
124445748|NCT00323297|447595565|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
124445749|NCT00323297|447595566|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
124445750|NCT00323297|447595565|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
124445751|NCT00323297|447595566|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
124445752|NCT00323297|447595565|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
124445753|NCT00323297|447595566|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
124445754|NCT00323297|447595565|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
124445755|NCT00323297|447595566|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
124899060|NCT00462943|449254771|FG001|Overall Study|Physician Decision|0|||
124899061|NCT00462943|449254772|FG002|Overall Study|Physician Decision|0|||
124899062|NCT00462943|449254770|FG000|Overall Study|Withdrawal by Subject|0|||
124899063|NCT00462943|449254771|FG001|Overall Study|Withdrawal by Subject|1|||
124899064|NCT00462943|449254772|FG002|Overall Study|Withdrawal by Subject|0|||
124899065|NCT00813488|449254778|FG000|Titration Period 1|Adverse Event|6|||
124899066|NCT00813488|449254779|FG001|Titration Period 1|Adverse Event|1|||
124445756|NCT00323297|447595565|FG000|Part B (Open-label)|Death|0|||
124899067|NCT00813488|449254778|FG000|Titration Period 1|Lack of Efficacy|9|||
124445757|NCT00323297|447595566|FG001|Part B (Open-label)|Death|1|||
124899068|NCT00813488|449254779|FG001|Titration Period 1|Lack of Efficacy|7|||
124899069|NCT00813488|449254778|FG000|Titration Period 1|Withdrawal by Subject|2|||
124899070|NCT00813488|449254779|FG001|Titration Period 1|Withdrawal by Subject|2|||
124899071|NCT00813488|449254778|FG000|Titration Period 1|Protocol Violation|4|||
124899072|NCT00813488|449254779|FG001|Titration Period 1|Protocol Violation|3|||
124899073|NCT00813488|449254778|FG000|Titration Period 1|Non-compliance to study medication|4|||
124899074|NCT00813488|449254779|FG001|Titration Period 1|Non-compliance to study medication|1|||
124899075|NCT00813488|449254778|FG000|Titration Period 1|Non-compliance to study procedures|2|||
124899076|NCT00813488|449254779|FG001|Titration Period 1|Non-compliance to study procedures|2|||
124899077|NCT00813488|449254778|FG000|Titration Period 1|Technical Difficulties|0|||
124899078|NCT00813488|449254779|FG001|Titration Period 1|Technical Difficulties|1|||
124899079|NCT00813488|449254778|FG000|Titration Period 2|Adverse Event|2|||
124899080|NCT00813488|449254779|FG001|Titration Period 2|Adverse Event|3|||
124899081|NCT00813488|449254778|FG000|Titration Period 2|Lack of Efficacy|8|||
124899082|NCT00813488|449254779|FG001|Titration Period 2|Lack of Efficacy|4|||
124899083|NCT00813488|449254778|FG000|Titration Period 2|Protocol Violation|3|||
124899084|NCT00813488|449254779|FG001|Titration Period 2|Protocol Violation|2|||
124899085|NCT00813488|449254778|FG000|Titration Period 2|Lost to Follow-up|1|||
124899086|NCT00813488|449254779|FG001|Titration Period 2|Lost to Follow-up|0|||
124899087|NCT00813488|449254778|FG000|Titration Period 2|Non-compliance with study procedures|2|||
124899088|NCT00813488|449254779|FG001|Titration Period 2|Non-compliance with study procedures|1|||
124899089|NCT00813488|449254778|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
124899090|NCT00813488|449254779|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
124899091|NCT00813488|449254778|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
124899092|NCT00813488|449254779|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
124899093|NCT00813488|449254778|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
124899094|NCT00813488|449254779|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
124899095|NCT00813488|449254778|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
124899096|NCT00813488|449254779|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
124899097|NCT00813488|449254778|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
124899098|NCT00813488|449254779|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
124899099|NCT00813488|449254778|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
124899100|NCT00813488|449254779|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
124899101|NCT00813488|449254778|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
124899102|NCT00813488|449254779|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
124899103|NCT00813488|449254778|FG000|Double-blind Treatment Period 2|Other|1|||
124899104|NCT00813488|449254779|FG001|Double-blind Treatment Period 2|Other|0|||
124899105|NCT00813488|449254778|FG000|Open-label Extension|Adverse Event|1|||
124899106|NCT00813488|449254779|FG001|Open-label Extension|Adverse Event|2|||
124899107|NCT00813488|449254778|FG000|Open-label Extension|Lack of Efficacy|3|||
124899108|NCT00813488|449254779|FG001|Open-label Extension|Lack of Efficacy|0|||
124899109|NCT00813488|449254778|FG000|Open-label Extension|Withdrawal by Subject|0|||
124899110|NCT00813488|449254779|FG001|Open-label Extension|Withdrawal by Subject|2|||
124899111|NCT00813488|449254778|FG000|Open-label Extension|Protocol Violation|1|||
124899112|NCT00813488|449254779|FG001|Open-label Extension|Protocol Violation|2|||
124899113|NCT00813488|449254778|FG000|Open-label Extension|Non-compliance study medication|4|||
124899114|NCT00813488|449254779|FG001|Open-label Extension|Non-compliance study medication|0|||
124899115|NCT00813488|449254778|FG000|Open-label Extension|Non-compliance study procedures|2|||
124899116|NCT00813488|449254779|FG001|Open-label Extension|Non-compliance study procedures|1|||
124899117|NCT00813488|449254778|FG000|Open-label Extension|Other|1|||
124899118|NCT00813488|449254779|FG001|Open-label Extension|Other|0|||
124899119|NCT01729871|449254781|FG000|Overall Study|Adverse Event|7|||
124899120|NCT01729871|449254782|FG001|Overall Study|Adverse Event|7|||
124899121|NCT01729871|449254781|FG000|Overall Study|Death|0|||
124899122|NCT01729871|449254782|FG001|Overall Study|Death|1|||
124899123|NCT01729871|449254781|FG000|Overall Study|Lack of Efficacy|0|||
124899124|NCT01729871|449254782|FG001|Overall Study|Lack of Efficacy|1|||
124899125|NCT01729871|449254781|FG000|Overall Study|Physician Decision|0|||
124899126|NCT01729871|449254782|FG001|Overall Study|Physician Decision|2|||
124899127|NCT01729871|449254781|FG000|Overall Study|Protocol Violation|1|||
124899128|NCT01729871|449254782|FG001|Overall Study|Protocol Violation|0|||
124899129|NCT01729871|449254781|FG000|Overall Study|Withdrawal by Subject|0|||
124899130|NCT01729871|449254782|FG001|Overall Study|Withdrawal by Subject|3|||
124899131|NCT01729871|449254781|FG000|Overall Study|Other|4|||
124899132|NCT01729871|449254782|FG001|Overall Study|Other|9|||
124899133|NCT01143077|449254783|FG000|Overall Study|Lack of Efficacy|0|||
124899134|NCT01143077|449254784|FG001|Overall Study|Lack of Efficacy|2|||
124688830|NCT02175758|448479883|FG001|Treatment Phase|Adverse Event|0|||
124688831|NCT02175758|448479884|FG002|Treatment Phase|Adverse Event|0|||
124688832|NCT02175758|448479885|FG003|Treatment Phase|Adverse Event|0|||
124688833|NCT02175758|448479886|FG004|Treatment Phase|Adverse Event|1|||
124688834|NCT02175758|448479887|FG005|Treatment Phase|Adverse Event|0|||
124688835|NCT02636283|448479888|FG000|Overall Study|Adverse Event|2|||
124688836|NCT02636283|448479889|FG001|Overall Study|Adverse Event|0|||
124445758|NCT00323297|447595565|FG000|Part B (Open-label)|Reason unspecified|0|||
124445759|NCT00323297|447595566|FG001|Part B (Open-label)|Reason unspecified|1|||
124445760|NCT00323297|447595565|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
124445761|NCT00323297|447595566|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
124445762|NCT00323297|447595565|FG000|Part B (Open-label)|Lack of Efficacy|3|||
124445763|NCT00323297|447595566|FG001|Part B (Open-label)|Lack of Efficacy|1|||
124445764|NCT00323297|447595565|FG000|Part B (Open-label)|Adverse Event|5|||
124445765|NCT00323297|447595566|FG001|Part B (Open-label)|Adverse Event|5|||
124445766|NCT00323297|447595565|FG000|Part B (Open-label)|Protocol Violation|0|||
124445767|NCT00323297|447595566|FG001|Part B (Open-label)|Protocol Violation|1|||
124445768|NCT01003990|447595567|FG000|Overall Study|Adverse Event|8|||
124688837|NCT02636283|448479888|FG000|Overall Study|Trial Terminated Prematurely|0|||
124688838|NCT02636283|448479889|FG001|Overall Study|Trial Terminated Prematurely|3|||
124688839|NCT03927157|448479892|FG000|Overall Study|Adverse Event|1|||
124688840|NCT03927157|448479893|FG001|Overall Study|Adverse Event|3|||
124899135|NCT01143077|449254785|FG002|Overall Study|Lack of Efficacy|1|||
124899136|NCT01143077|449254783|FG000|Overall Study|Adverse Event|5|||
124899137|NCT01143077|449254784|FG001|Overall Study|Adverse Event|6|||
124899138|NCT01143077|449254785|FG002|Overall Study|Adverse Event|5|||
124899139|NCT01143077|449254783|FG000|Overall Study|Lost to Follow-up|2|||
124899140|NCT01143077|449254784|FG001|Overall Study|Lost to Follow-up|3|||
124899141|NCT01143077|449254785|FG002|Overall Study|Lost to Follow-up|4|||
124899142|NCT01143077|449254783|FG000|Overall Study|Protocol Violation|2|||
124899143|NCT01143077|449254784|FG001|Overall Study|Protocol Violation|0|||
124899144|NCT01143077|449254785|FG002|Overall Study|Protocol Violation|0|||
124899145|NCT01143077|449254783|FG000|Overall Study|Withdrawal by Subject|4|||
124899146|NCT01143077|449254784|FG001|Overall Study|Withdrawal by Subject|3|||
124899147|NCT01143077|449254785|FG002|Overall Study|Withdrawal by Subject|3|||
124899148|NCT01143077|449254783|FG000|Overall Study|Non-compliance with study drug|0|||
124899149|NCT01143077|449254784|FG001|Overall Study|Non-compliance with study drug|1|||
124899150|NCT01143077|449254785|FG002|Overall Study|Non-compliance with study drug|1|||
124899151|NCT01143077|449254783|FG000|Overall Study|Administrative|1|||
124899152|NCT01143077|449254784|FG001|Overall Study|Administrative|0|||
124899153|NCT01143077|449254785|FG002|Overall Study|Administrative|0|||
124899154|NCT01143077|449254783|FG000|Overall Study|Principal Investigator Decision|2|||
124899155|NCT01143077|449254784|FG001|Overall Study|Principal Investigator Decision|0|||
124688841|NCT03927157|448479892|FG000|Overall Study|Protocol Violation|1|||
124688842|NCT03927157|448479893|FG001|Overall Study|Protocol Violation|2|||
124688843|NCT03927157|448479892|FG000|Overall Study|Withdrawal by Subject|8|||
124688844|NCT03927157|448479893|FG001|Overall Study|Withdrawal by Subject|21|||
124688845|NCT03927157|448479892|FG000|Overall Study|Due to COVID-19 pandemic|5|||
124688846|NCT03927157|448479893|FG001|Overall Study|Due to COVID-19 pandemic|2|||
124688847|NCT03927157|448479892|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
124688848|NCT03927157|448479893|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
124688849|NCT03927157|448479892|FG000|Overall Study|Other than above|0|||
124688850|NCT03927157|448479893|FG001|Overall Study|Other than above|1|||
124688851|NCT00726557|448479894|FG000|Overall Study|Screening failure|4|||
124688852|NCT00726557|448479894|FG000|Overall Study|No end of treatment documentation|37|||
124688853|NCT00726557|448479894|FG000|Overall Study|No follow-up documentation available|55|||
124688854|NCT00726557|448479894|FG000|Overall Study|Treatment less than 3 months|17|||
124688855|NCT00726557|448479894|FG000|Overall Study|Inclusion criteria not met|15|||
124688856|NCT01239745|448479895|FG000|Overall Study|Study terminated by sponsor|45|||
124688857|NCT01239745|448479895|FG000|Overall Study|Adverse Event|1|||
124899156|NCT01143077|449254785|FG002|Overall Study|Principal Investigator Decision|1|||
124899157|NCT00871429|449254790|FG000|Overall Study|Lost to Follow-up|6|||
124899158|NCT00871429|449254790|FG000|Overall Study|Withdrawal by Subject|17|||
124899159|NCT00871429|449254790|FG000|Overall Study|Questionnaire not completed|1|||
124899160|NCT05526911|449255959|FG000|Overall Study|Adverse Event|2|||
124445769|NCT01003990|447595568|FG001|Overall Study|Adverse Event|5|||
124445770|NCT01003990|447595569|FG002|Overall Study|Adverse Event|11|||
124688858|NCT00081458|448479896|FG000|Overall Study|Adverse Event|1|||
124899161|NCT05025449|449255960|FG000|Overall Study|Withdrawal by Subject|1|||
124445771|NCT01003990|447595567|FG000|Overall Study|Death|0|||
124445772|NCT01003990|447595568|FG001|Overall Study|Death|8|||
124688859|NCT00081458|448479897|FG001|Overall Study|Adverse Event|5|||
124688860|NCT00081458|448479898|FG002|Overall Study|Adverse Event|2|||
124688861|NCT00081458|448479896|FG000|Overall Study|Withdrawal by Subject|0|||
124899162|NCT05025449|449255960|FG000|Overall Study|Patient emergently taken to operating room|1|||
124899163|NCT00613301|449255961|FG000|Overall Study|Adverse Event|49|||
124688862|NCT00081458|448479897|FG001|Overall Study|Withdrawal by Subject|3|||
124899164|NCT00613301|449255961|FG000|Overall Study|Lost to Follow-up|88|||
124899165|NCT00613301|449255961|FG000|Overall Study|Withdrawal by Subject|5|||
124899166|NCT00613301|449255961|FG000|Overall Study|Death|6|||
124899167|NCT00613301|449255961|FG000|Overall Study|Lack of Efficacy|13|||
124445773|NCT01003990|447595569|FG002|Overall Study|Death|1|||
124445774|NCT01003990|447595567|FG000|Overall Study|Lack of Efficacy|10|||
124445775|NCT01003990|447595568|FG001|Overall Study|Lack of Efficacy|2|||
124445776|NCT01003990|447595569|FG002|Overall Study|Lack of Efficacy|3|||
124445777|NCT01003990|447595567|FG000|Overall Study|Lost to Follow-up|30|||
124445778|NCT01003990|447595568|FG001|Overall Study|Lost to Follow-up|12|||
124445779|NCT01003990|447595569|FG002|Overall Study|Lost to Follow-up|7|||
124445780|NCT01003990|447595567|FG000|Overall Study|Reasons Not Identified|14|||
124445781|NCT01003990|447595568|FG001|Overall Study|Reasons Not Identified|13|||
124445782|NCT01003990|447595569|FG002|Overall Study|Reasons Not Identified|8|||
124445783|NCT01003990|447595567|FG000|Overall Study|Poor/Non-compliance|4|||
124445784|NCT01003990|447595568|FG001|Overall Study|Poor/Non-compliance|3|||
124445785|NCT01003990|447595569|FG002|Overall Study|Poor/Non-compliance|2|||
124445786|NCT01003990|447595567|FG000|Overall Study|Pregnancy|10|||
124445787|NCT01003990|447595568|FG001|Overall Study|Pregnancy|2|||
124445788|NCT01003990|447595569|FG002|Overall Study|Pregnancy|4|||
124899168|NCT00613301|449255961|FG000|Overall Study|Physician Decision|2|||
124899169|NCT00613301|449255961|FG000|Overall Study|No data was collected|53|||
124899170|NCT00613301|449255961|FG000|Overall Study|Irregularly enrolled patients|12|||
124899171|NCT00569946|449255962|FG000|Overall Study|Adverse Event|16|||
124899172|NCT00569946|449255962|FG000|Overall Study|Objective Progression or Relapse|42|||
124899173|NCT00569946|449255962|FG000|Overall Study|Global Deterioration of Health Status|1|||
124899174|NCT00470626|449255967|FG000|Overall Study|Lost to Follow-up|10|||
124899175|NCT00470626|449255967|FG000|Overall Study|Withdrawal by Subject|7|||
124899176|NCT01801930|449255972|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
124899177|NCT01801930|449255973|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
124899178|NCT01801930|449255974|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
124899179|NCT01801930|449255975|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
124899180|NCT01801930|449255972|FG000|Overall Study|DLT occurs|0|||
124899181|NCT01801930|449255973|FG001|Overall Study|DLT occurs|1|||
124899182|NCT01801930|449255974|FG002|Overall Study|DLT occurs|0|||
124899183|NCT01801930|449255975|FG003|Overall Study|DLT occurs|0|||
124899184|NCT03396835|449255981|FG000|Overall Study|Withdrawn prior to completion|1|||
124899185|NCT03396835|449255981|FG000|Overall Study|Did not meet criteria for data analysis|1|||
124899186|NCT03721016|449255988|FG000|Overall Study|Adverse Event|0|||
124899187|NCT03721016|449255989|FG001|Overall Study|Adverse Event|1|||
124899188|NCT03721016|449255990|FG002|Overall Study|Adverse Event|1|||
124899189|NCT03721016|449255988|FG000|Overall Study|Withdrawal by Subject|8|||
124445789|NCT01003990|447595567|FG000|Overall Study|No Longer Met Study Criteria|4|||
124445790|NCT01003990|447595568|FG001|Overall Study|No Longer Met Study Criteria|1|||
124445791|NCT01003990|447595569|FG002|Overall Study|No Longer Met Study Criteria|0|||
124445792|NCT01003990|447595567|FG000|Overall Study|Subject Withdrew Consent|12|||
124445793|NCT01003990|447595568|FG001|Overall Study|Subject Withdrew Consent|5|||
124445794|NCT01003990|447595569|FG002|Overall Study|Subject Withdrew Consent|7|||
124445795|NCT00634010|447595574|FG000|Overall Study|Adverse Event|2|||
124445796|NCT00634010|447595575|FG001|Overall Study|Adverse Event|5|||
124445797|NCT00634010|447595574|FG000|Overall Study|Withdrawal by Subject|5|||
124445798|NCT00634010|447595575|FG001|Overall Study|Withdrawal by Subject|6|||
124445799|NCT00634010|447595574|FG000|Overall Study|Physician Decision|1|||
124445800|NCT00634010|447595575|FG001|Overall Study|Physician Decision|1|||
124445801|NCT00634010|447595574|FG000|Overall Study|Disease Progression|1|||
124445802|NCT00634010|447595575|FG001|Overall Study|Disease Progression|1|||
124445803|NCT00634010|447595574|FG000|Overall Study|Non-Compliant|1|||
124445804|NCT00634010|447595575|FG001|Overall Study|Non-Compliant|1|||
124445805|NCT00448435|447595580|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
124445806|NCT00448435|447595581|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
124445807|NCT01822522|447595583|FG000|Overall Study|Adverse Event|1|||
124445808|NCT01822522|447595584|FG001|Overall Study|Adverse Event|1|||
124445809|NCT01822522|447595585|FG002|Overall Study|Adverse Event|1|||
124445810|NCT01822522|447595586|FG003|Overall Study|Adverse Event|0|||
124445811|NCT01822522|447595587|FG004|Overall Study|Adverse Event|0|||
124899190|NCT03721016|449255989|FG001|Overall Study|Withdrawal by Subject|16|||
124899191|NCT03721016|449255990|FG002|Overall Study|Withdrawal by Subject|13|||
124445812|NCT01822522|447595588|FG005|Overall Study|Adverse Event|1|||
124445813|NCT01822522|447595583|FG000|Overall Study|Death|3|||
124445814|NCT01822522|447595584|FG001|Overall Study|Death|0|||
124445815|NCT01822522|447595585|FG002|Overall Study|Death|2|||
124445816|NCT01822522|447595586|FG003|Overall Study|Death|0|||
124445817|NCT01822522|447595587|FG004|Overall Study|Death|0|||
124445818|NCT01822522|447595588|FG005|Overall Study|Death|0|||
124445819|NCT01822522|447595583|FG000|Overall Study|Lost to Follow-up|0|||
124899192|NCT03721016|449255988|FG000|Overall Study|Lost to Follow-up|4|||
124899193|NCT03721016|449255989|FG001|Overall Study|Lost to Follow-up|6|||
124899194|NCT03721016|449255990|FG002|Overall Study|Lost to Follow-up|5|||
124445820|NCT01822522|447595584|FG001|Overall Study|Lost to Follow-up|0|||
124445821|NCT01822522|447595585|FG002|Overall Study|Lost to Follow-up|1|||
124445822|NCT01822522|447595586|FG003|Overall Study|Lost to Follow-up|1|||
124445823|NCT01822522|447595587|FG004|Overall Study|Lost to Follow-up|0|||
124445824|NCT01822522|447595588|FG005|Overall Study|Lost to Follow-up|1|||
124445825|NCT01822522|447595583|FG000|Overall Study|Withdrawal by Subject|0|||
124445826|NCT01822522|447595584|FG001|Overall Study|Withdrawal by Subject|0|||
124899195|NCT03721016|449255988|FG000|Overall Study|Physician Decision|0|||
124899196|NCT03721016|449255989|FG001|Overall Study|Physician Decision|1|||
124899197|NCT03721016|449255990|FG002|Overall Study|Physician Decision|2|||
124899198|NCT03721016|449255988|FG000|Overall Study|Protocol Violation|0|||
124899199|NCT03721016|449255989|FG001|Overall Study|Protocol Violation|1|||
124899200|NCT03721016|449255990|FG002|Overall Study|Protocol Violation|0|||
124899201|NCT03721016|449255988|FG000|Overall Study|Site terminated by sponsor|3|||
124899202|NCT03721016|449255989|FG001|Overall Study|Site terminated by sponsor|7|||
124899203|NCT03721016|449255990|FG002|Overall Study|Site terminated by sponsor|6|||
124899204|NCT03721016|449255988|FG000|Overall Study|Subject exited early due to COVID-19|1|||
124899205|NCT03721016|449255989|FG001|Overall Study|Subject exited early due to COVID-19|0|||
124899206|NCT03721016|449255990|FG002|Overall Study|Subject exited early due to COVID-19|0|||
124899207|NCT02232178|449255991|FG000|Overall Study|Lost to Follow-up|0|||
124899208|NCT02232178|449255992|FG001|Overall Study|Lost to Follow-up|1|||
124899209|NCT02232178|449255993|FG002|Overall Study|Lost to Follow-up|0|||
124899210|NCT02232178|449255991|FG000|Overall Study|ineligibility|0|||
124445827|NCT01822522|447595585|FG002|Overall Study|Withdrawal by Subject|0|||
124445828|NCT01822522|447595586|FG003|Overall Study|Withdrawal by Subject|1|||
124445829|NCT01822522|447595587|FG004|Overall Study|Withdrawal by Subject|0|||
124445830|NCT01822522|447595588|FG005|Overall Study|Withdrawal by Subject|0|||
124445831|NCT01822522|447595583|FG000|Overall Study|Lack of Efficacy|0|||
124445832|NCT01822522|447595584|FG001|Overall Study|Lack of Efficacy|0|||
124445833|NCT01822522|447595585|FG002|Overall Study|Lack of Efficacy|0|||
124445834|NCT01822522|447595586|FG003|Overall Study|Lack of Efficacy|0|||
124445835|NCT01822522|447595587|FG004|Overall Study|Lack of Efficacy|0|||
124445836|NCT01822522|447595588|FG005|Overall Study|Lack of Efficacy|2|||
124445837|NCT00890929|447595589|FG000|Overall Study|Death before treatment|2|||
124445838|NCT00890929|447595589|FG000|Overall Study|Withdrawal by Subject|3|||
124445839|NCT00890929|447595589|FG000|Overall Study|Physician Decision|1|||
124445840|NCT01006265|447595592|FG000|Overall Study|Lost to Follow-up|1|||
124445841|NCT01006265|447595593|FG001|Overall Study|Lost to Follow-up|0|||
124445842|NCT01006265|447595594|FG002|Overall Study|Lost to Follow-up|1|||
124445843|NCT01006265|447595595|FG003|Overall Study|Lost to Follow-up|0|||
124445844|NCT01006265|447595592|FG000|Overall Study|Withdrawal by Subject|4|||
124445845|NCT01006265|447595593|FG001|Overall Study|Withdrawal by Subject|7|||
124445846|NCT01006265|447595594|FG002|Overall Study|Withdrawal by Subject|5|||
124759497|NCT01307319|448744729|FG002|Overall Study|Withdrawal by Subject|2|||
124759498|NCT01307319|448744727|FG000|Overall Study|Other|0|||
124759499|NCT01307319|448744728|FG001|Overall Study|Other|4|||
124759500|NCT01307319|448744729|FG002|Overall Study|Other|3|||
124759501|NCT01731912|448744732|FG000|Overall Study|noncompliance|2|||
124759502|NCT02222558|448744733|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
124759503|NCT02222558|448744734|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
124445847|NCT01006265|447595595|FG003|Overall Study|Withdrawal by Subject|5|||
124445848|NCT01006265|447595592|FG000|Overall Study|Administrative reason|1|||
124445849|NCT01006265|447595593|FG001|Overall Study|Administrative reason|2|||
124445850|NCT01006265|447595594|FG002|Overall Study|Administrative reason|3|||
124445851|NCT01006265|447595595|FG003|Overall Study|Administrative reason|0|||
124445852|NCT01272947|447595596|FG000|Overall Study|Abnormal Laboratory Value|2|||
124445853|NCT01272947|447595597|FG001|Overall Study|Abnormal Laboratory Value|2|||
124445854|NCT02510560|447595600|FG000|Overall Study|Discontinued from Treatment|27|||
124445855|NCT02510560|447595601|FG001|Overall Study|Discontinued from Treatment|18|||
124445856|NCT02510560|447595602|FG002|Overall Study|Discontinued from Treatment|19|||
124445857|NCT02510560|447595600|FG000|Overall Study|Other|4|||
124445858|NCT02510560|447595601|FG001|Overall Study|Other|4|||
124445859|NCT02510560|447595602|FG002|Overall Study|Other|3|||
124445860|NCT00132496|447595603|FG000|Overall Study|Withdrawal by Subject|1|||
124445861|NCT00132496|447595604|FG001|Overall Study|Withdrawal by Subject|2|||
124445862|NCT00132496|447595603|FG000|Overall Study|Physician Decision|1|||
124445863|NCT00132496|447595604|FG001|Overall Study|Physician Decision|0|||
124445864|NCT01093625|447595609|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
124445865|NCT01093625|447595610|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
124445866|NCT01093625|447595609|FG000|2-Week Visit|Withdrawal by Subject|1|||
124445867|NCT01093625|447595610|FG001|2-Week Visit|Withdrawal by Subject|0|||
124445868|NCT01093625|447595609|FG000|1-Month Visit|Lost to Follow-up|2|||
124445869|NCT01093625|447595610|FG001|1-Month Visit|Lost to Follow-up|0|||
124445870|NCT01093625|447595609|FG000|3-Month Visit|Lost to Follow-up|2|||
124759504|NCT02222558|448744735|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
124445871|NCT01093625|447595610|FG001|3-Month Visit|Lost to Follow-up|0|||
124759505|NCT02222558|448744736|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
124445872|NCT01093625|447595609|FG000|6-Month Visit|Withdrawal by Subject|6|||
124445873|NCT01093625|447595610|FG001|6-Month Visit|Withdrawal by Subject|7|||
124445874|NCT01093625|447595609|FG000|6-Month Visit|Lost to Follow-up|2|||
124445875|NCT01093625|447595610|FG001|6-Month Visit|Lost to Follow-up|2|||
124445876|NCT01093625|447595609|FG000|1-Year Visit|Lost to Follow-up|5|||
124759506|NCT02222558|448744737|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
124899211|NCT02232178|449255992|FG001|Overall Study|ineligibility|0|||
124899212|NCT02232178|449255993|FG002|Overall Study|ineligibility|1|||
124445877|NCT01093625|447595610|FG001|1-Year Visit|Lost to Follow-up|3|||
124445878|NCT02014740|447595611|FG000|Overall Study|Lost to Follow-up|4|||
124445879|NCT02014740|447595612|FG001|Overall Study|Lost to Follow-up|4|||
124445880|NCT02014740|447595611|FG000|Overall Study|Withdrawal by Subject|2|||
124445881|NCT02014740|447595612|FG001|Overall Study|Withdrawal by Subject|1|||
124445882|NCT01431534|447595613|FG000|Treatment Phase|Adverse Event|0|||
124445883|NCT01431534|447595614|FG001|Treatment Phase|Adverse Event|0|||
124445884|NCT01431534|447595615|FG002|Treatment Phase|Adverse Event|1|||
124445885|NCT01431534|447595613|FG000|Treatment Phase|Progressive Disease|4|||
124445886|NCT01431534|447595614|FG001|Treatment Phase|Progressive Disease|3|||
124445887|NCT01431534|447595615|FG002|Treatment Phase|Progressive Disease|10|||
124445888|NCT04427501|447595618|FG000|Overall Study|Death|0|||
124445889|NCT04427501|447595619|FG001|Overall Study|Death|0|||
124445890|NCT04427501|447595620|FG002|Overall Study|Death|0|||
124445891|NCT04427501|447595621|FG003|Overall Study|Death|0|||
124445892|NCT04427501|447595622|FG004|Overall Study|Death|0|||
124445893|NCT04427501|447595623|FG005|Overall Study|Death|15|||
124445894|NCT04427501|447595624|FG006|Overall Study|Death|0|||
124445895|NCT04427501|447595625|FG007|Overall Study|Death|0|||
124445896|NCT04427501|447595626|FG008|Overall Study|Death|0|||
124445897|NCT04427501|447595627|FG009|Overall Study|Death|0|||
124445898|NCT04427501|447595628|FG010|Overall Study|Death|0|||
124445899|NCT04427501|447595629|FG011|Overall Study|Death|0|||
124445900|NCT04427501|447595618|FG000|Overall Study|Lost to Follow-up|5|||
124445901|NCT04427501|447595619|FG001|Overall Study|Lost to Follow-up|1|||
124445902|NCT04427501|447595620|FG002|Overall Study|Lost to Follow-up|2|||
124445903|NCT04427501|447595621|FG003|Overall Study|Lost to Follow-up|0|||
124445904|NCT04427501|447595622|FG004|Overall Study|Lost to Follow-up|2|||
124445905|NCT04427501|447595623|FG005|Overall Study|Lost to Follow-up|11|||
124445906|NCT04427501|447595624|FG006|Overall Study|Lost to Follow-up|10|||
124445907|NCT04427501|447595625|FG007|Overall Study|Lost to Follow-up|10|||
124445908|NCT04427501|447595626|FG008|Overall Study|Lost to Follow-up|2|||
124445909|NCT04427501|447595627|FG009|Overall Study|Lost to Follow-up|5|||
124445910|NCT04427501|447595628|FG010|Overall Study|Lost to Follow-up|2|||
124445911|NCT04427501|447595629|FG011|Overall Study|Lost to Follow-up|0|||
124445912|NCT04427501|447595618|FG000|Overall Study|Physician Decision|0|||
124445913|NCT04427501|447595619|FG001|Overall Study|Physician Decision|3|||
124445914|NCT04427501|447595620|FG002|Overall Study|Physician Decision|0|||
124445915|NCT04427501|447595621|FG003|Overall Study|Physician Decision|0|||
124445916|NCT04427501|447595622|FG004|Overall Study|Physician Decision|0|||
124445917|NCT04427501|447595623|FG005|Overall Study|Physician Decision|0|||
124445918|NCT04427501|447595624|FG006|Overall Study|Physician Decision|2|||
124445919|NCT04427501|447595625|FG007|Overall Study|Physician Decision|0|||
124445920|NCT04427501|447595626|FG008|Overall Study|Physician Decision|0|||
124445921|NCT04427501|447595627|FG009|Overall Study|Physician Decision|0|||
124445922|NCT04427501|447595628|FG010|Overall Study|Physician Decision|0|||
124445923|NCT04427501|447595629|FG011|Overall Study|Physician Decision|0|||
124759507|NCT02222558|448744738|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
124759508|NCT02222558|448744733|FG000|Period 3|Withdrawal by Subject|0|||
124759509|NCT02222558|448744734|FG001|Period 3|Withdrawal by Subject|0|||
124445924|NCT04427501|447595618|FG000|Overall Study|Withdrawal by Subject|9|||
124445925|NCT04427501|447595619|FG001|Overall Study|Withdrawal by Subject|2|||
124445926|NCT04427501|447595620|FG002|Overall Study|Withdrawal by Subject|2|||
124445927|NCT04427501|447595621|FG003|Overall Study|Withdrawal by Subject|3|||
124759510|NCT02222558|448744735|FG002|Period 3|Withdrawal by Subject|0|||
124759511|NCT02222558|448744736|FG003|Period 3|Withdrawal by Subject|0|||
124759512|NCT02222558|448744737|FG004|Period 3|Withdrawal by Subject|0|||
124759513|NCT02222558|448744738|FG005|Period 3|Withdrawal by Subject|1|||
124759514|NCT03400852|448744739|FG000|Blinded Treatment Period|Physician Decision|0|||
124759515|NCT03400852|448744740|FG001|Blinded Treatment Period|Physician Decision|1|||
124759516|NCT03400852|448744741|FG002|Blinded Treatment Period|Physician Decision|0|||
124759517|NCT03400852|448744739|FG000|Blinded Treatment Period|Adverse Event|1|||
124759518|NCT03400852|448744740|FG001|Blinded Treatment Period|Adverse Event|1|||
124445928|NCT04427501|447595622|FG004|Overall Study|Withdrawal by Subject|7|||
124445929|NCT04427501|447595623|FG005|Overall Study|Withdrawal by Subject|25|||
124445930|NCT04427501|447595624|FG006|Overall Study|Withdrawal by Subject|15|||
124445931|NCT04427501|447595625|FG007|Overall Study|Withdrawal by Subject|7|||
124445932|NCT04427501|447595626|FG008|Overall Study|Withdrawal by Subject|4|||
124445933|NCT04427501|447595627|FG009|Overall Study|Withdrawal by Subject|1|||
124445934|NCT04427501|447595628|FG010|Overall Study|Withdrawal by Subject|4|||
124445935|NCT04427501|447595629|FG011|Overall Study|Withdrawal by Subject|0|||
124445936|NCT04427501|447595618|FG000|Overall Study|Other - as reported by the investigator|1|||
124445937|NCT04427501|447595619|FG001|Overall Study|Other - as reported by the investigator|0|||
124445938|NCT04427501|447595620|FG002|Overall Study|Other - as reported by the investigator|0|||
124759519|NCT03400852|448744741|FG002|Blinded Treatment Period|Adverse Event|0|||
124759520|NCT03400852|448744739|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
124445939|NCT04427501|447595621|FG003|Overall Study|Other - as reported by the investigator|0|||
124445940|NCT04427501|447595622|FG004|Overall Study|Other - as reported by the investigator|0|||
124445941|NCT04427501|447595623|FG005|Overall Study|Other - as reported by the investigator|6|||
124445942|NCT04427501|447595624|FG006|Overall Study|Other - as reported by the investigator|6|||
124445943|NCT04427501|447595625|FG007|Overall Study|Other - as reported by the investigator|0|||
124445944|NCT04427501|447595626|FG008|Overall Study|Other - as reported by the investigator|0|||
124445945|NCT04427501|447595627|FG009|Overall Study|Other - as reported by the investigator|0|||
124445946|NCT04427501|447595628|FG010|Overall Study|Other - as reported by the investigator|0|||
124445947|NCT04427501|447595629|FG011|Overall Study|Other - as reported by the investigator|0|||
124445948|NCT04427501|447595618|FG000|Overall Study|Other|0|||
124445949|NCT04427501|447595619|FG001|Overall Study|Other|0|||
124445950|NCT04427501|447595620|FG002|Overall Study|Other|0|||
124445951|NCT04427501|447595621|FG003|Overall Study|Other|0|||
124445952|NCT04427501|447595622|FG004|Overall Study|Other|0|||
124445953|NCT04427501|447595623|FG005|Overall Study|Other|0|||
124445954|NCT04427501|447595624|FG006|Overall Study|Other|0|||
124445955|NCT04427501|447595625|FG007|Overall Study|Other|0|||
124445956|NCT04427501|447595626|FG008|Overall Study|Other|0|||
124445957|NCT04427501|447595627|FG009|Overall Study|Other|0|||
124445958|NCT04427501|447595628|FG010|Overall Study|Other|0|||
124445959|NCT04427501|447595629|FG011|Overall Study|Other|1|||
124445960|NCT00639223|447595630|FG000|Overall Study|Lost to Follow-up|0|||
124445961|NCT00639223|447595631|FG001|Overall Study|Lost to Follow-up|2|||
124445962|NCT04936841|447595632|FG000|Overall Study|Death|1|||
124445963|NCT02499770|447595640|FG000|Overall Study|Death|17|||
124445964|NCT02499770|447595641|FG001|Overall Study|Death|56|||
124445965|NCT02499770|447595640|FG000|Overall Study|Study completion|1|||
124445966|NCT02499770|447595641|FG001|Overall Study|Study completion|10|||
124445967|NCT02499770|447595640|FG000|Overall Study|Withdrawal by Subject|0|||
124445968|NCT02499770|447595641|FG001|Overall Study|Withdrawal by Subject|7|||
124445969|NCT02499770|447595640|FG000|Overall Study|Lost to Follow-up|0|||
124445970|NCT02499770|447595641|FG001|Overall Study|Lost to Follow-up|2|||
124445971|NCT02499770|447595640|FG000|Overall Study|Subject declined further treatment|1|||
124445972|NCT02499770|447595641|FG001|Overall Study|Subject declined further treatment|0|||
124445973|NCT02499770|447595640|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
124445974|NCT02499770|447595641|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
124445975|NCT02499770|447595640|FG000|Overall Study|Randomized but not enrolled|0|||
124445976|NCT02499770|447595641|FG001|Overall Study|Randomized but not enrolled|1|||
124445977|NCT01298518|447595645|FG000|Overall Study|Withdrawal by Subject|0|||
124445978|NCT01298518|447595646|FG001|Overall Study|Withdrawal by Subject|0|||
124445979|NCT01298518|447595647|FG002|Overall Study|Withdrawal by Subject|1|||
124445980|NCT01019980|447595648|FG000|Overall Study|Drug not available.|2|||
124445981|NCT01019980|447595649|FG001|Overall Study|Drug not available.|0|||
124445982|NCT02038920|447595663|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
124445983|NCT02038920|447595664|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
124445984|NCT02038920|447595665|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
124445985|NCT02038920|447595666|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
124445986|NCT02038920|447595667|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
124445987|NCT02038920|447595668|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
124445988|NCT02038920|447595663|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
124445989|NCT02038920|447595664|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
124445990|NCT02038920|447595665|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
124445991|NCT02038920|447595666|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
124445992|NCT02038920|447595667|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
124445993|NCT02038920|447595668|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
124445994|NCT02038920|447595663|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
124445995|NCT02038920|447595664|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
124445996|NCT02038920|447595665|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
124445997|NCT02038920|447595666|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
124445998|NCT02038920|447595667|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
124445999|NCT02038920|447595668|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
124446000|NCT02038920|447595663|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
124446001|NCT02038920|447595664|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
124446002|NCT02038920|447595665|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
124446003|NCT02038920|447595666|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
124446004|NCT02038920|447595667|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
124446005|NCT02038920|447595668|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
124446006|NCT02038920|447595663|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
124446007|NCT02038920|447595664|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
124446008|NCT02038920|447595665|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
124759521|NCT03400852|448744740|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
124899213|NCT02232178|449255991|FG000|Overall Study|surgical complication|1|||
124899214|NCT02232178|449255992|FG001|Overall Study|surgical complication|0|||
124759522|NCT03400852|448744741|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
124759523|NCT03400852|448744739|FG000|Open Label Period|Physician Decision|0|||
124759524|NCT03400852|448744740|FG001|Open Label Period|Physician Decision|0|||
124759525|NCT03400852|448744741|FG002|Open Label Period|Physician Decision|1|||
124759526|NCT03400852|448744739|FG000|Open Label Period|Study terminated by sponsor|0|||
124759527|NCT03400852|448744740|FG001|Open Label Period|Study terminated by sponsor|0|||
124759528|NCT03400852|448744741|FG002|Open Label Period|Study terminated by sponsor|21|||
124759529|NCT00936702|448744742|FG000|Overall Study|Disease progression|34|||
124759530|NCT00936702|448744742|FG000|Overall Study|Adverse Event|8|||
124759531|NCT00936702|448744742|FG000|Overall Study|Withdrawal by Subject|2|||
124759532|NCT00936702|448744742|FG000|Overall Study|Alternative Treatment|1|||
124759533|NCT00936702|448744742|FG000|Overall Study|Other|1|||
124759534|NCT02532465|448744743|FG000|Overall Study|Protocol Violation|1|||
124759535|NCT02532465|448744744|FG001|Overall Study|Protocol Violation|0|||
124759536|NCT02532465|448744743|FG000|Overall Study|Lack of Efficacy|0|||
124759537|NCT02532465|448744744|FG001|Overall Study|Lack of Efficacy|1|||
124759538|NCT00622505|448744745|FG000|Overall Study|Adverse Event|9|||
124759539|NCT00622505|448744746|FG001|Overall Study|Adverse Event|7|||
124759540|NCT00622505|448744745|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
124759541|NCT00622505|448744746|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
124759542|NCT00622505|448744745|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
124759543|NCT00622505|448744746|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
124759544|NCT00622505|448744745|FG000|Overall Study|Withdrawal by Subject|12|||
124759545|NCT00622505|448744746|FG001|Overall Study|Withdrawal by Subject|5|||
124759546|NCT00622505|448744745|FG000|Overall Study|Administrative Problems|2|||
124759547|NCT00622505|448744746|FG001|Overall Study|Administrative Problems|4|||
124759548|NCT00622505|448744745|FG000|Overall Study|Death|2|||
124759549|NCT00622505|448744746|FG001|Overall Study|Death|2|||
124759550|NCT00965081|448744749|FG000|Overall Study|Adverse Event|14|||
124759551|NCT00965081|448744750|FG001|Overall Study|Adverse Event|9|||
124759552|NCT00965081|448744749|FG000|Overall Study|Lack of Efficacy|2|||
124759553|NCT00965081|448744750|FG001|Overall Study|Lack of Efficacy|5|||
124759554|NCT00965081|448744749|FG000|Overall Study|Lost to Follow-up|4|||
124759555|NCT00965081|448744750|FG001|Overall Study|Lost to Follow-up|5|||
124446009|NCT02038920|447595666|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
124759556|NCT00965081|448744749|FG000|Overall Study|Physician Decision|2|||
124759557|NCT00965081|448744750|FG001|Overall Study|Physician Decision|0|||
124759558|NCT00965081|448744749|FG000|Overall Study|Protocol Violation|2|||
124759559|NCT00965081|448744750|FG001|Overall Study|Protocol Violation|5|||
124759560|NCT00965081|448744749|FG000|Overall Study|Sponsor Decision|1|||
124759561|NCT00965081|448744750|FG001|Overall Study|Sponsor Decision|0|||
124759562|NCT00965081|448744749|FG000|Overall Study|Withdrawal by Subject|4|||
124446010|NCT02038920|447595667|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
124446011|NCT02038920|447595668|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
124446012|NCT02038920|447595663|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
124446013|NCT02038920|447595664|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
124446014|NCT02038920|447595665|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
124446015|NCT02038920|447595666|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
124446016|NCT02038920|447595667|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
124446017|NCT02038920|447595668|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
124446018|NCT02038920|447595663|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
124446019|NCT02038920|447595664|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
124446020|NCT02038920|447595665|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
124446021|NCT02038920|447595666|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
124446022|NCT02038920|447595667|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
124446023|NCT02038920|447595668|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
124446024|NCT02038920|447595663|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
124446025|NCT02038920|447595664|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
124446026|NCT02038920|447595665|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
124446027|NCT02038920|447595666|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
124446028|NCT02038920|447595667|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
124446029|NCT02038920|447595668|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
124446030|NCT02038920|447595663|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
124446031|NCT02038920|447595664|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
124446032|NCT02038920|447595665|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
124446033|NCT02038920|447595666|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
124446034|NCT02038920|447595667|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
124446035|NCT02038920|447595668|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
124446036|NCT02038920|447595663|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
124446037|NCT02038920|447595664|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
124446038|NCT02038920|447595665|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
124446039|NCT02038920|447595666|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
124446040|NCT02038920|447595667|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
124446041|NCT02038920|447595668|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
124446042|NCT02038920|447595663|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
124446043|NCT02038920|447595664|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
124446044|NCT02038920|447595665|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
124446045|NCT02038920|447595666|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
124446046|NCT02038920|447595667|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
124446047|NCT02038920|447595668|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
124446048|NCT02038920|447595663|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
124446049|NCT02038920|447595664|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
124446050|NCT02038920|447595665|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
124446051|NCT02038920|447595666|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
124446052|NCT02038920|447595667|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
124446053|NCT02038920|447595668|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
124446054|NCT00047320|447595670|FG000|Overall Study|Lack of Efficacy|8|||
124446055|NCT00047320|447595670|FG000|Overall Study|Lost to Follow-up|1|||
124446056|NCT00047320|447595670|FG000|Overall Study|Physician Decision|8|||
124446057|NCT00047320|447595670|FG000|Overall Study|Withdrawal by Subject|9|||
124446058|NCT00047320|447595670|FG000|Overall Study|Ineligible|2|||
124446059|NCT02383589|447595671|FG000|Treatment Period|Adverse Event|1|||
124446060|NCT02383589|447595672|FG001|Treatment Period|Adverse Event|3|||
124446061|NCT02383589|447595671|FG000|Treatment Period|Lost to Follow-up|0|||
124446062|NCT02383589|447595672|FG001|Treatment Period|Lost to Follow-up|1|||
124446063|NCT02383589|447595671|FG000|Treatment Period|Withdrawal by Subject|0|||
124446064|NCT02383589|447595672|FG001|Treatment Period|Withdrawal by Subject|5|||
124446065|NCT02383589|447595671|FG000|Treatment Period|Non-compliance with study drug|0|||
124446066|NCT02383589|447595672|FG001|Treatment Period|Non-compliance with study drug|1|||
124446067|NCT02383589|447595671|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
124446068|NCT02383589|447595672|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
124446069|NCT02383589|447595671|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
124446070|NCT02383589|447595672|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
124446071|NCT02383589|447595671|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
124446072|NCT02383589|447595672|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
124446073|NCT00866697|447595673|FG000|Overall Study|Study closed/terminated|156|||
124446074|NCT00866697|447595674|FG001|Overall Study|Study closed/terminated|138|||
124446075|NCT00866697|447595673|FG000|Overall Study|Lost to Follow-up|22|||
124446076|NCT00866697|447595674|FG001|Overall Study|Lost to Follow-up|28|||
124446077|NCT00866697|447595673|FG000|Overall Study|Physician Decision|3|||
124446078|NCT00866697|447595674|FG001|Overall Study|Physician Decision|5|||
124446079|NCT00866697|447595673|FG000|Overall Study|Withdrawal by Subject|33|||
124446080|NCT00866697|447595674|FG001|Overall Study|Withdrawal by Subject|57|||
124446081|NCT04376060|447595675|FG000|Overall Study|Physician Decision|1|||
124446082|NCT04275297|447595676|FG000|Overall Study|Lost to Follow-up|1|||
124446083|NCT04275297|447595677|FG001|Overall Study|Lost to Follow-up|1|||
124446084|NCT02818920|447595678|FG000|Overall Study|Unresectable|4|||
124446085|NCT02818920|447595678|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
124446086|NCT02818920|447595678|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
124446087|NCT02818920|447595678|FG000|Overall Study|Adverse Event|3|||
124446088|NCT02818920|447595678|FG000|Overall Study|Developed Other Disease|1|||
124446089|NCT02818920|447595678|FG000|Overall Study|Refused Further Treatment|1|||
124446090|NCT05460273|447595679|FG000|Overall Study|Death|43|||
124446091|NCT05460273|447595680|FG001|Overall Study|Death|9|||
124446092|NCT05460273|447595679|FG000|Overall Study|Lost to Follow-up|7|||
124446093|NCT05460273|447595680|FG001|Overall Study|Lost to Follow-up|0|||
124446094|NCT05460273|447595679|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
124446095|NCT05460273|447595680|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
124446096|NCT04890054|447597605|FG000|Overall Study|Lost to Follow-up|202|||
124446097|NCT04890054|447597606|FG001|Overall Study|Lost to Follow-up|219|||
124446098|NCT02748018|447597609|FG000|Study Period|Adverse Event|1|||
124688863|NCT00081458|448479898|FG002|Overall Study|Withdrawal by Subject|1|||
124688864|NCT00081458|448479896|FG000|Overall Study|Randomized but not dosed|0|||
124688865|NCT00081458|448479897|FG001|Overall Study|Randomized but not dosed|0|||
124688866|NCT00081458|448479898|FG002|Overall Study|Randomized but not dosed|1|||
124688867|NCT02541903|448479899|FG000|Overall Study|Death|1|||
124688868|NCT03384966|448479900|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
124688869|NCT03384966|448479901|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
124688870|NCT03384966|448479902|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
124688871|NCT03384966|448479900|FG000|Follow-up Period|Adverse Event|1|||
124688872|NCT03384966|448479901|FG001|Follow-up Period|Adverse Event|0|||
124688873|NCT03384966|448479902|FG002|Follow-up Period|Adverse Event|0|||
124688874|NCT02202616|448479903|FG000|Overall Study|Screen failed|24|||
124688875|NCT02202616|448479903|FG000|Overall Study|Adverse Event|32|||
124688876|NCT02202616|448479903|FG000|Overall Study|Protocol deviation|18|||
124688877|NCT02202616|448479903|FG000|Overall Study|Patient withdrew consent|12|||
124688878|NCT02202616|448479903|FG000|Overall Study|Lost to Follow-up|6|||
124688879|NCT02202616|448479903|FG000|Overall Study|Administrative problems|6|||
124688880|NCT02202616|448479903|FG000|Overall Study|Abnormal test procedure result|1|||
124688881|NCT02202616|448479903|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124688882|NCT01334515|448479904|FG000|Overall Study|Adverse Event|1|||
124688883|NCT01334515|448479905|FG001|Overall Study|Adverse Event|6|||
124688884|NCT01334515|448479904|FG000|Overall Study|Death|1|||
124688885|NCT01334515|448479905|FG001|Overall Study|Death|0|||
124688886|NCT01334515|448479904|FG000|Overall Study|Lack of Efficacy|8|||
124688887|NCT01334515|448479905|FG001|Overall Study|Lack of Efficacy|21|||
124688888|NCT01334515|448479904|FG000|Overall Study|Physician Decision|1|||
124688889|NCT01334515|448479905|FG001|Overall Study|Physician Decision|1|||
124688890|NCT01334515|448479904|FG000|Overall Study|Withdrawal by Subject|1|||
124688891|NCT01334515|448479905|FG001|Overall Study|Withdrawal by Subject|1|||
124688892|NCT02836769|448479909|FG000|Overall Study|Lost to Follow-up|10|||
124688893|NCT02836769|448479909|FG000|Overall Study|Medical withdrawal|2|||
124688894|NCT02836769|448479909|FG000|Overall Study|Withdrawal by Subject|3|||
124688895|NCT01786109|448479920|FG000|Overall Study|fail manometry barostat tube placement|1|||
124688896|NCT01786109|448479921|FG001|Overall Study|fail manometry barostat tube placement|0|||
124688897|NCT01786109|448479922|FG002|Overall Study|fail manometry barostat tube placement|0|||
124688898|NCT01786109|448479920|FG000|Overall Study|unrelated illness|0|||
124688899|NCT01786109|448479921|FG001|Overall Study|unrelated illness|0|||
124688900|NCT01786109|448479922|FG002|Overall Study|unrelated illness|1|||
124688901|NCT01786109|448479920|FG000|Overall Study|adverse effects colon preparation|0|||
124688902|NCT01786109|448479921|FG001|Overall Study|adverse effects colon preparation|0|||
124688903|NCT01786109|448479922|FG002|Overall Study|adverse effects colon preparation|1|||
124688904|NCT02949934|448479928|FG000|Natural Drinking Period|Adverse Event|1|||
124688905|NCT02949934|448479929|FG001|Natural Drinking Period|Adverse Event|0|||
124688906|NCT02949934|448479930|FG002|Natural Drinking Period|Adverse Event|0|||
124688907|NCT02949934|448479931|FG003|Natural Drinking Period|Adverse Event|1|||
124688908|NCT02949934|448479932|FG004|Natural Drinking Period|Adverse Event|0|||
124688909|NCT02949934|448479933|FG005|Natural Drinking Period|Adverse Event|0|||
124688910|NCT02949934|448479928|FG000|Natural Drinking Period|Lost to Follow-up|0|||
124688911|NCT02949934|448479929|FG001|Natural Drinking Period|Lost to Follow-up|0|||
124688912|NCT02949934|448479930|FG002|Natural Drinking Period|Lost to Follow-up|0|||
124688913|NCT02949934|448479931|FG003|Natural Drinking Period|Lost to Follow-up|0|||
124688914|NCT02949934|448479932|FG004|Natural Drinking Period|Lost to Follow-up|1|||
124688915|NCT02949934|448479933|FG005|Natural Drinking Period|Lost to Follow-up|0|||
124446099|NCT02748018|447597610|FG001|Study Period|Adverse Event|3|||
124446100|NCT02748018|447597611|FG002|Study Period|Adverse Event|4|||
124446101|NCT02748018|447597612|FG003|Study Period|Adverse Event|0|||
124446102|NCT02748018|447597613|FG004|Study Period|Adverse Event|3|||
124446103|NCT02748018|447597614|FG005|Study Period|Adverse Event|3|||
124446104|NCT02748018|447597609|FG000|Study Period|Withdrawal by Subject|7|||
124446105|NCT02748018|447597610|FG001|Study Period|Withdrawal by Subject|4|||
124446106|NCT02748018|447597611|FG002|Study Period|Withdrawal by Subject|4|||
124446107|NCT02748018|447597612|FG003|Study Period|Withdrawal by Subject|11|||
124446108|NCT02748018|447597613|FG004|Study Period|Withdrawal by Subject|12|||
124446109|NCT02748018|447597614|FG005|Study Period|Withdrawal by Subject|10|||
124446110|NCT02748018|447597609|FG000|Study Period|Pregnancy|0|||
124446111|NCT02748018|447597610|FG001|Study Period|Pregnancy|1|||
124446112|NCT02748018|447597611|FG002|Study Period|Pregnancy|0|||
124446113|NCT02748018|447597612|FG003|Study Period|Pregnancy|0|||
124446114|NCT02748018|447597613|FG004|Study Period|Pregnancy|1|||
124446115|NCT02748018|447597614|FG005|Study Period|Pregnancy|0|||
124446116|NCT02748018|447597609|FG000|Study Period|Physician Decision|2|||
124446117|NCT02748018|447597610|FG001|Study Period|Physician Decision|2|||
124446118|NCT02748018|447597611|FG002|Study Period|Physician Decision|1|||
124446119|NCT02748018|447597612|FG003|Study Period|Physician Decision|0|||
124446120|NCT02748018|447597613|FG004|Study Period|Physician Decision|2|||
124446121|NCT02748018|447597614|FG005|Study Period|Physician Decision|0|||
124446122|NCT02748018|447597609|FG000|Study Period|Lost to Follow-up|0|||
124446123|NCT02748018|447597610|FG001|Study Period|Lost to Follow-up|0|||
124446124|NCT02748018|447597611|FG002|Study Period|Lost to Follow-up|0|||
124446125|NCT02748018|447597612|FG003|Study Period|Lost to Follow-up|2|||
124446126|NCT02748018|447597613|FG004|Study Period|Lost to Follow-up|0|||
124446127|NCT02748018|447597614|FG005|Study Period|Lost to Follow-up|1|||
124446128|NCT02748018|447597609|FG000|Continuation Period|Adverse Event|2|||
124446129|NCT02748018|447597610|FG001|Continuation Period|Adverse Event|0|||
124446130|NCT02748018|447597611|FG002|Continuation Period|Adverse Event|1|||
124446131|NCT02748018|447597612|FG003|Continuation Period|Adverse Event|1|||
124446132|NCT02748018|447597613|FG004|Continuation Period|Adverse Event|1|||
124446133|NCT02748018|447597614|FG005|Continuation Period|Adverse Event|4|||
124446134|NCT02748018|447597609|FG000|Continuation Period|Withdrawal by Subject|3|||
124446135|NCT02748018|447597610|FG001|Continuation Period|Withdrawal by Subject|5|||
124446136|NCT02748018|447597611|FG002|Continuation Period|Withdrawal by Subject|3|||
124446137|NCT02748018|447597612|FG003|Continuation Period|Withdrawal by Subject|9|||
124446138|NCT02748018|447597613|FG004|Continuation Period|Withdrawal by Subject|11|||
124446139|NCT02748018|447597614|FG005|Continuation Period|Withdrawal by Subject|1|||
124446140|NCT02748018|447597609|FG000|Continuation Period|Lost to Follow-up|0|||
124446141|NCT02748018|447597610|FG001|Continuation Period|Lost to Follow-up|2|||
124688916|NCT02949934|448479928|FG000|Neuroimaging|Protocol Violation|2|||
124688917|NCT02949934|448479929|FG001|Neuroimaging|Protocol Violation|0|||
124688918|NCT02949934|448479930|FG002|Neuroimaging|Protocol Violation|0|||
124688919|NCT02949934|448479931|FG003|Neuroimaging|Protocol Violation|0|||
124688920|NCT02949934|448479932|FG004|Neuroimaging|Protocol Violation|1|||
124446142|NCT02748018|447597611|FG002|Continuation Period|Lost to Follow-up|1|||
124446143|NCT02748018|447597612|FG003|Continuation Period|Lost to Follow-up|0|||
124446144|NCT02748018|447597613|FG004|Continuation Period|Lost to Follow-up|1|||
124446145|NCT02748018|447597614|FG005|Continuation Period|Lost to Follow-up|0|||
124446146|NCT02748018|447597609|FG000|Continuation Period|Pregnancy|1|||
124446147|NCT02748018|447597610|FG001|Continuation Period|Pregnancy|2|||
124446148|NCT02748018|447597611|FG002|Continuation Period|Pregnancy|0|||
124446149|NCT02748018|447597612|FG003|Continuation Period|Pregnancy|0|||
124446150|NCT02748018|447597613|FG004|Continuation Period|Pregnancy|0|||
124446151|NCT02748018|447597614|FG005|Continuation Period|Pregnancy|0|||
124446152|NCT02748018|447597609|FG000|Continuation Period|Physician Decision|0|||
124446153|NCT02748018|447597610|FG001|Continuation Period|Physician Decision|1|||
124446154|NCT02748018|447597611|FG002|Continuation Period|Physician Decision|2|||
124446155|NCT02748018|447597612|FG003|Continuation Period|Physician Decision|0|||
124446156|NCT02748018|447597613|FG004|Continuation Period|Physician Decision|2|||
124446157|NCT02748018|447597614|FG005|Continuation Period|Physician Decision|1|||
124446158|NCT02748018|447597609|FG000|Continuation Period|Protocol Violation|0|||
124446159|NCT02748018|447597610|FG001|Continuation Period|Protocol Violation|1|||
124446160|NCT02748018|447597611|FG002|Continuation Period|Protocol Violation|0|||
124446161|NCT02748018|447597612|FG003|Continuation Period|Protocol Violation|0|||
124688921|NCT02949934|448479933|FG005|Neuroimaging|Protocol Violation|0|||
124688922|NCT02949934|448479928|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
124446162|NCT02748018|447597613|FG004|Continuation Period|Protocol Violation|0|||
124446163|NCT02748018|447597614|FG005|Continuation Period|Protocol Violation|0|||
124446164|NCT02315898|447597617|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
124446165|NCT02315898|447597618|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
124446166|NCT02315898|447597619|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
124446167|NCT02315898|447597620|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
124688923|NCT02949934|448479929|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
124446168|NCT05352048|447597621|FG000|Overall Study|Lost to Follow-up|1|||
124446169|NCT05352048|447597621|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
124446170|NCT01214187|447597622|FG000|Overall Study|Adverse Event|6|||
124446171|NCT01214187|447597623|FG001|Overall Study|Adverse Event|2|||
124446172|NCT01214187|447597622|FG000|Overall Study|Death|1|||
124446173|NCT01214187|447597623|FG001|Overall Study|Death|1|||
124446174|NCT01214187|447597622|FG000|Overall Study|Withdrawal by Subject|0|||
124446175|NCT01214187|447597623|FG001|Overall Study|Withdrawal by Subject|3|||
124446176|NCT01233869|447597625|FG000|Initial Treatment Period (24 Months)|Death|1|||
124446177|NCT01233869|447597626|FG001|Initial Treatment Period (24 Months)|Death|0|||
124446178|NCT01233869|447597627|FG002|Initial Treatment Period (24 Months)|Death|0|||
124446179|NCT01233869|447597628|FG003|Initial Treatment Period (24 Months)|Death|0|||
124446180|NCT01233869|447597625|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
124446181|NCT01233869|447597626|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
124446182|NCT01233869|447597627|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
124446183|NCT01233869|447597628|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
124446184|NCT01233869|447597625|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
124446185|NCT01233869|447597626|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
124446186|NCT01233869|447597627|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
124446187|NCT01233869|447597628|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
124446188|NCT01233869|447597625|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
124446189|NCT01233869|447597626|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
124446190|NCT01233869|447597627|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
124446191|NCT01233869|447597628|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
124446192|NCT01233869|447597625|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
124446193|NCT01233869|447597626|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
124446194|NCT01233869|447597627|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
124446195|NCT01233869|447597628|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
124446196|NCT01233869|447597625|FG000|Extended Treatment Period (46 Months)|Other|3|||
124446197|NCT01233869|447597626|FG001|Extended Treatment Period (46 Months)|Other|0|||
124446198|NCT01233869|447597627|FG002|Extended Treatment Period (46 Months)|Other|0|||
124446199|NCT01233869|447597628|FG003|Extended Treatment Period (46 Months)|Other|3|||
124446200|NCT01233869|447597625|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
124446201|NCT01233869|447597626|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
124446202|NCT01233869|447597627|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
124446203|NCT01233869|447597628|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
124446204|NCT03678103|447597629|FG000|Overall Study|Withdrawn prior to completion|4|||
124446205|NCT01296035|447597631|FG000|Overall Study|Withdrawal by Subject|1|||
124446206|NCT05696236|447597636|FG000|Overall Study|Lost to Follow-up|1|||
124446207|NCT05696236|447597637|FG001|Overall Study|Lost to Follow-up|0|||
124446208|NCT05696236|447597636|FG000|Overall Study|Later determined to not be eligible for participation|0|||
124446209|NCT05696236|447597637|FG001|Overall Study|Later determined to not be eligible for participation|1|||
124446210|NCT05696236|447597636|FG000|Overall Study|Withdrawal by Subject|2|||
124446211|NCT05696236|447597637|FG001|Overall Study|Withdrawal by Subject|2|||
124446212|NCT01829360|447597640|FG000|Overall Study|Protocol Violation|0|||
124446213|NCT01829360|447597641|FG001|Overall Study|Protocol Violation|0|||
124446214|NCT01829360|447597642|FG002|Overall Study|Protocol Violation|1|||
124446215|NCT01829360|447597643|FG003|Overall Study|Protocol Violation|0|||
124446216|NCT01145495|447597646|FG000|Overall Study|Adverse Event|6|||
124446217|NCT01145495|447597646|FG000|Overall Study|Withdrawal by Subject|6|||
124446218|NCT01145495|447597646|FG000|Overall Study|Disease progression after respone|2|||
124446219|NCT02378220|447597647|FG000|Overall Study|Death|6|||
124446220|NCT02378220|447597648|FG001|Overall Study|Death|1|||
124446221|NCT00312221|447597649|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
124446222|NCT00312221|447597650|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
124446223|NCT00312221|447597651|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
124446224|NCT00312221|447597652|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
124446225|NCT00312221|447597649|FG000|Open-label Run-in Period|Adverse Event|74|||
124446226|NCT00312221|447597650|FG001|Open-label Run-in Period|Adverse Event|0|||
124446227|NCT00312221|447597651|FG002|Open-label Run-in Period|Adverse Event|0|||
124446228|NCT00312221|447597652|FG003|Open-label Run-in Period|Adverse Event|0|||
124446229|NCT00312221|447597649|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
124446230|NCT00312221|447597650|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
124446231|NCT00312221|447597651|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
124446232|NCT00312221|447597652|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
124446233|NCT00312221|447597649|FG000|Open-label Run-in Period|Administrative|42|||
124446234|NCT00312221|447597650|FG001|Open-label Run-in Period|Administrative|0|||
124688924|NCT02949934|448479930|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
124688925|NCT02949934|448479931|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
124688926|NCT02949934|448479932|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
124446235|NCT00312221|447597651|FG002|Open-label Run-in Period|Administrative|0|||
124446236|NCT00312221|447597652|FG003|Open-label Run-in Period|Administrative|0|||
124446237|NCT00312221|447597649|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
124446238|NCT00312221|447597650|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
124446239|NCT00312221|447597651|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
124446240|NCT00312221|447597652|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
124446241|NCT00312221|447597649|FG000|Open-label Run-in Period|Did not qualify|5|||
124446242|NCT00312221|447597650|FG001|Open-label Run-in Period|Did not qualify|0|||
124446243|NCT00312221|447597651|FG002|Open-label Run-in Period|Did not qualify|0|||
124446244|NCT00312221|447597652|FG003|Open-label Run-in Period|Did not qualify|0|||
124446245|NCT00312221|447597649|FG000|Double-blind Phase|Withdrawal by Subject|0|||
124446246|NCT00312221|447597650|FG001|Double-blind Phase|Withdrawal by Subject|6|||
124446247|NCT00312221|447597651|FG002|Double-blind Phase|Withdrawal by Subject|8|||
124446248|NCT00312221|447597652|FG003|Double-blind Phase|Withdrawal by Subject|7|||
124446249|NCT00312221|447597649|FG000|Double-blind Phase|Adverse Event|0|||
124446250|NCT00312221|447597650|FG001|Double-blind Phase|Adverse Event|10|||
124446251|NCT00312221|447597651|FG002|Double-blind Phase|Adverse Event|19|||
124446252|NCT00312221|447597652|FG003|Double-blind Phase|Adverse Event|18|||
124446253|NCT00312221|447597649|FG000|Double-blind Phase|Lost to Follow-up|0|||
124446254|NCT00312221|447597650|FG001|Double-blind Phase|Lost to Follow-up|0|||
124446255|NCT00312221|447597651|FG002|Double-blind Phase|Lost to Follow-up|2|||
124446256|NCT00312221|447597652|FG003|Double-blind Phase|Lost to Follow-up|2|||
124446257|NCT00312221|447597649|FG000|Double-blind Phase|Administrative|0|||
124446258|NCT00312221|447597650|FG001|Double-blind Phase|Administrative|26|||
124446259|NCT00312221|447597651|FG002|Double-blind Phase|Administrative|37|||
124446260|NCT00312221|447597652|FG003|Double-blind Phase|Administrative|33|||
124446261|NCT00312221|447597649|FG000|Double-blind Phase|Lack of Efficacy|0|||
124446262|NCT00312221|447597650|FG001|Double-blind Phase|Lack of Efficacy|17|||
124446263|NCT00312221|447597651|FG002|Double-blind Phase|Lack of Efficacy|6|||
124446264|NCT00312221|447597652|FG003|Double-blind Phase|Lack of Efficacy|10|||
124446265|NCT00866723|447597653|FG000|Overall Study|Withdrawal by Subject|1|||
124446266|NCT00866723|447597653|FG000|Overall Study|Disease Progression|4|||
124446267|NCT02178553|447597656|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
124446268|NCT02178553|447597657|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
124446269|NCT02178553|447597656|FG000|Overall Study|Physician Decision|0|||
124446270|NCT02178553|447597657|FG001|Overall Study|Physician Decision|4|||
124446271|NCT02178553|447597656|FG000|Overall Study|Technical problem with injection|1|||
124446272|NCT02178553|447597657|FG001|Overall Study|Technical problem with injection|3|||
124446273|NCT01975428|447597658|FG000|Overall Study|Lost to Follow-up|17|||
124446274|NCT01975428|447597659|FG001|Overall Study|Lost to Follow-up|4|||
124446275|NCT01975428|447597658|FG000|Overall Study|Withdrawal by Subject|3|||
124446276|NCT01975428|447597659|FG001|Overall Study|Withdrawal by Subject|10|||
124446277|NCT02187809|447597660|FG000|Overall Study|The study was terminated|3|||
124446278|NCT01641809|447597661|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
124446279|NCT01641809|447597662|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
124446280|NCT01641809|447597663|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
124446281|NCT01641809|447597664|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
124446282|NCT01641809|447597661|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
124446283|NCT01641809|447597662|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
124446284|NCT01641809|447597663|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
124446285|NCT01641809|447597664|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
124446286|NCT01641809|447597661|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
124446287|NCT01641809|447597662|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
124446288|NCT01641809|447597663|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
124446289|NCT01641809|447597664|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
124446290|NCT01641809|447597661|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
124446291|NCT01641809|447597662|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
124446292|NCT01641809|447597663|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
124446293|NCT01641809|447597664|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
124446294|NCT01641809|447597661|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
124446295|NCT01641809|447597662|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
124446296|NCT01641809|447597663|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
124446297|NCT01641809|447597664|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
124446298|NCT01641809|447597661|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
124446299|NCT01641809|447597662|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
124446300|NCT01641809|447597663|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
124446301|NCT01641809|447597664|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
124446302|NCT01641809|447597661|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
124446303|NCT01641809|447597662|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
124446304|NCT01641809|447597663|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
124446305|NCT01641809|447597664|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
124446306|NCT01641809|447597661|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
124446307|NCT01641809|447597662|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
124446308|NCT01641809|447597663|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
124446309|NCT01641809|447597664|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
124446310|NCT01641809|447597661|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
124446311|NCT01641809|447597662|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
124446312|NCT01641809|447597663|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
124446313|NCT01641809|447597664|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
124446314|NCT01641809|447597661|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
124446315|NCT01641809|447597662|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
124446316|NCT01641809|447597663|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
124446317|NCT01641809|447597664|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
124446318|NCT01641809|447597661|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
124446319|NCT01641809|447597662|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
124446320|NCT01641809|447597663|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
124446321|NCT01641809|447597664|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
124446322|NCT01641809|447597661|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
124446323|NCT01641809|447597662|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
124446324|NCT01641809|447597663|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
124446325|NCT01641809|447597664|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
124446326|NCT01641809|447597661|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
124446327|NCT01641809|447597662|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
124446328|NCT01641809|447597663|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
124446329|NCT01641809|447597664|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
124446330|NCT01641809|447597661|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
124446331|NCT01641809|447597662|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
124446332|NCT01641809|447597663|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
124446333|NCT01641809|447597664|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
124446334|NCT01641809|447597661|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
124446335|NCT01641809|447597662|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
124446336|NCT01641809|447597663|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
124446337|NCT01641809|447597664|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
124446338|NCT01641809|447597661|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
124446339|NCT01641809|447597662|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
124446340|NCT01641809|447597663|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
124446341|NCT01641809|447597664|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
124446342|NCT01641809|447597661|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
124446343|NCT01641809|447597662|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
124446344|NCT01641809|447597663|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
124446345|NCT01641809|447597664|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
124446346|NCT01641809|447597661|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
124446347|NCT01641809|447597662|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
124446348|NCT01641809|447597663|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
124446349|NCT01641809|447597664|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
124446350|NCT03690141|447597665|FG000|Overall Study|Adverse Event|5|||
124446351|NCT03690141|447597665|FG000|Overall Study|Withdrawal by Subject|3|||
124446352|NCT03690141|447597665|FG000|Overall Study|Physician Decision|4|||
124446353|NCT03690141|447597665|FG000|Overall Study|Disease progression|4|||
124446354|NCT00778622|447597666|FG000|Overall Study|Adverse Event|5|||
124446355|NCT00778622|447597667|FG001|Overall Study|Adverse Event|4|||
124446356|NCT00778622|447597668|FG002|Overall Study|Adverse Event|7|||
124446357|NCT00778622|447597666|FG000|Overall Study|Withdrawal by Subject|4|||
124446358|NCT00778622|447597667|FG001|Overall Study|Withdrawal by Subject|5|||
124446359|NCT00778622|447597668|FG002|Overall Study|Withdrawal by Subject|5|||
124446360|NCT00778622|447597666|FG000|Overall Study|Lost to Follow-up|3|||
124446361|NCT00778622|447597667|FG001|Overall Study|Lost to Follow-up|3|||
124446362|NCT00778622|447597668|FG002|Overall Study|Lost to Follow-up|2|||
124446363|NCT00778622|447597666|FG000|Overall Study|Protocol Violation|0|||
124446364|NCT00778622|447597667|FG001|Overall Study|Protocol Violation|3|||
124446365|NCT00778622|447597668|FG002|Overall Study|Protocol Violation|0|||
124446366|NCT00778622|447597666|FG000|Overall Study|Lack of Efficacy|2|||
124688927|NCT02949934|448479933|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
124688928|NCT02949934|448479928|FG000|Neuroimaging|Not scanned|0|||
124446367|NCT00778622|447597667|FG001|Overall Study|Lack of Efficacy|0|||
124688929|NCT02949934|448479929|FG001|Neuroimaging|Not scanned|0|||
124446368|NCT00778622|447597668|FG002|Overall Study|Lack of Efficacy|0|||
124446369|NCT00778622|447597666|FG000|Overall Study|immigration|1|||
124446370|NCT00778622|447597667|FG001|Overall Study|immigration|0|||
124688930|NCT02949934|448479930|FG002|Neuroimaging|Not scanned|1|||
124688931|NCT02949934|448479931|FG003|Neuroimaging|Not scanned|0|||
124688932|NCT02949934|448479932|FG004|Neuroimaging|Not scanned|0|||
124446371|NCT00778622|447597668|FG002|Overall Study|immigration|0|||
124688933|NCT02949934|448479933|FG005|Neuroimaging|Not scanned|2|||
124446372|NCT00778622|447597666|FG000|Overall Study|Other|1|||
124446373|NCT00778622|447597667|FG001|Overall Study|Other|0|||
124446374|NCT00778622|447597668|FG002|Overall Study|Other|1|||
124446375|NCT01505010|447597669|FG000|Overall Study|Protocol Violation|0|||
124446376|NCT01505010|447597670|FG001|Overall Study|Protocol Violation|1|||
124446377|NCT01505010|447597669|FG000|Overall Study|Lost to Follow-up|0|||
124446378|NCT01505010|447597670|FG001|Overall Study|Lost to Follow-up|1|||
124446379|NCT02558231|447597674|FG000|Overall Study|Death|4|||
124446380|NCT02558231|447597675|FG001|Overall Study|Death|12|||
124446381|NCT02558231|447597674|FG000|Overall Study|Lost to Follow-up|7|||
124446382|NCT02558231|447597675|FG001|Overall Study|Lost to Follow-up|4|||
124446383|NCT02558231|447597674|FG000|Overall Study|Withdrawal by Subject|7|||
124446384|NCT02558231|447597675|FG001|Overall Study|Withdrawal by Subject|4|||
124446385|NCT02558231|447597674|FG000|Overall Study|Physician Decision|7|||
124446386|NCT02558231|447597675|FG001|Overall Study|Physician Decision|5|||
124446387|NCT02558231|447597674|FG000|Overall Study|Sponsor Decision|0|||
124446388|NCT02558231|447597675|FG001|Overall Study|Sponsor Decision|1|||
124446389|NCT02536755|447597677|FG000|Overall Study|Adverse Event|4|||
124446390|NCT02301936|447597678|FG000|Overall Study|Lost to Follow-up|1|||
124446391|NCT02301936|447597679|FG001|Overall Study|Lost to Follow-up|0|||
124446392|NCT03065023|447597681|FG000|Overall Study|Progressive Disease|0|||
124446393|NCT03065023|447597682|FG001|Overall Study|Progressive Disease|1|||
124446394|NCT03065023|447597683|FG002|Overall Study|Progressive Disease|0|||
124446395|NCT03065023|447597684|FG003|Overall Study|Progressive Disease|0|||
124446396|NCT03065023|447597685|FG004|Overall Study|Progressive Disease|0|||
124446397|NCT03065023|447597681|FG000|Overall Study|Death|2|||
124899215|NCT02232178|449255993|FG002|Overall Study|surgical complication|0|||
124899216|NCT00817635|449255994|FG000|Overall Study|Adverse Event|1|||
124899217|NCT00817635|449255995|FG001|Overall Study|Adverse Event|0|||
124446398|NCT03065023|447597682|FG001|Overall Study|Death|0|||
124446399|NCT03065023|447597683|FG002|Overall Study|Death|1|||
124446400|NCT03065023|447597684|FG003|Overall Study|Death|1|||
124446401|NCT03065023|447597685|FG004|Overall Study|Death|0|||
124446402|NCT03065023|447597681|FG000|Overall Study|Lost to Follow-up|0|||
124446403|NCT03065023|447597682|FG001|Overall Study|Lost to Follow-up|1|||
124446404|NCT03065023|447597683|FG002|Overall Study|Lost to Follow-up|0|||
124446405|NCT03065023|447597684|FG003|Overall Study|Lost to Follow-up|0|||
124446406|NCT03065023|447597685|FG004|Overall Study|Lost to Follow-up|0|||
124446407|NCT03065023|447597681|FG000|Overall Study|Participant Decision|0|||
124446408|NCT03065023|447597682|FG001|Overall Study|Participant Decision|0|||
124446409|NCT03065023|447597683|FG002|Overall Study|Participant Decision|0|||
124446410|NCT03065023|447597684|FG003|Overall Study|Participant Decision|1|||
124446411|NCT03065023|447597685|FG004|Overall Study|Participant Decision|0|||
124446412|NCT03065023|447597681|FG000|Overall Study|Withdrawal by Subject|0|||
124446413|NCT03065023|447597682|FG001|Overall Study|Withdrawal by Subject|0|||
124446414|NCT03065023|447597683|FG002|Overall Study|Withdrawal by Subject|0|||
124446415|NCT03065023|447597684|FG003|Overall Study|Withdrawal by Subject|1|||
124446416|NCT03065023|447597685|FG004|Overall Study|Withdrawal by Subject|0|||
124446417|NCT04029961|447597686|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
124446418|NCT04029961|447597687|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
124446419|NCT04029961|447597686|FG000|Overall Study|Change in Treatment Course|0|||
124446420|NCT04029961|447597687|FG001|Overall Study|Change in Treatment Course|1|||
124446421|NCT03427125|447597688|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
124446422|NCT03427125|447597689|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
124446423|NCT03427125|447597690|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
124446424|NCT05975840|447597693|FG000|Overall Study|Other|1|||
124446425|NCT05975840|447597694|FG001|Overall Study|Other|0|||
124446426|NCT05975840|447597695|FG002|Overall Study|Other|0|||
124446427|NCT05975840|447597696|FG003|Overall Study|Other|0|||
124446428|NCT05975840|447597697|FG004|Overall Study|Other|1|||
124759563|NCT00965081|448744750|FG001|Overall Study|Withdrawal by Subject|7|||
124899218|NCT00817635|449255996|FG002|Overall Study|Adverse Event|0|||
124446429|NCT05975840|447597698|FG005|Overall Study|Other|0|||
124446430|NCT05975840|447597699|FG006|Overall Study|Other|0|||
124446431|NCT05975840|447597700|FG007|Overall Study|Other|0|||
124446432|NCT05975840|447597693|FG000|Overall Study|Lost to Follow-up|3|||
124446433|NCT05975840|447597694|FG001|Overall Study|Lost to Follow-up|6|||
124446434|NCT05975840|447597695|FG002|Overall Study|Lost to Follow-up|3|||
124446435|NCT05975840|447597696|FG003|Overall Study|Lost to Follow-up|1|||
124446436|NCT05975840|447597697|FG004|Overall Study|Lost to Follow-up|4|||
124446437|NCT05975840|447597698|FG005|Overall Study|Lost to Follow-up|1|||
124446438|NCT05975840|447597699|FG006|Overall Study|Lost to Follow-up|2|||
124446439|NCT05975840|447597700|FG007|Overall Study|Lost to Follow-up|4|||
124446440|NCT05975840|447597693|FG000|Overall Study|Migrated/moved from the study area|1|||
124446441|NCT05975840|447597694|FG001|Overall Study|Migrated/moved from the study area|0|||
124899219|NCT00817635|449255997|FG003|Overall Study|Adverse Event|1|||
124899220|NCT00817635|449255998|FG004|Overall Study|Adverse Event|1|||
124446442|NCT05975840|447597695|FG002|Overall Study|Migrated/moved from the study area|0|||
124446443|NCT05975840|447597696|FG003|Overall Study|Migrated/moved from the study area|0|||
124446444|NCT05975840|447597697|FG004|Overall Study|Migrated/moved from the study area|0|||
124446445|NCT05975840|447597698|FG005|Overall Study|Migrated/moved from the study area|0|||
124446446|NCT05975840|447597699|FG006|Overall Study|Migrated/moved from the study area|0|||
124446447|NCT05975840|447597700|FG007|Overall Study|Migrated/moved from the study area|0|||
124446448|NCT05975840|447597693|FG000|Overall Study|Withdrawal by Subject|0|||
124446449|NCT05975840|447597694|FG001|Overall Study|Withdrawal by Subject|5|||
124446450|NCT05975840|447597695|FG002|Overall Study|Withdrawal by Subject|2|||
124446451|NCT05975840|447597696|FG003|Overall Study|Withdrawal by Subject|2|||
124446452|NCT05975840|447597697|FG004|Overall Study|Withdrawal by Subject|0|||
124446453|NCT05975840|447597698|FG005|Overall Study|Withdrawal by Subject|2|||
124446454|NCT05975840|447597699|FG006|Overall Study|Withdrawal by Subject|2|||
124446455|NCT05975840|447597700|FG007|Overall Study|Withdrawal by Subject|1|||
124446456|NCT05975840|447597693|FG000|Overall Study|Protocol Violation|0|||
124446457|NCT05975840|447597694|FG001|Overall Study|Protocol Violation|1|||
124446458|NCT05975840|447597695|FG002|Overall Study|Protocol Violation|0|||
124446459|NCT05975840|447597696|FG003|Overall Study|Protocol Violation|0|||
124446460|NCT05975840|447597697|FG004|Overall Study|Protocol Violation|0|||
124446461|NCT05975840|447597698|FG005|Overall Study|Protocol Violation|0|||
124446462|NCT05975840|447597699|FG006|Overall Study|Protocol Violation|0|||
124446463|NCT05975840|447597700|FG007|Overall Study|Protocol Violation|0|||
124446464|NCT05975840|447597693|FG000|Overall Study|Adverse Event|0|||
124446465|NCT05975840|447597694|FG001|Overall Study|Adverse Event|0|||
124446466|NCT05975840|447597695|FG002|Overall Study|Adverse Event|0|||
124446467|NCT05975840|447597696|FG003|Overall Study|Adverse Event|1|||
124688934|NCT02949934|448479928|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
124688935|NCT02949934|448479929|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
124688936|NCT02949934|448479930|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
124688937|NCT02949934|448479931|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
124446468|NCT05975840|447597697|FG004|Overall Study|Adverse Event|0|||
124446469|NCT05975840|447597698|FG005|Overall Study|Adverse Event|0|||
124446470|NCT05975840|447597699|FG006|Overall Study|Adverse Event|0|||
124446471|NCT05975840|447597700|FG007|Overall Study|Adverse Event|0|||
124446472|NCT05975840|447597693|FG000|Overall Study|Death|0|||
124446473|NCT05975840|447597694|FG001|Overall Study|Death|1|||
124446474|NCT05975840|447597695|FG002|Overall Study|Death|0|||
124446475|NCT05975840|447597696|FG003|Overall Study|Death|0|||
124446476|NCT05975840|447597697|FG004|Overall Study|Death|0|||
124446477|NCT05975840|447597698|FG005|Overall Study|Death|0|||
124446478|NCT05975840|447597699|FG006|Overall Study|Death|0|||
124446479|NCT05975840|447597700|FG007|Overall Study|Death|1|||
124446480|NCT04014361|447597703|FG000|Period 2|Physician Decision|0|||
124446481|NCT04014361|447597704|FG001|Period 2|Physician Decision|0|||
124446482|NCT04014361|447597705|FG002|Period 2|Physician Decision|0|||
124446483|NCT04014361|447597706|FG003|Period 2|Physician Decision|1|||
124446484|NCT04014361|447597707|FG004|Period 2|Physician Decision|0|||
124446485|NCT04014361|447597708|FG005|Period 2|Physician Decision|0|||
124446486|NCT04014361|447597709|FG006|Period 2|Physician Decision|0|||
124446487|NCT04014361|447597710|FG007|Period 2|Physician Decision|0|||
124446488|NCT01130051|447597712|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
124446489|NCT01130051|447597713|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
124446490|NCT01130051|447597712|FG000|Washout Period of 14 Days|Protocol Violation|1|||
124446491|NCT01130051|447597713|FG001|Washout Period of 14 Days|Protocol Violation|1|||
124446492|NCT04252287|447597716|FG000|Overall Study|Death|5|||
124446493|NCT04252287|447597717|FG001|Overall Study|Death|3|||
124446494|NCT04252287|447597716|FG000|Overall Study|Lost to Follow-up|4|||
124446495|NCT04252287|447597717|FG001|Overall Study|Lost to Follow-up|6|||
124446496|NCT04252287|447597716|FG000|Overall Study|Withdrawal by Subject|19|||
124446497|NCT04252287|447597717|FG001|Overall Study|Withdrawal by Subject|16|||
124446498|NCT04252287|447597716|FG000|Overall Study|Protocol Violation|3|||
124446499|NCT04252287|447597717|FG001|Overall Study|Protocol Violation|4|||
124446500|NCT02273726|447597720|FG000|Overall Study|Death|70|||
124446501|NCT02273726|447597721|FG001|Overall Study|Death|62|||
124446502|NCT02273726|447597720|FG000|Overall Study|Withdrawal by Subject|41|||
124446503|NCT02273726|447597721|FG001|Overall Study|Withdrawal by Subject|29|||
124446504|NCT02273726|447597720|FG000|Overall Study|Kidney transplant|31|||
124446505|NCT02273726|447597721|FG001|Overall Study|Kidney transplant|39|||
124446506|NCT02273726|447597720|FG000|Overall Study|Physician Decision|30|||
124446507|NCT02273726|447597721|FG001|Overall Study|Physician Decision|15|||
124446508|NCT02273726|447597720|FG000|Overall Study|Adverse Event|27|||
124446509|NCT02273726|447597721|FG001|Overall Study|Adverse Event|9|||
124446510|NCT02273726|447597720|FG000|Overall Study|Lost to Follow-up|6|||
124446511|NCT02273726|447597721|FG001|Overall Study|Lost to Follow-up|3|||
124446512|NCT02273726|447597720|FG000|Overall Study|Lack of Efficacy|6|||
124446513|NCT02273726|447597721|FG001|Overall Study|Lack of Efficacy|1|||
124446514|NCT02273726|447597720|FG000|Overall Study|Protocol Violation|4|||
124446515|NCT02273726|447597721|FG001|Overall Study|Protocol Violation|0|||
124446516|NCT02273726|447597720|FG000|Overall Study|Other than specified|28|||
124446517|NCT02273726|447597721|FG001|Overall Study|Other than specified|30|||
124446518|NCT03610165|447597722|FG000|Overall Study|Device didn't work|0|||
124688938|NCT02949934|448479932|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
124446519|NCT03610165|447597723|FG001|Overall Study|Device didn't work|1|||
124446520|NCT02129205|447597724|FG000|Overall Study|Withdrawal by Subject|0|||
124446521|NCT02129205|447597725|FG001|Overall Study|Withdrawal by Subject|0|||
124688939|NCT02949934|448479933|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
124688940|NCT02949934|448479928|FG000|Bar Laboratory|Adverse Event|1|||
124688941|NCT02949934|448479929|FG001|Bar Laboratory|Adverse Event|0|||
124446522|NCT02129205|447597726|FG002|Overall Study|Withdrawal by Subject|0|||
124446523|NCT02129205|447597727|FG003|Overall Study|Withdrawal by Subject|0|||
124446524|NCT02129205|447597728|FG004|Overall Study|Withdrawal by Subject|1|||
124446525|NCT02129205|447597729|FG005|Overall Study|Withdrawal by Subject|1|||
124446526|NCT02129205|447597730|FG006|Overall Study|Withdrawal by Subject|1|||
124446527|NCT02129205|447597731|FG007|Overall Study|Withdrawal by Subject|0|||
124446528|NCT02129205|447597732|FG008|Overall Study|Withdrawal by Subject|1|||
124446529|NCT02129205|447597733|FG009|Overall Study|Withdrawal by Subject|0|||
124446530|NCT02129205|447597724|FG000|Overall Study|Other|1|||
124446531|NCT02129205|447597725|FG001|Overall Study|Other|0|||
124446532|NCT02129205|447597726|FG002|Overall Study|Other|0|||
124446533|NCT02129205|447597727|FG003|Overall Study|Other|0|||
124446534|NCT02129205|447597728|FG004|Overall Study|Other|2|||
124446535|NCT02129205|447597729|FG005|Overall Study|Other|3|||
124446536|NCT02129205|447597730|FG006|Overall Study|Other|3|||
124446537|NCT02129205|447597731|FG007|Overall Study|Other|2|||
124446538|NCT02129205|447597732|FG008|Overall Study|Other|1|||
124446539|NCT02129205|447597733|FG009|Overall Study|Other|0|||
124446540|NCT02877927|447597736|FG000|Overall Study|Adverse Event|1|||
124446541|NCT02877927|447597737|FG001|Overall Study|Adverse Event|0|||
124446542|NCT02877927|447597736|FG000|Overall Study|Lost to Follow-up|37|||
124446543|NCT02877927|447597737|FG001|Overall Study|Lost to Follow-up|38|||
124446544|NCT02877927|447597736|FG000|Overall Study|Withdrawal by Subject|11|||
124446545|NCT02877927|447597737|FG001|Overall Study|Withdrawal by Subject|12|||
124446546|NCT02877927|447597736|FG000|Overall Study|Physician Decision|0|||
124446547|NCT02877927|447597737|FG001|Overall Study|Physician Decision|1|||
124446548|NCT02877927|447597736|FG000|Overall Study|Missed EOT/PTE Visit|5|||
124446549|NCT02877927|447597737|FG001|Overall Study|Missed EOT/PTE Visit|6|||
124446550|NCT00708175|447597738|FG000|Overall Study|Adverse Event|4|||
124446551|NCT00708175|447597739|FG001|Overall Study|Adverse Event|5|||
124446552|NCT00708175|447597738|FG000|Overall Study|Protocol Violation|2|||
124446553|NCT00708175|447597739|FG001|Overall Study|Protocol Violation|3|||
124446554|NCT00708175|447597738|FG000|Overall Study|Lost to Follow-up|5|||
124446555|NCT00708175|447597739|FG001|Overall Study|Lost to Follow-up|3|||
124446556|NCT00708175|447597738|FG000|Overall Study|Withdrawal by Subject|5|||
124446557|NCT00708175|447597739|FG001|Overall Study|Withdrawal by Subject|7|||
124446558|NCT00708175|447597738|FG000|Overall Study|BMD loss >7%|2|||
124446559|NCT00708175|447597739|FG001|Overall Study|BMD loss >7%|3|||
124446560|NCT02906787|447597743|FG000|Overall Study|Withdrawal by Subject|12|||
124446561|NCT02906787|447597744|FG001|Overall Study|Withdrawal by Subject|10|||
124688942|NCT02949934|448479930|FG002|Bar Laboratory|Adverse Event|2|||
124446562|NCT02906787|447597743|FG000|Overall Study|Missed|24|||
124446563|NCT02906787|447597744|FG001|Overall Study|Missed|22|||
124446564|NCT04435782|447597747|FG000|Overall Study|Study terminated by sponsor|4|||
124446565|NCT03672461|447597748|FG000|Overall Study|COVID Related|4|||
124446566|NCT03672461|447597749|FG001|Overall Study|COVID Related|2|||
124446567|NCT03672461|447597748|FG000|Overall Study|Adverse Event|2|||
124446568|NCT03672461|447597749|FG001|Overall Study|Adverse Event|0|||
124446569|NCT03672461|447597748|FG000|Overall Study|Serious Adverse Event|0|||
124446570|NCT03672461|447597749|FG001|Overall Study|Serious Adverse Event|1|||
124446571|NCT03672461|447597748|FG000|Overall Study|Too Busy|3|||
124446572|NCT03672461|447597749|FG001|Overall Study|Too Busy|1|||
124446573|NCT03672461|447597748|FG000|Overall Study|Lost to Follow-up|1|||
124446574|NCT03672461|447597749|FG001|Overall Study|Lost to Follow-up|2|||
124446575|NCT03672461|447597748|FG000|Overall Study|Family|2|||
124446576|NCT03672461|447597749|FG001|Overall Study|Family|2|||
124446577|NCT03672461|447597748|FG000|Overall Study|No remote technology access|0|||
124446578|NCT03672461|447597749|FG001|Overall Study|No remote technology access|1|||
124446579|NCT03672461|447597748|FG000|Overall Study|Withdrawal by Subject|1|||
124446580|NCT03672461|447597749|FG001|Overall Study|Withdrawal by Subject|0|||
124688943|NCT02949934|448479931|FG003|Bar Laboratory|Adverse Event|0|||
124688944|NCT02949934|448479932|FG004|Bar Laboratory|Adverse Event|1|||
124688945|NCT02949934|448479933|FG005|Bar Laboratory|Adverse Event|0|||
124688946|NCT02949934|448479928|FG000|Bar Laboratory|Protocol Violation|0|||
124688947|NCT02949934|448479929|FG001|Bar Laboratory|Protocol Violation|0|||
124688948|NCT02949934|448479930|FG002|Bar Laboratory|Protocol Violation|0|||
124446581|NCT03672461|447597748|FG000|Overall Study|Cannot tolerate intervention|1|||
124446582|NCT03672461|447597749|FG001|Overall Study|Cannot tolerate intervention|0|||
124446583|NCT03672461|447597748|FG000|Overall Study|Incomplete outcome data|6|||
124446584|NCT03672461|447597749|FG001|Overall Study|Incomplete outcome data|1|||
124446585|NCT04667247|447597751|FG000|Overall Study|Withdrawal by Subject|0|||
124446586|NCT04667247|447597752|FG001|Overall Study|Withdrawal by Subject|1|||
124446587|NCT06950879|447597753|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
124688949|NCT02949934|448479931|FG003|Bar Laboratory|Protocol Violation|1|||
124688950|NCT02949934|448479932|FG004|Bar Laboratory|Protocol Violation|0|||
124446588|NCT01310803|447599351|FG000|Overall Study|Subject terminated by Sponsor|1|||
124446589|NCT01310803|447599352|FG001|Overall Study|Subject terminated by Sponsor|0|||
124446590|NCT01306890|447599353|FG000|Overall Study|Adverse Event|2|||
124446591|NCT01306890|447599353|FG000|Overall Study|Death|1223|||
124446592|NCT01306890|447599353|FG000|Overall Study|Lost to Follow-up|58|||
124446593|NCT01306890|447599353|FG000|Overall Study|Withdrawal by Subject|88|||
124446594|NCT01306890|447599353|FG000|Overall Study|Unspecified reasons|104|||
124446595|NCT01306890|447599353|FG000|Overall Study|Study Termination|3|||
124446596|NCT01306890|447599353|FG000|Overall Study|No discontinuation documentation|41|||
124688951|NCT02949934|448479933|FG005|Bar Laboratory|Protocol Violation|0|||
124688952|NCT00118287|448479937|FG000|Overall Study|Intracranial haemorrhage|1|||
124446597|NCT03739762|447599358|FG000|Overall Study|Lost to Follow-up|1|||
124446598|NCT03739762|447599359|FG001|Overall Study|Lost to Follow-up|1|||
124446599|NCT03739762|447599358|FG000|Overall Study|Withdrawal by Subject|2|||
124446600|NCT03739762|447599359|FG001|Overall Study|Withdrawal by Subject|6|||
124446601|NCT01131351|447599361|FG000|Overall Study|Adverse Event|0|||
124446602|NCT01131351|447599362|FG001|Overall Study|Adverse Event|2|||
124446603|NCT01131351|447599361|FG000|Overall Study|Protocol Deviation|0|||
124446604|NCT01131351|447599362|FG001|Overall Study|Protocol Deviation|1|||
124446605|NCT02294682|447599363|FG000|Overall Study|Could not swallow pills|1|||
124446606|NCT02294682|447599364|FG001|Overall Study|Could not swallow pills|0|||
124446607|NCT03422172|447599367|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
124446608|NCT03422172|447599367|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
124446609|NCT03422172|447599367|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
124446610|NCT00059839|447599370|FG000|Overall Study|Death|1|||
124446611|NCT00059839|447599371|FG001|Overall Study|Death|1|||
124446612|NCT00059839|447599370|FG000|Overall Study|Lack of Efficacy|6|||
124899221|NCT00817635|449255994|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
124899222|NCT00817635|449255995|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
124899223|NCT00817635|449255996|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
124899224|NCT00817635|449255997|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
124899225|NCT00817635|449255998|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
124899226|NCT00817635|449255994|FG000|Overall Study|Withdrawal by Subject|2|||
124899227|NCT00817635|449255995|FG001|Overall Study|Withdrawal by Subject|1|||
124899228|NCT00817635|449255996|FG002|Overall Study|Withdrawal by Subject|0|||
124899229|NCT00817635|449255997|FG003|Overall Study|Withdrawal by Subject|1|||
124899230|NCT00817635|449255998|FG004|Overall Study|Withdrawal by Subject|2|||
124899231|NCT00817635|449255994|FG000|Overall Study|Lost to Follow-up|0|||
124899232|NCT00817635|449255995|FG001|Overall Study|Lost to Follow-up|1|||
124899233|NCT00817635|449255996|FG002|Overall Study|Lost to Follow-up|0|||
124899234|NCT00817635|449255997|FG003|Overall Study|Lost to Follow-up|1|||
124899235|NCT00817635|449255998|FG004|Overall Study|Lost to Follow-up|0|||
124899236|NCT00817635|449255994|FG000|Overall Study|Administrative Problems|0|||
124899237|NCT00817635|449255995|FG001|Overall Study|Administrative Problems|0|||
124899238|NCT00817635|449255996|FG002|Overall Study|Administrative Problems|0|||
124899239|NCT00817635|449255997|FG003|Overall Study|Administrative Problems|0|||
124899240|NCT00817635|449255998|FG004|Overall Study|Administrative Problems|1|||
124899241|NCT00817635|449255994|FG000|Overall Study|Protocol Violation|5|||
124899242|NCT00817635|449255995|FG001|Overall Study|Protocol Violation|1|||
124899243|NCT00817635|449255996|FG002|Overall Study|Protocol Violation|3|||
124899244|NCT00817635|449255997|FG003|Overall Study|Protocol Violation|2|||
124899245|NCT00817635|449255998|FG004|Overall Study|Protocol Violation|3|||
124899246|NCT01720446|449255999|FG000|Overall Study|Lost to Follow-up|12|||
124899247|NCT01720446|449256000|FG001|Overall Study|Lost to Follow-up|6|||
124899248|NCT01720446|449256001|FG002|Overall Study|Lost to Follow-up|16|||
124899249|NCT01720446|449256002|FG003|Overall Study|Lost to Follow-up|16|||
124899250|NCT01720446|449255999|FG000|Overall Study|Withdrawal by Subject|2|||
124899251|NCT01720446|449256000|FG001|Overall Study|Withdrawal by Subject|5|||
124899252|NCT01720446|449256001|FG002|Overall Study|Withdrawal by Subject|4|||
124899253|NCT01720446|449256002|FG003|Overall Study|Withdrawal by Subject|4|||
124899254|NCT01072357|449256005|FG000|Overall Study|Lost to Follow-up|0|||
124899255|NCT01072357|449256006|FG001|Overall Study|Lost to Follow-up|1|||
124899256|NCT01876511|449256007|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
124899257|NCT01876511|449256008|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
124899258|NCT01876511|449256009|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
124899259|NCT01876511|449256007|FG000|Overall Study|Death (unrelated)|3|||
124899260|NCT01876511|449256008|FG001|Overall Study|Death (unrelated)|0|||
124899261|NCT01876511|449256009|FG002|Overall Study|Death (unrelated)|2|||
124899262|NCT01876511|449256007|FG000|Overall Study|Drug-related Toxicity|5|||
124899263|NCT01876511|449256008|FG001|Overall Study|Drug-related Toxicity|1|||
124899264|NCT01876511|449256009|FG002|Overall Study|Drug-related Toxicity|6|||
124899265|NCT01876511|449256007|FG000|Overall Study|Patient Decision|3|||
124899266|NCT01876511|449256008|FG001|Overall Study|Patient Decision|0|||
124899267|NCT01876511|449256009|FG002|Overall Study|Patient Decision|6|||
124899268|NCT01876511|449256007|FG000|Overall Study|Physician Decision|1|||
124899269|NCT01876511|449256008|FG001|Overall Study|Physician Decision|0|||
124899270|NCT01876511|449256009|FG002|Overall Study|Physician Decision|1|||
124899271|NCT00606580|449256011|FG000|Overall Study|Lost to Follow-up|1|||
124899272|NCT00606580|449256012|FG001|Overall Study|Lost to Follow-up|1|||
124899273|NCT00606580|449256013|FG002|Overall Study|Lost to Follow-up|4|||
124899274|NCT00606580|449256011|FG000|Overall Study|Clinical failures|1|||
124899275|NCT00606580|449256012|FG001|Overall Study|Clinical failures|0|||
124899276|NCT00606580|449256013|FG002|Overall Study|Clinical failures|12|||
124446613|NCT00059839|447599371|FG001|Overall Study|Lack of Efficacy|5|||
124759564|NCT00965081|448744749|FG000|Overall Study|Switched to Rescue Arm|5|||
124899277|NCT00606580|449256011|FG000|Overall Study|Withdrawal by investigator|0|||
124899278|NCT00606580|449256012|FG001|Overall Study|Withdrawal by investigator|1|||
124899279|NCT00606580|449256013|FG002|Overall Study|Withdrawal by investigator|6|||
124899280|NCT00606580|449256011|FG000|Overall Study|Withdrawal by Subject|0|||
124899281|NCT00606580|449256012|FG001|Overall Study|Withdrawal by Subject|1|||
124899282|NCT00606580|449256013|FG002|Overall Study|Withdrawal by Subject|0|||
124446614|NCT00059839|447599370|FG000|Overall Study|Lost to Follow-up|2|||
124899283|NCT01250002|449256018|FG000|Overall Study|Change to open surgical procedure|4|||
124899284|NCT01250002|449256019|FG001|Overall Study|Change to open surgical procedure|3|||
124899285|NCT03256344|449256029|FG000|Overall Study|Death|6|||
124899286|NCT03256344|449256030|FG001|Overall Study|Death|22|||
124899287|NCT03256344|449256029|FG000|Overall Study|Withdrawal by Subject|3|||
124899288|NCT03256344|449256030|FG001|Overall Study|Withdrawal by Subject|3|||
124899289|NCT03256344|449256029|FG000|Overall Study|Sponsor Decision|1|||
124899290|NCT03256344|449256030|FG001|Overall Study|Sponsor Decision|0|||
124899291|NCT00843193|449256033|FG000|Overall Study|Adverse Event|2|||
124899292|NCT00843193|449256034|FG001|Overall Study|Adverse Event|4|||
124899293|NCT00843193|449256033|FG000|Overall Study|Lack of Efficacy|1|||
124899294|NCT00843193|449256034|FG001|Overall Study|Lack of Efficacy|1|||
124899295|NCT00843193|449256033|FG000|Overall Study|Protocol Violation|1|||
124899296|NCT00843193|449256034|FG001|Overall Study|Protocol Violation|2|||
124899297|NCT00843193|449256033|FG000|Overall Study|Lost to Follow-up|1|||
124899298|NCT00843193|449256034|FG001|Overall Study|Lost to Follow-up|0|||
124899299|NCT00843193|449256033|FG000|Overall Study|Physician Decision|0|||
124899300|NCT00843193|449256034|FG001|Overall Study|Physician Decision|1|||
124899301|NCT00843193|449256033|FG000|Overall Study|Withdrawal by Subject|3|||
124899302|NCT00843193|449256034|FG001|Overall Study|Withdrawal by Subject|3|||
124899303|NCT00544440|449256035|FG000|Overall Study|Other|1|||
124899304|NCT00544440|449256035|FG000|Overall Study|Adverse Event|1|||
124899305|NCT00544440|449256035|FG000|Overall Study|Withdrawal by Subject|2|||
124899306|NCT00544440|449256035|FG000|Overall Study|Subject Non-compliance|1|||
124899307|NCT00544440|449256035|FG000|Overall Study|Progressive Disease|47|||
124899308|NCT00544440|449256035|FG000|Overall Study|Other|5|||
124899309|NCT03586167|449256036|FG000|Overall Study|Other|1|||
124899310|NCT03586167|449256037|FG001|Overall Study|Other|0|||
124899311|NCT00591838|449256038|FG000|Overall Study|Withdrawal by Subject|0|||
124899312|NCT00591838|449256039|FG001|Overall Study|Withdrawal by Subject|0|||
124899313|NCT00591838|449256040|FG002|Overall Study|Withdrawal by Subject|0|||
124899314|NCT00591838|449256041|FG003|Overall Study|Withdrawal by Subject|1|||
124899315|NCT00591838|449256042|FG004|Overall Study|Withdrawal by Subject|0|||
124899316|NCT02512042|449256043|FG000|Overall Study|Adverse Event|0|||
124899317|NCT02512042|449256044|FG001|Overall Study|Adverse Event|4|||
124899318|NCT02512042|449256043|FG000|Overall Study|Withdrawal by Subject|6|||
124899319|NCT02512042|449256044|FG001|Overall Study|Withdrawal by Subject|6|||
124899320|NCT02512042|449256043|FG000|Overall Study|Non-compliance with study drug|1|||
124759565|NCT00965081|448744750|FG001|Overall Study|Switched to Rescue Arm|12|||
124899321|NCT02512042|449256044|FG001|Overall Study|Non-compliance with study drug|2|||
124899322|NCT02512042|449256043|FG000|Overall Study|Lost to Follow-up|5|||
124899323|NCT02512042|449256044|FG001|Overall Study|Lost to Follow-up|2|||
124759566|NCT01147666|448744755|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
124899324|NCT02512042|449256043|FG000|Overall Study|Other|11|||
124899325|NCT02512042|449256044|FG001|Overall Study|Other|11|||
124899326|NCT04163458|449256045|FG000|Overall Study|Protocol Deviation|7|||
124899327|NCT04163458|449256046|FG001|Overall Study|Protocol Deviation|13|||
124899328|NCT04163458|449256045|FG000|Overall Study|Adverse Event|5|||
124899329|NCT04163458|449256046|FG001|Overall Study|Adverse Event|8|||
124899330|NCT04163458|449256045|FG000|Overall Study|Due to COVID-19 pandemic|4|||
124899331|NCT04163458|449256046|FG001|Overall Study|Due to COVID-19 pandemic|2|||
124899332|NCT04163458|449256045|FG000|Overall Study|Participant withdrew consent|2|||
124899333|NCT04163458|449256046|FG001|Overall Study|Participant withdrew consent|3|||
124899334|NCT04163458|449256045|FG000|Overall Study|Randomization failure|2|||
124899335|NCT04163458|449256046|FG001|Overall Study|Randomization failure|2|||
124899336|NCT04163458|449256045|FG000|Overall Study|Other|4|||
124899337|NCT04163458|449256046|FG001|Overall Study|Other|2|||
124899338|NCT01467700|449256050|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
124899339|NCT01467700|449256051|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
124899340|NCT01467700|449256052|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
124899341|NCT01467700|449256053|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
124899342|NCT01467700|449256050|FG000|Overall Study|Major Protocol Deviation|3|||
124899343|NCT01467700|449256051|FG001|Overall Study|Major Protocol Deviation|3|||
124899344|NCT01467700|449256052|FG002|Overall Study|Major Protocol Deviation|2|||
124899345|NCT01467700|449256053|FG003|Overall Study|Major Protocol Deviation|3|||
124899346|NCT01467700|449256050|FG000|Overall Study|Lost to Follow-up|6|||
124899347|NCT01467700|449256051|FG001|Overall Study|Lost to Follow-up|5|||
124899348|NCT01467700|449256052|FG002|Overall Study|Lost to Follow-up|2|||
124446615|NCT00059839|447599371|FG001|Overall Study|Lost to Follow-up|0|||
124446616|NCT00059839|447599370|FG000|Overall Study|Physician Decision|1|||
124446617|NCT00059839|447599371|FG001|Overall Study|Physician Decision|2|||
124446618|NCT00059839|447599370|FG000|Overall Study|Withdrawal by Subject|1|||
124446619|NCT00059839|447599371|FG001|Overall Study|Withdrawal by Subject|6|||
124446620|NCT00059839|447599370|FG000|Overall Study|Ineligible|1|||
124446621|NCT00059839|447599371|FG001|Overall Study|Ineligible|3|||
124446622|NCT00129623|447599372|FG000|Overall Study|Adverse Event|3|||
124446623|NCT00129623|447599373|FG001|Overall Study|Adverse Event|7|||
124446624|NCT00129623|447599372|FG000|Overall Study|Refused Treatment|5|||
124446625|NCT00129623|447599373|FG001|Overall Study|Refused Treatment|3|||
124446626|NCT00129623|447599372|FG000|Overall Study|Failure to Return|1|||
124446627|NCT00129623|447599373|FG001|Overall Study|Failure to Return|1|||
124446628|NCT00129623|447599372|FG000|Overall Study|Relocated job out of state|1|||
124446629|NCT00129623|447599373|FG001|Overall Study|Relocated job out of state|0|||
124446630|NCT00129623|447599372|FG000|Overall Study|Uncertainty to return|0|||
124446631|NCT00129623|447599373|FG001|Overall Study|Uncertainty to return|1|||
124446632|NCT03155373|447599374|FG000|Overall Study|No longer required surgery|1|||
124446633|NCT03155373|447599374|FG000|Overall Study|Protocol Violation|1|||
124446634|NCT03155373|447599374|FG000|Overall Study|Death|2|||
124446635|NCT03155373|447599374|FG000|Overall Study|Withdrawal by Subject|3|||
124446636|NCT00537485|447599383|FG000|Overall Study|Adverse Event|10|||
124446637|NCT00537485|447599384|FG001|Overall Study|Adverse Event|5|||
124446638|NCT00537485|447599383|FG000|Overall Study|Withdrawal by Subject|3|||
124446639|NCT00537485|447599384|FG001|Overall Study|Withdrawal by Subject|2|||
124446640|NCT00537485|447599383|FG000|Overall Study|Withdrawal by Subject|1|||
124446641|NCT00537485|447599384|FG001|Overall Study|Withdrawal by Subject|3|||
124446642|NCT00537485|447599383|FG000|Overall Study|Physician Decision|1|||
124446643|NCT00537485|447599384|FG001|Overall Study|Physician Decision|0|||
124446644|NCT01241552|447599390|FG000|Overall Study|Lack of Efficacy|1|||
124446645|NCT01241552|447599391|FG001|Overall Study|Lack of Efficacy|0|||
124446646|NCT01241552|447599392|FG002|Overall Study|Lack of Efficacy|0|||
124446647|NCT01241552|447599393|FG003|Overall Study|Lack of Efficacy|0|||
124446648|NCT01241552|447599390|FG000|Overall Study|Death|26|||
124446649|NCT01241552|447599391|FG001|Overall Study|Death|30|||
124446650|NCT01241552|447599392|FG002|Overall Study|Death|20|||
124446651|NCT01241552|447599393|FG003|Overall Study|Death|25|||
124446652|NCT01241552|447599390|FG000|Overall Study|Adverse Event|1|||
124446653|NCT01241552|447599391|FG001|Overall Study|Adverse Event|1|||
124446654|NCT01241552|447599392|FG002|Overall Study|Adverse Event|0|||
124446655|NCT01241552|447599393|FG003|Overall Study|Adverse Event|0|||
124446656|NCT01241552|447599390|FG000|Overall Study|Technical Problems|2|||
124899349|NCT01467700|449256053|FG003|Overall Study|Lost to Follow-up|3|||
124446657|NCT01241552|447599391|FG001|Overall Study|Technical Problems|0|||
124446658|NCT01241552|447599392|FG002|Overall Study|Technical Problems|2|||
124446659|NCT01241552|447599393|FG003|Overall Study|Technical Problems|2|||
124446660|NCT01241552|447599390|FG000|Overall Study|Progressive Disease|0|||
124446661|NCT01241552|447599391|FG001|Overall Study|Progressive Disease|0|||
124899350|NCT01467700|449256050|FG000|Overall Study|Voluntary Withdrawal|5|||
124899351|NCT01467700|449256051|FG001|Overall Study|Voluntary Withdrawal|7|||
124899352|NCT01467700|449256052|FG002|Overall Study|Voluntary Withdrawal|6|||
124899353|NCT01467700|449256053|FG003|Overall Study|Voluntary Withdrawal|2|||
124446662|NCT01241552|447599392|FG002|Overall Study|Progressive Disease|1|||
124446663|NCT01241552|447599393|FG003|Overall Study|Progressive Disease|2|||
124446664|NCT01241552|447599390|FG000|Overall Study|Protocol Violation|0|||
124446665|NCT01241552|447599391|FG001|Overall Study|Protocol Violation|2|||
124446666|NCT01241552|447599392|FG002|Overall Study|Protocol Violation|6|||
124446667|NCT01241552|447599393|FG003|Overall Study|Protocol Violation|1|||
124446668|NCT01241552|447599390|FG000|Overall Study|Withdrawal by Subject|7|||
124446669|NCT01241552|447599391|FG001|Overall Study|Withdrawal by Subject|15|||
124446670|NCT01241552|447599392|FG002|Overall Study|Withdrawal by Subject|14|||
124446671|NCT01241552|447599393|FG003|Overall Study|Withdrawal by Subject|15|||
124446672|NCT01241552|447599390|FG000|Overall Study|Physician Decision|2|||
124446673|NCT01241552|447599391|FG001|Overall Study|Physician Decision|4|||
124446674|NCT01241552|447599392|FG002|Overall Study|Physician Decision|2|||
124446675|NCT01241552|447599393|FG003|Overall Study|Physician Decision|3|||
124446676|NCT01241552|447599390|FG000|Overall Study|Lost to Follow-up|2|||
124446677|NCT01241552|447599391|FG001|Overall Study|Lost to Follow-up|11|||
124446678|NCT01241552|447599392|FG002|Overall Study|Lost to Follow-up|15|||
124446679|NCT01241552|447599393|FG003|Overall Study|Lost to Follow-up|16|||
124446680|NCT01886313|447599396|FG000|Overall Study|Adverse Event|1|||
124446681|NCT01886313|447599397|FG001|Overall Study|Adverse Event|1|||
124446682|NCT03838198|447599398|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
124446683|NCT03838198|447599399|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
124446684|NCT03838198|447599400|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
124446685|NCT03838198|447599401|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
124446686|NCT03838198|447599398|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
124446687|NCT03838198|447599399|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
124446688|NCT03838198|447599400|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
124446689|NCT03838198|447599401|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
124446690|NCT02060721|447599402|FG000|Overall Study|Lost to Follow-up|1|||
124446691|NCT02060721|447599402|FG000|Overall Study|Physician Decision|2|||
124446692|NCT02060721|447599402|FG000|Overall Study|Death|14|||
124446693|NCT02060721|447599402|FG000|Overall Study|Withdrawal by Subject|2|||
124446694|NCT02060721|447599402|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
124446695|NCT00117507|447599403|FG000|Overall Study|Adverse Event|4|||
124446696|NCT00117507|447599403|FG000|Overall Study|Abnormal laboratory values|3|||
124446697|NCT00117507|447599403|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124446698|NCT00117507|447599403|FG000|Overall Study|Patient withdrew consent|4|||
124446699|NCT00117507|447599403|FG000|Overall Study|Death|3|||
124446700|NCT01271803|447599404|FG000|Overall Study|Progressive disease|0|||
124446701|NCT01271803|447599405|FG001|Overall Study|Progressive disease|0|||
124446702|NCT01271803|447599406|FG002|Overall Study|Progressive disease|2|||
124446703|NCT01271803|447599404|FG000|Overall Study|Death|53|||
124446704|NCT01271803|447599405|FG001|Overall Study|Death|34|||
124446705|NCT01271803|447599406|FG002|Overall Study|Death|0|||
124446706|NCT01271803|447599404|FG000|Overall Study|Withdrawal by Subject|1|||
124446707|NCT01271803|447599405|FG001|Overall Study|Withdrawal by Subject|5|||
124446708|NCT01271803|447599406|FG002|Overall Study|Withdrawal by Subject|0|||
124446709|NCT01271803|447599404|FG000|Overall Study|Lost to Follow-up|1|||
124446710|NCT01271803|447599405|FG001|Overall Study|Lost to Follow-up|0|||
124446711|NCT01271803|447599406|FG002|Overall Study|Lost to Follow-up|0|||
124446712|NCT01862640|447599410|FG000|Overall Study|Adverse Event|4|||
124446713|NCT01862640|447599411|FG001|Overall Study|Adverse Event|10|||
124899354|NCT01467700|449256050|FG000|Overall Study|Study Termination|6|||
124899355|NCT01467700|449256051|FG001|Overall Study|Study Termination|5|||
124899356|NCT01467700|449256052|FG002|Overall Study|Study Termination|10|||
124899357|NCT01467700|449256053|FG003|Overall Study|Study Termination|7|||
124899358|NCT01467700|449256050|FG000|Overall Study|Pregnancy|0|||
124899359|NCT01467700|449256051|FG001|Overall Study|Pregnancy|1|||
124899360|NCT01467700|449256052|FG002|Overall Study|Pregnancy|1|||
124446714|NCT01862640|447599412|FG002|Overall Study|Adverse Event|6|||
124446715|NCT01862640|447599413|FG003|Overall Study|Adverse Event|8|||
124899361|NCT01467700|449256053|FG003|Overall Study|Pregnancy|0|||
124899362|NCT01467700|449256050|FG000|Overall Study|Lack of Efficacy|2|||
124899363|NCT01467700|449256051|FG001|Overall Study|Lack of Efficacy|0|||
124899364|NCT01467700|449256052|FG002|Overall Study|Lack of Efficacy|2|||
124899365|NCT01467700|449256053|FG003|Overall Study|Lack of Efficacy|1|||
124899366|NCT01467700|449256050|FG000|Overall Study|Reason not Specified|1|||
124899367|NCT01467700|449256051|FG001|Overall Study|Reason not Specified|3|||
124899368|NCT01467700|449256052|FG002|Overall Study|Reason not Specified|2|||
124899369|NCT01467700|449256053|FG003|Overall Study|Reason not Specified|8|||
124899370|NCT01253226|449256054|FG000|Overall Study|Adverse Event|0|||
124899371|NCT01253226|449256055|FG001|Overall Study|Adverse Event|0|||
124899372|NCT01253226|449256056|FG002|Overall Study|Adverse Event|1|||
124899373|NCT01253226|449256057|FG003|Overall Study|Adverse Event|0|||
124899374|NCT01253226|449256058|FG004|Overall Study|Adverse Event|0|||
124899375|NCT01253226|449256054|FG000|Overall Study|Death|0|||
124899376|NCT01253226|449256055|FG001|Overall Study|Death|1|||
124899377|NCT01253226|449256056|FG002|Overall Study|Death|0|||
124899378|NCT01253226|449256057|FG003|Overall Study|Death|0|||
124899379|NCT01253226|449256058|FG004|Overall Study|Death|0|||
124899380|NCT01253226|449256054|FG000|Overall Study|Physician Decision|0|||
124899381|NCT01253226|449256055|FG001|Overall Study|Physician Decision|0|||
124899382|NCT01253226|449256056|FG002|Overall Study|Physician Decision|0|||
124899383|NCT01253226|449256057|FG003|Overall Study|Physician Decision|0|||
124899384|NCT01253226|449256058|FG004|Overall Study|Physician Decision|2|||
124899385|NCT01253226|449256054|FG000|Overall Study|Withdrawal by Subject|0|||
124899386|NCT01253226|449256055|FG001|Overall Study|Withdrawal by Subject|0|||
124899387|NCT01253226|449256056|FG002|Overall Study|Withdrawal by Subject|0|||
124899388|NCT01253226|449256057|FG003|Overall Study|Withdrawal by Subject|1|||
124899389|NCT01253226|449256058|FG004|Overall Study|Withdrawal by Subject|0|||
124899390|NCT00988637|449256059|FG000|Overall Study|Lost to Follow-up|2|||
124899391|NCT00988637|449256060|FG001|Overall Study|Lost to Follow-up|1|||
124899392|NCT00988637|449256059|FG000|Overall Study|Withdrawal by Subject|1|||
124899393|NCT00988637|449256060|FG001|Overall Study|Withdrawal by Subject|1|||
124899394|NCT00988637|449256059|FG000|Overall Study|non-compliance with study drug|0|||
124899395|NCT00988637|449256060|FG001|Overall Study|non-compliance with study drug|1|||
124899396|NCT03593070|449256062|FG000|Overall Study|administrative withdrawal|1|||
124899397|NCT03593070|449256063|FG001|Overall Study|administrative withdrawal|1|||
124899398|NCT01582945|449256064|FG000|Overall Study|Intolerable side-effects|1|||
124899399|NCT01582945|449256064|FG000|Overall Study|Scheduling conflicts|1|||
124899400|NCT03310983|449256065|FG000|Overall Study|Lost to Follow-up|15|||
124899401|NCT03310983|449256066|FG001|Overall Study|Lost to Follow-up|17|||
124899402|NCT01656304|449256068|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
124899403|NCT00881335|449256076|FG000|Overall Study|Lost to Follow-up|3|||
124899404|NCT00881335|449256077|FG001|Overall Study|Lost to Follow-up|2|||
124899405|NCT00477412|449256078|FG000|Overall Study|Death|0|||
124899406|NCT00477412|449256079|FG001|Overall Study|Death|0|||
124899407|NCT00477412|449256080|FG002|Overall Study|Death|0|||
124899408|NCT00477412|449256081|FG003|Overall Study|Death|4|||
124899409|NCT00477412|449256078|FG000|Overall Study|Lost to Follow-up|0|||
124899410|NCT00477412|449256079|FG001|Overall Study|Lost to Follow-up|0|||
124899411|NCT00477412|449256080|FG002|Overall Study|Lost to Follow-up|0|||
124688953|NCT00118287|448479937|FG000|Overall Study|Muscle pain|1|||
124688954|NCT03442569|448479940|FG000|Overall Study|Subject was ineligible after enrollment|1|||
124688955|NCT01214720|448479943|FG000|Overall Study|Alive and still on treatment|34|||
124899412|NCT00477412|449256081|FG003|Overall Study|Lost to Follow-up|1|||
124899413|NCT00477412|449256078|FG000|Overall Study|Withdrawal by Subject|0|||
124899414|NCT00477412|449256079|FG001|Overall Study|Withdrawal by Subject|0|||
124899415|NCT00477412|449256080|FG002|Overall Study|Withdrawal by Subject|0|||
124899416|NCT00477412|449256081|FG003|Overall Study|Withdrawal by Subject|2|||
124899417|NCT00477412|449256078|FG000|Overall Study|Second Malignancy|0|||
124899418|NCT00477412|449256079|FG001|Overall Study|Second Malignancy|0|||
124899419|NCT00477412|449256080|FG002|Overall Study|Second Malignancy|0|||
124899420|NCT00477412|449256081|FG003|Overall Study|Second Malignancy|1|||
124899421|NCT00477412|449256078|FG000|Overall Study|Adverse Event|1|||
124899422|NCT00477412|449256079|FG001|Overall Study|Adverse Event|0|||
124899423|NCT00477412|449256080|FG002|Overall Study|Adverse Event|1|||
124899424|NCT00477412|449256081|FG003|Overall Study|Adverse Event|0|||
124899425|NCT01838200|449256082|FG000|Overall Study|Adverse Event|0|||
124899426|NCT01838200|449256083|FG001|Overall Study|Adverse Event|2|||
124899427|NCT01838200|449256082|FG000|Overall Study|Progressive disease|3|||
124899428|NCT01838200|449256083|FG001|Overall Study|Progressive disease|0|||
124899429|NCT00762463|449257876|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
124899430|NCT00762463|449257877|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
124899431|NCT00762463|449257878|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
124899432|NCT00762463|449257879|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
124899433|NCT00762463|449257876|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
124899434|NCT00762463|449257877|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
124899435|NCT00762463|449257878|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
124759567|NCT01147666|448744756|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
124759568|NCT01147666|448744757|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
124759569|NCT01147666|448744758|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
124899436|NCT00762463|449257879|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
124899437|NCT00762463|449257876|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
124899438|NCT00762463|449257877|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
124899439|NCT00762463|449257878|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
124899440|NCT00762463|449257879|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
124899441|NCT00762463|449257876|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
124899442|NCT00762463|449257877|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
124899443|NCT00762463|449257878|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
124899444|NCT00762463|449257879|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
124899445|NCT00762463|449257876|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
124899446|NCT00762463|449257877|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
124899447|NCT00762463|449257878|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
124899448|NCT00762463|449257879|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
124899449|NCT00762463|449257876|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
124899450|NCT00762463|449257877|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
124899451|NCT00762463|449257878|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
124899452|NCT00762463|449257879|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
124899453|NCT00762463|449257876|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
124899454|NCT00762463|449257877|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
124899455|NCT00762463|449257878|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
124899456|NCT00762463|449257879|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
124899457|NCT00762463|449257876|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
124899458|NCT00762463|449257877|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
124899459|NCT00762463|449257878|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
124899460|NCT00762463|449257879|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
124899461|NCT01306331|449257880|FG000|Overall Study|Adverse Event|28|||
124899462|NCT01306331|449257881|FG001|Overall Study|Adverse Event|25|||
124899463|NCT01306331|449257880|FG000|Overall Study|Lost to Follow-up|321|||
124899464|NCT01306331|449257881|FG001|Overall Study|Lost to Follow-up|323|||
124899465|NCT01306331|449257880|FG000|Overall Study|Physician Decision|26|||
124899466|NCT01306331|449257881|FG001|Overall Study|Physician Decision|22|||
124899467|NCT01306331|449257880|FG000|Overall Study|Pregnancy|136|||
124899468|NCT01306331|449257881|FG001|Overall Study|Pregnancy|151|||
124899469|NCT01306331|449257880|FG000|Overall Study|Protocol Violation|154|||
124899470|NCT01306331|449257881|FG001|Overall Study|Protocol Violation|124|||
124899471|NCT01306331|449257880|FG000|Overall Study|Withdrawal by Subject|163|||
124899472|NCT01306331|449257881|FG001|Overall Study|Withdrawal by Subject|152|||
124899473|NCT01306331|449257880|FG000|Overall Study|Not sexually active|29|||
124899474|NCT01306331|449257881|FG001|Overall Study|Not sexually active|28|||
124899475|NCT01306331|449257880|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
124899476|NCT01306331|449257881|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
124899477|NCT01306331|449257880|FG000|Overall Study|Other|34|||
124899478|NCT01306331|449257881|FG001|Overall Study|Other|32|||
124899479|NCT00172185|449257884|FG000|Overall Study|Adverse Event|0|||
124899480|NCT00172185|449257885|FG001|Overall Study|Adverse Event|1|||
124899481|NCT00172185|449257886|FG002|Overall Study|Adverse Event|3|||
124899482|NCT00172185|449257887|FG003|Overall Study|Adverse Event|4|||
124899483|NCT00172185|449257884|FG000|Overall Study|Physician Decision|0|||
124899484|NCT00172185|449257885|FG001|Overall Study|Physician Decision|0|||
124899485|NCT00172185|449257886|FG002|Overall Study|Physician Decision|1|||
124899486|NCT00172185|449257887|FG003|Overall Study|Physician Decision|0|||
124899487|NCT00172185|449257884|FG000|Overall Study|SPONSOR Decision|0|||
124899488|NCT00172185|449257885|FG001|Overall Study|SPONSOR Decision|1|||
124899489|NCT00172185|449257886|FG002|Overall Study|SPONSOR Decision|0|||
124899490|NCT00172185|449257887|FG003|Overall Study|SPONSOR Decision|0|||
124899491|NCT00172185|449257884|FG000|Overall Study|Withdrawal by Subject|0|||
124899492|NCT00172185|449257885|FG001|Overall Study|Withdrawal by Subject|0|||
124899493|NCT00172185|449257886|FG002|Overall Study|Withdrawal by Subject|1|||
124899494|NCT00172185|449257887|FG003|Overall Study|Withdrawal by Subject|0|||
124899495|NCT04048135|449257888|FG000|Overall Study|Withdrawal by Subject|1|||
124899496|NCT04048135|449257889|FG001|Overall Study|Withdrawal by Subject|1|||
124899497|NCT04048135|449257890|FG002|Overall Study|Withdrawal by Subject|1|||
124899498|NCT04048135|449257891|FG003|Overall Study|Withdrawal by Subject|2|||
124899499|NCT04048135|449257892|FG004|Overall Study|Withdrawal by Subject|0|||
124899500|NCT04048135|449257893|FG005|Overall Study|Withdrawal by Subject|0|||
124899501|NCT04048135|449257894|FG006|Overall Study|Withdrawal by Subject|1|||
124899502|NCT04048135|449257895|FG007|Overall Study|Withdrawal by Subject|1|||
124899503|NCT04048135|449257888|FG000|Overall Study|Adverse Event|0|||
124899504|NCT04048135|449257889|FG001|Overall Study|Adverse Event|0|||
124899505|NCT04048135|449257890|FG002|Overall Study|Adverse Event|0|||
124899506|NCT04048135|449257891|FG003|Overall Study|Adverse Event|1|||
124899507|NCT04048135|449257892|FG004|Overall Study|Adverse Event|1|||
124899508|NCT04048135|449257893|FG005|Overall Study|Adverse Event|0|||
124899509|NCT04048135|449257894|FG006|Overall Study|Adverse Event|0|||
124899510|NCT04048135|449257895|FG007|Overall Study|Adverse Event|0|||
124899511|NCT04048135|449257888|FG000|Overall Study|Protocol Violation|0|||
124899512|NCT04048135|449257889|FG001|Overall Study|Protocol Violation|0|||
124899513|NCT04048135|449257890|FG002|Overall Study|Protocol Violation|0|||
124899514|NCT04048135|449257891|FG003|Overall Study|Protocol Violation|0|||
124899515|NCT04048135|449257892|FG004|Overall Study|Protocol Violation|0|||
124899516|NCT04048135|449257893|FG005|Overall Study|Protocol Violation|1|||
124899517|NCT04048135|449257894|FG006|Overall Study|Protocol Violation|0|||
124899518|NCT04048135|449257895|FG007|Overall Study|Protocol Violation|0|||
124899519|NCT01677936|449257896|FG000|Overall Study|Lost to Follow-up|4|||
124899520|NCT01677936|449257897|FG001|Overall Study|Lost to Follow-up|1|||
124899521|NCT01677936|449257896|FG000|Overall Study|Protocol Violation|3|||
124899522|NCT01677936|449257897|FG001|Overall Study|Protocol Violation|0|||
124899523|NCT01677936|449257896|FG000|Overall Study|Adverse Event|1|||
124899524|NCT01677936|449257897|FG001|Overall Study|Adverse Event|0|||
124899525|NCT01677936|449257896|FG000|Overall Study|Lost to Follow-up|1|||
124899526|NCT01677936|449257897|FG001|Overall Study|Lost to Follow-up|0|||
124899527|NCT01677936|449257896|FG000|Overall Study|Protocol Violation|0|||
124899528|NCT01677936|449257897|FG001|Overall Study|Protocol Violation|4|||
124899529|NCT04358549|449257898|FG000|Overall Study|Adverse Event|0|||
124899530|NCT04358549|449257899|FG001|Overall Study|Adverse Event|1|||
124899531|NCT04358549|449257898|FG000|Overall Study|Death|1|||
124899532|NCT04358549|449257899|FG001|Overall Study|Death|0|||
124899533|NCT04358549|449257898|FG000|Overall Study|Lost to Follow-up|2|||
124899534|NCT04358549|449257899|FG001|Overall Study|Lost to Follow-up|1|||
124899535|NCT04358549|449257898|FG000|Overall Study|Withdrawal by Subject|6|||
124899536|NCT04358549|449257899|FG001|Overall Study|Withdrawal by Subject|6|||
124899537|NCT04358549|449257898|FG000|Overall Study|Start remdesivir|1|||
124899538|NCT04358549|449257899|FG001|Overall Study|Start remdesivir|0|||
124899539|NCT03895034|449257900|FG000|Overall Study|Lost to Follow-up|2|||
124899540|NCT01118377|449257901|FG000|Overall Study|Did Not Receive Study Medication|1|||
124899541|NCT01118377|449257901|FG000|Overall Study|Death|38|||
124899542|NCT01118377|449257901|FG000|Overall Study|Failure to Return|3|||
124899543|NCT01510912|449257906|FG000|Overall Study|Adverse Event|99|||
124899544|NCT01510912|449257906|FG000|Overall Study|Lack of Efficacy|12|||
124899545|NCT01510912|449257906|FG000|Overall Study|Non-compliance with trial drug|23|||
124899546|NCT01510912|449257906|FG000|Overall Study|Withdrawal by Subject|49|||
124899547|NCT01510912|449257906|FG000|Overall Study|Physician Decision|1|||
124899548|NCT01510912|449257906|FG000|Overall Study|Protocol Violation|27|||
124899549|NCT01510912|449257906|FG000|Overall Study|Lost to Follow-up|26|||
124899550|NCT01510912|449257906|FG000|Overall Study|Other, including joint replacement|5|||
124899551|NCT00157014|449257907|FG000|Overall Study|Death|4|||
124899552|NCT00157014|449257908|FG001|Overall Study|Death|2|||
124899553|NCT00157014|449257909|FG002|Overall Study|Death|1|||
124899554|NCT00157014|449257910|FG003|Overall Study|Death|1|||
124899555|NCT00157014|449257907|FG000|Overall Study|Physician Decision|0|||
124899556|NCT00157014|449257908|FG001|Overall Study|Physician Decision|1|||
124899557|NCT00157014|449257909|FG002|Overall Study|Physician Decision|0|||
124899558|NCT00157014|449257910|FG003|Overall Study|Physician Decision|0|||
124899559|NCT00157014|449257907|FG000|Overall Study|Medications withdrawn on family request|0|||
124899560|NCT00157014|449257908|FG001|Overall Study|Medications withdrawn on family request|1|||
124899561|NCT00157014|449257909|FG002|Overall Study|Medications withdrawn on family request|0|||
124899562|NCT00157014|449257910|FG003|Overall Study|Medications withdrawn on family request|0|||
124899563|NCT00157014|449257907|FG000|Overall Study|Patient withdrawn by investigator|1|||
124899564|NCT00157014|449257908|FG001|Overall Study|Patient withdrawn by investigator|0|||
124899565|NCT00157014|449257909|FG002|Overall Study|Patient withdrawn by investigator|0|||
124899566|NCT00157014|449257910|FG003|Overall Study|Patient withdrawn by investigator|0|||
124899567|NCT00157014|449257907|FG000|Overall Study|Patient unable to return in nursing home|1|||
124899568|NCT00157014|449257908|FG001|Overall Study|Patient unable to return in nursing home|0|||
124899569|NCT00157014|449257909|FG002|Overall Study|Patient unable to return in nursing home|0|||
124899570|NCT00157014|449257910|FG003|Overall Study|Patient unable to return in nursing home|0|||
124899571|NCT00157014|449257907|FG000|Overall Study|Patient would not receive transplant|0|||
124899572|NCT00157014|449257908|FG001|Overall Study|Patient would not receive transplant|1|||
124899573|NCT00157014|449257909|FG002|Overall Study|Patient would not receive transplant|0|||
124899574|NCT00157014|449257910|FG003|Overall Study|Patient would not receive transplant|0|||
124899575|NCT00157014|449257907|FG000|Overall Study|Withdrawal by Subject|1|||
124899576|NCT00157014|449257908|FG001|Overall Study|Withdrawal by Subject|0|||
124899577|NCT00157014|449257909|FG002|Overall Study|Withdrawal by Subject|0|||
124899578|NCT00157014|449257910|FG003|Overall Study|Withdrawal by Subject|0|||
124899579|NCT03181958|449257911|FG000|Overall Study|Lost to Follow-up|17|||
124899580|NCT03181958|449257912|FG001|Overall Study|Lost to Follow-up|21|||
124899581|NCT03181958|449257913|FG002|Overall Study|Lost to Follow-up|15|||
124899582|NCT01257503|449257914|FG000|Overall Study|Lost to Follow-up|7|||
124899583|NCT01257503|449257915|FG001|Overall Study|Lost to Follow-up|10|||
124899584|NCT01257503|449257914|FG000|Overall Study|Over 5 years old at enrollment|0|||
124899585|NCT01257503|449257915|FG001|Overall Study|Over 5 years old at enrollment|1|||
124899586|NCT01257503|449257914|FG000|Overall Study|strep culture positive at enrollment|1|||
124899587|NCT01257503|449257915|FG001|Overall Study|strep culture positive at enrollment|0|||
124899588|NCT04867902|449257916|FG000|Overall Study|Lost to Follow-up|1|||
124899589|NCT04867902|449257916|FG000|Overall Study|Withdrawal by Subject|2|||
124899590|NCT04867902|449257916|FG000|Overall Study|Protocol Violation|1|||
124899591|NCT05355116|449257917|FG000|Overall Study|Withdrawal by Subject|2|||
124446716|NCT01862640|447599410|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
124446717|NCT01862640|447599411|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
124446718|NCT01862640|447599412|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
124446719|NCT01862640|447599413|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
124446720|NCT01862640|447599410|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
124446721|NCT01862640|447599411|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
124446722|NCT01862640|447599412|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
124446723|NCT01862640|447599413|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
124446724|NCT01862640|447599410|FG000|Overall Study|Withdrawal by Subject|2|||
124446725|NCT01862640|447599411|FG001|Overall Study|Withdrawal by Subject|4|||
124446726|NCT01862640|447599412|FG002|Overall Study|Withdrawal by Subject|8|||
124446727|NCT01862640|447599413|FG003|Overall Study|Withdrawal by Subject|5|||
124446728|NCT01862640|447599410|FG000|Overall Study|Protocol Deviation|0|||
124446729|NCT01862640|447599411|FG001|Overall Study|Protocol Deviation|0|||
124446730|NCT01862640|447599412|FG002|Overall Study|Protocol Deviation|1|||
124446731|NCT01862640|447599413|FG003|Overall Study|Protocol Deviation|0|||
124899592|NCT02380742|449257918|FG000|Overall Study|Withdrawal by Subject|1|||
124899593|NCT02380742|449257919|FG001|Overall Study|Withdrawal by Subject|0|||
124899594|NCT00151996|449257920|FG000|Overall Study|Adverse Event|3|||
124899595|NCT00151996|449257921|FG001|Overall Study|Adverse Event|2|||
124446732|NCT05211739|447599414|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
124446733|NCT05211739|447599415|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
124466439|NCT01882907|447666400|FG000|Overall Study|Withdrawal by Subject|0|||
124899596|NCT00151996|449257920|FG000|Overall Study|Withdrawal by Subject|1|||
124899597|NCT00151996|449257921|FG001|Overall Study|Withdrawal by Subject|1|||
124899598|NCT00151996|449257920|FG000|Overall Study|Protocol Violation|1|||
124899599|NCT00151996|449257921|FG001|Overall Study|Protocol Violation|2|||
124899600|NCT00151996|449257920|FG000|Overall Study|Sponsor's decision|0|||
124899601|NCT00151996|449257921|FG001|Overall Study|Sponsor's decision|2|||
124899602|NCT03439124|449257922|FG000|Overall Study|Adverse Event|2|||
124899603|NCT03439124|449257923|FG001|Overall Study|Adverse Event|0|||
124899604|NCT03439124|449257922|FG000|Overall Study|Lost to Follow-up|1|||
124899605|NCT03439124|449257923|FG001|Overall Study|Lost to Follow-up|0|||
124899606|NCT03439124|449257922|FG000|Overall Study|Other reasons|1|||
124899607|NCT03439124|449257923|FG001|Overall Study|Other reasons|0|||
124899608|NCT02236559|449257924|FG000|Overall Study|Met Exclusion|3|||
124899609|NCT02236559|449257925|FG001|Overall Study|Met Exclusion|6|||
124899610|NCT02236559|449257924|FG000|Overall Study|Did not Meet Inclusion|3|||
124899611|NCT02236559|449257925|FG001|Overall Study|Did not Meet Inclusion|3|||
124899612|NCT02236559|449257924|FG000|Overall Study|Subject Did Not Consent|4|||
124899613|NCT02236559|449257925|FG001|Overall Study|Subject Did Not Consent|2|||
124899614|NCT02236559|449257924|FG000|Overall Study|Physician Decision|1|||
124899615|NCT02236559|449257925|FG001|Overall Study|Physician Decision|1|||
124899616|NCT02236559|449257924|FG000|Overall Study|Withdrawal by Subject|1|||
124899617|NCT02236559|449257925|FG001|Overall Study|Withdrawal by Subject|0|||
124899618|NCT01117480|449257926|FG000|Overall Study|Protocol Violation|8|||
124899619|NCT01117480|449257926|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
124899620|NCT00943605|449257927|FG000|Overall Study|Study termination|30|||
124899621|NCT00943605|449257928|FG001|Overall Study|Study termination|30|||
124899622|NCT02131324|449257931|FG000|Overall Study|Withdrawal by Subject|1|||
124446734|NCT05211739|447599414|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
124688956|NCT01214720|448479944|FG001|Overall Study|Alive and still on treatment|18|||
124688957|NCT01214720|448479943|FG000|Overall Study|Alive and in follow-up|45|||
124688958|NCT01214720|448479944|FG001|Overall Study|Alive and in follow-up|48|||
124688959|NCT01214720|448479943|FG000|Overall Study|Lost to Follow-up|6|||
124688960|NCT01214720|448479944|FG001|Overall Study|Lost to Follow-up|2|||
124688961|NCT02347787|448479945|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
124688962|NCT02347787|448479946|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
124688963|NCT02347787|448479945|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
124688964|NCT02347787|448479946|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
124446735|NCT05211739|447599415|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
124446736|NCT05211739|447599414|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
124446737|NCT05211739|447599415|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
124446738|NCT05211739|447599414|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
124446739|NCT05211739|447599415|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
124446740|NCT05085665|447599416|FG000|Overall Study|Physician Decision|2|||
124446741|NCT00728481|447599417|FG000|Overall Study|Withdrawal by Subject|0|||
124446742|NCT00728481|447599418|FG001|Overall Study|Withdrawal by Subject|1|||
124446743|NCT00728481|447599417|FG000|Overall Study|Adverse Event|0|||
124446744|NCT00728481|447599418|FG001|Overall Study|Adverse Event|1|||
124446745|NCT00728481|447599417|FG000|Overall Study|Study medication non-compliance|0|||
124446746|NCT00728481|447599418|FG001|Overall Study|Study medication non-compliance|2|||
124446747|NCT00728481|447599417|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
124688965|NCT02347787|448479945|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
124688966|NCT02347787|448479946|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
124688967|NCT02347787|448479945|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
124688968|NCT02347787|448479946|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
124688969|NCT00875667|448480937|FG000|Overall Study|Adverse Event|29|||
124688970|NCT00875667|448480938|FG001|Overall Study|Adverse Event|10|||
124688971|NCT00875667|448480937|FG000|Overall Study|Withdrawal by Subject|17|||
124688972|NCT00875667|448480938|FG001|Overall Study|Withdrawal by Subject|5|||
124688973|NCT00875667|448480937|FG000|Overall Study|Death|7|||
124688974|NCT00875667|448480938|FG001|Overall Study|Death|2|||
124688975|NCT00875667|448480937|FG000|Overall Study|Protocol Violation|2|||
124688976|NCT00875667|448480938|FG001|Overall Study|Protocol Violation|0|||
124688977|NCT00875667|448480937|FG000|Overall Study|Disease Progression|100|||
124688978|NCT00875667|448480938|FG001|Overall Study|Disease Progression|49|||
124688979|NCT00875667|448480937|FG000|Overall Study|Miscellaneous|12|||
124899623|NCT02131324|449257932|FG001|Overall Study|Withdrawal by Subject|2|||
124899624|NCT02131324|449257931|FG000|Overall Study|Lost to Follow-up|1|||
124899625|NCT02131324|449257932|FG001|Overall Study|Lost to Follow-up|1|||
124899626|NCT00891618|449257933|FG000|Overall Study|Withdrawal by Subject|1|||
124899627|NCT01693614|449257934|FG000|Overall Study|Adverse Event|7|||
124688980|NCT00875667|448480938|FG001|Overall Study|Miscellaneous|6|||
124446748|NCT00728481|447599418|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
124446749|NCT01251120|447599422|FG000|Overall Study|Lack of Efficacy|0|||
124688981|NCT00875667|448480937|FG000|Overall Study|Randomized but no Study Drug Given|3|||
124688982|NCT00875667|448480938|FG001|Overall Study|Randomized but no Study Drug Given|1|||
124688983|NCT00894647|448480939|FG000|Overall Study|Adverse Event|5|||
124688984|NCT00894647|448480940|FG001|Overall Study|Adverse Event|4|||
124688985|NCT00894647|448480939|FG000|Overall Study|Withdrawal by Subject|4|||
124688986|NCT00894647|448480940|FG001|Overall Study|Withdrawal by Subject|4|||
124688987|NCT00894647|448480939|FG000|Overall Study|Lost to Follow-up|0|||
124688988|NCT00894647|448480940|FG001|Overall Study|Lost to Follow-up|2|||
124688989|NCT00894647|448480939|FG000|Overall Study|Non-compliance with study procedures|0|||
124688990|NCT00894647|448480940|FG001|Overall Study|Non-compliance with study procedures|2|||
124688991|NCT00894647|448480939|FG000|Overall Study|Other, not due to AE|1|||
124688992|NCT00894647|448480940|FG001|Overall Study|Other, not due to AE|2|||
124688993|NCT00195429|448480946|FG000|Overall Study|Adverse Event|2|||
124688994|NCT00195429|448480947|FG001|Overall Study|Adverse Event|4|||
124688995|NCT00195429|448480946|FG000|Overall Study|Lack of Efficacy|2|||
124688996|NCT00195429|448480947|FG001|Overall Study|Lack of Efficacy|1|||
124688997|NCT00195429|448480946|FG000|Overall Study|Lost to Follow-up|1|||
124688998|NCT00195429|448480947|FG001|Overall Study|Lost to Follow-up|0|||
124688999|NCT04795323|448480948|FG000|Overall Study|Did not interact with TARA|1|||
124689000|NCT04795323|448480949|FG001|Overall Study|Did not interact with TARA|0|||
124689001|NCT02691663|448480951|FG000|Overall Study|Screen failure after baseline|2|||
124689002|NCT02691663|448480952|FG001|Overall Study|Screen failure after baseline|2|||
124689003|NCT02691663|448480951|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
124689004|NCT02691663|448480952|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
124689005|NCT02691663|448480951|FG000|Overall Study|Withdrawn after Follow up 2|1|||
124689006|NCT02691663|448480952|FG001|Overall Study|Withdrawn after Follow up 2|1|||
124689007|NCT02691663|448480951|FG000|Overall Study|Lost to Follow-up|3|||
124689008|NCT02691663|448480952|FG001|Overall Study|Lost to Follow-up|2|||
124446750|NCT01251120|447599423|FG001|Overall Study|Lack of Efficacy|1|||
124446751|NCT01807923|447599428|FG000|Overall Study|Adverse Event|2|||
124446752|NCT01807923|447599429|FG001|Overall Study|Adverse Event|1|||
124446753|NCT01807923|447599430|FG002|Overall Study|Adverse Event|2|||
124446754|NCT01807923|447599428|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
124446755|NCT01807923|447599429|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
124446756|NCT01807923|447599430|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
124446757|NCT01807923|447599428|FG000|Overall Study|Physician Decision|0|||
124446758|NCT01807923|447599429|FG001|Overall Study|Physician Decision|0|||
124446759|NCT01807923|447599430|FG002|Overall Study|Physician Decision|1|||
124446760|NCT01807923|447599428|FG000|Overall Study|Not Eligible (Genotype)|0|||
124446761|NCT01807923|447599429|FG001|Overall Study|Not Eligible (Genotype)|0|||
124446762|NCT01807923|447599430|FG002|Overall Study|Not Eligible (Genotype)|1|||
124446763|NCT01807923|447599428|FG000|Overall Study|Randomized But Not Treated|3|||
124446764|NCT01807923|447599429|FG001|Overall Study|Randomized But Not Treated|2|||
124446765|NCT01807923|447599430|FG002|Overall Study|Randomized But Not Treated|5|||
124446766|NCT00108069|447599431|FG000|Overall Study|Never rec'd study drug|0|||
124446767|NCT00108069|447599432|FG001|Overall Study|Never rec'd study drug|1|||
124446768|NCT00108069|447599431|FG000|Overall Study|Adverse Event|1|||
124446769|NCT00108069|447599432|FG001|Overall Study|Adverse Event|1|||
124446770|NCT00108069|447599431|FG000|Overall Study|Withdrawal by Subject|1|||
124446771|NCT00108069|447599432|FG001|Overall Study|Withdrawal by Subject|0|||
124446772|NCT00108069|447599431|FG000|Overall Study|Death|1|||
124689009|NCT03142750|448480953|FG000|Overall Study|Lost to Follow-up|4|||
124689010|NCT03142750|448480954|FG001|Overall Study|Lost to Follow-up|1|||
124689011|NCT04925934|448480955|FG000|Overall Study|Adverse Event|1|||
124689012|NCT04925934|448480956|FG001|Overall Study|Adverse Event|0|||
124689013|NCT04925934|448480957|FG002|Overall Study|Adverse Event|0|||
124689014|NCT04925934|448480955|FG000|Overall Study|Lost to Follow-up|2|||
124689015|NCT04925934|448480956|FG001|Overall Study|Lost to Follow-up|0|||
124689016|NCT04925934|448480957|FG002|Overall Study|Lost to Follow-up|1|||
124689017|NCT04925934|448480955|FG000|Overall Study|Death|0|||
124689018|NCT04925934|448480956|FG001|Overall Study|Death|1|||
124689019|NCT04925934|448480957|FG002|Overall Study|Death|0|||
124689020|NCT04925934|448480955|FG000|Overall Study|Withdrawal by Subject|8|||
124689021|NCT04925934|448480956|FG001|Overall Study|Withdrawal by Subject|5|||
124689022|NCT04925934|448480957|FG002|Overall Study|Withdrawal by Subject|9|||
124689023|NCT04925934|448480955|FG000|Overall Study|Other|2|||
124689024|NCT04925934|448480956|FG001|Overall Study|Other|2|||
124689025|NCT04925934|448480957|FG002|Overall Study|Other|2|||
124689026|NCT04925934|448480955|FG000|Overall Study|Eastern European Conflict|7|||
124689027|NCT04925934|448480956|FG001|Overall Study|Eastern European Conflict|3|||
124689028|NCT04925934|448480957|FG002|Overall Study|Eastern European Conflict|2|||
124689029|NCT03158688|448480958|FG000|Overall Study|Withdrawal by Subject|14|||
124689030|NCT03158688|448480959|FG001|Overall Study|Withdrawal by Subject|28|||
124446773|NCT00108069|447599432|FG001|Overall Study|Death|0|||
124446774|NCT00108069|447599431|FG000|Overall Study|Progessive disease|27|||
124446775|NCT00108069|447599432|FG001|Overall Study|Progessive disease|11|||
124446776|NCT00995007|447599433|FG000|Overall Study|Withdrew consent|1|||
124446777|NCT00995007|447599434|FG001|Overall Study|Withdrew consent|0|||
124446778|NCT00995007|447599433|FG000|Overall Study|Refused further treatment|8|||
124689031|NCT03158688|448480958|FG000|Overall Study|Decision by sponsor|13|||
124689032|NCT03158688|448480959|FG001|Overall Study|Decision by sponsor|37|||
124689033|NCT03158688|448480958|FG000|Overall Study|Lost to Follow-up|4|||
124689034|NCT03158688|448480959|FG001|Overall Study|Lost to Follow-up|3|||
124689035|NCT03158688|448480958|FG000|Overall Study|Death|74|||
124689036|NCT03158688|448480959|FG001|Overall Study|Death|142|||
124689037|NCT01944774|448480967|FG000|Overall Study|Withdrawal by Subject|2|||
124689038|NCT01944774|448480968|FG001|Overall Study|Withdrawal by Subject|3|||
124689039|NCT01944774|448480969|FG002|Overall Study|Withdrawal by Subject|3|||
124689040|NCT01944774|448480967|FG000|Overall Study|Adverse Event|3|||
124689041|NCT01944774|448480968|FG001|Overall Study|Adverse Event|2|||
124689042|NCT01944774|448480969|FG002|Overall Study|Adverse Event|3|||
124689043|NCT01944774|448480967|FG000|Overall Study|Lack of Efficacy|1|||
124689044|NCT01944774|448480968|FG001|Overall Study|Lack of Efficacy|2|||
124689045|NCT01944774|448480969|FG002|Overall Study|Lack of Efficacy|2|||
124689046|NCT01944774|448480967|FG000|Overall Study|Lost to Follow-up|0|||
124689047|NCT01944774|448480968|FG001|Overall Study|Lost to Follow-up|1|||
124689048|NCT01944774|448480969|FG002|Overall Study|Lost to Follow-up|0|||
124689049|NCT03325439|448480970|FG000|Overall Study|Ineligibility|3|||
124689050|NCT03188185|448480971|FG000|Stage 1|Adverse Event|4|||
124689051|NCT03188185|448480972|FG001|Stage 1|Adverse Event|12|||
124689052|NCT03188185|448480973|FG002|Stage 1|Adverse Event|0|||
124689053|NCT03188185|448480974|FG003|Stage 1|Adverse Event|0|||
124689054|NCT03188185|448480971|FG000|Stage 1|Lack of Efficacy|0|||
124689055|NCT03188185|448480972|FG001|Stage 1|Lack of Efficacy|2|||
124689056|NCT03188185|448480973|FG002|Stage 1|Lack of Efficacy|0|||
124689057|NCT03188185|448480974|FG003|Stage 1|Lack of Efficacy|0|||
124689058|NCT03188185|448480971|FG000|Stage 1|Lost to Follow-up|6|||
124689059|NCT03188185|448480972|FG001|Stage 1|Lost to Follow-up|1|||
124689060|NCT03188185|448480973|FG002|Stage 1|Lost to Follow-up|0|||
124689061|NCT03188185|448480974|FG003|Stage 1|Lost to Follow-up|0|||
124689062|NCT03188185|448480971|FG000|Stage 1|Withdrawal by Subject|9|||
124689063|NCT03188185|448480972|FG001|Stage 1|Withdrawal by Subject|0|||
124689064|NCT03188185|448480973|FG002|Stage 1|Withdrawal by Subject|0|||
124689065|NCT03188185|448480974|FG003|Stage 1|Withdrawal by Subject|0|||
124689066|NCT03188185|448480971|FG000|Stage 1|Identified as a professional patient|0|||
124689067|NCT03188185|448480972|FG001|Stage 1|Identified as a professional patient|1|||
124689068|NCT03188185|448480973|FG002|Stage 1|Identified as a professional patient|0|||
124689069|NCT03188185|448480974|FG003|Stage 1|Identified as a professional patient|0|||
124689070|NCT03188185|448480971|FG000|Stage 2|Adverse Event|0|||
124689071|NCT03188185|448480972|FG001|Stage 2|Adverse Event|0|||
124899628|NCT01693614|449257935|FG001|Overall Study|Adverse Event|11|||
124899629|NCT01693614|449257936|FG002|Overall Study|Adverse Event|5|||
124899630|NCT01693614|449257934|FG000|Overall Study|Disease progression|11|||
124899631|NCT01693614|449257935|FG001|Overall Study|Disease progression|8|||
124899632|NCT01693614|449257936|FG002|Overall Study|Disease progression|7|||
124689072|NCT03188185|448480973|FG002|Stage 2|Adverse Event|2|||
124689073|NCT03188185|448480974|FG003|Stage 2|Adverse Event|4|||
124689074|NCT03188185|448480971|FG000|Stage 2|Lack of Efficacy|0|||
124689075|NCT03188185|448480972|FG001|Stage 2|Lack of Efficacy|0|||
124689076|NCT03188185|448480973|FG002|Stage 2|Lack of Efficacy|3|||
124689077|NCT03188185|448480974|FG003|Stage 2|Lack of Efficacy|0|||
124899633|NCT01693614|449257934|FG000|Overall Study|Protocol Violation|5|||
124899634|NCT01693614|449257935|FG001|Overall Study|Protocol Violation|2|||
124899635|NCT01693614|449257936|FG002|Overall Study|Protocol Violation|1|||
124899636|NCT01693614|449257934|FG000|Overall Study|Death|1|||
124899637|NCT01693614|449257935|FG001|Overall Study|Death|0|||
124899638|NCT01693614|449257936|FG002|Overall Study|Death|0|||
124899639|NCT01693614|449257934|FG000|Overall Study|Physician Decision|1|||
124689078|NCT03188185|448480971|FG000|Stage 2|Lost to Follow-up|0|||
124689079|NCT03188185|448480972|FG001|Stage 2|Lost to Follow-up|0|||
124689080|NCT03188185|448480973|FG002|Stage 2|Lost to Follow-up|1|||
124689081|NCT03188185|448480974|FG003|Stage 2|Lost to Follow-up|0|||
124689082|NCT03188185|448480971|FG000|Stage 2|Physician Decision|0|||
124689083|NCT03188185|448480972|FG001|Stage 2|Physician Decision|0|||
124689084|NCT03188185|448480973|FG002|Stage 2|Physician Decision|0|||
124689085|NCT03188185|448480974|FG003|Stage 2|Physician Decision|1|||
124689086|NCT03188185|448480971|FG000|Stage 2|Withdrawal by Subject|0|||
124689087|NCT03188185|448480972|FG001|Stage 2|Withdrawal by Subject|0|||
124689088|NCT03188185|448480973|FG002|Stage 2|Withdrawal by Subject|3|||
124689089|NCT03188185|448480974|FG003|Stage 2|Withdrawal by Subject|1|||
124899640|NCT01693614|449257935|FG001|Overall Study|Physician Decision|1|||
124899641|NCT01693614|449257936|FG002|Overall Study|Physician Decision|4|||
124899642|NCT01693614|449257934|FG000|Overall Study|Withdrawal by subject/guardian|0|||
124899643|NCT01693614|449257935|FG001|Overall Study|Withdrawal by subject/guardian|0|||
124899644|NCT01693614|449257936|FG002|Overall Study|Withdrawal by subject/guardian|2|||
124899645|NCT01693614|449257934|FG000|Overall Study|Withdrawal by Subject|1|||
124899646|NCT01693614|449257935|FG001|Overall Study|Withdrawal by Subject|0|||
124899647|NCT01693614|449257936|FG002|Overall Study|Withdrawal by Subject|5|||
124899648|NCT01048788|449257937|FG000|Overall Study|Adverse Event|5|||
124899649|NCT01048788|449257938|FG001|Overall Study|Adverse Event|1|||
124899650|NCT01048788|449257939|FG002|Overall Study|Adverse Event|1|||
124899651|NCT01048788|449257937|FG000|Overall Study|Lack of Efficacy|0|||
124899652|NCT01048788|449257938|FG001|Overall Study|Lack of Efficacy|0|||
124899653|NCT01048788|449257939|FG002|Overall Study|Lack of Efficacy|1|||
124899654|NCT01048788|449257937|FG000|Overall Study|Withdrawal by Subject|0|||
124899655|NCT01048788|449257938|FG001|Overall Study|Withdrawal by Subject|1|||
124899656|NCT01048788|449257939|FG002|Overall Study|Withdrawal by Subject|0|||
124899657|NCT00420316|449257942|FG000|Overall Study|Withdrawal by Subject|0|||
124899658|NCT00420316|449257943|FG001|Overall Study|Withdrawal by Subject|1|||
124899659|NCT00420316|449257942|FG000|Overall Study|Lost to Follow-up|12|||
124899660|NCT00420316|449257943|FG001|Overall Study|Lost to Follow-up|8|||
124899661|NCT01196988|449257944|FG000|Overall Study|Adverse Event|1|||
124899662|NCT01196988|449257945|FG001|Overall Study|Adverse Event|2|||
124899663|NCT01196988|449257946|FG002|Overall Study|Adverse Event|0|||
124899664|NCT01196988|449257947|FG003|Overall Study|Adverse Event|0|||
124899665|NCT01196988|449257944|FG000|Overall Study|Withdrawal by Subject|5|||
124899666|NCT01196988|449257945|FG001|Overall Study|Withdrawal by Subject|1|||
124899667|NCT01196988|449257946|FG002|Overall Study|Withdrawal by Subject|4|||
124899668|NCT01196988|449257947|FG003|Overall Study|Withdrawal by Subject|0|||
124899669|NCT01196988|449257944|FG000|Overall Study|Lost to Follow-up|16|||
124899670|NCT01196988|449257945|FG001|Overall Study|Lost to Follow-up|29|||
124899671|NCT01196988|449257946|FG002|Overall Study|Lost to Follow-up|21|||
124899672|NCT01196988|449257947|FG003|Overall Study|Lost to Follow-up|1|||
124899673|NCT01196988|449257944|FG000|Overall Study|Other|2|||
124689090|NCT00774748|448480979|FG000|Overall Study|Lost to Follow-up|3|||
124689091|NCT02503865|448480980|FG000|Overall Study|Moved out of area|1|||
124689092|NCT02503865|448480981|FG001|Overall Study|Moved out of area|8|||
124689093|NCT02503865|448480982|FG002|Overall Study|Moved out of area|0|||
124689094|NCT02503865|448480980|FG000|Overall Study|Refused treatment|4|||
124689095|NCT02503865|448480981|FG001|Overall Study|Refused treatment|39|||
124689096|NCT02503865|448480982|FG002|Overall Study|Refused treatment|2|||
124689097|NCT00303953|448480983|FG000|Overall Study|Ineligible|1|||
124689098|NCT00303953|448480983|FG000|Overall Study|Death|1|||
124899674|NCT01196988|449257945|FG001|Overall Study|Other|0|||
124446779|NCT00995007|447599434|FG001|Overall Study|Refused further treatment|2|||
124689099|NCT00303953|448480983|FG000|Overall Study|Adverse Event|4|||
124689100|NCT00303953|448480983|FG000|Overall Study|Lack of Efficacy|12|||
124689101|NCT00303953|448480983|FG000|Overall Study|Physician Decision|1|||
124689102|NCT01132755|448480986|FG000|Overall Study|Procedure not done due to medical reason|23|||
124446780|NCT00995007|447599433|FG000|Overall Study|Toxicity|8|||
124446781|NCT00995007|447599434|FG001|Overall Study|Toxicity|0|||
124446782|NCT01910116|447599435|FG000|Overall Study|Adverse Event|0|||
124446783|NCT01910116|447599436|FG001|Overall Study|Adverse Event|3|||
124446784|NCT01910116|447599435|FG000|Overall Study|Lack of Efficacy|3|||
124446785|NCT01910116|447599436|FG001|Overall Study|Lack of Efficacy|4|||
124446786|NCT01910116|447599435|FG000|Overall Study|Lost to Follow-up|1|||
124446787|NCT01910116|447599436|FG001|Overall Study|Lost to Follow-up|0|||
124689103|NCT01132755|448480986|FG000|Overall Study|Protocol Violation|15|||
124689104|NCT01132755|448480986|FG000|Overall Study|Withdrawal by Subject|4|||
124689105|NCT02232698|448480987|FG000|Overall Study|Pregnancy|1|||
124689106|NCT02232698|448480988|FG001|Overall Study|Pregnancy|1|||
124689107|NCT02232698|448480987|FG000|Overall Study|Met exclusion criteria|1|||
124689108|NCT02232698|448480988|FG001|Overall Study|Met exclusion criteria|1|||
124689109|NCT02232698|448480987|FG000|Overall Study|Had device-associated symptoms|7|||
124689110|NCT02232698|448480988|FG001|Overall Study|Had device-associated symptoms|0|||
124689111|NCT02232698|448480987|FG000|Overall Study|Non-compliance with study device|1|||
124689112|NCT02232698|448480988|FG001|Overall Study|Non-compliance with study device|4|||
124899675|NCT01196988|449257946|FG002|Overall Study|Other|0|||
124899676|NCT01196988|449257947|FG003|Overall Study|Other|0|||
124446788|NCT01910116|447599435|FG000|Overall Study|Protocol Violation|1|||
124446789|NCT01910116|447599436|FG001|Overall Study|Protocol Violation|2|||
124899677|NCT05419557|449257948|FG000|Overall Study|Lost to Follow-up|11|||
124899678|NCT05419557|449257949|FG001|Overall Study|Lost to Follow-up|4|||
124446790|NCT01910116|447599435|FG000|Overall Study|Withdrawal by Subject|8|||
124446791|NCT01910116|447599436|FG001|Overall Study|Withdrawal by Subject|3|||
124689113|NCT02232698|448480987|FG000|Overall Study|Allocated to control group|0|||
124689114|NCT02232698|448480988|FG001|Overall Study|Allocated to control group|3|||
124689115|NCT02232698|448480987|FG000|Overall Study|Withdrawal by Subject|0|||
124689116|NCT02232698|448480988|FG001|Overall Study|Withdrawal by Subject|11|||
124899679|NCT00868192|449257951|FG000|Overall Study|Ineligible|4|||
124759570|NCT01147666|448744759|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
124689117|NCT00387127|448480989|FG000|Overall Study|Lost to Follow-up|0|||
124689118|NCT00387127|448480990|FG001|Overall Study|Lost to Follow-up|4|||
124689119|NCT00387127|448480989|FG000|Overall Study|Death|16|||
124689120|NCT00387127|448480990|FG001|Overall Study|Death|16|||
124689121|NCT00387127|448480989|FG000|Overall Study|Physician Decision|0|||
124689122|NCT00387127|448480990|FG001|Overall Study|Physician Decision|1|||
124689123|NCT00387127|448480989|FG000|Overall Study|Withdrawal by Subject|3|||
124689124|NCT00387127|448480990|FG001|Overall Study|Withdrawal by Subject|2|||
124689125|NCT00387127|448480989|FG000|Overall Study|Required by Protocol Amendment #4|12|||
124689126|NCT00387127|448480990|FG001|Overall Study|Required by Protocol Amendment #4|10|||
124689127|NCT00387127|448480989|FG000|Overall Study|Serious Adverse Event|1|||
124689128|NCT00387127|448480990|FG001|Overall Study|Serious Adverse Event|1|||
124446792|NCT01910116|447599435|FG000|Overall Study|uncertain allocation|1|||
124446793|NCT01910116|447599436|FG001|Overall Study|uncertain allocation|3|||
124446794|NCT01910116|447599435|FG000|Overall Study|incomplete data|0|||
124446795|NCT01910116|447599436|FG001|Overall Study|incomplete data|1|||
124446796|NCT03606980|447599437|FG000|Overall Study|Lost to Follow-up|3|||
124446797|NCT03606980|447599438|FG001|Overall Study|Lost to Follow-up|2|||
124446798|NCT03606980|447599439|FG002|Overall Study|Lost to Follow-up|3|||
124446799|NCT03606980|447599437|FG000|Overall Study|Withdrawal by Subject|1|||
124446800|NCT03606980|447599438|FG001|Overall Study|Withdrawal by Subject|0|||
124446801|NCT03606980|447599439|FG002|Overall Study|Withdrawal by Subject|4|||
124446802|NCT02469896|447599440|FG000|Overall Study|Withdrawal by Subject|2|||
124759571|NCT01147666|448744760|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
124759572|NCT01147666|448744761|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
124689129|NCT00387127|448480989|FG000|Overall Study|Sponsor Unblinded|1|||
124689130|NCT00387127|448480990|FG001|Overall Study|Sponsor Unblinded|0|||
124689131|NCT02393755|448480991|FG000|Overall Study|Withdrawal by Subject|0|||
124689132|NCT02393755|448480992|FG001|Overall Study|Withdrawal by Subject|3|||
124689133|NCT02393755|448480991|FG000|Overall Study|Adverse Event|0|||
124689134|NCT02393755|448480992|FG001|Overall Study|Adverse Event|2|||
124689135|NCT02393755|448480991|FG000|Overall Study|Physician Decision|0|||
124689136|NCT02393755|448480992|FG001|Overall Study|Physician Decision|2|||
124689137|NCT04069520|448480995|FG000|Overall Study|Lost to Follow-up|0|||
124689138|NCT04069520|448480996|FG001|Overall Study|Lost to Follow-up|2|||
124689139|NCT04069520|448480995|FG000|Overall Study|Withdrawal by Subject|0|||
124689140|NCT04069520|448480996|FG001|Overall Study|Withdrawal by Subject|1|||
124689141|NCT04069520|448480995|FG000|Overall Study|Prior Injury|1|||
124689142|NCT04069520|448480996|FG001|Overall Study|Prior Injury|0|||
124689143|NCT04069520|448480995|FG000|Overall Study|Orthodontia|1|||
124689144|NCT04069520|448480996|FG001|Overall Study|Orthodontia|0|||
124689145|NCT04069520|448480995|FG000|Overall Study|Cut from team|0|||
124689146|NCT04069520|448480996|FG001|Overall Study|Cut from team|2|||
124689147|NCT01068912|448480997|FG000|Overall Study|Adverse Event|2|||
124689148|NCT01068912|448480998|FG001|Overall Study|Adverse Event|3|||
124689149|NCT01068912|448480999|FG002|Overall Study|Adverse Event|2|||
124689150|NCT01068912|448480997|FG000|Overall Study|Withdrawal by Subject|5|||
124446803|NCT02469896|447599441|FG001|Overall Study|Withdrawal by Subject|0|||
124446804|NCT01294150|447599444|FG000|Overall Study|Physician Decision|2|||
124446805|NCT01294150|447599445|FG001|Overall Study|Physician Decision|2|||
124759573|NCT01147666|448744762|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
124759574|NCT01147666|448744763|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
124759575|NCT01147666|448744764|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
124759576|NCT01147666|448744765|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
124759577|NCT01147666|448744766|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
124759578|NCT01147666|448744767|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
124759579|NCT01147666|448744768|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
124759580|NCT01147666|448744769|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
124759581|NCT01147666|448744755|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
124759582|NCT01147666|448744756|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
124689151|NCT01068912|448480998|FG001|Overall Study|Withdrawal by Subject|6|||
124689152|NCT01068912|448480999|FG002|Overall Study|Withdrawal by Subject|6|||
124689153|NCT01068912|448480997|FG000|Overall Study|Lost to Follow-up|3|||
124759583|NCT01147666|448744757|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
124446806|NCT03675776|447599446|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
124446807|NCT03675776|447599447|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
124446808|NCT03675776|447599448|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
124446809|NCT03675776|447599446|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
124689154|NCT01068912|448480998|FG001|Overall Study|Lost to Follow-up|7|||
124689155|NCT01068912|448480999|FG002|Overall Study|Lost to Follow-up|3|||
124689156|NCT01068912|448480997|FG000|Overall Study|Protocol Violation|0|||
124689157|NCT01068912|448480998|FG001|Overall Study|Protocol Violation|2|||
124689158|NCT01068912|448480999|FG002|Overall Study|Protocol Violation|0|||
124689159|NCT01068912|448480997|FG000|Overall Study|aggravation influenza|1|||
124689160|NCT01068912|448480998|FG001|Overall Study|aggravation influenza|1|||
124689161|NCT01068912|448480999|FG002|Overall Study|aggravation influenza|1|||
124689162|NCT01068912|448480997|FG000|Overall Study|other underlying illness|0|||
124689163|NCT01068912|448480998|FG001|Overall Study|other underlying illness|3|||
124689164|NCT01068912|448480999|FG002|Overall Study|other underlying illness|3|||
124689165|NCT04822194|448481000|FG000|Overall Study|Withdrawal by Subject|5|||
124689166|NCT04822194|448481001|FG001|Overall Study|Withdrawal by Subject|4|||
124689167|NCT04822194|448481000|FG000|Overall Study|Technical issues with MR scanner|1|||
124689168|NCT04822194|448481001|FG001|Overall Study|Technical issues with MR scanner|0|||
124689169|NCT04822194|448481000|FG000|Overall Study|Lost to Follow-up|5|||
124689170|NCT04822194|448481001|FG001|Overall Study|Lost to Follow-up|7|||
124689171|NCT01947933|448481003|FG000|Overall Study|Withdrawal by Subject|0|||
124689172|NCT01947933|448481004|FG001|Overall Study|Withdrawal by Subject|0|||
124899680|NCT04304534|449257952|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
124446810|NCT03675776|447599447|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
124446811|NCT03675776|447599448|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
124446812|NCT04233164|447599451|FG000|Overall Study|Unable to obtain specimen|0|||
124446813|NCT04233164|447599452|FG001|Overall Study|Unable to obtain specimen|1|||
124446814|NCT01840605|447599453|FG000|Overall Study|Adverse Event|0|||
124446815|NCT01840605|447599454|FG001|Overall Study|Adverse Event|1|||
124446816|NCT01840605|447599453|FG000|Overall Study|Physician Decision|2|||
124446817|NCT01840605|447599454|FG001|Overall Study|Physician Decision|1|||
124446818|NCT01351623|447599456|FG000|Overall Study|Protocol Violation|2|||
124446819|NCT01351623|447599456|FG000|Overall Study|Adverse Event|4|||
124446820|NCT01351623|447599456|FG000|Overall Study|Withdrawal by Subject|1|||
124446821|NCT01351623|447599456|FG000|Overall Study|Death|2|||
124446822|NCT01130974|447599457|FG000|Overall Study|Protocol Violation|10|||
124446823|NCT01130974|447599458|FG001|Overall Study|Protocol Violation|10|||
124446824|NCT01130974|447599457|FG000|Overall Study|Withdrawal by Subject|0|||
124446825|NCT01130974|447599458|FG001|Overall Study|Withdrawal by Subject|1|||
124446826|NCT01130974|447599457|FG000|Overall Study|Ineligibility criteria|5|||
124446827|NCT01130974|447599458|FG001|Overall Study|Ineligibility criteria|2|||
124446828|NCT00387764|447599459|FG000|Overall Study|Adverse Event|12|||
124446829|NCT00387764|447599459|FG000|Overall Study|Withdrawal by Subject|8|||
124446830|NCT00387764|447599459|FG000|Overall Study|Sponsor Terminated Study|1|||
124446831|NCT00387764|447599459|FG000|Overall Study|Physician Decision|1|||
124446832|NCT00387764|447599459|FG000|Overall Study|Other|2|||
124446833|NCT00387764|447599459|FG000|Overall Study|Death|7|||
124446834|NCT04399122|447599460|FG000|Overall Study|Lost to Follow-up|2|||
124446835|NCT04399122|447599461|FG001|Overall Study|Lost to Follow-up|0|||
124446836|NCT04399122|447599460|FG000|Overall Study|Withdrawal by Subject|1|||
124446837|NCT04399122|447599461|FG001|Overall Study|Withdrawal by Subject|0|||
124446838|NCT01102803|447599464|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
124446839|NCT01102803|447599465|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
124446840|NCT01102803|447599464|FG000|Post to Follow-Up|Lost to Follow-up|1|||
124446841|NCT01102803|447599465|FG001|Post to Follow-Up|Lost to Follow-up|3|||
124446842|NCT02684279|447599466|FG000|Overall Study|Adverse Event|87|||
124446843|NCT02684279|447599466|FG000|Overall Study|Lack of Efficacy|4|||
124446844|NCT02684279|447599466|FG000|Overall Study|Lost to Follow-up|61|||
124446845|NCT02684279|447599466|FG000|Overall Study|Protocol Violation|6|||
124446846|NCT02684279|447599466|FG000|Overall Study|Pregnancy|8|||
124446847|NCT02684279|447599466|FG000|Overall Study|Withdrawal by Subject|92|||
124446848|NCT02684279|447599466|FG000|Overall Study|non-compliance with study drug|9|||
124446849|NCT02684279|447599466|FG000|Overall Study|non compliance with study visits|2|||
124446850|NCT02684279|447599466|FG000|Overall Study|subject to have surgery|1|||
124446851|NCT02684279|447599466|FG000|Overall Study|family emergency|1|||
124446852|NCT02684279|447599466|FG000|Overall Study|Site closures|7|||
124446853|NCT02684279|447599466|FG000|Overall Study|Physician Decision|1|||
124446854|NCT02733185|447599467|FG000|Overall Study|Withdrawal by Subject|12|||
124446855|NCT02733185|447599468|FG001|Overall Study|Withdrawal by Subject|10|||
124446856|NCT02733185|447599469|FG002|Overall Study|Withdrawal by Subject|17|||
124446857|NCT02733185|447599470|FG003|Overall Study|Withdrawal by Subject|21|||
124446858|NCT02733185|447599467|FG000|Overall Study|Death|46|||
124446859|NCT02733185|447599468|FG001|Overall Study|Death|34|||
124446860|NCT02733185|447599469|FG002|Overall Study|Death|35|||
124446861|NCT02733185|447599470|FG003|Overall Study|Death|43|||
124446862|NCT02733185|447599467|FG000|Overall Study|Lost to Follow-up|17|||
124446863|NCT02733185|447599468|FG001|Overall Study|Lost to Follow-up|18|||
124689173|NCT01947933|448481005|FG002|Overall Study|Withdrawal by Subject|1|||
124899681|NCT04304534|449257953|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
124446864|NCT02733185|447599469|FG002|Overall Study|Lost to Follow-up|16|||
124446865|NCT02733185|447599470|FG003|Overall Study|Lost to Follow-up|11|||
124446866|NCT00671554|447599474|FG000|Overall Study|Disease progression|3|||
124446867|NCT00601250|447599475|FG000|Overall Study|Adverse Event|3|||
124446868|NCT00601250|447599476|FG001|Overall Study|Adverse Event|9|||
124446869|NCT00601250|447599475|FG000|Overall Study|Protocol Violation|3|||
124446870|NCT00601250|447599476|FG001|Overall Study|Protocol Violation|2|||
124689174|NCT01947933|448481006|FG003|Overall Study|Withdrawal by Subject|0|||
124689175|NCT01947933|448481007|FG004|Overall Study|Withdrawal by Subject|0|||
124446871|NCT00601250|447599475|FG000|Overall Study|Lost to Follow-up|2|||
124446872|NCT00601250|447599476|FG001|Overall Study|Lost to Follow-up|6|||
124446873|NCT00601250|447599475|FG000|Overall Study|Withdrawal by Subject|4|||
124446874|NCT00601250|447599476|FG001|Overall Study|Withdrawal by Subject|13|||
124446875|NCT00601250|447599475|FG000|Overall Study|Other incl. lack of efficacy|2|||
124446876|NCT00601250|447599476|FG001|Overall Study|Other incl. lack of efficacy|9|||
124446877|NCT01810016|447599477|FG000|Overall Study|Progressive disease|1|||
124446878|NCT01810016|447599478|FG001|Overall Study|Progressive disease|1|||
124446879|NCT01810016|447599479|FG002|Overall Study|Progressive disease|0|||
124689176|NCT01947933|448481008|FG005|Overall Study|Withdrawal by Subject|0|||
124689177|NCT01947933|448481009|FG006|Overall Study|Withdrawal by Subject|0|||
124689178|NCT01947933|448481010|FG007|Overall Study|Withdrawal by Subject|0|||
124689179|NCT01947933|448481011|FG008|Overall Study|Withdrawal by Subject|0|||
124689180|NCT01947933|448481003|FG000|Overall Study|Lost to Follow-up|0|||
124689181|NCT01947933|448481004|FG001|Overall Study|Lost to Follow-up|0|||
124689182|NCT01947933|448481005|FG002|Overall Study|Lost to Follow-up|0|||
124689183|NCT01947933|448481006|FG003|Overall Study|Lost to Follow-up|0|||
124689184|NCT01947933|448481007|FG004|Overall Study|Lost to Follow-up|0|||
124689185|NCT01947933|448481008|FG005|Overall Study|Lost to Follow-up|0|||
124689186|NCT01947933|448481009|FG006|Overall Study|Lost to Follow-up|0|||
124689187|NCT01947933|448481010|FG007|Overall Study|Lost to Follow-up|0|||
124689188|NCT01947933|448481011|FG008|Overall Study|Lost to Follow-up|1|||
124689189|NCT00294398|448481014|FG000|Overall Study|Lost to Follow-up|21|||
124689190|NCT00294398|448481015|FG001|Overall Study|Lost to Follow-up|26|||
124689191|NCT02965833|448481016|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
124689192|NCT02965833|448481017|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
124689193|NCT02965833|448481016|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
124689194|NCT02965833|448481017|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
124689195|NCT02965833|448481016|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
124689196|NCT02965833|448481017|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
124689197|NCT02965833|448481016|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
124689198|NCT02965833|448481017|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
124689199|NCT02965833|448481016|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
124689200|NCT02965833|448481017|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
124689201|NCT03407482|448481021|FG000|Overall Study|Adverse Event|12|||
124689202|NCT03407482|448481021|FG000|Overall Study|Disease Relapse|1|||
124689203|NCT03407482|448481021|FG000|Overall Study|Lost to Follow-up|1|||
124689204|NCT03407482|448481021|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124689205|NCT03407482|448481021|FG000|Overall Study|Pregnancy|2|||
124689206|NCT03407482|448481021|FG000|Overall Study|Protocol Violation|1|||
124689207|NCT03407482|448481021|FG000|Overall Study|Study Terminated By Sponsor|106|||
124689208|NCT03407482|448481021|FG000|Overall Study|Withdrawal by Subject|6|||
124689209|NCT03407482|448481021|FG000|Overall Study|Data Entry Error|1|||
124689210|NCT01685437|448481024|FG000|Overall Study|Withdrawal by Subject|22|||
124689211|NCT01685437|448481024|FG000|Overall Study|Lost to Follow-up|3|||
124689212|NCT01685437|448481024|FG000|Overall Study|Adverse Event|1|||
124689213|NCT01685437|448481024|FG000|Overall Study|Protocol Violation|4|||
124689214|NCT01685437|448481024|FG000|Overall Study|Unable to make visits due to work|1|||
124689215|NCT03770455|448481031|FG000|Overall Study|Screen failures|3|||
124689216|NCT01039675|448481032|FG000|Overall Study|Adverse Event|0|||
124899682|NCT04304534|449257954|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
124899683|NCT04304534|449257955|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
124446880|NCT01810016|447599477|FG000|Overall Study|Death|0|||
124446881|NCT01810016|447599478|FG001|Overall Study|Death|0|||
124446882|NCT01810016|447599479|FG002|Overall Study|Death|1|||
124446883|NCT03828292|447599482|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
124446884|NCT03828292|447599483|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
124446885|NCT03828292|447599484|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
124446886|NCT03828292|447599485|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
124446887|NCT03828292|447599486|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
124446888|NCT03828292|447599487|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
124446889|NCT03828292|447599482|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
124446890|NCT03828292|447599483|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
124446891|NCT03828292|447599484|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
124689217|NCT01039675|448481033|FG001|Overall Study|Adverse Event|2|||
124689218|NCT01039675|448481032|FG000|Overall Study|Lack of Efficacy|0|||
124446892|NCT03828292|447599485|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
124689219|NCT01039675|448481033|FG001|Overall Study|Lack of Efficacy|2|||
124689220|NCT01039675|448481032|FG000|Overall Study|Withdrawal by Subject|0|||
124689221|NCT01039675|448481033|FG001|Overall Study|Withdrawal by Subject|1|||
124689222|NCT01039675|448481032|FG000|Overall Study|Lost to Follow-up|0|||
124689223|NCT01039675|448481033|FG001|Overall Study|Lost to Follow-up|1|||
124689224|NCT01039675|448481032|FG000|Overall Study|Physician Decision|0|||
124689225|NCT01039675|448481033|FG001|Overall Study|Physician Decision|1|||
124689226|NCT05643794|448482430|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
124689227|NCT05643794|448482431|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
124689228|NCT05643794|448482432|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
124689229|NCT05643794|448482430|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
124689230|NCT05643794|448482431|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124689231|NCT05643794|448482432|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124446893|NCT03828292|447599486|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
124446894|NCT03828292|447599487|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
124446895|NCT03828292|447599482|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
124446896|NCT03828292|447599483|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
124446897|NCT03828292|447599484|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
124446898|NCT03828292|447599485|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
124446899|NCT03828292|447599486|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
124446900|NCT03828292|447599487|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
124446901|NCT03828292|447599482|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
124446902|NCT03828292|447599483|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
124446903|NCT03828292|447599484|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
124446904|NCT03828292|447599485|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
124446905|NCT03828292|447599486|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
124446906|NCT03828292|447599487|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
124446907|NCT03828292|447599482|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
124446908|NCT03828292|447599483|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
124446909|NCT03828292|447599484|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
124446910|NCT03828292|447599485|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
124446911|NCT03828292|447599486|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
124446912|NCT03828292|447599487|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
124446913|NCT01444651|447601001|FG000|Overall Study|Adverse Event|3|||
124446914|NCT01444651|447601002|FG001|Overall Study|Adverse Event|2|||
124446915|NCT01444651|447601001|FG000|Overall Study|Lost to Follow-up|5|||
124446916|NCT01444651|447601002|FG001|Overall Study|Lost to Follow-up|5|||
124446917|NCT01444651|447601001|FG000|Overall Study|Non-fasting|2|||
124446918|NCT01444651|447601002|FG001|Overall Study|Non-fasting|1|||
124446919|NCT01444651|447601001|FG000|Overall Study|Missing data|1|||
124446920|NCT01444651|447601002|FG001|Overall Study|Missing data|1|||
124446921|NCT03383289|447601005|FG000|Overall Study|Death|83|||
124446922|NCT03383289|447601006|FG001|Overall Study|Death|78|||
124446923|NCT03383289|447601005|FG000|Overall Study|discharge from facility|84|||
124446924|NCT03383289|447601006|FG001|Overall Study|discharge from facility|84|||
124446925|NCT03383289|447601005|FG000|Overall Study|Withdrawal by Subject|4|||
124446926|NCT03383289|447601006|FG001|Overall Study|Withdrawal by Subject|1|||
124446927|NCT00832117|447601007|FG000|Overall Study|Death|1|||
124446928|NCT00832117|447601007|FG000|Overall Study|Disease Progression|11|||
124446929|NCT00404066|447601008|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
124446930|NCT00404066|447601008|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
124446931|NCT01524133|447601011|FG000|Treatment Phase|Withdrawal by Subject|13|||
124446932|NCT01524133|447601012|FG001|Treatment Phase|Withdrawal by Subject|28|||
124446933|NCT01524133|447601013|FG002|Treatment Phase|Withdrawal by Subject|31|||
124446934|NCT01524133|447601011|FG000|Treatment Phase|Physician Decision|6|||
124446935|NCT01524133|447601012|FG001|Treatment Phase|Physician Decision|3|||
124446936|NCT01524133|447601013|FG002|Treatment Phase|Physician Decision|3|||
124446937|NCT01524133|447601011|FG000|Treatment Phase|Lost to Follow-up|0|||
124446938|NCT01524133|447601012|FG001|Treatment Phase|Lost to Follow-up|1|||
124446939|NCT01524133|447601013|FG002|Treatment Phase|Lost to Follow-up|2|||
124446940|NCT01524133|447601011|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
124446941|NCT01524133|447601012|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
124446942|NCT01524133|447601013|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
124446943|NCT01524133|447601011|FG000|Overall Study 52 Weeks|Physician Decision|1|||
124446944|NCT01524133|447601012|FG001|Overall Study 52 Weeks|Physician Decision|0|||
124446945|NCT01524133|447601013|FG002|Overall Study 52 Weeks|Physician Decision|2|||
124446946|NCT01524133|447601011|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
124689232|NCT05643794|448482430|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
124446947|NCT01524133|447601012|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
124446948|NCT01524133|447601013|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
124446949|NCT03842163|447601018|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
124446950|NCT03842163|447601018|FG000|Overall Study|Scintigraphy was not performed|44|||
124446951|NCT03829241|447601019|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
124446952|NCT03829241|447601020|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
124446953|NCT03829241|447601019|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
124446954|NCT03829241|447601020|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
124689233|NCT05643794|448482431|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
124446955|NCT03829241|447601019|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
124689234|NCT05643794|448482432|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
124689235|NCT05643794|448482430|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
124689236|NCT05643794|448482431|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
124689237|NCT05643794|448482432|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
124689238|NCT05643794|448482430|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
124689239|NCT05643794|448482431|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
124689240|NCT05643794|448482432|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
124689241|NCT05643794|448482430|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
124689242|NCT05643794|448482431|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
124689243|NCT05643794|448482432|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
124689244|NCT01363076|448482437|FG000|Overall Study|Withdrawal by Subject|0|||
124689245|NCT01363076|448482438|FG001|Overall Study|Withdrawal by Subject|1|||
124689246|NCT04706403|448482439|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
124689247|NCT04706403|448482440|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
124689248|NCT04706403|448482441|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
124689249|NCT04706403|448482442|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
124689250|NCT04706403|448482443|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
124689251|NCT00182637|448482444|FG000|Overall Study|Adverse Event|2|||
124689252|NCT00182637|448482444|FG000|Overall Study|Disease Progression|1|||
124689253|NCT04766333|448482446|FG000|Overall Study|Lost to Follow-up|40|||
124689254|NCT04766333|448482447|FG001|Overall Study|Lost to Follow-up|826|||
124689255|NCT00639379|448482451|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
124689256|NCT00639379|448482452|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
124689257|NCT00639379|448482451|FG000|Period 1 - 2 Weeks|lens issue|3|||
124689258|NCT00639379|448482452|FG001|Period 1 - 2 Weeks|lens issue|0|||
124689259|NCT00723944|448482453|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
124689260|NCT00723944|448482454|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
124689261|NCT00723944|448482453|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
124689262|NCT00723944|448482454|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
124689263|NCT00723944|448482453|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
124689264|NCT00723944|448482454|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
124689265|NCT02400736|448482455|FG000|Overall Study|Lost to Follow-up|6|||
124689266|NCT02400736|448482456|FG001|Overall Study|Lost to Follow-up|6|||
124689267|NCT02400736|448482455|FG000|Overall Study|Withdrawal by Subject|2|||
124689268|NCT02400736|448482456|FG001|Overall Study|Withdrawal by Subject|1|||
124899684|NCT04304534|449257952|FG000|Overall Study|Non-Compliance with study drug|0|||
124899685|NCT04304534|449257953|FG001|Overall Study|Non-Compliance with study drug|1|||
124446956|NCT03829241|447601020|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
124446957|NCT03829241|447601019|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
124446958|NCT03829241|447601020|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
124446959|NCT03829241|447601019|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
124446960|NCT03829241|447601020|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
124446961|NCT03829241|447601019|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
124446962|NCT03829241|447601020|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
124446963|NCT03829241|447601019|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
124446964|NCT03829241|447601020|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
124446965|NCT03829241|447601019|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
124446966|NCT03829241|447601020|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
124446967|NCT03829241|447601019|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
124446968|NCT03829241|447601020|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
124446969|NCT03829241|447601019|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
124446970|NCT03829241|447601020|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
124446971|NCT03829241|447601019|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
124446972|NCT03829241|447601020|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
124446973|NCT03829241|447601019|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
124446974|NCT03829241|447601020|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
124446975|NCT03829241|447601019|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
124446976|NCT03829241|447601020|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
124446977|NCT03829241|447601019|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
124446978|NCT03829241|447601020|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
124446979|NCT00698451|447601021|FG000|Overall Study|Adverse Event|22|||
124446980|NCT00698451|447601021|FG000|Overall Study|Physician Decision|2|||
124446981|NCT00698451|447601021|FG000|Overall Study|Protocol Violation|6|||
124446982|NCT00698451|447601021|FG000|Overall Study|Withdrawal by Subject|6|||
124446983|NCT00698451|447601021|FG000|Overall Study|Disease progression|3|||
124446984|NCT02224599|447601022|FG000|Overall Study|Physician Decision|1|||
124446985|NCT02224599|447601022|FG000|Overall Study|Progression of Disease|1|||
124446986|NCT01187550|447601023|FG000|Overall Study|Protocol Violation|3|||
124446987|NCT01187550|447601024|FG001|Overall Study|Protocol Violation|1|||
124446988|NCT01187550|447601023|FG000|Overall Study|Other|3|||
124446989|NCT01187550|447601024|FG001|Overall Study|Other|0|||
124446990|NCT01187550|447601023|FG000|Overall Study|Randomized but not treated|8|||
124446991|NCT01187550|447601024|FG001|Overall Study|Randomized but not treated|0|||
124446992|NCT00733304|447601025|FG000|Overall Study|Adverse Event|3|||
124446993|NCT00733304|447601026|FG001|Overall Study|Adverse Event|0|||
124446994|NCT00733304|447601027|FG002|Overall Study|Adverse Event|0|||
124446995|NCT00733304|447601025|FG000|Overall Study|Lack of Efficacy|0|||
124446996|NCT00733304|447601026|FG001|Overall Study|Lack of Efficacy|0|||
124446997|NCT00733304|447601027|FG002|Overall Study|Lack of Efficacy|2|||
124446998|NCT00733304|447601025|FG000|Overall Study|Lost to Follow-up|0|||
124689269|NCT02400736|448482455|FG000|Overall Study|Moved from the area|3|||
124689270|NCT02400736|448482456|FG001|Overall Study|Moved from the area|1|||
124689271|NCT02582632|448482460|FG000|Overall Study|Other|1|||
124689272|NCT03298061|448482461|FG000|Overall Study|Adverse Event|3|||
124689273|NCT03298061|448482461|FG000|Overall Study|Lack of Efficacy|6|||
124689274|NCT03298061|448482461|FG000|Overall Study|Protocol Violation|1|||
124689275|NCT03298061|448482461|FG000|Overall Study|Physician Decision|7|||
124689276|NCT03298061|448482461|FG000|Overall Study|Withdrawal by Subject|10|||
124689277|NCT00992836|448482465|FG000|Overall Study|Lost to Follow-up|1|||
124689278|NCT00992836|448482465|FG000|Overall Study|Withdrawal by Subject|2|||
124689279|NCT00992836|448482465|FG000|Overall Study|Protocol Violation|2|||
124689280|NCT01617967|448482468|FG000|Overall Study|Protocol Violation|0|||
124689281|NCT01617967|448482469|FG001|Overall Study|Protocol Violation|0|||
124689282|NCT01617967|448482470|FG002|Overall Study|Protocol Violation|0|||
124689283|NCT01617967|448482471|FG003|Overall Study|Protocol Violation|1|||
124689284|NCT01617967|448482472|FG004|Overall Study|Protocol Violation|0|||
124899686|NCT04304534|449257954|FG002|Overall Study|Non-Compliance with study drug|1|||
124899687|NCT04304534|449257955|FG003|Overall Study|Non-Compliance with study drug|1|||
124899688|NCT04304534|449257952|FG000|Overall Study|Lost to Follow-up|0|||
124899689|NCT04304534|449257953|FG001|Overall Study|Lost to Follow-up|1|||
124899690|NCT04304534|449257954|FG002|Overall Study|Lost to Follow-up|2|||
124899691|NCT04304534|449257955|FG003|Overall Study|Lost to Follow-up|3|||
124899692|NCT04304534|449257952|FG000|Overall Study|Unspecific|4|||
124899693|NCT04304534|449257953|FG001|Overall Study|Unspecific|2|||
124689285|NCT01617967|448482473|FG005|Overall Study|Protocol Violation|0|||
124689286|NCT01617967|448482468|FG000|Overall Study|Withdrawal by Subject|0|||
124689287|NCT01617967|448482469|FG001|Overall Study|Withdrawal by Subject|0|||
124689288|NCT01617967|448482470|FG002|Overall Study|Withdrawal by Subject|0|||
124689289|NCT01617967|448482471|FG003|Overall Study|Withdrawal by Subject|0|||
124689290|NCT01617967|448482472|FG004|Overall Study|Withdrawal by Subject|0|||
124689291|NCT01617967|448482473|FG005|Overall Study|Withdrawal by Subject|1|||
124689292|NCT01617967|448482468|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
124689293|NCT01617967|448482469|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
124689294|NCT01617967|448482470|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
124689295|NCT01617967|448482471|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
124689296|NCT01617967|448482472|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
124689297|NCT01617967|448482473|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
124689298|NCT01137812|448482480|FG000|Overall Study|Adverse Event|21|||
124689299|NCT01137812|448482481|FG001|Overall Study|Adverse Event|14|||
124689300|NCT01137812|448482480|FG000|Overall Study|Lost to Follow-up|6|||
124899694|NCT04304534|449257954|FG002|Overall Study|Unspecific|2|||
124899695|NCT04304534|449257955|FG003|Overall Study|Unspecific|2|||
124899696|NCT04304534|449257952|FG000|Overall Study|Technical Problems|2|||
124899697|NCT04304534|449257953|FG001|Overall Study|Technical Problems|2|||
124899698|NCT04304534|449257954|FG002|Overall Study|Technical Problems|3|||
124899699|NCT04304534|449257955|FG003|Overall Study|Technical Problems|4|||
124689301|NCT01137812|448482481|FG001|Overall Study|Lost to Follow-up|8|||
124689302|NCT01137812|448482480|FG000|Overall Study|Physician Decision|25|||
124899700|NCT04304534|449257952|FG000|Overall Study|Death|7|||
124899701|NCT04304534|449257953|FG001|Overall Study|Death|2|||
124899702|NCT04304534|449257954|FG002|Overall Study|Death|4|||
124899703|NCT04304534|449257955|FG003|Overall Study|Death|3|||
124899704|NCT04304534|449257952|FG000|Overall Study|Withdrawal by Subject|7|||
124899705|NCT04304534|449257953|FG001|Overall Study|Withdrawal by Subject|2|||
124899706|NCT04304534|449257954|FG002|Overall Study|Withdrawal by Subject|7|||
124899707|NCT04304534|449257955|FG003|Overall Study|Withdrawal by Subject|4|||
124899708|NCT04304534|449257952|FG000|Overall Study|Physician Decision|4|||
124899709|NCT04304534|449257953|FG001|Overall Study|Physician Decision|9|||
124899710|NCT04304534|449257954|FG002|Overall Study|Physician Decision|9|||
124899711|NCT04304534|449257955|FG003|Overall Study|Physician Decision|5|||
124899712|NCT04304534|449257952|FG000|Overall Study|Subject Decision|34|||
124446999|NCT00733304|447601026|FG001|Overall Study|Lost to Follow-up|1|||
124447000|NCT00733304|447601027|FG002|Overall Study|Lost to Follow-up|0|||
124689303|NCT01137812|448482481|FG001|Overall Study|Physician Decision|17|||
124447001|NCT00733304|447601025|FG000|Overall Study|Physician Decision|3|||
124689304|NCT01137812|448482480|FG000|Overall Study|Protocol Violation|5|||
124689305|NCT01137812|448482481|FG001|Overall Study|Protocol Violation|4|||
124689306|NCT01137812|448482480|FG000|Overall Study|Withdrawal by Subject|5|||
124689307|NCT01137812|448482481|FG001|Overall Study|Withdrawal by Subject|13|||
124689308|NCT01137812|448482480|FG000|Overall Study|Death|2|||
124899713|NCT04304534|449257953|FG001|Overall Study|Subject Decision|25|||
124689309|NCT01137812|448482481|FG001|Overall Study|Death|0|||
124689310|NCT01137812|448482480|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
124899714|NCT04304534|449257954|FG002|Overall Study|Subject Decision|25|||
124899715|NCT04304534|449257955|FG003|Overall Study|Subject Decision|26|||
124899716|NCT04304534|449257952|FG000|Overall Study|Adverse Event|35|||
124899717|NCT04304534|449257953|FG001|Overall Study|Adverse Event|40|||
124899718|NCT04304534|449257954|FG002|Overall Study|Adverse Event|39|||
124899719|NCT04304534|449257955|FG003|Overall Study|Adverse Event|44|||
124899720|NCT00464672|449257956|FG000|Overall Study|withdrawal of consent|0|||
124689311|NCT01137812|448482481|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
124689312|NCT01137812|448482480|FG000|Overall Study|Other|19|||
124689313|NCT01137812|448482481|FG001|Overall Study|Other|27|||
124689314|NCT02383173|448482485|FG000|Overall Study|Palliative Care Team withdrew|0|||
124689315|NCT02383173|448482486|FG001|Overall Study|Palliative Care Team withdrew|2|||
124689316|NCT04621760|448482487|FG000|Overall Study|Lost to Follow-up|2|||
124689317|NCT04621760|448482488|FG001|Overall Study|Lost to Follow-up|4|||
124689318|NCT04621760|448482487|FG000|Overall Study|Withdrawal by Subject|1|||
124689319|NCT04621760|448482488|FG001|Overall Study|Withdrawal by Subject|0|||
124689320|NCT01297244|448482489|FG000|Overall Study|Progressive disease|22|||
124899721|NCT00464672|449257957|FG001|Overall Study|withdrawal of consent|0|||
124899722|NCT00464672|449257958|FG002|Overall Study|withdrawal of consent|0|||
124899723|NCT00464672|449257959|FG003|Overall Study|withdrawal of consent|1|||
124899724|NCT00464672|449257960|FG004|Overall Study|withdrawal of consent|9|||
124899725|NCT00464672|449257961|FG005|Overall Study|withdrawal of consent|4|||
124899726|NCT00464672|449257956|FG000|Overall Study|Lost to Follow-up|25|||
124899727|NCT00464672|449257957|FG001|Overall Study|Lost to Follow-up|10|||
124899728|NCT00464672|449257958|FG002|Overall Study|Lost to Follow-up|0|||
124899729|NCT00464672|449257959|FG003|Overall Study|Lost to Follow-up|0|||
124899730|NCT00464672|449257960|FG004|Overall Study|Lost to Follow-up|1|||
124689321|NCT01297244|448482490|FG001|Overall Study|Progressive disease|3|||
124689322|NCT01297244|448482489|FG000|Overall Study|Adverse Event|9|||
124689323|NCT01297244|448482490|FG001|Overall Study|Adverse Event|1|||
124689324|NCT01297244|448482489|FG000|Overall Study|Death|1|||
124689325|NCT01297244|448482490|FG001|Overall Study|Death|1|||
124689326|NCT01297244|448482489|FG000|Overall Study|Clinical progression|1|||
124759584|NCT01147666|448744758|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
124759585|NCT01147666|448744759|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
124759586|NCT01147666|448744760|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
124759587|NCT01147666|448744761|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
124759588|NCT01147666|448744762|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
124759589|NCT01147666|448744763|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
124759590|NCT01147666|448744764|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
124759591|NCT01147666|448744765|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
124759592|NCT01147666|448744766|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
124759593|NCT01147666|448744767|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
124759594|NCT01147666|448744768|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
124759595|NCT01147666|448744769|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
124759596|NCT01147666|448744755|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
124759597|NCT01147666|448744756|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
124759598|NCT01147666|448744757|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
124899731|NCT00464672|449257961|FG005|Overall Study|Lost to Follow-up|0|||
124899732|NCT00957229|449257962|FG000|Study Start|Adverse Event|0|||
124899733|NCT00957229|449257963|FG001|Study Start|Adverse Event|3|||
124899734|NCT00957229|449257962|FG000|Study Start|Disease Progression|1|||
124447002|NCT00733304|447601026|FG001|Overall Study|Physician Decision|1|||
124689327|NCT01297244|448482490|FG001|Overall Study|Clinical progression|1|||
124689328|NCT01297244|448482489|FG000|Overall Study|Withdrawal by Subject|2|||
124689329|NCT01297244|448482490|FG001|Overall Study|Withdrawal by Subject|0|||
124689330|NCT03677401|448482491|FG000|Overall Study|Adverse Event|4|||
124689331|NCT03677401|448482492|FG001|Overall Study|Adverse Event|14|||
124689332|NCT03677401|448482491|FG000|Overall Study|Lack of Efficacy|3|||
124689333|NCT03677401|448482492|FG001|Overall Study|Lack of Efficacy|1|||
124689334|NCT03677401|448482491|FG000|Overall Study|Withdrawal by Subject|2|||
124759599|NCT01147666|448744758|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
124899735|NCT00957229|449257963|FG001|Study Start|Disease Progression|0|||
124899736|NCT00957229|449257962|FG000|Reallocated to or Continued Vismodegib|Death|1|||
124899737|NCT00957229|449257963|FG001|Reallocated to or Continued Vismodegib|Death|1|||
124899738|NCT00957229|449257962|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
124899739|NCT00957229|449257963|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
124899740|NCT04044664|449257971|FG000|Stage 1|Adverse Event|3|||
124899741|NCT04044664|449257972|FG001|Stage 1|Adverse Event|3|||
124899742|NCT04044664|449257973|FG002|Stage 1|Adverse Event|1|||
124899743|NCT04044664|449257971|FG000|Stage 1|Lost to Follow-up|3|||
124899744|NCT04044664|449257972|FG001|Stage 1|Lost to Follow-up|2|||
124899745|NCT04044664|449257973|FG002|Stage 1|Lost to Follow-up|2|||
124899746|NCT04044664|449257971|FG000|Stage 1|Withdrawal by Subject|9|||
124759600|NCT01147666|448744759|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
124759601|NCT01147666|448744760|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
124899747|NCT04044664|449257972|FG001|Stage 1|Withdrawal by Subject|1|||
124899748|NCT04044664|449257973|FG002|Stage 1|Withdrawal by Subject|0|||
124899749|NCT04044664|449257971|FG000|Stage 1|noncompliance, personal reason|2|||
124759602|NCT01147666|448744761|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
124759603|NCT01147666|448744762|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
124759604|NCT01147666|448744763|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
124759605|NCT01147666|448744764|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
124689335|NCT03677401|448482492|FG001|Overall Study|Withdrawal by Subject|2|||
124689336|NCT03677401|448482491|FG000|Overall Study|Sponsor decision|0|||
124689337|NCT03677401|448482492|FG001|Overall Study|Sponsor decision|1|||
124689338|NCT03677401|448482491|FG000|Overall Study|Reason Unspecified|1|||
124689339|NCT03677401|448482492|FG001|Overall Study|Reason Unspecified|0|||
124689340|NCT01177410|448482495|FG000|Overall Study|Adverse Event|0|||
124689341|NCT01177410|448482496|FG001|Overall Study|Adverse Event|2|||
124689342|NCT01177410|448482497|FG002|Overall Study|Adverse Event|2|||
124689343|NCT01177410|448482495|FG000|Overall Study|Withdrawal by Subject|1|||
124689344|NCT01177410|448482496|FG001|Overall Study|Withdrawal by Subject|4|||
124689345|NCT01177410|448482497|FG002|Overall Study|Withdrawal by Subject|3|||
124689346|NCT01177410|448482495|FG000|Overall Study|Lost to Follow-up|0|||
124689347|NCT01177410|448482496|FG001|Overall Study|Lost to Follow-up|1|||
124689348|NCT01177410|448482497|FG002|Overall Study|Lost to Follow-up|0|||
124689349|NCT02143778|448482500|FG000|Overall Study|Withdrawal by Subject|2|||
124689350|NCT02143778|448482500|FG000|Overall Study|Device malfunction|1|||
124447003|NCT00733304|447601027|FG002|Overall Study|Physician Decision|3|||
124689351|NCT00625378|448482502|FG000|Overall Study|Adverse Event|22|||
124689352|NCT00625378|448482503|FG001|Overall Study|Adverse Event|0|||
124689353|NCT00625378|448482502|FG000|Overall Study|Withdrawal by Subject|16|||
124689354|NCT00625378|448482503|FG001|Overall Study|Withdrawal by Subject|0|||
124689355|NCT00625378|448482502|FG000|Overall Study|Death|38|||
124689356|NCT00625378|448482503|FG001|Overall Study|Death|0|||
124689357|NCT00625378|448482502|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
124689358|NCT00625378|448482503|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
124899750|NCT04044664|449257972|FG001|Stage 1|noncompliance, personal reason|0|||
124899751|NCT04044664|449257973|FG002|Stage 1|noncompliance, personal reason|0|||
124689359|NCT00625378|448482502|FG000|Overall Study|Lost to Follow-up|17|||
124689360|NCT00625378|448482503|FG001|Overall Study|Lost to Follow-up|0|||
124689361|NCT00625378|448482502|FG000|Overall Study|Non-compliant with study medication|3|||
124689362|NCT00625378|448482503|FG001|Overall Study|Non-compliant with study medication|0|||
124689363|NCT00625378|448482502|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
124689364|NCT00625378|448482503|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
124689365|NCT00625378|448482502|FG000|Overall Study|Medical decision|1|||
124689366|NCT00625378|448482503|FG001|Overall Study|Medical decision|0|||
124689367|NCT00625378|448482502|FG000|Overall Study|Multiple toxicities|1|||
124689368|NCT00625378|448482503|FG001|Overall Study|Multiple toxicities|0|||
124689369|NCT00625378|448482502|FG000|Overall Study|New cancer|1|||
124689370|NCT00625378|448482503|FG001|Overall Study|New cancer|0|||
124447004|NCT00733304|447601025|FG000|Overall Study|Withdrawal by Subject|1|||
124447005|NCT00733304|447601026|FG001|Overall Study|Withdrawal by Subject|1|||
124447006|NCT00733304|447601027|FG002|Overall Study|Withdrawal by Subject|0|||
124447007|NCT02616614|447601037|FG000|Overall Study|Withdrawal by Subject|10|||
124447008|NCT02616614|447601038|FG001|Overall Study|Withdrawal by Subject|5|||
124447009|NCT02616614|447601039|FG002|Overall Study|Withdrawal by Subject|6|||
124447010|NCT02616614|447601037|FG000|Overall Study|Physician Decision|2|||
124447011|NCT02616614|447601038|FG001|Overall Study|Physician Decision|1|||
124447012|NCT02616614|447601039|FG002|Overall Study|Physician Decision|0|||
124447013|NCT02616614|447601037|FG000|Overall Study|Adverse Event|1|||
124447014|NCT02616614|447601038|FG001|Overall Study|Adverse Event|4|||
124447015|NCT02616614|447601039|FG002|Overall Study|Adverse Event|1|||
124447016|NCT02616614|447601037|FG000|Overall Study|Protocol Violation|0|||
124447017|NCT02616614|447601038|FG001|Overall Study|Protocol Violation|3|||
124447018|NCT02616614|447601039|FG002|Overall Study|Protocol Violation|1|||
124447019|NCT02616614|447601037|FG000|Overall Study|Prohibited Medication|12|||
124447020|NCT02616614|447601038|FG001|Overall Study|Prohibited Medication|9|||
124447021|NCT02616614|447601039|FG002|Overall Study|Prohibited Medication|5|||
124447022|NCT02616614|447601037|FG000|Overall Study|More than 3 applications missed|6|||
124447023|NCT02616614|447601038|FG001|Overall Study|More than 3 applications missed|8|||
124447024|NCT02616614|447601039|FG002|Overall Study|More than 3 applications missed|1|||
124447025|NCT02616614|447601037|FG000|Overall Study|Lost to Follow-up|31|||
124447026|NCT02616614|447601038|FG001|Overall Study|Lost to Follow-up|28|||
124447027|NCT02616614|447601039|FG002|Overall Study|Lost to Follow-up|13|||
124447028|NCT02616614|447601037|FG000|Overall Study|Pregnancy|2|||
124447029|NCT02616614|447601038|FG001|Overall Study|Pregnancy|0|||
124447030|NCT02616614|447601039|FG002|Overall Study|Pregnancy|1|||
124447031|NCT02616614|447601037|FG000|Overall Study|Other|1|||
124447032|NCT02616614|447601038|FG001|Overall Study|Other|2|||
124447033|NCT02616614|447601039|FG002|Overall Study|Other|1|||
124447034|NCT00596934|447601040|FG000|Overall Study|Protocol Violation|1|||
124447035|NCT00596934|447601040|FG000|Overall Study|Withdrawal by Subject|1|||
124447036|NCT02445755|447601041|FG000|Overall Study|Withdrawal by Subject|2|||
124447037|NCT02445755|447601041|FG000|Overall Study|Protocol Violation|6|||
124447038|NCT02445755|447601041|FG000|Overall Study|Screen Failure|5|||
124447039|NCT03239483|447601042|FG000|Overall Study|Lost to Follow-up|1|||
124447040|NCT03239483|447601043|FG001|Overall Study|Lost to Follow-up|0|||
124447041|NCT03239483|447601042|FG000|Overall Study|Withdrawal by Subject|1|||
124447042|NCT03239483|447601043|FG001|Overall Study|Withdrawal by Subject|0|||
124447043|NCT02308007|447601044|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
124447044|NCT02308007|447601045|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
124447045|NCT02308007|447601046|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
124447046|NCT02308007|447601044|FG000|Overall Study|Positive for STD at Baseline|7|||
124447047|NCT02308007|447601045|FG001|Overall Study|Positive for STD at Baseline|11|||
124447048|NCT02308007|447601046|FG002|Overall Study|Positive for STD at Baseline|7|||
124447049|NCT02308007|447601044|FG000|Overall Study|Lost to Follow-up|3|||
124447050|NCT02308007|447601045|FG001|Overall Study|Lost to Follow-up|0|||
124447051|NCT02308007|447601046|FG002|Overall Study|Lost to Follow-up|1|||
124447052|NCT00528567|447601051|FG000|Overall Study|Death|4|||
124447053|NCT00528567|447601052|FG001|Overall Study|Death|5|||
124447054|NCT00528567|447601051|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
124689371|NCT00625378|448482502|FG000|Overall Study|PTA program|2|||
124447055|NCT00528567|447601052|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
124447056|NCT00528567|447601051|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
124447057|NCT00528567|447601052|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
124447058|NCT00528567|447601051|FG000|Overall Study|Violation Criteria at Entry|3|||
124447059|NCT00528567|447601052|FG001|Overall Study|Violation Criteria at Entry|17|||
124689372|NCT00625378|448482503|FG001|Overall Study|PTA program|0|||
124689373|NCT00625378|448482502|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
124447060|NCT00528567|447601051|FG000|Overall Study|Withdrew Consent|59|||
124447061|NCT00528567|447601052|FG001|Overall Study|Withdrew Consent|55|||
124447062|NCT00528567|447601051|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
124689374|NCT00625378|448482503|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
124689375|NCT00625378|448482502|FG000|Overall Study|Sponsor decision|1|||
124689376|NCT00625378|448482503|FG001|Overall Study|Sponsor decision|0|||
124689377|NCT00625378|448482502|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
124689378|NCT00625378|448482503|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
124689379|NCT00625378|448482502|FG000|Overall Study|Switch to commercial drug|6|||
124689380|NCT00625378|448482503|FG001|Overall Study|Switch to commercial drug|1|||
124689381|NCT00625378|448482502|FG000|Overall Study|Missing|2|||
124689382|NCT00625378|448482503|FG001|Overall Study|Missing|0|||
124689383|NCT00625378|448482502|FG000|Overall Study|End of treatment not available|2|||
124689384|NCT00625378|448482503|FG001|Overall Study|End of treatment not available|0|||
124689385|NCT00625378|448482502|FG000|Overall Study|Never treated|2|||
124689386|NCT00625378|448482503|FG001|Overall Study|Never treated|0|||
124689387|NCT02639559|448482505|FG000|Overall Study|Mobilization failure|0|||
124689388|NCT02639559|448482506|FG001|Overall Study|Mobilization failure|3|||
124689389|NCT02639559|448482505|FG000|Overall Study|Issues with vascular acess|1|||
124759606|NCT01147666|448744765|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
124689390|NCT02639559|448482506|FG001|Overall Study|Issues with vascular acess|0|||
124689391|NCT03880565|448482507|FG000|Overall Study|Withdrawal by Subject|1|||
124447063|NCT00528567|447601052|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
124447064|NCT00528567|447601051|FG000|Overall Study|Failure to Return|1|||
124447065|NCT00528567|447601052|FG001|Overall Study|Failure to Return|4|||
124447066|NCT00528567|447601051|FG000|Overall Study|Other Protocol Violation|5|||
124447067|NCT00528567|447601052|FG001|Overall Study|Other Protocol Violation|21|||
124447068|NCT00528567|447601051|FG000|Overall Study|Administrative/Other|22|||
124447069|NCT00528567|447601052|FG001|Overall Study|Administrative/Other|75|||
124447070|NCT03085758|447601055|FG000|Overall Study|Death|26|||
124447071|NCT03085758|447601056|FG001|Overall Study|Death|24|||
124447072|NCT03085758|447601057|FG002|Overall Study|Death|53|||
124447073|NCT03085758|447601055|FG000|Overall Study|Lost to Follow-up|1|||
124447074|NCT03085758|447601056|FG001|Overall Study|Lost to Follow-up|1|||
124447075|NCT03085758|447601057|FG002|Overall Study|Lost to Follow-up|1|||
124447076|NCT03085758|447601055|FG000|Overall Study|Withdrawal by Subject|2|||
124447077|NCT03085758|447601056|FG001|Overall Study|Withdrawal by Subject|2|||
124447078|NCT03085758|447601057|FG002|Overall Study|Withdrawal by Subject|1|||
124447079|NCT03085758|447601055|FG000|Overall Study|Refusal to recall it up to day 90|0|||
124447080|NCT03085758|447601056|FG001|Overall Study|Refusal to recall it up to day 90|0|||
124447081|NCT03085758|447601057|FG002|Overall Study|Refusal to recall it up to day 90|1|||
124447082|NCT03085758|447601055|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
124447083|NCT03085758|447601056|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
124447084|NCT03085758|447601057|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
124447085|NCT04004429|447601060|FG000|Overall Study|Protocol Violation|1|||
124759607|NCT01147666|448744766|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
124759608|NCT01147666|448744767|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
124759609|NCT01147666|448744768|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
124759610|NCT01147666|448744769|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
124759611|NCT01147666|448744755|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
124759612|NCT01147666|448744756|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
124759613|NCT01147666|448744757|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
124759614|NCT01147666|448744758|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
124759615|NCT01147666|448744759|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
124759616|NCT01147666|448744760|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
124759617|NCT01147666|448744761|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
124759618|NCT01147666|448744762|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
124759619|NCT01147666|448744763|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
124447086|NCT04004429|447601061|FG001|Overall Study|Protocol Violation|0|||
124447087|NCT04004429|447601062|FG002|Overall Study|Protocol Violation|0|||
124447088|NCT04004429|447601060|FG000|Overall Study|Physician Decision|0|||
124447089|NCT04004429|447601061|FG001|Overall Study|Physician Decision|1|||
124447090|NCT04004429|447601062|FG002|Overall Study|Physician Decision|1|||
124447091|NCT04004429|447601060|FG000|Overall Study|Withdrawal by Subject|1|||
124447092|NCT04004429|447601061|FG001|Overall Study|Withdrawal by Subject|1|||
124447093|NCT04004429|447601062|FG002|Overall Study|Withdrawal by Subject|1|||
124447094|NCT00631189|447601063|FG000|Initial Phase|Protocol Violation|347|||
124447095|NCT00631189|447601064|FG001|Initial Phase|Protocol Violation|0|||
124447096|NCT00631189|447601065|FG002|Initial Phase|Protocol Violation|0|||
124447097|NCT00631189|447601066|FG003|Initial Phase|Protocol Violation|0|||
124447098|NCT00631189|447601063|FG000|Initial Phase|Withdrawal by Subject|4|||
124447099|NCT00631189|447601064|FG001|Initial Phase|Withdrawal by Subject|0|||
124447100|NCT00631189|447601065|FG002|Initial Phase|Withdrawal by Subject|0|||
124447101|NCT00631189|447601066|FG003|Initial Phase|Withdrawal by Subject|0|||
124447102|NCT00631189|447601063|FG000|Treatment Phase|Withdrawal by Subject|0|||
124447103|NCT00631189|447601064|FG001|Treatment Phase|Withdrawal by Subject|2|||
124447104|NCT00631189|447601065|FG002|Treatment Phase|Withdrawal by Subject|1|||
124447105|NCT00631189|447601066|FG003|Treatment Phase|Withdrawal by Subject|1|||
124447106|NCT00631189|447601063|FG000|Treatment Phase|Protocol Violation|0|||
124447107|NCT00631189|447601064|FG001|Treatment Phase|Protocol Violation|1|||
124447108|NCT00631189|447601065|FG002|Treatment Phase|Protocol Violation|6|||
124447109|NCT00631189|447601066|FG003|Treatment Phase|Protocol Violation|2|||
124447110|NCT00631189|447601063|FG000|Treatment Phase|Adverse Event|0|||
124447111|NCT00631189|447601064|FG001|Treatment Phase|Adverse Event|3|||
124447112|NCT00631189|447601065|FG002|Treatment Phase|Adverse Event|2|||
124447113|NCT00631189|447601066|FG003|Treatment Phase|Adverse Event|4|||
124447114|NCT00631189|447601063|FG000|Treatment Phase|Lost to Follow-up|0|||
124447115|NCT00631189|447601064|FG001|Treatment Phase|Lost to Follow-up|1|||
124447116|NCT00631189|447601065|FG002|Treatment Phase|Lost to Follow-up|0|||
124447117|NCT00631189|447601066|FG003|Treatment Phase|Lost to Follow-up|0|||
124447118|NCT00631189|447601063|FG000|Treatment Phase|Pregnancy|0|||
124447119|NCT00631189|447601064|FG001|Treatment Phase|Pregnancy|0|||
124447120|NCT00631189|447601065|FG002|Treatment Phase|Pregnancy|1|||
124447121|NCT00631189|447601066|FG003|Treatment Phase|Pregnancy|0|||
124447122|NCT00631189|447601063|FG000|Treatment Phase|patient did not take pravastatin|0|||
124899752|NCT04044664|449257971|FG000|Stage 1|randomization error|0|||
124447123|NCT00631189|447601064|FG001|Treatment Phase|patient did not take pravastatin|0|||
124447124|NCT00631189|447601065|FG002|Treatment Phase|patient did not take pravastatin|1|||
124689392|NCT03880565|448482508|FG001|Overall Study|Withdrawal by Subject|0|||
124689393|NCT02969018|448482513|FG000|Overall Study|Adverse Event|2|||
124689394|NCT02969018|448482514|FG001|Overall Study|Adverse Event|4|||
124689395|NCT02969018|448482515|FG002|Overall Study|Adverse Event|1|||
124689396|NCT02969018|448482516|FG003|Overall Study|Adverse Event|2|||
124689397|NCT02969018|448482517|FG004|Overall Study|Adverse Event|0|||
124689398|NCT02969018|448482518|FG005|Overall Study|Adverse Event|1|||
124689399|NCT02969018|448482519|FG006|Overall Study|Adverse Event|2|||
124689400|NCT02969018|448482520|FG007|Overall Study|Adverse Event|0|||
124689401|NCT02969018|448482513|FG000|Overall Study|Lack of Efficacy|0|||
124689402|NCT02969018|448482514|FG001|Overall Study|Lack of Efficacy|1|||
124689403|NCT02969018|448482515|FG002|Overall Study|Lack of Efficacy|0|||
124689404|NCT02969018|448482516|FG003|Overall Study|Lack of Efficacy|0|||
124689405|NCT02969018|448482517|FG004|Overall Study|Lack of Efficacy|1|||
124689406|NCT02969018|448482518|FG005|Overall Study|Lack of Efficacy|1|||
124689407|NCT02969018|448482519|FG006|Overall Study|Lack of Efficacy|1|||
124689408|NCT02969018|448482520|FG007|Overall Study|Lack of Efficacy|1|||
124689409|NCT02969018|448482513|FG000|Overall Study|Lost to Follow-up|1|||
124689410|NCT02969018|448482514|FG001|Overall Study|Lost to Follow-up|2|||
124689411|NCT02969018|448482515|FG002|Overall Study|Lost to Follow-up|2|||
124689412|NCT02969018|448482516|FG003|Overall Study|Lost to Follow-up|0|||
124689413|NCT02969018|448482517|FG004|Overall Study|Lost to Follow-up|1|||
124689414|NCT02969018|448482518|FG005|Overall Study|Lost to Follow-up|1|||
124689415|NCT02969018|448482519|FG006|Overall Study|Lost to Follow-up|0|||
124689416|NCT02969018|448482520|FG007|Overall Study|Lost to Follow-up|1|||
124689417|NCT02969018|448482513|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
124689418|NCT02969018|448482514|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
124689419|NCT02969018|448482515|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
124689420|NCT02969018|448482516|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
124689421|NCT02969018|448482517|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
124689422|NCT02969018|448482518|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
124689423|NCT02969018|448482519|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
124689424|NCT02969018|448482520|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
124689425|NCT02969018|448482513|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124689426|NCT02969018|448482514|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124689427|NCT02969018|448482515|FG002|Overall Study|Non-Compliance With Study Drug|0|||
124689428|NCT02969018|448482516|FG003|Overall Study|Non-Compliance With Study Drug|0|||
124689429|NCT02969018|448482517|FG004|Overall Study|Non-Compliance With Study Drug|0|||
124689430|NCT02969018|448482518|FG005|Overall Study|Non-Compliance With Study Drug|0|||
124689431|NCT02969018|448482519|FG006|Overall Study|Non-Compliance With Study Drug|0|||
124689432|NCT02969018|448482520|FG007|Overall Study|Non-Compliance With Study Drug|0|||
124689433|NCT02969018|448482513|FG000|Overall Study|Other|0|||
124689434|NCT02969018|448482514|FG001|Overall Study|Other|0|||
124689435|NCT02969018|448482515|FG002|Overall Study|Other|0|||
124689436|NCT02969018|448482516|FG003|Overall Study|Other|1|||
124689437|NCT02969018|448482517|FG004|Overall Study|Other|0|||
124689438|NCT02969018|448482518|FG005|Overall Study|Other|0|||
124689439|NCT02969018|448482519|FG006|Overall Study|Other|0|||
124689440|NCT02969018|448482520|FG007|Overall Study|Other|2|||
124689441|NCT02969018|448482513|FG000|Overall Study|Pregnancy|0|||
124689442|NCT02969018|448482514|FG001|Overall Study|Pregnancy|0|||
124689443|NCT02969018|448482515|FG002|Overall Study|Pregnancy|0|||
124689444|NCT02969018|448482516|FG003|Overall Study|Pregnancy|0|||
124689445|NCT02969018|448482517|FG004|Overall Study|Pregnancy|0|||
124689446|NCT02969018|448482518|FG005|Overall Study|Pregnancy|1|||
124689447|NCT02969018|448482519|FG006|Overall Study|Pregnancy|0|||
124689448|NCT02969018|448482520|FG007|Overall Study|Pregnancy|0|||
124689449|NCT02969018|448482513|FG000|Overall Study|Protocol Violation|0|||
124689450|NCT02969018|448482514|FG001|Overall Study|Protocol Violation|0|||
124689451|NCT02969018|448482515|FG002|Overall Study|Protocol Violation|1|||
124759620|NCT01147666|448744764|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
124899753|NCT04044664|449257972|FG001|Stage 1|randomization error|1|||
124899754|NCT04044664|449257973|FG002|Stage 1|randomization error|0|||
124899755|NCT04044664|449257971|FG000|Stage 2|Adverse Event|2|||
124899756|NCT04044664|449257972|FG001|Stage 2|Adverse Event|0|||
124689452|NCT02969018|448482516|FG003|Overall Study|Protocol Violation|1|||
124689453|NCT02969018|448482517|FG004|Overall Study|Protocol Violation|0|||
124689454|NCT02969018|448482518|FG005|Overall Study|Protocol Violation|0|||
124689455|NCT02969018|448482519|FG006|Overall Study|Protocol Violation|0|||
124689456|NCT02969018|448482520|FG007|Overall Study|Protocol Violation|0|||
124689457|NCT02969018|448482513|FG000|Overall Study|Withdrawal by Subject|0|||
124689458|NCT02969018|448482514|FG001|Overall Study|Withdrawal by Subject|1|||
124689459|NCT02969018|448482515|FG002|Overall Study|Withdrawal by Subject|2|||
124689460|NCT02969018|448482516|FG003|Overall Study|Withdrawal by Subject|1|||
124689461|NCT02969018|448482517|FG004|Overall Study|Withdrawal by Subject|0|||
124689462|NCT02969018|448482518|FG005|Overall Study|Withdrawal by Subject|4|||
124689463|NCT02969018|448482519|FG006|Overall Study|Withdrawal by Subject|4|||
124689464|NCT02969018|448482520|FG007|Overall Study|Withdrawal by Subject|3|||
124899757|NCT04044664|449257973|FG002|Stage 2|Adverse Event|0|||
124689465|NCT00367458|448482521|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
124689466|NCT00367458|448482522|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
124689467|NCT05762679|448482528|FG000|Overall Study|Withdrawal by Subject|1|||
124689468|NCT05762679|448482528|FG000|Overall Study|No analyzable imaging data|1|||
124689469|NCT03670628|448482529|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
124689470|NCT03670628|448482530|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
124689471|NCT03670628|448482529|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
124689472|NCT03670628|448482530|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
124689473|NCT02942407|448482531|FG000|Overall Study|Lost to Follow-up|3|||
124689474|NCT02942407|448482532|FG001|Overall Study|Lost to Follow-up|2|||
124689475|NCT02942407|448482531|FG000|Overall Study|Withdrawal by Subject|7|||
124689476|NCT02942407|448482532|FG001|Overall Study|Withdrawal by Subject|9|||
124689477|NCT02942407|448482531|FG000|Overall Study|Death|16|||
124689478|NCT02942407|448482532|FG001|Overall Study|Death|13|||
124689479|NCT01716156|448482534|FG000|Overall Study|Protocol Violation|1|||
124689480|NCT01716156|448482535|FG001|Overall Study|Protocol Violation|0|||
124689481|NCT01716156|448482536|FG002|Overall Study|Protocol Violation|0|||
124689482|NCT01716156|448482534|FG000|Overall Study|Withdrawal by Subject|0|||
124689483|NCT01716156|448482535|FG001|Overall Study|Withdrawal by Subject|1|||
124689484|NCT01716156|448482536|FG002|Overall Study|Withdrawal by Subject|2|||
124689485|NCT01716156|448482534|FG000|Overall Study|Lost to Follow-up|1|||
124689486|NCT01716156|448482535|FG001|Overall Study|Lost to Follow-up|0|||
124689487|NCT01716156|448482536|FG002|Overall Study|Lost to Follow-up|0|||
124689488|NCT03925220|448482537|FG000|Overall Study|Withdrawal by Subject|4|||
124689489|NCT03925220|448482538|FG001|Overall Study|Withdrawal by Subject|4|||
124899758|NCT04044664|449257971|FG000|Stage 2|Lost to Follow-up|3|||
124899759|NCT04044664|449257972|FG001|Stage 2|Lost to Follow-up|2|||
124899760|NCT04044664|449257973|FG002|Stage 2|Lost to Follow-up|1|||
124899761|NCT04044664|449257971|FG000|Stage 2|Withdrawal by Subject|3|||
124899762|NCT04044664|449257972|FG001|Stage 2|Withdrawal by Subject|0|||
124899763|NCT04044664|449257973|FG002|Stage 2|Withdrawal by Subject|0|||
124899764|NCT04044664|449257971|FG000|Stage 2|protocol deviation|1|||
124899765|NCT04044664|449257972|FG001|Stage 2|protocol deviation|0|||
124899766|NCT04044664|449257973|FG002|Stage 2|protocol deviation|0|||
124899767|NCT00001575|449257974|FG000|Overall Study|Screening failures-Ph I portion|22|||
124899768|NCT00001575|449257974|FG000|Overall Study|Withdrawn/deaths|23|||
124899769|NCT03736785|449257975|FG000|Overall Study|Adverse Event|1|||
124899770|NCT03736785|449257976|FG001|Overall Study|Adverse Event|1|||
124899771|NCT03736785|449257977|FG002|Overall Study|Adverse Event|1|||
124899772|NCT03736785|449257975|FG000|Overall Study|Death|1|||
124899773|NCT03736785|449257976|FG001|Overall Study|Death|0|||
124899774|NCT03736785|449257977|FG002|Overall Study|Death|1|||
124899775|NCT03736785|449257975|FG000|Overall Study|Lost to Follow-up|0|||
124899776|NCT03736785|449257976|FG001|Overall Study|Lost to Follow-up|2|||
124899777|NCT03736785|449257977|FG002|Overall Study|Lost to Follow-up|3|||
124899778|NCT03736785|449257975|FG000|Overall Study|Non compliance with study drug|1|||
124899779|NCT03736785|449257976|FG001|Overall Study|Non compliance with study drug|1|||
124899780|NCT03736785|449257977|FG002|Overall Study|Non compliance with study drug|0|||
124899781|NCT03736785|449257975|FG000|Overall Study|Physician Decision|0|||
124899782|NCT03736785|449257976|FG001|Overall Study|Physician Decision|1|||
124899783|NCT03736785|449257977|FG002|Overall Study|Physician Decision|1|||
124899784|NCT03736785|449257975|FG000|Overall Study|Protocol Violation|1|||
124899785|NCT03736785|449257976|FG001|Overall Study|Protocol Violation|4|||
124899786|NCT03736785|449257977|FG002|Overall Study|Protocol Violation|3|||
124899787|NCT03736785|449257975|FG000|Overall Study|Sponsor Decision|1|||
124899788|NCT03736785|449257976|FG001|Overall Study|Sponsor Decision|0|||
124899789|NCT03736785|449257977|FG002|Overall Study|Sponsor Decision|0|||
124899790|NCT03736785|449257975|FG000|Overall Study|Unknown/Missing data|3|||
124899791|NCT03736785|449257976|FG001|Overall Study|Unknown/Missing data|2|||
124899792|NCT03736785|449257977|FG002|Overall Study|Unknown/Missing data|1|||
124899793|NCT03736785|449257975|FG000|Overall Study|Withdrawal by Subject|9|||
124899794|NCT03736785|449257976|FG001|Overall Study|Withdrawal by Subject|6|||
124899795|NCT03736785|449257977|FG002|Overall Study|Withdrawal by Subject|4|||
124689490|NCT03925220|448482539|FG002|Overall Study|Withdrawal by Subject|4|||
124689491|NCT03925220|448482540|FG003|Overall Study|Withdrawal by Subject|4|||
124689492|NCT03925220|448482537|FG000|Overall Study|Lost to Follow-up|40|||
124899796|NCT01744691|449257987|FG000|Overall Study|Progressive Disease|18|||
124899797|NCT01744691|449257987|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
124899798|NCT01744691|449257987|FG000|Overall Study|Withdrawal of consent for treatment|3|||
124899799|NCT01744691|449257987|FG000|Overall Study|Physician Decision|4|||
124899800|NCT01190150|449257989|FG000|First Treatment|Withdrawal by Subject|1|||
124899801|NCT01190150|449257990|FG001|First Treatment|Withdrawal by Subject|0|||
124899802|NCT01190150|449257989|FG000|Washout|Withdrawal by Subject|0|||
124899803|NCT01190150|449257990|FG001|Washout|Withdrawal by Subject|1|||
124899804|NCT01190150|449257989|FG000|Washout|Difficulty in adherence|0|||
124899805|NCT01190150|449257990|FG001|Washout|Difficulty in adherence|1|||
124899806|NCT04511650|449257993|FG000|Overall Study|Lost to Follow-up|1|||
124899807|NCT04511650|449257994|FG001|Overall Study|Lost to Follow-up|0|||
124899808|NCT04511650|449257995|FG002|Overall Study|Lost to Follow-up|0|||
124899809|NCT04511650|449257993|FG000|Overall Study|Withdrawal by Subject|1|||
124899810|NCT04511650|449257994|FG001|Overall Study|Withdrawal by Subject|0|||
124899811|NCT04511650|449257995|FG002|Overall Study|Withdrawal by Subject|0|||
124899812|NCT04511650|449257993|FG000|Overall Study|reason not provided|0|||
124899813|NCT04511650|449257994|FG001|Overall Study|reason not provided|0|||
124899814|NCT04511650|449257995|FG002|Overall Study|reason not provided|1|||
124899815|NCT04511650|449257993|FG000|Overall Study|Death|1|||
124899816|NCT04511650|449257994|FG001|Overall Study|Death|1|||
124899817|NCT04511650|449257995|FG002|Overall Study|Death|1|||
124899818|NCT01081145|449258006|FG000|Open-Label Phase|Lack of Efficacy|56|||
124899819|NCT01081145|449258007|FG001|Open-Label Phase|Lack of Efficacy|0|||
124899820|NCT01081145|449258006|FG000|Open-Label Phase|Response criteria not met|46|||
124899821|NCT01081145|449258007|FG001|Open-Label Phase|Response criteria not met|0|||
124899822|NCT01081145|449258006|FG000|Open-Label Phase|Adverse Event|42|||
124899823|NCT01081145|449258007|FG001|Open-Label Phase|Adverse Event|0|||
124899824|NCT01081145|449258006|FG000|Open-Label Phase|Withdrawal by Subject|41|||
124899825|NCT01081145|449258007|FG001|Open-Label Phase|Withdrawal by Subject|0|||
124899826|NCT01081145|449258006|FG000|Open-Label Phase|Other|12|||
124899827|NCT01081145|449258007|FG001|Open-Label Phase|Other|0|||
124899828|NCT01081145|449258006|FG000|Open-Label Phase|Lost to Follow-up|11|||
124899829|NCT01081145|449258007|FG001|Open-Label Phase|Lost to Follow-up|0|||
124899830|NCT01081145|449258006|FG000|Open-Label Phase|Protocol Violation|4|||
124899831|NCT01081145|449258007|FG001|Open-Label Phase|Protocol Violation|0|||
124899832|NCT01081145|449258006|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
124899833|NCT01081145|449258007|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
124899834|NCT01081145|449258006|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
124899835|NCT01081145|449258007|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
124899836|NCT01081145|449258006|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
124899837|NCT01081145|449258007|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
124899838|NCT01081145|449258006|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
124899839|NCT01081145|449258007|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
124899840|NCT01081145|449258006|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
124899841|NCT01081145|449258007|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
124899842|NCT01081145|449258006|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
124899843|NCT01081145|449258007|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
124899844|NCT01081145|449258006|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
124899845|NCT01081145|449258007|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
124899846|NCT02197234|449258008|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
124899847|NCT02197234|449258008|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
124447125|NCT00631189|447601066|FG003|Treatment Phase|patient did not take pravastatin|0|||
124447126|NCT04464265|447601067|FG000|Overall Study|Physician Decision|2|||
124447127|NCT00974090|447601072|FG000|Period 1: Double Blind Period|Adverse Event|2|||
124447128|NCT00974090|447601073|FG001|Period 1: Double Blind Period|Adverse Event|1|||
124447129|NCT00974090|447601072|FG000|Period 1: Double Blind Period|Physician Decision|1|||
124447130|NCT00974090|447601073|FG001|Period 1: Double Blind Period|Physician Decision|0|||
124759621|NCT01147666|448744765|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
124899848|NCT02197234|449258008|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
124899849|NCT02197234|449258008|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
124899850|NCT02197234|449258008|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
124899851|NCT02197234|449258008|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
124447131|NCT00974090|447601072|FG000|Period 2: Open-label Period|Adverse Event|4|||
124447132|NCT00974090|447601073|FG001|Period 2: Open-label Period|Adverse Event|6|||
124899852|NCT05826431|449258010|FG000|Overall Study|Withdrawal by Subject|1|||
124899853|NCT04771273|449258011|FG000|Dose Escalation Period|Not treated with trial medication|0|||
124899854|NCT04771273|449258012|FG001|Dose Escalation Period|Not treated with trial medication|1|||
124899855|NCT04771273|449258013|FG002|Dose Escalation Period|Not treated with trial medication|1|||
124899856|NCT04771273|449258014|FG003|Dose Escalation Period|Not treated with trial medication|0|||
124899857|NCT04771273|449258011|FG000|Dose Escalation Period|Other reasons than listed|2|||
124899858|NCT04771273|449258012|FG001|Dose Escalation Period|Other reasons than listed|0|||
124899859|NCT04771273|449258013|FG002|Dose Escalation Period|Other reasons than listed|2|||
124899860|NCT04771273|449258014|FG003|Dose Escalation Period|Other reasons than listed|1|||
124899861|NCT04771273|449258011|FG000|Dose Escalation Period|Protocol Violation|0|||
124899862|NCT04771273|449258012|FG001|Dose Escalation Period|Protocol Violation|0|||
124899863|NCT04771273|449258013|FG002|Dose Escalation Period|Protocol Violation|3|||
124899864|NCT04771273|449258014|FG003|Dose Escalation Period|Protocol Violation|1|||
124447133|NCT00974090|447601072|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
124447134|NCT00974090|447601073|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
124447135|NCT00974090|447601072|FG000|Period 2: Open-label Period|Physician Decision|0|||
124447136|NCT00974090|447601073|FG001|Period 2: Open-label Period|Physician Decision|3|||
124447137|NCT00974090|447601072|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
124447138|NCT00974090|447601073|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
124447139|NCT00056862|447601074|FG000|Overall Study|Protocol Violation|1|||
124447140|NCT00056862|447601075|FG001|Overall Study|Protocol Violation|0|||
124447141|NCT01122576|447601076|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
124447142|NCT01122576|447601077|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
124447143|NCT01122576|447601078|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
124447144|NCT01122576|447601076|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
124447145|NCT01122576|447601077|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
124447146|NCT01122576|447601078|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
124447147|NCT01122576|447601076|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
124447148|NCT01122576|447601077|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
124447149|NCT01122576|447601078|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
124447150|NCT00381563|447601083|FG000|Overall Study|Withdrawal by Subject|5|||
124447151|NCT00381563|447601084|FG001|Overall Study|Withdrawal by Subject|5|||
124447152|NCT00381563|447601083|FG000|Overall Study|Lost to Follow-up|2|||
124447153|NCT00381563|447601084|FG001|Overall Study|Lost to Follow-up|0|||
124447154|NCT00381563|447601083|FG000|Overall Study|Protocol Violation|0|||
124447155|NCT00381563|447601084|FG001|Overall Study|Protocol Violation|1|||
124447156|NCT00931944|447601086|FG000|Overall Study|Adverse Event|4|||
124447157|NCT00931944|447601086|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
124447158|NCT00931944|447601086|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
124447159|NCT00931944|447601086|FG000|Overall Study|Death|28|||
124447160|NCT00931944|447601086|FG000|Overall Study|Other|2|||
124447161|NCT01132612|447601087|FG000|Overall Study|Death|0|||
124447162|NCT01132612|447601088|FG001|Overall Study|Death|0|||
124447163|NCT01132612|447601089|FG002|Overall Study|Death|1|||
124447164|NCT01132612|447601087|FG000|Overall Study|Protocol deviation|0|||
124759622|NCT01147666|448744766|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
124899865|NCT04771273|449258011|FG000|Dose Escalation Period|Burden of study procedures|1|||
124899866|NCT04771273|449258012|FG001|Dose Escalation Period|Burden of study procedures|0|||
124899867|NCT04771273|449258013|FG002|Dose Escalation Period|Burden of study procedures|0|||
124899868|NCT04771273|449258014|FG003|Dose Escalation Period|Burden of study procedures|0|||
124899869|NCT04771273|449258011|FG000|Dose Escalation Period|Change of residence|0|||
124899870|NCT04771273|449258012|FG001|Dose Escalation Period|Change of residence|0|||
124899871|NCT04771273|449258013|FG002|Dose Escalation Period|Change of residence|0|||
124899872|NCT04771273|449258014|FG003|Dose Escalation Period|Change of residence|1|||
124899873|NCT04771273|449258011|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
124899874|NCT04771273|449258012|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
124899875|NCT04771273|449258013|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
124899876|NCT04771273|449258014|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
124899877|NCT04771273|449258011|FG000|Dose Escalation Period|Adverse Event|8|||
124899878|NCT04771273|449258012|FG001|Dose Escalation Period|Adverse Event|9|||
124899879|NCT04771273|449258013|FG002|Dose Escalation Period|Adverse Event|12|||
124899880|NCT04771273|449258014|FG003|Dose Escalation Period|Adverse Event|2|||
124899881|NCT04771273|449258011|FG000|Maintenance Period|Other than listed|4|||
124899882|NCT04771273|449258012|FG001|Maintenance Period|Other than listed|2|||
124899883|NCT04771273|449258013|FG002|Maintenance Period|Other than listed|0|||
124689493|NCT03925220|448482538|FG001|Overall Study|Lost to Follow-up|46|||
124689494|NCT03925220|448482539|FG002|Overall Study|Lost to Follow-up|37|||
124689495|NCT03925220|448482540|FG003|Overall Study|Lost to Follow-up|38|||
124689496|NCT05221866|448482541|FG000|Overall Study|Withdrawal by Subject|5|||
124689497|NCT05221866|448482542|FG001|Overall Study|Withdrawal by Subject|7|||
124689498|NCT05221866|448482543|FG002|Overall Study|Withdrawal by Subject|6|||
124689499|NCT05221866|448482544|FG003|Overall Study|Withdrawal by Subject|4|||
124689500|NCT05221866|448482541|FG000|Overall Study|Physician Decision|3|||
124689501|NCT05221866|448482542|FG001|Overall Study|Physician Decision|2|||
124689502|NCT05221866|448482543|FG002|Overall Study|Physician Decision|1|||
124689503|NCT05221866|448482544|FG003|Overall Study|Physician Decision|4|||
124689504|NCT05221866|448482541|FG000|Overall Study|Lost to Follow-up|12|||
124689505|NCT05221866|448482542|FG001|Overall Study|Lost to Follow-up|17|||
124689506|NCT05221866|448482543|FG002|Overall Study|Lost to Follow-up|14|||
124689507|NCT05221866|448482544|FG003|Overall Study|Lost to Follow-up|14|||
124689508|NCT05221866|448482541|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
124899884|NCT04771273|449258014|FG003|Maintenance Period|Other than listed|3|||
124899885|NCT04771273|449258011|FG000|Maintenance Period|Burden of study procedures|1|||
124899886|NCT04771273|449258012|FG001|Maintenance Period|Burden of study procedures|0|||
124899887|NCT04771273|449258013|FG002|Maintenance Period|Burden of study procedures|0|||
124899888|NCT04771273|449258014|FG003|Maintenance Period|Burden of study procedures|0|||
124899889|NCT04771273|449258011|FG000|Maintenance Period|Change of residence|0|||
124447165|NCT01132612|447601088|FG001|Overall Study|Protocol deviation|0|||
124447166|NCT01132612|447601089|FG002|Overall Study|Protocol deviation|3|||
124689509|NCT05221866|448482542|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
124689510|NCT05221866|448482543|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
124689511|NCT05221866|448482544|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
124689512|NCT05561140|448482545|FG000|Randomized Treatment Period|Adverse Event|1|||
124689513|NCT05561140|448482546|FG001|Randomized Treatment Period|Adverse Event|0|||
124689514|NCT05561140|448482545|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
124689515|NCT05561140|448482546|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
124689516|NCT05561140|448482545|FG000|Open Label Treatment Period|Adverse Event|6|||
124689517|NCT05561140|448482546|FG001|Open Label Treatment Period|Adverse Event|4|||
124689518|NCT05561140|448482545|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
124689519|NCT05561140|448482546|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
124689520|NCT05561140|448482545|FG000|Open Label Treatment Period|Physician Decision|0|||
124689521|NCT05561140|448482546|FG001|Open Label Treatment Period|Physician Decision|1|||
124689522|NCT05561140|448482545|FG000|Open Label Treatment Period|Pregnancy|1|||
124689523|NCT05561140|448482546|FG001|Open Label Treatment Period|Pregnancy|0|||
124689524|NCT05561140|448482545|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
124689525|NCT05561140|448482546|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
124689526|NCT05561140|448482545|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
124689527|NCT05561140|448482546|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
124689528|NCT05561140|448482545|FG000|Open Label Treatment Period|Other|1|||
124689529|NCT05561140|448482546|FG001|Open Label Treatment Period|Other|0|||
124689530|NCT06377488|448482547|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
124689531|NCT06377488|448482547|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
124689532|NCT06377488|448482547|FG000|Overall Study|Protocol Violation|1|||
124447167|NCT01132612|447601087|FG000|Overall Study|Lost to Follow-up|2|||
124447168|NCT01132612|447601088|FG001|Overall Study|Lost to Follow-up|2|||
124447169|NCT01132612|447601089|FG002|Overall Study|Lost to Follow-up|7|||
124689533|NCT06377488|448482547|FG000|Overall Study|Lost to Follow-up|1|||
124899890|NCT04771273|449258012|FG001|Maintenance Period|Change of residence|1|||
124899891|NCT04771273|449258013|FG002|Maintenance Period|Change of residence|3|||
124447170|NCT01132612|447601087|FG000|Overall Study|Adverse Event|5|||
124447171|NCT01132612|447601088|FG001|Overall Study|Adverse Event|2|||
124689534|NCT06377488|448482547|FG000|Overall Study|Incorrect Lens Dispensed|2|||
124689535|NCT00866320|448482548|FG000|Overall Study|Withdrawal by Subject|4|||
124689536|NCT00866320|448482548|FG000|Overall Study|Death|2|||
124689537|NCT05073315|448482549|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
124899892|NCT04771273|449258014|FG003|Maintenance Period|Change of residence|0|||
124689538|NCT05073315|448482550|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
124689539|NCT05073315|448482551|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
124689540|NCT05073315|448482549|FG000|Period 1 (Lead-in Period)|Death|1|||
124689541|NCT05073315|448482550|FG001|Period 1 (Lead-in Period)|Death|0|||
124689542|NCT05073315|448482551|FG002|Period 1 (Lead-in Period)|Death|0|||
124689543|NCT05073315|448482549|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
124689544|NCT05073315|448482550|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
124689545|NCT05073315|448482551|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
124689546|NCT05073315|448482549|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
124689547|NCT05073315|448482550|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
124689548|NCT05073315|448482551|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
124689549|NCT05073315|448482549|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
124689550|NCT05073315|448482550|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
124689551|NCT05073315|448482551|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
124899893|NCT04771273|449258011|FG000|Maintenance Period|Perceived lack of efficacy|0|||
124899894|NCT04771273|449258012|FG001|Maintenance Period|Perceived lack of efficacy|0|||
124899895|NCT04771273|449258013|FG002|Maintenance Period|Perceived lack of efficacy|0|||
124689552|NCT05073315|448482549|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
124689553|NCT05073315|448482550|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
124689554|NCT05073315|448482551|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
124689555|NCT05073315|448482549|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
124689556|NCT05073315|448482550|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
124689557|NCT05073315|448482551|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
124689558|NCT05073315|448482549|FG000|Period 2|Adverse Event|0|||
124689559|NCT05073315|448482550|FG001|Period 2|Adverse Event|3|||
124689560|NCT05073315|448482551|FG002|Period 2|Adverse Event|6|||
124689561|NCT05073315|448482549|FG000|Period 2|Lost to Follow-up|0|||
124689562|NCT05073315|448482550|FG001|Period 2|Lost to Follow-up|5|||
124689563|NCT05073315|448482551|FG002|Period 2|Lost to Follow-up|5|||
124689564|NCT05073315|448482549|FG000|Period 2|Withdrawal by Subject|0|||
124689565|NCT05073315|448482550|FG001|Period 2|Withdrawal by Subject|4|||
124689566|NCT05073315|448482551|FG002|Period 2|Withdrawal by Subject|9|||
124689567|NCT05073315|448482549|FG000|Period 2|Protocol Violation|0|||
124689568|NCT05073315|448482550|FG001|Period 2|Protocol Violation|0|||
124689569|NCT05073315|448482551|FG002|Period 2|Protocol Violation|1|||
124689570|NCT01529268|448482552|FG000|Overall Study|Lost to Follow-up|9|||
124689571|NCT01529268|448482553|FG001|Overall Study|Lost to Follow-up|3|||
124689572|NCT01529268|448482552|FG000|Overall Study|Moved|3|||
124689573|NCT01529268|448482553|FG001|Overall Study|Moved|0|||
124689574|NCT02691572|448482554|FG000|Overall Study|Withdrawal by Subject|1|||
124689575|NCT02691572|448482555|FG001|Overall Study|Withdrawal by Subject|0|||
124689576|NCT02691572|448482554|FG000|Overall Study|Protocol Violation|0|||
124689577|NCT02691572|448482555|FG001|Overall Study|Protocol Violation|1|||
124689578|NCT00699751|448482556|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
124899896|NCT04771273|449258014|FG003|Maintenance Period|Perceived lack of efficacy|1|||
124689579|NCT00699751|448482557|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
124689580|NCT00699751|448482556|FG000|Period 1: Without/Before Drug Switch|Death|28|||
124689581|NCT00699751|448482557|FG001|Period 1: Without/Before Drug Switch|Death|29|||
124689582|NCT00699751|448482556|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
124689583|NCT00699751|448482557|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
124689584|NCT00699751|448482556|FG000|Period 1: Without/Before Drug Switch|Other|30|||
124689585|NCT00699751|448482557|FG001|Period 1: Without/Before Drug Switch|Other|20|||
124899897|NCT04771273|449258011|FG000|Maintenance Period|Adverse Event|4|||
124689586|NCT00699751|448482556|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
124689587|NCT00699751|448482557|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
124689588|NCT00699751|448482556|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
124689589|NCT00699751|448482557|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
124689590|NCT00699751|448482556|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
124689591|NCT00699751|448482557|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
124689592|NCT00699751|448482556|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
124689593|NCT00699751|448482557|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
124689594|NCT05089357|448482560|FG000|Overall Study|Withdrawal by Subject|23|||
124689595|NCT05089357|448482560|FG000|Overall Study|Lost to Follow-up|6|||
124689596|NCT05089357|448482560|FG000|Overall Study|Medical reason|1|||
124689597|NCT05089357|448482560|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
124689598|NCT05089357|448482560|FG000|Overall Study|Pregnancy|2|||
124689599|NCT05537571|448482561|FG000|Overall Study|Withdrawal by Subject|1|||
124689600|NCT05537571|448482562|FG001|Overall Study|Withdrawal by Subject|1|||
124689601|NCT05537571|448482563|FG002|Overall Study|Withdrawal by Subject|0|||
124689602|NCT05537571|448482564|FG003|Overall Study|Withdrawal by Subject|0|||
124689603|NCT05537571|448482565|FG004|Overall Study|Withdrawal by Subject|0|||
124689604|NCT05537571|448482561|FG000|Overall Study|Adverse Event|2|||
124689605|NCT05537571|448482562|FG001|Overall Study|Adverse Event|0|||
124689606|NCT05537571|448482563|FG002|Overall Study|Adverse Event|0|||
124689607|NCT05537571|448482564|FG003|Overall Study|Adverse Event|0|||
124689608|NCT05537571|448482565|FG004|Overall Study|Adverse Event|0|||
124689609|NCT05537571|448482561|FG000|Overall Study|Hepatitis A screening result|2|||
124689610|NCT05537571|448482562|FG001|Overall Study|Hepatitis A screening result|0|||
124689611|NCT05537571|448482563|FG002|Overall Study|Hepatitis A screening result|0|||
124689612|NCT05537571|448482564|FG003|Overall Study|Hepatitis A screening result|0|||
124447172|NCT01132612|447601089|FG002|Overall Study|Adverse Event|15|||
124447173|NCT01132612|447601087|FG000|Overall Study|Withdrawal by Subject|5|||
124689613|NCT05537571|448482565|FG004|Overall Study|Hepatitis A screening result|0|||
124689614|NCT05537571|448482561|FG000|Overall Study|Lost to Follow-up|0|||
124689615|NCT05537571|448482562|FG001|Overall Study|Lost to Follow-up|0|||
124689616|NCT05537571|448482563|FG002|Overall Study|Lost to Follow-up|1|||
124689617|NCT05537571|448482564|FG003|Overall Study|Lost to Follow-up|0|||
124689618|NCT05537571|448482565|FG004|Overall Study|Lost to Follow-up|1|||
124689619|NCT05752487|448482570|FG000|Overall Study|Enrolled, not treated|9|||
124689620|NCT05752487|448482570|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
124689621|NCT05752487|448482570|FG000|Overall Study|Withdrawal by Subject|2|||
124689622|NCT03091439|448482571|FG000|Overall Study|Study Terminated by the Sponsor|1|||
124689623|NCT03091439|448482572|FG001|Overall Study|Study Terminated by the Sponsor|0|||
124689624|NCT01860989|448482573|FG000|Overall Study|Unsatisfactory therapeutic|5|||
124447174|NCT01132612|447601088|FG001|Overall Study|Withdrawal by Subject|8|||
124447175|NCT01132612|447601089|FG002|Overall Study|Withdrawal by Subject|19|||
124447176|NCT01132612|447601087|FG000|Overall Study|Administrative problems|5|||
124447177|NCT01132612|447601088|FG001|Overall Study|Administrative problems|1|||
124447178|NCT01132612|447601089|FG002|Overall Study|Administrative problems|52|||
124447179|NCT01132612|447601087|FG000|Overall Study|Lack of Efficacy|23|||
124447180|NCT01132612|447601088|FG001|Overall Study|Lack of Efficacy|22|||
124447181|NCT01132612|447601089|FG002|Overall Study|Lack of Efficacy|73|||
124447182|NCT02252536|447601090|FG000|Overall Study|Lost to Follow-up|5|||
124447183|NCT02252536|447601091|FG001|Overall Study|Lost to Follow-up|3|||
124447184|NCT01438151|447601094|FG000|Overall Study|study terminated|8|||
124447185|NCT00006392|447601101|FG000|Overall Study|Ineligible|11|||
124447186|NCT00006392|447601102|FG001|Overall Study|Ineligible|3|||
124447187|NCT00006392|447601103|FG002|Overall Study|Ineligible|5|||
124447188|NCT00006392|447601104|FG003|Overall Study|Ineligible|5|||
124447189|NCT00006392|447601101|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
124689625|NCT00134719|448484163|FG000|Primary Vaccination Phase|Adverse Event|4|||
124689626|NCT00134719|448484164|FG001|Primary Vaccination Phase|Adverse Event|0|||
124689627|NCT00134719|448484165|FG002|Primary Vaccination Phase|Adverse Event|0|||
124689628|NCT00134719|448484163|FG000|Primary Vaccination Phase|Protocol Violation|1|||
124689629|NCT00134719|448484164|FG001|Primary Vaccination Phase|Protocol Violation|0|||
124689630|NCT00134719|448484165|FG002|Primary Vaccination Phase|Protocol Violation|0|||
124447190|NCT00006392|447601102|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
124447191|NCT00006392|447601103|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
124447192|NCT00006392|447601104|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
124447193|NCT02545322|447601106|FG000|Overall Study|Withdrawal by Subject|3|||
124447194|NCT02401412|447601107|FG000|Overall Study|Lost to Follow-up|1|||
124689631|NCT00134719|448484163|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
124689632|NCT00134719|448484164|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
124689633|NCT00134719|448484165|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
124689634|NCT00134719|448484163|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
124689635|NCT00134719|448484164|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
124689636|NCT00134719|448484165|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
124689637|NCT00134719|448484163|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
124689638|NCT00134719|448484164|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
124689639|NCT00134719|448484165|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
124689640|NCT00134719|448484163|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
124689641|NCT00134719|448484164|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
124689642|NCT00134719|448484165|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
124689643|NCT03439839|448484166|FG000|Overall Study|Death|3|||
124689644|NCT03439839|448484167|FG001|Overall Study|Death|0|||
124689645|NCT05276804|448484172|FG000|Overall Study|screen failure|23|||
124689646|NCT05276804|448484173|FG001|Overall Study|screen failure|0|||
124689647|NCT02827708|448484174|FG000|Overall Study|Lost to Follow-up|3|||
124689648|NCT02827708|448484175|FG001|Overall Study|Lost to Follow-up|1|||
124689649|NCT02827708|448484174|FG000|Overall Study|Withdrawal by Subject|1|||
124689650|NCT02827708|448484175|FG001|Overall Study|Withdrawal by Subject|2|||
124689651|NCT02827708|448484174|FG000|Overall Study|Death|1|||
124689652|NCT02827708|448484175|FG001|Overall Study|Death|2|||
124689653|NCT04602000|448484176|FG000|Overall Study|Withdrawal by Subject|3|||
124689654|NCT04602000|448484177|FG001|Overall Study|Withdrawal by Subject|6|||
124689655|NCT04602000|448484178|FG002|Overall Study|Withdrawal by Subject|3|||
124689656|NCT04602000|448484179|FG003|Overall Study|Withdrawal by Subject|27|||
124689657|NCT04602000|448484180|FG004|Overall Study|Withdrawal by Subject|39|||
124689658|NCT04602000|448484176|FG000|Overall Study|Physician Decision|1|||
124689659|NCT04602000|448484177|FG001|Overall Study|Physician Decision|0|||
124689660|NCT04602000|448484178|FG002|Overall Study|Physician Decision|0|||
124689661|NCT04602000|448484179|FG003|Overall Study|Physician Decision|2|||
124689662|NCT04602000|448484180|FG004|Overall Study|Physician Decision|2|||
124689663|NCT04602000|448484176|FG000|Overall Study|Death|0|||
124689664|NCT04602000|448484177|FG001|Overall Study|Death|1|||
124689665|NCT04602000|448484178|FG002|Overall Study|Death|0|||
124689666|NCT04602000|448484179|FG003|Overall Study|Death|1|||
124689667|NCT04602000|448484180|FG004|Overall Study|Death|2|||
124689668|NCT04602000|448484176|FG000|Overall Study|Lost to Follow-up|0|||
124689669|NCT04602000|448484177|FG001|Overall Study|Lost to Follow-up|0|||
124689670|NCT04602000|448484178|FG002|Overall Study|Lost to Follow-up|0|||
124689671|NCT04602000|448484179|FG003|Overall Study|Lost to Follow-up|3|||
124689672|NCT04602000|448484180|FG004|Overall Study|Lost to Follow-up|4|||
124689673|NCT04602000|448484176|FG000|Overall Study|Other|4|||
124689674|NCT04602000|448484177|FG001|Overall Study|Other|1|||
124689675|NCT04602000|448484178|FG002|Overall Study|Other|2|||
124689676|NCT04602000|448484179|FG003|Overall Study|Other|5|||
124689677|NCT04602000|448484180|FG004|Overall Study|Other|4|||
124689678|NCT04602000|448484176|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
124689679|NCT04602000|448484177|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
124689680|NCT04602000|448484178|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
124689681|NCT04602000|448484179|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
124689682|NCT04602000|448484180|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
124689683|NCT00471354|448484181|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
124689684|NCT00471354|448484181|FG000|Overall Study|Adverse Event|13|||
124689685|NCT00471354|448484181|FG000|Overall Study|Protocol Violation|12|||
124689686|NCT00471354|448484181|FG000|Overall Study|Withdrawal by Subject|1|||
124689687|NCT00471354|448484181|FG000|Overall Study|Physician Decision|4|||
124689688|NCT00471354|448484181|FG000|Overall Study|Sponsor Decision|1|||
124689689|NCT00471354|448484181|FG000|Overall Study|Lost to Follow-up|3|||
124689690|NCT00471354|448484181|FG000|Overall Study|Lack of Efficacy|5|||
124689691|NCT00471354|448484181|FG000|Overall Study|Patient/Caregiver Decision|12|||
124689692|NCT01875237|448484182|FG000|Overall Study|GVDH before DLI|1|||
124689693|NCT01875237|448484183|FG001|Overall Study|GVDH before DLI|0|||
124689694|NCT01875237|448484182|FG000|Overall Study|DLI cells could not be produced|1|||
124689695|NCT01875237|448484183|FG001|Overall Study|DLI cells could not be produced|0|||
124689696|NCT01913470|448484187|FG000|Overall Study|Lost to Follow-up|0|||
124689697|NCT01913470|448484188|FG001|Overall Study|Lost to Follow-up|1|||
124689698|NCT01913470|448484187|FG000|Overall Study|Physician Decision|0|||
124689699|NCT01913470|448484188|FG001|Overall Study|Physician Decision|1|||
124689700|NCT01913470|448484187|FG000|Overall Study|Withdrawal by Subject|0|||
124689701|NCT01913470|448484188|FG001|Overall Study|Withdrawal by Subject|1|||
124689702|NCT02573467|448484189|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
124689703|NCT02573467|448484190|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
124689704|NCT02573467|448484191|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
124689705|NCT02573467|448484192|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
124689706|NCT02573467|448484189|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
124689707|NCT02573467|448484190|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
124689708|NCT02573467|448484191|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
124689709|NCT02573467|448484192|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
124689710|NCT02573467|448484189|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
124689711|NCT02573467|448484190|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
124689712|NCT02573467|448484191|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
124689713|NCT02573467|448484192|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
124689714|NCT02573467|448484189|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
124689715|NCT02573467|448484190|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
124689716|NCT02573467|448484191|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
124689717|NCT02573467|448484192|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
124689718|NCT02573467|448484189|FG000|Post-treatment Follow up Epoch|Death|1|||
124689719|NCT02573467|448484190|FG001|Post-treatment Follow up Epoch|Death|1|||
124689720|NCT02573467|448484191|FG002|Post-treatment Follow up Epoch|Death|0|||
124689721|NCT02573467|448484192|FG003|Post-treatment Follow up Epoch|Death|1|||
124689722|NCT02573467|448484189|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
124689723|NCT02573467|448484190|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
124689724|NCT02573467|448484191|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
124689725|NCT02573467|448484192|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
124689726|NCT02573467|448484189|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
124689727|NCT02573467|448484190|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
124899898|NCT04771273|449258012|FG001|Maintenance Period|Adverse Event|5|||
124899899|NCT04771273|449258013|FG002|Maintenance Period|Adverse Event|5|||
124899900|NCT04771273|449258014|FG003|Maintenance Period|Adverse Event|0|||
124899901|NCT01543685|449258015|FG000|Overall Study|Lack of Efficacy|1|||
124899902|NCT01543685|449258016|FG001|Overall Study|Lack of Efficacy|2|||
124899903|NCT01543685|449258017|FG002|Overall Study|Lack of Efficacy|2|||
124899904|NCT01543685|449258018|FG003|Overall Study|Lack of Efficacy|0|||
124899905|NCT01543685|449258019|FG004|Overall Study|Lack of Efficacy|2|||
124899906|NCT01543685|449258015|FG000|Overall Study|Adverse Event|2|||
124899907|NCT01543685|449258016|FG001|Overall Study|Adverse Event|1|||
124447195|NCT02401412|447601108|FG001|Overall Study|Lost to Follow-up|0|||
124689728|NCT02573467|448484191|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
124689729|NCT02573467|448484192|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
124689730|NCT00923702|448484193|FG000|Overall Study|Ongoing enrollment|0|||
124689731|NCT00923702|448484194|FG001|Overall Study|Ongoing enrollment|0|||
124689732|NCT00923702|448484195|FG002|Overall Study|Ongoing enrollment|0|||
124689733|NCT00923702|448484196|FG003|Overall Study|Ongoing enrollment|0|||
124689734|NCT00923702|448484197|FG004|Overall Study|Ongoing enrollment|354|||
124689735|NCT02153827|448484198|FG000|Overall Study|Lost to Follow-up|3|||
124689736|NCT02153827|448484199|FG001|Overall Study|Lost to Follow-up|9|||
124689737|NCT02448043|448484205|FG000|Overall Study|Withdrawal by Subject|2|||
124689738|NCT02448043|448484206|FG001|Overall Study|Withdrawal by Subject|2|||
124899908|NCT01543685|449258017|FG002|Overall Study|Adverse Event|0|||
124899909|NCT01543685|449258018|FG003|Overall Study|Adverse Event|0|||
124689739|NCT02448043|448484205|FG000|Overall Study|Protocol Violation|1|||
124689740|NCT02448043|448484206|FG001|Overall Study|Protocol Violation|2|||
124689741|NCT04790201|448484207|FG000|Overall Study|Lost to Follow-up|0|||
124689742|NCT04790201|448484208|FG001|Overall Study|Lost to Follow-up|0|||
124689743|NCT04790201|448484209|FG002|Overall Study|Lost to Follow-up|2|||
124689744|NCT04790201|448484207|FG000|Overall Study|Death|0|||
124689745|NCT04790201|448484208|FG001|Overall Study|Death|1|||
124689746|NCT04790201|448484209|FG002|Overall Study|Death|0|||
124689747|NCT04790201|448484207|FG000|Overall Study|Protocol Violation|1|||
124689748|NCT04790201|448484208|FG001|Overall Study|Protocol Violation|0|||
124689749|NCT04790201|448484209|FG002|Overall Study|Protocol Violation|1|||
124689750|NCT04339972|448484215|FG000|Overall Study|Scheduling Issues|3|||
124689751|NCT04339972|448484216|FG001|Overall Study|Scheduling Issues|3|||
124689752|NCT04339972|448484215|FG000|Overall Study|dropout|1|||
124689753|NCT04339972|448484216|FG001|Overall Study|dropout|1|||
124689754|NCT04339972|448484215|FG000|Overall Study|Technical issues|1|||
124689755|NCT04339972|448484216|FG001|Overall Study|Technical issues|0|||
124689756|NCT04339972|448484215|FG000|Overall Study|Claustraphobia|0|||
124689757|NCT04339972|448484216|FG001|Overall Study|Claustraphobia|1|||
124689758|NCT02112552|448484227|FG000|Overall Study|Withdrawal by Subject|1|||
124689759|NCT02112552|448484227|FG000|Overall Study|Adverse Event|1|||
124689760|NCT01131585|448484228|FG000|Overall Study|Adverse Event|0|||
124689761|NCT01131585|448484229|FG001|Overall Study|Adverse Event|2|||
124689762|NCT01131585|448484228|FG000|Overall Study|Abnormal laboratory value|1|||
124689763|NCT01131585|448484229|FG001|Overall Study|Abnormal laboratory value|0|||
124689764|NCT01131585|448484228|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124689765|NCT01131585|448484229|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
124689766|NCT01131585|448484228|FG000|Overall Study|Protocol Violation|2|||
124689767|NCT01131585|448484229|FG001|Overall Study|Protocol Violation|1|||
124689768|NCT01131585|448484228|FG000|Overall Study|Withdrawal by Subject|3|||
124689769|NCT01131585|448484229|FG001|Overall Study|Withdrawal by Subject|3|||
124689770|NCT01131585|448484228|FG000|Overall Study|Lost to Follow-up|0|||
124689771|NCT01131585|448484229|FG001|Overall Study|Lost to Follow-up|1|||
124899910|NCT01543685|449258019|FG004|Overall Study|Adverse Event|2|||
124899911|NCT02163915|449258020|FG000|Overall Study|Withdrawal by Subject|2|||
124899912|NCT02163915|449258021|FG001|Overall Study|Withdrawal by Subject|0|||
124689772|NCT01131585|448484228|FG000|Overall Study|Administrative problems|1|||
124689773|NCT01131585|448484229|FG001|Overall Study|Administrative problems|1|||
124689774|NCT01131585|448484228|FG000|Overall Study|Study termination|78|||
124689775|NCT01131585|448484229|FG001|Overall Study|Study termination|32|||
124689776|NCT00812097|448484230|FG000|Overall Study|Death|3|||
124689777|NCT00812097|448484231|FG001|Overall Study|Death|10|||
124689778|NCT00812097|448484232|FG002|Overall Study|Death|3|||
124689779|NCT00812097|448484233|FG003|Overall Study|Death|3|||
124689780|NCT00812097|448484230|FG000|Overall Study|Withdrawal by Subject|14|||
124689781|NCT00812097|448484231|FG001|Overall Study|Withdrawal by Subject|12|||
124689782|NCT00812097|448484232|FG002|Overall Study|Withdrawal by Subject|8|||
124689783|NCT00812097|448484233|FG003|Overall Study|Withdrawal by Subject|2|||
124689784|NCT00812097|448484230|FG000|Overall Study|Lost to Follow-up|90|||
124689785|NCT00812097|448484231|FG001|Overall Study|Lost to Follow-up|14|||
124759623|NCT01147666|448744767|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
124689786|NCT00812097|448484232|FG002|Overall Study|Lost to Follow-up|17|||
124689787|NCT00812097|448484233|FG003|Overall Study|Lost to Follow-up|5|||
124689788|NCT00812097|448484230|FG000|Overall Study|Explantation of study device(s)|27|||
124689789|NCT00812097|448484231|FG001|Overall Study|Explantation of study device(s)|29|||
124689790|NCT00812097|448484232|FG002|Overall Study|Explantation of study device(s)|14|||
124689791|NCT00812097|448484233|FG003|Overall Study|Explantation of study device(s)|20|||
124689792|NCT00812097|448484230|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
124689793|NCT00812097|448484231|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
124689794|NCT00812097|448484232|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
124689795|NCT00812097|448484233|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
124689796|NCT00317369|448484234|FG000|Overall Study|Adverse Event|2|||
124689797|NCT00317369|448484235|FG001|Overall Study|Adverse Event|1|||
124899913|NCT02163915|449258022|FG002|Overall Study|Withdrawal by Subject|2|||
124689798|NCT00317369|448484236|FG002|Overall Study|Adverse Event|0|||
124689799|NCT00317369|448484234|FG000|Overall Study|Lack of Efficacy|0|||
124689800|NCT00317369|448484235|FG001|Overall Study|Lack of Efficacy|1|||
124689801|NCT00317369|448484236|FG002|Overall Study|Lack of Efficacy|1|||
124689802|NCT00317369|448484234|FG000|Overall Study|Withdrawal by Subject|0|||
124899914|NCT02163915|449258023|FG003|Overall Study|Withdrawal by Subject|2|||
124899915|NCT02163915|449258024|FG004|Overall Study|Withdrawal by Subject|2|||
124899916|NCT02163915|449258020|FG000|Overall Study|Study termination|1|||
124899917|NCT02163915|449258021|FG001|Overall Study|Study termination|0|||
124899918|NCT02163915|449258022|FG002|Overall Study|Study termination|0|||
124899919|NCT02163915|449258023|FG003|Overall Study|Study termination|0|||
124899920|NCT02163915|449258024|FG004|Overall Study|Study termination|2|||
124899921|NCT02163915|449258020|FG000|Overall Study|Physician Decision|0|||
124899922|NCT02163915|449258021|FG001|Overall Study|Physician Decision|0|||
124899923|NCT02163915|449258022|FG002|Overall Study|Physician Decision|0|||
124899924|NCT02163915|449258023|FG003|Overall Study|Physician Decision|1|||
124899925|NCT02163915|449258024|FG004|Overall Study|Physician Decision|0|||
124899926|NCT02013037|449258025|FG000|Overall Study|Death|6|||
124899927|NCT02013037|449258025|FG000|Overall Study|Withdrawal by Subject|1|||
124899928|NCT02013037|449258025|FG000|Overall Study|Awaiting Transplantation|7|||
124899929|NCT02013037|449258025|FG000|Overall Study|Transplanted without DSA|2|||
124899930|NCT02465359|449258026|FG000|Overall Study|Lack of Efficacy|1|||
124899931|NCT02465359|449258026|FG000|Overall Study|Withdrawal by Subject|1|||
124899932|NCT02465359|449258026|FG000|Overall Study|Adverse Event|1|||
124899933|NCT01304147|449258027|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
124899934|NCT01304147|449258028|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
124899935|NCT00708097|449258029|FG000|Period 1|Protocol Violation|0|||
124899936|NCT00708097|449258030|FG001|Period 1|Protocol Violation|1|||
124899937|NCT00708097|449258031|FG002|Period 1|Protocol Violation|0|||
124689803|NCT00317369|448484235|FG001|Overall Study|Withdrawal by Subject|0|||
124689804|NCT00317369|448484236|FG002|Overall Study|Withdrawal by Subject|1|||
124689805|NCT00849472|448484237|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
124689806|NCT00849472|448484237|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
124689807|NCT00849472|448484237|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
124689808|NCT00849472|448484237|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
124689809|NCT00849472|448484237|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
124689810|NCT00849472|448484237|FG000|Weekly Paclitaxel|Disease Progression|1|||
124689811|NCT00849472|448484237|FG000|Weekly Paclitaxel|Adverse Event|11|||
124689812|NCT00849472|448484237|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
124689813|NCT00849472|448484237|FG000|Weekly Paclitaxel|Physician Decision|3|||
124689814|NCT00849472|448484237|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
124689815|NCT00849472|448484237|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
124689816|NCT00849472|448484237|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
124689817|NCT00849472|448484237|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
124689818|NCT00849472|448484237|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
124689819|NCT00849472|448484237|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
124689820|NCT00849472|448484237|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
124899938|NCT00708097|449258032|FG003|Period 1|Protocol Violation|2|||
124899939|NCT00708097|449258033|FG004|Period 1|Protocol Violation|0|||
124899940|NCT00708097|449258029|FG000|Period 1|Other Reason|0|||
124899941|NCT00708097|449258030|FG001|Period 1|Other Reason|0|||
124899942|NCT00708097|449258031|FG002|Period 1|Other Reason|0|||
124899943|NCT00708097|449258032|FG003|Period 1|Other Reason|0|||
124899944|NCT00708097|449258033|FG004|Period 1|Other Reason|1|||
124899945|NCT00708097|449258029|FG000|Period 2|Protocol Violation|0|||
124899946|NCT00708097|449258030|FG001|Period 2|Protocol Violation|1|||
124899947|NCT00708097|449258031|FG002|Period 2|Protocol Violation|1|||
124899948|NCT00708097|449258032|FG003|Period 2|Protocol Violation|1|||
124899949|NCT00708097|449258033|FG004|Period 2|Protocol Violation|0|||
124899950|NCT01244828|449258034|FG000|Overall Study|Adverse Event|37|||
124899951|NCT01244828|449258034|FG000|Overall Study|Withdrawal by Subject|31|||
124899952|NCT01244828|449258034|FG000|Overall Study|Lack of Efficacy|7|||
124899953|NCT01244828|449258034|FG000|Overall Study|Lost to Follow-up|2|||
124899954|NCT01244828|449258034|FG000|Overall Study|Other reason (not specified)|1|||
124899955|NCT01278862|449258035|FG000|Overall Study|Lost to Follow-up|1|||
124899956|NCT01278862|449258036|FG001|Overall Study|Lost to Follow-up|1|||
124689821|NCT00849472|448484237|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
124689822|NCT03370302|448484246|FG000|Dose Escalation Phase|Other|0|||
124689823|NCT03370302|448484247|FG001|Dose Escalation Phase|Other|1|||
124689824|NCT03370302|448484248|FG002|Dose Escalation Phase|Other|1|||
124899957|NCT02952261|449258038|FG000|Overall Study|Withdrawal by Subject|4|||
124899958|NCT02952261|449258039|FG001|Overall Study|Withdrawal by Subject|5|||
124899959|NCT02952261|449258038|FG000|Overall Study|Protocol Violation|1|||
124899960|NCT02952261|449258039|FG001|Overall Study|Protocol Violation|0|||
124899961|NCT00603447|449258040|FG000|Overall Study|Adverse Event|0|||
124899962|NCT00603447|449258041|FG001|Overall Study|Adverse Event|1|||
124899963|NCT00603447|449258042|FG002|Overall Study|Adverse Event|1|||
124759624|NCT01147666|448744768|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
124759625|NCT01147666|448744769|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
124759626|NCT01147666|448744755|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
124759627|NCT01147666|448744756|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
124759628|NCT01147666|448744757|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
124759629|NCT01147666|448744758|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
124759630|NCT01147666|448744759|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
124759631|NCT01147666|448744760|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
124759632|NCT01147666|448744761|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
124759633|NCT01147666|448744762|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
124759634|NCT01147666|448744763|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
124759635|NCT01147666|448744764|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
124759636|NCT01147666|448744765|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
124759637|NCT01147666|448744766|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
124759638|NCT01147666|448744767|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
124759639|NCT01147666|448744768|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
124759640|NCT01147666|448744769|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
124759641|NCT01147666|448744755|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
124759642|NCT01147666|448744756|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
124759643|NCT01147666|448744757|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
124759644|NCT01147666|448744758|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
124759645|NCT01147666|448744759|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
124759646|NCT01147666|448744760|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
124759647|NCT01147666|448744761|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
124759648|NCT01147666|448744762|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
124759649|NCT01147666|448744763|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
124759650|NCT01147666|448744764|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
124759651|NCT01147666|448744765|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
124759652|NCT01147666|448744766|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
124759653|NCT01147666|448744767|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
124759654|NCT01147666|448744768|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
124759655|NCT01147666|448744769|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
124759656|NCT01147666|448744755|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
124759657|NCT01147666|448744756|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
124759658|NCT01147666|448744757|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
124759659|NCT01147666|448744758|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
124759660|NCT01147666|448744759|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
124759661|NCT01147666|448744760|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
124759662|NCT01147666|448744761|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
124759663|NCT01147666|448744762|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
124759664|NCT01147666|448744763|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
124759665|NCT01147666|448744764|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
124759666|NCT01147666|448744765|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
124759667|NCT01147666|448744766|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
124759668|NCT01147666|448744767|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
124759669|NCT01147666|448744768|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
124759670|NCT01147666|448744769|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
124759671|NCT01147666|448744755|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
124759672|NCT01147666|448744756|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
124759673|NCT01147666|448744757|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
124759674|NCT01147666|448744758|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
124759675|NCT01147666|448744759|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
124759676|NCT01147666|448744760|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
124759677|NCT01147666|448744761|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
124759678|NCT01147666|448744762|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
124759679|NCT01147666|448744763|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
124759680|NCT01147666|448744764|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
124759681|NCT01147666|448744765|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
124899964|NCT00603447|449258043|FG003|Overall Study|Adverse Event|2|||
124899965|NCT00603447|449258044|FG004|Overall Study|Adverse Event|1|||
124899966|NCT00603447|449258045|FG005|Overall Study|Adverse Event|2|||
124899967|NCT00603447|449258046|FG006|Overall Study|Adverse Event|10|||
124899968|NCT00603447|449258040|FG000|Overall Study|Other|0|||
124899969|NCT00603447|449258041|FG001|Overall Study|Other|0|||
124899970|NCT00603447|449258042|FG002|Overall Study|Other|1|||
124447196|NCT02401412|447601107|FG000|Overall Study|Discontinued Intervention|15|||
124447197|NCT02401412|447601108|FG001|Overall Study|Discontinued Intervention|21|||
124447198|NCT02401412|447601107|FG000|Overall Study|Withdrawal by Subject|4|||
124447199|NCT02401412|447601108|FG001|Overall Study|Withdrawal by Subject|4|||
124447200|NCT02401412|447601107|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
124447201|NCT02401412|447601108|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
124447202|NCT02401412|447601107|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
124447203|NCT02401412|447601108|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
124447204|NCT01184053|447601109|FG000|Overall Study|progression while on treatment|3|||
124447205|NCT01174238|447601110|FG000|Overall Study|Lost to Follow-up|2|||
124447206|NCT02593786|447601111|FG000|Overall Study|Disease progression|12|||
124447207|NCT02593786|447601112|FG001|Overall Study|Disease progression|16|||
124447208|NCT02593786|447601113|FG002|Overall Study|Disease progression|10|||
124447209|NCT02593786|447601114|FG003|Overall Study|Disease progression|7|||
124447210|NCT02593786|447601111|FG000|Overall Study|Study drug toxicity|1|||
124447211|NCT02593786|447601112|FG001|Overall Study|Study drug toxicity|0|||
124447212|NCT02593786|447601113|FG002|Overall Study|Study drug toxicity|0|||
124447213|NCT02593786|447601114|FG003|Overall Study|Study drug toxicity|0|||
124447214|NCT02593786|447601111|FG000|Overall Study|Adverse event unrelated to study drug|1|||
124447215|NCT02593786|447601112|FG001|Overall Study|Adverse event unrelated to study drug|1|||
124447216|NCT02593786|447601113|FG002|Overall Study|Adverse event unrelated to study drug|1|||
124447217|NCT02593786|447601114|FG003|Overall Study|Adverse event unrelated to study drug|0|||
124447218|NCT02593786|447601111|FG000|Overall Study|Participant request to discontinue study therapy|0|||
124447219|NCT02593786|447601112|FG001|Overall Study|Participant request to discontinue study therapy|2|||
124447220|NCT02593786|447601113|FG002|Overall Study|Participant request to discontinue study therapy|0|||
124447221|NCT02593786|447601114|FG003|Overall Study|Participant request to discontinue study therapy|0|||
124447222|NCT02593786|447601111|FG000|Overall Study|Other reasons|1|||
124447223|NCT02593786|447601112|FG001|Overall Study|Other reasons|1|||
124447224|NCT02593786|447601113|FG002|Overall Study|Other reasons|0|||
124447225|NCT02593786|447601114|FG003|Overall Study|Other reasons|5|||
124447226|NCT01479829|447601115|FG000|Overall Study|Withdrawal by Subject|8|||
124689825|NCT03370302|448484249|FG003|Dose Escalation Phase|Other|0|||
124689826|NCT03370302|448484250|FG004|Dose Escalation Phase|Other|0|||
124689827|NCT03370302|448484251|FG005|Dose Escalation Phase|Other|0|||
124689828|NCT03370302|448484246|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
124689829|NCT03370302|448484247|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
124689830|NCT03370302|448484248|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
124689831|NCT03370302|448484249|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
124689832|NCT03370302|448484250|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
124689833|NCT03370302|448484251|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
124689834|NCT03370302|448484246|FG000|Dose Escalation Phase|Adverse Event|1|||
124689835|NCT03370302|448484247|FG001|Dose Escalation Phase|Adverse Event|0|||
124689836|NCT03370302|448484248|FG002|Dose Escalation Phase|Adverse Event|2|||
124689837|NCT03370302|448484249|FG003|Dose Escalation Phase|Adverse Event|0|||
124689838|NCT03370302|448484250|FG004|Dose Escalation Phase|Adverse Event|0|||
124689839|NCT03370302|448484251|FG005|Dose Escalation Phase|Adverse Event|0|||
124689840|NCT03370302|448484246|FG000|Dose Escalation Phase|Progressive Disease|2|||
124689841|NCT03370302|448484247|FG001|Dose Escalation Phase|Progressive Disease|4|||
124689842|NCT03370302|448484248|FG002|Dose Escalation Phase|Progressive Disease|2|||
124689843|NCT03370302|448484249|FG003|Dose Escalation Phase|Progressive Disease|0|||
124689844|NCT03370302|448484250|FG004|Dose Escalation Phase|Progressive Disease|3|||
124689845|NCT03370302|448484251|FG005|Dose Escalation Phase|Progressive Disease|1|||
124689846|NCT03370302|448484246|FG000|Dose Expansion Phase|Progressive Disease|0|||
124689847|NCT03370302|448484247|FG001|Dose Expansion Phase|Progressive Disease|0|||
124899971|NCT00603447|449258043|FG003|Overall Study|Other|0|||
124447227|NCT01479829|447601116|FG001|Overall Study|Withdrawal by Subject|10|||
124899972|NCT00603447|449258044|FG004|Overall Study|Other|3|||
124447228|NCT01791803|447601118|FG000|Overall Study|Withdrawal by Subject|0|||
124447229|NCT01791803|447601119|FG001|Overall Study|Withdrawal by Subject|0|||
124447230|NCT01791803|447601120|FG002|Overall Study|Withdrawal by Subject|0|||
124447231|NCT01791803|447601121|FG003|Overall Study|Withdrawal by Subject|2|||
124447232|NCT01791803|447601118|FG000|Overall Study|Physician Decision|0|||
124689848|NCT03370302|448484248|FG002|Dose Expansion Phase|Progressive Disease|0|||
124689849|NCT03370302|448484249|FG003|Dose Expansion Phase|Progressive Disease|6|||
124689850|NCT03370302|448484250|FG004|Dose Expansion Phase|Progressive Disease|0|||
124689851|NCT03370302|448484251|FG005|Dose Expansion Phase|Progressive Disease|0|||
124689852|NCT00985790|448484252|FG000|Overall Study|Withdrawal by Subject|1|||
124899973|NCT00603447|449258045|FG005|Overall Study|Other|0|||
124899974|NCT00603447|449258046|FG006|Overall Study|Other|13|||
124689853|NCT00985790|448484253|FG001|Overall Study|Withdrawal by Subject|1|||
124689854|NCT00985790|448484252|FG000|Overall Study|Lost to Follow-up|6|||
124689855|NCT00985790|448484253|FG001|Overall Study|Lost to Follow-up|7|||
124689856|NCT04180696|448484255|FG000|Overall Study|Death|5|||
124689857|NCT04180696|448484256|FG001|Overall Study|Death|6|||
124689858|NCT04180696|448484255|FG000|Overall Study|Lost to Follow-up|1|||
124689859|NCT04180696|448484256|FG001|Overall Study|Lost to Follow-up|0|||
124689860|NCT04180696|448484255|FG000|Overall Study|Withdrawal by Subject|0|||
124689861|NCT04180696|448484256|FG001|Overall Study|Withdrawal by Subject|1|||
124689862|NCT02593864|448484259|FG000|Overall Study|Withdrawal by Subject|3|||
124689863|NCT02593864|448484259|FG000|Overall Study|Lost to Follow-up|3|||
124689864|NCT04739709|448484260|FG000|Overall Study|Physician Decision|1|||
124689865|NCT04739709|448484261|FG001|Overall Study|Physician Decision|0|||
124689866|NCT04124965|448484262|FG000|Overall Study|Adverse event, non-fatal|3|||
124899975|NCT00603447|449258040|FG000|Overall Study|Withdrew Consent|0|||
124689867|NCT04124965|448484263|FG001|Overall Study|Adverse event, non-fatal|1|||
124899976|NCT00603447|449258041|FG001|Overall Study|Withdrew Consent|2|||
124447233|NCT01791803|447601119|FG001|Overall Study|Physician Decision|2|||
124447234|NCT01791803|447601120|FG002|Overall Study|Physician Decision|0|||
124447235|NCT01791803|447601121|FG003|Overall Study|Physician Decision|1|||
124447236|NCT01791803|447601118|FG000|Overall Study|Death|0|||
124447237|NCT01791803|447601119|FG001|Overall Study|Death|0|||
124447238|NCT01791803|447601120|FG002|Overall Study|Death|2|||
124447239|NCT01791803|447601121|FG003|Overall Study|Death|2|||
124447240|NCT01093326|447601125|FG000|Overall Study|Death|0|||
124447241|NCT01093326|447601126|FG001|Overall Study|Death|1|||
124447242|NCT01093326|447601127|FG002|Overall Study|Death|0|||
124447243|NCT01093326|447601125|FG000|Overall Study|Lack of Efficacy|7|||
124447244|NCT01093326|447601126|FG001|Overall Study|Lack of Efficacy|6|||
124447245|NCT01093326|447601127|FG002|Overall Study|Lack of Efficacy|3|||
124447246|NCT01093326|447601125|FG000|Overall Study|Lost to Follow-up|2|||
124447247|NCT01093326|447601126|FG001|Overall Study|Lost to Follow-up|5|||
124447248|NCT01093326|447601127|FG002|Overall Study|Lost to Follow-up|4|||
124447249|NCT01093326|447601125|FG000|Overall Study|Physician Decision|3|||
124447250|NCT01093326|447601126|FG001|Overall Study|Physician Decision|1|||
124447251|NCT01093326|447601127|FG002|Overall Study|Physician Decision|3|||
124447252|NCT01093326|447601125|FG000|Overall Study|Withdrawal by Subject|30|||
124447253|NCT01093326|447601126|FG001|Overall Study|Withdrawal by Subject|27|||
124447254|NCT01093326|447601127|FG002|Overall Study|Withdrawal by Subject|26|||
124447255|NCT01093326|447601125|FG000|Overall Study|Adverse Event|2|||
124447256|NCT01093326|447601126|FG001|Overall Study|Adverse Event|1|||
124447257|NCT01093326|447601127|FG002|Overall Study|Adverse Event|4|||
124447258|NCT01093326|447601125|FG000|Overall Study|Other|0|||
124447259|NCT01093326|447601126|FG001|Overall Study|Other|0|||
124447260|NCT01093326|447601127|FG002|Overall Study|Other|1|||
124447261|NCT01444456|447601128|FG000|Overall Study|Withdrawal by Subject|21|||
124447262|NCT01444456|447601128|FG000|Overall Study|Physician Decision|9|||
124447263|NCT01444456|447601128|FG000|Overall Study|Lost to Follow-up|37|||
124447264|NCT01444456|447601128|FG000|Overall Study|Death|73|||
124447265|NCT01444456|447601128|FG000|Overall Study|Ineligibility determined|23|||
124447266|NCT01444456|447601128|FG000|Overall Study|Other|18|||
124447267|NCT01444456|447601128|FG000|Overall Study|Not treated|104|||
124447268|NCT04263896|447601129|FG000|Overall Study|Withdrawal by Subject|2|||
124689868|NCT04124965|448484262|FG000|Overall Study|Withdrawal by Subject|1|||
124689869|NCT04124965|448484263|FG001|Overall Study|Withdrawal by Subject|1|||
124689870|NCT04124965|448484262|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
124689871|NCT04124965|448484263|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
124689872|NCT04124965|448484262|FG000|Overall Study|Pregnancy|1|||
124689873|NCT04124965|448484263|FG001|Overall Study|Pregnancy|0|||
124899977|NCT00603447|449258042|FG002|Overall Study|Withdrew Consent|0|||
124899978|NCT00603447|449258043|FG003|Overall Study|Withdrew Consent|0|||
124899979|NCT00603447|449258044|FG004|Overall Study|Withdrew Consent|1|||
124447269|NCT04263896|447601130|FG001|Overall Study|Withdrawal by Subject|4|||
124447270|NCT04263896|447601129|FG000|Overall Study|converted to open procedure|0|||
124447271|NCT04263896|447601130|FG001|Overall Study|converted to open procedure|1|||
124447272|NCT04263896|447601129|FG000|Overall Study|Lost to Follow-up|9|||
124447273|NCT04263896|447601130|FG001|Overall Study|Lost to Follow-up|11|||
124899980|NCT00603447|449258045|FG005|Overall Study|Withdrew Consent|0|||
124447274|NCT04263896|447601129|FG000|Overall Study|surveys lost in mail|5|||
124447275|NCT04263896|447601130|FG001|Overall Study|surveys lost in mail|3|||
124447276|NCT04263896|447601129|FG000|Overall Study|excluded from analysis|1|||
124447277|NCT04263896|447601130|FG001|Overall Study|excluded from analysis|0|||
124447278|NCT01436071|447602649|FG000|Overall Study|Adverse Event|1|||
124447279|NCT01436071|447602650|FG001|Overall Study|Adverse Event|0|||
124447280|NCT01436071|447602649|FG000|Overall Study|Lack of Efficacy|16|||
124689874|NCT04124965|448484262|FG000|Overall Study|Sponsor and participant decision|0|||
124689875|NCT04124965|448484263|FG001|Overall Study|Sponsor and participant decision|1|||
124689876|NCT04124965|448484262|FG000|Overall Study|Personal surgery|0|||
124689877|NCT04124965|448484263|FG001|Overall Study|Personal surgery|1|||
124899981|NCT00603447|449258046|FG006|Overall Study|Withdrew Consent|1|||
124447281|NCT01436071|447602650|FG001|Overall Study|Lack of Efficacy|7|||
124447282|NCT01436071|447602649|FG000|Overall Study|Protocol Violation|0|||
124447283|NCT01436071|447602650|FG001|Overall Study|Protocol Violation|1|||
124447284|NCT01436071|447602649|FG000|Overall Study|Lost to Follow-up|3|||
124447285|NCT01436071|447602650|FG001|Overall Study|Lost to Follow-up|1|||
124447286|NCT01436071|447602649|FG000|Overall Study|Physician Decision|1|||
124447287|NCT01436071|447602650|FG001|Overall Study|Physician Decision|0|||
124447288|NCT01436071|447602649|FG000|Overall Study|Withdrawal by Subject|2|||
124447289|NCT01436071|447602650|FG001|Overall Study|Withdrawal by Subject|2|||
124447290|NCT01436071|447602649|FG000|Overall Study|Did Not Receive Trial Medication|3|||
124447291|NCT01436071|447602650|FG001|Overall Study|Did Not Receive Trial Medication|3|||
124447292|NCT03047551|447602654|FG000|Overall Study|Did not receive TAS|1|||
124447293|NCT03047551|447602655|FG001|Overall Study|Did not receive TAS|0|||
124447294|NCT03047551|447602654|FG000|Overall Study|Physician Decision|1|||
124447295|NCT03047551|447602655|FG001|Overall Study|Physician Decision|0|||
124447296|NCT03047551|447602654|FG000|Overall Study|Withdrawal by Subject|0|||
124447297|NCT03047551|447602655|FG001|Overall Study|Withdrawal by Subject|1|||
124447298|NCT03047551|447602654|FG000|Overall Study|Probe malfunction|0|||
124447299|NCT03047551|447602655|FG001|Overall Study|Probe malfunction|1|||
124447300|NCT03047551|447602654|FG000|Overall Study|Ineligible|0|||
124447301|NCT03047551|447602655|FG001|Overall Study|Ineligible|1|||
124447302|NCT00726622|447602656|FG000|Overall Study|Withdrawal by Subject|16|||
124899982|NCT05233085|449258047|FG000|Overall Study|Adverse Event|1|||
124899983|NCT05233085|449258048|FG001|Overall Study|Adverse Event|0|||
124899984|NCT05233085|449258049|FG002|Overall Study|Adverse Event|0|||
124899985|NCT05233085|449258050|FG003|Overall Study|Adverse Event|0|||
124899986|NCT00798265|449258051|FG000|Overall Study|Lost to Follow-up|1|||
124899987|NCT00798265|449258052|FG001|Overall Study|Lost to Follow-up|10|||
124899988|NCT00798265|449258051|FG000|Overall Study|Study closing|7|||
124899989|NCT00798265|449258052|FG001|Overall Study|Study closing|6|||
124899990|NCT00798265|449258051|FG000|Overall Study|Withdrawal by Subject|0|||
124899991|NCT00798265|449258052|FG001|Overall Study|Withdrawal by Subject|1|||
124899992|NCT00798265|449258051|FG000|Overall Study|Screen failure|0|||
124447303|NCT00726622|447602657|FG001|Overall Study|Withdrawal by Subject|2|||
124447304|NCT00726622|447602656|FG000|Overall Study|Physician Decision|0|||
124447305|NCT00726622|447602657|FG001|Overall Study|Physician Decision|1|||
124689878|NCT04124965|448484262|FG000|Overall Study|Physician Decision|0|||
124689879|NCT04124965|448484263|FG001|Overall Study|Physician Decision|1|||
124689880|NCT02184156|448484264|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
124689881|NCT02184156|448484265|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
124689882|NCT02184156|448484264|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
124689883|NCT02184156|448484265|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
124689884|NCT00002874|448484266|FG000|Overall Study|Withdrawal by Subject|1|||
124689885|NCT00002874|448484267|FG001|Overall Study|Withdrawal by Subject|1|||
124689886|NCT00002874|448484266|FG000|Overall Study|Protocol Violation|44|||
124689887|NCT00002874|448484267|FG001|Overall Study|Protocol Violation|34|||
124689888|NCT01397747|448484270|FG000|Overall Study|Multitarget DNA test excluded|689|||
124689889|NCT01397747|448484270|FG000|Overall Study|Colonoscopy excluded|304|||
124689890|NCT01397747|448484270|FG000|Overall Study|FIT excluded|34|||
124689891|NCT03828383|448484273|FG000|Overall Study|Lost to Follow-up|3|||
124689892|NCT03828383|448484274|FG001|Overall Study|Lost to Follow-up|2|||
124689893|NCT03828383|448484273|FG000|Overall Study|Withdrawal by Subject|4|||
124689894|NCT03828383|448484274|FG001|Overall Study|Withdrawal by Subject|5|||
124689895|NCT00504309|448484275|FG000|Overall Study|Death|0|||
124689896|NCT00504309|448484276|FG001|Overall Study|Death|0|||
124689897|NCT00504309|448484277|FG002|Overall Study|Death|0|||
124689898|NCT00504309|448484278|FG003|Overall Study|Death|0|||
124689899|NCT00504309|448484279|FG004|Overall Study|Death|1|||
124689900|NCT00504309|448484280|FG005|Overall Study|Death|0|||
124689901|NCT00504309|448484275|FG000|Overall Study|Withdrawal by Subject|0|||
124689902|NCT00504309|448484276|FG001|Overall Study|Withdrawal by Subject|0|||
124689903|NCT00504309|448484277|FG002|Overall Study|Withdrawal by Subject|1|||
124899993|NCT00798265|449258052|FG001|Overall Study|Screen failure|1|||
124447306|NCT00726622|447602656|FG000|Overall Study|Metastasis|2|||
124447307|NCT00726622|447602657|FG001|Overall Study|Metastasis|0|||
124447308|NCT02462928|447602658|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
124447309|NCT02462928|447602659|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
124447310|NCT02462928|447602660|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
124447311|NCT02462928|447602658|FG000|Overall Study|Adverse Event|47|||
124447312|NCT02462928|447602659|FG001|Overall Study|Adverse Event|51|||
124447313|NCT02462928|447602660|FG002|Overall Study|Adverse Event|25|||
124689904|NCT00504309|448484278|FG003|Overall Study|Withdrawal by Subject|0|||
124689905|NCT00504309|448484279|FG004|Overall Study|Withdrawal by Subject|0|||
124689906|NCT00504309|448484280|FG005|Overall Study|Withdrawal by Subject|0|||
124689907|NCT03158311|448484283|FG000|Overall Study|Subject/Guardian Decision|10|||
124899994|NCT00739102|449259489|FG000|Overall Study|Death|5|||
124899995|NCT00739102|449259489|FG000|Overall Study|Withdrawal by Subject|10|||
124899996|NCT03784963|449259490|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
124447314|NCT02462928|447602658|FG000|Overall Study|Lack of Efficacy|3|||
124447315|NCT02462928|447602659|FG001|Overall Study|Lack of Efficacy|8|||
124447316|NCT02462928|447602660|FG002|Overall Study|Lack of Efficacy|3|||
124447317|NCT02462928|447602658|FG000|Overall Study|Lost to Follow-up|4|||
124447318|NCT02462928|447602659|FG001|Overall Study|Lost to Follow-up|4|||
124447319|NCT02462928|447602660|FG002|Overall Study|Lost to Follow-up|1|||
124447320|NCT02462928|447602658|FG000|Overall Study|Withdrawal by Patient|31|||
124447321|NCT02462928|447602659|FG001|Overall Study|Withdrawal by Patient|21|||
124447322|NCT02462928|447602660|FG002|Overall Study|Withdrawal by Patient|21|||
124447323|NCT02462928|447602658|FG000|Overall Study|Protocol Violation|0|||
124447324|NCT02462928|447602659|FG001|Overall Study|Protocol Violation|1|||
124447325|NCT02462928|447602660|FG002|Overall Study|Protocol Violation|0|||
124447326|NCT02462928|447602658|FG000|Overall Study|Reason not Specified|4|||
124447327|NCT02462928|447602659|FG001|Overall Study|Reason not Specified|6|||
124447328|NCT02462928|447602660|FG002|Overall Study|Reason not Specified|5|||
124447329|NCT01493557|447602661|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
124689908|NCT03158311|448484284|FG001|Overall Study|Subject/Guardian Decision|6|||
124689909|NCT03158311|448484285|FG002|Overall Study|Subject/Guardian Decision|11|||
124689910|NCT03158311|448484283|FG000|Overall Study|Adverse Event|5|||
124689911|NCT03158311|448484284|FG001|Overall Study|Adverse Event|3|||
124689912|NCT03158311|448484285|FG002|Overall Study|Adverse Event|3|||
124447330|NCT01493557|447602662|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
124447331|NCT01493557|447602663|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
124447332|NCT01493557|447602661|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
124447333|NCT01493557|447602662|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
124447334|NCT01493557|447602663|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
124447335|NCT01493557|447602661|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
124447336|NCT01493557|447602662|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
124447337|NCT01493557|447602663|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
124447338|NCT01493557|447602661|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
124447339|NCT01493557|447602662|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
124447340|NCT01493557|447602663|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
124447341|NCT01493557|447602661|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
124447342|NCT01493557|447602662|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
124447343|NCT01493557|447602663|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
124447344|NCT01493557|447602661|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
124447345|NCT01493557|447602662|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
124447346|NCT01493557|447602663|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
124447347|NCT01493557|447602661|FG000|Not Randomized to Management Strategies|Early termination|0|||
124447348|NCT01493557|447602662|FG001|Not Randomized to Management Strategies|Early termination|0|||
124447349|NCT01493557|447602663|FG002|Not Randomized to Management Strategies|Early termination|34|||
124447350|NCT01493557|447602661|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
124447351|NCT01493557|447602662|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
124447352|NCT01493557|447602663|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
124447353|NCT01493557|447602661|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
124447354|NCT01493557|447602662|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
124447355|NCT01493557|447602663|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
124447356|NCT01493557|447602661|FG000|Randomized to Management Strategies|Other adverse event|8|||
124689913|NCT03158311|448484283|FG000|Overall Study|Techinical Problems|3|||
124689914|NCT03158311|448484284|FG001|Overall Study|Techinical Problems|1|||
124689915|NCT03158311|448484285|FG002|Overall Study|Techinical Problems|5|||
124689916|NCT03158311|448484283|FG000|Overall Study|Physician Decision|2|||
124689917|NCT03158311|448484284|FG001|Overall Study|Physician Decision|3|||
124689918|NCT03158311|448484285|FG002|Overall Study|Physician Decision|7|||
124689919|NCT03158311|448484283|FG000|Overall Study|Lost to Follow-up|1|||
124689920|NCT03158311|448484284|FG001|Overall Study|Lost to Follow-up|1|||
124689921|NCT03158311|448484285|FG002|Overall Study|Lost to Follow-up|1|||
124689922|NCT03158311|448484283|FG000|Overall Study|Sponsor decision|1|||
124689923|NCT03158311|448484284|FG001|Overall Study|Sponsor decision|0|||
124689924|NCT03158311|448484285|FG002|Overall Study|Sponsor decision|0|||
124689925|NCT03158311|448484283|FG000|Overall Study|Pregnancy|0|||
124689926|NCT03158311|448484284|FG001|Overall Study|Pregnancy|2|||
124689927|NCT03158311|448484285|FG002|Overall Study|Pregnancy|0|||
124689928|NCT03158311|448484283|FG000|Overall Study|Randomized in error|0|||
124689929|NCT03158311|448484284|FG001|Overall Study|Randomized in error|0|||
124689930|NCT03158311|448484285|FG002|Overall Study|Randomized in error|1|||
124689931|NCT01018953|448484286|FG000|Overall Study|Adverse Event|2|||
124689932|NCT01018953|448484286|FG000|Overall Study|Withdrawal by Subject|1|||
124689933|NCT01018953|448484286|FG000|Overall Study|Study termination by sponsor|5|||
124689934|NCT01928771|448484293|FG000|Overall Study|Adverse Event|6|||
124447357|NCT01493557|447602662|FG001|Randomized to Management Strategies|Other adverse event|5|||
124447358|NCT01493557|447602663|FG002|Randomized to Management Strategies|Other adverse event|0|||
124447359|NCT01493557|447602661|FG000|Randomized to Management Strategies|Protocol Violation|3|||
124447360|NCT01493557|447602662|FG001|Randomized to Management Strategies|Protocol Violation|0|||
124447361|NCT01493557|447602663|FG002|Randomized to Management Strategies|Protocol Violation|0|||
124447362|NCT01493557|447602661|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
124447363|NCT01493557|447602662|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
124447364|NCT01493557|447602663|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
124447365|NCT01493557|447602661|FG000|Randomized to Management Strategies|Other than stated above|1|||
124447366|NCT01493557|447602662|FG001|Randomized to Management Strategies|Other than stated above|3|||
124447367|NCT01493557|447602663|FG002|Randomized to Management Strategies|Other than stated above|0|||
124447368|NCT01493557|447602661|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
124447369|NCT01493557|447602662|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
124447370|NCT01493557|447602663|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
124447371|NCT01493557|447602661|FG000|Adding the Second Strategy|Other adverse event|1|||
124447372|NCT01493557|447602662|FG001|Adding the Second Strategy|Other adverse event|2|||
124447373|NCT01493557|447602663|FG002|Adding the Second Strategy|Other adverse event|0|||
124447374|NCT01493557|447602661|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
124447375|NCT01493557|447602662|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
124447376|NCT01493557|447602663|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
124447377|NCT01890148|447602678|FG000|Overall Study|Adverse Event|1|||
124447378|NCT01215175|447602679|FG000|Overall Study|Lost to Follow-up|0|||
124447379|NCT01215175|447602680|FG001|Overall Study|Lost to Follow-up|1|||
124447380|NCT01215175|447602681|FG002|Overall Study|Lost to Follow-up|0|||
124447381|NCT01215175|447602682|FG003|Overall Study|Lost to Follow-up|1|||
124447382|NCT01215175|447602683|FG004|Overall Study|Lost to Follow-up|0|||
124689935|NCT01928771|448484294|FG001|Overall Study|Adverse Event|5|||
124689936|NCT01928771|448484295|FG002|Overall Study|Adverse Event|1|||
124689937|NCT01928771|448484293|FG000|Overall Study|Death|2|||
124447383|NCT01678209|447602684|FG000|Overall Study|could not scan twice|1|||
124447384|NCT01678209|447602685|FG001|Overall Study|could not scan twice|1|||
124447385|NCT01678209|447602686|FG002|Overall Study|could not scan twice|1|||
124447386|NCT01678209|447602684|FG000|Overall Study|scheduling conflicts|0|||
124447387|NCT01678209|447602685|FG001|Overall Study|scheduling conflicts|0|||
124447388|NCT01678209|447602686|FG002|Overall Study|scheduling conflicts|1|||
124447389|NCT01678209|447602684|FG000|Overall Study|screen fail|16|||
124447390|NCT01678209|447602685|FG001|Overall Study|screen fail|17|||
124447391|NCT01678209|447602686|FG002|Overall Study|screen fail|16|||
124447392|NCT00702845|447602687|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
124447393|NCT00702845|447602688|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
124689938|NCT01928771|448484294|FG001|Overall Study|Death|2|||
124689939|NCT01928771|448484295|FG002|Overall Study|Death|2|||
124689940|NCT01928771|448484293|FG000|Overall Study|Lost to Follow-up|5|||
124689941|NCT01928771|448484294|FG001|Overall Study|Lost to Follow-up|6|||
124689942|NCT01928771|448484295|FG002|Overall Study|Lost to Follow-up|3|||
124689943|NCT01928771|448484293|FG000|Overall Study|Withdrawal by Subject|20|||
124689944|NCT01928771|448484294|FG001|Overall Study|Withdrawal by Subject|15|||
124689945|NCT01928771|448484295|FG002|Overall Study|Withdrawal by Subject|17|||
124689946|NCT01928771|448484293|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
124689947|NCT01928771|448484294|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
124689948|NCT01928771|448484295|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
124689949|NCT01928771|448484293|FG000|Overall Study|Other Reasons|9|||
124689950|NCT01928771|448484294|FG001|Overall Study|Other Reasons|9|||
124689951|NCT01928771|448484295|FG002|Overall Study|Other Reasons|14|||
124689952|NCT01928771|448484293|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
124689953|NCT01928771|448484294|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
124689954|NCT01928771|448484295|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
124689955|NCT03932331|448484296|FG000|Overall Study|Death|0|||
124689956|NCT03932331|448484297|FG001|Overall Study|Death|7|||
124689957|NCT03932331|448484298|FG002|Overall Study|Death|2|||
124689958|NCT03932331|448484296|FG000|Overall Study|Withdrawal by Subject|0|||
124689959|NCT03932331|448484297|FG001|Overall Study|Withdrawal by Subject|3|||
124689960|NCT03932331|448484298|FG002|Overall Study|Withdrawal by Subject|0|||
124689961|NCT03932331|448484296|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
124447394|NCT00702845|447602687|FG000|Overall Study|Too high ovarian response|5|||
124447395|NCT00702845|447602688|FG001|Overall Study|Too high ovarian response|1|||
124689962|NCT03932331|448484297|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
124689963|NCT03932331|448484298|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
124689964|NCT03932331|448484296|FG000|Overall Study|Progressive disease|3|||
124689965|NCT03932331|448484297|FG001|Overall Study|Progressive disease|0|||
124689966|NCT03932331|448484298|FG002|Overall Study|Progressive disease|0|||
124689967|NCT03932331|448484296|FG000|Overall Study|Lung infection|1|||
124689968|NCT03932331|448484297|FG001|Overall Study|Lung infection|0|||
124447396|NCT00702845|447602687|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
124447397|NCT00702845|447602688|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
124447398|NCT00702845|447602687|FG000|Overall Study|Insufficient ovarian response|1|||
124447399|NCT00702845|447602688|FG001|Overall Study|Insufficient ovarian response|0|||
124447400|NCT00702845|447602687|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
124447401|NCT00702845|447602688|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
124447402|NCT00702845|447602687|FG000|Overall Study|No or abnormal fertilization|4|||
124689969|NCT03932331|448484298|FG002|Overall Study|Lung infection|0|||
124447403|NCT00702845|447602688|FG001|Overall Study|No or abnormal fertilization|2|||
124447404|NCT00702845|447602687|FG000|Overall Study|Patient's decision|2|||
124447405|NCT00702845|447602688|FG001|Overall Study|Patient's decision|1|||
124447406|NCT00702845|447602687|FG000|Overall Study|Not randomized|0|||
124689970|NCT03932331|448484296|FG000|Overall Study|Other|0|||
124689971|NCT03932331|448484297|FG001|Overall Study|Other|0|||
124689972|NCT03932331|448484298|FG002|Overall Study|Other|58|||
124689973|NCT01407367|448484303|FG000|Overall Study|Death|24|||
124689974|NCT01407367|448484304|FG001|Overall Study|Death|32|||
124689975|NCT01407367|448484303|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
124689976|NCT01407367|448484304|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
124689977|NCT01407367|448484303|FG000|Overall Study|Withdrawal by Subject|4|||
124689978|NCT01407367|448484304|FG001|Overall Study|Withdrawal by Subject|15|||
124689979|NCT01407367|448484303|FG000|Overall Study|Lost to Follow-up|0|||
124689980|NCT01407367|448484304|FG001|Overall Study|Lost to Follow-up|2|||
124689981|NCT01452347|448484305|FG000|Overall Study|Adverse Event|2|||
124689982|NCT01452347|448484306|FG001|Overall Study|Adverse Event|1|||
124689983|NCT01452347|448484305|FG000|Overall Study|Non compliance protocol|2|||
124689984|NCT01452347|448484306|FG001|Overall Study|Non compliance protocol|0|||
124689985|NCT01452347|448484305|FG000|Overall Study|Lost to Follow-up|2|||
124689986|NCT01452347|448484306|FG001|Overall Study|Lost to Follow-up|0|||
124689987|NCT01452347|448484305|FG000|Overall Study|Withdrawal by Subject|3|||
124689988|NCT01452347|448484306|FG001|Overall Study|Withdrawal by Subject|3|||
124689989|NCT01452347|448484305|FG000|Overall Study|Not treated|6|||
124689990|NCT01452347|448484306|FG001|Overall Study|Not treated|3|||
124689991|NCT01452347|448484305|FG000|Overall Study|Other reason not defined above|2|||
124689992|NCT01452347|448484306|FG001|Overall Study|Other reason not defined above|0|||
124689993|NCT02642679|448485995|FG000|Overall Study|Withdrawal by Subject|1|||
124689994|NCT02642679|448485995|FG000|Overall Study|Physician Decision|1|||
124689995|NCT02642679|448485995|FG000|Overall Study|Physician Decision|1|||
124689996|NCT01112267|448485997|FG000|Overall Study|Adverse Event|24|||
124689997|NCT01112267|448485998|FG001|Overall Study|Adverse Event|6|||
124689998|NCT01112267|448485997|FG000|Overall Study|Withdrawal by Subject|3|||
124689999|NCT01112267|448485998|FG001|Overall Study|Withdrawal by Subject|5|||
124690000|NCT01112267|448485997|FG000|Overall Study|Protocol Violation|5|||
124690001|NCT01112267|448485998|FG001|Overall Study|Protocol Violation|3|||
124690002|NCT01112267|448485997|FG000|Overall Study|Participants not compliant|1|||
124690003|NCT01112267|448485998|FG001|Overall Study|Participants not compliant|2|||
124690004|NCT01112267|448485997|FG000|Overall Study|Participants not receive any study drug|1|||
124690005|NCT01112267|448485998|FG001|Overall Study|Participants not receive any study drug|2|||
124690006|NCT05638737|448486001|FG000|Overall Study|Withdrawal by Subject|4|||
124690007|NCT05638737|448486002|FG001|Overall Study|Withdrawal by Subject|7|||
124690008|NCT04633447|448486005|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
124690009|NCT04633447|448486006|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
124690010|NCT04633447|448486005|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
124690011|NCT04633447|448486006|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
124690012|NCT04633447|448486005|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
124690013|NCT04633447|448486006|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
124690014|NCT04633447|448486005|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
124690015|NCT04633447|448486006|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
124690016|NCT04633447|448486005|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
124690017|NCT04633447|448486006|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
124690018|NCT04633447|448486005|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
124690019|NCT04633447|448486006|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
124447407|NCT00702845|447602688|FG001|Overall Study|Not randomized|1|||
124447408|NCT02973425|447602692|FG000|Overall Study|Lost to Follow-up|49|||
124447409|NCT02973425|447602693|FG001|Overall Study|Lost to Follow-up|53|||
124447410|NCT03876171|447602694|FG000|Overall Study|Withdrawal by Subject|3|||
124447411|NCT03876171|447602695|FG001|Overall Study|Withdrawal by Subject|3|||
124447412|NCT03876171|447602694|FG000|Overall Study|Re-arrest|0|||
124690020|NCT03641924|448486007|FG000|Overall Study|Withdrawal by Subject|26|||
124690021|NCT03641924|448486007|FG000|Overall Study|Lost to Follow-up|16|||
124690022|NCT03641924|448486007|FG000|Overall Study|Protocol Violation|10|||
124690023|NCT04333498|448486008|FG000|Overall Study|Lost to Follow-up|1|||
124690024|NCT04333498|448486009|FG001|Overall Study|Lost to Follow-up|0|||
124690025|NCT04333498|448486008|FG000|Overall Study|Lost to Follow-up|0|||
124447413|NCT03876171|447602695|FG001|Overall Study|Re-arrest|4|||
124447414|NCT03503513|447602700|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
124447415|NCT03503513|447602700|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
124447416|NCT03503513|447602700|FG000|Overall Study|Physician Decision|3|||
124447417|NCT03503513|447602700|FG000|Overall Study|Withdrawal by Subject|2|||
124447418|NCT03503513|447602700|FG000|Overall Study|Lost to Follow-up|1|||
124447419|NCT00929656|447602701|FG000|Overall Study|Lost to Follow-up|0|||
124447420|NCT00929656|447602702|FG001|Overall Study|Lost to Follow-up|1|||
124447421|NCT00607880|447602703|FG000|Overall Study|Unable to place port due to occlusion|1|||
124690026|NCT04333498|448486009|FG001|Overall Study|Lost to Follow-up|1|||
124690027|NCT01565694|448486010|FG000|Dose-Titration Period|Adverse Event|4|||
124690028|NCT01565694|448486010|FG000|Dose-Titration Period|Protocol Violation|10|||
124690029|NCT01565694|448486010|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
124690030|NCT02724644|448486015|FG000|Overall Study|Adverse Event|7|||
124690031|NCT02724644|448486016|FG001|Overall Study|Adverse Event|1|||
124690032|NCT02724644|448486015|FG000|Overall Study|Lost to Follow-up|6|||
124690033|NCT02724644|448486016|FG001|Overall Study|Lost to Follow-up|2|||
124690034|NCT02724644|448486015|FG000|Overall Study|Withdrawal by Subject|7|||
124690035|NCT02724644|448486016|FG001|Overall Study|Withdrawal by Subject|1|||
124690036|NCT02724644|448486015|FG000|Overall Study|Administrative|1|||
124690037|NCT02724644|448486016|FG001|Overall Study|Administrative|0|||
124690038|NCT05417113|448486017|FG000|Overall Study|Lost to Follow-up|2|||
124690039|NCT05417113|448486018|FG001|Overall Study|Lost to Follow-up|2|||
124690040|NCT01022580|448486019|FG000|Overall Study|Death|18|||
124690041|NCT01022580|448486020|FG001|Overall Study|Death|22|||
124690042|NCT00541229|448486021|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
124690043|NCT00541229|448486022|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
124690044|NCT00541229|448486023|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
124690045|NCT00541229|448486024|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
124690046|NCT00541229|448486025|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
124690047|NCT00541229|448486026|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
124690048|NCT00541229|448486021|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
124690049|NCT00541229|448486022|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
124690050|NCT00541229|448486023|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
124690051|NCT00541229|448486024|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
124690052|NCT00541229|448486025|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
124690053|NCT00541229|448486026|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
124690054|NCT00541229|448486021|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
124690055|NCT00541229|448486022|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
124690056|NCT00541229|448486023|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
124690057|NCT00541229|448486024|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
124690058|NCT00541229|448486025|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
124690059|NCT00541229|448486026|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
124690060|NCT00541229|448486021|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
124690061|NCT00541229|448486022|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
124690062|NCT00541229|448486023|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
124690063|NCT00541229|448486024|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
124690064|NCT00541229|448486025|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
124690065|NCT00541229|448486026|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
124690066|NCT00541229|448486021|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
124690067|NCT00541229|448486022|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
124690068|NCT00541229|448486023|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
124690069|NCT00541229|448486024|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
124690070|NCT00541229|448486025|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
124690071|NCT00541229|448486026|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
124690072|NCT00541229|448486021|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
124690073|NCT00541229|448486022|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
124690074|NCT00541229|448486023|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
124690075|NCT00541229|448486024|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
124690076|NCT00541229|448486025|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
124690077|NCT00541229|448486026|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
124690078|NCT00541229|448486021|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
124690079|NCT00541229|448486022|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
124690080|NCT00541229|448486023|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
124690081|NCT00541229|448486024|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
124690082|NCT00541229|448486025|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
124690083|NCT00541229|448486026|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
124690084|NCT00541229|448486021|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
124690085|NCT00541229|448486022|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
124690086|NCT00541229|448486023|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
124690087|NCT00541229|448486024|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
124447422|NCT00607880|447602704|FG001|Overall Study|Unable to place port due to occlusion|0|||
124447423|NCT01170039|447602707|FG000|Overall Study|Withdrawal by Subject|5|||
124447424|NCT01170039|447602708|FG001|Overall Study|Withdrawal by Subject|3|||
124447425|NCT01170039|447602707|FG000|Overall Study|Lack of funding, drug not available|3|||
124447426|NCT01170039|447602708|FG001|Overall Study|Lack of funding, drug not available|3|||
124447427|NCT00908583|447602709|FG000|Phase 1|Withdrawal by Subject|1|||
124447428|NCT00908583|447602709|FG000|Phase 1|Adverse Event|4|||
124447429|NCT00908583|447602709|FG000|Phase 2|Physician Decision|1|||
124447430|NCT00908583|447602709|FG000|Phase 2|Adverse Event|1|||
124447431|NCT00908583|447602709|FG000|Phase 3|Adverse Event|2|||
124447432|NCT00908583|447602709|FG000|Phase 4|Adverse Event|1|||
124447433|NCT00908583|447602709|FG000|Phase 4|Physician Decision|1|||
124447434|NCT00908583|447602709|FG000|Phase 5|Adverse Event|3|||
124447435|NCT00993954|447602710|FG000|Overall Study|Protocol Violation|21|||
124447436|NCT00993954|447602711|FG001|Overall Study|Protocol Violation|2|||
124447437|NCT00860951|447602712|FG000|Overall Study|Withdrawal by Subject|2|||
124447438|NCT00860951|447602712|FG000|Overall Study|Lost to Follow-up|5|||
124447439|NCT00727649|447602713|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
124447440|NCT00727649|447602714|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
124447441|NCT00727649|447602713|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
124447442|NCT00727649|447602714|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
124447443|NCT00727649|447602713|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
124447444|NCT00727649|447602714|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
124447445|NCT00727649|447602713|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
124447446|NCT00727649|447602714|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
124447447|NCT00727649|447602713|FG000|Second Intervention (4-weeks)|Death|1|||
124447448|NCT00727649|447602714|FG001|Second Intervention (4-weeks)|Death|0|||
124447449|NCT00727649|447602713|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
124447450|NCT00727649|447602714|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
124447451|NCT00727649|447602713|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
124447452|NCT00727649|447602714|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
124447453|NCT03627767|447602715|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
124447454|NCT03627767|447602716|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
124447455|NCT03627767|447602717|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
124447456|NCT03627767|447602718|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
124447457|NCT03627767|447602719|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
124447458|NCT03627767|447602715|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
124447459|NCT03627767|447602716|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
124447460|NCT03627767|447602717|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
124447461|NCT03627767|447602718|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
124690088|NCT00541229|448486025|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
124690089|NCT00541229|448486026|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
124690090|NCT00541229|448486021|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
124690091|NCT00541229|448486022|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
124690092|NCT00541229|448486023|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
124690093|NCT00541229|448486024|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
124690094|NCT00541229|448486025|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
124690095|NCT00541229|448486026|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
124690096|NCT00541229|448486021|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
124690097|NCT00541229|448486022|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
124690098|NCT00541229|448486023|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
124690099|NCT00541229|448486024|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
124690100|NCT00541229|448486025|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
124690101|NCT00541229|448486026|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
124690102|NCT00541229|448486021|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
124690103|NCT00541229|448486022|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
124690104|NCT00541229|448486023|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
124690105|NCT00541229|448486024|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
124690106|NCT00541229|448486025|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
124690107|NCT00541229|448486026|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
124690108|NCT00541229|448486021|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
124690109|NCT00541229|448486022|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
124690110|NCT00541229|448486023|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
124690111|NCT00541229|448486024|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
124690112|NCT00541229|448486025|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
124690113|NCT00541229|448486026|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
124690114|NCT00541229|448486021|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
124690115|NCT00541229|448486022|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
124690116|NCT00541229|448486023|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
124447462|NCT03627767|447602719|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
124447463|NCT03627767|447602715|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
124447464|NCT03627767|447602716|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
124447465|NCT03627767|447602717|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
124690117|NCT00541229|448486024|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
124690118|NCT00541229|448486025|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
124690119|NCT00541229|448486026|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
124690120|NCT00541229|448486021|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
124690121|NCT00541229|448486022|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
124690122|NCT00541229|448486023|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
124690123|NCT00541229|448486024|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
124690124|NCT00541229|448486025|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
124690125|NCT00541229|448486026|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
124690126|NCT00541229|448486021|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
124690127|NCT00541229|448486022|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
124690128|NCT00541229|448486023|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
124690129|NCT00541229|448486024|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
124690130|NCT00541229|448486025|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
124690131|NCT00541229|448486026|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
124690132|NCT00541229|448486021|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
124690133|NCT00541229|448486022|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
124690134|NCT00541229|448486023|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
124690135|NCT00541229|448486024|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
124690136|NCT00541229|448486025|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
124690137|NCT00541229|448486026|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
124690138|NCT01807520|448486027|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
124690139|NCT01807520|448486028|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
124690140|NCT01807520|448486029|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
124690141|NCT01807520|448486030|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
124690142|NCT01807520|448486031|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
124690143|NCT01807520|448486032|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
124690144|NCT01807520|448486033|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
124690145|NCT01807520|448486027|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
124690146|NCT01807520|448486028|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
124690147|NCT01807520|448486029|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
124690148|NCT01807520|448486030|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
124690149|NCT01807520|448486031|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
124690150|NCT01807520|448486032|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
124690151|NCT01807520|448486033|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
124690152|NCT01807520|448486027|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
124690153|NCT01807520|448486028|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
124690154|NCT01807520|448486029|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
124690155|NCT01807520|448486030|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
124690156|NCT01807520|448486031|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
124690157|NCT01807520|448486032|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
124759682|NCT01147666|448744766|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
124759683|NCT01147666|448744767|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
124759684|NCT01147666|448744768|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
124759685|NCT01147666|448744769|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
124759686|NCT01147666|448744755|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
124759687|NCT01147666|448744756|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
124759688|NCT01147666|448744757|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
124759689|NCT01147666|448744758|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
124759690|NCT01147666|448744759|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
124759691|NCT01147666|448744760|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
124759692|NCT01147666|448744761|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
124759693|NCT01147666|448744762|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
124759694|NCT01147666|448744763|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
124759695|NCT01147666|448744764|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
124759696|NCT01147666|448744765|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
124759697|NCT01147666|448744766|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
124759698|NCT01147666|448744767|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
124759699|NCT01147666|448744768|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
124759700|NCT01147666|448744769|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
124759701|NCT01147666|448744755|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
124690158|NCT01807520|448486033|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
124690159|NCT01807520|448486027|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
124690160|NCT01807520|448486028|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
124690161|NCT01807520|448486029|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
124690162|NCT01807520|448486030|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
124690163|NCT01807520|448486031|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
124690164|NCT01807520|448486032|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
124690165|NCT01807520|448486033|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
124690166|NCT01807520|448486027|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
124690167|NCT01807520|448486028|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
124690168|NCT01807520|448486029|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
124690169|NCT01807520|448486030|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
124690170|NCT01807520|448486031|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
124690171|NCT01807520|448486032|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
124690172|NCT01807520|448486033|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
124690173|NCT01807520|448486027|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
124690174|NCT01807520|448486028|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
124690175|NCT01807520|448486029|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
124690176|NCT01807520|448486030|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
124690177|NCT01807520|448486031|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
124690178|NCT01807520|448486032|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
124690179|NCT01807520|448486033|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
124690180|NCT01807520|448486027|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
124690181|NCT01807520|448486028|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
124690182|NCT01807520|448486029|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
124690183|NCT01807520|448486030|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
124690184|NCT01807520|448486031|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
124690185|NCT01807520|448486032|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
124690186|NCT01807520|448486033|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
124690187|NCT01807520|448486027|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
124690188|NCT01807520|448486028|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
124690189|NCT01807520|448486029|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
124690190|NCT01807520|448486030|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
124690191|NCT01807520|448486031|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
124690192|NCT01807520|448486032|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
124690193|NCT01807520|448486033|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
124690194|NCT01807520|448486027|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
124690195|NCT01807520|448486028|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
124690196|NCT01807520|448486029|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
124690197|NCT01807520|448486030|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
124690198|NCT01807520|448486031|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
124690199|NCT01807520|448486032|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
124690200|NCT01807520|448486033|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
124690201|NCT01807520|448486027|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
124690202|NCT01807520|448486028|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
124690203|NCT01807520|448486029|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
124690204|NCT01807520|448486030|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
124690205|NCT01807520|448486031|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
124690206|NCT01807520|448486032|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
124690207|NCT01807520|448486033|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
124690208|NCT01807520|448486027|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
124690209|NCT01807520|448486028|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
124690210|NCT01807520|448486029|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
124690211|NCT01807520|448486030|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
124690212|NCT01807520|448486031|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
124690213|NCT01807520|448486032|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
124690214|NCT01807520|448486033|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
124690215|NCT01807520|448486027|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
124690216|NCT01807520|448486028|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
124690217|NCT01807520|448486029|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
124690218|NCT01807520|448486030|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
124690219|NCT01807520|448486031|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
124690220|NCT01807520|448486032|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
124690221|NCT01807520|448486033|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
124690222|NCT01807520|448486027|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
124690223|NCT01807520|448486028|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
124690224|NCT01807520|448486029|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
124690225|NCT01807520|448486030|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
124690226|NCT01807520|448486031|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
124690227|NCT01807520|448486032|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
124690228|NCT01807520|448486033|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
124690229|NCT01807520|448486027|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
124690230|NCT01807520|448486028|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
124690231|NCT01807520|448486029|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
124690232|NCT01807520|448486030|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
124690233|NCT01807520|448486031|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
124690234|NCT01807520|448486032|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
124690235|NCT01807520|448486033|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
124690236|NCT01807520|448486027|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
124690237|NCT01807520|448486028|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
124690238|NCT01807520|448486029|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
124690239|NCT01807520|448486030|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
124690240|NCT01807520|448486031|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
124690241|NCT01807520|448486032|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
124690242|NCT01807520|448486033|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
124690243|NCT01807520|448486027|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
124690244|NCT01807520|448486028|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
124690245|NCT01807520|448486029|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
124690246|NCT01807520|448486030|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
124690247|NCT01807520|448486031|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
124690248|NCT01807520|448486032|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
124690249|NCT01807520|448486033|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
124690250|NCT01807520|448486027|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
124447466|NCT03627767|447602718|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
124447467|NCT03627767|447602719|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
124447468|NCT03627767|447602715|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
124447469|NCT03627767|447602716|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
124447470|NCT03627767|447602717|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
124447471|NCT03627767|447602718|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
124447472|NCT03627767|447602719|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
124447473|NCT03627767|447602715|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
124447474|NCT03627767|447602716|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
124447475|NCT03627767|447602717|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
124447476|NCT03627767|447602718|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
124447477|NCT03627767|447602719|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
124447478|NCT03627767|447602715|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
124447479|NCT03627767|447602716|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
124447480|NCT03627767|447602717|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
124447481|NCT03627767|447602718|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
124447482|NCT03627767|447602719|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
124447483|NCT03627767|447602715|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
124447484|NCT03627767|447602716|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
124447485|NCT03627767|447602717|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
124690251|NCT01807520|448486028|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
124690252|NCT01807520|448486029|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
124690253|NCT01807520|448486030|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
124690254|NCT01807520|448486031|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
124690255|NCT01807520|448486032|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
124690256|NCT01807520|448486033|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
124690257|NCT01500096|448486034|FG000|Overall Study|Lost to Follow-up|1|||
124690258|NCT01500096|448486035|FG001|Overall Study|Lost to Follow-up|0|||
124690259|NCT01500096|448486036|FG002|Overall Study|Lost to Follow-up|0|||
124690260|NCT01500096|448486037|FG003|Overall Study|Lost to Follow-up|2|||
124690261|NCT01797185|448486038|FG000|Overall Study|Adverse Event|5|||
124690262|NCT01797185|448486039|FG001|Overall Study|Adverse Event|15|||
124690263|NCT01797185|448486040|FG002|Overall Study|Adverse Event|6|||
124690264|NCT01797185|448486038|FG000|Overall Study|Withdrawal by Subject|6|||
124690265|NCT01797185|448486039|FG001|Overall Study|Withdrawal by Subject|9|||
124690266|NCT01797185|448486040|FG002|Overall Study|Withdrawal by Subject|5|||
124690267|NCT01797185|448486038|FG000|Overall Study|Site terminated|8|||
124690268|NCT01797185|448486039|FG001|Overall Study|Site terminated|4|||
124690269|NCT01797185|448486040|FG002|Overall Study|Site terminated|0|||
124690270|NCT01797185|448486038|FG000|Overall Study|Lost to Follow-up|2|||
124690271|NCT01797185|448486039|FG001|Overall Study|Lost to Follow-up|6|||
124690272|NCT01797185|448486040|FG002|Overall Study|Lost to Follow-up|1|||
124690273|NCT01797185|448486038|FG000|Overall Study|Withdrawn per sponsor|5|||
124690274|NCT01797185|448486039|FG001|Overall Study|Withdrawn per sponsor|0|||
124690275|NCT01797185|448486040|FG002|Overall Study|Withdrawn per sponsor|0|||
124690276|NCT01797185|448486038|FG000|Overall Study|Physician Decision|1|||
124690277|NCT01797185|448486039|FG001|Overall Study|Physician Decision|3|||
124690278|NCT01797185|448486040|FG002|Overall Study|Physician Decision|0|||
124690279|NCT01797185|448486038|FG000|Overall Study|Protocol Violation|1|||
124690280|NCT01797185|448486039|FG001|Overall Study|Protocol Violation|1|||
124690281|NCT01797185|448486040|FG002|Overall Study|Protocol Violation|0|||
124690282|NCT03520569|448486041|FG000|Overall Study|Withdrawal by Subject|1|||
124690283|NCT03418675|448486044|FG000|Overall Study|Lost to Follow-up|13|||
124690284|NCT03418675|448486045|FG001|Overall Study|Lost to Follow-up|10|||
124690285|NCT03418675|448486044|FG000|Overall Study|Adverse Event|2|||
124690286|NCT03418675|448486045|FG001|Overall Study|Adverse Event|0|||
124690287|NCT03422718|448486046|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
124690288|NCT03422718|448486047|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
124899997|NCT03784963|449259491|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
124899998|NCT03784963|449259492|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
124899999|NCT03784963|449259493|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
124900000|NCT03179787|449259494|FG000|Overall Study|Lost to Follow-up|15|||
124900001|NCT03179787|449259494|FG000|Overall Study|Case report failures|2|||
124690289|NCT03422718|448486048|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
124690290|NCT03422718|448486049|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
124690291|NCT03422718|448486050|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
124690292|NCT03422718|448486051|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
124690293|NCT03422718|448486052|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
124759702|NCT01147666|448744756|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
124759703|NCT01147666|448744757|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
124759704|NCT01147666|448744758|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
124759705|NCT01147666|448744759|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
124759706|NCT01147666|448744760|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
124759707|NCT01147666|448744761|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
124759708|NCT01147666|448744762|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
124759709|NCT01147666|448744763|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
124759710|NCT01147666|448744764|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
124759711|NCT01147666|448744765|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
124759712|NCT01147666|448744766|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
124759713|NCT01147666|448744767|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
124759714|NCT01147666|448744768|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
124759715|NCT01147666|448744769|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
124759716|NCT01147666|448744755|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
124759717|NCT01147666|448744756|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
124759718|NCT01147666|448744757|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
124759719|NCT01147666|448744758|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
124759720|NCT01147666|448744759|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
124900002|NCT03179787|449259494|FG000|Overall Study|Treatment not administered|1|||
124900003|NCT01090024|449259495|FG000|Period 1|Met exclusion criteria|0|||
124900004|NCT01090024|449259496|FG001|Period 1|Met exclusion criteria|0|||
124900005|NCT01090024|449259497|FG002|Period 1|Met exclusion criteria|0|||
124900006|NCT01090024|449259498|FG003|Period 1|Met exclusion criteria|0|||
124900007|NCT01090024|449259499|FG004|Period 1|Met exclusion criteria|0|||
124900008|NCT01090024|449259500|FG005|Period 1|Met exclusion criteria|0|||
124900009|NCT01090024|449259501|FG006|Period 1|Met exclusion criteria|0|||
124900010|NCT01090024|449259502|FG007|Period 1|Met exclusion criteria|0|||
124900011|NCT01090024|449259503|FG008|Period 1|Met exclusion criteria|0|||
124900012|NCT01090024|449259504|FG009|Period 1|Met exclusion criteria|0|||
124900013|NCT01090024|449259505|FG010|Period 1|Met exclusion criteria|0|||
124900014|NCT01090024|449259506|FG011|Period 1|Met exclusion criteria|0|||
124900015|NCT01090024|449259507|FG012|Period 1|Met exclusion criteria|0|||
124900016|NCT01090024|449259508|FG013|Period 1|Met exclusion criteria|0|||
124900017|NCT01090024|449259509|FG014|Period 1|Met exclusion criteria|1|||
124900018|NCT01090024|449259510|FG015|Period 1|Met exclusion criteria|0|||
124900019|NCT01090024|449259511|FG016|Period 1|Met exclusion criteria|0|||
124690294|NCT03422718|448486053|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
124690295|NCT03422718|448486046|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
124690296|NCT03422718|448486047|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
124690297|NCT03422718|448486048|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
124690298|NCT03422718|448486049|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
124690299|NCT03422718|448486050|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
124690300|NCT03422718|448486051|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
124690301|NCT03422718|448486052|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
124690302|NCT03422718|448486053|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
124690303|NCT03422718|448486046|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
124690304|NCT03422718|448486047|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
124690305|NCT03422718|448486048|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
124690306|NCT03422718|448486049|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
124690307|NCT03422718|448486050|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
124690308|NCT03422718|448486051|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
124690309|NCT03422718|448486052|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
124690310|NCT03422718|448486053|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
124690311|NCT03422718|448486046|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
124690312|NCT03422718|448486047|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
124690313|NCT03422718|448486048|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
124690314|NCT03422718|448486049|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
124690315|NCT03422718|448486050|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
124690316|NCT03422718|448486051|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
124690317|NCT03422718|448486052|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
124690318|NCT03422718|448486053|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
124690319|NCT03422718|448486046|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
124690320|NCT03422718|448486047|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
124690321|NCT03422718|448486048|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
124690322|NCT03422718|448486049|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
124690323|NCT03422718|448486050|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
124690324|NCT03422718|448486051|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
124690325|NCT03422718|448486052|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
124690326|NCT03422718|448486053|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
124690327|NCT03422718|448486046|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
124690328|NCT03422718|448486047|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
124690329|NCT03422718|448486048|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
124690330|NCT03422718|448486049|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
124690331|NCT03422718|448486050|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
124690332|NCT03422718|448486051|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
124690333|NCT03422718|448486052|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
124690334|NCT03422718|448486053|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
124690335|NCT01178411|448486054|FG000|Overall Study|Adverse Event|5|||
124690336|NCT01178411|448486054|FG000|Overall Study|Withdrawal by Subject|4|||
124690337|NCT01178411|448486054|FG000|Overall Study|Protocol Violation|1|||
124690338|NCT01178411|448486054|FG000|Overall Study|Progressive disease per RECIST|32|||
124690339|NCT01178411|448486054|FG000|Overall Study|Progressive disease per clinician|9|||
124690340|NCT01178411|448486054|FG000|Overall Study|Physician Decision|6|||
124690341|NCT01178411|448486054|FG000|Overall Study|Death|1|||
124690342|NCT01178411|448486054|FG000|Overall Study|No reason provided|1|||
124690343|NCT01178411|448486054|FG000|Overall Study|Drug manufacturing ended|1|||
124690344|NCT01129284|448486055|FG000|Overall Study|Adverse Event|2|||
124690345|NCT01129284|448486056|FG001|Overall Study|Adverse Event|0|||
124690346|NCT01129284|448486057|FG002|Overall Study|Adverse Event|1|||
124690347|NCT01625182|448486065|FG000|Overall Study|Administrative problems|1|||
124900020|NCT01090024|449259512|FG017|Period 1|Met exclusion criteria|0|||
124690348|NCT01625182|448486066|FG001|Overall Study|Administrative problems|0|||
124900021|NCT01090024|449259495|FG000|Period 1|Adverse Event|0|||
124900022|NCT01090024|449259496|FG001|Period 1|Adverse Event|0|||
124447486|NCT03627767|447602718|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
124447487|NCT03627767|447602719|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
124447488|NCT03627767|447602715|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
124447489|NCT03627767|447602716|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
124447490|NCT03627767|447602717|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
124447491|NCT03627767|447602718|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
124447492|NCT03627767|447602719|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
124447493|NCT03627767|447602715|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
124447494|NCT03627767|447602716|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
124447495|NCT03627767|447602717|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
124447496|NCT03627767|447602718|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
124447497|NCT03627767|447602719|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
124447498|NCT03627767|447602715|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
124447499|NCT03627767|447602716|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
124447500|NCT03627767|447602717|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
124447501|NCT03627767|447602718|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
124447502|NCT03627767|447602719|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
124447503|NCT03627767|447602715|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
124447504|NCT03627767|447602716|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
124447505|NCT03627767|447602717|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
124447506|NCT03627767|447602718|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
124447507|NCT03627767|447602719|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
124447508|NCT03627767|447602715|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
124447509|NCT03627767|447602716|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
124447510|NCT03627767|447602717|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
124447511|NCT03627767|447602718|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
124447512|NCT03627767|447602719|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
124447513|NCT03627767|447602715|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
124447514|NCT03627767|447602716|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
124447515|NCT03627767|447602717|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
124447516|NCT03627767|447602718|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
124690349|NCT01625182|448486065|FG000|Overall Study|Protocol deviation|0|||
124690350|NCT01625182|448486066|FG001|Overall Study|Protocol deviation|2|||
124690351|NCT01625182|448486065|FG000|Overall Study|Adverse Event|2|||
124447517|NCT03627767|447602719|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
124447518|NCT03627767|447602715|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
124447519|NCT03627767|447602716|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
124447520|NCT03627767|447602717|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
124447521|NCT03627767|447602718|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
124447522|NCT03627767|447602719|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
124447523|NCT03627767|447602715|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
124447524|NCT03627767|447602716|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
124447525|NCT03627767|447602717|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
124447526|NCT03627767|447602718|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
124447527|NCT03627767|447602719|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
124447528|NCT03627767|447602715|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
124447529|NCT03627767|447602716|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
124447530|NCT03627767|447602717|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
124447531|NCT03627767|447602718|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
124447532|NCT03627767|447602719|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
124447533|NCT03627767|447602715|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
124447534|NCT03627767|447602716|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
124447535|NCT03627767|447602717|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
124447536|NCT03627767|447602718|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
124447537|NCT03627767|447602719|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
124447538|NCT03627767|447602715|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
124447539|NCT03627767|447602716|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
124690352|NCT01625182|448486066|FG001|Overall Study|Adverse Event|0|||
124690353|NCT01625182|448486065|FG000|Overall Study|Withdrawal by Subject|5|||
124447540|NCT03627767|447602717|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
124447541|NCT03627767|447602718|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
124690354|NCT01625182|448486066|FG001|Overall Study|Withdrawal by Subject|1|||
124690355|NCT01625182|448486065|FG000|Overall Study|Lack of Efficacy|12|||
124690356|NCT01625182|448486066|FG001|Overall Study|Lack of Efficacy|8|||
124690357|NCT00447278|448486069|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
124690358|NCT00447278|448486070|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
124690359|NCT00447278|448486069|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
124690360|NCT00447278|448486070|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
124690361|NCT00447278|448486069|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
124690362|NCT00447278|448486070|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
124690363|NCT00447278|448486069|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
124690364|NCT00447278|448486070|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
124690365|NCT00447278|448486069|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
124690366|NCT00447278|448486070|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
124690367|NCT00447278|448486069|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
124690368|NCT00447278|448486070|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
124690369|NCT00447278|448486069|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
124690370|NCT00447278|448486070|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
124690371|NCT00447278|448486069|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
124690372|NCT00447278|448486070|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
124690373|NCT00447278|448486069|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
124690374|NCT00447278|448486070|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
124690375|NCT00447278|448486069|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
124690376|NCT00447278|448486070|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
124690377|NCT00447278|448486069|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
124690378|NCT00447278|448486070|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
124690379|NCT00447278|448486069|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
124690380|NCT00447278|448486070|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
124690381|NCT00447278|448486069|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
124690382|NCT00447278|448486070|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
124690383|NCT00447278|448486069|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
124690384|NCT00447278|448486070|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
124690385|NCT05427916|448486074|FG000|Overall Study|Adverse Event|3|||
124690386|NCT05427916|448486075|FG001|Overall Study|Adverse Event|0|||
124690387|NCT05427916|448486074|FG000|Overall Study|Lack of Efficacy|6|||
124690388|NCT05427916|448486075|FG001|Overall Study|Lack of Efficacy|0|||
124690389|NCT05427916|448486074|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
124690390|NCT05427916|448486075|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
124690391|NCT03558672|448486076|FG000|Overall Study|Study Early Termination|10|||
124690392|NCT00421733|448486077|FG000|Overall Study|Adverse Event|4|||
124690393|NCT00421733|448486078|FG001|Overall Study|Adverse Event|9|||
124690394|NCT00421733|448486079|FG002|Overall Study|Adverse Event|2|||
124690395|NCT00421733|448486077|FG000|Overall Study|Lost to Follow-up|1|||
124690396|NCT00421733|448486078|FG001|Overall Study|Lost to Follow-up|2|||
124690397|NCT00421733|448486079|FG002|Overall Study|Lost to Follow-up|4|||
124690398|NCT00421733|448486077|FG000|Overall Study|Withdrawal by Subject|1|||
124690399|NCT00421733|448486078|FG001|Overall Study|Withdrawal by Subject|2|||
124690400|NCT00421733|448486079|FG002|Overall Study|Withdrawal by Subject|7|||
124690401|NCT00421733|448486077|FG000|Overall Study|Death|0|||
124690402|NCT00421733|448486078|FG001|Overall Study|Death|3|||
124690403|NCT00421733|448486079|FG002|Overall Study|Death|0|||
124690404|NCT00421733|448486077|FG000|Overall Study|Required dialysis|1|||
124690405|NCT00421733|448486078|FG001|Overall Study|Required dialysis|0|||
124690406|NCT00421733|448486079|FG002|Overall Study|Required dialysis|0|||
124690407|NCT00421733|448486077|FG000|Overall Study|Administrative|2|||
124690408|NCT00421733|448486078|FG001|Overall Study|Administrative|0|||
124447542|NCT03627767|447602719|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
124690409|NCT00421733|448486079|FG002|Overall Study|Administrative|0|||
124690410|NCT00421733|448486077|FG000|Overall Study|Did not satisfy entry criteria|1|||
124690411|NCT00421733|448486078|FG001|Overall Study|Did not satisfy entry criteria|3|||
124690412|NCT00421733|448486079|FG002|Overall Study|Did not satisfy entry criteria|2|||
124690413|NCT00421733|448486077|FG000|Overall Study|Sponsor request|1|||
124690414|NCT00421733|448486078|FG001|Overall Study|Sponsor request|0|||
124690415|NCT00421733|448486079|FG002|Overall Study|Sponsor request|3|||
124690416|NCT00421733|448486077|FG000|Overall Study|Protocol deviation|4|||
124690417|NCT00421733|448486078|FG001|Overall Study|Protocol deviation|7|||
124690418|NCT00421733|448486079|FG002|Overall Study|Protocol deviation|2|||
124690419|NCT02265744|448486080|FG000|Overall Study|Poor/Non-compliance|1|||
124690420|NCT02265744|448486081|FG001|Overall Study|Poor/Non-compliance|1|||
124690421|NCT02265744|448486082|FG002|Overall Study|Poor/Non-compliance|0|||
124690422|NCT02265744|448486083|FG003|Overall Study|Poor/Non-compliance|0|||
124690423|NCT02265744|448486084|FG004|Overall Study|Poor/Non-compliance|2|||
124690424|NCT02265744|448486080|FG000|Overall Study|Lost to Follow-up|0|||
124690425|NCT02265744|448486081|FG001|Overall Study|Lost to Follow-up|0|||
124690426|NCT02265744|448486082|FG002|Overall Study|Lost to Follow-up|0|||
124690427|NCT02265744|448486083|FG003|Overall Study|Lost to Follow-up|1|||
124690428|NCT02265744|448486084|FG004|Overall Study|Lost to Follow-up|0|||
124690429|NCT02265744|448486080|FG000|Overall Study|Death|0|||
124690430|NCT02265744|448486081|FG001|Overall Study|Death|0|||
124690431|NCT02265744|448486082|FG002|Overall Study|Death|0|||
124690432|NCT02265744|448486083|FG003|Overall Study|Death|2|||
124690433|NCT02265744|448486084|FG004|Overall Study|Death|0|||
124690434|NCT02265744|448486080|FG000|Overall Study|Withdrawal by Subject|2|||
124690435|NCT02265744|448486081|FG001|Overall Study|Withdrawal by Subject|0|||
124690436|NCT02265744|448486082|FG002|Overall Study|Withdrawal by Subject|0|||
124690437|NCT02265744|448486083|FG003|Overall Study|Withdrawal by Subject|2|||
124690438|NCT02265744|448486084|FG004|Overall Study|Withdrawal by Subject|0|||
124690439|NCT02265744|448486080|FG000|Overall Study|Participant request to discontinue|2|||
124690440|NCT02265744|448486081|FG001|Overall Study|Participant request to discontinue|2|||
124690441|NCT02265744|448486082|FG002|Overall Study|Participant request to discontinue|2|||
124690442|NCT02265744|448486083|FG003|Overall Study|Participant request to discontinue|0|||
124690443|NCT02265744|448486084|FG004|Overall Study|Participant request to discontinue|0|||
124690444|NCT02265744|448486080|FG000|Overall Study|Adverse Event|8|||
124690445|NCT02265744|448486081|FG001|Overall Study|Adverse Event|4|||
124690446|NCT02265744|448486082|FG002|Overall Study|Adverse Event|9|||
124690447|NCT02265744|448486083|FG003|Overall Study|Adverse Event|8|||
124690448|NCT02265744|448486084|FG004|Overall Study|Adverse Event|2|||
124690449|NCT02265744|448486080|FG000|Overall Study|Lack of Efficacy|2|||
124690450|NCT02265744|448486081|FG001|Overall Study|Lack of Efficacy|4|||
124690451|NCT02265744|448486082|FG002|Overall Study|Lack of Efficacy|3|||
124690452|NCT02265744|448486083|FG003|Overall Study|Lack of Efficacy|4|||
124690453|NCT02265744|448486084|FG004|Overall Study|Lack of Efficacy|5|||
124690454|NCT02265744|448486080|FG000|Overall Study|Reason not provided by Investigator|1|||
124690455|NCT02265744|448486081|FG001|Overall Study|Reason not provided by Investigator|0|||
124690456|NCT02265744|448486082|FG002|Overall Study|Reason not provided by Investigator|0|||
124690457|NCT02265744|448486083|FG003|Overall Study|Reason not provided by Investigator|2|||
124690458|NCT02265744|448486084|FG004|Overall Study|Reason not provided by Investigator|0|||
124690459|NCT02265744|448486080|FG000|Overall Study|Administrative reason by sponsor|3|||
124690460|NCT02265744|448486081|FG001|Overall Study|Administrative reason by sponsor|2|||
124690461|NCT02265744|448486082|FG002|Overall Study|Administrative reason by sponsor|2|||
124690462|NCT02265744|448486083|FG003|Overall Study|Administrative reason by sponsor|3|||
124690463|NCT02265744|448486084|FG004|Overall Study|Administrative reason by sponsor|3|||
124690464|NCT02265744|448486080|FG000|Overall Study|Subject no longer meets study criteria|0|||
124690465|NCT02265744|448486081|FG001|Overall Study|Subject no longer meets study criteria|0|||
124690466|NCT02265744|448486082|FG002|Overall Study|Subject no longer meets study criteria|0|||
124690467|NCT02265744|448486083|FG003|Overall Study|Subject no longer meets study criteria|0|||
124690468|NCT02265744|448486084|FG004|Overall Study|Subject no longer meets study criteria|1|||
124690469|NCT02265744|448486080|FG000|Overall Study|Pregnancy|1|||
124690470|NCT02265744|448486081|FG001|Overall Study|Pregnancy|2|||
124447543|NCT03627767|447602715|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
124447544|NCT03627767|447602716|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
124447545|NCT03627767|447602717|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
124447546|NCT03627767|447602718|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
124690471|NCT02265744|448486082|FG002|Overall Study|Pregnancy|1|||
124690472|NCT02265744|448486083|FG003|Overall Study|Pregnancy|1|||
124690473|NCT02265744|448486084|FG004|Overall Study|Pregnancy|0|||
124690474|NCT05161936|448486085|FG000|Overall Study|Study terminated by Sponsor|1|||
124690475|NCT05161936|448486086|FG001|Overall Study|Study terminated by Sponsor|0|||
124690476|NCT05161936|448486087|FG002|Overall Study|Study terminated by Sponsor|0|||
124690477|NCT05161936|448486085|FG000|Overall Study|Withdrawal by Subject|0|||
124690478|NCT05161936|448486086|FG001|Overall Study|Withdrawal by Subject|0|||
124690479|NCT05161936|448486087|FG002|Overall Study|Withdrawal by Subject|1|||
124690480|NCT04999020|448486092|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
124690481|NCT04999020|448486093|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
124690482|NCT04999020|448486094|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
124690483|NCT04999020|448486095|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
124690484|NCT04999020|448486092|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
124690485|NCT04999020|448486093|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
124690486|NCT04999020|448486094|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
124690487|NCT04999020|448486095|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
124690488|NCT04999020|448486092|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
124690489|NCT04999020|448486093|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
124690490|NCT04999020|448486094|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
124690491|NCT04999020|448486095|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
124690492|NCT04999020|448486092|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
124690493|NCT04999020|448486093|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
124690494|NCT04999020|448486094|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
124690495|NCT04999020|448486095|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
124690496|NCT04999020|448486092|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
124690497|NCT04999020|448486093|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
124690498|NCT04999020|448486094|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
124690499|NCT04999020|448486095|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
124690500|NCT04999020|448486092|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
124690501|NCT04999020|448486093|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
124690502|NCT04999020|448486094|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
124690503|NCT04999020|448486095|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
124690504|NCT04999020|448486092|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
124690505|NCT04999020|448486093|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
124690506|NCT04999020|448486094|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
124690507|NCT04999020|448486095|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
124690508|NCT04999020|448486092|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
124690509|NCT04999020|448486093|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
124690510|NCT04999020|448486094|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
124690511|NCT04999020|448486095|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
124690512|NCT00933166|448486096|FG000|Overall Study|Lost to Follow-up|4|||
124690513|NCT00933166|448486096|FG000|Overall Study|Lack of Efficacy|9|||
124690514|NCT00933166|448486096|FG000|Overall Study|Unavailable|4|||
124690515|NCT00933166|448486096|FG000|Overall Study|Withdrawal by Subject|1|||
124690516|NCT04465955|448486100|FG000|Overall Study|Withdrew consent|6|||
124690517|NCT04465955|448486101|FG001|Overall Study|Withdrew consent|10|||
124690518|NCT04465955|448486102|FG002|Overall Study|Withdrew consent|7|||
124690519|NCT04465955|448486100|FG000|Overall Study|Adverse Event|6|||
124690520|NCT04465955|448486101|FG001|Overall Study|Adverse Event|5|||
124690521|NCT04465955|448486102|FG002|Overall Study|Adverse Event|1|||
124690522|NCT04465955|448486100|FG000|Overall Study|Lost to Follow-up|2|||
124690523|NCT04465955|448486101|FG001|Overall Study|Lost to Follow-up|0|||
124690524|NCT04465955|448486102|FG002|Overall Study|Lost to Follow-up|3|||
124690525|NCT04465955|448486100|FG000|Overall Study|Other|1|||
124690526|NCT04465955|448486101|FG001|Overall Study|Other|1|||
124690527|NCT04465955|448486102|FG002|Overall Study|Other|3|||
124690528|NCT03501277|448486105|FG000|Intervention Period 1 (4 Days)|Other|0|||
124690529|NCT03501277|448486106|FG001|Intervention Period 1 (4 Days)|Other|0|||
124690530|NCT03501277|448486107|FG002|Intervention Period 1 (4 Days)|Other|1|||
124690531|NCT03501277|448486108|FG003|Intervention Period 1 (4 Days)|Other|0|||
124690532|NCT03501277|448486105|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
124690533|NCT03501277|448486106|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
124690534|NCT03501277|448486107|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
124690535|NCT03501277|448486108|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
124690536|NCT03501277|448486105|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
124690537|NCT03501277|448486106|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
124690538|NCT03501277|448486107|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
124690539|NCT03501277|448486108|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
124690540|NCT03501277|448486105|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
124690541|NCT03501277|448486106|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
124690542|NCT03501277|448486107|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
124690543|NCT03501277|448486108|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
124690544|NCT01327703|448486109|FG000|Second Treatment Period|Adverse Event|1|||
124690545|NCT01327703|448486110|FG001|Second Treatment Period|Adverse Event|1|||
124690546|NCT01327703|448486109|FG000|Second Treatment Period|Protocol Violation|0|||
124690547|NCT01327703|448486110|FG001|Second Treatment Period|Protocol Violation|1|||
124690548|NCT00927082|448486111|FG000|Overall Study|Lost to Follow-up|9|||
124690549|NCT00927082|448486112|FG001|Overall Study|Lost to Follow-up|8|||
124690550|NCT00927082|448486113|FG002|Overall Study|Lost to Follow-up|12|||
124690551|NCT00927082|448486114|FG003|Overall Study|Lost to Follow-up|16|||
124690552|NCT00927082|448486111|FG000|Overall Study|Withdrawal by Subject|3|||
124690553|NCT00927082|448486112|FG001|Overall Study|Withdrawal by Subject|2|||
124690554|NCT00927082|448486113|FG002|Overall Study|Withdrawal by Subject|7|||
124690555|NCT00927082|448486114|FG003|Overall Study|Withdrawal by Subject|2|||
124690556|NCT00927082|448486111|FG000|Overall Study|Death|0|||
124690557|NCT00927082|448486112|FG001|Overall Study|Death|0|||
124690558|NCT00927082|448486113|FG002|Overall Study|Death|1|||
124690559|NCT00927082|448486114|FG003|Overall Study|Death|0|||
124690560|NCT00927082|448486111|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
124690561|NCT00927082|448486112|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
124690562|NCT00927082|448486113|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
124690563|NCT00927082|448486114|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
124690564|NCT00825175|448486115|FG000|Overall Study|Withdrawal by Subject|0|||
124690565|NCT00825175|448486116|FG001|Overall Study|Withdrawal by Subject|5|||
124690566|NCT01428128|448486117|FG000|Overall Study|Withdrawal by Subject|4|||
124690567|NCT01428128|448486117|FG000|Overall Study|Screen failure by p53|10|||
124690568|NCT01428128|448486117|FG000|Overall Study|Received Neulasta in one cycle|2|||
124690569|NCT01428128|448486117|FG000|Overall Study|Adverse Event|1|||
124690570|NCT00424008|448486118|FG000|Overall Study|Adverse Event|8|||
124690571|NCT00424008|448486119|FG001|Overall Study|Adverse Event|6|||
124690572|NCT00424008|448486118|FG000|Overall Study|Lack of Efficacy|40|||
124690573|NCT00424008|448486119|FG001|Overall Study|Lack of Efficacy|34|||
124690574|NCT00424008|448486118|FG000|Overall Study|Lost to Follow-up|1|||
124690575|NCT00424008|448486119|FG001|Overall Study|Lost to Follow-up|2|||
124690576|NCT00424008|448486118|FG000|Overall Study|Withdrawal by Subject|5|||
124690577|NCT00424008|448486119|FG001|Overall Study|Withdrawal by Subject|8|||
124690578|NCT00424008|448486118|FG000|Overall Study|Noncompliance with protocol|13|||
124690579|NCT00424008|448486119|FG001|Overall Study|Noncompliance with protocol|7|||
124690580|NCT00424008|448486118|FG000|Overall Study|Did not meet protocol eligibility|16|||
124690581|NCT00424008|448486119|FG001|Overall Study|Did not meet protocol eligibility|21|||
124690582|NCT00424008|448486118|FG000|Overall Study|Administrative|266|||
124690583|NCT00424008|448486119|FG001|Overall Study|Administrative|257|||
124690584|NCT02530242|448486136|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
124690585|NCT02530242|448486137|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
124690586|NCT00283959|448486138|FG000|Extension Period|Low Compliance|1|||
124690587|NCT05591755|448486139|FG000|Overall Study|Screen Failure|1|||
124690588|NCT05591755|448486140|FG001|Overall Study|Screen Failure|0|||
124690589|NCT05591755|448486141|FG002|Overall Study|Screen Failure|0|||
124690590|NCT05591755|448486142|FG003|Overall Study|Screen Failure|0|||
124690591|NCT05591755|448486139|FG000|Overall Study|Protocol Violation|0|||
124690592|NCT05591755|448486140|FG001|Overall Study|Protocol Violation|0|||
124690593|NCT05591755|448486141|FG002|Overall Study|Protocol Violation|2|||
124690594|NCT05591755|448486142|FG003|Overall Study|Protocol Violation|0|||
124690595|NCT05591755|448486139|FG000|Overall Study|Withdrawal by Subject|0|||
124690596|NCT05591755|448486140|FG001|Overall Study|Withdrawal by Subject|1|||
124690597|NCT05591755|448486141|FG002|Overall Study|Withdrawal by Subject|0|||
124690598|NCT05591755|448486142|FG003|Overall Study|Withdrawal by Subject|0|||
124690599|NCT00433290|448486143|FG000|Overall Study|Adverse Event|24|||
124690600|NCT00433290|448486144|FG001|Overall Study|Adverse Event|7|||
124690601|NCT00433290|448486143|FG000|Overall Study|Lack of Efficacy|1|||
124690602|NCT00433290|448486144|FG001|Overall Study|Lack of Efficacy|5|||
124690603|NCT00433290|448486143|FG000|Overall Study|Withdrawal by Subject|4|||
124690604|NCT00433290|448486144|FG001|Overall Study|Withdrawal by Subject|2|||
124690605|NCT00433290|448486143|FG000|Overall Study|Protocol Violation|3|||
124690606|NCT00433290|448486144|FG001|Overall Study|Protocol Violation|2|||
124690607|NCT00433290|448486143|FG000|Overall Study|Physician Decision|2|||
124690608|NCT00433290|448486144|FG001|Overall Study|Physician Decision|0|||
124690609|NCT00433290|448486143|FG000|Overall Study|Entry Criteria Not Met|0|||
124690610|NCT00433290|448486144|FG001|Overall Study|Entry Criteria Not Met|1|||
124690611|NCT00433290|448486143|FG000|Overall Study|Lost to Follow-up|1|||
124690612|NCT00433290|448486144|FG001|Overall Study|Lost to Follow-up|0|||
124690613|NCT01483651|448486145|FG000|Overall Study|Withdrawal by Subject|0|||
124690614|NCT01483651|448486146|FG001|Overall Study|Withdrawal by Subject|1|||
124690615|NCT01483651|448486147|FG002|Overall Study|Withdrawal by Subject|1|||
124690616|NCT01483651|448486148|FG003|Overall Study|Withdrawal by Subject|0|||
124690617|NCT01483651|448486149|FG004|Overall Study|Withdrawal by Subject|0|||
124690618|NCT01483651|448486150|FG005|Overall Study|Withdrawal by Subject|1|||
124690619|NCT00308685|448486157|FG000|Overall Study|Lost to Follow-up|1|||
124690620|NCT00308685|448486158|FG001|Overall Study|Lost to Follow-up|0|||
124690621|NCT00308685|448486157|FG000|Overall Study|Need to administer prohibited medication|1|||
124690622|NCT00308685|448486158|FG001|Overall Study|Need to administer prohibited medication|2|||
124447547|NCT03627767|447602719|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
124447548|NCT03627767|447602715|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
124447549|NCT03627767|447602716|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
124447550|NCT03627767|447602717|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
124447551|NCT03627767|447602718|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
124447552|NCT03627767|447602719|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
124447553|NCT01873417|447602720|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
124447554|NCT01873417|447602720|FG000|Overall Study|Adverse Event|24|||
124447555|NCT01873417|447602720|FG000|Overall Study|Lost to Follow-up|2|||
124447556|NCT01873417|447602720|FG000|Overall Study|Withdrawal by Subject|2|||
124447557|NCT01873417|447602720|FG000|Overall Study|Physician Decision|3|||
124447558|NCT00785044|447602721|FG000|Overall Study|Dosed at non-participating sites|152|||
124447559|NCT00785044|447602721|FG000|Overall Study|Death|77|||
124447560|NCT00785044|447602721|FG000|Overall Study|Lost to Follow-up|266|||
124447561|NCT00785044|447602721|FG000|Overall Study|Withdrawal by Subject|1|||
124447562|NCT00385203|447602722|FG000|Overall Study|Adverse Event|5|||
124447563|NCT00385203|447602723|FG001|Overall Study|Adverse Event|4|||
124690623|NCT00308685|448486157|FG000|Overall Study|Other than specified|1|||
124690624|NCT00308685|448486158|FG001|Overall Study|Other than specified|3|||
124690625|NCT03345095|448486159|FG000|Overall Study|Lack of Efficacy|184|||
124690626|NCT03345095|448486160|FG001|Overall Study|Lack of Efficacy|156|||
124447564|NCT00385203|447602722|FG000|Overall Study|Death|1|||
124447565|NCT00385203|447602723|FG001|Overall Study|Death|0|||
124447566|NCT00385203|447602722|FG000|Overall Study|Condition under investigation worsened|18|||
124447567|NCT00385203|447602723|FG001|Overall Study|Condition under investigation worsened|3|||
124447568|NCT00385203|447602722|FG000|Overall Study|Incorrect enrollment|2|||
124690627|NCT03345095|448486159|FG000|Overall Study|Adverse Event|36|||
124690628|NCT03345095|448486160|FG001|Overall Study|Adverse Event|118|||
124690629|NCT03345095|448486159|FG000|Overall Study|Withdrawal by Subject|22|||
124690630|NCT03345095|448486160|FG001|Overall Study|Withdrawal by Subject|59|||
124690631|NCT03345095|448486159|FG000|Overall Study|Physician Decision|3|||
124690632|NCT03345095|448486160|FG001|Overall Study|Physician Decision|18|||
124690633|NCT03345095|448486159|FG000|Overall Study|Death|2|||
124690634|NCT03345095|448486160|FG001|Overall Study|Death|4|||
124690635|NCT03345095|448486159|FG000|Overall Study|Other reasons|2|||
124690636|NCT03345095|448486160|FG001|Overall Study|Other reasons|11|||
124690637|NCT03345095|448486159|FG000|Overall Study|Protocol Violation|0|||
124690638|NCT03345095|448486160|FG001|Overall Study|Protocol Violation|1|||
124690639|NCT01121575|448486161|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
124690640|NCT01121575|448486162|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
124690641|NCT01121575|448486163|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
124690642|NCT01121575|448486164|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
124690643|NCT01121575|448486165|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
124690644|NCT01121575|448486166|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
124690645|NCT01121575|448486161|FG000|Overall Study|Unspecified Reasons|8|||
124690646|NCT01121575|448486162|FG001|Overall Study|Unspecified Reasons|6|||
124690647|NCT01121575|448486163|FG002|Overall Study|Unspecified Reasons|7|||
124690648|NCT01121575|448486164|FG003|Overall Study|Unspecified Reasons|5|||
124690649|NCT01121575|448486165|FG004|Overall Study|Unspecified Reasons|13|||
124690650|NCT01121575|448486166|FG005|Overall Study|Unspecified Reasons|10|||
124690651|NCT01121575|448486161|FG000|Overall Study|Death|6|||
124690652|NCT01121575|448486162|FG001|Overall Study|Death|0|||
124690653|NCT01121575|448486163|FG002|Overall Study|Death|0|||
124690654|NCT01121575|448486164|FG003|Overall Study|Death|1|||
124690655|NCT01121575|448486165|FG004|Overall Study|Death|7|||
124690656|NCT01121575|448486166|FG005|Overall Study|Death|1|||
124690657|NCT02665455|448486168|FG000|Overall Study|Withdrawal by Subject|6|||
124690658|NCT02665455|448486168|FG000|Overall Study|Lost to Follow-up|1|||
124690659|NCT02665455|448486168|FG000|Overall Study|Adverse Event|1|||
124690660|NCT02665455|448486168|FG000|Overall Study|Protocol Violation|1|||
124690661|NCT00724503|448486169|FG000|Overall Study|Lost to Follow-up|4|||
124690662|NCT00724503|448486170|FG001|Overall Study|Lost to Follow-up|8|||
124690663|NCT00724503|448486169|FG000|Overall Study|Withdrawal by Subject|11|||
124690664|NCT00724503|448486170|FG001|Overall Study|Withdrawal by Subject|23|||
124690665|NCT00724503|448486169|FG000|Overall Study|Death|190|||
124447569|NCT00385203|447602723|FG001|Overall Study|Incorrect enrollment|0|||
124447570|NCT01798992|447602724|FG000|Overall Study|Administrative withdrawal|0|||
124447571|NCT01798992|447602725|FG001|Overall Study|Administrative withdrawal|1|||
124447572|NCT01798992|447602726|FG002|Overall Study|Administrative withdrawal|0|||
124690666|NCT00724503|448486170|FG001|Overall Study|Death|182|||
124690667|NCT00724503|448486169|FG000|Overall Study|Adverse Event|1|||
124447573|NCT01798992|447602727|FG003|Overall Study|Administrative withdrawal|1|||
124447574|NCT01798992|447602724|FG000|Overall Study|Lost to Follow-up|0|||
124447575|NCT01798992|447602725|FG001|Overall Study|Lost to Follow-up|1|||
124447576|NCT01798992|447602726|FG002|Overall Study|Lost to Follow-up|1|||
124690668|NCT00724503|448486170|FG001|Overall Study|Adverse Event|0|||
124690669|NCT00724503|448486169|FG000|Overall Study|Not otherwise specified|4|||
124690670|NCT00724503|448486170|FG001|Overall Study|Not otherwise specified|7|||
124447577|NCT01798992|447602727|FG003|Overall Study|Lost to Follow-up|0|||
124447578|NCT01798992|447602724|FG000|Overall Study|Insufficient biopsy tissue|0|||
124447579|NCT01798992|447602725|FG001|Overall Study|Insufficient biopsy tissue|0|||
124447580|NCT01798992|447602726|FG002|Overall Study|Insufficient biopsy tissue|1|||
124447581|NCT01798992|447602727|FG003|Overall Study|Insufficient biopsy tissue|0|||
124447582|NCT03823404|447602728|FG000|Overall Study|Lost to Follow-up|1|||
124447583|NCT03823404|447602729|FG001|Overall Study|Lost to Follow-up|2|||
124447584|NCT03823404|447602730|FG002|Overall Study|Lost to Follow-up|3|||
124447585|NCT03823404|447602728|FG000|Overall Study|Protocol Violation|2|||
124447586|NCT03823404|447602729|FG001|Overall Study|Protocol Violation|0|||
124447587|NCT03823404|447602730|FG002|Overall Study|Protocol Violation|2|||
124447588|NCT03823404|447602728|FG000|Overall Study|Adverse Event|35|||
124447589|NCT03823404|447602729|FG001|Overall Study|Adverse Event|38|||
124447590|NCT03823404|447602730|FG002|Overall Study|Adverse Event|8|||
124447591|NCT03823404|447602728|FG000|Overall Study|Withdrawal by Subject|38|||
124447592|NCT03823404|447602729|FG001|Overall Study|Withdrawal by Subject|40|||
124447593|NCT03823404|447602730|FG002|Overall Study|Withdrawal by Subject|35|||
124447594|NCT03823404|447602728|FG000|Overall Study|Death|4|||
124447595|NCT03823404|447602729|FG001|Overall Study|Death|0|||
124447596|NCT03823404|447602730|FG002|Overall Study|Death|0|||
124447597|NCT03823404|447602728|FG000|Overall Study|Other: Various reasons provided|5|||
124447598|NCT03823404|447602729|FG001|Overall Study|Other: Various reasons provided|5|||
124447599|NCT03823404|447602730|FG002|Overall Study|Other: Various reasons provided|6|||
124447600|NCT03189862|447602731|FG000|Overall Study|Withdrawal by Subject|1|||
124447601|NCT03189862|447602732|FG001|Overall Study|Withdrawal by Subject|0|||
124447602|NCT03189862|447602731|FG000|Overall Study|Lost to Follow-up|54|||
124447603|NCT03189862|447602732|FG001|Overall Study|Lost to Follow-up|62|||
124447604|NCT00024167|447602733|FG000|Overall Study|Death|53|||
124447605|NCT00024167|447602734|FG001|Overall Study|Death|47|||
124447606|NCT02459769|447602748|FG000|Overall Study|Withdrawal by Subject|7|||
124447607|NCT02459769|447602749|FG001|Overall Study|Withdrawal by Subject|4|||
124447608|NCT02459769|447602750|FG002|Overall Study|Withdrawal by Subject|8|||
124447609|NCT02459769|447602751|FG003|Overall Study|Withdrawal by Subject|5|||
124447610|NCT02459769|447602748|FG000|Overall Study|Lost to Follow-up|1|||
124447611|NCT02459769|447602749|FG001|Overall Study|Lost to Follow-up|0|||
124447612|NCT02459769|447602750|FG002|Overall Study|Lost to Follow-up|1|||
124447613|NCT02459769|447602751|FG003|Overall Study|Lost to Follow-up|0|||
124447614|NCT01186796|447602752|FG000|Overall Study|Adverse Event|3|||
124447615|NCT01186796|447602753|FG001|Overall Study|Adverse Event|0|||
124447616|NCT01186796|447602752|FG000|Overall Study|Withdrawal by Subject|1|||
124759721|NCT01147666|448744760|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
124759722|NCT01147666|448744761|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
124759723|NCT01147666|448744762|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
124759724|NCT01147666|448744763|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
124759725|NCT01147666|448744764|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
124759726|NCT01147666|448744765|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
124759727|NCT01147666|448744766|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
124759728|NCT01147666|448744767|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
124759729|NCT01147666|448744768|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
124759730|NCT01147666|448744769|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
124759731|NCT01147666|448744755|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
124759732|NCT01147666|448744756|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
124759733|NCT01147666|448744757|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
124447617|NCT01186796|447602753|FG001|Overall Study|Withdrawal by Subject|1|||
124447618|NCT01186796|447602752|FG000|Overall Study|Protocol Violation|0|||
124447619|NCT01186796|447602753|FG001|Overall Study|Protocol Violation|1|||
124447620|NCT01287364|447602754|FG000|Overall Study|Adverse Event|0|||
124447621|NCT01287364|447602755|FG001|Overall Study|Adverse Event|3|||
124447622|NCT01287364|447602754|FG000|Overall Study|Protocol Violation|5|||
124447623|NCT01287364|447602755|FG001|Overall Study|Protocol Violation|5|||
124447624|NCT01287364|447602754|FG000|Overall Study|Other Reason|4|||
124447625|NCT01287364|447602755|FG001|Overall Study|Other Reason|2|||
124447626|NCT01379573|447602760|FG000|Overall Study|Lost to Follow-up|1|||
124447627|NCT01379573|447602760|FG000|Overall Study|Screen Failure|10|||
124900023|NCT01090024|449259497|FG002|Period 1|Adverse Event|0|||
124447628|NCT00962390|447602761|FG000|Overall Study|Adverse Event|0|||
124447629|NCT00962390|447602762|FG001|Overall Study|Adverse Event|0|||
124447630|NCT00962390|447602763|FG002|Overall Study|Adverse Event|3|||
124447631|NCT00962390|447602764|FG003|Overall Study|Adverse Event|1|||
124447632|NCT00962390|447602761|FG000|Overall Study|Lost to Follow-up|2|||
124447633|NCT00962390|447602762|FG001|Overall Study|Lost to Follow-up|2|||
124447634|NCT00962390|447602763|FG002|Overall Study|Lost to Follow-up|0|||
124447635|NCT00962390|447602764|FG003|Overall Study|Lost to Follow-up|0|||
124447636|NCT00962390|447602761|FG000|Overall Study|Protocol Violation|1|||
124447637|NCT00962390|447602762|FG001|Overall Study|Protocol Violation|0|||
124447638|NCT00962390|447602763|FG002|Overall Study|Protocol Violation|0|||
124447639|NCT00962390|447602764|FG003|Overall Study|Protocol Violation|0|||
124447640|NCT00962390|447602761|FG000|Overall Study|Withdrawal by Subject|1|||
124447641|NCT00962390|447602762|FG001|Overall Study|Withdrawal by Subject|1|||
124447642|NCT00962390|447602763|FG002|Overall Study|Withdrawal by Subject|1|||
124447643|NCT00962390|447602764|FG003|Overall Study|Withdrawal by Subject|0|||
124447644|NCT03740997|447602773|FG000|Overall Study|Withdrawal by Subject|1|||
124447645|NCT03740997|447602774|FG001|Overall Study|Withdrawal by Subject|0|||
124447646|NCT03740997|447602773|FG000|Overall Study|Participant was unable to complete study procedures|1|||
124447647|NCT03740997|447602774|FG001|Overall Study|Participant was unable to complete study procedures|0|||
124690671|NCT01186419|448486171|FG000|Overall Study|Withdrawal by Subject|5|||
124690672|NCT01186419|448486172|FG001|Overall Study|Withdrawal by Subject|3|||
124690673|NCT01186419|448486171|FG000|Overall Study|Adverse Event|1|||
124690674|NCT01186419|448486172|FG001|Overall Study|Adverse Event|2|||
124690675|NCT01186419|448486171|FG000|Overall Study|Physician Decision|0|||
124690676|NCT01186419|448486172|FG001|Overall Study|Physician Decision|3|||
124690677|NCT01186419|448486171|FG000|Overall Study|Other|1|||
124690678|NCT01186419|448486172|FG001|Overall Study|Other|1|||
124690679|NCT01937117|448486173|FG000|Overall Study|Disease Progression|7|||
124690680|NCT01937117|448486173|FG000|Overall Study|Physician Decision|4|||
124690681|NCT01937117|448486173|FG000|Overall Study|Adverse Event|2|||
124690682|NCT01671059|448486174|FG000|Overall Study|Adverse Event|4|||
124690683|NCT01671059|448486174|FG000|Overall Study|Lack of Efficacy|1|||
124690684|NCT01560416|448486175|FG000|Randomized Phase|Crossover Participants|7|||
124690685|NCT01560416|448486176|FG001|Randomized Phase|Crossover Participants|0|||
124690686|NCT01179399|448486177|FG000|Overall Study|Adverse Event|1|||
124690687|NCT01179399|448486177|FG000|Overall Study|Lack of Efficacy|30|||
124690688|NCT01179399|448486177|FG000|Overall Study|Withdrawal by Subject|1|||
124690689|NCT04073407|448486179|FG000|Part 1|Withdrawal by Subject|1|||
124447648|NCT01026142|447602775|FG000|Overall Study|Death|136|||
124447649|NCT01026142|447602776|FG001|Overall Study|Death|134|||
124690690|NCT04073407|448486180|FG001|Part 1|Withdrawal by Subject|0|||
124690691|NCT04073407|448486179|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
124690692|NCT04073407|448486180|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
124690693|NCT04073407|448486179|FG000|Part 2|Withdrawal by Subject|0|||
124690694|NCT04073407|448486180|FG001|Part 2|Withdrawal by Subject|1|||
124690695|NCT03921541|448487930|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
124690696|NCT03921541|448487931|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
124690697|NCT01653262|448487932|FG000|Overall Study|Lack of Efficacy|1|||
124690698|NCT01653262|448487932|FG000|Overall Study|SAE, non-fatal|1|||
124690699|NCT01653262|448487932|FG000|Overall Study|AE, non-serious non-fatal|1|||
124690700|NCT00420407|448487934|FG000|Overall Study|Lost to Follow-up|0|||
124690701|NCT00420407|448487935|FG001|Overall Study|Lost to Follow-up|3|||
124690702|NCT00420407|448487934|FG000|Overall Study|Physician Decision|2|||
124690703|NCT00420407|448487935|FG001|Overall Study|Physician Decision|1|||
124690704|NCT00420407|448487934|FG000|Overall Study|subject identified as detainee|1|||
124690705|NCT00420407|448487935|FG001|Overall Study|subject identified as detainee|0|||
124690706|NCT00420407|448487934|FG000|Overall Study|subject identified as Jehovah's witness|1|||
124690707|NCT00420407|448487935|FG001|Overall Study|subject identified as Jehovah's witness|0|||
124690708|NCT00420407|448487934|FG000|Overall Study|Withdrawal by Subject|0|||
124690709|NCT00420407|448487935|FG001|Overall Study|Withdrawal by Subject|2|||
124690710|NCT01734928|448487936|FG000|Randomization|Physician Decision|0|||
124690711|NCT01734928|448487937|FG001|Randomization|Physician Decision|1|||
124690712|NCT01734928|448487936|FG000|Randomization|clinical progression|0|||
124447650|NCT01026142|447602775|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
124447651|NCT01026142|447602776|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
124690713|NCT01734928|448487937|FG001|Randomization|clinical progression|1|||
124690714|NCT01734928|448487936|FG000|Randomization|progressive disease|0|||
124690715|NCT01734928|448487937|FG001|Randomization|progressive disease|2|||
124447652|NCT01829425|447602777|FG000|Overall Study|Withdrawal by Subject|4|||
124447653|NCT01829425|447602778|FG001|Overall Study|Withdrawal by Subject|3|||
124447654|NCT01829425|447602777|FG000|Overall Study|Lost to Follow-up|2|||
124447655|NCT01829425|447602778|FG001|Overall Study|Lost to Follow-up|1|||
124447656|NCT04178967|447602779|FG000|Induction Period|Adverse Event|4|||
124447657|NCT04178967|447602780|FG001|Induction Period|Adverse Event|6|||
124447658|NCT04178967|447602781|FG002|Induction Period|Adverse Event|0|||
124447659|NCT04178967|447602782|FG003|Induction Period|Adverse Event|0|||
124447660|NCT04178967|447602783|FG004|Induction Period|Adverse Event|0|||
124447661|NCT04178967|447602784|FG005|Induction Period|Adverse Event|0|||
124447662|NCT04178967|447602785|FG006|Induction Period|Adverse Event|0|||
124447663|NCT04178967|447602786|FG007|Induction Period|Adverse Event|0|||
124690716|NCT01734928|448487936|FG000|Randomization|Withdrew informed consent|0|||
124690717|NCT01734928|448487937|FG001|Randomization|Withdrew informed consent|4|||
124690718|NCT01734928|448487936|FG000|Randomization|Death|1|||
124690719|NCT01734928|448487937|FG001|Randomization|Death|0|||
124690720|NCT01734928|448487936|FG000|Randomization|Randomization error|1|||
124690721|NCT01734928|448487937|FG001|Randomization|Randomization error|0|||
124690722|NCT01734928|448487936|FG000|Randomization|Lost to Follow-up|1|||
124690723|NCT01734928|448487937|FG001|Randomization|Lost to Follow-up|0|||
124690724|NCT01734928|448487936|FG000|Treatment Period|Lost to Follow-up|0|||
124690725|NCT01734928|448487937|FG001|Treatment Period|Lost to Follow-up|2|||
124690726|NCT01734928|448487936|FG000|Treatment Period|Progressive Disease|167|||
124690727|NCT01734928|448487937|FG001|Treatment Period|Progressive Disease|165|||
124690728|NCT01734928|448487936|FG000|Treatment Period|Adverse Event|39|||
124690729|NCT01734928|448487937|FG001|Treatment Period|Adverse Event|52|||
124690730|NCT01734928|448487936|FG000|Treatment Period|Withdrawal of Consent|25|||
124690731|NCT01734928|448487937|FG001|Treatment Period|Withdrawal of Consent|22|||
124690732|NCT01734928|448487936|FG000|Treatment Period|Death|20|||
124690733|NCT01734928|448487937|FG001|Treatment Period|Death|9|||
124690734|NCT01734928|448487936|FG000|Treatment Period|Other Reasons|27|||
124690735|NCT01734928|448487937|FG001|Treatment Period|Other Reasons|19|||
124690736|NCT01734928|448487936|FG000|Treatment Period|Pregnancy|0|||
124690737|NCT01734928|448487937|FG001|Treatment Period|Pregnancy|1|||
124690738|NCT01778985|448487938|FG000|Overall Study|Lost to Follow-up|1|||
124690739|NCT01778985|448487939|FG001|Overall Study|Lost to Follow-up|0|||
124690740|NCT01778985|448487938|FG000|Overall Study|Physician Decision|2|||
124690741|NCT01778985|448487939|FG001|Overall Study|Physician Decision|2|||
124690742|NCT01778985|448487938|FG000|Overall Study|Protocol Violation|4|||
124690743|NCT01778985|448487939|FG001|Overall Study|Protocol Violation|1|||
124690744|NCT01631188|448487945|FG000|Overall Study|Physician Decision|75|||
124690745|NCT03600350|448487946|FG000|Overall Study|Death|1|||
124690746|NCT03600350|448487946|FG000|Overall Study|On Follow Up|18|||
124690747|NCT00835978|448487947|FG000|Overall Study|Death|33|||
124690748|NCT00835978|448487948|FG001|Overall Study|Death|40|||
124690749|NCT00835978|448487949|FG002|Overall Study|Death|49|||
124690750|NCT00835978|448487950|FG003|Overall Study|Death|4|||
124690751|NCT00835978|448487947|FG000|Overall Study|Lost to Follow-up|3|||
124690752|NCT00835978|448487948|FG001|Overall Study|Lost to Follow-up|4|||
124690753|NCT00835978|448487949|FG002|Overall Study|Lost to Follow-up|2|||
124690754|NCT00835978|448487950|FG003|Overall Study|Lost to Follow-up|1|||
124690755|NCT00835978|448487947|FG000|Overall Study|Other|5|||
124690756|NCT00835978|448487948|FG001|Overall Study|Other|1|||
124690757|NCT00835978|448487949|FG002|Overall Study|Other|8|||
124690758|NCT00835978|448487950|FG003|Overall Study|Other|0|||
124690759|NCT00835978|448487947|FG000|Overall Study|Objective progression or relapse|2|||
124690760|NCT00835978|448487948|FG001|Overall Study|Objective progression or relapse|0|||
124690761|NCT00835978|448487949|FG002|Overall Study|Objective progression or relapse|1|||
124759734|NCT01147666|448744758|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
124447664|NCT04178967|447602787|FG008|Induction Period|Adverse Event|0|||
124447665|NCT04178967|447602788|FG009|Induction Period|Adverse Event|0|||
124690762|NCT00835978|448487950|FG003|Overall Study|Objective progression or relapse|0|||
124690763|NCT00835978|448487947|FG000|Overall Study|Adverse Event|1|||
124690764|NCT00835978|448487948|FG001|Overall Study|Adverse Event|0|||
124690765|NCT00835978|448487949|FG002|Overall Study|Adverse Event|1|||
124690766|NCT00835978|448487950|FG003|Overall Study|Adverse Event|0|||
124690767|NCT00835978|448487947|FG000|Overall Study|Withdrawal by Subject|0|||
124690768|NCT00835978|448487948|FG001|Overall Study|Withdrawal by Subject|3|||
124690769|NCT00835978|448487949|FG002|Overall Study|Withdrawal by Subject|0|||
124447666|NCT04178967|447602789|FG010|Induction Period|Adverse Event|0|||
124447667|NCT04178967|447602779|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
124447668|NCT04178967|447602780|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
124447669|NCT04178967|447602781|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
124447670|NCT04178967|447602782|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
124447671|NCT04178967|447602783|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
124447672|NCT04178967|447602784|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
124447673|NCT04178967|447602785|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
124447674|NCT04178967|447602786|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
124447675|NCT04178967|447602787|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
124447676|NCT04178967|447602788|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
124447677|NCT04178967|447602789|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
124447678|NCT04178967|447602779|FG000|Induction Period|Lack of Efficacy|4|||
124447679|NCT04178967|447602780|FG001|Induction Period|Lack of Efficacy|1|||
124447680|NCT04178967|447602781|FG002|Induction Period|Lack of Efficacy|0|||
124447681|NCT04178967|447602782|FG003|Induction Period|Lack of Efficacy|0|||
124447682|NCT04178967|447602783|FG004|Induction Period|Lack of Efficacy|0|||
124447683|NCT04178967|447602784|FG005|Induction Period|Lack of Efficacy|0|||
124447684|NCT04178967|447602785|FG006|Induction Period|Lack of Efficacy|0|||
124447685|NCT04178967|447602786|FG007|Induction Period|Lack of Efficacy|0|||
124447686|NCT04178967|447602787|FG008|Induction Period|Lack of Efficacy|0|||
124447687|NCT04178967|447602788|FG009|Induction Period|Lack of Efficacy|0|||
124447688|NCT04178967|447602789|FG010|Induction Period|Lack of Efficacy|0|||
124447689|NCT04178967|447602779|FG000|Induction Period|Protocol Violation|0|||
124447690|NCT04178967|447602780|FG001|Induction Period|Protocol Violation|6|||
124447691|NCT04178967|447602781|FG002|Induction Period|Protocol Violation|0|||
124447692|NCT04178967|447602782|FG003|Induction Period|Protocol Violation|0|||
124690770|NCT00835978|448487950|FG003|Overall Study|Withdrawal by Subject|5|||
124690771|NCT00835978|448487947|FG000|Overall Study|Study terminated by sponsor|12|||
124690772|NCT00835978|448487948|FG001|Overall Study|Study terminated by sponsor|8|||
124690773|NCT00835978|448487949|FG002|Overall Study|Study terminated by sponsor|30|||
124690774|NCT00835978|448487950|FG003|Overall Study|Study terminated by sponsor|0|||
124690775|NCT03684057|448487951|FG000|Overall Study|Withdrawal by Subject|4|||
124690776|NCT03684057|448487952|FG001|Overall Study|Withdrawal by Subject|5|||
124690777|NCT01105130|448487953|FG000|Overall Study|Withdrawal by Subject|4|||
124690778|NCT01105130|448487954|FG001|Overall Study|Withdrawal by Subject|6|||
124690779|NCT01105130|448487955|FG002|Overall Study|Withdrawal by Subject|2|||
124690780|NCT01105130|448487953|FG000|Overall Study|Never Started|2|||
124690781|NCT01105130|448487954|FG001|Overall Study|Never Started|2|||
124690782|NCT01105130|448487955|FG002|Overall Study|Never Started|4|||
124690783|NCT01105130|448487953|FG000|Overall Study|Toxicity|1|||
124690784|NCT01105130|448487954|FG001|Overall Study|Toxicity|3|||
124690785|NCT01105130|448487955|FG002|Overall Study|Toxicity|2|||
124690786|NCT01105130|448487953|FG000|Overall Study|Multiple Reasons|3|||
124690787|NCT01105130|448487954|FG001|Overall Study|Multiple Reasons|0|||
124690788|NCT01105130|448487955|FG002|Overall Study|Multiple Reasons|2|||
124690789|NCT00327171|448487958|FG000|Overall Study|Did not receive study medication|3|||
124690790|NCT00327171|448487959|FG001|Overall Study|Did not receive study medication|0|||
124690791|NCT00327171|448487958|FG000|Overall Study|Adverse Event|23|||
124690792|NCT00327171|448487959|FG001|Overall Study|Adverse Event|23|||
124690793|NCT00327171|448487958|FG000|Overall Study|Disease progression/lack of efficacy|68|||
124690794|NCT00327171|448487959|FG001|Overall Study|Disease progression/lack of efficacy|69|||
124690795|NCT00327171|448487958|FG000|Overall Study|Investigator/participant request|1|||
124690796|NCT00327171|448487959|FG001|Overall Study|Investigator/participant request|8|||
124690797|NCT00327171|448487958|FG000|Overall Study|Clinical progression|12|||
124690798|NCT00327171|448487959|FG001|Overall Study|Clinical progression|8|||
124690799|NCT00327171|448487958|FG000|Overall Study|Undisclosed history of ischemia|0|||
124690800|NCT00327171|448487959|FG001|Overall Study|Undisclosed history of ischemia|1|||
124690801|NCT00327171|448487958|FG000|Overall Study|Other|1|||
124690802|NCT00327171|448487959|FG001|Overall Study|Other|0|||
124690803|NCT01363440|448487960|FG000|Overall Study|Adverse Event|5|||
124690804|NCT01363440|448487961|FG001|Overall Study|Adverse Event|4|||
124690805|NCT01363440|448487962|FG002|Overall Study|Adverse Event|4|||
124690806|NCT01363440|448487960|FG000|Overall Study|Death|3|||
124690807|NCT01363440|448487961|FG001|Overall Study|Death|7|||
124447693|NCT04178967|447602783|FG004|Induction Period|Protocol Violation|0|||
124447694|NCT04178967|447602784|FG005|Induction Period|Protocol Violation|0|||
124447695|NCT04178967|447602785|FG006|Induction Period|Protocol Violation|0|||
124447696|NCT04178967|447602786|FG007|Induction Period|Protocol Violation|0|||
124447697|NCT04178967|447602787|FG008|Induction Period|Protocol Violation|0|||
124690808|NCT01363440|448487962|FG002|Overall Study|Death|5|||
124690809|NCT01363440|448487960|FG000|Overall Study|Withdrawal by Subject|9|||
124690810|NCT01363440|448487961|FG001|Overall Study|Withdrawal by Subject|11|||
124690811|NCT01363440|448487962|FG002|Overall Study|Withdrawal by Subject|11|||
124690812|NCT01363440|448487960|FG000|Overall Study|Lost to Follow-up|2|||
124690813|NCT01363440|448487961|FG001|Overall Study|Lost to Follow-up|4|||
124447698|NCT04178967|447602788|FG009|Induction Period|Protocol Violation|0|||
124690814|NCT01363440|448487962|FG002|Overall Study|Lost to Follow-up|5|||
124690815|NCT01363440|448487960|FG000|Overall Study|Other|4|||
124690816|NCT01363440|448487961|FG001|Overall Study|Other|5|||
124690817|NCT01363440|448487962|FG002|Overall Study|Other|2|||
124690818|NCT02323334|448487963|FG000|Period 3|Lost to Follow-up|0|||
124690819|NCT02323334|448487964|FG001|Period 3|Lost to Follow-up|0|||
124690820|NCT02323334|448487965|FG002|Period 3|Lost to Follow-up|1|||
124690821|NCT02323334|448487966|FG003|Period 3|Lost to Follow-up|0|||
124690822|NCT02323334|448487967|FG004|Period 3|Lost to Follow-up|0|||
124690823|NCT02323334|448487968|FG005|Period 3|Lost to Follow-up|0|||
124690824|NCT02323334|448487969|FG006|Period 3|Lost to Follow-up|0|||
124690825|NCT02323334|448487970|FG007|Period 3|Lost to Follow-up|0|||
124690826|NCT02323334|448487971|FG008|Period 3|Lost to Follow-up|0|||
124690827|NCT02323334|448487972|FG009|Period 3|Lost to Follow-up|0|||
124690828|NCT02323334|448487973|FG010|Period 3|Lost to Follow-up|0|||
124690829|NCT02323334|448487974|FG011|Period 3|Lost to Follow-up|0|||
124690830|NCT02323334|448487975|FG012|Period 3|Lost to Follow-up|0|||
124690831|NCT02323334|448487976|FG013|Period 3|Lost to Follow-up|0|||
124690832|NCT02323334|448487977|FG014|Period 3|Lost to Follow-up|0|||
124690833|NCT02323334|448487978|FG015|Period 3|Lost to Follow-up|0|||
124690834|NCT02323334|448487979|FG016|Period 3|Lost to Follow-up|0|||
124690835|NCT02323334|448487963|FG000|Period 3|Withdrawal by Subject|1|||
124690836|NCT02323334|448487964|FG001|Period 3|Withdrawal by Subject|0|||
124690837|NCT02323334|448487965|FG002|Period 3|Withdrawal by Subject|0|||
124690838|NCT02323334|448487966|FG003|Period 3|Withdrawal by Subject|0|||
124690839|NCT02323334|448487967|FG004|Period 3|Withdrawal by Subject|0|||
124690840|NCT02323334|448487968|FG005|Period 3|Withdrawal by Subject|0|||
124690841|NCT02323334|448487969|FG006|Period 3|Withdrawal by Subject|0|||
124690842|NCT02323334|448487970|FG007|Period 3|Withdrawal by Subject|0|||
124690843|NCT02323334|448487971|FG008|Period 3|Withdrawal by Subject|0|||
124690844|NCT02323334|448487972|FG009|Period 3|Withdrawal by Subject|0|||
124690845|NCT02323334|448487973|FG010|Period 3|Withdrawal by Subject|0|||
124690846|NCT02323334|448487974|FG011|Period 3|Withdrawal by Subject|0|||
124690847|NCT02323334|448487975|FG012|Period 3|Withdrawal by Subject|0|||
124690848|NCT02323334|448487976|FG013|Period 3|Withdrawal by Subject|0|||
124690849|NCT02323334|448487977|FG014|Period 3|Withdrawal by Subject|0|||
124690850|NCT02323334|448487978|FG015|Period 3|Withdrawal by Subject|0|||
124690851|NCT02323334|448487979|FG016|Period 3|Withdrawal by Subject|0|||
124690852|NCT00530075|448487980|FG000|Overall Study|Adverse Event|1|||
124690853|NCT00530075|448487980|FG000|Overall Study|Death|1|||
124690854|NCT00530075|448487980|FG000|Overall Study|Lack of Efficacy|3|||
124690855|NCT00530075|448487980|FG000|Overall Study|Protocol Violation|1|||
124690856|NCT00530075|448487980|FG000|Overall Study|Withdrawal by Subject|1|||
124690857|NCT00845182|448487982|FG000|Overall Study|Lost to Follow-up|3|||
124690858|NCT00845182|448487983|FG001|Overall Study|Lost to Follow-up|3|||
124690859|NCT00845182|448487984|FG002|Overall Study|Lost to Follow-up|4|||
124690860|NCT00845182|448487982|FG000|Overall Study|Adverse Event|0|||
124690861|NCT00845182|448487983|FG001|Overall Study|Adverse Event|1|||
124690862|NCT00845182|448487984|FG002|Overall Study|Adverse Event|1|||
124690863|NCT00845182|448487982|FG000|Overall Study|Physician Decision|0|||
124690864|NCT00845182|448487983|FG001|Overall Study|Physician Decision|0|||
124690865|NCT00845182|448487984|FG002|Overall Study|Physician Decision|1|||
124690866|NCT01158404|448487992|FG000|Overall Study|Withdrawal by Subject|0|||
124690867|NCT01158404|448487993|FG001|Overall Study|Withdrawal by Subject|1|||
124690868|NCT01158404|448487994|FG002|Overall Study|Withdrawal by Subject|0|||
124690869|NCT01158404|448487995|FG003|Overall Study|Withdrawal by Subject|0|||
124690870|NCT01158404|448487996|FG004|Overall Study|Withdrawal by Subject|3|||
124690871|NCT01158404|448487997|FG005|Overall Study|Withdrawal by Subject|1|||
124690872|NCT01158404|448487998|FG006|Overall Study|Withdrawal by Subject|0|||
124690873|NCT01158404|448487999|FG007|Overall Study|Withdrawal by Subject|1|||
124690874|NCT01158404|448487992|FG000|Overall Study|Physician Decision|0|||
124690875|NCT01158404|448487993|FG001|Overall Study|Physician Decision|0|||
124690876|NCT01158404|448487994|FG002|Overall Study|Physician Decision|0|||
124690877|NCT01158404|448487995|FG003|Overall Study|Physician Decision|0|||
124690878|NCT01158404|448487996|FG004|Overall Study|Physician Decision|0|||
124690879|NCT01158404|448487997|FG005|Overall Study|Physician Decision|0|||
124690880|NCT01158404|448487998|FG006|Overall Study|Physician Decision|0|||
124690881|NCT01158404|448487999|FG007|Overall Study|Physician Decision|1|||
124690882|NCT01158404|448487992|FG000|Overall Study|Progressive Disease|0|||
124690883|NCT01158404|448487993|FG001|Overall Study|Progressive Disease|0|||
124690884|NCT01158404|448487994|FG002|Overall Study|Progressive Disease|0|||
124690885|NCT01158404|448487995|FG003|Overall Study|Progressive Disease|0|||
124690886|NCT01158404|448487996|FG004|Overall Study|Progressive Disease|0|||
124690887|NCT01158404|448487997|FG005|Overall Study|Progressive Disease|0|||
124690888|NCT01158404|448487998|FG006|Overall Study|Progressive Disease|1|||
124690889|NCT01158404|448487999|FG007|Overall Study|Progressive Disease|0|||
124690890|NCT02384460|448488001|FG000|Overall Study|Protocol Violation|0|||
124690891|NCT02384460|448488002|FG001|Overall Study|Protocol Violation|1|||
124690892|NCT02384460|448488001|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
124690893|NCT02384460|448488002|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
124690894|NCT02384460|448488001|FG000|Overall Study|Adverse Event|5|||
124690895|NCT02384460|448488002|FG001|Overall Study|Adverse Event|2|||
124690896|NCT02384460|448488001|FG000|Overall Study|Withdrawal by Subject|0|||
124690897|NCT02384460|448488002|FG001|Overall Study|Withdrawal by Subject|3|||
124690898|NCT02384460|448488001|FG000|Overall Study|Elective medical treatment|1|||
124690899|NCT02384460|448488002|FG001|Overall Study|Elective medical treatment|0|||
124690900|NCT02384460|448488001|FG000|Overall Study|Non-compliance|1|||
124690901|NCT02384460|448488002|FG001|Overall Study|Non-compliance|0|||
124690902|NCT01060111|448488003|FG000|Overall Study|Adverse Event|9|||
124690903|NCT01060111|448488004|FG001|Overall Study|Adverse Event|5|||
124690904|NCT01060111|448488005|FG002|Overall Study|Adverse Event|18|||
124690905|NCT01060111|448488003|FG000|Overall Study|Lack of Efficacy|2|||
124690906|NCT01060111|448488004|FG001|Overall Study|Lack of Efficacy|1|||
124690907|NCT01060111|448488005|FG002|Overall Study|Lack of Efficacy|0|||
124690908|NCT01060111|448488003|FG000|Overall Study|Inappropriate participant|5|||
124690909|NCT01060111|448488004|FG001|Overall Study|Inappropriate participant|4|||
124690910|NCT01060111|448488005|FG002|Overall Study|Inappropriate participant|5|||
124690911|NCT01060111|448488003|FG000|Overall Study|Participants' evasion for hospital visit|0|||
124690912|NCT01060111|448488004|FG001|Overall Study|Participants' evasion for hospital visit|3|||
124690913|NCT01060111|448488005|FG002|Overall Study|Participants' evasion for hospital visit|2|||
124690914|NCT01060111|448488003|FG000|Overall Study|Participants' non-cooperation|8|||
124690915|NCT01060111|448488004|FG001|Overall Study|Participants' non-cooperation|6|||
124690916|NCT01060111|448488005|FG002|Overall Study|Participants' non-cooperation|6|||
124690917|NCT01060111|448488003|FG000|Overall Study|Adverse event and insufficient effect|0|||
124690918|NCT01060111|448488004|FG001|Overall Study|Adverse event and insufficient effect|1|||
124690919|NCT01060111|448488005|FG002|Overall Study|Adverse event and insufficient effect|0|||
124690920|NCT01060111|448488003|FG000|Overall Study|Participants' non-cooperation|1|||
124759735|NCT01147666|448744759|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
124759736|NCT01147666|448744760|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
124759737|NCT01147666|448744761|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
124759738|NCT01147666|448744762|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
124759739|NCT01147666|448744763|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
124759740|NCT01147666|448744764|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
124759741|NCT01147666|448744765|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
124759742|NCT01147666|448744766|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
124759743|NCT01147666|448744767|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
124759744|NCT01147666|448744768|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
124759745|NCT01147666|448744769|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
124759746|NCT01147666|448744755|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
124759747|NCT01147666|448744756|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
124759748|NCT01147666|448744757|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
124759749|NCT01147666|448744758|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
124759750|NCT01147666|448744759|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
124759751|NCT01147666|448744760|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
124759752|NCT01147666|448744761|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
124759753|NCT01147666|448744762|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
124759754|NCT01147666|448744763|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
124759755|NCT01147666|448744764|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
124759756|NCT01147666|448744765|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
124759757|NCT01147666|448744766|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
124759758|NCT01147666|448744767|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
124759759|NCT01147666|448744768|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
124759760|NCT01147666|448744769|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
124759761|NCT01147666|448744755|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
124759762|NCT01147666|448744756|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
124900024|NCT01090024|449259498|FG003|Period 1|Adverse Event|0|||
124690921|NCT01060111|448488004|FG001|Overall Study|Participants' non-cooperation|0|||
124900025|NCT01090024|449259499|FG004|Period 1|Adverse Event|0|||
124690922|NCT01060111|448488005|FG002|Overall Study|Participants' non-cooperation|0|||
124690923|NCT01060111|448488003|FG000|Overall Study|Other|2|||
124690924|NCT01060111|448488004|FG001|Overall Study|Other|3|||
124690925|NCT01060111|448488005|FG002|Overall Study|Other|4|||
124690926|NCT00997126|448488008|FG000|Overall Study|Physician Decision|7|||
124690927|NCT00997126|448488009|FG001|Overall Study|Physician Decision|11|||
124690928|NCT00896233|448488016|FG000|Overall Study|Claustrophobia during MRI|1|||
124690929|NCT04280562|448488017|FG000|Study|Adverse Event|2|||
124690930|NCT04280562|448488018|FG001|Study|Adverse Event|0|||
124690931|NCT04280562|448488017|FG000|Study|Lost to Follow-up|3|||
124690932|NCT04280562|448488018|FG001|Study|Lost to Follow-up|3|||
124690933|NCT02965456|448488019|FG000|Overall Study|Lost to Follow-up|40|||
124690934|NCT02965456|448488020|FG001|Overall Study|Lost to Follow-up|18|||
124690935|NCT02965456|448488019|FG000|Overall Study|Subject Request|22|||
124690936|NCT02965456|448488020|FG001|Overall Study|Subject Request|13|||
124690937|NCT02965456|448488019|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
124690938|NCT02965456|448488020|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
124690939|NCT02965456|448488019|FG000|Overall Study|Adverse Event|3|||
124690940|NCT02965456|448488020|FG001|Overall Study|Adverse Event|0|||
124690941|NCT02965456|448488019|FG000|Overall Study|Noncompliance with Study Drug|1|||
124690942|NCT02965456|448488020|FG001|Overall Study|Noncompliance with Study Drug|1|||
124690943|NCT02965456|448488019|FG000|Overall Study|Worsening Condition|0|||
124690944|NCT02965456|448488020|FG001|Overall Study|Worsening Condition|2|||
124690945|NCT02965456|448488019|FG000|Overall Study|Lack of Efficacy|1|||
124690946|NCT02965456|448488020|FG001|Overall Study|Lack of Efficacy|0|||
124690947|NCT02965456|448488019|FG000|Overall Study|Physician Decision|0|||
124690948|NCT02965456|448488020|FG001|Overall Study|Physician Decision|1|||
124900026|NCT01090024|449259500|FG005|Period 1|Adverse Event|0|||
124900027|NCT01090024|449259501|FG006|Period 1|Adverse Event|0|||
124900028|NCT01090024|449259502|FG007|Period 1|Adverse Event|0|||
124900029|NCT01090024|449259503|FG008|Period 1|Adverse Event|0|||
124690949|NCT02965456|448488019|FG000|Overall Study|Pregnancy|1|||
124690950|NCT02965456|448488020|FG001|Overall Study|Pregnancy|0|||
124690951|NCT02965456|448488019|FG000|Overall Study|Protocol Violation|0|||
124690952|NCT02965456|448488020|FG001|Overall Study|Protocol Violation|1|||
124690953|NCT02965456|448488019|FG000|Overall Study|Participant ran out of study drug|0|||
124690954|NCT02965456|448488020|FG001|Overall Study|Participant ran out of study drug|1|||
124690955|NCT02583477|448488021|FG000|Overall Study|Adverse Event|0|||
124690956|NCT02583477|448488022|FG001|Overall Study|Adverse Event|2|||
124690957|NCT02583477|448488021|FG000|Overall Study|Death|1|||
124690958|NCT02583477|448488022|FG001|Overall Study|Death|16|||
124900030|NCT01090024|449259504|FG009|Period 1|Adverse Event|1|||
124900031|NCT01090024|449259505|FG010|Period 1|Adverse Event|0|||
124900032|NCT01090024|449259506|FG011|Period 1|Adverse Event|1|||
124900033|NCT01090024|449259507|FG012|Period 1|Adverse Event|0|||
124900034|NCT01090024|449259508|FG013|Period 1|Adverse Event|0|||
124900035|NCT01090024|449259509|FG014|Period 1|Adverse Event|0|||
124447699|NCT04178967|447602789|FG010|Induction Period|Protocol Violation|0|||
124900036|NCT01090024|449259510|FG015|Period 1|Adverse Event|0|||
124900037|NCT01090024|449259511|FG016|Period 1|Adverse Event|0|||
124900038|NCT01090024|449259512|FG017|Period 1|Adverse Event|1|||
124447700|NCT04178967|447602779|FG000|Induction Period|Withdrawal by Subject|6|||
124690959|NCT02583477|448488021|FG000|Overall Study|Study terminated|2|||
124690960|NCT02583477|448488022|FG001|Overall Study|Study terminated|2|||
124690961|NCT01860404|448488027|FG000|Overall Study|Lost to Follow-up|3|||
124690962|NCT01860404|448488028|FG001|Overall Study|Lost to Follow-up|4|||
124690963|NCT01860404|448488029|FG002|Overall Study|Lost to Follow-up|1|||
124900039|NCT01090024|449259495|FG000|Period 1|Withdrawal by Subject|0|||
124900040|NCT01090024|449259496|FG001|Period 1|Withdrawal by Subject|0|||
124900041|NCT01090024|449259497|FG002|Period 1|Withdrawal by Subject|0|||
124900042|NCT01090024|449259498|FG003|Period 1|Withdrawal by Subject|1|||
124759763|NCT01147666|448744757|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
124759764|NCT01147666|448744758|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
124447701|NCT04178967|447602780|FG001|Induction Period|Withdrawal by Subject|4|||
124759765|NCT01147666|448744759|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
124759766|NCT01147666|448744760|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
124759767|NCT01147666|448744761|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
124759768|NCT01147666|448744762|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
124759769|NCT01147666|448744763|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
124759770|NCT01147666|448744764|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
124759771|NCT01147666|448744765|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
124759772|NCT01147666|448744766|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
124759773|NCT01147666|448744767|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
124759774|NCT01147666|448744768|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
124759775|NCT01147666|448744769|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
124759776|NCT02159066|448744770|FG000|Part I|Adverse Event|7|||
124759777|NCT02159066|448744771|FG001|Part I|Adverse Event|5|||
124759778|NCT02159066|448744772|FG002|Part I|Adverse Event|0|||
124759779|NCT02159066|448744773|FG003|Part I|Adverse Event|0|||
124759780|NCT02159066|448744774|FG004|Part I|Adverse Event|0|||
124759781|NCT02159066|448744775|FG005|Part I|Adverse Event|0|||
124759782|NCT02159066|448744770|FG000|Part I|Death|11|||
124759783|NCT02159066|448744771|FG001|Part I|Death|9|||
124759784|NCT02159066|448744772|FG002|Part I|Death|0|||
124759785|NCT02159066|448744773|FG003|Part I|Death|0|||
124759786|NCT02159066|448744774|FG004|Part I|Death|0|||
124759787|NCT02159066|448744775|FG005|Part I|Death|0|||
124759788|NCT02159066|448744770|FG000|Part I|Progressive Disease|37|||
124759789|NCT02159066|448744771|FG001|Part I|Progressive Disease|46|||
124759790|NCT02159066|448744772|FG002|Part I|Progressive Disease|0|||
124759791|NCT02159066|448744773|FG003|Part I|Progressive Disease|0|||
124759792|NCT02159066|448744774|FG004|Part I|Progressive Disease|0|||
124759793|NCT02159066|448744775|FG005|Part I|Progressive Disease|0|||
124759794|NCT02159066|448744770|FG000|Part I|New Therapy for Study Indication|5|||
124759795|NCT02159066|448744771|FG001|Part I|New Therapy for Study Indication|4|||
124759796|NCT02159066|448744772|FG002|Part I|New Therapy for Study Indication|0|||
124759797|NCT02159066|448744773|FG003|Part I|New Therapy for Study Indication|0|||
124759798|NCT02159066|448744774|FG004|Part I|New Therapy for Study Indication|0|||
124759799|NCT02159066|448744775|FG005|Part I|New Therapy for Study Indication|0|||
124759800|NCT02159066|448744770|FG000|Part I|Termination of participants from the study|3|||
124759801|NCT02159066|448744771|FG001|Part I|Termination of participants from the study|3|||
124759802|NCT02159066|448744772|FG002|Part I|Termination of participants from the study|0|||
124759803|NCT02159066|448744773|FG003|Part I|Termination of participants from the study|0|||
124759804|NCT02159066|448744774|FG004|Part I|Termination of participants from the study|0|||
124759805|NCT02159066|448744775|FG005|Part I|Termination of participants from the study|0|||
124759806|NCT02159066|448744770|FG000|Part I|Physician Decision|2|||
124759807|NCT02159066|448744771|FG001|Part I|Physician Decision|9|||
124759808|NCT02159066|448744772|FG002|Part I|Physician Decision|0|||
124759809|NCT02159066|448744773|FG003|Part I|Physician Decision|0|||
124759810|NCT02159066|448744774|FG004|Part I|Physician Decision|0|||
124759811|NCT02159066|448744775|FG005|Part I|Physician Decision|0|||
124447702|NCT04178967|447602781|FG002|Induction Period|Withdrawal by Subject|0|||
124447703|NCT04178967|447602782|FG003|Induction Period|Withdrawal by Subject|0|||
124447704|NCT04178967|447602783|FG004|Induction Period|Withdrawal by Subject|0|||
124447705|NCT04178967|447602784|FG005|Induction Period|Withdrawal by Subject|0|||
124447706|NCT04178967|447602785|FG006|Induction Period|Withdrawal by Subject|0|||
124447707|NCT04178967|447602786|FG007|Induction Period|Withdrawal by Subject|0|||
124447708|NCT04178967|447602787|FG008|Induction Period|Withdrawal by Subject|0|||
124447709|NCT04178967|447602788|FG009|Induction Period|Withdrawal by Subject|0|||
124447710|NCT04178967|447602789|FG010|Induction Period|Withdrawal by Subject|0|||
124447711|NCT04178967|447602779|FG000|Induction Period|Lost to Follow-up|2|||
124447712|NCT04178967|447602780|FG001|Induction Period|Lost to Follow-up|0|||
124759812|NCT02159066|448744770|FG000|Part I|Participant/Guardian Decision|9|||
124759813|NCT02159066|448744771|FG001|Part I|Participant/Guardian Decision|3|||
124759814|NCT02159066|448744772|FG002|Part I|Participant/Guardian Decision|0|||
124759815|NCT02159066|448744773|FG003|Part I|Participant/Guardian Decision|0|||
124759816|NCT02159066|448744774|FG004|Part I|Participant/Guardian Decision|0|||
124759817|NCT02159066|448744775|FG005|Part I|Participant/Guardian Decision|0|||
124759818|NCT02159066|448744770|FG000|Part I|Missing Data|1|||
124447713|NCT04178967|447602781|FG002|Induction Period|Lost to Follow-up|0|||
124447714|NCT04178967|447602782|FG003|Induction Period|Lost to Follow-up|0|||
124759819|NCT02159066|448744771|FG001|Part I|Missing Data|0|||
124759820|NCT02159066|448744772|FG002|Part I|Missing Data|0|||
124759821|NCT02159066|448744773|FG003|Part I|Missing Data|0|||
124759822|NCT02159066|448744774|FG004|Part I|Missing Data|0|||
124759823|NCT02159066|448744775|FG005|Part I|Missing Data|0|||
124447715|NCT04178967|447602783|FG004|Induction Period|Lost to Follow-up|0|||
124900043|NCT01090024|449259499|FG004|Period 1|Withdrawal by Subject|0|||
124900044|NCT01090024|449259500|FG005|Period 1|Withdrawal by Subject|0|||
124900045|NCT01090024|449259501|FG006|Period 1|Withdrawal by Subject|0|||
124900046|NCT01090024|449259502|FG007|Period 1|Withdrawal by Subject|0|||
124900047|NCT01090024|449259503|FG008|Period 1|Withdrawal by Subject|0|||
124900048|NCT01090024|449259504|FG009|Period 1|Withdrawal by Subject|0|||
124900049|NCT01090024|449259505|FG010|Period 1|Withdrawal by Subject|0|||
124900050|NCT01090024|449259506|FG011|Period 1|Withdrawal by Subject|0|||
124900051|NCT01090024|449259507|FG012|Period 1|Withdrawal by Subject|0|||
124900052|NCT01090024|449259508|FG013|Period 1|Withdrawal by Subject|0|||
124900053|NCT01090024|449259509|FG014|Period 1|Withdrawal by Subject|0|||
124900054|NCT01090024|449259510|FG015|Period 1|Withdrawal by Subject|0|||
124900055|NCT01090024|449259511|FG016|Period 1|Withdrawal by Subject|0|||
124900056|NCT01090024|449259512|FG017|Period 1|Withdrawal by Subject|0|||
124900057|NCT01090024|449259495|FG000|Period 1|Lost to Follow-up|0|||
124900058|NCT01090024|449259496|FG001|Period 1|Lost to Follow-up|1|||
124900059|NCT01090024|449259497|FG002|Period 1|Lost to Follow-up|0|||
124900060|NCT01090024|449259498|FG003|Period 1|Lost to Follow-up|0|||
124900061|NCT01090024|449259499|FG004|Period 1|Lost to Follow-up|0|||
124900062|NCT01090024|449259500|FG005|Period 1|Lost to Follow-up|0|||
124900063|NCT01090024|449259501|FG006|Period 1|Lost to Follow-up|0|||
124900064|NCT01090024|449259502|FG007|Period 1|Lost to Follow-up|0|||
124900065|NCT01090024|449259503|FG008|Period 1|Lost to Follow-up|0|||
124900066|NCT01090024|449259504|FG009|Period 1|Lost to Follow-up|0|||
124900067|NCT01090024|449259505|FG010|Period 1|Lost to Follow-up|0|||
124900068|NCT01090024|449259506|FG011|Period 1|Lost to Follow-up|0|||
124900069|NCT01090024|449259507|FG012|Period 1|Lost to Follow-up|0|||
124900070|NCT01090024|449259508|FG013|Period 1|Lost to Follow-up|0|||
124900071|NCT01090024|449259509|FG014|Period 1|Lost to Follow-up|0|||
124900072|NCT01090024|449259510|FG015|Period 1|Lost to Follow-up|0|||
124900073|NCT01090024|449259511|FG016|Period 1|Lost to Follow-up|0|||
124900074|NCT01090024|449259512|FG017|Period 1|Lost to Follow-up|0|||
124900075|NCT01090024|449259495|FG000|Period 2|Lost to Follow-up|0|||
124900076|NCT01090024|449259496|FG001|Period 2|Lost to Follow-up|0|||
124900077|NCT01090024|449259497|FG002|Period 2|Lost to Follow-up|0|||
124900078|NCT01090024|449259498|FG003|Period 2|Lost to Follow-up|1|||
124900079|NCT01090024|449259499|FG004|Period 2|Lost to Follow-up|0|||
124900080|NCT01090024|449259500|FG005|Period 2|Lost to Follow-up|0|||
124900081|NCT01090024|449259501|FG006|Period 2|Lost to Follow-up|0|||
124900082|NCT01090024|449259502|FG007|Period 2|Lost to Follow-up|0|||
124900083|NCT01090024|449259503|FG008|Period 2|Lost to Follow-up|0|||
124900084|NCT01090024|449259504|FG009|Period 2|Lost to Follow-up|0|||
124900085|NCT01090024|449259505|FG010|Period 2|Lost to Follow-up|0|||
124900086|NCT01090024|449259506|FG011|Period 2|Lost to Follow-up|0|||
124900087|NCT01090024|449259507|FG012|Period 2|Lost to Follow-up|0|||
124900088|NCT01090024|449259508|FG013|Period 2|Lost to Follow-up|0|||
124900089|NCT01090024|449259509|FG014|Period 2|Lost to Follow-up|0|||
124900090|NCT01090024|449259510|FG015|Period 2|Lost to Follow-up|0|||
124900091|NCT01090024|449259511|FG016|Period 2|Lost to Follow-up|0|||
124900092|NCT01090024|449259512|FG017|Period 2|Lost to Follow-up|0|||
124900093|NCT01090024|449259495|FG000|Period 2|Adverse Event|1|||
124900094|NCT01090024|449259496|FG001|Period 2|Adverse Event|0|||
124900095|NCT01090024|449259497|FG002|Period 2|Adverse Event|0|||
124900096|NCT01090024|449259498|FG003|Period 2|Adverse Event|0|||
124900097|NCT01090024|449259499|FG004|Period 2|Adverse Event|0|||
124900098|NCT01090024|449259500|FG005|Period 2|Adverse Event|0|||
124900099|NCT01090024|449259501|FG006|Period 2|Adverse Event|0|||
124900100|NCT01090024|449259502|FG007|Period 2|Adverse Event|0|||
124900101|NCT01090024|449259503|FG008|Period 2|Adverse Event|0|||
124900102|NCT01090024|449259504|FG009|Period 2|Adverse Event|0|||
124900103|NCT01090024|449259505|FG010|Period 2|Adverse Event|0|||
124900104|NCT01090024|449259506|FG011|Period 2|Adverse Event|0|||
124900105|NCT01090024|449259507|FG012|Period 2|Adverse Event|0|||
124900106|NCT01090024|449259508|FG013|Period 2|Adverse Event|0|||
124900107|NCT01090024|449259509|FG014|Period 2|Adverse Event|0|||
124900108|NCT01090024|449259510|FG015|Period 2|Adverse Event|0|||
124900109|NCT01090024|449259511|FG016|Period 2|Adverse Event|0|||
124900110|NCT01090024|449259512|FG017|Period 2|Adverse Event|0|||
124900111|NCT01090024|449259495|FG000|Period 3|Withdrawal by Subject|0|||
124900112|NCT01090024|449259496|FG001|Period 3|Withdrawal by Subject|0|||
124900113|NCT01090024|449259497|FG002|Period 3|Withdrawal by Subject|0|||
124900114|NCT01090024|449259498|FG003|Period 3|Withdrawal by Subject|0|||
124900115|NCT01090024|449259499|FG004|Period 3|Withdrawal by Subject|0|||
124900116|NCT01090024|449259500|FG005|Period 3|Withdrawal by Subject|0|||
124900117|NCT01090024|449259501|FG006|Period 3|Withdrawal by Subject|0|||
124900118|NCT01090024|449259502|FG007|Period 3|Withdrawal by Subject|0|||
124900119|NCT01090024|449259503|FG008|Period 3|Withdrawal by Subject|0|||
124900120|NCT01090024|449259504|FG009|Period 3|Withdrawal by Subject|0|||
124900121|NCT01090024|449259505|FG010|Period 3|Withdrawal by Subject|0|||
124900122|NCT01090024|449259506|FG011|Period 3|Withdrawal by Subject|0|||
124900123|NCT01090024|449259507|FG012|Period 3|Withdrawal by Subject|0|||
124900124|NCT01090024|449259508|FG013|Period 3|Withdrawal by Subject|0|||
124900125|NCT01090024|449259509|FG014|Period 3|Withdrawal by Subject|0|||
124900126|NCT01090024|449259510|FG015|Period 3|Withdrawal by Subject|1|||
124900127|NCT01090024|449259511|FG016|Period 3|Withdrawal by Subject|0|||
124900128|NCT01090024|449259512|FG017|Period 3|Withdrawal by Subject|0|||
124900129|NCT01090024|449259495|FG000|Period 3|Protocol Violation|0|||
124900130|NCT01090024|449259496|FG001|Period 3|Protocol Violation|0|||
124900131|NCT01090024|449259497|FG002|Period 3|Protocol Violation|0|||
124900132|NCT01090024|449259498|FG003|Period 3|Protocol Violation|0|||
124900133|NCT01090024|449259499|FG004|Period 3|Protocol Violation|0|||
124900134|NCT01090024|449259500|FG005|Period 3|Protocol Violation|0|||
124900135|NCT01090024|449259501|FG006|Period 3|Protocol Violation|0|||
124900136|NCT01090024|449259502|FG007|Period 3|Protocol Violation|0|||
124900137|NCT01090024|449259503|FG008|Period 3|Protocol Violation|1|||
124900138|NCT01090024|449259504|FG009|Period 3|Protocol Violation|0|||
124900139|NCT01090024|449259505|FG010|Period 3|Protocol Violation|0|||
124900140|NCT01090024|449259506|FG011|Period 3|Protocol Violation|0|||
124900141|NCT01090024|449259507|FG012|Period 3|Protocol Violation|0|||
124900142|NCT01090024|449259508|FG013|Period 3|Protocol Violation|0|||
124900143|NCT01090024|449259509|FG014|Period 3|Protocol Violation|0|||
124900144|NCT01090024|449259510|FG015|Period 3|Protocol Violation|0|||
124900145|NCT01090024|449259511|FG016|Period 3|Protocol Violation|0|||
124900146|NCT01090024|449259512|FG017|Period 3|Protocol Violation|0|||
124900147|NCT01090024|449259495|FG000|Period 3|Adverse Event|0|||
124900148|NCT01090024|449259496|FG001|Period 3|Adverse Event|0|||
124900149|NCT01090024|449259497|FG002|Period 3|Adverse Event|0|||
124900150|NCT01090024|449259498|FG003|Period 3|Adverse Event|0|||
124900151|NCT01090024|449259499|FG004|Period 3|Adverse Event|0|||
124900152|NCT01090024|449259500|FG005|Period 3|Adverse Event|1|||
124900153|NCT01090024|449259501|FG006|Period 3|Adverse Event|0|||
124900154|NCT01090024|449259502|FG007|Period 3|Adverse Event|0|||
124900155|NCT01090024|449259503|FG008|Period 3|Adverse Event|0|||
124900156|NCT01090024|449259504|FG009|Period 3|Adverse Event|0|||
124900157|NCT01090024|449259505|FG010|Period 3|Adverse Event|0|||
124900158|NCT01090024|449259506|FG011|Period 3|Adverse Event|0|||
124900159|NCT01090024|449259507|FG012|Period 3|Adverse Event|0|||
124900160|NCT01090024|449259508|FG013|Period 3|Adverse Event|0|||
124900161|NCT01090024|449259509|FG014|Period 3|Adverse Event|0|||
124900162|NCT01090024|449259510|FG015|Period 3|Adverse Event|0|||
124900163|NCT01090024|449259511|FG016|Period 3|Adverse Event|0|||
124447716|NCT04178967|447602784|FG005|Induction Period|Lost to Follow-up|0|||
124447717|NCT04178967|447602785|FG006|Induction Period|Lost to Follow-up|0|||
124447718|NCT04178967|447602786|FG007|Induction Period|Lost to Follow-up|0|||
124447719|NCT04178967|447602787|FG008|Induction Period|Lost to Follow-up|0|||
124447720|NCT04178967|447602788|FG009|Induction Period|Lost to Follow-up|0|||
124447721|NCT04178967|447602789|FG010|Induction Period|Lost to Follow-up|0|||
124447722|NCT04178967|447602779|FG000|Induction Period|Participant Missed Study Visits|0|||
124447723|NCT04178967|447602780|FG001|Induction Period|Participant Missed Study Visits|1|||
124900164|NCT01090024|449259512|FG017|Period 3|Adverse Event|0|||
124447724|NCT04178967|447602781|FG002|Induction Period|Participant Missed Study Visits|0|||
124447725|NCT04178967|447602782|FG003|Induction Period|Participant Missed Study Visits|0|||
124447726|NCT04178967|447602783|FG004|Induction Period|Participant Missed Study Visits|0|||
124447727|NCT04178967|447602784|FG005|Induction Period|Participant Missed Study Visits|0|||
124447728|NCT04178967|447602785|FG006|Induction Period|Participant Missed Study Visits|0|||
124447729|NCT04178967|447602786|FG007|Induction Period|Participant Missed Study Visits|0|||
124447730|NCT04178967|447602787|FG008|Induction Period|Participant Missed Study Visits|0|||
124447731|NCT04178967|447602788|FG009|Induction Period|Participant Missed Study Visits|0|||
124447732|NCT04178967|447602789|FG010|Induction Period|Participant Missed Study Visits|0|||
124447733|NCT04178967|447602779|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
124447734|NCT04178967|447602780|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
124447735|NCT04178967|447602781|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
124900165|NCT00777556|449259515|FG000|Overall Study|Inappropriate self-selection|34|||
124447736|NCT04178967|447602782|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
124447737|NCT04178967|447602783|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
124447738|NCT04178967|447602784|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
124900166|NCT00777556|449259515|FG000|Overall Study|Dispensed but did not use product|12|||
124900167|NCT00777556|449259515|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
124447739|NCT04178967|447602785|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
124447740|NCT04178967|447602786|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
124900168|NCT00920686|449259519|FG000|Overall Study|Lost to Follow-up|2|||
124900169|NCT00920686|449259520|FG001|Overall Study|Lost to Follow-up|3|||
124900170|NCT00920686|449259521|FG002|Overall Study|Lost to Follow-up|1|||
124900171|NCT00920686|449259519|FG000|Overall Study|Study drug dosing criteria not met|17|||
124900172|NCT00920686|449259520|FG001|Overall Study|Study drug dosing criteria not met|19|||
124900173|NCT00920686|449259521|FG002|Overall Study|Study drug dosing criteria not met|12|||
124900174|NCT01313182|449259522|FG000|Overall Study|Protocol Violation|66|||
124900175|NCT01313182|449259523|FG001|Overall Study|Protocol Violation|92|||
124900176|NCT01695317|449259524|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
124900177|NCT01695317|449259525|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
124690964|NCT01860404|448488030|FG003|Overall Study|Lost to Follow-up|6|||
124447741|NCT04178967|447602787|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
124447742|NCT04178967|447602788|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
124447743|NCT04178967|447602789|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
124690965|NCT01860404|448488031|FG004|Overall Study|Lost to Follow-up|4|||
124690966|NCT01860404|448488027|FG000|Overall Study|Withdrawal by Subject|0|||
124690967|NCT01860404|448488028|FG001|Overall Study|Withdrawal by Subject|0|||
124690968|NCT01860404|448488029|FG002|Overall Study|Withdrawal by Subject|4|||
124690969|NCT01860404|448488030|FG003|Overall Study|Withdrawal by Subject|0|||
124690970|NCT01860404|448488031|FG004|Overall Study|Withdrawal by Subject|0|||
124690971|NCT02762604|448488032|FG000|Overall Study|Lost to Follow-up|2|||
124690972|NCT02762604|448488033|FG001|Overall Study|Lost to Follow-up|7|||
124690973|NCT02762604|448488032|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
124690974|NCT02762604|448488033|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
124690975|NCT06038643|448488034|FG000|Overall Study|Withdrawal by Subject|9|||
124690976|NCT06038643|448488035|FG001|Overall Study|Withdrawal by Subject|4|||
124690977|NCT06038643|448488034|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
124690978|NCT06038643|448488035|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
124690979|NCT05259033|448488045|FG000|Overall Study|Withdrawal by Subject|10|||
124690980|NCT05259033|448488046|FG001|Overall Study|Withdrawal by Subject|5|||
124690981|NCT05259033|448488045|FG000|Overall Study|Lost to Follow-up|1|||
124690982|NCT05259033|448488046|FG001|Overall Study|Lost to Follow-up|0|||
124690983|NCT05259033|448488045|FG000|Overall Study|Death|2|||
124690984|NCT05259033|448488046|FG001|Overall Study|Death|0|||
124690985|NCT04210375|448488047|FG000|Overall Study|Death|0|||
124690986|NCT04210375|448488048|FG001|Overall Study|Death|1|||
124690987|NCT04210375|448488049|FG002|Overall Study|Death|0|||
124690988|NCT04210375|448488050|FG003|Overall Study|Death|0|||
124690989|NCT01405911|448488051|FG000|Overall Study|Pre-treatment lab AE|0|||
124690990|NCT01405911|448488052|FG001|Overall Study|Pre-treatment lab AE|1|||
124690991|NCT01405911|448488053|FG002|Overall Study|Pre-treatment lab AE|0|||
124690992|NCT01405911|448488051|FG000|Overall Study|Lost to Follow-up|0|||
124690993|NCT01405911|448488052|FG001|Overall Study|Lost to Follow-up|1|||
124690994|NCT01405911|448488053|FG002|Overall Study|Lost to Follow-up|0|||
124690995|NCT01405911|448488051|FG000|Overall Study|Protocol Violation|1|||
124690996|NCT01405911|448488052|FG001|Overall Study|Protocol Violation|0|||
124690997|NCT01405911|448488053|FG002|Overall Study|Protocol Violation|0|||
124690998|NCT01405911|448488051|FG000|Overall Study|Withdrawal by Subject|3|||
124690999|NCT01405911|448488052|FG001|Overall Study|Withdrawal by Subject|1|||
124691000|NCT01405911|448488053|FG002|Overall Study|Withdrawal by Subject|1|||
124691001|NCT01980888|448488056|FG000|Overall Study|Study Terminated by Sponsor|116|||
124691002|NCT01980888|448488057|FG001|Overall Study|Study Terminated by Sponsor|122|||
124691003|NCT01980888|448488056|FG000|Overall Study|Withdrew Consent|17|||
124691004|NCT01980888|448488057|FG001|Overall Study|Withdrew Consent|6|||
124691005|NCT01980888|448488056|FG000|Overall Study|Investigator's Discretion|8|||
124691006|NCT01980888|448488057|FG001|Overall Study|Investigator's Discretion|3|||
124691007|NCT01980888|448488056|FG000|Overall Study|Non-Compliance with Study Drug|3|||
124691008|NCT01980888|448488057|FG001|Overall Study|Non-Compliance with Study Drug|2|||
124691009|NCT02015104|448488059|FG000|Overall Study|Withdrew consent after first dose drug|1|||
124691010|NCT02015104|448488060|FG001|Overall Study|Withdrew consent after first dose drug|0|||
124691011|NCT02015104|448488059|FG000|Overall Study|Withdrew consent prior to treatment|0|||
124691012|NCT02015104|448488060|FG001|Overall Study|Withdrew consent prior to treatment|1|||
124691013|NCT05762744|448488061|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
124691014|NCT05762744|448488062|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
124691015|NCT05762744|448488061|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
124691016|NCT05762744|448488062|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
124691017|NCT01030900|448488069|FG000|Overall Study|Not treated due to congestive heart failure|1|||
124691018|NCT01030900|448488069|FG000|Overall Study|Not treated due to rapid disease|1|||
124691019|NCT00441896|448488070|FG000|Overall Study|Withdrawal by Subject|0|||
124691020|NCT00441896|448488071|FG001|Overall Study|Withdrawal by Subject|0|||
124691021|NCT00441896|448488072|FG002|Overall Study|Withdrawal by Subject|0|||
124691022|NCT00441896|448488073|FG003|Overall Study|Withdrawal by Subject|1|||
124691023|NCT00441896|448488074|FG004|Overall Study|Withdrawal by Subject|0|||
124691024|NCT00441896|448488075|FG005|Overall Study|Withdrawal by Subject|0|||
124691025|NCT00441896|448488076|FG006|Overall Study|Withdrawal by Subject|0|||
124691026|NCT00441896|448488077|FG007|Overall Study|Withdrawal by Subject|0|||
124691027|NCT00441896|448488078|FG008|Overall Study|Withdrawal by Subject|0|||
124691028|NCT00441896|448488079|FG009|Overall Study|Withdrawal by Subject|0|||
124447744|NCT04178967|447602779|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124691029|NCT00441896|448488070|FG000|Overall Study|Other|0|||
124759824|NCT02159066|448744770|FG000|Part II|Adverse Event|0|||
124447745|NCT04178967|447602780|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124691030|NCT00441896|448488071|FG001|Overall Study|Other|0|||
124691031|NCT00441896|448488072|FG002|Overall Study|Other|0|||
124691032|NCT00441896|448488073|FG003|Overall Study|Other|0|||
124900178|NCT01695317|449259524|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
124900179|NCT01695317|449259525|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
124900180|NCT04580303|449259526|FG000|Overall Study|Adverse Event|0|||
124900181|NCT04580303|449259527|FG001|Overall Study|Adverse Event|1|||
124900182|NCT04580303|449259528|FG002|Overall Study|Adverse Event|0|||
124900183|NCT04580303|449259529|FG003|Overall Study|Adverse Event|0|||
124900184|NCT04580303|449259526|FG000|Overall Study|Withdrawal by Subject|0|||
124900185|NCT04580303|449259527|FG001|Overall Study|Withdrawal by Subject|0|||
124900186|NCT04580303|449259528|FG002|Overall Study|Withdrawal by Subject|1|||
124900187|NCT04580303|449259529|FG003|Overall Study|Withdrawal by Subject|0|||
124900188|NCT02299635|449259533|FG000|Overall Study|Adverse Event|2|||
124900189|NCT02299635|449259533|FG000|Overall Study|Death|1|||
124900190|NCT02299635|449259533|FG000|Overall Study|Global deterioration of health status|1|||
124900191|NCT02299635|449259533|FG000|Overall Study|Objective progression or relapse|10|||
124900192|NCT02299635|449259533|FG000|Overall Study|Withdrawal by Subject|2|||
124900193|NCT02299635|449259533|FG000|Overall Study|Other|3|||
124900194|NCT00927823|449259534|FG000|Continuous Dosing Period|Death|0|||
124900195|NCT00927823|449259535|FG001|Continuous Dosing Period|Death|0|||
124900196|NCT00927823|449259536|FG002|Continuous Dosing Period|Death|6|||
124900197|NCT00927823|449259537|FG003|Continuous Dosing Period|Death|0|||
124900198|NCT00927823|449259534|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
124900199|NCT00927823|449259535|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
124900200|NCT00927823|449259536|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
124900201|NCT00927823|449259537|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
124900202|NCT00927823|449259534|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
124900203|NCT00927823|449259535|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
124900204|NCT00927823|449259536|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
124900205|NCT00927823|449259537|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
124900206|NCT00927823|449259534|FG000|Continuous Dosing Period|Other|1|||
124900207|NCT00927823|449259535|FG001|Continuous Dosing Period|Other|2|||
124900208|NCT00927823|449259536|FG002|Continuous Dosing Period|Other|9|||
124900209|NCT00927823|449259537|FG003|Continuous Dosing Period|Other|3|||
124900210|NCT00828672|449259538|FG000|Study Treatment|Lost to Follow-up|1|||
124900211|NCT00828672|449259539|FG001|Study Treatment|Lost to Follow-up|0|||
124900212|NCT00828672|449259538|FG000|Study Treatment|Adverse Event|0|||
124900213|NCT00828672|449259539|FG001|Study Treatment|Adverse Event|1|||
124900214|NCT00828672|449259538|FG000|Study Treatment|Complete response, no surgery|1|||
124900215|NCT00828672|449259539|FG001|Study Treatment|Complete response, no surgery|1|||
124900216|NCT00828672|449259538|FG000|Post-surgery (<30 Days)|No central review materials|0|||
124900217|NCT00828672|449259539|FG001|Post-surgery (<30 Days)|No central review materials|1|||
124900218|NCT00831792|449259540|FG000|Overall Study|Not Eligible|3|||
124900219|NCT00831792|449259540|FG000|Overall Study|Adverse Event|1|||
124900220|NCT00831792|449259540|FG000|Overall Study|Death|1|||
124900221|NCT00831792|449259540|FG000|Overall Study|Lack of Efficacy|1|||
124900222|NCT02701361|449259544|FG000|Overall Study|Lost to Follow-up|5|||
124900223|NCT02701361|449259545|FG001|Overall Study|Lost to Follow-up|2|||
124900224|NCT02701361|449259546|FG002|Overall Study|Lost to Follow-up|1|||
124900225|NCT02701361|449259544|FG000|Overall Study|Withdrawal by Subject|4|||
124900226|NCT02701361|449259545|FG001|Overall Study|Withdrawal by Subject|0|||
124900227|NCT02701361|449259546|FG002|Overall Study|Withdrawal by Subject|0|||
124900228|NCT02701361|449259544|FG000|Overall Study|timed out in rehab center|0|||
124900229|NCT02701361|449259545|FG001|Overall Study|timed out in rehab center|1|||
124900230|NCT02701361|449259546|FG002|Overall Study|timed out in rehab center|0|||
124900231|NCT02701361|449259544|FG000|Overall Study|incarceration|0|||
124900232|NCT02701361|449259545|FG001|Overall Study|incarceration|0|||
124900233|NCT02701361|449259546|FG002|Overall Study|incarceration|1|||
124900234|NCT04588480|449259547|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
124900235|NCT04588480|449259548|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
124900236|NCT04588480|449259549|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
124900237|NCT04588480|449259547|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
124900238|NCT04588480|449259548|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
124900239|NCT04588480|449259549|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
124900240|NCT00246012|449259550|FG000|Overall Study|Adverse Event|0|||
124900241|NCT00246012|449259551|FG001|Overall Study|Adverse Event|0|||
124900242|NCT00246012|449259552|FG002|Overall Study|Adverse Event|0|||
124900243|NCT00246012|449259553|FG003|Overall Study|Adverse Event|0|||
124900244|NCT00246012|449259554|FG004|Overall Study|Adverse Event|0|||
124900245|NCT00246012|449259555|FG005|Overall Study|Adverse Event|1|||
124900246|NCT00246012|449259556|FG006|Overall Study|Adverse Event|0|||
124900247|NCT00246012|449259557|FG007|Overall Study|Adverse Event|0|||
124900248|NCT00246012|449259558|FG008|Overall Study|Adverse Event|2|||
124900249|NCT00246012|449259550|FG000|Overall Study|Withdrawal by Subject|0|||
124900250|NCT00246012|449259551|FG001|Overall Study|Withdrawal by Subject|0|||
124900251|NCT00246012|449259552|FG002|Overall Study|Withdrawal by Subject|0|||
124900252|NCT00246012|449259553|FG003|Overall Study|Withdrawal by Subject|0|||
124900253|NCT00246012|449259554|FG004|Overall Study|Withdrawal by Subject|0|||
124900254|NCT00246012|449259555|FG005|Overall Study|Withdrawal by Subject|1|||
124900255|NCT00246012|449259556|FG006|Overall Study|Withdrawal by Subject|0|||
124900256|NCT00246012|449259557|FG007|Overall Study|Withdrawal by Subject|0|||
124900257|NCT00246012|449259558|FG008|Overall Study|Withdrawal by Subject|0|||
124900258|NCT00246012|449259550|FG000|Overall Study|Disease progression|3|||
124900259|NCT00246012|449259551|FG001|Overall Study|Disease progression|1|||
124900260|NCT00246012|449259552|FG002|Overall Study|Disease progression|2|||
124900261|NCT00246012|449259553|FG003|Overall Study|Disease progression|3|||
124900262|NCT00246012|449259554|FG004|Overall Study|Disease progression|3|||
124900263|NCT00246012|449259555|FG005|Overall Study|Disease progression|25|||
124900264|NCT00246012|449259556|FG006|Overall Study|Disease progression|30|||
124900265|NCT00246012|449259557|FG007|Overall Study|Disease progression|27|||
124900266|NCT00246012|449259558|FG008|Overall Study|Disease progression|26|||
124900267|NCT00246012|449259550|FG000|Overall Study|Other|0|||
124900268|NCT00246012|449259551|FG001|Overall Study|Other|0|||
124900269|NCT00246012|449259552|FG002|Overall Study|Other|0|||
124900270|NCT00246012|449259553|FG003|Overall Study|Other|0|||
124900271|NCT00246012|449259554|FG004|Overall Study|Other|0|||
124900272|NCT00246012|449259555|FG005|Overall Study|Other|0|||
124900273|NCT00246012|449259556|FG006|Overall Study|Other|0|||
124900274|NCT00246012|449259557|FG007|Overall Study|Other|1|||
124900275|NCT00246012|449259558|FG008|Overall Study|Other|0|||
124900276|NCT00246012|449259550|FG000|Overall Study|Randomly assigned but not treated|0|||
124900277|NCT00246012|449259551|FG001|Overall Study|Randomly assigned but not treated|0|||
124900278|NCT00246012|449259552|FG002|Overall Study|Randomly assigned but not treated|0|||
124900279|NCT00246012|449259553|FG003|Overall Study|Randomly assigned but not treated|0|||
124900280|NCT00246012|449259554|FG004|Overall Study|Randomly assigned but not treated|0|||
124900281|NCT00246012|449259555|FG005|Overall Study|Randomly assigned but not treated|1|||
124900282|NCT00246012|449259556|FG006|Overall Study|Randomly assigned but not treated|1|||
124900283|NCT00246012|449259557|FG007|Overall Study|Randomly assigned but not treated|0|||
124900284|NCT00246012|449259558|FG008|Overall Study|Randomly assigned but not treated|0|||
124900285|NCT01242085|449259559|FG000|Overall Study|Withdrawal by Subject|4|||
124900286|NCT01242085|449259560|FG001|Overall Study|Withdrawal by Subject|2|||
124900287|NCT01242085|449259561|FG002|Overall Study|Withdrawal by Subject|0|||
124900288|NCT01242085|449259559|FG000|Overall Study|medically unable to have surgery|4|||
124900289|NCT01242085|449259560|FG001|Overall Study|medically unable to have surgery|5|||
124900290|NCT01242085|449259561|FG002|Overall Study|medically unable to have surgery|0|||
124900291|NCT01178762|449259562|FG000|Overall Study|Lost to Follow-up|15|||
124900292|NCT01651949|449259571|FG000|Overall Study|Unknown status|4|||
124900293|NCT01651949|449259572|FG001|Overall Study|Unknown status|4|||
124900294|NCT01651949|449259573|FG002|Overall Study|Unknown status|0|||
124900295|NCT01651949|449259571|FG000|Overall Study|Lost to Follow-up|30|||
124900296|NCT01651949|449259572|FG001|Overall Study|Lost to Follow-up|56|||
124900297|NCT01651949|449259573|FG002|Overall Study|Lost to Follow-up|20|||
124900298|NCT01651949|449259571|FG000|Overall Study|Protocol Violation|0|||
124900299|NCT01651949|449259572|FG001|Overall Study|Protocol Violation|2|||
124900300|NCT01651949|449259573|FG002|Overall Study|Protocol Violation|1|||
124900301|NCT01651949|449259571|FG000|Overall Study|Physician Decision|0|||
124900302|NCT01651949|449259572|FG001|Overall Study|Physician Decision|2|||
124900303|NCT01651949|449259573|FG002|Overall Study|Physician Decision|0|||
124900304|NCT01651949|449259571|FG000|Overall Study|Adverse Event|0|||
124900305|NCT01651949|449259572|FG001|Overall Study|Adverse Event|2|||
124900306|NCT01651949|449259573|FG002|Overall Study|Adverse Event|1|||
124900307|NCT01651949|449259571|FG000|Overall Study|Screen failure|2|||
124900308|NCT01651949|449259572|FG001|Overall Study|Screen failure|2|||
124900309|NCT01651949|449259573|FG002|Overall Study|Screen failure|0|||
124900310|NCT01651949|449259571|FG000|Overall Study|Withdrawal by Subject|17|||
124900311|NCT01651949|449259572|FG001|Overall Study|Withdrawal by Subject|18|||
124900312|NCT01651949|449259573|FG002|Overall Study|Withdrawal by Subject|9|||
124900313|NCT01806714|449259574|FG000|Overall Study|No functioning phone number|200|||
124900314|NCT01806714|449259575|FG001|Overall Study|No functioning phone number|170|||
124900315|NCT02469064|449259576|FG000|Overall Study|Request not to receive intervention.|1|||
124900316|NCT02469064|449259577|FG001|Overall Study|Request not to receive intervention.|3|||
124900317|NCT00678795|449259578|FG000|Overall Study|Adverse Event|7|||
124900318|NCT00678795|449259579|FG001|Overall Study|Adverse Event|3|||
124900319|NCT00678795|449259578|FG000|Overall Study|Withdrawal by Subject|3|||
124900320|NCT00678795|449259579|FG001|Overall Study|Withdrawal by Subject|0|||
124900321|NCT00678795|449259578|FG000|Overall Study|Protocol Violation|0|||
124900322|NCT00678795|449259579|FG001|Overall Study|Protocol Violation|1|||
124900323|NCT00678795|449259578|FG000|Overall Study|Lost to Follow-up|0|||
124900324|NCT00678795|449259579|FG001|Overall Study|Lost to Follow-up|1|||
124900325|NCT00678795|449259578|FG000|Overall Study|Lack of Efficacy|1|||
124900326|NCT00678795|449259579|FG001|Overall Study|Lack of Efficacy|1|||
124900327|NCT02750709|449259580|FG000|Treatment Period 1|Adverse Event|0|||
124900328|NCT02750709|449259581|FG001|Treatment Period 1|Adverse Event|0|||
124900329|NCT02750709|449259582|FG002|Treatment Period 1|Adverse Event|0|||
124759825|NCT02159066|448744771|FG001|Part II|Adverse Event|0|||
124900330|NCT02750709|449259583|FG003|Treatment Period 1|Adverse Event|0|||
124900331|NCT02750709|449259584|FG004|Treatment Period 1|Adverse Event|0|||
124900332|NCT02750709|449259585|FG005|Treatment Period 1|Adverse Event|1|||
124900333|NCT00404079|449259587|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
124900334|NCT00404079|449259588|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
124900335|NCT01120275|449259589|FG000|Overall Study|Adverse Event|3|||
124900336|NCT01120275|449259589|FG000|Overall Study|Progression|27|||
124900337|NCT01120275|449259589|FG000|Overall Study|Ineligible|3|||
124900338|NCT01120275|449259589|FG000|Overall Study|Withdrawal by Subject|1|||
124900339|NCT01120275|449259589|FG000|Overall Study|Refusal|1|||
124900340|NCT01120275|449259589|FG000|Overall Study|Not specific|1|||
124900341|NCT02595398|449259590|FG000|Overall Study|Non-compliance|1|||
124900342|NCT02595398|449259591|FG001|Overall Study|Non-compliance|0|||
124900343|NCT02595398|449259590|FG000|Overall Study|Withdrawal by Subject|2|||
124900344|NCT02595398|449259591|FG001|Overall Study|Withdrawal by Subject|1|||
124900345|NCT02595398|449259590|FG000|Overall Study|Lost to Follow-up|1|||
124900346|NCT02595398|449259591|FG001|Overall Study|Lost to Follow-up|0|||
124900347|NCT00197015|449259594|FG000|Overall Study|Adverse Event|3|||
124900348|NCT00197015|449259595|FG001|Overall Study|Adverse Event|0|||
124900349|NCT00197015|449259596|FG002|Overall Study|Adverse Event|1|||
124900350|NCT00197015|449259594|FG000|Overall Study|Protocol Violation|0|||
124900351|NCT00197015|449259595|FG001|Overall Study|Protocol Violation|3|||
124900352|NCT00197015|449259596|FG002|Overall Study|Protocol Violation|3|||
124900353|NCT00197015|449259594|FG000|Overall Study|Withdrawal by Subject|17|||
124900354|NCT00197015|449259595|FG001|Overall Study|Withdrawal by Subject|37|||
124900355|NCT00197015|449259596|FG002|Overall Study|Withdrawal by Subject|34|||
124900356|NCT00197015|449259594|FG000|Overall Study|Lost to Follow-up|28|||
124900357|NCT00197015|449259595|FG001|Overall Study|Lost to Follow-up|46|||
124900358|NCT00197015|449259596|FG002|Overall Study|Lost to Follow-up|37|||
124900359|NCT00197015|449259594|FG000|Overall Study|Other|2|||
124900360|NCT00197015|449259595|FG001|Overall Study|Other|3|||
124900361|NCT00197015|449259596|FG002|Overall Study|Other|2|||
124900362|NCT00880906|449259597|FG000|Overall Study|Lost to Follow-up|0|||
124900363|NCT00880906|449259598|FG001|Overall Study|Lost to Follow-up|1|||
124900364|NCT00880906|449259597|FG000|Overall Study|Did not meet criteria following patholog|12|||
124900365|NCT00880906|449259598|FG001|Overall Study|Did not meet criteria following patholog|6|||
124900366|NCT02982213|449259605|FG000|Overall Study|Did not complete follow up questionnaire|5|||
124900367|NCT02982213|449259606|FG001|Overall Study|Did not complete follow up questionnaire|1|||
124900368|NCT01549652|449259607|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
124900369|NCT01549652|449259608|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
124900370|NCT01549652|449259609|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
124900371|NCT01549652|449259610|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
124900372|NCT01549652|449259607|FG000|Overall Study|Study Drug Titration Failure|5|||
124900373|NCT01549652|449259608|FG001|Overall Study|Study Drug Titration Failure|6|||
124900374|NCT01549652|449259609|FG002|Overall Study|Study Drug Titration Failure|0|||
124900375|NCT01549652|449259610|FG003|Overall Study|Study Drug Titration Failure|0|||
124900376|NCT01549652|449259607|FG000|Overall Study|Withdrawal Effect|0|||
124900377|NCT01549652|449259608|FG001|Overall Study|Withdrawal Effect|2|||
124900378|NCT01549652|449259609|FG002|Overall Study|Withdrawal Effect|0|||
124900379|NCT01549652|449259610|FG003|Overall Study|Withdrawal Effect|0|||
124900380|NCT01549652|449259607|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
124900381|NCT01549652|449259608|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
124900382|NCT01549652|449259609|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
124900383|NCT01549652|449259610|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
124900384|NCT01549652|449259607|FG000|Overall Study|Problem with Infusion|1|||
124900385|NCT01549652|449259608|FG001|Overall Study|Problem with Infusion|0|||
124900386|NCT01549652|449259609|FG002|Overall Study|Problem with Infusion|0|||
124900387|NCT01549652|449259610|FG003|Overall Study|Problem with Infusion|0|||
124900388|NCT01549652|449259607|FG000|Overall Study|Titration Non-Compliance|1|||
124900389|NCT01549652|449259608|FG001|Overall Study|Titration Non-Compliance|3|||
124900390|NCT01549652|449259609|FG002|Overall Study|Titration Non-Compliance|4|||
124900391|NCT01549652|449259610|FG003|Overall Study|Titration Non-Compliance|5|||
124900392|NCT01549652|449259607|FG000|Overall Study|Titration Side Effects|0|||
124900393|NCT01549652|449259608|FG001|Overall Study|Titration Side Effects|0|||
124900394|NCT01549652|449259609|FG002|Overall Study|Titration Side Effects|6|||
124900395|NCT01549652|449259610|FG003|Overall Study|Titration Side Effects|3|||
124900396|NCT01549652|449259607|FG000|Overall Study|Withdrawal by Subject|0|||
124900397|NCT01549652|449259608|FG001|Overall Study|Withdrawal by Subject|0|||
124900398|NCT01549652|449259609|FG002|Overall Study|Withdrawal by Subject|5|||
124900399|NCT01549652|449259610|FG003|Overall Study|Withdrawal by Subject|3|||
124900400|NCT01972152|449259611|FG000|First Treatment Visit|Lost to Follow-up|0|||
124900401|NCT01972152|449259612|FG001|First Treatment Visit|Lost to Follow-up|1|||
124900402|NCT01972152|449259613|FG002|First Treatment Visit|Lost to Follow-up|0|||
124900403|NCT01972152|449259614|FG003|First Treatment Visit|Lost to Follow-up|0|||
124900404|NCT01972152|449259615|FG004|First Treatment Visit|Lost to Follow-up|0|||
124900405|NCT01972152|449259616|FG005|First Treatment Visit|Lost to Follow-up|0|||
124900406|NCT01972152|449259611|FG000|Second Treatment Visit|Protocol Violation|0|||
124900407|NCT01972152|449259612|FG001|Second Treatment Visit|Protocol Violation|1|||
124900408|NCT01972152|449259613|FG002|Second Treatment Visit|Protocol Violation|0|||
124900409|NCT01972152|449259614|FG003|Second Treatment Visit|Protocol Violation|0|||
124900410|NCT01972152|449259615|FG004|Second Treatment Visit|Protocol Violation|0|||
124900411|NCT01972152|449259616|FG005|Second Treatment Visit|Protocol Violation|0|||
124900412|NCT00559949|449259617|FG000|Overall Study|Progressive Disease during cycle 1|1|||
124900413|NCT00559949|449259617|FG000|Overall Study|Adverse Event|1|||
124900414|NCT00559949|449259617|FG000|Overall Study|Withdrawal by Subject|4|||
124900415|NCT00559949|449259617|FG000|Overall Study|No disease evaluation per protocol|1|||
124900416|NCT00414648|449259620|FG000|Overall Study|Adverse Event|5|||
124900417|NCT00414648|449259621|FG001|Overall Study|Adverse Event|5|||
124900418|NCT00414648|449259620|FG000|Overall Study|Death|0|||
124900419|NCT00414648|449259621|FG001|Overall Study|Death|1|||
124900420|NCT00414648|449259620|FG000|Overall Study|Lack of Efficacy|0|||
124900421|NCT00414648|449259621|FG001|Overall Study|Lack of Efficacy|2|||
124900422|NCT00414648|449259620|FG000|Overall Study|Withdrawal by Subject|0|||
124900423|NCT00414648|449259621|FG001|Overall Study|Withdrawal by Subject|1|||
124900424|NCT01194258|449259622|FG000|Titration Period|Withdrawal by Subject|6|||
124900425|NCT01194258|449259623|FG001|Titration Period|Withdrawal by Subject|0|||
124900426|NCT01194258|449259624|FG002|Titration Period|Withdrawal by Subject|0|||
124900427|NCT01194258|449259625|FG003|Titration Period|Withdrawal by Subject|0|||
124900428|NCT01194258|449259626|FG004|Titration Period|Withdrawal by Subject|0|||
124900429|NCT01194258|449259622|FG000|Titration Period|Lost to Follow-up|2|||
124900430|NCT01194258|449259623|FG001|Titration Period|Lost to Follow-up|0|||
124691033|NCT00441896|448488074|FG004|Overall Study|Other|1|||
124691034|NCT00441896|448488075|FG005|Overall Study|Other|0|||
124900431|NCT01194258|449259624|FG002|Titration Period|Lost to Follow-up|0|||
124900432|NCT01194258|449259625|FG003|Titration Period|Lost to Follow-up|0|||
124900433|NCT01194258|449259626|FG004|Titration Period|Lost to Follow-up|0|||
124900434|NCT01194258|449259622|FG000|Titration Period|Titration failure|3|||
124900435|NCT01194258|449259623|FG001|Titration Period|Titration failure|0|||
124900436|NCT01194258|449259624|FG002|Titration Period|Titration failure|0|||
124900437|NCT01194258|449259625|FG003|Titration Period|Titration failure|0|||
124900438|NCT01194258|449259626|FG004|Titration Period|Titration failure|0|||
124900439|NCT01194258|449259622|FG000|Period 1 (12 Weeks)|Death|0|||
124900440|NCT01194258|449259623|FG001|Period 1 (12 Weeks)|Death|0|||
124900441|NCT01194258|449259624|FG002|Period 1 (12 Weeks)|Death|0|||
124691035|NCT00441896|448488076|FG006|Overall Study|Other|0|||
124900442|NCT01194258|449259625|FG003|Period 1 (12 Weeks)|Death|0|||
124900443|NCT01194258|449259626|FG004|Period 1 (12 Weeks)|Death|1|||
124900444|NCT01194258|449259622|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
124900445|NCT01194258|449259623|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
124900446|NCT01194258|449259624|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
124900447|NCT01194258|449259625|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
124900448|NCT01194258|449259626|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
124900449|NCT01194258|449259622|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
124900450|NCT01194258|449259623|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
124900451|NCT01194258|449259624|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
124900452|NCT01194258|449259625|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
124900453|NCT01194258|449259626|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
124900454|NCT01194258|449259622|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124900455|NCT01194258|449259623|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
124900456|NCT01194258|449259624|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
124900457|NCT01194258|449259625|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124900458|NCT01194258|449259626|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124900459|NCT03523962|449259627|FG000|Closed Fractures|Death|86|||
124900460|NCT03523962|449259628|FG001|Closed Fractures|Death|71|||
124900461|NCT03523962|449259629|FG002|Closed Fractures|Death|0|||
124900462|NCT03523962|449259630|FG003|Closed Fractures|Death|0|||
124900463|NCT03523962|449259627|FG000|Closed Fractures|Lost to Follow-up|62|||
124900464|NCT03523962|449259628|FG001|Closed Fractures|Lost to Follow-up|36|||
124900465|NCT03523962|449259629|FG002|Closed Fractures|Lost to Follow-up|0|||
124900466|NCT03523962|449259630|FG003|Closed Fractures|Lost to Follow-up|0|||
124900467|NCT03523962|449259627|FG000|Closed Fractures|Withdrawal by Subject|19|||
124900468|NCT03523962|449259628|FG001|Closed Fractures|Withdrawal by Subject|29|||
124900469|NCT03523962|449259629|FG002|Closed Fractures|Withdrawal by Subject|0|||
124900470|NCT03523962|449259630|FG003|Closed Fractures|Withdrawal by Subject|0|||
124900471|NCT03523962|449259627|FG000|Closed Fractures|Incarceration|1|||
124900472|NCT03523962|449259628|FG001|Closed Fractures|Incarceration|4|||
124900473|NCT03523962|449259629|FG002|Closed Fractures|Incarceration|0|||
124900474|NCT03523962|449259630|FG003|Closed Fractures|Incarceration|0|||
124900475|NCT03523962|449259627|FG000|Open Fractures|Death|0|||
124900476|NCT03523962|449259628|FG001|Open Fractures|Death|0|||
124900477|NCT03523962|449259629|FG002|Open Fractures|Death|11|||
124900478|NCT03523962|449259630|FG003|Open Fractures|Death|6|||
124900479|NCT03523962|449259627|FG000|Open Fractures|Lost to Follow-up|0|||
124900480|NCT03523962|449259628|FG001|Open Fractures|Lost to Follow-up|0|||
124900481|NCT03523962|449259629|FG002|Open Fractures|Lost to Follow-up|15|||
124900482|NCT03523962|449259630|FG003|Open Fractures|Lost to Follow-up|8|||
124900483|NCT03523962|449259627|FG000|Open Fractures|Withdrawal by Subject|0|||
124900484|NCT03523962|449259628|FG001|Open Fractures|Withdrawal by Subject|0|||
124900485|NCT03523962|449259629|FG002|Open Fractures|Withdrawal by Subject|6|||
124900486|NCT03523962|449259630|FG003|Open Fractures|Withdrawal by Subject|2|||
124900487|NCT03523962|449259627|FG000|Open Fractures|Incarceration|0|||
124900488|NCT03523962|449259628|FG001|Open Fractures|Incarceration|0|||
124900489|NCT03523962|449259629|FG002|Open Fractures|Incarceration|1|||
124900490|NCT03523962|449259630|FG003|Open Fractures|Incarceration|0|||
124900491|NCT03098030|449259631|FG000|Overall Study|Death|10|||
124900492|NCT03098030|449259632|FG001|Overall Study|Death|156|||
124900493|NCT03098030|449259633|FG002|Overall Study|Death|156|||
124900494|NCT03098030|449259634|FG003|Overall Study|Death|82|||
124900495|NCT03098030|449259631|FG000|Overall Study|Withdrawal by Subject|0|||
124900496|NCT03098030|449259632|FG001|Overall Study|Withdrawal by Subject|7|||
124900497|NCT03098030|449259633|FG002|Overall Study|Withdrawal by Subject|8|||
124900498|NCT03098030|449259634|FG003|Overall Study|Withdrawal by Subject|2|||
124447746|NCT04178967|447602781|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124447747|NCT04178967|447602782|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124447748|NCT04178967|447602783|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124447749|NCT04178967|447602784|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
124900499|NCT03098030|449259631|FG000|Overall Study|Lost to Follow-up|0|||
124900500|NCT03098030|449259632|FG001|Overall Study|Lost to Follow-up|0|||
124900501|NCT03098030|449259633|FG002|Overall Study|Lost to Follow-up|2|||
124900502|NCT03098030|449259634|FG003|Overall Study|Lost to Follow-up|1|||
124900503|NCT01726023|449259635|FG000|Overall Study|Death|1|||
124900504|NCT01726023|449259636|FG001|Overall Study|Death|1|||
124900505|NCT01726023|449259635|FG000|Overall Study|Lost to Follow-up|5|||
124900506|NCT01726023|449259636|FG001|Overall Study|Lost to Follow-up|10|||
124900507|NCT01726023|449259635|FG000|Overall Study|Other Eligibility criteria|7|||
124900508|NCT01726023|449259636|FG001|Overall Study|Other Eligibility criteria|7|||
124900509|NCT01726023|449259635|FG000|Overall Study|Withdrawal by Subject|16|||
124447750|NCT04178967|447602785|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124900510|NCT01726023|449259636|FG001|Overall Study|Withdrawal by Subject|8|||
124900511|NCT03394027|449259639|FG000|Overall Study|Ineligible|3|||
124900512|NCT03394027|449259640|FG001|Overall Study|Ineligible|1|||
124900513|NCT03394027|449259641|FG002|Overall Study|Ineligible|3|||
124900514|NCT03394027|449259639|FG000|Overall Study|Participant declined to participate before treatment started|0|||
124900515|NCT03394027|449259640|FG001|Overall Study|Participant declined to participate before treatment started|0|||
124900516|NCT03394027|449259641|FG002|Overall Study|Participant declined to participate before treatment started|1|||
124447751|NCT04178967|447602786|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124691036|NCT00441896|448488077|FG007|Overall Study|Other|0|||
124447752|NCT04178967|447602787|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124447753|NCT04178967|447602788|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124447754|NCT04178967|447602789|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124447755|NCT04178967|447602779|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124447756|NCT04178967|447602780|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124447757|NCT04178967|447602781|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124447758|NCT04178967|447602782|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
124447759|NCT04178967|447602783|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124447760|NCT04178967|447602784|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124447761|NCT04178967|447602785|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124447762|NCT04178967|447602786|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124447763|NCT04178967|447602787|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124447764|NCT04178967|447602788|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124447765|NCT04178967|447602789|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124447766|NCT04178967|447602779|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
124447767|NCT04178967|447602780|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
124447768|NCT04178967|447602781|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
124447769|NCT04178967|447602782|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
124447770|NCT04178967|447602783|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
124447771|NCT04178967|447602784|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
124447772|NCT04178967|447602785|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
124447773|NCT04178967|447602786|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
124447774|NCT04178967|447602787|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
124447775|NCT04178967|447602788|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
124447776|NCT04178967|447602789|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
124447777|NCT04178967|447602779|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
124447778|NCT04178967|447602780|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
124447779|NCT04178967|447602781|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
124447780|NCT04178967|447602782|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
124447781|NCT04178967|447602783|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
124447782|NCT04178967|447602784|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
124447783|NCT04178967|447602785|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
124447784|NCT04178967|447602786|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
124447785|NCT04178967|447602787|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
124447786|NCT04178967|447602788|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
124447787|NCT04178967|447602789|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
124447788|NCT04178967|447602779|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
124447789|NCT04178967|447602780|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
124447790|NCT04178967|447602781|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
124447791|NCT04178967|447602782|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
124447792|NCT04178967|447602783|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
124447793|NCT04178967|447602784|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
124447794|NCT04178967|447602785|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
124447795|NCT04178967|447602786|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
124447796|NCT04178967|447602787|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
124447797|NCT04178967|447602788|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
124447798|NCT04178967|447602789|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
124447799|NCT04178967|447602779|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
124447800|NCT04178967|447602780|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
124447801|NCT04178967|447602781|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
124447802|NCT04178967|447602782|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
124447803|NCT04178967|447602783|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
124447804|NCT04178967|447602784|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
124447805|NCT04178967|447602785|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
124447806|NCT04178967|447602786|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
124447807|NCT04178967|447602787|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
124447808|NCT04178967|447602788|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
124447809|NCT04178967|447602789|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
124691037|NCT00441896|448488078|FG008|Overall Study|Other|0|||
124691038|NCT00441896|448488079|FG009|Overall Study|Other|0|||
124447810|NCT04178967|447602779|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
124447811|NCT04178967|447602780|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
124447812|NCT04178967|447602781|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
124691039|NCT01301092|448488080|FG000|Overall Study|Lost to Follow-up|0|||
124691040|NCT01301092|448488081|FG001|Overall Study|Lost to Follow-up|0|||
124900522|NCT03643211|449259643|FG000|Overall Study|Contract violation/deficiency|12|||
124900523|NCT03643211|449259643|FG000|Overall Study|Invalid registration|3|||
124900524|NCT03643211|449259643|FG000|Overall Study|No treatment information|2|||
124900525|NCT03643211|449259643|FG000|Overall Study|No adverse event information - No revisit|4|||
124900526|NCT04858425|449259644|FG000|Overall Study|Adverse Event|2|||
124900527|NCT04858425|449259645|FG001|Overall Study|Adverse Event|2|||
124900528|NCT04858425|449259644|FG000|Overall Study|Withdrawal by Subject|3|||
124900529|NCT04858425|449259645|FG001|Overall Study|Withdrawal by Subject|1|||
124900530|NCT04858425|449259644|FG000|Overall Study|Lost to Follow-up|4|||
124900531|NCT04858425|449259645|FG001|Overall Study|Lost to Follow-up|2|||
124900532|NCT04858425|449259644|FG000|Overall Study|Lost to Follow-up|1|||
124900533|NCT04858425|449259645|FG001|Overall Study|Lost to Follow-up|0|||
124900534|NCT03368001|449259648|FG000|Allocation|Lost to Pretest|16|||
124900535|NCT03368001|449259649|FG001|Allocation|Lost to Pretest|25|||
124900536|NCT03368001|449259648|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
124900537|NCT03368001|449259649|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
124900538|NCT03368001|449259648|FG000|Posttest|Lost to Posttest|7|||
124900539|NCT03368001|449259649|FG001|Posttest|Lost to Posttest|11|||
124900540|NCT03368001|449259648|FG000|Posttest|Discontinued Intervention|6|||
124900541|NCT03368001|449259649|FG001|Posttest|Discontinued Intervention|19|||
124900542|NCT03368001|449259648|FG000|Follow-up|Lost to Follow-up|6|||
124900543|NCT03368001|449259649|FG001|Follow-up|Lost to Follow-up|3|||
124900544|NCT00604721|449259656|FG000|Overall Study|Physician Decision|1|||
124900545|NCT00604721|449259656|FG000|Overall Study|Withdrawal by Subject|1|||
124900546|NCT04776213|449259657|FG000|Overall Study|Other|1|||
124900547|NCT04776213|449259657|FG000|Overall Study|Withdrawal by Subject|7|||
124900548|NCT04776213|449259657|FG000|Overall Study|Protocol Violation|1|||
124900549|NCT04776213|449259657|FG000|Overall Study|Lost to Follow-up|2|||
124900550|NCT02317016|449259658|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
124900551|NCT02317016|449259658|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
124900552|NCT02317016|449259658|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
124900553|NCT02317016|449259658|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
124900554|NCT02317016|449259658|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
124900555|NCT02317016|449259658|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
124900556|NCT02317016|449259658|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
124900557|NCT00536380|449259659|FG000|Overall Study|Adverse Event|0|||
124900558|NCT00536380|449259660|FG001|Overall Study|Adverse Event|2|||
124900559|NCT00536380|449259661|FG002|Overall Study|Adverse Event|2|||
124900560|NCT00536380|449259659|FG000|Overall Study|Lost to Follow-up|0|||
124900561|NCT00536380|449259660|FG001|Overall Study|Lost to Follow-up|0|||
124900562|NCT00536380|449259661|FG002|Overall Study|Lost to Follow-up|1|||
124900563|NCT00536380|449259659|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
124900564|NCT00536380|449259660|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
124900565|NCT00536380|449259661|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
124900566|NCT00536380|449259659|FG000|Overall Study|Withdrawal related to study drug|7|||
124900567|NCT00536380|449259660|FG001|Overall Study|Withdrawal related to study drug|5|||
124900568|NCT00536380|449259661|FG002|Overall Study|Withdrawal related to study drug|2|||
124900569|NCT00536380|449259659|FG000|Overall Study|Noncompliance with protocol|3|||
124691041|NCT01301092|448488082|FG002|Overall Study|Lost to Follow-up|1|||
124900570|NCT00536380|449259660|FG001|Overall Study|Noncompliance with protocol|2|||
124900571|NCT00536380|449259661|FG002|Overall Study|Noncompliance with protocol|2|||
124900572|NCT00536380|449259659|FG000|Overall Study|Did not meet protocol eligibility|0|||
124900573|NCT00536380|449259660|FG001|Overall Study|Did not meet protocol eligibility|0|||
124900574|NCT00536380|449259661|FG002|Overall Study|Did not meet protocol eligibility|1|||
124900575|NCT00536380|449259659|FG000|Overall Study|Administrative|0|||
124900576|NCT00536380|449259660|FG001|Overall Study|Administrative|0|||
124900577|NCT00536380|449259661|FG002|Overall Study|Administrative|1|||
124900578|NCT02931396|449259665|FG000|Overall Study|Lost to Follow-up|3|||
124900579|NCT02931396|449259666|FG001|Overall Study|Lost to Follow-up|0|||
124900580|NCT02931396|449259665|FG000|Overall Study|Withdrawal by Subject|2|||
124900581|NCT02931396|449259666|FG001|Overall Study|Withdrawal by Subject|0|||
124900582|NCT02132702|449259667|FG000|Overall Study|Protocol Violation|2|||
124900583|NCT02132702|449259667|FG000|Overall Study|Adverse Event|3|||
124900584|NCT02132702|449259667|FG000|Overall Study|Withdrawal by Subject|3|||
124900585|NCT02738840|449261313|FG000|Overall Study|MRI Scan not Performed|5|||
124900586|NCT02738840|449261313|FG000|Overall Study|Lost to Follow-up|1|||
124900587|NCT02738840|449261313|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
124900588|NCT02738840|449261313|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
124900589|NCT01311648|449261316|FG000|Main Study|Protocol Violation|0|||
124900590|NCT01311648|449261317|FG001|Main Study|Protocol Violation|1|||
124900591|NCT01311648|449261316|FG000|Main Study|Adverse Event|0|||
124900592|NCT01311648|449261317|FG001|Main Study|Adverse Event|1|||
124900593|NCT01311648|449261316|FG000|Main Study|Inhibitor management|0|||
124900594|NCT01311648|449261317|FG001|Main Study|Inhibitor management|17|||
124900595|NCT01311648|449261316|FG000|Main Study|Withdrawal by Subject|0|||
124900596|NCT01311648|449261317|FG001|Main Study|Withdrawal by Subject|2|||
124900597|NCT01311648|449261316|FG000|Extension Study|Physician Decision|0|||
124900598|NCT01311648|449261317|FG001|Extension Study|Physician Decision|1|||
124900599|NCT01311648|449261316|FG000|Extension Study|ITI therapy with marketed product|0|||
124900600|NCT01311648|449261317|FG001|Extension Study|ITI therapy with marketed product|1|||
124900601|NCT01311648|449261316|FG000|Extension Study|Incorrect visit planning|0|||
124900602|NCT01311648|449261317|FG001|Extension Study|Incorrect visit planning|1|||
124900603|NCT01311648|449261316|FG000|Extension Study|Family's decision|0|||
124900604|NCT01311648|449261317|FG001|Extension Study|Family's decision|1|||
124900605|NCT01311648|449261316|FG000|Extension Study|Failure of ITI therapy|0|||
124447813|NCT04178967|447602782|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
124447814|NCT04178967|447602783|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
124447815|NCT04178967|447602784|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
124447816|NCT04178967|447602785|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
124447817|NCT04178967|447602786|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
124447818|NCT04178967|447602787|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
124447819|NCT04178967|447602788|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
124447820|NCT04178967|447602789|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
124447821|NCT04178967|447602779|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124447822|NCT04178967|447602780|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124447823|NCT04178967|447602781|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124447824|NCT04178967|447602782|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124447825|NCT04178967|447602783|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124447826|NCT04178967|447602784|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124447827|NCT04178967|447602785|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124447828|NCT04178967|447602786|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124447829|NCT04178967|447602787|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
124447830|NCT04178967|447602788|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
124447831|NCT04178967|447602789|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
124447832|NCT04178967|447602779|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124900606|NCT01311648|449261317|FG001|Extension Study|Failure of ITI therapy|3|||
124900607|NCT01311648|449261316|FG000|Extension Study|Long travel|0|||
124900608|NCT01311648|449261317|FG001|Extension Study|Long travel|1|||
124691042|NCT03334175|448488083|FG000|Overall Study|Lost to Follow-up|0|||
124900609|NCT01311648|449261316|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
124900610|NCT01311648|449261317|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
124900611|NCT01311648|449261316|FG000|Extension Study|Withdrawal by Subject|0|||
124900612|NCT01311648|449261317|FG001|Extension Study|Withdrawal by Subject|1|||
124447833|NCT04178967|447602780|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124447834|NCT04178967|447602781|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124447835|NCT04178967|447602782|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124447836|NCT04178967|447602783|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124447837|NCT04178967|447602784|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124447838|NCT04178967|447602785|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124447839|NCT04178967|447602786|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124447840|NCT04178967|447602787|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124447841|NCT04178967|447602788|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
124447842|NCT04178967|447602789|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124447843|NCT04178967|447602779|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124447844|NCT04178967|447602780|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124447845|NCT04178967|447602781|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124447846|NCT04178967|447602782|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124447847|NCT04178967|447602783|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124447848|NCT04178967|447602784|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124447849|NCT04178967|447602785|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124447850|NCT04178967|447602786|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124759826|NCT02159066|448744772|FG002|Part II|Adverse Event|1|||
124759827|NCT02159066|448744773|FG003|Part II|Adverse Event|0|||
124759828|NCT02159066|448744774|FG004|Part II|Adverse Event|1|||
124759829|NCT02159066|448744775|FG005|Part II|Adverse Event|1|||
124759830|NCT02159066|448744770|FG000|Part II|Death|0|||
124759831|NCT02159066|448744771|FG001|Part II|Death|0|||
124759832|NCT02159066|448744772|FG002|Part II|Death|1|||
124759833|NCT02159066|448744773|FG003|Part II|Death|0|||
124759834|NCT02159066|448744774|FG004|Part II|Death|2|||
124759835|NCT02159066|448744775|FG005|Part II|Death|1|||
124759836|NCT02159066|448744770|FG000|Part II|Progressive Disease|0|||
124759837|NCT02159066|448744771|FG001|Part II|Progressive Disease|0|||
124759838|NCT02159066|448744772|FG002|Part II|Progressive Disease|35|||
124759839|NCT02159066|448744773|FG003|Part II|Progressive Disease|1|||
124759840|NCT02159066|448744774|FG004|Part II|Progressive Disease|7|||
124759841|NCT02159066|448744775|FG005|Part II|Progressive Disease|4|||
124759842|NCT02159066|448744770|FG000|Part II|New Therapy for Study Indication|0|||
124759843|NCT02159066|448744771|FG001|Part II|New Therapy for Study Indication|0|||
124759844|NCT02159066|448744772|FG002|Part II|New Therapy for Study Indication|0|||
124759845|NCT02159066|448744773|FG003|Part II|New Therapy for Study Indication|0|||
124759846|NCT02159066|448744774|FG004|Part II|New Therapy for Study Indication|1|||
124759847|NCT02159066|448744775|FG005|Part II|New Therapy for Study Indication|0|||
124759848|NCT02159066|448744770|FG000|Part II|Physician Decision|0|||
124759849|NCT02159066|448744771|FG001|Part II|Physician Decision|0|||
124759850|NCT02159066|448744772|FG002|Part II|Physician Decision|1|||
124900613|NCT01311648|449261316|FG000|Extension Study|Inhibitor management|0|||
124900614|NCT01311648|449261317|FG001|Extension Study|Inhibitor management|2|||
124900615|NCT01645111|449261318|FG000|Overall Study|Did not require Clevidipine|15|||
124900616|NCT04057196|449261319|FG000|Overall Study|Withdrawal by Subject|3|||
124900617|NCT04057196|449261319|FG000|Overall Study|Death|3|||
124900618|NCT01062126|449261320|FG000|Overall Study|Death|209|||
124447851|NCT04178967|447602787|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
124447852|NCT04178967|447602788|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
124447853|NCT04178967|447602789|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
124447854|NCT04178967|447602779|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
124447855|NCT04178967|447602780|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
124447856|NCT04178967|447602781|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
124447857|NCT04178967|447602782|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
124447858|NCT04178967|447602783|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
124447859|NCT04178967|447602784|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
124447860|NCT04178967|447602785|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
124447861|NCT04178967|447602786|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
124759851|NCT02159066|448744773|FG003|Part II|Physician Decision|0|||
124759852|NCT02159066|448744774|FG004|Part II|Physician Decision|0|||
124759853|NCT02159066|448744775|FG005|Part II|Physician Decision|0|||
124759854|NCT02159066|448744770|FG000|Part II|Participant/Guardian Decision|0|||
124759855|NCT02159066|448744771|FG001|Part II|Participant/Guardian Decision|0|||
124900619|NCT01062126|449261320|FG000|Overall Study|All Withdrawals|324|||
124900620|NCT03837028|449261323|FG000|Overall Study|Lost to Follow-up|4|||
124900621|NCT03837028|449261324|FG001|Overall Study|Lost to Follow-up|0|||
124447862|NCT04178967|447602787|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
124759856|NCT02159066|448744772|FG002|Part II|Participant/Guardian Decision|0|||
124759857|NCT02159066|448744773|FG003|Part II|Participant/Guardian Decision|0|||
124759858|NCT02159066|448744774|FG004|Part II|Participant/Guardian Decision|2|||
124759859|NCT02159066|448744775|FG005|Part II|Participant/Guardian Decision|0|||
124900622|NCT03837028|449261325|FG002|Overall Study|Lost to Follow-up|2|||
124900623|NCT03837028|449261326|FG003|Overall Study|Lost to Follow-up|0|||
124900624|NCT03837028|449261323|FG000|Overall Study|Withdrawal by Subject|12|||
124900625|NCT03837028|449261324|FG001|Overall Study|Withdrawal by Subject|11|||
124900626|NCT03837028|449261325|FG002|Overall Study|Withdrawal by Subject|11|||
124900627|NCT03837028|449261326|FG003|Overall Study|Withdrawal by Subject|7|||
124900628|NCT01091454|449261327|FG000|Overall Study|Ineligible|1|||
124900629|NCT00646451|449261328|FG000|Overall Study|Adverse Event|3|||
124900630|NCT00646451|449261329|FG001|Overall Study|Adverse Event|0|||
124900631|NCT00646451|449261328|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
124900632|NCT00646451|449261329|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
124900633|NCT01362491|449261330|FG000|Overall Study|Ineligible|1|||
124900634|NCT01362491|449261331|FG001|Overall Study|Ineligible|0|||
124900635|NCT01362491|449261332|FG002|Overall Study|Ineligible|0|||
124900636|NCT02030028|449261333|FG000|Overall Study|Withdrawal by Subject|4|||
124900637|NCT02030028|449261333|FG000|Overall Study|lack of transportation|1|||
124900638|NCT00567879|449261334|FG000|Overall Study|Adverse Event|2|||
124900639|NCT00567879|449261335|FG001|Overall Study|Adverse Event|0|||
124900640|NCT00567879|449261336|FG002|Overall Study|Adverse Event|1|||
124900641|NCT00567879|449261337|FG003|Overall Study|Adverse Event|0|||
124900642|NCT00567879|449261338|FG004|Overall Study|Adverse Event|1|||
124900643|NCT00567879|449261339|FG005|Overall Study|Adverse Event|0|||
124900644|NCT00567879|449261334|FG000|Overall Study|Abnormal test procedure(s)|0|||
124900645|NCT00567879|449261335|FG001|Overall Study|Abnormal test procedure(s)|0|||
124900646|NCT00567879|449261336|FG002|Overall Study|Abnormal test procedure(s)|1|||
124900647|NCT00567879|449261337|FG003|Overall Study|Abnormal test procedure(s)|0|||
124900648|NCT00567879|449261338|FG004|Overall Study|Abnormal test procedure(s)|0|||
124900649|NCT00567879|449261339|FG005|Overall Study|Abnormal test procedure(s)|0|||
124900650|NCT00567879|449261334|FG000|Overall Study|Withdrawal by Subject|0|||
124900651|NCT00567879|449261335|FG001|Overall Study|Withdrawal by Subject|0|||
124900652|NCT00567879|449261336|FG002|Overall Study|Withdrawal by Subject|3|||
124900653|NCT00567879|449261337|FG003|Overall Study|Withdrawal by Subject|1|||
124900654|NCT00567879|449261338|FG004|Overall Study|Withdrawal by Subject|0|||
124900655|NCT00567879|449261339|FG005|Overall Study|Withdrawal by Subject|0|||
124900656|NCT00567879|449261334|FG000|Overall Study|New cancer therapy|0|||
124900657|NCT00567879|449261335|FG001|Overall Study|New cancer therapy|0|||
124900658|NCT00567879|449261336|FG002|Overall Study|New cancer therapy|1|||
124900659|NCT00567879|449261337|FG003|Overall Study|New cancer therapy|0|||
124900660|NCT00567879|449261338|FG004|Overall Study|New cancer therapy|0|||
124900661|NCT00567879|449261339|FG005|Overall Study|New cancer therapy|0|||
124900662|NCT00567879|449261334|FG000|Overall Study|Disease progression|5|||
124900663|NCT00567879|449261335|FG001|Overall Study|Disease progression|7|||
124900664|NCT00567879|449261336|FG002|Overall Study|Disease progression|15|||
124447863|NCT04178967|447602788|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
124447864|NCT04178967|447602789|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
124447865|NCT04178967|447602779|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
124447866|NCT04178967|447602780|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
124447867|NCT04178967|447602781|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
124447868|NCT04178967|447602782|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
124447869|NCT04178967|447602783|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
124447870|NCT04178967|447602784|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
124447871|NCT04178967|447602785|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
124447872|NCT04178967|447602786|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
124447873|NCT04178967|447602787|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
124447874|NCT04178967|447602788|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
124447875|NCT04178967|447602789|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
124447876|NCT00628251|447602790|FG000|Randomised Part|Withdrawal by Subject|0|||
124447877|NCT00628251|447602791|FG001|Randomised Part|Withdrawal by Subject|0|||
124447878|NCT00628251|447602792|FG002|Randomised Part|Withdrawal by Subject|1|||
124447879|NCT00628251|447602790|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
124447880|NCT00628251|447602791|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
124447881|NCT00628251|447602792|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
124447882|NCT00628251|447602790|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
124900665|NCT00567879|449261337|FG003|Overall Study|Disease progression|5|||
124900666|NCT00567879|449261338|FG004|Overall Study|Disease progression|11|||
124900667|NCT00567879|449261339|FG005|Overall Study|Disease progression|3|||
124900668|NCT01249092|449261340|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
124900669|NCT01249092|449261340|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
124900670|NCT02930343|449261344|FG000|Overall Study|Lost to Follow-up|9|||
124900671|NCT02930343|449261345|FG001|Overall Study|Lost to Follow-up|7|||
124900672|NCT00954707|449261346|FG000|Overall Study|Death|34|||
124900673|NCT00954707|449261346|FG000|Overall Study|Withdrawal by Subject|100|||
124900674|NCT00954707|449261346|FG000|Overall Study|Lost to Follow-up|33|||
124900675|NCT02987543|449261349|FG000|Overall Study|Ongoing study at data cut off|49|||
124900676|NCT02987543|449261350|FG001|Overall Study|Ongoing study at data cut off|21|||
124900677|NCT02987543|449261351|FG002|Overall Study|Ongoing study at data cut off|19|||
124900678|NCT02987543|449261352|FG003|Overall Study|Ongoing study at data cut off|12|||
124900679|NCT02987543|449261349|FG000|Overall Study|Death|88|||
124900680|NCT02987543|449261350|FG001|Overall Study|Death|54|||
124900681|NCT02987543|449261351|FG002|Overall Study|Death|67|||
124900682|NCT02987543|449261352|FG003|Overall Study|Death|28|||
124900683|NCT02987543|449261349|FG000|Overall Study|Lost to Follow-up|3|||
124900684|NCT02987543|449261350|FG001|Overall Study|Lost to Follow-up|0|||
124900685|NCT02987543|449261351|FG002|Overall Study|Lost to Follow-up|1|||
124900686|NCT02987543|449261352|FG003|Overall Study|Lost to Follow-up|0|||
124900687|NCT02987543|449261349|FG000|Overall Study|Screen failure|0|||
124900688|NCT02987543|449261350|FG001|Overall Study|Screen failure|0|||
124900689|NCT02987543|449261351|FG002|Overall Study|Screen failure|0|||
124900690|NCT02987543|449261352|FG003|Overall Study|Screen failure|1|||
124900691|NCT02987543|449261349|FG000|Overall Study|Withdrawal by Subject|21|||
124900692|NCT02987543|449261350|FG001|Overall Study|Withdrawal by Subject|7|||
124900693|NCT02987543|449261351|FG002|Overall Study|Withdrawal by Subject|7|||
124900694|NCT02987543|449261352|FG003|Overall Study|Withdrawal by Subject|6|||
124900695|NCT02987543|449261349|FG000|Overall Study|Study terminated by sponsor|1|||
124900696|NCT02987543|449261350|FG001|Overall Study|Study terminated by sponsor|0|||
124900697|NCT02987543|449261351|FG002|Overall Study|Study terminated by sponsor|0|||
124900698|NCT02987543|449261352|FG003|Overall Study|Study terminated by sponsor|0|||
124900699|NCT02987543|449261349|FG000|Overall Study|Investigator decision|0|||
124900700|NCT02987543|449261350|FG001|Overall Study|Investigator decision|1|||
124900701|NCT02987543|449261351|FG002|Overall Study|Investigator decision|0|||
124900702|NCT02987543|449261352|FG003|Overall Study|Investigator decision|0|||
124900703|NCT02987543|449261349|FG000|Overall Study|Disease progression|0|||
124900704|NCT02987543|449261350|FG001|Overall Study|Disease progression|0|||
124900705|NCT02987543|449261351|FG002|Overall Study|Disease progression|0|||
124900706|NCT02987543|449261352|FG003|Overall Study|Disease progression|1|||
124900707|NCT00309452|449261353|FG000|Overall Study|Withdrawal by Subject|3|||
124900708|NCT00309452|449261354|FG001|Overall Study|Withdrawal by Subject|0|||
124900709|NCT01977612|449261355|FG000|Overall Study|Lost to Follow-up|1|||
124900710|NCT01977612|449261356|FG001|Overall Study|Lost to Follow-up|1|||
124900711|NCT01451814|449261357|FG000|Overall Study|Withdrawal by Subject|1|||
124900712|NCT01451814|449261358|FG001|Overall Study|Withdrawal by Subject|1|||
124900713|NCT01451814|449261357|FG000|Overall Study|Lost to Follow-up|5|||
124900714|NCT01451814|449261358|FG001|Overall Study|Lost to Follow-up|4|||
124900715|NCT01280591|449261360|FG000|Overall Study|Withdrawal by Subject|0|||
124900716|NCT01280591|449261361|FG001|Overall Study|Withdrawal by Subject|0|||
124900717|NCT01280591|449261362|FG002|Overall Study|Withdrawal by Subject|0|||
124900718|NCT01280591|449261363|FG003|Overall Study|Withdrawal by Subject|2|||
124900719|NCT01280591|449261360|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
124900720|NCT01280591|449261361|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
124900721|NCT01280591|449261362|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
124691043|NCT03334175|448488084|FG001|Overall Study|Lost to Follow-up|1|||
124691044|NCT01350973|448488088|FG000|Overall Study|Adverse Event|4|||
124691045|NCT01350973|448488089|FG001|Overall Study|Adverse Event|7|||
124691046|NCT01350973|448488090|FG002|Overall Study|Adverse Event|7|||
124691047|NCT01350973|448488088|FG000|Overall Study|Voluntary Withdrawal|2|||
124900722|NCT01280591|449261363|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
124900723|NCT01883492|449261364|FG000|Overall Study|Lost to Follow-up|3|||
124900724|NCT01883492|449261365|FG001|Overall Study|Lost to Follow-up|4|||
124900725|NCT01883492|449261364|FG000|Overall Study|Surgery on contra-lateral hip|0|||
124900726|NCT01883492|449261365|FG001|Overall Study|Surgery on contra-lateral hip|1|||
124900727|NCT01883492|449261364|FG000|Overall Study|Poor X-ray quality|7|||
124900728|NCT01883492|449261365|FG001|Overall Study|Poor X-ray quality|4|||
124900729|NCT01883492|449261364|FG000|Overall Study|Withdrawal by Subject|1|||
124900730|NCT01883492|449261365|FG001|Overall Study|Withdrawal by Subject|0|||
124900731|NCT01883492|449261364|FG000|Overall Study|inappropriate implant used|1|||
124900732|NCT01883492|449261365|FG001|Overall Study|inappropriate implant used|1|||
124900733|NCT01883492|449261364|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
124900734|NCT01883492|449261365|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
124900735|NCT03357341|449261366|FG000|Overall Study|Withdrawal by Subject|3|||
124900736|NCT03357341|449261367|FG001|Overall Study|Withdrawal by Subject|6|||
124900737|NCT03357341|449261366|FG000|Overall Study|Lost to Follow-up|4|||
124691048|NCT01350973|448488089|FG001|Overall Study|Voluntary Withdrawal|1|||
124691049|NCT01350973|448488090|FG002|Overall Study|Voluntary Withdrawal|1|||
124900738|NCT03357341|449261367|FG001|Overall Study|Lost to Follow-up|5|||
124900739|NCT03357341|449261366|FG000|Overall Study|Death|0|||
124900740|NCT03357341|449261367|FG001|Overall Study|Death|1|||
124900741|NCT01259102|449261368|FG000|Overall Study|Adverse Event|1|||
124900742|NCT01259102|449261369|FG001|Overall Study|Adverse Event|0|||
124900743|NCT01259102|449261370|FG002|Overall Study|Adverse Event|1|||
124900744|NCT01259102|449261371|FG003|Overall Study|Adverse Event|1|||
124900745|NCT01259102|449261372|FG004|Overall Study|Adverse Event|0|||
124900746|NCT01259102|449261368|FG000|Overall Study|Other|0|||
124900747|NCT01259102|449261369|FG001|Overall Study|Other|0|||
124900748|NCT01259102|449261370|FG002|Overall Study|Other|1|||
124900749|NCT01259102|449261371|FG003|Overall Study|Other|1|||
124447883|NCT00628251|447602791|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
124447884|NCT00628251|447602792|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
124447885|NCT00628251|447602790|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
124447886|NCT00628251|447602791|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
124447887|NCT00628251|447602792|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
124447888|NCT00628251|447602790|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
124447889|NCT00628251|447602791|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
124447890|NCT00628251|447602792|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
124447891|NCT00628251|447602790|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
124447892|NCT00628251|447602791|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
124447893|NCT00628251|447602792|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
124447894|NCT00041067|447602793|FG000|Overall Study|Adverse Event|20|||
124447895|NCT00041067|447602793|FG000|Overall Study|Progression|19|||
124447896|NCT00041067|447602793|FG000|Overall Study|Patient refusal|12|||
124447897|NCT00041067|447602793|FG000|Overall Study|Other reasons|23|||
124447898|NCT00041067|447602793|FG000|Overall Study|Ineligible|2|||
124447899|NCT00882310|447602796|FG000|Overall Study|Screen Failure|10|||
124447900|NCT00882310|447602796|FG000|Overall Study|Never received treatment|1|||
124447901|NCT00882310|447602796|FG000|Overall Study|Death|6|||
124447902|NCT00882310|447602796|FG000|Overall Study|Progression of disease|4|||
124447903|NCT00882310|447602796|FG000|Overall Study|Adverse Event|1|||
124447904|NCT04246801|447602799|FG000|Overall Study|Adverse Event|1|||
124447905|NCT04246801|447602800|FG001|Overall Study|Adverse Event|1|||
124447906|NCT04246801|447602799|FG000|Overall Study|Protocol Violation|1|||
124447907|NCT04246801|447602800|FG001|Overall Study|Protocol Violation|1|||
124447908|NCT04246801|447602799|FG000|Overall Study|Lack of Efficacy|0|||
124447909|NCT04246801|447602800|FG001|Overall Study|Lack of Efficacy|2|||
124447910|NCT04246801|447602799|FG000|Overall Study|Lost to Follow-up|1|||
124447911|NCT04246801|447602800|FG001|Overall Study|Lost to Follow-up|1|||
124447912|NCT04246801|447602799|FG000|Overall Study|Withdrawal by Subject|2|||
124447913|NCT04246801|447602800|FG001|Overall Study|Withdrawal by Subject|1|||
124447914|NCT03684642|447602801|FG000|Overall Study|Adverse Event|6|||
124447915|NCT03684642|447602802|FG001|Overall Study|Adverse Event|15|||
124447916|NCT03684642|447602803|FG002|Overall Study|Adverse Event|11|||
124447917|NCT03684642|447602801|FG000|Overall Study|Withdrawal by Subject|35|||
124447918|NCT03684642|447602802|FG001|Overall Study|Withdrawal by Subject|53|||
124447919|NCT03684642|447602803|FG002|Overall Study|Withdrawal by Subject|23|||
124447920|NCT03684642|447602801|FG000|Overall Study|Lack of Efficacy|0|||
124447921|NCT03684642|447602802|FG001|Overall Study|Lack of Efficacy|0|||
124447922|NCT03684642|447602803|FG002|Overall Study|Lack of Efficacy|1|||
124447923|NCT03684642|447602801|FG000|Overall Study|Poor compliance to protocol|0|||
124447924|NCT03684642|447602802|FG001|Overall Study|Poor compliance to protocol|4|||
124447925|NCT03684642|447602803|FG002|Overall Study|Poor compliance to protocol|1|||
124759860|NCT00474955|448744776|FG000|Overall Study|Adverse Event|2|||
124759861|NCT00474955|448744776|FG000|Overall Study|Drug unavailability|1|||
124759862|NCT00474955|448744776|FG000|Overall Study|Personal reasons|5|||
124447926|NCT03684642|447602801|FG000|Overall Study|Other than specified|62|||
124447927|NCT03684642|447602802|FG001|Overall Study|Other than specified|60|||
124447928|NCT03684642|447602803|FG002|Overall Study|Other than specified|67|||
124447929|NCT03684642|447602801|FG000|Overall Study|Randomized and not treated|0|||
124447930|NCT03684642|447602802|FG001|Overall Study|Randomized and not treated|0|||
124447931|NCT03684642|447602803|FG002|Overall Study|Randomized and not treated|1|||
124447932|NCT03684642|447602801|FG000|Overall Study|Missing completion status but alive at last contact|0|||
124447933|NCT03684642|447602802|FG001|Overall Study|Missing completion status but alive at last contact|1|||
124900750|NCT01259102|449261372|FG004|Overall Study|Other|1|||
124900751|NCT01956669|449261376|FG000|Overall Study|Disease Progression|12|||
124900752|NCT01956669|449261377|FG001|Overall Study|Disease Progression|7|||
124900753|NCT01956669|449261378|FG002|Overall Study|Disease Progression|7|||
124900754|NCT01956669|449261379|FG003|Overall Study|Disease Progression|8|||
124900755|NCT01956669|449261380|FG004|Overall Study|Disease Progression|4|||
124900756|NCT01956669|449261381|FG005|Overall Study|Disease Progression|3|||
124900757|NCT01956669|449261382|FG006|Overall Study|Disease Progression|5|||
124447934|NCT03684642|447602803|FG002|Overall Study|Missing completion status but alive at last contact|2|||
124447935|NCT00835120|447602814|FG000|Overall Study|Lack of Efficacy|1|||
124900758|NCT01956669|449261376|FG000|Overall Study|Adverse Event|0|||
124447936|NCT00835120|447602814|FG000|Overall Study|Lost to Follow-up|3|||
124447937|NCT00835120|447602814|FG000|Overall Study|Adverse Event|2|||
124447938|NCT00835120|447602814|FG000|Overall Study|Withdrawal by Subject|2|||
124447939|NCT00232141|447602815|FG000|Overall Study|Adverse Event|9|||
124447940|NCT00232141|447602816|FG001|Overall Study|Adverse Event|4|||
124447941|NCT00232141|447602815|FG000|Overall Study|Lack of Efficacy|0|||
124447942|NCT00232141|447602816|FG001|Overall Study|Lack of Efficacy|3|||
124447943|NCT00232141|447602815|FG000|Overall Study|Lost to Follow-up|9|||
124447944|NCT00232141|447602816|FG001|Overall Study|Lost to Follow-up|6|||
124447945|NCT00232141|447602815|FG000|Overall Study|Other|8|||
124447946|NCT00232141|447602816|FG001|Overall Study|Other|10|||
124447947|NCT00232141|447602815|FG000|Overall Study|Withdrawal by Subject|5|||
124447948|NCT00232141|447602816|FG001|Overall Study|Withdrawal by Subject|3|||
124447949|NCT04572854|447602817|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
124447950|NCT04572854|447602818|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
124447951|NCT04572854|447602819|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
124447952|NCT04572854|447602820|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
124447953|NCT04572854|447602817|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
124447954|NCT04572854|447602818|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
124447955|NCT04572854|447602819|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
124447956|NCT04572854|447602820|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
124447957|NCT04752475|447604367|FG000|Overall Study|Withdrawal by Subject|1|||
124447958|NCT04752475|447604368|FG001|Overall Study|Withdrawal by Subject|1|||
124447959|NCT00594516|447604373|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
124447960|NCT00594516|447604374|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
124447961|NCT00594516|447604375|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
124447962|NCT00594516|447604373|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
124447963|NCT00594516|447604374|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
124447964|NCT00594516|447604375|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
124447965|NCT00594516|447604373|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
124447966|NCT00594516|447604374|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
124447967|NCT00594516|447604375|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
124447968|NCT00594516|447604373|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
124447969|NCT00594516|447604374|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
124447970|NCT00594516|447604375|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
124447971|NCT00594516|447604373|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
124447972|NCT00594516|447604374|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
124447973|NCT00594516|447604375|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
124447974|NCT00594516|447604373|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
124447975|NCT00594516|447604374|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
124447976|NCT00594516|447604375|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
124447977|NCT00594516|447604373|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
124447978|NCT00594516|447604374|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
124447979|NCT00594516|447604375|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
124447980|NCT00594516|447604373|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
124447981|NCT00594516|447604374|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
124447982|NCT00594516|447604375|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
124447983|NCT00594516|447604373|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
124447984|NCT00594516|447604374|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
124447985|NCT00594516|447604375|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
124447986|NCT00088907|447604376|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
124447987|NCT00088907|447604377|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
124447988|NCT00088907|447604376|FG000|Randomized Study (Step 1)|Adverse Event|14|||
124447989|NCT00088907|447604377|FG001|Randomized Study (Step 1)|Adverse Event|19|||
124447990|NCT00088907|447604376|FG000|Randomized Study (Step 1)|Death|11|||
124447991|NCT00088907|447604377|FG001|Randomized Study (Step 1)|Death|12|||
124447992|NCT00088907|447604376|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
124447993|NCT00088907|447604377|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
124447994|NCT00088907|447604376|FG000|Randomized Study (Step 1)|complicating disease|3|||
124447995|NCT00088907|447604377|FG001|Randomized Study (Step 1)|complicating disease|1|||
124447996|NCT00088907|447604376|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
124447997|NCT00088907|447604377|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
124447998|NCT00088907|447604376|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
124691050|NCT03738215|448488091|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
124759863|NCT01135134|448744777|FG000|Overall Study|Adverse Event|1|||
124447999|NCT00088907|447604377|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
124448000|NCT00088907|447604376|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
124448001|NCT00088907|447604377|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
124448002|NCT00088907|447604376|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
124448003|NCT00088907|447604377|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
124900759|NCT01956669|449261377|FG001|Overall Study|Adverse Event|2|||
124900760|NCT01956669|449261378|FG002|Overall Study|Adverse Event|2|||
124900761|NCT01956669|449261379|FG003|Overall Study|Adverse Event|1|||
124900762|NCT01956669|449261380|FG004|Overall Study|Adverse Event|0|||
124900763|NCT01956669|449261381|FG005|Overall Study|Adverse Event|0|||
124900764|NCT01956669|449261382|FG006|Overall Study|Adverse Event|0|||
124900765|NCT01956669|449261376|FG000|Overall Study|Physician Decision|0|||
124900766|NCT01956669|449261377|FG001|Overall Study|Physician Decision|2|||
124900767|NCT01956669|449261378|FG002|Overall Study|Physician Decision|0|||
124900768|NCT01956669|449261379|FG003|Overall Study|Physician Decision|0|||
124448004|NCT00088907|447604376|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
124448005|NCT00088907|447604377|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
124448006|NCT00088907|447604376|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
124448007|NCT00088907|447604377|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
124448008|NCT03426787|447604382|FG000|Overall Study|Withdrawal by Subject|6|||
124448009|NCT03426787|447604382|FG000|Overall Study|Lost to Follow-up|7|||
124448010|NCT03426787|447604382|FG000|Overall Study|Unrelated to intervention death|1|||
124448011|NCT02217436|447604383|FG000|Overall Study|Protocol Violation|1|||
124448012|NCT02217436|447604384|FG001|Overall Study|Protocol Violation|1|||
124448013|NCT02217436|447604383|FG000|Overall Study|Incomplete data|0|||
124448014|NCT02217436|447604384|FG001|Overall Study|Incomplete data|1|||
124448015|NCT04641299|447604385|FG000|Overall Study|Adverse Event|0|||
124448016|NCT04641299|447604386|FG001|Overall Study|Adverse Event|0|||
124448017|NCT04641299|447604387|FG002|Overall Study|Adverse Event|2|||
124448018|NCT04641299|447604388|FG003|Overall Study|Adverse Event|0|||
124448019|NCT04641299|447604385|FG000|Overall Study|Lost to Follow-up|0|||
124448020|NCT04641299|447604386|FG001|Overall Study|Lost to Follow-up|1|||
124448021|NCT04641299|447604387|FG002|Overall Study|Lost to Follow-up|0|||
124448022|NCT04641299|447604388|FG003|Overall Study|Lost to Follow-up|0|||
124448023|NCT04641299|447604385|FG000|Overall Study|Withdrawal by Subject|1|||
124448024|NCT04641299|447604386|FG001|Overall Study|Withdrawal by Subject|0|||
124448025|NCT04641299|447604387|FG002|Overall Study|Withdrawal by Subject|0|||
124448026|NCT04641299|447604388|FG003|Overall Study|Withdrawal by Subject|0|||
124448027|NCT04641299|447604385|FG000|Overall Study|Reason not given|1|||
124448028|NCT04641299|447604386|FG001|Overall Study|Reason not given|0|||
124448029|NCT04641299|447604387|FG002|Overall Study|Reason not given|0|||
124448030|NCT04641299|447604388|FG003|Overall Study|Reason not given|0|||
124448031|NCT01016964|447604391|FG000|Overall Study|Lost to Follow-up|3|||
124448032|NCT01016964|447604392|FG001|Overall Study|Lost to Follow-up|3|||
124900769|NCT01956669|449261380|FG004|Overall Study|Physician Decision|0|||
124900770|NCT01956669|449261381|FG005|Overall Study|Physician Decision|1|||
124448033|NCT01330914|447604399|FG000|Overall Study|Withdrawal by Subject|4|||
124448034|NCT01330914|447604399|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
124448035|NCT01650285|447604402|FG000|Overall Study|Adverse Event|1|||
124448036|NCT00659529|447604403|FG000|Overall Study|Withdrawal by Subject|4|||
124448037|NCT00659529|447604403|FG000|Overall Study|Protocol Violation|3|||
124448038|NCT00659529|447604403|FG000|Overall Study|Screen failure|9|||
124448039|NCT00907257|447604406|FG000|Overall Study|Adverse Event|0|||
124900771|NCT01956669|449261382|FG006|Overall Study|Physician Decision|0|||
124900772|NCT01956669|449261376|FG000|Overall Study|Withdrawal by Subject|0|||
124691051|NCT03738215|448488092|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
124900773|NCT01956669|449261377|FG001|Overall Study|Withdrawal by Subject|0|||
124900774|NCT01956669|449261378|FG002|Overall Study|Withdrawal by Subject|1|||
124900775|NCT01956669|449261379|FG003|Overall Study|Withdrawal by Subject|1|||
124900776|NCT01956669|449261380|FG004|Overall Study|Withdrawal by Subject|0|||
124900777|NCT01956669|449261381|FG005|Overall Study|Withdrawal by Subject|0|||
124900778|NCT01956669|449261382|FG006|Overall Study|Withdrawal by Subject|1|||
124900779|NCT01233050|449261383|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
124900780|NCT01233050|449261384|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
124900781|NCT01368406|449261386|FG000|Overall Study|Lost to Follow-up|8|||
124900782|NCT01368406|449261387|FG001|Overall Study|Lost to Follow-up|4|||
124900783|NCT01368406|449261386|FG000|Overall Study|Withdrawal by Subject|8|||
124900784|NCT01368406|449261387|FG001|Overall Study|Withdrawal by Subject|4|||
124900785|NCT01368406|449261386|FG000|Overall Study|relapse of the disease|3|||
124900786|NCT01368406|449261387|FG001|Overall Study|relapse of the disease|2|||
124691052|NCT03738215|448488093|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
124691053|NCT03738215|448488091|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
124900787|NCT01368406|449261386|FG000|Overall Study|started working|2|||
124900788|NCT01368406|449261387|FG001|Overall Study|started working|3|||
124900789|NCT01466881|449261388|FG000|Overall Study|Ineligible|5|||
124900790|NCT01466881|449261388|FG000|Overall Study|Adverse Event|6|||
124900791|NCT01466881|449261388|FG000|Overall Study|Progression/relapse|20|||
124900792|NCT01466881|449261388|FG000|Overall Study|Death|4|||
124900793|NCT01466881|449261388|FG000|Overall Study|Other reason not protocol specified|5|||
124900794|NCT01710514|449261398|FG000|Overall Study|Adverse Event|6|||
124900795|NCT01710514|449261399|FG001|Overall Study|Adverse Event|7|||
124900796|NCT01710514|449261398|FG000|Overall Study|Withdrawal by Subject|1|||
124900797|NCT01710514|449261399|FG001|Overall Study|Withdrawal by Subject|0|||
124900798|NCT02155829|449261403|FG000|Overall Study|Adverse Event|1|||
124900799|NCT02155829|449261404|FG001|Overall Study|Adverse Event|0|||
124900800|NCT02155829|449261403|FG000|Overall Study|Withdrawal by Subject|3|||
124900801|NCT02155829|449261404|FG001|Overall Study|Withdrawal by Subject|3|||
124900802|NCT02155829|449261403|FG000|Overall Study|Protocol Violation|2|||
124900803|NCT02155829|449261404|FG001|Overall Study|Protocol Violation|0|||
124900804|NCT00290732|449261408|FG000|Overall Study|Inability to instill drug intraductally.|0|||
124900805|NCT00290732|449261409|FG001|Overall Study|Inability to instill drug intraductally.|1|||
124900806|NCT00290732|449261410|FG002|Overall Study|Inability to instill drug intraductally.|1|||
124900807|NCT00290732|449261411|FG003|Overall Study|Inability to instill drug intraductally.|0|||
124900808|NCT00290732|449261412|FG004|Overall Study|Inability to instill drug intraductally.|0|||
124900809|NCT00542386|449261416|FG000|Overall Study|Adverse Event|1|||
124900810|NCT00542386|449261417|FG001|Overall Study|Adverse Event|7|||
124900811|NCT00542386|449261418|FG002|Overall Study|Adverse Event|7|||
124900812|NCT00542386|449261419|FG003|Overall Study|Adverse Event|8|||
124900813|NCT00542386|449261420|FG004|Overall Study|Adverse Event|13|||
124900814|NCT00542386|449261421|FG005|Overall Study|Adverse Event|4|||
124900815|NCT00542386|449261416|FG000|Overall Study|Death|0|||
124900816|NCT00542386|449261417|FG001|Overall Study|Death|0|||
124900817|NCT00542386|449261418|FG002|Overall Study|Death|1|||
124900818|NCT00542386|449261419|FG003|Overall Study|Death|2|||
124900819|NCT00542386|449261420|FG004|Overall Study|Death|1|||
124691054|NCT03738215|448488092|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
124900820|NCT00542386|449261421|FG005|Overall Study|Death|2|||
124900821|NCT00542386|449261416|FG000|Overall Study|Lack of Efficacy|32|||
124900822|NCT00542386|449261417|FG001|Overall Study|Lack of Efficacy|12|||
124900823|NCT00542386|449261418|FG002|Overall Study|Lack of Efficacy|10|||
124900824|NCT00542386|449261419|FG003|Overall Study|Lack of Efficacy|13|||
124900825|NCT00542386|449261420|FG004|Overall Study|Lack of Efficacy|7|||
124900826|NCT00542386|449261421|FG005|Overall Study|Lack of Efficacy|31|||
124900827|NCT00542386|449261416|FG000|Overall Study|Physician Decision|1|||
124900828|NCT00542386|449261417|FG001|Overall Study|Physician Decision|0|||
124900829|NCT00542386|449261418|FG002|Overall Study|Physician Decision|0|||
124900830|NCT00542386|449261419|FG003|Overall Study|Physician Decision|1|||
124900831|NCT00542386|449261420|FG004|Overall Study|Physician Decision|0|||
124900832|NCT00542386|449261421|FG005|Overall Study|Physician Decision|0|||
124900833|NCT00542386|449261416|FG000|Overall Study|Protocol Violation|0|||
124900834|NCT00542386|449261417|FG001|Overall Study|Protocol Violation|0|||
124900835|NCT00542386|449261418|FG002|Overall Study|Protocol Violation|1|||
124900836|NCT00542386|449261419|FG003|Overall Study|Protocol Violation|0|||
124900837|NCT00542386|449261420|FG004|Overall Study|Protocol Violation|0|||
124900838|NCT00542386|449261421|FG005|Overall Study|Protocol Violation|4|||
124900839|NCT00542386|449261416|FG000|Overall Study|Withdrawal by Subject|5|||
124900840|NCT00542386|449261417|FG001|Overall Study|Withdrawal by Subject|8|||
124900841|NCT00542386|449261418|FG002|Overall Study|Withdrawal by Subject|10|||
124900842|NCT00542386|449261419|FG003|Overall Study|Withdrawal by Subject|11|||
124900843|NCT00542386|449261420|FG004|Overall Study|Withdrawal by Subject|15|||
124900844|NCT00542386|449261421|FG005|Overall Study|Withdrawal by Subject|7|||
124900845|NCT00542386|449261416|FG000|Overall Study|Other Reasons|4|||
124900846|NCT00542386|449261417|FG001|Overall Study|Other Reasons|1|||
124900847|NCT00542386|449261418|FG002|Overall Study|Other Reasons|4|||
124900848|NCT00542386|449261419|FG003|Overall Study|Other Reasons|3|||
124900849|NCT00542386|449261420|FG004|Overall Study|Other Reasons|4|||
124900850|NCT00542386|449261421|FG005|Overall Study|Other Reasons|2|||
124900851|NCT01191788|449261426|FG000|Overall Study|Lost to Follow-up|21|||
124900852|NCT01191788|449261427|FG001|Overall Study|Lost to Follow-up|22|||
124900853|NCT02596035|449261428|FG000|Overall Study|Disease Progression|64|||
124900854|NCT02596035|449261429|FG001|Overall Study|Disease Progression|32|||
124900855|NCT02596035|449261430|FG002|Overall Study|Disease Progression|1|||
124691055|NCT03738215|448488093|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
124691056|NCT03738215|448488091|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
124900856|NCT02596035|449261428|FG000|Overall Study|study drug toxicity|12|||
124900857|NCT02596035|449261429|FG001|Overall Study|study drug toxicity|3|||
124900858|NCT02596035|449261430|FG002|Overall Study|study drug toxicity|0|||
124900859|NCT02596035|449261428|FG000|Overall Study|AE unrelated to study drug|5|||
124900860|NCT02596035|449261429|FG001|Overall Study|AE unrelated to study drug|2|||
124900861|NCT02596035|449261430|FG002|Overall Study|AE unrelated to study drug|0|||
124900862|NCT02596035|449261428|FG000|Overall Study|participant request to discontinue study treatment|2|||
124900863|NCT02596035|449261429|FG001|Overall Study|participant request to discontinue study treatment|0|||
124900864|NCT02596035|449261430|FG002|Overall Study|participant request to discontinue study treatment|0|||
124900865|NCT02596035|449261428|FG000|Overall Study|participant withdrew consent|2|||
124900866|NCT02596035|449261429|FG001|Overall Study|participant withdrew consent|2|||
124900867|NCT02596035|449261430|FG002|Overall Study|participant withdrew consent|0|||
124900868|NCT02596035|449261428|FG000|Overall Study|Poor/Non Comlpiance|0|||
124448040|NCT00907257|447604407|FG001|Overall Study|Adverse Event|4|||
124448041|NCT00907257|447604406|FG000|Overall Study|Protocol Violation|1|||
124448042|NCT00907257|447604407|FG001|Overall Study|Protocol Violation|2|||
124448043|NCT00907257|447604406|FG000|Overall Study|Lost to Follow-up|3|||
124448044|NCT00907257|447604407|FG001|Overall Study|Lost to Follow-up|3|||
124448045|NCT00907257|447604406|FG000|Overall Study|Withdrawal by Subject|1|||
124448046|NCT00907257|447604407|FG001|Overall Study|Withdrawal by Subject|2|||
124448047|NCT00907257|447604406|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
124900869|NCT02596035|449261429|FG001|Overall Study|Poor/Non Comlpiance|1|||
124900870|NCT02596035|449261430|FG002|Overall Study|Poor/Non Comlpiance|0|||
124900871|NCT02596035|449261428|FG000|Overall Study|participant no longer meets study criteria|1|||
124900872|NCT02596035|449261429|FG001|Overall Study|participant no longer meets study criteria|0|||
124900873|NCT02596035|449261430|FG002|Overall Study|participant no longer meets study criteria|0|||
124900874|NCT02596035|449261428|FG000|Overall Study|other reasons|11|||
124900875|NCT02596035|449261429|FG001|Overall Study|other reasons|4|||
124900876|NCT02596035|449261430|FG002|Overall Study|other reasons|0|||
124900877|NCT01235949|449261431|FG000|Primary Phase|Migrated/moved from study area|1|||
124900878|NCT01235949|449261432|FG001|Primary Phase|Migrated/moved from study area|1|||
124900879|NCT01235949|449261433|FG002|Primary Phase|Migrated/moved from study area|0|||
124900880|NCT01235949|449261434|FG003|Primary Phase|Migrated/moved from study area|0|||
124900881|NCT01235949|449261435|FG004|Primary Phase|Migrated/moved from study area|1|||
124900882|NCT01235949|449261436|FG005|Primary Phase|Migrated/moved from study area|2|||
124759864|NCT01135134|448744778|FG001|Overall Study|Adverse Event|1|||
124900883|NCT01235949|449261437|FG006|Primary Phase|Migrated/moved from study area|0|||
124900884|NCT01235949|449261438|FG007|Primary Phase|Migrated/moved from study area|0|||
124448048|NCT00907257|447604407|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
124448049|NCT00907257|447604406|FG000|Overall Study|Moved|1|||
124448050|NCT00907257|447604407|FG001|Overall Study|Moved|0|||
124448051|NCT00907257|447604406|FG000|Overall Study|Personal Reasons|6|||
124448052|NCT00907257|447604407|FG001|Overall Study|Personal Reasons|1|||
124448053|NCT00283049|447604408|FG000|Overall Study|Adverse Event|6|||
124448054|NCT00283049|447604409|FG001|Overall Study|Adverse Event|1|||
124448055|NCT00283049|447604410|FG002|Overall Study|Adverse Event|4|||
124448056|NCT00283049|447604408|FG000|Overall Study|Protocol Violation|3|||
124448057|NCT00283049|447604409|FG001|Overall Study|Protocol Violation|0|||
124448058|NCT00283049|447604410|FG002|Overall Study|Protocol Violation|3|||
124448059|NCT00283049|447604408|FG000|Overall Study|Death|1|||
124448060|NCT00283049|447604409|FG001|Overall Study|Death|1|||
124448061|NCT00283049|447604410|FG002|Overall Study|Death|1|||
124448062|NCT00283049|447604408|FG000|Overall Study|Lack of Efficacy|0|||
124448063|NCT00283049|447604409|FG001|Overall Study|Lack of Efficacy|1|||
124448064|NCT00283049|447604410|FG002|Overall Study|Lack of Efficacy|1|||
124448065|NCT00283049|447604408|FG000|Overall Study|Lost to Follow-up|4|||
124448066|NCT00283049|447604409|FG001|Overall Study|Lost to Follow-up|2|||
124448067|NCT00283049|447604410|FG002|Overall Study|Lost to Follow-up|5|||
124448068|NCT00283049|447604408|FG000|Overall Study|Withdrawal by Subject|26|||
124448069|NCT00283049|447604409|FG001|Overall Study|Withdrawal by Subject|24|||
124448070|NCT00283049|447604410|FG002|Overall Study|Withdrawal by Subject|19|||
124448071|NCT00283049|447604408|FG000|Overall Study|Discontinuation of Study|18|||
124448072|NCT00283049|447604409|FG001|Overall Study|Discontinuation of Study|16|||
124448073|NCT00283049|447604410|FG002|Overall Study|Discontinuation of Study|20|||
124448074|NCT00283049|447604408|FG000|Overall Study|No longer requires study treatment|0|||
124448075|NCT00283049|447604409|FG001|Overall Study|No longer requires study treatment|0|||
124448076|NCT00283049|447604410|FG002|Overall Study|No longer requires study treatment|1|||
124448077|NCT00295633|447604411|FG000|Overall Study|Lack of Efficacy|19|||
124448078|NCT00295633|447604412|FG001|Overall Study|Lack of Efficacy|7|||
124448079|NCT00295633|447604413|FG002|Overall Study|Lack of Efficacy|16|||
124448080|NCT00295633|447604411|FG000|Overall Study|Withdrawal of consent by subject|16|||
124448081|NCT00295633|447604412|FG001|Overall Study|Withdrawal of consent by subject|16|||
124448082|NCT00295633|447604413|FG002|Overall Study|Withdrawal of consent by subject|26|||
124448083|NCT00295633|447604411|FG000|Overall Study|Adverse Event|9|||
124448084|NCT00295633|447604412|FG001|Overall Study|Adverse Event|17|||
124448085|NCT00295633|447604413|FG002|Overall Study|Adverse Event|9|||
124448086|NCT00295633|447604411|FG000|Overall Study|Lost to Follow-up|6|||
124448087|NCT00295633|447604412|FG001|Overall Study|Lost to Follow-up|11|||
124448088|NCT00295633|447604413|FG002|Overall Study|Lost to Follow-up|7|||
124448089|NCT00295633|447604411|FG000|Overall Study|Physician Decision|9|||
124448090|NCT00295633|447604412|FG001|Overall Study|Physician Decision|10|||
124448091|NCT00295633|447604413|FG002|Overall Study|Physician Decision|8|||
124448092|NCT00295633|447604411|FG000|Overall Study|Poor/Noncompliance|2|||
124448093|NCT00295633|447604412|FG001|Overall Study|Poor/Noncompliance|2|||
124448094|NCT00295633|447604413|FG002|Overall Study|Poor/Noncompliance|6|||
124448095|NCT00295633|447604411|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
124448096|NCT00295633|447604412|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
124448097|NCT00295633|447604413|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
124448098|NCT00295633|447604411|FG000|Overall Study|Death|1|||
124448099|NCT00295633|447604412|FG001|Overall Study|Death|1|||
124448100|NCT00295633|447604413|FG002|Overall Study|Death|0|||
124448101|NCT00295633|447604411|FG000|Overall Study|Administrative reason by sponsor|0|||
124448102|NCT00295633|447604412|FG001|Overall Study|Administrative reason by sponsor|0|||
124448103|NCT00295633|447604413|FG002|Overall Study|Administrative reason by sponsor|1|||
124448104|NCT00763971|447604414|FG000|Overall Study|Adverse Event|5|||
124448105|NCT00763971|447604415|FG001|Overall Study|Adverse Event|2|||
124448106|NCT00763971|447604416|FG002|Overall Study|Adverse Event|4|||
124448107|NCT00763971|447604414|FG000|Overall Study|Protocol Violation|3|||
124448108|NCT00763971|447604415|FG001|Overall Study|Protocol Violation|3|||
124448109|NCT00763971|447604416|FG002|Overall Study|Protocol Violation|2|||
124448110|NCT00763971|447604414|FG000|Overall Study|Withdrawal by Subject|4|||
124448111|NCT00763971|447604415|FG001|Overall Study|Withdrawal by Subject|5|||
124448112|NCT00763971|447604416|FG002|Overall Study|Withdrawal by Subject|5|||
124448113|NCT00763971|447604414|FG000|Overall Study|Lost to Follow-up|0|||
124448114|NCT00763971|447604415|FG001|Overall Study|Lost to Follow-up|1|||
124448115|NCT00763971|447604416|FG002|Overall Study|Lost to Follow-up|0|||
124448116|NCT00763971|447604414|FG000|Overall Study|Lack of Efficacy|11|||
124448117|NCT00763971|447604415|FG001|Overall Study|Lack of Efficacy|22|||
124448118|NCT00763971|447604416|FG002|Overall Study|Lack of Efficacy|54|||
124448119|NCT00763971|447604414|FG000|Overall Study|Unable to swallow capsule|2|||
124448120|NCT00763971|447604415|FG001|Overall Study|Unable to swallow capsule|1|||
124448121|NCT00763971|447604416|FG002|Overall Study|Unable to swallow capsule|1|||
124448122|NCT00763971|447604414|FG000|Overall Study|Personal reason|3|||
124448123|NCT00763971|447604415|FG001|Overall Study|Personal reason|0|||
124448124|NCT00763971|447604416|FG002|Overall Study|Personal reason|0|||
124448125|NCT00763971|447604414|FG000|Overall Study|Exclusion criteria met|1|||
124900885|NCT01235949|449261439|FG008|Primary Phase|Migrated/moved from study area|0|||
124900886|NCT01235949|449261440|FG009|Primary Phase|Migrated/moved from study area|0|||
124900887|NCT01235949|449261441|FG010|Primary Phase|Migrated/moved from study area|0|||
124900888|NCT01235949|449261442|FG011|Primary Phase|Migrated/moved from study area|0|||
124900889|NCT01235949|449261443|FG012|Primary Phase|Migrated/moved from study area|0|||
124900890|NCT01235949|449261444|FG013|Primary Phase|Migrated/moved from study area|0|||
124448126|NCT00763971|447604415|FG001|Overall Study|Exclusion criteria met|0|||
124448127|NCT00763971|447604416|FG002|Overall Study|Exclusion criteria met|0|||
124448128|NCT00763971|447604414|FG000|Overall Study|Sponsor decision|1|||
124448129|NCT00763971|447604415|FG001|Overall Study|Sponsor decision|0|||
124448130|NCT00763971|447604416|FG002|Overall Study|Sponsor decision|0|||
124448131|NCT00763971|447604414|FG000|Overall Study|Due to holiday season|2|||
124448132|NCT00763971|447604415|FG001|Overall Study|Due to holiday season|0|||
124448133|NCT00763971|447604416|FG002|Overall Study|Due to holiday season|1|||
124448134|NCT00763971|447604414|FG000|Overall Study|Randomization error|0|||
124448135|NCT00763971|447604415|FG001|Overall Study|Randomization error|0|||
124448136|NCT00763971|447604416|FG002|Overall Study|Randomization error|1|||
124448137|NCT00763971|447604414|FG000|Overall Study|Medical monitor decision|0|||
124448138|NCT00763971|447604415|FG001|Overall Study|Medical monitor decision|0|||
124448139|NCT00763971|447604416|FG002|Overall Study|Medical monitor decision|1|||
124448140|NCT00763971|447604414|FG000|Overall Study|Moved to another country|0|||
124448141|NCT00763971|447604415|FG001|Overall Study|Moved to another country|1|||
124448142|NCT00763971|447604416|FG002|Overall Study|Moved to another country|0|||
124448143|NCT00763971|447604414|FG000|Overall Study|Subject wanted dose reduction|0|||
124448144|NCT00763971|447604415|FG001|Overall Study|Subject wanted dose reduction|1|||
124448145|NCT00763971|447604416|FG002|Overall Study|Subject wanted dose reduction|0|||
124448146|NCT00763971|447604414|FG000|Overall Study|Lack of availability|0|||
124448147|NCT00763971|447604415|FG001|Overall Study|Lack of availability|1|||
124448148|NCT00763971|447604416|FG002|Overall Study|Lack of availability|0|||
124448149|NCT00763971|447604414|FG000|Overall Study|Performed final visit on phone|0|||
124448150|NCT00763971|447604415|FG001|Overall Study|Performed final visit on phone|1|||
124448151|NCT00763971|447604416|FG002|Overall Study|Performed final visit on phone|0|||
124448152|NCT00763971|447604414|FG000|Overall Study|Participation in 489-326 required|1|||
124448153|NCT00763971|447604415|FG001|Overall Study|Participation in 489-326 required|0|||
124448154|NCT00763971|447604416|FG002|Overall Study|Participation in 489-326 required|0|||
124448155|NCT03631667|447604426|FG000|Overall Study|Withdrawal by Subject|3|||
124448156|NCT04439071|447604427|FG000|Overall Study|Lost to Follow-up|0|||
124448157|NCT04439071|447604428|FG001|Overall Study|Lost to Follow-up|3|||
124448158|NCT04439071|447604427|FG000|Overall Study|Withdrawal by Subject|3|||
124448159|NCT04439071|447604428|FG001|Overall Study|Withdrawal by Subject|8|||
124448160|NCT04439071|447604427|FG000|Overall Study|Death|6|||
124448161|NCT04439071|447604428|FG001|Overall Study|Death|4|||
124448162|NCT04439071|447604427|FG000|Overall Study|Other than specified|3|||
124448163|NCT04439071|447604428|FG001|Overall Study|Other than specified|3|||
124448164|NCT04439071|447604427|FG000|Overall Study|Randomized but not treated|2|||
124448165|NCT04439071|447604428|FG001|Overall Study|Randomized but not treated|0|||
124448166|NCT01446016|447604431|FG000|Overall Study|Lost to Follow-up|3|||
124448167|NCT01446016|447604431|FG000|Overall Study|Withdrawal by Subject|1|||
124448168|NCT01446016|447604431|FG000|Overall Study|Toxicity|3|||
124448169|NCT01087957|447604433|FG000|Overall Study|Death|2|||
124448170|NCT01087957|447604434|FG001|Overall Study|Death|2|||
124448171|NCT01087957|447604433|FG000|Overall Study|Lost to Follow-up|3|||
124448172|NCT01087957|447604434|FG001|Overall Study|Lost to Follow-up|4|||
124448173|NCT01087957|447604433|FG000|Overall Study|Protocol Violation|13|||
124448174|NCT01087957|447604434|FG001|Overall Study|Protocol Violation|25|||
124448175|NCT01087957|447604433|FG000|Overall Study|Withdrawal by Subject|18|||
124448176|NCT01087957|447604434|FG001|Overall Study|Withdrawal by Subject|15|||
124448177|NCT01087957|447604433|FG000|Overall Study|Physician Decision|5|||
124448178|NCT01087957|447604434|FG001|Overall Study|Physician Decision|9|||
124448179|NCT01754857|447604435|FG000|Overall Study|Adverse Event|7|||
124448180|NCT01754857|447604435|FG000|Overall Study|Disease progression|3|||
124448181|NCT01754857|447604435|FG000|Overall Study|Physician Decision|2|||
124448182|NCT01754857|447604435|FG000|Overall Study|Withdrawal by Subject|3|||
124448183|NCT01754857|447604435|FG000|Overall Study|other complicating disease|1|||
124448184|NCT01754857|447604435|FG000|Overall Study|ineligible to continue onto maintenance|1|||
124448185|NCT01754857|447604435|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
124448186|NCT01754857|447604435|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
124448187|NCT01399190|447604438|FG000|Overall Study|Not Eligible for Final Analysis|5|||
124448188|NCT01399190|447604438|FG000|Overall Study|Adverse Event|8|||
124448189|NCT01399190|447604438|FG000|Overall Study|Participant's Request|5|||
124448190|NCT01399190|447604438|FG000|Overall Study|Physician Decision|2|||
124448191|NCT00436618|447604439|FG000|Overall Study|Withdrawal by Subject|5|||
124448192|NCT00436618|447604440|FG001|Overall Study|Withdrawal by Subject|8|||
124448193|NCT00436618|447604441|FG002|Overall Study|Withdrawal by Subject|11|||
124448194|NCT00436618|447604439|FG000|Overall Study|Adverse Event|8|||
124448195|NCT00436618|447604440|FG001|Overall Study|Adverse Event|8|||
124448196|NCT00436618|447604441|FG002|Overall Study|Adverse Event|9|||
124448197|NCT00436618|447604439|FG000|Overall Study|Alternate Treatment|3|||
124448198|NCT00436618|447604440|FG001|Overall Study|Alternate Treatment|4|||
124448199|NCT00436618|447604441|FG002|Overall Study|Alternate Treatment|12|||
124448200|NCT00436618|447604439|FG000|Overall Study|Other Medical Problems|3|||
124448201|NCT00436618|447604440|FG001|Overall Study|Other Medical Problems|1|||
124448202|NCT00436618|447604441|FG002|Overall Study|Other Medical Problems|7|||
124448203|NCT00436618|447604439|FG000|Overall Study|Death|4|||
124448204|NCT00436618|447604440|FG001|Overall Study|Death|2|||
124448205|NCT00436618|447604441|FG002|Overall Study|Death|3|||
124448206|NCT00436618|447604439|FG000|Overall Study|New Primary or Other Reasons|6|||
124448207|NCT00436618|447604440|FG001|Overall Study|New Primary or Other Reasons|2|||
124448208|NCT00436618|447604441|FG002|Overall Study|New Primary or Other Reasons|12|||
124448209|NCT00436618|447604439|FG000|Overall Study|Still on treatment|1|||
124448210|NCT00436618|447604440|FG001|Overall Study|Still on treatment|2|||
124448211|NCT00436618|447604441|FG002|Overall Study|Still on treatment|7|||
124448212|NCT00698204|447604442|FG000|Overall Study|Withdrawal by Subject|1|||
124448213|NCT00698204|447604443|FG001|Overall Study|Withdrawal by Subject|0|||
124448214|NCT00314249|447604444|FG000|Overall Study|Adverse Event|73|||
124448215|NCT00314249|447604445|FG001|Overall Study|Adverse Event|94|||
124448216|NCT00314249|447604444|FG000|Overall Study|Lack of Efficacy|33|||
124448217|NCT00314249|447604445|FG001|Overall Study|Lack of Efficacy|24|||
124448218|NCT00314249|447604444|FG000|Overall Study|Withdrawal by Subject|21|||
124448219|NCT00314249|447604445|FG001|Overall Study|Withdrawal by Subject|28|||
124448220|NCT00314249|447604444|FG000|Overall Study|Lost to Follow-up|15|||
124448221|NCT00314249|447604445|FG001|Overall Study|Lost to Follow-up|9|||
124448222|NCT00314249|447604444|FG000|Overall Study|Physician Decision|1|||
124448223|NCT00314249|447604445|FG001|Overall Study|Physician Decision|1|||
124448224|NCT00314249|447604444|FG000|Overall Study|Withdrawn for other reasons|4|||
124448225|NCT00314249|447604445|FG001|Overall Study|Withdrawn for other reasons|1|||
124448226|NCT00314249|447604444|FG000|Overall Study|Non-Compliant|5|||
124448227|NCT00314249|447604445|FG001|Overall Study|Non-Compliant|6|||
124448228|NCT00210184|447604446|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
124448229|NCT01118325|447604449|FG000|Overall Study|Adverse Event|1|||
124448230|NCT01118325|447604450|FG001|Overall Study|Adverse Event|0|||
124448231|NCT01118325|447604451|FG002|Overall Study|Adverse Event|1|||
124448232|NCT03334409|447604452|FG000|Overall Study|Did not meet inclusion criteria|1|||
124448233|NCT03334409|447604453|FG001|Overall Study|Did not meet inclusion criteria|0|||
124448234|NCT00975715|447604454|FG000|Titration Period|Adverse Event|6|||
124448235|NCT00975715|447604455|FG001|Titration Period|Adverse Event|0|||
124448236|NCT00975715|447604454|FG000|Titration Period|Protocol Violation|1|||
124448237|NCT00975715|447604455|FG001|Titration Period|Protocol Violation|0|||
124448238|NCT00975715|447604454|FG000|Maintenance Period|Adverse Event|2|||
124448239|NCT00975715|447604455|FG001|Maintenance Period|Adverse Event|1|||
124448240|NCT01674712|447604460|FG000|Overall Study|Adverse Event|5|||
124448241|NCT01674712|447604461|FG001|Overall Study|Adverse Event|6|||
124448242|NCT01674712|447604462|FG002|Overall Study|Adverse Event|3|||
124448243|NCT01674712|447604463|FG003|Overall Study|Adverse Event|4|||
124448244|NCT01674712|447604464|FG004|Overall Study|Adverse Event|6|||
124448245|NCT01674712|447604460|FG000|Overall Study|Lost to Follow-up|1|||
124448246|NCT01674712|447604461|FG001|Overall Study|Lost to Follow-up|0|||
124448247|NCT01674712|447604462|FG002|Overall Study|Lost to Follow-up|0|||
124448248|NCT01674712|447604463|FG003|Overall Study|Lost to Follow-up|0|||
124448249|NCT01674712|447604464|FG004|Overall Study|Lost to Follow-up|0|||
124448250|NCT01674712|447604460|FG000|Overall Study|Protocol Violation|2|||
124448251|NCT01674712|447604461|FG001|Overall Study|Protocol Violation|0|||
124448252|NCT01674712|447604462|FG002|Overall Study|Protocol Violation|0|||
124448253|NCT01674712|447604463|FG003|Overall Study|Protocol Violation|0|||
124448254|NCT01674712|447604464|FG004|Overall Study|Protocol Violation|0|||
124448255|NCT01674712|447604460|FG000|Overall Study|Withdrawal by Subject|2|||
124448256|NCT01674712|447604461|FG001|Overall Study|Withdrawal by Subject|2|||
124448257|NCT01674712|447604462|FG002|Overall Study|Withdrawal by Subject|5|||
124448258|NCT01674712|447604463|FG003|Overall Study|Withdrawal by Subject|4|||
124448259|NCT01674712|447604464|FG004|Overall Study|Withdrawal by Subject|3|||
124448260|NCT01674712|447604460|FG000|Overall Study|Administrative|0|||
124448261|NCT01674712|447604461|FG001|Overall Study|Administrative|1|||
124691057|NCT03738215|448488092|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
124691058|NCT03738215|448488093|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
124691059|NCT03738215|448488091|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
124448262|NCT01674712|447604462|FG002|Overall Study|Administrative|0|||
124448263|NCT01674712|447604463|FG003|Overall Study|Administrative|0|||
124691060|NCT03738215|448488092|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
124691061|NCT03738215|448488093|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
124691062|NCT03738215|448488091|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
124448264|NCT01674712|447604464|FG004|Overall Study|Administrative|1|||
124448265|NCT01674712|447604460|FG000|Overall Study|Lack of Efficacy|0|||
124448266|NCT01674712|447604461|FG001|Overall Study|Lack of Efficacy|0|||
124448267|NCT01674712|447604462|FG002|Overall Study|Lack of Efficacy|1|||
124448268|NCT01674712|447604463|FG003|Overall Study|Lack of Efficacy|0|||
124448269|NCT01674712|447604464|FG004|Overall Study|Lack of Efficacy|1|||
124448270|NCT00874770|447604465|FG000|Overall Study|Lack of Efficacy|2|||
124448271|NCT00874770|447604466|FG001|Overall Study|Lack of Efficacy|0|||
124448272|NCT00874770|447604467|FG002|Overall Study|Lack of Efficacy|0|||
124448273|NCT00874770|447604468|FG003|Overall Study|Lack of Efficacy|2|||
124448274|NCT00874770|447604465|FG000|Overall Study|Adverse Event|1|||
124448275|NCT00874770|447604466|FG001|Overall Study|Adverse Event|1|||
124448276|NCT00874770|447604467|FG002|Overall Study|Adverse Event|4|||
124448277|NCT00874770|447604468|FG003|Overall Study|Adverse Event|2|||
124448278|NCT00874770|447604465|FG000|Overall Study|Lost to Follow-up|1|||
124448279|NCT00874770|447604466|FG001|Overall Study|Lost to Follow-up|0|||
124448280|NCT00874770|447604467|FG002|Overall Study|Lost to Follow-up|0|||
124448281|NCT00874770|447604468|FG003|Overall Study|Lost to Follow-up|1|||
124448282|NCT00874770|447604465|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
124448283|NCT00874770|447604466|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
124448284|NCT00874770|447604467|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
124448285|NCT00874770|447604468|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
124448286|NCT05395104|447604469|FG000|Overall Study|Met Liver Stopping Criteria|1|||
124448287|NCT05395104|447604469|FG000|Overall Study|Withdrawal by Subject|1|||
124448288|NCT03974334|447604470|FG000|Overall Study|Lost to Follow-up|1|||
124448289|NCT01109173|447604471|FG000|Overall Study|Adverse Event|15|||
124448290|NCT01109173|447604472|FG001|Overall Study|Adverse Event|17|||
124448291|NCT01109173|447604473|FG002|Overall Study|Adverse Event|9|||
124448292|NCT01109173|447604474|FG003|Overall Study|Adverse Event|6|||
124448293|NCT01109173|447604471|FG000|Overall Study|Lost to Follow-up|0|||
124448294|NCT01109173|447604472|FG001|Overall Study|Lost to Follow-up|1|||
124448295|NCT01109173|447604473|FG002|Overall Study|Lost to Follow-up|0|||
124448296|NCT01109173|447604474|FG003|Overall Study|Lost to Follow-up|0|||
124448297|NCT01109173|447604471|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
124448298|NCT01109173|447604472|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
124448299|NCT01109173|447604473|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
124448300|NCT01109173|447604474|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
124448301|NCT01109173|447604471|FG000|Overall Study|Noncompliance|0|||
124448302|NCT01109173|447604472|FG001|Overall Study|Noncompliance|1|||
124448303|NCT01109173|447604473|FG002|Overall Study|Noncompliance|0|||
124448304|NCT01109173|447604474|FG003|Overall Study|Noncompliance|0|||
124448305|NCT01109173|447604471|FG000|Overall Study|Treatment Failure|25|||
124448306|NCT01109173|447604472|FG001|Overall Study|Treatment Failure|32|||
124448307|NCT01109173|447604473|FG002|Overall Study|Treatment Failure|69|||
124448308|NCT01109173|447604474|FG003|Overall Study|Treatment Failure|64|||
124448309|NCT01109173|447604471|FG000|Overall Study|Protocol Violation|4|||
124448310|NCT01109173|447604472|FG001|Overall Study|Protocol Violation|5|||
124448311|NCT01109173|447604473|FG002|Overall Study|Protocol Violation|1|||
124448312|NCT01109173|447604474|FG003|Overall Study|Protocol Violation|2|||
124448313|NCT01109173|447604471|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
124448314|NCT01109173|447604472|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
124448315|NCT01109173|447604473|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
124448316|NCT01109173|447604474|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
124448317|NCT01109173|447604471|FG000|Overall Study|Not Specifiied|5|||
124448318|NCT01109173|447604472|FG001|Overall Study|Not Specifiied|4|||
124448319|NCT01109173|447604473|FG002|Overall Study|Not Specifiied|9|||
124448320|NCT01109173|447604474|FG003|Overall Study|Not Specifiied|14|||
124448321|NCT00770770|447604477|FG000|Overall Study|Lost to Follow-up|1|||
124448322|NCT00770770|447604478|FG001|Overall Study|Lost to Follow-up|0|||
124448323|NCT00770770|447604477|FG000|Overall Study|Withdrawal by Subject|1|||
124448324|NCT00770770|447604478|FG001|Overall Study|Withdrawal by Subject|0|||
124448325|NCT00770770|447604477|FG000|Overall Study|Death|0|||
124448326|NCT00770770|447604478|FG001|Overall Study|Death|1|||
124448327|NCT00770770|447604477|FG000|Overall Study|Study Terminated|8|||
124448328|NCT00770770|447604478|FG001|Overall Study|Study Terminated|0|||
124448329|NCT05372653|447604483|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
124448330|NCT05372653|447604484|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
124448331|NCT05372653|447604483|FG000|Overall Study|Adverse Event|0|||
124448332|NCT05372653|447604484|FG001|Overall Study|Adverse Event|1|||
124448333|NCT00711529|447604491|FG000|Overall Study|Protocol Violation|2|||
124448334|NCT00711529|447604492|FG001|Overall Study|Protocol Violation|0|||
124448335|NCT00711529|447604491|FG000|Overall Study|Withdrawal by Subject|2|||
124448336|NCT00711529|447604492|FG001|Overall Study|Withdrawal by Subject|6|||
124448337|NCT03681951|447604497|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
124448338|NCT03681951|447604498|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
124448339|NCT03681951|447604499|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
124448340|NCT03681951|447604500|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
124448341|NCT03681951|447604501|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
124448342|NCT03681951|447604502|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
124448343|NCT03681951|447604503|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
124448344|NCT03681951|447604504|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
124448345|NCT03681951|447604497|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
124448346|NCT03681951|447604498|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
124448347|NCT03681951|447604499|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
124448348|NCT03681951|447604500|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
124448349|NCT03681951|447604501|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
124448350|NCT03681951|447604502|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
124448351|NCT03681951|447604503|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
124900891|NCT01235949|449261445|FG014|Primary Phase|Migrated/moved from study area|0|||
124900892|NCT01235949|449261446|FG015|Primary Phase|Migrated/moved from study area|0|||
124900893|NCT01235949|449261447|FG016|Primary Phase|Migrated/moved from study area|0|||
124900894|NCT01235949|449261448|FG017|Primary Phase|Migrated/moved from study area|0|||
124900895|NCT01235949|449261431|FG000|Primary Phase|Adverse Event|0|||
124900896|NCT01235949|449261432|FG001|Primary Phase|Adverse Event|0|||
124448352|NCT03681951|447604504|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
124448353|NCT03681951|447604497|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
124900897|NCT01235949|449261433|FG002|Primary Phase|Adverse Event|0|||
124900898|NCT01235949|449261434|FG003|Primary Phase|Adverse Event|1|||
124900899|NCT01235949|449261435|FG004|Primary Phase|Adverse Event|0|||
124900900|NCT01235949|449261436|FG005|Primary Phase|Adverse Event|0|||
124900901|NCT01235949|449261437|FG006|Primary Phase|Adverse Event|0|||
124900902|NCT01235949|449261438|FG007|Primary Phase|Adverse Event|0|||
124900903|NCT01235949|449261439|FG008|Primary Phase|Adverse Event|0|||
124448354|NCT03681951|447604498|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
124448355|NCT03681951|447604499|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
124448356|NCT03681951|447604500|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
124448357|NCT03681951|447604501|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
124448358|NCT03681951|447604502|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
124448359|NCT03681951|447604503|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
124448360|NCT03681951|447604504|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
124448361|NCT01020448|447604505|FG000|Pre-assignment|Adverse Event|6|||
124448362|NCT01020448|447604505|FG000|Pre-assignment|Withdrawal by Subject|5|||
124448363|NCT01020448|447604505|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
124448364|NCT01020448|447604505|FG000|Treatment|Adverse Event|11|||
124448365|NCT01020448|447604505|FG000|Treatment|Consent Withdrawn|3|||
124448366|NCT01020448|447604505|FG000|Treatment|Disease Progression|2|||
124448367|NCT01020448|447604505|FG000|Treatment|Lack of Efficacy|8|||
124448368|NCT01020448|447604505|FG000|Treatment|Lost to Follow-up|2|||
124448369|NCT01230554|447604506|FG000|Overall Study|Lost to Follow-up|2|||
124448370|NCT01230554|447604506|FG000|Overall Study|Inability to maintain visit schedule|1|||
124900904|NCT01235949|449261440|FG009|Primary Phase|Adverse Event|0|||
124900905|NCT01235949|449261441|FG010|Primary Phase|Adverse Event|0|||
124900906|NCT01235949|449261442|FG011|Primary Phase|Adverse Event|0|||
124900907|NCT01235949|449261443|FG012|Primary Phase|Adverse Event|0|||
124900908|NCT01235949|449261444|FG013|Primary Phase|Adverse Event|0|||
124900909|NCT01235949|449261445|FG014|Primary Phase|Adverse Event|0|||
124900910|NCT01235949|449261446|FG015|Primary Phase|Adverse Event|0|||
124448371|NCT01968070|447604507|FG000|Period 1|Withdrawal by Subject|0|||
124448372|NCT01968070|447604508|FG001|Period 1|Withdrawal by Subject|1|||
124448373|NCT01968070|447604509|FG002|Period 1|Withdrawal by Subject|0|||
124448374|NCT01968070|447604510|FG003|Period 1|Withdrawal by Subject|0|||
124448375|NCT01968070|447604511|FG004|Period 1|Withdrawal by Subject|0|||
124448376|NCT01968070|447604512|FG005|Period 1|Withdrawal by Subject|0|||
124448377|NCT01968070|447604513|FG006|Period 1|Withdrawal by Subject|1|||
124448378|NCT01968070|447604514|FG007|Period 1|Withdrawal by Subject|0|||
124448379|NCT01968070|447604515|FG008|Period 1|Withdrawal by Subject|0|||
124448380|NCT01968070|447604516|FG009|Period 1|Withdrawal by Subject|0|||
124448381|NCT01968070|447604517|FG010|Period 1|Withdrawal by Subject|0|||
124448382|NCT01968070|447604518|FG011|Period 1|Withdrawal by Subject|0|||
124448383|NCT01968070|447604519|FG012|Period 1|Withdrawal by Subject|0|||
124448384|NCT01968070|447604520|FG013|Period 1|Withdrawal by Subject|0|||
124900911|NCT01235949|449261447|FG016|Primary Phase|Adverse Event|0|||
124448385|NCT01968070|447604521|FG014|Period 1|Withdrawal by Subject|0|||
124448386|NCT01968070|447604522|FG015|Period 1|Withdrawal by Subject|1|||
124448387|NCT01968070|447604523|FG016|Period 1|Withdrawal by Subject|0|||
124448388|NCT01968070|447604524|FG017|Period 1|Withdrawal by Subject|0|||
124448389|NCT01968070|447604507|FG000|Period 1|Protocol Violation|0|||
124448390|NCT01968070|447604508|FG001|Period 1|Protocol Violation|0|||
124448391|NCT01968070|447604509|FG002|Period 1|Protocol Violation|0|||
124448392|NCT01968070|447604510|FG003|Period 1|Protocol Violation|1|||
124900912|NCT01235949|449261448|FG017|Primary Phase|Adverse Event|0|||
124900913|NCT01235949|449261431|FG000|Primary Phase|Withdrawal by Subject|3|||
124448393|NCT01968070|447604511|FG004|Period 1|Protocol Violation|1|||
124448394|NCT01968070|447604512|FG005|Period 1|Protocol Violation|0|||
124448395|NCT01968070|447604513|FG006|Period 1|Protocol Violation|0|||
124448396|NCT01968070|447604514|FG007|Period 1|Protocol Violation|0|||
124900914|NCT01235949|449261432|FG001|Primary Phase|Withdrawal by Subject|2|||
124900915|NCT01235949|449261433|FG002|Primary Phase|Withdrawal by Subject|2|||
124900916|NCT01235949|449261434|FG003|Primary Phase|Withdrawal by Subject|0|||
124900917|NCT01235949|449261435|FG004|Primary Phase|Withdrawal by Subject|0|||
124900918|NCT01235949|449261436|FG005|Primary Phase|Withdrawal by Subject|3|||
124900919|NCT01235949|449261437|FG006|Primary Phase|Withdrawal by Subject|0|||
124900920|NCT01235949|449261438|FG007|Primary Phase|Withdrawal by Subject|0|||
124900921|NCT01235949|449261439|FG008|Primary Phase|Withdrawal by Subject|0|||
124900922|NCT01235949|449261440|FG009|Primary Phase|Withdrawal by Subject|0|||
124900923|NCT01235949|449261441|FG010|Primary Phase|Withdrawal by Subject|0|||
124900924|NCT01235949|449261442|FG011|Primary Phase|Withdrawal by Subject|0|||
124900925|NCT01235949|449261443|FG012|Primary Phase|Withdrawal by Subject|0|||
124900926|NCT01235949|449261444|FG013|Primary Phase|Withdrawal by Subject|0|||
124900927|NCT01235949|449261445|FG014|Primary Phase|Withdrawal by Subject|0|||
124900928|NCT01235949|449261446|FG015|Primary Phase|Withdrawal by Subject|0|||
124900929|NCT01235949|449261447|FG016|Primary Phase|Withdrawal by Subject|0|||
124900930|NCT01235949|449261448|FG017|Primary Phase|Withdrawal by Subject|0|||
124900931|NCT01235949|449261431|FG000|Primary Phase|Lost to Follow-up|0|||
124900932|NCT01235949|449261432|FG001|Primary Phase|Lost to Follow-up|0|||
124900933|NCT01235949|449261433|FG002|Primary Phase|Lost to Follow-up|1|||
124900934|NCT01235949|449261434|FG003|Primary Phase|Lost to Follow-up|1|||
124900935|NCT01235949|449261435|FG004|Primary Phase|Lost to Follow-up|0|||
124900936|NCT01235949|449261436|FG005|Primary Phase|Lost to Follow-up|2|||
124900937|NCT01235949|449261437|FG006|Primary Phase|Lost to Follow-up|0|||
124900938|NCT01235949|449261438|FG007|Primary Phase|Lost to Follow-up|0|||
124900939|NCT01235949|449261439|FG008|Primary Phase|Lost to Follow-up|0|||
124900940|NCT01235949|449261440|FG009|Primary Phase|Lost to Follow-up|0|||
124900941|NCT01235949|449261441|FG010|Primary Phase|Lost to Follow-up|0|||
124900942|NCT01235949|449261442|FG011|Primary Phase|Lost to Follow-up|0|||
124900943|NCT01235949|449261443|FG012|Primary Phase|Lost to Follow-up|0|||
124900944|NCT01235949|449261444|FG013|Primary Phase|Lost to Follow-up|0|||
124900945|NCT01235949|449261445|FG014|Primary Phase|Lost to Follow-up|0|||
124900946|NCT01235949|449261446|FG015|Primary Phase|Lost to Follow-up|0|||
124900947|NCT01235949|449261447|FG016|Primary Phase|Lost to Follow-up|0|||
124900948|NCT01235949|449261448|FG017|Primary Phase|Lost to Follow-up|0|||
124900949|NCT01235949|449261431|FG000|Booster Phase|Migrated/moved from study area|0|||
124900950|NCT01235949|449261432|FG001|Booster Phase|Migrated/moved from study area|0|||
124900951|NCT01235949|449261433|FG002|Booster Phase|Migrated/moved from study area|0|||
124900952|NCT01235949|449261434|FG003|Booster Phase|Migrated/moved from study area|0|||
124900953|NCT01235949|449261435|FG004|Booster Phase|Migrated/moved from study area|0|||
124900954|NCT01235949|449261436|FG005|Booster Phase|Migrated/moved from study area|0|||
124900955|NCT01235949|449261437|FG006|Booster Phase|Migrated/moved from study area|0|||
124900956|NCT01235949|449261438|FG007|Booster Phase|Migrated/moved from study area|0|||
124900957|NCT01235949|449261439|FG008|Booster Phase|Migrated/moved from study area|0|||
124900958|NCT01235949|449261440|FG009|Booster Phase|Migrated/moved from study area|0|||
124900959|NCT01235949|449261441|FG010|Booster Phase|Migrated/moved from study area|0|||
124900960|NCT01235949|449261442|FG011|Booster Phase|Migrated/moved from study area|1|||
124900961|NCT01235949|449261443|FG012|Booster Phase|Migrated/moved from study area|1|||
124900962|NCT01235949|449261444|FG013|Booster Phase|Migrated/moved from study area|0|||
124900963|NCT01235949|449261445|FG014|Booster Phase|Migrated/moved from study area|0|||
124900964|NCT01235949|449261446|FG015|Booster Phase|Migrated/moved from study area|0|||
124900965|NCT01235949|449261447|FG016|Booster Phase|Migrated/moved from study area|0|||
124900966|NCT01235949|449261448|FG017|Booster Phase|Migrated/moved from study area|1|||
124900967|NCT01235949|449261431|FG000|Booster Phase|Adverse Event|0|||
124900968|NCT01235949|449261432|FG001|Booster Phase|Adverse Event|0|||
124900969|NCT01235949|449261433|FG002|Booster Phase|Adverse Event|0|||
124900970|NCT01235949|449261434|FG003|Booster Phase|Adverse Event|0|||
124900971|NCT01235949|449261435|FG004|Booster Phase|Adverse Event|0|||
124900972|NCT01235949|449261436|FG005|Booster Phase|Adverse Event|0|||
124900973|NCT01235949|449261437|FG006|Booster Phase|Adverse Event|0|||
124900974|NCT01235949|449261438|FG007|Booster Phase|Adverse Event|0|||
124900975|NCT01235949|449261439|FG008|Booster Phase|Adverse Event|0|||
124900976|NCT01235949|449261440|FG009|Booster Phase|Adverse Event|0|||
124900977|NCT01235949|449261441|FG010|Booster Phase|Adverse Event|0|||
124900978|NCT01235949|449261442|FG011|Booster Phase|Adverse Event|0|||
124900979|NCT01235949|449261443|FG012|Booster Phase|Adverse Event|0|||
124900980|NCT01235949|449261444|FG013|Booster Phase|Adverse Event|0|||
124900981|NCT01235949|449261445|FG014|Booster Phase|Adverse Event|0|||
124900982|NCT01235949|449261446|FG015|Booster Phase|Adverse Event|1|||
124900983|NCT01235949|449261447|FG016|Booster Phase|Adverse Event|0|||
124900984|NCT01235949|449261448|FG017|Booster Phase|Adverse Event|0|||
124900985|NCT01235949|449261431|FG000|Booster Phase|Withdrawal by Subject|0|||
124900986|NCT01235949|449261432|FG001|Booster Phase|Withdrawal by Subject|0|||
124900987|NCT01235949|449261433|FG002|Booster Phase|Withdrawal by Subject|0|||
124900988|NCT01235949|449261434|FG003|Booster Phase|Withdrawal by Subject|0|||
124900989|NCT01235949|449261435|FG004|Booster Phase|Withdrawal by Subject|0|||
124900990|NCT01235949|449261436|FG005|Booster Phase|Withdrawal by Subject|0|||
124900991|NCT01235949|449261437|FG006|Booster Phase|Withdrawal by Subject|0|||
124900992|NCT01235949|449261438|FG007|Booster Phase|Withdrawal by Subject|1|||
124900993|NCT01235949|449261439|FG008|Booster Phase|Withdrawal by Subject|1|||
124691063|NCT03738215|448488092|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
124691064|NCT03738215|448488093|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
124691065|NCT03738215|448488091|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
124691066|NCT03738215|448488092|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
124691067|NCT03738215|448488093|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
124691068|NCT03738215|448488091|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
124691069|NCT03738215|448488092|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
124691070|NCT03738215|448488093|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
124691071|NCT03738215|448488091|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
124691072|NCT03738215|448488092|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
124691073|NCT03738215|448488093|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
124691074|NCT03738215|448488091|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
124691075|NCT03738215|448488092|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
124691076|NCT03738215|448488093|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
124691077|NCT03738215|448488091|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
124691078|NCT03738215|448488092|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
124900994|NCT01235949|449261440|FG009|Booster Phase|Withdrawal by Subject|0|||
124900995|NCT01235949|449261441|FG010|Booster Phase|Withdrawal by Subject|1|||
124900996|NCT01235949|449261442|FG011|Booster Phase|Withdrawal by Subject|1|||
124900997|NCT01235949|449261443|FG012|Booster Phase|Withdrawal by Subject|2|||
124900998|NCT01235949|449261444|FG013|Booster Phase|Withdrawal by Subject|0|||
124900999|NCT01235949|449261445|FG014|Booster Phase|Withdrawal by Subject|2|||
124901000|NCT01235949|449261446|FG015|Booster Phase|Withdrawal by Subject|0|||
124901001|NCT01235949|449261447|FG016|Booster Phase|Withdrawal by Subject|0|||
124901002|NCT01235949|449261448|FG017|Booster Phase|Withdrawal by Subject|0|||
124901003|NCT01235949|449261431|FG000|Booster Phase|Lost to Follow-up|0|||
124901004|NCT01235949|449261432|FG001|Booster Phase|Lost to Follow-up|0|||
124901005|NCT01235949|449261433|FG002|Booster Phase|Lost to Follow-up|0|||
124901006|NCT01235949|449261434|FG003|Booster Phase|Lost to Follow-up|0|||
124901007|NCT01235949|449261435|FG004|Booster Phase|Lost to Follow-up|0|||
124901008|NCT01235949|449261436|FG005|Booster Phase|Lost to Follow-up|0|||
124901009|NCT01235949|449261437|FG006|Booster Phase|Lost to Follow-up|0|||
124901010|NCT01235949|449261438|FG007|Booster Phase|Lost to Follow-up|0|||
124901011|NCT01235949|449261439|FG008|Booster Phase|Lost to Follow-up|1|||
124901012|NCT01235949|449261440|FG009|Booster Phase|Lost to Follow-up|1|||
124901013|NCT01235949|449261441|FG010|Booster Phase|Lost to Follow-up|1|||
124901014|NCT01235949|449261442|FG011|Booster Phase|Lost to Follow-up|1|||
124901015|NCT01235949|449261443|FG012|Booster Phase|Lost to Follow-up|0|||
124901016|NCT01235949|449261444|FG013|Booster Phase|Lost to Follow-up|0|||
124901017|NCT01235949|449261445|FG014|Booster Phase|Lost to Follow-up|0|||
124901018|NCT01235949|449261446|FG015|Booster Phase|Lost to Follow-up|0|||
124901019|NCT01235949|449261447|FG016|Booster Phase|Lost to Follow-up|0|||
124901020|NCT01235949|449261448|FG017|Booster Phase|Lost to Follow-up|1|||
124901021|NCT04173572|449261449|FG000|Overall Study|Withdrawal by Subject|1|||
124901022|NCT04173572|449261450|FG001|Overall Study|Withdrawal by Subject|5|||
124901023|NCT04173572|449261449|FG000|Overall Study|Lost to Follow-up|3|||
124901024|NCT04173572|449261450|FG001|Overall Study|Lost to Follow-up|1|||
124901025|NCT01839877|449261451|FG000|Overall Study|Protocol Violation|1|||
124901026|NCT04536077|449261455|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
124901027|NCT04536077|449261456|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
124901028|NCT04536077|449261455|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
124901029|NCT04536077|449261456|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
124901030|NCT05484726|449261457|FG000|Overall Study|Protocol Violation|3|||
124901031|NCT05484726|449261458|FG001|Overall Study|Protocol Violation|3|||
124901032|NCT05484726|449261457|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
124901033|NCT05484726|449261458|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
124901034|NCT05484726|449261457|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
124901035|NCT05484726|449261458|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
124901036|NCT05484726|449261457|FG000|Overall Study|continued need of mechanical ventilation|2|||
124901037|NCT05484726|449261458|FG001|Overall Study|continued need of mechanical ventilation|3|||
124901038|NCT05484726|449261457|FG000|Overall Study|Withdrawal by Subject|2|||
124901039|NCT05484726|449261458|FG001|Overall Study|Withdrawal by Subject|3|||
124901040|NCT05484726|449261457|FG000|Overall Study|IVH (G III & IV)|2|||
124901041|NCT05484726|449261458|FG001|Overall Study|IVH (G III & IV)|1|||
124901042|NCT05484726|449261457|FG000|Overall Study|NEC (stage II & III)|2|||
124691079|NCT03738215|448488093|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
124901043|NCT05484726|449261458|FG001|Overall Study|NEC (stage II & III)|3|||
124901044|NCT02824432|449261459|FG000|Overall Study|Major Protocol Deviation|1|||
124901045|NCT02824432|449261460|FG001|Overall Study|Major Protocol Deviation|0|||
124691080|NCT01033071|448488094|FG000|Overall Study|Adverse Event|28|||
124901046|NCT00554801|449261461|FG000|Overall Study|left area before completion|5|||
124901047|NCT00554801|449261462|FG001|Overall Study|left area before completion|0|||
124901048|NCT00554801|449261461|FG000|Overall Study|Withdrawal by Subject|14|||
124901049|NCT00554801|449261462|FG001|Overall Study|Withdrawal by Subject|0|||
124901050|NCT04436120|449261463|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
124901051|NCT04436120|449261464|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
124901052|NCT04436120|449261465|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
124901053|NCT04436120|449261466|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
124901054|NCT04436120|449261467|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
124901055|NCT04436120|449261468|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
124901056|NCT04436120|449261469|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
124901057|NCT01838551|449261475|FG000|Overall Study|Adverse Event|16|||
124901058|NCT01838551|449261475|FG000|Overall Study|Death|1|||
124901059|NCT01838551|449261475|FG000|Overall Study|Lack of Efficacy|10|||
124901060|NCT01838551|449261475|FG000|Overall Study|Physician Decision|4|||
124901061|NCT01838551|449261475|FG000|Overall Study|Withdrawal by Subject|10|||
124901062|NCT01838551|449261475|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
124901063|NCT01981356|449261476|FG000|Overall Study|Lost to Follow-up|4|||
124901064|NCT01981356|449261477|FG001|Overall Study|Lost to Follow-up|1|||
124901065|NCT01981356|449261476|FG000|Overall Study|Withdrawal by Subject|1|||
124901066|NCT01981356|449261477|FG001|Overall Study|Withdrawal by Subject|1|||
124901067|NCT01981356|449261476|FG000|Overall Study|Protocol Violation|2|||
124901068|NCT01981356|449261477|FG001|Overall Study|Protocol Violation|0|||
124901069|NCT02486588|449261478|FG000|Overall Study|Randomized in error- ineligible|738|||
124901070|NCT02486588|449261479|FG001|Overall Study|Randomized in error- ineligible|750|||
124901071|NCT02486588|449261480|FG002|Overall Study|Randomized in error- ineligible|755|||
124901072|NCT02486588|449261481|FG003|Overall Study|Randomized in error- ineligible|738|||
124901073|NCT02486588|449261482|FG004|Overall Study|Randomized in error- ineligible|746|||
124901074|NCT02486588|449261483|FG005|Overall Study|Randomized in error- ineligible|746|||
124901075|NCT03354390|449261484|FG000|Level 1|Death|2|||
124901076|NCT03354390|449261485|FG001|Level 1|Death|0|||
124901077|NCT03354390|449261486|FG002|Level 1|Death|0|||
124901078|NCT03354390|449261487|FG003|Level 1|Death|0|||
124901079|NCT03354390|449261484|FG000|Level 1|Physician Decision|1|||
124901080|NCT03354390|449261485|FG001|Level 1|Physician Decision|0|||
124901081|NCT03354390|449261486|FG002|Level 1|Physician Decision|0|||
124901082|NCT03354390|449261487|FG003|Level 1|Physician Decision|0|||
124901083|NCT03354390|449261484|FG000|Level 2|Physician Decision|0|||
124901084|NCT03354390|449261485|FG001|Level 2|Physician Decision|2|||
124901085|NCT03354390|449261486|FG002|Level 2|Physician Decision|0|||
124901086|NCT03354390|449261487|FG003|Level 2|Physician Decision|0|||
124901087|NCT03354390|449261484|FG000|Level 2|Lack of Efficacy|0|||
124901088|NCT03354390|449261485|FG001|Level 2|Lack of Efficacy|1|||
124901089|NCT03354390|449261486|FG002|Level 2|Lack of Efficacy|0|||
124901090|NCT03354390|449261487|FG003|Level 2|Lack of Efficacy|0|||
124901091|NCT03354390|449261484|FG000|Level 2|Lost to Follow-up|0|||
124901092|NCT03354390|449261485|FG001|Level 2|Lost to Follow-up|1|||
124901093|NCT03354390|449261486|FG002|Level 2|Lost to Follow-up|0|||
124901094|NCT03354390|449261487|FG003|Level 2|Lost to Follow-up|0|||
124901095|NCT03354390|449261484|FG000|Level 3|Death|0|||
124901096|NCT03354390|449261485|FG001|Level 3|Death|0|||
124901097|NCT03354390|449261486|FG002|Level 3|Death|1|||
124901098|NCT03354390|449261487|FG003|Level 3|Death|0|||
124901099|NCT03354390|449261484|FG000|Level 3|Physician Decision|0|||
124901100|NCT03354390|449261485|FG001|Level 3|Physician Decision|0|||
124901101|NCT03354390|449261486|FG002|Level 3|Physician Decision|2|||
124901102|NCT03354390|449261487|FG003|Level 3|Physician Decision|0|||
124901103|NCT03354390|449261484|FG000|Level 4|Death|0|||
124901104|NCT03354390|449261485|FG001|Level 4|Death|0|||
124901105|NCT03354390|449261486|FG002|Level 4|Death|0|||
124901106|NCT03354390|449261487|FG003|Level 4|Death|3|||
124901107|NCT03227757|449263264|FG000|Overall Study|Death|25|||
124901108|NCT03227757|449263264|FG000|Overall Study|Withdrawal|10|||
124901109|NCT03227757|449263264|FG000|Overall Study|Missed visits|1|||
124901110|NCT03227757|449263264|FG000|Overall Study|Lost to Follow-up|2|||
124901111|NCT01875250|449263266|FG000|Overall Study|Adverse Event|2|||
124901112|NCT01875250|449263267|FG001|Overall Study|Adverse Event|0|||
124901113|NCT03068468|449263270|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
124901114|NCT03068468|449263271|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
124901115|NCT03068468|449263272|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
124901116|NCT03068468|449263273|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
124691081|NCT01033071|448488095|FG001|Overall Study|Adverse Event|51|||
124691082|NCT01033071|448488096|FG002|Overall Study|Adverse Event|26|||
124691083|NCT01033071|448488094|FG000|Overall Study|Protocol Violation|0|||
124901117|NCT03068468|449263270|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
124901118|NCT03068468|449263271|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
124901119|NCT03068468|449263272|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
124901120|NCT03068468|449263273|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
124901121|NCT03068468|449263270|FG000|Placebo-Controlled Period|Adverse Event|16|||
124901122|NCT03068468|449263271|FG001|Placebo-Controlled Period|Adverse Event|21|||
124901123|NCT03068468|449263272|FG002|Placebo-Controlled Period|Adverse Event|0|||
124901124|NCT03068468|449263273|FG003|Placebo-Controlled Period|Adverse Event|0|||
124901125|NCT03068468|449263270|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
124901126|NCT03068468|449263271|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
124901127|NCT03068468|449263272|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
124901128|NCT03068468|449263273|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
124901129|NCT03068468|449263270|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
124901130|NCT03068468|449263271|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
124901131|NCT03068468|449263272|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
124901132|NCT03068468|449263273|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
124901133|NCT03068468|449263270|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
124901134|NCT03068468|449263271|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
124901135|NCT03068468|449263272|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
124901136|NCT03068468|449263273|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
124901137|NCT03068468|449263270|FG000|Placebo-Controlled Period|Death|0|||
124901138|NCT03068468|449263271|FG001|Placebo-Controlled Period|Death|1|||
124901139|NCT03068468|449263272|FG002|Placebo-Controlled Period|Death|0|||
124901140|NCT03068468|449263273|FG003|Placebo-Controlled Period|Death|0|||
124901141|NCT03068468|449263270|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
124901142|NCT03068468|449263271|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
124901143|NCT03068468|449263272|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
124901144|NCT03068468|449263273|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
124901145|NCT03068468|449263270|FG000|Open-Label Extension Period|Adverse Event|0|||
124901146|NCT03068468|449263271|FG001|Open-Label Extension Period|Adverse Event|0|||
124901147|NCT03068468|449263272|FG002|Open-Label Extension Period|Adverse Event|13|||
124901148|NCT03068468|449263273|FG003|Open-Label Extension Period|Adverse Event|17|||
124901149|NCT03068468|449263270|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
124448397|NCT01968070|447604515|FG008|Period 1|Protocol Violation|0|||
124448398|NCT01968070|447604516|FG009|Period 1|Protocol Violation|0|||
124448399|NCT01968070|447604517|FG010|Period 1|Protocol Violation|0|||
124448400|NCT01968070|447604518|FG011|Period 1|Protocol Violation|0|||
124448401|NCT01968070|447604519|FG012|Period 1|Protocol Violation|0|||
124901150|NCT03068468|449263271|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
124901151|NCT03068468|449263272|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
124901152|NCT03068468|449263273|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
124901153|NCT03068468|449263270|FG000|Open-Label Extension Period|Death|0|||
124901154|NCT03068468|449263271|FG001|Open-Label Extension Period|Death|0|||
124901155|NCT03068468|449263272|FG002|Open-Label Extension Period|Death|0|||
124901156|NCT03068468|449263273|FG003|Open-Label Extension Period|Death|1|||
124901157|NCT03068468|449263270|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
124901158|NCT03068468|449263271|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
124901159|NCT03068468|449263272|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
124901160|NCT03068468|449263273|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
124901161|NCT03068468|449263270|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
124901162|NCT03068468|449263271|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
124901163|NCT03068468|449263272|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
124901164|NCT03068468|449263273|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
124901165|NCT03068468|449263270|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
124901166|NCT03068468|449263271|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
124901167|NCT03068468|449263272|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
124901168|NCT03068468|449263273|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
124901169|NCT03068468|449263270|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
124901170|NCT03068468|449263271|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
124901171|NCT03068468|449263272|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
124901172|NCT03068468|449263273|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
124901173|NCT03068468|449263270|FG000|Open-Label Extension Period|Reason not Specified|0|||
124901174|NCT03068468|449263271|FG001|Open-Label Extension Period|Reason not Specified|0|||
124448402|NCT01968070|447604520|FG013|Period 1|Protocol Violation|0|||
124448403|NCT01968070|447604521|FG014|Period 1|Protocol Violation|0|||
124448404|NCT01968070|447604522|FG015|Period 1|Protocol Violation|0|||
124448405|NCT01968070|447604523|FG016|Period 1|Protocol Violation|0|||
124448406|NCT01968070|447604524|FG017|Period 1|Protocol Violation|0|||
124448407|NCT01968070|447604507|FG000|Period 1|Lost to Follow-up|0|||
124448408|NCT01968070|447604508|FG001|Period 1|Lost to Follow-up|0|||
124448409|NCT01968070|447604509|FG002|Period 1|Lost to Follow-up|0|||
124448410|NCT01968070|447604510|FG003|Period 1|Lost to Follow-up|1|||
124448411|NCT01968070|447604511|FG004|Period 1|Lost to Follow-up|0|||
124448412|NCT01968070|447604512|FG005|Period 1|Lost to Follow-up|0|||
124448413|NCT01968070|447604513|FG006|Period 1|Lost to Follow-up|0|||
124448414|NCT01968070|447604514|FG007|Period 1|Lost to Follow-up|0|||
124901175|NCT03068468|449263272|FG002|Open-Label Extension Period|Reason not Specified|1|||
124901176|NCT03068468|449263273|FG003|Open-Label Extension Period|Reason not Specified|4|||
124901177|NCT02466516|449263275|FG000|Overall Study|Adverse Event|1|||
124901178|NCT02466516|449263276|FG001|Overall Study|Adverse Event|1|||
124901179|NCT02466516|449263277|FG002|Overall Study|Adverse Event|0|||
124901180|NCT02466516|449263278|FG003|Overall Study|Adverse Event|0|||
124901181|NCT02466516|449263279|FG004|Overall Study|Adverse Event|0|||
124901182|NCT02466516|449263275|FG000|Overall Study|Withdrew Consent|1|||
124901183|NCT02466516|449263276|FG001|Overall Study|Withdrew Consent|0|||
124448415|NCT01968070|447604515|FG008|Period 1|Lost to Follow-up|0|||
124901184|NCT02466516|449263277|FG002|Overall Study|Withdrew Consent|0|||
124901185|NCT02466516|449263278|FG003|Overall Study|Withdrew Consent|0|||
124901186|NCT02466516|449263279|FG004|Overall Study|Withdrew Consent|0|||
124448416|NCT01968070|447604516|FG009|Period 1|Lost to Follow-up|0|||
124448417|NCT01968070|447604517|FG010|Period 1|Lost to Follow-up|0|||
124448418|NCT01968070|447604518|FG011|Period 1|Lost to Follow-up|0|||
124901187|NCT02466516|449263275|FG000|Overall Study|Lost to Follow-up|2|||
124901188|NCT02466516|449263276|FG001|Overall Study|Lost to Follow-up|0|||
124901189|NCT02466516|449263277|FG002|Overall Study|Lost to Follow-up|1|||
124901190|NCT02466516|449263278|FG003|Overall Study|Lost to Follow-up|0|||
124901191|NCT02466516|449263279|FG004|Overall Study|Lost to Follow-up|0|||
124901192|NCT03712930|449263280|FG000|Overall Study|Death|7|||
124901193|NCT03712930|449263280|FG000|Overall Study|Physician Decision|1|||
124901194|NCT03712930|449263280|FG000|Overall Study|Study Terminated by Sponsor|3|||
124901195|NCT03712930|449263280|FG000|Overall Study|Progressive Disease|2|||
124901196|NCT00486759|449263284|FG000|Treatment|Adverse event/intercurrent illness|86|||
124901197|NCT00486759|449263285|FG001|Treatment|Adverse event/intercurrent illness|39|||
124901198|NCT00486759|449263284|FG000|Treatment|Insufficient therapeutic response|37|||
124901199|NCT00486759|449263285|FG001|Treatment|Insufficient therapeutic response|39|||
124901200|NCT00486759|449263284|FG000|Treatment|Death|17|||
124901201|NCT00486759|449263285|FG001|Treatment|Death|10|||
124901202|NCT00486759|449263284|FG000|Treatment|Withdrew consent|15|||
124901203|NCT00486759|449263285|FG001|Treatment|Withdrew consent|12|||
124901204|NCT00486759|449263284|FG000|Treatment|Administrative/reason not specified|17|||
124901205|NCT00486759|449263285|FG001|Treatment|Administrative/reason not specified|21|||
124901206|NCT00486759|449263284|FG000|Treatment|Refused treatment|10|||
124901207|NCT00486759|449263285|FG001|Treatment|Refused treatment|7|||
124901208|NCT00486759|449263284|FG000|Treatment|Violation of selection criteria at entry|3|||
124901209|NCT00486759|449263285|FG001|Treatment|Violation of selection criteria at entry|3|||
124901210|NCT00486759|449263284|FG000|Treatment|Other protocol violation|1|||
124901211|NCT00486759|449263285|FG001|Treatment|Other protocol violation|5|||
124901212|NCT00486759|449263284|FG000|Treatment|Failure to return|1|||
124901213|NCT00486759|449263285|FG001|Treatment|Failure to return|1|||
124901214|NCT00486759|449263284|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
124901215|NCT00486759|449263285|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
124901216|NCT00486759|449263284|FG000|Safety Follow-up|Death|40|||
124901217|NCT00486759|449263285|FG001|Safety Follow-up|Death|29|||
124901218|NCT00486759|449263284|FG000|Safety Follow-up|Withdrew consent|32|||
124901219|NCT00486759|449263285|FG001|Safety Follow-up|Withdrew consent|23|||
124901220|NCT00486759|449263284|FG000|Safety Follow-up|Failure to return|9|||
124901221|NCT00486759|449263285|FG001|Safety Follow-up|Failure to return|6|||
124901222|NCT00486759|449263284|FG000|Safety Follow-up|Administrative/not specified|8|||
124901223|NCT00486759|449263285|FG001|Safety Follow-up|Administrative/not specified|6|||
124901224|NCT00486759|449263284|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
124901225|NCT00486759|449263285|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
124901226|NCT00486759|449263284|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
124901227|NCT00486759|449263285|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
124901228|NCT02001623|449263288|FG000|Overall Study|Disease Progression|2|||
124901229|NCT02001623|449263289|FG001|Overall Study|Disease Progression|2|||
124901230|NCT02001623|449263290|FG002|Overall Study|Disease Progression|3|||
124901231|NCT02001623|449263291|FG003|Overall Study|Disease Progression|2|||
124901232|NCT02001623|449263292|FG004|Overall Study|Disease Progression|3|||
124901233|NCT02001623|449263293|FG005|Overall Study|Disease Progression|2|||
124901234|NCT02001623|449263294|FG006|Overall Study|Disease Progression|3|||
124901235|NCT02001623|449263295|FG007|Overall Study|Disease Progression|3|||
124901236|NCT02001623|449263296|FG008|Overall Study|Disease Progression|7|||
124901237|NCT02001623|449263297|FG009|Overall Study|Disease Progression|40|||
124901238|NCT02001623|449263298|FG010|Overall Study|Disease Progression|5|||
124901239|NCT02001623|449263299|FG011|Overall Study|Disease Progression|9|||
124901240|NCT02001623|449263300|FG012|Overall Study|Disease Progression|9|||
124901241|NCT02001623|449263301|FG013|Overall Study|Disease Progression|20|||
124901242|NCT02001623|449263302|FG014|Overall Study|Disease Progression|9|||
124901243|NCT02001623|449263288|FG000|Overall Study|Physician Decision|0|||
124901244|NCT02001623|449263289|FG001|Overall Study|Physician Decision|0|||
124901245|NCT02001623|449263290|FG002|Overall Study|Physician Decision|0|||
124901246|NCT02001623|449263291|FG003|Overall Study|Physician Decision|0|||
124901247|NCT02001623|449263292|FG004|Overall Study|Physician Decision|0|||
124901248|NCT02001623|449263293|FG005|Overall Study|Physician Decision|0|||
124901249|NCT02001623|449263294|FG006|Overall Study|Physician Decision|0|||
124901250|NCT02001623|449263295|FG007|Overall Study|Physician Decision|0|||
124901251|NCT02001623|449263296|FG008|Overall Study|Physician Decision|3|||
124901252|NCT02001623|449263297|FG009|Overall Study|Physician Decision|2|||
124901253|NCT02001623|449263298|FG010|Overall Study|Physician Decision|3|||
124901254|NCT02001623|449263299|FG011|Overall Study|Physician Decision|3|||
124901255|NCT02001623|449263300|FG012|Overall Study|Physician Decision|1|||
124901256|NCT02001623|449263301|FG013|Overall Study|Physician Decision|2|||
124901257|NCT02001623|449263302|FG014|Overall Study|Physician Decision|1|||
124901258|NCT02001623|449263288|FG000|Overall Study|Death|0|||
124901259|NCT02001623|449263289|FG001|Overall Study|Death|1|||
124901260|NCT02001623|449263290|FG002|Overall Study|Death|0|||
124901261|NCT02001623|449263291|FG003|Overall Study|Death|0|||
124901262|NCT02001623|449263292|FG004|Overall Study|Death|0|||
124901263|NCT02001623|449263293|FG005|Overall Study|Death|0|||
124901264|NCT02001623|449263294|FG006|Overall Study|Death|0|||
124901265|NCT02001623|449263295|FG007|Overall Study|Death|0|||
124901266|NCT02001623|449263296|FG008|Overall Study|Death|0|||
124901267|NCT02001623|449263297|FG009|Overall Study|Death|0|||
124901268|NCT02001623|449263298|FG010|Overall Study|Death|0|||
124901269|NCT02001623|449263299|FG011|Overall Study|Death|0|||
124901270|NCT02001623|449263300|FG012|Overall Study|Death|0|||
124691084|NCT01033071|448488095|FG001|Overall Study|Protocol Violation|2|||
124691085|NCT01033071|448488096|FG002|Overall Study|Protocol Violation|1|||
124691086|NCT01033071|448488094|FG000|Overall Study|Lost to Follow-up|4|||
124448419|NCT01968070|447604519|FG012|Period 1|Lost to Follow-up|0|||
124448420|NCT01968070|447604520|FG013|Period 1|Lost to Follow-up|0|||
124901271|NCT02001623|449263301|FG013|Overall Study|Death|0|||
124901272|NCT02001623|449263302|FG014|Overall Study|Death|0|||
124901273|NCT02001623|449263288|FG000|Overall Study|Adverse Event|0|||
124901274|NCT02001623|449263289|FG001|Overall Study|Adverse Event|0|||
124901275|NCT02001623|449263290|FG002|Overall Study|Adverse Event|0|||
124901276|NCT02001623|449263291|FG003|Overall Study|Adverse Event|0|||
124901277|NCT02001623|449263292|FG004|Overall Study|Adverse Event|0|||
124901278|NCT02001623|449263293|FG005|Overall Study|Adverse Event|1|||
124901279|NCT02001623|449263294|FG006|Overall Study|Adverse Event|0|||
124901280|NCT02001623|449263295|FG007|Overall Study|Adverse Event|3|||
124901281|NCT02001623|449263296|FG008|Overall Study|Adverse Event|4|||
124901282|NCT02001623|449263297|FG009|Overall Study|Adverse Event|6|||
124901283|NCT02001623|449263298|FG010|Overall Study|Adverse Event|4|||
124901284|NCT02001623|449263299|FG011|Overall Study|Adverse Event|0|||
124901285|NCT02001623|449263300|FG012|Overall Study|Adverse Event|3|||
124901286|NCT02001623|449263301|FG013|Overall Study|Adverse Event|5|||
124901287|NCT02001623|449263302|FG014|Overall Study|Adverse Event|6|||
124901288|NCT02001623|449263288|FG000|Overall Study|Other - Miscellaneous|0|||
124901289|NCT02001623|449263289|FG001|Overall Study|Other - Miscellaneous|0|||
124901290|NCT02001623|449263290|FG002|Overall Study|Other - Miscellaneous|0|||
124901291|NCT02001623|449263291|FG003|Overall Study|Other - Miscellaneous|0|||
124901292|NCT02001623|449263292|FG004|Overall Study|Other - Miscellaneous|0|||
124901293|NCT02001623|449263293|FG005|Overall Study|Other - Miscellaneous|0|||
124901294|NCT02001623|449263294|FG006|Overall Study|Other - Miscellaneous|0|||
124901295|NCT02001623|449263295|FG007|Overall Study|Other - Miscellaneous|0|||
124901296|NCT02001623|449263296|FG008|Overall Study|Other - Miscellaneous|0|||
124901297|NCT02001623|449263297|FG009|Overall Study|Other - Miscellaneous|1|||
124901298|NCT02001623|449263298|FG010|Overall Study|Other - Miscellaneous|0|||
124901299|NCT02001623|449263299|FG011|Overall Study|Other - Miscellaneous|0|||
124901300|NCT02001623|449263300|FG012|Overall Study|Other - Miscellaneous|0|||
124901301|NCT02001623|449263301|FG013|Overall Study|Other - Miscellaneous|1|||
124901302|NCT02001623|449263302|FG014|Overall Study|Other - Miscellaneous|0|||
124901303|NCT02001623|449263288|FG000|Overall Study|Withdrawal by Subject|1|||
124901304|NCT02001623|449263289|FG001|Overall Study|Withdrawal by Subject|0|||
124901305|NCT02001623|449263290|FG002|Overall Study|Withdrawal by Subject|0|||
124901306|NCT02001623|449263291|FG003|Overall Study|Withdrawal by Subject|0|||
124901307|NCT02001623|449263292|FG004|Overall Study|Withdrawal by Subject|0|||
124901308|NCT02001623|449263293|FG005|Overall Study|Withdrawal by Subject|0|||
124901309|NCT02001623|449263294|FG006|Overall Study|Withdrawal by Subject|0|||
124901310|NCT02001623|449263295|FG007|Overall Study|Withdrawal by Subject|0|||
124901311|NCT02001623|449263296|FG008|Overall Study|Withdrawal by Subject|1|||
124901312|NCT02001623|449263297|FG009|Overall Study|Withdrawal by Subject|3|||
124448421|NCT01968070|447604521|FG014|Period 1|Lost to Follow-up|0|||
124448422|NCT01968070|447604522|FG015|Period 1|Lost to Follow-up|0|||
124448423|NCT01968070|447604523|FG016|Period 1|Lost to Follow-up|0|||
124448424|NCT01968070|447604524|FG017|Period 1|Lost to Follow-up|0|||
124448425|NCT01968070|447604507|FG000|Period 1|Adverse Event|0|||
124448426|NCT01968070|447604508|FG001|Period 1|Adverse Event|0|||
124448427|NCT01968070|447604509|FG002|Period 1|Adverse Event|0|||
124691087|NCT01033071|448488095|FG001|Overall Study|Lost to Follow-up|5|||
124691088|NCT01033071|448488096|FG002|Overall Study|Lost to Follow-up|5|||
124691089|NCT01033071|448488094|FG000|Overall Study|Withdrawal by Subject|17|||
124691090|NCT01033071|448488095|FG001|Overall Study|Withdrawal by Subject|14|||
124691091|NCT01033071|448488096|FG002|Overall Study|Withdrawal by Subject|11|||
124691092|NCT01033071|448488094|FG000|Overall Study|Lack of Efficacy|0|||
124691093|NCT01033071|448488095|FG001|Overall Study|Lack of Efficacy|1|||
124691094|NCT01033071|448488096|FG002|Overall Study|Lack of Efficacy|1|||
124901313|NCT02001623|449263298|FG010|Overall Study|Withdrawal by Subject|2|||
124901314|NCT02001623|449263299|FG011|Overall Study|Withdrawal by Subject|2|||
124901315|NCT02001623|449263300|FG012|Overall Study|Withdrawal by Subject|1|||
124901316|NCT02001623|449263301|FG013|Overall Study|Withdrawal by Subject|5|||
124901317|NCT02001623|449263302|FG014|Overall Study|Withdrawal by Subject|2|||
124901318|NCT02001623|449263288|FG000|Overall Study|Lost to Follow-up|0|||
124901319|NCT02001623|449263289|FG001|Overall Study|Lost to Follow-up|0|||
124448428|NCT01968070|447604510|FG003|Period 1|Adverse Event|0|||
124448429|NCT01968070|447604511|FG004|Period 1|Adverse Event|0|||
124448430|NCT01968070|447604512|FG005|Period 1|Adverse Event|0|||
124691095|NCT01033071|448488094|FG000|Overall Study|Other|6|||
124691096|NCT01033071|448488095|FG001|Overall Study|Other|4|||
124448431|NCT01968070|447604513|FG006|Period 1|Adverse Event|1|||
124901320|NCT02001623|449263290|FG002|Overall Study|Lost to Follow-up|0|||
124901321|NCT02001623|449263291|FG003|Overall Study|Lost to Follow-up|0|||
124901322|NCT02001623|449263292|FG004|Overall Study|Lost to Follow-up|0|||
124901323|NCT02001623|449263293|FG005|Overall Study|Lost to Follow-up|0|||
124901324|NCT02001623|449263294|FG006|Overall Study|Lost to Follow-up|0|||
124901325|NCT02001623|449263295|FG007|Overall Study|Lost to Follow-up|0|||
124901326|NCT02001623|449263296|FG008|Overall Study|Lost to Follow-up|0|||
124901327|NCT02001623|449263297|FG009|Overall Study|Lost to Follow-up|1|||
124901328|NCT02001623|449263298|FG010|Overall Study|Lost to Follow-up|0|||
124901329|NCT02001623|449263299|FG011|Overall Study|Lost to Follow-up|0|||
124901330|NCT02001623|449263300|FG012|Overall Study|Lost to Follow-up|0|||
124901331|NCT02001623|449263301|FG013|Overall Study|Lost to Follow-up|0|||
124901332|NCT02001623|449263302|FG014|Overall Study|Lost to Follow-up|0|||
124901333|NCT02001623|449263288|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
124901334|NCT02001623|449263289|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
124901335|NCT02001623|449263290|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
124901336|NCT02001623|449263291|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
124901337|NCT02001623|449263292|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
124901338|NCT02001623|449263293|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
124901339|NCT02001623|449263294|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
124901340|NCT02001623|449263295|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
124901341|NCT02001623|449263296|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
124901342|NCT02001623|449263297|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
124901343|NCT02001623|449263298|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
124901344|NCT02001623|449263299|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
124901345|NCT02001623|449263300|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
124901346|NCT02001623|449263301|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
124901347|NCT02001623|449263302|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
124901348|NCT02001623|449263288|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
124901349|NCT02001623|449263289|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
124901350|NCT02001623|449263290|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
124901351|NCT02001623|449263291|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
124901352|NCT02001623|449263292|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
124901353|NCT02001623|449263293|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
124901354|NCT02001623|449263294|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
124901355|NCT02001623|449263295|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
124901356|NCT02001623|449263296|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
124901357|NCT02001623|449263297|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
124901358|NCT02001623|449263298|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
124901359|NCT02001623|449263299|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
124901360|NCT02001623|449263300|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
124901361|NCT02001623|449263301|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
124901362|NCT02001623|449263302|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
124448432|NCT01968070|447604514|FG007|Period 1|Adverse Event|0|||
124448433|NCT01968070|447604515|FG008|Period 1|Adverse Event|0|||
124448434|NCT01968070|447604516|FG009|Period 1|Adverse Event|0|||
124448435|NCT01968070|447604517|FG010|Period 1|Adverse Event|0|||
124448436|NCT01968070|447604518|FG011|Period 1|Adverse Event|0|||
124448437|NCT01968070|447604519|FG012|Period 1|Adverse Event|0|||
124759865|NCT01135134|448744777|FG000|Overall Study|Did not meet protocol eligibility|1|||
124448438|NCT01968070|447604520|FG013|Period 1|Adverse Event|0|||
124448439|NCT01968070|447604521|FG014|Period 1|Adverse Event|0|||
124448440|NCT01968070|447604522|FG015|Period 1|Adverse Event|0|||
124448441|NCT01968070|447604523|FG016|Period 1|Adverse Event|0|||
124448442|NCT01968070|447604524|FG017|Period 1|Adverse Event|0|||
124448443|NCT01968070|447604507|FG000|Period 1|Physician Decision|0|||
124448444|NCT01968070|447604508|FG001|Period 1|Physician Decision|0|||
124448445|NCT01968070|447604509|FG002|Period 1|Physician Decision|0|||
124448446|NCT01968070|447604510|FG003|Period 1|Physician Decision|0|||
124448447|NCT01968070|447604511|FG004|Period 1|Physician Decision|0|||
124448448|NCT01968070|447604512|FG005|Period 1|Physician Decision|0|||
124759866|NCT01135134|448744778|FG001|Overall Study|Did not meet protocol eligibility|0|||
124759867|NCT00256724|448744783|FG000|Overall Study|Physician Decision|2|||
124759868|NCT00256724|448744784|FG001|Overall Study|Physician Decision|5|||
124759869|NCT00256724|448744783|FG000|Overall Study|Protocol Violation|3|||
124759870|NCT00256724|448744784|FG001|Overall Study|Protocol Violation|3|||
124759871|NCT01569841|448744787|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
124901363|NCT00686517|449263303|FG000|Treatment|Serious Adverse Event|1|||
124901364|NCT00686517|449263304|FG001|Treatment|Serious Adverse Event|2|||
124901365|NCT00686517|449263305|FG002|Treatment|Serious Adverse Event|1|||
124901366|NCT00686517|449263303|FG000|Treatment|Adverse Event|2|||
124901367|NCT00686517|449263304|FG001|Treatment|Adverse Event|0|||
124901368|NCT00686517|449263305|FG002|Treatment|Adverse Event|0|||
124901369|NCT00686517|449263303|FG000|Treatment|Poor Protocol Compliance|1|||
124901370|NCT00686517|449263304|FG001|Treatment|Poor Protocol Compliance|0|||
124901371|NCT00686517|449263305|FG002|Treatment|Poor Protocol Compliance|0|||
124901372|NCT00686517|449263303|FG000|Treatment|Protocol Violation|2|||
124901373|NCT00686517|449263304|FG001|Treatment|Protocol Violation|1|||
124901374|NCT00686517|449263305|FG002|Treatment|Protocol Violation|0|||
124901375|NCT02281318|449263306|FG000|Overall Study|Adverse Event|2|||
124448449|NCT01968070|447604513|FG006|Period 1|Physician Decision|0|||
124759872|NCT01569841|448744788|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
124901376|NCT02281318|449263307|FG001|Overall Study|Adverse Event|2|||
124901377|NCT02281318|449263306|FG000|Overall Study|Lack of Efficacy|2|||
124901378|NCT02281318|449263307|FG001|Overall Study|Lack of Efficacy|0|||
124901379|NCT02281318|449263306|FG000|Overall Study|Lost to Follow-up|2|||
124901380|NCT02281318|449263307|FG001|Overall Study|Lost to Follow-up|1|||
124901381|NCT02281318|449263306|FG000|Overall Study|Physician Decision|2|||
124901382|NCT02281318|449263307|FG001|Overall Study|Physician Decision|0|||
124901383|NCT02281318|449263306|FG000|Overall Study|Withdrawal by Subject|6|||
124901384|NCT02281318|449263307|FG001|Overall Study|Withdrawal by Subject|2|||
124901385|NCT01064817|449263310|FG000|Study Completion|Physician Decision|1|||
124901386|NCT01064817|449263311|FG001|Study Completion|Physician Decision|0|||
124901387|NCT01064817|449263310|FG000|Study Completion|Withdrawal by Subject|1|||
124901388|NCT01064817|449263311|FG001|Study Completion|Withdrawal by Subject|0|||
124901389|NCT03670602|449263322|FG000|Overall Study|Lost to Follow-up|1|||
124901390|NCT03670602|449263323|FG001|Overall Study|Lost to Follow-up|0|||
124901391|NCT03670602|449263322|FG000|Overall Study|Withdrawal by Subject|0|||
124901392|NCT03670602|449263323|FG001|Overall Study|Withdrawal by Subject|3|||
124901393|NCT01456936|449263324|FG000|Overall Study|Other reason|41|||
124901394|NCT01456936|449263325|FG001|Overall Study|Other reason|30|||
124901395|NCT01456936|449263326|FG002|Overall Study|Other reason|36|||
124901396|NCT01456936|449263327|FG003|Overall Study|Other reason|33|||
124901397|NCT01456936|449263324|FG000|Overall Study|No longer meets eligibility criteria|4|||
124901398|NCT01456936|449263325|FG001|Overall Study|No longer meets eligibility criteria|8|||
124901399|NCT01456936|449263326|FG002|Overall Study|No longer meets eligibility criteria|6|||
124901400|NCT01456936|449263327|FG003|Overall Study|No longer meets eligibility criteria|5|||
124901401|NCT01456936|449263324|FG000|Overall Study|Protocol Violation|4|||
124901402|NCT01456936|449263325|FG001|Overall Study|Protocol Violation|2|||
124901403|NCT01456936|449263326|FG002|Overall Study|Protocol Violation|5|||
124901404|NCT01456936|449263327|FG003|Overall Study|Protocol Violation|5|||
124901405|NCT01456936|449263324|FG000|Overall Study|Pregnancy|1|||
124901406|NCT01456936|449263325|FG001|Overall Study|Pregnancy|0|||
124901407|NCT01456936|449263326|FG002|Overall Study|Pregnancy|0|||
124901408|NCT01456936|449263327|FG003|Overall Study|Pregnancy|1|||
124901409|NCT01456936|449263324|FG000|Overall Study|Insufficient clinical response|4|||
124901410|NCT01456936|449263325|FG001|Overall Study|Insufficient clinical response|4|||
124448450|NCT01968070|447604514|FG007|Period 1|Physician Decision|0|||
124448451|NCT01968070|447604515|FG008|Period 1|Physician Decision|0|||
124448452|NCT01968070|447604516|FG009|Period 1|Physician Decision|0|||
124448453|NCT01968070|447604517|FG010|Period 1|Physician Decision|0|||
124448454|NCT01968070|447604518|FG011|Period 1|Physician Decision|1|||
124448455|NCT01968070|447604519|FG012|Period 1|Physician Decision|0|||
124901411|NCT01456936|449263326|FG002|Overall Study|Insufficient clinical response|14|||
124901412|NCT01456936|449263327|FG003|Overall Study|Insufficient clinical response|13|||
124901413|NCT01456936|449263324|FG000|Overall Study|No longer willing to participate|195|||
124901414|NCT01456936|449263325|FG001|Overall Study|No longer willing to participate|218|||
124901415|NCT01456936|449263326|FG002|Overall Study|No longer willing to participate|224|||
124901416|NCT01456936|449263327|FG003|Overall Study|No longer willing to participate|248|||
124901417|NCT01456936|449263324|FG000|Overall Study|Lost to Follow-up|135|||
124901418|NCT01456936|449263325|FG001|Overall Study|Lost to Follow-up|126|||
124448456|NCT01968070|447604520|FG013|Period 1|Physician Decision|0|||
124448457|NCT01968070|447604521|FG014|Period 1|Physician Decision|0|||
124448458|NCT01968070|447604522|FG015|Period 1|Physician Decision|0|||
124448459|NCT01968070|447604523|FG016|Period 1|Physician Decision|0|||
124448460|NCT01968070|447604524|FG017|Period 1|Physician Decision|0|||
124448461|NCT01968070|447604507|FG000|Period 2|Withdrawal by Subject|0|||
124448462|NCT01968070|447604508|FG001|Period 2|Withdrawal by Subject|0|||
124448463|NCT01968070|447604509|FG002|Period 2|Withdrawal by Subject|0|||
124448464|NCT01968070|447604510|FG003|Period 2|Withdrawal by Subject|0|||
124448465|NCT01968070|447604511|FG004|Period 2|Withdrawal by Subject|1|||
124448466|NCT01968070|447604512|FG005|Period 2|Withdrawal by Subject|0|||
124448467|NCT01968070|447604513|FG006|Period 2|Withdrawal by Subject|0|||
124448468|NCT01968070|447604514|FG007|Period 2|Withdrawal by Subject|0|||
124448469|NCT01968070|447604515|FG008|Period 2|Withdrawal by Subject|0|||
124448470|NCT01968070|447604516|FG009|Period 2|Withdrawal by Subject|0|||
124448471|NCT01968070|447604517|FG010|Period 2|Withdrawal by Subject|0|||
124901419|NCT01456936|449263326|FG002|Overall Study|Lost to Follow-up|144|||
124901420|NCT01456936|449263327|FG003|Overall Study|Lost to Follow-up|127|||
124901421|NCT01456936|449263324|FG000|Overall Study|Medication error|0|||
124901422|NCT01456936|449263325|FG001|Overall Study|Medication error|1|||
124901423|NCT01456936|449263326|FG002|Overall Study|Medication error|0|||
124901424|NCT01456936|449263327|FG003|Overall Study|Medication error|1|||
124448472|NCT01968070|447604518|FG011|Period 2|Withdrawal by Subject|0|||
124448473|NCT01968070|447604519|FG012|Period 2|Withdrawal by Subject|0|||
124901425|NCT01456936|449263324|FG000|Overall Study|Adverse event (study drug)|25|||
124448474|NCT01968070|447604520|FG013|Period 2|Withdrawal by Subject|0|||
124448475|NCT01968070|447604521|FG014|Period 2|Withdrawal by Subject|0|||
124901426|NCT01456936|449263325|FG001|Overall Study|Adverse event (study drug)|21|||
124448476|NCT01968070|447604522|FG015|Period 2|Withdrawal by Subject|0|||
124901427|NCT01456936|449263326|FG002|Overall Study|Adverse event (study drug)|26|||
124901428|NCT01456936|449263327|FG003|Overall Study|Adverse event (study drug)|17|||
124901429|NCT01456936|449263324|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
124901430|NCT01456936|449263325|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
124901431|NCT01456936|449263326|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
124901432|NCT01456936|449263327|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
124901433|NCT01456936|449263324|FG000|Overall Study|Death|0|||
124901434|NCT01456936|449263325|FG001|Overall Study|Death|3|||
124901435|NCT01456936|449263326|FG002|Overall Study|Death|1|||
124901436|NCT01456936|449263327|FG003|Overall Study|Death|3|||
124901437|NCT01456936|449263324|FG000|Overall Study|Randomized but not treated|21|||
124901438|NCT01456936|449263325|FG001|Overall Study|Randomized but not treated|28|||
124901439|NCT01456936|449263326|FG002|Overall Study|Randomized but not treated|16|||
124901440|NCT01456936|449263327|FG003|Overall Study|Randomized but not treated|21|||
124901441|NCT00543725|449263328|FG000|Overall Study|Adverse Event|18|||
124901442|NCT00543725|449263329|FG001|Overall Study|Adverse Event|27|||
124901443|NCT00543725|449263328|FG000|Overall Study|Sponsor's Decision|0|||
124901444|NCT00543725|449263329|FG001|Overall Study|Sponsor's Decision|1|||
124901445|NCT00543725|449263328|FG000|Overall Study|Subject Non-Compliant|4|||
124901446|NCT00543725|449263329|FG001|Overall Study|Subject Non-Compliant|4|||
124901447|NCT00543725|449263328|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
124901448|NCT00543725|449263329|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
124901449|NCT00543725|449263328|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
124901450|NCT00543725|449263329|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
124901451|NCT00543725|449263328|FG000|Overall Study|Protocol Violation|0|||
124901452|NCT00543725|449263329|FG001|Overall Study|Protocol Violation|1|||
124901453|NCT00543725|449263328|FG000|Overall Study|Withdrawal by Subject|4|||
124901454|NCT00543725|449263329|FG001|Overall Study|Withdrawal by Subject|13|||
124901455|NCT00543725|449263328|FG000|Overall Study|Lost to Follow-up|15|||
124901456|NCT00543725|449263329|FG001|Overall Study|Lost to Follow-up|11|||
124901457|NCT00543725|449263328|FG000|Overall Study|Other|3|||
124901458|NCT00543725|449263329|FG001|Overall Study|Other|3|||
124901459|NCT00906698|449263330|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
124901460|NCT00906698|449263331|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
124901461|NCT00906698|449263332|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
124901462|NCT00906698|449263333|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
124901463|NCT00906698|449263334|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
124901464|NCT00906698|449263335|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
124901465|NCT00906698|449263330|FG000|Overall Study|Adverse Event|0|||
124901466|NCT00906698|449263331|FG001|Overall Study|Adverse Event|0|||
124901467|NCT00906698|449263332|FG002|Overall Study|Adverse Event|2|||
124901468|NCT00906698|449263333|FG003|Overall Study|Adverse Event|0|||
124901469|NCT00906698|449263334|FG004|Overall Study|Adverse Event|4|||
124901470|NCT00906698|449263335|FG005|Overall Study|Adverse Event|1|||
124901471|NCT00906698|449263330|FG000|Overall Study|Disease progression|3|||
124901472|NCT00906698|449263331|FG001|Overall Study|Disease progression|12|||
124901473|NCT00906698|449263332|FG002|Overall Study|Disease progression|4|||
124901474|NCT00906698|449263333|FG003|Overall Study|Disease progression|4|||
124901475|NCT00906698|449263334|FG004|Overall Study|Disease progression|12|||
124901476|NCT00906698|449263335|FG005|Overall Study|Disease progression|4|||
124901477|NCT00906698|449263330|FG000|Overall Study|Withdrawal by Subject|0|||
124901478|NCT00906698|449263331|FG001|Overall Study|Withdrawal by Subject|0|||
124901479|NCT00906698|449263332|FG002|Overall Study|Withdrawal by Subject|0|||
124901480|NCT00906698|449263333|FG003|Overall Study|Withdrawal by Subject|0|||
124901481|NCT00906698|449263334|FG004|Overall Study|Withdrawal by Subject|1|||
124901482|NCT00906698|449263335|FG005|Overall Study|Withdrawal by Subject|0|||
124901483|NCT00906698|449263330|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
124901484|NCT00906698|449263331|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
124901485|NCT00906698|449263332|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
124901486|NCT00906698|449263333|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
124901487|NCT00906698|449263334|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
124901488|NCT00906698|449263335|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
124901489|NCT02846415|449263337|FG000|Overall Study|Lost to Follow-up|2|||
124901490|NCT02846415|449263338|FG001|Overall Study|Lost to Follow-up|0|||
124901491|NCT02846415|449263337|FG000|Overall Study|Withdrawal by Subject|1|||
124901492|NCT02846415|449263338|FG001|Overall Study|Withdrawal by Subject|1|||
124901493|NCT03383887|449263339|FG000|Overall Study|Lost to Follow-up|0|||
124901494|NCT03383887|449263340|FG001|Overall Study|Lost to Follow-up|1|||
124901495|NCT02322216|449263342|FG000|Overall Study|Adverse Event|1|||
124901496|NCT02322216|449263343|FG001|Overall Study|Adverse Event|0|||
124901497|NCT02322216|449263342|FG000|Overall Study|Withdrawal by Subject|1|||
124901498|NCT02322216|449263343|FG001|Overall Study|Withdrawal by Subject|4|||
124901499|NCT01585038|449263344|FG000|Overall Study|Adverse Event|2|||
124901500|NCT01585038|449263345|FG001|Overall Study|Adverse Event|2|||
124901501|NCT00754936|449263350|FG000|Overall Study|Lost to Follow-up|3|||
124901502|NCT00754936|449263350|FG000|Overall Study|Physician Decision|1|||
124901503|NCT00754936|449263350|FG000|Overall Study|Withdrawal by Subject|2|||
124901504|NCT00754936|449263350|FG000|Overall Study|Side Effects|3|||
124901505|NCT00754936|449263350|FG000|Overall Study|Inter-current medical events|3|||
124901506|NCT00835380|449263356|FG000|Overall Study|Withdrawal by Subject|2|||
124901507|NCT03247543|449263357|FG000|Overall Study|Adverse Event|3|||
124901508|NCT03247543|449263358|FG001|Overall Study|Adverse Event|6|||
124901509|NCT03247543|449263359|FG002|Overall Study|Adverse Event|4|||
124901510|NCT03247543|449263357|FG000|Overall Study|Lost to Follow-up|10|||
124901511|NCT03247543|449263358|FG001|Overall Study|Lost to Follow-up|7|||
124901512|NCT03247543|449263359|FG002|Overall Study|Lost to Follow-up|8|||
124901513|NCT03247543|449263357|FG000|Overall Study|Consent withdrawn by caregiver|2|||
124901514|NCT03247543|449263358|FG001|Overall Study|Consent withdrawn by caregiver|2|||
124901515|NCT03247543|449263359|FG002|Overall Study|Consent withdrawn by caregiver|9|||
124901516|NCT03247543|449263357|FG000|Overall Study|Withdrawal by Subject|0|||
124901517|NCT03247543|449263358|FG001|Overall Study|Withdrawal by Subject|0|||
124901518|NCT03247543|449263359|FG002|Overall Study|Withdrawal by Subject|1|||
124901519|NCT03247543|449263357|FG000|Overall Study|Failure to Follow study procedures|1|||
124901520|NCT03247543|449263358|FG001|Overall Study|Failure to Follow study procedures|3|||
124901521|NCT03247543|449263359|FG002|Overall Study|Failure to Follow study procedures|1|||
124901522|NCT03247543|449263357|FG000|Overall Study|Lack of Efficacy|1|||
124901523|NCT03247543|449263358|FG001|Overall Study|Lack of Efficacy|0|||
124901524|NCT03247543|449263359|FG002|Overall Study|Lack of Efficacy|0|||
124901525|NCT03247543|449263357|FG000|Overall Study|Non-compliance with study visits|0|||
124901526|NCT03247543|449263358|FG001|Overall Study|Non-compliance with study visits|1|||
124901527|NCT03247543|449263359|FG002|Overall Study|Non-compliance with study visits|0|||
124901528|NCT02059980|449263362|FG000|Overall Study|Lost to Follow-up|2|||
124901529|NCT02059980|449263363|FG001|Overall Study|Lost to Follow-up|1|||
124901530|NCT01104415|449263364|FG000|Core Phase|Consent withdrawn by subjects|1|||
124901531|NCT01104415|449263365|FG001|Core Phase|Consent withdrawn by subjects|0|||
124901532|NCT01104415|449263364|FG000|Extension Period|Progressive disease|0|||
124901533|NCT01104415|449263365|FG001|Extension Period|Progressive disease|4|||
124901534|NCT01104415|449263364|FG000|Extension Period|Death|0|||
124901535|NCT01104415|449263365|FG001|Extension Period|Death|1|||
124901536|NCT01104415|449263364|FG000|Extension Period|Physician Decision|0|||
124901537|NCT01104415|449263365|FG001|Extension Period|Physician Decision|1|||
124901538|NCT01104415|449263364|FG000|Extension Period|Transition to Study LX1606.302|0|||
124901539|NCT01104415|449263365|FG001|Extension Period|Transition to Study LX1606.302|4|||
124901540|NCT01104415|449263364|FG000|Extension Period|Heart surgery/feeling miserable|0|||
124901541|NCT01104415|449263365|FG001|Extension Period|Heart surgery/feeling miserable|1|||
124901542|NCT02341625|449263370|FG000|Overall Study|Disease Progression|2|||
124901543|NCT02341625|449263371|FG001|Overall Study|Disease Progression|2|||
124901544|NCT02341625|449263372|FG002|Overall Study|Disease Progression|3|||
124901545|NCT02341625|449263373|FG003|Overall Study|Disease Progression|6|||
124901546|NCT02341625|449263374|FG004|Overall Study|Disease Progression|7|||
124901547|NCT02341625|449263375|FG005|Overall Study|Disease Progression|7|||
124901548|NCT02341625|449263376|FG006|Overall Study|Disease Progression|28|||
124901549|NCT02341625|449263377|FG007|Overall Study|Disease Progression|5|||
124901550|NCT02341625|449263378|FG008|Overall Study|Disease Progression|4|||
124901551|NCT02341625|449263379|FG009|Overall Study|Disease Progression|19|||
124901552|NCT02341625|449263370|FG000|Overall Study|Study Drug Toxicity|0|||
124901553|NCT02341625|449263371|FG001|Overall Study|Study Drug Toxicity|0|||
124901554|NCT02341625|449263372|FG002|Overall Study|Study Drug Toxicity|0|||
124901555|NCT02341625|449263373|FG003|Overall Study|Study Drug Toxicity|1|||
124901556|NCT02341625|449263374|FG004|Overall Study|Study Drug Toxicity|0|||
124901557|NCT02341625|449263375|FG005|Overall Study|Study Drug Toxicity|3|||
124901558|NCT02341625|449263376|FG006|Overall Study|Study Drug Toxicity|10|||
124448477|NCT01968070|447604523|FG016|Period 2|Withdrawal by Subject|0|||
124901559|NCT02341625|449263377|FG007|Overall Study|Study Drug Toxicity|0|||
124901560|NCT02341625|449263378|FG008|Overall Study|Study Drug Toxicity|0|||
124901561|NCT02341625|449263379|FG009|Overall Study|Study Drug Toxicity|3|||
124901562|NCT02341625|449263370|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
124901563|NCT02341625|449263371|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
124901564|NCT02341625|449263372|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
124901565|NCT02341625|449263373|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
124901566|NCT02341625|449263374|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
124901567|NCT02341625|449263375|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
124901568|NCT02341625|449263376|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
124901569|NCT02341625|449263377|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
124901570|NCT02341625|449263378|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
124901571|NCT02341625|449263379|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
124901572|NCT02341625|449263370|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
124901573|NCT02341625|449263371|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
124901574|NCT02341625|449263372|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
124901575|NCT02341625|449263373|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
124901576|NCT02341625|449263374|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
124901577|NCT02341625|449263375|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
124901578|NCT02341625|449263376|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
124901579|NCT02341625|449263377|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
124901580|NCT02341625|449263378|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
124901581|NCT02341625|449263379|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
124901582|NCT02341625|449263370|FG000|Overall Study|Participant Withdrew Consent|0|||
124901583|NCT02341625|449263371|FG001|Overall Study|Participant Withdrew Consent|0|||
124901584|NCT02341625|449263372|FG002|Overall Study|Participant Withdrew Consent|0|||
124901585|NCT02341625|449263373|FG003|Overall Study|Participant Withdrew Consent|1|||
124901586|NCT02341625|449263374|FG004|Overall Study|Participant Withdrew Consent|0|||
124901587|NCT02341625|449263375|FG005|Overall Study|Participant Withdrew Consent|0|||
124901588|NCT02341625|449263376|FG006|Overall Study|Participant Withdrew Consent|0|||
124901589|NCT02341625|449263377|FG007|Overall Study|Participant Withdrew Consent|0|||
124901590|NCT02341625|449263378|FG008|Overall Study|Participant Withdrew Consent|0|||
124901591|NCT02341625|449263379|FG009|Overall Study|Participant Withdrew Consent|0|||
124901592|NCT02341625|449263370|FG000|Overall Study|Completed Treatment as per Protocol|0|||
124901593|NCT02341625|449263371|FG001|Overall Study|Completed Treatment as per Protocol|0|||
124901594|NCT02341625|449263372|FG002|Overall Study|Completed Treatment as per Protocol|0|||
124901595|NCT02341625|449263373|FG003|Overall Study|Completed Treatment as per Protocol|0|||
124901596|NCT02341625|449263374|FG004|Overall Study|Completed Treatment as per Protocol|0|||
124901597|NCT02341625|449263375|FG005|Overall Study|Completed Treatment as per Protocol|0|||
124901598|NCT02341625|449263376|FG006|Overall Study|Completed Treatment as per Protocol|0|||
124901599|NCT02341625|449263377|FG007|Overall Study|Completed Treatment as per Protocol|0|||
124901600|NCT02341625|449263378|FG008|Overall Study|Completed Treatment as per Protocol|0|||
124901601|NCT02341625|449263379|FG009|Overall Study|Completed Treatment as per Protocol|1|||
124901602|NCT02341625|449263370|FG000|Overall Study|Other Reasons|0|||
124901603|NCT02341625|449263371|FG001|Overall Study|Other Reasons|0|||
124901604|NCT02341625|449263372|FG002|Overall Study|Other Reasons|0|||
124901605|NCT02341625|449263373|FG003|Overall Study|Other Reasons|0|||
124901606|NCT02341625|449263374|FG004|Overall Study|Other Reasons|1|||
124901607|NCT02341625|449263375|FG005|Overall Study|Other Reasons|0|||
124901608|NCT02341625|449263376|FG006|Overall Study|Other Reasons|5|||
124901609|NCT02341625|449263377|FG007|Overall Study|Other Reasons|0|||
124901610|NCT02341625|449263378|FG008|Overall Study|Other Reasons|0|||
124901611|NCT02341625|449263379|FG009|Overall Study|Other Reasons|2|||
124901612|NCT02341625|449263370|FG000|Overall Study|Not Reported|0|||
124901613|NCT02341625|449263371|FG001|Overall Study|Not Reported|0|||
124901614|NCT02341625|449263372|FG002|Overall Study|Not Reported|0|||
124901615|NCT02341625|449263373|FG003|Overall Study|Not Reported|0|||
124901616|NCT02341625|449263374|FG004|Overall Study|Not Reported|0|||
124901617|NCT02341625|449263375|FG005|Overall Study|Not Reported|0|||
124901618|NCT02341625|449263376|FG006|Overall Study|Not Reported|0|||
124691097|NCT01033071|448488096|FG002|Overall Study|Other|3|||
124901619|NCT02341625|449263377|FG007|Overall Study|Not Reported|0|||
124691098|NCT01695772|448488099|FG000|Overall Study|Withdrawal by Subject|18|||
124691099|NCT01695772|448488099|FG000|Overall Study|Progressive Disease|8|||
124691100|NCT01695772|448488099|FG000|Overall Study|Investigator Decision|5|||
124691101|NCT01695772|448488099|FG000|Overall Study|Lost to Follow-up|4|||
124691102|NCT01695772|448488099|FG000|Overall Study|Protocol Violation|2|||
124691103|NCT01695772|448488099|FG000|Overall Study|Unspecified Reason|1|||
124901620|NCT02341625|449263378|FG008|Overall Study|Not Reported|0|||
124901621|NCT02341625|449263379|FG009|Overall Study|Not Reported|3|||
124901622|NCT01227707|449263388|FG000|Overall Study|Adverse Event|10|||
124901623|NCT01227707|449263388|FG000|Overall Study|Progression of disease|3|||
124691104|NCT04941898|448489969|FG000|Overall Study|Protocol Violation|1|||
124691105|NCT03022630|448489970|FG000|Overall Study|Death|9|||
124691106|NCT03022630|448489971|FG001|Overall Study|Death|7|||
124691107|NCT03022630|448489970|FG000|Overall Study|Withdrawal by Subject|0|||
124691108|NCT03022630|448489971|FG001|Overall Study|Withdrawal by Subject|5|||
124691109|NCT00088881|448489976|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
124691110|NCT00088881|448489976|FG000|Step 1 - R-CHOP|Adverse Event|1|||
124691111|NCT00088881|448489976|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
124691112|NCT00088881|448489976|FG000|Step 1 - R-CHOP|Physician Decision|1|||
124691113|NCT00088881|448489976|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
124691114|NCT00088881|448489976|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
124901624|NCT01227707|449263388|FG000|Overall Study|Withdrawal by Subject|1|||
124901625|NCT01227707|449263388|FG000|Overall Study|Patient non-compliance|3|||
124901626|NCT01227707|449263388|FG000|Overall Study|Medical decision|6|||
124901627|NCT01227707|449263388|FG000|Overall Study|Death|1|||
124901628|NCT02357784|449263393|FG000|Overall Study|Withdrawal by Subject|1|||
124901629|NCT02698241|449263396|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
124901630|NCT02698241|449263396|FG000|Overall Study|Screening not met|7|||
124901631|NCT02698241|449263396|FG000|Overall Study|Withdrawal by Subject|7|||
124759873|NCT01859923|448744795|FG000|Overall Study|Adverse Event|0|||
124759874|NCT01859923|448744796|FG001|Overall Study|Adverse Event|0|||
124759875|NCT01859923|448744797|FG002|Overall Study|Adverse Event|1|||
124759876|NCT01859923|448744798|FG003|Overall Study|Adverse Event|1|||
124759877|NCT00764361|448744804|FG000|Overall Study|Withdrawal by Subject|2|||
124759878|NCT00764361|448744805|FG001|Overall Study|Withdrawal by Subject|3|||
124759879|NCT00764361|448744804|FG000|Overall Study|Adverse Event|0|||
124901632|NCT02698241|449263396|FG000|Overall Study|Physician Decision|2|||
124901633|NCT02698241|449263396|FG000|Overall Study|Subject underwent system modification|2|||
124691115|NCT00088881|448489976|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
124691116|NCT02927145|448489979|FG000|Initial Recruitment|Withdrawal by Subject|0|||
124691117|NCT02927145|448489980|FG001|Initial Recruitment|Withdrawal by Subject|1|||
124691118|NCT02927145|448489981|FG002|Initial Recruitment|Withdrawal by Subject|1|||
124691119|NCT02927145|448489982|FG003|Initial Recruitment|Withdrawal by Subject|4|||
124691120|NCT02927145|448489983|FG004|Initial Recruitment|Withdrawal by Subject|1|||
124691121|NCT02927145|448489984|FG005|Initial Recruitment|Withdrawal by Subject|1|||
124691122|NCT02927145|448489985|FG006|Initial Recruitment|Withdrawal by Subject|0|||
124691123|NCT02927145|448489986|FG007|Initial Recruitment|Withdrawal by Subject|0|||
124691124|NCT02927145|448489987|FG008|Initial Recruitment|Withdrawal by Subject|2|||
124691125|NCT02927145|448489979|FG000|Initial Recruitment|Adverse Event|0|||
124691126|NCT02927145|448489980|FG001|Initial Recruitment|Adverse Event|0|||
124691127|NCT02927145|448489981|FG002|Initial Recruitment|Adverse Event|0|||
124691128|NCT02927145|448489982|FG003|Initial Recruitment|Adverse Event|0|||
124691129|NCT02927145|448489983|FG004|Initial Recruitment|Adverse Event|2|||
124691130|NCT02927145|448489984|FG005|Initial Recruitment|Adverse Event|0|||
124691131|NCT02927145|448489985|FG006|Initial Recruitment|Adverse Event|0|||
124691132|NCT02927145|448489986|FG007|Initial Recruitment|Adverse Event|0|||
124691133|NCT02927145|448489987|FG008|Initial Recruitment|Adverse Event|0|||
124691134|NCT02927145|448489979|FG000|Invitation for Additional Challenge|Pregnancy|0|||
124691135|NCT02927145|448489980|FG001|Invitation for Additional Challenge|Pregnancy|0|||
124691136|NCT02927145|448489981|FG002|Invitation for Additional Challenge|Pregnancy|0|||
124691137|NCT02927145|448489982|FG003|Invitation for Additional Challenge|Pregnancy|0|||
124691138|NCT02927145|448489983|FG004|Invitation for Additional Challenge|Pregnancy|0|||
124691139|NCT02927145|448489984|FG005|Invitation for Additional Challenge|Pregnancy|0|||
124691140|NCT02927145|448489985|FG006|Invitation for Additional Challenge|Pregnancy|1|||
124691141|NCT02927145|448489986|FG007|Invitation for Additional Challenge|Pregnancy|0|||
124691142|NCT02927145|448489987|FG008|Invitation for Additional Challenge|Pregnancy|0|||
124691143|NCT01002105|448489988|FG000|Overall Study|Lost to Follow-up|10|||
124691144|NCT01002105|448489989|FG001|Overall Study|Lost to Follow-up|16|||
124691145|NCT01002105|448489988|FG000|Overall Study|non compliance|5|||
124691146|NCT01002105|448489989|FG001|Overall Study|non compliance|3|||
124691147|NCT01002105|448489988|FG000|Overall Study|condition worsened|4|||
124691148|NCT01002105|448489989|FG001|Overall Study|condition worsened|2|||
124691149|NCT00266812|448489991|FG000|Overall Study|Disease Progression|9|||
124691150|NCT00266812|448489992|FG001|Overall Study|Disease Progression|3|||
124691151|NCT00266812|448489991|FG000|Overall Study|Death|5|||
124691152|NCT00266812|448489992|FG001|Overall Study|Death|4|||
124691153|NCT00266812|448489991|FG000|Overall Study|Adverse Event|3|||
124691154|NCT00266812|448489992|FG001|Overall Study|Adverse Event|1|||
124691155|NCT00266812|448489991|FG000|Overall Study|Protocol Violation|0|||
124691156|NCT00266812|448489992|FG001|Overall Study|Protocol Violation|1|||
124691157|NCT00266812|448489991|FG000|Overall Study|Withdrawal by Subject|0|||
124691158|NCT00266812|448489992|FG001|Overall Study|Withdrawal by Subject|2|||
124691159|NCT00266812|448489991|FG000|Overall Study|Discontinued before starting study drug|4|||
124691160|NCT00266812|448489992|FG001|Overall Study|Discontinued before starting study drug|0|||
124691161|NCT03695094|448489994|FG000|Overall Study|Adverse Event|1|||
124691162|NCT03695094|448489995|FG001|Overall Study|Adverse Event|1|||
124691163|NCT03695094|448489994|FG000|Overall Study|Withdrawal by Subject|1|||
124691164|NCT03695094|448489995|FG001|Overall Study|Withdrawal by Subject|0|||
124691165|NCT02506036|448489998|FG000|First Intervention (4-6 Weeks)|Death|1|||
124901634|NCT02698241|449263396|FG000|Overall Study|Lost to Follow-up|3|||
124901635|NCT02698241|449263396|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
124901636|NCT02698241|449263396|FG000|Overall Study|geographic and licensing issue|1|||
124691166|NCT02506036|448489999|FG001|First Intervention (4-6 Weeks)|Death|0|||
124691167|NCT02506036|448489998|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
124691168|NCT02506036|448489999|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
124759880|NCT00764361|448744805|FG001|Overall Study|Adverse Event|1|||
124691169|NCT02506036|448489998|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
124901637|NCT02698241|449263396|FG000|Overall Study|Death|2|||
124901638|NCT01837641|449263397|FG000|Overall Study|Sponsor decision|1|||
124901639|NCT01837641|449263398|FG001|Overall Study|Sponsor decision|0|||
124901640|NCT01837641|449263399|FG002|Overall Study|Sponsor decision|0|||
124901641|NCT01837641|449263400|FG003|Overall Study|Sponsor decision|0|||
124901642|NCT01837641|449263401|FG004|Overall Study|Sponsor decision|0|||
124901643|NCT01837641|449263402|FG005|Overall Study|Sponsor decision|1|||
124901644|NCT01837641|449263403|FG006|Overall Study|Sponsor decision|0|||
124901645|NCT01837641|449263404|FG007|Overall Study|Sponsor decision|0|||
124901646|NCT01837641|449263397|FG000|Overall Study|Adverse Event|0|||
124901647|NCT01837641|449263398|FG001|Overall Study|Adverse Event|0|||
124901648|NCT01837641|449263399|FG002|Overall Study|Adverse Event|0|||
124901649|NCT01837641|449263400|FG003|Overall Study|Adverse Event|0|||
124901650|NCT01837641|449263401|FG004|Overall Study|Adverse Event|0|||
124901651|NCT01837641|449263402|FG005|Overall Study|Adverse Event|1|||
124901652|NCT01837641|449263403|FG006|Overall Study|Adverse Event|0|||
124901653|NCT01837641|449263404|FG007|Overall Study|Adverse Event|0|||
124901654|NCT01837641|449263397|FG000|Overall Study|Withdrawal by Subject|0|||
124901655|NCT01837641|449263398|FG001|Overall Study|Withdrawal by Subject|0|||
124901656|NCT01837641|449263399|FG002|Overall Study|Withdrawal by Subject|0|||
124901657|NCT01837641|449263400|FG003|Overall Study|Withdrawal by Subject|0|||
124901658|NCT01837641|449263401|FG004|Overall Study|Withdrawal by Subject|1|||
124901659|NCT01837641|449263402|FG005|Overall Study|Withdrawal by Subject|0|||
124901660|NCT01837641|449263403|FG006|Overall Study|Withdrawal by Subject|1|||
124901661|NCT01837641|449263404|FG007|Overall Study|Withdrawal by Subject|0|||
124901662|NCT00906282|449263407|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
124901663|NCT00906282|449263407|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
124901664|NCT00906282|449263407|FG000|Preoperative Chemotherapy|Progressive disease|6|||
124901665|NCT00906282|449263407|FG000|Preoperative Chemotherapy|Toxicity|1|||
124901666|NCT02540213|449263408|FG000|Overall Study|Death/adverse event|18|||
124901667|NCT02540213|449263408|FG000|Overall Study|Administrative reasons|3|||
124901668|NCT02540213|449263408|FG000|Overall Study|Kidney transplant|3|||
124901669|NCT02540213|449263408|FG000|Overall Study|Lack of Efficacy|6|||
124901670|NCT02540213|449263408|FG000|Overall Study|Consent withdrawn|7|||
124901671|NCT02540213|449263408|FG000|Overall Study|Enrolled but not treated|2|||
124901672|NCT02289560|449263409|FG000|Overall Study|Lost to Follow-up|6|||
124901673|NCT02289560|449263409|FG000|Overall Study|Alternative Treatment|4|||
124901674|NCT02289560|449263409|FG000|Overall Study|Inadequate Treatment|2|||
124901675|NCT02289560|449263409|FG000|Overall Study|Withdrawal by Subject|23|||
124901676|NCT00290706|449263412|FG000|Overall Study|Withdrawal by Subject|2|||
124901677|NCT00290706|449263413|FG001|Overall Study|Withdrawal by Subject|0|||
124901678|NCT00290706|449263414|FG002|Overall Study|Withdrawal by Subject|0|||
124901679|NCT00290706|449263415|FG003|Overall Study|Withdrawal by Subject|0|||
124901680|NCT00290706|449263412|FG000|Overall Study|Progressive Disease|3|||
124901681|NCT00290706|449263413|FG001|Overall Study|Progressive Disease|5|||
124901682|NCT00290706|449263414|FG002|Overall Study|Progressive Disease|4|||
124901683|NCT00290706|449263415|FG003|Overall Study|Progressive Disease|10|||
124901684|NCT00290706|449263412|FG000|Overall Study|Adverse Event|0|||
124901685|NCT00290706|449263413|FG001|Overall Study|Adverse Event|1|||
124901686|NCT00290706|449263414|FG002|Overall Study|Adverse Event|2|||
124901687|NCT00290706|449263415|FG003|Overall Study|Adverse Event|0|||
124901688|NCT00290706|449263412|FG000|Overall Study|Receive auto transplant or radiation|0|||
124901689|NCT00290706|449263413|FG001|Overall Study|Receive auto transplant or radiation|0|||
124691170|NCT02506036|448489999|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
124691171|NCT02316613|448490000|FG000|Overall Study|Death|63|||
124901690|NCT00290706|449263414|FG002|Overall Study|Receive auto transplant or radiation|0|||
124901691|NCT00290706|449263415|FG003|Overall Study|Receive auto transplant or radiation|1|||
124901692|NCT00290706|449263412|FG000|Overall Study|Physician Decision|0|||
124901693|NCT00290706|449263413|FG001|Overall Study|Physician Decision|0|||
124901694|NCT00290706|449263414|FG002|Overall Study|Physician Decision|0|||
124901695|NCT00290706|449263415|FG003|Overall Study|Physician Decision|1|||
124901696|NCT00605033|449263418|FG000|Overall Study|Adverse Event|2|||
124901697|NCT00605033|449263419|FG001|Overall Study|Adverse Event|2|||
124901698|NCT00605033|449263418|FG000|Overall Study|Lost to Follow-up|1|||
124901699|NCT00605033|449263419|FG001|Overall Study|Lost to Follow-up|1|||
124691172|NCT02316613|448490000|FG000|Overall Study|Lost to Follow-up|9|||
124691173|NCT02316613|448490000|FG000|Overall Study|Lymphoma transformation|2|||
124901700|NCT00605033|449263418|FG000|Overall Study|Withdrawal by Subject|3|||
124901701|NCT00605033|449263419|FG001|Overall Study|Withdrawal by Subject|4|||
124901702|NCT00605033|449263418|FG000|Overall Study|Protocol Violation|1|||
124901703|NCT00605033|449263419|FG001|Overall Study|Protocol Violation|1|||
124901704|NCT03395353|449263420|FG000|Overall Study|Adverse Event|20|||
124901705|NCT03395353|449263420|FG000|Overall Study|Protocol Violation|1|||
124901706|NCT03395353|449263420|FG000|Overall Study|Lack of Efficacy|3|||
124901707|NCT03395353|449263420|FG000|Overall Study|Withdrawal by Subject|24|||
124901708|NCT03395353|449263420|FG000|Overall Study|Discontinued visit|1|||
124901709|NCT03395353|449263420|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
124691174|NCT02316613|448490000|FG000|Overall Study|Participant moved/changed medical team|11|||
124691175|NCT02316613|448490000|FG000|Overall Study|No data and duplicate cases|5|||
124691176|NCT02316613|448490000|FG000|Overall Study|Did not met selection criteria|14|||
124691177|NCT01166945|448490001|FG000|Randomized|diagnosed with Group A strep|4|||
124691178|NCT01166945|448490002|FG001|Randomized|diagnosed with Group A strep|4|||
124901710|NCT03395353|449263420|FG000|Overall Study|Physician Decision|4|||
124901711|NCT03395353|449263420|FG000|Overall Study|Early termination of overall study|33|||
124901712|NCT01196429|449263421|FG000|Overall Study|Ineligible - inadequate pathology|1|||
124901713|NCT01196429|449263422|FG001|Overall Study|Ineligible - inadequate pathology|0|||
124901714|NCT01196429|449263421|FG000|Overall Study|Ineligible - wrong cell type|1|||
124901715|NCT01196429|449263422|FG001|Overall Study|Ineligible - wrong cell type|0|||
124901716|NCT01196429|449263421|FG000|Overall Study|Refused - Never Treated|1|||
124901717|NCT01196429|449263422|FG001|Overall Study|Refused - Never Treated|0|||
124901718|NCT01144468|449265125|FG000|Overall Study|Lost to Follow-up|4|||
124901719|NCT01144468|449265126|FG001|Overall Study|Lost to Follow-up|7|||
124901720|NCT01144468|449265125|FG000|Overall Study|Adverse Event|3|||
124901721|NCT01144468|449265126|FG001|Overall Study|Adverse Event|2|||
124901722|NCT01144468|449265125|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
124901723|NCT01144468|449265126|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
124901724|NCT02960659|449265127|FG000|Overall Study|Withdrawal by Subject|1|||
124901725|NCT02960659|449265128|FG001|Overall Study|Withdrawal by Subject|0|||
124901726|NCT02960659|449265127|FG000|Overall Study|Poor compliance|0|||
124901727|NCT02960659|449265128|FG001|Overall Study|Poor compliance|1|||
124901728|NCT03140176|449265134|FG000|Overall Study|Reason missing|23|||
124901729|NCT03140176|449265134|FG000|Overall Study|Death|33|||
124901730|NCT03140176|449265134|FG000|Overall Study|Disease progression|1|||
124901731|NCT03140176|449265134|FG000|Overall Study|Physician Decision|1|||
124901732|NCT03140176|449265134|FG000|Overall Study|Withdrawal by Subject|1|||
124901733|NCT03140176|449265134|FG000|Overall Study|Lost to Follow-up|15|||
124901734|NCT01331824|449265135|FG000|Overall Study|Adverse Event|2|||
124691179|NCT01166945|448490001|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
124691180|NCT01166945|448490002|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
124691181|NCT01166945|448490001|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
124691182|NCT01166945|448490002|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
124901735|NCT01331824|449265135|FG000|Overall Study|Death|1|||
124901736|NCT01331824|449265135|FG000|Overall Study|Disease Progression|9|||
124901737|NCT01331824|449265135|FG000|Overall Study|Withdrawal by Subject|1|||
124901738|NCT00149630|449265136|FG000|Overall Study|Incarceration|2|||
124901739|NCT00149630|449265137|FG001|Overall Study|Incarceration|0|||
124901740|NCT00149630|449265136|FG000|Overall Study|Treatment Programs|4|||
124901741|NCT00149630|449265137|FG001|Overall Study|Treatment Programs|5|||
124759881|NCT02090426|448744806|FG000|Overall Study|Lost to Follow-up|12|||
124901742|NCT00149630|449265136|FG000|Overall Study|Adverse Event|2|||
124901743|NCT00149630|449265137|FG001|Overall Study|Adverse Event|0|||
124901744|NCT05298111|449265142|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
124901745|NCT05298111|449265143|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
124901746|NCT02689349|449265144|FG000|Overall Study|Not implanted|4|||
124901747|NCT02689349|449265145|FG001|Overall Study|Not implanted|0|||
124901748|NCT02689349|449265144|FG000|Overall Study|Withdrawal by Subject|9|||
124901749|NCT02689349|449265145|FG001|Overall Study|Withdrawal by Subject|0|||
124901750|NCT03518112|449265146|FG000|Overall Study|Withdrawal by Subject|1|||
124901751|NCT01185522|449265147|FG000|Overall Study|Lack of Efficacy|28|||
124901752|NCT01185522|449265147|FG000|Overall Study|Lost to Follow-up|19|||
124901753|NCT01185522|449265147|FG000|Overall Study|Withdrawal by Subject|10|||
124901754|NCT01185522|449265147|FG000|Overall Study|Poor tolerance|39|||
124901755|NCT01185522|449265147|FG000|Overall Study|Other reasons|12|||
124901756|NCT00918957|449265148|FG000|Overall Study|Adverse Event|2|||
124901757|NCT00918957|449265149|FG001|Overall Study|Adverse Event|0|||
124901758|NCT00918957|449265148|FG000|Overall Study|Withdrawal by Subject|1|||
124901759|NCT00918957|449265149|FG001|Overall Study|Withdrawal by Subject|0|||
124759882|NCT02090426|448744807|FG001|Overall Study|Lost to Follow-up|6|||
124901760|NCT01803646|449265150|FG000|Overall Study|Protocol Violation|1|||
124901761|NCT01803646|449265151|FG001|Overall Study|Protocol Violation|0|||
124901762|NCT01803646|449265150|FG000|Overall Study|Adverse Event|1|||
124691183|NCT01166945|448490001|FG000|Day 30|Lost to Follow-up|4|||
124691184|NCT01166945|448490002|FG001|Day 30|Lost to Follow-up|3|||
124901763|NCT01803646|449265151|FG001|Overall Study|Adverse Event|1|||
124759883|NCT01141712|448744811|FG000|Overall Study|Disease progression|3|||
124448478|NCT01968070|447604524|FG017|Period 2|Withdrawal by Subject|0|||
124901764|NCT01803646|449265150|FG000|Overall Study|Withdrawal by Subject|9|||
124901765|NCT01803646|449265151|FG001|Overall Study|Withdrawal by Subject|6|||
124901766|NCT01803646|449265150|FG000|Overall Study|Randomization error|1|||
124901767|NCT01803646|449265151|FG001|Overall Study|Randomization error|2|||
124901768|NCT01803646|449265150|FG000|Overall Study|Lost to Follow-up|5|||
124901769|NCT01803646|449265151|FG001|Overall Study|Lost to Follow-up|1|||
124901770|NCT01131494|449265152|FG000|Overall Study|Withdrawal by Subject|2|||
124901771|NCT02614560|449265153|FG000|Overall Study|Death|6|||
124901772|NCT02614560|449265154|FG001|Overall Study|Death|2|||
124901773|NCT03923491|449265155|FG000|Overall Study|Lost to Follow-up|5|||
124901774|NCT03923491|449265156|FG001|Overall Study|Lost to Follow-up|8|||
124901775|NCT03923491|449265155|FG000|Overall Study|Withdrawal by Subject|4|||
124901776|NCT03923491|449265156|FG001|Overall Study|Withdrawal by Subject|6|||
124448479|NCT04201821|447604527|FG000|Overall Study|Withdrawal by Subject|2|||
124448480|NCT01326728|447604528|FG000|Overall Study|Death|13|||
124448481|NCT01326728|447604529|FG001|Overall Study|Death|0|||
124448482|NCT01326728|447604528|FG000|Overall Study|Early closure of study|34|||
124448483|NCT01326728|447604529|FG001|Overall Study|Early closure of study|9|||
124448484|NCT03785678|447604532|FG000|Overall Study|Death|44|||
124448485|NCT03785678|447604533|FG001|Overall Study|Death|42|||
124448486|NCT03785678|447604532|FG000|Overall Study|Lost to Follow-up|4|||
124448487|NCT03785678|447604533|FG001|Overall Study|Lost to Follow-up|2|||
124901777|NCT02174562|449265157|FG000|Overall Study|Withdrawal by Subject|7|||
124448488|NCT03785678|447604532|FG000|Overall Study|Physician Decision|0|||
124448489|NCT03785678|447604533|FG001|Overall Study|Physician Decision|2|||
124448490|NCT03785678|447604532|FG000|Overall Study|Withdrawal by Subject|5|||
124448491|NCT03785678|447604533|FG001|Overall Study|Withdrawal by Subject|3|||
124448492|NCT01660451|447604534|FG000|Overall Study|Protocol Violation|0|||
124448493|NCT01660451|447604535|FG001|Overall Study|Protocol Violation|1|||
124448494|NCT01660451|447604536|FG002|Overall Study|Protocol Violation|1|||
124901778|NCT02174562|449265158|FG001|Overall Study|Withdrawal by Subject|2|||
124901779|NCT02174562|449265157|FG000|Overall Study|Death|2|||
124901780|NCT02174562|449265158|FG001|Overall Study|Death|0|||
124901781|NCT02174562|449265157|FG000|Overall Study|Lost to Follow-up|0|||
124901782|NCT02174562|449265158|FG001|Overall Study|Lost to Follow-up|3|||
124901783|NCT05193318|449265159|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
124901784|NCT05193318|449265159|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
124448495|NCT01660451|447604534|FG000|Overall Study|AE not associated with clinical disease progression|13|||
124448496|NCT01660451|447604535|FG001|Overall Study|AE not associated with clinical disease progression|10|||
124448497|NCT01660451|447604536|FG002|Overall Study|AE not associated with clinical disease progression|40|||
124448498|NCT01660451|447604534|FG000|Overall Study|AE associated with clinical disease progression|1|||
124448499|NCT01660451|447604535|FG001|Overall Study|AE associated with clinical disease progression|3|||
124448500|NCT01660451|447604536|FG002|Overall Study|AE associated with clinical disease progression|11|||
124448501|NCT01660451|447604534|FG000|Overall Study|Sponsor Decision|0|||
124448502|NCT01660451|447604535|FG001|Overall Study|Sponsor Decision|0|||
124448503|NCT01660451|447604536|FG002|Overall Study|Sponsor Decision|1|||
124448504|NCT01660451|447604534|FG000|Overall Study|Protocol Deviation|0|||
124448505|NCT01660451|447604535|FG001|Overall Study|Protocol Deviation|0|||
124448506|NCT01660451|447604536|FG002|Overall Study|Protocol Deviation|1|||
124691185|NCT00758043|448490006|FG000|Overall Study|Adverse Event|1|||
124691186|NCT00758043|448490007|FG001|Overall Study|Adverse Event|20|||
124691187|NCT00758043|448490008|FG002|Overall Study|Adverse Event|12|||
124691188|NCT00758043|448490009|FG003|Overall Study|Adverse Event|62|||
124691189|NCT00758043|448490006|FG000|Overall Study|Lack of Efficacy|0|||
124691190|NCT00758043|448490007|FG001|Overall Study|Lack of Efficacy|6|||
124901785|NCT00798096|449265160|FG000|Overall Study|Ongoing|2|||
124901786|NCT01833065|449265161|FG000|Overall Study|Adverse Event|6|||
124901787|NCT01833065|449265162|FG001|Overall Study|Adverse Event|1|||
124901788|NCT01833065|449265163|FG002|Overall Study|Adverse Event|0|||
124901789|NCT01833065|449265164|FG003|Overall Study|Adverse Event|2|||
124901790|NCT01833065|449265165|FG004|Overall Study|Adverse Event|3|||
124901791|NCT01833065|449265161|FG000|Overall Study|Protocol Violation|1|||
124901792|NCT01833065|449265162|FG001|Overall Study|Protocol Violation|0|||
124901793|NCT01833065|449265163|FG002|Overall Study|Protocol Violation|0|||
124901794|NCT01833065|449265164|FG003|Overall Study|Protocol Violation|0|||
124901795|NCT01833065|449265165|FG004|Overall Study|Protocol Violation|2|||
124901796|NCT01833065|449265161|FG000|Overall Study|Lost to Follow-up|1|||
124901797|NCT01833065|449265162|FG001|Overall Study|Lost to Follow-up|0|||
124901798|NCT01833065|449265163|FG002|Overall Study|Lost to Follow-up|0|||
124448507|NCT01660451|447604534|FG000|Overall Study|Physician Decision|1|||
124448508|NCT01660451|447604535|FG001|Overall Study|Physician Decision|2|||
124448509|NCT01660451|447604536|FG002|Overall Study|Physician Decision|5|||
124448510|NCT01660451|447604534|FG000|Overall Study|Withdrawal by Subject|1|||
124691191|NCT00758043|448490008|FG002|Overall Study|Lack of Efficacy|18|||
124901799|NCT01833065|449265164|FG003|Overall Study|Lost to Follow-up|0|||
124901800|NCT01833065|449265165|FG004|Overall Study|Lost to Follow-up|3|||
124901801|NCT01833065|449265161|FG000|Overall Study|Withdrawal by Subject|6|||
124448511|NCT01660451|447604535|FG001|Overall Study|Withdrawal by Subject|1|||
124448512|NCT01660451|447604536|FG002|Overall Study|Withdrawal by Subject|20|||
124448513|NCT01660451|447604534|FG000|Overall Study|Trial closure.|0|||
124448514|NCT01660451|447604535|FG001|Overall Study|Trial closure.|0|||
124448515|NCT01660451|447604536|FG002|Overall Study|Trial closure.|1|||
124448516|NCT01660451|447604534|FG000|Overall Study|Switching to other therapy|0|||
124448517|NCT01660451|447604535|FG001|Overall Study|Switching to other therapy|1|||
124448518|NCT01660451|447604536|FG002|Overall Study|Switching to other therapy|1|||
124691192|NCT00758043|448490009|FG003|Overall Study|Lack of Efficacy|12|||
124691193|NCT00758043|448490006|FG000|Overall Study|Refused Further Treatment|0|||
124691194|NCT00758043|448490007|FG001|Overall Study|Refused Further Treatment|11|||
124691195|NCT00758043|448490008|FG002|Overall Study|Refused Further Treatment|5|||
124691196|NCT00758043|448490009|FG003|Overall Study|Refused Further Treatment|8|||
124901802|NCT01833065|449265162|FG001|Overall Study|Withdrawal by Subject|2|||
124901803|NCT01833065|449265163|FG002|Overall Study|Withdrawal by Subject|4|||
124901804|NCT01833065|449265164|FG003|Overall Study|Withdrawal by Subject|3|||
124901805|NCT01833065|449265165|FG004|Overall Study|Withdrawal by Subject|11|||
124901806|NCT01833065|449265161|FG000|Overall Study|Subject's substantial non-compliance|0|||
124901807|NCT01833065|449265162|FG001|Overall Study|Subject's substantial non-compliance|1|||
124901808|NCT01833065|449265163|FG002|Overall Study|Subject's substantial non-compliance|0|||
124901809|NCT01833065|449265164|FG003|Overall Study|Subject's substantial non-compliance|0|||
124901810|NCT01833065|449265165|FG004|Overall Study|Subject's substantial non-compliance|0|||
124901811|NCT01833065|449265161|FG000|Overall Study|Trial terminated by sponsor|8|||
124901812|NCT01833065|449265162|FG001|Overall Study|Trial terminated by sponsor|8|||
124901813|NCT01833065|449265163|FG002|Overall Study|Trial terminated by sponsor|7|||
124901814|NCT01833065|449265164|FG003|Overall Study|Trial terminated by sponsor|3|||
124901815|NCT01833065|449265165|FG004|Overall Study|Trial terminated by sponsor|13|||
124901816|NCT01833065|449265161|FG000|Overall Study|Others|2|||
124901817|NCT01833065|449265162|FG001|Overall Study|Others|1|||
124901818|NCT01833065|449265163|FG002|Overall Study|Others|1|||
124901819|NCT01833065|449265164|FG003|Overall Study|Others|1|||
124901820|NCT01833065|449265165|FG004|Overall Study|Others|4|||
124901821|NCT00241644|449265166|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
124901822|NCT00241644|449265167|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
124901823|NCT00241644|449265168|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
124901824|NCT00241644|449265169|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
124901825|NCT00241644|449265166|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
124448519|NCT01660451|447604534|FG000|Overall Study|Progressive disease - clinical progression|4|||
124691197|NCT00758043|448490006|FG000|Overall Study|Lost to Follow-up|0|||
124901826|NCT00241644|449265167|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
124901827|NCT00241644|449265168|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
124901828|NCT00241644|449265169|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
124691198|NCT00758043|448490007|FG001|Overall Study|Lost to Follow-up|2|||
124691199|NCT00758043|448490008|FG002|Overall Study|Lost to Follow-up|2|||
124691200|NCT00758043|448490009|FG003|Overall Study|Lost to Follow-up|5|||
124448520|NCT01660451|447604535|FG001|Overall Study|Progressive disease - clinical progression|10|||
124448521|NCT01660451|447604536|FG002|Overall Study|Progressive disease - clinical progression|9|||
124448522|NCT01660451|447604534|FG000|Overall Study|Progressive disease - radiological progression|12|||
124448523|NCT01660451|447604535|FG001|Overall Study|Progressive disease - radiological progression|23|||
124448524|NCT01660451|447604536|FG002|Overall Study|Progressive disease - radiological progression|50|||
124448525|NCT01660451|447604534|FG000|Overall Study|Death|1|||
124448526|NCT01660451|447604535|FG001|Overall Study|Death|0|||
124448527|NCT01660451|447604536|FG002|Overall Study|Death|1|||
124448528|NCT01660451|447604534|FG000|Overall Study|Other|0|||
124448529|NCT01660451|447604535|FG001|Overall Study|Other|0|||
124448530|NCT01660451|447604536|FG002|Overall Study|Other|1|||
124448531|NCT02374021|447604538|FG000|Overall Study|Adverse Event|1|||
124448532|NCT02374021|447604539|FG001|Overall Study|Adverse Event|0|||
124448533|NCT02374021|447604538|FG000|Overall Study|Lost to Follow-up|3|||
124448534|NCT02374021|447604539|FG001|Overall Study|Lost to Follow-up|2|||
124448535|NCT02374021|447604538|FG000|Overall Study|Physician Decision|0|||
124448536|NCT02374021|447604539|FG001|Overall Study|Physician Decision|3|||
124448537|NCT02374021|447604538|FG000|Overall Study|Withdrawal by Subject|6|||
124448538|NCT02374021|447604539|FG001|Overall Study|Withdrawal by Subject|5|||
124448539|NCT02374021|447604538|FG000|Overall Study|Poor Adherence|0|||
124448540|NCT02374021|447604539|FG001|Overall Study|Poor Adherence|1|||
124448541|NCT02374021|447604538|FG000|Overall Study|Scan protocol not followed|0|||
124448542|NCT02374021|447604539|FG001|Overall Study|Scan protocol not followed|1|||
124448543|NCT02374021|447604538|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
124448544|NCT02374021|447604539|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
124448545|NCT01667107|447604540|FG000|Overall Study|Adverse Event|4|||
124448546|NCT01667107|447604541|FG001|Overall Study|Adverse Event|3|||
124448547|NCT01667107|447604540|FG000|Overall Study|Tolerability issues|0|||
124448548|NCT01667107|447604541|FG001|Overall Study|Tolerability issues|2|||
124448549|NCT01667107|447604540|FG000|Overall Study|Protocol Violation|0|||
124448550|NCT01667107|447604541|FG001|Overall Study|Protocol Violation|1|||
124448551|NCT01667107|447604540|FG000|Overall Study|Lack of Efficacy|0|||
124448552|NCT01667107|447604541|FG001|Overall Study|Lack of Efficacy|1|||
124448553|NCT01162239|447604542|FG000|Treatment Phase|Withdrawal by Subject|1|||
124448554|NCT01162239|447604543|FG001|Treatment Phase|Withdrawal by Subject|3|||
124448555|NCT01162239|447604544|FG002|Treatment Phase|Withdrawal by Subject|2|||
124448556|NCT01162239|447604545|FG003|Treatment Phase|Withdrawal by Subject|3|||
124448557|NCT01162239|447604542|FG000|Treatment Phase|Death|0|||
124448558|NCT01162239|447604543|FG001|Treatment Phase|Death|0|||
124448559|NCT01162239|447604544|FG002|Treatment Phase|Death|0|||
124448560|NCT01162239|447604545|FG003|Treatment Phase|Death|1|||
124448561|NCT01162239|447604542|FG000|Treatment Phase|Lost to Follow-up|5|||
124448562|NCT01162239|447604543|FG001|Treatment Phase|Lost to Follow-up|4|||
124448563|NCT01162239|447604544|FG002|Treatment Phase|Lost to Follow-up|2|||
124448564|NCT01162239|447604545|FG003|Treatment Phase|Lost to Follow-up|1|||
124448565|NCT01162239|447604542|FG000|Extended Follow-up|Lost to Follow-up|8|||
124448566|NCT01162239|447604543|FG001|Extended Follow-up|Lost to Follow-up|13|||
124448567|NCT01162239|447604544|FG002|Extended Follow-up|Lost to Follow-up|8|||
124448568|NCT01162239|447604545|FG003|Extended Follow-up|Lost to Follow-up|6|||
124448569|NCT00228566|447604546|FG000|Overall Study|Adverse Event|31|||
124448570|NCT00228566|447604546|FG000|Overall Study|Lack of Efficacy|14|||
124448571|NCT00228566|447604546|FG000|Overall Study|Lost to Follow-up|16|||
124448572|NCT00228566|447604546|FG000|Overall Study|Physician Decision|5|||
124448573|NCT00228566|447604546|FG000|Overall Study|Withdrawal by Subject|4|||
124448574|NCT00228566|447604546|FG000|Overall Study|Miscellaneous|1|||
124448575|NCT04448756|447604549|FG000|Overall Study|Adverse Event|0|||
124448576|NCT04448756|447604550|FG001|Overall Study|Adverse Event|1|||
124448577|NCT04448756|447604551|FG002|Overall Study|Adverse Event|0|||
124448578|NCT04448756|447604549|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
124448579|NCT04448756|447604550|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
124448580|NCT04448756|447604551|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
124448581|NCT04448756|447604549|FG000|Overall Study|Withdrawal by Subject|0|||
124448582|NCT04448756|447604550|FG001|Overall Study|Withdrawal by Subject|3|||
124448583|NCT04448756|447604551|FG002|Overall Study|Withdrawal by Subject|1|||
124448584|NCT04448756|447604549|FG000|Overall Study|Death|2|||
124448585|NCT04448756|447604550|FG001|Overall Study|Death|1|||
124448586|NCT04448756|447604551|FG002|Overall Study|Death|0|||
124448587|NCT01624259|447604552|FG000|Overall Study|Adverse Event|18|||
124448588|NCT01624259|447604553|FG001|Overall Study|Adverse Event|18|||
124448589|NCT01624259|447604552|FG000|Overall Study|Protocol Violation|1|||
124448590|NCT01624259|447604553|FG001|Overall Study|Protocol Violation|2|||
124448591|NCT01624259|447604552|FG000|Overall Study|Withdrawal by Subject|5|||
124448592|NCT01624259|447604553|FG001|Overall Study|Withdrawal by Subject|7|||
124448593|NCT01624259|447604552|FG000|Overall Study|Physician Decision|1|||
124448594|NCT01624259|447604553|FG001|Overall Study|Physician Decision|1|||
124759884|NCT01308736|448744812|FG000|Overall Study|Did not attend a single session|6|||
124759885|NCT01308736|448744813|FG001|Overall Study|Did not attend a single session|5|||
124759886|NCT03634085|448744814|FG000|Overall Study|Adverse Event|1|||
124759887|NCT03634085|448744815|FG001|Overall Study|Adverse Event|0|||
124759888|NCT03634085|448744814|FG000|Overall Study|Withdrawal by Subject|0|||
124759889|NCT03634085|448744815|FG001|Overall Study|Withdrawal by Subject|2|||
124759890|NCT00296816|448744820|FG000|Overall Study|Disease Progression|37|||
124759891|NCT00296816|448744820|FG000|Overall Study|Adverse Event|18|||
124759892|NCT00296816|448744820|FG000|Overall Study|Investigator/Participant request|5|||
124759893|NCT00296816|448744820|FG000|Overall Study|Non-compliance|1|||
124759894|NCT00296816|448744820|FG000|Overall Study|Missing for end of treatment|4|||
124759895|NCT00296816|448744820|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
124759896|NCT00296816|448744820|FG000|Overall Study|Poor performance status|1|||
124759897|NCT00296816|448744820|FG000|Overall Study|Relocation to Florida|1|||
124759898|NCT00296816|448744820|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
124759899|NCT00296816|448744820|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
124759900|NCT00296816|448744820|FG000|Overall Study|Neuropathy/patient preference|1|||
124759901|NCT00296816|448744820|FG000|Overall Study|Proteinuria|1|||
124759902|NCT00296816|448744820|FG000|Overall Study|ineligibility due to radiation treatment|1|||
124759903|NCT00985465|448744824|FG000|Overall Study|Withdrawal by Subject|1|||
124901829|NCT00241644|449265166|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
124901830|NCT00241644|449265167|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
124901831|NCT00241644|449265168|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
124901832|NCT00241644|449265169|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
124759904|NCT00985465|448744825|FG001|Overall Study|Withdrawal by Subject|2|||
124759905|NCT00985465|448744824|FG000|Overall Study|Considered to be part of the other group|0|||
124759906|NCT00985465|448744825|FG001|Overall Study|Considered to be part of the other group|1|||
124759907|NCT04701333|448744828|FG000|Overall Study|Lost to Follow-up|3|||
124759908|NCT04701333|448744829|FG001|Overall Study|Lost to Follow-up|7|||
124759909|NCT04701333|448744828|FG000|Overall Study|Withdrawal by Subject|0|||
124759910|NCT04701333|448744829|FG001|Overall Study|Withdrawal by Subject|1|||
124759911|NCT01012258|448744830|FG000|Overall Study|Death|14|||
124901833|NCT00241644|449265166|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
124901834|NCT00241644|449265167|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
124901835|NCT00241644|449265168|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
124901836|NCT00241644|449265169|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
124901837|NCT00241644|449265166|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
124901838|NCT00241644|449265167|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
124901839|NCT00241644|449265168|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
124901840|NCT00241644|449265169|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
124901841|NCT00241644|449265166|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
124901842|NCT00241644|449265167|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
124901843|NCT00241644|449265168|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
124901844|NCT00241644|449265169|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
124901845|NCT00241644|449265166|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
124901846|NCT00241644|449265167|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
124901847|NCT00241644|449265168|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
124901848|NCT00241644|449265169|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
124901849|NCT00241644|449265166|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
124901850|NCT00241644|449265167|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
124901851|NCT00241644|449265168|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
124901852|NCT00241644|449265169|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
124901853|NCT00241644|449265166|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
124901854|NCT00241644|449265167|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
124901855|NCT00241644|449265168|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
124691201|NCT00758043|448490006|FG000|Overall Study|Withdrawal by Subject|0|||
124691202|NCT00758043|448490007|FG001|Overall Study|Withdrawal by Subject|1|||
124691203|NCT00758043|448490008|FG002|Overall Study|Withdrawal by Subject|1|||
124691204|NCT00758043|448490009|FG003|Overall Study|Withdrawal by Subject|4|||
124691205|NCT00758043|448490006|FG000|Overall Study|Required Prohibited Medication|0|||
124691206|NCT00758043|448490007|FG001|Overall Study|Required Prohibited Medication|0|||
124691207|NCT00758043|448490008|FG002|Overall Study|Required Prohibited Medication|1|||
124759912|NCT01012258|448744830|FG000|Overall Study|Lost to Follow-up|1|||
124759913|NCT01012258|448744830|FG000|Overall Study|Adverse Event|1|||
124901856|NCT00241644|449265169|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
124759914|NCT01012258|448744830|FG000|Overall Study|Progressive Disease (PD)|18|||
124759915|NCT01012258|448744830|FG000|Overall Study|Symptomatic Deterioration|1|||
124759916|NCT01012258|448744830|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
124759917|NCT01012258|448744830|FG000|Overall Study|Another Tumor Discovered|1|||
124759918|NCT01012258|448744830|FG000|Overall Study|Ongoing|29|||
124759919|NCT00580723|448744840|FG000|Overall Study|Did not want to participate in extension|3|||
124901857|NCT00241644|449265166|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
124901858|NCT00241644|449265167|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
124901859|NCT00241644|449265168|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
124901860|NCT00241644|449265169|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
124901861|NCT00241644|449265166|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
124901862|NCT00241644|449265167|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
124901863|NCT00241644|449265168|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
124901864|NCT00241644|449265169|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
124901865|NCT00241644|449265166|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
124901866|NCT00241644|449265167|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
124901867|NCT00241644|449265168|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
124901868|NCT00241644|449265169|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
124901869|NCT00241644|449265166|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
124901870|NCT00241644|449265167|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
124901871|NCT00241644|449265168|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
124901872|NCT00241644|449265169|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
124901873|NCT03095508|449265170|FG000|Overall Study|Adverse Event|0|||
124901874|NCT03095508|449265171|FG001|Overall Study|Adverse Event|1|||
124901875|NCT01027286|449265172|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
124901876|NCT01027286|449265173|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
124901877|NCT01027286|449265172|FG000|Overall Study|Lost to Follow-up|0|||
124901878|NCT01027286|449265173|FG001|Overall Study|Lost to Follow-up|1|||
124901879|NCT03201809|449265174|FG000|Overall Study|Lost to Follow-up|2|||
124901880|NCT03201809|449265175|FG001|Overall Study|Lost to Follow-up|0|||
124901881|NCT00545844|449265176|FG000|Overall Study|Lost to Follow-up|9|||
124901882|NCT00545844|449265176|FG000|Overall Study|Protocol Violation|1|||
124901883|NCT00545844|449265176|FG000|Overall Study|Withdrawal by Subject|2|||
124901884|NCT00975806|449265177|FG000|Overall Study|Adverse Event|2|||
124901885|NCT00975806|449265178|FG001|Overall Study|Adverse Event|1|||
124901886|NCT00975806|449265179|FG002|Overall Study|Adverse Event|2|||
124901887|NCT00975806|449265177|FG000|Overall Study|Disease Progression|1|||
124901888|NCT00975806|449265178|FG001|Overall Study|Disease Progression|5|||
124901889|NCT00975806|449265179|FG002|Overall Study|Disease Progression|1|||
124901890|NCT00975806|449265177|FG000|Overall Study|Withdrawal by Subject|1|||
124901891|NCT00975806|449265178|FG001|Overall Study|Withdrawal by Subject|0|||
124901892|NCT00975806|449265179|FG002|Overall Study|Withdrawal by Subject|0|||
124901893|NCT00975806|449265177|FG000|Overall Study|Death|0|||
124901894|NCT00975806|449265178|FG001|Overall Study|Death|1|||
124901895|NCT00975806|449265179|FG002|Overall Study|Death|0|||
124901896|NCT00975806|449265177|FG000|Overall Study|Physician decision and disease related|1|||
124901897|NCT00975806|449265178|FG001|Overall Study|Physician decision and disease related|0|||
124901898|NCT00975806|449265179|FG002|Overall Study|Physician decision and disease related|1|||
124901899|NCT02377362|449265180|FG000|Part A Second Treatment|Protocol Violation|0|||
124901900|NCT02377362|449265181|FG001|Part A Second Treatment|Protocol Violation|0|||
124901901|NCT02377362|449265182|FG002|Part A Second Treatment|Protocol Violation|0|||
124901902|NCT02377362|449265183|FG003|Part A Second Treatment|Protocol Violation|0|||
124901903|NCT02377362|449265184|FG004|Part A Second Treatment|Protocol Violation|1|||
124901904|NCT02377362|449265185|FG005|Part A Second Treatment|Protocol Violation|0|||
124901905|NCT02377362|449265186|FG006|Part A Second Treatment|Protocol Violation|0|||
124901906|NCT02377362|449265187|FG007|Part A Second Treatment|Protocol Violation|0|||
124901907|NCT02377362|449265188|FG008|Part A Second Treatment|Protocol Violation|0|||
124901908|NCT02377362|449265189|FG009|Part A Second Treatment|Protocol Violation|0|||
124901909|NCT02377362|449265190|FG010|Part A Second Treatment|Protocol Violation|0|||
124901910|NCT02377362|449265191|FG011|Part A Second Treatment|Protocol Violation|0|||
124901911|NCT02377362|449265192|FG012|Part A Second Treatment|Protocol Violation|0|||
124901912|NCT02377362|449265180|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901913|NCT02377362|449265181|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901914|NCT02377362|449265182|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901915|NCT02377362|449265183|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
124901916|NCT02377362|449265184|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
124901917|NCT02377362|449265185|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
124901918|NCT02377362|449265186|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901919|NCT02377362|449265187|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901920|NCT02377362|449265188|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901921|NCT02377362|449265189|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901922|NCT02377362|449265190|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901923|NCT02377362|449265191|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901924|NCT02377362|449265192|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
124901925|NCT02377362|449265180|FG000|Part B Overall|Protocol Violation|0|||
124901926|NCT02377362|449265181|FG001|Part B Overall|Protocol Violation|0|||
124901927|NCT02377362|449265182|FG002|Part B Overall|Protocol Violation|0|||
124901928|NCT02377362|449265183|FG003|Part B Overall|Protocol Violation|0|||
124901929|NCT02377362|449265184|FG004|Part B Overall|Protocol Violation|0|||
124901930|NCT02377362|449265185|FG005|Part B Overall|Protocol Violation|0|||
124901931|NCT02377362|449265186|FG006|Part B Overall|Protocol Violation|0|||
124901932|NCT02377362|449265187|FG007|Part B Overall|Protocol Violation|0|||
124901933|NCT02377362|449265188|FG008|Part B Overall|Protocol Violation|0|||
124901934|NCT02377362|449265189|FG009|Part B Overall|Protocol Violation|1|||
124901935|NCT02377362|449265190|FG010|Part B Overall|Protocol Violation|0|||
124901936|NCT02377362|449265191|FG011|Part B Overall|Protocol Violation|0|||
124901937|NCT02377362|449265192|FG012|Part B Overall|Protocol Violation|0|||
124901938|NCT02377362|449265180|FG000|Part B Overall|Adverse Event|0|||
124901939|NCT02377362|449265181|FG001|Part B Overall|Adverse Event|0|||
124901940|NCT02377362|449265182|FG002|Part B Overall|Adverse Event|0|||
124901941|NCT02377362|449265183|FG003|Part B Overall|Adverse Event|0|||
124901942|NCT02377362|449265184|FG004|Part B Overall|Adverse Event|0|||
124901943|NCT02377362|449265185|FG005|Part B Overall|Adverse Event|0|||
124901944|NCT02377362|449265186|FG006|Part B Overall|Adverse Event|1|||
124901945|NCT02377362|449265187|FG007|Part B Overall|Adverse Event|1|||
124901946|NCT02377362|449265188|FG008|Part B Overall|Adverse Event|0|||
124901947|NCT02377362|449265189|FG009|Part B Overall|Adverse Event|0|||
124901948|NCT02377362|449265190|FG010|Part B Overall|Adverse Event|0|||
124901949|NCT02377362|449265191|FG011|Part B Overall|Adverse Event|0|||
124901950|NCT02377362|449265192|FG012|Part B Overall|Adverse Event|0|||
124901951|NCT02377362|449265180|FG000|Part B Overall|Withdrawal by Subject|0|||
124901952|NCT02377362|449265181|FG001|Part B Overall|Withdrawal by Subject|0|||
124901953|NCT02377362|449265182|FG002|Part B Overall|Withdrawal by Subject|0|||
124901954|NCT02377362|449265183|FG003|Part B Overall|Withdrawal by Subject|0|||
124901955|NCT02377362|449265184|FG004|Part B Overall|Withdrawal by Subject|0|||
124901956|NCT02377362|449265185|FG005|Part B Overall|Withdrawal by Subject|0|||
124901957|NCT02377362|449265186|FG006|Part B Overall|Withdrawal by Subject|1|||
124901958|NCT02377362|449265187|FG007|Part B Overall|Withdrawal by Subject|0|||
124901959|NCT02377362|449265188|FG008|Part B Overall|Withdrawal by Subject|0|||
124901960|NCT02377362|449265189|FG009|Part B Overall|Withdrawal by Subject|0|||
124901961|NCT02377362|449265190|FG010|Part B Overall|Withdrawal by Subject|0|||
124901962|NCT02377362|449265191|FG011|Part B Overall|Withdrawal by Subject|1|||
124901963|NCT02377362|449265192|FG012|Part B Overall|Withdrawal by Subject|0|||
124901964|NCT00094809|449265193|FG000|Overall Study|Protocol deviation|2|||
124901965|NCT00094809|449265194|FG001|Overall Study|Protocol deviation|2|||
124901966|NCT00094809|449265193|FG000|Overall Study|Noncompliance|1|||
124901967|NCT00094809|449265194|FG001|Overall Study|Noncompliance|0|||
124901968|NCT00094809|449265193|FG000|Overall Study|Adverse Event|3|||
124901969|NCT00094809|449265194|FG001|Overall Study|Adverse Event|1|||
124901970|NCT00094809|449265193|FG000|Overall Study|Withdrawal by Subject|8|||
124901971|NCT00094809|449265194|FG001|Overall Study|Withdrawal by Subject|9|||
124901972|NCT00094809|449265193|FG000|Overall Study|Disease progression|3|||
124901973|NCT00094809|449265194|FG001|Overall Study|Disease progression|3|||
124901974|NCT00094809|449265193|FG000|Overall Study|Physician Decision|3|||
124901975|NCT00094809|449265194|FG001|Overall Study|Physician Decision|5|||
124901976|NCT00094809|449265193|FG000|Overall Study|Lost to Follow-up|6|||
124901977|NCT00094809|449265194|FG001|Overall Study|Lost to Follow-up|6|||
124901978|NCT00094809|449265193|FG000|Overall Study|Death|19|||
124901979|NCT00094809|449265194|FG001|Overall Study|Death|25|||
124901980|NCT00094809|449265193|FG000|Overall Study|Protocol-specified criteria|1|||
124901981|NCT00094809|449265194|FG001|Overall Study|Protocol-specified criteria|1|||
124901982|NCT00094809|449265193|FG000|Overall Study|Other|2|||
124901983|NCT00094809|449265194|FG001|Overall Study|Other|4|||
124901984|NCT00094809|449265193|FG000|Overall Study|Informed consent signed after treatment|1|||
124901985|NCT00094809|449265194|FG001|Overall Study|Informed consent signed after treatment|0|||
124901986|NCT00094809|449265193|FG000|Overall Study|Study drug not received|2|||
124901987|NCT00094809|449265194|FG001|Overall Study|Study drug not received|8|||
124901988|NCT00094809|449265193|FG000|Overall Study|Other|1|||
124901989|NCT00094809|449265194|FG001|Overall Study|Other|1|||
124901990|NCT04889664|449265195|FG000|Screen|Lost to Follow-up|1|||
124901991|NCT04889664|449265195|FG000|Screen|Failed to meet screening criteria|1|||
124901992|NCT04889664|449265195|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
124901993|NCT04107805|449265200|FG000|Overall Study|Adverse Event|0|||
124901994|NCT04107805|449265201|FG001|Overall Study|Adverse Event|0|||
124901995|NCT04107805|449265202|FG002|Overall Study|Adverse Event|0|||
124901996|NCT04107805|449265203|FG003|Overall Study|Adverse Event|1|||
124448595|NCT01624259|447604552|FG000|Overall Study|Lost to Follow-up|2|||
124901997|NCT04107805|449265204|FG004|Overall Study|Adverse Event|0|||
124901998|NCT04107805|449265205|FG005|Overall Study|Adverse Event|1|||
124901999|NCT04107805|449265206|FG006|Overall Study|Adverse Event|0|||
124902000|NCT04107805|449265207|FG007|Overall Study|Adverse Event|0|||
124902001|NCT04107805|449265208|FG008|Overall Study|Adverse Event|1|||
124448596|NCT01624259|447604553|FG001|Overall Study|Lost to Follow-up|3|||
124902002|NCT01191086|449265220|FG000|Overall Study|Adverse Event|20|||
124902003|NCT01191086|449265220|FG000|Overall Study|Lack of Efficacy|10|||
124902004|NCT01191086|449265220|FG000|Overall Study|Lost to Follow-up|4|||
124902005|NCT01191086|449265220|FG000|Overall Study|Physician Decision|2|||
124902006|NCT01191086|449265220|FG000|Overall Study|Withdrawal by Subject|24|||
124902007|NCT01191086|449265220|FG000|Overall Study|Discontinuation criterion met|1|||
124902008|NCT01191086|449265220|FG000|Overall Study|Other|1|||
124902009|NCT00771849|449265221|FG000|Overall Study|Lost to Follow-up|1|||
124902010|NCT00771849|449265222|FG001|Overall Study|Lost to Follow-up|2|||
124902011|NCT00771849|449265221|FG000|Overall Study|Withdrawal by Subject|1|||
124902012|NCT00771849|449265222|FG001|Overall Study|Withdrawal by Subject|1|||
124902013|NCT00771849|449265221|FG000|Overall Study|Not vaccinated|0|||
124902014|NCT00771849|449265222|FG001|Overall Study|Not vaccinated|1|||
124902015|NCT02046616|449265227|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
124902016|NCT02046616|449265227|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
124902017|NCT02046616|449265227|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
124902018|NCT02046616|449265227|FG000|24-Week Treatment Period|Physician Decision|3|||
124902019|NCT02046616|449265227|FG000|24-Week Treatment Period|Other|1|||
124902020|NCT02046616|449265227|FG000|8-Week FU Period|Lost to Follow-up|1|||
124902021|NCT02736799|449265228|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
124902022|NCT02736799|449265229|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
124902023|NCT02736799|449265230|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
124902024|NCT02736799|449265231|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
124902025|NCT01156116|449265234|FG000|Overall Study|Withdrawal by Subject|3|||
124902026|NCT01156116|449265235|FG001|Overall Study|Withdrawal by Subject|1|||
124902027|NCT01156116|449265234|FG000|Overall Study|CPAP intolerance|2|||
124902028|NCT01156116|449265235|FG001|Overall Study|CPAP intolerance|0|||
124902029|NCT00344019|449265236|FG000|Overall Study|did not meet final inclusion criteria|0|||
124902030|NCT00344019|449265237|FG001|Overall Study|did not meet final inclusion criteria|0|||
124902031|NCT00344019|449265238|FG002|Overall Study|did not meet final inclusion criteria|74|||
124902032|NCT02057718|449265239|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
124902033|NCT02057718|449265240|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
124902034|NCT02057718|449265239|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
124902035|NCT02057718|449265240|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
124902036|NCT02057718|449265239|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
124902037|NCT02057718|449265240|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
124902038|NCT02057718|449265239|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
124902039|NCT02057718|449265240|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
124902040|NCT02057718|449265239|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
124902041|NCT02057718|449265240|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
124902042|NCT02057718|449265239|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
124902043|NCT02057718|449265240|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
124902044|NCT02057718|449265239|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
124902045|NCT02057718|449265240|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
124902046|NCT02057718|449265239|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
124902047|NCT02057718|449265240|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
124902048|NCT02057718|449265239|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
124902049|NCT02057718|449265240|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
124902050|NCT02057718|449265239|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
124902051|NCT02057718|449265240|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
124902052|NCT02057718|449265239|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
124902053|NCT02057718|449265240|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
124902054|NCT02503202|449265241|FG000|Base Study: Up to Month 6|Death|1|||
124902055|NCT02503202|449265242|FG001|Base Study: Up to Month 6|Death|1|||
124902056|NCT02503202|449265243|FG002|Base Study: Up to Month 6|Death|0|||
124902057|NCT02503202|449265244|FG003|Base Study: Up to Month 6|Death|0|||
124902058|NCT02503202|449265245|FG004|Base Study: Up to Month 6|Death|0|||
124902059|NCT02503202|449265241|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
124902060|NCT02503202|449265242|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
124902061|NCT02503202|449265243|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
124902062|NCT02503202|449265244|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
124902063|NCT02503202|449265245|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
124902064|NCT02503202|449265241|FG000|Base Study: Up to Month 6|Physician Decision|0|||
124902065|NCT02503202|449265242|FG001|Base Study: Up to Month 6|Physician Decision|0|||
124902066|NCT02503202|449265243|FG002|Base Study: Up to Month 6|Physician Decision|0|||
124902067|NCT02503202|449265244|FG003|Base Study: Up to Month 6|Physician Decision|0|||
124902068|NCT02503202|449265245|FG004|Base Study: Up to Month 6|Physician Decision|1|||
124902069|NCT02503202|449265241|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
124902070|NCT02503202|449265242|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
124902071|NCT02503202|449265243|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
124902072|NCT02503202|449265244|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
124902073|NCT02503202|449265245|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
124902074|NCT02503202|449265241|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
124902075|NCT02503202|449265242|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
124902076|NCT02503202|449265243|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
124902077|NCT02503202|449265244|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
124902078|NCT02503202|449265245|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
124902079|NCT02503202|449265241|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
124902080|NCT02503202|449265242|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
124902081|NCT02503202|449265243|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
124902082|NCT02503202|449265244|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
124902083|NCT02503202|449265245|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
124902084|NCT02503202|449265241|FG000|Extension: Month 6 to 24|Death|1|||
124902085|NCT02503202|449265242|FG001|Extension: Month 6 to 24|Death|0|||
124902086|NCT02503202|449265243|FG002|Extension: Month 6 to 24|Death|0|||
124902087|NCT02503202|449265244|FG003|Extension: Month 6 to 24|Death|0|||
124902088|NCT02503202|449265245|FG004|Extension: Month 6 to 24|Death|0|||
124902089|NCT02503202|449265241|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
124902090|NCT02503202|449265242|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
124902091|NCT02503202|449265243|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
124902092|NCT02503202|449265244|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
124902093|NCT02503202|449265245|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
124902094|NCT02503202|449265241|FG000|Extension: Month 6 to 24|Physician Decision|1|||
124902095|NCT02503202|449265242|FG001|Extension: Month 6 to 24|Physician Decision|0|||
124902096|NCT02503202|449265243|FG002|Extension: Month 6 to 24|Physician Decision|1|||
124691208|NCT00758043|448490009|FG003|Overall Study|Required Prohibited Medication|3|||
124902097|NCT02503202|449265244|FG003|Extension: Month 6 to 24|Physician Decision|3|||
124902098|NCT02503202|449265245|FG004|Extension: Month 6 to 24|Physician Decision|0|||
124902099|NCT02503202|449265241|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
124902100|NCT02503202|449265242|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
124902101|NCT02503202|449265243|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
124902102|NCT02503202|449265244|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
124902103|NCT02503202|449265245|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
124902104|NCT01050569|449265249|FG000|Overall Study|Lost to Follow-up|20|||
124902105|NCT01050569|449265250|FG001|Overall Study|Lost to Follow-up|14|||
124902106|NCT01050569|449265251|FG002|Overall Study|Lost to Follow-up|16|||
124902107|NCT01050569|449265249|FG000|Overall Study|Withdrawal by Subject|9|||
124902108|NCT01050569|449265250|FG001|Overall Study|Withdrawal by Subject|3|||
124902109|NCT01050569|449265251|FG002|Overall Study|Withdrawal by Subject|11|||
124902110|NCT01050569|449265249|FG000|Overall Study|Lack of Efficacy|5|||
124902111|NCT01050569|449265250|FG001|Overall Study|Lack of Efficacy|4|||
124902112|NCT01050569|449265251|FG002|Overall Study|Lack of Efficacy|3|||
124902113|NCT01050569|449265249|FG000|Overall Study|Adverse Event|1|||
124902114|NCT01050569|449265250|FG001|Overall Study|Adverse Event|0|||
124902115|NCT01050569|449265251|FG002|Overall Study|Adverse Event|0|||
124902116|NCT01050569|449265249|FG000|Overall Study|Physician Decision|3|||
124902117|NCT01050569|449265250|FG001|Overall Study|Physician Decision|3|||
124902118|NCT01050569|449265251|FG002|Overall Study|Physician Decision|3|||
124902119|NCT03525119|449265253|FG000|Overall Study|Adverse Event|0|||
124902120|NCT03525119|449265254|FG001|Overall Study|Adverse Event|1|||
124902121|NCT03525119|449265255|FG002|Overall Study|Adverse Event|0|||
124902122|NCT03525119|449265253|FG000|Overall Study|Lost to Follow-up|32|||
124902123|NCT03525119|449265254|FG001|Overall Study|Lost to Follow-up|33|||
124902124|NCT03525119|449265255|FG002|Overall Study|Lost to Follow-up|37|||
124902125|NCT03525119|449265253|FG000|Overall Study|Withdrawal by Subject|5|||
124902126|NCT03525119|449265254|FG001|Overall Study|Withdrawal by Subject|4|||
124902127|NCT03525119|449265255|FG002|Overall Study|Withdrawal by Subject|2|||
124902128|NCT03525119|449265253|FG000|Overall Study|Reason not Specified|2|||
124902129|NCT03525119|449265254|FG001|Overall Study|Reason not Specified|1|||
124902130|NCT03525119|449265255|FG002|Overall Study|Reason not Specified|2|||
124902131|NCT03525119|449265253|FG000|Overall Study|Randomized but not Vaccinated|1|||
124902132|NCT03525119|449265254|FG001|Overall Study|Randomized but not Vaccinated|0|||
124902133|NCT03525119|449265255|FG002|Overall Study|Randomized but not Vaccinated|2|||
124902134|NCT01959412|449265256|FG000|Overall Study|Protocol deviation|1|||
124902135|NCT01959412|449265257|FG001|Overall Study|Protocol deviation|1|||
124902136|NCT01959412|449265258|FG002|Overall Study|Protocol deviation|0|||
124902137|NCT01959412|449265259|FG003|Overall Study|Protocol deviation|1|||
124902138|NCT01959412|449265260|FG004|Overall Study|Protocol deviation|3|||
124902139|NCT01959412|449265261|FG005|Overall Study|Protocol deviation|0|||
124902140|NCT01959412|449265256|FG000|Overall Study|Adverse Event|0|||
124902141|NCT01959412|449265257|FG001|Overall Study|Adverse Event|0|||
124902142|NCT01959412|449265258|FG002|Overall Study|Adverse Event|0|||
124902143|NCT01959412|449265259|FG003|Overall Study|Adverse Event|1|||
124902144|NCT01959412|449265260|FG004|Overall Study|Adverse Event|0|||
124902145|NCT01959412|449265261|FG005|Overall Study|Adverse Event|0|||
124902146|NCT00509769|449265262|FG000|Overall Study|Progressive disease|77|||
124902147|NCT00509769|449265262|FG000|Overall Study|Adverse Event|4|||
124902148|NCT00509769|449265262|FG000|Overall Study|Patient's decision|1|||
124902149|NCT00509769|449265262|FG000|Overall Study|Physician Decision|8|||
124902150|NCT00509769|449265262|FG000|Overall Study|Use of prohibited therapies during study|1|||
124902151|NCT04364269|449265263|FG000|Overall Study|Adverse Event|1|||
124902152|NCT04364269|449265264|FG001|Overall Study|Adverse Event|0|||
124902153|NCT04364269|449265265|FG002|Overall Study|Adverse Event|0|||
124902154|NCT04364269|449265263|FG000|Overall Study|Withdrawal by Subject|0|||
124902155|NCT04364269|449265264|FG001|Overall Study|Withdrawal by Subject|1|||
124902156|NCT04364269|449265265|FG002|Overall Study|Withdrawal by Subject|0|||
124902157|NCT00383188|449265266|FG000|Overall Study|Adverse Event|4|||
124902158|NCT00383188|449265267|FG001|Overall Study|Adverse Event|7|||
124902159|NCT00383188|449265268|FG002|Overall Study|Adverse Event|9|||
124902160|NCT00383188|449265269|FG003|Overall Study|Adverse Event|8|||
124902161|NCT00383188|449265270|FG004|Overall Study|Adverse Event|8|||
124902162|NCT00383188|449265266|FG000|Overall Study|Lack of Efficacy|9|||
124902163|NCT00383188|449265267|FG001|Overall Study|Lack of Efficacy|3|||
124902164|NCT00383188|449265268|FG002|Overall Study|Lack of Efficacy|3|||
124902165|NCT00383188|449265269|FG003|Overall Study|Lack of Efficacy|2|||
124902166|NCT00383188|449265270|FG004|Overall Study|Lack of Efficacy|6|||
124902167|NCT00383188|449265266|FG000|Overall Study|Other|3|||
124902168|NCT00383188|449265267|FG001|Overall Study|Other|1|||
124902169|NCT00383188|449265268|FG002|Overall Study|Other|0|||
124902170|NCT00383188|449265269|FG003|Overall Study|Other|2|||
124902171|NCT00383188|449265270|FG004|Overall Study|Other|6|||
124902172|NCT00383188|449265266|FG000|Overall Study|No longer willing to participate|1|||
124448597|NCT01624259|447604552|FG000|Overall Study|Abnormal laboratory measure|3|||
124448598|NCT01624259|447604553|FG001|Overall Study|Abnormal laboratory measure|0|||
124902173|NCT00383188|449265267|FG001|Overall Study|No longer willing to participate|0|||
124902174|NCT00383188|449265268|FG002|Overall Study|No longer willing to participate|1|||
124902175|NCT00383188|449265269|FG003|Overall Study|No longer willing to participate|0|||
124448599|NCT04313153|447605718|FG000|Overall Study|Adverse Event (includes Death)|14|||
124448600|NCT04313153|447605719|FG001|Overall Study|Adverse Event (includes Death)|19|||
124448601|NCT04313153|447605720|FG002|Overall Study|Adverse Event (includes Death)|10|||
124448602|NCT04313153|447605718|FG000|Overall Study|Physician Decision|4|||
124448603|NCT04313153|447605719|FG001|Overall Study|Physician Decision|2|||
124448604|NCT04313153|447605720|FG002|Overall Study|Physician Decision|1|||
124448605|NCT04313153|447605718|FG000|Overall Study|Withdrawal by Subject|7|||
124448606|NCT04313153|447605719|FG001|Overall Study|Withdrawal by Subject|6|||
124448607|NCT04313153|447605720|FG002|Overall Study|Withdrawal by Subject|2|||
124448608|NCT04313153|447605718|FG000|Overall Study|Lack of Efficacy|3|||
124448609|NCT04313153|447605719|FG001|Overall Study|Lack of Efficacy|3|||
124448610|NCT04313153|447605720|FG002|Overall Study|Lack of Efficacy|0|||
124902176|NCT00383188|449265270|FG004|Overall Study|No longer willing to participate|2|||
124902177|NCT00383188|449265266|FG000|Overall Study|Lost to Follow-up|0|||
124902178|NCT00383188|449265267|FG001|Overall Study|Lost to Follow-up|0|||
124902179|NCT00383188|449265268|FG002|Overall Study|Lost to Follow-up|0|||
124902180|NCT00383188|449265269|FG003|Overall Study|Lost to Follow-up|0|||
124902181|NCT00383188|449265270|FG004|Overall Study|Lost to Follow-up|1|||
124902182|NCT01093534|449265271|FG000|Overall Study|Adverse Event|2|||
124902183|NCT01093534|449265272|FG001|Overall Study|Adverse Event|5|||
124902184|NCT01093534|449265273|FG002|Overall Study|Adverse Event|2|||
124902185|NCT01093534|449265271|FG000|Overall Study|Lack of Efficacy|2|||
124902186|NCT01093534|449265272|FG001|Overall Study|Lack of Efficacy|1|||
124902187|NCT01093534|449265273|FG002|Overall Study|Lack of Efficacy|1|||
124902188|NCT01093534|449265271|FG000|Overall Study|Withdrawal by Subject|5|||
124902189|NCT01093534|449265272|FG001|Overall Study|Withdrawal by Subject|7|||
124902190|NCT01093534|449265273|FG002|Overall Study|Withdrawal by Subject|2|||
124448611|NCT04313153|447605718|FG000|Overall Study|Lost to Follow-up|1|||
124448612|NCT04313153|447605719|FG001|Overall Study|Lost to Follow-up|0|||
124448613|NCT04313153|447605720|FG002|Overall Study|Lost to Follow-up|2|||
124448614|NCT04313153|447605718|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
124448615|NCT04313153|447605719|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
124448616|NCT04313153|447605720|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
124448617|NCT04313153|447605718|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
124448618|NCT04313153|447605719|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
124448619|NCT04313153|447605720|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
124448620|NCT04313153|447605718|FG000|Overall Study|Change in Dialysis Modality|0|||
124902191|NCT01093534|449265271|FG000|Overall Study|Other|1|||
124902192|NCT01093534|449265272|FG001|Overall Study|Other|3|||
124902193|NCT01093534|449265273|FG002|Overall Study|Other|4|||
124902194|NCT03418324|449265288|FG000|Overall Study|Death|0|||
124902195|NCT03418324|449265289|FG001|Overall Study|Death|1|||
124902196|NCT03418324|449265288|FG000|Overall Study|Physician Decision|1|||
124902197|NCT03418324|449265289|FG001|Overall Study|Physician Decision|1|||
124902198|NCT01768676|449265290|FG000|Overall Study|Adverse Event|3|||
124902199|NCT01768676|449265291|FG001|Overall Study|Adverse Event|3|||
124902200|NCT01768676|449265290|FG000|Overall Study|Lost to Follow-up|13|||
124902201|NCT01768676|449265291|FG001|Overall Study|Lost to Follow-up|16|||
124902202|NCT01768676|449265290|FG000|Overall Study|Protocol Violation|1|||
124902203|NCT01768676|449265291|FG001|Overall Study|Protocol Violation|1|||
124902204|NCT01768676|449265290|FG000|Overall Study|Physician Decision|4|||
124902205|NCT01768676|449265291|FG001|Overall Study|Physician Decision|1|||
124902206|NCT01768676|449265290|FG000|Overall Study|Withdrawal by Subject|3|||
124902207|NCT01768676|449265291|FG001|Overall Study|Withdrawal by Subject|10|||
124902208|NCT04248829|449265292|FG000|Overall Study|Disease progression|44|||
124902209|NCT04248829|449265293|FG001|Overall Study|Disease progression|109|||
124448621|NCT04313153|447605719|FG001|Overall Study|Change in Dialysis Modality|1|||
124448622|NCT04313153|447605720|FG002|Overall Study|Change in Dialysis Modality|2|||
124902210|NCT04248829|449265292|FG000|Overall Study|Adverse Event|19|||
124902211|NCT04248829|449265293|FG001|Overall Study|Adverse Event|18|||
124902212|NCT04248829|449265292|FG000|Overall Study|Withdrawal by Subject|11|||
124902213|NCT04248829|449265293|FG001|Overall Study|Withdrawal by Subject|2|||
124902214|NCT04248829|449265292|FG000|Overall Study|Lost to Follow-up|0|||
124448623|NCT04313153|447605718|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
124902215|NCT04248829|449265293|FG001|Overall Study|Lost to Follow-up|1|||
124902216|NCT04248829|449265292|FG000|Overall Study|Death|12|||
124902217|NCT04248829|449265293|FG001|Overall Study|Death|14|||
124902218|NCT04248829|449265292|FG000|Overall Study|Physician Decision|2|||
124902219|NCT04248829|449265293|FG001|Overall Study|Physician Decision|4|||
124902220|NCT04248829|449265292|FG000|Overall Study|Any reason not specifically recorded|0|||
124902221|NCT04248829|449265293|FG001|Overall Study|Any reason not specifically recorded|2|||
124902222|NCT02685033|449265294|FG000|Overall Study|Withdrawal of Consent|0|||
124902223|NCT02685033|449265295|FG001|Overall Study|Withdrawal of Consent|1|||
124902224|NCT02685033|449265294|FG000|Overall Study|Lost to Follow-up|2|||
124902225|NCT02685033|449265295|FG001|Overall Study|Lost to Follow-up|1|||
124902226|NCT02685033|449265294|FG000|Overall Study|Adverse Event|1|||
124902227|NCT02685033|449265295|FG001|Overall Study|Adverse Event|0|||
124902228|NCT01066923|449265296|FG000|Overall Study|Withdrawal by Subject|3|||
124902229|NCT01066923|449265297|FG001|Overall Study|Withdrawal by Subject|3|||
124902230|NCT01066923|449265298|FG002|Overall Study|Withdrawal by Subject|8|||
124902231|NCT01066923|449265299|FG003|Overall Study|Withdrawal by Subject|8|||
124902232|NCT01546155|449266577|FG000|Overall Study|could not tolerate long scan duration|3|||
124902233|NCT00771667|449266579|FG000|Induction Phase|Adverse Event|5|||
124902234|NCT00771667|449266580|FG001|Induction Phase|Adverse Event|2|||
124902235|NCT00771667|449266581|FG002|Induction Phase|Adverse Event|4|||
124902236|NCT00771667|449266582|FG003|Induction Phase|Adverse Event|1|||
124902237|NCT00771667|449266583|FG004|Induction Phase|Adverse Event|0|||
124902238|NCT00771667|449266584|FG005|Induction Phase|Adverse Event|0|||
124902239|NCT00771667|449266585|FG006|Induction Phase|Adverse Event|0|||
124902240|NCT00771667|449266586|FG007|Induction Phase|Adverse Event|0|||
124902241|NCT00771667|449266587|FG008|Induction Phase|Adverse Event|0|||
124902242|NCT00771667|449266588|FG009|Induction Phase|Adverse Event|0|||
124902243|NCT00771667|449266579|FG000|Induction Phase|Lack of Efficacy|9|||
124902244|NCT00771667|449266580|FG001|Induction Phase|Lack of Efficacy|2|||
124902245|NCT00771667|449266581|FG002|Induction Phase|Lack of Efficacy|4|||
124902246|NCT00771667|449266582|FG003|Induction Phase|Lack of Efficacy|3|||
124902247|NCT00771667|449266583|FG004|Induction Phase|Lack of Efficacy|0|||
124902248|NCT00771667|449266584|FG005|Induction Phase|Lack of Efficacy|0|||
124902249|NCT00771667|449266585|FG006|Induction Phase|Lack of Efficacy|0|||
124902250|NCT00771667|449266586|FG007|Induction Phase|Lack of Efficacy|0|||
124902251|NCT00771667|449266587|FG008|Induction Phase|Lack of Efficacy|0|||
124902252|NCT00771667|449266588|FG009|Induction Phase|Lack of Efficacy|0|||
124902253|NCT00771667|449266579|FG000|Induction Phase|Lost to Follow-up|1|||
124902254|NCT00771667|449266580|FG001|Induction Phase|Lost to Follow-up|0|||
124902255|NCT00771667|449266581|FG002|Induction Phase|Lost to Follow-up|1|||
124902256|NCT00771667|449266582|FG003|Induction Phase|Lost to Follow-up|0|||
124902257|NCT00771667|449266583|FG004|Induction Phase|Lost to Follow-up|0|||
124902258|NCT00771667|449266584|FG005|Induction Phase|Lost to Follow-up|0|||
124902259|NCT00771667|449266585|FG006|Induction Phase|Lost to Follow-up|0|||
124902260|NCT00771667|449266586|FG007|Induction Phase|Lost to Follow-up|0|||
124902261|NCT00771667|449266587|FG008|Induction Phase|Lost to Follow-up|0|||
124902262|NCT00771667|449266588|FG009|Induction Phase|Lost to Follow-up|0|||
124902263|NCT00771667|449266579|FG000|Induction Phase|Other|4|||
124902264|NCT00771667|449266580|FG001|Induction Phase|Other|6|||
124902265|NCT00771667|449266581|FG002|Induction Phase|Other|3|||
124902266|NCT00771667|449266582|FG003|Induction Phase|Other|4|||
124902267|NCT00771667|449266583|FG004|Induction Phase|Other|0|||
124902268|NCT00771667|449266584|FG005|Induction Phase|Other|0|||
124902269|NCT00771667|449266585|FG006|Induction Phase|Other|0|||
124902270|NCT00771667|449266586|FG007|Induction Phase|Other|0|||
124902271|NCT00771667|449266587|FG008|Induction Phase|Other|0|||
124902272|NCT00771667|449266588|FG009|Induction Phase|Other|0|||
124902273|NCT00771667|449266579|FG000|Maintenance Phase|Adverse Event|0|||
124902274|NCT00771667|449266580|FG001|Maintenance Phase|Adverse Event|0|||
124902275|NCT00771667|449266581|FG002|Maintenance Phase|Adverse Event|0|||
124902276|NCT00771667|449266582|FG003|Maintenance Phase|Adverse Event|0|||
124902277|NCT00771667|449266583|FG004|Maintenance Phase|Adverse Event|1|||
124902278|NCT00771667|449266584|FG005|Maintenance Phase|Adverse Event|3|||
124902279|NCT00771667|449266585|FG006|Maintenance Phase|Adverse Event|5|||
124902280|NCT00771667|449266586|FG007|Maintenance Phase|Adverse Event|1|||
124902281|NCT00771667|449266587|FG008|Maintenance Phase|Adverse Event|8|||
124902282|NCT00771667|449266588|FG009|Maintenance Phase|Adverse Event|7|||
124902283|NCT00771667|449266579|FG000|Maintenance Phase|Lack of Efficacy|0|||
124902284|NCT00771667|449266580|FG001|Maintenance Phase|Lack of Efficacy|0|||
124902285|NCT00771667|449266581|FG002|Maintenance Phase|Lack of Efficacy|0|||
124902286|NCT00771667|449266582|FG003|Maintenance Phase|Lack of Efficacy|0|||
124902287|NCT00771667|449266583|FG004|Maintenance Phase|Lack of Efficacy|1|||
124902288|NCT00771667|449266584|FG005|Maintenance Phase|Lack of Efficacy|3|||
124902289|NCT00771667|449266585|FG006|Maintenance Phase|Lack of Efficacy|3|||
124902290|NCT00771667|449266586|FG007|Maintenance Phase|Lack of Efficacy|2|||
124902291|NCT00771667|449266587|FG008|Maintenance Phase|Lack of Efficacy|11|||
124902292|NCT00771667|449266588|FG009|Maintenance Phase|Lack of Efficacy|7|||
124902293|NCT00771667|449266579|FG000|Maintenance Phase|Other|0|||
124902294|NCT00771667|449266580|FG001|Maintenance Phase|Other|0|||
124902295|NCT00771667|449266581|FG002|Maintenance Phase|Other|0|||
124902296|NCT00771667|449266582|FG003|Maintenance Phase|Other|0|||
124902297|NCT00771667|449266583|FG004|Maintenance Phase|Other|0|||
124902298|NCT00771667|449266584|FG005|Maintenance Phase|Other|1|||
124902299|NCT00771667|449266585|FG006|Maintenance Phase|Other|2|||
124902300|NCT00771667|449266586|FG007|Maintenance Phase|Other|2|||
124902301|NCT00771667|449266587|FG008|Maintenance Phase|Other|3|||
124902302|NCT00771667|449266588|FG009|Maintenance Phase|Other|3|||
124902303|NCT00109967|449266589|FG000|Overall Study|Cancel Prior to Treatment|2|||
124902304|NCT00109967|449266590|FG001|Overall Study|Cancel Prior to Treatment|0|||
124902305|NCT00109967|449266589|FG000|Overall Study|Adverse Event|12|||
124902306|NCT00109967|449266590|FG001|Overall Study|Adverse Event|1|||
124902307|NCT00109967|449266589|FG000|Overall Study|Withdrawal by Subject|5|||
124902308|NCT00109967|449266590|FG001|Overall Study|Withdrawal by Subject|0|||
124902309|NCT00109967|449266589|FG000|Overall Study|Physician Decision|1|||
124902310|NCT00109967|449266590|FG001|Overall Study|Physician Decision|3|||
124902311|NCT00109967|449266589|FG000|Overall Study|Death|0|||
124902312|NCT00109967|449266590|FG001|Overall Study|Death|2|||
124902313|NCT00628862|449266597|FG000|Overall Study|Adverse Event|6|||
124902314|NCT00628862|449266598|FG001|Overall Study|Adverse Event|8|||
124902315|NCT00628862|449266599|FG002|Overall Study|Adverse Event|10|||
124902316|NCT00628862|449266597|FG000|Overall Study|Withdrawal by Subject|4|||
124902317|NCT00628862|449266598|FG001|Overall Study|Withdrawal by Subject|6|||
124902318|NCT00628862|449266599|FG002|Overall Study|Withdrawal by Subject|11|||
124902319|NCT00628862|449266597|FG000|Overall Study|Lost to Follow-up|0|||
124902320|NCT00628862|449266598|FG001|Overall Study|Lost to Follow-up|2|||
124902321|NCT00628862|449266599|FG002|Overall Study|Lost to Follow-up|1|||
124902322|NCT00628862|449266597|FG000|Overall Study|Protocol Violation|1|||
124902323|NCT00628862|449266598|FG001|Overall Study|Protocol Violation|0|||
124902324|NCT00628862|449266599|FG002|Overall Study|Protocol Violation|0|||
124902325|NCT00628862|449266597|FG000|Overall Study|COPD Exacerbation|0|||
124902326|NCT00628862|449266598|FG001|Overall Study|COPD Exacerbation|1|||
124902327|NCT00628862|449266599|FG002|Overall Study|COPD Exacerbation|0|||
124902328|NCT01063036|449266600|FG000|Participants Treated With Study Drug|Adverse Event|1|||
124902329|NCT01063036|449266600|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
124902330|NCT01063036|449266600|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
124691209|NCT00758043|448490006|FG000|Overall Study|Non-Compliant With study Drug|0|||
124691210|NCT00758043|448490007|FG001|Overall Study|Non-Compliant With study Drug|0|||
124902331|NCT01063036|449266600|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
124902332|NCT01063036|449266600|FG000|Participants Treated With Study Drug|Pregnancy|1|||
124902333|NCT01063036|449266600|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
124902334|NCT01063036|449266600|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
124902335|NCT01063036|449266600|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
124902336|NCT00703911|449266603|FG000|Overall Study|Death|1|||
124902337|NCT00703911|449266603|FG000|Overall Study|Physician Decision|6|||
124902338|NCT00703911|449266603|FG000|Overall Study|Lost to Follow-up|1|||
124902339|NCT00703911|449266603|FG000|Overall Study|Withdrawal by Subject|2|||
124902340|NCT00853827|449266606|FG000|Single Blind Period (1 Week)|Other|4|||
124902341|NCT00853827|449266607|FG001|Single Blind Period (1 Week)|Other|0|||
124902342|NCT00853827|449266606|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
124902343|NCT00853827|449266607|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
124902344|NCT00853827|449266606|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
124902345|NCT00853827|449266607|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
124902346|NCT00853827|449266606|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
124902347|NCT00853827|449266607|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
124902348|NCT00853827|449266606|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
124902349|NCT00853827|449266607|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
124902350|NCT00853827|449266606|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
124902351|NCT00853827|449266607|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
124902352|NCT00853827|449266606|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
124902353|NCT00853827|449266607|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
124902354|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
124902355|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
124902356|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
124902357|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
124902358|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
124902359|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
124902360|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
124902361|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
124902362|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
124902363|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
124902364|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
124902365|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
124902366|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
124902367|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
124902368|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
124902369|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
124902370|NCT00853827|449266606|FG000|Double Blind Period (103 Weeks)|Death|1|||
124902371|NCT00853827|449266607|FG001|Double Blind Period (103 Weeks)|Death|6|||
124902372|NCT00906035|449266609|FG000|Overall Study|Withdrawal by Subject|2|||
124902373|NCT00906035|449266610|FG001|Overall Study|Withdrawal by Subject|3|||
124902374|NCT00906035|449266611|FG002|Overall Study|Withdrawal by Subject|0|||
124902375|NCT03058991|449266614|FG000|Overall Study|Lost to Follow-up|17|||
124902376|NCT03058991|449266615|FG001|Overall Study|Lost to Follow-up|12|||
124902377|NCT03058991|449266616|FG002|Overall Study|Lost to Follow-up|12|||
124902378|NCT03058991|449266614|FG000|Overall Study|Withdrawal by Subject|1|||
124902379|NCT03058991|449266615|FG001|Overall Study|Withdrawal by Subject|0|||
124902380|NCT03058991|449266616|FG002|Overall Study|Withdrawal by Subject|0|||
124902381|NCT00130637|449266617|FG000|Overall Study|Adverse Event|2|||
124902382|NCT00130637|449266617|FG000|Overall Study|Withdrawal by Subject|1|||
124902383|NCT01460342|449266619|FG000|Overall Study|Adverse Event|5|||
124902384|NCT01460342|449266620|FG001|Overall Study|Adverse Event|4|||
124902385|NCT01460342|449266619|FG000|Overall Study|Lost to Follow-up|1|||
124902386|NCT01460342|449266620|FG001|Overall Study|Lost to Follow-up|2|||
124902387|NCT01460342|449266619|FG000|Overall Study|Protocol Violation|0|||
124902388|NCT01460342|449266620|FG001|Overall Study|Protocol Violation|1|||
124902389|NCT01460342|449266619|FG000|Overall Study|Withdrawal by Subject|3|||
124902390|NCT01460342|449266620|FG001|Overall Study|Withdrawal by Subject|4|||
124902391|NCT01460342|449266619|FG000|Overall Study|Physician Decision|1|||
124902392|NCT01460342|449266620|FG001|Overall Study|Physician Decision|3|||
124902393|NCT01460342|449266619|FG000|Overall Study|Lack of Efficacy|1|||
124902394|NCT01460342|449266620|FG001|Overall Study|Lack of Efficacy|0|||
124902395|NCT01689519|449266621|FG000|Intent to Treat|Death|157|||
124902396|NCT01689519|449266622|FG001|Intent to Treat|Death|167|||
124902397|NCT01689519|449266621|FG000|Intent to Treat|Lost to Follow-up|4|||
124902398|NCT01689519|449266622|FG001|Intent to Treat|Lost to Follow-up|8|||
124902399|NCT01689519|449266621|FG000|Intent to Treat|Other|2|||
124902400|NCT01689519|449266622|FG001|Intent to Treat|Other|4|||
124902401|NCT01689519|449266621|FG000|Intent to Treat|Physician Decision|4|||
124902402|NCT01689519|449266622|FG001|Intent to Treat|Physician Decision|1|||
124902403|NCT01689519|449266621|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
124902404|NCT01689519|449266622|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
124902405|NCT01689519|449266621|FG000|Intent to Treat|Withdrawal by Subject|21|||
124902406|NCT01689519|449266622|FG001|Intent to Treat|Withdrawal by Subject|20|||
124902407|NCT01689519|449266621|FG000|Safety Population|Death|158|||
124902408|NCT01689519|449266622|FG001|Safety Population|Death|165|||
124902409|NCT01689519|449266621|FG000|Safety Population|Lost to Follow-up|4|||
124902410|NCT01689519|449266622|FG001|Safety Population|Lost to Follow-up|8|||
124902411|NCT01689519|449266621|FG000|Safety Population|Other|2|||
124759920|NCT00580723|448744840|FG000|Overall Study|Lost to Follow-up|5|||
124759921|NCT00148759|448744841|FG000|Overall Study|Withdrawal by Subject|1|||
124759922|NCT00148759|448744842|FG001|Overall Study|Withdrawal by Subject|1|||
124759923|NCT00148759|448744841|FG000|Overall Study|Lost to Follow-up|1|||
124759924|NCT00148759|448744842|FG001|Overall Study|Lost to Follow-up|0|||
124759925|NCT01454596|448744843|FG000|Overall Study|Death|0|||
124759926|NCT01454596|448744844|FG001|Overall Study|Death|0|||
124759927|NCT01454596|448744845|FG002|Overall Study|Death|0|||
124759928|NCT01454596|448744846|FG003|Overall Study|Death|0|||
124759929|NCT01454596|448744847|FG004|Overall Study|Death|0|||
124759930|NCT01454596|448744848|FG005|Overall Study|Death|0|||
124759931|NCT01454596|448744849|FG006|Overall Study|Death|0|||
124759932|NCT01454596|448744850|FG007|Overall Study|Death|0|||
124759933|NCT01454596|448744851|FG008|Overall Study|Death|0|||
124759934|NCT01454596|448744852|FG009|Overall Study|Death|1|||
124759935|NCT01454596|448744853|FG010|Overall Study|Death|1|||
124759936|NCT01454596|448744854|FG011|Overall Study|Death|0|||
124759937|NCT00857285|448744855|FG000|Overall Study|Adverse Event|4|||
124759938|NCT00857285|448744856|FG001|Overall Study|Adverse Event|2|||
124759939|NCT00857285|448744855|FG000|Overall Study|Lack of Efficacy|0|||
124902412|NCT01689519|449266622|FG001|Safety Population|Other|4|||
124902413|NCT01689519|449266621|FG000|Safety Population|Physician Decision|4|||
124902414|NCT01689519|449266622|FG001|Safety Population|Physician Decision|1|||
124902415|NCT01689519|449266621|FG000|Safety Population|Study Terminated By Sponsor|60|||
124902416|NCT01689519|449266622|FG001|Safety Population|Study Terminated By Sponsor|47|||
124902417|NCT01689519|449266621|FG000|Safety Population|Withdrawal by Subject|20|||
124902418|NCT01689519|449266622|FG001|Safety Population|Withdrawal by Subject|20|||
124902419|NCT01713530|449266623|FG000|Overall Study|Adverse Event|0|||
124902420|NCT01713530|449266624|FG001|Overall Study|Adverse Event|5|||
124902421|NCT01713530|449266623|FG000|Overall Study|Withdrawal criteria|21|||
124902422|NCT01713530|449266624|FG001|Overall Study|Withdrawal criteria|12|||
124902423|NCT01713530|449266623|FG000|Overall Study|Unclassified|4|||
124902424|NCT01713530|449266624|FG001|Overall Study|Unclassified|2|||
124902425|NCT03939819|449266625|FG000|Overall Study|Death|2|||
124902426|NCT03939819|449266626|FG001|Overall Study|Death|0|||
124902427|NCT02613364|449266627|FG000|Overall Study|Other|19|||
124902428|NCT02613364|449266628|FG001|Overall Study|Other|29|||
124902429|NCT02613364|449266629|FG002|Overall Study|Other|17|||
124902430|NCT02613364|449266627|FG000|Overall Study|Too time consuming|21|||
124902431|NCT02613364|449266628|FG001|Overall Study|Too time consuming|26|||
124902432|NCT02613364|449266629|FG002|Overall Study|Too time consuming|26|||
124902433|NCT02613364|449266627|FG000|Overall Study|Withdrawal by Subject|13|||
124902434|NCT02613364|449266628|FG001|Overall Study|Withdrawal by Subject|18|||
124902435|NCT02613364|449266629|FG002|Overall Study|Withdrawal by Subject|17|||
124902436|NCT02613364|449266627|FG000|Overall Study|Medical|12|||
124902437|NCT02613364|449266628|FG001|Overall Study|Medical|13|||
124902438|NCT02613364|449266629|FG002|Overall Study|Medical|9|||
124902439|NCT02613364|449266627|FG000|Overall Study|Disliked Study Procedure|1|||
124902440|NCT02613364|449266628|FG001|Overall Study|Disliked Study Procedure|1|||
124902441|NCT02613364|449266629|FG002|Overall Study|Disliked Study Procedure|4|||
124902442|NCT02613364|449266627|FG000|Overall Study|Disliked Intervention|0|||
124902443|NCT02613364|449266628|FG001|Overall Study|Disliked Intervention|3|||
124902444|NCT02613364|449266629|FG002|Overall Study|Disliked Intervention|3|||
124902445|NCT00436644|449266630|FG000|Overall Study|Adverse Event|2|||
124902446|NCT00436644|449266630|FG000|Overall Study|Death|1|||
124902447|NCT00619645|449266631|FG000|Overall Study|Adverse Event|1|||
124902448|NCT00972504|449266633|FG000|Overall Study|Adverse Event|2|||
124902449|NCT00972504|449266633|FG000|Overall Study|Investigator discretion|1|||
124902450|NCT00597519|449266634|FG000|Overall Study|Death|1|||
124902451|NCT04246762|449266635|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
124902452|NCT00410124|449266636|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
124902453|NCT00410124|449266637|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
124902454|NCT00410124|449266636|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
124902455|NCT00410124|449266637|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
124902456|NCT00410124|449266636|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
124759940|NCT00857285|448744856|FG001|Overall Study|Lack of Efficacy|2|||
124759941|NCT00857285|448744855|FG000|Overall Study|Protocol Violation|3|||
124759942|NCT00857285|448744856|FG001|Overall Study|Protocol Violation|1|||
124759943|NCT00857285|448744855|FG000|Overall Study|Withdrawal by Subject|4|||
124759944|NCT00857285|448744856|FG001|Overall Study|Withdrawal by Subject|0|||
124759945|NCT00857285|448744855|FG000|Overall Study|Randomization criteria not met|1|||
124902457|NCT00410124|449266637|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
124902458|NCT00410124|449266636|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
124902459|NCT00410124|449266637|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
124902460|NCT00410124|449266636|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
124902461|NCT00410124|449266637|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
124902462|NCT00410124|449266636|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
124902463|NCT00410124|449266637|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
124902464|NCT00410124|449266636|FG000|Core Phase Double Blind (15 Months)|Death|7|||
124902465|NCT00410124|449266637|FG001|Core Phase Double Blind (15 Months)|Death|4|||
124902466|NCT00410124|449266636|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
124902467|NCT00410124|449266637|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
124902468|NCT00410124|449266636|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
124902469|NCT00410124|449266637|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
124902470|NCT00410124|449266636|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
124902471|NCT00410124|449266637|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
124902472|NCT00410124|449266636|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
124902473|NCT00410124|449266637|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
124902474|NCT00410124|449266636|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
124902475|NCT00410124|449266637|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
124902476|NCT00410124|449266636|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
124902477|NCT00410124|449266637|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
124902478|NCT00410124|449266636|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
124902479|NCT00410124|449266637|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
124902480|NCT00410124|449266636|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
124902481|NCT00410124|449266637|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
124902482|NCT00410124|449266636|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
124902483|NCT00410124|449266637|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
124902484|NCT00741988|449266641|FG000|Overall Study|Adverse Event|2|||
124902485|NCT00741988|449266642|FG001|Overall Study|Adverse Event|4|||
124902486|NCT00741988|449266641|FG000|Overall Study|Lack of Efficacy|2|||
124902487|NCT00741988|449266642|FG001|Overall Study|Lack of Efficacy|0|||
124902488|NCT00811057|449266643|FG000|Overall Study|Protocol Violation|5|||
124902489|NCT00811057|449266644|FG001|Overall Study|Protocol Violation|10|||
124902490|NCT00811057|449266645|FG002|Overall Study|Protocol Violation|10|||
124902491|NCT00768651|449266650|FG000|Overall Study|Withdrawal by Subject|1|||
124902492|NCT02104765|449266651|FG000|Overall Study|Lost to Follow-up|0|||
124902493|NCT02104765|449266652|FG001|Overall Study|Lost to Follow-up|0|||
124902494|NCT02104765|449266653|FG002|Overall Study|Lost to Follow-up|1|||
124902495|NCT02104765|449266654|FG003|Overall Study|Lost to Follow-up|0|||
124902496|NCT02104765|449266655|FG004|Overall Study|Lost to Follow-up|0|||
124902497|NCT02104765|449266656|FG005|Overall Study|Lost to Follow-up|0|||
124902498|NCT02104765|449266657|FG006|Overall Study|Lost to Follow-up|0|||
124902499|NCT02104765|449266651|FG000|Overall Study|Withdrawal by Subject|0|||
124902500|NCT02104765|449266652|FG001|Overall Study|Withdrawal by Subject|0|||
124902501|NCT02104765|449266653|FG002|Overall Study|Withdrawal by Subject|0|||
124902502|NCT02104765|449266654|FG003|Overall Study|Withdrawal by Subject|1|||
124902503|NCT02104765|449266655|FG004|Overall Study|Withdrawal by Subject|1|||
124902504|NCT02104765|449266656|FG005|Overall Study|Withdrawal by Subject|0|||
124902505|NCT02104765|449266657|FG006|Overall Study|Withdrawal by Subject|1|||
124902506|NCT00995709|449266662|FG000|Overall Study|Adverse Event|4|||
124902507|NCT00995709|449266663|FG001|Overall Study|Adverse Event|2|||
124902508|NCT00995709|449266664|FG002|Overall Study|Adverse Event|0|||
124902509|NCT00995709|449266662|FG000|Overall Study|Lack of Efficacy|0|||
124902510|NCT00995709|449266663|FG001|Overall Study|Lack of Efficacy|1|||
124902511|NCT00995709|449266664|FG002|Overall Study|Lack of Efficacy|4|||
124902512|NCT00995709|449266662|FG000|Overall Study|Withdrawal by Subject|0|||
124902513|NCT00995709|449266663|FG001|Overall Study|Withdrawal by Subject|4|||
124902514|NCT00995709|449266664|FG002|Overall Study|Withdrawal by Subject|1|||
124902515|NCT00995709|449266662|FG000|Overall Study|Lost to Follow-up|1|||
124902516|NCT00995709|449266663|FG001|Overall Study|Lost to Follow-up|0|||
124902517|NCT00995709|449266664|FG002|Overall Study|Lost to Follow-up|0|||
124902518|NCT00995709|449266662|FG000|Overall Study|Death|0|||
124902519|NCT00995709|449266663|FG001|Overall Study|Death|1|||
124902520|NCT00995709|449266664|FG002|Overall Study|Death|0|||
124902521|NCT00995709|449266662|FG000|Overall Study|Protocol Violation|2|||
124902522|NCT00995709|449266663|FG001|Overall Study|Protocol Violation|1|||
124902523|NCT00995709|449266664|FG002|Overall Study|Protocol Violation|0|||
124448624|NCT04313153|447605719|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
124448625|NCT04313153|447605720|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
124448626|NCT04313153|447605718|FG000|Overall Study|Other|5|||
124448627|NCT04313153|447605719|FG001|Overall Study|Other|3|||
124448628|NCT04313153|447605720|FG002|Overall Study|Other|2|||
124902524|NCT01697319|449266665|FG000|Primary Phase|Withdrawal by Subject|1|||
124902525|NCT01697319|449266665|FG000|Extension Phase|Terminated by Sponsor|15|||
124902526|NCT04222959|449266666|FG000|Overall Study|Lost to Follow-up|76|||
124902527|NCT04222959|449266667|FG001|Overall Study|Lost to Follow-up|28|||
124902528|NCT03008915|449266672|FG000|Treatment 1|Withdrawal by Subject|0|||
124902529|NCT03008915|449266673|FG001|Treatment 1|Withdrawal by Subject|1|||
124448629|NCT05586269|447605721|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
124448630|NCT05586269|447605722|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
124448631|NCT05586269|447605723|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
124448632|NCT05586269|447605724|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
124448633|NCT05586269|447605721|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
124448634|NCT05586269|447605722|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
124691211|NCT00758043|448490008|FG002|Overall Study|Non-Compliant With study Drug|0|||
124902530|NCT00712166|449266676|FG000|Overall Study|Noncompliance|0|||
124902531|NCT00712166|449266677|FG001|Overall Study|Noncompliance|1|||
124902532|NCT01773122|449266678|FG000|Overall Study|Due to amended age eligibility criteria|3|||
124902533|NCT01773122|449266679|FG001|Overall Study|Due to amended age eligibility criteria|1|||
124902534|NCT01773122|449266680|FG002|Overall Study|Due to amended age eligibility criteria|0|||
124902535|NCT01773122|449266681|FG003|Overall Study|Due to amended age eligibility criteria|1|||
124902536|NCT01264718|449266682|FG000|Overall Study|Lost to Follow-up|3|||
124902537|NCT01264718|449266683|FG001|Overall Study|Lost to Follow-up|2|||
124902538|NCT01264718|449266682|FG000|Overall Study|Withdrawal by Subject|9|||
124902539|NCT01264718|449266683|FG001|Overall Study|Withdrawal by Subject|15|||
124902540|NCT01264718|449266682|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
124902541|NCT01264718|449266683|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
124902542|NCT01769391|449266686|FG000|Overall Study|Death|10|||
124902543|NCT01769391|449266687|FG001|Overall Study|Death|1|||
124902544|NCT01769391|449266686|FG000|Overall Study|Adverse Event|0|||
124902545|NCT01769391|449266687|FG001|Overall Study|Adverse Event|3|||
124902546|NCT01769391|449266686|FG000|Overall Study|Progressive Disease|1|||
124902547|NCT01769391|449266687|FG001|Overall Study|Progressive Disease|2|||
124902548|NCT01769391|449266686|FG000|Overall Study|Withdrawal by Subject|4|||
124902549|NCT01769391|449266687|FG001|Overall Study|Withdrawal by Subject|3|||
124902550|NCT01769391|449266686|FG000|Overall Study|Investigator Decision|2|||
124902551|NCT01769391|449266687|FG001|Overall Study|Investigator Decision|0|||
124902552|NCT03386929|449266688|FG000|Overall Study|Death|0|||
124902553|NCT03386929|449266689|FG001|Overall Study|Death|0|||
124902554|NCT03386929|449266690|FG002|Overall Study|Death|1|||
124902555|NCT03386929|449266688|FG000|Overall Study|Withdrawal by Subject|0|||
124902556|NCT03386929|449266689|FG001|Overall Study|Withdrawal by Subject|1|||
124902557|NCT03386929|449266690|FG002|Overall Study|Withdrawal by Subject|0|||
124902558|NCT03386929|449266688|FG000|Overall Study|Physician Decision|0|||
124902559|NCT03386929|449266689|FG001|Overall Study|Physician Decision|0|||
124902560|NCT03386929|449266690|FG002|Overall Study|Physician Decision|1|||
124902561|NCT03386929|449266688|FG000|Overall Study|Progression|4|||
124902562|NCT03386929|449266689|FG001|Overall Study|Progression|4|||
124902563|NCT03386929|449266690|FG002|Overall Study|Progression|0|||
124902564|NCT03386929|449266688|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
124902565|NCT03386929|449266689|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
124902566|NCT03386929|449266690|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
124902567|NCT03386929|449266688|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
124902568|NCT03386929|449266689|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
124902569|NCT03386929|449266690|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
124902570|NCT01144182|449266694|FG000|Overall Study|Death|5|||
124902571|NCT01144182|449266695|FG001|Overall Study|Death|6|||
124902572|NCT01144182|449266694|FG000|Overall Study|Withdrawal by Subject|3|||
124902573|NCT01144182|449266695|FG001|Overall Study|Withdrawal by Subject|6|||
124902574|NCT01144182|449266694|FG000|Overall Study|Lost to Follow-up|9|||
124902575|NCT01144182|449266695|FG001|Overall Study|Lost to Follow-up|9|||
124902576|NCT03264456|449266700|FG000|Overall Study|Withdrawal by Subject|3|||
124448635|NCT05586269|447605723|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
124691212|NCT00758043|448490009|FG003|Overall Study|Non-Compliant With study Drug|1|||
124691213|NCT00758043|448490006|FG000|Overall Study|Other Reasons|0|||
124691214|NCT00758043|448490007|FG001|Overall Study|Other Reasons|1|||
124691215|NCT00758043|448490008|FG002|Overall Study|Other Reasons|0|||
124691216|NCT00758043|448490009|FG003|Overall Study|Other Reasons|5|||
124691217|NCT00552058|448490012|FG000|Overall Study|Adverse Event|8|||
124759946|NCT00857285|448744856|FG001|Overall Study|Randomization criteria not met|1|||
124902577|NCT03264456|449266700|FG000|Overall Study|Lost to Follow-up|1|||
124902578|NCT03538054|449266701|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
124448636|NCT05586269|447605724|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
124691218|NCT00552058|448490013|FG001|Overall Study|Adverse Event|7|||
124902579|NCT03538054|449266701|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
124902580|NCT03538054|449266701|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
124902581|NCT03254394|449266702|FG000|Overall Study|Withdrawal by Subject|0|||
124902582|NCT03254394|449266703|FG001|Overall Study|Withdrawal by Subject|2|||
124902583|NCT02351180|449266706|FG000|Overall Study|Withdrawal by Subject|1|||
124902584|NCT02351180|449266707|FG001|Overall Study|Withdrawal by Subject|0|||
124902585|NCT01751724|449266708|FG000|Overall Study|extubated bef.start assigned treatment|1|||
124902586|NCT01751724|449266709|FG001|Overall Study|extubated bef.start assigned treatment|0|||
124902587|NCT01751724|449266708|FG000|Overall Study|withdrawn by parent|0|||
124902588|NCT01751724|449266709|FG001|Overall Study|withdrawn by parent|2|||
124902589|NCT03121950|449266711|FG000|Overall Study|Withdrawal by Subject|11|||
124902590|NCT03121950|449266712|FG001|Overall Study|Withdrawal by Subject|2|||
124902591|NCT01867580|449266713|FG000|Overall Study|Withdrawal by Subject|2|||
124902592|NCT01867580|449266714|FG001|Overall Study|Withdrawal by Subject|3|||
124902593|NCT01867580|449266713|FG000|Overall Study|Physician Decision|17|||
124902594|NCT01867580|449266714|FG001|Overall Study|Physician Decision|12|||
124902595|NCT01867580|449266713|FG000|Overall Study|Lost to Follow-up|3|||
124902596|NCT01867580|449266714|FG001|Overall Study|Lost to Follow-up|5|||
124902597|NCT01867580|449266713|FG000|Overall Study|Sponsor terminated study|1|||
124902598|NCT01867580|449266714|FG001|Overall Study|Sponsor terminated study|0|||
124902599|NCT01867580|449266713|FG000|Overall Study|Missed follow-up assessment|2|||
124902600|NCT01867580|449266714|FG001|Overall Study|Missed follow-up assessment|1|||
124902601|NCT01867580|449266713|FG000|Overall Study|Interruption to therapy|3|||
124902602|NCT01867580|449266714|FG001|Overall Study|Interruption to therapy|0|||
124902603|NCT01867580|449266713|FG000|Overall Study|Osteomyelitis|0|||
124902604|NCT01867580|449266714|FG001|Overall Study|Osteomyelitis|1|||
124902605|NCT01867580|449266713|FG000|Overall Study|Continuation of therapy|0|||
124902606|NCT01867580|449266714|FG001|Overall Study|Continuation of therapy|1|||
124902607|NCT01867580|449266713|FG000|Overall Study|Wound recurrence|0|||
124902608|NCT01867580|449266714|FG001|Overall Study|Wound recurrence|1|||
124902609|NCT03425643|449266717|FG000|Overall Study|Withdrawal by Subject|10|||
124902610|NCT03425643|449266718|FG001|Overall Study|Withdrawal by Subject|12|||
124902611|NCT03425643|449266717|FG000|Overall Study|Lost to Follow-up|2|||
124902612|NCT03425643|449266718|FG001|Overall Study|Lost to Follow-up|0|||
124902613|NCT03425643|449266717|FG000|Overall Study|Death|109|||
124902614|NCT03425643|449266718|FG001|Overall Study|Death|141|||
124902615|NCT03425643|449266717|FG000|Overall Study|Ongoing in study|276|||
124902616|NCT03425643|449266718|FG001|Overall Study|Ongoing in study|247|||
124902617|NCT03141788|449266719|FG000|Overall Study|Lost to Follow-up|1|||
124902618|NCT03141788|449266719|FG000|Overall Study|Protocol Violation|3|||
124902619|NCT03141788|449266719|FG000|Overall Study|Withdrawal by Subject|4|||
124902620|NCT01025843|449268303|FG000|Washout 4|Withdrawal by Subject|0|||
124902621|NCT01025843|449268304|FG001|Washout 4|Withdrawal by Subject|0|||
124902622|NCT01025843|449268305|FG002|Washout 4|Withdrawal by Subject|1|||
124902623|NCT01025843|449268306|FG003|Washout 4|Withdrawal by Subject|1|||
124902624|NCT01025843|449268307|FG004|Washout 4|Withdrawal by Subject|0|||
124902625|NCT01025843|449268308|FG005|Washout 4|Withdrawal by Subject|0|||
124902626|NCT01025843|449268309|FG006|Washout 4|Withdrawal by Subject|0|||
124902627|NCT01025843|449268310|FG007|Washout 4|Withdrawal by Subject|0|||
124902628|NCT01025843|449268311|FG008|Washout 4|Withdrawal by Subject|0|||
124902629|NCT01025843|449268312|FG009|Washout 4|Withdrawal by Subject|0|||
124902630|NCT00377455|449268315|FG000|Overall Study|Withdrawal by Subject|1|||
124902631|NCT01070888|449268316|FG000|First Intervention (14 Days)|Adverse Event|0|||
124902632|NCT01070888|449268317|FG001|First Intervention (14 Days)|Adverse Event|1|||
124902633|NCT01070888|449268316|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
124902634|NCT01070888|449268317|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
124902635|NCT01070888|449268316|FG000|Washout (14 Days)|Physician Decision|1|||
124902636|NCT01070888|449268317|FG001|Washout (14 Days)|Physician Decision|0|||
124902637|NCT01897233|449268322|FG000|Part B (24 Weeks)|Adverse Event|1|||
124902638|NCT01897233|449268322|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
124902639|NCT01897233|449268322|FG000|Part B (24 Weeks)|Physician Decision|1|||
124902640|NCT02715258|449268323|FG000|Overall Study|Withdrawal by Subject|6|||
124902641|NCT02715258|449268324|FG001|Overall Study|Withdrawal by Subject|1|||
124902642|NCT02715258|449268323|FG000|Overall Study|Lost to Follow-up|7|||
124902643|NCT02715258|449268324|FG001|Overall Study|Lost to Follow-up|1|||
124902644|NCT02715258|449268323|FG000|Overall Study|Terminated by Sponsor|0|||
124902645|NCT02715258|449268324|FG001|Overall Study|Terminated by Sponsor|1|||
124902646|NCT02715258|449268323|FG000|Overall Study|Death|0|||
124902647|NCT02715258|449268324|FG001|Overall Study|Death|1|||
124902648|NCT02715258|449268323|FG000|Overall Study|Subject non-compliant|1|||
124902649|NCT02715258|449268324|FG001|Overall Study|Subject non-compliant|1|||
124902650|NCT02715258|449268323|FG000|Overall Study|GCP violation|2|||
124902651|NCT02715258|449268324|FG001|Overall Study|GCP violation|1|||
124902652|NCT02814643|449268325|FG000|Overall Study|Lost to Follow-up|0|||
124902653|NCT02814643|449268326|FG001|Overall Study|Lost to Follow-up|1|||
124902654|NCT02814643|449268325|FG000|Overall Study|Withdrawal by Subject|1|||
124902655|NCT02814643|449268326|FG001|Overall Study|Withdrawal by Subject|2|||
124902656|NCT02263508|449268327|FG000|Overall Study|Withdrawal by Subject|1|||
124902657|NCT02263508|449268328|FG001|Overall Study|Withdrawal by Subject|23|||
124902658|NCT02263508|449268329|FG002|Overall Study|Withdrawal by Subject|17|||
124902659|NCT02263508|449268327|FG000|Overall Study|Sponsor Decision|12|||
124902660|NCT02263508|449268328|FG001|Overall Study|Sponsor Decision|165|||
124902661|NCT02263508|449268329|FG002|Overall Study|Sponsor Decision|182|||
124902662|NCT02263508|449268327|FG000|Overall Study|Lost to Follow-up|2|||
124902663|NCT02263508|449268328|FG001|Overall Study|Lost to Follow-up|7|||
124902664|NCT02263508|449268329|FG002|Overall Study|Lost to Follow-up|7|||
124448637|NCT00523718|447605725|FG000|Overall Study|Withdrawal by Subject|1|||
124448638|NCT00523718|447605726|FG001|Overall Study|Withdrawal by Subject|0|||
124448639|NCT00523718|447605725|FG000|Overall Study|Protocol Violation|2|||
124448640|NCT00523718|447605726|FG001|Overall Study|Protocol Violation|0|||
124448641|NCT02113579|447605727|FG000|Overall Study|Adverse Event|1|||
124448642|NCT02113579|447605728|FG001|Overall Study|Adverse Event|0|||
124448643|NCT02113579|447605727|FG000|Overall Study|Withdrawal by Subject|3|||
124448644|NCT02113579|447605728|FG001|Overall Study|Withdrawal by Subject|2|||
124448645|NCT02113579|447605727|FG000|Overall Study|Lost to Follow-up|6|||
124448646|NCT02113579|447605728|FG001|Overall Study|Lost to Follow-up|2|||
124448647|NCT02060383|447605729|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
124448648|NCT02060383|447605730|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
124448649|NCT02060383|447605731|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
124448650|NCT02060383|447605732|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
124448651|NCT02060383|447605733|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
124448652|NCT02060383|447605729|FG000|Core Phase|Adverse Event|2|||
124448653|NCT02060383|447605730|FG001|Core Phase|Adverse Event|0|||
124448654|NCT02060383|447605731|FG002|Core Phase|Adverse Event|0|||
124448655|NCT02060383|447605732|FG003|Core Phase|Adverse Event|2|||
124448656|NCT02060383|447605733|FG004|Core Phase|Adverse Event|6|||
124448657|NCT02060383|447605729|FG000|Core Phase|Administrative problems|0|||
124448658|NCT02060383|447605730|FG001|Core Phase|Administrative problems|1|||
124448659|NCT02060383|447605731|FG002|Core Phase|Administrative problems|0|||
124448660|NCT02060383|447605732|FG003|Core Phase|Administrative problems|0|||
124448661|NCT02060383|447605733|FG004|Core Phase|Administrative problems|0|||
124448662|NCT02060383|447605729|FG000|Core Phase|Protocol Violation|0|||
124448663|NCT02060383|447605730|FG001|Core Phase|Protocol Violation|0|||
124448664|NCT02060383|447605731|FG002|Core Phase|Protocol Violation|0|||
124448665|NCT02060383|447605732|FG003|Core Phase|Protocol Violation|1|||
124448666|NCT02060383|447605733|FG004|Core Phase|Protocol Violation|0|||
124448667|NCT02060383|447605729|FG000|Core Phase|Withdrawal by Subject|0|||
124448668|NCT02060383|447605730|FG001|Core Phase|Withdrawal by Subject|0|||
124448669|NCT02060383|447605731|FG002|Core Phase|Withdrawal by Subject|0|||
124448670|NCT02060383|447605732|FG003|Core Phase|Withdrawal by Subject|4|||
124448671|NCT02060383|447605733|FG004|Core Phase|Withdrawal by Subject|2|||
124448672|NCT02060383|447605729|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
124448673|NCT02060383|447605730|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
124448674|NCT02060383|447605731|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
124448675|NCT02060383|447605732|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
124448676|NCT02060383|447605733|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
124448677|NCT02060383|447605729|FG000|Extension Phase|Adverse Event|1|||
124448678|NCT02060383|447605730|FG001|Extension Phase|Adverse Event|1|||
124448679|NCT02060383|447605731|FG002|Extension Phase|Adverse Event|2|||
124448680|NCT02060383|447605732|FG003|Extension Phase|Adverse Event|0|||
124448681|NCT02060383|447605733|FG004|Extension Phase|Adverse Event|1|||
124448682|NCT02060383|447605729|FG000|Extension Phase|Withdrawal by Subject|0|||
124448683|NCT02060383|447605730|FG001|Extension Phase|Withdrawal by Subject|1|||
124448684|NCT02060383|447605731|FG002|Extension Phase|Withdrawal by Subject|0|||
124448685|NCT02060383|447605732|FG003|Extension Phase|Withdrawal by Subject|0|||
124448686|NCT02060383|447605733|FG004|Extension Phase|Withdrawal by Subject|2|||
124448687|NCT02060383|447605729|FG000|Extension Phase|Administrative problems|1|||
124448688|NCT02060383|447605730|FG001|Extension Phase|Administrative problems|0|||
124448689|NCT02060383|447605731|FG002|Extension Phase|Administrative problems|0|||
124448690|NCT02060383|447605732|FG003|Extension Phase|Administrative problems|0|||
124448691|NCT02060383|447605733|FG004|Extension Phase|Administrative problems|0|||
124448692|NCT02060383|447605729|FG000|Extension Phase|Death|0|||
124448693|NCT02060383|447605730|FG001|Extension Phase|Death|0|||
124691219|NCT00552058|448490012|FG000|Overall Study|Lack of Efficacy|1|||
124691220|NCT00552058|448490013|FG001|Overall Study|Lack of Efficacy|5|||
124691221|NCT00552058|448490012|FG000|Overall Study|Lost to Follow-up|1|||
124691222|NCT00552058|448490013|FG001|Overall Study|Lost to Follow-up|0|||
124691223|NCT00552058|448490012|FG000|Overall Study|Withdrawal by Subject|4|||
124691224|NCT00552058|448490013|FG001|Overall Study|Withdrawal by Subject|4|||
124691225|NCT00552058|448490012|FG000|Overall Study|Other: Protocol Violation|0|||
124448694|NCT02060383|447605731|FG002|Extension Phase|Death|1|||
124448695|NCT02060383|447605732|FG003|Extension Phase|Death|0|||
124448696|NCT02060383|447605733|FG004|Extension Phase|Death|1|||
124448697|NCT02060383|447605729|FG000|Extension Phase|Protocol Violation|0|||
124448698|NCT02060383|447605730|FG001|Extension Phase|Protocol Violation|0|||
124448699|NCT02060383|447605731|FG002|Extension Phase|Protocol Violation|0|||
124448700|NCT02060383|447605732|FG003|Extension Phase|Protocol Violation|0|||
124448701|NCT02060383|447605733|FG004|Extension Phase|Protocol Violation|1|||
124448702|NCT00332839|447605734|FG000|Core (Months 0 - 12)|Administrative problems|1|||
124448703|NCT00332839|447605735|FG001|Core (Months 0 - 12)|Administrative problems|1|||
124448704|NCT00332839|447605734|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
124448705|NCT00332839|447605735|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
124448706|NCT00332839|447605734|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
124902665|NCT02263508|449268327|FG000|Overall Study|Death|6|||
124902666|NCT02263508|449268328|FG001|Overall Study|Death|151|||
124902667|NCT02263508|449268329|FG002|Overall Study|Death|140|||
124902668|NCT03265210|449268332|FG000|Overall Study|Withdrawal by Subject|7|||
124902669|NCT03265210|449268333|FG001|Overall Study|Withdrawal by Subject|9|||
124902670|NCT03265210|449268332|FG000|Overall Study|Lost to Follow-up|2|||
124902671|NCT03265210|449268333|FG001|Overall Study|Lost to Follow-up|0|||
124902672|NCT03265210|449268332|FG000|Overall Study|Physician Decision|2|||
124902673|NCT03265210|449268333|FG001|Overall Study|Physician Decision|0|||
124902674|NCT03265210|449268332|FG000|Overall Study|Adverse Event|1|||
124902675|NCT03265210|449268333|FG001|Overall Study|Adverse Event|0|||
124902676|NCT01281813|449268342|FG000|Overall Study|Adverse Event|0|||
124902677|NCT01281813|449268343|FG001|Overall Study|Adverse Event|0|||
124902678|NCT01281813|449268344|FG002|Overall Study|Adverse Event|10|||
124902679|NCT01281813|449268342|FG000|Overall Study|Lost to Follow-up|0|||
124902680|NCT01281813|449268343|FG001|Overall Study|Lost to Follow-up|0|||
124902681|NCT01281813|449268344|FG002|Overall Study|Lost to Follow-up|31|||
124902682|NCT01281813|449268342|FG000|Overall Study|Withdrawal by Subject|0|||
124902683|NCT01281813|449268343|FG001|Overall Study|Withdrawal by Subject|0|||
124902684|NCT01281813|449268344|FG002|Overall Study|Withdrawal by Subject|13|||
124902685|NCT01281813|449268342|FG000|Overall Study|Subject Non-Compliant|0|||
124902686|NCT01281813|449268343|FG001|Overall Study|Subject Non-Compliant|0|||
124902687|NCT01281813|449268344|FG002|Overall Study|Subject Non-Compliant|6|||
124902688|NCT01281813|449268342|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
124902689|NCT01281813|449268343|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
124902690|NCT01281813|449268344|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
124902691|NCT01281813|449268342|FG000|Overall Study|Sponsor's Decision|4|||
124902692|NCT01281813|449268343|FG001|Overall Study|Sponsor's Decision|3|||
124902693|NCT01281813|449268344|FG002|Overall Study|Sponsor's Decision|7|||
124902694|NCT01281813|449268342|FG000|Overall Study|Switched to Commercially Available Medication|0|||
124902695|NCT01281813|449268343|FG001|Overall Study|Switched to Commercially Available Medication|0|||
124902696|NCT01281813|449268344|FG002|Overall Study|Switched to Commercially Available Medication|26|||
124902697|NCT01281813|449268342|FG000|Overall Study|Other|0|||
124902698|NCT01281813|449268343|FG001|Overall Study|Other|1|||
124902699|NCT01281813|449268344|FG002|Overall Study|Other|39|||
124902700|NCT03546907|449268345|FG000|Overall Study|Lack of Efficacy|1|||
124902701|NCT03546907|449268346|FG001|Overall Study|Lack of Efficacy|1|||
124902702|NCT03546907|449268345|FG000|Overall Study|Withdrawal by Subject|8|||
124902703|NCT03546907|449268346|FG001|Overall Study|Withdrawal by Subject|9|||
124902704|NCT03546907|449268345|FG000|Overall Study|Adverse events (AEs)|7|||
124902705|NCT03546907|449268346|FG001|Overall Study|Adverse events (AEs)|10|||
124902706|NCT03546907|449268345|FG000|Overall Study|Other-unspecified|1|||
124902707|NCT03546907|449268346|FG001|Overall Study|Other-unspecified|1|||
124902708|NCT04033432|449268351|FG000|Overall Study|Progressive Disease|8|||
124902709|NCT04033432|449268351|FG000|Overall Study|Adverse Event|4|||
124902710|NCT04033432|449268351|FG000|Overall Study|Death|1|||
124902711|NCT02192606|449268352|FG000|Overall Study|surgery type was changed|1|||
124902712|NCT02192606|449268353|FG001|Overall Study|surgery type was changed|1|||
124902713|NCT02192606|449268352|FG000|Overall Study|Physician Decision|1|||
124902714|NCT02192606|449268353|FG001|Overall Study|Physician Decision|2|||
124902715|NCT02192606|449268352|FG000|Overall Study|3D equipment rep unable to join|0|||
124902716|NCT02192606|449268353|FG001|Overall Study|3D equipment rep unable to join|1|||
124902717|NCT01458210|449268357|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
124902718|NCT01458210|449268357|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
124902719|NCT01458210|449268357|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
124902720|NCT01458210|449268357|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
124902721|NCT00957658|449268363|FG000|Overall Study|Death|1|||
124902722|NCT00957658|449268363|FG000|Overall Study|Lost to Follow-up|4|||
124902723|NCT00957658|449268363|FG000|Overall Study|Withdrawal by Subject|12|||
124902724|NCT00957658|449268363|FG000|Overall Study|Revision|1|||
124902725|NCT00957658|449268363|FG000|Overall Study|Incomplete 2 yr data|28|||
124902726|NCT00957658|449268363|FG000|Overall Study|Site termination|10|||
124902727|NCT00957658|449268363|FG000|Overall Study|unwilling/unable to return|2|||
124902728|NCT00957658|449268363|FG000|Overall Study|surgery cancelled|2|||
124902729|NCT00957658|449268363|FG000|Overall Study|Protocol Violation|5|||
124902730|NCT01833832|449268364|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
124902731|NCT01193153|449268365|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
124902732|NCT01193153|449268366|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
124902733|NCT01193153|449268365|FG000|Open-label Lead in Period|Pregnancy|1|||
124902734|NCT01193153|449268366|FG001|Open-label Lead in Period|Pregnancy|0|||
124902735|NCT01193153|449268365|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
124902736|NCT01193153|449268366|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
124902737|NCT01193153|449268365|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
124902738|NCT01193153|449268366|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
124902739|NCT01193153|449268365|FG000|Open-label Lead in Period|Other|14|||
124902740|NCT01193153|449268366|FG001|Open-label Lead in Period|Other|0|||
124902741|NCT01193153|449268365|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
124902742|NCT01193153|449268366|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
124902743|NCT01193153|449268365|FG000|Open-label Lead in Period|Adverse Event|41|||
124902744|NCT01193153|449268366|FG001|Open-label Lead in Period|Adverse Event|0|||
124902745|NCT01193153|449268365|FG000|Open-label Lead in Period|Death|1|||
124902746|NCT01193153|449268366|FG001|Open-label Lead in Period|Death|0|||
124902747|NCT01193153|449268365|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
124902748|NCT01193153|449268366|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
124902749|NCT01193153|449268365|FG000|Open-label Stabilization Period|Adverse Event|9|||
124902750|NCT01193153|449268366|FG001|Open-label Stabilization Period|Adverse Event|0|||
124902751|NCT01193153|449268365|FG000|Open-label Stabilization Period|Death|2|||
124902752|NCT01193153|449268366|FG001|Open-label Stabilization Period|Death|0|||
124902753|NCT01193153|449268365|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
124902754|NCT01193153|449268366|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
124902755|NCT01193153|449268365|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
124902756|NCT01193153|449268366|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
124902757|NCT01193153|449268365|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
124902758|NCT01193153|449268366|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
124902759|NCT01193153|449268365|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
124902760|NCT01193153|449268366|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
124902761|NCT01193153|449268365|FG000|Open-label Stabilization Period|Other|8|||
124902762|NCT01193153|449268366|FG001|Open-label Stabilization Period|Other|0|||
124902763|NCT01193153|449268365|FG000|Double Blind Relapse Prevention Period|Other|2|||
124902764|NCT01193153|449268366|FG001|Double Blind Relapse Prevention Period|Other|3|||
124902765|NCT01193153|449268365|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
124902766|NCT01193153|449268366|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
124902767|NCT01193153|449268365|FG000|Double Blind Relapse Prevention Period|Death|2|||
124902768|NCT01193153|449268366|FG001|Double Blind Relapse Prevention Period|Death|0|||
124902769|NCT01193153|449268365|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
124902770|NCT01193153|449268366|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
124902771|NCT01193153|449268365|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
124902772|NCT01193153|449268366|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
124902773|NCT01193153|449268365|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
124902774|NCT01193153|449268366|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
124902775|NCT01193153|449268365|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
124902776|NCT01193153|449268366|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
124902777|NCT01193153|449268365|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
124902778|NCT01193153|449268366|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
124902779|NCT01988233|449268367|FG000|Overall Study|Lost to Follow-up|64|||
124902780|NCT01988233|449268368|FG001|Overall Study|Lost to Follow-up|51|||
124902781|NCT03621761|449268369|FG000|Overall Study|Lost to Follow-up|1|||
124902782|NCT03621761|449268370|FG001|Overall Study|Lost to Follow-up|1|||
124902783|NCT03621761|449268371|FG002|Overall Study|Lost to Follow-up|2|||
124902784|NCT03621761|449268369|FG000|Overall Study|Withdrawal by Subject|2|||
124902785|NCT03621761|449268370|FG001|Overall Study|Withdrawal by Subject|1|||
124902786|NCT03621761|449268371|FG002|Overall Study|Withdrawal by Subject|1|||
124902787|NCT03621761|449268369|FG000|Overall Study|Became Ineligible|0|||
124902788|NCT03621761|449268370|FG001|Overall Study|Became Ineligible|2|||
124902789|NCT03621761|449268371|FG002|Overall Study|Became Ineligible|0|||
124902790|NCT05046132|449268372|FG000|Overall Study|Adverse Event|4|||
124902791|NCT05046132|449268373|FG001|Overall Study|Adverse Event|0|||
124902792|NCT05046132|449268374|FG002|Overall Study|Adverse Event|0|||
124902793|NCT05046132|449268372|FG000|Overall Study|Withdrawal by Subject|3|||
124902794|NCT05046132|449268373|FG001|Overall Study|Withdrawal by Subject|0|||
124902795|NCT05046132|449268374|FG002|Overall Study|Withdrawal by Subject|0|||
124691226|NCT00552058|448490013|FG001|Overall Study|Other: Protocol Violation|1|||
124691227|NCT00552058|448490012|FG000|Overall Study|Other: Non Compliance|1|||
124691228|NCT00552058|448490013|FG001|Overall Study|Other: Non Compliance|2|||
124902796|NCT05046132|449268372|FG000|Overall Study|Positive Covid19 Result.|0|||
124902797|NCT05046132|449268373|FG001|Overall Study|Positive Covid19 Result.|1|||
124691229|NCT00552058|448490012|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
124691230|NCT00552058|448490013|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
124691231|NCT00552058|448490012|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
124691232|NCT00552058|448490013|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
124448707|NCT00332839|447605735|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
124448708|NCT00332839|447605734|FG000|Core (Months 0 - 12)|Adverse Event|5|||
124448709|NCT00332839|447605735|FG001|Core (Months 0 - 12)|Adverse Event|15|||
124448710|NCT00332839|447605734|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
124448711|NCT00332839|447605735|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
124448712|NCT00332839|447605734|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
124448713|NCT00332839|447605735|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
124448714|NCT00332839|447605734|FG000|Follow-up (Months 12 - 60)|Death|1|||
124448715|NCT00332839|447605735|FG001|Follow-up (Months 12 - 60)|Death|1|||
124448716|NCT02020863|447605739|FG000|Overall Study|Discovery of Metastatic disease|4|||
124448717|NCT02020863|447605739|FG000|Overall Study|Team chose not to place an a line|1|||
124448718|NCT01920594|447605740|FG000|Overall Study|Adverse Event|4|||
124448719|NCT01920594|447605741|FG001|Overall Study|Adverse Event|2|||
124448720|NCT01920594|447605740|FG000|Overall Study|Lost to Follow-up|1|||
124448721|NCT01920594|447605741|FG001|Overall Study|Lost to Follow-up|0|||
124448722|NCT01920594|447605740|FG000|Overall Study|Recovery|2|||
124448723|NCT01920594|447605741|FG001|Overall Study|Recovery|0|||
124448724|NCT01920594|447605740|FG000|Overall Study|Investigator discretion|0|||
124448725|NCT01920594|447605741|FG001|Overall Study|Investigator discretion|1|||
124448726|NCT00928564|447605744|FG000|Overall Study|Lost to Follow-up|6|||
124448727|NCT00928564|447605745|FG001|Overall Study|Lost to Follow-up|0|||
124448728|NCT02460497|447605747|FG000|Overall Study|Participant Requested Withdrawal|4|||
124448729|NCT02460497|447605747|FG000|Overall Study|Non-Compliance|1|||
124448730|NCT02460497|447605747|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
124448731|NCT02460497|447605747|FG000|Overall Study|Lost to Follow-up|2|||
124448732|NCT02460497|447605747|FG000|Overall Study|Investigator Decision|1|||
124448733|NCT02012296|447605748|FG000|Overall Study|Lack of Efficacy|0|||
124448734|NCT02012296|447605749|FG001|Overall Study|Lack of Efficacy|0|||
124448735|NCT02012296|447605750|FG002|Overall Study|Lack of Efficacy|15|||
124448736|NCT02012296|447605748|FG000|Overall Study|Adverse Event|0|||
124448737|NCT02012296|447605749|FG001|Overall Study|Adverse Event|0|||
124448738|NCT02012296|447605750|FG002|Overall Study|Adverse Event|2|||
124448739|NCT02012296|447605748|FG000|Overall Study|Early study closure|0|||
124902798|NCT05046132|449268374|FG002|Overall Study|Positive Covid19 Result.|0|||
124902799|NCT01186848|449268380|FG000|Overall Study|Lost to Follow-up|4|||
124902800|NCT01186848|449268380|FG000|Overall Study|Withdrawal by Subject|2|||
124902801|NCT01186848|449268380|FG000|Overall Study|Adverse Event|2|||
124902802|NCT01183780|449268389|FG000|Overall Study|Withdrawal by Subject|25|||
124902803|NCT01183780|449268390|FG001|Overall Study|Withdrawal by Subject|14|||
124902804|NCT01183780|449268389|FG000|Overall Study|Lost to Follow-up|6|||
124902805|NCT01183780|449268390|FG001|Overall Study|Lost to Follow-up|11|||
124902806|NCT04379713|449268391|FG000|Overall Study|Adverse Event|2|||
124902807|NCT04379713|449268392|FG001|Overall Study|Adverse Event|0|||
124902808|NCT04379713|449268391|FG000|Overall Study|Physician Decision|2|||
124902809|NCT04379713|449268392|FG001|Overall Study|Physician Decision|1|||
124902810|NCT04379713|449268391|FG000|Overall Study|Protocol Violation|11|||
124902811|NCT04379713|449268392|FG001|Overall Study|Protocol Violation|6|||
124448740|NCT02012296|447605749|FG001|Overall Study|Early study closure|0|||
124448741|NCT02012296|447605750|FG002|Overall Study|Early study closure|5|||
124448742|NCT02012296|447605748|FG000|Overall Study|Protocol Violation|0|||
124448743|NCT02012296|447605749|FG001|Overall Study|Protocol Violation|1|||
124448744|NCT02012296|447605750|FG002|Overall Study|Protocol Violation|0|||
124448745|NCT01448213|447605751|FG000|Overall Study|Lost to Follow-up|12|||
124448746|NCT01448213|447605752|FG001|Overall Study|Lost to Follow-up|10|||
124448747|NCT01448213|447605751|FG000|Overall Study|Adverse Event|4|||
124448748|NCT01448213|447605752|FG001|Overall Study|Adverse Event|10|||
124448749|NCT01448213|447605751|FG000|Overall Study|Protocol Violation|1|||
124448750|NCT01448213|447605752|FG001|Overall Study|Protocol Violation|2|||
124448751|NCT02615470|447605753|FG000|Overall Study|Lost to Follow-up|21|||
124448752|NCT02615470|447605754|FG001|Overall Study|Lost to Follow-up|32|||
124448753|NCT04163900|447605760|FG000|Overall Study|Radiological disease progression|112|||
124448754|NCT04163900|447605761|FG001|Overall Study|Radiological disease progression|127|||
124902812|NCT04379713|449268391|FG000|Overall Study|No longer met eligibility criteria|14|||
124902813|NCT04379713|449268392|FG001|Overall Study|No longer met eligibility criteria|11|||
124902814|NCT04379713|449268391|FG000|Overall Study|Withdrawal by parent/guardian|36|||
124448755|NCT04163900|447605760|FG000|Overall Study|Study closure|98|||
124448756|NCT04163900|447605761|FG001|Overall Study|Study closure|133|||
124448757|NCT04163900|447605760|FG000|Overall Study|Adverse Event|78|||
124448758|NCT04163900|447605761|FG001|Overall Study|Adverse Event|32|||
124448759|NCT04163900|447605760|FG000|Overall Study|Withdrawal by Subject|37|||
124448760|NCT04163900|447605761|FG001|Overall Study|Withdrawal by Subject|34|||
124448761|NCT04163900|447605760|FG000|Overall Study|Death|29|||
124448762|NCT04163900|447605761|FG001|Overall Study|Death|16|||
124448763|NCT04163900|447605760|FG000|Overall Study|Physician Decision|17|||
124448764|NCT04163900|447605761|FG001|Overall Study|Physician Decision|25|||
124448765|NCT04163900|447605760|FG000|Overall Study|Clinical disease progression|14|||
124448766|NCT04163900|447605761|FG001|Overall Study|Clinical disease progression|13|||
124448767|NCT04163900|447605760|FG000|Overall Study|Protocol Violation|3|||
124902815|NCT04379713|449268392|FG001|Overall Study|Withdrawal by parent/guardian|15|||
124902816|NCT04379713|449268391|FG000|Overall Study|Lost to Follow-up|31|||
124902817|NCT04379713|449268392|FG001|Overall Study|Lost to Follow-up|21|||
124902818|NCT02148133|449268397|FG000|Overall Study|Investigator discretion|1|||
124902819|NCT02148133|449268397|FG000|Overall Study|Lack of Efficacy|1|||
124902820|NCT02148133|449268397|FG000|Overall Study|Protocol deviation|1|||
124691233|NCT00552058|448490012|FG000|Overall Study|Other: Positive Stool Result|0|||
124691234|NCT00552058|448490013|FG001|Overall Study|Other: Positive Stool Result|1|||
124691235|NCT00552058|448490012|FG000|Overall Study|Other: Randomized in error|0|||
124691236|NCT00552058|448490013|FG001|Overall Study|Other: Randomized in error|1|||
124691237|NCT00552058|448490012|FG000|Overall Study|Other: Sponsors Decision|0|||
124691238|NCT00552058|448490013|FG001|Overall Study|Other: Sponsors Decision|1|||
124902821|NCT02148133|449268397|FG000|Overall Study|Protocol-defined stopping criteria|2|||
124902822|NCT03808883|449268398|FG000|Overall Study|Withdrawal by Subject|2|||
124902823|NCT03808883|449268399|FG001|Overall Study|Withdrawal by Subject|0|||
124902824|NCT03808883|449268398|FG000|Overall Study|Did not complete pre test or post test survey|4|||
124902825|NCT03808883|449268399|FG001|Overall Study|Did not complete pre test or post test survey|3|||
124902826|NCT04567888|449268400|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
124902827|NCT04567888|449268401|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
124902828|NCT04567888|449268400|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
124902829|NCT04567888|449268401|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
124902830|NCT04567888|449268400|FG000|Overall Study|Reported Unusual Birth Year|2|||
124902831|NCT04567888|449268401|FG001|Overall Study|Reported Unusual Birth Year|3|||
124902832|NCT04567888|449268400|FG000|Overall Study|Duplicate Responses|0|||
124902833|NCT04567888|449268401|FG001|Overall Study|Duplicate Responses|1|||
124902834|NCT00371566|449268404|FG000|Treatment Phase|Withdrawal by Subject|0|||
124902835|NCT00371566|449268405|FG001|Treatment Phase|Withdrawal by Subject|1|||
124902836|NCT00371566|449268404|FG000|Treatment Phase|Adverse Event|0|||
124902837|NCT00371566|449268405|FG001|Treatment Phase|Adverse Event|1|||
124902838|NCT00371566|449268404|FG000|Treatment Phase|Protocol Violation|0|||
124902839|NCT00371566|449268405|FG001|Treatment Phase|Protocol Violation|1|||
124902840|NCT00371566|449268404|FG000|Chemoradiation Phase|Physician Decision|2|||
124902841|NCT00371566|449268405|FG001|Chemoradiation Phase|Physician Decision|0|||
124902842|NCT00371566|449268404|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
124902843|NCT00371566|449268405|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
124902844|NCT00371566|449268404|FG000|Chemoradiation Phase|Non compliant|0|||
124902845|NCT00371566|449268405|FG001|Chemoradiation Phase|Non compliant|1|||
124902846|NCT00371566|449268404|FG000|Chemoradiation Phase|Progressive Disease|1|||
124902847|NCT00371566|449268405|FG001|Chemoradiation Phase|Progressive Disease|1|||
124902848|NCT00371566|449268404|FG000|Chemoradiation Phase|Death|2|||
124902849|NCT00371566|449268405|FG001|Chemoradiation Phase|Death|0|||
124902850|NCT00371566|449268404|FG000|Follow Up Phase|Death|0|||
124902851|NCT00371566|449268405|FG001|Follow Up Phase|Death|5|||
124902852|NCT00371566|449268404|FG000|Follow Up Phase|Disease progression|1|||
124902853|NCT00371566|449268405|FG001|Follow Up Phase|Disease progression|0|||
124902854|NCT00371566|449268404|FG000|Follow Up Phase|Withdrawal by Subject|0|||
124902855|NCT00371566|449268405|FG001|Follow Up Phase|Withdrawal by Subject|1|||
124902856|NCT00371566|449268404|FG000|Follow Up Phase|Physician Decision|1|||
124902857|NCT00371566|449268405|FG001|Follow Up Phase|Physician Decision|1|||
124902858|NCT00371566|449268404|FG000|Follow Up Phase|Lost to Follow-up|1|||
124902859|NCT00371566|449268405|FG001|Follow Up Phase|Lost to Follow-up|0|||
124902860|NCT00878722|449268406|FG000|Overall Study|Progressive disease|3|||
124902861|NCT00878722|449268407|FG001|Overall Study|Progressive disease|3|||
124902862|NCT00878722|449268408|FG002|Overall Study|Progressive disease|3|||
124902863|NCT00878722|449268409|FG003|Overall Study|Progressive disease|7|||
124902864|NCT00878722|449268410|FG004|Overall Study|Progressive disease|7|||
124902865|NCT00878722|449268411|FG005|Overall Study|Progressive disease|1|||
124902866|NCT00878722|449268412|FG006|Overall Study|Progressive disease|4|||
124902867|NCT00878722|449268413|FG007|Overall Study|Progressive disease|3|||
124902868|NCT00878722|449268406|FG000|Overall Study|Death|0|||
124902869|NCT00878722|449268407|FG001|Overall Study|Death|0|||
124902870|NCT00878722|449268408|FG002|Overall Study|Death|0|||
124902871|NCT00878722|449268409|FG003|Overall Study|Death|1|||
124902872|NCT00878722|449268410|FG004|Overall Study|Death|0|||
124902873|NCT00878722|449268411|FG005|Overall Study|Death|1|||
124902874|NCT00878722|449268412|FG006|Overall Study|Death|0|||
124902875|NCT00878722|449268413|FG007|Overall Study|Death|2|||
124902876|NCT00878722|449268406|FG000|Overall Study|Adverse Event|0|||
124902877|NCT00878722|449268407|FG001|Overall Study|Adverse Event|0|||
124691239|NCT00552058|448490012|FG000|Overall Study|Other: Early Roll Over|1|||
124902878|NCT00878722|449268408|FG002|Overall Study|Adverse Event|0|||
124902879|NCT00878722|449268409|FG003|Overall Study|Adverse Event|0|||
124902880|NCT00878722|449268410|FG004|Overall Study|Adverse Event|0|||
124902881|NCT00878722|449268411|FG005|Overall Study|Adverse Event|0|||
124902882|NCT00878722|449268412|FG006|Overall Study|Adverse Event|2|||
124902883|NCT00878722|449268413|FG007|Overall Study|Adverse Event|0|||
124902884|NCT00878722|449268406|FG000|Overall Study|Withdrawal by Subject|0|||
124902885|NCT00878722|449268407|FG001|Overall Study|Withdrawal by Subject|0|||
124902886|NCT00878722|449268408|FG002|Overall Study|Withdrawal by Subject|0|||
124902887|NCT00878722|449268409|FG003|Overall Study|Withdrawal by Subject|0|||
124902888|NCT00878722|449268410|FG004|Overall Study|Withdrawal by Subject|0|||
124902889|NCT00878722|449268411|FG005|Overall Study|Withdrawal by Subject|0|||
124902890|NCT00878722|449268412|FG006|Overall Study|Withdrawal by Subject|0|||
124902891|NCT00878722|449268413|FG007|Overall Study|Withdrawal by Subject|2|||
124902892|NCT00878722|449268406|FG000|Overall Study|Relapse|0|||
124902893|NCT00878722|449268407|FG001|Overall Study|Relapse|0|||
124902894|NCT00878722|449268408|FG002|Overall Study|Relapse|0|||
124902895|NCT00878722|449268409|FG003|Overall Study|Relapse|1|||
124902896|NCT00878722|449268410|FG004|Overall Study|Relapse|0|||
124902897|NCT00878722|449268411|FG005|Overall Study|Relapse|0|||
124902898|NCT00878722|449268412|FG006|Overall Study|Relapse|0|||
124902899|NCT00878722|449268413|FG007|Overall Study|Relapse|0|||
124902900|NCT00319436|449268414|FG000|Overall Study|Withdrawal by Subject|6|||
124902901|NCT00319436|449268415|FG001|Overall Study|Withdrawal by Subject|7|||
124902902|NCT01161498|449268416|FG000|Overall Study|Disease Progression|0|||
124902903|NCT01161498|449268417|FG001|Overall Study|Disease Progression|1|||
124902904|NCT02807493|449268420|FG000|Overall Study|Adverse Event|5|||
124902905|NCT02807493|449268421|FG001|Overall Study|Adverse Event|2|||
124902906|NCT02807493|449268420|FG000|Overall Study|Lost to Follow-up|6|||
124902907|NCT02807493|449268421|FG001|Overall Study|Lost to Follow-up|0|||
124902908|NCT02807493|449268420|FG000|Overall Study|Physician Decision|4|||
124902909|NCT02807493|449268421|FG001|Overall Study|Physician Decision|1|||
124902910|NCT02807493|449268420|FG000|Overall Study|Protocol Violation|7|||
124902911|NCT02807493|449268421|FG001|Overall Study|Protocol Violation|0|||
124902912|NCT02807493|449268420|FG000|Overall Study|Withdrawal by Subject|17|||
124902913|NCT02807493|449268421|FG001|Overall Study|Withdrawal by Subject|10|||
124902914|NCT02807493|449268420|FG000|Overall Study|Other withdrawal|17|||
124902915|NCT02807493|449268421|FG001|Overall Study|Other withdrawal|0|||
124902916|NCT02807493|449268420|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
124902917|NCT02807493|449268421|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
124902918|NCT02781584|449268422|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
124902919|NCT02781584|449268423|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
124902920|NCT02781584|449268424|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
124902921|NCT02781584|449268425|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
124902922|NCT02781584|449268426|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
124902923|NCT02781584|449268427|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
124902924|NCT02781584|449268428|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
124902925|NCT02781584|449268429|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
124902926|NCT02781584|449268430|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
124902927|NCT02781584|449268431|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
124902928|NCT02781584|449268432|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
124902929|NCT02781584|449268433|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
124902930|NCT02781584|449268434|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
124902931|NCT02781584|449268422|FG000|Pre-treatment Phase|Adverse Event|0|||
124902932|NCT02781584|449268423|FG001|Pre-treatment Phase|Adverse Event|0|||
124902933|NCT02781584|449268424|FG002|Pre-treatment Phase|Adverse Event|0|||
124902934|NCT02781584|449268425|FG003|Pre-treatment Phase|Adverse Event|0|||
124902935|NCT02781584|449268426|FG004|Pre-treatment Phase|Adverse Event|0|||
124902936|NCT02781584|449268427|FG005|Pre-treatment Phase|Adverse Event|0|||
124902937|NCT02781584|449268428|FG006|Pre-treatment Phase|Adverse Event|0|||
124902938|NCT02781584|449268429|FG007|Pre-treatment Phase|Adverse Event|0|||
124902939|NCT02781584|449268430|FG008|Pre-treatment Phase|Adverse Event|0|||
124902940|NCT02781584|449268431|FG009|Pre-treatment Phase|Adverse Event|0|||
124902941|NCT02781584|449268432|FG010|Pre-treatment Phase|Adverse Event|0|||
124902942|NCT02781584|449268433|FG011|Pre-treatment Phase|Adverse Event|1|||
124902943|NCT02781584|449268434|FG012|Pre-treatment Phase|Adverse Event|0|||
124902944|NCT02781584|449268422|FG000|Treatment Phase|Withdrew Consent|0|||
124902945|NCT02781584|449268423|FG001|Treatment Phase|Withdrew Consent|0|||
124902946|NCT02781584|449268424|FG002|Treatment Phase|Withdrew Consent|0|||
124902947|NCT02781584|449268425|FG003|Treatment Phase|Withdrew Consent|0|||
124902948|NCT02781584|449268426|FG004|Treatment Phase|Withdrew Consent|0|||
124902949|NCT02781584|449268427|FG005|Treatment Phase|Withdrew Consent|1|||
124902950|NCT02781584|449268428|FG006|Treatment Phase|Withdrew Consent|0|||
124902951|NCT02781584|449268429|FG007|Treatment Phase|Withdrew Consent|0|||
124902952|NCT02781584|449268430|FG008|Treatment Phase|Withdrew Consent|0|||
124902953|NCT02781584|449268431|FG009|Treatment Phase|Withdrew Consent|0|||
124902954|NCT02781584|449268432|FG010|Treatment Phase|Withdrew Consent|1|||
124902955|NCT02781584|449268433|FG011|Treatment Phase|Withdrew Consent|2|||
124902956|NCT02781584|449268434|FG012|Treatment Phase|Withdrew Consent|0|||
124902957|NCT02781584|449268422|FG000|Treatment Phase|Adverse Event|0|||
124902958|NCT02781584|449268423|FG001|Treatment Phase|Adverse Event|0|||
124902959|NCT02781584|449268424|FG002|Treatment Phase|Adverse Event|0|||
124902960|NCT02781584|449268425|FG003|Treatment Phase|Adverse Event|0|||
124902961|NCT02781584|449268426|FG004|Treatment Phase|Adverse Event|0|||
124902962|NCT02781584|449268427|FG005|Treatment Phase|Adverse Event|0|||
124902963|NCT02781584|449268428|FG006|Treatment Phase|Adverse Event|0|||
124902964|NCT02781584|449268429|FG007|Treatment Phase|Adverse Event|1|||
124902965|NCT02781584|449268430|FG008|Treatment Phase|Adverse Event|0|||
124902966|NCT02781584|449268431|FG009|Treatment Phase|Adverse Event|0|||
124902967|NCT02781584|449268432|FG010|Treatment Phase|Adverse Event|0|||
124902968|NCT02781584|449268433|FG011|Treatment Phase|Adverse Event|0|||
124902969|NCT02781584|449268434|FG012|Treatment Phase|Adverse Event|0|||
124902970|NCT01123083|449268441|FG000|Overall Study|Investigator recommendation|1|||
124902971|NCT01123083|449268442|FG001|Overall Study|Investigator recommendation|1|||
124902972|NCT01123083|449268441|FG000|Overall Study|Administrative reasons|0|||
124902973|NCT01123083|449268442|FG001|Overall Study|Administrative reasons|4|||
124902974|NCT01123083|449268441|FG000|Overall Study|Lost to Follow-up|2|||
124902975|NCT01123083|449268442|FG001|Overall Study|Lost to Follow-up|6|||
124902976|NCT01123083|449268441|FG000|Overall Study|Adverse Event|1|||
124902977|NCT01123083|449268442|FG001|Overall Study|Adverse Event|0|||
124902978|NCT01123083|449268441|FG000|Overall Study|Withdrew for another reason not covered|0|||
124902979|NCT01123083|449268442|FG001|Overall Study|Withdrew for another reason not covered|1|||
124902980|NCT01123083|449268441|FG000|Overall Study|Participant/legal representative request|7|||
124902981|NCT01123083|449268442|FG001|Overall Study|Participant/legal representative request|3|||
124902982|NCT02385669|449270002|FG000|Overall Study|Adverse Event|2|||
124902983|NCT02810080|449270003|FG000|Overall Study|Adverse Event|3|||
124902984|NCT02810080|449270004|FG001|Overall Study|Adverse Event|0|||
124902985|NCT02810080|449270003|FG000|Overall Study|Death|0|||
124902986|NCT02810080|449270004|FG001|Overall Study|Death|2|||
124902987|NCT02810080|449270003|FG000|Overall Study|Physician Decision|4|||
124902988|NCT02810080|449270004|FG001|Overall Study|Physician Decision|0|||
124902989|NCT02810080|449270003|FG000|Overall Study|Withdrawal by Subject|0|||
124902990|NCT02810080|449270004|FG001|Overall Study|Withdrawal by Subject|2|||
124902991|NCT05257798|449270006|FG000|Follow-up Phase|Lost to Follow-up|1|||
124902992|NCT05257798|449270007|FG001|Follow-up Phase|Lost to Follow-up|0|||
124902993|NCT00419094|449270010|FG000|Overall Study|Adverse Event|3|||
124902994|NCT00419094|449270011|FG001|Overall Study|Adverse Event|7|||
124902995|NCT00419094|449270010|FG000|Overall Study|Lack of Efficacy|1|||
124902996|NCT00419094|449270011|FG001|Overall Study|Lack of Efficacy|0|||
124902997|NCT00419094|449270010|FG000|Overall Study|Lost to Follow-up|0|||
124902998|NCT00419094|449270011|FG001|Overall Study|Lost to Follow-up|2|||
124902999|NCT00419094|449270010|FG000|Overall Study|Protocol Violation|1|||
124903000|NCT00419094|449270011|FG001|Overall Study|Protocol Violation|14|||
124903001|NCT00419094|449270010|FG000|Overall Study|Withdrawal of consent|1|||
124903002|NCT00419094|449270011|FG001|Overall Study|Withdrawal of consent|5|||
124903003|NCT00419094|449270010|FG000|Overall Study|Other: Error determining exit criteria|1|||
124903004|NCT00419094|449270011|FG001|Overall Study|Other: Error determining exit criteria|0|||
124903005|NCT00419094|449270010|FG000|Overall Study|Other: Patient non-compliant|0|||
124903006|NCT00419094|449270011|FG001|Overall Study|Other: Patient non-compliant|1|||
124903007|NCT00419094|449270010|FG000|Overall Study|Other: No contact for extended period|0|||
124903008|NCT00419094|449270011|FG001|Overall Study|Other: No contact for extended period|1|||
124903009|NCT02034916|449270013|FG000|Overall Study|Death|39|||
124903010|NCT02034916|449270014|FG001|Overall Study|Death|28|||
124903011|NCT02034916|449270013|FG000|Overall Study|Withdrawal by Subject|2|||
124903012|NCT02034916|449270014|FG001|Overall Study|Withdrawal by Subject|1|||
124903013|NCT02034916|449270013|FG000|Overall Study|Lost to Follow-up|4|||
124903014|NCT02034916|449270014|FG001|Overall Study|Lost to Follow-up|1|||
124903015|NCT02034916|449270013|FG000|Overall Study|Study terminated by sponsor|4|||
124903016|NCT02034916|449270014|FG001|Overall Study|Study terminated by sponsor|5|||
124903017|NCT01616654|449270019|FG000|Overall Study|Lack of Efficacy|1|||
124903018|NCT01616654|449270020|FG001|Overall Study|Lack of Efficacy|0|||
124903019|NCT01616654|449270021|FG002|Overall Study|Lack of Efficacy|0|||
124903020|NCT01616654|449270022|FG003|Overall Study|Lack of Efficacy|0|||
124903021|NCT01616654|449270023|FG004|Overall Study|Lack of Efficacy|1|||
124903022|NCT01616654|449270019|FG000|Overall Study|Adverse Event|0|||
124903023|NCT01616654|449270020|FG001|Overall Study|Adverse Event|1|||
124903024|NCT01616654|449270021|FG002|Overall Study|Adverse Event|2|||
124903025|NCT01616654|449270022|FG003|Overall Study|Adverse Event|1|||
124903026|NCT01616654|449270023|FG004|Overall Study|Adverse Event|0|||
124903027|NCT01616654|449270019|FG000|Overall Study|Withdrawal by Subject|2|||
124903028|NCT01616654|449270020|FG001|Overall Study|Withdrawal by Subject|2|||
124903029|NCT01616654|449270021|FG002|Overall Study|Withdrawal by Subject|3|||
124903030|NCT01616654|449270022|FG003|Overall Study|Withdrawal by Subject|1|||
124903031|NCT01616654|449270023|FG004|Overall Study|Withdrawal by Subject|5|||
124903032|NCT01616654|449270019|FG000|Overall Study|Protocol Violation|0|||
124903033|NCT01616654|449270020|FG001|Overall Study|Protocol Violation|5|||
124903034|NCT01616654|449270021|FG002|Overall Study|Protocol Violation|2|||
124903035|NCT01616654|449270022|FG003|Overall Study|Protocol Violation|4|||
124903036|NCT01616654|449270023|FG004|Overall Study|Protocol Violation|4|||
124903037|NCT01616654|449270019|FG000|Overall Study|Lost to Follow-up|1|||
124903038|NCT01616654|449270020|FG001|Overall Study|Lost to Follow-up|0|||
124903039|NCT01616654|449270021|FG002|Overall Study|Lost to Follow-up|3|||
124903040|NCT01616654|449270022|FG003|Overall Study|Lost to Follow-up|2|||
124903041|NCT01616654|449270023|FG004|Overall Study|Lost to Follow-up|1|||
124903042|NCT01616654|449270019|FG000|Overall Study|Pregnancy|1|||
124903043|NCT01616654|449270020|FG001|Overall Study|Pregnancy|0|||
124903044|NCT01616654|449270021|FG002|Overall Study|Pregnancy|0|||
124759947|NCT01236521|448744860|FG000|Overall Study|Withdrawal by Subject|12|||
124759948|NCT01236521|448744861|FG001|Overall Study|Withdrawal by Subject|17|||
124759949|NCT01236521|448744860|FG000|Overall Study|Death|2|||
124759950|NCT01236521|448744861|FG001|Overall Study|Death|1|||
124759951|NCT01236521|448744860|FG000|Overall Study|Lost to Follow-up|9|||
124759952|NCT01236521|448744861|FG001|Overall Study|Lost to Follow-up|7|||
124759953|NCT00350844|448744878|FG000|Overall Study|Lost to Follow-up|1|||
124759954|NCT01420926|448744879|FG000|Overall Study|Adverse Event|6|||
124759955|NCT01420926|448744880|FG001|Overall Study|Adverse Event|4|||
124759956|NCT01420926|448744879|FG000|Overall Study|Death|18|||
124759957|NCT01420926|448744880|FG001|Overall Study|Death|17|||
124759958|NCT01420926|448744879|FG000|Overall Study|Withdrawal by Subject|11|||
124759959|NCT01420926|448744880|FG001|Overall Study|Withdrawal by Subject|17|||
124759960|NCT01420926|448744879|FG000|Overall Study|Non-protocol treatment|17|||
124759961|NCT01420926|448744880|FG001|Overall Study|Non-protocol treatment|20|||
124759962|NCT01420926|448744879|FG000|Overall Study|Physician Decision|8|||
124759963|NCT01420926|448744880|FG001|Overall Study|Physician Decision|5|||
124759964|NCT02775916|448744883|FG000|Overall Study|Adverse Event|1|||
124759965|NCT02775916|448744884|FG001|Overall Study|Adverse Event|0|||
124759966|NCT02775916|448744883|FG000|Overall Study|Subject/Guardian Decision|2|||
124759967|NCT02775916|448744884|FG001|Overall Study|Subject/Guardian Decision|0|||
124759968|NCT02252146|448746720|FG000|Overall Study|Lack of Efficacy|4|||
124759969|NCT02252146|448746720|FG000|Overall Study|Entered hospice care|1|||
124759970|NCT02252146|448746720|FG000|Overall Study|Inability to travel to study site|1|||
124759971|NCT00531284|448746721|FG000|Overall Study|Progressive Disease|1|||
124759972|NCT00531284|448746722|FG001|Overall Study|Progressive Disease|3|||
124759973|NCT00531284|448746723|FG002|Overall Study|Progressive Disease|5|||
124759974|NCT00531284|448746724|FG003|Overall Study|Progressive Disease|42|||
124759975|NCT00531284|448746725|FG004|Overall Study|Progressive Disease|4|||
124759976|NCT00531284|448746726|FG005|Overall Study|Progressive Disease|4|||
124759977|NCT00531284|448746727|FG006|Overall Study|Progressive Disease|3|||
124759978|NCT00531284|448746728|FG007|Overall Study|Progressive Disease|8|||
124903045|NCT01616654|449270022|FG003|Overall Study|Pregnancy|0|||
124903046|NCT01616654|449270023|FG004|Overall Study|Pregnancy|1|||
124903047|NCT02057692|449270024|FG000|Overall Study|Adverse Event|1|||
124691240|NCT00552058|448490013|FG001|Overall Study|Other: Early Roll Over|0|||
124691241|NCT01348698|448490014|FG000|Overall Study|Does not meet lesion size criteria|1|||
124691242|NCT01348698|448490014|FG000|Overall Study|Death|3|||
124691243|NCT01348698|448490014|FG000|Overall Study|PI decision to close study|68|||
124691244|NCT02595749|448490015|FG000|Overall Study|Withdrawal by Subject|12|||
124691245|NCT02595749|448490016|FG001|Overall Study|Withdrawal by Subject|7|||
124691246|NCT00263562|448490017|FG000|Overall Study|Protocol Violation|3|||
124691247|NCT00263562|448490018|FG001|Overall Study|Protocol Violation|0|||
124691248|NCT00986232|448490021|FG000|Overall Study|Adverse Event|1|||
124691249|NCT00986232|448490022|FG001|Overall Study|Adverse Event|2|||
124691250|NCT00986232|448490023|FG002|Overall Study|Adverse Event|3|||
124691251|NCT00986232|448490024|FG003|Overall Study|Adverse Event|0|||
124691252|NCT00986232|448490021|FG000|Overall Study|Lost to Follow-up|19|||
124691253|NCT00986232|448490022|FG001|Overall Study|Lost to Follow-up|12|||
124691254|NCT00986232|448490023|FG002|Overall Study|Lost to Follow-up|12|||
124691255|NCT00986232|448490024|FG003|Overall Study|Lost to Follow-up|7|||
124691256|NCT00986232|448490021|FG000|Overall Study|Protocol Violation|2|||
124691257|NCT00986232|448490022|FG001|Overall Study|Protocol Violation|3|||
124691258|NCT00986232|448490023|FG002|Overall Study|Protocol Violation|0|||
124691259|NCT00986232|448490024|FG003|Overall Study|Protocol Violation|1|||
124691260|NCT00986232|448490021|FG000|Overall Study|Withdrawal by Subject|13|||
124691261|NCT00986232|448490022|FG001|Overall Study|Withdrawal by Subject|16|||
124691262|NCT00986232|448490023|FG002|Overall Study|Withdrawal by Subject|12|||
124691263|NCT00986232|448490024|FG003|Overall Study|Withdrawal by Subject|3|||
124691264|NCT00986232|448490021|FG000|Overall Study|Missed one or more bleeds|13|||
124691265|NCT00986232|448490022|FG001|Overall Study|Missed one or more bleeds|10|||
124691266|NCT00986232|448490023|FG002|Overall Study|Missed one or more bleeds|6|||
124691267|NCT00986232|448490024|FG003|Overall Study|Missed one or more bleeds|7|||
124759979|NCT00531284|448746729|FG008|Overall Study|Progressive Disease|6|||
124903048|NCT02057692|449270025|FG001|Overall Study|Adverse Event|0|||
124691268|NCT00986232|448490021|FG000|Overall Study|Incomplete safety follow-up|3|||
124759980|NCT00531284|448746730|FG009|Overall Study|Progressive Disease|3|||
124691269|NCT00986232|448490022|FG001|Overall Study|Incomplete safety follow-up|7|||
124691270|NCT00986232|448490023|FG002|Overall Study|Incomplete safety follow-up|2|||
124759981|NCT00531284|448746731|FG010|Overall Study|Progressive Disease|3|||
124759982|NCT00531284|448746732|FG011|Overall Study|Progressive Disease|14|||
124759983|NCT00531284|448746733|FG012|Overall Study|Progressive Disease|2|||
124691271|NCT00986232|448490024|FG003|Overall Study|Incomplete safety follow-up|2|||
124691272|NCT05558410|448490025|FG000|Overall Study|Adverse Event|1|||
124903049|NCT02057692|449270026|FG002|Overall Study|Adverse Event|0|||
124903050|NCT02057692|449270027|FG003|Overall Study|Adverse Event|0|||
124691273|NCT05558410|448490026|FG001|Overall Study|Adverse Event|2|||
124903051|NCT02057692|449270024|FG000|Overall Study|Lost to Follow-up|0|||
124903052|NCT02057692|449270025|FG001|Overall Study|Lost to Follow-up|0|||
124903053|NCT02057692|449270026|FG002|Overall Study|Lost to Follow-up|0|||
124903054|NCT02057692|449270027|FG003|Overall Study|Lost to Follow-up|1|||
124903055|NCT00864682|449270028|FG000|Overall Study|Protocol Violation|2|||
124903056|NCT00864682|449270029|FG001|Overall Study|Protocol Violation|1|||
124903057|NCT00864682|449270030|FG002|Overall Study|Protocol Violation|2|||
124903058|NCT02393716|449270032|FG000|Overall Study|Death|29|||
124903059|NCT02393716|449270032|FG000|Overall Study|Withdrawal by Subject|8|||
124903060|NCT02393716|449270032|FG000|Overall Study|Device Explanted|8|||
124903061|NCT02393716|449270032|FG000|Overall Study|Missed visit|16|||
124903062|NCT04842604|449270035|FG000|Overall Study|Death|1|||
124903063|NCT04842604|449270036|FG001|Overall Study|Death|0|||
124903064|NCT04842604|449270035|FG000|Overall Study|Other|4|||
124903065|NCT04842604|449270036|FG001|Overall Study|Other|4|||
124903066|NCT04842604|449270035|FG000|Overall Study|Randomized but not treated|1|||
124903067|NCT04842604|449270036|FG001|Overall Study|Randomized but not treated|0|||
124903068|NCT01648140|449270037|FG000|Overall Study|Physician Decision|1|||
124903069|NCT01648140|449270038|FG001|Overall Study|Physician Decision|0|||
124903070|NCT01648140|449270039|FG002|Overall Study|Physician Decision|0|||
124903071|NCT01648140|449270040|FG003|Overall Study|Physician Decision|0|||
124903072|NCT01648140|449270037|FG000|Overall Study|Lack of Efficacy|4|||
124903073|NCT01648140|449270038|FG001|Overall Study|Lack of Efficacy|7|||
124903074|NCT01648140|449270039|FG002|Overall Study|Lack of Efficacy|1|||
124903075|NCT01648140|449270040|FG003|Overall Study|Lack of Efficacy|0|||
124903076|NCT01648140|449270037|FG000|Overall Study|Adverse Event|3|||
124903077|NCT01648140|449270038|FG001|Overall Study|Adverse Event|1|||
124903078|NCT01648140|449270039|FG002|Overall Study|Adverse Event|2|||
124903079|NCT01648140|449270040|FG003|Overall Study|Adverse Event|0|||
124903080|NCT01648140|449270037|FG000|Overall Study|Withdrawal by Subject|2|||
124903081|NCT01648140|449270038|FG001|Overall Study|Withdrawal by Subject|3|||
124903082|NCT01648140|449270039|FG002|Overall Study|Withdrawal by Subject|3|||
124903083|NCT01648140|449270040|FG003|Overall Study|Withdrawal by Subject|2|||
124903084|NCT01648140|449270037|FG000|Overall Study|Lost to Follow-up|2|||
124903085|NCT01648140|449270038|FG001|Overall Study|Lost to Follow-up|1|||
124903086|NCT01648140|449270039|FG002|Overall Study|Lost to Follow-up|2|||
124903087|NCT01648140|449270040|FG003|Overall Study|Lost to Follow-up|0|||
124903088|NCT00608907|449270043|FG000|Overall Study|Adverse Event|6|||
124903089|NCT00608907|449270044|FG001|Overall Study|Adverse Event|0|||
124903090|NCT00608907|449270045|FG002|Overall Study|Adverse Event|1|||
124903091|NCT00608907|449270043|FG000|Overall Study|Death|1|||
124903092|NCT00608907|449270044|FG001|Overall Study|Death|0|||
124903093|NCT00608907|449270045|FG002|Overall Study|Death|0|||
124903094|NCT00608907|449270043|FG000|Overall Study|Withdrawal by Subject|4|||
124903095|NCT00608907|449270044|FG001|Overall Study|Withdrawal by Subject|0|||
124903096|NCT00608907|449270045|FG002|Overall Study|Withdrawal by Subject|0|||
124903097|NCT00608907|449270043|FG000|Overall Study|Progressive Disease|1|||
124903098|NCT00608907|449270044|FG001|Overall Study|Progressive Disease|0|||
124903099|NCT00608907|449270045|FG002|Overall Study|Progressive Disease|0|||
124903100|NCT00758602|449270054|FG000|Overall Study|Adverse Event|11|||
124903101|NCT00758602|449270055|FG001|Overall Study|Adverse Event|10|||
124903102|NCT00758602|449270054|FG000|Overall Study|Lost to Follow-up|4|||
124903103|NCT00758602|449270055|FG001|Overall Study|Lost to Follow-up|3|||
124903104|NCT00758602|449270054|FG000|Overall Study|Withdrawal by Subject|1|||
124903105|NCT00758602|449270055|FG001|Overall Study|Withdrawal by Subject|3|||
124903106|NCT00758602|449270054|FG000|Overall Study|Protocol Violation|0|||
124903107|NCT00758602|449270055|FG001|Overall Study|Protocol Violation|2|||
124903108|NCT00758602|449270054|FG000|Overall Study|Death|0|||
124903109|NCT00758602|449270055|FG001|Overall Study|Death|1|||
124903110|NCT00758602|449270054|FG000|Overall Study|Reason not specified|3|||
124903111|NCT00758602|449270055|FG001|Overall Study|Reason not specified|3|||
124903112|NCT00158054|449270057|FG000|Overall Study|Refused to continue|3|||
124903113|NCT00158054|449270058|FG001|Overall Study|Refused to continue|0|||
124903114|NCT00158054|449270057|FG000|Overall Study|Unavailable for follow up|7|||
124903115|NCT00158054|449270058|FG001|Overall Study|Unavailable for follow up|3|||
124903116|NCT00079183|449270074|FG000|Overall Study|Withdrawal by Subject|4|||
124903117|NCT00079183|449270074|FG000|Overall Study|Study medication non-compliance|2|||
124903118|NCT00079183|449270074|FG000|Overall Study|Specimen collection non-compliance|1|||
124903119|NCT02371746|449270075|FG000|Overall Study|Consent withdrawn|0|||
124903120|NCT02371746|449270076|FG001|Overall Study|Consent withdrawn|0|||
124903121|NCT02371746|449270077|FG002|Overall Study|Consent withdrawn|0|||
124903122|NCT02371746|449270078|FG003|Overall Study|Consent withdrawn|0|||
124903123|NCT02371746|449270079|FG004|Overall Study|Consent withdrawn|0|||
124903124|NCT02371746|449270080|FG005|Overall Study|Consent withdrawn|0|||
124903125|NCT02371746|449270081|FG006|Overall Study|Consent withdrawn|1|||
124903126|NCT03743246|449270083|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
124903127|NCT03743246|449270084|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
124903128|NCT03743246|449270085|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
124903129|NCT03743246|449270086|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
124903130|NCT03743246|449270083|FG000|Pre-Treatment Period|Death|0|||
124903131|NCT03743246|449270084|FG001|Pre-Treatment Period|Death|1|||
124903132|NCT03743246|449270085|FG002|Pre-Treatment Period|Death|0|||
124903133|NCT03743246|449270086|FG003|Pre-Treatment Period|Death|1|||
124903134|NCT03743246|449270083|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
124903135|NCT03743246|449270084|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
124903136|NCT03743246|449270085|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
124903137|NCT03743246|449270086|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
124903138|NCT03743246|449270083|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
124903139|NCT03743246|449270084|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
124903140|NCT03743246|449270085|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
124903141|NCT03743246|449270086|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
124903142|NCT03743246|449270083|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
124903143|NCT03743246|449270084|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
124903144|NCT03743246|449270085|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
124903145|NCT03743246|449270086|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
124903146|NCT03743246|449270083|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
124903147|NCT03743246|449270084|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
124903148|NCT03743246|449270085|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
124903149|NCT03743246|449270086|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
124903150|NCT03743246|449270083|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
124903151|NCT03743246|449270084|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
124903152|NCT03743246|449270085|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
124903153|NCT03743246|449270086|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
124903154|NCT03743246|449270083|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
124903155|NCT03743246|449270084|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
124903156|NCT03743246|449270085|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
124903157|NCT03743246|449270086|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
124903158|NCT03743246|449270083|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
124903159|NCT03743246|449270084|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
124903160|NCT03743246|449270085|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
124903161|NCT03743246|449270086|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
124903162|NCT01490580|449270087|FG000|Overall Study|Parents withdrew consent|0|||
124903163|NCT01490580|449270088|FG001|Overall Study|Parents withdrew consent|2|||
124903164|NCT00949975|449270089|FG000|Overall Study|Voluntary discontinuation|6|||
124903165|NCT00949975|449270090|FG001|Overall Study|Voluntary discontinuation|5|||
124903166|NCT00949975|449270091|FG002|Overall Study|Voluntary discontinuation|3|||
124903167|NCT00949975|449270092|FG003|Overall Study|Voluntary discontinuation|6|||
124903168|NCT00949975|449270089|FG000|Overall Study|Adverse Event|11|||
124903169|NCT00949975|449270090|FG001|Overall Study|Adverse Event|11|||
124903170|NCT00949975|449270091|FG002|Overall Study|Adverse Event|10|||
124903171|NCT00949975|449270092|FG003|Overall Study|Adverse Event|10|||
124903172|NCT00949975|449270089|FG000|Overall Study|Safety reason|0|||
124903173|NCT00949975|449270090|FG001|Overall Study|Safety reason|1|||
124903174|NCT00949975|449270091|FG002|Overall Study|Safety reason|0|||
124903175|NCT00949975|449270092|FG003|Overall Study|Safety reason|0|||
124903176|NCT00949975|449270089|FG000|Overall Study|Study-specific criteria|0|||
124903177|NCT00949975|449270090|FG001|Overall Study|Study-specific criteria|1|||
124903178|NCT00949975|449270091|FG002|Overall Study|Study-specific criteria|1|||
124903179|NCT00949975|449270092|FG003|Overall Study|Study-specific criteria|0|||
124903180|NCT00949975|449270089|FG000|Overall Study|Incorrect enrolment|5|||
124903181|NCT00949975|449270090|FG001|Overall Study|Incorrect enrolment|10|||
124903182|NCT00949975|449270091|FG002|Overall Study|Incorrect enrolment|4|||
124691274|NCT05558410|448490027|FG002|Overall Study|Adverse Event|0|||
124691275|NCT05558410|448490025|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
124903183|NCT00949975|449270092|FG003|Overall Study|Incorrect enrolment|7|||
124903184|NCT00949975|449270089|FG000|Overall Study|Severe non-compliance|3|||
124903185|NCT00949975|449270090|FG001|Overall Study|Severe non-compliance|1|||
124903186|NCT00949975|449270091|FG002|Overall Study|Severe non-compliance|0|||
124903187|NCT00949975|449270092|FG003|Overall Study|Severe non-compliance|2|||
124903188|NCT00949975|449270089|FG000|Overall Study|Lost to Follow-up|1|||
124903189|NCT00949975|449270090|FG001|Overall Study|Lost to Follow-up|0|||
124903190|NCT00949975|449270091|FG002|Overall Study|Lost to Follow-up|1|||
124903191|NCT00949975|449270092|FG003|Overall Study|Lost to Follow-up|3|||
124903192|NCT00949975|449270089|FG000|Overall Study|Other|1|||
124903193|NCT00949975|449270090|FG001|Overall Study|Other|0|||
124903194|NCT00949975|449270091|FG002|Overall Study|Other|0|||
124903195|NCT00949975|449270092|FG003|Overall Study|Other|0|||
124903196|NCT02873754|449270093|FG000|Overall Study|Lost to Follow-up|5|||
124903197|NCT02873754|449270093|FG000|Overall Study|Couldn't complete study procedures|1|||
124903198|NCT00082810|449270106|FG000|Overall Study|Adverse Event|3|||
124903199|NCT00082810|449270106|FG000|Overall Study|Progressive disease|24|||
124903200|NCT00082810|449270106|FG000|Overall Study|Withdrawal by Subject|4|||
124691276|NCT05558410|448490026|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
124691277|NCT05558410|448490027|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
124691278|NCT05558410|448490025|FG000|Overall Study|Lost to Follow-up|10|||
124691279|NCT05558410|448490026|FG001|Overall Study|Lost to Follow-up|17|||
124691280|NCT05558410|448490027|FG002|Overall Study|Lost to Follow-up|19|||
124691281|NCT05558410|448490025|FG000|Overall Study|Death|1|||
124691282|NCT05558410|448490026|FG001|Overall Study|Death|0|||
124691283|NCT05558410|448490027|FG002|Overall Study|Death|0|||
124691284|NCT05558410|448490025|FG000|Overall Study|Other non-compliance|0|||
124691285|NCT05558410|448490026|FG001|Overall Study|Other non-compliance|1|||
124691286|NCT05558410|448490027|FG002|Overall Study|Other non-compliance|2|||
124691287|NCT05558410|448490025|FG000|Overall Study|Sponsor Decision|1|||
124691288|NCT05558410|448490026|FG001|Overall Study|Sponsor Decision|0|||
124691289|NCT05558410|448490027|FG002|Overall Study|Sponsor Decision|0|||
124691290|NCT05558410|448490025|FG000|Overall Study|Other|1|||
124691291|NCT05558410|448490026|FG001|Overall Study|Other|0|||
124759984|NCT00531284|448746734|FG013|Overall Study|Progressive Disease|1|||
124903201|NCT02950558|449270107|FG000|Overall Study|Lost to Follow-up|2|||
124903202|NCT02950558|449270108|FG001|Overall Study|Lost to Follow-up|0|||
124759985|NCT00531284|448746735|FG014|Overall Study|Progressive Disease|2|||
124759986|NCT00531284|448746736|FG015|Overall Study|Progressive Disease|11|||
124759987|NCT00531284|448746737|FG016|Overall Study|Progressive Disease|5|||
124759988|NCT00531284|448746721|FG000|Overall Study|Adverse Event|0|||
124759989|NCT00531284|448746722|FG001|Overall Study|Adverse Event|1|||
124759990|NCT00531284|448746723|FG002|Overall Study|Adverse Event|1|||
124759991|NCT00531284|448746724|FG003|Overall Study|Adverse Event|7|||
124759992|NCT00531284|448746725|FG004|Overall Study|Adverse Event|0|||
124759993|NCT00531284|448746726|FG005|Overall Study|Adverse Event|2|||
124759994|NCT00531284|448746727|FG006|Overall Study|Adverse Event|3|||
124759995|NCT00531284|448746728|FG007|Overall Study|Adverse Event|2|||
124759996|NCT00531284|448746729|FG008|Overall Study|Adverse Event|3|||
124759997|NCT00531284|448746730|FG009|Overall Study|Adverse Event|0|||
124759998|NCT00531284|448746731|FG010|Overall Study|Adverse Event|0|||
124759999|NCT00531284|448746732|FG011|Overall Study|Adverse Event|5|||
124760000|NCT00531284|448746733|FG012|Overall Study|Adverse Event|0|||
124760001|NCT00531284|448746734|FG013|Overall Study|Adverse Event|1|||
124760002|NCT00531284|448746735|FG014|Overall Study|Adverse Event|1|||
124760003|NCT00531284|448746736|FG015|Overall Study|Adverse Event|0|||
124760004|NCT00531284|448746737|FG016|Overall Study|Adverse Event|2|||
124760005|NCT00531284|448746721|FG000|Overall Study|Withdrawal by Subject|1|||
124760006|NCT00531284|448746722|FG001|Overall Study|Withdrawal by Subject|0|||
124760007|NCT00531284|448746723|FG002|Overall Study|Withdrawal by Subject|0|||
124760008|NCT00531284|448746724|FG003|Overall Study|Withdrawal by Subject|4|||
124903203|NCT01321606|449270111|FG000|Overall Study|Lost to Follow-up|0|||
124903204|NCT01321606|449270112|FG001|Overall Study|Lost to Follow-up|0|||
124448768|NCT04163900|447605761|FG001|Overall Study|Protocol Violation|4|||
124448769|NCT04163900|447605760|FG000|Overall Study|Lost to Follow-up|0|||
124448770|NCT04163900|447605761|FG001|Overall Study|Lost to Follow-up|1|||
124448771|NCT01830855|447605762|FG000|Overall Study|Other|7|||
124448772|NCT01830855|447605763|FG001|Overall Study|Other|1|||
124448773|NCT01830855|447605764|FG002|Overall Study|Other|4|||
124448774|NCT01830855|447605765|FG003|Overall Study|Other|4|||
124448775|NCT01830855|447605762|FG000|Overall Study|Medication error without associated AE|1|||
124448776|NCT01830855|447605763|FG001|Overall Study|Medication error without associated AE|0|||
124448777|NCT01830855|447605764|FG002|Overall Study|Medication error without associated AE|0|||
124448778|NCT01830855|447605765|FG003|Overall Study|Medication error without associated AE|1|||
124691292|NCT05558410|448490027|FG002|Overall Study|Other|1|||
124691293|NCT02400580|448490028|FG000|Overall Study|Withdrawal by Subject|1|||
124691294|NCT02400580|448490029|FG001|Overall Study|Withdrawal by Subject|1|||
124691295|NCT02400580|448490028|FG000|Overall Study|Adverse Event|1|||
124760009|NCT00531284|448746725|FG004|Overall Study|Withdrawal by Subject|0|||
124760010|NCT00531284|448746726|FG005|Overall Study|Withdrawal by Subject|0|||
124760011|NCT00531284|448746727|FG006|Overall Study|Withdrawal by Subject|0|||
124760012|NCT00531284|448746728|FG007|Overall Study|Withdrawal by Subject|0|||
124760013|NCT00531284|448746729|FG008|Overall Study|Withdrawal by Subject|0|||
124903205|NCT01321606|449270113|FG002|Overall Study|Lost to Follow-up|0|||
124903206|NCT01321606|449270114|FG003|Overall Study|Lost to Follow-up|1|||
124448779|NCT01830855|447605762|FG000|Overall Study|Pregnancy|3|||
124691296|NCT02400580|448490029|FG001|Overall Study|Adverse Event|0|||
124760014|NCT00531284|448746730|FG009|Overall Study|Withdrawal by Subject|0|||
124903207|NCT02914522|449270115|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
124903208|NCT02914522|449270116|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
124903209|NCT02914522|449270117|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
124903210|NCT02914522|449270118|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
124903211|NCT02914522|449270119|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
124903212|NCT02914522|449270120|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
124903213|NCT02914522|449270121|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
124903214|NCT02914522|449270122|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
124903215|NCT02914522|449270123|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
124903216|NCT02914522|449270124|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
124903217|NCT02914522|449270125|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
124903218|NCT02914522|449270115|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
124903219|NCT02914522|449270116|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
124903220|NCT02914522|449270117|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
124903221|NCT02914522|449270118|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
124903222|NCT02914522|449270119|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
124903223|NCT02914522|449270120|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
124903224|NCT02914522|449270121|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
124903225|NCT02914522|449270122|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
124903226|NCT02914522|449270123|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
124903227|NCT02914522|449270124|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
124903228|NCT02914522|449270125|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
124903229|NCT02914522|449270115|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
124903230|NCT02914522|449270116|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
124903231|NCT02914522|449270117|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
124903232|NCT02914522|449270118|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
124903233|NCT02914522|449270119|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
124903234|NCT02914522|449270120|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
124903235|NCT02914522|449270121|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
124903236|NCT02914522|449270122|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
124903237|NCT02914522|449270123|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
124903238|NCT02914522|449270124|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
124903239|NCT02914522|449270125|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
124691297|NCT00965094|448490030|FG000|Overall Study|Adverse Event|5|||
124691298|NCT00965094|448490031|FG001|Overall Study|Adverse Event|0|||
124691299|NCT00965094|448490030|FG000|Overall Study|Lost to Follow-up|0|||
124691300|NCT00965094|448490031|FG001|Overall Study|Lost to Follow-up|1|||
124903240|NCT02914522|449270115|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
124903241|NCT02914522|449270116|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
124903242|NCT02914522|449270117|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
124903243|NCT02914522|449270118|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
124691301|NCT01336972|448490032|FG000|Overall Study|Adverse Event|1|||
124691302|NCT01336972|448490033|FG001|Overall Study|Adverse Event|1|||
124903244|NCT02914522|449270119|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
124903245|NCT02914522|449270120|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
124903246|NCT02914522|449270121|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
124903247|NCT02914522|449270122|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
124903248|NCT02914522|449270123|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
124903249|NCT02914522|449270124|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
124903250|NCT02914522|449270125|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
124903251|NCT02914522|449270115|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903252|NCT02914522|449270116|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903253|NCT02914522|449270117|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903254|NCT02914522|449270118|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903255|NCT02914522|449270119|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
124903256|NCT02914522|449270120|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903257|NCT02914522|449270121|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903258|NCT02914522|449270122|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903259|NCT02914522|449270123|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903260|NCT02914522|449270124|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903261|NCT02914522|449270125|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
124903262|NCT02914522|449270115|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
124903263|NCT02914522|449270116|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903264|NCT02914522|449270117|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903265|NCT02914522|449270118|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903266|NCT02914522|449270119|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903267|NCT02914522|449270120|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903268|NCT02914522|449270121|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903269|NCT02914522|449270122|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124760015|NCT00531284|448746731|FG010|Overall Study|Withdrawal by Subject|0|||
124760016|NCT00531284|448746732|FG011|Overall Study|Withdrawal by Subject|3|||
124760017|NCT00531284|448746733|FG012|Overall Study|Withdrawal by Subject|0|||
124760018|NCT00531284|448746734|FG013|Overall Study|Withdrawal by Subject|1|||
124760019|NCT00531284|448746735|FG014|Overall Study|Withdrawal by Subject|0|||
124760020|NCT00531284|448746736|FG015|Overall Study|Withdrawal by Subject|1|||
124760021|NCT00531284|448746737|FG016|Overall Study|Withdrawal by Subject|1|||
124760022|NCT00531284|448746721|FG000|Overall Study|Other|1|||
124760023|NCT00531284|448746722|FG001|Overall Study|Other|0|||
124760024|NCT00531284|448746723|FG002|Overall Study|Other|0|||
124760025|NCT00531284|448746724|FG003|Overall Study|Other|10|||
124760026|NCT00531284|448746725|FG004|Overall Study|Other|2|||
124760027|NCT00531284|448746726|FG005|Overall Study|Other|1|||
124760028|NCT00531284|448746727|FG006|Overall Study|Other|0|||
124760029|NCT00531284|448746728|FG007|Overall Study|Other|0|||
124760030|NCT00531284|448746729|FG008|Overall Study|Other|2|||
124760031|NCT00531284|448746730|FG009|Overall Study|Other|1|||
124760032|NCT00531284|448746731|FG010|Overall Study|Other|0|||
124760033|NCT00531284|448746732|FG011|Overall Study|Other|2|||
124760034|NCT00531284|448746733|FG012|Overall Study|Other|0|||
124760035|NCT00531284|448746734|FG013|Overall Study|Other|0|||
124903270|NCT02914522|449270123|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903271|NCT02914522|449270124|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903272|NCT02914522|449270125|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
124903273|NCT02914522|449270115|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
124903274|NCT02914522|449270116|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
124448780|NCT01830855|447605763|FG001|Overall Study|Pregnancy|1|||
124448781|NCT01830855|447605764|FG002|Overall Study|Pregnancy|2|||
124448782|NCT01830855|447605765|FG003|Overall Study|Pregnancy|1|||
124448783|NCT01830855|447605762|FG000|Overall Study|No longer meets eligibility criteria|11|||
124448784|NCT01830855|447605763|FG001|Overall Study|No longer meets eligibility criteria|2|||
124760036|NCT00531284|448746735|FG014|Overall Study|Other|1|||
124903275|NCT02914522|449270117|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
124903276|NCT02914522|449270118|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
124903277|NCT02914522|449270119|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
124903278|NCT02914522|449270120|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
124903279|NCT02914522|449270121|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
124903280|NCT02914522|449270122|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
124903281|NCT02914522|449270123|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
124903282|NCT02914522|449270124|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
124903283|NCT02914522|449270125|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
124903284|NCT02914522|449270115|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
124760037|NCT00531284|448746736|FG015|Overall Study|Other|0|||
124760038|NCT00531284|448746737|FG016|Overall Study|Other|0|||
124448785|NCT01830855|447605764|FG002|Overall Study|No longer meets eligibility criteria|3|||
124760039|NCT02219464|448746739|FG000|Overall Study|Withdrawal by Subject|1|||
124760040|NCT02219464|448746740|FG001|Overall Study|Withdrawal by Subject|0|||
124903285|NCT02914522|449270116|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
124903286|NCT02914522|449270117|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
124903287|NCT02914522|449270118|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
124903288|NCT02914522|449270119|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
124903289|NCT02914522|449270120|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
124903290|NCT02914522|449270121|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
124903291|NCT02914522|449270122|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
124903292|NCT02914522|449270123|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
124903293|NCT02914522|449270124|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
124903294|NCT02914522|449270125|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
124903295|NCT02914522|449270115|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
124903296|NCT02914522|449270116|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
124903297|NCT02914522|449270117|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
124903298|NCT02914522|449270118|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
124903299|NCT02914522|449270119|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
124903300|NCT02914522|449270120|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
124903301|NCT02914522|449270121|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
124903302|NCT02914522|449270122|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
124903303|NCT02914522|449270123|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
124903304|NCT02914522|449270124|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
124903305|NCT02914522|449270125|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
124903306|NCT02914522|449270115|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
124903307|NCT02914522|449270116|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
124903308|NCT02914522|449270117|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
124903309|NCT02914522|449270118|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
124903310|NCT02914522|449270119|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
124903311|NCT02914522|449270120|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
124903312|NCT02914522|449270121|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
124903313|NCT02914522|449270122|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
124903314|NCT02914522|449270123|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
124903315|NCT02914522|449270124|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
124903316|NCT02914522|449270125|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
124903317|NCT02914522|449270115|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
124903318|NCT02914522|449270116|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
124903319|NCT02914522|449270117|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
124903320|NCT02914522|449270118|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
124903321|NCT02914522|449270119|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
124903322|NCT02914522|449270120|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
124903323|NCT02914522|449270121|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
124903324|NCT02914522|449270122|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
124903325|NCT02914522|449270123|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
124903326|NCT02914522|449270124|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
124903327|NCT02914522|449270125|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
124903328|NCT02914522|449270115|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
124903329|NCT02914522|449270116|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
124903330|NCT02914522|449270117|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
124903331|NCT02914522|449270118|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
124903332|NCT02914522|449270119|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
124903333|NCT02914522|449270120|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
124903334|NCT02914522|449270121|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
124903335|NCT02914522|449270122|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
124903336|NCT02914522|449270123|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
124903337|NCT02914522|449270124|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
124903338|NCT02914522|449270125|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
124903339|NCT02914522|449270115|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
124903340|NCT02914522|449270116|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
124903341|NCT02914522|449270117|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
124903342|NCT02914522|449270118|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
124903343|NCT02914522|449270119|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
124903344|NCT02914522|449270120|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
124903345|NCT02914522|449270121|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
124903346|NCT02914522|449270122|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
124903347|NCT02914522|449270123|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
124903348|NCT02914522|449270124|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
124903349|NCT02914522|449270125|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
124903350|NCT02914522|449270115|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903351|NCT02914522|449270116|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903352|NCT02914522|449270117|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903353|NCT02914522|449270118|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903354|NCT02914522|449270119|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903355|NCT02914522|449270120|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903356|NCT02914522|449270121|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903357|NCT02914522|449270122|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
124903358|NCT02914522|449270123|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
124903359|NCT02914522|449270124|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903360|NCT02914522|449270125|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
124903361|NCT02914522|449270115|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903362|NCT02914522|449270116|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903363|NCT02914522|449270117|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903364|NCT02914522|449270118|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903365|NCT02914522|449270119|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903366|NCT02914522|449270120|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903367|NCT02914522|449270121|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903368|NCT02914522|449270122|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903369|NCT02914522|449270123|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
124903370|NCT02914522|449270124|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
124903371|NCT02914522|449270125|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
124903372|NCT02914522|449270115|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903373|NCT02914522|449270116|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903374|NCT02914522|449270117|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903375|NCT02914522|449270118|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903376|NCT02914522|449270119|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903377|NCT02914522|449270120|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903378|NCT02914522|449270121|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903379|NCT02914522|449270122|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903380|NCT02914522|449270123|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903381|NCT02914522|449270124|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
124903382|NCT02914522|449270125|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
124903383|NCT00756730|449270126|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
124903384|NCT00756730|449270127|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
124448786|NCT01830855|447605765|FG003|Overall Study|No longer meets eligibility criteria|5|||
124448787|NCT01830855|447605762|FG000|Overall Study|Adverse Event|11|||
124903385|NCT00756730|449270126|FG000|Overall Study|persistent low-level viremmia|0|||
124903386|NCT00756730|449270127|FG001|Overall Study|persistent low-level viremmia|1|||
124903387|NCT05382104|449270129|FG000|Period 2 (2 Days)|Adverse Event|0|||
124903388|NCT05382104|449270130|FG001|Period 2 (2 Days)|Adverse Event|1|||
124903389|NCT05382104|449270131|FG002|Period 2 (2 Days)|Adverse Event|0|||
124903390|NCT05382104|449270132|FG003|Period 2 (2 Days)|Adverse Event|0|||
124903391|NCT05382104|449270133|FG004|Period 2 (2 Days)|Adverse Event|0|||
124903392|NCT05382104|449270134|FG005|Period 2 (2 Days)|Adverse Event|0|||
124903393|NCT00639002|449270135|FG000|Overall Study|Death|1|||
124903394|NCT00639002|449270135|FG000|Overall Study|Adverse Event|1|||
124903395|NCT00639002|449270135|FG000|Overall Study|Protocol Violation|1|||
124903396|NCT00639002|449270135|FG000|Overall Study|Disease progression|3|||
124903397|NCT00639002|449270135|FG000|Overall Study|Physician Decision|6|||
124903398|NCT00639002|449270135|FG000|Overall Study|Lack of Efficacy|1|||
124448788|NCT01830855|447605763|FG001|Overall Study|Adverse Event|5|||
124903399|NCT05686421|449270143|FG000|Overall Study|Screen failure|22|||
124903400|NCT05686421|449270144|FG001|Overall Study|Screen failure|0|||
124903401|NCT05686421|449270145|FG002|Overall Study|Screen failure|0|||
124903402|NCT05686421|449270146|FG003|Overall Study|Screen failure|0|||
124903403|NCT00940992|449270147|FG000|Overall Study|Adverse Event|2|||
124903404|NCT00940992|449270148|FG001|Overall Study|Adverse Event|0|||
124903405|NCT00940992|449270149|FG002|Overall Study|Adverse Event|1|||
124903406|NCT00940992|449270147|FG000|Overall Study|subject request|2|||
124903407|NCT00940992|449270148|FG001|Overall Study|subject request|1|||
124903408|NCT00940992|449270149|FG002|Overall Study|subject request|0|||
124903409|NCT00940992|449270147|FG000|Overall Study|Lost to Follow-up|0|||
124903410|NCT00940992|449270148|FG001|Overall Study|Lost to Follow-up|1|||
124903411|NCT00940992|449270149|FG002|Overall Study|Lost to Follow-up|1|||
124903412|NCT00361283|449270154|FG000|Overall Study|Lost to Follow-up|27|||
124448789|NCT01830855|447605764|FG002|Overall Study|Adverse Event|6|||
124691303|NCT01336972|448490034|FG002|Overall Study|Adverse Event|0|||
124691304|NCT03446573|448490038|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
124691305|NCT03446573|448490039|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
124691306|NCT03446573|448490038|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
124691307|NCT03446573|448490039|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
124691308|NCT03446573|448490038|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
124691309|NCT03446573|448490039|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
124691310|NCT03446573|448490038|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
124691311|NCT03446573|448490039|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
124691312|NCT03446573|448490038|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
124691313|NCT03446573|448490039|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
124691314|NCT03446573|448490038|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
124691315|NCT03446573|448490039|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
124691316|NCT03446573|448490038|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
124691317|NCT03446573|448490039|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
124691318|NCT03446573|448490038|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
124691319|NCT03446573|448490039|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
124691320|NCT03446573|448490038|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
124691321|NCT03446573|448490039|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
124691322|NCT03446573|448490038|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
124691323|NCT03446573|448490039|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
124691324|NCT03446573|448490038|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
124691325|NCT03446573|448490039|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
124691326|NCT03446573|448490038|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
124691327|NCT03446573|448490039|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
124691328|NCT03446573|448490038|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
124691329|NCT03446573|448490039|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
124691330|NCT05987540|448490042|FG000|Overall Study|Withdrawal by Subject|2|||
124691331|NCT05987540|448490042|FG000|Overall Study|Death|1|||
124691332|NCT05987540|448490042|FG000|Overall Study|Study Termination|1|||
124691333|NCT05987540|448490042|FG000|Overall Study|Adverse Event|2|||
124691334|NCT00471107|448490043|FG000|Overall Study|Technical problems/data loss|3|||
124691335|NCT00471107|448490044|FG001|Overall Study|Technical problems/data loss|1|||
124691336|NCT00471107|448490045|FG002|Overall Study|Technical problems/data loss|3|||
124691337|NCT04996264|448490046|FG000|Overall Study|Lost to Follow-up|0|||
124691338|NCT04996264|448490047|FG001|Overall Study|Lost to Follow-up|1|||
124691339|NCT04996264|448490046|FG000|Overall Study|Withdrawal by Subject|4|||
124691340|NCT04996264|448490047|FG001|Overall Study|Withdrawal by Subject|3|||
124691341|NCT04996264|448490046|FG000|Overall Study|1 left AMA|0|||
124691342|NCT04996264|448490047|FG001|Overall Study|1 left AMA|1|||
124691343|NCT04996264|448490046|FG000|Overall Study|Subject changed hospitals|0|||
124691344|NCT04996264|448490047|FG001|Overall Study|Subject changed hospitals|1|||
124691345|NCT04996264|448490046|FG000|Overall Study|unable to complete due to work|0|||
124691346|NCT04996264|448490047|FG001|Overall Study|unable to complete due to work|1|||
124691347|NCT04433975|448490048|FG000|1-month Follow Up|Withdrawal by Subject|1|||
124691348|NCT04433975|448490049|FG001|1-month Follow Up|Withdrawal by Subject|1|||
124691349|NCT04433975|448490048|FG000|1-month Follow Up|Lost to Follow-up|21|||
124691350|NCT04433975|448490049|FG001|1-month Follow Up|Lost to Follow-up|25|||
124691351|NCT04433975|448490048|FG000|3-month Follow Up|Lost to Follow-up|20|||
124691352|NCT04433975|448490049|FG001|3-month Follow Up|Lost to Follow-up|24|||
124691353|NCT04433975|448490048|FG000|3-month Follow Up|Death|1|||
124691354|NCT04433975|448490049|FG001|3-month Follow Up|Death|0|||
124760041|NCT02219464|448746739|FG000|Overall Study|case cancelled|1|||
124448790|NCT01830855|447605765|FG003|Overall Study|Adverse Event|3|||
124903413|NCT00208767|449270155|FG000|Overall Study|Adverse Event|9|||
124903414|NCT00208767|449270156|FG001|Overall Study|Adverse Event|1|||
124903415|NCT00208767|449270155|FG000|Overall Study|Withdrawal by Subject|14|||
124903416|NCT00208767|449270156|FG001|Overall Study|Withdrawal by Subject|3|||
124903417|NCT00208767|449270155|FG000|Overall Study|Death|1|||
124903418|NCT00208767|449270156|FG001|Overall Study|Death|0|||
124903419|NCT00208767|449270155|FG000|Overall Study|Lost to Follow-up|3|||
124903420|NCT00208767|449270156|FG001|Overall Study|Lost to Follow-up|3|||
124903421|NCT05052983|449270158|FG000|Overall Study|Lack of Efficacy|3|||
124903422|NCT05052983|449270159|FG001|Overall Study|Lack of Efficacy|12|||
124903423|NCT05052983|449270158|FG000|Overall Study|Adverse Event|1|||
124903424|NCT05052983|449270159|FG001|Overall Study|Adverse Event|0|||
124903425|NCT04133363|449270160|FG000|Overall Study|Lost to Follow-up|2|||
124903426|NCT04133363|449270161|FG001|Overall Study|Lost to Follow-up|1|||
124903427|NCT04133363|449270162|FG002|Overall Study|Lost to Follow-up|4|||
124903428|NCT00849147|449270166|FG000|Overall Study|Withdrawal by Subject|1|||
124903429|NCT00849147|449270166|FG000|Overall Study|Protocol Violation|2|||
124903430|NCT00849147|449270166|FG000|Overall Study|Disease Relapse/Progression|2|||
124903431|NCT00482729|449272353|FG000|Overall Study|Adverse Event|29|||
124903432|NCT00482729|449272354|FG001|Overall Study|Adverse Event|33|||
124903433|NCT00482729|449272353|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
124903434|NCT00482729|449272354|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
124903435|NCT00482729|449272353|FG000|Overall Study|Hyperglycemia Criteria|7|||
124903436|NCT00482729|449272354|FG001|Overall Study|Hyperglycemia Criteria|5|||
124903437|NCT00482729|449272353|FG000|Overall Study|Lack of Efficacy|4|||
124903438|NCT00482729|449272354|FG001|Overall Study|Lack of Efficacy|16|||
124903439|NCT00482729|449272353|FG000|Overall Study|Lost to Follow-up|86|||
124903440|NCT00482729|449272354|FG001|Overall Study|Lost to Follow-up|66|||
124903441|NCT00482729|449272353|FG000|Overall Study|Physician Decision|10|||
124903442|NCT00482729|449272354|FG001|Overall Study|Physician Decision|7|||
124903443|NCT00482729|449272353|FG000|Overall Study|Pregnancy|4|||
124903444|NCT00482729|449272354|FG001|Overall Study|Pregnancy|2|||
124903445|NCT00482729|449272353|FG000|Overall Study|Protocol Violation|10|||
124903446|NCT00482729|449272354|FG001|Overall Study|Protocol Violation|18|||
124903447|NCT00482729|449272353|FG000|Overall Study|Withdrawal by Subject|67|||
124903448|NCT00482729|449272354|FG001|Overall Study|Withdrawal by Subject|69|||
124903449|NCT02631148|449272358|FG000|Overall Study|8 were ineligible|8|||
124903450|NCT02631148|449272359|FG001|Overall Study|8 were ineligible|0|||
124903451|NCT02631148|449272358|FG000|Overall Study|Withdrawal by Subject|1|||
124903452|NCT02631148|449272359|FG001|Overall Study|Withdrawal by Subject|0|||
124903453|NCT02631148|449272358|FG000|Overall Study|PAH not available to study participant|1|||
124903454|NCT02631148|449272359|FG001|Overall Study|PAH not available to study participant|0|||
124903455|NCT04860258|449272361|FG000|Overall Study|Withdrawal by Subject|0|||
124903456|NCT04860258|449272362|FG001|Overall Study|Withdrawal by Subject|0|||
124903457|NCT04860258|449272363|FG002|Overall Study|Withdrawal by Subject|4|||
124903458|NCT04860258|449272364|FG003|Overall Study|Withdrawal by Subject|1|||
124903459|NCT04860258|449272365|FG004|Overall Study|Withdrawal by Subject|4|||
124903460|NCT04860258|449272366|FG005|Overall Study|Withdrawal by Subject|1|||
124903461|NCT04860258|449272367|FG006|Overall Study|Withdrawal by Subject|0|||
124903462|NCT00028769|449272368|FG000|Overall Study|Adverse Event|2|||
124903463|NCT00028769|449272368|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
124903464|NCT00028769|449272368|FG000|Overall Study|Progression or Death|31|||
124903465|NCT00028769|449272368|FG000|Overall Study|Other - Not Protocol Specified|1|||
124448791|NCT01830855|447605762|FG000|Overall Study|Protocol deviation|10|||
124448792|NCT01830855|447605763|FG001|Overall Study|Protocol deviation|5|||
124448793|NCT01830855|447605764|FG002|Overall Study|Protocol deviation|6|||
124448794|NCT01830855|447605765|FG003|Overall Study|Protocol deviation|6|||
124448795|NCT01830855|447605762|FG000|Overall Study|Withdrawal by Subject|33|||
124448796|NCT01830855|447605763|FG001|Overall Study|Withdrawal by Subject|14|||
124448797|NCT01830855|447605764|FG002|Overall Study|Withdrawal by Subject|10|||
124448798|NCT01830855|447605765|FG003|Overall Study|Withdrawal by Subject|12|||
124448799|NCT01830855|447605762|FG000|Overall Study|No longer willing to participate|32|||
124903466|NCT00028769|449272368|FG000|Overall Study|Ineligible|5|||
124903467|NCT00028769|449272368|FG000|Overall Study|Not Analyzable|1|||
124903468|NCT01134562|449272369|FG000|Overall Study|Adverse Event|0|||
124903469|NCT01134562|449272370|FG001|Overall Study|Adverse Event|1|||
124903470|NCT01134562|449272371|FG002|Overall Study|Adverse Event|0|||
124903471|NCT01134562|449272372|FG003|Overall Study|Adverse Event|0|||
124903472|NCT01134562|449272373|FG004|Overall Study|Adverse Event|0|||
124691355|NCT04433975|448490048|FG000|3-month Follow Up|Withdrawal by Subject|2|||
124691356|NCT04433975|448490049|FG001|3-month Follow Up|Withdrawal by Subject|0|||
124903473|NCT00357396|449272374|FG000|Overall Study|Adverse Event|1|||
124903474|NCT00357396|449272375|FG001|Overall Study|Adverse Event|0|||
124903475|NCT02496702|449272377|FG000|Overall Study|Lost to Follow-up|8|||
124691357|NCT04433975|448490048|FG000|6-month Follow Up|Lost to Follow-up|23|||
124448800|NCT01830855|447605763|FG001|Overall Study|No longer willing to participate|13|||
124448801|NCT01830855|447605764|FG002|Overall Study|No longer willing to participate|12|||
124448802|NCT01830855|447605765|FG003|Overall Study|No longer willing to participate|17|||
124903476|NCT02496702|449272378|FG001|Overall Study|Lost to Follow-up|6|||
124903477|NCT02496702|449272377|FG000|Overall Study|Only partially tested|0|||
124903478|NCT02496702|449272378|FG001|Overall Study|Only partially tested|2|||
124903479|NCT00487578|449272379|FG000|Overall Study|Adverse Event|1|||
124903480|NCT00487578|449272380|FG001|Overall Study|Adverse Event|2|||
124903481|NCT00487578|449272379|FG000|Overall Study|Lack of Efficacy|0|||
124903482|NCT00487578|449272380|FG001|Overall Study|Lack of Efficacy|1|||
124903483|NCT00487578|449272379|FG000|Overall Study|Lost to Follow-up|0|||
124903484|NCT00487578|449272380|FG001|Overall Study|Lost to Follow-up|1|||
124903485|NCT02525796|449272385|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
124903486|NCT02525796|449272386|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
124903487|NCT02525796|449272387|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
124903488|NCT02525796|449272385|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
124903489|NCT02525796|449272386|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
124903490|NCT02525796|449272387|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
124903491|NCT02525796|449272385|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
124903492|NCT02525796|449272386|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
124903493|NCT02525796|449272387|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
124903494|NCT02525796|449272385|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
124903495|NCT02525796|449272386|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
124903496|NCT02525796|449272387|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
124903497|NCT02525796|449272385|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
124903498|NCT02525796|449272386|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
124903499|NCT02525796|449272387|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
124903500|NCT00726999|449272390|FG000|Overall Study|Physician Decision|0|||
124903501|NCT00726999|449272391|FG001|Overall Study|Physician Decision|1|||
124903502|NCT00726999|449272390|FG000|Overall Study|Withdrawal by Subject|2|||
124903503|NCT00726999|449272391|FG001|Overall Study|Withdrawal by Subject|0|||
124903504|NCT00726999|449272390|FG000|Overall Study|Protocol Violation|1|||
124903505|NCT00726999|449272391|FG001|Overall Study|Protocol Violation|0|||
124903506|NCT00955825|449272392|FG000|Overall Study|Adverse Event|15|||
124903507|NCT00955825|449272393|FG001|Overall Study|Adverse Event|2|||
124903508|NCT00955825|449272392|FG000|Overall Study|Withdrawal by Subject|4|||
124903509|NCT00955825|449272393|FG001|Overall Study|Withdrawal by Subject|6|||
124903510|NCT00955825|449272392|FG000|Overall Study|Any other reason not above-mentioned|7|||
124903511|NCT00955825|449272393|FG001|Overall Study|Any other reason not above-mentioned|9|||
124903512|NCT01499134|449272394|FG000|Overall Study|Withdrawal by Subject|0|||
124903513|NCT01499134|449272395|FG001|Overall Study|Withdrawal by Subject|1|||
124903514|NCT02488980|449272396|FG000|Overall Study|Protocol Violation|2|||
124903515|NCT02488980|449272397|FG001|Overall Study|Protocol Violation|2|||
124903516|NCT02488980|449272398|FG002|Overall Study|Protocol Violation|2|||
124903517|NCT01198275|449272399|FG000|Overall Study|Adverse Event|2|||
124903518|NCT01198275|449272400|FG001|Overall Study|Adverse Event|3|||
124903519|NCT01198275|449272399|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
124903520|NCT01198275|449272400|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
124903521|NCT00391846|449272401|FG000|Overall Study|Adverse Event|4|||
124903522|NCT00391846|449272402|FG001|Overall Study|Adverse Event|1|||
124903523|NCT00391846|449272401|FG000|Overall Study|Did not meet the required elig. crit|2|||
124903524|NCT00391846|449272402|FG001|Overall Study|Did not meet the required elig. crit|2|||
124691358|NCT04433975|448490049|FG001|6-month Follow Up|Lost to Follow-up|28|||
124691359|NCT04433975|448490048|FG000|6-month Follow Up|Withdrawal by Subject|1|||
124691360|NCT04433975|448490049|FG001|6-month Follow Up|Withdrawal by Subject|1|||
124691361|NCT04433975|448490048|FG000|9-month Follow Up|Lost to Follow-up|27|||
124691362|NCT04433975|448490049|FG001|9-month Follow Up|Lost to Follow-up|36|||
124691363|NCT04433975|448490048|FG000|9-month Follow Up|Death|0|||
124691364|NCT04433975|448490049|FG001|9-month Follow Up|Death|1|||
124903525|NCT00391846|449272401|FG000|Overall Study|Withdrawal by Subject|2|||
124903526|NCT00391846|449272402|FG001|Overall Study|Withdrawal by Subject|3|||
124903527|NCT00391846|449272401|FG000|Overall Study|Developed study specific DC criteria|0|||
124903528|NCT00391846|449272402|FG001|Overall Study|Developed study specific DC criteria|1|||
124903529|NCT00150176|449272403|FG000|Overall Study|Adverse Event|16|||
124903530|NCT00150176|449272404|FG001|Overall Study|Adverse Event|53|||
124903531|NCT00150176|449272403|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
124903532|NCT00150176|449272404|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
124903533|NCT00150176|449272403|FG000|Overall Study|Withdrawal by Subject|19|||
124903534|NCT00150176|449272404|FG001|Overall Study|Withdrawal by Subject|12|||
124903535|NCT00150176|449272403|FG000|Overall Study|Lost to Follow-up|3|||
124903536|NCT00150176|449272404|FG001|Overall Study|Lost to Follow-up|3|||
124903537|NCT00150176|449272403|FG000|Overall Study|OTHER|11|||
124903538|NCT00150176|449272404|FG001|Overall Study|OTHER|13|||
124903539|NCT00970307|449272407|FG000|Overall Study|Serious Adverse Event|1|||
124903540|NCT00970307|449272408|FG001|Overall Study|Serious Adverse Event|0|||
124903541|NCT00970307|449272409|FG002|Overall Study|Serious Adverse Event|0|||
124903542|NCT00970307|449272407|FG000|Overall Study|Withdrawal by Subject|2|||
124448803|NCT01830855|447605762|FG000|Overall Study|Lost to Follow-up|47|||
124691365|NCT04433975|448490048|FG000|12-month Follow Up|Lost to Follow-up|27|||
124760042|NCT02219464|448746740|FG001|Overall Study|case cancelled|0|||
124448804|NCT01830855|447605763|FG001|Overall Study|Lost to Follow-up|20|||
124448805|NCT01830855|447605764|FG002|Overall Study|Lost to Follow-up|23|||
124448806|NCT01830855|447605765|FG003|Overall Study|Lost to Follow-up|33|||
124448807|NCT01667081|447605766|FG000|Overall Study|Death|43|||
124448808|NCT01667081|447605767|FG001|Overall Study|Death|3|||
124448809|NCT01667081|447605766|FG000|Overall Study|Lost to Follow-up|99|||
124448810|NCT01667081|447605767|FG001|Overall Study|Lost to Follow-up|48|||
124448811|NCT01667081|447605766|FG000|Overall Study|Physician Decision|16|||
124448812|NCT01667081|447605767|FG001|Overall Study|Physician Decision|2|||
124448813|NCT01667081|447605766|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
124448814|NCT01667081|447605767|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
124448815|NCT01667081|447605766|FG000|Overall Study|Withdrawal by Subject|90|||
124448816|NCT01667081|447605767|FG001|Overall Study|Withdrawal by Subject|35|||
124448817|NCT00930722|447605768|FG000|Overall Study|Lost to Follow-up|16|||
124448818|NCT00930722|447605768|FG000|Overall Study|No longer willing to participate|9|||
124448819|NCT00930722|447605768|FG000|Overall Study|Study terminated by sponsor|2|||
124448820|NCT03034460|447605769|FG000|Overall Study|Adverse Event|0|||
124448821|NCT03034460|447605770|FG001|Overall Study|Adverse Event|1|||
124448822|NCT03034460|447605769|FG000|Overall Study|Withdrawal by Subject|2|||
124448823|NCT03034460|447605770|FG001|Overall Study|Withdrawal by Subject|2|||
124448824|NCT03034460|447605769|FG000|Overall Study|Personal Reasons|1|||
124448825|NCT03034460|447605770|FG001|Overall Study|Personal Reasons|0|||
124448826|NCT00419120|447605771|FG000|Long Term Follow up Period|study ongoing|10|||
124448827|NCT01186939|447605780|FG000|Overall Study|Death|7|||
124448828|NCT01186939|447605780|FG000|Overall Study|Withdrawal by Subject|2|||
124448829|NCT01186939|447605780|FG000|Overall Study|No longer receiving clinical benefit|17|||
124448830|NCT01186939|447605780|FG000|Overall Study|Program closed|5|||
124448831|NCT01186939|447605780|FG000|Overall Study|Sponsor decision|4|||
124448832|NCT01186939|447605780|FG000|Overall Study|Started additional treatment|1|||
124448833|NCT01186939|447605780|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
124448834|NCT01186939|447605780|FG000|Overall Study|Myocardial infarction|1|||
124448835|NCT01186939|447605780|FG000|Overall Study|Bone marrow transplant|1|||
124448836|NCT01186939|447605780|FG000|Overall Study|Transformation to AML|1|||
124448837|NCT01509079|447605781|FG000|Overall Study|Lack of Efficacy|0|||
124448838|NCT01509079|447605782|FG001|Overall Study|Lack of Efficacy|2|||
124448839|NCT01509079|447605781|FG000|Overall Study|started an excluded medication|0|||
124448840|NCT01509079|447605782|FG001|Overall Study|started an excluded medication|1|||
124448841|NCT01949155|447605786|FG000|Overall Study|Lost to Follow-up|1|||
124448842|NCT01949155|447605787|FG001|Overall Study|Lost to Follow-up|0|||
124448843|NCT01949155|447605786|FG000|Overall Study|Protocol Violation|1|||
124448844|NCT01949155|447605787|FG001|Overall Study|Protocol Violation|0|||
124448845|NCT00685685|447605788|FG000|Washout Period of 7 Days|Adverse Event|2|||
124448846|NCT00685685|447605789|FG001|Washout Period of 7 Days|Adverse Event|0|||
124448847|NCT00685685|447605788|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
124448848|NCT00685685|447605789|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
124448849|NCT02941926|447605790|FG000|Core Phase|Progressive disease|1109|||
124448850|NCT02941926|447605790|FG000|Core Phase|Adverse Event|504|||
124448851|NCT02941926|447605790|FG000|Core Phase|Subject/guardian decision|127|||
124448852|NCT02941926|447605790|FG000|Core Phase|Physician Decision|112|||
124448853|NCT02941926|447605790|FG000|Core Phase|Death|46|||
124448854|NCT02941926|447605790|FG000|Core Phase|Protocol deviation|34|||
124448855|NCT02941926|447605790|FG000|Core Phase|Lost to Follow-up|8|||
124448856|NCT02941926|447605790|FG000|Core Phase|Technical problems|5|||
124448857|NCT02941926|447605790|FG000|Extension Phase|Physician Decision|155|||
124448858|NCT02941926|447605790|FG000|Extension Phase|Progressive disease|115|||
124448859|NCT02941926|447605790|FG000|Extension Phase|Adverse Event|13|||
124448860|NCT02941926|447605790|FG000|Extension Phase|Subject/Guardian decision|12|||
124448861|NCT02941926|447605790|FG000|Extension Phase|Death|6|||
124448862|NCT02729740|447605791|FG000|Overall Study|Early Termination|130|||
124903543|NCT00970307|449272408|FG001|Overall Study|Withdrawal by Subject|3|||
124448863|NCT02729740|447605791|FG000|Overall Study|Other|1|||
124448864|NCT00307333|447605792|FG000|Overall Study|Lost to Follow-up|11|||
124448865|NCT00307333|447605793|FG001|Overall Study|Lost to Follow-up|3|||
124448866|NCT00601705|447605797|FG000|Overall Study|Withdrawal by Subject|1|||
124448867|NCT04513665|447605798|FG000|Overall Study|Adverse Event|2|||
124448868|NCT04513665|447605799|FG001|Overall Study|Adverse Event|0|||
124448869|NCT04513665|447605798|FG000|Overall Study|Lack of Efficacy|14|||
124448870|NCT04513665|447605799|FG001|Overall Study|Lack of Efficacy|0|||
124448871|NCT02608879|447605816|FG000|Overall Study|Lost to Follow-up|1|||
124448872|NCT02608879|447605817|FG001|Overall Study|Lost to Follow-up|0|||
124448873|NCT02608879|447605818|FG002|Overall Study|Lost to Follow-up|0|||
124448874|NCT02608879|447605816|FG000|Overall Study|Did not meet continuation criteria|0|||
124448875|NCT02608879|447605817|FG001|Overall Study|Did not meet continuation criteria|0|||
124448876|NCT02608879|447605818|FG002|Overall Study|Did not meet continuation criteria|3|||
124448877|NCT00760669|447605819|FG000|Overall Study|Not assessed for overall improvement|18|||
124448878|NCT00760669|447605819|FG000|Overall Study|Participants missing efficacy assessment|6|||
124903544|NCT00970307|449272409|FG002|Overall Study|Withdrawal by Subject|2|||
124903545|NCT00393848|449272416|FG000|Overall Study|Surgical schedule|0|||
124903546|NCT00393848|449272417|FG001|Overall Study|Surgical schedule|0|||
124903547|NCT00393848|449272418|FG002|Overall Study|Surgical schedule|0|||
124903548|NCT00393848|449272419|FG003|Overall Study|Surgical schedule|1|||
124903549|NCT00393848|449272416|FG000|Overall Study|Personal reasons|0|||
124903550|NCT00393848|449272417|FG001|Overall Study|Personal reasons|0|||
124903551|NCT00393848|449272418|FG002|Overall Study|Personal reasons|2|||
124903552|NCT00393848|449272419|FG003|Overall Study|Personal reasons|0|||
124903553|NCT02082158|449272423|FG000|Overall Study|Withdrawal by Subject|0|||
124903554|NCT02082158|449272424|FG001|Overall Study|Withdrawal by Subject|0|||
124903555|NCT02082158|449272425|FG002|Overall Study|Withdrawal by Subject|0|||
124903556|NCT02082158|449272426|FG003|Overall Study|Withdrawal by Subject|0|||
124903557|NCT02082158|449272427|FG004|Overall Study|Withdrawal by Subject|1|||
124903558|NCT02082158|449272428|FG005|Overall Study|Withdrawal by Subject|0|||
124903559|NCT02082158|449272423|FG000|Overall Study|Failed Fit-testing|8|||
124903560|NCT02082158|449272424|FG001|Overall Study|Failed Fit-testing|8|||
124903561|NCT02082158|449272425|FG002|Overall Study|Failed Fit-testing|14|||
124903562|NCT02082158|449272426|FG003|Overall Study|Failed Fit-testing|4|||
124903563|NCT02082158|449272427|FG004|Overall Study|Failed Fit-testing|3|||
124903564|NCT02082158|449272428|FG005|Overall Study|Failed Fit-testing|7|||
124903565|NCT00738699|449272429|FG000|Overall Study|Withdrawal by Subject|5|||
124903566|NCT00738699|449272430|FG001|Overall Study|Withdrawal by Subject|0|||
124903567|NCT00738699|449272429|FG000|Overall Study|Lost to Follow-up|1|||
124903568|NCT00738699|449272430|FG001|Overall Study|Lost to Follow-up|0|||
124903569|NCT00738699|449272429|FG000|Overall Study|Death|144|||
124903570|NCT00738699|449272430|FG001|Overall Study|Death|68|||
124903571|NCT00738699|449272429|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
124903572|NCT00738699|449272430|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
124903573|NCT00738699|449272429|FG000|Overall Study|Other|2|||
124903574|NCT00738699|449272430|FG001|Overall Study|Other|0|||
124903575|NCT00943735|449272441|FG000|Overall Study|Adverse Event|12|||
124448879|NCT00760669|447605819|FG000|Overall Study|Participants with overlapping cases|1|||
124448880|NCT00760669|447605819|FG000|Overall Study|Took drug before entering in contract|5|||
124448881|NCT01572675|447605820|FG000|Overall Study|End of prescribed treatment|140|||
124448882|NCT01572675|447605821|FG001|Overall Study|End of prescribed treatment|118|||
124448883|NCT01572675|447605820|FG000|Overall Study|Recovery|16|||
124448884|NCT01572675|447605821|FG001|Overall Study|Recovery|23|||
124448885|NCT01572675|447605820|FG000|Overall Study|Lack of Efficacy|31|||
124448886|NCT01572675|447605821|FG001|Overall Study|Lack of Efficacy|31|||
124448887|NCT01572675|447605820|FG000|Overall Study|Intolerance|6|||
124448888|NCT01572675|447605821|FG001|Overall Study|Intolerance|5|||
124448889|NCT01572675|447605820|FG000|Overall Study|Improved symptoms|8|||
124448890|NCT01572675|447605821|FG001|Overall Study|Improved symptoms|2|||
124448891|NCT01572675|447605820|FG000|Overall Study|Surgical intervention|3|||
124448892|NCT01572675|447605821|FG001|Overall Study|Surgical intervention|6|||
124448893|NCT01572675|447605820|FG000|Overall Study|Withdrawal by Subject|5|||
124448894|NCT01572675|447605821|FG001|Overall Study|Withdrawal by Subject|1|||
124448895|NCT01572675|447605820|FG000|Overall Study|Physician Decision|2|||
124448896|NCT01572675|447605821|FG001|Overall Study|Physician Decision|2|||
124448897|NCT01572675|447605820|FG000|Overall Study|Death unrelated to coxibs|1|||
124448898|NCT01572675|447605821|FG001|Overall Study|Death unrelated to coxibs|1|||
124448899|NCT01572675|447605820|FG000|Overall Study|Other disease detected|1|||
124448900|NCT01572675|447605821|FG001|Overall Study|Other disease detected|1|||
124448901|NCT01572675|447605820|FG000|Overall Study|Unknown reason|1|||
124448902|NCT01572675|447605821|FG001|Overall Study|Unknown reason|1|||
124448903|NCT01572675|447605820|FG000|Overall Study|Rheumatologist new evaluation|0|||
124448904|NCT01572675|447605821|FG001|Overall Study|Rheumatologist new evaluation|1|||
124448905|NCT01572675|447605820|FG000|Overall Study|Missing data|1|||
124448906|NCT01572675|447605821|FG001|Overall Study|Missing data|4|||
124448907|NCT01572675|447605820|FG000|Overall Study|Lost to Follow-up|22|||
124448908|NCT01572675|447605821|FG001|Overall Study|Lost to Follow-up|27|||
124448909|NCT02966223|447605823|FG000|Overall Study|Physician Decision|3|||
124448910|NCT02966223|447605823|FG000|Overall Study|Withdrawal by Subject|11|||
124448911|NCT02966223|447605823|FG000|Overall Study|Lost to Follow-up|1|||
124448912|NCT02456662|447605825|FG000|Overall Study|Lost to Follow-up|2|||
124448913|NCT02456662|447605826|FG001|Overall Study|Lost to Follow-up|1|||
124903576|NCT00943735|449272441|FG000|Overall Study|Withdrawal by Subject|8|||
124903577|NCT00943735|449272441|FG000|Overall Study|Death|1|||
124903578|NCT00943735|449272441|FG000|Overall Study|Other|8|||
124903579|NCT00943735|449272441|FG000|Overall Study|Other|3|||
124903580|NCT03804918|449272442|FG000|Overall Study|Participant did not use the app|1|||
124903581|NCT01329328|449272443|FG000|Overall Study|Withdrawal by Subject|2|||
124448914|NCT00805025|447605828|FG000|Overall Study|Screened but not enrolled/treated|42|||
124448915|NCT00805025|447605828|FG000|Overall Study|Adverse Event|4|||
124448916|NCT00805025|447605828|FG000|Overall Study|Withdrawal by Subject|2|||
124448917|NCT00805025|447605828|FG000|Overall Study|Physician Decision|1|||
124448918|NCT00375219|447605829|FG000|Overall Study|Failure to achieve a response|16|||
124903582|NCT01329328|449272444|FG001|Overall Study|Withdrawal by Subject|4|||
124903583|NCT01329328|449272445|FG002|Overall Study|Withdrawal by Subject|3|||
124903584|NCT00964366|449272446|FG000|Overall Study|Did not qualify at Day 1|1|||
124903585|NCT00964366|449272447|FG001|Overall Study|Did not qualify at Day 1|0|||
124903586|NCT00964366|449272446|FG000|Overall Study|Withdrawal by Subject|0|||
124903587|NCT00964366|449272447|FG001|Overall Study|Withdrawal by Subject|1|||
124903588|NCT01370694|449272448|FG000|Overall Study|Switched to rituximab|4|||
124903589|NCT01370694|449272448|FG000|Overall Study|Progressive disease|2|||
124903590|NCT02957539|449272449|FG000|Baseline to Week 16|Lost to Follow-up|8|||
124903591|NCT02957539|449272450|FG001|Baseline to Week 16|Lost to Follow-up|10|||
124903592|NCT02957539|449272451|FG002|Baseline to Week 16|Lost to Follow-up|16|||
124903593|NCT02957539|449272449|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
124903594|NCT02957539|449272450|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
124903595|NCT02957539|449272451|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
124903596|NCT02957539|449272449|FG000|Week 16 to 32|Withdrawal by Subject|3|||
124903597|NCT02957539|449272450|FG001|Week 16 to 32|Withdrawal by Subject|3|||
124903598|NCT02957539|449272451|FG002|Week 16 to 32|Withdrawal by Subject|1|||
124903599|NCT02957539|449272449|FG000|Week 16 to 32|Lost to Follow-up|8|||
124903600|NCT02957539|449272450|FG001|Week 16 to 32|Lost to Follow-up|7|||
124903601|NCT02957539|449272451|FG002|Week 16 to 32|Lost to Follow-up|5|||
124903602|NCT02957539|449272449|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
124903603|NCT02957539|449272450|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
124903604|NCT02957539|449272451|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
124903605|NCT02957539|449272449|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
124903606|NCT02957539|449272450|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
124903607|NCT02957539|449272451|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
124903608|NCT01563354|449272454|FG000|Core Phase|Adverse Event|5|||
124903609|NCT01563354|449272455|FG001|Core Phase|Adverse Event|15|||
124903610|NCT01563354|449272456|FG002|Core Phase|Adverse Event|13|||
124903611|NCT01563354|449272454|FG000|Core Phase|Withdrawal by Subject|1|||
124903612|NCT01563354|449272455|FG001|Core Phase|Withdrawal by Subject|0|||
124903613|NCT01563354|449272456|FG002|Core Phase|Withdrawal by Subject|3|||
124903614|NCT01563354|449272454|FG000|Core Phase|Lost to Follow-up|1|||
124903615|NCT01563354|449272455|FG001|Core Phase|Lost to Follow-up|0|||
124903616|NCT01563354|449272456|FG002|Core Phase|Lost to Follow-up|0|||
124903617|NCT01563354|449272454|FG000|Core Phase|Death|1|||
124903618|NCT01563354|449272455|FG001|Core Phase|Death|5|||
124903619|NCT01563354|449272456|FG002|Core Phase|Death|2|||
124903620|NCT01563354|449272454|FG000|Core Phase|Diseasse progression|18|||
124903621|NCT01563354|449272455|FG001|Core Phase|Diseasse progression|7|||
124903622|NCT01563354|449272456|FG002|Core Phase|Diseasse progression|8|||
124903623|NCT01563354|449272454|FG000|Core Phase|Protocol deviation|2|||
124903624|NCT01563354|449272455|FG001|Core Phase|Protocol deviation|0|||
124903625|NCT01563354|449272456|FG002|Core Phase|Protocol deviation|0|||
124903626|NCT01563354|449272454|FG000|Core Phase|PI decision - did not enter extension|0|||
124903627|NCT01563354|449272455|FG001|Core Phase|PI decision - did not enter extension|1|||
124903628|NCT01563354|449272456|FG002|Core Phase|PI decision - did not enter extension|0|||
124903629|NCT01563354|449272454|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
124903630|NCT01563354|449272455|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
124903631|NCT01563354|449272456|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
124903632|NCT01563354|449272454|FG000|Extension Phase|Adverse Event|0|||
124903633|NCT01563354|449272455|FG001|Extension Phase|Adverse Event|3|||
124903634|NCT01563354|449272456|FG002|Extension Phase|Adverse Event|2|||
124903635|NCT01563354|449272454|FG000|Extension Phase|Withdrawal by Subject|0|||
124903636|NCT01563354|449272455|FG001|Extension Phase|Withdrawal by Subject|1|||
124903637|NCT01563354|449272456|FG002|Extension Phase|Withdrawal by Subject|0|||
124903638|NCT01563354|449272454|FG000|Extension Phase|Administration problems|3|||
124903639|NCT01563354|449272455|FG001|Extension Phase|Administration problems|2|||
124903640|NCT01563354|449272456|FG002|Extension Phase|Administration problems|3|||
124903641|NCT01563354|449272454|FG000|Extension Phase|Disease progression|9|||
124903642|NCT01563354|449272455|FG001|Extension Phase|Disease progression|8|||
124903643|NCT01563354|449272456|FG002|Extension Phase|Disease progression|10|||
124903644|NCT01565928|449272457|FG000|Overall Study|Adverse Event|3|||
124903645|NCT01565928|449272457|FG000|Overall Study|Other|3|||
124903646|NCT01565928|449272457|FG000|Overall Study|Progressive Disease|13|||
124903647|NCT01565928|449272457|FG000|Overall Study|Withdrawal by Subject|1|||
124903648|NCT01565928|449272457|FG000|Overall Study|Death|2|||
124903649|NCT01119950|449272458|FG000|Overall Study|Adverse Event|25|||
124903650|NCT01119950|449272458|FG000|Overall Study|Withdrawal by Subject|9|||
124903651|NCT01119950|449272458|FG000|Overall Study|Protocol Violation|5|||
124903652|NCT01119950|449272458|FG000|Overall Study|Lost to Follow-up|4|||
124903653|NCT01119950|449272458|FG000|Overall Study|Administrative|2|||
124903654|NCT01119950|449272458|FG000|Overall Study|Abnormal lab value|1|||
124903655|NCT01119950|449272458|FG000|Overall Study|Death|1|||
124903656|NCT01591616|449272461|FG000|Overall Study|Withdrawal by Subject|1|||
124903657|NCT00855465|449272462|FG000|Treatment Period|Adverse Event|4|||
124903658|NCT00855465|449272463|FG001|Treatment Period|Adverse Event|2|||
124903659|NCT00855465|449272462|FG000|Treatment Period|Death|2|||
124903660|NCT00855465|449272463|FG001|Treatment Period|Death|2|||
124903661|NCT00855465|449272462|FG000|Treatment Period|Lack of Efficacy|2|||
124903662|NCT00855465|449272463|FG001|Treatment Period|Lack of Efficacy|1|||
124903663|NCT00855465|449272462|FG000|Treatment Period|Non-compliance|1|||
124903664|NCT00855465|449272463|FG001|Treatment Period|Non-compliance|0|||
124903665|NCT00855465|449272462|FG000|Treatment Period|Protocol Violation|2|||
124903666|NCT00855465|449272463|FG001|Treatment Period|Protocol Violation|0|||
124903667|NCT00855465|449272462|FG000|Treatment Period|Withdrawal by Subject|2|||
124903668|NCT00855465|449272463|FG001|Treatment Period|Withdrawal by Subject|0|||
124903669|NCT00855465|449272462|FG000|Treatment Period|Not treated|1|||
124903670|NCT00855465|449272463|FG001|Treatment Period|Not treated|0|||
124903671|NCT00855465|449272462|FG000|Follow-up Period (FUP)|Adverse Event|0|||
124903672|NCT00855465|449272463|FG001|Follow-up Period (FUP)|Adverse Event|1|||
124903673|NCT00855465|449272462|FG000|Follow-up Period (FUP)|Death|0|||
124903674|NCT00855465|449272463|FG001|Follow-up Period (FUP)|Death|1|||
124903675|NCT00855465|449272462|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
124903676|NCT00855465|449272463|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
124903677|NCT00855465|449272462|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
124903678|NCT00855465|449272463|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
124903679|NCT00855465|449272462|FG000|Follow-up Period (FUP)|Missing|1|||
124903680|NCT00855465|449272463|FG001|Follow-up Period (FUP)|Missing|0|||
124903681|NCT01157182|449272468|FG000|Washout of 28 Days|Adverse Event|2|||
124903682|NCT01157182|449272469|FG001|Washout of 28 Days|Adverse Event|0|||
124903683|NCT00716144|449272470|FG000|Overall Study|Withdrawal by Subject|4|||
124903684|NCT00716144|449272471|FG001|Overall Study|Withdrawal by Subject|2|||
124903685|NCT00716144|449272472|FG002|Overall Study|Withdrawal by Subject|6|||
124903686|NCT00716144|449272473|FG003|Overall Study|Withdrawal by Subject|6|||
124903687|NCT00716144|449272470|FG000|Overall Study|Lost to Follow-up|2|||
124903688|NCT00716144|449272471|FG001|Overall Study|Lost to Follow-up|2|||
124903689|NCT00716144|449272472|FG002|Overall Study|Lost to Follow-up|1|||
124903690|NCT00716144|449272473|FG003|Overall Study|Lost to Follow-up|2|||
124903691|NCT00716144|449272470|FG000|Overall Study|Adverse Event|0|||
124903692|NCT00716144|449272471|FG001|Overall Study|Adverse Event|0|||
124903693|NCT00716144|449272472|FG002|Overall Study|Adverse Event|0|||
124903694|NCT00716144|449272473|FG003|Overall Study|Adverse Event|2|||
124903695|NCT00716144|449272470|FG000|Overall Study|Non-compliance|1|||
124903696|NCT00716144|449272471|FG001|Overall Study|Non-compliance|0|||
124903697|NCT00716144|449272472|FG002|Overall Study|Non-compliance|0|||
124903698|NCT00716144|449272473|FG003|Overall Study|Non-compliance|0|||
124903699|NCT00716144|449272470|FG000|Overall Study|Protocol Violation|2|||
124903700|NCT00716144|449272471|FG001|Overall Study|Protocol Violation|0|||
124903701|NCT00716144|449272472|FG002|Overall Study|Protocol Violation|1|||
124903702|NCT00716144|449272473|FG003|Overall Study|Protocol Violation|0|||
124903703|NCT00716144|449272470|FG000|Overall Study|Physician Decision|0|||
124903704|NCT00716144|449272471|FG001|Overall Study|Physician Decision|1|||
124903705|NCT00716144|449272472|FG002|Overall Study|Physician Decision|2|||
124903706|NCT00716144|449272473|FG003|Overall Study|Physician Decision|2|||
124903707|NCT00716144|449272470|FG000|Overall Study|Intercurrent illness|0|||
124903708|NCT00716144|449272471|FG001|Overall Study|Intercurrent illness|0|||
124903709|NCT00716144|449272472|FG002|Overall Study|Intercurrent illness|1|||
124903710|NCT00716144|449272473|FG003|Overall Study|Intercurrent illness|0|||
124903711|NCT00716144|449272470|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
124903712|NCT00716144|449272471|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
124903713|NCT00716144|449272472|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
124903714|NCT00716144|449272473|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
124903715|NCT00716144|449272470|FG000|Overall Study|Adverse event: left foot pain|0|||
124903716|NCT00716144|449272471|FG001|Overall Study|Adverse event: left foot pain|1|||
124903717|NCT00716144|449272472|FG002|Overall Study|Adverse event: left foot pain|0|||
124903718|NCT00716144|449272473|FG003|Overall Study|Adverse event: left foot pain|0|||
124903719|NCT00716144|449272470|FG000|Overall Study|Clinical Depression|0|||
124903720|NCT00716144|449272471|FG001|Overall Study|Clinical Depression|1|||
124903721|NCT00716144|449272472|FG002|Overall Study|Clinical Depression|0|||
124903722|NCT00716144|449272473|FG003|Overall Study|Clinical Depression|0|||
124903723|NCT00909363|449272474|FG000|Overall Study|Withdrawal by Subject|1|||
124903724|NCT00909363|449272475|FG001|Overall Study|Withdrawal by Subject|0|||
124903725|NCT00909363|449272476|FG002|Overall Study|Withdrawal by Subject|0|||
124448919|NCT00375219|447605830|FG001|Overall Study|Failure to achieve a response|2|||
124448920|NCT00375219|447605831|FG002|Overall Study|Failure to achieve a response|0|||
124448921|NCT00375219|447605829|FG000|Overall Study|Adverse Event|8|||
124448922|NCT00375219|447605830|FG001|Overall Study|Adverse Event|2|||
124448923|NCT00375219|447605831|FG002|Overall Study|Adverse Event|1|||
124448924|NCT00375219|447605829|FG000|Overall Study|Protocol Violation|1|||
124448925|NCT00375219|447605830|FG001|Overall Study|Protocol Violation|0|||
124448926|NCT00375219|447605831|FG002|Overall Study|Protocol Violation|1|||
124448927|NCT00375219|447605829|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
124448928|NCT00375219|447605830|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
124448929|NCT00375219|447605831|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
124448930|NCT00375219|447605829|FG000|Overall Study|Lost to Follow-up|1|||
124448931|NCT00375219|447605830|FG001|Overall Study|Lost to Follow-up|1|||
124448932|NCT00375219|447605831|FG002|Overall Study|Lost to Follow-up|0|||
124448933|NCT00375219|447605829|FG000|Overall Study|Disease progression|18|||
124448934|NCT00375219|447605830|FG001|Overall Study|Disease progression|9|||
124448935|NCT00375219|447605831|FG002|Overall Study|Disease progression|12|||
124448936|NCT00375219|447605829|FG000|Overall Study|Death|4|||
124448937|NCT00375219|447605830|FG001|Overall Study|Death|3|||
124448938|NCT00375219|447605831|FG002|Overall Study|Death|7|||
124448939|NCT00375219|447605829|FG000|Overall Study|Hematologic resistance|1|||
124448940|NCT00375219|447605830|FG001|Overall Study|Hematologic resistance|0|||
124448941|NCT00375219|447605831|FG002|Overall Study|Hematologic resistance|0|||
124448942|NCT00375219|447605829|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
124448943|NCT00375219|447605830|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
124448944|NCT00375219|447605831|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
124691366|NCT04433975|448490049|FG001|12-month Follow Up|Lost to Follow-up|31|||
124691367|NCT04606771|448490050|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
124691368|NCT04606771|448490051|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
124691369|NCT04606771|448490050|FG000|Overall Study|Death|5|||
124691370|NCT04606771|448490051|FG001|Overall Study|Death|6|||
124691371|NCT04606771|448490050|FG000|Overall Study|Wrong randomisation|0|||
124448945|NCT00375219|447605829|FG000|Overall Study|Allograft|2|||
124448946|NCT00375219|447605830|FG001|Overall Study|Allograft|0|||
124448947|NCT00375219|447605831|FG002|Overall Study|Allograft|0|||
124448948|NCT00375219|447605829|FG000|Overall Study|Cord blood transplantation|1|||
124448949|NCT00375219|447605830|FG001|Overall Study|Cord blood transplantation|0|||
124448950|NCT00375219|447605831|FG002|Overall Study|Cord blood transplantation|0|||
124448951|NCT00375219|447605829|FG000|Overall Study|Withdrawal by Subject|1|||
124448952|NCT00375219|447605830|FG001|Overall Study|Withdrawal by Subject|0|||
124448953|NCT00375219|447605831|FG002|Overall Study|Withdrawal by Subject|0|||
124448954|NCT03007979|447605836|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
124448955|NCT00482703|447605837|FG000|Overall Study|Poor compliance|1|||
124448956|NCT00482703|447605838|FG001|Overall Study|Poor compliance|0|||
124448957|NCT01428661|447605839|FG000|Double-Masked Phase|Protocol Violation|9|||
124448958|NCT01428661|447605840|FG001|Double-Masked Phase|Protocol Violation|4|||
124448959|NCT01428661|447605841|FG002|Double-Masked Phase|Protocol Violation|0|||
124448960|NCT01428661|447605839|FG000|Double-Masked Phase|Adverse Event|13|||
124448961|NCT01428661|447605840|FG001|Double-Masked Phase|Adverse Event|4|||
124448962|NCT01428661|447605841|FG002|Double-Masked Phase|Adverse Event|0|||
124448963|NCT01428661|447605839|FG000|Double-Masked Phase|Lost to Follow-up|14|||
124448964|NCT01428661|447605840|FG001|Double-Masked Phase|Lost to Follow-up|14|||
124448965|NCT01428661|447605841|FG002|Double-Masked Phase|Lost to Follow-up|0|||
124448966|NCT01428661|447605839|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
124448967|NCT01428661|447605840|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
124448968|NCT01428661|447605841|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
124448969|NCT01428661|447605839|FG000|Double-Masked Phase|Lack of Efficacy|2|||
124448970|NCT01428661|447605840|FG001|Double-Masked Phase|Lack of Efficacy|1|||
124448971|NCT01428661|447605841|FG002|Double-Masked Phase|Lack of Efficacy|0|||
124448972|NCT01428661|447605839|FG000|Double-Masked Phase|*Various|1|||
124448973|NCT01428661|447605840|FG001|Double-Masked Phase|*Various|6|||
124448974|NCT01428661|447605841|FG002|Double-Masked Phase|*Various|0|||
124448975|NCT01428661|447605839|FG000|Open Label Extension|Protocol Violation|0|||
124448976|NCT01428661|447605840|FG001|Open Label Extension|Protocol Violation|0|||
124448977|NCT01428661|447605841|FG002|Open Label Extension|Protocol Violation|9|||
124691372|NCT04606771|448490051|FG001|Overall Study|Wrong randomisation|1|||
124691373|NCT04392635|448490054|FG000|Overall Study|Lost to Follow-up|0|||
124448978|NCT01428661|447605839|FG000|Open Label Extension|Adverse Event|0|||
124448979|NCT01428661|447605840|FG001|Open Label Extension|Adverse Event|0|||
124448980|NCT01428661|447605841|FG002|Open Label Extension|Adverse Event|15|||
124448981|NCT01428661|447605839|FG000|Open Label Extension|Lost to Follow-up|0|||
124448982|NCT01428661|447605840|FG001|Open Label Extension|Lost to Follow-up|0|||
124448983|NCT01428661|447605841|FG002|Open Label Extension|Lost to Follow-up|38|||
124448984|NCT01428661|447605839|FG000|Open Label Extension|Withdrawal by Subject|0|||
124448985|NCT01428661|447605840|FG001|Open Label Extension|Withdrawal by Subject|0|||
124691374|NCT04392635|448490055|FG001|Overall Study|Lost to Follow-up|1|||
124691375|NCT02030418|448490056|FG000|Overall Study|Death|78|||
124903726|NCT00909363|449272474|FG000|Overall Study|Lack of Efficacy|1|||
124903727|NCT00909363|449272475|FG001|Overall Study|Lack of Efficacy|0|||
124903728|NCT00909363|449272476|FG002|Overall Study|Lack of Efficacy|0|||
124448986|NCT01428661|447605841|FG002|Open Label Extension|Withdrawal by Subject|49|||
124448987|NCT01428661|447605839|FG000|Open Label Extension|Lack of Efficacy|0|||
124903729|NCT05641311|449272477|FG000|Dosing Period 1|Adverse Event|1|||
124448988|NCT01428661|447605840|FG001|Open Label Extension|Lack of Efficacy|0|||
124448989|NCT01428661|447605841|FG002|Open Label Extension|Lack of Efficacy|24|||
124448990|NCT01428661|447605839|FG000|Open Label Extension|**Various|0|||
124448991|NCT01428661|447605840|FG001|Open Label Extension|**Various|0|||
124448992|NCT01428661|447605841|FG002|Open Label Extension|**Various|185|||
124448993|NCT00972777|447605842|FG000|Overall Study|Adverse Event|3|||
124448994|NCT00972777|447605843|FG001|Overall Study|Adverse Event|2|||
124448995|NCT00972777|447605842|FG000|Overall Study|Lost to Follow-up|0|||
124448996|NCT00972777|447605843|FG001|Overall Study|Lost to Follow-up|4|||
124691376|NCT02030418|448490056|FG000|Overall Study|Missed 12-Month Visit|9|||
124691377|NCT02030418|448490056|FG000|Overall Study|Withdrawn|57|||
124903730|NCT05641311|449272478|FG001|Dosing Period 1|Adverse Event|0|||
124903731|NCT00367055|449272480|FG000|Overall Study|Adverse Event|6|||
124903732|NCT00367055|449272481|FG001|Overall Study|Adverse Event|3|||
124903733|NCT00367055|449272480|FG000|Overall Study|Patient's Willing|3|||
124903734|NCT00367055|449272481|FG001|Overall Study|Patient's Willing|2|||
124903735|NCT00367055|449272480|FG000|Overall Study|Lack of Efficacy|1|||
124903736|NCT00367055|449272481|FG001|Overall Study|Lack of Efficacy|2|||
124903737|NCT00367055|449272480|FG000|Overall Study|Lost to Follow-up|1|||
124448997|NCT00972777|447605842|FG000|Overall Study|Withdrawal by Subject|4|||
124448998|NCT00972777|447605843|FG001|Overall Study|Withdrawal by Subject|5|||
124448999|NCT00972777|447605842|FG000|Overall Study|Physician Decision|4|||
124449000|NCT00972777|447605843|FG001|Overall Study|Physician Decision|0|||
124449001|NCT00972777|447605842|FG000|Overall Study|Protocol Violation|0|||
124449002|NCT00972777|447605843|FG001|Overall Study|Protocol Violation|2|||
124449003|NCT00972777|447605842|FG000|Overall Study|Screening Failure|2|||
124449004|NCT00972777|447605843|FG001|Overall Study|Screening Failure|1|||
124449005|NCT00972777|447605842|FG000|Overall Study|Missed visit|1|||
124449006|NCT00972777|447605843|FG001|Overall Study|Missed visit|0|||
124449007|NCT03523728|447606871|FG000|Stage 1 (24 Months)|Adverse Event|2|||
124449008|NCT03523728|447606872|FG001|Stage 1 (24 Months)|Adverse Event|2|||
124449009|NCT03523728|447606873|FG002|Stage 1 (24 Months)|Adverse Event|4|||
124449010|NCT03523728|447606874|FG003|Stage 1 (24 Months)|Adverse Event|0|||
124449011|NCT03523728|447606875|FG004|Stage 1 (24 Months)|Adverse Event|0|||
124449012|NCT03523728|447606871|FG000|Stage 1 (24 Months)|Progressive disease|0|||
124449013|NCT03523728|447606872|FG001|Stage 1 (24 Months)|Progressive disease|0|||
124449014|NCT03523728|447606873|FG002|Stage 1 (24 Months)|Progressive disease|1|||
124449015|NCT03523728|447606874|FG003|Stage 1 (24 Months)|Progressive disease|0|||
124449016|NCT03523728|447606875|FG004|Stage 1 (24 Months)|Progressive disease|0|||
124449017|NCT03523728|447606871|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
124449018|NCT03523728|447606872|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
124449019|NCT03523728|447606873|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
124449020|NCT03523728|447606874|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
124449021|NCT03523728|447606875|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
124449022|NCT03523728|447606871|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
124449023|NCT03523728|447606872|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
124449024|NCT03523728|447606873|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
124449025|NCT03523728|447606874|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
124449026|NCT03523728|447606875|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
124449027|NCT03523728|447606871|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
124449028|NCT03523728|447606872|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
124449029|NCT03523728|447606873|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
124449030|NCT03523728|447606874|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
124449031|NCT03523728|447606875|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
124449032|NCT03523728|447606871|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
124449033|NCT03523728|447606872|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
124449034|NCT03523728|447606873|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
124691378|NCT00888849|448490057|FG000|Overall Study|Death|4|||
124903738|NCT00367055|449272481|FG001|Overall Study|Lost to Follow-up|1|||
124449035|NCT03523728|447606874|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
124903739|NCT00367055|449272480|FG000|Overall Study|Protocol Violation|0|||
124449036|NCT03523728|447606875|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
124449037|NCT03523728|447606871|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
124449038|NCT03523728|447606872|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
124449039|NCT03523728|447606873|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
124691379|NCT00888849|448490058|FG001|Overall Study|Death|7|||
124691380|NCT00888849|448490057|FG000|Overall Study|Lost to Follow-up|1|||
124903740|NCT00367055|449272481|FG001|Overall Study|Protocol Violation|1|||
124449040|NCT03523728|447606874|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
124449041|NCT03523728|447606875|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
124903741|NCT00367055|449272480|FG000|Overall Study|Stopping Criterion Met|0|||
124691381|NCT00888849|448490058|FG001|Overall Study|Lost to Follow-up|2|||
124691382|NCT04149353|448490064|FG000|Overall Study|Study terminated|1|||
124691383|NCT02068599|448490065|FG000|Overall Study|Adverse Event|4|||
124691384|NCT02068599|448490066|FG001|Overall Study|Adverse Event|1|||
124691385|NCT02068599|448490067|FG002|Overall Study|Adverse Event|1|||
124691386|NCT02068599|448490065|FG000|Overall Study|Withdrawal by Subject|2|||
124691387|NCT02068599|448490066|FG001|Overall Study|Withdrawal by Subject|7|||
124691388|NCT02068599|448490067|FG002|Overall Study|Withdrawal by Subject|5|||
124691389|NCT02068599|448490065|FG000|Overall Study|Protocol Violation|4|||
124691390|NCT02068599|448490066|FG001|Overall Study|Protocol Violation|2|||
124691391|NCT02068599|448490067|FG002|Overall Study|Protocol Violation|3|||
124691392|NCT02068599|448490065|FG000|Overall Study|Lost to Follow-up|1|||
124691393|NCT02068599|448490066|FG001|Overall Study|Lost to Follow-up|0|||
124691394|NCT02068599|448490067|FG002|Overall Study|Lost to Follow-up|0|||
124691395|NCT02068599|448490065|FG000|Overall Study|Lack of Efficacy|0|||
124691396|NCT02068599|448490066|FG001|Overall Study|Lack of Efficacy|0|||
124691397|NCT02068599|448490067|FG002|Overall Study|Lack of Efficacy|3|||
124691398|NCT02068599|448490065|FG000|Overall Study|Noncompliance|0|||
124691399|NCT02068599|448490066|FG001|Overall Study|Noncompliance|0|||
124691400|NCT02068599|448490067|FG002|Overall Study|Noncompliance|1|||
124691401|NCT00356421|448490071|FG000|Overall Study|Lack of Efficacy|3|||
124691402|NCT00356421|448490072|FG001|Overall Study|Lack of Efficacy|0|||
124691403|NCT00356421|448490071|FG000|Overall Study|Withdrawal by Subject|9|||
124691404|NCT00356421|448490072|FG001|Overall Study|Withdrawal by Subject|2|||
124903742|NCT00367055|449272481|FG001|Overall Study|Stopping Criterion Met|1|||
124903743|NCT00367055|449272480|FG000|Overall Study|Participant Living too Far from Hospital|0|||
124903744|NCT00367055|449272481|FG001|Overall Study|Participant Living too Far from Hospital|1|||
124903745|NCT02459899|449272482|FG000|Overall Study|Adverse Event|1|||
124903746|NCT02459899|449272483|FG001|Overall Study|Adverse Event|1|||
124903747|NCT02459899|449272484|FG002|Overall Study|Adverse Event|0|||
124903748|NCT02459899|449272485|FG003|Overall Study|Adverse Event|0|||
124903749|NCT02459899|449272482|FG000|Overall Study|Lost to Follow-up|1|||
124903750|NCT02459899|449272483|FG001|Overall Study|Lost to Follow-up|2|||
124903751|NCT02459899|449272484|FG002|Overall Study|Lost to Follow-up|0|||
124903752|NCT02459899|449272485|FG003|Overall Study|Lost to Follow-up|1|||
124903753|NCT02459899|449272482|FG000|Overall Study|Non-compliance with the treatment|0|||
124903754|NCT02459899|449272483|FG001|Overall Study|Non-compliance with the treatment|0|||
124903755|NCT02459899|449272484|FG002|Overall Study|Non-compliance with the treatment|0|||
124903756|NCT02459899|449272485|FG003|Overall Study|Non-compliance with the treatment|1|||
124903757|NCT02459899|449272482|FG000|Overall Study|Withdrawal by Subject|1|||
124903758|NCT02459899|449272483|FG001|Overall Study|Withdrawal by Subject|3|||
124903759|NCT02459899|449272484|FG002|Overall Study|Withdrawal by Subject|0|||
124903760|NCT02459899|449272485|FG003|Overall Study|Withdrawal by Subject|0|||
124903761|NCT03612804|449272502|FG000|Overall Study|Death|0|||
124903762|NCT03612804|449272503|FG001|Overall Study|Death|7|||
124903763|NCT03612804|449272504|FG002|Overall Study|Death|0|||
124903764|NCT03612804|449272505|FG003|Overall Study|Death|8|||
124903765|NCT03612804|449272502|FG000|Overall Study|Medication copay coverage issues|0|||
124691405|NCT00356421|448490071|FG000|Overall Study|Related to study drug|15|||
124760043|NCT02219464|448746739|FG000|Overall Study|catheter malfunction|1|||
124760044|NCT02219464|448746740|FG001|Overall Study|catheter malfunction|0|||
124903766|NCT03612804|449272503|FG001|Overall Study|Medication copay coverage issues|0|||
124903767|NCT03612804|449272504|FG002|Overall Study|Medication copay coverage issues|0|||
124903768|NCT03612804|449272505|FG003|Overall Study|Medication copay coverage issues|17|||
124449042|NCT03523728|447606871|FG000|Stage 2 (24 Months)|Adverse Event|0|||
124449043|NCT03523728|447606872|FG001|Stage 2 (24 Months)|Adverse Event|0|||
124449044|NCT03523728|447606873|FG002|Stage 2 (24 Months)|Adverse Event|0|||
124449045|NCT03523728|447606874|FG003|Stage 2 (24 Months)|Adverse Event|1|||
124449046|NCT03523728|447606875|FG004|Stage 2 (24 Months)|Adverse Event|2|||
124449047|NCT03523728|447606871|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
124449048|NCT03523728|447606872|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
124449049|NCT03523728|447606873|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
124449050|NCT03523728|447606874|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
124449051|NCT03523728|447606875|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
124449052|NCT03523728|447606871|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
124449053|NCT03523728|447606872|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
124449054|NCT03523728|447606873|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
124449055|NCT03523728|447606874|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
124449056|NCT03523728|447606875|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
124449057|NCT03523728|447606871|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
124449058|NCT03523728|447606872|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
124449059|NCT03523728|447606873|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
124449060|NCT03523728|447606874|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
124449061|NCT03523728|447606875|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
124903769|NCT03612804|449272502|FG000|Overall Study|Not current smoker at time of screening|0|||
124449062|NCT03523728|447606871|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
124544396|NCT00948896|447946798|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
124544397|NCT00948896|447946799|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
124544398|NCT00948896|447946800|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
124544399|NCT00948896|447946793|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
124544400|NCT00948896|447946794|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
124544401|NCT00948896|447946795|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
124544402|NCT00948896|447946796|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
124544403|NCT00948896|447946797|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
124544404|NCT00948896|447946798|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
124544405|NCT00948896|447946799|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
124544406|NCT00948896|447946800|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
124544407|NCT00948896|447946793|FG000|24 Months of Age to 36 Months of Age|Death|0|||
124544408|NCT00948896|447946794|FG001|24 Months of Age to 36 Months of Age|Death|2|||
124544409|NCT00948896|447946795|FG002|24 Months of Age to 36 Months of Age|Death|2|||
124544410|NCT00948896|447946796|FG003|24 Months of Age to 36 Months of Age|Death|0|||
124544411|NCT00948896|447946797|FG004|24 Months of Age to 36 Months of Age|Death|0|||
124544412|NCT00948896|447946798|FG005|24 Months of Age to 36 Months of Age|Death|1|||
124544413|NCT00948896|447946799|FG006|24 Months of Age to 36 Months of Age|Death|0|||
124544414|NCT00948896|447946800|FG007|24 Months of Age to 36 Months of Age|Death|0|||
124544415|NCT00948896|447946793|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
124544416|NCT00948896|447946794|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
124544417|NCT00948896|447946795|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
124544418|NCT00948896|447946796|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
124544419|NCT00948896|447946797|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
124544420|NCT00948896|447946798|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
124544421|NCT00948896|447946799|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
124544422|NCT00948896|447946800|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
124544423|NCT00948896|447946793|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
124544424|NCT00948896|447946794|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
124544425|NCT00948896|447946795|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
124544426|NCT00948896|447946796|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
124544427|NCT00948896|447946797|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
124544428|NCT00948896|447946798|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
124544429|NCT00948896|447946799|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
124544430|NCT00948896|447946800|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
124544431|NCT00948896|447946793|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
124544432|NCT00948896|447946794|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
124544433|NCT00948896|447946795|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
124544434|NCT00948896|447946796|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
124544435|NCT00948896|447946797|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
124544436|NCT00948896|447946798|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
124544437|NCT00948896|447946799|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
124544438|NCT00948896|447946800|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
124544439|NCT00948896|447946793|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
124544440|NCT00948896|447946794|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
124544441|NCT00948896|447946795|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
124544442|NCT00948896|447946796|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
124544443|NCT00948896|447946797|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
124544444|NCT00948896|447946798|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
124544445|NCT00948896|447946799|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
124544446|NCT00948896|447946800|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
124691406|NCT00356421|448490072|FG001|Overall Study|Related to study drug|12|||
124691407|NCT00356421|448490071|FG000|Overall Study|Not related to study drug|5|||
124691408|NCT00356421|448490072|FG001|Overall Study|Not related to study drug|3|||
124691409|NCT00887588|448490073|FG000|Core Period|Death|1|||
124903770|NCT03612804|449272503|FG001|Overall Study|Not current smoker at time of screening|1|||
124903771|NCT03612804|449272504|FG002|Overall Study|Not current smoker at time of screening|0|||
124903772|NCT03612804|449272505|FG003|Overall Study|Not current smoker at time of screening|3|||
124903773|NCT03612804|449272502|FG000|Overall Study|Non-veteran status|0|||
124903774|NCT03612804|449272503|FG001|Overall Study|Non-veteran status|1|||
124903775|NCT03612804|449272504|FG002|Overall Study|Non-veteran status|0|||
124903776|NCT03612804|449272505|FG003|Overall Study|Non-veteran status|0|||
124903777|NCT03612804|449272502|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
124903778|NCT03612804|449272503|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
124903779|NCT03612804|449272504|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
124903780|NCT03612804|449272505|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
124903781|NCT03612804|449272502|FG000|Overall Study|Provider retired from VA|0|||
124903782|NCT03612804|449272503|FG001|Overall Study|Provider retired from VA|0|||
124903783|NCT03612804|449272504|FG002|Overall Study|Provider retired from VA|2|||
124903784|NCT03612804|449272505|FG003|Overall Study|Provider retired from VA|0|||
124903785|NCT03612804|449272502|FG000|Overall Study|Withdrawal by Subject|0|||
124903786|NCT03612804|449272503|FG001|Overall Study|Withdrawal by Subject|0|||
124903787|NCT03612804|449272504|FG002|Overall Study|Withdrawal by Subject|7|||
124903788|NCT03612804|449272505|FG003|Overall Study|Withdrawal by Subject|0|||
124903789|NCT03612804|449272502|FG000|Overall Study|Provider involved with study activities|1|||
124903790|NCT03612804|449272503|FG001|Overall Study|Provider involved with study activities|0|||
124903791|NCT03612804|449272504|FG002|Overall Study|Provider involved with study activities|0|||
124903792|NCT03612804|449272505|FG003|Overall Study|Provider involved with study activities|0|||
124903793|NCT05019729|449272513|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
124903794|NCT05019729|449272514|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
124903795|NCT05019729|449272515|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
124903796|NCT05019729|449272516|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
124903797|NCT05019729|449272517|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
124903798|NCT05019729|449272518|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
124903799|NCT00038103|449272523|FG000|Overall Study|Adverse Event|5|||
124903800|NCT00038103|449272524|FG001|Overall Study|Adverse Event|6|||
124903801|NCT00038103|449272523|FG000|Overall Study|Lack of Efficacy|48|||
124903802|NCT00038103|449272524|FG001|Overall Study|Lack of Efficacy|41|||
124903803|NCT00038103|449272523|FG000|Overall Study|Withdrawal by Subject|0|||
124903804|NCT00038103|449272524|FG001|Overall Study|Withdrawal by Subject|3|||
124903805|NCT00038103|449272523|FG000|Overall Study|Lost to Follow-up|0|||
124903806|NCT00038103|449272524|FG001|Overall Study|Lost to Follow-up|3|||
124903807|NCT00038103|449272523|FG000|Overall Study|Protocol Violation|0|||
124903808|NCT00038103|449272524|FG001|Overall Study|Protocol Violation|2|||
124903809|NCT00038103|449272523|FG000|Overall Study|Sponsor Decision|0|||
124903810|NCT00038103|449272524|FG001|Overall Study|Sponsor Decision|1|||
124903811|NCT00038103|449272523|FG000|Overall Study|Randomized/never treated|2|||
124903812|NCT00038103|449272524|FG001|Overall Study|Randomized/never treated|0|||
124903813|NCT03545984|449272527|FG000|Overall Study|CSF cases not present during rotation|11|||
124903814|NCT03545984|449272528|FG001|Overall Study|CSF cases not present during rotation|9|||
124903815|NCT00387465|449272529|FG000|Overall Study|Withdrawal by Subject|0|||
124903816|NCT00387465|449272530|FG001|Overall Study|Withdrawal by Subject|1|||
124903817|NCT00387465|449272531|FG002|Overall Study|Withdrawal by Subject|0|||
124903818|NCT01212757|449272537|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
124903819|NCT01212757|449272538|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
124903820|NCT01212757|449272539|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
124903821|NCT01212757|449272540|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124903822|NCT01212757|449272541|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124903823|NCT01212757|449272542|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124903824|NCT01212757|449272543|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124903825|NCT01212757|449272544|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124903826|NCT01212757|449272545|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124903827|NCT01212757|449272537|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
124903828|NCT01212757|449272538|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
124903829|NCT01212757|449272539|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
124903830|NCT01212757|449272540|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124903831|NCT01212757|449272541|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124903832|NCT01212757|449272542|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124903833|NCT01212757|449272543|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124903834|NCT01212757|449272544|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124903835|NCT01212757|449272545|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124903836|NCT01212757|449272537|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
124903837|NCT01212757|449272538|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
124903838|NCT01212757|449272539|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
124903839|NCT01212757|449272540|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124903840|NCT01212757|449272541|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124903841|NCT01212757|449272542|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124903842|NCT01212757|449272543|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124903843|NCT01212757|449272544|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124903844|NCT01212757|449272545|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124691410|NCT00887588|448490074|FG001|Core Period|Death|1|||
124903845|NCT01212757|449272537|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
124903846|NCT01212757|449272538|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124903847|NCT01212757|449272539|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
124903848|NCT01212757|449272540|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124903849|NCT01212757|449272541|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124903850|NCT01212757|449272542|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124903851|NCT01212757|449272543|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124903852|NCT01212757|449272544|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124903853|NCT01212757|449272545|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124903854|NCT01212757|449272537|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
124903855|NCT01212757|449272538|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
124903856|NCT01212757|449272539|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
124449063|NCT03523728|447606872|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
124449064|NCT03523728|447606873|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
124449065|NCT03523728|447606874|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
124449066|NCT03523728|447606875|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
124449067|NCT00621751|447606876|FG000|Overall Study|Adverse Event|0|||
124449068|NCT00621751|447606877|FG001|Overall Study|Adverse Event|1|||
124449069|NCT01950247|447606879|FG000|Overall Study|Withdrawal by Subject|28|||
124449070|NCT01950247|447606880|FG001|Overall Study|Withdrawal by Subject|13|||
124449071|NCT01950247|447606879|FG000|Overall Study|Lost to Follow-up|18|||
124449072|NCT01950247|447606880|FG001|Overall Study|Lost to Follow-up|16|||
124449073|NCT01950247|447606879|FG000|Overall Study|Physician Decision|3|||
124449074|NCT01950247|447606880|FG001|Overall Study|Physician Decision|4|||
124449075|NCT01950247|447606879|FG000|Overall Study|Adverse Event|3|||
124449076|NCT01950247|447606880|FG001|Overall Study|Adverse Event|2|||
124449077|NCT01950247|447606879|FG000|Overall Study|Death|1|||
124449078|NCT01950247|447606880|FG001|Overall Study|Death|1|||
124449079|NCT01950247|447606879|FG000|Overall Study|Not Defined|4|||
124449080|NCT01950247|447606880|FG001|Overall Study|Not Defined|10|||
124449081|NCT00710879|447606883|FG000|Overall Study|Lost to Follow-up|2|||
124449082|NCT00710879|447606884|FG001|Overall Study|Lost to Follow-up|1|||
124449083|NCT00710879|447606883|FG000|Overall Study|Protocol Violation|0|||
124449084|NCT00710879|447606884|FG001|Overall Study|Protocol Violation|3|||
124449085|NCT01809132|447606885|FG000|Overall Study|Withdrawal by Subject|0|||
124449086|NCT01809132|447606886|FG001|Overall Study|Withdrawal by Subject|0|||
124449087|NCT01809132|447606887|FG002|Overall Study|Withdrawal by Subject|1|||
124449088|NCT00434421|447606888|FG000|Overall Study|Withdrawal by Subject|1|||
124449089|NCT00434421|447606888|FG000|Overall Study|Non-compliance with study treatment|1|||
124449090|NCT01688466|447606889|FG000|Overall Study|Withdrawal by Subject|2|||
124449091|NCT01688466|447606890|FG001|Overall Study|Withdrawal by Subject|1|||
124449092|NCT01688466|447606889|FG000|Overall Study|Death|0|||
124449093|NCT01688466|447606890|FG001|Overall Study|Death|1|||
124449094|NCT01688466|447606889|FG000|Overall Study|Adverse Event|0|||
124449095|NCT01688466|447606890|FG001|Overall Study|Adverse Event|4|||
124449096|NCT01688466|447606889|FG000|Overall Study|Not evaluable|0|||
124449097|NCT01688466|447606890|FG001|Overall Study|Not evaluable|1|||
124449098|NCT01205438|447606891|FG000|Overall Study|Adverse Event|19|||
124449099|NCT01205438|447606892|FG001|Overall Study|Adverse Event|17|||
124449100|NCT01205438|447606893|FG002|Overall Study|Adverse Event|24|||
124449101|NCT01205438|447606891|FG000|Overall Study|Death|1|||
124449102|NCT01205438|447606892|FG001|Overall Study|Death|1|||
124449103|NCT01205438|447606893|FG002|Overall Study|Death|3|||
124449104|NCT01205438|447606891|FG000|Overall Study|Entry Criteria Not Met|16|||
124449105|NCT01205438|447606892|FG001|Overall Study|Entry Criteria Not Met|15|||
124449106|NCT01205438|447606893|FG002|Overall Study|Entry Criteria Not Met|13|||
124449107|NCT01205438|447606891|FG000|Overall Study|Lack of Efficacy|14|||
124449108|NCT01205438|447606892|FG001|Overall Study|Lack of Efficacy|11|||
124449109|NCT01205438|447606893|FG002|Overall Study|Lack of Efficacy|14|||
124449110|NCT01205438|447606891|FG000|Overall Study|Lost to Follow-up|6|||
124449111|NCT01205438|447606892|FG001|Overall Study|Lost to Follow-up|7|||
124449112|NCT01205438|447606893|FG002|Overall Study|Lost to Follow-up|8|||
124449113|NCT01205438|447606891|FG000|Overall Study|Withdrawal by Subject|19|||
124449114|NCT01205438|447606892|FG001|Overall Study|Withdrawal by Subject|25|||
124449115|NCT01205438|447606893|FG002|Overall Study|Withdrawal by Subject|19|||
124449116|NCT01205438|447606891|FG000|Overall Study|Physician Decision|0|||
124449117|NCT01205438|447606892|FG001|Overall Study|Physician Decision|3|||
124449118|NCT01205438|447606893|FG002|Overall Study|Physician Decision|2|||
124449119|NCT01205438|447606891|FG000|Overall Study|Protocol Violation|2|||
124449120|NCT01205438|447606892|FG001|Overall Study|Protocol Violation|7|||
124449121|NCT01205438|447606893|FG002|Overall Study|Protocol Violation|4|||
124449122|NCT01205438|447606891|FG000|Overall Study|Sponsor Decision|0|||
124449123|NCT01205438|447606892|FG001|Overall Study|Sponsor Decision|1|||
124449124|NCT01205438|447606893|FG002|Overall Study|Sponsor Decision|1|||
124449125|NCT00884325|447606909|FG000|Overall Study|Lost to Follow-up|1|||
124449126|NCT00884325|447606910|FG001|Overall Study|Lost to Follow-up|2|||
124903857|NCT01212757|449272540|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124903858|NCT01212757|449272541|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124903859|NCT01212757|449272542|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124903860|NCT01212757|449272543|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124903861|NCT01212757|449272544|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124903862|NCT01212757|449272545|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124903863|NCT01212757|449272537|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124903864|NCT01212757|449272538|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
124903865|NCT01212757|449272539|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
124903866|NCT01212757|449272540|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124903867|NCT01212757|449272541|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124903868|NCT01212757|449272542|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124903869|NCT01212757|449272543|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124903870|NCT01212757|449272544|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124903871|NCT01212757|449272545|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124903872|NCT01212757|449272537|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
124903873|NCT01212757|449272538|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
124903874|NCT01212757|449272539|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124903875|NCT01212757|449272540|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124903876|NCT01212757|449272541|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124903877|NCT01212757|449272542|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124903878|NCT01212757|449272543|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124903879|NCT01212757|449272544|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124903880|NCT01212757|449272545|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124903881|NCT01212757|449272537|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
124903882|NCT01212757|449272538|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
124903883|NCT01212757|449272539|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
124903884|NCT01212757|449272540|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
124903885|NCT01212757|449272541|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
124903886|NCT01212757|449272542|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
124903887|NCT01212757|449272543|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
124903888|NCT01212757|449272544|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
124903889|NCT01212757|449272545|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
124903890|NCT01212757|449272537|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
124903891|NCT01212757|449272538|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
124903892|NCT01212757|449272539|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
124903893|NCT01212757|449272540|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
124903894|NCT01212757|449272541|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
124903895|NCT01212757|449272542|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
124903896|NCT01212757|449272543|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
124903897|NCT01212757|449272544|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
124903898|NCT01212757|449272545|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
124903899|NCT01212757|449272537|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
124903900|NCT01212757|449272538|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
124903901|NCT01212757|449272539|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
124903902|NCT01212757|449272540|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
124903903|NCT01212757|449272541|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
124903904|NCT01212757|449272542|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
124903905|NCT01212757|449272543|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
124903906|NCT01212757|449272544|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
124903907|NCT01212757|449272545|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
124903908|NCT01212757|449272537|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
124903909|NCT01212757|449272538|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
124903910|NCT01212757|449272539|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
124903911|NCT01212757|449272540|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
124903912|NCT01212757|449272541|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
124903913|NCT01212757|449272542|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
124903914|NCT01212757|449272543|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
124903915|NCT01212757|449272544|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
124903916|NCT01212757|449272545|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
124903917|NCT01212757|449272537|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
124903918|NCT01212757|449272538|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
124903919|NCT01212757|449272539|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
124903920|NCT01212757|449272540|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
124544447|NCT03795233|447946801|FG000|Overall Study|Withdrawal by Subject|2|||
124544448|NCT03795233|447946802|FG001|Overall Study|Withdrawal by Subject|1|||
124544449|NCT03795233|447946801|FG000|Overall Study|Lost to Follow-up|1|||
124544450|NCT03795233|447946802|FG001|Overall Study|Lost to Follow-up|0|||
124544451|NCT03795233|447946801|FG000|Overall Study|Death|1|||
124544452|NCT03795233|447946802|FG001|Overall Study|Death|0|||
124544453|NCT05403502|447946803|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
124544454|NCT05403502|447946803|FG000|Humalog Lead-In Period|Physician Decision|2|||
124544455|NCT05403502|447946803|FG000|Humalog Lead-In Period|Protocol Violation|1|||
124544456|NCT05403502|447946803|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
124544457|NCT05403502|447946803|FG000|Lyumjev Treatment Period|Physician Decision|2|||
124544458|NCT01054443|447946804|FG000|Overall Study|Withdrawal by Subject|0|||
124544459|NCT01054443|447946805|FG001|Overall Study|Withdrawal by Subject|0|||
124544460|NCT01054443|447946806|FG002|Overall Study|Withdrawal by Subject|0|||
124544461|NCT01054443|447946807|FG003|Overall Study|Withdrawal by Subject|1|||
124544462|NCT01003691|447946811|FG000|Overall Study|Adverse Event|0|||
124544463|NCT01003691|447946812|FG001|Overall Study|Adverse Event|0|||
124544464|NCT01003691|447946813|FG002|Overall Study|Adverse Event|0|||
124544465|NCT01003691|447946814|FG003|Overall Study|Adverse Event|1|||
124544466|NCT00167414|447946815|FG000|Overall Study|Death|10|||
124544467|NCT01869959|447946816|FG000|Randomization Period|Physician Decision|0|||
124544468|NCT01869959|447946817|FG001|Randomization Period|Physician Decision|0|||
124544469|NCT01869959|447946818|FG002|Randomization Period|Physician Decision|0|||
124544470|NCT01869959|447946819|FG003|Randomization Period|Physician Decision|0|||
124544471|NCT01869959|447946820|FG004|Randomization Period|Physician Decision|1|||
124544472|NCT01869959|447946816|FG000|Treatment Period|Adverse Event|1|||
124544473|NCT01869959|447946817|FG001|Treatment Period|Adverse Event|0|||
124544474|NCT01869959|447946818|FG002|Treatment Period|Adverse Event|3|||
124544475|NCT01869959|447946819|FG003|Treatment Period|Adverse Event|1|||
124544476|NCT01869959|447946820|FG004|Treatment Period|Adverse Event|0|||
124544477|NCT01869959|447946816|FG000|Treatment Period|Sponsor decision|0|||
124544478|NCT01869959|447946817|FG001|Treatment Period|Sponsor decision|1|||
124544479|NCT01869959|447946818|FG002|Treatment Period|Sponsor decision|0|||
124544480|NCT01869959|447946819|FG003|Treatment Period|Sponsor decision|1|||
124544481|NCT01869959|447946820|FG004|Treatment Period|Sponsor decision|0|||
124544482|NCT01869959|447946816|FG000|Treatment Period|Withdrawal by Subject|0|||
124691411|NCT00887588|448490073|FG000|Core Period|Lost to Follow-up|3|||
124903921|NCT01212757|449272541|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
124903922|NCT01212757|449272542|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
124903923|NCT01212757|449272543|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
124903924|NCT01212757|449272544|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
124903925|NCT01212757|449272545|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
124903926|NCT01212757|449272537|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
124903927|NCT01212757|449272538|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
124903928|NCT01212757|449272539|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
124903929|NCT01212757|449272540|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
124903930|NCT01212757|449272541|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
124903931|NCT01212757|449272542|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
124903932|NCT01212757|449272543|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
124903933|NCT01212757|449272544|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
124903934|NCT01212757|449272545|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
124903935|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
124903936|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
124903937|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
124903938|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
124903939|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
124903940|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
124903941|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
124903942|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
124903943|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
124903944|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
124903945|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
124903946|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
124903947|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
124903948|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
124903949|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
124544483|NCT01869959|447946817|FG001|Treatment Period|Withdrawal by Subject|1|||
124544484|NCT01869959|447946818|FG002|Treatment Period|Withdrawal by Subject|0|||
124544485|NCT01869959|447946819|FG003|Treatment Period|Withdrawal by Subject|0|||
124544486|NCT01869959|447946820|FG004|Treatment Period|Withdrawal by Subject|0|||
124544487|NCT02576951|447946824|FG000|Overall Study|Lost to Follow-up|0|||
124544488|NCT02576951|447946825|FG001|Overall Study|Lost to Follow-up|0|||
124544489|NCT02576951|447946826|FG002|Overall Study|Lost to Follow-up|2|||
124691412|NCT00887588|448490074|FG001|Core Period|Lost to Follow-up|1|||
124691413|NCT00887588|448490073|FG000|Core Period|Withdrawal by Subject|6|||
124691414|NCT00887588|448490074|FG001|Core Period|Withdrawal by Subject|8|||
124691415|NCT00887588|448490073|FG000|Core Period|Adverse Event|9|||
124691416|NCT00887588|448490074|FG001|Core Period|Adverse Event|11|||
124691417|NCT00887588|448490073|FG000|Extension Period|Adverse Event|4|||
124903950|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
124903951|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
124903952|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
124903953|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
124903954|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
124903955|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
124903956|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
124903957|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
124903958|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
124903959|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
124903960|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
124903961|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
124903962|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124903963|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
124903964|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
124903965|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124903966|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124903967|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124903968|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124903969|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
124903970|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
124903971|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
124903972|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
124903973|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
124903974|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
124903975|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
124903976|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
124903977|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
124903978|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
124903979|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
124903980|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
124903981|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
124903982|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
124903983|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
124903984|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
124903985|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
124903986|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
124903987|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
124903988|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
124903989|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
124903990|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
124903991|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
124903992|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
124903993|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
124903994|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
124903995|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
124903996|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
124903997|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
124903998|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
124903999|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
124904000|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
124904001|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
124904002|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
124904003|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
124904004|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
124691418|NCT00887588|448490074|FG001|Extension Period|Adverse Event|4|||
124691419|NCT00887588|448490073|FG000|Extension Period|Death|0|||
124760045|NCT02544321|448746752|FG000|Overall Study|Withdrawal by Subject|1|||
124760046|NCT02544321|448746753|FG001|Overall Study|Withdrawal by Subject|2|||
124904005|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
124904006|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
124760047|NCT02544321|448746752|FG000|Overall Study|Adverse Event|1|||
124691420|NCT00887588|448490074|FG001|Extension Period|Death|1|||
124691421|NCT00887588|448490073|FG000|Extension Period|Protocol deviation|1|||
124760048|NCT02544321|448746753|FG001|Overall Study|Adverse Event|1|||
124904007|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124904008|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
124904009|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
124904010|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124904011|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124904012|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124904013|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124904014|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
124904015|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
124904016|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
124449127|NCT00884325|447606909|FG000|Overall Study|Lack of Efficacy|0|||
124449128|NCT00884325|447606910|FG001|Overall Study|Lack of Efficacy|1|||
124449129|NCT00884325|447606909|FG000|Overall Study|Withdrawal by Subject|1|||
124449130|NCT00884325|447606910|FG001|Overall Study|Withdrawal by Subject|1|||
124449131|NCT00884325|447606909|FG000|Overall Study|Not provided|1|||
124449132|NCT00884325|447606910|FG001|Overall Study|Not provided|0|||
124449133|NCT00892177|447606916|FG000|Phase II|Ineligible|0|||
124449134|NCT00892177|447606917|FG001|Phase II|Ineligible|0|||
124449135|NCT00892177|447606918|FG002|Phase II|Ineligible|0|||
124449136|NCT00892177|447606919|FG003|Phase II|Ineligible|0|||
124449137|NCT00892177|447606920|FG004|Phase II|Ineligible|1|||
124691422|NCT00887588|448490074|FG001|Extension Period|Protocol deviation|0|||
124904017|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
124904018|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
124904019|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
124904020|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
124904021|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
124904022|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
124904023|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
124904024|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
124904025|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
124904026|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
124904027|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
124904028|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
124904029|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
124904030|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
124904031|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
124904032|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
124904033|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
124904034|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
124904035|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
124904036|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
124904037|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
124904038|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
124904039|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
124904040|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
124904041|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
124904042|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
124904043|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
124904044|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
124904045|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
124904046|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
124904047|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
124904048|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
124904049|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
124904050|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
124904051|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
124904052|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
124904053|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
124904054|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
124904055|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
124904056|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
124904057|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
124904058|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
124904059|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
124904060|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
124904061|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
124904062|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
124904063|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
124904064|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
124904065|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
124904066|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
124904067|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
124904068|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
124904069|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
124904070|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124904071|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
124904072|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
124904073|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124449138|NCT00892177|447606921|FG005|Phase II|Ineligible|1|||
124904074|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124904075|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124904076|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124691423|NCT00887588|448490073|FG000|Extension Period|Lost to Follow-up|1|||
124691424|NCT00887588|448490074|FG001|Extension Period|Lost to Follow-up|0|||
124691425|NCT02958527|448490079|FG000|Overall Study|Not collected CRFs|12|||
124904077|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
124904078|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
124904079|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
124904080|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
124904081|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
124904082|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
124904083|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
124904084|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
124904085|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
124904086|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
124904087|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
124904088|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
124904089|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
124904090|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
124904091|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
124904092|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
124904093|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
124904094|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
124904095|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
124904096|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
124904097|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124904098|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
124904099|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
124904100|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124904101|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124904102|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124904103|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124904104|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
124904105|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
124904106|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
124904107|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
124904108|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
124904109|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
124904110|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
124904111|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
124904112|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
124904113|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
124904114|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
124904115|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
124904116|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
124904117|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
124904118|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
124904119|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
124904120|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
124904121|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
124904122|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
124904123|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
124904124|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
124904125|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
124904126|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
124904127|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
124904128|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
124904129|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
124904130|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
124904131|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
124904132|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
124904133|NCT01212757|449272537|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
124691426|NCT03753542|448490082|FG000|Overall Study|Lost to Follow-up|9|||
124691427|NCT03753542|448490083|FG001|Overall Study|Lost to Follow-up|14|||
124691428|NCT06100250|448490084|FG000|Overall Study|Lost to Follow-up|5|||
124904134|NCT01212757|449272538|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
124904135|NCT01212757|449272539|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
124904136|NCT01212757|449272540|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
124449139|NCT00892177|447606916|FG000|Phase II|Withdrawal by Subject|0|||
124691429|NCT02021318|448490085|FG000|Overall Study|Adverse Event|2|||
124904137|NCT01212757|449272541|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
124904138|NCT01212757|449272542|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
124904139|NCT01212757|449272543|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
124904140|NCT01212757|449272544|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
124904141|NCT01212757|449272545|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
124904142|NCT02983617|449274023|FG000|Overall Study|Adverse Event|0|||
124904143|NCT02983617|449274024|FG001|Overall Study|Adverse Event|7|||
124904144|NCT02983617|449274023|FG000|Overall Study|Death|0|||
124904145|NCT02983617|449274024|FG001|Overall Study|Death|1|||
124904146|NCT02983617|449274023|FG000|Overall Study|Investigator's Discretion|0|||
124904147|NCT02983617|449274024|FG001|Overall Study|Investigator's Discretion|1|||
124904148|NCT02698891|449274029|FG000|Overall Study|Withdrawal by Subject|2|||
124904149|NCT02698891|449274029|FG000|Overall Study|deemed ineligible|1|||
124904150|NCT02698891|449274029|FG000|Overall Study|Adverse Event|9|||
124904151|NCT00516386|449274030|FG000|Overall Study|not interested in the study|4|||
124904152|NCT00516386|449274030|FG000|Overall Study|Lost to Follow-up|2|||
124904153|NCT00818454|449274031|FG000|Treatment Period 1|Adverse Event|0|||
124904154|NCT00818454|449274032|FG001|Treatment Period 1|Adverse Event|1|||
124904155|NCT00818454|449274033|FG002|Treatment Period 1|Adverse Event|0|||
124904156|NCT00818454|449274034|FG003|Treatment Period 1|Adverse Event|0|||
124904157|NCT00818454|449274031|FG000|Treatment Period 1|Other|3|||
124904158|NCT00818454|449274032|FG001|Treatment Period 1|Other|0|||
124904159|NCT00818454|449274033|FG002|Treatment Period 1|Other|0|||
124904160|NCT00818454|449274034|FG003|Treatment Period 1|Other|0|||
124904161|NCT00818454|449274031|FG000|Washout Period of 1 Week|Adverse Event|1|||
124904162|NCT00818454|449274032|FG001|Washout Period of 1 Week|Adverse Event|1|||
124904163|NCT00818454|449274033|FG002|Washout Period of 1 Week|Adverse Event|0|||
124904164|NCT00818454|449274034|FG003|Washout Period of 1 Week|Adverse Event|0|||
124904165|NCT00818454|449274031|FG000|Washout Period of 1 Week|Protocol Violation|2|||
124904166|NCT00818454|449274032|FG001|Washout Period of 1 Week|Protocol Violation|0|||
124904167|NCT00818454|449274033|FG002|Washout Period of 1 Week|Protocol Violation|0|||
124904168|NCT00818454|449274034|FG003|Washout Period of 1 Week|Protocol Violation|0|||
124904169|NCT00818454|449274031|FG000|Washout Period of 1 Week|Other|1|||
124904170|NCT00818454|449274032|FG001|Washout Period of 1 Week|Other|2|||
124904171|NCT00818454|449274033|FG002|Washout Period of 1 Week|Other|0|||
124904172|NCT00818454|449274034|FG003|Washout Period of 1 Week|Other|0|||
124904173|NCT00818454|449274031|FG000|Treatment Period 2|Other|2|||
124904174|NCT00818454|449274032|FG001|Treatment Period 2|Other|1|||
124904175|NCT00818454|449274033|FG002|Treatment Period 2|Other|0|||
124904176|NCT00818454|449274034|FG003|Treatment Period 2|Other|0|||
124904177|NCT00818454|449274031|FG000|Treatment Period 3|Adverse Event|0|||
124904178|NCT00818454|449274032|FG001|Treatment Period 3|Adverse Event|0|||
124904179|NCT00818454|449274033|FG002|Treatment Period 3|Adverse Event|0|||
124904180|NCT00818454|449274034|FG003|Treatment Period 3|Adverse Event|1|||
124904181|NCT01171625|449274040|FG000|Overall Study|On-Protocol|67|||
124904182|NCT01171625|449274040|FG000|Overall Study|Death|38|||
124904183|NCT01171625|449274040|FG000|Overall Study|Withdrawal by Subject|31|||
124904184|NCT01171625|449274040|FG000|Overall Study|Explanted|10|||
124904185|NCT01171625|449274040|FG000|Overall Study|Lost to Follow-up|5|||
124904186|NCT01171625|449274040|FG000|Overall Study|Patient received valve-in-valve|3|||
124904187|NCT01171625|449274040|FG000|Overall Study|Other|1|||
124904188|NCT01171625|449274040|FG000|Overall Study|Consented but did not receive device|25|||
124904189|NCT01376089|449274041|FG000|Overall Study|Patient received no contrast media|3|||
124904190|NCT01376089|449274042|FG001|Overall Study|Patient received no contrast media|4|||
124544490|NCT02576951|447946827|FG003|Overall Study|Lost to Follow-up|2|||
124904191|NCT00549848|449274043|FG000|Overall Study|Death|1|||
124544491|NCT02576951|447946824|FG000|Overall Study|Withdrawal by Subject|1|||
124904192|NCT00549848|449274044|FG001|Overall Study|Death|4|||
124904193|NCT00549848|449274045|FG002|Overall Study|Death|13|||
124904194|NCT00549848|449274043|FG000|Overall Study|Physician Decision|0|||
124904195|NCT00549848|449274044|FG001|Overall Study|Physician Decision|0|||
124904196|NCT00549848|449274045|FG002|Overall Study|Physician Decision|4|||
124904197|NCT00549848|449274043|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
124904198|NCT00549848|449274044|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
124904199|NCT00549848|449274045|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
124904200|NCT00549848|449274043|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
124904201|NCT00549848|449274044|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
124904202|NCT00549848|449274045|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
124904203|NCT00549848|449274043|FG000|Overall Study|Participant/Family Withdraw|2|||
124904204|NCT00549848|449274044|FG001|Overall Study|Participant/Family Withdraw|3|||
124904205|NCT00549848|449274045|FG002|Overall Study|Participant/Family Withdraw|5|||
124904206|NCT00549848|449274043|FG000|Overall Study|Second Malignancy|1|||
124904207|NCT00549848|449274044|FG001|Overall Study|Second Malignancy|0|||
124904208|NCT00549848|449274045|FG002|Overall Study|Second Malignancy|0|||
124904209|NCT00549848|449274043|FG000|Overall Study|Transplant|3|||
124904210|NCT00549848|449274044|FG001|Overall Study|Transplant|3|||
124904211|NCT00549848|449274045|FG002|Overall Study|Transplant|18|||
124904212|NCT00549848|449274043|FG000|Overall Study|Unacceptable Toxicity|1|||
124904213|NCT00549848|449274044|FG001|Overall Study|Unacceptable Toxicity|6|||
124904214|NCT00549848|449274045|FG002|Overall Study|Unacceptable Toxicity|6|||
124904215|NCT03262935|449274048|FG000|Overall Study|Withdrawal by Subject|6|||
124904216|NCT03262935|449274049|FG001|Overall Study|Withdrawal by Subject|7|||
124904217|NCT03262935|449274048|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
124904218|NCT03262935|449274049|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
124904219|NCT03262935|449274048|FG000|Overall Study|Death|181|||
124904220|NCT03262935|449274049|FG001|Overall Study|Death|94|||
124904221|NCT03262935|449274048|FG000|Overall Study|Lost to Follow-up|9|||
124904222|NCT03262935|449274049|FG001|Overall Study|Lost to Follow-up|4|||
124904223|NCT03262935|449274048|FG000|Overall Study|Other reason|5|||
124904224|NCT03262935|449274049|FG001|Overall Study|Other reason|0|||
124904225|NCT01811706|449274050|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
124904226|NCT01811706|449274051|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
124904227|NCT00753012|449274053|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
124904228|NCT00753012|449274054|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
124904229|NCT00753012|449274053|FG000|Overall Study|Adverse Event|2|||
124904230|NCT00753012|449274054|FG001|Overall Study|Adverse Event|0|||
124904231|NCT00753012|449274053|FG000|Overall Study|Withdrawal by Subject|0|||
124904232|NCT00753012|449274054|FG001|Overall Study|Withdrawal by Subject|1|||
124904233|NCT00753012|449274053|FG000|Overall Study|Lost to Follow-up|4|||
124904234|NCT00753012|449274054|FG001|Overall Study|Lost to Follow-up|0|||
124904235|NCT00753012|449274053|FG000|Overall Study|Confounded endpoint data|1|||
124904236|NCT00753012|449274054|FG001|Overall Study|Confounded endpoint data|0|||
124904237|NCT00217672|449274058|FG000|Allocation|Ineligible|2|||
124904238|NCT00217672|449274059|FG001|Allocation|Ineligible|0|||
124904239|NCT00217672|449274058|FG000|Treatment|disease progression|33|||
124904240|NCT00217672|449274059|FG001|Treatment|disease progression|4|||
124904241|NCT00217672|449274058|FG000|Treatment|Adverse Event|18|||
124904242|NCT00217672|449274059|FG001|Treatment|Adverse Event|2|||
124904243|NCT00217672|449274058|FG000|Treatment|reqd treatment not permitted by protocol|6|||
124904244|NCT00217672|449274059|FG001|Treatment|reqd treatment not permitted by protocol|0|||
124904245|NCT00217672|449274058|FG000|Treatment|Physician Decision|6|||
124904246|NCT00217672|449274059|FG001|Treatment|Physician Decision|0|||
124904247|NCT00217672|449274058|FG000|Treatment|insurance issues|1|||
124904248|NCT00217672|449274059|FG001|Treatment|insurance issues|1|||
124904249|NCT00217672|449274058|FG000|Treatment|Death|2|||
124904250|NCT00217672|449274059|FG001|Treatment|Death|0|||
124904251|NCT00217672|449274058|FG000|Treatment|secondary malignancy|1|||
124904252|NCT00217672|449274059|FG001|Treatment|secondary malignancy|0|||
124904253|NCT00217672|449274058|FG000|Follow-up|Withdrawal by Subject|4|||
124904254|NCT00217672|449274059|FG001|Follow-up|Withdrawal by Subject|0|||
124904255|NCT00217672|449274058|FG000|Follow-up|Lost to Follow-up|1|||
124904256|NCT00217672|449274059|FG001|Follow-up|Lost to Follow-up|0|||
124904257|NCT01596504|449274064|FG000|Overall Study|Participant's Private Reason|0|||
124904258|NCT01596504|449274065|FG001|Overall Study|Participant's Private Reason|1|||
124904259|NCT01596504|449274066|FG002|Overall Study|Participant's Private Reason|0|||
124904260|NCT01596504|449274064|FG000|Overall Study|Adverse Event|1|||
124904261|NCT01596504|449274065|FG001|Overall Study|Adverse Event|2|||
124449140|NCT00892177|447606917|FG001|Phase II|Withdrawal by Subject|0|||
124449141|NCT00892177|447606918|FG002|Phase II|Withdrawal by Subject|0|||
124904262|NCT01596504|449274066|FG002|Overall Study|Adverse Event|1|||
124904263|NCT01596504|449274064|FG000|Overall Study|Withdrawal by Subject|1|||
124449142|NCT00892177|447606919|FG003|Phase II|Withdrawal by Subject|0|||
124449143|NCT00892177|447606920|FG004|Phase II|Withdrawal by Subject|4|||
124449144|NCT00892177|447606921|FG005|Phase II|Withdrawal by Subject|1|||
124449145|NCT00616434|447606925|FG000|Overall Study|Adverse Event|5|||
124449146|NCT00616434|447606926|FG001|Overall Study|Adverse Event|2|||
124904264|NCT01596504|449274065|FG001|Overall Study|Withdrawal by Subject|0|||
124904265|NCT01596504|449274066|FG002|Overall Study|Withdrawal by Subject|0|||
124904266|NCT01901276|449274067|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
124904267|NCT01901276|449274068|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
124904268|NCT04347954|449274069|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
124904269|NCT04347954|449274070|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
124904270|NCT04347954|449274071|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
124904271|NCT04347954|449274069|FG000|Overall Study|Lost to Follow-up|0|||
124904272|NCT04347954|449274070|FG001|Overall Study|Lost to Follow-up|1|||
124904273|NCT04347954|449274071|FG002|Overall Study|Lost to Follow-up|0|||
124904274|NCT03257813|449274075|FG000|Overall Study|Protocol Violation|6|||
124904275|NCT03257813|449274076|FG001|Overall Study|Protocol Violation|3|||
124904276|NCT02878330|449274077|FG000|Overall Study|Death|3|||
124904277|NCT02878330|449274078|FG001|Overall Study|Death|2|||
124904278|NCT02878330|449274077|FG000|Overall Study|Lost to Follow-up|11|||
124904279|NCT02878330|449274078|FG001|Overall Study|Lost to Follow-up|26|||
124904280|NCT02878330|449274077|FG000|Overall Study|Withdrawal by Subject|11|||
124904281|NCT02878330|449274078|FG001|Overall Study|Withdrawal by Subject|21|||
124904282|NCT02878330|449274077|FG000|Overall Study|Other|4|||
124904283|NCT02878330|449274078|FG001|Overall Study|Other|7|||
124904284|NCT02954848|449274081|FG000|Overall Study|Randomized but Not Treated|0|||
124904285|NCT02954848|449274082|FG001|Overall Study|Randomized but Not Treated|1|||
124904286|NCT02954848|449274081|FG000|Overall Study|Adverse Event|2|||
124904287|NCT02954848|449274082|FG001|Overall Study|Adverse Event|3|||
124904288|NCT02954848|449274081|FG000|Overall Study|Withdrawal by Participant|0|||
124904289|NCT02954848|449274082|FG001|Overall Study|Withdrawal by Participant|1|||
124904290|NCT01069341|449274083|FG000|Overall Study|Lost to Follow-up|1|||
124904291|NCT00922207|449274084|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
124904292|NCT00922207|449274085|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
124904293|NCT00922207|449274086|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
124904294|NCT00922207|449274084|FG000|Overall Study|Insufficient Therapeutic Response|0|||
124904295|NCT00922207|449274085|FG001|Overall Study|Insufficient Therapeutic Response|0|||
124904296|NCT00922207|449274086|FG002|Overall Study|Insufficient Therapeutic Response|1|||
124904297|NCT00922207|449274084|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
124904298|NCT00922207|449274085|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
124904299|NCT00922207|449274086|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
124904300|NCT00922207|449274084|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
124904301|NCT00922207|449274085|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
124904302|NCT00922207|449274086|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
124904303|NCT00922207|449274084|FG000|Overall Study|Withdrew Consent|2|||
124904304|NCT00922207|449274085|FG001|Overall Study|Withdrew Consent|5|||
124904305|NCT00922207|449274086|FG002|Overall Study|Withdrew Consent|2|||
124904306|NCT00922207|449274084|FG000|Overall Study|Abnormality of Laboratory Test|0|||
124904307|NCT00922207|449274085|FG001|Overall Study|Abnormality of Laboratory Test|1|||
124904308|NCT00922207|449274086|FG002|Overall Study|Abnormality of Laboratory Test|1|||
124904309|NCT01802632|449274087|FG000|Overall Study|Death|28|||
124904310|NCT01802632|449274088|FG001|Overall Study|Death|1|||
124904311|NCT01802632|449274089|FG002|Overall Study|Death|38|||
124904312|NCT01802632|449274090|FG003|Overall Study|Death|0|||
124904313|NCT01802632|449274091|FG004|Overall Study|Death|2|||
124904314|NCT01802632|449274092|FG005|Overall Study|Death|0|||
124904315|NCT01802632|449274087|FG000|Overall Study|Withdrawal by Subject|4|||
124904316|NCT01802632|449274088|FG001|Overall Study|Withdrawal by Subject|2|||
124904317|NCT01802632|449274089|FG002|Overall Study|Withdrawal by Subject|7|||
124904318|NCT01802632|449274090|FG003|Overall Study|Withdrawal by Subject|3|||
124904319|NCT01802632|449274091|FG004|Overall Study|Withdrawal by Subject|0|||
124904320|NCT01802632|449274092|FG005|Overall Study|Withdrawal by Subject|1|||
124904321|NCT01802632|449274087|FG000|Overall Study|Objective Disease Progression|1|||
124904322|NCT01802632|449274088|FG001|Overall Study|Objective Disease Progression|12|||
124904323|NCT01802632|449274089|FG002|Overall Study|Objective Disease Progression|104|||
124904324|NCT01802632|449274090|FG003|Overall Study|Objective Disease Progression|6|||
124904325|NCT01802632|449274091|FG004|Overall Study|Objective Disease Progression|4|||
124904326|NCT01802632|449274092|FG005|Overall Study|Objective Disease Progression|4|||
124904327|NCT01802632|449274087|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
124904328|NCT01802632|449274088|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
124904329|NCT01802632|449274089|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
124904330|NCT01802632|449274090|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
124904331|NCT01802632|449274091|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
124904332|NCT01802632|449274092|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
124904333|NCT01802632|449274087|FG000|Overall Study|Other (not specified)|0|||
124904334|NCT01802632|449274088|FG001|Overall Study|Other (not specified)|0|||
124904335|NCT01802632|449274089|FG002|Overall Study|Other (not specified)|7|||
124904336|NCT01802632|449274090|FG003|Overall Study|Other (not specified)|1|||
124904337|NCT01802632|449274091|FG004|Overall Study|Other (not specified)|0|||
124904338|NCT01802632|449274092|FG005|Overall Study|Other (not specified)|1|||
124904339|NCT02880241|449274105|FG000|Overall Study|Lack of Efficacy|1|||
124904340|NCT02880241|449274106|FG001|Overall Study|Lack of Efficacy|0|||
124904341|NCT02880241|449274107|FG002|Overall Study|Lack of Efficacy|0|||
124904342|NCT02880241|449274108|FG003|Overall Study|Lack of Efficacy|0|||
124904343|NCT02880241|449274109|FG004|Overall Study|Lack of Efficacy|0|||
124904344|NCT02880241|449274110|FG005|Overall Study|Lack of Efficacy|0|||
124904345|NCT02705586|449274112|FG000|Overall Study|Health Issues|2|||
124904346|NCT02705586|449274112|FG000|Overall Study|Transportation Difficulties|5|||
124904347|NCT02705586|449274112|FG000|Overall Study|Vacation/Planned Absence|1|||
124904348|NCT02194933|449274116|FG000|Overall Study|Lost to Follow-up|1|||
124904349|NCT02194933|449274117|FG001|Overall Study|Lost to Follow-up|2|||
124904350|NCT02194933|449274116|FG000|Overall Study|Participant met withdrawal criteria|1|||
124904351|NCT02194933|449274117|FG001|Overall Study|Participant met withdrawal criteria|3|||
124904352|NCT02194933|449274116|FG000|Overall Study|Withdrawal by Subject|0|||
124904353|NCT02194933|449274117|FG001|Overall Study|Withdrawal by Subject|2|||
124904354|NCT02194933|449274116|FG000|Overall Study|Lack of Efficacy|1|||
124904355|NCT02194933|449274117|FG001|Overall Study|Lack of Efficacy|2|||
124904356|NCT02045836|449274121|FG000|Overall Study|Adverse Event|4|||
124904357|NCT02045836|449274122|FG001|Overall Study|Adverse Event|4|||
124904358|NCT02045836|449274121|FG000|Overall Study|Withdrawal by Subject|1|||
124904359|NCT02045836|449274122|FG001|Overall Study|Withdrawal by Subject|1|||
124904360|NCT02045836|449274121|FG000|Overall Study|Lost to Follow-up|4|||
124904361|NCT02045836|449274122|FG001|Overall Study|Lost to Follow-up|7|||
124904362|NCT02045836|449274121|FG000|Overall Study|Migrated from study area|0|||
124904363|NCT02045836|449274122|FG001|Overall Study|Migrated from study area|2|||
124904364|NCT03920215|449274126|FG000|Overall Study|Lost to Follow-up|1|||
124904365|NCT03920215|449274127|FG001|Overall Study|Lost to Follow-up|2|||
124904366|NCT03920215|449274128|FG002|Overall Study|Lost to Follow-up|0|||
124904367|NCT03920215|449274129|FG003|Overall Study|Lost to Follow-up|0|||
124904368|NCT03920215|449274126|FG000|Overall Study|Death|0|||
124904369|NCT03920215|449274127|FG001|Overall Study|Death|0|||
124904370|NCT03920215|449274128|FG002|Overall Study|Death|0|||
124904371|NCT03920215|449274129|FG003|Overall Study|Death|1|||
124904372|NCT02000817|449274130|FG000|Overall Study|Withdrawal by Subject|2|||
124904373|NCT02000817|449274131|FG001|Overall Study|Withdrawal by Subject|0|||
124904374|NCT02000817|449274132|FG002|Overall Study|Withdrawal by Subject|0|||
124904375|NCT02000817|449274133|FG003|Overall Study|Withdrawal by Subject|0|||
124904376|NCT02000817|449274130|FG000|Overall Study|Adverse Event|0|||
124904377|NCT02000817|449274131|FG001|Overall Study|Adverse Event|1|||
124904378|NCT02000817|449274132|FG002|Overall Study|Adverse Event|0|||
124904379|NCT02000817|449274133|FG003|Overall Study|Adverse Event|0|||
124904380|NCT02000817|449274130|FG000|Overall Study|Lost to Follow-up|0|||
124904381|NCT02000817|449274131|FG001|Overall Study|Lost to Follow-up|0|||
124904382|NCT02000817|449274132|FG002|Overall Study|Lost to Follow-up|1|||
124904383|NCT02000817|449274133|FG003|Overall Study|Lost to Follow-up|0|||
124904384|NCT00177216|449274136|FG000|Overall Study|Withdrawal by Subject|6|||
124904385|NCT00177216|449274137|FG001|Overall Study|Withdrawal by Subject|3|||
124904386|NCT00177216|449274138|FG002|Overall Study|Withdrawal by Subject|1|||
124904387|NCT03383146|449274143|FG000|Overall Study|Screen Failure|1|||
124904388|NCT03383146|449274144|FG001|Overall Study|Screen Failure|0|||
124904389|NCT03383146|449274143|FG000|Overall Study|Adverse Event|6|||
124904390|NCT03383146|449274144|FG001|Overall Study|Adverse Event|18|||
124904391|NCT03383146|449274143|FG000|Overall Study|Lack of Efficacy|0|||
124904392|NCT03383146|449274144|FG001|Overall Study|Lack of Efficacy|3|||
124904393|NCT03383146|449274143|FG000|Overall Study|Withdrawal by Subject|20|||
124904394|NCT03383146|449274144|FG001|Overall Study|Withdrawal by Subject|36|||
124904395|NCT03383146|449274143|FG000|Overall Study|Lost to Follow-up|5|||
124904396|NCT03383146|449274144|FG001|Overall Study|Lost to Follow-up|15|||
124904397|NCT03383146|449274143|FG000|Overall Study|Death|0|||
124904398|NCT03383146|449274144|FG001|Overall Study|Death|2|||
124904399|NCT03383146|449274143|FG000|Overall Study|Physician Decision|0|||
124904400|NCT03383146|449274144|FG001|Overall Study|Physician Decision|1|||
124904401|NCT03383146|449274143|FG000|Overall Study|Protocol Deviation|1|||
124904402|NCT03383146|449274144|FG001|Overall Study|Protocol Deviation|8|||
124904403|NCT03383146|449274143|FG000|Overall Study|Study Terminated by the Sponsor|48|||
124904404|NCT03383146|449274144|FG001|Overall Study|Study Terminated by the Sponsor|95|||
124904405|NCT03383146|449274143|FG000|Overall Study|Reason not Specified|4|||
124904406|NCT03383146|449274144|FG001|Overall Study|Reason not Specified|6|||
124904407|NCT02739035|449274149|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
124904408|NCT02739035|449274150|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
124904409|NCT02739035|449274149|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
124904410|NCT02739035|449274150|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
124904411|NCT02739035|449274149|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
124904412|NCT02739035|449274150|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
124904413|NCT02739035|449274149|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
124904414|NCT02739035|449274150|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
124904415|NCT03210402|449274151|FG000|Overall Study|Withdrawal by Subject|0|||
124904416|NCT03210402|449274152|FG001|Overall Study|Withdrawal by Subject|1|||
124904417|NCT02517307|449274155|FG000|Overall Study|Withdrawal by Subject|1|||
124904418|NCT02517307|449274156|FG001|Overall Study|Withdrawal by Subject|0|||
124904419|NCT02517307|449274157|FG002|Overall Study|Withdrawal by Subject|1|||
124904420|NCT02517307|449274158|FG003|Overall Study|Withdrawal by Subject|0|||
124904421|NCT02517307|449274155|FG000|Overall Study|Protocol Violation|0|||
124904422|NCT02517307|449274156|FG001|Overall Study|Protocol Violation|0|||
124904423|NCT02517307|449274157|FG002|Overall Study|Protocol Violation|1|||
124904424|NCT02517307|449274158|FG003|Overall Study|Protocol Violation|1|||
124904425|NCT00823979|449274159|FG000|Overall Study|Lack of Efficacy|13|||
124904426|NCT00823979|449274160|FG001|Overall Study|Lack of Efficacy|16|||
124904427|NCT00823979|449274161|FG002|Overall Study|Lack of Efficacy|9|||
124904428|NCT00823979|449274159|FG000|Overall Study|Lost to Follow-up|2|||
124904429|NCT00823979|449274160|FG001|Overall Study|Lost to Follow-up|1|||
124904430|NCT00823979|449274161|FG002|Overall Study|Lost to Follow-up|0|||
124904431|NCT00823979|449274159|FG000|Overall Study|Withdrawal by Subject|2|||
124904432|NCT00823979|449274160|FG001|Overall Study|Withdrawal by Subject|3|||
124904433|NCT00823979|449274161|FG002|Overall Study|Withdrawal by Subject|2|||
124904434|NCT00823979|449274159|FG000|Overall Study|Protocol Violation|1|||
124904435|NCT00823979|449274160|FG001|Overall Study|Protocol Violation|1|||
124904436|NCT00823979|449274161|FG002|Overall Study|Protocol Violation|0|||
124904437|NCT00823979|449274159|FG000|Overall Study|Pregnancy|0|||
124904438|NCT00823979|449274160|FG001|Overall Study|Pregnancy|1|||
124904439|NCT00823979|449274161|FG002|Overall Study|Pregnancy|0|||
124904440|NCT00823979|449274159|FG000|Overall Study|Adverse Event|0|||
124904441|NCT00823979|449274160|FG001|Overall Study|Adverse Event|2|||
124904442|NCT00823979|449274161|FG002|Overall Study|Adverse Event|4|||
124904443|NCT00823979|449274159|FG000|Overall Study|Other|2|||
124904444|NCT00823979|449274160|FG001|Overall Study|Other|0|||
124904445|NCT00823979|449274161|FG002|Overall Study|Other|1|||
124904446|NCT00823979|449274159|FG000|Overall Study|Randomized but not Treated|4|||
124904447|NCT00823979|449274160|FG001|Overall Study|Randomized but not Treated|3|||
124904448|NCT00823979|449274161|FG002|Overall Study|Randomized but not Treated|1|||
124904449|NCT00823979|449274159|FG000|Overall Study|Study Terminated by Sponsor|5|||
124904450|NCT00823979|449274160|FG001|Overall Study|Study Terminated by Sponsor|5|||
124904451|NCT00823979|449274161|FG002|Overall Study|Study Terminated by Sponsor|7|||
124904452|NCT03586544|449274162|FG000|First Intervention|Adverse Event|0|||
124904453|NCT03586544|449274163|FG001|First Intervention|Adverse Event|1|||
124904454|NCT03586544|449274162|FG000|Second Intervention|Withdrawal by Subject|0|||
124904455|NCT03586544|449274163|FG001|Second Intervention|Withdrawal by Subject|1|||
124904456|NCT03523091|449274164|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
124904457|NCT03523091|449274165|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
124904458|NCT03523091|449274164|FG000|Overall Study|Withdrawal by Subject|0|||
124904459|NCT03523091|449274165|FG001|Overall Study|Withdrawal by Subject|3|||
124904460|NCT03523091|449274164|FG000|Overall Study|Increase Botox dose|0|||
124904461|NCT03523091|449274165|FG001|Overall Study|Increase Botox dose|1|||
124904462|NCT03863834|449274171|FG000|Overall Study|Lost to Follow-up|3|||
124904463|NCT02685488|449274172|FG000|Overall Study|Withdrawal by Subject|0|||
124904464|NCT02685488|449274173|FG001|Overall Study|Withdrawal by Subject|1|||
124904465|NCT00324038|449274174|FG000|Overall Study|Adverse Event|38|||
124904466|NCT00324038|449274175|FG001|Overall Study|Adverse Event|23|||
124904467|NCT00324038|449274174|FG000|Overall Study|Lack of Efficacy|5|||
124904468|NCT00324038|449274175|FG001|Overall Study|Lack of Efficacy|13|||
124904469|NCT00324038|449274174|FG000|Overall Study|Lost to Follow-up|0|||
124904470|NCT00324038|449274175|FG001|Overall Study|Lost to Follow-up|2|||
124904471|NCT00324038|449274174|FG000|Overall Study|Other|6|||
124904472|NCT00324038|449274175|FG001|Overall Study|Other|13|||
124904473|NCT02770248|449274176|FG000|Overall Study|Adverse Event|0|||
124904474|NCT02770248|449274177|FG001|Overall Study|Adverse Event|1|||
124904475|NCT02770248|449274176|FG000|Overall Study|Randomized in error, prior to treatment|0|||
124904476|NCT02770248|449274177|FG001|Overall Study|Randomized in error, prior to treatment|1|||
124449147|NCT00616434|447606925|FG000|Overall Study|Physician Decision|0|||
124449148|NCT00616434|447606926|FG001|Overall Study|Physician Decision|4|||
124904477|NCT03768206|449274180|FG000|Overall Study|Lost to Follow-up|2|||
124449149|NCT00616434|447606925|FG000|Overall Study|Withdrawal by Subject|1|||
124449150|NCT00616434|447606926|FG001|Overall Study|Withdrawal by Subject|1|||
124449151|NCT00616434|447606925|FG000|Overall Study|Protocol deviation|0|||
124904478|NCT03768206|449274181|FG001|Overall Study|Lost to Follow-up|1|||
124904479|NCT03768206|449274180|FG000|Overall Study|Withdrawal by Subject|0|||
124904480|NCT03768206|449274181|FG001|Overall Study|Withdrawal by Subject|1|||
124904481|NCT04493242|449274182|FG000|Overall Study|Death|10|||
124904482|NCT04493242|449274183|FG001|Overall Study|Death|14|||
124904483|NCT04493242|449274184|FG002|Overall Study|Death|16|||
124904484|NCT04493242|449274182|FG000|Overall Study|Lost to Follow-up|1|||
124904485|NCT04493242|449274183|FG001|Overall Study|Lost to Follow-up|1|||
124904486|NCT04493242|449274184|FG002|Overall Study|Lost to Follow-up|0|||
124449152|NCT00616434|447606926|FG001|Overall Study|Protocol deviation|1|||
124904487|NCT04493242|449274182|FG000|Overall Study|Withdrawal by Subject|1|||
124904488|NCT04493242|449274183|FG001|Overall Study|Withdrawal by Subject|0|||
124904489|NCT04493242|449274184|FG002|Overall Study|Withdrawal by Subject|0|||
124904490|NCT04493242|449274182|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
124904491|NCT04493242|449274183|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
124904492|NCT04493242|449274184|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
124904493|NCT04493242|449274182|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
124691430|NCT02021318|448490086|FG001|Overall Study|Adverse Event|1|||
124691431|NCT02021318|448490085|FG000|Overall Study|Death|33|||
124904494|NCT04493242|449274183|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
124904495|NCT04493242|449274184|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
124904496|NCT02812966|449274187|FG000|Overall Study|Death|1|||
124904497|NCT02812966|449274188|FG001|Overall Study|Death|0|||
124904498|NCT04257058|449276261|FG000|Overall Study|Lost to Follow-up|31|||
124904499|NCT05147233|449276268|FG000|Overall Study|Adverse Event|0|||
124904500|NCT05147233|449276269|FG001|Overall Study|Adverse Event|1|||
124904501|NCT05147233|449276268|FG000|Overall Study|Lost to Follow-up|1|||
124904502|NCT05147233|449276269|FG001|Overall Study|Lost to Follow-up|1|||
124904503|NCT05147233|449276268|FG000|Overall Study|Protocol Violation|0|||
124904504|NCT05147233|449276269|FG001|Overall Study|Protocol Violation|1|||
124904505|NCT05147233|449276268|FG000|Overall Study|Withdrawal by Subject|2|||
124904506|NCT05147233|449276269|FG001|Overall Study|Withdrawal by Subject|1|||
124904507|NCT04517864|449276276|FG000|Placebo-Controlled Phase|Adverse Event|1|||
124904508|NCT04517864|449276277|FG001|Placebo-Controlled Phase|Adverse Event|0|||
124904509|NCT04517864|449276278|FG002|Placebo-Controlled Phase|Adverse Event|0|||
124904510|NCT04517864|449276276|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
124904511|NCT04517864|449276277|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
124904512|NCT04517864|449276278|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
124904513|NCT04517864|449276276|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
124904514|NCT04517864|449276277|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
124691432|NCT02021318|448490086|FG001|Overall Study|Death|34|||
124691433|NCT02021318|448490085|FG000|Overall Study|Lost to Follow-up|3|||
124904515|NCT04517864|449276278|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
124904516|NCT04517864|449276276|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
124904517|NCT04517864|449276277|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
124904518|NCT04517864|449276278|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
124904519|NCT04517864|449276276|FG000|Active Therapy Extension Phase|Adverse Event|1|||
124904520|NCT04517864|449276277|FG001|Active Therapy Extension Phase|Adverse Event|0|||
124904521|NCT04517864|449276278|FG002|Active Therapy Extension Phase|Adverse Event|0|||
124904522|NCT04517864|449276276|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
124904523|NCT04517864|449276277|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
124904524|NCT04517864|449276278|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
124904525|NCT04517864|449276276|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
124691434|NCT02021318|448490086|FG001|Overall Study|Lost to Follow-up|3|||
124691435|NCT02021318|448490085|FG000|Overall Study|Progressive Disease|0|||
124904526|NCT04517864|449276277|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
124904527|NCT04517864|449276278|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
124904528|NCT04517864|449276276|FG000|Active Therapy Extension Phase|Physician Decision|1|||
124904529|NCT04517864|449276277|FG001|Active Therapy Extension Phase|Physician Decision|0|||
124904530|NCT04517864|449276278|FG002|Active Therapy Extension Phase|Physician Decision|0|||
124904531|NCT04517864|449276276|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
124904532|NCT04517864|449276277|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
124904533|NCT04517864|449276278|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
124904534|NCT04517864|449276276|FG000|Extension Phase|Adverse Event|0|||
124904535|NCT04517864|449276277|FG001|Extension Phase|Adverse Event|0|||
124904536|NCT04517864|449276278|FG002|Extension Phase|Adverse Event|1|||
124904537|NCT04517864|449276276|FG000|Extension Phase|Lack of Efficacy|0|||
124904538|NCT04517864|449276277|FG001|Extension Phase|Lack of Efficacy|0|||
124904539|NCT04517864|449276278|FG002|Extension Phase|Lack of Efficacy|2|||
124904540|NCT04517864|449276276|FG000|Extension Phase|Study Terminated By Sponsor|0|||
124904541|NCT04517864|449276277|FG001|Extension Phase|Study Terminated By Sponsor|0|||
124904542|NCT04517864|449276278|FG002|Extension Phase|Study Terminated By Sponsor|32|||
124904543|NCT04517864|449276276|FG000|Extension Phase|Withdrawal by Subject|0|||
124904544|NCT04517864|449276277|FG001|Extension Phase|Withdrawal by Subject|0|||
124904545|NCT04517864|449276278|FG002|Extension Phase|Withdrawal by Subject|3|||
124904546|NCT04517864|449276276|FG000|Extension Phase|Approved Drug Available for Indication|0|||
124904547|NCT04517864|449276277|FG001|Extension Phase|Approved Drug Available for Indication|0|||
124904548|NCT04517864|449276278|FG002|Extension Phase|Approved Drug Available for Indication|7|||
124904549|NCT04199728|449276279|FG000|Overall Study|Adverse Event|1|||
124904550|NCT04199728|449276280|FG001|Overall Study|Adverse Event|0|||
124449153|NCT03945591|447606927|FG000|Overall Study|Participant not transplanted|1|||
124904551|NCT04199728|449276279|FG000|Overall Study|Withdrawal by Subject|8|||
124904552|NCT04199728|449276280|FG001|Overall Study|Withdrawal by Subject|3|||
124904553|NCT04199728|449276279|FG000|Overall Study|Screen fail after consent|0|||
124904554|NCT04199728|449276280|FG001|Overall Study|Screen fail after consent|1|||
124691436|NCT02021318|448490086|FG001|Overall Study|Progressive Disease|1|||
124691437|NCT02021318|448490085|FG000|Overall Study|Withdrawal by Subject|30|||
124904555|NCT04199728|449276279|FG000|Overall Study|Early withdraw criteria met|0|||
124904556|NCT04199728|449276280|FG001|Overall Study|Early withdraw criteria met|1|||
124904557|NCT04199728|449276279|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
124904558|NCT04199728|449276280|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
124904559|NCT04722003|449276281|FG000|Overall Study|Lost to Follow-up|2|||
124904560|NCT04722003|449276282|FG001|Overall Study|Lost to Follow-up|0|||
124904561|NCT04722003|449276281|FG000|Overall Study|Physician Decision|1|||
124904562|NCT04722003|449276282|FG001|Overall Study|Physician Decision|0|||
124904563|NCT01049503|449276283|FG000|Overall Study|Lost to Follow-up|11|||
124904564|NCT01049503|449276284|FG001|Overall Study|Lost to Follow-up|12|||
124904565|NCT01049503|449276285|FG002|Overall Study|Lost to Follow-up|24|||
124904566|NCT01049503|449276286|FG003|Overall Study|Lost to Follow-up|26|||
124904567|NCT01049503|449276287|FG004|Overall Study|Lost to Follow-up|27|||
124904568|NCT01049503|449276288|FG005|Overall Study|Lost to Follow-up|8|||
124691438|NCT02021318|448490086|FG001|Overall Study|Withdrawal by Subject|18|||
124691439|NCT02021318|448490085|FG000|Overall Study|Physician Decision|3|||
124691440|NCT02021318|448490086|FG001|Overall Study|Physician Decision|3|||
124691441|NCT02021318|448490085|FG000|Overall Study|Miscellaneous|2|||
124691442|NCT02021318|448490086|FG001|Overall Study|Miscellaneous|3|||
124691443|NCT00421993|448490088|FG000|Overall Study|Withdrawal by Subject|22|||
124691444|NCT00421993|448490089|FG001|Overall Study|Withdrawal by Subject|23|||
124691445|NCT00421993|448490090|FG002|Overall Study|Withdrawal by Subject|23|||
124691446|NCT00421993|448490091|FG003|Overall Study|Withdrawal by Subject|24|||
124691447|NCT00421993|448490088|FG000|Overall Study|Lost to Follow-up|18|||
124691448|NCT00421993|448490089|FG001|Overall Study|Lost to Follow-up|19|||
124691449|NCT00421993|448490090|FG002|Overall Study|Lost to Follow-up|22|||
124691450|NCT00421993|448490091|FG003|Overall Study|Lost to Follow-up|20|||
124691451|NCT00421993|448490088|FG000|Overall Study|Adverse Event|11|||
124691452|NCT00421993|448490089|FG001|Overall Study|Adverse Event|1|||
124691453|NCT00421993|448490090|FG002|Overall Study|Adverse Event|6|||
124691454|NCT00421993|448490091|FG003|Overall Study|Adverse Event|4|||
124691455|NCT00421993|448490088|FG000|Overall Study|Protocol Violation|2|||
124691456|NCT00421993|448490089|FG001|Overall Study|Protocol Violation|2|||
124691457|NCT00421993|448490090|FG002|Overall Study|Protocol Violation|0|||
124691458|NCT00421993|448490091|FG003|Overall Study|Protocol Violation|1|||
124691459|NCT00421993|448490088|FG000|Overall Study|Lack of Efficacy|0|||
124691460|NCT00421993|448490089|FG001|Overall Study|Lack of Efficacy|3|||
124691461|NCT00421993|448490090|FG002|Overall Study|Lack of Efficacy|0|||
124691462|NCT00421993|448490091|FG003|Overall Study|Lack of Efficacy|5|||
124691463|NCT00421993|448490088|FG000|Overall Study|Pregnancy|0|||
124691464|NCT00421993|448490089|FG001|Overall Study|Pregnancy|1|||
124691465|NCT00421993|448490090|FG002|Overall Study|Pregnancy|1|||
124691466|NCT00421993|448490091|FG003|Overall Study|Pregnancy|2|||
124691467|NCT00421993|448490088|FG000|Overall Study|Subject transportation issues|0|||
124691468|NCT00421993|448490089|FG001|Overall Study|Subject transportation issues|0|||
124691469|NCT00421993|448490090|FG002|Overall Study|Subject transportation issues|0|||
124691470|NCT00421993|448490091|FG003|Overall Study|Subject transportation issues|1|||
124691471|NCT02638493|448490096|FG000|Overall Study|Inability to provide semen samples|2|||
124691472|NCT02638493|448490097|FG001|Overall Study|Inability to provide semen samples|0|||
124691473|NCT02638493|448490098|FG002|Overall Study|Inability to provide semen samples|0|||
124691474|NCT00004859|448490099|FG000|Overall Study|Lack of Efficacy|43|||
124691475|NCT00004859|448490100|FG001|Overall Study|Lack of Efficacy|113|||
124691476|NCT00004859|448490099|FG000|Overall Study|Adverse Event|31|||
124691477|NCT00004859|448490100|FG001|Overall Study|Adverse Event|93|||
124691478|NCT00004859|448490099|FG000|Overall Study|Death|5|||
124691479|NCT00004859|448490100|FG001|Overall Study|Death|5|||
124691480|NCT00004859|448490099|FG000|Overall Study|Withdrawal by Subject|7|||
124691481|NCT00004859|448490100|FG001|Overall Study|Withdrawal by Subject|33|||
124691482|NCT00004859|448490099|FG000|Overall Study|Protocol Violation|2|||
124691483|NCT00004859|448490100|FG001|Overall Study|Protocol Violation|2|||
124691484|NCT00004859|448490099|FG000|Overall Study|other disease|0|||
124691485|NCT00004859|448490100|FG001|Overall Study|other disease|3|||
124904569|NCT00726596|449276289|FG000|Overall Study|Adverse Event|2|||
124904570|NCT00726596|449276290|FG001|Overall Study|Adverse Event|1|||
124904571|NCT00726596|449276289|FG000|Overall Study|Withdrawal by Subject|3|||
124904572|NCT00726596|449276290|FG001|Overall Study|Withdrawal by Subject|3|||
124691486|NCT00004859|448490099|FG000|Overall Study|error|3|||
124691487|NCT00004859|448490100|FG001|Overall Study|error|1|||
124691488|NCT00004859|448490099|FG000|Overall Study|missing data|14|||
124691489|NCT00004859|448490100|FG001|Overall Study|missing data|11|||
124691490|NCT00004859|448490099|FG000|Overall Study|Other|13|||
124691491|NCT00004859|448490100|FG001|Overall Study|Other|21|||
124691492|NCT00884949|448492135|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
124691493|NCT00884949|448492135|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
124691494|NCT01567085|448492138|FG000|Overall Study|Death|6|||
124691495|NCT01567085|448492138|FG000|Overall Study|Adverse Event|6|||
124691496|NCT01567085|448492138|FG000|Overall Study|Lost to Follow-up|3|||
124691497|NCT01567085|448492138|FG000|Overall Study|Graft loss|2|||
124691498|NCT01567085|448492138|FG000|Overall Study|Renal transplantectomy|1|||
124904573|NCT02974634|449276294|FG000|Overall Study|Advanced disease|12|||
124904574|NCT02974634|449276295|FG001|Overall Study|Advanced disease|3|||
124904575|NCT02974634|449276294|FG000|Overall Study|Noncompliance|3|||
124904576|NCT02974634|449276295|FG001|Overall Study|Noncompliance|7|||
124904577|NCT02974634|449276294|FG000|Overall Study|intervention technology related issues|5|||
124904578|NCT02974634|449276295|FG001|Overall Study|intervention technology related issues|0|||
124904579|NCT02974634|449276294|FG000|Overall Study|Death|8|||
124904580|NCT02974634|449276295|FG001|Overall Study|Death|11|||
124904581|NCT00661778|449276297|FG000|Overall Study|Disease Progression|23|||
124904582|NCT00661778|449276297|FG000|Overall Study|Adverse Event|18|||
124904583|NCT00661778|449276297|FG000|Overall Study|Reason not Specified|6|||
124904584|NCT00661778|449276297|FG000|Overall Study|Protocol Violation|2|||
124904585|NCT00661778|449276297|FG000|Overall Study|Withdrawal of Consent|1|||
124904586|NCT02962674|449276303|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
124904587|NCT00364286|449276304|FG000|Overall Study|Withdrawal by Subject|1|||
124904588|NCT00364286|449276304|FG000|Overall Study|Adverse Event|2|||
124904589|NCT02577523|449276307|FG000|Overall Study|Adverse Event|1|||
124904590|NCT02577523|449276308|FG001|Overall Study|Adverse Event|1|||
124904591|NCT02577523|449276307|FG000|Overall Study|Lack of Efficacy|1|||
124904592|NCT02577523|449276308|FG001|Overall Study|Lack of Efficacy|1|||
124904593|NCT02577523|449276307|FG000|Overall Study|Withdrawal by Subject|1|||
124904594|NCT02577523|449276308|FG001|Overall Study|Withdrawal by Subject|0|||
124904595|NCT01266265|449276311|FG000|Overall Study|Death|95|||
124904596|NCT01266265|449276312|FG001|Overall Study|Death|73|||
124904597|NCT01266265|449276311|FG000|Overall Study|Lost to Follow-up|23|||
124904598|NCT01266265|449276312|FG001|Overall Study|Lost to Follow-up|28|||
124904599|NCT01266265|449276311|FG000|Overall Study|Withdrawal by Subject|13|||
124904600|NCT01266265|449276312|FG001|Overall Study|Withdrawal by Subject|11|||
124904601|NCT01266265|449276311|FG000|Overall Study|Respiratory-related adverse event|2|||
124904602|NCT01266265|449276312|FG001|Overall Study|Respiratory-related adverse event|1|||
124904603|NCT01266265|449276311|FG000|Overall Study|Transferred care to another provider|22|||
124904604|NCT01266265|449276312|FG001|Overall Study|Transferred care to another provider|28|||
124904605|NCT01266265|449276311|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
124904606|NCT01266265|449276312|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
124904607|NCT01266265|449276311|FG000|Overall Study|Enrolled in another clinical study|15|||
124904608|NCT01266265|449276312|FG001|Overall Study|Enrolled in another clinical study|26|||
124904609|NCT01266265|449276311|FG000|Overall Study|Non-compliance|8|||
124904610|NCT01266265|449276312|FG001|Overall Study|Non-compliance|5|||
124904611|NCT01266265|449276311|FG000|Overall Study|Lung transplant|6|||
124904612|NCT01266265|449276312|FG001|Overall Study|Lung transplant|5|||
124904613|NCT01266265|449276311|FG000|Overall Study|Site closed early|4|||
124904614|NCT01266265|449276312|FG001|Overall Study|Site closed early|3|||
124904615|NCT01266265|449276311|FG000|Overall Study|Clinical worsening|1|||
124904616|NCT01266265|449276312|FG001|Overall Study|Clinical worsening|1|||
124904617|NCT01580293|449276313|FG000|Part A_Main Trial|Adverse Event|0|||
124904618|NCT01580293|449276314|FG001|Part A_Main Trial|Adverse Event|2|||
124904619|NCT01580293|449276315|FG002|Part A_Main Trial|Adverse Event|0|||
124904620|NCT01580293|449276313|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
124904621|NCT01580293|449276314|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
124449154|NCT03945591|447606927|FG000|Overall Study|Change in treatment plan|3|||
124449155|NCT03945591|447606927|FG000|Overall Study|Adverse Event|1|||
124449156|NCT03083847|447606928|FG000|Main|Physician Decision|0|||
124449157|NCT03083847|447606929|FG001|Main|Physician Decision|0|||
124449158|NCT03083847|447606930|FG002|Main|Physician Decision|0|||
124449159|NCT03083847|447606931|FG003|Main|Physician Decision|0|||
124449160|NCT03083847|447606932|FG004|Main|Physician Decision|0|||
124449161|NCT03083847|447606933|FG005|Main|Physician Decision|1|||
124449162|NCT03083847|447606934|FG006|Main|Physician Decision|0|||
124449163|NCT03083847|447606935|FG007|Main|Physician Decision|0|||
124449164|NCT03083847|447606936|FG008|Main|Physician Decision|0|||
124449165|NCT03083847|447606937|FG009|Main|Physician Decision|0|||
124449166|NCT03083847|447606928|FG000|Main|Pregnancy|0|||
124449167|NCT03083847|447606929|FG001|Main|Pregnancy|0|||
124449168|NCT03083847|447606930|FG002|Main|Pregnancy|0|||
124449169|NCT03083847|447606931|FG003|Main|Pregnancy|0|||
124760049|NCT02544321|448746752|FG000|Overall Study|Protocol Violation|0|||
124904622|NCT01580293|449276315|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
124904623|NCT01580293|449276313|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
124904624|NCT01580293|449276314|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
124904625|NCT01580293|449276315|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
124904626|NCT01580293|449276313|FG000|Part A_Extension|Adverse Event|0|||
124904627|NCT01580293|449276314|FG001|Part A_Extension|Adverse Event|2|||
124904628|NCT01580293|449276315|FG002|Part A_Extension|Adverse Event|0|||
124904629|NCT01580293|449276313|FG000|Part A_Extension|Withdrawal by Subject|0|||
124904630|NCT01580293|449276314|FG001|Part A_Extension|Withdrawal by Subject|3|||
124449170|NCT03083847|447606932|FG004|Main|Pregnancy|0|||
124449171|NCT03083847|447606933|FG005|Main|Pregnancy|0|||
124449172|NCT03083847|447606934|FG006|Main|Pregnancy|0|||
124449173|NCT03083847|447606935|FG007|Main|Pregnancy|1|||
124904631|NCT01580293|449276315|FG002|Part A_Extension|Withdrawal by Subject|0|||
124904632|NCT01580293|449276313|FG000|Part A_Extension|Lost to Follow-up|0|||
124904633|NCT01580293|449276314|FG001|Part A_Extension|Lost to Follow-up|1|||
124904634|NCT01580293|449276315|FG002|Part A_Extension|Lost to Follow-up|0|||
124904635|NCT01580293|449276313|FG000|Part A_Extension|Other Reason|0|||
124904636|NCT01580293|449276314|FG001|Part A_Extension|Other Reason|1|||
124904637|NCT01580293|449276315|FG002|Part A_Extension|Other Reason|0|||
124904638|NCT01580293|449276313|FG000|Part A_Extension|Completed Japan only|0|||
124904639|NCT01580293|449276314|FG001|Part A_Extension|Completed Japan only|5|||
124904640|NCT01580293|449276315|FG002|Part A_Extension|Completed Japan only|0|||
124904641|NCT01580293|449276313|FG000|Part B|Withdrawal by Subject|0|||
124904642|NCT01580293|449276314|FG001|Part B|Withdrawal by Subject|0|||
124904643|NCT01580293|449276315|FG002|Part B|Withdrawal by Subject|1|||
124904644|NCT01580293|449276313|FG000|Part B|Other reason|0|||
124904645|NCT01580293|449276314|FG001|Part B|Other reason|0|||
124904646|NCT01580293|449276315|FG002|Part B|Other reason|1|||
124904647|NCT00768664|449276318|FG000|Overall Study|Death|57|||
124904648|NCT00768664|449276318|FG000|Overall Study|Lost to Follow-up|2|||
124904649|NCT00768664|449276318|FG000|Overall Study|Other|9|||
124904650|NCT00768664|449276318|FG000|Overall Study|Participant refused|1|||
124449174|NCT03083847|447606936|FG008|Main|Pregnancy|0|||
124904651|NCT00708032|449276321|FG000|Overall Study|Adverse Event|0|||
124449175|NCT03083847|447606937|FG009|Main|Pregnancy|0|||
124904652|NCT00708032|449276322|FG001|Overall Study|Adverse Event|2|||
124904653|NCT00708032|449276321|FG000|Overall Study|Lost to Follow-up|1|||
124904654|NCT00708032|449276322|FG001|Overall Study|Lost to Follow-up|2|||
124904655|NCT00708032|449276321|FG000|Overall Study|Pregnancy|0|||
124904656|NCT00708032|449276322|FG001|Overall Study|Pregnancy|1|||
124691499|NCT01567085|448492138|FG000|Overall Study|Returned to chronic dialysis|1|||
124691500|NCT01567085|448492138|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
124691501|NCT00504231|448492139|FG000|Overall Study|Discrepant chart documentation re route|0|||
124691502|NCT00504231|448492140|FG001|Overall Study|Discrepant chart documentation re route|0|||
124691503|NCT00504231|448492141|FG002|Overall Study|Discrepant chart documentation re route|1|||
124691504|NCT00504231|448492142|FG003|Overall Study|Discrepant chart documentation re route|0|||
124691505|NCT03928704|448492143|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
124904657|NCT00708032|449276321|FG000|Overall Study|Poor vision|0|||
124904658|NCT00708032|449276322|FG001|Overall Study|Poor vision|6|||
124904659|NCT00708032|449276321|FG000|Overall Study|Visit out of range at month 12|4|||
124904660|NCT00708032|449276322|FG001|Overall Study|Visit out of range at month 12|1|||
124904661|NCT00708032|449276321|FG000|Overall Study|Did not meet protocol criteria|1|||
124904662|NCT00708032|449276322|FG001|Overall Study|Did not meet protocol criteria|2|||
124904663|NCT00708032|449276321|FG000|Overall Study|Protocol Violation|4|||
124904664|NCT00708032|449276322|FG001|Overall Study|Protocol Violation|1|||
124904665|NCT00708032|449276321|FG000|Overall Study|Withdrawal by Subject|0|||
124904666|NCT00708032|449276322|FG001|Overall Study|Withdrawal by Subject|1|||
124904667|NCT01400776|449276323|FG000|Overall Study|Adverse Event|7|||
124904668|NCT01400776|449276324|FG001|Overall Study|Adverse Event|2|||
124904669|NCT01400776|449276325|FG002|Overall Study|Adverse Event|9|||
124904670|NCT01400776|449276326|FG003|Overall Study|Adverse Event|2|||
124904671|NCT01400776|449276323|FG000|Overall Study|Lost to Follow-up|1|||
124904672|NCT01400776|449276324|FG001|Overall Study|Lost to Follow-up|0|||
124904673|NCT01400776|449276325|FG002|Overall Study|Lost to Follow-up|4|||
124904674|NCT01400776|449276326|FG003|Overall Study|Lost to Follow-up|1|||
124904675|NCT01400776|449276323|FG000|Overall Study|Withdrew Consent|4|||
124904676|NCT01400776|449276324|FG001|Overall Study|Withdrew Consent|2|||
124904677|NCT01400776|449276325|FG002|Overall Study|Withdrew Consent|6|||
124904678|NCT01400776|449276326|FG003|Overall Study|Withdrew Consent|1|||
124904679|NCT01400776|449276323|FG000|Overall Study|Protocol Deviation|6|||
124904680|NCT01400776|449276324|FG001|Overall Study|Protocol Deviation|1|||
124904681|NCT01400776|449276325|FG002|Overall Study|Protocol Deviation|5|||
124904682|NCT01400776|449276326|FG003|Overall Study|Protocol Deviation|2|||
124904683|NCT01400776|449276323|FG000|Overall Study|Reason not Specified|3|||
124904684|NCT01400776|449276324|FG001|Overall Study|Reason not Specified|0|||
124904685|NCT01400776|449276325|FG002|Overall Study|Reason not Specified|4|||
124904686|NCT01400776|449276326|FG003|Overall Study|Reason not Specified|3|||
124904687|NCT01227278|449276327|FG000|Overall Study|Withdrawal by Subject|4|||
124904688|NCT01227278|449276328|FG001|Overall Study|Withdrawal by Subject|4|||
124449176|NCT03083847|447606928|FG000|Main|Adverse Event|0|||
124449177|NCT03083847|447606929|FG001|Main|Adverse Event|0|||
124449178|NCT03083847|447606930|FG002|Main|Adverse Event|0|||
124449179|NCT03083847|447606931|FG003|Main|Adverse Event|0|||
124449180|NCT03083847|447606932|FG004|Main|Adverse Event|0|||
124449181|NCT03083847|447606933|FG005|Main|Adverse Event|0|||
124449182|NCT03083847|447606934|FG006|Main|Adverse Event|0|||
124449183|NCT03083847|447606935|FG007|Main|Adverse Event|2|||
124449184|NCT03083847|447606936|FG008|Main|Adverse Event|0|||
124449185|NCT03083847|447606937|FG009|Main|Adverse Event|0|||
124449186|NCT03083847|447606928|FG000|Main|Withdrawal by Subject|0|||
124449187|NCT03083847|447606929|FG001|Main|Withdrawal by Subject|0|||
124449188|NCT03083847|447606930|FG002|Main|Withdrawal by Subject|0|||
124449189|NCT03083847|447606931|FG003|Main|Withdrawal by Subject|0|||
124449190|NCT03083847|447606932|FG004|Main|Withdrawal by Subject|0|||
124449191|NCT03083847|447606933|FG005|Main|Withdrawal by Subject|0|||
124449192|NCT03083847|447606934|FG006|Main|Withdrawal by Subject|1|||
124449193|NCT03083847|447606935|FG007|Main|Withdrawal by Subject|1|||
124449194|NCT03083847|447606936|FG008|Main|Withdrawal by Subject|0|||
124691506|NCT03928704|448492144|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
124760050|NCT02544321|448746753|FG001|Overall Study|Protocol Violation|1|||
124904689|NCT01227278|449276327|FG000|Overall Study|Death|0|||
124904690|NCT01227278|449276328|FG001|Overall Study|Death|2|||
124449195|NCT03083847|447606937|FG009|Main|Withdrawal by Subject|0|||
124449196|NCT00058552|447606939|FG000|Overall Study|Died prior to receiving treatment|4|||
124449197|NCT00058552|447606940|FG001|Overall Study|Died prior to receiving treatment|2|||
124449198|NCT00058552|447606939|FG000|Overall Study|Disease progression|52|||
124449199|NCT00058552|447606940|FG001|Overall Study|Disease progression|44|||
124449200|NCT00058552|447606939|FG000|Overall Study|Adverse Event|4|||
124904691|NCT01227278|449276327|FG000|Overall Study|Other|1|||
124904692|NCT01227278|449276328|FG001|Overall Study|Other|2|||
124904693|NCT00423098|449276329|FG000|Overall Study|Adverse Event|1|||
124449201|NCT00058552|447606940|FG001|Overall Study|Adverse Event|2|||
124449202|NCT00058552|447606939|FG000|Overall Study|Withdrawal by Subject|3|||
124449203|NCT00058552|447606940|FG001|Overall Study|Withdrawal by Subject|5|||
124760051|NCT01584232|448746754|FG000|Overall Study|Adverse Event|3|||
124904694|NCT00423098|449276330|FG001|Overall Study|Adverse Event|2|||
124904695|NCT00423098|449276329|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124904696|NCT00423098|449276330|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124544492|NCT02576951|447946825|FG001|Overall Study|Withdrawal by Subject|0|||
124760052|NCT01584232|448746755|FG001|Overall Study|Adverse Event|1|||
124760053|NCT01584232|448746754|FG000|Overall Study|Withdrawal by Subject|2|||
124760054|NCT01584232|448746755|FG001|Overall Study|Withdrawal by Subject|1|||
124760055|NCT01584232|448746754|FG000|Overall Study|Physician Decision|2|||
124760056|NCT01584232|448746755|FG001|Overall Study|Physician Decision|1|||
124760057|NCT01584232|448746754|FG000|Overall Study|Lost to Follow-up|1|||
124760058|NCT01584232|448746755|FG001|Overall Study|Lost to Follow-up|0|||
124760059|NCT03347123|448746756|FG000|Overall Study|Death|1|||
124760060|NCT03347123|448746757|FG001|Overall Study|Death|2|||
124760061|NCT03347123|448746758|FG002|Overall Study|Death|0|||
124760062|NCT03347123|448746759|FG003|Overall Study|Death|0|||
124760063|NCT03347123|448746760|FG004|Overall Study|Death|0|||
124760064|NCT03347123|448746761|FG005|Overall Study|Death|0|||
124760065|NCT03347123|448746762|FG006|Overall Study|Death|0|||
124760066|NCT03347123|448746756|FG000|Overall Study|Withdrawal by Subject|1|||
124904697|NCT00423098|449276329|FG000|Overall Study|Administrative problems|0|||
124904698|NCT00423098|449276330|FG001|Overall Study|Administrative problems|1|||
124904699|NCT00423098|449276329|FG000|Overall Study|Death|2|||
124904700|NCT00423098|449276330|FG001|Overall Study|Death|0|||
124904701|NCT04035668|449276332|FG000|Overall Study|Adverse Event|3|||
124544493|NCT02576951|447946826|FG002|Overall Study|Withdrawal by Subject|0|||
124544494|NCT02576951|447946827|FG003|Overall Study|Withdrawal by Subject|2|||
124544495|NCT02576951|447946824|FG000|Overall Study|Protocol Violation|0|||
124544496|NCT02576951|447946825|FG001|Overall Study|Protocol Violation|0|||
124544497|NCT02576951|447946826|FG002|Overall Study|Protocol Violation|0|||
124544498|NCT02576951|447946827|FG003|Overall Study|Protocol Violation|1|||
124544499|NCT00822237|447949164|FG000|Dose 1 Vaccination|Not vaccinated|3|||
124544500|NCT00822237|447949165|FG001|Dose 1 Vaccination|Not vaccinated|0|||
124544501|NCT00822237|447949164|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
124544502|NCT00822237|447949165|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
124544503|NCT00822237|447949164|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
124544504|NCT00822237|447949165|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
124544505|NCT00822237|447949164|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
124544506|NCT00822237|447949165|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
124544507|NCT00822237|447949164|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
124544508|NCT00822237|447949165|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
124544509|NCT00968539|447949170|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
124544510|NCT00968539|447949171|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
124904702|NCT04035668|449276333|FG001|Overall Study|Adverse Event|4|||
124904703|NCT04035668|449276334|FG002|Overall Study|Adverse Event|2|||
124904704|NCT04035668|449276332|FG000|Overall Study|Lost to Follow-up|0|||
124904705|NCT04035668|449276333|FG001|Overall Study|Lost to Follow-up|1|||
124904706|NCT04035668|449276334|FG002|Overall Study|Lost to Follow-up|0|||
124904707|NCT04035668|449276332|FG000|Overall Study|Physician Decision|2|||
124904708|NCT04035668|449276333|FG001|Overall Study|Physician Decision|1|||
124904709|NCT04035668|449276334|FG002|Overall Study|Physician Decision|1|||
124904710|NCT04035668|449276332|FG000|Overall Study|Subject Decision|2|||
124904711|NCT04035668|449276333|FG001|Overall Study|Subject Decision|2|||
124904712|NCT04035668|449276334|FG002|Overall Study|Subject Decision|0|||
124904713|NCT02320123|449276336|FG000|Overall Study|Lost to Follow-up|4|||
124544511|NCT00457249|447949172|FG000|Overall Study|Lost to Follow-up|3|||
124544512|NCT00457249|447949173|FG001|Overall Study|Lost to Follow-up|0|||
124544513|NCT00457249|447949172|FG000|Overall Study|Protocol Violation|4|||
124760067|NCT03347123|448746757|FG001|Overall Study|Withdrawal by Subject|0|||
124760068|NCT03347123|448746758|FG002|Overall Study|Withdrawal by Subject|0|||
124760069|NCT03347123|448746759|FG003|Overall Study|Withdrawal by Subject|0|||
124760070|NCT03347123|448746760|FG004|Overall Study|Withdrawal by Subject|0|||
124760071|NCT03347123|448746761|FG005|Overall Study|Withdrawal by Subject|0|||
124760072|NCT03347123|448746762|FG006|Overall Study|Withdrawal by Subject|0|||
124760073|NCT03347123|448746756|FG000|Overall Study|Reason not Specified|3|||
124760074|NCT03347123|448746757|FG001|Overall Study|Reason not Specified|4|||
124904714|NCT02320123|449276337|FG001|Overall Study|Lost to Follow-up|6|||
124904715|NCT02320123|449276336|FG000|Overall Study|Death|6|||
124904716|NCT02320123|449276337|FG001|Overall Study|Death|5|||
124904717|NCT04480827|449276338|FG000|Overall Study|Adverse Event|0|||
124904718|NCT04480827|449276339|FG001|Overall Study|Adverse Event|0|||
124544514|NCT00457249|447949173|FG001|Overall Study|Protocol Violation|1|||
124544515|NCT00457249|447949172|FG000|Overall Study|Withdrawal by Subject|3|||
124544516|NCT00457249|447949173|FG001|Overall Study|Withdrawal by Subject|1|||
124544517|NCT00457249|447949172|FG000|Overall Study|Serious Adverse Events|2|||
124544518|NCT00457249|447949173|FG001|Overall Study|Serious Adverse Events|0|||
124760075|NCT03347123|448746758|FG002|Overall Study|Reason not Specified|0|||
124760076|NCT03347123|448746759|FG003|Overall Study|Reason not Specified|0|||
124904719|NCT04480827|449276340|FG002|Overall Study|Adverse Event|0|||
124904720|NCT04480827|449276341|FG003|Overall Study|Adverse Event|0|||
124904721|NCT04480827|449276342|FG004|Overall Study|Adverse Event|0|||
124904722|NCT04480827|449276343|FG005|Overall Study|Adverse Event|1|||
124904723|NCT04480827|449276344|FG006|Overall Study|Adverse Event|0|||
124691507|NCT03928704|448492145|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
124691508|NCT03928704|448492146|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
124691509|NCT03928704|448492147|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
124691510|NCT03928704|448492148|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
124691511|NCT03928704|448492143|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
124691512|NCT03928704|448492144|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
124691513|NCT03928704|448492145|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
124904724|NCT00465816|449276345|FG000|Overall Study|Lost to Follow-up|0|||
124904725|NCT00465816|449276346|FG001|Overall Study|Lost to Follow-up|0|||
124904726|NCT00465816|449276347|FG002|Overall Study|Lost to Follow-up|2|||
124904727|NCT00941655|449276350|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
124904728|NCT00941655|449276351|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
124904729|NCT00941655|449276350|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
124904730|NCT00941655|449276351|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
124904731|NCT00941655|449276350|FG000|Overall Study|progressed while on chemo|0|||
124904732|NCT00941655|449276351|FG001|Overall Study|progressed while on chemo|2|||
124904733|NCT00941655|449276350|FG000|Overall Study|refused further treatment|0|||
124904734|NCT00941655|449276351|FG001|Overall Study|refused further treatment|1|||
124904735|NCT00941655|449276350|FG000|Overall Study|withdrew consent|0|||
124904736|NCT00941655|449276351|FG001|Overall Study|withdrew consent|1|||
124904737|NCT00941655|449276350|FG000|Overall Study|non-compliant|0|||
124904738|NCT00941655|449276351|FG001|Overall Study|non-compliant|1|||
124904739|NCT02477670|449276352|FG000|Stage 1|Adverse Event|2|||
124904740|NCT02477670|449276353|FG001|Stage 1|Adverse Event|7|||
124904741|NCT02477670|449276354|FG002|Stage 1|Adverse Event|0|||
124904742|NCT02477670|449276355|FG003|Stage 1|Adverse Event|0|||
124904743|NCT02477670|449276356|FG004|Stage 1|Adverse Event|0|||
124904744|NCT02477670|449276357|FG005|Stage 1|Adverse Event|0|||
124904745|NCT02477670|449276358|FG006|Stage 1|Adverse Event|0|||
124544519|NCT00326118|447949174|FG000|Active Phase|Withdrawal by Subject|4|||
124904746|NCT02477670|449276352|FG000|Stage 1|Lost to Follow-up|0|||
124904747|NCT02477670|449276353|FG001|Stage 1|Lost to Follow-up|2|||
124904748|NCT02477670|449276354|FG002|Stage 1|Lost to Follow-up|0|||
124904749|NCT02477670|449276355|FG003|Stage 1|Lost to Follow-up|0|||
124904750|NCT02477670|449276356|FG004|Stage 1|Lost to Follow-up|0|||
124691514|NCT03928704|448492146|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
124691515|NCT03928704|448492147|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
124691516|NCT03928704|448492148|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
124691517|NCT03928704|448492143|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
124691518|NCT03928704|448492144|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
124691519|NCT03928704|448492145|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
124691520|NCT03928704|448492146|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
124691521|NCT03928704|448492147|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
124904751|NCT02477670|449276357|FG005|Stage 1|Lost to Follow-up|0|||
124904752|NCT02477670|449276358|FG006|Stage 1|Lost to Follow-up|0|||
124691522|NCT03928704|448492148|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
124904753|NCT02477670|449276352|FG000|Stage 1|Withdrawal by Subject|1|||
124904754|NCT02477670|449276353|FG001|Stage 1|Withdrawal by Subject|2|||
124904755|NCT02477670|449276354|FG002|Stage 1|Withdrawal by Subject|0|||
124904756|NCT02477670|449276355|FG003|Stage 1|Withdrawal by Subject|0|||
124904757|NCT02477670|449276356|FG004|Stage 1|Withdrawal by Subject|0|||
124904758|NCT02477670|449276357|FG005|Stage 1|Withdrawal by Subject|0|||
124904759|NCT02477670|449276358|FG006|Stage 1|Withdrawal by Subject|0|||
124904760|NCT02477670|449276352|FG000|Stage 1|Non-compliance with Study Drug|1|||
124904761|NCT02477670|449276353|FG001|Stage 1|Non-compliance with Study Drug|2|||
124904762|NCT02477670|449276354|FG002|Stage 1|Non-compliance with Study Drug|0|||
124904763|NCT02477670|449276355|FG003|Stage 1|Non-compliance with Study Drug|0|||
124904764|NCT02477670|449276356|FG004|Stage 1|Non-compliance with Study Drug|0|||
124904765|NCT02477670|449276357|FG005|Stage 1|Non-compliance with Study Drug|0|||
124904766|NCT02477670|449276358|FG006|Stage 1|Non-compliance with Study Drug|0|||
124904767|NCT02477670|449276352|FG000|Stage 2|Adverse Event|0|||
124904768|NCT02477670|449276353|FG001|Stage 2|Adverse Event|0|||
124904769|NCT02477670|449276354|FG002|Stage 2|Adverse Event|1|||
124904770|NCT02477670|449276355|FG003|Stage 2|Adverse Event|0|||
124904771|NCT02477670|449276356|FG004|Stage 2|Adverse Event|0|||
124904772|NCT02477670|449276357|FG005|Stage 2|Adverse Event|0|||
124904773|NCT02477670|449276358|FG006|Stage 2|Adverse Event|0|||
124904774|NCT02477670|449276352|FG000|Stage 2|Antipsychotic Medication Changed|0|||
124904775|NCT02477670|449276353|FG001|Stage 2|Antipsychotic Medication Changed|0|||
124904776|NCT02477670|449276354|FG002|Stage 2|Antipsychotic Medication Changed|1|||
124904777|NCT02477670|449276355|FG003|Stage 2|Antipsychotic Medication Changed|0|||
124904778|NCT02477670|449276356|FG004|Stage 2|Antipsychotic Medication Changed|0|||
124904779|NCT02477670|449276357|FG005|Stage 2|Antipsychotic Medication Changed|0|||
124904780|NCT02477670|449276358|FG006|Stage 2|Antipsychotic Medication Changed|0|||
124904781|NCT02477670|449276352|FG000|Stage 2|Withdrawal by Subject|0|||
124904782|NCT02477670|449276353|FG001|Stage 2|Withdrawal by Subject|0|||
124904783|NCT02477670|449276354|FG002|Stage 2|Withdrawal by Subject|0|||
124904784|NCT02477670|449276355|FG003|Stage 2|Withdrawal by Subject|1|||
124904785|NCT02477670|449276356|FG004|Stage 2|Withdrawal by Subject|0|||
124904786|NCT02477670|449276357|FG005|Stage 2|Withdrawal by Subject|0|||
124904787|NCT02477670|449276358|FG006|Stage 2|Withdrawal by Subject|0|||
124904788|NCT00446550|449276363|FG000|Overall Study|Adverse Event|1|||
124904789|NCT00446550|449276364|FG001|Overall Study|Adverse Event|0|||
124904790|NCT02937831|449276365|FG000|Overall Study|Protocol Violation|4|||
124904791|NCT03720210|449276370|FG000|Overall Study|Lost to Follow-up|1|||
124904792|NCT00114244|449276371|FG000|Overall Study|Adverse Event|2|||
124904793|NCT00114244|449276372|FG001|Overall Study|Adverse Event|5|||
124449204|NCT00058552|447606939|FG000|Overall Study|Physician Decision|2|||
124449205|NCT00058552|447606940|FG001|Overall Study|Physician Decision|5|||
124449206|NCT00058552|447606939|FG000|Overall Study|Clinical disease progression|0|||
124449207|NCT00058552|447606940|FG001|Overall Study|Clinical disease progression|4|||
124449208|NCT02319668|447606941|FG000|Overall Study|Other (Not specified)|0|||
124449209|NCT02319668|447606942|FG001|Overall Study|Other (Not specified)|2|||
124449210|NCT02316340|447606945|FG000|First Progression|Clinical progression|2|||
124449211|NCT02316340|447606946|FG001|First Progression|Clinical progression|1|||
124449212|NCT02316340|447606945|FG000|First Progression|Withdrawal by Subject|1|||
124449213|NCT02316340|447606946|FG001|First Progression|Withdrawal by Subject|0|||
124449214|NCT01986920|447606947|FG000|A- 101 25%|Withdrawal by Subject|1|||
124449215|NCT01986920|447606948|FG001|A- 101 25%|Withdrawal by Subject|0|||
124449216|NCT01986920|447606949|FG002|A- 101 25%|Withdrawal by Subject|0|||
124449217|NCT01986920|447606950|FG003|A- 101 25%|Withdrawal by Subject|0|||
124449218|NCT01986920|447606947|FG000|A-101 32.5%|Withdrawal by Subject|0|||
124449219|NCT01986920|447606948|FG001|A-101 32.5%|Withdrawal by Subject|1|||
124449220|NCT01986920|447606949|FG002|A-101 32.5%|Withdrawal by Subject|0|||
124449221|NCT01986920|447606950|FG003|A-101 32.5%|Withdrawal by Subject|0|||
124449222|NCT01986920|447606947|FG000|A-101 40%|Withdrawal by Subject|0|||
124449223|NCT01986920|447606948|FG001|A-101 40%|Withdrawal by Subject|0|||
124904794|NCT00114244|449276371|FG000|Overall Study|Withdrawal by Subject|0|||
124904795|NCT00114244|449276372|FG001|Overall Study|Withdrawal by Subject|2|||
124904796|NCT00711958|449276373|FG000|Overall Study|Withdrawal by Subject|6|||
124904797|NCT00711958|449276374|FG001|Overall Study|Withdrawal by Subject|8|||
124904798|NCT00711958|449276373|FG000|Overall Study|Lack of Efficacy|3|||
124691523|NCT03928704|448492143|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
124691524|NCT03928704|448492144|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
124904799|NCT00711958|449276374|FG001|Overall Study|Lack of Efficacy|1|||
124904800|NCT00711958|449276373|FG000|Overall Study|Clinical deterioration|1|||
124904801|NCT00711958|449276374|FG001|Overall Study|Clinical deterioration|0|||
124904802|NCT00711958|449276373|FG000|Overall Study|Adverse Event|9|||
124904803|NCT00711958|449276374|FG001|Overall Study|Adverse Event|7|||
124904804|NCT00711958|449276373|FG000|Overall Study|Protocol Violation|1|||
124904805|NCT00711958|449276374|FG001|Overall Study|Protocol Violation|0|||
124904806|NCT00711958|449276373|FG000|Overall Study|Lost to Follow-up|2|||
124904807|NCT00711958|449276374|FG001|Overall Study|Lost to Follow-up|2|||
124904808|NCT00711958|449276373|FG000|Overall Study|Death|10|||
124904809|NCT00711958|449276374|FG001|Overall Study|Death|5|||
124904810|NCT00711958|449276373|FG000|Overall Study|Progression of disease|1|||
124904811|NCT00711958|449276374|FG001|Overall Study|Progression of disease|0|||
124904812|NCT02694978|449276377|FG000|Overall Study|Adverse Event|10|||
124904813|NCT02694978|449276378|FG001|Overall Study|Adverse Event|9|||
124904814|NCT02694978|449276377|FG000|Overall Study|Withdrawal by Subject|22|||
124904815|NCT02694978|449276378|FG001|Overall Study|Withdrawal by Subject|19|||
124904816|NCT02694978|449276377|FG000|Overall Study|Lost to Follow-up|14|||
124904817|NCT02694978|449276378|FG001|Overall Study|Lost to Follow-up|17|||
124904818|NCT02694978|449276377|FG000|Overall Study|Death|4|||
124904819|NCT02694978|449276378|FG001|Overall Study|Death|1|||
124904820|NCT02694978|449276377|FG000|Overall Study|Other-Decision of Participant|6|||
124449224|NCT01986920|447606949|FG002|A-101 40%|Withdrawal by Subject|1|||
124449225|NCT01986920|447606950|FG003|A-101 40%|Withdrawal by Subject|0|||
124449226|NCT01986920|447606947|FG000|Placebo|Withdrawal by Subject|0|||
124449227|NCT01986920|447606948|FG001|Placebo|Withdrawal by Subject|0|||
124449228|NCT01986920|447606949|FG002|Placebo|Withdrawal by Subject|0|||
124449229|NCT01986920|447606950|FG003|Placebo|Withdrawal by Subject|1|||
124449230|NCT03781323|447606951|FG000|Overall Study|Withdrawal by Subject|1|||
124449231|NCT01338415|447606952|FG000|Core + Extension|Adverse Event|8|||
124449232|NCT01338415|447606953|FG001|Core + Extension|Adverse Event|6|||
124449233|NCT01338415|447606954|FG002|Core + Extension|Adverse Event|0|||
124449234|NCT01338415|447606952|FG000|Core + Extension|Withdrawal by Subject|1|||
124449235|NCT01338415|447606953|FG001|Core + Extension|Withdrawal by Subject|1|||
124449236|NCT01338415|447606954|FG002|Core + Extension|Withdrawal by Subject|0|||
124449237|NCT01338415|447606952|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
124449238|NCT01338415|447606953|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
124449239|NCT01338415|447606954|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
124449240|NCT01338415|447606952|FG000|Core + Extension|Other (administrative reason)|1|||
124449241|NCT01338415|447606953|FG001|Core + Extension|Other (administrative reason)|0|||
124449242|NCT01338415|447606954|FG002|Core + Extension|Other (administrative reason)|0|||
124449243|NCT01338415|447606952|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
124449244|NCT01338415|447606953|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
124449245|NCT01338415|447606954|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
124449246|NCT01338415|447606952|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
124449247|NCT01338415|447606953|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
124449248|NCT01338415|447606954|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
124449249|NCT01338415|447606952|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
124449250|NCT01338415|447606953|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
124449251|NCT01338415|447606954|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
124449252|NCT01338415|447606952|FG000|Exceptional Use Treatment Period|Death|0|||
124449253|NCT01338415|447606953|FG001|Exceptional Use Treatment Period|Death|0|||
124449254|NCT01338415|447606954|FG002|Exceptional Use Treatment Period|Death|1|||
124449255|NCT04880447|447606960|FG000|Overall Study|No vaccination information|1|||
124449256|NCT04880447|447606960|FG000|Overall Study|No adverse event information (missing information)|1|||
124449257|NCT04880447|447606960|FG000|Overall Study|Disease not covered in this study|35|||
124449258|NCT01970488|447606961|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
124449259|NCT01970488|447606962|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
124449260|NCT01970488|447606963|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
124449261|NCT01970488|447606964|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
124449262|NCT01970488|447606965|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
124449263|NCT01970488|447606961|FG000|Part 1: Through Week 16|Protocol Violation|1|||
124449264|NCT01970488|447606962|FG001|Part 1: Through Week 16|Protocol Violation|2|||
124449265|NCT01970488|447606963|FG002|Part 1: Through Week 16|Protocol Violation|0|||
124449266|NCT01970488|447606964|FG003|Part 1: Through Week 16|Protocol Violation|0|||
124904821|NCT02694978|449276378|FG001|Overall Study|Other-Decision of Participant|1|||
124904822|NCT02694978|449276377|FG000|Overall Study|Other-Investigator's decision|1|||
124904823|NCT02694978|449276378|FG001|Overall Study|Other-Investigator's decision|0|||
124904824|NCT02694978|449276377|FG000|Overall Study|Other-Unable to be reached|0|||
124904825|NCT02694978|449276378|FG001|Overall Study|Other-Unable to be reached|1|||
124904826|NCT02694978|449276377|FG000|Overall Study|Other-Protocol noncompliant|2|||
124904827|NCT02694978|449276378|FG001|Overall Study|Other-Protocol noncompliant|1|||
124904828|NCT02694978|449276377|FG000|Overall Study|Other-Personal reasons|3|||
124904829|NCT02694978|449276378|FG001|Overall Study|Other-Personal reasons|3|||
124904830|NCT02694978|449276377|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
124904831|NCT02694978|449276378|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
124904832|NCT01613716|449276379|FG000|Overall Study|screen failures|3|||
124904833|NCT01613716|449276379|FG000|Overall Study|Lost to Follow-up|4|||
124904834|NCT02224924|449276380|FG000|Overall Study|Withdrawal by Subject|7|||
124904835|NCT02224924|449276381|FG001|Overall Study|Withdrawal by Subject|6|||
124904836|NCT02224924|449276380|FG000|Overall Study|Biopsy cancelled|20|||
124904837|NCT02224924|449276381|FG001|Overall Study|Biopsy cancelled|14|||
124904838|NCT02224924|449276380|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
124904839|NCT02224924|449276381|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
124904840|NCT02224924|449276380|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
124904841|NCT02224924|449276381|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
124904842|NCT03020745|449276382|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904843|NCT03020745|449276383|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904844|NCT03020745|449276384|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904845|NCT03020745|449276385|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904846|NCT03020745|449276386|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904847|NCT03020745|449276387|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904848|NCT03020745|449276388|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904849|NCT03020745|449276389|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904850|NCT03020745|449276390|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
124904851|NCT03020745|449276391|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
124904852|NCT03020745|449276382|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
124904853|NCT03020745|449276383|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
124904854|NCT03020745|449276384|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
124904855|NCT03020745|449276385|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
124904856|NCT03020745|449276386|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
124904857|NCT03020745|449276387|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
124904858|NCT03020745|449276388|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
124904859|NCT03020745|449276389|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
124904860|NCT03020745|449276390|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
124904861|NCT03020745|449276391|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
124449267|NCT01970488|447606965|FG004|Part 1: Through Week 16|Protocol Violation|0|||
124449268|NCT01970488|447606961|FG000|Part 1: Through Week 16|Adverse Event|6|||
124904862|NCT03020745|449276382|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
124904863|NCT03020745|449276383|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
124904864|NCT03020745|449276384|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
124904865|NCT03020745|449276385|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
124904866|NCT03020745|449276386|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
124691525|NCT03928704|448492145|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
124904867|NCT03020745|449276387|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
124904868|NCT03020745|449276388|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
124904869|NCT03020745|449276389|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
124904870|NCT03020745|449276390|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
124904871|NCT03020745|449276391|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
124904872|NCT03020745|449276382|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904873|NCT03020745|449276383|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904874|NCT03020745|449276384|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904875|NCT03020745|449276385|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904876|NCT03020745|449276386|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904877|NCT03020745|449276387|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904878|NCT03020745|449276388|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904879|NCT03020745|449276389|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904880|NCT03020745|449276390|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
124904881|NCT03020745|449276391|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
124904882|NCT03184558|449276394|FG000|Overall Study|Withdrawal by Subject|2|||
124904883|NCT03184558|449276394|FG000|Overall Study|Death|16|||
124904884|NCT03184558|449276394|FG000|Overall Study|Lost to Follow-up|2|||
124904885|NCT03184558|449276394|FG000|Overall Study|Other|9|||
124904886|NCT02506257|449276395|FG000|Overall Study|Adverse Event|0|||
124904887|NCT02506257|449276396|FG001|Overall Study|Adverse Event|2|||
124904888|NCT02506257|449276397|FG002|Overall Study|Adverse Event|3|||
124904889|NCT02506257|449276398|FG003|Overall Study|Adverse Event|0|||
124904890|NCT02506257|449276395|FG000|Overall Study|Protocol Violation|0|||
124904891|NCT02506257|449276396|FG001|Overall Study|Protocol Violation|0|||
124904892|NCT02506257|449276397|FG002|Overall Study|Protocol Violation|1|||
124904893|NCT02506257|449276398|FG003|Overall Study|Protocol Violation|0|||
124904894|NCT01924767|449276401|FG000|Overall Study|Adverse Event|1|||
124904895|NCT01924767|449276402|FG001|Overall Study|Adverse Event|0|||
124904896|NCT01924767|449276403|FG002|Overall Study|Adverse Event|1|||
124904897|NCT01924767|449276404|FG003|Overall Study|Adverse Event|0|||
124904898|NCT01924767|449276405|FG004|Overall Study|Adverse Event|0|||
124904899|NCT00139737|449276413|FG000|Overall Study|Withdrawal by Subject|190|||
124904900|NCT00139737|449276413|FG000|Overall Study|Adverse Event|58|||
124904901|NCT00139737|449276413|FG000|Overall Study|Lack of Efficacy|40|||
124904902|NCT00139737|449276413|FG000|Overall Study|Lost to Follow-up|8|||
124904903|NCT00139737|449276413|FG000|Overall Study|Death|3|||
124904904|NCT00139737|449276413|FG000|Overall Study|Laboratory Abnormality|2|||
124904905|NCT00139737|449276413|FG000|Overall Study|Protocol Violation|18|||
124904906|NCT00139737|449276413|FG000|Overall Study|Withdrew During Screening Phase|8|||
124904907|NCT00139737|449276413|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
124904908|NCT00139737|449276413|FG000|Overall Study|Screened, Not Treated|13|||
124904909|NCT03781336|449276416|FG000|Overall Study|Withdrawal by Subject|2|||
124904910|NCT03781336|449276417|FG001|Overall Study|Withdrawal by Subject|2|||
124904911|NCT03460756|449276418|FG000|Overall Study|Adverse Event|0|||
124904912|NCT03460756|449276419|FG001|Overall Study|Adverse Event|0|||
124904913|NCT03460756|449276420|FG002|Overall Study|Adverse Event|0|||
124904914|NCT03460756|449276421|FG003|Overall Study|Adverse Event|1|||
124904915|NCT03460756|449276418|FG000|Overall Study|Lack of Efficacy|0|||
124904916|NCT03460756|449276419|FG001|Overall Study|Lack of Efficacy|0|||
124904917|NCT03460756|449276420|FG002|Overall Study|Lack of Efficacy|0|||
124904918|NCT03460756|449276421|FG003|Overall Study|Lack of Efficacy|2|||
124904919|NCT03460756|449276418|FG000|Overall Study|Lost to Follow-up|0|||
124904920|NCT03460756|449276419|FG001|Overall Study|Lost to Follow-up|1|||
124544520|NCT00326118|447949175|FG001|Active Phase|Withdrawal by Subject|1|||
124544521|NCT02916056|447949176|FG000|Overall Study|Adverse Event|6|||
124544522|NCT02916056|447949176|FG000|Overall Study|Lost to Follow-up|1|||
124544523|NCT02916056|447949176|FG000|Overall Study|Other|12|||
124544524|NCT02916056|447949176|FG000|Overall Study|Protocol Violation|1|||
124544525|NCT02916056|447949176|FG000|Overall Study|Withdrawal by Subject|8|||
124544526|NCT02916056|447949176|FG000|Overall Study|Study Terminated by Sponsor|269|||
124544527|NCT00290511|447949177|FG000|Overall Study|Adverse Event|1|||
124544528|NCT00290511|447949177|FG000|Overall Study|Death|1|||
124544529|NCT00290511|447949177|FG000|Overall Study|Physician Decision|1|||
124544530|NCT00290511|447949177|FG000|Overall Study|Withdrawal by Subject|1|||
124544531|NCT00122954|447949178|FG000|Overall Study|Withdrawal by Subject|2|||
124544532|NCT00122954|447949179|FG001|Overall Study|Withdrawal by Subject|2|||
124544533|NCT00122954|447949178|FG000|Overall Study|Protocol Violation|0|||
124544534|NCT00122954|447949179|FG001|Overall Study|Protocol Violation|1|||
124544535|NCT00526162|447949185|FG000|Overall Study|Device not implanted|3|||
124544536|NCT05279807|447949186|FG000|Overall Study|Withdrawal by Subject|1|||
124544537|NCT05279807|447949187|FG001|Overall Study|Withdrawal by Subject|0|||
124544538|NCT05279807|447949186|FG000|Overall Study|Adverse Event|0|||
124544539|NCT05279807|447949187|FG001|Overall Study|Adverse Event|1|||
124544540|NCT05279807|447949186|FG000|Overall Study|Laboratory Abnormal Results|1|||
124544541|NCT05279807|447949187|FG001|Overall Study|Laboratory Abnormal Results|0|||
124544542|NCT05993299|447949188|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
124544543|NCT05993299|447949188|FG000|Overall Study|Ongoing|4|||
124544544|NCT03110107|447949189|FG000|Treatment Period|Disease Progression|3|||
124544545|NCT03110107|447949190|FG001|Treatment Period|Disease Progression|9|||
124544546|NCT03110107|447949191|FG002|Treatment Period|Disease Progression|8|||
124544547|NCT03110107|447949192|FG003|Treatment Period|Disease Progression|11|||
124544548|NCT03110107|447949193|FG004|Treatment Period|Disease Progression|8|||
124544549|NCT03110107|447949194|FG005|Treatment Period|Disease Progression|4|||
124544550|NCT03110107|447949195|FG006|Treatment Period|Disease Progression|6|||
124544551|NCT03110107|447949196|FG007|Treatment Period|Disease Progression|7|||
124544552|NCT03110107|447949197|FG008|Treatment Period|Disease Progression|2|||
124544553|NCT03110107|447949198|FG009|Treatment Period|Disease Progression|10|||
124544554|NCT03110107|447949199|FG010|Treatment Period|Disease Progression|5|||
124544555|NCT03110107|447949200|FG011|Treatment Period|Disease Progression|2|||
124544556|NCT03110107|447949201|FG012|Treatment Period|Disease Progression|0|||
124544557|NCT03110107|447949202|FG013|Treatment Period|Disease Progression|5|||
124544558|NCT03110107|447949203|FG014|Treatment Period|Disease Progression|14|||
124544559|NCT03110107|447949204|FG015|Treatment Period|Disease Progression|14|||
124544560|NCT03110107|447949205|FG016|Treatment Period|Disease Progression|4|||
124544561|NCT03110107|447949206|FG017|Treatment Period|Disease Progression|3|||
124544562|NCT03110107|447949207|FG018|Treatment Period|Disease Progression|16|||
124544563|NCT03110107|447949208|FG019|Treatment Period|Disease Progression|14|||
124544564|NCT03110107|447949209|FG020|Treatment Period|Disease Progression|12|||
124544565|NCT03110107|447949210|FG021|Treatment Period|Disease Progression|16|||
124544566|NCT03110107|447949211|FG022|Treatment Period|Disease Progression|18|||
124544567|NCT03110107|447949212|FG023|Treatment Period|Disease Progression|13|||
124544568|NCT03110107|447949213|FG024|Treatment Period|Disease Progression|16|||
124544569|NCT03110107|447949214|FG025|Treatment Period|Disease Progression|31|||
124544570|NCT03110107|447949189|FG000|Treatment Period|Study drug toxicity|1|||
124544571|NCT03110107|447949190|FG001|Treatment Period|Study drug toxicity|0|||
124544572|NCT03110107|447949191|FG002|Treatment Period|Study drug toxicity|1|||
124544573|NCT03110107|447949192|FG003|Treatment Period|Study drug toxicity|2|||
124544574|NCT03110107|447949193|FG004|Treatment Period|Study drug toxicity|0|||
124544575|NCT03110107|447949194|FG005|Treatment Period|Study drug toxicity|3|||
124544576|NCT03110107|447949195|FG006|Treatment Period|Study drug toxicity|1|||
124544577|NCT03110107|447949196|FG007|Treatment Period|Study drug toxicity|1|||
124544578|NCT03110107|447949197|FG008|Treatment Period|Study drug toxicity|3|||
124544579|NCT03110107|447949198|FG009|Treatment Period|Study drug toxicity|2|||
124544580|NCT03110107|447949199|FG010|Treatment Period|Study drug toxicity|0|||
124544581|NCT03110107|447949200|FG011|Treatment Period|Study drug toxicity|2|||
124544582|NCT03110107|447949201|FG012|Treatment Period|Study drug toxicity|0|||
124544583|NCT03110107|447949202|FG013|Treatment Period|Study drug toxicity|0|||
124544584|NCT03110107|447949203|FG014|Treatment Period|Study drug toxicity|2|||
124544585|NCT03110107|447949204|FG015|Treatment Period|Study drug toxicity|3|||
124544586|NCT03110107|447949205|FG016|Treatment Period|Study drug toxicity|3|||
124544587|NCT03110107|447949206|FG017|Treatment Period|Study drug toxicity|3|||
124544588|NCT03110107|447949207|FG018|Treatment Period|Study drug toxicity|1|||
124544589|NCT03110107|447949208|FG019|Treatment Period|Study drug toxicity|2|||
124544590|NCT03110107|447949209|FG020|Treatment Period|Study drug toxicity|2|||
124544591|NCT03110107|447949210|FG021|Treatment Period|Study drug toxicity|0|||
124544592|NCT03110107|447949211|FG022|Treatment Period|Study drug toxicity|2|||
124544593|NCT03110107|447949212|FG023|Treatment Period|Study drug toxicity|6|||
124544594|NCT03110107|447949213|FG024|Treatment Period|Study drug toxicity|7|||
124544595|NCT03110107|447949214|FG025|Treatment Period|Study drug toxicity|6|||
124544596|NCT03110107|447949189|FG000|Treatment Period|Death|0|||
124544597|NCT03110107|447949190|FG001|Treatment Period|Death|0|||
124544598|NCT03110107|447949191|FG002|Treatment Period|Death|0|||
124544599|NCT03110107|447949192|FG003|Treatment Period|Death|0|||
124544600|NCT03110107|447949193|FG004|Treatment Period|Death|0|||
124544601|NCT03110107|447949194|FG005|Treatment Period|Death|0|||
124544602|NCT03110107|447949195|FG006|Treatment Period|Death|0|||
124544603|NCT03110107|447949196|FG007|Treatment Period|Death|0|||
124544604|NCT03110107|447949197|FG008|Treatment Period|Death|0|||
124544605|NCT03110107|447949198|FG009|Treatment Period|Death|0|||
124544606|NCT03110107|447949199|FG010|Treatment Period|Death|0|||
124544607|NCT03110107|447949200|FG011|Treatment Period|Death|0|||
124544608|NCT03110107|447949201|FG012|Treatment Period|Death|1|||
124544609|NCT03110107|447949202|FG013|Treatment Period|Death|0|||
124544610|NCT03110107|447949203|FG014|Treatment Period|Death|0|||
124544611|NCT03110107|447949204|FG015|Treatment Period|Death|0|||
124544612|NCT03110107|447949205|FG016|Treatment Period|Death|0|||
124544613|NCT03110107|447949206|FG017|Treatment Period|Death|0|||
124544614|NCT03110107|447949207|FG018|Treatment Period|Death|0|||
124544615|NCT03110107|447949208|FG019|Treatment Period|Death|0|||
124544616|NCT03110107|447949209|FG020|Treatment Period|Death|0|||
124544617|NCT03110107|447949210|FG021|Treatment Period|Death|0|||
124544618|NCT03110107|447949211|FG022|Treatment Period|Death|0|||
124544619|NCT03110107|447949212|FG023|Treatment Period|Death|0|||
124544620|NCT03110107|447949213|FG024|Treatment Period|Death|0|||
124544621|NCT03110107|447949214|FG025|Treatment Period|Death|0|||
124544622|NCT03110107|447949189|FG000|Treatment Period|Adverse Event|0|||
124904921|NCT03460756|449276420|FG002|Overall Study|Lost to Follow-up|2|||
124904922|NCT03460756|449276421|FG003|Overall Study|Lost to Follow-up|1|||
124904923|NCT03460756|449276418|FG000|Overall Study|Pregnancy|0|||
124904924|NCT03460756|449276419|FG001|Overall Study|Pregnancy|0|||
124904925|NCT03460756|449276420|FG002|Overall Study|Pregnancy|0|||
124904926|NCT03460756|449276421|FG003|Overall Study|Pregnancy|1|||
124904927|NCT03460756|449276418|FG000|Overall Study|Protocol Violation|0|||
124904928|NCT03460756|449276419|FG001|Overall Study|Protocol Violation|0|||
124904929|NCT03460756|449276420|FG002|Overall Study|Protocol Violation|0|||
124904930|NCT03460756|449276421|FG003|Overall Study|Protocol Violation|1|||
124904931|NCT03460756|449276418|FG000|Overall Study|Withdrawal by Subject|0|||
124449269|NCT01970488|447606962|FG001|Part 1: Through Week 16|Adverse Event|5|||
124449270|NCT01970488|447606963|FG002|Part 1: Through Week 16|Adverse Event|0|||
124449271|NCT01970488|447606964|FG003|Part 1: Through Week 16|Adverse Event|0|||
124449272|NCT01970488|447606965|FG004|Part 1: Through Week 16|Adverse Event|0|||
124449273|NCT01970488|447606961|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
124449274|NCT01970488|447606962|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
124449275|NCT01970488|447606963|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
124449276|NCT01970488|447606964|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
124449277|NCT01970488|447606965|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
124449278|NCT01970488|447606961|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
124904932|NCT03460756|449276419|FG001|Overall Study|Withdrawal by Subject|4|||
124904933|NCT03460756|449276420|FG002|Overall Study|Withdrawal by Subject|7|||
124904934|NCT03460756|449276421|FG003|Overall Study|Withdrawal by Subject|3|||
124904935|NCT03987451|449276422|FG000|Overall Study|Lost to Follow-up|1|||
124904936|NCT03987451|449276423|FG001|Overall Study|Lost to Follow-up|0|||
124904937|NCT03987451|449276422|FG000|Overall Study|Withdrawal by Subject|1|||
124904938|NCT03987451|449276423|FG001|Overall Study|Withdrawal by Subject|1|||
124904939|NCT02441036|449276425|FG000|Overall Study|No tissue resected|0|||
124904940|NCT02441036|449276426|FG001|Overall Study|No tissue resected|1|||
124904941|NCT02441036|449276427|FG002|Overall Study|No tissue resected|0|||
124449279|NCT01970488|447606962|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
124449280|NCT01970488|447606963|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
124544623|NCT03110107|447949190|FG001|Treatment Period|Adverse Event|0|||
124544624|NCT03110107|447949191|FG002|Treatment Period|Adverse Event|1|||
124904942|NCT02441036|449276428|FG003|Overall Study|No tissue resected|1|||
124544625|NCT03110107|447949192|FG003|Treatment Period|Adverse Event|0|||
124544626|NCT03110107|447949193|FG004|Treatment Period|Adverse Event|0|||
124544627|NCT03110107|447949194|FG005|Treatment Period|Adverse Event|2|||
124544628|NCT03110107|447949195|FG006|Treatment Period|Adverse Event|0|||
124544629|NCT03110107|447949196|FG007|Treatment Period|Adverse Event|2|||
124544630|NCT03110107|447949197|FG008|Treatment Period|Adverse Event|0|||
124544631|NCT03110107|447949198|FG009|Treatment Period|Adverse Event|1|||
124544632|NCT03110107|447949199|FG010|Treatment Period|Adverse Event|0|||
124544633|NCT03110107|447949200|FG011|Treatment Period|Adverse Event|0|||
124544634|NCT03110107|447949201|FG012|Treatment Period|Adverse Event|0|||
124544635|NCT03110107|447949202|FG013|Treatment Period|Adverse Event|0|||
124544636|NCT03110107|447949203|FG014|Treatment Period|Adverse Event|0|||
124544637|NCT03110107|447949204|FG015|Treatment Period|Adverse Event|2|||
124904943|NCT02441036|449276429|FG004|Overall Study|No tissue resected|0|||
124904944|NCT00004124|449278279|FG000|Overall Study|Received no protocol therapy|12|||
124904945|NCT00004124|449278280|FG001|Overall Study|Received no protocol therapy|20|||
124904946|NCT02296424|449278281|FG000|Part 1|New therapy for study indication|0|||
124904947|NCT02296424|449278282|FG001|Part 1|New therapy for study indication|1|||
124449281|NCT01970488|447606964|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
124449282|NCT01970488|447606965|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
124449283|NCT01970488|447606961|FG000|Part 2: Post Week 16|Physician Decision|0|||
124449284|NCT01970488|447606962|FG001|Part 2: Post Week 16|Physician Decision|0|||
124449285|NCT01970488|447606963|FG002|Part 2: Post Week 16|Physician Decision|0|||
124449286|NCT01970488|447606964|FG003|Part 2: Post Week 16|Physician Decision|0|||
124449287|NCT01970488|447606965|FG004|Part 2: Post Week 16|Physician Decision|1|||
124449288|NCT01970488|447606961|FG000|Part 2: Post Week 16|Non-compliance|0|||
124449289|NCT01970488|447606962|FG001|Part 2: Post Week 16|Non-compliance|0|||
124449290|NCT01970488|447606963|FG002|Part 2: Post Week 16|Non-compliance|1|||
124449291|NCT01970488|447606964|FG003|Part 2: Post Week 16|Non-compliance|0|||
124449292|NCT01970488|447606965|FG004|Part 2: Post Week 16|Non-compliance|0|||
124449293|NCT01970488|447606961|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
124449294|NCT01970488|447606962|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
124449295|NCT01970488|447606963|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
124449296|NCT01970488|447606964|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
124449297|NCT01970488|447606965|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
124449298|NCT01970488|447606961|FG000|Part 2: Post Week 16|Adverse Event|0|||
124449299|NCT01970488|447606962|FG001|Part 2: Post Week 16|Adverse Event|0|||
124449300|NCT01970488|447606963|FG002|Part 2: Post Week 16|Adverse Event|5|||
124449301|NCT01970488|447606964|FG003|Part 2: Post Week 16|Adverse Event|1|||
124449302|NCT01970488|447606965|FG004|Part 2: Post Week 16|Adverse Event|1|||
124449303|NCT01970488|447606961|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
124449304|NCT01970488|447606962|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
124449305|NCT01970488|447606963|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
124449306|NCT01970488|447606964|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
124449307|NCT01970488|447606965|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
124449308|NCT01970488|447606961|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
124449309|NCT01970488|447606962|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
124449310|NCT01970488|447606963|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
124449311|NCT01970488|447606964|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
124449312|NCT01970488|447606965|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
124449313|NCT04060563|447606966|FG000|Overall Study|Lost to Follow-up|1|||
124449314|NCT04060563|447606967|FG001|Overall Study|Lost to Follow-up|1|||
124449315|NCT04060563|447606966|FG000|Overall Study|Physician Decision|0|||
124449316|NCT04060563|447606967|FG001|Overall Study|Physician Decision|1|||
124449317|NCT01478360|447606974|FG000|Overall Study|Lost to Follow-up|1|||
124449318|NCT01478360|447606975|FG001|Overall Study|Lost to Follow-up|0|||
124449319|NCT01478360|447606974|FG000|Overall Study|Adverse Event|0|||
124449320|NCT01478360|447606975|FG001|Overall Study|Adverse Event|1|||
124449321|NCT01478360|447606974|FG000|Overall Study|Administrative problems|1|||
124449322|NCT01478360|447606975|FG001|Overall Study|Administrative problems|2|||
124449323|NCT04029116|447606976|FG000|Overall Study|Adverse Event|0|||
124449324|NCT04029116|447606977|FG001|Overall Study|Adverse Event|2|||
124449325|NCT04029116|447606976|FG000|Overall Study|Lost to Follow-up|3|||
124449326|NCT04029116|447606977|FG001|Overall Study|Lost to Follow-up|5|||
124691526|NCT03928704|448492146|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
124691527|NCT03928704|448492147|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
124691528|NCT03928704|448492148|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
124904948|NCT02296424|449278283|FG002|Part 1|New therapy for study indication|0|||
124904949|NCT02296424|449278284|FG003|Part 1|New therapy for study indication|0|||
124904950|NCT02296424|449278281|FG000|Part 1|Protocol Violation|0|||
124904951|NCT02296424|449278282|FG001|Part 1|Protocol Violation|1|||
124904952|NCT02296424|449278283|FG002|Part 1|Protocol Violation|0|||
124904953|NCT02296424|449278284|FG003|Part 1|Protocol Violation|0|||
124904954|NCT02296424|449278281|FG000|Part 1|Withdrawal by Subject|0|||
124904955|NCT02296424|449278282|FG001|Part 1|Withdrawal by Subject|2|||
124904956|NCT02296424|449278283|FG002|Part 1|Withdrawal by Subject|0|||
124904957|NCT02296424|449278284|FG003|Part 1|Withdrawal by Subject|0|||
124904958|NCT02296424|449278281|FG000|Part 1|Study terminated by sponsor|0|||
124904959|NCT02296424|449278282|FG001|Part 1|Study terminated by sponsor|1|||
124904960|NCT02296424|449278283|FG002|Part 1|Study terminated by sponsor|0|||
124904961|NCT02296424|449278284|FG003|Part 1|Study terminated by sponsor|0|||
124904962|NCT02296424|449278281|FG000|Part 1|Adverse Event|2|||
124904963|NCT02296424|449278282|FG001|Part 1|Adverse Event|11|||
124904964|NCT02296424|449278283|FG002|Part 1|Adverse Event|0|||
124449327|NCT04029116|447606976|FG000|Overall Study|Physician Decision|2|||
124449328|NCT04029116|447606977|FG001|Overall Study|Physician Decision|0|||
124449329|NCT04029116|447606976|FG000|Overall Study|Pregnancy|1|||
124449330|NCT04029116|447606977|FG001|Overall Study|Pregnancy|2|||
124449331|NCT04029116|447606976|FG000|Overall Study|Withdrawal by Subject|4|||
124449332|NCT04029116|447606977|FG001|Overall Study|Withdrawal by Subject|6|||
124449333|NCT04029116|447606976|FG000|Overall Study|Other|2|||
124544638|NCT03110107|447949205|FG016|Treatment Period|Adverse Event|0|||
124904965|NCT02296424|449278284|FG003|Part 1|Adverse Event|0|||
124544639|NCT03110107|447949206|FG017|Treatment Period|Adverse Event|1|||
124904966|NCT02296424|449278281|FG000|Part 1|Lack of Efficacy|5|||
124904967|NCT02296424|449278282|FG001|Part 1|Lack of Efficacy|17|||
124904968|NCT02296424|449278283|FG002|Part 1|Lack of Efficacy|0|||
124904969|NCT02296424|449278284|FG003|Part 1|Lack of Efficacy|0|||
124904970|NCT02296424|449278281|FG000|Part 1|16 directly started part II|16|||
124904971|NCT02296424|449278282|FG001|Part 1|16 directly started part II|0|||
124904972|NCT02296424|449278283|FG002|Part 1|16 directly started part II|0|||
124904973|NCT02296424|449278284|FG003|Part 1|16 directly started part II|0|||
124904974|NCT02296424|449278281|FG000|Part 2|Lack of Efficacy|0|||
124904975|NCT02296424|449278282|FG001|Part 2|Lack of Efficacy|0|||
124904976|NCT02296424|449278283|FG002|Part 2|Lack of Efficacy|1|||
124904977|NCT02296424|449278284|FG003|Part 2|Lack of Efficacy|0|||
124904978|NCT02296424|449278281|FG000|Part 2|Adverse Event|0|||
124904979|NCT02296424|449278282|FG001|Part 2|Adverse Event|0|||
124904980|NCT02296424|449278283|FG002|Part 2|Adverse Event|1|||
124904981|NCT02296424|449278284|FG003|Part 2|Adverse Event|0|||
124904982|NCT02296424|449278281|FG000|Part 2|Lost to Follow-up|0|||
124904983|NCT02296424|449278282|FG001|Part 2|Lost to Follow-up|0|||
124904984|NCT02296424|449278283|FG002|Part 2|Lost to Follow-up|1|||
124904985|NCT02296424|449278284|FG003|Part 2|Lost to Follow-up|0|||
124904986|NCT04956575|449278285|FG000|Overall Study|Death|1|||
124904987|NCT04956575|449278286|FG001|Overall Study|Death|0|||
124691529|NCT03928704|448492143|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
124904988|NCT04956575|449278287|FG002|Overall Study|Death|0|||
124904989|NCT04956575|449278288|FG003|Overall Study|Death|0|||
124904990|NCT04956575|449278289|FG004|Overall Study|Death|0|||
124904991|NCT04956575|449278290|FG005|Overall Study|Death|0|||
124904992|NCT04956575|449278291|FG006|Overall Study|Death|0|||
124904993|NCT04956575|449278292|FG007|Overall Study|Death|1|||
124904994|NCT04956575|449278293|FG008|Overall Study|Death|0|||
124904995|NCT04956575|449278294|FG009|Overall Study|Death|1|||
124904996|NCT04956575|449278295|FG010|Overall Study|Death|0|||
124904997|NCT04956575|449278296|FG011|Overall Study|Death|0|||
124904998|NCT04956575|449278285|FG000|Overall Study|Lost to Follow-up|3|||
124904999|NCT04956575|449278286|FG001|Overall Study|Lost to Follow-up|4|||
124905000|NCT04956575|449278287|FG002|Overall Study|Lost to Follow-up|2|||
124905001|NCT04956575|449278288|FG003|Overall Study|Lost to Follow-up|3|||
124905002|NCT04956575|449278289|FG004|Overall Study|Lost to Follow-up|1|||
124905003|NCT04956575|449278290|FG005|Overall Study|Lost to Follow-up|10|||
124905004|NCT04956575|449278291|FG006|Overall Study|Lost to Follow-up|11|||
124905005|NCT04956575|449278292|FG007|Overall Study|Lost to Follow-up|7|||
124905006|NCT04956575|449278293|FG008|Overall Study|Lost to Follow-up|4|||
124905007|NCT04956575|449278294|FG009|Overall Study|Lost to Follow-up|2|||
124905008|NCT04956575|449278295|FG010|Overall Study|Lost to Follow-up|3|||
124905009|NCT04956575|449278296|FG011|Overall Study|Lost to Follow-up|8|||
124905010|NCT04956575|449278285|FG000|Overall Study|Withdrawal by Subject|1|||
124905011|NCT04956575|449278286|FG001|Overall Study|Withdrawal by Subject|2|||
124905012|NCT04956575|449278287|FG002|Overall Study|Withdrawal by Subject|1|||
124905013|NCT04956575|449278288|FG003|Overall Study|Withdrawal by Subject|4|||
124905014|NCT04956575|449278289|FG004|Overall Study|Withdrawal by Subject|2|||
124905015|NCT04956575|449278290|FG005|Overall Study|Withdrawal by Subject|8|||
124905016|NCT04956575|449278291|FG006|Overall Study|Withdrawal by Subject|5|||
124905017|NCT04956575|449278292|FG007|Overall Study|Withdrawal by Subject|1|||
124905018|NCT04956575|449278293|FG008|Overall Study|Withdrawal by Subject|1|||
124905019|NCT04956575|449278294|FG009|Overall Study|Withdrawal by Subject|0|||
124905020|NCT04956575|449278295|FG010|Overall Study|Withdrawal by Subject|3|||
124905021|NCT04956575|449278296|FG011|Overall Study|Withdrawal by Subject|1|||
124905022|NCT03593876|449278297|FG000|Overall Study|Withdrawal by Subject|1|||
124905023|NCT03593876|449278297|FG000|Overall Study|Discharged home before intervention completion|2|||
124905024|NCT03287622|449278298|FG000|Overall Study|Withdrawal by Subject|1|||
124905025|NCT03287622|449278299|FG001|Overall Study|Withdrawal by Subject|0|||
124905026|NCT03287622|449278298|FG000|Overall Study|Lost to Follow-up|27|||
124449334|NCT04029116|447606977|FG001|Overall Study|Other|1|||
124449335|NCT01514136|447606981|FG000|Test Period 1; Test A|Protocol Violation|1|||
124905027|NCT03287622|449278299|FG001|Overall Study|Lost to Follow-up|15|||
124905028|NCT03287622|449278298|FG000|Overall Study|No prescripion after surgery|28|||
124905029|NCT03287622|449278299|FG001|Overall Study|No prescripion after surgery|31|||
124905030|NCT03287622|449278298|FG000|Overall Study|prolonged Length of stay|2|||
124905031|NCT03287622|449278299|FG001|Overall Study|prolonged Length of stay|0|||
124905032|NCT03287622|449278298|FG000|Overall Study|surgery related|0|||
124905033|NCT03287622|449278299|FG001|Overall Study|surgery related|2|||
124905034|NCT03823300|449278302|FG000|Overall Study|Withdrawal by Subject|16|||
124905035|NCT03823300|449278303|FG001|Overall Study|Withdrawal by Subject|22|||
124905036|NCT03823300|449278302|FG000|Overall Study|Death|10|||
124905037|NCT03823300|449278303|FG001|Overall Study|Death|14|||
124905038|NCT03823300|449278302|FG000|Overall Study|Adverse Event|3|||
124905039|NCT03823300|449278303|FG001|Overall Study|Adverse Event|5|||
124905040|NCT03823300|449278302|FG000|Overall Study|Physician Decision|1|||
124905041|NCT03823300|449278303|FG001|Overall Study|Physician Decision|7|||
124905042|NCT03823300|449278302|FG000|Overall Study|Lost to Follow-up|1|||
124905043|NCT03823300|449278303|FG001|Overall Study|Lost to Follow-up|3|||
124905044|NCT03823300|449278302|FG000|Overall Study|Protocol Violation|1|||
124905045|NCT03823300|449278303|FG001|Overall Study|Protocol Violation|1|||
124905046|NCT03823300|449278302|FG000|Overall Study|Lack of Efficacy|1|||
124905047|NCT03823300|449278303|FG001|Overall Study|Lack of Efficacy|1|||
124905048|NCT03823300|449278302|FG000|Overall Study|Not Eligible|0|||
124905049|NCT03823300|449278303|FG001|Overall Study|Not Eligible|1|||
124905050|NCT03823300|449278302|FG000|Overall Study|Other|1|||
124905051|NCT03823300|449278303|FG001|Overall Study|Other|0|||
124905052|NCT00507689|449278306|FG000|Pre-Randomization Period|Adverse Event|1|||
124905053|NCT00507689|449278307|FG001|Pre-Randomization Period|Adverse Event|0|||
124905054|NCT00507689|449278306|FG000|Pre-Randomization Period|Physician Decision|1|||
124905055|NCT00507689|449278307|FG001|Pre-Randomization Period|Physician Decision|0|||
124905056|NCT00507689|449278306|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
124905057|NCT00507689|449278307|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
124905058|NCT00507689|449278306|FG000|Randomized Period|Adverse Event|1|||
124905059|NCT00507689|449278307|FG001|Randomized Period|Adverse Event|1|||
124905060|NCT00507689|449278306|FG000|Randomized Period|Withdrawal by Subject|0|||
124905061|NCT00507689|449278307|FG001|Randomized Period|Withdrawal by Subject|1|||
124905062|NCT01786564|449278308|FG000|Overall Study|Lost to Follow-up|47|||
124905063|NCT01786564|449278308|FG000|Overall Study|Ineligible|17|||
124905064|NCT00486330|449278309|FG000|Overall Study|Adverse Event|2|||
124905065|NCT01290224|449278310|FG000|Overall Study|Adverse Event|1|||
124905066|NCT01290224|449278310|FG000|Overall Study|Refused Further Treatment|4|||
124905067|NCT00346333|449278311|FG000|Overall Study|Death|1|||
124905068|NCT00346333|449278312|FG001|Overall Study|Death|0|||
124905069|NCT00346333|449278311|FG000|Overall Study|unwilling or unable to continue|4|||
124905070|NCT00346333|449278312|FG001|Overall Study|unwilling or unable to continue|8|||
124905071|NCT00723450|449278313|FG000|Open-Label Phase|Adverse Event|26|||
124905072|NCT00723450|449278314|FG001|Open-Label Phase|Adverse Event|0|||
124905073|NCT00723450|449278315|FG002|Open-Label Phase|Adverse Event|0|||
124905074|NCT00723450|449278313|FG000|Open-Label Phase|Lack of Efficacy|18|||
124905075|NCT00723450|449278314|FG001|Open-Label Phase|Lack of Efficacy|0|||
124905076|NCT00723450|449278315|FG002|Open-Label Phase|Lack of Efficacy|0|||
124905077|NCT00723450|449278313|FG000|Open-Label Phase|Protocol Violation|35|||
124905078|NCT00723450|449278314|FG001|Open-Label Phase|Protocol Violation|0|||
124905079|NCT00723450|449278315|FG002|Open-Label Phase|Protocol Violation|0|||
124905080|NCT00723450|449278313|FG000|Open-Label Phase|Lost to Follow-up|7|||
124905081|NCT00723450|449278314|FG001|Open-Label Phase|Lost to Follow-up|0|||
124905082|NCT00723450|449278315|FG002|Open-Label Phase|Lost to Follow-up|0|||
124905083|NCT00723450|449278313|FG000|Open-Label Phase|Physician Decision|2|||
124905084|NCT00723450|449278314|FG001|Open-Label Phase|Physician Decision|0|||
124449336|NCT01514136|447606982|FG001|Test Period 1; Test A|Protocol Violation|0|||
124449337|NCT01514136|447606983|FG002|Test Period 1; Test A|Protocol Violation|0|||
124449338|NCT01514136|447606984|FG003|Test Period 1; Test A|Protocol Violation|0|||
124449339|NCT01514136|447606985|FG004|Test Period 1; Test A|Protocol Violation|0|||
124449340|NCT01514136|447606986|FG005|Test Period 1; Test A|Protocol Violation|0|||
124449341|NCT01514136|447606987|FG006|Test Period 1; Test A|Protocol Violation|0|||
124449342|NCT01514136|447606988|FG007|Test Period 1; Test A|Protocol Violation|0|||
124449343|NCT01514136|447606981|FG000|Test Period 1; Test A|Break from study holiday|2|||
124449344|NCT01514136|447606982|FG001|Test Period 1; Test A|Break from study holiday|0|||
124449345|NCT01514136|447606983|FG002|Test Period 1; Test A|Break from study holiday|0|||
124449346|NCT01514136|447606984|FG003|Test Period 1; Test A|Break from study holiday|0|||
124449347|NCT01514136|447606985|FG004|Test Period 1; Test A|Break from study holiday|0|||
124449348|NCT01514136|447606986|FG005|Test Period 1; Test A|Break from study holiday|0|||
124691530|NCT03928704|448492144|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
124449349|NCT01514136|447606987|FG006|Test Period 1; Test A|Break from study holiday|0|||
124905085|NCT00723450|449278315|FG002|Open-Label Phase|Physician Decision|0|||
124905086|NCT00723450|449278313|FG000|Open-Label Phase|Withdrawal by Subject|37|||
124905087|NCT00723450|449278314|FG001|Open-Label Phase|Withdrawal by Subject|0|||
124449350|NCT01514136|447606988|FG007|Test Period 1; Test A|Break from study holiday|0|||
124449351|NCT01514136|447606981|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
124691531|NCT03928704|448492145|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
124905088|NCT00723450|449278315|FG002|Open-Label Phase|Withdrawal by Subject|0|||
124905089|NCT00723450|449278313|FG000|Randomized Phase|Adverse Event|0|||
124905090|NCT00723450|449278314|FG001|Randomized Phase|Adverse Event|26|||
124905091|NCT00723450|449278315|FG002|Randomized Phase|Adverse Event|17|||
124905092|NCT00723450|449278313|FG000|Randomized Phase|Lack of Efficacy|0|||
124905093|NCT00723450|449278314|FG001|Randomized Phase|Lack of Efficacy|11|||
124905094|NCT00723450|449278315|FG002|Randomized Phase|Lack of Efficacy|11|||
124905095|NCT00723450|449278313|FG000|Randomized Phase|Protocol Violation|0|||
124905096|NCT00723450|449278314|FG001|Randomized Phase|Protocol Violation|9|||
124905097|NCT00723450|449278315|FG002|Randomized Phase|Protocol Violation|13|||
124905098|NCT00723450|449278313|FG000|Randomized Phase|Lost to Follow-up|0|||
124905099|NCT00723450|449278314|FG001|Randomized Phase|Lost to Follow-up|2|||
124905100|NCT00723450|449278315|FG002|Randomized Phase|Lost to Follow-up|3|||
124905101|NCT00723450|449278313|FG000|Randomized Phase|Physician Decision|0|||
124449352|NCT01514136|447606982|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
124449353|NCT01514136|447606983|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
124449354|NCT01514136|447606984|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
124905102|NCT00723450|449278314|FG001|Randomized Phase|Physician Decision|3|||
124905103|NCT00723450|449278315|FG002|Randomized Phase|Physician Decision|1|||
124905104|NCT00723450|449278313|FG000|Randomized Phase|Withdrawal by Subject|0|||
124905105|NCT00723450|449278314|FG001|Randomized Phase|Withdrawal by Subject|14|||
124905106|NCT00723450|449278315|FG002|Randomized Phase|Withdrawal by Subject|22|||
124905107|NCT00612586|449278317|FG000|Overall Study|Adverse Event|6|||
124905108|NCT00612586|449278318|FG001|Overall Study|Adverse Event|2|||
124905109|NCT00612586|449278317|FG000|Overall Study|Death|1|||
124449355|NCT01514136|447606985|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
124449356|NCT01514136|447606986|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
124449357|NCT01514136|447606987|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
124449358|NCT01514136|447606988|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
124449359|NCT01514136|447606981|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
124449360|NCT01514136|447606982|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
124449361|NCT01514136|447606983|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
124449362|NCT01514136|447606984|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
124449363|NCT01514136|447606985|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
124449364|NCT01514136|447606986|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
124449365|NCT01514136|447606987|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
124449366|NCT01514136|447606988|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
124449367|NCT01514136|447606981|FG000|Test Period 2; Test A*|Adverse Event|0|||
124449368|NCT01514136|447606982|FG001|Test Period 2; Test A*|Adverse Event|0|||
124449369|NCT01514136|447606983|FG002|Test Period 2; Test A*|Adverse Event|0|||
124449370|NCT01514136|447606984|FG003|Test Period 2; Test A*|Adverse Event|0|||
124449371|NCT01514136|447606985|FG004|Test Period 2; Test A*|Adverse Event|1|||
124449372|NCT01514136|447606986|FG005|Test Period 2; Test A*|Adverse Event|0|||
124449373|NCT01514136|447606987|FG006|Test Period 2; Test A*|Adverse Event|0|||
124449374|NCT01514136|447606988|FG007|Test Period 2; Test A*|Adverse Event|0|||
124449375|NCT01514136|447606981|FG000|Test Period 2; Test A*|Holiday|0|||
124449376|NCT01514136|447606982|FG001|Test Period 2; Test A*|Holiday|0|||
124449377|NCT01514136|447606983|FG002|Test Period 2; Test A*|Holiday|0|||
124449378|NCT01514136|447606984|FG003|Test Period 2; Test A*|Holiday|0|||
124449379|NCT01514136|447606985|FG004|Test Period 2; Test A*|Holiday|1|||
124449380|NCT01514136|447606986|FG005|Test Period 2; Test A*|Holiday|0|||
124449381|NCT01514136|447606987|FG006|Test Period 2; Test A*|Holiday|0|||
124449382|NCT01514136|447606988|FG007|Test Period 2; Test A*|Holiday|0|||
124449383|NCT01514136|447606981|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
124449384|NCT01514136|447606982|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
124449385|NCT01514136|447606983|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
124449386|NCT01514136|447606984|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
124449387|NCT01514136|447606985|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
124449388|NCT01514136|447606986|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
124449389|NCT01514136|447606987|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
124691532|NCT03928704|448492146|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
124691533|NCT03928704|448492147|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
124691534|NCT03928704|448492148|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
124449390|NCT01514136|447606988|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
124449391|NCT01514136|447606981|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
124449392|NCT01514136|447606982|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
124449393|NCT01514136|447606983|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
124449394|NCT01514136|447606984|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
124691535|NCT03928704|448492143|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
124449395|NCT01514136|447606985|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
124449396|NCT01514136|447606986|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
124691536|NCT03928704|448492144|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
124905110|NCT00612586|449278318|FG001|Overall Study|Death|0|||
124905111|NCT00612586|449278317|FG000|Overall Study|Entry Criteria Not Met|0|||
124905112|NCT00612586|449278318|FG001|Overall Study|Entry Criteria Not Met|2|||
124905113|NCT00612586|449278317|FG000|Overall Study|Withdrawal by Subject|7|||
124905114|NCT00612586|449278318|FG001|Overall Study|Withdrawal by Subject|9|||
124905115|NCT00612586|449278317|FG000|Overall Study|Physician Decision|1|||
124905116|NCT00612586|449278318|FG001|Overall Study|Physician Decision|2|||
124905117|NCT00612586|449278317|FG000|Overall Study|Sponsor Decision|1|||
124905118|NCT00612586|449278318|FG001|Overall Study|Sponsor Decision|1|||
124905119|NCT00612586|449278317|FG000|Overall Study|Progressive Disease|26|||
124905120|NCT00612586|449278318|FG001|Overall Study|Progressive Disease|24|||
124905121|NCT00612586|449278317|FG000|Overall Study|Randomized and Not Treated|1|||
124905122|NCT00612586|449278318|FG001|Overall Study|Randomized and Not Treated|1|||
124905123|NCT03192046|449278319|FG000|Overall Study|Withdrawal by Subject|1|||
124905124|NCT03192046|449278320|FG001|Overall Study|Withdrawal by Subject|1|||
124905125|NCT00762606|449278321|FG000|Overall Study|Lost to Follow-up|18|||
124905126|NCT00762606|449278322|FG001|Overall Study|Lost to Follow-up|13|||
124905127|NCT01194154|449278323|FG000|Overall Study|Adverse Event|12|||
124905128|NCT01194154|449278324|FG001|Overall Study|Adverse Event|7|||
124905129|NCT01194154|449278323|FG000|Overall Study|Lost to Follow-up|2|||
124905130|NCT01194154|449278324|FG001|Overall Study|Lost to Follow-up|3|||
124905131|NCT01194154|449278323|FG000|Overall Study|Protocol Violation|0|||
124905132|NCT01194154|449278324|FG001|Overall Study|Protocol Violation|1|||
124905133|NCT01194154|449278323|FG000|Overall Study|Withdrawal by Subject|5|||
124905134|NCT01194154|449278324|FG001|Overall Study|Withdrawal by Subject|6|||
124905135|NCT01194154|449278323|FG000|Overall Study|Blood pressure increase|5|||
124905136|NCT01194154|449278324|FG001|Overall Study|Blood pressure increase|3|||
124905137|NCT01194154|449278323|FG000|Overall Study|Hemoglobin decrease|0|||
124905138|NCT01194154|449278324|FG001|Overall Study|Hemoglobin decrease|1|||
124905139|NCT01194154|449278323|FG000|Overall Study|Hemoglobin increase|12|||
124905140|NCT01194154|449278324|FG001|Overall Study|Hemoglobin increase|3|||
124905141|NCT01194154|449278323|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
124905142|NCT01194154|449278324|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
124905143|NCT01194154|449278323|FG000|Overall Study|Treatment with prohibited medication|4|||
124905144|NCT01194154|449278324|FG001|Overall Study|Treatment with prohibited medication|5|||
124905145|NCT01194154|449278323|FG000|Overall Study|Other|4|||
124905146|NCT01194154|449278324|FG001|Overall Study|Other|0|||
124449397|NCT01514136|447606987|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
124449398|NCT01514136|447606988|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
124449399|NCT01514136|447606981|FG000|Test Period 2; Test C*|holiday|0|||
124449400|NCT01514136|447606982|FG001|Test Period 2; Test C*|holiday|0|||
124449401|NCT01514136|447606983|FG002|Test Period 2; Test C*|holiday|0|||
124449402|NCT01514136|447606984|FG003|Test Period 2; Test C*|holiday|0|||
124449403|NCT01514136|447606985|FG004|Test Period 2; Test C*|holiday|0|||
124449404|NCT01514136|447606986|FG005|Test Period 2; Test C*|holiday|0|||
124449405|NCT01514136|447606987|FG006|Test Period 2; Test C*|holiday|1|||
124449406|NCT01514136|447606988|FG007|Test Period 2; Test C*|holiday|0|||
124449407|NCT01514136|447606981|FG000|Test Period 2; Test C*|Protocol Violation|0|||
124449408|NCT01514136|447606982|FG001|Test Period 2; Test C*|Protocol Violation|0|||
124449409|NCT01514136|447606983|FG002|Test Period 2; Test C*|Protocol Violation|0|||
124449410|NCT01514136|447606984|FG003|Test Period 2; Test C*|Protocol Violation|0|||
124449411|NCT01514136|447606985|FG004|Test Period 2; Test C*|Protocol Violation|0|||
124449412|NCT01514136|447606986|FG005|Test Period 2; Test C*|Protocol Violation|0|||
124449413|NCT01514136|447606987|FG006|Test Period 2; Test C*|Protocol Violation|1|||
124449414|NCT01514136|447606988|FG007|Test Period 2; Test C*|Protocol Violation|0|||
124449415|NCT03346057|447606991|FG000|Overall Study|Death|1|||
124449416|NCT03346057|447606992|FG001|Overall Study|Death|2|||
124449417|NCT03346057|447606993|FG002|Overall Study|Death|0|||
124449418|NCT03346057|447606994|FG003|Overall Study|Death|0|||
124905147|NCT01194154|449278323|FG000|Overall Study|Did not receive study medication|2|||
124905148|NCT01194154|449278324|FG001|Overall Study|Did not receive study medication|4|||
124905149|NCT01909336|449278325|FG000|Overall Study|Lost to Follow-up|4|||
124905150|NCT01909336|449278326|FG001|Overall Study|Lost to Follow-up|2|||
124905151|NCT01909336|449278327|FG002|Overall Study|Lost to Follow-up|2|||
124905152|NCT01909336|449278325|FG000|Overall Study|Physician Decision|0|||
124905153|NCT01909336|449278326|FG001|Overall Study|Physician Decision|1|||
124905154|NCT01909336|449278327|FG002|Overall Study|Physician Decision|1|||
124905155|NCT01505881|449278328|FG000|Overall Study|Adverse Event|0|||
124449419|NCT03346057|447606991|FG000|Overall Study|Lost to Follow-up|0|||
124905156|NCT01505881|449278329|FG001|Overall Study|Adverse Event|1|||
124449420|NCT03346057|447606992|FG001|Overall Study|Lost to Follow-up|2|||
124449421|NCT03346057|447606993|FG002|Overall Study|Lost to Follow-up|1|||
124449422|NCT03346057|447606994|FG003|Overall Study|Lost to Follow-up|0|||
124449423|NCT03346057|447606991|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
124905157|NCT01505881|449278328|FG000|Overall Study|Lost to Follow-up|2|||
124905158|NCT01505881|449278329|FG001|Overall Study|Lost to Follow-up|0|||
124905159|NCT01505881|449278328|FG000|Overall Study|Withdrawal by Subject|2|||
124449424|NCT03346057|447606992|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
124449425|NCT03346057|447606993|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
124449426|NCT03346057|447606994|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
124905160|NCT01505881|449278329|FG001|Overall Study|Withdrawal by Subject|0|||
124905161|NCT00842257|449278330|FG000|Overall Study|Adverse Event|1|||
124905162|NCT00395018|449278331|FG000|On-Treatment|Death|4|||
124905163|NCT00395018|449278331|FG000|On-Treatment|Other Reason|2|||
124905164|NCT00395018|449278331|FG000|On-Treatment|Poor/non-compliance|2|||
124905165|NCT00395018|449278331|FG000|On-Treatment|Subject no longer meets study criteria|2|||
124905166|NCT00395018|449278331|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
124905167|NCT00395018|449278331|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
124905168|NCT00395018|449278331|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
124905169|NCT02314117|449278332|FG000|Overall Study|Lost to Follow-up|9|||
124905170|NCT02314117|449278333|FG001|Overall Study|Lost to Follow-up|14|||
124905171|NCT02314117|449278332|FG000|Overall Study|Withdrawal by Subject|3|||
124905172|NCT02314117|449278333|FG001|Overall Study|Withdrawal by Subject|2|||
124905173|NCT02026258|449278334|FG000|Randomized|Did not start treatment|2|||
124905174|NCT02026258|449278335|FG001|Randomized|Did not start treatment|1|||
124905175|NCT02026258|449278334|FG000|Randomized|Change in treatment plan|1|||
124905176|NCT02026258|449278335|FG001|Randomized|Change in treatment plan|0|||
124905177|NCT02026258|449278334|FG000|Randomized|Presence of periodontal disease|1|||
124905178|NCT02026258|449278335|FG001|Randomized|Presence of periodontal disease|1|||
124905179|NCT02026258|449278334|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
124905180|NCT02026258|449278335|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
124905181|NCT02026258|449278334|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
124905182|NCT02026258|449278335|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
124905183|NCT04439799|449278336|FG000|Overall Study|Lost to Follow-up|6|||
124905184|NCT04439799|449278337|FG001|Overall Study|Lost to Follow-up|6|||
124905185|NCT04439799|449278336|FG000|Overall Study|Withdrawal by Subject|2|||
124905186|NCT04439799|449278337|FG001|Overall Study|Withdrawal by Subject|6|||
124905187|NCT04439799|449278336|FG000|Overall Study|Adverse Event|2|||
124905188|NCT04439799|449278337|FG001|Overall Study|Adverse Event|5|||
124905189|NCT00530842|449278343|FG000|Overall Study|Adverse Event|10|||
124905190|NCT00530842|449278344|FG001|Overall Study|Adverse Event|6|||
124905191|NCT00530842|449278343|FG000|Overall Study|Lack of Efficacy|2|||
124905192|NCT00530842|449278344|FG001|Overall Study|Lack of Efficacy|1|||
124905193|NCT00530842|449278343|FG000|Overall Study|Lost to Follow-up|0|||
124905194|NCT00530842|449278344|FG001|Overall Study|Lost to Follow-up|4|||
124905195|NCT00530842|449278343|FG000|Overall Study|Protocol Violation|3|||
124905196|NCT00530842|449278344|FG001|Overall Study|Protocol Violation|2|||
124905197|NCT00530842|449278343|FG000|Overall Study|Withdrawal by Subject|4|||
124905198|NCT00530842|449278344|FG001|Overall Study|Withdrawal by Subject|5|||
124905199|NCT00530842|449278343|FG000|Overall Study|Individual different reasons|4|||
124905200|NCT00530842|449278344|FG001|Overall Study|Individual different reasons|3|||
124905201|NCT00530842|449278343|FG000|Period 1|Adverse Event|7|||
124905202|NCT00530842|449278344|FG001|Period 1|Adverse Event|3|||
124905203|NCT00530842|449278343|FG000|Period 1|Lack of Efficacy|1|||
124905204|NCT00530842|449278344|FG001|Period 1|Lack of Efficacy|1|||
124905205|NCT00530842|449278343|FG000|Period 1|Protocol Violation|2|||
124905206|NCT00530842|449278344|FG001|Period 1|Protocol Violation|1|||
124905207|NCT00530842|449278343|FG000|Period 1|Withdrawal by Subject|2|||
124905208|NCT00530842|449278344|FG001|Period 1|Withdrawal by Subject|3|||
124905209|NCT00530842|449278343|FG000|Period 1|Individual different reasons|2|||
124905210|NCT00530842|449278344|FG001|Period 1|Individual different reasons|3|||
124905211|NCT00530842|449278343|FG000|Period 2|Adverse Event|3|||
124905212|NCT00530842|449278344|FG001|Period 2|Adverse Event|3|||
124905213|NCT00530842|449278343|FG000|Period 2|Lack of Efficacy|1|||
124905214|NCT00530842|449278344|FG001|Period 2|Lack of Efficacy|0|||
124905215|NCT00530842|449278343|FG000|Period 2|Lost to Follow-up|0|||
124905216|NCT00530842|449278344|FG001|Period 2|Lost to Follow-up|4|||
124905217|NCT00530842|449278343|FG000|Period 2|Protocol Violation|1|||
124905218|NCT00530842|449278344|FG001|Period 2|Protocol Violation|0|||
124905219|NCT00530842|449278343|FG000|Period 2|Withdrawal by Subject|1|||
124905220|NCT00530842|449278344|FG001|Period 2|Withdrawal by Subject|2|||
124905221|NCT00530842|449278343|FG000|Period 2|Individual different reasons|2|||
124905222|NCT00530842|449278344|FG001|Period 2|Individual different reasons|0|||
124905223|NCT02534350|449278345|FG000|Overall Study|Randomized But Not Treated|1|||
124905224|NCT02534350|449278346|FG001|Overall Study|Randomized But Not Treated|0|||
124905225|NCT02534350|449278345|FG000|Overall Study|Protocol Violation|1|||
124905226|NCT02534350|449278346|FG001|Overall Study|Protocol Violation|0|||
124905227|NCT02534350|449278345|FG000|Overall Study|Withdrew Consent|2|||
124905228|NCT02534350|449278346|FG001|Overall Study|Withdrew Consent|0|||
124905229|NCT00880048|449278355|FG000|Overall Study|Adverse Event|2|||
124905230|NCT00880048|449278356|FG001|Overall Study|Adverse Event|3|||
124905231|NCT00880048|449278357|FG002|Overall Study|Adverse Event|5|||
124905232|NCT00880048|449278355|FG000|Overall Study|Lack of Efficacy|1|||
124905233|NCT00880048|449278356|FG001|Overall Study|Lack of Efficacy|2|||
124905234|NCT00880048|449278357|FG002|Overall Study|Lack of Efficacy|2|||
124905235|NCT00880048|449278355|FG000|Overall Study|Protocol Violation|4|||
124905236|NCT00880048|449278356|FG001|Overall Study|Protocol Violation|6|||
124905237|NCT00880048|449278357|FG002|Overall Study|Protocol Violation|5|||
124905238|NCT00880048|449278355|FG000|Overall Study|Lost to Follow-up|6|||
124905239|NCT00880048|449278356|FG001|Overall Study|Lost to Follow-up|6|||
124905240|NCT00880048|449278357|FG002|Overall Study|Lost to Follow-up|5|||
124905241|NCT00880048|449278355|FG000|Overall Study|Physician Decision|1|||
124905242|NCT00880048|449278356|FG001|Overall Study|Physician Decision|1|||
124905243|NCT00880048|449278357|FG002|Overall Study|Physician Decision|7|||
124905244|NCT00880048|449278355|FG000|Overall Study|Withdrawal by Subject|5|||
124905245|NCT00880048|449278356|FG001|Overall Study|Withdrawal by Subject|8|||
124905246|NCT00880048|449278357|FG002|Overall Study|Withdrawal by Subject|5|||
124905247|NCT00880048|449278355|FG000|Overall Study|Study closed/terminated|9|||
124905248|NCT00880048|449278356|FG001|Overall Study|Study closed/terminated|7|||
124905249|NCT00880048|449278357|FG002|Overall Study|Study closed/terminated|6|||
124905250|NCT00346151|449278359|FG000|Overall Study|Withdrawal by Subject|3|||
124905251|NCT00790790|449278367|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
124905252|NCT00790790|449278368|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
124905253|NCT00790790|449278369|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
124905254|NCT00790790|449278367|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
124905255|NCT00790790|449278368|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
124905256|NCT00790790|449278369|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
124905257|NCT00790790|449278367|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
124905258|NCT00790790|449278368|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
124905259|NCT00790790|449278369|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
124905260|NCT00790790|449278367|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
124905261|NCT00790790|449278368|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
124905262|NCT00790790|449278369|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
124905263|NCT00790790|449278367|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
124905264|NCT00790790|449278368|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
124905265|NCT00790790|449278369|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
124905266|NCT02570711|449278372|FG000|Overall Study|Death|1|||
124905267|NCT02570711|449278373|FG001|Overall Study|Death|0|||
124905268|NCT02570711|449278372|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
124905269|NCT02570711|449278373|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
124905270|NCT02798835|449278374|FG000|Overall Study|Protocol Violation|0|||
124905271|NCT02798835|449278375|FG001|Overall Study|Protocol Violation|0|||
124905272|NCT02798835|449278376|FG002|Overall Study|Protocol Violation|3|||
124905273|NCT03070483|449278378|FG000|Overall Study|Lost to Follow-up|2|||
124905274|NCT01585558|449278381|FG000|Overall Study|Withdrawal by Subject|4|||
124905275|NCT01585558|449278382|FG001|Overall Study|Withdrawal by Subject|5|||
124905276|NCT01585558|449278383|FG002|Overall Study|Withdrawal by Subject|8|||
124905277|NCT01585558|449278381|FG000|Overall Study|Lost to Follow-up|2|||
124905278|NCT01585558|449278382|FG001|Overall Study|Lost to Follow-up|0|||
124905279|NCT01585558|449278383|FG002|Overall Study|Lost to Follow-up|3|||
124905280|NCT01585558|449278381|FG000|Overall Study|Adverse Event|3|||
124905281|NCT01585558|449278382|FG001|Overall Study|Adverse Event|4|||
124905282|NCT01585558|449278383|FG002|Overall Study|Adverse Event|1|||
124905283|NCT01585558|449278381|FG000|Overall Study|Protocol Violation|4|||
124905284|NCT01585558|449278382|FG001|Overall Study|Protocol Violation|3|||
124905285|NCT01585558|449278383|FG002|Overall Study|Protocol Violation|2|||
124905286|NCT01585558|449278381|FG000|Overall Study|Lack of Efficacy|0|||
124905287|NCT01585558|449278382|FG001|Overall Study|Lack of Efficacy|0|||
124905288|NCT01585558|449278383|FG002|Overall Study|Lack of Efficacy|1|||
124905289|NCT00094575|449278389|FG000|Overall Study|Death|146|||
124905290|NCT00094575|449278390|FG001|Overall Study|Death|146|||
124905291|NCT01390402|449278391|FG000|Overall Study|Death|1|||
124905292|NCT01390402|449278391|FG000|Overall Study|Disease Progression|4|||
124905293|NCT00430300|449278392|FG000|Overall Study|Adverse Event|0|||
124905294|NCT00430300|449278393|FG001|Overall Study|Adverse Event|2|||
124905295|NCT00430300|449278394|FG002|Overall Study|Adverse Event|1|||
124449427|NCT03346057|447606991|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
124449428|NCT03346057|447606992|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
124449429|NCT03346057|447606993|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
124449430|NCT03346057|447606994|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
124449431|NCT03346057|447606991|FG000|Overall Study|Physician Decision|3|||
124449432|NCT03346057|447606992|FG001|Overall Study|Physician Decision|2|||
124449433|NCT03346057|447606993|FG002|Overall Study|Physician Decision|0|||
124449434|NCT03346057|447606994|FG003|Overall Study|Physician Decision|2|||
124449435|NCT03346057|447606991|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
124449436|NCT03346057|447606992|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
124449437|NCT03346057|447606993|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
124905296|NCT00430300|449278395|FG003|Overall Study|Adverse Event|1|||
124905297|NCT00430300|449278392|FG000|Overall Study|Withdrawal by Subject|1|||
124905298|NCT00430300|449278393|FG001|Overall Study|Withdrawal by Subject|0|||
124905299|NCT00430300|449278394|FG002|Overall Study|Withdrawal by Subject|5|||
124905300|NCT00430300|449278395|FG003|Overall Study|Withdrawal by Subject|0|||
124905301|NCT00430300|449278392|FG000|Overall Study|Laboratory abnormality|1|||
124905302|NCT00430300|449278393|FG001|Overall Study|Laboratory abnormality|0|||
124905303|NCT00430300|449278394|FG002|Overall Study|Laboratory abnormality|0|||
124905304|NCT00430300|449278395|FG003|Overall Study|Laboratory abnormality|0|||
124905305|NCT00430300|449278392|FG000|Overall Study|Other|0|||
124905306|NCT00430300|449278393|FG001|Overall Study|Other|0|||
124905307|NCT00430300|449278394|FG002|Overall Study|Other|0|||
124905308|NCT00430300|449278395|FG003|Overall Study|Other|1|||
124905309|NCT02754479|449278396|FG000|Overall Study|Lost to Follow-up|1|||
124905310|NCT00617201|449278399|FG000|Overall Study|Lost to Follow-up|9|||
124905311|NCT00617201|449278400|FG001|Overall Study|Lost to Follow-up|13|||
124905312|NCT00546871|449278401|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
124905313|NCT00546871|449278402|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
124905314|NCT00546871|449278401|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
124905315|NCT00546871|449278402|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
124905316|NCT00546871|449278401|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
124905317|NCT00546871|449278402|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
124905318|NCT00546871|449278401|FG000|Study Extension Period|Protocol Violation|1|||
124905319|NCT00546871|449278402|FG001|Study Extension Period|Protocol Violation|0|||
124905320|NCT00546871|449278401|FG000|Study Extension Period|Withdrawal by Subject|0|||
124905321|NCT00546871|449278402|FG001|Study Extension Period|Withdrawal by Subject|1|||
124905322|NCT03183518|449278403|FG000|Overall Study|Other (Not specified)|2|||
124905323|NCT03183518|449278403|FG000|Overall Study|Other (Withdrawal of consent)|1|||
124905324|NCT02299336|449278404|FG000|Overall Study|Withdrawal by Subject|11|||
124905325|NCT02299336|449278404|FG000|Overall Study|Adverse Event|1|||
124905326|NCT02299336|449278404|FG000|Overall Study|Death|1|||
124905327|NCT02299336|449278404|FG000|Overall Study|Lost to Follow-up|1|||
124905328|NCT02106442|449278406|FG000|Overall Study|Case Report Forms Uncollected|7|||
124905329|NCT02106442|449278406|FG000|Overall Study|Protocol Deviation|30|||
124760077|NCT03347123|448746760|FG004|Overall Study|Reason not Specified|0|||
124760078|NCT03347123|448746761|FG005|Overall Study|Reason not Specified|0|||
124760079|NCT03347123|448746762|FG006|Overall Study|Reason not Specified|0|||
124760080|NCT01132807|448746763|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
124905330|NCT04513522|449281041|FG000|Overall Study|Other reasons|1|||
124760081|NCT01132807|448746764|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
124760082|NCT01132807|448746765|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
124760083|NCT01132807|448746763|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
124760084|NCT01132807|448746764|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
124760085|NCT01132807|448746765|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
124760086|NCT02043938|448746769|FG000|Overall Study|Withdrawal by Subject|7|||
124905331|NCT04513522|449281041|FG000|Overall Study|Adverse event unrelated to study drug|9|||
124905332|NCT04513522|449281041|FG000|Overall Study|Study drug toxicity|14|||
124905333|NCT04513522|449281041|FG000|Overall Study|Disease progression|39|||
124544640|NCT03110107|447949207|FG018|Treatment Period|Adverse Event|2|||
124905334|NCT04513522|449281041|FG000|Overall Study|Participants withdrew consent|2|||
124905335|NCT00589667|449281044|FG000|Overall Study|Adverse Event|2|||
124905336|NCT00589667|449281044|FG000|Overall Study|Withdrawal by Subject|1|||
124905337|NCT03538041|449281045|FG000|12-Week Treatment Period|Adverse Event|1|||
124905338|NCT03538041|449281046|FG001|12-Week Treatment Period|Adverse Event|1|||
124905339|NCT03538041|449281045|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
124905340|NCT03538041|449281046|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
124905341|NCT03538041|449281045|FG000|Treatment Extension Period|Adverse Event|4|||
124905342|NCT03538041|449281046|FG001|Treatment Extension Period|Adverse Event|1|||
124905343|NCT03538041|449281045|FG000|Treatment Extension Period|Physician Decision|1|||
124905344|NCT03538041|449281046|FG001|Treatment Extension Period|Physician Decision|1|||
124544641|NCT03110107|447949208|FG019|Treatment Period|Adverse Event|1|||
124544642|NCT03110107|447949209|FG020|Treatment Period|Adverse Event|4|||
124544643|NCT03110107|447949210|FG021|Treatment Period|Adverse Event|2|||
124544644|NCT03110107|447949211|FG022|Treatment Period|Adverse Event|2|||
124544645|NCT03110107|447949212|FG023|Treatment Period|Adverse Event|2|||
124905345|NCT03538041|449281045|FG000|Treatment Extension Period|Lack of Efficacy|1|||
124905346|NCT03538041|449281046|FG001|Treatment Extension Period|Lack of Efficacy|4|||
124905347|NCT03538041|449281045|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
124905348|NCT03538041|449281046|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
124905349|NCT03538041|449281045|FG000|Treatment Extension Period|Death|0|||
124905350|NCT03538041|449281046|FG001|Treatment Extension Period|Death|1|||
124905351|NCT00743444|449281049|FG000|First Intervention|Catheter placement problems|0|||
124449438|NCT03346057|447606994|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
124449439|NCT03346057|447606991|FG000|Overall Study|Withdrawal by Subject|1|||
124449440|NCT03346057|447606992|FG001|Overall Study|Withdrawal by Subject|0|||
124449441|NCT03346057|447606993|FG002|Overall Study|Withdrawal by Subject|0|||
124449442|NCT03346057|447606994|FG003|Overall Study|Withdrawal by Subject|0|||
124449443|NCT02003014|447606995|FG000|Overall Study|Case report forms uncollected|9|||
124449444|NCT02003014|447606995|FG000|Overall Study|Treatment started after contract period|1|||
124449445|NCT02003014|447606995|FG000|Overall Study|Patient did not visit the study site|5|||
124449446|NCT02003014|447606995|FG000|Overall Study|Investigator's transfer|4|||
124449447|NCT01159912|447606996|FG000|Overall Study|Adverse Event|2|||
124449448|NCT01159912|447606997|FG001|Overall Study|Adverse Event|2|||
124449449|NCT01159912|447606998|FG002|Overall Study|Adverse Event|3|||
124449450|NCT01159912|447606996|FG000|Overall Study|Lack of Efficacy|23|||
124449451|NCT01159912|447606997|FG001|Overall Study|Lack of Efficacy|15|||
124449452|NCT01159912|447606998|FG002|Overall Study|Lack of Efficacy|14|||
124449453|NCT01159912|447606996|FG000|Overall Study|Protocol Violation|1|||
124449454|NCT01159912|447606997|FG001|Overall Study|Protocol Violation|2|||
124449455|NCT01159912|447606998|FG002|Overall Study|Protocol Violation|3|||
124449456|NCT01159912|447606996|FG000|Overall Study|Lost to Follow-up|4|||
124449457|NCT01159912|447606997|FG001|Overall Study|Lost to Follow-up|0|||
124449458|NCT01159912|447606998|FG002|Overall Study|Lost to Follow-up|0|||
124449459|NCT01159912|447606996|FG000|Overall Study|Physician Decision|0|||
124449460|NCT01159912|447606997|FG001|Overall Study|Physician Decision|0|||
124449461|NCT01159912|447606998|FG002|Overall Study|Physician Decision|3|||
124449462|NCT01159912|447606996|FG000|Overall Study|Withdrawal by Subject|10|||
124449463|NCT01159912|447606997|FG001|Overall Study|Withdrawal by Subject|3|||
124449464|NCT01159912|447606998|FG002|Overall Study|Withdrawal by Subject|3|||
124449465|NCT02281357|447606999|FG000|Overall Study|Adverse Event|2|||
124449466|NCT02281357|447607000|FG001|Overall Study|Adverse Event|1|||
124449467|NCT02281357|447606999|FG000|Overall Study|Lost to Follow-up|1|||
124449468|NCT02281357|447607000|FG001|Overall Study|Lost to Follow-up|0|||
124449469|NCT02281357|447606999|FG000|Overall Study|Withdrawal by Subject|4|||
124449470|NCT02281357|447607000|FG001|Overall Study|Withdrawal by Subject|3|||
124449471|NCT04223791|447607008|FG000|Overall Study|Lost to Follow-up|0|||
124449472|NCT04223791|447607009|FG001|Overall Study|Lost to Follow-up|4|||
124449473|NCT04223791|447607008|FG000|Overall Study|Physician Decision|5|||
124449474|NCT04223791|447607009|FG001|Overall Study|Physician Decision|1|||
124449475|NCT04223791|447607008|FG000|Overall Study|Protocol Violation|1|||
124449476|NCT04223791|447607009|FG001|Overall Study|Protocol Violation|1|||
124449477|NCT04223791|447607008|FG000|Overall Study|Withdrawal by Subject|10|||
124449478|NCT04223791|447607009|FG001|Overall Study|Withdrawal by Subject|12|||
124449479|NCT04223791|447607008|FG000|Overall Study|Pregnancy|1|||
124449480|NCT04223791|447607009|FG001|Overall Study|Pregnancy|1|||
124449481|NCT04223791|447607008|FG000|Overall Study|Ongoing in Study|305|||
124449482|NCT04223791|447607009|FG001|Overall Study|Ongoing in Study|302|||
124449483|NCT00729378|447609426|FG000|Baseline|Did not complete study measurements|72|||
124449484|NCT00729378|447609427|FG001|Baseline|Did not complete study measurements|33|||
124449485|NCT00729378|447609426|FG000|Baseline|Withdrawal by Subject|66|||
124449486|NCT00729378|447609427|FG001|Baseline|Withdrawal by Subject|59|||
124449487|NCT00729378|447609426|FG000|12-months|Lost to Follow-up|100|||
124449488|NCT00729378|447609427|FG001|12-months|Lost to Follow-up|65|||
124449489|NCT00729378|447609426|FG000|24-months|Lost to Follow-up|72|||
124449490|NCT00729378|447609427|FG001|24-months|Lost to Follow-up|51|||
124449491|NCT00729378|447609426|FG000|36-months|Lost to Follow-up|15|||
124449492|NCT00729378|447609427|FG001|36-months|Lost to Follow-up|6|||
124449493|NCT02246582|447609430|FG000|Overall Study|Withdrawal by Subject|3|||
124449494|NCT02246582|447609431|FG001|Overall Study|Withdrawal by Subject|4|||
124449495|NCT03441334|447609433|FG000|Overall Study|Withdrawal by Subject|1|||
124449496|NCT03441334|447609434|FG001|Overall Study|Withdrawal by Subject|0|||
124449497|NCT00395863|447609435|FG000|Overall Study|Patients did not complete both exams|2|||
124449498|NCT00395863|447609436|FG001|Overall Study|Patients did not complete both exams|3|||
124449499|NCT02592551|447609439|FG000|Overall Study|Not evaluable|1|||
124449500|NCT02592551|447609440|FG001|Overall Study|Not evaluable|3|||
124449501|NCT02592551|447609441|FG002|Overall Study|Not evaluable|0|||
124449502|NCT01876251|447609442|FG000|Overall Study|Clinical progression|1|||
124449503|NCT01876251|447609443|FG001|Overall Study|Clinical progression|0|||
124449504|NCT01876251|447609444|FG002|Overall Study|Clinical progression|0|||
124449505|NCT01876251|447609442|FG000|Overall Study|Death|2|||
124449506|NCT01876251|447609443|FG001|Overall Study|Death|0|||
124905352|NCT00743444|449281050|FG001|First Intervention|Catheter placement problems|1|||
124905353|NCT00743444|449281049|FG000|Washout Period|Adverse Event|0|||
124905354|NCT00743444|449281050|FG001|Washout Period|Adverse Event|1|||
124905355|NCT00807144|449281053|FG000|Overall Study|Lost to Follow-up|0|||
124905356|NCT00807144|449281054|FG001|Overall Study|Lost to Follow-up|1|||
124905357|NCT01307267|449281055|FG000|Overall Study|Death|4|||
124905358|NCT01307267|449281056|FG001|Overall Study|Death|3|||
124449507|NCT01876251|447609444|FG002|Overall Study|Death|1|||
124449508|NCT01876251|447609442|FG000|Overall Study|Participant started new treatment|1|||
124449509|NCT01876251|447609443|FG001|Overall Study|Participant started new treatment|0|||
124449510|NCT01876251|447609444|FG002|Overall Study|Participant started new treatment|1|||
124449511|NCT01876251|447609442|FG000|Overall Study|Participant refused further follow-up|0|||
124449512|NCT01876251|447609443|FG001|Overall Study|Participant refused further follow-up|0|||
124449513|NCT01876251|447609444|FG002|Overall Study|Participant refused further follow-up|1|||
124449514|NCT01876251|447609442|FG000|Overall Study|Study terminated|1|||
124449515|NCT01876251|447609443|FG001|Overall Study|Study terminated|0|||
124449516|NCT01876251|447609444|FG002|Overall Study|Study terminated|0|||
124449517|NCT01876251|447609442|FG000|Overall Study|Objective progression or relapse|10|||
124449518|NCT01876251|447609443|FG001|Overall Study|Objective progression or relapse|3|||
124449519|NCT01876251|447609444|FG002|Overall Study|Objective progression or relapse|8|||
124449520|NCT00268437|447609445|FG000|Overall Study|Ineligible|1|||
124449521|NCT01628107|447609449|FG000|Overall Study|Withdrawal by Subject|17|||
124449522|NCT01628107|447609449|FG000|Overall Study|Lost to Follow-up|4|||
124449523|NCT01628107|447609449|FG000|Overall Study|Adverse Event|33|||
124449524|NCT01628107|447609449|FG000|Overall Study|Physician Decision|2|||
124449525|NCT01628107|447609449|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
124449526|NCT01628107|447609449|FG000|Overall Study|Non-compliant with Study Procedures|10|||
124449527|NCT01628107|447609449|FG000|Overall Study|Not Treated|8|||
124449528|NCT01628107|447609449|FG000|Overall Study|Sponsor Decision|11|||
124449529|NCT01628107|447609449|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
124449530|NCT01628107|447609449|FG000|Overall Study|Relocated|8|||
124449531|NCT01628107|447609449|FG000|Overall Study|Kidney Transplant|9|||
124449532|NCT01628107|447609449|FG000|Overall Study|Use of Standard of Care|9|||
124449533|NCT01086410|447609450|FG000|Overall Study|Adverse Event|1|||
124449534|NCT01086410|447609451|FG001|Overall Study|Adverse Event|0|||
124449535|NCT01086410|447609452|FG002|Overall Study|Adverse Event|0|||
124449536|NCT01086410|447609453|FG003|Overall Study|Adverse Event|2|||
124449537|NCT01086410|447609450|FG000|Overall Study|Lack of Efficacy|1|||
124449538|NCT01086410|447609451|FG001|Overall Study|Lack of Efficacy|1|||
124449539|NCT01086410|447609452|FG002|Overall Study|Lack of Efficacy|0|||
124449540|NCT01086410|447609453|FG003|Overall Study|Lack of Efficacy|0|||
124449541|NCT01086410|447609450|FG000|Overall Study|Protocol Violation|1|||
124449542|NCT01086410|447609451|FG001|Overall Study|Protocol Violation|1|||
124449543|NCT01086410|447609452|FG002|Overall Study|Protocol Violation|0|||
124449544|NCT01086410|447609453|FG003|Overall Study|Protocol Violation|0|||
124449545|NCT01086410|447609450|FG000|Overall Study|Lost to Follow-up|0|||
124449546|NCT01086410|447609451|FG001|Overall Study|Lost to Follow-up|0|||
124449547|NCT01086410|447609452|FG002|Overall Study|Lost to Follow-up|1|||
124449548|NCT01086410|447609453|FG003|Overall Study|Lost to Follow-up|0|||
124449549|NCT02953639|447609454|FG000|Overall Study|Adverse Event|2|||
124449550|NCT02953639|447609455|FG001|Overall Study|Adverse Event|0|||
124905359|NCT01307267|449281057|FG002|Overall Study|Death|5|||
124905360|NCT01307267|449281058|FG003|Overall Study|Death|3|||
124905361|NCT01307267|449281059|FG004|Overall Study|Death|1|||
124905362|NCT01307267|449281060|FG005|Overall Study|Death|26|||
124905363|NCT01307267|449281061|FG006|Overall Study|Death|2|||
124905364|NCT01307267|449281062|FG007|Overall Study|Death|2|||
124905365|NCT01307267|449281063|FG008|Overall Study|Death|21|||
124905366|NCT01307267|449281064|FG009|Overall Study|Death|2|||
124905367|NCT01307267|449281065|FG010|Overall Study|Death|3|||
124905368|NCT01307267|449281066|FG011|Overall Study|Death|9|||
124449551|NCT02953639|447609456|FG002|Overall Study|Adverse Event|1|||
124449552|NCT02953639|447609454|FG000|Overall Study|Lost to Follow-up|8|||
124449553|NCT02953639|447609455|FG001|Overall Study|Lost to Follow-up|4|||
124449554|NCT02953639|447609456|FG002|Overall Study|Lost to Follow-up|3|||
124449555|NCT02953639|447609454|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124449556|NCT02953639|447609455|FG001|Overall Study|Non-Compliance With Study Drug|2|||
124449557|NCT02953639|447609456|FG002|Overall Study|Non-Compliance With Study Drug|1|||
124449558|NCT02953639|447609454|FG000|Overall Study|Multiple Reasons|1|||
124449559|NCT02953639|447609455|FG001|Overall Study|Multiple Reasons|0|||
124449560|NCT02953639|447609456|FG002|Overall Study|Multiple Reasons|1|||
124449561|NCT02953639|447609454|FG000|Overall Study|Physician Decision|1|||
124449562|NCT02953639|447609455|FG001|Overall Study|Physician Decision|0|||
124905369|NCT01307267|449281067|FG012|Overall Study|Death|0|||
124905370|NCT01307267|449281068|FG013|Overall Study|Death|0|||
124449563|NCT02953639|447609456|FG002|Overall Study|Physician Decision|0|||
124449564|NCT02953639|447609454|FG000|Overall Study|Withdrawal by Subject|7|||
124905371|NCT01307267|449281069|FG014|Overall Study|Death|0|||
124905372|NCT01307267|449281070|FG015|Overall Study|Death|0|||
124449565|NCT02953639|447609455|FG001|Overall Study|Withdrawal by Subject|8|||
124905373|NCT01307267|449281071|FG016|Overall Study|Death|1|||
124905374|NCT01307267|449281072|FG017|Overall Study|Death|1|||
124905375|NCT01307267|449281073|FG018|Overall Study|Death|2|||
124905376|NCT01307267|449281074|FG019|Overall Study|Death|8|||
124905377|NCT01307267|449281075|FG020|Overall Study|Death|1|||
124905378|NCT01307267|449281076|FG021|Overall Study|Death|2|||
124905379|NCT01307267|449281077|FG022|Overall Study|Death|2|||
124905380|NCT01307267|449281055|FG000|Overall Study|Lost to Follow-up|0|||
124905381|NCT01307267|449281056|FG001|Overall Study|Lost to Follow-up|0|||
124905382|NCT01307267|449281057|FG002|Overall Study|Lost to Follow-up|0|||
124905383|NCT01307267|449281058|FG003|Overall Study|Lost to Follow-up|0|||
124905384|NCT01307267|449281059|FG004|Overall Study|Lost to Follow-up|0|||
124905385|NCT01307267|449281060|FG005|Overall Study|Lost to Follow-up|7|||
124905386|NCT01307267|449281061|FG006|Overall Study|Lost to Follow-up|0|||
124905387|NCT01307267|449281062|FG007|Overall Study|Lost to Follow-up|0|||
124905388|NCT01307267|449281063|FG008|Overall Study|Lost to Follow-up|1|||
124905389|NCT01307267|449281064|FG009|Overall Study|Lost to Follow-up|2|||
124905390|NCT01307267|449281065|FG010|Overall Study|Lost to Follow-up|1|||
124905391|NCT01307267|449281066|FG011|Overall Study|Lost to Follow-up|0|||
124905392|NCT01307267|449281067|FG012|Overall Study|Lost to Follow-up|0|||
124905393|NCT01307267|449281068|FG013|Overall Study|Lost to Follow-up|0|||
124905394|NCT01307267|449281069|FG014|Overall Study|Lost to Follow-up|0|||
124905395|NCT01307267|449281070|FG015|Overall Study|Lost to Follow-up|0|||
124905396|NCT01307267|449281071|FG016|Overall Study|Lost to Follow-up|0|||
124905397|NCT01307267|449281072|FG017|Overall Study|Lost to Follow-up|0|||
124905398|NCT01307267|449281073|FG018|Overall Study|Lost to Follow-up|0|||
124449566|NCT02953639|447609456|FG002|Overall Study|Withdrawal by Subject|10|||
124449567|NCT02953639|447609454|FG000|Overall Study|Completed or Discontinued information is missing|1|||
124449568|NCT02953639|447609455|FG001|Overall Study|Completed or Discontinued information is missing|0|||
124449569|NCT02953639|447609456|FG002|Overall Study|Completed or Discontinued information is missing|0|||
124449570|NCT04196803|447609457|FG000|Overall Study|Withdrawal by Subject|1|||
124449571|NCT04196803|447609458|FG001|Overall Study|Withdrawal by Subject|3|||
124449572|NCT04196803|447609457|FG000|Overall Study|Adverse Event|4|||
124449573|NCT04196803|447609458|FG001|Overall Study|Adverse Event|2|||
124449574|NCT04196803|447609457|FG000|Overall Study|Lost to Follow-up|0|||
124449575|NCT04196803|447609458|FG001|Overall Study|Lost to Follow-up|1|||
124449576|NCT01022996|447609459|FG000|Overall Study|Adverse Event|14|||
124449577|NCT01022996|447609459|FG000|Overall Study|Withdrawal by Subject|3|||
124449578|NCT01022996|447609459|FG000|Overall Study|Lost to Follow-up|1|||
124449579|NCT01022996|447609459|FG000|Overall Study|Administrative problems|6|||
124449580|NCT01022996|447609459|FG000|Overall Study|Disease Progression|32|||
124449581|NCT01022996|447609459|FG000|Overall Study|Protocol Violation|1|||
124449582|NCT03349775|447609460|FG000|Overall Study|Side Effects|1|||
124449583|NCT03349775|447609461|FG001|Overall Study|Side Effects|2|||
124449584|NCT03349775|447609460|FG000|Overall Study|Withdrawal by Subject|1|||
124449585|NCT03349775|447609461|FG001|Overall Study|Withdrawal by Subject|1|||
124449586|NCT03349775|447609460|FG000|Overall Study|No primary outcome measurements|0|||
124449587|NCT03349775|447609461|FG001|Overall Study|No primary outcome measurements|1|||
124449588|NCT01516970|447609462|FG000|Overall Study|Lost to Follow-up|7|||
124449589|NCT01516970|447609463|FG001|Overall Study|Lost to Follow-up|8|||
124449590|NCT01516970|447609462|FG000|Overall Study|Adverse Event|1|||
124449591|NCT01516970|447609463|FG001|Overall Study|Adverse Event|5|||
124449592|NCT01516970|447609462|FG000|Overall Study|Withdrawal by Subject|1|||
124449593|NCT01516970|447609463|FG001|Overall Study|Withdrawal by Subject|1|||
124449594|NCT01516970|447609462|FG000|Overall Study|Other|9|||
124449595|NCT01516970|447609463|FG001|Overall Study|Other|7|||
124449596|NCT01756040|447609464|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
124544646|NCT03110107|447949213|FG024|Treatment Period|Adverse Event|2|||
124544647|NCT03110107|447949214|FG025|Treatment Period|Adverse Event|4|||
124905399|NCT01307267|449281074|FG019|Overall Study|Lost to Follow-up|2|||
124449597|NCT01756040|447609464|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
124449598|NCT01756040|447609464|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
124449599|NCT02613884|447609467|FG000|Overall Study|Death|1|||
124449600|NCT02613884|447609467|FG000|Overall Study|Lost to Follow-up|1|||
124449601|NCT00433914|447609471|FG000|Overall Study|Withdrawal by Subject|0|||
124449602|NCT00433914|447609472|FG001|Overall Study|Withdrawal by Subject|2|||
124449603|NCT00433914|447609471|FG000|Overall Study|Lost to Follow-up|0|||
124449604|NCT00433914|447609472|FG001|Overall Study|Lost to Follow-up|1|||
124905400|NCT01307267|449281075|FG020|Overall Study|Lost to Follow-up|0|||
124905401|NCT01307267|449281076|FG021|Overall Study|Lost to Follow-up|0|||
124905402|NCT01307267|449281077|FG022|Overall Study|Lost to Follow-up|0|||
124905403|NCT01307267|449281055|FG000|Overall Study|Withdrawal by Subject|0|||
124905404|NCT01307267|449281056|FG001|Overall Study|Withdrawal by Subject|0|||
124449605|NCT02486653|447609473|FG000|Overall Study|Withdrawal by Subject|1|||
124449606|NCT02486653|447609474|FG001|Overall Study|Withdrawal by Subject|3|||
124449607|NCT02486653|447609473|FG000|Overall Study|Protocol Violation|1|||
124449608|NCT02486653|447609474|FG001|Overall Study|Protocol Violation|0|||
124544648|NCT03110107|447949189|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
124905405|NCT01307267|449281057|FG002|Overall Study|Withdrawal by Subject|0|||
124905406|NCT01307267|449281058|FG003|Overall Study|Withdrawal by Subject|0|||
124905407|NCT01307267|449281059|FG004|Overall Study|Withdrawal by Subject|0|||
124905408|NCT01307267|449281060|FG005|Overall Study|Withdrawal by Subject|1|||
124905409|NCT01307267|449281061|FG006|Overall Study|Withdrawal by Subject|0|||
124905410|NCT01307267|449281062|FG007|Overall Study|Withdrawal by Subject|1|||
124905411|NCT01307267|449281063|FG008|Overall Study|Withdrawal by Subject|5|||
124905412|NCT01307267|449281064|FG009|Overall Study|Withdrawal by Subject|1|||
124905413|NCT01307267|449281065|FG010|Overall Study|Withdrawal by Subject|1|||
124905414|NCT01307267|449281066|FG011|Overall Study|Withdrawal by Subject|1|||
124905415|NCT01307267|449281067|FG012|Overall Study|Withdrawal by Subject|0|||
124905416|NCT01307267|449281068|FG013|Overall Study|Withdrawal by Subject|0|||
124905417|NCT01307267|449281069|FG014|Overall Study|Withdrawal by Subject|0|||
124905418|NCT01307267|449281070|FG015|Overall Study|Withdrawal by Subject|0|||
124905419|NCT01307267|449281071|FG016|Overall Study|Withdrawal by Subject|0|||
124905420|NCT01307267|449281072|FG017|Overall Study|Withdrawal by Subject|0|||
124905421|NCT01307267|449281073|FG018|Overall Study|Withdrawal by Subject|0|||
124905422|NCT01307267|449281074|FG019|Overall Study|Withdrawal by Subject|3|||
124449609|NCT02486653|447609473|FG000|Overall Study|surgery cancelled|4|||
124449610|NCT02486653|447609474|FG001|Overall Study|surgery cancelled|1|||
124449611|NCT02678416|447609498|FG000|Part 1|Withdrawal by Subject|1|||
124449612|NCT02678416|447609498|FG000|Part 2|Adverse Event|2|||
124449613|NCT02678416|447609498|FG000|Part 2|Withdrawal by Subject|1|||
124449614|NCT04556136|447609499|FG000|Overall Study|Lost to Follow-up|6|||
124449615|NCT04556136|447609500|FG001|Overall Study|Lost to Follow-up|6|||
124449616|NCT04556136|447609499|FG000|Overall Study|Physician Decision|2|||
124449617|NCT04556136|447609500|FG001|Overall Study|Physician Decision|1|||
124449618|NCT04556136|447609499|FG000|Overall Study|Withdrawal by Subject|2|||
124449619|NCT04556136|447609500|FG001|Overall Study|Withdrawal by Subject|1|||
124449620|NCT01848353|447609501|FG000|Phase 1|Withdrawal by Subject|3|||
124449621|NCT01848353|447609502|FG001|Phase 1|Withdrawal by Subject|1|||
124449622|NCT01848353|447609503|FG002|Phase 1|Withdrawal by Subject|0|||
124449623|NCT01848353|447609504|FG003|Phase 1|Withdrawal by Subject|0|||
124449624|NCT01848353|447609501|FG000|Phase 2|Withdrawal by Subject|3|||
124449625|NCT01848353|447609502|FG001|Phase 2|Withdrawal by Subject|2|||
124449626|NCT01848353|447609503|FG002|Phase 2|Withdrawal by Subject|0|||
124449627|NCT01848353|447609504|FG003|Phase 2|Withdrawal by Subject|0|||
124449628|NCT01848353|447609501|FG000|Phase 3|Withdrawal by Subject|1|||
124449629|NCT01848353|447609502|FG001|Phase 3|Withdrawal by Subject|1|||
124449630|NCT01848353|447609503|FG002|Phase 3|Withdrawal by Subject|0|||
124449631|NCT01848353|447609504|FG003|Phase 3|Withdrawal by Subject|0|||
124449632|NCT03933397|447609505|FG000|Overall Study|No emergency department visit|65|||
124449633|NCT03933397|447609506|FG001|Overall Study|No emergency department visit|71|||
124449634|NCT03933397|447609505|FG000|Overall Study|Missed emergency department visit|25|||
124449635|NCT03933397|447609506|FG001|Overall Study|Missed emergency department visit|30|||
124449636|NCT03933397|447609505|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
124449637|NCT03933397|447609506|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
124449638|NCT03933397|447609505|FG000|Overall Study|Withdrawal by Subject|1|||
124449639|NCT03933397|447609506|FG001|Overall Study|Withdrawal by Subject|0|||
124449640|NCT03933397|447609505|FG000|Overall Study|Physician Decision|1|||
124449641|NCT03933397|447609506|FG001|Overall Study|Physician Decision|1|||
124449642|NCT03933397|447609505|FG000|Overall Study|missing pain score|1|||
124449643|NCT03933397|447609506|FG001|Overall Study|missing pain score|1|||
124449644|NCT03933397|447609505|FG000|Overall Study|Confirmed COVID-19|1|||
124449645|NCT03933397|447609506|FG001|Overall Study|Confirmed COVID-19|2|||
124449646|NCT00935272|447609509|FG000|Overall Study|Lost to Follow-up|10|||
124449647|NCT00935272|447609510|FG001|Overall Study|Lost to Follow-up|3|||
124449648|NCT00935272|447609509|FG000|Overall Study|Withdrawal by Subject|8|||
124449649|NCT00935272|447609510|FG001|Overall Study|Withdrawal by Subject|2|||
124449650|NCT00935272|447609509|FG000|Overall Study|Physician Decision|1|||
124449651|NCT00935272|447609510|FG001|Overall Study|Physician Decision|0|||
124449652|NCT00935272|447609509|FG000|Overall Study|Protocol Violation|0|||
124905423|NCT01307267|449281075|FG020|Overall Study|Withdrawal by Subject|0|||
124905424|NCT01307267|449281076|FG021|Overall Study|Withdrawal by Subject|0|||
124449653|NCT00935272|447609510|FG001|Overall Study|Protocol Violation|1|||
124449654|NCT02289352|447609520|FG000|Overall Study|Withdrawal by Subject|1|||
124449655|NCT02289352|447609521|FG001|Overall Study|Withdrawal by Subject|1|||
124449656|NCT02289352|447609522|FG002|Overall Study|Withdrawal by Subject|0|||
124449657|NCT04340557|447609523|FG000|Overall Study|Transferred to ICU and/or death|1|||
124449658|NCT04340557|447609524|FG001|Overall Study|Transferred to ICU and/or death|2|||
124449659|NCT01177384|447609525|FG000|Overall Study|Adverse Event|6|||
124449660|NCT01177384|447609526|FG001|Overall Study|Adverse Event|4|||
124905425|NCT01307267|449281077|FG022|Overall Study|Withdrawal by Subject|0|||
124905426|NCT01307267|449281055|FG000|Overall Study|Other|0|||
124905427|NCT01307267|449281056|FG001|Overall Study|Other|0|||
124449661|NCT01177384|447609525|FG000|Overall Study|Lack of Efficacy|0|||
124449662|NCT01177384|447609526|FG001|Overall Study|Lack of Efficacy|1|||
124449663|NCT01177384|447609525|FG000|Overall Study|Lost to Follow-up|3|||
124544649|NCT03110107|447949190|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
124544650|NCT03110107|447949191|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
124544651|NCT03110107|447949192|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
124544652|NCT03110107|447949193|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
124905428|NCT01307267|449281057|FG002|Overall Study|Other|0|||
124905429|NCT01307267|449281058|FG003|Overall Study|Other|0|||
124905430|NCT01307267|449281059|FG004|Overall Study|Other|0|||
124905431|NCT01307267|449281060|FG005|Overall Study|Other|7|||
124905432|NCT01307267|449281061|FG006|Overall Study|Other|0|||
124905433|NCT01307267|449281062|FG007|Overall Study|Other|1|||
124544653|NCT03110107|447949194|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
124544654|NCT03110107|447949195|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
124544655|NCT03110107|447949196|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
124544656|NCT03110107|447949197|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
124544657|NCT03110107|447949198|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
124544658|NCT03110107|447949199|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
124544659|NCT03110107|447949200|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
124544660|NCT03110107|447949201|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
124544661|NCT03110107|447949202|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
124544662|NCT03110107|447949203|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
124544663|NCT03110107|447949204|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
124544664|NCT03110107|447949205|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
124544665|NCT03110107|447949206|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
124544666|NCT03110107|447949207|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
124544667|NCT03110107|447949208|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
124544668|NCT03110107|447949209|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
124544669|NCT03110107|447949210|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
124544670|NCT03110107|447949211|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
124544671|NCT03110107|447949212|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
124544672|NCT03110107|447949213|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
124544673|NCT03110107|447949214|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
124544674|NCT03110107|447949189|FG000|Treatment Period|Participant withdrew consent|0|||
124544675|NCT03110107|447949190|FG001|Treatment Period|Participant withdrew consent|0|||
124544676|NCT03110107|447949191|FG002|Treatment Period|Participant withdrew consent|1|||
124544677|NCT03110107|447949192|FG003|Treatment Period|Participant withdrew consent|0|||
124544678|NCT03110107|447949193|FG004|Treatment Period|Participant withdrew consent|4|||
124544679|NCT03110107|447949194|FG005|Treatment Period|Participant withdrew consent|3|||
124544680|NCT03110107|447949195|FG006|Treatment Period|Participant withdrew consent|0|||
124544681|NCT03110107|447949196|FG007|Treatment Period|Participant withdrew consent|0|||
124544682|NCT03110107|447949197|FG008|Treatment Period|Participant withdrew consent|0|||
124544683|NCT03110107|447949198|FG009|Treatment Period|Participant withdrew consent|1|||
124544684|NCT03110107|447949199|FG010|Treatment Period|Participant withdrew consent|0|||
124544685|NCT03110107|447949200|FG011|Treatment Period|Participant withdrew consent|0|||
124544686|NCT03110107|447949201|FG012|Treatment Period|Participant withdrew consent|0|||
124544687|NCT03110107|447949202|FG013|Treatment Period|Participant withdrew consent|0|||
124544688|NCT03110107|447949203|FG014|Treatment Period|Participant withdrew consent|0|||
124544689|NCT03110107|447949204|FG015|Treatment Period|Participant withdrew consent|0|||
124544690|NCT03110107|447949205|FG016|Treatment Period|Participant withdrew consent|0|||
124544691|NCT03110107|447949206|FG017|Treatment Period|Participant withdrew consent|0|||
124544692|NCT03110107|447949207|FG018|Treatment Period|Participant withdrew consent|0|||
124905434|NCT01307267|449281063|FG008|Overall Study|Other|3|||
124905435|NCT01307267|449281064|FG009|Overall Study|Other|0|||
124905436|NCT01307267|449281065|FG010|Overall Study|Other|1|||
124905437|NCT01307267|449281066|FG011|Overall Study|Other|1|||
124905438|NCT01307267|449281067|FG012|Overall Study|Other|1|||
124905439|NCT01307267|449281068|FG013|Overall Study|Other|0|||
124544693|NCT03110107|447949208|FG019|Treatment Period|Participant withdrew consent|1|||
124544694|NCT03110107|447949209|FG020|Treatment Period|Participant withdrew consent|0|||
124544695|NCT03110107|447949210|FG021|Treatment Period|Participant withdrew consent|2|||
124544696|NCT03110107|447949211|FG022|Treatment Period|Participant withdrew consent|0|||
124905440|NCT01307267|449281069|FG014|Overall Study|Other|2|||
124905441|NCT01307267|449281070|FG015|Overall Study|Other|1|||
124905442|NCT01307267|449281071|FG016|Overall Study|Other|0|||
124544697|NCT03110107|447949212|FG023|Treatment Period|Participant withdrew consent|0|||
124905443|NCT01307267|449281072|FG017|Overall Study|Other|0|||
124905444|NCT01307267|449281073|FG018|Overall Study|Other|0|||
124905445|NCT01307267|449281074|FG019|Overall Study|Other|19|||
124905446|NCT01307267|449281075|FG020|Overall Study|Other|2|||
124905447|NCT01307267|449281076|FG021|Overall Study|Other|3|||
124905448|NCT01307267|449281077|FG022|Overall Study|Other|2|||
124905449|NCT05174013|449281080|FG000|Overall Study|Lost to Follow-up|0|||
124905450|NCT05174013|449281081|FG001|Overall Study|Lost to Follow-up|0|||
124905451|NCT05174013|449281082|FG002|Overall Study|Lost to Follow-up|0|||
124905452|NCT05174013|449281083|FG003|Overall Study|Lost to Follow-up|1|||
124905453|NCT05174013|449281084|FG004|Overall Study|Lost to Follow-up|0|||
124905454|NCT05174013|449281085|FG005|Overall Study|Lost to Follow-up|0|||
124905455|NCT05174013|449281080|FG000|Overall Study|Withdrawal by Subject|0|||
124905456|NCT05174013|449281081|FG001|Overall Study|Withdrawal by Subject|0|||
124905457|NCT05174013|449281082|FG002|Overall Study|Withdrawal by Subject|1|||
124905458|NCT05174013|449281083|FG003|Overall Study|Withdrawal by Subject|0|||
124905459|NCT05174013|449281084|FG004|Overall Study|Withdrawal by Subject|0|||
124905460|NCT05174013|449281085|FG005|Overall Study|Withdrawal by Subject|0|||
124905461|NCT00854906|449281089|FG000|Overall Study|One person had no ocular history|1|||
124905462|NCT00814346|449281090|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
124905463|NCT00814346|449281091|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
124905464|NCT00814346|449281090|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
124905465|NCT00814346|449281091|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
124905466|NCT00814346|449281090|FG000|Open Phase (17 Months)|Adverse Event|5|||
124905467|NCT00814346|449281091|FG001|Open Phase (17 Months)|Adverse Event|0|||
124905468|NCT00814346|449281090|FG000|Open Phase (17 Months)|Consent|2|||
124905469|NCT00814346|449281091|FG001|Open Phase (17 Months)|Consent|0|||
124905470|NCT00814346|449281090|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
124905471|NCT00814346|449281091|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
124905472|NCT00814346|449281090|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
124905473|NCT00814346|449281091|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
124905474|NCT05136443|449281094|FG000|Overall Study|Lost to Follow-up|2|||
124905475|NCT05136443|449281094|FG000|Overall Study|Adverse Event|2|||
124905476|NCT02613871|449281095|FG000|Overall Study|Death|2|||
124905477|NCT02613871|449281095|FG000|Overall Study|Withdrew Consent|1|||
124905478|NCT00494442|449281096|FG000|Overall Study|Death|1|||
124905479|NCT00494442|449281097|FG001|Overall Study|Death|1|||
124905480|NCT00494442|449281096|FG000|Overall Study|Lack of Efficacy|16|||
124905481|NCT00494442|449281097|FG001|Overall Study|Lack of Efficacy|10|||
124905482|NCT00494442|449281096|FG000|Overall Study|Adverse Event|0|||
124905483|NCT00494442|449281097|FG001|Overall Study|Adverse Event|2|||
124905484|NCT00494442|449281096|FG000|Overall Study|Physician Decision|0|||
124905485|NCT00494442|449281097|FG001|Overall Study|Physician Decision|1|||
124905486|NCT00494442|449281096|FG000|Overall Study|Non-compliance|0|||
124905487|NCT00494442|449281097|FG001|Overall Study|Non-compliance|1|||
124905488|NCT00494442|449281096|FG000|Overall Study|Intercurrent illness|0|||
124905489|NCT00494442|449281097|FG001|Overall Study|Intercurrent illness|1|||
124905490|NCT00831415|449281100|FG000|Overall Study|Adverse Event|14|||
124905491|NCT00831415|449281100|FG000|Overall Study|Failed to return|3|||
124905492|NCT00831415|449281100|FG000|Overall Study|Physician Decision|6|||
124905493|NCT00831415|449281100|FG000|Overall Study|Lost to Follow-up|9|||
124905494|NCT00831415|449281100|FG000|Overall Study|Protocol Violation|3|||
124905495|NCT00831415|449281100|FG000|Overall Study|Withdrawal by Subject|35|||
124905496|NCT00831415|449281100|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
124905497|NCT00831415|449281100|FG000|Overall Study|Death|1|||
124905498|NCT01241292|449281101|FG000|Overall Study|Administrative Reason by Sponsor|1|||
124905499|NCT01241292|449281102|FG001|Overall Study|Administrative Reason by Sponsor|0|||
124905500|NCT01241292|449281101|FG000|Overall Study|Disease Progression|2|||
124905501|NCT01241292|449281102|FG001|Overall Study|Disease Progression|0|||
124905502|NCT01241292|449281101|FG000|Overall Study|Study Drug Toxicity|0|||
124905503|NCT01241292|449281102|FG001|Overall Study|Study Drug Toxicity|1|||
124905504|NCT01241292|449281101|FG000|Overall Study|Participant Discontinued Treatment|0|||
124905505|NCT01241292|449281102|FG001|Overall Study|Participant Discontinued Treatment|2|||
124905506|NCT03034915|449281105|FG000|Overall Study|Adverse Event|29|||
124905507|NCT03034915|449281106|FG001|Overall Study|Adverse Event|32|||
124905508|NCT03034915|449281107|FG002|Overall Study|Adverse Event|22|||
124905509|NCT03034915|449281105|FG000|Overall Study|Lost to Follow-up|5|||
124905510|NCT03034915|449281106|FG001|Overall Study|Lost to Follow-up|13|||
124905511|NCT03034915|449281107|FG002|Overall Study|Lost to Follow-up|3|||
124905512|NCT03034915|449281105|FG000|Overall Study|Withdrawal by Subject|29|||
124905513|NCT03034915|449281106|FG001|Overall Study|Withdrawal by Subject|46|||
124905514|NCT03034915|449281107|FG002|Overall Study|Withdrawal by Subject|41|||
124905515|NCT03034915|449281105|FG000|Overall Study|Protocol Deviation|2|||
124905516|NCT03034915|449281106|FG001|Overall Study|Protocol Deviation|14|||
124905517|NCT03034915|449281107|FG002|Overall Study|Protocol Deviation|7|||
124905518|NCT03034915|449281105|FG000|Overall Study|Lack of Efficacy|8|||
124905519|NCT03034915|449281106|FG001|Overall Study|Lack of Efficacy|16|||
124905520|NCT03034915|449281107|FG002|Overall Study|Lack of Efficacy|18|||
124905521|NCT03034915|449281105|FG000|Overall Study|Site closed|2|||
124905522|NCT03034915|449281106|FG001|Overall Study|Site closed|2|||
124905523|NCT03034915|449281107|FG002|Overall Study|Site closed|4|||
124905524|NCT03034915|449281105|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
124905525|NCT03034915|449281106|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
124905526|NCT03034915|449281107|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
124905527|NCT03034915|449281105|FG000|Overall Study|Physician Decision|1|||
124905528|NCT03034915|449281106|FG001|Overall Study|Physician Decision|5|||
124905529|NCT03034915|449281107|FG002|Overall Study|Physician Decision|2|||
124905530|NCT03861767|449281108|FG000|Overall Study|Withdrawal by Subject|2|||
124905531|NCT03861767|449281109|FG001|Overall Study|Withdrawal by Subject|1|||
124905532|NCT03861767|449281110|FG002|Overall Study|Withdrawal by Subject|0|||
124905533|NCT03861767|449281111|FG003|Overall Study|Withdrawal by Subject|5|||
124905534|NCT03861767|449281112|FG004|Overall Study|Withdrawal by Subject|2|||
124905535|NCT03861767|449281113|FG005|Overall Study|Withdrawal by Subject|1|||
124905536|NCT03861767|449281114|FG006|Overall Study|Withdrawal by Subject|3|||
124905537|NCT03861767|449281115|FG007|Overall Study|Withdrawal by Subject|1|||
124905538|NCT03861767|449281116|FG008|Overall Study|Withdrawal by Subject|0|||
124905539|NCT03861767|449281117|FG009|Overall Study|Withdrawal by Subject|5|||
124905540|NCT01087762|449281118|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
124905541|NCT01087762|449281119|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
124905542|NCT01087762|449281120|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
124905543|NCT01087762|449281121|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
124905544|NCT01087762|449281122|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
124905545|NCT01087762|449281118|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
124905546|NCT01087762|449281119|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
124905547|NCT01087762|449281120|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
124905548|NCT01087762|449281121|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
124905549|NCT01087762|449281122|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
124905550|NCT01087762|449281118|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
124905551|NCT01087762|449281119|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
124905552|NCT01087762|449281120|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
124905553|NCT01087762|449281121|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
124905554|NCT01087762|449281122|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
124905555|NCT01087762|449281118|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
124905556|NCT01087762|449281119|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
124905557|NCT01087762|449281120|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
124905558|NCT01087762|449281121|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
124905559|NCT01087762|449281122|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
124449664|NCT01177384|447609526|FG001|Overall Study|Lost to Follow-up|4|||
124449665|NCT01177384|447609525|FG000|Overall Study|Physician Decision|0|||
124449666|NCT01177384|447609526|FG001|Overall Study|Physician Decision|3|||
124449667|NCT01177384|447609525|FG000|Overall Study|Protocol Violation|0|||
124449668|NCT01177384|447609526|FG001|Overall Study|Protocol Violation|2|||
124449669|NCT01177384|447609525|FG000|Overall Study|Withdrawal by Subject|5|||
124449670|NCT01177384|447609526|FG001|Overall Study|Withdrawal by Subject|12|||
124449671|NCT01849497|447609527|FG000|Overall Study|Withdrawal by Subject|1|||
124449672|NCT01849497|447609528|FG001|Overall Study|Withdrawal by Subject|2|||
124449673|NCT01849497|447609527|FG000|Overall Study|Sponsor Decision|0|||
124449674|NCT01849497|447609528|FG001|Overall Study|Sponsor Decision|1|||
124449675|NCT01849497|447609527|FG000|Overall Study|Lost to Follow-up|0|||
124449676|NCT01849497|447609528|FG001|Overall Study|Lost to Follow-up|1|||
124449677|NCT00911625|447609554|FG000|Overall Study|Lost to Follow-up|7|||
124449678|NCT00911625|447609555|FG001|Overall Study|Lost to Follow-up|0|||
124449679|NCT00529451|447609556|FG000|Overall Study|Subject withdrew consent|16|||
124449680|NCT00529451|447609557|FG001|Overall Study|Subject withdrew consent|21|||
124449681|NCT00529451|447609558|FG002|Overall Study|Subject withdrew consent|13|||
124449682|NCT00529451|447609559|FG003|Overall Study|Subject withdrew consent|12|||
124449683|NCT00529451|447609556|FG000|Overall Study|Adverse Event|9|||
124905560|NCT01087762|449281118|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
124905561|NCT01087762|449281119|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
124905562|NCT01087762|449281120|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
124905563|NCT01087762|449281121|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
124905564|NCT01087762|449281122|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
124449684|NCT00529451|447609557|FG001|Overall Study|Adverse Event|16|||
124449685|NCT00529451|447609558|FG002|Overall Study|Adverse Event|14|||
124905565|NCT01087762|449281118|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
124905566|NCT01087762|449281119|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
124449686|NCT00529451|447609559|FG003|Overall Study|Adverse Event|8|||
124449687|NCT00529451|447609556|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
124905567|NCT01087762|449281120|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
124449688|NCT00529451|447609557|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
124905568|NCT01087762|449281121|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
124905569|NCT01087762|449281122|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
124905570|NCT01087762|449281118|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
124905571|NCT01087762|449281119|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
124905572|NCT01087762|449281120|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
124905573|NCT01087762|449281121|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
124905574|NCT01087762|449281122|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
124905575|NCT01087762|449281118|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
124905576|NCT01087762|449281119|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
124905577|NCT01087762|449281120|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
124905578|NCT01087762|449281121|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
124905579|NCT01087762|449281122|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
124905580|NCT01087762|449281118|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
124905581|NCT01087762|449281119|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
124905582|NCT01087762|449281120|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
124905583|NCT01087762|449281121|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
124905584|NCT01087762|449281122|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
124905585|NCT01087762|449281118|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
124905586|NCT01087762|449281119|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
124905587|NCT01087762|449281120|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
124905588|NCT01087762|449281121|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
124905589|NCT01087762|449281122|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
124905590|NCT01087762|449281118|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
124905591|NCT01087762|449281119|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
124905592|NCT01087762|449281120|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
124905593|NCT01087762|449281121|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
124905594|NCT01087762|449281122|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
124905595|NCT01087762|449281118|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
124905596|NCT01087762|449281119|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
124905597|NCT01087762|449281120|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
124905598|NCT01087762|449281121|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
124905599|NCT01087762|449281122|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
124905600|NCT01087762|449281118|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
124905601|NCT01087762|449281119|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
124905602|NCT01087762|449281120|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
124905603|NCT01087762|449281121|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
124905604|NCT01087762|449281122|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
124905605|NCT00813904|449281123|FG000|Overall Study|Death|1|||
124905606|NCT00424762|449281129|FG000|Overall Study|Withdrawal by Subject|18|||
124905607|NCT00424762|449281130|FG001|Overall Study|Withdrawal by Subject|19|||
124905608|NCT00424762|449281129|FG000|Overall Study|Lost to Follow-up|2|||
124905609|NCT00424762|449281130|FG001|Overall Study|Lost to Follow-up|3|||
124905610|NCT01405924|449281133|FG000|Overall Study|Protocol Violation|8|||
124905611|NCT01405924|449281133|FG000|Overall Study|Missing/Incomplete Data|2|||
124905612|NCT00770965|449281137|FG000|Safety Set|Withdrawal by Subject|0|||
124905613|NCT00770965|449281138|FG001|Safety Set|Withdrawal by Subject|0|||
124905614|NCT00770965|449281139|FG002|Safety Set|Withdrawal by Subject|0|||
124905615|NCT00770965|449281140|FG003|Safety Set|Withdrawal by Subject|1|||
124905616|NCT00770965|449281137|FG000|Safety Set|Protocol deviation|0|||
124449689|NCT00529451|447609558|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
124449690|NCT00529451|447609559|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
124449691|NCT00529451|447609556|FG000|Overall Study|Lost to Follow-up|4|||
124449692|NCT00529451|447609557|FG001|Overall Study|Lost to Follow-up|7|||
124449693|NCT00529451|447609558|FG002|Overall Study|Lost to Follow-up|4|||
124449694|NCT00529451|447609559|FG003|Overall Study|Lost to Follow-up|4|||
124691537|NCT03928704|448492145|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
124691538|NCT03928704|448492146|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
124691539|NCT03928704|448492147|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
124905617|NCT00770965|449281138|FG001|Safety Set|Protocol deviation|0|||
124905618|NCT00770965|449281139|FG002|Safety Set|Protocol deviation|1|||
124905619|NCT00770965|449281140|FG003|Safety Set|Protocol deviation|0|||
124905620|NCT00770965|449281137|FG000|Excluded Set|Administrative problems|14|||
124905621|NCT00770965|449281138|FG001|Excluded Set|Administrative problems|12|||
124905622|NCT00770965|449281139|FG002|Excluded Set|Administrative problems|12|||
124905623|NCT00770965|449281140|FG003|Excluded Set|Administrative problems|10|||
124905624|NCT00770965|449281137|FG000|Excluded Set|Withdrawal by Subject|1|||
124905625|NCT00770965|449281138|FG001|Excluded Set|Withdrawal by Subject|1|||
124905626|NCT00770965|449281139|FG002|Excluded Set|Withdrawal by Subject|2|||
124905627|NCT00770965|449281140|FG003|Excluded Set|Withdrawal by Subject|3|||
124905628|NCT01391130|449281143|FG000|Overall Study|Withdrawal by Subject|3|||
124905629|NCT01391130|449281144|FG001|Overall Study|Withdrawal by Subject|2|||
124905630|NCT01391130|449281143|FG000|Overall Study|Physician Decision|2|||
124905631|NCT01391130|449281144|FG001|Overall Study|Physician Decision|3|||
124905632|NCT01391130|449281143|FG000|Overall Study|Did not Receive Drug|1|||
124905633|NCT01391130|449281144|FG001|Overall Study|Did not Receive Drug|1|||
124905634|NCT03478696|449281145|FG000|Overall Study|Adverse Event|1|||
124905635|NCT03478696|449281146|FG001|Overall Study|Adverse Event|5|||
124905636|NCT03478696|449281145|FG000|Overall Study|Lost to Follow-up|1|||
124905637|NCT03478696|449281146|FG001|Overall Study|Lost to Follow-up|0|||
124905638|NCT03478696|449281145|FG000|Overall Study|Physician Decision|6|||
124905639|NCT03478696|449281146|FG001|Overall Study|Physician Decision|3|||
124905640|NCT03478696|449281145|FG000|Overall Study|Withdrawal by Subject|9|||
124905641|NCT03478696|449281146|FG001|Overall Study|Withdrawal by Subject|4|||
124905642|NCT03615924|449281147|FG000|Overall Study|Withdrawal by Subject|2|||
124905643|NCT03615924|449281148|FG001|Overall Study|Withdrawal by Subject|5|||
124905644|NCT03615924|449281147|FG000|Overall Study|Death|3|||
124905645|NCT03615924|449281148|FG001|Overall Study|Death|1|||
124905646|NCT03615924|449281147|FG000|Overall Study|Lost to Follow-up|1|||
124905647|NCT03615924|449281148|FG001|Overall Study|Lost to Follow-up|0|||
124905648|NCT03615924|449281147|FG000|Overall Study|Randomized in error|1|||
124905649|NCT03615924|449281148|FG001|Overall Study|Randomized in error|0|||
124905650|NCT03615924|449281147|FG000|Overall Study|Study termination by Sponsor|94|||
124905651|NCT03615924|449281148|FG001|Overall Study|Study termination by Sponsor|86|||
124905652|NCT00367991|449281154|FG000|Overall Study|Withdrawal by Subject|1|||
124905653|NCT00367991|449281155|FG001|Overall Study|Withdrawal by Subject|1|||
124905654|NCT00367991|449281154|FG000|Overall Study|Adverse Event|1|||
124905655|NCT00367991|449281155|FG001|Overall Study|Adverse Event|1|||
124905656|NCT01184508|449281156|FG000|Overall Study|Adverse Event|4|||
124905657|NCT01184508|449281157|FG001|Overall Study|Adverse Event|6|||
124905658|NCT01184508|449281156|FG000|Overall Study|Lack of Efficacy|1|||
124905659|NCT01184508|449281157|FG001|Overall Study|Lack of Efficacy|1|||
124905660|NCT01184508|449281156|FG000|Overall Study|Lost to Follow-up|1|||
124905661|NCT01184508|449281157|FG001|Overall Study|Lost to Follow-up|1|||
124905662|NCT01184508|449281156|FG000|Overall Study|Physician Decision|1|||
124905663|NCT01184508|449281157|FG001|Overall Study|Physician Decision|0|||
124905664|NCT01184508|449281156|FG000|Overall Study|Protocol Violation|3|||
124905665|NCT01184508|449281157|FG001|Overall Study|Protocol Violation|1|||
124449695|NCT00529451|447609556|FG000|Overall Study|Protocol deviation|1|||
124449696|NCT00529451|447609557|FG001|Overall Study|Protocol deviation|1|||
124449697|NCT00529451|447609558|FG002|Overall Study|Protocol deviation|4|||
124905666|NCT01184508|449281156|FG000|Overall Study|Sponsor Decision|5|||
124905667|NCT01184508|449281157|FG001|Overall Study|Sponsor Decision|2|||
124905668|NCT01184508|449281156|FG000|Overall Study|Withdrawal by Subject|1|||
124905669|NCT01184508|449281157|FG001|Overall Study|Withdrawal by Subject|3|||
124905670|NCT01184508|449281156|FG000|Overall Study|Randomized, Not Treated|0|||
124905671|NCT01184508|449281157|FG001|Overall Study|Randomized, Not Treated|1|||
124449698|NCT00529451|447609559|FG003|Overall Study|Protocol deviation|1|||
124449699|NCT00529451|447609556|FG000|Overall Study|Administrative problems|1|||
124905672|NCT04707313|449281164|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
124905673|NCT04707313|449281165|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
124905674|NCT04707313|449281166|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
124905675|NCT04707313|449281167|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
124905676|NCT04707313|449281168|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
124905677|NCT04707313|449281169|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
124905678|NCT04707313|449281170|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
124691540|NCT03928704|448492148|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
124905679|NCT04707313|449281171|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
124905680|NCT04707313|449281172|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
124905681|NCT04707313|449281173|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
124905682|NCT04707313|449281174|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
124905683|NCT04707313|449281175|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
124905684|NCT04707313|449281176|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
124905685|NCT04707313|449281164|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
124905686|NCT04707313|449281165|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
124905687|NCT04707313|449281166|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905688|NCT04707313|449281167|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905689|NCT04707313|449281168|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
124905690|NCT04707313|449281169|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905691|NCT04707313|449281170|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905692|NCT04707313|449281171|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905693|NCT04707313|449281172|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905694|NCT04707313|449281173|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905695|NCT04707313|449281174|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905696|NCT04707313|449281175|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905697|NCT04707313|449281176|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
124905698|NCT04707313|449281164|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
124905699|NCT04707313|449281165|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
124905700|NCT04707313|449281166|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
124905701|NCT04707313|449281167|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
124905702|NCT04707313|449281168|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
124905703|NCT04707313|449281169|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
124905704|NCT04707313|449281170|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
124905705|NCT04707313|449281171|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
124905706|NCT04707313|449281172|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
124905707|NCT04707313|449281173|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
124905708|NCT04707313|449281174|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
124905709|NCT04707313|449281175|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
124905710|NCT04707313|449281176|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
124905711|NCT04707313|449281164|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905712|NCT04707313|449281165|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
124905713|NCT04707313|449281166|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
124905714|NCT04707313|449281167|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905715|NCT04707313|449281168|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
124905716|NCT04707313|449281169|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905717|NCT04707313|449281170|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905718|NCT04707313|449281171|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905719|NCT04707313|449281172|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905720|NCT04707313|449281173|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905721|NCT04707313|449281174|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905722|NCT04707313|449281175|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124905723|NCT04707313|449281176|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
124449700|NCT00529451|447609557|FG001|Overall Study|Administrative problems|1|||
124449701|NCT00529451|447609558|FG002|Overall Study|Administrative problems|0|||
124449702|NCT00529451|447609559|FG003|Overall Study|Administrative problems|2|||
124905724|NCT04707313|449281164|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
124905725|NCT04707313|449281165|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
124905726|NCT04707313|449281166|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
124905727|NCT04707313|449281167|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
124905728|NCT04707313|449281168|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
124905729|NCT04707313|449281169|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
124905730|NCT04707313|449281170|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
124905731|NCT04707313|449281171|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
124905732|NCT04707313|449281172|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
124905733|NCT04707313|449281173|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
124905734|NCT04707313|449281174|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
124905735|NCT04707313|449281175|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
124905736|NCT04707313|449281176|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
124905737|NCT04707313|449281164|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
124905738|NCT04707313|449281165|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
124449703|NCT01289821|447609562|FG000|Treatment Period|Withdrawal by Subject|1|||
124905739|NCT04707313|449281166|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
124905740|NCT04707313|449281167|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
124449704|NCT01289821|447609562|FG000|Treatment Period|Physician Decision|3|||
124905741|NCT04707313|449281168|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
124905742|NCT04707313|449281169|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
124905743|NCT04707313|449281170|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
124905744|NCT04707313|449281171|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
124905745|NCT04707313|449281172|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
124905746|NCT04707313|449281173|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
124905747|NCT04707313|449281174|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
124905748|NCT04707313|449281175|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
124905749|NCT04707313|449281176|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
124905750|NCT04707313|449281164|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
124905751|NCT04707313|449281165|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
124905752|NCT04707313|449281166|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
124449705|NCT01289821|447609562|FG000|Treatment Period|Adverse Event|4|||
124449706|NCT01289821|447609562|FG000|Treatment Period|Radiological Progression|43|||
124905753|NCT04707313|449281167|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
124449707|NCT01289821|447609562|FG000|Treatment Period|Clinical Progression|2|||
124449708|NCT01289821|447609562|FG000|Treatment Period|Therapeutic procedure required|1|||
124449709|NCT01289821|447609562|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
124905754|NCT04707313|449281168|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
124905755|NCT04707313|449281169|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
124905756|NCT04707313|449281170|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
124905757|NCT04707313|449281171|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
124905758|NCT04707313|449281172|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
124905759|NCT04707313|449281173|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
124905760|NCT04707313|449281174|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
124905761|NCT04707313|449281175|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
124905762|NCT04707313|449281176|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
124449710|NCT01289821|447609562|FG000|Safety Follow-up Period|Protocol Violation|3|||
124449711|NCT01289821|447609562|FG000|Safety Follow-up Period|Unspecified reason|1|||
124449712|NCT01289821|447609562|FG000|Survival Follow-up Period|Protocol Violation|1|||
124449713|NCT01289821|447609562|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
124449714|NCT01289821|447609562|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
124449715|NCT00773136|447609568|FG000|Overall Study|Physician Decision|2|||
124449716|NCT01010633|447609571|FG000|Overall Study|Adverse Event|1|||
124449717|NCT01010633|447609572|FG001|Overall Study|Adverse Event|1|||
124449718|NCT01010633|447609571|FG000|Overall Study|Protocol Violation|1|||
124449719|NCT01010633|447609572|FG001|Overall Study|Protocol Violation|2|||
124449720|NCT01010633|447609571|FG000|Overall Study|Withdrawal by Subject|2|||
124449721|NCT01010633|447609572|FG001|Overall Study|Withdrawal by Subject|1|||
124449722|NCT01010633|447609571|FG000|Overall Study|Investigator decision|0|||
124449723|NCT01010633|447609572|FG001|Overall Study|Investigator decision|1|||
124449724|NCT00097773|447609574|FG000|Overall Study|Lost to Follow-up|2|||
124449725|NCT00097773|447609575|FG001|Overall Study|Lost to Follow-up|2|||
124449726|NCT00097773|447609576|FG002|Overall Study|Lost to Follow-up|0|||
124449727|NCT00097773|447609577|FG003|Overall Study|Lost to Follow-up|1|||
124449728|NCT00097773|447609574|FG000|Overall Study|Physician Decision|2|||
124449729|NCT00097773|447609575|FG001|Overall Study|Physician Decision|2|||
124449730|NCT00097773|447609576|FG002|Overall Study|Physician Decision|3|||
124449731|NCT00097773|447609577|FG003|Overall Study|Physician Decision|1|||
124449732|NCT00097773|447609574|FG000|Overall Study|Withdrawal by Subject|3|||
124449733|NCT00097773|447609575|FG001|Overall Study|Withdrawal by Subject|3|||
124449734|NCT00097773|447609576|FG002|Overall Study|Withdrawal by Subject|3|||
124449735|NCT00097773|447609577|FG003|Overall Study|Withdrawal by Subject|1|||
124449736|NCT00097773|447609574|FG000|Overall Study|Adverse Event|0|||
124449737|NCT00097773|447609575|FG001|Overall Study|Adverse Event|1|||
124449738|NCT00097773|447609576|FG002|Overall Study|Adverse Event|0|||
124449739|NCT00097773|447609577|FG003|Overall Study|Adverse Event|0|||
124449740|NCT00097773|447609574|FG000|Overall Study|Other|1|||
124449741|NCT00097773|447609575|FG001|Overall Study|Other|0|||
124449742|NCT00097773|447609576|FG002|Overall Study|Other|2|||
124449743|NCT00097773|447609577|FG003|Overall Study|Other|0|||
124544698|NCT03110107|447949213|FG024|Treatment Period|Participant withdrew consent|0|||
124449744|NCT00003702|447609578|FG000|Overall Study|Ineligible cell types|2|||
124760087|NCT02043938|448746769|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
124760088|NCT02043938|448746769|FG000|Overall Study|No show by subject|1|||
124449745|NCT00003702|447609579|FG001|Overall Study|Ineligible cell types|2|||
124905763|NCT04707313|449281164|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905764|NCT04707313|449281165|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905765|NCT04707313|449281166|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
124905766|NCT04707313|449281167|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905767|NCT04707313|449281168|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905768|NCT04707313|449281169|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905769|NCT04707313|449281170|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905770|NCT04707313|449281171|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
124905771|NCT04707313|449281172|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905772|NCT04707313|449281173|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905773|NCT04707313|449281174|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905774|NCT04707313|449281175|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905775|NCT04707313|449281176|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
124905776|NCT04707313|449281164|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905777|NCT04707313|449281165|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905778|NCT04707313|449281166|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905779|NCT04707313|449281167|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905780|NCT04707313|449281168|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905781|NCT04707313|449281169|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905782|NCT04707313|449281170|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905783|NCT04707313|449281171|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905784|NCT04707313|449281172|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905785|NCT04707313|449281173|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
124905786|NCT04707313|449281174|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
124905787|NCT04707313|449281175|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
124905788|NCT04707313|449281176|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
124905789|NCT04707313|449281164|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905790|NCT04707313|449281165|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905791|NCT04707313|449281166|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905792|NCT04707313|449281167|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905793|NCT04707313|449281168|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905794|NCT04707313|449281169|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905795|NCT04707313|449281170|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905796|NCT04707313|449281171|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905797|NCT04707313|449281172|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905798|NCT04707313|449281173|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
124905799|NCT04707313|449281174|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
124905800|NCT04707313|449281175|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
124905801|NCT04707313|449281176|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
124905802|NCT04707313|449281164|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905803|NCT04707313|449281165|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905804|NCT04707313|449281166|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905805|NCT04707313|449281167|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905806|NCT04707313|449281168|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905807|NCT04707313|449281169|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905808|NCT04707313|449281170|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905809|NCT04707313|449281171|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905810|NCT04707313|449281172|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
124905811|NCT04707313|449281173|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
124905812|NCT04707313|449281174|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
124905813|NCT04707313|449281175|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
124905814|NCT04707313|449281176|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
124905815|NCT04707313|449281164|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905816|NCT04707313|449281165|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905817|NCT04707313|449281166|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905818|NCT04707313|449281167|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905819|NCT04707313|449281168|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905820|NCT04707313|449281169|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905821|NCT04707313|449281170|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905822|NCT04707313|449281171|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905823|NCT04707313|449281172|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905824|NCT04707313|449281173|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
124449746|NCT00003702|447609578|FG000|Overall Study|Did not meet criteria for persistence|8|||
124449747|NCT00003702|447609579|FG001|Overall Study|Did not meet criteria for persistence|5|||
124449748|NCT00003702|447609578|FG000|Overall Study|WHO score > 6|2|||
124905825|NCT04707313|449281174|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
124905826|NCT04707313|449281175|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
124905827|NCT04707313|449281176|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
124449749|NCT00003702|447609579|FG001|Overall Study|WHO score > 6|1|||
124449750|NCT00003702|447609578|FG000|Overall Study|Inadequate documentation of disease|1|||
124449751|NCT00003702|447609579|FG001|Overall Study|Inadequate documentation of disease|3|||
124449752|NCT01009034|447609580|FG000|Overall Study|Lost to Follow-up|2|||
124449753|NCT01009034|447609580|FG000|Overall Study|Withdrawal by Subject|2|||
124691541|NCT03928704|448492143|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
124691542|NCT03928704|448492144|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
124691543|NCT03928704|448492145|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
124691544|NCT03928704|448492146|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
124691545|NCT03928704|448492147|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
124691546|NCT03928704|448492148|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
124691547|NCT03928704|448492143|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
124691548|NCT03928704|448492144|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
124691549|NCT03928704|448492145|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
124691550|NCT03928704|448492146|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
124691551|NCT03928704|448492147|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
124691552|NCT03928704|448492148|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
124691553|NCT03928704|448492143|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
124691554|NCT03928704|448492144|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
124691555|NCT03928704|448492145|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
124691556|NCT03928704|448492146|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
124905828|NCT04707313|449281164|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905829|NCT04707313|449281165|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905830|NCT04707313|449281166|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905831|NCT04707313|449281167|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905832|NCT04707313|449281168|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905833|NCT04707313|449281169|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905834|NCT04707313|449281170|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905835|NCT04707313|449281171|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124691557|NCT03928704|448492147|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
124691558|NCT03928704|448492148|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
124691559|NCT03928704|448492143|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
124905836|NCT04707313|449281172|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905837|NCT04707313|449281173|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
124905838|NCT04707313|449281174|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
124905839|NCT04707313|449281175|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905840|NCT04707313|449281176|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
124905841|NCT04707313|449281164|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905842|NCT04707313|449281165|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905843|NCT04707313|449281166|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905844|NCT04707313|449281167|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905845|NCT04707313|449281168|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905846|NCT04707313|449281169|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905847|NCT04707313|449281170|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905848|NCT04707313|449281171|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905849|NCT04707313|449281172|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
124905850|NCT04707313|449281173|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
124905851|NCT04707313|449281174|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
124691560|NCT03928704|448492144|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
124905852|NCT04707313|449281175|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
124905853|NCT04707313|449281176|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
124691561|NCT03928704|448492145|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
124691562|NCT03928704|448492146|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
124691563|NCT03928704|448492147|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
124691564|NCT03928704|448492148|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
124691565|NCT04575324|448492151|FG000|Overall Study|Lost to Follow-up|29|||
124691566|NCT04575324|448492152|FG001|Overall Study|Lost to Follow-up|25|||
124691567|NCT04575324|448492151|FG000|Overall Study|Death|1|||
124691568|NCT04575324|448492152|FG001|Overall Study|Death|2|||
124691569|NCT04575324|448492151|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
124691570|NCT04575324|448492152|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
124905854|NCT00834834|449281179|FG000|Overall Study|Withdrawal by Subject|4|||
124905855|NCT00834834|449281180|FG001|Overall Study|Withdrawal by Subject|3|||
124905856|NCT00539292|449281181|FG000|Overall Study|Physician Decision|1|||
124905857|NCT00539292|449281182|FG001|Overall Study|Physician Decision|0|||
124905858|NCT02020616|449281183|FG000|Overall Study|Adverse Event|0|||
124905859|NCT02020616|449281184|FG001|Overall Study|Adverse Event|0|||
124905860|NCT02020616|449281185|FG002|Overall Study|Adverse Event|0|||
124905861|NCT02020616|449281186|FG003|Overall Study|Adverse Event|0|||
124905862|NCT02020616|449281187|FG004|Overall Study|Adverse Event|0|||
124905863|NCT02020616|449281188|FG005|Overall Study|Adverse Event|1|||
124905864|NCT02020616|449281189|FG006|Overall Study|Adverse Event|1|||
124905865|NCT02020616|449281183|FG000|Overall Study|Physician Decision|0|||
124905866|NCT02020616|449281184|FG001|Overall Study|Physician Decision|0|||
124905867|NCT02020616|449281185|FG002|Overall Study|Physician Decision|0|||
124905868|NCT02020616|449281186|FG003|Overall Study|Physician Decision|0|||
124905869|NCT02020616|449281187|FG004|Overall Study|Physician Decision|0|||
124905870|NCT02020616|449281188|FG005|Overall Study|Physician Decision|1|||
124905871|NCT02020616|449281189|FG006|Overall Study|Physician Decision|2|||
124905872|NCT02020616|449281183|FG000|Overall Study|Withdrawal by Subject|0|||
124905873|NCT02020616|449281184|FG001|Overall Study|Withdrawal by Subject|0|||
124905874|NCT02020616|449281185|FG002|Overall Study|Withdrawal by Subject|1|||
124905875|NCT02020616|449281186|FG003|Overall Study|Withdrawal by Subject|0|||
124691571|NCT00456612|448492156|FG000|Overall Study|Withdrawal by Subject|3|||
124691572|NCT03309605|448492159|FG000|Overall Study|Adverse Event|0|||
124905876|NCT02020616|449281187|FG004|Overall Study|Withdrawal by Subject|0|||
124905877|NCT02020616|449281188|FG005|Overall Study|Withdrawal by Subject|1|||
124905878|NCT02020616|449281189|FG006|Overall Study|Withdrawal by Subject|1|||
124905879|NCT02020616|449281183|FG000|Overall Study|Lost to Follow-up|0|||
124905880|NCT02020616|449281184|FG001|Overall Study|Lost to Follow-up|1|||
124905881|NCT02020616|449281185|FG002|Overall Study|Lost to Follow-up|0|||
124691573|NCT03309605|448492160|FG001|Overall Study|Adverse Event|0|||
124905882|NCT02020616|449281186|FG003|Overall Study|Lost to Follow-up|1|||
124905883|NCT02020616|449281187|FG004|Overall Study|Lost to Follow-up|1|||
124905884|NCT02020616|449281188|FG005|Overall Study|Lost to Follow-up|1|||
124905885|NCT02020616|449281189|FG006|Overall Study|Lost to Follow-up|0|||
124905886|NCT02020616|449281183|FG000|Overall Study|Early Termination Criteria Met|0|||
124905887|NCT02020616|449281184|FG001|Overall Study|Early Termination Criteria Met|0|||
124905888|NCT02020616|449281185|FG002|Overall Study|Early Termination Criteria Met|1|||
124905889|NCT02020616|449281186|FG003|Overall Study|Early Termination Criteria Met|0|||
124905890|NCT02020616|449281187|FG004|Overall Study|Early Termination Criteria Met|0|||
124905891|NCT02020616|449281188|FG005|Overall Study|Early Termination Criteria Met|1|||
124905892|NCT02020616|449281189|FG006|Overall Study|Early Termination Criteria Met|0|||
124905893|NCT02020616|449281183|FG000|Overall Study|Randomized in Error|0|||
124905894|NCT02020616|449281184|FG001|Overall Study|Randomized in Error|0|||
124905895|NCT02020616|449281185|FG002|Overall Study|Randomized in Error|0|||
124905896|NCT02020616|449281186|FG003|Overall Study|Randomized in Error|1|||
124905897|NCT02020616|449281187|FG004|Overall Study|Randomized in Error|0|||
124905898|NCT02020616|449281188|FG005|Overall Study|Randomized in Error|0|||
124905899|NCT02020616|449281189|FG006|Overall Study|Randomized in Error|0|||
124905900|NCT02020616|449281183|FG000|Overall Study|Lack of Efficacy|0|||
124905901|NCT02020616|449281184|FG001|Overall Study|Lack of Efficacy|0|||
124905902|NCT02020616|449281185|FG002|Overall Study|Lack of Efficacy|0|||
124905903|NCT02020616|449281186|FG003|Overall Study|Lack of Efficacy|0|||
124905904|NCT02020616|449281187|FG004|Overall Study|Lack of Efficacy|1|||
124905905|NCT02020616|449281188|FG005|Overall Study|Lack of Efficacy|0|||
124905906|NCT02020616|449281189|FG006|Overall Study|Lack of Efficacy|0|||
124905907|NCT00305695|449281194|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
124905908|NCT00305695|449281195|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
124905909|NCT00305695|449281194|FG000|Overall Study|Did not have baseline scan|1|||
124905910|NCT00305695|449281195|FG001|Overall Study|Did not have baseline scan|1|||
124905911|NCT02031471|449281198|FG000|24 Week Treatment Period|Adverse Event|6|||
124905912|NCT02031471|449281198|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
124905913|NCT02031471|449281198|FG000|24 Week Treatment Period|Protocol Violation|1|||
124905914|NCT02031471|449281198|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
124905915|NCT02031471|449281198|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
124905916|NCT02031471|449281198|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
124905917|NCT02031471|449281198|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
124905918|NCT00997386|449281199|FG000|Overall Study|Death|7|||
124905919|NCT00961636|449281209|FG000|Overall Study|Adverse Event|35|||
124905920|NCT00961636|449281210|FG001|Overall Study|Adverse Event|54|||
124905921|NCT00961636|449281211|FG002|Overall Study|Adverse Event|13|||
124905922|NCT00961636|449281209|FG000|Overall Study|Flushing Symptoms|29|||
124905923|NCT00961636|449281210|FG001|Overall Study|Flushing Symptoms|46|||
124905924|NCT00961636|449281211|FG002|Overall Study|Flushing Symptoms|3|||
124905925|NCT00961636|449281209|FG000|Overall Study|Lost to Follow-up|2|||
124905926|NCT00961636|449281210|FG001|Overall Study|Lost to Follow-up|3|||
124905927|NCT00961636|449281211|FG002|Overall Study|Lost to Follow-up|1|||
124905928|NCT00961636|449281209|FG000|Overall Study|Physician Decision|3|||
124905929|NCT00961636|449281210|FG001|Overall Study|Physician Decision|1|||
124905930|NCT00961636|449281211|FG002|Overall Study|Physician Decision|1|||
124905931|NCT00961636|449281209|FG000|Overall Study|Protocol Violation|9|||
124449754|NCT01494350|447609581|FG000|Overall Study|Worsening of lesion|1|||
124449755|NCT00698932|447609582|FG000|Overall Study|Adverse Event|0|||
124449756|NCT00698932|447609583|FG001|Overall Study|Adverse Event|2|||
124449757|NCT00698932|447609582|FG000|Overall Study|Incorrect enrollment|0|||
124449758|NCT00698932|447609583|FG001|Overall Study|Incorrect enrollment|2|||
124449759|NCT00698932|447609582|FG000|Overall Study|Study specific discontinuation criteria|3|||
124449760|NCT00698932|447609583|FG001|Overall Study|Study specific discontinuation criteria|4|||
124449761|NCT00698932|447609582|FG000|Overall Study|Withdrawal by Subject|11|||
124449762|NCT00698932|447609583|FG001|Overall Study|Withdrawal by Subject|23|||
124449763|NCT00698932|447609582|FG000|Overall Study|Lost to Follow-up|6|||
124449764|NCT00698932|447609583|FG001|Overall Study|Lost to Follow-up|1|||
124449765|NCT00698932|447609582|FG000|Overall Study|Severe non-compliance to protocol|1|||
124449766|NCT00698932|447609583|FG001|Overall Study|Severe non-compliance to protocol|2|||
124449767|NCT00698932|447609582|FG000|Overall Study|Safety reasons|0|||
124449768|NCT00698932|447609583|FG001|Overall Study|Safety reasons|2|||
124449769|NCT00698932|447609582|FG000|Overall Study|Death|1|||
124449770|NCT00698932|447609583|FG001|Overall Study|Death|0|||
124449771|NCT01245387|447609584|FG000|Overall Study|Lost to Follow-up|106|||
124449772|NCT01245387|447609584|FG000|Overall Study|Lack of Efficacy|195|||
124449773|NCT01245387|447609584|FG000|Overall Study|Adverse Event|9|||
124449774|NCT01245387|447609584|FG000|Overall Study|Death|3|||
124905932|NCT00961636|449281210|FG001|Overall Study|Protocol Violation|5|||
124905933|NCT00961636|449281211|FG002|Overall Study|Protocol Violation|1|||
124905934|NCT00961636|449281209|FG000|Overall Study|Withdrawal by Subject|29|||
124905935|NCT00961636|449281210|FG001|Overall Study|Withdrawal by Subject|22|||
124905936|NCT00961636|449281211|FG002|Overall Study|Withdrawal by Subject|13|||
124905937|NCT02551055|449281214|FG000|Overall Study|Death|2|||
124905938|NCT02551055|449281215|FG001|Overall Study|Death|4|||
124905939|NCT02551055|449281216|FG002|Overall Study|Death|2|||
124905940|NCT02551055|449281217|FG003|Overall Study|Death|2|||
124905941|NCT02551055|449281218|FG004|Overall Study|Death|2|||
124905942|NCT02551055|449281219|FG005|Overall Study|Death|1|||
124905943|NCT02551055|449281220|FG006|Overall Study|Death|2|||
124905944|NCT02551055|449281221|FG007|Overall Study|Death|0|||
124905945|NCT02551055|449281214|FG000|Overall Study|Study Terminated by Sponsor|1|||
124905946|NCT02551055|449281215|FG001|Overall Study|Study Terminated by Sponsor|1|||
124691574|NCT03309605|448492161|FG002|Overall Study|Adverse Event|0|||
124691575|NCT03309605|448492162|FG003|Overall Study|Adverse Event|1|||
124691576|NCT03309605|448492163|FG004|Overall Study|Adverse Event|0|||
124691577|NCT03309605|448492164|FG005|Overall Study|Adverse Event|0|||
124691578|NCT03309605|448492165|FG006|Overall Study|Adverse Event|2|||
124691579|NCT03309605|448492166|FG007|Overall Study|Adverse Event|1|||
124691580|NCT03309605|448492159|FG000|Overall Study|Withdrawal by Subject|0|||
124691581|NCT03309605|448492160|FG001|Overall Study|Withdrawal by Subject|0|||
124691582|NCT03309605|448492161|FG002|Overall Study|Withdrawal by Subject|0|||
124691583|NCT03309605|448492162|FG003|Overall Study|Withdrawal by Subject|0|||
124691584|NCT03309605|448492163|FG004|Overall Study|Withdrawal by Subject|1|||
124691585|NCT03309605|448492164|FG005|Overall Study|Withdrawal by Subject|0|||
124691586|NCT03309605|448492165|FG006|Overall Study|Withdrawal by Subject|1|||
124905947|NCT02551055|449281216|FG002|Overall Study|Study Terminated by Sponsor|0|||
124905948|NCT02551055|449281217|FG003|Overall Study|Study Terminated by Sponsor|2|||
124905949|NCT02551055|449281218|FG004|Overall Study|Study Terminated by Sponsor|2|||
124905950|NCT02551055|449281219|FG005|Overall Study|Study Terminated by Sponsor|0|||
124905951|NCT02551055|449281220|FG006|Overall Study|Study Terminated by Sponsor|0|||
124905952|NCT02551055|449281221|FG007|Overall Study|Study Terminated by Sponsor|0|||
124905953|NCT02551055|449281214|FG000|Overall Study|Withdrawal by Subject|1|||
124905954|NCT02551055|449281215|FG001|Overall Study|Withdrawal by Subject|1|||
124905955|NCT02551055|449281216|FG002|Overall Study|Withdrawal by Subject|0|||
124905956|NCT02551055|449281217|FG003|Overall Study|Withdrawal by Subject|1|||
124905957|NCT02551055|449281218|FG004|Overall Study|Withdrawal by Subject|2|||
124905958|NCT02551055|449281219|FG005|Overall Study|Withdrawal by Subject|0|||
124905959|NCT02551055|449281220|FG006|Overall Study|Withdrawal by Subject|0|||
124905960|NCT02551055|449281221|FG007|Overall Study|Withdrawal by Subject|0|||
124905961|NCT02551055|449281214|FG000|Overall Study|Reason not specified|0|||
124905962|NCT02551055|449281215|FG001|Overall Study|Reason not specified|0|||
124905963|NCT02551055|449281216|FG002|Overall Study|Reason not specified|0|||
124905964|NCT02551055|449281217|FG003|Overall Study|Reason not specified|0|||
124905965|NCT02551055|449281218|FG004|Overall Study|Reason not specified|1|||
124905966|NCT02551055|449281219|FG005|Overall Study|Reason not specified|0|||
124905967|NCT02551055|449281220|FG006|Overall Study|Reason not specified|1|||
124905968|NCT02551055|449281221|FG007|Overall Study|Reason not specified|0|||
124905969|NCT02041104|449281229|FG000|Overall Study|Lost to Follow-up|1|||
124905970|NCT02041104|449281230|FG001|Overall Study|Lost to Follow-up|4|||
124905971|NCT02041104|449281229|FG000|Overall Study|discomfort during OGTT|0|||
124905972|NCT02041104|449281230|FG001|Overall Study|discomfort during OGTT|3|||
124905973|NCT01063517|449281231|FG000|Overall Study|Consent withdrawal|1|||
124905974|NCT01063517|449281232|FG001|Overall Study|Consent withdrawal|0|||
124905975|NCT01063517|449281231|FG000|Overall Study|Study reached data cut-off|19|||
124905976|NCT01063517|449281232|FG001|Overall Study|Study reached data cut-off|7|||
124905977|NCT01063517|449281231|FG000|Overall Study|Lost to Follow-up|4|||
124905978|NCT01063517|449281232|FG001|Overall Study|Lost to Follow-up|3|||
124905979|NCT01063517|449281231|FG000|Overall Study|Withdrawal by Subject|1|||
124905980|NCT01063517|449281232|FG001|Overall Study|Withdrawal by Subject|2|||
124905981|NCT01063517|449281231|FG000|Overall Study|Death|33|||
124905982|NCT01063517|449281232|FG001|Overall Study|Death|48|||
124905983|NCT01350804|449281233|FG000|Core Study|Withdrawal by Subject|11|||
124905984|NCT01350804|449281234|FG001|Core Study|Withdrawal by Subject|17|||
124691587|NCT03309605|448492166|FG007|Overall Study|Withdrawal by Subject|1|||
124691588|NCT00784927|448492167|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
124691589|NCT00784927|448492167|FG000|Overall Study|Protocol Violation|1|||
124905985|NCT01350804|449281235|FG002|Core Study|Withdrawal by Subject|16|||
124905986|NCT01350804|449281236|FG003|Core Study|Withdrawal by Subject|7|||
124905987|NCT01350804|449281233|FG000|Core Study|Study terminated by Sponsor|0|||
124905988|NCT01350804|449281234|FG001|Core Study|Study terminated by Sponsor|0|||
124905989|NCT01350804|449281235|FG002|Core Study|Study terminated by Sponsor|0|||
124905990|NCT01350804|449281236|FG003|Core Study|Study terminated by Sponsor|2|||
124905991|NCT01350804|449281233|FG000|Core Study|Protocol deviation|1|||
124905992|NCT01350804|449281234|FG001|Core Study|Protocol deviation|0|||
124905993|NCT01350804|449281235|FG002|Core Study|Protocol deviation|1|||
124905994|NCT01350804|449281236|FG003|Core Study|Protocol deviation|0|||
124905995|NCT01350804|449281233|FG000|Core Study|Physician Decision|1|||
124905996|NCT01350804|449281234|FG001|Core Study|Physician Decision|0|||
124905997|NCT01350804|449281235|FG002|Core Study|Physician Decision|1|||
124905998|NCT01350804|449281236|FG003|Core Study|Physician Decision|3|||
124905999|NCT01350804|449281233|FG000|Core Study|Lost to Follow-up|3|||
124906000|NCT01350804|449281234|FG001|Core Study|Lost to Follow-up|0|||
124906001|NCT01350804|449281235|FG002|Core Study|Lost to Follow-up|2|||
124906002|NCT01350804|449281236|FG003|Core Study|Lost to Follow-up|1|||
124906003|NCT01350804|449281233|FG000|Core Study|Lack of Efficacy|16|||
124906004|NCT01350804|449281234|FG001|Core Study|Lack of Efficacy|19|||
124906005|NCT01350804|449281235|FG002|Core Study|Lack of Efficacy|18|||
124906006|NCT01350804|449281236|FG003|Core Study|Lack of Efficacy|5|||
124906007|NCT01350804|449281233|FG000|Core Study|Death|1|||
124906008|NCT01350804|449281234|FG001|Core Study|Death|1|||
124906009|NCT01350804|449281235|FG002|Core Study|Death|1|||
124906010|NCT01350804|449281236|FG003|Core Study|Death|0|||
124906011|NCT01350804|449281233|FG000|Core Study|Adverse Event|8|||
124906012|NCT01350804|449281234|FG001|Core Study|Adverse Event|10|||
124906013|NCT01350804|449281235|FG002|Core Study|Adverse Event|8|||
124906014|NCT01350804|449281236|FG003|Core Study|Adverse Event|8|||
124906015|NCT01350804|449281233|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
124906016|NCT01350804|449281234|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
124449775|NCT01245387|447609584|FG000|Overall Study|Other|131|||
124691590|NCT00784927|448492167|FG000|Overall Study|Ineligible|1|||
124691591|NCT01795937|448492174|FG000|Overall Study|Withdrawal by Subject|1|||
124691592|NCT01795937|448492175|FG001|Overall Study|Withdrawal by Subject|0|||
124691593|NCT01795937|448492176|FG002|Overall Study|Withdrawal by Subject|0|||
124691594|NCT01795937|448492174|FG000|Overall Study|Physician Decision|0|||
124691595|NCT01795937|448492175|FG001|Overall Study|Physician Decision|1|||
124691596|NCT01795937|448492176|FG002|Overall Study|Physician Decision|0|||
124691597|NCT04027946|448492177|FG000|Overall Study|Screen failures|3|||
124691598|NCT01028053|448492178|FG000|Overall Study|Screen Failure|113|||
124691599|NCT01028053|448492178|FG000|Overall Study|Patient Request|11|||
124691600|NCT01028053|448492178|FG000|Overall Study|Protocol Violation|1|||
124691601|NCT01028053|448492178|FG000|Overall Study|Physician Decision|2|||
124691602|NCT01028053|448492178|FG000|Overall Study|Technical Problem|1|||
124691603|NCT01028053|448492178|FG000|Overall Study|Terminated by Sponsor|1|||
124691604|NCT01028053|448492178|FG000|Overall Study|Various reasons|4|||
124691605|NCT00983957|448492179|FG000|Overall Study|Adverse Event|1|||
124691606|NCT00983957|448492179|FG000|Overall Study|Personal Reasons|1|||
124691607|NCT00790933|448492180|FG000|Overall Study|Adverse Event|94|||
124691608|NCT00790933|448492181|FG001|Overall Study|Adverse Event|119|||
124691609|NCT00790933|448492182|FG002|Overall Study|Adverse Event|65|||
124691610|NCT00790933|448492183|FG003|Overall Study|Adverse Event|5|||
124691611|NCT00790933|448492184|FG004|Overall Study|Adverse Event|69|||
124691612|NCT00790933|448492180|FG000|Overall Study|Protocol Violation(s)|8|||
124691613|NCT00790933|448492181|FG001|Overall Study|Protocol Violation(s)|18|||
124691614|NCT00790933|448492182|FG002|Overall Study|Protocol Violation(s)|7|||
124691615|NCT00790933|448492183|FG003|Overall Study|Protocol Violation(s)|0|||
124691616|NCT00790933|448492184|FG004|Overall Study|Protocol Violation(s)|12|||
124691617|NCT00790933|448492180|FG000|Overall Study|Lack of Efficacy|192|||
124691618|NCT00790933|448492181|FG001|Overall Study|Lack of Efficacy|176|||
124906017|NCT01350804|449281235|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
124906018|NCT01350804|449281236|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
124906019|NCT01350804|449281233|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
124906020|NCT01350804|449281234|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
124906021|NCT01350804|449281235|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
124906022|NCT01350804|449281236|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
124906023|NCT01350804|449281233|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
124906024|NCT01350804|449281234|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
124906025|NCT01350804|449281235|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
124906026|NCT01350804|449281236|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
124906027|NCT01350804|449281233|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
124906028|NCT01350804|449281234|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
124906029|NCT01350804|449281235|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
124906030|NCT01350804|449281236|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
124906031|NCT01350804|449281233|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
124906032|NCT01350804|449281234|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
124906033|NCT01350804|449281235|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
124906034|NCT01350804|449281236|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
124906035|NCT01350804|449281233|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
124906036|NCT01350804|449281234|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
124906037|NCT01350804|449281235|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
124906038|NCT01350804|449281236|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
124906039|NCT01713946|449281237|FG000|Overall Study|Death|0|||
124906040|NCT01713946|449281238|FG001|Overall Study|Death|2|||
124906041|NCT01713946|449281239|FG002|Overall Study|Death|2|||
124906042|NCT01713946|449281237|FG000|Overall Study|Adverse Event|19|||
124906043|NCT01713946|449281238|FG001|Overall Study|Adverse Event|14|||
124906044|NCT01713946|449281239|FG002|Overall Study|Adverse Event|13|||
124906045|NCT01713946|449281237|FG000|Overall Study|Withdrawal by Subject|12|||
124906046|NCT01713946|449281238|FG001|Overall Study|Withdrawal by Subject|12|||
124906047|NCT01713946|449281239|FG002|Overall Study|Withdrawal by Subject|8|||
124906048|NCT01713946|449281237|FG000|Overall Study|Lack of Efficacy|8|||
124906049|NCT01713946|449281238|FG001|Overall Study|Lack of Efficacy|8|||
124906050|NCT01713946|449281239|FG002|Overall Study|Lack of Efficacy|14|||
124906051|NCT01713946|449281237|FG000|Overall Study|Protocol Violation|2|||
124906052|NCT01713946|449281238|FG001|Overall Study|Protocol Violation|4|||
124906053|NCT01713946|449281239|FG002|Overall Study|Protocol Violation|1|||
124906054|NCT01713946|449281237|FG000|Overall Study|Lost to Follow-up|0|||
124906055|NCT01713946|449281238|FG001|Overall Study|Lost to Follow-up|0|||
124906056|NCT01713946|449281239|FG002|Overall Study|Lost to Follow-up|1|||
124906057|NCT01713946|449281237|FG000|Overall Study|Administrative problems|1|||
124906058|NCT01713946|449281238|FG001|Overall Study|Administrative problems|0|||
124906059|NCT01713946|449281239|FG002|Overall Study|Administrative problems|0|||
124906060|NCT01713946|449281237|FG000|Overall Study|Did not continue in Ext|0|||
124906061|NCT01713946|449281238|FG001|Overall Study|Did not continue in Ext|3|||
124906062|NCT01713946|449281239|FG002|Overall Study|Did not continue in Ext|0|||
124906063|NCT01713946|449281237|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
124906064|NCT01713946|449281238|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
124906065|NCT01713946|449281239|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
124906066|NCT01713946|449281237|FG000|Overall Study|Patients never switched to everolimus|0|||
124906067|NCT01713946|449281238|FG001|Overall Study|Patients never switched to everolimus|0|||
124906068|NCT01713946|449281239|FG002|Overall Study|Patients never switched to everolimus|5|||
124906069|NCT03622580|449282648|FG000|Overall Study|Death|16|||
124906070|NCT03622580|449282649|FG001|Overall Study|Death|21|||
124544699|NCT03110107|447949214|FG025|Treatment Period|Participant withdrew consent|2|||
124544700|NCT03110107|447949189|FG000|Treatment Period|Participants no longer meets study criteria|0|||
124544701|NCT03110107|447949190|FG001|Treatment Period|Participants no longer meets study criteria|0|||
124544702|NCT03110107|447949191|FG002|Treatment Period|Participants no longer meets study criteria|0|||
124544703|NCT03110107|447949192|FG003|Treatment Period|Participants no longer meets study criteria|0|||
124544704|NCT03110107|447949193|FG004|Treatment Period|Participants no longer meets study criteria|0|||
124906071|NCT03622580|449282650|FG002|Overall Study|Death|13|||
124906072|NCT03622580|449282648|FG000|Overall Study|Adverse Event|6|||
124691619|NCT00790933|448492182|FG002|Overall Study|Lack of Efficacy|130|||
124906073|NCT03622580|449282649|FG001|Overall Study|Adverse Event|6|||
124906074|NCT03622580|449282650|FG002|Overall Study|Adverse Event|5|||
124906075|NCT03622580|449282648|FG000|Overall Study|Withdrawal by Subject|12|||
124906076|NCT03622580|449282649|FG001|Overall Study|Withdrawal by Subject|7|||
124906077|NCT03622580|449282650|FG002|Overall Study|Withdrawal by Subject|19|||
124906078|NCT03622580|449282648|FG000|Overall Study|Lost to Follow-up|12|||
124906079|NCT03622580|449282649|FG001|Overall Study|Lost to Follow-up|9|||
124906080|NCT03622580|449282650|FG002|Overall Study|Lost to Follow-up|9|||
124906081|NCT03622580|449282648|FG000|Overall Study|Protocol Violation|1|||
124691620|NCT00790933|448492183|FG003|Overall Study|Lack of Efficacy|1|||
124906082|NCT03622580|449282649|FG001|Overall Study|Protocol Violation|0|||
124906083|NCT03622580|449282650|FG002|Overall Study|Protocol Violation|1|||
124906084|NCT03622580|449282648|FG000|Overall Study|Physician Decision|3|||
124906085|NCT03622580|449282649|FG001|Overall Study|Physician Decision|0|||
124906086|NCT03622580|449282650|FG002|Overall Study|Physician Decision|1|||
124906087|NCT03622580|449282648|FG000|Overall Study|Pregnancy|0|||
124906088|NCT03622580|449282649|FG001|Overall Study|Pregnancy|1|||
124906089|NCT03622580|449282650|FG002|Overall Study|Pregnancy|0|||
124906090|NCT03622580|449282648|FG000|Overall Study|Lack of Efficacy|0|||
124906091|NCT03622580|449282649|FG001|Overall Study|Lack of Efficacy|0|||
124906092|NCT03622580|449282650|FG002|Overall Study|Lack of Efficacy|1|||
124906093|NCT03622580|449282648|FG000|Overall Study|Other|2|||
124906094|NCT03622580|449282649|FG001|Overall Study|Other|0|||
124906095|NCT03622580|449282650|FG002|Overall Study|Other|3|||
124906096|NCT01930045|449282655|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
124906097|NCT01930045|449282656|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
124906098|NCT01930045|449282657|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
124906099|NCT01930045|449282658|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
124906100|NCT01930045|449282659|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
124906101|NCT01930045|449282660|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
124906102|NCT01930045|449282655|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
124906103|NCT01930045|449282656|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
124906104|NCT01930045|449282657|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
124906105|NCT01930045|449282658|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
124906106|NCT01930045|449282659|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
124906107|NCT01930045|449282660|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
124906108|NCT01147341|449282667|FG000|Double Blind Period|Lack of Efficacy|1|||
124906109|NCT01147341|449282668|FG001|Double Blind Period|Lack of Efficacy|1|||
124906110|NCT01147341|449282667|FG000|Double Blind Period|Withdrawal by Subject|0|||
124906111|NCT01147341|449282668|FG001|Double Blind Period|Withdrawal by Subject|1|||
124906112|NCT01147341|449282667|FG000|Open Label Period|Lack of Efficacy|3|||
124906113|NCT01147341|449282668|FG001|Open Label Period|Lack of Efficacy|0|||
124906114|NCT01147341|449282667|FG000|Open Label Period|Subject moved|1|||
124906115|NCT01147341|449282668|FG001|Open Label Period|Subject moved|0|||
124906116|NCT02808338|449282671|FG000|Screening|Screen Failure|10|||
124906117|NCT02808338|449282671|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
124906118|NCT02808338|449282671|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
124906119|NCT00057837|449282672|FG000|Overall Study|Progression/relapse|12|||
124906120|NCT00057837|449282673|FG001|Overall Study|Progression/relapse|14|||
124906121|NCT00057837|449282672|FG000|Overall Study|Adverse Event|2|||
124906122|NCT00057837|449282673|FG001|Overall Study|Adverse Event|12|||
124906123|NCT00057837|449282672|FG000|Overall Study|Death|5|||
124906124|NCT00057837|449282673|FG001|Overall Study|Death|4|||
124906125|NCT00057837|449282672|FG000|Overall Study|Withdrawal by Subject|5|||
124906126|NCT00057837|449282673|FG001|Overall Study|Withdrawal by Subject|3|||
124906127|NCT00057837|449282672|FG000|Overall Study|Alternative therapy|0|||
124906128|NCT00057837|449282673|FG001|Overall Study|Alternative therapy|1|||
124906129|NCT00057837|449282672|FG000|Overall Study|Other complicating disease|2|||
124906130|NCT00057837|449282673|FG001|Overall Study|Other complicating disease|1|||
124906131|NCT00057837|449282672|FG000|Overall Study|Physician Decision|1|||
124906132|NCT00057837|449282673|FG001|Overall Study|Physician Decision|0|||
124906133|NCT00057837|449282672|FG000|Overall Study|Ineligible|3|||
124906134|NCT00057837|449282673|FG001|Overall Study|Ineligible|3|||
124906135|NCT00057837|449282672|FG000|Overall Study|Never started treatment|1|||
124906136|NCT00057837|449282673|FG001|Overall Study|Never started treatment|1|||
124906137|NCT00463788|449282675|FG000|Overall Study|Progressive Disease|86|||
124906138|NCT00463788|449282676|FG001|Overall Study|Progressive Disease|42|||
124906139|NCT00463788|449282675|FG000|Overall Study|Adverse Event|6|||
124906140|NCT00463788|449282676|FG001|Overall Study|Adverse Event|2|||
124906141|NCT00463788|449282675|FG000|Overall Study|Withdrawal by Subject|6|||
124906142|NCT00463788|449282676|FG001|Overall Study|Withdrawal by Subject|2|||
124906143|NCT00463788|449282675|FG000|Overall Study|Death|4|||
124906144|NCT00463788|449282676|FG001|Overall Study|Death|3|||
124906145|NCT00463788|449282675|FG000|Overall Study|Symptomatic Deterioration|2|||
124906146|NCT00463788|449282676|FG001|Overall Study|Symptomatic Deterioration|3|||
124691621|NCT00790933|448492184|FG004|Overall Study|Lack of Efficacy|121|||
124906147|NCT00463788|449282675|FG000|Overall Study|Lost to Follow-up|1|||
124906148|NCT00463788|449282676|FG001|Overall Study|Lost to Follow-up|0|||
124906149|NCT00463788|449282675|FG000|Overall Study|Protocol Violation|0|||
124906150|NCT00463788|449282676|FG001|Overall Study|Protocol Violation|1|||
124906151|NCT00463788|449282675|FG000|Overall Study|Other|3|||
124906152|NCT00463788|449282676|FG001|Overall Study|Other|0|||
124906153|NCT00463788|449282675|FG000|Overall Study|Randomized but not treated|1|||
124906154|NCT00463788|449282676|FG001|Overall Study|Randomized but not treated|1|||
124906155|NCT00360698|449282677|FG000|Run-In|Physician Decision|0|||
124906156|NCT00360698|449282678|FG001|Run-In|Physician Decision|1|||
124906157|NCT00360698|449282677|FG000|Run-In|Withdrawal by Subject|0|||
124906158|NCT00360698|449282678|FG001|Run-In|Withdrawal by Subject|2|||
124906159|NCT00360698|449282677|FG000|Run-In|Non compliance with treatment procedure|0|||
124906160|NCT00360698|449282678|FG001|Run-In|Non compliance with treatment procedure|1|||
124906161|NCT00360698|449282677|FG000|Run-In|Sponsor request|0|||
124906162|NCT00360698|449282678|FG001|Run-In|Sponsor request|2|||
124906163|NCT00360698|449282677|FG000|Run-In|Patient did not meet inclusion criteria|0|||
124906164|NCT00360698|449282678|FG001|Run-In|Patient did not meet inclusion criteria|1|||
124906165|NCT00360698|449282677|FG000|Run-In|Patient personal reasons|0|||
124906166|NCT00360698|449282678|FG001|Run-In|Patient personal reasons|2|||
124906167|NCT00360698|449282677|FG000|Run-In|Need of insulin with meals|0|||
124906168|NCT00360698|449282678|FG001|Run-In|Need of insulin with meals|1|||
124906169|NCT00360698|449282677|FG000|Treatment Period|Non compliance with treatment procedure|1|||
124906170|NCT00360698|449282678|FG001|Treatment Period|Non compliance with treatment procedure|0|||
124906171|NCT00360698|449282677|FG000|Treatment Period|Early termination by error|0|||
124906172|NCT00360698|449282678|FG001|Treatment Period|Early termination by error|1|||
124906173|NCT03024606|449282683|FG000|Overall Study|Withdrawal by Subject|9|||
124906174|NCT03024606|449282684|FG001|Overall Study|Withdrawal by Subject|10|||
124906175|NCT01692938|449282685|FG000|Overall Study|Protocol Deviation|1|||
124906176|NCT01692938|449282686|FG001|Overall Study|Protocol Deviation|1|||
124906177|NCT01692938|449282685|FG000|Overall Study|Study completed prior to site completion|3|||
124906178|NCT01692938|449282686|FG001|Overall Study|Study completed prior to site completion|3|||
124906179|NCT02547922|449282690|FG000|Overall Study|Withdrawal by Subject|9|||
124906180|NCT02547922|449282691|FG001|Overall Study|Withdrawal by Subject|6|||
124906181|NCT02547922|449282692|FG002|Overall Study|Withdrawal by Subject|10|||
124906182|NCT02547922|449282690|FG000|Overall Study|Adverse Event|3|||
124906183|NCT02547922|449282691|FG001|Overall Study|Adverse Event|1|||
124906184|NCT02547922|449282692|FG002|Overall Study|Adverse Event|2|||
124906185|NCT02547922|449282690|FG000|Overall Study|Lost to Follow-up|1|||
124906186|NCT02547922|449282691|FG001|Overall Study|Lost to Follow-up|0|||
124906187|NCT02547922|449282692|FG002|Overall Study|Lost to Follow-up|0|||
124906188|NCT02547922|449282690|FG000|Overall Study|Lack of Efficacy|5|||
124906189|NCT02547922|449282691|FG001|Overall Study|Lack of Efficacy|7|||
124906190|NCT02547922|449282692|FG002|Overall Study|Lack of Efficacy|4|||
124906191|NCT02547922|449282690|FG000|Overall Study|Death|1|||
124906192|NCT02547922|449282691|FG001|Overall Study|Death|0|||
124906193|NCT02547922|449282692|FG002|Overall Study|Death|0|||
124906194|NCT02547922|449282690|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
124906195|NCT02547922|449282691|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
124906196|NCT02547922|449282692|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
124906197|NCT02547922|449282690|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
124906198|NCT02547922|449282691|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
124906199|NCT02547922|449282692|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
124906200|NCT02547922|449282690|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
124906201|NCT02547922|449282691|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
124906202|NCT02547922|449282692|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
124906203|NCT02547922|449282690|FG000|Overall Study|Physician Decision|2|||
124906204|NCT02547922|449282691|FG001|Overall Study|Physician Decision|1|||
124906205|NCT02547922|449282692|FG002|Overall Study|Physician Decision|2|||
124906206|NCT02547922|449282690|FG000|Overall Study|Patients did not receive IP|1|||
124906207|NCT02547922|449282691|FG001|Overall Study|Patients did not receive IP|1|||
124906208|NCT02547922|449282692|FG002|Overall Study|Patients did not receive IP|0|||
124906209|NCT01317420|449282697|FG000|Overall Study|Progressive disease according to RECIST|2|||
124906210|NCT01317420|449282698|FG001|Overall Study|Progressive disease according to RECIST|3|||
124906211|NCT01317420|449282699|FG002|Overall Study|Progressive disease according to RECIST|3|||
124906212|NCT01317420|449282700|FG003|Overall Study|Progressive disease according to RECIST|3|||
124906213|NCT01317420|449282701|FG004|Overall Study|Progressive disease according to RECIST|3|||
124906214|NCT01317420|449282702|FG005|Overall Study|Progressive disease according to RECIST|3|||
124906215|NCT01317420|449282703|FG006|Overall Study|Progressive disease according to RECIST|3|||
124906216|NCT01317420|449282704|FG007|Overall Study|Progressive disease according to RECIST|3|||
124906217|NCT01317420|449282705|FG008|Overall Study|Progressive disease according to RECIST|3|||
124906218|NCT01317420|449282706|FG009|Overall Study|Progressive disease according to RECIST|2|||
124906219|NCT01317420|449282707|FG010|Overall Study|Progressive disease according to RECIST|3|||
124906220|NCT01317420|449282708|FG011|Overall Study|Progressive disease according to RECIST|11|||
124906221|NCT01317420|449282709|FG012|Overall Study|Progressive disease according to RECIST|16|||
124906222|NCT01317420|449282697|FG000|Overall Study|Other adverse event|1|||
124906223|NCT01317420|449282698|FG001|Overall Study|Other adverse event|0|||
124906224|NCT01317420|449282699|FG002|Overall Study|Other adverse event|0|||
124906225|NCT01317420|449282700|FG003|Overall Study|Other adverse event|0|||
124906226|NCT01317420|449282701|FG004|Overall Study|Other adverse event|0|||
124906227|NCT01317420|449282702|FG005|Overall Study|Other adverse event|0|||
124906228|NCT01317420|449282703|FG006|Overall Study|Other adverse event|0|||
124906229|NCT01317420|449282704|FG007|Overall Study|Other adverse event|0|||
124906230|NCT01317420|449282705|FG008|Overall Study|Other adverse event|0|||
124760089|NCT02043938|448746769|FG000|Overall Study|Investigator decision|1|||
124760090|NCT00248495|448746770|FG000|Overall Study|Withdrawal by Subject|1|||
124760091|NCT03812380|448746771|FG000|Overall Study|Protocol Violation|3|||
124760092|NCT03812380|448746772|FG001|Overall Study|Protocol Violation|3|||
124760093|NCT03812380|448746771|FG000|Overall Study|Withdrawal by Subject|5|||
124760094|NCT03812380|448746772|FG001|Overall Study|Withdrawal by Subject|4|||
124760095|NCT03812380|448746771|FG000|Overall Study|Early termination of study|14|||
124760096|NCT03812380|448746772|FG001|Overall Study|Early termination of study|14|||
124906231|NCT01317420|449282706|FG009|Overall Study|Other adverse event|0|||
124906232|NCT01317420|449282707|FG010|Overall Study|Other adverse event|0|||
124906233|NCT01317420|449282708|FG011|Overall Study|Other adverse event|0|||
124906234|NCT01317420|449282709|FG012|Overall Study|Other adverse event|2|||
124906235|NCT01317420|449282697|FG000|Overall Study|Non-compliant with protocol|0|||
124906236|NCT01317420|449282698|FG001|Overall Study|Non-compliant with protocol|0|||
124906237|NCT01317420|449282699|FG002|Overall Study|Non-compliant with protocol|0|||
124906238|NCT01317420|449282700|FG003|Overall Study|Non-compliant with protocol|0|||
124906239|NCT01317420|449282701|FG004|Overall Study|Non-compliant with protocol|0|||
124906240|NCT01317420|449282702|FG005|Overall Study|Non-compliant with protocol|0|||
124906241|NCT01317420|449282703|FG006|Overall Study|Non-compliant with protocol|0|||
124906242|NCT01317420|449282704|FG007|Overall Study|Non-compliant with protocol|0|||
124906243|NCT01317420|449282705|FG008|Overall Study|Non-compliant with protocol|0|||
124760097|NCT01285401|448746773|FG000|Overall Study|Prematurely withdrawn from the study|17|||
124760098|NCT01285401|448746774|FG001|Overall Study|Prematurely withdrawn from the study|29|||
124906244|NCT01317420|449282706|FG009|Overall Study|Non-compliant with protocol|0|||
124906245|NCT01317420|449282707|FG010|Overall Study|Non-compliant with protocol|0|||
124906246|NCT01317420|449282708|FG011|Overall Study|Non-compliant with protocol|0|||
124906247|NCT01317420|449282709|FG012|Overall Study|Non-compliant with protocol|1|||
124906248|NCT01317420|449282697|FG000|Overall Study|Refused to cont. taking trial medication|0|||
124906249|NCT01317420|449282698|FG001|Overall Study|Refused to cont. taking trial medication|0|||
124760099|NCT02366312|448746784|FG000|Overall Study|Lost to Follow-up|0|||
124760100|NCT02366312|448746785|FG001|Overall Study|Lost to Follow-up|1|||
124760101|NCT00354679|448746791|FG000|Overall Study|Patient Not Treated|1|||
124906250|NCT01317420|449282699|FG002|Overall Study|Refused to cont. taking trial medication|0|||
124760102|NCT03719131|448746792|FG000|Overall Study|Death|1|||
124760103|NCT03719131|448746793|FG001|Overall Study|Death|2|||
124760104|NCT01544920|448746794|FG000|Overall Study|Adverse Event|0|||
124760105|NCT01544920|448746795|FG001|Overall Study|Adverse Event|3|||
124906251|NCT01317420|449282700|FG003|Overall Study|Refused to cont. taking trial medication|0|||
124906252|NCT01317420|449282701|FG004|Overall Study|Refused to cont. taking trial medication|0|||
124906253|NCT01317420|449282702|FG005|Overall Study|Refused to cont. taking trial medication|0|||
124906254|NCT01317420|449282703|FG006|Overall Study|Refused to cont. taking trial medication|0|||
124906255|NCT01317420|449282704|FG007|Overall Study|Refused to cont. taking trial medication|0|||
124906256|NCT01317420|449282705|FG008|Overall Study|Refused to cont. taking trial medication|0|||
124906257|NCT01317420|449282706|FG009|Overall Study|Refused to cont. taking trial medication|0|||
124906258|NCT01317420|449282707|FG010|Overall Study|Refused to cont. taking trial medication|0|||
124906259|NCT01317420|449282708|FG011|Overall Study|Refused to cont. taking trial medication|0|||
124760106|NCT01544920|448746794|FG000|Overall Study|Death|0|||
124760107|NCT01544920|448746795|FG001|Overall Study|Death|1|||
124760108|NCT01544920|448746794|FG000|Overall Study|Lost to Follow-up|11|||
124760109|NCT01544920|448746795|FG001|Overall Study|Lost to Follow-up|12|||
124760110|NCT01544920|448746794|FG000|Overall Study|Protocol Violation|0|||
124760111|NCT01544920|448746795|FG001|Overall Study|Protocol Violation|2|||
124760112|NCT01544920|448746794|FG000|Overall Study|Physician Decision|4|||
124760113|NCT01544920|448746795|FG001|Overall Study|Physician Decision|1|||
124760114|NCT01544920|448746794|FG000|Overall Study|Withdrawal by Subject|4|||
124760115|NCT01544920|448746795|FG001|Overall Study|Withdrawal by Subject|4|||
124760116|NCT00466440|448746796|FG000|Overall Study|Adverse Event|0|||
124760117|NCT00466440|448746797|FG001|Overall Study|Adverse Event|3|||
124760118|NCT00466440|448746798|FG002|Overall Study|Adverse Event|1|||
124760119|NCT00466440|448746796|FG000|Overall Study|Death|1|||
124760120|NCT00466440|448746797|FG001|Overall Study|Death|1|||
124760121|NCT00466440|448746798|FG002|Overall Study|Death|0|||
124906260|NCT01317420|449282709|FG012|Overall Study|Refused to cont. taking trial medication|1|||
124760122|NCT00466440|448746796|FG000|Overall Study|Progressive disease|13|||
124760123|NCT00466440|448746797|FG001|Overall Study|Progressive disease|5|||
124760124|NCT00466440|448746798|FG002|Overall Study|Progressive disease|4|||
124760125|NCT00466440|448746796|FG000|Overall Study|Lost to Follow-up|0|||
124760126|NCT00466440|448746797|FG001|Overall Study|Lost to Follow-up|1|||
124760127|NCT00466440|448746798|FG002|Overall Study|Lost to Follow-up|0|||
124760128|NCT00466440|448746796|FG000|Overall Study|Physician Decision|0|||
124760129|NCT00466440|448746797|FG001|Overall Study|Physician Decision|1|||
124760130|NCT00466440|448746798|FG002|Overall Study|Physician Decision|2|||
124906261|NCT01317420|449282697|FG000|Overall Study|Reason other than those specified|0|||
124906262|NCT01317420|449282698|FG001|Overall Study|Reason other than those specified|0|||
124906263|NCT01317420|449282699|FG002|Overall Study|Reason other than those specified|0|||
124906264|NCT01317420|449282700|FG003|Overall Study|Reason other than those specified|0|||
124906265|NCT01317420|449282701|FG004|Overall Study|Reason other than those specified|0|||
124906266|NCT01317420|449282702|FG005|Overall Study|Reason other than those specified|0|||
124906267|NCT01317420|449282703|FG006|Overall Study|Reason other than those specified|0|||
124906268|NCT01317420|449282704|FG007|Overall Study|Reason other than those specified|0|||
124691622|NCT00790933|448492180|FG000|Overall Study|Study Terminated by Sponsor|0|||
124906269|NCT01317420|449282705|FG008|Overall Study|Reason other than those specified|0|||
124691623|NCT00790933|448492181|FG001|Overall Study|Study Terminated by Sponsor|0|||
124906270|NCT01317420|449282706|FG009|Overall Study|Reason other than those specified|1|||
124906271|NCT01317420|449282707|FG010|Overall Study|Reason other than those specified|0|||
124906272|NCT01317420|449282708|FG011|Overall Study|Reason other than those specified|0|||
124906273|NCT01317420|449282709|FG012|Overall Study|Reason other than those specified|0|||
124906274|NCT03194958|449282710|FG000|Overall Study|Death|0|||
124906275|NCT03194958|449282711|FG001|Overall Study|Death|1|||
124906276|NCT03194958|449282712|FG002|Overall Study|Death|1|||
124906277|NCT03194958|449282713|FG003|Overall Study|Death|1|||
124906278|NCT03194958|449282710|FG000|Overall Study|Withdrawal by Subject|24|||
124906279|NCT03194958|449282711|FG001|Overall Study|Withdrawal by Subject|27|||
124906280|NCT03194958|449282712|FG002|Overall Study|Withdrawal by Subject|7|||
124906281|NCT03194958|449282713|FG003|Overall Study|Withdrawal by Subject|22|||
124906282|NCT03194958|449282710|FG000|Overall Study|Lost to Follow-up|168|||
124906283|NCT03194958|449282711|FG001|Overall Study|Lost to Follow-up|196|||
124906284|NCT03194958|449282712|FG002|Overall Study|Lost to Follow-up|174|||
124906285|NCT03194958|449282713|FG003|Overall Study|Lost to Follow-up|186|||
124906286|NCT01968226|449282715|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
124906287|NCT04975308|449282720|FG000|Overall Study|Withdrawal by Subject|6|||
124906288|NCT04975308|449282721|FG001|Overall Study|Withdrawal by Subject|16|||
124906289|NCT04975308|449282722|FG002|Overall Study|Withdrawal by Subject|6|||
124906290|NCT04975308|449282720|FG000|Overall Study|Physician Decision|0|||
124906291|NCT04975308|449282721|FG001|Overall Study|Physician Decision|3|||
124906292|NCT04975308|449282722|FG002|Overall Study|Physician Decision|1|||
124906293|NCT04975308|449282720|FG000|Overall Study|Adverse Event|10|||
124906294|NCT04975308|449282721|FG001|Overall Study|Adverse Event|1|||
124906295|NCT04975308|449282722|FG002|Overall Study|Adverse Event|12|||
124906296|NCT04975308|449282720|FG000|Overall Study|On study treatment (Ongoing)|65|||
124906297|NCT04975308|449282721|FG001|Overall Study|On study treatment (Ongoing)|43|||
124906298|NCT04975308|449282722|FG002|Overall Study|On study treatment (Ongoing)|75|||
124906299|NCT04975308|449282720|FG000|Overall Study|Protocol Deviation|4|||
124906300|NCT04975308|449282721|FG001|Overall Study|Protocol Deviation|3|||
124906301|NCT04975308|449282722|FG002|Overall Study|Protocol Deviation|2|||
124449776|NCT01245387|447609584|FG000|Overall Study|Missing discontinuation status|369|||
124449777|NCT03061175|447609587|FG000|Baseline|Participant was deemed ineligible|1|||
124449778|NCT03061175|447609588|FG001|Baseline|Participant was deemed ineligible|0|||
124449779|NCT03061175|447609587|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
124449780|NCT03061175|447609588|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
124449781|NCT03061175|447609587|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
124449782|NCT03061175|447609588|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
124449783|NCT03061175|447609587|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
124449784|NCT03061175|447609588|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
124449785|NCT02243865|447609589|FG000|Overall Study|Protocol Violation|1|||
124449786|NCT02243865|447609590|FG001|Overall Study|Protocol Violation|3|||
124906302|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
124906303|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
124906304|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
124906305|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
124906306|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
124906307|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
124906308|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
124906309|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
124906310|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
124906311|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
124906312|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
124906313|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
124906314|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
124906315|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
124906316|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
124906317|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
124906318|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
124906319|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
124906320|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
124906321|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
124906322|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
124906323|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
124906324|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
124906325|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
124906326|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
124906327|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
124906328|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
124906329|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
124906330|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
124906331|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
124906332|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
124906333|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
124906334|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
124906335|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
124906336|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
124906337|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
124906338|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
124906339|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
124906340|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
124906341|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
124906342|NCT02709655|449282723|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
124906343|NCT02709655|449282724|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
124906344|NCT02709655|449282725|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
124906345|NCT02709655|449282726|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
124906346|NCT02709655|449282727|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
124906347|NCT02709655|449282723|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
124906348|NCT02709655|449282724|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
124906349|NCT02709655|449282725|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
124906350|NCT02709655|449282726|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
124449787|NCT02243865|447609589|FG000|Overall Study|Lost to Follow-up|1|||
124449788|NCT02243865|447609590|FG001|Overall Study|Lost to Follow-up|1|||
124449789|NCT02243865|447609589|FG000|Overall Study|Withdrawal by Subject|1|||
124449790|NCT02243865|447609590|FG001|Overall Study|Withdrawal by Subject|0|||
124906351|NCT02709655|449282727|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
124906352|NCT02709655|449282723|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
124906353|NCT02709655|449282724|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
124449791|NCT02243865|447609589|FG000|Overall Study|Adverse Event|1|||
124906354|NCT02709655|449282725|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
124906355|NCT02709655|449282726|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
124906356|NCT02709655|449282727|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
124906357|NCT02709655|449282723|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
124906358|NCT02709655|449282724|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
124906359|NCT02709655|449282725|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
124906360|NCT02709655|449282726|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
124906361|NCT02709655|449282727|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
124906362|NCT02709655|449282723|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
124906363|NCT02709655|449282724|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
124906364|NCT02709655|449282725|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
124906365|NCT02709655|449282726|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
124906366|NCT02709655|449282727|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
124906367|NCT02709655|449282723|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
124906368|NCT02709655|449282724|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
124906369|NCT02709655|449282725|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
124906370|NCT02709655|449282726|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
124906371|NCT02709655|449282727|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
124906372|NCT02709655|449282723|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
124906373|NCT02709655|449282724|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
124906374|NCT02709655|449282725|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
124906375|NCT02709655|449282726|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
124906376|NCT02709655|449282727|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
124906377|NCT02709655|449282723|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
124906378|NCT02709655|449282724|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
124906379|NCT02709655|449282725|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
124906380|NCT02709655|449282726|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
124906381|NCT02709655|449282727|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
124906382|NCT00102063|449282728|FG000|Overall Study|Lack of Efficacy|5|||
124906383|NCT00102063|449282729|FG001|Overall Study|Lack of Efficacy|1|||
124906384|NCT00102063|449282730|FG002|Overall Study|Lack of Efficacy|1|||
124906385|NCT00102063|449282728|FG000|Overall Study|Adverse Event|7|||
124906386|NCT00102063|449282729|FG001|Overall Study|Adverse Event|4|||
124906387|NCT00102063|449282730|FG002|Overall Study|Adverse Event|2|||
124906388|NCT00102063|449282728|FG000|Overall Study|Withdrawal by Subject|4|||
124906389|NCT00102063|449282729|FG001|Overall Study|Withdrawal by Subject|12|||
124906390|NCT00102063|449282730|FG002|Overall Study|Withdrawal by Subject|5|||
124906391|NCT00102063|449282728|FG000|Overall Study|Lost to Follow-up|0|||
124906392|NCT00102063|449282729|FG001|Overall Study|Lost to Follow-up|0|||
124906393|NCT00102063|449282730|FG002|Overall Study|Lost to Follow-up|1|||
124906394|NCT00102063|449282728|FG000|Overall Study|Protocol Violation|0|||
124906395|NCT00102063|449282729|FG001|Overall Study|Protocol Violation|1|||
124906396|NCT00102063|449282730|FG002|Overall Study|Protocol Violation|1|||
124906397|NCT05082025|449282731|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
124906398|NCT04210180|449282732|FG000|Overall Study|Withdrawal by Subject|2|||
124906399|NCT01179334|449282733|FG000|Treatment Period|Adverse Event|1|||
124906400|NCT01179334|449282734|FG001|Treatment Period|Adverse Event|0|||
124906401|NCT01179334|449282733|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
124906402|NCT01179334|449282734|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
124906403|NCT01179334|449282733|FG000|Long-term Extension (LTE) Period|Death|3|||
124906404|NCT01179334|449282734|FG001|Long-term Extension (LTE) Period|Death|0|||
124906405|NCT01179334|449282733|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
124906406|NCT01179334|449282734|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
124449792|NCT02243865|447609590|FG001|Overall Study|Adverse Event|1|||
124449793|NCT02101021|447609591|FG000|Overall Study|Death|4|||
124449794|NCT02101021|447609592|FG001|Overall Study|Death|3|||
124449795|NCT02101021|447609593|FG002|Overall Study|Death|6|||
124449796|NCT02101021|447609594|FG003|Overall Study|Death|0|||
124449797|NCT02101021|447609595|FG004|Overall Study|Death|3|||
124449798|NCT02101021|447609591|FG000|Overall Study|Withdrew Consent from study|1|||
124449799|NCT02101021|447609592|FG001|Overall Study|Withdrew Consent from study|1|||
124691624|NCT00790933|448492182|FG002|Overall Study|Study Terminated by Sponsor|1|||
124691625|NCT00790933|448492183|FG003|Overall Study|Study Terminated by Sponsor|0|||
124449800|NCT02101021|447609593|FG002|Overall Study|Withdrew Consent from study|0|||
124449801|NCT02101021|447609594|FG003|Overall Study|Withdrew Consent from study|2|||
124906407|NCT05190419|449282735|FG000|Overall Study|Lack of Efficacy|8|||
124906408|NCT05190419|449282736|FG001|Overall Study|Lack of Efficacy|0|||
124906409|NCT05190419|449282737|FG002|Overall Study|Lack of Efficacy|1|||
124906410|NCT05190419|449282738|FG003|Overall Study|Lack of Efficacy|0|||
124906411|NCT05190419|449282735|FG000|Overall Study|Withdrawal by Subject|7|||
124906412|NCT05190419|449282736|FG001|Overall Study|Withdrawal by Subject|1|||
124906413|NCT05190419|449282737|FG002|Overall Study|Withdrawal by Subject|2|||
124449802|NCT02101021|447609595|FG004|Overall Study|Withdrew Consent from study|0|||
124449803|NCT02101021|447609591|FG000|Overall Study|Lost to Follow-up|1|||
124449804|NCT02101021|447609592|FG001|Overall Study|Lost to Follow-up|0|||
124449805|NCT02101021|447609593|FG002|Overall Study|Lost to Follow-up|0|||
124449806|NCT02101021|447609594|FG003|Overall Study|Lost to Follow-up|0|||
124449807|NCT02101021|447609595|FG004|Overall Study|Lost to Follow-up|0|||
124449808|NCT02101021|447609591|FG000|Overall Study|Study Terminated by Sponsor|1|||
124449809|NCT02101021|447609592|FG001|Overall Study|Study Terminated by Sponsor|0|||
124449810|NCT02101021|447609593|FG002|Overall Study|Study Terminated by Sponsor|1|||
124449811|NCT02101021|447609594|FG003|Overall Study|Study Terminated by Sponsor|1|||
124449812|NCT02101021|447609595|FG004|Overall Study|Study Terminated by Sponsor|1|||
124449813|NCT01621542|447609596|FG000|Overall Study|Adverse Event|0|||
124449814|NCT01621542|447609597|FG001|Overall Study|Adverse Event|0|||
124449815|NCT01621542|447609598|FG002|Overall Study|Adverse Event|1|||
124449816|NCT01621542|447609599|FG003|Overall Study|Adverse Event|3|||
124906414|NCT05190419|449282738|FG003|Overall Study|Withdrawal by Subject|2|||
124906415|NCT05190419|449282735|FG000|Overall Study|Adverse Event|2|||
124906416|NCT05190419|449282736|FG001|Overall Study|Adverse Event|10|||
124906417|NCT05190419|449282737|FG002|Overall Study|Adverse Event|11|||
124906418|NCT05190419|449282738|FG003|Overall Study|Adverse Event|21|||
124906419|NCT05190419|449282735|FG000|Overall Study|Lost to Follow-up|1|||
124906420|NCT05190419|449282736|FG001|Overall Study|Lost to Follow-up|2|||
124906421|NCT05190419|449282737|FG002|Overall Study|Lost to Follow-up|3|||
124906422|NCT05190419|449282738|FG003|Overall Study|Lost to Follow-up|1|||
124906423|NCT05190419|449282735|FG000|Overall Study|Other|1|||
124906424|NCT05190419|449282736|FG001|Overall Study|Other|1|||
124906425|NCT05190419|449282737|FG002|Overall Study|Other|0|||
124906426|NCT05190419|449282738|FG003|Overall Study|Other|3|||
124906427|NCT00919763|449282739|FG000|Overall Study|Adverse Event|7|||
124906428|NCT00919763|449282740|FG001|Overall Study|Adverse Event|1|||
124906429|NCT00919763|449282739|FG000|Overall Study|Lost to Follow-up|1|||
124906430|NCT00919763|449282740|FG001|Overall Study|Lost to Follow-up|0|||
124906431|NCT00919763|449282739|FG000|Overall Study|Protocol Violation|1|||
124906432|NCT00919763|449282740|FG001|Overall Study|Protocol Violation|1|||
124906433|NCT00919763|449282739|FG000|Overall Study|Withdrawal by Subject|3|||
124906434|NCT00919763|449282740|FG001|Overall Study|Withdrawal by Subject|1|||
124906435|NCT00919763|449282739|FG000|Overall Study|Non-compliance|0|||
124906436|NCT00919763|449282740|FG001|Overall Study|Non-compliance|1|||
124906437|NCT00256243|449282744|FG000|Overall Study|Lost to Follow-up|2|||
124906438|NCT00256243|449282744|FG000|Overall Study|Death|7|||
124906439|NCT00256243|449282744|FG000|Overall Study|Not treated|1|||
124906440|NCT05061693|449282745|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
124906441|NCT05061693|449282746|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
124906442|NCT05061693|449282747|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
124906443|NCT05061693|449282748|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906444|NCT05061693|449282749|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906445|NCT05061693|449282750|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906446|NCT05061693|449282751|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906447|NCT05061693|449282752|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906448|NCT05061693|449282753|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906449|NCT05061693|449282754|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906450|NCT05061693|449282755|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906451|NCT05061693|449282756|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
124906452|NCT05061693|449282745|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
124906453|NCT05061693|449282746|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
124906454|NCT05061693|449282747|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
124906455|NCT05061693|449282748|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
124906456|NCT05061693|449282749|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
124906457|NCT05061693|449282750|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
124906458|NCT05061693|449282751|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
124906459|NCT05061693|449282752|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
124906460|NCT05061693|449282753|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
124906461|NCT05061693|449282754|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
124906462|NCT05061693|449282755|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
124449817|NCT01621542|447609600|FG004|Overall Study|Adverse Event|0|||
124449818|NCT01621542|447609601|FG005|Overall Study|Adverse Event|0|||
124449819|NCT01621542|447609596|FG000|Overall Study|Death|0|||
124906463|NCT05061693|449282756|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
124906464|NCT05061693|449282745|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
124906465|NCT05061693|449282746|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906466|NCT05061693|449282747|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906467|NCT05061693|449282748|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906468|NCT05061693|449282749|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906469|NCT05061693|449282750|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906470|NCT05061693|449282751|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124691626|NCT00790933|448492184|FG004|Overall Study|Study Terminated by Sponsor|0|||
124691627|NCT00790933|448492180|FG000|Overall Study|Withdrawal by Subject|123|||
124691628|NCT00790933|448492181|FG001|Overall Study|Withdrawal by Subject|120|||
124691629|NCT00790933|448492182|FG002|Overall Study|Withdrawal by Subject|52|||
124691630|NCT00790933|448492183|FG003|Overall Study|Withdrawal by Subject|6|||
124906471|NCT05061693|449282752|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906472|NCT05061693|449282753|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906473|NCT05061693|449282754|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906474|NCT05061693|449282755|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906475|NCT05061693|449282756|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
124906476|NCT05061693|449282745|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906477|NCT05061693|449282746|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906478|NCT05061693|449282747|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
124906479|NCT05061693|449282748|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906480|NCT05061693|449282749|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906481|NCT05061693|449282750|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906482|NCT05061693|449282751|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906483|NCT05061693|449282752|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906484|NCT05061693|449282753|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906485|NCT05061693|449282754|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906486|NCT05061693|449282755|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906487|NCT05061693|449282756|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
124906488|NCT05061693|449282745|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
124906489|NCT05061693|449282746|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
124906490|NCT05061693|449282747|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
124906491|NCT05061693|449282748|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
124906492|NCT05061693|449282749|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
124906493|NCT05061693|449282750|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
124906494|NCT05061693|449282751|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
124449820|NCT01621542|447609597|FG001|Overall Study|Death|1|||
124449821|NCT01621542|447609598|FG002|Overall Study|Death|0|||
124449822|NCT01621542|447609599|FG003|Overall Study|Death|0|||
124449823|NCT01621542|447609600|FG004|Overall Study|Death|0|||
124449824|NCT01621542|447609601|FG005|Overall Study|Death|0|||
124449825|NCT01621542|447609596|FG000|Overall Study|Physician Decision|1|||
124449826|NCT01621542|447609597|FG001|Overall Study|Physician Decision|0|||
124449827|NCT01621542|447609598|FG002|Overall Study|Physician Decision|1|||
124449828|NCT01621542|447609599|FG003|Overall Study|Physician Decision|13|||
124449829|NCT01621542|447609600|FG004|Overall Study|Physician Decision|3|||
124449830|NCT01621542|447609601|FG005|Overall Study|Physician Decision|1|||
124449831|NCT01621542|447609596|FG000|Overall Study|Withdrawal by Subject|2|||
124449832|NCT01621542|447609597|FG001|Overall Study|Withdrawal by Subject|0|||
124449833|NCT01621542|447609598|FG002|Overall Study|Withdrawal by Subject|1|||
124449834|NCT01621542|447609599|FG003|Overall Study|Withdrawal by Subject|3|||
124449835|NCT01621542|447609600|FG004|Overall Study|Withdrawal by Subject|3|||
124449836|NCT01621542|447609601|FG005|Overall Study|Withdrawal by Subject|3|||
124449837|NCT01621542|447609596|FG000|Overall Study|progression/treatment failure|2|||
124449838|NCT01621542|447609597|FG001|Overall Study|progression/treatment failure|4|||
124449839|NCT01621542|447609598|FG002|Overall Study|progression/treatment failure|3|||
124449840|NCT01621542|447609599|FG003|Overall Study|progression/treatment failure|7|||
124449841|NCT01621542|447609600|FG004|Overall Study|progression/treatment failure|3|||
124449842|NCT01621542|447609601|FG005|Overall Study|progression/treatment failure|5|||
124449843|NCT01621542|447609596|FG000|Overall Study|Protocol Violation|0|||
124449844|NCT01621542|447609597|FG001|Overall Study|Protocol Violation|0|||
124449845|NCT01621542|447609598|FG002|Overall Study|Protocol Violation|0|||
124449846|NCT01621542|447609599|FG003|Overall Study|Protocol Violation|1|||
124449847|NCT01621542|447609600|FG004|Overall Study|Protocol Violation|0|||
124449848|NCT01621542|447609601|FG005|Overall Study|Protocol Violation|0|||
124449849|NCT01621542|447609596|FG000|Overall Study|study stopped by sponsor|0|||
124906495|NCT05061693|449282752|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
124906496|NCT05061693|449282753|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
124449850|NCT01621542|447609597|FG001|Overall Study|study stopped by sponsor|0|||
124449851|NCT01621542|447609598|FG002|Overall Study|study stopped by sponsor|0|||
124691631|NCT00790933|448492184|FG004|Overall Study|Withdrawal by Subject|50|||
124906497|NCT05061693|449282754|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
124449852|NCT01621542|447609599|FG003|Overall Study|study stopped by sponsor|1|||
124449853|NCT01621542|447609600|FG004|Overall Study|study stopped by sponsor|0|||
124449854|NCT01621542|447609601|FG005|Overall Study|study stopped by sponsor|0|||
124449855|NCT02632721|447609602|FG000|Overall Study|Adverse Event|0|||
124449856|NCT02632721|447609603|FG001|Overall Study|Adverse Event|0|||
124691632|NCT00790933|448492180|FG000|Overall Study|Lost to Follow-up|13|||
124691633|NCT00790933|448492181|FG001|Overall Study|Lost to Follow-up|31|||
124760131|NCT00466440|448746796|FG000|Overall Study|Protocol entry criteria not met|0|||
124760132|NCT00466440|448746797|FG001|Overall Study|Protocol entry criteria not met|0|||
124760133|NCT00466440|448746798|FG002|Overall Study|Protocol entry criteria not met|4|||
124760134|NCT00466440|448746796|FG000|Overall Study|Withdrawal by Subject|0|||
124760135|NCT00466440|448746797|FG001|Overall Study|Withdrawal by Subject|1|||
124760136|NCT00466440|448746798|FG002|Overall Study|Withdrawal by Subject|0|||
124760137|NCT00466440|448746796|FG000|Overall Study|Sponsor decision|0|||
124760138|NCT00466440|448746797|FG001|Overall Study|Sponsor decision|0|||
124760139|NCT00466440|448746798|FG002|Overall Study|Sponsor decision|1|||
124760140|NCT03294590|448746801|FG000|Overall Study|Lost to Follow-up|105|||
124760141|NCT03294590|448746802|FG001|Overall Study|Lost to Follow-up|107|||
124760142|NCT00255190|448746805|FG000|Overall Study|Adverse Event|17|||
124760143|NCT00255190|448746806|FG001|Overall Study|Adverse Event|36|||
124760144|NCT00255190|448746805|FG000|Overall Study|Protocol Violation|2|||
124760145|NCT00255190|448746806|FG001|Overall Study|Protocol Violation|2|||
124760146|NCT00255190|448746805|FG000|Overall Study|Lost to Follow-up|10|||
124760147|NCT00255190|448746806|FG001|Overall Study|Lost to Follow-up|27|||
124760148|NCT00255190|448746805|FG000|Overall Study|Withdrew Consent|17|||
124760149|NCT00255190|448746806|FG001|Overall Study|Withdrew Consent|48|||
124760150|NCT00255190|448746805|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
124760151|NCT00255190|448746806|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
124760152|NCT00255190|448746805|FG000|Overall Study|Erosive esophagitis not healed|0|||
124760153|NCT00255190|448746806|FG001|Overall Study|Erosive esophagitis not healed|20|||
124760154|NCT00255190|448746805|FG000|Overall Study|Various|4|||
124760155|NCT00255190|448746806|FG001|Overall Study|Various|23|||
124760156|NCT03367858|448746811|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
124760157|NCT03367858|448746812|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
124760158|NCT03367858|448746811|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
124760159|NCT03367858|448746812|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
124760160|NCT03367858|448746811|FG000|3 Month Follow Up|Lost to Follow-up|8|||
124760161|NCT03367858|448746812|FG001|3 Month Follow Up|Lost to Follow-up|3|||
124760162|NCT03367858|448746811|FG000|3 Month Follow Up|Moved out of study area|2|||
124760163|NCT03367858|448746812|FG001|3 Month Follow Up|Moved out of study area|6|||
124760164|NCT03367858|448746811|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
124760165|NCT03367858|448746812|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
124760166|NCT03367858|448746811|FG000|3 Month Follow Up|MRI contraindication|2|||
124760167|NCT03367858|448746812|FG001|3 Month Follow Up|MRI contraindication|1|||
124760168|NCT03367858|448746811|FG000|3 Month Follow Up|Incarcerated|0|||
124760169|NCT03367858|448746812|FG001|3 Month Follow Up|Incarcerated|1|||
124760170|NCT03367858|448746811|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
124760171|NCT03367858|448746812|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
124760172|NCT03367858|448746811|FG000|6 Month Follow Up|Lost to Follow-up|5|||
124760173|NCT03367858|448746812|FG001|6 Month Follow Up|Lost to Follow-up|2|||
124760174|NCT03367858|448746811|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
124760175|NCT03367858|448746812|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
124760176|NCT03367858|448746811|FG000|12 Month Follow Up|Lost to Follow-up|3|||
124760177|NCT03367858|448746812|FG001|12 Month Follow Up|Lost to Follow-up|3|||
124760178|NCT03367858|448746811|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
124760179|NCT03367858|448746812|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
124760180|NCT01217463|448746815|FG000|Overall Study|Adverse Event|8|||
124760181|NCT01217463|448746816|FG001|Overall Study|Adverse Event|5|||
124906498|NCT05061693|449282755|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
124906499|NCT05061693|449282756|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
124906500|NCT05061693|449282745|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
124906501|NCT05061693|449282746|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
124906502|NCT05061693|449282747|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
124906503|NCT05061693|449282748|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
124544705|NCT03110107|447949194|FG005|Treatment Period|Participants no longer meets study criteria|0|||
124760182|NCT01217463|448746815|FG000|Overall Study|Physician Decision|0|||
124760183|NCT01217463|448746816|FG001|Overall Study|Physician Decision|1|||
124760184|NCT01217463|448746815|FG000|Overall Study|Withdrawal by Subject|3|||
124760185|NCT01217463|448746816|FG001|Overall Study|Withdrawal by Subject|0|||
124760186|NCT01217463|448746815|FG000|Overall Study|Surgery on the Target Limb|0|||
124760187|NCT01217463|448746816|FG001|Overall Study|Surgery on the Target Limb|1|||
124760188|NCT01217463|448746815|FG000|Overall Study|Patient Non-compliant|1|||
124760189|NCT01217463|448746816|FG001|Overall Study|Patient Non-compliant|0|||
124760190|NCT01217463|448746815|FG000|Overall Study|Other|1|||
124760191|NCT01217463|448746816|FG001|Overall Study|Other|1|||
124906504|NCT05061693|449282749|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
124760192|NCT01623115|448746817|FG000|Overall Study|Randomized but not treated|0|||
124760193|NCT01623115|448746818|FG001|Overall Study|Randomized but not treated|1|||
124906505|NCT05061693|449282750|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
124760194|NCT01623115|448746817|FG000|Overall Study|Physician Decision|1|||
124760195|NCT01623115|448746818|FG001|Overall Study|Physician Decision|0|||
124906506|NCT05061693|449282751|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
124906507|NCT05061693|449282752|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
124906508|NCT05061693|449282753|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
124906509|NCT05061693|449282754|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
124906510|NCT05061693|449282755|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
124906511|NCT05061693|449282756|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
124906512|NCT05061693|449282745|FG000|24-week Extension Period|Adverse Event|0|||
124906513|NCT05061693|449282746|FG001|24-week Extension Period|Adverse Event|0|||
124906514|NCT05061693|449282747|FG002|24-week Extension Period|Adverse Event|0|||
124906515|NCT05061693|449282748|FG003|24-week Extension Period|Adverse Event|0|||
124906516|NCT05061693|449282749|FG004|24-week Extension Period|Adverse Event|0|||
124906517|NCT05061693|449282750|FG005|24-week Extension Period|Adverse Event|0|||
124906518|NCT05061693|449282751|FG006|24-week Extension Period|Adverse Event|0|||
124906519|NCT05061693|449282752|FG007|24-week Extension Period|Adverse Event|2|||
124906520|NCT05061693|449282753|FG008|24-week Extension Period|Adverse Event|2|||
124906521|NCT05061693|449282754|FG009|24-week Extension Period|Adverse Event|0|||
124906522|NCT05061693|449282755|FG010|24-week Extension Period|Adverse Event|1|||
124906523|NCT05061693|449282756|FG011|24-week Extension Period|Adverse Event|3|||
124906524|NCT05061693|449282745|FG000|24-week Extension Period|Lack of Efficacy|0|||
124906525|NCT05061693|449282746|FG001|24-week Extension Period|Lack of Efficacy|0|||
124906526|NCT05061693|449282747|FG002|24-week Extension Period|Lack of Efficacy|0|||
124906527|NCT05061693|449282748|FG003|24-week Extension Period|Lack of Efficacy|0|||
124906528|NCT05061693|449282749|FG004|24-week Extension Period|Lack of Efficacy|0|||
124906529|NCT05061693|449282750|FG005|24-week Extension Period|Lack of Efficacy|0|||
124906530|NCT05061693|449282751|FG006|24-week Extension Period|Lack of Efficacy|0|||
124906531|NCT05061693|449282752|FG007|24-week Extension Period|Lack of Efficacy|0|||
124906532|NCT05061693|449282753|FG008|24-week Extension Period|Lack of Efficacy|0|||
124906533|NCT05061693|449282754|FG009|24-week Extension Period|Lack of Efficacy|0|||
124906534|NCT05061693|449282755|FG010|24-week Extension Period|Lack of Efficacy|2|||
124906535|NCT05061693|449282756|FG011|24-week Extension Period|Lack of Efficacy|0|||
124906536|NCT05061693|449282745|FG000|24-week Extension Period|Lost to Follow-up|0|||
124906537|NCT05061693|449282746|FG001|24-week Extension Period|Lost to Follow-up|0|||
124906538|NCT05061693|449282747|FG002|24-week Extension Period|Lost to Follow-up|0|||
124906539|NCT05061693|449282748|FG003|24-week Extension Period|Lost to Follow-up|0|||
124906540|NCT05061693|449282749|FG004|24-week Extension Period|Lost to Follow-up|0|||
124906541|NCT05061693|449282750|FG005|24-week Extension Period|Lost to Follow-up|0|||
124906542|NCT05061693|449282751|FG006|24-week Extension Period|Lost to Follow-up|1|||
124906543|NCT05061693|449282752|FG007|24-week Extension Period|Lost to Follow-up|0|||
124906544|NCT05061693|449282753|FG008|24-week Extension Period|Lost to Follow-up|1|||
124906545|NCT05061693|449282754|FG009|24-week Extension Period|Lost to Follow-up|1|||
124906546|NCT05061693|449282755|FG010|24-week Extension Period|Lost to Follow-up|0|||
124760196|NCT01623115|448746817|FG000|Overall Study|Participants moved|1|||
124906547|NCT05061693|449282756|FG011|24-week Extension Period|Lost to Follow-up|0|||
124906548|NCT05061693|449282745|FG000|24-week Extension Period|Withdrawal by Subject|0|||
124906549|NCT05061693|449282746|FG001|24-week Extension Period|Withdrawal by Subject|0|||
124906550|NCT05061693|449282747|FG002|24-week Extension Period|Withdrawal by Subject|0|||
124906551|NCT05061693|449282748|FG003|24-week Extension Period|Withdrawal by Subject|0|||
124906552|NCT05061693|449282749|FG004|24-week Extension Period|Withdrawal by Subject|0|||
124906553|NCT05061693|449282750|FG005|24-week Extension Period|Withdrawal by Subject|0|||
124906554|NCT05061693|449282751|FG006|24-week Extension Period|Withdrawal by Subject|0|||
124906555|NCT05061693|449282752|FG007|24-week Extension Period|Withdrawal by Subject|0|||
124906556|NCT05061693|449282753|FG008|24-week Extension Period|Withdrawal by Subject|1|||
124906557|NCT05061693|449282754|FG009|24-week Extension Period|Withdrawal by Subject|2|||
124906558|NCT05061693|449282755|FG010|24-week Extension Period|Withdrawal by Subject|2|||
124906559|NCT05061693|449282756|FG011|24-week Extension Period|Withdrawal by Subject|1|||
124906560|NCT05061693|449282745|FG000|24-week Extension Period|Sponsor Decision|0|||
124906561|NCT05061693|449282746|FG001|24-week Extension Period|Sponsor Decision|0|||
124906562|NCT05061693|449282747|FG002|24-week Extension Period|Sponsor Decision|0|||
124906563|NCT05061693|449282748|FG003|24-week Extension Period|Sponsor Decision|0|||
124906564|NCT05061693|449282749|FG004|24-week Extension Period|Sponsor Decision|0|||
124760197|NCT01623115|448746818|FG001|Overall Study|Participants moved|5|||
124906565|NCT05061693|449282750|FG005|24-week Extension Period|Sponsor Decision|0|||
124906566|NCT05061693|449282751|FG006|24-week Extension Period|Sponsor Decision|0|||
124906567|NCT05061693|449282752|FG007|24-week Extension Period|Sponsor Decision|1|||
124760198|NCT01623115|448746817|FG000|Overall Study|Adverse Event|10|||
124760199|NCT01623115|448746818|FG001|Overall Study|Adverse Event|13|||
124760200|NCT01623115|448746817|FG000|Overall Study|Poor compliance to protocol|4|||
124906568|NCT05061693|449282753|FG008|24-week Extension Period|Sponsor Decision|0|||
124906569|NCT05061693|449282754|FG009|24-week Extension Period|Sponsor Decision|0|||
124760201|NCT01623115|448746818|FG001|Overall Study|Poor compliance to protocol|10|||
124906570|NCT05061693|449282755|FG010|24-week Extension Period|Sponsor Decision|0|||
124906571|NCT05061693|449282756|FG011|24-week Extension Period|Sponsor Decision|0|||
124906572|NCT05061693|449282745|FG000|24-week Extension Period|Site Closure|0|||
124906573|NCT05061693|449282746|FG001|24-week Extension Period|Site Closure|0|||
124906574|NCT05061693|449282747|FG002|24-week Extension Period|Site Closure|0|||
124906575|NCT05061693|449282748|FG003|24-week Extension Period|Site Closure|0|||
124906576|NCT05061693|449282749|FG004|24-week Extension Period|Site Closure|0|||
124906577|NCT05061693|449282750|FG005|24-week Extension Period|Site Closure|0|||
124906578|NCT05061693|449282751|FG006|24-week Extension Period|Site Closure|0|||
124906579|NCT05061693|449282752|FG007|24-week Extension Period|Site Closure|0|||
124906580|NCT05061693|449282753|FG008|24-week Extension Period|Site Closure|1|||
124906581|NCT05061693|449282754|FG009|24-week Extension Period|Site Closure|0|||
124906582|NCT05061693|449282755|FG010|24-week Extension Period|Site Closure|0|||
124906583|NCT05061693|449282756|FG011|24-week Extension Period|Site Closure|1|||
124906584|NCT01152190|449282757|FG000|Overall Study|Adverse Event|2|||
124906585|NCT01152190|449282758|FG001|Overall Study|Adverse Event|4|||
124906586|NCT01152190|449282757|FG000|Overall Study|Death|1|||
124906587|NCT01152190|449282758|FG001|Overall Study|Death|0|||
124906588|NCT01152190|449282757|FG000|Overall Study|Protocol Violation|1|||
124906589|NCT01152190|449282758|FG001|Overall Study|Protocol Violation|1|||
124906590|NCT01152190|449282757|FG000|Overall Study|Withdrawal by Subject|1|||
124906591|NCT01152190|449282758|FG001|Overall Study|Withdrawal by Subject|3|||
124906592|NCT03823911|449282759|FG000|Overall Study|Lost to Follow-up|1|||
124906593|NCT03823911|449282760|FG001|Overall Study|Lost to Follow-up|5|||
124906594|NCT03823911|449282761|FG002|Overall Study|Lost to Follow-up|2|||
124906595|NCT03823911|449282759|FG000|Overall Study|Did not meet eligibility criteria|13|||
124906596|NCT03823911|449282760|FG001|Overall Study|Did not meet eligibility criteria|7|||
124906597|NCT03823911|449282761|FG002|Overall Study|Did not meet eligibility criteria|4|||
124906598|NCT03823911|449282759|FG000|Overall Study|Death|0|||
124906599|NCT03823911|449282760|FG001|Overall Study|Death|1|||
124906600|NCT03823911|449282761|FG002|Overall Study|Death|0|||
124906601|NCT00547118|449282762|FG000|Overall Study|Did not qualify prior to starting drug|1|||
124906602|NCT00547118|449282763|FG001|Overall Study|Did not qualify prior to starting drug|1|||
124906603|NCT00547118|449282762|FG000|Overall Study|Study suspended|7|||
124906604|NCT00547118|449282763|FG001|Overall Study|Study suspended|8|||
124906605|NCT00442117|449282766|FG000|Overall Study|Adverse Event|3|||
124906606|NCT00442117|449282767|FG001|Overall Study|Adverse Event|2|||
124906607|NCT00442117|449282766|FG000|Overall Study|Lack of Efficacy|2|||
124906608|NCT00442117|449282767|FG001|Overall Study|Lack of Efficacy|6|||
124906609|NCT00442117|449282766|FG000|Overall Study|Lost to Follow-up|1|||
124906610|NCT00442117|449282767|FG001|Overall Study|Lost to Follow-up|2|||
124906611|NCT00442117|449282766|FG000|Overall Study|Withdrawal by Subject|2|||
124906612|NCT00442117|449282767|FG001|Overall Study|Withdrawal by Subject|2|||
124906613|NCT00442117|449282766|FG000|Overall Study|Major Deviation|25|||
124906614|NCT00442117|449282767|FG001|Overall Study|Major Deviation|20|||
124906615|NCT00442117|449282766|FG000|Overall Study|Non compliance with protocol|3|||
124906616|NCT00442117|449282767|FG001|Overall Study|Non compliance with protocol|5|||
124906617|NCT00442117|449282766|FG000|Overall Study|Met Withdrawal Criteria|2|||
124906618|NCT00442117|449282767|FG001|Overall Study|Met Withdrawal Criteria|1|||
124906619|NCT04009577|449282773|FG000|Core Study|Adverse Event|1|||
124906620|NCT04009577|449282774|FG001|Core Study|Adverse Event|0|||
124906621|NCT04009577|449282775|FG002|Core Study|Adverse Event|2|||
124906622|NCT04009577|449282776|FG003|Core Study|Adverse Event|4|||
124906623|NCT04009577|449282773|FG000|Core Study|Withdrawal by Subject|0|||
124906624|NCT04009577|449282774|FG001|Core Study|Withdrawal by Subject|0|||
124906625|NCT04009577|449282775|FG002|Core Study|Withdrawal by Subject|2|||
124906626|NCT04009577|449282776|FG003|Core Study|Withdrawal by Subject|0|||
124906627|NCT04009577|449282773|FG000|Core Study|Other|0|||
124906628|NCT04009577|449282774|FG001|Core Study|Other|0|||
124906629|NCT04009577|449282775|FG002|Core Study|Other|0|||
124760202|NCT01623115|448746817|FG000|Overall Study|Consent withdrawn by participant|2|||
124760203|NCT01623115|448746818|FG001|Overall Study|Consent withdrawn by participant|6|||
124760204|NCT01623115|448746817|FG000|Overall Study|Related to study drug administration|0|||
124760205|NCT01623115|448746818|FG001|Overall Study|Related to study drug administration|2|||
124760206|NCT01623115|448746817|FG000|Overall Study|Last visit outside protocol visit window|14|||
124760207|NCT01623115|448746818|FG001|Overall Study|Last visit outside protocol visit window|26|||
124760208|NCT01623115|448746817|FG000|Overall Study|Site closure|1|||
124906630|NCT04009577|449282776|FG003|Core Study|Other|1|||
124906631|NCT04009577|449282773|FG000|Extension Phase|Adverse Event|0|||
124906632|NCT04009577|449282774|FG001|Extension Phase|Adverse Event|0|||
124906633|NCT04009577|449282775|FG002|Extension Phase|Adverse Event|0|||
124906634|NCT04009577|449282776|FG003|Extension Phase|Adverse Event|1|||
124906635|NCT04009577|449282773|FG000|Extension Phase|Inadequate therapeutic effect|0|||
124906636|NCT04009577|449282774|FG001|Extension Phase|Inadequate therapeutic effect|0|||
124906637|NCT04009577|449282775|FG002|Extension Phase|Inadequate therapeutic effect|1|||
124906638|NCT04009577|449282776|FG003|Extension Phase|Inadequate therapeutic effect|0|||
124906639|NCT04009577|449282773|FG000|Extension Phase|Withdrawal by Subject|0|||
124906640|NCT04009577|449282774|FG001|Extension Phase|Withdrawal by Subject|0|||
124906641|NCT04009577|449282775|FG002|Extension Phase|Withdrawal by Subject|1|||
124691634|NCT00790933|448492182|FG002|Overall Study|Lost to Follow-up|10|||
124691635|NCT00790933|448492183|FG003|Overall Study|Lost to Follow-up|1|||
124691636|NCT00790933|448492184|FG004|Overall Study|Lost to Follow-up|15|||
124691637|NCT00790933|448492180|FG000|Overall Study|Reason Not Specified|8|||
124691638|NCT00790933|448492181|FG001|Overall Study|Reason Not Specified|16|||
124906642|NCT04009577|449282776|FG003|Extension Phase|Withdrawal by Subject|0|||
124906643|NCT04009577|449282773|FG000|Extension Phase|Not Treated|0|||
124906644|NCT04009577|449282774|FG001|Extension Phase|Not Treated|0|||
124906645|NCT04009577|449282775|FG002|Extension Phase|Not Treated|2|||
124906646|NCT04009577|449282776|FG003|Extension Phase|Not Treated|0|||
124906649|NCT00841035|449282782|FG000|Phase 1 Overall Study|Physician Decision|13|||
124906650|NCT02994654|449282784|FG000|Overall Study|Lost to Follow-up|1|||
124906651|NCT05328297|449284123|FG000|Overall Study|Adverse Event|5|||
124906652|NCT05328297|449284124|FG001|Overall Study|Adverse Event|7|||
124906653|NCT05328297|449284123|FG000|Overall Study|Withdrawal by Subject|4|||
124906654|NCT05328297|449284124|FG001|Overall Study|Withdrawal by Subject|3|||
124906655|NCT05328297|449284123|FG000|Overall Study|Lack of Efficacy|1|||
124906656|NCT05328297|449284124|FG001|Overall Study|Lack of Efficacy|0|||
124906657|NCT05328297|449284123|FG000|Overall Study|Lost to Follow-up|1|||
124906658|NCT05328297|449284124|FG001|Overall Study|Lost to Follow-up|0|||
124906659|NCT05328297|449284123|FG000|Overall Study|Protocol Violation|1|||
124906660|NCT05328297|449284124|FG001|Overall Study|Protocol Violation|0|||
124906661|NCT05328297|449284123|FG000|Overall Study|Randomized but not treated|1|||
124906662|NCT05328297|449284124|FG001|Overall Study|Randomized but not treated|1|||
124906663|NCT03544515|449284134|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
124906664|NCT03544515|449284135|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
124906665|NCT03544515|449284134|FG000|Overall Study|Lost to Follow-up|2|||
124906666|NCT03544515|449284135|FG001|Overall Study|Lost to Follow-up|0|||
124906667|NCT03175172|449284136|FG000|Overall Study|Death|3|||
124906668|NCT03175172|449284136|FG000|Overall Study|Withdrawal by Subject|3|||
124906669|NCT03175172|449284136|FG000|Overall Study|Lost to Follow-up|1|||
124906670|NCT03175172|449284136|FG000|Overall Study|Study Terminated by Sponsor|3|||
124906671|NCT03169244|449284137|FG000|Overall Study|Lost to Follow-up|1|||
124906672|NCT03169244|449284138|FG001|Overall Study|Lost to Follow-up|2|||
124906673|NCT03169244|449284137|FG000|Overall Study|Adverse Event|1|||
124906674|NCT03169244|449284138|FG001|Overall Study|Adverse Event|0|||
124906675|NCT03169244|449284137|FG000|Overall Study|Withdrawal by Subject|2|||
124906676|NCT03169244|449284138|FG001|Overall Study|Withdrawal by Subject|2|||
124906677|NCT03169244|449284137|FG000|Overall Study|Physician Decision|1|||
124906678|NCT03169244|449284138|FG001|Overall Study|Physician Decision|0|||
124906679|NCT01662336|449284139|FG000|Overall Study|Adverse Event|1|||
124906680|NCT01662336|449284139|FG000|Overall Study|No longer on LPV/r|30|||
124906681|NCT01662336|449284139|FG000|Overall Study|Other|29|||
124906682|NCT01662336|449284139|FG000|Overall Study|Withdrawal by Subject|6|||
124906683|NCT03622593|449284143|FG000|Overall Study|Withdrawal by Subject|11|||
124906684|NCT03622593|449284144|FG001|Overall Study|Withdrawal by Subject|9|||
124906685|NCT03622593|449284145|FG002|Overall Study|Withdrawal by Subject|13|||
124906686|NCT03622593|449284143|FG000|Overall Study|Death|12|||
124906687|NCT03622593|449284144|FG001|Overall Study|Death|9|||
124906688|NCT03622593|449284145|FG002|Overall Study|Death|10|||
124691639|NCT00790933|448492182|FG002|Overall Study|Reason Not Specified|4|||
124691640|NCT00790933|448492183|FG003|Overall Study|Reason Not Specified|1|||
124691641|NCT00790933|448492184|FG004|Overall Study|Reason Not Specified|9|||
124691642|NCT00245570|448492187|FG000|Washout Between Periods III and IV|Adverse Event|0|||
124691643|NCT00245570|448492188|FG001|Washout Between Periods III and IV|Adverse Event|1|||
124691644|NCT00245570|448492189|FG002|Washout Between Periods III and IV|Adverse Event|0|||
124691645|NCT00245570|448492190|FG003|Washout Between Periods III and IV|Adverse Event|0|||
124691646|NCT00245570|448492191|FG004|Washout Between Periods III and IV|Adverse Event|0|||
124691647|NCT00245570|448492192|FG005|Washout Between Periods III and IV|Adverse Event|0|||
124691648|NCT01829165|448492193|FG000|Overall Study|Did not complete intervention|2|||
124691649|NCT01829165|448492194|FG001|Overall Study|Did not complete intervention|0|||
124691650|NCT04233580|448492215|FG000|Overall Study|Adverse Event|3|||
124691651|NCT04233580|448492216|FG001|Overall Study|Adverse Event|3|||
124691652|NCT04233580|448492215|FG000|Overall Study|Withdrawal by Subject|2|||
124691653|NCT04233580|448492216|FG001|Overall Study|Withdrawal by Subject|1|||
124691654|NCT02441114|448492218|FG000|Washout2|Withdrawal by Subject|4|||
124691655|NCT01371565|448492219|FG000|Overall Study|Withdrawal by Subject|1|||
124691656|NCT01371565|448492219|FG000|Overall Study|Death|1|||
124906689|NCT03622593|449284143|FG000|Overall Study|Lost to Follow-up|11|||
124906690|NCT03622593|449284144|FG001|Overall Study|Lost to Follow-up|5|||
124906691|NCT03622593|449284145|FG002|Overall Study|Lost to Follow-up|8|||
124906692|NCT03622593|449284143|FG000|Overall Study|Adverse Event|4|||
124691657|NCT01371565|448492219|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
124906693|NCT03622593|449284144|FG001|Overall Study|Adverse Event|5|||
124906694|NCT03622593|449284145|FG002|Overall Study|Adverse Event|6|||
124760209|NCT01623115|448746818|FG001|Overall Study|Site closure|7|||
124760210|NCT01623115|448746817|FG000|Overall Study|Death|0|||
124760211|NCT01623115|448746818|FG001|Overall Study|Death|4|||
124760212|NCT01623115|448746817|FG000|Overall Study|Other than specified above|0|||
124760213|NCT01623115|448746818|FG001|Overall Study|Other than specified above|3|||
124760214|NCT03827655|448746819|FG000|Overall Study|Death|0|||
124760215|NCT03827655|448746820|FG001|Overall Study|Death|0|||
124760216|NCT03827655|448746821|FG002|Overall Study|Death|0|||
124760217|NCT03827655|448746822|FG003|Overall Study|Death|0|||
124760218|NCT03827655|448746823|FG004|Overall Study|Death|1|||
124760219|NCT03827655|448746819|FG000|Overall Study|Protocol Deviation|1|||
124760220|NCT03827655|448746820|FG001|Overall Study|Protocol Deviation|0|||
124760221|NCT03827655|448746821|FG002|Overall Study|Protocol Deviation|1|||
124760222|NCT03827655|448746822|FG003|Overall Study|Protocol Deviation|1|||
124760223|NCT03827655|448746823|FG004|Overall Study|Protocol Deviation|0|||
124760224|NCT03827655|448746819|FG000|Overall Study|Withdrawal by Subject|3|||
124760225|NCT03827655|448746820|FG001|Overall Study|Withdrawal by Subject|2|||
124760226|NCT03827655|448746821|FG002|Overall Study|Withdrawal by Subject|2|||
124760227|NCT03827655|448746822|FG003|Overall Study|Withdrawal by Subject|0|||
124760228|NCT03827655|448746823|FG004|Overall Study|Withdrawal by Subject|1|||
124760229|NCT03827655|448746819|FG000|Overall Study|Reason not Specified|3|||
124760230|NCT03827655|448746820|FG001|Overall Study|Reason not Specified|1|||
124691658|NCT02070991|448492220|FG000|Overall Study|Death|2|||
124691659|NCT02070991|448492221|FG001|Overall Study|Death|0|||
124691660|NCT02070991|448492220|FG000|Overall Study|Withdrawal by Subject|1|||
124691661|NCT02070991|448492221|FG001|Overall Study|Withdrawal by Subject|0|||
124691662|NCT00827242|448492222|FG000|Overall Study|Withdrawal by Subject|2|||
124691663|NCT00827242|448492223|FG001|Overall Study|Withdrawal by Subject|4|||
124691664|NCT00827242|448492222|FG000|Overall Study|Protocol Violation|1|||
124691665|NCT00827242|448492223|FG001|Overall Study|Protocol Violation|3|||
124691666|NCT00827242|448492222|FG000|Overall Study|Lost to Follow-up|0|||
124691667|NCT00827242|448492223|FG001|Overall Study|Lost to Follow-up|3|||
124691668|NCT00827242|448492222|FG000|Overall Study|Adverse Event Excluding Death|2|||
124760231|NCT03827655|448746821|FG002|Overall Study|Reason not Specified|1|||
124760232|NCT03827655|448746822|FG003|Overall Study|Reason not Specified|1|||
124760233|NCT03827655|448746823|FG004|Overall Study|Reason not Specified|1|||
124760234|NCT01721161|448746825|FG000|Overall Study|Adverse Event|2|||
124760235|NCT01721161|448746826|FG001|Overall Study|Adverse Event|3|||
124760236|NCT01721161|448746825|FG000|Overall Study|Lost to Follow-up|1|||
124760237|NCT01721161|448746826|FG001|Overall Study|Lost to Follow-up|2|||
124760238|NCT01721161|448746825|FG000|Overall Study|Withdrawal by Subject|1|||
124760239|NCT01721161|448746826|FG001|Overall Study|Withdrawal by Subject|1|||
124760240|NCT01721161|448746825|FG000|Overall Study|Other|0|||
124760241|NCT01721161|448746826|FG001|Overall Study|Other|1|||
124760242|NCT02888106|448746830|FG000|Overall Study|Withdrawal by Subject|1|||
124760243|NCT02888106|448746831|FG001|Overall Study|Withdrawal by Subject|2|||
124760244|NCT02888106|448746832|FG002|Overall Study|Withdrawal by Subject|0|||
124760245|NCT02888106|448746833|FG003|Overall Study|Withdrawal by Subject|1|||
124760246|NCT02888106|448746834|FG004|Overall Study|Withdrawal by Subject|0|||
124760247|NCT02888106|448746835|FG005|Overall Study|Withdrawal by Subject|0|||
124760248|NCT02888106|448746830|FG000|Overall Study|Lost to Follow-up|1|||
124760249|NCT02888106|448746831|FG001|Overall Study|Lost to Follow-up|0|||
124760250|NCT02888106|448746832|FG002|Overall Study|Lost to Follow-up|0|||
124760251|NCT02888106|448746833|FG003|Overall Study|Lost to Follow-up|1|||
124760252|NCT02888106|448746834|FG004|Overall Study|Lost to Follow-up|0|||
124760253|NCT02888106|448746835|FG005|Overall Study|Lost to Follow-up|1|||
124760254|NCT02888106|448746830|FG000|Overall Study|Adverse Event|2|||
124760255|NCT02888106|448746831|FG001|Overall Study|Adverse Event|0|||
124760256|NCT02888106|448746832|FG002|Overall Study|Adverse Event|0|||
124760257|NCT02888106|448746833|FG003|Overall Study|Adverse Event|0|||
124544706|NCT03110107|447949195|FG006|Treatment Period|Participants no longer meets study criteria|0|||
124691669|NCT00827242|448492223|FG001|Overall Study|Adverse Event Excluding Death|1|||
124691670|NCT00827242|448492222|FG000|Overall Study|Entry Criteria Not Met|4|||
124691671|NCT00827242|448492223|FG001|Overall Study|Entry Criteria Not Met|1|||
124691672|NCT00827242|448492222|FG000|Overall Study|Physician Decision|2|||
124760258|NCT02888106|448746834|FG004|Overall Study|Adverse Event|0|||
124760259|NCT02888106|448746835|FG005|Overall Study|Adverse Event|0|||
124760260|NCT02888106|448746830|FG000|Overall Study|Withdrawal of consent|0|||
124760261|NCT02888106|448746831|FG001|Overall Study|Withdrawal of consent|0|||
124760262|NCT02888106|448746832|FG002|Overall Study|Withdrawal of consent|0|||
124760263|NCT02888106|448746833|FG003|Overall Study|Withdrawal of consent|0|||
124760264|NCT02888106|448746834|FG004|Overall Study|Withdrawal of consent|1|||
124544707|NCT03110107|447949196|FG007|Treatment Period|Participants no longer meets study criteria|0|||
124760265|NCT02888106|448746835|FG005|Overall Study|Withdrawal of consent|0|||
124760266|NCT02888106|448746830|FG000|Overall Study|Pregnancy|1|||
124760267|NCT02888106|448746831|FG001|Overall Study|Pregnancy|0|||
124760268|NCT02888106|448746832|FG002|Overall Study|Pregnancy|0|||
124760269|NCT02888106|448746833|FG003|Overall Study|Pregnancy|0|||
124760270|NCT02888106|448746834|FG004|Overall Study|Pregnancy|0|||
124691673|NCT00827242|448492223|FG001|Overall Study|Physician Decision|0|||
124691674|NCT00827242|448492222|FG000|Overall Study|Death|1|||
124691675|NCT00827242|448492223|FG001|Overall Study|Death|0|||
124691676|NCT00827242|448492222|FG000|Overall Study|Lack of Efficacy|1|||
124691677|NCT00827242|448492223|FG001|Overall Study|Lack of Efficacy|0|||
124691678|NCT00899847|448492224|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
124691679|NCT01769443|448492225|FG000|Overall Study|Study closure|1|||
124691680|NCT01769443|448492226|FG001|Overall Study|Study closure|0|||
124691681|NCT01279200|448492227|FG000|Overall Study|Withdrawal by Subject|1|||
124691682|NCT01279200|448492228|FG001|Overall Study|Withdrawal by Subject|3|||
124691683|NCT01279200|448492227|FG000|Overall Study|Patient withdrawal due to high cost|0|||
124691684|NCT01279200|448492228|FG001|Overall Study|Patient withdrawal due to high cost|1|||
124691685|NCT01279200|448492227|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
124691686|NCT01279200|448492228|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
124691687|NCT01279200|448492227|FG000|Overall Study|ultrasound screening failure|0|||
124691688|NCT01279200|448492228|FG001|Overall Study|ultrasound screening failure|1|||
124691689|NCT01279200|448492227|FG000|Overall Study|Lost to Follow-up|0|||
124691690|NCT01279200|448492228|FG001|Overall Study|Lost to Follow-up|1|||
124691691|NCT01279200|448492227|FG000|Overall Study|Adverse Event|1|||
124691692|NCT01279200|448492228|FG001|Overall Study|Adverse Event|0|||
124691693|NCT01149538|448492233|FG000|Overall Study|Lost to Follow-up|0|||
124691694|NCT01149538|448492234|FG001|Overall Study|Lost to Follow-up|1|||
124691695|NCT01149538|448492233|FG000|Overall Study|Withdrawal by Subject|5|||
124691696|NCT01149538|448492234|FG001|Overall Study|Withdrawal by Subject|3|||
124691697|NCT05507450|448492238|FG000|Overall Study|Death|0|||
124691698|NCT05507450|448492239|FG001|Overall Study|Death|0|||
124691699|NCT05507450|448492240|FG002|Overall Study|Death|1|||
124691700|NCT05507450|448492241|FG003|Overall Study|Death|0|||
124691701|NCT05507450|448492238|FG000|Overall Study|Lost to Follow-up|22|||
124691702|NCT05507450|448492239|FG001|Overall Study|Lost to Follow-up|20|||
124691703|NCT05507450|448492240|FG002|Overall Study|Lost to Follow-up|20|||
124691704|NCT05507450|448492241|FG003|Overall Study|Lost to Follow-up|7|||
124691705|NCT05507450|448492238|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124691706|NCT05507450|448492239|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
124691707|NCT05507450|448492240|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
124906695|NCT03622593|449284143|FG000|Overall Study|Physician Decision|2|||
124906696|NCT03622593|449284144|FG001|Overall Study|Physician Decision|1|||
124906697|NCT03622593|449284145|FG002|Overall Study|Physician Decision|6|||
124906698|NCT03622593|449284143|FG000|Overall Study|Other|2|||
124906699|NCT03622593|449284144|FG001|Overall Study|Other|2|||
124906700|NCT03622593|449284145|FG002|Overall Study|Other|3|||
124906701|NCT03622593|449284143|FG000|Overall Study|Protocol Violation|0|||
124906702|NCT03622593|449284144|FG001|Overall Study|Protocol Violation|0|||
124906703|NCT03622593|449284145|FG002|Overall Study|Protocol Violation|1|||
124906704|NCT03622593|449284143|FG000|Overall Study|Pregnancy|0|||
124906705|NCT03622593|449284144|FG001|Overall Study|Pregnancy|0|||
124906706|NCT03622593|449284145|FG002|Overall Study|Pregnancy|1|||
124906707|NCT03762668|449284146|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
124906708|NCT03762668|449284147|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
124906709|NCT00178399|449284148|FG000|Overall Study|Physician Decision|4|||
124906710|NCT00178399|449284148|FG000|Overall Study|Withdrawal by Subject|8|||
124906711|NCT00178399|449284148|FG000|Overall Study|Lost to Follow-up|1|||
124906712|NCT01393119|449284149|FG000|Overall Study|Adverse Event|1|||
124906713|NCT01393119|449284150|FG001|Overall Study|Adverse Event|1|||
124906714|NCT01393119|449284151|FG002|Overall Study|Adverse Event|0|||
124906715|NCT01393119|449284152|FG003|Overall Study|Adverse Event|1|||
124906716|NCT01393119|449284149|FG000|Overall Study|Withdrawal by Subject|0|||
124906717|NCT01393119|449284150|FG001|Overall Study|Withdrawal by Subject|1|||
124906718|NCT01393119|449284151|FG002|Overall Study|Withdrawal by Subject|1|||
124906719|NCT01393119|449284152|FG003|Overall Study|Withdrawal by Subject|0|||
124906720|NCT01393119|449284149|FG000|Overall Study|Lack of Efficacy|1|||
124906721|NCT01393119|449284150|FG001|Overall Study|Lack of Efficacy|0|||
124906722|NCT01393119|449284151|FG002|Overall Study|Lack of Efficacy|2|||
124906723|NCT01393119|449284152|FG003|Overall Study|Lack of Efficacy|1|||
124906724|NCT01393119|449284149|FG000|Overall Study|Protocol Violation|0|||
124691708|NCT05507450|448492241|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124691709|NCT05507450|448492238|FG000|Overall Study|Withdrawal by Subject|4|||
124691710|NCT05507450|448492239|FG001|Overall Study|Withdrawal by Subject|11|||
124691711|NCT05507450|448492240|FG002|Overall Study|Withdrawal by Subject|7|||
124691712|NCT05507450|448492241|FG003|Overall Study|Withdrawal by Subject|3|||
124906725|NCT01393119|449284150|FG001|Overall Study|Protocol Violation|0|||
124906726|NCT01393119|449284151|FG002|Overall Study|Protocol Violation|1|||
124906727|NCT01393119|449284152|FG003|Overall Study|Protocol Violation|0|||
124906728|NCT01393119|449284149|FG000|Overall Study|Death|0|||
124906729|NCT01393119|449284150|FG001|Overall Study|Death|0|||
124691713|NCT05507450|448492238|FG000|Overall Study|Participant left the country|0|||
124691714|NCT05507450|448492239|FG001|Overall Study|Participant left the country|0|||
124906730|NCT01393119|449284151|FG002|Overall Study|Death|0|||
124691715|NCT05507450|448492240|FG002|Overall Study|Participant left the country|1|||
124691716|NCT05507450|448492241|FG003|Overall Study|Participant left the country|0|||
124691717|NCT00514917|448492245|FG000|Overall Study|Death|4|||
124691718|NCT00514917|448492246|FG001|Overall Study|Death|10|||
124691719|NCT00514917|448492245|FG000|Overall Study|Protocol Violation|1|||
124906731|NCT01393119|449284152|FG003|Overall Study|Death|1|||
124906732|NCT01393119|449284149|FG000|Overall Study|Randomized but Not treated|1|||
124906733|NCT01393119|449284150|FG001|Overall Study|Randomized but Not treated|0|||
124906734|NCT01393119|449284151|FG002|Overall Study|Randomized but Not treated|1|||
124906735|NCT01393119|449284152|FG003|Overall Study|Randomized but Not treated|1|||
124906736|NCT01393119|449284149|FG000|Overall Study|Sponsor Termination of Study|11|||
124906737|NCT01393119|449284150|FG001|Overall Study|Sponsor Termination of Study|12|||
124906738|NCT01393119|449284151|FG002|Overall Study|Sponsor Termination of Study|9|||
124906739|NCT01393119|449284152|FG003|Overall Study|Sponsor Termination of Study|12|||
124906740|NCT02544152|449284153|FG000|Overall Study|Adverse Event|0|||
124906741|NCT02544152|449284154|FG001|Overall Study|Adverse Event|4|||
124906742|NCT02544152|449284153|FG000|Overall Study|Withdrawal by Subject|0|||
124906743|NCT02544152|449284154|FG001|Overall Study|Withdrawal by Subject|3|||
124906744|NCT02544152|449284153|FG000|Overall Study|Other|1|||
124906745|NCT02544152|449284154|FG001|Overall Study|Other|0|||
124906746|NCT01759264|449284157|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
124906747|NCT01759264|449284157|FG000|Overall Study|Adverse Event|1|||
124906748|NCT01759264|449284157|FG000|Overall Study|Other|2|||
124906749|NCT01759264|449284157|FG000|Overall Study|Lost to Follow-up|2|||
124906750|NCT01759264|449284157|FG000|Overall Study|Withdrawal by Subject|3|||
124906751|NCT01759264|449284157|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
124906752|NCT00516321|449284158|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
124906753|NCT00516321|449284159|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
124906754|NCT00516321|449284160|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
124906755|NCT00516321|449284158|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
124906756|NCT00516321|449284159|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
124906757|NCT00516321|449284160|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
124906758|NCT00516321|449284158|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
124906759|NCT00516321|449284159|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
124906760|NCT00516321|449284160|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
124906761|NCT00516321|449284158|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
124906762|NCT00516321|449284159|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
124906763|NCT00516321|449284160|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
124906764|NCT00516321|449284158|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
124906765|NCT00516321|449284159|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
124906766|NCT00516321|449284160|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
124906767|NCT00516321|449284158|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
124906768|NCT00516321|449284159|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
124906769|NCT00516321|449284160|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
124906770|NCT00516321|449284158|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
124906771|NCT00516321|449284159|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
124906772|NCT00516321|449284160|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
124906773|NCT00516321|449284158|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
124906774|NCT00516321|449284159|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
124906775|NCT00516321|449284160|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
124906776|NCT00516321|449284158|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
124906777|NCT00516321|449284159|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
124906778|NCT00516321|449284160|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
124906779|NCT00516321|449284158|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
124906780|NCT00516321|449284159|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
124691720|NCT00514917|448492246|FG001|Overall Study|Protocol Violation|0|||
124691721|NCT00514917|448492245|FG000|Overall Study|Lost to Follow-up|4|||
124691722|NCT00514917|448492246|FG001|Overall Study|Lost to Follow-up|3|||
124691723|NCT00514917|448492245|FG000|Overall Study|Withdrawal by Subject|18|||
124691724|NCT00514917|448492246|FG001|Overall Study|Withdrawal by Subject|16|||
124691725|NCT00514917|448492245|FG000|Overall Study|Discontinued due to study closure|88|||
124691726|NCT00514917|448492246|FG001|Overall Study|Discontinued due to study closure|81|||
124691727|NCT00514917|448492245|FG000|Overall Study|Undefined|11|||
124691728|NCT00514917|448492246|FG001|Overall Study|Undefined|5|||
124906781|NCT00516321|449284160|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
124906782|NCT00516321|449284158|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
124906783|NCT00516321|449284159|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
124906784|NCT00516321|449284160|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
124691729|NCT02697422|448492247|FG000|Overall Study|Declined exit survey|9|||
124691730|NCT02697422|448492248|FG001|Overall Study|Declined exit survey|2|||
124906785|NCT02027558|449284162|FG000|Overall Study|Death|0|||
124906786|NCT02027558|449284163|FG001|Overall Study|Death|1|||
124906787|NCT02027558|449284162|FG000|Overall Study|Withdrawal by Subject|2|||
124906788|NCT02027558|449284163|FG001|Overall Study|Withdrawal by Subject|0|||
124906789|NCT02027558|449284162|FG000|Overall Study|Lost to Follow-up|4|||
124906790|NCT02027558|449284163|FG001|Overall Study|Lost to Follow-up|1|||
124906791|NCT02027558|449284162|FG000|Overall Study|Refused assessment|3|||
124906792|NCT02027558|449284163|FG001|Overall Study|Refused assessment|0|||
124906793|NCT02139046|449284164|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
124906794|NCT02139046|449284165|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
124906795|NCT02139046|449284166|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
124906796|NCT02139046|449284167|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
124906797|NCT02139046|449284168|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
124906798|NCT02139046|449284164|FG000|Overall Study|Major Protocol Deviation|9|||
124906799|NCT02139046|449284165|FG001|Overall Study|Major Protocol Deviation|10|||
124906800|NCT02139046|449284166|FG002|Overall Study|Major Protocol Deviation|16|||
124906801|NCT02139046|449284167|FG003|Overall Study|Major Protocol Deviation|12|||
124906802|NCT02139046|449284168|FG004|Overall Study|Major Protocol Deviation|6|||
124906803|NCT02139046|449284164|FG000|Overall Study|Lost to Follow-up|13|||
124906804|NCT02139046|449284165|FG001|Overall Study|Lost to Follow-up|16|||
124906805|NCT02139046|449284166|FG002|Overall Study|Lost to Follow-up|16|||
124906806|NCT02139046|449284167|FG003|Overall Study|Lost to Follow-up|18|||
124906807|NCT02139046|449284168|FG004|Overall Study|Lost to Follow-up|13|||
124906808|NCT02139046|449284164|FG000|Overall Study|Voluntary Withdrawal|20|||
124906809|NCT02139046|449284165|FG001|Overall Study|Voluntary Withdrawal|8|||
124906810|NCT02139046|449284166|FG002|Overall Study|Voluntary Withdrawal|10|||
124906811|NCT02139046|449284167|FG003|Overall Study|Voluntary Withdrawal|15|||
124906812|NCT02139046|449284168|FG004|Overall Study|Voluntary Withdrawal|16|||
124906813|NCT02139046|449284164|FG000|Overall Study|Lack of Efficacy|0|||
124906814|NCT02139046|449284165|FG001|Overall Study|Lack of Efficacy|1|||
124906815|NCT02139046|449284166|FG002|Overall Study|Lack of Efficacy|2|||
124906816|NCT02139046|449284167|FG003|Overall Study|Lack of Efficacy|1|||
124906817|NCT02139046|449284168|FG004|Overall Study|Lack of Efficacy|2|||
124906818|NCT02139046|449284164|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
124906819|NCT02139046|449284165|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
124906820|NCT02139046|449284166|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
124906821|NCT02139046|449284167|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
124906822|NCT02139046|449284168|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
124906823|NCT02139046|449284164|FG000|Overall Study|Other Miscellaneous Reasons|10|||
124906824|NCT02139046|449284165|FG001|Overall Study|Other Miscellaneous Reasons|9|||
124906825|NCT02139046|449284166|FG002|Overall Study|Other Miscellaneous Reasons|4|||
124906826|NCT02139046|449284167|FG003|Overall Study|Other Miscellaneous Reasons|9|||
124906827|NCT02139046|449284168|FG004|Overall Study|Other Miscellaneous Reasons|12|||
124906828|NCT02383472|449284169|FG000|Overall Study|Withdrawal by Subject|1|||
124906829|NCT02383472|449284170|FG001|Overall Study|Withdrawal by Subject|1|||
124906830|NCT01111526|449284171|FG000|Overall Study|GVHD Disease Progression|0|||
124906831|NCT01111526|449284172|FG001|Overall Study|GVHD Disease Progression|1|||
124906832|NCT01111526|449284173|FG002|Overall Study|GVHD Disease Progression|2|||
124906833|NCT02013830|449284174|FG000|Overall Study|Adverse Event|3|||
124906834|NCT02013830|449284174|FG000|Overall Study|Death|1|||
124906835|NCT02013830|449284174|FG000|Overall Study|Insufficient therapeutic response|25|||
124906836|NCT02013830|449284174|FG000|Overall Study|Refused treatment|1|||
124906837|NCT02015546|449284175|FG000|Overall Study|Withdrawal by Subject|1|||
124906838|NCT02015546|449284176|FG001|Overall Study|Withdrawal by Subject|1|||
124906839|NCT02015546|449284177|FG002|Overall Study|Withdrawal by Subject|1|||
124906840|NCT02015546|449284175|FG000|Overall Study|Screem Failure|2|||
124906841|NCT02015546|449284176|FG001|Overall Study|Screem Failure|1|||
124691731|NCT02697422|448492247|FG000|Overall Study|Lost to Follow-up|13|||
124691732|NCT02697422|448492248|FG001|Overall Study|Lost to Follow-up|8|||
124691733|NCT02697422|448492247|FG000|Overall Study|Death|2|||
124691734|NCT02697422|448492248|FG001|Overall Study|Death|1|||
124691735|NCT02697422|448492247|FG000|Overall Study|Withdrawal by Subject|0|||
124691736|NCT02697422|448492248|FG001|Overall Study|Withdrawal by Subject|1|||
124691737|NCT02697422|448492247|FG000|Overall Study|Physician Decision|1|||
124691738|NCT02697422|448492248|FG001|Overall Study|Physician Decision|1|||
124691739|NCT02697422|448492247|FG000|Overall Study|Exit survey data lost|1|||
124906842|NCT02015546|449284177|FG002|Overall Study|Screem Failure|3|||
124906843|NCT04424641|449284178|FG000|Overall Study|Death|1|||
124906844|NCT04424641|449284179|FG001|Overall Study|Death|2|||
124906845|NCT04424641|449284180|FG002|Overall Study|Death|3|||
124906846|NCT04424641|449284181|FG003|Overall Study|Death|0|||
124906847|NCT04424641|449284182|FG004|Overall Study|Death|3|||
124906848|NCT04424641|449284183|FG005|Overall Study|Death|0|||
124906849|NCT04424641|449284184|FG006|Overall Study|Death|1|||
124691740|NCT02697422|448492248|FG001|Overall Study|Exit survey data lost|0|||
124691741|NCT01873833|448492252|FG000|Overall Study|Withdrawal by Subject|1|||
124906850|NCT04424641|449284185|FG007|Overall Study|Death|2|||
124906851|NCT04424641|449284178|FG000|Overall Study|Sponsor decision|0|||
124906852|NCT04424641|449284179|FG001|Overall Study|Sponsor decision|2|||
124906853|NCT04424641|449284180|FG002|Overall Study|Sponsor decision|3|||
124906854|NCT04424641|449284181|FG003|Overall Study|Sponsor decision|7|||
124906855|NCT04424641|449284182|FG004|Overall Study|Sponsor decision|2|||
124906856|NCT04424641|449284183|FG005|Overall Study|Sponsor decision|2|||
124906857|NCT04424641|449284184|FG006|Overall Study|Sponsor decision|3|||
124906858|NCT04424641|449284185|FG007|Overall Study|Sponsor decision|4|||
124906859|NCT04424641|449284178|FG000|Overall Study|Withdrawal by Subject|0|||
124906860|NCT04424641|449284179|FG001|Overall Study|Withdrawal by Subject|0|||
124906861|NCT04424641|449284180|FG002|Overall Study|Withdrawal by Subject|0|||
124906862|NCT04424641|449284181|FG003|Overall Study|Withdrawal by Subject|0|||
124906863|NCT04424641|449284182|FG004|Overall Study|Withdrawal by Subject|1|||
124906864|NCT04424641|449284183|FG005|Overall Study|Withdrawal by Subject|0|||
124906865|NCT04424641|449284184|FG006|Overall Study|Withdrawal by Subject|0|||
124906866|NCT04424641|449284185|FG007|Overall Study|Withdrawal by Subject|0|||
124906867|NCT04424641|449284178|FG000|Overall Study|Other|0|||
124906868|NCT04424641|449284179|FG001|Overall Study|Other|0|||
124906869|NCT04424641|449284180|FG002|Overall Study|Other|1|||
124906870|NCT04424641|449284181|FG003|Overall Study|Other|0|||
124906871|NCT04424641|449284182|FG004|Overall Study|Other|0|||
124906872|NCT04424641|449284183|FG005|Overall Study|Other|0|||
124906873|NCT04424641|449284184|FG006|Overall Study|Other|0|||
124906874|NCT04424641|449284185|FG007|Overall Study|Other|0|||
124906875|NCT01426269|449284194|FG000|Period 1: 12 Weeks|Adverse Event|5|||
124906876|NCT01426269|449284195|FG001|Period 1: 12 Weeks|Adverse Event|0|||
124906877|NCT01426269|449284196|FG002|Period 1: 12 Weeks|Adverse Event|0|||
124906878|NCT01426269|449284194|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
124906879|NCT01426269|449284195|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
124906880|NCT01426269|449284196|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
124906881|NCT01426269|449284194|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
124906882|NCT01426269|449284195|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
124906883|NCT01426269|449284196|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
124906884|NCT01426269|449284194|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
124906885|NCT01426269|449284195|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
124906886|NCT01426269|449284196|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
124906887|NCT01426269|449284194|FG000|Period 1: 12 Weeks|Pregnancy|1|||
124906888|NCT01426269|449284195|FG001|Period 1: 12 Weeks|Pregnancy|0|||
124906889|NCT01426269|449284196|FG002|Period 1: 12 Weeks|Pregnancy|0|||
124906890|NCT01426269|449284194|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
124906891|NCT01426269|449284195|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
124906892|NCT01426269|449284196|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
124906893|NCT01426269|449284194|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
124906894|NCT01426269|449284195|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
124906895|NCT01426269|449284196|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
124906896|NCT01426269|449284194|FG000|Period 2: 40 Weeks|Adverse Event|0|||
124906897|NCT01426269|449284195|FG001|Period 2: 40 Weeks|Adverse Event|1|||
124906898|NCT01426269|449284196|FG002|Period 2: 40 Weeks|Adverse Event|2|||
124906899|NCT01426269|449284194|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
124906900|NCT01426269|449284195|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
124906901|NCT01426269|449284196|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
124906902|NCT01426269|449284194|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
124906903|NCT01426269|449284195|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
124906904|NCT01426269|449284196|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
124906905|NCT01426269|449284194|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
124906906|NCT01426269|449284195|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
124906907|NCT01426269|449284196|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
124906908|NCT01426269|449284194|FG000|Period 2: 40 Weeks|Site closed|0|||
124906909|NCT01426269|449284195|FG001|Period 2: 40 Weeks|Site closed|6|||
124906910|NCT01426269|449284196|FG002|Period 2: 40 Weeks|Site closed|5|||
124906911|NCT01426269|449284194|FG000|Period 2: 40 Weeks|Relapsed|0|||
124449857|NCT02632721|447609604|FG002|Overall Study|Adverse Event|2|||
124449858|NCT02632721|447609605|FG003|Overall Study|Adverse Event|5|||
124760271|NCT02888106|448746835|FG005|Overall Study|Pregnancy|0|||
124906912|NCT01426269|449284195|FG001|Period 2: 40 Weeks|Relapsed|9|||
124906913|NCT01426269|449284196|FG002|Period 2: 40 Weeks|Relapsed|18|||
124449859|NCT02632721|447609606|FG004|Overall Study|Adverse Event|3|||
124449860|NCT02632721|447609602|FG000|Overall Study|Dose limiting toxicity|0|||
124906914|NCT00186186|449284198|FG000|Overall Study|Lack of Efficacy|3|||
124906915|NCT00186186|449284198|FG000|Overall Study|Withdrawal by Subject|3|||
124906916|NCT00186186|449284198|FG000|Overall Study|Not reported as to reason|2|||
124906917|NCT01337635|449284199|FG000|Overall Study|Lost to Follow-up|0|||
124906918|NCT01337635|449284200|FG001|Overall Study|Lost to Follow-up|1|||
124906919|NCT03959241|449284204|FG000|Overall Study|Withdrawal by Subject|7|||
124906920|NCT03959241|449284205|FG001|Overall Study|Withdrawal by Subject|8|||
124906921|NCT03959241|449284204|FG000|Overall Study|Lost to Follow-up|1|||
124906922|NCT03959241|449284205|FG001|Overall Study|Lost to Follow-up|0|||
124906923|NCT03959241|449284204|FG000|Overall Study|Move to Hospice Care|1|||
124906924|NCT03959241|449284205|FG001|Overall Study|Move to Hospice Care|0|||
124906925|NCT03959241|449284204|FG000|Overall Study|Screen Failure|1|||
124906926|NCT03959241|449284205|FG001|Overall Study|Screen Failure|0|||
124691742|NCT03983109|448492255|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
124906927|NCT03959241|449284204|FG000|Overall Study|Disease Relapse|0|||
124906928|NCT03959241|449284205|FG001|Overall Study|Disease Relapse|1|||
124906929|NCT03959241|449284204|FG000|Overall Study|Off Study|1|||
124906930|NCT03959241|449284205|FG001|Overall Study|Off Study|0|||
124906931|NCT01145885|449284206|FG000|Overall Study|Progressive Disease|7|||
124906932|NCT03691428|449284207|FG000|Overall Study|Withdrawal by Subject|6|||
124906933|NCT03691428|449284208|FG001|Overall Study|Withdrawal by Subject|8|||
124906934|NCT02527148|449284209|FG000|Overall Study|Did not receive study intervention|1|||
124906935|NCT02527148|449284210|FG001|Overall Study|Did not receive study intervention|0|||
124906936|NCT01140048|449284211|FG000|Overall Study|Physician Decision|1|||
124906937|NCT01140048|449284211|FG000|Overall Study|Withdrawal by Subject|13|||
124906938|NCT01140048|449284211|FG000|Overall Study|Lost to Follow-up|31|||
124906939|NCT01831791|449284212|FG000|Overall Study|Withdrawal by Subject|10|||
124906940|NCT00494780|449284213|FG000|Overall Study|Adverse Event|1|||
124906941|NCT00494780|449284214|FG001|Overall Study|Adverse Event|0|||
124906942|NCT00494780|449284213|FG000|Overall Study|Withdrew before Dosed|0|||
124906943|NCT00494780|449284214|FG001|Overall Study|Withdrew before Dosed|1|||
124906944|NCT00494780|449284213|FG000|Overall Study|Progression of Study Disease|7|||
124906945|NCT00494780|449284214|FG001|Overall Study|Progression of Study Disease|8|||
124906946|NCT00494780|449284213|FG000|Overall Study|New Treatment|2|||
124906947|NCT00494780|449284214|FG001|Overall Study|New Treatment|2|||
124906948|NCT00494780|449284213|FG000|Overall Study|Non-compliance|1|||
124906949|NCT00494780|449284214|FG001|Overall Study|Non-compliance|0|||
124906950|NCT00494780|449284213|FG000|Overall Study|Residual Tumour Mass|0|||
124906951|NCT00494780|449284214|FG001|Overall Study|Residual Tumour Mass|1|||
124906952|NCT00494780|449284213|FG000|Overall Study|Insurance Issues|0|||
124906953|NCT00494780|449284214|FG001|Overall Study|Insurance Issues|1|||
124906954|NCT04054635|449284223|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
124906955|NCT04054635|449284224|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
124906956|NCT04054635|449284225|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
124906957|NCT04054635|449284223|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
124906958|NCT04054635|449284224|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
124906959|NCT04054635|449284225|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
124906960|NCT00891930|449284226|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
124906961|NCT00891930|449284226|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
124906962|NCT00891930|449284226|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
124906963|NCT00891930|449284226|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
124906964|NCT00891930|449284226|FG000|Part 2 Panitumumab + AMG479|Death|30|||
124906965|NCT02537522|449284233|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
124906966|NCT02537522|449284234|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
124906967|NCT02537522|449284235|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
124906968|NCT02537522|449284236|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
124906969|NCT02537522|449284233|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
124906970|NCT02537522|449284234|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
124906971|NCT02537522|449284235|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
124906972|NCT02537522|449284236|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
124906973|NCT02537522|449284233|FG000|Phase I - Contralateral|incorrect randomization|0|||
124906974|NCT02537522|449284234|FG001|Phase I - Contralateral|incorrect randomization|1|||
124906975|NCT02537522|449284235|FG002|Phase I - Contralateral|incorrect randomization|0|||
124906976|NCT02537522|449284236|FG003|Phase I - Contralateral|incorrect randomization|0|||
124906977|NCT02537522|449284233|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
124906978|NCT02537522|449284234|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
124906979|NCT02537522|449284235|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
124906980|NCT02537522|449284236|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
124906981|NCT02537522|449284233|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
124906982|NCT02537522|449284234|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
124906983|NCT02537522|449284235|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
124906984|NCT02537522|449284236|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
124906985|NCT01493778|449284240|FG000|Overall Study|Withdrawal by Subject|8|||
124906986|NCT00857649|449284241|FG000|Overall Study|Adverse Event|15|||
124906987|NCT00857649|449284242|FG001|Overall Study|Adverse Event|10|||
124906988|NCT00857649|449284241|FG000|Overall Study|Non-compliance|1|||
124906989|NCT00857649|449284242|FG001|Overall Study|Non-compliance|1|||
124906990|NCT00857649|449284241|FG000|Overall Study|Protocol Violation|2|||
124906991|NCT00857649|449284242|FG001|Overall Study|Protocol Violation|2|||
124906992|NCT00857649|449284241|FG000|Overall Study|Withdrawal of Consent|10|||
124906993|NCT00857649|449284242|FG001|Overall Study|Withdrawal of Consent|7|||
124906994|NCT00857649|449284241|FG000|Overall Study|Nursing Home Placement|2|||
124906995|NCT00857649|449284242|FG001|Overall Study|Nursing Home Placement|9|||
124906996|NCT00857649|449284241|FG000|Overall Study|Other Reasons|1|||
124906997|NCT00857649|449284242|FG001|Overall Study|Other Reasons|3|||
124906998|NCT04177394|449284245|FG000|Overall Study|Death|16|||
124906999|NCT04177394|449284245|FG000|Overall Study|Withdrawal by Subject|19|||
124907000|NCT04177394|449284245|FG000|Overall Study|Missed visits|61|||
124907001|NCT04177394|449284245|FG000|Overall Study|Expected Visits|15|||
124907002|NCT00258895|449284246|FG000|Overall Study|Lost to Follow-up|3|||
124907003|NCT00258895|449284247|FG001|Overall Study|Lost to Follow-up|1|||
124907004|NCT00258895|449284246|FG000|Overall Study|Protocol Violation|6|||
124907005|NCT00258895|449284247|FG001|Overall Study|Protocol Violation|2|||
124907006|NCT00258895|449284246|FG000|Overall Study|Withdrawal by Subject|1|||
124907007|NCT00258895|449284247|FG001|Overall Study|Withdrawal by Subject|0|||
124907008|NCT00630786|449284248|FG000|Overall Study|Physician Decision|0|||
124907009|NCT00630786|449284249|FG001|Overall Study|Physician Decision|0|||
124907010|NCT00630786|449284250|FG002|Overall Study|Physician Decision|1|||
124907011|NCT00630786|449284248|FG000|Overall Study|Withdrawal by Subject|0|||
124907012|NCT00630786|449284249|FG001|Overall Study|Withdrawal by Subject|1|||
124907013|NCT00630786|449284250|FG002|Overall Study|Withdrawal by Subject|1|||
124907014|NCT00630786|449284248|FG000|Overall Study|Lost to Follow-up|0|||
124907015|NCT00630786|449284249|FG001|Overall Study|Lost to Follow-up|1|||
124907016|NCT00630786|449284250|FG002|Overall Study|Lost to Follow-up|0|||
124907017|NCT00630786|449284248|FG000|Overall Study|Other|1|||
124907018|NCT00630786|449284249|FG001|Overall Study|Other|0|||
124907019|NCT00630786|449284250|FG002|Overall Study|Other|0|||
124907020|NCT03603717|449284254|FG000|Overall Study|Lost to Follow-up|20|||
124907021|NCT03603717|449284255|FG001|Overall Study|Lost to Follow-up|20|||
124907022|NCT03603717|449284254|FG000|Overall Study|Withdrawal by Subject|16|||
124907023|NCT03603717|449284255|FG001|Overall Study|Withdrawal by Subject|10|||
124907024|NCT04668339|449285708|FG000|Overall Study|Physician Decision|1|||
124907025|NCT04668339|449285709|FG001|Overall Study|Physician Decision|0|||
124907026|NCT04668339|449285710|FG002|Overall Study|Physician Decision|1|||
124907027|NCT04668339|449285711|FG003|Overall Study|Physician Decision|1|||
124907028|NCT04668339|449285708|FG000|Overall Study|Lost to Follow-up|14|||
124907029|NCT04668339|449285709|FG001|Overall Study|Lost to Follow-up|12|||
124907030|NCT04668339|449285710|FG002|Overall Study|Lost to Follow-up|8|||
124907031|NCT04668339|449285711|FG003|Overall Study|Lost to Follow-up|5|||
124907032|NCT04668339|449285708|FG000|Overall Study|Adverse Event|0|||
124907033|NCT04668339|449285709|FG001|Overall Study|Adverse Event|0|||
124907034|NCT04668339|449285710|FG002|Overall Study|Adverse Event|1|||
124907035|NCT04668339|449285711|FG003|Overall Study|Adverse Event|0|||
124907036|NCT04668339|449285708|FG000|Overall Study|Other than specified|3|||
124907037|NCT04668339|449285709|FG001|Overall Study|Other than specified|0|||
124907038|NCT04668339|449285710|FG002|Overall Study|Other than specified|1|||
124907039|NCT04668339|449285711|FG003|Overall Study|Other than specified|0|||
124907040|NCT04668339|449285708|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
124907041|NCT04668339|449285709|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
124907042|NCT04668339|449285710|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
124907043|NCT04668339|449285711|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
124907044|NCT04668339|449285708|FG000|Overall Study|Vaccine not Administered|0|||
124907045|NCT04668339|449285709|FG001|Overall Study|Vaccine not Administered|0|||
124907046|NCT04668339|449285710|FG002|Overall Study|Vaccine not Administered|1|||
124907047|NCT04668339|449285711|FG003|Overall Study|Vaccine not Administered|0|||
124907048|NCT04668339|449285708|FG000|Overall Study|Protocol Violation|18|||
124907049|NCT04668339|449285709|FG001|Overall Study|Protocol Violation|23|||
124907050|NCT04668339|449285710|FG002|Overall Study|Protocol Violation|12|||
124907051|NCT04668339|449285711|FG003|Overall Study|Protocol Violation|20|||
124907052|NCT04668339|449285708|FG000|Overall Study|Withdrawal by Subject|45|||
124907053|NCT04668339|449285709|FG001|Overall Study|Withdrawal by Subject|46|||
124907054|NCT04668339|449285710|FG002|Overall Study|Withdrawal by Subject|46|||
124907055|NCT04668339|449285711|FG003|Overall Study|Withdrawal by Subject|27|||
124907056|NCT04668339|449285708|FG000|Overall Study|Study Terminated by Sponsor|59|||
124907057|NCT04668339|449285709|FG001|Overall Study|Study Terminated by Sponsor|59|||
124907058|NCT04668339|449285710|FG002|Overall Study|Study Terminated by Sponsor|71|||
124907059|NCT04668339|449285711|FG003|Overall Study|Study Terminated by Sponsor|1|||
124907060|NCT00002842|449285719|FG000|Overall Study|ineligible for surgical resection|27|||
124907061|NCT03557008|449285721|FG000|Overall Study|Withdrawal by Subject|2|||
124907062|NCT03557008|449285722|FG001|Overall Study|Withdrawal by Subject|2|||
124907063|NCT03557008|449285721|FG000|Overall Study|Early termination from study|3|||
124907064|NCT03557008|449285722|FG001|Overall Study|Early termination from study|1|||
124449861|NCT02632721|447609603|FG001|Overall Study|Dose limiting toxicity|0|||
124449862|NCT02632721|447609604|FG002|Overall Study|Dose limiting toxicity|0|||
124449863|NCT02632721|447609605|FG003|Overall Study|Dose limiting toxicity|1|||
124907065|NCT01113931|449285725|FG000|Overall Study|Adverse Event|2|||
124907066|NCT01113931|449285726|FG001|Overall Study|Adverse Event|2|||
124907067|NCT01113931|449285725|FG000|Overall Study|Physician Decision|0|||
124907068|NCT01113931|449285726|FG001|Overall Study|Physician Decision|2|||
124907069|NCT01113931|449285725|FG000|Overall Study|Lost to Follow-up|12|||
124907070|NCT01113931|449285726|FG001|Overall Study|Lost to Follow-up|9|||
124907071|NCT01113931|449285725|FG000|Overall Study|Various|2|||
124907072|NCT01113931|449285726|FG001|Overall Study|Various|4|||
124907073|NCT01113931|449285725|FG000|Overall Study|Withdrawal by Subject|3|||
124907074|NCT01113931|449285726|FG001|Overall Study|Withdrawal by Subject|0|||
124907075|NCT02567656|449285727|FG000|Overall Study|Premature discontinuation due to PD|1|||
124907076|NCT02567656|449285728|FG001|Overall Study|Premature discontinuation due to PD|1|||
124907077|NCT02567656|449285729|FG002|Overall Study|Premature discontinuation due to PD|2|||
124907078|NCT02567656|449285730|FG003|Overall Study|Premature discontinuation due to PD|0|||
124907079|NCT02567656|449285731|FG004|Overall Study|Premature discontinuation due to PD|0|||
124907080|NCT02567656|449285732|FG005|Overall Study|Premature discontinuation due to PD|0|||
124907081|NCT01424397|449285733|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907082|NCT01424397|449285734|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907083|NCT01424397|449285735|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
124907084|NCT01424397|449285736|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907085|NCT01424397|449285737|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907086|NCT01424397|449285738|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907087|NCT01424397|449285739|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907088|NCT01424397|449285740|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907089|NCT01424397|449285741|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907090|NCT01424397|449285742|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907091|NCT01424397|449285743|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907092|NCT01424397|449285744|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
124907093|NCT00980330|449285749|FG000|Overall Study|Adverse Event|0|||
124907094|NCT00980330|449285750|FG001|Overall Study|Adverse Event|0|||
124907095|NCT00980330|449285751|FG002|Overall Study|Adverse Event|0|||
124907096|NCT00980330|449285752|FG003|Overall Study|Adverse Event|1|||
124907097|NCT00980330|449285753|FG004|Overall Study|Adverse Event|0|||
124907098|NCT00980330|449285754|FG005|Overall Study|Adverse Event|0|||
124907099|NCT00980330|449285755|FG006|Overall Study|Adverse Event|0|||
124907100|NCT00980330|449285749|FG000|Overall Study|Lost to Follow-up|1|||
124907101|NCT00980330|449285750|FG001|Overall Study|Lost to Follow-up|1|||
124907102|NCT00980330|449285751|FG002|Overall Study|Lost to Follow-up|4|||
124907103|NCT00980330|449285752|FG003|Overall Study|Lost to Follow-up|2|||
124907104|NCT00980330|449285753|FG004|Overall Study|Lost to Follow-up|1|||
124907105|NCT00980330|449285754|FG005|Overall Study|Lost to Follow-up|1|||
124907106|NCT00980330|449285755|FG006|Overall Study|Lost to Follow-up|2|||
124907107|NCT00980330|449285749|FG000|Overall Study|Withdrawal by Subject|2|||
124907108|NCT00980330|449285750|FG001|Overall Study|Withdrawal by Subject|4|||
124907109|NCT00980330|449285751|FG002|Overall Study|Withdrawal by Subject|4|||
124907110|NCT00980330|449285752|FG003|Overall Study|Withdrawal by Subject|1|||
124907111|NCT00980330|449285753|FG004|Overall Study|Withdrawal by Subject|3|||
124907112|NCT00980330|449285754|FG005|Overall Study|Withdrawal by Subject|2|||
124907113|NCT00980330|449285755|FG006|Overall Study|Withdrawal by Subject|5|||
124907114|NCT00980330|449285749|FG000|Overall Study|(not specified)|2|||
124907115|NCT00980330|449285750|FG001|Overall Study|(not specified)|0|||
124907116|NCT00980330|449285751|FG002|Overall Study|(not specified)|0|||
124907117|NCT00980330|449285752|FG003|Overall Study|(not specified)|1|||
124907118|NCT00980330|449285753|FG004|Overall Study|(not specified)|1|||
124907119|NCT00980330|449285754|FG005|Overall Study|(not specified)|1|||
124907120|NCT00980330|449285755|FG006|Overall Study|(not specified)|0|||
124907121|NCT00666276|449285756|FG000|Overall Study|Protocol Violation|34|||
124907122|NCT03299816|449285757|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
124907123|NCT03299816|449285758|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
124907124|NCT03299816|449285757|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
124907125|NCT03299816|449285758|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
124907126|NCT03299816|449285757|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
124907127|NCT03299816|449285758|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
124907128|NCT03520413|449285759|FG000|Overall Study|Lost to Follow-up|1|||
124449864|NCT02632721|447609606|FG004|Overall Study|Dose limiting toxicity|0|||
124449865|NCT02632721|447609602|FG000|Overall Study|Progressive disease|3|||
124449866|NCT02632721|447609603|FG001|Overall Study|Progressive disease|0|||
124449867|NCT02632721|447609604|FG002|Overall Study|Progressive disease|4|||
124449868|NCT02632721|447609605|FG003|Overall Study|Progressive disease|6|||
124449869|NCT02632721|447609606|FG004|Overall Study|Progressive disease|5|||
124691743|NCT03983109|448492256|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
124691744|NCT01871727|448492257|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
124907129|NCT03520413|449285760|FG001|Overall Study|Lost to Follow-up|1|||
124907130|NCT03520413|449285759|FG000|Overall Study|Withdrawal by Subject|1|||
124907131|NCT03520413|449285760|FG001|Overall Study|Withdrawal by Subject|2|||
124691745|NCT01871727|448492258|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
124907132|NCT03520413|449285759|FG000|Overall Study|Death|0|||
124907133|NCT03520413|449285760|FG001|Overall Study|Death|1|||
124907134|NCT03520413|449285759|FG000|Overall Study|Physician Decision|3|||
124907135|NCT03520413|449285760|FG001|Overall Study|Physician Decision|3|||
124907136|NCT03520413|449285759|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
124907137|NCT03520413|449285760|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
124449870|NCT02632721|447609602|FG000|Overall Study|Refused to continue taking trial medication|0|||
124907138|NCT05001945|449285766|FG000|Overall Study|Adverse Event|0|||
124907139|NCT05001945|449285767|FG001|Overall Study|Adverse Event|0|||
124907140|NCT05001945|449285768|FG002|Overall Study|Adverse Event|0|||
124907141|NCT05001945|449285769|FG003|Overall Study|Adverse Event|1|||
124907142|NCT05001945|449285770|FG004|Overall Study|Adverse Event|0|||
124907143|NCT05001945|449285771|FG005|Overall Study|Adverse Event|0|||
124907144|NCT05001945|449285772|FG006|Overall Study|Adverse Event|0|||
124907145|NCT05001945|449285773|FG007|Overall Study|Adverse Event|0|||
124907146|NCT05001945|449285766|FG000|Overall Study|Lost to Follow-up|0|||
124907147|NCT05001945|449285767|FG001|Overall Study|Lost to Follow-up|1|||
124907148|NCT05001945|449285768|FG002|Overall Study|Lost to Follow-up|1|||
124907149|NCT05001945|449285769|FG003|Overall Study|Lost to Follow-up|2|||
124907150|NCT05001945|449285770|FG004|Overall Study|Lost to Follow-up|0|||
124907151|NCT05001945|449285771|FG005|Overall Study|Lost to Follow-up|1|||
124907152|NCT05001945|449285772|FG006|Overall Study|Lost to Follow-up|0|||
124907153|NCT05001945|449285773|FG007|Overall Study|Lost to Follow-up|0|||
124907154|NCT05001945|449285766|FG000|Overall Study|Protocol Violation|1|||
124907155|NCT05001945|449285767|FG001|Overall Study|Protocol Violation|0|||
124907156|NCT05001945|449285768|FG002|Overall Study|Protocol Violation|1|||
124907157|NCT05001945|449285769|FG003|Overall Study|Protocol Violation|1|||
124907158|NCT05001945|449285770|FG004|Overall Study|Protocol Violation|0|||
124907159|NCT05001945|449285771|FG005|Overall Study|Protocol Violation|1|||
124907160|NCT05001945|449285772|FG006|Overall Study|Protocol Violation|0|||
124907161|NCT05001945|449285773|FG007|Overall Study|Protocol Violation|0|||
124907162|NCT05001945|449285766|FG000|Overall Study|Withdrawal by Subject|0|||
124907163|NCT05001945|449285767|FG001|Overall Study|Withdrawal by Subject|0|||
124907164|NCT05001945|449285768|FG002|Overall Study|Withdrawal by Subject|0|||
124907165|NCT05001945|449285769|FG003|Overall Study|Withdrawal by Subject|1|||
124907166|NCT05001945|449285770|FG004|Overall Study|Withdrawal by Subject|1|||
124907167|NCT05001945|449285771|FG005|Overall Study|Withdrawal by Subject|1|||
124907168|NCT05001945|449285772|FG006|Overall Study|Withdrawal by Subject|0|||
124907169|NCT05001945|449285773|FG007|Overall Study|Withdrawal by Subject|1|||
124907170|NCT05001945|449285766|FG000|Overall Study|Not specified by Investigator|0|||
124907171|NCT05001945|449285767|FG001|Overall Study|Not specified by Investigator|3|||
124907172|NCT05001945|449285768|FG002|Overall Study|Not specified by Investigator|0|||
124907173|NCT05001945|449285769|FG003|Overall Study|Not specified by Investigator|0|||
124907174|NCT05001945|449285770|FG004|Overall Study|Not specified by Investigator|1|||
124907175|NCT05001945|449285771|FG005|Overall Study|Not specified by Investigator|0|||
124907176|NCT05001945|449285772|FG006|Overall Study|Not specified by Investigator|0|||
124907177|NCT05001945|449285773|FG007|Overall Study|Not specified by Investigator|0|||
124449871|NCT02632721|447609603|FG001|Overall Study|Refused to continue taking trial medication|1|||
124449872|NCT02632721|447609604|FG002|Overall Study|Refused to continue taking trial medication|1|||
124449873|NCT02632721|447609605|FG003|Overall Study|Refused to continue taking trial medication|1|||
124449874|NCT02632721|447609606|FG004|Overall Study|Refused to continue taking trial medication|2|||
124449875|NCT02632721|447609602|FG000|Overall Study|Inadequate clinical condition|0|||
124449876|NCT02632721|447609603|FG001|Overall Study|Inadequate clinical condition|0|||
124449877|NCT02632721|447609604|FG002|Overall Study|Inadequate clinical condition|0|||
124449878|NCT02632721|447609605|FG003|Overall Study|Inadequate clinical condition|0|||
124449879|NCT02632721|447609606|FG004|Overall Study|Inadequate clinical condition|1|||
124449880|NCT02632721|447609602|FG000|Overall Study|No meet eligibility|0|||
124449881|NCT02632721|447609603|FG001|Overall Study|No meet eligibility|0|||
124449882|NCT02632721|447609604|FG002|Overall Study|No meet eligibility|0|||
124449883|NCT02632721|447609605|FG003|Overall Study|No meet eligibility|0|||
124449884|NCT02632721|447609606|FG004|Overall Study|No meet eligibility|1|||
124449885|NCT02632721|447609602|FG000|Overall Study|Allergic reaction|0|||
124449886|NCT02632721|447609603|FG001|Overall Study|Allergic reaction|0|||
124449887|NCT02632721|447609604|FG002|Overall Study|Allergic reaction|0|||
124449888|NCT02632721|447609605|FG003|Overall Study|Allergic reaction|1|||
124449889|NCT02632721|447609606|FG004|Overall Study|Allergic reaction|0|||
124449890|NCT02632721|447609602|FG000|Overall Study|Receiving Decitabine locally|0|||
124907178|NCT02448446|449285774|FG000|Overall Study|Withdrawal by Subject|1|||
124907179|NCT02448446|449285775|FG001|Overall Study|Withdrawal by Subject|0|||
124449891|NCT02632721|447609603|FG001|Overall Study|Receiving Decitabine locally|0|||
124449892|NCT02632721|447609604|FG002|Overall Study|Receiving Decitabine locally|1|||
124449893|NCT02632721|447609605|FG003|Overall Study|Receiving Decitabine locally|0|||
124449894|NCT02632721|447609606|FG004|Overall Study|Receiving Decitabine locally|0|||
124449895|NCT02632721|447609602|FG000|Overall Study|No benefit from study treatment|1|||
124907180|NCT02425111|449285776|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
124907181|NCT02425111|449285776|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
124907182|NCT02425111|449285776|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
124907183|NCT02425111|449285776|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
124907184|NCT02425111|449285776|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
124907185|NCT02425111|449285776|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
124449896|NCT02632721|447609603|FG001|Overall Study|No benefit from study treatment|1|||
124907186|NCT00545077|449285778|FG000|Overall Study|Treatment not received|5|||
124907187|NCT00545077|449285779|FG001|Overall Study|Treatment not received|1|||
124907188|NCT00545077|449285778|FG000|Overall Study|Disease Progression|131|||
124907189|NCT00545077|449285779|FG001|Overall Study|Disease Progression|98|||
124907190|NCT00545077|449285778|FG000|Overall Study|Withdrawal by Subject|3|||
124907191|NCT00545077|449285779|FG001|Overall Study|Withdrawal by Subject|14|||
124907192|NCT00545077|449285778|FG000|Overall Study|Physician Decision|6|||
124907193|NCT00545077|449285779|FG001|Overall Study|Physician Decision|3|||
124907194|NCT00545077|449285778|FG000|Overall Study|Lost to Follow-up|2|||
124907195|NCT00545077|449285779|FG001|Overall Study|Lost to Follow-up|0|||
124907196|NCT00545077|449285778|FG000|Overall Study|Protocol Violation|1|||
124907197|NCT00545077|449285779|FG001|Overall Study|Protocol Violation|0|||
124907198|NCT00545077|449285778|FG000|Overall Study|Adverse Event|0|||
124907199|NCT00545077|449285779|FG001|Overall Study|Adverse Event|31|||
124907200|NCT00545077|449285778|FG000|Overall Study|Death|0|||
124907201|NCT00545077|449285779|FG001|Overall Study|Death|8|||
124907202|NCT02202499|449285780|FG000|Overall Study|Cancer diagnosis|0|||
124907203|NCT02202499|449285781|FG001|Overall Study|Cancer diagnosis|0|||
124907204|NCT02202499|449285782|FG002|Overall Study|Cancer diagnosis|1|||
124907205|NCT02202499|449285780|FG000|Overall Study|Moved from area|0|||
124907206|NCT02202499|449285781|FG001|Overall Study|Moved from area|0|||
124691746|NCT01871727|448492259|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
124691747|NCT01871727|448492260|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
124691748|NCT01871727|448492261|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
124691749|NCT01871727|448492257|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
124691750|NCT01871727|448492258|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
124691751|NCT01871727|448492259|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
124691752|NCT01871727|448492260|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
124691753|NCT01871727|448492261|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
124691754|NCT01871727|448492257|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
124691755|NCT01871727|448492258|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
124691756|NCT01871727|448492259|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
124691757|NCT01871727|448492260|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
124691758|NCT01871727|448492261|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
124691759|NCT01871727|448492257|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
124691760|NCT01871727|448492258|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
124907207|NCT02202499|449285782|FG002|Overall Study|Moved from area|1|||
124907208|NCT02202499|449285780|FG000|Overall Study|Declined before randomization|1|||
124907209|NCT02202499|449285781|FG001|Overall Study|Declined before randomization|0|||
124907210|NCT02202499|449285782|FG002|Overall Study|Declined before randomization|0|||
124907211|NCT02202499|449285780|FG000|Overall Study|Auto accident|1|||
124907212|NCT02202499|449285781|FG001|Overall Study|Auto accident|0|||
124907213|NCT02202499|449285782|FG002|Overall Study|Auto accident|0|||
124907214|NCT00535145|449285783|FG000|Phase I|Adverse Event|3|||
124907215|NCT00535145|449285783|FG000|Phase I|Lost to Follow-up|7|||
124907216|NCT00535145|449285783|FG000|Phase I|Withdrawal by Subject|6|||
124907217|NCT00535145|449285783|FG000|Phase I|(eligibility)|8|||
124907218|NCT00535145|449285783|FG000|Phase I|(protocol violation)|1|||
124907219|NCT00535145|449285783|FG000|Phase I|(PI decision)|1|||
124907220|NCT00535145|449285783|FG000|Phase I|(diagnosis)|3|||
124907221|NCT00535145|449285783|FG000|Phase II|Adverse Event|2|||
124907222|NCT00535145|449285783|FG000|Phase II|Lack of Efficacy|1|||
124907223|NCT00535145|449285783|FG000|Phase II|Lost to Follow-up|5|||
124907224|NCT00535145|449285783|FG000|Phase II|Withdrawal by Subject|5|||
124907225|NCT00535145|449285783|FG000|Phase II|Subject non-compliance|2|||
124907226|NCT02200770|449285784|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
124907227|NCT02200770|449285785|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
124907228|NCT02200770|449285784|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
124907229|NCT02200770|449285785|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
124907230|NCT02200770|449285784|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
124907231|NCT02200770|449285785|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
124907232|NCT02200770|449285784|FG000|Randomized-controlled Period (RCP)|Other|1|||
124907233|NCT02200770|449285785|FG001|Randomized-controlled Period (RCP)|Other|2|||
124907234|NCT02200770|449285784|FG000|Open-label Period (OLP)|Adverse Event|1|||
124907235|NCT02200770|449285785|FG001|Open-label Period (OLP)|Adverse Event|2|||
124907236|NCT02200770|449285784|FG000|Open-label Period (OLP)|Death|1|||
124691761|NCT01871727|448492259|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
124907237|NCT02200770|449285785|FG001|Open-label Period (OLP)|Death|2|||
124907238|NCT02200770|449285784|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
124907239|NCT02200770|449285785|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
124907240|NCT02200770|449285784|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
124907241|NCT02200770|449285785|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
124907242|NCT02200770|449285784|FG000|Open-label Period (OLP)|Other|6|||
124907243|NCT02200770|449285785|FG001|Open-label Period (OLP)|Other|15|||
124907244|NCT00712335|449285791|FG000|Overall Study|Withdrawal by Subject|0|||
124691762|NCT01871727|448492260|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
124691763|NCT01871727|448492261|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
124691764|NCT01871727|448492257|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
124907245|NCT00712335|449285792|FG001|Overall Study|Withdrawal by Subject|7|||
124907246|NCT00712335|449285793|FG002|Overall Study|Withdrawal by Subject|2|||
124907247|NCT00712335|449285794|FG003|Overall Study|Withdrawal by Subject|3|||
124907248|NCT00712335|449285795|FG004|Overall Study|Withdrawal by Subject|0|||
124907249|NCT00712335|449285791|FG000|Overall Study|Lost to Follow-up|2|||
124907250|NCT00712335|449285792|FG001|Overall Study|Lost to Follow-up|5|||
124907251|NCT00712335|449285793|FG002|Overall Study|Lost to Follow-up|0|||
124907252|NCT00712335|449285794|FG003|Overall Study|Lost to Follow-up|1|||
124907253|NCT00712335|449285795|FG004|Overall Study|Lost to Follow-up|0|||
124907254|NCT00712335|449285791|FG000|Overall Study|Protocol Violation|1|||
124907255|NCT00712335|449285792|FG001|Overall Study|Protocol Violation|2|||
124907256|NCT00712335|449285793|FG002|Overall Study|Protocol Violation|1|||
124907257|NCT00712335|449285794|FG003|Overall Study|Protocol Violation|0|||
124907258|NCT00712335|449285795|FG004|Overall Study|Protocol Violation|0|||
124907259|NCT00712335|449285791|FG000|Overall Study|Lack of Efficacy|0|||
124907260|NCT00712335|449285792|FG001|Overall Study|Lack of Efficacy|0|||
124907261|NCT00712335|449285793|FG002|Overall Study|Lack of Efficacy|1|||
124907262|NCT00712335|449285794|FG003|Overall Study|Lack of Efficacy|1|||
124907263|NCT00712335|449285795|FG004|Overall Study|Lack of Efficacy|0|||
124907264|NCT00712335|449285791|FG000|Overall Study|Other Reason|0|||
124907265|NCT00712335|449285792|FG001|Overall Study|Other Reason|3|||
124907266|NCT00712335|449285793|FG002|Overall Study|Other Reason|1|||
124907267|NCT00712335|449285794|FG003|Overall Study|Other Reason|0|||
124907268|NCT00712335|449285795|FG004|Overall Study|Other Reason|0|||
124907269|NCT03401112|449285797|FG000|Overall Study|Adverse Event|1|||
124907270|NCT03401112|449285798|FG001|Overall Study|Adverse Event|2|||
124907271|NCT03401112|449285799|FG002|Overall Study|Adverse Event|3|||
124907272|NCT03401112|449285800|FG003|Overall Study|Adverse Event|2|||
124907273|NCT03401112|449285801|FG004|Overall Study|Adverse Event|0|||
124907274|NCT03401112|449285797|FG000|Overall Study|Lost to Follow-up|1|||
124907275|NCT03401112|449285798|FG001|Overall Study|Lost to Follow-up|0|||
124907276|NCT03401112|449285799|FG002|Overall Study|Lost to Follow-up|0|||
124907277|NCT03401112|449285800|FG003|Overall Study|Lost to Follow-up|0|||
124907278|NCT03401112|449285801|FG004|Overall Study|Lost to Follow-up|0|||
124907279|NCT03401112|449285797|FG000|Overall Study|Noncompliance|1|||
124907280|NCT03401112|449285798|FG001|Overall Study|Noncompliance|2|||
124907281|NCT03401112|449285799|FG002|Overall Study|Noncompliance|3|||
124907282|NCT03401112|449285800|FG003|Overall Study|Noncompliance|0|||
124907283|NCT03401112|449285801|FG004|Overall Study|Noncompliance|0|||
124907284|NCT03401112|449285797|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
124907285|NCT03401112|449285798|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
124907286|NCT03401112|449285799|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
124907287|NCT03401112|449285800|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
124907288|NCT03401112|449285801|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
124907289|NCT03401112|449285797|FG000|Overall Study|Withdrawal by Subject|0|||
124907290|NCT03401112|449285798|FG001|Overall Study|Withdrawal by Subject|3|||
124907291|NCT03401112|449285799|FG002|Overall Study|Withdrawal by Subject|2|||
124907292|NCT03401112|449285800|FG003|Overall Study|Withdrawal by Subject|1|||
124907293|NCT03401112|449285801|FG004|Overall Study|Withdrawal by Subject|0|||
124907294|NCT03401112|449285797|FG000|Overall Study|Physician Decision|0|||
124907295|NCT03401112|449285798|FG001|Overall Study|Physician Decision|0|||
124907296|NCT03401112|449285799|FG002|Overall Study|Physician Decision|0|||
124907297|NCT03401112|449285800|FG003|Overall Study|Physician Decision|2|||
124907298|NCT03401112|449285801|FG004|Overall Study|Physician Decision|0|||
124907299|NCT03401112|449285797|FG000|Overall Study|Study was Terminated by Sponsor|0|||
124907300|NCT03401112|449285798|FG001|Overall Study|Study was Terminated by Sponsor|0|||
124691765|NCT01871727|448492258|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
124691766|NCT01871727|448492259|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
124691767|NCT01871727|448492260|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
124691768|NCT01871727|448492261|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
124907301|NCT03401112|449285799|FG002|Overall Study|Study was Terminated by Sponsor|0|||
124907302|NCT03401112|449285800|FG003|Overall Study|Study was Terminated by Sponsor|1|||
124907303|NCT03401112|449285801|FG004|Overall Study|Study was Terminated by Sponsor|0|||
124907304|NCT03401112|449285797|FG000|Overall Study|Day 1 Assessment not Done|1|||
124907305|NCT03401112|449285798|FG001|Overall Study|Day 1 Assessment not Done|0|||
124907306|NCT03401112|449285799|FG002|Overall Study|Day 1 Assessment not Done|0|||
124907307|NCT03401112|449285800|FG003|Overall Study|Day 1 Assessment not Done|0|||
124907308|NCT03401112|449285801|FG004|Overall Study|Day 1 Assessment not Done|0|||
124907309|NCT03401112|449285797|FG000|Overall Study|Not Dosed|0|||
124907310|NCT03401112|449285798|FG001|Overall Study|Not Dosed|0|||
124907311|NCT03401112|449285799|FG002|Overall Study|Not Dosed|1|||
124907312|NCT03401112|449285800|FG003|Overall Study|Not Dosed|0|||
124907313|NCT03401112|449285801|FG004|Overall Study|Not Dosed|0|||
124907314|NCT03401112|449285797|FG000|Overall Study|Missed Clinical Visit|0|||
124907315|NCT03401112|449285798|FG001|Overall Study|Missed Clinical Visit|0|||
124907316|NCT03401112|449285799|FG002|Overall Study|Missed Clinical Visit|1|||
124907317|NCT03401112|449285800|FG003|Overall Study|Missed Clinical Visit|0|||
124907318|NCT03401112|449285801|FG004|Overall Study|Missed Clinical Visit|0|||
124907319|NCT03401112|449285797|FG000|Overall Study|Missed Doses|0|||
124907320|NCT03401112|449285798|FG001|Overall Study|Missed Doses|0|||
124907321|NCT03401112|449285799|FG002|Overall Study|Missed Doses|1|||
124907322|NCT03401112|449285800|FG003|Overall Study|Missed Doses|0|||
124907323|NCT03401112|449285801|FG004|Overall Study|Missed Doses|0|||
124907324|NCT03475316|449285802|FG000|6 Month Intervention|Adverse Event|2|||
124907325|NCT03475316|449285803|FG001|6 Month Intervention|Adverse Event|1|||
124907326|NCT03475316|449285802|FG000|6 Month Intervention|Withdrawal by Subject|2|||
124907327|NCT03475316|449285803|FG001|6 Month Intervention|Withdrawal by Subject|0|||
124907328|NCT03475316|449285802|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
124907329|NCT03475316|449285803|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
124907330|NCT03475316|449285802|FG000|9 Months|Study stopped due to COVID pandemic|3|||
124907331|NCT03475316|449285803|FG001|9 Months|Study stopped due to COVID pandemic|4|||
124907332|NCT00424645|449285804|FG000|Overall Study|Death|1|||
124907333|NCT00424645|449285805|FG001|Overall Study|Death|0|||
124907334|NCT02555215|449285806|FG000|Overall Study|Other|1|||
124907335|NCT02555215|449285806|FG000|Overall Study|Investigator Decision|2|||
124907336|NCT00529789|449285807|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
124907337|NCT00529789|449285807|FG000|Study Period II/III|Adverse Event|3|||
124907338|NCT00529789|449285807|FG000|Study Period II/III|Lack of Efficacy|2|||
124907339|NCT00529789|449285807|FG000|Study Period II/III|Withdrawal by Subject|1|||
124907340|NCT00529789|449285807|FG000|Study Period II/III|Protocol Violation|3|||
124907341|NCT00529789|449285807|FG000|Study Period II/III|Physician Decision|3|||
124907342|NCT00529789|449285807|FG000|Study Period II/III|Lost to Follow-up|3|||
124907343|NCT00529789|449285807|FG000|Study Period IV|Parent/Caregiver Decision|1|||
124907344|NCT00529789|449285807|FG000|Study Period IV|Adverse Event|1|||
124907345|NCT00529789|449285807|FG000|Study Period IV|Lack of Efficacy|1|||
124907346|NCT00529789|449285807|FG000|Study Period IV|Lost to Follow-up|3|||
124907347|NCT01430611|449285808|FG000|Overall Study|Adverse Event|0|||
124907348|NCT01430611|449285809|FG001|Overall Study|Adverse Event|1|||
124907349|NCT01430611|449285808|FG000|Overall Study|Protocol Violation|1|||
124907350|NCT01430611|449285809|FG001|Overall Study|Protocol Violation|0|||
124907351|NCT01430611|449285808|FG000|Overall Study|Lost to Follow-up|1|||
124907352|NCT01430611|449285809|FG001|Overall Study|Lost to Follow-up|0|||
124907353|NCT01430611|449285808|FG000|Overall Study|Withdrawal by Subject|15|||
124907354|NCT01430611|449285809|FG001|Overall Study|Withdrawal by Subject|14|||
124907355|NCT00959946|449285810|FG000|Overall Study|Adverse Event|0|||
124907356|NCT00959946|449285811|FG001|Overall Study|Adverse Event|0|||
124907357|NCT00959946|449285812|FG002|Overall Study|Adverse Event|2|||
124907358|NCT00959946|449285813|FG003|Overall Study|Adverse Event|1|||
124907359|NCT00959946|449285814|FG004|Overall Study|Adverse Event|0|||
124907360|NCT00959946|449285815|FG005|Overall Study|Adverse Event|1|||
124907361|NCT00959946|449285816|FG006|Overall Study|Adverse Event|0|||
124907362|NCT00959946|449285817|FG007|Overall Study|Adverse Event|0|||
124907363|NCT00959946|449285810|FG000|Overall Study|Death|0|||
124907364|NCT00959946|449285811|FG001|Overall Study|Death|0|||
124907365|NCT00959946|449285812|FG002|Overall Study|Death|0|||
124907366|NCT00959946|449285813|FG003|Overall Study|Death|0|||
124907367|NCT00959946|449285814|FG004|Overall Study|Death|0|||
124449897|NCT02632721|447609604|FG002|Overall Study|No benefit from study treatment|0|||
124449898|NCT02632721|447609605|FG003|Overall Study|No benefit from study treatment|0|||
124449899|NCT02632721|447609606|FG004|Overall Study|No benefit from study treatment|1|||
124449900|NCT02632721|447609602|FG000|Overall Study|Patient wish for other treatment|0|||
124449901|NCT02632721|447609603|FG001|Overall Study|Patient wish for other treatment|1|||
124449902|NCT02632721|447609604|FG002|Overall Study|Patient wish for other treatment|0|||
124449903|NCT02632721|447609605|FG003|Overall Study|Patient wish for other treatment|0|||
124449904|NCT02632721|447609606|FG004|Overall Study|Patient wish for other treatment|0|||
124449905|NCT02632721|447609602|FG000|Overall Study|Relapsed Pneumonia|0|||
124449906|NCT02632721|447609603|FG001|Overall Study|Relapsed Pneumonia|0|||
124449907|NCT02632721|447609604|FG002|Overall Study|Relapsed Pneumonia|0|||
124907368|NCT00959946|449285815|FG005|Overall Study|Death|1|||
124907369|NCT00959946|449285816|FG006|Overall Study|Death|0|||
124907370|NCT00959946|449285817|FG007|Overall Study|Death|0|||
124907371|NCT00959946|449285810|FG000|Overall Study|Disease Progression|2|||
124907372|NCT00959946|449285811|FG001|Overall Study|Disease Progression|4|||
124907373|NCT00959946|449285812|FG002|Overall Study|Disease Progression|2|||
124907374|NCT00959946|449285813|FG003|Overall Study|Disease Progression|4|||
124907375|NCT00959946|449285814|FG004|Overall Study|Disease Progression|4|||
124907376|NCT00959946|449285815|FG005|Overall Study|Disease Progression|6|||
124449908|NCT02632721|447609605|FG003|Overall Study|Relapsed Pneumonia|0|||
124907377|NCT00959946|449285816|FG006|Overall Study|Disease Progression|2|||
124907378|NCT00959946|449285817|FG007|Overall Study|Disease Progression|2|||
124907379|NCT00959946|449285810|FG000|Overall Study|Withdrawal by Subject|0|||
124907380|NCT00959946|449285811|FG001|Overall Study|Withdrawal by Subject|0|||
124907381|NCT00959946|449285812|FG002|Overall Study|Withdrawal by Subject|0|||
124907382|NCT00959946|449285813|FG003|Overall Study|Withdrawal by Subject|0|||
124907383|NCT00959946|449285814|FG004|Overall Study|Withdrawal by Subject|0|||
124907384|NCT00959946|449285815|FG005|Overall Study|Withdrawal by Subject|1|||
124907385|NCT00959946|449285816|FG006|Overall Study|Withdrawal by Subject|0|||
124907386|NCT00959946|449285817|FG007|Overall Study|Withdrawal by Subject|0|||
124907387|NCT01202955|449285820|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
124907388|NCT01202955|449285821|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
124907389|NCT02115139|449285822|FG000|Overall Study|Protocol Violation|1|||
124907390|NCT02115139|449285822|FG000|Overall Study|treatment discontinuation|6|||
124907391|NCT01909778|449285823|FG000|Overall Study|failed screening|1|||
124907392|NCT02471755|449285825|FG000|Overall Study|Withdrawal by Subject|1|||
124907393|NCT02471755|449285826|FG001|Overall Study|Withdrawal by Subject|0|||
124907394|NCT02471755|449285825|FG000|Overall Study|Lost to Follow-up|0|||
124907395|NCT02471755|449285826|FG001|Overall Study|Lost to Follow-up|1|||
124907396|NCT04740164|449285830|FG000|Overall Study|Lack of Efficacy|4|||
124907397|NCT04740164|449285831|FG001|Overall Study|Lack of Efficacy|0|||
124907398|NCT04740164|449285830|FG000|Overall Study|Physician Decision|3|||
124907399|NCT04740164|449285831|FG001|Overall Study|Physician Decision|3|||
124907400|NCT05323734|449285832|FG000|Overall Study|Adverse Event|5|||
124907401|NCT05323734|449285833|FG001|Overall Study|Adverse Event|2|||
124907402|NCT05323734|449285832|FG000|Overall Study|Physician Decision|1|||
124907403|NCT05323734|449285833|FG001|Overall Study|Physician Decision|0|||
124907404|NCT05323734|449285832|FG000|Overall Study|Lack of Efficacy|1|||
124907405|NCT05323734|449285833|FG001|Overall Study|Lack of Efficacy|2|||
124907406|NCT05323734|449285832|FG000|Overall Study|Withdrawal by Subject|2|||
124907407|NCT05323734|449285833|FG001|Overall Study|Withdrawal by Subject|0|||
124907408|NCT05323734|449285832|FG000|Overall Study|Participant Withdrawn Due|0|||
124907409|NCT05323734|449285833|FG001|Overall Study|Participant Withdrawn Due|1|||
124907410|NCT02486718|449285834|FG000|Enrollment Phase|Death|19|||
124907411|NCT02486718|449285835|FG001|Enrollment Phase|Death|0|||
124907412|NCT02486718|449285836|FG002|Enrollment Phase|Death|0|||
124907413|NCT02486718|449285834|FG000|Enrollment Phase|Symptomatic deterioration|1|||
124907414|NCT02486718|449285835|FG001|Enrollment Phase|Symptomatic deterioration|0|||
124907415|NCT02486718|449285836|FG002|Enrollment Phase|Symptomatic deterioration|0|||
124907416|NCT02486718|449285834|FG000|Enrollment Phase|Withdrawal by Subject|86|||
124907417|NCT02486718|449285835|FG001|Enrollment Phase|Withdrawal by Subject|0|||
124907418|NCT02486718|449285836|FG002|Enrollment Phase|Withdrawal by Subject|0|||
124907419|NCT02486718|449285834|FG000|Enrollment Phase|Protocol Violation|18|||
124907420|NCT02486718|449285835|FG001|Enrollment Phase|Protocol Violation|0|||
124907421|NCT02486718|449285836|FG002|Enrollment Phase|Protocol Violation|0|||
124907422|NCT02486718|449285834|FG000|Enrollment Phase|Physician Decision|18|||
124907423|NCT02486718|449285835|FG001|Enrollment Phase|Physician Decision|0|||
124907424|NCT02486718|449285836|FG002|Enrollment Phase|Physician Decision|0|||
124907425|NCT02486718|449285834|FG000|Enrollment Phase|Reason not provided|41|||
124907426|NCT02486718|449285835|FG001|Enrollment Phase|Reason not provided|0|||
124907427|NCT02486718|449285836|FG002|Enrollment Phase|Reason not provided|0|||
124907428|NCT02486718|449285834|FG000|Enrollment Phase|Disease relapse|54|||
124907429|NCT02486718|449285835|FG001|Enrollment Phase|Disease relapse|0|||
124907430|NCT02486718|449285836|FG002|Enrollment Phase|Disease relapse|0|||
124907431|NCT02486718|449285834|FG000|Enrollment Phase|Lost to Follow-up|4|||
124449909|NCT02632721|447609606|FG004|Overall Study|Relapsed Pneumonia|1|||
124691769|NCT01871727|448492257|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
124691770|NCT01871727|448492258|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
124691771|NCT01871727|448492259|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
124691772|NCT01871727|448492260|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
124691773|NCT01871727|448492261|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
124691774|NCT01871727|448492257|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
124691775|NCT01871727|448492258|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
124691776|NCT01871727|448492259|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
124691777|NCT01871727|448492260|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
124691778|NCT01871727|448492261|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
124907432|NCT02486718|449285835|FG001|Enrollment Phase|Lost to Follow-up|0|||
124907433|NCT02486718|449285836|FG002|Enrollment Phase|Lost to Follow-up|0|||
124907434|NCT02486718|449285834|FG000|Enrollment Phase|Adverse Event|34|||
124907435|NCT02486718|449285835|FG001|Enrollment Phase|Adverse Event|0|||
124907436|NCT02486718|449285836|FG002|Enrollment Phase|Adverse Event|0|||
124907437|NCT02486718|449285834|FG000|Randomized Phase|Withdrawal by Subject|0|||
124907438|NCT02486718|449285835|FG001|Randomized Phase|Withdrawal by Subject|44|||
124907439|NCT02486718|449285836|FG002|Randomized Phase|Withdrawal by Subject|47|||
124907440|NCT02486718|449285834|FG000|Randomized Phase|Protocol Violation|0|||
124907441|NCT02486718|449285835|FG001|Randomized Phase|Protocol Violation|2|||
124907442|NCT02486718|449285836|FG002|Randomized Phase|Protocol Violation|0|||
124907443|NCT02486718|449285834|FG000|Randomized Phase|Physician Decision|0|||
124907444|NCT02486718|449285835|FG001|Randomized Phase|Physician Decision|0|||
124907445|NCT02486718|449285836|FG002|Randomized Phase|Physician Decision|3|||
124691779|NCT00309244|448492262|FG000|Overall Study|Adverse Event|29|||
124691780|NCT00309244|448492263|FG001|Overall Study|Adverse Event|12|||
124907446|NCT02486718|449285834|FG000|Randomized Phase|Lost to Follow-up|0|||
124907447|NCT02486718|449285835|FG001|Randomized Phase|Lost to Follow-up|5|||
124907448|NCT02486718|449285836|FG002|Randomized Phase|Lost to Follow-up|11|||
124907449|NCT02486718|449285834|FG000|Randomized Phase|Disease Relapse|0|||
124907450|NCT02486718|449285835|FG001|Randomized Phase|Disease Relapse|1|||
124907451|NCT02486718|449285836|FG002|Randomized Phase|Disease Relapse|0|||
124907452|NCT02486718|449285834|FG000|Randomized Phase|Death|0|||
124907453|NCT02486718|449285835|FG001|Randomized Phase|Death|154|||
124907454|NCT02486718|449285836|FG002|Randomized Phase|Death|155|||
124907455|NCT02486718|449285834|FG000|Randomized Phase|Ongoing|0|||
124907456|NCT02486718|449285835|FG001|Randomized Phase|Ongoing|301|||
124907457|NCT02486718|449285836|FG002|Randomized Phase|Ongoing|282|||
124907458|NCT02248480|449285837|FG000|Overall Study|Lack of Efficacy|4|||
124907459|NCT02248480|449285838|FG001|Overall Study|Lack of Efficacy|6|||
124907460|NCT02248480|449285837|FG000|Overall Study|Adverse Event|11|||
124907461|NCT02248480|449285838|FG001|Overall Study|Adverse Event|2|||
124907462|NCT02248480|449285837|FG000|Overall Study|Withdrawal by Subject|2|||
124907463|NCT02248480|449285838|FG001|Overall Study|Withdrawal by Subject|4|||
124907464|NCT02248480|449285837|FG000|Overall Study|Entry Criteria Not Met|0|||
124907465|NCT02248480|449285838|FG001|Overall Study|Entry Criteria Not Met|1|||
124907466|NCT02248480|449285837|FG000|Overall Study|Other:Physician Decision|0|||
124907467|NCT02248480|449285838|FG001|Overall Study|Other:Physician Decision|1|||
124907468|NCT01595321|449285839|FG000|Overall Study|Adverse Event|1|||
124907469|NCT01595321|449285840|FG001|Overall Study|Adverse Event|1|||
124907470|NCT01595321|449285841|FG002|Overall Study|Adverse Event|1|||
124907471|NCT01595321|449285839|FG000|Overall Study|Lack of Efficacy|0|||
124907472|NCT01595321|449285840|FG001|Overall Study|Lack of Efficacy|0|||
124907473|NCT01595321|449285841|FG002|Overall Study|Lack of Efficacy|4|||
124907474|NCT04504916|449285842|FG000|Overall Study|Study terminated|7|||
124907475|NCT04504916|449285843|FG001|Overall Study|Study terminated|8|||
124907476|NCT04504916|449285842|FG000|Overall Study|Death|54|||
124907477|NCT04504916|449285843|FG001|Overall Study|Death|18|||
124907478|NCT04504916|449285842|FG000|Overall Study|Lost to Follow-up|1|||
124907479|NCT04504916|449285843|FG001|Overall Study|Lost to Follow-up|1|||
124907480|NCT04504916|449285842|FG000|Overall Study|Withdrawal by Subject|8|||
124907481|NCT04504916|449285843|FG001|Overall Study|Withdrawal by Subject|4|||
124907482|NCT04504916|449285842|FG000|Overall Study|Did not agree to follow-up|0|||
124907483|NCT04504916|449285843|FG001|Overall Study|Did not agree to follow-up|1|||
124907484|NCT00373529|449285845|FG000|Overall Study|Physician Decision|19|||
124907485|NCT00373529|449285845|FG000|Overall Study|Withdrawal by Subject|7|||
124907486|NCT00373529|449285845|FG000|Overall Study|Adverse Event|7|||
124907487|NCT00373529|449285845|FG000|Overall Study|Treatment failure|36|||
124907488|NCT00373529|449285845|FG000|Overall Study|Disease recurrence|10|||
124907489|NCT00373529|449285845|FG000|Overall Study|Death|16|||
124907490|NCT00373529|449285845|FG000|Overall Study|Need for treatment prohibited by study|1|||
124907491|NCT00373529|449285845|FG000|Overall Study|Other|8|||
124907492|NCT00373529|449285845|FG000|Overall Study|Failed independent confirmation of AML|3|||
124907493|NCT00373529|449285845|FG000|Overall Study|Consent violation|1|||
124907494|NCT01579916|449285847|FG000|Overall Study|Lost to Follow-up|6|||
124907495|NCT01579916|449285848|FG001|Overall Study|Lost to Follow-up|1|||
124907496|NCT01579916|449285847|FG000|Overall Study|Withdrawal by Subject|1|||
124907497|NCT01579916|449285848|FG001|Overall Study|Withdrawal by Subject|1|||
124907498|NCT01579916|449285847|FG000|Overall Study|Death|1|||
124907499|NCT01579916|449285848|FG001|Overall Study|Death|0|||
124907500|NCT00732381|449285854|FG000|Overall Study|Adverse Event|1|||
124907501|NCT00732381|449285855|FG001|Overall Study|Adverse Event|0|||
124907502|NCT00732381|449285854|FG000|Overall Study|Treatment Failure|1|||
124449910|NCT02632721|447609602|FG000|Overall Study|Therapy refractory AML|0|||
124449911|NCT02632721|447609603|FG001|Overall Study|Therapy refractory AML|0|||
124449912|NCT02632721|447609604|FG002|Overall Study|Therapy refractory AML|0|||
124449913|NCT02632721|447609605|FG003|Overall Study|Therapy refractory AML|0|||
124449914|NCT02632721|447609606|FG004|Overall Study|Therapy refractory AML|1|||
124449915|NCT02632721|447609602|FG000|Overall Study|Increase of white blood cell count|0|||
124691781|NCT00309244|448492262|FG000|Overall Study|Lost to Follow-up|6|||
124907503|NCT00732381|449285855|FG001|Overall Study|Treatment Failure|1|||
124691782|NCT00309244|448492263|FG001|Overall Study|Lost to Follow-up|22|||
124691783|NCT00309244|448492262|FG000|Overall Study|Physician Decision|5|||
124907504|NCT00457691|449285857|FG000|Overall Study|Adverse Event|4|||
124907505|NCT00457691|449285858|FG001|Overall Study|Adverse Event|1|||
124907506|NCT00457691|449285857|FG000|Overall Study|Death|163|||
124907507|NCT00457691|449285858|FG001|Overall Study|Death|148|||
124907508|NCT00457691|449285857|FG000|Overall Study|Protocol Violation|1|||
124907509|NCT00457691|449285858|FG001|Overall Study|Protocol Violation|3|||
124907510|NCT00457691|449285857|FG000|Overall Study|Lost to Follow-up|23|||
124907511|NCT00457691|449285858|FG001|Overall Study|Lost to Follow-up|14|||
124907512|NCT00457691|449285857|FG000|Overall Study|Study terminated by Sponsor|1|||
124907513|NCT00457691|449285858|FG001|Overall Study|Study terminated by Sponsor|1|||
124907514|NCT00457691|449285857|FG000|Overall Study|Subject refused (reason other than AE)|14|||
124449916|NCT02632721|447609603|FG001|Overall Study|Increase of white blood cell count|0|||
124449917|NCT02632721|447609604|FG002|Overall Study|Increase of white blood cell count|0|||
124449918|NCT02632721|447609605|FG003|Overall Study|Increase of white blood cell count|0|||
124449919|NCT02632721|447609606|FG004|Overall Study|Increase of white blood cell count|1|||
124449920|NCT02632721|447609602|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
124449921|NCT02632721|447609603|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
124449922|NCT02632721|447609604|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
124449923|NCT02632721|447609605|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
124449924|NCT02632721|447609606|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
124449925|NCT02921269|447609613|FG000|Overall Study|Did not complete DLT period|1|||
124449926|NCT02054325|447609614|FG000|Overall Study|Lost to Follow-up|8|||
124449927|NCT02054325|447609615|FG001|Overall Study|Lost to Follow-up|5|||
124449928|NCT02322229|447609618|FG000|Overall Study|Physician Decision|2|||
124449929|NCT03250832|447609619|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
124449930|NCT03250832|447609620|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
124449931|NCT03250832|447609621|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
124449932|NCT03250832|447609622|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
124449933|NCT03250832|447609623|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
124449934|NCT03250832|447609624|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
124449935|NCT03250832|447609625|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
124449936|NCT03250832|447609626|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
124449937|NCT03250832|447609627|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
124449938|NCT03250832|447609628|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
124449939|NCT03250832|447609629|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
124449940|NCT03250832|447609630|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
124449941|NCT03250832|447609619|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
124449942|NCT03250832|447609620|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
124449943|NCT03250832|447609621|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
124449944|NCT03250832|447609622|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
124449945|NCT03250832|447609623|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
124449946|NCT03250832|447609624|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
124449947|NCT03250832|447609625|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
124449948|NCT03250832|447609626|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
124449949|NCT03250832|447609627|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
124449950|NCT03250832|447609628|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
124449951|NCT03250832|447609629|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
124449952|NCT03250832|447609630|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
124449953|NCT03250832|447609619|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
124449954|NCT03250832|447609620|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
124449955|NCT03250832|447609621|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
124449956|NCT03250832|447609622|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
124449957|NCT03250832|447609623|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
124449958|NCT03250832|447609624|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
124449959|NCT03250832|447609625|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
124449960|NCT03250832|447609626|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
124449961|NCT03250832|447609627|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
124449962|NCT03250832|447609628|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
124449963|NCT03250832|447609629|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
124449964|NCT03250832|447609630|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
124449965|NCT03250832|447609619|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
124449966|NCT03250832|447609620|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
124449967|NCT03250832|447609621|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
124449968|NCT03250832|447609622|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
124907515|NCT00457691|449285858|FG001|Overall Study|Subject refused (reason other than AE)|19|||
124907516|NCT00457691|449285857|FG000|Overall Study|Disease progression, study terminated|180|||
124907517|NCT00457691|449285858|FG001|Overall Study|Disease progression, study terminated|196|||
124907518|NCT01121549|449285863|FG000|Overall Study|Adverse Event|10|||
124907519|NCT01121549|449285863|FG000|Overall Study|Lack of Efficacy|11|||
124907520|NCT01121549|449285863|FG000|Overall Study|Lost to Follow-up|12|||
124907521|NCT01121549|449285863|FG000|Overall Study|Did not meet entrance criteria|9|||
124907522|NCT01121549|449285863|FG000|Overall Study|Study terminated by sponsor|197|||
124907523|NCT01121549|449285863|FG000|Overall Study|Pregnancy|1|||
124907524|NCT01121549|449285863|FG000|Overall Study|Protocol Violation|33|||
124907525|NCT01121549|449285863|FG000|Overall Study|Withdrawal by Subject|16|||
124907526|NCT01121549|449285863|FG000|Overall Study|Other|58|||
124449969|NCT03250832|447609623|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
124907527|NCT00493649|449286735|FG000|Overall Study|Adverse Event|44|||
124907528|NCT00493649|449286735|FG000|Overall Study|Patient Request|21|||
124907529|NCT00493649|449286735|FG000|Overall Study|Investigator Request|2|||
124907530|NCT00493649|449286735|FG000|Overall Study|Disease Progression|1|||
124907531|NCT00493649|449286735|FG000|Overall Study|Lost to Follow-up|1|||
124907532|NCT00493649|449286735|FG000|Overall Study|Other|13|||
124907533|NCT05219253|449286736|FG000|Overall Study|Withdrawal by Subject|1|||
124449970|NCT03250832|447609624|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
124449971|NCT03250832|447609625|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
124449972|NCT03250832|447609626|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
124449973|NCT03250832|447609627|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
124449974|NCT03250832|447609628|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
124449975|NCT03250832|447609629|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
124449976|NCT03250832|447609630|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
124449977|NCT03250832|447609619|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
124449978|NCT03250832|447609620|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
124449979|NCT03250832|447609621|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
124449980|NCT03250832|447609622|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
124449981|NCT03250832|447609623|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
124449982|NCT03250832|447609624|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
124449983|NCT03250832|447609625|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
124449984|NCT03250832|447609626|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
124449985|NCT03250832|447609627|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
124449986|NCT03250832|447609628|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
124907534|NCT05219253|449286737|FG001|Overall Study|Withdrawal by Subject|2|||
124907535|NCT03086369|449286738|FG000|Overall Study|Lost to Follow-up|1|||
124907536|NCT03086369|449286739|FG001|Overall Study|Lost to Follow-up|0|||
124907537|NCT03086369|449286740|FG002|Overall Study|Lost to Follow-up|0|||
124907538|NCT03086369|449286741|FG003|Overall Study|Lost to Follow-up|2|||
124907539|NCT03086369|449286742|FG004|Overall Study|Lost to Follow-up|1|||
124907540|NCT03086369|449286738|FG000|Overall Study|Physician Decision|0|||
124907541|NCT03086369|449286739|FG001|Overall Study|Physician Decision|0|||
124449987|NCT03250832|447609629|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
124449988|NCT03250832|447609630|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
124449989|NCT03250832|447609619|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
124449990|NCT03250832|447609620|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
124907542|NCT03086369|449286740|FG002|Overall Study|Physician Decision|0|||
124907543|NCT03086369|449286741|FG003|Overall Study|Physician Decision|1|||
124907544|NCT03086369|449286742|FG004|Overall Study|Physician Decision|2|||
124907545|NCT03086369|449286738|FG000|Overall Study|Withdrawal by Subject|0|||
124907546|NCT03086369|449286739|FG001|Overall Study|Withdrawal by Subject|0|||
124907547|NCT03086369|449286740|FG002|Overall Study|Withdrawal by Subject|0|||
124907548|NCT03086369|449286741|FG003|Overall Study|Withdrawal by Subject|5|||
124907549|NCT03086369|449286742|FG004|Overall Study|Withdrawal by Subject|3|||
124907550|NCT03086369|449286738|FG000|Overall Study|Progressive Disease|0|||
124907551|NCT03086369|449286739|FG001|Overall Study|Progressive Disease|0|||
124907552|NCT03086369|449286740|FG002|Overall Study|Progressive Disease|0|||
124907553|NCT03086369|449286741|FG003|Overall Study|Progressive Disease|1|||
124907554|NCT03086369|449286742|FG004|Overall Study|Progressive Disease|1|||
124907555|NCT04603924|449286745|FG000|Overall Study|Not Dosed|2|||
124907556|NCT04603924|449286746|FG001|Overall Study|Not Dosed|1|||
124907557|NCT04603924|449286745|FG000|Overall Study|Withdrawal by Subject|6|||
124907558|NCT04603924|449286746|FG001|Overall Study|Withdrawal by Subject|6|||
124907559|NCT04603924|449286745|FG000|Overall Study|Adverse Event|2|||
124907560|NCT04603924|449286746|FG001|Overall Study|Adverse Event|2|||
124907561|NCT01765543|449286749|FG000|Overall Study|Death|1|||
124907562|NCT01765543|449286749|FG000|Overall Study|Withdrawal by Subject|2|||
124907563|NCT05876949|449286750|FG000|Overall Study|Withdrawal by Subject|1|||
124907564|NCT05876949|449286751|FG001|Overall Study|Withdrawal by Subject|3|||
124907565|NCT05876949|449286750|FG000|Overall Study|Physician Decision|0|||
124907566|NCT05876949|449286751|FG001|Overall Study|Physician Decision|2|||
124907567|NCT05876949|449286750|FG000|Overall Study|Death|0|||
124907568|NCT05876949|449286751|FG001|Overall Study|Death|1|||
124907569|NCT03644849|449286752|FG000|Overall Study|Lost to Follow-up|1|||
124907570|NCT03644849|449286753|FG001|Overall Study|Lost to Follow-up|3|||
124907571|NCT00071799|449286754|FG000|Overall Study|Adverse Event|19|||
124907572|NCT00071799|449286755|FG001|Overall Study|Adverse Event|10|||
124907573|NCT00071799|449286754|FG000|Overall Study|Protocol Violation|1|||
124907574|NCT00071799|449286755|FG001|Overall Study|Protocol Violation|7|||
124907575|NCT00071799|449286754|FG000|Overall Study|Lost to Follow-up|1|||
124907576|NCT00071799|449286755|FG001|Overall Study|Lost to Follow-up|1|||
124907577|NCT00071799|449286754|FG000|Overall Study|Withdrawal by Subject|15|||
124907578|NCT00071799|449286755|FG001|Overall Study|Withdrawal by Subject|37|||
124907579|NCT00071799|449286754|FG000|Overall Study|Physician Decision|0|||
124907580|NCT00071799|449286755|FG001|Overall Study|Physician Decision|2|||
124907581|NCT00071799|449286754|FG000|Overall Study|Lack of Efficacy|11|||
124907582|NCT00071799|449286755|FG001|Overall Study|Lack of Efficacy|18|||
124907583|NCT00071799|449286754|FG000|Overall Study|Disease Progression|23|||
124907584|NCT00071799|449286755|FG001|Overall Study|Disease Progression|20|||
124907585|NCT00071799|449286754|FG000|Overall Study|Different Central+Local Pathology Review|0|||
124907586|NCT00071799|449286755|FG001|Overall Study|Different Central+Local Pathology Review|1|||
124907587|NCT00071799|449286754|FG000|Overall Study|Not Documented|0|||
124907588|NCT00071799|449286755|FG001|Overall Study|Not Documented|2|||
124907589|NCT00979992|449286756|FG000|Overall Study|Ineligible - inadequate pathology|1|||
124907590|NCT00979992|449286756|FG000|Overall Study|Ineligible - wrong cell type|2|||
124907591|NCT00979992|449286756|FG000|Overall Study|Refused - Never Treated|2|||
124907592|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
124907593|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
124907594|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
124907595|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
124907596|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
124907597|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
124907598|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
124907599|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
124907600|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
124907601|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
124907602|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
124907603|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
124907604|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
124907605|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
124907606|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
124907607|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
124907608|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
124907609|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
124907610|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
124907611|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
124907612|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
124907613|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
124907614|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
124907615|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
124907616|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
124907617|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
124907618|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
124760272|NCT01894607|448746836|FG000|Overall Study|Ineligible|1|||
124760273|NCT03259555|448746851|FG000|Overall Study|Adverse Event|6|||
124760274|NCT03259555|448746852|FG001|Overall Study|Adverse Event|4|||
124760275|NCT03259555|448746851|FG000|Overall Study|Lack of Efficacy|6|||
124760276|NCT03259555|448746852|FG001|Overall Study|Lack of Efficacy|4|||
124760277|NCT03259555|448746851|FG000|Overall Study|Lost to Follow-up|0|||
124760278|NCT03259555|448746852|FG001|Overall Study|Lost to Follow-up|2|||
124760279|NCT03259555|448746851|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124760280|NCT03259555|448746852|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124760281|NCT03259555|448746851|FG000|Overall Study|Progressive Disease|0|||
124760282|NCT03259555|448746852|FG001|Overall Study|Progressive Disease|2|||
124760283|NCT03259555|448746851|FG000|Overall Study|Withdrawal by Subject|19|||
124760284|NCT03259555|448746852|FG001|Overall Study|Withdrawal by Subject|16|||
124760285|NCT03259555|448746851|FG000|Overall Study|Physician Decision|1|||
124760286|NCT03259555|448746852|FG001|Overall Study|Physician Decision|2|||
124907619|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
124760287|NCT03259555|448746851|FG000|Overall Study|Other|1|||
124760288|NCT03259555|448746852|FG001|Overall Study|Other|0|||
124760289|NCT04393493|448746853|FG000|First 4 Days of Intervention|Early improvement|5|||
124907620|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
124907621|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
124907622|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
124907623|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
124907624|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
124907625|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
124907626|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
124907627|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
124907628|NCT03593213|449286757|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
124907629|NCT03593213|449286758|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
124907630|NCT03593213|449286759|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
124907631|NCT03593213|449286760|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
124907632|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
124907633|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
124907634|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
124907635|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
124907636|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
124907637|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
124907638|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
124907639|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
124907640|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
124907641|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
124907642|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
124907643|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
124907644|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
124907645|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
124907646|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
124907647|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
124907648|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
124907649|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
124907650|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
124907651|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
124907652|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
124907653|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
124907654|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
124907655|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
124907656|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
124907657|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
124907658|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
124907659|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
124691784|NCT00309244|448492263|FG001|Overall Study|Physician Decision|8|||
124691785|NCT00309244|448492262|FG000|Overall Study|Protocol Violation|6|||
124691786|NCT00309244|448492263|FG001|Overall Study|Protocol Violation|3|||
124691787|NCT00309244|448492262|FG000|Overall Study|Withdrawal by Subject|50|||
124691788|NCT00309244|448492263|FG001|Overall Study|Withdrawal by Subject|32|||
124691789|NCT00309244|448492262|FG000|Overall Study|Various|7|||
124691790|NCT00309244|448492263|FG001|Overall Study|Various|7|||
124691791|NCT00309244|448492262|FG000|Overall Study|Randomized but not dosed|11|||
124691792|NCT00309244|448492263|FG001|Overall Study|Randomized but not dosed|12|||
124691793|NCT00309244|448492262|FG000|Overall Study|Death|4|||
124691794|NCT00309244|448492263|FG001|Overall Study|Death|1|||
124691795|NCT01263028|448492264|FG000|Overall Study|Withdrawal by Subject|1|||
124691796|NCT01263028|448492264|FG000|Overall Study|Adverse Event|1|||
124691797|NCT01263028|448492264|FG000|Overall Study|Study terminated due to low enrollment.|4|||
124691798|NCT03019588|448492265|FG000|Overall Study|Death|44|||
124691799|NCT03019588|448492266|FG001|Overall Study|Death|46|||
124691800|NCT03019588|448492265|FG000|Overall Study|Study terminated by Sponsor|3|||
124691801|NCT03019588|448492266|FG001|Overall Study|Study terminated by Sponsor|1|||
124907660|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
124907661|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
124907662|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
124907663|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
124907664|NCT03593213|449286757|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
124907665|NCT03593213|449286758|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
124907666|NCT03593213|449286759|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
124907667|NCT03593213|449286760|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
124907668|NCT01254019|449286763|FG000|Overall Study|Adverse Event|0|||
124907669|NCT01254019|449286764|FG001|Overall Study|Adverse Event|2|||
124907670|NCT01254019|449286763|FG000|Overall Study|Protocol Violation|1|||
124907671|NCT01254019|449286764|FG001|Overall Study|Protocol Violation|0|||
124907672|NCT01254019|449286763|FG000|Overall Study|Withdrawal by Subject|0|||
124907673|NCT01254019|449286764|FG001|Overall Study|Withdrawal by Subject|2|||
124907674|NCT00665444|449286769|FG000|Overall Study|Physician Decision|1|||
124907675|NCT00665444|449286769|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
124907676|NCT00638963|449286771|FG000|Overall Study|Withdrawal by Subject|1|||
124907677|NCT00638963|449286772|FG001|Overall Study|Withdrawal by Subject|0|||
124907678|NCT03260140|449286774|FG000|Overall Study|Death|4|||
124907679|NCT03260140|449286775|FG001|Overall Study|Death|1|||
124907680|NCT03260140|449286774|FG000|Overall Study|Withdrawal by Subject|1|||
124907681|NCT03260140|449286775|FG001|Overall Study|Withdrawal by Subject|4|||
124907682|NCT01444417|449286776|FG000|Overall Study|Ineligibility Determined|0|||
124907683|NCT01444417|449286777|FG001|Overall Study|Ineligibility Determined|1|||
124907684|NCT01444417|449286776|FG000|Overall Study|Withdrawal by Subject|2|||
124907685|NCT01444417|449286777|FG001|Overall Study|Withdrawal by Subject|0|||
124907686|NCT02423291|449286778|FG000|Overall Study|Lack of Efficacy|14|||
124907687|NCT02423291|449286778|FG000|Overall Study|Adverse Event|1|||
124907688|NCT05283395|449286782|FG000|Overall Study|Adverse Event|4|||
124907689|NCT05283395|449286783|FG001|Overall Study|Adverse Event|4|||
124907690|NCT05283395|449286784|FG002|Overall Study|Adverse Event|0|||
124907691|NCT05283395|449286782|FG000|Overall Study|Patient Lost to Follow-Up|0|||
124907692|NCT05283395|449286783|FG001|Overall Study|Patient Lost to Follow-Up|0|||
124907693|NCT05283395|449286784|FG002|Overall Study|Patient Lost to Follow-Up|1|||
124907694|NCT05283395|449286782|FG000|Overall Study|Patient Withdrawal|2|||
124907695|NCT05283395|449286783|FG001|Overall Study|Patient Withdrawal|4|||
124907696|NCT05283395|449286784|FG002|Overall Study|Patient Withdrawal|2|||
124907697|NCT05283395|449286782|FG000|Overall Study|Investigator Decision|1|||
124907698|NCT05283395|449286783|FG001|Overall Study|Investigator Decision|0|||
124907699|NCT05283395|449286784|FG002|Overall Study|Investigator Decision|1|||
124907700|NCT05283395|449286782|FG000|Overall Study|Enrolled in error|0|||
124907701|NCT05283395|449286783|FG001|Overall Study|Enrolled in error|0|||
124907702|NCT05283395|449286784|FG002|Overall Study|Enrolled in error|1|||
124907703|NCT03144674|449286787|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
124907704|NCT03144674|449286788|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
124907705|NCT03144674|449286789|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
124907706|NCT03144674|449286790|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
124907707|NCT03144674|449286787|FG000|Overall Study|Death|3|||
124907708|NCT03144674|449286788|FG001|Overall Study|Death|2|||
124907709|NCT03144674|449286789|FG002|Overall Study|Death|6|||
124907710|NCT03144674|449286790|FG003|Overall Study|Death|24|||
124907711|NCT03144674|449286787|FG000|Overall Study|Lost to Follow-up|0|||
124907712|NCT03144674|449286788|FG001|Overall Study|Lost to Follow-up|1|||
124907713|NCT03144674|449286789|FG002|Overall Study|Lost to Follow-up|0|||
124907714|NCT03144674|449286790|FG003|Overall Study|Lost to Follow-up|4|||
124907715|NCT03144674|449286787|FG000|Overall Study|Withdrawal by Participant|0|||
124907716|NCT03144674|449286788|FG001|Overall Study|Withdrawal by Participant|0|||
124907717|NCT03144674|449286789|FG002|Overall Study|Withdrawal by Participant|2|||
124907718|NCT03144674|449286790|FG003|Overall Study|Withdrawal by Participant|6|||
124907719|NCT03144674|449286787|FG000|Overall Study|Discharged from the Trust|0|||
124907720|NCT03144674|449286788|FG001|Overall Study|Discharged from the Trust|0|||
124907721|NCT03144674|449286789|FG002|Overall Study|Discharged from the Trust|1|||
124907722|NCT03144674|449286790|FG003|Overall Study|Discharged from the Trust|0|||
124907723|NCT03144674|449286787|FG000|Overall Study|Exclusion Criteria Met|0|||
124907724|NCT03144674|449286788|FG001|Overall Study|Exclusion Criteria Met|0|||
124760290|NCT04393493|448746854|FG001|First 4 Days of Intervention|Early improvement|7|||
124760291|NCT01125800|448746855|FG000|Phase I|Protocol Violation|0|||
124760292|NCT01125800|448746856|FG001|Phase I|Protocol Violation|3|||
124760293|NCT01125800|448746857|FG002|Phase I|Protocol Violation|1|||
124760294|NCT01125800|448746858|FG003|Phase I|Protocol Violation|1|||
124760295|NCT01125800|448746859|FG004|Phase I|Protocol Violation|0|||
124760296|NCT01125800|448746855|FG000|Phase I|Adverse Event|2|||
124760297|NCT01125800|448746856|FG001|Phase I|Adverse Event|2|||
124544708|NCT03110107|447949197|FG008|Treatment Period|Participants no longer meets study criteria|0|||
124760298|NCT01125800|448746857|FG002|Phase I|Adverse Event|1|||
124907725|NCT03144674|449286789|FG002|Overall Study|Exclusion Criteria Met|1|||
124907726|NCT03144674|449286790|FG003|Overall Study|Exclusion Criteria Met|0|||
124907727|NCT03144674|449286787|FG000|Overall Study|Changed Physicians|0|||
124907728|NCT03144674|449286788|FG001|Overall Study|Changed Physicians|0|||
124907729|NCT03144674|449286789|FG002|Overall Study|Changed Physicians|0|||
124907730|NCT03144674|449286790|FG003|Overall Study|Changed Physicians|1|||
124760299|NCT01125800|448746858|FG003|Phase I|Adverse Event|7|||
124907731|NCT03144674|449286787|FG000|Overall Study|Removed for Safety|0|||
124907732|NCT03144674|449286788|FG001|Overall Study|Removed for Safety|0|||
124907733|NCT03144674|449286789|FG002|Overall Study|Removed for Safety|0|||
124907734|NCT03144674|449286790|FG003|Overall Study|Removed for Safety|1|||
124907735|NCT03144674|449286787|FG000|Overall Study|Site Closed|0|||
124907736|NCT03144674|449286788|FG001|Overall Study|Site Closed|0|||
124907737|NCT03144674|449286789|FG002|Overall Study|Site Closed|0|||
124907738|NCT03144674|449286790|FG003|Overall Study|Site Closed|1|||
124907739|NCT03144674|449286787|FG000|Overall Study|Histological Criteria Not Met|0|||
124907740|NCT03144674|449286788|FG001|Overall Study|Histological Criteria Not Met|0|||
124907741|NCT03144674|449286789|FG002|Overall Study|Histological Criteria Not Met|0|||
124907742|NCT03144674|449286790|FG003|Overall Study|Histological Criteria Not Met|1|||
124760300|NCT01125800|448746859|FG004|Phase I|Adverse Event|0|||
124760301|NCT01125800|448746855|FG000|Phase I|Administrative problems|1|||
124907743|NCT03144674|449286787|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
124760302|NCT01125800|448746856|FG001|Phase I|Administrative problems|0|||
124760303|NCT01125800|448746857|FG002|Phase I|Administrative problems|0|||
124760304|NCT01125800|448746858|FG003|Phase I|Administrative problems|0|||
124760305|NCT01125800|448746859|FG004|Phase I|Administrative problems|0|||
124760306|NCT01125800|448746855|FG000|Phase I|Withdrawal by Subject|0|||
124760307|NCT01125800|448746856|FG001|Phase I|Withdrawal by Subject|0|||
124760308|NCT01125800|448746857|FG002|Phase I|Withdrawal by Subject|1|||
124760309|NCT01125800|448746858|FG003|Phase I|Withdrawal by Subject|0|||
124760310|NCT01125800|448746859|FG004|Phase I|Withdrawal by Subject|0|||
124760311|NCT01125800|448746855|FG000|Phase I|Disease progression|5|||
124760312|NCT01125800|448746856|FG001|Phase I|Disease progression|4|||
124760313|NCT01125800|448746857|FG002|Phase I|Disease progression|1|||
124760314|NCT01125800|448746858|FG003|Phase I|Disease progression|3|||
124760315|NCT01125800|448746859|FG004|Phase I|Disease progression|0|||
124760316|NCT01125800|448746855|FG000|Phase II|Protocol Violation|0|||
124760317|NCT01125800|448746856|FG001|Phase II|Protocol Violation|0|||
124760318|NCT01125800|448746857|FG002|Phase II|Protocol Violation|0|||
124760319|NCT01125800|448746858|FG003|Phase II|Protocol Violation|0|||
124760320|NCT01125800|448746859|FG004|Phase II|Protocol Violation|1|||
124760321|NCT01125800|448746855|FG000|Phase II|Adverse Event|0|||
124760322|NCT01125800|448746856|FG001|Phase II|Adverse Event|0|||
124760323|NCT01125800|448746857|FG002|Phase II|Adverse Event|0|||
124760324|NCT01125800|448746858|FG003|Phase II|Adverse Event|0|||
124760325|NCT01125800|448746859|FG004|Phase II|Adverse Event|2|||
124760326|NCT01125800|448746855|FG000|Phase II|Disease progression|0|||
124760327|NCT01125800|448746856|FG001|Phase II|Disease progression|0|||
124760328|NCT01125800|448746857|FG002|Phase II|Disease progression|0|||
124760329|NCT01125800|448746858|FG003|Phase II|Disease progression|1|||
124760330|NCT01125800|448746859|FG004|Phase II|Disease progression|8|||
124760331|NCT04332107|448746864|FG000|Day 3|Lost to Follow-up|23|||
124760332|NCT04332107|448746865|FG001|Day 3|Lost to Follow-up|14|||
124760333|NCT04332107|448746864|FG000|Day 3|Missing outcome data|3|||
124760334|NCT04332107|448746865|FG001|Day 3|Missing outcome data|6|||
124760335|NCT04332107|448746864|FG000|Day 14|Lost to Follow-up|13|||
124760336|NCT04332107|448746865|FG001|Day 14|Lost to Follow-up|4|||
124760337|NCT04332107|448746864|FG000|Day 14|Missing outcome data|4|||
124907744|NCT03144674|449286788|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
124907745|NCT03144674|449286789|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
124760338|NCT04332107|448746865|FG001|Day 14|Missing outcome data|4|||
124760339|NCT04332107|448746864|FG000|Day 21|Lost to Follow-up|10|||
124760340|NCT04332107|448746865|FG001|Day 21|Lost to Follow-up|2|||
124760341|NCT01670721|448746870|FG000|Overall Study|Participant's decision|15|||
124760342|NCT01670721|448746870|FG000|Overall Study|Other than specified above|38|||
124760343|NCT04970654|448746873|FG000|Overall Study|Withdrawal by parents/guardian|1|||
124760344|NCT04970654|448746874|FG001|Overall Study|Withdrawal by parents/guardian|2|||
124907746|NCT03144674|449286790|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
124907747|NCT03144674|449286787|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
124760345|NCT04970654|448746873|FG000|Overall Study|Unclassified|2|||
124760346|NCT04970654|448746874|FG001|Overall Study|Unclassified|1|||
124760347|NCT04970654|448746873|FG000|Overall Study|Lost to Follow-up|1|||
124907748|NCT03144674|449286788|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
124907749|NCT03144674|449286789|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
124760348|NCT04970654|448746874|FG001|Overall Study|Lost to Follow-up|0|||
124907750|NCT03144674|449286790|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
124760349|NCT05579977|448746882|FG000|Treatment Phase|Other|0|||
124760350|NCT05579977|448746883|FG001|Treatment Phase|Other|0|||
124760351|NCT05579977|448746884|FG002|Treatment Phase|Other|0|||
124760352|NCT05579977|448746885|FG003|Treatment Phase|Other|2|||
124907751|NCT00206375|449286791|FG000|Overall Study|Lost to Follow-up|1|||
124907752|NCT00206375|449286792|FG001|Overall Study|Lost to Follow-up|0|||
124907753|NCT00206375|449286793|FG002|Overall Study|Lost to Follow-up|0|||
124907754|NCT00206375|449286791|FG000|Overall Study|Withdrawal by Subject|2|||
124907755|NCT00206375|449286792|FG001|Overall Study|Withdrawal by Subject|1|||
124907756|NCT00206375|449286793|FG002|Overall Study|Withdrawal by Subject|3|||
124907757|NCT00206375|449286791|FG000|Overall Study|Study terminated due to lack of funds|0|||
124907758|NCT00206375|449286792|FG001|Overall Study|Study terminated due to lack of funds|1|||
124907759|NCT00206375|449286793|FG002|Overall Study|Study terminated due to lack of funds|1|||
124907760|NCT03368664|449286794|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
124907761|NCT03368664|449286794|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
124907762|NCT03368664|449286794|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
124907763|NCT03368664|449286794|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
124907764|NCT00837616|449286795|FG000|Overall Study|Withdrawal by Subject|0|||
124907765|NCT00837616|449286796|FG001|Overall Study|Withdrawal by Subject|1|||
124907766|NCT01810263|449286803|FG000|Overall Study|Lost to Follow-up|8|||
124907767|NCT01810263|449286804|FG001|Overall Study|Lost to Follow-up|7|||
124907768|NCT00688519|449286808|FG000|Overall Study|Adverse Event|2|||
124907769|NCT00688519|449286809|FG001|Overall Study|Adverse Event|3|||
124907770|NCT00688519|449286808|FG000|Overall Study|Lost to Follow-up|3|||
124907771|NCT00688519|449286809|FG001|Overall Study|Lost to Follow-up|3|||
124907772|NCT00688519|449286808|FG000|Overall Study|Lack of Efficacy|3|||
124907773|NCT00688519|449286809|FG001|Overall Study|Lack of Efficacy|1|||
124907774|NCT00688519|449286808|FG000|Overall Study|Withdrawal by Subject|7|||
124907775|NCT00688519|449286809|FG001|Overall Study|Withdrawal by Subject|6|||
124907776|NCT00688519|449286808|FG000|Overall Study|Prohibited medication|1|||
124907777|NCT00688519|449286809|FG001|Overall Study|Prohibited medication|0|||
124907778|NCT00688519|449286808|FG000|Overall Study|Non-compliance|0|||
124907779|NCT00688519|449286809|FG001|Overall Study|Non-compliance|1|||
124907780|NCT00688519|449286808|FG000|Overall Study|Subject moved out of state|1|||
124907781|NCT00688519|449286809|FG001|Overall Study|Subject moved out of state|0|||
124907782|NCT00688519|449286808|FG000|Overall Study|Investigator decision|1|||
124907783|NCT00688519|449286809|FG001|Overall Study|Investigator decision|0|||
124907784|NCT00688519|449286808|FG000|Overall Study|Subject moved out of area|1|||
124907785|NCT00688519|449286809|FG001|Overall Study|Subject moved out of area|0|||
124907786|NCT00688519|449286808|FG000|Overall Study|Pregnancy|0|||
124907787|NCT00688519|449286809|FG001|Overall Study|Pregnancy|1|||
124907788|NCT01685606|449286812|FG000|Overall Study|Withdrawal by Subject|1|||
124907789|NCT01353963|449286813|FG000|Overall Study|Adverse Event|2|||
124907790|NCT04789408|449286814|FG000|Overall Study|Death|4|||
124907791|NCT04789408|449286815|FG001|Overall Study|Death|3|||
124907792|NCT04789408|449286816|FG002|Overall Study|Death|6|||
124907793|NCT04789408|449286814|FG000|Overall Study|Did not meet eligibility criteria|1|||
124907794|NCT04789408|449286815|FG001|Overall Study|Did not meet eligibility criteria|0|||
124907795|NCT04789408|449286816|FG002|Overall Study|Did not meet eligibility criteria|0|||
124907796|NCT04789408|449286814|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
124907797|NCT04789408|449286815|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
124907798|NCT04789408|449286816|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
124907799|NCT02999477|449286819|FG000|Overall Study|found ineligible after first dose|0|||
124907800|NCT02999477|449286820|FG001|Overall Study|found ineligible after first dose|1|||
124907801|NCT02999477|449286819|FG000|Overall Study|Withdrawal by Subject|1|||
124907802|NCT02999477|449286820|FG001|Overall Study|Withdrawal by Subject|1|||
124907803|NCT00573833|449286821|FG000|Overall Study|Not Treated|2|||
124907804|NCT03351075|449288531|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
124907805|NCT03351075|449288532|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
124907806|NCT03351075|449288531|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
124907807|NCT03351075|449288532|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
124907808|NCT03351075|449288531|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
124760353|NCT05579977|448746886|FG004|Treatment Phase|Other|1|||
124544709|NCT03110107|447949198|FG009|Treatment Period|Participants no longer meets study criteria|0|||
124544710|NCT03110107|447949199|FG010|Treatment Period|Participants no longer meets study criteria|0|||
124907809|NCT03351075|449288532|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
124907810|NCT03351075|449288531|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
124907811|NCT03351075|449288532|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
124907812|NCT00925899|449288533|FG000|Part 1|Death|1|||
124907813|NCT00925899|449288534|FG001|Part 1|Death|2|||
124907814|NCT00925899|449288533|FG000|Part 1|Withdrawal by Subject|10|||
124907815|NCT00925899|449288534|FG001|Part 1|Withdrawal by Subject|9|||
124907816|NCT02396316|449288535|FG000|Overall Study|Physician Decision|1|||
124907817|NCT02396316|449288536|FG001|Overall Study|Physician Decision|0|||
124691802|NCT00501085|448492267|FG000|Overall Study|Lost to Follow-up|195|||
124691803|NCT00501085|448492267|FG000|Overall Study|Withdrawal by Subject|34|||
124691804|NCT00501085|448492267|FG000|Overall Study|Subject Decision|1|||
124691805|NCT00501085|448492267|FG000|Overall Study|Revision Surgery|7|||
124907818|NCT02396316|449288535|FG000|Overall Study|Progressive disease|6|||
124907819|NCT02396316|449288536|FG001|Overall Study|Progressive disease|3|||
124907820|NCT02396316|449288535|FG000|Overall Study|Protocol Violation|0|||
124907821|NCT02396316|449288536|FG001|Overall Study|Protocol Violation|1|||
124907822|NCT02396316|449288535|FG000|Overall Study|Treatment unblinded|0|||
124907823|NCT02396316|449288536|FG001|Overall Study|Treatment unblinded|1|||
124907824|NCT00566735|449288537|FG000|Overall Study|Withdrawal by Subject|0|||
124907825|NCT00566735|449288538|FG001|Overall Study|Withdrawal by Subject|1|||
124907826|NCT00566735|449288537|FG000|Overall Study|Refused neuropsychological testing|2|||
124907827|NCT00566735|449288538|FG001|Overall Study|Refused neuropsychological testing|5|||
124907828|NCT00566735|449288537|FG000|Overall Study|Switched into a manic episode|0|||
124907829|NCT00566735|449288538|FG001|Overall Study|Switched into a manic episode|1|||
124907830|NCT00925587|449288540|FG000|Overall Study|Protocol Specified Criteria|6|||
124907831|NCT00925587|449288541|FG001|Overall Study|Protocol Specified Criteria|6|||
124907832|NCT00925587|449288540|FG000|Overall Study|Physician Decision|4|||
124907833|NCT00925587|449288541|FG001|Overall Study|Physician Decision|1|||
124907834|NCT00925587|449288540|FG000|Overall Study|Protocol Violation|6|||
124907835|NCT00925587|449288541|FG001|Overall Study|Protocol Violation|4|||
124907836|NCT00925587|449288540|FG000|Overall Study|Withdrawal by Subject|9|||
124907837|NCT00925587|449288541|FG001|Overall Study|Withdrawal by Subject|6|||
124907838|NCT00925587|449288540|FG000|Overall Study|Death|5|||
124907839|NCT00925587|449288541|FG001|Overall Study|Death|5|||
124907840|NCT00925587|449288540|FG000|Overall Study|Adverse Event|6|||
124907841|NCT00925587|449288541|FG001|Overall Study|Adverse Event|2|||
124907842|NCT00925587|449288540|FG000|Overall Study|Lost to Follow-up|0|||
124907843|NCT00925587|449288541|FG001|Overall Study|Lost to Follow-up|1|||
124907844|NCT03454529|449288544|FG000|Overall Study|Did not receive treatment|6|||
124907845|NCT03454529|449288544|FG000|Overall Study|Received < 80% doses|1|||
124907846|NCT01582100|449288545|FG000|Overall Study|Adverse Event|1|||
124907847|NCT01582100|449288545|FG000|Overall Study|Withdrawal by Subject|1|||
124907848|NCT01078116|449288546|FG000|Overall Study|Lost to Follow-up|17|||
124907849|NCT01078116|449288546|FG000|Overall Study|Adverse Event|5|||
124907850|NCT01078116|449288546|FG000|Overall Study|Withdrawal by Subject|8|||
124907851|NCT01078116|449288546|FG000|Overall Study|Lack of effectiveness|15|||
124907852|NCT01078116|449288546|FG000|Overall Study|Case report form not completed|3|||
124907853|NCT01177670|449288549|FG000|Overall Study|Study Terminated|115|||
124907854|NCT01177670|449288549|FG000|Overall Study|Physician Decision|50|||
124907855|NCT01177670|449288549|FG000|Overall Study|Withdrawal by Subject|4|||
124907856|NCT04532528|449288553|FG000|Overall Study|Adverse Event|12|||
124907857|NCT04532528|449288554|FG001|Overall Study|Adverse Event|17|||
124907858|NCT04532528|449288553|FG000|Overall Study|Withdrawal of consent|16|||
124907859|NCT04532528|449288554|FG001|Overall Study|Withdrawal of consent|17|||
124907860|NCT04532528|449288553|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
124907861|NCT04532528|449288554|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
124907862|NCT04532528|449288553|FG000|Overall Study|Lost to Follow-up|69|||
124907863|NCT04532528|449288554|FG001|Overall Study|Lost to Follow-up|68|||
124907864|NCT04532528|449288553|FG000|Overall Study|Administrative problems|12|||
124907865|NCT04532528|449288554|FG001|Overall Study|Administrative problems|14|||
124907866|NCT04532528|449288553|FG000|Overall Study|Death|3|||
124907867|NCT04532528|449288554|FG001|Overall Study|Death|3|||
124907868|NCT04532528|449288553|FG000|Overall Study|Other|38|||
124907869|NCT04532528|449288554|FG001|Overall Study|Other|46|||
124907870|NCT03061474|449288559|FG000|Overall Study|Adverse Event|2|||
124907871|NCT03061474|449288560|FG001|Overall Study|Adverse Event|0|||
124907872|NCT03061474|449288559|FG000|Overall Study|Safety Risk|0|||
124907873|NCT03061474|449288560|FG001|Overall Study|Safety Risk|1|||
124907874|NCT03061474|449288559|FG000|Overall Study|Participant unwilling or unable to participate|0|||
124907875|NCT03061474|449288560|FG001|Overall Study|Participant unwilling or unable to participate|2|||
124907876|NCT03061474|449288559|FG000|Overall Study|Lost to Follow-up|0|||
124907877|NCT03061474|449288560|FG001|Overall Study|Lost to Follow-up|1|||
124907878|NCT02888080|449288561|FG000|Overall Study|Subject / Guardian decision|1|||
124907879|NCT02888080|449288562|FG001|Overall Study|Subject / Guardian decision|3|||
124907880|NCT02888080|449288561|FG000|Overall Study|New Therapy for study indication|1|||
124907881|NCT02888080|449288562|FG001|Overall Study|New Therapy for study indication|0|||
124907882|NCT02888080|449288561|FG000|Overall Study|Lack of Efficacy|0|||
124907883|NCT02888080|449288562|FG001|Overall Study|Lack of Efficacy|1|||
124907884|NCT02888080|449288561|FG000|Overall Study|Adverse Event|0|||
124907885|NCT02888080|449288562|FG001|Overall Study|Adverse Event|1|||
124907886|NCT00845832|449288563|FG000|Treatment Period|Adverse Event|0|||
124907887|NCT00845832|449288564|FG001|Treatment Period|Adverse Event|2|||
124907888|NCT00845832|449288565|FG002|Treatment Period|Adverse Event|0|||
124907889|NCT00845832|449288563|FG000|Treatment Period|Protocol Violation|1|||
124907890|NCT00845832|449288564|FG001|Treatment Period|Protocol Violation|1|||
124907891|NCT00845832|449288565|FG002|Treatment Period|Protocol Violation|0|||
124907892|NCT00845832|449288563|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
124907893|NCT00845832|449288564|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
124691806|NCT00501085|448492267|FG000|Overall Study|Explantation Surgery|26|||
124907894|NCT00845832|449288565|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
124907895|NCT00845832|449288563|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
124907896|NCT00845832|449288564|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
124907897|NCT00845832|449288565|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
124907898|NCT00189202|449288570|FG000|Overall Study|Physician Decision|5|||
124907899|NCT01039688|449288571|FG000|Overall Study|Adverse Event|38|||
124907900|NCT01039688|449288572|FG001|Overall Study|Adverse Event|39|||
124907901|NCT01039688|449288573|FG002|Overall Study|Adverse Event|24|||
124907902|NCT01039688|449288571|FG000|Overall Study|Lack of Efficacy|20|||
124907903|NCT01039688|449288572|FG001|Overall Study|Lack of Efficacy|11|||
124907904|NCT01039688|449288573|FG002|Overall Study|Lack of Efficacy|26|||
124907905|NCT01039688|449288571|FG000|Overall Study|Lost to Follow-up|11|||
124907906|NCT01039688|449288572|FG001|Overall Study|Lost to Follow-up|9|||
124907907|NCT01039688|449288573|FG002|Overall Study|Lost to Follow-up|5|||
124907908|NCT01039688|449288571|FG000|Overall Study|Other|13|||
124907909|NCT01039688|449288572|FG001|Overall Study|Other|25|||
124907910|NCT01039688|449288573|FG002|Overall Study|Other|12|||
124907911|NCT01039688|449288571|FG000|Overall Study|Withdrawal by Subject|23|||
124907912|NCT01039688|449288572|FG001|Overall Study|Withdrawal by Subject|27|||
124907913|NCT01039688|449288573|FG002|Overall Study|Withdrawal by Subject|13|||
124907914|NCT01039688|449288571|FG000|Overall Study|Death|2|||
124907915|NCT01039688|449288572|FG001|Overall Study|Death|0|||
124907916|NCT01039688|449288573|FG002|Overall Study|Death|0|||
124907917|NCT00668863|449288574|FG000|Overall Study|Objective Progression or Relapse|42|||
124907918|NCT00668863|449288574|FG000|Overall Study|Adverse Event|13|||
124907919|NCT00668863|449288574|FG000|Overall Study|Study Terminated by Sponsor|8|||
124907920|NCT00668863|449288574|FG000|Overall Study|Global Deterioration of Health Status|4|||
124907921|NCT00668863|449288574|FG000|Overall Study|Withdrawal by Subject|1|||
124907922|NCT00668863|449288574|FG000|Overall Study|Surgery|1|||
124907923|NCT00668863|449288574|FG000|Overall Study|Subject's work scheduling problem|1|||
124907924|NCT00668863|449288574|FG000|Overall Study|Physician Decision|1|||
124907925|NCT03844269|449288579|FG000|Overall Study|Withdrawal pre-intervention|1|||
124907926|NCT03844269|449288579|FG000|Overall Study|Did not complete the intervention|2|||
124907927|NCT00101010|449288581|FG000|Overall Study|Physician Decision|1|||
124907928|NCT00869323|449288584|FG000|Maintenance Therapy|concurrent illness|1|||
124907929|NCT01135511|449288585|FG000|Overall Study|Adverse Event|0|||
124907930|NCT01135511|449288586|FG001|Overall Study|Adverse Event|1|||
124907931|NCT01135511|449288587|FG002|Overall Study|Adverse Event|2|||
124907932|NCT01135511|449288588|FG003|Overall Study|Adverse Event|0|||
124907933|NCT01135511|449288589|FG004|Overall Study|Adverse Event|0|||
124907934|NCT01135511|449288590|FG005|Overall Study|Adverse Event|1|||
124907935|NCT01135511|449288591|FG006|Overall Study|Adverse Event|0|||
124907936|NCT01135511|449288592|FG007|Overall Study|Adverse Event|1|||
124907937|NCT01135511|449288593|FG008|Overall Study|Adverse Event|0|||
124907938|NCT01135511|449288585|FG000|Overall Study|Lack of Efficacy|0|||
124907939|NCT01135511|449288586|FG001|Overall Study|Lack of Efficacy|1|||
124907940|NCT01135511|449288587|FG002|Overall Study|Lack of Efficacy|1|||
124907941|NCT01135511|449288588|FG003|Overall Study|Lack of Efficacy|2|||
124907942|NCT01135511|449288589|FG004|Overall Study|Lack of Efficacy|0|||
124907943|NCT01135511|449288590|FG005|Overall Study|Lack of Efficacy|0|||
124907944|NCT01135511|449288591|FG006|Overall Study|Lack of Efficacy|0|||
124907945|NCT01135511|449288592|FG007|Overall Study|Lack of Efficacy|0|||
124907946|NCT01135511|449288593|FG008|Overall Study|Lack of Efficacy|0|||
124907947|NCT01135511|449288585|FG000|Overall Study|Protocol Violation|0|||
124907948|NCT01135511|449288586|FG001|Overall Study|Protocol Violation|0|||
124907949|NCT01135511|449288587|FG002|Overall Study|Protocol Violation|3|||
124907950|NCT01135511|449288588|FG003|Overall Study|Protocol Violation|0|||
124907951|NCT01135511|449288589|FG004|Overall Study|Protocol Violation|0|||
124907952|NCT01135511|449288590|FG005|Overall Study|Protocol Violation|0|||
124907953|NCT01135511|449288591|FG006|Overall Study|Protocol Violation|0|||
124907954|NCT01135511|449288592|FG007|Overall Study|Protocol Violation|0|||
124691807|NCT00501085|448492267|FG000|Overall Study|Adverse Event|4|||
124691808|NCT00501085|448492267|FG000|Overall Study|Non-Compliance|24|||
124907955|NCT01135511|449288593|FG008|Overall Study|Protocol Violation|0|||
124907956|NCT01135511|449288585|FG000|Overall Study|Pregnancy|0|||
124907957|NCT01135511|449288586|FG001|Overall Study|Pregnancy|0|||
124907958|NCT01135511|449288587|FG002|Overall Study|Pregnancy|0|||
124907959|NCT01135511|449288588|FG003|Overall Study|Pregnancy|1|||
124907960|NCT01135511|449288589|FG004|Overall Study|Pregnancy|0|||
124907961|NCT01135511|449288590|FG005|Overall Study|Pregnancy|0|||
124907962|NCT01135511|449288591|FG006|Overall Study|Pregnancy|0|||
124907963|NCT01135511|449288592|FG007|Overall Study|Pregnancy|0|||
124907964|NCT01135511|449288593|FG008|Overall Study|Pregnancy|0|||
124907965|NCT01135511|449288585|FG000|Overall Study|could not visit the clinic|0|||
124907966|NCT01135511|449288586|FG001|Overall Study|could not visit the clinic|1|||
124907967|NCT01135511|449288587|FG002|Overall Study|could not visit the clinic|2|||
124907968|NCT01135511|449288588|FG003|Overall Study|could not visit the clinic|0|||
124907969|NCT01135511|449288589|FG004|Overall Study|could not visit the clinic|0|||
124691809|NCT00501085|448492267|FG000|Overall Study|Study closed by sponsor|109|||
124907970|NCT01135511|449288590|FG005|Overall Study|could not visit the clinic|0|||
124907971|NCT01135511|449288591|FG006|Overall Study|could not visit the clinic|0|||
124907972|NCT01135511|449288592|FG007|Overall Study|could not visit the clinic|0|||
124907973|NCT01135511|449288593|FG008|Overall Study|could not visit the clinic|0|||
124907974|NCT01135511|449288585|FG000|Overall Study|noncompliance with study drug taken|0|||
124907975|NCT01135511|449288586|FG001|Overall Study|noncompliance with study drug taken|0|||
124907976|NCT01135511|449288587|FG002|Overall Study|noncompliance with study drug taken|0|||
124907977|NCT01135511|449288588|FG003|Overall Study|noncompliance with study drug taken|0|||
124907978|NCT01135511|449288589|FG004|Overall Study|noncompliance with study drug taken|1|||
124907979|NCT01135511|449288590|FG005|Overall Study|noncompliance with study drug taken|0|||
124907980|NCT01135511|449288591|FG006|Overall Study|noncompliance with study drug taken|0|||
124907981|NCT01135511|449288592|FG007|Overall Study|noncompliance with study drug taken|0|||
124907982|NCT01135511|449288593|FG008|Overall Study|noncompliance with study drug taken|0|||
124907983|NCT01135511|449288585|FG000|Overall Study|Withdrawal by Subject|0|||
124907984|NCT01135511|449288586|FG001|Overall Study|Withdrawal by Subject|0|||
124907985|NCT01135511|449288587|FG002|Overall Study|Withdrawal by Subject|0|||
124907986|NCT01135511|449288588|FG003|Overall Study|Withdrawal by Subject|0|||
124907987|NCT01135511|449288589|FG004|Overall Study|Withdrawal by Subject|0|||
124907988|NCT01135511|449288590|FG005|Overall Study|Withdrawal by Subject|0|||
124907989|NCT01135511|449288591|FG006|Overall Study|Withdrawal by Subject|1|||
124907990|NCT01135511|449288592|FG007|Overall Study|Withdrawal by Subject|0|||
124907991|NCT01135511|449288593|FG008|Overall Study|Withdrawal by Subject|1|||
124907992|NCT05082935|449288609|FG000|Overall Study|Lost to Follow-up|549|||
124907993|NCT05082935|449288610|FG001|Overall Study|Lost to Follow-up|631|||
124907994|NCT05082935|449288609|FG000|Overall Study|Withdrawal by Subject|27|||
124907995|NCT05082935|449288610|FG001|Overall Study|Withdrawal by Subject|58|||
124907996|NCT02957136|449288612|FG000|Overall Study|Withdrawal by Subject|2|||
124907997|NCT02957136|449288613|FG001|Overall Study|Withdrawal by Subject|1|||
124907998|NCT01595061|449288614|FG000|Overall Study|Never Treated|3|||
124907999|NCT01595061|449288614|FG000|Overall Study|Inadequate Pathology|1|||
124908000|NCT00960141|449288615|FG000|Overall Study|Adverse Event|4|||
124908001|NCT00960141|449288616|FG001|Overall Study|Adverse Event|8|||
124908002|NCT00960141|449288617|FG002|Overall Study|Adverse Event|2|||
124908003|NCT00960141|449288615|FG000|Overall Study|Lack of Efficacy|3|||
124908004|NCT00960141|449288616|FG001|Overall Study|Lack of Efficacy|4|||
124908005|NCT00960141|449288617|FG002|Overall Study|Lack of Efficacy|2|||
124908006|NCT00960141|449288615|FG000|Overall Study|Lost to Follow-up|1|||
124908007|NCT00960141|449288616|FG001|Overall Study|Lost to Follow-up|0|||
124908008|NCT00960141|449288617|FG002|Overall Study|Lost to Follow-up|0|||
124908009|NCT00960141|449288615|FG000|Overall Study|Protocol Violation|1|||
124908010|NCT00960141|449288616|FG001|Overall Study|Protocol Violation|3|||
124908011|NCT00960141|449288617|FG002|Overall Study|Protocol Violation|2|||
124908012|NCT00960141|449288615|FG000|Overall Study|Withdrawal by Subject|1|||
124908013|NCT00960141|449288616|FG001|Overall Study|Withdrawal by Subject|2|||
124908014|NCT00960141|449288617|FG002|Overall Study|Withdrawal by Subject|1|||
124908015|NCT00566527|449288620|FG000|Overall Study|Reason not provided|3|||
124908016|NCT00566527|449288621|FG001|Overall Study|Reason not provided|11|||
124908017|NCT00566527|449288622|FG002|Overall Study|Reason not provided|10|||
124908018|NCT00566527|449288620|FG000|Overall Study|Adverse Event|2|||
124908019|NCT00566527|449288621|FG001|Overall Study|Adverse Event|0|||
124908020|NCT00566527|449288622|FG002|Overall Study|Adverse Event|1|||
124908021|NCT00566527|449288620|FG000|Overall Study|Physician Decision|3|||
124908022|NCT00566527|449288621|FG001|Overall Study|Physician Decision|8|||
124908023|NCT00566527|449288622|FG002|Overall Study|Physician Decision|20|||
124908024|NCT00566527|449288620|FG000|Overall Study|Lost to Follow-up|3|||
124908025|NCT00566527|449288621|FG001|Overall Study|Lost to Follow-up|4|||
124908026|NCT00566527|449288622|FG002|Overall Study|Lost to Follow-up|4|||
124908027|NCT00566527|449288620|FG000|Overall Study|Withdrawal by Subject|6|||
124908028|NCT00566527|449288621|FG001|Overall Study|Withdrawal by Subject|43|||
124908029|NCT00566527|449288622|FG002|Overall Study|Withdrawal by Subject|43|||
124908030|NCT00457743|449288623|FG000|Overall Study|Adverse Event|0|||
124908031|NCT00457743|449288624|FG001|Overall Study|Adverse Event|4|||
124908032|NCT00457743|449288625|FG002|Overall Study|Adverse Event|0|||
124908033|NCT00457743|449288623|FG000|Overall Study|Lack of Efficacy|3|||
124908034|NCT00457743|449288624|FG001|Overall Study|Lack of Efficacy|23|||
124908035|NCT00457743|449288625|FG002|Overall Study|Lack of Efficacy|3|||
124908036|NCT00356265|449288626|FG000|Overall Study|Withdrawal by Subject|0|||
124908037|NCT00356265|449288627|FG001|Overall Study|Withdrawal by Subject|0|||
124908038|NCT00356265|449288628|FG002|Overall Study|Withdrawal by Subject|1|||
124908039|NCT01837966|449288629|FG000|Overall Study|Withdrawal by Subject|2|||
124908040|NCT01837966|449288630|FG001|Overall Study|Withdrawal by Subject|1|||
124908041|NCT01278394|449288634|FG000|Overall Study|Lost to Follow-up|1|||
124908042|NCT01236560|449288637|FG000|Overall Study|Adverse Event|0|||
124908043|NCT01236560|449288638|FG001|Overall Study|Adverse Event|2|||
124908044|NCT01236560|449288639|FG002|Overall Study|Adverse Event|1|||
124908045|NCT01236560|449288640|FG003|Overall Study|Adverse Event|3|||
124908046|NCT01236560|449288641|FG004|Overall Study|Adverse Event|0|||
124908047|NCT01236560|449288642|FG005|Overall Study|Adverse Event|0|||
124908048|NCT01236560|449288637|FG000|Overall Study|Death|0|||
124908049|NCT01236560|449288638|FG001|Overall Study|Death|1|||
124908050|NCT01236560|449288639|FG002|Overall Study|Death|0|||
124908051|NCT01236560|449288640|FG003|Overall Study|Death|1|||
124908052|NCT01236560|449288641|FG004|Overall Study|Death|0|||
124908053|NCT01236560|449288642|FG005|Overall Study|Death|0|||
124908054|NCT01236560|449288637|FG000|Overall Study|Lost to Follow-up|0|||
124908055|NCT01236560|449288638|FG001|Overall Study|Lost to Follow-up|1|||
124908056|NCT01236560|449288639|FG002|Overall Study|Lost to Follow-up|1|||
124908057|NCT01236560|449288640|FG003|Overall Study|Lost to Follow-up|0|||
124908058|NCT01236560|449288641|FG004|Overall Study|Lost to Follow-up|0|||
124908059|NCT01236560|449288642|FG005|Overall Study|Lost to Follow-up|0|||
124908060|NCT01236560|449288637|FG000|Overall Study|Physician Decision|0|||
124908061|NCT01236560|449288638|FG001|Overall Study|Physician Decision|1|||
124908062|NCT01236560|449288639|FG002|Overall Study|Physician Decision|8|||
124908063|NCT01236560|449288640|FG003|Overall Study|Physician Decision|0|||
124908064|NCT01236560|449288641|FG004|Overall Study|Physician Decision|0|||
124908065|NCT01236560|449288642|FG005|Overall Study|Physician Decision|0|||
124908066|NCT01236560|449288637|FG000|Overall Study|Withdrawal by Subject|0|||
124908067|NCT01236560|449288638|FG001|Overall Study|Withdrawal by Subject|0|||
124908068|NCT01236560|449288639|FG002|Overall Study|Withdrawal by Subject|1|||
124908069|NCT01236560|449288640|FG003|Overall Study|Withdrawal by Subject|2|||
124908070|NCT01236560|449288641|FG004|Overall Study|Withdrawal by Subject|0|||
124908071|NCT01236560|449288642|FG005|Overall Study|Withdrawal by Subject|0|||
124908072|NCT01236560|449288637|FG000|Overall Study|Progressive disease|5|||
124908073|NCT01236560|449288638|FG001|Overall Study|Progressive disease|19|||
124908074|NCT01236560|449288639|FG002|Overall Study|Progressive disease|9|||
124908075|NCT01236560|449288640|FG003|Overall Study|Progressive disease|16|||
124908076|NCT01236560|449288641|FG004|Overall Study|Progressive disease|0|||
124908077|NCT01236560|449288642|FG005|Overall Study|Progressive disease|0|||
124908078|NCT01792830|449288646|FG000|Overall Study|Withdrawal by Subject|22|||
124908079|NCT01792830|449288647|FG001|Overall Study|Withdrawal by Subject|0|||
124908080|NCT01792830|449288648|FG002|Overall Study|Withdrawal by Subject|0|||
124908081|NCT01792830|449288649|FG003|Overall Study|Withdrawal by Subject|2|||
124908082|NCT01792830|449288650|FG004|Overall Study|Withdrawal by Subject|1|||
124908083|NCT01792830|449288651|FG005|Overall Study|Withdrawal by Subject|1|||
124908084|NCT01792830|449288652|FG006|Overall Study|Withdrawal by Subject|1|||
124908085|NCT01792830|449288653|FG007|Overall Study|Withdrawal by Subject|1|||
124908086|NCT01792830|449288654|FG008|Overall Study|Withdrawal by Subject|7|||
124908087|NCT01792830|449288655|FG009|Overall Study|Withdrawal by Subject|0|||
124908088|NCT01792830|449288656|FG010|Overall Study|Withdrawal by Subject|2|||
124908089|NCT01792830|449288646|FG000|Overall Study|Death|3|||
124908090|NCT01792830|449288647|FG001|Overall Study|Death|0|||
124908091|NCT01792830|449288648|FG002|Overall Study|Death|0|||
124908092|NCT01792830|449288649|FG003|Overall Study|Death|1|||
124449991|NCT03250832|447609621|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
124449992|NCT03250832|447609622|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
124449993|NCT03250832|447609623|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
124449994|NCT03250832|447609624|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
124449995|NCT03250832|447609625|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
124908093|NCT01792830|449288650|FG004|Overall Study|Death|0|||
124908094|NCT01792830|449288651|FG005|Overall Study|Death|0|||
124908095|NCT01792830|449288652|FG006|Overall Study|Death|1|||
124908096|NCT01792830|449288653|FG007|Overall Study|Death|0|||
124908097|NCT01792830|449288654|FG008|Overall Study|Death|1|||
124449996|NCT03250832|447609626|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
124449997|NCT03250832|447609627|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
124449998|NCT03250832|447609628|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
124449999|NCT03250832|447609629|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
124544711|NCT03110107|447949200|FG011|Treatment Period|Participants no longer meets study criteria|0|||
124908098|NCT01792830|449288655|FG009|Overall Study|Death|0|||
124908099|NCT01792830|449288656|FG010|Overall Study|Death|1|||
124908100|NCT01792830|449288646|FG000|Overall Study|Adverse Event|0|||
124908101|NCT01792830|449288647|FG001|Overall Study|Adverse Event|0|||
124544712|NCT03110107|447949201|FG012|Treatment Period|Participants no longer meets study criteria|0|||
124544713|NCT03110107|447949202|FG013|Treatment Period|Participants no longer meets study criteria|0|||
124691810|NCT00501085|448492267|FG000|Overall Study|Other loss to follow-up|32|||
124691811|NCT00366535|448492268|FG000|First Phase: 12 Weeks|Adverse Event|1|||
124908102|NCT01792830|449288648|FG002|Overall Study|Adverse Event|0|||
124908103|NCT01792830|449288649|FG003|Overall Study|Adverse Event|0|||
124908104|NCT01792830|449288650|FG004|Overall Study|Adverse Event|0|||
124908105|NCT01792830|449288651|FG005|Overall Study|Adverse Event|0|||
124908106|NCT01792830|449288652|FG006|Overall Study|Adverse Event|0|||
124908107|NCT01792830|449288653|FG007|Overall Study|Adverse Event|0|||
124908108|NCT01792830|449288654|FG008|Overall Study|Adverse Event|1|||
124908109|NCT01792830|449288655|FG009|Overall Study|Adverse Event|0|||
124908110|NCT01792830|449288656|FG010|Overall Study|Adverse Event|0|||
124908111|NCT01198028|449288657|FG000|Overall Study|Adverse Event|5|||
124908112|NCT01198028|449288657|FG000|Overall Study|Death|3|||
124908113|NCT01198028|449288657|FG000|Overall Study|Physician Decision|2|||
124908114|NCT00658996|449288660|FG000|First Intervention|Positive slit lamp finding|1|||
124908115|NCT00658996|449288661|FG001|First Intervention|Positive slit lamp finding|0|||
124908116|NCT00658996|449288660|FG000|First Intervention|Lack of lenses|0|||
124908117|NCT00658996|449288661|FG001|First Intervention|Lack of lenses|1|||
124908118|NCT00658996|449288660|FG000|Crossover Period|Physician Decision|1|||
124908119|NCT00658996|449288661|FG001|Crossover Period|Physician Decision|0|||
124908120|NCT00658996|449288660|FG000|Crossover Period|Ineligible|1|||
124908121|NCT00658996|449288661|FG001|Crossover Period|Ineligible|1|||
124908122|NCT00658996|449288660|FG000|Second Intervention|Developed a stye on upper lid|1|||
124908123|NCT00658996|449288661|FG001|Second Intervention|Developed a stye on upper lid|0|||
124908124|NCT00658996|449288660|FG000|Second Intervention|Positive slit lamp finding|0|||
124908125|NCT00658996|449288661|FG001|Second Intervention|Positive slit lamp finding|1|||
124908126|NCT02079844|449288662|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
124908127|NCT02079844|449288663|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
124908128|NCT02079844|449288664|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
124908129|NCT02079844|449288662|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
124908130|NCT02079844|449288663|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
124908131|NCT02079844|449288664|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
124908132|NCT01420549|449288665|FG000|Overall Study|Adverse Event|1|||
124908133|NCT01420549|449288666|FG001|Overall Study|Adverse Event|1|||
124908134|NCT01420549|449288665|FG000|Overall Study|Lost to Follow-up|2|||
124908135|NCT01420549|449288666|FG001|Overall Study|Lost to Follow-up|2|||
124908136|NCT01420549|449288665|FG000|Overall Study|Protocol Violation|0|||
124908137|NCT01420549|449288666|FG001|Overall Study|Protocol Violation|1|||
124908138|NCT01420549|449288665|FG000|Overall Study|Non-adherence to medication|4|||
124908139|NCT01420549|449288666|FG001|Overall Study|Non-adherence to medication|1|||
124908140|NCT00683696|449290432|FG000|Overall Study|Withdrawn due to study closure|337|||
124908141|NCT00683696|449290433|FG001|Overall Study|Withdrawn due to study closure|338|||
124908142|NCT00683696|449290432|FG000|Overall Study|Withdrawn prior to study closure|13|||
124908143|NCT00683696|449290433|FG001|Overall Study|Withdrawn prior to study closure|28|||
124908144|NCT00683696|449290432|FG000|Overall Study|Lost to Follow-up|5|||
124908145|NCT00683696|449290433|FG001|Overall Study|Lost to Follow-up|6|||
124908146|NCT00683696|449290432|FG000|Overall Study|Vital status follow-up only|3|||
124908147|NCT00683696|449290433|FG001|Overall Study|Vital status follow-up only|3|||
124908148|NCT00683696|449290432|FG000|Overall Study|Death|46|||
124908149|NCT00683696|449290433|FG001|Overall Study|Death|30|||
124908150|NCT03648762|449290437|FG000|Overall Study|Lost to Follow-up|1|||
124908151|NCT03648762|449290438|FG001|Overall Study|Lost to Follow-up|2|||
124908152|NCT03648762|449290439|FG002|Overall Study|Lost to Follow-up|0|||
124908153|NCT03648762|449290437|FG000|Overall Study|Withdrawal by Subject|5|||
124908154|NCT03648762|449290438|FG001|Overall Study|Withdrawal by Subject|2|||
124908155|NCT03648762|449290439|FG002|Overall Study|Withdrawal by Subject|1|||
124908156|NCT01040689|449290448|FG000|Overall Study|Adverse Event|0|||
124908157|NCT01040689|449290449|FG001|Overall Study|Adverse Event|0|||
124908158|NCT01040689|449290450|FG002|Overall Study|Adverse Event|2|||
124908159|NCT01040689|449290451|FG003|Overall Study|Adverse Event|4|||
124908160|NCT01040689|449290448|FG000|Overall Study|Lack of Efficacy|0|||
124908161|NCT01040689|449290449|FG001|Overall Study|Lack of Efficacy|0|||
124908162|NCT01040689|449290450|FG002|Overall Study|Lack of Efficacy|1|||
124450000|NCT03250832|447609630|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
124450001|NCT03250832|447609619|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
124450002|NCT03250832|447609620|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
124450003|NCT03250832|447609621|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
124450004|NCT03250832|447609622|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
124450005|NCT03250832|447609623|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
124450006|NCT03250832|447609624|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
124450007|NCT03250832|447609625|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
124691812|NCT00366535|448492269|FG001|First Phase: 12 Weeks|Adverse Event|3|||
124691813|NCT00366535|448492268|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
124908163|NCT01040689|449290451|FG003|Overall Study|Lack of Efficacy|0|||
124908164|NCT01040689|449290448|FG000|Overall Study|Lost to Follow-up|1|||
124908165|NCT01040689|449290449|FG001|Overall Study|Lost to Follow-up|0|||
124908166|NCT01040689|449290450|FG002|Overall Study|Lost to Follow-up|0|||
124908167|NCT01040689|449290451|FG003|Overall Study|Lost to Follow-up|0|||
124908168|NCT01040689|449290448|FG000|Overall Study|Withdrawal by Subject|2|||
124908169|NCT01040689|449290449|FG001|Overall Study|Withdrawal by Subject|1|||
124691814|NCT00366535|448492269|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
124908170|NCT01040689|449290450|FG002|Overall Study|Withdrawal by Subject|1|||
124908171|NCT01040689|449290451|FG003|Overall Study|Withdrawal by Subject|0|||
124908172|NCT01040689|449290448|FG000|Overall Study|Other reasons not listed above|0|||
124908173|NCT01040689|449290449|FG001|Overall Study|Other reasons not listed above|1|||
124450008|NCT03250832|447609626|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
124450009|NCT03250832|447609627|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
124450010|NCT03250832|447609628|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
124450011|NCT03250832|447609629|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
124450012|NCT03250832|447609630|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
124908174|NCT01040689|449290450|FG002|Overall Study|Other reasons not listed above|0|||
124908175|NCT01040689|449290451|FG003|Overall Study|Other reasons not listed above|0|||
124908176|NCT01185561|449290452|FG000|Overall Study|Lost to Follow-up|0|||
124908177|NCT01185561|449290453|FG001|Overall Study|Lost to Follow-up|4|||
124908178|NCT01185561|449290452|FG000|Overall Study|Withdrawal by Subject|2|||
124908179|NCT01185561|449290453|FG001|Overall Study|Withdrawal by Subject|8|||
124908180|NCT02616900|449290454|FG000|Overall Study|Lack of Efficacy|7|||
124908181|NCT02616900|449290454|FG000|Overall Study|Lost to Follow-up|2|||
124908182|NCT02616900|449290454|FG000|Overall Study|Protocol Violation|5|||
124908183|NCT02616900|449290454|FG000|Overall Study|Withdrawal by Subject|3|||
124908184|NCT02616900|449290454|FG000|Overall Study|Incomplete data|6|||
124908185|NCT02499159|449290455|FG000|Randomization|Protocol Violation|1|||
124908186|NCT02499159|449290456|FG001|Randomization|Protocol Violation|1|||
124908187|NCT02499159|449290455|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
124908188|NCT02499159|449290456|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
124908189|NCT02499159|449290455|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
124908190|NCT02499159|449290456|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
124908191|NCT02499159|449290455|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
124908192|NCT02499159|449290456|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
124908193|NCT02499159|449290455|FG000|30-Day Follow-Up Phone Call|Other|1|||
124908194|NCT02499159|449290456|FG001|30-Day Follow-Up Phone Call|Other|0|||
124908195|NCT02601820|449290457|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
124908196|NCT02601820|449290457|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
124908197|NCT02601820|449290457|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
124908198|NCT02601820|449290457|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
124908199|NCT02242487|449290458|FG000|Overall Study|Adverse Event|13|||
124908200|NCT02242487|449290459|FG001|Overall Study|Adverse Event|15|||
124908201|NCT02242487|449290458|FG000|Overall Study|Lack of Efficacy|4|||
124908202|NCT02242487|449290459|FG001|Overall Study|Lack of Efficacy|6|||
124908203|NCT02242487|449290458|FG000|Overall Study|Protocol Violation|2|||
124908204|NCT02242487|449290459|FG001|Overall Study|Protocol Violation|0|||
124908205|NCT02242487|449290458|FG000|Overall Study|Lost to Follow-up|2|||
124908206|NCT02242487|449290459|FG001|Overall Study|Lost to Follow-up|1|||
124908207|NCT02242487|449290458|FG000|Overall Study|Other - Miscellaneous|4|||
124908208|NCT02242487|449290459|FG001|Overall Study|Other - Miscellaneous|6|||
124908209|NCT02242487|449290458|FG000|Overall Study|Withdrawal by Subject|37|||
124908210|NCT02242487|449290459|FG001|Overall Study|Withdrawal by Subject|19|||
124908211|NCT01599793|449290460|FG000|Overall Study|Adverse Event|2|||
124908212|NCT02564744|449290464|FG000|Overall Study|Investigator decision|0|||
124908213|NCT02564744|449290465|FG001|Overall Study|Investigator decision|0|||
124908214|NCT02564744|449290466|FG002|Overall Study|Investigator decision|0|||
124908215|NCT02564744|449290467|FG003|Overall Study|Investigator decision|0|||
124908216|NCT02564744|449290468|FG004|Overall Study|Investigator decision|1|||
124908217|NCT02564744|449290464|FG000|Overall Study|Death|10|||
124908218|NCT02564744|449290465|FG001|Overall Study|Death|5|||
124908219|NCT02564744|449290466|FG002|Overall Study|Death|4|||
124908220|NCT02564744|449290467|FG003|Overall Study|Death|16|||
124908221|NCT02564744|449290468|FG004|Overall Study|Death|16|||
124908222|NCT02564744|449290464|FG000|Overall Study|End of study Page Missing|0|||
124908223|NCT02564744|449290465|FG001|Overall Study|End of study Page Missing|0|||
124908224|NCT02564744|449290466|FG002|Overall Study|End of study Page Missing|3|||
124908225|NCT02564744|449290467|FG003|Overall Study|End of study Page Missing|3|||
124908226|NCT02564744|449290468|FG004|Overall Study|End of study Page Missing|0|||
124908227|NCT02564744|449290464|FG000|Overall Study|Subject Withdrew Consent|1|||
124908228|NCT02564744|449290465|FG001|Overall Study|Subject Withdrew Consent|1|||
124908229|NCT02564744|449290466|FG002|Overall Study|Subject Withdrew Consent|1|||
124908230|NCT02564744|449290467|FG003|Overall Study|Subject Withdrew Consent|0|||
124908231|NCT02564744|449290468|FG004|Overall Study|Subject Withdrew Consent|2|||
124908232|NCT02564744|449290464|FG000|Overall Study|Lost to Follow-up|0|||
124908233|NCT02564744|449290465|FG001|Overall Study|Lost to Follow-up|1|||
124908234|NCT02564744|449290466|FG002|Overall Study|Lost to Follow-up|0|||
124908235|NCT02564744|449290467|FG003|Overall Study|Lost to Follow-up|0|||
124450013|NCT03250832|447609619|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
124450014|NCT03250832|447609620|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
124908236|NCT02564744|449290468|FG004|Overall Study|Lost to Follow-up|1|||
124908237|NCT02564744|449290464|FG000|Overall Study|Reason not specified|1|||
124450015|NCT03250832|447609621|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
124908238|NCT02564744|449290465|FG001|Overall Study|Reason not specified|0|||
124908239|NCT02564744|449290466|FG002|Overall Study|Reason not specified|0|||
124908240|NCT02564744|449290467|FG003|Overall Study|Reason not specified|0|||
124908241|NCT02564744|449290468|FG004|Overall Study|Reason not specified|0|||
124908242|NCT00508924|449290472|FG000|Overall Study|Protocol Violation|0|||
124908243|NCT00508924|449290473|FG001|Overall Study|Protocol Violation|0|||
124908244|NCT00508924|449290474|FG002|Overall Study|Protocol Violation|1|||
124908245|NCT00508924|449290475|FG003|Overall Study|Protocol Violation|1|||
124908246|NCT02755805|449290476|FG000|Overall Study|Lost to Follow-up|1|||
124908247|NCT02755805|449290477|FG001|Overall Study|Lost to Follow-up|2|||
124908248|NCT02755805|449290476|FG000|Overall Study|Refused assessments|1|||
124908249|NCT02755805|449290477|FG001|Overall Study|Refused assessments|0|||
124908250|NCT02755805|449290476|FG000|Overall Study|Withdrawal by Subject|0|||
124908251|NCT02755805|449290477|FG001|Overall Study|Withdrawal by Subject|2|||
124908252|NCT02252042|449290480|FG000|Overall Study|Adverse Event|9|||
124908253|NCT02252042|449290481|FG001|Overall Study|Adverse Event|6|||
124908254|NCT02252042|449290480|FG000|Overall Study|Death|209|||
124908255|NCT02252042|449290481|FG001|Overall Study|Death|217|||
124908256|NCT02252042|449290480|FG000|Overall Study|Physician Decision|0|||
124908257|NCT02252042|449290481|FG001|Overall Study|Physician Decision|2|||
124908258|NCT02252042|449290480|FG000|Overall Study|Transferred to Extension Study|7|||
124908259|NCT02252042|449290481|FG001|Overall Study|Transferred to Extension Study|1|||
124908260|NCT02252042|449290480|FG000|Overall Study|Did Not Continue on Extension Study|7|||
124908261|NCT02252042|449290481|FG001|Overall Study|Did Not Continue on Extension Study|2|||
124908262|NCT02252042|449290480|FG000|Overall Study|Withdrawal by Subject|15|||
124908263|NCT02252042|449290481|FG001|Overall Study|Withdrawal by Subject|20|||
124908264|NCT01460290|449290484|FG000|Overall Study|Adverse Event|3|||
124908265|NCT01460290|449290484|FG000|Overall Study|Elevated liver function|1|||
124908266|NCT01190007|449290489|FG000|Overall Study|Withdrawal by Subject|4|||
124908267|NCT01190007|449290489|FG000|Overall Study|Adverse Event|8|||
124908268|NCT01190007|449290489|FG000|Overall Study|Difficulty of visit for complications|1|||
124908269|NCT01190007|449290489|FG000|Overall Study|Participant was arrested|1|||
124908270|NCT00439569|449290494|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
124908271|NCT00439569|449290494|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
124908272|NCT00439569|449290494|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
124908273|NCT02755116|449290495|FG000|Overall Study|surgery converted to open, pt admitted|3|||
124908274|NCT02755116|449290496|FG001|Overall Study|surgery converted to open, pt admitted|1|||
124908275|NCT01124734|449290497|FG000|Overall Study|Disease progression|13|||
124908276|NCT01124734|449290497|FG000|Overall Study|Adverse Event|1|||
124908277|NCT01124734|449290497|FG000|Overall Study|Withdrawal by Subject|1|||
124908278|NCT01124734|449290497|FG000|Overall Study|Elected for alternative treatment|2|||
124908279|NCT02214160|449290498|FG000|Overall Study|Withdrawal by Subject|1|||
124908280|NCT02214160|449290499|FG001|Overall Study|Withdrawal by Subject|0|||
124908281|NCT02214160|449290500|FG002|Overall Study|Withdrawal by Subject|6|||
124908282|NCT02214160|449290498|FG000|Overall Study|Death|2|||
124908283|NCT02214160|449290499|FG001|Overall Study|Death|2|||
124908284|NCT02214160|449290500|FG002|Overall Study|Death|1|||
124908285|NCT02214160|449290498|FG000|Overall Study|Subject Non-Compliance|0|||
124691815|NCT00366535|448492268|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
124691816|NCT00366535|448492269|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
124691817|NCT00366535|448492268|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
124691818|NCT00366535|448492269|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
124908286|NCT02214160|449290499|FG001|Overall Study|Subject Non-Compliance|3|||
124908287|NCT02214160|449290500|FG002|Overall Study|Subject Non-Compliance|1|||
124691819|NCT00250718|448492272|FG000|Overall Study|Death|1|||
124691820|NCT00250718|448492272|FG000|Overall Study|Adverse Event|1|||
124691821|NCT00250718|448492272|FG000|Overall Study|Withdrawal by Subject|1|||
124691822|NCT01666314|448492273|FG000|Overall Study|Adverse Event|3|||
124691823|NCT01666314|448492274|FG001|Overall Study|Adverse Event|13|||
124691824|NCT01666314|448492275|FG002|Overall Study|Adverse Event|7|||
124691825|NCT01666314|448492276|FG003|Overall Study|Adverse Event|7|||
124691826|NCT01666314|448492273|FG000|Overall Study|Progressive Disease|11|||
124691827|NCT01666314|448492274|FG001|Overall Study|Progressive Disease|9|||
124691828|NCT01666314|448492275|FG002|Overall Study|Progressive Disease|19|||
124691829|NCT01666314|448492276|FG003|Overall Study|Progressive Disease|20|||
124691830|NCT01666314|448492273|FG000|Overall Study|Symptomatic Deterioration|1|||
124691831|NCT01666314|448492274|FG001|Overall Study|Symptomatic Deterioration|0|||
124691832|NCT01666314|448492275|FG002|Overall Study|Symptomatic Deterioration|2|||
124691833|NCT01666314|448492276|FG003|Overall Study|Symptomatic Deterioration|0|||
124691834|NCT01666314|448492273|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
124691835|NCT01666314|448492274|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
124691836|NCT01666314|448492275|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
124691837|NCT01666314|448492276|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
124691838|NCT01666314|448492273|FG000|Overall Study|Withdrawal by Subject|1|||
124691839|NCT01666314|448492274|FG001|Overall Study|Withdrawal by Subject|1|||
124691840|NCT01666314|448492275|FG002|Overall Study|Withdrawal by Subject|2|||
124691841|NCT01666314|448492276|FG003|Overall Study|Withdrawal by Subject|3|||
124691842|NCT01666314|448492273|FG000|Overall Study|Reason not Specified|10|||
124691843|NCT01666314|448492274|FG001|Overall Study|Reason not Specified|7|||
124908288|NCT02214160|449290498|FG000|Overall Study|Adverse Event|0|||
124450016|NCT03250832|447609622|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
124450017|NCT03250832|447609623|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
124450018|NCT03250832|447609624|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
124450019|NCT03250832|447609625|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
124450020|NCT03250832|447609626|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
124450021|NCT03250832|447609627|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
124450022|NCT03250832|447609628|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
124450023|NCT03250832|447609629|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
124450024|NCT03250832|447609630|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
124450025|NCT03250832|447609619|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
124450026|NCT03250832|447609620|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
124450027|NCT03250832|447609621|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
124450028|NCT03250832|447609622|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
124450029|NCT03250832|447609623|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
124450030|NCT03250832|447609624|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
124450031|NCT03250832|447609625|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
124908289|NCT02214160|449290499|FG001|Overall Study|Adverse Event|1|||
124908290|NCT02214160|449290500|FG002|Overall Study|Adverse Event|1|||
124908291|NCT02214160|449290498|FG000|Overall Study|Sponsor Decision|0|||
124908292|NCT02214160|449290499|FG001|Overall Study|Sponsor Decision|2|||
124908293|NCT02214160|449290500|FG002|Overall Study|Sponsor Decision|0|||
124908294|NCT02214160|449290498|FG000|Overall Study|Protocol Violation|1|||
124908295|NCT02214160|449290499|FG001|Overall Study|Protocol Violation|0|||
124908296|NCT02214160|449290500|FG002|Overall Study|Protocol Violation|0|||
124908297|NCT02214160|449290498|FG000|Overall Study|Physician Decision|0|||
124908298|NCT02214160|449290499|FG001|Overall Study|Physician Decision|0|||
124908299|NCT02214160|449290500|FG002|Overall Study|Physician Decision|1|||
124908300|NCT02423798|449290501|FG000|Overall Study|Withdrawal by Subject|3|||
124908301|NCT01063972|449290502|FG000|Overall Study|Death|12|||
124908302|NCT01063972|449290503|FG001|Overall Study|Death|11|||
124908303|NCT01063972|449290502|FG000|Overall Study|Incarcerated|2|||
124908304|NCT01063972|449290503|FG001|Overall Study|Incarcerated|1|||
124908305|NCT01510717|449290505|FG000|Overall Study|Adverse Event|1|||
124908306|NCT01510717|449290506|FG001|Overall Study|Adverse Event|2|||
124908307|NCT01510717|449290505|FG000|Overall Study|Death|1|||
124908308|NCT01510717|449290506|FG001|Overall Study|Death|0|||
124908309|NCT01510717|449290505|FG000|Overall Study|Lost to Follow-up|0|||
124908310|NCT01510717|449290506|FG001|Overall Study|Lost to Follow-up|1|||
124908311|NCT01510717|449290505|FG000|Overall Study|Withdrawal by Subject|0|||
124908312|NCT01510717|449290506|FG001|Overall Study|Withdrawal by Subject|2|||
124450032|NCT03250832|447609626|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
124450033|NCT03250832|447609627|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
124450034|NCT03250832|447609628|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
124450035|NCT03250832|447609629|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
124450036|NCT03250832|447609630|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
124450037|NCT03250832|447609619|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
124450038|NCT03250832|447609620|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
124450039|NCT03250832|447609621|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
124450040|NCT03250832|447609622|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
124450041|NCT03250832|447609623|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
124450042|NCT03250832|447609624|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
124450043|NCT03250832|447609625|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
124450044|NCT03250832|447609626|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
124450045|NCT03250832|447609627|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
124450046|NCT03250832|447609628|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
124450047|NCT03250832|447609629|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
124450048|NCT03250832|447609630|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
124450049|NCT03250832|447609619|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
124450050|NCT03250832|447609620|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
124450051|NCT03250832|447609621|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
124450052|NCT03250832|447609622|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
124450053|NCT03250832|447609623|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
124450054|NCT03250832|447609624|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
124450055|NCT03250832|447609625|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
124691844|NCT01666314|448492275|FG002|Overall Study|Reason not Specified|5|||
124691845|NCT01666314|448492276|FG003|Overall Study|Reason not Specified|5|||
124908313|NCT01264679|449290507|FG000|Overall Study|Participation in Another Clinical Trial|1|||
124691846|NCT03003468|448492279|FG000|Overall Study|Withdrawal by Subject|0|||
124908314|NCT01264679|449290507|FG000|Overall Study|Physician Decision|1|||
124908315|NCT01264679|449290507|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
124908316|NCT01264679|449290507|FG000|Overall Study|Withdrawal by Subject|1|||
124908317|NCT00468052|449290512|FG000|Overall Study|Protocol Violation|7|||
124908318|NCT00468052|449290513|FG001|Overall Study|Protocol Violation|8|||
124908319|NCT02204982|449290516|FG000|Overall Study|Patient ineligible-medical monitor|1|||
124908320|NCT02204982|449290517|FG001|Overall Study|Patient ineligible-medical monitor|0|||
124908321|NCT02204982|449290516|FG000|Overall Study|Withdrawal by Subject|1|||
124908322|NCT02204982|449290517|FG001|Overall Study|Withdrawal by Subject|0|||
124908323|NCT02204982|449290516|FG000|Overall Study|Adverse Event|1|||
124908324|NCT02204982|449290517|FG001|Overall Study|Adverse Event|0|||
124908325|NCT02204982|449290516|FG000|Overall Study|Adverse Event and Investigator decision|1|||
124908326|NCT02204982|449290517|FG001|Overall Study|Adverse Event and Investigator decision|0|||
124908327|NCT02204982|449290516|FG000|Overall Study|Physician Decision|0|||
124908328|NCT02204982|449290517|FG001|Overall Study|Physician Decision|2|||
124908329|NCT02204982|449290516|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
124908330|NCT02204982|449290517|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
124908331|NCT02204982|449290516|FG000|Overall Study|Termination of Study bySponsor|0|||
124908332|NCT02204982|449290517|FG001|Overall Study|Termination of Study bySponsor|1|||
124908333|NCT00159783|449290518|FG000|Overall Study|Adverse Event|5|||
124908334|NCT00159783|449290519|FG001|Overall Study|Adverse Event|7|||
124908335|NCT00159783|449290520|FG002|Overall Study|Adverse Event|9|||
124908336|NCT00159783|449290518|FG000|Overall Study|Lack of Efficacy|1|||
124908337|NCT00159783|449290519|FG001|Overall Study|Lack of Efficacy|2|||
124908338|NCT00159783|449290520|FG002|Overall Study|Lack of Efficacy|3|||
124908339|NCT00159783|449290518|FG000|Overall Study|Withdrawal by Subject|7|||
124908340|NCT00159783|449290519|FG001|Overall Study|Withdrawal by Subject|11|||
124908341|NCT00159783|449290520|FG002|Overall Study|Withdrawal by Subject|12|||
124908342|NCT00159783|449290518|FG000|Overall Study|Lost to Follow-up|6|||
124908343|NCT00159783|449290519|FG001|Overall Study|Lost to Follow-up|5|||
124908344|NCT00159783|449290520|FG002|Overall Study|Lost to Follow-up|11|||
124908345|NCT00159783|449290518|FG000|Overall Study|Other|0|||
124908346|NCT00159783|449290519|FG001|Overall Study|Other|2|||
124908347|NCT00159783|449290520|FG002|Overall Study|Other|4|||
124908348|NCT02928224|449290521|FG000|Overall Study|Lost to Follow-up|1|||
124908349|NCT02928224|449290522|FG001|Overall Study|Lost to Follow-up|1|||
124908350|NCT02928224|449290523|FG002|Overall Study|Lost to Follow-up|3|||
124908351|NCT02928224|449290524|FG003|Overall Study|Lost to Follow-up|0|||
124908352|NCT02928224|449290521|FG000|Overall Study|Death|30|||
124908353|NCT02928224|449290522|FG001|Overall Study|Death|209|||
124908354|NCT02928224|449290523|FG002|Overall Study|Death|193|||
124908355|NCT02928224|449290524|FG003|Overall Study|Death|198|||
124908356|NCT02928224|449290521|FG000|Overall Study|Withdrawal by Subject|0|||
124908357|NCT02928224|449290522|FG001|Overall Study|Withdrawal by Subject|3|||
124908358|NCT02928224|449290523|FG002|Overall Study|Withdrawal by Subject|7|||
124908359|NCT02928224|449290524|FG003|Overall Study|Withdrawal by Subject|20|||
124908360|NCT02928224|449290521|FG000|Overall Study|Study participation terminated by sponsor|3|||
124908361|NCT02928224|449290522|FG001|Overall Study|Study participation terminated by sponsor|8|||
124691847|NCT03003468|448492280|FG001|Overall Study|Withdrawal by Subject|0|||
124691848|NCT03003468|448492281|FG002|Overall Study|Withdrawal by Subject|1|||
124908362|NCT02928224|449290523|FG002|Overall Study|Study participation terminated by sponsor|12|||
124908363|NCT02928224|449290524|FG003|Overall Study|Study participation terminated by sponsor|3|||
124908364|NCT02928224|449290521|FG000|Overall Study|Other|3|||
124908365|NCT02928224|449290522|FG001|Overall Study|Other|3|||
124908366|NCT02928224|449290523|FG002|Overall Study|Other|5|||
124908367|NCT02928224|449290524|FG003|Overall Study|Other|0|||
124908368|NCT00468910|449290525|FG000|Overall Study|Lost to Follow-up|2|||
124908369|NCT00468910|449290526|FG001|Overall Study|Lost to Follow-up|1|||
124908370|NCT00468910|449290525|FG000|Overall Study|Withdrawal by Subject|2|||
124908371|NCT00468910|449290526|FG001|Overall Study|Withdrawal by Subject|1|||
124691849|NCT03003468|448492279|FG000|Overall Study|No measurable lesions|0|||
124691850|NCT03003468|448492280|FG001|Overall Study|No measurable lesions|0|||
124691851|NCT03003468|448492281|FG002|Overall Study|No measurable lesions|1|||
124691852|NCT02114684|448492282|FG000|Overall Study|Death|6|||
124691853|NCT02114684|448492283|FG001|Overall Study|Death|4|||
124691854|NCT02114684|448492282|FG000|Overall Study|Lost to Follow-up|1|||
124691855|NCT02114684|448492283|FG001|Overall Study|Lost to Follow-up|2|||
124691856|NCT02114684|448492282|FG000|Overall Study|Withdrawal by Subject|1|||
124691857|NCT02114684|448492283|FG001|Overall Study|Withdrawal by Subject|2|||
124691858|NCT02114684|448492282|FG000|Overall Study|Relocation|3|||
124691859|NCT02114684|448492283|FG001|Overall Study|Relocation|1|||
124691860|NCT02114684|448492282|FG000|Overall Study|Rifampicin resistant on culture|0|||
124691861|NCT02114684|448492283|FG001|Overall Study|Rifampicin resistant on culture|1|||
124760354|NCT05579977|448746887|FG005|Treatment Phase|Other|2|||
124760355|NCT05579977|448746888|FG006|Treatment Phase|Other|1|||
124691862|NCT02114684|448492282|FG000|Overall Study|Patient Incarcerated|1|||
124691863|NCT02114684|448492283|FG001|Overall Study|Patient Incarcerated|0|||
124691864|NCT00003474|448492293|FG000|Overall Study|Not Evaluable|14|||
124691865|NCT02487199|448492302|FG000|Overall Study|Withdrew Consent|0|||
124908372|NCT00468910|449290525|FG000|Overall Study|Medical Contraindication|0|||
124908373|NCT00468910|449290526|FG001|Overall Study|Medical Contraindication|1|||
124908374|NCT01576484|449290527|FG000|Overall Study|Adverse Event|1|||
124908375|NCT01576484|449290528|FG001|Overall Study|Adverse Event|1|||
124908376|NCT01576484|449290527|FG000|Overall Study|Protocol Violation|0|||
124908377|NCT01576484|449290528|FG001|Overall Study|Protocol Violation|2|||
124908378|NCT01576484|449290527|FG000|Overall Study|Sponsor Decision|2|||
124908379|NCT01576484|449290528|FG001|Overall Study|Sponsor Decision|8|||
124908380|NCT01576484|449290527|FG000|Overall Study|Withdrawal by Subject|0|||
124908381|NCT01576484|449290528|FG001|Overall Study|Withdrawal by Subject|3|||
124908382|NCT01576484|449290527|FG000|Overall Study|Other|2|||
124908383|NCT01576484|449290528|FG001|Overall Study|Other|5|||
124908384|NCT01943799|449290545|FG000|Overall Study|Lost to Follow-up|0|||
124908385|NCT01943799|449290546|FG001|Overall Study|Lost to Follow-up|1|||
124908386|NCT01943799|449290547|FG002|Overall Study|Lost to Follow-up|1|||
124908387|NCT01943799|449290548|FG003|Overall Study|Lost to Follow-up|0|||
124760356|NCT05579977|448746889|FG007|Treatment Phase|Other|2|||
124908388|NCT01943799|449290545|FG000|Overall Study|Protocol Violation|1|||
124908389|NCT01943799|449290546|FG001|Overall Study|Protocol Violation|0|||
124908390|NCT01943799|449290547|FG002|Overall Study|Protocol Violation|0|||
124908391|NCT01943799|449290548|FG003|Overall Study|Protocol Violation|0|||
124908392|NCT01943799|449290545|FG000|Overall Study|Withdrawal by Subject|4|||
124908393|NCT01943799|449290546|FG001|Overall Study|Withdrawal by Subject|2|||
124908394|NCT01943799|449290547|FG002|Overall Study|Withdrawal by Subject|1|||
124908395|NCT01943799|449290548|FG003|Overall Study|Withdrawal by Subject|0|||
124908396|NCT04594759|449290549|FG000|Overall Study|Lost to Follow-up|3|||
124908397|NCT03811574|449290550|FG000|Overall Study|Withdrawal by Subject|2|||
124908398|NCT03811574|449290551|FG001|Overall Study|Withdrawal by Subject|4|||
124908399|NCT03811574|449290552|FG002|Overall Study|Withdrawal by Subject|0|||
124908400|NCT01832480|449290553|FG000|Overall Study|Lost to Follow-up|33|||
124908401|NCT01832480|449290554|FG001|Overall Study|Lost to Follow-up|30|||
124908402|NCT01832480|449290553|FG000|Overall Study|Withdrawal by Subject|0|||
124908403|NCT01832480|449290554|FG001|Overall Study|Withdrawal by Subject|2|||
124908404|NCT01832480|449290553|FG000|Overall Study|post randomization ineligible|8|||
124908405|NCT01832480|449290554|FG001|Overall Study|post randomization ineligible|10|||
124908406|NCT00958633|449290557|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
124908407|NCT00958633|449290558|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
124908408|NCT00958633|449290559|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
124908409|NCT00958633|449290557|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
124908410|NCT00958633|449290558|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
124908411|NCT00958633|449290559|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
124908412|NCT00958633|449290557|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
124908413|NCT00958633|449290558|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
124908414|NCT00958633|449290559|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
124908415|NCT00958633|449290557|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
124908416|NCT00958633|449290558|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
124908417|NCT00958633|449290559|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
124908418|NCT00958633|449290557|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
124908419|NCT00958633|449290558|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
124908420|NCT00958633|449290559|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
124908421|NCT00958633|449290557|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
124908422|NCT00958633|449290558|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
124908423|NCT00958633|449290559|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
124908424|NCT00958633|449290557|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
124908425|NCT00958633|449290558|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
124908426|NCT00958633|449290559|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
124908427|NCT02674750|449290568|FG000|Overall Study|Death|4|||
124908428|NCT02674750|449290569|FG001|Overall Study|Death|5|||
124908429|NCT02674750|449290570|FG002|Overall Study|Death|8|||
124908430|NCT02674750|449290568|FG000|Overall Study|Lost to Follow-up|0|||
124760357|NCT05579977|448746890|FG008|Treatment Phase|Other|2|||
124760358|NCT05579977|448746891|FG009|Treatment Phase|Other|1|||
124908431|NCT02674750|449290569|FG001|Overall Study|Lost to Follow-up|8|||
124908432|NCT02674750|449290570|FG002|Overall Study|Lost to Follow-up|0|||
124908433|NCT02674750|449290568|FG000|Overall Study|Lack of Efficacy|1|||
124908434|NCT02674750|449290569|FG001|Overall Study|Lack of Efficacy|17|||
124908435|NCT02674750|449290570|FG002|Overall Study|Lack of Efficacy|3|||
124908436|NCT02674750|449290568|FG000|Overall Study|Withdrawal by Subject|0|||
124908437|NCT02674750|449290569|FG001|Overall Study|Withdrawal by Subject|7|||
124908438|NCT02674750|449290570|FG002|Overall Study|Withdrawal by Subject|1|||
124908439|NCT02674750|449290568|FG000|Overall Study|Other|0|||
124908440|NCT02674750|449290569|FG001|Overall Study|Other|8|||
124908441|NCT02674750|449290570|FG002|Overall Study|Other|0|||
124760359|NCT05579977|448746892|FG010|Treatment Phase|Other|0|||
124908442|NCT01597258|449290571|FG000|Overall Study|No Drug Administration|1|||
124908443|NCT01415349|449290572|FG000|Treatment Period 1|Adverse Event|0|||
124908444|NCT01415349|449290573|FG001|Treatment Period 1|Adverse Event|1|||
124908445|NCT01415349|449290572|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124908446|NCT01415349|449290573|FG001|Treatment Period 1|Withdrawal by Subject|1|||
124908447|NCT01616459|449290574|FG000|Overall Study|Adverse Event|1|||
124908448|NCT01616459|449290575|FG001|Overall Study|Adverse Event|1|||
124908449|NCT01616459|449290576|FG002|Overall Study|Adverse Event|2|||
124908450|NCT01616459|449290577|FG003|Overall Study|Adverse Event|0|||
124908451|NCT01616459|449290574|FG000|Overall Study|Lost to Follow-up|1|||
124908452|NCT01616459|449290575|FG001|Overall Study|Lost to Follow-up|11|||
124908453|NCT01616459|449290576|FG002|Overall Study|Lost to Follow-up|3|||
124908454|NCT01616459|449290577|FG003|Overall Study|Lost to Follow-up|2|||
124908455|NCT01616459|449290574|FG000|Overall Study|Protocol Violation|0|||
124908456|NCT01616459|449290575|FG001|Overall Study|Protocol Violation|0|||
124908457|NCT01616459|449290576|FG002|Overall Study|Protocol Violation|0|||
124908458|NCT01616459|449290577|FG003|Overall Study|Protocol Violation|2|||
124908459|NCT01616459|449290574|FG000|Overall Study|Withdrawal by Subject|2|||
124450056|NCT03250832|447609626|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
124450057|NCT03250832|447609627|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
124450058|NCT03250832|447609628|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
124450059|NCT03250832|447609629|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
124450060|NCT03250832|447609630|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
124450061|NCT03250832|447609619|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
124450062|NCT03250832|447609620|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
124450063|NCT03250832|447609621|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
124450064|NCT03250832|447609622|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
124450065|NCT03250832|447609623|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
124450066|NCT03250832|447609624|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
124450067|NCT03250832|447609625|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
124450068|NCT03250832|447609626|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
124450069|NCT03250832|447609627|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
124450070|NCT03250832|447609628|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
124450071|NCT03250832|447609629|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
124450072|NCT03250832|447609630|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
124450073|NCT04411628|447609631|FG000|Overall Study|Withdrawal by Subject|1|||
124450074|NCT04411628|447609632|FG001|Overall Study|Withdrawal by Subject|1|||
124450075|NCT04411628|447609633|FG002|Overall Study|Withdrawal by Subject|2|||
124450076|NCT04411628|447609634|FG003|Overall Study|Withdrawal by Subject|0|||
124450077|NCT04411628|447609631|FG000|Overall Study|Lost to Follow-up|0|||
124450078|NCT04411628|447609632|FG001|Overall Study|Lost to Follow-up|1|||
124450079|NCT04411628|447609633|FG002|Overall Study|Lost to Follow-up|0|||
124450080|NCT04411628|447609634|FG003|Overall Study|Lost to Follow-up|0|||
124450081|NCT01252810|447609635|FG000|Overall Study|Withdrawal by Subject|4|||
124450082|NCT01252810|447609636|FG001|Overall Study|Withdrawal by Subject|1|||
124450083|NCT01252810|447609635|FG000|Overall Study|Lost to Follow-up|0|||
124450084|NCT01252810|447609636|FG001|Overall Study|Lost to Follow-up|1|||
124450085|NCT01252810|447609635|FG000|Overall Study|Physician Decision|2|||
124450086|NCT01252810|447609636|FG001|Overall Study|Physician Decision|1|||
124450087|NCT01252810|447609635|FG000|Overall Study|Various reasons|8|||
124450088|NCT01252810|447609636|FG001|Overall Study|Various reasons|0|||
124466440|NCT01882907|447666401|FG001|Overall Study|Withdrawal by Subject|6|||
124466441|NCT03286842|447666403|FG000|Overall Study|Patients rolled over to another study|80|||
124466442|NCT01453855|447666407|FG000|Overall Study|Adverse Event|3|||
124466443|NCT01453855|447666408|FG001|Overall Study|Adverse Event|4|||
124466444|NCT01453855|447666407|FG000|Overall Study|Lost to Follow-up|2|||
124466445|NCT01453855|447666408|FG001|Overall Study|Lost to Follow-up|1|||
124466446|NCT01453855|447666407|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
124466447|NCT01453855|447666408|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
124466448|NCT01453855|447666407|FG000|Overall Study|Noncompliance|1|||
124466449|NCT01453855|447666408|FG001|Overall Study|Noncompliance|0|||
124466450|NCT01453855|447666407|FG000|Overall Study|Inadequate Control of IOP|1|||
124466451|NCT01453855|447666408|FG001|Overall Study|Inadequate Control of IOP|5|||
124466452|NCT01453855|447666407|FG000|Overall Study|Other|0|||
124466453|NCT01453855|447666408|FG001|Overall Study|Other|1|||
124466454|NCT01441063|447666413|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
124466455|NCT01441063|447666413|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
124691866|NCT02487199|448492303|FG001|Overall Study|Withdrew Consent|1|||
124466456|NCT02574637|447666416|FG000|Double-blind Period|Adverse Event|1|||
124466457|NCT02574637|447666417|FG001|Double-blind Period|Adverse Event|0|||
124466458|NCT02574637|447666418|FG002|Double-blind Period|Adverse Event|0|||
124466459|NCT02574637|447666419|FG003|Double-blind Period|Adverse Event|0|||
124466460|NCT02574637|447666420|FG004|Double-blind Period|Adverse Event|0|||
124466461|NCT02574637|447666421|FG005|Double-blind Period|Adverse Event|0|||
124466462|NCT02574637|447666422|FG006|Double-blind Period|Adverse Event|0|||
124466463|NCT02574637|447666423|FG007|Double-blind Period|Adverse Event|0|||
124908460|NCT01616459|449290575|FG001|Overall Study|Withdrawal by Subject|4|||
124908461|NCT01616459|449290576|FG002|Overall Study|Withdrawal by Subject|4|||
124691867|NCT00853047|448492304|FG000|Core Phase|Participant Request|0|||
124691868|NCT00853047|448492305|FG001|Core Phase|Participant Request|0|||
124691869|NCT00853047|448492306|FG002|Core Phase|Participant Request|0|||
124691870|NCT00853047|448492307|FG003|Core Phase|Participant Request|1|||
124691871|NCT00853047|448492308|FG004|Core Phase|Participant Request|0|||
124691872|NCT00853047|448492309|FG005|Core Phase|Participant Request|0|||
124691873|NCT00853047|448492304|FG000|Open-Label Extension Phase|Participant Request|0|||
124691874|NCT00853047|448492305|FG001|Open-Label Extension Phase|Participant Request|0|||
124691875|NCT00853047|448492306|FG002|Open-Label Extension Phase|Participant Request|0|||
124691876|NCT00853047|448492307|FG003|Open-Label Extension Phase|Participant Request|0|||
124691877|NCT00853047|448492308|FG004|Open-Label Extension Phase|Participant Request|0|||
124691878|NCT00853047|448492309|FG005|Open-Label Extension Phase|Participant Request|7|||
124691879|NCT00853047|448492304|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
124691880|NCT00853047|448492305|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
124691881|NCT00853047|448492306|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
124691882|NCT00853047|448492307|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
124908462|NCT01616459|449290577|FG003|Overall Study|Withdrawal by Subject|4|||
124908463|NCT01616459|449290574|FG000|Overall Study|Other reason|0|||
124908464|NCT01616459|449290575|FG001|Overall Study|Other reason|1|||
124908465|NCT01616459|449290576|FG002|Overall Study|Other reason|1|||
124908466|NCT01616459|449290577|FG003|Overall Study|Other reason|0|||
124908467|NCT04980755|449290578|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
124908468|NCT04980755|449290578|FG000|Body Reprogramming Courses|Work commitment|2|||
124908469|NCT04980755|449290578|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
124691883|NCT00853047|448492308|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
124691884|NCT00853047|448492309|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
124691885|NCT00853047|448492304|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
124691886|NCT00853047|448492305|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
124691887|NCT00853047|448492306|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
124691888|NCT00853047|448492307|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
124691889|NCT00853047|448492308|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
124691890|NCT00853047|448492309|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
124691891|NCT00853047|448492304|FG000|Open-Label Extension Phase|Investigator Decision|0|||
124691892|NCT00853047|448492305|FG001|Open-Label Extension Phase|Investigator Decision|0|||
124691893|NCT00853047|448492306|FG002|Open-Label Extension Phase|Investigator Decision|0|||
124691894|NCT00853047|448492307|FG003|Open-Label Extension Phase|Investigator Decision|0|||
124691895|NCT00853047|448492308|FG004|Open-Label Extension Phase|Investigator Decision|0|||
124691896|NCT00853047|448492309|FG005|Open-Label Extension Phase|Investigator Decision|1|||
124691897|NCT00853047|448492304|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
124691898|NCT00853047|448492305|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
124691899|NCT00853047|448492306|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
124691900|NCT00853047|448492307|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
124691901|NCT00853047|448492308|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
124691902|NCT00853047|448492309|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
124691903|NCT00422461|448494587|FG000|Overall Study|Adverse Event|1|||
124691904|NCT00422461|448494588|FG001|Overall Study|Adverse Event|2|||
124691905|NCT00422461|448494589|FG002|Overall Study|Adverse Event|1|||
124691906|NCT00422461|448494590|FG003|Overall Study|Adverse Event|1|||
124691907|NCT00422461|448494587|FG000|Overall Study|Other|0|||
124691908|NCT00422461|448494588|FG001|Overall Study|Other|0|||
124691909|NCT00422461|448494589|FG002|Overall Study|Other|0|||
124691910|NCT00422461|448494590|FG003|Overall Study|Other|2|||
124691911|NCT00422461|448494587|FG000|Overall Study|Participants no longer willing to participate in study|1|||
124691912|NCT00422461|448494588|FG001|Overall Study|Participants no longer willing to participate in study|0|||
124691913|NCT00422461|448494589|FG002|Overall Study|Participants no longer willing to participate in study|0|||
124691914|NCT00422461|448494590|FG003|Overall Study|Participants no longer willing to participate in study|0|||
124691915|NCT00422461|448494587|FG000|Overall Study|Randomized but not treated|1|||
124908470|NCT04980755|449290578|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
124908471|NCT00304031|449292011|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
124908472|NCT00304031|449292012|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
124908473|NCT00304031|449292013|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
124908474|NCT00304031|449292011|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
124908475|NCT00304031|449292012|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
124691916|NCT00422461|448494588|FG001|Overall Study|Randomized but not treated|1|||
124691917|NCT00422461|448494589|FG002|Overall Study|Randomized but not treated|0|||
124691918|NCT00422461|448494590|FG003|Overall Study|Randomized but not treated|0|||
124691919|NCT01471574|448494591|FG000|Treatment Period|Lack of Efficacy|12|||
124691920|NCT01471574|448494592|FG001|Treatment Period|Lack of Efficacy|4|||
124691921|NCT01471574|448494593|FG002|Treatment Period|Lack of Efficacy|14|||
124691922|NCT01471574|448494594|FG003|Treatment Period|Lack of Efficacy|1|||
124691923|NCT01471574|448494591|FG000|Treatment Period|Adverse Event|7|||
124908476|NCT00304031|449292013|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
124908477|NCT00304031|449292011|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
124908478|NCT00304031|449292012|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
124908479|NCT00304031|449292013|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
124908480|NCT00304031|449292011|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
124908481|NCT00304031|449292012|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
124908482|NCT00304031|449292013|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
124908483|NCT00304031|449292011|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
124908484|NCT00304031|449292012|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
124908485|NCT00304031|449292013|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
124908486|NCT00304031|449292011|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
124908487|NCT00304031|449292012|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
124908488|NCT00304031|449292013|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
124908489|NCT00304031|449292011|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
124908490|NCT00304031|449292012|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
124908491|NCT00304031|449292013|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
124908492|NCT00304031|449292011|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
124908493|NCT00304031|449292012|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
124908494|NCT00304031|449292013|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
124908495|NCT00304031|449292011|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
124908496|NCT00304031|449292012|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
124908497|NCT00304031|449292013|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
124908498|NCT01188655|449292014|FG000|Overall Study|Lack of Efficacy|1|||
124908499|NCT01188655|449292014|FG000|Overall Study|Lost to Follow-up|1|||
124908500|NCT01188655|449292014|FG000|Overall Study|Other|11|||
124908501|NCT01875848|449292024|FG000|Overall Study|Withdrawal by Subject|2|||
124908502|NCT01875848|449292025|FG001|Overall Study|Withdrawal by Subject|0|||
124908503|NCT02189252|449292026|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
124908504|NCT02189252|449292027|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
124908505|NCT02189252|449292028|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
124908506|NCT02189252|449292029|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
124908507|NCT02189252|449292026|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
124908508|NCT02189252|449292027|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
124908509|NCT02189252|449292028|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
124908510|NCT02189252|449292029|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
124908511|NCT00840177|449292030|FG000|Overall Study|Adverse Event|5|||
124908512|NCT00840177|449292031|FG001|Overall Study|Adverse Event|1|||
124908513|NCT00840177|449292032|FG002|Overall Study|Adverse Event|1|||
124908514|NCT00840177|449292030|FG000|Overall Study|Refusal unrelated to adverse events|1|||
124908515|NCT00840177|449292031|FG001|Overall Study|Refusal unrelated to adverse events|0|||
124908516|NCT00840177|449292032|FG002|Overall Study|Refusal unrelated to adverse events|1|||
124908517|NCT00840177|449292030|FG000|Overall Study|Progression/relapse|2|||
124908518|NCT00840177|449292031|FG001|Overall Study|Progression/relapse|0|||
124908519|NCT00840177|449292032|FG002|Overall Study|Progression/relapse|0|||
124908520|NCT00840177|449292030|FG000|Overall Study|Death|4|||
124908521|NCT00840177|449292031|FG001|Overall Study|Death|5|||
124908522|NCT00840177|449292032|FG002|Overall Study|Death|5|||
124908523|NCT00840177|449292030|FG000|Overall Study|not protocol specified|6|||
124908524|NCT00840177|449292031|FG001|Overall Study|not protocol specified|3|||
124908525|NCT00840177|449292032|FG002|Overall Study|not protocol specified|0|||
124908526|NCT00840177|449292030|FG000|Overall Study|Ineligible|0|||
124760360|NCT05579977|448746893|FG011|Treatment Phase|Other|0|||
124908527|NCT00840177|449292031|FG001|Overall Study|Ineligible|0|||
124908528|NCT00840177|449292032|FG002|Overall Study|Ineligible|3|||
124908529|NCT00840177|449292030|FG000|Overall Study|Did not start treatment|0|||
124908530|NCT00840177|449292031|FG001|Overall Study|Did not start treatment|0|||
124908531|NCT00840177|449292032|FG002|Overall Study|Did not start treatment|1|||
124908532|NCT01391832|449292033|FG000|Overall Study|Withdrawal by Subject|21|||
124908533|NCT01391832|449292034|FG001|Overall Study|Withdrawal by Subject|22|||
124908534|NCT01391832|449292033|FG000|Overall Study|Lost to Follow-up|0|||
124908535|NCT01391832|449292034|FG001|Overall Study|Lost to Follow-up|1|||
124908536|NCT03345901|449292038|FG000|Overall Study|The study was terminated|18|||
124908537|NCT00722046|449292039|FG000|Overall Study|Adverse Event|0|||
124908538|NCT00722046|449292040|FG001|Overall Study|Adverse Event|1|||
124908539|NCT00722046|449292041|FG002|Overall Study|Adverse Event|2|||
124544714|NCT03110107|447949203|FG014|Treatment Period|Participants no longer meets study criteria|0|||
124544715|NCT03110107|447949204|FG015|Treatment Period|Participants no longer meets study criteria|0|||
124544716|NCT03110107|447949205|FG016|Treatment Period|Participants no longer meets study criteria|0|||
124544717|NCT03110107|447949206|FG017|Treatment Period|Participants no longer meets study criteria|0|||
124544718|NCT03110107|447949207|FG018|Treatment Period|Participants no longer meets study criteria|0|||
124544719|NCT03110107|447949208|FG019|Treatment Period|Participants no longer meets study criteria|0|||
124544720|NCT03110107|447949209|FG020|Treatment Period|Participants no longer meets study criteria|0|||
124544721|NCT03110107|447949210|FG021|Treatment Period|Participants no longer meets study criteria|0|||
124544722|NCT03110107|447949211|FG022|Treatment Period|Participants no longer meets study criteria|0|||
124544723|NCT03110107|447949212|FG023|Treatment Period|Participants no longer meets study criteria|1|||
124544724|NCT03110107|447949213|FG024|Treatment Period|Participants no longer meets study criteria|0|||
124544725|NCT03110107|447949214|FG025|Treatment Period|Participants no longer meets study criteria|0|||
124544726|NCT03110107|447949189|FG000|Treatment Period|Other Reasons|0|||
124544727|NCT03110107|447949190|FG001|Treatment Period|Other Reasons|0|||
124544728|NCT03110107|447949191|FG002|Treatment Period|Other Reasons|1|||
124544729|NCT03110107|447949192|FG003|Treatment Period|Other Reasons|1|||
124544730|NCT03110107|447949193|FG004|Treatment Period|Other Reasons|0|||
124544731|NCT03110107|447949194|FG005|Treatment Period|Other Reasons|1|||
124544732|NCT03110107|447949195|FG006|Treatment Period|Other Reasons|0|||
124544733|NCT03110107|447949196|FG007|Treatment Period|Other Reasons|0|||
124544734|NCT03110107|447949197|FG008|Treatment Period|Other Reasons|0|||
124544735|NCT03110107|447949198|FG009|Treatment Period|Other Reasons|0|||
124544736|NCT03110107|447949199|FG010|Treatment Period|Other Reasons|0|||
124544737|NCT03110107|447949200|FG011|Treatment Period|Other Reasons|0|||
124544738|NCT03110107|447949201|FG012|Treatment Period|Other Reasons|0|||
124544739|NCT03110107|447949202|FG013|Treatment Period|Other Reasons|0|||
124544740|NCT03110107|447949203|FG014|Treatment Period|Other Reasons|0|||
124544741|NCT03110107|447949204|FG015|Treatment Period|Other Reasons|0|||
124544742|NCT03110107|447949205|FG016|Treatment Period|Other Reasons|0|||
124544743|NCT03110107|447949206|FG017|Treatment Period|Other Reasons|0|||
124544744|NCT03110107|447949207|FG018|Treatment Period|Other Reasons|0|||
124544745|NCT03110107|447949208|FG019|Treatment Period|Other Reasons|0|||
124544746|NCT03110107|447949209|FG020|Treatment Period|Other Reasons|0|||
124544747|NCT03110107|447949210|FG021|Treatment Period|Other Reasons|0|||
124544748|NCT03110107|447949211|FG022|Treatment Period|Other Reasons|0|||
124544749|NCT03110107|447949212|FG023|Treatment Period|Other Reasons|0|||
124544750|NCT03110107|447949213|FG024|Treatment Period|Other Reasons|1|||
124544751|NCT03110107|447949214|FG025|Treatment Period|Other Reasons|0|||
124544752|NCT03985982|447949215|FG000|Double-Blind Phase|Lost to Follow-up|4|||
124544753|NCT03985982|447949216|FG001|Double-Blind Phase|Lost to Follow-up|3|||
124544754|NCT03985982|447949217|FG002|Double-Blind Phase|Lost to Follow-up|0|||
124544755|NCT03985982|447949215|FG000|Double-Blind Phase|Physician Decision|1|||
124544756|NCT03985982|447949216|FG001|Double-Blind Phase|Physician Decision|0|||
124544757|NCT03985982|447949217|FG002|Double-Blind Phase|Physician Decision|0|||
124544758|NCT03985982|447949215|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
124544759|NCT03985982|447949216|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
124544760|NCT03985982|447949217|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
124544761|NCT03985982|447949215|FG000|Double-Blind Phase|COVID-19|1|||
124544762|NCT03985982|447949216|FG001|Double-Blind Phase|COVID-19|0|||
124544763|NCT03985982|447949217|FG002|Double-Blind Phase|COVID-19|0|||
124544764|NCT03985982|447949215|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
124544765|NCT03985982|447949216|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
124544766|NCT03985982|447949217|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
124544767|NCT03985982|447949215|FG000|Open-Label Phase|Lost to Follow-up|0|||
124544768|NCT03985982|447949216|FG001|Open-Label Phase|Lost to Follow-up|0|||
124544769|NCT03985982|447949217|FG002|Open-Label Phase|Lost to Follow-up|13|||
124544770|NCT03985982|447949215|FG000|Open-Label Phase|Physician Decision|0|||
124544771|NCT03985982|447949216|FG001|Open-Label Phase|Physician Decision|0|||
124544772|NCT03985982|447949217|FG002|Open-Label Phase|Physician Decision|2|||
124544773|NCT03985982|447949215|FG000|Open-Label Phase|Withdrawal by Subject|0|||
124908540|NCT00722046|449292042|FG003|Overall Study|Adverse Event|1|||
124908541|NCT00722046|449292043|FG004|Overall Study|Adverse Event|2|||
124544774|NCT03985982|447949216|FG001|Open-Label Phase|Withdrawal by Subject|0|||
124544775|NCT03985982|447949217|FG002|Open-Label Phase|Withdrawal by Subject|11|||
124544776|NCT03526549|447949219|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
124544777|NCT03526549|447949220|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
124544778|NCT03526549|447949219|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
124908542|NCT00722046|449292044|FG005|Overall Study|Adverse Event|1|||
124908543|NCT00722046|449292045|FG006|Overall Study|Adverse Event|0|||
124544779|NCT03526549|447949220|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
124544780|NCT03526549|447949219|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
124908544|NCT00722046|449292039|FG000|Overall Study|Death|0|||
124691924|NCT01471574|448494592|FG001|Treatment Period|Adverse Event|3|||
124691925|NCT01471574|448494593|FG002|Treatment Period|Adverse Event|6|||
124908545|NCT00722046|449292040|FG001|Overall Study|Death|1|||
124908546|NCT00722046|449292041|FG002|Overall Study|Death|0|||
124908547|NCT00722046|449292042|FG003|Overall Study|Death|0|||
124908548|NCT00722046|449292043|FG004|Overall Study|Death|0|||
124908549|NCT00722046|449292044|FG005|Overall Study|Death|0|||
124908550|NCT00722046|449292045|FG006|Overall Study|Death|2|||
124544781|NCT03526549|447949220|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
124544782|NCT03526549|447949219|FG000|Open-label Phase|Adverse Event|4|||
124544783|NCT03526549|447949220|FG001|Open-label Phase|Adverse Event|0|||
124544784|NCT03526549|447949219|FG000|Open-label Phase|Withdrawal by Subject|54|||
124544785|NCT03526549|447949220|FG001|Open-label Phase|Withdrawal by Subject|0|||
124544786|NCT03526549|447949219|FG000|Open-label Phase|Lost to Follow-up|35|||
124544787|NCT03526549|447949220|FG001|Open-label Phase|Lost to Follow-up|0|||
124544788|NCT03526549|447949219|FG000|Open-label Phase|Other than Specified|5|||
124544789|NCT03526549|447949220|FG001|Open-label Phase|Other than Specified|0|||
124544790|NCT05981365|447949227|FG000|Period 1|Adverse Event|1|||
124544791|NCT05981365|447949228|FG001|Period 1|Adverse Event|0|||
124544792|NCT04780776|447949229|FG000|Titration Week 1-5|Lost to Follow-up|2|||
124544793|NCT04780776|447949230|FG001|Titration Week 1-5|Lost to Follow-up|8|||
124544794|NCT04780776|447949229|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
124544795|NCT04780776|447949230|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
124544796|NCT04780776|447949229|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
124544797|NCT04780776|447949230|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
124544798|NCT03927989|447949231|FG000|Overall Study|Withdrawal by Subject|0|||
124544799|NCT03927989|447949232|FG001|Overall Study|Withdrawal by Subject|1|||
124544800|NCT03772574|447949233|FG000|Overall Study|Protocol Violation|2|||
124544801|NCT03772574|447949234|FG001|Overall Study|Protocol Violation|0|||
124544802|NCT03772574|447949235|FG002|Overall Study|Protocol Violation|0|||
124544803|NCT03772574|447949233|FG000|Overall Study|Discomfort|0|||
124544804|NCT03772574|447949234|FG001|Overall Study|Discomfort|5|||
124544805|NCT03772574|447949235|FG002|Overall Study|Discomfort|4|||
124544806|NCT03193996|447949239|FG000|Overall Study|Withdrawal by Subject|4|||
124544807|NCT03193996|447949239|FG000|Overall Study|Lost to Follow-up|4|||
124544808|NCT03193996|447949239|FG000|Overall Study|Physician Decision|2|||
124544809|NCT03193996|447949239|FG000|Overall Study|Pregnancy|1|||
124544810|NCT03193996|447949239|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
124544811|NCT03193996|447949239|FG000|Overall Study|Complicating disease|1|||
124544812|NCT00593385|447949243|FG000|Overall Study|Death|14|||
124544813|NCT00593385|447949243|FG000|Overall Study|Lost to Follow-up|17|||
124544814|NCT00593385|447949243|FG000|Overall Study|Withdrawal by Subject|9|||
124544815|NCT00348348|447949244|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
124544816|NCT00348348|447949245|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
124544817|NCT00348348|447949244|FG000|Overall Study|Lack of Efficacy|1|||
124544818|NCT00348348|447949245|FG001|Overall Study|Lack of Efficacy|1|||
124544819|NCT00348348|447949244|FG000|Overall Study|Lost to Follow-up|8|||
124544820|NCT00348348|447949245|FG001|Overall Study|Lost to Follow-up|10|||
124544821|NCT00348348|447949244|FG000|Overall Study|Withdrawal by Subject|4|||
124544822|NCT00348348|447949245|FG001|Overall Study|Withdrawal by Subject|1|||
124544823|NCT00348348|447949244|FG000|Overall Study|Other|7|||
124544824|NCT00348348|447949245|FG001|Overall Study|Other|4|||
124544825|NCT00348348|447949244|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
124544826|NCT00348348|447949245|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
124544827|NCT00348348|447949244|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
124691926|NCT01471574|448494594|FG003|Treatment Period|Adverse Event|1|||
124691927|NCT01471574|448494591|FG000|Treatment Period|Withdrawal by Subject|5|||
124691928|NCT01471574|448494592|FG001|Treatment Period|Withdrawal by Subject|1|||
124691929|NCT01471574|448494593|FG002|Treatment Period|Withdrawal by Subject|1|||
124691930|NCT01471574|448494594|FG003|Treatment Period|Withdrawal by Subject|0|||
124691931|NCT01471574|448494591|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
124908551|NCT00722046|449292039|FG000|Overall Study|Protocol Violation|1|||
124908552|NCT00722046|449292040|FG001|Overall Study|Protocol Violation|0|||
124908553|NCT00722046|449292041|FG002|Overall Study|Protocol Violation|0|||
124691932|NCT01471574|448494592|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
124760361|NCT05579977|448746894|FG012|Treatment Phase|Other|3|||
124544828|NCT00348348|447949245|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
124544829|NCT00348348|447949244|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
124544830|NCT00348348|447949245|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
124544831|NCT00348348|447949244|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
124544832|NCT00348348|447949245|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
124544833|NCT00348348|447949244|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
124544834|NCT00348348|447949245|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
124691933|NCT01471574|448494593|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
124908554|NCT00722046|449292042|FG003|Overall Study|Protocol Violation|0|||
124908555|NCT00722046|449292043|FG004|Overall Study|Protocol Violation|0|||
124908556|NCT00722046|449292044|FG005|Overall Study|Protocol Violation|1|||
124908557|NCT00722046|449292045|FG006|Overall Study|Protocol Violation|0|||
124908558|NCT00722046|449292039|FG000|Overall Study|Withdrawal by Subject|3|||
124908559|NCT00722046|449292040|FG001|Overall Study|Withdrawal by Subject|3|||
124908560|NCT00722046|449292041|FG002|Overall Study|Withdrawal by Subject|4|||
124908561|NCT00722046|449292042|FG003|Overall Study|Withdrawal by Subject|4|||
124908562|NCT00722046|449292043|FG004|Overall Study|Withdrawal by Subject|4|||
124908563|NCT00722046|449292044|FG005|Overall Study|Withdrawal by Subject|7|||
124908564|NCT00722046|449292045|FG006|Overall Study|Withdrawal by Subject|3|||
124908565|NCT00722046|449292039|FG000|Overall Study|Randomized, but not treated|1|||
124908566|NCT00722046|449292040|FG001|Overall Study|Randomized, but not treated|1|||
124908567|NCT00722046|449292041|FG002|Overall Study|Randomized, but not treated|0|||
124908568|NCT00722046|449292042|FG003|Overall Study|Randomized, but not treated|2|||
124908569|NCT00722046|449292043|FG004|Overall Study|Randomized, but not treated|0|||
124908570|NCT00722046|449292044|FG005|Overall Study|Randomized, but not treated|0|||
124908571|NCT00722046|449292045|FG006|Overall Study|Randomized, but not treated|0|||
124908572|NCT00722046|449292039|FG000|Overall Study|Other|0|||
124908573|NCT00722046|449292040|FG001|Overall Study|Other|0|||
124908574|NCT00722046|449292041|FG002|Overall Study|Other|1|||
124908575|NCT00722046|449292042|FG003|Overall Study|Other|1|||
124908576|NCT00722046|449292043|FG004|Overall Study|Other|3|||
124908577|NCT00722046|449292044|FG005|Overall Study|Other|2|||
124908578|NCT00722046|449292045|FG006|Overall Study|Other|1|||
124908579|NCT00686855|449292049|FG000|Overall Study|Lost to Follow-up|1|||
124908580|NCT00686855|449292050|FG001|Overall Study|Lost to Follow-up|0|||
124691934|NCT01471574|448494594|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
124691935|NCT01471574|448494591|FG000|Treatment Period|Lost to Follow-up|1|||
124691936|NCT01471574|448494592|FG001|Treatment Period|Lost to Follow-up|2|||
124691937|NCT01471574|448494593|FG002|Treatment Period|Lost to Follow-up|2|||
124691938|NCT01471574|448494594|FG003|Treatment Period|Lost to Follow-up|0|||
124691939|NCT01471574|448494591|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
124691940|NCT01471574|448494592|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
124908581|NCT00686855|449292049|FG000|Overall Study|Progressive GVHD|0|||
124908582|NCT00686855|449292050|FG001|Overall Study|Progressive GVHD|1|||
124908583|NCT02731755|449292056|FG000|First Intervention|Withdrawal by Subject|0|||
124908584|NCT02731755|449292057|FG001|First Intervention|Withdrawal by Subject|2|||
124908585|NCT00414544|449292060|FG000|Overall Study|Lost to Follow-up|14|||
124908586|NCT00799396|449292062|FG000|Clopidogrel Treatment|Adverse Event|6|||
124908587|NCT00799396|449292062|FG000|Clopidogrel Treatment|Physician Decision|5|||
124908588|NCT00799396|449292062|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
124908589|NCT00799396|449292062|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
124908590|NCT00799396|449292062|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
124908591|NCT01318382|449292065|FG000|Overall Study|Physician Decision|2|||
124908592|NCT01318382|449292065|FG000|Overall Study|Device Malfunction|10|||
124908593|NCT01318382|449292065|FG000|Overall Study|Protocol Violation|1|||
124908594|NCT01867216|449292066|FG000|Overall Study|Withdrawal by Subject|2|||
124908595|NCT01867216|449292067|FG001|Overall Study|Withdrawal by Subject|0|||
124908596|NCT01867216|449292068|FG002|Overall Study|Withdrawal by Subject|0|||
124908597|NCT01867216|449292069|FG003|Overall Study|Withdrawal by Subject|0|||
124908598|NCT01867216|449292070|FG004|Overall Study|Withdrawal by Subject|1|||
124908599|NCT01867216|449292071|FG005|Overall Study|Withdrawal by Subject|0|||
124908600|NCT01867216|449292072|FG006|Overall Study|Withdrawal by Subject|1|||
124908601|NCT01867216|449292066|FG000|Overall Study|Physician Decision|1|||
124908602|NCT01867216|449292067|FG001|Overall Study|Physician Decision|0|||
124908603|NCT01867216|449292068|FG002|Overall Study|Physician Decision|0|||
124908604|NCT01867216|449292069|FG003|Overall Study|Physician Decision|0|||
124908605|NCT01867216|449292070|FG004|Overall Study|Physician Decision|0|||
124908606|NCT01867216|449292071|FG005|Overall Study|Physician Decision|0|||
124908607|NCT01867216|449292072|FG006|Overall Study|Physician Decision|0|||
124908608|NCT01867216|449292066|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
124691941|NCT01471574|448494593|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
124691942|NCT01471574|448494594|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
124908609|NCT01867216|449292067|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
124908610|NCT01867216|449292068|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
124908611|NCT01867216|449292069|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
124908612|NCT01867216|449292070|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
124908613|NCT01867216|449292071|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
124908614|NCT01867216|449292072|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
124908615|NCT01599104|449292073|FG000|Overall Study|Withdrawal by Subject|1|||
124908616|NCT01599104|449292074|FG001|Overall Study|Withdrawal by Subject|1|||
124908617|NCT01599104|449292075|FG002|Overall Study|Withdrawal by Subject|2|||
124691943|NCT01471574|448494591|FG000|Treatment Period|Other|1|||
124908618|NCT01599104|449292073|FG000|Overall Study|Technical Problems|1|||
124908619|NCT01599104|449292074|FG001|Overall Study|Technical Problems|0|||
124908620|NCT01599104|449292075|FG002|Overall Study|Technical Problems|0|||
124908621|NCT01599104|449292073|FG000|Overall Study|Physician Decision|3|||
124908622|NCT01599104|449292074|FG001|Overall Study|Physician Decision|2|||
124691944|NCT01471574|448494592|FG001|Treatment Period|Other|0|||
124908623|NCT01599104|449292075|FG002|Overall Study|Physician Decision|2|||
124908624|NCT01599104|449292073|FG000|Overall Study|Non-compliance with study treatment|0|||
124908625|NCT01599104|449292074|FG001|Overall Study|Non-compliance with study treatment|1|||
124908626|NCT01599104|449292075|FG002|Overall Study|Non-compliance with study treatment|0|||
124908627|NCT01599104|449292073|FG000|Overall Study|Lack of Efficacy|4|||
124908628|NCT01599104|449292074|FG001|Overall Study|Lack of Efficacy|4|||
124908629|NCT01599104|449292075|FG002|Overall Study|Lack of Efficacy|10|||
124908630|NCT01599104|449292073|FG000|Overall Study|Adverse Event|7|||
124908631|NCT01599104|449292074|FG001|Overall Study|Adverse Event|6|||
124908632|NCT01599104|449292075|FG002|Overall Study|Adverse Event|12|||
124908633|NCT00714714|449292078|FG000|Overall Study|Adverse Event|1|||
124908634|NCT01308567|449292087|FG000|Overall Study|Lost to Follow-up|2|||
124908635|NCT01308567|449292088|FG001|Overall Study|Lost to Follow-up|4|||
124908636|NCT01308567|449292089|FG002|Overall Study|Lost to Follow-up|4|||
124908637|NCT01149369|449292102|FG000|Overall Study|Adverse Event|6|||
124908638|NCT01149369|449292103|FG001|Overall Study|Adverse Event|3|||
124908639|NCT02593149|449292104|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
124908640|NCT02593149|449292105|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
124908641|NCT02593149|449292104|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
124908642|NCT02593149|449292105|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
124908643|NCT01636687|449292107|FG000|Induction Period|Withdrawal by Subject|1|||
124908644|NCT01636687|449292108|FG001|Induction Period|Withdrawal by Subject|0|||
124908645|NCT01636687|449292109|FG002|Induction Period|Withdrawal by Subject|0|||
124908646|NCT01636687|449292110|FG003|Induction Period|Withdrawal by Subject|0|||
124908647|NCT01636687|449292111|FG004|Induction Period|Withdrawal by Subject|0|||
124908648|NCT01636687|449292107|FG000|Induction Period|Adverse Event|1|||
124908649|NCT01636687|449292108|FG001|Induction Period|Adverse Event|0|||
124908650|NCT01636687|449292109|FG002|Induction Period|Adverse Event|0|||
124908651|NCT01636687|449292110|FG003|Induction Period|Adverse Event|0|||
124908652|NCT01636687|449292111|FG004|Induction Period|Adverse Event|1|||
124908653|NCT01636687|449292107|FG000|Induction Period|Lack of Efficacy|0|||
124908654|NCT01636687|449292108|FG001|Induction Period|Lack of Efficacy|0|||
124908655|NCT01636687|449292109|FG002|Induction Period|Lack of Efficacy|0|||
124908656|NCT01636687|449292110|FG003|Induction Period|Lack of Efficacy|0|||
124908657|NCT01636687|449292111|FG004|Induction Period|Lack of Efficacy|1|||
124908658|NCT01636687|449292107|FG000|Induction Period|Physician Decision|1|||
124908659|NCT01636687|449292108|FG001|Induction Period|Physician Decision|0|||
124908660|NCT01636687|449292109|FG002|Induction Period|Physician Decision|0|||
124908661|NCT01636687|449292110|FG003|Induction Period|Physician Decision|0|||
124908662|NCT01636687|449292111|FG004|Induction Period|Physician Decision|0|||
124908663|NCT01636687|449292107|FG000|Maintenance Period|Withdrawal by Subject|2|||
124908664|NCT01636687|449292108|FG001|Maintenance Period|Withdrawal by Subject|0|||
124908665|NCT01636687|449292109|FG002|Maintenance Period|Withdrawal by Subject|2|||
124908666|NCT01636687|449292110|FG003|Maintenance Period|Withdrawal by Subject|0|||
124908667|NCT01636687|449292111|FG004|Maintenance Period|Withdrawal by Subject|0|||
124908668|NCT01636687|449292107|FG000|Maintenance Period|Adverse Event|1|||
124908669|NCT01636687|449292108|FG001|Maintenance Period|Adverse Event|0|||
124908670|NCT01636687|449292109|FG002|Maintenance Period|Adverse Event|0|||
124908671|NCT01636687|449292110|FG003|Maintenance Period|Adverse Event|0|||
124908672|NCT01636687|449292111|FG004|Maintenance Period|Adverse Event|0|||
124908673|NCT01636687|449292107|FG000|Maintenance Period|Lack of Efficacy|4|||
124908674|NCT01636687|449292108|FG001|Maintenance Period|Lack of Efficacy|1|||
124908675|NCT01636687|449292109|FG002|Maintenance Period|Lack of Efficacy|0|||
124908676|NCT01636687|449292110|FG003|Maintenance Period|Lack of Efficacy|0|||
124908677|NCT01636687|449292111|FG004|Maintenance Period|Lack of Efficacy|0|||
124908678|NCT01636687|449292107|FG000|Maintenance Period|Lost to Follow-up|1|||
124908679|NCT01636687|449292108|FG001|Maintenance Period|Lost to Follow-up|1|||
124908680|NCT01636687|449292109|FG002|Maintenance Period|Lost to Follow-up|0|||
124908681|NCT01636687|449292110|FG003|Maintenance Period|Lost to Follow-up|0|||
124908682|NCT01636687|449292111|FG004|Maintenance Period|Lost to Follow-up|1|||
124908683|NCT01636687|449292107|FG000|Maintenance Period|Physician Decision|0|||
124908684|NCT01636687|449292108|FG001|Maintenance Period|Physician Decision|0|||
124908685|NCT01636687|449292109|FG002|Maintenance Period|Physician Decision|0|||
124908686|NCT01636687|449292110|FG003|Maintenance Period|Physician Decision|0|||
124908687|NCT01636687|449292111|FG004|Maintenance Period|Physician Decision|1|||
124450089|NCT05162027|447611860|FG000|Overall Study|Adverse Event|1|||
124450090|NCT05162027|447611861|FG001|Overall Study|Adverse Event|0|||
124450091|NCT02767323|447611865|FG000|Overall Study|Withdrawal by Subject|17|||
124908688|NCT01636687|449292107|FG000|Extension Period|technical problems|0|||
124908689|NCT01636687|449292108|FG001|Extension Period|technical problems|1|||
124908690|NCT01636687|449292109|FG002|Extension Period|technical problems|2|||
124908691|NCT01636687|449292110|FG003|Extension Period|technical problems|1|||
124908692|NCT01636687|449292111|FG004|Extension Period|technical problems|0|||
124908693|NCT01636687|449292107|FG000|Extension Period|Adverse Event|4|||
124450092|NCT02767323|447611866|FG001|Overall Study|Withdrawal by Subject|5|||
124908694|NCT01636687|449292108|FG001|Extension Period|Adverse Event|3|||
124544835|NCT00348348|447949244|FG000|Overall Study|Adverse event probably related to study|1|||
124544836|NCT00348348|447949245|FG001|Overall Study|Adverse event probably related to study|0|||
124544837|NCT01471197|447949246|FG000|Overall Study|Disease Progression|4|||
124544838|NCT01471197|447949247|FG001|Overall Study|Disease Progression|2|||
124544839|NCT01471197|447949246|FG000|Overall Study|Death|1|||
124544840|NCT01471197|447949247|FG001|Overall Study|Death|0|||
124544841|NCT01471197|447949246|FG000|Overall Study|Study Drug Toxicity|1|||
124544842|NCT01471197|447949247|FG001|Overall Study|Study Drug Toxicity|0|||
124544843|NCT00924313|447949248|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
124544844|NCT00326625|447949251|FG000|Overall Study|Adverse Event|20|||
124544845|NCT00326625|447949252|FG001|Overall Study|Adverse Event|9|||
124544846|NCT00326625|447949251|FG000|Overall Study|Withdrawal by Subject|15|||
124544847|NCT00326625|447949252|FG001|Overall Study|Withdrawal by Subject|12|||
124544848|NCT00326625|447949251|FG000|Overall Study|Death|18|||
124544849|NCT00326625|447949252|FG001|Overall Study|Death|16|||
124544850|NCT00326625|447949251|FG000|Overall Study|Lost to Follow-up|1|||
124544851|NCT00326625|447949252|FG001|Overall Study|Lost to Follow-up|0|||
124544852|NCT00326625|447949251|FG000|Overall Study|prescheduled medical intervention|0|||
124544853|NCT00326625|447949252|FG001|Overall Study|prescheduled medical intervention|1|||
124544854|NCT00491322|447949253|FG000|Overall Study|Protocol Violation|1|||
124544855|NCT00491322|447949254|FG001|Overall Study|Protocol Violation|0|||
124544856|NCT00491322|447949253|FG000|Overall Study|Pregnancy|0|||
124544857|NCT00491322|447949254|FG001|Overall Study|Pregnancy|1|||
124544858|NCT05275673|447949256|FG000|Overall Study|Study Termination by Sponsor|2|||
124544859|NCT05275673|447949257|FG001|Overall Study|Study Termination by Sponsor|3|||
124544860|NCT05275673|447949256|FG000|Overall Study|Death|1|||
124544861|NCT05275673|447949257|FG001|Overall Study|Death|0|||
124544862|NCT05275673|447949256|FG000|Overall Study|Withdrawal by Subject|1|||
124544863|NCT05275673|447949257|FG001|Overall Study|Withdrawal by Subject|0|||
124908695|NCT01636687|449292109|FG002|Extension Period|Adverse Event|2|||
124908696|NCT01636687|449292110|FG003|Extension Period|Adverse Event|1|||
124908697|NCT01636687|449292111|FG004|Extension Period|Adverse Event|0|||
124908698|NCT01636687|449292107|FG000|Extension Period|Lack of Efficacy|7|||
124908699|NCT01636687|449292108|FG001|Extension Period|Lack of Efficacy|0|||
124908700|NCT01636687|449292109|FG002|Extension Period|Lack of Efficacy|2|||
124908701|NCT01636687|449292110|FG003|Extension Period|Lack of Efficacy|1|||
124908702|NCT01636687|449292111|FG004|Extension Period|Lack of Efficacy|0|||
124908703|NCT01636687|449292107|FG000|Extension Period|Lost to Follow-up|1|||
124908704|NCT01636687|449292108|FG001|Extension Period|Lost to Follow-up|0|||
124908705|NCT01636687|449292109|FG002|Extension Period|Lost to Follow-up|1|||
124908706|NCT01636687|449292110|FG003|Extension Period|Lost to Follow-up|0|||
124908707|NCT01636687|449292111|FG004|Extension Period|Lost to Follow-up|0|||
124908708|NCT01636687|449292107|FG000|Extension Period|Physician Decision|1|||
124908709|NCT01636687|449292108|FG001|Extension Period|Physician Decision|0|||
124908710|NCT01636687|449292109|FG002|Extension Period|Physician Decision|0|||
124908711|NCT01636687|449292110|FG003|Extension Period|Physician Decision|1|||
124908712|NCT01636687|449292111|FG004|Extension Period|Physician Decision|0|||
124908713|NCT01636687|449292107|FG000|Extension Period|study terminated by sponsor|33|||
124908714|NCT01636687|449292108|FG001|Extension Period|study terminated by sponsor|50|||
124908715|NCT01636687|449292109|FG002|Extension Period|study terminated by sponsor|17|||
124908716|NCT01636687|449292110|FG003|Extension Period|study terminated by sponsor|23|||
124908717|NCT01636687|449292111|FG004|Extension Period|study terminated by sponsor|0|||
124908718|NCT01636687|449292107|FG000|Extension Period|Withdrawal by Subject|1|||
124908719|NCT01636687|449292108|FG001|Extension Period|Withdrawal by Subject|0|||
124908720|NCT01636687|449292109|FG002|Extension Period|Withdrawal by Subject|1|||
124908721|NCT01636687|449292110|FG003|Extension Period|Withdrawal by Subject|1|||
124908722|NCT01636687|449292111|FG004|Extension Period|Withdrawal by Subject|0|||
124908723|NCT01636687|449292107|FG000|Follow-up Period|Withdrawal by Subject|1|||
124908724|NCT01636687|449292108|FG001|Follow-up Period|Withdrawal by Subject|0|||
124908725|NCT01636687|449292109|FG002|Follow-up Period|Withdrawal by Subject|0|||
124908726|NCT01636687|449292110|FG003|Follow-up Period|Withdrawal by Subject|0|||
124908727|NCT01636687|449292111|FG004|Follow-up Period|Withdrawal by Subject|1|||
124908728|NCT01254188|449292117|FG000|Overall Study|Disease Progression|6|||
124908729|NCT01254188|449292117|FG000|Overall Study|Protocol Violation|6|||
124908730|NCT01254188|449292117|FG000|Overall Study|Pregnancy|2|||
124544864|NCT02331680|447949258|FG000|Overall Study|Adverse Event|3|||
124760362|NCT05579977|448746882|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
124544865|NCT02331680|447949259|FG001|Overall Study|Adverse Event|0|||
124544866|NCT02331680|447949260|FG002|Overall Study|Adverse Event|2|||
124544867|NCT02331680|447949258|FG000|Overall Study|Physician Decision|1|||
124544868|NCT02331680|447949259|FG001|Overall Study|Physician Decision|1|||
124544869|NCT02331680|447949260|FG002|Overall Study|Physician Decision|2|||
124544870|NCT02331680|447949258|FG000|Overall Study|Withdrawal by Subject|0|||
124544871|NCT02331680|447949259|FG001|Overall Study|Withdrawal by Subject|1|||
124908731|NCT01254188|449292117|FG000|Overall Study|Death|4|||
124908732|NCT01254188|449292117|FG000|Overall Study|Lost to Follow-up|5|||
124544872|NCT02331680|447949260|FG002|Overall Study|Withdrawal by Subject|2|||
124908733|NCT01254188|449292117|FG000|Overall Study|Withdrawal by Subject|7|||
124908734|NCT01254188|449292117|FG000|Overall Study|Adverse Event|43|||
124908735|NCT01254188|449292117|FG000|Overall Study|per investigator discretion|20|||
124908736|NCT03482011|449292118|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
124908737|NCT03482011|449292119|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
124908738|NCT03482011|449292120|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
124908739|NCT03482011|449292121|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
124908740|NCT03482011|449292122|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
124908741|NCT03482011|449292123|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
124908742|NCT03482011|449292124|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
124908743|NCT03482011|449292125|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
124908744|NCT03482011|449292118|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
124908745|NCT03482011|449292119|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
124908746|NCT03482011|449292120|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124908747|NCT03482011|449292121|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124908748|NCT03482011|449292122|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124908749|NCT03482011|449292123|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124908750|NCT03482011|449292124|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124908751|NCT03482011|449292125|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124908752|NCT03482011|449292118|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
124908753|NCT03482011|449292119|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
124908754|NCT03482011|449292120|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
124908755|NCT03482011|449292121|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
124908756|NCT03482011|449292122|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
124908757|NCT03482011|449292123|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
124908758|NCT03482011|449292124|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
124908759|NCT03482011|449292125|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
124760363|NCT05579977|448746883|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
124760364|NCT05579977|448746884|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
124760365|NCT05579977|448746885|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
124760366|NCT05579977|448746886|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
124760367|NCT05579977|448746887|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
124760368|NCT05579977|448746888|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
124760369|NCT05579977|448746889|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
124760370|NCT05579977|448746890|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
124760371|NCT05579977|448746891|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
124760372|NCT05579977|448746892|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
124760373|NCT05579977|448746893|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
124760374|NCT05579977|448746894|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
124760375|NCT05579977|448746882|FG000|Treatment Phase|Withdrawal by Subject|2|||
124760376|NCT05579977|448746883|FG001|Treatment Phase|Withdrawal by Subject|0|||
124760377|NCT05579977|448746884|FG002|Treatment Phase|Withdrawal by Subject|0|||
124760378|NCT05579977|448746885|FG003|Treatment Phase|Withdrawal by Subject|1|||
124760379|NCT05579977|448746886|FG004|Treatment Phase|Withdrawal by Subject|2|||
124760380|NCT05579977|448746887|FG005|Treatment Phase|Withdrawal by Subject|0|||
124760381|NCT05579977|448746888|FG006|Treatment Phase|Withdrawal by Subject|1|||
124760382|NCT05579977|448746889|FG007|Treatment Phase|Withdrawal by Subject|8|||
124760383|NCT05579977|448746890|FG008|Treatment Phase|Withdrawal by Subject|3|||
124760384|NCT05579977|448746891|FG009|Treatment Phase|Withdrawal by Subject|3|||
124760385|NCT05579977|448746892|FG010|Treatment Phase|Withdrawal by Subject|5|||
124760386|NCT05579977|448746893|FG011|Treatment Phase|Withdrawal by Subject|1|||
124760387|NCT05579977|448746894|FG012|Treatment Phase|Withdrawal by Subject|3|||
124760388|NCT05579977|448746882|FG000|Treatment Phase|Study terminated by sponsor|70|||
124760389|NCT05579977|448746883|FG001|Treatment Phase|Study terminated by sponsor|70|||
124760390|NCT05579977|448746884|FG002|Treatment Phase|Study terminated by sponsor|61|||
124760391|NCT05579977|448746885|FG003|Treatment Phase|Study terminated by sponsor|59|||
124760392|NCT05579977|448746886|FG004|Treatment Phase|Study terminated by sponsor|63|||
124760393|NCT05579977|448746887|FG005|Treatment Phase|Study terminated by sponsor|53|||
124760394|NCT05579977|448746888|FG006|Treatment Phase|Study terminated by sponsor|66|||
124760395|NCT05579977|448746889|FG007|Treatment Phase|Study terminated by sponsor|48|||
124760396|NCT05579977|448746890|FG008|Treatment Phase|Study terminated by sponsor|47|||
124760397|NCT05579977|448746891|FG009|Treatment Phase|Study terminated by sponsor|37|||
124760398|NCT05579977|448746892|FG010|Treatment Phase|Study terminated by sponsor|44|||
124760399|NCT05579977|448746893|FG011|Treatment Phase|Study terminated by sponsor|36|||
124760400|NCT05579977|448746894|FG012|Treatment Phase|Study terminated by sponsor|32|||
124908760|NCT03482011|449292118|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
124908761|NCT03482011|449292119|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
124908762|NCT03482011|449292120|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
124908763|NCT03482011|449292121|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
124908764|NCT03482011|449292122|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
124908765|NCT03482011|449292123|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
124908766|NCT03482011|449292124|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
124908767|NCT03482011|449292125|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
124908768|NCT03482011|449292118|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
124908769|NCT03482011|449292119|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
124908770|NCT03482011|449292120|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124908771|NCT03482011|449292121|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124908772|NCT03482011|449292122|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124908773|NCT03482011|449292123|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124908774|NCT03482011|449292124|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124908775|NCT03482011|449292125|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124908776|NCT03482011|449292118|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
124908777|NCT03482011|449292119|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
124908778|NCT03482011|449292120|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
124908779|NCT03482011|449292121|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
124908780|NCT03482011|449292122|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
124908781|NCT03482011|449292123|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
124908782|NCT03482011|449292124|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
124908783|NCT03482011|449292125|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
124908784|NCT03482011|449292118|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
124908785|NCT03482011|449292119|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
124908786|NCT03482011|449292120|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
124908787|NCT03482011|449292121|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
124908788|NCT03482011|449292122|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
124908789|NCT03482011|449292123|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
124908790|NCT03482011|449292124|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
124908791|NCT03482011|449292125|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
124908792|NCT03482011|449292118|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124908793|NCT03482011|449292119|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124908794|NCT03482011|449292120|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124908795|NCT03482011|449292121|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124908796|NCT03482011|449292122|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
124908797|NCT03482011|449292123|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124908798|NCT03482011|449292124|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124908799|NCT03482011|449292125|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
124908800|NCT03482011|449292118|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
124908801|NCT03482011|449292119|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
124908802|NCT03482011|449292120|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
124908803|NCT03482011|449292121|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
124908804|NCT03482011|449292122|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
124908805|NCT03482011|449292123|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
124908806|NCT03482011|449292124|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
124908807|NCT03482011|449292125|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
124908808|NCT03482011|449292118|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124908809|NCT03482011|449292119|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124908810|NCT03482011|449292120|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124908811|NCT03482011|449292121|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
124908812|NCT03482011|449292122|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
124908813|NCT03482011|449292123|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
124908814|NCT03482011|449292124|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
124908815|NCT03482011|449292125|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
124908816|NCT03482011|449292118|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
124450093|NCT02767323|447611867|FG002|Overall Study|Withdrawal by Subject|13|||
124450094|NCT02767323|447611868|FG003|Overall Study|Withdrawal by Subject|0|||
124450095|NCT02767323|447611865|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
124450096|NCT02767323|447611866|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
124450097|NCT02767323|447611867|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
124450098|NCT02767323|447611868|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
124450099|NCT01069120|447611870|FG000|Overall Study|Study prematurely terminated|27|||
124908817|NCT03482011|449292119|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
124908818|NCT03482011|449292120|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
124908819|NCT03482011|449292121|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
124450100|NCT00388505|447611871|FG000|Overall Study|Adverse Event or Death|43|||
124450101|NCT00388505|447611872|FG001|Overall Study|Adverse Event or Death|17|||
124450102|NCT00388505|447611871|FG000|Overall Study|Withdrawal by Subject|24|||
124450103|NCT00388505|447611872|FG001|Overall Study|Withdrawal by Subject|9|||
124450104|NCT00388505|447611871|FG000|Overall Study|Lost to Follow-up|5|||
124450105|NCT00388505|447611872|FG001|Overall Study|Lost to Follow-up|3|||
124450106|NCT00388505|447611871|FG000|Overall Study|Inappropriate Enrollment|0|||
124450107|NCT00388505|447611872|FG001|Overall Study|Inappropriate Enrollment|1|||
124908820|NCT03482011|449292122|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
124908821|NCT03482011|449292123|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
124908822|NCT03482011|449292124|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
124908823|NCT03482011|449292125|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
124908824|NCT03482011|449292118|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
124908825|NCT03482011|449292119|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
124908826|NCT03482011|449292120|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
124908827|NCT03482011|449292121|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
124908828|NCT03482011|449292122|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
124908829|NCT03482011|449292123|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
124908830|NCT03482011|449292124|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
124908831|NCT03482011|449292125|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
124908832|NCT03482011|449292118|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
124908833|NCT03482011|449292119|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
124908834|NCT03482011|449292120|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
124908835|NCT03482011|449292121|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
124908836|NCT03482011|449292122|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
124908837|NCT03482011|449292123|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
124908838|NCT03482011|449292124|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
124908839|NCT03482011|449292125|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
124908840|NCT03482011|449292118|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
124908841|NCT03482011|449292119|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
124908842|NCT03482011|449292120|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
124908843|NCT03482011|449292121|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
124908844|NCT03482011|449292122|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
124908845|NCT03482011|449292123|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
124908846|NCT03482011|449292124|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
124908847|NCT03482011|449292125|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
124908848|NCT03482011|449292118|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
124908849|NCT03482011|449292119|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
124908850|NCT03482011|449292120|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
124908851|NCT03482011|449292121|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
124908852|NCT03482011|449292122|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
124908853|NCT03482011|449292123|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
124908854|NCT03482011|449292124|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
124908855|NCT03482011|449292125|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
124908856|NCT05609032|449292135|FG000|Overall Study|Lost to Follow-up|3|||
124908857|NCT05609032|449292136|FG001|Overall Study|Lost to Follow-up|1|||
124908858|NCT05609032|449292135|FG000|Overall Study|Withdrawal by Subject|1|||
124908859|NCT05609032|449292136|FG001|Overall Study|Withdrawal by Subject|0|||
124908860|NCT02261467|449292137|FG000|Overall Study|Enrolled in Error|1|||
124908861|NCT02261467|449292138|FG001|Overall Study|Enrolled in Error|0|||
124908862|NCT02261467|449292137|FG000|Overall Study|Protocol Violation|0|||
124908863|NCT02261467|449292138|FG001|Overall Study|Protocol Violation|1|||
124908864|NCT02261467|449292137|FG000|Overall Study|Personal Reasons|17|||
124908865|NCT02261467|449292138|FG001|Overall Study|Personal Reasons|22|||
124908866|NCT02261467|449292137|FG000|Overall Study|Lost to Follow-up|2|||
124450108|NCT00388505|447611871|FG000|Overall Study|Administrative Reason|1|||
124450109|NCT00388505|447611872|FG001|Overall Study|Administrative Reason|0|||
124450110|NCT00388505|447611871|FG000|Overall Study|Protocol Violation|6|||
124450111|NCT00388505|447611872|FG001|Overall Study|Protocol Violation|5|||
124450112|NCT00388505|447611871|FG000|Overall Study|Unable to classify|4|||
124450113|NCT00388505|447611872|FG001|Overall Study|Unable to classify|3|||
124450114|NCT01480284|447611875|FG000|Overall Study|Withdrawal by Subject|2|||
124544873|NCT02331680|447949258|FG000|Overall Study|Met withdrawal criteria|2|||
124544874|NCT02331680|447949259|FG001|Overall Study|Met withdrawal criteria|2|||
124908867|NCT02261467|449292138|FG001|Overall Study|Lost to Follow-up|13|||
124908868|NCT02261467|449292137|FG000|Overall Study|Adverse Event|1|||
124908869|NCT02261467|449292138|FG001|Overall Study|Adverse Event|1|||
124908870|NCT00433199|449292142|FG000|Double-Blind Period|Adverse Event|0|||
124908871|NCT00433199|449292143|FG001|Double-Blind Period|Adverse Event|25|||
124450115|NCT01480284|447611876|FG001|Overall Study|Withdrawal by Subject|0|||
124544875|NCT02331680|447949260|FG002|Overall Study|Met withdrawal criteria|5|||
124544876|NCT02331680|447949258|FG000|Overall Study|Non-compliance with study drug|0|||
124908872|NCT00433199|449292142|FG000|Double-Blind Period|Lack of Efficacy|0|||
124908873|NCT00433199|449292143|FG001|Double-Blind Period|Lack of Efficacy|2|||
124908874|NCT00433199|449292142|FG000|Double-Blind Period|Lost to Follow-up|2|||
124908875|NCT00433199|449292143|FG001|Double-Blind Period|Lost to Follow-up|5|||
124908876|NCT00433199|449292142|FG000|Double-Blind Period|Withdrawal by Subject|8|||
124450116|NCT01480284|447611875|FG000|Overall Study|Adverse Event|1|||
124450117|NCT01480284|447611876|FG001|Overall Study|Adverse Event|0|||
124450118|NCT01480284|447611875|FG000|Overall Study|Study closed/terminated|3|||
124450119|NCT01480284|447611876|FG001|Overall Study|Study closed/terminated|0|||
124691945|NCT01471574|448494593|FG002|Treatment Period|Other|0|||
124691946|NCT01471574|448494594|FG003|Treatment Period|Other|0|||
124691947|NCT01471574|448494591|FG000|Follow-up Period|Withdrawal by Subject|3|||
124691948|NCT01471574|448494592|FG001|Follow-up Period|Withdrawal by Subject|0|||
124691949|NCT01471574|448494593|FG002|Follow-up Period|Withdrawal by Subject|3|||
124691950|NCT01471574|448494594|FG003|Follow-up Period|Withdrawal by Subject|1|||
124691951|NCT01471574|448494591|FG000|Follow-up Period|Lost to Follow-up|4|||
124691952|NCT01471574|448494592|FG001|Follow-up Period|Lost to Follow-up|1|||
124691953|NCT01471574|448494593|FG002|Follow-up Period|Lost to Follow-up|3|||
124691954|NCT01471574|448494594|FG003|Follow-up Period|Lost to Follow-up|2|||
124691955|NCT01471574|448494591|FG000|Follow-up Period|Death|0|||
124691956|NCT01471574|448494592|FG001|Follow-up Period|Death|0|||
124691957|NCT01471574|448494593|FG002|Follow-up Period|Death|1|||
124691958|NCT01471574|448494594|FG003|Follow-up Period|Death|0|||
124691959|NCT01471574|448494591|FG000|Follow-up Period|Follow-up no longer required|0|||
124691960|NCT01471574|448494592|FG001|Follow-up Period|Follow-up no longer required|1|||
124691961|NCT01471574|448494593|FG002|Follow-up Period|Follow-up no longer required|0|||
124691962|NCT01471574|448494594|FG003|Follow-up Period|Follow-up no longer required|0|||
124691963|NCT00864513|448494600|FG000|Overall Study|Withdrawal by Subject|3|||
124691964|NCT00762788|448494601|FG000|Overall Study|Lost to Follow-up|26|||
124691965|NCT00762788|448494602|FG001|Overall Study|Lost to Follow-up|37|||
124691966|NCT00762788|448494603|FG002|Overall Study|Lost to Follow-up|21|||
124691967|NCT00762788|448494604|FG003|Overall Study|Lost to Follow-up|26|||
124691968|NCT00762788|448494605|FG004|Overall Study|Lost to Follow-up|13|||
124691969|NCT00762788|448494606|FG005|Overall Study|Lost to Follow-up|21|||
124691970|NCT03073109|448494607|FG000|Overall Study|Adverse Event|0|||
124691971|NCT03073109|448494608|FG001|Overall Study|Adverse Event|1|||
124691972|NCT03073109|448494607|FG000|Overall Study|Other|2|||
124691973|NCT03073109|448494608|FG001|Overall Study|Other|0|||
124691974|NCT03073109|448494607|FG000|Overall Study|Lost to Follow-up|8|||
124691975|NCT03073109|448494608|FG001|Overall Study|Lost to Follow-up|1|||
124691976|NCT01562444|448494613|FG000|Overall Study|Did not meet entry criteria|2|||
124691977|NCT01562444|448494614|FG001|Overall Study|Did not meet entry criteria|0|||
124691978|NCT01562444|448494615|FG002|Overall Study|Did not meet entry criteria|3|||
124691979|NCT01562444|448494613|FG000|Overall Study|Did not comply with blood draw schedule|1|||
124691980|NCT01562444|448494614|FG001|Overall Study|Did not comply with blood draw schedule|0|||
124691981|NCT01562444|448494615|FG002|Overall Study|Did not comply with blood draw schedule|1|||
124691982|NCT01562444|448494613|FG000|Overall Study|Unavailable serological results|0|||
124691983|NCT01562444|448494614|FG001|Overall Study|Unavailable serological results|2|||
124691984|NCT01562444|448494615|FG002|Overall Study|Unavailable serological results|2|||
124691985|NCT01562444|448494613|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
124691986|NCT01562444|448494614|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
124691987|NCT01562444|448494615|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
124691988|NCT01562444|448494613|FG000|Overall Study|Protocol forbidden medication|1|||
124691989|NCT01562444|448494614|FG001|Overall Study|Protocol forbidden medication|0|||
124691990|NCT01562444|448494615|FG002|Overall Study|Protocol forbidden medication|0|||
124760401|NCT05579977|448746882|FG000|Treatment Phase|Pregnancy|0|||
124760402|NCT05579977|448746883|FG001|Treatment Phase|Pregnancy|0|||
124908877|NCT00433199|449292143|FG001|Double-Blind Period|Withdrawal by Subject|19|||
124908878|NCT00433199|449292142|FG000|Double-Blind Period|Protocol Violation|1|||
124908879|NCT00433199|449292143|FG001|Double-Blind Period|Protocol Violation|10|||
124908880|NCT00433199|449292142|FG000|Double-Blind Period|Administrative|1|||
124908881|NCT00433199|449292143|FG001|Double-Blind Period|Administrative|5|||
124908882|NCT00433199|449292142|FG000|Open-Label Period|Adverse Event|0|||
124908883|NCT00433199|449292143|FG001|Open-Label Period|Adverse Event|19|||
124908884|NCT00433199|449292142|FG000|Open-Label Period|Lack of Efficacy|0|||
124908885|NCT00433199|449292143|FG001|Open-Label Period|Lack of Efficacy|2|||
124908886|NCT00433199|449292142|FG000|Open-Label Period|Lost to Follow-up|0|||
124908887|NCT00433199|449292143|FG001|Open-Label Period|Lost to Follow-up|3|||
124908888|NCT00433199|449292142|FG000|Open-Label Period|Withdrawal by Subject|0|||
124908889|NCT00433199|449292143|FG001|Open-Label Period|Withdrawal by Subject|7|||
124908890|NCT00433199|449292142|FG000|Open-Label Period|Protocol Violation|0|||
124908891|NCT00433199|449292143|FG001|Open-Label Period|Protocol Violation|2|||
124908892|NCT00433199|449292142|FG000|Open-Label Period|Administrative|0|||
124908893|NCT00433199|449292143|FG001|Open-Label Period|Administrative|1|||
124691991|NCT02930941|448494622|FG000|Overall Study|Lost to Follow-up|1|||
124691992|NCT02930941|448494623|FG001|Overall Study|Lost to Follow-up|2|||
124691993|NCT00574951|448494624|FG000|Overall Study|Ineligible - improper prior treatment|1|||
124691994|NCT00585585|448494625|FG000|Overall Study|Adverse Event|1|||
124691995|NCT00710970|448494626|FG000|Overall Study|Never took drug|3|||
124760403|NCT05579977|448746884|FG002|Treatment Phase|Pregnancy|0|||
124908900|NCT01170962|449292147|FG000|Treatment Period|Lack of Efficacy|96|||
124908901|NCT01170962|449292148|FG001|Treatment Period|Lack of Efficacy|91|||
124908902|NCT01170962|449292149|FG002|Treatment Period|Lack of Efficacy|7|||
124908903|NCT01170962|449292147|FG000|Treatment Period|Adverse Event|11|||
124908904|NCT01170962|449292148|FG001|Treatment Period|Adverse Event|12|||
124908905|NCT01170962|449292149|FG002|Treatment Period|Adverse Event|3|||
124908906|NCT01170962|449292147|FG000|Treatment Period|Withdrawal by Subject|2|||
124908907|NCT01170962|449292148|FG001|Treatment Period|Withdrawal by Subject|1|||
124908908|NCT01170962|449292149|FG002|Treatment Period|Withdrawal by Subject|0|||
124908909|NCT01170962|449292147|FG000|Treatment Period|Lost to Follow-up|1|||
124908910|NCT01170962|449292148|FG001|Treatment Period|Lost to Follow-up|1|||
124908911|NCT01170962|449292149|FG002|Treatment Period|Lost to Follow-up|1|||
124908912|NCT01170962|449292147|FG000|Treatment Period|Participant no longer meets criteria|0|||
124908913|NCT01170962|449292148|FG001|Treatment Period|Participant no longer meets criteria|1|||
124908914|NCT01170962|449292149|FG002|Treatment Period|Participant no longer meets criteria|0|||
124908915|NCT01170962|449292147|FG000|Treatment Period|Request to discontinue treatment|7|||
124908916|NCT01170962|449292148|FG001|Treatment Period|Request to discontinue treatment|3|||
124908917|NCT01170962|449292149|FG002|Treatment Period|Request to discontinue treatment|1|||
124908918|NCT01170962|449292147|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
124908919|NCT01170962|449292148|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
124908920|NCT01170962|449292149|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
124908921|NCT01170962|449292147|FG000|Follow up Period|Withdrawal by Subject|14|||
124908922|NCT01170962|449292148|FG001|Follow up Period|Withdrawal by Subject|10|||
124908923|NCT01170962|449292149|FG002|Follow up Period|Withdrawal by Subject|2|||
124908924|NCT01170962|449292147|FG000|Follow up Period|Lost to Follow-up|13|||
124908925|NCT01170962|449292148|FG001|Follow up Period|Lost to Follow-up|8|||
124908926|NCT01170962|449292149|FG002|Follow up Period|Lost to Follow-up|1|||
124908927|NCT01170962|449292147|FG000|Follow up Period|Death|2|||
124908928|NCT01170962|449292148|FG001|Follow up Period|Death|2|||
124908929|NCT01170962|449292149|FG002|Follow up Period|Death|0|||
124450120|NCT01480284|447611875|FG000|Overall Study|Lost to Follow-up|1|||
124450121|NCT01480284|447611876|FG001|Overall Study|Lost to Follow-up|0|||
124450122|NCT01480284|447611875|FG000|Overall Study|Physician Decision|1|||
124450123|NCT01480284|447611876|FG001|Overall Study|Physician Decision|0|||
124450124|NCT01641237|447611877|FG000|Period II|Withdrawal by Subject|1|||
124450125|NCT01641237|447611878|FG001|Period II|Withdrawal by Subject|0|||
124450126|NCT01641237|447611879|FG002|Period II|Withdrawal by Subject|0|||
124450127|NCT01641237|447611880|FG003|Period II|Withdrawal by Subject|0|||
124450128|NCT01641237|447611877|FG000|Period III|Lost to Follow-up|1|||
124450129|NCT01641237|447611878|FG001|Period III|Lost to Follow-up|0|||
124450130|NCT01641237|447611879|FG002|Period III|Lost to Follow-up|0|||
124450131|NCT01641237|447611880|FG003|Period III|Lost to Follow-up|0|||
124450132|NCT02716675|447611881|FG000|Overall Study|Death|2|||
124450133|NCT02716675|447611882|FG001|Overall Study|Death|3|||
124450134|NCT02716675|447611883|FG002|Overall Study|Death|0|||
124450135|NCT02716675|447611881|FG000|Overall Study|Physician Decision|2|||
124450136|NCT02716675|447611882|FG001|Overall Study|Physician Decision|1|||
124450137|NCT02716675|447611883|FG002|Overall Study|Physician Decision|1|||
124450138|NCT02716675|447611881|FG000|Overall Study|Lost to Follow-up|100|||
124450139|NCT02716675|447611882|FG001|Overall Study|Lost to Follow-up|87|||
124450140|NCT02716675|447611883|FG002|Overall Study|Lost to Follow-up|99|||
124450141|NCT02716675|447611881|FG000|Overall Study|Withdrawal by Subject|22|||
124450142|NCT02716675|447611882|FG001|Overall Study|Withdrawal by Subject|25|||
124450143|NCT02716675|447611883|FG002|Overall Study|Withdrawal by Subject|20|||
124450144|NCT02716675|447611881|FG000|Overall Study|Protocol Violation|0|||
124450145|NCT02716675|447611882|FG001|Overall Study|Protocol Violation|3|||
124450146|NCT02716675|447611883|FG002|Overall Study|Protocol Violation|1|||
124450147|NCT02716675|447611881|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
124450148|NCT02716675|447611882|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
124450149|NCT02716675|447611883|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
124450150|NCT02716675|447611881|FG000|Overall Study|Other|38|||
124450151|NCT02716675|447611882|FG001|Overall Study|Other|47|||
124908930|NCT01170962|449292147|FG000|Follow up Period|Others|10|||
124908931|NCT01170962|449292148|FG001|Follow up Period|Others|7|||
124908932|NCT01170962|449292149|FG002|Follow up Period|Others|3|||
124450152|NCT02716675|447611883|FG002|Overall Study|Other|48|||
124908933|NCT02407249|449293536|FG000|Overall Study|Did not complete 12-month follow-up|13|||
124908934|NCT02407249|449293536|FG000|Overall Study|Not treated|13|||
124908935|NCT01460446|449293539|FG000|Overall Study|Non-compliance|2|||
124908936|NCT01460446|449293540|FG001|Overall Study|Non-compliance|9|||
124908937|NCT01460446|449293539|FG000|Overall Study|Consent Withdrawn|0|||
124908938|NCT01460446|449293540|FG001|Overall Study|Consent Withdrawn|4|||
124908939|NCT01460446|449293539|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
124908940|NCT01460446|449293540|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
124908941|NCT01460446|449293539|FG000|Overall Study|Surgery/Illness|1|||
124908942|NCT01460446|449293540|FG001|Overall Study|Surgery/Illness|1|||
124908943|NCT01460446|449293539|FG000|Overall Study|Pregnancy|1|||
124908944|NCT01460446|449293540|FG001|Overall Study|Pregnancy|0|||
124908945|NCT01460446|449293539|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
124908946|NCT01460446|449293540|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
124908947|NCT00542789|449293541|FG000|Overall Study|Adverse Event|18|||
124908948|NCT00542789|449293542|FG001|Overall Study|Adverse Event|17|||
124908949|NCT00542789|449293541|FG000|Overall Study|Withdrawal by Subject|7|||
124908950|NCT00542789|449293542|FG001|Overall Study|Withdrawal by Subject|3|||
124908951|NCT00542789|449293541|FG000|Overall Study|Protocol Violation|8|||
124908952|NCT00542789|449293542|FG001|Overall Study|Protocol Violation|1|||
124908953|NCT00542789|449293541|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
124908954|NCT00542789|449293542|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
124908955|NCT00636207|449293545|FG000|Overall Study|Adverse Event|1|||
124908956|NCT00636207|449293546|FG001|Overall Study|Adverse Event|0|||
124908957|NCT00636207|449293547|FG002|Overall Study|Adverse Event|0|||
124908958|NCT00636207|449293548|FG003|Overall Study|Adverse Event|0|||
124908959|NCT00636207|449293549|FG004|Overall Study|Adverse Event|0|||
124908960|NCT00636207|449293550|FG005|Overall Study|Adverse Event|0|||
124908961|NCT00636207|449293551|FG006|Overall Study|Adverse Event|0|||
124908962|NCT00636207|449293545|FG000|Overall Study|Withdrawal by Subject|0|||
124908963|NCT00636207|449293546|FG001|Overall Study|Withdrawal by Subject|1|||
124908964|NCT00636207|449293547|FG002|Overall Study|Withdrawal by Subject|0|||
124908965|NCT00636207|449293548|FG003|Overall Study|Withdrawal by Subject|0|||
124908966|NCT00636207|449293549|FG004|Overall Study|Withdrawal by Subject|1|||
124908967|NCT00636207|449293550|FG005|Overall Study|Withdrawal by Subject|0|||
124908968|NCT00636207|449293551|FG006|Overall Study|Withdrawal by Subject|0|||
124908969|NCT01641198|449293554|FG000|After 12 Months of Function|Lost to Follow-up|3|||
124908970|NCT01641198|449293555|FG001|After 12 Months of Function|Lost to Follow-up|2|||
124908971|NCT01641198|449293556|FG002|After 12 Months of Function|Lost to Follow-up|2|||
124908972|NCT01641198|449293554|FG000|After 12 Months of Function|Protocol Violation|1|||
124908973|NCT01641198|449293555|FG001|After 12 Months of Function|Protocol Violation|0|||
124908974|NCT01641198|449293556|FG002|After 12 Months of Function|Protocol Violation|0|||
124908975|NCT01641198|449293554|FG000|After 12 Months of Function|Adverse Event|0|||
124908976|NCT01641198|449293555|FG001|After 12 Months of Function|Adverse Event|1|||
124908977|NCT01641198|449293556|FG002|After 12 Months of Function|Adverse Event|0|||
124908978|NCT01641198|449293554|FG000|After 24 Months of Function|Lost to Follow-up|4|||
124908979|NCT01641198|449293555|FG001|After 24 Months of Function|Lost to Follow-up|9|||
124908980|NCT01641198|449293556|FG002|After 24 Months of Function|Lost to Follow-up|6|||
124908981|NCT01641198|449293554|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
124908982|NCT01641198|449293555|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
124908983|NCT01641198|449293556|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
124908984|NCT01641198|449293554|FG000|At 15-20 Years of Function|Death|1|||
124908985|NCT01641198|449293555|FG001|At 15-20 Years of Function|Death|0|||
124908986|NCT01641198|449293556|FG002|At 15-20 Years of Function|Death|1|||
124908987|NCT02594735|449293558|FG000|Overall Study|Adverse Event|1|||
124908988|NCT02529995|449293559|FG000|Part A|Ongoing Study at Data Cut-off|14|||
124908989|NCT02529995|449293560|FG001|Part A|Ongoing Study at Data Cut-off|16|||
124908990|NCT02529995|449293559|FG000|Part A|Discontinued Study|1|||
124908991|NCT02529995|449293560|FG001|Part A|Discontinued Study|0|||
124908992|NCT02529995|449293559|FG000|Part B|Ongoing Study at Data Cut-off|0|||
124908993|NCT02529995|449293560|FG001|Part B|Ongoing Study at Data Cut-off|7|||
124908994|NCT02529995|449293559|FG000|Part B|Discontinued Study|6|||
124908995|NCT02529995|449293560|FG001|Part B|Discontinued Study|5|||
124908996|NCT01075217|449293564|FG000|Overall Study|Adverse Event|1|||
124908997|NCT01075217|449293565|FG001|Overall Study|Adverse Event|1|||
124544877|NCT02331680|447949259|FG001|Overall Study|Non-compliance with study drug|0|||
124544878|NCT02331680|447949260|FG002|Overall Study|Non-compliance with study drug|1|||
124544879|NCT02331680|447949258|FG000|Overall Study|Protocol Violation|0|||
124544880|NCT02331680|447949259|FG001|Overall Study|Protocol Violation|0|||
124691996|NCT01960842|448494631|FG000|Overall Study|Adverse Event|1|||
124908998|NCT01075217|449293564|FG000|Overall Study|Physician Decision|1|||
124908999|NCT01075217|449293565|FG001|Overall Study|Physician Decision|0|||
124909000|NCT02969863|449293566|FG000|Overall Study|Physician Decision|1|||
124909001|NCT02969863|449293567|FG001|Overall Study|Physician Decision|0|||
124909002|NCT02969863|449293568|FG002|Overall Study|Physician Decision|0|||
124909003|NCT02969863|449293569|FG003|Overall Study|Physician Decision|0|||
124909004|NCT02969863|449293570|FG004|Overall Study|Physician Decision|0|||
124909005|NCT02969863|449293571|FG005|Overall Study|Physician Decision|0|||
124909006|NCT03737240|449293572|FG000|Overall Study|Lost to Follow-up|16|||
124909007|NCT03737240|449293573|FG001|Overall Study|Lost to Follow-up|15|||
124909008|NCT01068743|449293574|FG000|Period 3|Adverse Event|0|||
124909009|NCT01068743|449293575|FG001|Period 3|Adverse Event|1|||
124909010|NCT01068743|449293576|FG002|Period 3|Adverse Event|0|||
124909011|NCT01068743|449293577|FG003|Period 3|Adverse Event|0|||
124909012|NCT00364013|449293578|FG000|Overall Study|Ineligibility determined|4|||
124909013|NCT00364013|449293579|FG001|Overall Study|Ineligibility determined|2|||
124909014|NCT00364013|449293578|FG000|Overall Study|Adverse Event|4|||
124909015|NCT00364013|449293579|FG001|Overall Study|Adverse Event|3|||
124909016|NCT00364013|449293578|FG000|Overall Study|Withdrawal by Subject|13|||
124909017|NCT00364013|449293579|FG001|Overall Study|Withdrawal by Subject|18|||
124909018|NCT00364013|449293578|FG000|Overall Study|Physician Decision|3|||
124909019|NCT00364013|449293579|FG001|Overall Study|Physician Decision|3|||
124909020|NCT00364013|449293578|FG000|Overall Study|Lost to Follow-up|10|||
124909021|NCT00364013|449293579|FG001|Overall Study|Lost to Follow-up|3|||
124909022|NCT00364013|449293578|FG000|Overall Study|Protocol-specified criteria|6|||
124909023|NCT00364013|449293579|FG001|Overall Study|Protocol-specified criteria|6|||
124909024|NCT00364013|449293578|FG000|Overall Study|Other|41|||
124909025|NCT00364013|449293579|FG001|Overall Study|Other|47|||
124909026|NCT00364013|449293578|FG000|Overall Study|Ongoing|20|||
124909027|NCT00364013|449293579|FG001|Overall Study|Ongoing|13|||
124909028|NCT00585533|449293581|FG000|Overall Study|objective or symptomatic progression|9|||
124909029|NCT01369498|449293583|FG000|Overall Study|Lack of Efficacy|9|||
124909030|NCT01369498|449293584|FG001|Overall Study|Lack of Efficacy|9|||
124909031|NCT01369498|449293585|FG002|Overall Study|Lack of Efficacy|1|||
124909032|NCT01369498|449293586|FG003|Overall Study|Lack of Efficacy|3|||
124909033|NCT01369498|449293583|FG000|Overall Study|Adverse Event|1|||
124909034|NCT01369498|449293584|FG001|Overall Study|Adverse Event|2|||
124909035|NCT01369498|449293585|FG002|Overall Study|Adverse Event|0|||
124909036|NCT01369498|449293586|FG003|Overall Study|Adverse Event|1|||
124909037|NCT01369498|449293583|FG000|Overall Study|Withdrawal of Consent|0|||
124909038|NCT01369498|449293584|FG001|Overall Study|Withdrawal of Consent|1|||
124909039|NCT01369498|449293585|FG002|Overall Study|Withdrawal of Consent|1|||
124909040|NCT01369498|449293586|FG003|Overall Study|Withdrawal of Consent|1|||
124909041|NCT01369498|449293583|FG000|Overall Study|Death|0|||
124909042|NCT01369498|449293584|FG001|Overall Study|Death|0|||
124909043|NCT01369498|449293585|FG002|Overall Study|Death|1|||
124909044|NCT01369498|449293586|FG003|Overall Study|Death|0|||
124909045|NCT01369498|449293583|FG000|Overall Study|Investigator's Discretion|1|||
124909046|NCT01369498|449293584|FG001|Overall Study|Investigator's Discretion|0|||
124909047|NCT01369498|449293585|FG002|Overall Study|Investigator's Discretion|1|||
124909048|NCT01369498|449293586|FG003|Overall Study|Investigator's Discretion|3|||
124909049|NCT01369498|449293583|FG000|Overall Study|Unknown Reason|1|||
124909050|NCT01369498|449293584|FG001|Overall Study|Unknown Reason|0|||
124909051|NCT01369498|449293585|FG002|Overall Study|Unknown Reason|11|||
124909052|NCT01369498|449293586|FG003|Overall Study|Unknown Reason|6|||
124909053|NCT01369498|449293583|FG000|Overall Study|Disease Progression|0|||
124909054|NCT01369498|449293584|FG001|Overall Study|Disease Progression|0|||
124909055|NCT01369498|449293585|FG002|Overall Study|Disease Progression|0|||
124909056|NCT01369498|449293586|FG003|Overall Study|Disease Progression|1|||
124909057|NCT01236001|449293589|FG000|Overall Study|Adverse Event|5|||
124909058|NCT01236001|449293590|FG001|Overall Study|Adverse Event|14|||
124909059|NCT01236001|449293589|FG000|Overall Study|Lack of Efficacy|6|||
124909060|NCT01236001|449293590|FG001|Overall Study|Lack of Efficacy|6|||
124909061|NCT01236001|449293589|FG000|Overall Study|Lost to Follow-up|6|||
124909062|NCT01236001|449293590|FG001|Overall Study|Lost to Follow-up|1|||
124909063|NCT01236001|449293589|FG000|Overall Study|Incompliance|1|||
124909064|NCT01236001|449293590|FG001|Overall Study|Incompliance|0|||
124909065|NCT01236001|449293589|FG000|Overall Study|Planned Visit After End of Study|0|||
124909066|NCT01236001|449293590|FG001|Overall Study|Planned Visit After End of Study|1|||
124909067|NCT02538107|449293592|FG000|Overall Study|Did not receive any Mircera dose|11|||
124909068|NCT02538107|449293592|FG000|Overall Study|Missing|5|||
124909069|NCT02538107|449293592|FG000|Overall Study|Necessity of dialysis|20|||
124909070|NCT02538107|449293592|FG000|Overall Study|Administration of other ESA|11|||
124909071|NCT02538107|449293592|FG000|Overall Study|No further treatment necessary|18|||
124909072|NCT02538107|449293592|FG000|Overall Study|Withdrawal by Subject|17|||
124909073|NCT02538107|449293592|FG000|Overall Study|Death|4|||
124909074|NCT02538107|449293592|FG000|Overall Study|Administrative reason|5|||
124909075|NCT02538107|449293592|FG000|Overall Study|Adverse Event|4|||
124909076|NCT02538107|449293592|FG000|Overall Study|Surgery|1|||
124909077|NCT02538107|449293592|FG000|Overall Study|Other|7|||
124909078|NCT02538107|449293592|FG000|Overall Study|Not recorded|7|||
124450153|NCT00709111|447611884|FG000|Overall Study|Withdrawal by Subject|1|||
124909079|NCT01943916|449293593|FG000|Overall Study|Technically invalid images|10|||
124450154|NCT00709111|447611884|FG000|Overall Study|Unable to attend clinic visits|1|||
124450155|NCT01301456|447611885|FG000|Stage 1|Withdrawal by Subject|0|||
124450156|NCT01301456|447611886|FG001|Stage 1|Withdrawal by Subject|0|||
124450157|NCT01301456|447611887|FG002|Stage 1|Withdrawal by Subject|1|||
124450158|NCT01301456|447611888|FG003|Stage 1|Withdrawal by Subject|0|||
124450159|NCT01301456|447611889|FG004|Stage 1|Withdrawal by Subject|1|||
124450160|NCT01301456|447611890|FG005|Stage 1|Withdrawal by Subject|0|||
124450161|NCT01301456|447611891|FG006|Stage 1|Withdrawal by Subject|0|||
124909080|NCT01943916|449293593|FG000|Overall Study|Enrollment Failure|23|||
124909081|NCT01943916|449293593|FG000|Overall Study|Pilot Phase exclusion|100|||
124450162|NCT01301456|447611892|FG007|Stage 1|Withdrawal by Subject|0|||
124450163|NCT01301456|447611893|FG008|Stage 1|Withdrawal by Subject|0|||
124450164|NCT01301456|447611894|FG009|Stage 1|Withdrawal by Subject|0|||
124450165|NCT01301456|447611895|FG010|Stage 1|Withdrawal by Subject|0|||
124450166|NCT01301456|447611896|FG011|Stage 1|Withdrawal by Subject|0|||
124909082|NCT01943916|449293593|FG000|Overall Study|Quality Assurance Reader Fail|130|||
124909083|NCT01943916|449293593|FG000|Overall Study|Technical Failure|39|||
124909084|NCT01943916|449293593|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
124450167|NCT01301456|447611885|FG000|Stage 1|Randomized but not treated|0|||
124450168|NCT01301456|447611886|FG001|Stage 1|Randomized but not treated|0|||
124450169|NCT01301456|447611887|FG002|Stage 1|Randomized but not treated|0|||
124909085|NCT01943916|449293593|FG000|Overall Study|No Truth Panel Review|38|||
124909086|NCT01943916|449293593|FG000|Overall Study|Protocol Deviation|1|||
124909087|NCT05782231|449293594|FG000|Overall Study|Withdrawal by Subject|1|||
124909088|NCT05274217|449293595|FG000|Overall Study|Study terminated.|11|||
124909089|NCT05274217|449293596|FG001|Overall Study|Study terminated.|0|||
124909090|NCT01373346|449293601|FG000|Overall Study|Death|1|||
124691997|NCT01960842|448494631|FG000|Overall Study|Withdrawal by Subject|2|||
124691998|NCT00397930|448494632|FG000|Overall Study|Personal reasons|14|||
124691999|NCT00397930|448494633|FG001|Overall Study|Personal reasons|8|||
124692000|NCT00397930|448494632|FG000|Overall Study|Other medical|9|||
124692001|NCT00397930|448494633|FG001|Overall Study|Other medical|4|||
124692002|NCT00397930|448494632|FG000|Overall Study|Unknown reasons|9|||
124692003|NCT00397930|448494633|FG001|Overall Study|Unknown reasons|14|||
124692004|NCT00397930|448494632|FG000|Overall Study|Noncompliant|3|||
124692005|NCT00397930|448494633|FG001|Overall Study|Noncompliant|2|||
124692006|NCT00397930|448494632|FG000|Overall Study|Too time-consuming|2|||
124692007|NCT00397930|448494633|FG001|Overall Study|Too time-consuming|9|||
124692008|NCT00397930|448494632|FG000|Overall Study|Started own yoga program|1|||
124692009|NCT00397930|448494633|FG001|Overall Study|Started own yoga program|1|||
124692010|NCT00397930|448494632|FG000|Overall Study|Did not want to be in control group|0|||
124692011|NCT00397930|448494633|FG001|Overall Study|Did not want to be in control group|1|||
124692012|NCT00397930|448494632|FG000|Overall Study|Withdrawal by Subject|0|||
124692013|NCT00397930|448494633|FG001|Overall Study|Withdrawal by Subject|8|||
124692014|NCT00397930|448494632|FG000|Overall Study|Missing data|0|||
124692015|NCT00397930|448494633|FG001|Overall Study|Missing data|4|||
124692016|NCT02391584|448494634|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
124692017|NCT02391584|448494635|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
124692018|NCT02391584|448494634|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
124692019|NCT02391584|448494635|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
124692020|NCT02391584|448494634|FG000|3 Month|Lost to Follow-up|1|||
124692021|NCT02391584|448494635|FG001|3 Month|Lost to Follow-up|0|||
124692022|NCT02391584|448494634|FG000|6 Month|Withdrawal by Subject|1|||
124692023|NCT02391584|448494635|FG001|6 Month|Withdrawal by Subject|0|||
124692024|NCT02391584|448494634|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
124692025|NCT02391584|448494635|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
124692026|NCT01160744|448494644|FG000|Overall Study|Withdrawal by Subject|11|||
124692027|NCT01160744|448494645|FG001|Overall Study|Withdrawal by Subject|5|||
124692028|NCT01160744|448494646|FG002|Overall Study|Withdrawal by Subject|6|||
124692029|NCT01160744|448494647|FG003|Overall Study|Withdrawal by Subject|4|||
124692030|NCT01160744|448494644|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
124692031|NCT01160744|448494645|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
124692032|NCT01160744|448494646|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
124692033|NCT01160744|448494647|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
124692034|NCT02056288|448494648|FG000|In-Hospital Data|Surgery cancelled|1|||
124692035|NCT02056288|448494649|FG001|In-Hospital Data|Surgery cancelled|0|||
124692036|NCT02056288|448494648|FG000|In-Hospital Data|Protocol Violation|3|||
124692037|NCT02056288|448494649|FG001|In-Hospital Data|Protocol Violation|0|||
124692038|NCT02056288|448494648|FG000|In-Hospital Data|Physician Decision|1|||
124692039|NCT02056288|448494649|FG001|In-Hospital Data|Physician Decision|0|||
124692040|NCT02056288|448494648|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
124692041|NCT02056288|448494649|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
124692042|NCT02301429|448494650|FG000|Overall Study|not acceptable vascular anatomy|3|||
124692043|NCT01502072|448494651|FG000|Overall Study|Withdrawal by Subject|1|||
124692044|NCT01502072|448494652|FG001|Overall Study|Withdrawal by Subject|0|||
124692045|NCT01502072|448494653|FG002|Overall Study|Withdrawal by Subject|0|||
124692046|NCT01502072|448494651|FG000|Overall Study|Death|0|||
124692047|NCT01502072|448494652|FG001|Overall Study|Death|1|||
124692048|NCT01502072|448494653|FG002|Overall Study|Death|0|||
124692049|NCT00500110|448494654|FG000|Overall Study|Withdrawal by Subject|3|||
124692050|NCT03954938|448494655|FG000|Overall Study|Withdrawal by Subject|2|||
124692051|NCT03954938|448494655|FG000|Overall Study|Adverse Event|1|||
124692052|NCT04676646|448494656|FG000|Open-label Run-in Phase|Adverse Event|3|||
124692053|NCT04676646|448494657|FG001|Open-label Run-in Phase|Adverse Event|0|||
124692054|NCT04676646|448494658|FG002|Open-label Run-in Phase|Adverse Event|0|||
124692055|NCT04676646|448494656|FG000|Open-label Run-in Phase|Death|3|||
124692056|NCT04676646|448494657|FG001|Open-label Run-in Phase|Death|0|||
124692057|NCT04676646|448494658|FG002|Open-label Run-in Phase|Death|0|||
124692058|NCT04676646|448494656|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
124692059|NCT04676646|448494657|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
124692060|NCT04676646|448494658|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
124692061|NCT04676646|448494656|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
124692062|NCT04676646|448494657|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
124692063|NCT04676646|448494658|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
124692064|NCT04676646|448494656|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
124692065|NCT04676646|448494657|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
124692066|NCT04676646|448494658|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
124692067|NCT04676646|448494656|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
124692068|NCT04676646|448494657|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
124692069|NCT04676646|448494658|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
124692070|NCT04676646|448494656|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
124909091|NCT01395758|449293602|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
124909092|NCT01395758|449293603|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
124909093|NCT01395758|449293604|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
124909094|NCT00357097|449293605|FG000|Overall Study|Did not meet inclusion criteria|5|||
124909095|NCT00357097|449293606|FG001|Overall Study|Did not meet inclusion criteria|3|||
124909096|NCT00357097|449293605|FG000|Overall Study|Adverse Event|34|||
124909097|NCT00357097|449293606|FG001|Overall Study|Adverse Event|6|||
124909098|NCT00357097|449293605|FG000|Overall Study|Withdrawal by Subject|8|||
124909099|NCT00357097|449293606|FG001|Overall Study|Withdrawal by Subject|7|||
124909100|NCT00357097|449293605|FG000|Overall Study|Non-compliance|1|||
124909101|NCT00357097|449293606|FG001|Overall Study|Non-compliance|2|||
124909102|NCT00357097|449293605|FG000|Overall Study|Lack of Efficacy|2|||
124909103|NCT00357097|449293606|FG001|Overall Study|Lack of Efficacy|8|||
124909104|NCT00357097|449293605|FG000|Overall Study|Met Exclusion Criteria|3|||
124909105|NCT00357097|449293606|FG001|Overall Study|Met Exclusion Criteria|1|||
124909106|NCT00357097|449293605|FG000|Overall Study|Other|1|||
124909107|NCT00357097|449293606|FG001|Overall Study|Other|1|||
124909108|NCT00357097|449293605|FG000|Overall Study|Increase of RLS Symptoms|0|||
124909109|NCT00357097|449293606|FG001|Overall Study|Increase of RLS Symptoms|1|||
124909110|NCT00794118|449293607|FG000|Overall Study|Lost to Follow-up|16|||
124909111|NCT00794118|449293607|FG000|Overall Study|Withdrawal by Subject|9|||
124909112|NCT00794118|449293607|FG000|Overall Study|Changed hospital center|2|||
124909113|NCT04305405|449293608|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124909114|NCT04305405|449293609|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124909115|NCT02528188|449293610|FG000|Overall Study|Adverse Event|23|||
124909116|NCT02528188|449293611|FG001|Overall Study|Adverse Event|22|||
124909117|NCT02528188|449293612|FG002|Overall Study|Adverse Event|8|||
124909118|NCT02528188|449293610|FG000|Overall Study|Protocol Violation|4|||
124909119|NCT02528188|449293611|FG001|Overall Study|Protocol Violation|6|||
124909120|NCT02528188|449293612|FG002|Overall Study|Protocol Violation|4|||
124909121|NCT02528188|449293610|FG000|Overall Study|Lack of Efficacy|19|||
124909122|NCT02528188|449293611|FG001|Overall Study|Lack of Efficacy|21|||
124909123|NCT02528188|449293612|FG002|Overall Study|Lack of Efficacy|22|||
124909124|NCT02528188|449293610|FG000|Overall Study|Withdrawal by Subject|97|||
124909125|NCT02528188|449293611|FG001|Overall Study|Withdrawal by Subject|104|||
124909126|NCT02528188|449293612|FG002|Overall Study|Withdrawal by Subject|100|||
124909127|NCT02528188|449293610|FG000|Overall Study|Lost to Follow-up|25|||
124909128|NCT02528188|449293611|FG001|Overall Study|Lost to Follow-up|21|||
124909129|NCT02528188|449293612|FG002|Overall Study|Lost to Follow-up|31|||
124909130|NCT02528188|449293610|FG000|Overall Study|Death|4|||
124909131|NCT02528188|449293611|FG001|Overall Study|Death|4|||
124909132|NCT02528188|449293612|FG002|Overall Study|Death|0|||
124909133|NCT02528188|449293610|FG000|Overall Study|Other|89|||
124909134|NCT02528188|449293611|FG001|Overall Study|Other|91|||
124909135|NCT02528188|449293612|FG002|Overall Study|Other|74|||
124909136|NCT02528188|449293610|FG000|Overall Study|Randomized but not treated|6|||
124909137|NCT02528188|449293611|FG001|Overall Study|Randomized but not treated|7|||
124909138|NCT02528188|449293612|FG002|Overall Study|Randomized but not treated|12|||
124909139|NCT00529659|449293613|FG000|Overall Study|Adverse Event|8|||
124909140|NCT00529659|449293614|FG001|Overall Study|Adverse Event|7|||
124909141|NCT00529659|449293613|FG000|Overall Study|Lost to Follow-up|0|||
124909142|NCT00529659|449293614|FG001|Overall Study|Lost to Follow-up|2|||
124909143|NCT00529659|449293613|FG000|Overall Study|Physician Decision|0|||
124909144|NCT00529659|449293614|FG001|Overall Study|Physician Decision|2|||
124909145|NCT00529659|449293613|FG000|Overall Study|Protocol Violation|2|||
124909146|NCT00529659|449293614|FG001|Overall Study|Protocol Violation|6|||
124909147|NCT00529659|449293613|FG000|Overall Study|Withdrawal by Subject|1|||
124909148|NCT00529659|449293614|FG001|Overall Study|Withdrawal by Subject|6|||
124909149|NCT03887650|449293615|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
124909150|NCT03887650|449293616|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
124909151|NCT03887650|449293615|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
124909152|NCT03887650|449293616|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
124450170|NCT01301456|447611888|FG003|Stage 1|Randomized but not treated|0|||
124450171|NCT01301456|447611889|FG004|Stage 1|Randomized but not treated|0|||
124909153|NCT03887650|449293615|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
124909154|NCT03887650|449293616|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
124450172|NCT01301456|447611890|FG005|Stage 1|Randomized but not treated|0|||
124450173|NCT01301456|447611891|FG006|Stage 1|Randomized but not treated|1|||
124909155|NCT03512756|449293621|FG000|Part 1|Death|23|||
124909156|NCT03512756|449293622|FG001|Part 1|Death|18|||
124909157|NCT03512756|449293623|FG002|Part 1|Death|0|||
124450174|NCT01301456|447611892|FG007|Stage 1|Randomized but not treated|0|||
124909158|NCT03512756|449293624|FG003|Part 1|Death|0|||
124909159|NCT03512756|449293621|FG000|Part 1|Lost to Follow-up|0|||
124909160|NCT03512756|449293622|FG001|Part 1|Lost to Follow-up|3|||
124909161|NCT03512756|449293623|FG002|Part 1|Lost to Follow-up|0|||
124909162|NCT03512756|449293624|FG003|Part 1|Lost to Follow-up|0|||
124909163|NCT03512756|449293621|FG000|Part 1|Physician Decision|0|||
124909164|NCT03512756|449293622|FG001|Part 1|Physician Decision|1|||
124692071|NCT04676646|448494657|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
124692072|NCT04676646|448494658|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
124692073|NCT04676646|448494656|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
124692074|NCT04676646|448494657|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
124692075|NCT04676646|448494658|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
124692076|NCT04676646|448494656|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
124909165|NCT03512756|449293623|FG002|Part 1|Physician Decision|0|||
124909166|NCT03512756|449293624|FG003|Part 1|Physician Decision|0|||
124909167|NCT03512756|449293621|FG000|Part 1|Withdrawal by Subject|2|||
124909168|NCT03512756|449293622|FG001|Part 1|Withdrawal by Subject|2|||
124692077|NCT04676646|448494657|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
124909169|NCT03512756|449293623|FG002|Part 1|Withdrawal by Subject|0|||
124909170|NCT03512756|449293624|FG003|Part 1|Withdrawal by Subject|0|||
124909171|NCT03512756|449293621|FG000|Part 2|Death|0|||
124909172|NCT03512756|449293622|FG001|Part 2|Death|0|||
124909173|NCT03512756|449293623|FG002|Part 2|Death|32|||
124909174|NCT03512756|449293624|FG003|Part 2|Death|21|||
124909175|NCT03512756|449293621|FG000|Part 2|Lost to Follow-up|0|||
124909176|NCT03512756|449293622|FG001|Part 2|Lost to Follow-up|0|||
124909177|NCT03512756|449293623|FG002|Part 2|Lost to Follow-up|1|||
124909178|NCT03512756|449293624|FG003|Part 2|Lost to Follow-up|0|||
124692078|NCT04676646|448494658|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
124760404|NCT05579977|448746885|FG003|Treatment Phase|Pregnancy|0|||
124760405|NCT05579977|448746886|FG004|Treatment Phase|Pregnancy|0|||
124760406|NCT05579977|448746887|FG005|Treatment Phase|Pregnancy|0|||
124760407|NCT05579977|448746888|FG006|Treatment Phase|Pregnancy|0|||
124760408|NCT05579977|448746889|FG007|Treatment Phase|Pregnancy|0|||
124760409|NCT05579977|448746890|FG008|Treatment Phase|Pregnancy|0|||
124760410|NCT05579977|448746891|FG009|Treatment Phase|Pregnancy|1|||
124760411|NCT05579977|448746892|FG010|Treatment Phase|Pregnancy|0|||
124760412|NCT05579977|448746893|FG011|Treatment Phase|Pregnancy|0|||
124760413|NCT05579977|448746894|FG012|Treatment Phase|Pregnancy|0|||
124760414|NCT05579977|448746882|FG000|Treatment Phase|Physician Decision|0|||
124760415|NCT05579977|448746883|FG001|Treatment Phase|Physician Decision|0|||
124760416|NCT05579977|448746884|FG002|Treatment Phase|Physician Decision|0|||
124760417|NCT05579977|448746885|FG003|Treatment Phase|Physician Decision|0|||
124760418|NCT05579977|448746886|FG004|Treatment Phase|Physician Decision|0|||
124760419|NCT05579977|448746887|FG005|Treatment Phase|Physician Decision|0|||
124760420|NCT05579977|448746888|FG006|Treatment Phase|Physician Decision|0|||
124760421|NCT05579977|448746889|FG007|Treatment Phase|Physician Decision|0|||
124760422|NCT05579977|448746890|FG008|Treatment Phase|Physician Decision|0|||
124760423|NCT05579977|448746891|FG009|Treatment Phase|Physician Decision|0|||
124760424|NCT05579977|448746892|FG010|Treatment Phase|Physician Decision|0|||
124760425|NCT05579977|448746893|FG011|Treatment Phase|Physician Decision|1|||
124760426|NCT05579977|448746894|FG012|Treatment Phase|Physician Decision|0|||
124760427|NCT05579977|448746882|FG000|Treatment Phase|Lost to Follow-up|0|||
124760428|NCT05579977|448746883|FG001|Treatment Phase|Lost to Follow-up|0|||
124760429|NCT05579977|448746884|FG002|Treatment Phase|Lost to Follow-up|0|||
124760430|NCT05579977|448746885|FG003|Treatment Phase|Lost to Follow-up|1|||
124760431|NCT05579977|448746886|FG004|Treatment Phase|Lost to Follow-up|1|||
124760432|NCT05579977|448746887|FG005|Treatment Phase|Lost to Follow-up|1|||
124760433|NCT05579977|448746888|FG006|Treatment Phase|Lost to Follow-up|0|||
124760434|NCT05579977|448746889|FG007|Treatment Phase|Lost to Follow-up|1|||
124760435|NCT05579977|448746890|FG008|Treatment Phase|Lost to Follow-up|2|||
124760436|NCT05579977|448746891|FG009|Treatment Phase|Lost to Follow-up|2|||
124760437|NCT05579977|448746892|FG010|Treatment Phase|Lost to Follow-up|1|||
124760438|NCT05579977|448746893|FG011|Treatment Phase|Lost to Follow-up|4|||
124760439|NCT05579977|448746894|FG012|Treatment Phase|Lost to Follow-up|3|||
124760440|NCT05579977|448746882|FG000|Treatment Phase|Death|1|||
124760441|NCT05579977|448746883|FG001|Treatment Phase|Death|0|||
124760442|NCT05579977|448746884|FG002|Treatment Phase|Death|0|||
124760443|NCT05579977|448746885|FG003|Treatment Phase|Death|0|||
124760444|NCT05579977|448746886|FG004|Treatment Phase|Death|0|||
124760445|NCT05579977|448746887|FG005|Treatment Phase|Death|0|||
124760446|NCT05579977|448746888|FG006|Treatment Phase|Death|0|||
124760447|NCT05579977|448746889|FG007|Treatment Phase|Death|0|||
124760448|NCT05579977|448746890|FG008|Treatment Phase|Death|0|||
124760449|NCT05579977|448746891|FG009|Treatment Phase|Death|0|||
124909179|NCT03512756|449293621|FG000|Part 2|Physician Decision|0|||
124909180|NCT03512756|449293622|FG001|Part 2|Physician Decision|0|||
124909181|NCT03512756|449293623|FG002|Part 2|Physician Decision|2|||
124909182|NCT03512756|449293624|FG003|Part 2|Physician Decision|4|||
124760450|NCT05579977|448746892|FG010|Treatment Phase|Death|0|||
124760451|NCT05579977|448746893|FG011|Treatment Phase|Death|0|||
124760452|NCT05579977|448746894|FG012|Treatment Phase|Death|0|||
124760453|NCT05579977|448746882|FG000|Treatment Phase|Adverse Event|0|||
124760454|NCT05579977|448746883|FG001|Treatment Phase|Adverse Event|3|||
124760455|NCT05579977|448746884|FG002|Treatment Phase|Adverse Event|11|||
124760456|NCT05579977|448746885|FG003|Treatment Phase|Adverse Event|10|||
124909183|NCT03512756|449293621|FG000|Part 2|Study Terminated by Sponsor|0|||
124909184|NCT03512756|449293622|FG001|Part 2|Study Terminated by Sponsor|0|||
124909185|NCT03512756|449293623|FG002|Part 2|Study Terminated by Sponsor|2|||
124909186|NCT03512756|449293624|FG003|Part 2|Study Terminated by Sponsor|6|||
124909187|NCT03512756|449293621|FG000|Part 2|Protocol Violation|0|||
124909188|NCT03512756|449293622|FG001|Part 2|Protocol Violation|0|||
124909189|NCT03512756|449293623|FG002|Part 2|Protocol Violation|1|||
124909190|NCT03512756|449293624|FG003|Part 2|Protocol Violation|0|||
124909191|NCT03512756|449293621|FG000|Part 2|Withdrawal by Subject|0|||
124909192|NCT03512756|449293622|FG001|Part 2|Withdrawal by Subject|0|||
124909193|NCT03512756|449293623|FG002|Part 2|Withdrawal by Subject|3|||
124909194|NCT03512756|449293624|FG003|Part 2|Withdrawal by Subject|9|||
124909195|NCT00736853|449293625|FG000|Open-Label Period|Physician Decision|2|||
124909196|NCT00736853|449293626|FG001|Open-Label Period|Physician Decision|0|||
124909197|NCT00736853|449293627|FG002|Open-Label Period|Physician Decision|0|||
124909198|NCT00736853|449293625|FG000|Open-Label Period|Adverse Event|31|||
124909199|NCT00736853|449293626|FG001|Open-Label Period|Adverse Event|0|||
124909200|NCT00736853|449293627|FG002|Open-Label Period|Adverse Event|0|||
124909201|NCT00736853|449293625|FG000|Open-Label Period|Withdrawal by Subject|16|||
124909202|NCT00736853|449293626|FG001|Open-Label Period|Withdrawal by Subject|0|||
124909203|NCT00736853|449293627|FG002|Open-Label Period|Withdrawal by Subject|0|||
124909204|NCT00736853|449293625|FG000|Open-Label Period|Started but not treated|42|||
124909205|NCT00736853|449293626|FG001|Open-Label Period|Started but not treated|0|||
124909206|NCT00736853|449293627|FG002|Open-Label Period|Started but not treated|0|||
124909207|NCT00736853|449293625|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
124909208|NCT00736853|449293626|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
124909209|NCT00736853|449293627|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
124450175|NCT01301456|447611893|FG008|Stage 1|Randomized but not treated|0|||
124450176|NCT01301456|447611894|FG009|Stage 1|Randomized but not treated|0|||
124450177|NCT01301456|447611895|FG010|Stage 1|Randomized but not treated|0|||
124450178|NCT01301456|447611896|FG011|Stage 1|Randomized but not treated|0|||
124450179|NCT01301456|447611885|FG000|Stage 2|Adverse Event|0|||
124450180|NCT01301456|447611886|FG001|Stage 2|Adverse Event|0|||
124450181|NCT01301456|447611887|FG002|Stage 2|Adverse Event|0|||
124450182|NCT01301456|447611888|FG003|Stage 2|Adverse Event|0|||
124450183|NCT01301456|447611889|FG004|Stage 2|Adverse Event|0|||
124450184|NCT01301456|447611890|FG005|Stage 2|Adverse Event|0|||
124450185|NCT01301456|447611891|FG006|Stage 2|Adverse Event|0|||
124760457|NCT05579977|448746886|FG004|Treatment Phase|Adverse Event|5|||
124760458|NCT05579977|448746887|FG005|Treatment Phase|Adverse Event|17|||
124760459|NCT05579977|448746888|FG006|Treatment Phase|Adverse Event|5|||
124450186|NCT01301456|447611892|FG007|Stage 2|Adverse Event|0|||
124450187|NCT01301456|447611893|FG008|Stage 2|Adverse Event|0|||
124450188|NCT01301456|447611894|FG009|Stage 2|Adverse Event|0|||
124760460|NCT05579977|448746889|FG007|Treatment Phase|Adverse Event|5|||
124760461|NCT05579977|448746890|FG008|Treatment Phase|Adverse Event|12|||
124760462|NCT05579977|448746891|FG009|Treatment Phase|Adverse Event|20|||
124760463|NCT05579977|448746892|FG010|Treatment Phase|Adverse Event|15|||
124760464|NCT05579977|448746893|FG011|Treatment Phase|Adverse Event|24|||
124760465|NCT05579977|448746894|FG012|Treatment Phase|Adverse Event|23|||
124760466|NCT05579977|448746882|FG000|Treatment Phase|Randomized not treated|0|||
124760467|NCT05579977|448746883|FG001|Treatment Phase|Randomized not treated|0|||
124909210|NCT00736853|449293625|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
124909211|NCT00736853|449293626|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
124909212|NCT00736853|449293627|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
124909213|NCT00736853|449293625|FG000|Double-Blind Period|Lack of Efficacy|0|||
124909214|NCT00736853|449293626|FG001|Double-Blind Period|Lack of Efficacy|19|||
124909215|NCT00736853|449293627|FG002|Double-Blind Period|Lack of Efficacy|42|||
124909216|NCT00736853|449293625|FG000|Double-Blind Period|Adverse Event|0|||
124909217|NCT00736853|449293626|FG001|Double-Blind Period|Adverse Event|3|||
124909218|NCT00736853|449293627|FG002|Double-Blind Period|Adverse Event|2|||
124909219|NCT00736853|449293625|FG000|Double-Blind Period|Withdrawal by Subject|0|||
124909220|NCT00736853|449293626|FG001|Double-Blind Period|Withdrawal by Subject|1|||
124450189|NCT01301456|447611895|FG010|Stage 2|Adverse Event|1|||
124450190|NCT01301456|447611896|FG011|Stage 2|Adverse Event|0|||
124760468|NCT05579977|448746884|FG002|Treatment Phase|Randomized not treated|0|||
124760469|NCT05579977|448746885|FG003|Treatment Phase|Randomized not treated|0|||
124909221|NCT00736853|449293627|FG002|Double-Blind Period|Withdrawal by Subject|4|||
124909222|NCT00736853|449293625|FG000|Double-Blind Period|Ineligible to participate the study|0|||
124909223|NCT00736853|449293626|FG001|Double-Blind Period|Ineligible to participate the study|1|||
124909224|NCT00736853|449293627|FG002|Double-Blind Period|Ineligible to participate the study|0|||
124909225|NCT01199705|449293628|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
124909226|NCT01764464|449293633|FG000|First Intervention|Withdrawal by Subject|1|||
124909227|NCT01764464|449293634|FG001|First Intervention|Withdrawal by Subject|0|||
124909228|NCT01764464|449293633|FG000|First Intervention|Lost to Follow-up|1|||
124909229|NCT01764464|449293634|FG001|First Intervention|Lost to Follow-up|0|||
124909230|NCT01764464|449293633|FG000|First Intervention|Adverse Event|0|||
124909231|NCT01764464|449293634|FG001|First Intervention|Adverse Event|2|||
124909232|NCT01764464|449293633|FG000|First Intervention|did not receive study drug|0|||
124909233|NCT01764464|449293634|FG001|First Intervention|did not receive study drug|1|||
124909234|NCT01764464|449293633|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
124909235|NCT01764464|449293634|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
124909236|NCT03215927|449295530|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
124909237|NCT03215927|449295531|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
124909238|NCT03215927|449295530|FG000|Open Label Extension|Adverse Event|1|||
124909239|NCT03215927|449295531|FG001|Open Label Extension|Adverse Event|0|||
124909240|NCT03215927|449295530|FG000|Open Label Extension|Lack of Efficacy|1|||
124909241|NCT03215927|449295531|FG001|Open Label Extension|Lack of Efficacy|0|||
124909242|NCT03215927|449295530|FG000|Open Label Extension|Death|0|||
124909243|NCT03215927|449295531|FG001|Open Label Extension|Death|1|||
124909244|NCT03889925|449295534|FG000|Overall Study|Lost to Follow-up|11|||
124909245|NCT03889925|449295535|FG001|Overall Study|Lost to Follow-up|10|||
124909246|NCT03073941|449295536|FG000|Overall Study|Received non-study device intraoperatively|0|||
124909247|NCT03073941|449295537|FG001|Overall Study|Received non-study device intraoperatively|2|||
124909248|NCT03073941|449295536|FG000|Overall Study|Death|1|||
124909249|NCT03073941|449295537|FG001|Overall Study|Death|0|||
124909250|NCT03073941|449295536|FG000|Overall Study|Withdrawal by Subject|1|||
124909251|NCT03073941|449295537|FG001|Overall Study|Withdrawal by Subject|3|||
124909252|NCT03073941|449295536|FG000|Overall Study|Lost to Follow-up|5|||
124909253|NCT03073941|449295537|FG001|Overall Study|Lost to Follow-up|4|||
124909254|NCT03073941|449295536|FG000|Overall Study|Adverse Event|4|||
124909255|NCT03073941|449295537|FG001|Overall Study|Adverse Event|2|||
124909256|NCT03073941|449295536|FG000|Overall Study|Met an exclusion criterion|0|||
124909257|NCT03073941|449295537|FG001|Overall Study|Met an exclusion criterion|1|||
124909258|NCT04250883|449295538|FG000|Overall Study|Lost to Follow-up|1|||
124909259|NCT04250883|449295539|FG001|Overall Study|Lost to Follow-up|0|||
124909260|NCT01823536|449295546|FG000|Overall Study|Lost to Follow-up|1|||
124909261|NCT01823536|449295547|FG001|Overall Study|Lost to Follow-up|0|||
124909262|NCT01823536|449295548|FG002|Overall Study|Lost to Follow-up|0|||
124909263|NCT01823536|449295549|FG003|Overall Study|Lost to Follow-up|1|||
124909264|NCT01823536|449295550|FG004|Overall Study|Lost to Follow-up|1|||
124909265|NCT01823536|449295551|FG005|Overall Study|Lost to Follow-up|0|||
124909266|NCT01823536|449295546|FG000|Overall Study|Protocol Violation|0|||
124909267|NCT01823536|449295547|FG001|Overall Study|Protocol Violation|1|||
124909268|NCT01823536|449295548|FG002|Overall Study|Protocol Violation|0|||
124909269|NCT01823536|449295549|FG003|Overall Study|Protocol Violation|0|||
124909270|NCT01823536|449295550|FG004|Overall Study|Protocol Violation|0|||
124909271|NCT01823536|449295551|FG005|Overall Study|Protocol Violation|0|||
124909272|NCT01823536|449295546|FG000|Overall Study|Withdrawal by Subject|1|||
124909273|NCT01823536|449295547|FG001|Overall Study|Withdrawal by Subject|1|||
124909274|NCT01823536|449295548|FG002|Overall Study|Withdrawal by Subject|0|||
124909275|NCT01823536|449295549|FG003|Overall Study|Withdrawal by Subject|0|||
124909276|NCT01823536|449295550|FG004|Overall Study|Withdrawal by Subject|0|||
124909277|NCT01823536|449295551|FG005|Overall Study|Withdrawal by Subject|0|||
124909278|NCT01823536|449295546|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
124450191|NCT00915772|447611897|FG000|Overall Study|Adverse Event|12|||
124909279|NCT01823536|449295547|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
124909280|NCT01823536|449295548|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
124909281|NCT01823536|449295549|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
124909282|NCT01823536|449295550|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
124909283|NCT01823536|449295551|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
124909284|NCT01823536|449295546|FG000|Overall Study|Met exclusion criterion No 6|0|||
124909285|NCT01823536|449295547|FG001|Overall Study|Met exclusion criterion No 6|0|||
124909286|NCT01823536|449295548|FG002|Overall Study|Met exclusion criterion No 6|0|||
124909287|NCT01823536|449295549|FG003|Overall Study|Met exclusion criterion No 6|1|||
124909288|NCT01823536|449295550|FG004|Overall Study|Met exclusion criterion No 6|0|||
124909289|NCT01823536|449295551|FG005|Overall Study|Met exclusion criterion No 6|0|||
124909290|NCT01823536|449295546|FG000|Overall Study|Subject moved out of the state|0|||
124909291|NCT01823536|449295547|FG001|Overall Study|Subject moved out of the state|0|||
124909292|NCT01823536|449295548|FG002|Overall Study|Subject moved out of the state|0|||
124909293|NCT01823536|449295549|FG003|Overall Study|Subject moved out of the state|0|||
124909294|NCT01823536|449295550|FG004|Overall Study|Subject moved out of the state|1|||
124909295|NCT01823536|449295551|FG005|Overall Study|Subject moved out of the state|0|||
124909296|NCT04425629|449295552|FG000|Overall Study|Adverse Event|0|||
124909297|NCT04425629|449295553|FG001|Overall Study|Adverse Event|0|||
124909298|NCT04425629|449295554|FG002|Overall Study|Adverse Event|0|||
124909299|NCT04425629|449295555|FG003|Overall Study|Adverse Event|0|||
124909300|NCT04425629|449295556|FG004|Overall Study|Adverse Event|1|||
124909301|NCT04425629|449295557|FG005|Overall Study|Adverse Event|0|||
124909302|NCT04425629|449295558|FG006|Overall Study|Adverse Event|0|||
124909303|NCT04425629|449295559|FG007|Overall Study|Adverse Event|0|||
124909304|NCT04425629|449295560|FG008|Overall Study|Adverse Event|0|||
124909305|NCT04425629|449295561|FG009|Overall Study|Adverse Event|3|||
124909306|NCT04425629|449295562|FG010|Overall Study|Adverse Event|2|||
124909307|NCT04425629|449295563|FG011|Overall Study|Adverse Event|1|||
124909308|NCT04425629|449295564|FG012|Overall Study|Adverse Event|1|||
124909309|NCT04425629|449295565|FG013|Overall Study|Adverse Event|0|||
124909310|NCT04425629|449295566|FG014|Overall Study|Adverse Event|0|||
124909311|NCT04425629|449295567|FG015|Overall Study|Adverse Event|0|||
124909312|NCT04425629|449295568|FG016|Overall Study|Adverse Event|0|||
124909313|NCT04425629|449295569|FG017|Overall Study|Adverse Event|0|||
124909314|NCT04425629|449295570|FG018|Overall Study|Adverse Event|0|||
124909315|NCT04425629|449295552|FG000|Overall Study|Lost to Follow-up|1|||
124909316|NCT04425629|449295553|FG001|Overall Study|Lost to Follow-up|3|||
124909317|NCT04425629|449295554|FG002|Overall Study|Lost to Follow-up|1|||
124909318|NCT04425629|449295555|FG003|Overall Study|Lost to Follow-up|7|||
124909319|NCT04425629|449295556|FG004|Overall Study|Lost to Follow-up|1|||
124909320|NCT04425629|449295557|FG005|Overall Study|Lost to Follow-up|2|||
124909321|NCT04425629|449295558|FG006|Overall Study|Lost to Follow-up|1|||
124909322|NCT04425629|449295559|FG007|Overall Study|Lost to Follow-up|0|||
124909323|NCT04425629|449295560|FG008|Overall Study|Lost to Follow-up|1|||
124909324|NCT04425629|449295561|FG009|Overall Study|Lost to Follow-up|64|||
124909325|NCT04425629|449295562|FG010|Overall Study|Lost to Follow-up|70|||
124909326|NCT04425629|449295563|FG011|Overall Study|Lost to Follow-up|98|||
124909327|NCT04425629|449295564|FG012|Overall Study|Lost to Follow-up|30|||
124909328|NCT04425629|449295565|FG013|Overall Study|Lost to Follow-up|0|||
124909329|NCT04425629|449295566|FG014|Overall Study|Lost to Follow-up|5|||
124909330|NCT04425629|449295567|FG015|Overall Study|Lost to Follow-up|4|||
124909331|NCT04425629|449295568|FG016|Overall Study|Lost to Follow-up|0|||
124909332|NCT04425629|449295569|FG017|Overall Study|Lost to Follow-up|3|||
124909333|NCT04425629|449295570|FG018|Overall Study|Lost to Follow-up|1|||
124909334|NCT04425629|449295552|FG000|Overall Study|Subject Decision|0|||
124909335|NCT04425629|449295553|FG001|Overall Study|Subject Decision|2|||
124909336|NCT04425629|449295554|FG002|Overall Study|Subject Decision|1|||
124909337|NCT04425629|449295555|FG003|Overall Study|Subject Decision|3|||
124909338|NCT04425629|449295556|FG004|Overall Study|Subject Decision|6|||
124909339|NCT04425629|449295557|FG005|Overall Study|Subject Decision|6|||
124909340|NCT04425629|449295558|FG006|Overall Study|Subject Decision|3|||
124909341|NCT04425629|449295559|FG007|Overall Study|Subject Decision|3|||
124909342|NCT04425629|449295560|FG008|Overall Study|Subject Decision|1|||
124909343|NCT04425629|449295561|FG009|Overall Study|Subject Decision|70|||
124909344|NCT04425629|449295562|FG010|Overall Study|Subject Decision|95|||
124909345|NCT04425629|449295563|FG011|Overall Study|Subject Decision|124|||
124909346|NCT04425629|449295564|FG012|Overall Study|Subject Decision|25|||
124909347|NCT04425629|449295565|FG013|Overall Study|Subject Decision|0|||
124909348|NCT04425629|449295566|FG014|Overall Study|Subject Decision|1|||
124909349|NCT04425629|449295567|FG015|Overall Study|Subject Decision|4|||
124692079|NCT04676646|448494656|FG000|Randomised-withdrawal Phase|Death|0|||
124692080|NCT04676646|448494657|FG001|Randomised-withdrawal Phase|Death|1|||
124909350|NCT04425629|449295568|FG016|Overall Study|Subject Decision|1|||
124909351|NCT04425629|449295569|FG017|Overall Study|Subject Decision|0|||
124909352|NCT04425629|449295570|FG018|Overall Study|Subject Decision|2|||
124909353|NCT04425629|449295552|FG000|Overall Study|Death|0|||
124909354|NCT04425629|449295553|FG001|Overall Study|Death|0|||
124909355|NCT04425629|449295554|FG002|Overall Study|Death|0|||
124909356|NCT04425629|449295555|FG003|Overall Study|Death|0|||
124909357|NCT04425629|449295556|FG004|Overall Study|Death|0|||
124909358|NCT04425629|449295557|FG005|Overall Study|Death|0|||
124909359|NCT04425629|449295558|FG006|Overall Study|Death|0|||
124909360|NCT04425629|449295559|FG007|Overall Study|Death|0|||
124909361|NCT04425629|449295560|FG008|Overall Study|Death|0|||
124909362|NCT04425629|449295561|FG009|Overall Study|Death|11|||
124909363|NCT04425629|449295562|FG010|Overall Study|Death|2|||
124909364|NCT04425629|449295563|FG011|Overall Study|Death|4|||
124909365|NCT04425629|449295564|FG012|Overall Study|Death|0|||
124909366|NCT04425629|449295565|FG013|Overall Study|Death|0|||
124909367|NCT04425629|449295566|FG014|Overall Study|Death|0|||
124909368|NCT04425629|449295567|FG015|Overall Study|Death|0|||
124692081|NCT04676646|448494658|FG002|Randomised-withdrawal Phase|Death|2|||
124909369|NCT04425629|449295568|FG016|Overall Study|Death|0|||
124909370|NCT04425629|449295569|FG017|Overall Study|Death|0|||
124909371|NCT04425629|449295570|FG018|Overall Study|Death|0|||
124909372|NCT04425629|449295552|FG000|Overall Study|Sponsor Request|0|||
124909373|NCT04425629|449295553|FG001|Overall Study|Sponsor Request|0|||
124909374|NCT04425629|449295554|FG002|Overall Study|Sponsor Request|0|||
124909375|NCT04425629|449295555|FG003|Overall Study|Sponsor Request|2|||
124909376|NCT04425629|449295556|FG004|Overall Study|Sponsor Request|2|||
124909377|NCT04425629|449295557|FG005|Overall Study|Sponsor Request|2|||
124909378|NCT04425629|449295558|FG006|Overall Study|Sponsor Request|1|||
124909379|NCT04425629|449295559|FG007|Overall Study|Sponsor Request|0|||
124909380|NCT04425629|449295560|FG008|Overall Study|Sponsor Request|0|||
124909381|NCT04425629|449295561|FG009|Overall Study|Sponsor Request|9|||
124909382|NCT04425629|449295562|FG010|Overall Study|Sponsor Request|9|||
124909383|NCT04425629|449295563|FG011|Overall Study|Sponsor Request|10|||
124909384|NCT04425629|449295564|FG012|Overall Study|Sponsor Request|8|||
124909385|NCT04425629|449295565|FG013|Overall Study|Sponsor Request|0|||
124909386|NCT04425629|449295566|FG014|Overall Study|Sponsor Request|0|||
124909387|NCT04425629|449295567|FG015|Overall Study|Sponsor Request|1|||
124909388|NCT04425629|449295568|FG016|Overall Study|Sponsor Request|0|||
124909389|NCT04425629|449295569|FG017|Overall Study|Sponsor Request|0|||
124909390|NCT04425629|449295570|FG018|Overall Study|Sponsor Request|0|||
124909391|NCT04425629|449295552|FG000|Overall Study|Physician Decision|0|||
124909392|NCT04425629|449295553|FG001|Overall Study|Physician Decision|0|||
124544881|NCT02331680|447949260|FG002|Overall Study|Protocol Violation|3|||
124544882|NCT03426995|447949261|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124544883|NCT03426995|447949262|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124544884|NCT03426995|447949263|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
124544885|NCT03426995|447949264|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124544886|NCT03426995|447949265|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124544887|NCT03426995|447949266|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124544888|NCT03426995|447949267|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124544889|NCT03426995|447949268|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124544890|NCT03426995|447949269|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124544891|NCT03426995|447949270|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124544892|NCT03426995|447949271|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124544893|NCT03426995|447949272|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124544894|NCT03426995|447949273|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124544895|NCT03426995|447949274|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124544896|NCT03426995|447949275|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124692082|NCT04676646|448494656|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
124692083|NCT04676646|448494657|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
124692084|NCT04676646|448494658|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
124692085|NCT04676646|448494656|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
124692086|NCT04676646|448494657|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
124692087|NCT04676646|448494658|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
124692088|NCT04676646|448494656|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
124692089|NCT04676646|448494657|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
124692090|NCT04676646|448494658|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
124692091|NCT04676646|448494656|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
124692092|NCT04676646|448494657|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
124692093|NCT04676646|448494658|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
124692094|NCT04676646|448494656|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
124692095|NCT04676646|448494657|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
124692096|NCT04676646|448494658|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
124692097|NCT04676646|448494656|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
124692098|NCT04676646|448494657|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
124692099|NCT04676646|448494658|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
124692100|NCT04676646|448494656|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
124909393|NCT04425629|449295554|FG002|Overall Study|Physician Decision|0|||
124909394|NCT04425629|449295555|FG003|Overall Study|Physician Decision|0|||
124909395|NCT04425629|449295556|FG004|Overall Study|Physician Decision|0|||
124909396|NCT04425629|449295557|FG005|Overall Study|Physician Decision|0|||
124909397|NCT04425629|449295558|FG006|Overall Study|Physician Decision|0|||
124909398|NCT04425629|449295559|FG007|Overall Study|Physician Decision|0|||
124909399|NCT04425629|449295560|FG008|Overall Study|Physician Decision|0|||
124909400|NCT04425629|449295561|FG009|Overall Study|Physician Decision|4|||
124692101|NCT04676646|448494657|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
124692102|NCT04676646|448494658|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
124692103|NCT02217982|448494659|FG000|Overall Study|Trial discontinued|1|||
124692104|NCT02217982|448494660|FG001|Overall Study|Trial discontinued|0|||
124692105|NCT02217982|448494659|FG000|Overall Study|Adverse Event|0|||
124692106|NCT02217982|448494660|FG001|Overall Study|Adverse Event|1|||
124909401|NCT04425629|449295562|FG010|Overall Study|Physician Decision|3|||
124450192|NCT00915772|447611898|FG001|Overall Study|Adverse Event|13|||
124692107|NCT04270760|448494661|FG000|Overall Study|Withdrawal by Subject|0|||
124692108|NCT04270760|448494662|FG001|Overall Study|Withdrawal by Subject|1|||
124692109|NCT04270760|448494663|FG002|Overall Study|Withdrawal by Subject|3|||
124692110|NCT04270760|448494664|FG003|Overall Study|Withdrawal by Subject|0|||
124692111|NCT04270760|448494665|FG004|Overall Study|Withdrawal by Subject|0|||
124692112|NCT04270760|448494661|FG000|Overall Study|Lost to Follow-up|1|||
124692113|NCT04270760|448494662|FG001|Overall Study|Lost to Follow-up|2|||
124450193|NCT00915772|447611899|FG002|Overall Study|Adverse Event|11|||
124450194|NCT00915772|447611897|FG000|Overall Study|Protocol Violation|4|||
124450195|NCT00915772|447611898|FG001|Overall Study|Protocol Violation|1|||
124450196|NCT00915772|447611899|FG002|Overall Study|Protocol Violation|2|||
124450197|NCT00915772|447611897|FG000|Overall Study|Lost to Follow-up|1|||
124450198|NCT00915772|447611898|FG001|Overall Study|Lost to Follow-up|2|||
124450199|NCT00915772|447611899|FG002|Overall Study|Lost to Follow-up|2|||
124450200|NCT00915772|447611897|FG000|Overall Study|Lack of Efficacy|9|||
124450201|NCT00915772|447611898|FG001|Overall Study|Lack of Efficacy|15|||
124450202|NCT00915772|447611899|FG002|Overall Study|Lack of Efficacy|3|||
124450203|NCT00915772|447611897|FG000|Overall Study|Refused to continue trial medication|6|||
124450204|NCT00915772|447611898|FG001|Overall Study|Refused to continue trial medication|8|||
124450205|NCT00915772|447611899|FG002|Overall Study|Refused to continue trial medication|4|||
124450206|NCT00915772|447611897|FG000|Overall Study|Any other reason|4|||
124450207|NCT00915772|447611898|FG001|Overall Study|Any other reason|7|||
124450208|NCT00915772|447611899|FG002|Overall Study|Any other reason|7|||
124450209|NCT03583450|447611900|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
124450210|NCT03583450|447611901|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
124450211|NCT03374995|447611902|FG000|Overall Study|Withdrawal by Subject|0|||
124450212|NCT03374995|447611903|FG001|Overall Study|Withdrawal by Subject|1|||
124450213|NCT01383096|447611904|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
124450214|NCT01383096|447611905|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
124450215|NCT01383096|447611906|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
124450216|NCT01383096|447611904|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
124450217|NCT01383096|447611905|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
124450218|NCT01383096|447611906|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
124450219|NCT01383096|447611904|FG000|Third Intervention (8 Days)|Elevated AST|0|||
124450220|NCT01383096|447611905|FG001|Third Intervention (8 Days)|Elevated AST|1|||
124450221|NCT01383096|447611906|FG002|Third Intervention (8 Days)|Elevated AST|0|||
124450222|NCT01383096|447611904|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
124450223|NCT01383096|447611905|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
124450224|NCT01383096|447611906|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
124450225|NCT01383096|447611904|FG000|Third Intervention (8 Days)|Adverse Event|1|||
124450226|NCT01383096|447611905|FG001|Third Intervention (8 Days)|Adverse Event|0|||
124450227|NCT01383096|447611906|FG002|Third Intervention (8 Days)|Adverse Event|0|||
124450228|NCT01383096|447611904|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
124450229|NCT01383096|447611905|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
124450230|NCT01383096|447611906|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
124450231|NCT01383096|447611904|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
124450232|NCT01383096|447611905|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
124450233|NCT01383096|447611906|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
124450234|NCT01383096|447611904|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
124450235|NCT01383096|447611905|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
124450236|NCT01383096|447611906|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
124450237|NCT01383096|447611904|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
124450238|NCT01383096|447611905|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
124692114|NCT04270760|448494663|FG002|Overall Study|Lost to Follow-up|1|||
124692115|NCT04270760|448494664|FG003|Overall Study|Lost to Follow-up|0|||
124909402|NCT04425629|449295563|FG011|Overall Study|Physician Decision|5|||
124450239|NCT01383096|447611906|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
124450240|NCT01383096|447611904|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
124450241|NCT01383096|447611905|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
124450242|NCT01383096|447611906|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
124692116|NCT04270760|448494665|FG004|Overall Study|Lost to Follow-up|0|||
124909403|NCT04425629|449295564|FG012|Overall Study|Physician Decision|1|||
124544897|NCT03426995|447949276|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124909404|NCT04425629|449295565|FG013|Overall Study|Physician Decision|0|||
124909405|NCT04425629|449295566|FG014|Overall Study|Physician Decision|0|||
124909406|NCT04425629|449295567|FG015|Overall Study|Physician Decision|1|||
124909407|NCT04425629|449295568|FG016|Overall Study|Physician Decision|0|||
124909408|NCT04425629|449295569|FG017|Overall Study|Physician Decision|0|||
124909409|NCT04425629|449295570|FG018|Overall Study|Physician Decision|0|||
124909410|NCT04425629|449295552|FG000|Overall Study|Lack of Efficacy|0|||
124909411|NCT04425629|449295553|FG001|Overall Study|Lack of Efficacy|0|||
124909412|NCT04425629|449295554|FG002|Overall Study|Lack of Efficacy|0|||
124909413|NCT04425629|449295555|FG003|Overall Study|Lack of Efficacy|0|||
124909414|NCT04425629|449295556|FG004|Overall Study|Lack of Efficacy|0|||
124909415|NCT04425629|449295557|FG005|Overall Study|Lack of Efficacy|0|||
124909416|NCT04425629|449295558|FG006|Overall Study|Lack of Efficacy|0|||
124909417|NCT04425629|449295559|FG007|Overall Study|Lack of Efficacy|0|||
124909418|NCT04425629|449295560|FG008|Overall Study|Lack of Efficacy|0|||
124909419|NCT04425629|449295561|FG009|Overall Study|Lack of Efficacy|0|||
124909420|NCT04425629|449295562|FG010|Overall Study|Lack of Efficacy|1|||
124909421|NCT04425629|449295563|FG011|Overall Study|Lack of Efficacy|0|||
124909422|NCT04425629|449295564|FG012|Overall Study|Lack of Efficacy|0|||
124909423|NCT04425629|449295565|FG013|Overall Study|Lack of Efficacy|0|||
124909424|NCT04425629|449295566|FG014|Overall Study|Lack of Efficacy|0|||
124909425|NCT04425629|449295567|FG015|Overall Study|Lack of Efficacy|0|||
124909426|NCT04425629|449295568|FG016|Overall Study|Lack of Efficacy|0|||
124909427|NCT04425629|449295569|FG017|Overall Study|Lack of Efficacy|0|||
124909428|NCT04425629|449295570|FG018|Overall Study|Lack of Efficacy|0|||
124692117|NCT04270760|448494661|FG000|Overall Study|Death|0|||
124692118|NCT04270760|448494662|FG001|Overall Study|Death|0|||
124692119|NCT04270760|448494663|FG002|Overall Study|Death|0|||
124692120|NCT04270760|448494664|FG003|Overall Study|Death|0|||
124692121|NCT04270760|448494665|FG004|Overall Study|Death|1|||
124692122|NCT02421510|448494666|FG000|Overall Study|Other|4|||
124692123|NCT02421510|448494667|FG001|Overall Study|Other|2|||
124692124|NCT02421510|448494668|FG002|Overall Study|Other|3|||
124692125|NCT02421510|448494666|FG000|Overall Study|Protocol Violation|1|||
124692126|NCT02421510|448494667|FG001|Overall Study|Protocol Violation|2|||
124692127|NCT02421510|448494668|FG002|Overall Study|Protocol Violation|0|||
124692128|NCT02421510|448494666|FG000|Overall Study|Death|1|||
124909429|NCT04218110|449295571|FG000|Overall Study|Withdrawal by Subject|0|||
124909430|NCT04218110|449295572|FG001|Overall Study|Withdrawal by Subject|0|||
124909431|NCT04218110|449295573|FG002|Overall Study|Withdrawal by Subject|0|||
124909432|NCT04218110|449295574|FG003|Overall Study|Withdrawal by Subject|1|||
124450243|NCT01383096|447611904|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
124450244|NCT01383096|447611905|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
124450245|NCT01383096|447611906|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
124450246|NCT01211535|447611907|FG000|Overall Study|Adverse Event|0|||
124450247|NCT01211535|447611908|FG001|Overall Study|Adverse Event|1|||
124450248|NCT03593850|447611913|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
124450249|NCT03593850|447611914|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
124450250|NCT01735279|447611915|FG000|Overall Study|Lost to Follow-up|11|||
124450251|NCT01735279|447611916|FG001|Overall Study|Lost to Follow-up|8|||
124450252|NCT05097716|447611921|FG000|Period 1|Adverse Event|1|||
124466464|NCT02574637|447666424|FG008|Double-blind Period|Adverse Event|0|||
124692129|NCT02421510|448494667|FG001|Overall Study|Death|0|||
124692130|NCT02421510|448494668|FG002|Overall Study|Death|0|||
124692131|NCT02421510|448494666|FG000|Overall Study|Noncompliance with study drug|1|||
124692132|NCT02421510|448494667|FG001|Overall Study|Noncompliance with study drug|0|||
124692133|NCT02421510|448494668|FG002|Overall Study|Noncompliance with study drug|0|||
124692134|NCT02421510|448494666|FG000|Overall Study|Physician Decision|1|||
124692135|NCT02421510|448494667|FG001|Overall Study|Physician Decision|1|||
124692136|NCT02421510|448494668|FG002|Overall Study|Physician Decision|3|||
124692137|NCT02421510|448494666|FG000|Overall Study|Adverse Event|9|||
124692138|NCT02421510|448494667|FG001|Overall Study|Adverse Event|10|||
124692139|NCT02421510|448494668|FG002|Overall Study|Adverse Event|18|||
124692140|NCT02421510|448494666|FG000|Overall Study|Pregnancy|1|||
124692141|NCT02421510|448494667|FG001|Overall Study|Pregnancy|1|||
124692142|NCT02421510|448494668|FG002|Overall Study|Pregnancy|0|||
124692143|NCT02421510|448494666|FG000|Overall Study|Withdrawal by Subject|14|||
124692144|NCT02421510|448494667|FG001|Overall Study|Withdrawal by Subject|18|||
124692145|NCT02421510|448494668|FG002|Overall Study|Withdrawal by Subject|12|||
124909433|NCT02271854|449295575|FG000|Overall Study|Withdrawal by Subject|2|||
124909434|NCT02271854|449295575|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
124909435|NCT02271854|449295575|FG000|Overall Study|Lost to Follow-up|1|||
124909436|NCT00446459|449295577|FG000|8 Months|Protocol Violation|12|||
124909437|NCT00446459|449295577|FG000|12 Months|Protocol Violation|4|||
124909438|NCT00446459|449295577|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
124909439|NCT02918279|449295578|FG000|Overall Study|Lost to Follow-up|3|||
124909440|NCT02918279|449295579|FG001|Overall Study|Lost to Follow-up|6|||
124909441|NCT02918279|449295578|FG000|Overall Study|Withdrawal by Subject|5|||
124909442|NCT02918279|449295579|FG001|Overall Study|Withdrawal by Subject|15|||
124909443|NCT02918279|449295578|FG000|Overall Study|Withdrawal by parent/guardian|2|||
124909444|NCT02918279|449295579|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124909445|NCT02918279|449295578|FG000|Overall Study|Other|3|||
124909446|NCT02918279|449295579|FG001|Overall Study|Other|1|||
124909447|NCT00309907|449295580|FG000|Overall Study|Death|4|||
124909448|NCT00309907|449295580|FG000|Overall Study|Physician Decision|1|||
124909449|NCT00309907|449295580|FG000|Overall Study|Ineligible|11|||
124909450|NCT00309907|449295580|FG000|Overall Study|Major infectious event|4|||
124909451|NCT00244855|449295581|FG000|Overall Study|Withdrawal by Subject|0|||
124909452|NCT00244855|449295582|FG001|Overall Study|Withdrawal by Subject|1|||
124909453|NCT00869258|449295583|FG000|Overall Study|Physician Decision|1|||
124909454|NCT02706717|449295584|FG000|Overall Study|Withdrawal by Subject|1|||
124909455|NCT02706717|449295585|FG001|Overall Study|Withdrawal by Subject|8|||
124909456|NCT02706717|449295584|FG000|Overall Study|Lost to Follow-up|0|||
124909457|NCT02706717|449295585|FG001|Overall Study|Lost to Follow-up|1|||
124692146|NCT02421510|448494666|FG000|Overall Study|Lost to Follow-up|1|||
124909458|NCT02706717|449295584|FG000|Overall Study|Physician Decision|0|||
124909459|NCT02706717|449295585|FG001|Overall Study|Physician Decision|1|||
124909460|NCT02706717|449295584|FG000|Overall Study|Death|0|||
124909461|NCT02706717|449295585|FG001|Overall Study|Death|1|||
124692147|NCT02421510|448494667|FG001|Overall Study|Lost to Follow-up|1|||
124692148|NCT02421510|448494668|FG002|Overall Study|Lost to Follow-up|0|||
124692149|NCT02609633|448494673|FG000|Overall Study|Consent Withdrawn|0|||
124692150|NCT02609633|448494674|FG001|Overall Study|Consent Withdrawn|1|||
124692151|NCT02609633|448494673|FG000|Overall Study|Protocol Deviation|1|||
124692152|NCT02609633|448494674|FG001|Overall Study|Protocol Deviation|0|||
124692153|NCT02609633|448494673|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
124692154|NCT02609633|448494674|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
124692155|NCT02609633|448494673|FG000|Overall Study|Reason not Specified|2|||
124692156|NCT02609633|448494674|FG001|Overall Study|Reason not Specified|1|||
124692157|NCT02287025|448494677|FG000|Overall Study|Not treated|2|||
124692158|NCT02287025|448494678|FG001|Overall Study|Not treated|0|||
124692159|NCT02287025|448494677|FG000|Overall Study|Progression of disease|3|||
124692160|NCT02287025|448494678|FG001|Overall Study|Progression of disease|2|||
124692161|NCT02287025|448494677|FG000|Overall Study|Adverse Event|2|||
124692162|NCT02287025|448494678|FG001|Overall Study|Adverse Event|4|||
124692163|NCT02287025|448494677|FG000|Overall Study|Withdrawal by Subject|2|||
124692164|NCT02287025|448494678|FG001|Overall Study|Withdrawal by Subject|2|||
124692165|NCT02287025|448494677|FG000|Overall Study|Screening failed|1|||
124692166|NCT02287025|448494678|FG001|Overall Study|Screening failed|1|||
124692167|NCT01096186|448494679|FG000|Overall Study|Adverse Event|16|||
124692168|NCT01096186|448494679|FG000|Overall Study|Death|4|||
124692169|NCT01096186|448494679|FG000|Overall Study|Lack of Efficacy|4|||
124692170|NCT01096186|448494679|FG000|Overall Study|Lost to Follow-up|2|||
124692171|NCT01096186|448494679|FG000|Overall Study|Withdrawal by Subject|22|||
124692172|NCT01096186|448494679|FG000|Overall Study|Physician Decision|1|||
124692173|NCT01096186|448494679|FG000|Overall Study|Noncompliance with study drug|1|||
124692174|NCT04053452|448494680|FG000|Overall Study|Withdrawal by Subject|1|||
124692175|NCT04053452|448494681|FG001|Overall Study|Withdrawal by Subject|0|||
124692176|NCT04053452|448494680|FG000|Overall Study|Time restraint due to inpatient needs|1|||
124692177|NCT04053452|448494681|FG001|Overall Study|Time restraint due to inpatient needs|2|||
124692178|NCT00122187|448494686|FG000|Overall Study|Withdrew because of resource limitations|2|||
124692179|NCT00122187|448494687|FG001|Overall Study|Withdrew because of resource limitations|2|||
124692180|NCT02061592|448494688|FG000|Period 1|Withdrawal by Subject|1|||
124692181|NCT02061592|448494689|FG001|Period 1|Withdrawal by Subject|0|||
124692182|NCT02061592|448494688|FG000|Period 1|Protocol Violation|1|||
124692183|NCT02061592|448494689|FG001|Period 1|Protocol Violation|0|||
124692184|NCT02061592|448494688|FG000|Period 2|Lost to Follow-up|0|||
124692185|NCT02061592|448494689|FG001|Period 2|Lost to Follow-up|1|||
124692186|NCT03338023|448494690|FG000|Overall Study|Withdrawal by Subject|3|||
124692187|NCT03338023|448494691|FG001|Overall Study|Withdrawal by Subject|4|||
124692188|NCT03338023|448494690|FG000|Overall Study|Protocol Violation|3|||
124692189|NCT03338023|448494691|FG001|Overall Study|Protocol Violation|3|||
124909462|NCT02512965|449295588|FG000|Overall Study|Withdrawal by Subject|0|||
124909463|NCT02512965|449295589|FG001|Overall Study|Withdrawal by Subject|4|||
124692190|NCT03338023|448494690|FG000|Overall Study|Lost to Follow-up|2|||
124692191|NCT03338023|448494691|FG001|Overall Study|Lost to Follow-up|1|||
124692192|NCT03338023|448494690|FG000|Overall Study|Physician Decision|1|||
124692193|NCT03338023|448494691|FG001|Overall Study|Physician Decision|2|||
124692194|NCT00799864|448494692|FG000|Overall Study|Participant reached a virologic endpoint|9|||
124692195|NCT00799864|448494693|FG001|Overall Study|Participant reached a virologic endpoint|2|||
124692196|NCT00799864|448494694|FG002|Overall Study|Participant reached a virologic endpoint|2|||
124692197|NCT00799864|448494695|FG003|Overall Study|Participant reached a virologic endpoint|0|||
124692198|NCT00799864|448494696|FG004|Overall Study|Participant reached a virologic endpoint|0|||
124909464|NCT00835770|449295593|FG000|Overall Study|MS Relapse|17|||
124909465|NCT00835770|449295594|FG001|Overall Study|MS Relapse|23|||
124909466|NCT00835770|449295593|FG000|Overall Study|MS Progression|14|||
124909467|NCT00835770|449295594|FG001|Overall Study|MS Progression|9|||
124909468|NCT00835770|449295593|FG000|Overall Study|Adverse Event|113|||
124909469|NCT00835770|449295594|FG001|Overall Study|Adverse Event|124|||
124909470|NCT00835770|449295593|FG000|Overall Study|Lost to Follow-up|22|||
124909471|NCT00835770|449295594|FG001|Overall Study|Lost to Follow-up|19|||
124909472|NCT00835770|449295593|FG000|Overall Study|Consent Withdrawn|144|||
124909473|NCT00835770|449295594|FG001|Overall Study|Consent Withdrawn|156|||
124909474|NCT00835770|449295593|FG000|Overall Study|Investigator Decision|42|||
124909475|NCT00835770|449295594|FG001|Overall Study|Investigator Decision|42|||
124909476|NCT00835770|449295593|FG000|Overall Study|Participant Non-Compliance|11|||
124909477|NCT00835770|449295594|FG001|Overall Study|Participant Non-Compliance|9|||
124909478|NCT00835770|449295593|FG000|Overall Study|Death|4|||
124909479|NCT00835770|449295594|FG001|Overall Study|Death|6|||
124909480|NCT00835770|449295593|FG000|Overall Study|Other|115|||
124909481|NCT00835770|449295594|FG001|Overall Study|Other|104|||
124909482|NCT00835770|449295593|FG000|Overall Study|Other|2|||
124909483|NCT00835770|449295594|FG001|Overall Study|Other|1|||
124909484|NCT01185782|449295595|FG000|Overall Study|Adverse Event|0|||
124909485|NCT01185782|449295596|FG001|Overall Study|Adverse Event|1|||
124909486|NCT01185782|449295595|FG000|Overall Study|Protocol Violation|1|||
124909487|NCT01185782|449295596|FG001|Overall Study|Protocol Violation|0|||
124909488|NCT01185782|449295595|FG000|Overall Study|Poor Response to Treatment|3|||
124909489|NCT01185782|449295596|FG001|Overall Study|Poor Response to Treatment|1|||
124909490|NCT01185782|449295595|FG000|Overall Study|Other|2|||
124909491|NCT01185782|449295596|FG001|Overall Study|Other|5|||
124909492|NCT01185782|449295595|FG000|Overall Study|Randomized but not treated|0|||
124909493|NCT01185782|449295596|FG001|Overall Study|Randomized but not treated|4|||
124909494|NCT02507752|449295597|FG000|Overall Study|Adverse Event|1|||
124909495|NCT02507752|449295597|FG000|Overall Study|Protocol Violation|6|||
124909496|NCT02507752|449295597|FG000|Overall Study|Lost to Follow-up|7|||
124909497|NCT02507752|449295597|FG000|Overall Study|Infusion reaction at first infusion|1|||
124909498|NCT02507752|449295597|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
124909499|NCT02507752|449295597|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
124909500|NCT01061151|449295602|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
124909501|NCT01061151|449295603|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
124909502|NCT01061151|449295604|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
124909503|NCT01061151|449295605|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
124909504|NCT01061151|449295602|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
124909505|NCT01061151|449295603|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
124909506|NCT01061151|449295604|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
124909507|NCT01061151|449295605|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
124909508|NCT01061151|449295602|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
124909509|NCT01061151|449295603|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
124909510|NCT01061151|449295604|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
124909511|NCT01061151|449295605|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
124909512|NCT01061151|449295602|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
124909513|NCT01061151|449295603|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
124909514|NCT01061151|449295604|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
124909515|NCT01061151|449295605|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
124909516|NCT01061151|449295602|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
124909517|NCT01061151|449295603|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
124909518|NCT01061151|449295604|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
124909519|NCT01061151|449295605|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
124909520|NCT01061151|449295602|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
124909521|NCT01061151|449295603|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
124450253|NCT05097716|447611921|FG000|Period 1|Close contact with highly-transmissible infection|1|||
124909522|NCT01061151|449295604|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
124909523|NCT01061151|449295605|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
124909524|NCT01061151|449295602|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
124909525|NCT01061151|449295603|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
124909526|NCT01061151|449295604|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
124909527|NCT01061151|449295605|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
124909528|NCT01061151|449295602|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
124909529|NCT01061151|449295603|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
124909530|NCT01061151|449295604|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
124909531|NCT01061151|449295605|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
124909532|NCT01061151|449295602|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
124909533|NCT01061151|449295603|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
124450254|NCT00922480|447611929|FG000|Main Study|Protocol Violation|3|||
124909534|NCT01061151|449295604|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
124909535|NCT01061151|449295605|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
124909536|NCT01061151|449295602|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
124909537|NCT01061151|449295603|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
124909538|NCT01061151|449295604|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
124909539|NCT01061151|449295605|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
124909540|NCT01061151|449295602|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
124909541|NCT01061151|449295603|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
124909542|NCT01061151|449295604|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
124909543|NCT01061151|449295605|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
124909544|NCT01061151|449295602|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
124909545|NCT01061151|449295603|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
124909546|NCT01061151|449295604|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
124909547|NCT01061151|449295605|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
124909548|NCT01061151|449295602|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
124909549|NCT01061151|449295603|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
124909550|NCT01061151|449295604|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
124909551|NCT01061151|449295605|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
124909552|NCT01061151|449295602|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
124909553|NCT01061151|449295603|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
124909554|NCT01061151|449295604|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
124909555|NCT01061151|449295605|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
124909556|NCT01061151|449295602|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
124909557|NCT01061151|449295603|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
124909558|NCT01061151|449295604|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
124909559|NCT01061151|449295605|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
124909560|NCT03740009|449295606|FG000|Overall Study|Physician Decision|9|||
124909561|NCT03740009|449295606|FG000|Overall Study|Lost to Follow-up|1|||
124909562|NCT01692730|449295622|FG000|Overall Study|Lost to Follow-up|225|||
124909563|NCT01692730|449295623|FG001|Overall Study|Lost to Follow-up|227|||
124909564|NCT00933400|449295624|FG000|Overall Study|Withdrawal by Subject|21|||
124909565|NCT00933400|449295625|FG001|Overall Study|Withdrawal by Subject|1|||
124909566|NCT01041417|449295628|FG000|Overall Study|Adverse Event|5|||
124909567|NCT01041417|449295629|FG001|Overall Study|Adverse Event|2|||
124909568|NCT01041417|449295628|FG000|Overall Study|Lost to Follow-up|1|||
124909569|NCT01041417|449295629|FG001|Overall Study|Lost to Follow-up|1|||
124909570|NCT01041417|449295628|FG000|Overall Study|Death|1|||
124909571|NCT01041417|449295629|FG001|Overall Study|Death|0|||
124909572|NCT02299375|449295630|FG000|Overall Study|Adverse Event, serious fatal|1|||
124909573|NCT02299375|449295631|FG001|Overall Study|Adverse Event, serious fatal|3|||
124909574|NCT02299375|449295630|FG000|Overall Study|Adverse Event, non-fatal|8|||
124909575|NCT02299375|449295631|FG001|Overall Study|Adverse Event, non-fatal|9|||
124909576|NCT02299375|449295630|FG000|Overall Study|Lack of Efficacy|1|||
124909577|NCT02299375|449295631|FG001|Overall Study|Lack of Efficacy|3|||
124909578|NCT02299375|449295630|FG000|Overall Study|Protocol Violation|1|||
124909579|NCT02299375|449295631|FG001|Overall Study|Protocol Violation|3|||
124909580|NCT02299375|449295630|FG000|Overall Study|Other: Met stopping criteria|1|||
124909581|NCT02299375|449295631|FG001|Overall Study|Other: Met stopping criteria|0|||
124909582|NCT02299375|449295630|FG000|Overall Study|Other: Study closed/terminated|66|||
124909583|NCT02299375|449295631|FG001|Overall Study|Other: Study closed/terminated|55|||
124909584|NCT02299375|449295630|FG000|Overall Study|Lost to Follow-up|0|||
124909585|NCT02299375|449295631|FG001|Overall Study|Lost to Follow-up|2|||
124909586|NCT02299375|449295630|FG000|Overall Study|Physician Decision|1|||
124909587|NCT02299375|449295631|FG001|Overall Study|Physician Decision|1|||
124909588|NCT02299375|449295630|FG000|Overall Study|Withdrawal by Subject|1|||
124909589|NCT02299375|449295631|FG001|Overall Study|Withdrawal by Subject|4|||
124909590|NCT00704184|449295632|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
124909591|NCT00704184|449295633|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
124909592|NCT00704184|449295634|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
124909593|NCT00704184|449295635|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
124909594|NCT00704184|449295636|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
124909595|NCT00704184|449295632|FG000|Open-Label Treatment|Adverse Event|0|||
124909596|NCT00704184|449295633|FG001|Open-Label Treatment|Adverse Event|0|||
124692199|NCT00799864|448494692|FG000|Overall Study|Other|2|||
124692200|NCT00799864|448494693|FG001|Overall Study|Other|1|||
124909597|NCT00704184|449295634|FG002|Open-Label Treatment|Adverse Event|2|||
124692201|NCT00799864|448494694|FG002|Overall Study|Other|0|||
124692202|NCT00799864|448494695|FG003|Overall Study|Other|0|||
124692203|NCT00799864|448494696|FG004|Overall Study|Other|0|||
124692204|NCT02346370|448494697|FG000|Overall Study|Not treated|1|||
124909598|NCT00704184|449295635|FG003|Open-Label Treatment|Adverse Event|0|||
124909599|NCT00704184|449295636|FG004|Open-Label Treatment|Adverse Event|1|||
124909600|NCT00704184|449295632|FG000|Open-Label Treatment|Lack of Efficacy|0|||
124909601|NCT00704184|449295633|FG001|Open-Label Treatment|Lack of Efficacy|2|||
124692205|NCT02346370|448494698|FG001|Overall Study|Not treated|0|||
124692206|NCT02346370|448494699|FG002|Overall Study|Not treated|0|||
124909602|NCT00704184|449295634|FG002|Open-Label Treatment|Lack of Efficacy|2|||
124909603|NCT00704184|449295635|FG003|Open-Label Treatment|Lack of Efficacy|2|||
124909604|NCT00704184|449295636|FG004|Open-Label Treatment|Lack of Efficacy|1|||
124909605|NCT00704184|449295632|FG000|Open-Label Treatment|Physician Decision|0|||
124909606|NCT00704184|449295633|FG001|Open-Label Treatment|Physician Decision|0|||
124909607|NCT00704184|449295634|FG002|Open-Label Treatment|Physician Decision|0|||
124909608|NCT00704184|449295635|FG003|Open-Label Treatment|Physician Decision|0|||
124909609|NCT00704184|449295636|FG004|Open-Label Treatment|Physician Decision|1|||
124909610|NCT00704184|449295632|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
124909611|NCT00704184|449295633|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
124909612|NCT00704184|449295634|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
124909613|NCT00704184|449295635|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
124909614|NCT00704184|449295636|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
124909615|NCT03473340|449295646|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
124909616|NCT03473340|449295647|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
124909617|NCT03473340|449295646|FG000|Overall Study|Withdrawal by Subject|1|||
124909618|NCT03473340|449295647|FG001|Overall Study|Withdrawal by Subject|0|||
124909619|NCT03473340|449295646|FG000|Overall Study|Lost to Follow-up|1|||
124909620|NCT03473340|449295647|FG001|Overall Study|Lost to Follow-up|2|||
124909621|NCT03394885|449295648|FG000|Overall Study|Adverse Event|4|||
124909622|NCT03394885|449295648|FG000|Overall Study|Lack of Efficacy|1|||
124909623|NCT03394885|449295648|FG000|Overall Study|Physician Decision|1|||
124909624|NCT03394885|449295648|FG000|Overall Study|Withdrawal by Subject|8|||
124909625|NCT03394885|449295648|FG000|Overall Study|Alternative Therapy|1|||
124909626|NCT01212991|449295649|FG000|Double-blind|Lost to Follow-up|8|||
124909627|NCT01212991|449295650|FG001|Double-blind|Lost to Follow-up|4|||
124909628|NCT01212991|449295651|FG002|Double-blind|Lost to Follow-up|0|||
124909629|NCT01212991|449295649|FG000|Double-blind|Death|699|||
124909630|NCT01212991|449295650|FG001|Double-blind|Death|550|||
124909631|NCT01212991|449295651|FG002|Double-blind|Death|0|||
124909632|NCT01212991|449295649|FG000|Double-blind|Withdrawal by Subject|16|||
124909633|NCT01212991|449295650|FG001|Double-blind|Withdrawal by Subject|19|||
124909634|NCT01212991|449295651|FG002|Double-blind|Withdrawal by Subject|0|||
124909635|NCT01212991|449295649|FG000|Double-blind|Other|7|||
124909636|NCT01212991|449295650|FG001|Double-blind|Other|0|||
124909637|NCT01212991|449295651|FG002|Double-blind|Other|0|||
124909638|NCT01212991|449295649|FG000|Double-blind|Sponsor decision|142|||
124909639|NCT01212991|449295650|FG001|Double-blind|Sponsor decision|38|||
124909640|NCT01212991|449295651|FG002|Double-blind|Sponsor decision|0|||
124909641|NCT01212991|449295649|FG000|Open-label|Death|0|||
124909642|NCT01212991|449295650|FG001|Open-label|Death|0|||
124909643|NCT01212991|449295651|FG002|Open-label|Death|166|||
124909644|NCT01212991|449295649|FG000|Open-label|Lost to Follow-up|0|||
124909645|NCT01212991|449295650|FG001|Open-label|Lost to Follow-up|0|||
124909646|NCT01212991|449295651|FG002|Open-label|Lost to Follow-up|5|||
124909647|NCT01212991|449295649|FG000|Open-label|Withdrawal by Subject|0|||
124909648|NCT01212991|449295650|FG001|Open-label|Withdrawal by Subject|0|||
124909649|NCT01212991|449295651|FG002|Open-label|Withdrawal by Subject|7|||
124909650|NCT01212991|449295649|FG000|Open-label|Sponsor decision|0|||
124909651|NCT01212991|449295650|FG001|Open-label|Sponsor decision|0|||
124909652|NCT01212991|449295651|FG002|Open-label|Sponsor decision|53|||
124909653|NCT01212991|449295649|FG000|Open-label|Other|0|||
124909654|NCT01212991|449295650|FG001|Open-label|Other|0|||
124909655|NCT01212991|449295651|FG002|Open-label|Other|3|||
124909656|NCT00801983|449295658|FG000|Period 1|Lost to Follow-up|2|||
124909657|NCT00801983|449295659|FG001|Period 1|Lost to Follow-up|0|||
124909658|NCT00801983|449295658|FG000|Period 1|Withdrawal by Subject|2|||
124909659|NCT00801983|449295659|FG001|Period 1|Withdrawal by Subject|8|||
124909660|NCT00801983|449295658|FG000|Period 2|Withdrawal by Subject|2|||
124909661|NCT00801983|449295659|FG001|Period 2|Withdrawal by Subject|1|||
124909662|NCT01251354|449295660|FG000|Overall Study|Adverse Event|1|||
124909663|NCT01251354|449295660|FG000|Overall Study|Investigator's Decision|1|||
124909664|NCT01251354|449295660|FG000|Overall Study|Disease Progression|4|||
124909665|NCT03807778|449295668|FG000|Overall Study|Adverse Event|0|||
124909666|NCT03807778|449295669|FG001|Overall Study|Adverse Event|0|||
124909667|NCT03807778|449295670|FG002|Overall Study|Adverse Event|3|||
124909668|NCT03807778|449295671|FG003|Overall Study|Adverse Event|5|||
124909669|NCT03807778|449295668|FG000|Overall Study|Progressive Disease|4|||
124909670|NCT03807778|449295669|FG001|Overall Study|Progressive Disease|2|||
124909671|NCT03807778|449295670|FG002|Overall Study|Progressive Disease|8|||
124760470|NCT05579977|448746886|FG004|Treatment Phase|Randomized not treated|1|||
124760471|NCT05579977|448746887|FG005|Treatment Phase|Randomized not treated|0|||
124760472|NCT05579977|448746888|FG006|Treatment Phase|Randomized not treated|0|||
124760473|NCT05579977|448746889|FG007|Treatment Phase|Randomized not treated|0|||
124909672|NCT03807778|449295671|FG003|Overall Study|Progressive Disease|15|||
124909673|NCT03807778|449295668|FG000|Overall Study|Symptomatic Deterioration|0|||
124909674|NCT03807778|449295669|FG001|Overall Study|Symptomatic Deterioration|1|||
124909675|NCT03807778|449295670|FG002|Overall Study|Symptomatic Deterioration|0|||
124909676|NCT03807778|449295671|FG003|Overall Study|Symptomatic Deterioration|1|||
124909677|NCT03807778|449295668|FG000|Overall Study|Withdrawal by Subject|0|||
124909678|NCT03807778|449295669|FG001|Overall Study|Withdrawal by Subject|1|||
124909679|NCT03807778|449295670|FG002|Overall Study|Withdrawal by Subject|0|||
124909680|NCT03807778|449295671|FG003|Overall Study|Withdrawal by Subject|1|||
124909681|NCT03807778|449295668|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
124909682|NCT03807778|449295669|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
124909683|NCT03807778|449295670|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
124909684|NCT03807778|449295671|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
124909685|NCT05135000|449295672|FG000|Overall Study|Adverse Event|2|||
124909686|NCT05135000|449295673|FG001|Overall Study|Adverse Event|0|||
124909687|NCT05135000|449295672|FG000|Overall Study|Lost to Follow-up|1|||
124909688|NCT05135000|449295673|FG001|Overall Study|Lost to Follow-up|0|||
124909689|NCT05135000|449295672|FG000|Overall Study|Study Terminated by Sponsor|6|||
124909690|NCT05135000|449295673|FG001|Overall Study|Study Terminated by Sponsor|3|||
124909691|NCT05094141|449295681|FG000|Overall Study|Death|0|||
124909692|NCT05094141|449295682|FG001|Overall Study|Death|0|||
124909693|NCT05094141|449295683|FG002|Overall Study|Death|1|||
124909694|NCT05094141|449295681|FG000|Overall Study|Withdrawal by Subject|0|||
124909695|NCT05094141|449295682|FG001|Overall Study|Withdrawal by Subject|0|||
124909696|NCT05094141|449295683|FG002|Overall Study|Withdrawal by Subject|1|||
124909697|NCT05094141|449295681|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
124909698|NCT05094141|449295682|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
124909699|NCT05094141|449295683|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
124909700|NCT05094141|449295681|FG000|Overall Study|Did not participate in randomization|0|||
124909701|NCT05094141|449295682|FG001|Overall Study|Did not participate in randomization|0|||
124909702|NCT05094141|449295683|FG002|Overall Study|Did not participate in randomization|33|||
124909703|NCT01170026|449297348|FG000|Overall Study|Lost to Follow-up|4|||
124909704|NCT01170026|449297349|FG001|Overall Study|Lost to Follow-up|2|||
124909705|NCT04411056|449297350|FG000|Overall Study|surgery cancelled|1|||
124909706|NCT04411056|449297351|FG001|Overall Study|surgery cancelled|0|||
124909707|NCT04411056|449297350|FG000|Overall Study|Equipment problem during intubation|0|||
124909708|NCT04411056|449297351|FG001|Overall Study|Equipment problem during intubation|1|||
124909709|NCT03785782|449297361|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
124909710|NCT03785782|449297362|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
124909711|NCT03785782|449297361|FG000|Overall Study|Withdrawal by Subject|1|||
124909712|NCT03785782|449297362|FG001|Overall Study|Withdrawal by Subject|1|||
124909713|NCT03785782|449297361|FG000|Overall Study|insufficient image quality.|3|||
124909714|NCT03785782|449297362|FG001|Overall Study|insufficient image quality.|0|||
124909715|NCT05777785|449297363|FG000|Overall Study|Withdrawal by Subject|5|||
124909716|NCT05777785|449297363|FG000|Overall Study|Lost to Follow-up|1|||
124909717|NCT02763319|449297365|FG000|Overall Study|Adverse Event|12|||
124909718|NCT02763319|449297366|FG001|Overall Study|Adverse Event|3|||
124909719|NCT02763319|449297365|FG000|Overall Study|Death|123|||
124909720|NCT02763319|449297366|FG001|Overall Study|Death|123|||
124909721|NCT02763319|449297365|FG000|Overall Study|Lost to Follow-up|6|||
124909722|NCT02763319|449297366|FG001|Overall Study|Lost to Follow-up|7|||
124909723|NCT02763319|449297365|FG000|Overall Study|Noncompliance with Study Drug|2|||
124450255|NCT00922480|447611930|FG001|Main Study|Protocol Violation|6|||
124692207|NCT02346370|448494697|FG000|Overall Study|Withdrawal of consent|1|||
124692208|NCT02346370|448494698|FG001|Overall Study|Withdrawal of consent|0|||
124692209|NCT02346370|448494699|FG002|Overall Study|Withdrawal of consent|0|||
124692210|NCT02346370|448494697|FG000|Overall Study|Death|1|||
124692211|NCT02346370|448494698|FG001|Overall Study|Death|3|||
124692212|NCT02346370|448494699|FG002|Overall Study|Death|1|||
124692213|NCT02346370|448494697|FG000|Overall Study|Sponsor discontinued study|5|||
124692214|NCT02346370|448494698|FG001|Overall Study|Sponsor discontinued study|0|||
124692215|NCT02346370|448494699|FG002|Overall Study|Sponsor discontinued study|2|||
124692216|NCT02346370|448494697|FG000|Overall Study|Radiologic progression|0|||
124692217|NCT02346370|448494698|FG001|Overall Study|Radiologic progression|0|||
124692218|NCT02346370|448494699|FG002|Overall Study|Radiologic progression|1|||
124692219|NCT02346370|448494697|FG000|Overall Study|Physician Decision|0|||
124692220|NCT02346370|448494698|FG001|Overall Study|Physician Decision|1|||
124692221|NCT02346370|448494699|FG002|Overall Study|Physician Decision|0|||
124692222|NCT00685698|448494702|FG000|Overall Study|Withdrawal by Subject|1|||
124692223|NCT00685698|448494702|FG000|Overall Study|Protocol Violation|6|||
124760474|NCT05579977|448746890|FG008|Treatment Phase|Randomized not treated|0|||
124760475|NCT05579977|448746891|FG009|Treatment Phase|Randomized not treated|0|||
124760476|NCT05579977|448746892|FG010|Treatment Phase|Randomized not treated|0|||
124760477|NCT05579977|448746893|FG011|Treatment Phase|Randomized not treated|0|||
124909724|NCT02763319|449297366|FG001|Overall Study|Noncompliance with Study Drug|0|||
124909725|NCT02763319|449297365|FG000|Overall Study|"Captured as Other in Database"|29|||
124909726|NCT02763319|449297366|FG001|Overall Study|"Captured as Other in Database"|34|||
124909727|NCT02763319|449297365|FG000|Overall Study|Physician Decision|1|||
124909728|NCT02763319|449297366|FG001|Overall Study|Physician Decision|7|||
124909729|NCT02763319|449297365|FG000|Overall Study|Progressive Disease|24|||
124909730|NCT02763319|449297366|FG001|Overall Study|Progressive Disease|27|||
124909731|NCT02763319|449297365|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
124909732|NCT02763319|449297366|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
124909733|NCT02763319|449297365|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
124909734|NCT02763319|449297366|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
124909735|NCT02763319|449297365|FG000|Overall Study|Withdrawal by Subject|26|||
124909736|NCT02763319|449297366|FG001|Overall Study|Withdrawal by Subject|25|||
124909737|NCT00089544|449297367|FG000|Overall Study|Ineligible|1|||
124909738|NCT00089544|449297368|FG001|Overall Study|Ineligible|0|||
124909739|NCT01622868|449297371|FG000|Overall Study|Protocol Violation|7|||
124909740|NCT01622868|449297372|FG001|Overall Study|Protocol Violation|0|||
124909741|NCT00610649|449297374|FG000|Overall Study|Adverse Event|1|||
124909742|NCT00610649|449297375|FG001|Overall Study|Adverse Event|0|||
124909743|NCT00610649|449297376|FG002|Overall Study|Adverse Event|0|||
124909744|NCT00610649|449297377|FG003|Overall Study|Adverse Event|0|||
124909745|NCT00610649|449297378|FG004|Overall Study|Adverse Event|0|||
124909746|NCT00610649|449297379|FG005|Overall Study|Adverse Event|0|||
124909747|NCT00610649|449297380|FG006|Overall Study|Adverse Event|0|||
124909748|NCT00610649|449297381|FG007|Overall Study|Adverse Event|0|||
124909749|NCT00610649|449297382|FG008|Overall Study|Adverse Event|0|||
124909750|NCT00610649|449297383|FG009|Overall Study|Adverse Event|0|||
124909751|NCT00610649|449297384|FG010|Overall Study|Adverse Event|1|||
124909752|NCT00610649|449297374|FG000|Overall Study|Family Emergency|0|||
124909753|NCT00610649|449297375|FG001|Overall Study|Family Emergency|1|||
124909754|NCT00610649|449297376|FG002|Overall Study|Family Emergency|0|||
124909755|NCT00610649|449297377|FG003|Overall Study|Family Emergency|0|||
124909756|NCT00610649|449297378|FG004|Overall Study|Family Emergency|0|||
124909757|NCT00610649|449297379|FG005|Overall Study|Family Emergency|0|||
124909758|NCT00610649|449297380|FG006|Overall Study|Family Emergency|0|||
124909759|NCT00610649|449297381|FG007|Overall Study|Family Emergency|0|||
124909760|NCT00610649|449297382|FG008|Overall Study|Family Emergency|0|||
124909761|NCT00610649|449297383|FG009|Overall Study|Family Emergency|0|||
124909762|NCT00610649|449297384|FG010|Overall Study|Family Emergency|0|||
124760478|NCT05579977|448746894|FG012|Treatment Phase|Randomized not treated|0|||
124909763|NCT00610649|449297374|FG000|Overall Study|Withdrawal by Subject|0|||
124909764|NCT00610649|449297375|FG001|Overall Study|Withdrawal by Subject|0|||
124909765|NCT00610649|449297376|FG002|Overall Study|Withdrawal by Subject|0|||
124909766|NCT00610649|449297377|FG003|Overall Study|Withdrawal by Subject|0|||
124909767|NCT00610649|449297378|FG004|Overall Study|Withdrawal by Subject|0|||
124909768|NCT00610649|449297379|FG005|Overall Study|Withdrawal by Subject|0|||
124909769|NCT00610649|449297380|FG006|Overall Study|Withdrawal by Subject|0|||
124909770|NCT00610649|449297381|FG007|Overall Study|Withdrawal by Subject|0|||
124909771|NCT00610649|449297382|FG008|Overall Study|Withdrawal by Subject|0|||
124909772|NCT00610649|449297383|FG009|Overall Study|Withdrawal by Subject|1|||
124692224|NCT00685698|448494702|FG000|Overall Study|Adverse Event|3|||
124692225|NCT00685698|448494702|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
124692226|NCT00685698|448494702|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
124692227|NCT00685698|448494702|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
124760479|NCT05579977|448746882|FG000|Follow up|Death|1|||
124760480|NCT05579977|448746883|FG001|Follow up|Death|0|||
124909773|NCT00610649|449297384|FG010|Overall Study|Withdrawal by Subject|0|||
124909774|NCT04252586|449297385|FG000|Overall Study|Withdrawal by parent/guardian|3|||
124909775|NCT04252586|449297385|FG000|Overall Study|Adverse Event|1|||
124909776|NCT04252586|449297385|FG000|Overall Study|Death|2|||
124909777|NCT04252586|449297385|FG000|Overall Study|Study terminated by sponsor|4|||
124909778|NCT04252586|449297385|FG000|Overall Study|Sponsor request|10|||
124909779|NCT04252586|449297385|FG000|Overall Study|Did not complete treatment period|1|||
124909780|NCT00232180|449297386|FG000|Double-blind (DB) Phase|Death|186|||
124909781|NCT00232180|449297387|FG001|Double-blind (DB) Phase|Death|222|||
124909782|NCT00232180|449297388|FG002|Double-blind (DB) Phase|Death|0|||
124909783|NCT00232180|449297386|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
124909784|NCT00232180|449297387|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
124909785|NCT00232180|449297388|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
124909786|NCT00232180|449297386|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
124909787|NCT00232180|449297387|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
124909788|NCT00232180|449297388|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
124909789|NCT00232180|449297386|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
124909790|NCT00232180|449297387|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
124909791|NCT00232180|449297388|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
124909792|NCT00232180|449297386|FG000|Double-blind (DB) Phase|Adverse Event|83|||
124909793|NCT00232180|449297387|FG001|Double-blind (DB) Phase|Adverse Event|100|||
124909794|NCT00232180|449297388|FG002|Double-blind (DB) Phase|Adverse Event|0|||
124909795|NCT00232180|449297386|FG000|Double-blind (DB) Phase|Other|70|||
124909796|NCT00232180|449297387|FG001|Double-blind (DB) Phase|Other|75|||
124909797|NCT00232180|449297388|FG002|Double-blind (DB) Phase|Other|0|||
124909798|NCT00232180|449297386|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
124909799|NCT00232180|449297387|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
124909800|NCT00232180|449297388|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
124909801|NCT00232180|449297386|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
124909802|NCT00232180|449297387|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
124909803|NCT00232180|449297388|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
124909804|NCT00232180|449297386|FG000|Open Label Phase|Death|0|||
124909805|NCT00232180|449297387|FG001|Open Label Phase|Death|0|||
124909806|NCT00232180|449297388|FG002|Open Label Phase|Death|48|||
124909807|NCT00232180|449297386|FG000|Open Label Phase|Lost to Follow-up|0|||
124909808|NCT00232180|449297387|FG001|Open Label Phase|Lost to Follow-up|0|||
124909809|NCT00232180|449297388|FG002|Open Label Phase|Lost to Follow-up|5|||
124909810|NCT00232180|449297386|FG000|Open Label Phase|Protocol Violation|0|||
124909811|NCT00232180|449297387|FG001|Open Label Phase|Protocol Violation|0|||
124909812|NCT00232180|449297388|FG002|Open Label Phase|Protocol Violation|3|||
124909813|NCT00232180|449297386|FG000|Open Label Phase|Study terminated by sponsor|0|||
124909814|NCT00232180|449297387|FG001|Open Label Phase|Study terminated by sponsor|0|||
124909815|NCT00232180|449297388|FG002|Open Label Phase|Study terminated by sponsor|3|||
124909816|NCT00232180|449297386|FG000|Open Label Phase|Withdrawal by Subject|0|||
124909817|NCT00232180|449297387|FG001|Open Label Phase|Withdrawal by Subject|0|||
124909818|NCT00232180|449297388|FG002|Open Label Phase|Withdrawal by Subject|37|||
124909819|NCT00232180|449297386|FG000|Open Label Phase|Other|0|||
124909820|NCT00232180|449297387|FG001|Open Label Phase|Other|0|||
124909821|NCT00232180|449297388|FG002|Open Label Phase|Other|16|||
124909822|NCT00232180|449297386|FG000|Open Label Phase|Adverse Event|0|||
124909823|NCT00232180|449297387|FG001|Open Label Phase|Adverse Event|0|||
124909824|NCT00232180|449297388|FG002|Open Label Phase|Adverse Event|25|||
124909825|NCT00232180|449297386|FG000|Open Label Phase|Laboratory abnormality|0|||
124909826|NCT00232180|449297387|FG001|Open Label Phase|Laboratory abnormality|0|||
124909827|NCT00232180|449297388|FG002|Open Label Phase|Laboratory abnormality|10|||
124909828|NCT00232180|449297386|FG000|Open Label Phase|Randomized but not treated|0|||
124909829|NCT00232180|449297387|FG001|Open Label Phase|Randomized but not treated|0|||
124909830|NCT00232180|449297388|FG002|Open Label Phase|Randomized but not treated|1|||
124909831|NCT03452189|449297389|FG000|First Intervention (3 Months)|Adverse Event|1|||
124909832|NCT03452189|449297390|FG001|First Intervention (3 Months)|Adverse Event|0|||
124909833|NCT03452189|449297389|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
124909834|NCT03452189|449297390|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
124909835|NCT01571596|449297399|FG000|Overall Study|Adverse Event|2|||
124909836|NCT01571596|449297400|FG001|Overall Study|Adverse Event|0|||
124450256|NCT00922480|447611929|FG000|Main Study|Adverse Event|6|||
124450257|NCT00922480|447611930|FG001|Main Study|Adverse Event|7|||
124450258|NCT00922480|447611929|FG000|Main Study|Lack of Efficacy|3|||
124909837|NCT01571596|449297401|FG002|Overall Study|Adverse Event|0|||
124909838|NCT01571596|449297399|FG000|Overall Study|Study Terminated by the Sponsor|0|||
124909839|NCT01571596|449297400|FG001|Overall Study|Study Terminated by the Sponsor|1|||
124909840|NCT01571596|449297401|FG002|Overall Study|Study Terminated by the Sponsor|1|||
124909841|NCT02767765|449297405|FG000|Overall Study|Adverse Event|4|||
124909842|NCT02767765|449297405|FG000|Overall Study|Death|1|||
124909843|NCT02767765|449297405|FG000|Overall Study|Insufficient response|1|||
124909844|NCT02767765|449297405|FG000|Overall Study|Lost to Follow-up|2|||
124909845|NCT02767765|449297405|FG000|Overall Study|Investigator decision|1|||
124909846|NCT02767765|449297405|FG000|Overall Study|Non-Compliance|1|||
124909847|NCT02767765|449297405|FG000|Overall Study|Withdrawal by Subject|1|||
124909848|NCT01951170|449297406|FG000|Overall Study|Investigator decision|1|||
124909849|NCT04512482|449297412|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
124909850|NCT04512482|449297413|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
124909851|NCT00774397|449297416|FG000|Overall Study|Adverse Event|1|||
124909852|NCT00774397|449297417|FG001|Overall Study|Adverse Event|3|||
124909853|NCT00774397|449297418|FG002|Overall Study|Adverse Event|16|||
124909854|NCT00774397|449297419|FG003|Overall Study|Adverse Event|8|||
124909855|NCT00774397|449297420|FG004|Overall Study|Adverse Event|8|||
124909856|NCT00774397|449297421|FG005|Overall Study|Adverse Event|3|||
124909857|NCT00774397|449297422|FG006|Overall Study|Adverse Event|16|||
124909858|NCT00774397|449297416|FG000|Overall Study|Lack of Efficacy|11|||
124909859|NCT00774397|449297417|FG001|Overall Study|Lack of Efficacy|4|||
124909860|NCT00774397|449297418|FG002|Overall Study|Lack of Efficacy|5|||
124909861|NCT00774397|449297419|FG003|Overall Study|Lack of Efficacy|3|||
124909862|NCT00774397|449297420|FG004|Overall Study|Lack of Efficacy|27|||
124909863|NCT00774397|449297421|FG005|Overall Study|Lack of Efficacy|15|||
124909864|NCT00774397|449297422|FG006|Overall Study|Lack of Efficacy|9|||
124909865|NCT00774397|449297416|FG000|Overall Study|Protocol Violation|0|||
124909866|NCT00774397|449297417|FG001|Overall Study|Protocol Violation|1|||
124909867|NCT00774397|449297418|FG002|Overall Study|Protocol Violation|3|||
124909868|NCT00774397|449297419|FG003|Overall Study|Protocol Violation|1|||
124909869|NCT00774397|449297420|FG004|Overall Study|Protocol Violation|2|||
124909870|NCT00774397|449297421|FG005|Overall Study|Protocol Violation|1|||
124909871|NCT00774397|449297422|FG006|Overall Study|Protocol Violation|0|||
124909872|NCT00774397|449297416|FG000|Overall Study|Lost to Follow-up|0|||
124909873|NCT00774397|449297417|FG001|Overall Study|Lost to Follow-up|1|||
124909874|NCT00774397|449297418|FG002|Overall Study|Lost to Follow-up|1|||
124909875|NCT00774397|449297419|FG003|Overall Study|Lost to Follow-up|1|||
124909876|NCT00774397|449297420|FG004|Overall Study|Lost to Follow-up|0|||
124909877|NCT00774397|449297421|FG005|Overall Study|Lost to Follow-up|1|||
124909878|NCT00774397|449297422|FG006|Overall Study|Lost to Follow-up|0|||
124909879|NCT00774397|449297416|FG000|Overall Study|Refused to continue trial medication|1|||
124909880|NCT00774397|449297417|FG001|Overall Study|Refused to continue trial medication|3|||
124909881|NCT00774397|449297418|FG002|Overall Study|Refused to continue trial medication|2|||
124909882|NCT00774397|449297419|FG003|Overall Study|Refused to continue trial medication|2|||
124909883|NCT00774397|449297420|FG004|Overall Study|Refused to continue trial medication|6|||
124909884|NCT00774397|449297421|FG005|Overall Study|Refused to continue trial medication|2|||
124909885|NCT00774397|449297422|FG006|Overall Study|Refused to continue trial medication|3|||
124909886|NCT00774397|449297416|FG000|Overall Study|Not treated|0|||
124909887|NCT00774397|449297417|FG001|Overall Study|Not treated|0|||
124909888|NCT00774397|449297418|FG002|Overall Study|Not treated|0|||
124909889|NCT00774397|449297419|FG003|Overall Study|Not treated|0|||
124909890|NCT00774397|449297420|FG004|Overall Study|Not treated|1|||
124909891|NCT00774397|449297421|FG005|Overall Study|Not treated|0|||
124909892|NCT00774397|449297422|FG006|Overall Study|Not treated|1|||
124909893|NCT00774397|449297416|FG000|Overall Study|Other than those stated above|1|||
124909894|NCT00774397|449297417|FG001|Overall Study|Other than those stated above|1|||
124909895|NCT00774397|449297418|FG002|Overall Study|Other than those stated above|3|||
124909896|NCT00774397|449297419|FG003|Overall Study|Other than those stated above|2|||
124909897|NCT00774397|449297420|FG004|Overall Study|Other than those stated above|2|||
124909898|NCT00774397|449297421|FG005|Overall Study|Other than those stated above|0|||
124909899|NCT00774397|449297422|FG006|Overall Study|Other than those stated above|1|||
124909900|NCT00077675|449297423|FG000|Overall Study|Adverse Event|1|||
124909901|NCT00077675|449297424|FG001|Overall Study|Adverse Event|2|||
124909902|NCT00077675|449297423|FG000|Overall Study|Lost to Follow-up|6|||
124909903|NCT00077675|449297424|FG001|Overall Study|Lost to Follow-up|3|||
124909904|NCT00077675|449297423|FG000|Overall Study|Withdrawal by Subject|1|||
124909905|NCT00077675|449297424|FG001|Overall Study|Withdrawal by Subject|0|||
124909906|NCT00077675|449297423|FG000|Overall Study|Other|0|||
124909907|NCT00077675|449297424|FG001|Overall Study|Other|1|||
124909908|NCT00077675|449297423|FG000|Overall Study|Never received study treatment|3|||
124909909|NCT00077675|449297424|FG001|Overall Study|Never received study treatment|3|||
124909910|NCT00391898|449297437|FG000|Overall Study|Adverse Event|3|||
124909911|NCT00391898|449297438|FG001|Overall Study|Adverse Event|0|||
124909912|NCT00391898|449297437|FG000|Overall Study|Other|8|||
124909913|NCT00391898|449297438|FG001|Overall Study|Other|10|||
124909914|NCT00293293|449297441|FG000|Overall Study|Withdrawal by Subject|1|||
124909915|NCT00293293|449297442|FG001|Overall Study|Withdrawal by Subject|1|||
124909916|NCT00293293|449297441|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
124909917|NCT00293293|449297442|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
124909918|NCT00293293|449297441|FG000|Overall Study|Patient discontinued chemotherapy|0|||
124909919|NCT00293293|449297442|FG001|Overall Study|Patient discontinued chemotherapy|1|||
124909920|NCT02988817|449297444|FG000|Overall Study|Withdrawal by Subject|1|||
124909921|NCT02988817|449297445|FG001|Overall Study|Withdrawal by Subject|0|||
124692228|NCT03528577|448494703|FG000|Sequence 1|Failed Spirometry|1|||
124909922|NCT02988817|449297446|FG002|Overall Study|Withdrawal by Subject|0|||
124909923|NCT02988817|449297447|FG003|Overall Study|Withdrawal by Subject|1|||
124909924|NCT02988817|449297448|FG004|Overall Study|Withdrawal by Subject|3|||
124909925|NCT02988817|449297449|FG005|Overall Study|Withdrawal by Subject|1|||
124909926|NCT02988817|449297450|FG006|Overall Study|Withdrawal by Subject|2|||
124909927|NCT02988817|449297451|FG007|Overall Study|Withdrawal by Subject|1|||
124909928|NCT02988817|449297452|FG008|Overall Study|Withdrawal by Subject|1|||
124909929|NCT02988817|449297453|FG009|Overall Study|Withdrawal by Subject|1|||
124909930|NCT02988817|449297454|FG010|Overall Study|Withdrawal by Subject|1|||
124909931|NCT02988817|449297455|FG011|Overall Study|Withdrawal by Subject|12|||
124909932|NCT02988817|449297456|FG012|Overall Study|Withdrawal by Subject|6|||
124909933|NCT02988817|449297457|FG013|Overall Study|Withdrawal by Subject|6|||
124909934|NCT02988817|449297458|FG014|Overall Study|Withdrawal by Subject|4|||
124909935|NCT02988817|449297459|FG015|Overall Study|Withdrawal by Subject|5|||
124909936|NCT02988817|449297460|FG016|Overall Study|Withdrawal by Subject|4|||
124909937|NCT02988817|449297461|FG017|Overall Study|Withdrawal by Subject|11|||
124909938|NCT02988817|449297462|FG018|Overall Study|Withdrawal by Subject|4|||
124909939|NCT02988817|449297463|FG019|Overall Study|Withdrawal by Subject|2|||
124909940|NCT02988817|449297444|FG000|Overall Study|Death|0|||
124909941|NCT02988817|449297445|FG001|Overall Study|Death|1|||
124909942|NCT02988817|449297446|FG002|Overall Study|Death|3|||
124909943|NCT02988817|449297447|FG003|Overall Study|Death|1|||
124909944|NCT02988817|449297448|FG004|Overall Study|Death|6|||
124909945|NCT02988817|449297449|FG005|Overall Study|Death|10|||
124909946|NCT02988817|449297450|FG006|Overall Study|Death|1|||
124909947|NCT02988817|449297451|FG007|Overall Study|Death|2|||
124909948|NCT02988817|449297452|FG008|Overall Study|Death|1|||
124909949|NCT02988817|449297453|FG009|Overall Study|Death|5|||
124909950|NCT02988817|449297454|FG010|Overall Study|Death|1|||
124909951|NCT02988817|449297455|FG011|Overall Study|Death|8|||
124909952|NCT02988817|449297456|FG012|Overall Study|Death|9|||
124909953|NCT02988817|449297457|FG013|Overall Study|Death|17|||
124909954|NCT02988817|449297458|FG014|Overall Study|Death|18|||
124909955|NCT02988817|449297459|FG015|Overall Study|Death|30|||
124909956|NCT02988817|449297460|FG016|Overall Study|Death|17|||
124909957|NCT02988817|449297461|FG017|Overall Study|Death|38|||
124909958|NCT02988817|449297462|FG018|Overall Study|Death|14|||
124909959|NCT02988817|449297463|FG019|Overall Study|Death|16|||
124909960|NCT02988817|449297444|FG000|Overall Study|Other|0|||
124909961|NCT02988817|449297445|FG001|Overall Study|Other|0|||
124909962|NCT02988817|449297446|FG002|Overall Study|Other|0|||
124909963|NCT02988817|449297447|FG003|Overall Study|Other|1|||
124909964|NCT02988817|449297448|FG004|Overall Study|Other|1|||
124909965|NCT02988817|449297449|FG005|Overall Study|Other|0|||
124909966|NCT02988817|449297450|FG006|Overall Study|Other|0|||
124909967|NCT02988817|449297451|FG007|Overall Study|Other|0|||
124909968|NCT02988817|449297452|FG008|Overall Study|Other|0|||
124909969|NCT02988817|449297453|FG009|Overall Study|Other|0|||
124909970|NCT02988817|449297454|FG010|Overall Study|Other|0|||
124909971|NCT02988817|449297455|FG011|Overall Study|Other|0|||
124909972|NCT02988817|449297456|FG012|Overall Study|Other|0|||
124909973|NCT02988817|449297457|FG013|Overall Study|Other|0|||
124909974|NCT02988817|449297458|FG014|Overall Study|Other|0|||
124909975|NCT02988817|449297459|FG015|Overall Study|Other|1|||
124909976|NCT02988817|449297460|FG016|Overall Study|Other|0|||
124909977|NCT02988817|449297461|FG017|Overall Study|Other|0|||
124909978|NCT02988817|449297462|FG018|Overall Study|Other|0|||
124909979|NCT02988817|449297463|FG019|Overall Study|Other|0|||
124909980|NCT02988817|449297444|FG000|Overall Study|Lost to Follow-up|0|||
124909981|NCT02988817|449297445|FG001|Overall Study|Lost to Follow-up|0|||
124909982|NCT02988817|449297446|FG002|Overall Study|Lost to Follow-up|0|||
124909983|NCT02988817|449297447|FG003|Overall Study|Lost to Follow-up|0|||
124909984|NCT02988817|449297448|FG004|Overall Study|Lost to Follow-up|0|||
124909985|NCT02988817|449297449|FG005|Overall Study|Lost to Follow-up|0|||
124909986|NCT02988817|449297450|FG006|Overall Study|Lost to Follow-up|0|||
124909987|NCT02988817|449297451|FG007|Overall Study|Lost to Follow-up|0|||
124692229|NCT03528577|448494703|FG000|Sequence 1|Restricted medication|1|||
124909988|NCT02988817|449297452|FG008|Overall Study|Lost to Follow-up|1|||
124909989|NCT02988817|449297453|FG009|Overall Study|Lost to Follow-up|0|||
124692230|NCT03528577|448494703|FG000|Sequence 2|Adverse Event|1|||
124692231|NCT03528577|448494703|FG000|Sequence 2|Withdrawal by Subject|1|||
124909990|NCT02988817|449297454|FG010|Overall Study|Lost to Follow-up|1|||
124909991|NCT02988817|449297455|FG011|Overall Study|Lost to Follow-up|1|||
124909992|NCT02988817|449297456|FG012|Overall Study|Lost to Follow-up|0|||
124909993|NCT02988817|449297457|FG013|Overall Study|Lost to Follow-up|0|||
124909994|NCT02988817|449297458|FG014|Overall Study|Lost to Follow-up|1|||
124909995|NCT02988817|449297459|FG015|Overall Study|Lost to Follow-up|1|||
124909996|NCT02988817|449297460|FG016|Overall Study|Lost to Follow-up|2|||
124909997|NCT02988817|449297461|FG017|Overall Study|Lost to Follow-up|3|||
124909998|NCT02988817|449297462|FG018|Overall Study|Lost to Follow-up|0|||
124909999|NCT02988817|449297463|FG019|Overall Study|Lost to Follow-up|0|||
124910000|NCT02988817|449297444|FG000|Overall Study|Sponsor decision|0|||
124910001|NCT02988817|449297445|FG001|Overall Study|Sponsor decision|0|||
124910002|NCT02988817|449297446|FG002|Overall Study|Sponsor decision|0|||
124910003|NCT02988817|449297447|FG003|Overall Study|Sponsor decision|0|||
124910004|NCT02988817|449297448|FG004|Overall Study|Sponsor decision|0|||
124910005|NCT02988817|449297449|FG005|Overall Study|Sponsor decision|0|||
124910006|NCT02988817|449297450|FG006|Overall Study|Sponsor decision|0|||
124910007|NCT02988817|449297451|FG007|Overall Study|Sponsor decision|0|||
124910008|NCT02988817|449297452|FG008|Overall Study|Sponsor decision|0|||
124910009|NCT02988817|449297453|FG009|Overall Study|Sponsor decision|0|||
124910010|NCT02988817|449297454|FG010|Overall Study|Sponsor decision|0|||
124910011|NCT02988817|449297455|FG011|Overall Study|Sponsor decision|1|||
124910012|NCT02988817|449297456|FG012|Overall Study|Sponsor decision|1|||
124910013|NCT02988817|449297457|FG013|Overall Study|Sponsor decision|2|||
124910014|NCT02988817|449297458|FG014|Overall Study|Sponsor decision|2|||
124910015|NCT02988817|449297459|FG015|Overall Study|Sponsor decision|6|||
124910016|NCT02988817|449297460|FG016|Overall Study|Sponsor decision|2|||
124910017|NCT02988817|449297461|FG017|Overall Study|Sponsor decision|3|||
124910018|NCT02988817|449297462|FG018|Overall Study|Sponsor decision|2|||
124910019|NCT02988817|449297463|FG019|Overall Study|Sponsor decision|7|||
124910020|NCT02988817|449297444|FG000|Overall Study|Physician Decision|0|||
124910021|NCT02988817|449297445|FG001|Overall Study|Physician Decision|0|||
124910022|NCT02988817|449297446|FG002|Overall Study|Physician Decision|0|||
124910023|NCT02988817|449297447|FG003|Overall Study|Physician Decision|0|||
124910024|NCT02988817|449297448|FG004|Overall Study|Physician Decision|0|||
124910025|NCT02988817|449297449|FG005|Overall Study|Physician Decision|0|||
124910026|NCT02988817|449297450|FG006|Overall Study|Physician Decision|0|||
124910027|NCT02988817|449297451|FG007|Overall Study|Physician Decision|0|||
124910028|NCT02988817|449297452|FG008|Overall Study|Physician Decision|0|||
124910029|NCT02988817|449297453|FG009|Overall Study|Physician Decision|0|||
124910030|NCT02988817|449297454|FG010|Overall Study|Physician Decision|0|||
124910031|NCT02988817|449297455|FG011|Overall Study|Physician Decision|0|||
124910032|NCT02988817|449297456|FG012|Overall Study|Physician Decision|0|||
124910033|NCT02988817|449297457|FG013|Overall Study|Physician Decision|0|||
124910034|NCT02988817|449297458|FG014|Overall Study|Physician Decision|0|||
124910035|NCT02988817|449297459|FG015|Overall Study|Physician Decision|1|||
124910036|NCT02988817|449297460|FG016|Overall Study|Physician Decision|0|||
124910037|NCT02988817|449297461|FG017|Overall Study|Physician Decision|0|||
124910038|NCT02988817|449297462|FG018|Overall Study|Physician Decision|1|||
124910039|NCT02988817|449297463|FG019|Overall Study|Physician Decision|1|||
124910040|NCT04530747|449297465|FG000|Overall Study|Withdrawal by Subject|1|||
124910041|NCT04530747|449297466|FG001|Overall Study|Withdrawal by Subject|0|||
124910042|NCT03292913|449297467|FG000|Overall Study|Death|9|||
124910043|NCT03292913|449297468|FG001|Overall Study|Death|3|||
124910044|NCT03292913|449297467|FG000|Overall Study|Lost to Follow-up|49|||
124910045|NCT03292913|449297468|FG001|Overall Study|Lost to Follow-up|49|||
124910046|NCT03292913|449297467|FG000|Overall Study|Withdrawal by Subject|2|||
124910047|NCT03292913|449297468|FG001|Overall Study|Withdrawal by Subject|0|||
124910048|NCT03292913|449297467|FG000|Overall Study|Clinic closed due to COVID|22|||
124910049|NCT03292913|449297468|FG001|Overall Study|Clinic closed due to COVID|36|||
124910050|NCT03950622|449297469|FG000|Overall Study|Withdrawal by Subject|1|||
124910051|NCT03950622|449297470|FG001|Overall Study|Withdrawal by Subject|0|||
124910052|NCT03950622|449297469|FG000|Overall Study|Protocol Deviation|0|||
124910053|NCT03950622|449297470|FG001|Overall Study|Protocol Deviation|1|||
124910054|NCT03950622|449297469|FG000|Overall Study|Physician Decision|1|||
124910055|NCT03950622|449297470|FG001|Overall Study|Physician Decision|0|||
124910056|NCT03950622|449297469|FG000|Overall Study|Lost to Follow-up|5|||
124910057|NCT03950622|449297470|FG001|Overall Study|Lost to Follow-up|5|||
124910058|NCT03950622|449297469|FG000|Overall Study|Death|1|||
124910059|NCT03950622|449297470|FG001|Overall Study|Death|1|||
124910060|NCT03752151|449297471|FG000|Overall Study|Withdrawal by Subject|1|||
124910061|NCT03752151|449297471|FG000|Overall Study|Protocol Violation|1|||
124910062|NCT00529516|449297472|FG000|Overall Study|Adverse Event|2|||
124910063|NCT00529516|449297473|FG001|Overall Study|Adverse Event|1|||
124910064|NCT00529516|449297474|FG002|Overall Study|Adverse Event|0|||
124910065|NCT00529516|449297472|FG000|Overall Study|Withdrawal by Subject|1|||
124910066|NCT00529516|449297473|FG001|Overall Study|Withdrawal by Subject|1|||
124910067|NCT00529516|449297474|FG002|Overall Study|Withdrawal by Subject|0|||
124910068|NCT00529516|449297472|FG000|Overall Study|Lost to Follow-up|0|||
124760481|NCT05579977|448746884|FG002|Follow up|Death|0|||
124760482|NCT05579977|448746885|FG003|Follow up|Death|0|||
124910069|NCT00529516|449297473|FG001|Overall Study|Lost to Follow-up|0|||
124760483|NCT05579977|448746886|FG004|Follow up|Death|0|||
124910070|NCT00529516|449297474|FG002|Overall Study|Lost to Follow-up|1|||
124910071|NCT00939510|449297479|FG000|Overall Study|Withdrawal by Subject|1|||
124910072|NCT03942042|449297492|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
124910073|NCT03942042|449297493|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
124760484|NCT05579977|448746887|FG005|Follow up|Death|0|||
124910074|NCT03942042|449297492|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
124910075|NCT03942042|449297493|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
124910076|NCT01787760|449297494|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
124910077|NCT01787760|449297495|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
124910078|NCT01787760|449297496|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
124910079|NCT01787760|449297494|FG000|Overall Study|Decompensated on left exotropia|0|||
124910080|NCT01787760|449297495|FG001|Overall Study|Decompensated on left exotropia|0|||
124910081|NCT01787760|449297496|FG002|Overall Study|Decompensated on left exotropia|1|||
124910082|NCT01787760|449297494|FG000|Overall Study|Dryness|0|||
124910083|NCT01787760|449297495|FG001|Overall Study|Dryness|1|||
124910084|NCT01787760|449297496|FG002|Overall Study|Dryness|0|||
124910085|NCT01787760|449297494|FG000|Overall Study|Relocation|1|||
124910086|NCT01787760|449297495|FG001|Overall Study|Relocation|1|||
124910087|NCT01787760|449297496|FG002|Overall Study|Relocation|0|||
124910088|NCT01787760|449297494|FG000|Overall Study|Lens discomfort|3|||
124910089|NCT01787760|449297495|FG001|Overall Study|Lens discomfort|0|||
124910090|NCT01787760|449297496|FG002|Overall Study|Lens discomfort|0|||
124910091|NCT01787760|449297494|FG000|Overall Study|Lens handling difficulty|1|||
124910092|NCT01787760|449297495|FG001|Overall Study|Lens handling difficulty|2|||
124910093|NCT01787760|449297496|FG002|Overall Study|Lens handling difficulty|0|||
124910094|NCT01787760|449297494|FG000|Overall Study|Protocol Violation|6|||
124910095|NCT01787760|449297495|FG001|Overall Study|Protocol Violation|0|||
124910096|NCT01787760|449297496|FG002|Overall Study|Protocol Violation|1|||
124910097|NCT01787760|449297494|FG000|Overall Study|Withdrawal by Subject|5|||
124910098|NCT01787760|449297495|FG001|Overall Study|Withdrawal by Subject|1|||
124910099|NCT01787760|449297496|FG002|Overall Study|Withdrawal by Subject|2|||
124910100|NCT01787760|449297494|FG000|Overall Study|Lost to Follow-up|1|||
124910101|NCT01787760|449297495|FG001|Overall Study|Lost to Follow-up|0|||
124910102|NCT01787760|449297496|FG002|Overall Study|Lost to Follow-up|1|||
124910103|NCT01787760|449297494|FG000|Overall Study|Stroke|1|||
124910104|NCT01787760|449297495|FG001|Overall Study|Stroke|0|||
124910105|NCT01787760|449297496|FG002|Overall Study|Stroke|0|||
124910106|NCT01787760|449297494|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
124910107|NCT01787760|449297495|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
124910108|NCT01787760|449297496|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
124910109|NCT01787760|449297494|FG000|Overall Study|Unsatisfactory physiological response|2|||
124910110|NCT01787760|449297495|FG001|Overall Study|Unsatisfactory physiological response|4|||
124910111|NCT01787760|449297496|FG002|Overall Study|Unsatisfactory physiological response|0|||
124910112|NCT01787760|449297494|FG000|Overall Study|Unsatisfactory visual response|1|||
124910113|NCT01787760|449297495|FG001|Overall Study|Unsatisfactory visual response|1|||
124910114|NCT01787760|449297496|FG002|Overall Study|Unsatisfactory visual response|0|||
124910115|NCT01787760|449297494|FG000|Overall Study|Near vision blur|1|||
124910116|NCT01787760|449297495|FG001|Overall Study|Near vision blur|0|||
124910117|NCT01787760|449297496|FG002|Overall Study|Near vision blur|0|||
124910118|NCT01849055|449297497|FG000|Overall Study|Withdrawal by Subject|0|||
124910119|NCT01849055|449297498|FG001|Overall Study|Withdrawal by Subject|0|||
124910120|NCT01849055|449297499|FG002|Overall Study|Withdrawal by Subject|1|||
124910121|NCT01849055|449297500|FG003|Overall Study|Withdrawal by Subject|0|||
124910122|NCT01849055|449297501|FG004|Overall Study|Withdrawal by Subject|0|||
124910123|NCT01849055|449297502|FG005|Overall Study|Withdrawal by Subject|0|||
124910124|NCT01239316|449297503|FG000|Overall Study|Progression/Relapse|11|||
124910125|NCT01239316|449297503|FG000|Overall Study|Adverse Event|1|||
124910126|NCT04623008|449298558|FG000|Baseline to T2|Withdrawal by Subject|4|||
124910127|NCT04623008|449298559|FG001|Baseline to T2|Withdrawal by Subject|2|||
124692232|NCT03528577|448494703|FG000|Sequence 2|Failed Spirometry|1|||
124692233|NCT03528577|448494703|FG000|Sequence 3|Failed Spirometry|1|||
124692234|NCT03528577|448494703|FG000|Sequence 4|Failed Spirometry|2|||
124910128|NCT04623008|449298558|FG000|Baseline to T3|Withdrawal by Subject|4|||
124910129|NCT04623008|449298559|FG001|Baseline to T3|Withdrawal by Subject|2|||
124910130|NCT03122886|449298560|FG000|Overall Study|Withdrawal by Subject|1|||
124910131|NCT03122886|449298561|FG001|Overall Study|Withdrawal by Subject|2|||
124910132|NCT03779048|449298562|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
124910133|NCT03779048|449298563|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
124910134|NCT03779048|449298564|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
124910135|NCT03779048|449298562|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
124910136|NCT03779048|449298563|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
124910137|NCT03779048|449298564|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
124910138|NCT03779048|449298562|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
124692235|NCT03528577|448494703|FG000|Sequence 4|Adverse Event|1|||
124692236|NCT04882215|448494704|FG000|Overall Study|Withdrawal by Subject|5|||
124910139|NCT03779048|449298563|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
124910140|NCT03779048|449298564|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
124910141|NCT03422276|449298565|FG000|Overall Study|Withdrawal by Subject|21|||
124910142|NCT03422276|449298566|FG001|Overall Study|Withdrawal by Subject|25|||
124910143|NCT03422276|449298567|FG002|Overall Study|Withdrawal by Subject|14|||
124910144|NCT03422276|449298568|FG003|Overall Study|Withdrawal by Subject|16|||
124910145|NCT03422276|449298565|FG000|Overall Study|Death|14|||
124910146|NCT03422276|449298566|FG001|Overall Study|Death|21|||
124910147|NCT03422276|449298567|FG002|Overall Study|Death|3|||
124910148|NCT03422276|449298568|FG003|Overall Study|Death|1|||
124910149|NCT03422276|449298565|FG000|Overall Study|Discontinued, ineligible|4|||
124910150|NCT03422276|449298566|FG001|Overall Study|Discontinued, ineligible|3|||
124910151|NCT03422276|449298567|FG002|Overall Study|Discontinued, ineligible|0|||
124910152|NCT03422276|449298568|FG003|Overall Study|Discontinued, ineligible|0|||
124910153|NCT03422276|449298565|FG000|Overall Study|Lost to Follow-up|15|||
124910154|NCT03422276|449298566|FG001|Overall Study|Lost to Follow-up|8|||
124910155|NCT03422276|449298567|FG002|Overall Study|Lost to Follow-up|13|||
124910156|NCT03422276|449298568|FG003|Overall Study|Lost to Follow-up|4|||
124910157|NCT03422276|449298565|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
124910158|NCT03422276|449298566|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
124910159|NCT03422276|449298567|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
124910160|NCT03422276|449298568|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
124910161|NCT03422276|449298565|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
124910162|NCT03422276|449298566|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
124910163|NCT03422276|449298567|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
124910164|NCT03422276|449298568|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
124910165|NCT03422276|449298565|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
124910166|NCT03422276|449298566|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
124910167|NCT03422276|449298567|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
124910168|NCT03422276|449298568|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
124910169|NCT03422276|449298565|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
124910170|NCT03422276|449298566|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
124910171|NCT03422276|449298567|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
124910172|NCT03422276|449298568|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
124910173|NCT03422276|449298565|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
124910174|NCT03422276|449298566|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
124910175|NCT03422276|449298567|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
124910176|NCT03422276|449298568|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
124910177|NCT05985044|449298569|FG000|Overall Study|Death|6|||
124910178|NCT05985044|449298569|FG000|Overall Study|Lost to Follow-up|4|||
124910179|NCT05985044|449298569|FG000|Overall Study|Incapacitation|3|||
124910180|NCT05985044|449298569|FG000|Overall Study|Withdrawal by Subject|2|||
124910181|NCT04588259|449298570|FG000|Run-in Period|Run-in failure|0|||
124910182|NCT04588259|449298571|FG001|Run-in Period|Run-in failure|23|||
124910183|NCT04588259|449298570|FG000|Run-in Period|Withdrawn before randomisation|0|||
124910184|NCT04588259|449298571|FG001|Run-in Period|Withdrawn before randomisation|8|||
124910185|NCT04588259|449298570|FG000|Treatment Period|Withdrawal by Subject|6|||
124910186|NCT04588259|449298571|FG001|Treatment Period|Withdrawal by Subject|6|||
124910187|NCT03051165|449298579|FG000|Overall Study|Withdrawal by Subject|1|||
124910188|NCT03051165|449298579|FG000|Overall Study|Early termination of study|12|||
124910189|NCT02092116|449298580|FG000|Overall Study|Withdrawal by Subject|0|||
124910190|NCT02092116|449298581|FG001|Overall Study|Withdrawal by Subject|3|||
124910191|NCT02092116|449298580|FG000|Overall Study|Adverse Event|0|||
124910192|NCT02092116|449298581|FG001|Overall Study|Adverse Event|1|||
124910193|NCT03074331|449298582|FG000|Overall Study|Enrolled but Not Treated|1|||
124910194|NCT03074331|449298582|FG000|Overall Study|Lost to Follow-up|5|||
124910195|NCT03074331|449298582|FG000|Overall Study|Withdrew Consent|1|||
124910196|NCT01546753|449298583|FG000|Overall Study|anxiety|1|||
124910197|NCT01546753|449298584|FG001|Overall Study|anxiety|1|||
124910198|NCT01546753|449298583|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
124910199|NCT01546753|449298584|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
124910200|NCT00546754|449298587|FG000|Overall Study|Serious Adverse Event|1|||
124910201|NCT00546754|449298588|FG001|Overall Study|Serious Adverse Event|1|||
124910202|NCT00546754|449298587|FG000|Overall Study|Adverse Event|11|||
124910203|NCT00546754|449298588|FG001|Overall Study|Adverse Event|16|||
124910204|NCT00546754|449298587|FG000|Overall Study|Lack of Efficacy|1|||
124910205|NCT00546754|449298588|FG001|Overall Study|Lack of Efficacy|1|||
124910206|NCT00546754|449298587|FG000|Overall Study|Lost to Follow-up|9|||
124450259|NCT00922480|447611930|FG001|Main Study|Lack of Efficacy|0|||
124910207|NCT00546754|449298588|FG001|Overall Study|Lost to Follow-up|15|||
124910208|NCT00546754|449298587|FG000|Overall Study|Protocol Violation|3|||
124910209|NCT00546754|449298588|FG001|Overall Study|Protocol Violation|0|||
124692237|NCT04882215|448494705|FG001|Overall Study|Withdrawal by Subject|0|||
124910210|NCT00546754|449298587|FG000|Overall Study|Withdrawal by Subject|6|||
124910211|NCT00546754|449298588|FG001|Overall Study|Withdrawal by Subject|7|||
124910212|NCT00546754|449298587|FG000|Overall Study|Dyspnea|1|||
124450260|NCT00922480|447611929|FG000|Main Study|Withdrawal by Subject|20|||
124450261|NCT00922480|447611930|FG001|Main Study|Withdrawal by Subject|15|||
124692238|NCT04098302|448494707|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
124910213|NCT00546754|449298588|FG001|Overall Study|Dyspnea|0|||
124910214|NCT00546754|449298587|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
124910215|NCT00546754|449298588|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
124910216|NCT00546754|449298587|FG000|Overall Study|Hip Replacement|1|||
124910217|NCT00546754|449298588|FG001|Overall Study|Hip Replacement|0|||
124910218|NCT00546754|449298587|FG000|Overall Study|Suicide|1|||
124910219|NCT00546754|449298588|FG001|Overall Study|Suicide|0|||
124910220|NCT00546754|449298587|FG000|Overall Study|Missing Cooperation|1|||
124910221|NCT00546754|449298588|FG001|Overall Study|Missing Cooperation|0|||
124910222|NCT00546754|449298587|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
124910223|NCT00546754|449298588|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
124910224|NCT00546754|449298587|FG000|Overall Study|Patient's Decision|0|||
124910225|NCT00546754|449298588|FG001|Overall Study|Patient's Decision|1|||
124910226|NCT00546754|449298587|FG000|Overall Study|Missing|14|||
124910227|NCT00546754|449298588|FG001|Overall Study|Missing|7|||
124910228|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
124910229|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
124910230|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
124910231|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
124910232|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
124910233|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
124910234|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
124910235|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
124910236|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
124910237|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
124910238|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
124910239|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
124910240|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
124910241|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
124910242|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
124910243|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
124910244|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
124910245|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
124910246|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
124910247|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
124910248|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
124910249|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
124910250|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
124910251|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
124910252|NCT00311363|449298591|FG000|24-Week Single-Blind Treatment Period|Death|1|||
124910253|NCT00311363|449298592|FG001|24-Week Single-Blind Treatment Period|Death|0|||
124910254|NCT00311363|449298593|FG002|24-Week Single-Blind Treatment Period|Death|0|||
124910255|NCT00311363|449298591|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
124910256|NCT00311363|449298592|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
124910257|NCT00311363|449298593|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
124910258|NCT00311363|449298591|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
124910259|NCT00311363|449298592|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
124910260|NCT00311363|449298593|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
124910261|NCT00311363|449298591|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
124910262|NCT00311363|449298592|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
124910263|NCT00311363|449298593|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
124910264|NCT00311363|449298591|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
124910265|NCT00311363|449298592|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
124910266|NCT00311363|449298593|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
124910267|NCT00311363|449298591|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
124910268|NCT00311363|449298592|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
124910269|NCT00311363|449298593|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
124910270|NCT00311363|449298591|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
124910271|NCT00311363|449298592|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
124910272|NCT00311363|449298593|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
124910273|NCT03830866|449298594|FG000|Overall Study|Death|90|||
124910274|NCT03830866|449298595|FG001|Overall Study|Death|111|||
124910275|NCT03830866|449298594|FG000|Overall Study|Lost to Follow-up|7|||
124910276|NCT03830866|449298595|FG001|Overall Study|Lost to Follow-up|7|||
124910277|NCT03830866|449298594|FG000|Overall Study|Withdrawal by Subject|19|||
124910278|NCT03830866|449298595|FG001|Overall Study|Withdrawal by Subject|16|||
124910279|NCT03830866|449298594|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
124910280|NCT03830866|449298595|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
124910281|NCT03830866|449298594|FG000|Overall Study|Other|1|||
124910282|NCT03830866|449298595|FG001|Overall Study|Other|1|||
124910283|NCT01759771|449298596|FG000|Overall Study|Withdrawal by Subject|1|||
124910284|NCT01759771|449298597|FG001|Overall Study|Withdrawal by Subject|1|||
124910285|NCT02139943|449298600|FG000|Overall Study|Adverse Event|0|||
124910286|NCT02139943|449298601|FG001|Overall Study|Adverse Event|1|||
124910287|NCT02139943|449298602|FG002|Overall Study|Adverse Event|2|||
124910288|NCT02139943|449298600|FG000|Overall Study|Lost to Follow-up|3|||
124910289|NCT02139943|449298601|FG001|Overall Study|Lost to Follow-up|2|||
124910290|NCT02139943|449298602|FG002|Overall Study|Lost to Follow-up|2|||
124910291|NCT02139943|449298600|FG000|Overall Study|Withdrawal by Subject|4|||
124910292|NCT02139943|449298601|FG001|Overall Study|Withdrawal by Subject|3|||
124910293|NCT02139943|449298602|FG002|Overall Study|Withdrawal by Subject|0|||
124910294|NCT02139943|449298600|FG000|Overall Study|Other|0|||
124910295|NCT02139943|449298601|FG001|Overall Study|Other|0|||
124910296|NCT02139943|449298602|FG002|Overall Study|Other|1|||
124910297|NCT02139943|449298600|FG000|Overall Study|Participant wishes to discontinue|2|||
124910298|NCT02139943|449298601|FG001|Overall Study|Participant wishes to discontinue|0|||
124910299|NCT02139943|449298602|FG002|Overall Study|Participant wishes to discontinue|0|||
124910300|NCT02139943|449298600|FG000|Overall Study|Participant in Poor Compliance|1|||
124910301|NCT02139943|449298601|FG001|Overall Study|Participant in Poor Compliance|0|||
124910302|NCT02139943|449298602|FG002|Overall Study|Participant in Poor Compliance|1|||
124910303|NCT02139943|449298600|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
124910304|NCT02139943|449298601|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
124910305|NCT02139943|449298602|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
124910306|NCT00716859|449298605|FG000|Overall Study|Adverse Event|4|||
124910307|NCT00716859|449298606|FG001|Overall Study|Adverse Event|1|||
124910308|NCT00716859|449298605|FG000|Overall Study|Lack of Efficacy|3|||
124910309|NCT00716859|449298606|FG001|Overall Study|Lack of Efficacy|0|||
124910310|NCT00716859|449298605|FG000|Overall Study|Withdrawal by Subject|1|||
124910311|NCT00716859|449298606|FG001|Overall Study|Withdrawal by Subject|3|||
124910312|NCT00716859|449298605|FG000|Overall Study|Not treated|1|||
124910313|NCT00716859|449298606|FG001|Overall Study|Not treated|1|||
124910314|NCT03750968|449298608|FG000|Overall Study|Adverse Event|2|||
124910315|NCT03750968|449298609|FG001|Overall Study|Adverse Event|0|||
124910316|NCT03750968|449298608|FG000|Overall Study|Lost to Follow-up|1|||
124910317|NCT03750968|449298609|FG001|Overall Study|Lost to Follow-up|3|||
124910318|NCT00088413|449298611|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
124910319|NCT00088413|449298612|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
124910320|NCT00088413|449298613|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
124910321|NCT00088413|449298614|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
124910322|NCT00088413|449298611|FG000|Overall Study|Adverse Events/Side Effects|0|||
124910323|NCT00088413|449298612|FG001|Overall Study|Adverse Events/Side Effects|1|||
124910324|NCT00088413|449298613|FG002|Overall Study|Adverse Events/Side Effects|1|||
124910325|NCT00088413|449298614|FG003|Overall Study|Adverse Events/Side Effects|0|||
124910326|NCT00088413|449298611|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
124910327|NCT00088413|449298612|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
124910328|NCT00088413|449298613|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
124910329|NCT00088413|449298614|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
124910330|NCT00088413|449298611|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
124910331|NCT00088413|449298612|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
124910332|NCT00088413|449298613|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
124910333|NCT00088413|449298614|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
124910334|NCT00088413|449298611|FG000|Overall Study|Death|0|||
124910335|NCT00088413|449298612|FG001|Overall Study|Death|1|||
124910336|NCT00088413|449298613|FG002|Overall Study|Death|0|||
124910337|NCT00088413|449298614|FG003|Overall Study|Death|0|||
124910338|NCT00088413|449298611|FG000|Overall Study|Progressive disease|9|||
124910339|NCT00088413|449298612|FG001|Overall Study|Progressive disease|11|||
124910340|NCT00088413|449298613|FG002|Overall Study|Progressive disease|8|||
124910341|NCT00088413|449298614|FG003|Overall Study|Progressive disease|14|||
124910342|NCT00088413|449298611|FG000|Overall Study|Other|0|||
124910343|NCT00088413|449298612|FG001|Overall Study|Other|1|||
124910344|NCT00088413|449298613|FG002|Overall Study|Other|0|||
124910345|NCT00088413|449298614|FG003|Overall Study|Other|0|||
124910346|NCT00088413|449298611|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
124910347|NCT00088413|449298612|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
124910348|NCT00088413|449298613|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
124910349|NCT00088413|449298614|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
124910350|NCT01551355|449298617|FG000|Overall Study|Lost to Follow-up|51|||
124910351|NCT01551355|449298618|FG001|Overall Study|Lost to Follow-up|49|||
124910352|NCT01551355|449298619|FG002|Overall Study|Lost to Follow-up|34|||
124910353|NCT01551355|449298620|FG003|Overall Study|Lost to Follow-up|24|||
124910354|NCT01551355|449298621|FG004|Overall Study|Lost to Follow-up|9|||
124910355|NCT01551355|449298622|FG005|Overall Study|Lost to Follow-up|6|||
124910356|NCT00411216|449298623|FG000|Overall Study|Ten participants were entered into the c|0|||
124692239|NCT04098302|448494708|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
124692240|NCT04098302|448494709|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
124692241|NCT04098302|448494710|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
124692242|NCT04098302|448494707|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
124692243|NCT04098302|448494708|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
124692244|NCT04098302|448494709|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
124692245|NCT04098302|448494710|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
124692246|NCT04098302|448494707|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
124692247|NCT04098302|448494708|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
124692248|NCT04098302|448494709|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
124692249|NCT04098302|448494710|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
124692250|NCT04098302|448494707|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
124692251|NCT04098302|448494708|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
124692252|NCT04098302|448494709|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
124692253|NCT04098302|448494710|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
124692254|NCT04098302|448494707|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
124692255|NCT04098302|448494708|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
124692256|NCT04098302|448494709|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
124692257|NCT04098302|448494710|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
124692258|NCT04098302|448494707|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
124692259|NCT04098302|448494708|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
124692260|NCT04098302|448494709|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
124692261|NCT04098302|448494710|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
124692262|NCT04098302|448494707|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
124692263|NCT04098302|448494708|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
124692264|NCT04098302|448494709|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
124692265|NCT04098302|448494710|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
124692266|NCT04098302|448494707|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
124692267|NCT04098302|448494708|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
124692268|NCT04098302|448494709|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
124692269|NCT04098302|448494710|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
124692270|NCT05061706|448494711|FG000|Overall Study|Adverse Event|29|||
124692271|NCT05061706|448494712|FG001|Overall Study|Adverse Event|1|||
124692272|NCT05061706|448494711|FG000|Overall Study|Lack of Efficacy|0|||
124692273|NCT05061706|448494712|FG001|Overall Study|Lack of Efficacy|1|||
124692274|NCT05061706|448494711|FG000|Overall Study|Lost to Follow-up|2|||
124692275|NCT05061706|448494712|FG001|Overall Study|Lost to Follow-up|2|||
124692276|NCT05061706|448494711|FG000|Overall Study|Protocol Violation|3|||
124692277|NCT05061706|448494712|FG001|Overall Study|Protocol Violation|1|||
124692278|NCT05061706|448494711|FG000|Overall Study|Withdrawal by Subject|3|||
124692279|NCT05061706|448494712|FG001|Overall Study|Withdrawal by Subject|9|||
124692280|NCT00724893|448494714|FG000|Overall Study|Adverse Event|76|||
124692281|NCT00724893|448494715|FG001|Overall Study|Adverse Event|142|||
124692282|NCT00724893|448494714|FG000|Overall Study|Withdrawal by Subject|0|||
124692283|NCT00724893|448494715|FG001|Overall Study|Withdrawal by Subject|1|||
124692284|NCT00724893|448494714|FG000|Overall Study|Lack of virologic response|94|||
124692285|NCT00724893|448494715|FG001|Overall Study|Lack of virologic response|202|||
124692286|NCT00724893|448494714|FG000|Overall Study|Reason not specified|193|||
124692287|NCT00724893|448494715|FG001|Overall Study|Reason not specified|7|||
124692288|NCT00724893|448494714|FG000|Overall Study|Patient choice|0|||
124692289|NCT00724893|448494715|FG001|Overall Study|Patient choice|26|||
124692290|NCT00724893|448494714|FG000|Overall Study|Geographic reasons|0|||
124692291|NCT00724893|448494715|FG001|Overall Study|Geographic reasons|11|||
124692292|NCT00724893|448494714|FG000|Overall Study|Incarceration|0|||
124692293|NCT00724893|448494715|FG001|Overall Study|Incarceration|9|||
124692294|NCT00724893|448494714|FG000|Overall Study|Substance abuse|0|||
124692295|NCT00724893|448494715|FG001|Overall Study|Substance abuse|3|||
124692296|NCT00724893|448494714|FG000|Overall Study|Financial reasons|0|||
124692297|NCT00724893|448494715|FG001|Overall Study|Financial reasons|2|||
124692298|NCT00724893|448494714|FG000|Overall Study|Assigned shorter treatment|0|||
124910357|NCT00411216|449298624|FG001|Overall Study|Ten participants were entered into the c|2|||
124910358|NCT02918071|449298625|FG000|Overall Study|Withdrawal by Subject|2|||
124910359|NCT02918071|449298625|FG000|Overall Study|Lost to Follow-up|1|||
124910360|NCT00203411|449298628|FG000|Follow-up|Progressive Disease|4|||
124692299|NCT00724893|448494715|FG001|Overall Study|Assigned shorter treatment|2|||
124692300|NCT00724893|448494714|FG000|Overall Study|Lost to Follow-up|0|||
124692301|NCT00724893|448494715|FG001|Overall Study|Lost to Follow-up|52|||
124910361|NCT00632424|449298631|FG000|Overall Study|Disease Progression|17|||
124692302|NCT00724893|448494714|FG000|Overall Study|Unknown, missing data|1|||
124692303|NCT00724893|448494715|FG001|Overall Study|Unknown, missing data|1|||
124692304|NCT01290731|448494716|FG000|Overall Study|Withdrawal by Subject|1|||
124910362|NCT00632424|449298631|FG000|Overall Study|Study Drug Toxicity|1|||
124910363|NCT02531113|449298632|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
124910364|NCT02531113|449298632|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
124910365|NCT02531113|449298632|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
124910366|NCT02531113|449298632|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
124910367|NCT02531113|449298632|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
124910368|NCT02531113|449298632|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
124910369|NCT02531113|449298632|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
124910370|NCT02531113|449298632|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
124692305|NCT05064800|448494717|FG000|Period 3|Withdrawal by Subject|0|||
124910371|NCT00774852|449298634|FG000|Overall Study|Adverse Event|9|||
124910372|NCT00774852|449298635|FG001|Overall Study|Adverse Event|6|||
124910373|NCT00774852|449298634|FG000|Overall Study|Death|2|||
124910374|NCT00774852|449298635|FG001|Overall Study|Death|1|||
124910375|NCT00774852|449298634|FG000|Overall Study|Lack of Efficacy|3|||
124910376|NCT00774852|449298635|FG001|Overall Study|Lack of Efficacy|7|||
124910377|NCT00774852|449298634|FG000|Overall Study|Lost to Follow-up|9|||
124910378|NCT00774852|449298635|FG001|Overall Study|Lost to Follow-up|5|||
124910379|NCT00774852|449298634|FG000|Overall Study|Physician Decision|2|||
124910380|NCT00774852|449298635|FG001|Overall Study|Physician Decision|6|||
124910381|NCT00774852|449298634|FG000|Overall Study|Pregnancy|1|||
124910382|NCT00774852|449298635|FG001|Overall Study|Pregnancy|2|||
124910383|NCT00774852|449298634|FG000|Overall Study|Withdrawal by Subject|2|||
124910384|NCT00774852|449298635|FG001|Overall Study|Withdrawal by Subject|2|||
124910385|NCT00774852|449298634|FG000|Overall Study|Non-responder|15|||
124910386|NCT00774852|449298635|FG001|Overall Study|Non-responder|11|||
124910387|NCT00774852|449298634|FG000|Overall Study|Subject non-compliance|0|||
124910388|NCT00774852|449298635|FG001|Overall Study|Subject non-compliance|1|||
124910389|NCT00774852|449298634|FG000|Overall Study|Protocol Violation|1|||
124910390|NCT00774852|449298635|FG001|Overall Study|Protocol Violation|0|||
124910391|NCT00774852|449298634|FG000|Overall Study|Subject received prohibited medication|1|||
124910392|NCT00774852|449298635|FG001|Overall Study|Subject received prohibited medication|0|||
124910393|NCT03997916|449298636|FG000|Overall Study|Protocol Violation|35|||
124910394|NCT03482635|449298640|FG000|Overall Study|Lack of Efficacy|0|||
124910395|NCT03482635|449298641|FG001|Overall Study|Lack of Efficacy|0|||
124910396|NCT03482635|449298642|FG002|Overall Study|Lack of Efficacy|1|||
124910397|NCT03482635|449298643|FG003|Overall Study|Lack of Efficacy|3|||
124910398|NCT03482635|449298640|FG000|Overall Study|Adverse Event|2|||
124910399|NCT03482635|449298641|FG001|Overall Study|Adverse Event|2|||
124910400|NCT03482635|449298642|FG002|Overall Study|Adverse Event|0|||
124910401|NCT03482635|449298643|FG003|Overall Study|Adverse Event|3|||
124910402|NCT03482635|449298640|FG000|Overall Study|Withdrawal by Subject|2|||
124910403|NCT03482635|449298641|FG001|Overall Study|Withdrawal by Subject|1|||
124910404|NCT03482635|449298642|FG002|Overall Study|Withdrawal by Subject|0|||
124910405|NCT03482635|449298643|FG003|Overall Study|Withdrawal by Subject|1|||
124910406|NCT03482635|449298640|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
124910407|NCT03482635|449298641|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
124910408|NCT03482635|449298642|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
124910409|NCT03482635|449298643|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
124910410|NCT03482635|449298640|FG000|Overall Study|Not treated|0|||
124910411|NCT03482635|449298641|FG001|Overall Study|Not treated|0|||
124910412|NCT03482635|449298642|FG002|Overall Study|Not treated|0|||
124910413|NCT03482635|449298643|FG003|Overall Study|Not treated|1|||
124910414|NCT02279095|449299757|FG000|Overall Study|Non-Compliance|1|||
124910415|NCT02279095|449299757|FG000|Overall Study|Withdrawal by Subject|8|||
124910416|NCT02279095|449299757|FG000|Overall Study|Adverse Event|2|||
124910417|NCT02279095|449299757|FG000|Overall Study|Other|7|||
124910418|NCT02279095|449299757|FG000|Overall Study|Lost to Follow-up|1|||
124910419|NCT05644444|449299758|FG000|Tolerance Phase|Adverse Event|0|||
124910420|NCT05644444|449299759|FG001|Tolerance Phase|Adverse Event|2|||
124910421|NCT05644444|449299758|FG000|Treatment Phase|Adverse Event|0|||
124910422|NCT05644444|449299759|FG001|Treatment Phase|Adverse Event|2|||
124910423|NCT03936660|449299760|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
124910424|NCT03936660|449299761|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
124910425|NCT02724592|449299764|FG000|Overall Study|Lost to Follow-up|4|||
124910426|NCT02724592|449299765|FG001|Overall Study|Lost to Follow-up|1|||
124692306|NCT05064800|448494718|FG001|Period 3|Withdrawal by Subject|0|||
124692307|NCT05064800|448494719|FG002|Period 3|Withdrawal by Subject|0|||
124910427|NCT02584829|449299766|FG000|Overall Study|Physician Decision|1|||
124910428|NCT02584829|449299767|FG001|Overall Study|Physician Decision|0|||
124910429|NCT02584829|449299766|FG000|Overall Study|Withdrawal by Subject|0|||
124910430|NCT02584829|449299767|FG001|Overall Study|Withdrawal by Subject|1|||
124910431|NCT02584829|449299766|FG000|Overall Study|Progressive Disease|0|||
124910432|NCT02584829|449299767|FG001|Overall Study|Progressive Disease|3|||
124910433|NCT04723394|449299768|FG000|Overall Study|Adverse Event|0|||
124910434|NCT04723394|449299769|FG001|Overall Study|Adverse Event|3|||
124692308|NCT05064800|448494720|FG003|Period 3|Withdrawal by Subject|0|||
124910435|NCT04723394|449299768|FG000|Overall Study|Death|8|||
124910436|NCT04723394|449299769|FG001|Overall Study|Death|8|||
124760485|NCT05579977|448746888|FG006|Follow up|Death|0|||
124760486|NCT05579977|448746889|FG007|Follow up|Death|0|||
124760487|NCT05579977|448746890|FG008|Follow up|Death|0|||
124760488|NCT05579977|448746891|FG009|Follow up|Death|0|||
124760489|NCT05579977|448746892|FG010|Follow up|Death|0|||
124760490|NCT05579977|448746893|FG011|Follow up|Death|0|||
124760491|NCT05579977|448746894|FG012|Follow up|Death|0|||
124760492|NCT05579977|448746882|FG000|Follow up|Lost to Follow-up|0|||
124760493|NCT05579977|448746883|FG001|Follow up|Lost to Follow-up|0|||
124760494|NCT05579977|448746884|FG002|Follow up|Lost to Follow-up|0|||
124760495|NCT05579977|448746885|FG003|Follow up|Lost to Follow-up|1|||
124760496|NCT05579977|448746886|FG004|Follow up|Lost to Follow-up|1|||
124760497|NCT05579977|448746887|FG005|Follow up|Lost to Follow-up|2|||
124760498|NCT05579977|448746888|FG006|Follow up|Lost to Follow-up|1|||
124760499|NCT05579977|448746889|FG007|Follow up|Lost to Follow-up|1|||
124760500|NCT05579977|448746890|FG008|Follow up|Lost to Follow-up|3|||
124760501|NCT05579977|448746891|FG009|Follow up|Lost to Follow-up|2|||
124760502|NCT05579977|448746892|FG010|Follow up|Lost to Follow-up|2|||
124760503|NCT05579977|448746893|FG011|Follow up|Lost to Follow-up|4|||
124760504|NCT05579977|448746894|FG012|Follow up|Lost to Follow-up|4|||
124760505|NCT05579977|448746882|FG000|Follow up|Withdrawal by Subject|2|||
124760506|NCT05579977|448746883|FG001|Follow up|Withdrawal by Subject|0|||
124760507|NCT05579977|448746884|FG002|Follow up|Withdrawal by Subject|0|||
124760508|NCT05579977|448746885|FG003|Follow up|Withdrawal by Subject|0|||
124760509|NCT05579977|448746886|FG004|Follow up|Withdrawal by Subject|1|||
124760510|NCT05579977|448746887|FG005|Follow up|Withdrawal by Subject|0|||
124760511|NCT05579977|448746888|FG006|Follow up|Withdrawal by Subject|1|||
124760512|NCT05579977|448746889|FG007|Follow up|Withdrawal by Subject|4|||
124760513|NCT05579977|448746890|FG008|Follow up|Withdrawal by Subject|2|||
124760514|NCT05579977|448746891|FG009|Follow up|Withdrawal by Subject|3|||
124760515|NCT05579977|448746892|FG010|Follow up|Withdrawal by Subject|3|||
124760516|NCT05579977|448746893|FG011|Follow up|Withdrawal by Subject|1|||
124910437|NCT04723394|449299768|FG000|Overall Study|Lost to Follow-up|20|||
124910438|NCT04723394|449299769|FG001|Overall Study|Lost to Follow-up|17|||
124910439|NCT04723394|449299768|FG000|Overall Study|Physician Decision|1|||
124910440|NCT04723394|449299769|FG001|Overall Study|Physician Decision|0|||
124910441|NCT04723394|449299768|FG000|Overall Study|Withdrawal by Subject|20|||
124910442|NCT04723394|449299769|FG001|Overall Study|Withdrawal by Subject|34|||
124910443|NCT04723394|449299768|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
124450262|NCT00922480|447611929|FG000|Main Study|Lost to Follow-up|5|||
124450263|NCT00922480|447611930|FG001|Main Study|Lost to Follow-up|0|||
124450264|NCT00922480|447611929|FG000|Main Study|Physician Decision|0|||
124450265|NCT00922480|447611930|FG001|Main Study|Physician Decision|1|||
124450266|NCT00922480|447611929|FG000|Extension Study|Protocol Violation|3|||
124450267|NCT00922480|447611930|FG001|Extension Study|Protocol Violation|0|||
124450268|NCT00922480|447611929|FG000|Extension Study|Adverse Event|1|||
124450269|NCT00922480|447611930|FG001|Extension Study|Adverse Event|1|||
124450270|NCT00922480|447611929|FG000|Extension Study|Withdrawal by Subject|1|||
124450271|NCT00922480|447611930|FG001|Extension Study|Withdrawal by Subject|1|||
124450272|NCT00922480|447611929|FG000|Extension Study|Others|0|||
124450273|NCT00922480|447611930|FG001|Extension Study|Others|1|||
124450274|NCT01011439|447611931|FG000|Overall Study|Death|37|||
124450275|NCT01011439|447611931|FG000|Overall Study|Lost to Follow-up|4|||
124450276|NCT01011439|447611931|FG000|Overall Study|Withdrawal by Subject|1|||
124450277|NCT01011439|447611931|FG000|Overall Study|Sponsor's decision|15|||
124450278|NCT01372150|447611932|FG000|Overall Study|Lack of Efficacy|3|||
124450279|NCT01372150|447611933|FG001|Overall Study|Lack of Efficacy|0|||
124450280|NCT01372150|447611934|FG002|Overall Study|Lack of Efficacy|1|||
124450281|NCT01372150|447611932|FG000|Overall Study|Lost to Follow-up|4|||
124450282|NCT01372150|447611933|FG001|Overall Study|Lost to Follow-up|5|||
124450283|NCT01372150|447611934|FG002|Overall Study|Lost to Follow-up|6|||
124450284|NCT01372150|447611932|FG000|Overall Study|Protocol Violation|1|||
124450285|NCT01372150|447611933|FG001|Overall Study|Protocol Violation|0|||
124450286|NCT01372150|447611934|FG002|Overall Study|Protocol Violation|3|||
124450287|NCT01372150|447611932|FG000|Overall Study|Withdrawal by Subject|2|||
124450288|NCT01372150|447611933|FG001|Overall Study|Withdrawal by Subject|7|||
124450289|NCT01372150|447611934|FG002|Overall Study|Withdrawal by Subject|2|||
124450290|NCT01372150|447611932|FG000|Overall Study|Other|1|||
124450291|NCT01372150|447611933|FG001|Overall Study|Other|0|||
124760517|NCT05579977|448746894|FG012|Follow up|Withdrawal by Subject|3|||
124760518|NCT00866814|448746895|FG000|Overall Study|Lost to Follow-up|12|||
124760519|NCT00866814|448746895|FG000|Overall Study|Adverse Event|2|||
124760520|NCT00866814|448746895|FG000|Overall Study|Physician Decision|1|||
124760521|NCT00866814|448746895|FG000|Overall Study|Death|1|||
124760522|NCT00866814|448746895|FG000|Overall Study|No longer wished to participate|1|||
124450292|NCT01372150|447611934|FG002|Overall Study|Other|2|||
124450293|NCT01372150|447611932|FG000|Overall Study|Adverse Event|2|||
124450294|NCT01372150|447611933|FG001|Overall Study|Adverse Event|1|||
124760523|NCT00866814|448746895|FG000|Overall Study|Unable to meet follow-up requirements|2|||
124760524|NCT00866814|448746895|FG000|Overall Study|Moved to area without study site|1|||
124760525|NCT01063153|448746896|FG000|Overall Study|Found Ineligible During Screening|2|||
124692309|NCT05064800|448494721|FG004|Period 3|Withdrawal by Subject|1|||
124692310|NCT05064800|448494722|FG005|Period 3|Withdrawal by Subject|0|||
124692311|NCT04477486|448494723|FG000|Overall Study|Death|2|||
124692312|NCT04477486|448494723|FG000|Overall Study|Ongoing at Time of Analysis|11|||
124692313|NCT01078545|448494726|FG000|Overall Study|Lost to Follow-up|13|||
124692314|NCT01078545|448494726|FG000|Overall Study|Physician Decision|6|||
124692315|NCT01078545|448494726|FG000|Overall Study|Withdrawal by Subject|3|||
124692316|NCT01078545|448494726|FG000|Overall Study|Death|3|||
124692317|NCT01078545|448494726|FG000|Overall Study|Participant moved to another physician|1|||
124692318|NCT01774370|448494729|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
124692319|NCT01774370|448494729|FG000|Overall Study|Administered prior to the contract date|4|||
124692320|NCT01774370|448494729|FG000|Overall Study|Subjects of contraindications|34|||
124692321|NCT01774370|448494729|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
124692322|NCT01774370|448494729|FG000|Overall Study|Follow-up failure|34|||
124692323|NCT05436288|448494730|FG000|Overall Study|Lost to Follow-up|1|||
124692324|NCT05436288|448494730|FG000|Overall Study|Adverse Event|1|||
124692325|NCT01436500|448494734|FG000|Overall Study|Death|1|||
124692326|NCT01436500|448494735|FG001|Overall Study|Death|0|||
124692327|NCT01436500|448494736|FG002|Overall Study|Death|0|||
124692328|NCT01436500|448494737|FG003|Overall Study|Death|0|||
124692329|NCT01436500|448494738|FG004|Overall Study|Death|0|||
124692330|NCT01436500|448494734|FG000|Overall Study|Adverse Event|0|||
124692331|NCT01436500|448494735|FG001|Overall Study|Adverse Event|2|||
124692332|NCT01436500|448494736|FG002|Overall Study|Adverse Event|2|||
124692333|NCT01436500|448494737|FG003|Overall Study|Adverse Event|0|||
124692334|NCT01436500|448494738|FG004|Overall Study|Adverse Event|1|||
124692335|NCT01436500|448494734|FG000|Overall Study|Withdrawal by Subject|0|||
124692336|NCT01436500|448494735|FG001|Overall Study|Withdrawal by Subject|0|||
124692337|NCT01436500|448494736|FG002|Overall Study|Withdrawal by Subject|2|||
124692338|NCT01436500|448494737|FG003|Overall Study|Withdrawal by Subject|0|||
124692339|NCT01436500|448494738|FG004|Overall Study|Withdrawal by Subject|2|||
124692340|NCT01436500|448494734|FG000|Overall Study|Physician Decision|0|||
124692341|NCT01436500|448494735|FG001|Overall Study|Physician Decision|0|||
124692342|NCT01436500|448494736|FG002|Overall Study|Physician Decision|1|||
124692343|NCT01436500|448494737|FG003|Overall Study|Physician Decision|0|||
124692344|NCT01436500|448494738|FG004|Overall Study|Physician Decision|0|||
124692345|NCT01436500|448494734|FG000|Overall Study|liver transplant|1|||
124692346|NCT01436500|448494735|FG001|Overall Study|liver transplant|0|||
124692347|NCT01436500|448494736|FG002|Overall Study|liver transplant|0|||
124692348|NCT01436500|448494737|FG003|Overall Study|liver transplant|0|||
124692349|NCT01436500|448494738|FG004|Overall Study|liver transplant|0|||
124692350|NCT01436500|448494734|FG000|Overall Study|initiation of dialysis|0|||
124692351|NCT01436500|448494735|FG001|Overall Study|initiation of dialysis|0|||
124692352|NCT01436500|448494736|FG002|Overall Study|initiation of dialysis|0|||
124692353|NCT01436500|448494737|FG003|Overall Study|initiation of dialysis|0|||
124692354|NCT01436500|448494738|FG004|Overall Study|initiation of dialysis|1|||
124692355|NCT01436500|448494734|FG000|Overall Study|discontinued study drug|1|||
124692356|NCT01436500|448494735|FG001|Overall Study|discontinued study drug|0|||
124692357|NCT01436500|448494736|FG002|Overall Study|discontinued study drug|0|||
124692358|NCT01436500|448494737|FG003|Overall Study|discontinued study drug|0|||
124692359|NCT01436500|448494738|FG004|Overall Study|discontinued study drug|0|||
124692360|NCT01436500|448494734|FG000|Overall Study|Other|0|||
124692361|NCT01436500|448494735|FG001|Overall Study|Other|1|||
124692362|NCT01436500|448494736|FG002|Overall Study|Other|0|||
124692363|NCT01436500|448494737|FG003|Overall Study|Other|1|||
124692364|NCT01436500|448494738|FG004|Overall Study|Other|0|||
124692365|NCT01487161|448494742|FG000|Overall Study|Adverse Event|1|||
124760526|NCT01063153|448746897|FG001|Overall Study|Found Ineligible During Screening|0|||
124760527|NCT01063153|448746896|FG000|Overall Study|Lost to Follow-up|0|||
124910444|NCT04723394|449299769|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
124910445|NCT02765100|449299775|FG000|Overall Study|subject found ineligible after baseline|1|||
124910446|NCT02765100|449299776|FG001|Overall Study|subject found ineligible after baseline|1|||
124910447|NCT02765100|449299775|FG000|Overall Study|Lost to Follow-up|0|||
124692366|NCT01487161|448494743|FG001|Overall Study|Adverse Event|0|||
124692367|NCT01487161|448494744|FG002|Overall Study|Adverse Event|0|||
124692368|NCT01487161|448494745|FG003|Overall Study|Adverse Event|0|||
124692369|NCT01487161|448494742|FG000|Overall Study|Withdrawal by Subject|1|||
124692370|NCT01487161|448494743|FG001|Overall Study|Withdrawal by Subject|1|||
124692371|NCT01487161|448494744|FG002|Overall Study|Withdrawal by Subject|1|||
124692372|NCT01487161|448494745|FG003|Overall Study|Withdrawal by Subject|2|||
124692373|NCT01487161|448494742|FG000|Overall Study|missing data|0|||
124692374|NCT01487161|448494743|FG001|Overall Study|missing data|1|||
124692375|NCT01487161|448494744|FG002|Overall Study|missing data|0|||
124692376|NCT01487161|448494745|FG003|Overall Study|missing data|0|||
124692377|NCT02945046|448494746|FG000|Overall Study|Adverse Event|1|||
124692378|NCT02945046|448494747|FG001|Overall Study|Adverse Event|0|||
124692379|NCT02945046|448494748|FG002|Overall Study|Adverse Event|2|||
124692380|NCT02945046|448494746|FG000|Overall Study|Withdrawal by Subject|3|||
124910448|NCT02765100|449299776|FG001|Overall Study|Lost to Follow-up|1|||
124910449|NCT02675244|449299777|FG000|Overall Study|Death|9|||
124910450|NCT02675244|449299778|FG001|Overall Study|Death|6|||
124910451|NCT02675244|449299777|FG000|Overall Study|Withdrawal by Subject|3|||
124910452|NCT02675244|449299778|FG001|Overall Study|Withdrawal by Subject|6|||
124910453|NCT02675244|449299777|FG000|Overall Study|Lost to Follow-up|1|||
124910454|NCT02675244|449299778|FG001|Overall Study|Lost to Follow-up|1|||
124910455|NCT02675244|449299777|FG000|Overall Study|Ongoing at 2 Years|190|||
124910456|NCT02675244|449299778|FG001|Overall Study|Ongoing at 2 Years|185|||
124910457|NCT02652442|449299782|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
124910458|NCT00914589|449299789|FG000|Overall Study|Adverse Event|1|||
124910459|NCT00914589|449299790|FG001|Overall Study|Adverse Event|0|||
124910460|NCT00914589|449299791|FG002|Overall Study|Adverse Event|1|||
124910461|NCT00914589|449299789|FG000|Overall Study|Protocol Violation|8|||
124910462|NCT00914589|449299790|FG001|Overall Study|Protocol Violation|6|||
124910463|NCT00914589|449299791|FG002|Overall Study|Protocol Violation|3|||
124910464|NCT00914589|449299789|FG000|Overall Study|unclassified|16|||
124910465|NCT00914589|449299790|FG001|Overall Study|unclassified|9|||
124910466|NCT00914589|449299791|FG002|Overall Study|unclassified|7|||
124910467|NCT00914589|449299789|FG000|Overall Study|Death|0|||
124910468|NCT00914589|449299790|FG001|Overall Study|Death|1|||
124910469|NCT00914589|449299791|FG002|Overall Study|Death|1|||
124450295|NCT01372150|447611934|FG002|Overall Study|Adverse Event|2|||
124450296|NCT01372150|447611932|FG000|Overall Study|Randomized but not treated|0|||
124450297|NCT01372150|447611933|FG001|Overall Study|Randomized but not treated|1|||
124450298|NCT01372150|447611934|FG002|Overall Study|Randomized but not treated|0|||
124450299|NCT00536809|447611935|FG000|Phase II|Adverse Event|1|||
124450300|NCT00536809|447611935|FG000|Phase II|Referred for surgical resection|1|||
124450301|NCT02092350|447611944|FG000|Overall Study|Adverse Event|0|||
124450302|NCT02092350|447611945|FG001|Overall Study|Adverse Event|3|||
124450303|NCT02092350|447611944|FG000|Overall Study|Death|2|||
124450304|NCT02092350|447611945|FG001|Overall Study|Death|5|||
124450305|NCT02092350|447611944|FG000|Overall Study|Lost to Follow-up|3|||
124450306|NCT02092350|447611945|FG001|Overall Study|Lost to Follow-up|1|||
124450307|NCT02092350|447611944|FG000|Overall Study|Protocol Violation|1|||
124450308|NCT02092350|447611945|FG001|Overall Study|Protocol Violation|0|||
124450309|NCT02092350|447611944|FG000|Overall Study|Physician Decision|1|||
124450310|NCT02092350|447611945|FG001|Overall Study|Physician Decision|1|||
124450311|NCT02092350|447611944|FG000|Overall Study|Screen Failure|1|||
124450312|NCT02092350|447611945|FG001|Overall Study|Screen Failure|0|||
124450313|NCT02092350|447611944|FG000|Overall Study|Withdrawal by Subject|2|||
124450314|NCT02092350|447611945|FG001|Overall Study|Withdrawal by Subject|2|||
124450315|NCT01303965|447611947|FG000|Overall Study|Adverse Event|1|||
124450316|NCT01303965|447611948|FG001|Overall Study|Adverse Event|1|||
124450317|NCT01303965|447611947|FG000|Overall Study|Death|0|||
124450318|NCT01303965|447611948|FG001|Overall Study|Death|3|||
124450319|NCT01303965|447611947|FG000|Overall Study|Withdrawal by Subject|1|||
124450320|NCT01303965|447611948|FG001|Overall Study|Withdrawal by Subject|0|||
124450321|NCT01303965|447611947|FG000|Overall Study|Disease Progression|1|||
124450322|NCT01303965|447611948|FG001|Overall Study|Disease Progression|6|||
124450323|NCT02448225|447611949|FG000|Overall Study|Withdrawal by Subject|1|||
124450324|NCT02448225|447611949|FG000|Overall Study|Did not get FSPG scan|18|||
124450325|NCT02448225|447611949|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
124450326|NCT00851682|447611950|FG000|Overall Study|screen failure|5|||
124450327|NCT00851682|447611951|FG001|Overall Study|screen failure|0|||
124450328|NCT00766090|447611954|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124450329|NCT00766090|447611955|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124450330|NCT00766090|447611956|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124450331|NCT00766090|447611957|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124450332|NCT00766090|447611958|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124450333|NCT00766090|447611959|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124450334|NCT00766090|447611960|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124450335|NCT00766090|447611961|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124910470|NCT01290341|449299792|FG000|Overall Study|Protocol Violation|7|||
124910471|NCT01290341|449299793|FG001|Overall Study|Protocol Violation|3|||
124910472|NCT01290341|449299792|FG000|Overall Study|Adverse Event|1|||
124450336|NCT00766090|447611962|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
124450337|NCT00766090|447611963|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124450338|NCT00766090|447611964|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124450339|NCT00766090|447611965|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124450340|NCT00766090|447611954|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
124450341|NCT00766090|447611955|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
124450342|NCT00766090|447611956|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
124450343|NCT00766090|447611957|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
124910473|NCT01290341|449299793|FG001|Overall Study|Adverse Event|0|||
124910474|NCT01290341|449299792|FG000|Overall Study|Lost to Follow-up|21|||
124910475|NCT01290341|449299793|FG001|Overall Study|Lost to Follow-up|10|||
124910476|NCT01290341|449299792|FG000|Overall Study|Withdrawal by Subject|19|||
124760528|NCT01063153|448746897|FG001|Overall Study|Lost to Follow-up|7|||
124450344|NCT00766090|447611958|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
124450345|NCT00766090|447611959|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
124450346|NCT00766090|447611960|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
124760529|NCT01063153|448746896|FG000|Overall Study|Withdrawal by Subject|0|||
124760530|NCT01063153|448746897|FG001|Overall Study|Withdrawal by Subject|1|||
124760531|NCT01063153|448746896|FG000|Overall Study|Physician Decision|0|||
124760532|NCT01063153|448746897|FG001|Overall Study|Physician Decision|4|||
124760533|NCT02614729|448749019|FG000|Overall Study|Withdrawal by Subject|1|||
124760534|NCT02614729|448749020|FG001|Overall Study|Withdrawal by Subject|0|||
124760535|NCT01232868|448749021|FG000|Overall Study|Lost to Follow-up|2|||
124760536|NCT01232868|448749022|FG001|Overall Study|Lost to Follow-up|4|||
124760537|NCT02539797|448749023|FG000|Overall Study|Lost to Follow-up|0|||
124760538|NCT02539797|448749024|FG001|Overall Study|Lost to Follow-up|1|||
124760539|NCT02539797|448749025|FG002|Overall Study|Lost to Follow-up|0|||
124760540|NCT04002960|448749027|FG000|Overall Study|Withdrawn prior to Completion|2|||
124760541|NCT00865345|448749030|FG000|Overall Study|Withdrawal by Subject|2|||
124760542|NCT00383786|448749031|FG000|Overall Study|Protocol Violation|2|||
124760543|NCT00383786|448749032|FG001|Overall Study|Protocol Violation|6|||
124760544|NCT00383786|448749031|FG000|Overall Study|Withdrawal by Subject|2|||
124760545|NCT00383786|448749032|FG001|Overall Study|Withdrawal by Subject|5|||
124760546|NCT00383786|448749031|FG000|Overall Study|Physician Decision|0|||
124760547|NCT00383786|448749032|FG001|Overall Study|Physician Decision|1|||
124760548|NCT01517750|448749035|FG000|Overall Study|Lost to Follow-up|1|||
124760549|NCT01517750|448749036|FG001|Overall Study|Lost to Follow-up|2|||
124760550|NCT01517750|448749037|FG002|Overall Study|Lost to Follow-up|4|||
124760551|NCT01517750|448749038|FG003|Overall Study|Lost to Follow-up|1|||
124760552|NCT02723773|448749039|FG000|Overall Study|Adverse Event|934|||
124760553|NCT02723773|448749040|FG001|Overall Study|Adverse Event|3|||
124760554|NCT02723773|448749041|FG002|Overall Study|Adverse Event|1|||
124760555|NCT02723773|448749042|FG003|Overall Study|Adverse Event|9|||
124760556|NCT02723773|448749039|FG000|Overall Study|Protocol Violation|1|||
124760557|NCT02723773|448749040|FG001|Overall Study|Protocol Violation|0|||
124760558|NCT02723773|448749041|FG002|Overall Study|Protocol Violation|0|||
124760559|NCT02723773|448749042|FG003|Overall Study|Protocol Violation|0|||
124760560|NCT02723773|448749039|FG000|Overall Study|Withdrawal by Subject|360|||
124760561|NCT02723773|448749040|FG001|Overall Study|Withdrawal by Subject|5|||
124760562|NCT02723773|448749041|FG002|Overall Study|Withdrawal by Subject|6|||
124760563|NCT02723773|448749042|FG003|Overall Study|Withdrawal by Subject|10|||
124760564|NCT02723773|448749039|FG000|Overall Study|Migrated/moved from study area|37|||
124760565|NCT02723773|448749040|FG001|Overall Study|Migrated/moved from study area|0|||
124760566|NCT02723773|448749041|FG002|Overall Study|Migrated/moved from study area|0|||
124760567|NCT02723773|448749042|FG003|Overall Study|Migrated/moved from study area|1|||
124760568|NCT02723773|448749039|FG000|Overall Study|Lost to Follow-up|198|||
124760569|NCT02723773|448749040|FG001|Overall Study|Lost to Follow-up|0|||
124760570|NCT02723773|448749041|FG002|Overall Study|Lost to Follow-up|0|||
124760571|NCT02723773|448749042|FG003|Overall Study|Lost to Follow-up|0|||
124760572|NCT02723773|448749039|FG000|Overall Study|Other|189|||
124760573|NCT02723773|448749040|FG001|Overall Study|Other|1|||
124760574|NCT02723773|448749041|FG002|Overall Study|Other|2|||
124760575|NCT02723773|448749042|FG003|Overall Study|Other|2|||
124910477|NCT01290341|449299793|FG001|Overall Study|Withdrawal by Subject|5|||
124910478|NCT01290341|449299792|FG000|Overall Study|Negative baseline culture and others|44|||
124910479|NCT01290341|449299793|FG001|Overall Study|Negative baseline culture and others|11|||
124910480|NCT03036813|449299798|FG000|Overall Study|Adverse Event|6|||
124910481|NCT03036813|449299799|FG001|Overall Study|Adverse Event|11|||
124910482|NCT03036813|449299800|FG002|Overall Study|Adverse Event|6|||
124910483|NCT03036813|449299798|FG000|Overall Study|Withdrawal by Subject|12|||
124910484|NCT03036813|449299799|FG001|Overall Study|Withdrawal by Subject|6|||
124910485|NCT03036813|449299800|FG002|Overall Study|Withdrawal by Subject|10|||
124910486|NCT03036813|449299798|FG000|Overall Study|Lost to Follow-up|1|||
124910487|NCT03036813|449299799|FG001|Overall Study|Lost to Follow-up|1|||
124910488|NCT03036813|449299800|FG002|Overall Study|Lost to Follow-up|0|||
124910489|NCT03036813|449299798|FG000|Overall Study|Physician Decision|2|||
124910490|NCT03036813|449299799|FG001|Overall Study|Physician Decision|1|||
124910491|NCT03036813|449299800|FG002|Overall Study|Physician Decision|1|||
124910492|NCT03036813|449299798|FG000|Overall Study|Non-Compliance|1|||
124910493|NCT03036813|449299799|FG001|Overall Study|Non-Compliance|5|||
124910494|NCT03036813|449299800|FG002|Overall Study|Non-Compliance|3|||
124910495|NCT03036813|449299798|FG000|Overall Study|Pregnancy|0|||
124910496|NCT03036813|449299799|FG001|Overall Study|Pregnancy|0|||
124450347|NCT00766090|447611961|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
124760576|NCT03629886|448749043|FG000|Overall Study|Migrated / moved from the study area|0|||
124760577|NCT03629886|448749044|FG001|Overall Study|Migrated / moved from the study area|55|||
124910497|NCT03036813|449299800|FG002|Overall Study|Pregnancy|1|||
124910498|NCT03036813|449299798|FG000|Overall Study|Other|0|||
124910499|NCT03036813|449299799|FG001|Overall Study|Other|3|||
124910500|NCT03036813|449299800|FG002|Overall Study|Other|5|||
124910501|NCT01102231|449299801|FG000|Overall Study|Protocol Violation|3|||
124760578|NCT03629886|448749043|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
124760579|NCT03629886|448749044|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
124760580|NCT03629886|448749043|FG000|Overall Study|Study vaccine not administrated|0|||
124760581|NCT03629886|448749044|FG001|Overall Study|Study vaccine not administrated|3|||
124760582|NCT03629886|448749043|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
124760583|NCT03629886|448749044|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
124760584|NCT03629886|448749043|FG000|Overall Study|Refused vaccination step of the study|0|||
124760585|NCT03629886|448749044|FG001|Overall Study|Refused vaccination step of the study|44|||
124760586|NCT00404651|448749045|FG000|Overall Study|Serious Adverse Event|0|||
124760587|NCT00404651|448749046|FG001|Overall Study|Serious Adverse Event|0|||
124760588|NCT00404651|448749047|FG002|Overall Study|Serious Adverse Event|2|||
124760589|NCT00404651|448749048|FG003|Overall Study|Serious Adverse Event|0|||
124760590|NCT00404651|448749045|FG000|Overall Study|Protocol Violation|10|||
124760591|NCT00404651|448749046|FG001|Overall Study|Protocol Violation|5|||
124760592|NCT00404651|448749047|FG002|Overall Study|Protocol Violation|14|||
124760593|NCT00404651|448749048|FG003|Overall Study|Protocol Violation|5|||
124910502|NCT01102231|449299801|FG000|Overall Study|Lack of Efficacy|2|||
124910503|NCT01102231|449299801|FG000|Overall Study|Death|2|||
124910504|NCT01102231|449299801|FG000|Overall Study|Adverse Event|3|||
124910505|NCT01102231|449299801|FG000|Overall Study|Withdrawal by Subject|1|||
124910506|NCT01102231|449299801|FG000|Overall Study|Did not received the treatment|4|||
124910507|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
124910508|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
124910509|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
124910510|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
124910511|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
124910512|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
124910513|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
124910514|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
124910515|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
124910516|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
124910517|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
124910518|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
124910519|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
124910520|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
124910521|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
124910522|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
124910523|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
124910524|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
124910525|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
124910526|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
124910527|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
124910528|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
124910529|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
124910530|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
124910531|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
124910532|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
124910533|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
124910534|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
124910535|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
124910536|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
124910537|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
124910538|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
124760594|NCT00404651|448749045|FG000|Overall Study|Lost to Follow-up|15|||
124760595|NCT00404651|448749046|FG001|Overall Study|Lost to Follow-up|11|||
124760596|NCT00404651|448749047|FG002|Overall Study|Lost to Follow-up|13|||
124760597|NCT00404651|448749048|FG003|Overall Study|Lost to Follow-up|10|||
124760598|NCT00404651|448749045|FG000|Overall Study|Withdrawal by Subject|14|||
124760599|NCT00404651|448749046|FG001|Overall Study|Withdrawal by Subject|12|||
124760600|NCT00404651|448749047|FG002|Overall Study|Withdrawal by Subject|16|||
124760601|NCT00404651|448749048|FG003|Overall Study|Withdrawal by Subject|6|||
124760602|NCT00346216|448749050|FG000|Overall Study|Other|181|||
124760603|NCT00346216|448749051|FG001|Overall Study|Other|231|||
124760604|NCT00346216|448749052|FG002|Overall Study|Other|205|||
124760605|NCT00346216|448749050|FG000|Overall Study|No longer willing to participate|600|||
124760606|NCT00346216|448749051|FG001|Overall Study|No longer willing to participate|606|||
124760607|NCT00346216|448749052|FG002|Overall Study|No longer willing to participate|585|||
124760608|NCT00346216|448749050|FG000|Overall Study|Withdrawal by Subject|661|||
124760609|NCT00346216|448749051|FG001|Overall Study|Withdrawal by Subject|692|||
124760610|NCT00346216|448749052|FG002|Overall Study|Withdrawal by Subject|651|||
124910539|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
124910540|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
124910541|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
124910542|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
124910543|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
124910544|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
124910545|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
124910546|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
124910547|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
124910548|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
124910549|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
124910550|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
124910551|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
124910552|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
124910553|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
124910554|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
124910555|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
124910556|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
124910557|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
124910558|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
124910559|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
124910560|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
124910561|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
124910562|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
124910563|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
124910564|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
124910565|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
124910566|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
124910567|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
124910568|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
124910569|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
124910570|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
124910571|NCT03903822|449299802|FG000|Treatment Phase (6 Weeks)|Other|2|||
124910572|NCT03903822|449299803|FG001|Treatment Phase (6 Weeks)|Other|1|||
124910573|NCT03903822|449299804|FG002|Treatment Phase (6 Weeks)|Other|0|||
124910574|NCT03903822|449299805|FG003|Treatment Phase (6 Weeks)|Other|0|||
124910575|NCT03903822|449299806|FG004|Treatment Phase (6 Weeks)|Other|1|||
124910576|NCT03903822|449299807|FG005|Treatment Phase (6 Weeks)|Other|1|||
124910577|NCT03903822|449299808|FG006|Treatment Phase (6 Weeks)|Other|0|||
124910578|NCT03903822|449299809|FG007|Treatment Phase (6 Weeks)|Other|0|||
124910579|NCT03903822|449299802|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
124910580|NCT03903822|449299803|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
124910581|NCT03903822|449299804|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
124910582|NCT03903822|449299805|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
124910583|NCT03903822|449299806|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
124910584|NCT03903822|449299807|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
124910585|NCT03903822|449299808|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
124910586|NCT03903822|449299809|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
124910587|NCT03903822|449299802|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
124910588|NCT03903822|449299803|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
124910589|NCT03903822|449299804|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
124910590|NCT03903822|449299805|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
124760611|NCT00346216|448749050|FG000|Overall Study|Lost to Follow-up|611|||
124760612|NCT00346216|448749051|FG001|Overall Study|Lost to Follow-up|588|||
124760613|NCT00346216|448749052|FG002|Overall Study|Lost to Follow-up|542|||
124760614|NCT00346216|448749050|FG000|Overall Study|Physician Decision|80|||
124760615|NCT00346216|448749051|FG001|Overall Study|Physician Decision|76|||
124760616|NCT00346216|448749052|FG002|Overall Study|Physician Decision|59|||
124760617|NCT00346216|448749050|FG000|Overall Study|Does not meet entrance criteria|13|||
124760618|NCT00346216|448749051|FG001|Overall Study|Does not meet entrance criteria|10|||
124760619|NCT00346216|448749052|FG002|Overall Study|Does not meet entrance criteria|8|||
124760620|NCT00346216|448749050|FG000|Overall Study|Death|189|||
124760621|NCT00346216|448749051|FG001|Overall Study|Death|192|||
124760622|NCT00346216|448749052|FG002|Overall Study|Death|228|||
124910591|NCT03903822|449299806|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
124910592|NCT03903822|449299807|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
124760623|NCT00346216|448749050|FG000|Overall Study|Study terminated by sponsor|11|||
124760624|NCT00346216|448749051|FG001|Overall Study|Study terminated by sponsor|4|||
124760625|NCT00346216|448749052|FG002|Overall Study|Study terminated by sponsor|8|||
124910593|NCT03903822|449299808|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
124910594|NCT03903822|449299809|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
124910595|NCT03903822|449299802|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
124760626|NCT00346216|448749050|FG000|Overall Study|Missing Subject Summary Status|62|||
124760627|NCT00346216|448749051|FG001|Overall Study|Missing Subject Summary Status|61|||
124760628|NCT00346216|448749052|FG002|Overall Study|Missing Subject Summary Status|62|||
124910596|NCT03903822|449299803|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
124910597|NCT03903822|449299804|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
124910598|NCT03903822|449299805|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
124910599|NCT03903822|449299806|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
124910600|NCT03903822|449299807|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
124910601|NCT03903822|449299808|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
124910602|NCT03903822|449299809|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
124910603|NCT03903822|449299802|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
124910604|NCT03903822|449299803|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
124910605|NCT03903822|449299804|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
124910606|NCT03903822|449299805|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
124910607|NCT03903822|449299806|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
124910608|NCT03903822|449299807|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
124910609|NCT03903822|449299808|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
124910610|NCT03903822|449299809|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
124910611|NCT03903822|449299802|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
124910612|NCT03903822|449299803|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
124910613|NCT03903822|449299804|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
124910614|NCT03903822|449299805|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
124910615|NCT03903822|449299806|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
124910616|NCT03903822|449299807|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
124910617|NCT03903822|449299808|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
124910618|NCT03903822|449299809|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
124910619|NCT03903822|449299802|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
124910620|NCT03903822|449299803|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
124910621|NCT03903822|449299804|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
124910622|NCT03903822|449299805|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
124910623|NCT03903822|449299806|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
124910624|NCT03903822|449299807|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
124910625|NCT03903822|449299808|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
124910626|NCT03903822|449299809|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
124910627|NCT03903822|449299802|FG000|Follow up Phase (4 Weeks)|Other|1|||
124910628|NCT03903822|449299803|FG001|Follow up Phase (4 Weeks)|Other|1|||
124910629|NCT03903822|449299804|FG002|Follow up Phase (4 Weeks)|Other|0|||
124450348|NCT00766090|447611962|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
124450349|NCT00766090|447611963|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
124450350|NCT00766090|447611964|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
124450351|NCT00766090|447611965|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
124450352|NCT00766090|447611954|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
124450353|NCT00766090|447611955|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124450354|NCT00766090|447611956|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124450355|NCT00766090|447611957|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
124692381|NCT02945046|448494747|FG001|Overall Study|Withdrawal by Subject|3|||
124692382|NCT02945046|448494748|FG002|Overall Study|Withdrawal by Subject|3|||
124692383|NCT02945046|448494746|FG000|Overall Study|Protocol Violation|2|||
124692384|NCT02945046|448494747|FG001|Overall Study|Protocol Violation|3|||
124692385|NCT02945046|448494748|FG002|Overall Study|Protocol Violation|2|||
124692386|NCT02945046|448494746|FG000|Overall Study|Lost to Follow-up|1|||
124692387|NCT02945046|448494747|FG001|Overall Study|Lost to Follow-up|1|||
124692388|NCT02945046|448494748|FG002|Overall Study|Lost to Follow-up|0|||
124692389|NCT02945046|448494746|FG000|Overall Study|Lack of Efficacy|1|||
124692390|NCT02945046|448494747|FG001|Overall Study|Lack of Efficacy|2|||
124910630|NCT03903822|449299805|FG003|Follow up Phase (4 Weeks)|Other|0|||
124910631|NCT03903822|449299806|FG004|Follow up Phase (4 Weeks)|Other|0|||
124910632|NCT03903822|449299807|FG005|Follow up Phase (4 Weeks)|Other|0|||
124910633|NCT03903822|449299808|FG006|Follow up Phase (4 Weeks)|Other|0|||
124910634|NCT03903822|449299809|FG007|Follow up Phase (4 Weeks)|Other|0|||
124910635|NCT00785512|449299810|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
124450356|NCT00766090|447611958|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124450357|NCT00766090|447611959|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124450358|NCT00766090|447611960|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124450359|NCT00766090|447611961|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124450360|NCT00766090|447611962|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124450361|NCT00766090|447611963|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124450362|NCT00766090|447611964|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124450363|NCT00766090|447611965|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124450364|NCT00766090|447611954|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
124450365|NCT00766090|447611955|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
124450366|NCT00766090|447611956|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
124450367|NCT00766090|447611957|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
124692391|NCT02945046|448494748|FG002|Overall Study|Lack of Efficacy|1|||
124910636|NCT00785512|449299811|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
124910637|NCT00785512|449299810|FG000|Overall Study|Adverse Event|0|||
124910638|NCT00785512|449299811|FG001|Overall Study|Adverse Event|0|||
124910639|NCT00785512|449299810|FG000|Overall Study|Lack of Efficacy|0|||
124910640|NCT00785512|449299811|FG001|Overall Study|Lack of Efficacy|2|||
124910641|NCT00785512|449299810|FG000|Overall Study|Withdrawal by Subject|0|||
124910642|NCT00785512|449299811|FG001|Overall Study|Withdrawal by Subject|1|||
124910643|NCT00785512|449299810|FG000|Overall Study|Lost to Follow-up|3|||
124910644|NCT00785512|449299811|FG001|Overall Study|Lost to Follow-up|0|||
124910645|NCT00785512|449299810|FG000|Overall Study|Precedure Refused|0|||
124910646|NCT00785512|449299811|FG001|Overall Study|Precedure Refused|0|||
124910647|NCT00785512|449299810|FG000|Overall Study|IVRS Programing Error|0|||
124910648|NCT00785512|449299811|FG001|Overall Study|IVRS Programing Error|0|||
124910649|NCT00785512|449299810|FG000|Overall Study|Physician Decision|0|||
124910650|NCT00785512|449299811|FG001|Overall Study|Physician Decision|0|||
124910651|NCT00785512|449299810|FG000|Overall Study|Lack of compliance|0|||
124910652|NCT00785512|449299811|FG001|Overall Study|Lack of compliance|1|||
124910653|NCT00529100|449299815|FG000|Overall Study|Adverse Event|0|||
124910654|NCT00529100|449299816|FG001|Overall Study|Adverse Event|5|||
124910655|NCT00529100|449299815|FG000|Overall Study|Protocol Violation|0|||
124910656|NCT00529100|449299816|FG001|Overall Study|Protocol Violation|1|||
124910657|NCT00529100|449299815|FG000|Overall Study|Progressive Disease|0|||
124910658|NCT00529100|449299816|FG001|Overall Study|Progressive Disease|1|||
124910659|NCT00529100|449299815|FG000|Overall Study|Withdrawal by Subject|0|||
124910660|NCT00529100|449299816|FG001|Overall Study|Withdrawal by Subject|1|||
124544898|NCT03426995|447949277|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124544899|NCT03426995|447949278|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124692392|NCT02945046|448494746|FG000|Overall Study|Other than specified|5|||
124692393|NCT02945046|448494747|FG001|Overall Study|Other than specified|4|||
124692394|NCT02945046|448494748|FG002|Overall Study|Other than specified|7|||
124692395|NCT03113136|448494749|FG000|Overall Study|Lost to Follow-up|22|||
124692396|NCT03113136|448494750|FG001|Overall Study|Lost to Follow-up|47|||
124692397|NCT03113136|448494751|FG002|Overall Study|Lost to Follow-up|54|||
124692398|NCT03113136|448494749|FG000|Overall Study|Withdrawal by Subject|4|||
124692399|NCT03113136|448494750|FG001|Overall Study|Withdrawal by Subject|13|||
124692400|NCT03113136|448494751|FG002|Overall Study|Withdrawal by Subject|14|||
124692401|NCT03113136|448494749|FG000|Overall Study|Ineligible|0|||
124692402|NCT03113136|448494750|FG001|Overall Study|Ineligible|2|||
124692403|NCT03113136|448494751|FG002|Overall Study|Ineligible|1|||
124692404|NCT03113136|448494749|FG000|Overall Study|Study Team Decision|1|||
124692405|NCT03113136|448494750|FG001|Overall Study|Study Team Decision|4|||
124692406|NCT03113136|448494751|FG002|Overall Study|Study Team Decision|0|||
124692407|NCT02675452|448494752|FG000|Overall Study|Sponsor decision|0|||
124692408|NCT02675452|448494753|FG001|Overall Study|Sponsor decision|0|||
124692409|NCT02675452|448494754|FG002|Overall Study|Sponsor decision|0|||
124692410|NCT02675452|448494755|FG003|Overall Study|Sponsor decision|0|||
124692411|NCT02675452|448494756|FG004|Overall Study|Sponsor decision|0|||
124692412|NCT02675452|448494757|FG005|Overall Study|Sponsor decision|0|||
124692413|NCT02675452|448494758|FG006|Overall Study|Sponsor decision|0|||
124692414|NCT02675452|448494759|FG007|Overall Study|Sponsor decision|0|||
124692415|NCT02675452|448494760|FG008|Overall Study|Sponsor decision|0|||
124692416|NCT02675452|448494761|FG009|Overall Study|Sponsor decision|1|||
124692417|NCT02675452|448494762|FG010|Overall Study|Sponsor decision|0|||
124692418|NCT02675452|448494763|FG011|Overall Study|Sponsor decision|0|||
124692419|NCT02675452|448494764|FG012|Overall Study|Sponsor decision|0|||
124692420|NCT02675452|448494765|FG013|Overall Study|Sponsor decision|2|||
124692421|NCT02675452|448494766|FG014|Overall Study|Sponsor decision|1|||
124692422|NCT02675452|448494767|FG015|Overall Study|Sponsor decision|0|||
124692423|NCT02675452|448494768|FG016|Overall Study|Sponsor decision|1|||
124692424|NCT02675452|448494769|FG017|Overall Study|Sponsor decision|0|||
124692425|NCT02675452|448494770|FG018|Overall Study|Sponsor decision|0|||
124692426|NCT02675452|448494771|FG019|Overall Study|Sponsor decision|0|||
124692427|NCT02675452|448494772|FG020|Overall Study|Sponsor decision|0|||
124692428|NCT02675452|448494773|FG021|Overall Study|Sponsor decision|0|||
124692429|NCT02675452|448494774|FG022|Overall Study|Sponsor decision|0|||
124692430|NCT02675452|448494775|FG023|Overall Study|Sponsor decision|0|||
124760629|NCT01220167|448749058|FG000|Period 3|Urine positive for substance abuse|0|||
124910661|NCT00529100|449299815|FG000|Overall Study|Participant Ineligibility|0|||
124910662|NCT00529100|449299816|FG001|Overall Study|Participant Ineligibility|1|||
124910663|NCT03733119|449299817|FG000|Overall Study|Physician Decision|2|||
124910664|NCT03733119|449299818|FG001|Overall Study|Physician Decision|1|||
124910665|NCT03733119|449299817|FG000|Overall Study|ineligible to treat per protocol|0|||
124910666|NCT03733119|449299818|FG001|Overall Study|ineligible to treat per protocol|1|||
124910667|NCT00807937|449299825|FG000|Overall Study|Adverse Event|12|||
124910668|NCT00807937|449299826|FG001|Overall Study|Adverse Event|12|||
124692431|NCT02675452|448494776|FG024|Overall Study|Sponsor decision|0|||
124692432|NCT02675452|448494777|FG025|Overall Study|Sponsor decision|0|||
124692433|NCT02675452|448494778|FG026|Overall Study|Sponsor decision|2|||
124692434|NCT02675452|448494779|FG027|Overall Study|Sponsor decision|0|||
124910669|NCT00807937|449299827|FG002|Overall Study|Adverse Event|5|||
124910670|NCT00807937|449299828|FG003|Overall Study|Adverse Event|4|||
124910671|NCT00807937|449299825|FG000|Overall Study|Protocol Violation|4|||
124910672|NCT00807937|449299826|FG001|Overall Study|Protocol Violation|5|||
124910673|NCT00807937|449299827|FG002|Overall Study|Protocol Violation|3|||
124910674|NCT00807937|449299828|FG003|Overall Study|Protocol Violation|3|||
124910675|NCT00807937|449299825|FG000|Overall Study|Withdrawal by Subject|5|||
124910676|NCT00807937|449299826|FG001|Overall Study|Withdrawal by Subject|4|||
124910677|NCT00807937|449299827|FG002|Overall Study|Withdrawal by Subject|1|||
124910678|NCT00807937|449299828|FG003|Overall Study|Withdrawal by Subject|4|||
124910679|NCT00807937|449299825|FG000|Overall Study|Lost to Follow-up|4|||
124910680|NCT00807937|449299826|FG001|Overall Study|Lost to Follow-up|0|||
124910681|NCT00807937|449299827|FG002|Overall Study|Lost to Follow-up|2|||
124910682|NCT00807937|449299828|FG003|Overall Study|Lost to Follow-up|1|||
124910683|NCT00807937|449299825|FG000|Overall Study|Lack of Efficacy|0|||
124910684|NCT00807937|449299826|FG001|Overall Study|Lack of Efficacy|0|||
124910685|NCT00807937|449299827|FG002|Overall Study|Lack of Efficacy|1|||
124910686|NCT00807937|449299828|FG003|Overall Study|Lack of Efficacy|2|||
124910687|NCT00807937|449299825|FG000|Overall Study|Intake of prohibited medicine|0|||
124910688|NCT00807937|449299826|FG001|Overall Study|Intake of prohibited medicine|0|||
124910689|NCT00807937|449299827|FG002|Overall Study|Intake of prohibited medicine|2|||
124910690|NCT00807937|449299828|FG003|Overall Study|Intake of prohibited medicine|0|||
124910691|NCT00807937|449299825|FG000|Overall Study|All other reasons (not provided)|2|||
124692435|NCT02675452|448494780|FG028|Overall Study|Sponsor decision|0|||
124910692|NCT00807937|449299826|FG001|Overall Study|All other reasons (not provided)|4|||
124910693|NCT00807937|449299827|FG002|Overall Study|All other reasons (not provided)|0|||
124910694|NCT00807937|449299828|FG003|Overall Study|All other reasons (not provided)|1|||
124910695|NCT02708108|449299831|FG000|Overall Study|Death|1|||
124910696|NCT02708108|449299832|FG001|Overall Study|Death|2|||
124910697|NCT02708108|449299831|FG000|Overall Study|Regimen change|1|||
124450368|NCT00766090|447611958|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
124450369|NCT00766090|447611959|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
124450370|NCT00766090|447611960|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
124450371|NCT00766090|447611961|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
124450372|NCT00766090|447611962|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
124450373|NCT00766090|447611963|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
124692436|NCT02675452|448494752|FG000|Overall Study|Withdrawal by Subject|0|||
124692437|NCT02675452|448494753|FG001|Overall Study|Withdrawal by Subject|0|||
124692438|NCT02675452|448494754|FG002|Overall Study|Withdrawal by Subject|0|||
124692439|NCT02675452|448494755|FG003|Overall Study|Withdrawal by Subject|0|||
124910698|NCT02708108|449299832|FG001|Overall Study|Regimen change|0|||
124910699|NCT02708108|449299831|FG000|Overall Study|No MRD and no imaging available|0|||
124910700|NCT02708108|449299832|FG001|Overall Study|No MRD and no imaging available|1|||
124910701|NCT00510887|449299833|FG000|Overall Study|Lost to Follow-up|1|||
124910702|NCT03485950|449299845|FG000|Overall Study|Adverse Event|1|||
124910703|NCT03485950|449299846|FG001|Overall Study|Adverse Event|0|||
124910704|NCT03485950|449299845|FG000|Overall Study|Death|3|||
124910705|NCT03485950|449299846|FG001|Overall Study|Death|2|||
124910706|NCT03485950|449299845|FG000|Overall Study|Withdrawal by Subject|3|||
124910707|NCT03485950|449299846|FG001|Overall Study|Withdrawal by Subject|0|||
124910708|NCT00988858|449299848|FG000|Overall Study|Adverse Event|7|||
124692440|NCT02675452|448494756|FG004|Overall Study|Withdrawal by Subject|0|||
124692441|NCT02675452|448494757|FG005|Overall Study|Withdrawal by Subject|0|||
124692442|NCT02675452|448494758|FG006|Overall Study|Withdrawal by Subject|0|||
124692443|NCT02675452|448494759|FG007|Overall Study|Withdrawal by Subject|0|||
124692444|NCT02675452|448494760|FG008|Overall Study|Withdrawal by Subject|0|||
124692445|NCT02675452|448494761|FG009|Overall Study|Withdrawal by Subject|1|||
124692446|NCT02675452|448494762|FG010|Overall Study|Withdrawal by Subject|0|||
124692447|NCT02675452|448494763|FG011|Overall Study|Withdrawal by Subject|1|||
124692448|NCT02675452|448494764|FG012|Overall Study|Withdrawal by Subject|0|||
124692449|NCT02675452|448494765|FG013|Overall Study|Withdrawal by Subject|1|||
124692450|NCT02675452|448494766|FG014|Overall Study|Withdrawal by Subject|1|||
124692451|NCT02675452|448494767|FG015|Overall Study|Withdrawal by Subject|0|||
124692452|NCT02675452|448494768|FG016|Overall Study|Withdrawal by Subject|2|||
124692453|NCT02675452|448494769|FG017|Overall Study|Withdrawal by Subject|0|||
124692454|NCT02675452|448494770|FG018|Overall Study|Withdrawal by Subject|0|||
124692455|NCT02675452|448494771|FG019|Overall Study|Withdrawal by Subject|0|||
124692456|NCT02675452|448494772|FG020|Overall Study|Withdrawal by Subject|0|||
124692457|NCT02675452|448494773|FG021|Overall Study|Withdrawal by Subject|0|||
124692458|NCT02675452|448494774|FG022|Overall Study|Withdrawal by Subject|3|||
124692459|NCT02675452|448494775|FG023|Overall Study|Withdrawal by Subject|0|||
124692460|NCT02675452|448494776|FG024|Overall Study|Withdrawal by Subject|1|||
124466465|NCT02574637|447666425|FG009|Double-blind Period|Adverse Event|0|||
124692461|NCT02675452|448494777|FG025|Overall Study|Withdrawal by Subject|0|||
124692462|NCT02675452|448494778|FG026|Overall Study|Withdrawal by Subject|1|||
124760630|NCT01220167|448749059|FG001|Period 3|Urine positive for substance abuse|1|||
124544900|NCT03426995|447949279|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
124544901|NCT03426995|447949261|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544902|NCT03426995|447949262|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544903|NCT03426995|447949263|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544904|NCT03426995|447949264|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544905|NCT03426995|447949265|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544906|NCT03426995|447949266|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
124544907|NCT03426995|447949267|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544908|NCT03426995|447949268|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544909|NCT03426995|447949269|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544910|NCT03426995|447949270|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544911|NCT03426995|447949271|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544912|NCT03426995|447949272|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544913|NCT03426995|447949273|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544914|NCT03426995|447949274|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544915|NCT03426995|447949275|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544916|NCT03426995|447949276|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544917|NCT03426995|447949277|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544918|NCT03426995|447949278|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544919|NCT03426995|447949279|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
124544920|NCT03426995|447949261|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124544921|NCT03426995|447949262|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124544922|NCT03426995|447949263|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124544923|NCT03426995|447949264|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124544924|NCT03426995|447949265|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
124544925|NCT03426995|447949266|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
124544926|NCT03426995|447949267|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124544927|NCT03426995|447949268|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124544928|NCT03426995|447949269|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124544929|NCT03426995|447949270|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124544930|NCT03426995|447949271|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124544931|NCT03426995|447949272|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124544932|NCT03426995|447949273|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124544933|NCT03426995|447949274|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124544934|NCT03426995|447949275|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124544935|NCT03426995|447949276|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124544936|NCT03426995|447949277|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124544937|NCT03426995|447949278|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124544938|NCT03426995|447949279|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
124544939|NCT03426995|447949261|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124544940|NCT03426995|447949262|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124544941|NCT03426995|447949263|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124544942|NCT03426995|447949264|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124544943|NCT03426995|447949265|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124544944|NCT03426995|447949266|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124544945|NCT03426995|447949267|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124544946|NCT03426995|447949268|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124544947|NCT03426995|447949269|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124544948|NCT03426995|447949270|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124544949|NCT03426995|447949271|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
124544950|NCT03426995|447949272|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124544951|NCT03426995|447949273|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124544952|NCT03426995|447949274|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124544953|NCT03426995|447949275|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124544954|NCT03426995|447949276|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124544955|NCT03426995|447949277|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124544956|NCT03426995|447949278|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124910709|NCT00988858|449299848|FG000|Overall Study|Death|1|||
124910710|NCT00988858|449299848|FG000|Overall Study|Physician Decision|1|||
124910711|NCT00988858|449299848|FG000|Overall Study|Sponsor Decision|1|||
124910712|NCT03764475|449299849|FG000|Overall Study|Adverse Event|11|||
124544957|NCT03426995|447949279|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
124692463|NCT02675452|448494779|FG027|Overall Study|Withdrawal by Subject|3|||
124692464|NCT02675452|448494780|FG028|Overall Study|Withdrawal by Subject|4|||
124910713|NCT03764475|449299850|FG001|Overall Study|Adverse Event|2|||
124910714|NCT03764475|449299849|FG000|Overall Study|Lost to Follow-up|24|||
124910715|NCT03764475|449299850|FG001|Overall Study|Lost to Follow-up|10|||
124910716|NCT03764475|449299849|FG000|Overall Study|Withdrawal by Subject|26|||
124910717|NCT03764475|449299850|FG001|Overall Study|Withdrawal by Subject|10|||
124910718|NCT03764475|449299849|FG000|Overall Study|Lack of Efficacy|3|||
124910719|NCT03764475|449299850|FG001|Overall Study|Lack of Efficacy|0|||
124910720|NCT03764475|449299849|FG000|Overall Study|COVID-19 Disruption|2|||
124910721|NCT03764475|449299850|FG001|Overall Study|COVID-19 Disruption|0|||
124910722|NCT05510245|449299854|FG000|Overall Study|Withdrawal by Subject|1|||
124910723|NCT05510245|449299855|FG001|Overall Study|Withdrawal by Subject|0|||
124910724|NCT05510245|449299856|FG002|Overall Study|Withdrawal by Subject|0|||
124910725|NCT00390299|449299857|FG000|Overall Study|Cancellation|1|||
124910726|NCT00390299|449299858|FG001|Overall Study|Cancellation|0|||
124910727|NCT00390299|449299859|FG002|Overall Study|Cancellation|0|||
124910728|NCT00390299|449299860|FG003|Overall Study|Cancellation|0|||
124910729|NCT00390299|449299861|FG004|Overall Study|Cancellation|0|||
124910730|NCT00970359|449299865|FG000|Overall Study|Not Treated|4|||
124910731|NCT00068601|449299866|FG000|Overall Study|Ineligible|11|||
124910732|NCT00068601|449299867|FG001|Overall Study|Ineligible|13|||
124910733|NCT00068601|449299866|FG000|Overall Study|Not evaluable: withdrew consent|5|||
124910734|NCT00068601|449299867|FG001|Overall Study|Not evaluable: withdrew consent|4|||
124910735|NCT00068601|449299866|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
124910736|NCT00068601|449299867|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
124910737|NCT00068601|449299866|FG000|Overall Study|Death|11|||
124910738|NCT00068601|449299867|FG001|Overall Study|Death|3|||
124910739|NCT00068601|449299866|FG000|Overall Study|Lost to Follow-up|3|||
124910740|NCT00068601|449299867|FG001|Overall Study|Lost to Follow-up|2|||
124910741|NCT00068601|449299866|FG000|Overall Study|Missing primary outcome data|30|||
124910742|NCT00068601|449299867|FG001|Overall Study|Missing primary outcome data|34|||
124910743|NCT01061671|449299868|FG000|Overall Study|Withdrawal by Subject|16|||
124910744|NCT01061671|449299869|FG001|Overall Study|Withdrawal by Subject|20|||
124910745|NCT01061671|449299868|FG000|Overall Study|Lost to Follow-up|3|||
124910746|NCT01061671|449299869|FG001|Overall Study|Lost to Follow-up|5|||
124910747|NCT01061671|449299868|FG000|Overall Study|Death|28|||
124910748|NCT01061671|449299869|FG001|Overall Study|Death|30|||
124910749|NCT05368831|449299870|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
124910750|NCT00223795|449299875|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
124910751|NCT00223795|449299876|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
124910752|NCT00223795|449299875|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
124910753|NCT00223795|449299876|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
124910754|NCT04732338|449299882|FG000|Overall Study|Lost to Follow-up|3|||
124910755|NCT04732338|449299883|FG001|Overall Study|Lost to Follow-up|3|||
124910756|NCT01803555|449299887|FG000|Overall Study|Adverse Event|3|||
124910757|NCT01803555|449299888|FG001|Overall Study|Adverse Event|2|||
124910758|NCT01803555|449299887|FG000|Overall Study|Withdrawal by Subject|3|||
124910759|NCT01803555|449299888|FG001|Overall Study|Withdrawal by Subject|3|||
124910760|NCT01803555|449299887|FG000|Overall Study|Non-compliance|1|||
124910761|NCT01803555|449299888|FG001|Overall Study|Non-compliance|1|||
124910762|NCT01803555|449299887|FG000|Overall Study|Protocol Violation|3|||
124910763|NCT01803555|449299888|FG001|Overall Study|Protocol Violation|5|||
124910764|NCT01803555|449299887|FG000|Overall Study|Lost to Follow-up|0|||
124910765|NCT01803555|449299888|FG001|Overall Study|Lost to Follow-up|2|||
124910766|NCT01803555|449299887|FG000|Overall Study|Other than specified|3|||
124910767|NCT01803555|449299888|FG001|Overall Study|Other than specified|5|||
124760631|NCT01220167|448749060|FG002|Period 3|Urine positive for substance abuse|0|||
124760632|NCT00619515|448749064|FG000|Overall Study|Study Termination by IRB|73|||
124910768|NCT05938413|449301500|FG000|Overall Study|Lost to Follow-up|1|||
124910769|NCT05938413|449301501|FG001|Overall Study|Lost to Follow-up|7|||
124910770|NCT05938413|449301500|FG000|Overall Study|Withdrawal by Subject|1|||
124910771|NCT05938413|449301501|FG001|Overall Study|Withdrawal by Subject|1|||
124910772|NCT04817670|449301506|FG000|Overall Study|Withdrawal by Subject|1|||
124910773|NCT04817670|449301507|FG001|Overall Study|Withdrawal by Subject|0|||
124910774|NCT04817670|449301508|FG002|Overall Study|Withdrawal by Subject|0|||
124910775|NCT04817670|449301509|FG003|Overall Study|Withdrawal by Subject|0|||
124910776|NCT04817670|449301510|FG004|Overall Study|Withdrawal by Subject|0|||
124760633|NCT02420093|448749068|FG000|Overall Study|Withdrawal by Subject|1|||
124760634|NCT02420093|448749069|FG001|Overall Study|Withdrawal by Subject|1|||
124910777|NCT04817670|449301506|FG000|Overall Study|Lost to Follow-up|0|||
124910778|NCT04817670|449301507|FG001|Overall Study|Lost to Follow-up|0|||
124910779|NCT04817670|449301508|FG002|Overall Study|Lost to Follow-up|1|||
124910780|NCT04817670|449301509|FG003|Overall Study|Lost to Follow-up|0|||
124910781|NCT04817670|449301510|FG004|Overall Study|Lost to Follow-up|0|||
124910782|NCT03312907|449301511|FG000|Overall Study|Adverse Event|1|||
124910783|NCT03312907|449301512|FG001|Overall Study|Adverse Event|6|||
124910784|NCT03312907|449301513|FG002|Overall Study|Adverse Event|1|||
124910785|NCT03312907|449301511|FG000|Overall Study|Protocol Violation|2|||
124910786|NCT03312907|449301512|FG001|Overall Study|Protocol Violation|3|||
124910787|NCT03312907|449301513|FG002|Overall Study|Protocol Violation|4|||
124910788|NCT03312907|449301511|FG000|Overall Study|Lost to Follow-up|2|||
124760635|NCT04862065|448749070|FG000|Screening|Protocol Violation|54|||
124910789|NCT03312907|449301512|FG001|Overall Study|Lost to Follow-up|3|||
124910790|NCT03312907|449301513|FG002|Overall Study|Lost to Follow-up|2|||
124910791|NCT03312907|449301511|FG000|Overall Study|Physician Decision|3|||
124910792|NCT03312907|449301512|FG001|Overall Study|Physician Decision|4|||
124910793|NCT03312907|449301513|FG002|Overall Study|Physician Decision|2|||
124910794|NCT03312907|449301511|FG000|Overall Study|Withdrawal by Subject|9|||
124910795|NCT03312907|449301512|FG001|Overall Study|Withdrawal by Subject|14|||
124910796|NCT03312907|449301513|FG002|Overall Study|Withdrawal by Subject|10|||
124910797|NCT02980276|449301517|FG000|Overall Study|Withdrawal by Subject|4|||
124910798|NCT02980276|449301518|FG001|Overall Study|Withdrawal by Subject|4|||
124910799|NCT02980276|449301517|FG000|Overall Study|Physician Decision|0|||
124910800|NCT02980276|449301518|FG001|Overall Study|Physician Decision|1|||
124910801|NCT02980276|449301517|FG000|Overall Study|Lost to Follow-up|18|||
124910802|NCT02980276|449301518|FG001|Overall Study|Lost to Follow-up|18|||
124910803|NCT02980276|449301517|FG000|Overall Study|Death|1|||
124910804|NCT02980276|449301518|FG001|Overall Study|Death|0|||
124910805|NCT02980276|449301517|FG000|Overall Study|Miscellaneous other|10|||
124910806|NCT02980276|449301518|FG001|Overall Study|Miscellaneous other|4|||
124910807|NCT01780298|449301520|FG000|Overall Study|Physician Decision|1|||
124910808|NCT01780298|449301521|FG001|Overall Study|Physician Decision|5|||
124910809|NCT01780298|449301522|FG002|Overall Study|Physician Decision|1|||
124910810|NCT01780298|449301523|FG003|Overall Study|Physician Decision|1|||
124910811|NCT01780298|449301520|FG000|Overall Study|Subject not matched|1|||
124910812|NCT01780298|449301521|FG001|Overall Study|Subject not matched|0|||
124910813|NCT01780298|449301522|FG002|Overall Study|Subject not matched|1|||
124910814|NCT01780298|449301523|FG003|Overall Study|Subject not matched|0|||
124910815|NCT01780298|449301520|FG000|Overall Study|Adverse Event|0|||
124910816|NCT01780298|449301521|FG001|Overall Study|Adverse Event|0|||
124910817|NCT01780298|449301522|FG002|Overall Study|Adverse Event|2|||
124910818|NCT01780298|449301523|FG003|Overall Study|Adverse Event|0|||
124910819|NCT04139668|449301524|FG000|Overall Study|Withdrawal by Subject|1|||
124910820|NCT03025789|449301529|FG000|Overall Study|Lack of Efficacy|6|||
124910821|NCT03025789|449301530|FG001|Overall Study|Lack of Efficacy|1|||
124910822|NCT03025789|449301529|FG000|Overall Study|Death|1|||
124910823|NCT03025789|449301530|FG001|Overall Study|Death|0|||
124910824|NCT03025789|449301529|FG000|Overall Study|Withdrawal by Subject|0|||
124910825|NCT03025789|449301530|FG001|Overall Study|Withdrawal by Subject|2|||
124910826|NCT04907474|449301532|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
124910827|NCT04907474|449301533|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
124910828|NCT02411084|449301535|FG000|Overall Study|Lack of Efficacy|6|||
124910829|NCT02411084|449301536|FG001|Overall Study|Lack of Efficacy|3|||
124910830|NCT02411084|449301535|FG000|Overall Study|Death|5|||
124910831|NCT02411084|449301536|FG001|Overall Study|Death|4|||
124910832|NCT02411084|449301535|FG000|Overall Study|Adverse Event|2|||
124910833|NCT02411084|449301536|FG001|Overall Study|Adverse Event|1|||
124910834|NCT02411084|449301535|FG000|Overall Study|Other reasons|0|||
124910835|NCT02411084|449301536|FG001|Overall Study|Other reasons|5|||
124910836|NCT04259450|449301537|FG000|Overall Study|Adverse event/ Toxicity|0|||
124910837|NCT04259450|449301538|FG001|Overall Study|Adverse event/ Toxicity|3|||
124910838|NCT04259450|449301539|FG002|Overall Study|Adverse event/ Toxicity|0|||
124910839|NCT04259450|449301540|FG003|Overall Study|Adverse event/ Toxicity|1|||
124910840|NCT04259450|449301541|FG004|Overall Study|Adverse event/ Toxicity|0|||
124910841|NCT04259450|449301542|FG005|Overall Study|Adverse event/ Toxicity|0|||
124910842|NCT04259450|449301543|FG006|Overall Study|Adverse event/ Toxicity|0|||
124910843|NCT04259450|449301544|FG007|Overall Study|Adverse event/ Toxicity|1|||
124910844|NCT04259450|449301545|FG008|Overall Study|Adverse event/ Toxicity|0|||
124910845|NCT04259450|449301546|FG009|Overall Study|Adverse event/ Toxicity|3|||
124910846|NCT04259450|449301537|FG000|Overall Study|Disease progression|2|||
124910847|NCT04259450|449301538|FG001|Overall Study|Disease progression|3|||
124910848|NCT04259450|449301539|FG002|Overall Study|Disease progression|4|||
124910849|NCT04259450|449301540|FG003|Overall Study|Disease progression|4|||
124910850|NCT04259450|449301541|FG004|Overall Study|Disease progression|6|||
124910851|NCT04259450|449301542|FG005|Overall Study|Disease progression|6|||
124910852|NCT04259450|449301543|FG006|Overall Study|Disease progression|6|||
124910853|NCT04259450|449301544|FG007|Overall Study|Disease progression|15|||
124910854|NCT04259450|449301545|FG008|Overall Study|Disease progression|6|||
124910855|NCT04259450|449301546|FG009|Overall Study|Disease progression|18|||
124910856|NCT04259450|449301537|FG000|Overall Study|Death|0|||
124910857|NCT04259450|449301538|FG001|Overall Study|Death|0|||
124910858|NCT04259450|449301539|FG002|Overall Study|Death|0|||
124910859|NCT04259450|449301540|FG003|Overall Study|Death|0|||
124910860|NCT04259450|449301541|FG004|Overall Study|Death|0|||
124910861|NCT04259450|449301542|FG005|Overall Study|Death|0|||
124910862|NCT04259450|449301543|FG006|Overall Study|Death|0|||
124910863|NCT04259450|449301544|FG007|Overall Study|Death|1|||
124910864|NCT04259450|449301545|FG008|Overall Study|Death|1|||
124910865|NCT04259450|449301546|FG009|Overall Study|Death|0|||
124910866|NCT04259450|449301537|FG000|Overall Study|Withdrawal by Subject|0|||
124910867|NCT04259450|449301538|FG001|Overall Study|Withdrawal by Subject|0|||
124910868|NCT04259450|449301539|FG002|Overall Study|Withdrawal by Subject|0|||
124544958|NCT03426995|447949261|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124544959|NCT03426995|447949262|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124544960|NCT03426995|447949263|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124544961|NCT03426995|447949264|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124910869|NCT04259450|449301540|FG003|Overall Study|Withdrawal by Subject|0|||
124544962|NCT03426995|447949265|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124910870|NCT04259450|449301541|FG004|Overall Study|Withdrawal by Subject|0|||
124910871|NCT04259450|449301542|FG005|Overall Study|Withdrawal by Subject|0|||
124910872|NCT04259450|449301543|FG006|Overall Study|Withdrawal by Subject|0|||
124910873|NCT04259450|449301544|FG007|Overall Study|Withdrawal by Subject|1|||
124910874|NCT04259450|449301545|FG008|Overall Study|Withdrawal by Subject|0|||
124910875|NCT04259450|449301546|FG009|Overall Study|Withdrawal by Subject|0|||
124910876|NCT04259450|449301537|FG000|Overall Study|Other than listed|0|||
124910877|NCT04259450|449301538|FG001|Overall Study|Other than listed|0|||
124910878|NCT04259450|449301539|FG002|Overall Study|Other than listed|0|||
124910879|NCT04259450|449301540|FG003|Overall Study|Other than listed|0|||
124544963|NCT03426995|447949266|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124544964|NCT03426995|447949267|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124544965|NCT03426995|447949268|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
124544966|NCT03426995|447949269|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124544967|NCT03426995|447949270|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124544968|NCT03426995|447949271|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124544969|NCT03426995|447949272|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124544970|NCT03426995|447949273|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124544971|NCT03426995|447949274|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124544972|NCT03426995|447949275|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124544973|NCT03426995|447949276|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124544974|NCT03426995|447949277|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124544975|NCT03426995|447949278|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124544976|NCT03426995|447949279|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
124544977|NCT03426995|447949261|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
124544978|NCT03426995|447949262|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
124544979|NCT03426995|447949263|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
124544980|NCT03426995|447949264|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
124544981|NCT03426995|447949265|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
124544982|NCT03426995|447949266|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
124544983|NCT03426995|447949267|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
124544984|NCT03426995|447949268|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
124544985|NCT03426995|447949269|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
124692465|NCT02675452|448494752|FG000|Overall Study|Death|0|||
124910880|NCT04259450|449301541|FG004|Overall Study|Other than listed|0|||
124910881|NCT04259450|449301542|FG005|Overall Study|Other than listed|0|||
124910882|NCT04259450|449301543|FG006|Overall Study|Other than listed|0|||
124910883|NCT04259450|449301544|FG007|Overall Study|Other than listed|1|||
124910884|NCT04259450|449301545|FG008|Overall Study|Other than listed|1|||
124910885|NCT04259450|449301546|FG009|Overall Study|Other than listed|2|||
124910886|NCT01534494|449301547|FG000|Overall Study|Withdrawal by Subject|1|||
124910887|NCT00434304|449301549|FG000|Overall Study|Adverse Event|14|||
124910888|NCT00434304|449301549|FG000|Overall Study|Lack of Efficacy|2|||
124544986|NCT03426995|447949270|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
124544987|NCT03426995|447949271|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
124692466|NCT02675452|448494753|FG001|Overall Study|Death|0|||
124692467|NCT02675452|448494754|FG002|Overall Study|Death|1|||
124692468|NCT02675452|448494755|FG003|Overall Study|Death|0|||
124692469|NCT02675452|448494756|FG004|Overall Study|Death|0|||
124692470|NCT02675452|448494757|FG005|Overall Study|Death|1|||
124910889|NCT00434304|449301549|FG000|Overall Study|Withdrawal by Subject|4|||
124910890|NCT01939899|449301558|FG000|Lead-in Dose Finding Phase|Death|0|||
124544988|NCT03426995|447949272|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
124544989|NCT03426995|447949273|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
124544990|NCT03426995|447949274|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
124544991|NCT03426995|447949275|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
124544992|NCT03426995|447949276|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
124692471|NCT02675452|448494758|FG006|Overall Study|Death|0|||
124692472|NCT02675452|448494759|FG007|Overall Study|Death|0|||
124692473|NCT02675452|448494760|FG008|Overall Study|Death|1|||
124692474|NCT02675452|448494761|FG009|Overall Study|Death|0|||
124692475|NCT02675452|448494762|FG010|Overall Study|Death|0|||
124910891|NCT01939899|449301559|FG001|Lead-in Dose Finding Phase|Death|3|||
124910892|NCT01939899|449301560|FG002|Lead-in Dose Finding Phase|Death|1|||
124910893|NCT01939899|449301561|FG003|Lead-in Dose Finding Phase|Death|0|||
124910894|NCT01939899|449301562|FG004|Lead-in Dose Finding Phase|Death|0|||
124910895|NCT01939899|449301558|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
124910896|NCT01939899|449301559|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
124910897|NCT01939899|449301560|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
124910898|NCT01939899|449301561|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
124910899|NCT01939899|449301562|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
124910900|NCT01939899|449301558|FG000|Lead-in Dose Finding Phase|Other|0|||
124910901|NCT01939899|449301559|FG001|Lead-in Dose Finding Phase|Other|0|||
124910902|NCT01939899|449301560|FG002|Lead-in Dose Finding Phase|Other|1|||
124910903|NCT01939899|449301561|FG003|Lead-in Dose Finding Phase|Other|0|||
124910904|NCT01939899|449301562|FG004|Lead-in Dose Finding Phase|Other|0|||
124910905|NCT01939899|449301558|FG000|Phase 2|Withdrawal by Subject|0|||
124910906|NCT01939899|449301559|FG001|Phase 2|Withdrawal by Subject|0|||
124910907|NCT01939899|449301560|FG002|Phase 2|Withdrawal by Subject|0|||
124910908|NCT01939899|449301561|FG003|Phase 2|Withdrawal by Subject|2|||
124910909|NCT01939899|449301562|FG004|Phase 2|Withdrawal by Subject|0|||
124910910|NCT01939899|449301558|FG000|Phase 2|Disease Progression|0|||
124910911|NCT01939899|449301559|FG001|Phase 2|Disease Progression|0|||
124910912|NCT01939899|449301560|FG002|Phase 2|Disease Progression|0|||
124910913|NCT01939899|449301561|FG003|Phase 2|Disease Progression|9|||
124910914|NCT01939899|449301562|FG004|Phase 2|Disease Progression|1|||
124910915|NCT00585052|449301563|FG000|Overall Study|Withdrawal by Subject|1|||
124910916|NCT00858117|449301564|FG000|Treatment on Study|Adverse Event|2|||
124910917|NCT00858117|449301564|FG000|Follow up for 5 Years|Death|4|||
124910918|NCT00858117|449301564|FG000|Follow up for 5 Years|No further data collected for study|9|||
124910919|NCT00371787|449301565|FG000|Overall Study|Withdrawal by Subject|3|||
124910920|NCT00371787|449301566|FG001|Overall Study|Withdrawal by Subject|1|||
124910921|NCT04425863|449301567|FG000|Overall Study|Death|0|||
124910922|NCT04425863|449301568|FG001|Overall Study|Death|0|||
124910923|NCT04425863|449301569|FG002|Overall Study|Death|1|||
124910924|NCT01854385|449301573|FG000|Pre-Treatment|Withdrawal by Subject|4|||
124910925|NCT01854385|449301573|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
124910926|NCT01854385|449301573|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
124910927|NCT01854385|449301573|FG000|Pre-Treatment|Unable to come for study visits|1|||
124910928|NCT01854385|449301573|FG000|Treatment|Lost to Follow-up|1|||
124910929|NCT00277355|449301575|FG000|Overall Study|Withdrawal by Subject|3|||
124910930|NCT00277355|449301576|FG001|Overall Study|Withdrawal by Subject|3|||
124910931|NCT00277355|449301575|FG000|Overall Study|Lost to Follow-up|2|||
124910932|NCT00277355|449301576|FG001|Overall Study|Lost to Follow-up|2|||
124910933|NCT00277355|449301575|FG000|Overall Study|Adverse Event|5|||
124910934|NCT00277355|449301576|FG001|Overall Study|Adverse Event|0|||
124910935|NCT00277355|449301575|FG000|Overall Study|Death|3|||
124910936|NCT00277355|449301576|FG001|Overall Study|Death|0|||
124910937|NCT00277355|449301575|FG000|Overall Study|Physician Decision|1|||
124910938|NCT00277355|449301576|FG001|Overall Study|Physician Decision|0|||
124910939|NCT02597920|449301579|FG000|Overall Study|Worsening of other pre-existing disease|0|||
124910940|NCT02597920|449301580|FG001|Overall Study|Worsening of other pre-existing disease|1|||
124910941|NCT02597920|449301581|FG002|Overall Study|Worsening of other pre-existing disease|0|||
124910942|NCT02597920|449301579|FG000|Overall Study|Other adverse event|20|||
124910943|NCT02597920|449301580|FG001|Overall Study|Other adverse event|30|||
124910944|NCT02597920|449301581|FG002|Overall Study|Other adverse event|0|||
124910945|NCT02597920|449301579|FG000|Overall Study|Lost to Follow-up|7|||
124910946|NCT02597920|449301580|FG001|Overall Study|Lost to Follow-up|9|||
124910947|NCT02597920|449301581|FG002|Overall Study|Lost to Follow-up|0|||
124910948|NCT02597920|449301579|FG000|Overall Study|Refuse to continue in the study|3|||
124910949|NCT02597920|449301580|FG001|Overall Study|Refuse to continue in the study|13|||
124910950|NCT02597920|449301581|FG002|Overall Study|Refuse to continue in the study|1|||
124910951|NCT02597920|449301579|FG000|Overall Study|Other than specified|10|||
124910952|NCT02597920|449301580|FG001|Overall Study|Other than specified|31|||
124910953|NCT02597920|449301581|FG002|Overall Study|Other than specified|5|||
124910954|NCT02597920|449301579|FG000|Overall Study|Other|1|||
124910955|NCT02597920|449301580|FG001|Overall Study|Other|0|||
124910956|NCT02597920|449301581|FG002|Overall Study|Other|0|||
124910957|NCT00642850|449301582|FG000|Overall Study|Death|7|||
124910958|NCT00642850|449301582|FG000|Overall Study|Adverse Event|2|||
124760636|NCT04862065|448749071|FG001|Screening|Protocol Violation|0|||
124910959|NCT00642850|449301582|FG000|Overall Study|Lack of Efficacy|1|||
124910960|NCT00642850|449301582|FG000|Overall Study|Protocol Violation|2|||
124910961|NCT00642850|449301582|FG000|Overall Study|Kidney transplantation|8|||
124910962|NCT00642850|449301582|FG000|Overall Study|Blood transfusion|6|||
124910963|NCT00642850|449301582|FG000|Overall Study|Other reasons|7|||
124910964|NCT05489484|449301585|FG000|Overall Study|withdrawn|1|||
124760637|NCT04862065|448749072|FG002|Screening|Protocol Violation|0|||
124910965|NCT00444600|449301588|FG000|Overall Study|Death|7|||
124910966|NCT00444600|449301589|FG001|Overall Study|Death|5|||
124910967|NCT00444600|449301590|FG002|Overall Study|Death|3|||
124910968|NCT00444600|449301591|FG003|Overall Study|Death|2|||
124910969|NCT00444600|449301588|FG000|Overall Study|Dropped|11|||
124910970|NCT00444600|449301589|FG001|Overall Study|Dropped|11|||
124910971|NCT00444600|449301590|FG002|Overall Study|Dropped|7|||
124910972|NCT00444600|449301591|FG003|Overall Study|Dropped|7|||
124910973|NCT00444600|449301588|FG000|Overall Study|Missed visit|1|||
124910974|NCT00444600|449301589|FG001|Overall Study|Missed visit|0|||
124910975|NCT00444600|449301590|FG002|Overall Study|Missed visit|0|||
124910976|NCT00444600|449301591|FG003|Overall Study|Missed visit|1|||
124910977|NCT05132478|449301592|FG000|Overall Study|did not complete survey after consent|1|||
124910978|NCT05132478|449301593|FG001|Overall Study|did not complete survey after consent|1|||
124910979|NCT05132478|449301592|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
124910980|NCT05132478|449301593|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
124910981|NCT01414738|449301596|FG000|Overall Study|Death|26|||
124910982|NCT01414738|449301596|FG000|Overall Study|Refused testing|5|||
124910983|NCT01414738|449301596|FG000|Overall Study|Lost to Follow-up|2|||
124910984|NCT01414738|449301596|FG000|Overall Study|Refused, disease progression|8|||
124910985|NCT01414738|449301596|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
124910986|NCT01839331|449301597|FG000|Overall Study|Early Termination|3|||
124910987|NCT01839331|449301598|FG001|Overall Study|Early Termination|0|||
124910988|NCT01839331|449301599|FG002|Overall Study|Early Termination|1|||
124910989|NCT01839331|449301600|FG003|Overall Study|Early Termination|2|||
124910990|NCT01839331|449301597|FG000|Overall Study|Protocol Violation|1|||
124910991|NCT01839331|449301598|FG001|Overall Study|Protocol Violation|6|||
124910992|NCT01839331|449301599|FG002|Overall Study|Protocol Violation|4|||
124910993|NCT01839331|449301600|FG003|Overall Study|Protocol Violation|3|||
124910994|NCT04056624|449301601|FG000|Overall Study|Withdrawal by Subject|0|||
124910995|NCT04056624|449301602|FG001|Overall Study|Withdrawal by Subject|0|||
124910996|NCT04056624|449301603|FG002|Overall Study|Withdrawal by Subject|1|||
124910997|NCT04056624|449301601|FG000|Overall Study|Protocol Violation|1|||
124910998|NCT04056624|449301602|FG001|Overall Study|Protocol Violation|2|||
124910999|NCT04056624|449301603|FG002|Overall Study|Protocol Violation|0|||
124450374|NCT00766090|447611964|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
124911000|NCT00703820|449301606|FG000|Overall Study|Adverse Event|12|||
124911001|NCT00703820|449301607|FG001|Overall Study|Adverse Event|17|||
124911002|NCT00703820|449301606|FG000|Overall Study|Death|5|||
124911003|NCT00703820|449301607|FG001|Overall Study|Death|0|||
124911004|NCT00703820|449301606|FG000|Overall Study|Lack of Efficacy|11|||
124911005|NCT00703820|449301607|FG001|Overall Study|Lack of Efficacy|11|||
124911006|NCT00703820|449301606|FG000|Overall Study|Received non-protocol therapy|1|||
124911007|NCT00703820|449301607|FG001|Overall Study|Received non-protocol therapy|0|||
124911008|NCT00703820|449301606|FG000|Overall Study|Physician Decision|4|||
124911009|NCT00703820|449301607|FG001|Overall Study|Physician Decision|5|||
124911010|NCT00703820|449301606|FG000|Overall Study|Withdrawal by Subject|2|||
124911011|NCT00703820|449301607|FG001|Overall Study|Withdrawal by Subject|1|||
124911012|NCT03531840|449301610|FG000|Overall Study|Death on study|3|||
124911013|NCT03531840|449301611|FG001|Overall Study|Death on study|2|||
124911014|NCT03531840|449301612|FG002|Overall Study|Death on study|1|||
124911015|NCT03531840|449301613|FG003|Overall Study|Death on study|2|||
124911016|NCT03531840|449301610|FG000|Overall Study|Death during follow up|2|||
124911017|NCT03531840|449301611|FG001|Overall Study|Death during follow up|3|||
124911018|NCT03531840|449301612|FG002|Overall Study|Death during follow up|4|||
124911019|NCT03531840|449301613|FG003|Overall Study|Death during follow up|1|||
124911020|NCT00761605|449301615|FG000|Overall Study|Adverse Event|26|||
124911021|NCT00761605|449301615|FG000|Overall Study|Death|2|||
124911022|NCT00761605|449301615|FG000|Overall Study|Lack of Efficacy|26|||
124911023|NCT00761605|449301615|FG000|Overall Study|Lost to Follow-up|29|||
124911024|NCT00761605|449301615|FG000|Overall Study|Withdrawal by Subject|37|||
124911025|NCT00761605|449301615|FG000|Overall Study|Other|21|||
124911026|NCT02267824|449301616|FG000|Overall Study|Pregnancy|1|||
124450375|NCT00766090|447611965|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
124450376|NCT00766090|447611954|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124911027|NCT02267824|449301617|FG001|Overall Study|Pregnancy|1|||
124911028|NCT02267824|449301616|FG000|Overall Study|Lost to Follow-up|4|||
124911029|NCT02267824|449301617|FG001|Overall Study|Lost to Follow-up|0|||
124911030|NCT02267824|449301616|FG000|Overall Study|Protocol Violation|3|||
124911031|NCT02267824|449301617|FG001|Overall Study|Protocol Violation|0|||
124911032|NCT02267824|449301616|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
124450377|NCT00766090|447611955|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124911033|NCT02267824|449301617|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
124450378|NCT00766090|447611956|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124450379|NCT00766090|447611957|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124450380|NCT00766090|447611958|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
124911034|NCT03451721|449301618|FG000|Overall Study|Death|1|||
124692476|NCT02675452|448494763|FG011|Overall Study|Death|0|||
124911035|NCT00350792|449301619|FG000|Overall Study|Adverse Event|11|||
124911036|NCT00350792|449301619|FG000|Overall Study|Death from Study Disease|1|||
124692477|NCT02675452|448494764|FG012|Overall Study|Death|1|||
124911037|NCT00350792|449301619|FG000|Overall Study|Death from Study Drug Toxicity|1|||
124911038|NCT00350792|449301619|FG000|Overall Study|Death Not Study Drug Related|2|||
124911039|NCT00350792|449301619|FG000|Overall Study|Protocol Violation|1|||
124911040|NCT00350792|449301619|FG000|Overall Study|Withdrawal by Subject|4|||
124911041|NCT00350792|449301619|FG000|Overall Study|Physician Decision|2|||
124911042|NCT00350792|449301619|FG000|Overall Study|Lack of Efficacy|11|||
124911043|NCT01985334|449301620|FG000|Overall Study|Administrative problems|1|||
124911044|NCT01985334|449301621|FG001|Overall Study|Administrative problems|1|||
124911045|NCT01985334|449301622|FG002|Overall Study|Administrative problems|0|||
124911046|NCT01985334|449301623|FG003|Overall Study|Administrative problems|2|||
124911047|NCT01985334|449301624|FG004|Overall Study|Administrative problems|0|||
124911048|NCT01985334|449301625|FG005|Overall Study|Administrative problems|1|||
124911049|NCT01985334|449301626|FG006|Overall Study|Administrative problems|1|||
124911050|NCT01985334|449301627|FG007|Overall Study|Administrative problems|3|||
124911051|NCT01985334|449301620|FG000|Overall Study|Death|1|||
124911052|NCT01985334|449301621|FG001|Overall Study|Death|0|||
124911053|NCT01985334|449301622|FG002|Overall Study|Death|0|||
124911054|NCT01985334|449301623|FG003|Overall Study|Death|3|||
124911055|NCT01985334|449301624|FG004|Overall Study|Death|0|||
124911056|NCT01985334|449301625|FG005|Overall Study|Death|0|||
124911057|NCT01985334|449301626|FG006|Overall Study|Death|1|||
124911058|NCT01985334|449301627|FG007|Overall Study|Death|2|||
124911059|NCT01985334|449301620|FG000|Overall Study|Worsening of disease|0|||
124911060|NCT01985334|449301621|FG001|Overall Study|Worsening of disease|0|||
124911061|NCT01985334|449301622|FG002|Overall Study|Worsening of disease|0|||
124911062|NCT01985334|449301623|FG003|Overall Study|Worsening of disease|1|||
124911063|NCT01985334|449301624|FG004|Overall Study|Worsening of disease|0|||
124911064|NCT01985334|449301625|FG005|Overall Study|Worsening of disease|3|||
124911065|NCT01985334|449301626|FG006|Overall Study|Worsening of disease|0|||
124911066|NCT01985334|449301627|FG007|Overall Study|Worsening of disease|1|||
124911067|NCT01985334|449301620|FG000|Overall Study|Other|2|||
124911068|NCT01985334|449301621|FG001|Overall Study|Other|9|||
124911069|NCT01985334|449301622|FG002|Overall Study|Other|7|||
124911070|NCT01985334|449301623|FG003|Overall Study|Other|17|||
124911071|NCT01985334|449301624|FG004|Overall Study|Other|4|||
124911072|NCT01985334|449301625|FG005|Overall Study|Other|8|||
124911073|NCT01985334|449301626|FG006|Overall Study|Other|4|||
124911074|NCT01985334|449301627|FG007|Overall Study|Other|7|||
124911075|NCT01985334|449301620|FG000|Overall Study|Protocol deviation|6|||
124911076|NCT01985334|449301621|FG001|Overall Study|Protocol deviation|31|||
124911077|NCT01985334|449301622|FG002|Overall Study|Protocol deviation|25|||
124911078|NCT01985334|449301623|FG003|Overall Study|Protocol deviation|84|||
124911079|NCT01985334|449301624|FG004|Overall Study|Protocol deviation|17|||
124911080|NCT01985334|449301625|FG005|Overall Study|Protocol deviation|47|||
124911081|NCT01985334|449301626|FG006|Overall Study|Protocol deviation|15|||
124911082|NCT01985334|449301627|FG007|Overall Study|Protocol deviation|42|||
124911083|NCT01985334|449301620|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
124911084|NCT01985334|449301621|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
124911085|NCT01985334|449301622|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
124911086|NCT01985334|449301623|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
124911087|NCT01985334|449301624|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
124911088|NCT01985334|449301625|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
124911089|NCT01985334|449301626|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
124911090|NCT01985334|449301627|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
124911091|NCT01985334|449301620|FG000|Overall Study|Subject withdrawal of consent|3|||
124760638|NCT04862065|448749070|FG000|Screening|Insufficient Sample|1|||
124760639|NCT04862065|448749071|FG001|Screening|Insufficient Sample|0|||
124760640|NCT04862065|448749072|FG002|Screening|Insufficient Sample|0|||
124760641|NCT04862065|448749070|FG000|Follow-Up|Lost to Follow-up|3|||
124760642|NCT04862065|448749071|FG001|Follow-Up|Lost to Follow-up|0|||
124760643|NCT04862065|448749072|FG002|Follow-Up|Lost to Follow-up|0|||
124760644|NCT03244917|448749076|FG000|Overall Study|Lost to Follow-up|2|||
124760645|NCT03244917|448749077|FG001|Overall Study|Lost to Follow-up|2|||
124760646|NCT03001557|448749078|FG000|Core Phase|Randomized but not treated|0|||
124760647|NCT03001557|448749079|FG001|Core Phase|Randomized but not treated|0|||
124760648|NCT03001557|448749080|FG002|Core Phase|Randomized but not treated|1|||
124760649|NCT03001557|448749081|FG003|Core Phase|Randomized but not treated|0|||
124760650|NCT03001557|448749082|FG004|Core Phase|Randomized but not treated|0|||
124760651|NCT03001557|448749083|FG005|Core Phase|Randomized but not treated|0|||
124760652|NCT03001557|448749084|FG006|Core Phase|Randomized but not treated|0|||
124760653|NCT03001557|448749085|FG007|Core Phase|Randomized but not treated|0|||
124760654|NCT03001557|448749078|FG000|Extension Phase|Adverse Event|0|||
124760655|NCT03001557|448749079|FG001|Extension Phase|Adverse Event|0|||
124760656|NCT03001557|448749080|FG002|Extension Phase|Adverse Event|0|||
124760657|NCT03001557|448749081|FG003|Extension Phase|Adverse Event|0|||
124760658|NCT03001557|448749082|FG004|Extension Phase|Adverse Event|0|||
124911092|NCT01985334|449301621|FG001|Overall Study|Subject withdrawal of consent|6|||
124911093|NCT01985334|449301622|FG002|Overall Study|Subject withdrawal of consent|2|||
124911094|NCT01985334|449301623|FG003|Overall Study|Subject withdrawal of consent|28|||
124911095|NCT01985334|449301624|FG004|Overall Study|Subject withdrawal of consent|4|||
124911096|NCT01985334|449301625|FG005|Overall Study|Subject withdrawal of consent|19|||
124911097|NCT01985334|449301626|FG006|Overall Study|Subject withdrawal of consent|0|||
124911098|NCT01985334|449301627|FG007|Overall Study|Subject withdrawal of consent|20|||
124911099|NCT01985334|449301620|FG000|Overall Study|Adverse Event|0|||
124911100|NCT01985334|449301621|FG001|Overall Study|Adverse Event|8|||
124911101|NCT01985334|449301622|FG002|Overall Study|Adverse Event|2|||
124911102|NCT01985334|449301623|FG003|Overall Study|Adverse Event|26|||
124911103|NCT01985334|449301624|FG004|Overall Study|Adverse Event|3|||
124911104|NCT01985334|449301625|FG005|Overall Study|Adverse Event|18|||
124911105|NCT01985334|449301626|FG006|Overall Study|Adverse Event|3|||
124911106|NCT01985334|449301627|FG007|Overall Study|Adverse Event|15|||
124911107|NCT01985334|449301620|FG000|Overall Study|Other|4|||
124911108|NCT01985334|449301621|FG001|Overall Study|Other|2|||
124911109|NCT01985334|449301622|FG002|Overall Study|Other|3|||
124911110|NCT01985334|449301623|FG003|Overall Study|Other|10|||
124911111|NCT01985334|449301624|FG004|Overall Study|Other|1|||
124911112|NCT01985334|449301625|FG005|Overall Study|Other|6|||
124911113|NCT01985334|449301626|FG006|Overall Study|Other|2|||
124911114|NCT01985334|449301627|FG007|Overall Study|Other|2|||
124911115|NCT01985334|449301620|FG000|Overall Study|Medication non-compliance|0|||
124911116|NCT01985334|449301621|FG001|Overall Study|Medication non-compliance|4|||
124911117|NCT01985334|449301622|FG002|Overall Study|Medication non-compliance|1|||
124911118|NCT01985334|449301623|FG003|Overall Study|Medication non-compliance|6|||
124911119|NCT01985334|449301624|FG004|Overall Study|Medication non-compliance|2|||
124911120|NCT01985334|449301625|FG005|Overall Study|Medication non-compliance|3|||
124911121|NCT01985334|449301626|FG006|Overall Study|Medication non-compliance|1|||
124911122|NCT01985334|449301627|FG007|Overall Study|Medication non-compliance|3|||
124911123|NCT01985334|449301620|FG000|Overall Study|Use of prohibited treatment|1|||
124911124|NCT01985334|449301621|FG001|Overall Study|Use of prohibited treatment|4|||
124911125|NCT01985334|449301622|FG002|Overall Study|Use of prohibited treatment|1|||
124911126|NCT01985334|449301623|FG003|Overall Study|Use of prohibited treatment|2|||
124911127|NCT01985334|449301624|FG004|Overall Study|Use of prohibited treatment|1|||
124911128|NCT01985334|449301625|FG005|Overall Study|Use of prohibited treatment|6|||
124911129|NCT01985334|449301626|FG006|Overall Study|Use of prohibited treatment|2|||
124760659|NCT03001557|448749083|FG005|Extension Phase|Adverse Event|2|||
124760660|NCT03001557|448749084|FG006|Extension Phase|Adverse Event|0|||
124760661|NCT03001557|448749085|FG007|Extension Phase|Adverse Event|0|||
124760662|NCT03001557|448749078|FG000|Extension Phase|Withdrawal by Subject|0|||
124760663|NCT03001557|448749079|FG001|Extension Phase|Withdrawal by Subject|0|||
124760664|NCT03001557|448749080|FG002|Extension Phase|Withdrawal by Subject|0|||
124760665|NCT03001557|448749081|FG003|Extension Phase|Withdrawal by Subject|0|||
124760666|NCT03001557|448749082|FG004|Extension Phase|Withdrawal by Subject|0|||
124760667|NCT03001557|448749083|FG005|Extension Phase|Withdrawal by Subject|1|||
124760668|NCT03001557|448749084|FG006|Extension Phase|Withdrawal by Subject|5|||
124760669|NCT03001557|448749085|FG007|Extension Phase|Withdrawal by Subject|2|||
124760670|NCT03001557|448749078|FG000|Extension Phase|Lost to Follow-up|0|||
124760671|NCT03001557|448749079|FG001|Extension Phase|Lost to Follow-up|0|||
124760672|NCT03001557|448749080|FG002|Extension Phase|Lost to Follow-up|0|||
124760673|NCT03001557|448749081|FG003|Extension Phase|Lost to Follow-up|0|||
124760674|NCT03001557|448749082|FG004|Extension Phase|Lost to Follow-up|0|||
124760675|NCT03001557|448749083|FG005|Extension Phase|Lost to Follow-up|0|||
124760676|NCT03001557|448749084|FG006|Extension Phase|Lost to Follow-up|2|||
124760677|NCT03001557|448749085|FG007|Extension Phase|Lost to Follow-up|1|||
124760678|NCT03001557|448749078|FG000|Extension Phase|Administrative Reason|0|||
124760679|NCT03001557|448749079|FG001|Extension Phase|Administrative Reason|0|||
124760680|NCT03001557|448749080|FG002|Extension Phase|Administrative Reason|0|||
124760681|NCT03001557|448749081|FG003|Extension Phase|Administrative Reason|0|||
124760682|NCT03001557|448749082|FG004|Extension Phase|Administrative Reason|0|||
124760683|NCT03001557|448749083|FG005|Extension Phase|Administrative Reason|1|||
124760684|NCT03001557|448749084|FG006|Extension Phase|Administrative Reason|3|||
124760685|NCT03001557|448749085|FG007|Extension Phase|Administrative Reason|3|||
124760686|NCT03001557|448749078|FG000|Extension Phase|Loss of caregiver|0|||
124760687|NCT03001557|448749079|FG001|Extension Phase|Loss of caregiver|0|||
124760688|NCT03001557|448749080|FG002|Extension Phase|Loss of caregiver|0|||
124760689|NCT03001557|448749081|FG003|Extension Phase|Loss of caregiver|0|||
124760690|NCT03001557|448749082|FG004|Extension Phase|Loss of caregiver|0|||
124760691|NCT03001557|448749083|FG005|Extension Phase|Loss of caregiver|0|||
124911130|NCT01985334|449301627|FG007|Overall Study|Use of prohibited treatment|0|||
124911131|NCT01985334|449301620|FG000|Overall Study|Investigator decision|0|||
124911132|NCT01985334|449301621|FG001|Overall Study|Investigator decision|3|||
124911133|NCT01985334|449301622|FG002|Overall Study|Investigator decision|0|||
124911134|NCT01985334|449301623|FG003|Overall Study|Investigator decision|7|||
124911135|NCT01985334|449301624|FG004|Overall Study|Investigator decision|1|||
124911136|NCT01985334|449301625|FG005|Overall Study|Investigator decision|1|||
124450381|NCT00766090|447611959|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124760692|NCT03001557|448749084|FG006|Extension Phase|Loss of caregiver|1|||
124911137|NCT01985334|449301626|FG006|Overall Study|Investigator decision|0|||
124911138|NCT01985334|449301627|FG007|Overall Study|Investigator decision|4|||
124911139|NCT01985334|449301620|FG000|Overall Study|Lost to Follow-up|0|||
124911140|NCT01985334|449301621|FG001|Overall Study|Lost to Follow-up|2|||
124911141|NCT01985334|449301622|FG002|Overall Study|Lost to Follow-up|0|||
124911142|NCT01985334|449301623|FG003|Overall Study|Lost to Follow-up|3|||
124911143|NCT01985334|449301624|FG004|Overall Study|Lost to Follow-up|1|||
124911144|NCT01985334|449301625|FG005|Overall Study|Lost to Follow-up|4|||
124911145|NCT01985334|449301626|FG006|Overall Study|Lost to Follow-up|0|||
124911146|NCT01985334|449301627|FG007|Overall Study|Lost to Follow-up|3|||
124911147|NCT00396084|449301630|FG000|Overall Study|Adverse Event|0|||
124911148|NCT00396084|449301631|FG001|Overall Study|Adverse Event|0|||
124911149|NCT00396084|449301632|FG002|Overall Study|Adverse Event|0|||
124911150|NCT00396084|449301633|FG003|Overall Study|Adverse Event|0|||
124911151|NCT00396084|449301634|FG004|Overall Study|Adverse Event|1|||
124911152|NCT00396084|449301635|FG005|Overall Study|Adverse Event|2|||
124911153|NCT00396084|449301630|FG000|Overall Study|Withdrawal by Subject|0|||
124911154|NCT00396084|449301631|FG001|Overall Study|Withdrawal by Subject|0|||
124911155|NCT00396084|449301632|FG002|Overall Study|Withdrawal by Subject|0|||
124911156|NCT00396084|449301633|FG003|Overall Study|Withdrawal by Subject|1|||
124911157|NCT00396084|449301634|FG004|Overall Study|Withdrawal by Subject|0|||
124911158|NCT00396084|449301635|FG005|Overall Study|Withdrawal by Subject|0|||
124911159|NCT01565148|449301641|FG000|Overall Study|Withdrawal by Subject|1|||
124911160|NCT01565148|449301642|FG001|Overall Study|Withdrawal by Subject|1|||
124911161|NCT01565148|449301643|FG002|Overall Study|Withdrawal by Subject|1|||
124911162|NCT01565148|449301644|FG003|Overall Study|Withdrawal by Subject|2|||
124911163|NCT01565148|449301641|FG000|Overall Study|Lost to Follow-up|4|||
124911164|NCT01565148|449301642|FG001|Overall Study|Lost to Follow-up|4|||
124911165|NCT01565148|449301643|FG002|Overall Study|Lost to Follow-up|0|||
124911166|NCT01565148|449301644|FG003|Overall Study|Lost to Follow-up|3|||
124911167|NCT01565148|449301641|FG000|Overall Study|Rescue Therapy|8|||
124911168|NCT01565148|449301642|FG001|Overall Study|Rescue Therapy|5|||
124911169|NCT01565148|449301643|FG002|Overall Study|Rescue Therapy|5|||
124911170|NCT01565148|449301644|FG003|Overall Study|Rescue Therapy|8|||
124911171|NCT01565148|449301641|FG000|Overall Study|Death|0|||
124911172|NCT01565148|449301642|FG001|Overall Study|Death|0|||
124911173|NCT01565148|449301643|FG002|Overall Study|Death|1|||
124911174|NCT01565148|449301644|FG003|Overall Study|Death|0|||
124450382|NCT00766090|447611960|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124450383|NCT00766090|447611961|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124450384|NCT00766090|447611962|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124450385|NCT00766090|447611963|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124450386|NCT00766090|447611964|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124450387|NCT00766090|447611965|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124450388|NCT00766090|447611954|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
124911175|NCT01565148|449301641|FG000|Overall Study|Physician Decision|2|||
124911176|NCT01565148|449301642|FG001|Overall Study|Physician Decision|5|||
124911177|NCT01565148|449301643|FG002|Overall Study|Physician Decision|0|||
124911178|NCT01565148|449301644|FG003|Overall Study|Physician Decision|0|||
124911179|NCT01199575|449301647|FG000|Overall Study|Withdrawal by Subject|5|||
124911180|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
124911181|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
124911182|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
124911183|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
124911184|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
124911185|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
124911186|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
124450389|NCT00766090|447611955|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
124450390|NCT00766090|447611956|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
124911187|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
124911188|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
124911189|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
124911190|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
124911191|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
124911192|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
124911193|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
124911194|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
124911195|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
124911196|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
124450391|NCT00766090|447611957|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
124450392|NCT00766090|447611958|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
124911197|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
124911198|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
124911199|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
124911200|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
124911201|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
124911202|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
124911203|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
124911204|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
124911205|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
124911206|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
124911207|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
124911208|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
124911209|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
124911210|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
124911211|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
124911212|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
124911213|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
124911214|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
124911215|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
124911216|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
124911217|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
124911218|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
124911219|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
124911220|NCT02409667|449301650|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
124911221|NCT02409667|449301651|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
124911222|NCT02409667|449301652|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
124911223|NCT02409667|449301653|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
124911224|NCT02409667|449301654|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
124911225|NCT02409667|449301650|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
124911226|NCT02409667|449301651|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
124911227|NCT02409667|449301652|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
124911228|NCT02409667|449301653|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
124911229|NCT02409667|449301654|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
124911230|NCT02409667|449301650|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
124911231|NCT02409667|449301651|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
124911232|NCT02409667|449301652|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
124911233|NCT02409667|449301653|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
124911234|NCT02409667|449301654|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
124911235|NCT02409667|449301650|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
124911236|NCT02409667|449301651|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
124911237|NCT02409667|449301652|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
124911238|NCT02409667|449301653|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
124911239|NCT02409667|449301654|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
124911240|NCT02409667|449301650|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
124911241|NCT02409667|449301651|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
124911242|NCT02409667|449301652|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
124911243|NCT02409667|449301653|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
124911244|NCT02409667|449301654|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
124911245|NCT02409667|449301650|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
124911246|NCT02409667|449301651|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
124911247|NCT02409667|449301652|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
124911248|NCT02409667|449301653|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
124911249|NCT02409667|449301654|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
124911250|NCT02409667|449301650|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
124911251|NCT02409667|449301651|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
124911252|NCT02409667|449301652|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
124911253|NCT02409667|449301653|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
124911254|NCT02409667|449301654|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
124911255|NCT02409667|449301650|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
124911256|NCT02409667|449301651|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
124911257|NCT02409667|449301652|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
124911258|NCT02409667|449301653|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
124911259|NCT02409667|449301654|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
124911260|NCT01925339|449301655|FG000|Overall Study|Adverse Event|2|||
124911261|NCT01925339|449301656|FG001|Overall Study|Adverse Event|0|||
124911262|NCT03960463|449302793|FG000|Overall Study|Withdrawal by Subject|2|||
124911263|NCT03960463|449302794|FG001|Overall Study|Withdrawal by Subject|0|||
124911264|NCT04999085|449302798|FG000|Overall Study|Death|1|||
124450393|NCT00766090|447611959|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
124911265|NCT02581215|449302799|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
124911266|NCT02581215|449302800|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
124911267|NCT02581215|449302799|FG000|Overall Study|Eligibility Criteria Not Met|0|||
124911268|NCT02581215|449302800|FG001|Overall Study|Eligibility Criteria Not Met|1|||
124911269|NCT03613740|449302801|FG000|Overall Study|Lost to Follow-up|1|||
124911270|NCT03613740|449302802|FG001|Overall Study|Lost to Follow-up|1|||
124911271|NCT04188379|449302803|FG000|Overall Study|Withdrawal by Subject|10|||
124911272|NCT04188379|449302804|FG001|Overall Study|Withdrawal by Subject|3|||
124911273|NCT04188379|449302803|FG000|Overall Study|Physician Decision|0|||
124911274|NCT04188379|449302804|FG001|Overall Study|Physician Decision|1|||
124911275|NCT04188379|449302803|FG000|Overall Study|Adverse Event|3|||
124911276|NCT04188379|449302804|FG001|Overall Study|Adverse Event|1|||
124911277|NCT04188379|449302803|FG000|Overall Study|Pregnancy|1|||
124911278|NCT04188379|449302804|FG001|Overall Study|Pregnancy|0|||
124911279|NCT04188379|449302803|FG000|Overall Study|Lack of Efficacy|8|||
124911280|NCT04188379|449302804|FG001|Overall Study|Lack of Efficacy|5|||
124911281|NCT04188379|449302803|FG000|Overall Study|Other|0|||
124911282|NCT04188379|449302804|FG001|Overall Study|Other|3|||
124911283|NCT02566902|449302807|FG000|Overall Study|Protocol Violation|2|||
124911284|NCT02566902|449302808|FG001|Overall Study|Protocol Violation|1|||
124911285|NCT03112174|449302811|FG000|Overall Study|Withdrawal by Subject|3|||
124911286|NCT03112174|449302812|FG001|Overall Study|Withdrawal by Subject|0|||
124911287|NCT03112174|449302813|FG002|Overall Study|Withdrawal by Subject|11|||
124911288|NCT03112174|449302814|FG003|Overall Study|Withdrawal by Subject|9|||
124911289|NCT03112174|449302815|FG004|Overall Study|Withdrawal by Subject|7|||
124911290|NCT03112174|449302811|FG000|Overall Study|Lost to Follow-up|1|||
124911291|NCT03112174|449302812|FG001|Overall Study|Lost to Follow-up|1|||
124911292|NCT03112174|449302813|FG002|Overall Study|Lost to Follow-up|2|||
124911293|NCT03112174|449302814|FG003|Overall Study|Lost to Follow-up|3|||
124911294|NCT03112174|449302815|FG004|Overall Study|Lost to Follow-up|2|||
124911295|NCT03112174|449302811|FG000|Overall Study|Death|8|||
124911296|NCT03112174|449302812|FG001|Overall Study|Death|3|||
124911297|NCT03112174|449302813|FG002|Overall Study|Death|67|||
124911298|NCT03112174|449302814|FG003|Overall Study|Death|73|||
124911299|NCT03112174|449302815|FG004|Overall Study|Death|18|||
124911300|NCT03112174|449302811|FG000|Overall Study|Other, Not Specified|1|||
124911301|NCT03112174|449302812|FG001|Overall Study|Other, Not Specified|0|||
124911302|NCT03112174|449302813|FG002|Overall Study|Other, Not Specified|1|||
124911303|NCT03112174|449302814|FG003|Overall Study|Other, Not Specified|2|||
124911304|NCT03112174|449302815|FG004|Overall Study|Other, Not Specified|0|||
124911305|NCT02748317|449302818|FG000|Overall Study|Withdrawal by Subject|14|||
124911306|NCT02748317|449302818|FG000|Overall Study|Lost to Follow-up|8|||
124911307|NCT02748317|449302818|FG000|Overall Study|Death|1|||
124911308|NCT00332241|449302821|FG000|Overall Study|Lack of Efficacy|6|||
124911309|NCT00332241|449302822|FG001|Overall Study|Lack of Efficacy|1|||
124911310|NCT00332241|449302821|FG000|Overall Study|Adverse Event|3|||
124911311|NCT00332241|449302822|FG001|Overall Study|Adverse Event|5|||
124911312|NCT00332241|449302821|FG000|Overall Study|Withdrawal by Subject|2|||
124911313|NCT00332241|449302822|FG001|Overall Study|Withdrawal by Subject|1|||
124911314|NCT00332241|449302821|FG000|Overall Study|Lost to Follow-up|4|||
124911315|NCT00332241|449302822|FG001|Overall Study|Lost to Follow-up|1|||
124911316|NCT00802464|449302824|FG000|Month 0 - Month 8|Adverse Event|0|||
124911317|NCT00802464|449302825|FG001|Month 0 - Month 8|Adverse Event|1|||
124911318|NCT00802464|449302826|FG002|Month 0 - Month 8|Adverse Event|1|||
124911319|NCT00802464|449302827|FG003|Month 0 - Month 8|Adverse Event|2|||
124911320|NCT00802464|449302824|FG000|Month 0 - Month 8|Protocol Violation|0|||
124911321|NCT00802464|449302825|FG001|Month 0 - Month 8|Protocol Violation|0|||
124911322|NCT00802464|449302826|FG002|Month 0 - Month 8|Protocol Violation|1|||
124911323|NCT00802464|449302827|FG003|Month 0 - Month 8|Protocol Violation|0|||
124692478|NCT02675452|448494765|FG013|Overall Study|Death|0|||
124911324|NCT00802464|449302824|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
124911325|NCT00802464|449302825|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
124911326|NCT00802464|449302826|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
124911327|NCT00802464|449302827|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
124911328|NCT00802464|449302824|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
124911329|NCT00802464|449302825|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
124911330|NCT00802464|449302826|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
124911331|NCT00802464|449302827|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
124911332|NCT00802464|449302824|FG000|Month 0 - Month 8|Other|0|||
124911333|NCT00802464|449302825|FG001|Month 0 - Month 8|Other|0|||
124911334|NCT00802464|449302826|FG002|Month 0 - Month 8|Other|1|||
124911335|NCT00802464|449302827|FG003|Month 0 - Month 8|Other|0|||
124911336|NCT00802464|449302824|FG000|Month 8 - Month 14|Adverse Event|0|||
124911337|NCT00802464|449302825|FG001|Month 8 - Month 14|Adverse Event|1|||
124911338|NCT00802464|449302826|FG002|Month 8 - Month 14|Adverse Event|0|||
124911339|NCT00802464|449302827|FG003|Month 8 - Month 14|Adverse Event|0|||
124911340|NCT00802464|449302824|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
124911341|NCT00802464|449302825|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
124692479|NCT02675452|448494766|FG014|Overall Study|Death|0|||
124911342|NCT00802464|449302826|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
124911343|NCT00802464|449302827|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
124911344|NCT00802464|449302824|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
124911345|NCT00802464|449302825|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
124911346|NCT00802464|449302826|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
124911347|NCT00802464|449302827|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
124911348|NCT00402246|449302828|FG000|Overall Study|Death|62|||
124911349|NCT00402246|449302829|FG001|Overall Study|Death|58|||
124911350|NCT00402246|449302828|FG000|Overall Study|Lost to Follow-up|20|||
124544993|NCT03426995|447949277|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
124544994|NCT03426995|447949278|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
124544995|NCT03426995|447949279|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
124544996|NCT03426995|447949261|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
124544997|NCT03426995|447949262|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
124544998|NCT03426995|447949263|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
124544999|NCT03426995|447949264|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
124911351|NCT00402246|449302829|FG001|Overall Study|Lost to Follow-up|28|||
124911352|NCT00402246|449302828|FG000|Overall Study|Withdrawal by Subject|72|||
124911353|NCT00402246|449302829|FG001|Overall Study|Withdrawal by Subject|87|||
124911354|NCT00402246|449302828|FG000|Overall Study|Physician Decision|24|||
124911355|NCT00402246|449302829|FG001|Overall Study|Physician Decision|26|||
124911356|NCT00402246|449302828|FG000|Overall Study|Protocol Violation|25|||
124911357|NCT00402246|449302829|FG001|Overall Study|Protocol Violation|24|||
124911358|NCT00402246|449302828|FG000|Overall Study|Missed Final Visit|1|||
124911359|NCT00402246|449302829|FG001|Overall Study|Missed Final Visit|2|||
124911360|NCT00402246|449302828|FG000|Overall Study|Insurance Issues|2|||
124911361|NCT00402246|449302829|FG001|Overall Study|Insurance Issues|1|||
124911362|NCT00402246|449302828|FG000|Overall Study|Heart Transplant|0|||
124911363|NCT00402246|449302829|FG001|Overall Study|Heart Transplant|1|||
124911364|NCT00402246|449302828|FG000|Overall Study|Patient's device explanted|6|||
124911365|NCT00402246|449302829|FG001|Overall Study|Patient's device explanted|2|||
124911366|NCT00402246|449302828|FG000|Overall Study|Center Closure|5|||
124911367|NCT00402246|449302829|FG001|Overall Study|Center Closure|3|||
124911368|NCT00402246|449302828|FG000|Overall Study|Deterioriating Condition|3|||
124911369|NCT00402246|449302829|FG001|Overall Study|Deterioriating Condition|2|||
124911370|NCT05262738|449302834|FG000|Overall Study|Withdrawal by Subject|1|||
124911371|NCT05262738|449302835|FG001|Overall Study|Withdrawal by Subject|0|||
124911372|NCT01471691|449302838|FG000|Overall Study|Lack of Efficacy|0|||
124911373|NCT01471691|449302839|FG001|Overall Study|Lack of Efficacy|1|||
124911374|NCT01808339|449302840|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
124911375|NCT01808339|449302841|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
124911376|NCT01808339|449302842|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
124911377|NCT01808339|449302843|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
124911378|NCT01808339|449302844|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
124911379|NCT01808339|449302845|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
124911380|NCT01808339|449302840|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124911381|NCT01808339|449302841|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
124911382|NCT01808339|449302842|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124911383|NCT01808339|449302843|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
124911384|NCT01808339|449302844|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124911385|NCT01808339|449302845|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124911386|NCT01808339|449302840|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
124911387|NCT01808339|449302841|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
124911388|NCT01808339|449302842|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
124911389|NCT01808339|449302843|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
124911390|NCT01808339|449302844|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
124911391|NCT01808339|449302845|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
124911392|NCT02622568|449302846|FG000|Overall Study|Lost to Follow-up|5|||
124911393|NCT02622568|449302847|FG001|Overall Study|Lost to Follow-up|5|||
124911394|NCT00106080|449302849|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
124911395|NCT00106080|449302850|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
124911396|NCT02549170|449302851|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
124911397|NCT02549170|449302852|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
124911398|NCT02549170|449302853|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
124911399|NCT02549170|449302854|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
124911400|NCT02549170|449302855|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
124911401|NCT02549170|449302851|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
124911402|NCT02549170|449302852|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
124911403|NCT02549170|449302853|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
124911404|NCT02549170|449302854|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
124911405|NCT02549170|449302855|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
124911406|NCT02549170|449302851|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
124911407|NCT02549170|449302852|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
124911408|NCT02549170|449302853|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
124911409|NCT02549170|449302854|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
124911410|NCT02549170|449302855|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
124911411|NCT02379819|449302856|FG000|Overall Study|Withdrawal by Subject|10|||
124911412|NCT02379819|449302856|FG000|Overall Study|Death|2|||
124911413|NCT02379819|449302856|FG000|Overall Study|Lack of Efficacy|1|||
124911414|NCT02379819|449302856|FG000|Overall Study|Lost to Follow-up|1|||
124911415|NCT03988023|449302862|FG000|Overall Study|Non-compliance|3|||
124911416|NCT03988023|449302863|FG001|Overall Study|Non-compliance|0|||
124911417|NCT03988023|449302862|FG000|Overall Study|Withdrawal by Subject|39|||
124911418|NCT03988023|449302863|FG001|Overall Study|Withdrawal by Subject|37|||
124911419|NCT03988023|449302862|FG000|Overall Study|Adverse Event|0|||
124911420|NCT03988023|449302863|FG001|Overall Study|Adverse Event|2|||
124911421|NCT03988023|449302862|FG000|Overall Study|Physician Decision|0|||
124911422|NCT03988023|449302863|FG001|Overall Study|Physician Decision|1|||
124911423|NCT03988023|449302862|FG000|Overall Study|Lost to Follow-up|5|||
124911424|NCT03988023|449302863|FG001|Overall Study|Lost to Follow-up|8|||
124911425|NCT03988023|449302862|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
124911426|NCT03988023|449302863|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
124911427|NCT03988023|449302862|FG000|Overall Study|Lack of Efficacy|3|||
124911428|NCT03988023|449302863|FG001|Overall Study|Lack of Efficacy|1|||
124911429|NCT03988023|449302862|FG000|Overall Study|COVID-19 pandemic|225|||
124911430|NCT03988023|449302863|FG001|Overall Study|COVID-19 pandemic|227|||
124911431|NCT03703336|449302864|FG000|Overall Study|Parent withdrew consent|29|||
124911432|NCT03703336|449302865|FG001|Overall Study|Parent withdrew consent|8|||
124911433|NCT03703336|449302864|FG000|Overall Study|Migration|3|||
124911434|NCT03703336|449302865|FG001|Overall Study|Migration|3|||
124911435|NCT03703336|449302864|FG000|Overall Study|Protocol Violation|3|||
124911436|NCT03703336|449302865|FG001|Overall Study|Protocol Violation|1|||
124911437|NCT03703336|449302864|FG000|Overall Study|Physician Decision|2|||
124911438|NCT03703336|449302865|FG001|Overall Study|Physician Decision|0|||
124911439|NCT03703336|449302864|FG000|Overall Study|Adverse Event|0|||
124911440|NCT03703336|449302865|FG001|Overall Study|Adverse Event|2|||
124911441|NCT03703336|449302864|FG000|Overall Study|Lost to Follow-up|1|||
124911442|NCT03703336|449302865|FG001|Overall Study|Lost to Follow-up|0|||
124911443|NCT02088853|449302868|FG000|Overall Study|Pregnancy|1|||
124911444|NCT02088853|449302869|FG001|Overall Study|Pregnancy|0|||
124911445|NCT02568683|449302870|FG000|Overall Study|Death|0|||
124911446|NCT02568683|449302871|FG001|Overall Study|Death|2|||
124911447|NCT02568683|449302870|FG000|Overall Study|Withdrew Consent|1|||
124911448|NCT02568683|449302871|FG001|Overall Study|Withdrew Consent|0|||
124911449|NCT02568683|449302870|FG000|Overall Study|Study Terminated By Sponsor|5|||
124911450|NCT02568683|449302871|FG001|Overall Study|Study Terminated By Sponsor|2|||
124911451|NCT01736215|449302872|FG000|Overall Study|Early termination of erythropoietin use|1|||
124911452|NCT01736215|449302872|FG000|Overall Study|Adverse Event|4|||
124911453|NCT01736215|449302872|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
124911454|NCT01736215|449302872|FG000|Overall Study|Insufficient data to perform analysis|8|||
124911455|NCT01248936|449302878|FG000|Overall Study|Sponsor Decision|259|||
124911456|NCT01248936|449302878|FG000|Overall Study|Progression of Disease|50|||
124911457|NCT01248936|449302878|FG000|Overall Study|Death|26|||
124911458|NCT01248936|449302878|FG000|Overall Study|Withdrawal of Consent|20|||
124911459|NCT01248936|449302878|FG000|Overall Study|Adverse Event|8|||
124911460|NCT01248936|449302878|FG000|Overall Study|Lost to Follow-up|7|||
124911461|NCT01248936|449302878|FG000|Overall Study|Refused Treatment|1|||
124911462|NCT01248936|449302878|FG000|Overall Study|Other reason|3|||
124911463|NCT03930420|449302879|FG000|Overall Study|Withdrawal by Subject|7|||
124911464|NCT03930420|449302880|FG001|Overall Study|Withdrawal by Subject|9|||
124911465|NCT04556981|449302881|FG000|Overall Study|Death|0|||
124911466|NCT04556981|449302882|FG001|Overall Study|Death|1|||
124911467|NCT04556981|449302881|FG000|Overall Study|Lost to Follow-up|2|||
124911468|NCT04556981|449302882|FG001|Overall Study|Lost to Follow-up|11|||
124911469|NCT04556981|449302881|FG000|Overall Study|Moved from the study area|1|||
124911470|NCT04556981|449302882|FG001|Overall Study|Moved from the study area|4|||
124911471|NCT04556981|449302881|FG000|Overall Study|Withdrawal by Subject|2|||
124911472|NCT04556981|449302882|FG001|Overall Study|Withdrawal by Subject|2|||
124692480|NCT02675452|448494767|FG015|Overall Study|Death|2|||
124692481|NCT02675452|448494768|FG016|Overall Study|Death|0|||
124692482|NCT02675452|448494769|FG017|Overall Study|Death|0|||
124692483|NCT02675452|448494770|FG018|Overall Study|Death|4|||
124692484|NCT02675452|448494771|FG019|Overall Study|Death|3|||
124692485|NCT02675452|448494772|FG020|Overall Study|Death|3|||
124911473|NCT04556981|449302881|FG000|Overall Study|Other|2|||
124911474|NCT04556981|449302882|FG001|Overall Study|Other|1|||
124911475|NCT00609336|449302883|FG000|Overall Study|Protocol Violation|3|||
124911476|NCT00609336|449302883|FG000|Overall Study|Death|1|||
124911477|NCT00609336|449302883|FG000|Overall Study|LA or Met at Surgery|9|||
124911478|NCT02238483|449302884|FG000|Overall Study|Withdrawal by Subject|2|||
124911479|NCT02238483|449302885|FG001|Overall Study|Withdrawal by Subject|7|||
124911480|NCT02238483|449302884|FG000|Overall Study|Lost to Follow-up|1|||
124911481|NCT02238483|449302885|FG001|Overall Study|Lost to Follow-up|1|||
124911482|NCT02238483|449302884|FG000|Overall Study|Protocol Violation|1|||
124911483|NCT02238483|449302885|FG001|Overall Study|Protocol Violation|2|||
124911484|NCT02238483|449302884|FG000|Overall Study|Death|1|||
124911485|NCT02238483|449302885|FG001|Overall Study|Death|0|||
124911486|NCT02238483|449302884|FG000|Overall Study|Adverse Event|7|||
124911487|NCT02238483|449302885|FG001|Overall Study|Adverse Event|3|||
124911488|NCT02238483|449302884|FG000|Overall Study|Withdrawn due to physician decision|1|||
124911489|NCT02238483|449302885|FG001|Overall Study|Withdrawn due to physician decision|0|||
124911490|NCT02238483|449302884|FG000|Overall Study|Completion status not recorded|1|||
124911491|NCT02238483|449302885|FG001|Overall Study|Completion status not recorded|1|||
124911492|NCT02238483|449302884|FG000|Overall Study|Illness in family member|1|||
124911493|NCT02238483|449302885|FG001|Overall Study|Illness in family member|0|||
124911494|NCT01388361|449302886|FG000|Overall Study|Adverse Event|0|||
124911495|NCT01388361|449302887|FG001|Overall Study|Adverse Event|5|||
124911496|NCT01388361|449302888|FG002|Overall Study|Adverse Event|1|||
124911497|NCT01388361|449302886|FG000|Overall Study|Protocol Violation|0|||
124911498|NCT01388361|449302887|FG001|Overall Study|Protocol Violation|0|||
124911499|NCT01388361|449302888|FG002|Overall Study|Protocol Violation|2|||
124911500|NCT01388361|449302886|FG000|Overall Study|Withdrawal criteria|12|||
124911501|NCT01388361|449302887|FG001|Overall Study|Withdrawal criteria|7|||
124911502|NCT01388361|449302888|FG002|Overall Study|Withdrawal criteria|10|||
124911503|NCT01388361|449302886|FG000|Overall Study|Unclassified|0|||
124911504|NCT01388361|449302887|FG001|Overall Study|Unclassified|0|||
124911505|NCT01388361|449302888|FG002|Overall Study|Unclassified|1|||
124911506|NCT00539734|449302889|FG000|Overall Study|Protocol Violation|1|||
124911507|NCT01070069|449302891|FG000|Overall Study|Death|1|||
124911508|NCT01070069|449302892|FG001|Overall Study|Death|0|||
124911509|NCT01070069|449302893|FG002|Overall Study|Death|2|||
124911510|NCT01070069|449302894|FG003|Overall Study|Death|0|||
124911511|NCT01070069|449302895|FG004|Overall Study|Death|1|||
124911512|NCT01070069|449302891|FG000|Overall Study|Withdrawal by Subject|1|||
124911513|NCT01070069|449302892|FG001|Overall Study|Withdrawal by Subject|1|||
124911514|NCT01070069|449302893|FG002|Overall Study|Withdrawal by Subject|4|||
124911515|NCT01070069|449302894|FG003|Overall Study|Withdrawal by Subject|0|||
124911516|NCT01070069|449302895|FG004|Overall Study|Withdrawal by Subject|0|||
124911517|NCT01070069|449302891|FG000|Overall Study|Lost to Follow-up|4|||
124911518|NCT01070069|449302892|FG001|Overall Study|Lost to Follow-up|1|||
124911519|NCT01070069|449302893|FG002|Overall Study|Lost to Follow-up|0|||
124911520|NCT01070069|449302894|FG003|Overall Study|Lost to Follow-up|0|||
124911521|NCT01070069|449302895|FG004|Overall Study|Lost to Follow-up|3|||
124911522|NCT00440011|449302908|FG000|Overall Study|Adverse Event|2|||
124911523|NCT00440011|449302909|FG001|Overall Study|Adverse Event|0|||
124911524|NCT00440011|449302908|FG000|Overall Study|Lost to Follow-up|0|||
124911525|NCT00440011|449302909|FG001|Overall Study|Lost to Follow-up|2|||
124911526|NCT00440011|449302908|FG000|Overall Study|Protocol Violation|1|||
124911527|NCT00440011|449302909|FG001|Overall Study|Protocol Violation|1|||
124911528|NCT00440011|449302908|FG000|Overall Study|Withdrawal by Subject|1|||
124911529|NCT00440011|449302909|FG001|Overall Study|Withdrawal by Subject|0|||
124911530|NCT00419341|449302910|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
124911531|NCT00419341|449302910|FG000|Wash in/Wash Out Period|Adverse Event|2|||
124911532|NCT00419341|449302910|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
124911533|NCT00419341|449302910|FG000|Efficacy Period|Withdrawal by Subject|6|||
124911534|NCT00419341|449302910|FG000|Efficacy Period|Protocol Violation|1|||
124911535|NCT00419341|449302910|FG000|Efficacy Period|Lost to Follow-up|1|||
124911536|NCT00419341|449302910|FG000|Efficacy Period|Non-compliance|1|||
124911537|NCT00419341|449302910|FG000|Efficacy Period|Termination of study site|1|||
124911538|NCT04200365|449302911|FG000|Overall Study|Adverse Event|2|||
124911539|NCT04200365|449302911|FG000|Overall Study|Progressive Disease|4|||
124911540|NCT04200365|449302911|FG000|Overall Study|Lack of Efficacy|1|||
124911541|NCT04200365|449302911|FG000|Overall Study|Study Closure|4|||
124911542|NCT01538719|449302917|FG000|Overall Study|Lost to Follow-up|2|||
124911543|NCT01538719|449302918|FG001|Overall Study|Lost to Follow-up|0|||
124911544|NCT03664960|449302919|FG000|Overall Study|Adverse Event|0|||
124692486|NCT02675452|448494773|FG021|Overall Study|Death|3|||
124692487|NCT02675452|448494774|FG022|Overall Study|Death|7|||
124911545|NCT03664960|449302920|FG001|Overall Study|Adverse Event|3|||
124911546|NCT03664960|449302919|FG000|Overall Study|Lost to Follow-up|3|||
124911547|NCT03664960|449302920|FG001|Overall Study|Lost to Follow-up|2|||
124911548|NCT03664960|449302919|FG000|Overall Study|Physician Decision|1|||
124911549|NCT03664960|449302920|FG001|Overall Study|Physician Decision|0|||
124911550|NCT03664960|449302919|FG000|Overall Study|Withdrawal by Subject|3|||
124911551|NCT03664960|449302920|FG001|Overall Study|Withdrawal by Subject|14|||
124911552|NCT03664960|449302919|FG000|Overall Study|Sponsor Decision|1|||
124911553|NCT03664960|449302920|FG001|Overall Study|Sponsor Decision|1|||
124911554|NCT03664960|449302919|FG000|Overall Study|Other|1|||
124911555|NCT03664960|449302920|FG001|Overall Study|Other|2|||
124911556|NCT03783026|449304749|FG000|Treatment Phase|Adverse Event|15|||
124911557|NCT03783026|449304749|FG000|Treatment Phase|Lack of Efficacy|11|||
124911558|NCT03783026|449304749|FG000|Treatment Phase|Withdrawal by Subject|6|||
124911559|NCT03783026|449304749|FG000|Treatment Phase|Lost to Follow-up|2|||
124911560|NCT03783026|449304749|FG000|Treatment Phase|Protocol Deviation|8|||
124911561|NCT03783026|449304749|FG000|Treatment Phase|Did Not Receive Treatment|1|||
124911562|NCT03783026|449304749|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
124911563|NCT05568615|449304768|FG000|Overall Study|Death|1|||
124911564|NCT05568615|449304768|FG000|Overall Study|Physician Decision|1|||
124545000|NCT03426995|447949265|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
124545001|NCT03426995|447949266|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
124545002|NCT03426995|447949267|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
124545003|NCT03426995|447949268|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
124911565|NCT03529110|449304769|FG000|Overall Study|Progressive Disease|66|||
124911566|NCT03529110|449304770|FG001|Overall Study|Progressive Disease|158|||
124911567|NCT03529110|449304769|FG000|Overall Study|Clinical Progression|4|||
124911568|NCT03529110|449304770|FG001|Overall Study|Clinical Progression|12|||
124911569|NCT03529110|449304769|FG000|Overall Study|Adverse Event|35|||
124911570|NCT03529110|449304770|FG001|Overall Study|Adverse Event|17|||
124911571|NCT03529110|449304769|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
124911572|NCT03529110|449304770|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
124450394|NCT00766090|447611960|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
124450395|NCT00766090|447611961|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
124450396|NCT00766090|447611962|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
124450397|NCT00766090|447611963|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
124450398|NCT00766090|447611964|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
124450399|NCT00766090|447611965|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
124450400|NCT00766090|447611954|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
124450401|NCT00766090|447611955|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
124450402|NCT00766090|447611956|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
124450403|NCT00766090|447611957|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
124450404|NCT00766090|447611958|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
124450405|NCT00766090|447611959|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
124450406|NCT00766090|447611960|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
124450407|NCT00766090|447611961|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
124450408|NCT00766090|447611962|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
124450409|NCT00766090|447611963|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
124450410|NCT00766090|447611964|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
124450411|NCT00766090|447611965|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
124450412|NCT00766090|447611954|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
124450413|NCT00766090|447611955|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
124450414|NCT00766090|447611956|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
124450415|NCT00766090|447611957|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
124450416|NCT00766090|447611958|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
124450417|NCT00766090|447611959|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
124450418|NCT00766090|447611960|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
124450419|NCT00766090|447611961|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
124450420|NCT00766090|447611962|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
124450421|NCT00766090|447611963|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
124450422|NCT00766090|447611964|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
124450423|NCT00766090|447611965|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
124450424|NCT00766090|447611954|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
124450425|NCT00766090|447611955|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
124450426|NCT00766090|447611956|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
124450427|NCT00766090|447611957|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
124545004|NCT03426995|447949269|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
124545005|NCT03426995|447949270|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
124545006|NCT03426995|447949271|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
124545007|NCT03426995|447949272|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
124450428|NCT00766090|447611958|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
124545008|NCT03426995|447949273|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
124911573|NCT03529110|449304769|FG000|Overall Study|Lack of Efficacy|3|||
124911574|NCT03529110|449304770|FG001|Overall Study|Lack of Efficacy|3|||
124911575|NCT03529110|449304769|FG000|Overall Study|Physician Decision|2|||
124911576|NCT03529110|449304770|FG001|Overall Study|Physician Decision|8|||
124911577|NCT03529110|449304769|FG000|Overall Study|Miscellaneous|2|||
124911578|NCT03529110|449304770|FG001|Overall Study|Miscellaneous|5|||
124911579|NCT03237481|449304771|FG000|Overall Study|Lost to Follow-up|1|||
124911580|NCT03237481|449304772|FG001|Overall Study|Lost to Follow-up|0|||
124911581|NCT03237481|449304773|FG002|Overall Study|Lost to Follow-up|0|||
124911582|NCT03237481|449304771|FG000|Overall Study|Protocol Violation|1|||
124911583|NCT03237481|449304772|FG001|Overall Study|Protocol Violation|0|||
124911584|NCT03237481|449304773|FG002|Overall Study|Protocol Violation|0|||
124911585|NCT03237481|449304771|FG000|Overall Study|Withdrawal by Subject|3|||
124911586|NCT03237481|449304772|FG001|Overall Study|Withdrawal by Subject|2|||
124911587|NCT03237481|449304773|FG002|Overall Study|Withdrawal by Subject|1|||
124911588|NCT03873779|449304778|FG000|Overall Study|Withdrawal by Subject|1|||
124911589|NCT04279574|449304781|FG000|Overall Study|Death|1|||
124911590|NCT04279574|449304782|FG001|Overall Study|Death|0|||
124911591|NCT04279574|449304781|FG000|Overall Study|lost restoration, tooth fracture|1|||
124911592|NCT04279574|449304782|FG001|Overall Study|lost restoration, tooth fracture|0|||
124911593|NCT04279574|449304781|FG000|Overall Study|Lost to Follow-up|0|||
124911594|NCT04279574|449304782|FG001|Overall Study|Lost to Follow-up|1|||
124911595|NCT05773313|449304784|FG000|Overall Study|Lost to Follow-up|3|||
124911596|NCT02374463|449304786|FG000|Overall Study|Withdrawal by Subject|3|||
124911597|NCT02374463|449304787|FG001|Overall Study|Withdrawal by Subject|3|||
124911598|NCT01266122|449304789|FG000|Overall Study|Lost to Follow-up|6|||
124692488|NCT02675452|448494775|FG023|Overall Study|Death|5|||
124692489|NCT02675452|448494776|FG024|Overall Study|Death|3|||
124692490|NCT02675452|448494777|FG025|Overall Study|Death|4|||
124692491|NCT02675452|448494778|FG026|Overall Study|Death|7|||
124692492|NCT02675452|448494779|FG027|Overall Study|Death|6|||
124911599|NCT01266122|449304790|FG001|Overall Study|Lost to Follow-up|6|||
124911600|NCT00421889|449304791|FG000|Overall Study|Adverse Event|1|||
124911601|NCT00421889|449304792|FG001|Overall Study|Adverse Event|0|||
124692493|NCT02675452|448494780|FG028|Overall Study|Death|9|||
124692494|NCT02675452|448494752|FG000|Overall Study|Lost to Follow-up|0|||
124692495|NCT02675452|448494753|FG001|Overall Study|Lost to Follow-up|1|||
124692496|NCT02675452|448494754|FG002|Overall Study|Lost to Follow-up|0|||
124692497|NCT02675452|448494755|FG003|Overall Study|Lost to Follow-up|0|||
124692498|NCT02675452|448494756|FG004|Overall Study|Lost to Follow-up|0|||
124692499|NCT02675452|448494757|FG005|Overall Study|Lost to Follow-up|0|||
124692500|NCT02675452|448494758|FG006|Overall Study|Lost to Follow-up|0|||
124692501|NCT02675452|448494759|FG007|Overall Study|Lost to Follow-up|0|||
124692502|NCT02675452|448494760|FG008|Overall Study|Lost to Follow-up|0|||
124692503|NCT02675452|448494761|FG009|Overall Study|Lost to Follow-up|0|||
124692504|NCT02675452|448494762|FG010|Overall Study|Lost to Follow-up|0|||
124692505|NCT02675452|448494763|FG011|Overall Study|Lost to Follow-up|0|||
124692506|NCT02675452|448494764|FG012|Overall Study|Lost to Follow-up|1|||
124692507|NCT02675452|448494765|FG013|Overall Study|Lost to Follow-up|0|||
124692508|NCT02675452|448494766|FG014|Overall Study|Lost to Follow-up|0|||
124692509|NCT02675452|448494767|FG015|Overall Study|Lost to Follow-up|0|||
124692510|NCT02675452|448494768|FG016|Overall Study|Lost to Follow-up|0|||
124692511|NCT02675452|448494769|FG017|Overall Study|Lost to Follow-up|0|||
124692512|NCT02675452|448494770|FG018|Overall Study|Lost to Follow-up|0|||
124692513|NCT02675452|448494771|FG019|Overall Study|Lost to Follow-up|0|||
124692514|NCT02675452|448494772|FG020|Overall Study|Lost to Follow-up|0|||
124692515|NCT02675452|448494773|FG021|Overall Study|Lost to Follow-up|0|||
124692516|NCT02675452|448494774|FG022|Overall Study|Lost to Follow-up|0|||
124692517|NCT02675452|448494775|FG023|Overall Study|Lost to Follow-up|0|||
124692518|NCT02675452|448494776|FG024|Overall Study|Lost to Follow-up|0|||
124692519|NCT02675452|448494777|FG025|Overall Study|Lost to Follow-up|0|||
124692520|NCT02675452|448494778|FG026|Overall Study|Lost to Follow-up|1|||
124692521|NCT02675452|448494779|FG027|Overall Study|Lost to Follow-up|0|||
124692522|NCT02675452|448494780|FG028|Overall Study|Lost to Follow-up|0|||
124692523|NCT02675452|448494752|FG000|Overall Study|Other|0|||
124692524|NCT02675452|448494753|FG001|Overall Study|Other|0|||
124692525|NCT02675452|448494754|FG002|Overall Study|Other|0|||
124692526|NCT02675452|448494755|FG003|Overall Study|Other|0|||
124692527|NCT02675452|448494756|FG004|Overall Study|Other|0|||
124692528|NCT02675452|448494757|FG005|Overall Study|Other|0|||
124692529|NCT02675452|448494758|FG006|Overall Study|Other|0|||
124692530|NCT02675452|448494759|FG007|Overall Study|Other|0|||
124911602|NCT00421889|449304793|FG002|Overall Study|Adverse Event|1|||
124911603|NCT00421889|449304794|FG003|Overall Study|Adverse Event|1|||
124911604|NCT00421889|449304795|FG004|Overall Study|Adverse Event|1|||
124692531|NCT02675452|448494760|FG008|Overall Study|Other|0|||
124692532|NCT02675452|448494761|FG009|Overall Study|Other|0|||
124692533|NCT02675452|448494762|FG010|Overall Study|Other|0|||
124692534|NCT02675452|448494763|FG011|Overall Study|Other|0|||
124692535|NCT02675452|448494764|FG012|Overall Study|Other|0|||
124692536|NCT02675452|448494765|FG013|Overall Study|Other|0|||
124692537|NCT02675452|448494766|FG014|Overall Study|Other|0|||
124911605|NCT00421889|449304796|FG005|Overall Study|Adverse Event|4|||
124692538|NCT02675452|448494767|FG015|Overall Study|Other|0|||
124692539|NCT02675452|448494768|FG016|Overall Study|Other|0|||
124692540|NCT02675452|448494769|FG017|Overall Study|Other|0|||
124692541|NCT02675452|448494770|FG018|Overall Study|Other|0|||
124692542|NCT02675452|448494771|FG019|Overall Study|Other|0|||
124911606|NCT00421889|449304797|FG006|Overall Study|Adverse Event|1|||
124545009|NCT03426995|447949274|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
124545010|NCT03426995|447949275|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
124545011|NCT03426995|447949276|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
124545012|NCT03426995|447949277|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
124545013|NCT03426995|447949278|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
124545014|NCT03426995|447949279|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
124545015|NCT05939388|447949280|FG000|Overall Study|Lost to Follow-up|1|||
124545016|NCT00602667|447949281|FG000|Overall Study|Still on Therapy|0|||
124545017|NCT00602667|447949282|FG001|Overall Study|Still on Therapy|2|||
124545018|NCT00602667|447949283|FG002|Overall Study|Still on Therapy|2|||
124545019|NCT00602667|447949281|FG000|Overall Study|Death|0|||
124545020|NCT00602667|447949282|FG001|Overall Study|Death|1|||
124545021|NCT00602667|447949283|FG002|Overall Study|Death|1|||
124545022|NCT00602667|447949281|FG000|Overall Study|Family request|3|||
124545023|NCT00602667|447949282|FG001|Overall Study|Family request|25|||
124545024|NCT00602667|447949283|FG002|Overall Study|Family request|6|||
124545025|NCT00602667|447949281|FG000|Overall Study|Excessive toxicity|1|||
124545026|NCT00602667|447949282|FG001|Overall Study|Excessive toxicity|1|||
124545027|NCT00602667|447949283|FG002|Overall Study|Excessive toxicity|0|||
124545028|NCT00602667|447949281|FG000|Overall Study|Second malignancy|0|||
124545029|NCT00602667|447949282|FG001|Overall Study|Second malignancy|1|||
124545030|NCT00602667|447949283|FG002|Overall Study|Second malignancy|0|||
124545031|NCT00602667|447949281|FG000|Overall Study|Physician Decision|2|||
124545032|NCT00602667|447949282|FG001|Overall Study|Physician Decision|3|||
124760693|NCT03001557|448749085|FG007|Extension Phase|Loss of caregiver|0|||
124760694|NCT03001557|448749078|FG000|Extension Phase|Others|0|||
124760695|NCT03001557|448749079|FG001|Extension Phase|Others|0|||
124911607|NCT00421889|449304798|FG007|Overall Study|Adverse Event|0|||
124911608|NCT00421889|449304799|FG008|Overall Study|Adverse Event|2|||
124911609|NCT00421889|449304791|FG000|Overall Study|Withdrawal by Subject|1|||
124911610|NCT00421889|449304792|FG001|Overall Study|Withdrawal by Subject|3|||
124911611|NCT00421889|449304793|FG002|Overall Study|Withdrawal by Subject|0|||
124911612|NCT00421889|449304794|FG003|Overall Study|Withdrawal by Subject|0|||
124911613|NCT00421889|449304795|FG004|Overall Study|Withdrawal by Subject|2|||
124911614|NCT00421889|449304796|FG005|Overall Study|Withdrawal by Subject|0|||
124911615|NCT00421889|449304797|FG006|Overall Study|Withdrawal by Subject|0|||
124911616|NCT00421889|449304798|FG007|Overall Study|Withdrawal by Subject|0|||
124911617|NCT00421889|449304799|FG008|Overall Study|Withdrawal by Subject|0|||
124911618|NCT00421889|449304791|FG000|Overall Study|Death|0|||
124911619|NCT00421889|449304792|FG001|Overall Study|Death|0|||
124911620|NCT00421889|449304793|FG002|Overall Study|Death|0|||
124911621|NCT00421889|449304794|FG003|Overall Study|Death|0|||
124911622|NCT00421889|449304795|FG004|Overall Study|Death|1|||
124911623|NCT00421889|449304796|FG005|Overall Study|Death|1|||
124911624|NCT00421889|449304797|FG006|Overall Study|Death|0|||
124911625|NCT00421889|449304798|FG007|Overall Study|Death|0|||
124911626|NCT00421889|449304799|FG008|Overall Study|Death|0|||
124911627|NCT00421889|449304791|FG000|Overall Study|Progressive disease|3|||
124911628|NCT00421889|449304792|FG001|Overall Study|Progressive disease|2|||
124911629|NCT00421889|449304793|FG002|Overall Study|Progressive disease|2|||
124911630|NCT00421889|449304794|FG003|Overall Study|Progressive disease|3|||
124911631|NCT00421889|449304795|FG004|Overall Study|Progressive disease|2|||
124911632|NCT00421889|449304796|FG005|Overall Study|Progressive disease|21|||
124911633|NCT00421889|449304797|FG006|Overall Study|Progressive disease|3|||
124911634|NCT00421889|449304798|FG007|Overall Study|Progressive disease|1|||
124911635|NCT00421889|449304799|FG008|Overall Study|Progressive disease|5|||
124911636|NCT00421889|449304791|FG000|Overall Study|Patient/Investigator request|0|||
124911637|NCT00421889|449304792|FG001|Overall Study|Patient/Investigator request|0|||
124911638|NCT00421889|449304793|FG002|Overall Study|Patient/Investigator request|0|||
124911639|NCT00421889|449304794|FG003|Overall Study|Patient/Investigator request|0|||
124545033|NCT00602667|447949283|FG002|Overall Study|Physician Decision|8|||
124545034|NCT00602667|447949281|FG000|Overall Study|Progressive disease|13|||
124545035|NCT00602667|447949282|FG001|Overall Study|Progressive disease|48|||
124545036|NCT00602667|447949283|FG002|Overall Study|Progressive disease|45|||
124545037|NCT00602667|447949281|FG000|Overall Study|Progressive disease prior to therapy|0|||
124545038|NCT00602667|447949282|FG001|Overall Study|Progressive disease prior to therapy|0|||
124545039|NCT00602667|447949283|FG002|Overall Study|Progressive disease prior to therapy|1|||
124545040|NCT05153629|447949284|FG000|Overall Study|Withdrawal by Subject|0|||
124545041|NCT05153629|447949285|FG001|Overall Study|Withdrawal by Subject|2|||
124545042|NCT00885677|447949288|FG000|Overall Study|Death|40|||
124545043|NCT00885677|447949289|FG001|Overall Study|Death|34|||
124760696|NCT03001557|448749080|FG002|Extension Phase|Others|0|||
124911640|NCT00421889|449304795|FG004|Overall Study|Patient/Investigator request|0|||
124911641|NCT00421889|449304796|FG005|Overall Study|Patient/Investigator request|9|||
124911642|NCT00421889|449304797|FG006|Overall Study|Patient/Investigator request|0|||
124911643|NCT00421889|449304798|FG007|Overall Study|Patient/Investigator request|1|||
124911644|NCT00421889|449304799|FG008|Overall Study|Patient/Investigator request|3|||
124450429|NCT00766090|447611959|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
124450430|NCT00766090|447611960|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
124450431|NCT00766090|447611961|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
124450432|NCT00766090|447611962|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
124450433|NCT00766090|447611963|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
124450434|NCT00766090|447611964|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
124450435|NCT00766090|447611965|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
124760697|NCT03001557|448749081|FG003|Extension Phase|Others|0|||
124760698|NCT03001557|448749082|FG004|Extension Phase|Others|0|||
124760699|NCT03001557|448749083|FG005|Extension Phase|Others|1|||
124760700|NCT03001557|448749084|FG006|Extension Phase|Others|3|||
124760701|NCT03001557|448749085|FG007|Extension Phase|Others|0|||
124760702|NCT01272232|448749086|FG000|Weeks 0-56|Adverse Event|39|||
124760703|NCT01272232|448749087|FG001|Weeks 0-56|Adverse Event|18|||
124760704|NCT01272232|448749088|FG002|Weeks 0-56|Adverse Event|7|||
124760705|NCT01272232|448749086|FG000|Weeks 0-56|Lack of Efficacy|0|||
124911645|NCT00421889|449304791|FG000|Overall Study|Lost to Follow-up|0|||
124911646|NCT00421889|449304792|FG001|Overall Study|Lost to Follow-up|0|||
124911647|NCT00421889|449304793|FG002|Overall Study|Lost to Follow-up|0|||
124911648|NCT00421889|449304794|FG003|Overall Study|Lost to Follow-up|0|||
124911649|NCT00421889|449304795|FG004|Overall Study|Lost to Follow-up|0|||
124911650|NCT00421889|449304796|FG005|Overall Study|Lost to Follow-up|0|||
124911651|NCT00421889|449304797|FG006|Overall Study|Lost to Follow-up|0|||
124911652|NCT00421889|449304798|FG007|Overall Study|Lost to Follow-up|0|||
124911653|NCT00421889|449304799|FG008|Overall Study|Lost to Follow-up|1|||
124911654|NCT03756571|449304800|FG000|Overall Study|Lost to Follow-up|1|||
124911655|NCT03756571|449304801|FG001|Overall Study|Lost to Follow-up|1|||
124911656|NCT00978042|449304802|FG000|Initial Treatment Period|Treated in Error|0|||
124911657|NCT00978042|449304803|FG001|Initial Treatment Period|Treated in Error|3|||
124911658|NCT00978042|449304802|FG000|Initial Treatment Period|Ineligibility|1|||
124450436|NCT00766090|447611954|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
124450437|NCT00766090|447611955|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
124450438|NCT00766090|447611956|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
124450439|NCT00766090|447611957|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
124450440|NCT00766090|447611958|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
124450441|NCT00766090|447611959|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
124450442|NCT00766090|447611960|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
124450443|NCT00766090|447611961|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
124450444|NCT00766090|447611962|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
124450445|NCT00766090|447611963|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
124450446|NCT00766090|447611964|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
124450447|NCT00766090|447611965|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
124450448|NCT00800436|447611966|FG000|Overall Study|Withdrawal by Subject|0|||
124450449|NCT00800436|447611967|FG001|Overall Study|Withdrawal by Subject|0|||
124450450|NCT00800436|447611968|FG002|Overall Study|Withdrawal by Subject|1|||
124450451|NCT00800436|447611969|FG003|Overall Study|Withdrawal by Subject|1|||
124450452|NCT00800436|447611970|FG004|Overall Study|Withdrawal by Subject|0|||
124450453|NCT00800436|447611971|FG005|Overall Study|Withdrawal by Subject|0|||
124450454|NCT00800436|447611972|FG006|Overall Study|Withdrawal by Subject|0|||
124450455|NCT01106027|447611976|FG000|Overall Study|Lost graft early, discontinued|1|||
124450456|NCT02653300|447611977|FG000|Overall Study|Withdrawal by Subject|2|||
124450457|NCT00369785|447611978|FG000|Overall Study|Physician Decision|3|||
124450458|NCT00369785|447611979|FG001|Overall Study|Physician Decision|2|||
124450459|NCT00369785|447611978|FG000|Overall Study|Death|1|||
124450460|NCT00369785|447611979|FG001|Overall Study|Death|2|||
124450461|NCT00369785|447611978|FG000|Overall Study|Withdrawal by Subject|7|||
124450462|NCT00369785|447611979|FG001|Overall Study|Withdrawal by Subject|6|||
124450463|NCT00369785|447611978|FG000|Overall Study|Toxicity|6|||
124450464|NCT00369785|447611979|FG001|Overall Study|Toxicity|4|||
124450465|NCT00369785|447611978|FG000|Overall Study|Never started|0|||
124450466|NCT00369785|447611979|FG001|Overall Study|Never started|2|||
124450467|NCT00369785|447611978|FG000|Overall Study|Progression|4|||
124911659|NCT00978042|449304803|FG001|Initial Treatment Period|Ineligibility|0|||
124450468|NCT00369785|447611979|FG001|Overall Study|Progression|4|||
124450469|NCT00369785|447611978|FG000|Overall Study|Multiple reasons|6|||
124450470|NCT00369785|447611979|FG001|Overall Study|Multiple reasons|5|||
124450471|NCT00888381|447611985|FG000|Overall Study|Lost to Follow-up|0|||
124450472|NCT00888381|447611986|FG001|Overall Study|Lost to Follow-up|1|||
124450473|NCT00757003|447611987|FG000|Overall Study|Death|33|||
124450474|NCT00757003|447611987|FG000|Overall Study|Lost to Follow-up|9|||
124450475|NCT00757003|447611987|FG000|Overall Study|Withdrawal by Subject|4|||
124911660|NCT00978042|449304802|FG000|Initial Treatment Period|Lost to Follow-up|21|||
124450476|NCT00757003|447611987|FG000|Overall Study|Surgically explanted|2|||
124760706|NCT01272232|448749087|FG001|Weeks 0-56|Lack of Efficacy|0|||
124760707|NCT01272232|448749088|FG002|Weeks 0-56|Lack of Efficacy|3|||
124760708|NCT01272232|448749086|FG000|Weeks 0-56|Protocol Violation|12|||
124760709|NCT01272232|448749087|FG001|Weeks 0-56|Protocol Violation|8|||
124911661|NCT00978042|449304803|FG001|Initial Treatment Period|Lost to Follow-up|3|||
124911662|NCT00978042|449304802|FG000|Initial Treatment Period|Adverse Event|2|||
124911663|NCT00978042|449304803|FG001|Initial Treatment Period|Adverse Event|0|||
124911664|NCT00978042|449304802|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
124911665|NCT00978042|449304803|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
124911666|NCT00978042|449304802|FG000|Initial Treatment Period|Consent withdrawn|22|||
124911667|NCT00978042|449304803|FG001|Initial Treatment Period|Consent withdrawn|9|||
124911668|NCT00978042|449304802|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
124911669|NCT00978042|449304803|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
124911670|NCT00520546|449304804|FG000|Overall Study|Withdrawal by Subject|1|||
124911671|NCT00520546|449304804|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
124911672|NCT02101281|449304805|FG000|Overall Study|Adverse Event|0|||
124911673|NCT02101281|449304806|FG001|Overall Study|Adverse Event|1|||
124911674|NCT04452318|449304807|FG000|Overall Study|Physician Decision|1|||
124911675|NCT04452318|449304808|FG001|Overall Study|Physician Decision|2|||
124911676|NCT04452318|449304809|FG002|Overall Study|Physician Decision|0|||
124911677|NCT04452318|449304810|FG003|Overall Study|Physician Decision|2|||
124450477|NCT00757003|447611987|FG000|Overall Study|Not implanted|1|||
124450478|NCT02146599|447611990|FG000|Overall Study|Failed to meet inclusion criteria|5|||
124450479|NCT03044249|447611996|FG000|Overall Study|Adverse Event|4|||
124450480|NCT03044249|447611997|FG001|Overall Study|Adverse Event|9|||
124450481|NCT03044249|447611996|FG000|Overall Study|Lost to Follow-up|1|||
124450482|NCT03044249|447611997|FG001|Overall Study|Lost to Follow-up|0|||
124450483|NCT03044249|447611996|FG000|Overall Study|Non-compliance with Study Drug|1|||
124545044|NCT00885677|447949288|FG000|Overall Study|Lost to Follow-up|15|||
124545045|NCT00885677|447949289|FG001|Overall Study|Lost to Follow-up|13|||
124450484|NCT03044249|447611997|FG001|Overall Study|Non-compliance with Study Drug|0|||
124450485|NCT03044249|447611996|FG000|Overall Study|Study Terminated by Sponsor|2|||
124450486|NCT03044249|447611997|FG001|Overall Study|Study Terminated by Sponsor|0|||
124545046|NCT00885677|447949288|FG000|Overall Study|Protocol Violation|54|||
124545047|NCT00885677|447949289|FG001|Overall Study|Protocol Violation|54|||
124545048|NCT00885677|447949288|FG000|Overall Study|premature study closure|41|||
124545049|NCT00885677|447949289|FG001|Overall Study|premature study closure|44|||
124545050|NCT00885677|447949288|FG000|Overall Study|device/lead revision or replacement|7|||
124545051|NCT00885677|447949289|FG001|Overall Study|device/lead revision or replacement|6|||
124545052|NCT00885677|447949288|FG000|Overall Study|Heart transplantation|1|||
124545053|NCT00885677|447949289|FG001|Overall Study|Heart transplantation|0|||
124545054|NCT00885677|447949288|FG000|Overall Study|Inclusion/exclusion not met|25|||
124545055|NCT00885677|447949289|FG001|Overall Study|Inclusion/exclusion not met|27|||
124545056|NCT00972309|447949290|FG000|Overall Study|Switched to alternative treatment|0|||
124545057|NCT00972309|447949291|FG001|Overall Study|Switched to alternative treatment|2|||
124545058|NCT00972309|447949290|FG000|Overall Study|Refused further treatment|0|||
124545059|NCT00972309|447949291|FG001|Overall Study|Refused further treatment|1|||
124545060|NCT00972309|447949290|FG000|Overall Study|Late determination of ineligibility|0|||
124545061|NCT00972309|447949291|FG001|Overall Study|Late determination of ineligibility|1|||
124545062|NCT00972309|447949290|FG000|Overall Study|Second malignancy|1|||
124545063|NCT00972309|447949291|FG001|Overall Study|Second malignancy|1|||
124545064|NCT00972309|447949290|FG000|Overall Study|Visa issues|0|||
124545065|NCT00972309|447949291|FG001|Overall Study|Visa issues|1|||
124692543|NCT02675452|448494772|FG020|Overall Study|Other|0|||
124692544|NCT02675452|448494773|FG021|Overall Study|Other|0|||
124692545|NCT02675452|448494774|FG022|Overall Study|Other|0|||
124692546|NCT02675452|448494775|FG023|Overall Study|Other|0|||
124545066|NCT00972309|447949290|FG000|Overall Study|Secondary cancer (SCC)|0|||
124692547|NCT02675452|448494776|FG024|Overall Study|Other|0|||
124692548|NCT02675452|448494777|FG025|Overall Study|Other|0|||
124692549|NCT02675452|448494778|FG026|Overall Study|Other|1|||
124692550|NCT02675452|448494779|FG027|Overall Study|Other|0|||
124692551|NCT02675452|448494780|FG028|Overall Study|Other|0|||
124692552|NCT02939781|448494781|FG000|Overall Study|Protocol Violation|8|||
124692553|NCT02939781|448494781|FG000|Overall Study|Withdrawal by Subject|1|||
124692554|NCT00689052|448494783|FG000|Overall Study|Adverse Event|4|||
124692555|NCT00689052|448494784|FG001|Overall Study|Adverse Event|6|||
124692556|NCT00689052|448494783|FG000|Overall Study|Protocol Violation|1|||
124692557|NCT00689052|448494784|FG001|Overall Study|Protocol Violation|0|||
124692558|NCT00689052|448494783|FG000|Overall Study|Lost to Follow-up|2|||
124692559|NCT00689052|448494784|FG001|Overall Study|Lost to Follow-up|0|||
124692560|NCT00689052|448494783|FG000|Overall Study|Withdrawal by Subject|2|||
124692561|NCT00689052|448494784|FG001|Overall Study|Withdrawal by Subject|0|||
124692562|NCT00689052|448494783|FG000|Overall Study|Early termination of the trial|22|||
124692563|NCT00689052|448494784|FG001|Overall Study|Early termination of the trial|24|||
124911678|NCT04452318|449304811|FG004|Overall Study|Physician Decision|0|||
124545067|NCT00972309|447949291|FG001|Overall Study|Secondary cancer (SCC)|1|||
124692564|NCT02569242|448494785|FG000|Overall Study|Death|1|||
124692565|NCT02569242|448494786|FG001|Overall Study|Death|0|||
124692566|NCT02569242|448494785|FG000|Overall Study|Withdrawal by Subject|0|||
124692567|NCT02569242|448494786|FG001|Overall Study|Withdrawal by Subject|1|||
124692568|NCT04625972|448494787|FG000|Overall Study|Death|3|||
124692569|NCT04625972|448494788|FG001|Overall Study|Death|2|||
124692570|NCT04625972|448494787|FG000|Overall Study|Lost to Follow-up|82|||
124692571|NCT04625972|448494788|FG001|Overall Study|Lost to Follow-up|38|||
124692572|NCT04625972|448494787|FG000|Overall Study|Physician Decision|2|||
124692573|NCT04625972|448494788|FG001|Overall Study|Physician Decision|0|||
124692574|NCT04625972|448494787|FG000|Overall Study|Protocol Violation|0|||
124692575|NCT04625972|448494788|FG001|Overall Study|Protocol Violation|1|||
124692576|NCT04625972|448494787|FG000|Overall Study|Withdrawal by Subject|37|||
124692577|NCT04625972|448494788|FG001|Overall Study|Withdrawal by Subject|24|||
124692578|NCT04625972|448494787|FG000|Overall Study|Not specified elsewhere|8|||
124692579|NCT04625972|448494788|FG001|Overall Study|Not specified elsewhere|6|||
124692580|NCT03259308|448494789|FG000|Overall Study|Adverse Event|5|||
124692581|NCT03259308|448494790|FG001|Overall Study|Adverse Event|4|||
124692582|NCT03259308|448494791|FG002|Overall Study|Adverse Event|1|||
124692583|NCT03259308|448494789|FG000|Overall Study|Withdrawal by Subject|2|||
124692584|NCT03259308|448494790|FG001|Overall Study|Withdrawal by Subject|1|||
124692585|NCT03259308|448494791|FG002|Overall Study|Withdrawal by Subject|3|||
124692586|NCT03259308|448494789|FG000|Overall Study|Lost to Follow-up|0|||
124692587|NCT03259308|448494790|FG001|Overall Study|Lost to Follow-up|0|||
124692588|NCT03259308|448494791|FG002|Overall Study|Lost to Follow-up|1|||
124692589|NCT03259308|448494789|FG000|Overall Study|Pregnancy|0|||
124692590|NCT03259308|448494790|FG001|Overall Study|Pregnancy|0|||
124692591|NCT03259308|448494791|FG002|Overall Study|Pregnancy|1|||
124692592|NCT03259308|448494789|FG000|Overall Study|Protocol Deviation|0|||
124692593|NCT03259308|448494790|FG001|Overall Study|Protocol Deviation|3|||
124692594|NCT03259308|448494791|FG002|Overall Study|Protocol Deviation|0|||
124692595|NCT03259308|448494789|FG000|Overall Study|Lack of Efficacy|0|||
124692596|NCT03259308|448494790|FG001|Overall Study|Lack of Efficacy|0|||
124692597|NCT03259308|448494791|FG002|Overall Study|Lack of Efficacy|1|||
124692598|NCT00694122|448494792|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
124692599|NCT00694122|448494793|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
124692600|NCT00694122|448494792|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
124692601|NCT00694122|448494793|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
124692602|NCT00694122|448494792|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
124692603|NCT00694122|448494793|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
124692604|NCT01727154|448494796|FG000|Overall Study|Death|17|||
124692605|NCT01727154|448494796|FG000|Overall Study|Withdrawal by Subject|14|||
124692606|NCT01727154|448494796|FG000|Overall Study|Subject Withdrew Consent|18|||
124692607|NCT01727154|448494796|FG000|Overall Study|Study Terminated|6|||
124692608|NCT01727154|448494796|FG000|Overall Study|No Discontinuation Documentation|4|||
124692609|NCT03020888|448494797|FG000|Overall Study|Physician Decision|4|||
124692610|NCT03020888|448494797|FG000|Overall Study|Withdrawal by Subject|6|||
124692611|NCT03020888|448494797|FG000|Overall Study|Insurance coverage|2|||
124692612|NCT03020888|448494797|FG000|Overall Study|Lost to Follow-up|1|||
124692613|NCT01198548|448494798|FG000|Overall Study|Disease Progression|9|||
124692614|NCT01198548|448494798|FG000|Overall Study|Administrative Decision|1|||
124692615|NCT01245062|448494800|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
124692616|NCT01245062|448494801|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
124692617|NCT01245062|448494802|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
124692618|NCT01245062|448494800|FG000|Randomization and Crossover Phase|Physician Decision|2|||
124692619|NCT01245062|448494801|FG001|Randomization and Crossover Phase|Physician Decision|4|||
124692620|NCT01245062|448494802|FG002|Randomization and Crossover Phase|Physician Decision|0|||
124692621|NCT01245062|448494800|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
124692622|NCT01245062|448494801|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
124760710|NCT01272232|448749088|FG002|Weeks 0-56|Protocol Violation|13|||
124450487|NCT03044249|447611996|FG000|Overall Study|Withdrawal by Subject|2|||
124450488|NCT03044249|447611997|FG001|Overall Study|Withdrawal by Subject|5|||
124450489|NCT00955279|447611998|FG000|Overall Study|Other|0|||
124450490|NCT00955279|447611999|FG001|Overall Study|Other|0|||
124450491|NCT00955279|447612000|FG002|Overall Study|Other|3|||
124450492|NCT00955279|447611998|FG000|Overall Study|Death|1|||
124450493|NCT00955279|447611999|FG001|Overall Study|Death|1|||
124450494|NCT00955279|447612000|FG002|Overall Study|Death|1|||
124450495|NCT00955279|447611998|FG000|Overall Study|Lost to Follow-up|0|||
124450496|NCT00955279|447611999|FG001|Overall Study|Lost to Follow-up|3|||
124692623|NCT01245062|448494802|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
124692624|NCT01245062|448494800|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
124692625|NCT01245062|448494801|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
124692626|NCT01245062|448494802|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
124692627|NCT01245062|448494800|FG000|Cross-over Phase|Lost to Follow-up|0|||
124692628|NCT01245062|448494801|FG001|Cross-over Phase|Lost to Follow-up|0|||
124692629|NCT01245062|448494802|FG002|Cross-over Phase|Lost to Follow-up|1|||
124692630|NCT01245062|448494800|FG000|Cross-over Phase|Physician Decision|0|||
124692631|NCT01245062|448494801|FG001|Cross-over Phase|Physician Decision|0|||
124692632|NCT01245062|448494802|FG002|Cross-over Phase|Physician Decision|1|||
124692633|NCT01245062|448494800|FG000|Cross-over Phase|Withdrew Consent|0|||
124692634|NCT01245062|448494801|FG001|Cross-over Phase|Withdrew Consent|0|||
124692635|NCT01245062|448494802|FG002|Cross-over Phase|Withdrew Consent|4|||
124692636|NCT01245062|448494800|FG000|Cross-over Phase|Study closed/ terminated|0|||
124692637|NCT01245062|448494801|FG001|Cross-over Phase|Study closed/ terminated|0|||
124692638|NCT01245062|448494802|FG002|Cross-over Phase|Study closed/ terminated|11|||
124692639|NCT06025695|448494803|FG000|Overall Study|Adverse Event|5|||
124545068|NCT00972309|447949290|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
124545069|NCT00972309|447949291|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
124545070|NCT00972309|447949290|FG000|Overall Study|Lost to Follow-up|1|||
124545071|NCT00972309|447949291|FG001|Overall Study|Lost to Follow-up|1|||
124692640|NCT06025695|448494804|FG001|Overall Study|Adverse Event|6|||
124692641|NCT06025695|448494803|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
124692642|NCT06025695|448494804|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
124692643|NCT06025695|448494803|FG000|Overall Study|Other|23|||
124692644|NCT06025695|448494804|FG001|Overall Study|Other|19|||
124692645|NCT06025695|448494803|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
124692646|NCT06025695|448494804|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
124692647|NCT03834883|448494805|FG000|Second Treatment|Withdrawal by Subject|1|||
124692648|NCT03834883|448494806|FG001|Second Treatment|Withdrawal by Subject|0|||
124692649|NCT03834883|448494807|FG002|Second Treatment|Withdrawal by Subject|0|||
124692650|NCT03834883|448494808|FG003|Second Treatment|Withdrawal by Subject|0|||
124692651|NCT03834883|448494805|FG000|Second Treatment|COVID-19 pandemic|1|||
124692652|NCT03834883|448494806|FG001|Second Treatment|COVID-19 pandemic|0|||
124692653|NCT03834883|448494807|FG002|Second Treatment|COVID-19 pandemic|1|||
124692654|NCT03834883|448494808|FG003|Second Treatment|COVID-19 pandemic|1|||
124692655|NCT04971837|448496360|FG000|Overall Study|Long Term Illness|1|||
124692656|NCT04971837|448496360|FG000|Overall Study|BMI too low|9|||
124692657|NCT04971837|448496360|FG000|Overall Study|geographic location|1|||
124692658|NCT04971837|448496360|FG000|Overall Study|Discontinued scheduling conflict|1|||
124692659|NCT00160615|448496361|FG000|Overall Study|Adverse Event|5|||
124692660|NCT00160615|448496362|FG001|Overall Study|Adverse Event|12|||
124692661|NCT00160615|448496361|FG000|Overall Study|Withdrawal by Subject|0|||
124692662|NCT00160615|448496362|FG001|Overall Study|Withdrawal by Subject|2|||
124692663|NCT00160615|448496361|FG000|Overall Study|Lack of Efficacy|11|||
124692664|NCT00160615|448496362|FG001|Overall Study|Lack of Efficacy|23|||
124692665|NCT00160615|448496361|FG000|Overall Study|Patient decision|1|||
124692666|NCT00160615|448496362|FG001|Overall Study|Patient decision|2|||
124692667|NCT00160615|448496361|FG000|Overall Study|Investigator decision|1|||
124692668|NCT00160615|448496362|FG001|Overall Study|Investigator decision|1|||
124450497|NCT00955279|447612000|FG002|Overall Study|Lost to Follow-up|1|||
124692669|NCT00160615|448496361|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
124692670|NCT00160615|448496362|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
124692671|NCT00160615|448496361|FG000|Overall Study|Switch to surgical treatment|0|||
124692672|NCT00160615|448496362|FG001|Overall Study|Switch to surgical treatment|2|||
124692673|NCT00160615|448496361|FG000|Overall Study|Non-compliance was suspected|0|||
124692674|NCT00160615|448496362|FG001|Overall Study|Non-compliance was suspected|1|||
124692675|NCT00160615|448496361|FG000|Overall Study|Poor compliance|0|||
124692676|NCT00160615|448496362|FG001|Overall Study|Poor compliance|1|||
124692677|NCT03166631|448496363|FG000|Overall Study|Progressive disease|2|||
124692678|NCT03166631|448496364|FG001|Overall Study|Progressive disease|1|||
124450498|NCT00955279|447611998|FG000|Overall Study|Withdrawal by Subject|2|||
124450499|NCT00955279|447611999|FG001|Overall Study|Withdrawal by Subject|0|||
124450500|NCT00955279|447612000|FG002|Overall Study|Withdrawal by Subject|3|||
124450501|NCT01368042|447612001|FG000|Overall Study|Death|14|||
124692679|NCT03166631|448496365|FG002|Overall Study|Progressive disease|3|||
124692680|NCT03166631|448496366|FG003|Overall Study|Progressive disease|4|||
124692681|NCT03166631|448496367|FG004|Overall Study|Progressive disease|2|||
124692682|NCT03166631|448496368|FG005|Overall Study|Progressive disease|2|||
124692683|NCT03166631|448496369|FG006|Overall Study|Progressive disease|5|||
124692684|NCT03166631|448496370|FG007|Overall Study|Progressive disease|6|||
124692685|NCT03166631|448496371|FG008|Overall Study|Progressive disease|11|||
124692686|NCT03166631|448496372|FG009|Overall Study|Progressive disease|5|||
124692687|NCT03166631|448496373|FG010|Overall Study|Progressive disease|7|||
124692688|NCT03166631|448496363|FG000|Overall Study|Physician Decision|0|||
124692689|NCT03166631|448496364|FG001|Overall Study|Physician Decision|0|||
124692690|NCT03166631|448496365|FG002|Overall Study|Physician Decision|0|||
124692691|NCT03166631|448496366|FG003|Overall Study|Physician Decision|0|||
124760711|NCT01272232|448749086|FG000|Weeks 0-56|Withdrawal criteria|32|||
124760712|NCT01272232|448749087|FG001|Weeks 0-56|Withdrawal criteria|14|||
124760713|NCT01272232|448749088|FG002|Weeks 0-56|Withdrawal criteria|37|||
124760714|NCT01272232|448749086|FG000|Weeks 0-56|Unclassified|16|||
124760715|NCT01272232|448749087|FG001|Weeks 0-56|Unclassified|7|||
124760716|NCT01272232|448749088|FG002|Weeks 0-56|Unclassified|12|||
124760717|NCT01272232|448749086|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
124760718|NCT01272232|448749087|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
124760719|NCT01272232|448749088|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
124760720|NCT01272232|448749086|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
124760721|NCT01272232|448749087|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
124760722|NCT01272232|448749088|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
124760723|NCT01272232|448749086|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
124760724|NCT01272232|448749087|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
124760725|NCT01272232|448749088|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
124760726|NCT01272232|448749086|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
124760727|NCT01272232|448749087|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
124760728|NCT01272232|448749088|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
124760729|NCT01272232|448749086|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
124760730|NCT01272232|448749087|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
124760731|NCT01272232|448749088|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
124760732|NCT01960140|448749092|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
124760733|NCT00628030|448749093|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
124760734|NCT00628030|448749094|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
124760735|NCT00628030|448749093|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
124760736|NCT00628030|448749094|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
124760737|NCT00628030|448749093|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
124760738|NCT00628030|448749094|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
124760739|NCT01156480|448749096|FG000|Overall Study|change in diagnosis|0|||
124760740|NCT01156480|448749097|FG001|Overall Study|change in diagnosis|1|||
124760741|NCT01176058|448749098|FG000|Overall Study|Adverse Event|1|||
124760742|NCT01176058|448749099|FG001|Overall Study|Adverse Event|0|||
124760743|NCT01176058|448749098|FG000|Overall Study|Insufficient clinical response|2|||
124760744|NCT01176058|448749099|FG001|Overall Study|Insufficient clinical response|2|||
124760745|NCT01176058|448749098|FG000|Overall Study|Insufficient mycological response|0|||
124760746|NCT01176058|448749099|FG001|Overall Study|Insufficient mycological response|1|||
124760747|NCT01176058|448749098|FG000|Overall Study|Withdrawal by Subject|1|||
124760748|NCT01176058|448749099|FG001|Overall Study|Withdrawal by Subject|0|||
124760749|NCT04276233|448749100|FG000|Overall Study|Adverse Event|1|||
124760750|NCT04276233|448749100|FG000|Overall Study|Lost to Follow-up|3|||
124760751|NCT04276233|448749100|FG000|Overall Study|Physician Decision|4|||
124760752|NCT04276233|448749100|FG000|Overall Study|Withdrawal by Subject|2|||
124760753|NCT01946139|448749101|FG000|Overall Study|Withdrawal by Subject|8|||
124760754|NCT01946139|448749101|FG000|Overall Study|ineligible|8|||
124760755|NCT01946139|448749101|FG000|Overall Study|Specimens not available|4|||
124760756|NCT02525471|448749108|FG000|Overall Study|Screen Failure|6|||
124760757|NCT02525471|448749108|FG000|Overall Study|Withdrawal by Subject|4|||
124760758|NCT02525471|448749108|FG000|Overall Study|Death|1|||
124760759|NCT00890825|448749109|FG000|Overall Study|Withdrawal by Subject|1|||
124760760|NCT00890825|448749110|FG001|Overall Study|Withdrawal by Subject|0|||
124760761|NCT00890825|448749109|FG000|Overall Study|Alive at data cut off (DCO)|13|||
124760762|NCT00890825|448749110|FG001|Overall Study|Alive at data cut off (DCO)|14|||
124760763|NCT02336607|448749111|FG000|Overall Study|Physician Decision|1|||
124760764|NCT02336607|448749112|FG001|Overall Study|Physician Decision|4|||
124760765|NCT02336607|448749113|FG002|Overall Study|Physician Decision|3|||
124760766|NCT02336607|448749114|FG003|Overall Study|Physician Decision|15|||
124760767|NCT02336607|448749111|FG000|Overall Study|Lack of Efficacy|1|||
124760768|NCT02336607|448749112|FG001|Overall Study|Lack of Efficacy|0|||
124692692|NCT03166631|448496367|FG004|Overall Study|Physician Decision|0|||
124760769|NCT02336607|448749113|FG002|Overall Study|Lack of Efficacy|0|||
124760770|NCT02336607|448749114|FG003|Overall Study|Lack of Efficacy|2|||
124760771|NCT02336607|448749111|FG000|Overall Study|Lost to Follow-up|2|||
124760772|NCT02336607|448749112|FG001|Overall Study|Lost to Follow-up|1|||
124911679|NCT04452318|449304812|FG005|Overall Study|Physician Decision|2|||
124911680|NCT04452318|449304813|FG006|Overall Study|Physician Decision|5|||
124911681|NCT04452318|449304807|FG000|Overall Study|Death|2|||
124911682|NCT04452318|449304808|FG001|Overall Study|Death|3|||
124911683|NCT04452318|449304809|FG002|Overall Study|Death|0|||
124911684|NCT04452318|449304810|FG003|Overall Study|Death|0|||
124911685|NCT04452318|449304811|FG004|Overall Study|Death|0|||
124911686|NCT04452318|449304812|FG005|Overall Study|Death|0|||
124911687|NCT04452318|449304813|FG006|Overall Study|Death|0|||
124760773|NCT02336607|448749113|FG002|Overall Study|Lost to Follow-up|0|||
124760774|NCT02336607|448749114|FG003|Overall Study|Lost to Follow-up|21|||
124760775|NCT02336607|448749111|FG000|Overall Study|Protocol Violation|0|||
124760776|NCT02336607|448749112|FG001|Overall Study|Protocol Violation|1|||
124760777|NCT02336607|448749113|FG002|Overall Study|Protocol Violation|1|||
124760778|NCT02336607|448749114|FG003|Overall Study|Protocol Violation|3|||
124760779|NCT02336607|448749111|FG000|Overall Study|Adverse Event|0|||
124760780|NCT02336607|448749112|FG001|Overall Study|Adverse Event|2|||
124760781|NCT02336607|448749113|FG002|Overall Study|Adverse Event|2|||
124760782|NCT02336607|448749114|FG003|Overall Study|Adverse Event|26|||
124760783|NCT02336607|448749111|FG000|Overall Study|Withdrawal by Subject|0|||
124760784|NCT02336607|448749112|FG001|Overall Study|Withdrawal by Subject|2|||
124760785|NCT02336607|448749113|FG002|Overall Study|Withdrawal by Subject|0|||
124760786|NCT02336607|448749114|FG003|Overall Study|Withdrawal by Subject|20|||
124760787|NCT01216202|448749117|FG000|Overall Study|Withdrawal by Subject|8|||
124760788|NCT01216202|448749118|FG001|Overall Study|Withdrawal by Subject|0|||
124760789|NCT01216202|448749117|FG000|Overall Study|Death|0|||
124760790|NCT01216202|448749118|FG001|Overall Study|Death|2|||
124760791|NCT01216202|448749117|FG000|Overall Study|Lost to Follow-up|14|||
124760792|NCT01216202|448749118|FG001|Overall Study|Lost to Follow-up|0|||
124760793|NCT02365649|448749127|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
124760794|NCT02365649|448749128|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
124760795|NCT02365649|448749129|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
124760796|NCT02365649|448749130|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
124760797|NCT02365649|448749131|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
124760798|NCT02365649|448749132|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
124760799|NCT02365649|448749133|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
124760800|NCT02365649|448749134|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
124760801|NCT02365649|448749135|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
124760802|NCT02365649|448749136|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
124760803|NCT02365649|448749127|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
124760804|NCT02365649|448749128|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
124760805|NCT02365649|448749129|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
124760806|NCT02365649|448749130|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
124760807|NCT02365649|448749131|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
124760808|NCT02365649|448749132|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
124760809|NCT02365649|448749133|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
124760810|NCT02365649|448749134|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
124760811|NCT02365649|448749135|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
124760812|NCT02365649|448749136|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
124760813|NCT02365649|448749127|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
124760814|NCT02365649|448749128|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
124760815|NCT02365649|448749129|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
124760816|NCT02365649|448749130|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
124760817|NCT02365649|448749131|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
124760818|NCT02365649|448749132|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
124760819|NCT02365649|448749133|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
124760820|NCT02365649|448749134|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
124760821|NCT02365649|448749135|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
124760822|NCT02365649|448749136|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
124760823|NCT02365649|448749127|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
124760824|NCT02365649|448749128|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
124760825|NCT02365649|448749129|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
124760826|NCT02365649|448749130|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
124760827|NCT02365649|448749131|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
124911688|NCT04452318|449304807|FG000|Overall Study|Lost to Follow-up|38|||
124911689|NCT04452318|449304808|FG001|Overall Study|Lost to Follow-up|28|||
124911690|NCT04452318|449304809|FG002|Overall Study|Lost to Follow-up|0|||
124911691|NCT04452318|449304810|FG003|Overall Study|Lost to Follow-up|3|||
124911692|NCT04452318|449304811|FG004|Overall Study|Lost to Follow-up|3|||
124911693|NCT04452318|449304812|FG005|Overall Study|Lost to Follow-up|2|||
124911694|NCT04452318|449304813|FG006|Overall Study|Lost to Follow-up|1|||
124911695|NCT04452318|449304807|FG000|Overall Study|Withdrawal by Subject|46|||
124760828|NCT02365649|448749132|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
124760829|NCT02365649|448749133|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
124760830|NCT02365649|448749134|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
124911696|NCT04452318|449304808|FG001|Overall Study|Withdrawal by Subject|40|||
124760831|NCT02365649|448749135|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
124760832|NCT02365649|448749136|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
124760833|NCT02365649|448749127|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
124760834|NCT02365649|448749128|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
124911697|NCT04452318|449304809|FG002|Overall Study|Withdrawal by Subject|0|||
124911698|NCT04452318|449304810|FG003|Overall Study|Withdrawal by Subject|18|||
124911699|NCT04452318|449304811|FG004|Overall Study|Withdrawal by Subject|6|||
124911700|NCT04452318|449304812|FG005|Overall Study|Withdrawal by Subject|8|||
124911701|NCT04452318|449304813|FG006|Overall Study|Withdrawal by Subject|6|||
124911702|NCT03951805|449304815|FG000|Overall Study|Adverse Event|1|||
124911703|NCT03951805|449304816|FG001|Overall Study|Adverse Event|0|||
124911704|NCT03951805|449304817|FG002|Overall Study|Adverse Event|0|||
124911705|NCT03951805|449304818|FG003|Overall Study|Adverse Event|0|||
124911706|NCT00604669|449304819|FG000|Overall Study|lack of information in chart|7|||
124911707|NCT01695954|449304820|FG000|Overall Study|Withdrawal by Subject|4|||
124911708|NCT01695954|449304821|FG001|Overall Study|Withdrawal by Subject|0|||
124911709|NCT01695954|449304820|FG000|Overall Study|Adverse Event|0|||
124911710|NCT01695954|449304821|FG001|Overall Study|Adverse Event|2|||
124911711|NCT04328727|449304823|FG000|Overall Study|Guardian Decision|1|||
124911712|NCT04328727|449304823|FG000|Overall Study|Participant decision|4|||
124911713|NCT04328727|449304823|FG000|Overall Study|Death|3|||
124911714|NCT03684044|449304824|FG000|Overall Study|Adverse Event|3|||
124911715|NCT03684044|449304825|FG001|Overall Study|Adverse Event|0|||
124911716|NCT03684044|449304824|FG000|Overall Study|Death|4|||
124911717|NCT03684044|449304825|FG001|Overall Study|Death|7|||
124911718|NCT03684044|449304824|FG000|Overall Study|Lost to Follow-up|3|||
124911719|NCT03684044|449304825|FG001|Overall Study|Lost to Follow-up|2|||
124911720|NCT03684044|449304824|FG000|Overall Study|Patient Not Available|0|||
124911721|NCT03684044|449304825|FG001|Overall Study|Patient Not Available|2|||
124911722|NCT03684044|449304824|FG000|Overall Study|Physician Decision|1|||
124911723|NCT03684044|449304825|FG001|Overall Study|Physician Decision|0|||
124911724|NCT03684044|449304824|FG000|Overall Study|Withdrawal by Subject|11|||
124911725|NCT03684044|449304825|FG001|Overall Study|Withdrawal by Subject|9|||
124911726|NCT00595413|449304826|FG000|Overall Study|Adverse Event|0|||
124911727|NCT00595413|449304827|FG001|Overall Study|Adverse Event|2|||
124911728|NCT00595413|449304828|FG002|Overall Study|Adverse Event|1|||
124911729|NCT00595413|449304829|FG003|Overall Study|Adverse Event|1|||
124911730|NCT00595413|449304826|FG000|Overall Study|Lost to Follow-up|2|||
124911731|NCT00595413|449304827|FG001|Overall Study|Lost to Follow-up|2|||
124911732|NCT00595413|449304828|FG002|Overall Study|Lost to Follow-up|1|||
124450502|NCT01368042|447612001|FG000|Overall Study|Protocol Violation|11|||
124450503|NCT01368042|447612001|FG000|Overall Study|Lost to Follow-up|4|||
124911733|NCT00595413|449304829|FG003|Overall Study|Lost to Follow-up|3|||
124911734|NCT00595413|449304826|FG000|Overall Study|Death|0|||
124911735|NCT00595413|449304827|FG001|Overall Study|Death|0|||
124911736|NCT00595413|449304828|FG002|Overall Study|Death|1|||
124692693|NCT03166631|448496368|FG005|Overall Study|Physician Decision|0|||
124692694|NCT03166631|448496369|FG006|Overall Study|Physician Decision|1|||
124911737|NCT00595413|449304829|FG003|Overall Study|Death|0|||
124911738|NCT00595413|449304826|FG000|Overall Study|Other|5|||
124911739|NCT00595413|449304827|FG001|Overall Study|Other|1|||
124911740|NCT00595413|449304828|FG002|Overall Study|Other|5|||
124911741|NCT00595413|449304829|FG003|Overall Study|Other|0|||
124911742|NCT04149002|449304830|FG000|Overall Study|Lost to Follow-up|1|||
124911743|NCT04149002|449304831|FG001|Overall Study|Lost to Follow-up|0|||
124911744|NCT04149002|449304830|FG000|Overall Study|Withdrawal by Subject|1|||
124911745|NCT04149002|449304831|FG001|Overall Study|Withdrawal by Subject|0|||
124911746|NCT04629950|449304832|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
124911747|NCT04629950|449304833|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
124911748|NCT04629950|449304834|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
124911749|NCT04629950|449304835|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
124911750|NCT04629950|449304832|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
124911751|NCT04629950|449304833|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
124911752|NCT04629950|449304834|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
124911753|NCT04629950|449304835|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
124450504|NCT01368042|447612001|FG000|Overall Study|Transplanted|1|||
124911754|NCT04629950|449304832|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
124911755|NCT04629950|449304833|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
124911756|NCT04629950|449304834|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
124911757|NCT04629950|449304835|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
124692695|NCT03166631|448496370|FG007|Overall Study|Physician Decision|0|||
124692696|NCT03166631|448496371|FG008|Overall Study|Physician Decision|1|||
124911758|NCT04629950|449304832|FG000|Extension Study|Withdrawal by Subject|0|||
124911759|NCT04629950|449304833|FG001|Extension Study|Withdrawal by Subject|0|||
124692697|NCT03166631|448496372|FG009|Overall Study|Physician Decision|0|||
124911760|NCT04629950|449304834|FG002|Extension Study|Withdrawal by Subject|1|||
124911761|NCT04629950|449304835|FG003|Extension Study|Withdrawal by Subject|0|||
124911762|NCT04629950|449304832|FG000|Extension Study|Adverse Event|0|||
124911763|NCT04629950|449304833|FG001|Extension Study|Adverse Event|0|||
124911764|NCT04629950|449304834|FG002|Extension Study|Adverse Event|0|||
124911765|NCT04629950|449304835|FG003|Extension Study|Adverse Event|1|||
124911766|NCT03233633|449304836|FG000|Overall Study|Adverse Event|2|||
124911767|NCT03233633|449304836|FG000|Overall Study|Less Than 3 Days of Data|6|||
124911768|NCT01198145|449304838|FG000|Overall Study|Withdrawal by Subject|1|||
124911769|NCT01198145|449304839|FG001|Overall Study|Withdrawal by Subject|1|||
124911770|NCT01697969|449304842|FG000|Overall Study|Did not meet inc/exc criteria|3|||
124911771|NCT01561989|449304843|FG000|Overall Study|accural target not met.|5|||
124911772|NCT01561989|449304844|FG001|Overall Study|accural target not met.|6|||
124911773|NCT03447249|449304848|FG000|Overall Study|Adverse Event|1|||
124911774|NCT03447249|449304849|FG001|Overall Study|Adverse Event|0|||
124911775|NCT03447249|449304848|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
124911776|NCT03447249|449304849|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
124692698|NCT03166631|448496373|FG010|Overall Study|Physician Decision|1|||
124692699|NCT03166631|448496363|FG000|Overall Study|Death|0|||
124692700|NCT03166631|448496364|FG001|Overall Study|Death|0|||
124692701|NCT03166631|448496365|FG002|Overall Study|Death|0|||
124692702|NCT03166631|448496366|FG003|Overall Study|Death|0|||
124692703|NCT03166631|448496367|FG004|Overall Study|Death|1|||
124692704|NCT03166631|448496368|FG005|Overall Study|Death|0|||
124692705|NCT03166631|448496369|FG006|Overall Study|Death|1|||
124692706|NCT03166631|448496370|FG007|Overall Study|Death|0|||
124692707|NCT03166631|448496371|FG008|Overall Study|Death|0|||
124692708|NCT03166631|448496372|FG009|Overall Study|Death|0|||
124692709|NCT03166631|448496373|FG010|Overall Study|Death|0|||
124692710|NCT03166631|448496363|FG000|Overall Study|Adverse Event|1|||
124692711|NCT03166631|448496364|FG001|Overall Study|Adverse Event|0|||
124692712|NCT03166631|448496365|FG002|Overall Study|Adverse Event|0|||
124692713|NCT03166631|448496366|FG003|Overall Study|Adverse Event|0|||
124692714|NCT03166631|448496367|FG004|Overall Study|Adverse Event|0|||
124692715|NCT03166631|448496368|FG005|Overall Study|Adverse Event|1|||
124692716|NCT03166631|448496369|FG006|Overall Study|Adverse Event|1|||
124692717|NCT03166631|448496370|FG007|Overall Study|Adverse Event|0|||
124692718|NCT03166631|448496371|FG008|Overall Study|Adverse Event|1|||
124692719|NCT03166631|448496372|FG009|Overall Study|Adverse Event|2|||
124692720|NCT03166631|448496373|FG010|Overall Study|Adverse Event|1|||
124692721|NCT03166631|448496363|FG000|Overall Study|Withdrawal by Subject|0|||
124692722|NCT03166631|448496364|FG001|Overall Study|Withdrawal by Subject|0|||
124692723|NCT03166631|448496365|FG002|Overall Study|Withdrawal by Subject|0|||
124692724|NCT03166631|448496366|FG003|Overall Study|Withdrawal by Subject|0|||
124692725|NCT03166631|448496367|FG004|Overall Study|Withdrawal by Subject|0|||
124692726|NCT03166631|448496368|FG005|Overall Study|Withdrawal by Subject|0|||
124692727|NCT03166631|448496369|FG006|Overall Study|Withdrawal by Subject|0|||
124692728|NCT03166631|448496370|FG007|Overall Study|Withdrawal by Subject|0|||
124692729|NCT03166631|448496371|FG008|Overall Study|Withdrawal by Subject|1|||
124692730|NCT03166631|448496372|FG009|Overall Study|Withdrawal by Subject|1|||
124692731|NCT03166631|448496373|FG010|Overall Study|Withdrawal by Subject|0|||
124692732|NCT00567580|448496376|FG000|Overall Study|Protocol Violation|28|||
124692733|NCT00567580|448496377|FG001|Overall Study|Protocol Violation|24|||
124692734|NCT00567580|448496378|FG002|Overall Study|Protocol Violation|24|||
124692735|NCT01245751|448496381|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
124692736|NCT01245751|448496382|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
124692737|NCT01245751|448496383|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
124692738|NCT01245751|448496384|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
124692739|NCT01245751|448496381|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
124692740|NCT01245751|448496382|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
124692741|NCT01245751|448496383|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
124692742|NCT01245751|448496384|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
124692743|NCT01245751|448496381|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
124692744|NCT01245751|448496382|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
124692745|NCT01245751|448496383|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
124692746|NCT01245751|448496384|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
124692747|NCT05788328|448496385|FG000|Treatment Period 4 (5 Days)|Other|1|||
124692748|NCT05788328|448496385|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
124692749|NCT03197935|448496386|FG000|Overall Study|Death due to any cause|26|||
124692750|NCT03197935|448496387|FG001|Overall Study|Death due to any cause|15|||
124692751|NCT03197935|448496386|FG000|Overall Study|Lost to Follow-up|3|||
124911777|NCT03447249|449304848|FG000|Overall Study|Other|3|||
124692752|NCT03197935|448496387|FG001|Overall Study|Lost to Follow-up|5|||
124692753|NCT03197935|448496386|FG000|Overall Study|Physician Decision|2|||
124692754|NCT03197935|448496387|FG001|Overall Study|Physician Decision|1|||
124692755|NCT03197935|448496386|FG000|Overall Study|Withdrawal by Subject|16|||
124692756|NCT03197935|448496387|FG001|Overall Study|Withdrawal by Subject|8|||
124692757|NCT02082483|448496388|FG000|Overall Study|Lost to Follow-up|1|||
124692758|NCT02082483|448496389|FG001|Overall Study|Lost to Follow-up|1|||
124692759|NCT02082483|448496388|FG000|Overall Study|Withdrawal by Subject|2|||
124692760|NCT02082483|448496389|FG001|Overall Study|Withdrawal by Subject|1|||
124692761|NCT02082483|448496388|FG000|Overall Study|Physician Decision|1|||
124692762|NCT02082483|448496389|FG001|Overall Study|Physician Decision|1|||
124911778|NCT03447249|449304849|FG001|Overall Study|Other|0|||
124911779|NCT02574455|449304851|FG000|Overall Study|Death|197|||
124692763|NCT02082483|448496388|FG000|Overall Study|Death|2|||
124692764|NCT02082483|448496389|FG001|Overall Study|Death|3|||
124692765|NCT00145327|448496391|FG000|Overall Study|Withdrawal by Subject|77|||
124692766|NCT00145327|448496392|FG001|Overall Study|Withdrawal by Subject|72|||
124692767|NCT00145327|448496393|FG002|Overall Study|Withdrawal by Subject|164|||
124692768|NCT00145327|448496391|FG000|Overall Study|Death|26|||
124692769|NCT00145327|448496392|FG001|Overall Study|Death|18|||
124692770|NCT00145327|448496393|FG002|Overall Study|Death|30|||
124692771|NCT00145327|448496391|FG000|Overall Study|Adverse Event|14|||
124692772|NCT00145327|448496392|FG001|Overall Study|Adverse Event|11|||
124692773|NCT00145327|448496393|FG002|Overall Study|Adverse Event|22|||
124692774|NCT00145327|448496391|FG000|Overall Study|Lost to Follow-up|9|||
124692775|NCT00145327|448496392|FG001|Overall Study|Lost to Follow-up|14|||
124692776|NCT00145327|448496393|FG002|Overall Study|Lost to Follow-up|14|||
124692777|NCT00145327|448496391|FG000|Overall Study|Administrative problems|12|||
124692778|NCT00145327|448496392|FG001|Overall Study|Administrative problems|9|||
124692779|NCT00145327|448496393|FG002|Overall Study|Administrative problems|13|||
124692780|NCT00145327|448496391|FG000|Overall Study|Protocol Violation|2|||
124692781|NCT00145327|448496392|FG001|Overall Study|Protocol Violation|0|||
124692782|NCT00145327|448496393|FG002|Overall Study|Protocol Violation|2|||
124692783|NCT00145327|448496391|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124692784|NCT00145327|448496392|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124692785|NCT00145327|448496393|FG002|Overall Study|Abnormal laboratory value(s)|2|||
124692786|NCT00145327|448496391|FG000|Overall Study|Missing - not stated|1|||
124692787|NCT00145327|448496392|FG001|Overall Study|Missing - not stated|0|||
124692788|NCT00145327|448496393|FG002|Overall Study|Missing - not stated|1|||
124692789|NCT05938010|448496394|FG000|Overall Study|Lost to Follow-up|2|||
124692790|NCT01454063|448496396|FG000|Randomized|Adverse Event|1|||
124692791|NCT01454063|448496397|FG001|Randomized|Adverse Event|1|||
124692792|NCT01454063|448496396|FG000|Randomized|Protocol Violation|0|||
124692793|NCT01454063|448496397|FG001|Randomized|Protocol Violation|1|||
124692794|NCT00509600|448496399|FG000|Overall Study|Adverse Event|1|||
124692795|NCT03055195|448496402|FG000|Overall Study|Lack of Efficacy|1|||
124692796|NCT03055195|448496403|FG001|Overall Study|Lack of Efficacy|0|||
124692797|NCT03055195|448496402|FG000|Overall Study|Withdrawal by Subject|6|||
124692798|NCT03055195|448496403|FG001|Overall Study|Withdrawal by Subject|7|||
124692799|NCT03055195|448496402|FG000|Overall Study|Study Terminated by Sponsor|2|||
124692800|NCT03055195|448496403|FG001|Overall Study|Study Terminated by Sponsor|6|||
124692801|NCT03055195|448496402|FG000|Overall Study|Protocol Violation|2|||
124692802|NCT03055195|448496403|FG001|Overall Study|Protocol Violation|1|||
124692803|NCT03055195|448496402|FG000|Overall Study|Physician Decision|1|||
124692804|NCT03055195|448496403|FG001|Overall Study|Physician Decision|0|||
124692805|NCT02568423|448496406|FG000|Overall Study|Lost to Follow-up|0|||
124692806|NCT02568423|448496407|FG001|Overall Study|Lost to Follow-up|2|||
124692807|NCT02568423|448496408|FG002|Overall Study|Lost to Follow-up|0|||
124692808|NCT02568423|448496409|FG003|Overall Study|Lost to Follow-up|0|||
124692809|NCT02568423|448496410|FG004|Overall Study|Lost to Follow-up|0|||
124692810|NCT02568423|448496411|FG005|Overall Study|Lost to Follow-up|0|||
124692811|NCT02568423|448496412|FG006|Overall Study|Lost to Follow-up|0|||
124692812|NCT02568423|448496413|FG007|Overall Study|Lost to Follow-up|0|||
124692813|NCT02568423|448496406|FG000|Overall Study|Physician Decision|0|||
124692814|NCT02568423|448496407|FG001|Overall Study|Physician Decision|0|||
124692815|NCT02568423|448496408|FG002|Overall Study|Physician Decision|0|||
124692816|NCT02568423|448496409|FG003|Overall Study|Physician Decision|0|||
124692817|NCT02568423|448496410|FG004|Overall Study|Physician Decision|0|||
124692818|NCT02568423|448496411|FG005|Overall Study|Physician Decision|1|||
124692819|NCT02568423|448496412|FG006|Overall Study|Physician Decision|0|||
124692820|NCT02568423|448496413|FG007|Overall Study|Physician Decision|0|||
124692821|NCT01027416|448496414|FG000|Overall Study|Withdrawal by Subject|0|||
124692822|NCT01027416|448496415|FG001|Overall Study|Withdrawal by Subject|1|||
124760835|NCT02365649|448749129|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
124450505|NCT00544648|447612005|FG000|Overall Study|Withdrawal by Subject|1|||
124450506|NCT00544648|447612006|FG001|Overall Study|Withdrawal by Subject|0|||
124450507|NCT00544648|447612005|FG000|Overall Study|Adverse Event|1|||
124450508|NCT00544648|447612006|FG001|Overall Study|Adverse Event|1|||
124450509|NCT00544648|447612005|FG000|Overall Study|progression of disease|1|||
124450510|NCT00544648|447612006|FG001|Overall Study|progression of disease|0|||
124450511|NCT02663271|447612007|FG000|Overall Study|Withdrawal by Subject|5|||
124450512|NCT02663271|447612007|FG000|Overall Study|Lack of Efficacy|1|||
124450513|NCT01235793|447612008|FG000|Overall Study|Death|6|||
124450514|NCT04166383|447612012|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
124450515|NCT04166383|447612012|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
124450516|NCT04166383|447612012|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
124692823|NCT01027416|448496414|FG000|Overall Study|Physician Decision|1|||
124450517|NCT03044886|447612013|FG000|Overall Study|Lost to Follow-up|15|||
124692824|NCT01027416|448496415|FG001|Overall Study|Physician Decision|4|||
124692825|NCT00676052|448496417|FG000|Overall Study|Adverse Event|0|||
124692826|NCT00676052|448496418|FG001|Overall Study|Adverse Event|1|||
124911780|NCT02574455|449304852|FG001|Overall Study|Death|210|||
124911781|NCT02574455|449304851|FG000|Overall Study|Withdrawal of Consent|11|||
124911782|NCT02574455|449304852|FG001|Overall Study|Withdrawal of Consent|28|||
124911783|NCT02574455|449304851|FG000|Overall Study|Lost to Follow-up|4|||
124450518|NCT03044886|447612014|FG001|Overall Study|Lost to Follow-up|10|||
124450519|NCT03044886|447612015|FG002|Overall Study|Lost to Follow-up|12|||
124450520|NCT00504153|447612032|FG000|Overall Study|Withdrawal by Subject|1|||
124450521|NCT00504153|447612032|FG000|Overall Study|Adverse Event|4|||
124450522|NCT00504153|447612032|FG000|Overall Study|Death|1|||
124450523|NCT00074581|447612034|FG000|Overall Study|Death|15|||
124450524|NCT00074581|447612035|FG001|Overall Study|Death|16|||
124450525|NCT00074581|447612034|FG000|Overall Study|Withdrawal by Subject|50|||
124450526|NCT00074581|447612035|FG001|Overall Study|Withdrawal by Subject|49|||
124450527|NCT00074581|447612034|FG000|Overall Study|Unable to adhere to visit schedule|13|||
124450528|NCT00074581|447612035|FG001|Overall Study|Unable to adhere to visit schedule|14|||
124450529|NCT00074581|447612034|FG000|Overall Study|Relocated|14|||
124450530|NCT00074581|447612035|FG001|Overall Study|Relocated|9|||
124450531|NCT00074581|447612034|FG000|Overall Study|Were withdrawn by investigator|5|||
124450532|NCT00074581|447612035|FG001|Overall Study|Were withdrawn by investigator|2|||
124450533|NCT00074581|447612034|FG000|Overall Study|Lost to Follow-up|16|||
124450534|NCT00074581|447612035|FG001|Overall Study|Lost to Follow-up|11|||
124450535|NCT00074581|447612034|FG000|Overall Study|Ended relationship w. index participant|117|||
124450536|NCT00074581|447612035|FG001|Overall Study|Ended relationship w. index participant|106|||
124450537|NCT00074581|447612034|FG000|Overall Study|Other|14|||
124450538|NCT00074581|447612035|FG001|Overall Study|Other|19|||
124450539|NCT00617604|447612037|FG000|Overall Study|Death|2|||
124450540|NCT00617604|447612038|FG001|Overall Study|Death|1|||
124450541|NCT00617604|447612037|FG000|Overall Study|Lost to Follow-up|1|||
124450542|NCT00617604|447612038|FG001|Overall Study|Lost to Follow-up|0|||
124450543|NCT00617604|447612037|FG000|Overall Study|Miscellaneous Reasons|8|||
124450544|NCT00617604|447612038|FG001|Overall Study|Miscellaneous Reasons|10|||
124450545|NCT00617604|447612037|FG000|Overall Study|Withdrawal by Subject|4|||
124450546|NCT00617604|447612038|FG001|Overall Study|Withdrawal by Subject|6|||
124450547|NCT00617604|447612037|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
124450548|NCT00617604|447612038|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
124450549|NCT02303704|447612039|FG000|Overall Study|Protocol Violation|5|||
124450550|NCT02303704|447612040|FG001|Overall Study|Protocol Violation|9|||
124450551|NCT00705432|447612043|FG000|Treatment Period|Adverse Event|45|||
124450552|NCT00705432|447612044|FG001|Treatment Period|Adverse Event|37|||
124450553|NCT00705432|447612045|FG002|Treatment Period|Adverse Event|51|||
124450554|NCT00705432|447612046|FG003|Treatment Period|Adverse Event|12|||
124450555|NCT00705432|447612047|FG004|Treatment Period|Adverse Event|8|||
124450556|NCT00705432|447612048|FG005|Treatment Period|Adverse Event|9|||
124450557|NCT00705432|447612043|FG000|Treatment Period|Treatment failure|92|||
124450558|NCT00705432|447612044|FG001|Treatment Period|Treatment failure|42|||
124450559|NCT00705432|447612045|FG002|Treatment Period|Treatment failure|33|||
124450560|NCT00705432|447612046|FG003|Treatment Period|Treatment failure|25|||
124450561|NCT00705432|447612047|FG004|Treatment Period|Treatment failure|13|||
124450562|NCT00705432|447612048|FG005|Treatment Period|Treatment failure|14|||
124450563|NCT00705432|447612043|FG000|Treatment Period|Non medical reason|26|||
124450564|NCT00705432|447612044|FG001|Treatment Period|Non medical reason|32|||
124450565|NCT00705432|447612045|FG002|Treatment Period|Non medical reason|37|||
124450566|NCT00705432|447612046|FG003|Treatment Period|Non medical reason|4|||
124450567|NCT00705432|447612047|FG004|Treatment Period|Non medical reason|7|||
124450568|NCT00705432|447612048|FG005|Treatment Period|Non medical reason|7|||
124450569|NCT00705432|447612043|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
124450570|NCT00705432|447612044|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
124450571|NCT00705432|447612045|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
124450572|NCT00705432|447612046|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
124450573|NCT00705432|447612047|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
124450574|NCT00705432|447612048|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
124450575|NCT00705432|447612043|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
124911784|NCT02574455|449304852|FG001|Overall Study|Lost to Follow-up|4|||
124450576|NCT00705432|447612044|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
124450577|NCT00705432|447612045|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
124450578|NCT00705432|447612046|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
124450579|NCT00705432|447612047|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
124450580|NCT00705432|447612048|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
124450581|NCT00732251|447612049|FG000|Overall Study|Lost to Follow-up|3|||
124450582|NCT00732251|447612049|FG000|Overall Study|Withdrawal by Subject|3|||
124450583|NCT00732251|447612049|FG000|Overall Study|Early Term due to Site Closure|1|||
124450584|NCT00521053|447612050|FG000|Observation Phase|Disease Progression|55|||
124450585|NCT00521053|447612050|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
124450586|NCT00521053|447612050|FG000|Observation Phase|Death|2|||
124450587|NCT00521053|447612050|FG000|Observation Phase|Adverse Event|1|||
124911785|NCT02574455|449304851|FG000|Overall Study|Sponsor's Decision|55|||
124692827|NCT00676052|448496419|FG002|Overall Study|Adverse Event|1|||
124692828|NCT00676052|448496420|FG003|Overall Study|Adverse Event|2|||
124692829|NCT00676052|448496421|FG004|Overall Study|Adverse Event|2|||
124692830|NCT00676052|448496422|FG005|Overall Study|Adverse Event|2|||
124692831|NCT00676052|448496417|FG000|Overall Study|Lack of Efficacy|2|||
124692832|NCT00676052|448496418|FG001|Overall Study|Lack of Efficacy|2|||
124692833|NCT00676052|448496419|FG002|Overall Study|Lack of Efficacy|1|||
124692834|NCT00676052|448496420|FG003|Overall Study|Lack of Efficacy|1|||
124692835|NCT00676052|448496421|FG004|Overall Study|Lack of Efficacy|2|||
124692836|NCT00676052|448496422|FG005|Overall Study|Lack of Efficacy|1|||
124692837|NCT00676052|448496417|FG000|Overall Study|Protocol Violation|5|||
124692838|NCT00676052|448496418|FG001|Overall Study|Protocol Violation|3|||
124692839|NCT00676052|448496419|FG002|Overall Study|Protocol Violation|2|||
124692840|NCT00676052|448496420|FG003|Overall Study|Protocol Violation|2|||
124692841|NCT00676052|448496421|FG004|Overall Study|Protocol Violation|1|||
124692842|NCT00676052|448496422|FG005|Overall Study|Protocol Violation|2|||
124692843|NCT00676052|448496417|FG000|Overall Study|Lost to Follow-up|0|||
124692844|NCT00676052|448496418|FG001|Overall Study|Lost to Follow-up|0|||
124911786|NCT02574455|449304852|FG001|Overall Study|Sponsor's Decision|20|||
124911787|NCT02677896|449304853|FG000|Double Blind Period (up to 35 Months)|Death|117|||
124911788|NCT02677896|449304854|FG001|Double Blind Period (up to 35 Months)|Death|197|||
124911789|NCT02677896|449304853|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
124911790|NCT02677896|449304854|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
124911791|NCT02677896|449304853|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
124911792|NCT02677896|449304854|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
124911793|NCT02677896|449304853|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
124911794|NCT02677896|449304854|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
124911795|NCT02677896|449304853|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
124911796|NCT02677896|449304854|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
124911797|NCT02677896|449304853|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
124911798|NCT02677896|449304854|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
124911799|NCT02677896|449304853|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
124911800|NCT02677896|449304854|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
124911801|NCT02677896|449304853|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
124911802|NCT02677896|449304854|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
124911803|NCT02677896|449304853|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
124911804|NCT02677896|449304854|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
124911805|NCT02677896|449304853|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
124911806|NCT02677896|449304854|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
124911807|NCT02677896|449304853|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
124911808|NCT02677896|449304854|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
124911809|NCT02677896|449304853|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
124911810|NCT02677896|449304854|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
124911811|NCT02677896|449304853|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
124911812|NCT02677896|449304854|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
124911813|NCT02677896|449304853|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
124911814|NCT02677896|449304854|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
124911815|NCT03565315|449304860|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
124911816|NCT03565315|449304861|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
124911817|NCT03565315|449304862|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
124911818|NCT03565315|449304863|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
124911819|NCT01499199|449304864|FG000|Overall Study|Adverse Event|1|||
124911820|NCT01499199|449304864|FG000|Overall Study|Lack of Efficacy|1|||
124911821|NCT02692417|449304865|FG000|Overall Study|Withdrawal by Subject|5|||
124911822|NCT02692417|449304866|FG001|Overall Study|Withdrawal by Subject|1|||
124692845|NCT00676052|448496419|FG002|Overall Study|Lost to Follow-up|0|||
124692846|NCT00676052|448496420|FG003|Overall Study|Lost to Follow-up|0|||
124692847|NCT00676052|448496421|FG004|Overall Study|Lost to Follow-up|1|||
124692848|NCT00676052|448496422|FG005|Overall Study|Lost to Follow-up|0|||
124692849|NCT00676052|448496417|FG000|Overall Study|Physician Decision|1|||
124692850|NCT00676052|448496418|FG001|Overall Study|Physician Decision|1|||
124692851|NCT00676052|448496419|FG002|Overall Study|Physician Decision|1|||
124692852|NCT00676052|448496420|FG003|Overall Study|Physician Decision|0|||
124692853|NCT00676052|448496421|FG004|Overall Study|Physician Decision|0|||
124692854|NCT00676052|448496422|FG005|Overall Study|Physician Decision|1|||
124692855|NCT00676052|448496417|FG000|Overall Study|Withdrawal by Subject|1|||
124692856|NCT00676052|448496418|FG001|Overall Study|Withdrawal by Subject|0|||
124692857|NCT00676052|448496419|FG002|Overall Study|Withdrawal by Subject|1|||
124692858|NCT00676052|448496420|FG003|Overall Study|Withdrawal by Subject|0|||
124692859|NCT00676052|448496421|FG004|Overall Study|Withdrawal by Subject|0|||
124692860|NCT00676052|448496422|FG005|Overall Study|Withdrawal by Subject|0|||
124692861|NCT00289978|448496423|FG000|Overall Study|Withdrawal by Subject|31|||
124545072|NCT00972309|447949290|FG000|Overall Study|Disease progression on study|10|||
124545073|NCT00972309|447949291|FG001|Overall Study|Disease progression on study|4|||
124545074|NCT01233284|447949295|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
124545075|NCT01233284|447949296|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
124545076|NCT01233284|447949297|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
124545077|NCT01233284|447949298|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
124545078|NCT01233284|447949299|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
124545079|NCT01233284|447949295|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
124545080|NCT01233284|447949296|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
124545081|NCT01233284|447949297|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
124545082|NCT01233284|447949298|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
124545083|NCT01233284|447949299|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
124545084|NCT01233284|447949295|FG000|Period 1 (4 Weeks)|Other|0|||
124545085|NCT01233284|447949296|FG001|Period 1 (4 Weeks)|Other|0|||
124545086|NCT01233284|447949297|FG002|Period 1 (4 Weeks)|Other|1|||
124692862|NCT00289978|448496424|FG001|Overall Study|Withdrawal by Subject|17|||
124692863|NCT00289978|448496425|FG002|Overall Study|Withdrawal by Subject|28|||
124692864|NCT00289978|448496423|FG000|Overall Study|Adverse Event|22|||
124692865|NCT00289978|448496424|FG001|Overall Study|Adverse Event|13|||
124692866|NCT00289978|448496425|FG002|Overall Study|Adverse Event|18|||
124692867|NCT00289978|448496423|FG000|Overall Study|Lack of Efficacy|13|||
124692868|NCT00289978|448496424|FG001|Overall Study|Lack of Efficacy|6|||
124692869|NCT00289978|448496425|FG002|Overall Study|Lack of Efficacy|25|||
124692870|NCT00289978|448496423|FG000|Overall Study|Abnormal laboratory value(s)|20|||
124692871|NCT00289978|448496424|FG001|Overall Study|Abnormal laboratory value(s)|9|||
124692872|NCT00289978|448496425|FG002|Overall Study|Abnormal laboratory value(s)|1|||
124692873|NCT00289978|448496423|FG000|Overall Study|Lost to Follow-up|3|||
124692874|NCT00289978|448496424|FG001|Overall Study|Lost to Follow-up|5|||
124692875|NCT00289978|448496425|FG002|Overall Study|Lost to Follow-up|7|||
124692876|NCT00289978|448496423|FG000|Overall Study|Protocol Violation|5|||
124692877|NCT00289978|448496424|FG001|Overall Study|Protocol Violation|5|||
124692878|NCT00289978|448496425|FG002|Overall Study|Protocol Violation|4|||
124692879|NCT00289978|448496423|FG000|Overall Study|Abnormal test procedure result(s)|2|||
124692880|NCT00289978|448496424|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124692881|NCT00289978|448496425|FG002|Overall Study|Abnormal test procedure result(s)|1|||
124692882|NCT00289978|448496423|FG000|Overall Study|Death|1|||
124692883|NCT00289978|448496424|FG001|Overall Study|Death|0|||
124692884|NCT00289978|448496425|FG002|Overall Study|Death|2|||
124692885|NCT01967277|448496429|FG000|Overall Study|Lost to Follow-up|1|||
124692886|NCT01967277|448496430|FG001|Overall Study|Lost to Follow-up|2|||
124692887|NCT01967277|448496429|FG000|Overall Study|Unrelated illness|0|||
124692888|NCT01967277|448496430|FG001|Overall Study|Unrelated illness|1|||
124692889|NCT00103506|448496437|FG000|Overall Study|Study closed by sponsor|34|||
124692890|NCT00103506|448496438|FG001|Overall Study|Study closed by sponsor|37|||
124692891|NCT00103506|448496437|FG000|Overall Study|Death|257|||
124692892|NCT00103506|448496438|FG001|Overall Study|Death|253|||
124692893|NCT00103506|448496437|FG000|Overall Study|Lost to Follow-up|13|||
124692894|NCT00103506|448496438|FG001|Overall Study|Lost to Follow-up|13|||
124692895|NCT00103506|448496437|FG000|Overall Study|Withdrawal by Subject|18|||
124692896|NCT00103506|448496438|FG001|Overall Study|Withdrawal by Subject|21|||
124692897|NCT00585169|448496439|FG000|Overall Study|Withdrawal by Subject|1|||
124692898|NCT01028560|448496440|FG000|Overall Study|Lack of Efficacy|3|||
124692899|NCT01028560|448496441|FG001|Overall Study|Lack of Efficacy|6|||
124692900|NCT01028560|448496440|FG000|Overall Study|Withdrawal by Subject|7|||
124692901|NCT01028560|448496441|FG001|Overall Study|Withdrawal by Subject|12|||
124692902|NCT03055221|448496442|FG000|Overall Study|Adverse Event|2|||
124911823|NCT02692417|449304865|FG000|Overall Study|Adverse Event|1|||
124911824|NCT02692417|449304866|FG001|Overall Study|Adverse Event|0|||
124911825|NCT02372253|449304875|FG000|Overall Study|Non Compliance|2|||
124911826|NCT02372253|449304876|FG001|Overall Study|Non Compliance|0|||
124911827|NCT00393484|449304879|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
124911828|NCT00393484|449304880|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
124760836|NCT02365649|448749130|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
124911829|NCT00393484|449304879|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
124911830|NCT00393484|449304880|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
124911831|NCT00393484|449304879|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
124911832|NCT00393484|449304880|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
124911833|NCT00393484|449304879|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
124911834|NCT00393484|449304880|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
124911835|NCT00393484|449304879|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
124911836|NCT00393484|449304880|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
124911837|NCT00393484|449304879|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
124911838|NCT00393484|449304880|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
124911839|NCT00393484|449304879|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
124545087|NCT01233284|447949298|FG003|Period 1 (4 Weeks)|Other|0|||
124692903|NCT03055221|448496442|FG000|Overall Study|Withdrawal by Subject|4|||
124692904|NCT03055221|448496442|FG000|Overall Study|Death|6|||
124692905|NCT03055221|448496442|FG000|Overall Study|Physician Decision|1|||
124692906|NCT03055221|448496442|FG000|Overall Study|Study terminated by Sponsor|3|||
124692907|NCT03055221|448496442|FG000|Overall Study|Lost to Follow-up|4|||
124692908|NCT01243424|448496443|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
124692909|NCT01243424|448496444|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
124692910|NCT01243424|448496443|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
124692911|NCT01243424|448496444|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
124450588|NCT00521053|447612050|FG000|Observation Phase|Other non-study melanoma treatment|1|||
124692912|NCT01243424|448496443|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
124692913|NCT01243424|448496444|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
124692914|NCT01243424|448496443|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
124692915|NCT01243424|448496444|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
124692916|NCT01243424|448496443|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
124692917|NCT01243424|448496444|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
124692918|NCT01243424|448496443|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
124692919|NCT01243424|448496444|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
124692920|NCT01243424|448496443|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
124692921|NCT01243424|448496444|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
124692922|NCT01243424|448496443|FG000|Discontinuation From Treatment|Not treated|5|||
124692923|NCT01243424|448496444|FG001|Discontinuation From Treatment|Not treated|4|||
124692924|NCT01243424|448496443|FG000|Discontinuation From Treatment|Adverse Event|457|||
124692925|NCT01243424|448496444|FG001|Discontinuation From Treatment|Adverse Event|523|||
124692926|NCT01243424|448496443|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
124692927|NCT01243424|448496444|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
124692928|NCT01243424|448496443|FG000|Discontinuation From Treatment|Protocol Violation|46|||
124692929|NCT01243424|448496444|FG001|Discontinuation From Treatment|Protocol Violation|47|||
124692930|NCT01243424|448496443|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
124692931|NCT01243424|448496444|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
124692932|NCT01243424|448496443|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
124692933|NCT01243424|448496444|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
124692934|NCT01243424|448496443|FG000|Discontinuation From Treatment|Other than listed above|230|||
124692935|NCT01243424|448496444|FG001|Discontinuation From Treatment|Other than listed above|211|||
124692936|NCT01441414|448496451|FG000|Overall Study|Participant died|9|||
124692937|NCT01441414|448496451|FG000|Overall Study|Other reasons|3|||
124692938|NCT01441414|448496451|FG000|Overall Study|Study terminated by sponsor|2|||
124692939|NCT01441414|448496451|FG000|Overall Study|Subject refused further follow-up|1|||
124692940|NCT01773889|448496458|FG000|Overall Study|lack of funding|2|||
124692941|NCT00976391|448496464|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
124692942|NCT00976391|448496465|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
124692943|NCT00976391|448496464|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
124692944|NCT00976391|448496465|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
124692945|NCT00976391|448496464|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
124692946|NCT00976391|448496465|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
124692947|NCT00976391|448496464|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
124692948|NCT00976391|448496465|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
124692949|NCT00976391|448496464|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
124692950|NCT00976391|448496465|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
124692951|NCT00976391|448496464|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
124692952|NCT00976391|448496465|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
124692953|NCT00976391|448496464|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
124450589|NCT00521053|447612050|FG000|Observation Phase|Physician Decision|1|||
124450590|NCT01034540|447612051|FG000|Overall Study|Adverse Event|0|||
124450591|NCT01034540|447612052|FG001|Overall Study|Adverse Event|1|||
124450592|NCT03519867|447612055|FG000|Overall Study|Adverse Event|1|||
124450593|NCT03519867|447612056|FG001|Overall Study|Adverse Event|1|||
124450594|NCT03519867|447612057|FG002|Overall Study|Adverse Event|0|||
124450595|NCT03519867|447612058|FG003|Overall Study|Adverse Event|0|||
124450596|NCT03519867|447612059|FG004|Overall Study|Adverse Event|0|||
124450597|NCT03519867|447612060|FG005|Overall Study|Adverse Event|0|||
124692954|NCT00976391|448496465|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
124692955|NCT00976391|448496464|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
124692956|NCT00976391|448496465|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
124692957|NCT00976391|448496464|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
124692958|NCT00976391|448496465|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
124450598|NCT03519867|447612061|FG006|Overall Study|Adverse Event|0|||
124450599|NCT03519867|447612062|FG007|Overall Study|Adverse Event|0|||
124450600|NCT03519867|447612063|FG008|Overall Study|Adverse Event|0|||
124692959|NCT00976391|448496464|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
124692960|NCT00976391|448496465|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
124692961|NCT00976391|448496464|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
124692962|NCT00976391|448496465|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
124692963|NCT00976391|448496464|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
124692964|NCT00976391|448496465|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
124692965|NCT00976391|448496464|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
124692966|NCT00976391|448496465|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
124692967|NCT00976391|448496464|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
124692968|NCT00976391|448496465|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
124692969|NCT00617903|448496466|FG000|Overall Study|Withdrawal by Subject|2|||
124692970|NCT00617903|448496467|FG001|Overall Study|Withdrawal by Subject|3|||
124692971|NCT00617903|448496466|FG000|Overall Study|Lost to Follow-up|1|||
124692972|NCT00617903|448496467|FG001|Overall Study|Lost to Follow-up|1|||
124692973|NCT00617903|448496466|FG000|Overall Study|Lack of Efficacy|0|||
124692974|NCT00617903|448496467|FG001|Overall Study|Lack of Efficacy|1|||
124692975|NCT00617903|448496466|FG000|Overall Study|Adverse Event|0|||
124692976|NCT00617903|448496467|FG001|Overall Study|Adverse Event|1|||
124692977|NCT00617903|448496466|FG000|Overall Study|noncompliance|0|||
124692978|NCT00617903|448496467|FG001|Overall Study|noncompliance|1|||
124692979|NCT05156125|448496468|FG000|Overall Study|Lack of Efficacy|1|||
124692980|NCT05156125|448496469|FG001|Overall Study|Lack of Efficacy|1|||
124692981|NCT05156125|448496470|FG002|Overall Study|Lack of Efficacy|1|||
124692982|NCT05156125|448496468|FG000|Overall Study|Physician Decision|0|||
124692983|NCT05156125|448496469|FG001|Overall Study|Physician Decision|0|||
124692984|NCT05156125|448496470|FG002|Overall Study|Physician Decision|1|||
124692985|NCT05156125|448496468|FG000|Overall Study|Non-compliance|0|||
124692986|NCT05156125|448496469|FG001|Overall Study|Non-compliance|1|||
124692987|NCT05156125|448496470|FG002|Overall Study|Non-compliance|1|||
124692988|NCT05156125|448496468|FG000|Overall Study|Withdrawal by Subject|0|||
124692989|NCT05156125|448496469|FG001|Overall Study|Withdrawal by Subject|0|||
124692990|NCT05156125|448496470|FG002|Overall Study|Withdrawal by Subject|1|||
124692991|NCT05156125|448496468|FG000|Overall Study|Adverse Event|2|||
124692992|NCT05156125|448496469|FG001|Overall Study|Adverse Event|1|||
124692993|NCT05156125|448496470|FG002|Overall Study|Adverse Event|0|||
124692994|NCT03123588|448496476|FG000|Overall Study|Study Terminated by Sponsor|2|||
124692995|NCT03123588|448496477|FG001|Overall Study|Study Terminated by Sponsor|5|||
124692996|NCT03123588|448496476|FG000|Overall Study|Withdrawal by Subject|1|||
124692997|NCT03123588|448496477|FG001|Overall Study|Withdrawal by Subject|0|||
124692998|NCT03123588|448496476|FG000|Overall Study|Adverse Event|1|||
124692999|NCT03123588|448496477|FG001|Overall Study|Adverse Event|0|||
124450601|NCT03519867|447612064|FG009|Overall Study|Adverse Event|0|||
124450602|NCT03519867|447612055|FG000|Overall Study|Protocol Violation|0|||
124450603|NCT03519867|447612056|FG001|Overall Study|Protocol Violation|0|||
124450604|NCT03519867|447612057|FG002|Overall Study|Protocol Violation|0|||
124450605|NCT03519867|447612058|FG003|Overall Study|Protocol Violation|0|||
124450606|NCT03519867|447612059|FG004|Overall Study|Protocol Violation|0|||
124450607|NCT03519867|447612060|FG005|Overall Study|Protocol Violation|1|||
124450608|NCT03519867|447612061|FG006|Overall Study|Protocol Violation|0|||
124450609|NCT03519867|447612062|FG007|Overall Study|Protocol Violation|0|||
124450610|NCT03519867|447612063|FG008|Overall Study|Protocol Violation|0|||
124450611|NCT03519867|447612064|FG009|Overall Study|Protocol Violation|0|||
124450612|NCT03519867|447612055|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
124450613|NCT03519867|447612056|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
124450614|NCT03519867|447612057|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
124450615|NCT03519867|447612058|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
124450616|NCT03519867|447612059|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
124450617|NCT03519867|447612060|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
124450618|NCT03519867|447612061|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
124450619|NCT03519867|447612062|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
124450620|NCT03519867|447612063|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
124760837|NCT02365649|448749131|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
124450621|NCT03519867|447612064|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
124693000|NCT03123588|448496476|FG000|Overall Study|Physician Decision|2|||
124693001|NCT03123588|448496477|FG001|Overall Study|Physician Decision|1|||
124693002|NCT01698008|448496480|FG000|Overall Study|Withdrawal by Subject|1|||
124693003|NCT01698008|448496481|FG001|Overall Study|Withdrawal by Subject|2|||
124693004|NCT01755637|448496485|FG000|Period 1|Adverse Event|0|||
124693005|NCT01755637|448496486|FG001|Period 1|Adverse Event|1|||
124693006|NCT01814332|448496487|FG000|Overall Study|Adverse Event|8|||
124760838|NCT02365649|448749132|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
124450622|NCT03519867|447612055|FG000|Overall Study|Admin. of other reversal agent|1|||
124693007|NCT01814332|448496488|FG001|Overall Study|Adverse Event|3|||
124693008|NCT01814332|448496487|FG000|Overall Study|Withdrawal by Subject|3|||
124693009|NCT01814332|448496488|FG001|Overall Study|Withdrawal by Subject|8|||
124450623|NCT03519867|447612056|FG001|Overall Study|Admin. of other reversal agent|1|||
124450624|NCT03519867|447612057|FG002|Overall Study|Admin. of other reversal agent|0|||
124450625|NCT03519867|447612058|FG003|Overall Study|Admin. of other reversal agent|0|||
124450626|NCT03519867|447612059|FG004|Overall Study|Admin. of other reversal agent|0|||
124450627|NCT03519867|447612060|FG005|Overall Study|Admin. of other reversal agent|1|||
124450628|NCT03519867|447612061|FG006|Overall Study|Admin. of other reversal agent|0|||
124450629|NCT03519867|447612062|FG007|Overall Study|Admin. of other reversal agent|0|||
124450630|NCT03519867|447612063|FG008|Overall Study|Admin. of other reversal agent|0|||
124450631|NCT03519867|447612064|FG009|Overall Study|Admin. of other reversal agent|0|||
124450632|NCT03519867|447612055|FG000|Overall Study|Reason not provided|1|||
124450633|NCT03519867|447612056|FG001|Overall Study|Reason not provided|1|||
124450634|NCT03519867|447612057|FG002|Overall Study|Reason not provided|1|||
124450635|NCT03519867|447612058|FG003|Overall Study|Reason not provided|1|||
124450636|NCT03519867|447612059|FG004|Overall Study|Reason not provided|0|||
124450637|NCT03519867|447612060|FG005|Overall Study|Reason not provided|1|||
124450638|NCT03519867|447612061|FG006|Overall Study|Reason not provided|0|||
124450639|NCT03519867|447612062|FG007|Overall Study|Reason not provided|1|||
124450640|NCT03519867|447612063|FG008|Overall Study|Reason not provided|1|||
124450641|NCT03519867|447612064|FG009|Overall Study|Reason not provided|0|||
124450642|NCT00667823|447612065|FG000|Overall Study|Lost to Follow-up|5|||
124450643|NCT00667823|447612065|FG000|Overall Study|Adverse Event|7|||
124450644|NCT00667823|447612065|FG000|Overall Study|Death|182|||
124450645|NCT00667823|447612065|FG000|Overall Study|Withdrawal by Subject|12|||
124450646|NCT00667823|447612065|FG000|Overall Study|Other|8|||
124450647|NCT00667823|447612065|FG000|Overall Study|Missing (completion page missing)|2|||
124450648|NCT04376827|447612066|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
124450649|NCT04376827|447612067|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
124450650|NCT04376827|447612066|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
124450651|NCT04376827|447612067|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
124450652|NCT04376827|447612066|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
124450653|NCT04376827|447612067|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
124450654|NCT04376827|447612066|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
124450655|NCT04376827|447612067|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
124450656|NCT04376827|447612066|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
124450657|NCT04376827|447612067|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
124450658|NCT00761306|447613531|FG000|Overall Study|Adverse Event|5|||
124450659|NCT00761306|447613531|FG000|Overall Study|Lack of Efficacy|4|||
124450660|NCT00761306|447613531|FG000|Overall Study|Protocol Violation|2|||
124450661|NCT00761306|447613531|FG000|Overall Study|Withdrawal of Consent|3|||
124450662|NCT00761306|447613531|FG000|Overall Study|Lost to Follow-up|1|||
124450663|NCT00761306|447613531|FG000|Overall Study|Administrative or Other Reasons|5|||
124450664|NCT04042740|447613532|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
124450665|NCT04042740|447613532|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
124450666|NCT00880555|447613533|FG000|Overall Study|Physician Decision|0|||
124450667|NCT00880555|447613534|FG001|Overall Study|Physician Decision|8|||
124450668|NCT00880555|447613535|FG002|Overall Study|Physician Decision|0|||
124450669|NCT00880555|447613536|FG003|Overall Study|Physician Decision|2|||
124450670|NCT00880555|447613537|FG004|Overall Study|Physician Decision|1|||
124450671|NCT00880555|447613538|FG005|Overall Study|Physician Decision|0|||
124450672|NCT00880555|447613533|FG000|Overall Study|Withdrawal by Subject|1|||
124450673|NCT00880555|447613534|FG001|Overall Study|Withdrawal by Subject|1|||
124450674|NCT00880555|447613535|FG002|Overall Study|Withdrawal by Subject|0|||
124450675|NCT00880555|447613536|FG003|Overall Study|Withdrawal by Subject|0|||
124450676|NCT00880555|447613537|FG004|Overall Study|Withdrawal by Subject|0|||
124450677|NCT00880555|447613538|FG005|Overall Study|Withdrawal by Subject|0|||
124450678|NCT00880555|447613533|FG000|Overall Study|Lack of resources (hired rater)|9|||
124450679|NCT00880555|447613534|FG001|Overall Study|Lack of resources (hired rater)|7|||
124450680|NCT00880555|447613535|FG002|Overall Study|Lack of resources (hired rater)|5|||
124450681|NCT00880555|447613536|FG003|Overall Study|Lack of resources (hired rater)|0|||
124450682|NCT00880555|447613537|FG004|Overall Study|Lack of resources (hired rater)|0|||
124450683|NCT00880555|447613538|FG005|Overall Study|Lack of resources (hired rater)|0|||
124450684|NCT00880555|447613533|FG000|Overall Study|Death|0|||
124450685|NCT00880555|447613534|FG001|Overall Study|Death|0|||
124450686|NCT00880555|447613535|FG002|Overall Study|Death|0|||
124450687|NCT00880555|447613536|FG003|Overall Study|Death|0|||
124450688|NCT00880555|447613537|FG004|Overall Study|Death|0|||
124450689|NCT00880555|447613538|FG005|Overall Study|Death|1|||
124450690|NCT00880555|447613533|FG000|Overall Study|Lost to Follow-up|0|||
124450691|NCT00880555|447613534|FG001|Overall Study|Lost to Follow-up|1|||
124450692|NCT00880555|447613535|FG002|Overall Study|Lost to Follow-up|0|||
124450693|NCT00880555|447613536|FG003|Overall Study|Lost to Follow-up|0|||
124450694|NCT00880555|447613537|FG004|Overall Study|Lost to Follow-up|0|||
124450695|NCT00880555|447613538|FG005|Overall Study|Lost to Follow-up|0|||
124693010|NCT01814332|448496487|FG000|Overall Study|Protocol Violation|0|||
124693011|NCT01814332|448496488|FG001|Overall Study|Protocol Violation|4|||
124693012|NCT01814332|448496487|FG000|Overall Study|Lost to Follow-up|5|||
124693013|NCT01814332|448496488|FG001|Overall Study|Lost to Follow-up|1|||
124693014|NCT02959892|448496489|FG000|Overall Study|PET tracer synthesis failure|1|||
124693015|NCT02959892|448496490|FG001|Overall Study|PET tracer synthesis failure|0|||
124693016|NCT02959892|448496489|FG000|Overall Study|Study termination|0|||
124693017|NCT02959892|448496490|FG001|Overall Study|Study termination|1|||
124693018|NCT04263532|448496493|FG000|Overall Study|Withdrawal by Subject|2|||
124693019|NCT04263532|448496494|FG001|Overall Study|Withdrawal by Subject|0|||
124693020|NCT01399099|448496501|FG000|Overall Study|Lost to Follow-up|14|||
124693021|NCT01399099|448496501|FG000|Overall Study|Physician Decision|1|||
124693022|NCT01399099|448496501|FG000|Overall Study|Protocol Violation|1|||
124693023|NCT01399099|448496501|FG000|Overall Study|Skin Irritation|13|||
124693024|NCT01399099|448496501|FG000|Overall Study|Infection|1|||
124693025|NCT01399099|448496501|FG000|Overall Study|Miscellaneous|4|||
124693026|NCT01668537|448496502|FG000|Overall Study|Request to Discontinue Prematurely|1|||
124693027|NCT01668537|448496503|FG001|Overall Study|Request to Discontinue Prematurely|1|||
124693028|NCT01668537|448496502|FG000|Overall Study|Subject unwilling/unable to comply|5|||
124693029|NCT01668537|448496503|FG001|Overall Study|Subject unwilling/unable to comply|0|||
124693030|NCT01668537|448496502|FG000|Overall Study|Reason Precludes Participation|1|||
124693031|NCT01668537|448496503|FG001|Overall Study|Reason Precludes Participation|0|||
124693032|NCT01668537|448496502|FG000|Overall Study|Lost to Follow-up|13|||
124693033|NCT01668537|448496503|FG001|Overall Study|Lost to Follow-up|6|||
124693034|NCT01668537|448496502|FG000|Overall Study|Other|2|||
124693035|NCT01668537|448496503|FG001|Overall Study|Other|3|||
124693036|NCT02497755|448496504|FG000|Overall Study|Protocol Violation|1|||
124911840|NCT00393484|449304880|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
124911841|NCT00393484|449304879|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
124911842|NCT00393484|449304880|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
124911843|NCT00393484|449304879|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
124911844|NCT00393484|449304880|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
124911845|NCT00393484|449304879|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
124911846|NCT00393484|449304880|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
124911847|NCT03201562|449304881|FG000|Overall Study|Physician Decision|0|||
124911848|NCT03201562|449304882|FG001|Overall Study|Physician Decision|0|||
124911849|NCT03201562|449304883|FG002|Overall Study|Physician Decision|1|||
124911850|NCT03201562|449304881|FG000|Overall Study|Adverse Event|0|||
124911851|NCT03201562|449304882|FG001|Overall Study|Adverse Event|0|||
124911852|NCT03201562|449304883|FG002|Overall Study|Adverse Event|1|||
124911853|NCT03201562|449304881|FG000|Overall Study|Lost to Follow-up|0|||
124911854|NCT03201562|449304882|FG001|Overall Study|Lost to Follow-up|1|||
124911855|NCT03201562|449304883|FG002|Overall Study|Lost to Follow-up|2|||
124911856|NCT00001277|449304884|FG000|Overall Study|Adverse Event|0|||
124911857|NCT00001277|449304885|FG001|Overall Study|Adverse Event|0|||
124911858|NCT00001277|449304886|FG002|Overall Study|Adverse Event|1|||
124911859|NCT00001277|449304884|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
124911860|NCT00001277|449304885|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
124911861|NCT00001277|449304886|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
124911862|NCT02539225|449304894|FG000|Part A|Adverse Event|13|||
124450696|NCT04479436|447613541|FG000|Overall Study|Progressive disease|26|||
124450697|NCT04479436|447613542|FG001|Overall Study|Progressive disease|1|||
124450698|NCT04479436|447613541|FG000|Overall Study|Adverse Event|6|||
124450699|NCT04479436|447613542|FG001|Overall Study|Adverse Event|0|||
124450700|NCT04479436|447613541|FG000|Overall Study|Withdrawal by Subject|5|||
124450701|NCT04479436|447613542|FG001|Overall Study|Withdrawal by Subject|0|||
124450702|NCT04479436|447613541|FG000|Overall Study|Clinical progression|1|||
124450703|NCT04479436|447613542|FG001|Overall Study|Clinical progression|0|||
124450704|NCT04479436|447613541|FG000|Overall Study|Physician Decision|1|||
124450705|NCT04479436|447613542|FG001|Overall Study|Physician Decision|0|||
124450706|NCT02357134|447613543|FG000|Overall Study|Lost to Follow-up|1|||
124450707|NCT02357134|447613544|FG001|Overall Study|Lost to Follow-up|0|||
124450708|NCT02357134|447613545|FG002|Overall Study|Lost to Follow-up|0|||
124450709|NCT02357134|447613546|FG003|Overall Study|Lost to Follow-up|0|||
124450710|NCT01380730|447613547|FG000|Overall Study|Death|0|||
124450711|NCT01380730|447613548|FG001|Overall Study|Death|0|||
124450712|NCT01380730|447613549|FG002|Overall Study|Death|0|||
124450713|NCT01380730|447613550|FG003|Overall Study|Death|0|||
124450714|NCT01380730|447613551|FG004|Overall Study|Death|1|||
124450715|NCT01380730|447613552|FG005|Overall Study|Death|0|||
124450716|NCT01380730|447613553|FG006|Overall Study|Death|0|||
124450717|NCT01380730|447613554|FG007|Overall Study|Death|0|||
124450718|NCT00467779|447613555|FG000|Stage 1|Adverse Event|1|||
124450719|NCT00467779|447613556|FG001|Stage 1|Adverse Event|0|||
124450720|NCT00467779|447613557|FG002|Stage 1|Adverse Event|0|||
124693037|NCT02497755|448496505|FG001|Overall Study|Protocol Violation|0|||
124450721|NCT00467779|447613558|FG003|Stage 1|Adverse Event|0|||
124450722|NCT00467779|447613559|FG004|Stage 1|Adverse Event|0|||
124450723|NCT00467779|447613560|FG005|Stage 1|Adverse Event|1|||
124545088|NCT01233284|447949299|FG004|Period 1 (4 Weeks)|Other|0|||
124545089|NCT01233284|447949295|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124545090|NCT01233284|447949296|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124545091|NCT01233284|447949297|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
124545092|NCT01233284|447949298|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124545093|NCT01233284|447949299|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124545094|NCT01233284|447949295|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
124545095|NCT01233284|447949296|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
124545096|NCT01233284|447949297|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
124545097|NCT01233284|447949298|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
124545098|NCT01233284|447949299|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
124545099|NCT01233284|447949295|FG000|Period 3 (4 Weeks)|Other|0|||
124545100|NCT01233284|447949296|FG001|Period 3 (4 Weeks)|Other|0|||
124545101|NCT01233284|447949297|FG002|Period 3 (4 Weeks)|Other|0|||
124545102|NCT01233284|447949298|FG003|Period 3 (4 Weeks)|Other|1|||
124545103|NCT01233284|447949299|FG004|Period 3 (4 Weeks)|Other|0|||
124545104|NCT01233284|447949295|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
124545105|NCT01233284|447949296|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
124545106|NCT01233284|447949297|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
124545107|NCT01233284|447949298|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
124545108|NCT01233284|447949299|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
124545109|NCT01233284|447949295|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
124545110|NCT01233284|447949296|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
124545111|NCT01233284|447949297|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
124545112|NCT01233284|447949298|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
124545113|NCT01233284|447949299|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
124545114|NCT00157820|447949309|FG000|Randomized|Physician Decision|4|||
124545115|NCT00157820|447949310|FG001|Randomized|Physician Decision|2|||
124545116|NCT00157820|447949311|FG002|Randomized|Physician Decision|3|||
124545117|NCT00157820|447949309|FG000|Randomized|Withdrawal by Subject|1|||
124545118|NCT00157820|447949310|FG001|Randomized|Withdrawal by Subject|2|||
124545119|NCT00157820|447949311|FG002|Randomized|Withdrawal by Subject|3|||
124545120|NCT00157820|447949309|FG000|Randomized|Protocol Violation|2|||
124545121|NCT00157820|447949310|FG001|Randomized|Protocol Violation|1|||
124545122|NCT00157820|447949311|FG002|Randomized|Protocol Violation|2|||
124545123|NCT00157820|447949309|FG000|1st 8 Month|Death|7|||
124545124|NCT00157820|447949310|FG001|1st 8 Month|Death|8|||
124545125|NCT00157820|447949311|FG002|1st 8 Month|Death|3|||
124545126|NCT00157820|447949309|FG000|1st 8 Month|Lost to Follow-up|1|||
124545127|NCT00157820|447949310|FG001|1st 8 Month|Lost to Follow-up|2|||
124545128|NCT00157820|447949311|FG002|1st 8 Month|Lost to Follow-up|1|||
124545129|NCT00157820|447949309|FG000|1st 8 Month|Premature cross-over|0|||
124545130|NCT00157820|447949310|FG001|1st 8 Month|Premature cross-over|2|||
124545131|NCT00157820|447949311|FG002|1st 8 Month|Premature cross-over|2|||
124545132|NCT00157820|447949309|FG000|2nd 8 Months|Death|3|||
124545133|NCT00157820|447949310|FG001|2nd 8 Months|Death|1|||
124545134|NCT00157820|447949311|FG002|2nd 8 Months|Death|3|||
124545135|NCT00157820|447949309|FG000|2nd 8 Months|Lost to Follow-up|1|||
124545136|NCT00157820|447949310|FG001|2nd 8 Months|Lost to Follow-up|5|||
124545137|NCT00157820|447949311|FG002|2nd 8 Months|Lost to Follow-up|2|||
124545138|NCT00157820|447949309|FG000|2nd 8 Months|Premature cross-over|1|||
124545139|NCT00157820|447949310|FG001|2nd 8 Months|Premature cross-over|7|||
124545140|NCT00157820|447949311|FG002|2nd 8 Months|Premature cross-over|9|||
124545141|NCT01721369|447949312|FG000|Overall Study|Not initial etiological diagnosis|12|||
124545142|NCT00563706|447951086|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
124545143|NCT00563706|447951087|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
124545144|NCT00563706|447951088|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
124545145|NCT00563706|447951089|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
124545146|NCT00563706|447951090|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
124545147|NCT00563706|447951091|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
124545148|NCT00563706|447951092|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
124545149|NCT00563706|447951093|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
124693038|NCT02280499|448496509|FG000|Overall Study|Death|14|||
124693039|NCT02280499|448496509|FG000|Overall Study|Lost to Follow-up|42|||
124693040|NCT02280499|448496509|FG000|Overall Study|Adverse Event|5|||
124545150|NCT00563706|447951094|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
124545151|NCT00563706|447951086|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
124545152|NCT00563706|447951087|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
124545153|NCT00563706|447951088|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
124545154|NCT00563706|447951089|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
124545155|NCT00563706|447951090|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
124545156|NCT00563706|447951091|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
124693041|NCT02547935|448496515|FG000|Overall Study|Other|0|||
124693042|NCT02547935|448496516|FG001|Overall Study|Other|1|||
124545157|NCT00563706|447951092|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
124545158|NCT00563706|447951093|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
124693043|NCT02547935|448496517|FG002|Overall Study|Other|0|||
124693044|NCT02547935|448496515|FG000|Overall Study|Withdrawal by Subject|2|||
124693045|NCT02547935|448496516|FG001|Overall Study|Withdrawal by Subject|3|||
124693046|NCT02547935|448496517|FG002|Overall Study|Withdrawal by Subject|4|||
124693047|NCT02547935|448496515|FG000|Overall Study|Screen Failure|2|||
124693048|NCT02547935|448496516|FG001|Overall Study|Screen Failure|0|||
124693049|NCT02547935|448496517|FG002|Overall Study|Screen Failure|0|||
124693050|NCT02547935|448496515|FG000|Overall Study|Physician Decision|0|||
124693051|NCT02547935|448496516|FG001|Overall Study|Physician Decision|1|||
124693052|NCT02547935|448496517|FG002|Overall Study|Physician Decision|0|||
124693053|NCT02547935|448496515|FG000|Overall Study|Lost to Follow-up|0|||
124693054|NCT02547935|448496516|FG001|Overall Study|Lost to Follow-up|2|||
124693055|NCT02547935|448496517|FG002|Overall Study|Lost to Follow-up|1|||
124693056|NCT02547935|448496515|FG000|Overall Study|Death|1|||
124693057|NCT02547935|448496516|FG001|Overall Study|Death|1|||
124693058|NCT02547935|448496517|FG002|Overall Study|Death|0|||
124693059|NCT03554473|448498567|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
124693060|NCT03554473|448498568|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
124911863|NCT02539225|449304895|FG001|Part A|Adverse Event|4|||
124911864|NCT02539225|449304894|FG000|Part A|Withdrawal by Subject|2|||
124911865|NCT02539225|449304895|FG001|Part A|Withdrawal by Subject|4|||
124911866|NCT02539225|449304894|FG000|Part A|Physician Decision|4|||
124911867|NCT02539225|449304895|FG001|Part A|Physician Decision|7|||
124911868|NCT02539225|449304894|FG000|Part A|Did Not Receive study Drug|1|||
124911869|NCT02539225|449304895|FG001|Part A|Did Not Receive study Drug|1|||
124911870|NCT02539225|449304894|FG000|Pre Treatment for Part B|Progressive disease|1|||
124911871|NCT02539225|449304895|FG001|Pre Treatment for Part B|Progressive disease|1|||
124911872|NCT02539225|449304894|FG000|Pre Treatment for Part B|Adverse Event|1|||
124911873|NCT02539225|449304895|FG001|Pre Treatment for Part B|Adverse Event|1|||
124911874|NCT02539225|449304894|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
124911875|NCT02539225|449304895|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
124911876|NCT02539225|449304894|FG000|Pre Treatment for Part B|Physician Decision|2|||
124911877|NCT02539225|449304895|FG001|Pre Treatment for Part B|Physician Decision|0|||
124911878|NCT02539225|449304894|FG000|Part B|Adverse Event|4|||
124911879|NCT02539225|449304895|FG001|Part B|Adverse Event|4|||
124911880|NCT02539225|449304894|FG000|Part B|Withdrawal by Subject|0|||
124911881|NCT02539225|449304895|FG001|Part B|Withdrawal by Subject|3|||
124911882|NCT02539225|449304894|FG000|Part B|Physician Decision|0|||
124911883|NCT02539225|449304895|FG001|Part B|Physician Decision|9|||
124911884|NCT03101371|449304896|FG000|Overall Study|Physician Decision|0|||
124911885|NCT03101371|449304897|FG001|Overall Study|Physician Decision|1|||
124911886|NCT03101371|449304896|FG000|Overall Study|Lost to Follow-up|1|||
124911887|NCT03101371|449304897|FG001|Overall Study|Lost to Follow-up|4|||
124911888|NCT03101371|449304896|FG000|Overall Study|Did not meet eligibility criteria|2|||
124911889|NCT03101371|449304897|FG001|Overall Study|Did not meet eligibility criteria|1|||
124911890|NCT02318134|449304898|FG000|Overall Study|Withdrawal by Subject|2|||
124911891|NCT02318134|449304899|FG001|Overall Study|Withdrawal by Subject|1|||
124911892|NCT04766034|449304900|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
124911893|NCT04766034|449304901|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
124911894|NCT04766034|449304902|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
124911895|NCT04766034|449304903|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
124911896|NCT04766034|449304904|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
124911897|NCT04766034|449304900|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
124911898|NCT04766034|449304901|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
124911899|NCT04766034|449304902|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
124911900|NCT04766034|449304903|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
124911901|NCT04766034|449304904|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
124911902|NCT04766034|449304900|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
124911903|NCT04766034|449304901|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
124911904|NCT04766034|449304902|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
124911905|NCT04766034|449304903|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
124911906|NCT04766034|449304904|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
124911907|NCT04766034|449304900|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
124911908|NCT04766034|449304901|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
124911909|NCT04766034|449304902|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
124911910|NCT04766034|449304903|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
124545159|NCT00563706|447951094|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
124911911|NCT04766034|449304904|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
124911912|NCT01976312|449304905|FG000|Overall Study|Pregnancy|0|||
124911913|NCT01976312|449304906|FG001|Overall Study|Pregnancy|1|||
124911914|NCT01976312|449304905|FG000|Overall Study|Lost to Follow-up|2|||
124911915|NCT01976312|449304906|FG001|Overall Study|Lost to Follow-up|0|||
124911916|NCT01976312|449304905|FG000|Overall Study|Withdrawal by Subject|7|||
124911917|NCT01976312|449304906|FG001|Overall Study|Withdrawal by Subject|2|||
124760839|NCT02365649|448749133|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
124760840|NCT02365649|448749134|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
124760841|NCT02365649|448749135|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
124760842|NCT02365649|448749136|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
124760843|NCT02365649|448749127|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
124760844|NCT02365649|448749128|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
124760845|NCT02365649|448749129|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
124760846|NCT02365649|448749130|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
124760847|NCT02365649|448749131|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
124760848|NCT02365649|448749132|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
124760849|NCT02365649|448749133|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
124760850|NCT02365649|448749134|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
124760851|NCT02365649|448749135|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
124760852|NCT02365649|448749136|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
124760853|NCT02365649|448749127|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
124760854|NCT02365649|448749128|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
124760855|NCT02365649|448749129|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
124760856|NCT02365649|448749130|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
124760857|NCT02365649|448749131|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
124760858|NCT02365649|448749132|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
124760859|NCT02365649|448749133|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
124760860|NCT02365649|448749134|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
124760861|NCT02365649|448749135|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
124760862|NCT02365649|448749136|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
124760863|NCT02365649|448749127|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
124760864|NCT02365649|448749128|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
124760865|NCT02365649|448749129|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
124760866|NCT02365649|448749130|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
124760867|NCT02365649|448749131|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
124760868|NCT02365649|448749132|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
124760869|NCT02365649|448749133|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
124760870|NCT02365649|448749134|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
124760871|NCT02365649|448749135|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
124760872|NCT02365649|448749136|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
124760873|NCT02365649|448749127|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
124760874|NCT02365649|448749128|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
124760875|NCT02365649|448749129|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
124760876|NCT02365649|448749130|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
124760877|NCT02365649|448749131|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
124760878|NCT02365649|448749132|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
124760879|NCT02365649|448749133|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
124760880|NCT02365649|448749134|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
124760881|NCT02365649|448749135|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
124760882|NCT02365649|448749136|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
124760883|NCT02365649|448749127|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
124760884|NCT02365649|448749128|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
124760885|NCT02365649|448749129|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
124760886|NCT02365649|448749130|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
124760887|NCT02365649|448749131|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
124760888|NCT02365649|448749132|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
124911918|NCT01976312|449304905|FG000|Overall Study|Adverse Event|6|||
124760889|NCT02365649|448749133|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
124760890|NCT02365649|448749134|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
124760891|NCT02365649|448749135|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
124760892|NCT02365649|448749136|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
124760893|NCT02365649|448749127|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
124760894|NCT02365649|448749128|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
124911919|NCT01976312|449304906|FG001|Overall Study|Adverse Event|6|||
124911920|NCT01976312|449304905|FG000|Overall Study|Protocol Violation|2|||
124693061|NCT03554473|448498569|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
124693062|NCT03554473|448498567|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
124693063|NCT03554473|448498568|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
124693064|NCT03554473|448498569|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
124693065|NCT03554473|448498567|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
124693066|NCT03554473|448498568|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
124693067|NCT03554473|448498569|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
124693068|NCT00382070|448498573|FG000|Overall Study|No follow up data mapped to Other|17|||
124693069|NCT00382070|448498574|FG001|Overall Study|No follow up data mapped to Other|19|||
124693070|NCT00382070|448498573|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
124693071|NCT00382070|448498574|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
124693072|NCT00382070|448498573|FG000|Overall Study|No clinical assessment|9|||
124693073|NCT00382070|448498574|FG001|Overall Study|No clinical assessment|11|||
124693074|NCT00284934|448498580|FG000|Overall Study|Adverse Event|1|||
124693075|NCT00284934|448498581|FG001|Overall Study|Adverse Event|2|||
124693076|NCT00284934|448498580|FG000|Overall Study|Other reasons|3|||
124693077|NCT00284934|448498581|FG001|Overall Study|Other reasons|1|||
124693078|NCT00520572|448498586|FG000|Overall Study|Adverse Event|9|||
124693079|NCT00520572|448498587|FG001|Overall Study|Adverse Event|3|||
124693080|NCT00520572|448498588|FG002|Overall Study|Adverse Event|6|||
124693081|NCT00520572|448498589|FG003|Overall Study|Adverse Event|9|||
124693082|NCT00520572|448498590|FG004|Overall Study|Adverse Event|7|||
124693083|NCT00520572|448498591|FG005|Overall Study|Adverse Event|2|||
124693084|NCT00520572|448498586|FG000|Overall Study|Withdrawal by Subject|0|||
124693085|NCT00520572|448498587|FG001|Overall Study|Withdrawal by Subject|9|||
124693086|NCT00520572|448498588|FG002|Overall Study|Withdrawal by Subject|5|||
124693087|NCT00520572|448498589|FG003|Overall Study|Withdrawal by Subject|2|||
124693088|NCT00520572|448498590|FG004|Overall Study|Withdrawal by Subject|2|||
124693089|NCT00520572|448498591|FG005|Overall Study|Withdrawal by Subject|0|||
124693090|NCT00520572|448498586|FG000|Overall Study|Protocol Violation|0|||
124911921|NCT01976312|449304906|FG001|Overall Study|Protocol Violation|0|||
124911922|NCT04048382|449304911|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
124911923|NCT04048382|449304912|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
124911924|NCT04048382|449304911|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
124911925|NCT04048382|449304912|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
124911926|NCT04048382|449304911|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
124911927|NCT04048382|449304912|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
124911928|NCT02556138|449304913|FG000|Overall Study|Withdrawal by Subject|1|||
124911929|NCT01205048|449304918|FG000|Overall Study|Withdrawal by Subject|14|||
124911930|NCT01205048|449304918|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
124911931|NCT01205048|449304918|FG000|Overall Study|Lost to Follow-up|4|||
124911932|NCT01205048|449304918|FG000|Overall Study|Other|2|||
124911933|NCT01255670|449304919|FG000|Overall Study|Adverse Event|10|||
124911934|NCT01255670|449304920|FG001|Overall Study|Adverse Event|10|||
124911935|NCT01255670|449304919|FG000|Overall Study|Lost to Follow-up|16|||
124911936|NCT01255670|449304920|FG001|Overall Study|Lost to Follow-up|10|||
124693091|NCT00520572|448498587|FG001|Overall Study|Protocol Violation|0|||
124693092|NCT00520572|448498588|FG002|Overall Study|Protocol Violation|1|||
124693093|NCT00520572|448498589|FG003|Overall Study|Protocol Violation|0|||
124911937|NCT02269475|449304921|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
124911938|NCT02269475|449304922|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
124911939|NCT02269475|449304921|FG000|Overall Study|Withdrawal by Subject|0|||
124450724|NCT00467779|447613561|FG006|Stage 1|Adverse Event|2|||
124450725|NCT00467779|447613562|FG007|Stage 1|Adverse Event|1|||
124693094|NCT00520572|448498590|FG004|Overall Study|Protocol Violation|0|||
124693095|NCT00520572|448498591|FG005|Overall Study|Protocol Violation|0|||
124693096|NCT00520572|448498586|FG000|Overall Study|Lack of Efficacy|1|||
124693097|NCT00520572|448498587|FG001|Overall Study|Lack of Efficacy|1|||
124693098|NCT00520572|448498588|FG002|Overall Study|Lack of Efficacy|1|||
124693099|NCT00520572|448498589|FG003|Overall Study|Lack of Efficacy|2|||
124693100|NCT00520572|448498590|FG004|Overall Study|Lack of Efficacy|1|||
124693101|NCT00520572|448498591|FG005|Overall Study|Lack of Efficacy|0|||
124693102|NCT00520572|448498586|FG000|Overall Study|Lost to Follow-up|0|||
124693103|NCT00520572|448498587|FG001|Overall Study|Lost to Follow-up|0|||
124693104|NCT00520572|448498588|FG002|Overall Study|Lost to Follow-up|0|||
124693105|NCT00520572|448498589|FG003|Overall Study|Lost to Follow-up|0|||
124693106|NCT00520572|448498590|FG004|Overall Study|Lost to Follow-up|1|||
124911940|NCT02269475|449304922|FG001|Overall Study|Withdrawal by Subject|1|||
124911941|NCT01037985|449304923|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
124911942|NCT01037985|449304924|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
124911943|NCT01037985|449304923|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
124911944|NCT01037985|449304924|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
124911945|NCT01037985|449304923|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
124911946|NCT01037985|449304924|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
124911947|NCT01037985|449304923|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
124911948|NCT01037985|449304924|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
124911949|NCT02730871|449304925|FG000|Overall Study|Adverse Event|6|||
124450726|NCT00467779|447613563|FG008|Stage 1|Adverse Event|0|||
124450727|NCT00467779|447613564|FG009|Stage 1|Adverse Event|0|||
124450728|NCT00467779|447613565|FG010|Stage 1|Adverse Event|0|||
124450729|NCT00467779|447613566|FG011|Stage 1|Adverse Event|0|||
124450730|NCT00467779|447613567|FG012|Stage 1|Adverse Event|0|||
124450731|NCT00467779|447613568|FG013|Stage 1|Adverse Event|0|||
124450732|NCT00467779|447613569|FG014|Stage 1|Adverse Event|0|||
124450733|NCT00467779|447613555|FG000|Stage 1|Disease Progression|2|||
124450734|NCT00467779|447613556|FG001|Stage 1|Disease Progression|2|||
124450735|NCT00467779|447613557|FG002|Stage 1|Disease Progression|2|||
124450736|NCT00467779|447613558|FG003|Stage 1|Disease Progression|3|||
124450737|NCT00467779|447613559|FG004|Stage 1|Disease Progression|2|||
124450738|NCT00467779|447613560|FG005|Stage 1|Disease Progression|2|||
124450739|NCT00467779|447613561|FG006|Stage 1|Disease Progression|4|||
124450740|NCT00467779|447613562|FG007|Stage 1|Disease Progression|5|||
124450741|NCT00467779|447613563|FG008|Stage 1|Disease Progression|0|||
124450742|NCT00467779|447613564|FG009|Stage 1|Disease Progression|0|||
124450743|NCT00467779|447613565|FG010|Stage 1|Disease Progression|0|||
124450744|NCT00467779|447613566|FG011|Stage 1|Disease Progression|0|||
124450745|NCT00467779|447613567|FG012|Stage 1|Disease Progression|0|||
124693107|NCT00520572|448498591|FG005|Overall Study|Lost to Follow-up|0|||
124693108|NCT00520572|448498586|FG000|Overall Study|Incorrect enrollment|1|||
124693109|NCT00520572|448498587|FG001|Overall Study|Incorrect enrollment|0|||
124693110|NCT00520572|448498588|FG002|Overall Study|Incorrect enrollment|1|||
124693111|NCT00520572|448498589|FG003|Overall Study|Incorrect enrollment|0|||
124693112|NCT00520572|448498590|FG004|Overall Study|Incorrect enrollment|1|||
124693113|NCT00520572|448498591|FG005|Overall Study|Incorrect enrollment|0|||
124693114|NCT00520572|448498586|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
124693115|NCT00520572|448498587|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
124693116|NCT00520572|448498588|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
124693117|NCT00520572|448498589|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
124693118|NCT00520572|448498590|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
124693119|NCT00520572|448498591|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
124693120|NCT00520572|448498586|FG000|Overall Study|Long break in taking Medication|0|||
124693121|NCT00520572|448498587|FG001|Overall Study|Long break in taking Medication|0|||
124693122|NCT00520572|448498588|FG002|Overall Study|Long break in taking Medication|0|||
124693123|NCT00520572|448498589|FG003|Overall Study|Long break in taking Medication|1|||
124693124|NCT00520572|448498590|FG004|Overall Study|Long break in taking Medication|0|||
124693125|NCT00520572|448498591|FG005|Overall Study|Long break in taking Medication|0|||
124693126|NCT00520572|448498586|FG000|Overall Study|Did not receive Treatment|1|||
124693127|NCT00520572|448498587|FG001|Overall Study|Did not receive Treatment|0|||
124693128|NCT00520572|448498588|FG002|Overall Study|Did not receive Treatment|1|||
124693129|NCT00520572|448498589|FG003|Overall Study|Did not receive Treatment|0|||
124693130|NCT00520572|448498590|FG004|Overall Study|Did not receive Treatment|0|||
124693131|NCT00520572|448498591|FG005|Overall Study|Did not receive Treatment|0|||
124693132|NCT02802865|448498592|FG000|Overall Study|Pregnancy|1|||
124693133|NCT02802865|448498593|FG001|Overall Study|Pregnancy|1|||
124693134|NCT02802865|448498592|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
124693135|NCT02802865|448498593|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
124693136|NCT03315689|448498594|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
124693137|NCT03315689|448498595|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
124760895|NCT02365649|448749129|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
124911950|NCT02730871|449304926|FG001|Overall Study|Adverse Event|0|||
124911951|NCT00823472|449304927|FG000|Overall Study|Physician Decision|24|||
124693138|NCT03315689|448498594|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
124693139|NCT03315689|448498595|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
124693140|NCT03315689|448498594|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
124450746|NCT00467779|447613568|FG013|Stage 1|Disease Progression|0|||
124911952|NCT00823472|449304928|FG001|Overall Study|Physician Decision|28|||
124911953|NCT04019444|449304929|FG000|Overall Study|Withdrawal by Subject|0|||
124911954|NCT04019444|449304930|FG001|Overall Study|Withdrawal by Subject|1|||
124911955|NCT04019444|449304931|FG002|Overall Study|Withdrawal by Subject|0|||
124911956|NCT04019444|449304932|FG003|Overall Study|Withdrawal by Subject|1|||
124911957|NCT04019444|449304929|FG000|Overall Study|Solicited Event|0|||
124911958|NCT04019444|449304930|FG001|Overall Study|Solicited Event|0|||
124911959|NCT04019444|449304931|FG002|Overall Study|Solicited Event|2|||
124911960|NCT04019444|449304932|FG003|Overall Study|Solicited Event|0|||
124450747|NCT00467779|447613569|FG014|Stage 1|Disease Progression|0|||
124450748|NCT00467779|447613555|FG000|Stage 1|Unspecified Reason|1|||
124450749|NCT00467779|447613556|FG001|Stage 1|Unspecified Reason|0|||
124450750|NCT00467779|447613557|FG002|Stage 1|Unspecified Reason|1|||
124450751|NCT00467779|447613558|FG003|Stage 1|Unspecified Reason|0|||
124450752|NCT00467779|447613559|FG004|Stage 1|Unspecified Reason|1|||
124450753|NCT00467779|447613560|FG005|Stage 1|Unspecified Reason|2|||
124911961|NCT01609218|449304933|FG000|Period 1|Adverse Event|3|||
124911962|NCT01609218|449304934|FG001|Period 1|Adverse Event|5|||
124911963|NCT01609218|449304933|FG000|Period 1|Sponsor Decision|0|||
124911964|NCT01609218|449304934|FG001|Period 1|Sponsor Decision|1|||
124911965|NCT01609218|449304933|FG000|Period 2|Adverse Event|1|||
124911966|NCT01609218|449304934|FG001|Period 2|Adverse Event|0|||
124911967|NCT04428112|449304940|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
124911968|NCT04428112|449304941|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
124911969|NCT04428112|449304940|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
124911970|NCT04428112|449304941|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
124911971|NCT04428112|449304940|FG000|Overall Study|Withdrawal by Subject|9|||
124911972|NCT04428112|449304941|FG001|Overall Study|Withdrawal by Subject|4|||
124911973|NCT04428112|449304940|FG000|Overall Study|Lost to Follow-up|27|||
124911974|NCT04428112|449304941|FG001|Overall Study|Lost to Follow-up|7|||
124911975|NCT01207492|449304942|FG000|Overall Study|Still on study|1|||
124911976|NCT01207492|449304942|FG000|Overall Study|Withdrawal by Subject|9|||
124911977|NCT01207492|449304942|FG000|Overall Study|Physician Decision|1|||
124911978|NCT01207492|449304942|FG000|Overall Study|Progressive disease|3|||
124911979|NCT01207492|449304942|FG000|Overall Study|Toxicity|1|||
124911980|NCT02769858|449304943|FG000|Overall Study|Withdrawal by Subject|2|||
124911981|NCT02807779|449304944|FG000|Overall Study|Lost to Follow-up|1|||
124911982|NCT02807779|449304945|FG001|Overall Study|Lost to Follow-up|0|||
124911983|NCT02807779|449304946|FG002|Overall Study|Lost to Follow-up|0|||
124911984|NCT02807779|449304944|FG000|Overall Study|Physician Decision|2|||
124911985|NCT02807779|449304945|FG001|Overall Study|Physician Decision|0|||
124911986|NCT02807779|449304946|FG002|Overall Study|Physician Decision|1|||
124911987|NCT02807779|449304944|FG000|Overall Study|Death|1|||
124911988|NCT02807779|449304945|FG001|Overall Study|Death|1|||
124911989|NCT02807779|449304946|FG002|Overall Study|Death|0|||
124911990|NCT04814186|449306952|FG000|Treatment Phase|Adverse Event|1|||
124911991|NCT04814186|449306952|FG000|Treatment Phase|Death|6|||
124911992|NCT04814186|449306952|FG000|Treatment Phase|Withdrawal by Subject|2|||
124911993|NCT04814186|449306952|FG000|Treatment Phase|Other|1|||
124911994|NCT04814186|449306952|FG000|Follow-Up Phase|Adverse Event|1|||
124911995|NCT04814186|449306952|FG000|Follow-Up Phase|Death|6|||
124911996|NCT04814186|449306952|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
124911997|NCT04814186|449306952|FG000|Follow-Up Phase|Other|1|||
124911998|NCT01853748|449306958|FG000|Allocation|Withdrawal by Subject|1|||
124911999|NCT01853748|449306959|FG001|Allocation|Withdrawal by Subject|13|||
124912000|NCT01853748|449306958|FG000|Allocation|not sufficient to receive intervention|0|||
124912001|NCT01853748|449306959|FG001|Allocation|not sufficient to receive intervention|1|||
124912002|NCT01853748|449306958|FG000|Follow-Up|Withdrawal by Subject|7|||
124450754|NCT00467779|447613561|FG006|Stage 1|Unspecified Reason|0|||
124450755|NCT00467779|447613562|FG007|Stage 1|Unspecified Reason|0|||
124450756|NCT00467779|447613563|FG008|Stage 1|Unspecified Reason|0|||
124450757|NCT00467779|447613564|FG009|Stage 1|Unspecified Reason|0|||
124450758|NCT00467779|447613565|FG010|Stage 1|Unspecified Reason|0|||
124450759|NCT00467779|447613566|FG011|Stage 1|Unspecified Reason|0|||
124450760|NCT00467779|447613567|FG012|Stage 1|Unspecified Reason|0|||
124450761|NCT00467779|447613568|FG013|Stage 1|Unspecified Reason|0|||
124450762|NCT00467779|447613569|FG014|Stage 1|Unspecified Reason|0|||
124912003|NCT01853748|449306959|FG001|Follow-Up|Withdrawal by Subject|6|||
124912004|NCT01853748|449306958|FG000|Follow-Up|Adverse Event|67|||
124912005|NCT01853748|449306959|FG001|Follow-Up|Adverse Event|7|||
124450763|NCT00467779|447613555|FG000|Stage 1|Physician Decision|0|||
124450764|NCT00467779|447613556|FG001|Stage 1|Physician Decision|1|||
124912006|NCT01853748|449306958|FG000|Follow-Up|not available for data collection|16|||
124912007|NCT01853748|449306959|FG001|Follow-Up|not available for data collection|4|||
124450765|NCT00467779|447613557|FG002|Stage 1|Physician Decision|0|||
124912008|NCT04043455|449306973|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
124912009|NCT04043455|449306974|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
124912010|NCT04043455|449306975|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
124912011|NCT04043455|449306976|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
124912012|NCT04043455|449306977|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
124912013|NCT04043455|449306978|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
124912014|NCT04043455|449306973|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
124912015|NCT04043455|449306974|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
124450766|NCT00467779|447613558|FG003|Stage 1|Physician Decision|0|||
124450767|NCT00467779|447613559|FG004|Stage 1|Physician Decision|0|||
124450768|NCT00467779|447613560|FG005|Stage 1|Physician Decision|0|||
124450769|NCT00467779|447613561|FG006|Stage 1|Physician Decision|0|||
124450770|NCT00467779|447613562|FG007|Stage 1|Physician Decision|0|||
124450771|NCT00467779|447613563|FG008|Stage 1|Physician Decision|0|||
124912016|NCT04043455|449306975|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
124912017|NCT04043455|449306976|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
124912018|NCT04043455|449306977|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
124912019|NCT04043455|449306978|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
124912020|NCT04043455|449306973|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
124912021|NCT04043455|449306974|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
124912022|NCT04043455|449306975|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
124912023|NCT04043455|449306976|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
124912024|NCT04043455|449306977|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
124912025|NCT04043455|449306978|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
124912026|NCT04043455|449306973|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
124912027|NCT04043455|449306974|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
124912028|NCT04043455|449306975|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
124912029|NCT04043455|449306976|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
124912030|NCT04043455|449306977|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
124912031|NCT04043455|449306978|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
124912032|NCT04043455|449306973|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
124912033|NCT04043455|449306974|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
124912034|NCT04043455|449306975|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
124912035|NCT04043455|449306976|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
124912036|NCT04043455|449306977|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
124912037|NCT04043455|449306978|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
124912038|NCT04043455|449306973|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
124912039|NCT04043455|449306974|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
124912040|NCT04043455|449306975|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
124912041|NCT04043455|449306976|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
124912042|NCT04043455|449306977|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
124912043|NCT04043455|449306978|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
124912044|NCT04043455|449306973|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
124912045|NCT04043455|449306974|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
124450772|NCT00467779|447613564|FG009|Stage 1|Physician Decision|0|||
124450773|NCT00467779|447613565|FG010|Stage 1|Physician Decision|0|||
124450774|NCT00467779|447613566|FG011|Stage 1|Physician Decision|0|||
124450775|NCT00467779|447613567|FG012|Stage 1|Physician Decision|0|||
124450776|NCT00467779|447613568|FG013|Stage 1|Physician Decision|0|||
124450777|NCT00467779|447613569|FG014|Stage 1|Physician Decision|0|||
124450778|NCT00467779|447613555|FG000|Stage 1|Withdrawal by Subject|0|||
124450779|NCT00467779|447613556|FG001|Stage 1|Withdrawal by Subject|0|||
124450780|NCT00467779|447613557|FG002|Stage 1|Withdrawal by Subject|0|||
124450781|NCT00467779|447613558|FG003|Stage 1|Withdrawal by Subject|0|||
124450782|NCT00467779|447613559|FG004|Stage 1|Withdrawal by Subject|0|||
124450783|NCT00467779|447613560|FG005|Stage 1|Withdrawal by Subject|0|||
124450784|NCT00467779|447613561|FG006|Stage 1|Withdrawal by Subject|1|||
124450785|NCT00467779|447613562|FG007|Stage 1|Withdrawal by Subject|1|||
124450786|NCT00467779|447613563|FG008|Stage 1|Withdrawal by Subject|0|||
124450787|NCT00467779|447613564|FG009|Stage 1|Withdrawal by Subject|0|||
124450788|NCT00467779|447613565|FG010|Stage 1|Withdrawal by Subject|0|||
124450789|NCT00467779|447613566|FG011|Stage 1|Withdrawal by Subject|0|||
124450790|NCT00467779|447613567|FG012|Stage 1|Withdrawal by Subject|0|||
124450791|NCT00467779|447613568|FG013|Stage 1|Withdrawal by Subject|0|||
124450792|NCT00467779|447613569|FG014|Stage 1|Withdrawal by Subject|0|||
124450793|NCT00467779|447613555|FG000|Stage 1A|Adverse Event|0|||
124450794|NCT00467779|447613556|FG001|Stage 1A|Adverse Event|0|||
124450795|NCT00467779|447613557|FG002|Stage 1A|Adverse Event|0|||
124912046|NCT04043455|449306975|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
124450796|NCT00467779|447613558|FG003|Stage 1A|Adverse Event|0|||
124912047|NCT04043455|449306976|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
124912048|NCT04043455|449306977|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
124912049|NCT04043455|449306978|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
124912050|NCT04043455|449306973|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
124693141|NCT03315689|448498595|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
124693142|NCT00985192|448498596|FG000|Overall Study|Withdrawal by Subject|1|||
124693143|NCT00985192|448498596|FG000|Overall Study|Disease Progression|1|||
124693144|NCT00985192|448498596|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
124693145|NCT00720083|448498599|FG000|Overall Study|Ineligible|1|||
124693146|NCT00720083|448498600|FG001|Overall Study|Ineligible|2|||
124693147|NCT02018887|448498606|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
124693148|NCT02018887|448498607|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
124693149|NCT02018887|448498608|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
124693150|NCT02018887|448498609|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
124693151|NCT02018887|448498610|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
124693152|NCT02018887|448498611|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
124693153|NCT02018887|448498612|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
124693154|NCT02018887|448498613|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
124693155|NCT02018887|448498614|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
124693156|NCT02018887|448498615|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
124693157|NCT02018887|448498616|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
124693158|NCT02018887|448498606|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
124693159|NCT02018887|448498607|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
124693160|NCT02018887|448498608|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
124693161|NCT02018887|448498609|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
124693162|NCT02018887|448498610|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
124693163|NCT02018887|448498611|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
124693164|NCT02018887|448498612|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
124693165|NCT02018887|448498613|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
124693166|NCT02018887|448498614|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
124693167|NCT02018887|448498615|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
124693168|NCT02018887|448498616|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
124693169|NCT02018887|448498606|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
124693170|NCT02018887|448498607|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
124693171|NCT02018887|448498608|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
124693172|NCT02018887|448498609|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
124693173|NCT02018887|448498610|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
124693174|NCT02018887|448498611|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
124693175|NCT02018887|448498612|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
124912051|NCT04043455|449306974|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
124912052|NCT04043455|449306975|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
124912053|NCT04043455|449306976|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
124912054|NCT04043455|449306977|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
124760896|NCT02365649|448749130|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
124760897|NCT02365649|448749131|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
124760898|NCT02365649|448749132|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
124760899|NCT02365649|448749133|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
124760900|NCT02365649|448749134|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
124760901|NCT02365649|448749135|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
124760902|NCT02365649|448749136|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
124760903|NCT02365649|448749127|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
124760904|NCT02365649|448749128|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
124760905|NCT02365649|448749129|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
124760906|NCT02365649|448749130|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
124760907|NCT02365649|448749131|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
124912055|NCT04043455|449306978|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
124912056|NCT04043455|449306973|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
124912057|NCT04043455|449306974|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
124450797|NCT00467779|447613559|FG004|Stage 1A|Adverse Event|0|||
124450798|NCT00467779|447613560|FG005|Stage 1A|Adverse Event|0|||
124450799|NCT00467779|447613561|FG006|Stage 1A|Adverse Event|0|||
124450800|NCT00467779|447613562|FG007|Stage 1A|Adverse Event|0|||
124693176|NCT02018887|448498613|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
124693177|NCT02018887|448498614|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
124693178|NCT02018887|448498615|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
124693179|NCT02018887|448498616|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
124693180|NCT02018887|448498606|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
124693181|NCT02018887|448498607|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
124693182|NCT02018887|448498608|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
124450801|NCT00467779|447613563|FG008|Stage 1A|Adverse Event|0|||
124760908|NCT02365649|448749132|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
124760909|NCT02365649|448749133|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
124760910|NCT02365649|448749134|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
124760911|NCT02365649|448749135|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
124760912|NCT02365649|448749136|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
124760913|NCT01188772|448749145|FG000|Overall Study|Randomized but Not Treated|0|||
124760914|NCT01188772|448749146|FG001|Overall Study|Randomized but Not Treated|1|||
124760915|NCT01188772|448749147|FG002|Overall Study|Randomized but Not Treated|0|||
124760916|NCT01188772|448749148|FG003|Overall Study|Randomized but Not Treated|0|||
124760917|NCT01188772|448749145|FG000|Overall Study|Adverse Event|0|||
124760918|NCT01188772|448749146|FG001|Overall Study|Adverse Event|1|||
124760919|NCT01188772|448749147|FG002|Overall Study|Adverse Event|2|||
124760920|NCT01188772|448749148|FG003|Overall Study|Adverse Event|0|||
124760921|NCT01188772|448749145|FG000|Overall Study|Lost to Follow-up|4|||
124760922|NCT01188772|448749146|FG001|Overall Study|Lost to Follow-up|1|||
124760923|NCT01188772|448749147|FG002|Overall Study|Lost to Follow-up|1|||
124760924|NCT01188772|448749148|FG003|Overall Study|Lost to Follow-up|1|||
124760925|NCT01188772|448749145|FG000|Overall Study|Non-responder|0|||
124760926|NCT01188772|448749146|FG001|Overall Study|Non-responder|0|||
124912058|NCT04043455|449306975|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
124912059|NCT04043455|449306976|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
124760927|NCT01188772|448749147|FG002|Overall Study|Non-responder|3|||
124760928|NCT01188772|448749148|FG003|Overall Study|Non-responder|0|||
124760929|NCT01188772|448749145|FG000|Overall Study|Physician Decision|0|||
124912060|NCT04043455|449306977|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
124912061|NCT04043455|449306978|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
124912062|NCT04043455|449306973|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
124912063|NCT04043455|449306974|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
124912064|NCT04043455|449306975|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
124912065|NCT04043455|449306976|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
124912066|NCT04043455|449306977|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
124912067|NCT04043455|449306978|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
124912068|NCT04043455|449306973|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
124912069|NCT04043455|449306974|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
124912070|NCT04043455|449306975|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
124912071|NCT04043455|449306976|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
124912072|NCT04043455|449306977|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
124912073|NCT04043455|449306978|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
124912074|NCT05194917|449306979|FG000|Overall Study|Lost to Follow-up|7|||
124912075|NCT05194917|449306980|FG001|Overall Study|Lost to Follow-up|5|||
124912076|NCT05194917|449306981|FG002|Overall Study|Lost to Follow-up|6|||
124912077|NCT05194917|449306982|FG003|Overall Study|Lost to Follow-up|5|||
124912078|NCT04922021|449306987|FG000|Overall Study|Withdrawal by Subject|4|||
124912079|NCT04922021|449306988|FG001|Overall Study|Withdrawal by Subject|10|||
124912080|NCT04922021|449306987|FG000|Overall Study|Adverse Event|2|||
124912081|NCT04922021|449306988|FG001|Overall Study|Adverse Event|2|||
124912082|NCT04922021|449306987|FG000|Overall Study|Lack of Efficacy|0|||
124912083|NCT04922021|449306988|FG001|Overall Study|Lack of Efficacy|1|||
124912084|NCT04922021|449306987|FG000|Overall Study|Multiple reasons|1|||
124912085|NCT04922021|449306988|FG001|Overall Study|Multiple reasons|0|||
124912086|NCT02544074|449307000|FG000|Overall Study|Withdrawal by Subject|0|||
124912087|NCT02544074|449307001|FG001|Overall Study|Withdrawal by Subject|1|||
124912088|NCT02544074|449307002|FG002|Overall Study|Withdrawal by Subject|0|||
124912089|NCT02544074|449307003|FG003|Overall Study|Withdrawal by Subject|0|||
124912090|NCT02544074|449307004|FG004|Overall Study|Withdrawal by Subject|0|||
124912091|NCT02544074|449307005|FG005|Overall Study|Withdrawal by Subject|0|||
124912092|NCT02544074|449307006|FG006|Overall Study|Withdrawal by Subject|0|||
124912093|NCT02544074|449307007|FG007|Overall Study|Withdrawal by Subject|0|||
124912094|NCT02544074|449307008|FG008|Overall Study|Withdrawal by Subject|0|||
124912095|NCT02544074|449307009|FG009|Overall Study|Withdrawal by Subject|0|||
124912096|NCT02544074|449307010|FG010|Overall Study|Withdrawal by Subject|0|||
124912097|NCT02544074|449307011|FG011|Overall Study|Withdrawal by Subject|0|||
124912098|NCT02544074|449307012|FG012|Overall Study|Withdrawal by Subject|0|||
124912099|NCT02544074|449307013|FG013|Overall Study|Withdrawal by Subject|0|||
124760930|NCT01188772|448749146|FG001|Overall Study|Physician Decision|0|||
124760931|NCT01188772|448749147|FG002|Overall Study|Physician Decision|1|||
124760932|NCT01188772|448749148|FG003|Overall Study|Physician Decision|0|||
124760933|NCT01188772|448749145|FG000|Overall Study|Terminated by Sponsor|0|||
124760934|NCT01188772|448749146|FG001|Overall Study|Terminated by Sponsor|0|||
124760935|NCT01188772|448749147|FG002|Overall Study|Terminated by Sponsor|1|||
124760936|NCT01188772|448749148|FG003|Overall Study|Terminated by Sponsor|0|||
124760937|NCT01188772|448749145|FG000|Overall Study|Treatment Failure|0|||
124760938|NCT01188772|448749146|FG001|Overall Study|Treatment Failure|0|||
124760939|NCT01188772|448749147|FG002|Overall Study|Treatment Failure|1|||
124760940|NCT01188772|448749148|FG003|Overall Study|Treatment Failure|0|||
124760941|NCT01188772|448749145|FG000|Overall Study|Virologic Failure|1|||
124760942|NCT01188772|448749146|FG001|Overall Study|Virologic Failure|0|||
124760943|NCT01188772|448749147|FG002|Overall Study|Virologic Failure|0|||
124760944|NCT01188772|448749148|FG003|Overall Study|Virologic Failure|0|||
124760945|NCT01188772|448749145|FG000|Overall Study|Withdrawal by Subject|0|||
124760946|NCT01188772|448749146|FG001|Overall Study|Withdrawal by Subject|0|||
124760947|NCT01188772|448749147|FG002|Overall Study|Withdrawal by Subject|2|||
124760948|NCT01188772|448749148|FG003|Overall Study|Withdrawal by Subject|0|||
124760949|NCT03370718|448749155|FG000|Overall Study|Withdrawal by Subject|1|||
124760950|NCT03863509|448749158|FG000|Overall Study|COVID-19 shutdown period|0|||
124760951|NCT03863509|448749159|FG001|Overall Study|COVID-19 shutdown period|4|||
124760952|NCT03863509|448749160|FG002|Overall Study|COVID-19 shutdown period|0|||
124760953|NCT03863509|448749158|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
124760954|NCT03863509|448749159|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
124912100|NCT02544074|449307014|FG014|Overall Study|Withdrawal by Subject|0|||
124912101|NCT02544074|449307015|FG015|Overall Study|Withdrawal by Subject|0|||
124912102|NCT02544074|449307016|FG016|Overall Study|Withdrawal by Subject|0|||
124912103|NCT02544074|449307017|FG017|Overall Study|Withdrawal by Subject|0|||
124912104|NCT02544074|449307018|FG018|Overall Study|Withdrawal by Subject|0|||
124912105|NCT02544074|449307019|FG019|Overall Study|Withdrawal by Subject|0|||
124912106|NCT02544074|449307020|FG020|Overall Study|Withdrawal by Subject|0|||
124912107|NCT02544074|449307000|FG000|Overall Study|Tablet error|0|||
124545160|NCT00563706|447951086|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
124760955|NCT03863509|448749160|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
124760956|NCT03863509|448749158|FG000|Overall Study|Lost to Follow-up|8|||
124912108|NCT02544074|449307001|FG001|Overall Study|Tablet error|0|||
124912109|NCT02544074|449307002|FG002|Overall Study|Tablet error|0|||
124912110|NCT02544074|449307003|FG003|Overall Study|Tablet error|0|||
124912111|NCT02544074|449307004|FG004|Overall Study|Tablet error|0|||
124912112|NCT02544074|449307005|FG005|Overall Study|Tablet error|1|||
124912113|NCT02544074|449307006|FG006|Overall Study|Tablet error|0|||
124912114|NCT02544074|449307007|FG007|Overall Study|Tablet error|0|||
124912115|NCT02544074|449307008|FG008|Overall Study|Tablet error|0|||
124912116|NCT02544074|449307009|FG009|Overall Study|Tablet error|1|||
124912117|NCT02544074|449307010|FG010|Overall Study|Tablet error|0|||
124912118|NCT02544074|449307011|FG011|Overall Study|Tablet error|0|||
124912119|NCT02544074|449307012|FG012|Overall Study|Tablet error|0|||
124912120|NCT02544074|449307013|FG013|Overall Study|Tablet error|0|||
124912121|NCT02544074|449307014|FG014|Overall Study|Tablet error|0|||
124912122|NCT02544074|449307015|FG015|Overall Study|Tablet error|0|||
124912123|NCT02544074|449307016|FG016|Overall Study|Tablet error|0|||
124912124|NCT02544074|449307017|FG017|Overall Study|Tablet error|0|||
124912125|NCT02544074|449307018|FG018|Overall Study|Tablet error|0|||
124912126|NCT02544074|449307019|FG019|Overall Study|Tablet error|0|||
124912127|NCT02544074|449307020|FG020|Overall Study|Tablet error|0|||
124912128|NCT03189524|449307021|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
124912129|NCT03189524|449307022|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
124912130|NCT03189524|449307023|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
124912131|NCT03189524|449307021|FG000|Overall Study|Death|2|||
124912132|NCT03189524|449307022|FG001|Overall Study|Death|2|||
124912133|NCT03189524|449307023|FG002|Overall Study|Death|1|||
124912134|NCT03189524|449307021|FG000|Overall Study|Lost to Follow-up|1|||
124912135|NCT03189524|449307022|FG001|Overall Study|Lost to Follow-up|0|||
124912136|NCT03189524|449307023|FG002|Overall Study|Lost to Follow-up|8|||
124912137|NCT03189524|449307021|FG000|Overall Study|Withdrawal by Subject|1|||
124912138|NCT03189524|449307022|FG001|Overall Study|Withdrawal by Subject|1|||
124760957|NCT03863509|448749159|FG001|Overall Study|Lost to Follow-up|0|||
124760958|NCT03863509|448749160|FG002|Overall Study|Lost to Follow-up|2|||
124912139|NCT03189524|449307023|FG002|Overall Study|Withdrawal by Subject|3|||
124912140|NCT03189524|449307021|FG000|Overall Study|Progressive Disease|0|||
124912141|NCT03189524|449307022|FG001|Overall Study|Progressive Disease|2|||
124912142|NCT03189524|449307023|FG002|Overall Study|Progressive Disease|0|||
124912143|NCT02723955|449307024|FG000|Escalation Phase|Death|1|||
124912144|NCT02723955|449307025|FG001|Escalation Phase|Death|1|||
124769817|NCT01502293|448785204|FG000|Overall Study|Reason Not Specified|2|||
124912145|NCT02723955|449307026|FG002|Escalation Phase|Death|2|||
124912146|NCT02723955|449307027|FG003|Escalation Phase|Death|7|||
124912147|NCT02723955|449307028|FG004|Escalation Phase|Death|18|||
124912148|NCT02723955|449307029|FG005|Escalation Phase|Death|17|||
124912149|NCT02723955|449307030|FG006|Escalation Phase|Death|11|||
124912150|NCT02723955|449307031|FG007|Escalation Phase|Death|21|||
124912151|NCT02723955|449307032|FG008|Escalation Phase|Death|3|||
124912152|NCT02723955|449307033|FG009|Escalation Phase|Death|0|||
124912153|NCT02723955|449307034|FG010|Escalation Phase|Death|0|||
124912154|NCT02723955|449307035|FG011|Escalation Phase|Death|0|||
124693183|NCT02018887|448498609|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
124693184|NCT02018887|448498610|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
124693185|NCT02018887|448498611|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
124693186|NCT02018887|448498612|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
124693187|NCT02018887|448498613|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
124693188|NCT02018887|448498614|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
124693189|NCT02018887|448498615|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
124693190|NCT02018887|448498616|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
124693191|NCT01058005|448498617|FG000|Overall Study|Adverse Event|0|||
124693192|NCT01058005|448498618|FG001|Overall Study|Adverse Event|2|||
124693193|NCT01058005|448498619|FG002|Overall Study|Adverse Event|1|||
124693194|NCT01058005|448498617|FG000|Overall Study|Physician Decision|2|||
124693195|NCT01058005|448498618|FG001|Overall Study|Physician Decision|2|||
124693196|NCT01058005|448498619|FG002|Overall Study|Physician Decision|0|||
124693197|NCT01058005|448498617|FG000|Overall Study|Withdrawal by Subject|4|||
124693198|NCT01058005|448498618|FG001|Overall Study|Withdrawal by Subject|5|||
124693199|NCT01058005|448498619|FG002|Overall Study|Withdrawal by Subject|11|||
124693200|NCT01058005|448498617|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
124693201|NCT01058005|448498618|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
124693202|NCT01058005|448498619|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
124693203|NCT01058005|448498617|FG000|Overall Study|Reason Missing|5|||
124693204|NCT01058005|448498618|FG001|Overall Study|Reason Missing|3|||
124693205|NCT01058005|448498619|FG002|Overall Study|Reason Missing|1|||
124693206|NCT01145222|448498620|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
124693207|NCT01145222|448498621|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
124693208|NCT01145222|448498622|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
124693209|NCT01145222|448498623|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
124693210|NCT01145222|448498620|FG000|Overall Study|Poor bowel preparation|0|||
124693211|NCT01145222|448498621|FG001|Overall Study|Poor bowel preparation|0|||
124693212|NCT01145222|448498622|FG002|Overall Study|Poor bowel preparation|0|||
124693213|NCT01145222|448498623|FG003|Overall Study|Poor bowel preparation|1|||
124693214|NCT00927186|448498624|FG000|12 Months Primary Study|Adverse Event|5|||
124693215|NCT00927186|448498625|FG001|12 Months Primary Study|Adverse Event|2|||
124693216|NCT00927186|448498624|FG000|12 Months Primary Study|Lost to Follow-up|1|||
124912155|NCT02723955|449307036|FG012|Escalation Phase|Death|2|||
124912156|NCT02723955|449307037|FG013|Escalation Phase|Death|4|||
124912157|NCT02723955|449307038|FG014|Escalation Phase|Death|5|||
124912158|NCT02723955|449307039|FG015|Escalation Phase|Death|6|||
124912159|NCT02723955|449307040|FG016|Escalation Phase|Death|6|||
124912160|NCT02723955|449307041|FG017|Escalation Phase|Death|7|||
124912161|NCT02723955|449307042|FG018|Escalation Phase|Death|1|||
124912162|NCT02723955|449307043|FG019|Escalation Phase|Death|3|||
124912163|NCT02723955|449307044|FG020|Escalation Phase|Death|13|||
124912164|NCT02723955|449307045|FG021|Escalation Phase|Death|3|||
124912165|NCT02723955|449307046|FG022|Escalation Phase|Death|2|||
124912166|NCT02723955|449307047|FG023|Escalation Phase|Death|4|||
124912167|NCT02723955|449307048|FG024|Escalation Phase|Death|31|||
124450802|NCT00467779|447613564|FG009|Stage 1A|Adverse Event|0|||
124450803|NCT00467779|447613565|FG010|Stage 1A|Adverse Event|0|||
124450804|NCT00467779|447613566|FG011|Stage 1A|Adverse Event|0|||
124450805|NCT00467779|447613567|FG012|Stage 1A|Adverse Event|1|||
124450806|NCT00467779|447613568|FG013|Stage 1A|Adverse Event|0|||
124450807|NCT00467779|447613569|FG014|Stage 1A|Adverse Event|0|||
124450808|NCT00467779|447613555|FG000|Stage 1A|Death|0|||
124450809|NCT00467779|447613556|FG001|Stage 1A|Death|0|||
124450810|NCT00467779|447613557|FG002|Stage 1A|Death|0|||
124450811|NCT00467779|447613558|FG003|Stage 1A|Death|0|||
124545161|NCT00563706|447951087|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
124912168|NCT02723955|449307049|FG025|Escalation Phase|Death|7|||
124912169|NCT02723955|449307050|FG026|Escalation Phase|Death|13|||
124693217|NCT00927186|448498625|FG001|12 Months Primary Study|Lost to Follow-up|0|||
124450812|NCT00467779|447613559|FG004|Stage 1A|Death|0|||
124693218|NCT00927186|448498624|FG000|12 Months Primary Study|Protocol Violation|0|||
124693219|NCT00927186|448498625|FG001|12 Months Primary Study|Protocol Violation|1|||
124693220|NCT00927186|448498624|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
124912170|NCT02723955|449307051|FG027|Escalation Phase|Death|0|||
124912171|NCT02723955|449307052|FG028|Escalation Phase|Death|1|||
124912172|NCT02723955|449307053|FG029|Escalation Phase|Death|0|||
124912173|NCT02723955|449307054|FG030|Escalation Phase|Death|0|||
124912174|NCT02723955|449307055|FG031|Escalation Phase|Death|0|||
124450813|NCT00467779|447613560|FG005|Stage 1A|Death|0|||
124450814|NCT00467779|447613561|FG006|Stage 1A|Death|0|||
124912175|NCT02723955|449307056|FG032|Escalation Phase|Death|0|||
124912176|NCT02723955|449307057|FG033|Escalation Phase|Death|0|||
124760959|NCT03863509|448749158|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
124760960|NCT03863509|448749159|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
124760961|NCT03863509|448749160|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
124760962|NCT03863509|448749158|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
124760963|NCT03863509|448749159|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
124760964|NCT03863509|448749160|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
124760965|NCT01572480|448749163|FG000|Participants Enrolled|Withdrawal by Subject|1|||
124760966|NCT01572480|448749163|FG000|Drug Administration|Discontinued drug/Off Study|1|||
124760967|NCT01572480|448749163|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
124760968|NCT01572480|448749163|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
124760969|NCT06172348|448749164|FG000|Treatment Period 2|Adverse Event|0|||
124760970|NCT06172348|448749165|FG001|Treatment Period 2|Adverse Event|0|||
124760971|NCT06172348|448749166|FG002|Treatment Period 2|Adverse Event|1|||
124760972|NCT06172348|448749167|FG003|Treatment Period 2|Adverse Event|0|||
124760973|NCT06172348|448749168|FG004|Treatment Period 2|Adverse Event|0|||
124760974|NCT06172348|448749169|FG005|Treatment Period 2|Adverse Event|0|||
124760975|NCT00191334|448749170|FG000|Overall Study|Adverse Event|4|||
124760976|NCT00191334|448749170|FG000|Overall Study|Disease Progression or Relapse|8|||
124760977|NCT00191334|448749170|FG000|Overall Study|Physician Decision|1|||
124760978|NCT00191334|448749170|FG000|Overall Study|Withdrawal by Subject|4|||
124760979|NCT02831764|448751518|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
124760980|NCT02831764|448751519|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
124760981|NCT02831764|448751520|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
124760982|NCT02831764|448751521|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
124760983|NCT02831764|448751522|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
124760984|NCT02831764|448751518|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
124450815|NCT00467779|447613562|FG007|Stage 1A|Death|0|||
124450816|NCT00467779|447613563|FG008|Stage 1A|Death|0|||
124450817|NCT00467779|447613564|FG009|Stage 1A|Death|0|||
124450818|NCT00467779|447613565|FG010|Stage 1A|Death|0|||
124450819|NCT00467779|447613566|FG011|Stage 1A|Death|1|||
124450820|NCT00467779|447613567|FG012|Stage 1A|Death|1|||
124450821|NCT00467779|447613568|FG013|Stage 1A|Death|0|||
124450822|NCT00467779|447613569|FG014|Stage 1A|Death|0|||
124450823|NCT00467779|447613555|FG000|Stage 1A|Disease Progression|0|||
124450824|NCT00467779|447613556|FG001|Stage 1A|Disease Progression|0|||
124450825|NCT00467779|447613557|FG002|Stage 1A|Disease Progression|0|||
124450826|NCT00467779|447613558|FG003|Stage 1A|Disease Progression|0|||
124693221|NCT00927186|448498625|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
124693222|NCT01421134|448498626|FG000|Overall Study|Adverse Event|3|||
124693223|NCT01421134|448498627|FG001|Overall Study|Adverse Event|5|||
124693224|NCT01421134|448498626|FG000|Overall Study|Lack of Efficacy|2|||
124693225|NCT01421134|448498627|FG001|Overall Study|Lack of Efficacy|4|||
124693226|NCT01421134|448498626|FG000|Overall Study|Protocol Violation|0|||
124693227|NCT01421134|448498627|FG001|Overall Study|Protocol Violation|3|||
124693228|NCT01421134|448498626|FG000|Overall Study|Withdrawal by Subject|1|||
124693229|NCT01421134|448498627|FG001|Overall Study|Withdrawal by Subject|1|||
124693230|NCT01421134|448498626|FG000|Overall Study|Administrative|0|||
124693231|NCT01421134|448498627|FG001|Overall Study|Administrative|1|||
124693232|NCT01421134|448498626|FG000|Overall Study|Lost to Follow-up|1|||
124693233|NCT01421134|448498627|FG001|Overall Study|Lost to Follow-up|1|||
124693234|NCT01851369|448498629|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
124693235|NCT01851369|448498630|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
124693236|NCT01851369|448498631|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
124693237|NCT01851369|448498632|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
124693238|NCT01851369|448498633|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
124693239|NCT01851369|448498634|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
124693240|NCT01851369|448498635|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
124693241|NCT01851369|448498636|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
124693242|NCT01851369|448498637|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
124693243|NCT01851369|448498638|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
124693244|NCT01851369|448498639|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
124693245|NCT01851369|448498640|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
124760985|NCT02831764|448751519|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
124450827|NCT00467779|447613559|FG004|Stage 1A|Disease Progression|0|||
124450828|NCT00467779|447613560|FG005|Stage 1A|Disease Progression|0|||
124450829|NCT00467779|447613561|FG006|Stage 1A|Disease Progression|0|||
124760986|NCT02831764|448751520|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
124760987|NCT02831764|448751521|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
124760988|NCT02831764|448751522|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
124760989|NCT02831764|448751518|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
124760990|NCT02831764|448751519|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
124760991|NCT02831764|448751520|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
124760992|NCT02831764|448751521|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
124760993|NCT02831764|448751522|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
124760994|NCT02831764|448751518|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
124912177|NCT02723955|449307058|FG034|Escalation Phase|Death|0|||
124912178|NCT02723955|449307059|FG035|Escalation Phase|Death|0|||
124912179|NCT02723955|449307060|FG036|Escalation Phase|Death|0|||
124912180|NCT02723955|449307061|FG037|Escalation Phase|Death|0|||
124912181|NCT02723955|449307062|FG038|Escalation Phase|Death|0|||
124912182|NCT02723955|449307063|FG039|Escalation Phase|Death|0|||
124912183|NCT02723955|449307064|FG040|Escalation Phase|Death|0|||
124912184|NCT02723955|449307065|FG041|Escalation Phase|Death|0|||
124912185|NCT02723955|449307066|FG042|Escalation Phase|Death|0|||
124450830|NCT00467779|447613562|FG007|Stage 1A|Disease Progression|0|||
124450831|NCT00467779|447613563|FG008|Stage 1A|Disease Progression|0|||
124450832|NCT00467779|447613564|FG009|Stage 1A|Disease Progression|2|||
124450833|NCT00467779|447613565|FG010|Stage 1A|Disease Progression|2|||
124450834|NCT00467779|447613566|FG011|Stage 1A|Disease Progression|5|||
124450835|NCT00467779|447613567|FG012|Stage 1A|Disease Progression|2|||
124450836|NCT00467779|447613568|FG013|Stage 1A|Disease Progression|0|||
124450837|NCT00467779|447613569|FG014|Stage 1A|Disease Progression|0|||
124450838|NCT00467779|447613555|FG000|Stage 1A|Physician Decision|0|||
124450839|NCT00467779|447613556|FG001|Stage 1A|Physician Decision|0|||
124450840|NCT00467779|447613557|FG002|Stage 1A|Physician Decision|0|||
124545162|NCT00563706|447951088|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
124545163|NCT00563706|447951089|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
124545164|NCT00563706|447951090|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
124545165|NCT00563706|447951091|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
124545166|NCT00563706|447951092|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
124545167|NCT00563706|447951093|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
124545168|NCT00563706|447951094|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
124545169|NCT00563706|447951086|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
124545170|NCT00563706|447951087|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
124545171|NCT00563706|447951088|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
124545172|NCT00563706|447951089|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
124545173|NCT00563706|447951090|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
124545174|NCT00563706|447951091|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
124545175|NCT00563706|447951092|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
124545176|NCT00563706|447951093|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
124545177|NCT00563706|447951094|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
124545178|NCT00563706|447951086|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
124760995|NCT02831764|448751519|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
124760996|NCT02831764|448751520|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
124760997|NCT02831764|448751521|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
124760998|NCT02831764|448751522|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
124760999|NCT02831764|448751518|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
124761000|NCT02831764|448751519|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
124761001|NCT02831764|448751520|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
124761002|NCT02831764|448751521|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
124761003|NCT02831764|448751522|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
124761004|NCT02831764|448751518|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
124912186|NCT02723955|449307024|FG000|Escalation Phase|Lost to Follow-up|0|||
124912187|NCT02723955|449307025|FG001|Escalation Phase|Lost to Follow-up|0|||
124912188|NCT02723955|449307026|FG002|Escalation Phase|Lost to Follow-up|0|||
124912189|NCT02723955|449307027|FG003|Escalation Phase|Lost to Follow-up|0|||
124912190|NCT02723955|449307028|FG004|Escalation Phase|Lost to Follow-up|0|||
124912191|NCT02723955|449307029|FG005|Escalation Phase|Lost to Follow-up|2|||
124450841|NCT00467779|447613558|FG003|Stage 1A|Physician Decision|0|||
124450842|NCT00467779|447613559|FG004|Stage 1A|Physician Decision|0|||
124450843|NCT00467779|447613560|FG005|Stage 1A|Physician Decision|0|||
124761005|NCT02831764|448751519|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
124912192|NCT02723955|449307030|FG006|Escalation Phase|Lost to Follow-up|1|||
124450844|NCT00467779|447613561|FG006|Stage 1A|Physician Decision|0|||
124450845|NCT00467779|447613562|FG007|Stage 1A|Physician Decision|0|||
124912193|NCT02723955|449307031|FG007|Escalation Phase|Lost to Follow-up|1|||
124912194|NCT02723955|449307032|FG008|Escalation Phase|Lost to Follow-up|1|||
124450846|NCT00467779|447613563|FG008|Stage 1A|Physician Decision|0|||
124450847|NCT00467779|447613564|FG009|Stage 1A|Physician Decision|1|||
124450848|NCT00467779|447613565|FG010|Stage 1A|Physician Decision|0|||
124450849|NCT00467779|447613566|FG011|Stage 1A|Physician Decision|0|||
124450850|NCT00467779|447613567|FG012|Stage 1A|Physician Decision|0|||
124450851|NCT00467779|447613568|FG013|Stage 1A|Physician Decision|0|||
124450852|NCT00467779|447613569|FG014|Stage 1A|Physician Decision|0|||
124450853|NCT00467779|447613555|FG000|Stage 1A|Withdrawal by Subject|0|||
124450854|NCT00467779|447613556|FG001|Stage 1A|Withdrawal by Subject|0|||
124450855|NCT00467779|447613557|FG002|Stage 1A|Withdrawal by Subject|0|||
124450856|NCT00467779|447613558|FG003|Stage 1A|Withdrawal by Subject|0|||
124450857|NCT00467779|447613559|FG004|Stage 1A|Withdrawal by Subject|0|||
124450858|NCT00467779|447613560|FG005|Stage 1A|Withdrawal by Subject|0|||
124450859|NCT00467779|447613561|FG006|Stage 1A|Withdrawal by Subject|0|||
124450860|NCT00467779|447613562|FG007|Stage 1A|Withdrawal by Subject|0|||
124450861|NCT00467779|447613563|FG008|Stage 1A|Withdrawal by Subject|0|||
124450862|NCT00467779|447613564|FG009|Stage 1A|Withdrawal by Subject|0|||
124450863|NCT00467779|447613565|FG010|Stage 1A|Withdrawal by Subject|1|||
124450864|NCT00467779|447613566|FG011|Stage 1A|Withdrawal by Subject|1|||
124450865|NCT00467779|447613567|FG012|Stage 1A|Withdrawal by Subject|1|||
124450866|NCT00467779|447613568|FG013|Stage 1A|Withdrawal by Subject|0|||
124450867|NCT00467779|447613569|FG014|Stage 1A|Withdrawal by Subject|0|||
124912195|NCT02723955|449307033|FG009|Escalation Phase|Lost to Follow-up|0|||
124912196|NCT02723955|449307034|FG010|Escalation Phase|Lost to Follow-up|0|||
124912197|NCT02723955|449307035|FG011|Escalation Phase|Lost to Follow-up|0|||
124912198|NCT02723955|449307036|FG012|Escalation Phase|Lost to Follow-up|1|||
124912199|NCT02723955|449307037|FG013|Escalation Phase|Lost to Follow-up|0|||
124912200|NCT02723955|449307038|FG014|Escalation Phase|Lost to Follow-up|0|||
124912201|NCT02723955|449307039|FG015|Escalation Phase|Lost to Follow-up|0|||
124912202|NCT02723955|449307040|FG016|Escalation Phase|Lost to Follow-up|1|||
124912203|NCT02723955|449307041|FG017|Escalation Phase|Lost to Follow-up|2|||
124912204|NCT02723955|449307042|FG018|Escalation Phase|Lost to Follow-up|0|||
124912205|NCT02723955|449307043|FG019|Escalation Phase|Lost to Follow-up|1|||
124912206|NCT02723955|449307044|FG020|Escalation Phase|Lost to Follow-up|2|||
124912207|NCT02723955|449307045|FG021|Escalation Phase|Lost to Follow-up|1|||
124912208|NCT02723955|449307046|FG022|Escalation Phase|Lost to Follow-up|0|||
124912209|NCT02723955|449307047|FG023|Escalation Phase|Lost to Follow-up|0|||
124450868|NCT00467779|447613555|FG000|Stage 1A|Unspecified Reason|0|||
124450869|NCT00467779|447613556|FG001|Stage 1A|Unspecified Reason|0|||
124693246|NCT01851369|448498641|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
124693247|NCT02453191|448498642|FG000|Overall Study|Withdrawal by Subject|1|||
124693248|NCT03364686|448498643|FG000|Overall Study|Physician Decision|2|||
124693249|NCT02336503|448498646|FG000|Overall Study|Lost to Follow-up|0|||
124693250|NCT02336503|448498647|FG001|Overall Study|Lost to Follow-up|3|||
124693251|NCT02336503|448498648|FG002|Overall Study|Lost to Follow-up|0|||
124693252|NCT02336503|448498649|FG003|Overall Study|Lost to Follow-up|2|||
124693253|NCT02336503|448498646|FG000|Overall Study|Withdrawal by Subject|2|||
124693254|NCT02336503|448498647|FG001|Overall Study|Withdrawal by Subject|0|||
124693255|NCT02336503|448498648|FG002|Overall Study|Withdrawal by Subject|0|||
124912210|NCT02723955|449307048|FG024|Escalation Phase|Lost to Follow-up|1|||
124912211|NCT02723955|449307049|FG025|Escalation Phase|Lost to Follow-up|1|||
124912212|NCT02723955|449307050|FG026|Escalation Phase|Lost to Follow-up|3|||
124912213|NCT02723955|449307051|FG027|Escalation Phase|Lost to Follow-up|0|||
124912214|NCT02723955|449307052|FG028|Escalation Phase|Lost to Follow-up|1|||
124912215|NCT02723955|449307053|FG029|Escalation Phase|Lost to Follow-up|0|||
124912216|NCT02723955|449307054|FG030|Escalation Phase|Lost to Follow-up|0|||
124912217|NCT02723955|449307055|FG031|Escalation Phase|Lost to Follow-up|0|||
124912218|NCT02723955|449307056|FG032|Escalation Phase|Lost to Follow-up|0|||
124912219|NCT02723955|449307057|FG033|Escalation Phase|Lost to Follow-up|0|||
124912220|NCT02723955|449307058|FG034|Escalation Phase|Lost to Follow-up|0|||
124912221|NCT02723955|449307059|FG035|Escalation Phase|Lost to Follow-up|0|||
124450870|NCT00467779|447613557|FG002|Stage 1A|Unspecified Reason|0|||
124450871|NCT00467779|447613558|FG003|Stage 1A|Unspecified Reason|0|||
124450872|NCT00467779|447613559|FG004|Stage 1A|Unspecified Reason|0|||
124450873|NCT00467779|447613560|FG005|Stage 1A|Unspecified Reason|0|||
124693256|NCT02336503|448498649|FG003|Overall Study|Withdrawal by Subject|4|||
124450874|NCT00467779|447613561|FG006|Stage 1A|Unspecified Reason|0|||
124693257|NCT02336503|448498646|FG000|Overall Study|Adverse Event|0|||
124912222|NCT02723955|449307060|FG036|Escalation Phase|Lost to Follow-up|0|||
124912223|NCT02723955|449307061|FG037|Escalation Phase|Lost to Follow-up|0|||
124912224|NCT02723955|449307062|FG038|Escalation Phase|Lost to Follow-up|0|||
124912225|NCT02723955|449307063|FG039|Escalation Phase|Lost to Follow-up|0|||
124912226|NCT02723955|449307064|FG040|Escalation Phase|Lost to Follow-up|0|||
124450875|NCT00467779|447613562|FG007|Stage 1A|Unspecified Reason|0|||
124693258|NCT02336503|448498647|FG001|Overall Study|Adverse Event|0|||
124761006|NCT02831764|448751520|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
124693259|NCT02336503|448498648|FG002|Overall Study|Adverse Event|1|||
124693260|NCT02336503|448498649|FG003|Overall Study|Adverse Event|0|||
124693261|NCT01543503|448498650|FG000|Overall Study|Lost to Follow-up|32|||
124693262|NCT01543503|448498651|FG001|Overall Study|Lost to Follow-up|36|||
124693263|NCT01543503|448498650|FG000|Overall Study|Adverse Event|9|||
124912227|NCT02723955|449307065|FG041|Escalation Phase|Lost to Follow-up|0|||
124912228|NCT02723955|449307066|FG042|Escalation Phase|Lost to Follow-up|0|||
124912229|NCT02723955|449307024|FG000|Escalation Phase|Physician Decision|0|||
124912230|NCT02723955|449307025|FG001|Escalation Phase|Physician Decision|0|||
124912231|NCT02723955|449307026|FG002|Escalation Phase|Physician Decision|0|||
124912232|NCT02723955|449307027|FG003|Escalation Phase|Physician Decision|0|||
124912233|NCT02723955|449307028|FG004|Escalation Phase|Physician Decision|0|||
124912234|NCT02723955|449307029|FG005|Escalation Phase|Physician Decision|2|||
124912235|NCT02723955|449307030|FG006|Escalation Phase|Physician Decision|0|||
124912236|NCT02723955|449307031|FG007|Escalation Phase|Physician Decision|0|||
124912237|NCT02723955|449307032|FG008|Escalation Phase|Physician Decision|0|||
124693264|NCT01543503|448498651|FG001|Overall Study|Adverse Event|13|||
124693265|NCT01543503|448498650|FG000|Overall Study|Lack of Efficacy|4|||
124693266|NCT01543503|448498651|FG001|Overall Study|Lack of Efficacy|16|||
124693267|NCT01543503|448498650|FG000|Overall Study|Participant withdrew informed consent|8|||
124912238|NCT02723955|449307033|FG009|Escalation Phase|Physician Decision|0|||
124912239|NCT02723955|449307034|FG010|Escalation Phase|Physician Decision|0|||
124912240|NCT02723955|449307035|FG011|Escalation Phase|Physician Decision|0|||
124912241|NCT02723955|449307036|FG012|Escalation Phase|Physician Decision|0|||
124912242|NCT02723955|449307037|FG013|Escalation Phase|Physician Decision|0|||
124912243|NCT02723955|449307038|FG014|Escalation Phase|Physician Decision|0|||
124912244|NCT02723955|449307039|FG015|Escalation Phase|Physician Decision|0|||
124693268|NCT01543503|448498651|FG001|Overall Study|Participant withdrew informed consent|10|||
124912245|NCT02723955|449307040|FG016|Escalation Phase|Physician Decision|0|||
124912246|NCT02723955|449307041|FG017|Escalation Phase|Physician Decision|0|||
124912247|NCT02723955|449307042|FG018|Escalation Phase|Physician Decision|0|||
124912248|NCT02723955|449307043|FG019|Escalation Phase|Physician Decision|0|||
124912249|NCT02723955|449307044|FG020|Escalation Phase|Physician Decision|0|||
124912250|NCT02723955|449307045|FG021|Escalation Phase|Physician Decision|0|||
124912251|NCT02723955|449307046|FG022|Escalation Phase|Physician Decision|0|||
124912252|NCT02723955|449307047|FG023|Escalation Phase|Physician Decision|0|||
124912253|NCT02723955|449307048|FG024|Escalation Phase|Physician Decision|0|||
124912254|NCT02723955|449307049|FG025|Escalation Phase|Physician Decision|0|||
124912255|NCT02723955|449307050|FG026|Escalation Phase|Physician Decision|2|||
124912256|NCT02723955|449307051|FG027|Escalation Phase|Physician Decision|0|||
124912257|NCT02723955|449307052|FG028|Escalation Phase|Physician Decision|0|||
124912258|NCT02723955|449307053|FG029|Escalation Phase|Physician Decision|0|||
124912259|NCT02723955|449307054|FG030|Escalation Phase|Physician Decision|0|||
124912260|NCT02723955|449307055|FG031|Escalation Phase|Physician Decision|0|||
124912261|NCT02723955|449307056|FG032|Escalation Phase|Physician Decision|0|||
124912262|NCT02723955|449307057|FG033|Escalation Phase|Physician Decision|0|||
124912263|NCT02723955|449307058|FG034|Escalation Phase|Physician Decision|0|||
124912264|NCT02723955|449307059|FG035|Escalation Phase|Physician Decision|0|||
124912265|NCT02723955|449307060|FG036|Escalation Phase|Physician Decision|0|||
124912266|NCT02723955|449307061|FG037|Escalation Phase|Physician Decision|0|||
124912267|NCT02723955|449307062|FG038|Escalation Phase|Physician Decision|0|||
124693269|NCT01543503|448498650|FG000|Overall Study|Change of jobs|0|||
124693270|NCT01543503|448498651|FG001|Overall Study|Change of jobs|1|||
124693271|NCT01543503|448498650|FG000|Overall Study|Intolerance to the biologic treatment|0|||
124693272|NCT01543503|448498651|FG001|Overall Study|Intolerance to the biologic treatment|1|||
124693273|NCT01543503|448498650|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
124693274|NCT01543503|448498651|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
124693275|NCT01543503|448498650|FG000|Overall Study|Participant did not complete last visit|0|||
124693276|NCT01543503|448498651|FG001|Overall Study|Participant did not complete last visit|2|||
124693277|NCT01543503|448498650|FG000|Overall Study|Refused to continue treatment|7|||
124761007|NCT02831764|448751521|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
124761008|NCT02831764|448751522|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
124912268|NCT02723955|449307063|FG039|Escalation Phase|Physician Decision|0|||
124912269|NCT02723955|449307064|FG040|Escalation Phase|Physician Decision|0|||
124912270|NCT02723955|449307065|FG041|Escalation Phase|Physician Decision|0|||
124912271|NCT02723955|449307066|FG042|Escalation Phase|Physician Decision|0|||
124912272|NCT02723955|449307024|FG000|Escalation Phase|Withdrawal by Subject|0|||
124912273|NCT02723955|449307025|FG001|Escalation Phase|Withdrawal by Subject|0|||
124912274|NCT02723955|449307026|FG002|Escalation Phase|Withdrawal by Subject|0|||
124450876|NCT00467779|447613563|FG008|Stage 1A|Unspecified Reason|0|||
124912275|NCT02723955|449307027|FG003|Escalation Phase|Withdrawal by Subject|0|||
124912276|NCT02723955|449307028|FG004|Escalation Phase|Withdrawal by Subject|1|||
124912277|NCT02723955|449307029|FG005|Escalation Phase|Withdrawal by Subject|1|||
124912278|NCT02723955|449307030|FG006|Escalation Phase|Withdrawal by Subject|1|||
124912279|NCT02723955|449307031|FG007|Escalation Phase|Withdrawal by Subject|1|||
124912280|NCT02723955|449307032|FG008|Escalation Phase|Withdrawal by Subject|0|||
124912281|NCT02723955|449307033|FG009|Escalation Phase|Withdrawal by Subject|0|||
124912282|NCT02723955|449307034|FG010|Escalation Phase|Withdrawal by Subject|0|||
124912283|NCT02723955|449307035|FG011|Escalation Phase|Withdrawal by Subject|0|||
124912284|NCT02723955|449307036|FG012|Escalation Phase|Withdrawal by Subject|1|||
124912285|NCT02723955|449307037|FG013|Escalation Phase|Withdrawal by Subject|0|||
124912286|NCT02723955|449307038|FG014|Escalation Phase|Withdrawal by Subject|0|||
124912287|NCT02723955|449307039|FG015|Escalation Phase|Withdrawal by Subject|0|||
124912288|NCT02723955|449307040|FG016|Escalation Phase|Withdrawal by Subject|1|||
124912289|NCT02723955|449307041|FG017|Escalation Phase|Withdrawal by Subject|0|||
124912290|NCT02723955|449307042|FG018|Escalation Phase|Withdrawal by Subject|0|||
124912291|NCT02723955|449307043|FG019|Escalation Phase|Withdrawal by Subject|0|||
124912292|NCT02723955|449307044|FG020|Escalation Phase|Withdrawal by Subject|0|||
124912293|NCT02723955|449307045|FG021|Escalation Phase|Withdrawal by Subject|0|||
124912294|NCT02723955|449307046|FG022|Escalation Phase|Withdrawal by Subject|0|||
124912295|NCT02723955|449307047|FG023|Escalation Phase|Withdrawal by Subject|2|||
124912296|NCT02723955|449307048|FG024|Escalation Phase|Withdrawal by Subject|0|||
124912297|NCT02723955|449307049|FG025|Escalation Phase|Withdrawal by Subject|1|||
124912298|NCT02723955|449307050|FG026|Escalation Phase|Withdrawal by Subject|0|||
124912299|NCT02723955|449307051|FG027|Escalation Phase|Withdrawal by Subject|0|||
124912300|NCT02723955|449307052|FG028|Escalation Phase|Withdrawal by Subject|1|||
124912301|NCT02723955|449307053|FG029|Escalation Phase|Withdrawal by Subject|0|||
124912302|NCT02723955|449307054|FG030|Escalation Phase|Withdrawal by Subject|0|||
124450877|NCT00467779|447613564|FG009|Stage 1A|Unspecified Reason|0|||
124450878|NCT00467779|447613565|FG010|Stage 1A|Unspecified Reason|0|||
124450879|NCT00467779|447613566|FG011|Stage 1A|Unspecified Reason|1|||
124450880|NCT00467779|447613567|FG012|Stage 1A|Unspecified Reason|1|||
124450881|NCT00467779|447613568|FG013|Stage 1A|Unspecified Reason|0|||
124450882|NCT00467779|447613569|FG014|Stage 1A|Unspecified Reason|0|||
124450883|NCT00467779|447613555|FG000|Stage 2|Adverse Event|0|||
124450884|NCT00467779|447613556|FG001|Stage 2|Adverse Event|0|||
124450885|NCT00467779|447613557|FG002|Stage 2|Adverse Event|0|||
124450886|NCT00467779|447613558|FG003|Stage 2|Adverse Event|0|||
124450887|NCT00467779|447613559|FG004|Stage 2|Adverse Event|0|||
124450888|NCT00467779|447613560|FG005|Stage 2|Adverse Event|0|||
124450889|NCT00467779|447613561|FG006|Stage 2|Adverse Event|0|||
124450890|NCT00467779|447613562|FG007|Stage 2|Adverse Event|0|||
124450891|NCT00467779|447613563|FG008|Stage 2|Adverse Event|1|||
124450892|NCT00467779|447613564|FG009|Stage 2|Adverse Event|0|||
124450893|NCT00467779|447613565|FG010|Stage 2|Adverse Event|0|||
124450894|NCT00467779|447613566|FG011|Stage 2|Adverse Event|0|||
124450895|NCT00467779|447613567|FG012|Stage 2|Adverse Event|0|||
124450896|NCT00467779|447613568|FG013|Stage 2|Adverse Event|0|||
124450897|NCT00467779|447613569|FG014|Stage 2|Adverse Event|0|||
124450898|NCT00467779|447613555|FG000|Stage 2|Death|0|||
124450899|NCT00467779|447613556|FG001|Stage 2|Death|0|||
124450900|NCT00467779|447613557|FG002|Stage 2|Death|0|||
124450901|NCT00467779|447613558|FG003|Stage 2|Death|0|||
124450902|NCT00467779|447613559|FG004|Stage 2|Death|0|||
124450903|NCT00467779|447613560|FG005|Stage 2|Death|0|||
124450904|NCT00467779|447613561|FG006|Stage 2|Death|0|||
124450905|NCT00467779|447613562|FG007|Stage 2|Death|0|||
124450906|NCT00467779|447613563|FG008|Stage 2|Death|1|||
124450907|NCT00467779|447613564|FG009|Stage 2|Death|0|||
124545179|NCT00563706|447951087|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
124693278|NCT01543503|448498651|FG001|Overall Study|Refused to continue treatment|0|||
124693279|NCT01543503|448498650|FG000|Overall Study|Incorrect medication received|1|||
124912303|NCT02723955|449307055|FG031|Escalation Phase|Withdrawal by Subject|0|||
124450908|NCT00467779|447613565|FG010|Stage 2|Death|0|||
124450909|NCT00467779|447613566|FG011|Stage 2|Death|0|||
124450910|NCT00467779|447613567|FG012|Stage 2|Death|0|||
124450911|NCT00467779|447613568|FG013|Stage 2|Death|0|||
124912304|NCT02723955|449307056|FG032|Escalation Phase|Withdrawal by Subject|0|||
124912305|NCT02723955|449307057|FG033|Escalation Phase|Withdrawal by Subject|0|||
124912306|NCT02723955|449307058|FG034|Escalation Phase|Withdrawal by Subject|0|||
124912307|NCT02723955|449307059|FG035|Escalation Phase|Withdrawal by Subject|0|||
124912308|NCT02723955|449307060|FG036|Escalation Phase|Withdrawal by Subject|0|||
124912309|NCT02723955|449307061|FG037|Escalation Phase|Withdrawal by Subject|0|||
124912310|NCT02723955|449307062|FG038|Escalation Phase|Withdrawal by Subject|0|||
124912311|NCT02723955|449307063|FG039|Escalation Phase|Withdrawal by Subject|0|||
124912312|NCT02723955|449307064|FG040|Escalation Phase|Withdrawal by Subject|0|||
124912313|NCT02723955|449307065|FG041|Escalation Phase|Withdrawal by Subject|0|||
124912314|NCT02723955|449307066|FG042|Escalation Phase|Withdrawal by Subject|0|||
124912315|NCT02723955|449307024|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912316|NCT02723955|449307025|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912317|NCT02723955|449307026|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912318|NCT02723955|449307027|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912319|NCT02723955|449307028|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
124912320|NCT02723955|449307029|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
124912321|NCT02723955|449307030|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
124912322|NCT02723955|449307031|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
124912323|NCT02723955|449307032|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
124912324|NCT02723955|449307033|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912325|NCT02723955|449307034|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912326|NCT02723955|449307035|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912327|NCT02723955|449307036|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912328|NCT02723955|449307037|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912329|NCT02723955|449307038|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912330|NCT02723955|449307039|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912331|NCT02723955|449307040|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912332|NCT02723955|449307041|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912333|NCT02723955|449307042|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912334|NCT02723955|449307043|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912335|NCT02723955|449307044|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912336|NCT02723955|449307045|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912337|NCT02723955|449307046|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912338|NCT02723955|449307047|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912339|NCT02723955|449307048|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912340|NCT02723955|449307049|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912341|NCT02723955|449307050|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912342|NCT02723955|449307051|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912343|NCT02723955|449307052|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912344|NCT02723955|449307053|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912345|NCT02723955|449307054|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912346|NCT02723955|449307055|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912347|NCT02723955|449307056|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912348|NCT02723955|449307057|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912349|NCT02723955|449307058|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912350|NCT02723955|449307059|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912351|NCT02723955|449307060|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912352|NCT02723955|449307061|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124693280|NCT01543503|448498651|FG001|Overall Study|Incorrect medication received|0|||
124693281|NCT01543503|448498650|FG000|Overall Study|Participant moved to another city|2|||
124693282|NCT01543503|448498651|FG001|Overall Study|Participant moved to another city|0|||
124693283|NCT01543503|448498650|FG000|Overall Study|Participant will not return for visits|0|||
124693284|NCT01543503|448498651|FG001|Overall Study|Participant will not return for visits|2|||
124693285|NCT01543503|448498650|FG000|Overall Study|Participant transferred to another city|1|||
124693286|NCT01543503|448498651|FG001|Overall Study|Participant transferred to another city|0|||
124693287|NCT01543503|448498650|FG000|Overall Study|Participant moved to Scotland|1|||
124693288|NCT01543503|448498651|FG001|Overall Study|Participant moved to Scotland|0|||
124693289|NCT01543503|448498650|FG000|Overall Study|Participant decision to stop treatment|1|||
124693290|NCT01543503|448498651|FG001|Overall Study|Participant decision to stop treatment|0|||
124450912|NCT00467779|447613569|FG014|Stage 2|Death|0|||
124693291|NCT01543503|448498650|FG000|Overall Study|Investigator did not wish to participate|1|||
124545180|NCT00563706|447951088|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
124545181|NCT00563706|447951089|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
124545182|NCT00563706|447951090|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
124545183|NCT00563706|447951091|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
124912353|NCT02723955|449307062|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912354|NCT02723955|449307063|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912355|NCT02723955|449307064|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124545184|NCT00563706|447951092|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
124545185|NCT00563706|447951093|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
124545186|NCT00563706|447951094|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
124545187|NCT03839693|447951097|FG000|Overall Study|Lost to Follow-up|0|||
124545188|NCT03839693|447951098|FG001|Overall Study|Lost to Follow-up|2|||
124545189|NCT03839693|447951099|FG002|Overall Study|Lost to Follow-up|2|||
124545190|NCT03839693|447951097|FG000|Overall Study|Withdrawal by Subject|1|||
124545191|NCT03839693|447951098|FG001|Overall Study|Withdrawal by Subject|0|||
124545192|NCT03839693|447951099|FG002|Overall Study|Withdrawal by Subject|2|||
124545193|NCT03839693|447951097|FG000|Overall Study|subject moved out of the area|1|||
124545194|NCT03839693|447951098|FG001|Overall Study|subject moved out of the area|0|||
124545195|NCT03839693|447951099|FG002|Overall Study|subject moved out of the area|0|||
124545196|NCT02503215|447951100|FG000|Overall Study|Unable to wear compression stockings|1|||
124545197|NCT02503215|447951100|FG000|Overall Study|Unable to use positive airway pressure|2|||
124545198|NCT00299546|447951101|FG000|Overall Study|Death|3|||
124545199|NCT00299546|447951102|FG001|Overall Study|Death|2|||
124545200|NCT00299546|447951103|FG002|Overall Study|Death|0|||
124693292|NCT01543503|448498651|FG001|Overall Study|Investigator did not wish to participate|1|||
124693293|NCT01543503|448498650|FG000|Overall Study|Participant recruited after closing date|0|||
124693294|NCT01543503|448498651|FG001|Overall Study|Participant recruited after closing date|1|||
124693295|NCT01543503|448498650|FG000|Overall Study|Site stopped participation|5|||
124693296|NCT01543503|448498651|FG001|Overall Study|Site stopped participation|1|||
124693297|NCT01543503|448498650|FG000|Overall Study|Participant did not attend a visit|1|||
124693298|NCT01543503|448498651|FG001|Overall Study|Participant did not attend a visit|0|||
124693299|NCT01543503|448498650|FG000|Overall Study|Moved to other rheumatologic site|0|||
124693300|NCT01543503|448498651|FG001|Overall Study|Moved to other rheumatologic site|1|||
124693301|NCT01543503|448498650|FG000|Overall Study|Participant consented to another study|0|||
124693302|NCT01543503|448498651|FG001|Overall Study|Participant consented to another study|2|||
124693303|NCT01543503|448498650|FG000|Overall Study|Participant went to United States|1|||
124693304|NCT01543503|448498651|FG001|Overall Study|Participant went to United States|0|||
124693305|NCT01543503|448498650|FG000|Overall Study|Screen failure|1|||
124693306|NCT01543503|448498651|FG001|Overall Study|Screen failure|0|||
124693307|NCT01936974|448498654|FG000|Overall Study|Physician Decision|2|||
124693308|NCT01936974|448498655|FG001|Overall Study|Physician Decision|5|||
124693309|NCT04584554|448498658|FG000|Overall Study|Withdrawal by Subject|2|||
124693310|NCT04584554|448498659|FG001|Overall Study|Withdrawal by Subject|2|||
124693311|NCT00063999|448498660|FG000|Overall Study|Withdrawal by Subject|1|||
124693312|NCT00063999|448498661|FG001|Overall Study|Withdrawal by Subject|0|||
124693313|NCT00063999|448498660|FG000|Overall Study|Ineligible|44|||
124693314|NCT00063999|448498661|FG001|Overall Study|Ineligible|24|||
124693315|NCT03767894|448498662|FG000|Overall Study|Withdrawal by Subject|1|||
124693316|NCT04243837|448498663|FG000|Overall Study|Adverse Event|2|||
124693317|NCT04243837|448498664|FG001|Overall Study|Adverse Event|1|||
124693318|NCT04243837|448498663|FG000|Overall Study|Withdrawal by Subject|4|||
124693319|NCT04243837|448498664|FG001|Overall Study|Withdrawal by Subject|2|||
124693320|NCT04243837|448498663|FG000|Overall Study|Covid-19 lock down|1|||
124693321|NCT04243837|448498664|FG001|Overall Study|Covid-19 lock down|0|||
124693322|NCT04243837|448498663|FG000|Overall Study|Study Terminated by Sponsor|11|||
124693323|NCT04243837|448498664|FG001|Overall Study|Study Terminated by Sponsor|12|||
124693324|NCT00977561|448498667|FG000|Overall Study|Death|3|||
124693325|NCT00977561|448498668|FG001|Overall Study|Death|2|||
124693326|NCT00977561|448498667|FG000|Overall Study|Study terminated|0|||
124693327|NCT00977561|448498668|FG001|Overall Study|Study terminated|2|||
124693328|NCT00977561|448498667|FG000|Overall Study|Other|2|||
124761009|NCT02831764|448751518|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
124761010|NCT02831764|448751519|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
124912356|NCT02723955|449307065|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124545201|NCT00299546|447951101|FG000|Overall Study|Lost to Follow-up|2|||
124545202|NCT00299546|447951102|FG001|Overall Study|Lost to Follow-up|2|||
124693329|NCT00977561|448498668|FG001|Overall Study|Other|0|||
124693330|NCT01968785|448498676|FG000|Overall Study|Withdrawal by Subject|1|||
124693331|NCT01968785|448498677|FG001|Overall Study|Withdrawal by Subject|0|||
124693332|NCT04000724|448498684|FG000|Overall Study|Withdrawal by Subject|5|||
124693333|NCT04000724|448498685|FG001|Overall Study|Withdrawal by Subject|3|||
124545203|NCT00299546|447951103|FG002|Overall Study|Lost to Follow-up|5|||
124545204|NCT00299546|447951101|FG000|Overall Study|Adverse Event|37|||
124761011|NCT02831764|448751520|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
124761012|NCT02831764|448751521|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
124761013|NCT02831764|448751522|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
124761014|NCT02831764|448751518|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
124761015|NCT02831764|448751519|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
124761016|NCT02831764|448751520|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
124761017|NCT02831764|448751521|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
124761018|NCT02831764|448751522|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
124761019|NCT02831764|448751518|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
124761020|NCT02831764|448751519|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
124761021|NCT02831764|448751520|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
124761022|NCT02831764|448751521|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
124761023|NCT02831764|448751522|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
124761024|NCT02831764|448751518|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
124761025|NCT02831764|448751519|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
124761026|NCT02831764|448751520|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
124761027|NCT02831764|448751521|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
124761028|NCT02831764|448751522|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
124761029|NCT02831764|448751518|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
124761030|NCT02831764|448751519|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
124761031|NCT02831764|448751520|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
124761032|NCT02831764|448751521|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
124761033|NCT02831764|448751522|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
124761034|NCT02831764|448751518|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
124761035|NCT02831764|448751519|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
124761036|NCT02831764|448751520|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
124761037|NCT02831764|448751521|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
124761038|NCT02831764|448751522|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
124761039|NCT02831764|448751518|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
124761040|NCT02831764|448751519|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
124761041|NCT02831764|448751520|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
124761042|NCT02831764|448751521|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
124761043|NCT02831764|448751522|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
124761044|NCT02831764|448751518|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
124761045|NCT02831764|448751519|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
124761046|NCT02831764|448751520|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
124761047|NCT02831764|448751521|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
124761048|NCT02831764|448751522|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
124761049|NCT02831764|448751518|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
124761050|NCT02831764|448751519|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
124761051|NCT02831764|448751520|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
124761052|NCT02831764|448751521|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
124761053|NCT02831764|448751522|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
124761054|NCT02831764|448751518|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
124761055|NCT02831764|448751519|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
124761056|NCT02831764|448751520|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
124761057|NCT02831764|448751521|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
124761058|NCT02831764|448751522|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
124761059|NCT02831764|448751518|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
124761060|NCT02831764|448751519|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
124761061|NCT02831764|448751520|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
124912357|NCT02723955|449307066|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
124912358|NCT02723955|449307024|FG000|Escalation Phase|Site Closed|0|||
124912359|NCT02723955|449307025|FG001|Escalation Phase|Site Closed|0|||
124912360|NCT02723955|449307026|FG002|Escalation Phase|Site Closed|0|||
124912361|NCT02723955|449307027|FG003|Escalation Phase|Site Closed|0|||
124912362|NCT02723955|449307028|FG004|Escalation Phase|Site Closed|0|||
124912363|NCT02723955|449307029|FG005|Escalation Phase|Site Closed|0|||
124912364|NCT02723955|449307030|FG006|Escalation Phase|Site Closed|0|||
124545205|NCT00299546|447951102|FG001|Overall Study|Adverse Event|22|||
124545206|NCT00299546|447951103|FG002|Overall Study|Adverse Event|27|||
124545207|NCT00299546|447951101|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
124545208|NCT00299546|447951102|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
124912365|NCT02723955|449307031|FG007|Escalation Phase|Site Closed|0|||
124912366|NCT02723955|449307032|FG008|Escalation Phase|Site Closed|0|||
124912367|NCT02723955|449307033|FG009|Escalation Phase|Site Closed|0|||
124912368|NCT02723955|449307034|FG010|Escalation Phase|Site Closed|0|||
124912369|NCT02723955|449307035|FG011|Escalation Phase|Site Closed|0|||
124912370|NCT02723955|449307036|FG012|Escalation Phase|Site Closed|0|||
124912371|NCT02723955|449307037|FG013|Escalation Phase|Site Closed|0|||
124912372|NCT02723955|449307038|FG014|Escalation Phase|Site Closed|0|||
124912373|NCT02723955|449307039|FG015|Escalation Phase|Site Closed|1|||
124912374|NCT02723955|449307040|FG016|Escalation Phase|Site Closed|0|||
124912375|NCT02723955|449307041|FG017|Escalation Phase|Site Closed|2|||
124912376|NCT02723955|449307042|FG018|Escalation Phase|Site Closed|0|||
124912377|NCT02723955|449307043|FG019|Escalation Phase|Site Closed|0|||
124912378|NCT02723955|449307044|FG020|Escalation Phase|Site Closed|1|||
124912379|NCT02723955|449307045|FG021|Escalation Phase|Site Closed|0|||
124912380|NCT02723955|449307046|FG022|Escalation Phase|Site Closed|0|||
124912381|NCT02723955|449307047|FG023|Escalation Phase|Site Closed|0|||
124912382|NCT02723955|449307048|FG024|Escalation Phase|Site Closed|3|||
124912383|NCT02723955|449307049|FG025|Escalation Phase|Site Closed|1|||
124912384|NCT02723955|449307050|FG026|Escalation Phase|Site Closed|3|||
124912385|NCT02723955|449307051|FG027|Escalation Phase|Site Closed|1|||
124545209|NCT00299546|447951103|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
124545210|NCT00299546|447951101|FG000|Overall Study|Other|24|||
124545211|NCT00299546|447951102|FG001|Overall Study|Other|26|||
124545212|NCT00299546|447951103|FG002|Overall Study|Other|19|||
124912386|NCT02723955|449307052|FG028|Escalation Phase|Site Closed|1|||
124912387|NCT02723955|449307053|FG029|Escalation Phase|Site Closed|0|||
124912388|NCT02723955|449307054|FG030|Escalation Phase|Site Closed|0|||
124912389|NCT02723955|449307055|FG031|Escalation Phase|Site Closed|0|||
124912390|NCT02723955|449307056|FG032|Escalation Phase|Site Closed|0|||
124912391|NCT02723955|449307057|FG033|Escalation Phase|Site Closed|0|||
124912392|NCT02723955|449307058|FG034|Escalation Phase|Site Closed|0|||
124912393|NCT02723955|449307059|FG035|Escalation Phase|Site Closed|0|||
124912394|NCT02723955|449307060|FG036|Escalation Phase|Site Closed|0|||
124912395|NCT02723955|449307061|FG037|Escalation Phase|Site Closed|0|||
124912396|NCT02723955|449307062|FG038|Escalation Phase|Site Closed|0|||
124912397|NCT02723955|449307063|FG039|Escalation Phase|Site Closed|0|||
124912398|NCT02723955|449307064|FG040|Escalation Phase|Site Closed|0|||
124912399|NCT02723955|449307065|FG041|Escalation Phase|Site Closed|0|||
124912400|NCT02723955|449307066|FG042|Escalation Phase|Site Closed|0|||
124693334|NCT04000724|448498686|FG002|Overall Study|Withdrawal by Subject|4|||
124693335|NCT04000724|448498684|FG000|Overall Study|Lost to Follow-up|11|||
124693336|NCT04000724|448498685|FG001|Overall Study|Lost to Follow-up|7|||
124693337|NCT04000724|448498686|FG002|Overall Study|Lost to Follow-up|13|||
124693338|NCT00455455|448498687|FG000|Washout|Withdrawal by Subject|0|||
124912401|NCT02723955|449307024|FG000|Expansion Phase|Death|0|||
124912402|NCT02723955|449307025|FG001|Expansion Phase|Death|0|||
124912403|NCT02723955|449307026|FG002|Expansion Phase|Death|0|||
124912404|NCT02723955|449307027|FG003|Expansion Phase|Death|0|||
124912405|NCT02723955|449307028|FG004|Expansion Phase|Death|0|||
124912406|NCT02723955|449307029|FG005|Expansion Phase|Death|0|||
124912407|NCT02723955|449307030|FG006|Expansion Phase|Death|0|||
124912408|NCT02723955|449307031|FG007|Expansion Phase|Death|0|||
124912409|NCT02723955|449307032|FG008|Expansion Phase|Death|0|||
124912410|NCT02723955|449307033|FG009|Expansion Phase|Death|25|||
124693339|NCT00455455|448498688|FG001|Washout|Withdrawal by Subject|1|||
124693340|NCT00455455|448498687|FG000|Washout|Withdrawal by Subject|1|||
124693341|NCT00455455|448498688|FG001|Washout|Withdrawal by Subject|0|||
124693342|NCT01827943|448498689|FG000|Overall Study|Protocol Violation|8|||
124693343|NCT01827943|448498689|FG000|Overall Study|Never treated because of an rapid progression|1|||
124693344|NCT04689009|448498690|FG000|Overall Study|Adverse Event|1|||
124912411|NCT02723955|449307034|FG010|Expansion Phase|Death|69|||
124912412|NCT02723955|449307035|FG011|Expansion Phase|Death|48|||
124693345|NCT04689009|448498691|FG001|Overall Study|Adverse Event|0|||
124912413|NCT02723955|449307036|FG012|Expansion Phase|Death|0|||
124912414|NCT02723955|449307037|FG013|Expansion Phase|Death|0|||
124912415|NCT02723955|449307038|FG014|Expansion Phase|Death|0|||
124912416|NCT02723955|449307039|FG015|Expansion Phase|Death|0|||
124912417|NCT02723955|449307040|FG016|Expansion Phase|Death|0|||
124912418|NCT02723955|449307041|FG017|Expansion Phase|Death|0|||
124912419|NCT02723955|449307042|FG018|Expansion Phase|Death|0|||
124545213|NCT00299546|447951101|FG000|Overall Study|Not treated|0|||
124693346|NCT04689009|448498690|FG000|Overall Study|Lost to Follow-up|1|||
124693347|NCT04689009|448498691|FG001|Overall Study|Lost to Follow-up|2|||
124693348|NCT04689009|448498690|FG000|Overall Study|Withdrawal by Subject|4|||
124912420|NCT02723955|449307043|FG019|Expansion Phase|Death|0|||
124912421|NCT02723955|449307044|FG020|Expansion Phase|Death|0|||
124912422|NCT02723955|449307045|FG021|Expansion Phase|Death|0|||
124912423|NCT02723955|449307046|FG022|Expansion Phase|Death|0|||
124912424|NCT02723955|449307047|FG023|Expansion Phase|Death|0|||
124912425|NCT02723955|449307048|FG024|Expansion Phase|Death|0|||
124912426|NCT02723955|449307049|FG025|Expansion Phase|Death|0|||
124912427|NCT02723955|449307050|FG026|Expansion Phase|Death|0|||
124912428|NCT02723955|449307051|FG027|Expansion Phase|Death|0|||
124912429|NCT02723955|449307052|FG028|Expansion Phase|Death|0|||
124912430|NCT02723955|449307053|FG029|Expansion Phase|Death|12|||
124912431|NCT02723955|449307054|FG030|Expansion Phase|Death|202|||
124693349|NCT04689009|448498691|FG001|Overall Study|Withdrawal by Subject|3|||
124693350|NCT04689009|448498690|FG000|Overall Study|Protocol Violation|1|||
124693351|NCT04689009|448498691|FG001|Overall Study|Protocol Violation|0|||
124693352|NCT00545948|448498693|FG000|Overall Study|Not Treated|1|||
124693353|NCT00545948|448498694|FG001|Overall Study|Not Treated|1|||
124693354|NCT00545948|448498695|FG002|Overall Study|Not Treated|7|||
124693355|NCT03467945|448498696|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124693356|NCT03467945|448498697|FG001|Treatment Period 2|Withdrawal by Subject|1|||
124693357|NCT03467945|448498698|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124693358|NCT03467945|448498699|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124693359|NCT03467945|448498696|FG000|Treatment Period 3|Withdrawal by Subject|1|||
124693360|NCT03467945|448498697|FG001|Treatment Period 3|Withdrawal by Subject|0|||
124693361|NCT03467945|448498698|FG002|Treatment Period 3|Withdrawal by Subject|2|||
124693362|NCT03467945|448498699|FG003|Treatment Period 3|Withdrawal by Subject|1|||
124693363|NCT02187055|448498702|FG000|Overall Study|Lack of Efficacy|10|||
124693364|NCT02187055|448498703|FG001|Overall Study|Lack of Efficacy|3|||
124693365|NCT02187055|448498704|FG002|Overall Study|Lack of Efficacy|7|||
124693366|NCT02187055|448498702|FG000|Overall Study|Lost to Follow-up|2|||
124693367|NCT02187055|448498703|FG001|Overall Study|Lost to Follow-up|7|||
124693368|NCT02187055|448498704|FG002|Overall Study|Lost to Follow-up|3|||
124693369|NCT02187055|448498702|FG000|Overall Study|No longer meets eligibility criteria|0|||
124693370|NCT02187055|448498703|FG001|Overall Study|No longer meets eligibility criteria|2|||
124693371|NCT02187055|448498704|FG002|Overall Study|No longer meets eligibility criteria|0|||
124693372|NCT02187055|448498702|FG000|Overall Study|No longer willing to participate|6|||
124693373|NCT02187055|448498703|FG001|Overall Study|No longer willing to participate|8|||
124693374|NCT02187055|448498704|FG002|Overall Study|No longer willing to participate|10|||
124693375|NCT02187055|448498702|FG000|Overall Study|Other|5|||
124693376|NCT02187055|448498703|FG001|Overall Study|Other|6|||
124693377|NCT02187055|448498704|FG002|Overall Study|Other|3|||
124693378|NCT02187055|448498702|FG000|Overall Study|Protocol Violation|9|||
124693379|NCT02187055|448498703|FG001|Overall Study|Protocol Violation|9|||
124693380|NCT02187055|448498704|FG002|Overall Study|Protocol Violation|4|||
124693381|NCT02187055|448498702|FG000|Overall Study|Pregnancy|3|||
124693382|NCT02187055|448498703|FG001|Overall Study|Pregnancy|1|||
124693383|NCT02187055|448498704|FG002|Overall Study|Pregnancy|0|||
124693384|NCT02187055|448498702|FG000|Overall Study|Withdrawal by Subject|11|||
124693385|NCT02187055|448498703|FG001|Overall Study|Withdrawal by Subject|11|||
124693386|NCT02187055|448498704|FG002|Overall Study|Withdrawal by Subject|11|||
124693387|NCT02187055|448498702|FG000|Overall Study|Adverse Event|21|||
124693388|NCT02187055|448498703|FG001|Overall Study|Adverse Event|26|||
124693389|NCT02187055|448498704|FG002|Overall Study|Adverse Event|36|||
124693390|NCT02187055|448498702|FG000|Overall Study|Death|2|||
124693391|NCT02187055|448498703|FG001|Overall Study|Death|0|||
124693392|NCT02187055|448498704|FG002|Overall Study|Death|0|||
124693393|NCT03520387|448498707|FG000|Pre-Randomization|Withdrawal by Subject|1|||
124693394|NCT03520387|448498708|FG001|Pre-Randomization|Withdrawal by Subject|0|||
124693395|NCT03520387|448498709|FG002|Pre-Randomization|Withdrawal by Subject|0|||
124693396|NCT03520387|448498710|FG003|Pre-Randomization|Withdrawal by Subject|0|||
124693397|NCT03520387|448498711|FG004|Pre-Randomization|Withdrawal by Subject|0|||
124693398|NCT03520387|448498707|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
124693399|NCT03520387|448498708|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
124693400|NCT03520387|448498709|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
124693401|NCT03520387|448498710|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
124693402|NCT03520387|448498711|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
124693403|NCT03336866|448498712|FG000|Overall Study|Lost to Follow-up|2|||
124693404|NCT03336866|448498713|FG001|Overall Study|Lost to Follow-up|0|||
124693405|NCT03336866|448498714|FG002|Overall Study|Lost to Follow-up|3|||
124912432|NCT02723955|449307055|FG031|Expansion Phase|Death|31|||
124693406|NCT03336866|448498712|FG000|Overall Study|Withdrawal by Subject|1|||
124693407|NCT03336866|448498713|FG001|Overall Study|Withdrawal by Subject|1|||
124693408|NCT03336866|448498714|FG002|Overall Study|Withdrawal by Subject|0|||
124693409|NCT03336866|448498712|FG000|Overall Study|Noncompliance with clinic house rules|0|||
124693410|NCT03336866|448498713|FG001|Overall Study|Noncompliance with clinic house rules|0|||
124912433|NCT02723955|449307056|FG032|Expansion Phase|Death|17|||
124693411|NCT03336866|448498714|FG002|Overall Study|Noncompliance with clinic house rules|1|||
124693412|NCT00541775|448498715|FG000|Overall Study|Adverse Event|3|||
124693413|NCT00541775|448498716|FG001|Overall Study|Adverse Event|2|||
124693414|NCT00541775|448498717|FG002|Overall Study|Adverse Event|1|||
124693415|NCT00541775|448498715|FG000|Overall Study|Lack of Efficacy|0|||
124693416|NCT00541775|448498716|FG001|Overall Study|Lack of Efficacy|0|||
124693417|NCT00541775|448498717|FG002|Overall Study|Lack of Efficacy|3|||
124912434|NCT02723955|449307057|FG033|Expansion Phase|Death|2|||
124450913|NCT00467779|447613555|FG000|Stage 2|Disease Progression|0|||
124761062|NCT02831764|448751521|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
124761063|NCT02831764|448751522|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
124761064|NCT02831764|448751518|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
124761065|NCT02831764|448751519|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
124761066|NCT02831764|448751520|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
124761067|NCT02831764|448751521|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
124761068|NCT02831764|448751522|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
124761069|NCT02831764|448751518|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
124761070|NCT02831764|448751519|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
124761071|NCT02831764|448751520|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
124761072|NCT02831764|448751521|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
124761073|NCT02831764|448751522|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
124761074|NCT04564846|448751523|FG000|Overall Study|Withdrawal by Subject|2|||
124761075|NCT04564846|448751524|FG001|Overall Study|Withdrawal by Subject|1|||
124761076|NCT04564846|448751523|FG000|Overall Study|Physician Decision|0|||
124912435|NCT02723955|449307058|FG034|Expansion Phase|Death|3|||
124912436|NCT02723955|449307059|FG035|Expansion Phase|Death|3|||
124912437|NCT02723955|449307060|FG036|Expansion Phase|Death|1|||
124912438|NCT02723955|449307061|FG037|Expansion Phase|Death|0|||
124912439|NCT02723955|449307062|FG038|Expansion Phase|Death|0|||
124912440|NCT02723955|449307063|FG039|Expansion Phase|Death|0|||
124912441|NCT02723955|449307064|FG040|Expansion Phase|Death|0|||
124912442|NCT02723955|449307065|FG041|Expansion Phase|Death|0|||
124912443|NCT02723955|449307066|FG042|Expansion Phase|Death|0|||
124912444|NCT02723955|449307024|FG000|Expansion Phase|Lost to Follow-up|0|||
124912445|NCT02723955|449307025|FG001|Expansion Phase|Lost to Follow-up|0|||
124912446|NCT02723955|449307026|FG002|Expansion Phase|Lost to Follow-up|0|||
124912447|NCT02723955|449307027|FG003|Expansion Phase|Lost to Follow-up|0|||
124912448|NCT02723955|449307028|FG004|Expansion Phase|Lost to Follow-up|0|||
124912449|NCT02723955|449307029|FG005|Expansion Phase|Lost to Follow-up|0|||
124912450|NCT02723955|449307030|FG006|Expansion Phase|Lost to Follow-up|0|||
124912451|NCT02723955|449307031|FG007|Expansion Phase|Lost to Follow-up|0|||
124912452|NCT02723955|449307032|FG008|Expansion Phase|Lost to Follow-up|0|||
124761077|NCT04564846|448751524|FG001|Overall Study|Physician Decision|1|||
124761078|NCT04564846|448751523|FG000|Overall Study|Lost to Follow-up|0|||
124761079|NCT04564846|448751524|FG001|Overall Study|Lost to Follow-up|1|||
124761080|NCT04564846|448751523|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
124761081|NCT04564846|448751524|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
124761082|NCT04564846|448751523|FG000|Overall Study|Subject non-compliance|1|||
124761083|NCT04564846|448751524|FG001|Overall Study|Subject non-compliance|0|||
124761084|NCT02735239|448751525|FG000|Overall Study|Adverse Event|0|||
124761085|NCT02735239|448751526|FG001|Overall Study|Adverse Event|0|||
124761086|NCT02735239|448751527|FG002|Overall Study|Adverse Event|4|||
124761087|NCT02735239|448751528|FG003|Overall Study|Adverse Event|0|||
124912453|NCT02723955|449307033|FG009|Expansion Phase|Lost to Follow-up|0|||
124912454|NCT02723955|449307034|FG010|Expansion Phase|Lost to Follow-up|4|||
124912455|NCT02723955|449307035|FG011|Expansion Phase|Lost to Follow-up|1|||
124912456|NCT02723955|449307036|FG012|Expansion Phase|Lost to Follow-up|0|||
124912457|NCT02723955|449307037|FG013|Expansion Phase|Lost to Follow-up|0|||
124912458|NCT02723955|449307038|FG014|Expansion Phase|Lost to Follow-up|0|||
124912459|NCT02723955|449307039|FG015|Expansion Phase|Lost to Follow-up|0|||
124912460|NCT02723955|449307040|FG016|Expansion Phase|Lost to Follow-up|0|||
124912461|NCT02723955|449307041|FG017|Expansion Phase|Lost to Follow-up|0|||
124912462|NCT02723955|449307042|FG018|Expansion Phase|Lost to Follow-up|0|||
124912463|NCT02723955|449307043|FG019|Expansion Phase|Lost to Follow-up|0|||
124912464|NCT02723955|449307044|FG020|Expansion Phase|Lost to Follow-up|0|||
124912465|NCT02723955|449307045|FG021|Expansion Phase|Lost to Follow-up|0|||
124912466|NCT02723955|449307046|FG022|Expansion Phase|Lost to Follow-up|0|||
124912467|NCT02723955|449307047|FG023|Expansion Phase|Lost to Follow-up|0|||
124912468|NCT02723955|449307048|FG024|Expansion Phase|Lost to Follow-up|0|||
124912469|NCT02723955|449307049|FG025|Expansion Phase|Lost to Follow-up|0|||
124912470|NCT02723955|449307050|FG026|Expansion Phase|Lost to Follow-up|0|||
124912471|NCT02723955|449307051|FG027|Expansion Phase|Lost to Follow-up|0|||
124912472|NCT02723955|449307052|FG028|Expansion Phase|Lost to Follow-up|0|||
124912473|NCT02723955|449307053|FG029|Expansion Phase|Lost to Follow-up|1|||
124912474|NCT02723955|449307054|FG030|Expansion Phase|Lost to Follow-up|19|||
124912475|NCT02723955|449307055|FG031|Expansion Phase|Lost to Follow-up|2|||
124912476|NCT02723955|449307056|FG032|Expansion Phase|Lost to Follow-up|1|||
124912477|NCT02723955|449307057|FG033|Expansion Phase|Lost to Follow-up|0|||
124912478|NCT02723955|449307058|FG034|Expansion Phase|Lost to Follow-up|0|||
124912479|NCT02723955|449307059|FG035|Expansion Phase|Lost to Follow-up|0|||
124912480|NCT02723955|449307060|FG036|Expansion Phase|Lost to Follow-up|0|||
124912481|NCT02723955|449307061|FG037|Expansion Phase|Lost to Follow-up|0|||
124912482|NCT02723955|449307062|FG038|Expansion Phase|Lost to Follow-up|0|||
124912483|NCT02723955|449307063|FG039|Expansion Phase|Lost to Follow-up|0|||
124912484|NCT02723955|449307064|FG040|Expansion Phase|Lost to Follow-up|0|||
124912485|NCT02723955|449307065|FG041|Expansion Phase|Lost to Follow-up|0|||
124912486|NCT02723955|449307066|FG042|Expansion Phase|Lost to Follow-up|0|||
124912487|NCT02723955|449307024|FG000|Expansion Phase|Physician Decision|0|||
124912488|NCT02723955|449307025|FG001|Expansion Phase|Physician Decision|0|||
124912489|NCT02723955|449307026|FG002|Expansion Phase|Physician Decision|0|||
124912490|NCT02723955|449307027|FG003|Expansion Phase|Physician Decision|0|||
124912491|NCT02723955|449307028|FG004|Expansion Phase|Physician Decision|0|||
124912492|NCT02723955|449307029|FG005|Expansion Phase|Physician Decision|0|||
124912493|NCT02723955|449307030|FG006|Expansion Phase|Physician Decision|0|||
124912494|NCT02723955|449307031|FG007|Expansion Phase|Physician Decision|0|||
124912495|NCT02723955|449307032|FG008|Expansion Phase|Physician Decision|0|||
124912496|NCT02723955|449307033|FG009|Expansion Phase|Physician Decision|0|||
124912497|NCT02723955|449307034|FG010|Expansion Phase|Physician Decision|0|||
124912498|NCT02723955|449307035|FG011|Expansion Phase|Physician Decision|0|||
124912499|NCT02723955|449307036|FG012|Expansion Phase|Physician Decision|0|||
124912500|NCT02723955|449307037|FG013|Expansion Phase|Physician Decision|0|||
124912501|NCT02723955|449307038|FG014|Expansion Phase|Physician Decision|0|||
124912502|NCT02723955|449307039|FG015|Expansion Phase|Physician Decision|0|||
124912503|NCT02723955|449307040|FG016|Expansion Phase|Physician Decision|0|||
124912504|NCT02723955|449307041|FG017|Expansion Phase|Physician Decision|0|||
124912505|NCT02723955|449307042|FG018|Expansion Phase|Physician Decision|0|||
124761088|NCT02735239|448751529|FG004|Overall Study|Adverse Event|0|||
124761089|NCT02735239|448751530|FG005|Overall Study|Adverse Event|0|||
124761090|NCT02735239|448751525|FG000|Overall Study|Death|1|||
124761091|NCT02735239|448751526|FG001|Overall Study|Death|1|||
124761092|NCT02735239|448751527|FG002|Overall Study|Death|0|||
124761093|NCT02735239|448751528|FG003|Overall Study|Death|0|||
124761094|NCT02735239|448751529|FG004|Overall Study|Death|0|||
124761095|NCT02735239|448751530|FG005|Overall Study|Death|0|||
124761096|NCT02735239|448751525|FG000|Overall Study|Physician Decision|0|||
124761097|NCT02735239|448751526|FG001|Overall Study|Physician Decision|0|||
124761098|NCT02735239|448751527|FG002|Overall Study|Physician Decision|1|||
124761099|NCT02735239|448751528|FG003|Overall Study|Physician Decision|0|||
124761100|NCT02735239|448751529|FG004|Overall Study|Physician Decision|0|||
124761101|NCT02735239|448751530|FG005|Overall Study|Physician Decision|0|||
124761102|NCT02735239|448751525|FG000|Overall Study|Progressive disease|3|||
124761103|NCT02735239|448751526|FG001|Overall Study|Progressive disease|1|||
124761104|NCT02735239|448751527|FG002|Overall Study|Progressive disease|3|||
124761105|NCT02735239|448751528|FG003|Overall Study|Progressive disease|0|||
124761106|NCT02735239|448751529|FG004|Overall Study|Progressive disease|0|||
124912506|NCT02723955|449307043|FG019|Expansion Phase|Physician Decision|0|||
124912507|NCT02723955|449307044|FG020|Expansion Phase|Physician Decision|0|||
124912508|NCT02723955|449307045|FG021|Expansion Phase|Physician Decision|0|||
124912509|NCT02723955|449307046|FG022|Expansion Phase|Physician Decision|0|||
124912510|NCT02723955|449307047|FG023|Expansion Phase|Physician Decision|0|||
124912511|NCT02723955|449307048|FG024|Expansion Phase|Physician Decision|0|||
124912512|NCT02723955|449307049|FG025|Expansion Phase|Physician Decision|0|||
124912513|NCT02723955|449307050|FG026|Expansion Phase|Physician Decision|0|||
124761107|NCT02735239|448751530|FG005|Overall Study|Progressive disease|2|||
124761108|NCT02735239|448751525|FG000|Overall Study|Withdrawal by Subject|0|||
124761109|NCT02735239|448751526|FG001|Overall Study|Withdrawal by Subject|1|||
124761110|NCT02735239|448751527|FG002|Overall Study|Withdrawal by Subject|0|||
124761111|NCT02735239|448751528|FG003|Overall Study|Withdrawal by Subject|0|||
124761112|NCT02735239|448751529|FG004|Overall Study|Withdrawal by Subject|0|||
124761113|NCT02735239|448751530|FG005|Overall Study|Withdrawal by Subject|0|||
124761114|NCT02038153|448751533|FG000|Overall Study|Withdrawal by Subject|1|||
124761115|NCT03016312|448751534|FG000|Overall Study|discontinued before the treatment started|0|||
124761116|NCT03016312|448751535|FG001|Overall Study|discontinued before the treatment started|1|||
124761117|NCT03016312|448751534|FG000|Overall Study|Withdrawal by Subject|37|||
124761118|NCT03016312|448751535|FG001|Overall Study|Withdrawal by Subject|44|||
124761119|NCT03016312|448751534|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
124761120|NCT03016312|448751535|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
124761121|NCT03016312|448751534|FG000|Overall Study|Physician Decision|1|||
124761122|NCT03016312|448751535|FG001|Overall Study|Physician Decision|3|||
124761123|NCT03016312|448751534|FG000|Overall Study|Lost to Follow-up|12|||
124761124|NCT03016312|448751535|FG001|Overall Study|Lost to Follow-up|12|||
124761125|NCT03016312|448751534|FG000|Overall Study|Death|210|||
124761126|NCT03016312|448751535|FG001|Overall Study|Death|184|||
124761127|NCT03016312|448751534|FG000|Overall Study|loss to contact|1|||
124761128|NCT03016312|448751535|FG001|Overall Study|loss to contact|0|||
124761129|NCT03016312|448751534|FG000|Overall Study|started a new cancer therapy|1|||
124761130|NCT03016312|448751535|FG001|Overall Study|started a new cancer therapy|0|||
124761131|NCT01050634|448751536|FG000|Overall Study|Enrolled, but Not Treated|56|||
124761132|NCT01050634|448751536|FG000|Overall Study|Death|2|||
124761133|NCT01050634|448751536|FG000|Overall Study|Adverse Event|42|||
124761134|NCT01050634|448751536|FG000|Overall Study|Lost to Follow-up|2|||
124761135|NCT01050634|448751536|FG000|Overall Study|Other|21|||
124761136|NCT01050634|448751536|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
124761137|NCT00496015|448751537|FG000|Overall Study|Other|1|||
124761138|NCT00496015|448751538|FG001|Overall Study|Other|0|||
124761139|NCT00496015|448751539|FG002|Overall Study|Other|0|||
124761140|NCT00496015|448751540|FG003|Overall Study|Other|1|||
124761141|NCT00496015|448751541|FG004|Overall Study|Other|0|||
124761142|NCT00527735|448751542|FG000|Overall Study|Disease progression|47|||
124761143|NCT00527735|448751543|FG001|Overall Study|Disease progression|61|||
124761144|NCT00527735|448751544|FG002|Overall Study|Disease progression|53|||
124761145|NCT00527735|448751542|FG000|Overall Study|Death|23|||
124761146|NCT00527735|448751543|FG001|Overall Study|Death|13|||
124761147|NCT00527735|448751544|FG002|Overall Study|Death|15|||
124761148|NCT00527735|448751542|FG000|Overall Study|Completed treatment in treatment phase|14|||
124761149|NCT00527735|448751543|FG001|Overall Study|Completed treatment in treatment phase|13|||
124761150|NCT00527735|448751544|FG002|Overall Study|Completed treatment in treatment phase|18|||
124761151|NCT00527735|448751542|FG000|Overall Study|Adverse Event|10|||
124761152|NCT00527735|448751543|FG001|Overall Study|Adverse Event|6|||
124761153|NCT00527735|448751544|FG002|Overall Study|Adverse Event|7|||
124761154|NCT00527735|448751542|FG000|Overall Study|Not identified|5|||
124761155|NCT00527735|448751543|FG001|Overall Study|Not identified|5|||
124761156|NCT00527735|448751544|FG002|Overall Study|Not identified|5|||
124761157|NCT00527735|448751542|FG000|Overall Study|Withdrawal by Subject|5|||
124761158|NCT00527735|448751543|FG001|Overall Study|Withdrawal by Subject|4|||
124761159|NCT00527735|448751544|FG002|Overall Study|Withdrawal by Subject|3|||
124761160|NCT00527735|448751542|FG000|Overall Study|No longer met study criteria|2|||
124761161|NCT00527735|448751543|FG001|Overall Study|No longer met study criteria|2|||
124761162|NCT00527735|448751544|FG002|Overall Study|No longer met study criteria|1|||
124761163|NCT00527735|448751542|FG000|Overall Study|Lost to Follow-up|0|||
124761164|NCT00527735|448751543|FG001|Overall Study|Lost to Follow-up|0|||
124761165|NCT00527735|448751544|FG002|Overall Study|Lost to Follow-up|3|||
124761166|NCT00527735|448751542|FG000|Overall Study|Poor compliance or noncompliance|0|||
124761167|NCT00527735|448751543|FG001|Overall Study|Poor compliance or noncompliance|1|||
124761168|NCT00527735|448751544|FG002|Overall Study|Poor compliance or noncompliance|1|||
124761169|NCT00527735|448751542|FG000|Overall Study|Completed treatment during maintenance|2|||
124545214|NCT00299546|447951102|FG001|Overall Study|Not treated|1|||
124761170|NCT00527735|448751543|FG001|Overall Study|Completed treatment during maintenance|2|||
124761171|NCT00527735|448751544|FG002|Overall Study|Completed treatment during maintenance|1|||
124761172|NCT01535807|448751545|FG000|Overall Study|Withdrawal by Subject|1|||
124761173|NCT01535807|448751546|FG001|Overall Study|Withdrawal by Subject|1|||
124761174|NCT01535807|448751545|FG000|Overall Study|Data collection error|1|||
124761175|NCT01535807|448751546|FG001|Overall Study|Data collection error|1|||
124761176|NCT02730728|448751549|FG000|Overall Study|Withdrawal by Subject|0|||
124761177|NCT02730728|448751550|FG001|Overall Study|Withdrawal by Subject|1|||
124912514|NCT02723955|449307051|FG027|Expansion Phase|Physician Decision|0|||
124912515|NCT02723955|449307052|FG028|Expansion Phase|Physician Decision|0|||
124912516|NCT02723955|449307053|FG029|Expansion Phase|Physician Decision|0|||
124912517|NCT02723955|449307054|FG030|Expansion Phase|Physician Decision|1|||
124912518|NCT02723955|449307055|FG031|Expansion Phase|Physician Decision|1|||
124912519|NCT02723955|449307056|FG032|Expansion Phase|Physician Decision|0|||
124693418|NCT00541775|448498715|FG000|Overall Study|Lost to Follow-up|0|||
124693419|NCT00541775|448498716|FG001|Overall Study|Lost to Follow-up|0|||
124693420|NCT00541775|448498717|FG002|Overall Study|Lost to Follow-up|2|||
124693421|NCT00541775|448498715|FG000|Overall Study|Protocol Violation|1|||
124693422|NCT00541775|448498716|FG001|Overall Study|Protocol Violation|0|||
124693423|NCT00541775|448498717|FG002|Overall Study|Protocol Violation|0|||
124693424|NCT00541775|448498715|FG000|Overall Study|Withdrawal by Subject and Other|5|||
124693425|NCT00541775|448498716|FG001|Overall Study|Withdrawal by Subject and Other|0|||
124693426|NCT00541775|448498717|FG002|Overall Study|Withdrawal by Subject and Other|2|||
124693427|NCT00032487|448498718|FG000|Overall Study|Withdrawal by Subject|67|||
124693428|NCT00032487|448498719|FG001|Overall Study|Withdrawal by Subject|43|||
124693429|NCT00032487|448498718|FG000|Overall Study|Adverse Event|3|||
124693430|NCT00032487|448498719|FG001|Overall Study|Adverse Event|7|||
124693431|NCT00032487|448498718|FG000|Overall Study|Lost to Follow-up|57|||
124693432|NCT00032487|448498719|FG001|Overall Study|Lost to Follow-up|58|||
124693433|NCT00032487|448498718|FG000|Overall Study|Had other reason|12|||
124693434|NCT00032487|448498719|FG001|Overall Study|Had other reason|12|||
124693435|NCT02975700|448498720|FG000|Overall Study|Adverse Event|1|||
124693436|NCT02975700|448498720|FG000|Overall Study|Progressive disease|3|||
124693437|NCT02975700|448498720|FG000|Overall Study|Failed screening criteria|2|||
124693438|NCT01541254|448498722|FG000|Overall Study|Withdrawal by Subject|1|||
124693439|NCT01541254|448498722|FG000|Overall Study|excluded - metal allergy|1|||
124693440|NCT01541254|448498722|FG000|Overall Study|enrolled after study closed|1|||
124693441|NCT01541254|448498722|FG000|Overall Study|GI bleed prior to procedure|1|||
124693442|NCT01541254|448498722|FG000|Overall Study|stent not required|1|||
124693443|NCT01541254|448498722|FG000|Overall Study|alternate stent used|1|||
124693444|NCT05660538|448498723|FG000|Overall Study|Adverse Event|0|||
124693445|NCT05660538|448498724|FG001|Overall Study|Adverse Event|0|||
124693446|NCT05660538|448498725|FG002|Overall Study|Adverse Event|1|||
124693447|NCT05660538|448498726|FG003|Overall Study|Adverse Event|0|||
124693448|NCT05660538|448498723|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
124693449|NCT05660538|448498724|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
124693450|NCT05660538|448498725|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
124693451|NCT05660538|448498726|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
124693452|NCT05660538|448498723|FG000|Overall Study|Lost to Follow-up|0|||
124693453|NCT05660538|448498724|FG001|Overall Study|Lost to Follow-up|0|||
124693454|NCT05660538|448498725|FG002|Overall Study|Lost to Follow-up|1|||
124693455|NCT05660538|448498726|FG003|Overall Study|Lost to Follow-up|1|||
124693456|NCT05660538|448498723|FG000|Overall Study|Death|0|||
124693457|NCT05660538|448498724|FG001|Overall Study|Death|0|||
124693458|NCT05660538|448498725|FG002|Overall Study|Death|1|||
124693459|NCT05660538|448498726|FG003|Overall Study|Death|0|||
124693460|NCT05660538|448498723|FG000|Overall Study|Physician Decision|0|||
124693461|NCT05660538|448498724|FG001|Overall Study|Physician Decision|0|||
124693462|NCT05660538|448498725|FG002|Overall Study|Physician Decision|0|||
124693463|NCT05660538|448498726|FG003|Overall Study|Physician Decision|1|||
124693464|NCT05660538|448498723|FG000|Overall Study|Sponsor Decision|1|||
124693465|NCT05660538|448498724|FG001|Overall Study|Sponsor Decision|0|||
124693466|NCT05660538|448498725|FG002|Overall Study|Sponsor Decision|0|||
124693467|NCT05660538|448498726|FG003|Overall Study|Sponsor Decision|0|||
124693468|NCT05660538|448498723|FG000|Overall Study|Other|1|||
124693469|NCT05660538|448498724|FG001|Overall Study|Other|0|||
124693470|NCT05660538|448498725|FG002|Overall Study|Other|0|||
124693471|NCT05660538|448498726|FG003|Overall Study|Other|1|||
124912520|NCT02723955|449307057|FG033|Expansion Phase|Physician Decision|0|||
124912521|NCT02723955|449307058|FG034|Expansion Phase|Physician Decision|0|||
124912522|NCT02723955|449307059|FG035|Expansion Phase|Physician Decision|0|||
124912523|NCT02723955|449307060|FG036|Expansion Phase|Physician Decision|0|||
124912524|NCT02723955|449307061|FG037|Expansion Phase|Physician Decision|0|||
124693472|NCT05660538|448498723|FG000|Overall Study|Randomized but did not receive study drug|1|||
124912525|NCT02723955|449307062|FG038|Expansion Phase|Physician Decision|0|||
124693473|NCT05660538|448498724|FG001|Overall Study|Randomized but did not receive study drug|0|||
124693474|NCT05660538|448498725|FG002|Overall Study|Randomized but did not receive study drug|0|||
124693475|NCT05660538|448498726|FG003|Overall Study|Randomized but did not receive study drug|1|||
124693476|NCT05660538|448498723|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
124693477|NCT05660538|448498724|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
124693478|NCT05660538|448498725|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
124693479|NCT05660538|448498726|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
124912526|NCT02723955|449307063|FG039|Expansion Phase|Physician Decision|0|||
124912527|NCT02723955|449307064|FG040|Expansion Phase|Physician Decision|0|||
124912528|NCT02723955|449307065|FG041|Expansion Phase|Physician Decision|0|||
124912529|NCT02723955|449307066|FG042|Expansion Phase|Physician Decision|0|||
124912530|NCT02723955|449307024|FG000|Expansion Phase|Withdrawal by Subject|0|||
124912531|NCT02723955|449307025|FG001|Expansion Phase|Withdrawal by Subject|0|||
124912532|NCT02723955|449307026|FG002|Expansion Phase|Withdrawal by Subject|0|||
124912533|NCT02723955|449307027|FG003|Expansion Phase|Withdrawal by Subject|0|||
124912534|NCT02723955|449307028|FG004|Expansion Phase|Withdrawal by Subject|0|||
124912535|NCT02723955|449307029|FG005|Expansion Phase|Withdrawal by Subject|0|||
124912536|NCT02723955|449307030|FG006|Expansion Phase|Withdrawal by Subject|0|||
124912537|NCT02723955|449307031|FG007|Expansion Phase|Withdrawal by Subject|0|||
124545215|NCT00299546|447951103|FG002|Overall Study|Not treated|1|||
124545216|NCT03099265|447951104|FG000|Overall Study|Adverse Event|1|||
124545217|NCT02526017|447951105|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
124545218|NCT02526017|447951106|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
124545219|NCT02526017|447951107|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
124545220|NCT02526017|447951108|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
124545221|NCT02526017|447951109|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
124545222|NCT02526017|447951110|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
124545223|NCT02526017|447951111|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
124545224|NCT02526017|447951112|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
124545225|NCT02526017|447951113|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
124545226|NCT02674568|447951117|FG000|Overall Study|Withdrawal by Subject|5|||
124545227|NCT02674568|447951117|FG000|Overall Study|Death|303|||
124545228|NCT02674568|447951117|FG000|Overall Study|Physician Decision|2|||
124545229|NCT02674568|447951117|FG000|Overall Study|Lost to Follow-up|9|||
124545230|NCT02674568|447951117|FG000|Overall Study|Other, Not Specified|20|||
124545231|NCT00396318|447951118|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
124545232|NCT00938392|447951119|FG000|Overall Study|Adverse Event|0|||
124545233|NCT00938392|447951120|FG001|Overall Study|Adverse Event|1|||
124545234|NCT00938392|447951119|FG000|Overall Study|Withdrawal by Subject|0|||
124545235|NCT00938392|447951120|FG001|Overall Study|Withdrawal by Subject|1|||
124545236|NCT00938392|447951119|FG000|Overall Study|Lost to Follow-up|2|||
124545237|NCT00938392|447951120|FG001|Overall Study|Lost to Follow-up|2|||
124545238|NCT00124709|447951121|FG000|Overall Study|Randomized but did not take medication|3|||
124545239|NCT00124709|447951122|FG001|Overall Study|Randomized but did not take medication|1|||
124545240|NCT00124709|447951121|FG000|Overall Study|Adverse Event|3|||
124545241|NCT00124709|447951122|FG001|Overall Study|Adverse Event|0|||
124693480|NCT04518410|448498728|FG000|Overall Study|Lost to Follow-up|1|||
124693481|NCT04518410|448498729|FG001|Overall Study|Lost to Follow-up|1|||
124693482|NCT04518410|448498730|FG002|Overall Study|Lost to Follow-up|8|||
124693483|NCT04518410|448498731|FG003|Overall Study|Lost to Follow-up|5|||
124693484|NCT04518410|448498732|FG004|Overall Study|Lost to Follow-up|92|||
124693485|NCT04518410|448498733|FG005|Overall Study|Lost to Follow-up|25|||
124693486|NCT04518410|448498734|FG006|Overall Study|Lost to Follow-up|25|||
124693487|NCT04518410|448498735|FG007|Overall Study|Lost to Follow-up|3|||
124693488|NCT04518410|448498736|FG008|Overall Study|Lost to Follow-up|2|||
124693489|NCT04518410|448498737|FG009|Overall Study|Lost to Follow-up|13|||
124693490|NCT04518410|448498738|FG010|Overall Study|Lost to Follow-up|9|||
124693491|NCT04518410|448498739|FG011|Overall Study|Lost to Follow-up|13|||
124693492|NCT04518410|448498740|FG012|Overall Study|Lost to Follow-up|9|||
124693493|NCT04518410|448498741|FG013|Overall Study|Lost to Follow-up|13|||
124693494|NCT04518410|448498742|FG014|Overall Study|Lost to Follow-up|8|||
124693495|NCT04518410|448498743|FG015|Overall Study|Lost to Follow-up|10|||
124693496|NCT04518410|448498744|FG016|Overall Study|Lost to Follow-up|6|||
124761178|NCT02730728|448751551|FG002|Overall Study|Withdrawal by Subject|0|||
124912538|NCT02723955|449307032|FG008|Expansion Phase|Withdrawal by Subject|0|||
124912539|NCT02723955|449307033|FG009|Expansion Phase|Withdrawal by Subject|2|||
124912540|NCT02723955|449307034|FG010|Expansion Phase|Withdrawal by Subject|1|||
124545242|NCT00124709|447951121|FG000|Overall Study|Lack of Efficacy|5|||
124545243|NCT00124709|447951122|FG001|Overall Study|Lack of Efficacy|10|||
124545244|NCT00124709|447951121|FG000|Overall Study|Protocol Violation|3|||
124545245|NCT00124709|447951122|FG001|Overall Study|Protocol Violation|5|||
124693497|NCT04518410|448498745|FG017|Overall Study|Lost to Follow-up|13|||
124693498|NCT04518410|448498746|FG018|Overall Study|Lost to Follow-up|21|||
124693499|NCT04518410|448498747|FG019|Overall Study|Lost to Follow-up|6|||
124693500|NCT04518410|448498748|FG020|Overall Study|Lost to Follow-up|7|||
124693501|NCT04518410|448498749|FG021|Overall Study|Lost to Follow-up|21|||
124912541|NCT02723955|449307035|FG011|Expansion Phase|Withdrawal by Subject|0|||
124912542|NCT02723955|449307036|FG012|Expansion Phase|Withdrawal by Subject|0|||
124912543|NCT02723955|449307037|FG013|Expansion Phase|Withdrawal by Subject|0|||
124912544|NCT02723955|449307038|FG014|Expansion Phase|Withdrawal by Subject|0|||
124912545|NCT02723955|449307039|FG015|Expansion Phase|Withdrawal by Subject|0|||
124912546|NCT02723955|449307040|FG016|Expansion Phase|Withdrawal by Subject|0|||
124912547|NCT02723955|449307041|FG017|Expansion Phase|Withdrawal by Subject|0|||
124912548|NCT02723955|449307042|FG018|Expansion Phase|Withdrawal by Subject|0|||
124912549|NCT02723955|449307043|FG019|Expansion Phase|Withdrawal by Subject|0|||
124912550|NCT02723955|449307044|FG020|Expansion Phase|Withdrawal by Subject|0|||
124912551|NCT02723955|449307045|FG021|Expansion Phase|Withdrawal by Subject|0|||
124912552|NCT02723955|449307046|FG022|Expansion Phase|Withdrawal by Subject|0|||
124912553|NCT02723955|449307047|FG023|Expansion Phase|Withdrawal by Subject|0|||
124912554|NCT02723955|449307048|FG024|Expansion Phase|Withdrawal by Subject|0|||
124912555|NCT02723955|449307049|FG025|Expansion Phase|Withdrawal by Subject|0|||
124912556|NCT02723955|449307050|FG026|Expansion Phase|Withdrawal by Subject|0|||
124912557|NCT02723955|449307051|FG027|Expansion Phase|Withdrawal by Subject|0|||
124912558|NCT02723955|449307052|FG028|Expansion Phase|Withdrawal by Subject|0|||
124912559|NCT02723955|449307053|FG029|Expansion Phase|Withdrawal by Subject|0|||
124912560|NCT02723955|449307054|FG030|Expansion Phase|Withdrawal by Subject|8|||
124912561|NCT02723955|449307055|FG031|Expansion Phase|Withdrawal by Subject|4|||
124912562|NCT02723955|449307056|FG032|Expansion Phase|Withdrawal by Subject|0|||
124912563|NCT02723955|449307057|FG033|Expansion Phase|Withdrawal by Subject|0|||
124912564|NCT02723955|449307058|FG034|Expansion Phase|Withdrawal by Subject|0|||
124912565|NCT02723955|449307059|FG035|Expansion Phase|Withdrawal by Subject|1|||
124912566|NCT02723955|449307060|FG036|Expansion Phase|Withdrawal by Subject|0|||
124912567|NCT02723955|449307061|FG037|Expansion Phase|Withdrawal by Subject|0|||
124912568|NCT02723955|449307062|FG038|Expansion Phase|Withdrawal by Subject|0|||
124912569|NCT02723955|449307063|FG039|Expansion Phase|Withdrawal by Subject|0|||
124912570|NCT02723955|449307064|FG040|Expansion Phase|Withdrawal by Subject|0|||
124912571|NCT02723955|449307065|FG041|Expansion Phase|Withdrawal by Subject|0|||
124912572|NCT02723955|449307066|FG042|Expansion Phase|Withdrawal by Subject|0|||
124912573|NCT02723955|449307024|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912574|NCT02723955|449307025|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912575|NCT02723955|449307026|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912576|NCT02723955|449307027|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912577|NCT02723955|449307028|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912578|NCT02723955|449307029|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912579|NCT02723955|449307030|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912580|NCT02723955|449307031|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912581|NCT02723955|449307032|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912582|NCT02723955|449307033|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
124912583|NCT02723955|449307034|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
124912584|NCT02723955|449307035|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
124912585|NCT02723955|449307036|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912586|NCT02723955|449307037|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912587|NCT02723955|449307038|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912588|NCT02723955|449307039|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912589|NCT02723955|449307040|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912590|NCT02723955|449307041|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912591|NCT02723955|449307042|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912592|NCT02723955|449307043|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912593|NCT02723955|449307044|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912594|NCT02723955|449307045|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912595|NCT02723955|449307046|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912596|NCT02723955|449307047|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912597|NCT02723955|449307048|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912598|NCT02723955|449307049|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912599|NCT02723955|449307050|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912600|NCT02723955|449307051|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912601|NCT02723955|449307052|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912602|NCT02723955|449307053|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912603|NCT02723955|449307054|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
124912604|NCT02723955|449307055|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912605|NCT02723955|449307056|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912606|NCT02723955|449307057|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912607|NCT02723955|449307058|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124693502|NCT04518410|448498750|FG022|Overall Study|Lost to Follow-up|1|||
124693503|NCT04518410|448498751|FG023|Overall Study|Lost to Follow-up|7|||
124693504|NCT04518410|448498752|FG024|Overall Study|Lost to Follow-up|6|||
124693505|NCT04518410|448498728|FG000|Overall Study|Withdrawal by Subject|1|||
124693506|NCT04518410|448498729|FG001|Overall Study|Withdrawal by Subject|2|||
124693507|NCT04518410|448498730|FG002|Overall Study|Withdrawal by Subject|2|||
124693508|NCT04518410|448498731|FG003|Overall Study|Withdrawal by Subject|3|||
124693509|NCT04518410|448498732|FG004|Overall Study|Withdrawal by Subject|20|||
124693510|NCT04518410|448498733|FG005|Overall Study|Withdrawal by Subject|20|||
124693511|NCT04518410|448498734|FG006|Overall Study|Withdrawal by Subject|25|||
124693512|NCT04518410|448498735|FG007|Overall Study|Withdrawal by Subject|6|||
124693513|NCT04518410|448498736|FG008|Overall Study|Withdrawal by Subject|1|||
124693514|NCT04518410|448498737|FG009|Overall Study|Withdrawal by Subject|12|||
124693515|NCT04518410|448498738|FG010|Overall Study|Withdrawal by Subject|5|||
124693516|NCT04518410|448498739|FG011|Overall Study|Withdrawal by Subject|7|||
124693517|NCT04518410|448498740|FG012|Overall Study|Withdrawal by Subject|2|||
124693518|NCT04518410|448498741|FG013|Overall Study|Withdrawal by Subject|13|||
124693519|NCT04518410|448498742|FG014|Overall Study|Withdrawal by Subject|4|||
124693520|NCT04518410|448498743|FG015|Overall Study|Withdrawal by Subject|9|||
124693521|NCT04518410|448498744|FG016|Overall Study|Withdrawal by Subject|0|||
124693522|NCT04518410|448498745|FG017|Overall Study|Withdrawal by Subject|15|||
124693523|NCT04518410|448498746|FG018|Overall Study|Withdrawal by Subject|12|||
124693524|NCT04518410|448498747|FG019|Overall Study|Withdrawal by Subject|9|||
124693525|NCT04518410|448498748|FG020|Overall Study|Withdrawal by Subject|14|||
124693526|NCT04518410|448498749|FG021|Overall Study|Withdrawal by Subject|3|||
124545246|NCT00124709|447951121|FG000|Overall Study|Withdrawal by Subject|127|||
124545247|NCT00124709|447951122|FG001|Overall Study|Withdrawal by Subject|136|||
124545248|NCT00124709|447951121|FG000|Overall Study|Lost to Follow-up|114|||
124545249|NCT00124709|447951122|FG001|Overall Study|Lost to Follow-up|120|||
124545250|NCT01728376|447951123|FG000|Overall Study|Adverse Event|1|||
124693527|NCT04518410|448498750|FG022|Overall Study|Withdrawal by Subject|2|||
124761179|NCT02730728|448751549|FG000|Overall Study|Lack of Efficacy|0|||
124761180|NCT02730728|448751550|FG001|Overall Study|Lack of Efficacy|1|||
124761181|NCT02730728|448751551|FG002|Overall Study|Lack of Efficacy|1|||
124761182|NCT01855412|448751552|FG000|Overall Study|Death|77|||
124761183|NCT01855412|448751553|FG001|Overall Study|Death|123|||
124761184|NCT01855412|448751554|FG002|Overall Study|Death|30|||
124912608|NCT02723955|449307059|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912609|NCT02723955|449307060|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912610|NCT02723955|449307061|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912611|NCT02723955|449307062|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912612|NCT02723955|449307063|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912613|NCT02723955|449307064|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912614|NCT02723955|449307065|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912615|NCT02723955|449307066|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
124912616|NCT02723955|449307024|FG000|Expansion Phase|Site Closed|0|||
124912617|NCT02723955|449307025|FG001|Expansion Phase|Site Closed|0|||
124912618|NCT02723955|449307026|FG002|Expansion Phase|Site Closed|0|||
124912619|NCT02723955|449307027|FG003|Expansion Phase|Site Closed|0|||
124912620|NCT02723955|449307028|FG004|Expansion Phase|Site Closed|0|||
124912621|NCT02723955|449307029|FG005|Expansion Phase|Site Closed|0|||
124912622|NCT02723955|449307030|FG006|Expansion Phase|Site Closed|0|||
124912623|NCT02723955|449307031|FG007|Expansion Phase|Site Closed|0|||
124912624|NCT02723955|449307032|FG008|Expansion Phase|Site Closed|0|||
124912625|NCT02723955|449307033|FG009|Expansion Phase|Site Closed|1|||
124912626|NCT02723955|449307034|FG010|Expansion Phase|Site Closed|2|||
124912627|NCT02723955|449307035|FG011|Expansion Phase|Site Closed|6|||
124545251|NCT01728376|447951124|FG001|Overall Study|Adverse Event|1|||
124912628|NCT02723955|449307036|FG012|Expansion Phase|Site Closed|0|||
124912629|NCT02723955|449307037|FG013|Expansion Phase|Site Closed|0|||
124912630|NCT02723955|449307038|FG014|Expansion Phase|Site Closed|0|||
124545252|NCT01728376|447951125|FG002|Overall Study|Adverse Event|1|||
124545253|NCT01728376|447951126|FG003|Overall Study|Adverse Event|1|||
124545254|NCT01728376|447951127|FG004|Overall Study|Adverse Event|1|||
124545255|NCT01728376|447951128|FG005|Overall Study|Adverse Event|0|||
124545256|NCT01728376|447951123|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
124693528|NCT04518410|448498751|FG023|Overall Study|Withdrawal by Subject|9|||
124693529|NCT04518410|448498752|FG024|Overall Study|Withdrawal by Subject|8|||
124693530|NCT04518410|448498728|FG000|Overall Study|Other|1|||
124761185|NCT01855412|448751552|FG000|Overall Study|Lost to Follow-up|28|||
124912631|NCT02723955|449307039|FG015|Expansion Phase|Site Closed|0|||
124912632|NCT02723955|449307040|FG016|Expansion Phase|Site Closed|0|||
124912633|NCT02723955|449307041|FG017|Expansion Phase|Site Closed|0|||
124912634|NCT02723955|449307042|FG018|Expansion Phase|Site Closed|0|||
124912635|NCT02723955|449307043|FG019|Expansion Phase|Site Closed|0|||
124693531|NCT04518410|448498729|FG001|Overall Study|Other|0|||
124693532|NCT04518410|448498730|FG002|Overall Study|Other|0|||
124693533|NCT04518410|448498731|FG003|Overall Study|Other|1|||
124912636|NCT02723955|449307044|FG020|Expansion Phase|Site Closed|0|||
124912637|NCT02723955|449307045|FG021|Expansion Phase|Site Closed|0|||
124912638|NCT02723955|449307046|FG022|Expansion Phase|Site Closed|0|||
124912639|NCT02723955|449307047|FG023|Expansion Phase|Site Closed|0|||
124912640|NCT02723955|449307048|FG024|Expansion Phase|Site Closed|0|||
124912641|NCT02723955|449307049|FG025|Expansion Phase|Site Closed|0|||
124912642|NCT02723955|449307050|FG026|Expansion Phase|Site Closed|0|||
124912643|NCT02723955|449307051|FG027|Expansion Phase|Site Closed|0|||
124912644|NCT02723955|449307052|FG028|Expansion Phase|Site Closed|0|||
124912645|NCT02723955|449307053|FG029|Expansion Phase|Site Closed|0|||
124912646|NCT02723955|449307054|FG030|Expansion Phase|Site Closed|8|||
124912647|NCT02723955|449307055|FG031|Expansion Phase|Site Closed|4|||
124912648|NCT02723955|449307056|FG032|Expansion Phase|Site Closed|2|||
124912649|NCT02723955|449307057|FG033|Expansion Phase|Site Closed|2|||
124912650|NCT02723955|449307058|FG034|Expansion Phase|Site Closed|0|||
124912651|NCT02723955|449307059|FG035|Expansion Phase|Site Closed|0|||
124912652|NCT02723955|449307060|FG036|Expansion Phase|Site Closed|0|||
124912653|NCT02723955|449307061|FG037|Expansion Phase|Site Closed|0|||
124912654|NCT02723955|449307062|FG038|Expansion Phase|Site Closed|0|||
124912655|NCT02723955|449307063|FG039|Expansion Phase|Site Closed|0|||
124912656|NCT02723955|449307064|FG040|Expansion Phase|Site Closed|0|||
124912657|NCT02723955|449307065|FG041|Expansion Phase|Site Closed|0|||
124912658|NCT02723955|449307066|FG042|Expansion Phase|Site Closed|0|||
124912659|NCT02723955|449307024|FG000|Crossover/ Re-treatment Phase|Death|0|||
124912660|NCT02723955|449307025|FG001|Crossover/ Re-treatment Phase|Death|0|||
124912661|NCT02723955|449307026|FG002|Crossover/ Re-treatment Phase|Death|0|||
124912662|NCT02723955|449307027|FG003|Crossover/ Re-treatment Phase|Death|0|||
124912663|NCT02723955|449307028|FG004|Crossover/ Re-treatment Phase|Death|0|||
124912664|NCT02723955|449307029|FG005|Crossover/ Re-treatment Phase|Death|0|||
124912665|NCT02723955|449307030|FG006|Crossover/ Re-treatment Phase|Death|0|||
124912666|NCT02723955|449307031|FG007|Crossover/ Re-treatment Phase|Death|0|||
124912667|NCT02723955|449307032|FG008|Crossover/ Re-treatment Phase|Death|0|||
124912668|NCT02723955|449307033|FG009|Crossover/ Re-treatment Phase|Death|0|||
124912669|NCT02723955|449307034|FG010|Crossover/ Re-treatment Phase|Death|0|||
124912670|NCT02723955|449307035|FG011|Crossover/ Re-treatment Phase|Death|0|||
124912671|NCT02723955|449307036|FG012|Crossover/ Re-treatment Phase|Death|0|||
124912672|NCT02723955|449307037|FG013|Crossover/ Re-treatment Phase|Death|0|||
124912673|NCT02723955|449307038|FG014|Crossover/ Re-treatment Phase|Death|0|||
124912674|NCT02723955|449307039|FG015|Crossover/ Re-treatment Phase|Death|0|||
124693534|NCT04518410|448498732|FG004|Overall Study|Other|6|||
124693535|NCT04518410|448498733|FG005|Overall Study|Other|6|||
124693536|NCT04518410|448498734|FG006|Overall Study|Other|5|||
124693537|NCT04518410|448498735|FG007|Overall Study|Other|2|||
124693538|NCT04518410|448498736|FG008|Overall Study|Other|0|||
124693539|NCT04518410|448498737|FG009|Overall Study|Other|1|||
124693540|NCT04518410|448498738|FG010|Overall Study|Other|0|||
124693541|NCT04518410|448498739|FG011|Overall Study|Other|2|||
124693542|NCT04518410|448498740|FG012|Overall Study|Other|0|||
124693543|NCT04518410|448498741|FG013|Overall Study|Other|0|||
124693544|NCT04518410|448498742|FG014|Overall Study|Other|0|||
124693545|NCT04518410|448498743|FG015|Overall Study|Other|3|||
124693546|NCT04518410|448498744|FG016|Overall Study|Other|1|||
124693547|NCT04518410|448498745|FG017|Overall Study|Other|1|||
124693548|NCT04518410|448498746|FG018|Overall Study|Other|1|||
124693549|NCT04518410|448498747|FG019|Overall Study|Other|0|||
124693550|NCT04518410|448498748|FG020|Overall Study|Other|1|||
124693551|NCT04518410|448498749|FG021|Overall Study|Other|0|||
124693552|NCT04518410|448498750|FG022|Overall Study|Other|1|||
124693553|NCT04518410|448498751|FG023|Overall Study|Other|2|||
124693554|NCT04518410|448498752|FG024|Overall Study|Other|2|||
124693555|NCT04518410|448498728|FG000|Overall Study|Protocol Violation|0|||
124693556|NCT04518410|448498729|FG001|Overall Study|Protocol Violation|0|||
124912675|NCT02723955|449307040|FG016|Crossover/ Re-treatment Phase|Death|0|||
124912676|NCT02723955|449307041|FG017|Crossover/ Re-treatment Phase|Death|0|||
124693557|NCT04518410|448498730|FG002|Overall Study|Protocol Violation|0|||
124693558|NCT04518410|448498731|FG003|Overall Study|Protocol Violation|2|||
124912677|NCT02723955|449307042|FG018|Crossover/ Re-treatment Phase|Death|0|||
124912678|NCT02723955|449307043|FG019|Crossover/ Re-treatment Phase|Death|0|||
124912679|NCT02723955|449307044|FG020|Crossover/ Re-treatment Phase|Death|0|||
124912680|NCT02723955|449307045|FG021|Crossover/ Re-treatment Phase|Death|0|||
124912681|NCT02723955|449307046|FG022|Crossover/ Re-treatment Phase|Death|0|||
124912682|NCT02723955|449307047|FG023|Crossover/ Re-treatment Phase|Death|0|||
124912683|NCT02723955|449307048|FG024|Crossover/ Re-treatment Phase|Death|0|||
124693559|NCT04518410|448498732|FG004|Overall Study|Protocol Violation|17|||
124693560|NCT04518410|448498733|FG005|Overall Study|Protocol Violation|1|||
124693561|NCT04518410|448498734|FG006|Overall Study|Protocol Violation|2|||
124693562|NCT04518410|448498735|FG007|Overall Study|Protocol Violation|1|||
124693563|NCT04518410|448498736|FG008|Overall Study|Protocol Violation|0|||
124693564|NCT04518410|448498737|FG009|Overall Study|Protocol Violation|0|||
124693565|NCT04518410|448498738|FG010|Overall Study|Protocol Violation|0|||
124693566|NCT04518410|448498739|FG011|Overall Study|Protocol Violation|0|||
124693567|NCT04518410|448498740|FG012|Overall Study|Protocol Violation|0|||
124693568|NCT04518410|448498741|FG013|Overall Study|Protocol Violation|0|||
124693569|NCT04518410|448498742|FG014|Overall Study|Protocol Violation|0|||
124693570|NCT04518410|448498743|FG015|Overall Study|Protocol Violation|0|||
124912684|NCT02723955|449307049|FG025|Crossover/ Re-treatment Phase|Death|0|||
124912685|NCT02723955|449307050|FG026|Crossover/ Re-treatment Phase|Death|0|||
124912686|NCT02723955|449307051|FG027|Crossover/ Re-treatment Phase|Death|0|||
124912687|NCT02723955|449307052|FG028|Crossover/ Re-treatment Phase|Death|0|||
124912688|NCT02723955|449307053|FG029|Crossover/ Re-treatment Phase|Death|0|||
124912689|NCT02723955|449307054|FG030|Crossover/ Re-treatment Phase|Death|0|||
124912690|NCT02723955|449307055|FG031|Crossover/ Re-treatment Phase|Death|0|||
124912691|NCT02723955|449307056|FG032|Crossover/ Re-treatment Phase|Death|0|||
124912692|NCT02723955|449307057|FG033|Crossover/ Re-treatment Phase|Death|0|||
124912693|NCT02723955|449307058|FG034|Crossover/ Re-treatment Phase|Death|0|||
124912694|NCT02723955|449307059|FG035|Crossover/ Re-treatment Phase|Death|0|||
124912695|NCT02723955|449307060|FG036|Crossover/ Re-treatment Phase|Death|0|||
124912696|NCT02723955|449307061|FG037|Crossover/ Re-treatment Phase|Death|1|||
124912697|NCT02723955|449307062|FG038|Crossover/ Re-treatment Phase|Death|14|||
124912698|NCT02723955|449307063|FG039|Crossover/ Re-treatment Phase|Death|32|||
124912699|NCT02723955|449307064|FG040|Crossover/ Re-treatment Phase|Death|2|||
124912700|NCT02723955|449307065|FG041|Crossover/ Re-treatment Phase|Death|1|||
124912701|NCT02723955|449307066|FG042|Crossover/ Re-treatment Phase|Death|0|||
124912702|NCT02723955|449307024|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912703|NCT02723955|449307025|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912704|NCT02723955|449307026|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912705|NCT02723955|449307027|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912706|NCT02723955|449307028|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912707|NCT02723955|449307029|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912708|NCT02723955|449307030|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912709|NCT02723955|449307031|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912710|NCT02723955|449307032|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912711|NCT02723955|449307033|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912712|NCT02723955|449307034|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912713|NCT02723955|449307035|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912714|NCT02723955|449307036|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912715|NCT02723955|449307037|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912716|NCT02723955|449307038|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912717|NCT02723955|449307039|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912718|NCT02723955|449307040|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124693571|NCT04518410|448498744|FG016|Overall Study|Protocol Violation|1|||
124693572|NCT04518410|448498745|FG017|Overall Study|Protocol Violation|1|||
124693573|NCT04518410|448498746|FG018|Overall Study|Protocol Violation|0|||
124693574|NCT04518410|448498747|FG019|Overall Study|Protocol Violation|0|||
124693575|NCT04518410|448498748|FG020|Overall Study|Protocol Violation|1|||
124912719|NCT02723955|449307041|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912720|NCT02723955|449307042|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912721|NCT02723955|449307043|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912722|NCT02723955|449307044|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912723|NCT02723955|449307045|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124693576|NCT04518410|448498749|FG021|Overall Study|Protocol Violation|2|||
124693577|NCT04518410|448498750|FG022|Overall Study|Protocol Violation|0|||
124912724|NCT02723955|449307046|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912725|NCT02723955|449307047|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912726|NCT02723955|449307048|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912727|NCT02723955|449307049|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912728|NCT02723955|449307050|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912729|NCT02723955|449307051|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912730|NCT02723955|449307052|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912731|NCT02723955|449307053|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124693578|NCT04518410|448498751|FG023|Overall Study|Protocol Violation|3|||
124912732|NCT02723955|449307054|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912733|NCT02723955|449307055|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912734|NCT02723955|449307056|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912735|NCT02723955|449307057|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124693579|NCT04518410|448498752|FG024|Overall Study|Protocol Violation|0|||
124693580|NCT04518410|448498728|FG000|Overall Study|Death|0|||
124693581|NCT04518410|448498729|FG001|Overall Study|Death|0|||
124693582|NCT04518410|448498730|FG002|Overall Study|Death|0|||
124693583|NCT04518410|448498731|FG003|Overall Study|Death|0|||
124912736|NCT02723955|449307058|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912737|NCT02723955|449307059|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912738|NCT02723955|449307060|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912739|NCT02723955|449307061|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912740|NCT02723955|449307062|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912741|NCT02723955|449307063|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
124912742|NCT02723955|449307064|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912743|NCT02723955|449307065|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912744|NCT02723955|449307066|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
124912745|NCT02723955|449307024|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912746|NCT02723955|449307025|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912747|NCT02723955|449307026|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912748|NCT02723955|449307027|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912749|NCT02723955|449307028|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912750|NCT02723955|449307029|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912751|NCT02723955|449307030|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912752|NCT02723955|449307031|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912753|NCT02723955|449307032|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912754|NCT02723955|449307033|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912755|NCT02723955|449307034|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912756|NCT02723955|449307035|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912757|NCT02723955|449307036|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912758|NCT02723955|449307037|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912759|NCT02723955|449307038|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912760|NCT02723955|449307039|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912761|NCT02723955|449307040|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912762|NCT02723955|449307041|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912763|NCT02723955|449307042|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912764|NCT02723955|449307043|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912765|NCT02723955|449307044|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912766|NCT02723955|449307045|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912767|NCT02723955|449307046|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912768|NCT02723955|449307047|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912769|NCT02723955|449307048|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912770|NCT02723955|449307049|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912771|NCT02723955|449307050|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912772|NCT02723955|449307051|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912773|NCT02723955|449307052|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912774|NCT02723955|449307053|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912775|NCT02723955|449307054|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912776|NCT02723955|449307055|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912777|NCT02723955|449307056|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912778|NCT02723955|449307057|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912779|NCT02723955|449307058|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912780|NCT02723955|449307059|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912781|NCT02723955|449307060|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912782|NCT02723955|449307061|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912783|NCT02723955|449307062|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
124912784|NCT02723955|449307063|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
124912785|NCT02723955|449307064|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912786|NCT02723955|449307065|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
124912787|NCT02723955|449307066|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
124912788|NCT02723955|449307024|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
124693584|NCT04518410|448498732|FG004|Overall Study|Death|12|||
124693585|NCT04518410|448498733|FG005|Overall Study|Death|2|||
124693586|NCT04518410|448498734|FG006|Overall Study|Death|11|||
124693587|NCT04518410|448498735|FG007|Overall Study|Death|0|||
124693588|NCT04518410|448498736|FG008|Overall Study|Death|1|||
124912789|NCT02723955|449307025|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
124693589|NCT04518410|448498737|FG009|Overall Study|Death|0|||
124912790|NCT02723955|449307026|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
124912791|NCT02723955|449307027|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
124912792|NCT02723955|449307028|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
124912793|NCT02723955|449307029|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
124693590|NCT04518410|448498738|FG010|Overall Study|Death|0|||
124912794|NCT02723955|449307030|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
124693591|NCT04518410|448498739|FG011|Overall Study|Death|0|||
124693592|NCT04518410|448498740|FG012|Overall Study|Death|0|||
124545257|NCT01728376|447951124|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
124912795|NCT02723955|449307031|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
124693593|NCT04518410|448498741|FG013|Overall Study|Death|1|||
124693594|NCT04518410|448498742|FG014|Overall Study|Death|1|||
124693595|NCT04518410|448498743|FG015|Overall Study|Death|0|||
124693596|NCT04518410|448498744|FG016|Overall Study|Death|0|||
124693597|NCT04518410|448498745|FG017|Overall Study|Death|1|||
124693598|NCT04518410|448498746|FG018|Overall Study|Death|4|||
124693599|NCT04518410|448498747|FG019|Overall Study|Death|4|||
124693600|NCT04518410|448498748|FG020|Overall Study|Death|1|||
124693601|NCT04518410|448498749|FG021|Overall Study|Death|0|||
124693602|NCT04518410|448498750|FG022|Overall Study|Death|0|||
124693603|NCT04518410|448498751|FG023|Overall Study|Death|0|||
124693604|NCT04518410|448498752|FG024|Overall Study|Death|0|||
124693605|NCT04518410|448498728|FG000|Overall Study|Requirement to start alternative therapy|0|||
124693606|NCT04518410|448498729|FG001|Overall Study|Requirement to start alternative therapy|0|||
124693607|NCT04518410|448498730|FG002|Overall Study|Requirement to start alternative therapy|1|||
124693608|NCT04518410|448498731|FG003|Overall Study|Requirement to start alternative therapy|0|||
124693609|NCT04518410|448498732|FG004|Overall Study|Requirement to start alternative therapy|0|||
124693610|NCT04518410|448498733|FG005|Overall Study|Requirement to start alternative therapy|0|||
124693611|NCT04518410|448498734|FG006|Overall Study|Requirement to start alternative therapy|0|||
124693612|NCT04518410|448498735|FG007|Overall Study|Requirement to start alternative therapy|0|||
124912796|NCT02723955|449307032|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
124912797|NCT02723955|449307033|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
124912798|NCT02723955|449307034|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
124912799|NCT02723955|449307035|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
124912800|NCT02723955|449307036|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
124912801|NCT02723955|449307037|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
124912802|NCT02723955|449307038|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
124912803|NCT02723955|449307039|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
124912804|NCT02723955|449307040|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
124912805|NCT02723955|449307041|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
124912806|NCT02723955|449307042|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
124912807|NCT02723955|449307043|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
124912808|NCT02723955|449307044|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
124912809|NCT02723955|449307045|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
124912810|NCT02723955|449307046|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
124912811|NCT02723955|449307047|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
124912812|NCT02723955|449307048|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
124912813|NCT02723955|449307049|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
124912814|NCT02723955|449307050|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
124912815|NCT02723955|449307051|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
124912816|NCT02723955|449307052|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
124912817|NCT02723955|449307053|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
124912818|NCT02723955|449307054|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
124912819|NCT02723955|449307055|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
124912820|NCT02723955|449307056|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
124912821|NCT02723955|449307057|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
124912822|NCT02723955|449307058|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
124912823|NCT02723955|449307059|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
124912824|NCT02723955|449307060|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
124912825|NCT02723955|449307061|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
124912826|NCT02723955|449307062|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
124912827|NCT02723955|449307063|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
124693613|NCT04518410|448498736|FG008|Overall Study|Requirement to start alternative therapy|0|||
124693614|NCT04518410|448498737|FG009|Overall Study|Requirement to start alternative therapy|0|||
124693615|NCT04518410|448498738|FG010|Overall Study|Requirement to start alternative therapy|0|||
124693616|NCT04518410|448498739|FG011|Overall Study|Requirement to start alternative therapy|0|||
124912828|NCT02723955|449307064|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
124912829|NCT02723955|449307065|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
124912830|NCT02723955|449307066|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
124912831|NCT04300647|449307067|FG000|Pre-Crossover|Death|19|||
124912832|NCT04300647|449307068|FG001|Pre-Crossover|Death|58|||
124912833|NCT04300647|449307069|FG002|Pre-Crossover|Death|0|||
124912834|NCT04300647|449307067|FG000|Pre-Crossover|Lost to Follow-up|0|||
124912835|NCT04300647|449307068|FG001|Pre-Crossover|Lost to Follow-up|3|||
124912836|NCT04300647|449307069|FG002|Pre-Crossover|Lost to Follow-up|0|||
124912837|NCT04300647|449307067|FG000|Pre-Crossover|Withdrawal by Subject|2|||
124912838|NCT04300647|449307068|FG001|Pre-Crossover|Withdrawal by Subject|4|||
124912839|NCT04300647|449307069|FG002|Pre-Crossover|Withdrawal by Subject|0|||
124693617|NCT04518410|448498740|FG012|Overall Study|Requirement to start alternative therapy|0|||
124693618|NCT04518410|448498741|FG013|Overall Study|Requirement to start alternative therapy|0|||
124693619|NCT04518410|448498742|FG014|Overall Study|Requirement to start alternative therapy|0|||
124693620|NCT04518410|448498743|FG015|Overall Study|Requirement to start alternative therapy|0|||
124912840|NCT04300647|449307067|FG000|Pre-Crossover|On-going in Study|24|||
124912841|NCT04300647|449307068|FG001|Pre-Crossover|On-going in Study|61|||
124912842|NCT04300647|449307069|FG002|Pre-Crossover|On-going in Study|0|||
124545258|NCT01728376|447951125|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
124912843|NCT04300647|449307067|FG000|Post-Crossover|Death|0|||
124912844|NCT04300647|449307068|FG001|Post-Crossover|Death|0|||
124912845|NCT04300647|449307069|FG002|Post-Crossover|Death|3|||
124912846|NCT04300647|449307067|FG000|Post-Crossover|Lost to Follow-up|0|||
124912847|NCT04300647|449307068|FG001|Post-Crossover|Lost to Follow-up|0|||
124912848|NCT04300647|449307069|FG002|Post-Crossover|Lost to Follow-up|1|||
124912849|NCT04300647|449307067|FG000|Post-Crossover|Withdrawal by Subject|0|||
124912850|NCT04300647|449307068|FG001|Post-Crossover|Withdrawal by Subject|0|||
124912851|NCT04300647|449307069|FG002|Post-Crossover|Withdrawal by Subject|1|||
124912852|NCT04300647|449307067|FG000|Post-Crossover|On-going in Study|0|||
124912853|NCT04300647|449307068|FG001|Post-Crossover|On-going in Study|0|||
124912854|NCT04300647|449307069|FG002|Post-Crossover|On-going in Study|8|||
124912855|NCT02824029|449307072|FG000|Overall Study|Didn't receive treatment|2|||
124912856|NCT02824029|449307072|FG000|Overall Study|Patient decision to discontinue treatment|3|||
124912857|NCT02824029|449307072|FG000|Overall Study|Non-compliant|5|||
124912858|NCT02824029|449307072|FG000|Overall Study|Progression of disease|15|||
124912859|NCT02824029|449307072|FG000|Overall Study|Inadequate response to therapy|2|||
124912860|NCT02824029|449307072|FG000|Overall Study|Possible progression per treating physician|1|||
124912861|NCT01693120|449307077|FG000|Enrollment|Lost to Follow-up|1|||
124912862|NCT01693120|449307077|FG000|Enrollment|Withdrawal by Subject|10|||
124912863|NCT01693120|449307077|FG000|Enrollment|Protocol Violation|46|||
124912864|NCT01693120|449307077|FG000|Enrollment|Physician Decision|3|||
124912865|NCT01693120|449307077|FG000|Enrollment|Adverse Event|1|||
124912866|NCT01693120|449307077|FG000|Enrollment|Study closed|8|||
124912867|NCT01693120|449307077|FG000|Enrollment|Other|1|||
124912868|NCT01693120|449307077|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
124912869|NCT01693120|449307077|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
124912870|NCT01693120|449307077|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
124912871|NCT01693120|449307077|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
124912872|NCT01693120|449307077|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
124912873|NCT04153565|449307078|FG000|Overall Study|Death|13|||
124912874|NCT03990649|449307092|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
124912875|NCT03990649|449307093|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
124912876|NCT03990649|449307094|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
124912877|NCT03990649|449307092|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
124912878|NCT03990649|449307093|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
124912879|NCT03990649|449307094|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
124912880|NCT03990649|449307092|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
124912881|NCT03990649|449307093|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
124912882|NCT03990649|449307094|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
124912883|NCT03990649|449307092|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
124912884|NCT03990649|449307093|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
124912885|NCT03990649|449307094|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
124912886|NCT03990649|449307092|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
124912887|NCT03990649|449307093|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
124912888|NCT03990649|449307094|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
124912889|NCT03990649|449307092|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
124912890|NCT03990649|449307093|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
124912891|NCT03990649|449307094|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
124912892|NCT03990649|449307092|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
124912893|NCT03990649|449307093|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
124912894|NCT03990649|449307094|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
124912895|NCT00505934|449307095|FG000|Overall Study|Adverse Event|1|||
124912896|NCT00505934|449307095|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
124912897|NCT00505934|449307095|FG000|Overall Study|Other: IV dose needed to be changed|1|||
124912898|NCT03050814|449307098|FG000|Overall Study|Screen failures|0|||
124912899|NCT03050814|449307099|FG001|Overall Study|Screen failures|0|||
124912900|NCT03050814|449307100|FG002|Overall Study|Screen failures|4|||
124912901|NCT01443845|449307101|FG000|Overall Study|Protocol Violation|43|||
124912902|NCT01443845|449307102|FG001|Overall Study|Protocol Violation|45|||
124912903|NCT01443845|449307101|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
124912904|NCT01443845|449307102|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
124912905|NCT01443845|449307101|FG000|Overall Study|Deterioration in pulmonary function|1|||
124912906|NCT01443845|449307102|FG001|Overall Study|Deterioration in pulmonary function|4|||
124912907|NCT01443845|449307101|FG000|Overall Study|Lack of Efficacy|10|||
124912908|NCT01443845|449307102|FG001|Overall Study|Lack of Efficacy|5|||
124912909|NCT01443845|449307101|FG000|Overall Study|Adverse Event|64|||
124912910|NCT01443845|449307102|FG001|Overall Study|Adverse Event|138|||
124912911|NCT01443845|449307101|FG000|Overall Study|Withdrawal by Subject|63|||
124912912|NCT01443845|449307102|FG001|Overall Study|Withdrawal by Subject|67|||
124912913|NCT01443845|449307101|FG000|Overall Study|Military Conflict - Site Terminated|20|||
124912914|NCT01443845|449307102|FG001|Overall Study|Military Conflict - Site Terminated|21|||
124912915|NCT01443845|449307101|FG000|Overall Study|Lost to Follow-up|9|||
124912916|NCT01443845|449307102|FG001|Overall Study|Lost to Follow-up|13|||
124912917|NCT05137236|449307106|FG000|Part A|Other than Specified|1|||
124912918|NCT05137236|449307107|FG001|Part A|Other than Specified|0|||
124912919|NCT05137236|449307108|FG002|Part A|Other than Specified|0|||
124912920|NCT05137236|449307109|FG003|Part A|Other than Specified|0|||
124912921|NCT05137236|449307110|FG004|Part A|Other than Specified|0|||
124912922|NCT05137236|449307111|FG005|Part A|Other than Specified|0|||
124912923|NCT05137236|449307112|FG006|Part A|Other than Specified|0|||
124912924|NCT05137236|449307113|FG007|Part A|Other than Specified|0|||
124912925|NCT05137236|449307106|FG000|Part A|Withdrawal by Subject|0|||
124912926|NCT05137236|449307107|FG001|Part A|Withdrawal by Subject|4|||
124912927|NCT05137236|449307108|FG002|Part A|Withdrawal by Subject|1|||
124912928|NCT05137236|449307109|FG003|Part A|Withdrawal by Subject|1|||
124912929|NCT05137236|449307110|FG004|Part A|Withdrawal by Subject|3|||
124912930|NCT05137236|449307111|FG005|Part A|Withdrawal by Subject|2|||
124912931|NCT05137236|449307112|FG006|Part A|Withdrawal by Subject|0|||
124912932|NCT05137236|449307113|FG007|Part A|Withdrawal by Subject|0|||
124912933|NCT05137236|449307106|FG000|Part A|Lost to Follow-up|5|||
124912934|NCT05137236|449307107|FG001|Part A|Lost to Follow-up|7|||
124912935|NCT05137236|449307108|FG002|Part A|Lost to Follow-up|1|||
124912936|NCT05137236|449307109|FG003|Part A|Lost to Follow-up|3|||
124912937|NCT05137236|449307110|FG004|Part A|Lost to Follow-up|3|||
124912938|NCT05137236|449307111|FG005|Part A|Lost to Follow-up|8|||
124912939|NCT05137236|449307112|FG006|Part A|Lost to Follow-up|0|||
124912940|NCT05137236|449307113|FG007|Part A|Lost to Follow-up|0|||
124912941|NCT05137236|449307106|FG000|Part B|Withdrawal by Subject|0|||
124912942|NCT05137236|449307107|FG001|Part B|Withdrawal by Subject|0|||
124912943|NCT05137236|449307108|FG002|Part B|Withdrawal by Subject|0|||
124912944|NCT05137236|449307109|FG003|Part B|Withdrawal by Subject|0|||
124912945|NCT05137236|449307110|FG004|Part B|Withdrawal by Subject|0|||
124912946|NCT05137236|449307111|FG005|Part B|Withdrawal by Subject|0|||
124912947|NCT05137236|449307112|FG006|Part B|Withdrawal by Subject|0|||
124912948|NCT05137236|449307113|FG007|Part B|Withdrawal by Subject|2|||
124912949|NCT05137236|449307106|FG000|Part B|Lost to Follow-up|0|||
124912950|NCT05137236|449307107|FG001|Part B|Lost to Follow-up|0|||
124450914|NCT00467779|447613556|FG001|Stage 2|Disease Progression|0|||
124450915|NCT00467779|447613557|FG002|Stage 2|Disease Progression|0|||
124450916|NCT00467779|447613558|FG003|Stage 2|Disease Progression|0|||
124450917|NCT00467779|447613559|FG004|Stage 2|Disease Progression|0|||
124450918|NCT00467779|447613560|FG005|Stage 2|Disease Progression|0|||
124450919|NCT00467779|447613561|FG006|Stage 2|Disease Progression|0|||
124450920|NCT00467779|447613562|FG007|Stage 2|Disease Progression|0|||
124450921|NCT00467779|447613563|FG008|Stage 2|Disease Progression|16|||
124450922|NCT00467779|447613564|FG009|Stage 2|Disease Progression|0|||
124912951|NCT05137236|449307108|FG002|Part B|Lost to Follow-up|0|||
124912952|NCT05137236|449307109|FG003|Part B|Lost to Follow-up|0|||
124450923|NCT00467779|447613565|FG010|Stage 2|Disease Progression|0|||
124450924|NCT00467779|447613566|FG011|Stage 2|Disease Progression|0|||
124450925|NCT00467779|447613567|FG012|Stage 2|Disease Progression|0|||
124450926|NCT00467779|447613568|FG013|Stage 2|Disease Progression|0|||
124450927|NCT00467779|447613569|FG014|Stage 2|Disease Progression|0|||
124450928|NCT00467779|447613555|FG000|Stage 2|Unspecified Reason|0|||
124450929|NCT00467779|447613556|FG001|Stage 2|Unspecified Reason|0|||
124450930|NCT00467779|447613557|FG002|Stage 2|Unspecified Reason|0|||
124450931|NCT00467779|447613558|FG003|Stage 2|Unspecified Reason|0|||
124450932|NCT00467779|447613559|FG004|Stage 2|Unspecified Reason|0|||
124450933|NCT00467779|447613560|FG005|Stage 2|Unspecified Reason|0|||
124450934|NCT00467779|447613561|FG006|Stage 2|Unspecified Reason|0|||
124450935|NCT00467779|447613562|FG007|Stage 2|Unspecified Reason|0|||
124450936|NCT00467779|447613563|FG008|Stage 2|Unspecified Reason|3|||
124450937|NCT00467779|447613564|FG009|Stage 2|Unspecified Reason|0|||
124450938|NCT00467779|447613565|FG010|Stage 2|Unspecified Reason|0|||
124450939|NCT00467779|447613566|FG011|Stage 2|Unspecified Reason|0|||
124450940|NCT00467779|447613567|FG012|Stage 2|Unspecified Reason|0|||
124450941|NCT00467779|447613568|FG013|Stage 2|Unspecified Reason|0|||
124450942|NCT00467779|447613569|FG014|Stage 2|Unspecified Reason|0|||
124450943|NCT00467779|447613555|FG000|Stage 2A|Adverse Event|0|||
124450944|NCT00467779|447613556|FG001|Stage 2A|Adverse Event|0|||
124450945|NCT00467779|447613557|FG002|Stage 2A|Adverse Event|0|||
124912953|NCT05137236|449307110|FG004|Part B|Lost to Follow-up|0|||
124912954|NCT05137236|449307111|FG005|Part B|Lost to Follow-up|0|||
124912955|NCT05137236|449307112|FG006|Part B|Lost to Follow-up|5|||
124912956|NCT05137236|449307113|FG007|Part B|Lost to Follow-up|5|||
124912957|NCT05137236|449307106|FG000|Part B|Death|0|||
124450946|NCT00467779|447613558|FG003|Stage 2A|Adverse Event|0|||
124450947|NCT00467779|447613559|FG004|Stage 2A|Adverse Event|0|||
124450948|NCT00467779|447613560|FG005|Stage 2A|Adverse Event|0|||
124693621|NCT04518410|448498744|FG016|Overall Study|Requirement to start alternative therapy|0|||
124693622|NCT04518410|448498745|FG017|Overall Study|Requirement to start alternative therapy|0|||
124693623|NCT04518410|448498746|FG018|Overall Study|Requirement to start alternative therapy|0|||
124693624|NCT04518410|448498747|FG019|Overall Study|Requirement to start alternative therapy|0|||
124761186|NCT01855412|448751553|FG001|Overall Study|Lost to Follow-up|46|||
124912958|NCT05137236|449307107|FG001|Part B|Death|0|||
124912959|NCT05137236|449307108|FG002|Part B|Death|0|||
124912960|NCT05137236|449307109|FG003|Part B|Death|0|||
124912961|NCT05137236|449307110|FG004|Part B|Death|0|||
124450949|NCT00467779|447613561|FG006|Stage 2A|Adverse Event|0|||
124450950|NCT00467779|447613562|FG007|Stage 2A|Adverse Event|0|||
124450951|NCT00467779|447613563|FG008|Stage 2A|Adverse Event|0|||
124450952|NCT00467779|447613564|FG009|Stage 2A|Adverse Event|0|||
124450953|NCT00467779|447613565|FG010|Stage 2A|Adverse Event|0|||
124912962|NCT05137236|449307111|FG005|Part B|Death|0|||
124912963|NCT05137236|449307112|FG006|Part B|Death|0|||
124912964|NCT05137236|449307113|FG007|Part B|Death|2|||
124912965|NCT02724956|449307114|FG000|Overall Study|Physician Decision|1|||
124912966|NCT02724956|449307115|FG001|Overall Study|Physician Decision|0|||
124912967|NCT02724956|449307114|FG000|Overall Study|Lack of Efficacy|0|||
124693625|NCT04518410|448498748|FG020|Overall Study|Requirement to start alternative therapy|0|||
124693626|NCT04518410|448498749|FG021|Overall Study|Requirement to start alternative therapy|0|||
124693627|NCT04518410|448498750|FG022|Overall Study|Requirement to start alternative therapy|0|||
124693628|NCT04518410|448498751|FG023|Overall Study|Requirement to start alternative therapy|0|||
124693629|NCT04518410|448498752|FG024|Overall Study|Requirement to start alternative therapy|0|||
124693630|NCT04518410|448498728|FG000|Overall Study|Randomized but not treated|0|||
124693631|NCT04518410|448498729|FG001|Overall Study|Randomized but not treated|0|||
124693632|NCT04518410|448498730|FG002|Overall Study|Randomized but not treated|0|||
124693633|NCT04518410|448498731|FG003|Overall Study|Randomized but not treated|2|||
124693634|NCT04518410|448498732|FG004|Overall Study|Randomized but not treated|6|||
124693635|NCT04518410|448498733|FG005|Overall Study|Randomized but not treated|4|||
124693636|NCT04518410|448498734|FG006|Overall Study|Randomized but not treated|3|||
124693637|NCT04518410|448498735|FG007|Overall Study|Randomized but not treated|3|||
124693638|NCT04518410|448498736|FG008|Overall Study|Randomized but not treated|0|||
124693639|NCT04518410|448498737|FG009|Overall Study|Randomized but not treated|4|||
124693640|NCT04518410|448498738|FG010|Overall Study|Randomized but not treated|0|||
124693641|NCT04518410|448498739|FG011|Overall Study|Randomized but not treated|0|||
124693642|NCT04518410|448498740|FG012|Overall Study|Randomized but not treated|1|||
124693643|NCT04518410|448498741|FG013|Overall Study|Randomized but not treated|3|||
124693644|NCT04518410|448498742|FG014|Overall Study|Randomized but not treated|3|||
124693645|NCT04518410|448498743|FG015|Overall Study|Randomized but not treated|3|||
124693646|NCT04518410|448498744|FG016|Overall Study|Randomized but not treated|4|||
124693647|NCT04518410|448498745|FG017|Overall Study|Randomized but not treated|5|||
124693648|NCT04518410|448498746|FG018|Overall Study|Randomized but not treated|4|||
124693649|NCT04518410|448498747|FG019|Overall Study|Randomized but not treated|0|||
124693650|NCT04518410|448498748|FG020|Overall Study|Randomized but not treated|0|||
124693651|NCT04518410|448498749|FG021|Overall Study|Randomized but not treated|5|||
124693652|NCT04518410|448498750|FG022|Overall Study|Randomized but not treated|0|||
124693653|NCT04518410|448498751|FG023|Overall Study|Randomized but not treated|3|||
124693654|NCT04518410|448498752|FG024|Overall Study|Randomized but not treated|1|||
124693655|NCT04518410|448498728|FG000|Overall Study|Screen Fail but Randomized|0|||
124693656|NCT04518410|448498729|FG001|Overall Study|Screen Fail but Randomized|0|||
124693657|NCT04518410|448498730|FG002|Overall Study|Screen Fail but Randomized|0|||
124693658|NCT04518410|448498731|FG003|Overall Study|Screen Fail but Randomized|0|||
124693659|NCT04518410|448498732|FG004|Overall Study|Screen Fail but Randomized|2|||
124693660|NCT04518410|448498733|FG005|Overall Study|Screen Fail but Randomized|0|||
124761187|NCT01855412|448751554|FG002|Overall Study|Lost to Follow-up|15|||
124912968|NCT02724956|449307115|FG001|Overall Study|Lack of Efficacy|1|||
124912969|NCT02724956|449307114|FG000|Overall Study|Withdrawal by Subject|0|||
124912970|NCT02724956|449307115|FG001|Overall Study|Withdrawal by Subject|1|||
124912971|NCT00431834|449307118|FG000|Overall Study|Withdrawal by Subject|7|||
124912972|NCT00431834|449307118|FG000|Overall Study|Death|3|||
124912973|NCT00431834|449307118|FG000|Overall Study|Missed Endpoint Visit|2|||
124912974|NCT00431834|449307118|FG000|Overall Study|Lost to Follow-up|1|||
124912975|NCT02461628|449307124|FG000|Overall Study|Refused to complete survey|4|||
124912976|NCT02461628|449307125|FG001|Overall Study|Refused to complete survey|7|||
124912977|NCT02647905|449307128|FG000|Overall Study|Lost to Follow-up|1|||
124912978|NCT02647905|449307128|FG000|Overall Study|Withdrawal by Subject|2|||
124912979|NCT02015520|449307129|FG000|Overall Study|Lack of Efficacy|1|||
124912980|NCT02015520|449307130|FG001|Overall Study|Lack of Efficacy|0|||
124912981|NCT02015520|449307131|FG002|Overall Study|Lack of Efficacy|3|||
124912982|NCT02015520|449307132|FG003|Overall Study|Lack of Efficacy|2|||
124912983|NCT02015520|449307129|FG000|Overall Study|Adverse Event|0|||
124912984|NCT02015520|449307130|FG001|Overall Study|Adverse Event|0|||
124912985|NCT02015520|449307131|FG002|Overall Study|Adverse Event|0|||
124912986|NCT02015520|449307132|FG003|Overall Study|Adverse Event|1|||
124912987|NCT02015520|449307129|FG000|Overall Study|Withdrawal by Subject|2|||
124912988|NCT02015520|449307130|FG001|Overall Study|Withdrawal by Subject|2|||
124912989|NCT02015520|449307131|FG002|Overall Study|Withdrawal by Subject|1|||
124912990|NCT02015520|449307132|FG003|Overall Study|Withdrawal by Subject|0|||
124912991|NCT02015520|449307129|FG000|Overall Study|Death|1|||
124912992|NCT02015520|449307130|FG001|Overall Study|Death|0|||
124912993|NCT02015520|449307131|FG002|Overall Study|Death|0|||
124450954|NCT00467779|447613566|FG011|Stage 2A|Adverse Event|0|||
124450955|NCT00467779|447613567|FG012|Stage 2A|Adverse Event|0|||
124450956|NCT00467779|447613568|FG013|Stage 2A|Adverse Event|2|||
124450957|NCT00467779|447613569|FG014|Stage 2A|Adverse Event|0|||
124450958|NCT00467779|447613555|FG000|Stage 2A|Death|0|||
124450959|NCT00467779|447613556|FG001|Stage 2A|Death|0|||
124450960|NCT00467779|447613557|FG002|Stage 2A|Death|0|||
124450961|NCT00467779|447613558|FG003|Stage 2A|Death|0|||
124450962|NCT00467779|447613559|FG004|Stage 2A|Death|0|||
124450963|NCT00467779|447613560|FG005|Stage 2A|Death|0|||
124450964|NCT00467779|447613561|FG006|Stage 2A|Death|0|||
124450965|NCT00467779|447613562|FG007|Stage 2A|Death|0|||
124450966|NCT00467779|447613563|FG008|Stage 2A|Death|0|||
124450967|NCT00467779|447613564|FG009|Stage 2A|Death|0|||
124450968|NCT00467779|447613565|FG010|Stage 2A|Death|0|||
124450969|NCT00467779|447613566|FG011|Stage 2A|Death|0|||
124545259|NCT01728376|447951126|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
124545260|NCT01728376|447951127|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
124545261|NCT01728376|447951128|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
124545262|NCT01728376|447951123|FG000|Overall Study|No relevant bacteria|2|||
124545263|NCT01728376|447951124|FG001|Overall Study|No relevant bacteria|0|||
124545264|NCT01728376|447951125|FG002|Overall Study|No relevant bacteria|0|||
124545265|NCT01728376|447951126|FG003|Overall Study|No relevant bacteria|0|||
124545266|NCT01728376|447951127|FG004|Overall Study|No relevant bacteria|1|||
124545267|NCT01728376|447951128|FG005|Overall Study|No relevant bacteria|1|||
124545268|NCT01728376|447951123|FG000|Overall Study|Did not receive treatment|0|||
124545269|NCT01728376|447951124|FG001|Overall Study|Did not receive treatment|1|||
124545270|NCT01728376|447951125|FG002|Overall Study|Did not receive treatment|0|||
124545271|NCT01728376|447951126|FG003|Overall Study|Did not receive treatment|0|||
124545272|NCT01728376|447951127|FG004|Overall Study|Did not receive treatment|0|||
124545273|NCT01728376|447951128|FG005|Overall Study|Did not receive treatment|0|||
124545274|NCT01728376|447951123|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
124545275|NCT01728376|447951124|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
124545276|NCT01728376|447951125|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
124545277|NCT01728376|447951126|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
124545278|NCT01728376|447951127|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
124545279|NCT01728376|447951128|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
124545280|NCT04341727|447951141|FG000|Overall Study|Withdrawal by Subject|0|||
124545281|NCT04341727|447951142|FG001|Overall Study|Withdrawal by Subject|0|||
124545282|NCT04341727|447951143|FG002|Overall Study|Withdrawal by Subject|1|||
124545283|NCT04341727|447951144|FG003|Overall Study|Withdrawal by Subject|0|||
124545284|NCT04341727|447951141|FG000|Overall Study|Lost to Follow-up|0|||
124545285|NCT04341727|447951142|FG001|Overall Study|Lost to Follow-up|0|||
124545286|NCT04341727|447951143|FG002|Overall Study|Lost to Follow-up|0|||
124545287|NCT04341727|447951144|FG003|Overall Study|Lost to Follow-up|1|||
124545288|NCT05604521|447951145|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
124545289|NCT05604521|447951146|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
124545290|NCT05604521|447951145|FG000|Overall Study|Adverse Event|1|||
124545291|NCT05604521|447951146|FG001|Overall Study|Adverse Event|0|||
124545292|NCT01491737|447951147|FG000|Overall Study|Withdrawal by Subject|20|||
124545293|NCT01491737|447951148|FG001|Overall Study|Withdrawal by Subject|17|||
124545294|NCT01491737|447951147|FG000|Overall Study|Lost to Follow-up|2|||
124545295|NCT01491737|447951148|FG001|Overall Study|Lost to Follow-up|10|||
124545296|NCT01491737|447951147|FG000|Overall Study|Death|63|||
124545297|NCT01491737|447951148|FG001|Overall Study|Death|57|||
124545298|NCT01491737|447951147|FG000|Overall Study|Study Termination by Sponsor|36|||
124545299|NCT01491737|447951148|FG001|Overall Study|Study Termination by Sponsor|36|||
124545300|NCT01491737|447951147|FG000|Overall Study|Reason Not Specified|8|||
124545301|NCT01491737|447951148|FG001|Overall Study|Reason Not Specified|9|||
124545302|NCT04311411|447951149|FG000|Overall Study|Adverse Event|2|||
124545303|NCT04311411|447951150|FG001|Overall Study|Adverse Event|3|||
124545304|NCT04311411|447951151|FG002|Overall Study|Adverse Event|2|||
124545305|NCT04311411|447951149|FG000|Overall Study|Withdrawal by Subject|3|||
124545306|NCT04311411|447951150|FG001|Overall Study|Withdrawal by Subject|3|||
124545307|NCT04311411|447951151|FG002|Overall Study|Withdrawal by Subject|0|||
124545308|NCT01976663|447951152|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
124545309|NCT01976663|447951152|FG000|Overall Study|Personal Reasons|6|||
124545310|NCT01976663|447951152|FG000|Overall Study|Withdrawal by Subject|4|||
124545311|NCT01976663|447951152|FG000|Overall Study|Screen Failure|3|||
124545312|NCT01976663|447951152|FG000|Overall Study|Adverse Event|2|||
124545313|NCT01976663|447951152|FG000|Overall Study|Lost to Follow-up|3|||
124545314|NCT01817764|447951153|FG000|Overall Study|Adverse Event|7|||
124545315|NCT01817764|447951154|FG001|Overall Study|Adverse Event|10|||
124545316|NCT01817764|447951153|FG000|Overall Study|Lack of Efficacy|9|||
124545317|NCT01817764|447951154|FG001|Overall Study|Lack of Efficacy|7|||
124545318|NCT01817764|447951153|FG000|Overall Study|Protocol Violation|7|||
124545319|NCT01817764|447951154|FG001|Overall Study|Protocol Violation|5|||
124693661|NCT04518410|448498734|FG006|Overall Study|Screen Fail but Randomized|0|||
124693662|NCT04518410|448498735|FG007|Overall Study|Screen Fail but Randomized|0|||
124693663|NCT04518410|448498736|FG008|Overall Study|Screen Fail but Randomized|0|||
124545320|NCT01817764|447951153|FG000|Overall Study|Lost to Follow-up|1|||
124545321|NCT01817764|447951154|FG001|Overall Study|Lost to Follow-up|4|||
124545322|NCT01817764|447951153|FG000|Overall Study|Withdrawal by Subject|10|||
124545323|NCT01817764|447951154|FG001|Overall Study|Withdrawal by Subject|12|||
124545324|NCT04888377|447951155|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
124545325|NCT04888377|447951156|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
124545326|NCT04888377|447951155|FG000|Overall Study|Physician Decision|6|||
124545327|NCT04888377|447951156|FG001|Overall Study|Physician Decision|6|||
124545328|NCT04888377|447951155|FG000|Overall Study|Withdrawal by Subject|7|||
124545329|NCT04888377|447951156|FG001|Overall Study|Withdrawal by Subject|3|||
124450970|NCT00467779|447613567|FG012|Stage 2A|Death|0|||
124450971|NCT00467779|447613568|FG013|Stage 2A|Death|1|||
124450972|NCT00467779|447613569|FG014|Stage 2A|Death|0|||
124450973|NCT00467779|447613555|FG000|Stage 2A|Disease Progression|0|||
124450974|NCT00467779|447613556|FG001|Stage 2A|Disease Progression|0|||
124450975|NCT00467779|447613557|FG002|Stage 2A|Disease Progression|0|||
124450976|NCT00467779|447613558|FG003|Stage 2A|Disease Progression|0|||
124450977|NCT00467779|447613559|FG004|Stage 2A|Disease Progression|0|||
124450978|NCT00467779|447613560|FG005|Stage 2A|Disease Progression|0|||
124450979|NCT00467779|447613561|FG006|Stage 2A|Disease Progression|0|||
124450980|NCT00467779|447613562|FG007|Stage 2A|Disease Progression|0|||
124912994|NCT02015520|449307132|FG003|Overall Study|Death|0|||
124912995|NCT02015520|449307129|FG000|Overall Study|Lost to Follow-up|0|||
124912996|NCT02015520|449307130|FG001|Overall Study|Lost to Follow-up|0|||
124912997|NCT02015520|449307131|FG002|Overall Study|Lost to Follow-up|1|||
124912998|NCT02015520|449307132|FG003|Overall Study|Lost to Follow-up|0|||
124912999|NCT02015520|449307129|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
124913000|NCT02015520|449307130|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
124450981|NCT00467779|447613563|FG008|Stage 2A|Disease Progression|0|||
124450982|NCT00467779|447613564|FG009|Stage 2A|Disease Progression|0|||
124450983|NCT00467779|447613565|FG010|Stage 2A|Disease Progression|0|||
124450984|NCT00467779|447613566|FG011|Stage 2A|Disease Progression|0|||
124450985|NCT00467779|447613567|FG012|Stage 2A|Disease Progression|0|||
124450986|NCT00467779|447613568|FG013|Stage 2A|Disease Progression|10|||
124450987|NCT00467779|447613569|FG014|Stage 2A|Disease Progression|0|||
124450988|NCT00467779|447613555|FG000|Stage 2A|Unspecified Reason|0|||
124450989|NCT00467779|447613556|FG001|Stage 2A|Unspecified Reason|0|||
124450990|NCT00467779|447613557|FG002|Stage 2A|Unspecified Reason|0|||
124450991|NCT00467779|447613558|FG003|Stage 2A|Unspecified Reason|0|||
124450992|NCT00467779|447613559|FG004|Stage 2A|Unspecified Reason|0|||
124450993|NCT00467779|447613560|FG005|Stage 2A|Unspecified Reason|0|||
124450994|NCT00467779|447613561|FG006|Stage 2A|Unspecified Reason|0|||
124450995|NCT00467779|447613562|FG007|Stage 2A|Unspecified Reason|0|||
124450996|NCT00467779|447613563|FG008|Stage 2A|Unspecified Reason|0|||
124450997|NCT00467779|447613564|FG009|Stage 2A|Unspecified Reason|0|||
124450998|NCT00467779|447613565|FG010|Stage 2A|Unspecified Reason|0|||
124450999|NCT00467779|447613566|FG011|Stage 2A|Unspecified Reason|0|||
124451000|NCT00467779|447613567|FG012|Stage 2A|Unspecified Reason|0|||
124451001|NCT00467779|447613568|FG013|Stage 2A|Unspecified Reason|7|||
124451002|NCT00467779|447613569|FG014|Stage 2A|Unspecified Reason|0|||
124451003|NCT00467779|447613555|FG000|Stage 2A|Withdrawal by Subject|0|||
124451004|NCT00467779|447613556|FG001|Stage 2A|Withdrawal by Subject|0|||
124451005|NCT00467779|447613557|FG002|Stage 2A|Withdrawal by Subject|0|||
124451006|NCT00467779|447613558|FG003|Stage 2A|Withdrawal by Subject|0|||
124451007|NCT00467779|447613559|FG004|Stage 2A|Withdrawal by Subject|0|||
124451008|NCT00467779|447613560|FG005|Stage 2A|Withdrawal by Subject|0|||
124451009|NCT00467779|447613561|FG006|Stage 2A|Withdrawal by Subject|0|||
124451010|NCT00467779|447613562|FG007|Stage 2A|Withdrawal by Subject|0|||
124451011|NCT00467779|447613563|FG008|Stage 2A|Withdrawal by Subject|0|||
124451012|NCT00467779|447613564|FG009|Stage 2A|Withdrawal by Subject|0|||
124451013|NCT00467779|447613565|FG010|Stage 2A|Withdrawal by Subject|0|||
124451014|NCT00467779|447613566|FG011|Stage 2A|Withdrawal by Subject|0|||
124451015|NCT00467779|447613567|FG012|Stage 2A|Withdrawal by Subject|0|||
124451016|NCT00467779|447613568|FG013|Stage 2A|Withdrawal by Subject|1|||
124451017|NCT00467779|447613569|FG014|Stage 2A|Withdrawal by Subject|0|||
124451018|NCT00467779|447613555|FG000|Stage 3|Adverse Event|0|||
124451019|NCT00467779|447613556|FG001|Stage 3|Adverse Event|0|||
124451020|NCT00467779|447613557|FG002|Stage 3|Adverse Event|0|||
124451021|NCT00467779|447613558|FG003|Stage 3|Adverse Event|0|||
124451022|NCT00467779|447613559|FG004|Stage 3|Adverse Event|0|||
124451023|NCT00467779|447613560|FG005|Stage 3|Adverse Event|0|||
124693664|NCT04518410|448498737|FG009|Overall Study|Screen Fail but Randomized|0|||
124913001|NCT02015520|449307131|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
124913002|NCT02015520|449307132|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
124913003|NCT02015520|449307129|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
124913004|NCT02015520|449307130|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
124451024|NCT00467779|447613561|FG006|Stage 3|Adverse Event|0|||
124451025|NCT00467779|447613562|FG007|Stage 3|Adverse Event|0|||
124693665|NCT04518410|448498738|FG010|Overall Study|Screen Fail but Randomized|0|||
124693666|NCT04518410|448498739|FG011|Overall Study|Screen Fail but Randomized|0|||
124451026|NCT00467779|447613563|FG008|Stage 3|Adverse Event|0|||
124451027|NCT00467779|447613564|FG009|Stage 3|Adverse Event|0|||
124451028|NCT00467779|447613565|FG010|Stage 3|Adverse Event|0|||
124451029|NCT00467779|447613566|FG011|Stage 3|Adverse Event|0|||
124451030|NCT00467779|447613567|FG012|Stage 3|Adverse Event|0|||
124451031|NCT00467779|447613568|FG013|Stage 3|Adverse Event|0|||
124451032|NCT00467779|447613569|FG014|Stage 3|Adverse Event|2|||
124451033|NCT00467779|447613555|FG000|Stage 3|Death|0|||
124451034|NCT00467779|447613556|FG001|Stage 3|Death|0|||
124451035|NCT00467779|447613557|FG002|Stage 3|Death|0|||
124451036|NCT00467779|447613558|FG003|Stage 3|Death|0|||
124693667|NCT04518410|448498740|FG012|Overall Study|Screen Fail but Randomized|0|||
124693668|NCT04518410|448498741|FG013|Overall Study|Screen Fail but Randomized|0|||
124693669|NCT04518410|448498742|FG014|Overall Study|Screen Fail but Randomized|0|||
124693670|NCT04518410|448498743|FG015|Overall Study|Screen Fail but Randomized|0|||
124693671|NCT04518410|448498744|FG016|Overall Study|Screen Fail but Randomized|0|||
124693672|NCT04518410|448498745|FG017|Overall Study|Screen Fail but Randomized|0|||
124693673|NCT04518410|448498746|FG018|Overall Study|Screen Fail but Randomized|0|||
124693674|NCT04518410|448498747|FG019|Overall Study|Screen Fail but Randomized|0|||
124693675|NCT04518410|448498748|FG020|Overall Study|Screen Fail but Randomized|0|||
124693676|NCT04518410|448498749|FG021|Overall Study|Screen Fail but Randomized|0|||
124913005|NCT02015520|449307131|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
124913006|NCT02015520|449307132|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
124693677|NCT04518410|448498750|FG022|Overall Study|Screen Fail but Randomized|0|||
124693678|NCT04518410|448498751|FG023|Overall Study|Screen Fail but Randomized|0|||
124693679|NCT04518410|448498752|FG024|Overall Study|Screen Fail but Randomized|0|||
124913007|NCT05119855|449307133|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
124913008|NCT05119855|449307134|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
124913009|NCT05119855|449307133|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
124913010|NCT05119855|449307134|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
124913011|NCT05119855|449307133|FG000|Overall Study|Lost to Follow-up|6|||
124913012|NCT05119855|449307134|FG001|Overall Study|Lost to Follow-up|8|||
124913013|NCT02932579|449307135|FG000|Overall Study|Withdrawal by Subject|4|||
124913014|NCT02932579|449307136|FG001|Overall Study|Withdrawal by Subject|1|||
124913015|NCT01972724|449307137|FG000|Double-Blind|Rescue Criteria Met|1|||
124545330|NCT05644756|447951157|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
124545331|NCT05644756|447951157|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
124545332|NCT00478933|447951162|FG000|Overall Study|Protocol Violation|22|||
124545333|NCT00478933|447951162|FG000|Overall Study|Informed consent not verified|3|||
124545334|NCT00478933|447951162|FG000|Overall Study|Inadequate data available|53|||
124545335|NCT03586427|447951165|FG000|Overall Study|Lost to Follow-up|0|||
124545336|NCT03586427|447951166|FG001|Overall Study|Lost to Follow-up|3|||
124545337|NCT03586427|447951167|FG002|Overall Study|Lost to Follow-up|1|||
124545338|NCT03586427|447951168|FG003|Overall Study|Lost to Follow-up|3|||
124545339|NCT03586427|447951169|FG004|Overall Study|Lost to Follow-up|3|||
124545340|NCT03586427|447951165|FG000|Overall Study|Withdrawal by Subject|0|||
124545341|NCT03586427|447951166|FG001|Overall Study|Withdrawal by Subject|1|||
124545342|NCT03586427|447951167|FG002|Overall Study|Withdrawal by Subject|2|||
124545343|NCT03586427|447951168|FG003|Overall Study|Withdrawal by Subject|1|||
124545344|NCT03586427|447951169|FG004|Overall Study|Withdrawal by Subject|1|||
124545345|NCT03586427|447951165|FG000|Overall Study|Adverse Event|0|||
124545346|NCT03586427|447951166|FG001|Overall Study|Adverse Event|0|||
124545347|NCT03586427|447951167|FG002|Overall Study|Adverse Event|1|||
124545348|NCT03586427|447951168|FG003|Overall Study|Adverse Event|0|||
124545349|NCT03586427|447951169|FG004|Overall Study|Adverse Event|0|||
124545350|NCT03586427|447951165|FG000|Overall Study|Protocol Violation|0|||
124545351|NCT03586427|447951166|FG001|Overall Study|Protocol Violation|0|||
124545352|NCT03586427|447951167|FG002|Overall Study|Protocol Violation|1|||
124545353|NCT03586427|447951168|FG003|Overall Study|Protocol Violation|0|||
124545354|NCT03586427|447951169|FG004|Overall Study|Protocol Violation|1|||
124545355|NCT03586427|447951165|FG000|Overall Study|Noncompliance with study drug|0|||
124545356|NCT03586427|447951166|FG001|Overall Study|Noncompliance with study drug|0|||
124545357|NCT03586427|447951167|FG002|Overall Study|Noncompliance with study drug|1|||
124545358|NCT03586427|447951168|FG003|Overall Study|Noncompliance with study drug|0|||
124545359|NCT03586427|447951169|FG004|Overall Study|Noncompliance with study drug|0|||
124545360|NCT00494234|447951170|FG000|Overall Study|Withdrawal by Subject|1|||
124693680|NCT04518410|448498728|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
124693681|NCT04518410|448498729|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
124693682|NCT04518410|448498730|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
124693683|NCT04518410|448498731|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
124913016|NCT01972724|449307138|FG001|Double-Blind|Rescue Criteria Met|0|||
124545361|NCT00494234|447951171|FG001|Overall Study|Withdrawal by Subject|0|||
124913017|NCT01972724|449307139|FG002|Double-Blind|Rescue Criteria Met|0|||
124913018|NCT01972724|449307137|FG000|Double-Blind|Adverse Event|1|||
124913019|NCT01972724|449307138|FG001|Double-Blind|Adverse Event|0|||
124545362|NCT00494234|447951170|FG000|Overall Study|Disease progression|11|||
124545363|NCT00494234|447951171|FG001|Overall Study|Disease progression|8|||
124545364|NCT00494234|447951170|FG000|Overall Study|Death|2|||
124545365|NCT00494234|447951171|FG001|Overall Study|Death|1|||
124913020|NCT01972724|449307139|FG002|Double-Blind|Adverse Event|0|||
124913021|NCT01972724|449307137|FG000|Double-Blind|Withdrawal of Consent|2|||
124545366|NCT00423137|447951172|FG000|Overall Study|Lost to Follow-up|0|||
124545367|NCT00423137|447951173|FG001|Overall Study|Lost to Follow-up|0|||
124913022|NCT01972724|449307138|FG001|Double-Blind|Withdrawal of Consent|1|||
124451037|NCT00467779|447613559|FG004|Stage 3|Death|0|||
124451038|NCT00467779|447613560|FG005|Stage 3|Death|0|||
124451039|NCT00467779|447613561|FG006|Stage 3|Death|0|||
124451040|NCT00467779|447613562|FG007|Stage 3|Death|0|||
124451041|NCT00467779|447613563|FG008|Stage 3|Death|0|||
124451042|NCT00467779|447613564|FG009|Stage 3|Death|0|||
124451043|NCT00467779|447613565|FG010|Stage 3|Death|0|||
124451044|NCT00467779|447613566|FG011|Stage 3|Death|0|||
124451045|NCT00467779|447613567|FG012|Stage 3|Death|0|||
124451046|NCT00467779|447613568|FG013|Stage 3|Death|0|||
124451047|NCT00467779|447613569|FG014|Stage 3|Death|1|||
124451048|NCT00467779|447613555|FG000|Stage 3|Disease Progression|0|||
124451049|NCT00467779|447613556|FG001|Stage 3|Disease Progression|0|||
124451050|NCT00467779|447613557|FG002|Stage 3|Disease Progression|0|||
124451051|NCT00467779|447613558|FG003|Stage 3|Disease Progression|0|||
124451052|NCT00467779|447613559|FG004|Stage 3|Disease Progression|0|||
124451053|NCT00467779|447613560|FG005|Stage 3|Disease Progression|0|||
124913023|NCT01972724|449307139|FG002|Double-Blind|Withdrawal of Consent|0|||
124913024|NCT01972724|449307137|FG000|Double-Blind|Significant Protocol Deviation|5|||
124913025|NCT01972724|449307138|FG001|Double-Blind|Significant Protocol Deviation|8|||
124913026|NCT01972724|449307139|FG002|Double-Blind|Significant Protocol Deviation|0|||
124913027|NCT01972724|449307137|FG000|Open-Label|Withdrew Consent|0|||
124913028|NCT01972724|449307138|FG001|Open-Label|Withdrew Consent|0|||
124913029|NCT01972724|449307139|FG002|Open-Label|Withdrew Consent|3|||
124913030|NCT01972724|449307137|FG000|Open-Label|Significant Protocol Deviation|0|||
124913031|NCT01972724|449307138|FG001|Open-Label|Significant Protocol Deviation|0|||
124913032|NCT01972724|449307139|FG002|Open-Label|Significant Protocol Deviation|2|||
124913033|NCT00111813|449307144|FG000|Overall Study|Adverse Event|1|||
124913034|NCT00111813|449307145|FG001|Overall Study|Adverse Event|2|||
124913035|NCT00111813|449307146|FG002|Overall Study|Adverse Event|4|||
124913036|NCT00111813|449307147|FG003|Overall Study|Adverse Event|2|||
124913037|NCT00111813|449307148|FG004|Overall Study|Adverse Event|2|||
124913038|NCT00111813|449307149|FG005|Overall Study|Adverse Event|2|||
124913039|NCT00111813|449307144|FG000|Overall Study|Progressive disease|2|||
124913040|NCT00111813|449307145|FG001|Overall Study|Progressive disease|1|||
124913041|NCT00111813|449307146|FG002|Overall Study|Progressive disease|5|||
124913042|NCT00111813|449307147|FG003|Overall Study|Progressive disease|3|||
124913043|NCT00111813|449307148|FG004|Overall Study|Progressive disease|4|||
124913044|NCT00111813|449307149|FG005|Overall Study|Progressive disease|3|||
124913045|NCT00111813|449307144|FG000|Overall Study|Lack of Efficacy|0|||
124913046|NCT00111813|449307145|FG001|Overall Study|Lack of Efficacy|0|||
124913047|NCT00111813|449307146|FG002|Overall Study|Lack of Efficacy|0|||
124913048|NCT00111813|449307147|FG003|Overall Study|Lack of Efficacy|0|||
124913049|NCT00111813|449307148|FG004|Overall Study|Lack of Efficacy|0|||
124913050|NCT00111813|449307149|FG005|Overall Study|Lack of Efficacy|1|||
124913051|NCT00111813|449307144|FG000|Overall Study|Other|0|||
124913052|NCT00111813|449307145|FG001|Overall Study|Other|0|||
124913053|NCT00111813|449307146|FG002|Overall Study|Other|1|||
124913054|NCT00111813|449307147|FG003|Overall Study|Other|0|||
124913055|NCT00111813|449307148|FG004|Overall Study|Other|0|||
124913056|NCT00111813|449307149|FG005|Overall Study|Other|0|||
124913057|NCT01000480|449307152|FG000|Induction Phase|Adverse Event|2|||
124913058|NCT01000480|449307152|FG000|Induction Phase|Lost to Follow-up|1|||
124913059|NCT01000480|449307152|FG000|Induction Phase|Physician Decision|1|||
124913060|NCT01000480|449307152|FG000|Induction Phase|Entry Criteria Not Met|3|||
124913061|NCT01000480|449307152|FG000|Concurrent Therapy Phase|Adverse Event|4|||
124913062|NCT01000480|449307152|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
124913063|NCT01000480|449307152|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
124913064|NCT01000480|449307152|FG000|Concurrent Therapy Phase|Physician Decision|1|||
124913065|NCT00174382|449307154|FG000|Overall Study|Death|2|||
124913066|NCT00174382|449307154|FG000|Overall Study|Adverse Event|19|||
124913067|NCT00174382|449307154|FG000|Overall Study|Withdrawal by Subject|6|||
124913068|NCT00174382|449307154|FG000|Overall Study|Protocol Violation|3|||
124451054|NCT00467779|447613561|FG006|Stage 3|Disease Progression|0|||
124451055|NCT00467779|447613562|FG007|Stage 3|Disease Progression|0|||
124451056|NCT00467779|447613563|FG008|Stage 3|Disease Progression|0|||
124451057|NCT00467779|447613564|FG009|Stage 3|Disease Progression|0|||
124451058|NCT00467779|447613565|FG010|Stage 3|Disease Progression|0|||
124451059|NCT00467779|447613566|FG011|Stage 3|Disease Progression|0|||
124545368|NCT00423137|447951174|FG002|Overall Study|Lost to Follow-up|1|||
124913069|NCT00174382|449307154|FG000|Overall Study|Arrived early for last visit in error|1|||
124913070|NCT00174382|449307154|FG000|Overall Study|Subject felt pill not effective enough|1|||
124913071|NCT00174382|449307154|FG000|Overall Study|Lost to Follow-up|1|||
124913072|NCT00296036|449307155|FG000|Overall Study|Withdrawal by Subject|1|||
124913073|NCT00296036|449307156|FG001|Overall Study|Withdrawal by Subject|0|||
124913074|NCT00296036|449307157|FG002|Overall Study|Withdrawal by Subject|2|||
124913075|NCT00296036|449307158|FG003|Overall Study|Withdrawal by Subject|1|||
124913076|NCT00296036|449307159|FG004|Overall Study|Withdrawal by Subject|2|||
124913077|NCT00296036|449307160|FG005|Overall Study|Withdrawal by Subject|1|||
124451060|NCT00467779|447613567|FG012|Stage 3|Disease Progression|0|||
124451061|NCT00467779|447613568|FG013|Stage 3|Disease Progression|0|||
124693684|NCT04518410|448498732|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
124693685|NCT04518410|448498733|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
124693686|NCT04518410|448498734|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
124693687|NCT04518410|448498735|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
124913078|NCT00296036|449307155|FG000|Overall Study|Protocol Violation|0|||
124913079|NCT00296036|449307156|FG001|Overall Study|Protocol Violation|0|||
124913080|NCT00296036|449307157|FG002|Overall Study|Protocol Violation|0|||
124913081|NCT00296036|449307158|FG003|Overall Study|Protocol Violation|0|||
124913082|NCT00296036|449307159|FG004|Overall Study|Protocol Violation|0|||
124913083|NCT00296036|449307160|FG005|Overall Study|Protocol Violation|3|||
124913084|NCT02576509|449308688|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
124913085|NCT02576509|449308689|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
124913086|NCT02576509|449308688|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
124913087|NCT02576509|449308689|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
124913088|NCT02576509|449308688|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
124913089|NCT02576509|449308689|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
124913090|NCT02576509|449308688|FG000|Treatment Period|Disease progression|263|||
124913091|NCT02576509|449308689|FG001|Treatment Period|Disease progression|244|||
124913092|NCT02576509|449308688|FG000|Treatment Period|Study drug toxicity|37|||
124913093|NCT02576509|449308689|FG001|Treatment Period|Study drug toxicity|41|||
124451062|NCT00467779|447613569|FG014|Stage 3|Disease Progression|9|||
124451063|NCT00467779|447613555|FG000|Stage 3|Unspecified Reason|0|||
124451064|NCT00467779|447613556|FG001|Stage 3|Unspecified Reason|0|||
124451065|NCT00467779|447613557|FG002|Stage 3|Unspecified Reason|0|||
124451066|NCT00467779|447613558|FG003|Stage 3|Unspecified Reason|0|||
124451067|NCT00467779|447613559|FG004|Stage 3|Unspecified Reason|0|||
124451068|NCT00467779|447613560|FG005|Stage 3|Unspecified Reason|0|||
124451069|NCT00467779|447613561|FG006|Stage 3|Unspecified Reason|0|||
124451070|NCT00467779|447613562|FG007|Stage 3|Unspecified Reason|0|||
124451071|NCT00467779|447613563|FG008|Stage 3|Unspecified Reason|0|||
124451072|NCT00467779|447613564|FG009|Stage 3|Unspecified Reason|0|||
124451073|NCT00467779|447613565|FG010|Stage 3|Unspecified Reason|0|||
124451074|NCT00467779|447613566|FG011|Stage 3|Unspecified Reason|0|||
124451075|NCT00467779|447613567|FG012|Stage 3|Unspecified Reason|0|||
124451076|NCT00467779|447613568|FG013|Stage 3|Unspecified Reason|0|||
124451077|NCT00467779|447613569|FG014|Stage 3|Unspecified Reason|5|||
124451078|NCT05111041|447613572|FG000|Overall Study|Lost to Follow-up|6|||
124451079|NCT05111041|447613573|FG001|Overall Study|Lost to Follow-up|7|||
124451080|NCT05111041|447613572|FG000|Overall Study|Withdrawal by Subject|1|||
124451081|NCT05111041|447613573|FG001|Overall Study|Withdrawal by Subject|0|||
124451082|NCT01205230|447613574|FG000|Overall Study|Adverse Event|4|||
124451083|NCT01205230|447613575|FG001|Overall Study|Adverse Event|0|||
124451084|NCT01205230|447613574|FG000|Overall Study|Physician Decision|1|||
124451085|NCT01205230|447613575|FG001|Overall Study|Physician Decision|0|||
124451086|NCT01701674|447613576|FG000|Overall Study|Unable to safely complete treatment|1|||
124451087|NCT00791258|447613577|FG000|Overall Study|Adverse Event|87|||
124451088|NCT00791258|447613577|FG000|Overall Study|Lost to Follow-up|18|||
124451089|NCT00791258|447613577|FG000|Overall Study|Protocol Violation|109|||
124451090|NCT00791258|447613577|FG000|Overall Study|Withdrawal by Subject|40|||
124451091|NCT00791258|447613577|FG000|Overall Study|Did not take medication for >3 days|1|||
124451092|NCT00791258|447613577|FG000|Overall Study|subject left area|2|||
124451093|NCT00791258|447613577|FG000|Overall Study|non-compliance|3|||
124451094|NCT00791258|447613577|FG000|Overall Study|Subject incarcerated|1|||
124451095|NCT00791258|447613577|FG000|Overall Study|Subject required restricted medication|1|||
124451096|NCT00791258|447613577|FG000|Overall Study|Lack of Efficacy|1|||
124451097|NCT00041080|447613578|FG000|Overall Study|Adverse Event|21|||
124451098|NCT00041080|447613579|FG001|Overall Study|Adverse Event|1|||
124451099|NCT00041080|447613578|FG000|Overall Study|Withdrawal by Subject|6|||
124451100|NCT00041080|447613579|FG001|Overall Study|Withdrawal by Subject|6|||
124451101|NCT00041080|447613578|FG000|Overall Study|Concommitant Illness/Other|1|||
124451102|NCT00041080|447613579|FG001|Overall Study|Concommitant Illness/Other|2|||
124451103|NCT00041080|447613578|FG000|Overall Study|Did not start therapy|1|||
124913094|NCT02576509|449308688|FG000|Treatment Period|Death|1|||
124913095|NCT02576509|449308689|FG001|Treatment Period|Death|1|||
124913096|NCT02576509|449308688|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
124451104|NCT00041080|447613579|FG001|Overall Study|Did not start therapy|1|||
124451105|NCT00041080|447613578|FG000|Overall Study|Ineligible|1|||
124451106|NCT00041080|447613579|FG001|Overall Study|Ineligible|0|||
124451107|NCT02066311|447613580|FG000|Overall Study|Adverse Event|4|||
124451108|NCT02066311|447613580|FG000|Overall Study|Withdrawal by Subject|1|||
124913097|NCT02576509|449308689|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
124451109|NCT03198520|447613583|FG000|Overall Study|Physician Decision|2|||
124451110|NCT03198520|447613583|FG000|Overall Study|Protocol Violation|2|||
124451111|NCT03198520|447613583|FG000|Overall Study|Withdrawal by Subject|1|||
124451112|NCT03198520|447613583|FG000|Overall Study|Study Ended|1|||
124693688|NCT04518410|448498736|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
124693689|NCT04518410|448498737|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
124693690|NCT04518410|448498738|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
124693691|NCT04518410|448498739|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
124693692|NCT04518410|448498740|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
124693693|NCT04518410|448498741|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
124693694|NCT04518410|448498742|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
124693695|NCT04518410|448498743|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
124693696|NCT04518410|448498744|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
124693697|NCT04518410|448498745|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
124693698|NCT04518410|448498746|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
124712014|NCT01343888|448570708|FG001|Overall Study|other than stated above|0|||
124913098|NCT02576509|449308688|FG000|Treatment Period|Participant request to stop treatment|8|||
124913099|NCT02576509|449308689|FG001|Treatment Period|Participant request to stop treatment|18|||
124693699|NCT04518410|448498747|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
124693700|NCT04518410|448498748|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
124693701|NCT04518410|448498749|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
124693702|NCT04518410|448498750|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
124693703|NCT04518410|448498751|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
124693704|NCT04518410|448498752|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
124693705|NCT04518410|448498728|FG000|Overall Study|Dual Enrolled Subject|0|||
124913100|NCT02576509|449308688|FG000|Treatment Period|Participant withdrew consent|3|||
124913101|NCT02576509|449308689|FG001|Treatment Period|Participant withdrew consent|7|||
124913102|NCT02576509|449308688|FG000|Treatment Period|Lost to Follow-up|0|||
124913103|NCT02576509|449308689|FG001|Treatment Period|Lost to Follow-up|1|||
124913104|NCT02576509|449308688|FG000|Treatment Period|Maximum clinical benefit|1|||
124913105|NCT02576509|449308689|FG001|Treatment Period|Maximum clinical benefit|0|||
124913106|NCT02576509|449308688|FG000|Treatment Period|Poor/non-compliance|1|||
124913107|NCT02576509|449308689|FG001|Treatment Period|Poor/non-compliance|1|||
124913108|NCT02576509|449308688|FG000|Treatment Period|Participant no longer meets criteria|1|||
124913109|NCT02576509|449308689|FG001|Treatment Period|Participant no longer meets criteria|0|||
124913110|NCT02576509|449308688|FG000|Treatment Period|Other reason|12|||
124913111|NCT02576509|449308689|FG001|Treatment Period|Other reason|8|||
124913112|NCT02576509|449308688|FG000|Treatment Period|NOT REPORTED|1|||
124913113|NCT02576509|449308689|FG001|Treatment Period|NOT REPORTED|0|||
124913114|NCT02576509|449308688|FG000|Treatment Period|Administrative reason by sponsor|0|||
124913115|NCT02576509|449308689|FG001|Treatment Period|Administrative reason by sponsor|1|||
124913116|NCT04688450|449308690|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
124913117|NCT04688450|449308690|FG000|Overall Study|Withdrawal by Subject|1|||
124913118|NCT01353313|449308693|FG000|Overall Study|Lost to Follow-up|22|||
124913119|NCT01353313|449308694|FG001|Overall Study|Lost to Follow-up|23|||
124913120|NCT01353313|449308693|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
124913121|NCT01353313|449308694|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
124913122|NCT04755660|449308695|FG000|Overall Study|Lost to Follow-up|1|||
124913123|NCT04755660|449308696|FG001|Overall Study|Lost to Follow-up|1|||
124913124|NCT04755660|449308697|FG002|Overall Study|Lost to Follow-up|0|||
124913125|NCT04755660|449308695|FG000|Overall Study|Withdrawal by Subject|0|||
124913126|NCT04755660|449308696|FG001|Overall Study|Withdrawal by Subject|1|||
124913127|NCT04755660|449308697|FG002|Overall Study|Withdrawal by Subject|1|||
124913128|NCT04755660|449308695|FG000|Overall Study|Physician Decision|0|||
124913129|NCT04755660|449308696|FG001|Overall Study|Physician Decision|0|||
124913130|NCT04755660|449308697|FG002|Overall Study|Physician Decision|1|||
124913131|NCT00670046|449308706|FG000|Overall Study|Lost to Follow-up|1|||
124913132|NCT00670046|449308707|FG001|Overall Study|Lost to Follow-up|1|||
124913133|NCT00670046|449308706|FG000|Overall Study|Withdrawal by Subject|0|||
124913134|NCT00670046|449308707|FG001|Overall Study|Withdrawal by Subject|1|||
124913135|NCT02121002|449308710|FG000|Overall Study|Physician Decision|2|||
124451113|NCT01670539|447613584|FG000|Overall Study|Death|3|||
124913136|NCT02121002|449308711|FG001|Overall Study|Physician Decision|0|||
124913137|NCT02121002|449308712|FG002|Overall Study|Physician Decision|0|||
124913138|NCT02121002|449308710|FG000|Overall Study|Withdrawal by Subject|3|||
124913139|NCT02121002|449308711|FG001|Overall Study|Withdrawal by Subject|1|||
124913140|NCT02121002|449308712|FG002|Overall Study|Withdrawal by Subject|4|||
124913141|NCT02121002|449308710|FG000|Overall Study|Protocol Violation|1|||
124913142|NCT02121002|449308711|FG001|Overall Study|Protocol Violation|2|||
124913143|NCT02121002|449308712|FG002|Overall Study|Protocol Violation|4|||
124913144|NCT02121002|449308710|FG000|Overall Study|Concomitant therapy|0|||
124913145|NCT02121002|449308711|FG001|Overall Study|Concomitant therapy|1|||
124913146|NCT02121002|449308712|FG002|Overall Study|Concomitant therapy|1|||
124913147|NCT02121002|449308710|FG000|Overall Study|Others|1|||
124693706|NCT04518410|448498729|FG001|Overall Study|Dual Enrolled Subject|0|||
124693707|NCT04518410|448498730|FG002|Overall Study|Dual Enrolled Subject|0|||
124693708|NCT04518410|448498731|FG003|Overall Study|Dual Enrolled Subject|0|||
124693709|NCT04518410|448498732|FG004|Overall Study|Dual Enrolled Subject|0|||
124693710|NCT04518410|448498733|FG005|Overall Study|Dual Enrolled Subject|0|||
124693711|NCT04518410|448498734|FG006|Overall Study|Dual Enrolled Subject|0|||
124693712|NCT04518410|448498735|FG007|Overall Study|Dual Enrolled Subject|0|||
124693713|NCT04518410|448498736|FG008|Overall Study|Dual Enrolled Subject|0|||
124693714|NCT04518410|448498737|FG009|Overall Study|Dual Enrolled Subject|0|||
124693715|NCT04518410|448498738|FG010|Overall Study|Dual Enrolled Subject|0|||
124693716|NCT04518410|448498739|FG011|Overall Study|Dual Enrolled Subject|0|||
124693717|NCT04518410|448498740|FG012|Overall Study|Dual Enrolled Subject|0|||
124693718|NCT04518410|448498741|FG013|Overall Study|Dual Enrolled Subject|0|||
124693719|NCT04518410|448498742|FG014|Overall Study|Dual Enrolled Subject|0|||
124693720|NCT04518410|448498743|FG015|Overall Study|Dual Enrolled Subject|0|||
124693721|NCT04518410|448498744|FG016|Overall Study|Dual Enrolled Subject|0|||
124693722|NCT04518410|448498745|FG017|Overall Study|Dual Enrolled Subject|1|||
124693723|NCT04518410|448498746|FG018|Overall Study|Dual Enrolled Subject|0|||
124693724|NCT04518410|448498747|FG019|Overall Study|Dual Enrolled Subject|0|||
124693725|NCT04518410|448498748|FG020|Overall Study|Dual Enrolled Subject|0|||
124693726|NCT04518410|448498749|FG021|Overall Study|Dual Enrolled Subject|0|||
124693727|NCT04518410|448498750|FG022|Overall Study|Dual Enrolled Subject|0|||
124693728|NCT04518410|448498751|FG023|Overall Study|Dual Enrolled Subject|0|||
124693729|NCT04518410|448498752|FG024|Overall Study|Dual Enrolled Subject|0|||
124693730|NCT05737745|448498753|FG000|Overall Study|Withdrawal by Subject|0|||
124693731|NCT05737745|448498754|FG001|Overall Study|Withdrawal by Subject|6|||
124693732|NCT05737745|448498755|FG002|Overall Study|Withdrawal by Subject|1|||
124693733|NCT05103332|448498756|FG000|Overall Study|Lost to Follow-up|0|||
124693734|NCT05103332|448498757|FG001|Overall Study|Lost to Follow-up|2|||
124693735|NCT05103332|448498758|FG002|Overall Study|Lost to Follow-up|1|||
124913148|NCT02121002|449308711|FG001|Overall Study|Others|0|||
124913149|NCT02121002|449308712|FG002|Overall Study|Others|1|||
124913150|NCT03403413|449308713|FG000|Overall Study|Lack of Efficacy|2|||
124913151|NCT03655262|449308714|FG000|Overall Study|Withdrawal by Subject|0|||
124913152|NCT03655262|449308715|FG001|Overall Study|Withdrawal by Subject|0|||
124913153|NCT03655262|449308716|FG002|Overall Study|Withdrawal by Subject|1|||
124913154|NCT04583423|449308719|FG000|Overall Study|Lost to Follow-up|0|||
124913155|NCT04583423|449308720|FG001|Overall Study|Lost to Follow-up|1|||
124913156|NCT04583423|449308721|FG002|Overall Study|Lost to Follow-up|0|||
124913157|NCT04583423|449308722|FG003|Overall Study|Lost to Follow-up|2|||
124913158|NCT04583423|449308719|FG000|Overall Study|Study Terminated by Sponsor|32|||
124913159|NCT04583423|449308720|FG001|Overall Study|Study Terminated by Sponsor|35|||
124913160|NCT04583423|449308721|FG002|Overall Study|Study Terminated by Sponsor|36|||
124913161|NCT04583423|449308722|FG003|Overall Study|Study Terminated by Sponsor|33|||
124913162|NCT04583423|449308719|FG000|Overall Study|Withdrawal by Subject|3|||
124913163|NCT04583423|449308720|FG001|Overall Study|Withdrawal by Subject|1|||
124913164|NCT04583423|449308721|FG002|Overall Study|Withdrawal by Subject|2|||
124913165|NCT04583423|449308722|FG003|Overall Study|Withdrawal by Subject|1|||
124913166|NCT04704284|449308728|FG000|Overall Study|Withdrawal by Subject|1|||
124913167|NCT00603954|449308732|FG000|Overall Study|Protocol Violation|1|||
124913168|NCT00603954|449308733|FG001|Overall Study|Protocol Violation|2|||
124913169|NCT00580866|449308736|FG000|Overall Study|Lost to Follow-up|2|||
124451114|NCT01670539|447613585|FG001|Overall Study|Death|5|||
124693736|NCT05103332|448498759|FG003|Overall Study|Lost to Follow-up|0|||
124693737|NCT05103332|448498760|FG004|Overall Study|Lost to Follow-up|0|||
124693738|NCT05103332|448498761|FG005|Overall Study|Lost to Follow-up|2|||
124913170|NCT00580866|449308737|FG001|Overall Study|Lost to Follow-up|2|||
124913171|NCT02477605|449308738|FG000|Overall Study|Discontinued prior to treatment|1|||
124913172|NCT02477605|449308739|FG001|Overall Study|Discontinued prior to treatment|0|||
124913173|NCT02477605|449308738|FG000|Overall Study|Lost to Follow-up|0|||
124913174|NCT02477605|449308739|FG001|Overall Study|Lost to Follow-up|2|||
124913175|NCT02477605|449308738|FG000|Overall Study|Withdrawal by Subject|0|||
124693739|NCT05103332|448498756|FG000|Overall Study|Physician Decision|0|||
124693740|NCT05103332|448498757|FG001|Overall Study|Physician Decision|1|||
124913176|NCT02477605|449308739|FG001|Overall Study|Withdrawal by Subject|1|||
124913177|NCT02477605|449308738|FG000|Overall Study|Administered gas during surgery|0|||
124913178|NCT02477605|449308739|FG001|Overall Study|Administered gas during surgery|1|||
124693741|NCT05103332|448498758|FG002|Overall Study|Physician Decision|0|||
124913179|NCT00567489|449308740|FG000|Overall Study|Adverse Event|6|||
124693742|NCT05103332|448498759|FG003|Overall Study|Physician Decision|1|||
124913180|NCT00567489|449308741|FG001|Overall Study|Adverse Event|14|||
124693743|NCT05103332|448498760|FG004|Overall Study|Physician Decision|0|||
124693744|NCT05103332|448498761|FG005|Overall Study|Physician Decision|0|||
124693745|NCT05103332|448498756|FG000|Overall Study|Participant Stopped Participation in the Study|2|||
124693746|NCT05103332|448498757|FG001|Overall Study|Participant Stopped Participation in the Study|3|||
124693747|NCT05103332|448498758|FG002|Overall Study|Participant Stopped Participation in the Study|5|||
124913181|NCT00567489|449308740|FG000|Overall Study|Physician Decision|0|||
124913182|NCT00567489|449308741|FG001|Overall Study|Physician Decision|4|||
124913183|NCT00567489|449308740|FG000|Overall Study|Withdrawal by Subject|0|||
124451115|NCT01670539|447613584|FG000|Overall Study|Withdrawal by Subject|3|||
124451116|NCT01670539|447613585|FG001|Overall Study|Withdrawal by Subject|0|||
124451117|NCT04353596|447613586|FG000|Overall Study|Protocol Violation|4|||
124451118|NCT04353596|447613587|FG001|Overall Study|Protocol Violation|4|||
124451119|NCT04353596|447613586|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
124451120|NCT04353596|447613587|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
124451121|NCT02665052|447613588|FG000|Overall Study|Lost to Follow-up|1|||
124451122|NCT02665052|447613589|FG001|Overall Study|Lost to Follow-up|0|||
124451123|NCT02665052|447613590|FG002|Overall Study|Lost to Follow-up|0|||
124451124|NCT02665052|447613591|FG003|Overall Study|Lost to Follow-up|0|||
124451125|NCT02665052|447613588|FG000|Overall Study|Withdrawal by Subject|1|||
124451126|NCT02665052|447613589|FG001|Overall Study|Withdrawal by Subject|1|||
124451127|NCT02665052|447613590|FG002|Overall Study|Withdrawal by Subject|0|||
124451128|NCT02665052|447613591|FG003|Overall Study|Withdrawal by Subject|5|||
124451129|NCT02665052|447613588|FG000|Overall Study|Adverse Event|1|||
124545369|NCT00423137|447951175|FG003|Overall Study|Lost to Follow-up|0|||
124545370|NCT00423137|447951172|FG000|Overall Study|Protocol Violation|0|||
124693748|NCT05103332|448498759|FG003|Overall Study|Participant Stopped Participation in the Study|3|||
124913184|NCT00567489|449308741|FG001|Overall Study|Withdrawal by Subject|2|||
124913185|NCT00567489|449308740|FG000|Overall Study|Renal Transplantation|0|||
124913186|NCT00567489|449308741|FG001|Overall Study|Renal Transplantation|3|||
124913187|NCT00567489|449308740|FG000|Overall Study|Other|1|||
124913188|NCT00567489|449308741|FG001|Overall Study|Other|0|||
124913189|NCT03101930|449308746|FG000|Overall Study|Withdrawal by Subject|2|||
124913190|NCT03101930|449308747|FG001|Overall Study|Withdrawal by Subject|1|||
124913191|NCT03101930|449308748|FG002|Overall Study|Withdrawal by Subject|2|||
124913192|NCT01083316|449308749|FG000|Overall Study|Adverse Event|2|||
124913193|NCT01083316|449308749|FG000|Overall Study|Withdrawal by Subject|1|||
124913194|NCT00331136|449308750|FG000|Overall Study|Adverse Event|3|||
124913195|NCT00331136|449308751|FG001|Overall Study|Adverse Event|5|||
124913196|NCT00331136|449308752|FG002|Overall Study|Adverse Event|0|||
124913197|NCT00331136|449308753|FG003|Overall Study|Adverse Event|1|||
124913198|NCT00331136|449308750|FG000|Overall Study|Withdrawal by Subject|0|||
124913199|NCT00331136|449308751|FG001|Overall Study|Withdrawal by Subject|1|||
124913200|NCT00331136|449308752|FG002|Overall Study|Withdrawal by Subject|0|||
124913201|NCT00331136|449308753|FG003|Overall Study|Withdrawal by Subject|0|||
124913202|NCT00331136|449308750|FG000|Overall Study|Lost to Follow-up|0|||
124913203|NCT00331136|449308751|FG001|Overall Study|Lost to Follow-up|1|||
124913204|NCT00331136|449308752|FG002|Overall Study|Lost to Follow-up|0|||
124913205|NCT00331136|449308753|FG003|Overall Study|Lost to Follow-up|0|||
124913206|NCT00331136|449308750|FG000|Overall Study|Protocol Violation|1|||
124913207|NCT00331136|449308751|FG001|Overall Study|Protocol Violation|0|||
124913208|NCT00331136|449308752|FG002|Overall Study|Protocol Violation|0|||
124913209|NCT00331136|449308753|FG003|Overall Study|Protocol Violation|0|||
124913210|NCT00331136|449308750|FG000|Overall Study|Not treated|1|||
124913211|NCT00331136|449308751|FG001|Overall Study|Not treated|0|||
124913212|NCT00331136|449308752|FG002|Overall Study|Not treated|0|||
124913213|NCT00331136|449308753|FG003|Overall Study|Not treated|0|||
124913214|NCT00065260|449308758|FG000|Overall Study|Death|0|||
124913215|NCT00065260|449308759|FG001|Overall Study|Death|1|||
124913216|NCT02178098|449308762|FG000|Overall Study|Withdrawal by Subject|0|||
124913217|NCT02178098|449308763|FG001|Overall Study|Withdrawal by Subject|6|||
124913218|NCT02178098|449308762|FG000|Overall Study|Adverse Event|1|||
124913219|NCT02178098|449308763|FG001|Overall Study|Adverse Event|2|||
124913220|NCT02178098|449308762|FG000|Overall Study|Protocol Violation|1|||
124913221|NCT02178098|449308763|FG001|Overall Study|Protocol Violation|1|||
124913222|NCT02178098|449308762|FG000|Overall Study|Lost to Follow-up|0|||
124913223|NCT02178098|449308763|FG001|Overall Study|Lost to Follow-up|1|||
124913224|NCT02178098|449308762|FG000|Overall Study|Sponsor Request|1|||
124693749|NCT05103332|448498760|FG004|Overall Study|Participant Stopped Participation in the Study|3|||
124913225|NCT02178098|449308763|FG001|Overall Study|Sponsor Request|0|||
124913226|NCT02178098|449308762|FG000|Overall Study|Other|2|||
124913227|NCT02178098|449308763|FG001|Overall Study|Other|2|||
124913228|NCT03432858|449308765|FG000|Overall Study|Protocol Violation|2|||
124913229|NCT03432858|449308766|FG001|Overall Study|Protocol Violation|1|||
124913230|NCT03432858|449308767|FG002|Overall Study|Protocol Violation|9|||
124451130|NCT02665052|447613589|FG001|Overall Study|Adverse Event|1|||
124451131|NCT02665052|447613590|FG002|Overall Study|Adverse Event|0|||
124913231|NCT03432858|449308765|FG000|Overall Study|Withdrawal by Subject|0|||
124913232|NCT03432858|449308766|FG001|Overall Study|Withdrawal by Subject|1|||
124913233|NCT03432858|449308767|FG002|Overall Study|Withdrawal by Subject|1|||
124913234|NCT03432858|449308765|FG000|Overall Study|Procedure canceled/rescheduled|0|||
124913235|NCT03432858|449308766|FG001|Overall Study|Procedure canceled/rescheduled|9|||
124913236|NCT03432858|449308767|FG002|Overall Study|Procedure canceled/rescheduled|6|||
124913237|NCT03432858|449308765|FG000|Overall Study|Required postop mobilization with splinting|0|||
124913238|NCT03432858|449308766|FG001|Overall Study|Required postop mobilization with splinting|0|||
124913239|NCT03432858|449308767|FG002|Overall Study|Required postop mobilization with splinting|1|||
124913240|NCT01044303|449308772|FG000|Overall Study|Lost to Follow-up|2|||
124913241|NCT01109524|449308773|FG000|Overall Study|Disease Progression|29|||
124913242|NCT01109524|449308773|FG000|Overall Study|Study Drug toxicity|6|||
124913243|NCT01109524|449308773|FG000|Overall Study|Adverse Event|4|||
124913244|NCT01109524|449308773|FG000|Overall Study|Withdrawal by Subject|2|||
124913245|NCT01109524|449308773|FG000|Overall Study|Maximum clinical benefit|3|||
124913246|NCT01109524|449308773|FG000|Overall Study|Death|2|||
124913247|NCT01109524|449308773|FG000|Overall Study|No longer meets criteria|2|||
124913248|NCT01109524|449308773|FG000|Overall Study|Participant requested to end treatment|4|||
124913249|NCT01109524|449308773|FG000|Overall Study|Other|5|||
124913250|NCT00031694|449308785|FG000|Overall Study|Adverse Event|12|||
124913251|NCT00031694|449308785|FG000|Overall Study|Death|2|||
124913252|NCT00031694|449308785|FG000|Overall Study|Withdrawal by Subject|5|||
124913253|NCT01303445|449308801|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
124913254|NCT01303445|449308802|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
124913255|NCT01303445|449308801|FG000|Second Intervention (7 Days)|Adverse Event|0|||
124913256|NCT01303445|449308802|FG001|Second Intervention (7 Days)|Adverse Event|2|||
124913257|NCT01303445|449308801|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
124913258|NCT01303445|449308802|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
124913259|NCT01303445|449308801|FG000|Washout (14 Days)|Protocol Violation|1|||
124913260|NCT01303445|449308802|FG001|Washout (14 Days)|Protocol Violation|0|||
124913261|NCT01303445|449308801|FG000|Washout (14 Days)|Lost to Follow-up|0|||
124913262|NCT01303445|449308802|FG001|Washout (14 Days)|Lost to Follow-up|2|||
124913263|NCT01303445|449308801|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
124913264|NCT01303445|449308802|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
124913265|NCT01303445|449308801|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
124693750|NCT05103332|448498761|FG005|Overall Study|Participant Stopped Participation in the Study|7|||
124693751|NCT05103332|448498756|FG000|Overall Study|Unspeccified|0|||
124693752|NCT05103332|448498757|FG001|Overall Study|Unspeccified|0|||
124693753|NCT05103332|448498758|FG002|Overall Study|Unspeccified|0|||
124693754|NCT05103332|448498759|FG003|Overall Study|Unspeccified|1|||
124693755|NCT05103332|448498760|FG004|Overall Study|Unspeccified|0|||
124693756|NCT05103332|448498761|FG005|Overall Study|Unspeccified|0|||
124693757|NCT00362609|448498762|FG000|Overall Study|Withdrawal by Subject|0|||
124693758|NCT00362609|448498763|FG001|Overall Study|Withdrawal by Subject|1|||
124693759|NCT00362609|448498762|FG000|Overall Study|Protocol Violation|0|||
124693760|NCT00362609|448498763|FG001|Overall Study|Protocol Violation|1|||
124693761|NCT01800058|448498772|FG000|Overall Study|Lost to Follow-up|1|||
124693762|NCT02186171|448498773|FG000|Overall Study|Withdrawal by Subject|1|||
124693763|NCT02186171|448498774|FG001|Overall Study|Withdrawal by Subject|9|||
124693764|NCT02186171|448498773|FG000|Overall Study|Lost to Follow-up|2|||
124693765|NCT02186171|448498774|FG001|Overall Study|Lost to Follow-up|2|||
124693766|NCT02186171|448498773|FG000|Overall Study|Death|1|||
124693767|NCT02186171|448498774|FG001|Overall Study|Death|2|||
124693768|NCT02186171|448498773|FG000|Overall Study|Protocol-specified Criteria|0|||
124693769|NCT02186171|448498774|FG001|Overall Study|Protocol-specified Criteria|2|||
124693770|NCT04289298|448500367|FG000|Overall Study|Lost to Follow-up|5|||
124693771|NCT04289298|448500368|FG001|Overall Study|Lost to Follow-up|0|||
124693772|NCT04289298|448500367|FG000|Overall Study|Withdrawal by Subject|2|||
124693773|NCT04289298|448500368|FG001|Overall Study|Withdrawal by Subject|0|||
124693774|NCT00620035|448500369|FG000|Overall Study|Adverse Event|106|||
124693775|NCT00620035|448500369|FG000|Overall Study|Withdrawal of Informed Consent|1|||
124693776|NCT00620035|448500369|FG000|Overall Study|Other Reason|38|||
124913266|NCT01303445|449308802|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
124913267|NCT04939246|449308803|FG000|After Treatment|Death|4|||
124913268|NCT04939246|449308803|FG000|After Treatment|Lost to Follow-up|1|||
124913269|NCT04939246|449308803|FG000|After Treatment|Discharged to hospice|2|||
124913270|NCT04994509|449308804|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
124913271|NCT04994509|449308805|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
124913272|NCT04994509|449308806|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
124451132|NCT02665052|447613591|FG003|Overall Study|Adverse Event|0|||
124451133|NCT00823823|447613592|FG000|Overall Study|Lost to Follow-up|3|||
124451134|NCT00823823|447613593|FG001|Overall Study|Lost to Follow-up|1|||
124451135|NCT00823823|447613592|FG000|Overall Study|Protocol Violation|5|||
124451136|NCT00823823|447613593|FG001|Overall Study|Protocol Violation|5|||
124451137|NCT01526551|447613597|FG000|Overall Study|Lack of returned parental consent form|424|||
124451138|NCT05215262|447613598|FG000|Overall Study|Lost to Follow-up|12|||
124451139|NCT05215262|447613599|FG001|Overall Study|Lost to Follow-up|0|||
124451140|NCT00718549|447613600|FG000|Induction Phase|Disease Progression|1|||
124451141|NCT00718549|447613601|FG001|Induction Phase|Disease Progression|0|||
124451142|NCT00718549|447613602|FG002|Induction Phase|Disease Progression|0|||
124451143|NCT00718549|447613600|FG000|Induction Phase|Eligibility Criteria Violation|2|||
124451144|NCT00718549|447613601|FG001|Induction Phase|Eligibility Criteria Violation|0|||
124451145|NCT00718549|447613602|FG002|Induction Phase|Eligibility Criteria Violation|0|||
124451146|NCT00718549|447613600|FG000|Induction Phase|Early Termination - No Additional Info|59|||
124451147|NCT00718549|447613601|FG001|Induction Phase|Early Termination - No Additional Info|0|||
124451148|NCT00718549|447613602|FG002|Induction Phase|Early Termination - No Additional Info|0|||
124451149|NCT00718549|447613600|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
124451150|NCT00718549|447613601|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
124451151|NCT00718549|447613602|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
124451152|NCT00718549|447613600|FG000|Maintenance/ Observation Phase|Death|0|||
124451153|NCT00718549|447613601|FG001|Maintenance/ Observation Phase|Death|1|||
124451154|NCT00718549|447613602|FG002|Maintenance/ Observation Phase|Death|2|||
124451155|NCT00718549|447613600|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
124451156|NCT00718549|447613601|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
124451157|NCT00718549|447613602|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
124451158|NCT00718549|447613600|FG000|Maintenance/ Observation Phase|Progression|0|||
124451159|NCT00718549|447613601|FG001|Maintenance/ Observation Phase|Progression|5|||
124451160|NCT00718549|447613602|FG002|Maintenance/ Observation Phase|Progression|14|||
124451161|NCT00718549|447613600|FG000|Maintenance/ Observation Phase|Relapse|0|||
124451162|NCT00718549|447613601|FG001|Maintenance/ Observation Phase|Relapse|3|||
124451163|NCT00718549|447613602|FG002|Maintenance/ Observation Phase|Relapse|2|||
124451164|NCT01353508|447613603|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
124451165|NCT01353508|447613604|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
124451166|NCT01353508|447613605|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
124451167|NCT01353508|447613606|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
124451168|NCT01353508|447613603|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
124913273|NCT04994509|449308804|FG000|Overall Study|Withdrew Consent|73|||
124913274|NCT04994509|449308805|FG001|Overall Study|Withdrew Consent|72|||
124451169|NCT01353508|447613604|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
124451170|NCT01353508|447613605|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
124451171|NCT01353508|447613606|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
124451172|NCT02606461|447613607|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
124451173|NCT02606461|447613608|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
124451174|NCT02606461|447613609|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
124451175|NCT02606461|447613610|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
124451176|NCT02606461|447613611|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
124451177|NCT02606461|447613612|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
124451178|NCT00239226|447613613|FG000|Overall Study|permAF during stabilization period|0|||
124545371|NCT00423137|447951173|FG001|Overall Study|Protocol Violation|0|||
124913275|NCT04994509|449308806|FG002|Overall Study|Withdrew Consent|46|||
124913276|NCT04994509|449308804|FG000|Overall Study|Lost to Follow-up|39|||
124913277|NCT04994509|449308805|FG001|Overall Study|Lost to Follow-up|36|||
124913278|NCT04994509|449308806|FG002|Overall Study|Lost to Follow-up|26|||
124913279|NCT04994509|449308804|FG000|Overall Study|HIV-1 Infection|4|||
124913280|NCT04994509|449308805|FG001|Overall Study|HIV-1 Infection|20|||
124913281|NCT04994509|449308806|FG002|Overall Study|HIV-1 Infection|12|||
124913282|NCT04994509|449308804|FG000|Overall Study|Investigator's Discretion|9|||
124913283|NCT04994509|449308805|FG001|Overall Study|Investigator's Discretion|8|||
124913284|NCT04994509|449308806|FG002|Overall Study|Investigator's Discretion|11|||
124451179|NCT00239226|447613614|FG001|Overall Study|permAF during stabilization period|0|||
124451180|NCT00239226|447613615|FG002|Overall Study|permAF during stabilization period|0|||
124451181|NCT00239226|447613616|FG003|Overall Study|permAF during stabilization period|3|||
124913285|NCT04994509|449308804|FG000|Overall Study|Randomized but Never Treated|10|||
124913286|NCT04994509|449308805|FG001|Overall Study|Randomized but Never Treated|10|||
124913287|NCT04994509|449308806|FG002|Overall Study|Randomized but Never Treated|3|||
124913288|NCT04994509|449308804|FG000|Overall Study|Pregnancy|5|||
124913289|NCT04994509|449308805|FG001|Overall Study|Pregnancy|5|||
124913290|NCT04994509|449308806|FG002|Overall Study|Pregnancy|0|||
124913291|NCT04994509|449308804|FG000|Overall Study|Death|0|||
124913292|NCT04994509|449308805|FG001|Overall Study|Death|5|||
124913293|NCT04994509|449308806|FG002|Overall Study|Death|0|||
124913294|NCT04994509|449308804|FG000|Overall Study|Adverse Event|2|||
124761188|NCT01855412|448751552|FG000|Overall Study|Withdrawal by Subject|77|||
124761189|NCT01855412|448751553|FG001|Overall Study|Withdrawal by Subject|123|||
124761190|NCT01855412|448751554|FG002|Overall Study|Withdrawal by Subject|24|||
124761191|NCT01855412|448751552|FG000|Overall Study|Physician Decision|25|||
124761192|NCT01855412|448751553|FG001|Overall Study|Physician Decision|31|||
124761193|NCT01855412|448751554|FG002|Overall Study|Physician Decision|3|||
124761194|NCT01855412|448751552|FG000|Overall Study|Site Closure|4|||
124761195|NCT01855412|448751553|FG001|Overall Study|Site Closure|18|||
124761196|NCT01855412|448751554|FG002|Overall Study|Site Closure|1|||
124761197|NCT01855412|448751552|FG000|Overall Study|Reason not Specified|1|||
124761198|NCT01855412|448751553|FG001|Overall Study|Reason not Specified|2|||
124761199|NCT01855412|448751554|FG002|Overall Study|Reason not Specified|3|||
124761200|NCT01702844|448751569|FG000|Overall Study|Adverse Event|9|||
124761201|NCT01702844|448751569|FG000|Overall Study|Death|1|||
124761202|NCT01702844|448751569|FG000|Overall Study|Withdrawal by Subject|3|||
124761203|NCT01702844|448751569|FG000|Overall Study|Physician Decision|6|||
124761204|NCT02123134|448751570|FG000|Overall Study|Withdrawal of consent|3|||
124761205|NCT02123134|448751571|FG001|Overall Study|Withdrawal of consent|2|||
124761206|NCT02123134|448751570|FG000|Overall Study|Administrative decision|0|||
124761207|NCT02123134|448751571|FG001|Overall Study|Administrative decision|1|||
124693777|NCT04193176|448500371|FG000|Overall Study|Withdrawal by Subject|6|||
124693778|NCT04193176|448500372|FG001|Overall Study|Withdrawal by Subject|10|||
124693779|NCT01629563|448500373|FG000|Overall Study|Adverse Event|16|||
124693780|NCT01629563|448500374|FG001|Overall Study|Adverse Event|16|||
124693781|NCT01629563|448500373|FG000|Overall Study|Death|2|||
124693782|NCT01629563|448500374|FG001|Overall Study|Death|0|||
124693783|NCT01629563|448500373|FG000|Overall Study|Lack of Efficacy|2|||
124693784|NCT01629563|448500374|FG001|Overall Study|Lack of Efficacy|3|||
124693785|NCT01629563|448500373|FG000|Overall Study|Lost to Follow-up|1|||
124693786|NCT01629563|448500374|FG001|Overall Study|Lost to Follow-up|0|||
124693787|NCT01629563|448500373|FG000|Overall Study|Pregnancy|1|||
124693788|NCT01629563|448500374|FG001|Overall Study|Pregnancy|2|||
124693789|NCT01629563|448500373|FG000|Overall Study|Protocol Violation|0|||
124693790|NCT01629563|448500374|FG001|Overall Study|Protocol Violation|1|||
124693791|NCT01629563|448500373|FG000|Overall Study|Withdrawal by Subject|27|||
124693792|NCT01629563|448500374|FG001|Overall Study|Withdrawal by Subject|20|||
124693793|NCT01629563|448500373|FG000|Overall Study|surgery|0|||
124693794|NCT01629563|448500374|FG001|Overall Study|surgery|3|||
124693795|NCT01629563|448500373|FG000|Overall Study|Lack of return of menses|12|||
124693796|NCT01629563|448500374|FG001|Overall Study|Lack of return of menses|7|||
124693797|NCT01629563|448500373|FG000|Overall Study|Protocol Violation|0|||
124693798|NCT01629563|448500374|FG001|Overall Study|Protocol Violation|1|||
124693799|NCT02370394|448500376|FG000|Overall Study|Lost to Follow-up|2|||
124693800|NCT02370394|448500377|FG001|Overall Study|Lost to Follow-up|1|||
124693801|NCT02370394|448500376|FG000|Overall Study|Withdrawal by Subject|0|||
124693802|NCT02370394|448500377|FG001|Overall Study|Withdrawal by Subject|1|||
124693803|NCT01108796|448500378|FG000|Overall Study|Adverse Event|0|||
124693804|NCT01108796|448500379|FG001|Overall Study|Adverse Event|1|||
124693805|NCT01108796|448500378|FG000|Overall Study|Lost to Follow-up|7|||
124693806|NCT01108796|448500379|FG001|Overall Study|Lost to Follow-up|6|||
124693807|NCT00454142|448500380|FG000|Overall Study|Withdrawal by Subject|1|||
124693808|NCT01902303|448500381|FG000|Overall Study|Adverse Event|0|||
124693809|NCT01902303|448500382|FG001|Overall Study|Adverse Event|1|||
124693810|NCT01902303|448500381|FG000|Overall Study|Lost to Follow-up|0|||
124693811|NCT01902303|448500382|FG001|Overall Study|Lost to Follow-up|1|||
124761208|NCT03431441|448751572|FG000|Overall Study|Withdrawal by Subject|2|||
124761209|NCT03431441|448751572|FG000|Overall Study|Adverse Event|2|||
124693812|NCT01902303|448500381|FG000|Overall Study|Protocol Violation|2|||
124693813|NCT01902303|448500382|FG001|Overall Study|Protocol Violation|2|||
124693814|NCT01902303|448500381|FG000|Overall Study|subject lost investigational product|0|||
124693815|NCT01902303|448500382|FG001|Overall Study|subject lost investigational product|1|||
124693816|NCT01902303|448500381|FG000|Overall Study|Did not develop a cold sore|21|||
124693817|NCT01902303|448500382|FG001|Overall Study|Did not develop a cold sore|19|||
124693818|NCT02821000|448500383|FG000|Overall Study|Death|89|||
124693819|NCT02821000|448500383|FG000|Overall Study|Sponsor Decision|12|||
124693820|NCT02821000|448500383|FG000|Overall Study|Withdrawal by Subject|2|||
124693821|NCT02545127|448500389|FG000|Overall Study|Lost to Follow-up|1|||
124693822|NCT02545127|448500390|FG001|Overall Study|Lost to Follow-up|0|||
124693823|NCT00960856|448500396|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
124693824|NCT00960856|448500397|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
124913295|NCT04994509|449308805|FG001|Overall Study|Adverse Event|1|||
124913296|NCT04994509|449308806|FG002|Overall Study|Adverse Event|0|||
124913297|NCT04994509|449308804|FG000|Overall Study|Non-compliance With Study Drug|1|||
124913298|NCT04994509|449308805|FG001|Overall Study|Non-compliance With Study Drug|1|||
124913299|NCT04994509|449308806|FG002|Overall Study|Non-compliance With Study Drug|1|||
124913300|NCT04994509|449308804|FG000|Overall Study|Withdrew Assent|3|||
124913301|NCT04994509|449308805|FG001|Overall Study|Withdrew Assent|0|||
124913302|NCT04994509|449308806|FG002|Overall Study|Withdrew Assent|0|||
124913303|NCT04994509|449308804|FG000|Overall Study|Protocol Violation|1|||
124913304|NCT04994509|449308805|FG001|Overall Study|Protocol Violation|0|||
124913305|NCT04994509|449308806|FG002|Overall Study|Protocol Violation|0|||
124913306|NCT04278586|449310139|FG000|Overall Study|Withdrawal by Subject|13|||
124761210|NCT03431441|448751572|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
124913307|NCT04278586|449310140|FG001|Overall Study|Withdrawal by Subject|6|||
124913308|NCT04278586|449310139|FG000|Overall Study|Lost to Follow-up|37|||
124913309|NCT04278586|449310140|FG001|Overall Study|Lost to Follow-up|24|||
124913310|NCT05386238|449310144|FG000|Overall Study|Lost to Follow-up|3|||
124913311|NCT05386238|449310145|FG001|Overall Study|Lost to Follow-up|2|||
124913312|NCT05386238|449310144|FG000|Overall Study|Withdrawal by Subject|0|||
124913313|NCT05386238|449310145|FG001|Overall Study|Withdrawal by Subject|1|||
124913314|NCT04714320|449310146|FG000|Overall Study|Voluntary Withdrawal|4|||
124913315|NCT04714320|449310147|FG001|Overall Study|Voluntary Withdrawal|1|||
124913316|NCT04714320|449310148|FG002|Overall Study|Voluntary Withdrawal|2|||
124913317|NCT04714320|449310146|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
124913318|NCT04714320|449310147|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
124913319|NCT04714320|449310148|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
124913320|NCT04714320|449310146|FG000|Overall Study|Reason Not Specified|1|||
124913321|NCT04714320|449310147|FG001|Overall Study|Reason Not Specified|3|||
124913322|NCT04714320|449310148|FG002|Overall Study|Reason Not Specified|3|||
124913323|NCT05057897|449310149|FG000|Overall Study|Site closure|2|||
124913324|NCT05057897|449310150|FG001|Overall Study|Site closure|2|||
124913325|NCT05057897|449310149|FG000|Overall Study|Death|1|||
124913326|NCT05057897|449310150|FG001|Overall Study|Death|0|||
124913327|NCT03346538|449310151|FG000|Overall Study|Physician Decision|0|||
124913328|NCT03346538|449310152|FG001|Overall Study|Physician Decision|1|||
124913329|NCT03346538|449310153|FG002|Overall Study|Physician Decision|0|||
124913330|NCT03346538|449310151|FG000|Overall Study|Withdrawal by Subject|3|||
124913331|NCT03346538|449310152|FG001|Overall Study|Withdrawal by Subject|2|||
124913332|NCT03346538|449310153|FG002|Overall Study|Withdrawal by Subject|0|||
124913333|NCT03346538|449310151|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
124913334|NCT03346538|449310152|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
124913335|NCT03346538|449310153|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
124913336|NCT05672667|449310154|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
124913337|NCT04524390|449310155|FG000|Double Blind|Consent Withdrawal by subject|2|||
124913338|NCT04524390|449310156|FG001|Double Blind|Consent Withdrawal by subject|1|||
124913339|NCT04524390|449310157|FG002|Double Blind|Consent Withdrawal by subject|0|||
124913340|NCT04524390|449310155|FG000|Double Blind|Adverse Event|5|||
124913341|NCT04524390|449310156|FG001|Double Blind|Adverse Event|3|||
124913342|NCT04524390|449310157|FG002|Double Blind|Adverse Event|0|||
124913343|NCT04524390|449310155|FG000|Double Blind|Liver Transplant|5|||
124913344|NCT04524390|449310156|FG001|Double Blind|Liver Transplant|6|||
124693825|NCT00960856|448500398|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
124693826|NCT00960856|448500399|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
124693827|NCT00960856|448500396|FG000|Washout Period of 7 Days|Adverse Event|0|||
124693828|NCT00960856|448500397|FG001|Washout Period of 7 Days|Adverse Event|0|||
124693829|NCT00960856|448500398|FG002|Washout Period of 7 Days|Adverse Event|1|||
124693830|NCT00960856|448500399|FG003|Washout Period of 7 Days|Adverse Event|0|||
124693831|NCT01783015|448500400|FG000|Blinded Treatment|Adverse Event|0|||
124693832|NCT01783015|448500401|FG001|Blinded Treatment|Adverse Event|1|||
124693833|NCT01783015|448500402|FG002|Blinded Treatment|Adverse Event|0|||
124693834|NCT01783015|448500400|FG000|Blinded Treatment|Protocol Violation|0|||
124693835|NCT01783015|448500401|FG001|Blinded Treatment|Protocol Violation|1|||
124693836|NCT01783015|448500402|FG002|Blinded Treatment|Protocol Violation|0|||
124693837|NCT01783015|448500400|FG000|Blinded Treatment|Withdrawal by Subject|0|||
124693838|NCT01783015|448500401|FG001|Blinded Treatment|Withdrawal by Subject|1|||
124693839|NCT01783015|448500402|FG002|Blinded Treatment|Withdrawal by Subject|0|||
124693840|NCT01783015|448500400|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
124451182|NCT00239226|447613613|FG000|Overall Study|Lost to Follow-up|1|||
124693841|NCT01783015|448500401|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
124693842|NCT01783015|448500402|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
124693843|NCT01783015|448500400|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
124693844|NCT01783015|448500401|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
124693845|NCT01783015|448500402|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
124693846|NCT00669331|448500403|FG000|Randomisation to First Dose|Adverse Event|1|||
124693847|NCT00669331|448500404|FG001|Randomisation to First Dose|Adverse Event|0|||
124693848|NCT00669331|448500403|FG000|Randomisation to First Dose|Protocol Violation|1|||
124693849|NCT00669331|448500404|FG001|Randomisation to First Dose|Protocol Violation|0|||
124693850|NCT00669331|448500403|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
124693851|NCT00669331|448500404|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
124693852|NCT00669331|448500403|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
124693853|NCT00669331|448500404|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
124761211|NCT00764699|448751586|FG000|Overall Study|PI left and study terminated|3|||
124913345|NCT04524390|449310157|FG002|Double Blind|Liver Transplant|0|||
124913346|NCT04524390|449310155|FG000|Double Blind|Disease Progression|0|||
124913347|NCT04524390|449310156|FG001|Double Blind|Disease Progression|1|||
124913348|NCT04524390|449310157|FG002|Double Blind|Disease Progression|0|||
124913349|NCT04524390|449310155|FG000|Open-Label|Drug interruption criteria|0|||
124913350|NCT04524390|449310156|FG001|Open-Label|Drug interruption criteria|0|||
124913351|NCT04524390|449310157|FG002|Open-Label|Drug interruption criteria|1|||
124913352|NCT04524390|449310155|FG000|Open-Label|Liver Transplant|0|||
124913353|NCT04524390|449310156|FG001|Open-Label|Liver Transplant|0|||
124913354|NCT04524390|449310157|FG002|Open-Label|Liver Transplant|1|||
124913355|NCT04524390|449310155|FG000|Open-Label|Disease Progression|0|||
124913356|NCT04524390|449310156|FG001|Open-Label|Disease Progression|0|||
124913357|NCT04524390|449310157|FG002|Open-Label|Disease Progression|1|||
124913358|NCT04524390|449310155|FG000|Open-Label|Adverse Event|0|||
124913359|NCT04524390|449310156|FG001|Open-Label|Adverse Event|0|||
124913360|NCT04524390|449310157|FG002|Open-Label|Adverse Event|3|||
124913361|NCT04524390|449310155|FG000|Open-Label|Study Termination by sponsor|0|||
124913362|NCT04524390|449310156|FG001|Open-Label|Study Termination by sponsor|0|||
124913363|NCT04524390|449310157|FG002|Open-Label|Study Termination by sponsor|45|||
124913364|NCT04540913|449310163|FG000|Overall Study|Withdrawal by Subject|14|||
124913365|NCT04540913|449310164|FG001|Overall Study|Withdrawal by Subject|3|||
124913366|NCT03438188|449310165|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
124913367|NCT03438188|449310166|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
124913368|NCT03438188|449310167|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
124913369|NCT03438188|449310165|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
124913370|NCT03438188|449310166|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
124913371|NCT03438188|449310167|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
124913372|NCT03438188|449310165|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
124913373|NCT03438188|449310166|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
124913374|NCT03438188|449310167|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
124913375|NCT03438188|449310165|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
124913376|NCT03438188|449310166|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
124913377|NCT03438188|449310167|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
124761212|NCT03985761|448751588|FG000|Overall Study|Withdrawal by Subject|2|||
124761213|NCT03985761|448751589|FG001|Overall Study|Withdrawal by Subject|3|||
124761214|NCT01755234|448751590|FG000|Overall Study|Lost to Follow-up|11|||
124761215|NCT01755234|448751591|FG001|Overall Study|Lost to Follow-up|6|||
124451183|NCT00239226|447613614|FG001|Overall Study|Lost to Follow-up|0|||
124761216|NCT01755234|448751590|FG000|Overall Study|Change in surgical case|2|||
124693854|NCT00669331|448500403|FG000|Randomisation to First Dose|Death|1|||
124693855|NCT00669331|448500404|FG001|Randomisation to First Dose|Death|0|||
124693856|NCT00669331|448500403|FG000|Randomisation to First Dose|Sponsor decision|0|||
124913378|NCT03438188|449310165|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
124451184|NCT00239226|447613615|FG002|Overall Study|Lost to Follow-up|1|||
124451185|NCT00239226|447613616|FG003|Overall Study|Lost to Follow-up|0|||
124451186|NCT00646906|447613618|FG000|Crossover Period 1|Withdrawal by Subject|1|||
124693857|NCT00669331|448500404|FG001|Randomisation to First Dose|Sponsor decision|1|||
124693858|NCT00669331|448500403|FG000|Randomisation to First Dose|Randomised in error|3|||
124693859|NCT00669331|448500404|FG001|Randomisation to First Dose|Randomised in error|10|||
124693860|NCT00669331|448500403|FG000|Blinded Treatment Period|Adverse Event|16|||
124451187|NCT00646906|447613619|FG001|Crossover Period 1|Withdrawal by Subject|0|||
124451188|NCT00646906|447613620|FG002|Crossover Period 1|Withdrawal by Subject|0|||
124913379|NCT03438188|449310166|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
124913380|NCT03438188|449310167|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
124451189|NCT00646906|447613621|FG003|Crossover Period 1|Withdrawal by Subject|0|||
124451190|NCT00646906|447613622|FG004|Crossover Period 1|Withdrawal by Subject|0|||
124451191|NCT00646906|447613623|FG005|Crossover Period 1|Withdrawal by Subject|1|||
124451192|NCT00646906|447613624|FG006|Crossover Period 1|Withdrawal by Subject|0|||
124451193|NCT00646906|447613618|FG000|Crossover Period 2|Withdrawal by Subject|0|||
124451194|NCT00646906|447613619|FG001|Crossover Period 2|Withdrawal by Subject|1|||
124451195|NCT00646906|447613620|FG002|Crossover Period 2|Withdrawal by Subject|2|||
124451196|NCT00646906|447613621|FG003|Crossover Period 2|Withdrawal by Subject|1|||
124451197|NCT00646906|447613622|FG004|Crossover Period 2|Withdrawal by Subject|0|||
124451198|NCT00646906|447613623|FG005|Crossover Period 2|Withdrawal by Subject|0|||
124451199|NCT00646906|447613624|FG006|Crossover Period 2|Withdrawal by Subject|0|||
124451200|NCT00646906|447613618|FG000|Crossover Period 2|Physician Decision|0|||
124451201|NCT00646906|447613619|FG001|Crossover Period 2|Physician Decision|0|||
124693861|NCT00669331|448500404|FG001|Blinded Treatment Period|Adverse Event|10|||
124693862|NCT00669331|448500403|FG000|Blinded Treatment Period|Protocol Violation|1|||
124693863|NCT00669331|448500404|FG001|Blinded Treatment Period|Protocol Violation|1|||
124913381|NCT02991807|449310168|FG000|Overall Study|Withdrawal by Subject|2|||
124913382|NCT02991807|449310169|FG001|Overall Study|Withdrawal by Subject|1|||
124913383|NCT02991807|449310168|FG000|Overall Study|Physician Decision|0|||
124913384|NCT02991807|449310169|FG001|Overall Study|Physician Decision|1|||
124913385|NCT02991807|449310168|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
124913386|NCT02991807|449310169|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
124913387|NCT02300298|449310170|FG000|Disposition for Nintedanib|Progressive disease|10|||
124913388|NCT02300298|449310171|FG001|Disposition for Nintedanib|Progressive disease|0|||
124913389|NCT02300298|449310170|FG000|Disposition for Docetaxel|Progressive disease|0|||
124913390|NCT02300298|449310171|FG001|Disposition for Docetaxel|Progressive disease|6|||
124913391|NCT02300298|449310170|FG000|Disposition for Docetaxel|other adverse event|0|||
124913392|NCT02300298|449310171|FG001|Disposition for Docetaxel|other adverse event|4|||
124913393|NCT00792636|449310172|FG000|Overall Study|Protocol Violation|17|||
124913394|NCT00792636|449310173|FG001|Overall Study|Protocol Violation|23|||
124913395|NCT00792636|449310174|FG002|Overall Study|Protocol Violation|20|||
124913396|NCT00792636|449310172|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
124913397|NCT00792636|449310173|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
124913398|NCT00792636|449310174|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
124913399|NCT00792636|449310172|FG000|Overall Study|Lost to Follow-up|13|||
124913400|NCT00792636|449310173|FG001|Overall Study|Lost to Follow-up|19|||
124913401|NCT00792636|449310174|FG002|Overall Study|Lost to Follow-up|14|||
124913402|NCT00792636|449310172|FG000|Overall Study|Withdrew Consent|10|||
124913403|NCT00792636|449310173|FG001|Overall Study|Withdrew Consent|13|||
124913404|NCT00792636|449310174|FG002|Overall Study|Withdrew Consent|9|||
124913405|NCT00792636|449310172|FG000|Overall Study|Lack of Efficacy|3|||
124913406|NCT00792636|449310173|FG001|Overall Study|Lack of Efficacy|4|||
124913407|NCT00792636|449310174|FG002|Overall Study|Lack of Efficacy|13|||
124913408|NCT00792636|449310172|FG000|Overall Study|Adverse Event|4|||
124913409|NCT00792636|449310173|FG001|Overall Study|Adverse Event|2|||
124913410|NCT00792636|449310174|FG002|Overall Study|Adverse Event|3|||
124913411|NCT00792636|449310172|FG000|Overall Study|Investigator Discretion|2|||
124913412|NCT00792636|449310173|FG001|Overall Study|Investigator Discretion|0|||
124913413|NCT00792636|449310174|FG002|Overall Study|Investigator Discretion|2|||
124913414|NCT01610297|449310175|FG000|Overall Study|Lost to Follow-up|1|||
124913415|NCT01007396|449310179|FG000|Overall Study|Lost to Follow-up|47|||
124913416|NCT02590432|449310180|FG000|Open-label Treatment Period|Adverse Event|97|||
124913417|NCT02590432|449310181|FG001|Open-label Treatment Period|Adverse Event|79|||
124913418|NCT02590432|449310182|FG002|Open-label Treatment Period|Adverse Event|0|||
124913419|NCT02590432|449310183|FG003|Open-label Treatment Period|Adverse Event|0|||
124913420|NCT02590432|449310184|FG004|Open-label Treatment Period|Adverse Event|0|||
124913421|NCT02590432|449310185|FG005|Open-label Treatment Period|Adverse Event|0|||
124451202|NCT00646906|447613620|FG002|Crossover Period 2|Physician Decision|0|||
124451203|NCT00646906|447613621|FG003|Crossover Period 2|Physician Decision|0|||
124693864|NCT00669331|448500403|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
124545372|NCT00423137|447951174|FG002|Overall Study|Protocol Violation|0|||
124913422|NCT02590432|449310186|FG006|Open-label Treatment Period|Adverse Event|0|||
124913423|NCT02590432|449310187|FG007|Open-label Treatment Period|Adverse Event|0|||
124913424|NCT02590432|449310188|FG008|Open-label Treatment Period|Adverse Event|0|||
124913425|NCT02590432|449310180|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
124913426|NCT02590432|449310181|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
124913427|NCT02590432|449310182|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
124913428|NCT02590432|449310183|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
124913429|NCT02590432|449310184|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
124913430|NCT02590432|449310185|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
124693865|NCT00669331|448500404|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
124913431|NCT02590432|449310186|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
124913432|NCT02590432|449310187|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
124913433|NCT02590432|449310188|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
124913434|NCT02590432|449310180|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
124913435|NCT02590432|449310181|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
124913436|NCT02590432|449310182|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
124913437|NCT02590432|449310183|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
124913438|NCT02590432|449310184|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
124913439|NCT02590432|449310185|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
124913440|NCT02590432|449310186|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
124913441|NCT02590432|449310187|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
124913442|NCT02590432|449310188|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
124693866|NCT00669331|448500403|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
124761217|NCT01755234|448751591|FG001|Overall Study|Change in surgical case|1|||
124761218|NCT01755234|448751590|FG000|Overall Study|case cancelled|1|||
124761219|NCT01755234|448751591|FG001|Overall Study|case cancelled|0|||
124761220|NCT01755234|448751590|FG000|Overall Study|Withdrawal by Subject|0|||
124761221|NCT01755234|448751591|FG001|Overall Study|Withdrawal by Subject|1|||
124761222|NCT01755234|448751590|FG000|Overall Study|unblinded|1|||
124761223|NCT01755234|448751591|FG001|Overall Study|unblinded|0|||
124761224|NCT02322281|448751594|FG000|Overall Study|Progressive Disease|42|||
124761225|NCT02322281|448751595|FG001|Overall Study|Progressive Disease|14|||
124761226|NCT02322281|448751596|FG002|Overall Study|Progressive Disease|49|||
124761227|NCT02322281|448751594|FG000|Overall Study|Adverse Event|3|||
124761228|NCT02322281|448751595|FG001|Overall Study|Adverse Event|4|||
124761229|NCT02322281|448751596|FG002|Overall Study|Adverse Event|6|||
124761230|NCT02322281|448751594|FG000|Overall Study|Death|3|||
124761231|NCT02322281|448751595|FG001|Overall Study|Death|3|||
124761232|NCT02322281|448751596|FG002|Overall Study|Death|3|||
124761233|NCT02322281|448751594|FG000|Overall Study|Withdrawal by Subject|1|||
124761234|NCT02322281|448751595|FG001|Overall Study|Withdrawal by Subject|1|||
124761235|NCT02322281|448751596|FG002|Overall Study|Withdrawal by Subject|6|||
124761236|NCT02322281|448751594|FG000|Overall Study|Physician Decision|2|||
124761237|NCT02322281|448751595|FG001|Overall Study|Physician Decision|0|||
124761238|NCT02322281|448751596|FG002|Overall Study|Physician Decision|5|||
124761239|NCT02322281|448751594|FG000|Overall Study|Study Terminated by Sponsor|2|||
124761240|NCT02322281|448751595|FG001|Overall Study|Study Terminated by Sponsor|0|||
124761241|NCT02322281|448751596|FG002|Overall Study|Study Terminated by Sponsor|0|||
124761242|NCT02322281|448751594|FG000|Overall Study|Missing|0|||
124761243|NCT02322281|448751595|FG001|Overall Study|Missing|0|||
124761244|NCT02322281|448751596|FG002|Overall Study|Missing|1|||
124761245|NCT02322281|448751594|FG000|Overall Study|Miscellaneous|0|||
124761246|NCT02322281|448751595|FG001|Overall Study|Miscellaneous|0|||
124761247|NCT02322281|448751596|FG002|Overall Study|Miscellaneous|4|||
124761248|NCT05789745|448751600|FG000|Overall Study|Withdrawal by Subject|0|||
124761249|NCT05789745|448751601|FG001|Overall Study|Withdrawal by Subject|0|||
124761250|NCT05789745|448751602|FG002|Overall Study|Withdrawal by Subject|0|||
124761251|NCT05789745|448751603|FG003|Overall Study|Withdrawal by Subject|0|||
124761252|NCT05789745|448751604|FG004|Overall Study|Withdrawal by Subject|1|||
124693867|NCT00669331|448500404|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
124693868|NCT00669331|448500403|FG000|Blinded Treatment Period|Death|0|||
124693869|NCT00669331|448500404|FG001|Blinded Treatment Period|Death|2|||
124693870|NCT00669331|448500403|FG000|Blinded Treatment Period|Physician Decision|3|||
124693871|NCT00669331|448500404|FG001|Blinded Treatment Period|Physician Decision|3|||
124693872|NCT00669331|448500403|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
124761253|NCT05470387|448751608|FG000|Overall Study|Protocol Violation|0|||
124761254|NCT05470387|448751609|FG001|Overall Study|Protocol Violation|3|||
124761255|NCT03275740|448751610|FG000|Overall Study|Adverse Event|0|||
124761256|NCT03275740|448751611|FG001|Overall Study|Adverse Event|0|||
124761257|NCT03275740|448751612|FG002|Overall Study|Adverse Event|0|||
124761258|NCT03275740|448751613|FG003|Overall Study|Adverse Event|0|||
124913443|NCT02590432|449310180|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
124761259|NCT03275740|448751614|FG004|Overall Study|Adverse Event|1|||
124761260|NCT03275740|448751615|FG005|Overall Study|Adverse Event|0|||
124761261|NCT03275740|448751616|FG006|Overall Study|Adverse Event|0|||
124761262|NCT03275740|448751617|FG007|Overall Study|Adverse Event|0|||
124761263|NCT03275740|448751618|FG008|Overall Study|Adverse Event|0|||
124761264|NCT03275740|448751619|FG009|Overall Study|Adverse Event|0|||
124761265|NCT03275740|448751620|FG010|Overall Study|Adverse Event|0|||
124761266|NCT03275740|448751621|FG011|Overall Study|Adverse Event|0|||
124761267|NCT03275740|448751610|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
124761268|NCT03275740|448751611|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
124761269|NCT03275740|448751612|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
124761270|NCT03275740|448751613|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
124761271|NCT03275740|448751614|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
124761272|NCT03275740|448751615|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
124761273|NCT03275740|448751616|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
124761274|NCT03275740|448751617|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
124761275|NCT03275740|448751618|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
124761276|NCT03275740|448751619|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
124761277|NCT03275740|448751620|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
124761278|NCT03275740|448751621|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
124761279|NCT03275740|448751610|FG000|Overall Study|Withdrawal by Subject|0|||
124761280|NCT03275740|448751611|FG001|Overall Study|Withdrawal by Subject|0|||
124761281|NCT03275740|448751612|FG002|Overall Study|Withdrawal by Subject|0|||
124761282|NCT03275740|448751613|FG003|Overall Study|Withdrawal by Subject|0|||
124761283|NCT03275740|448751614|FG004|Overall Study|Withdrawal by Subject|0|||
124761284|NCT03275740|448751615|FG005|Overall Study|Withdrawal by Subject|0|||
124761285|NCT03275740|448751616|FG006|Overall Study|Withdrawal by Subject|0|||
124761286|NCT03275740|448751617|FG007|Overall Study|Withdrawal by Subject|0|||
124761287|NCT03275740|448751618|FG008|Overall Study|Withdrawal by Subject|1|||
124761288|NCT03275740|448751619|FG009|Overall Study|Withdrawal by Subject|1|||
124761289|NCT03275740|448751620|FG010|Overall Study|Withdrawal by Subject|0|||
124761290|NCT03275740|448751621|FG011|Overall Study|Withdrawal by Subject|0|||
124761291|NCT00687401|448751623|FG000|Overall Study|Protocol Violation|7|||
124761292|NCT00687401|448751623|FG000|Overall Study|Adverse Event|6|||
124761293|NCT00687401|448751623|FG000|Overall Study|Lack of Efficacy|6|||
124761294|NCT00687401|448751623|FG000|Overall Study|Withdrawal by Subject|4|||
124761295|NCT00687401|448751623|FG000|Overall Study|Did not return for visit|3|||
124761296|NCT00687401|448751623|FG000|Overall Study|For reasons different from those above|4|||
124761297|NCT02920892|448751624|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
124761298|NCT02920892|448751625|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
124761299|NCT02920892|448751626|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
124761300|NCT02920892|448751624|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
124761301|NCT02920892|448751625|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
124761302|NCT02920892|448751626|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
124761303|NCT02920892|448751624|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
124761304|NCT02920892|448751625|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
124761305|NCT02920892|448751626|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
124761306|NCT02920892|448751624|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
124761307|NCT02920892|448751625|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
124761308|NCT02920892|448751626|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
124761309|NCT02920892|448751624|FG000|Placebo-Controlled Period|Physician Decision|0|||
124761310|NCT02920892|448751625|FG001|Placebo-Controlled Period|Physician Decision|0|||
124761311|NCT02920892|448751626|FG002|Placebo-Controlled Period|Physician Decision|1|||
124761312|NCT02920892|448751624|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
124761313|NCT02920892|448751625|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
124761314|NCT02920892|448751626|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
124761315|NCT02920892|448751624|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
124761316|NCT02920892|448751625|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
124761317|NCT02920892|448751626|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
124761318|NCT02920892|448751624|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
124761319|NCT02920892|448751625|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
124761320|NCT02920892|448751626|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
124761321|NCT04486235|448751627|FG000|Overall Study|Pregnancy|1|||
124761322|NCT04486235|448751628|FG001|Overall Study|Pregnancy|0|||
124761323|NCT04486235|448751627|FG000|Overall Study|Lost to Follow-up|1|||
124761324|NCT04486235|448751628|FG001|Overall Study|Lost to Follow-up|0|||
124761325|NCT03935126|448751629|FG000|Overall Study|Study termination by sponsor|3|||
124761326|NCT03649217|448751630|FG000|Overall Study|subject had severe ataxia not initially found|1|||
124761327|NCT03649217|448751630|FG000|Overall Study|subject had cognitive issues not initially found|1|||
124761328|NCT02520726|448751631|FG000|Overall Study|Lost to Follow-up|3|||
124761329|NCT02520726|448751632|FG001|Overall Study|Lost to Follow-up|2|||
124761330|NCT01092728|448751633|FG000|Overall Study|Withdrawal by Subject|2|||
124761331|NCT01092728|448751634|FG001|Overall Study|Withdrawal by Subject|0|||
124761332|NCT01092728|448751633|FG000|Overall Study|Adverse Event|0|||
124761333|NCT01092728|448751634|FG001|Overall Study|Adverse Event|1|||
124761334|NCT01092728|448751633|FG000|Overall Study|Disease Progression|1|||
124761335|NCT01092728|448751634|FG001|Overall Study|Disease Progression|13|||
124761336|NCT01092728|448751633|FG000|Overall Study|Prohibited Concomitant Medications|1|||
124761337|NCT01092728|448751634|FG001|Overall Study|Prohibited Concomitant Medications|0|||
124761338|NCT02552966|448751635|FG000|Overall Study|Lost to Follow-up|2|||
124761339|NCT02552966|448751635|FG000|Overall Study|Withdrawal by Subject|3|||
124761340|NCT00721396|448751636|FG000|Overall Study|Adverse Event|4|||
124761341|NCT00721396|448751637|FG001|Overall Study|Adverse Event|7|||
124761342|NCT00721396|448751638|FG002|Overall Study|Adverse Event|2|||
124761343|NCT00721396|448751639|FG003|Overall Study|Adverse Event|0|||
124761344|NCT00721396|448751636|FG000|Overall Study|Withdrawal by Subject|12|||
124761345|NCT00721396|448751637|FG001|Overall Study|Withdrawal by Subject|15|||
124761346|NCT00721396|448751638|FG002|Overall Study|Withdrawal by Subject|3|||
124761347|NCT00721396|448751639|FG003|Overall Study|Withdrawal by Subject|7|||
124761348|NCT00721396|448751636|FG000|Overall Study|Lost to Follow-up|7|||
124761349|NCT00721396|448751637|FG001|Overall Study|Lost to Follow-up|9|||
124761350|NCT00721396|448751638|FG002|Overall Study|Lost to Follow-up|3|||
124761351|NCT00721396|448751639|FG003|Overall Study|Lost to Follow-up|3|||
124761352|NCT00721396|448751636|FG000|Overall Study|Protocol Violation|4|||
124761353|NCT00721396|448751637|FG001|Overall Study|Protocol Violation|3|||
124761354|NCT00721396|448751638|FG002|Overall Study|Protocol Violation|1|||
124761355|NCT00721396|448751639|FG003|Overall Study|Protocol Violation|0|||
124761356|NCT00721396|448751636|FG000|Overall Study|Inappropriate enrollment|0|||
124761357|NCT00721396|448751637|FG001|Overall Study|Inappropriate enrollment|2|||
124761358|NCT00721396|448751638|FG002|Overall Study|Inappropriate enrollment|0|||
124761359|NCT00721396|448751639|FG003|Overall Study|Inappropriate enrollment|0|||
124761360|NCT00721396|448751636|FG000|Overall Study|Administrative reason|3|||
124761361|NCT00721396|448751637|FG001|Overall Study|Administrative reason|0|||
124761362|NCT00721396|448751638|FG002|Overall Study|Administrative reason|1|||
124761363|NCT00721396|448751639|FG003|Overall Study|Administrative reason|0|||
124761364|NCT01091675|448751641|FG000|Overall Study|Adverse Event|7|||
124761365|NCT01091675|448751641|FG000|Overall Study|Lack of Efficacy|27|||
124761366|NCT00614380|448751642|FG000|Overall Study|Adverse Event|14|||
124761367|NCT00614380|448751643|FG001|Overall Study|Adverse Event|4|||
124761368|NCT00614380|448751644|FG002|Overall Study|Adverse Event|0|||
124761369|NCT00614380|448751645|FG003|Overall Study|Adverse Event|0|||
124761370|NCT00614380|448751642|FG000|Overall Study|Lost to Follow-up|6|||
124761371|NCT00614380|448751643|FG001|Overall Study|Lost to Follow-up|1|||
124761372|NCT00614380|448751644|FG002|Overall Study|Lost to Follow-up|0|||
124761373|NCT00614380|448751645|FG003|Overall Study|Lost to Follow-up|0|||
124761374|NCT00614380|448751642|FG000|Overall Study|Non compliant with the protocol|12|||
124761375|NCT00614380|448751643|FG001|Overall Study|Non compliant with the protocol|2|||
124761376|NCT00614380|448751644|FG002|Overall Study|Non compliant with the protocol|1|||
124761377|NCT00614380|448751645|FG003|Overall Study|Non compliant with the protocol|2|||
124761378|NCT00614380|448751642|FG000|Overall Study|Consent withdrawn|3|||
124761379|NCT00614380|448751643|FG001|Overall Study|Consent withdrawn|1|||
124761380|NCT00614380|448751644|FG002|Overall Study|Consent withdrawn|0|||
124761381|NCT00614380|448751645|FG003|Overall Study|Consent withdrawn|0|||
124761382|NCT02021565|448751659|FG000|Baseline Through Intervention|Death|0|||
124761383|NCT02021565|448751660|FG001|Baseline Through Intervention|Death|1|||
124761384|NCT02021565|448751659|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
124761385|NCT02021565|448751660|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
124761386|NCT02021565|448751659|FG000|Baseline Through Intervention|Protocol Violation|0|||
124761387|NCT02021565|448751660|FG001|Baseline Through Intervention|Protocol Violation|7|||
124761388|NCT02021565|448751659|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
124761389|NCT02021565|448751660|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
124761390|NCT02021565|448751659|FG000|3-month Follow-up|Death|3|||
124761391|NCT02021565|448751660|FG001|3-month Follow-up|Death|0|||
124761392|NCT02021565|448751659|FG000|3-month Follow-up|Withdrawal by Subject|4|||
124761393|NCT02021565|448751660|FG001|3-month Follow-up|Withdrawal by Subject|0|||
124761394|NCT02021565|448751659|FG000|3-month Follow-up|Protocol Violation|3|||
124761395|NCT02021565|448751660|FG001|3-month Follow-up|Protocol Violation|2|||
124761396|NCT03318549|448751661|FG000|Overall Study|Withdrawal by Subject|5|||
124761397|NCT03318549|448751662|FG001|Overall Study|Withdrawal by Subject|19|||
124761398|NCT03318549|448751663|FG002|Overall Study|Withdrawal by Subject|2|||
124761399|NCT03318549|448751664|FG003|Overall Study|Withdrawal by Subject|0|||
124761400|NCT03318549|448751665|FG004|Overall Study|Withdrawal by Subject|0|||
124761401|NCT03318549|448751666|FG005|Overall Study|Withdrawal by Subject|0|||
124761402|NCT03318549|448751667|FG006|Overall Study|Withdrawal by Subject|0|||
124761403|NCT03318549|448751661|FG000|Overall Study|Physician Decision|0|||
124761404|NCT03318549|448751662|FG001|Overall Study|Physician Decision|4|||
124761405|NCT03318549|448751663|FG002|Overall Study|Physician Decision|1|||
124761406|NCT03318549|448751664|FG003|Overall Study|Physician Decision|0|||
124913444|NCT02590432|449310181|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
124761407|NCT03318549|448751665|FG004|Overall Study|Physician Decision|0|||
124913445|NCT02590432|449310182|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
124913446|NCT02590432|449310183|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
124693873|NCT00669331|448500404|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
124693874|NCT03387046|448500405|FG000|Overall Study|Adverse Event|1|||
124693875|NCT03387046|448500406|FG001|Overall Study|Adverse Event|1|||
124693876|NCT03794544|448500407|FG000|Overall Study|Withdrawal by Subject|1|||
124693877|NCT03794544|448500408|FG001|Overall Study|Withdrawal by Subject|1|||
124693878|NCT03794544|448500409|FG002|Overall Study|Withdrawal by Subject|0|||
124693879|NCT03794544|448500410|FG003|Overall Study|Withdrawal by Subject|0|||
124693880|NCT03794544|448500407|FG000|Overall Study|Death|0|||
124693881|NCT03794544|448500408|FG001|Overall Study|Death|0|||
124693882|NCT03794544|448500409|FG002|Overall Study|Death|0|||
124693883|NCT03794544|448500410|FG003|Overall Study|Death|1|||
124693884|NCT03794544|448500407|FG000|Overall Study|Lost to Follow-up|0|||
124693885|NCT03794544|448500408|FG001|Overall Study|Lost to Follow-up|1|||
124693886|NCT03794544|448500409|FG002|Overall Study|Lost to Follow-up|1|||
124693887|NCT03794544|448500410|FG003|Overall Study|Lost to Follow-up|0|||
124693888|NCT03794544|448500407|FG000|Overall Study|Other|0|||
124693889|NCT03794544|448500408|FG001|Overall Study|Other|1|||
124693890|NCT03794544|448500409|FG002|Overall Study|Other|0|||
124693891|NCT03794544|448500410|FG003|Overall Study|Other|0|||
124693892|NCT00120250|448500414|FG000|Overall Study|Lost to Follow-up|1|||
124693893|NCT00120250|448500415|FG001|Overall Study|Lost to Follow-up|1|||
124693894|NCT00120250|448500414|FG000|Overall Study|Protocol Violation|0|||
124693895|NCT00120250|448500415|FG001|Overall Study|Protocol Violation|1|||
124693896|NCT01964560|448500422|FG000|Overall Study|Adverse Event|23|||
124693897|NCT01964560|448500422|FG000|Overall Study|Lack of Efficacy|46|||
124693898|NCT01964560|448500422|FG000|Overall Study|Protocol deviation|2|||
124693899|NCT01964560|448500422|FG000|Overall Study|Lost to Follow-up|4|||
124693900|NCT01964560|448500422|FG000|Overall Study|Withdrawal by Subject|64|||
124693901|NCT01964560|448500422|FG000|Overall Study|Surgery-hemispherotomy|1|||
124693902|NCT01964560|448500422|FG000|Overall Study|Surgery|1|||
124693903|NCT01964560|448500422|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
124693904|NCT01964560|448500422|FG000|Overall Study|Patient and Investigator choice|1|||
124693905|NCT01964560|448500422|FG000|Overall Study|Patient was prescribed CBD|1|||
124693906|NCT01964560|448500422|FG000|Overall Study|Participant moved to another country|1|||
124693907|NCT00710554|448500423|FG000|Overall Study|Adverse Event|24|||
124693908|NCT00710554|448500424|FG001|Overall Study|Adverse Event|7|||
124693909|NCT00710554|448500423|FG000|Overall Study|Withdrawal by Subject|7|||
124693910|NCT00710554|448500424|FG001|Overall Study|Withdrawal by Subject|3|||
124693911|NCT00710554|448500423|FG000|Overall Study|Lost to Follow-up|7|||
124693912|NCT00710554|448500424|FG001|Overall Study|Lost to Follow-up|1|||
124693913|NCT00710554|448500423|FG000|Overall Study|Lack of Efficacy|11|||
124693914|NCT00710554|448500424|FG001|Overall Study|Lack of Efficacy|12|||
124693915|NCT00710554|448500423|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
124693916|NCT00710554|448500424|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
124693917|NCT01433978|448500425|FG000|Core Study|Adverse Event, Non-Fatal|0|||
124693918|NCT01433978|448500426|FG001|Core Study|Adverse Event, Non-Fatal|1|||
124693919|NCT01433978|448500427|FG002|Core Study|Adverse Event, Non-Fatal|0|||
124693920|NCT01433978|448500425|FG000|Core Study|Lack of Efficacy|5|||
124693921|NCT01433978|448500426|FG001|Core Study|Lack of Efficacy|1|||
124693922|NCT01433978|448500427|FG002|Core Study|Lack of Efficacy|0|||
124693923|NCT01433978|448500425|FG000|Core Study|Study Terminated by Sponsor|6|||
124693924|NCT01433978|448500426|FG001|Core Study|Study Terminated by Sponsor|9|||
124693925|NCT01433978|448500427|FG002|Core Study|Study Terminated by Sponsor|0|||
124693926|NCT01433978|448500425|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
124693927|NCT01433978|448500426|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
124693928|NCT01433978|448500427|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
124693929|NCT01433978|448500425|FG000|Extension Phase|Lack of Efficacy|0|||
124693930|NCT01433978|448500426|FG001|Extension Phase|Lack of Efficacy|0|||
124693931|NCT01433978|448500427|FG002|Extension Phase|Lack of Efficacy|1|||
124693932|NCT01433978|448500425|FG000|Extension Phase|Study Terminated by Sponsor|0|||
124693933|NCT01433978|448500426|FG001|Extension Phase|Study Terminated by Sponsor|0|||
124693934|NCT01433978|448500427|FG002|Extension Phase|Study Terminated by Sponsor|4|||
124693935|NCT00378560|448500428|FG000|Overall Study|Adverse Event|1|||
124693936|NCT00378560|448500429|FG001|Overall Study|Adverse Event|0|||
124693937|NCT00378560|448500428|FG000|Overall Study|Lost to Follow-up|24|||
124693938|NCT00378560|448500429|FG001|Overall Study|Lost to Follow-up|29|||
124693939|NCT00378560|448500428|FG000|Overall Study|Protocol Violation|2|||
124693940|NCT00378560|448500429|FG001|Overall Study|Protocol Violation|0|||
124693941|NCT00378560|448500428|FG000|Overall Study|Withdrawal by Subject|17|||
124693942|NCT00378560|448500429|FG001|Overall Study|Withdrawal by Subject|21|||
124693943|NCT00378560|448500428|FG000|Overall Study|Moved|4|||
124693944|NCT00378560|448500429|FG001|Overall Study|Moved|3|||
124693945|NCT00378560|448500428|FG000|Overall Study|Pregnancy|7|||
124693946|NCT00378560|448500429|FG001|Overall Study|Pregnancy|5|||
124545373|NCT00423137|447951175|FG003|Overall Study|Protocol Violation|1|||
124913447|NCT02590432|449310184|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
124913448|NCT02590432|449310185|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
124913449|NCT02590432|449310186|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
124913450|NCT02590432|449310187|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
124913451|NCT02590432|449310188|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
124913452|NCT02590432|449310180|FG000|Open-label Treatment Period|Protocol Violation|10|||
124913453|NCT02590432|449310181|FG001|Open-label Treatment Period|Protocol Violation|4|||
124913454|NCT02590432|449310182|FG002|Open-label Treatment Period|Protocol Violation|0|||
124913455|NCT02590432|449310183|FG003|Open-label Treatment Period|Protocol Violation|0|||
124913456|NCT02590432|449310184|FG004|Open-label Treatment Period|Protocol Violation|0|||
124913457|NCT02590432|449310185|FG005|Open-label Treatment Period|Protocol Violation|0|||
124913458|NCT02590432|449310186|FG006|Open-label Treatment Period|Protocol Violation|0|||
124913459|NCT02590432|449310187|FG007|Open-label Treatment Period|Protocol Violation|0|||
124913460|NCT02590432|449310188|FG008|Open-label Treatment Period|Protocol Violation|0|||
124913461|NCT02590432|449310180|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
124913462|NCT02590432|449310181|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
124913463|NCT02590432|449310182|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
124913464|NCT02590432|449310183|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
124913465|NCT02590432|449310184|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
124913466|NCT02590432|449310185|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
124913467|NCT02590432|449310186|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
124913468|NCT02590432|449310187|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
124913469|NCT02590432|449310188|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
124913470|NCT02590432|449310180|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
124913471|NCT02590432|449310181|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
124913472|NCT02590432|449310182|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
124913473|NCT02590432|449310183|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
124913474|NCT02590432|449310184|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
124913475|NCT02590432|449310185|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
124913476|NCT02590432|449310186|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
124913477|NCT02590432|449310187|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
124451204|NCT00646906|447613622|FG004|Crossover Period 2|Physician Decision|0|||
124451205|NCT00646906|447613623|FG005|Crossover Period 2|Physician Decision|0|||
124451206|NCT00646906|447613624|FG006|Crossover Period 2|Physician Decision|1|||
124451207|NCT02844920|447613629|FG000|Overall Study|Lost to Follow-up|2|||
124451208|NCT02871778|447613636|FG000|Part A: Treatment Period 1|Adverse Event|1|||
124451209|NCT02871778|447613637|FG001|Part A: Treatment Period 1|Adverse Event|1|||
124451210|NCT02871778|447613638|FG002|Part A: Treatment Period 1|Adverse Event|1|||
124451211|NCT02871778|447613639|FG003|Part A: Treatment Period 1|Adverse Event|0|||
124451212|NCT02871778|447613640|FG004|Part A: Treatment Period 1|Adverse Event|0|||
124451213|NCT02871778|447613641|FG005|Part A: Treatment Period 1|Adverse Event|0|||
124451214|NCT02871778|447613642|FG006|Part A: Treatment Period 1|Adverse Event|0|||
124451215|NCT02871778|447613643|FG007|Part A: Treatment Period 1|Adverse Event|0|||
124693947|NCT00378560|448500428|FG000|Overall Study|Laboratory test values abnormal|1|||
124693948|NCT00378560|448500429|FG001|Overall Study|Laboratory test values abnormal|0|||
124693949|NCT02852434|448500430|FG000|Overall Study|Withdrawal by Subject|0|||
124693950|NCT02852434|448500431|FG001|Overall Study|Withdrawal by Subject|1|||
124693951|NCT02852434|448500430|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
124693952|NCT02852434|448500431|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
124693953|NCT01011283|448500435|FG000|Overall Study|Adverse Event|4|||
124693954|NCT01011283|448500436|FG001|Overall Study|Adverse Event|2|||
124693955|NCT01011283|448500435|FG000|Overall Study|Progressive Disease|0|||
124693956|NCT01011283|448500436|FG001|Overall Study|Progressive Disease|2|||
124693957|NCT01011283|448500435|FG000|Overall Study|Terminated by Sponsor|5|||
124693958|NCT01011283|448500436|FG001|Overall Study|Terminated by Sponsor|5|||
124693959|NCT01011283|448500435|FG000|Overall Study|Other|2|||
124693960|NCT01011283|448500436|FG001|Overall Study|Other|2|||
124693961|NCT01623752|448500438|FG000|Phase 1 (78 Weeks)|No Data|249|||
124693962|NCT01623752|448500439|FG001|Phase 1 (78 Weeks)|No Data|66|||
124693963|NCT01623752|448500440|FG002|Phase 1 (78 Weeks)|No Data|2|||
124693964|NCT01623752|448500438|FG000|Phase 1 (78 Weeks)|Other|33|||
124693965|NCT01623752|448500439|FG001|Phase 1 (78 Weeks)|Other|20|||
124693966|NCT01623752|448500440|FG002|Phase 1 (78 Weeks)|Other|0|||
124693967|NCT01623752|448500438|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
124693968|NCT01623752|448500439|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
124693969|NCT01623752|448500440|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
124693970|NCT01623752|448500438|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
124693971|NCT01623752|448500439|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
124693972|NCT01623752|448500440|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
124693973|NCT01623752|448500438|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
124693974|NCT01623752|448500439|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
124693975|NCT01623752|448500440|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
124693976|NCT01623752|448500438|FG000|Phase 2 (78 Weeks)|Other|5|||
124693977|NCT01623752|448500439|FG001|Phase 2 (78 Weeks)|Other|1|||
124693978|NCT01623752|448500440|FG002|Phase 2 (78 Weeks)|Other|0|||
124693979|NCT01623752|448500438|FG000|Phase 2 (78 Weeks)|No Data|43|||
124693980|NCT01623752|448500439|FG001|Phase 2 (78 Weeks)|No Data|11|||
124693981|NCT01623752|448500440|FG002|Phase 2 (78 Weeks)|No Data|0|||
124693982|NCT01623752|448500438|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
124693983|NCT01623752|448500439|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
124693984|NCT01623752|448500440|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
124693985|NCT03994120|448500443|FG000|Overall Study|Lost to Follow-up|3|||
124693986|NCT03994120|448500444|FG001|Overall Study|Lost to Follow-up|1|||
124693987|NCT04865978|448500445|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
124693988|NCT04865978|448500446|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
124693989|NCT03835117|448500447|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
124693990|NCT03835117|448500448|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
124693991|NCT00609973|448500450|FG000|Overall Study|Adverse Event|2|||
124693992|NCT00609973|448500451|FG001|Overall Study|Adverse Event|1|||
124693993|NCT00609973|448500450|FG000|Overall Study|Protocol Violation|4|||
124693994|NCT00609973|448500451|FG001|Overall Study|Protocol Violation|3|||
124693995|NCT00609973|448500450|FG000|Overall Study|Lost to Follow-up|2|||
124693996|NCT00609973|448500451|FG001|Overall Study|Lost to Follow-up|1|||
124693997|NCT00609973|448500450|FG000|Overall Study|Withdrawal by Subject|0|||
124693998|NCT00609973|448500451|FG001|Overall Study|Withdrawal by Subject|1|||
124693999|NCT00191152|448500453|FG000|Initial Treatment|Adverse Event|43|||
124694000|NCT00191152|448500454|FG001|Initial Treatment|Adverse Event|67|||
124694001|NCT00191152|448500453|FG000|Initial Treatment|Physician Decision|40|||
124694002|NCT00191152|448500454|FG001|Initial Treatment|Physician Decision|31|||
124694003|NCT00191152|448500453|FG000|Initial Treatment|Withdrawal by Subject|40|||
124694004|NCT00191152|448500454|FG001|Initial Treatment|Withdrawal by Subject|28|||
124694005|NCT00191152|448500453|FG000|Initial Treatment|Lost to Follow-up|0|||
124694006|NCT00191152|448500454|FG001|Initial Treatment|Lost to Follow-up|6|||
124913478|NCT02590432|449310188|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
124913479|NCT02590432|449310180|FG000|Double-blind Treatment Period|Adverse Event|0|||
124913480|NCT02590432|449310181|FG001|Double-blind Treatment Period|Adverse Event|0|||
124913481|NCT02590432|449310182|FG002|Double-blind Treatment Period|Adverse Event|14|||
124913482|NCT02590432|449310183|FG003|Double-blind Treatment Period|Adverse Event|12|||
124913483|NCT02590432|449310184|FG004|Double-blind Treatment Period|Adverse Event|6|||
124913484|NCT02590432|449310185|FG005|Double-blind Treatment Period|Adverse Event|22|||
124913485|NCT02590432|449310186|FG006|Double-blind Treatment Period|Adverse Event|20|||
124913486|NCT02590432|449310187|FG007|Double-blind Treatment Period|Adverse Event|0|||
124913487|NCT02590432|449310188|FG008|Double-blind Treatment Period|Adverse Event|0|||
124913488|NCT02590432|449310180|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
124913489|NCT02590432|449310181|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
124913490|NCT02590432|449310182|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
124913491|NCT02590432|449310183|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
124913492|NCT02590432|449310184|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
124913493|NCT02590432|449310185|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
124694007|NCT00191152|448500453|FG000|Initial Treatment|Other|18|||
124694008|NCT00191152|448500454|FG001|Initial Treatment|Other|21|||
124694009|NCT00191152|448500453|FG000|Crossover Treatment|Adverse Event|8|||
124694010|NCT00191152|448500454|FG001|Crossover Treatment|Adverse Event|8|||
124694011|NCT00191152|448500453|FG000|Crossover Treatment|Physician Decision|7|||
124694012|NCT00191152|448500454|FG001|Crossover Treatment|Physician Decision|7|||
124694013|NCT00191152|448500453|FG000|Crossover Treatment|Withdrawal by Subject|6|||
124694014|NCT00191152|448500454|FG001|Crossover Treatment|Withdrawal by Subject|9|||
124694015|NCT00191152|448500453|FG000|Crossover Treatment|Lost to Follow-up|2|||
124694016|NCT00191152|448500454|FG001|Crossover Treatment|Lost to Follow-up|1|||
124694017|NCT00191152|448500453|FG000|Crossover Treatment|Other|4|||
124694018|NCT00191152|448500454|FG001|Crossover Treatment|Other|3|||
124694019|NCT00114777|448500458|FG000|Randomization to Month 36|Death|10|||
124694020|NCT00114777|448500459|FG001|Randomization to Month 36|Death|4|||
124694021|NCT00114777|448500460|FG002|Randomization to Month 36|Death|3|||
124694022|NCT00114777|448500458|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
124694023|NCT00114777|448500459|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
124694024|NCT00114777|448500460|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
124761408|NCT03318549|448751666|FG005|Overall Study|Physician Decision|0|||
124694025|NCT00114777|448500458|FG000|Randomization to Month 36|Lack of Efficacy|19|||
124761409|NCT03318549|448751667|FG006|Overall Study|Physician Decision|0|||
124761410|NCT03318549|448751661|FG000|Overall Study|Lost to Follow-up|0|||
124694026|NCT00114777|448500459|FG001|Randomization to Month 36|Lack of Efficacy|15|||
124694027|NCT00114777|448500460|FG002|Randomization to Month 36|Lack of Efficacy|17|||
124694028|NCT00114777|448500458|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
124913494|NCT02590432|449310186|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
124694029|NCT00114777|448500459|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
124913495|NCT02590432|449310187|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
124913496|NCT02590432|449310188|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
124913497|NCT02590432|449310180|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
124913498|NCT02590432|449310181|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
124913499|NCT02590432|449310182|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
124913500|NCT02590432|449310183|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
124913501|NCT02590432|449310184|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
124913502|NCT02590432|449310185|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
124913503|NCT02590432|449310186|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
124913504|NCT02590432|449310187|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
124913505|NCT02590432|449310188|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
124913506|NCT02590432|449310180|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
124913507|NCT02590432|449310181|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
124913508|NCT02590432|449310182|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
124913509|NCT02590432|449310183|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
124913510|NCT02590432|449310184|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
124913511|NCT02590432|449310185|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
124913512|NCT02590432|449310186|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
124913513|NCT02590432|449310187|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
124913514|NCT02590432|449310188|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
124913515|NCT02590432|449310180|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
124913516|NCT02590432|449310181|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
124913517|NCT02590432|449310182|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
124913518|NCT02590432|449310183|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
124913519|NCT02590432|449310184|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
124913520|NCT02590432|449310185|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
124913521|NCT02590432|449310186|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
124913522|NCT02590432|449310187|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
124913523|NCT02590432|449310188|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
124913524|NCT02590432|449310180|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
124913525|NCT02590432|449310181|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
124913526|NCT02590432|449310182|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
124913527|NCT02590432|449310183|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
124913528|NCT02590432|449310184|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
124913529|NCT02590432|449310185|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
124913530|NCT02590432|449310186|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
124913531|NCT02590432|449310187|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
124913532|NCT02590432|449310188|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
124913533|NCT02590432|449310180|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
124913534|NCT02590432|449310181|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
124913535|NCT02590432|449310182|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
124913536|NCT02590432|449310183|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
124913537|NCT02590432|449310184|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
124913538|NCT02590432|449310185|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
124913539|NCT02590432|449310186|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
124913540|NCT02590432|449310187|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
124913541|NCT02590432|449310188|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
124913542|NCT02590432|449310180|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
124913543|NCT02590432|449310181|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
124913544|NCT02590432|449310182|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
124913545|NCT02590432|449310183|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
124913546|NCT02590432|449310184|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
124913547|NCT02590432|449310185|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
124913548|NCT02590432|449310186|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
124913549|NCT02590432|449310187|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
124913550|NCT02590432|449310188|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
124913551|NCT02590432|449310180|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
124913552|NCT02590432|449310181|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
124913553|NCT02590432|449310182|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
124913554|NCT02590432|449310183|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
124913555|NCT02590432|449310184|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
124913556|NCT02590432|449310185|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
124913557|NCT02590432|449310186|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
124913558|NCT02590432|449310187|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
124913559|NCT02590432|449310188|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
124913560|NCT02590432|449310180|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
124913561|NCT02590432|449310181|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
124913562|NCT02590432|449310182|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
124913563|NCT02590432|449310183|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
124913564|NCT02590432|449310184|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
124913565|NCT02590432|449310185|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
124913566|NCT02590432|449310186|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
124913567|NCT02590432|449310187|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
124913568|NCT02590432|449310188|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
124913569|NCT02590432|449310180|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
124913570|NCT02590432|449310181|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
124913571|NCT02590432|449310182|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
124913572|NCT02590432|449310183|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
124913573|NCT02590432|449310184|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
124913574|NCT02590432|449310185|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
124913575|NCT02590432|449310186|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
124913576|NCT02590432|449310187|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
124913577|NCT02590432|449310188|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
124913578|NCT02590432|449310180|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
124913579|NCT02590432|449310181|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
124913580|NCT02590432|449310182|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
124913581|NCT02590432|449310183|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
124913582|NCT02590432|449310184|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
124913583|NCT02590432|449310185|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
124913584|NCT02590432|449310186|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
124913585|NCT02590432|449310187|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
124913586|NCT02590432|449310188|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
124913587|NCT02740231|449310193|FG000|Overall Study|Withdrawal by Subject|1|||
124913588|NCT02740231|449310194|FG001|Overall Study|Withdrawal by Subject|1|||
124913589|NCT02740231|449310195|FG002|Overall Study|Withdrawal by Subject|1|||
124913590|NCT02740231|449310196|FG003|Overall Study|Withdrawal by Subject|0|||
124913591|NCT02740231|449310193|FG000|Overall Study|Lack of Efficacy|0|||
124913592|NCT02740231|449310194|FG001|Overall Study|Lack of Efficacy|1|||
124913593|NCT02740231|449310195|FG002|Overall Study|Lack of Efficacy|0|||
124913594|NCT02740231|449310196|FG003|Overall Study|Lack of Efficacy|4|||
124913595|NCT02740231|449310193|FG000|Overall Study|Lost to Follow-up|1|||
124451216|NCT02871778|447613636|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
124451217|NCT02871778|447613637|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
124451218|NCT02871778|447613638|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
124451219|NCT02871778|447613639|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
124451220|NCT02871778|447613640|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
124451221|NCT02871778|447613641|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
124451222|NCT02871778|447613642|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
124451223|NCT02871778|447613643|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
124451224|NCT02871778|447613636|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
124451225|NCT02871778|447613637|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
124451226|NCT02871778|447613638|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
124451227|NCT02871778|447613639|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
124451228|NCT02871778|447613640|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
124451229|NCT02871778|447613641|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
124451230|NCT02871778|447613642|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
124451231|NCT02871778|447613643|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
124451232|NCT02871778|447613636|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
124451233|NCT02871778|447613637|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
124451234|NCT02871778|447613638|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
124451235|NCT02871778|447613639|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
124451236|NCT02871778|447613640|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
124451237|NCT02871778|447613641|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
124913596|NCT02740231|449310194|FG001|Overall Study|Lost to Follow-up|3|||
124913597|NCT02740231|449310195|FG002|Overall Study|Lost to Follow-up|0|||
124913598|NCT02740231|449310196|FG003|Overall Study|Lost to Follow-up|3|||
124913599|NCT02740231|449310193|FG000|Overall Study|Adverse Event|0|||
124694030|NCT00114777|448500460|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
124694031|NCT00114777|448500458|FG000|Randomization to Month 36|Adverse Event|34|||
124694032|NCT00114777|448500459|FG001|Randomization to Month 36|Adverse Event|35|||
124694033|NCT00114777|448500460|FG002|Randomization to Month 36|Adverse Event|44|||
124694034|NCT00114777|448500458|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
124694035|NCT00114777|448500459|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
124694036|NCT00114777|448500460|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
124694037|NCT00114777|448500458|FG000|Randomization to Month 36|Other|9|||
124694038|NCT00114777|448500459|FG001|Randomization to Month 36|Other|3|||
124694039|NCT00114777|448500460|FG002|Randomization to Month 36|Other|12|||
124694040|NCT00114777|448500458|FG000|Long-Term Extension to Month 84|Death|8|||
124694041|NCT00114777|448500459|FG001|Long-Term Extension to Month 84|Death|13|||
124694042|NCT00114777|448500460|FG002|Long-Term Extension to Month 84|Death|7|||
124694043|NCT00114777|448500458|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
124694044|NCT00114777|448500459|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
124694045|NCT00114777|448500460|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
124694046|NCT00114777|448500458|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
124694047|NCT00114777|448500459|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
124694048|NCT00114777|448500460|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
124694049|NCT00114777|448500458|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
124694050|NCT00114777|448500459|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
124694051|NCT00114777|448500460|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
124694052|NCT00114777|448500458|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
124694053|NCT00114777|448500459|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
124694054|NCT00114777|448500460|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
124694055|NCT00114777|448500458|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
124694056|NCT00114777|448500459|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
124694057|NCT00114777|448500460|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
124694058|NCT00114777|448500458|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
124694059|NCT00114777|448500459|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
124694060|NCT00114777|448500460|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
124694061|NCT00114777|448500458|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
124694062|NCT00114777|448500459|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
124694063|NCT00114777|448500460|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
124694064|NCT00114777|448500458|FG000|Long-Term Extension to Month 84|Other|2|||
124694065|NCT00114777|448500459|FG001|Long-Term Extension to Month 84|Other|0|||
124694066|NCT00114777|448500460|FG002|Long-Term Extension to Month 84|Other|2|||
124694067|NCT00629239|448500461|FG000|Overall Study|Adverse Event|7|||
124694068|NCT00629239|448500462|FG001|Overall Study|Adverse Event|4|||
124694069|NCT00629239|448500461|FG000|Overall Study|Physician Decision|1|||
124694070|NCT00629239|448500462|FG001|Overall Study|Physician Decision|0|||
124694071|NCT02460380|448500463|FG000|Overall Study|Withdrawal by Subject|10|||
124694072|NCT02460380|448500464|FG001|Overall Study|Withdrawal by Subject|5|||
124545374|NCT00423137|447951172|FG000|Overall Study|Adverse Event Study disease worse|1|||
124545375|NCT00423137|447951173|FG001|Overall Study|Adverse Event Study disease worse|0|||
124694073|NCT03566550|448500471|FG000|Overall Study|Withdrawal by Subject|0|||
124694074|NCT03566550|448500472|FG001|Overall Study|Withdrawal by Subject|1|||
124694075|NCT00052715|448500478|FG000|Overall Study|wrong histology|1|||
124694076|NCT01210443|448500479|FG000|Overall Study|Study terminated by sponsor|2|||
124913600|NCT02740231|449310194|FG001|Overall Study|Adverse Event|1|||
124913601|NCT02740231|449310195|FG002|Overall Study|Adverse Event|0|||
124694077|NCT02807181|448500480|FG000|Overall Study|Death|28|||
124694078|NCT02807181|448500481|FG001|Overall Study|Death|24|||
124694079|NCT02807181|448500480|FG000|Overall Study|Withdrawal by Subject|1|||
124694080|NCT02807181|448500481|FG001|Overall Study|Withdrawal by Subject|1|||
124694081|NCT02807181|448500480|FG000|Overall Study|Lost to Follow-up|0|||
124694082|NCT02807181|448500481|FG001|Overall Study|Lost to Follow-up|2|||
124694083|NCT02807181|448500480|FG000|Overall Study|Subject decision|1|||
124694084|NCT02807181|448500481|FG001|Overall Study|Subject decision|0|||
124694085|NCT02807181|448500480|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
124694086|NCT02807181|448500481|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
124694087|NCT02807181|448500480|FG000|Overall Study|In Study|3|||
124694088|NCT02807181|448500481|FG001|Overall Study|In Study|3|||
124694089|NCT02807181|448500480|FG000|Overall Study|Post Progression|3|||
124694090|NCT02807181|448500481|FG001|Overall Study|Post Progression|2|||
124694091|NCT01063881|448500482|FG000|Overall Study|Adverse Event|12|||
124694092|NCT01063881|448500483|FG001|Overall Study|Adverse Event|2|||
124694093|NCT01063881|448500484|FG002|Overall Study|Adverse Event|0|||
124694094|NCT01063881|448500482|FG000|Overall Study|Lost to Follow-up|13|||
124694095|NCT01063881|448500483|FG001|Overall Study|Lost to Follow-up|7|||
124694096|NCT01063881|448500484|FG002|Overall Study|Lost to Follow-up|1|||
124694097|NCT01063881|448500482|FG000|Overall Study|Withdrawal by Subject|25|||
124694098|NCT01063881|448500483|FG001|Overall Study|Withdrawal by Subject|1|||
124694099|NCT01063881|448500484|FG002|Overall Study|Withdrawal by Subject|0|||
124694100|NCT01063881|448500482|FG000|Overall Study|Reason for not completed not specified|5|||
124694101|NCT01063881|448500483|FG001|Overall Study|Reason for not completed not specified|1|||
124694102|NCT01063881|448500484|FG002|Overall Study|Reason for not completed not specified|0|||
124913602|NCT02740231|449310196|FG003|Overall Study|Adverse Event|1|||
124913603|NCT00243503|449310199|FG000|Overall Study|Adverse Event|11|||
124913604|NCT00243503|449310199|FG000|Overall Study|Withdrawal by Subject|1|||
124913605|NCT00243503|449310199|FG000|Overall Study|Lack of Efficacy|44|||
124913606|NCT00243503|449310199|FG000|Overall Study|Death|1|||
124913607|NCT00243503|449310199|FG000|Overall Study|Other|1|||
124913608|NCT03076515|449310202|FG000|Overall Study|DMC decision based on interim analysis|25|||
124913609|NCT03076515|449310203|FG001|Overall Study|DMC decision based on interim analysis|29|||
124913610|NCT02374307|449310204|FG000|3-months Follow-up|Lost to Follow-up|1|||
124913611|NCT02374307|449310205|FG001|3-months Follow-up|Lost to Follow-up|2|||
124913612|NCT02374307|449310204|FG000|3-months Follow-up|Withdrawal by Subject|1|||
124913613|NCT02374307|449310205|FG001|3-months Follow-up|Withdrawal by Subject|4|||
124913614|NCT02374307|449310204|FG000|3-months Follow-up|Death|1|||
124913615|NCT02374307|449310205|FG001|3-months Follow-up|Death|2|||
124913616|NCT02374307|449310204|FG000|3-months Follow-up|Missed first follow-up|5|||
124913617|NCT02374307|449310205|FG001|3-months Follow-up|Missed first follow-up|1|||
124913618|NCT02374307|449310204|FG000|6-months Follow-up|Lost to Follow-up|1|||
124913619|NCT02374307|449310205|FG001|6-months Follow-up|Lost to Follow-up|2|||
124913620|NCT02374307|449310204|FG000|6-months Follow-up|Death|2|||
124913621|NCT02374307|449310205|FG001|6-months Follow-up|Death|1|||
124913622|NCT02374307|449310204|FG000|6-months Follow-up|Withdrawal by Subject|0|||
124913623|NCT02374307|449310205|FG001|6-months Follow-up|Withdrawal by Subject|3|||
124913624|NCT00999167|449310206|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
124913625|NCT00999167|449310207|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
124913626|NCT00999167|449310208|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
124913627|NCT00999167|449310206|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
124913628|NCT00999167|449310207|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
124913629|NCT00999167|449310208|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
124913630|NCT00999167|449310206|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
124913631|NCT00999167|449310207|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
124913632|NCT00999167|449310208|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
124913633|NCT00999167|449310206|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
124913634|NCT00999167|449310207|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
124913635|NCT00999167|449310208|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
124913636|NCT00999167|449310206|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
124913637|NCT00999167|449310207|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
124913638|NCT00999167|449310208|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
124913639|NCT00999167|449310206|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
124913640|NCT00999167|449310207|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
124913641|NCT00999167|449310208|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
124913642|NCT00999167|449310206|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
124913643|NCT00999167|449310207|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
124913644|NCT00999167|449310208|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
124913645|NCT00999167|449310206|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
124913646|NCT00999167|449310207|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
124913647|NCT00999167|449310208|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
124913648|NCT02554786|449310209|FG000|Overall Study|Subject/guardian decision|29|||
124913649|NCT02554786|449310210|FG001|Overall Study|Subject/guardian decision|17|||
124913650|NCT02554786|449310211|FG002|Overall Study|Subject/guardian decision|18|||
124913651|NCT02554786|449310212|FG003|Overall Study|Subject/guardian decision|30|||
124913652|NCT02554786|449310213|FG004|Overall Study|Subject/guardian decision|20|||
124913653|NCT02554786|449310209|FG000|Overall Study|Lost to Follow-up|4|||
124913654|NCT02554786|449310210|FG001|Overall Study|Lost to Follow-up|3|||
124694103|NCT01309100|448500485|FG000|Overall Study|Protocol Violation|1|||
124694104|NCT01309100|448500485|FG000|Overall Study|Positive Slit lamp finding|1|||
124694105|NCT04146909|448500493|FG000|Overall Study|Withdrawal by Subject|3|||
124694106|NCT04146909|448500493|FG000|Overall Study|Did not qualify after consented|1|||
124694107|NCT03808909|448500494|FG000|Overall Study|Lost to Follow-up|3|||
124694108|NCT03808909|448500495|FG001|Overall Study|Lost to Follow-up|0|||
124694109|NCT03335566|448500496|FG000|Overall Study|Adverse Event|0|||
124694110|NCT03335566|448500497|FG001|Overall Study|Adverse Event|1|||
124694111|NCT03335566|448500496|FG000|Overall Study|Lost to Follow-up|1|||
124694112|NCT03335566|448500497|FG001|Overall Study|Lost to Follow-up|0|||
124694113|NCT03335566|448500496|FG000|Overall Study|Technical Problems|1|||
124694114|NCT03335566|448500497|FG001|Overall Study|Technical Problems|0|||
124694115|NCT03335566|448500496|FG000|Overall Study|Protocol Violation|1|||
124694116|NCT03335566|448500497|FG001|Overall Study|Protocol Violation|0|||
124761411|NCT03318549|448751662|FG001|Overall Study|Lost to Follow-up|3|||
124761412|NCT03318549|448751663|FG002|Overall Study|Lost to Follow-up|3|||
124913655|NCT02554786|449310211|FG002|Overall Study|Lost to Follow-up|4|||
124913656|NCT02554786|449310212|FG003|Overall Study|Lost to Follow-up|2|||
124913657|NCT02554786|449310213|FG004|Overall Study|Lost to Follow-up|2|||
124913658|NCT02554786|449310209|FG000|Overall Study|Protocol deviation|1|||
124913659|NCT02554786|449310210|FG001|Overall Study|Protocol deviation|3|||
124913660|NCT02554786|449310211|FG002|Overall Study|Protocol deviation|3|||
124913661|NCT02554786|449310212|FG003|Overall Study|Protocol deviation|4|||
124913662|NCT02554786|449310213|FG004|Overall Study|Protocol deviation|2|||
124913663|NCT02554786|449310209|FG000|Overall Study|Technical problems|1|||
124913664|NCT02554786|449310210|FG001|Overall Study|Technical problems|1|||
124913665|NCT02554786|449310211|FG002|Overall Study|Technical problems|0|||
124913666|NCT02554786|449310212|FG003|Overall Study|Technical problems|2|||
124913667|NCT02554786|449310213|FG004|Overall Study|Technical problems|1|||
124913668|NCT02554786|449310209|FG000|Overall Study|Adverse Event|0|||
124913669|NCT02554786|449310210|FG001|Overall Study|Adverse Event|0|||
124913670|NCT02554786|449310211|FG002|Overall Study|Adverse Event|0|||
124913671|NCT02554786|449310212|FG003|Overall Study|Adverse Event|0|||
124913672|NCT02554786|449310213|FG004|Overall Study|Adverse Event|2|||
124913673|NCT02554786|449310209|FG000|Overall Study|Death|0|||
124913674|NCT02554786|449310210|FG001|Overall Study|Death|0|||
124913675|NCT02554786|449310211|FG002|Overall Study|Death|0|||
124913676|NCT02554786|449310212|FG003|Overall Study|Death|1|||
124913677|NCT02554786|449310213|FG004|Overall Study|Death|0|||
124913678|NCT02554786|449310209|FG000|Overall Study|Non-compliance with study treatment|0|||
124913679|NCT02554786|449310210|FG001|Overall Study|Non-compliance with study treatment|1|||
124913680|NCT02554786|449310211|FG002|Overall Study|Non-compliance with study treatment|1|||
124913681|NCT02554786|449310212|FG003|Overall Study|Non-compliance with study treatment|0|||
124913682|NCT02554786|449310213|FG004|Overall Study|Non-compliance with study treatment|1|||
124913683|NCT02554786|449310209|FG000|Overall Study|Physician Decision|0|||
124913684|NCT02554786|449310210|FG001|Overall Study|Physician Decision|1|||
124913685|NCT02554786|449310211|FG002|Overall Study|Physician Decision|4|||
124913686|NCT02554786|449310212|FG003|Overall Study|Physician Decision|1|||
124913687|NCT02554786|449310213|FG004|Overall Study|Physician Decision|1|||
124913688|NCT02554786|449310209|FG000|Overall Study|Pregnancy|0|||
124913689|NCT02554786|449310210|FG001|Overall Study|Pregnancy|0|||
124451238|NCT02871778|447613642|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
124451239|NCT02871778|447613643|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
124451240|NCT02871778|447613636|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
124451241|NCT02871778|447613637|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
124451242|NCT02871778|447613638|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
124451243|NCT02871778|447613639|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
124451244|NCT02871778|447613640|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
124451245|NCT02871778|447613641|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
124451246|NCT02871778|447613642|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
124451247|NCT02871778|447613643|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
124451248|NCT02871778|447613636|FG000|Part A: Treatment Period 2|Adverse Event|2|||
124451249|NCT02871778|447613637|FG001|Part A: Treatment Period 2|Adverse Event|2|||
124451250|NCT02871778|447613638|FG002|Part A: Treatment Period 2|Adverse Event|0|||
124451251|NCT02871778|447613639|FG003|Part A: Treatment Period 2|Adverse Event|0|||
124451252|NCT02871778|447613640|FG004|Part A: Treatment Period 2|Adverse Event|0|||
124913690|NCT02554786|449310211|FG002|Overall Study|Pregnancy|0|||
124913691|NCT02554786|449310212|FG003|Overall Study|Pregnancy|1|||
124913692|NCT02554786|449310213|FG004|Overall Study|Pregnancy|1|||
124913693|NCT05052996|449310214|FG000|Overall Study|Still on study|0|||
124913694|NCT05052996|449310215|FG001|Overall Study|Still on study|0|||
124913695|NCT05052996|449310216|FG002|Overall Study|Still on study|47|||
124913696|NCT05052996|449310217|FG003|Overall Study|Still on study|44|||
124913697|NCT05052996|449310214|FG000|Overall Study|Cohort terminated by sponsor|21|||
124913698|NCT05052996|449310215|FG001|Overall Study|Cohort terminated by sponsor|12|||
124913699|NCT05052996|449310216|FG002|Overall Study|Cohort terminated by sponsor|0|||
124913700|NCT05052996|449310217|FG003|Overall Study|Cohort terminated by sponsor|0|||
124913701|NCT05052996|449310214|FG000|Overall Study|Withdrew consent|1|||
124913702|NCT05052996|449310215|FG001|Overall Study|Withdrew consent|0|||
124913703|NCT05052996|449310216|FG002|Overall Study|Withdrew consent|1|||
124913704|NCT05052996|449310217|FG003|Overall Study|Withdrew consent|2|||
124913705|NCT05052996|449310214|FG000|Overall Study|Lost to Follow-up|1|||
124913706|NCT05052996|449310215|FG001|Overall Study|Lost to Follow-up|0|||
124913707|NCT05052996|449310216|FG002|Overall Study|Lost to Follow-up|0|||
124913708|NCT05052996|449310217|FG003|Overall Study|Lost to Follow-up|2|||
124694117|NCT03335566|448500496|FG000|Overall Study|Other than specified above|1|||
124913709|NCT05052996|449310214|FG000|Overall Study|Adverse Event|0|||
124913710|NCT05052996|449310215|FG001|Overall Study|Adverse Event|0|||
124913711|NCT05052996|449310216|FG002|Overall Study|Adverse Event|2|||
124694118|NCT03335566|448500497|FG001|Overall Study|Other than specified above|2|||
124913712|NCT05052996|449310217|FG003|Overall Study|Adverse Event|0|||
124913713|NCT05052996|449310214|FG000|Overall Study|Randomized but never treated|0|||
124913714|NCT05052996|449310215|FG001|Overall Study|Randomized but never treated|0|||
124913715|NCT05052996|449310216|FG002|Overall Study|Randomized but never treated|1|||
124913716|NCT05052996|449310217|FG003|Overall Study|Randomized but never treated|1|||
124913717|NCT05052996|449310214|FG000|Overall Study|Protocol Violation|1|||
124913718|NCT05052996|449310215|FG001|Overall Study|Protocol Violation|0|||
124913719|NCT05052996|449310216|FG002|Overall Study|Protocol Violation|0|||
124913720|NCT05052996|449310217|FG003|Overall Study|Protocol Violation|0|||
124913721|NCT00522951|449310218|FG000|Period 1|body motion|0|||
124913722|NCT00522951|449310219|FG001|Period 1|body motion|1|||
124913723|NCT00522951|449310218|FG000|Washout Period|Adverse Event|0|||
124913724|NCT00522951|449310219|FG001|Washout Period|Adverse Event|1|||
124913725|NCT00522951|449310218|FG000|Washout Period|Death|0|||
124913726|NCT00522951|449310219|FG001|Washout Period|Death|1|||
124913727|NCT00522951|449310218|FG000|Period 2|Withdrawal by Subject|1|||
124913728|NCT00522951|449310219|FG001|Period 2|Withdrawal by Subject|0|||
124913729|NCT00522951|449310218|FG000|Period 2|residual contrast medium|1|||
124913730|NCT00522951|449310219|FG001|Period 2|residual contrast medium|1|||
124913731|NCT02794480|449310220|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
124913732|NCT02794480|449310221|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
124913733|NCT02794480|449310222|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
124913734|NCT02794480|449310223|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
124913735|NCT02794480|449310220|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
124913736|NCT02794480|449310221|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
124913737|NCT02794480|449310222|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
124913738|NCT02794480|449310223|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
124913739|NCT02794480|449310220|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124913740|NCT02794480|449310221|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124913741|NCT02794480|449310222|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124913742|NCT02794480|449310223|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
124913743|NCT02794480|449310220|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124913744|NCT02794480|449310221|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
124913745|NCT02794480|449310222|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124913746|NCT02794480|449310223|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
124913747|NCT02794480|449310220|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
124913748|NCT02794480|449310221|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124913749|NCT02794480|449310222|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124913750|NCT02794480|449310223|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
124913751|NCT01017146|449310224|FG000|Overall Study|Adverse Event|11|||
124913752|NCT01017146|449310225|FG001|Overall Study|Adverse Event|1|||
124913753|NCT01017146|449310224|FG000|Overall Study|Lost to Follow-up|14|||
124913754|NCT01017146|449310225|FG001|Overall Study|Lost to Follow-up|14|||
124913755|NCT01017146|449310224|FG000|Overall Study|Noncompliance with Study Product|1|||
124913756|NCT01017146|449310225|FG001|Overall Study|Noncompliance with Study Product|1|||
124913757|NCT01017146|449310224|FG000|Overall Study|Withdrawal by Subject|32|||
124913758|NCT01017146|449310225|FG001|Overall Study|Withdrawal by Subject|16|||
124913759|NCT01017146|449310224|FG000|Overall Study|Relocation|0|||
124913760|NCT01017146|449310225|FG001|Overall Study|Relocation|4|||
124913761|NCT01017146|449310224|FG000|Overall Study|Pregnancy|2|||
124913762|NCT01017146|449310225|FG001|Overall Study|Pregnancy|1|||
124913763|NCT01017146|449310224|FG000|Overall Study|Protocol Violation|2|||
124913764|NCT01017146|449310225|FG001|Overall Study|Protocol Violation|0|||
124913765|NCT01017146|449310224|FG000|Overall Study|Took Excluded Medication|2|||
124913766|NCT01017146|449310225|FG001|Overall Study|Took Excluded Medication|0|||
124913767|NCT01017146|449310224|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
124913768|NCT01017146|449310225|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
124913769|NCT01017146|449310224|FG000|Overall Study|Change in Work Situation|1|||
124913770|NCT01017146|449310225|FG001|Overall Study|Change in Work Situation|0|||
124913771|NCT01771731|449310226|FG000|Overall Study|Physician Decision|1|||
124913772|NCT01771731|449310227|FG001|Overall Study|Physician Decision|0|||
124913773|NCT01771731|449310226|FG000|Overall Study|Protocol Violation|0|||
124913774|NCT01771731|449310227|FG001|Overall Study|Protocol Violation|1|||
124913775|NCT01771731|449310226|FG000|Overall Study|Adverse event: Pain Crisis|1|||
124913776|NCT01771731|449310227|FG001|Overall Study|Adverse event: Pain Crisis|1|||
124694119|NCT01084135|448500498|FG000|20 Week|Physician Decision|0|||
124694120|NCT01084135|448500499|FG001|20 Week|Physician Decision|1|||
124694121|NCT00663351|448500500|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
124913777|NCT01747486|449310228|FG000|Stage 1|Physician Decision|3|||
124913778|NCT01747486|449310229|FG001|Stage 1|Physician Decision|0|||
124913779|NCT01747486|449310228|FG000|Stage 1|Withdrawal by Subject|4|||
124913780|NCT01747486|449310229|FG001|Stage 1|Withdrawal by Subject|3|||
124913781|NCT01747486|449310228|FG000|Stage 1|Disease progression|4|||
124694122|NCT00663351|448500501|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
124694123|NCT00663351|448500500|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
124913782|NCT01747486|449310229|FG001|Stage 1|Disease progression|9|||
124913783|NCT01747486|449310228|FG000|Stage 1|Death|1|||
124913784|NCT01747486|449310229|FG001|Stage 1|Death|1|||
124913785|NCT01747486|449310228|FG000|Stage 2|Physician Decision|2|||
124913786|NCT01747486|449310229|FG001|Stage 2|Physician Decision|0|||
124913787|NCT01747486|449310228|FG000|Stage 2|Withdrawal by Subject|1|||
124913788|NCT01747486|449310229|FG001|Stage 2|Withdrawal by Subject|0|||
124913789|NCT01747486|449310228|FG000|Stage 2|New Cancer Therapy|3|||
124913790|NCT01747486|449310229|FG001|Stage 2|New Cancer Therapy|0|||
124913791|NCT01747486|449310228|FG000|Stage 2|Disease Progression|3|||
124913792|NCT01747486|449310229|FG001|Stage 2|Disease Progression|0|||
124913793|NCT00087139|449310230|FG000|Overall Study|Adverse Event|18|||
124913794|NCT00087139|449310231|FG001|Overall Study|Adverse Event|17|||
124913795|NCT00087139|449310232|FG002|Overall Study|Adverse Event|13|||
124913796|NCT00087139|449310230|FG000|Overall Study|Death|2|||
124913797|NCT00087139|449310231|FG001|Overall Study|Death|1|||
124913798|NCT00087139|449310232|FG002|Overall Study|Death|0|||
124913799|NCT00087139|449310230|FG000|Overall Study|Withdrawal by Subject|3|||
124913800|NCT00087139|449310231|FG001|Overall Study|Withdrawal by Subject|2|||
124913801|NCT00087139|449310232|FG002|Overall Study|Withdrawal by Subject|2|||
124913802|NCT00087139|449310230|FG000|Overall Study|Physician Decision|1|||
124913803|NCT00087139|449310231|FG001|Overall Study|Physician Decision|1|||
124913804|NCT00087139|449310232|FG002|Overall Study|Physician Decision|1|||
124913805|NCT00087139|449310230|FG000|Overall Study|Disease progression|9|||
124913806|NCT00087139|449310231|FG001|Overall Study|Disease progression|19|||
124913807|NCT00087139|449310232|FG002|Overall Study|Disease progression|12|||
124913808|NCT00087139|449310230|FG000|Overall Study|Ineligible|4|||
124913809|NCT00087139|449310231|FG001|Overall Study|Ineligible|7|||
124913810|NCT00087139|449310232|FG002|Overall Study|Ineligible|4|||
124913811|NCT00087139|449310230|FG000|Overall Study|Symptomatic deterioration|1|||
124913812|NCT00087139|449310231|FG001|Overall Study|Symptomatic deterioration|1|||
124913813|NCT00087139|449310232|FG002|Overall Study|Symptomatic deterioration|3|||
124913814|NCT00087139|449310230|FG000|Overall Study|Use of coumadin|1|||
124913815|NCT00087139|449310231|FG001|Overall Study|Use of coumadin|0|||
124913816|NCT00087139|449310232|FG002|Overall Study|Use of coumadin|0|||
124913817|NCT00087139|449310230|FG000|Overall Study|Response achieved|0|||
124913818|NCT00087139|449310231|FG001|Overall Study|Response achieved|1|||
124913819|NCT00087139|449310232|FG002|Overall Study|Response achieved|0|||
124913820|NCT00087139|449310230|FG000|Overall Study|Extradural disease|0|||
124913821|NCT00087139|449310231|FG001|Overall Study|Extradural disease|0|||
124913822|NCT00087139|449310232|FG002|Overall Study|Extradural disease|1|||
124913823|NCT00976495|449310233|FG000|Overall Study|Withdrawal by Subject|0|||
124913824|NCT00976495|449310234|FG001|Overall Study|Withdrawal by Subject|1|||
124913825|NCT00976495|449310235|FG002|Overall Study|Withdrawal by Subject|0|||
124913826|NCT02321514|449310236|FG000|Overall Study|Death|15|||
124913827|NCT02321514|449310236|FG000|Overall Study|Missed Visit|7|||
124913828|NCT02321514|449310236|FG000|Overall Study|Study Exit|3|||
124913829|NCT04128319|449310237|FG000|Overall Study|Death|3|||
124913830|NCT04484935|449310238|FG000|Overall Study|Other|0|||
124913831|NCT04484935|449310239|FG001|Overall Study|Other|1|||
124913832|NCT04484935|449310238|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124913833|NCT04484935|449310239|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124913834|NCT04484935|449310238|FG000|Overall Study|Lost to Follow-up|1|||
124913835|NCT04484935|449310239|FG001|Overall Study|Lost to Follow-up|0|||
124913836|NCT04484935|449310238|FG000|Overall Study|Death|2|||
124913837|NCT04484935|449310239|FG001|Overall Study|Death|1|||
124913838|NCT01094184|449310242|FG000|Overall Study|Death|35|||
124913839|NCT01094184|449310243|FG001|Overall Study|Death|11|||
124913840|NCT03892564|449310247|FG000|Overall Study|Withdrawal by Subject|2|||
124913841|NCT04992390|449310248|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
124913842|NCT04992390|449310249|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
124913843|NCT04992390|449310250|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
124913844|NCT04992390|449310248|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
124913845|NCT04992390|449310249|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
124913846|NCT04992390|449310250|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
124913847|NCT04992390|449310248|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
124913848|NCT04992390|449310249|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
124913849|NCT04992390|449310250|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
124913850|NCT04992390|449310248|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
124913851|NCT04992390|449310249|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
124913852|NCT04992390|449310250|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
124913853|NCT04992390|449310248|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
124913854|NCT04992390|449310249|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
124913855|NCT04992390|449310250|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
124913856|NCT04992390|449310248|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
124913857|NCT04992390|449310249|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
124913858|NCT04992390|449310250|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
124913859|NCT04992390|449310248|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
124913860|NCT04992390|449310249|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
124913861|NCT04992390|449310250|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
124913862|NCT04992390|449310248|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
124694124|NCT00663351|448500501|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
124694125|NCT00663351|448500500|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
124694126|NCT00663351|448500501|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
124694127|NCT00663351|448500500|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
124913863|NCT04992390|449310249|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
124913864|NCT04992390|449310250|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
124913865|NCT04992390|449310248|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
124913866|NCT04992390|449310249|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
124913867|NCT04992390|449310250|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
124913868|NCT04992390|449310248|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
124913869|NCT04992390|449310249|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
124913870|NCT04992390|449310250|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
124913871|NCT04992390|449310248|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
124694128|NCT00663351|448500501|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
124694129|NCT00663351|448500500|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
124761413|NCT03318549|448751664|FG003|Overall Study|Lost to Follow-up|0|||
124913872|NCT04992390|449310249|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
124913873|NCT04992390|449310250|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
124913874|NCT04992390|449310248|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
124913875|NCT04992390|449310249|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
124913876|NCT04992390|449310250|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
124913877|NCT04992390|449310248|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
124913878|NCT04992390|449310249|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
124913879|NCT04992390|449310250|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
124913880|NCT04992390|449310248|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
124913881|NCT04992390|449310249|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
124913882|NCT04992390|449310250|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
124913883|NCT04992390|449310248|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
124913884|NCT04992390|449310249|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
124913885|NCT04992390|449310250|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
124913886|NCT04992390|449310248|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
124913887|NCT04992390|449310249|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
124913888|NCT04992390|449310250|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
124913889|NCT01216176|449312362|FG000|Overall Study|Adverse Event|0|||
124913890|NCT01216176|449312363|FG001|Overall Study|Adverse Event|8|||
124913891|NCT01216176|449312364|FG002|Overall Study|Adverse Event|0|||
124913892|NCT01216176|449312362|FG000|Overall Study|Physician Decision|0|||
124913893|NCT01216176|449312363|FG001|Overall Study|Physician Decision|0|||
124913894|NCT01216176|449312364|FG002|Overall Study|Physician Decision|1|||
124913895|NCT03725722|449312367|FG000|Overall Study|Lack of Efficacy|2|||
124913896|NCT03725722|449312368|FG001|Overall Study|Lack of Efficacy|1|||
124913897|NCT03725722|449312369|FG002|Overall Study|Lack of Efficacy|2|||
124913898|NCT03725722|449312370|FG003|Overall Study|Lack of Efficacy|0|||
124913899|NCT03725722|449312371|FG004|Overall Study|Lack of Efficacy|2|||
124913900|NCT03725722|449312367|FG000|Overall Study|Adverse Event|2|||
124913901|NCT03725722|449312368|FG001|Overall Study|Adverse Event|2|||
124913902|NCT03725722|449312369|FG002|Overall Study|Adverse Event|1|||
124913903|NCT03725722|449312370|FG003|Overall Study|Adverse Event|0|||
124913904|NCT03725722|449312371|FG004|Overall Study|Adverse Event|6|||
124913905|NCT03725722|449312367|FG000|Overall Study|Withdrawal by Subject|4|||
124913906|NCT03725722|449312368|FG001|Overall Study|Withdrawal by Subject|1|||
124913907|NCT03725722|449312369|FG002|Overall Study|Withdrawal by Subject|0|||
124913908|NCT03725722|449312370|FG003|Overall Study|Withdrawal by Subject|4|||
124913909|NCT03725722|449312371|FG004|Overall Study|Withdrawal by Subject|4|||
124913910|NCT03725722|449312367|FG000|Overall Study|Lost to Follow-up|3|||
124913911|NCT03725722|449312368|FG001|Overall Study|Lost to Follow-up|1|||
124913912|NCT03725722|449312369|FG002|Overall Study|Lost to Follow-up|2|||
124913913|NCT03725722|449312370|FG003|Overall Study|Lost to Follow-up|2|||
124913914|NCT03725722|449312371|FG004|Overall Study|Lost to Follow-up|1|||
124913915|NCT03725722|449312367|FG000|Overall Study|Personal reasons|0|||
124913916|NCT03725722|449312368|FG001|Overall Study|Personal reasons|0|||
124913917|NCT03725722|449312369|FG002|Overall Study|Personal reasons|1|||
124913918|NCT03725722|449312370|FG003|Overall Study|Personal reasons|0|||
124913919|NCT03725722|449312371|FG004|Overall Study|Personal reasons|1|||
124913920|NCT03725722|449312367|FG000|Overall Study|COVID-19 situation|0|||
124913921|NCT03725722|449312368|FG001|Overall Study|COVID-19 situation|1|||
124913922|NCT03725722|449312369|FG002|Overall Study|COVID-19 situation|0|||
124694130|NCT00663351|448500501|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
124694131|NCT00663351|448500500|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
124694132|NCT00663351|448500501|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
124694133|NCT02362412|448500502|FG000|Treatment Period III|Lost to Follow-up|0|||
124694134|NCT02362412|448500503|FG001|Treatment Period III|Lost to Follow-up|1|||
124694135|NCT03462563|448500504|FG000|Overall Study|Death|1|||
124694136|NCT03462563|448500505|FG001|Overall Study|Death|1|||
124913923|NCT03725722|449312370|FG003|Overall Study|COVID-19 situation|0|||
124913924|NCT03725722|449312371|FG004|Overall Study|COVID-19 situation|0|||
124913925|NCT05505045|449312372|FG000|Overall Study|Withdrawal by Subject|2|||
124913926|NCT05505045|449312373|FG001|Overall Study|Withdrawal by Subject|1|||
124913927|NCT01643070|449312374|FG000|Overall Study|Withdrawal by Subject|3|||
124913928|NCT01643070|449312375|FG001|Overall Study|Withdrawal by Subject|1|||
124913929|NCT01643070|449312374|FG000|Overall Study|Death|1|||
124913930|NCT01643070|449312375|FG001|Overall Study|Death|0|||
124913931|NCT01643070|449312374|FG000|Overall Study|Pregressive disease|0|||
124913932|NCT01643070|449312375|FG001|Overall Study|Pregressive disease|2|||
124913933|NCT01600014|449312376|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
124913934|NCT01600014|449312377|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
124913935|NCT01600014|449312376|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
124913936|NCT01600014|449312377|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
124913937|NCT01600014|449312376|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
124913938|NCT01600014|449312377|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
124913939|NCT01600014|449312376|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
124913940|NCT01600014|449312377|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
124913941|NCT01600014|449312376|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
124913942|NCT01600014|449312377|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
124913943|NCT01600014|449312376|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
124913944|NCT01600014|449312377|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
124913945|NCT01600014|449312376|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
124913946|NCT01600014|449312377|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
124913947|NCT01600014|449312376|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
124913948|NCT01600014|449312377|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
124913949|NCT01600014|449312376|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
124913950|NCT01600014|449312377|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
124913951|NCT01600014|449312376|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
124913952|NCT01600014|449312377|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
124913953|NCT01600014|449312376|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
124913954|NCT01600014|449312377|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
124913955|NCT01600014|449312376|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
124913956|NCT01600014|449312377|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
124913957|NCT01600014|449312376|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
124913958|NCT01600014|449312377|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
124913959|NCT01600014|449312376|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
124694137|NCT03462563|448500504|FG000|Overall Study|Termination of study|2|||
124913960|NCT01600014|449312377|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
124913961|NCT01600014|449312376|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
124913962|NCT01600014|449312377|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
124913963|NCT01600014|449312376|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
124694138|NCT03462563|448500505|FG001|Overall Study|Termination of study|1|||
124694139|NCT03462563|448500504|FG000|Overall Study|Adverse Event|1|||
124913964|NCT01600014|449312377|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
124913965|NCT01600014|449312376|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
124913966|NCT01600014|449312377|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
124913967|NCT01259401|449312380|FG000|4-month Follow-up|Death|0|||
124913968|NCT01259401|449312381|FG001|4-month Follow-up|Death|1|||
124913969|NCT01259401|449312380|FG000|4-month Follow-up|Lost to Follow-up|0|||
124913970|NCT01259401|449312381|FG001|4-month Follow-up|Lost to Follow-up|1|||
124913971|NCT03481777|449312386|FG000|Overall Study|Withdrawal by Subject|36|||
124913972|NCT03481777|449312387|FG001|Overall Study|Withdrawal by Subject|31|||
124913973|NCT03481777|449312386|FG000|Overall Study|Non stroke = non target population|277|||
124913974|NCT03481777|449312387|FG001|Overall Study|Non stroke = non target population|254|||
124913975|NCT05696080|449312388|FG000|Overall Study|Lost to Follow-up|2|||
124913976|NCT05696080|449312389|FG001|Overall Study|Lost to Follow-up|1|||
124913977|NCT05696080|449312388|FG000|Overall Study|Physician Decision|1|||
124451253|NCT02871778|447613641|FG005|Part A: Treatment Period 2|Adverse Event|0|||
124451254|NCT02871778|447613642|FG006|Part A: Treatment Period 2|Adverse Event|0|||
124451255|NCT02871778|447613643|FG007|Part A: Treatment Period 2|Adverse Event|0|||
124451256|NCT02871778|447613636|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
124694140|NCT03462563|448500505|FG001|Overall Study|Adverse Event|3|||
124913978|NCT05696080|449312389|FG001|Overall Study|Physician Decision|0|||
124451257|NCT02871778|447613637|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
124451258|NCT02871778|447613638|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
124694141|NCT03462563|448500504|FG000|Overall Study|Unspecified reason|10|||
124913979|NCT05696080|449312388|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124913980|NCT05696080|449312389|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
124913981|NCT05696080|449312388|FG000|Overall Study|Withdrawal by Subject|12|||
124913982|NCT05696080|449312389|FG001|Overall Study|Withdrawal by Subject|0|||
124913983|NCT03954184|449312396|FG000|Overall Study|Lost to Follow-up|500|||
124913984|NCT03954184|449312397|FG001|Overall Study|Lost to Follow-up|0|||
124913985|NCT03398200|449312398|FG000|Overall Study|Withdrawal by Subject|0|||
124913986|NCT03398200|449312399|FG001|Overall Study|Withdrawal by Subject|1|||
124913987|NCT01649271|449312400|FG000|Overall Study|Progressive disease|4|||
124913988|NCT01649271|449312401|FG001|Overall Study|Progressive disease|5|||
124913989|NCT01649271|449312400|FG000|Overall Study|Other Adverse Event|0|||
124913990|NCT01649271|449312401|FG001|Overall Study|Other Adverse Event|2|||
124913991|NCT01649271|449312400|FG000|Overall Study|Withdrawal by Subject|1|||
124913992|NCT01649271|449312401|FG001|Overall Study|Withdrawal by Subject|0|||
124913993|NCT01649271|449312400|FG000|Overall Study|Other than stated above|1|||
124913994|NCT01649271|449312401|FG001|Overall Study|Other than stated above|0|||
124913995|NCT05756075|449312404|FG000|Overall Study|Withdrawal by Subject|16|||
124913996|NCT05756075|449312405|FG001|Overall Study|Withdrawal by Subject|9|||
124913997|NCT04038957|449312409|FG000|Overall Study|Withdrawal by Subject|1|||
124913998|NCT04038957|449312409|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
124913999|NCT03821844|449312410|FG000|Overall Study|Death|37|||
124914000|NCT03821844|449312411|FG001|Overall Study|Death|31|||
124914001|NCT03821844|449312410|FG000|Overall Study|Discharged|10|||
124914002|NCT03821844|449312411|FG001|Overall Study|Discharged|14|||
124914003|NCT03821844|449312410|FG000|Overall Study|Not present in facility at followup|2|||
124914004|NCT03821844|449312411|FG001|Overall Study|Not present in facility at followup|3|||
124914005|NCT01998984|449312416|FG000|Overall Study|Adverse Event|0|||
124914006|NCT01998984|449312417|FG001|Overall Study|Adverse Event|0|||
124914007|NCT01998984|449312418|FG002|Overall Study|Adverse Event|0|||
124914008|NCT01998984|449312419|FG003|Overall Study|Adverse Event|1|||
124914009|NCT01998984|449312416|FG000|Overall Study|Lost to Follow-up|0|||
124914010|NCT01998984|449312417|FG001|Overall Study|Lost to Follow-up|1|||
124914011|NCT01998984|449312418|FG002|Overall Study|Lost to Follow-up|0|||
124914012|NCT01998984|449312419|FG003|Overall Study|Lost to Follow-up|1|||
124914013|NCT01998984|449312416|FG000|Overall Study|Withdrawal by Subject|0|||
124914014|NCT01998984|449312417|FG001|Overall Study|Withdrawal by Subject|0|||
124914015|NCT01998984|449312418|FG002|Overall Study|Withdrawal by Subject|1|||
124914016|NCT01998984|449312419|FG003|Overall Study|Withdrawal by Subject|0|||
124914017|NCT01998984|449312416|FG000|Overall Study|Other|0|||
124914018|NCT01998984|449312417|FG001|Overall Study|Other|0|||
124914019|NCT01998984|449312418|FG002|Overall Study|Other|0|||
124914020|NCT01998984|449312419|FG003|Overall Study|Other|1|||
124914021|NCT01843374|449312421|FG000|Overall Study|Death|155|||
124914022|NCT01843374|449312422|FG001|Overall Study|Death|313|||
124914023|NCT01843374|449312421|FG000|Overall Study|Withdrawal by Subject|14|||
124914024|NCT01843374|449312422|FG001|Overall Study|Withdrawal by Subject|20|||
124914025|NCT01843374|449312421|FG000|Overall Study|Withdrawing due to Other reason|20|||
124914026|NCT01843374|449312422|FG001|Overall Study|Withdrawing due to Other reason|46|||
124914027|NCT03397108|449312423|FG000|Overall Study|Lost to Follow-up|15|||
124914028|NCT03397108|449312424|FG001|Overall Study|Lost to Follow-up|0|||
124914029|NCT03397108|449312423|FG000|Overall Study|Insufficient milk production|3|||
124914030|NCT03397108|449312424|FG001|Overall Study|Insufficient milk production|2|||
124914031|NCT03397108|449312423|FG000|Overall Study|Withdrawal by Subject|2|||
124914032|NCT03397108|449312424|FG001|Overall Study|Withdrawal by Subject|0|||
124914033|NCT03554265|449312425|FG000|Overall Study|Withdrawal by Subject|2|||
124914034|NCT03554265|449312426|FG001|Overall Study|Withdrawal by Subject|2|||
124914035|NCT03554265|449312427|FG002|Overall Study|Withdrawal by Subject|3|||
124914036|NCT03554265|449312425|FG000|Overall Study|Physician Decision|0|||
124914037|NCT03554265|449312426|FG001|Overall Study|Physician Decision|0|||
124914038|NCT03554265|449312427|FG002|Overall Study|Physician Decision|1|||
124914039|NCT02605837|449312428|FG000|Overall Study|Adverse Event|3|||
124914040|NCT02605837|449312429|FG001|Overall Study|Adverse Event|1|||
124914041|NCT02605837|449312428|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124914042|NCT02605837|449312429|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124914043|NCT02605837|449312428|FG000|Overall Study|Withdrawal by Subject|8|||
124914044|NCT02605837|449312429|FG001|Overall Study|Withdrawal by Subject|8|||
124914045|NCT02605837|449312428|FG000|Overall Study|Physician Decision|0|||
124914046|NCT02605837|449312429|FG001|Overall Study|Physician Decision|1|||
124914047|NCT02652260|449312430|FG000|Base Study|Pregnancy|0|||
124914048|NCT02652260|449312431|FG001|Base Study|Pregnancy|1|||
124914049|NCT02652260|449312430|FG000|Base Study|Withdrawal by Subject|0|||
124914050|NCT02652260|449312431|FG001|Base Study|Withdrawal by Subject|1|||
124914051|NCT02652260|449312430|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
124914052|NCT02652260|449312431|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
124914053|NCT02652260|449312430|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
124914054|NCT02652260|449312431|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
124914055|NCT02652260|449312430|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
124914056|NCT02652260|449312431|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
124914057|NCT02652260|449312430|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
124914058|NCT02652260|449312431|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
124914059|NCT02652260|449312430|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
124914060|NCT02652260|449312431|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
124914061|NCT02652260|449312430|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
124914062|NCT02652260|449312431|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
124914063|NCT02652260|449312430|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
124914064|NCT02652260|449312431|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
124914065|NCT02652260|449312430|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
124914066|NCT02652260|449312431|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
124914067|NCT02652260|449312430|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
124914068|NCT02652260|449312431|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
124914069|NCT02652260|449312430|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
124914070|NCT02652260|449312431|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
124914071|NCT02652260|449312430|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
124914072|NCT02652260|449312431|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
124914073|NCT02652260|449312430|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
124914074|NCT02652260|449312431|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
124914075|NCT05056246|449312432|FG000|Overall Study|Adverse Event|0|||
124914076|NCT05056246|449312433|FG001|Overall Study|Adverse Event|0|||
124914077|NCT05056246|449312434|FG002|Overall Study|Adverse Event|0|||
124914078|NCT05056246|449312435|FG003|Overall Study|Adverse Event|0|||
124914079|NCT05056246|449312436|FG004|Overall Study|Adverse Event|1|||
124914080|NCT05056246|449312432|FG000|Overall Study|Lost to Follow-up|0|||
124914081|NCT05056246|449312433|FG001|Overall Study|Lost to Follow-up|0|||
124914082|NCT05056246|449312434|FG002|Overall Study|Lost to Follow-up|0|||
124914083|NCT05056246|449312435|FG003|Overall Study|Lost to Follow-up|2|||
124914084|NCT05056246|449312436|FG004|Overall Study|Lost to Follow-up|0|||
124914085|NCT05056246|449312432|FG000|Overall Study|Withdrawal by Subject|0|||
124914086|NCT05056246|449312433|FG001|Overall Study|Withdrawal by Subject|1|||
124914087|NCT05056246|449312434|FG002|Overall Study|Withdrawal by Subject|0|||
124914088|NCT05056246|449312435|FG003|Overall Study|Withdrawal by Subject|0|||
124914089|NCT05056246|449312436|FG004|Overall Study|Withdrawal by Subject|0|||
124914090|NCT03899961|449312447|FG000|Overall Study|-delivery prior to|2|||
124914091|NCT03899961|449312448|FG001|Overall Study|-delivery prior to|7|||
124914092|NCT03899961|449312447|FG000|Overall Study|req general anesth|1|||
124914093|NCT03899961|449312448|FG001|Overall Study|req general anesth|2|||
124914094|NCT03899961|449312447|FG000|Overall Study|capacity|5|||
124914095|NCT03899961|449312448|FG001|Overall Study|capacity|6|||
124694142|NCT03462563|448500505|FG001|Overall Study|Unspecified reason|12|||
124914096|NCT03899961|449312447|FG000|Overall Study|Withdrawal by Subject|1|||
124914097|NCT03899961|449312448|FG001|Overall Study|Withdrawal by Subject|1|||
124914098|NCT05656911|449312449|FG000|Treatment Phase|Physician Decision|2|||
124914099|NCT05656911|449312450|FG001|Treatment Phase|Physician Decision|0|||
124914100|NCT05656911|449312449|FG000|Treatment Phase|Lack of Efficacy|6|||
124914101|NCT05656911|449312450|FG001|Treatment Phase|Lack of Efficacy|3|||
124914102|NCT05656911|449312449|FG000|Treatment Phase|Subject Decision|4|||
124914103|NCT05656911|449312450|FG001|Treatment Phase|Subject Decision|2|||
124914104|NCT05656911|449312449|FG000|Treatment Phase|Other Reasons|1|||
124914105|NCT05656911|449312450|FG001|Treatment Phase|Other Reasons|0|||
124914106|NCT05656911|449312449|FG000|Treatment Phase|Adverse Event|3|||
124914107|NCT05656911|449312450|FG001|Treatment Phase|Adverse Event|1|||
124914108|NCT05656911|449312449|FG000|Follow-up Phase|Subject Decision|0|||
124914109|NCT05656911|449312450|FG001|Follow-up Phase|Subject Decision|1|||
124914110|NCT05656911|449312449|FG000|Follow-up Phase|Missing|1|||
124914111|NCT05656911|449312450|FG001|Follow-up Phase|Missing|0|||
124914112|NCT02837510|449312451|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
124914113|NCT02837510|449312452|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
124914114|NCT02837510|449312451|FG000|Washout (2 Weeks)|Adverse Event|0|||
124914115|NCT02837510|449312452|FG001|Washout (2 Weeks)|Adverse Event|1|||
124694143|NCT03462563|448500504|FG000|Overall Study|Physician Decision|1|||
124694144|NCT03462563|448500505|FG001|Overall Study|Physician Decision|0|||
124694145|NCT02218268|448500506|FG000|24 Hour Washout|Physician Decision|11|||
124694146|NCT02218268|448500507|FG001|24 Hour Washout|Physician Decision|9|||
124694147|NCT03651336|448500508|FG000|Overall Study|Withdrawal by Subject|4|||
124694148|NCT01740427|448500509|FG000|Overall Study|Objective Progression or Relapse|286|||
124694149|NCT01740427|448500510|FG001|Overall Study|Objective Progression or Relapse|172|||
124914116|NCT02837510|449312451|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
124914117|NCT02837510|449312452|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
124914118|NCT02837510|449312451|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
124914119|NCT02837510|449312452|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
124914120|NCT02837510|449312451|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
124914121|NCT02837510|449312452|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
124914122|NCT02837510|449312451|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
124914123|NCT02837510|449312452|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
124914124|NCT03088813|449312453|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
124914125|NCT03088813|449312454|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
124914126|NCT03088813|449312455|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
124914127|NCT03088813|449312456|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
124914128|NCT03088813|449312453|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
124914129|NCT03088813|449312454|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
124914130|NCT03088813|449312455|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
124914131|NCT03088813|449312456|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
124914132|NCT03088813|449312453|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
124914133|NCT03088813|449312454|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
124914134|NCT03088813|449312455|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
124914135|NCT03088813|449312456|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
124914136|NCT03088813|449312453|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
124914137|NCT03088813|449312454|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
124914138|NCT03088813|449312455|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
124914139|NCT03088813|449312456|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
124914140|NCT03088813|449312453|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
124914141|NCT03088813|449312454|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
124914142|NCT03088813|449312455|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
124914143|NCT03088813|449312456|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
124914144|NCT03088813|449312453|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
124914145|NCT03088813|449312454|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
124914146|NCT03088813|449312455|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
124914147|NCT03088813|449312456|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
124914148|NCT03088813|449312453|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
124914149|NCT03088813|449312454|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
124914150|NCT03088813|449312455|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
124914151|NCT03088813|449312456|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
124914152|NCT02780388|449312457|FG000|Overall Study|Lost to Follow-up|0|||
124914153|NCT02780388|449312458|FG001|Overall Study|Lost to Follow-up|1|||
124914154|NCT02780388|449312459|FG002|Overall Study|Lost to Follow-up|0|||
124914155|NCT02780388|449312460|FG003|Overall Study|Lost to Follow-up|0|||
124914156|NCT02780388|449312461|FG004|Overall Study|Lost to Follow-up|0|||
124914157|NCT02780388|449312457|FG000|Overall Study|Withdrawal by Subject|1|||
124914158|NCT02780388|449312458|FG001|Overall Study|Withdrawal by Subject|1|||
124914159|NCT02780388|449312459|FG002|Overall Study|Withdrawal by Subject|0|||
124914160|NCT02780388|449312460|FG003|Overall Study|Withdrawal by Subject|0|||
124914161|NCT02780388|449312461|FG004|Overall Study|Withdrawal by Subject|0|||
124914162|NCT04527146|449312462|FG000|Overall Study|Withdrawal by Subject|12|||
124914163|NCT04527146|449312463|FG001|Overall Study|Withdrawal by Subject|15|||
124914164|NCT04527146|449312464|FG002|Overall Study|Withdrawal by Subject|7|||
124914165|NCT04527146|449312465|FG003|Overall Study|Withdrawal by Subject|16|||
124914166|NCT04527146|449312462|FG000|Overall Study|Lost to Follow-up|13|||
124914167|NCT04527146|449312463|FG001|Overall Study|Lost to Follow-up|9|||
124914168|NCT04527146|449312464|FG002|Overall Study|Lost to Follow-up|16|||
124914169|NCT04527146|449312465|FG003|Overall Study|Lost to Follow-up|13|||
124914170|NCT04527146|449312462|FG000|Overall Study|Death|0|||
124914171|NCT04527146|449312463|FG001|Overall Study|Death|1|||
124914172|NCT04527146|449312464|FG002|Overall Study|Death|1|||
124914173|NCT04527146|449312465|FG003|Overall Study|Death|0|||
124914174|NCT04527146|449312462|FG000|Overall Study|Adverse Event|0|||
124914175|NCT04527146|449312463|FG001|Overall Study|Adverse Event|0|||
124914176|NCT04527146|449312464|FG002|Overall Study|Adverse Event|1|||
124914177|NCT04527146|449312465|FG003|Overall Study|Adverse Event|0|||
124914178|NCT04527146|449312462|FG000|Overall Study|Ineligible after randomization|2|||
124914179|NCT04527146|449312463|FG001|Overall Study|Ineligible after randomization|0|||
124914180|NCT04527146|449312464|FG002|Overall Study|Ineligible after randomization|2|||
124914181|NCT04527146|449312465|FG003|Overall Study|Ineligible after randomization|2|||
124914182|NCT04527146|449312462|FG000|Overall Study|Moved to a different group|6|||
124914183|NCT04527146|449312463|FG001|Overall Study|Moved to a different group|3|||
124914184|NCT04527146|449312464|FG002|Overall Study|Moved to a different group|0|||
124914185|NCT04527146|449312465|FG003|Overall Study|Moved to a different group|2|||
124914186|NCT05107401|449312466|FG000|Overall Study|Lost to Follow-up|13|||
124914187|NCT05107401|449312467|FG001|Overall Study|Lost to Follow-up|12|||
124914188|NCT01903811|449312479|FG000|Overall Study|No measurable disease|1|||
124914189|NCT01903811|449312480|FG001|Overall Study|No measurable disease|1|||
124694150|NCT01740427|448500509|FG000|Overall Study|Adverse Event|32|||
124914190|NCT01903811|449312479|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
124914191|NCT01903811|449312480|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
124914192|NCT01903811|449312479|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
124914193|NCT01903811|449312480|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
124914194|NCT01903811|449312479|FG000|Overall Study|Withdrawal by Subject|0|||
124914195|NCT01903811|449312480|FG001|Overall Study|Withdrawal by Subject|1|||
124914196|NCT04468776|449312483|FG000|Overall Study|Lost to Follow-up|4|||
124914197|NCT04468776|449312484|FG001|Overall Study|Lost to Follow-up|3|||
124914198|NCT04468776|449312485|FG002|Overall Study|Lost to Follow-up|4|||
124914199|NCT04468776|449312483|FG000|Overall Study|Withdrawal by Subject|1|||
124914200|NCT04468776|449312484|FG001|Overall Study|Withdrawal by Subject|10|||
124914201|NCT04468776|449312485|FG002|Overall Study|Withdrawal by Subject|4|||
124914202|NCT04468776|449312483|FG000|Overall Study|Physician Decision|0|||
124914203|NCT04468776|449312484|FG001|Overall Study|Physician Decision|1|||
124914204|NCT04468776|449312485|FG002|Overall Study|Physician Decision|1|||
124914205|NCT04440176|449312488|FG000|Overall Study|Withdrawal by Subject|5|||
124914206|NCT04440176|449312489|FG001|Overall Study|Withdrawal by Subject|3|||
124914207|NCT04440176|449312488|FG000|Overall Study|Withdrawal by parent/guardian|4|||
124914208|NCT04440176|449312489|FG001|Overall Study|Withdrawal by parent/guardian|5|||
124914209|NCT04440176|449312488|FG000|Overall Study|Adverse Event|2|||
124914210|NCT04440176|449312489|FG001|Overall Study|Adverse Event|6|||
124914211|NCT04440176|449312488|FG000|Overall Study|Lost to Follow-up|22|||
124914212|NCT04440176|449312489|FG001|Overall Study|Lost to Follow-up|23|||
124914213|NCT04440176|449312488|FG000|Overall Study|Medication error without associated adverse event|0|||
124914214|NCT04440176|449312489|FG001|Overall Study|Medication error without associated adverse event|1|||
124914215|NCT04440176|449312488|FG000|Overall Study|No longer met eligibility criteria|7|||
124914216|NCT04440176|449312489|FG001|Overall Study|No longer met eligibility criteria|1|||
124914217|NCT04440176|449312488|FG000|Overall Study|Other|1|||
124914218|NCT04440176|449312489|FG001|Overall Study|Other|2|||
124914219|NCT04440176|449312488|FG000|Overall Study|Protocol deviation|6|||
124914220|NCT04440176|449312489|FG001|Overall Study|Protocol deviation|8|||
124914221|NCT04440176|449312488|FG000|Overall Study|Randomized but not vaccinated|6|||
124914222|NCT04440176|449312489|FG001|Overall Study|Randomized but not vaccinated|3|||
124914223|NCT01704079|449312493|FG000|Overall Study|Withdrawal by Subject|5|||
124914224|NCT01704079|449312494|FG001|Overall Study|Withdrawal by Subject|7|||
124914225|NCT01704079|449312493|FG000|Overall Study|Lost to Follow-up|2|||
124914226|NCT01704079|449312494|FG001|Overall Study|Lost to Follow-up|5|||
124914227|NCT01704079|449312493|FG000|Overall Study|Adverse Event|4|||
124914228|NCT01704079|449312494|FG001|Overall Study|Adverse Event|7|||
124914229|NCT01704079|449312493|FG000|Overall Study|Protocol Violation|1|||
124914230|NCT01704079|449312494|FG001|Overall Study|Protocol Violation|0|||
124914231|NCT01704079|449312493|FG000|Overall Study|Subject noncompliance|2|||
124914232|NCT01704079|449312494|FG001|Overall Study|Subject noncompliance|3|||
124914233|NCT01704079|449312493|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
124914234|NCT01704079|449312494|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
124914235|NCT03285763|449312497|FG000|Overall Study|Death|470|||
124914236|NCT03285763|449312497|FG000|Overall Study|Lost to Follow-up|18|||
124914237|NCT03285763|449312497|FG000|Overall Study|Physician Decision|2|||
124914238|NCT03285763|449312497|FG000|Overall Study|Study Terminated By Sponsor|79|||
124914239|NCT03285763|449312497|FG000|Overall Study|Withdrawal by Subject|33|||
124914240|NCT03624972|449312498|FG000|Overall Study|Lost to Follow-up|2|||
124914241|NCT03624972|449312499|FG001|Overall Study|Lost to Follow-up|0|||
124914242|NCT03624972|449312500|FG002|Overall Study|Lost to Follow-up|0|||
124914243|NCT03624972|449312498|FG000|Overall Study|Withdrawal by Subject|0|||
124914244|NCT03624972|449312499|FG001|Overall Study|Withdrawal by Subject|2|||
124914245|NCT03624972|449312500|FG002|Overall Study|Withdrawal by Subject|0|||
124914246|NCT03456076|449312501|FG000|Overall Study|Withdrawal by Subject|5|||
124914247|NCT03456076|449312502|FG001|Overall Study|Withdrawal by Subject|9|||
124914248|NCT03456076|449312501|FG000|Overall Study|Protocol deviation|0|||
124914249|NCT03456076|449312502|FG001|Overall Study|Protocol deviation|1|||
124914250|NCT03456076|449312501|FG000|Overall Study|Lost to Follow-up|0|||
124914251|NCT03456076|449312502|FG001|Overall Study|Lost to Follow-up|1|||
124914252|NCT03456076|449312501|FG000|Overall Study|Death|2|||
124914253|NCT03456076|449312502|FG001|Overall Study|Death|5|||
124914254|NCT03456076|449312501|FG000|Overall Study|Study ongoing|123|||
124914255|NCT03456076|449312502|FG001|Overall Study|Study ongoing|111|||
124914256|NCT04579250|449312506|FG000|Overall Study|Withdrawal by Subject|1|||
124914257|NCT04579250|449312507|FG001|Overall Study|Withdrawal by Subject|1|||
124914258|NCT04579250|449312508|FG002|Overall Study|Withdrawal by Subject|0|||
124914259|NCT04579250|449312506|FG000|Overall Study|Lost to Follow-up|1|||
124914260|NCT04579250|449312507|FG001|Overall Study|Lost to Follow-up|1|||
124914261|NCT04579250|449312508|FG002|Overall Study|Lost to Follow-up|0|||
124914262|NCT04579250|449312506|FG000|Overall Study|Moved from area|0|||
124914263|NCT04579250|449312507|FG001|Overall Study|Moved from area|1|||
124914264|NCT04579250|449312508|FG002|Overall Study|Moved from area|2|||
124914265|NCT04711135|449312513|FG000|Overall Study|Physician Decision|0|||
124914266|NCT04711135|449312514|FG001|Overall Study|Physician Decision|1|||
124914267|NCT04711135|449312513|FG000|Overall Study|Ongoing treatment|0|||
124914268|NCT04711135|449312514|FG001|Overall Study|Ongoing treatment|1|||
124914269|NCT00998881|449312515|FG000|Overall Study|Adverse Event|2|||
124914270|NCT00998881|449312516|FG001|Overall Study|Adverse Event|2|||
124914271|NCT00998881|449312515|FG000|Overall Study|Lack of Efficacy|1|||
124914272|NCT00998881|449312516|FG001|Overall Study|Lack of Efficacy|0|||
124914273|NCT00998881|449312515|FG000|Overall Study|Physician Decision|3|||
124914274|NCT00998881|449312516|FG001|Overall Study|Physician Decision|0|||
124914275|NCT00998881|449312515|FG000|Overall Study|Withdrawal by Subject|1|||
124914276|NCT00998881|449312516|FG001|Overall Study|Withdrawal by Subject|0|||
124914277|NCT00998881|449312515|FG000|Overall Study|Personal matter|1|||
124914278|NCT00998881|449312516|FG001|Overall Study|Personal matter|0|||
124914279|NCT00818246|449312518|FG000|Overall Study|Impossible to match pictures|5|||
124914280|NCT02006758|449312522|FG000|Overall Study|Protocol Violation|1|||
124914281|NCT02006758|449312522|FG000|Overall Study|Death|1|||
124914282|NCT02006758|449312522|FG000|Overall Study|Lost to Follow-up|4|||
124914283|NCT02006758|449312522|FG000|Overall Study|Withdrawal by Subject|4|||
124914284|NCT02006758|449312522|FG000|Overall Study|Procedurally excluded|1|||
124914285|NCT02006758|449312522|FG000|Overall Study|Other|2|||
124914286|NCT04788641|449312524|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
124914287|NCT04788641|449312525|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
124914288|NCT04788641|449312526|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
124914289|NCT04788641|449312527|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
124914290|NCT04788641|449312524|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
124914291|NCT04788641|449312525|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
124914292|NCT04788641|449312526|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
124914293|NCT04788641|449312527|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
124914294|NCT04788641|449312524|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
124914295|NCT04788641|449312525|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
124914296|NCT04788641|449312526|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
124914297|NCT04788641|449312527|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
124914298|NCT03283371|449312528|FG000|Placebo-controlled|Adverse Event|1|||
124914299|NCT03283371|449312529|FG001|Placebo-controlled|Adverse Event|1|||
124914300|NCT03283371|449312530|FG002|Placebo-controlled|Adverse Event|0|||
124914301|NCT03283371|449312531|FG003|Placebo-controlled|Adverse Event|0|||
124914302|NCT03283371|449312528|FG000|Placebo-controlled|Lack of Efficacy|1|||
124914303|NCT03283371|449312529|FG001|Placebo-controlled|Lack of Efficacy|0|||
124914304|NCT03283371|449312530|FG002|Placebo-controlled|Lack of Efficacy|0|||
124914305|NCT03283371|449312531|FG003|Placebo-controlled|Lack of Efficacy|0|||
124914306|NCT03283371|449312528|FG000|Placebo-controlled|Withdrawal by Subject|1|||
124914307|NCT03283371|449312529|FG001|Placebo-controlled|Withdrawal by Subject|1|||
124914308|NCT03283371|449312530|FG002|Placebo-controlled|Withdrawal by Subject|0|||
124914309|NCT03283371|449312531|FG003|Placebo-controlled|Withdrawal by Subject|0|||
124914310|NCT03283371|449312528|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
124914311|NCT03283371|449312529|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
124914312|NCT03283371|449312530|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
124914313|NCT03283371|449312531|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
124914314|NCT03283371|449312528|FG000|Open-label Phase|Adverse Event|0|||
124914315|NCT03283371|449312529|FG001|Open-label Phase|Adverse Event|0|||
124914316|NCT03283371|449312530|FG002|Open-label Phase|Adverse Event|2|||
124914317|NCT03283371|449312531|FG003|Open-label Phase|Adverse Event|0|||
124914318|NCT03283371|449312528|FG000|Open-label Phase|Withdrawal by Subject|0|||
124914319|NCT03283371|449312529|FG001|Open-label Phase|Withdrawal by Subject|0|||
124914320|NCT03283371|449312530|FG002|Open-label Phase|Withdrawal by Subject|1|||
124914321|NCT03283371|449312531|FG003|Open-label Phase|Withdrawal by Subject|0|||
124914322|NCT03283371|449312528|FG000|Open-label Phase|Other|0|||
124914323|NCT03283371|449312529|FG001|Open-label Phase|Other|0|||
124914324|NCT03283371|449312530|FG002|Open-label Phase|Other|1|||
124914325|NCT03283371|449312531|FG003|Open-label Phase|Other|1|||
124914326|NCT02462759|449312532|FG000|Part 1: Double Blind|Death|1|||
124914327|NCT02462759|449312533|FG001|Part 1: Double Blind|Death|0|||
124914328|NCT02462759|449312534|FG002|Part 1: Double Blind|Death|0|||
124914329|NCT00093015|449312535|FG000|Overall Study|Withdrawal by Subject|194|||
124914330|NCT00093015|449312536|FG001|Overall Study|Withdrawal by Subject|171|||
124914331|NCT00093015|449312535|FG000|Overall Study|Lost to Follow-up|96|||
124914332|NCT00093015|449312536|FG001|Overall Study|Lost to Follow-up|108|||
124914333|NCT00093015|449312535|FG000|Overall Study|Death|375|||
124914334|NCT00093015|449312536|FG001|Overall Study|Death|385|||
124914335|NCT04600752|449312539|FG000|Overall Study|Physician Decision|0|||
124914336|NCT04600752|449312540|FG001|Overall Study|Physician Decision|0|||
124914337|NCT04600752|449312541|FG002|Overall Study|Physician Decision|1|||
124914338|NCT04600752|449312539|FG000|Overall Study|Adverse Event|0|||
124914339|NCT04600752|449312540|FG001|Overall Study|Adverse Event|1|||
124914340|NCT04600752|449312541|FG002|Overall Study|Adverse Event|0|||
124914341|NCT04600752|449312539|FG000|Overall Study|Withdrawal by Subject|2|||
124914342|NCT04600752|449312540|FG001|Overall Study|Withdrawal by Subject|1|||
124914343|NCT04600752|449312541|FG002|Overall Study|Withdrawal by Subject|0|||
124914344|NCT04600752|449312539|FG000|Overall Study|Lack of Efficacy|1|||
124914345|NCT04600752|449312540|FG001|Overall Study|Lack of Efficacy|0|||
124914346|NCT04600752|449312541|FG002|Overall Study|Lack of Efficacy|0|||
124914347|NCT03398148|449314606|FG000|Substudy 1 Period 1|Adverse Event|5|||
124914348|NCT03398148|449314607|FG001|Substudy 1 Period 1|Adverse Event|2|||
124914349|NCT03398148|449314608|FG002|Substudy 1 Period 1|Adverse Event|2|||
124914350|NCT03398148|449314609|FG003|Substudy 1 Period 1|Adverse Event|0|||
124914351|NCT03398148|449314610|FG004|Substudy 1 Period 1|Adverse Event|8|||
124914352|NCT03398148|449314611|FG005|Substudy 1 Period 1|Adverse Event|0|||
124914353|NCT03398148|449314612|FG006|Substudy 1 Period 1|Adverse Event|0|||
124914354|NCT03398148|449314613|FG007|Substudy 1 Period 1|Adverse Event|0|||
124914355|NCT03398148|449314614|FG008|Substudy 1 Period 1|Adverse Event|0|||
124914356|NCT03398148|449314615|FG009|Substudy 1 Period 1|Adverse Event|0|||
124914357|NCT03398148|449314616|FG010|Substudy 1 Period 1|Adverse Event|0|||
124914358|NCT03398148|449314617|FG011|Substudy 1 Period 1|Adverse Event|0|||
124914359|NCT03398148|449314618|FG012|Substudy 1 Period 1|Adverse Event|0|||
124914360|NCT03398148|449314619|FG013|Substudy 1 Period 1|Adverse Event|0|||
124914361|NCT03398148|449314620|FG014|Substudy 1 Period 1|Adverse Event|0|||
124914362|NCT03398148|449314606|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
124914363|NCT03398148|449314607|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
124914364|NCT03398148|449314608|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914365|NCT03398148|449314609|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
124914366|NCT03398148|449314610|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
124914367|NCT03398148|449314611|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914368|NCT03398148|449314612|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914369|NCT03398148|449314613|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914370|NCT03398148|449314614|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914371|NCT03398148|449314615|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914372|NCT03398148|449314616|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914373|NCT03398148|449314617|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914374|NCT03398148|449314618|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914375|NCT03398148|449314619|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914376|NCT03398148|449314620|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
124914377|NCT03398148|449314606|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
124914378|NCT03398148|449314607|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
124914379|NCT03398148|449314608|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
124914380|NCT03398148|449314609|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
124914381|NCT03398148|449314610|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
124914382|NCT03398148|449314611|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
124914383|NCT03398148|449314612|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
124914384|NCT03398148|449314613|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
124914385|NCT03398148|449314614|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
124914386|NCT03398148|449314615|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
124914387|NCT03398148|449314616|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
124914388|NCT03398148|449314617|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
124914389|NCT03398148|449314618|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
124914390|NCT03398148|449314619|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
124914391|NCT03398148|449314620|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
124914392|NCT03398148|449314606|FG000|Substudy 1 Period 1|Other|0|||
124914393|NCT03398148|449314607|FG001|Substudy 1 Period 1|Other|1|||
124914394|NCT03398148|449314608|FG002|Substudy 1 Period 1|Other|0|||
124914395|NCT03398148|449314609|FG003|Substudy 1 Period 1|Other|0|||
124914396|NCT03398148|449314610|FG004|Substudy 1 Period 1|Other|3|||
124914397|NCT03398148|449314611|FG005|Substudy 1 Period 1|Other|0|||
124914398|NCT03398148|449314612|FG006|Substudy 1 Period 1|Other|0|||
124914399|NCT03398148|449314613|FG007|Substudy 1 Period 1|Other|0|||
124914400|NCT03398148|449314614|FG008|Substudy 1 Period 1|Other|0|||
124914401|NCT03398148|449314615|FG009|Substudy 1 Period 1|Other|0|||
124914402|NCT03398148|449314616|FG010|Substudy 1 Period 1|Other|0|||
124914403|NCT03398148|449314617|FG011|Substudy 1 Period 1|Other|0|||
124914404|NCT03398148|449314618|FG012|Substudy 1 Period 1|Other|0|||
124914405|NCT03398148|449314619|FG013|Substudy 1 Period 1|Other|0|||
124914406|NCT03398148|449314620|FG014|Substudy 1 Period 1|Other|0|||
124914407|NCT03398148|449314606|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914408|NCT03398148|449314607|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914409|NCT03398148|449314608|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
124451259|NCT02871778|447613639|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
124451260|NCT02871778|447613640|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
124451261|NCT02871778|447613641|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
124451262|NCT02871778|447613642|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
124914410|NCT03398148|449314609|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914411|NCT03398148|449314610|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
124914412|NCT03398148|449314611|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914413|NCT03398148|449314612|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914414|NCT03398148|449314613|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914415|NCT03398148|449314614|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914416|NCT03398148|449314615|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914417|NCT03398148|449314616|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914418|NCT03398148|449314617|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914419|NCT03398148|449314618|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914420|NCT03398148|449314619|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914421|NCT03398148|449314620|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
124914422|NCT03398148|449314606|FG000|Substudy 1 Period 2|Adverse Event|0|||
124914423|NCT03398148|449314607|FG001|Substudy 1 Period 2|Adverse Event|0|||
124914424|NCT03398148|449314608|FG002|Substudy 1 Period 2|Adverse Event|0|||
124914425|NCT03398148|449314609|FG003|Substudy 1 Period 2|Adverse Event|0|||
124451263|NCT02871778|447613643|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
124451264|NCT02871778|447613636|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
124451265|NCT02871778|447613637|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
124451266|NCT02871778|447613638|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
124451267|NCT02871778|447613639|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
124451268|NCT02871778|447613640|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
124451269|NCT02871778|447613641|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
124451270|NCT02871778|447613642|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
124451271|NCT02871778|447613643|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
124451272|NCT02871778|447613636|FG000|Part B: Treatment Period 3|Adverse Event|0|||
124451273|NCT02871778|447613637|FG001|Part B: Treatment Period 3|Adverse Event|0|||
124451274|NCT02871778|447613638|FG002|Part B: Treatment Period 3|Adverse Event|0|||
124451275|NCT02871778|447613639|FG003|Part B: Treatment Period 3|Adverse Event|0|||
124451276|NCT02871778|447613640|FG004|Part B: Treatment Period 3|Adverse Event|1|||
124451277|NCT02871778|447613641|FG005|Part B: Treatment Period 3|Adverse Event|1|||
124451278|NCT02871778|447613642|FG006|Part B: Treatment Period 3|Adverse Event|1|||
124451279|NCT02871778|447613643|FG007|Part B: Treatment Period 3|Adverse Event|0|||
124914426|NCT03398148|449314610|FG004|Substudy 1 Period 2|Adverse Event|0|||
124914427|NCT03398148|449314611|FG005|Substudy 1 Period 2|Adverse Event|2|||
124914428|NCT03398148|449314612|FG006|Substudy 1 Period 2|Adverse Event|4|||
124914429|NCT03398148|449314613|FG007|Substudy 1 Period 2|Adverse Event|0|||
124914430|NCT03398148|449314614|FG008|Substudy 1 Period 2|Adverse Event|0|||
124914431|NCT03398148|449314615|FG009|Substudy 1 Period 2|Adverse Event|0|||
124914432|NCT03398148|449314616|FG010|Substudy 1 Period 2|Adverse Event|0|||
124914433|NCT03398148|449314617|FG011|Substudy 1 Period 2|Adverse Event|0|||
124914434|NCT03398148|449314618|FG012|Substudy 1 Period 2|Adverse Event|0|||
124914435|NCT03398148|449314619|FG013|Substudy 1 Period 2|Adverse Event|0|||
124914436|NCT03398148|449314620|FG014|Substudy 1 Period 2|Adverse Event|0|||
124914437|NCT03398148|449314606|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914438|NCT03398148|449314607|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914439|NCT03398148|449314608|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914440|NCT03398148|449314609|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914441|NCT03398148|449314610|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914442|NCT03398148|449314611|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914443|NCT03398148|449314612|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
124914444|NCT03398148|449314613|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
124914445|NCT03398148|449314614|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914446|NCT03398148|449314615|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124451280|NCT02170779|447613644|FG000|Overall Study|Withdrawal by Subject|1|||
124694151|NCT01740427|448500510|FG001|Overall Study|Adverse Event|9|||
124694152|NCT01740427|448500509|FG000|Overall Study|Global Deterioration of Health Status|28|||
124694153|NCT01740427|448500510|FG001|Overall Study|Global Deterioration of Health Status|12|||
124694154|NCT01740427|448500509|FG000|Overall Study|Participant Refused Continued Treatment|27|||
124694155|NCT01740427|448500510|FG001|Overall Study|Participant Refused Continued Treatment|15|||
124914447|NCT03398148|449314616|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914448|NCT03398148|449314617|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914449|NCT03398148|449314618|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914450|NCT03398148|449314619|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914451|NCT03398148|449314620|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
124914452|NCT03398148|449314606|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
124914453|NCT03398148|449314607|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
124914454|NCT03398148|449314608|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
124914455|NCT03398148|449314609|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
124914456|NCT03398148|449314610|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
124914457|NCT03398148|449314611|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
124914458|NCT03398148|449314612|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
124914459|NCT03398148|449314613|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
124914460|NCT03398148|449314614|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
124914461|NCT03398148|449314615|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
124914462|NCT03398148|449314616|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
124914463|NCT03398148|449314617|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
124914464|NCT03398148|449314618|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
124914465|NCT03398148|449314619|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
124914466|NCT03398148|449314620|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
124914467|NCT03398148|449314606|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914468|NCT03398148|449314607|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914469|NCT03398148|449314608|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914470|NCT03398148|449314609|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914471|NCT03398148|449314610|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914472|NCT03398148|449314611|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914473|NCT03398148|449314612|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
124914474|NCT03398148|449314613|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124451281|NCT02170779|447613645|FG001|Overall Study|Withdrawal by Subject|0|||
124451282|NCT02170779|447613644|FG000|Overall Study|Lost to Follow-up|0|||
124451283|NCT02170779|447613645|FG001|Overall Study|Lost to Follow-up|1|||
124451284|NCT00800683|447613646|FG000|Overall Study|Adverse Event|11|||
124451285|NCT00800683|447613647|FG001|Overall Study|Adverse Event|8|||
124451286|NCT00800683|447613646|FG000|Overall Study|Lost to Follow-up|3|||
124451287|NCT00800683|447613647|FG001|Overall Study|Lost to Follow-up|1|||
124451288|NCT00800683|447613646|FG000|Overall Study|Withdrawal by Subject|1|||
124451289|NCT00800683|447613647|FG001|Overall Study|Withdrawal by Subject|7|||
124451290|NCT00800683|447613646|FG000|Overall Study|Lack of Efficacy|1|||
124451291|NCT00800683|447613647|FG001|Overall Study|Lack of Efficacy|1|||
124451292|NCT00800683|447613646|FG000|Overall Study|Other|1|||
124451293|NCT00800683|447613647|FG001|Overall Study|Other|2|||
124451294|NCT03492554|447613648|FG000|Overall Study|Protocol Violation|0|||
124451295|NCT03492554|447613649|FG001|Overall Study|Protocol Violation|14|||
124451296|NCT02463071|447613652|FG000|Overall Study|Adverse Event|3|||
124451297|NCT02463071|447613653|FG001|Overall Study|Adverse Event|5|||
124451298|NCT02463071|447613654|FG002|Overall Study|Adverse Event|1|||
124451299|NCT02463071|447613652|FG000|Overall Study|Death|1|||
124451300|NCT02463071|447613653|FG001|Overall Study|Death|0|||
124451301|NCT02463071|447613654|FG002|Overall Study|Death|0|||
124451302|NCT02463071|447613652|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
124451303|NCT02463071|447613653|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124451304|NCT02463071|447613654|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
124451305|NCT02463071|447613652|FG000|Overall Study|Reason not specified|7|||
124451306|NCT02463071|447613653|FG001|Overall Study|Reason not specified|9|||
124451307|NCT02463071|447613654|FG002|Overall Study|Reason not specified|4|||
124451308|NCT02463071|447613652|FG000|Overall Study|Protocol Violation|0|||
124451309|NCT02463071|447613653|FG001|Overall Study|Protocol Violation|2|||
124451310|NCT02463071|447613654|FG002|Overall Study|Protocol Violation|0|||
124451311|NCT02463071|447613652|FG000|Overall Study|Lost to Follow-up|0|||
124451312|NCT02463071|447613653|FG001|Overall Study|Lost to Follow-up|0|||
124451313|NCT02463071|447613654|FG002|Overall Study|Lost to Follow-up|1|||
124451314|NCT03986866|447613655|FG000|Overall Study|Withdrawal by Subject|0|||
124451315|NCT03986866|447613656|FG001|Overall Study|Withdrawal by Subject|3|||
124694156|NCT01740427|448500509|FG000|Overall Study|Unspecified reasons|52|||
124694157|NCT01740427|448500510|FG001|Overall Study|Unspecified reasons|8|||
124694158|NCT01740427|448500509|FG000|Overall Study|Death|10|||
124914475|NCT03398148|449314614|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914476|NCT03398148|449314615|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914477|NCT03398148|449314616|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124451316|NCT03986866|447613655|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
124451317|NCT03986866|447613656|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
124914478|NCT03398148|449314617|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914479|NCT03398148|449314618|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914480|NCT03398148|449314619|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914481|NCT03398148|449314620|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124451318|NCT05093322|447613659|FG000|Overall Study|Death|6|||
124451319|NCT05093322|447613660|FG001|Overall Study|Death|2|||
124451320|NCT05093322|447613659|FG000|Overall Study|Other|4|||
124694159|NCT01740427|448500510|FG001|Overall Study|Death|3|||
124694160|NCT01740427|448500509|FG000|Overall Study|Protocol Violation|5|||
124914482|NCT03398148|449314606|FG000|Substudy 1 Period 2|Other|0|||
124914483|NCT03398148|449314607|FG001|Substudy 1 Period 2|Other|0|||
124914484|NCT03398148|449314608|FG002|Substudy 1 Period 2|Other|0|||
124694161|NCT01740427|448500510|FG001|Overall Study|Protocol Violation|3|||
124694162|NCT01740427|448500509|FG000|Overall Study|Lost to Follow-up|3|||
124694163|NCT01740427|448500510|FG001|Overall Study|Lost to Follow-up|0|||
124694164|NCT01740427|448500509|FG000|Overall Study|Site Terminated by Sponsor|1|||
124694165|NCT01740427|448500510|FG001|Overall Study|Site Terminated by Sponsor|0|||
124694166|NCT04796207|448500513|FG000|Overall Study|Lost to Follow-up|7|||
124694167|NCT04796207|448500514|FG001|Overall Study|Lost to Follow-up|2|||
124694168|NCT05206604|448501891|FG000|Overall Study|Non-compliance with study drug|0|||
124694169|NCT05206604|448501892|FG001|Overall Study|Non-compliance with study drug|0|||
124694170|NCT05206604|448501893|FG002|Overall Study|Non-compliance with study drug|0|||
124694171|NCT05206604|448501894|FG003|Overall Study|Non-compliance with study drug|0|||
124694172|NCT05206604|448501895|FG004|Overall Study|Non-compliance with study drug|0|||
124694173|NCT05206604|448501896|FG005|Overall Study|Non-compliance with study drug|1|||
124694174|NCT05206604|448501897|FG006|Overall Study|Non-compliance with study drug|0|||
124694175|NCT05206604|448501898|FG007|Overall Study|Non-compliance with study drug|0|||
124694176|NCT03735498|448501899|FG000|Overall Study|Withdrawal by Subject|3|||
124694177|NCT03735498|448501899|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
124694178|NCT03787212|448501901|FG000|Period 1|Study Termination|2|||
124694179|NCT03787212|448501902|FG001|Period 1|Study Termination|2|||
124694180|NCT02014103|448501903|FG000|Overall Study|Protocol Violation|7|||
124694181|NCT02014103|448501904|FG001|Overall Study|Protocol Violation|7|||
124694182|NCT02014103|448501903|FG000|Overall Study|Adverse Event|1|||
124694183|NCT02014103|448501904|FG001|Overall Study|Adverse Event|0|||
124694184|NCT02014103|448501903|FG000|Overall Study|Lost venous access|1|||
124694185|NCT02014103|448501904|FG001|Overall Study|Lost venous access|0|||
124694186|NCT02014103|448501903|FG000|Overall Study|Withdrawal by Subject|0|||
124694187|NCT02014103|448501904|FG001|Overall Study|Withdrawal by Subject|2|||
124694188|NCT00394472|448501906|FG000|Overall Study|Protocol Violation|1|||
124694189|NCT00394472|448501907|FG001|Overall Study|Protocol Violation|3|||
124694190|NCT00394472|448501906|FG000|Overall Study|incorrect enrolment|4|||
124694191|NCT00394472|448501907|FG001|Overall Study|incorrect enrolment|2|||
124694192|NCT00394472|448501906|FG000|Overall Study|Adverse Event|4|||
124694193|NCT00394472|448501907|FG001|Overall Study|Adverse Event|2|||
124694194|NCT00394472|448501906|FG000|Overall Study|Withdrawal by Subject|0|||
124694195|NCT00394472|448501907|FG001|Overall Study|Withdrawal by Subject|2|||
124694196|NCT00394472|448501906|FG000|Overall Study|Physician Decision|0|||
124694197|NCT00394472|448501907|FG001|Overall Study|Physician Decision|1|||
124694198|NCT00394472|448501906|FG000|Overall Study|Lost to Follow-up|0|||
124694199|NCT00394472|448501907|FG001|Overall Study|Lost to Follow-up|1|||
124694200|NCT02181621|448501908|FG000|Overall Study|Adverse Event|1|||
124694201|NCT02181621|448501909|FG001|Overall Study|Adverse Event|0|||
124694202|NCT02181621|448501908|FG000|Overall Study|Previously Enrolled|0|||
124694203|NCT02181621|448501909|FG001|Overall Study|Previously Enrolled|1|||
124694204|NCT02181621|448501908|FG000|Overall Study|Enrollment Hold|1|||
124694205|NCT02181621|448501909|FG001|Overall Study|Enrollment Hold|1|||
124694206|NCT01301001|448501921|FG000|First Intervention|Lost to Follow-up|4|||
124694207|NCT01301001|448501922|FG001|First Intervention|Lost to Follow-up|4|||
124694208|NCT01301001|448501921|FG000|First Intervention|Withdrawal by Subject|1|||
124694209|NCT01301001|448501922|FG001|First Intervention|Withdrawal by Subject|4|||
124694210|NCT01301001|448501921|FG000|First Intervention|Adverse Event|5|||
124914485|NCT03398148|449314609|FG003|Substudy 1 Period 2|Other|0|||
124914486|NCT03398148|449314610|FG004|Substudy 1 Period 2|Other|0|||
124914487|NCT03398148|449314611|FG005|Substudy 1 Period 2|Other|0|||
124914488|NCT03398148|449314612|FG006|Substudy 1 Period 2|Other|1|||
124914489|NCT03398148|449314613|FG007|Substudy 1 Period 2|Other|0|||
124914490|NCT03398148|449314614|FG008|Substudy 1 Period 2|Other|0|||
124914491|NCT03398148|449314615|FG009|Substudy 1 Period 2|Other|0|||
124914492|NCT03398148|449314616|FG010|Substudy 1 Period 2|Other|0|||
124451321|NCT05093322|447613660|FG001|Overall Study|Other|1|||
124451322|NCT00932425|447613663|FG000|Overall Study|Lost to Follow-up|0|||
124451323|NCT00932425|447613664|FG001|Overall Study|Lost to Follow-up|1|||
124451324|NCT00932425|447613663|FG000|Overall Study|Withdrawal by Subject|0|||
124451325|NCT00932425|447613664|FG001|Overall Study|Withdrawal by Subject|1|||
124451326|NCT00397033|447613668|FG000|Overall Study|Adverse Event|7|||
124451327|NCT00397033|447613669|FG001|Overall Study|Adverse Event|10|||
124451328|NCT00397033|447613670|FG002|Overall Study|Adverse Event|4|||
124761414|NCT03318549|448751665|FG004|Overall Study|Lost to Follow-up|0|||
124694211|NCT01301001|448501922|FG001|First Intervention|Adverse Event|0|||
124694212|NCT01301001|448501921|FG000|First Intervention|Protocol Violation|0|||
124694213|NCT01301001|448501922|FG001|First Intervention|Protocol Violation|1|||
124694214|NCT01301001|448501921|FG000|Second Intervention|Adverse Event|2|||
124694215|NCT01301001|448501922|FG001|Second Intervention|Adverse Event|0|||
124694216|NCT01301001|448501921|FG000|Second Intervention|Withdrawal by Subject|2|||
124694217|NCT01301001|448501922|FG001|Second Intervention|Withdrawal by Subject|0|||
124694218|NCT01560988|448501923|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
124914493|NCT03398148|449314617|FG011|Substudy 1 Period 2|Other|0|||
124914494|NCT03398148|449314618|FG012|Substudy 1 Period 2|Other|0|||
124694219|NCT01560988|448501924|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
124914495|NCT03398148|449314619|FG013|Substudy 1 Period 2|Other|0|||
124451329|NCT00397033|447613668|FG000|Overall Study|Lack of Efficacy|22|||
124451330|NCT00397033|447613669|FG001|Overall Study|Lack of Efficacy|12|||
124694220|NCT01560988|448501923|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
124914496|NCT03398148|449314620|FG014|Substudy 1 Period 2|Other|0|||
124914497|NCT03398148|449314606|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914498|NCT03398148|449314607|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914499|NCT03398148|449314608|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914500|NCT03398148|449314609|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914501|NCT03398148|449314610|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914502|NCT03398148|449314611|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914503|NCT03398148|449314612|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
124914504|NCT03398148|449314613|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914505|NCT03398148|449314614|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914506|NCT03398148|449314615|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914507|NCT03398148|449314616|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914508|NCT03398148|449314617|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914509|NCT03398148|449314618|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914510|NCT03398148|449314619|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914511|NCT03398148|449314620|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
124914512|NCT03398148|449314606|FG000|Substudy 2 Period 1|Adverse Event|0|||
124914513|NCT03398148|449314607|FG001|Substudy 2 Period 1|Adverse Event|0|||
124914514|NCT03398148|449314608|FG002|Substudy 2 Period 1|Adverse Event|0|||
124914515|NCT03398148|449314609|FG003|Substudy 2 Period 1|Adverse Event|0|||
124914516|NCT03398148|449314610|FG004|Substudy 2 Period 1|Adverse Event|0|||
124914517|NCT03398148|449314611|FG005|Substudy 2 Period 1|Adverse Event|0|||
124694221|NCT01560988|448501924|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
124694222|NCT01560988|448501923|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
124694223|NCT01560988|448501924|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
124914518|NCT03398148|449314612|FG006|Substudy 2 Period 1|Adverse Event|0|||
124914519|NCT03398148|449314613|FG007|Substudy 2 Period 1|Adverse Event|0|||
124914520|NCT03398148|449314614|FG008|Substudy 2 Period 1|Adverse Event|0|||
124914521|NCT03398148|449314615|FG009|Substudy 2 Period 1|Adverse Event|12|||
124914522|NCT03398148|449314616|FG010|Substudy 2 Period 1|Adverse Event|2|||
124914523|NCT03398148|449314617|FG011|Substudy 2 Period 1|Adverse Event|0|||
124914524|NCT03398148|449314618|FG012|Substudy 2 Period 1|Adverse Event|0|||
124914525|NCT03398148|449314619|FG013|Substudy 2 Period 1|Adverse Event|0|||
124914526|NCT03398148|449314620|FG014|Substudy 2 Period 1|Adverse Event|0|||
124914527|NCT03398148|449314606|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914528|NCT03398148|449314607|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914529|NCT03398148|449314608|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914530|NCT03398148|449314609|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914531|NCT03398148|449314610|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914532|NCT03398148|449314611|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914533|NCT03398148|449314612|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914534|NCT03398148|449314613|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914535|NCT03398148|449314614|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914536|NCT03398148|449314615|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
124694224|NCT01346709|448501925|FG000|Overall Study|Protocol Violation|35|||
124694225|NCT01346709|448501925|FG000|Overall Study|Lost to Follow-up|31|||
124694226|NCT01346709|448501925|FG000|Overall Study|Missing data in candidate risk factor|285|||
124694227|NCT00458705|448501930|FG000|Overall Study|Adverse Event|4|||
124694228|NCT00458705|448501930|FG000|Overall Study|Not Treated|1|||
124694229|NCT02565186|448501931|FG000|Overall Study|Adverse Event|113|||
124694230|NCT02565186|448501932|FG001|Overall Study|Adverse Event|148|||
124694231|NCT02565186|448501931|FG000|Overall Study|Lost to Follow-up|102|||
124694232|NCT02565186|448501932|FG001|Overall Study|Lost to Follow-up|93|||
124694233|NCT02565186|448501931|FG000|Overall Study|Non-Compliance|57|||
124694234|NCT02565186|448501932|FG001|Overall Study|Non-Compliance|55|||
124694235|NCT02565186|448501931|FG000|Overall Study|Withdrawal by Subject|229|||
124694236|NCT02565186|448501932|FG001|Overall Study|Withdrawal by Subject|214|||
124694237|NCT02565186|448501931|FG000|Overall Study|Physician Decision|18|||
124694238|NCT02565186|448501932|FG001|Overall Study|Physician Decision|16|||
124694239|NCT02565186|448501931|FG000|Overall Study|Sponsor Request|5|||
124694240|NCT02565186|448501932|FG001|Overall Study|Sponsor Request|9|||
124694241|NCT02565186|448501931|FG000|Overall Study|Missing|1|||
124694242|NCT02565186|448501932|FG001|Overall Study|Missing|0|||
124694243|NCT02565186|448501931|FG000|Overall Study|Did Not Receive Study Drug|55|||
124694244|NCT02565186|448501932|FG001|Overall Study|Did Not Receive Study Drug|86|||
124694245|NCT00337194|448501933|FG000|Overall Study|Adverse Event|5|||
124914537|NCT03398148|449314616|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
124914538|NCT03398148|449314617|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914539|NCT03398148|449314618|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914540|NCT03398148|449314619|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914541|NCT03398148|449314620|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
124914542|NCT03398148|449314606|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
124914543|NCT03398148|449314607|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
124694246|NCT00337194|448501934|FG001|Overall Study|Adverse Event|1|||
124694247|NCT00337194|448501933|FG000|Overall Study|Death|2|||
124694248|NCT00337194|448501934|FG001|Overall Study|Death|0|||
124694249|NCT00337194|448501933|FG000|Overall Study|Withdrawal by Subject|1|||
124694250|NCT00337194|448501934|FG001|Overall Study|Withdrawal by Subject|0|||
124694251|NCT00337194|448501933|FG000|Overall Study|Disease progression|1|||
124694252|NCT00337194|448501934|FG001|Overall Study|Disease progression|2|||
124694253|NCT00337194|448501933|FG000|Overall Study|Subsequent non-protocol therapy|3|||
124694254|NCT00337194|448501934|FG001|Overall Study|Subsequent non-protocol therapy|1|||
124694255|NCT03188705|448501935|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
124694256|NCT03188705|448501935|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
124694257|NCT01174459|448501936|FG000|Overall Study|case report form (CRF) not collected|5|||
124694258|NCT03511066|448501937|FG000|Overall Study|Withdrawal by Subject|1|||
124694259|NCT03511066|448501938|FG001|Overall Study|Withdrawal by Subject|2|||
124694260|NCT03511066|448501939|FG002|Overall Study|Withdrawal by Subject|3|||
124694261|NCT03511066|448501937|FG000|Overall Study|Lost to Follow-up|2|||
124694262|NCT03511066|448501938|FG001|Overall Study|Lost to Follow-up|3|||
124694263|NCT03511066|448501939|FG002|Overall Study|Lost to Follow-up|0|||
124694264|NCT00165698|448501942|FG000|Overall Study|Adverse Event|2|||
124694265|NCT00165698|448501943|FG001|Overall Study|Adverse Event|10|||
124761415|NCT03318549|448751666|FG005|Overall Study|Lost to Follow-up|0|||
124761416|NCT03318549|448751667|FG006|Overall Study|Lost to Follow-up|0|||
124761417|NCT00510835|448751670|FG000|Overall Study|Withdrawal by Subject|6|||
124761418|NCT00510835|448751671|FG001|Overall Study|Withdrawal by Subject|2|||
124914544|NCT03398148|449314608|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
124914545|NCT03398148|449314609|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
124914546|NCT03398148|449314610|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
124914547|NCT03398148|449314611|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
124914548|NCT03398148|449314612|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
124914549|NCT03398148|449314613|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
124914550|NCT03398148|449314614|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
124914551|NCT03398148|449314615|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
124914552|NCT03398148|449314616|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
124914553|NCT03398148|449314617|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
124914554|NCT03398148|449314618|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
124914555|NCT03398148|449314619|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
124914556|NCT03398148|449314620|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
124914557|NCT03398148|449314606|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914558|NCT03398148|449314607|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914559|NCT03398148|449314608|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914560|NCT03398148|449314609|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914561|NCT03398148|449314610|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914562|NCT03398148|449314611|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914563|NCT03398148|449314612|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914564|NCT03398148|449314613|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914565|NCT03398148|449314614|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914566|NCT03398148|449314615|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914567|NCT03398148|449314616|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
124914568|NCT03398148|449314617|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914569|NCT03398148|449314618|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914570|NCT03398148|449314619|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914571|NCT03398148|449314620|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
124914572|NCT03398148|449314606|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914573|NCT03398148|449314607|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124694266|NCT00165698|448501942|FG000|Overall Study|Lost to Follow-up|2|||
124761419|NCT00510835|448751672|FG002|Overall Study|Withdrawal by Subject|2|||
124761420|NCT00607087|448751676|FG000|Overall Study|Withdrawal by Subject|9|||
124761421|NCT00607087|448751677|FG001|Overall Study|Withdrawal by Subject|4|||
124761422|NCT00607087|448751678|FG002|Overall Study|Withdrawal by Subject|4|||
124761423|NCT00607087|448751676|FG000|Overall Study|Adverse Event|3|||
124761424|NCT00607087|448751677|FG001|Overall Study|Adverse Event|2|||
124761425|NCT00607087|448751678|FG002|Overall Study|Adverse Event|3|||
124761426|NCT00607087|448751676|FG000|Overall Study|Other reason|1|||
124761427|NCT00607087|448751677|FG001|Overall Study|Other reason|5|||
124914574|NCT03398148|449314608|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914575|NCT03398148|449314609|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124694267|NCT00165698|448501943|FG001|Overall Study|Lost to Follow-up|2|||
124694268|NCT00165698|448501942|FG000|Overall Study|Withdrawal by Subject|2|||
124694269|NCT00165698|448501943|FG001|Overall Study|Withdrawal by Subject|1|||
124694270|NCT00165698|448501942|FG000|Overall Study|Protocol Violation|1|||
124694271|NCT00165698|448501943|FG001|Overall Study|Protocol Violation|0|||
124761428|NCT00607087|448751678|FG002|Overall Study|Other reason|2|||
124761429|NCT00607087|448751676|FG000|Overall Study|Poor compliance to protocol|1|||
124914576|NCT03398148|449314610|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914577|NCT03398148|449314611|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124694272|NCT00165698|448501942|FG000|Overall Study|Not Taken/Lost the medicine|1|||
124694273|NCT00165698|448501943|FG001|Overall Study|Not Taken/Lost the medicine|2|||
124694274|NCT01026038|448501944|FG000|Overall Study|Lost to Follow-up|1|||
124694275|NCT01026038|448501945|FG001|Overall Study|Lost to Follow-up|1|||
124694276|NCT01026038|448501946|FG002|Overall Study|Lost to Follow-up|0|||
124694277|NCT01107457|448501947|FG000|Part A|Adverse Event|1|||
124694278|NCT01107457|448501948|FG001|Part A|Adverse Event|2|||
124694279|NCT01107457|448501949|FG002|Part A|Adverse Event|1|||
124694280|NCT01107457|448501950|FG003|Part A|Adverse Event|0|||
124694281|NCT01107457|448501951|FG004|Part A|Adverse Event|0|||
124694282|NCT01107457|448501952|FG005|Part A|Adverse Event|0|||
124694283|NCT01107457|448501947|FG000|Part A|Withdrawal by Subject|3|||
124694284|NCT01107457|448501948|FG001|Part A|Withdrawal by Subject|3|||
124694285|NCT01107457|448501949|FG002|Part A|Withdrawal by Subject|0|||
124694286|NCT01107457|448501950|FG003|Part A|Withdrawal by Subject|3|||
124694287|NCT01107457|448501951|FG004|Part A|Withdrawal by Subject|1|||
124694288|NCT01107457|448501952|FG005|Part A|Withdrawal by Subject|0|||
124694289|NCT01107457|448501947|FG000|Part A|Lost to Follow-up|0|||
124694290|NCT01107457|448501948|FG001|Part A|Lost to Follow-up|1|||
124694291|NCT01107457|448501949|FG002|Part A|Lost to Follow-up|0|||
124694292|NCT01107457|448501950|FG003|Part A|Lost to Follow-up|0|||
124694293|NCT01107457|448501951|FG004|Part A|Lost to Follow-up|0|||
124694294|NCT01107457|448501952|FG005|Part A|Lost to Follow-up|0|||
124694295|NCT01107457|448501947|FG000|Part A|Lack of Efficacy|1|||
124694296|NCT01107457|448501948|FG001|Part A|Lack of Efficacy|0|||
124694297|NCT01107457|448501949|FG002|Part A|Lack of Efficacy|0|||
124694298|NCT01107457|448501950|FG003|Part A|Lack of Efficacy|0|||
124694299|NCT01107457|448501951|FG004|Part A|Lack of Efficacy|0|||
124694300|NCT01107457|448501952|FG005|Part A|Lack of Efficacy|0|||
124694301|NCT01107457|448501947|FG000|Part A|Protocol Violation|0|||
124694302|NCT01107457|448501948|FG001|Part A|Protocol Violation|1|||
124694303|NCT01107457|448501949|FG002|Part A|Protocol Violation|0|||
124694304|NCT01107457|448501950|FG003|Part A|Protocol Violation|0|||
124694305|NCT01107457|448501951|FG004|Part A|Protocol Violation|0|||
124914578|NCT03398148|449314612|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914579|NCT03398148|449314613|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914580|NCT03398148|449314614|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914581|NCT03398148|449314615|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914582|NCT03398148|449314616|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
124694306|NCT01107457|448501952|FG005|Part A|Protocol Violation|0|||
124694307|NCT01107457|448501947|FG000|Part B and C|Adverse Event|0|||
124694308|NCT01107457|448501948|FG001|Part B and C|Adverse Event|0|||
124761430|NCT00607087|448751677|FG001|Overall Study|Poor compliance to protocol|0|||
124914583|NCT03398148|449314617|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914584|NCT03398148|449314618|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914585|NCT03398148|449314619|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914586|NCT03398148|449314620|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
124914587|NCT03398148|449314606|FG000|Substudy 2 Period 1|Other|0|||
124694309|NCT01107457|448501949|FG002|Part B and C|Adverse Event|0|||
124694310|NCT01107457|448501950|FG003|Part B and C|Adverse Event|0|||
124694311|NCT01107457|448501951|FG004|Part B and C|Adverse Event|0|||
124694312|NCT01107457|448501952|FG005|Part B and C|Adverse Event|12|||
124694313|NCT01107457|448501947|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
124694314|NCT01107457|448501948|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
124694315|NCT01107457|448501949|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
124694316|NCT01107457|448501950|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
124694317|NCT01107457|448501951|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
124914588|NCT03398148|449314607|FG001|Substudy 2 Period 1|Other|0|||
124914589|NCT03398148|449314608|FG002|Substudy 2 Period 1|Other|0|||
124914590|NCT03398148|449314609|FG003|Substudy 2 Period 1|Other|0|||
124914591|NCT03398148|449314610|FG004|Substudy 2 Period 1|Other|0|||
124914592|NCT03398148|449314611|FG005|Substudy 2 Period 1|Other|0|||
124914593|NCT03398148|449314612|FG006|Substudy 2 Period 1|Other|0|||
124914594|NCT03398148|449314613|FG007|Substudy 2 Period 1|Other|0|||
124914595|NCT03398148|449314614|FG008|Substudy 2 Period 1|Other|0|||
124914596|NCT03398148|449314615|FG009|Substudy 2 Period 1|Other|4|||
124914597|NCT03398148|449314616|FG010|Substudy 2 Period 1|Other|4|||
124914598|NCT03398148|449314617|FG011|Substudy 2 Period 1|Other|0|||
124694318|NCT01107457|448501952|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
124694319|NCT01107457|448501947|FG000|Part B and C|Physician Decision|0|||
124694320|NCT01107457|448501948|FG001|Part B and C|Physician Decision|0|||
124694321|NCT01107457|448501949|FG002|Part B and C|Physician Decision|0|||
124694322|NCT01107457|448501950|FG003|Part B and C|Physician Decision|0|||
124694323|NCT01107457|448501951|FG004|Part B and C|Physician Decision|0|||
124694324|NCT01107457|448501952|FG005|Part B and C|Physician Decision|3|||
124914599|NCT03398148|449314618|FG012|Substudy 2 Period 1|Other|0|||
124914600|NCT03398148|449314619|FG013|Substudy 2 Period 1|Other|0|||
124914601|NCT03398148|449314620|FG014|Substudy 2 Period 1|Other|0|||
124914602|NCT03398148|449314606|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914603|NCT03398148|449314607|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
124694325|NCT01107457|448501947|FG000|Part B and C|Lack of Efficacy|0|||
124914604|NCT03398148|449314608|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914605|NCT03398148|449314609|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914606|NCT03398148|449314610|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914607|NCT03398148|449314611|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914608|NCT03398148|449314612|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914609|NCT03398148|449314613|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914610|NCT03398148|449314614|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914611|NCT03398148|449314615|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914612|NCT03398148|449314616|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
124914613|NCT03398148|449314617|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914614|NCT03398148|449314618|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914615|NCT03398148|449314619|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914616|NCT03398148|449314620|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
124914617|NCT03398148|449314606|FG000|Substudy 2 Period 2|Adverse Event|0|||
124914618|NCT03398148|449314607|FG001|Substudy 2 Period 2|Adverse Event|0|||
124914619|NCT03398148|449314608|FG002|Substudy 2 Period 2|Adverse Event|0|||
124914620|NCT03398148|449314609|FG003|Substudy 2 Period 2|Adverse Event|0|||
124914621|NCT03398148|449314610|FG004|Substudy 2 Period 2|Adverse Event|0|||
124914622|NCT03398148|449314611|FG005|Substudy 2 Period 2|Adverse Event|0|||
124914623|NCT03398148|449314612|FG006|Substudy 2 Period 2|Adverse Event|0|||
124914624|NCT03398148|449314613|FG007|Substudy 2 Period 2|Adverse Event|0|||
124914625|NCT03398148|449314614|FG008|Substudy 2 Period 2|Adverse Event|0|||
124914626|NCT03398148|449314615|FG009|Substudy 2 Period 2|Adverse Event|0|||
124914627|NCT03398148|449314616|FG010|Substudy 2 Period 2|Adverse Event|0|||
124914628|NCT03398148|449314617|FG011|Substudy 2 Period 2|Adverse Event|0|||
124914629|NCT03398148|449314618|FG012|Substudy 2 Period 2|Adverse Event|0|||
124914630|NCT03398148|449314619|FG013|Substudy 2 Period 2|Adverse Event|1|||
124914631|NCT03398148|449314620|FG014|Substudy 2 Period 2|Adverse Event|3|||
124914632|NCT03398148|449314606|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
124914633|NCT03398148|449314607|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
124914634|NCT03398148|449314608|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
124914635|NCT03398148|449314609|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
124914636|NCT03398148|449314610|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
124914637|NCT03398148|449314611|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
124914638|NCT03398148|449314612|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
124914639|NCT03398148|449314613|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
124914640|NCT03398148|449314614|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
124914641|NCT03398148|449314615|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
124914642|NCT03398148|449314616|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
124914643|NCT03398148|449314617|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
124914644|NCT03398148|449314618|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
124914645|NCT03398148|449314619|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
124914646|NCT03398148|449314620|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
124914647|NCT03398148|449314606|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914648|NCT03398148|449314607|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914649|NCT03398148|449314608|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914650|NCT03398148|449314609|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914651|NCT03398148|449314610|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914652|NCT03398148|449314611|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914653|NCT03398148|449314612|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914654|NCT03398148|449314613|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914655|NCT03398148|449314614|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914656|NCT03398148|449314615|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914657|NCT03398148|449314616|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914658|NCT03398148|449314617|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
124914659|NCT03398148|449314618|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
124914660|NCT03398148|449314619|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
124914661|NCT03398148|449314620|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
124914662|NCT03398148|449314606|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
124914663|NCT03398148|449314607|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
124914664|NCT03398148|449314608|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
124914665|NCT03398148|449314609|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
124914666|NCT03398148|449314610|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
124914667|NCT03398148|449314611|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
124451331|NCT00397033|447613670|FG002|Overall Study|Lack of Efficacy|9|||
124451332|NCT00397033|447613668|FG000|Overall Study|Lost to Follow-up|3|||
124914668|NCT03398148|449314612|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
124914669|NCT03398148|449314613|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
124914670|NCT03398148|449314614|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
124914671|NCT03398148|449314615|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
124914672|NCT03398148|449314616|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
124914673|NCT03398148|449314617|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
124914674|NCT03398148|449314618|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
124914675|NCT03398148|449314619|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
124914676|NCT03398148|449314620|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
124914677|NCT03398148|449314606|FG000|Substudy 2 Period 2|Other|0|||
124914678|NCT03398148|449314607|FG001|Substudy 2 Period 2|Other|0|||
124914679|NCT03398148|449314608|FG002|Substudy 2 Period 2|Other|0|||
124914680|NCT03398148|449314609|FG003|Substudy 2 Period 2|Other|0|||
124914681|NCT03398148|449314610|FG004|Substudy 2 Period 2|Other|0|||
124914682|NCT03398148|449314611|FG005|Substudy 2 Period 2|Other|0|||
124914683|NCT03398148|449314612|FG006|Substudy 2 Period 2|Other|0|||
124914684|NCT03398148|449314613|FG007|Substudy 2 Period 2|Other|0|||
124914685|NCT03398148|449314614|FG008|Substudy 2 Period 2|Other|0|||
124914686|NCT03398148|449314615|FG009|Substudy 2 Period 2|Other|0|||
124914687|NCT03398148|449314616|FG010|Substudy 2 Period 2|Other|0|||
124914688|NCT03398148|449314617|FG011|Substudy 2 Period 2|Other|0|||
124914689|NCT03398148|449314618|FG012|Substudy 2 Period 2|Other|0|||
124914690|NCT03398148|449314619|FG013|Substudy 2 Period 2|Other|1|||
124914691|NCT03398148|449314620|FG014|Substudy 2 Period 2|Other|1|||
124914692|NCT03398148|449314606|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914693|NCT03398148|449314607|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914694|NCT03398148|449314608|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914695|NCT03398148|449314609|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914696|NCT03398148|449314610|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914697|NCT03398148|449314611|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914698|NCT03398148|449314612|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914699|NCT03398148|449314613|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914700|NCT03398148|449314614|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914701|NCT03398148|449314615|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914702|NCT03398148|449314616|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914703|NCT03398148|449314617|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914704|NCT03398148|449314618|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
124914705|NCT03398148|449314619|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
124914706|NCT03398148|449314620|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
124451333|NCT00397033|447613669|FG001|Overall Study|Lost to Follow-up|3|||
124451334|NCT00397033|447613670|FG002|Overall Study|Lost to Follow-up|3|||
124451335|NCT00397033|447613668|FG000|Overall Study|Withdrawal by Subject|12|||
124451336|NCT00397033|447613669|FG001|Overall Study|Withdrawal by Subject|7|||
124451337|NCT00397033|447613670|FG002|Overall Study|Withdrawal by Subject|5|||
124451338|NCT00397033|447613668|FG000|Overall Study|Other|0|||
124451339|NCT00397033|447613669|FG001|Overall Study|Other|5|||
124451340|NCT00397033|447613670|FG002|Overall Study|Other|2|||
124451341|NCT01984164|447613671|FG000|Overall Study|Withdrawal by Subject|4|||
124451342|NCT01984164|447613672|FG001|Overall Study|Withdrawal by Subject|3|||
124451343|NCT01984164|447613671|FG000|Overall Study|Adverse Event|5|||
124451344|NCT01984164|447613672|FG001|Overall Study|Adverse Event|19|||
124451345|NCT01984164|447613671|FG000|Overall Study|Lost to Follow-up|1|||
124451346|NCT01984164|447613672|FG001|Overall Study|Lost to Follow-up|3|||
124451347|NCT05293743|447613673|FG000|Overall Study|Withdrawal by Subject|1|||
124451348|NCT05293743|447613674|FG001|Overall Study|Withdrawal by Subject|0|||
124451349|NCT02546765|447613675|FG000|Overall Study|Withdrawal by Subject|0|||
124451350|NCT02546765|447613676|FG001|Overall Study|Withdrawal by Subject|1|||
124451351|NCT02546765|447613677|FG002|Overall Study|Withdrawal by Subject|0|||
124451352|NCT02546765|447613678|FG003|Overall Study|Withdrawal by Subject|0|||
124451353|NCT02064920|447613679|FG000|Overall Study|Adverse Event|0|||
124451354|NCT02064920|447613680|FG001|Overall Study|Adverse Event|4|||
124451355|NCT02064920|447613679|FG000|Overall Study|Physician Decision|0|||
124451356|NCT02064920|447613680|FG001|Overall Study|Physician Decision|1|||
124451357|NCT02064920|447613679|FG000|Overall Study|Technical Problems|0|||
124451358|NCT02064920|447613680|FG001|Overall Study|Technical Problems|1|||
124451359|NCT02064920|447613679|FG000|Overall Study|Withdrawal by Subject|1|||
124451360|NCT02064920|447613680|FG001|Overall Study|Withdrawal by Subject|3|||
124451361|NCT01129921|447613683|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
124451362|NCT01129921|447613684|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
124451363|NCT01129921|447613683|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
124451364|NCT01129921|447613684|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
124451365|NCT01129921|447613683|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
124451366|NCT01129921|447613684|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
124451367|NCT01129921|447613683|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
124451368|NCT01129921|447613684|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
124451369|NCT00583024|447613685|FG000|Overall Study|Lost to Follow-up|4|||
124451370|NCT02229539|447615045|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
124451371|NCT02229539|447615046|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
124451372|NCT02229539|447615047|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
124451373|NCT02229539|447615045|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
124694326|NCT01107457|448501948|FG001|Part B and C|Lack of Efficacy|0|||
124914707|NCT02791230|449314621|FG000|Overall Study|Adverse Event|10|||
124914708|NCT02791230|449314622|FG001|Overall Study|Adverse Event|9|||
124914709|NCT02791230|449314623|FG002|Overall Study|Adverse Event|66|||
124914710|NCT02791230|449314621|FG000|Overall Study|Death|38|||
124914711|NCT02791230|449314622|FG001|Overall Study|Death|25|||
124914712|NCT02791230|449314623|FG002|Overall Study|Death|184|||
124914713|NCT02791230|449314621|FG000|Overall Study|Lack of Efficacy|1|||
124914714|NCT02791230|449314622|FG001|Overall Study|Lack of Efficacy|0|||
124914715|NCT02791230|449314623|FG002|Overall Study|Lack of Efficacy|3|||
124914716|NCT02791230|449314621|FG000|Overall Study|Lost to Follow-up|0|||
124914717|NCT02791230|449314622|FG001|Overall Study|Lost to Follow-up|0|||
124914718|NCT02791230|449314623|FG002|Overall Study|Lost to Follow-up|10|||
124914719|NCT02791230|449314621|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
124914720|NCT02791230|449314622|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
124914721|NCT02791230|449314623|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
124914722|NCT02791230|449314621|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
124914723|NCT02791230|449314622|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
124914724|NCT02791230|449314623|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
124914725|NCT02791230|449314621|FG000|Overall Study|Study sites terminated by sponsor|1|||
124914726|NCT02791230|449314622|FG001|Overall Study|Study sites terminated by sponsor|0|||
124914727|NCT02791230|449314623|FG002|Overall Study|Study sites terminated by sponsor|5|||
124914728|NCT02791230|449314621|FG000|Overall Study|Other|9|||
124914729|NCT02791230|449314622|FG001|Overall Study|Other|1|||
124914730|NCT02791230|449314623|FG002|Overall Study|Other|28|||
124914731|NCT02791230|449314621|FG000|Overall Study|Protocol Violation|0|||
124914732|NCT02791230|449314622|FG001|Overall Study|Protocol Violation|0|||
124914733|NCT02791230|449314623|FG002|Overall Study|Protocol Violation|4|||
124914734|NCT02791230|449314621|FG000|Overall Study|Withdrawal by Subject|24|||
124914735|NCT02791230|449314622|FG001|Overall Study|Withdrawal by Subject|13|||
124914736|NCT02791230|449314623|FG002|Overall Study|Withdrawal by Subject|172|||
124914737|NCT02791230|449314621|FG000|Overall Study|Enrolled but not treated|0|||
124914738|NCT02791230|449314622|FG001|Overall Study|Enrolled but not treated|0|||
124914739|NCT02791230|449314623|FG002|Overall Study|Enrolled but not treated|5|||
124914740|NCT04201834|449314631|FG000|Overall Study|Screen fail|1|||
124914741|NCT00212355|449314632|FG000|Overall Study|Adverse Event|1|||
124914742|NCT00212355|449314632|FG000|Overall Study|Withdrawal by Subject|1|||
124914743|NCT00212355|449314632|FG000|Overall Study|A change of address|1|||
124914744|NCT04310735|449314634|FG000|Overall Study|Withdrawal by Subject|1|||
124914745|NCT04310735|449314635|FG001|Overall Study|Withdrawal by Subject|3|||
124914746|NCT04310735|449314636|FG002|Overall Study|Withdrawal by Subject|8|||
124914747|NCT04310735|449314634|FG000|Overall Study|Equipment malfunction|0|||
124914748|NCT04310735|449314635|FG001|Overall Study|Equipment malfunction|1|||
124914749|NCT04310735|449314636|FG002|Overall Study|Equipment malfunction|0|||
124914750|NCT04104321|449314637|FG000|Overall Study|didn't take the study drug|3|||
124914751|NCT04608045|449314638|FG000|Overall Study|Physician Decision|1|||
124914752|NCT03517553|449314639|FG000|Overall Study|Withdrawal by Subject|2|||
124914753|NCT03271151|449314640|FG000|Overall Study|Lost to Follow-up|1|||
124914754|NCT03271151|449314641|FG001|Overall Study|Lost to Follow-up|3|||
124914755|NCT03271151|449314640|FG000|Overall Study|Withdrawal by Subject|1|||
124914756|NCT03271151|449314641|FG001|Overall Study|Withdrawal by Subject|0|||
124914757|NCT03575052|449314642|FG000|Overall Study|Adverse Event|6|||
124914758|NCT03575052|449314643|FG001|Overall Study|Adverse Event|10|||
124914759|NCT03575052|449314642|FG000|Overall Study|Not further specified|5|||
124914760|NCT03575052|449314643|FG001|Overall Study|Not further specified|7|||
124914761|NCT03575052|449314642|FG000|Overall Study|Withdrawal by Subject|5|||
124914762|NCT03575052|449314643|FG001|Overall Study|Withdrawal by Subject|6|||
124914763|NCT03575052|449314642|FG000|Overall Study|Lost to Follow-up|3|||
124914764|NCT03575052|449314643|FG001|Overall Study|Lost to Follow-up|0|||
124914765|NCT03575052|449314642|FG000|Overall Study|Death|2|||
124914766|NCT03575052|449314643|FG001|Overall Study|Death|1|||
124914767|NCT03575052|449314642|FG000|Overall Study|Lack of Efficacy|2|||
124914768|NCT03575052|449314643|FG001|Overall Study|Lack of Efficacy|1|||
124914769|NCT03575052|449314642|FG000|Overall Study|Study drug noncompliance|1|||
124914770|NCT03575052|449314643|FG001|Overall Study|Study drug noncompliance|2|||
124914771|NCT03575052|449314642|FG000|Overall Study|Protocol Violation|0|||
124914772|NCT03575052|449314643|FG001|Overall Study|Protocol Violation|2|||
124914773|NCT03575052|449314642|FG000|Overall Study|Physician Decision|1|||
124914774|NCT03575052|449314643|FG001|Overall Study|Physician Decision|0|||
124914775|NCT03103321|449314644|FG000|Overall Study|Protocol Violation|1|||
124914776|NCT03103321|449314645|FG001|Overall Study|Protocol Violation|1|||
124914777|NCT03103321|449314646|FG002|Overall Study|Protocol Violation|1|||
124914778|NCT03103321|449314647|FG003|Overall Study|Protocol Violation|0|||
124914779|NCT04247542|449314648|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
124914780|NCT04247542|449314649|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
124914781|NCT04247542|449314650|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
124914782|NCT04247542|449314648|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
124914783|NCT04247542|449314649|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
124914784|NCT04247542|449314650|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
124914785|NCT04118452|449314651|FG000|Overall Study|Lost to Follow-up|5|||
124914786|NCT04118452|449314652|FG001|Overall Study|Lost to Follow-up|5|||
124914787|NCT04118452|449314651|FG000|Overall Study|Withdrawal by Subject|17|||
124694327|NCT01107457|448501949|FG002|Part B and C|Lack of Efficacy|0|||
124694328|NCT01107457|448501950|FG003|Part B and C|Lack of Efficacy|0|||
124694329|NCT01107457|448501951|FG004|Part B and C|Lack of Efficacy|0|||
124694330|NCT01107457|448501952|FG005|Part B and C|Lack of Efficacy|7|||
124694331|NCT01107457|448501947|FG000|Part B and C|Lost to Follow-up|0|||
124694332|NCT01107457|448501948|FG001|Part B and C|Lost to Follow-up|0|||
124694333|NCT01107457|448501949|FG002|Part B and C|Lost to Follow-up|0|||
124694334|NCT01107457|448501950|FG003|Part B and C|Lost to Follow-up|0|||
124694335|NCT01107457|448501951|FG004|Part B and C|Lost to Follow-up|0|||
124694336|NCT01107457|448501952|FG005|Part B and C|Lost to Follow-up|10|||
124694337|NCT01107457|448501947|FG000|Part B and C|Protocol Violation|0|||
124694338|NCT01107457|448501948|FG001|Part B and C|Protocol Violation|0|||
124694339|NCT01107457|448501949|FG002|Part B and C|Protocol Violation|0|||
124694340|NCT01107457|448501950|FG003|Part B and C|Protocol Violation|0|||
124694341|NCT01107457|448501951|FG004|Part B and C|Protocol Violation|0|||
124694342|NCT01107457|448501952|FG005|Part B and C|Protocol Violation|1|||
124694343|NCT01107457|448501947|FG000|Part B and C|Sponsor Decision|0|||
124694344|NCT01107457|448501948|FG001|Part B and C|Sponsor Decision|0|||
124694345|NCT01107457|448501949|FG002|Part B and C|Sponsor Decision|0|||
124694346|NCT01107457|448501950|FG003|Part B and C|Sponsor Decision|0|||
124694347|NCT01107457|448501951|FG004|Part B and C|Sponsor Decision|0|||
124694348|NCT01107457|448501952|FG005|Part B and C|Sponsor Decision|66|||
124694349|NCT01107457|448501947|FG000|Part B and C|Withdrawal by Subject|0|||
124694350|NCT01107457|448501948|FG001|Part B and C|Withdrawal by Subject|0|||
124694351|NCT01107457|448501949|FG002|Part B and C|Withdrawal by Subject|0|||
124694352|NCT01107457|448501950|FG003|Part B and C|Withdrawal by Subject|0|||
124694353|NCT01107457|448501951|FG004|Part B and C|Withdrawal by Subject|0|||
124694354|NCT01107457|448501952|FG005|Part B and C|Withdrawal by Subject|16|||
124694355|NCT01107457|448501947|FG000|Part B and C|Clinical Relapse|0|||
124694356|NCT01107457|448501948|FG001|Part B and C|Clinical Relapse|0|||
124694357|NCT01107457|448501949|FG002|Part B and C|Clinical Relapse|0|||
124694358|NCT01107457|448501950|FG003|Part B and C|Clinical Relapse|0|||
124694359|NCT01107457|448501951|FG004|Part B and C|Clinical Relapse|0|||
124694360|NCT01107457|448501952|FG005|Part B and C|Clinical Relapse|4|||
124694361|NCT03679884|448501953|FG000|Overall Study|Other|12|||
124694362|NCT03679884|448501954|FG001|Overall Study|Other|12|||
124694363|NCT03679884|448501955|FG002|Overall Study|Other|12|||
124694364|NCT03679884|448501956|FG003|Overall Study|Other|7|||
124694365|NCT03679884|448501957|FG004|Overall Study|Other|8|||
124694366|NCT03679884|448501953|FG000|Overall Study|Lack of Efficacy|15|||
124694367|NCT03679884|448501954|FG001|Overall Study|Lack of Efficacy|29|||
124694368|NCT03679884|448501955|FG002|Overall Study|Lack of Efficacy|13|||
124694369|NCT03679884|448501956|FG003|Overall Study|Lack of Efficacy|29|||
124694370|NCT03679884|448501957|FG004|Overall Study|Lack of Efficacy|10|||
124694371|NCT03679884|448501953|FG000|Overall Study|Death|1|||
124694372|NCT03679884|448501954|FG001|Overall Study|Death|0|||
124694373|NCT03679884|448501955|FG002|Overall Study|Death|0|||
124694374|NCT03679884|448501956|FG003|Overall Study|Death|0|||
124694375|NCT03679884|448501957|FG004|Overall Study|Death|0|||
124694376|NCT03679884|448501953|FG000|Overall Study|Adverse Event|2|||
124694377|NCT03679884|448501954|FG001|Overall Study|Adverse Event|10|||
124694378|NCT03679884|448501955|FG002|Overall Study|Adverse Event|9|||
124694379|NCT03679884|448501956|FG003|Overall Study|Adverse Event|6|||
124694380|NCT03679884|448501957|FG004|Overall Study|Adverse Event|6|||
124694381|NCT03679884|448501953|FG000|Overall Study|Withdrawal by Subject|12|||
124694382|NCT03679884|448501954|FG001|Overall Study|Withdrawal by Subject|23|||
124694383|NCT03679884|448501955|FG002|Overall Study|Withdrawal by Subject|8|||
124694384|NCT03679884|448501956|FG003|Overall Study|Withdrawal by Subject|8|||
124694385|NCT03679884|448501957|FG004|Overall Study|Withdrawal by Subject|9|||
124694386|NCT03679884|448501953|FG000|Overall Study|Lost to Follow-up|1|||
124694387|NCT03679884|448501954|FG001|Overall Study|Lost to Follow-up|4|||
124694388|NCT03679884|448501955|FG002|Overall Study|Lost to Follow-up|2|||
124694389|NCT03679884|448501956|FG003|Overall Study|Lost to Follow-up|0|||
124694390|NCT03679884|448501957|FG004|Overall Study|Lost to Follow-up|3|||
124694391|NCT03601052|448501958|FG000|Overall Study|Lost to Follow-up|2|||
124694392|NCT00837330|448501959|FG000|Overall Study|Lost to Follow-up|1|||
124694393|NCT00837330|448501960|FG001|Overall Study|Lost to Follow-up|3|||
124694394|NCT01227395|448501961|FG000|Overall Study|Protocol Violation|0|||
124694395|NCT01227395|448501962|FG001|Overall Study|Protocol Violation|1|||
124694396|NCT00086307|448501967|FG000|Overall Study|Lack of Efficacy|1|||
124694397|NCT00086307|448501968|FG001|Overall Study|Lack of Efficacy|1|||
124694398|NCT00086307|448501969|FG002|Overall Study|Lack of Efficacy|2|||
124694399|NCT00086307|448501967|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
124694400|NCT00086307|448501968|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
124694401|NCT00086307|448501969|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
124694402|NCT00086307|448501967|FG000|Overall Study|Nausea and headaches|0|||
124694403|NCT00086307|448501968|FG001|Overall Study|Nausea and headaches|0|||
124694404|NCT00086307|448501969|FG002|Overall Study|Nausea and headaches|1|||
124694405|NCT00086307|448501967|FG000|Overall Study|Constipation and sleepiness|0|||
124694406|NCT00086307|448501968|FG001|Overall Study|Constipation and sleepiness|0|||
124694407|NCT00086307|448501969|FG002|Overall Study|Constipation and sleepiness|1|||
124694408|NCT00086307|448501967|FG000|Overall Study|Suicidal ideation|0|||
124694409|NCT00086307|448501968|FG001|Overall Study|Suicidal ideation|0|||
124694410|NCT00086307|448501969|FG002|Overall Study|Suicidal ideation|1|||
124694411|NCT00086307|448501967|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
124694412|NCT00086307|448501968|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
124694413|NCT00086307|448501969|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
124694414|NCT00086307|448501967|FG000|Overall Study|Withdrawal by Subject|0|||
124694415|NCT00086307|448501968|FG001|Overall Study|Withdrawal by Subject|0|||
124694416|NCT00086307|448501969|FG002|Overall Study|Withdrawal by Subject|2|||
124694417|NCT00105508|448501970|FG000|Overall Study|Prephase Dropout|1|||
124694418|NCT00105508|448501971|FG001|Overall Study|Prephase Dropout|0|||
124694419|NCT00105508|448501970|FG000|Overall Study|Adverse Event|16|||
124694420|NCT00105508|448501971|FG001|Overall Study|Adverse Event|19|||
124694421|NCT00105508|448501970|FG000|Overall Study|Insufficient Efficacy|1|||
124694422|NCT00105508|448501971|FG001|Overall Study|Insufficient Efficacy|0|||
124694423|NCT00105508|448501970|FG000|Overall Study|Withdrawal by Subject|10|||
124694424|NCT00105508|448501971|FG001|Overall Study|Withdrawal by Subject|6|||
124694425|NCT00105508|448501970|FG000|Overall Study|Lost to Follow-up|3|||
124694426|NCT00105508|448501971|FG001|Overall Study|Lost to Follow-up|0|||
124694427|NCT00105508|448501970|FG000|Overall Study|Protocol Violation|1|||
124694428|NCT00105508|448501971|FG001|Overall Study|Protocol Violation|2|||
124694429|NCT00105508|448501970|FG000|Overall Study|Other|8|||
124761431|NCT00607087|448751678|FG002|Overall Study|Poor compliance to protocol|1|||
124761432|NCT00607087|448751676|FG000|Overall Study|Lost to Follow-up|1|||
124761433|NCT00607087|448751677|FG001|Overall Study|Lost to Follow-up|0|||
124761434|NCT00607087|448751678|FG002|Overall Study|Lost to Follow-up|0|||
124761435|NCT00607087|448751676|FG000|Period 1|Withdrawal by Subject|7|||
124914788|NCT04118452|449314652|FG001|Overall Study|Withdrawal by Subject|17|||
124914789|NCT05086744|449314653|FG000|Part A|Adverse Event|0|||
124914790|NCT05086744|449314654|FG001|Part A|Adverse Event|1|||
124914791|NCT05086744|449314653|FG000|Part A|Lack of Efficacy|3|||
124914792|NCT05086744|449314654|FG001|Part A|Lack of Efficacy|0|||
124914793|NCT05086744|449314653|FG000|Part A|Protocol deviation|1|||
124914794|NCT05086744|449314654|FG001|Part A|Protocol deviation|0|||
124914795|NCT05086744|449314653|FG000|Part A|Subject decision|1|||
124914796|NCT05086744|449314654|FG001|Part A|Subject decision|0|||
124914797|NCT05086744|449314653|FG000|Part B|Adverse Event|0|||
124914798|NCT05086744|449314654|FG001|Part B|Adverse Event|1|||
124914799|NCT05086744|449314653|FG000|Part B|Lack of Efficacy|0|||
124914800|NCT05086744|449314654|FG001|Part B|Lack of Efficacy|1|||
124914801|NCT05086744|449314653|FG000|Part B|Study terminated by sponsor|1|||
124914802|NCT05086744|449314654|FG001|Part B|Study terminated by sponsor|6|||
124914803|NCT04300231|449314655|FG000|Overall Study|Protocol Violation|4|||
124914804|NCT04300231|449314656|FG001|Overall Study|Protocol Violation|3|||
124914805|NCT04300231|449314657|FG002|Overall Study|Protocol Violation|0|||
124914806|NCT04300231|449314658|FG003|Overall Study|Protocol Violation|2|||
124914807|NCT05986565|449314664|FG000|Overall Study|Lost to Follow-up|8|||
124914808|NCT05986565|449314665|FG001|Overall Study|Lost to Follow-up|3|||
124914809|NCT05986565|449314664|FG000|Overall Study|Withdrawal by Subject|0|||
124914810|NCT05986565|449314665|FG001|Overall Study|Withdrawal by Subject|1|||
124914811|NCT02058108|449314669|FG000|Overall Study|Abnormal Laboratory Values|0|||
124914812|NCT02058108|449314670|FG001|Overall Study|Abnormal Laboratory Values|1|||
124914813|NCT02058108|449314669|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
124914814|NCT02058108|449314670|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
124914815|NCT02058108|449314669|FG000|Overall Study|No longer requires study drug|0|||
124694430|NCT00105508|448501971|FG001|Overall Study|Other|9|||
124694431|NCT00683384|448501972|FG000|Overall Study|Death|1|||
124761436|NCT00607087|448751677|FG001|Period 1|Withdrawal by Subject|2|||
124761437|NCT00607087|448751678|FG002|Period 1|Withdrawal by Subject|3|||
124761438|NCT00607087|448751676|FG000|Period 1|Adverse Event|3|||
124761439|NCT00607087|448751677|FG001|Period 1|Adverse Event|0|||
124914816|NCT02058108|449314670|FG001|Overall Study|No longer requires study drug|1|||
124694432|NCT00683384|448501972|FG000|Overall Study|Adverse Event|1|||
124694433|NCT00120874|448501974|FG000|Overall Study|Death|0|||
124694434|NCT00120874|448501975|FG001|Overall Study|Death|1|||
124694435|NCT00300495|448501982|FG000|Overall Study|Protocol Violation|4|||
124694436|NCT00300495|448501983|FG001|Overall Study|Protocol Violation|1|||
124694437|NCT03632720|448501984|FG000|Overall Study|Adverse Event|2|||
124694438|NCT03632720|448501985|FG001|Overall Study|Adverse Event|0|||
124914817|NCT02058108|449314669|FG000|Overall Study|Withdrawal by Subject|1|||
124914818|NCT02058108|449314670|FG001|Overall Study|Withdrawal by Subject|0|||
124914819|NCT02058108|449314669|FG000|Overall Study|Administrative problems|3|||
124914820|NCT02058108|449314670|FG001|Overall Study|Administrative problems|3|||
124694439|NCT03632720|448501986|FG002|Overall Study|Adverse Event|0|||
124761440|NCT00607087|448751678|FG002|Period 1|Adverse Event|0|||
124761441|NCT00607087|448751676|FG000|Period 1|Poor compliance to protocol|1|||
124914821|NCT02058108|449314669|FG000|Overall Study|Protocol Violation|0|||
124914822|NCT02058108|449314670|FG001|Overall Study|Protocol Violation|1|||
124914823|NCT00411151|449314674|FG000|Overall Study|Death|38|||
124451374|NCT02229539|447615046|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
124451375|NCT02229539|447615047|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
124451376|NCT02229539|447615045|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
124451377|NCT02229539|447615046|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
124451378|NCT02229539|447615047|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
124451379|NCT02229539|447615045|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
124451380|NCT02229539|447615046|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
124451381|NCT02229539|447615047|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
124451382|NCT02229539|447615045|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
124451383|NCT02229539|447615046|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
124451384|NCT02229539|447615047|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
124914824|NCT00411151|449314674|FG000|Overall Study|Withdrawal by Subject|2|||
124451385|NCT02229539|447615045|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
124451386|NCT02229539|447615046|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
124451387|NCT02229539|447615047|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
124451388|NCT00574145|447615048|FG000|Overall Study|Withdrawal by Subject|2|||
124451389|NCT00574145|447615049|FG001|Overall Study|Withdrawal by Subject|1|||
124451390|NCT02737852|447615050|FG000|Overall Study|Withdrawal by Subject|2|||
124451391|NCT04050670|447615051|FG000|Period 3|Physician Decision|0|||
124451392|NCT04050670|447615052|FG001|Period 3|Physician Decision|1|||
124451393|NCT04050670|447615053|FG002|Period 3|Physician Decision|0|||
124451394|NCT02553265|447615056|FG000|Enrollment|Death|0|||
124451395|NCT02553265|447615057|FG001|Enrollment|Death|0|||
124451396|NCT02553265|447615058|FG002|Enrollment|Death|1|||
124451397|NCT02553265|447615056|FG000|First Intervention (28 Days)|Adverse Event|1|||
124451398|NCT02553265|447615057|FG001|First Intervention (28 Days)|Adverse Event|0|||
124451399|NCT02553265|447615058|FG002|First Intervention (28 Days)|Adverse Event|0|||
124451400|NCT02553265|447615056|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
124451401|NCT02553265|447615057|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
124451402|NCT02553265|447615058|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
124451403|NCT02553265|447615056|FG000|Second Intervention (28 Days)|Adverse Event|1|||
124451404|NCT02553265|447615057|FG001|Second Intervention (28 Days)|Adverse Event|0|||
124451405|NCT02553265|447615058|FG002|Second Intervention (28 Days)|Adverse Event|0|||
124451406|NCT02553265|447615056|FG000|Third Intervention (28 Days)|Adverse Event|1|||
124451407|NCT02553265|447615057|FG001|Third Intervention (28 Days)|Adverse Event|0|||
124451408|NCT02553265|447615058|FG002|Third Intervention (28 Days)|Adverse Event|0|||
124451409|NCT02553265|447615056|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
124451410|NCT02553265|447615057|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
124451411|NCT02553265|447615058|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
124451412|NCT02982239|447615061|FG000|Overall Study|Lost to Follow-up|3|||
124451413|NCT02982239|447615062|FG001|Overall Study|Lost to Follow-up|2|||
124451414|NCT02982590|447615067|FG000|Overall Study|Lost to Follow-up|0|||
124451415|NCT02982590|447615068|FG001|Overall Study|Lost to Follow-up|1|||
124451416|NCT02982590|447615067|FG000|Overall Study|Death|4|||
124451417|NCT02982590|447615068|FG001|Overall Study|Death|0|||
124451418|NCT01168973|447615069|FG000|Overall Study|Progressive Disease|341|||
124451419|NCT01168973|447615070|FG001|Overall Study|Progressive Disease|429|||
124451420|NCT01168973|447615069|FG000|Overall Study|Adverse Event|94|||
124451421|NCT01168973|447615070|FG001|Overall Study|Adverse Event|55|||
124451422|NCT01168973|447615069|FG000|Overall Study|Withdrawal by Subject|90|||
124914825|NCT00411151|449314674|FG000|Overall Study|Lost to Follow-up|2|||
124914826|NCT00411151|449314674|FG000|Overall Study|Protocol Violation|1|||
124914827|NCT00411151|449314674|FG000|Overall Study|Trial prematurely closed|4|||
124914828|NCT01121991|449314677|FG000|Overall Study|Lack of Ovarian Response|2|||
124914829|NCT01121991|449314677|FG000|Overall Study|No Oocytes Retrieved|3|||
124914830|NCT01121991|449314677|FG000|Overall Study|No Fertilization|1|||
124914831|NCT00409838|449314678|FG000|Short-term Period|Adverse Event|0|||
124914832|NCT00409838|449314679|FG001|Short-term Period|Adverse Event|1|||
124914833|NCT00409838|449314678|FG000|Short-term Period|Lost to Follow-up|0|||
124914834|NCT00409838|449314679|FG001|Short-term Period|Lost to Follow-up|1|||
124914835|NCT00409838|449314678|FG000|Short-term Period|Withdrawal by Subject|2|||
124451423|NCT01168973|447615070|FG001|Overall Study|Withdrawal by Subject|53|||
124451424|NCT01168973|447615069|FG000|Overall Study|Death|42|||
124451425|NCT01168973|447615070|FG001|Overall Study|Death|45|||
124451426|NCT01168973|447615069|FG000|Overall Study|Physician Decision|37|||
124451427|NCT01168973|447615070|FG001|Overall Study|Physician Decision|19|||
124914836|NCT00409838|449314679|FG001|Short-term Period|Withdrawal by Subject|3|||
124914837|NCT00409838|449314678|FG000|Short-term Period|Never Treated|1|||
124914838|NCT00409838|449314679|FG001|Short-term Period|Never Treated|0|||
124914839|NCT00409838|449314678|FG000|Long-term Extension Period|Adverse Event|10|||
124914840|NCT00409838|449314679|FG001|Long-term Extension Period|Adverse Event|0|||
124914841|NCT00409838|449314678|FG000|Long-term Extension Period|Death|1|||
124914842|NCT00409838|449314679|FG001|Long-term Extension Period|Death|0|||
124451428|NCT01168973|447615069|FG000|Overall Study|Sponsor Decision|2|||
124451429|NCT01168973|447615070|FG001|Overall Study|Sponsor Decision|1|||
124914843|NCT00409838|449314678|FG000|Long-term Extension Period|Lack of Efficacy|2|||
124914844|NCT00409838|449314679|FG001|Long-term Extension Period|Lack of Efficacy|0|||
124914845|NCT00409838|449314678|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
124914846|NCT00409838|449314679|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
124914847|NCT00409838|449314678|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
124914848|NCT00409838|449314679|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
124914849|NCT00409838|449314678|FG000|Long-term Extension Period|Pregnancy|1|||
124914850|NCT00409838|449314679|FG001|Long-term Extension Period|Pregnancy|0|||
124914851|NCT01619410|449314680|FG000|Overall Study|Lost to Follow-up|7|||
124914852|NCT01619410|449314681|FG001|Overall Study|Lost to Follow-up|4|||
124451430|NCT01168973|447615069|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
124451431|NCT01168973|447615070|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
124451432|NCT01195090|447615075|FG000|Overall Study|Adverse Event|1|||
124451433|NCT01195090|447615076|FG001|Overall Study|Adverse Event|2|||
124451434|NCT01195090|447615075|FG000|Overall Study|Lost to Follow-up|2|||
124451435|NCT01195090|447615076|FG001|Overall Study|Lost to Follow-up|2|||
124451436|NCT01195090|447615075|FG000|Overall Study|Protocol Violation|3|||
124451437|NCT01195090|447615076|FG001|Overall Study|Protocol Violation|4|||
124451438|NCT04784897|447615077|FG000|Overall Study|Death|4|||
124451439|NCT04784897|447615078|FG001|Overall Study|Death|2|||
124451440|NCT04784897|447615079|FG002|Overall Study|Death|1|||
124451441|NCT04784897|447615077|FG000|Overall Study|Withdrawal by Subject|0|||
124451442|NCT04784897|447615078|FG001|Overall Study|Withdrawal by Subject|0|||
124451443|NCT04784897|447615079|FG002|Overall Study|Withdrawal by Subject|1|||
124451444|NCT04667377|447615080|FG000|Dose Escalation Period|Other not specified below|3|||
124451445|NCT04667377|447615081|FG001|Dose Escalation Period|Other not specified below|3|||
124451446|NCT04667377|447615082|FG002|Dose Escalation Period|Other not specified below|2|||
124451447|NCT04667377|447615083|FG003|Dose Escalation Period|Other not specified below|1|||
124451448|NCT04667377|447615084|FG004|Dose Escalation Period|Other not specified below|3|||
124451449|NCT04667377|447615080|FG000|Dose Escalation Period|Protocol Violation|2|||
124451450|NCT04667377|447615081|FG001|Dose Escalation Period|Protocol Violation|2|||
124451451|NCT04667377|447615082|FG002|Dose Escalation Period|Protocol Violation|0|||
124451452|NCT04667377|447615083|FG003|Dose Escalation Period|Protocol Violation|2|||
124451453|NCT04667377|447615084|FG004|Dose Escalation Period|Protocol Violation|1|||
124451454|NCT04667377|447615080|FG000|Dose Escalation Period|Burden of study procedures|2|||
124451455|NCT04667377|447615081|FG001|Dose Escalation Period|Burden of study procedures|1|||
124451456|NCT04667377|447615082|FG002|Dose Escalation Period|Burden of study procedures|1|||
124451457|NCT04667377|447615083|FG003|Dose Escalation Period|Burden of study procedures|1|||
124451458|NCT04667377|447615084|FG004|Dose Escalation Period|Burden of study procedures|5|||
124451459|NCT04667377|447615080|FG000|Dose Escalation Period|Change of residence|0|||
124451460|NCT04667377|447615081|FG001|Dose Escalation Period|Change of residence|0|||
124451461|NCT04667377|447615082|FG002|Dose Escalation Period|Change of residence|1|||
124451462|NCT04667377|447615083|FG003|Dose Escalation Period|Change of residence|0|||
124451463|NCT04667377|447615084|FG004|Dose Escalation Period|Change of residence|0|||
124451464|NCT04667377|447615080|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
124451465|NCT04667377|447615081|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
124451466|NCT04667377|447615082|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
124451467|NCT04667377|447615083|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
124451468|NCT04667377|447615084|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
124451469|NCT04667377|447615080|FG000|Dose Escalation Period|Adverse Event|9|||
124451470|NCT04667377|447615081|FG001|Dose Escalation Period|Adverse Event|10|||
124451471|NCT04667377|447615082|FG002|Dose Escalation Period|Adverse Event|12|||
124451472|NCT04667377|447615083|FG003|Dose Escalation Period|Adverse Event|17|||
124451473|NCT04667377|447615084|FG004|Dose Escalation Period|Adverse Event|3|||
124451474|NCT04667377|447615080|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
124451475|NCT04667377|447615081|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
124451476|NCT04667377|447615082|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
124451477|NCT04667377|447615083|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
124451478|NCT04667377|447615084|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
124451479|NCT04667377|447615080|FG000|Dose Escalation Period|Not treated|1|||
124451480|NCT04667377|447615081|FG001|Dose Escalation Period|Not treated|0|||
124451481|NCT04667377|447615082|FG002|Dose Escalation Period|Not treated|0|||
124694440|NCT03632720|448501984|FG000|Overall Study|Lost to Follow-up|0|||
124694441|NCT03632720|448501985|FG001|Overall Study|Lost to Follow-up|1|||
124694442|NCT03632720|448501986|FG002|Overall Study|Lost to Follow-up|0|||
124914853|NCT01250769|449314682|FG000|Overall Study|Withdrawal by Subject|0|||
124451482|NCT04667377|447615083|FG003|Dose Escalation Period|Not treated|0|||
124451483|NCT04667377|447615084|FG004|Dose Escalation Period|Not treated|0|||
124694443|NCT03632720|448501984|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
124694444|NCT03632720|448501985|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
124914854|NCT01250769|449314683|FG001|Overall Study|Withdrawal by Subject|1|||
124914855|NCT01250769|449314684|FG002|Overall Study|Withdrawal by Subject|1|||
124914856|NCT01250769|449314685|FG003|Overall Study|Withdrawal by Subject|0|||
124914857|NCT01250769|449314682|FG000|Overall Study|Adverse Event|0|||
124914858|NCT01250769|449314683|FG001|Overall Study|Adverse Event|0|||
124914859|NCT01250769|449314684|FG002|Overall Study|Adverse Event|1|||
124914860|NCT01250769|449314685|FG003|Overall Study|Adverse Event|0|||
124914861|NCT02538900|449314686|FG000|Overall Study|Death|2|||
124914862|NCT02538900|449314687|FG001|Overall Study|Death|2|||
124914863|NCT02538900|449314688|FG002|Overall Study|Death|2|||
124914864|NCT02538900|449314686|FG000|Overall Study|Withdrawal by Subject|18|||
124914865|NCT02538900|449314687|FG001|Overall Study|Withdrawal by Subject|16|||
124914866|NCT02538900|449314688|FG002|Overall Study|Withdrawal by Subject|15|||
124914867|NCT04110054|449314689|FG000|Overall Study|COVID-19 reason other than AE|0|||
124914868|NCT04110054|449314690|FG001|Overall Study|COVID-19 reason other than AE|0|||
124914869|NCT04110054|449314691|FG002|Overall Study|COVID-19 reason other than AE|2|||
124914870|NCT04110054|449314692|FG003|Overall Study|COVID-19 reason other than AE|0|||
124914871|NCT04110054|449314689|FG000|Overall Study|Withdrawal by Subject|0|||
124914872|NCT04110054|449314690|FG001|Overall Study|Withdrawal by Subject|3|||
124914873|NCT04110054|449314691|FG002|Overall Study|Withdrawal by Subject|2|||
124914874|NCT04110054|449314692|FG003|Overall Study|Withdrawal by Subject|0|||
124914875|NCT04110054|449314689|FG000|Overall Study|Adverse Event|1|||
124914876|NCT04110054|449314690|FG001|Overall Study|Adverse Event|1|||
124914877|NCT04110054|449314691|FG002|Overall Study|Adverse Event|4|||
124914878|NCT04110054|449314692|FG003|Overall Study|Adverse Event|3|||
124914879|NCT02874534|449314693|FG000|Overall Study|Withdrawal by Subject|5|||
124914880|NCT02874534|449314694|FG001|Overall Study|Withdrawal by Subject|8|||
124914881|NCT02874534|449314693|FG000|Overall Study|Lost to Follow-up|2|||
124914882|NCT02874534|449314694|FG001|Overall Study|Lost to Follow-up|2|||
124914883|NCT02874534|449314693|FG000|Overall Study|Ongoing in study|1|||
124914884|NCT02874534|449314694|FG001|Overall Study|Ongoing in study|1|||
124914885|NCT02923180|449314696|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
124914886|NCT02923180|449314696|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
124914887|NCT04287985|449314706|FG000|Overall Study|Adverse Event|1|||
124914888|NCT04287985|449314707|FG001|Overall Study|Adverse Event|0|||
124914889|NCT04287985|449314708|FG002|Overall Study|Adverse Event|0|||
124914890|NCT04287985|449314709|FG003|Overall Study|Adverse Event|0|||
124914891|NCT04287985|449314706|FG000|Overall Study|Protocol Violation|0|||
124914892|NCT04287985|449314707|FG001|Overall Study|Protocol Violation|1|||
124914893|NCT04287985|449314708|FG002|Overall Study|Protocol Violation|0|||
124914894|NCT04287985|449314709|FG003|Overall Study|Protocol Violation|0|||
124914895|NCT04287985|449314706|FG000|Overall Study|Physician Decision|0|||
124914896|NCT04287985|449314707|FG001|Overall Study|Physician Decision|0|||
124914897|NCT04287985|449314708|FG002|Overall Study|Physician Decision|0|||
124914898|NCT04287985|449314709|FG003|Overall Study|Physician Decision|1|||
124914899|NCT04287985|449314706|FG000|Overall Study|Withdrawal by Subject|2|||
124914900|NCT04287985|449314707|FG001|Overall Study|Withdrawal by Subject|1|||
124914901|NCT04287985|449314708|FG002|Overall Study|Withdrawal by Subject|1|||
124914902|NCT04287985|449314709|FG003|Overall Study|Withdrawal by Subject|2|||
124914903|NCT01340066|449314714|FG000|Placebo Run in Period|Screen Failures|27|||
124914904|NCT01340066|449314715|FG001|Placebo Run in Period|Screen Failures|0|||
124914905|NCT01340066|449314716|FG002|Placebo Run in Period|Screen Failures|0|||
124914906|NCT01340066|449314714|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
124914907|NCT01340066|449314715|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
124914908|NCT01340066|449314716|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
124914909|NCT01340066|449314714|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
124914910|NCT01340066|449314715|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
124914911|NCT01340066|449314716|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
124914912|NCT01340066|449314714|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
124914913|NCT01340066|449314715|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
124914914|NCT01340066|449314716|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
124451484|NCT04667377|447615080|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
124451485|NCT04667377|447615081|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
124761442|NCT00607087|448751677|FG001|Period 1|Poor compliance to protocol|0|||
124761443|NCT00607087|448751678|FG002|Period 1|Poor compliance to protocol|0|||
124914915|NCT02789020|449314717|FG000|Overall Study|Withdrawal by Subject|6|||
124914916|NCT02789020|449314718|FG001|Overall Study|Withdrawal by Subject|5|||
124914917|NCT03771352|449314729|FG000|Overall Study|Screen failure|2|||
124914918|NCT03771352|449314729|FG000|Overall Study|Withdrawal by Subject|2|||
124914919|NCT03380390|449314730|FG000|Overall Study|Adverse Event|3|||
124914920|NCT05171777|449314733|FG000|Treatment Crossover Period|Adverse Event|9|||
124914921|NCT05171777|449314734|FG001|Treatment Crossover Period|Adverse Event|6|||
124914922|NCT05171777|449314735|FG002|Treatment Crossover Period|Adverse Event|0|||
124914923|NCT05171777|449314736|FG003|Treatment Crossover Period|Adverse Event|0|||
124914924|NCT05171777|449314733|FG000|Treatment Crossover Period|Death|5|||
124914925|NCT05171777|449314734|FG001|Treatment Crossover Period|Death|5|||
124914926|NCT05171777|449314735|FG002|Treatment Crossover Period|Death|0|||
124914927|NCT05171777|449314736|FG003|Treatment Crossover Period|Death|0|||
124694445|NCT03632720|448501986|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
124694446|NCT03632720|448501984|FG000|Overall Study|Screen failure|0|||
124694447|NCT03632720|448501985|FG001|Overall Study|Screen failure|1|||
124694448|NCT03632720|448501986|FG002|Overall Study|Screen failure|0|||
124694449|NCT00682435|448501989|FG000|Overall Study|Insufficient data|5|||
124694450|NCT00682435|448501989|FG000|Overall Study|Erroneously enrolled twice|2|||
124694451|NCT01049828|448501995|FG000|Overall Study|Claustrophibia and Frustration|2|||
124694452|NCT00290238|448501996|FG000|Overall Study|Study terminated|27|||
124694453|NCT00290238|448501997|FG001|Overall Study|Study terminated|27|||
124694454|NCT00290238|448501996|FG000|Overall Study|Lost to Follow-up|0|||
124694455|NCT00290238|448501997|FG001|Overall Study|Lost to Follow-up|1|||
124694456|NCT00290238|448501996|FG000|Overall Study|Withdrawal by Subject|15|||
124694457|NCT00290238|448501997|FG001|Overall Study|Withdrawal by Subject|13|||
124694458|NCT06868667|448502000|FG000|Overall Study|Death|0|||
124694459|NCT06868667|448502001|FG001|Overall Study|Death|4|||
124694460|NCT06868667|448502000|FG000|Overall Study|Lost to Follow-up|0|||
124694461|NCT06868667|448502001|FG001|Overall Study|Lost to Follow-up|1|||
124694462|NCT06868667|448502000|FG000|Overall Study|Withdrawal by Subject|1|||
124694463|NCT06868667|448502001|FG001|Overall Study|Withdrawal by Subject|0|||
124694464|NCT06868667|448502000|FG000|Overall Study|Ongoing|9|||
124694465|NCT06868667|448502001|FG001|Overall Study|Ongoing|9|||
124694466|NCT05330429|448502002|FG000|Overall Study|Study Terminated by Sponsor|4|||
124694467|NCT05330429|448502003|FG001|Overall Study|Study Terminated by Sponsor|33|||
124694468|NCT05330429|448502004|FG002|Overall Study|Study Terminated by Sponsor|12|||
124914928|NCT05171777|449314733|FG000|Treatment Crossover Period|Disease Relapse|0|||
124914929|NCT05171777|449314734|FG001|Treatment Crossover Period|Disease Relapse|1|||
124914930|NCT05171777|449314735|FG002|Treatment Crossover Period|Disease Relapse|0|||
124914931|NCT05171777|449314736|FG003|Treatment Crossover Period|Disease Relapse|0|||
124914932|NCT05171777|449314733|FG000|Treatment Crossover Period|Reason not Specified|2|||
124914933|NCT05171777|449314734|FG001|Treatment Crossover Period|Reason not Specified|1|||
124914934|NCT05171777|449314735|FG002|Treatment Crossover Period|Reason not Specified|0|||
124914935|NCT05171777|449314736|FG003|Treatment Crossover Period|Reason not Specified|0|||
124914936|NCT05171777|449314733|FG000|Treatment Crossover Period|Physician Decision|0|||
124914937|NCT05171777|449314734|FG001|Treatment Crossover Period|Physician Decision|1|||
124914938|NCT05171777|449314735|FG002|Treatment Crossover Period|Physician Decision|0|||
124914939|NCT05171777|449314736|FG003|Treatment Crossover Period|Physician Decision|0|||
124914940|NCT05171777|449314733|FG000|Treatment Crossover Period|Progressive Disease|13|||
124914941|NCT05171777|449314734|FG001|Treatment Crossover Period|Progressive Disease|9|||
124914942|NCT05171777|449314735|FG002|Treatment Crossover Period|Progressive Disease|0|||
124914943|NCT05171777|449314736|FG003|Treatment Crossover Period|Progressive Disease|0|||
124914944|NCT05171777|449314733|FG000|Treatment Crossover Period|Protocol Violation|0|||
124914945|NCT05171777|449314734|FG001|Treatment Crossover Period|Protocol Violation|2|||
124914946|NCT05171777|449314735|FG002|Treatment Crossover Period|Protocol Violation|0|||
124914947|NCT05171777|449314736|FG003|Treatment Crossover Period|Protocol Violation|0|||
124914948|NCT05171777|449314733|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
124914949|NCT05171777|449314734|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
124914950|NCT05171777|449314735|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
124914951|NCT05171777|449314736|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
124914952|NCT05171777|449314733|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
124914953|NCT05171777|449314734|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
124914954|NCT05171777|449314735|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
124914955|NCT05171777|449314736|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
124451486|NCT04667377|447615082|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
124451487|NCT04667377|447615083|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
124451488|NCT04667377|447615084|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
124451489|NCT04667377|447615080|FG000|Dose Escalation Period|Lost to Follow-up|0|||
124694469|NCT05330429|448502002|FG000|Overall Study|Death|5|||
124694470|NCT05330429|448502003|FG001|Overall Study|Death|2|||
124694471|NCT05330429|448502004|FG002|Overall Study|Death|4|||
124694472|NCT05330429|448502002|FG000|Overall Study|Withdrew Consent|0|||
124694473|NCT05330429|448502003|FG001|Overall Study|Withdrew Consent|5|||
124694474|NCT05330429|448502004|FG002|Overall Study|Withdrew Consent|4|||
124694475|NCT05330429|448502002|FG000|Overall Study|Investigator's Discretion|0|||
124694476|NCT05330429|448502003|FG001|Overall Study|Investigator's Discretion|1|||
124694477|NCT05330429|448502004|FG002|Overall Study|Investigator's Discretion|3|||
124694478|NCT05330429|448502002|FG000|Overall Study|Subject Decision|1|||
124694479|NCT05330429|448502003|FG001|Overall Study|Subject Decision|2|||
124694480|NCT05330429|448502004|FG002|Overall Study|Subject Decision|0|||
124694481|NCT05330429|448502002|FG000|Overall Study|Lost to Follow-up|0|||
124694482|NCT05330429|448502003|FG001|Overall Study|Lost to Follow-up|1|||
124694483|NCT05330429|448502004|FG002|Overall Study|Lost to Follow-up|0|||
124694484|NCT03572218|448502005|FG000|Overall Study|Lost to Follow-up|3|||
124914956|NCT05171777|449314733|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
124914957|NCT05171777|449314734|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
124914958|NCT05171777|449314735|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
124914959|NCT05171777|449314736|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
124914960|NCT05171777|449314733|FG000|Treatment Continuation Period|Death|0|||
124914961|NCT05171777|449314734|FG001|Treatment Continuation Period|Death|0|||
124914962|NCT05171777|449314735|FG002|Treatment Continuation Period|Death|1|||
124914963|NCT05171777|449314736|FG003|Treatment Continuation Period|Death|6|||
124914964|NCT05171777|449314733|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
124914965|NCT05171777|449314734|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
124914966|NCT05171777|449314735|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
124914967|NCT05171777|449314736|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
124914968|NCT02538341|449314737|FG000|Overall Study|Lost to Follow-up|51|||
124914969|NCT02538341|449314738|FG001|Overall Study|Lost to Follow-up|46|||
124914970|NCT02538341|449314737|FG000|Overall Study|Withdrawal by Subject|3|||
124914971|NCT02538341|449314738|FG001|Overall Study|Withdrawal by Subject|1|||
124914972|NCT02538341|449314737|FG000|Overall Study|Death|2|||
124914973|NCT02538341|449314738|FG001|Overall Study|Death|0|||
124914974|NCT00632749|449314739|FG000|Overall Study|Progressive disease|3|||
124914975|NCT00632749|449314740|FG001|Overall Study|Progressive disease|2|||
124914976|NCT00632749|449314741|FG002|Overall Study|Progressive disease|2|||
124914977|NCT00632749|449314742|FG003|Overall Study|Progressive disease|2|||
124914978|NCT00632749|449314743|FG004|Overall Study|Progressive disease|4|||
124914979|NCT00632749|449314744|FG005|Overall Study|Progressive disease|4|||
124914980|NCT00632749|449314745|FG006|Overall Study|Progressive disease|3|||
124914981|NCT00632749|449314746|FG007|Overall Study|Progressive disease|2|||
124914982|NCT00632749|449314747|FG008|Overall Study|Progressive disease|3|||
124914983|NCT00632749|449314748|FG009|Overall Study|Progressive disease|2|||
124914984|NCT00632749|449314749|FG010|Overall Study|Progressive disease|4|||
124914985|NCT00632749|449314750|FG011|Overall Study|Progressive disease|3|||
124914986|NCT00632749|449314751|FG012|Overall Study|Progressive disease|2|||
124914987|NCT00632749|449314752|FG013|Overall Study|Progressive disease|4|||
124914988|NCT00632749|449314739|FG000|Overall Study|Other Adverse event|1|||
124914989|NCT00632749|449314740|FG001|Overall Study|Other Adverse event|1|||
124914990|NCT00632749|449314741|FG002|Overall Study|Other Adverse event|1|||
124914991|NCT00632749|449314742|FG003|Overall Study|Other Adverse event|1|||
124914992|NCT00632749|449314743|FG004|Overall Study|Other Adverse event|2|||
124914993|NCT00632749|449314744|FG005|Overall Study|Other Adverse event|4|||
124914994|NCT00632749|449314745|FG006|Overall Study|Other Adverse event|1|||
124914995|NCT00632749|449314746|FG007|Overall Study|Other Adverse event|2|||
124914996|NCT00632749|449314747|FG008|Overall Study|Other Adverse event|2|||
124914997|NCT00632749|449314748|FG009|Overall Study|Other Adverse event|0|||
124914998|NCT00632749|449314749|FG010|Overall Study|Other Adverse event|1|||
124914999|NCT00632749|449314750|FG011|Overall Study|Other Adverse event|0|||
124915000|NCT00632749|449314751|FG012|Overall Study|Other Adverse event|1|||
124915001|NCT00632749|449314752|FG013|Overall Study|Other Adverse event|0|||
124915002|NCT00632749|449314739|FG000|Overall Study|Refuse to continue medication|0|||
124915003|NCT00632749|449314740|FG001|Overall Study|Refuse to continue medication|0|||
124915004|NCT00632749|449314741|FG002|Overall Study|Refuse to continue medication|0|||
124915005|NCT00632749|449314742|FG003|Overall Study|Refuse to continue medication|1|||
124915006|NCT00632749|449314743|FG004|Overall Study|Refuse to continue medication|0|||
124451490|NCT04667377|447615081|FG001|Dose Escalation Period|Lost to Follow-up|1|||
124451491|NCT04667377|447615082|FG002|Dose Escalation Period|Lost to Follow-up|0|||
124761444|NCT00607087|448751676|FG000|Period 1|Lost to Follow-up|1|||
124761445|NCT00607087|448751677|FG001|Period 1|Lost to Follow-up|0|||
124761446|NCT00607087|448751678|FG002|Period 1|Lost to Follow-up|0|||
124761447|NCT00607087|448751676|FG000|Period 1|Other reason|0|||
124761448|NCT00607087|448751677|FG001|Period 1|Other reason|4|||
124761449|NCT00607087|448751678|FG002|Period 1|Other reason|2|||
124761450|NCT00607087|448751676|FG000|Period 2|Withdrawal by Subject|0|||
124761451|NCT00607087|448751677|FG001|Period 2|Withdrawal by Subject|1|||
124761452|NCT00607087|448751678|FG002|Period 2|Withdrawal by Subject|1|||
124761453|NCT00607087|448751676|FG000|Period 2|Other reason|1|||
124761454|NCT00607087|448751677|FG001|Period 2|Other reason|1|||
124761455|NCT00607087|448751678|FG002|Period 2|Other reason|0|||
124761456|NCT00607087|448751676|FG000|Period 2|Adverse Event|0|||
124915007|NCT00632749|449314744|FG005|Overall Study|Refuse to continue medication|0|||
124915008|NCT00632749|449314745|FG006|Overall Study|Refuse to continue medication|0|||
124915009|NCT00632749|449314746|FG007|Overall Study|Refuse to continue medication|0|||
124915010|NCT00632749|449314747|FG008|Overall Study|Refuse to continue medication|0|||
124915011|NCT00632749|449314748|FG009|Overall Study|Refuse to continue medication|1|||
124915012|NCT00632749|449314749|FG010|Overall Study|Refuse to continue medication|0|||
124915013|NCT00632749|449314750|FG011|Overall Study|Refuse to continue medication|0|||
124761457|NCT00607087|448751677|FG001|Period 2|Adverse Event|1|||
124761458|NCT00607087|448751678|FG002|Period 2|Adverse Event|3|||
124761459|NCT00607087|448751676|FG000|Period 2|Poor compliance to protocol|0|||
124761460|NCT00607087|448751677|FG001|Period 2|Poor compliance to protocol|0|||
124761461|NCT00607087|448751678|FG002|Period 2|Poor compliance to protocol|1|||
124761462|NCT00607087|448751676|FG000|Period 3|Withdrawal by Subject|2|||
124915014|NCT00632749|449314751|FG012|Overall Study|Refuse to continue medication|0|||
124915015|NCT00632749|449314752|FG013|Overall Study|Refuse to continue medication|0|||
124915016|NCT00632749|449314739|FG000|Overall Study|Reason other than those specified above|0|||
124915017|NCT00632749|449314740|FG001|Overall Study|Reason other than those specified above|2|||
124915018|NCT00632749|449314741|FG002|Overall Study|Reason other than those specified above|0|||
124915019|NCT00632749|449314742|FG003|Overall Study|Reason other than those specified above|0|||
124915020|NCT00632749|449314743|FG004|Overall Study|Reason other than those specified above|1|||
124915021|NCT00632749|449314744|FG005|Overall Study|Reason other than those specified above|0|||
124915022|NCT00632749|449314745|FG006|Overall Study|Reason other than those specified above|1|||
124915023|NCT00632749|449314746|FG007|Overall Study|Reason other than those specified above|0|||
124915024|NCT00632749|449314747|FG008|Overall Study|Reason other than those specified above|0|||
124915025|NCT00632749|449314748|FG009|Overall Study|Reason other than those specified above|0|||
124694485|NCT03572218|448502006|FG001|Overall Study|Lost to Follow-up|2|||
124694486|NCT03572218|448502005|FG000|Overall Study|No longer available for study visits|2|||
124694487|NCT03572218|448502006|FG001|Overall Study|No longer available for study visits|1|||
124694488|NCT03572218|448502005|FG000|Overall Study|No longer interested|1|||
124694489|NCT03572218|448502006|FG001|Overall Study|No longer interested|2|||
124694490|NCT00286455|448502007|FG000|Overall Study|Hyperglycemia rescue|19|||
124694491|NCT00286455|448502008|FG001|Overall Study|Hyperglycemia rescue|13|||
124694492|NCT00286455|448502009|FG002|Overall Study|Hyperglycemia rescue|10|||
124694493|NCT00286455|448502007|FG000|Overall Study|Adverse Event|1|||
124694494|NCT00286455|448502008|FG001|Overall Study|Adverse Event|3|||
124694495|NCT00286455|448502009|FG002|Overall Study|Adverse Event|2|||
124694496|NCT00286455|448502007|FG000|Overall Study|Lost to Follow-up|0|||
124694497|NCT00286455|448502008|FG001|Overall Study|Lost to Follow-up|3|||
124694498|NCT00286455|448502009|FG002|Overall Study|Lost to Follow-up|3|||
124694499|NCT00286455|448502007|FG000|Overall Study|Physician Decision|3|||
124694500|NCT00286455|448502008|FG001|Overall Study|Physician Decision|0|||
124694501|NCT00286455|448502009|FG002|Overall Study|Physician Decision|2|||
124694502|NCT00286455|448502007|FG000|Overall Study|Protocol Violation|1|||
124694503|NCT00286455|448502008|FG001|Overall Study|Protocol Violation|1|||
124915026|NCT00632749|449314749|FG010|Overall Study|Reason other than those specified above|2|||
124915027|NCT00632749|449314750|FG011|Overall Study|Reason other than those specified above|1|||
124915028|NCT00632749|449314751|FG012|Overall Study|Reason other than those specified above|0|||
124915029|NCT00632749|449314752|FG013|Overall Study|Reason other than those specified above|2|||
124915030|NCT03988842|449314755|FG000|Overall Study|Death|1|||
124915031|NCT01227265|449314757|FG000|Overall Study|Did Not Receive Treatment|1|||
124915032|NCT01227265|449314758|FG001|Overall Study|Did Not Receive Treatment|2|||
124915033|NCT01227265|449314759|FG002|Overall Study|Did Not Receive Treatment|0|||
124915034|NCT01227265|449314757|FG000|Overall Study|Administrative|1|||
124915035|NCT01227265|449314758|FG001|Overall Study|Administrative|0|||
124915036|NCT01227265|449314759|FG002|Overall Study|Administrative|2|||
124915037|NCT01227265|449314757|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
124915038|NCT01227265|449314758|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
124915039|NCT01227265|449314759|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
124915040|NCT01227265|449314757|FG000|Overall Study|Protocol Violation|2|||
124915041|NCT01227265|449314758|FG001|Overall Study|Protocol Violation|1|||
124915042|NCT01227265|449314759|FG002|Overall Study|Protocol Violation|0|||
124915043|NCT01227265|449314757|FG000|Overall Study|Withdrawal by Subject|7|||
124915044|NCT01227265|449314758|FG001|Overall Study|Withdrawal by Subject|7|||
124915045|NCT01227265|449314759|FG002|Overall Study|Withdrawal by Subject|3|||
124915046|NCT01227265|449314757|FG000|Overall Study|Lost to Follow-up|2|||
124915047|NCT01227265|449314758|FG001|Overall Study|Lost to Follow-up|0|||
124915048|NCT01227265|449314759|FG002|Overall Study|Lost to Follow-up|3|||
124915049|NCT01227265|449314757|FG000|Overall Study|Adverse Event|6|||
124915050|NCT01227265|449314758|FG001|Overall Study|Adverse Event|10|||
124915051|NCT01227265|449314759|FG002|Overall Study|Adverse Event|5|||
124915052|NCT03690206|449314761|FG000|Overall Study|Withdrawal by Subject|2|||
124915053|NCT03690206|449314762|FG001|Overall Study|Withdrawal by Subject|0|||
124915054|NCT03690206|449314763|FG002|Overall Study|Withdrawal by Subject|0|||
124915055|NCT03690206|449314761|FG000|Overall Study|ICF withdrawal|2|||
124915056|NCT03690206|449314762|FG001|Overall Study|ICF withdrawal|0|||
124915057|NCT03690206|449314763|FG002|Overall Study|ICF withdrawal|0|||
124915058|NCT05028582|449314764|FG000|Overall Study|Lost to Follow-up|11|||
124915059|NCT05028582|449314765|FG001|Overall Study|Lost to Follow-up|9|||
124915060|NCT05028582|449314764|FG000|Overall Study|Withdrawal by Subject|9|||
124915061|NCT05028582|449314765|FG001|Overall Study|Withdrawal by Subject|10|||
124694504|NCT00286455|448502009|FG002|Overall Study|Protocol Violation|0|||
124694505|NCT00286455|448502007|FG000|Overall Study|Participant Non-compliance|1|||
124694506|NCT00286455|448502008|FG001|Overall Study|Participant Non-compliance|0|||
124694507|NCT00286455|448502009|FG002|Overall Study|Participant Non-compliance|0|||
124694508|NCT00286455|448502007|FG000|Overall Study|Withdrawal by Subject|0|||
124694509|NCT00286455|448502008|FG001|Overall Study|Withdrawal by Subject|8|||
124694510|NCT00286455|448502009|FG002|Overall Study|Withdrawal by Subject|7|||
124694511|NCT06097273|448502014|FG000|Overall Study|Death|2|||
124915062|NCT05028582|449314764|FG000|Overall Study|Adverse Event|5|||
124915063|NCT05028582|449314765|FG001|Overall Study|Adverse Event|2|||
124915064|NCT05028582|449314764|FG000|Overall Study|Miscellaneous|3|||
124915065|NCT05028582|449314765|FG001|Overall Study|Miscellaneous|2|||
124915066|NCT05028582|449314764|FG000|Overall Study|Lack of Efficacy|3|||
124915067|NCT05028582|449314765|FG001|Overall Study|Lack of Efficacy|1|||
124694512|NCT06097273|448502015|FG001|Overall Study|Death|1|||
124694513|NCT06097273|448502016|FG002|Overall Study|Death|2|||
124915068|NCT05028582|449314764|FG000|Overall Study|Physician Decision|0|||
124694514|NCT06097273|448502017|FG003|Overall Study|Death|2|||
124694515|NCT06097273|448502014|FG000|Overall Study|Lost to Follow-up|27|||
124694516|NCT06097273|448502015|FG001|Overall Study|Lost to Follow-up|18|||
124694517|NCT06097273|448502016|FG002|Overall Study|Lost to Follow-up|36|||
124694518|NCT06097273|448502017|FG003|Overall Study|Lost to Follow-up|31|||
124694519|NCT06097273|448502014|FG000|Overall Study|Physician Decision|0|||
124694520|NCT06097273|448502015|FG001|Overall Study|Physician Decision|1|||
124694521|NCT06097273|448502016|FG002|Overall Study|Physician Decision|0|||
124694522|NCT06097273|448502017|FG003|Overall Study|Physician Decision|3|||
124694523|NCT06097273|448502014|FG000|Overall Study|Protocol Violation|1|||
124915069|NCT05028582|449314765|FG001|Overall Study|Physician Decision|1|||
124915070|NCT01959698|449314766|FG000|Overall Study|Adverse Event|0|||
124915071|NCT01959698|449314767|FG001|Overall Study|Adverse Event|0|||
124915072|NCT01959698|449314768|FG002|Overall Study|Adverse Event|0|||
124915073|NCT01959698|449314769|FG003|Overall Study|Adverse Event|0|||
124915074|NCT01959698|449314770|FG004|Overall Study|Adverse Event|0|||
124915075|NCT01959698|449314771|FG005|Overall Study|Adverse Event|0|||
124915076|NCT01959698|449314772|FG006|Overall Study|Adverse Event|1|||
124915077|NCT01959698|449314766|FG000|Overall Study|Physician Decision|1|||
124915078|NCT01959698|449314767|FG001|Overall Study|Physician Decision|0|||
124915079|NCT01959698|449314768|FG002|Overall Study|Physician Decision|1|||
124915080|NCT01959698|449314769|FG003|Overall Study|Physician Decision|2|||
124915081|NCT01959698|449314770|FG004|Overall Study|Physician Decision|0|||
124915082|NCT01959698|449314771|FG005|Overall Study|Physician Decision|3|||
124915083|NCT01959698|449314772|FG006|Overall Study|Physician Decision|3|||
124915084|NCT04402294|449314773|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
124694524|NCT06097273|448502015|FG001|Overall Study|Protocol Violation|1|||
124694525|NCT06097273|448502016|FG002|Overall Study|Protocol Violation|2|||
124761463|NCT00607087|448751677|FG001|Period 3|Withdrawal by Subject|1|||
124761464|NCT00607087|448751678|FG002|Period 3|Withdrawal by Subject|0|||
124761465|NCT00607087|448751676|FG000|Period 3|Adverse Event|0|||
124761466|NCT00607087|448751677|FG001|Period 3|Adverse Event|1|||
124761467|NCT00607087|448751678|FG002|Period 3|Adverse Event|0|||
124761468|NCT00650767|448751680|FG000|Overall Study|Adverse Event|0|||
124761469|NCT00650767|448751681|FG001|Overall Study|Adverse Event|3|||
124761470|NCT00650767|448751682|FG002|Overall Study|Adverse Event|10|||
124761471|NCT00650767|448751683|FG003|Overall Study|Adverse Event|8|||
124761472|NCT00650767|448751680|FG000|Overall Study|Death|1|||
124761473|NCT00650767|448751681|FG001|Overall Study|Death|0|||
124761474|NCT00650767|448751682|FG002|Overall Study|Death|0|||
124761475|NCT00650767|448751683|FG003|Overall Study|Death|0|||
124761476|NCT00650767|448751680|FG000|Overall Study|Withdrawal by Subject|2|||
124761477|NCT00650767|448751681|FG001|Overall Study|Withdrawal by Subject|4|||
124761478|NCT00650767|448751682|FG002|Overall Study|Withdrawal by Subject|3|||
124761479|NCT00650767|448751683|FG003|Overall Study|Withdrawal by Subject|3|||
124761480|NCT00650767|448751680|FG000|Overall Study|Lost to Follow-up|1|||
124761481|NCT00650767|448751681|FG001|Overall Study|Lost to Follow-up|1|||
124761482|NCT00650767|448751682|FG002|Overall Study|Lost to Follow-up|1|||
124761483|NCT00650767|448751683|FG003|Overall Study|Lost to Follow-up|0|||
124761484|NCT00650767|448751680|FG000|Overall Study|Other|1|||
124761485|NCT00650767|448751681|FG001|Overall Study|Other|1|||
124915085|NCT04402294|449314774|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
124915086|NCT04402294|449314773|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
124915087|NCT04402294|449314774|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
124915088|NCT00186992|449316398|FG000|Overall Study|Withdrawal by Subject|5|||
124915089|NCT00186992|449316398|FG000|Overall Study|Physician's discretion|13|||
124915090|NCT00186992|449316398|FG000|Overall Study|PI Discretion|4|||
124915091|NCT00186992|449316398|FG000|Overall Study|Ineligible|2|||
124915092|NCT00186992|449316398|FG000|Overall Study|Lost to Follow-up|2|||
124694526|NCT06097273|448502017|FG003|Overall Study|Protocol Violation|1|||
124694527|NCT06097273|448502014|FG000|Overall Study|Withdrawal by Subject|14|||
124694528|NCT06097273|448502015|FG001|Overall Study|Withdrawal by Subject|11|||
124761486|NCT00650767|448751682|FG002|Overall Study|Other|0|||
124761487|NCT00650767|448751683|FG003|Overall Study|Other|0|||
124761488|NCT01774799|448751684|FG000|Overall Study|Lost to Follow-up|1|||
124761489|NCT01774799|448751685|FG001|Overall Study|Lost to Follow-up|1|||
124761490|NCT01774799|448751686|FG002|Overall Study|Lost to Follow-up|0|||
124761491|NCT01774799|448751687|FG003|Overall Study|Lost to Follow-up|0|||
124761492|NCT02586623|448751688|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
124761493|NCT02586623|448751689|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
124761494|NCT02586623|448751690|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
124915093|NCT00186992|449316398|FG000|Overall Study|Still on Study|9|||
124915094|NCT03769168|449316399|FG000|Overall Study|Adverse Event|0|||
124915095|NCT03769168|449316400|FG001|Overall Study|Adverse Event|1|||
124915096|NCT03769168|449316399|FG000|Overall Study|Lack of Efficacy|2|||
124915097|NCT03769168|449316400|FG001|Overall Study|Lack of Efficacy|4|||
124915098|NCT03769168|449316399|FG000|Overall Study|Post study access to treatment|3|||
124915099|NCT03769168|449316400|FG001|Overall Study|Post study access to treatment|11|||
124915100|NCT03769168|449316399|FG000|Overall Study|Physician Decision|1|||
124915101|NCT03769168|449316400|FG001|Overall Study|Physician Decision|4|||
124915102|NCT03769168|449316399|FG000|Overall Study|Subject Decision|2|||
124915103|NCT03769168|449316400|FG001|Overall Study|Subject Decision|4|||
124915104|NCT03769168|449316399|FG000|Overall Study|Guardian decision|1|||
124451492|NCT04667377|447615083|FG003|Dose Escalation Period|Lost to Follow-up|0|||
124451493|NCT04667377|447615084|FG004|Dose Escalation Period|Lost to Follow-up|0|||
124451494|NCT04667377|447615080|FG000|Maintenance Period|Perceived lack of efficacy|0|||
124451495|NCT04667377|447615081|FG001|Maintenance Period|Perceived lack of efficacy|2|||
124451496|NCT04667377|447615082|FG002|Maintenance Period|Perceived lack of efficacy|1|||
124761495|NCT02586623|448751688|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
124761496|NCT02586623|448751689|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
124761497|NCT02586623|448751690|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
124761498|NCT02586623|448751688|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
124761499|NCT02586623|448751689|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
124761500|NCT02586623|448751690|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
124761501|NCT02586623|448751688|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
124761502|NCT02586623|448751689|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
124761503|NCT02586623|448751690|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
124761504|NCT02586623|448751688|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
124761505|NCT02586623|448751689|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
124761506|NCT02586623|448751690|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
124761507|NCT02586623|448751688|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
124761508|NCT02586623|448751689|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
124761509|NCT02586623|448751690|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
124761510|NCT02586623|448751688|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
124761511|NCT02586623|448751689|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
124761512|NCT02586623|448751690|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
124761513|NCT02586623|448751688|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
124761514|NCT02586623|448751689|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
124761515|NCT02586623|448751690|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
124761516|NCT02586623|448751688|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
124761517|NCT02586623|448751689|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
124761518|NCT02586623|448751690|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
124761519|NCT02586623|448751688|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
124761520|NCT02586623|448751689|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
124761521|NCT02586623|448751690|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
124761522|NCT02586623|448751688|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
124761523|NCT02586623|448751689|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
124761524|NCT02586623|448751690|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
124761525|NCT02586623|448751688|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
124761526|NCT02586623|448751689|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
124761527|NCT02586623|448751690|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
124761528|NCT02586623|448751688|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
124761529|NCT02586623|448751689|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
124761530|NCT02586623|448751690|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
124761531|NCT02586623|448751688|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
124761532|NCT02586623|448751689|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
124761533|NCT02586623|448751690|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
124761534|NCT02586623|448751688|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
124761535|NCT02586623|448751689|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
124761536|NCT02586623|448751690|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
124761537|NCT02586623|448751688|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
124915105|NCT03769168|449316400|FG001|Overall Study|Guardian decision|0|||
124915106|NCT05478525|449316401|FG000|Overall Study|Withdrawal by Subject|0|||
124915107|NCT05478525|449316402|FG001|Overall Study|Withdrawal by Subject|1|||
124915108|NCT05478525|449316403|FG002|Overall Study|Withdrawal by Subject|2|||
124915109|NCT05478525|449316404|FG003|Overall Study|Withdrawal by Subject|0|||
124915110|NCT05478525|449316401|FG000|Overall Study|COVID-19 Infection|2|||
124761538|NCT02586623|448751689|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
124761539|NCT02586623|448751690|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
124761540|NCT02586623|448751688|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
124761541|NCT02586623|448751689|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
124761542|NCT02586623|448751690|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
124761543|NCT02586623|448751688|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
124761544|NCT02586623|448751689|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
124761545|NCT02586623|448751690|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
124761546|NCT02586623|448751688|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
124761547|NCT02586623|448751689|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
124761548|NCT02586623|448751690|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
124761549|NCT02586623|448751688|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
124761550|NCT02586623|448751689|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
124761551|NCT02586623|448751690|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
124761552|NCT02586623|448751688|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
124761553|NCT02586623|448751689|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
124761554|NCT02586623|448751690|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
124761555|NCT02910466|448751691|FG000|Overall Study|Adverse Event|1|||
124761556|NCT02910466|448751691|FG000|Overall Study|Withdrawal by Subject|3|||
124761557|NCT02910466|448751691|FG000|Overall Study|Lost to Follow-up|5|||
124761558|NCT02910466|448751691|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
124761559|NCT02910466|448751691|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
124761560|NCT01808196|448751698|FG000|Overall Study|Lost to Follow-up|1|||
124761561|NCT00479713|448751699|FG000|Overall Study|Adverse Event|8|||
124761562|NCT00479713|448751700|FG001|Overall Study|Adverse Event|6|||
124761563|NCT00479713|448751699|FG000|Overall Study|Death|1|||
124761564|NCT00479713|448751700|FG001|Overall Study|Death|0|||
124761565|NCT00479713|448751699|FG000|Overall Study|Lost to Follow-up|0|||
124761566|NCT00479713|448751700|FG001|Overall Study|Lost to Follow-up|1|||
124761567|NCT00479713|448751699|FG000|Overall Study|Protocol Violation|0|||
124761568|NCT00479713|448751700|FG001|Overall Study|Protocol Violation|1|||
124761569|NCT00479713|448751699|FG000|Overall Study|Withdrawal by Subject|4|||
124761570|NCT00479713|448751700|FG001|Overall Study|Withdrawal by Subject|1|||
124761571|NCT00141102|448751701|FG000|Overall Study|Adverse Event|233|||
124761572|NCT00141102|448751702|FG001|Overall Study|Adverse Event|305|||
124761573|NCT00141102|448751701|FG000|Overall Study|Laboratory Abnormality|9|||
124761574|NCT00141102|448751702|FG001|Overall Study|Laboratory Abnormality|33|||
124761575|NCT00141102|448751701|FG000|Overall Study|Lack of Efficacy|21|||
124761576|NCT00141102|448751702|FG001|Overall Study|Lack of Efficacy|26|||
124761577|NCT00141102|448751701|FG000|Overall Study|Lost to Follow-up|29|||
124761578|NCT00141102|448751702|FG001|Overall Study|Lost to Follow-up|32|||
124761579|NCT00141102|448751701|FG000|Overall Study|Other|87|||
124761580|NCT00141102|448751702|FG001|Overall Study|Other|76|||
124761581|NCT00141102|448751701|FG000|Overall Study|Withdrawal by Subject|112|||
124761582|NCT00141102|448751702|FG001|Overall Study|Withdrawal by Subject|142|||
124761583|NCT00141102|448751701|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
124761584|NCT00141102|448751702|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
124761585|NCT00141102|448751701|FG000|Overall Study|Death|2|||
124761586|NCT00141102|448751702|FG001|Overall Study|Death|2|||
124915111|NCT05478525|449316402|FG001|Overall Study|COVID-19 Infection|0|||
124915112|NCT05478525|449316403|FG002|Overall Study|COVID-19 Infection|1|||
124915113|NCT05478525|449316404|FG003|Overall Study|COVID-19 Infection|1|||
124915114|NCT05644002|449316407|FG000|Overall Study|Lost to Follow-up|1|||
124915115|NCT05644002|449316408|FG001|Overall Study|Lost to Follow-up|2|||
124915116|NCT05644002|449316407|FG000|Overall Study|Withdrawal by Subject|0|||
124915117|NCT05644002|449316408|FG001|Overall Study|Withdrawal by Subject|1|||
124915118|NCT04842500|449316409|FG000|Overall Study|Withdrawal by Subject|4|||
124915119|NCT04842500|449316410|FG001|Overall Study|Withdrawal by Subject|1|||
124915120|NCT04842500|449316411|FG002|Overall Study|Withdrawal by Subject|2|||
124915121|NCT04842500|449316412|FG003|Overall Study|Withdrawal by Subject|3|||
124915122|NCT04842500|449316409|FG000|Overall Study|Protocol Violation|1|||
124915123|NCT04842500|449316410|FG001|Overall Study|Protocol Violation|0|||
124915124|NCT04842500|449316411|FG002|Overall Study|Protocol Violation|0|||
124915125|NCT04842500|449316412|FG003|Overall Study|Protocol Violation|1|||
124915126|NCT05104697|449316414|FG000|Overall Study|Withdrawal by Subject|0|||
124915127|NCT05104697|449316415|FG001|Overall Study|Withdrawal by Subject|1|||
124915128|NCT03845465|449316416|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
124915129|NCT03845465|449316417|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
124915130|NCT03845465|449316416|FG000|6-month Data Collection|Withdrawal by Subject|0|||
124761587|NCT00410956|448751703|FG000|Overall Study|Adverse Event|1|||
124761588|NCT00410956|448751703|FG000|Overall Study|Death|2|||
124761589|NCT00410956|448751703|FG000|Overall Study|Lack of Efficacy|10|||
124761590|NCT00410956|448751703|FG000|Overall Study|Physician Decision|6|||
124761591|NCT01871519|448751706|FG000|Overall Study|Death|26|||
124761592|NCT01871519|448751706|FG000|Overall Study|Lost to Follow-up|15|||
124761593|NCT01871519|448751706|FG000|Overall Study|Withdrawal by Subject|49|||
124761594|NCT00794950|448751707|FG000|BCG Induction|Withdrawal by Subject|2|||
124761595|NCT00794950|448751707|FG000|BCG Induction|ineligible|3|||
124761596|NCT00794950|448751707|FG000|BCG Induction|noncompliant w. BCG|1|||
124694529|NCT06097273|448502016|FG002|Overall Study|Withdrawal by Subject|14|||
124694530|NCT06097273|448502017|FG003|Overall Study|Withdrawal by Subject|15|||
124694531|NCT06097273|448502014|FG000|Overall Study|Other Than Specified|7|||
124694532|NCT06097273|448502015|FG001|Overall Study|Other Than Specified|3|||
124694533|NCT06097273|448502016|FG002|Overall Study|Other Than Specified|11|||
124694534|NCT06097273|448502017|FG003|Overall Study|Other Than Specified|6|||
124694535|NCT03882801|448503438|FG000|Period 1|Adverse Event|0|||
124694536|NCT03882801|448503439|FG001|Period 1|Adverse Event|1|||
124694537|NCT03882801|448503438|FG000|Period 1|Non-compliance with study drug|1|||
124694538|NCT03882801|448503439|FG001|Period 1|Non-compliance with study drug|1|||
124694539|NCT03882801|448503438|FG000|Period 1|Never treated with study drug|1|||
124694540|NCT03882801|448503439|FG001|Period 1|Never treated with study drug|0|||
124694541|NCT03882801|448503438|FG000|Washout Period|Physician Decision|0|||
124694542|NCT03882801|448503439|FG001|Washout Period|Physician Decision|1|||
124694543|NCT03882801|448503438|FG000|Period 2|Non-compliance with study drug|0|||
124694544|NCT03882801|448503439|FG001|Period 2|Non-compliance with study drug|1|||
124694545|NCT03548415|448503443|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
124694546|NCT03548415|448503444|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
124694547|NCT03548415|448503445|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
124694548|NCT03548415|448503446|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
124694549|NCT03548415|448503447|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
124694550|NCT01803737|448503448|FG000|Overall Study|Lack of Time|1|||
124694551|NCT01803737|448503449|FG001|Overall Study|Lack of Time|0|||
124694552|NCT01803737|448503448|FG000|Overall Study|Medical Reason|0|||
124694553|NCT01803737|448503449|FG001|Overall Study|Medical Reason|1|||
124694554|NCT01803737|448503448|FG000|Overall Study|Lost to Follow-up|0|||
124694555|NCT01803737|448503449|FG001|Overall Study|Lost to Follow-up|2|||
124694556|NCT01748552|448503450|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
124694557|NCT01748552|448503451|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
124694558|NCT01748552|448503452|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
124694559|NCT01748552|448503453|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
124694560|NCT01748552|448503454|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
124694561|NCT01748552|448503455|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
124694562|NCT01748552|448503456|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
124694563|NCT01748552|448503457|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
124694564|NCT01748552|448503458|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
124761597|NCT00794950|448751707|FG000|BCG Induction|Adverse Event|1|||
124915131|NCT03845465|449316417|FG001|6-month Data Collection|Withdrawal by Subject|2|||
124915132|NCT03845465|449316416|FG000|12-month Data Collection|Withdrawal by Subject|0|||
124915133|NCT03845465|449316417|FG001|12-month Data Collection|Withdrawal by Subject|2|||
124915134|NCT03547908|449316418|FG000|Blinded Phase|Lost to Follow-up|3|||
124915135|NCT03547908|449316419|FG001|Blinded Phase|Lost to Follow-up|3|||
124915136|NCT03547908|449316420|FG002|Blinded Phase|Lost to Follow-up|0|||
124915137|NCT03547908|449316421|FG003|Blinded Phase|Lost to Follow-up|0|||
124915138|NCT03547908|449316418|FG000|Blinded Phase|Withdrew Consent|2|||
124915139|NCT03547908|449316419|FG001|Blinded Phase|Withdrew Consent|3|||
124915140|NCT03547908|449316420|FG002|Blinded Phase|Withdrew Consent|0|||
124915141|NCT03547908|449316421|FG003|Blinded Phase|Withdrew Consent|0|||
124915142|NCT03547908|449316418|FG000|Blinded Phase|Investigator's Discretion|2|||
124915143|NCT03547908|449316419|FG001|Blinded Phase|Investigator's Discretion|1|||
124915144|NCT03547908|449316420|FG002|Blinded Phase|Investigator's Discretion|0|||
124915145|NCT03547908|449316421|FG003|Blinded Phase|Investigator's Discretion|0|||
124915146|NCT03547908|449316418|FG000|Blinded Phase|Death|2|||
124915147|NCT03547908|449316419|FG001|Blinded Phase|Death|0|||
124915148|NCT03547908|449316420|FG002|Blinded Phase|Death|0|||
124915149|NCT03547908|449316421|FG003|Blinded Phase|Death|0|||
124915150|NCT03547908|449316418|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
124915151|NCT03547908|449316419|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
124915152|NCT03547908|449316420|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
124915153|NCT03547908|449316421|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
124915154|NCT03547908|449316418|FG000|Blinded Phase|Adverse Event|1|||
124915155|NCT03547908|449316419|FG001|Blinded Phase|Adverse Event|0|||
124915156|NCT03547908|449316420|FG002|Blinded Phase|Adverse Event|0|||
124915157|NCT03547908|449316421|FG003|Blinded Phase|Adverse Event|0|||
124915158|NCT03547908|449316418|FG000|Blinded Phase|Randomized But Never Treated|1|||
124694565|NCT01748552|448503459|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
124694566|NCT01748552|448503460|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
124694567|NCT01748552|448503461|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
124761598|NCT00794950|448751707|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
124545376|NCT00423137|447951174|FG002|Overall Study|Adverse Event Study disease worse|3|||
124694568|NCT01748552|448503450|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
124761599|NCT00794950|448751707|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
124915159|NCT03547908|449316419|FG001|Blinded Phase|Randomized But Never Treated|0|||
124915160|NCT03547908|449316420|FG002|Blinded Phase|Randomized But Never Treated|0|||
124915161|NCT03547908|449316421|FG003|Blinded Phase|Randomized But Never Treated|0|||
124915162|NCT03547908|449316418|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
124915163|NCT03547908|449316419|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
124915164|NCT03547908|449316420|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
124915165|NCT03547908|449316421|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
124915166|NCT03547908|449316418|FG000|Open-label Extension Phase|Death|0|||
124915167|NCT03547908|449316419|FG001|Open-label Extension Phase|Death|0|||
124915168|NCT03547908|449316420|FG002|Open-label Extension Phase|Death|1|||
124694569|NCT01748552|448503451|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
124694570|NCT01748552|448503452|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
124694571|NCT01748552|448503453|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
124694572|NCT01748552|448503454|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
124694573|NCT01748552|448503455|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
124694574|NCT01748552|448503456|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
124694575|NCT01748552|448503457|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
124694576|NCT01748552|448503458|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
124694577|NCT01748552|448503459|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
124694578|NCT01748552|448503460|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
124694579|NCT01748552|448503461|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
124694580|NCT00004228|448503468|FG000|Overall Study|Adverse Event|0|||
124694581|NCT00004228|448503469|FG001|Overall Study|Adverse Event|1|||
124694582|NCT00004228|448503470|FG002|Overall Study|Adverse Event|0|||
124694583|NCT00004228|448503471|FG003|Overall Study|Adverse Event|0|||
124694584|NCT00004228|448503472|FG004|Overall Study|Adverse Event|1|||
124694585|NCT00004228|448503473|FG005|Overall Study|Adverse Event|0|||
124694586|NCT00004228|448503474|FG006|Overall Study|Adverse Event|0|||
124694587|NCT00004228|448503468|FG000|Overall Study|Death|0|||
124694588|NCT00004228|448503469|FG001|Overall Study|Death|1|||
124694589|NCT00004228|448503470|FG002|Overall Study|Death|2|||
124694590|NCT00004228|448503471|FG003|Overall Study|Death|0|||
124694591|NCT00004228|448503472|FG004|Overall Study|Death|1|||
124694592|NCT00004228|448503473|FG005|Overall Study|Death|0|||
124694593|NCT00004228|448503474|FG006|Overall Study|Death|0|||
124694594|NCT00004228|448503468|FG000|Overall Study|Lack of Efficacy|1|||
124694595|NCT00004228|448503469|FG001|Overall Study|Lack of Efficacy|6|||
124694596|NCT00004228|448503470|FG002|Overall Study|Lack of Efficacy|5|||
124451497|NCT04667377|447615083|FG003|Maintenance Period|Perceived lack of efficacy|0|||
124451498|NCT04667377|447615084|FG004|Maintenance Period|Perceived lack of efficacy|1|||
124451499|NCT04667377|447615080|FG000|Maintenance Period|Adverse Event|2|||
124451500|NCT04667377|447615081|FG001|Maintenance Period|Adverse Event|8|||
124451501|NCT04667377|447615082|FG002|Maintenance Period|Adverse Event|5|||
124694597|NCT00004228|448503471|FG003|Overall Study|Lack of Efficacy|3|||
124915169|NCT03547908|449316421|FG003|Open-label Extension Phase|Death|0|||
124915170|NCT03416023|449316424|FG000|Overall Study|Exclusion criteria failure|1|||
124915171|NCT03416023|449316424|FG000|Overall Study|Withdrawal by Subject|6|||
124915172|NCT03416023|449316424|FG000|Overall Study|Explanted|7|||
124915173|NCT03416023|449316424|FG000|Overall Study|Physician Decision|1|||
124915174|NCT03416023|449316424|FG000|Overall Study|Lost to Follow-up|1|||
124915175|NCT03416023|449316424|FG000|Overall Study|Death|1|||
124915176|NCT05419505|449316425|FG000|Overall Study|Adverse Event|0|||
124915177|NCT05419505|449316426|FG001|Overall Study|Adverse Event|0|||
124915178|NCT05419505|449316427|FG002|Overall Study|Adverse Event|0|||
124915179|NCT05419505|449316428|FG003|Overall Study|Adverse Event|1|||
124915180|NCT05419505|449316429|FG004|Overall Study|Adverse Event|0|||
124915181|NCT05419505|449316430|FG005|Overall Study|Adverse Event|0|||
124915182|NCT05419505|449316431|FG006|Overall Study|Adverse Event|0|||
124915183|NCT05419505|449316432|FG007|Overall Study|Adverse Event|0|||
124915184|NCT05419505|449316425|FG000|Overall Study|Withdrawal by Subject|1|||
124915185|NCT05419505|449316426|FG001|Overall Study|Withdrawal by Subject|2|||
124915186|NCT05419505|449316427|FG002|Overall Study|Withdrawal by Subject|0|||
124915187|NCT05419505|449316428|FG003|Overall Study|Withdrawal by Subject|0|||
124915188|NCT05419505|449316429|FG004|Overall Study|Withdrawal by Subject|0|||
124915189|NCT05419505|449316430|FG005|Overall Study|Withdrawal by Subject|0|||
124694598|NCT00004228|448503472|FG004|Overall Study|Lack of Efficacy|9|||
124694599|NCT00004228|448503473|FG005|Overall Study|Lack of Efficacy|8|||
124694600|NCT00004228|448503474|FG006|Overall Study|Lack of Efficacy|4|||
124694601|NCT00004228|448503468|FG000|Overall Study|Lost to Follow-up|0|||
124694602|NCT00004228|448503469|FG001|Overall Study|Lost to Follow-up|0|||
124694603|NCT00004228|448503470|FG002|Overall Study|Lost to Follow-up|1|||
124915190|NCT05419505|449316431|FG006|Overall Study|Withdrawal by Subject|1|||
124915191|NCT05419505|449316432|FG007|Overall Study|Withdrawal by Subject|0|||
124915192|NCT05419505|449316425|FG000|Overall Study|Lost to Follow-up|2|||
124915193|NCT05419505|449316426|FG001|Overall Study|Lost to Follow-up|1|||
124915194|NCT05419505|449316427|FG002|Overall Study|Lost to Follow-up|0|||
124915195|NCT05419505|449316428|FG003|Overall Study|Lost to Follow-up|0|||
124915196|NCT05419505|449316429|FG004|Overall Study|Lost to Follow-up|1|||
124915197|NCT05419505|449316430|FG005|Overall Study|Lost to Follow-up|2|||
124915198|NCT05419505|449316431|FG006|Overall Study|Lost to Follow-up|0|||
124915199|NCT05419505|449316432|FG007|Overall Study|Lost to Follow-up|1|||
124915200|NCT03358875|449316433|FG000|Overall Study|Death|409|||
124915201|NCT03358875|449316434|FG001|Overall Study|Death|223|||
124915202|NCT03358875|449316433|FG000|Overall Study|Study Closed by Sponsor|66|||
124915203|NCT03358875|449316434|FG001|Overall Study|Study Closed by Sponsor|29|||
124915204|NCT03358875|449316433|FG000|Overall Study|Withdrawal by Subject|13|||
124915205|NCT03358875|449316434|FG001|Overall Study|Withdrawal by Subject|16|||
124915206|NCT03358875|449316433|FG000|Overall Study|Lost to Follow-up|13|||
124915207|NCT03358875|449316434|FG001|Overall Study|Lost to Follow-up|2|||
124915208|NCT03358875|449316433|FG000|Overall Study|Miscellaneous|33|||
124915209|NCT03358875|449316434|FG001|Overall Study|Miscellaneous|0|||
124915210|NCT03358875|449316433|FG000|Overall Study|Remained on Study|1|||
124915211|NCT03358875|449316434|FG001|Overall Study|Remained on Study|0|||
124915212|NCT01064440|449316439|FG000|Overall Study|Lost to Follow-up|1|||
124915213|NCT01064440|449316440|FG001|Overall Study|Lost to Follow-up|1|||
124915214|NCT01064440|449316441|FG002|Overall Study|Lost to Follow-up|1|||
124915215|NCT01064440|449316439|FG000|Overall Study|Non-compliance|0|||
124915216|NCT01064440|449316440|FG001|Overall Study|Non-compliance|1|||
124915217|NCT01064440|449316441|FG002|Overall Study|Non-compliance|0|||
124915218|NCT01064440|449316439|FG000|Overall Study|Death|1|||
124915219|NCT01064440|449316440|FG001|Overall Study|Death|0|||
124915220|NCT01064440|449316441|FG002|Overall Study|Death|1|||
124915221|NCT01064440|449316439|FG000|Overall Study|Withdrawal by Subject|0|||
124915222|NCT01064440|449316440|FG001|Overall Study|Withdrawal by Subject|1|||
124915223|NCT01064440|449316441|FG002|Overall Study|Withdrawal by Subject|1|||
124915224|NCT01064440|449316439|FG000|Overall Study|Other: amputation|1|||
124915225|NCT01064440|449316440|FG001|Overall Study|Other: amputation|0|||
124915226|NCT01064440|449316441|FG002|Overall Study|Other: amputation|0|||
124915227|NCT06194214|449316443|FG000|Overall Study|Adverse Event|1|||
124915228|NCT01631214|449316453|FG000|Overall Study|Withdrawal by Subject|276|||
124915229|NCT01631214|449316454|FG001|Overall Study|Withdrawal by Subject|290|||
124915230|NCT01631214|449316453|FG000|Overall Study|Death|113|||
124915231|NCT01631214|449316454|FG001|Overall Study|Death|106|||
124915232|NCT01631214|449316453|FG000|Overall Study|Lost to Follow-up|54|||
124915233|NCT01631214|449316454|FG001|Overall Study|Lost to Follow-up|40|||
124915234|NCT01631214|449316453|FG000|Overall Study|Adverse Event|45|||
124915235|NCT01631214|449316454|FG001|Overall Study|Adverse Event|45|||
124915236|NCT01631214|449316453|FG000|Overall Study|Other|22|||
124915237|NCT01631214|449316454|FG001|Overall Study|Other|19|||
124915238|NCT01631214|449316453|FG000|Overall Study|Noncompliance|16|||
124915239|NCT01631214|449316454|FG001|Overall Study|Noncompliance|15|||
124915240|NCT01631214|449316453|FG000|Overall Study|Requirement for Alternative Therapy|8|||
124915241|NCT01631214|449316454|FG001|Overall Study|Requirement for Alternative Therapy|3|||
124915242|NCT01631214|449316453|FG000|Overall Study|Protocol Deviation|4|||
124915243|NCT01631214|449316454|FG001|Overall Study|Protocol Deviation|3|||
124915244|NCT01631214|449316453|FG000|Overall Study|Ineligibility determined|5|||
124915245|NCT01631214|449316454|FG001|Overall Study|Ineligibility determined|2|||
124915246|NCT01631214|449316453|FG000|Overall Study|Administrative Decision|1|||
124915247|NCT01631214|449316454|FG001|Overall Study|Administrative Decision|0|||
124915248|NCT04093362|449316462|FG000|Overall Study|Study Termination|1|||
124915249|NCT04093362|449316463|FG001|Overall Study|Study Termination|1|||
124915250|NCT04093362|449316462|FG000|Overall Study|Withdrawal of Consent|1|||
124915251|NCT04093362|449316463|FG001|Overall Study|Withdrawal of Consent|0|||
124915252|NCT04093362|449316462|FG000|Overall Study|Death|1|||
124915253|NCT04093362|449316463|FG001|Overall Study|Death|3|||
124915254|NCT04093362|449316462|FG000|Overall Study|Reason not Specified|1|||
124915255|NCT04093362|449316463|FG001|Overall Study|Reason not Specified|2|||
124915256|NCT05288283|449316476|FG000|Overall Study|Study Terminated Early|1|||
124915257|NCT05288283|449316477|FG001|Overall Study|Study Terminated Early|1|||
124915258|NCT01046136|449316481|FG000|Overall Study|Withdrawal by Subject|0|||
124915259|NCT01046136|449316482|FG001|Overall Study|Withdrawal by Subject|4|||
124915260|NCT01046136|449316481|FG000|Overall Study|Physician Decision|1|||
124915261|NCT01046136|449316482|FG001|Overall Study|Physician Decision|1|||
124915262|NCT01046136|449316481|FG000|Overall Study|Lost to Follow-up|3|||
124915263|NCT01046136|449316482|FG001|Overall Study|Lost to Follow-up|3|||
124915264|NCT04759833|449316483|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
124915265|NCT04759833|449316484|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
124915266|NCT04759833|449316485|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
124915267|NCT04759833|449316486|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
124915268|NCT04759833|449316487|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
124915269|NCT04759833|449316483|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
124915270|NCT04759833|449316484|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
124915271|NCT04759833|449316485|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
124915272|NCT04759833|449316486|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
124915273|NCT04759833|449316487|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
124694604|NCT00004228|448503471|FG003|Overall Study|Lost to Follow-up|0|||
124694605|NCT00004228|448503472|FG004|Overall Study|Lost to Follow-up|0|||
124694606|NCT00004228|448503473|FG005|Overall Study|Lost to Follow-up|0|||
124694607|NCT00004228|448503474|FG006|Overall Study|Lost to Follow-up|0|||
124915274|NCT04759833|449316483|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
124915275|NCT04759833|449316484|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
124915276|NCT04759833|449316485|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
124915277|NCT04759833|449316486|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
124915278|NCT04759833|449316487|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
124915279|NCT04759833|449316483|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
124451502|NCT04667377|447615083|FG003|Maintenance Period|Adverse Event|4|||
124451503|NCT04667377|447615084|FG004|Maintenance Period|Adverse Event|1|||
124451504|NCT04667377|447615080|FG000|Maintenance Period|Adverse event: COVID infection|0|||
124451505|NCT04667377|447615081|FG001|Maintenance Period|Adverse event: COVID infection|1|||
124451506|NCT04667377|447615082|FG002|Maintenance Period|Adverse event: COVID infection|0|||
124451507|NCT04667377|447615083|FG003|Maintenance Period|Adverse event: COVID infection|0|||
124451508|NCT04667377|447615084|FG004|Maintenance Period|Adverse event: COVID infection|0|||
124451509|NCT04667377|447615080|FG000|Maintenance Period|COVID-related|0|||
124451510|NCT04667377|447615081|FG001|Maintenance Period|COVID-related|0|||
124451511|NCT04667377|447615082|FG002|Maintenance Period|COVID-related|1|||
124451512|NCT04667377|447615083|FG003|Maintenance Period|COVID-related|1|||
124451513|NCT04667377|447615084|FG004|Maintenance Period|COVID-related|0|||
124451514|NCT04667377|447615080|FG000|Maintenance Period|Protocol Violation|1|||
124451515|NCT04667377|447615081|FG001|Maintenance Period|Protocol Violation|0|||
124451516|NCT04667377|447615082|FG002|Maintenance Period|Protocol Violation|0|||
124451517|NCT04667377|447615083|FG003|Maintenance Period|Protocol Violation|0|||
124451518|NCT04667377|447615084|FG004|Maintenance Period|Protocol Violation|1|||
124451519|NCT04667377|447615080|FG000|Maintenance Period|Burden of study procedures|1|||
124694608|NCT00004228|448503468|FG000|Overall Study|Physician Decision|1|||
124694609|NCT00004228|448503469|FG001|Overall Study|Physician Decision|0|||
124451520|NCT04667377|447615081|FG001|Maintenance Period|Burden of study procedures|2|||
124451521|NCT04667377|447615082|FG002|Maintenance Period|Burden of study procedures|0|||
124694610|NCT00004228|448503470|FG002|Overall Study|Physician Decision|3|||
124694611|NCT00004228|448503471|FG003|Overall Study|Physician Decision|2|||
124694612|NCT00004228|448503472|FG004|Overall Study|Physician Decision|1|||
124694613|NCT00004228|448503473|FG005|Overall Study|Physician Decision|1|||
124694614|NCT00004228|448503474|FG006|Overall Study|Physician Decision|1|||
124694615|NCT00004228|448503468|FG000|Overall Study|Protocol Violation|0|||
124694616|NCT00004228|448503469|FG001|Overall Study|Protocol Violation|5|||
124694617|NCT00004228|448503470|FG002|Overall Study|Protocol Violation|2|||
124694618|NCT00004228|448503471|FG003|Overall Study|Protocol Violation|1|||
124694619|NCT00004228|448503472|FG004|Overall Study|Protocol Violation|1|||
124694620|NCT00004228|448503473|FG005|Overall Study|Protocol Violation|2|||
124694621|NCT00004228|448503474|FG006|Overall Study|Protocol Violation|0|||
124694622|NCT00004228|448503468|FG000|Overall Study|Withdrawal by Subject|3|||
124694623|NCT00004228|448503469|FG001|Overall Study|Withdrawal by Subject|0|||
124761600|NCT00794950|448751707|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
124451522|NCT04667377|447615083|FG003|Maintenance Period|Burden of study procedures|1|||
124451523|NCT04667377|447615084|FG004|Maintenance Period|Burden of study procedures|0|||
124451524|NCT04667377|447615080|FG000|Maintenance Period|Change of residence|0|||
124451525|NCT04667377|447615081|FG001|Maintenance Period|Change of residence|1|||
124451526|NCT04667377|447615082|FG002|Maintenance Period|Change of residence|0|||
124451527|NCT04667377|447615083|FG003|Maintenance Period|Change of residence|0|||
124451528|NCT04667377|447615084|FG004|Maintenance Period|Change of residence|1|||
124451529|NCT04667377|447615080|FG000|Maintenance Period|Missing|1|||
124451530|NCT04667377|447615081|FG001|Maintenance Period|Missing|0|||
124451531|NCT04667377|447615082|FG002|Maintenance Period|Missing|0|||
124451532|NCT04667377|447615083|FG003|Maintenance Period|Missing|0|||
124451533|NCT04667377|447615084|FG004|Maintenance Period|Missing|0|||
124451534|NCT04667377|447615080|FG000|Maintenance Period|Other than listed above|2|||
124694624|NCT00004228|448503470|FG002|Overall Study|Withdrawal by Subject|1|||
124694625|NCT00004228|448503471|FG003|Overall Study|Withdrawal by Subject|0|||
124694626|NCT00004228|448503472|FG004|Overall Study|Withdrawal by Subject|2|||
124915280|NCT04759833|449316484|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
124915281|NCT04759833|449316485|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
124915282|NCT04759833|449316486|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
124915283|NCT04759833|449316487|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
124451535|NCT04667377|447615081|FG001|Maintenance Period|Other than listed above|0|||
124451536|NCT04667377|447615082|FG002|Maintenance Period|Other than listed above|3|||
124451537|NCT04667377|447615083|FG003|Maintenance Period|Other than listed above|2|||
124694627|NCT00004228|448503473|FG005|Overall Study|Withdrawal by Subject|1|||
124694628|NCT00004228|448503474|FG006|Overall Study|Withdrawal by Subject|2|||
124694629|NCT00004228|448503468|FG000|Overall Study|Other|0|||
124694630|NCT00004228|448503469|FG001|Overall Study|Other|0|||
124915284|NCT04759833|449316483|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
124915285|NCT04759833|449316484|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
124915286|NCT04759833|449316485|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
124915287|NCT04759833|449316486|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
124915288|NCT04759833|449316487|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
124915289|NCT04759833|449316483|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
124915290|NCT04759833|449316484|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
124969515|NCT03520075|449517409|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124761601|NCT00794950|448751707|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
124761602|NCT02485704|448751708|FG000|Overall Study|Lost to Follow-up|4|||
124761603|NCT02485704|448751709|FG001|Overall Study|Lost to Follow-up|5|||
124761604|NCT02485704|448751708|FG000|Overall Study|Withdrawal by Subject|0|||
124761605|NCT02485704|448751709|FG001|Overall Study|Withdrawal by Subject|3|||
124761606|NCT02485704|448751708|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
124761607|NCT02485704|448751709|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
124761608|NCT04481243|448753433|FG000|Overall Study|Withdrawal by Subject|4|||
124761609|NCT02173769|448753435|FG000|Overall Study|Protocol Violation|4|||
124761610|NCT04388111|448753436|FG000|Overall Study|Lost to Follow-up|5|||
124761611|NCT04388111|448753437|FG001|Overall Study|Lost to Follow-up|3|||
124761612|NCT04388111|448753436|FG000|Overall Study|Adverse Event|1|||
124761613|NCT04388111|448753437|FG001|Overall Study|Adverse Event|1|||
124761614|NCT04388111|448753436|FG000|Overall Study|Protocol Violation|2|||
124761615|NCT04388111|448753437|FG001|Overall Study|Protocol Violation|4|||
124761616|NCT04388111|448753436|FG000|Overall Study|Withdrawal by Subject|1|||
124761617|NCT04388111|448753437|FG001|Overall Study|Withdrawal by Subject|0|||
124761618|NCT00928486|448753438|FG000|Overall Study|Adverse Event|2|||
124761619|NCT00928486|448753438|FG000|Overall Study|Disease Progression|7|||
124761620|NCT00928486|448753438|FG000|Overall Study|Withdrawal by Subject|1|||
124761621|NCT01342913|448753439|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
124761622|NCT01342913|448753440|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
124761623|NCT01342913|448753441|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
124761624|NCT01342913|448753439|FG000|2-week Run-in Period|Physician Decision|6|||
124761625|NCT01342913|448753440|FG001|2-week Run-in Period|Physician Decision|0|||
124761626|NCT01342913|448753441|FG002|2-week Run-in Period|Physician Decision|0|||
124761627|NCT01342913|448753439|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
124761628|NCT01342913|448753440|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
124761629|NCT01342913|448753441|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
124761630|NCT01342913|448753439|FG000|2-week Run-in Period|Adverse Event|2|||
124761631|NCT01342913|448753440|FG001|2-week Run-in Period|Adverse Event|0|||
124761632|NCT01342913|448753441|FG002|2-week Run-in Period|Adverse Event|0|||
124761633|NCT01342913|448753439|FG000|2-week Run-in Period|Protocol Violation|5|||
124761634|NCT01342913|448753440|FG001|2-week Run-in Period|Protocol Violation|0|||
124761635|NCT01342913|448753441|FG002|2-week Run-in Period|Protocol Violation|0|||
124761636|NCT01342913|448753439|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
124761637|NCT01342913|448753440|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
124761638|NCT01342913|448753441|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
124761639|NCT01342913|448753439|FG000|Double-Blind Treatment Period|Adverse Event|0|||
124761640|NCT01342913|448753440|FG001|Double-Blind Treatment Period|Adverse Event|3|||
124761641|NCT01342913|448753441|FG002|Double-Blind Treatment Period|Adverse Event|6|||
124761642|NCT01342913|448753439|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
124761643|NCT01342913|448753440|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
124761644|NCT01342913|448753441|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
124761645|NCT01342913|448753439|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
124761646|NCT01342913|448753440|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
124761647|NCT01342913|448753441|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
124761648|NCT01342913|448753439|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124761649|NCT01342913|448753440|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
124761650|NCT01342913|448753441|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
124761651|NCT01342913|448753439|FG000|Double-Blind Treatment Period|Physician Decision|0|||
124761652|NCT01342913|448753440|FG001|Double-Blind Treatment Period|Physician Decision|2|||
124761653|NCT01342913|448753441|FG002|Double-Blind Treatment Period|Physician Decision|0|||
124761654|NCT01342913|448753439|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124761655|NCT01342913|448753440|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
124761656|NCT01342913|448753441|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
124761657|NCT00387881|448753446|FG000|Overall Study|Lost to Follow-up|23|||
124761658|NCT00387881|448753447|FG001|Overall Study|Lost to Follow-up|23|||
124761659|NCT00387881|448753446|FG000|Overall Study|Protocol Violation|2|||
124761660|NCT00387881|448753447|FG001|Overall Study|Protocol Violation|12|||
124761661|NCT00387881|448753446|FG000|Overall Study|Withdrawal by Subject|15|||
124761662|NCT00387881|448753447|FG001|Overall Study|Withdrawal by Subject|18|||
124761663|NCT00387881|448753446|FG000|Overall Study|Sponsor terminated Study|0|||
124915291|NCT04759833|449316485|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
124915292|NCT04759833|449316486|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
124915293|NCT04759833|449316487|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
124915294|NCT04759833|449316483|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
124915295|NCT04759833|449316484|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
124915296|NCT04759833|449316485|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
124915297|NCT04759833|449316486|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
124451538|NCT04667377|447615084|FG004|Maintenance Period|Other than listed above|6|||
124451539|NCT04667377|447615080|FG000|Maintenance Period|Withdrawal by Subject|0|||
124451540|NCT04667377|447615081|FG001|Maintenance Period|Withdrawal by Subject|1|||
124451541|NCT04667377|447615082|FG002|Maintenance Period|Withdrawal by Subject|0|||
124451542|NCT04667377|447615083|FG003|Maintenance Period|Withdrawal by Subject|0|||
124451543|NCT04667377|447615084|FG004|Maintenance Period|Withdrawal by Subject|0|||
124451544|NCT04667377|447615080|FG000|Maintenance Period|Lost to Follow-up|1|||
124451545|NCT04667377|447615081|FG001|Maintenance Period|Lost to Follow-up|0|||
124451546|NCT04667377|447615082|FG002|Maintenance Period|Lost to Follow-up|1|||
124451547|NCT04667377|447615083|FG003|Maintenance Period|Lost to Follow-up|0|||
124451548|NCT04667377|447615084|FG004|Maintenance Period|Lost to Follow-up|1|||
124451549|NCT02428855|447615085|FG000|Overall Study|Withdrawal by Subject|2|||
124451550|NCT05418673|447615090|FG000|Overall Study|Study Terminated by Sponsor|2|||
124451551|NCT05418673|447615091|FG001|Overall Study|Study Terminated by Sponsor|4|||
124451552|NCT05418673|447615090|FG000|Overall Study|Lost to Follow-up|1|||
124451553|NCT05418673|447615091|FG001|Overall Study|Lost to Follow-up|0|||
124451554|NCT04422990|447615100|FG000|Overall Study|Withdrawal by Subject|0|||
124451555|NCT04422990|447615101|FG001|Overall Study|Withdrawal by Subject|1|||
124451556|NCT04422990|447615100|FG000|Overall Study|Travel|3|||
124451557|NCT04422990|447615101|FG001|Overall Study|Travel|0|||
124451558|NCT01490814|447615102|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
124451559|NCT01490814|447615103|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
124451560|NCT01490814|447615102|FG000|Overall Study|Physician Decision|1|||
124451561|NCT01490814|447615103|FG001|Overall Study|Physician Decision|0|||
124451562|NCT01490814|447615102|FG000|Overall Study|Withdrawal by Subject|0|||
124451563|NCT01490814|447615103|FG001|Overall Study|Withdrawal by Subject|5|||
124451564|NCT03024970|447615112|FG000|First Intervention|Adverse Event|1|||
124451565|NCT03024970|447615113|FG001|First Intervention|Adverse Event|0|||
124694631|NCT00004228|448503470|FG002|Overall Study|Other|1|||
124694632|NCT00004228|448503471|FG003|Overall Study|Other|0|||
124694633|NCT00004228|448503472|FG004|Overall Study|Other|0|||
124694634|NCT00004228|448503473|FG005|Overall Study|Other|0|||
124694635|NCT00004228|448503474|FG006|Overall Study|Other|0|||
124694636|NCT00004228|448503468|FG000|Overall Study|ineligible|4|||
124694637|NCT00004228|448503469|FG001|Overall Study|ineligible|2|||
124694638|NCT00004228|448503470|FG002|Overall Study|ineligible|4|||
124694639|NCT00004228|448503471|FG003|Overall Study|ineligible|1|||
124694640|NCT00004228|448503472|FG004|Overall Study|ineligible|1|||
124694641|NCT00004228|448503473|FG005|Overall Study|ineligible|2|||
124694642|NCT00004228|448503474|FG006|Overall Study|ineligible|5|||
124694643|NCT02255279|448503475|FG000|Overall Study|Lost to Follow-up|2|||
124694644|NCT02255279|448503476|FG001|Overall Study|Lost to Follow-up|2|||
124694645|NCT02255279|448503475|FG000|Overall Study|Protocol Violation|0|||
124694646|NCT02255279|448503476|FG001|Overall Study|Protocol Violation|1|||
124694647|NCT02255279|448503475|FG000|Overall Study|Withdrawal by Subject|3|||
124694648|NCT02255279|448503476|FG001|Overall Study|Withdrawal by Subject|6|||
124694649|NCT03607695|448503477|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
124694650|NCT03607695|448503477|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
124694651|NCT02741193|448503478|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
124694652|NCT02741193|448503478|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
124694653|NCT00527748|448503479|FG000|Overall Study|Other|3|||
124694654|NCT02533674|448503480|FG000|Dose Level I|Progressive disease|1|||
124694655|NCT02533674|448503481|FG001|Dose Level I|Progressive disease|0|||
124694656|NCT02533674|448503482|FG002|Dose Level I|Progressive disease|0|||
124694657|NCT02533674|448503483|FG003|Dose Level I|Progressive disease|0|||
124694658|NCT02533674|448503484|FG004|Dose Level I|Progressive disease|0|||
124694659|NCT02533674|448503485|FG005|Dose Level I|Progressive disease|0|||
124694660|NCT02533674|448503486|FG006|Dose Level I|Progressive disease|0|||
124694661|NCT02533674|448503487|FG007|Dose Level I|Progressive disease|0|||
124694662|NCT02533674|448503480|FG000|Dose Level I|Withdrawal by Subject|1|||
124694663|NCT02533674|448503481|FG001|Dose Level I|Withdrawal by Subject|0|||
124694664|NCT02533674|448503482|FG002|Dose Level I|Withdrawal by Subject|0|||
124451566|NCT03024970|447615112|FG000|Second Intervention|Lost to Follow-up|1|||
124451567|NCT03024970|447615113|FG001|Second Intervention|Lost to Follow-up|0|||
124451568|NCT01221727|447615117|FG000|Overall Study|Physician Decision|2|||
124694665|NCT02533674|448503483|FG003|Dose Level I|Withdrawal by Subject|0|||
124694666|NCT02533674|448503484|FG004|Dose Level I|Withdrawal by Subject|0|||
124694667|NCT02533674|448503485|FG005|Dose Level I|Withdrawal by Subject|0|||
124694668|NCT02533674|448503486|FG006|Dose Level I|Withdrawal by Subject|0|||
124694669|NCT02533674|448503487|FG007|Dose Level I|Withdrawal by Subject|0|||
124694670|NCT02533674|448503480|FG000|Dose Level I|Physician Decision|1|||
124694671|NCT02533674|448503481|FG001|Dose Level I|Physician Decision|0|||
124694672|NCT02533674|448503482|FG002|Dose Level I|Physician Decision|0|||
124694673|NCT02533674|448503483|FG003|Dose Level I|Physician Decision|0|||
124694674|NCT02533674|448503484|FG004|Dose Level I|Physician Decision|0|||
124694675|NCT02533674|448503485|FG005|Dose Level I|Physician Decision|0|||
124694676|NCT02533674|448503486|FG006|Dose Level I|Physician Decision|0|||
124694677|NCT02533674|448503487|FG007|Dose Level I|Physician Decision|0|||
124694678|NCT02533674|448503480|FG000|Dose Level I|Death|1|||
124694679|NCT02533674|448503481|FG001|Dose Level I|Death|0|||
124915298|NCT04759833|449316487|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
124915299|NCT04759833|449316483|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
124915300|NCT04759833|449316484|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
124915301|NCT04759833|449316485|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
124915302|NCT04759833|449316486|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
124915303|NCT04759833|449316487|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
124915304|NCT04759833|449316483|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
124915305|NCT04759833|449316484|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
124915306|NCT04759833|449316485|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
124915307|NCT04759833|449316486|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
124915308|NCT04759833|449316487|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
124915309|NCT04759833|449316483|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
124915310|NCT04759833|449316484|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
124915311|NCT04759833|449316485|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
124915312|NCT04759833|449316486|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
124915313|NCT04759833|449316487|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
124915314|NCT04759833|449316483|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
124915315|NCT04759833|449316484|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
124915316|NCT04759833|449316485|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
124915317|NCT04759833|449316486|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
124915318|NCT04759833|449316487|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
124915319|NCT04759833|449316483|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
124915320|NCT04759833|449316484|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
124915321|NCT04759833|449316485|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
124915322|NCT04759833|449316486|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
124915323|NCT04759833|449316487|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
124915324|NCT04759833|449316483|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
124915325|NCT04759833|449316484|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
124915326|NCT04759833|449316485|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
124915327|NCT04759833|449316486|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
124915328|NCT04759833|449316487|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
124915329|NCT03446157|449316488|FG000|Overall Study|Death|11|||
124915330|NCT03446157|449316489|FG001|Overall Study|Death|9|||
124915331|NCT03446157|449316488|FG000|Overall Study|Lost to Follow-up|0|||
124915332|NCT03446157|449316489|FG001|Overall Study|Lost to Follow-up|1|||
124915333|NCT03446157|449316488|FG000|Overall Study|Withdrawal by Subject|2|||
124915334|NCT03446157|449316489|FG001|Overall Study|Withdrawal by Subject|1|||
124915335|NCT01989455|449316492|FG000|Overall Study|Adverse Event|0|||
124915336|NCT01989455|449316493|FG001|Overall Study|Adverse Event|1|||
124915337|NCT01989455|449316494|FG002|Overall Study|Adverse Event|0|||
124915338|NCT01989455|449316495|FG003|Overall Study|Adverse Event|0|||
124915339|NCT01989455|449316496|FG004|Overall Study|Adverse Event|0|||
124915340|NCT01989455|449316492|FG000|Overall Study|Withdrawal by Subject|0|||
124915341|NCT01989455|449316493|FG001|Overall Study|Withdrawal by Subject|1|||
124915342|NCT01989455|449316494|FG002|Overall Study|Withdrawal by Subject|0|||
124761664|NCT00387881|448753447|FG001|Overall Study|Sponsor terminated Study|1|||
124694680|NCT02533674|448503482|FG002|Dose Level I|Death|0|||
124694681|NCT02533674|448503483|FG003|Dose Level I|Death|0|||
124694682|NCT02533674|448503484|FG004|Dose Level I|Death|0|||
124694683|NCT02533674|448503485|FG005|Dose Level I|Death|0|||
124694684|NCT02533674|448503486|FG006|Dose Level I|Death|0|||
124694685|NCT02533674|448503487|FG007|Dose Level I|Death|0|||
124694686|NCT02533674|448503480|FG000|Dose Level I|Never Treated|1|||
124694687|NCT02533674|448503481|FG001|Dose Level I|Never Treated|0|||
124694688|NCT02533674|448503482|FG002|Dose Level I|Never Treated|0|||
124694689|NCT02533674|448503483|FG003|Dose Level I|Never Treated|0|||
124761665|NCT00387881|448753446|FG000|Overall Study|Not eligible|6|||
124694690|NCT02533674|448503484|FG004|Dose Level I|Never Treated|0|||
124761666|NCT00387881|448753447|FG001|Overall Study|Not eligible|7|||
124915343|NCT01989455|449316495|FG003|Overall Study|Withdrawal by Subject|0|||
124915344|NCT01989455|449316496|FG004|Overall Study|Withdrawal by Subject|0|||
124915345|NCT01989455|449316492|FG000|Overall Study|Technical problems with infusion|0|||
124915346|NCT01989455|449316493|FG001|Overall Study|Technical problems with infusion|0|||
124915347|NCT01989455|449316494|FG002|Overall Study|Technical problems with infusion|1|||
124915348|NCT01989455|449316495|FG003|Overall Study|Technical problems with infusion|0|||
124915349|NCT01989455|449316496|FG004|Overall Study|Technical problems with infusion|1|||
124451569|NCT01221727|447615118|FG001|Overall Study|Physician Decision|0|||
124915350|NCT00632203|449316497|FG000|Overall Study|Did not start study treatment|1|||
124915351|NCT00632203|449316498|FG001|Overall Study|Did not start study treatment|0|||
124915352|NCT04238247|449316501|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
124915353|NCT04238247|449316502|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
124915354|NCT04238247|449316503|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
124915355|NCT04238247|449316504|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
124915356|NCT04238247|449316501|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
124915357|NCT04238247|449316502|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
124915358|NCT04238247|449316503|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
124915359|NCT04238247|449316504|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
124915360|NCT04238247|449316501|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
124915361|NCT04238247|449316502|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
124915362|NCT04238247|449316503|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
124451570|NCT01221727|447615117|FG000|Overall Study|Withdrawal by Subject|1|||
124451571|NCT01221727|447615118|FG001|Overall Study|Withdrawal by Subject|1|||
124451572|NCT00590044|447615119|FG000|Overall Study|Withdrawal by Subject|2|||
124451573|NCT00590044|447615120|FG001|Overall Study|Withdrawal by Subject|2|||
124451574|NCT00590044|447615119|FG000|Overall Study|wrong insulin arm assigned|1|||
124451575|NCT00590044|447615120|FG001|Overall Study|wrong insulin arm assigned|0|||
124694691|NCT02533674|448503485|FG005|Dose Level I|Never Treated|0|||
124694692|NCT02533674|448503486|FG006|Dose Level I|Never Treated|0|||
124694693|NCT02533674|448503487|FG007|Dose Level I|Never Treated|0|||
124694694|NCT02533674|448503480|FG000|Dose Level II|Progressive disease|0|||
124694695|NCT02533674|448503481|FG001|Dose Level II|Progressive disease|3|||
124694696|NCT02533674|448503482|FG002|Dose Level II|Progressive disease|0|||
124694697|NCT02533674|448503483|FG003|Dose Level II|Progressive disease|0|||
124694698|NCT02533674|448503484|FG004|Dose Level II|Progressive disease|0|||
124694699|NCT02533674|448503485|FG005|Dose Level II|Progressive disease|0|||
124694700|NCT02533674|448503486|FG006|Dose Level II|Progressive disease|0|||
124694701|NCT02533674|448503487|FG007|Dose Level II|Progressive disease|0|||
124694702|NCT02533674|448503480|FG000|Dose Level II|Withdrawal by Subject|0|||
124694703|NCT02533674|448503481|FG001|Dose Level II|Withdrawal by Subject|1|||
124694704|NCT02533674|448503482|FG002|Dose Level II|Withdrawal by Subject|0|||
124694705|NCT02533674|448503483|FG003|Dose Level II|Withdrawal by Subject|0|||
124694706|NCT02533674|448503484|FG004|Dose Level II|Withdrawal by Subject|0|||
124694707|NCT02533674|448503485|FG005|Dose Level II|Withdrawal by Subject|0|||
124694708|NCT02533674|448503486|FG006|Dose Level II|Withdrawal by Subject|0|||
124694709|NCT02533674|448503487|FG007|Dose Level II|Withdrawal by Subject|0|||
124694710|NCT02533674|448503480|FG000|Dose Level II|Treatment-related AE|0|||
124694711|NCT02533674|448503481|FG001|Dose Level II|Treatment-related AE|1|||
124694712|NCT02533674|448503482|FG002|Dose Level II|Treatment-related AE|0|||
124694713|NCT02533674|448503483|FG003|Dose Level II|Treatment-related AE|0|||
124694714|NCT02533674|448503484|FG004|Dose Level II|Treatment-related AE|0|||
124694715|NCT02533674|448503485|FG005|Dose Level II|Treatment-related AE|0|||
124694716|NCT02533674|448503486|FG006|Dose Level II|Treatment-related AE|0|||
124694717|NCT02533674|448503487|FG007|Dose Level II|Treatment-related AE|0|||
124694718|NCT02533674|448503480|FG000|Dose Level II|Physician Decision|0|||
124694719|NCT02533674|448503481|FG001|Dose Level II|Physician Decision|1|||
124694720|NCT02533674|448503482|FG002|Dose Level II|Physician Decision|0|||
124694721|NCT02533674|448503483|FG003|Dose Level II|Physician Decision|0|||
124694722|NCT02533674|448503484|FG004|Dose Level II|Physician Decision|0|||
124694723|NCT02533674|448503485|FG005|Dose Level II|Physician Decision|0|||
124694724|NCT02533674|448503486|FG006|Dose Level II|Physician Decision|0|||
124694725|NCT02533674|448503487|FG007|Dose Level II|Physician Decision|0|||
124694726|NCT02533674|448503480|FG000|Dose Level II|Non-treatment-related AE|0|||
124694727|NCT02533674|448503481|FG001|Dose Level II|Non-treatment-related AE|1|||
124694728|NCT02533674|448503482|FG002|Dose Level II|Non-treatment-related AE|0|||
124915363|NCT04238247|449316504|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
124915364|NCT04238247|449316501|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
124451576|NCT00590044|447615119|FG000|Overall Study|Protocol Violation|1|||
124451577|NCT00590044|447615120|FG001|Overall Study|Protocol Violation|0|||
124694729|NCT02533674|448503483|FG003|Dose Level II|Non-treatment-related AE|0|||
124694730|NCT02533674|448503484|FG004|Dose Level II|Non-treatment-related AE|0|||
124694731|NCT02533674|448503485|FG005|Dose Level II|Non-treatment-related AE|0|||
124694732|NCT02533674|448503486|FG006|Dose Level II|Non-treatment-related AE|0|||
124694733|NCT02533674|448503487|FG007|Dose Level II|Non-treatment-related AE|0|||
124915365|NCT04238247|449316502|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
124915366|NCT04238247|449316503|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
124915367|NCT04238247|449316504|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
124915368|NCT05064735|449316505|FG000|Overall Study|Withdrawal by Subject|7|||
124915369|NCT05064735|449316506|FG001|Overall Study|Withdrawal by Subject|8|||
124915370|NCT05064735|449316505|FG000|Overall Study|Lost to Follow-up|7|||
124915371|NCT05064735|449316506|FG001|Overall Study|Lost to Follow-up|2|||
124915372|NCT05064735|449316505|FG000|Overall Study|Physician Decision|2|||
124915373|NCT05064735|449316506|FG001|Overall Study|Physician Decision|1|||
124915374|NCT05064735|449316505|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
124915375|NCT05064735|449316506|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
124915376|NCT05064735|449316505|FG000|Overall Study|Site Closure|7|||
124915377|NCT05064735|449316506|FG001|Overall Study|Site Closure|2|||
124915378|NCT02886286|449316507|FG000|Overall Study|pump motor stall|0|||
124915379|NCT02886286|449316508|FG001|Overall Study|pump motor stall|1|||
124915380|NCT02376790|449316509|FG000|Overall Study|Withdrawal by Subject|43|||
124915381|NCT02376790|449316510|FG001|Overall Study|Withdrawal by Subject|36|||
124915382|NCT02376790|449316511|FG002|Overall Study|Withdrawal by Subject|37|||
124915383|NCT02376790|449316509|FG000|Overall Study|Decision by Sponsor|2|||
124915384|NCT02376790|449316510|FG001|Overall Study|Decision by Sponsor|1|||
124915385|NCT02376790|449316511|FG002|Overall Study|Decision by Sponsor|4|||
124915386|NCT02376790|449316509|FG000|Overall Study|Lost to Follow-up|15|||
124915387|NCT02376790|449316510|FG001|Overall Study|Lost to Follow-up|10|||
124915388|NCT02376790|449316511|FG002|Overall Study|Lost to Follow-up|12|||
124915389|NCT03014453|449316512|FG000|Overall Study|Lost to Follow-up|12|||
124915390|NCT03014453|449316512|FG000|Overall Study|Discontinued GER|3|||
124915391|NCT03014453|449316512|FG000|Overall Study|Excluded|19|||
124915392|NCT03014453|449316512|FG000|Overall Study|Refused to take part in|37|||
124915393|NCT00901901|449316513|FG000|Treatment Period|Adverse Event|120|||
124915394|NCT00901901|449316514|FG001|Treatment Period|Adverse Event|128|||
124694734|NCT02533674|448503480|FG000|Dose Level III|Progressive disease|0|||
124694735|NCT02533674|448503481|FG001|Dose Level III|Progressive disease|0|||
124694736|NCT02533674|448503482|FG002|Dose Level III|Progressive disease|2|||
124694737|NCT02533674|448503483|FG003|Dose Level III|Progressive disease|0|||
124694738|NCT02533674|448503484|FG004|Dose Level III|Progressive disease|0|||
124694739|NCT02533674|448503485|FG005|Dose Level III|Progressive disease|0|||
124694740|NCT02533674|448503486|FG006|Dose Level III|Progressive disease|0|||
124694741|NCT02533674|448503487|FG007|Dose Level III|Progressive disease|0|||
124694742|NCT02533674|448503480|FG000|Dose Level III|Withdrawal by Subject|0|||
124694743|NCT02533674|448503481|FG001|Dose Level III|Withdrawal by Subject|0|||
124694744|NCT02533674|448503482|FG002|Dose Level III|Withdrawal by Subject|1|||
124694745|NCT02533674|448503483|FG003|Dose Level III|Withdrawal by Subject|0|||
124694746|NCT02533674|448503484|FG004|Dose Level III|Withdrawal by Subject|0|||
124694747|NCT02533674|448503485|FG005|Dose Level III|Withdrawal by Subject|0|||
124694748|NCT02533674|448503486|FG006|Dose Level III|Withdrawal by Subject|0|||
124694749|NCT02533674|448503487|FG007|Dose Level III|Withdrawal by Subject|0|||
124694750|NCT02533674|448503480|FG000|Dose Level III|Treatment-related AE|0|||
124694751|NCT02533674|448503481|FG001|Dose Level III|Treatment-related AE|0|||
124694752|NCT02533674|448503482|FG002|Dose Level III|Treatment-related AE|1|||
124694753|NCT02533674|448503483|FG003|Dose Level III|Treatment-related AE|0|||
124694754|NCT02533674|448503484|FG004|Dose Level III|Treatment-related AE|0|||
124694755|NCT02533674|448503485|FG005|Dose Level III|Treatment-related AE|0|||
124915395|NCT00901901|449316513|FG000|Treatment Period|Withdrawal by Subject|26|||
124915396|NCT00901901|449316514|FG001|Treatment Period|Withdrawal by Subject|24|||
124915397|NCT00901901|449316513|FG000|Treatment Period|Physician Decision|2|||
124915398|NCT00901901|449316514|FG001|Treatment Period|Physician Decision|2|||
124915399|NCT00901901|449316513|FG000|Treatment Period|Lost to Follow-up|3|||
124915400|NCT00901901|449316514|FG001|Treatment Period|Lost to Follow-up|5|||
124915401|NCT00901901|449316513|FG000|Treatment Period|Noncompliance with study medication|4|||
124915402|NCT00901901|449316514|FG001|Treatment Period|Noncompliance with study medication|1|||
124915403|NCT00901901|449316513|FG000|Treatment Period|Missing|1|||
124915404|NCT00901901|449316514|FG001|Treatment Period|Missing|0|||
124915405|NCT00901901|449316513|FG000|Treatment Period|Never treated|0|||
124761667|NCT00387881|448753446|FG000|Overall Study|No opportunity to treat headache|32|||
124915406|NCT00901901|449316514|FG001|Treatment Period|Never treated|3|||
124451578|NCT02790138|447615121|FG000|Overall Study|Adverse Event|5|||
124451579|NCT02790138|447615122|FG001|Overall Study|Adverse Event|2|||
124694756|NCT02533674|448503486|FG006|Dose Level III|Treatment-related AE|0|||
124694757|NCT02533674|448503487|FG007|Dose Level III|Treatment-related AE|0|||
124694758|NCT02533674|448503480|FG000|Dose Level IV|Progressive disease|0|||
124694759|NCT02533674|448503481|FG001|Dose Level IV|Progressive disease|0|||
124694760|NCT02533674|448503482|FG002|Dose Level IV|Progressive disease|0|||
124915407|NCT00901901|449316513|FG000|Treatment Period|Protocol driven decision point|0|||
124915408|NCT00901901|449316514|FG001|Treatment Period|Protocol driven decision point|2|||
124915409|NCT00901901|449316513|FG000|Treatment Period|Study terminated by sponsor|2|||
124915410|NCT00901901|449316514|FG001|Treatment Period|Study terminated by sponsor|0|||
124915411|NCT00901901|449316513|FG000|Treatment Period|Protocol Violation|5|||
124915412|NCT00901901|449316514|FG001|Treatment Period|Protocol Violation|9|||
124915413|NCT00901901|449316513|FG000|Treatment Period|Switch to commercial drug|1|||
124915414|NCT00901901|449316514|FG001|Treatment Period|Switch to commercial drug|1|||
124915415|NCT00901901|449316513|FG000|Treatment Period|Transfer to treatment continuation study|5|||
124915416|NCT00901901|449316514|FG001|Treatment Period|Transfer to treatment continuation study|2|||
124915417|NCT00901901|449316513|FG000|Follow-up Period|Death|181|||
124915418|NCT00901901|449316514|FG001|Follow-up Period|Death|208|||
124915419|NCT00901901|449316513|FG000|Follow-up Period|Protocol driven decision point|47|||
124915420|NCT00901901|449316514|FG001|Follow-up Period|Protocol driven decision point|36|||
124915421|NCT00901901|449316513|FG000|Follow-up Period|Withdrawal by Subject|6|||
124915422|NCT00901901|449316514|FG001|Follow-up Period|Withdrawal by Subject|9|||
124915423|NCT00901901|449316513|FG000|Follow-up Period|Lost to Follow-up|12|||
124915424|NCT00901901|449316514|FG001|Follow-up Period|Lost to Follow-up|8|||
124915425|NCT00901901|449316513|FG000|Follow-up Period|Missing|94|||
124915426|NCT00901901|449316514|FG001|Follow-up Period|Missing|80|||
124915427|NCT02272816|449316515|FG000|Overall Study|Adverse Event|1|||
124915428|NCT01136876|449316516|FG000|Overall Study|Lost to Follow-up|0|||
124915429|NCT01136876|449316517|FG001|Overall Study|Lost to Follow-up|1|||
124915430|NCT01136876|449316516|FG000|Overall Study|Physician Decision|3|||
124915431|NCT01136876|449316517|FG001|Overall Study|Physician Decision|5|||
124915432|NCT01136876|449316516|FG000|Overall Study|Missing NGAL measurement|2|||
124915433|NCT01136876|449316517|FG001|Overall Study|Missing NGAL measurement|5|||
124915434|NCT00976937|449316520|FG000|Overall Study|Adverse Event|4|||
124915435|NCT00976937|449316521|FG001|Overall Study|Adverse Event|5|||
124915436|NCT00976937|449316520|FG000|Overall Study|Lost to Follow-up|2|||
124915437|NCT00976937|449316521|FG001|Overall Study|Lost to Follow-up|1|||
124915438|NCT00976937|449316520|FG000|Overall Study|Withdrawal by Subject|5|||
124915439|NCT00976937|449316521|FG001|Overall Study|Withdrawal by Subject|3|||
124915440|NCT00976937|449316520|FG000|Overall Study|Poor compliance to protocol|3|||
124915441|NCT00976937|449316521|FG001|Overall Study|Poor compliance to protocol|0|||
124915442|NCT00976937|449316520|FG000|Overall Study|Personal and Familial Reason|2|||
124915443|NCT00976937|449316521|FG001|Overall Study|Personal and Familial Reason|2|||
124915444|NCT01011946|449316522|FG000|Overall Study|Transferred to another hospital|2|||
124915445|NCT01011946|449316522|FG000|Overall Study|No pathological lab value|1|||
124915446|NCT04820686|449316523|FG000|Overall Study|Withdrawal by Subject|5|||
124915447|NCT04820686|449316524|FG001|Overall Study|Withdrawal by Subject|2|||
124915448|NCT04820686|449316525|FG002|Overall Study|Withdrawal by Subject|3|||
124915449|NCT04820686|449316523|FG000|Overall Study|Study Termination|25|||
124915450|NCT04820686|449316524|FG001|Overall Study|Study Termination|13|||
124915451|NCT04820686|449316525|FG002|Overall Study|Study Termination|14|||
124915452|NCT04820686|449316523|FG000|Overall Study|Adverse Event|0|||
124915453|NCT04820686|449316524|FG001|Overall Study|Adverse Event|1|||
124915454|NCT04820686|449316525|FG002|Overall Study|Adverse Event|0|||
124915455|NCT01424670|449316526|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
124915456|NCT01424670|449316527|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
124915457|NCT01424670|449316526|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
124915458|NCT01424670|449316527|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
124915459|NCT01424670|449316526|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
124915460|NCT01424670|449316527|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
124915461|NCT01424670|449316526|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
124915462|NCT01424670|449316527|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
124915463|NCT01424670|449316526|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
124915464|NCT01424670|449316527|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
124915465|NCT01424670|449316526|FG000|Continuation Period|Adverse Event|13|||
124915466|NCT01424670|449316527|FG001|Continuation Period|Adverse Event|5|||
124915467|NCT01424670|449316526|FG000|Continuation Period|Lost to Follow-up|2|||
124915468|NCT01424670|449316527|FG001|Continuation Period|Lost to Follow-up|0|||
124915469|NCT01424670|449316526|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
124915470|NCT01424670|449316527|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
124915471|NCT01424670|449316526|FG000|Continuation Period|Physician Decision|5|||
124915472|NCT01424670|449316527|FG001|Continuation Period|Physician Decision|4|||
124915473|NCT01424670|449316526|FG000|Continuation Period|Withdrawal by Subject|13|||
124761668|NCT00387881|448753447|FG001|Overall Study|No opportunity to treat headache|34|||
124915474|NCT01424670|449316527|FG001|Continuation Period|Withdrawal by Subject|4|||
124915475|NCT02891915|449316530|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
124915476|NCT02891915|449316531|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
124915477|NCT02891915|449316530|FG000|Overall Study|Withdrawal by Subject|3|||
124915478|NCT02891915|449316531|FG001|Overall Study|Withdrawal by Subject|3|||
124915479|NCT02891915|449316530|FG000|Overall Study|Became Ineligible After Enrollment|2|||
124915480|NCT02891915|449316531|FG001|Overall Study|Became Ineligible After Enrollment|1|||
124915481|NCT02891915|449316530|FG000|Overall Study|Lost to Follow-up|1|||
124915482|NCT02891915|449316531|FG001|Overall Study|Lost to Follow-up|4|||
124915483|NCT02891915|449316530|FG000|Overall Study|Physician Decision|1|||
124915484|NCT02891915|449316531|FG001|Overall Study|Physician Decision|0|||
124915485|NCT00709098|449316532|FG000|Double-blind Period|Withdrawal of consent|3|||
124915486|NCT00709098|449316533|FG001|Double-blind Period|Withdrawal of consent|3|||
124915487|NCT00709098|449316534|FG002|Double-blind Period|Withdrawal of consent|0|||
124915488|NCT00709098|449316532|FG000|Double-blind Period|Administrative reason|1|||
124915489|NCT00709098|449316533|FG001|Double-blind Period|Administrative reason|3|||
124915490|NCT00709098|449316534|FG002|Double-blind Period|Administrative reason|0|||
124915491|NCT00709098|449316532|FG000|Double-blind Period|Death|1|||
124915492|NCT00709098|449316533|FG001|Double-blind Period|Death|1|||
124915493|NCT00709098|449316534|FG002|Double-blind Period|Death|0|||
124915494|NCT00709098|449316532|FG000|Double-blind Period|Lost to Follow-up|1|||
124915495|NCT00709098|449316533|FG001|Double-blind Period|Lost to Follow-up|1|||
124915496|NCT00709098|449316534|FG002|Double-blind Period|Lost to Follow-up|0|||
124915497|NCT00709098|449316532|FG000|Open-label Period|Withdrawal of consent|0|||
124451580|NCT02790138|447615121|FG000|Overall Study|Significant Protocol Deviation|0|||
124451581|NCT02790138|447615122|FG001|Overall Study|Significant Protocol Deviation|1|||
124451582|NCT02790138|447615121|FG000|Overall Study|Lost to Follow-up|1|||
124451583|NCT02790138|447615122|FG001|Overall Study|Lost to Follow-up|0|||
124451584|NCT02790138|447615121|FG000|Overall Study|Voluntary Withdrawal|8|||
124451585|NCT02790138|447615122|FG001|Overall Study|Voluntary Withdrawal|9|||
124451586|NCT02790138|447615121|FG000|Overall Study|Lack of Efficacy|6|||
124451587|NCT02790138|447615122|FG001|Overall Study|Lack of Efficacy|7|||
124451588|NCT02790138|447615121|FG000|Overall Study|Reason not Specified|1|||
124451589|NCT02790138|447615122|FG001|Overall Study|Reason not Specified|0|||
124451590|NCT03199040|447615123|FG000|Overall Study|Lack of Efficacy|2|||
124451591|NCT03199040|447615124|FG001|Overall Study|Lack of Efficacy|0|||
124694761|NCT02533674|448503483|FG003|Dose Level IV|Progressive disease|3|||
124694762|NCT02533674|448503484|FG004|Dose Level IV|Progressive disease|0|||
124694763|NCT02533674|448503485|FG005|Dose Level IV|Progressive disease|0|||
124694764|NCT02533674|448503486|FG006|Dose Level IV|Progressive disease|0|||
124694765|NCT02533674|448503487|FG007|Dose Level IV|Progressive disease|0|||
124694766|NCT02533674|448503480|FG000|Dose Level IV|Withdrawal by Subject|0|||
124694767|NCT02533674|448503481|FG001|Dose Level IV|Withdrawal by Subject|0|||
124694768|NCT02533674|448503482|FG002|Dose Level IV|Withdrawal by Subject|0|||
124694769|NCT02533674|448503483|FG003|Dose Level IV|Withdrawal by Subject|1|||
124694770|NCT02533674|448503484|FG004|Dose Level IV|Withdrawal by Subject|0|||
124694771|NCT02533674|448503485|FG005|Dose Level IV|Withdrawal by Subject|0|||
124694772|NCT02533674|448503486|FG006|Dose Level IV|Withdrawal by Subject|0|||
124694773|NCT02533674|448503487|FG007|Dose Level IV|Withdrawal by Subject|0|||
124694774|NCT02533674|448503480|FG000|Dose Level IV|Physician Decision|0|||
124694775|NCT02533674|448503481|FG001|Dose Level IV|Physician Decision|0|||
124694776|NCT02533674|448503482|FG002|Dose Level IV|Physician Decision|0|||
124694777|NCT02533674|448503483|FG003|Dose Level IV|Physician Decision|1|||
124694778|NCT02533674|448503484|FG004|Dose Level IV|Physician Decision|0|||
124694779|NCT02533674|448503485|FG005|Dose Level IV|Physician Decision|0|||
124694780|NCT02533674|448503486|FG006|Dose Level IV|Physician Decision|0|||
124915498|NCT00709098|449316533|FG001|Open-label Period|Withdrawal of consent|0|||
124915499|NCT00709098|449316534|FG002|Open-label Period|Withdrawal of consent|7|||
124915500|NCT00709098|449316532|FG000|Open-label Period|Administrative reason|0|||
124915501|NCT00709098|449316533|FG001|Open-label Period|Administrative reason|0|||
124915502|NCT00709098|449316534|FG002|Open-label Period|Administrative reason|5|||
124915503|NCT00709098|449316532|FG000|Open-label Period|Death|0|||
124451592|NCT03199040|447615123|FG000|Overall Study|Withdrawal by Subject|2|||
124451593|NCT03199040|447615124|FG001|Overall Study|Withdrawal by Subject|0|||
124451594|NCT03199040|447615123|FG000|Overall Study|Adverse Event|0|||
124451595|NCT03199040|447615124|FG001|Overall Study|Adverse Event|1|||
124451596|NCT03199040|447615123|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
124694781|NCT02533674|448503487|FG007|Dose Level IV|Physician Decision|0|||
124694782|NCT02533674|448503480|FG000|Dose Level V|Progressive disease|0|||
124694783|NCT02533674|448503481|FG001|Dose Level V|Progressive disease|0|||
124915504|NCT00709098|449316533|FG001|Open-label Period|Death|0|||
124915505|NCT00709098|449316534|FG002|Open-label Period|Death|1|||
124915506|NCT00709098|449316532|FG000|Open-label Period|Lost to Follow-up|0|||
124915507|NCT00709098|449316533|FG001|Open-label Period|Lost to Follow-up|0|||
124451597|NCT03199040|447615124|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
124451598|NCT01786603|447615125|FG000|Overall Study|Death|5|||
124694784|NCT02533674|448503482|FG002|Dose Level V|Progressive disease|0|||
124694785|NCT02533674|448503483|FG003|Dose Level V|Progressive disease|0|||
124694786|NCT02533674|448503484|FG004|Dose Level V|Progressive disease|3|||
124694787|NCT02533674|448503485|FG005|Dose Level V|Progressive disease|0|||
124451599|NCT01786603|447615126|FG001|Overall Study|Death|1|||
124915508|NCT00709098|449316534|FG002|Open-label Period|Lost to Follow-up|1|||
124915509|NCT03481816|449316536|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
124915510|NCT03481816|449316537|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
124694788|NCT02533674|448503486|FG006|Dose Level V|Progressive disease|0|||
124694789|NCT02533674|448503487|FG007|Dose Level V|Progressive disease|0|||
124694790|NCT02533674|448503480|FG000|Dose Level V|Withdrawal by Subject|0|||
124694791|NCT02533674|448503481|FG001|Dose Level V|Withdrawal by Subject|0|||
124915511|NCT03481816|449316536|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
124915512|NCT03481816|449316537|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
124915513|NCT03481816|449316536|FG000|Dose Expansion|Withdrawal by Subject|0|||
124915514|NCT03481816|449316537|FG001|Dose Expansion|Withdrawal by Subject|2|||
124451600|NCT01786603|447615125|FG000|Overall Study|Adverse Event|6|||
124451601|NCT01786603|447615126|FG001|Overall Study|Adverse Event|2|||
124451602|NCT01786603|447615125|FG000|Overall Study|Physician decision to withdraw|6|||
124451603|NCT01786603|447615126|FG001|Overall Study|Physician decision to withdraw|7|||
124694792|NCT02533674|448503482|FG002|Dose Level V|Withdrawal by Subject|0|||
124694793|NCT02533674|448503483|FG003|Dose Level V|Withdrawal by Subject|0|||
124694794|NCT02533674|448503484|FG004|Dose Level V|Withdrawal by Subject|1|||
124694795|NCT02533674|448503485|FG005|Dose Level V|Withdrawal by Subject|0|||
124694796|NCT02533674|448503486|FG006|Dose Level V|Withdrawal by Subject|0|||
124694797|NCT02533674|448503487|FG007|Dose Level V|Withdrawal by Subject|0|||
124694798|NCT02533674|448503480|FG000|Dose Level V|Physician Decision|0|||
124694799|NCT02533674|448503481|FG001|Dose Level V|Physician Decision|0|||
124694800|NCT02533674|448503482|FG002|Dose Level V|Physician Decision|0|||
124694801|NCT02533674|448503483|FG003|Dose Level V|Physician Decision|0|||
124694802|NCT02533674|448503484|FG004|Dose Level V|Physician Decision|1|||
124694803|NCT02533674|448503485|FG005|Dose Level V|Physician Decision|0|||
124694804|NCT02533674|448503486|FG006|Dose Level V|Physician Decision|0|||
124694805|NCT02533674|448503487|FG007|Dose Level V|Physician Decision|0|||
124694806|NCT02533674|448503480|FG000|Dose Level VI|Progressive disease|0|||
124694807|NCT02533674|448503481|FG001|Dose Level VI|Progressive disease|0|||
124694808|NCT02533674|448503482|FG002|Dose Level VI|Progressive disease|0|||
124694809|NCT02533674|448503483|FG003|Dose Level VI|Progressive disease|0|||
124694810|NCT02533674|448503484|FG004|Dose Level VI|Progressive disease|0|||
124694811|NCT02533674|448503485|FG005|Dose Level VI|Progressive disease|7|||
124694812|NCT02533674|448503486|FG006|Dose Level VI|Progressive disease|0|||
124694813|NCT02533674|448503487|FG007|Dose Level VI|Progressive disease|0|||
124694814|NCT02533674|448503480|FG000|Dose Level VI|Withdrawal by Subject|0|||
124694815|NCT02533674|448503481|FG001|Dose Level VI|Withdrawal by Subject|0|||
124694816|NCT02533674|448503482|FG002|Dose Level VI|Withdrawal by Subject|0|||
124694817|NCT02533674|448503483|FG003|Dose Level VI|Withdrawal by Subject|0|||
124694818|NCT02533674|448503484|FG004|Dose Level VI|Withdrawal by Subject|0|||
124694819|NCT02533674|448503485|FG005|Dose Level VI|Withdrawal by Subject|1|||
124451604|NCT01786603|447615125|FG000|Overall Study|Lost to Follow-up|1|||
124451605|NCT01786603|447615126|FG001|Overall Study|Lost to Follow-up|2|||
124451606|NCT01226459|447615127|FG000|Overall Study|Adverse Event|2|||
124451607|NCT01226459|447615128|FG001|Overall Study|Adverse Event|8|||
124451608|NCT01226459|447615127|FG000|Overall Study|Protocol Violation|4|||
124451609|NCT01226459|447615128|FG001|Overall Study|Protocol Violation|3|||
124451610|NCT01226459|447615127|FG000|Overall Study|Withdrawal by Subject|10|||
124451611|NCT01226459|447615128|FG001|Overall Study|Withdrawal by Subject|13|||
124451612|NCT01226459|447615127|FG000|Overall Study|Lost to Follow-up|4|||
124451613|NCT01226459|447615128|FG001|Overall Study|Lost to Follow-up|8|||
124451614|NCT01226459|447615127|FG000|Overall Study|Pregnancy|1|||
124451615|NCT01226459|447615128|FG001|Overall Study|Pregnancy|0|||
124451616|NCT00474708|447615129|FG000|Overall Study|Lack of Efficacy|11|||
124451617|NCT00474708|447615130|FG001|Overall Study|Lack of Efficacy|5|||
124451618|NCT00474708|447615129|FG000|Overall Study|Suicide ideation/behavior|0|||
124451619|NCT00474708|447615130|FG001|Overall Study|Suicide ideation/behavior|1|||
124451620|NCT00474708|447615129|FG000|Overall Study|Withdrawal by Subject|7|||
124451621|NCT00474708|447615130|FG001|Overall Study|Withdrawal by Subject|0|||
124694820|NCT02533674|448503486|FG006|Dose Level VI|Withdrawal by Subject|0|||
124694821|NCT02533674|448503487|FG007|Dose Level VI|Withdrawal by Subject|0|||
124694822|NCT02533674|448503480|FG000|Dose Level VI|Treatment-related AE|0|||
124915515|NCT03481816|449316536|FG000|Dose Expansion|Physician Decision|0|||
124694823|NCT02533674|448503481|FG001|Dose Level VI|Treatment-related AE|0|||
124451622|NCT00474708|447615129|FG000|Overall Study|Lack of compliance|12|||
124451623|NCT00474708|447615130|FG001|Overall Study|Lack of compliance|4|||
124451624|NCT00474708|447615129|FG000|Overall Study|Lost to Follow-up|18|||
124451625|NCT00474708|447615130|FG001|Overall Study|Lost to Follow-up|9|||
124451626|NCT00474708|447615129|FG000|Overall Study|Physician Decision|9|||
124451627|NCT00474708|447615130|FG001|Overall Study|Physician Decision|6|||
124451628|NCT03700320|447615131|FG000|Overall Study|Adverse Event|5|||
124451629|NCT03700320|447615132|FG001|Overall Study|Adverse Event|31|||
124451630|NCT03700320|447615131|FG000|Overall Study|Lack of Efficacy|2|||
124694824|NCT02533674|448503482|FG002|Dose Level VI|Treatment-related AE|0|||
124694825|NCT02533674|448503483|FG003|Dose Level VI|Treatment-related AE|0|||
124694826|NCT02533674|448503484|FG004|Dose Level VI|Treatment-related AE|0|||
124694827|NCT02533674|448503485|FG005|Dose Level VI|Treatment-related AE|1|||
124694828|NCT02533674|448503486|FG006|Dose Level VI|Treatment-related AE|0|||
124694829|NCT02533674|448503487|FG007|Dose Level VI|Treatment-related AE|0|||
124694830|NCT02533674|448503480|FG000|Dose Level VII|Progressive disease|0|||
124694831|NCT02533674|448503481|FG001|Dose Level VII|Progressive disease|0|||
124694832|NCT02533674|448503482|FG002|Dose Level VII|Progressive disease|0|||
124915516|NCT03481816|449316537|FG001|Dose Expansion|Physician Decision|5|||
124915517|NCT01091168|449316540|FG000|Overall Study|Progressive disease|250|||
124915518|NCT01091168|449316541|FG001|Overall Study|Progressive disease|234|||
124915519|NCT01091168|449316540|FG000|Overall Study|Adverse Event|21|||
124915520|NCT01091168|449316541|FG001|Overall Study|Adverse Event|24|||
124915521|NCT01091168|449316540|FG000|Overall Study|Lost to Follow-up|0|||
124915522|NCT01091168|449316541|FG001|Overall Study|Lost to Follow-up|1|||
124694833|NCT02533674|448503483|FG003|Dose Level VII|Progressive disease|0|||
124694834|NCT02533674|448503484|FG004|Dose Level VII|Progressive disease|0|||
124915523|NCT01091168|449316540|FG000|Overall Study|Physician, patient's decision, other|27|||
124915524|NCT01091168|449316541|FG001|Overall Study|Physician, patient's decision, other|37|||
124915525|NCT03582722|449316544|FG000|Overall Study|Lost to Follow-up|1|||
124915526|NCT03582722|449316545|FG001|Overall Study|Lost to Follow-up|4|||
124915527|NCT03582722|449316544|FG000|Overall Study|Withdrawal by Subject|3|||
124915528|NCT03582722|449316545|FG001|Overall Study|Withdrawal by Subject|3|||
124915529|NCT06024174|449316546|FG000|Overall Study|Other Reasons|1|||
124915530|NCT06024174|449316546|FG000|Overall Study|Study terminated by Sponsor|4|||
124915531|NCT04567615|449316547|FG000|Randomization|Participant withdrew consent|1|||
124915532|NCT04567615|449316548|FG001|Randomization|Participant withdrew consent|0|||
124915533|NCT04567615|449316549|FG002|Randomization|Participant withdrew consent|0|||
124915534|NCT04567615|449316547|FG000|Randomization|Adverse event unrelated to study drug|0|||
124915535|NCT04567615|449316548|FG001|Randomization|Adverse event unrelated to study drug|1|||
124915536|NCT04567615|449316549|FG002|Randomization|Adverse event unrelated to study drug|0|||
124915537|NCT04567615|449316547|FG000|Treatment Period|Participant Withdrew Consent|2|||
124915538|NCT04567615|449316548|FG001|Treatment Period|Participant Withdrew Consent|5|||
124915539|NCT04567615|449316549|FG002|Treatment Period|Participant Withdrew Consent|1|||
124915540|NCT04567615|449316547|FG000|Treatment Period|Death|1|||
124915541|NCT04567615|449316548|FG001|Treatment Period|Death|2|||
124915542|NCT04567615|449316549|FG002|Treatment Period|Death|0|||
124915543|NCT04567615|449316547|FG000|Treatment Period|Lost to Follow-up|0|||
124915544|NCT04567615|449316548|FG001|Treatment Period|Lost to Follow-up|1|||
124915545|NCT04567615|449316549|FG002|Treatment Period|Lost to Follow-up|0|||
124915546|NCT04567615|449316547|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
124915547|NCT04567615|449316548|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
124915548|NCT04567615|449316549|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
124915549|NCT04567615|449316547|FG000|Treatment Period|Disease Progression|85|||
124915550|NCT04567615|449316548|FG001|Treatment Period|Disease Progression|63|||
124915551|NCT04567615|449316549|FG002|Treatment Period|Disease Progression|16|||
124915552|NCT04567615|449316547|FG000|Treatment Period|Study Drug Toxicity|3|||
124915553|NCT04567615|449316548|FG001|Treatment Period|Study Drug Toxicity|10|||
124915554|NCT04567615|449316549|FG002|Treatment Period|Study Drug Toxicity|4|||
124915555|NCT04567615|449316547|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
124915556|NCT04567615|449316548|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
124915557|NCT04567615|449316549|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
124915558|NCT04567615|449316547|FG000|Treatment Period|Other Reasons|1|||
124915559|NCT04567615|449316548|FG001|Treatment Period|Other Reasons|2|||
124915560|NCT04567615|449316549|FG002|Treatment Period|Other Reasons|0|||
124915561|NCT04567615|449316547|FG000|Treatment Period|Still On-going Treatment|21|||
124915562|NCT04567615|449316548|FG001|Treatment Period|Still On-going Treatment|22|||
124915563|NCT04567615|449316549|FG002|Treatment Period|Still On-going Treatment|2|||
124915564|NCT03481660|449318572|FG000|Overall Study|Adverse Event|5|||
124915565|NCT03481660|449318573|FG001|Overall Study|Adverse Event|4|||
124915566|NCT03481660|449318572|FG000|Overall Study|Death|13|||
124915567|NCT03481660|449318573|FG001|Overall Study|Death|9|||
124915568|NCT03481660|449318572|FG000|Overall Study|Lost to Follow-up|2|||
124915569|NCT03481660|449318573|FG001|Overall Study|Lost to Follow-up|2|||
124915570|NCT03481660|449318572|FG000|Overall Study|Physician Decision|2|||
124915571|NCT03481660|449318573|FG001|Overall Study|Physician Decision|3|||
124915572|NCT03481660|449318572|FG000|Overall Study|Withdrawal by Subject|14|||
124915573|NCT03481660|449318573|FG001|Overall Study|Withdrawal by Subject|7|||
124915574|NCT03012841|449318574|FG000|Overall Study|Protocol Violation|0|||
124915575|NCT03012841|449318575|FG001|Overall Study|Protocol Violation|10|||
124915576|NCT03012841|449318574|FG000|Overall Study|Lost to Follow-up|6|||
124694835|NCT02533674|448503485|FG005|Dose Level VII|Progressive disease|0|||
124694836|NCT02533674|448503486|FG006|Dose Level VII|Progressive disease|10|||
124915577|NCT03012841|449318575|FG001|Overall Study|Lost to Follow-up|1|||
124915578|NCT03012841|449318574|FG000|Overall Study|Withdrawal by Subject|6|||
124694837|NCT02533674|448503487|FG007|Dose Level VII|Progressive disease|0|||
124694838|NCT02533674|448503480|FG000|Dose Level VII|Withdrawal by Subject|0|||
124915579|NCT03012841|449318575|FG001|Overall Study|Withdrawal by Subject|0|||
124915580|NCT03012841|449318574|FG000|Overall Study|Unable to complete 12 month visit|6|||
124915581|NCT03012841|449318575|FG001|Overall Study|Unable to complete 12 month visit|0|||
124915582|NCT03012841|449318574|FG000|Overall Study|Subject relocation|1|||
124694839|NCT02533674|448503481|FG001|Dose Level VII|Withdrawal by Subject|0|||
124694840|NCT02533674|448503482|FG002|Dose Level VII|Withdrawal by Subject|0|||
124694841|NCT02533674|448503483|FG003|Dose Level VII|Withdrawal by Subject|0|||
124915583|NCT03012841|449318575|FG001|Overall Study|Subject relocation|0|||
124915584|NCT03012841|449318574|FG000|Overall Study|Seasonal winter travel|1|||
124915585|NCT03012841|449318575|FG001|Overall Study|Seasonal winter travel|0|||
124915586|NCT03012841|449318574|FG000|Overall Study|Physician Decision|0|||
124915587|NCT03012841|449318575|FG001|Overall Study|Physician Decision|2|||
124915588|NCT03012841|449318574|FG000|Overall Study|No ablation performed|0|||
124915589|NCT03012841|449318575|FG001|Overall Study|No ablation performed|2|||
124915590|NCT03012841|449318574|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
124915591|NCT03012841|449318575|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
124915592|NCT03012841|449318574|FG000|Overall Study|Insurance change|0|||
124915593|NCT03012841|449318575|FG001|Overall Study|Insurance change|1|||
124915594|NCT03683069|449318576|FG000|Overall Study|see limitations|12|||
124915595|NCT03683069|449318577|FG001|Overall Study|see limitations|13|||
124915596|NCT04941287|449318578|FG000|Overall Study|Rapid decline before starting treatment|3|||
124915597|NCT04941287|449318579|FG001|Overall Study|Rapid decline before starting treatment|1|||
124915598|NCT04065048|449318580|FG000|Overall Study|Withdrawal by Subject|1|||
124915599|NCT04065048|449318581|FG001|Overall Study|Withdrawal by Subject|2|||
124915600|NCT04065048|449318582|FG002|Overall Study|Withdrawal by Subject|1|||
124915601|NCT04065048|449318583|FG003|Overall Study|Withdrawal by Subject|1|||
124915602|NCT04065048|449318580|FG000|Overall Study|Adverse Event|1|||
124915603|NCT04065048|449318581|FG001|Overall Study|Adverse Event|0|||
124915604|NCT04065048|449318582|FG002|Overall Study|Adverse Event|1|||
124915605|NCT04065048|449318583|FG003|Overall Study|Adverse Event|0|||
124915606|NCT05369208|449318592|FG000|Core Phase|Prohibited Medication Required|2|||
124915607|NCT05369208|449318592|FG000|Core Phase|Adverse Event|1|||
124915608|NCT05369208|449318592|FG000|Core Phase|Lack of Efficacy|1|||
124915609|NCT05096819|449318593|FG000|Overall Study|Withdrawal by Subject|3|||
124915610|NCT05096819|449318594|FG001|Overall Study|Withdrawal by Subject|0|||
124915611|NCT05307978|449318595|FG000|Overall Study|Lost to Follow-up|0|||
124915612|NCT05307978|449318596|FG001|Overall Study|Lost to Follow-up|1|||
124915613|NCT05307978|449318597|FG002|Overall Study|Lost to Follow-up|0|||
124915614|NCT05307978|449318598|FG003|Overall Study|Lost to Follow-up|4|||
124915615|NCT05307978|449318599|FG004|Overall Study|Lost to Follow-up|0|||
124915616|NCT05307978|449318600|FG005|Overall Study|Lost to Follow-up|0|||
124915617|NCT05307978|449318601|FG006|Overall Study|Lost to Follow-up|1|||
124915618|NCT03324984|449318602|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
124915619|NCT03324984|449318603|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
124915620|NCT04607044|449318608|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
124915621|NCT04607044|449318608|FG000|Overall Study|Adverse Event|1|||
124915622|NCT04607044|449318608|FG000|Overall Study|Did not receive study device|3|||
124915623|NCT04607044|449318608|FG000|Overall Study|Death|1|||
124915624|NCT05075408|449318609|FG000|Overall Study|Withdrawal by Subject|5|||
124915625|NCT05075408|449318610|FG001|Overall Study|Withdrawal by Subject|3|||
124915626|NCT05075408|449318611|FG002|Overall Study|Withdrawal by Subject|4|||
124915627|NCT05075408|449318609|FG000|Overall Study|Adverse Event|5|||
124915628|NCT05075408|449318610|FG001|Overall Study|Adverse Event|7|||
124915629|NCT05075408|449318611|FG002|Overall Study|Adverse Event|8|||
124915630|NCT05075408|449318609|FG000|Overall Study|Protocol Violation|0|||
124915631|NCT05075408|449318610|FG001|Overall Study|Protocol Violation|1|||
124915632|NCT05075408|449318611|FG002|Overall Study|Protocol Violation|0|||
124915633|NCT05075408|449318609|FG000|Overall Study|Lost to Follow-up|2|||
124915634|NCT05075408|449318610|FG001|Overall Study|Lost to Follow-up|1|||
124915635|NCT05075408|449318611|FG002|Overall Study|Lost to Follow-up|1|||
124915636|NCT05075408|449318609|FG000|Overall Study|Physician Decision|1|||
124915637|NCT05075408|449318610|FG001|Overall Study|Physician Decision|0|||
124915638|NCT05075408|449318611|FG002|Overall Study|Physician Decision|0|||
124915639|NCT05075408|449318609|FG000|Overall Study|Other-unspecified|3|||
124915640|NCT05075408|449318610|FG001|Overall Study|Other-unspecified|2|||
124915641|NCT05075408|449318611|FG002|Overall Study|Other-unspecified|0|||
124915642|NCT04878354|449318615|FG000|Overall Study|Adverse Event|4|||
124915643|NCT04878354|449318616|FG001|Overall Study|Adverse Event|13|||
124915644|NCT04878354|449318615|FG000|Overall Study|Withdrawal by Subject|14|||
124694842|NCT02533674|448503484|FG004|Dose Level VII|Withdrawal by Subject|0|||
124915645|NCT04878354|449318616|FG001|Overall Study|Withdrawal by Subject|12|||
124915646|NCT04878354|449318615|FG000|Overall Study|Lost to Follow-up|4|||
124694843|NCT02533674|448503485|FG005|Dose Level VII|Withdrawal by Subject|0|||
124694844|NCT02533674|448503486|FG006|Dose Level VII|Withdrawal by Subject|3|||
124694845|NCT02533674|448503487|FG007|Dose Level VII|Withdrawal by Subject|0|||
124915647|NCT04878354|449318616|FG001|Overall Study|Lost to Follow-up|1|||
124915648|NCT04878354|449318615|FG000|Overall Study|Lack of Efficacy|1|||
124915649|NCT04878354|449318616|FG001|Overall Study|Lack of Efficacy|0|||
124915650|NCT04878354|449318615|FG000|Overall Study|Protocol Violation|0|||
124915651|NCT04878354|449318616|FG001|Overall Study|Protocol Violation|1|||
124915652|NCT04878354|449318615|FG000|Overall Study|"Reason stated as other in CRF"|2|||
124915653|NCT04878354|449318616|FG001|Overall Study|"Reason stated as other in CRF"|3|||
124915654|NCT04847999|449318617|FG000|Overall Study|Lost to Follow-up|0|||
124694846|NCT02533674|448503480|FG000|Dose Level VII|Treatment-related AE|0|||
124694847|NCT02533674|448503481|FG001|Dose Level VII|Treatment-related AE|0|||
124694848|NCT02533674|448503482|FG002|Dose Level VII|Treatment-related AE|0|||
124694849|NCT02533674|448503483|FG003|Dose Level VII|Treatment-related AE|0|||
124694850|NCT02533674|448503484|FG004|Dose Level VII|Treatment-related AE|0|||
124694851|NCT02533674|448503485|FG005|Dose Level VII|Treatment-related AE|0|||
124694852|NCT02533674|448503486|FG006|Dose Level VII|Treatment-related AE|1|||
124694853|NCT02533674|448503487|FG007|Dose Level VII|Treatment-related AE|0|||
124694854|NCT02533674|448503480|FG000|Dose Level VII|Death|0|||
124694855|NCT02533674|448503481|FG001|Dose Level VII|Death|0|||
124694856|NCT02533674|448503482|FG002|Dose Level VII|Death|0|||
124694857|NCT02533674|448503483|FG003|Dose Level VII|Death|0|||
124694858|NCT02533674|448503484|FG004|Dose Level VII|Death|0|||
124694859|NCT02533674|448503485|FG005|Dose Level VII|Death|0|||
124694860|NCT02533674|448503486|FG006|Dose Level VII|Death|2|||
124694861|NCT02533674|448503487|FG007|Dose Level VII|Death|0|||
124694862|NCT02533674|448503480|FG000|Dose Level VIII|Progressive disease|0|||
124694863|NCT02533674|448503481|FG001|Dose Level VIII|Progressive disease|0|||
124694864|NCT02533674|448503482|FG002|Dose Level VIII|Progressive disease|0|||
124694865|NCT02533674|448503483|FG003|Dose Level VIII|Progressive disease|0|||
124694866|NCT02533674|448503484|FG004|Dose Level VIII|Progressive disease|0|||
124694867|NCT02533674|448503485|FG005|Dose Level VIII|Progressive disease|0|||
124694868|NCT02533674|448503486|FG006|Dose Level VIII|Progressive disease|0|||
124694869|NCT02533674|448503487|FG007|Dose Level VIII|Progressive disease|3|||
124694870|NCT02533674|448503480|FG000|Dose Level VIII|Withdrawal by Subject|0|||
124694871|NCT02533674|448503481|FG001|Dose Level VIII|Withdrawal by Subject|0|||
124694872|NCT02533674|448503482|FG002|Dose Level VIII|Withdrawal by Subject|0|||
124694873|NCT02533674|448503483|FG003|Dose Level VIII|Withdrawal by Subject|0|||
124694874|NCT02533674|448503484|FG004|Dose Level VIII|Withdrawal by Subject|0|||
124694875|NCT02533674|448503485|FG005|Dose Level VIII|Withdrawal by Subject|0|||
124694876|NCT02533674|448503486|FG006|Dose Level VIII|Withdrawal by Subject|0|||
124694877|NCT02533674|448503487|FG007|Dose Level VIII|Withdrawal by Subject|1|||
124694878|NCT02533674|448503480|FG000|Dose Level VIII|Treatment-related AE|0|||
124694879|NCT02533674|448503481|FG001|Dose Level VIII|Treatment-related AE|0|||
124694880|NCT02533674|448503482|FG002|Dose Level VIII|Treatment-related AE|0|||
124694881|NCT02533674|448503483|FG003|Dose Level VIII|Treatment-related AE|0|||
124915655|NCT04847999|449318618|FG001|Overall Study|Lost to Follow-up|1|||
124915656|NCT02879448|449318619|FG000|Overall Study|Death|251|||
124915657|NCT02879448|449318620|FG001|Overall Study|Death|263|||
124915658|NCT02879448|449318619|FG000|Overall Study|Lost to Follow-up|23|||
124915659|NCT02879448|449318620|FG001|Overall Study|Lost to Follow-up|28|||
124915660|NCT02879448|449318619|FG000|Overall Study|Withdrawal by Subject|42|||
124915661|NCT02879448|449318620|FG001|Overall Study|Withdrawal by Subject|79|||
124915662|NCT02879448|449318619|FG000|Overall Study|Other Reasons|8|||
124915663|NCT02879448|449318620|FG001|Overall Study|Other Reasons|12|||
124915664|NCT03433339|449318621|FG000|Overall Study|Lost to Follow-up|2|||
124915665|NCT03433339|449318622|FG001|Overall Study|Lost to Follow-up|0|||
124915666|NCT03433339|449318621|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
124915667|NCT03433339|449318622|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
124915668|NCT03433339|449318621|FG000|Overall Study|Withdrawal by Subject|0|||
124915669|NCT03433339|449318622|FG001|Overall Study|Withdrawal by Subject|2|||
124915670|NCT05952076|449318623|FG000|Overall Study|Death|1|||
124915671|NCT05952076|449318624|FG001|Overall Study|Death|1|||
124915672|NCT05952076|449318623|FG000|Overall Study|Lost to Follow-up|0|||
124915673|NCT05952076|449318624|FG001|Overall Study|Lost to Follow-up|1|||
124915674|NCT04143061|449318626|FG000|Overall Study|Protocol Deviation|0|||
124915675|NCT04143061|449318627|FG001|Overall Study|Protocol Deviation|0|||
124915676|NCT04143061|449318628|FG002|Overall Study|Protocol Deviation|0|||
124915677|NCT04143061|449318629|FG003|Overall Study|Protocol Deviation|0|||
124915678|NCT04143061|449318630|FG004|Overall Study|Protocol Deviation|0|||
124915679|NCT04143061|449318631|FG005|Overall Study|Protocol Deviation|0|||
124915680|NCT04143061|449318632|FG006|Overall Study|Protocol Deviation|5|||
124694882|NCT02533674|448503484|FG004|Dose Level VIII|Treatment-related AE|0|||
124915681|NCT04143061|449318633|FG007|Overall Study|Protocol Deviation|5|||
124915682|NCT04143061|449318626|FG000|Overall Study|Withdrawal by Subject|2|||
124915683|NCT04143061|449318627|FG001|Overall Study|Withdrawal by Subject|0|||
124915684|NCT04143061|449318628|FG002|Overall Study|Withdrawal by Subject|0|||
124915685|NCT04143061|449318629|FG003|Overall Study|Withdrawal by Subject|0|||
124915686|NCT04143061|449318630|FG004|Overall Study|Withdrawal by Subject|0|||
124915687|NCT04143061|449318631|FG005|Overall Study|Withdrawal by Subject|1|||
124694883|NCT02533674|448503485|FG005|Dose Level VIII|Treatment-related AE|0|||
124694884|NCT02533674|448503486|FG006|Dose Level VIII|Treatment-related AE|0|||
124694885|NCT02533674|448503487|FG007|Dose Level VIII|Treatment-related AE|1|||
124694886|NCT02533674|448503480|FG000|Dose Level VIII|Never treated|0|||
124694887|NCT02533674|448503481|FG001|Dose Level VIII|Never treated|0|||
124915688|NCT04143061|449318632|FG006|Overall Study|Withdrawal by Subject|0|||
124915689|NCT04143061|449318633|FG007|Overall Study|Withdrawal by Subject|0|||
124915690|NCT04143061|449318626|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124915691|NCT04143061|449318627|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124915692|NCT04143061|449318628|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
124915693|NCT04143061|449318629|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
124915694|NCT04143061|449318630|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
124915695|NCT04143061|449318631|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
124915696|NCT04143061|449318632|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
124915697|NCT04143061|449318633|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
124915698|NCT01718743|449318634|FG000|Overall Study|Physician Decision|7|||
124915699|NCT01718743|449318634|FG000|Overall Study|Withdrawal by Subject|14|||
124915700|NCT01718743|449318634|FG000|Overall Study|Progressive Disease|22|||
124915701|NCT01718743|449318634|FG000|Overall Study|Toxicity|1|||
124915702|NCT01718743|449318634|FG000|Overall Study|Malignancy|1|||
124915703|NCT03739996|449318637|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
124915704|NCT03739996|449318637|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
124915705|NCT03739996|449318637|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
124915706|NCT03739996|449318637|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
124915707|NCT03739996|449318637|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
124915708|NCT03739996|449318637|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
124915709|NCT03739996|449318637|FG000|Step 3 (SOC ART)|Death|1|||
124915710|NCT03739996|449318637|FG000|Step 3 (SOC ART)|Participant moved|1|||
124915711|NCT01673984|449318638|FG000|Overall Study|Adverse Event|1|||
124915712|NCT01673984|449318639|FG001|Overall Study|Adverse Event|0|||
124915713|NCT01673984|449318638|FG000|Overall Study|Study termination|9|||
124915714|NCT01673984|449318639|FG001|Overall Study|Study termination|6|||
124915715|NCT02553642|449318640|FG000|Overall Study|Withdrawal by Subject|0|||
124915716|NCT02553642|449318641|FG001|Overall Study|Withdrawal by Subject|3|||
124915717|NCT02553642|449318640|FG000|Overall Study|Physician Decision|0|||
124915718|NCT02553642|449318641|FG001|Overall Study|Physician Decision|1|||
124915719|NCT02553642|449318640|FG000|Overall Study|Additional cancer dx|0|||
124915720|NCT02553642|449318641|FG001|Overall Study|Additional cancer dx|1|||
124915721|NCT02553642|449318640|FG000|Overall Study|Never started treatment|0|||
124915722|NCT02553642|449318641|FG001|Overall Study|Never started treatment|1|||
124915723|NCT04437433|449318642|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
124915724|NCT04437433|449318643|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
124451631|NCT03700320|447615132|FG001|Overall Study|Lack of Efficacy|5|||
124451632|NCT03700320|447615131|FG000|Overall Study|Withdrawal by Subject|29|||
124451633|NCT03700320|447615132|FG001|Overall Study|Withdrawal by Subject|75|||
124451634|NCT03700320|447615131|FG000|Overall Study|Lost to Follow-up|16|||
124451635|NCT03700320|447615132|FG001|Overall Study|Lost to Follow-up|23|||
124451636|NCT03700320|447615131|FG000|Overall Study|Pregnancy|2|||
124451637|NCT03700320|447615132|FG001|Overall Study|Pregnancy|4|||
124451638|NCT03700320|447615131|FG000|Overall Study|Protocol Deviation|7|||
124451639|NCT03700320|447615132|FG001|Overall Study|Protocol Deviation|31|||
124451640|NCT03700320|447615131|FG000|Overall Study|Non-compliance with Study Drug|1|||
124451641|NCT03700320|447615132|FG001|Overall Study|Non-compliance with Study Drug|3|||
124451642|NCT03700320|447615131|FG000|Overall Study|Reason not Specified|0|||
124451643|NCT03700320|447615132|FG001|Overall Study|Reason not Specified|1|||
124451644|NCT00175877|447615136|FG000|Overall Study|Adverse Event|136|||
124451645|NCT00175877|447615136|FG000|Overall Study|Withdrawal by Subject|141|||
124761669|NCT00387881|448753446|FG000|Overall Study|Not otherwise specified|11|||
124915725|NCT04437433|449318642|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
124915726|NCT04437433|449318643|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
124915727|NCT04437433|449318642|FG000|Overall Study|Adverse Event|9|||
124915728|NCT04437433|449318643|FG001|Overall Study|Adverse Event|0|||
124915729|NCT04437433|449318642|FG000|Overall Study|Lack of Efficacy|4|||
124915730|NCT04437433|449318643|FG001|Overall Study|Lack of Efficacy|0|||
124915731|NCT04437433|449318642|FG000|Overall Study|Withdrawal by Subject|4|||
124915732|NCT04437433|449318643|FG001|Overall Study|Withdrawal by Subject|1|||
124915733|NCT04437433|449318642|FG000|Overall Study|Protocol Deviation|0|||
124915734|NCT04437433|449318643|FG001|Overall Study|Protocol Deviation|1|||
124915735|NCT04437433|449318642|FG000|Overall Study|Other, not specified|0|||
124915736|NCT04437433|449318643|FG001|Overall Study|Other, not specified|1|||
124915737|NCT00894543|449318646|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
124915738|NCT00894543|449318647|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
124915739|NCT00894543|449318646|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
124915740|NCT00894543|449318647|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
124451646|NCT00175877|447615136|FG000|Overall Study|Lost to Follow-up|9|||
124451647|NCT00175877|447615136|FG000|Overall Study|Lack of Efficacy|26|||
124451648|NCT00175877|447615136|FG000|Overall Study|Protocol Violation|15|||
124451649|NCT00175877|447615136|FG000|Overall Study|Other Reason|20|||
124451650|NCT00175877|447615136|FG000|Overall Study|AE & Other|1|||
124915741|NCT04048681|449318648|FG000|Overall Study|family emergency|0|||
124915742|NCT04048681|449318649|FG001|Overall Study|family emergency|0|||
124915743|NCT04048681|449318650|FG002|Overall Study|family emergency|0|||
124915744|NCT04048681|449318651|FG003|Overall Study|family emergency|1|||
124915745|NCT04048681|449318652|FG004|Overall Study|family emergency|0|||
124915746|NCT01532388|449318653|FG000|3-month Follow-up|Lost to Follow-up|68|||
124915747|NCT01532388|449318654|FG001|3-month Follow-up|Lost to Follow-up|68|||
124915748|NCT01532388|449318653|FG000|6-month Follow-up|Lost to Follow-up|74|||
124915749|NCT01532388|449318654|FG001|6-month Follow-up|Lost to Follow-up|66|||
124915750|NCT01532388|449318653|FG000|12-month Follow-up|Lost to Follow-up|69|||
124915751|NCT01532388|449318654|FG001|12-month Follow-up|Lost to Follow-up|67|||
124915752|NCT02919449|449318655|FG000|Overall Study|Withdrawal by Subject|1|||
124915753|NCT02919449|449318655|FG000|Overall Study|Investigator decision|1|||
124915754|NCT00727909|449318656|FG000|Overall Study|Withdrawal by Subject|5|||
124915755|NCT00727909|449318657|FG001|Overall Study|Withdrawal by Subject|11|||
124915756|NCT00727909|449318658|FG002|Overall Study|Withdrawal by Subject|8|||
124915757|NCT00727909|449318659|FG003|Overall Study|Withdrawal by Subject|5|||
124915758|NCT00727909|449318656|FG000|Overall Study|Death|0|||
124915759|NCT00727909|449318657|FG001|Overall Study|Death|0|||
124915760|NCT00727909|449318658|FG002|Overall Study|Death|1|||
124915761|NCT00727909|449318659|FG003|Overall Study|Death|0|||
124915762|NCT03578536|449318662|FG000|Overall Study|Lost to Follow-up|1|||
124915763|NCT05198310|449318663|FG000|Overall Study|Lost to Follow-up|0|||
124451651|NCT00175877|447615136|FG000|Overall Study|Withdrawal by subject & Other|1|||
124451652|NCT01092143|447615139|FG000|Overall Study|Adverse Event|10|||
124451653|NCT01092143|447615140|FG001|Overall Study|Adverse Event|5|||
124451654|NCT01092143|447615141|FG002|Overall Study|Adverse Event|1|||
124451655|NCT01092143|447615142|FG003|Overall Study|Adverse Event|4|||
124451656|NCT01092143|447615143|FG004|Overall Study|Adverse Event|3|||
124451657|NCT01092143|447615139|FG000|Overall Study|Lost to Follow-up|1|||
124451658|NCT01092143|447615140|FG001|Overall Study|Lost to Follow-up|0|||
124451659|NCT01092143|447615141|FG002|Overall Study|Lost to Follow-up|1|||
124451660|NCT01092143|447615142|FG003|Overall Study|Lost to Follow-up|0|||
124451661|NCT01092143|447615143|FG004|Overall Study|Lost to Follow-up|0|||
124451662|NCT01092143|447615139|FG000|Overall Study|Consent withdrawn|2|||
124451663|NCT01092143|447615140|FG001|Overall Study|Consent withdrawn|1|||
124451664|NCT01092143|447615141|FG002|Overall Study|Consent withdrawn|0|||
124451665|NCT01092143|447615142|FG003|Overall Study|Consent withdrawn|1|||
124451666|NCT01092143|447615143|FG004|Overall Study|Consent withdrawn|3|||
124451667|NCT01092143|447615139|FG000|Overall Study|Not treated|0|||
124451668|NCT01092143|447615140|FG001|Overall Study|Not treated|0|||
124451669|NCT01092143|447615141|FG002|Overall Study|Not treated|1|||
124451670|NCT01092143|447615142|FG003|Overall Study|Not treated|0|||
124451671|NCT01092143|447615143|FG004|Overall Study|Not treated|0|||
124451672|NCT01092143|447615139|FG000|Overall Study|did not reversibility criteria|0|||
124451673|NCT01092143|447615140|FG001|Overall Study|did not reversibility criteria|0|||
124451674|NCT01092143|447615141|FG002|Overall Study|did not reversibility criteria|1|||
124451675|NCT01092143|447615142|FG003|Overall Study|did not reversibility criteria|0|||
124451676|NCT01092143|447615143|FG004|Overall Study|did not reversibility criteria|0|||
124451677|NCT01092143|447615139|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
124451678|NCT01092143|447615140|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
124451679|NCT01092143|447615141|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
124451680|NCT01092143|447615142|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
124451681|NCT01092143|447615143|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
124451682|NCT01092143|447615139|FG000|Overall Study|Ineligible patient|1|||
124451683|NCT01092143|447615140|FG001|Overall Study|Ineligible patient|0|||
124451684|NCT01092143|447615141|FG002|Overall Study|Ineligible patient|0|||
124451685|NCT01092143|447615142|FG003|Overall Study|Ineligible patient|0|||
124451686|NCT01092143|447615143|FG004|Overall Study|Ineligible patient|0|||
124451687|NCT01092143|447615139|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
124451688|NCT01092143|447615140|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
124451689|NCT01092143|447615141|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
124451690|NCT01092143|447615142|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
124451691|NCT01092143|447615143|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
124545377|NCT00423137|447951175|FG003|Overall Study|Adverse Event Study disease worse|1|||
124915764|NCT05198310|449318664|FG001|Overall Study|Lost to Follow-up|1|||
124915765|NCT05198310|449318665|FG002|Overall Study|Lost to Follow-up|0|||
124915766|NCT05198310|449318666|FG003|Overall Study|Lost to Follow-up|0|||
124451692|NCT01092143|447615139|FG000|Overall Study|Patient travel|0|||
124451693|NCT01092143|447615140|FG001|Overall Study|Patient travel|0|||
124451694|NCT01092143|447615141|FG002|Overall Study|Patient travel|0|||
124451695|NCT01092143|447615142|FG003|Overall Study|Patient travel|0|||
124451696|NCT01092143|447615143|FG004|Overall Study|Patient travel|1|||
124451697|NCT01092143|447615139|FG000|Overall Study|Non compliance with study medication|0|||
124451698|NCT01092143|447615140|FG001|Overall Study|Non compliance with study medication|0|||
124451699|NCT01092143|447615141|FG002|Overall Study|Non compliance with study medication|0|||
124545378|NCT00423137|447951172|FG000|Overall Study|Adverse Event Other|0|||
124545379|NCT00423137|447951173|FG001|Overall Study|Adverse Event Other|0|||
124915767|NCT05198310|449318667|FG004|Overall Study|Lost to Follow-up|0|||
124915768|NCT05198310|449318668|FG005|Overall Study|Lost to Follow-up|0|||
124915769|NCT05198310|449318669|FG006|Overall Study|Lost to Follow-up|0|||
124915770|NCT05198310|449318670|FG007|Overall Study|Lost to Follow-up|0|||
124915771|NCT05198310|449318663|FG000|Overall Study|Withdrawal by Subject|0|||
124915772|NCT05198310|449318664|FG001|Overall Study|Withdrawal by Subject|0|||
124915773|NCT05198310|449318665|FG002|Overall Study|Withdrawal by Subject|0|||
124915774|NCT05198310|449318666|FG003|Overall Study|Withdrawal by Subject|2|||
124915775|NCT05198310|449318667|FG004|Overall Study|Withdrawal by Subject|0|||
124915776|NCT05198310|449318668|FG005|Overall Study|Withdrawal by Subject|2|||
124915777|NCT05198310|449318669|FG006|Overall Study|Withdrawal by Subject|1|||
124915778|NCT05198310|449318670|FG007|Overall Study|Withdrawal by Subject|3|||
124915779|NCT04436107|449318671|FG000|Overall Study|Sponsor Ended Study|2|||
124915780|NCT04436107|449318672|FG001|Overall Study|Sponsor Ended Study|4|||
124915781|NCT04436107|449318673|FG002|Overall Study|Sponsor Ended Study|8|||
124915782|NCT04436107|449318674|FG003|Overall Study|Sponsor Ended Study|20|||
124915783|NCT04436107|449318671|FG000|Overall Study|Death|3|||
124694888|NCT02533674|448503482|FG002|Dose Level VIII|Never treated|0|||
124694889|NCT02533674|448503483|FG003|Dose Level VIII|Never treated|0|||
124694890|NCT02533674|448503484|FG004|Dose Level VIII|Never treated|0|||
124694891|NCT02533674|448503485|FG005|Dose Level VIII|Never treated|0|||
124915784|NCT04436107|449318672|FG001|Overall Study|Death|5|||
124915785|NCT04436107|449318673|FG002|Overall Study|Death|3|||
124915786|NCT04436107|449318674|FG003|Overall Study|Death|18|||
124915787|NCT04436107|449318671|FG000|Overall Study|Withdrawal by Subject|1|||
124915788|NCT04436107|449318672|FG001|Overall Study|Withdrawal by Subject|1|||
124915789|NCT04436107|449318673|FG002|Overall Study|Withdrawal by Subject|0|||
124915790|NCT04436107|449318674|FG003|Overall Study|Withdrawal by Subject|1|||
124915791|NCT00448669|449318677|FG000|Overall Study|Lost to Follow-up|52|||
124915792|NCT00448669|449318678|FG001|Overall Study|Lost to Follow-up|63|||
124915793|NCT00448669|449318677|FG000|Overall Study|Withdrawal by Subject|90|||
124694892|NCT02533674|448503486|FG006|Dose Level VIII|Never treated|0|||
124694893|NCT02533674|448503487|FG007|Dose Level VIII|Never treated|1|||
124694894|NCT01292473|448503491|FG000|Overall Study|Adverse Event|1|||
124694895|NCT01292473|448503492|FG001|Overall Study|Adverse Event|0|||
124694896|NCT01292473|448503493|FG002|Overall Study|Adverse Event|1|||
124694897|NCT01292473|448503494|FG003|Overall Study|Adverse Event|1|||
124915794|NCT00448669|449318678|FG001|Overall Study|Withdrawal by Subject|74|||
124915795|NCT00448669|449318677|FG000|Overall Study|Relocated|49|||
124694898|NCT01292473|448503491|FG000|Overall Study|Lost to Follow-up|1|||
124694899|NCT01292473|448503492|FG001|Overall Study|Lost to Follow-up|1|||
124694900|NCT01292473|448503493|FG002|Overall Study|Lost to Follow-up|2|||
124694901|NCT01292473|448503494|FG003|Overall Study|Lost to Follow-up|2|||
124694902|NCT01292473|448503491|FG000|Overall Study|Withdrawal by Subject|3|||
124694903|NCT01292473|448503492|FG001|Overall Study|Withdrawal by Subject|4|||
124694904|NCT01292473|448503493|FG002|Overall Study|Withdrawal by Subject|3|||
124694905|NCT01292473|448503494|FG003|Overall Study|Withdrawal by Subject|3|||
124694906|NCT01292473|448503491|FG000|Overall Study|Physician Decision|0|||
124694907|NCT01292473|448503492|FG001|Overall Study|Physician Decision|1|||
124694908|NCT01292473|448503493|FG002|Overall Study|Physician Decision|0|||
124694909|NCT01292473|448503494|FG003|Overall Study|Physician Decision|0|||
124694910|NCT01292473|448503491|FG000|Overall Study|Disease Progression|0|||
124694911|NCT01292473|448503492|FG001|Overall Study|Disease Progression|1|||
124694912|NCT01292473|448503493|FG002|Overall Study|Disease Progression|3|||
124694913|NCT01292473|448503494|FG003|Overall Study|Disease Progression|6|||
124694914|NCT01717859|448503500|FG000|Overall Study|Adverse Event|5|||
124694915|NCT01717859|448503500|FG000|Overall Study|Moved out of state|1|||
124694916|NCT01717859|448503500|FG000|Overall Study|Patient concerned about mental health|1|||
124694917|NCT01717859|448503500|FG000|Overall Study|Lost to Follow-up|1|||
124694918|NCT01717859|448503500|FG000|Overall Study|Withdrawal by Subject|2|||
124694919|NCT04389671|448503501|FG000|Overall Study|Death|7|||
124915796|NCT00448669|449318678|FG001|Overall Study|Relocated|36|||
124915797|NCT00448669|449318677|FG000|Overall Study|Were withdrawn by investigator|10|||
124694920|NCT00474968|448503502|FG000|Overall Study|Withdrawal by Subject|8|||
124694921|NCT00474968|448503503|FG001|Overall Study|Withdrawal by Subject|7|||
124694922|NCT00474968|448503502|FG000|Overall Study|Protocol Violation|9|||
124694923|NCT00474968|448503503|FG001|Overall Study|Protocol Violation|8|||
124694924|NCT00474968|448503502|FG000|Overall Study|Sample not collected|1|||
124694925|NCT00474968|448503503|FG001|Overall Study|Sample not collected|1|||
124694926|NCT01111292|448503504|FG000|Treatment|Physician Decision|1|||
124694927|NCT01111292|448503505|FG001|Treatment|Physician Decision|1|||
124694928|NCT01750281|448503506|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
124915798|NCT00448669|449318678|FG001|Overall Study|Were withdrawn by investigator|6|||
124915799|NCT00448669|449318677|FG000|Overall Study|Death|2|||
124915800|NCT00448669|449318678|FG001|Overall Study|Death|4|||
124915801|NCT00448669|449318677|FG000|Overall Study|Had other reasons|5|||
124915802|NCT00448669|449318678|FG001|Overall Study|Had other reasons|6|||
124915803|NCT00448669|449318677|FG000|Overall Study|HIV-infected at enrollment|1|||
124694929|NCT01750281|448503507|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
124694930|NCT01750281|448503508|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
124694931|NCT01750281|448503506|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
124915804|NCT00448669|449318678|FG001|Overall Study|HIV-infected at enrollment|2|||
124915805|NCT00448669|449318677|FG000|Overall Study|Never started drug|9|||
124915806|NCT00448669|449318678|FG001|Overall Study|Never started drug|7|||
124915807|NCT02638337|449318679|FG000|Overall Study|Adverse Event|6|||
124915808|NCT02638337|449318680|FG001|Overall Study|Adverse Event|10|||
124915809|NCT02638337|449318679|FG000|Overall Study|Protocol Violation|3|||
124915810|NCT02638337|449318680|FG001|Overall Study|Protocol Violation|0|||
124915811|NCT02638337|449318679|FG000|Overall Study|Withdrawal by Subject|13|||
124915812|NCT02638337|449318680|FG001|Overall Study|Withdrawal by Subject|16|||
124915813|NCT02638337|449318679|FG000|Overall Study|Lost to Follow-up|7|||
124915814|NCT02638337|449318680|FG001|Overall Study|Lost to Follow-up|7|||
124915815|NCT02638337|449318679|FG000|Overall Study|Other - Miscellaneous|4|||
124915816|NCT02638337|449318680|FG001|Overall Study|Other - Miscellaneous|3|||
124915817|NCT03338816|449318694|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
124915818|NCT03338816|449318695|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
124915819|NCT03338816|449318696|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
124915820|NCT03338816|449318697|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
124915821|NCT03338816|449318694|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
124915822|NCT03338816|449318695|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
124915823|NCT03338816|449318696|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
124915824|NCT03338816|449318697|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
124915825|NCT03338816|449318694|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
124915826|NCT03338816|449318695|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
124915827|NCT03338816|449318696|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
124915828|NCT03338816|449318697|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
124915829|NCT03338816|449318694|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
124915830|NCT03338816|449318695|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
124915831|NCT03338816|449318696|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
124915832|NCT03338816|449318697|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
124915833|NCT03338816|449318694|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
124915834|NCT03338816|449318695|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
124915835|NCT03338816|449318696|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
124915836|NCT03338816|449318697|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
124915837|NCT03338816|449318694|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
124915838|NCT03338816|449318695|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
124915839|NCT03338816|449318696|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
124915840|NCT03338816|449318697|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
124915841|NCT03338816|449318694|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
124915842|NCT03338816|449318695|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
124915843|NCT03338816|449318696|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
124915844|NCT03338816|449318697|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
124915845|NCT03092726|449318698|FG000|Overall Study|Adverse Event|3|||
124915846|NCT03092726|449318699|FG001|Overall Study|Adverse Event|10|||
124915847|NCT03092726|449318698|FG000|Overall Study|Lack of Efficacy|0|||
124915848|NCT03092726|449318699|FG001|Overall Study|Lack of Efficacy|1|||
124915849|NCT03092726|449318698|FG000|Overall Study|Lost to Follow-up|1|||
124915850|NCT03092726|449318699|FG001|Overall Study|Lost to Follow-up|0|||
124915851|NCT03092726|449318698|FG000|Overall Study|Withdrawal by Subject|5|||
124915852|NCT03092726|449318699|FG001|Overall Study|Withdrawal by Subject|3|||
124915853|NCT04950127|449318700|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
124915854|NCT04950127|449318701|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
124915855|NCT04950127|449318702|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
124915856|NCT04950127|449318703|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
124915857|NCT04950127|449318704|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
124915858|NCT04950127|449318705|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
124915859|NCT04950127|449318700|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
124915860|NCT04950127|449318701|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
124915861|NCT04950127|449318702|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
124915862|NCT04950127|449318703|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
124915863|NCT04950127|449318704|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
124915864|NCT04950127|449318705|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
124915865|NCT04950127|449318700|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
124915866|NCT04950127|449318701|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
124915867|NCT04950127|449318702|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
124915868|NCT04950127|449318703|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
124915869|NCT04950127|449318704|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
124915870|NCT04950127|449318705|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
124915871|NCT04950127|449318700|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
124915872|NCT04950127|449318701|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
124915873|NCT04950127|449318702|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
124915874|NCT04950127|449318703|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
124915875|NCT04950127|449318704|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
124915876|NCT04950127|449318705|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
124915877|NCT04950127|449318700|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
124915878|NCT04950127|449318701|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
124915879|NCT04950127|449318702|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
124915880|NCT04950127|449318703|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
124915881|NCT04950127|449318704|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
124915882|NCT04950127|449318705|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
124915883|NCT03833167|449318710|FG000|Overall Study|Withdrawal by Subject|4|||
124915884|NCT03833167|449318711|FG001|Overall Study|Withdrawal by Subject|6|||
124915885|NCT03833167|449318710|FG000|Overall Study|Ongoing|186|||
124915886|NCT03833167|449318711|FG001|Overall Study|Ongoing|194|||
124915887|NCT03833167|449318710|FG000|Overall Study|Lost to Follow-up|1|||
124915888|NCT03833167|449318711|FG001|Overall Study|Lost to Follow-up|1|||
124915889|NCT03833167|449318710|FG000|Overall Study|Physician Decision|0|||
124915890|NCT03833167|449318711|FG001|Overall Study|Physician Decision|2|||
124915891|NCT03833167|449318710|FG000|Overall Study|Death|34|||
124915892|NCT03833167|449318711|FG001|Overall Study|Death|22|||
124915893|NCT01948661|449318713|FG000|Overall Study|Withdrawal by Subject|2|||
124915894|NCT01948661|449318714|FG001|Overall Study|Withdrawal by Subject|4|||
124915895|NCT03271489|449318715|FG000|Double-Blind (DB) Period|Adverse Event|4|||
124915896|NCT03271489|449318716|FG001|Double-Blind (DB) Period|Adverse Event|1|||
124915897|NCT03271489|449318715|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
124915898|NCT03271489|449318716|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
124915899|NCT03271489|449318715|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
124915900|NCT03271489|449318716|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
124915901|NCT03271489|449318715|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
124915902|NCT03271489|449318716|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
124915903|NCT03271489|449318715|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
124915904|NCT03271489|449318716|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
124915905|NCT03271489|449318715|FG000|Double-Blind (DB) Period|Other|6|||
124915906|NCT03271489|449318716|FG001|Double-Blind (DB) Period|Other|1|||
124915907|NCT03271489|449318715|FG000|Double-Blind (DB) Period|Missing|1|||
124915908|NCT03271489|449318716|FG001|Double-Blind (DB) Period|Missing|0|||
124915909|NCT03271489|449318715|FG000|Open-Label (OL) Period|Adverse Event|2|||
124915910|NCT03271489|449318716|FG001|Open-Label (OL) Period|Adverse Event|0|||
124915911|NCT03271489|449318715|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
124915912|NCT03271489|449318716|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
124915913|NCT03271489|449318715|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
124915914|NCT03271489|449318716|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
124915915|NCT03271489|449318715|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
124915916|NCT03271489|449318716|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
124915917|NCT03271489|449318715|FG000|Open-Label (OL) Period|No Specified|2|||
124915918|NCT03271489|449318716|FG001|Open-Label (OL) Period|No Specified|2|||
124915919|NCT03271489|449318715|FG000|Open-Label (OL) Period|Missing|2|||
124915920|NCT03271489|449318716|FG001|Open-Label (OL) Period|Missing|0|||
124915921|NCT03271489|449318715|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
124915922|NCT03271489|449318716|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
124915923|NCT03271489|449318715|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
124915924|NCT03271489|449318716|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
124915925|NCT03271489|449318715|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
124915926|NCT03271489|449318716|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
124915927|NCT03271489|449318715|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
124915928|NCT03271489|449318716|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
124915929|NCT03271489|449318715|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
124915930|NCT03271489|449318716|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
124915931|NCT03271489|449318715|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
124915932|NCT03271489|449318716|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
124915933|NCT03271489|449318715|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
124915934|NCT03271489|449318716|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
124915935|NCT03271489|449318715|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
124915936|NCT03271489|449318716|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
124915937|NCT02860130|449318717|FG000|Overall Study|Adverse Event|2|||
124915938|NCT02860130|449318718|FG001|Overall Study|Adverse Event|3|||
124915939|NCT02860130|449318717|FG000|Overall Study|Protocol Violation|1|||
124915940|NCT02860130|449318718|FG001|Overall Study|Protocol Violation|1|||
124915941|NCT02860130|449318717|FG000|Overall Study|Withdrawal by Subject|0|||
124915942|NCT02860130|449318718|FG001|Overall Study|Withdrawal by Subject|2|||
124915943|NCT02860130|449318717|FG000|Overall Study|Physician Decision|2|||
124761670|NCT00387881|448753447|FG001|Overall Study|Not otherwise specified|7|||
124761671|NCT00453154|448753448|FG000|Double BIind Maintenance|Adverse Event|0|||
124915944|NCT02860130|449318718|FG001|Overall Study|Physician Decision|2|||
124915945|NCT02860130|449318717|FG000|Overall Study|Other|2|||
124915946|NCT02860130|449318718|FG001|Overall Study|Other|1|||
124915947|NCT03330795|449318719|FG000|Overall Study|Death|3|||
124915948|NCT03330795|449318719|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
124915949|NCT05575076|449318721|FG000|Overall Study|Adverse Event|24|||
124915950|NCT05575076|449318721|FG000|Overall Study|Death|7|||
124915951|NCT05575076|449318721|FG000|Overall Study|Lost to Follow-up|16|||
124915952|NCT05575076|449318721|FG000|Overall Study|Non-Compliance|3|||
124915953|NCT05575076|449318721|FG000|Overall Study|Physician Decision|6|||
124915954|NCT05575076|449318721|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
124915955|NCT05575076|449318721|FG000|Overall Study|Withdrawal by Subject|71|||
124915956|NCT05575076|449318721|FG000|Overall Study|Study Terminated by Sponsor|630|||
124915957|NCT05575076|449318721|FG000|Overall Study|Other|17|||
124915958|NCT01127373|449318722|FG000|Overall Study|Not Treated|3|||
124915959|NCT01127373|449318722|FG000|Overall Study|Lost to Follow-up|7|||
124915960|NCT01127373|449318722|FG000|Overall Study|Withdrawal by Subject|1|||
124915961|NCT01127373|449318722|FG000|Overall Study|Disease progression|1|||
124915962|NCT01426412|449318729|FG000|Overall Study|Withdrawal by Subject|1|||
124915963|NCT01426412|449318730|FG001|Overall Study|Withdrawal by Subject|0|||
124915964|NCT01426412|449318731|FG002|Overall Study|Withdrawal by Subject|0|||
124915965|NCT01426412|449318732|FG003|Overall Study|Withdrawal by Subject|0|||
124915966|NCT01426412|449318733|FG004|Overall Study|Withdrawal by Subject|1|||
124915967|NCT01426412|449318734|FG005|Overall Study|Withdrawal by Subject|0|||
124915968|NCT01426412|449318735|FG006|Overall Study|Withdrawal by Subject|0|||
124915969|NCT01426412|449318736|FG007|Overall Study|Withdrawal by Subject|3|||
124915970|NCT01426412|449318737|FG008|Overall Study|Withdrawal by Subject|1|||
124915971|NCT05450458|449318738|FG000|Overall Study|Lost to Follow-up|4|||
124915972|NCT04157348|449318740|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
124915973|NCT04157348|449318741|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
124915974|NCT04157348|449318740|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
124915975|NCT04157348|449318741|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
124915976|NCT04157348|449318740|FG000|Double-blind Treatment Period|Adverse Event|0|||
124915977|NCT04157348|449318741|FG001|Double-blind Treatment Period|Adverse Event|1|||
124915978|NCT04157348|449318740|FG000|Open-label Extension Period|Adverse Event|1|||
124915979|NCT04157348|449318741|FG001|Open-label Extension Period|Adverse Event|1|||
124915980|NCT04157348|449318740|FG000|Open-label Extension Period|Death|0|||
124915981|NCT04157348|449318741|FG001|Open-label Extension Period|Death|1|||
124915982|NCT04157348|449318740|FG000|Open-label Extension Period|Lack of Efficacy|2|||
124915983|NCT04157348|449318741|FG001|Open-label Extension Period|Lack of Efficacy|2|||
124915984|NCT04157348|449318740|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
124915985|NCT04157348|449318741|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
124915986|NCT04157348|449318740|FG000|Open-label Extension Period|Ongoing|60|||
124915987|NCT04157348|449318741|FG001|Open-label Extension Period|Ongoing|57|||
124915988|NCT04157348|449318740|FG000|Open-label Extension Period|other reasons|1|||
124915989|NCT04157348|449318741|FG001|Open-label Extension Period|other reasons|1|||
124915990|NCT02965846|449318742|FG000|Overall Study|Lost to Follow-up|1|||
124915991|NCT02965846|449318743|FG001|Overall Study|Lost to Follow-up|0|||
124915992|NCT02965846|449318744|FG002|Overall Study|Lost to Follow-up|0|||
124915993|NCT02965846|449318742|FG000|Overall Study|Withdrawal by Subject|0|||
124915994|NCT02965846|449318743|FG001|Overall Study|Withdrawal by Subject|1|||
124915995|NCT02965846|449318744|FG002|Overall Study|Withdrawal by Subject|0|||
124915996|NCT02965846|449318742|FG000|Overall Study|Study Terminated By Sponsor|4|||
124915997|NCT02965846|449318743|FG001|Overall Study|Study Terminated By Sponsor|4|||
124915998|NCT02965846|449318744|FG002|Overall Study|Study Terminated By Sponsor|0|||
124915999|NCT02965846|449318742|FG000|Overall Study|Participants not randomized|0|||
124916000|NCT02965846|449318743|FG001|Overall Study|Participants not randomized|0|||
124916001|NCT02965846|449318744|FG002|Overall Study|Participants not randomized|33|||
124916002|NCT00262301|449318745|FG000|Double-blind Phase|Lost to Follow-up|1|||
124916003|NCT00262301|449318746|FG001|Double-blind Phase|Lost to Follow-up|0|||
124545380|NCT00423137|447951174|FG002|Overall Study|Adverse Event Other|2|||
124916004|NCT00262301|449318747|FG002|Double-blind Phase|Lost to Follow-up|0|||
124916005|NCT00262301|449318745|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
124916006|NCT00262301|449318746|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
124916007|NCT00262301|449318747|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
124916008|NCT01084707|449318748|FG000|Overall Study|Withdrawal by Subject|6|||
124916009|NCT02412748|449318752|FG000|Overall Study|Lost to Follow-up|38|||
124916010|NCT02412748|449318753|FG001|Overall Study|Lost to Follow-up|39|||
124916011|NCT03069313|449318754|FG000|Overall Study|Adverse Event|5|||
124916012|NCT01872078|449318756|FG000|Overall Study|Adverse Event|0|||
124916013|NCT01872078|449318757|FG001|Overall Study|Adverse Event|0|||
124916014|NCT01872078|449318758|FG002|Overall Study|Adverse Event|1|||
124916015|NCT01872078|449318759|FG003|Overall Study|Adverse Event|0|||
124916016|NCT01872078|449318756|FG000|Overall Study|Dose administration non-compliance|0|||
124545381|NCT00423137|447951175|FG003|Overall Study|Adverse Event Other|0|||
124916017|NCT01872078|449318757|FG001|Overall Study|Dose administration non-compliance|0|||
124916018|NCT01872078|449318758|FG002|Overall Study|Dose administration non-compliance|0|||
124916019|NCT01872078|449318759|FG003|Overall Study|Dose administration non-compliance|1|||
124916020|NCT01872078|449318756|FG000|Overall Study|Protocol Violation|0|||
124916021|NCT01872078|449318757|FG001|Overall Study|Protocol Violation|0|||
124916022|NCT01872078|449318758|FG002|Overall Study|Protocol Violation|1|||
124916023|NCT01872078|449318759|FG003|Overall Study|Protocol Violation|0|||
124916024|NCT01872078|449318756|FG000|Overall Study|Withdrawal by Subject|0|||
124916025|NCT01872078|449318757|FG001|Overall Study|Withdrawal by Subject|0|||
124916026|NCT01872078|449318758|FG002|Overall Study|Withdrawal by Subject|1|||
124916027|NCT01872078|449318759|FG003|Overall Study|Withdrawal by Subject|0|||
124916028|NCT01872078|449318756|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
124916029|NCT01872078|449318757|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
124916030|NCT01872078|449318758|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
124916031|NCT01872078|449318759|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
124916032|NCT01494922|449318760|FG000|Overall Study|Adverse Event|1|||
124916033|NCT02152137|449320232|FG000|Overall Study|Withdrawal by Subject|1|||
124916034|NCT02152137|449320232|FG000|Overall Study|Originally assigned to Arm B|3|||
124916035|NCT05510232|449320233|FG000|Overall Study|Withdrawal by Subject|2|||
124761672|NCT00453154|448753449|FG001|Double BIind Maintenance|Adverse Event|0|||
124761673|NCT00453154|448753450|FG002|Double BIind Maintenance|Adverse Event|3|||
124916036|NCT05510232|449320234|FG001|Overall Study|Withdrawal by Subject|7|||
124916037|NCT05510232|449320235|FG002|Overall Study|Withdrawal by Subject|6|||
124916038|NCT04337372|449320242|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
124916039|NCT04337372|449320243|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
124916040|NCT04337372|449320244|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
124916041|NCT04337372|449320245|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
124916042|NCT04337372|449320242|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
124916043|NCT04337372|449320243|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
124916044|NCT04337372|449320244|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
124916045|NCT04337372|449320245|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
124916046|NCT04337372|449320242|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
124916047|NCT04337372|449320243|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
124916048|NCT04337372|449320244|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
124916049|NCT04337372|449320245|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
124916050|NCT04337372|449320242|FG000|Day 2: EEG Measures|Protocol Violation|6|||
124916051|NCT04337372|449320243|FG001|Day 2: EEG Measures|Protocol Violation|6|||
124916052|NCT04337372|449320244|FG002|Day 2: EEG Measures|Protocol Violation|5|||
124916053|NCT04337372|449320245|FG003|Day 2: EEG Measures|Protocol Violation|17|||
124916054|NCT05307783|449320246|FG000|Overall Study|Death|7|||
124916055|NCT05307783|449320246|FG000|Overall Study|Lost to Follow-up|4|||
124761674|NCT00453154|448753451|FG003|Double BIind Maintenance|Adverse Event|12|||
124761675|NCT00453154|448753448|FG000|Double BIind Maintenance|Death|0|||
124761676|NCT00453154|448753449|FG001|Double BIind Maintenance|Death|0|||
124761677|NCT00453154|448753450|FG002|Double BIind Maintenance|Death|2|||
124761678|NCT00453154|448753451|FG003|Double BIind Maintenance|Death|1|||
124761679|NCT00453154|448753448|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
124761680|NCT00453154|448753449|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
124761681|NCT00453154|448753450|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
124761682|NCT00453154|448753451|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
124761683|NCT00453154|448753448|FG000|Double BIind Maintenance|Progression|0|||
124761684|NCT00453154|448753449|FG001|Double BIind Maintenance|Progression|0|||
124761685|NCT00453154|448753450|FG002|Double BIind Maintenance|Progression|29|||
124761686|NCT00453154|448753451|FG003|Double BIind Maintenance|Progression|26|||
124761687|NCT00453154|448753448|FG000|Double BIind Maintenance|Medical Issues|0|||
124761688|NCT00453154|448753449|FG001|Double BIind Maintenance|Medical Issues|0|||
124761689|NCT00453154|448753450|FG002|Double BIind Maintenance|Medical Issues|3|||
124761690|NCT00453154|448753451|FG003|Double BIind Maintenance|Medical Issues|1|||
124761691|NCT00453154|448753448|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
124761692|NCT00453154|448753449|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
124761693|NCT00453154|448753450|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
124916056|NCT04883645|449320247|FG000|Overall Study|Death|1|||
124916057|NCT00979576|449320248|FG000|Combination Treatment Phase|Progressive disease|3|||
124916058|NCT00979576|449320249|FG001|Combination Treatment Phase|Progressive disease|1|||
124916059|NCT00979576|449320250|FG002|Combination Treatment Phase|Progressive disease|5|||
124916060|NCT00979576|449320248|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
124916061|NCT00979576|449320249|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
124916062|NCT00979576|449320250|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
124916063|NCT00979576|449320248|FG000|Combination Treatment Phase|Adverse Event|0|||
124761694|NCT00453154|448753451|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
124761695|NCT01790594|448753453|FG000|Overall Study|Death|1|||
124761696|NCT01790594|448753454|FG001|Overall Study|Death|0|||
124761697|NCT01790594|448753455|FG002|Overall Study|Death|0|||
124761698|NCT01790594|448753453|FG000|Overall Study|Physician Decision|2|||
124761699|NCT01790594|448753454|FG001|Overall Study|Physician Decision|1|||
124761700|NCT01790594|448753455|FG002|Overall Study|Physician Decision|0|||
124761701|NCT01790594|448753453|FG000|Overall Study|Withdrawal by Subject|2|||
124761702|NCT01790594|448753454|FG001|Overall Study|Withdrawal by Subject|0|||
124761703|NCT01790594|448753455|FG002|Overall Study|Withdrawal by Subject|0|||
124761704|NCT01790594|448753453|FG000|Overall Study|Transplant was not done|0|||
124761705|NCT01790594|448753454|FG001|Overall Study|Transplant was not done|0|||
124761706|NCT01790594|448753455|FG002|Overall Study|Transplant was not done|3|||
124761707|NCT01790594|448753453|FG000|Overall Study|Terminated prior to week 76|0|||
124761708|NCT01790594|448753454|FG001|Overall Study|Terminated prior to week 76|2|||
124761709|NCT01790594|448753455|FG002|Overall Study|Terminated prior to week 76|0|||
124761710|NCT03291067|448753457|FG000|Overall Study|Adverse Event|0|||
124761711|NCT03291067|448753458|FG001|Overall Study|Adverse Event|2|||
124761712|NCT03291067|448753459|FG002|Overall Study|Adverse Event|17|||
124761713|NCT03291067|448753460|FG003|Overall Study|Adverse Event|3|||
124761714|NCT03291067|448753457|FG000|Overall Study|Lost to Follow-up|2|||
124761715|NCT03291067|448753458|FG001|Overall Study|Lost to Follow-up|1|||
124761716|NCT03291067|448753459|FG002|Overall Study|Lost to Follow-up|0|||
124761717|NCT03291067|448753460|FG003|Overall Study|Lost to Follow-up|1|||
124761718|NCT03291067|448753457|FG000|Overall Study|Physician Decision|0|||
124761719|NCT03291067|448753458|FG001|Overall Study|Physician Decision|0|||
124761720|NCT03291067|448753459|FG002|Overall Study|Physician Decision|1|||
124761721|NCT03291067|448753460|FG003|Overall Study|Physician Decision|0|||
124761722|NCT03291067|448753457|FG000|Overall Study|Protocol Violation|5|||
124761723|NCT03291067|448753458|FG001|Overall Study|Protocol Violation|3|||
124761724|NCT03291067|448753459|FG002|Overall Study|Protocol Violation|4|||
124761725|NCT03291067|448753460|FG003|Overall Study|Protocol Violation|2|||
124761726|NCT03291067|448753457|FG000|Overall Study|Withdrawal by Subject|3|||
124761727|NCT03291067|448753458|FG001|Overall Study|Withdrawal by Subject|4|||
124761728|NCT03291067|448753459|FG002|Overall Study|Withdrawal by Subject|7|||
124761729|NCT03291067|448753460|FG003|Overall Study|Withdrawal by Subject|5|||
124761730|NCT03291067|448753457|FG000|Overall Study|Other|0|||
124694932|NCT01750281|448503507|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
124916064|NCT00979576|449320249|FG001|Combination Treatment Phase|Adverse Event|2|||
124916065|NCT00979576|449320250|FG002|Combination Treatment Phase|Adverse Event|2|||
124916066|NCT00979576|449320248|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
124916067|NCT00979576|449320249|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
124916068|NCT00979576|449320250|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
124916069|NCT05687903|449320251|FG000|Overall Study|Protocol Deviation|1|||
124916070|NCT05687903|449320252|FG001|Overall Study|Protocol Deviation|1|||
124916071|NCT05687903|449320253|FG002|Overall Study|Protocol Deviation|0|||
124916072|NCT05687903|449320254|FG003|Overall Study|Protocol Deviation|1|||
124916073|NCT05687903|449320255|FG004|Overall Study|Protocol Deviation|0|||
124916074|NCT04855760|449320256|FG000|Overall Study|Adverse Event|21|||
124916075|NCT04855760|449320256|FG000|Overall Study|Withdrawal by Subject|116|||
124694933|NCT01750281|448503508|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
124694934|NCT01750281|448503506|FG000|Overall Study|Did not receive treatment|0|||
124694935|NCT01750281|448503507|FG001|Overall Study|Did not receive treatment|1|||
124694936|NCT01750281|448503508|FG002|Overall Study|Did not receive treatment|0|||
124694937|NCT05463705|448503513|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
124694938|NCT05463705|448503514|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
124694939|NCT05463705|448503515|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
124694940|NCT05463705|448503516|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
124694941|NCT05463705|448503517|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
124694942|NCT05463705|448503518|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
124694943|NCT05529173|448503519|FG000|Overall Study|Physician Decision|3|||
124694944|NCT05529173|448503520|FG001|Overall Study|Physician Decision|6|||
124694945|NCT05529173|448503519|FG000|Overall Study|Sample shipment delay more than one day|4|||
124694946|NCT05529173|448503520|FG001|Overall Study|Sample shipment delay more than one day|0|||
124694947|NCT01530997|448503526|FG000|Overall Study|Physician Decision|1|||
124761731|NCT03291067|448753458|FG001|Overall Study|Other|4|||
124761732|NCT03291067|448753459|FG002|Overall Study|Other|4|||
124761733|NCT03291067|448753460|FG003|Overall Study|Other|6|||
124761734|NCT02152631|448753461|FG000|Overall Study|Adverse Event|32|||
124761735|NCT02152631|448753462|FG001|Overall Study|Adverse Event|4|||
124761736|NCT02152631|448753461|FG000|Overall Study|Withdrawal by Subject|13|||
124761737|NCT02152631|448753462|FG001|Overall Study|Withdrawal by Subject|16|||
124761738|NCT02152631|448753461|FG000|Overall Study|Noncompliance with study drug|1|||
124761739|NCT02152631|448753462|FG001|Overall Study|Noncompliance with study drug|0|||
124916076|NCT04855760|449320256|FG000|Overall Study|Lack of Efficacy|21|||
124916077|NCT04855760|449320256|FG000|Overall Study|Lost to Follow-up|49|||
124451700|NCT01092143|447615142|FG003|Overall Study|Non compliance with study medication|0|||
124761740|NCT02152631|448753461|FG000|Overall Study|Physician Decision|1|||
124916078|NCT04855760|449320256|FG000|Overall Study|Protocol Violation|2|||
124694948|NCT01530997|448503526|FG000|Overall Study|Withdrawal by Subject|1|||
124694949|NCT02181738|448503529|FG000|Overall Study|Participant Withdrew Consent|2|||
124694950|NCT02181738|448503530|FG001|Overall Study|Participant Withdrew Consent|1|||
124694951|NCT02181738|448503531|FG002|Overall Study|Participant Withdrew Consent|1|||
124694952|NCT02181738|448503532|FG003|Overall Study|Participant Withdrew Consent|1|||
124694953|NCT02181738|448503529|FG000|Overall Study|Lost to Follow-up|1|||
124694954|NCT02181738|448503530|FG001|Overall Study|Lost to Follow-up|2|||
124694955|NCT02181738|448503531|FG002|Overall Study|Lost to Follow-up|1|||
124694956|NCT02181738|448503532|FG003|Overall Study|Lost to Follow-up|1|||
124694957|NCT02181738|448503529|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
124694958|NCT02181738|448503530|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
124694959|NCT02181738|448503531|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
124694960|NCT02181738|448503532|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
124694961|NCT02181738|448503529|FG000|Overall Study|Poor/Non-Compliance|1|||
124694962|NCT02181738|448503530|FG001|Overall Study|Poor/Non-Compliance|0|||
124694963|NCT02181738|448503531|FG002|Overall Study|Poor/Non-Compliance|2|||
124694964|NCT02181738|448503532|FG003|Overall Study|Poor/Non-Compliance|1|||
124694965|NCT02181738|448503529|FG000|Overall Study|Disease Progression|28|||
124694966|NCT02181738|448503530|FG001|Overall Study|Disease Progression|35|||
124694967|NCT02181738|448503531|FG002|Overall Study|Disease Progression|40|||
124694968|NCT02181738|448503532|FG003|Overall Study|Disease Progression|0|||
124694969|NCT02181738|448503529|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
124694970|NCT02181738|448503530|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
124694971|NCT02181738|448503531|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
124694972|NCT02181738|448503532|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
124694973|NCT02181738|448503529|FG000|Overall Study|Study Drug Toxicity|6|||
124694974|NCT02181738|448503530|FG001|Overall Study|Study Drug Toxicity|11|||
124694975|NCT02181738|448503531|FG002|Overall Study|Study Drug Toxicity|8|||
124694976|NCT02181738|448503532|FG003|Overall Study|Study Drug Toxicity|1|||
124694977|NCT02181738|448503529|FG000|Overall Study|Other Reasons|14|||
124694978|NCT02181738|448503530|FG001|Overall Study|Other Reasons|16|||
124694979|NCT02181738|448503531|FG002|Overall Study|Other Reasons|28|||
124694980|NCT02181738|448503532|FG003|Overall Study|Other Reasons|0|||
124694981|NCT02181738|448503529|FG000|Overall Study|Maximum Clinical Benefit|3|||
124694982|NCT02181738|448503530|FG001|Overall Study|Maximum Clinical Benefit|0|||
124694983|NCT02181738|448503531|FG002|Overall Study|Maximum Clinical Benefit|1|||
124694984|NCT02181738|448503532|FG003|Overall Study|Maximum Clinical Benefit|0|||
124694985|NCT02181738|448503529|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
124694986|NCT02181738|448503530|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
124694987|NCT02181738|448503531|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
124694988|NCT02181738|448503532|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
124694989|NCT01691482|448503536|FG000|Treatment Period 2|Adverse Event|0|||
124694990|NCT01691482|448503537|FG001|Treatment Period 2|Adverse Event|1|||
124694991|NCT01691482|448503536|FG000|Treatment Period 2|Protocol Violation|1|||
124694992|NCT01691482|448503537|FG001|Treatment Period 2|Protocol Violation|1|||
124694993|NCT00183391|448503538|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
124694994|NCT00183391|448503539|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
124694995|NCT00183391|448503538|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
124694996|NCT00183391|448503539|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
124694997|NCT01986751|448503540|FG000|Overall Study|improperly consented|10|||
124694998|NCT01986751|448503541|FG001|Overall Study|improperly consented|2|||
124694999|NCT01478087|448503542|FG000|Overall Study|due to sponsor closing study|1|||
124695000|NCT04576949|448503543|FG000|Overall Study|Adverse Event|1|||
124695001|NCT04576949|448503544|FG001|Overall Study|Adverse Event|3|||
124695002|NCT04576949|448503545|FG002|Overall Study|Adverse Event|2|||
124695003|NCT04576949|448503543|FG000|Overall Study|Withdrawal by Subject|41|||
124695004|NCT04576949|448503544|FG001|Overall Study|Withdrawal by Subject|26|||
124695005|NCT04576949|448503545|FG002|Overall Study|Withdrawal by Subject|18|||
124695006|NCT04576949|448503543|FG000|Overall Study|Physician Decision|3|||
124695007|NCT04576949|448503544|FG001|Overall Study|Physician Decision|0|||
124695008|NCT04576949|448503545|FG002|Overall Study|Physician Decision|0|||
124695009|NCT04576949|448503543|FG000|Overall Study|Death|0|||
124695010|NCT04576949|448503544|FG001|Overall Study|Death|1|||
124695011|NCT04576949|448503545|FG002|Overall Study|Death|0|||
124695012|NCT04576949|448503543|FG000|Overall Study|Lost to Follow-up|29|||
124695013|NCT04576949|448503544|FG001|Overall Study|Lost to Follow-up|37|||
124695014|NCT04576949|448503545|FG002|Overall Study|Lost to Follow-up|24|||
124695015|NCT04576949|448503543|FG000|Overall Study|Other, Not Specified|2|||
124695016|NCT04576949|448503544|FG001|Overall Study|Other, Not Specified|3|||
124916079|NCT04855760|449320256|FG000|Overall Study|Physician Decision|5|||
124916080|NCT04855760|449320256|FG000|Overall Study|Pregnancy|1|||
124916081|NCT04855760|449320256|FG000|Overall Study|Non-Compliance with Study Drug|11|||
124916082|NCT04855760|449320256|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
124916083|NCT04855760|449320256|FG000|Overall Study|Study Completed by Sponsor|202|||
124916084|NCT04855760|449320256|FG000|Overall Study|Other|13|||
124916085|NCT05613205|449320257|FG000|Overall Study|Lost to Follow-up|0|||
124916086|NCT05613205|449320258|FG001|Overall Study|Lost to Follow-up|0|||
124916087|NCT05613205|449320259|FG002|Overall Study|Lost to Follow-up|1|||
124916088|NCT05613205|449320260|FG003|Overall Study|Lost to Follow-up|1|||
124916089|NCT05613205|449320261|FG004|Overall Study|Lost to Follow-up|0|||
124695017|NCT04576949|448503545|FG002|Overall Study|Other, Not Specified|1|||
124695018|NCT04576949|448503543|FG000|Overall Study|Other|1|||
124695019|NCT04576949|448503544|FG001|Overall Study|Other|0|||
124695020|NCT04576949|448503545|FG002|Overall Study|Other|0|||
124916090|NCT05613205|449320257|FG000|Overall Study|Withdrawal by Subject|0|||
124916091|NCT05613205|449320258|FG001|Overall Study|Withdrawal by Subject|0|||
124916092|NCT05613205|449320259|FG002|Overall Study|Withdrawal by Subject|1|||
124916093|NCT05613205|449320260|FG003|Overall Study|Withdrawal by Subject|1|||
124916094|NCT05613205|449320261|FG004|Overall Study|Withdrawal by Subject|0|||
124916095|NCT04869982|449320264|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
124916096|NCT04869982|449320265|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
124916097|NCT04869982|449320264|FG000|Overall Study|Migrated / moved from the study area|1|||
124916098|NCT04869982|449320265|FG001|Overall Study|Migrated / moved from the study area|1|||
124916099|NCT04869982|449320264|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
124916100|NCT04869982|449320265|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
124916101|NCT04869982|449320264|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
124916102|NCT04869982|449320265|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
124916103|NCT04869982|449320264|FG000|Overall Study|Solicited adverse event|2|||
124916104|NCT04869982|449320265|FG001|Overall Study|Solicited adverse event|1|||
124916105|NCT04112316|449320267|FG000|First Period (8 Weeks)|Protocol Violation|1|||
124916106|NCT04112316|449320268|FG001|First Period (8 Weeks)|Protocol Violation|0|||
124916107|NCT04112316|449320267|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
124916108|NCT04112316|449320268|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
124916109|NCT03857620|449320269|FG000|Overall Study|Death|4|||
124916110|NCT03857620|449320270|FG001|Overall Study|Death|5|||
124916111|NCT03857620|449320271|FG002|Overall Study|Death|7|||
124916112|NCT03857620|449320269|FG000|Overall Study|Lost to Follow-up|2|||
124916113|NCT03857620|449320270|FG001|Overall Study|Lost to Follow-up|5|||
124916114|NCT03857620|449320271|FG002|Overall Study|Lost to Follow-up|3|||
124916115|NCT03857620|449320269|FG000|Overall Study|Disease progression or relapse after study registration|1|||
124916116|NCT03857620|449320270|FG001|Overall Study|Disease progression or relapse after study registration|5|||
124916117|NCT03857620|449320271|FG002|Overall Study|Disease progression or relapse after study registration|1|||
124916118|NCT03857620|449320269|FG000|Overall Study|Ineligible|5|||
124916119|NCT03857620|449320270|FG001|Overall Study|Ineligible|0|||
124916120|NCT03857620|449320271|FG002|Overall Study|Ineligible|2|||
124695021|NCT00407030|448503546|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
124695022|NCT00407030|448503547|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
124695023|NCT00407030|448503548|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
124695024|NCT00407030|448503546|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
124916121|NCT03857620|449320269|FG000|Overall Study|No malignancy|1|||
124916122|NCT03857620|449320270|FG001|Overall Study|No malignancy|0|||
124916123|NCT03857620|449320271|FG002|Overall Study|No malignancy|1|||
124916124|NCT03857620|449320269|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
124916125|NCT03857620|449320270|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
124916126|NCT03857620|449320271|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
124916127|NCT03857620|449320269|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
124916128|NCT03857620|449320270|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
124916129|NCT03857620|449320271|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
124916130|NCT03857620|449320269|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
124916131|NCT03857620|449320270|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
124916132|NCT03857620|449320271|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
124916133|NCT03857620|449320269|FG000|Overall Study|Surgery not performed, patient decision|0|||
124916134|NCT03857620|449320270|FG001|Overall Study|Surgery not performed, patient decision|3|||
124916135|NCT03857620|449320271|FG002|Overall Study|Surgery not performed, patient decision|1|||
124916136|NCT03857620|449320269|FG000|Overall Study|Surgery not performed, other reason|3|||
124916137|NCT03857620|449320270|FG001|Overall Study|Surgery not performed, other reason|1|||
124916138|NCT03857620|449320271|FG002|Overall Study|Surgery not performed, other reason|4|||
124916139|NCT03857620|449320269|FG000|Overall Study|Worsening performance status after surgery performed|0|||
124916140|NCT03857620|449320270|FG001|Overall Study|Worsening performance status after surgery performed|1|||
124916141|NCT03857620|449320271|FG002|Overall Study|Worsening performance status after surgery performed|1|||
124916142|NCT02473250|449320272|FG000|Overall Study|Lost to Follow-up|10|||
124916143|NCT02473250|449320272|FG000|Overall Study|Physician Decision|5|||
124916144|NCT02473250|449320272|FG000|Overall Study|Did not tolerate medication washout|3|||
124916145|NCT02473250|449320272|FG000|Overall Study|Antidepressant effect of divalproex|2|||
124916146|NCT00567398|449320273|FG000|Overall Study|Adverse Event|6|||
124916147|NCT00567398|449320274|FG001|Overall Study|Adverse Event|14|||
124916148|NCT00567398|449320273|FG000|Overall Study|Physician Decision|0|||
124916149|NCT00567398|449320274|FG001|Overall Study|Physician Decision|4|||
124916150|NCT00567398|449320273|FG000|Overall Study|Withdrawal by Subject|0|||
124916151|NCT00567398|449320274|FG001|Overall Study|Withdrawal by Subject|2|||
124916152|NCT00567398|449320273|FG000|Overall Study|Renal Transplantation|0|||
124916153|NCT00567398|449320274|FG001|Overall Study|Renal Transplantation|3|||
124761741|NCT02152631|448753462|FG001|Overall Study|Physician Decision|2|||
124761742|NCT02152631|448753461|FG000|Overall Study|Lost to Follow-up|0|||
124761743|NCT02152631|448753462|FG001|Overall Study|Lost to Follow-up|1|||
124761744|NCT02152631|448753461|FG000|Overall Study|On Treatment|19|||
124761745|NCT02152631|448753462|FG001|Overall Study|On Treatment|3|||
124761746|NCT05473026|448753463|FG000|Overall Study|Lost to Follow-up|5|||
124761747|NCT05473026|448753464|FG001|Overall Study|Lost to Follow-up|2|||
124761748|NCT03683173|448753475|FG000|Completed Follow-up|Unavailable|235|||
124761749|NCT03683173|448753476|FG001|Completed Follow-up|Unavailable|217|||
124761750|NCT03683173|448753475|FG000|Completed Follow-up|Refused|69|||
124761751|NCT03683173|448753476|FG001|Completed Follow-up|Refused|59|||
124761752|NCT03683173|448753475|FG000|Completed Follow-up|Disconnected phone|65|||
124761753|NCT03683173|448753476|FG001|Completed Follow-up|Disconnected phone|95|||
124761754|NCT03683173|448753475|FG000|Completed Follow-up|Health issue/deceased|10|||
124761755|NCT03683173|448753476|FG001|Completed Follow-up|Health issue/deceased|4|||
124761756|NCT03683173|448753475|FG000|Completed Follow-up|Moved away|8|||
124761757|NCT03683173|448753476|FG001|Completed Follow-up|Moved away|1|||
124761758|NCT02210000|448753477|FG000|Overall Study|Study Terminated|11|||
124761759|NCT02210000|448753478|FG001|Overall Study|Study Terminated|12|||
124761760|NCT02210000|448753477|FG000|Overall Study|Withdrawal by Subject|7|||
124761761|NCT02210000|448753478|FG001|Overall Study|Withdrawal by Subject|1|||
124761762|NCT02210000|448753477|FG000|Overall Study|Adverse Event|1|||
124761763|NCT02210000|448753478|FG001|Overall Study|Adverse Event|5|||
124916154|NCT00567398|449320273|FG000|Overall Study|Other|1|||
124761764|NCT02210000|448753477|FG000|Overall Study|Lost to Follow-up|0|||
124761765|NCT02210000|448753478|FG001|Overall Study|Lost to Follow-up|2|||
124761766|NCT02210000|448753477|FG000|Overall Study|Physician Decision|0|||
124761767|NCT02210000|448753478|FG001|Overall Study|Physician Decision|1|||
124916155|NCT00567398|449320274|FG001|Overall Study|Other|0|||
124916156|NCT03602014|449320280|FG000|Overall Study|Lost to Follow-up|2|||
124916157|NCT03602014|449320281|FG001|Overall Study|Lost to Follow-up|0|||
124916158|NCT03602014|449320282|FG002|Overall Study|Lost to Follow-up|0|||
124916159|NCT01898494|449320283|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
124916160|NCT01898494|449320284|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
124916161|NCT01898494|449320285|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
124916162|NCT01898494|449320286|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
124916163|NCT01898494|449320287|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
124916164|NCT01898494|449320283|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
124916165|NCT01898494|449320284|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
124916166|NCT01898494|449320285|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
124916167|NCT01898494|449320286|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
124916168|NCT01898494|449320287|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
124916169|NCT01898494|449320283|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
124916170|NCT01898494|449320284|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
124916171|NCT01898494|449320285|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
124916172|NCT01898494|449320286|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
124916173|NCT01898494|449320287|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
124916174|NCT01898494|449320283|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
124916175|NCT01898494|449320284|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
124916176|NCT01898494|449320285|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
124916177|NCT01898494|449320286|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
124916178|NCT01898494|449320287|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
124916179|NCT01898494|449320283|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
124916180|NCT01898494|449320284|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
124916181|NCT01898494|449320285|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
124916182|NCT01898494|449320286|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
124916183|NCT01898494|449320287|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
124916184|NCT01898494|449320283|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
124916185|NCT01898494|449320284|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
124916186|NCT01898494|449320285|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
124916187|NCT01898494|449320286|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
124695025|NCT00407030|448503547|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
124695026|NCT00407030|448503548|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
124695027|NCT00407030|448503546|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
124695028|NCT00407030|448503547|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
124695029|NCT00407030|448503548|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
124695030|NCT00407030|448503546|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
124695031|NCT00407030|448503547|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
124695032|NCT00407030|448503548|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
124695033|NCT00407030|448503546|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
124695034|NCT00407030|448503547|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
124695035|NCT00407030|448503548|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
124695036|NCT00407030|448503546|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
124695037|NCT00407030|448503547|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
124695038|NCT00407030|448503548|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
124695039|NCT00407030|448503546|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
124695040|NCT00407030|448503547|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
124695041|NCT00407030|448503548|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
124695042|NCT00407030|448503546|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
124695043|NCT00407030|448503547|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
124695044|NCT00407030|448503548|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
124695045|NCT00407030|448503546|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
124695046|NCT00407030|448503547|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
124695047|NCT00407030|448503548|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
124695048|NCT00407030|448503546|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
124695049|NCT00407030|448503547|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
124916188|NCT01898494|449320287|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
124916189|NCT01898494|449320283|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
124916190|NCT01898494|449320284|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
124916191|NCT01898494|449320285|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
124916192|NCT01898494|449320286|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
124916193|NCT01898494|449320287|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
124916194|NCT01898494|449320283|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
124916195|NCT01898494|449320284|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
124916196|NCT01898494|449320285|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
124916197|NCT01898494|449320286|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
124916198|NCT01898494|449320287|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
124916199|NCT01898494|449320283|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
124916200|NCT01898494|449320284|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
124916201|NCT01898494|449320285|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
124916202|NCT01898494|449320286|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
124916203|NCT01898494|449320287|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
124916204|NCT01898494|449320283|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
124916205|NCT01898494|449320284|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
124916206|NCT01898494|449320285|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
124916207|NCT01898494|449320286|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
124916208|NCT01898494|449320287|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
124916209|NCT01898494|449320283|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
124916210|NCT01898494|449320284|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
124916211|NCT01898494|449320285|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
124916212|NCT01898494|449320286|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
124916213|NCT01898494|449320287|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
124916214|NCT01898494|449320283|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
124916215|NCT01898494|449320284|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
124916216|NCT01898494|449320285|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
124916217|NCT01898494|449320286|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
124916218|NCT01898494|449320287|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
124695050|NCT00407030|448503548|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
124695051|NCT00407030|448503546|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
124695052|NCT00407030|448503547|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
124695053|NCT00407030|448503548|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
124695054|NCT00407030|448503546|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
124695055|NCT00407030|448503547|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
124695056|NCT00407030|448503548|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
124695057|NCT00407030|448503546|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
124695058|NCT00407030|448503547|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
124695059|NCT00407030|448503548|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
124761768|NCT01329263|448753481|FG000|Overall Study|Lost to Follow-up|4|||
124761769|NCT01329263|448753482|FG001|Overall Study|Lost to Follow-up|21|||
124761770|NCT01329263|448753481|FG000|Overall Study|Withdrawal by Subject|1|||
124761771|NCT01329263|448753482|FG001|Overall Study|Withdrawal by Subject|2|||
124761772|NCT00308139|448753484|FG000|Overall Study|Adverse Event|20|||
124761773|NCT00308139|448753485|FG001|Overall Study|Adverse Event|14|||
124761774|NCT00308139|448753484|FG000|Overall Study|Lost to Follow-up|13|||
124761775|NCT00308139|448753485|FG001|Overall Study|Lost to Follow-up|8|||
124761776|NCT00308139|448753484|FG000|Overall Study|Protocol Violation|3|||
124761777|NCT00308139|448753485|FG001|Overall Study|Protocol Violation|2|||
124451701|NCT01092143|447615143|FG004|Overall Study|Non compliance with study medication|1|||
124451702|NCT01092143|447615139|FG000|Overall Study|Randomized by mistake|0|||
124451703|NCT01092143|447615140|FG001|Overall Study|Randomized by mistake|0|||
124451704|NCT01092143|447615141|FG002|Overall Study|Randomized by mistake|0|||
124451705|NCT01092143|447615142|FG003|Overall Study|Randomized by mistake|1|||
124761778|NCT00308139|448753484|FG000|Overall Study|Withdrawal of Consent|40|||
124761779|NCT00308139|448753485|FG001|Overall Study|Withdrawal of Consent|42|||
124761780|NCT00308139|448753484|FG000|Overall Study|Investigator Decision|11|||
124761781|NCT00308139|448753485|FG001|Overall Study|Investigator Decision|10|||
124761782|NCT00308139|448753484|FG000|Overall Study|Loss of Glucose Control|5|||
124451706|NCT01092143|447615143|FG004|Overall Study|Randomized by mistake|0|||
124451707|NCT01092143|447615139|FG000|Overall Study|Pregnancy|0|||
124451708|NCT01092143|447615140|FG001|Overall Study|Pregnancy|0|||
124761783|NCT00308139|448753485|FG001|Overall Study|Loss of Glucose Control|7|||
124761784|NCT00308139|448753484|FG000|Overall Study|Administrative|1|||
124761785|NCT00308139|448753485|FG001|Overall Study|Administrative|4|||
124761786|NCT00308139|448753484|FG000|Overall Study|Other|1|||
124761787|NCT00308139|448753485|FG001|Overall Study|Other|0|||
124761788|NCT00833040|448753488|FG000|Overall Study|Adverse Event|0|||
124761789|NCT00833040|448753489|FG001|Overall Study|Adverse Event|0|||
124761790|NCT00833040|448753490|FG002|Overall Study|Adverse Event|0|||
124761791|NCT00833040|448753491|FG003|Overall Study|Adverse Event|0|||
124761792|NCT00833040|448753492|FG004|Overall Study|Adverse Event|0|||
124545382|NCT01298362|447951185|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
124761793|NCT00833040|448753493|FG005|Overall Study|Adverse Event|1|||
124761794|NCT02313766|448753494|FG000|Overall Study|surgery cancelled|1|||
124761795|NCT02313766|448753495|FG001|Overall Study|surgery cancelled|0|||
124761796|NCT02313766|448753496|FG002|Overall Study|surgery cancelled|0|||
124761797|NCT02313766|448753494|FG000|Overall Study|Lost to Follow-up|0|||
124761798|NCT02313766|448753495|FG001|Overall Study|Lost to Follow-up|2|||
124761799|NCT02313766|448753496|FG002|Overall Study|Lost to Follow-up|0|||
124761800|NCT02313766|448753494|FG000|Overall Study|Adverse Event|0|||
124761801|NCT02313766|448753495|FG001|Overall Study|Adverse Event|1|||
124761802|NCT02313766|448753496|FG002|Overall Study|Adverse Event|0|||
124761803|NCT02193776|448753498|FG000|Overall Study|Consent withdrawn|1|||
124761804|NCT02193776|448753499|FG001|Overall Study|Consent withdrawn|0|||
124761805|NCT02193776|448753500|FG002|Overall Study|Consent withdrawn|0|||
124761806|NCT02193776|448753501|FG003|Overall Study|Consent withdrawn|0|||
124761807|NCT02193776|448753498|FG000|Overall Study|Failure to comply with protocol|0|||
124761808|NCT02193776|448753499|FG001|Overall Study|Failure to comply with protocol|1|||
124761809|NCT02193776|448753500|FG002|Overall Study|Failure to comply with protocol|0|||
124761810|NCT02193776|448753501|FG003|Overall Study|Failure to comply with protocol|0|||
124761811|NCT02193776|448753498|FG000|Overall Study|Investigator/Sponsor decision|1|||
124761812|NCT02193776|448753499|FG001|Overall Study|Investigator/Sponsor decision|1|||
124761813|NCT02193776|448753500|FG002|Overall Study|Investigator/Sponsor decision|0|||
124761814|NCT02193776|448753501|FG003|Overall Study|Investigator/Sponsor decision|0|||
124761815|NCT02193776|448753498|FG000|Overall Study|Death|1|||
124761816|NCT02193776|448753499|FG001|Overall Study|Death|0|||
124761817|NCT02193776|448753500|FG002|Overall Study|Death|0|||
124761818|NCT02193776|448753501|FG003|Overall Study|Death|0|||
124761819|NCT02193776|448753498|FG000|Overall Study|Adverse event/Specific toxicity|5|||
124761820|NCT02193776|448753499|FG001|Overall Study|Adverse event/Specific toxicity|5|||
124761821|NCT02193776|448753500|FG002|Overall Study|Adverse event/Specific toxicity|2|||
124761822|NCT02193776|448753501|FG003|Overall Study|Adverse event/Specific toxicity|2|||
124761823|NCT01169103|448753502|FG000|Overall Study|Lost to Follow-up|3|||
124761824|NCT01169103|448753503|FG001|Overall Study|Lost to Follow-up|3|||
124761825|NCT01169103|448753502|FG000|Overall Study|Withdrawal by Subject|3|||
124761826|NCT01169103|448753503|FG001|Overall Study|Withdrawal by Subject|1|||
124761827|NCT01458639|448753504|FG000|Overall Study|Physician Decision|4|||
124761828|NCT01458639|448753504|FG000|Overall Study|Equipment issue|1|||
124761829|NCT01458639|448753504|FG000|Overall Study|Inability to obtain subject blood sample|1|||
124761830|NCT01884077|448753505|FG000|Overall Study|screen fail|0|||
124761831|NCT01884077|448753506|FG001|Overall Study|screen fail|2|||
124761832|NCT01884077|448753505|FG000|Overall Study|canceled surgery|2|||
124761833|NCT01884077|448753506|FG001|Overall Study|canceled surgery|0|||
124761834|NCT01884077|448753505|FG000|Overall Study|Lost to Follow-up|0|||
124761835|NCT01884077|448753506|FG001|Overall Study|Lost to Follow-up|4|||
124761836|NCT01884077|448753505|FG000|Overall Study|study closed|6|||
124761837|NCT01884077|448753506|FG001|Overall Study|study closed|4|||
124761838|NCT00981149|448753507|FG000|Overall Study|Lost to Follow-up|1|||
124761839|NCT00981149|448753508|FG001|Overall Study|Lost to Follow-up|2|||
124761840|NCT00981149|448753507|FG000|Overall Study|Withdrawal by Subject|1|||
124761841|NCT00981149|448753508|FG001|Overall Study|Withdrawal by Subject|1|||
124761842|NCT02648204|448753509|FG000|Overall Study|Withdrawal by Subject|12|||
124761843|NCT02648204|448753510|FG001|Overall Study|Withdrawal by Subject|8|||
124761844|NCT02648204|448753511|FG002|Overall Study|Withdrawal by Subject|2|||
124761845|NCT02648204|448753512|FG003|Overall Study|Withdrawal by Subject|6|||
124761846|NCT02648204|448753509|FG000|Overall Study|Lost to Follow-up|5|||
124761847|NCT02648204|448753510|FG001|Overall Study|Lost to Follow-up|8|||
124761848|NCT02648204|448753511|FG002|Overall Study|Lost to Follow-up|4|||
124761849|NCT02648204|448753512|FG003|Overall Study|Lost to Follow-up|6|||
124761850|NCT02648204|448753509|FG000|Overall Study|Missing follow-up information|4|||
124761851|NCT02648204|448753510|FG001|Overall Study|Missing follow-up information|4|||
124761852|NCT02648204|448753511|FG002|Overall Study|Missing follow-up information|4|||
124761853|NCT02648204|448753512|FG003|Overall Study|Missing follow-up information|2|||
124761854|NCT02648204|448753509|FG000|Overall Study|Death|1|||
124761855|NCT02648204|448753510|FG001|Overall Study|Death|1|||
124545383|NCT01298362|447951186|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
124761856|NCT02648204|448753511|FG002|Overall Study|Death|2|||
124761857|NCT02648204|448753512|FG003|Overall Study|Death|2|||
124761858|NCT02648204|448753509|FG000|Overall Study|Adverse Event|0|||
124695060|NCT01489358|448503549|FG000|Overall Study|Lost to Follow-up|0|||
124695061|NCT01489358|448503550|FG001|Overall Study|Lost to Follow-up|0|||
124695062|NCT01489358|448503551|FG002|Overall Study|Lost to Follow-up|2|||
124695063|NCT00736476|448503552|FG000|Overall Study|Adverse Event|1|||
124695064|NCT00736476|448503553|FG001|Overall Study|Adverse Event|0|||
124695065|NCT03518203|448503559|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
124695066|NCT03518203|448503559|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
124695067|NCT02829957|448503560|FG000|Overall Study|Lost to Follow-up|2|||
124695068|NCT02829957|448503561|FG001|Overall Study|Lost to Follow-up|1|||
124695069|NCT04560309|448503563|FG000|Overall Study|Meet drop out criteria|1|||
124695070|NCT04560309|448503564|FG001|Overall Study|Meet drop out criteria|1|||
124695071|NCT05085405|448503565|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
124695072|NCT05085405|448503566|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
124695073|NCT05085405|448503567|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
124451709|NCT01092143|447615141|FG002|Overall Study|Pregnancy|0|||
124695074|NCT05085405|448503568|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
124695075|NCT05085405|448503569|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
124695076|NCT05085405|448503570|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
124695077|NCT05085405|448503565|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
124695078|NCT05085405|448503566|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
124695079|NCT05085405|448503567|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
124916219|NCT01898494|449320283|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
124916220|NCT01898494|449320284|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
124916221|NCT01898494|449320285|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
124916222|NCT01898494|449320286|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
124916223|NCT01898494|449320287|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
124916224|NCT01898494|449320283|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
124916225|NCT01898494|449320284|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
124916226|NCT01898494|449320285|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
124916227|NCT01898494|449320286|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
124916228|NCT01898494|449320287|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
124916229|NCT03289039|449320288|FG000|Overall Study|Withdrawal by Subject|0|||
124916230|NCT03289039|449320289|FG001|Overall Study|Withdrawal by Subject|1|||
124916231|NCT03289039|449320288|FG000|Overall Study|Became ineligible prior to treatment start|0|||
124916232|NCT03289039|449320289|FG001|Overall Study|Became ineligible prior to treatment start|1|||
124916233|NCT03289039|449320288|FG000|Overall Study|progressed before treatment start|1|||
124916234|NCT03289039|449320289|FG001|Overall Study|progressed before treatment start|0|||
124916235|NCT04732494|449320292|FG000|Overall Study|Death|39|||
124916236|NCT04732494|449320293|FG001|Overall Study|Death|36|||
124916237|NCT04732494|449320292|FG000|Overall Study|Study Closed by Sponsor|20|||
124916238|NCT04732494|449320293|FG001|Overall Study|Study Closed by Sponsor|15|||
124916239|NCT04732494|449320292|FG000|Overall Study|Withdrawal by Subject|2|||
124916240|NCT04732494|449320293|FG001|Overall Study|Withdrawal by Subject|7|||
124916241|NCT04732494|449320292|FG000|Overall Study|Lost to Follow-up|1|||
124916242|NCT04732494|449320293|FG001|Overall Study|Lost to Follow-up|5|||
124916243|NCT03897686|449320294|FG000|Overall Study|Protocol Violation|1|||
124916244|NCT03897686|449320295|FG001|Overall Study|Protocol Violation|1|||
124916245|NCT03897686|449320294|FG000|Overall Study|Withdrawal by Subject|1|||
124916246|NCT03897686|449320295|FG001|Overall Study|Withdrawal by Subject|1|||
124916247|NCT04905407|449320296|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
124916248|NCT04905407|449320297|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
124916249|NCT04905407|449320298|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
124916250|NCT04905407|449320299|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
124916251|NCT04905407|449320296|FG000|Part 1 and Part 2|Death|7|||
124916252|NCT04905407|449320297|FG001|Part 1 and Part 2|Death|7|||
124916253|NCT04905407|449320298|FG002|Part 1 and Part 2|Death|7|||
124916254|NCT04905407|449320299|FG003|Part 1 and Part 2|Death|0|||
124916255|NCT04905407|449320296|FG000|Part 1 and Part 2|Other than specified|0|||
124916256|NCT04905407|449320297|FG001|Part 1 and Part 2|Other than specified|0|||
124916257|NCT04905407|449320298|FG002|Part 1 and Part 2|Other than specified|1|||
124916258|NCT04905407|449320299|FG003|Part 1 and Part 2|Other than specified|0|||
124916259|NCT04905407|449320296|FG000|Part 3|Death|0|||
124916260|NCT04905407|449320297|FG001|Part 3|Death|0|||
124916261|NCT04905407|449320298|FG002|Part 3|Death|0|||
124916262|NCT04905407|449320299|FG003|Part 3|Death|2|||
124916263|NCT03263026|449320302|FG000|Overall Study|Withdrawal by Subject|1|||
124916264|NCT03263026|449320303|FG001|Overall Study|Withdrawal by Subject|0|||
124916265|NCT03263026|449320302|FG000|Overall Study|Death|1|||
124916266|NCT03263026|449320303|FG001|Overall Study|Death|0|||
124916267|NCT03263026|449320302|FG000|Overall Study|Other/ Various|41|||
124916268|NCT03263026|449320303|FG001|Overall Study|Other/ Various|29|||
124916269|NCT02697136|449320305|FG000|Overall Study|Adverse Event|3|||
124916270|NCT02697136|449320306|FG001|Overall Study|Adverse Event|0|||
124761859|NCT02648204|448753510|FG001|Overall Study|Adverse Event|0|||
124761860|NCT02648204|448753511|FG002|Overall Study|Adverse Event|1|||
124761861|NCT02648204|448753512|FG003|Overall Study|Adverse Event|0|||
124761862|NCT02634333|448753513|FG000|Overall Study|Completed out of Window|3|||
124761863|NCT02634333|448753514|FG001|Overall Study|Completed out of Window|2|||
124761864|NCT02634333|448753513|FG000|Overall Study|Missed Visit|5|||
124761865|NCT02634333|448753514|FG001|Overall Study|Missed Visit|2|||
124761866|NCT02634333|448753513|FG000|Overall Study|Lost to Follow-up|12|||
124761867|NCT02634333|448753514|FG001|Overall Study|Lost to Follow-up|7|||
124761868|NCT02634333|448753513|FG000|Overall Study|Withdrawal by Subject|9|||
124761869|NCT02634333|448753514|FG001|Overall Study|Withdrawal by Subject|13|||
124916271|NCT01095796|449320307|FG000|Overall Study|Randomized but Not Treated|5|||
124916272|NCT01095796|449320308|FG001|Overall Study|Randomized but Not Treated|2|||
124916273|NCT01095796|449320307|FG000|Overall Study|Adverse Event|9|||
124916274|NCT01095796|449320308|FG001|Overall Study|Adverse Event|19|||
124916275|NCT01095796|449320307|FG000|Overall Study|Death|3|||
124916276|NCT01095796|449320308|FG001|Overall Study|Death|2|||
124916277|NCT01095796|449320307|FG000|Overall Study|Pregnancy|2|||
124916278|NCT01095796|449320308|FG001|Overall Study|Pregnancy|0|||
124916279|NCT01095796|449320307|FG000|Overall Study|Lack of Efficacy|5|||
124916280|NCT01095796|449320308|FG001|Overall Study|Lack of Efficacy|3|||
124916281|NCT01095796|449320307|FG000|Overall Study|Investigator's Discretion|7|||
124916282|NCT01095796|449320308|FG001|Overall Study|Investigator's Discretion|2|||
124916283|NCT01095796|449320307|FG000|Overall Study|Withdrew Consent|16|||
124451710|NCT01092143|447615142|FG003|Overall Study|Pregnancy|1|||
124451711|NCT01092143|447615143|FG004|Overall Study|Pregnancy|0|||
124451712|NCT00199836|447615146|FG000|Overall Study|Progressive Disease|5|||
124451713|NCT00199836|447615146|FG000|Overall Study|Death|1|||
124451714|NCT01708291|447615147|FG000|Overall Study|fighting|2|||
124451715|NCT01708291|447615148|FG001|Overall Study|fighting|1|||
124451716|NCT01843972|447615149|FG000|Overall Study|Withdrawal by Subject|0|||
124451717|NCT01843972|447615150|FG001|Overall Study|Withdrawal by Subject|0|||
124451718|NCT01843972|447615151|FG002|Overall Study|Withdrawal by Subject|0|||
124451719|NCT01843972|447615152|FG003|Overall Study|Withdrawal by Subject|0|||
124451720|NCT01843972|447615153|FG004|Overall Study|Withdrawal by Subject|1|||
124451721|NCT01843972|447615154|FG005|Overall Study|Withdrawal by Subject|0|||
124916284|NCT01095796|449320308|FG001|Overall Study|Withdrew Consent|22|||
124916285|NCT01095796|449320307|FG000|Overall Study|Lost to Follow-up|27|||
124916286|NCT01095796|449320308|FG001|Overall Study|Lost to Follow-up|29|||
124916287|NCT01095796|449320307|FG000|Overall Study|Participant Noncompliance|5|||
124916288|NCT01095796|449320308|FG001|Overall Study|Participant Noncompliance|10|||
124916289|NCT01095796|449320307|FG000|Overall Study|Protocol Violation|1|||
124916290|NCT01095796|449320308|FG001|Overall Study|Protocol Violation|0|||
124916291|NCT01095796|449320307|FG000|Overall Study|Participant Transferred to Another Study|215|||
124916292|NCT01095796|449320308|FG001|Overall Study|Participant Transferred to Another Study|200|||
124916293|NCT04116736|449320311|FG000|Overall Study|Withdrew consent during study|3|||
124916294|NCT04116736|449320312|FG001|Overall Study|Withdrew consent during study|1|||
124916295|NCT04116736|449320311|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
124916296|NCT04116736|449320312|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
124916297|NCT04116736|449320311|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
124916298|NCT04116736|449320312|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
124916299|NCT04116736|449320311|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
124916300|NCT04116736|449320312|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
124916301|NCT04116736|449320311|FG000|Overall Study|Subject was enrolled in error|2|||
124916302|NCT04116736|449320312|FG001|Overall Study|Subject was enrolled in error|0|||
124916303|NCT04116736|449320311|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
124916304|NCT04116736|449320312|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
124916305|NCT04116736|449320311|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
124916306|NCT04116736|449320312|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
124916307|NCT04116736|449320311|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
124916308|NCT04116736|449320312|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
124916309|NCT05512962|449320316|FG000|Overall Study|Withdrawal by Subject|1|||
124916310|NCT05512962|449320317|FG001|Overall Study|Withdrawal by Subject|0|||
124916311|NCT00879333|449320318|FG000|Overall Study|Adverse Event|94|||
124916312|NCT00879333|449320319|FG001|Overall Study|Adverse Event|34|||
124916313|NCT00879333|449320318|FG000|Overall Study|Abnormal Laboratory Value|1|||
124916314|NCT00879333|449320319|FG001|Overall Study|Abnormal Laboratory Value|0|||
124916315|NCT00879333|449320318|FG000|Overall Study|Withdrawal by Subject|20|||
124916316|NCT00879333|449320319|FG001|Overall Study|Withdrawal by Subject|7|||
124916317|NCT00879333|449320318|FG000|Overall Study|Lost to Follow-up|2|||
124916318|NCT00879333|449320319|FG001|Overall Study|Lost to Follow-up|1|||
124916319|NCT00879333|449320318|FG000|Overall Study|Administrative Problems|2|||
124916320|NCT00879333|449320319|FG001|Overall Study|Administrative Problems|0|||
124916321|NCT00879333|449320318|FG000|Overall Study|Death|16|||
124916322|NCT00879333|449320319|FG001|Overall Study|Death|5|||
124916323|NCT00879333|449320318|FG000|Overall Study|Disease Progression|292|||
124916324|NCT00879333|449320319|FG001|Overall Study|Disease Progression|169|||
124916325|NCT00879333|449320318|FG000|Overall Study|Protocol Violation|1|||
124916326|NCT00879333|449320319|FG001|Overall Study|Protocol Violation|1|||
124916327|NCT02671435|449320321|FG000|Overall Study|Death|1|||
124916328|NCT02671435|449320322|FG001|Overall Study|Death|3|||
124916329|NCT02671435|449320323|FG002|Overall Study|Death|0|||
124916330|NCT02671435|449320324|FG003|Overall Study|Death|16|||
124916331|NCT02671435|449320325|FG004|Overall Study|Death|14|||
124916332|NCT02671435|449320326|FG005|Overall Study|Death|29|||
124916333|NCT02671435|449320327|FG006|Overall Study|Death|34|||
124916334|NCT02671435|449320328|FG007|Overall Study|Death|28|||
124916335|NCT02671435|449320329|FG008|Overall Study|Death|19|||
124451722|NCT01843972|447615155|FG006|Overall Study|Withdrawal by Subject|0|||
124451723|NCT01843972|447615156|FG007|Overall Study|Withdrawal by Subject|0|||
124451724|NCT01843972|447615157|FG008|Overall Study|Withdrawal by Subject|0|||
124451725|NCT01843972|447615158|FG009|Overall Study|Withdrawal by Subject|0|||
124545384|NCT00762073|447951189|FG000|Overall Study|Lack of Efficacy|1|||
124695080|NCT05085405|448503568|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
124695081|NCT05085405|448503569|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
124916336|NCT02671435|449320330|FG009|Overall Study|Death|10|||
124916337|NCT02671435|449320331|FG010|Overall Study|Death|8|||
124916338|NCT02671435|449320332|FG011|Overall Study|Death|29|||
124761870|NCT02634333|448753513|FG000|Overall Study|Death|11|||
124761871|NCT02634333|448753514|FG001|Overall Study|Death|8|||
124761872|NCT01794000|448753515|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
124761873|NCT01794000|448753516|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
124761874|NCT01794000|448753515|FG000|Double-Blind Phase (DBP)|Death|1|||
124761875|NCT01794000|448753516|FG001|Double-Blind Phase (DBP)|Death|2|||
124761876|NCT01794000|448753515|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
124761877|NCT01794000|448753516|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
124761878|NCT01794000|448753515|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
124761879|NCT01794000|448753516|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
124761880|NCT01794000|448753515|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
124761881|NCT01794000|448753516|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
124761882|NCT01794000|448753515|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
124761883|NCT01794000|448753516|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
124761884|NCT01794000|448753515|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
124761885|NCT01794000|448753516|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
124761886|NCT01794000|448753515|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
124761887|NCT01794000|448753516|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
124761888|NCT02748863|448753517|FG000|Treatment Period 1|Adverse Event|0|||
124761889|NCT02748863|448753518|FG001|Treatment Period 1|Adverse Event|1|||
124761890|NCT02748863|448753519|FG002|Treatment Period 1|Adverse Event|0|||
124761891|NCT02748863|448753520|FG003|Treatment Period 1|Adverse Event|0|||
124761892|NCT02748863|448753521|FG004|Treatment Period 1|Adverse Event|0|||
124761893|NCT02748863|448753517|FG000|Treatment Period 1|Lack of Efficacy|0|||
124761894|NCT02748863|448753518|FG001|Treatment Period 1|Lack of Efficacy|0|||
124761895|NCT02748863|448753519|FG002|Treatment Period 1|Lack of Efficacy|1|||
124761896|NCT02748863|448753520|FG003|Treatment Period 1|Lack of Efficacy|0|||
124761897|NCT02748863|448753521|FG004|Treatment Period 1|Lack of Efficacy|0|||
124761898|NCT02748863|448753517|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124451726|NCT01854645|447615164|FG000|Overall Study|Protocol-Specified Criteria|13|||
124761899|NCT02748863|448753518|FG001|Treatment Period 1|Withdrawal by Subject|1|||
124695082|NCT05085405|448503570|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
124695083|NCT01370538|448503573|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
124695084|NCT01370538|448503574|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
124695085|NCT01370538|448503573|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124695086|NCT01370538|448503574|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
124695087|NCT01370538|448503573|FG000|Overall Study|Adverse Event|1|||
124761900|NCT02748863|448753519|FG002|Treatment Period 1|Withdrawal by Subject|1|||
124761901|NCT02748863|448753520|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124761902|NCT02748863|448753521|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124761903|NCT02748863|448753517|FG000|Treatment Period 2|Lost to Follow-up|2|||
124761904|NCT02748863|448753518|FG001|Treatment Period 2|Lost to Follow-up|0|||
124761905|NCT02748863|448753519|FG002|Treatment Period 2|Lost to Follow-up|0|||
124761906|NCT02748863|448753520|FG003|Treatment Period 2|Lost to Follow-up|0|||
124761907|NCT02748863|448753521|FG004|Treatment Period 2|Lost to Follow-up|0|||
124761908|NCT02748863|448753517|FG000|Treatment Period 2|Adverse Event|3|||
124761909|NCT02748863|448753518|FG001|Treatment Period 2|Adverse Event|2|||
124761910|NCT02748863|448753519|FG002|Treatment Period 2|Adverse Event|0|||
124761911|NCT02748863|448753520|FG003|Treatment Period 2|Adverse Event|2|||
124761912|NCT02748863|448753521|FG004|Treatment Period 2|Adverse Event|0|||
124761913|NCT02748863|448753517|FG000|Treatment Period 2|Lack of Efficacy|0|||
124761914|NCT02748863|448753518|FG001|Treatment Period 2|Lack of Efficacy|1|||
124761915|NCT02748863|448753519|FG002|Treatment Period 2|Lack of Efficacy|0|||
124761916|NCT02748863|448753520|FG003|Treatment Period 2|Lack of Efficacy|0|||
124761917|NCT02748863|448753521|FG004|Treatment Period 2|Lack of Efficacy|0|||
124761918|NCT02748863|448753517|FG000|Treatment Period 2|Pregnancy|0|||
124761919|NCT02748863|448753518|FG001|Treatment Period 2|Pregnancy|0|||
124761920|NCT02748863|448753519|FG002|Treatment Period 2|Pregnancy|0|||
124695088|NCT01370538|448503574|FG001|Overall Study|Adverse Event|0|||
124695089|NCT01370538|448503573|FG000|Overall Study|Protocol Violation|8|||
124695090|NCT01370538|448503574|FG001|Overall Study|Protocol Violation|5|||
124695091|NCT01370538|448503573|FG000|Overall Study|Development of study specific withdrawal|1|||
124695092|NCT01370538|448503574|FG001|Overall Study|Development of study specific withdrawal|1|||
124695093|NCT01370538|448503573|FG000|Overall Study|Lost to follow up|6|||
124695094|NCT01370538|448503574|FG001|Overall Study|Lost to follow up|10|||
124695095|NCT04193527|448503575|FG000|Overall Study|Other|1|||
124695096|NCT04193527|448503576|FG001|Overall Study|Other|1|||
124695097|NCT04193527|448503577|FG002|Overall Study|Other|0|||
124695098|NCT02366130|448503578|FG000|Overall Study|Withdrawal by Subject|3|||
124695099|NCT02366130|448503578|FG000|Overall Study|Ineligible|6|||
124695100|NCT00567112|448503579|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
124695101|NCT00567112|448503580|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
124695102|NCT00567112|448503581|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
124695103|NCT00567112|448503579|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
124695104|NCT00567112|448503580|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
124695105|NCT00567112|448503581|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
124695106|NCT00567112|448503579|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
124695107|NCT00567112|448503580|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
124695108|NCT00567112|448503581|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
124695109|NCT04595370|448503592|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
124695110|NCT04595370|448503593|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
124695111|NCT04595370|448503594|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
124761921|NCT02748863|448753520|FG003|Treatment Period 2|Pregnancy|0|||
124761922|NCT02748863|448753521|FG004|Treatment Period 2|Pregnancy|1|||
124761923|NCT04537793|448753522|FG000|Part B (24 Weeks)|Adverse Event|0|||
124761924|NCT04537793|448753523|FG001|Part B (24 Weeks)|Adverse Event|1|||
124761925|NCT01255423|448753524|FG000|Overall Study|Abnormal Laboratory value|3|||
124761926|NCT01255423|448753525|FG001|Overall Study|Abnormal Laboratory value|2|||
124695112|NCT04595370|448503595|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
124695113|NCT04595370|448503596|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
124695114|NCT04595370|448503597|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
124695115|NCT04595370|448503592|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
124695116|NCT04595370|448503593|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
124761927|NCT01255423|448753524|FG000|Overall Study|Use of prohibited medications|0|||
124761928|NCT01255423|448753525|FG001|Overall Study|Use of prohibited medications|1|||
124761929|NCT00657046|448753527|FG000|Overall Study|Adverse Event|1|||
124761930|NCT00657046|448753528|FG001|Overall Study|Adverse Event|1|||
124761931|NCT00657046|448753529|FG002|Overall Study|Adverse Event|0|||
124761932|NCT00657046|448753527|FG000|Overall Study|Protocol Violation|2|||
124695117|NCT04595370|448503594|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
124695118|NCT04595370|448503595|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
124695119|NCT04595370|448503596|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
124695120|NCT04595370|448503597|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
124761933|NCT00657046|448753528|FG001|Overall Study|Protocol Violation|2|||
124761934|NCT00657046|448753529|FG002|Overall Study|Protocol Violation|0|||
124761935|NCT00657046|448753527|FG000|Overall Study|Withdrawal by Subject|1|||
124761936|NCT00657046|448753528|FG001|Overall Study|Withdrawal by Subject|0|||
124761937|NCT00657046|448753529|FG002|Overall Study|Withdrawal by Subject|0|||
124761938|NCT00657046|448753527|FG000|Overall Study|Death|0|||
124761939|NCT00657046|448753528|FG001|Overall Study|Death|0|||
124761940|NCT00657046|448753529|FG002|Overall Study|Death|1|||
124761941|NCT00657046|448753527|FG000|Overall Study|Surgery|0|||
124761942|NCT00657046|448753528|FG001|Overall Study|Surgery|0|||
124761943|NCT00657046|448753529|FG002|Overall Study|Surgery|1|||
124761944|NCT01858363|448753530|FG000|Overall Study|Death|35|||
124761945|NCT01858363|448753531|FG001|Overall Study|Death|9|||
124761946|NCT01858363|448753530|FG000|Overall Study|Withdrawal by Subject|28|||
124761947|NCT01858363|448753531|FG001|Overall Study|Withdrawal by Subject|14|||
124761948|NCT01858363|448753530|FG000|Overall Study|Lost to Follow-up|13|||
124761949|NCT01858363|448753531|FG001|Overall Study|Lost to Follow-up|3|||
124761950|NCT03480152|448753541|FG000|Phase I|Signed consent. Died before treatment.|1|||
124761951|NCT03480152|448753542|FG001|Phase I|Signed consent. Died before treatment.|0|||
124761952|NCT03480152|448753543|FG002|Phase I|Signed consent. Died before treatment.|0|||
124761953|NCT00101686|448753544|FG000|Overall Study|Progressive Disease|37|||
124761954|NCT00101686|448753545|FG001|Overall Study|Progressive Disease|28|||
124761955|NCT00101686|448753546|FG002|Overall Study|Progressive Disease|37|||
124761956|NCT00101686|448753547|FG003|Overall Study|Progressive Disease|38|||
124761957|NCT00101686|448753548|FG004|Overall Study|Progressive Disease|28|||
124761958|NCT00101686|448753549|FG005|Overall Study|Progressive Disease|25|||
124761959|NCT00101686|448753550|FG006|Overall Study|Progressive Disease|5|||
124761960|NCT00101686|448753551|FG007|Overall Study|Progressive Disease|7|||
124761961|NCT00101686|448753552|FG008|Overall Study|Progressive Disease|10|||
124761962|NCT00101686|448753553|FG009|Overall Study|Progressive Disease|8|||
124761963|NCT00101686|448753544|FG000|Overall Study|initiation other anti-cancer treatment|4|||
124761964|NCT00101686|448753545|FG001|Overall Study|initiation other anti-cancer treatment|3|||
124761965|NCT00101686|448753546|FG002|Overall Study|initiation other anti-cancer treatment|4|||
124761966|NCT00101686|448753547|FG003|Overall Study|initiation other anti-cancer treatment|3|||
124761967|NCT00101686|448753548|FG004|Overall Study|initiation other anti-cancer treatment|1|||
124916339|NCT02671435|449320333|FG012|Overall Study|Death|29|||
124916340|NCT02671435|449320334|FG013|Overall Study|Death|29|||
124916341|NCT02671435|449320335|FG014|Overall Study|Death|27|||
124916342|NCT02671435|449320321|FG000|Overall Study|Lost to Follow-up|0|||
124916343|NCT02671435|449320322|FG001|Overall Study|Lost to Follow-up|0|||
124916344|NCT02671435|449320323|FG002|Overall Study|Lost to Follow-up|1|||
124916345|NCT02671435|449320324|FG003|Overall Study|Lost to Follow-up|0|||
124916346|NCT02671435|449320325|FG004|Overall Study|Lost to Follow-up|1|||
124916347|NCT02671435|449320326|FG005|Overall Study|Lost to Follow-up|1|||
124916348|NCT02671435|449320327|FG006|Overall Study|Lost to Follow-up|2|||
124916349|NCT02671435|449320328|FG007|Overall Study|Lost to Follow-up|2|||
124916350|NCT02671435|449320329|FG008|Overall Study|Lost to Follow-up|0|||
124916351|NCT02671435|449320330|FG009|Overall Study|Lost to Follow-up|2|||
124916352|NCT02671435|449320331|FG010|Overall Study|Lost to Follow-up|0|||
124916353|NCT02671435|449320332|FG011|Overall Study|Lost to Follow-up|3|||
124916354|NCT02671435|449320333|FG012|Overall Study|Lost to Follow-up|3|||
124916355|NCT02671435|449320334|FG013|Overall Study|Lost to Follow-up|2|||
124916356|NCT02671435|449320335|FG014|Overall Study|Lost to Follow-up|0|||
124916357|NCT02671435|449320321|FG000|Overall Study|Withdrawal by Subject|2|||
124916358|NCT02671435|449320322|FG001|Overall Study|Withdrawal by Subject|0|||
124916359|NCT02671435|449320323|FG002|Overall Study|Withdrawal by Subject|2|||
124916360|NCT02671435|449320324|FG003|Overall Study|Withdrawal by Subject|2|||
124916361|NCT02671435|449320325|FG004|Overall Study|Withdrawal by Subject|2|||
124916362|NCT02671435|449320326|FG005|Overall Study|Withdrawal by Subject|7|||
124916363|NCT02671435|449320327|FG006|Overall Study|Withdrawal by Subject|2|||
124916364|NCT02671435|449320328|FG007|Overall Study|Withdrawal by Subject|7|||
124916365|NCT02671435|449320329|FG008|Overall Study|Withdrawal by Subject|1|||
124761968|NCT00101686|448753549|FG005|Overall Study|initiation other anti-cancer treatment|1|||
124916366|NCT02671435|449320330|FG009|Overall Study|Withdrawal by Subject|1|||
124916367|NCT02671435|449320331|FG010|Overall Study|Withdrawal by Subject|2|||
124761969|NCT00101686|448753550|FG006|Overall Study|initiation other anti-cancer treatment|2|||
124761970|NCT00101686|448753551|FG007|Overall Study|initiation other anti-cancer treatment|2|||
124761971|NCT00101686|448753552|FG008|Overall Study|initiation other anti-cancer treatment|3|||
124761972|NCT00101686|448753553|FG009|Overall Study|initiation other anti-cancer treatment|3|||
124761973|NCT00101686|448753544|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
124916368|NCT02671435|449320332|FG011|Overall Study|Withdrawal by Subject|4|||
124916369|NCT02671435|449320333|FG012|Overall Study|Withdrawal by Subject|4|||
124916370|NCT02671435|449320334|FG013|Overall Study|Withdrawal by Subject|4|||
124916371|NCT02671435|449320335|FG014|Overall Study|Withdrawal by Subject|2|||
124916372|NCT02671435|449320321|FG000|Overall Study|Un-specified|0|||
124916373|NCT02671435|449320322|FG001|Overall Study|Un-specified|0|||
124916374|NCT02671435|449320323|FG002|Overall Study|Un-specified|0|||
124761974|NCT00101686|448753545|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
124761975|NCT00101686|448753546|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
124761976|NCT00101686|448753547|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
124761977|NCT00101686|448753548|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
124761978|NCT00101686|448753549|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
124761979|NCT00101686|448753550|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
124761980|NCT00101686|448753551|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
124761981|NCT00101686|448753552|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
124761982|NCT00101686|448753553|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
124916375|NCT02671435|449320324|FG003|Overall Study|Un-specified|0|||
124916376|NCT02671435|449320325|FG004|Overall Study|Un-specified|1|||
124916377|NCT02671435|449320326|FG005|Overall Study|Un-specified|3|||
124916378|NCT02671435|449320327|FG006|Overall Study|Un-specified|2|||
124916379|NCT02671435|449320328|FG007|Overall Study|Un-specified|3|||
124916380|NCT02671435|449320329|FG008|Overall Study|Un-specified|0|||
124761983|NCT00101686|448753544|FG000|Overall Study|unacceptable toxicity|3|||
124761984|NCT00101686|448753545|FG001|Overall Study|unacceptable toxicity|9|||
124761985|NCT00101686|448753546|FG002|Overall Study|unacceptable toxicity|10|||
124916381|NCT02671435|449320330|FG009|Overall Study|Un-specified|5|||
124916382|NCT02671435|449320331|FG010|Overall Study|Un-specified|8|||
124916383|NCT02671435|449320332|FG011|Overall Study|Un-specified|4|||
124916384|NCT02671435|449320333|FG012|Overall Study|Un-specified|5|||
124916385|NCT02671435|449320334|FG013|Overall Study|Un-specified|9|||
124916386|NCT02671435|449320335|FG014|Overall Study|Un-specified|8|||
124916387|NCT00761189|449320340|FG000|Overall Study|Adverse Event|42|||
124916388|NCT00761189|449320340|FG000|Overall Study|Lack of Efficacy|45|||
124916389|NCT00761189|449320340|FG000|Overall Study|Lost to Follow-up|36|||
124916390|NCT00761189|449320340|FG000|Overall Study|Withdrawal by Subject|49|||
124916391|NCT00761189|449320340|FG000|Overall Study|Other|13|||
124916392|NCT02759016|449320341|FG000|Overall Study|Not treated with BI 836826|1|||
124916393|NCT02759016|449320342|FG001|Overall Study|Not treated with BI 836826|0|||
124916394|NCT02759016|449320341|FG000|Overall Study|Progressive disease|1|||
124916395|NCT02759016|449320342|FG001|Overall Study|Progressive disease|0|||
124916396|NCT02759016|449320341|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
124916397|NCT02759016|449320342|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
124916398|NCT02759016|449320341|FG000|Overall Study|Other not defined above|2|||
124916399|NCT02759016|449320342|FG001|Overall Study|Other not defined above|1|||
124916400|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
124916401|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
124916402|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
124916403|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
124916404|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
124916405|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
124916406|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
124916407|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
124916408|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
124916409|NCT03939312|449320343|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
124916410|NCT03939312|449320343|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
124916411|NCT03939312|449320343|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
124916412|NCT02119650|449320344|FG000|Overall Study|Adverse Event|3|||
124916413|NCT02119650|449320345|FG001|Overall Study|Adverse Event|4|||
124761986|NCT00101686|448753547|FG003|Overall Study|unacceptable toxicity|6|||
124761987|NCT00101686|448753548|FG004|Overall Study|unacceptable toxicity|16|||
124761988|NCT00101686|448753549|FG005|Overall Study|unacceptable toxicity|10|||
124761989|NCT00101686|448753550|FG006|Overall Study|unacceptable toxicity|4|||
124761990|NCT00101686|448753551|FG007|Overall Study|unacceptable toxicity|2|||
124761991|NCT00101686|448753552|FG008|Overall Study|unacceptable toxicity|1|||
124761992|NCT00101686|448753553|FG009|Overall Study|unacceptable toxicity|4|||
124761993|NCT00101686|448753544|FG000|Overall Study|Randomized but did not receive treament|1|||
124916414|NCT02119650|449320344|FG000|Overall Study|Subject decision|2|||
124916415|NCT02119650|449320345|FG001|Overall Study|Subject decision|3|||
124916416|NCT02119650|449320344|FG000|Overall Study|Disease progression|11|||
124761994|NCT00101686|448753545|FG001|Overall Study|Randomized but did not receive treament|6|||
124761995|NCT00101686|448753546|FG002|Overall Study|Randomized but did not receive treament|2|||
124761996|NCT00101686|448753547|FG003|Overall Study|Randomized but did not receive treament|2|||
124916417|NCT02119650|449320345|FG001|Overall Study|Disease progression|14|||
124916418|NCT02119650|449320344|FG000|Overall Study|Death|5|||
124916419|NCT02119650|449320345|FG001|Overall Study|Death|1|||
124916420|NCT02119650|449320344|FG000|Overall Study|Noncompliance with study treatment|1|||
124916421|NCT02119650|449320345|FG001|Overall Study|Noncompliance with study treatment|1|||
124916422|NCT02119650|449320344|FG000|Overall Study|Study terminated by the sponsor|1|||
124916423|NCT02119650|449320345|FG001|Overall Study|Study terminated by the sponsor|0|||
124916424|NCT02119650|449320344|FG000|Overall Study|Physician Decision|0|||
124916425|NCT02119650|449320345|FG001|Overall Study|Physician Decision|2|||
124695121|NCT04595370|448503592|FG000|Overall Study|Adverse Event|0|||
124695122|NCT04595370|448503593|FG001|Overall Study|Adverse Event|4|||
124695123|NCT04595370|448503594|FG002|Overall Study|Adverse Event|3|||
124695124|NCT04595370|448503595|FG003|Overall Study|Adverse Event|1|||
124695125|NCT04595370|448503596|FG004|Overall Study|Adverse Event|1|||
124695126|NCT04595370|448503597|FG005|Overall Study|Adverse Event|1|||
124695127|NCT04595370|448503592|FG000|Overall Study|Withdrawal of Consent|1|||
124695128|NCT04595370|448503593|FG001|Overall Study|Withdrawal of Consent|1|||
124695129|NCT04595370|448503594|FG002|Overall Study|Withdrawal of Consent|1|||
124695130|NCT04595370|448503595|FG003|Overall Study|Withdrawal of Consent|0|||
124695131|NCT04595370|448503596|FG004|Overall Study|Withdrawal of Consent|0|||
124916426|NCT02119650|449320344|FG000|Overall Study|Multiple reasons for termination|2|||
124916427|NCT02119650|449320345|FG001|Overall Study|Multiple reasons for termination|1|||
124916428|NCT01721291|449320346|FG000|Overall Study|Withdrawal by Subject|1|||
124916429|NCT01721291|449320347|FG001|Overall Study|Withdrawal by Subject|0|||
124916430|NCT01721291|449320346|FG000|Overall Study|did not like the treatment|1|||
124916431|NCT01721291|449320347|FG001|Overall Study|did not like the treatment|0|||
124916432|NCT03744312|449321518|FG000|Overall Study|Withdrawal by Subject|0|||
124916433|NCT03744312|449321519|FG001|Overall Study|Withdrawal by Subject|1|||
124916434|NCT03744312|449321518|FG000|Overall Study|Screen fail|0|||
124916435|NCT03744312|449321519|FG001|Overall Study|Screen fail|1|||
124916436|NCT05134337|449321520|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
124916437|NCT05134337|449321521|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
124916438|NCT03152786|449321525|FG000|Overall Study|Withdrawal by Subject|2|||
124695132|NCT04595370|448503597|FG005|Overall Study|Withdrawal of Consent|0|||
124695133|NCT04595370|448503592|FG000|Overall Study|Death|0|||
124695134|NCT04595370|448503593|FG001|Overall Study|Death|1|||
124695135|NCT04595370|448503594|FG002|Overall Study|Death|0|||
124695136|NCT04595370|448503595|FG003|Overall Study|Death|0|||
124916439|NCT03152786|449321526|FG001|Overall Study|Withdrawal by Subject|1|||
124916440|NCT04924062|449321527|FG000|Overall Study|Death|49|||
124916441|NCT04924062|449321528|FG001|Overall Study|Death|63|||
124916442|NCT04924062|449321527|FG000|Overall Study|Participant On-going|26|||
124916443|NCT04924062|449321528|FG001|Overall Study|Participant On-going|20|||
124916444|NCT04059354|449321535|FG000|Overall Study|COVID-19 pandemic|3|||
124916445|NCT05403801|449321536|FG000|Overall Study|Withdrawal by Subject|2|||
124916446|NCT03651895|449321538|FG000|First Drug Assignment|Adverse Event|4|||
124916447|NCT03651895|449321539|FG001|First Drug Assignment|Adverse Event|5|||
124916448|NCT03651895|449321538|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
124916449|NCT03651895|449321539|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
124916450|NCT02525692|449321540|FG000|Overall Study|Withdrawal by Subject|1|||
124916451|NCT02525692|449321541|FG001|Overall Study|Withdrawal by Subject|1|||
124916452|NCT02525692|449321542|FG002|Overall Study|Withdrawal by Subject|0|||
124916453|NCT02525692|449321543|FG003|Overall Study|Withdrawal by Subject|5|||
124916454|NCT02525692|449321544|FG004|Overall Study|Withdrawal by Subject|0|||
124916455|NCT02525692|449321545|FG005|Overall Study|Withdrawal by Subject|1|||
124916456|NCT02525692|449321540|FG000|Overall Study|Death|16|||
124916457|NCT02525692|449321541|FG001|Overall Study|Death|18|||
124916458|NCT02525692|449321542|FG002|Overall Study|Death|7|||
124916459|NCT02525692|449321543|FG003|Overall Study|Death|20|||
124916460|NCT02525692|449321544|FG004|Overall Study|Death|3|||
124916461|NCT02525692|449321545|FG005|Overall Study|Death|6|||
124916462|NCT02525692|449321540|FG000|Overall Study|Lost to Follow-up|0|||
124916463|NCT02525692|449321541|FG001|Overall Study|Lost to Follow-up|0|||
124916464|NCT02525692|449321542|FG002|Overall Study|Lost to Follow-up|1|||
124916465|NCT02525692|449321543|FG003|Overall Study|Lost to Follow-up|5|||
124916466|NCT02525692|449321544|FG004|Overall Study|Lost to Follow-up|0|||
124916467|NCT02525692|449321545|FG005|Overall Study|Lost to Follow-up|0|||
124916468|NCT02396199|449321546|FG000|Overall Study|Lost to Follow-up|1|||
124916469|NCT02396199|449321546|FG000|Overall Study|Death|4|||
124916470|NCT02349412|449321550|FG000|Overall Study|Withdrawal by Subject|7|||
124916471|NCT02349412|449321551|FG001|Overall Study|Withdrawal by Subject|7|||
124916472|NCT03460236|449321552|FG000|Overall Study|failed radiographic screening|16|||
124916473|NCT03460236|449321552|FG000|Overall Study|Withdrawal by Subject|11|||
124916474|NCT04840199|449321555|FG000|Overall Study|Study Terminated by Sponsor|8|||
124695137|NCT04595370|448503596|FG004|Overall Study|Death|1|||
124695138|NCT04595370|448503597|FG005|Overall Study|Death|0|||
124695139|NCT04595370|448503592|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
124916475|NCT04840199|449321556|FG001|Overall Study|Study Terminated by Sponsor|9|||
124916476|NCT04840199|449321555|FG000|Overall Study|Lost to Follow-up|0|||
124916477|NCT04840199|449321556|FG001|Overall Study|Lost to Follow-up|2|||
124916478|NCT04840199|449321555|FG000|Overall Study|Withdrawal by Subject|2|||
124916479|NCT04840199|449321556|FG001|Overall Study|Withdrawal by Subject|0|||
124916480|NCT04840199|449321555|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
124695140|NCT04595370|448503593|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
124916481|NCT04840199|449321556|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
124916482|NCT00753090|449321557|FG000|Overall Study|Withdrawal by Subject|10|||
124916483|NCT00753090|449321558|FG001|Overall Study|Withdrawal by Subject|10|||
124916484|NCT00753090|449321557|FG000|Overall Study|Death|17|||
124916485|NCT00753090|449321558|FG001|Overall Study|Death|6|||
124916486|NCT00753090|449321557|FG000|Overall Study|Study Prosthesis Removed|12|||
124916487|NCT00753090|449321558|FG001|Overall Study|Study Prosthesis Removed|3|||
124916488|NCT00753090|449321557|FG000|Overall Study|Lost to Follow-up|2|||
124916489|NCT00753090|449321558|FG001|Overall Study|Lost to Follow-up|2|||
124916490|NCT00753090|449321557|FG000|Overall Study|Other|127|||
124916491|NCT00753090|449321558|FG001|Overall Study|Other|75|||
124916492|NCT02201108|449321559|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
124916493|NCT02201108|449321560|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
124916494|NCT02201108|449321561|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
124916495|NCT02201108|449321559|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
124916496|NCT02201108|449321560|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
124916497|NCT02201108|449321561|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
124916498|NCT02201108|449321559|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
124916499|NCT02201108|449321560|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
124916500|NCT02201108|449321561|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
124916501|NCT02201108|449321559|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
124916502|NCT02201108|449321560|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
124916503|NCT02201108|449321561|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
124916504|NCT02201108|449321559|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
124916505|NCT02201108|449321560|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
124916506|NCT02201108|449321561|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
124916507|NCT02201108|449321559|FG000|Open Label Period (up to Week 192)|Other reason|4|||
124916508|NCT02201108|449321560|FG001|Open Label Period (up to Week 192)|Other reason|7|||
124916509|NCT02201108|449321561|FG002|Open Label Period (up to Week 192)|Other reason|0|||
124916510|NCT02201108|449321559|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
124916511|NCT02201108|449321560|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
124916512|NCT02201108|449321561|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
124916513|NCT02201108|449321559|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
124916514|NCT02201108|449321560|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
124916515|NCT02201108|449321561|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
124916516|NCT02201108|449321559|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
124916517|NCT02201108|449321560|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
124916518|NCT02201108|449321561|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
124916519|NCT03055377|449321571|FG000|Treatment Phase|Lost to Follow-up|28|||
124916520|NCT03055377|449321572|FG001|Treatment Phase|Lost to Follow-up|24|||
124916521|NCT03055377|449321571|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
124916522|NCT03055377|449321572|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
124916523|NCT04934722|449321573|FG000|Overall Study|Death|4|||
124916524|NCT04934722|449321574|FG001|Overall Study|Death|3|||
124916525|NCT04934722|449321573|FG000|Overall Study|Participants Ongoing|88|||
124916526|NCT04934722|449321574|FG001|Overall Study|Participants Ongoing|91|||
124916527|NCT05215847|449321575|FG000|Overall Study|Lost to Follow-up|1|||
124916528|NCT03157167|449321576|FG000|Overall Study|Withdrawal by Subject|1|||
124916529|NCT03157167|449321577|FG001|Overall Study|Withdrawal by Subject|0|||
124916530|NCT03157167|449321578|FG002|Overall Study|Withdrawal by Subject|0|||
124916531|NCT06023082|449321581|FG000|Overall Study|Withdrawal by Subject|2|||
124916532|NCT06023082|449321581|FG000|Overall Study|Lost to Follow-up|15|||
124916533|NCT06023082|449321581|FG000|Overall Study|Side effects|5|||
124916534|NCT04823611|449321582|FG000|Overall Study|Adverse Event|2|||
124916535|NCT04823611|449321583|FG001|Overall Study|Adverse Event|0|||
124916536|NCT04823611|449321584|FG002|Overall Study|Adverse Event|1|||
124916537|NCT04823611|449321585|FG003|Overall Study|Adverse Event|0|||
124916538|NCT04823611|449321586|FG004|Overall Study|Adverse Event|0|||
124695141|NCT04595370|448503594|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
124916539|NCT04823611|449321587|FG005|Overall Study|Adverse Event|0|||
124916540|NCT04823611|449321588|FG006|Overall Study|Adverse Event|0|||
124451727|NCT01854645|447615165|FG001|Overall Study|Protocol-Specified Criteria|10|||
124695142|NCT04595370|448503595|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
124695143|NCT04595370|448503596|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
124695144|NCT04595370|448503597|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
124916541|NCT05444192|449321589|FG000|Overall Study|Lost to Follow-up|1|||
124916542|NCT05444192|449321590|FG001|Overall Study|Lost to Follow-up|0|||
124916543|NCT05623345|449321592|FG000|Overall Study|Withdrawal by Subject|14|||
124916544|NCT05623345|449321593|FG001|Overall Study|Withdrawal by Subject|0|||
124916545|NCT05623345|449321594|FG002|Overall Study|Withdrawal by Subject|9|||
124916546|NCT05623345|449321595|FG003|Overall Study|Withdrawal by Subject|20|||
124916547|NCT05623345|449321592|FG000|Overall Study|Lost to Follow-up|3|||
124916548|NCT05623345|449321593|FG001|Overall Study|Lost to Follow-up|0|||
124916549|NCT05623345|449321594|FG002|Overall Study|Lost to Follow-up|7|||
124695145|NCT04595370|448503592|FG000|Overall Study|Withdrawal by Subject|0|||
124695146|NCT04595370|448503593|FG001|Overall Study|Withdrawal by Subject|0|||
124695147|NCT04595370|448503594|FG002|Overall Study|Withdrawal by Subject|1|||
124695148|NCT04595370|448503595|FG003|Overall Study|Withdrawal by Subject|0|||
124695149|NCT04595370|448503596|FG004|Overall Study|Withdrawal by Subject|2|||
124695150|NCT04595370|448503597|FG005|Overall Study|Withdrawal by Subject|0|||
124695151|NCT04595370|448503592|FG000|Overall Study|Lost to Follow-up|0|||
124695152|NCT04595370|448503593|FG001|Overall Study|Lost to Follow-up|0|||
124695153|NCT04595370|448503594|FG002|Overall Study|Lost to Follow-up|0|||
124695154|NCT04595370|448503595|FG003|Overall Study|Lost to Follow-up|0|||
124695155|NCT04595370|448503596|FG004|Overall Study|Lost to Follow-up|1|||
124695156|NCT04595370|448503597|FG005|Overall Study|Lost to Follow-up|0|||
124695157|NCT04595370|448503592|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
124695158|NCT04595370|448503593|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
124695159|NCT04595370|448503594|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
124695160|NCT04595370|448503595|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
124695161|NCT04595370|448503596|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
124695162|NCT04595370|448503597|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
124695163|NCT01945242|448503598|FG000|Overall Study|Physician Decision|3|||
124695164|NCT01945242|448503599|FG001|Overall Study|Physician Decision|3|||
124695165|NCT05661734|448503602|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
124695166|NCT05661734|448503602|FG000|Overall Study|Lost to Follow-up|13|||
124695167|NCT05661734|448503602|FG000|Overall Study|Enrolled but not dosed|2|||
124695168|NCT01125748|448503603|FG000|Overall Study|Adverse Event|0|||
124695169|NCT01125748|448503604|FG001|Overall Study|Adverse Event|2|||
124695170|NCT01125748|448503603|FG000|Overall Study|Lost to Follow-up|0|||
124695171|NCT01125748|448503604|FG001|Overall Study|Lost to Follow-up|1|||
124695172|NCT01125748|448503603|FG000|Overall Study|Physician Decision|8|||
124695173|NCT01125748|448503604|FG001|Overall Study|Physician Decision|7|||
124695174|NCT01125748|448503603|FG000|Overall Study|Patient Decision to Withdraw|2|||
124695175|NCT01125748|448503604|FG001|Overall Study|Patient Decision to Withdraw|4|||
124695176|NCT02405962|448503605|FG000|Overall Study|Lost to Follow-up|1|||
124695177|NCT02405962|448503606|FG001|Overall Study|Lost to Follow-up|4|||
124695178|NCT02405962|448503605|FG000|Overall Study|A participant has moved to another place|0|||
124695179|NCT02405962|448503606|FG001|Overall Study|A participant has moved to another place|1|||
124695180|NCT01028391|448503607|FG000|Overall Study|Adverse Event|4|||
124695181|NCT01028391|448503608|FG001|Overall Study|Adverse Event|0|||
124695182|NCT01028391|448503607|FG000|Overall Study|Lack of Efficacy|0|||
124695183|NCT01028391|448503608|FG001|Overall Study|Lack of Efficacy|2|||
124695184|NCT01028391|448503607|FG000|Overall Study|Lost to Follow-up|3|||
124695185|NCT01028391|448503608|FG001|Overall Study|Lost to Follow-up|4|||
124695186|NCT01028391|448503607|FG000|Overall Study|Physician Decision|0|||
124695187|NCT01028391|448503608|FG001|Overall Study|Physician Decision|1|||
124695188|NCT01028391|448503607|FG000|Overall Study|Withdrawal by Subject|6|||
124695189|NCT01028391|448503608|FG001|Overall Study|Withdrawal by Subject|3|||
124695190|NCT01028391|448503607|FG000|Overall Study|Needed excluded medication|1|||
124761997|NCT00101686|448753548|FG004|Overall Study|Randomized but did not receive treament|2|||
124916550|NCT05623345|449321595|FG003|Overall Study|Lost to Follow-up|2|||
124916551|NCT05623345|449321592|FG000|Overall Study|Termination of Study By Sponsor|37|||
124916552|NCT05623345|449321593|FG001|Overall Study|Termination of Study By Sponsor|4|||
124916553|NCT05623345|449321594|FG002|Overall Study|Termination of Study By Sponsor|40|||
124916554|NCT05623345|449321595|FG003|Overall Study|Termination of Study By Sponsor|38|||
124916555|NCT01385176|449321596|FG000|Randomization Phase|Death|1|||
124916556|NCT01385176|449321597|FG001|Randomization Phase|Death|2|||
124916557|NCT01385176|449321596|FG000|6-18 Month All VNS Active|Death|1|||
124916558|NCT01385176|449321597|FG001|6-18 Month All VNS Active|Death|2|||
124916559|NCT01385176|449321596|FG000|6-18 Month All VNS Active|Physician Decision|0|||
124916560|NCT01385176|449321597|FG001|6-18 Month All VNS Active|Physician Decision|1|||
124916561|NCT01385176|449321596|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
124916562|NCT01385176|449321597|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
124916563|NCT01385176|449321596|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
124916564|NCT01385176|449321597|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
124916565|NCT05384730|449321598|FG000|Overall Study|Adverse Event|1|||
124916566|NCT05384730|449321599|FG001|Overall Study|Adverse Event|0|||
124695191|NCT01028391|448503608|FG001|Overall Study|Needed excluded medication|1|||
124761998|NCT00101686|448753549|FG005|Overall Study|Randomized but did not receive treament|2|||
124761999|NCT00101686|448753550|FG006|Overall Study|Randomized but did not receive treament|0|||
124916567|NCT05384730|449321598|FG000|Overall Study|Lack of social support|2|||
124916568|NCT05384730|449321599|FG001|Overall Study|Lack of social support|0|||
124916569|NCT05384730|449321598|FG000|Overall Study|Hospital readmission|2|||
124916570|NCT05384730|449321599|FG001|Overall Study|Hospital readmission|0|||
124695192|NCT01184118|448503609|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
124695193|NCT01184118|448503609|FG000|Overall Study|No physiologic confirmation of asthma|8|||
124916571|NCT05384730|449321598|FG000|Overall Study|Disease progression|5|||
124916572|NCT05384730|449321599|FG001|Overall Study|Disease progression|0|||
124916573|NCT05384730|449321598|FG000|Overall Study|Overwhelmed with College commitments|0|||
124916574|NCT05384730|449321599|FG001|Overall Study|Overwhelmed with College commitments|2|||
124916575|NCT01772472|449321600|FG000|Overall Study|Death|126|||
124916576|NCT01772472|449321601|FG001|Overall Study|Death|94|||
124916577|NCT01772472|449321600|FG000|Overall Study|Lost to Follow-up|51|||
124916578|NCT01772472|449321601|FG001|Overall Study|Lost to Follow-up|50|||
124916579|NCT01772472|449321600|FG000|Overall Study|Other|9|||
124916580|NCT01772472|449321601|FG001|Overall Study|Other|7|||
124916581|NCT01772472|449321600|FG000|Overall Study|Physician Decision|1|||
124916582|NCT01772472|449321601|FG001|Overall Study|Physician Decision|7|||
124916583|NCT01772472|449321600|FG000|Overall Study|Withdrawal by Subject|115|||
124916584|NCT01772472|449321601|FG001|Overall Study|Withdrawal by Subject|90|||
124916585|NCT01772472|449321600|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
124916586|NCT01772472|449321601|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
124916587|NCT04431726|449321610|FG000|Overall Study|Ongoing in the Study|55|||
124916588|NCT04093752|449321612|FG000|Overall Study|Adverse Event|7|||
124916589|NCT04093752|449321613|FG001|Overall Study|Adverse Event|19|||
124916590|NCT04093752|449321614|FG002|Overall Study|Adverse Event|18|||
124916591|NCT04093752|449321615|FG003|Overall Study|Adverse Event|4|||
124916592|NCT04093752|449321612|FG000|Overall Study|Withdrawal by Subject|6|||
124916593|NCT04093752|449321613|FG001|Overall Study|Withdrawal by Subject|6|||
124916594|NCT04093752|449321614|FG002|Overall Study|Withdrawal by Subject|8|||
124916595|NCT04093752|449321615|FG003|Overall Study|Withdrawal by Subject|20|||
124916596|NCT04093752|449321612|FG000|Overall Study|Lost to Follow-up|2|||
124916597|NCT04093752|449321613|FG001|Overall Study|Lost to Follow-up|1|||
124916598|NCT04093752|449321614|FG002|Overall Study|Lost to Follow-up|1|||
124916599|NCT04093752|449321615|FG003|Overall Study|Lost to Follow-up|1|||
124916600|NCT04093752|449321612|FG000|Overall Study|Death|0|||
124916601|NCT04093752|449321613|FG001|Overall Study|Death|0|||
124916602|NCT04093752|449321614|FG002|Overall Study|Death|1|||
124916603|NCT04093752|449321615|FG003|Overall Study|Death|2|||
124916604|NCT04093752|449321612|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
124916605|NCT04093752|449321613|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
124916606|NCT04093752|449321614|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
124916607|NCT04093752|449321615|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
124916608|NCT04093752|449321612|FG000|Overall Study|Covid 19|0|||
124916609|NCT04093752|449321613|FG001|Overall Study|Covid 19|0|||
124916610|NCT04093752|449321614|FG002|Overall Study|Covid 19|0|||
124916611|NCT04093752|449321615|FG003|Overall Study|Covid 19|1|||
124916612|NCT04093752|449321612|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
124916613|NCT04093752|449321613|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
124916614|NCT04093752|449321614|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
124916615|NCT04093752|449321615|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
124916616|NCT04093752|449321612|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
124916617|NCT04093752|449321613|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
124916618|NCT04093752|449321614|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
124916619|NCT04093752|449321615|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
124916620|NCT04093752|449321612|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
124916621|NCT04093752|449321613|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
124916622|NCT04093752|449321614|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
124916623|NCT04093752|449321615|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
124916624|NCT01101451|449321616|FG000|Overall Study|Eligible and never treated|0|||
124916625|NCT01101451|449321617|FG001|Overall Study|Eligible and never treated|5|||
124916626|NCT01101451|449321616|FG000|Overall Study|Ineligible and treated|12|||
124916627|NCT01101451|449321617|FG001|Overall Study|Ineligible and treated|8|||
124916628|NCT01101451|449321616|FG000|Overall Study|Ineligible and never treated|2|||
124916629|NCT01101451|449321617|FG001|Overall Study|Ineligible and never treated|2|||
124916630|NCT04854096|449321618|FG000|Overall Study|Adverse Event|1|||
124916631|NCT04854096|449321619|FG001|Overall Study|Adverse Event|0|||
124916632|NCT04854096|449321618|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
124916633|NCT04854096|449321619|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
124916634|NCT04854096|449321618|FG000|Overall Study|Withdrawal by Subject|1|||
124916635|NCT04854096|449321619|FG001|Overall Study|Withdrawal by Subject|0|||
124916636|NCT04854096|449321618|FG000|Overall Study|Other reasons|1|||
124916637|NCT04854096|449321619|FG001|Overall Study|Other reasons|0|||
124916638|NCT04757610|449321620|FG000|Overall Study|Adverse Event|13|||
124916639|NCT04757610|449321621|FG001|Overall Study|Adverse Event|10|||
124916640|NCT04757610|449321622|FG002|Overall Study|Adverse Event|5|||
124916641|NCT04757610|449321620|FG000|Overall Study|Death|5|||
124545385|NCT00762073|447951190|FG001|Overall Study|Lack of Efficacy|1|||
124916642|NCT04757610|449321621|FG001|Overall Study|Death|13|||
124916643|NCT04757610|449321622|FG002|Overall Study|Death|8|||
124916644|NCT04757610|449321620|FG000|Overall Study|Lack of Efficacy|1|||
124916645|NCT04757610|449321621|FG001|Overall Study|Lack of Efficacy|2|||
124916646|NCT04757610|449321622|FG002|Overall Study|Lack of Efficacy|3|||
124916647|NCT04757610|449321620|FG000|Overall Study|Lost to Follow-up|7|||
124916648|NCT04757610|449321621|FG001|Overall Study|Lost to Follow-up|2|||
124916649|NCT04757610|449321622|FG002|Overall Study|Lost to Follow-up|7|||
124916650|NCT04757610|449321620|FG000|Overall Study|Physician Decision|4|||
124916651|NCT04757610|449321621|FG001|Overall Study|Physician Decision|1|||
124916652|NCT04757610|449321622|FG002|Overall Study|Physician Decision|2|||
124916653|NCT04757610|449321620|FG000|Overall Study|Withdrawal by Subject|26|||
124916654|NCT04757610|449321621|FG001|Overall Study|Withdrawal by Subject|25|||
124916655|NCT04757610|449321622|FG002|Overall Study|Withdrawal by Subject|25|||
124916656|NCT04757610|449321620|FG000|Overall Study|Study Terminated by Sponsor|105|||
124916657|NCT04757610|449321621|FG001|Overall Study|Study Terminated by Sponsor|105|||
124916658|NCT04757610|449321622|FG002|Overall Study|Study Terminated by Sponsor|110|||
124916659|NCT04757610|449321620|FG000|Overall Study|Randomized in Error|1|||
124916660|NCT04757610|449321621|FG001|Overall Study|Randomized in Error|0|||
124916661|NCT04757610|449321622|FG002|Overall Study|Randomized in Error|0|||
124916662|NCT00073749|449321623|FG000|Overall Study|Disease Progression|2|||
124916663|NCT00073749|449321624|FG001|Overall Study|Disease Progression|0|||
124916664|NCT00073749|449321625|FG002|Overall Study|Disease Progression|3|||
124916665|NCT00073749|449321626|FG003|Overall Study|Disease Progression|2|||
124916666|NCT00073749|449321627|FG004|Overall Study|Disease Progression|3|||
124916667|NCT00073749|449321628|FG005|Overall Study|Disease Progression|1|||
124916668|NCT00073749|449321629|FG006|Overall Study|Disease Progression|3|||
124916669|NCT00073749|449321623|FG000|Overall Study|Death|0|||
124916670|NCT00073749|449321624|FG001|Overall Study|Death|1|||
124916671|NCT00073749|449321625|FG002|Overall Study|Death|1|||
124916672|NCT00073749|449321626|FG003|Overall Study|Death|0|||
124916673|NCT00073749|449321627|FG004|Overall Study|Death|0|||
124916674|NCT00073749|449321628|FG005|Overall Study|Death|0|||
124916675|NCT00073749|449321629|FG006|Overall Study|Death|29|||
124916676|NCT00073749|449321623|FG000|Overall Study|Adverse Event|0|||
124916677|NCT00073749|449321624|FG001|Overall Study|Adverse Event|3|||
124916678|NCT00073749|449321625|FG002|Overall Study|Adverse Event|6|||
124916679|NCT00073749|449321626|FG003|Overall Study|Adverse Event|4|||
124916680|NCT00073749|449321627|FG004|Overall Study|Adverse Event|2|||
124916681|NCT00073749|449321628|FG005|Overall Study|Adverse Event|1|||
124916682|NCT00073749|449321629|FG006|Overall Study|Adverse Event|0|||
124916683|NCT00073749|449321623|FG000|Overall Study|Physician Decision|0|||
124916684|NCT00073749|449321624|FG001|Overall Study|Physician Decision|0|||
124916685|NCT00073749|449321625|FG002|Overall Study|Physician Decision|1|||
124916686|NCT00073749|449321626|FG003|Overall Study|Physician Decision|0|||
124916687|NCT00073749|449321627|FG004|Overall Study|Physician Decision|0|||
124916688|NCT00073749|449321628|FG005|Overall Study|Physician Decision|2|||
124916689|NCT00073749|449321629|FG006|Overall Study|Physician Decision|0|||
124916690|NCT00073749|449321623|FG000|Overall Study|Withdrawal by Subject|0|||
124916691|NCT00073749|449321624|FG001|Overall Study|Withdrawal by Subject|1|||
124695194|NCT01184118|448503609|FG000|Overall Study|FEV1 <60% predicted|2|||
124695195|NCT01184118|448503609|FG000|Overall Study|Exclusionary medical condition|2|||
124916692|NCT00073749|449321625|FG002|Overall Study|Withdrawal by Subject|0|||
124916693|NCT00073749|449321626|FG003|Overall Study|Withdrawal by Subject|0|||
124916694|NCT00073749|449321627|FG004|Overall Study|Withdrawal by Subject|1|||
124916695|NCT00073749|449321628|FG005|Overall Study|Withdrawal by Subject|0|||
124916696|NCT00073749|449321629|FG006|Overall Study|Withdrawal by Subject|2|||
124916697|NCT00073749|449321623|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
124916698|NCT00073749|449321624|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
124916699|NCT00073749|449321625|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
124916700|NCT00073749|449321626|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
124916701|NCT00073749|449321627|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
124916702|NCT00073749|449321628|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
124916703|NCT00073749|449321629|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
124916704|NCT00073749|449321623|FG000|Overall Study|Lost to Follow-up|0|||
124916705|NCT00073749|449321624|FG001|Overall Study|Lost to Follow-up|0|||
124916706|NCT00073749|449321625|FG002|Overall Study|Lost to Follow-up|0|||
124916707|NCT00073749|449321626|FG003|Overall Study|Lost to Follow-up|0|||
124916708|NCT00073749|449321627|FG004|Overall Study|Lost to Follow-up|0|||
124916709|NCT00073749|449321628|FG005|Overall Study|Lost to Follow-up|0|||
124916710|NCT00073749|449321629|FG006|Overall Study|Lost to Follow-up|2|||
124916711|NCT00073749|449321623|FG000|Overall Study|Other|0|||
124916712|NCT00073749|449321624|FG001|Overall Study|Other|0|||
124916713|NCT00073749|449321625|FG002|Overall Study|Other|0|||
124916714|NCT00073749|449321626|FG003|Overall Study|Other|0|||
124916715|NCT00073749|449321627|FG004|Overall Study|Other|0|||
124545386|NCT00762073|447951191|FG002|Overall Study|Lack of Efficacy|0|||
124916716|NCT00073749|449321628|FG005|Overall Study|Other|2|||
124916717|NCT00073749|449321629|FG006|Overall Study|Other|0|||
124916718|NCT04154384|449321630|FG000|Overall Study|Lost to Follow-up|24|||
124916719|NCT04154384|449321631|FG001|Overall Study|Lost to Follow-up|33|||
124916720|NCT04154384|449321632|FG002|Overall Study|Lost to Follow-up|0|||
124916721|NCT04154384|449321630|FG000|Overall Study|Withdrawal by Subject|7|||
124916722|NCT04154384|449321631|FG001|Overall Study|Withdrawal by Subject|18|||
124916723|NCT04154384|449321632|FG002|Overall Study|Withdrawal by Subject|0|||
124916724|NCT04154384|449321630|FG000|Overall Study|Missing outcome data|1|||
124916725|NCT04154384|449321631|FG001|Overall Study|Missing outcome data|0|||
124916726|NCT04154384|449321632|FG002|Overall Study|Missing outcome data|0|||
124916727|NCT05048186|449321633|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
124916728|NCT05048186|449321634|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
124916729|NCT05048186|449321633|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
124916730|NCT05048186|449321634|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
124916731|NCT00951379|449321635|FG000|Overall Study|Adverse Event|4|||
124916732|NCT00951379|449321636|FG001|Overall Study|Adverse Event|1|||
124916733|NCT00951379|449321635|FG000|Overall Study|Withdrawal by Subject|1|||
124916734|NCT00951379|449321636|FG001|Overall Study|Withdrawal by Subject|0|||
124916735|NCT00951379|449321635|FG000|Overall Study|Noncompliance|1|||
124916736|NCT00951379|449321636|FG001|Overall Study|Noncompliance|0|||
124916737|NCT00951379|449321635|FG000|Overall Study|Disease Progression|0|||
124916738|NCT00951379|449321636|FG001|Overall Study|Disease Progression|1|||
124916739|NCT04218266|449321638|FG000|Overall Study|Death|1|||
124916740|NCT04218266|449321639|FG001|Overall Study|Death|2|||
124916741|NCT04218266|449321640|FG002|Overall Study|Death|3|||
124916742|NCT04218266|449321638|FG000|Overall Study|Adverse Event|13|||
124916743|NCT04218266|449321639|FG001|Overall Study|Adverse Event|14|||
124916744|NCT04218266|449321640|FG002|Overall Study|Adverse Event|11|||
124916745|NCT04218266|449321638|FG000|Overall Study|Other|7|||
124916746|NCT04218266|449321639|FG001|Overall Study|Other|5|||
124916747|NCT04218266|449321640|FG002|Overall Study|Other|14|||
124916748|NCT04218266|449321638|FG000|Overall Study|Physician Decision|1|||
124916749|NCT04218266|449321639|FG001|Overall Study|Physician Decision|3|||
124916750|NCT04218266|449321640|FG002|Overall Study|Physician Decision|2|||
124916751|NCT04218266|449321638|FG000|Overall Study|Non-compliance with study drug|0|||
124916752|NCT04218266|449321639|FG001|Overall Study|Non-compliance with study drug|0|||
124916753|NCT04218266|449321640|FG002|Overall Study|Non-compliance with study drug|1|||
124916754|NCT04218266|449321638|FG000|Overall Study|Withdrawal by Subject|1|||
124916755|NCT04218266|449321639|FG001|Overall Study|Withdrawal by Subject|3|||
124916756|NCT04218266|449321640|FG002|Overall Study|Withdrawal by Subject|1|||
124916757|NCT04218266|449321638|FG000|Overall Study|Study drug never administered|2|||
124762000|NCT00101686|448753551|FG007|Overall Study|Randomized but did not receive treament|1|||
124762001|NCT00101686|448753552|FG008|Overall Study|Randomized but did not receive treament|0|||
124762002|NCT00101686|448753553|FG009|Overall Study|Randomized but did not receive treament|1|||
124762003|NCT00101686|448753544|FG000|Overall Study|intercurrent non-cancer related illness|0|||
124916758|NCT04218266|449321639|FG001|Overall Study|Study drug never administered|0|||
124916759|NCT04218266|449321640|FG002|Overall Study|Study drug never administered|0|||
124916760|NCT02742519|449321641|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
124916761|NCT02742519|449321642|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
124916762|NCT02742519|449321643|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
124916763|NCT02742519|449321641|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
124916764|NCT02742519|449321642|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
124916765|NCT02742519|449321643|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
124916766|NCT02742519|449321641|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
124916767|NCT02742519|449321642|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
124916768|NCT02742519|449321643|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
124916769|NCT04377308|449321644|FG000|Overall Study|Withdrawal by Subject|0|||
124916770|NCT04377308|449321645|FG001|Overall Study|Withdrawal by Subject|1|||
124916771|NCT03580369|449321646|FG000|Overall Study|No treatment due to mis-randomization|1|||
124916772|NCT03580369|449321647|FG001|Overall Study|No treatment due to mis-randomization|0|||
124916773|NCT03580369|449321648|FG002|Overall Study|No treatment due to mis-randomization|0|||
124916774|NCT03580369|449321649|FG003|Overall Study|No treatment due to mis-randomization|0|||
124916775|NCT03580369|449321650|FG004|Overall Study|No treatment due to mis-randomization|3|||
124916776|NCT03580369|449321651|FG005|Overall Study|No treatment due to mis-randomization|0|||
124916777|NCT03580369|449321652|FG006|Overall Study|No treatment due to mis-randomization|0|||
124916778|NCT03580369|449321653|FG007|Overall Study|No treatment due to mis-randomization|0|||
124916779|NCT03580369|449321646|FG000|Overall Study|Reason unknown|0|||
124916780|NCT03580369|449321647|FG001|Overall Study|Reason unknown|0|||
124916781|NCT03580369|449321648|FG002|Overall Study|Reason unknown|1|||
124916782|NCT03580369|449321649|FG003|Overall Study|Reason unknown|0|||
124916783|NCT03580369|449321650|FG004|Overall Study|Reason unknown|0|||
124916784|NCT03580369|449321651|FG005|Overall Study|Reason unknown|0|||
124916785|NCT03580369|449321652|FG006|Overall Study|Reason unknown|0|||
124762004|NCT00101686|448753545|FG001|Overall Study|intercurrent non-cancer related illness|0|||
124762005|NCT00101686|448753546|FG002|Overall Study|intercurrent non-cancer related illness|2|||
124916786|NCT03580369|449321653|FG007|Overall Study|Reason unknown|0|||
124916787|NCT03580369|449321646|FG000|Overall Study|Technical problems|0|||
124916788|NCT03580369|449321647|FG001|Overall Study|Technical problems|0|||
124916789|NCT03580369|449321648|FG002|Overall Study|Technical problems|0|||
124916790|NCT03580369|449321649|FG003|Overall Study|Technical problems|0|||
124916791|NCT03580369|449321650|FG004|Overall Study|Technical problems|1|||
124916792|NCT03580369|449321651|FG005|Overall Study|Technical problems|0|||
124916793|NCT03580369|449321652|FG006|Overall Study|Technical problems|2|||
124916794|NCT03580369|449321653|FG007|Overall Study|Technical problems|0|||
124916795|NCT03580369|449321646|FG000|Overall Study|Pregnancy|2|||
124916796|NCT03580369|449321647|FG001|Overall Study|Pregnancy|0|||
124916797|NCT03580369|449321648|FG002|Overall Study|Pregnancy|3|||
124916798|NCT03580369|449321649|FG003|Overall Study|Pregnancy|0|||
124916799|NCT03580369|449321650|FG004|Overall Study|Pregnancy|2|||
124916800|NCT03580369|449321651|FG005|Overall Study|Pregnancy|0|||
124916801|NCT03580369|449321652|FG006|Overall Study|Pregnancy|0|||
124916802|NCT03580369|449321653|FG007|Overall Study|Pregnancy|0|||
124916803|NCT03580369|449321646|FG000|Overall Study|Lost to Follow-up|2|||
124916804|NCT03580369|449321647|FG001|Overall Study|Lost to Follow-up|0|||
124916805|NCT03580369|449321648|FG002|Overall Study|Lost to Follow-up|2|||
124916806|NCT03580369|449321649|FG003|Overall Study|Lost to Follow-up|0|||
124916807|NCT03580369|449321650|FG004|Overall Study|Lost to Follow-up|3|||
124916808|NCT03580369|449321651|FG005|Overall Study|Lost to Follow-up|0|||
124916809|NCT03580369|449321652|FG006|Overall Study|Lost to Follow-up|1|||
124916810|NCT03580369|449321653|FG007|Overall Study|Lost to Follow-up|0|||
124916811|NCT03580369|449321646|FG000|Overall Study|Physician Decision|4|||
124916812|NCT03580369|449321647|FG001|Overall Study|Physician Decision|0|||
124916813|NCT03580369|449321648|FG002|Overall Study|Physician Decision|4|||
124916814|NCT03580369|449321649|FG003|Overall Study|Physician Decision|1|||
124916815|NCT03580369|449321650|FG004|Overall Study|Physician Decision|1|||
124916816|NCT03580369|449321651|FG005|Overall Study|Physician Decision|0|||
124916817|NCT03580369|449321652|FG006|Overall Study|Physician Decision|0|||
124916818|NCT03580369|449321653|FG007|Overall Study|Physician Decision|0|||
124916819|NCT03580369|449321646|FG000|Overall Study|Lack of Efficacy|3|||
124916820|NCT03580369|449321647|FG001|Overall Study|Lack of Efficacy|0|||
124916821|NCT03580369|449321648|FG002|Overall Study|Lack of Efficacy|7|||
124916822|NCT03580369|449321649|FG003|Overall Study|Lack of Efficacy|0|||
124916823|NCT03580369|449321650|FG004|Overall Study|Lack of Efficacy|2|||
124916824|NCT03580369|449321651|FG005|Overall Study|Lack of Efficacy|0|||
124916825|NCT03580369|449321652|FG006|Overall Study|Lack of Efficacy|3|||
124916826|NCT03580369|449321653|FG007|Overall Study|Lack of Efficacy|0|||
124916827|NCT03580369|449321646|FG000|Overall Study|Protocol Violation|6|||
124916828|NCT03580369|449321647|FG001|Overall Study|Protocol Violation|0|||
124916829|NCT03580369|449321648|FG002|Overall Study|Protocol Violation|6|||
124916830|NCT03580369|449321649|FG003|Overall Study|Protocol Violation|1|||
124916831|NCT03580369|449321650|FG004|Overall Study|Protocol Violation|8|||
124916832|NCT03580369|449321651|FG005|Overall Study|Protocol Violation|2|||
124916833|NCT03580369|449321652|FG006|Overall Study|Protocol Violation|1|||
124916834|NCT03580369|449321653|FG007|Overall Study|Protocol Violation|0|||
124916835|NCT03580369|449321646|FG000|Overall Study|Adverse Event|7|||
124916836|NCT03580369|449321647|FG001|Overall Study|Adverse Event|0|||
124916837|NCT03580369|449321648|FG002|Overall Study|Adverse Event|14|||
124916838|NCT03580369|449321649|FG003|Overall Study|Adverse Event|1|||
124916839|NCT03580369|449321650|FG004|Overall Study|Adverse Event|6|||
124916840|NCT03580369|449321651|FG005|Overall Study|Adverse Event|0|||
124916841|NCT03580369|449321652|FG006|Overall Study|Adverse Event|1|||
124916842|NCT03580369|449321653|FG007|Overall Study|Adverse Event|0|||
124916843|NCT03580369|449321646|FG000|Overall Study|Withdrawal by Subject|19|||
124916844|NCT03580369|449321647|FG001|Overall Study|Withdrawal by Subject|0|||
124916845|NCT03580369|449321648|FG002|Overall Study|Withdrawal by Subject|17|||
124916846|NCT03580369|449321649|FG003|Overall Study|Withdrawal by Subject|0|||
124916847|NCT03580369|449321650|FG004|Overall Study|Withdrawal by Subject|16|||
124916848|NCT03580369|449321651|FG005|Overall Study|Withdrawal by Subject|1|||
124916849|NCT03580369|449321652|FG006|Overall Study|Withdrawal by Subject|7|||
124916850|NCT03580369|449321653|FG007|Overall Study|Withdrawal by Subject|0|||
124451728|NCT01854645|447615166|FG002|Overall Study|Protocol-Specified Criteria|8|||
124451729|NCT01854645|447615167|FG003|Overall Study|Protocol-Specified Criteria|5|||
124916851|NCT04774237|449321657|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
124916852|NCT04774237|449321658|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
124916853|NCT04774237|449321659|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
124916854|NCT04774237|449321660|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
124916855|NCT04774237|449321661|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
124916856|NCT04774237|449321662|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
124451730|NCT01854645|447615168|FG004|Overall Study|Protocol-Specified Criteria|7|||
124916857|NCT04923347|449323504|FG000|Overall Study|Withdrawal by Subject|14|||
124916858|NCT06066541|449323511|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
124916859|NCT06066541|449323512|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
124916860|NCT06066541|449323513|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
124916861|NCT06066541|449323514|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
124916862|NCT06066541|449323515|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
124916863|NCT06066541|449323516|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
124916864|NCT06066541|449323517|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
124916865|NCT06066541|449323511|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
124916866|NCT06066541|449323512|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
124695196|NCT01184118|448503609|FG000|Overall Study|Withdrawal by Subject|5|||
124695197|NCT02946996|448503611|FG000|Overall Study|non-evaluable|3|||
124916867|NCT06066541|449323513|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
124916868|NCT06066541|449323514|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
124916869|NCT06066541|449323515|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
124916870|NCT06066541|449323516|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
124916871|NCT06066541|449323517|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
124916872|NCT02819843|449323518|FG000|Overall Study|Disease progression before RT|0|||
124916873|NCT02819843|449323519|FG001|Overall Study|Disease progression before RT|1|||
124916874|NCT03055858|449323521|FG000|Overall Study|Death|9|||
124545387|NCT00762073|447951192|FG003|Overall Study|Lack of Efficacy|0|||
124545388|NCT00762073|447951189|FG000|Overall Study|Adverse Event|1|||
124545389|NCT00762073|447951190|FG001|Overall Study|Adverse Event|0|||
124695198|NCT02946996|448503612|FG001|Overall Study|non-evaluable|6|||
124916875|NCT03055858|449323521|FG000|Overall Study|Withdrawal by Subject|11|||
124916876|NCT03055858|449323521|FG000|Overall Study|Lost to Follow-up|6|||
124916877|NCT03055858|449323521|FG000|Overall Study|Missed Follow-Up Visits|18|||
124916878|NCT04586920|449323522|FG000|Overall Study|Lost to Follow-up|0|||
124916879|NCT04586920|449323523|FG001|Overall Study|Lost to Follow-up|0|||
124916880|NCT04586920|449323524|FG002|Overall Study|Lost to Follow-up|0|||
124916881|NCT04586920|449323525|FG003|Overall Study|Lost to Follow-up|0|||
124916882|NCT04586920|449323526|FG004|Overall Study|Lost to Follow-up|0|||
124916883|NCT04586920|449323527|FG005|Overall Study|Lost to Follow-up|0|||
124916884|NCT04586920|449323528|FG006|Overall Study|Lost to Follow-up|1|||
124916885|NCT04586920|449323529|FG007|Overall Study|Lost to Follow-up|1|||
124916886|NCT04586920|449323530|FG008|Overall Study|Lost to Follow-up|0|||
124916887|NCT04586920|449323531|FG009|Overall Study|Lost to Follow-up|1|||
124916888|NCT04586920|449323532|FG010|Overall Study|Lost to Follow-up|0|||
124916889|NCT04586920|449323533|FG011|Overall Study|Lost to Follow-up|0|||
124916890|NCT04586920|449323534|FG012|Overall Study|Lost to Follow-up|0|||
124916891|NCT04586920|449323535|FG013|Overall Study|Lost to Follow-up|1|||
124916892|NCT04586920|449323536|FG014|Overall Study|Lost to Follow-up|0|||
124916893|NCT04586920|449323537|FG015|Overall Study|Lost to Follow-up|0|||
124916894|NCT04586920|449323538|FG016|Overall Study|Lost to Follow-up|0|||
124916895|NCT04586920|449323539|FG017|Overall Study|Lost to Follow-up|0|||
124916896|NCT04586920|449323522|FG000|Overall Study|Withdrawal by Subject|0|||
124916897|NCT04586920|449323523|FG001|Overall Study|Withdrawal by Subject|0|||
124916898|NCT04586920|449323524|FG002|Overall Study|Withdrawal by Subject|0|||
124916899|NCT04586920|449323525|FG003|Overall Study|Withdrawal by Subject|0|||
124916900|NCT04586920|449323526|FG004|Overall Study|Withdrawal by Subject|0|||
124916901|NCT04586920|449323527|FG005|Overall Study|Withdrawal by Subject|0|||
124695199|NCT02946996|448503613|FG002|Overall Study|non-evaluable|5|||
124695200|NCT04359680|448505804|FG000|Overall Study|Withdrawal by Subject|29|||
124695201|NCT04359680|448505805|FG001|Overall Study|Withdrawal by Subject|24|||
124916902|NCT04586920|449323528|FG006|Overall Study|Withdrawal by Subject|0|||
124916903|NCT04586920|449323529|FG007|Overall Study|Withdrawal by Subject|1|||
124916904|NCT04586920|449323530|FG008|Overall Study|Withdrawal by Subject|0|||
124916905|NCT04586920|449323531|FG009|Overall Study|Withdrawal by Subject|1|||
124916906|NCT04586920|449323532|FG010|Overall Study|Withdrawal by Subject|0|||
124916907|NCT04586920|449323533|FG011|Overall Study|Withdrawal by Subject|1|||
124916908|NCT04586920|449323534|FG012|Overall Study|Withdrawal by Subject|0|||
124695202|NCT04359680|448505804|FG000|Overall Study|Adverse Event|6|||
124695203|NCT04359680|448505805|FG001|Overall Study|Adverse Event|2|||
124695204|NCT04359680|448505804|FG000|Overall Study|Lost to Follow-up|56|||
124695205|NCT04359680|448505805|FG001|Overall Study|Lost to Follow-up|59|||
124695206|NCT04359680|448505804|FG000|Overall Study|Protocol Violation|3|||
124695207|NCT04359680|448505805|FG001|Overall Study|Protocol Violation|5|||
124695208|NCT04359680|448505804|FG000|Overall Study|Physician Decision|1|||
124695209|NCT04359680|448505805|FG001|Overall Study|Physician Decision|1|||
124695210|NCT04359680|448505804|FG000|Overall Study|Sponsor Decision|0|||
124916909|NCT04586920|449323535|FG013|Overall Study|Withdrawal by Subject|0|||
124916910|NCT04586920|449323536|FG014|Overall Study|Withdrawal by Subject|0|||
124916911|NCT04586920|449323537|FG015|Overall Study|Withdrawal by Subject|0|||
124545390|NCT00762073|447951191|FG002|Overall Study|Adverse Event|1|||
124695211|NCT04359680|448505805|FG001|Overall Study|Sponsor Decision|1|||
124695212|NCT03931785|448505807|FG000|Overall Study|Lost to Follow-up|4|||
124916912|NCT04586920|449323538|FG016|Overall Study|Withdrawal by Subject|0|||
124916913|NCT04586920|449323539|FG017|Overall Study|Withdrawal by Subject|0|||
124916914|NCT04052516|449323544|FG000|Overall Study|Withdrawal by Subject|4|||
124916915|NCT04052516|449323545|FG001|Overall Study|Withdrawal by Subject|5|||
124916916|NCT04052516|449323546|FG002|Overall Study|Withdrawal by Subject|6|||
124916917|NCT04052516|449323544|FG000|Overall Study|Adverse Event|3|||
124916918|NCT04052516|449323545|FG001|Overall Study|Adverse Event|2|||
124916919|NCT04052516|449323546|FG002|Overall Study|Adverse Event|8|||
124916920|NCT04052516|449323544|FG000|Overall Study|Lost to Follow-up|2|||
124916921|NCT04052516|449323545|FG001|Overall Study|Lost to Follow-up|5|||
124916922|NCT04052516|449323546|FG002|Overall Study|Lost to Follow-up|3|||
124916923|NCT04052516|449323544|FG000|Overall Study|Protocol Violation|1|||
124916924|NCT04052516|449323545|FG001|Overall Study|Protocol Violation|1|||
124916925|NCT04052516|449323546|FG002|Overall Study|Protocol Violation|0|||
124916926|NCT04052516|449323544|FG000|Overall Study|Death|1|||
124916927|NCT04052516|449323545|FG001|Overall Study|Death|0|||
124916928|NCT04052516|449323546|FG002|Overall Study|Death|0|||
124916929|NCT04052516|449323544|FG000|Overall Study|Physician Decision|0|||
124916930|NCT04052516|449323545|FG001|Overall Study|Physician Decision|1|||
124916931|NCT04052516|449323546|FG002|Overall Study|Physician Decision|0|||
124916932|NCT04052516|449323544|FG000|Overall Study|Pregnancy|1|||
124916933|NCT04052516|449323545|FG001|Overall Study|Pregnancy|0|||
124916934|NCT04052516|449323546|FG002|Overall Study|Pregnancy|0|||
124916935|NCT04052516|449323544|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
124916936|NCT04052516|449323545|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
124916937|NCT04052516|449323546|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
124916938|NCT04052516|449323544|FG000|Overall Study|Reason not recorded|0|||
124916939|NCT04052516|449323545|FG001|Overall Study|Reason not recorded|1|||
124916940|NCT04052516|449323546|FG002|Overall Study|Reason not recorded|0|||
124916941|NCT03948763|449323550|FG000|Overall Study|Sponsor's decision|0|||
124916942|NCT03948763|449323551|FG001|Overall Study|Sponsor's decision|2|||
124916943|NCT03948763|449323552|FG002|Overall Study|Sponsor's decision|6|||
124916944|NCT03948763|449323553|FG003|Overall Study|Sponsor's decision|4|||
124916945|NCT03948763|449323554|FG004|Overall Study|Sponsor's decision|0|||
124916946|NCT03948763|449323550|FG000|Overall Study|Physician Decision|0|||
124916947|NCT03948763|449323551|FG001|Overall Study|Physician Decision|0|||
124916948|NCT03948763|449323552|FG002|Overall Study|Physician Decision|1|||
124916949|NCT03948763|449323553|FG003|Overall Study|Physician Decision|0|||
124916950|NCT03948763|449323554|FG004|Overall Study|Physician Decision|0|||
124916951|NCT03948763|449323550|FG000|Overall Study|Lost to Follow-up|0|||
124916952|NCT03948763|449323551|FG001|Overall Study|Lost to Follow-up|0|||
124916953|NCT03948763|449323552|FG002|Overall Study|Lost to Follow-up|0|||
124916954|NCT03948763|449323553|FG003|Overall Study|Lost to Follow-up|0|||
124916955|NCT03948763|449323554|FG004|Overall Study|Lost to Follow-up|1|||
124916956|NCT03948763|449323550|FG000|Overall Study|Death|2|||
124916957|NCT03948763|449323551|FG001|Overall Study|Death|12|||
124916958|NCT03948763|449323552|FG002|Overall Study|Death|13|||
124916959|NCT03948763|449323553|FG003|Overall Study|Death|10|||
124916960|NCT03948763|449323554|FG004|Overall Study|Death|11|||
124916961|NCT03948763|449323550|FG000|Overall Study|Withdrawal by Subject|1|||
124916962|NCT03948763|449323551|FG001|Overall Study|Withdrawal by Subject|1|||
124916963|NCT03948763|449323552|FG002|Overall Study|Withdrawal by Subject|0|||
124916964|NCT03948763|449323553|FG003|Overall Study|Withdrawal by Subject|2|||
124916965|NCT03948763|449323554|FG004|Overall Study|Withdrawal by Subject|4|||
124916966|NCT05415436|449323555|FG000|Overall Study|Surgeon cancelled procedure|1|||
124916967|NCT05415436|449323556|FG001|Overall Study|Surgeon cancelled procedure|0|||
124916968|NCT05415436|449323555|FG000|Overall Study|Death|1|||
124916969|NCT05415436|449323556|FG001|Overall Study|Death|0|||
124916970|NCT02597946|449323570|FG000|Overall Study|Withdrawal by Subject|1|||
124916971|NCT02597946|449323570|FG000|Overall Study|Progressive disease|16|||
124695213|NCT03931785|448505808|FG001|Overall Study|Lost to Follow-up|1|||
124916972|NCT02597946|449323570|FG000|Overall Study|Other than above|1|||
124695214|NCT03931785|448505809|FG002|Overall Study|Lost to Follow-up|4|||
124695215|NCT03931785|448505810|FG003|Overall Study|Lost to Follow-up|3|||
124695216|NCT03931785|448505807|FG000|Overall Study|Adverse Event|1|||
124695217|NCT03931785|448505808|FG001|Overall Study|Adverse Event|0|||
124695218|NCT03931785|448505809|FG002|Overall Study|Adverse Event|3|||
124916973|NCT05058391|449323577|FG000|Overall Study|Adverse Event|1|||
124916974|NCT05136404|449323578|FG000|Period 1|Adverse Event|0|||
124916975|NCT05136404|449323579|FG001|Period 1|Adverse Event|1|||
124916976|NCT05136404|449323580|FG002|Period 1|Adverse Event|1|||
124916977|NCT05136404|449323578|FG000|Period 2|Inappropriate Behavior|0|||
124916978|NCT05136404|449323579|FG001|Period 2|Inappropriate Behavior|0|||
124916979|NCT05136404|449323580|FG002|Period 2|Inappropriate Behavior|1|||
124916980|NCT05136404|449323578|FG000|Period 3|Adverse Event|0|||
124916981|NCT05136404|449323579|FG001|Period 3|Adverse Event|0|||
124916982|NCT05136404|449323580|FG002|Period 3|Adverse Event|1|||
124916983|NCT03584516|449323581|FG000|Part 1|Death|2|||
124916984|NCT03584516|449323582|FG001|Part 1|Death|3|||
124695219|NCT03931785|448505810|FG003|Overall Study|Adverse Event|4|||
124916985|NCT03584516|449323583|FG002|Part 1|Death|0|||
124916986|NCT03584516|449323584|FG003|Part 1|Death|0|||
124916987|NCT03584516|449323585|FG004|Part 1|Death|0|||
124916988|NCT03584516|449323586|FG005|Part 1|Death|0|||
124916989|NCT03584516|449323581|FG000|Part 1|Withdrawal by Subject|2|||
124916990|NCT03584516|449323582|FG001|Part 1|Withdrawal by Subject|0|||
124916991|NCT03584516|449323583|FG002|Part 1|Withdrawal by Subject|0|||
124916992|NCT03584516|449323584|FG003|Part 1|Withdrawal by Subject|0|||
124916993|NCT03584516|449323585|FG004|Part 1|Withdrawal by Subject|0|||
124916994|NCT03584516|449323586|FG005|Part 1|Withdrawal by Subject|0|||
124916995|NCT03584516|449323581|FG000|Part 1|Lost to Follow-up|1|||
124916996|NCT03584516|449323582|FG001|Part 1|Lost to Follow-up|0|||
124916997|NCT03584516|449323583|FG002|Part 1|Lost to Follow-up|0|||
124916998|NCT03584516|449323584|FG003|Part 1|Lost to Follow-up|0|||
124916999|NCT03584516|449323585|FG004|Part 1|Lost to Follow-up|0|||
124917000|NCT03584516|449323586|FG005|Part 1|Lost to Follow-up|0|||
124917001|NCT03584516|449323581|FG000|Part 1|Study Terminated by Sponsor|0|||
124917002|NCT03584516|449323582|FG001|Part 1|Study Terminated by Sponsor|2|||
124917003|NCT03584516|449323583|FG002|Part 1|Study Terminated by Sponsor|0|||
124917004|NCT03584516|449323584|FG003|Part 1|Study Terminated by Sponsor|0|||
124917005|NCT03584516|449323585|FG004|Part 1|Study Terminated by Sponsor|0|||
124917006|NCT03584516|449323586|FG005|Part 1|Study Terminated by Sponsor|0|||
124917007|NCT03584516|449323581|FG000|Part 1 Expansion|Death|0|||
124917008|NCT03584516|449323582|FG001|Part 1 Expansion|Death|0|||
124917009|NCT03584516|449323583|FG002|Part 1 Expansion|Death|9|||
124917010|NCT03584516|449323584|FG003|Part 1 Expansion|Death|8|||
124917011|NCT03584516|449323585|FG004|Part 1 Expansion|Death|4|||
124917012|NCT03584516|449323586|FG005|Part 1 Expansion|Death|5|||
124917013|NCT03584516|449323581|FG000|Part 1 Expansion|Lost to Follow-up|0|||
124917014|NCT03584516|449323582|FG001|Part 1 Expansion|Lost to Follow-up|0|||
124917015|NCT03584516|449323583|FG002|Part 1 Expansion|Lost to Follow-up|0|||
124917016|NCT03584516|449323584|FG003|Part 1 Expansion|Lost to Follow-up|1|||
124917017|NCT03584516|449323585|FG004|Part 1 Expansion|Lost to Follow-up|0|||
124917018|NCT03584516|449323586|FG005|Part 1 Expansion|Lost to Follow-up|0|||
124917019|NCT03584516|449323581|FG000|Part 1 Expansion|Physician Decision|0|||
124917020|NCT03584516|449323582|FG001|Part 1 Expansion|Physician Decision|0|||
124917021|NCT03584516|449323583|FG002|Part 1 Expansion|Physician Decision|4|||
124917022|NCT03584516|449323584|FG003|Part 1 Expansion|Physician Decision|3|||
124917023|NCT03584516|449323585|FG004|Part 1 Expansion|Physician Decision|2|||
124917024|NCT03584516|449323586|FG005|Part 1 Expansion|Physician Decision|3|||
124917025|NCT03584516|449323581|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
124917026|NCT03584516|449323582|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
124917027|NCT03584516|449323583|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
124917028|NCT03584516|449323584|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
124917029|NCT03584516|449323585|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
124917030|NCT03584516|449323586|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
124917031|NCT03584516|449323581|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
124917032|NCT03584516|449323582|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
124917033|NCT03584516|449323583|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
124917034|NCT03584516|449323584|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
124917035|NCT03584516|449323585|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
124917036|NCT03584516|449323586|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
124917037|NCT03584516|449323581|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
124917038|NCT03584516|449323582|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
124917039|NCT03584516|449323583|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
124917040|NCT03584516|449323584|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
124917041|NCT03584516|449323585|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
124917042|NCT03584516|449323586|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
124917043|NCT03584516|449323581|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
124917044|NCT03584516|449323582|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
124917045|NCT03584516|449323583|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
124917046|NCT03584516|449323584|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
124917047|NCT03584516|449323585|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
124917048|NCT03584516|449323586|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
124917049|NCT04868110|449323588|FG000|Overall Study|Withdrawal by Subject|3|||
124917050|NCT04868110|449323589|FG001|Overall Study|Withdrawal by Subject|4|||
124917051|NCT04511702|449323598|FG000|Overall Study|Lost to Follow-up|3|||
124917052|NCT04511702|449323599|FG001|Overall Study|Lost to Follow-up|0|||
124917053|NCT04511702|449323600|FG002|Overall Study|Lost to Follow-up|4|||
124917054|NCT04511702|449323598|FG000|Overall Study|Withdrawal by Subject|17|||
124917055|NCT04511702|449323599|FG001|Overall Study|Withdrawal by Subject|1|||
124917056|NCT04511702|449323600|FG002|Overall Study|Withdrawal by Subject|8|||
124917057|NCT01894061|449323601|FG000|Overall Study|Screen failure|1|||
124917058|NCT01894061|449323601|FG000|Overall Study|Withdrawal by Subject|1|||
124917059|NCT02840474|449323604|FG000|Overall Study|Lost to Follow-up|1|||
124917060|NCT02840474|449323605|FG001|Overall Study|Lost to Follow-up|0|||
124917061|NCT03192891|449323606|FG000|Overall Study|Lost to Follow-up|55|||
124917062|NCT05141903|449323607|FG000|Overall Study|Withdrawal by Subject|0|||
124917063|NCT05141903|449323608|FG001|Overall Study|Withdrawal by Subject|1|||
124917064|NCT05141903|449323609|FG002|Overall Study|Withdrawal by Subject|1|||
124917065|NCT05141903|449323610|FG003|Overall Study|Withdrawal by Subject|0|||
124917066|NCT05141903|449323611|FG004|Overall Study|Withdrawal by Subject|0|||
124917067|NCT05141903|449323607|FG000|Overall Study|Other|1|||
124917068|NCT05141903|449323608|FG001|Overall Study|Other|1|||
124917069|NCT05141903|449323609|FG002|Overall Study|Other|0|||
124917070|NCT05141903|449323610|FG003|Overall Study|Other|0|||
124917071|NCT05141903|449323611|FG004|Overall Study|Other|0|||
124917072|NCT03089398|449323614|FG000|Overall Study|Death|4|||
124917073|NCT03089398|449323615|FG001|Overall Study|Death|9|||
124917074|NCT03089398|449323614|FG000|Overall Study|Lost to Follow-up|21|||
124917075|NCT03089398|449323615|FG001|Overall Study|Lost to Follow-up|30|||
124917076|NCT03089398|449323614|FG000|Overall Study|Withdrawal by Subject|2|||
124917077|NCT03089398|449323615|FG001|Overall Study|Withdrawal by Subject|2|||
124917078|NCT05062265|449323616|FG000|Overall Study|Withdrawal by Subject|1|||
124917079|NCT05062265|449323617|FG001|Overall Study|Withdrawal by Subject|0|||
124917080|NCT05439603|449323618|FG000|Overall Study|met withdrawal criteria|2|||
124917081|NCT02682316|449323621|FG000|Overall Study|Benign Final Pathology|27|||
124917082|NCT02682316|449323622|FG001|Overall Study|Benign Final Pathology|26|||
124917083|NCT02682316|449323621|FG000|Overall Study|Reoperation before 30 days|7|||
124917084|NCT02682316|449323622|FG001|Overall Study|Reoperation before 30 days|6|||
124917085|NCT02682316|449323621|FG000|Overall Study|Ineligible|1|||
124917086|NCT02682316|449323622|FG001|Overall Study|Ineligible|0|||
124917087|NCT02682316|449323621|FG000|Overall Study|Death|1|||
124917088|NCT02682316|449323622|FG001|Overall Study|Death|0|||
124917089|NCT02682316|449323621|FG000|Overall Study|Lost to Follow-up|7|||
124917090|NCT02682316|449323622|FG001|Overall Study|Lost to Follow-up|3|||
124917091|NCT05927753|449323624|FG000|Overall Study|Withdrawal by Subject|0|||
124917092|NCT05927753|449323625|FG001|Overall Study|Withdrawal by Subject|2|||
124917093|NCT05927753|449323624|FG000|Overall Study|Physician Decision|0|||
124917094|NCT05927753|449323625|FG001|Overall Study|Physician Decision|1|||
124917095|NCT00150813|449323626|FG000|Overall Study|Adverse Event|1|||
124917096|NCT00150813|449323626|FG000|Overall Study|Lack of Efficacy|1|||
124917097|NCT00150813|449323626|FG000|Overall Study|Lost to Follow-up|5|||
124917098|NCT00150813|449323626|FG000|Overall Study|Withdrawal by Subject|5|||
124917099|NCT00150813|449323626|FG000|Overall Study|Remission|3|||
124917100|NCT00150813|449323626|FG000|Overall Study|Planned pregancy|1|||
124917101|NCT00150813|449323626|FG000|Overall Study|Switch to commercially available LEV|2|||
124917102|NCT03052608|449323628|FG000|Treatment Phase|Adverse Event|10|||
124917103|NCT03052608|449323629|FG001|Treatment Phase|Adverse Event|12|||
124917104|NCT03052608|449323628|FG000|Treatment Phase|Death|6|||
124917105|NCT03052608|449323629|FG001|Treatment Phase|Death|4|||
124917106|NCT03052608|449323628|FG000|Treatment Phase|Withdrawal by Subject|4|||
124917107|NCT03052608|449323629|FG001|Treatment Phase|Withdrawal by Subject|12|||
124917108|NCT03052608|449323628|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
124917109|NCT03052608|449323629|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
124917110|NCT03052608|449323628|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
124917111|NCT03052608|449323629|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
124917112|NCT03052608|449323628|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
124917113|NCT03052608|449323629|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
124917114|NCT03052608|449323628|FG000|Treatment Phase|Ongoing|103|||
124917115|NCT03052608|449323629|FG001|Treatment Phase|Ongoing|31|||
124917116|NCT03052608|449323628|FG000|Long-Term Follow-up Phase|Death|23|||
124917117|NCT03052608|449323629|FG001|Long-Term Follow-up Phase|Death|28|||
124917118|NCT03052608|449323628|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
124917119|NCT03052608|449323629|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
124917120|NCT03052608|449323628|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
124917121|NCT03052608|449323629|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
124917122|NCT03052608|449323628|FG000|Long-Term Follow-up Phase|Ongoing|122|||
124917123|NCT03052608|449323629|FG001|Long-Term Follow-up Phase|Ongoing|99|||
124917124|NCT03113500|449323630|FG000|Overall Study|Withdrawal by Subject|1|||
124917125|NCT04820855|449323634|FG000|Overall Study|Lost to Follow-up|6|||
124917126|NCT04820855|449323635|FG001|Overall Study|Lost to Follow-up|9|||
124917127|NCT00650104|449323645|FG000|Overall Study|Adverse Event|17|||
124917128|NCT00650104|449323645|FG000|Overall Study|Death|2|||
124917129|NCT00650104|449323645|FG000|Overall Study|Withdrawal by Subject|11|||
124917130|NCT00650104|449323645|FG000|Overall Study|Physician Decision|7|||
124917131|NCT00650104|449323645|FG000|Overall Study|Lost to Follow-up|1|||
124917132|NCT00650104|449323645|FG000|Overall Study|Non-compliance|2|||
124917133|NCT00650104|449323645|FG000|Overall Study|Sponsor Terminated Dosing|1|||
124917134|NCT00931710|449323646|FG000|Overall Study|Adverse Event|16|||
124917135|NCT00931710|449323647|FG001|Overall Study|Adverse Event|10|||
124917136|NCT00931710|449323646|FG000|Overall Study|Abnormal test procedure results|2|||
124917137|NCT00931710|449323647|FG001|Overall Study|Abnormal test procedure results|0|||
124917138|NCT00931710|449323646|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
124917139|NCT00931710|449323647|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
124917140|NCT00931710|449323646|FG000|Overall Study|Patient withdrew consent|4|||
124917141|NCT00931710|449323647|FG001|Overall Study|Patient withdrew consent|9|||
124917142|NCT00931710|449323646|FG000|Overall Study|Lost to Follow-up|6|||
124917143|NCT00931710|449323647|FG001|Overall Study|Lost to Follow-up|5|||
124917144|NCT00931710|449323646|FG000|Overall Study|Protocol deviation|1|||
124917145|NCT00931710|449323647|FG001|Overall Study|Protocol deviation|2|||
124917146|NCT01376700|449323648|FG000|Overall Study|Sponsor terminated study early|8|||
124917147|NCT01376700|449323648|FG000|Overall Study|Low or high titer inhibitor|8|||
124917148|NCT00601900|449323660|FG000|Overall Study|Withdrawal by Subject|0|||
124917149|NCT00601900|449323661|FG001|Overall Study|Withdrawal by Subject|3|||
124695220|NCT03931785|448505807|FG000|Overall Study|Protocol Violation|0|||
124917150|NCT02140645|449323667|FG000|Overall Study|Not linked|5489|||
124917151|NCT02140645|449323668|FG001|Overall Study|Not linked|61654|||
124917152|NCT02140645|449323669|FG002|Overall Study|Not linked|4236|||
124917153|NCT02140645|449323670|FG003|Overall Study|Not linked|13833|||
124917154|NCT02140645|449323671|FG004|Overall Study|Not linked|3286|||
124695221|NCT03931785|448505808|FG001|Overall Study|Protocol Violation|1|||
124695222|NCT03931785|448505809|FG002|Overall Study|Protocol Violation|0|||
124695223|NCT03931785|448505810|FG003|Overall Study|Protocol Violation|0|||
124695224|NCT03931785|448505807|FG000|Overall Study|Noncompliance With Study drug|0|||
124695225|NCT03931785|448505808|FG001|Overall Study|Noncompliance With Study drug|1|||
124695226|NCT03931785|448505809|FG002|Overall Study|Noncompliance With Study drug|0|||
124695227|NCT03931785|448505810|FG003|Overall Study|Noncompliance With Study drug|0|||
124695228|NCT03931785|448505807|FG000|Overall Study|Other Not specified|0|||
124695229|NCT03931785|448505808|FG001|Overall Study|Other Not specified|2|||
124695230|NCT03931785|448505809|FG002|Overall Study|Other Not specified|2|||
124695231|NCT03931785|448505810|FG003|Overall Study|Other Not specified|2|||
124695232|NCT03931785|448505807|FG000|Overall Study|Withdrawal by Subject|0|||
124695233|NCT03931785|448505808|FG001|Overall Study|Withdrawal by Subject|2|||
124695234|NCT03931785|448505809|FG002|Overall Study|Withdrawal by Subject|4|||
124695235|NCT03931785|448505810|FG003|Overall Study|Withdrawal by Subject|1|||
124695236|NCT03931785|448505807|FG000|Overall Study|Pregnancy|0|||
124695237|NCT03931785|448505808|FG001|Overall Study|Pregnancy|0|||
124695238|NCT03931785|448505809|FG002|Overall Study|Pregnancy|0|||
124695239|NCT03931785|448505810|FG003|Overall Study|Pregnancy|1|||
124695240|NCT04605588|448505814|FG000|Overall Study|Withdrawal by Subject|1|||
124695241|NCT04605588|448505815|FG001|Overall Study|Withdrawal by Subject|0|||
124695242|NCT01230814|448505816|FG000|Overall Study|Lost to Follow-up|11|||
124695243|NCT01230814|448505817|FG001|Overall Study|Lost to Follow-up|3|||
124695244|NCT01230814|448505816|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
124917155|NCT02140645|449323672|FG005|Overall Study|Not linked|70896|||
124917156|NCT00593489|449323676|FG000|Allocation|did not attend workshop; allocation not|2|||
124917157|NCT00593489|449323677|FG001|Allocation|did not attend workshop; allocation not|1|||
124917158|NCT00611559|449323678|FG000|Overall Study|Lost to Follow-up|0|||
124917159|NCT00611559|449323679|FG001|Overall Study|Lost to Follow-up|1|||
124917160|NCT00611559|449323680|FG002|Overall Study|Lost to Follow-up|0|||
124917161|NCT00611559|449323678|FG000|Overall Study|Protocol Violation|1|||
124917162|NCT00611559|449323679|FG001|Overall Study|Protocol Violation|0|||
124917163|NCT00611559|449323680|FG002|Overall Study|Protocol Violation|1|||
124917164|NCT04442126|449323681|FG000|Overall Study|Withdrawal by Subject|0|||
124917165|NCT04442126|449323682|FG001|Overall Study|Withdrawal by Subject|0|||
124917166|NCT04442126|449323683|FG002|Overall Study|Withdrawal by Subject|0|||
124917167|NCT04442126|449323684|FG003|Overall Study|Withdrawal by Subject|2|||
124917168|NCT04442126|449323685|FG004|Overall Study|Withdrawal by Subject|1|||
124917169|NCT04442126|449323686|FG005|Overall Study|Withdrawal by Subject|0|||
124917170|NCT04442126|449323687|FG006|Overall Study|Withdrawal by Subject|1|||
124917171|NCT04442126|449323688|FG007|Overall Study|Withdrawal by Subject|1|||
124917172|NCT04442126|449323689|FG008|Overall Study|Withdrawal by Subject|3|||
124917173|NCT04442126|449323681|FG000|Overall Study|Death|1|||
124917174|NCT04442126|449323682|FG001|Overall Study|Death|0|||
124917175|NCT04442126|449323683|FG002|Overall Study|Death|0|||
124917176|NCT04442126|449323684|FG003|Overall Study|Death|1|||
124917177|NCT04442126|449323685|FG004|Overall Study|Death|2|||
124917178|NCT04442126|449323686|FG005|Overall Study|Death|2|||
124695245|NCT01230814|448505817|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
124695246|NCT02596893|448505820|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
124917179|NCT04442126|449323687|FG006|Overall Study|Death|4|||
124917180|NCT04442126|449323688|FG007|Overall Study|Death|1|||
124917181|NCT04442126|449323689|FG008|Overall Study|Death|5|||
124695247|NCT02596893|448505821|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
124695248|NCT02596893|448505822|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
124695249|NCT02596893|448505823|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
124917182|NCT04442126|449323681|FG000|Overall Study|Study Terminated by Sponsor|0|||
124917183|NCT04442126|449323682|FG001|Overall Study|Study Terminated by Sponsor|0|||
124917184|NCT04442126|449323683|FG002|Overall Study|Study Terminated by Sponsor|0|||
124917185|NCT04442126|449323684|FG003|Overall Study|Study Terminated by Sponsor|0|||
124917186|NCT04442126|449323685|FG004|Overall Study|Study Terminated by Sponsor|0|||
124695250|NCT02596893|448505820|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
124917187|NCT04442126|449323686|FG005|Overall Study|Study Terminated by Sponsor|1|||
124762006|NCT00101686|448753547|FG003|Overall Study|intercurrent non-cancer related illness|0|||
124762007|NCT00101686|448753548|FG004|Overall Study|intercurrent non-cancer related illness|1|||
124762008|NCT00101686|448753549|FG005|Overall Study|intercurrent non-cancer related illness|3|||
124762009|NCT00101686|448753550|FG006|Overall Study|intercurrent non-cancer related illness|1|||
124762010|NCT00101686|448753551|FG007|Overall Study|intercurrent non-cancer related illness|0|||
124762011|NCT00101686|448753552|FG008|Overall Study|intercurrent non-cancer related illness|1|||
124762012|NCT00101686|448753553|FG009|Overall Study|intercurrent non-cancer related illness|1|||
124762013|NCT00101686|448753544|FG000|Overall Study|Physician Decision|10|||
124762014|NCT00101686|448753545|FG001|Overall Study|Physician Decision|13|||
124762015|NCT00101686|448753546|FG002|Overall Study|Physician Decision|6|||
124762016|NCT00101686|448753547|FG003|Overall Study|Physician Decision|7|||
124762017|NCT00101686|448753548|FG004|Overall Study|Physician Decision|8|||
124762018|NCT00101686|448753549|FG005|Overall Study|Physician Decision|9|||
124762019|NCT00101686|448753550|FG006|Overall Study|Physician Decision|5|||
124762020|NCT00101686|448753551|FG007|Overall Study|Physician Decision|5|||
124762021|NCT00101686|448753552|FG008|Overall Study|Physician Decision|1|||
124762022|NCT00101686|448753553|FG009|Overall Study|Physician Decision|1|||
124762023|NCT00101686|448753544|FG000|Overall Study|Other|1|||
124762024|NCT00101686|448753545|FG001|Overall Study|Other|4|||
124762025|NCT00101686|448753546|FG002|Overall Study|Other|1|||
124762026|NCT00101686|448753547|FG003|Overall Study|Other|6|||
124695251|NCT02596893|448505821|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
124695252|NCT02596893|448505822|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
124695253|NCT02596893|448505823|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
124695254|NCT02596893|448505820|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
124695255|NCT02596893|448505821|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
124695256|NCT02596893|448505822|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
124695257|NCT02596893|448505823|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
124695258|NCT02596893|448505820|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
124695259|NCT02596893|448505821|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
124695260|NCT02596893|448505822|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
124695261|NCT02596893|448505823|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
124695262|NCT02596893|448505820|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
124695263|NCT02596893|448505821|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
124695264|NCT02596893|448505822|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
124695265|NCT02596893|448505823|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
124695266|NCT02596893|448505820|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
124695267|NCT02596893|448505821|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
124695268|NCT02596893|448505822|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
124695269|NCT02596893|448505823|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
124695270|NCT02596893|448505820|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
124695271|NCT02596893|448505821|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
124695272|NCT02596893|448505822|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
124695273|NCT02596893|448505823|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
124695274|NCT02596893|448505820|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
124695275|NCT02596893|448505821|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
124695276|NCT02596893|448505822|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
124695277|NCT02596893|448505823|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
124695278|NCT02596893|448505820|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
124695279|NCT02596893|448505821|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
124695280|NCT02596893|448505822|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
124695281|NCT02596893|448505823|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
124695282|NCT02596893|448505820|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
124695283|NCT02596893|448505821|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
124695284|NCT02596893|448505822|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
124695285|NCT02596893|448505823|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
124695286|NCT02596893|448505820|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
124695287|NCT02596893|448505821|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
124695288|NCT02596893|448505822|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
124695289|NCT02596893|448505823|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
124762027|NCT00101686|448753548|FG004|Overall Study|Other|2|||
124695290|NCT03280615|448505824|FG000|Overall Study|Lost to Follow-up|1|||
124762028|NCT00101686|448753549|FG005|Overall Study|Other|12|||
124762029|NCT00101686|448753550|FG006|Overall Study|Other|1|||
124762030|NCT00101686|448753551|FG007|Overall Study|Other|5|||
124695291|NCT03280615|448505825|FG001|Overall Study|Lost to Follow-up|2|||
124695292|NCT03280615|448505824|FG000|Overall Study|Adverse Event|1|||
124762031|NCT00101686|448753552|FG008|Overall Study|Other|3|||
124762032|NCT00101686|448753553|FG009|Overall Study|Other|3|||
124762033|NCT00101686|448753544|FG000|Overall Study|Withdrawal by Subject|9|||
124917188|NCT04442126|449323687|FG006|Overall Study|Study Terminated by Sponsor|4|||
124917189|NCT04442126|449323688|FG007|Overall Study|Study Terminated by Sponsor|2|||
124917190|NCT04442126|449323689|FG008|Overall Study|Study Terminated by Sponsor|10|||
124917191|NCT04442126|449323681|FG000|Overall Study|Lost to Follow-up|0|||
124917192|NCT04442126|449323682|FG001|Overall Study|Lost to Follow-up|0|||
124917193|NCT04442126|449323683|FG002|Overall Study|Lost to Follow-up|0|||
124917194|NCT04442126|449323684|FG003|Overall Study|Lost to Follow-up|0|||
124917195|NCT04442126|449323685|FG004|Overall Study|Lost to Follow-up|0|||
124917196|NCT04442126|449323686|FG005|Overall Study|Lost to Follow-up|0|||
124917197|NCT04442126|449323687|FG006|Overall Study|Lost to Follow-up|0|||
124917198|NCT04442126|449323688|FG007|Overall Study|Lost to Follow-up|1|||
124917199|NCT04442126|449323689|FG008|Overall Study|Lost to Follow-up|2|||
124917200|NCT04442126|449323681|FG000|Overall Study|Progressive Disease|0|||
124917201|NCT04442126|449323682|FG001|Overall Study|Progressive Disease|1|||
124917202|NCT04442126|449323683|FG002|Overall Study|Progressive Disease|3|||
124917203|NCT04442126|449323684|FG003|Overall Study|Progressive Disease|0|||
124917204|NCT04442126|449323685|FG004|Overall Study|Progressive Disease|3|||
124917205|NCT04442126|449323686|FG005|Overall Study|Progressive Disease|0|||
124917206|NCT04442126|449323687|FG006|Overall Study|Progressive Disease|0|||
124917207|NCT04442126|449323688|FG007|Overall Study|Progressive Disease|0|||
124695293|NCT03280615|448505825|FG001|Overall Study|Adverse Event|1|||
124695294|NCT03280615|448505824|FG000|Overall Study|Withdrawal by Subject|2|||
124695295|NCT03280615|448505825|FG001|Overall Study|Withdrawal by Subject|2|||
124695296|NCT01529112|448505826|FG000|Overall Study|Adverse Event|2|||
124695297|NCT01529112|448505827|FG001|Overall Study|Adverse Event|0|||
124917208|NCT04442126|449323689|FG008|Overall Study|Progressive Disease|0|||
124695298|NCT01529112|448505826|FG000|Overall Study|Death|59|||
124695299|NCT01529112|448505827|FG001|Overall Study|Death|38|||
124695300|NCT01529112|448505826|FG000|Overall Study|Protocol Violation|1|||
124695301|NCT01529112|448505827|FG001|Overall Study|Protocol Violation|0|||
124695302|NCT01529112|448505826|FG000|Overall Study|Withdrawal by Subject|7|||
124695303|NCT01529112|448505827|FG001|Overall Study|Withdrawal by Subject|3|||
124695304|NCT02502383|448505830|FG000|Overall Study|Lost to Follow-up|130|||
124695305|NCT02502383|448505831|FG001|Overall Study|Lost to Follow-up|131|||
124695306|NCT02502383|448505830|FG000|Overall Study|Withdrawal by Subject|31|||
124695307|NCT02502383|448505831|FG001|Overall Study|Withdrawal by Subject|24|||
124695308|NCT00363467|448505832|FG000|Overall Study|Physician Decision|1|||
124695309|NCT00903344|448505833|FG000|Overall Study|Pregnancy|2|||
124695310|NCT00903344|448505834|FG001|Overall Study|Pregnancy|3|||
124695311|NCT00903344|448505833|FG000|Overall Study|Lost to Follow-up|3|||
124695312|NCT00903344|448505834|FG001|Overall Study|Lost to Follow-up|0|||
124695313|NCT01524705|448505835|FG000|Overall Study|Adverse Event|2|||
124695314|NCT01524705|448505836|FG001|Overall Study|Adverse Event|0|||
124695315|NCT01524705|448505835|FG000|Overall Study|Death|1|||
124695316|NCT01524705|448505836|FG001|Overall Study|Death|0|||
124695317|NCT01524705|448505835|FG000|Overall Study|Lost to Follow-up|0|||
124695318|NCT01524705|448505836|FG001|Overall Study|Lost to Follow-up|1|||
124695319|NCT01524705|448505835|FG000|Overall Study|Withdrawal by Subject|0|||
124695320|NCT01524705|448505836|FG001|Overall Study|Withdrawal by Subject|1|||
124695321|NCT01524705|448505835|FG000|Overall Study|Pancreatic Cancer|0|||
124695322|NCT01524705|448505836|FG001|Overall Study|Pancreatic Cancer|1|||
124695323|NCT00090402|448505837|FG000|Overall Study|Death|1|||
124695324|NCT00090402|448505838|FG001|Overall Study|Death|1|||
124695325|NCT00090402|448505839|FG002|Overall Study|Death|0|||
124695326|NCT00090402|448505837|FG000|Overall Study|subject moved|0|||
124695327|NCT00090402|448505838|FG001|Overall Study|subject moved|1|||
124917209|NCT04442126|449323681|FG000|Overall Study|Other|0|||
124917210|NCT04442126|449323682|FG001|Overall Study|Other|0|||
124917211|NCT04442126|449323683|FG002|Overall Study|Other|0|||
124917212|NCT04442126|449323684|FG003|Overall Study|Other|0|||
124695328|NCT00090402|448505839|FG002|Overall Study|subject moved|0|||
124917213|NCT04442126|449323685|FG004|Overall Study|Other|0|||
124695329|NCT00090402|448505837|FG000|Overall Study|stopped taking study medication|1|||
124695330|NCT00090402|448505838|FG001|Overall Study|stopped taking study medication|0|||
124695331|NCT00090402|448505839|FG002|Overall Study|stopped taking study medication|1|||
124695332|NCT01530256|448505842|FG000|Overall Study|Death|2|||
124695333|NCT02004275|448505844|FG000|Phase 1|Ineligible|0|||
124695334|NCT02004275|448505845|FG001|Phase 1|Ineligible|0|||
124695335|NCT02004275|448505846|FG002|Phase 1|Ineligible|0|||
124695336|NCT02004275|448505847|FG003|Phase 1|Ineligible|1|||
124695337|NCT02004275|448505848|FG004|Phase 1|Ineligible|1|||
124695338|NCT02004275|448505849|FG005|Phase 1|Ineligible|0|||
124695339|NCT02004275|448505844|FG000|Phase 1|Protocol Violation|0|||
124917214|NCT04442126|449323686|FG005|Overall Study|Other|0|||
124917215|NCT04442126|449323687|FG006|Overall Study|Other|0|||
124917216|NCT04442126|449323688|FG007|Overall Study|Other|0|||
124695340|NCT02004275|448505845|FG001|Phase 1|Protocol Violation|0|||
124695341|NCT02004275|448505846|FG002|Phase 1|Protocol Violation|0|||
124695342|NCT02004275|448505847|FG003|Phase 1|Protocol Violation|1|||
124695343|NCT02004275|448505848|FG004|Phase 1|Protocol Violation|0|||
124917217|NCT04442126|449323689|FG008|Overall Study|Other|1|||
124917218|NCT06450405|449323690|FG000|Overall Study|Study funding terminated.|0|||
124695344|NCT02004275|448505849|FG005|Phase 1|Protocol Violation|5|||
124695345|NCT02004275|448505844|FG000|Phase 2 Part 1|Ineligible|6|||
124917219|NCT06450405|449323691|FG001|Overall Study|Study funding terminated.|2|||
124917220|NCT03424811|449325169|FG000|Overall Study|Lost to Follow-up|9|||
124917221|NCT03424811|449325170|FG001|Overall Study|Lost to Follow-up|0|||
124917222|NCT02728557|449325182|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
124917223|NCT02728557|449325183|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
124917224|NCT02728557|449325182|FG000|Overall Study|Dissatisfaction with research tasks|0|||
124917225|NCT02728557|449325183|FG001|Overall Study|Dissatisfaction with research tasks|1|||
124917226|NCT02728557|449325182|FG000|Overall Study|Scheduling or change in availability|1|||
124917227|NCT02728557|449325183|FG001|Overall Study|Scheduling or change in availability|1|||
124917228|NCT03416010|449325184|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
124917229|NCT03416010|449325185|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
124917230|NCT03416010|449325184|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
124917231|NCT03416010|449325185|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
124917232|NCT03416010|449325184|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
124917233|NCT03416010|449325185|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
124917234|NCT03416010|449325184|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
124917235|NCT03416010|449325185|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
124917236|NCT03416010|449325184|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
124917237|NCT03416010|449325185|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
124917238|NCT03416010|449325184|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
124917239|NCT03416010|449325185|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
124917240|NCT03416010|449325184|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
124917241|NCT03416010|449325185|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
124917242|NCT03819686|449325190|FG000|Overall Study|Lost to Follow-up|2|||
124917243|NCT03819686|449325191|FG001|Overall Study|Lost to Follow-up|3|||
124917244|NCT01938547|449325203|FG000|Overall Study|Physician Decision|1|||
124917245|NCT05038566|449325204|FG000|Overall Study|Technical Difficulties with the Device|0|||
124917246|NCT05038566|449325205|FG001|Overall Study|Technical Difficulties with the Device|1|||
124917247|NCT04842643|449325206|FG000|Overall Study|Physician Decision|1|||
124917248|NCT04842643|449325206|FG000|Overall Study|Other|1|||
124917249|NCT00739648|449325209|FG000|Overall Study|Adverse Event|3|||
124917250|NCT00739648|449325210|FG001|Overall Study|Adverse Event|15|||
124917251|NCT00739648|449325209|FG000|Overall Study|Withdrawal by Subject|13|||
124917252|NCT00739648|449325210|FG001|Overall Study|Withdrawal by Subject|25|||
124917253|NCT00739648|449325209|FG000|Overall Study|Lost to Follow-up|4|||
124917254|NCT00739648|449325210|FG001|Overall Study|Lost to Follow-up|7|||
124917255|NCT00739648|449325209|FG000|Overall Study|Death|2|||
124917256|NCT00739648|449325210|FG001|Overall Study|Death|0|||
124917257|NCT00739648|449325209|FG000|Overall Study|Do not know|4|||
124917258|NCT00739648|449325210|FG001|Overall Study|Do not know|6|||
124917259|NCT01757665|449325211|FG000|Overall Study|Still on Study - Visit Completed|240|||
124917260|NCT01757665|449325212|FG001|Overall Study|Still on Study - Visit Completed|30|||
124917261|NCT01757665|449325211|FG000|Overall Study|Still on Study - Visit Pending|398|||
124917262|NCT01757665|449325212|FG001|Overall Study|Still on Study - Visit Pending|40|||
124917263|NCT01757665|449325211|FG000|Overall Study|Still on Study - Missed Visit|14|||
124917264|NCT01757665|449325212|FG001|Overall Study|Still on Study - Missed Visit|1|||
124917265|NCT01757665|449325211|FG000|Overall Study|Death|25|||
124917266|NCT01757665|449325212|FG001|Overall Study|Death|8|||
124917267|NCT01757665|449325211|FG000|Overall Study|Explant|1|||
124917268|NCT01757665|449325212|FG001|Overall Study|Explant|2|||
124917269|NCT01757665|449325211|FG000|Overall Study|Withdrawal by Subject|10|||
124917270|NCT01757665|449325212|FG001|Overall Study|Withdrawal by Subject|0|||
124917271|NCT01757665|449325211|FG000|Overall Study|Lost to Follow-up|1|||
124917272|NCT01757665|449325212|FG001|Overall Study|Lost to Follow-up|1|||
124917273|NCT01757665|449325211|FG000|Overall Study|Not Implanted with Device|5|||
124917274|NCT01757665|449325212|FG001|Overall Study|Not Implanted with Device|1|||
124917275|NCT05387447|449325214|FG000|Overall Study|Participants changed their minds about study participation.|3|||
124917276|NCT05387447|449325215|FG001|Overall Study|Participants changed their minds about study participation.|5|||
124917277|NCT03391466|449325218|FG000|Overall Study|Death|82|||
124917278|NCT03391466|449325219|FG001|Overall Study|Death|85|||
124917279|NCT03391466|449325218|FG000|Overall Study|Still on study|93|||
124695346|NCT02004275|448505845|FG001|Phase 2 Part 1|Ineligible|9|||
124695347|NCT02004275|448505846|FG002|Phase 2 Part 1|Ineligible|0|||
124695348|NCT02004275|448505847|FG003|Phase 2 Part 1|Ineligible|0|||
124695349|NCT02004275|448505848|FG004|Phase 2 Part 1|Ineligible|0|||
124917280|NCT03391466|449325219|FG001|Overall Study|Still on study|74|||
124917281|NCT03391466|449325218|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
124917282|NCT03391466|449325219|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
124917283|NCT03391466|449325218|FG000|Overall Study|Lost to Follow-up|5|||
124917284|NCT03391466|449325219|FG001|Overall Study|Lost to Follow-up|5|||
124695350|NCT02004275|448505849|FG005|Phase 2 Part 1|Ineligible|0|||
124917285|NCT03391466|449325218|FG000|Overall Study|Investigator decision|0|||
124917286|NCT03391466|449325219|FG001|Overall Study|Investigator decision|1|||
124917287|NCT03391466|449325218|FG000|Overall Study|Other|0|||
124917288|NCT03391466|449325219|FG001|Overall Study|Other|1|||
124917289|NCT03655132|449325220|FG000|Overall Study|Lost to Follow-up|2|||
124917290|NCT03655132|449325221|FG001|Overall Study|Lost to Follow-up|1|||
124917291|NCT03655132|449325220|FG000|Overall Study|Withdrawal by Subject|0|||
124917292|NCT03655132|449325221|FG001|Overall Study|Withdrawal by Subject|1|||
124917293|NCT03655132|449325220|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
124917294|NCT03655132|449325221|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
124917295|NCT05919082|449325225|FG000|Overall Study|Adverse Event|3|||
124917296|NCT05919082|449325226|FG001|Overall Study|Adverse Event|0|||
124917297|NCT05919082|449325225|FG000|Overall Study|Lost to Follow-up|0|||
124917298|NCT05919082|449325226|FG001|Overall Study|Lost to Follow-up|1|||
124917299|NCT05919082|449325225|FG000|Overall Study|Withdrawal by Subject|8|||
124917300|NCT05919082|449325226|FG001|Overall Study|Withdrawal by Subject|9|||
124917301|NCT05919082|449325225|FG000|Overall Study|Lack of Efficacy|0|||
124917302|NCT05919082|449325226|FG001|Overall Study|Lack of Efficacy|1|||
124917303|NCT05919082|449325225|FG000|Overall Study|Investigator Decision|1|||
124917304|NCT05919082|449325226|FG001|Overall Study|Investigator Decision|0|||
124917305|NCT04703322|449325232|FG000|Overall Study|Ongoing|8|||
124917306|NCT04703322|449325232|FG000|Overall Study|Withdrawal by Subject|1|||
124917307|NCT06311084|449325233|FG000|Overall Study|Lost to Follow-up|14|||
124917308|NCT05249439|449325239|FG000|Overall Study|Withdrawal by Subject|2|||
124917309|NCT05249439|449325240|FG001|Overall Study|Withdrawal by Subject|5|||
124917310|NCT05249439|449325239|FG000|Overall Study|Physician Decision|3|||
124917311|NCT05249439|449325240|FG001|Overall Study|Physician Decision|1|||
124917312|NCT01707030|449325241|FG000|Overall Study|Death|1|||
124917313|NCT01707030|449325242|FG001|Overall Study|Death|1|||
124917314|NCT01707030|449325241|FG000|Overall Study|Withdrawal by Subject|2|||
124917315|NCT01707030|449325242|FG001|Overall Study|Withdrawal by Subject|3|||
124917316|NCT01707030|449325241|FG000|Overall Study|Lost to Follow-up|8|||
124917317|NCT01707030|449325242|FG001|Overall Study|Lost to Follow-up|13|||
124917318|NCT03526861|449325243|FG000|Initial Treatment Period|Not dosed|1|||
124917319|NCT03526861|449325244|FG001|Initial Treatment Period|Not dosed|1|||
124917320|NCT03526861|449325245|FG002|Initial Treatment Period|Not dosed|1|||
124917321|NCT03526861|449325246|FG003|Initial Treatment Period|Not dosed|0|||
124917322|NCT03526861|449325247|FG004|Initial Treatment Period|Not dosed|0|||
124917323|NCT03526861|449325248|FG005|Initial Treatment Period|Not dosed|0|||
124917324|NCT03526861|449325249|FG006|Initial Treatment Period|Not dosed|0|||
124917325|NCT03526861|449325250|FG007|Initial Treatment Period|Not dosed|0|||
124917326|NCT03526861|449325251|FG008|Initial Treatment Period|Not dosed|0|||
124917327|NCT03526861|449325243|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
124917328|NCT03526861|449325244|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
124917329|NCT03526861|449325245|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
124917330|NCT03526861|449325246|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917331|NCT03526861|449325247|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917332|NCT03526861|449325248|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917333|NCT03526861|449325249|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917334|NCT03526861|449325250|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917335|NCT03526861|449325251|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124545391|NCT00762073|447951192|FG003|Overall Study|Adverse Event|1|||
124695351|NCT02004275|448505844|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
124695352|NCT02004275|448505845|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
124695353|NCT02004275|448505846|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
124695354|NCT02004275|448505847|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
124695355|NCT02004275|448505848|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
124695356|NCT02004275|448505849|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
124695357|NCT04621786|448505852|FG000|Overall Study|Lost to Follow-up|9|||
124695358|NCT04621786|448505852|FG000|Overall Study|Protocol Violation|3|||
124695359|NCT01093885|448505853|FG000|Overall Study|Adverse Event|4|||
124695360|NCT01093885|448505853|FG000|Overall Study|Lost to Follow-up|1|||
124695361|NCT00292370|448505854|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
124695362|NCT00292370|448505855|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
124695363|NCT00292370|448505856|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
124695364|NCT00292370|448505854|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
124695365|NCT00292370|448505855|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
124695366|NCT00292370|448505856|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
124695367|NCT00292370|448505854|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
124917336|NCT03526861|449325243|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
124917337|NCT03526861|449325244|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
124917338|NCT03526861|449325245|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
124917339|NCT03526861|449325246|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
124917340|NCT03526861|449325247|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
124917341|NCT03526861|449325248|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
124917342|NCT03526861|449325249|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
124917343|NCT03526861|449325250|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
124917344|NCT03526861|449325251|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
124917345|NCT03526861|449325243|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917346|NCT03526861|449325244|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917347|NCT03526861|449325245|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917348|NCT03526861|449325246|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
124917349|NCT03526861|449325247|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
124917350|NCT03526861|449325248|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917351|NCT03526861|449325249|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
124917352|NCT03526861|449325250|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917353|NCT03526861|449325251|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917354|NCT03526861|449325243|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
124917355|NCT03526861|449325244|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
124917356|NCT03526861|449325245|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
124917357|NCT03526861|449325246|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
124917358|NCT03526861|449325247|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
124917359|NCT03526861|449325248|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
124917360|NCT03526861|449325249|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
124917361|NCT03526861|449325250|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
124917362|NCT03526861|449325251|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
124917363|NCT03526861|449325243|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917364|NCT03526861|449325244|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917365|NCT03526861|449325245|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917366|NCT03526861|449325246|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
124917367|NCT03526861|449325247|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917368|NCT03526861|449325248|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917369|NCT03526861|449325249|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917370|NCT03526861|449325250|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917371|NCT03526861|449325251|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917372|NCT03526861|449325243|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917373|NCT03526861|449325244|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917374|NCT03526861|449325245|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917375|NCT03526861|449325246|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917376|NCT03526861|449325247|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917377|NCT03526861|449325248|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917378|NCT03526861|449325249|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917379|NCT03526861|449325250|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
124917380|NCT03526861|449325251|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
124917381|NCT03526861|449325243|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
124917382|NCT03526861|449325244|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
124917383|NCT03526861|449325245|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
124917384|NCT03526861|449325246|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
124917385|NCT03526861|449325247|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
124969516|NCT03520075|449517410|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
124762034|NCT00101686|448753545|FG001|Overall Study|Withdrawal by Subject|8|||
124917386|NCT03526861|449325248|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
124917387|NCT03526861|449325249|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
124917388|NCT03526861|449325250|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
124917389|NCT03526861|449325251|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
124917390|NCT03526861|449325243|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917391|NCT03526861|449325244|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917392|NCT03526861|449325245|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917393|NCT03526861|449325246|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917394|NCT03526861|449325247|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917395|NCT03526861|449325248|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917396|NCT03526861|449325249|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917397|NCT03526861|449325250|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
124917398|NCT03526861|449325251|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
124917399|NCT05862870|449325252|FG000|Overall Study|Lost to Follow-up|3|||
124917400|NCT00274469|449325254|FG000|Overall Study|Death|63|||
124917401|NCT00274469|449325255|FG001|Overall Study|Death|74|||
124917402|NCT00274469|449325254|FG000|Overall Study|Did not consent to OS follow-up|16|||
124917403|NCT00274469|449325255|FG001|Overall Study|Did not consent to OS follow-up|19|||
124917404|NCT04095104|449325261|FG000|Overall Study|Withdrawal by Subject|0|||
124917405|NCT04095104|449325262|FG001|Overall Study|Withdrawal by Subject|1|||
124917406|NCT03912831|449325265|FG000|Overall Study|Death|1|||
124917407|NCT03912831|449325266|FG001|Overall Study|Death|1|||
124917408|NCT03912831|449325267|FG002|Overall Study|Death|1|||
124917409|NCT03912831|449325268|FG003|Overall Study|Death|1|||
124917410|NCT03912831|449325269|FG004|Overall Study|Death|1|||
124917411|NCT03912831|449325270|FG005|Overall Study|Death|1|||
124917412|NCT03912831|449325265|FG000|Overall Study|Reason not Specified|0|||
124917413|NCT03912831|449325266|FG001|Overall Study|Reason not Specified|0|||
124917414|NCT03912831|449325267|FG002|Overall Study|Reason not Specified|0|||
124917415|NCT03912831|449325268|FG003|Overall Study|Reason not Specified|0|||
124917416|NCT03912831|449325269|FG004|Overall Study|Reason not Specified|1|||
124917417|NCT03912831|449325270|FG005|Overall Study|Reason not Specified|0|||
124917418|NCT03912831|449325265|FG000|Overall Study|Withdrawal by Participant|0|||
124917419|NCT03912831|449325266|FG001|Overall Study|Withdrawal by Participant|0|||
124917420|NCT03912831|449325267|FG002|Overall Study|Withdrawal by Participant|0|||
124917421|NCT03912831|449325268|FG003|Overall Study|Withdrawal by Participant|0|||
124917422|NCT03912831|449325269|FG004|Overall Study|Withdrawal by Participant|1|||
124917423|NCT03912831|449325270|FG005|Overall Study|Withdrawal by Participant|0|||
124917424|NCT03527160|449325271|FG000|Overall Study|No urine collected|13|||
124917425|NCT03527160|449325271|FG000|Overall Study|No clinical serum creatinine collected|6|||
124917426|NCT03527160|449325271|FG000|Overall Study|Did not meet inclusion|2|||
124917427|NCT02910713|449325274|FG000|Overall Study|Protocol Violation|2|||
124917428|NCT02910713|449325274|FG000|Overall Study|Subject Choice|4|||
124917429|NCT02910713|449325274|FG000|Overall Study|Received One Application|10|||
124917430|NCT02910713|449325274|FG000|Overall Study|Received Neither Application|18|||
124917431|NCT02910713|449325274|FG000|Overall Study|Enrollment cap|7|||
124917432|NCT02910713|449325274|FG000|Overall Study|Investigator Discretion|1|||
124917433|NCT03767517|449325276|FG000|Overall Study|Lost to Follow-up|16|||
124917434|NCT03767517|449325277|FG001|Overall Study|Lost to Follow-up|10|||
124917435|NCT03767517|449325276|FG000|Overall Study|Death|2|||
124917436|NCT03767517|449325277|FG001|Overall Study|Death|3|||
124917437|NCT05792423|449325278|FG000|Overall Study|Withdrawal by Subject|2|||
124917438|NCT05338086|449326070|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
124917439|NCT05338086|449326071|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
124917440|NCT05338086|449326072|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
124917441|NCT05338086|449326073|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
124917442|NCT05338086|449326074|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
124917443|NCT05338086|449326070|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
124917444|NCT05338086|449326071|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
124917445|NCT05338086|449326072|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
124917446|NCT05338086|449326073|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
124917447|NCT05338086|449326074|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
124917448|NCT05338086|449326070|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
124451731|NCT01854645|447615164|FG000|Overall Study|Administrative Reasons / Missing|0|||
124917449|NCT05338086|449326071|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
124917450|NCT05338086|449326072|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
124917451|NCT05338086|449326073|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
124917452|NCT05338086|449326074|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
124917453|NCT05338086|449326070|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
124917454|NCT05338086|449326071|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
124917455|NCT05338086|449326072|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
124917456|NCT05338086|449326073|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
124917457|NCT05338086|449326074|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
124917458|NCT05338086|449326070|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
124917459|NCT05338086|449326071|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
124917460|NCT05338086|449326072|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
124917461|NCT05338086|449326073|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
124917462|NCT05338086|449326074|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
124917463|NCT05338086|449326070|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
124917464|NCT05338086|449326071|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
124917465|NCT05338086|449326072|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
124917466|NCT05338086|449326073|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
124917467|NCT05338086|449326074|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
124917468|NCT05338086|449326070|FG000|Transition Period (M12 to M18)|Death|0|||
124917469|NCT05338086|449326071|FG001|Transition Period (M12 to M18)|Death|0|||
124917470|NCT05338086|449326072|FG002|Transition Period (M12 to M18)|Death|1|||
124917471|NCT05338086|449326073|FG003|Transition Period (M12 to M18)|Death|0|||
124917472|NCT05338086|449326074|FG004|Transition Period (M12 to M18)|Death|0|||
124917473|NCT05338086|449326070|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
124917474|NCT05338086|449326071|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
124917475|NCT05338086|449326072|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
124917476|NCT05338086|449326073|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
124917477|NCT05338086|449326074|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
124917478|NCT05338086|449326070|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
124917479|NCT05338086|449326071|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
124917480|NCT05338086|449326072|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
124917481|NCT05338086|449326073|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
124917482|NCT05338086|449326074|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
124917483|NCT05338086|449326070|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
124917484|NCT05338086|449326071|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
124917485|NCT05338086|449326072|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
124917486|NCT05338086|449326073|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
124917487|NCT05338086|449326074|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
124917488|NCT04533022|449326075|FG000|Overall Study|Withdrawal by Subject|15|||
124917489|NCT04533022|449326075|FG000|Overall Study|Adverse Event|6|||
124917490|NCT04533022|449326075|FG000|Overall Study|Death|1|||
124917491|NCT04533022|449326075|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
124917492|NCT04533022|449326075|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
124917493|NCT02163447|449326076|FG000|Overall Study|Withdrawal by Subject|2|||
124917494|NCT02163447|449326077|FG001|Overall Study|Withdrawal by Subject|0|||
124451732|NCT01854645|447615165|FG001|Overall Study|Administrative Reasons / Missing|0|||
124695368|NCT00292370|448505855|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
124695369|NCT00292370|448505856|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
124695370|NCT00292370|448505854|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
124695371|NCT00292370|448505855|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
124695372|NCT00292370|448505856|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
124695373|NCT00292370|448505854|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
124695374|NCT00292370|448505855|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
124695375|NCT00292370|448505856|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
124695376|NCT00292370|448505854|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
124695377|NCT00292370|448505855|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
124695378|NCT00292370|448505856|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
124695379|NCT02123511|448505857|FG000|Overall Study|Cancelled treatment|1|||
124695380|NCT02123511|448505858|FG001|Overall Study|Cancelled treatment|0|||
124695381|NCT02123511|448505857|FG000|Overall Study|Incomplete data|1|||
124695382|NCT02123511|448505858|FG001|Overall Study|Incomplete data|3|||
124451733|NCT01854645|447615166|FG002|Overall Study|Administrative Reasons / Missing|0|||
124695383|NCT02123511|448505857|FG000|Overall Study|Ineligible|0|||
124695384|NCT02123511|448505858|FG001|Overall Study|Ineligible|1|||
124917495|NCT02163447|449326078|FG002|Overall Study|Withdrawal by Subject|1|||
124917496|NCT02163447|449326076|FG000|Overall Study|Lost to Follow-up|1|||
124917497|NCT02163447|449326077|FG001|Overall Study|Lost to Follow-up|3|||
124917498|NCT02163447|449326078|FG002|Overall Study|Lost to Follow-up|0|||
124917499|NCT02163447|449326076|FG000|Overall Study|Moved out of study area|2|||
124917500|NCT02163447|449326077|FG001|Overall Study|Moved out of study area|3|||
124917501|NCT02163447|449326078|FG002|Overall Study|Moved out of study area|2|||
124917502|NCT02163447|449326076|FG000|Overall Study|Became HIV infected at time of delivery|1|||
124917503|NCT02163447|449326077|FG001|Overall Study|Became HIV infected at time of delivery|0|||
124917504|NCT02163447|449326078|FG002|Overall Study|Became HIV infected at time of delivery|0|||
124917505|NCT05113966|449326080|FG000|Overall Study|Death|21|||
124917506|NCT05113966|449326080|FG000|Overall Study|Study Terminated by Sponsor|9|||
124917507|NCT05386355|449326081|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
124917508|NCT05386355|449326082|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
124917509|NCT05386355|449326083|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
124917510|NCT05386355|449326084|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
124917511|NCT06143670|449326085|FG000|Overall Study|Lost to Follow-up|0|||
124917512|NCT06143670|449326086|FG001|Overall Study|Lost to Follow-up|1|||
124917513|NCT06143670|449326085|FG000|Overall Study|Withdrawal by Subject|3|||
124917514|NCT06143670|449326086|FG001|Overall Study|Withdrawal by Subject|0|||
124917515|NCT03747484|449326087|FG000|Overall Study|Lack of Efficacy|0|||
124917516|NCT03747484|449326088|FG001|Overall Study|Lack of Efficacy|1|||
124917517|NCT03747484|449326089|FG002|Overall Study|Lack of Efficacy|1|||
124917518|NCT03747484|449326090|FG003|Overall Study|Lack of Efficacy|2|||
124917519|NCT03747484|449326091|FG004|Overall Study|Lack of Efficacy|2|||
124917520|NCT03833245|449326092|FG000|Overall Study|Death|0|||
124917521|NCT03833245|449326093|FG001|Overall Study|Death|1|||
124917522|NCT03775109|449326094|FG000|Overall Study|Adverse Event|1|||
124917523|NCT03775109|449326095|FG001|Overall Study|Adverse Event|0|||
124917524|NCT03775109|449326094|FG000|Overall Study|COVID-19 outbreak|2|||
124917525|NCT03775109|449326095|FG001|Overall Study|COVID-19 outbreak|0|||
124917526|NCT03775109|449326094|FG000|Overall Study|Lost to Follow-up|0|||
124917527|NCT03775109|449326095|FG001|Overall Study|Lost to Follow-up|2|||
124917528|NCT03775109|449326094|FG000|Overall Study|Withdrawal by Subject|1|||
124917529|NCT03775109|449326095|FG001|Overall Study|Withdrawal by Subject|1|||
124917530|NCT03775109|449326094|FG000|Overall Study|Death|0|||
124917531|NCT03775109|449326095|FG001|Overall Study|Death|1|||
124917532|NCT03775109|449326094|FG000|Overall Study|Lack of Efficacy|1|||
124917533|NCT03775109|449326095|FG001|Overall Study|Lack of Efficacy|0|||
124917534|NCT03347383|449326096|FG000|Overall Study|Death|39|||
124917535|NCT03347383|449326096|FG000|Overall Study|Withdrawal by Subject|3|||
124917536|NCT03347383|449326096|FG000|Overall Study|Lost to Follow-up|9|||
124917537|NCT05691452|449326098|FG000|Overall Study|Withdrawal by Subject|1|||
124917538|NCT05691452|449326099|FG001|Overall Study|Withdrawal by Subject|1|||
124917539|NCT05691452|449326100|FG002|Overall Study|Withdrawal by Subject|0|||
124917540|NCT05691452|449326098|FG000|Overall Study|Physician Decision|1|||
124917541|NCT05691452|449326099|FG001|Overall Study|Physician Decision|0|||
124917542|NCT05691452|449326100|FG002|Overall Study|Physician Decision|0|||
124917543|NCT05691452|449326098|FG000|Overall Study|Lost to Follow-up|0|||
124917544|NCT05691452|449326099|FG001|Overall Study|Lost to Follow-up|0|||
124917545|NCT05691452|449326100|FG002|Overall Study|Lost to Follow-up|1|||
124917546|NCT05691452|449326098|FG000|Overall Study|Adverse Event|0|||
124917547|NCT05691452|449326099|FG001|Overall Study|Adverse Event|0|||
124917548|NCT05691452|449326100|FG002|Overall Study|Adverse Event|1|||
124917549|NCT05110495|449326103|FG000|Overall Study|Lost to Follow-up|1|||
124917550|NCT05110495|449326103|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
124917551|NCT04716634|449326106|FG000|Overall Study|Death|24|||
124917552|NCT04716634|449326107|FG001|Overall Study|Death|24|||
124917553|NCT04716634|449326108|FG002|Overall Study|Death|8|||
124917554|NCT04716634|449326106|FG000|Overall Study|Closed by Sponsor|4|||
124917555|NCT04716634|449326107|FG001|Overall Study|Closed by Sponsor|4|||
124917556|NCT04716634|449326108|FG002|Overall Study|Closed by Sponsor|5|||
124917557|NCT04716634|449326106|FG000|Overall Study|Lost to Follow-up|1|||
124917558|NCT04716634|449326107|FG001|Overall Study|Lost to Follow-up|0|||
124917559|NCT04716634|449326108|FG002|Overall Study|Lost to Follow-up|1|||
124451734|NCT01854645|447615167|FG003|Overall Study|Administrative Reasons / Missing|1|||
124451735|NCT01854645|447615168|FG004|Overall Study|Administrative Reasons / Missing|1|||
124917560|NCT04716634|449326106|FG000|Overall Study|Withdrawal by Subject|0|||
124917561|NCT04716634|449326107|FG001|Overall Study|Withdrawal by Subject|0|||
124917562|NCT04716634|449326108|FG002|Overall Study|Withdrawal by Subject|1|||
124917563|NCT04593472|449326112|FG000|Overall Study|Death|31|||
124917564|NCT04593472|449326113|FG001|Overall Study|Death|27|||
124917565|NCT04593472|449326112|FG000|Overall Study|Withdrawal by Subject|12|||
124917566|NCT04593472|449326113|FG001|Overall Study|Withdrawal by Subject|12|||
124917567|NCT04593472|449326112|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
124917568|NCT04593472|449326113|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
124917569|NCT04593472|449326112|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
124917570|NCT04593472|449326113|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
124917571|NCT04593472|449326112|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
124917572|NCT04593472|449326113|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
124917573|NCT04593472|449326112|FG000|Overall Study|Lost to Follow-up|0|||
124917574|NCT04593472|449326113|FG001|Overall Study|Lost to Follow-up|2|||
124917575|NCT04593472|449326112|FG000|Overall Study|Still collecting 24-month assessment|17|||
124917576|NCT04593472|449326113|FG001|Overall Study|Still collecting 24-month assessment|10|||
124917577|NCT04538417|449326115|FG000|Overall Study|Withdrawal by Subject|2|||
124917578|NCT04549168|449326119|FG000|Randomization Phase|Adverse Event|0|||
124917579|NCT04549168|449326120|FG001|Randomization Phase|Adverse Event|0|||
124917580|NCT04549168|449326121|FG002|Randomization Phase|Adverse Event|1|||
124917581|NCT04549168|449326119|FG000|Randomization Phase|Other|0|||
124917582|NCT04549168|449326120|FG001|Randomization Phase|Other|2|||
124917583|NCT04549168|449326121|FG002|Randomization Phase|Other|0|||
124917584|NCT04549168|449326119|FG000|Randomization Phase|Withdrawal by Subject|0|||
124917585|NCT04549168|449326120|FG001|Randomization Phase|Withdrawal by Subject|2|||
124917586|NCT04549168|449326121|FG002|Randomization Phase|Withdrawal by Subject|1|||
124917587|NCT03988634|449326125|FG000|Double-Blind|Adverse Event|4|||
124917588|NCT03988634|449326126|FG001|Double-Blind|Adverse Event|0|||
124917589|NCT03988634|449326127|FG002|Double-Blind|Adverse Event|0|||
124917590|NCT03988634|449326125|FG000|Double-Blind|Death|18|||
124917591|NCT03988634|449326126|FG001|Double-Blind|Death|26|||
124917592|NCT03988634|449326127|FG002|Double-Blind|Death|0|||
124917593|NCT03988634|449326125|FG000|Double-Blind|Lost to Follow-up|6|||
124917594|NCT03988634|449326126|FG001|Double-Blind|Lost to Follow-up|7|||
124917595|NCT03988634|449326127|FG002|Double-Blind|Lost to Follow-up|0|||
124917596|NCT03988634|449326125|FG000|Double-Blind|Physician Decision|9|||
124917597|NCT03988634|449326126|FG001|Double-Blind|Physician Decision|5|||
124917598|NCT03988634|449326127|FG002|Double-Blind|Physician Decision|0|||
124917599|NCT03988634|449326125|FG000|Double-Blind|Subject decision|24|||
124917600|NCT03988634|449326126|FG001|Double-Blind|Subject decision|13|||
124917601|NCT03988634|449326127|FG002|Double-Blind|Subject decision|0|||
124917602|NCT03988634|449326125|FG000|Open-Label|Adverse Event|0|||
124917603|NCT03988634|449326126|FG001|Open-Label|Adverse Event|0|||
124917604|NCT03988634|449326127|FG002|Open-Label|Adverse Event|7|||
124917605|NCT03988634|449326125|FG000|Open-Label|Physician Decision|0|||
124917606|NCT03988634|449326126|FG001|Open-Label|Physician Decision|0|||
124917607|NCT03988634|449326127|FG002|Open-Label|Physician Decision|1|||
124917608|NCT03988634|449326125|FG000|Open-Label|Technical problems|0|||
124917609|NCT03988634|449326126|FG001|Open-Label|Technical problems|0|||
124917610|NCT03988634|449326127|FG002|Open-Label|Technical problems|1|||
124917611|NCT04725240|449326128|FG000|Overall Study|Adverse Event|2|||
124917612|NCT02249949|449326129|FG000|Overall Study|Cancelled prior to treatment|2|||
124917613|NCT02867384|449326132|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
124917614|NCT02867384|449326133|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
124917615|NCT02867384|449326134|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
124917616|NCT02867384|449326132|FG000|Overall Study|Progression/ Relapse|15|||
124917617|NCT02867384|449326133|FG001|Overall Study|Progression/ Relapse|19|||
124917618|NCT02867384|449326134|FG002|Overall Study|Progression/ Relapse|0|||
124917619|NCT02867384|449326132|FG000|Overall Study|Adverse Event|13|||
124917620|NCT02867384|449326133|FG001|Overall Study|Adverse Event|1|||
124917621|NCT02867384|449326134|FG002|Overall Study|Adverse Event|0|||
124917622|NCT02867384|449326132|FG000|Overall Study|Withdrawal by Subject|6|||
124917623|NCT02867384|449326133|FG001|Overall Study|Withdrawal by Subject|5|||
124917624|NCT02867384|449326134|FG002|Overall Study|Withdrawal by Subject|0|||
124917625|NCT02867384|449326132|FG000|Overall Study|Physician Decision|1|||
124695385|NCT04821245|448505859|FG000|Overall Study|Withdrawal by Subject|3|||
124917626|NCT02867384|449326133|FG001|Overall Study|Physician Decision|2|||
124917627|NCT02867384|449326134|FG002|Overall Study|Physician Decision|0|||
124695386|NCT04821245|448505859|FG000|Overall Study|Physician Decision|1|||
124695387|NCT04821245|448505859|FG000|Overall Study|Protocol Violation|5|||
124695388|NCT01133977|448505860|FG000|Overall Study|Adverse Event|0|||
124695389|NCT01133977|448505861|FG001|Overall Study|Adverse Event|0|||
124917628|NCT02867384|449326132|FG000|Overall Study|Patient compliance|1|||
124917629|NCT02867384|449326133|FG001|Overall Study|Patient compliance|0|||
124917630|NCT02867384|449326134|FG002|Overall Study|Patient compliance|0|||
124917631|NCT02867384|449326132|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
124917632|NCT02867384|449326133|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
124917633|NCT02867384|449326134|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
124451736|NCT01854645|447615164|FG000|Overall Study|Protocol Violation|3|||
124451737|NCT01854645|447615165|FG001|Overall Study|Protocol Violation|0|||
124451738|NCT01854645|447615166|FG002|Overall Study|Protocol Violation|5|||
124917634|NCT02867384|449326132|FG000|Overall Study|Never start treatment|0|||
124917635|NCT02867384|449326133|FG001|Overall Study|Never start treatment|0|||
124917636|NCT02867384|449326134|FG002|Overall Study|Never start treatment|3|||
124917637|NCT05633407|449326142|FG000|Overall Study|Physician Decision|2|||
124917638|NCT05633407|449326143|FG001|Overall Study|Physician Decision|0|||
124917639|NCT05633407|449326142|FG000|Overall Study|Adverse Event|1|||
124917640|NCT05633407|449326143|FG001|Overall Study|Adverse Event|0|||
124917641|NCT05633407|449326142|FG000|Overall Study|Withdrawal by Subject|1|||
124917642|NCT05633407|449326143|FG001|Overall Study|Withdrawal by Subject|0|||
124917643|NCT05633407|449326142|FG000|Overall Study|Other|1|||
124917644|NCT05633407|449326143|FG001|Overall Study|Other|1|||
124917645|NCT02500758|449326144|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
124917646|NCT02500758|449326145|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
124917647|NCT02500758|449326144|FG000|Washout (1 Week)|Lost to Follow-up|2|||
124917648|NCT02500758|449326145|FG001|Washout (1 Week)|Lost to Follow-up|2|||
124917649|NCT02500758|449326144|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
124917650|NCT02500758|449326145|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
124917651|NCT02500758|449326144|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
124917652|NCT02500758|449326145|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
124917653|NCT02500758|449326144|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
124917654|NCT02500758|449326145|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
124917655|NCT04999592|449326148|FG000|Overall Study|Withdrawal by Subject|1|||
124917656|NCT04999592|449326149|FG001|Overall Study|Withdrawal by Subject|0|||
124917657|NCT05179395|449326150|FG000|Overall Study|Lack of Efficacy|1|||
124695390|NCT01133977|448505862|FG002|Overall Study|Adverse Event|1|||
124695391|NCT01133977|448505863|FG003|Overall Study|Adverse Event|0|||
124695392|NCT01133977|448505864|FG004|Overall Study|Adverse Event|0|||
124695393|NCT01133977|448505860|FG000|Overall Study|Death|1|||
124695394|NCT01133977|448505861|FG001|Overall Study|Death|1|||
124695395|NCT01133977|448505862|FG002|Overall Study|Death|1|||
124695396|NCT01133977|448505863|FG003|Overall Study|Death|7|||
124695397|NCT01133977|448505864|FG004|Overall Study|Death|3|||
124695398|NCT01133977|448505860|FG000|Overall Study|Started a New Line of Therapy|2|||
124695399|NCT01133977|448505861|FG001|Overall Study|Started a New Line of Therapy|6|||
124695400|NCT01133977|448505862|FG002|Overall Study|Started a New Line of Therapy|4|||
124695401|NCT01133977|448505863|FG003|Overall Study|Started a New Line of Therapy|25|||
124695402|NCT01133977|448505864|FG004|Overall Study|Started a New Line of Therapy|33|||
124695403|NCT01133977|448505860|FG000|Overall Study|Lost to Follow-up|0|||
124695404|NCT01133977|448505861|FG001|Overall Study|Lost to Follow-up|0|||
124695405|NCT01133977|448505862|FG002|Overall Study|Lost to Follow-up|0|||
124695406|NCT01133977|448505863|FG003|Overall Study|Lost to Follow-up|2|||
124695407|NCT01133977|448505864|FG004|Overall Study|Lost to Follow-up|1|||
124695408|NCT01133977|448505860|FG000|Overall Study|Withdrawal by Subject|0|||
124695409|NCT01133977|448505861|FG001|Overall Study|Withdrawal by Subject|0|||
124695410|NCT01133977|448505862|FG002|Overall Study|Withdrawal by Subject|0|||
124695411|NCT01133977|448505863|FG003|Overall Study|Withdrawal by Subject|5|||
124695412|NCT01133977|448505864|FG004|Overall Study|Withdrawal by Subject|1|||
124695413|NCT01975285|448505867|FG000|Overall Study|Failed Block and follow up|2|||
124695414|NCT01975285|448505868|FG001|Overall Study|Failed Block and follow up|2|||
124695415|NCT00604383|448505876|FG000|Overall Study|Withdrawal by Subject|33|||
124695416|NCT00604383|448505877|FG001|Overall Study|Withdrawal by Subject|31|||
124695417|NCT00604383|448505876|FG000|Overall Study|Lost to Follow-up|24|||
124695418|NCT00604383|448505877|FG001|Overall Study|Lost to Follow-up|19|||
124695419|NCT00604383|448505876|FG000|Overall Study|Death|14|||
124695420|NCT00604383|448505877|FG001|Overall Study|Death|22|||
124695421|NCT00604383|448505876|FG000|Overall Study|Adverse Event|16|||
124695422|NCT00604383|448505877|FG001|Overall Study|Adverse Event|9|||
124695423|NCT00604383|448505876|FG000|Overall Study|Physician Decision|0|||
124695424|NCT00604383|448505877|FG001|Overall Study|Physician Decision|3|||
124695425|NCT00281580|448505878|FG000|Overall Study|Adverse Event|2|||
124695426|NCT00281580|448505879|FG001|Overall Study|Adverse Event|0|||
124695427|NCT00281580|448505880|FG002|Overall Study|Adverse Event|2|||
124695428|NCT00281580|448505881|FG003|Overall Study|Adverse Event|4|||
124695429|NCT00281580|448505882|FG004|Overall Study|Adverse Event|1|||
124695430|NCT00281580|448505883|FG005|Overall Study|Adverse Event|0|||
124695431|NCT00281580|448505884|FG006|Overall Study|Adverse Event|1|||
124695432|NCT00281580|448505885|FG007|Overall Study|Adverse Event|0|||
124695433|NCT00281580|448505886|FG008|Overall Study|Adverse Event|1|||
124695434|NCT00281580|448505887|FG009|Overall Study|Adverse Event|6|||
124762035|NCT00101686|448753546|FG002|Overall Study|Withdrawal by Subject|6|||
124917658|NCT02471638|449326154|FG000|Overall Study|Early Term Withdrawal|10|||
124917659|NCT03940703|449327119|FG000|Overall Study|Still under treatment|31|||
124917660|NCT03940703|449327120|FG001|Overall Study|Still under treatment|0|||
124695435|NCT00281580|448505888|FG010|Overall Study|Adverse Event|0|||
124695436|NCT00281580|448505889|FG011|Overall Study|Adverse Event|5|||
124695437|NCT00281580|448505890|FG012|Overall Study|Adverse Event|8|||
124695438|NCT00281580|448505891|FG013|Overall Study|Adverse Event|2|||
124695439|NCT00281580|448505892|FG014|Overall Study|Adverse Event|3|||
124695440|NCT00281580|448505893|FG015|Overall Study|Adverse Event|3|||
124917661|NCT04521478|449327121|FG000|Overall Study|Protocol Violation|2|||
124917662|NCT04521478|449327122|FG001|Overall Study|Protocol Violation|0|||
124917663|NCT04521478|449327123|FG002|Overall Study|Protocol Violation|1|||
124917664|NCT04521478|449327124|FG003|Overall Study|Protocol Violation|0|||
124917665|NCT04521478|449327125|FG004|Overall Study|Protocol Violation|0|||
124917666|NCT04521478|449327126|FG005|Overall Study|Protocol Violation|0|||
124917667|NCT04521478|449327121|FG000|Overall Study|Technical Problems|0|||
124917668|NCT04521478|449327122|FG001|Overall Study|Technical Problems|0|||
124917669|NCT04521478|449327123|FG002|Overall Study|Technical Problems|0|||
124917670|NCT04521478|449327124|FG003|Overall Study|Technical Problems|1|||
124917671|NCT04521478|449327125|FG004|Overall Study|Technical Problems|0|||
124917672|NCT04521478|449327126|FG005|Overall Study|Technical Problems|0|||
124917673|NCT04521478|449327121|FG000|Overall Study|Burden of Study Procedures|1|||
124545392|NCT00762073|447951189|FG000|Overall Study|Significant Subject Noncompliance|0|||
124917674|NCT04521478|449327122|FG001|Overall Study|Burden of Study Procedures|0|||
124545393|NCT00762073|447951190|FG001|Overall Study|Significant Subject Noncompliance|1|||
124545394|NCT00762073|447951191|FG002|Overall Study|Significant Subject Noncompliance|0|||
124917675|NCT04521478|449327123|FG002|Overall Study|Burden of Study Procedures|0|||
124917676|NCT04521478|449327124|FG003|Overall Study|Burden of Study Procedures|1|||
124917677|NCT04521478|449327125|FG004|Overall Study|Burden of Study Procedures|0|||
124917678|NCT04521478|449327126|FG005|Overall Study|Burden of Study Procedures|1|||
124917679|NCT04521478|449327121|FG000|Overall Study|Lack of Efficacy|0|||
124917680|NCT04521478|449327122|FG001|Overall Study|Lack of Efficacy|0|||
124917681|NCT04521478|449327123|FG002|Overall Study|Lack of Efficacy|0|||
124917682|NCT04521478|449327124|FG003|Overall Study|Lack of Efficacy|0|||
124917683|NCT04521478|449327125|FG004|Overall Study|Lack of Efficacy|1|||
124917684|NCT04521478|449327126|FG005|Overall Study|Lack of Efficacy|1|||
124917685|NCT04521478|449327121|FG000|Overall Study|Adverse Event|7|||
124917686|NCT04521478|449327122|FG001|Overall Study|Adverse Event|0|||
124917687|NCT04521478|449327123|FG002|Overall Study|Adverse Event|2|||
124917688|NCT04521478|449327124|FG003|Overall Study|Adverse Event|1|||
124917689|NCT04521478|449327125|FG004|Overall Study|Adverse Event|2|||
124917690|NCT04521478|449327126|FG005|Overall Study|Adverse Event|7|||
124917691|NCT04521478|449327121|FG000|Overall Study|No Reason Available|0|||
124917692|NCT04521478|449327122|FG001|Overall Study|No Reason Available|2|||
124917693|NCT04521478|449327123|FG002|Overall Study|No Reason Available|0|||
124917694|NCT04521478|449327124|FG003|Overall Study|No Reason Available|0|||
124917695|NCT04521478|449327125|FG004|Overall Study|No Reason Available|1|||
124917696|NCT04521478|449327126|FG005|Overall Study|No Reason Available|0|||
124545395|NCT00762073|447951192|FG003|Overall Study|Significant Subject Noncompliance|1|||
124545396|NCT00762073|447951189|FG000|Overall Study|Withdrawal by Subject|1|||
124545397|NCT00762073|447951190|FG001|Overall Study|Withdrawal by Subject|2|||
124545398|NCT00762073|447951191|FG002|Overall Study|Withdrawal by Subject|1|||
124545399|NCT00762073|447951192|FG003|Overall Study|Withdrawal by Subject|1|||
124545400|NCT00762073|447951189|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
124545401|NCT00762073|447951190|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
124545402|NCT00762073|447951191|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
124545403|NCT00762073|447951192|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
124545404|NCT01265875|447951194|FG000|Overall Study|Uncooperative/unreliable|1|||
124545405|NCT04456998|447951195|FG000|Overall Study|Adverse Event|0|||
124545406|NCT04456998|447951196|FG001|Overall Study|Adverse Event|4|||
124545407|NCT04456998|447951195|FG000|Overall Study|Protocol Deviation|0|||
124545408|NCT04456998|447951196|FG001|Overall Study|Protocol Deviation|1|||
124545409|NCT04456998|447951195|FG000|Overall Study|Withdrawal by Subject|0|||
124695441|NCT00281580|448505878|FG000|Overall Study|Protocol Violation|0|||
124695442|NCT00281580|448505879|FG001|Overall Study|Protocol Violation|0|||
124695443|NCT00281580|448505880|FG002|Overall Study|Protocol Violation|1|||
124695444|NCT00281580|448505881|FG003|Overall Study|Protocol Violation|1|||
124695445|NCT00281580|448505882|FG004|Overall Study|Protocol Violation|0|||
124695446|NCT00281580|448505883|FG005|Overall Study|Protocol Violation|0|||
124695447|NCT00281580|448505884|FG006|Overall Study|Protocol Violation|1|||
124695448|NCT00281580|448505885|FG007|Overall Study|Protocol Violation|0|||
124695449|NCT00281580|448505886|FG008|Overall Study|Protocol Violation|2|||
124695450|NCT00281580|448505887|FG009|Overall Study|Protocol Violation|0|||
124695451|NCT00281580|448505888|FG010|Overall Study|Protocol Violation|1|||
124695452|NCT00281580|448505889|FG011|Overall Study|Protocol Violation|2|||
124695453|NCT00281580|448505890|FG012|Overall Study|Protocol Violation|0|||
124695454|NCT00281580|448505891|FG013|Overall Study|Protocol Violation|1|||
124917697|NCT04521478|449327121|FG000|Overall Study|Other than listed|3|||
124917698|NCT04521478|449327122|FG001|Overall Study|Other than listed|3|||
124545410|NCT04456998|447951196|FG001|Overall Study|Withdrawal by Subject|1|||
124695455|NCT00281580|448505892|FG014|Overall Study|Protocol Violation|1|||
124695456|NCT00281580|448505893|FG015|Overall Study|Protocol Violation|3|||
124917699|NCT04521478|449327123|FG002|Overall Study|Other than listed|3|||
124917700|NCT04521478|449327124|FG003|Overall Study|Other than listed|2|||
124917701|NCT04521478|449327125|FG004|Overall Study|Other than listed|3|||
124917702|NCT04521478|449327126|FG005|Overall Study|Other than listed|3|||
124917703|NCT04521478|449327121|FG000|Overall Study|Not treated|0|||
124917704|NCT04521478|449327122|FG001|Overall Study|Not treated|0|||
124917705|NCT04521478|449327123|FG002|Overall Study|Not treated|0|||
124917706|NCT04521478|449327124|FG003|Overall Study|Not treated|0|||
124917707|NCT04521478|449327125|FG004|Overall Study|Not treated|0|||
124917708|NCT04521478|449327126|FG005|Overall Study|Not treated|1|||
124917709|NCT05320432|449327134|FG000|Overall Study|Withdrawal by Subject|0|||
124917710|NCT05320432|449327135|FG001|Overall Study|Withdrawal by Subject|2|||
124917711|NCT04173663|449327142|FG000|Overall Study|Withdrawal by Subject|1|||
124917712|NCT04173663|449327143|FG001|Overall Study|Withdrawal by Subject|6|||
124917713|NCT04173663|449327142|FG000|Overall Study|Lost to Follow-up|17|||
124917714|NCT04173663|449327143|FG001|Overall Study|Lost to Follow-up|24|||
124917715|NCT04850807|449327145|FG000|Overall Study|Death|50|||
124917716|NCT04850807|449327146|FG001|Overall Study|Death|55|||
124917717|NCT04850807|449327145|FG000|Overall Study|Discharged|17|||
124917718|NCT04850807|449327146|FG001|Overall Study|Discharged|13|||
124917719|NCT04850807|449327145|FG000|Overall Study|Incomplete baseline data|3|||
124917720|NCT04850807|449327146|FG001|Overall Study|Incomplete baseline data|2|||
124917721|NCT02187003|449327150|FG000|Overall Study|Adverse Event|2|||
124917722|NCT02187003|449327151|FG001|Overall Study|Adverse Event|0|||
124917723|NCT02187003|449327150|FG000|Overall Study|Lost to Follow-up|14|||
124917724|NCT02187003|449327151|FG001|Overall Study|Lost to Follow-up|10|||
124917725|NCT02187003|449327150|FG000|Overall Study|Withdrawal by Subject|3|||
124917726|NCT02187003|449327151|FG001|Overall Study|Withdrawal by Subject|7|||
124917727|NCT02187003|449327150|FG000|Overall Study|Protocol Violation|2|||
124917728|NCT02187003|449327151|FG001|Overall Study|Protocol Violation|4|||
124917729|NCT02187003|449327150|FG000|Overall Study|Other|5|||
124917730|NCT02187003|449327151|FG001|Overall Study|Other|5|||
124917731|NCT02187003|449327150|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
124917732|NCT02187003|449327151|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
124917733|NCT05816551|449327152|FG000|Overall Study|Withdrawal by Subject|0|||
124917734|NCT05816551|449327153|FG001|Overall Study|Withdrawal by Subject|1|||
124917735|NCT05816551|449327152|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
124917736|NCT05816551|449327153|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
124917737|NCT02630823|449327160|FG000|Overall Study|Withdrawal by Subject|1|||
124917738|NCT02630823|449327160|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
124917739|NCT04178733|449327161|FG000|Overall Study|Investigator Decision|0|||
124917740|NCT04178733|449327162|FG001|Overall Study|Investigator Decision|0|||
124917741|NCT04178733|449327163|FG002|Overall Study|Investigator Decision|0|||
124917742|NCT04178733|449327164|FG003|Overall Study|Investigator Decision|1|||
124917743|NCT04178733|449327165|FG004|Overall Study|Investigator Decision|2|||
124917744|NCT04833777|449327173|FG000|Overall Study|Lost to Follow-up|1|||
124917745|NCT04833777|449327174|FG001|Overall Study|Lost to Follow-up|0|||
124917746|NCT05461131|449327185|FG000|Overall Study|Lost to Follow-up|0|||
124917747|NCT05461131|449327186|FG001|Overall Study|Lost to Follow-up|2|||
124917748|NCT03896516|449327187|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
124917749|NCT03896516|449327188|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
124917750|NCT03896516|449327187|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
124917751|NCT03896516|449327188|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
124917752|NCT03896516|449327187|FG000|Washout Period|Physician Decision|3|||
124917753|NCT03896516|449327188|FG001|Washout Period|Physician Decision|1|||
124917754|NCT03896516|449327187|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
124917755|NCT03896516|449327188|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
124917756|NCT03648840|449327193|FG000|First IV Infusion Session|Adverse Event|0|||
124917757|NCT03648840|449327194|FG001|First IV Infusion Session|Adverse Event|2|||
124917758|NCT03648840|449327193|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
124917759|NCT03648840|449327194|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
124917760|NCT03648840|449327193|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
124917761|NCT03648840|449327194|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
124917762|NCT03648840|449327193|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
124917763|NCT03648840|449327194|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
124917764|NCT05382936|449327197|FG000|Overall Study|Progressive Disease|3|||
124917765|NCT05382936|449327198|FG001|Overall Study|Progressive Disease|5|||
124917766|NCT05382936|449327199|FG002|Overall Study|Progressive Disease|2|||
124917767|NCT05382936|449327200|FG003|Overall Study|Progressive Disease|5|||
124917768|NCT05382936|449327197|FG000|Overall Study|Adverse Event|0|||
124917769|NCT05382936|449327198|FG001|Overall Study|Adverse Event|1|||
124917770|NCT05382936|449327199|FG002|Overall Study|Adverse Event|1|||
124917771|NCT05382936|449327200|FG003|Overall Study|Adverse Event|0|||
124917772|NCT05382936|449327197|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
124917773|NCT05382936|449327198|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
124917774|NCT05382936|449327199|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
124917775|NCT05382936|449327200|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
124917776|NCT05382936|449327197|FG000|Overall Study|Withdrawal by Subject|0|||
124917777|NCT05382936|449327198|FG001|Overall Study|Withdrawal by Subject|0|||
124917778|NCT05382936|449327199|FG002|Overall Study|Withdrawal by Subject|1|||
124917779|NCT05382936|449327200|FG003|Overall Study|Withdrawal by Subject|1|||
124917780|NCT03101904|449327204|FG000|Wash Out (10 Days)|Adverse Event|1|||
124917781|NCT03101904|449327205|FG001|Wash Out (10 Days)|Adverse Event|0|||
124917782|NCT03101904|449327204|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
124917783|NCT03101904|449327205|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
124917784|NCT05054374|449327206|FG000|Overall Study|Withdrawal by Subject|1|||
124917785|NCT05054374|449327207|FG001|Overall Study|Withdrawal by Subject|0|||
124917786|NCT05054374|449327208|FG002|Overall Study|Withdrawal by Subject|0|||
124917787|NCT05054374|449327209|FG003|Overall Study|Withdrawal by Subject|0|||
124917788|NCT05054374|449327206|FG000|Overall Study|Progressive Disease|5|||
124917789|NCT05054374|449327207|FG001|Overall Study|Progressive Disease|0|||
124917790|NCT05054374|449327208|FG002|Overall Study|Progressive Disease|0|||
124917791|NCT05054374|449327209|FG003|Overall Study|Progressive Disease|0|||
124917792|NCT03453619|449327210|FG000|Core Study (Part A)|Physician Decision|0|||
124917793|NCT03453619|449327211|FG001|Core Study (Part A)|Physician Decision|0|||
124917794|NCT03453619|449327212|FG002|Core Study (Part A)|Physician Decision|2|||
124917795|NCT03453619|449327213|FG003|Core Study (Part A)|Physician Decision|0|||
124917796|NCT03453619|449327210|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
124917797|NCT03453619|449327211|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
124917798|NCT03453619|449327212|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
124917799|NCT03453619|449327213|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
124917800|NCT03453619|449327210|FG000|Core Study (Part A)|Other|0|||
124917801|NCT03453619|449327211|FG001|Core Study (Part A)|Other|1|||
124917802|NCT03453619|449327212|FG002|Core Study (Part A)|Other|0|||
124917803|NCT03453619|449327213|FG003|Core Study (Part A)|Other|0|||
124695457|NCT00281580|448505878|FG000|Overall Study|Withdrawal by Subject|3|||
124695458|NCT00281580|448505879|FG001|Overall Study|Withdrawal by Subject|0|||
124695459|NCT00281580|448505880|FG002|Overall Study|Withdrawal by Subject|1|||
124695460|NCT00281580|448505881|FG003|Overall Study|Withdrawal by Subject|1|||
124695461|NCT00281580|448505882|FG004|Overall Study|Withdrawal by Subject|1|||
124695462|NCT00281580|448505883|FG005|Overall Study|Withdrawal by Subject|2|||
124917804|NCT03453619|449327210|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
124917805|NCT03453619|449327211|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
124917806|NCT03453619|449327212|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
124917807|NCT03453619|449327213|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
124917808|NCT03453619|449327210|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
124917809|NCT03453619|449327211|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
124917810|NCT03453619|449327212|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
124917811|NCT03453619|449327213|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
124695463|NCT00281580|448505884|FG006|Overall Study|Withdrawal by Subject|2|||
124695464|NCT00281580|448505885|FG007|Overall Study|Withdrawal by Subject|0|||
124695465|NCT00281580|448505886|FG008|Overall Study|Withdrawal by Subject|1|||
124695466|NCT00281580|448505887|FG009|Overall Study|Withdrawal by Subject|4|||
124695467|NCT00281580|448505888|FG010|Overall Study|Withdrawal by Subject|1|||
124695468|NCT00281580|448505889|FG011|Overall Study|Withdrawal by Subject|1|||
124695469|NCT00281580|448505890|FG012|Overall Study|Withdrawal by Subject|2|||
124695470|NCT00281580|448505891|FG013|Overall Study|Withdrawal by Subject|2|||
124695471|NCT00281580|448505892|FG014|Overall Study|Withdrawal by Subject|1|||
124695472|NCT00281580|448505893|FG015|Overall Study|Withdrawal by Subject|5|||
124695473|NCT00281580|448505878|FG000|Overall Study|Lack of Efficacy|2|||
124695474|NCT00281580|448505879|FG001|Overall Study|Lack of Efficacy|1|||
124695475|NCT00281580|448505880|FG002|Overall Study|Lack of Efficacy|1|||
124695476|NCT00281580|448505881|FG003|Overall Study|Lack of Efficacy|6|||
124695477|NCT00281580|448505882|FG004|Overall Study|Lack of Efficacy|2|||
124695478|NCT00281580|448505883|FG005|Overall Study|Lack of Efficacy|0|||
124695479|NCT00281580|448505884|FG006|Overall Study|Lack of Efficacy|0|||
124695480|NCT00281580|448505885|FG007|Overall Study|Lack of Efficacy|0|||
124695481|NCT00281580|448505886|FG008|Overall Study|Lack of Efficacy|0|||
124695482|NCT00281580|448505887|FG009|Overall Study|Lack of Efficacy|0|||
124695483|NCT00281580|448505888|FG010|Overall Study|Lack of Efficacy|0|||
124695484|NCT00281580|448505889|FG011|Overall Study|Lack of Efficacy|1|||
124695485|NCT00281580|448505890|FG012|Overall Study|Lack of Efficacy|0|||
124695486|NCT00281580|448505891|FG013|Overall Study|Lack of Efficacy|2|||
124695487|NCT00281580|448505892|FG014|Overall Study|Lack of Efficacy|1|||
124917812|NCT03453619|449327210|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
124451739|NCT01854645|447615167|FG003|Overall Study|Protocol Violation|4|||
124451740|NCT01854645|447615168|FG004|Overall Study|Protocol Violation|1|||
124451741|NCT01854645|447615164|FG000|Overall Study|Lost to Follow-up|10|||
124695488|NCT00281580|448505893|FG015|Overall Study|Lack of Efficacy|0|||
124695489|NCT00281580|448505878|FG000|Overall Study|Lost to Follow-up|0|||
124695490|NCT00281580|448505879|FG001|Overall Study|Lost to Follow-up|0|||
124695491|NCT00281580|448505880|FG002|Overall Study|Lost to Follow-up|0|||
124695492|NCT00281580|448505881|FG003|Overall Study|Lost to Follow-up|3|||
124917813|NCT03453619|449327211|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
124917814|NCT03453619|449327212|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
124917815|NCT03453619|449327213|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
124917816|NCT03453619|449327210|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
124917817|NCT03453619|449327211|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
124917818|NCT03453619|449327212|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
124917819|NCT03453619|449327213|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
124917820|NCT03625882|449328527|FG000|Overall Study|Protocol Violation|3|||
124917821|NCT03484702|449328535|FG000|Treatment Period|Death|3|||
124917822|NCT03484702|449328536|FG001|Treatment Period|Death|1|||
124917823|NCT03484702|449328537|FG002|Treatment Period|Death|0|||
124917824|NCT03484702|449328538|FG003|Treatment Period|Death|0|||
124917825|NCT03484702|449328539|FG004|Treatment Period|Death|0|||
124917826|NCT03484702|449328540|FG005|Treatment Period|Death|0|||
124917827|NCT03484702|449328535|FG000|Treatment Period|Adverse Event|1|||
124917828|NCT03484702|449328536|FG001|Treatment Period|Adverse Event|0|||
124917829|NCT03484702|449328537|FG002|Treatment Period|Adverse Event|0|||
124917830|NCT03484702|449328538|FG003|Treatment Period|Adverse Event|0|||
124917831|NCT03484702|449328539|FG004|Treatment Period|Adverse Event|0|||
124917832|NCT03484702|449328540|FG005|Treatment Period|Adverse Event|0|||
124917833|NCT03484702|449328535|FG000|Treatment Period|Participant Withdrew from Study|0|||
124917834|NCT03484702|449328536|FG001|Treatment Period|Participant Withdrew from Study|1|||
124917835|NCT03484702|449328537|FG002|Treatment Period|Participant Withdrew from Study|0|||
124917836|NCT03484702|449328538|FG003|Treatment Period|Participant Withdrew from Study|0|||
124917837|NCT03484702|449328539|FG004|Treatment Period|Participant Withdrew from Study|0|||
124917838|NCT03484702|449328540|FG005|Treatment Period|Participant Withdrew from Study|0|||
124917839|NCT03484702|449328535|FG000|Treatment Period|Physician Decision|0|||
124917840|NCT03484702|449328536|FG001|Treatment Period|Physician Decision|1|||
124917841|NCT03484702|449328537|FG002|Treatment Period|Physician Decision|0|||
124917842|NCT03484702|449328538|FG003|Treatment Period|Physician Decision|0|||
124917843|NCT03484702|449328539|FG004|Treatment Period|Physician Decision|0|||
124917844|NCT03484702|449328540|FG005|Treatment Period|Physician Decision|1|||
124917845|NCT02651324|449328543|FG000|Overall Study|drug not administered, due dispensing issue|1|||
124917846|NCT02651324|449328544|FG001|Overall Study|drug not administered, due dispensing issue|0|||
124917847|NCT01195831|449328547|FG000|Overall Study|Lost to Follow-up|2|||
124917848|NCT01195831|449328548|FG001|Overall Study|Lost to Follow-up|4|||
124917849|NCT01195831|449328547|FG000|Overall Study|Withdrawal by Subject|2|||
124917850|NCT01195831|449328548|FG001|Overall Study|Withdrawal by Subject|2|||
124917851|NCT01195831|449328547|FG000|Overall Study|Adverse Event|4|||
124917852|NCT01195831|449328548|FG001|Overall Study|Adverse Event|2|||
124917853|NCT01195831|449328547|FG000|Overall Study|Protocol Violation|0|||
124917854|NCT01195831|449328548|FG001|Overall Study|Protocol Violation|2|||
124917855|NCT01857934|449328549|FG000|Overall Study|Relapse or progression|2|||
124917856|NCT01857934|449328549|FG000|Overall Study|Unacceptable toxicity|3|||
124917857|NCT01857934|449328549|FG000|Overall Study|Unwillingness or inability to comply|2|||
124917858|NCT01857934|449328549|FG000|Overall Study|Physician Decision|3|||
124917859|NCT03713086|449328552|FG000|Overall Study|Withdrawal by Subject|0|||
124917860|NCT03713086|449328553|FG001|Overall Study|Withdrawal by Subject|2|||
124917861|NCT03713086|449328554|FG002|Overall Study|Withdrawal by Subject|1|||
124917862|NCT03713086|449328555|FG003|Overall Study|Withdrawal by Subject|0|||
124917863|NCT03713086|449328552|FG000|Overall Study|Lost to Follow-up|0|||
124917864|NCT03713086|449328553|FG001|Overall Study|Lost to Follow-up|1|||
124917865|NCT03713086|449328554|FG002|Overall Study|Lost to Follow-up|0|||
124917866|NCT03713086|449328555|FG003|Overall Study|Lost to Follow-up|1|||
124917867|NCT02662062|449328560|FG000|Overall Study|Withdrawal by Subject|1|||
124917868|NCT05406921|449328565|FG000|Overall Study|Withdrawal by Subject|25|||
124917869|NCT05406921|449328566|FG001|Overall Study|Withdrawal by Subject|0|||
124917870|NCT05406921|449328567|FG002|Overall Study|Withdrawal by Subject|25|||
124917871|NCT05406921|449328565|FG000|Overall Study|Protocol Violation|0|||
124917872|NCT05406921|449328566|FG001|Overall Study|Protocol Violation|12|||
124917873|NCT05406921|449328567|FG002|Overall Study|Protocol Violation|0|||
124917874|NCT00676715|449328571|FG000|Treatment Period (TP)|Adverse Event|0|||
124917875|NCT00676715|449328572|FG001|Treatment Period (TP)|Adverse Event|3|||
124917876|NCT00676715|449328573|FG002|Treatment Period (TP)|Adverse Event|2|||
124917877|NCT00676715|449328574|FG003|Treatment Period (TP)|Adverse Event|2|||
124917878|NCT00676715|449328571|FG000|Treatment Period (TP)|Death|0|||
124917879|NCT00676715|449328572|FG001|Treatment Period (TP)|Death|0|||
124917880|NCT00676715|449328573|FG002|Treatment Period (TP)|Death|1|||
124917881|NCT00676715|449328574|FG003|Treatment Period (TP)|Death|0|||
124917882|NCT00676715|449328571|FG000|Treatment Period (TP)|Failure to return|1|||
124917883|NCT00676715|449328572|FG001|Treatment Period (TP)|Failure to return|0|||
124917884|NCT00676715|449328573|FG002|Treatment Period (TP)|Failure to return|0|||
124917885|NCT00676715|449328574|FG003|Treatment Period (TP)|Failure to return|0|||
124917886|NCT00676715|449328571|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
124917887|NCT00676715|449328572|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
124917888|NCT00676715|449328573|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
124917889|NCT00676715|449328574|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
124917890|NCT00676715|449328571|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
124917891|NCT00676715|449328572|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
124917892|NCT00676715|449328573|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
124917893|NCT00676715|449328574|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
124917894|NCT00676715|449328571|FG000|Treatment Period (TP)|Withdrew consent|3|||
124917895|NCT00676715|449328572|FG001|Treatment Period (TP)|Withdrew consent|3|||
124917896|NCT00676715|449328573|FG002|Treatment Period (TP)|Withdrew consent|3|||
124917897|NCT00676715|449328574|FG003|Treatment Period (TP)|Withdrew consent|3|||
124917898|NCT00676715|449328571|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
124917899|NCT00676715|449328572|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
124917900|NCT00676715|449328573|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
124917901|NCT00676715|449328574|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
124917902|NCT00676715|449328571|FG000|Treatment Period (TP)|Administrative|0|||
124917903|NCT00676715|449328572|FG001|Treatment Period (TP)|Administrative|0|||
124917904|NCT00676715|449328573|FG002|Treatment Period (TP)|Administrative|0|||
124917905|NCT00676715|449328574|FG003|Treatment Period (TP)|Administrative|1|||
124917906|NCT00676715|449328571|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
124917907|NCT00676715|449328572|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
124917908|NCT00676715|449328573|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
124917909|NCT00676715|449328574|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
124917910|NCT00676715|449328571|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
124917911|NCT00676715|449328572|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
124917912|NCT00676715|449328573|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
124917913|NCT00676715|449328574|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
124917914|NCT00676715|449328571|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
124917915|NCT00676715|449328572|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
124917916|NCT00676715|449328573|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
124917917|NCT00676715|449328574|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
124917918|NCT00676715|449328571|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
124917919|NCT00676715|449328572|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
124917920|NCT00676715|449328573|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
124917921|NCT00676715|449328574|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
124917922|NCT00676715|449328571|FG000|Treatment-free Period (TFP)|Death|1|||
124917923|NCT00676715|449328572|FG001|Treatment-free Period (TFP)|Death|1|||
124917924|NCT00676715|449328573|FG002|Treatment-free Period (TFP)|Death|1|||
124917925|NCT00676715|449328574|FG003|Treatment-free Period (TFP)|Death|0|||
124917926|NCT00676715|449328571|FG000|Open Label Extension (OLE)|Reason not provided|3|||
124917927|NCT00676715|449328572|FG001|Open Label Extension (OLE)|Reason not provided|4|||
124917928|NCT00676715|449328573|FG002|Open Label Extension (OLE)|Reason not provided|1|||
124917929|NCT00676715|449328574|FG003|Open Label Extension (OLE)|Reason not provided|4|||
124917930|NCT00676715|449328571|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
124917931|NCT00676715|449328572|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
124917932|NCT00676715|449328573|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
124917933|NCT00676715|449328574|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
124917934|NCT00676715|449328571|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
124917935|NCT00676715|449328572|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
124917936|NCT00676715|449328573|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
124917937|NCT00676715|449328574|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
124917938|NCT00676715|449328571|FG000|Open Label Extension (OLE)|Adverse Event|0|||
124917939|NCT00676715|449328572|FG001|Open Label Extension (OLE)|Adverse Event|3|||
124917940|NCT00676715|449328573|FG002|Open Label Extension (OLE)|Adverse Event|1|||
124917941|NCT00676715|449328574|FG003|Open Label Extension (OLE)|Adverse Event|0|||
124917942|NCT00676715|449328571|FG000|Open Label Extension (OLE)|Death|2|||
124917943|NCT00676715|449328572|FG001|Open Label Extension (OLE)|Death|0|||
124917944|NCT00676715|449328573|FG002|Open Label Extension (OLE)|Death|2|||
124917945|NCT00676715|449328574|FG003|Open Label Extension (OLE)|Death|2|||
124917946|NCT01820260|449328575|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917947|NCT01820260|449328576|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917948|NCT01820260|449328577|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917949|NCT01820260|449328578|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917950|NCT01820260|449328579|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917951|NCT01820260|449328580|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917952|NCT01820260|449328581|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
124917953|NCT01820260|449328582|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917954|NCT01820260|449328583|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124969517|NCT03520075|449517411|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969518|NCT03520075|449517412|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
124917955|NCT01820260|449328584|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917956|NCT01820260|449328585|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917957|NCT01820260|449328586|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917958|NCT01820260|449328587|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917959|NCT01820260|449328588|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
124917960|NCT01820260|449328575|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917961|NCT01820260|449328576|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917962|NCT01820260|449328577|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917963|NCT01820260|449328578|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917964|NCT01820260|449328579|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917965|NCT01820260|449328580|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917966|NCT01820260|449328581|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917967|NCT01820260|449328582|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917968|NCT01820260|449328583|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917969|NCT01820260|449328584|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
124917970|NCT01820260|449328585|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917971|NCT01820260|449328586|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917972|NCT01820260|449328587|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917973|NCT01820260|449328588|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
124917974|NCT04831281|449328590|FG000|Overall Study|Adverse Event|1|||
124917975|NCT04831281|449328591|FG001|Overall Study|Adverse Event|0|||
124917976|NCT04831281|449328592|FG002|Overall Study|Adverse Event|3|||
124917977|NCT04831281|449328590|FG000|Overall Study|Withdrawal by Subject|0|||
124917978|NCT04831281|449328591|FG001|Overall Study|Withdrawal by Subject|1|||
124917979|NCT04831281|449328592|FG002|Overall Study|Withdrawal by Subject|2|||
124917980|NCT04831281|449328590|FG000|Overall Study|Undetermined|1|||
124917981|NCT04831281|449328591|FG001|Overall Study|Undetermined|1|||
124917982|NCT04831281|449328592|FG002|Overall Study|Undetermined|0|||
124917983|NCT02097420|449328593|FG000|Overall Study|Death|6|||
124917984|NCT02097420|449328593|FG000|Overall Study|Valve explanted|13|||
124917985|NCT02097420|449328593|FG000|Overall Study|Other Reason|1|||
124917986|NCT03161379|449328607|FG000|Overall Study|Withdrawal by Subject|4|||
124917987|NCT03161379|449328607|FG000|Overall Study|disease progression during chemotherapy|5|||
124917988|NCT03161379|449328607|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
124917989|NCT03161379|449328607|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
124917990|NCT02728076|449328608|FG000|Overall Study|Physician Decision|4|||
124917991|NCT04089371|449328614|FG000|Overall Study|Withdrawal by Subject|0|||
124917992|NCT04089371|449328615|FG001|Overall Study|Withdrawal by Subject|1|||
124917993|NCT04089371|449328614|FG000|Overall Study|Study terminated early|0|||
124917994|NCT04089371|449328615|FG001|Overall Study|Study terminated early|9|||
124917995|NCT04936035|449328619|FG000|Overall Study|Adverse Event|0|||
124917996|NCT04936035|449328620|FG001|Overall Study|Adverse Event|1|||
124917997|NCT04936035|449328621|FG002|Overall Study|Adverse Event|0|||
124917998|NCT04936035|449328622|FG003|Overall Study|Adverse Event|0|||
124917999|NCT04936035|449328623|FG004|Overall Study|Adverse Event|0|||
124918000|NCT04936035|449328619|FG000|Overall Study|Death|0|||
124918001|NCT04936035|449328620|FG001|Overall Study|Death|0|||
124918002|NCT04936035|449328621|FG002|Overall Study|Death|0|||
124918003|NCT04936035|449328622|FG003|Overall Study|Death|1|||
124918004|NCT04936035|449328623|FG004|Overall Study|Death|0|||
124918005|NCT04936035|449328619|FG000|Overall Study|Lost to Follow-up|0|||
124918006|NCT04936035|449328620|FG001|Overall Study|Lost to Follow-up|1|||
124918007|NCT04936035|449328621|FG002|Overall Study|Lost to Follow-up|1|||
124918008|NCT04936035|449328622|FG003|Overall Study|Lost to Follow-up|2|||
124918009|NCT04936035|449328623|FG004|Overall Study|Lost to Follow-up|1|||
124918010|NCT04936035|449328619|FG000|Overall Study|Physician Decision|0|||
124918011|NCT04936035|449328620|FG001|Overall Study|Physician Decision|1|||
124918012|NCT04936035|449328621|FG002|Overall Study|Physician Decision|0|||
124918013|NCT04936035|449328622|FG003|Overall Study|Physician Decision|0|||
124918014|NCT04936035|449328623|FG004|Overall Study|Physician Decision|0|||
124695493|NCT00281580|448505882|FG004|Overall Study|Lost to Follow-up|0|||
124918015|NCT04936035|449328619|FG000|Overall Study|Protocol Deviation|0|||
124918016|NCT04936035|449328620|FG001|Overall Study|Protocol Deviation|0|||
124918017|NCT04936035|449328621|FG002|Overall Study|Protocol Deviation|1|||
124918018|NCT04936035|449328622|FG003|Overall Study|Protocol Deviation|0|||
124918019|NCT04936035|449328623|FG004|Overall Study|Protocol Deviation|0|||
124451742|NCT01854645|447615165|FG001|Overall Study|Lost to Follow-up|7|||
124451743|NCT01854645|447615166|FG002|Overall Study|Lost to Follow-up|8|||
124451744|NCT01854645|447615167|FG003|Overall Study|Lost to Follow-up|5|||
124451745|NCT01854645|447615168|FG004|Overall Study|Lost to Follow-up|0|||
124451746|NCT01854645|447615164|FG000|Overall Study|Physician Decision|1|||
124451747|NCT01854645|447615165|FG001|Overall Study|Physician Decision|5|||
124451748|NCT01854645|447615166|FG002|Overall Study|Physician Decision|3|||
124451749|NCT01854645|447615167|FG003|Overall Study|Physician Decision|3|||
124451750|NCT01854645|447615168|FG004|Overall Study|Physician Decision|7|||
124451751|NCT01854645|447615164|FG000|Overall Study|Withdrawal by Subject|31|||
124918020|NCT04936035|449328619|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
124918021|NCT04936035|449328620|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
124918022|NCT04936035|449328621|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
124918023|NCT04936035|449328622|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
124918024|NCT04936035|449328623|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
124918025|NCT04936035|449328619|FG000|Overall Study|Reason Unknown|0|||
124918026|NCT04936035|449328620|FG001|Overall Study|Reason Unknown|0|||
124918027|NCT04936035|449328621|FG002|Overall Study|Reason Unknown|0|||
124918028|NCT04936035|449328622|FG003|Overall Study|Reason Unknown|0|||
124918029|NCT04936035|449328623|FG004|Overall Study|Reason Unknown|1|||
124918030|NCT04936035|449328619|FG000|Overall Study|Withdrawal by Subject|1|||
124918031|NCT04936035|449328620|FG001|Overall Study|Withdrawal by Subject|0|||
124918032|NCT04936035|449328621|FG002|Overall Study|Withdrawal by Subject|0|||
124918033|NCT04936035|449328622|FG003|Overall Study|Withdrawal by Subject|0|||
124918034|NCT04936035|449328623|FG004|Overall Study|Withdrawal by Subject|0|||
124918035|NCT04936035|449328619|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
124918036|NCT04936035|449328620|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
124918037|NCT04936035|449328621|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
124918038|NCT04936035|449328622|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
124918039|NCT04936035|449328623|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
124918040|NCT04936035|449328619|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
124918041|NCT04936035|449328620|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
124918042|NCT04936035|449328621|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
124918043|NCT04936035|449328622|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
124918044|NCT04936035|449328623|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
124918045|NCT04936035|449328619|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
124918046|NCT04936035|449328620|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
124918047|NCT04936035|449328621|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
124918048|NCT04936035|449328622|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
124918049|NCT04936035|449328623|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
124918050|NCT03978871|449328632|FG000|Overall Study|Lost to Follow-up|11|||
124918051|NCT03978871|449328633|FG001|Overall Study|Lost to Follow-up|12|||
124918052|NCT04450342|449328634|FG000|Overall Study|Adverse Event|1|||
124918053|NCT04450342|449328635|FG001|Overall Study|Adverse Event|1|||
124918054|NCT04450342|449328636|FG002|Overall Study|Adverse Event|0|||
124918055|NCT04450342|449328634|FG000|Overall Study|Device not used|1|||
124918056|NCT04450342|449328635|FG001|Overall Study|Device not used|0|||
124918057|NCT04450342|449328636|FG002|Overall Study|Device not used|0|||
124918058|NCT04450342|449328634|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
124918059|NCT04450342|449328635|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
124918060|NCT04450342|449328636|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
124918061|NCT04450342|449328634|FG000|Overall Study|Physician Decision|1|||
124918062|NCT04450342|449328635|FG001|Overall Study|Physician Decision|0|||
124918063|NCT04450342|449328636|FG002|Overall Study|Physician Decision|1|||
124918064|NCT04450342|449328634|FG000|Overall Study|Protocol Deviation|0|||
124918065|NCT04450342|449328635|FG001|Overall Study|Protocol Deviation|1|||
124918066|NCT04450342|449328636|FG002|Overall Study|Protocol Deviation|0|||
124918067|NCT04450342|449328634|FG000|Overall Study|Reoperation|1|||
124918068|NCT04450342|449328635|FG001|Overall Study|Reoperation|1|||
124918069|NCT04450342|449328636|FG002|Overall Study|Reoperation|0|||
124918070|NCT04450342|449328634|FG000|Overall Study|Screen Failures|0|||
124918071|NCT04450342|449328635|FG001|Overall Study|Screen Failures|0|||
124918072|NCT04450342|449328636|FG002|Overall Study|Screen Failures|2|||
124918073|NCT04450342|449328634|FG000|Overall Study|Site Terminated by Sponsor|1|||
124918074|NCT04450342|449328635|FG001|Overall Study|Site Terminated by Sponsor|1|||
124918075|NCT04450342|449328636|FG002|Overall Study|Site Terminated by Sponsor|1|||
124918076|NCT04450342|449328634|FG000|Overall Study|Study Terminated by Sponsor|31|||
124918077|NCT04450342|449328635|FG001|Overall Study|Study Terminated by Sponsor|29|||
124695494|NCT00281580|448505883|FG005|Overall Study|Lost to Follow-up|1|||
124695495|NCT00281580|448505884|FG006|Overall Study|Lost to Follow-up|0|||
124695496|NCT00281580|448505885|FG007|Overall Study|Lost to Follow-up|1|||
124695497|NCT00281580|448505886|FG008|Overall Study|Lost to Follow-up|2|||
124695498|NCT00281580|448505887|FG009|Overall Study|Lost to Follow-up|1|||
124695499|NCT00281580|448505888|FG010|Overall Study|Lost to Follow-up|1|||
124918078|NCT04450342|449328636|FG002|Overall Study|Study Terminated by Sponsor|6|||
124918079|NCT04450342|449328634|FG000|Overall Study|Withdrawal by Subject|0|||
124918080|NCT04450342|449328635|FG001|Overall Study|Withdrawal by Subject|1|||
124918081|NCT04450342|449328636|FG002|Overall Study|Withdrawal by Subject|2|||
124918082|NCT00220740|449328637|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
124918083|NCT00220740|449328638|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
124918084|NCT00220740|449328637|FG000|Efficacy Period|Adverse Event|1|||
124918085|NCT00220740|449328638|FG001|Efficacy Period|Adverse Event|1|||
124918086|NCT00220740|449328637|FG000|Efficacy Period|Withdrawal by Subject|1|||
124918087|NCT00220740|449328638|FG001|Efficacy Period|Withdrawal by Subject|0|||
124918088|NCT00220740|449328637|FG000|Efficacy Period|Protocol Violation|1|||
124918089|NCT00220740|449328638|FG001|Efficacy Period|Protocol Violation|0|||
124918090|NCT00220740|449328637|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
124918091|NCT00220740|449328638|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
124918092|NCT04314895|449328641|FG000|Overall Study|Lost to Follow-up|1|||
124918093|NCT04314895|449328641|FG000|Overall Study|Death|10|||
124918094|NCT04314895|449328641|FG000|Overall Study|Physician Decision|2|||
124918095|NCT03941860|449328642|FG000|Overall Study|Withdrawal by Subject|0|||
124918096|NCT03941860|449328643|FG001|Overall Study|Withdrawal by Subject|1|||
124918097|NCT03396588|449328647|FG000|Overall Study|Physician Decision|2|||
124918098|NCT03396588|449328648|FG001|Overall Study|Physician Decision|3|||
124918099|NCT00812461|449328649|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
124918100|NCT00812461|449328650|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
124918101|NCT00812461|449328649|FG000|All Treated Patients|Adverse Event|8|||
124918102|NCT00812461|449328650|FG001|All Treated Patients|Adverse Event|15|||
124918103|NCT00812461|449328649|FG000|All Treated Patients|Lack of Efficacy|13|||
124918104|NCT00812461|449328650|FG001|All Treated Patients|Lack of Efficacy|7|||
124918105|NCT00812461|449328649|FG000|All Treated Patients|Non-compliance|6|||
124918106|NCT00812461|449328650|FG001|All Treated Patients|Non-compliance|9|||
124918107|NCT00812461|449328649|FG000|All Treated Patients|Protocol Violation|36|||
124918108|NCT00812461|449328650|FG001|All Treated Patients|Protocol Violation|27|||
124918109|NCT00812461|449328649|FG000|All Treated Patients|Withdrawal by Subject|45|||
124918110|NCT00812461|449328650|FG001|All Treated Patients|Withdrawal by Subject|54|||
124918111|NCT00812461|449328649|FG000|All Treated Patients|Lost to Follow-up|11|||
124918112|NCT00812461|449328650|FG001|All Treated Patients|Lost to Follow-up|14|||
124918113|NCT00812461|449328649|FG000|All Treated Patients|Other Reason|13|||
124918114|NCT00812461|449328650|FG001|All Treated Patients|Other Reason|21|||
124918115|NCT04402489|449330322|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
124918116|NCT04402489|449330323|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
124918117|NCT04402489|449330324|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
124918118|NCT04402489|449330325|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
124918119|NCT04402489|449330326|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
124918120|NCT04402489|449330322|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
124918121|NCT04402489|449330323|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
124918122|NCT04402489|449330324|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
124918123|NCT04402489|449330325|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
124918124|NCT04402489|449330326|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
124918125|NCT04402489|449330322|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
124918126|NCT04402489|449330323|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
124695500|NCT00281580|448505889|FG011|Overall Study|Lost to Follow-up|0|||
124918127|NCT04402489|449330324|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
124918128|NCT04402489|449330325|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
124918129|NCT04402489|449330326|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
124918130|NCT04402489|449330322|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
124918131|NCT04402489|449330323|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
124918132|NCT04402489|449330324|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
124918133|NCT04402489|449330325|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
124918134|NCT04402489|449330326|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
124695501|NCT00281580|448505890|FG012|Overall Study|Lost to Follow-up|1|||
124695502|NCT00281580|448505891|FG013|Overall Study|Lost to Follow-up|0|||
124918135|NCT04402489|449330322|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
124918136|NCT04402489|449330323|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
124918137|NCT04402489|449330324|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
124918138|NCT04402489|449330325|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
124918139|NCT04402489|449330326|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
124918140|NCT04402489|449330322|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
124918141|NCT04402489|449330323|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
124918142|NCT04402489|449330324|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
124918143|NCT04402489|449330325|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
124918144|NCT04402489|449330326|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
124918145|NCT02287311|449330333|FG000|Cohort 1: Dose Level 1|Death|2|||
124918146|NCT02287311|449330334|FG001|Cohort 1: Dose Level 1|Death|0|||
124918147|NCT02287311|449330335|FG002|Cohort 1: Dose Level 1|Death|0|||
124918148|NCT02287311|449330336|FG003|Cohort 1: Dose Level 1|Death|3|||
124918149|NCT02287311|449330337|FG004|Cohort 1: Dose Level 1|Death|0|||
124918150|NCT02287311|449330338|FG005|Cohort 1: Dose Level 1|Death|0|||
124918151|NCT02287311|449330339|FG006|Cohort 1: Dose Level 1|Death|1|||
124918152|NCT02287311|449330340|FG007|Cohort 1: Dose Level 1|Death|0|||
124918153|NCT02287311|449330341|FG008|Cohort 1: Dose Level 1|Death|0|||
124918154|NCT02287311|449330333|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
124918155|NCT02287311|449330334|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
124918156|NCT02287311|449330335|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
124918157|NCT02287311|449330336|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
124918158|NCT02287311|449330337|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
124918159|NCT02287311|449330338|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
124918160|NCT02287311|449330339|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
124918161|NCT02287311|449330340|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
124918162|NCT02287311|449330341|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
124918163|NCT02287311|449330333|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
124918164|NCT02287311|449330334|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
124918165|NCT02287311|449330335|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
124918166|NCT02287311|449330336|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
124918167|NCT02287311|449330337|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
124918168|NCT02287311|449330338|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
124918169|NCT02287311|449330339|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
124695503|NCT00281580|448505892|FG014|Overall Study|Lost to Follow-up|0|||
124695504|NCT00281580|448505893|FG015|Overall Study|Lost to Follow-up|0|||
124695505|NCT00281580|448505878|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
124695506|NCT00281580|448505879|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
124695507|NCT00281580|448505880|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
124695508|NCT00281580|448505881|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
124695509|NCT00281580|448505882|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
124695510|NCT00281580|448505883|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
124695511|NCT00281580|448505884|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
124695512|NCT00281580|448505885|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
124695513|NCT00281580|448505886|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
124695514|NCT00281580|448505887|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
124695515|NCT00281580|448505888|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
124695516|NCT00281580|448505889|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
124695517|NCT00281580|448505890|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
124695518|NCT00281580|448505891|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
124918170|NCT02287311|449330340|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
124918171|NCT02287311|449330341|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
124918172|NCT02287311|449330333|FG000|Cohort 2: Dose Level 2|Death|0|||
124918173|NCT02287311|449330334|FG001|Cohort 2: Dose Level 2|Death|2|||
124918174|NCT02287311|449330335|FG002|Cohort 2: Dose Level 2|Death|0|||
124695519|NCT00281580|448505892|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
124695520|NCT00281580|448505893|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
124695521|NCT01122680|448505894|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
124695522|NCT01122680|448505895|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
124695523|NCT01122680|448505896|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
124695524|NCT01122680|448505897|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
124695525|NCT01122680|448505894|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
124695526|NCT01122680|448505895|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
124918175|NCT02287311|449330336|FG003|Cohort 2: Dose Level 2|Death|0|||
124918176|NCT02287311|449330337|FG004|Cohort 2: Dose Level 2|Death|2|||
124918177|NCT02287311|449330338|FG005|Cohort 2: Dose Level 2|Death|0|||
124918178|NCT02287311|449330339|FG006|Cohort 2: Dose Level 2|Death|0|||
124918179|NCT02287311|449330340|FG007|Cohort 2: Dose Level 2|Death|2|||
124695527|NCT01122680|448505896|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
124695528|NCT01122680|448505897|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
124695529|NCT01122680|448505894|FG000|Period 1 (4 Weeks)|Other|1|||
124695530|NCT01122680|448505895|FG001|Period 1 (4 Weeks)|Other|1|||
124695531|NCT01122680|448505896|FG002|Period 1 (4 Weeks)|Other|0|||
124918180|NCT02287311|449330341|FG008|Cohort 2: Dose Level 2|Death|0|||
124918181|NCT02287311|449330333|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
124695532|NCT01122680|448505897|FG003|Period 1 (4 Weeks)|Other|0|||
124695533|NCT01122680|448505894|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
124695534|NCT01122680|448505895|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
124695535|NCT01122680|448505896|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
124695536|NCT01122680|448505897|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
124695537|NCT01122680|448505894|FG000|Period 2 (4 Weeks)|Other|1|||
124695538|NCT01122680|448505895|FG001|Period 2 (4 Weeks)|Other|0|||
124695539|NCT01122680|448505896|FG002|Period 2 (4 Weeks)|Other|0|||
124695540|NCT01122680|448505897|FG003|Period 2 (4 Weeks)|Other|0|||
124695541|NCT01122680|448505894|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
124918182|NCT02287311|449330334|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
124918183|NCT02287311|449330335|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
124918184|NCT02287311|449330336|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
124918185|NCT02287311|449330337|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
124918186|NCT02287311|449330338|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
124918187|NCT02287311|449330339|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
124918188|NCT02287311|449330340|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
124918189|NCT02287311|449330341|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
124918190|NCT02287311|449330333|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
124918191|NCT02287311|449330334|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
124918192|NCT02287311|449330335|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
124918193|NCT02287311|449330336|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
124918194|NCT02287311|449330337|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
124918195|NCT02287311|449330338|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
124918196|NCT02287311|449330339|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
124918197|NCT02287311|449330340|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
124918198|NCT02287311|449330341|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
124918199|NCT02287311|449330333|FG000|Cohort 3: Dose Level 3|Death|0|||
124918200|NCT02287311|449330334|FG001|Cohort 3: Dose Level 3|Death|0|||
124918201|NCT02287311|449330335|FG002|Cohort 3: Dose Level 3|Death|4|||
124918202|NCT02287311|449330336|FG003|Cohort 3: Dose Level 3|Death|0|||
124918203|NCT02287311|449330337|FG004|Cohort 3: Dose Level 3|Death|0|||
124918204|NCT02287311|449330338|FG005|Cohort 3: Dose Level 3|Death|4|||
124918205|NCT02287311|449330339|FG006|Cohort 3: Dose Level 3|Death|0|||
124918206|NCT02287311|449330340|FG007|Cohort 3: Dose Level 3|Death|0|||
124762036|NCT00101686|448753547|FG003|Overall Study|Withdrawal by Subject|8|||
124762037|NCT00101686|448753548|FG004|Overall Study|Withdrawal by Subject|8|||
124762038|NCT00101686|448753549|FG005|Overall Study|Withdrawal by Subject|7|||
124918207|NCT02287311|449330341|FG008|Cohort 3: Dose Level 3|Death|2|||
124918208|NCT02287311|449330333|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
124918209|NCT02287311|449330334|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
124695542|NCT01122680|448505895|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
124695543|NCT01122680|448505896|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
124695544|NCT01122680|448505897|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
124695545|NCT01122680|448505894|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
124762039|NCT00101686|448753550|FG006|Overall Study|Withdrawal by Subject|7|||
124762040|NCT00101686|448753551|FG007|Overall Study|Withdrawal by Subject|7|||
124762041|NCT00101686|448753552|FG008|Overall Study|Withdrawal by Subject|8|||
124762042|NCT00101686|448753553|FG009|Overall Study|Withdrawal by Subject|9|||
124918210|NCT02287311|449330335|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
124918211|NCT02287311|449330336|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
124918212|NCT02287311|449330337|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
124918213|NCT02287311|449330338|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
124918214|NCT02287311|449330339|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
124918215|NCT02287311|449330340|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
124918216|NCT02287311|449330341|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
124918217|NCT02287311|449330333|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
124918218|NCT02287311|449330334|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
124918219|NCT02287311|449330335|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
124918220|NCT02287311|449330336|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
124695546|NCT01122680|448505895|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
124695547|NCT01122680|448505896|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
124695548|NCT01122680|448505897|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
124695549|NCT01550965|448505898|FG000|Overall Study|Adverse Event|26|||
124918221|NCT02287311|449330337|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
124918222|NCT02287311|449330338|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
124918223|NCT02287311|449330339|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
124918224|NCT02287311|449330340|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
124918225|NCT02287311|449330341|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
124918226|NCT05418296|449330344|FG000|Overall Study|Withdrawal by Subject|4|||
124918227|NCT05418296|449330345|FG001|Overall Study|Withdrawal by Subject|1|||
124695550|NCT01550965|448505898|FG000|Overall Study|Withdrawal by Subject|10|||
124918228|NCT00616967|449330349|FG000|Overall Study|Withdrawal by Subject|0|||
124918229|NCT00616967|449330350|FG001|Overall Study|Withdrawal by Subject|0|||
124918230|NCT00616967|449330351|FG002|Overall Study|Withdrawal by Subject|1|||
124918231|NCT05059262|449330352|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
124918232|NCT05059262|449330353|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
124918233|NCT05059262|449330352|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
124918234|NCT05059262|449330353|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
124918235|NCT05059262|449330352|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
124918236|NCT05059262|449330353|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
124918237|NCT05059262|449330352|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
124918238|NCT05059262|449330353|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
124918239|NCT05059262|449330352|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
124918240|NCT05059262|449330353|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
124918241|NCT05059262|449330352|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
124918242|NCT05059262|449330353|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
124918243|NCT05059262|449330352|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
124918244|NCT05059262|449330353|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
124918245|NCT05059262|449330352|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
124918246|NCT05059262|449330353|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
124918247|NCT05059262|449330352|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
124918248|NCT05059262|449330353|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
124918249|NCT02312960|449330361|FG000|Overall Study|Death|24|||
124918250|NCT02312960|449330362|FG001|Overall Study|Death|32|||
124918251|NCT02312960|449330363|FG002|Overall Study|Death|25|||
124695551|NCT01550965|448505898|FG000|Overall Study|Lost to Follow-up|2|||
124695552|NCT01550965|448505898|FG000|Overall Study|Lack of Efficacy|59|||
124695553|NCT01550965|448505898|FG000|Overall Study|Other|13|||
124695554|NCT03016403|448505901|FG000|Baseline|Death|5|||
124918252|NCT02312960|449330364|FG003|Overall Study|Death|11|||
124918253|NCT02312960|449330365|FG004|Overall Study|Death|5|||
124918254|NCT02312960|449330366|FG005|Overall Study|Death|5|||
124918255|NCT02312960|449330367|FG006|Overall Study|Death|8|||
124918256|NCT02312960|449330368|FG007|Overall Study|Death|5|||
124918257|NCT02312960|449330369|FG008|Overall Study|Death|7|||
124918258|NCT02312960|449330370|FG009|Overall Study|Death|3|||
124918259|NCT02312960|449330371|FG010|Overall Study|Death|3|||
124918260|NCT02312960|449330372|FG011|Overall Study|Death|1|||
124918261|NCT02312960|449330373|FG012|Overall Study|Death|25|||
124918262|NCT02312960|449330374|FG013|Overall Study|Death|19|||
124918263|NCT02312960|449330361|FG000|Overall Study|Missing|0|||
124918264|NCT02312960|449330362|FG001|Overall Study|Missing|0|||
124918265|NCT02312960|449330363|FG002|Overall Study|Missing|2|||
124918266|NCT02312960|449330364|FG003|Overall Study|Missing|0|||
124918267|NCT02312960|449330365|FG004|Overall Study|Missing|0|||
124918268|NCT02312960|449330366|FG005|Overall Study|Missing|0|||
124918269|NCT02312960|449330367|FG006|Overall Study|Missing|0|||
124918270|NCT02312960|449330368|FG007|Overall Study|Missing|0|||
124918271|NCT02312960|449330369|FG008|Overall Study|Missing|0|||
124918272|NCT02312960|449330370|FG009|Overall Study|Missing|0|||
124918273|NCT02312960|449330371|FG010|Overall Study|Missing|0|||
124918274|NCT02312960|449330372|FG011|Overall Study|Missing|0|||
124918275|NCT02312960|449330373|FG012|Overall Study|Missing|0|||
124918276|NCT02312960|449330374|FG013|Overall Study|Missing|0|||
124918277|NCT02312960|449330361|FG000|Overall Study|Lost to Follow-up|0|||
124918278|NCT02312960|449330362|FG001|Overall Study|Lost to Follow-up|0|||
124918279|NCT02312960|449330363|FG002|Overall Study|Lost to Follow-up|1|||
124918280|NCT02312960|449330364|FG003|Overall Study|Lost to Follow-up|0|||
124918281|NCT02312960|449330365|FG004|Overall Study|Lost to Follow-up|0|||
124918282|NCT02312960|449330366|FG005|Overall Study|Lost to Follow-up|0|||
124918283|NCT02312960|449330367|FG006|Overall Study|Lost to Follow-up|1|||
124918284|NCT02312960|449330368|FG007|Overall Study|Lost to Follow-up|1|||
124918285|NCT02312960|449330369|FG008|Overall Study|Lost to Follow-up|0|||
124918286|NCT02312960|449330370|FG009|Overall Study|Lost to Follow-up|1|||
124918287|NCT02312960|449330371|FG010|Overall Study|Lost to Follow-up|0|||
124918288|NCT02312960|449330372|FG011|Overall Study|Lost to Follow-up|0|||
124451752|NCT01854645|447615165|FG001|Overall Study|Withdrawal by Subject|41|||
124918289|NCT02312960|449330373|FG012|Overall Study|Lost to Follow-up|1|||
124918290|NCT02312960|449330374|FG013|Overall Study|Lost to Follow-up|0|||
124918291|NCT02312960|449330361|FG000|Overall Study|Withdrawal by Subject|1|||
124918292|NCT02312960|449330362|FG001|Overall Study|Withdrawal by Subject|2|||
124918293|NCT02312960|449330363|FG002|Overall Study|Withdrawal by Subject|0|||
124918294|NCT02312960|449330364|FG003|Overall Study|Withdrawal by Subject|0|||
124918295|NCT02312960|449330365|FG004|Overall Study|Withdrawal by Subject|1|||
124918296|NCT02312960|449330366|FG005|Overall Study|Withdrawal by Subject|0|||
124918297|NCT02312960|449330367|FG006|Overall Study|Withdrawal by Subject|1|||
124695555|NCT03016403|448505902|FG001|Baseline|Death|8|||
124695556|NCT03016403|448505903|FG002|Baseline|Death|1|||
124918298|NCT02312960|449330368|FG007|Overall Study|Withdrawal by Subject|2|||
124918299|NCT02312960|449330369|FG008|Overall Study|Withdrawal by Subject|2|||
124918300|NCT02312960|449330370|FG009|Overall Study|Withdrawal by Subject|3|||
124918301|NCT02312960|449330371|FG010|Overall Study|Withdrawal by Subject|0|||
124918302|NCT02312960|449330372|FG011|Overall Study|Withdrawal by Subject|0|||
124918303|NCT02312960|449330373|FG012|Overall Study|Withdrawal by Subject|2|||
124918304|NCT02312960|449330374|FG013|Overall Study|Withdrawal by Subject|0|||
124918305|NCT03281291|449330377|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
124918306|NCT03281291|449330378|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
124918307|NCT03281291|449330379|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
124918308|NCT03281291|449330380|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
124918309|NCT03281291|449330381|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
124918310|NCT03281291|449330377|FG000|Overall Study|Protocol Deviation|2|||
124918311|NCT03281291|449330378|FG001|Overall Study|Protocol Deviation|0|||
124918312|NCT03281291|449330379|FG002|Overall Study|Protocol Deviation|1|||
124918313|NCT03281291|449330380|FG003|Overall Study|Protocol Deviation|2|||
124918314|NCT03281291|449330381|FG004|Overall Study|Protocol Deviation|1|||
124918315|NCT03281291|449330377|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
124918316|NCT03281291|449330378|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
124918317|NCT03281291|449330379|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
124918318|NCT03281291|449330380|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
124918319|NCT03281291|449330381|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
124918320|NCT03281291|449330377|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
124918321|NCT03281291|449330378|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
124918322|NCT03281291|449330379|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
124918323|NCT03281291|449330380|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
124918324|NCT03281291|449330381|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
124918325|NCT03281291|449330377|FG000|Overall Study|Lost to Follow-up|10|||
124918326|NCT03281291|449330378|FG001|Overall Study|Lost to Follow-up|10|||
124918327|NCT03281291|449330379|FG002|Overall Study|Lost to Follow-up|4|||
124918328|NCT03281291|449330380|FG003|Overall Study|Lost to Follow-up|6|||
124918329|NCT03281291|449330381|FG004|Overall Study|Lost to Follow-up|10|||
124918330|NCT03281291|449330377|FG000|Overall Study|Other|0|||
124918331|NCT03281291|449330378|FG001|Overall Study|Other|2|||
124918332|NCT03281291|449330379|FG002|Overall Study|Other|0|||
124918333|NCT03281291|449330380|FG003|Overall Study|Other|2|||
124918334|NCT03281291|449330381|FG004|Overall Study|Other|1|||
124918335|NCT04382898|449330382|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
124918336|NCT04382898|449330383|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
124918337|NCT04382898|449330384|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
124918338|NCT04382898|449330385|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
124918339|NCT04382898|449330386|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
124918340|NCT04382898|449330382|FG000|Part 1: Dose Titration|Death|6|||
124918341|NCT04382898|449330383|FG001|Part 1: Dose Titration|Death|0|||
124918342|NCT04382898|449330384|FG002|Part 1: Dose Titration|Death|0|||
124918343|NCT04382898|449330385|FG003|Part 1: Dose Titration|Death|0|||
124918344|NCT04382898|449330386|FG004|Part 1: Dose Titration|Death|0|||
124918345|NCT04382898|449330382|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124918346|NCT04382898|449330383|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124918347|NCT04382898|449330384|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
124918348|NCT04382898|449330385|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124918349|NCT04382898|449330386|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124918350|NCT04382898|449330382|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
124918351|NCT04382898|449330383|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
124918352|NCT04382898|449330384|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
124918353|NCT04382898|449330385|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
124918354|NCT04382898|449330386|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
124918355|NCT04382898|449330382|FG000|Part 2: Dose Expansion|Death|0|||
124918356|NCT04382898|449330383|FG001|Part 2: Dose Expansion|Death|17|||
124918357|NCT04382898|449330384|FG002|Part 2: Dose Expansion|Death|13|||
124918358|NCT04382898|449330385|FG003|Part 2: Dose Expansion|Death|1|||
124918359|NCT04382898|449330386|FG004|Part 2: Dose Expansion|Death|0|||
124918360|NCT04382898|449330382|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
124918361|NCT04382898|449330383|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
124918362|NCT04382898|449330384|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
124918363|NCT04382898|449330385|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
124918364|NCT04382898|449330386|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
124918365|NCT04382898|449330382|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
124762043|NCT00867165|448753554|FG000|Overall Study|Adverse Event|3|||
124918366|NCT04382898|449330383|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
124918367|NCT04382898|449330384|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
124762044|NCT00867165|448753555|FG001|Overall Study|Adverse Event|0|||
124762045|NCT00867165|448753554|FG000|Overall Study|Withdrawal by Subject|1|||
124918368|NCT04382898|449330385|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
124918369|NCT04382898|449330386|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
124918370|NCT04382898|449330382|FG000|Part 2: Dose Expansion|Other|0|||
124918371|NCT04382898|449330383|FG001|Part 2: Dose Expansion|Other|0|||
124918372|NCT04382898|449330384|FG002|Part 2: Dose Expansion|Other|1|||
124918373|NCT04382898|449330385|FG003|Part 2: Dose Expansion|Other|0|||
124918374|NCT04382898|449330386|FG004|Part 2: Dose Expansion|Other|0|||
124918375|NCT05229120|449330387|FG000|Overall Study|Withdrawal by Subject|8|||
124918376|NCT02900924|449330388|FG000|Overall Study|Death|52|||
124918377|NCT02900924|449330388|FG000|Overall Study|Lost to Follow-up|4|||
124918378|NCT02900924|449330388|FG000|Overall Study|Withdrawal by Subject|20|||
124918379|NCT02900924|449330388|FG000|Overall Study|Missed Visit|33|||
124918380|NCT02365766|449330408|FG000|Overall Study|Withdrawal by Subject|0|||
124918381|NCT02365766|449330409|FG001|Overall Study|Withdrawal by Subject|0|||
124918382|NCT02365766|449330410|FG002|Overall Study|Withdrawal by Subject|1|||
124918383|NCT02365766|449330408|FG000|Overall Study|Eligibility Criteria Not Met|0|||
124918384|NCT02365766|449330409|FG001|Overall Study|Eligibility Criteria Not Met|0|||
124918385|NCT02365766|449330410|FG002|Overall Study|Eligibility Criteria Not Met|1|||
124918386|NCT01566695|449330411|FG000|Overall Study|Lack of Efficacy|1|||
124918387|NCT01566695|449330412|FG001|Overall Study|Lack of Efficacy|0|||
124918388|NCT01566695|449330411|FG000|Overall Study|Adverse Event|3|||
124918389|NCT01566695|449330412|FG001|Overall Study|Adverse Event|0|||
124918390|NCT01566695|449330411|FG000|Overall Study|Death|79|||
124918391|NCT01566695|449330412|FG001|Overall Study|Death|86|||
124918392|NCT01566695|449330411|FG000|Overall Study|Withdrawal by Subject|13|||
124918393|NCT01566695|449330412|FG001|Overall Study|Withdrawal by Subject|12|||
124918394|NCT01566695|449330411|FG000|Overall Study|Lost to Follow-up|0|||
124918395|NCT01566695|449330412|FG001|Overall Study|Lost to Follow-up|3|||
124918396|NCT01566695|449330411|FG000|Overall Study|Other reasons|11|||
124918397|NCT01566695|449330412|FG001|Overall Study|Other reasons|8|||
124918398|NCT03763708|449330413|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
124918399|NCT03763708|449330414|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
124918400|NCT03763708|449330415|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
124918401|NCT03763708|449330416|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
124918402|NCT03763708|449330417|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
124918403|NCT03763708|449330418|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
124918404|NCT03763708|449330419|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
124918405|NCT03763708|449330420|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
124918406|NCT03763708|449330421|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
124918407|NCT03763708|449330413|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
124918408|NCT03763708|449330414|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
124918409|NCT03763708|449330415|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
124918410|NCT03763708|449330416|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
124918411|NCT03763708|449330417|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
124918412|NCT03763708|449330418|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
124918413|NCT03763708|449330419|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
124918414|NCT03763708|449330420|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
124918415|NCT03763708|449330421|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
124918416|NCT03763708|449330413|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
124918417|NCT03763708|449330414|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
124918418|NCT03763708|449330415|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
124918419|NCT03763708|449330416|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
124918420|NCT03763708|449330417|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
124918421|NCT03763708|449330418|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
124918422|NCT03763708|449330419|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
124918423|NCT03763708|449330420|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
124918424|NCT03763708|449330421|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
124918425|NCT03763708|449330413|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
124918426|NCT03763708|449330414|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
124918427|NCT03763708|449330415|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
124918428|NCT03763708|449330416|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
124918429|NCT03763708|449330417|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
124918430|NCT03763708|449330418|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
124918431|NCT03763708|449330419|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
124918432|NCT03763708|449330420|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
124918433|NCT03763708|449330421|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
124918434|NCT03763708|449330413|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
124545411|NCT00400985|447951197|FG000|Overall Study|Withdrawal by Subject|5|||
124545412|NCT00400985|447951197|FG000|Overall Study|system modification|8|||
124762046|NCT00867165|448753555|FG001|Overall Study|Withdrawal by Subject|0|||
124918435|NCT03763708|449330414|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
124918436|NCT03763708|449330415|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
124918437|NCT03763708|449330416|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
124918438|NCT03763708|449330417|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
124918439|NCT03763708|449330418|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
124918440|NCT03763708|449330419|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
124918441|NCT03763708|449330420|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
124918442|NCT03763708|449330421|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
124918443|NCT03763708|449330413|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
124918444|NCT03763708|449330414|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
124918445|NCT03763708|449330415|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
124918446|NCT03763708|449330416|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
124918447|NCT03763708|449330417|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
124918448|NCT03763708|449330418|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
124918449|NCT03763708|449330419|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
124918450|NCT03763708|449330420|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
124918451|NCT03763708|449330421|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
124918452|NCT03763708|449330413|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
124918453|NCT03763708|449330414|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
124918454|NCT03763708|449330415|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
124918455|NCT03763708|449330416|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
124918456|NCT03763708|449330417|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
124918457|NCT03763708|449330418|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
124918458|NCT03763708|449330419|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
124918459|NCT03763708|449330420|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
124918460|NCT03763708|449330421|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
124918461|NCT03763708|449330413|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
124918462|NCT03763708|449330414|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
124918463|NCT03763708|449330415|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
124918464|NCT03763708|449330416|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
124918465|NCT03763708|449330417|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
124918466|NCT03763708|449330418|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
124918467|NCT03763708|449330419|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
124918468|NCT03763708|449330420|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
124918469|NCT03763708|449330421|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
124918470|NCT03763708|449330413|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
124918471|NCT03763708|449330414|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
124918472|NCT03763708|449330415|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
124918473|NCT03763708|449330416|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
124918474|NCT03763708|449330417|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
124918475|NCT03763708|449330418|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
124918476|NCT03763708|449330419|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
124918477|NCT03763708|449330420|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
124918478|NCT03763708|449330421|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
124918479|NCT05470400|449330424|FG000|Overall Study|Lost to Follow-up|0|||
124918480|NCT05470400|449330425|FG001|Overall Study|Lost to Follow-up|0|||
124918481|NCT05470400|449330426|FG002|Overall Study|Lost to Follow-up|0|||
124918482|NCT05470400|449330427|FG003|Overall Study|Lost to Follow-up|0|||
124695557|NCT03016403|448505904|FG003|Baseline|Death|0|||
124695558|NCT03016403|448505901|FG000|Baseline|Withdrawal by Subject|2|||
124918483|NCT05470400|449330428|FG004|Overall Study|Lost to Follow-up|0|||
124918484|NCT05470400|449330429|FG005|Overall Study|Lost to Follow-up|0|||
124918485|NCT05470400|449330430|FG006|Overall Study|Lost to Follow-up|0|||
124918486|NCT05470400|449330431|FG007|Overall Study|Lost to Follow-up|1|||
124918487|NCT05470400|449330424|FG000|Overall Study|Withdrawal by Subject|1|||
124918488|NCT05470400|449330425|FG001|Overall Study|Withdrawal by Subject|0|||
124918489|NCT05470400|449330426|FG002|Overall Study|Withdrawal by Subject|0|||
124918490|NCT05470400|449330427|FG003|Overall Study|Withdrawal by Subject|0|||
124918491|NCT05470400|449330428|FG004|Overall Study|Withdrawal by Subject|0|||
124695559|NCT03016403|448505902|FG001|Baseline|Withdrawal by Subject|8|||
124918492|NCT05470400|449330429|FG005|Overall Study|Withdrawal by Subject|1|||
124918493|NCT05470400|449330430|FG006|Overall Study|Withdrawal by Subject|0|||
124918494|NCT05470400|449330431|FG007|Overall Study|Withdrawal by Subject|2|||
124918495|NCT05956002|449330433|FG000|Treatment Period 3|Adverse Event|0|||
124918496|NCT05956002|449330434|FG001|Treatment Period 3|Adverse Event|0|||
124918497|NCT05956002|449330435|FG002|Treatment Period 3|Adverse Event|1|||
124918498|NCT05956002|449330436|FG003|Treatment Period 3|Adverse Event|0|||
124918499|NCT02307565|449330439|FG000|Overall Study|Adverse Event|3|||
124918500|NCT02307565|449330440|FG001|Overall Study|Adverse Event|2|||
124918501|NCT02307565|449330439|FG000|Overall Study|Withdrawal by Subject|2|||
124918502|NCT02307565|449330440|FG001|Overall Study|Withdrawal by Subject|2|||
124918503|NCT04401800|449330443|FG000|Overall Study|Death|17|||
124918504|NCT04401800|449330443|FG000|Overall Study|Lost to Follow-up|5|||
124918505|NCT04401800|449330443|FG000|Overall Study|Withdrawal by Subject|4|||
124918506|NCT03385629|449330444|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
124695560|NCT03016403|448505903|FG002|Baseline|Withdrawal by Subject|4|||
124695561|NCT03016403|448505904|FG003|Baseline|Withdrawal by Subject|10|||
124695562|NCT03016403|448505901|FG000|Baseline|Lost to Follow-up|9|||
124695563|NCT03016403|448505902|FG001|Baseline|Lost to Follow-up|11|||
124695564|NCT03016403|448505903|FG002|Baseline|Lost to Follow-up|6|||
124695565|NCT03016403|448505904|FG003|Baseline|Lost to Follow-up|24|||
124918507|NCT03385629|449330445|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
124918508|NCT03385629|449330444|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
124918509|NCT03385629|449330445|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
124918510|NCT03385629|449330444|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
124918511|NCT03385629|449330445|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
124918512|NCT02281955|449330454|FG000|Overall Study|Death|1|||
124695566|NCT03016403|448505901|FG000|6-week Follow-up|Death|1|||
124695567|NCT03016403|448505902|FG001|6-week Follow-up|Death|4|||
124695568|NCT03016403|448505903|FG002|6-week Follow-up|Death|0|||
124695569|NCT03016403|448505904|FG003|6-week Follow-up|Death|0|||
124695570|NCT03016403|448505901|FG000|6-week Follow-up|Lost to Follow-up|2|||
124695571|NCT03016403|448505902|FG001|6-week Follow-up|Lost to Follow-up|7|||
124695572|NCT03016403|448505903|FG002|6-week Follow-up|Lost to Follow-up|4|||
124918513|NCT02913872|449330455|FG000|Overall Study|Withdrawal by Subject|1|||
124695573|NCT03016403|448505904|FG003|6-week Follow-up|Lost to Follow-up|8|||
124918514|NCT04072822|449330456|FG000|Treatment|Adverse Event|9|||
124918515|NCT04072822|449330457|FG001|Treatment|Adverse Event|5|||
124918516|NCT04072822|449330456|FG000|Treatment|Met Stopping Criteria|13|||
124918517|NCT04072822|449330457|FG001|Treatment|Met Stopping Criteria|24|||
124695574|NCT03016403|448505901|FG000|6-week Follow-up|Withdrawal by Subject|0|||
124695575|NCT03016403|448505902|FG001|6-week Follow-up|Withdrawal by Subject|2|||
124695576|NCT03016403|448505903|FG002|6-week Follow-up|Withdrawal by Subject|0|||
124695577|NCT03016403|448505904|FG003|6-week Follow-up|Withdrawal by Subject|1|||
124695578|NCT03016403|448505901|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
124695579|NCT03016403|448505902|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
124695580|NCT03016403|448505903|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
124695581|NCT03016403|448505904|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
124762047|NCT02738008|448753556|FG000|Overall Study|Study Terminated by Sponsor|1|||
124918518|NCT04072822|449330456|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
124918519|NCT04072822|449330457|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
124918520|NCT04072822|449330456|FG000|Treatment|Withdrawal by Subject|0|||
124918521|NCT04072822|449330457|FG001|Treatment|Withdrawal by Subject|2|||
124918522|NCT04072822|449330456|FG000|Treatment|Death|0|||
124918523|NCT04072822|449330457|FG001|Treatment|Death|2|||
124918524|NCT04072822|449330456|FG000|Treatment|Lost to Follow-up|11|||
124918525|NCT04072822|449330457|FG001|Treatment|Lost to Follow-up|3|||
124918526|NCT04072822|449330456|FG000|Treatment|Physician Decision|1|||
124762048|NCT02738008|448753557|FG001|Overall Study|Study Terminated by Sponsor|5|||
124918527|NCT04072822|449330457|FG001|Treatment|Physician Decision|0|||
124762049|NCT02738008|448753558|FG002|Overall Study|Study Terminated by Sponsor|3|||
124451753|NCT01854645|447615166|FG002|Overall Study|Withdrawal by Subject|30|||
124762050|NCT02738008|448753556|FG000|Overall Study|Adverse Event|0|||
124918528|NCT04072822|449330456|FG000|Treatment|Other|7|||
124451754|NCT01854645|447615167|FG003|Overall Study|Withdrawal by Subject|21|||
124695582|NCT03016403|448505901|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
124695583|NCT03016403|448505902|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
124695584|NCT03016403|448505903|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
124918529|NCT04072822|449330457|FG001|Treatment|Other|9|||
124918530|NCT04072822|449330456|FG000|Follow-up|Withdrawal by Subject|1|||
124918531|NCT04072822|449330457|FG001|Follow-up|Withdrawal by Subject|0|||
124918532|NCT04072822|449330456|FG000|Follow-up|Lost to Follow-up|5|||
124918533|NCT04072822|449330457|FG001|Follow-up|Lost to Follow-up|4|||
124918534|NCT04391894|449330459|FG000|Overall Study|Adverse Event|1|||
124918535|NCT04391894|449330460|FG001|Overall Study|Adverse Event|1|||
124918536|NCT04391894|449330461|FG002|Overall Study|Adverse Event|1|||
124918537|NCT04391894|449330462|FG003|Overall Study|Adverse Event|1|||
124918538|NCT04391894|449330463|FG004|Overall Study|Adverse Event|1|||
124918539|NCT04391894|449330459|FG000|Overall Study|Lost to Follow-up|1|||
124918540|NCT04391894|449330460|FG001|Overall Study|Lost to Follow-up|0|||
124918541|NCT04391894|449330461|FG002|Overall Study|Lost to Follow-up|0|||
124918542|NCT04391894|449330462|FG003|Overall Study|Lost to Follow-up|0|||
124918543|NCT04391894|449330463|FG004|Overall Study|Lost to Follow-up|0|||
124918544|NCT04391894|449330459|FG000|Overall Study|Protocol Violation|0|||
124918545|NCT04391894|449330460|FG001|Overall Study|Protocol Violation|0|||
124918546|NCT04391894|449330461|FG002|Overall Study|Protocol Violation|0|||
124918547|NCT04391894|449330462|FG003|Overall Study|Protocol Violation|1|||
124918548|NCT04391894|449330463|FG004|Overall Study|Protocol Violation|0|||
124918549|NCT04391894|449330459|FG000|Overall Study|Withdrawal by Subject|2|||
124918550|NCT04391894|449330460|FG001|Overall Study|Withdrawal by Subject|0|||
124918551|NCT04391894|449330461|FG002|Overall Study|Withdrawal by Subject|3|||
124918552|NCT04391894|449330462|FG003|Overall Study|Withdrawal by Subject|0|||
124918553|NCT04391894|449330463|FG004|Overall Study|Withdrawal by Subject|1|||
124918554|NCT04391894|449330459|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
124918555|NCT04391894|449330460|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
124918556|NCT04391894|449330461|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
124918557|NCT04391894|449330462|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
124918558|NCT04391894|449330463|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
124918559|NCT02323321|449330467|FG000|Overall Study|Re-Transplant|1|||
124918560|NCT02323321|449330467|FG000|Overall Study|Death|12|||
124918561|NCT00446225|449330468|FG000|Overall Study|Protocol Violation|1|||
124918562|NCT00446225|449330469|FG001|Overall Study|Protocol Violation|0|||
124918563|NCT01057433|449330470|FG000|Overall Study|Adverse Event|1|||
124918564|NCT02811679|449330471|FG000|Overall Study|Adverse Event|1|||
124918565|NCT02811679|449330471|FG000|Overall Study|Lack of Efficacy|6|||
124918566|NCT02811679|449330471|FG000|Overall Study|Early study closure due to slow accrual|3|||
124918567|NCT03361748|449330477|FG000|Overall Study|Death|77|||
124918568|NCT03361748|449330477|FG000|Overall Study|Lost to Follow-up|4|||
124918569|NCT03361748|449330477|FG000|Overall Study|Withdrawal by Subject|20|||
124918570|NCT02814838|449330483|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
124918571|NCT02814838|449330484|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
124918572|NCT02814838|449330483|FG000|Overall Study|Consent withdrawal|1|||
124918573|NCT02814838|449330484|FG001|Overall Study|Consent withdrawal|1|||
124918574|NCT01361711|449330486|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
124918575|NCT01361711|449330486|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
124918576|NCT01361711|449330486|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
124918577|NCT01361711|449330486|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
124918578|NCT01361711|449330486|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
124918579|NCT01361711|449330486|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
124918580|NCT01361711|449330486|FG000|Completed Week 18 of Treatment|Other|9|||
124918581|NCT01361711|449330486|FG000|10 Year Follow-up|Still in follow-up|22|||
124918582|NCT01361711|449330486|FG000|10 Year Follow-up|Death|7|||
124918583|NCT01361711|449330486|FG000|10 Year Follow-up|Developed new cancer|1|||
124918584|NCT01361711|449330486|FG000|10 Year Follow-up|Lost to Follow-up|2|||
124918585|NCT01361711|449330486|FG000|10 Year Follow-up|New treatment started|6|||
124918586|NCT01361711|449330486|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
124918587|NCT01361711|449330486|FG000|10 Year Follow-up|Progressive Disease|1|||
124918588|NCT02596126|449330487|FG000|Overall Study|Lost to Follow-up|12|||
124918589|NCT02596126|449330488|FG001|Overall Study|Lost to Follow-up|21|||
124918590|NCT02596126|449330487|FG000|Overall Study|Protocol Violation|7|||
124545413|NCT00400985|447951197|FG000|Overall Study|Death|30|||
124545414|NCT00400985|447951197|FG000|Overall Study|Lost to Follow-up|9|||
124695585|NCT03016403|448505904|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
124695586|NCT03016403|448505901|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
124695587|NCT03016403|448505902|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
124695588|NCT03016403|448505903|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
124918591|NCT02596126|449330488|FG001|Overall Study|Protocol Violation|9|||
124918592|NCT05063994|449332334|FG000|Cortef Run-In|Withdrawal of Consent|1|||
124918593|NCT05063994|449332335|FG001|Cortef Run-In|Withdrawal of Consent|0|||
124918594|NCT05063994|449332336|FG002|Cortef Run-In|Withdrawal of Consent|0|||
124918595|NCT05063994|449332334|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
124918596|NCT05063994|449332335|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
124918597|NCT05063994|449332336|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
124918598|NCT05063994|449332334|FG000|Treatment|Physician Decision|0|||
124918599|NCT05063994|449332335|FG001|Treatment|Physician Decision|0|||
124918600|NCT05063994|449332336|FG002|Treatment|Physician Decision|1|||
124918601|NCT05063994|449332334|FG000|Treatment|Withdrawal by Subject|0|||
124918602|NCT05063994|449332335|FG001|Treatment|Withdrawal by Subject|0|||
124918603|NCT05063994|449332336|FG002|Treatment|Withdrawal by Subject|1|||
124918604|NCT05063994|449332334|FG000|Treatment|Withdrawal of Consent|0|||
124918605|NCT05063994|449332335|FG001|Treatment|Withdrawal of Consent|0|||
124918606|NCT05063994|449332336|FG002|Treatment|Withdrawal of Consent|1|||
124918607|NCT04630262|449332337|FG000|Overall Study|Intraoperative Screen Failure|5|||
124918608|NCT04630262|449332337|FG000|Overall Study|Study terminated prematurely|71|||
124918609|NCT04630262|449332337|FG000|Overall Study|Withdrawal by Subject|2|||
124918610|NCT04630262|449332337|FG000|Overall Study|Physician Decision|2|||
124918611|NCT04638998|449332343|FG000|Overall Study|Withdrawal by Subject|1|||
124918612|NCT04638998|449332344|FG001|Overall Study|Withdrawal by Subject|3|||
124918613|NCT03692676|449332345|FG000|Overall Study|exclude patients with prior use|4424|||
124918614|NCT03692676|449332346|FG001|Overall Study|exclude patients with prior use|24726|||
124918615|NCT03692676|449332347|FG002|Overall Study|exclude patients with prior use|0|||
124918616|NCT03692676|449332348|FG003|Overall Study|exclude patients with prior use|0|||
124918617|NCT03692676|449332345|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
124918618|NCT03692676|449332346|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
124918619|NCT03692676|449332347|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
124918620|NCT03692676|449332348|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
124918621|NCT03692676|449332345|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
124918622|NCT03692676|449332346|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
124918623|NCT03692676|449332347|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
124918624|NCT03692676|449332348|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
124918625|NCT03692676|449332345|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
124918626|NCT03692676|449332346|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
124918627|NCT03692676|449332347|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
124918628|NCT03692676|449332348|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
124918629|NCT03692676|449332345|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
124918630|NCT03692676|449332346|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
124918631|NCT03692676|449332347|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
124918632|NCT03692676|449332348|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
124918633|NCT03692676|449332345|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
124918634|NCT03692676|449332346|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
124918635|NCT03692676|449332347|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
124918636|NCT03692676|449332348|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
124918637|NCT03692676|449332345|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
124918638|NCT03692676|449332346|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
124918639|NCT03692676|449332347|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
124918640|NCT03692676|449332348|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
124918641|NCT03692676|449332345|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
124918642|NCT03692676|449332346|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
124918643|NCT03692676|449332347|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
124918644|NCT03692676|449332348|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
124918645|NCT03692676|449332345|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
124918646|NCT03692676|449332346|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
124918647|NCT03692676|449332347|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
124918648|NCT03692676|449332348|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
124918649|NCT03692676|449332345|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
124918650|NCT03692676|449332346|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
124918651|NCT03692676|449332347|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
124545415|NCT03792633|447951202|FG000|Overall Study|Alternative Treatment|17|||
124545416|NCT03792633|447951203|FG001|Overall Study|Alternative Treatment|19|||
124695589|NCT03016403|448505904|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
124545417|NCT03792633|447951202|FG000|Overall Study|Death|2|||
124695590|NCT00225758|448505905|FG000|Overall Study|Adverse Event|4|||
124762051|NCT02738008|448753557|FG001|Overall Study|Adverse Event|1|||
124762052|NCT02738008|448753558|FG002|Overall Study|Adverse Event|2|||
124762053|NCT03550378|448753561|FG000|Overall Study|Death|0|||
124762054|NCT03550378|448753562|FG001|Overall Study|Death|1|||
124762055|NCT00468299|448753563|FG000|Overall Study|Withdrawal by Subject|0|||
124762056|NCT00468299|448753564|FG001|Overall Study|Withdrawal by Subject|1|||
124762057|NCT03546621|448753565|FG000|Overall Study|Withdrawal by Subject|0|||
124762058|NCT03546621|448753566|FG001|Overall Study|Withdrawal by Subject|1|||
124762059|NCT03546621|448753567|FG002|Overall Study|Withdrawal by Subject|2|||
124762060|NCT03546621|448753568|FG003|Overall Study|Withdrawal by Subject|1|||
124762061|NCT03546621|448753565|FG000|Overall Study|Lost to Follow-up|0|||
124762062|NCT03546621|448753566|FG001|Overall Study|Lost to Follow-up|1|||
124762063|NCT03546621|448753567|FG002|Overall Study|Lost to Follow-up|0|||
124918652|NCT03692676|449332348|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
124918653|NCT03692676|449332345|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
124918654|NCT03692676|449332346|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
124918655|NCT03692676|449332347|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
124918656|NCT03692676|449332348|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
124918657|NCT03692676|449332345|FG000|Overall Study|Other|0|||
124918658|NCT03692676|449332346|FG001|Overall Study|Other|805|||
124918659|NCT03692676|449332347|FG002|Overall Study|Other|758|||
124918660|NCT03692676|449332348|FG003|Overall Study|Other|277|||
124762064|NCT03546621|448753568|FG003|Overall Study|Lost to Follow-up|0|||
124918661|NCT03692676|449332345|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
124918662|NCT03692676|449332346|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
124918663|NCT03692676|449332347|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
124918664|NCT03692676|449332348|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
124918665|NCT01180634|449332350|FG000|Overall Study|Adverse Event|4|||
124918666|NCT01180634|449332351|FG001|Overall Study|Adverse Event|1|||
124918667|NCT01180634|449332350|FG000|Overall Study|Miscellaneous|2|||
124918668|NCT01180634|449332351|FG001|Overall Study|Miscellaneous|0|||
124918669|NCT01180634|449332350|FG000|Overall Study|Withdrawal by Subject|4|||
124918670|NCT01180634|449332351|FG001|Overall Study|Withdrawal by Subject|0|||
124918671|NCT03692611|449332352|FG000|Overall Study|Found to be ineligible postrandomization|3|||
124918672|NCT03692611|449332353|FG001|Overall Study|Found to be ineligible postrandomization|0|||
124918673|NCT04419168|449332354|FG000|Overall Study|Protocol Violation|1|||
124918674|NCT04419168|449332355|FG001|Overall Study|Protocol Violation|1|||
124918675|NCT04419168|449332354|FG000|Overall Study|Lost to Follow-up|7|||
124918676|NCT04419168|449332355|FG001|Overall Study|Lost to Follow-up|7|||
124918677|NCT04419168|449332354|FG000|Overall Study|Missed 6-month Visit|48|||
124918678|NCT04419168|449332355|FG001|Overall Study|Missed 6-month Visit|45|||
124918679|NCT04490915|449332356|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
124918680|NCT04490915|449332357|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
124918681|NCT04490915|449332356|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
124918682|NCT04490915|449332357|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
124918683|NCT04490915|449332356|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
124918684|NCT04490915|449332357|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
124918685|NCT04490915|449332356|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
124918686|NCT04490915|449332357|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
124918687|NCT04490915|449332356|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
124918688|NCT04490915|449332357|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
124918689|NCT04490915|449332356|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
124918690|NCT04490915|449332357|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
124918691|NCT04490915|449332356|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
124918692|NCT04490915|449332357|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
124918693|NCT05009251|449332358|FG000|Overall Study|Protocol Violation|100|||
124918694|NCT05009251|449332359|FG001|Overall Study|Protocol Violation|105|||
124762065|NCT03546621|448753565|FG000|Overall Study|Adverse Event|0|||
124762066|NCT03546621|448753566|FG001|Overall Study|Adverse Event|1|||
124762067|NCT03546621|448753567|FG002|Overall Study|Adverse Event|0|||
124918695|NCT05009251|449332360|FG002|Overall Study|Protocol Violation|119|||
124918696|NCT05009251|449332361|FG003|Overall Study|Protocol Violation|120|||
124918697|NCT05009251|449332362|FG004|Overall Study|Protocol Violation|119|||
124918698|NCT05009251|449332358|FG000|Overall Study|Death|25|||
124918699|NCT05009251|449332359|FG001|Overall Study|Death|22|||
124918700|NCT05009251|449332360|FG002|Overall Study|Death|24|||
124918701|NCT05009251|449332361|FG003|Overall Study|Death|19|||
124918702|NCT05009251|449332362|FG004|Overall Study|Death|15|||
124918703|NCT05374837|449332363|FG000|Overall Study|Lost to Follow-up|17|||
124918704|NCT05374837|449332364|FG001|Overall Study|Lost to Follow-up|18|||
124918705|NCT03786783|449332368|FG000|Overall Study|Death|1|||
124918706|NCT03786783|449332368|FG000|Overall Study|Physician Decision|6|||
124918707|NCT03786783|449332368|FG000|Overall Study|Withdrawal by Subject|2|||
124918708|NCT03786783|449332368|FG000|Overall Study|Disease Progression|7|||
124918709|NCT03786783|449332368|FG000|Overall Study|Patient/Parent Refusal|4|||
124918710|NCT02910583|449332369|FG000|Overall Study|Death|7|||
124918711|NCT02910583|449332370|FG001|Overall Study|Death|3|||
124918712|NCT02910583|449332369|FG000|Overall Study|Lost to Follow-up|1|||
124918713|NCT02910583|449332370|FG001|Overall Study|Lost to Follow-up|0|||
124918714|NCT02910583|449332369|FG000|Overall Study|Withdrawal by Subject|12|||
124918715|NCT02910583|449332370|FG001|Overall Study|Withdrawal by Subject|8|||
124918716|NCT02910583|449332369|FG000|Overall Study|Other, Not Specified|6|||
124918717|NCT02910583|449332370|FG001|Overall Study|Other, Not Specified|3|||
124918718|NCT01331005|449332372|FG000|Overall Study|Lost to Follow-up|2|||
124918719|NCT01331005|449332373|FG001|Overall Study|Lost to Follow-up|1|||
124918720|NCT01331005|449332372|FG000|Overall Study|Withdrawal by Subject|2|||
124918721|NCT01331005|449332373|FG001|Overall Study|Withdrawal by Subject|3|||
124918722|NCT02029443|449332376|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
124918723|NCT02029443|449332377|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
124918724|NCT02029443|449332378|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
124918725|NCT02029443|449332379|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
124918726|NCT02029443|449332380|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
124918727|NCT02029443|449332376|FG000|Overall Study|Death|13|||
124918728|NCT02029443|449332377|FG001|Overall Study|Death|2|||
124918729|NCT02029443|449332378|FG002|Overall Study|Death|2|||
124918730|NCT02029443|449332379|FG003|Overall Study|Death|11|||
124918731|NCT02029443|449332380|FG004|Overall Study|Death|2|||
124918732|NCT02029443|449332376|FG000|Overall Study|Lost to Follow-up|1|||
124918733|NCT02029443|449332377|FG001|Overall Study|Lost to Follow-up|0|||
124918734|NCT02029443|449332378|FG002|Overall Study|Lost to Follow-up|1|||
124918735|NCT02029443|449332379|FG003|Overall Study|Lost to Follow-up|1|||
124918736|NCT02029443|449332380|FG004|Overall Study|Lost to Follow-up|0|||
124918737|NCT02029443|449332376|FG000|Overall Study|Started other anti-cancer therapy|17|||
124918738|NCT02029443|449332377|FG001|Overall Study|Started other anti-cancer therapy|4|||
124918739|NCT02029443|449332378|FG002|Overall Study|Started other anti-cancer therapy|7|||
124918740|NCT02029443|449332379|FG003|Overall Study|Started other anti-cancer therapy|9|||
124918741|NCT02029443|449332380|FG004|Overall Study|Started other anti-cancer therapy|3|||
124918742|NCT02029443|449332376|FG000|Overall Study|Withdrawal by Subject|3|||
124918743|NCT02029443|449332377|FG001|Overall Study|Withdrawal by Subject|1|||
124918744|NCT02029443|449332378|FG002|Overall Study|Withdrawal by Subject|1|||
124918745|NCT02029443|449332379|FG003|Overall Study|Withdrawal by Subject|1|||
124918746|NCT02029443|449332380|FG004|Overall Study|Withdrawal by Subject|0|||
124918747|NCT02029443|449332376|FG000|Overall Study|Other|6|||
124918748|NCT02029443|449332377|FG001|Overall Study|Other|6|||
124918749|NCT02029443|449332378|FG002|Overall Study|Other|4|||
124918750|NCT02029443|449332379|FG003|Overall Study|Other|2|||
124918751|NCT02029443|449332380|FG004|Overall Study|Other|0|||
124918752|NCT03393975|449332383|FG000|Urgent Treatment Period|Physician Decision|0|||
124918753|NCT03393975|449332384|FG001|Urgent Treatment Period|Physician Decision|0|||
124918754|NCT03393975|449332385|FG002|Urgent Treatment Period|Physician Decision|0|||
124918755|NCT03393975|449332386|FG003|Urgent Treatment Period|Physician Decision|1|||
124918756|NCT03393975|449332383|FG000|Prophylaxis Period 1|Reason not Specified|0|||
124918757|NCT03393975|449332384|FG001|Prophylaxis Period 1|Reason not Specified|1|||
124918758|NCT03393975|449332385|FG002|Prophylaxis Period 1|Reason not Specified|0|||
124918759|NCT03393975|449332386|FG003|Prophylaxis Period 1|Reason not Specified|0|||
124918760|NCT03393975|449332383|FG000|Prophylaxis Period 2|Reason not Specified|0|||
124918761|NCT03393975|449332384|FG001|Prophylaxis Period 2|Reason not Specified|1|||
124918762|NCT03393975|449332385|FG002|Prophylaxis Period 2|Reason not Specified|0|||
124918763|NCT03393975|449332386|FG003|Prophylaxis Period 2|Reason not Specified|0|||
124918764|NCT04083235|449332387|FG000|Overall Study|Death|252|||
124918765|NCT04083235|449332388|FG001|Overall Study|Death|277|||
124918766|NCT04083235|449332387|FG000|Overall Study|Withdrawal by Subject|13|||
124918767|NCT04083235|449332388|FG001|Overall Study|Withdrawal by Subject|17|||
124918768|NCT04083235|449332387|FG000|Overall Study|Lost to Follow-up|1|||
124918769|NCT04083235|449332388|FG001|Overall Study|Lost to Follow-up|1|||
124918770|NCT04083235|449332387|FG000|Overall Study|Does not meet entry criteria|1|||
124918771|NCT04083235|449332388|FG001|Overall Study|Does not meet entry criteria|0|||
124918772|NCT04083235|449332387|FG000|Overall Study|Did not receive treatment|13|||
124918773|NCT04083235|449332388|FG001|Overall Study|Did not receive treatment|8|||
124918774|NCT04083235|449332387|FG000|Overall Study|Ongoing at the time of DCO|44|||
124918775|NCT04083235|449332388|FG001|Overall Study|Ongoing at the time of DCO|7|||
124918776|NCT02549339|449332391|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
124918777|NCT02549339|449332392|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
124918778|NCT02549339|449332391|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
124918779|NCT02549339|449332392|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
124918780|NCT02549339|449332391|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
124918781|NCT02549339|449332392|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
124918782|NCT02549339|449332391|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
124918783|NCT02549339|449332392|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
124918784|NCT02549339|449332391|FG000|12-month Follow-up|Lack of Efficacy|0|||
124918785|NCT02549339|449332392|FG001|12-month Follow-up|Lack of Efficacy|2|||
124918786|NCT02549339|449332391|FG000|12-month Follow-up|Withdrawal by Subject|8|||
124918787|NCT02549339|449332392|FG001|12-month Follow-up|Withdrawal by Subject|3|||
124918788|NCT02549339|449332391|FG000|12-month Follow-up|Lost to Follow-up|1|||
124918789|NCT02549339|449332392|FG001|12-month Follow-up|Lost to Follow-up|3|||
124918790|NCT02549339|449332391|FG000|12-month Follow-up|Other|0|||
124918791|NCT02549339|449332392|FG001|12-month Follow-up|Other|3|||
124918792|NCT03016169|449332393|FG000|Overall Study|Lost to Follow-up|4|||
124918793|NCT03016169|449332393|FG000|Overall Study|Death|54|||
124918794|NCT03016169|449332393|FG000|Overall Study|Device Explant|11|||
124918795|NCT03016169|449332393|FG000|Overall Study|Withdrawal by Subject|19|||
124918796|NCT03016169|449332393|FG000|Overall Study|Other Reasons|1|||
124918797|NCT05458011|449332395|FG000|DB Period (12 Weeks)|Adverse Event|2|||
124918798|NCT05458011|449332396|FG001|DB Period (12 Weeks)|Adverse Event|1|||
124918799|NCT05458011|449332397|FG002|DB Period (12 Weeks)|Adverse Event|1|||
124918800|NCT05458011|449332395|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
124918801|NCT05458011|449332396|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
124918802|NCT05458011|449332397|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
124918803|NCT05458011|449332395|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
124918804|NCT05458011|449332396|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
124918805|NCT05458011|449332397|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
124918806|NCT05458011|449332395|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
124918807|NCT05458011|449332396|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
124918808|NCT05458011|449332397|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
124918809|NCT05458011|449332395|FG000|OL Period (12 Weeks)|Adverse Event|1|||
124918810|NCT05458011|449332396|FG001|OL Period (12 Weeks)|Adverse Event|2|||
124918811|NCT05458011|449332397|FG002|OL Period (12 Weeks)|Adverse Event|1|||
124918812|NCT05458011|449332395|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
124918813|NCT05458011|449332396|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
124918814|NCT05458011|449332397|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
124918815|NCT02724878|449332414|FG000|Overall Study|Still on Active Therapy|15|||
124918816|NCT02724878|449332414|FG000|Overall Study|Disease Progression|31|||
124918817|NCT02724878|449332414|FG000|Overall Study|Toxicity|5|||
124918818|NCT02724878|449332414|FG000|Overall Study|Death|1|||
124918819|NCT02724878|449332414|FG000|Overall Study|Withdrawal by Subject|4|||
124918820|NCT02724878|449332414|FG000|Overall Study|Lost to Follow-up|2|||
124918821|NCT02724878|449332414|FG000|Overall Study|Protocol Violation|1|||
124918822|NCT02724878|449332414|FG000|Overall Study|Ineligible for Study Drug|5|||
124918823|NCT02724878|449332414|FG000|Overall Study|not started|1|||
124918824|NCT04838262|449332415|FG000|Overall Study|Withdrawal by Subject|9|||
124918825|NCT04838262|449332416|FG001|Overall Study|Withdrawal by Subject|4|||
124918826|NCT05082909|449332419|FG000|Overall Study|Protocol Violation|0|||
124918827|NCT05082909|449332420|FG001|Overall Study|Protocol Violation|0|||
124918828|NCT05082909|449332421|FG002|Overall Study|Protocol Violation|1|||
124918829|NCT05082909|449332422|FG003|Overall Study|Protocol Violation|0|||
124918830|NCT05082909|449332423|FG004|Overall Study|Protocol Violation|0|||
124918831|NCT05082909|449332424|FG005|Overall Study|Protocol Violation|0|||
124918832|NCT03175029|449332427|FG000|Overall Study|Withdrawal by Subject|2|||
124918833|NCT03175029|449332428|FG001|Overall Study|Withdrawal by Subject|1|||
124918834|NCT03175029|449332427|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
124918835|NCT03175029|449332428|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
124918836|NCT05227209|449332433|FG000|Overall Study|Adverse Event|11|||
124918837|NCT05227209|449332433|FG000|Overall Study|Lost to Follow-up|1|||
124918838|NCT05227209|449332433|FG000|Overall Study|Withdrawal by Subject|7|||
124918839|NCT05227209|449332433|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
124918840|NCT04950660|449332434|FG000|Overall Study|Protocol Violation|4|||
124918841|NCT04950660|449332435|FG001|Overall Study|Protocol Violation|2|||
124918842|NCT04950660|449332434|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
124918843|NCT04950660|449332435|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
124918844|NCT04950660|449332434|FG000|Overall Study|Withdrawal by Subject|0|||
124918845|NCT04950660|449332435|FG001|Overall Study|Withdrawal by Subject|1|||
124918846|NCT04950660|449332434|FG000|Overall Study|Hypotension|1|||
124918847|NCT04950660|449332435|FG001|Overall Study|Hypotension|0|||
124918848|NCT05524233|449332438|FG000|Overall Study|Lost to Follow-up|2|||
124918849|NCT05524233|449332438|FG000|Overall Study|Adverse Event|2|||
124918850|NCT05524233|449332438|FG000|Overall Study|Withdrawal by Subject|1|||
124918851|NCT02530671|449332441|FG000|Overall Study|Lost to Follow-up|2|||
124918852|NCT02530671|449332442|FG001|Overall Study|Lost to Follow-up|0|||
124918853|NCT02530671|449332441|FG000|Overall Study|Withdrawal by Subject|1|||
124918854|NCT02530671|449332442|FG001|Overall Study|Withdrawal by Subject|0|||
124918855|NCT02736409|449332443|FG000|Overall Study|Withdrawal by Subject|4|||
124918856|NCT02736409|449332444|FG001|Overall Study|Withdrawal by Subject|2|||
124918857|NCT02736409|449332445|FG002|Overall Study|Withdrawal by Subject|17|||
124918858|NCT02736409|449332446|FG003|Overall Study|Withdrawal by Subject|3|||
124918859|NCT02736409|449332443|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124918860|NCT02736409|449332444|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124918861|NCT02736409|449332445|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124918862|NCT02736409|449332446|FG003|Overall Study|Non-Compliance with Study Drug|1|||
124918863|NCT02736409|449332443|FG000|Overall Study|Adverse Event|0|||
124918864|NCT02736409|449332444|FG001|Overall Study|Adverse Event|1|||
124918865|NCT02736409|449332445|FG002|Overall Study|Adverse Event|5|||
124918866|NCT02736409|449332446|FG003|Overall Study|Adverse Event|4|||
124918867|NCT02736409|449332443|FG000|Overall Study|Other|0|||
124918868|NCT02736409|449332444|FG001|Overall Study|Other|0|||
124918869|NCT02736409|449332445|FG002|Overall Study|Other|1|||
124918870|NCT02736409|449332446|FG003|Overall Study|Other|1|||
124918871|NCT02736409|449332443|FG000|Overall Study|Pregnancy|0|||
124918872|NCT02736409|449332444|FG001|Overall Study|Pregnancy|0|||
124918873|NCT02736409|449332445|FG002|Overall Study|Pregnancy|1|||
124918874|NCT02736409|449332446|FG003|Overall Study|Pregnancy|0|||
124918875|NCT02736409|449332443|FG000|Overall Study|Lost to Follow-up|0|||
124918876|NCT02736409|449332444|FG001|Overall Study|Lost to Follow-up|0|||
124918877|NCT02736409|449332445|FG002|Overall Study|Lost to Follow-up|2|||
124918878|NCT02736409|449332446|FG003|Overall Study|Lost to Follow-up|1|||
124918879|NCT02736409|449332443|FG000|Overall Study|Physician Decision|0|||
124918880|NCT02736409|449332444|FG001|Overall Study|Physician Decision|0|||
124918881|NCT02736409|449332445|FG002|Overall Study|Physician Decision|0|||
124918882|NCT02736409|449332446|FG003|Overall Study|Physician Decision|2|||
124918883|NCT04390048|449332447|FG000|Overall Study|Withdrawal by Subject|1|||
124918884|NCT04390048|449332448|FG001|Overall Study|Withdrawal by Subject|3|||
124918885|NCT03126019|449332450|FG000|Overall Study|Death|5|||
124918886|NCT03126019|449332451|FG001|Overall Study|Death|27|||
124918887|NCT03126019|449332450|FG000|Overall Study|Lost to Follow-up|2|||
124918888|NCT03126019|449332451|FG001|Overall Study|Lost to Follow-up|4|||
124918889|NCT03126019|449332450|FG000|Overall Study|Withdrawal by Subject|1|||
124918890|NCT03126019|449332451|FG001|Overall Study|Withdrawal by Subject|9|||
124918891|NCT03126019|449332450|FG000|Overall Study|Physician Decision|1|||
124918892|NCT03126019|449332451|FG001|Overall Study|Physician Decision|0|||
124918893|NCT03126019|449332450|FG000|Overall Study|Transitioned to Rollover Study|0|||
124918894|NCT03126019|449332451|FG001|Overall Study|Transitioned to Rollover Study|11|||
124918895|NCT03126019|449332450|FG000|Overall Study|Did Not Return to Site for Care|0|||
124918896|NCT03126019|449332451|FG001|Overall Study|Did Not Return to Site for Care|1|||
124918897|NCT03126019|449332450|FG000|Overall Study|Site Closed|0|||
124918898|NCT03126019|449332451|FG001|Overall Study|Site Closed|1|||
124918899|NCT01809691|449332457|FG000|Overall Study|Currently on Treatment|192|||
124918900|NCT01809691|449332458|FG001|Overall Study|Currently on Treatment|100|||
124918901|NCT01809691|449332457|FG000|Overall Study|No Protocol Treatment|10|||
124918902|NCT01809691|449332458|FG001|Overall Study|No Protocol Treatment|11|||
124918903|NCT01809691|449332457|FG000|Overall Study|Adverse Event|80|||
124918904|NCT01809691|449332458|FG001|Overall Study|Adverse Event|21|||
124451755|NCT01854645|447615168|FG004|Overall Study|Withdrawal by Subject|24|||
124918905|NCT01809691|449332457|FG000|Overall Study|Disease Progression|226|||
124918906|NCT01809691|449332458|FG001|Overall Study|Disease Progression|372|||
124918907|NCT01809691|449332457|FG000|Overall Study|Death|26|||
124918908|NCT01809691|449332458|FG001|Overall Study|Death|13|||
124918909|NCT01809691|449332457|FG000|Overall Study|Participant Refusal|70|||
124918910|NCT01809691|449332458|FG001|Overall Study|Participant Refusal|72|||
124918911|NCT01809691|449332457|FG000|Overall Study|Other, Not Specified|34|||
124918912|NCT01809691|449332458|FG001|Overall Study|Other, Not Specified|52|||
124918913|NCT04533347|449332462|FG000|Overall Study|Adverse Event|1|||
124918914|NCT04533347|449332463|FG001|Overall Study|Adverse Event|2|||
124918915|NCT04533347|449332462|FG000|Overall Study|Lost to Follow-up|2|||
124918916|NCT04533347|449332463|FG001|Overall Study|Lost to Follow-up|0|||
124918917|NCT04533347|449332462|FG000|Overall Study|Withdrawal by Subject|1|||
124918918|NCT04533347|449332463|FG001|Overall Study|Withdrawal by Subject|0|||
124918919|NCT04831216|449332467|FG000|Overall Study|Lost to Follow-up|32|||
124918920|NCT05268302|449332472|FG000|Overall Study|Death|0|||
124918921|NCT05268302|449332473|FG001|Overall Study|Death|1|||
124918922|NCT04285567|449332474|FG000|Overall Study|Death|3|||
124918923|NCT04285567|449332475|FG001|Overall Study|Death|3|||
124918924|NCT04285567|449332474|FG000|Overall Study|Lost to Follow-up|1|||
124918925|NCT04285567|449332475|FG001|Overall Study|Lost to Follow-up|1|||
124918926|NCT04285567|449332474|FG000|Overall Study|Reason Not Specified|1|||
124918927|NCT04285567|449332475|FG001|Overall Study|Reason Not Specified|1|||
124918928|NCT04285567|449332474|FG000|Overall Study|Physician Decision|2|||
124918929|NCT04285567|449332475|FG001|Overall Study|Physician Decision|1|||
124918930|NCT04285567|449332474|FG000|Overall Study|Withdrawal by Subject|2|||
124918931|NCT04285567|449332475|FG001|Overall Study|Withdrawal by Subject|6|||
124918932|NCT04285567|449332474|FG000|Overall Study|Adverse Event|1|||
124918933|NCT04285567|449332475|FG001|Overall Study|Adverse Event|0|||
124918934|NCT04285567|449332474|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
124918935|NCT04285567|449332475|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
124918936|NCT05319860|449332476|FG000|Overall Study|Death|1|||
124918937|NCT05319860|449332477|FG001|Overall Study|Death|1|||
124918938|NCT05319860|449332476|FG000|Overall Study|Lost to Follow-up|3|||
124918939|NCT05319860|449332477|FG001|Overall Study|Lost to Follow-up|1|||
124918940|NCT05319860|449332476|FG000|Overall Study|Withdrawal by Subject|1|||
124918941|NCT05319860|449332477|FG001|Overall Study|Withdrawal by Subject|7|||
124918942|NCT04263311|449334173|FG000|Overall Study|Lost to Follow-up|1|||
124918943|NCT04263311|449334174|FG001|Overall Study|Lost to Follow-up|2|||
124918944|NCT04263311|449334175|FG002|Overall Study|Lost to Follow-up|0|||
124918945|NCT04263311|449334173|FG000|Overall Study|Health Issues|1|||
124918946|NCT04263311|449334174|FG001|Overall Study|Health Issues|0|||
124918947|NCT04263311|449334175|FG002|Overall Study|Health Issues|0|||
124918948|NCT04263311|449334173|FG000|Overall Study|Left the country|1|||
124918949|NCT04263311|449334174|FG001|Overall Study|Left the country|0|||
124918950|NCT04263311|449334175|FG002|Overall Study|Left the country|0|||
124918951|NCT04263311|449334173|FG000|Overall Study|Unable to maintain time commitment|1|||
124918952|NCT04263311|449334174|FG001|Overall Study|Unable to maintain time commitment|0|||
124918953|NCT04263311|449334175|FG002|Overall Study|Unable to maintain time commitment|0|||
124918954|NCT04263311|449334173|FG000|Overall Study|No longer interested|1|||
124918955|NCT04263311|449334174|FG001|Overall Study|No longer interested|0|||
124918956|NCT04263311|449334175|FG002|Overall Study|No longer interested|0|||
124918957|NCT04263311|449334173|FG000|Overall Study|Ineligible post consent|0|||
124918958|NCT04263311|449334174|FG001|Overall Study|Ineligible post consent|0|||
124918959|NCT04263311|449334175|FG002|Overall Study|Ineligible post consent|5|||
124918960|NCT02954341|449334176|FG000|Overall Study|Attempted Implant unsuccessful|5|||
124918961|NCT02954341|449334176|FG000|Overall Study|Death|90|||
124918962|NCT02954341|449334176|FG000|Overall Study|Withdrawal by Subject|4|||
124918963|NCT02954341|449334176|FG000|Overall Study|Physician Decision|13|||
124918964|NCT02954341|449334176|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
124918965|NCT02954341|449334176|FG000|Overall Study|Not implanted due to physician's decision|1|||
124918966|NCT02954341|449334176|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
124918967|NCT06074523|449334180|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
124918968|NCT06074523|449334180|FG000|Overall Study|Withdrawal by Subject|1|||
124918969|NCT01426425|449334181|FG000|Overall Study|Exited prior to EP study|22|||
124918970|NCT01426425|449334181|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
124918971|NCT01426425|449334181|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
124918972|NCT00512070|449334189|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
124918973|NCT00512070|449334190|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
124918974|NCT00512070|449334191|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
124918975|NCT00512070|449334189|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
124918976|NCT00512070|449334190|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
124918977|NCT00512070|449334191|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
124918978|NCT02506959|449334192|FG000|Overall Study|Physician Decision|2|||
124918979|NCT02506959|449334193|FG001|Overall Study|Physician Decision|1|||
124918980|NCT03932682|449334195|FG000|Overall Study|Death|1|||
124918981|NCT03932682|449334196|FG001|Overall Study|Death|2|||
124918982|NCT03932682|449334195|FG000|Overall Study|Withdrawal by Subject|37|||
124918983|NCT03932682|449334196|FG001|Overall Study|Withdrawal by Subject|45|||
124918984|NCT03932682|449334195|FG000|Overall Study|Lost to Follow-up|19|||
124918985|NCT03932682|449334196|FG001|Overall Study|Lost to Follow-up|25|||
124918986|NCT03932682|449334195|FG000|Overall Study|Protocol Violation|0|||
124918987|NCT03932682|449334196|FG001|Overall Study|Protocol Violation|2|||
124918988|NCT03932682|449334195|FG000|Overall Study|Other|9|||
124918989|NCT03932682|449334196|FG001|Overall Study|Other|23|||
124918990|NCT04806594|449334199|FG000|Overall Study|Withdrawal by Subject|2|||
124918991|NCT04806594|449334199|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
124918992|NCT02543281|449334200|FG000|Overall Study|Lost to Follow-up|0|||
124918993|NCT02543281|449334201|FG001|Overall Study|Lost to Follow-up|0|||
124918994|NCT02543281|449334202|FG002|Overall Study|Lost to Follow-up|1|||
124918995|NCT03143153|449334203|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
124918996|NCT03143153|449334204|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
124918997|NCT03143153|449334205|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
124918998|NCT03143153|449334203|FG000|Pre-Treatment|Participant withdrew consent|0|||
124918999|NCT03143153|449334204|FG001|Pre-Treatment|Participant withdrew consent|1|||
124919000|NCT03143153|449334205|FG002|Pre-Treatment|Participant withdrew consent|12|||
124919001|NCT03143153|449334203|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
124919002|NCT03143153|449334204|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
124919003|NCT03143153|449334205|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
124919004|NCT03143153|449334203|FG000|Pre-Treatment|Other Reasons|1|||
124919005|NCT03143153|449334204|FG001|Pre-Treatment|Other Reasons|2|||
124919006|NCT03143153|449334205|FG002|Pre-Treatment|Other Reasons|1|||
124919007|NCT03143153|449334203|FG000|Pre-Treatment|Disease Progression|1|||
124919008|NCT03143153|449334204|FG001|Pre-Treatment|Disease Progression|1|||
124919009|NCT03143153|449334205|FG002|Pre-Treatment|Disease Progression|2|||
124919010|NCT03143153|449334203|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
124919011|NCT03143153|449334204|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
124919012|NCT03143153|449334205|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
124919013|NCT03143153|449334203|FG000|Treatment|Disease progression|174|||
124919014|NCT03143153|449334204|FG001|Treatment|Disease progression|184|||
124919015|NCT03143153|449334205|FG002|Treatment|Disease progression|193|||
124919016|NCT03143153|449334203|FG000|Treatment|Study drug toxicity|59|||
124919017|NCT03143153|449334204|FG001|Treatment|Study drug toxicity|33|||
124919018|NCT03143153|449334205|FG002|Treatment|Study drug toxicity|40|||
124919019|NCT03143153|449334203|FG000|Treatment|Death|5|||
124919020|NCT03143153|449334204|FG001|Treatment|Death|3|||
124919021|NCT03143153|449334205|FG002|Treatment|Death|4|||
124919022|NCT03143153|449334203|FG000|Treatment|Adverse event unrelated to study drug|19|||
124919023|NCT03143153|449334204|FG001|Treatment|Adverse event unrelated to study drug|28|||
124919024|NCT03143153|449334205|FG002|Treatment|Adverse event unrelated to study drug|12|||
124919025|NCT03143153|449334203|FG000|Treatment|Participant request to discontinue study treatment|13|||
124919026|NCT03143153|449334204|FG001|Treatment|Participant request to discontinue study treatment|15|||
124919027|NCT03143153|449334205|FG002|Treatment|Participant request to discontinue study treatment|20|||
124919028|NCT03143153|449334203|FG000|Treatment|Participant withdrew consent|3|||
124919029|NCT03143153|449334204|FG001|Treatment|Participant withdrew consent|4|||
124919030|NCT03143153|449334205|FG002|Treatment|Participant withdrew consent|12|||
124919031|NCT03143153|449334203|FG000|Treatment|Pregnancy|1|||
124919032|NCT03143153|449334204|FG001|Treatment|Pregnancy|0|||
124919033|NCT03143153|449334205|FG002|Treatment|Pregnancy|0|||
124919034|NCT03143153|449334203|FG000|Treatment|Maximum clinical benefit|1|||
124919035|NCT03143153|449334204|FG001|Treatment|Maximum clinical benefit|3|||
124919036|NCT03143153|449334205|FG002|Treatment|Maximum clinical benefit|4|||
124919037|NCT03143153|449334203|FG000|Treatment|Completed treatment as per Protocol|13|||
124919038|NCT03143153|449334204|FG001|Treatment|Completed treatment as per Protocol|8|||
124919039|NCT03143153|449334205|FG002|Treatment|Completed treatment as per Protocol|0|||
124919040|NCT03143153|449334203|FG000|Treatment|Other reasons|12|||
124919041|NCT03143153|449334204|FG001|Treatment|Other reasons|7|||
124919042|NCT03143153|449334205|FG002|Treatment|Other reasons|15|||
124919043|NCT03143153|449334203|FG000|Treatment|Not reported|1|||
124919044|NCT03143153|449334204|FG001|Treatment|Not reported|0|||
124919045|NCT03143153|449334205|FG002|Treatment|Not reported|0|||
124919046|NCT02312557|449334206|FG000|Overall Study|Survival follow-up|4|||
124919047|NCT04237298|449334207|FG000|Overall Study|Lost to Follow-up|4|||
124919048|NCT04237298|449334208|FG001|Overall Study|Lost to Follow-up|5|||
124919049|NCT01415154|449334214|FG000|Overall Study|Lack of Efficacy|4|||
124919050|NCT01415154|449334215|FG001|Overall Study|Lack of Efficacy|5|||
124762068|NCT03546621|448753568|FG003|Overall Study|Adverse Event|1|||
124919051|NCT01415154|449334214|FG000|Overall Study|Withdrawal by Subject|7|||
124919052|NCT01415154|449334215|FG001|Overall Study|Withdrawal by Subject|8|||
124919053|NCT01415154|449334214|FG000|Overall Study|Lost to Follow-up|1|||
124919054|NCT01415154|449334215|FG001|Overall Study|Lost to Follow-up|4|||
124919055|NCT01415154|449334214|FG000|Overall Study|Protocol Violation|0|||
124919056|NCT01415154|449334215|FG001|Overall Study|Protocol Violation|1|||
124919057|NCT01415154|449334214|FG000|Overall Study|Satisfactory Response|0|||
124919058|NCT01415154|449334215|FG001|Overall Study|Satisfactory Response|1|||
124919059|NCT01415154|449334214|FG000|Overall Study|Adverse Event|1|||
124919060|NCT01415154|449334215|FG001|Overall Study|Adverse Event|1|||
124919061|NCT00170573|449334220|FG000|Overall Study|Violation of inclusion criteria|13|||
124919062|NCT04556656|449334222|FG000|Overall Study|Withdrawal by Subject|14|||
124919063|NCT04556656|449334223|FG001|Overall Study|Withdrawal by Subject|12|||
124919064|NCT04556656|449334222|FG000|Overall Study|Physician Decision|1|||
124919065|NCT04556656|449334223|FG001|Overall Study|Physician Decision|0|||
124919066|NCT04556656|449334222|FG000|Overall Study|Adverse Event|4|||
124919067|NCT04556656|449334223|FG001|Overall Study|Adverse Event|7|||
124919068|NCT04556656|449334222|FG000|Overall Study|Death|4|||
124919069|NCT04556656|449334223|FG001|Overall Study|Death|0|||
124919070|NCT04556656|449334222|FG000|Overall Study|Lost to Follow-up|3|||
124919071|NCT04556656|449334223|FG001|Overall Study|Lost to Follow-up|2|||
124919072|NCT04556656|449334222|FG000|Overall Study|Not further specified|2|||
124919073|NCT04556656|449334223|FG001|Overall Study|Not further specified|1|||
124919074|NCT05323084|449334245|FG000|Period 2 - Washout|Lost to Follow-up|0|||
124919075|NCT05323084|449334246|FG001|Period 2 - Washout|Lost to Follow-up|1|||
124919076|NCT04382404|449334247|FG000|Overall Study|Adverse Event|1|||
124919077|NCT04382404|449334247|FG000|Overall Study|Lost to Follow-up|2|||
124919078|NCT02960893|449334249|FG000|Randomization Phase (8-week)|Adverse Event|5|||
124919079|NCT02960893|449334250|FG001|Randomization Phase (8-week)|Adverse Event|0|||
124919080|NCT02960893|449334249|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
124919081|NCT02960893|449334250|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
124919082|NCT02960893|449334249|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
124919083|NCT02960893|449334250|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
124919084|NCT02960893|449334249|FG000|Extension Phase (48-week)|Adverse Event|2|||
124919085|NCT02960893|449334250|FG001|Extension Phase (48-week)|Adverse Event|3|||
124919086|NCT02960893|449334249|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
124919087|NCT02960893|449334250|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
124919088|NCT02960893|449334249|FG000|Extension Phase (48-week)|Other Reason|2|||
124919089|NCT02960893|449334250|FG001|Extension Phase (48-week)|Other Reason|1|||
124919090|NCT02960893|449334249|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
124919091|NCT02960893|449334250|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
124919092|NCT02960893|449334249|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
124919093|NCT02960893|449334250|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
124919094|NCT05687916|449334252|FG000|Overall Study|Adverse Event|1|||
124919095|NCT05687916|449334253|FG001|Overall Study|Adverse Event|2|||
124919096|NCT05687916|449334254|FG002|Overall Study|Adverse Event|0|||
124919097|NCT05687916|449334252|FG000|Overall Study|Withdrawal by Subject|1|||
124919098|NCT05687916|449334253|FG001|Overall Study|Withdrawal by Subject|0|||
124919099|NCT05687916|449334254|FG002|Overall Study|Withdrawal by Subject|1|||
124919100|NCT05687916|449334252|FG000|Overall Study|Protocol Violation|0|||
124919101|NCT05687916|449334253|FG001|Overall Study|Protocol Violation|2|||
124919102|NCT05687916|449334254|FG002|Overall Study|Protocol Violation|1|||
124919103|NCT05687916|449334252|FG000|Overall Study|Reason not Specified|1|||
124919104|NCT05687916|449334253|FG001|Overall Study|Reason not Specified|0|||
124919105|NCT05687916|449334254|FG002|Overall Study|Reason not Specified|0|||
124919106|NCT03792555|449334264|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
124919107|NCT03792555|449334265|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
124919108|NCT03792555|449334266|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
124919109|NCT03792555|449334264|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
124919110|NCT03792555|449334265|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
124919111|NCT03792555|449334266|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
124919112|NCT03792555|449334264|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
124919113|NCT03792555|449334265|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
124919114|NCT03792555|449334266|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
124919115|NCT04485039|449334267|FG000|TPOXX Only|Adverse Event|2|||
124919116|NCT04485039|449334267|FG000|TPOXX Only|Physician Decision|1|||
124919117|NCT04485039|449334267|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
124919118|NCT04485039|449334267|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
124919119|NCT04005716|449334268|FG000|Overall Study|Death|175|||
124919120|NCT04005716|449334269|FG001|Overall Study|Death|196|||
124919121|NCT04005716|449334268|FG000|Overall Study|Withdrawal by Subject|1|||
124919122|NCT04005716|449334269|FG001|Overall Study|Withdrawal by Subject|6|||
124919123|NCT04005716|449334268|FG000|Overall Study|Lost to Follow-up|2|||
124919124|NCT04005716|449334269|FG001|Overall Study|Lost to Follow-up|2|||
124919125|NCT04021602|449334272|FG000|Overall Study|Lost to Follow-up|3|||
124919126|NCT04021602|449334273|FG001|Overall Study|Lost to Follow-up|3|||
124919127|NCT04021602|449334274|FG002|Overall Study|Lost to Follow-up|1|||
124919128|NCT04021602|449334272|FG000|Overall Study|Adverse Event|1|||
124919129|NCT04021602|449334273|FG001|Overall Study|Adverse Event|0|||
124919130|NCT04021602|449334274|FG002|Overall Study|Adverse Event|1|||
124919131|NCT02783300|449334275|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919132|NCT02783300|449334276|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919133|NCT02783300|449334277|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919134|NCT02783300|449334278|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919135|NCT02783300|449334279|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919136|NCT02783300|449334280|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124762069|NCT03546621|448753565|FG000|Overall Study|Progressive disease|0|||
124762070|NCT03546621|448753566|FG001|Overall Study|Progressive disease|0|||
124762071|NCT03546621|448753567|FG002|Overall Study|Progressive disease|0|||
124762072|NCT03546621|448753568|FG003|Overall Study|Progressive disease|1|||
124762073|NCT00377520|448753573|FG000|Overall Study|Ineligible (Prior radiation)|1|||
124762074|NCT00462306|448753580|FG000|Overall Study|insufficient data|0|||
124762075|NCT00462306|448753581|FG001|Overall Study|insufficient data|13|||
124762076|NCT00154297|448753583|FG000|Overall Study|Death|5|||
124762077|NCT00154297|448753584|FG001|Overall Study|Death|2|||
124762078|NCT00154297|448753583|FG000|Overall Study|Withdrawal by Subject|0|||
124762079|NCT00154297|448753584|FG001|Overall Study|Withdrawal by Subject|5|||
124762080|NCT00154297|448753583|FG000|Overall Study|Lost to Follow-up|3|||
124762081|NCT00154297|448753584|FG001|Overall Study|Lost to Follow-up|0|||
124762082|NCT05051579|448753586|FG000|Overall Study|Withdrawal by Subject|3|||
124762083|NCT05051579|448753587|FG001|Overall Study|Withdrawal by Subject|5|||
124762084|NCT05051579|448753588|FG002|Overall Study|Withdrawal by Subject|2|||
124762085|NCT05051579|448753589|FG003|Overall Study|Withdrawal by Subject|1|||
124762086|NCT05051579|448753590|FG004|Overall Study|Withdrawal by Subject|4|||
124762087|NCT05051579|448753591|FG005|Overall Study|Withdrawal by Subject|0|||
124762088|NCT05051579|448753592|FG006|Overall Study|Withdrawal by Subject|4|||
124762089|NCT05051579|448753586|FG000|Overall Study|Lost to Follow-up|1|||
124762090|NCT05051579|448753587|FG001|Overall Study|Lost to Follow-up|0|||
124762091|NCT05051579|448753588|FG002|Overall Study|Lost to Follow-up|0|||
124762092|NCT05051579|448753589|FG003|Overall Study|Lost to Follow-up|0|||
124762093|NCT05051579|448753590|FG004|Overall Study|Lost to Follow-up|1|||
124762094|NCT05051579|448753591|FG005|Overall Study|Lost to Follow-up|0|||
124762095|NCT05051579|448753592|FG006|Overall Study|Lost to Follow-up|1|||
124762096|NCT05051579|448753586|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
124762097|NCT05051579|448753587|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
124762098|NCT05051579|448753588|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
124762099|NCT05051579|448753589|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
124762100|NCT05051579|448753590|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
124762101|NCT05051579|448753591|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
124762102|NCT05051579|448753592|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
124762103|NCT05051579|448753586|FG000|Overall Study|Adverse Event|2|||
124762104|NCT05051579|448753587|FG001|Overall Study|Adverse Event|1|||
124762105|NCT05051579|448753588|FG002|Overall Study|Adverse Event|0|||
124762106|NCT05051579|448753589|FG003|Overall Study|Adverse Event|4|||
124762107|NCT05051579|448753590|FG004|Overall Study|Adverse Event|1|||
124762108|NCT05051579|448753591|FG005|Overall Study|Adverse Event|2|||
124762109|NCT05051579|448753592|FG006|Overall Study|Adverse Event|0|||
124762110|NCT05051579|448753586|FG000|Overall Study|Inadvertent Enrollment|0|||
124762111|NCT05051579|448753587|FG001|Overall Study|Inadvertent Enrollment|0|||
124762112|NCT05051579|448753588|FG002|Overall Study|Inadvertent Enrollment|0|||
124762113|NCT05051579|448753589|FG003|Overall Study|Inadvertent Enrollment|0|||
124762114|NCT05051579|448753590|FG004|Overall Study|Inadvertent Enrollment|0|||
124762115|NCT05051579|448753591|FG005|Overall Study|Inadvertent Enrollment|0|||
124919137|NCT02783300|449334281|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
124919138|NCT02783300|449334282|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919139|NCT02783300|449334283|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919140|NCT02783300|449334284|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919141|NCT02783300|449334285|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919142|NCT02783300|449334286|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919143|NCT02783300|449334287|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919144|NCT02783300|449334288|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919145|NCT02783300|449334289|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919146|NCT02783300|449334290|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919147|NCT02783300|449334291|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919148|NCT02783300|449334292|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919149|NCT02783300|449334293|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124762116|NCT05051579|448753592|FG006|Overall Study|Inadvertent Enrollment|1|||
124762117|NCT05051579|448753586|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
124762118|NCT05051579|448753587|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
124762119|NCT05051579|448753588|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
124919150|NCT02783300|449334294|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124762120|NCT05051579|448753589|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
124762121|NCT05051579|448753590|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
124762122|NCT05051579|448753591|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
124919151|NCT02783300|449334295|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919152|NCT02783300|449334296|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919153|NCT02783300|449334297|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919154|NCT02783300|449334298|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919155|NCT02783300|449334299|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919156|NCT02783300|449334300|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919157|NCT02783300|449334301|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
124919158|NCT02783300|449334275|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919159|NCT02783300|449334276|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919160|NCT02783300|449334277|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919161|NCT02783300|449334278|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
124919162|NCT02783300|449334279|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919163|NCT02783300|449334280|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919164|NCT02783300|449334281|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919165|NCT02783300|449334282|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919166|NCT02783300|449334283|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919167|NCT02783300|449334284|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919168|NCT02783300|449334285|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919169|NCT02783300|449334286|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919170|NCT02783300|449334287|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919171|NCT02783300|449334288|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919172|NCT02783300|449334289|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919173|NCT02783300|449334290|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919174|NCT02783300|449334291|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919175|NCT02783300|449334292|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919176|NCT02783300|449334293|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919177|NCT02783300|449334294|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919178|NCT02783300|449334295|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919179|NCT02783300|449334296|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919180|NCT02783300|449334297|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919181|NCT02783300|449334298|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919182|NCT02783300|449334299|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919183|NCT02783300|449334300|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919184|NCT02783300|449334301|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
124919185|NCT02783300|449334275|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
124919186|NCT02783300|449334276|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
124919187|NCT02783300|449334277|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
124919188|NCT02783300|449334278|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
124919189|NCT02783300|449334279|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
124919190|NCT02783300|449334280|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
124919191|NCT02783300|449334281|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
124919192|NCT02783300|449334282|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
124919193|NCT02783300|449334283|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
124919194|NCT02783300|449334284|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
124919195|NCT02783300|449334285|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
124919196|NCT02783300|449334286|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
124919197|NCT02783300|449334287|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
124919198|NCT02783300|449334288|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
124919199|NCT02783300|449334289|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
124919200|NCT02783300|449334290|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
124919201|NCT02783300|449334291|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
124919202|NCT02783300|449334292|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
124919203|NCT02783300|449334293|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
124919204|NCT02783300|449334294|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
124919205|NCT02783300|449334295|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
124919206|NCT02783300|449334296|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
124919207|NCT02783300|449334297|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
124919208|NCT02783300|449334298|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
124919209|NCT02783300|449334299|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
124919210|NCT02783300|449334300|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
124919211|NCT02783300|449334301|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
124919212|NCT02783300|449334275|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919213|NCT02783300|449334276|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919214|NCT02783300|449334277|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919215|NCT02783300|449334278|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919216|NCT02783300|449334279|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919217|NCT02783300|449334280|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919218|NCT02783300|449334281|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
124919219|NCT02783300|449334282|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919220|NCT02783300|449334283|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919221|NCT02783300|449334284|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919222|NCT02783300|449334285|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919223|NCT02783300|449334286|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919224|NCT02783300|449334287|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
124919225|NCT02783300|449334288|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919226|NCT02783300|449334289|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919227|NCT02783300|449334290|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919228|NCT02783300|449334291|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919229|NCT02783300|449334292|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919230|NCT02783300|449334293|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919231|NCT02783300|449334294|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919232|NCT02783300|449334295|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919233|NCT02783300|449334296|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919234|NCT02783300|449334297|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919235|NCT02783300|449334298|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919236|NCT02783300|449334299|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919237|NCT02783300|449334300|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919238|NCT02783300|449334301|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
124919239|NCT02783300|449334275|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919240|NCT02783300|449334276|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919241|NCT02783300|449334277|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919242|NCT02783300|449334278|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919243|NCT02783300|449334279|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
124919244|NCT02783300|449334280|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919245|NCT02783300|449334281|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
124919246|NCT02783300|449334282|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919247|NCT02783300|449334283|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919248|NCT02783300|449334284|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
124919249|NCT02783300|449334285|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919250|NCT02783300|449334286|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919251|NCT02783300|449334287|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
124919252|NCT02783300|449334288|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919253|NCT02783300|449334289|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919254|NCT02783300|449334290|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919255|NCT02783300|449334291|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919256|NCT02783300|449334292|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919257|NCT02783300|449334293|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919258|NCT02783300|449334294|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919259|NCT02783300|449334295|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919260|NCT02783300|449334296|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919261|NCT02783300|449334297|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919262|NCT02783300|449334298|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919263|NCT02783300|449334299|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919264|NCT02783300|449334300|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919265|NCT02783300|449334301|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
124919266|NCT02783300|449334275|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919267|NCT02783300|449334276|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919268|NCT02783300|449334277|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919269|NCT02783300|449334278|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919270|NCT02783300|449334279|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919271|NCT02783300|449334280|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919272|NCT02783300|449334281|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919273|NCT02783300|449334282|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919274|NCT02783300|449334283|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919275|NCT02783300|449334284|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919276|NCT02783300|449334285|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919277|NCT02783300|449334286|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919278|NCT02783300|449334287|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919279|NCT02783300|449334288|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919280|NCT02783300|449334289|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919281|NCT02783300|449334290|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
124919282|NCT02783300|449334291|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919283|NCT02783300|449334292|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
124919284|NCT02783300|449334293|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
124919285|NCT02783300|449334294|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
124919286|NCT02783300|449334295|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919287|NCT02783300|449334296|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919288|NCT02783300|449334297|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919289|NCT02783300|449334298|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919290|NCT02783300|449334299|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
124919291|NCT02783300|449334300|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919292|NCT02783300|449334301|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
124919293|NCT02783300|449334275|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919294|NCT02783300|449334276|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919295|NCT02783300|449334277|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919296|NCT02783300|449334278|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919297|NCT02783300|449334279|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919298|NCT02783300|449334280|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919299|NCT02783300|449334281|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919300|NCT02783300|449334282|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919301|NCT02783300|449334283|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919302|NCT02783300|449334284|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919303|NCT02783300|449334285|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124545418|NCT03792633|447951203|FG001|Overall Study|Death|0|||
124545419|NCT03792633|447951202|FG000|Overall Study|Disease progression|8|||
124545420|NCT03792633|447951203|FG001|Overall Study|Disease progression|9|||
124545421|NCT03792633|447951202|FG000|Overall Study|Lost to Follow-up|1|||
124919304|NCT02783300|449334286|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919305|NCT02783300|449334287|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919306|NCT02783300|449334288|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919307|NCT02783300|449334289|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919308|NCT02783300|449334290|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919309|NCT02783300|449334291|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
124919310|NCT02783300|449334292|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919311|NCT02783300|449334293|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
124919312|NCT02783300|449334294|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
124919313|NCT02783300|449334295|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919314|NCT02783300|449334296|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919315|NCT02783300|449334297|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919316|NCT02783300|449334298|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919317|NCT02783300|449334299|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919318|NCT02783300|449334300|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919319|NCT02783300|449334301|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
124919320|NCT02783300|449334275|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919321|NCT02783300|449334276|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919322|NCT02783300|449334277|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919323|NCT02783300|449334278|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919324|NCT02783300|449334279|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919325|NCT02783300|449334280|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919326|NCT02783300|449334281|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919327|NCT02783300|449334282|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919328|NCT02783300|449334283|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919329|NCT02783300|449334284|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919330|NCT02783300|449334285|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919331|NCT02783300|449334286|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919332|NCT02783300|449334287|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919333|NCT02783300|449334288|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919334|NCT02783300|449334289|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919335|NCT02783300|449334290|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919336|NCT02783300|449334291|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
124919337|NCT02783300|449334292|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919338|NCT02783300|449334293|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
124919339|NCT02783300|449334294|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
124919340|NCT02783300|449334295|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
124919341|NCT02783300|449334296|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919342|NCT02783300|449334297|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919343|NCT02783300|449334298|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919344|NCT02783300|449334299|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919345|NCT02783300|449334300|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919346|NCT02783300|449334301|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
124919347|NCT02783300|449334275|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919348|NCT02783300|449334276|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919349|NCT02783300|449334277|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919350|NCT02783300|449334278|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919351|NCT02783300|449334279|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919352|NCT02783300|449334280|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919353|NCT02783300|449334281|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919354|NCT02783300|449334282|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919355|NCT02783300|449334283|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919356|NCT02783300|449334284|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919357|NCT02783300|449334285|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919358|NCT02783300|449334286|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919359|NCT02783300|449334287|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919360|NCT02783300|449334288|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919361|NCT02783300|449334289|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919362|NCT02783300|449334290|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
124919363|NCT02783300|449334291|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919364|NCT02783300|449334292|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919365|NCT02783300|449334293|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919366|NCT02783300|449334294|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919367|NCT02783300|449334295|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919368|NCT02783300|449334296|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919369|NCT02783300|449334297|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
124919370|NCT02783300|449334298|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919371|NCT02783300|449334299|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919372|NCT02783300|449334300|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919373|NCT02783300|449334301|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
124919374|NCT02783300|449334275|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919375|NCT02783300|449334276|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919376|NCT02783300|449334277|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919377|NCT02783300|449334278|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919378|NCT02783300|449334279|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919379|NCT02783300|449334280|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919380|NCT02783300|449334281|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919381|NCT02783300|449334282|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919382|NCT02783300|449334283|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919383|NCT02783300|449334284|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919384|NCT02783300|449334285|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124762123|NCT05051579|448753592|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
124919385|NCT02783300|449334286|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919386|NCT02783300|449334287|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919387|NCT02783300|449334288|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
124919388|NCT02783300|449334289|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
124919389|NCT02783300|449334290|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
124919390|NCT02783300|449334291|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
124919391|NCT02783300|449334292|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919392|NCT02783300|449334293|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
124919393|NCT02783300|449334294|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
124919394|NCT02783300|449334295|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919395|NCT02783300|449334296|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919396|NCT02783300|449334297|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919397|NCT02783300|449334298|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919398|NCT02783300|449334299|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919399|NCT02783300|449334300|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919400|NCT02783300|449334301|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
124919401|NCT02783300|449334275|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919402|NCT02783300|449334276|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919403|NCT02783300|449334277|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919404|NCT02783300|449334278|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919405|NCT02783300|449334279|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919406|NCT02783300|449334280|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919407|NCT02783300|449334281|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919408|NCT02783300|449334282|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919409|NCT02783300|449334283|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919410|NCT02783300|449334284|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919411|NCT02783300|449334285|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919412|NCT02783300|449334286|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919413|NCT02783300|449334287|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919414|NCT02783300|449334288|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
124919415|NCT02783300|449334289|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
124919416|NCT02783300|449334290|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
124919417|NCT02783300|449334291|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
124919418|NCT02783300|449334292|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
124919419|NCT02783300|449334293|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
124919420|NCT02783300|449334294|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
124762124|NCT05051579|448753586|FG000|Overall Study|Sponsor Decision|0|||
124762125|NCT05051579|448753587|FG001|Overall Study|Sponsor Decision|0|||
124762126|NCT05051579|448753588|FG002|Overall Study|Sponsor Decision|0|||
124919421|NCT02783300|449334295|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
124762127|NCT05051579|448753589|FG003|Overall Study|Sponsor Decision|0|||
124762128|NCT05051579|448753590|FG004|Overall Study|Sponsor Decision|1|||
124919422|NCT02783300|449334296|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
124919423|NCT02783300|449334297|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
124919424|NCT02783300|449334298|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
124919425|NCT02783300|449334299|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
124919426|NCT02783300|449334300|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
124919427|NCT02783300|449334301|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
124919428|NCT02783300|449334275|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919429|NCT02783300|449334276|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919430|NCT02783300|449334277|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919431|NCT02783300|449334278|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919432|NCT02783300|449334279|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919433|NCT02783300|449334280|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919434|NCT02783300|449334281|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919435|NCT02783300|449334282|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919436|NCT02783300|449334283|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919437|NCT02783300|449334284|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919438|NCT02783300|449334285|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919439|NCT02783300|449334286|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919440|NCT02783300|449334287|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919441|NCT02783300|449334288|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919442|NCT02783300|449334289|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919443|NCT02783300|449334290|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919444|NCT02783300|449334291|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919445|NCT02783300|449334292|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919446|NCT02783300|449334293|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919447|NCT02783300|449334294|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919448|NCT02783300|449334295|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919449|NCT02783300|449334296|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919450|NCT02783300|449334297|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919451|NCT02783300|449334298|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919452|NCT02783300|449334299|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919453|NCT02783300|449334300|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
124919454|NCT02783300|449334301|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
124919455|NCT02783300|449334275|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919456|NCT02783300|449334276|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919457|NCT02783300|449334277|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919458|NCT02783300|449334278|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919459|NCT02783300|449334279|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919460|NCT02783300|449334280|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919461|NCT02783300|449334281|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919462|NCT02783300|449334282|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919463|NCT02783300|449334283|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919464|NCT02783300|449334284|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919465|NCT02783300|449334285|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919466|NCT02783300|449334286|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919467|NCT02783300|449334287|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919468|NCT02783300|449334288|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919469|NCT02783300|449334289|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919470|NCT02783300|449334290|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919471|NCT02783300|449334291|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919472|NCT02783300|449334292|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919473|NCT02783300|449334293|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919474|NCT02783300|449334294|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919475|NCT02783300|449334295|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919476|NCT02783300|449334296|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919477|NCT02783300|449334297|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919478|NCT02783300|449334298|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919479|NCT02783300|449334299|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919480|NCT02783300|449334300|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
124919481|NCT02783300|449334301|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
124919482|NCT03535272|449334302|FG000|Overall Study|Lost to Follow-up|71|||
124919483|NCT03535272|449334303|FG001|Overall Study|Lost to Follow-up|73|||
124919484|NCT03892616|449334306|FG000|Washout Period 2|Met discontinuation criterion|0|||
124762129|NCT05051579|448753591|FG005|Overall Study|Sponsor Decision|0|||
124919485|NCT03892616|449334307|FG001|Washout Period 2|Met discontinuation criterion|0|||
124451756|NCT01854645|447615164|FG000|Overall Study|Lack of Efficacy|7|||
124919486|NCT03892616|449334308|FG002|Washout Period 2|Met discontinuation criterion|0|||
124919487|NCT03892616|449334309|FG003|Washout Period 2|Met discontinuation criterion|0|||
124919488|NCT03892616|449334310|FG004|Washout Period 2|Met discontinuation criterion|0|||
124919489|NCT03892616|449334311|FG005|Washout Period 2|Met discontinuation criterion|0|||
124919490|NCT03892616|449334312|FG006|Washout Period 2|Met discontinuation criterion|0|||
124919491|NCT03892616|449334313|FG007|Washout Period 2|Met discontinuation criterion|0|||
124919492|NCT03892616|449334314|FG008|Washout Period 2|Met discontinuation criterion|1|||
124919493|NCT03892616|449334315|FG009|Washout Period 2|Met discontinuation criterion|0|||
124919494|NCT03892616|449334316|FG010|Washout Period 2|Met discontinuation criterion|0|||
124919495|NCT03892616|449334317|FG011|Washout Period 2|Met discontinuation criterion|0|||
124919496|NCT00378105|449334318|FG000|Overall Study|Adverse Event|3|||
124919497|NCT00378105|449334319|FG001|Overall Study|Adverse Event|1|||
124919498|NCT00378105|449334318|FG000|Overall Study|Withdrawal by Subject|3|||
124919499|NCT00378105|449334319|FG001|Overall Study|Withdrawal by Subject|3|||
124919500|NCT00378105|449334318|FG000|Overall Study|Death|1|||
124919501|NCT00378105|449334319|FG001|Overall Study|Death|0|||
124919502|NCT00378105|449334318|FG000|Overall Study|Going to transplant|7|||
124919503|NCT00378105|449334319|FG001|Overall Study|Going to transplant|8|||
124919504|NCT00378105|449334318|FG000|Overall Study|Progressive disease|3|||
124919505|NCT00378105|449334319|FG001|Overall Study|Progressive disease|3|||
124919506|NCT00378105|449334318|FG000|Overall Study|remain on study|3|||
124919507|NCT00378105|449334319|FG001|Overall Study|remain on study|11|||
124919508|NCT00378105|449334318|FG000|Overall Study|Physician Decision|0|||
124919509|NCT00378105|449334319|FG001|Overall Study|Physician Decision|2|||
124919510|NCT00378105|449334318|FG000|Overall Study|Going non-protocol therapy|0|||
124919511|NCT00378105|449334319|FG001|Overall Study|Going non-protocol therapy|1|||
124919512|NCT00378105|449334318|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
124919513|NCT00378105|449334319|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
124919514|NCT05192200|449334320|FG000|Treatment Period|Other|1|||
124919515|NCT05192200|449334320|FG000|Treatment Period|Lack of Efficacy|1|||
124919516|NCT05192200|449334320|FG000|Treatment Period|Withdrawal by Subject|1|||
124919517|NCT05192200|449334320|FG000|Follow-up|Withdrawal by Subject|1|||
124919518|NCT03907397|449334321|FG000|Overall Study|Lost to Follow-up|0|||
124919519|NCT03907397|449334322|FG001|Overall Study|Lost to Follow-up|1|||
124919520|NCT03907397|449334321|FG000|Overall Study|Physician Decision|2|||
124919521|NCT03907397|449334322|FG001|Overall Study|Physician Decision|1|||
124919522|NCT03907397|449334321|FG000|Overall Study|Withdrawal by Subject|5|||
124919523|NCT03907397|449334322|FG001|Overall Study|Withdrawal by Subject|4|||
124919524|NCT03907397|449334321|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
124919525|NCT03907397|449334322|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
124919526|NCT03930342|449334334|FG000|Overall Study|Lost to Follow-up|70|||
124919527|NCT03930342|449334335|FG001|Overall Study|Lost to Follow-up|77|||
124919528|NCT05021640|449336101|FG000|Overall Study|Lost to Follow-up|0|||
124919529|NCT05021640|449336102|FG001|Overall Study|Lost to Follow-up|0|||
124919530|NCT05021640|449336103|FG002|Overall Study|Lost to Follow-up|0|||
124919531|NCT05021640|449336104|FG003|Overall Study|Lost to Follow-up|0|||
124919532|NCT05021640|449336105|FG004|Overall Study|Lost to Follow-up|1|||
124919533|NCT04737772|449336106|FG000|Phase 2 Study|Lost to Follow-up|15|||
124919534|NCT04737772|449336107|FG001|Phase 2 Study|Lost to Follow-up|15|||
124919535|NCT04737772|449336106|FG000|Phase 2 Study|Withdrawal by Subject|0|||
124919536|NCT04737772|449336107|FG001|Phase 2 Study|Withdrawal by Subject|1|||
124919537|NCT04737772|449336106|FG000|Phase 2 Study|Did not take any coaching calls|4|||
124919538|NCT04737772|449336107|FG001|Phase 2 Study|Did not take any coaching calls|0|||
124919539|NCT04737772|449336106|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
124919540|NCT04737772|449336107|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
124919541|NCT04737772|449336106|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
124919542|NCT04737772|449336107|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
124919543|NCT05691309|449336108|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
124919544|NCT05691309|449336108|FG000|Overall Study|vancomycin levels not evaluable|2|||
124919545|NCT03376321|449336110|FG000|Overall Study|Other|5|||
124919546|NCT03376321|449336111|FG001|Overall Study|Other|1|||
124919547|NCT03376321|449336110|FG000|Overall Study|Withdrawal by Subject|8|||
124919548|NCT03376321|449336111|FG001|Overall Study|Withdrawal by Subject|14|||
124919549|NCT03376321|449336110|FG000|Overall Study|Lost to Follow-up|1|||
124919550|NCT03376321|449336111|FG001|Overall Study|Lost to Follow-up|7|||
124919551|NCT03376321|449336110|FG000|Overall Study|Death|4|||
124919552|NCT03376321|449336111|FG001|Overall Study|Death|0|||
124919553|NCT03376321|449336110|FG000|Overall Study|Randomized, not treated|5|||
124919554|NCT03376321|449336111|FG001|Overall Study|Randomized, not treated|3|||
124919555|NCT02992925|449336116|FG000|Cohort 2|Physician Decision|0|||
124545422|NCT03792633|447951203|FG001|Overall Study|Lost to Follow-up|1|||
124545423|NCT03792633|447951202|FG000|Overall Study|Screen fail|1|||
124919556|NCT02992925|449336117|FG001|Cohort 2|Physician Decision|0|||
124919557|NCT02992925|449336118|FG002|Cohort 2|Physician Decision|1|||
124919558|NCT02992925|449336119|FG003|Cohort 2|Physician Decision|0|||
124919559|NCT02992925|449336116|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
124919560|NCT02992925|449336117|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
124919561|NCT02992925|449336118|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
124919562|NCT02992925|449336119|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
124919563|NCT01804816|449336120|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
124919564|NCT01804816|449336120|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
124919565|NCT04421378|449336126|FG000|Overall Study|Adverse Event|2|||
124919566|NCT04421378|449336127|FG001|Overall Study|Adverse Event|7|||
124919567|NCT04421378|449336128|FG002|Overall Study|Adverse Event|0|||
124919568|NCT04421378|449336129|FG003|Overall Study|Adverse Event|1|||
124919569|NCT04421378|449336130|FG004|Overall Study|Adverse Event|0|||
124919570|NCT04421378|449336126|FG000|Overall Study|Physician Decision|1|||
124919571|NCT04421378|449336127|FG001|Overall Study|Physician Decision|2|||
124919572|NCT04421378|449336128|FG002|Overall Study|Physician Decision|0|||
124919573|NCT04421378|449336129|FG003|Overall Study|Physician Decision|0|||
124919574|NCT04421378|449336130|FG004|Overall Study|Physician Decision|0|||
124919575|NCT04421378|449336126|FG000|Overall Study|Progressive Disease|16|||
124919576|NCT04421378|449336127|FG001|Overall Study|Progressive Disease|4|||
124919577|NCT04421378|449336128|FG002|Overall Study|Progressive Disease|18|||
124919578|NCT04421378|449336129|FG003|Overall Study|Progressive Disease|11|||
124919579|NCT04421378|449336130|FG004|Overall Study|Progressive Disease|3|||
124919580|NCT04421378|449336126|FG000|Overall Study|Study Terminated by Sponsor|0|||
124919581|NCT04421378|449336127|FG001|Overall Study|Study Terminated by Sponsor|1|||
124919582|NCT04421378|449336128|FG002|Overall Study|Study Terminated by Sponsor|1|||
124919583|NCT04421378|449336129|FG003|Overall Study|Study Terminated by Sponsor|0|||
124919584|NCT04421378|449336130|FG004|Overall Study|Study Terminated by Sponsor|0|||
124919585|NCT04421378|449336126|FG000|Overall Study|Withdrawal by Subject|3|||
124919586|NCT04421378|449336127|FG001|Overall Study|Withdrawal by Subject|1|||
124919587|NCT04421378|449336128|FG002|Overall Study|Withdrawal by Subject|0|||
124919588|NCT04421378|449336129|FG003|Overall Study|Withdrawal by Subject|2|||
124919589|NCT04421378|449336130|FG004|Overall Study|Withdrawal by Subject|0|||
124919590|NCT04421378|449336126|FG000|Overall Study|Other|1|||
124919591|NCT04421378|449336127|FG001|Overall Study|Other|0|||
124919592|NCT04421378|449336128|FG002|Overall Study|Other|0|||
124919593|NCT04421378|449336129|FG003|Overall Study|Other|0|||
124919594|NCT04421378|449336130|FG004|Overall Study|Other|0|||
124919595|NCT04150718|449336131|FG000|Overall Study|Withdrawal by Subject|2|||
124919596|NCT04150718|449336132|FG001|Overall Study|Withdrawal by Subject|7|||
124919597|NCT04150718|449336133|FG002|Overall Study|Withdrawal by Subject|1|||
124919598|NCT04150718|449336131|FG000|Overall Study|Lost to Follow-up|1|||
124919599|NCT04150718|449336132|FG001|Overall Study|Lost to Follow-up|2|||
124919600|NCT04150718|449336133|FG002|Overall Study|Lost to Follow-up|0|||
124919601|NCT04150718|449336131|FG000|Overall Study|Ineligible|1|||
124919602|NCT04150718|449336132|FG001|Overall Study|Ineligible|0|||
124919603|NCT04150718|449336133|FG002|Overall Study|Ineligible|10|||
124919604|NCT02592330|449336134|FG000|Overall Study|Withdrawal by Subject|1|||
124919605|NCT02592330|449336135|FG001|Overall Study|Withdrawal by Subject|0|||
124919606|NCT02592330|449336134|FG000|Overall Study|Failed Biopsy|1|||
124919607|NCT02592330|449336135|FG001|Overall Study|Failed Biopsy|0|||
124919608|NCT03090152|449336136|FG000|Overall Study|Withdrawal by Subject|0|||
124919609|NCT03090152|449336137|FG001|Overall Study|Withdrawal by Subject|2|||
124919610|NCT03090152|449336138|FG002|Overall Study|Withdrawal by Subject|1|||
124919611|NCT03090152|449336136|FG000|Overall Study|Surgery Canceled|1|||
124919612|NCT03090152|449336137|FG001|Overall Study|Surgery Canceled|0|||
124919613|NCT03090152|449336138|FG002|Overall Study|Surgery Canceled|0|||
124919614|NCT03090152|449336136|FG000|Overall Study|Epidural catheter could not be placed|0|||
124919615|NCT03090152|449336137|FG001|Overall Study|Epidural catheter could not be placed|2|||
124762130|NCT05051579|448753592|FG006|Overall Study|Sponsor Decision|0|||
124762131|NCT05051579|448753586|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
124762132|NCT05051579|448753587|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
124769818|NCT01502293|448785205|FG001|Overall Study|Reason Not Specified|0|||
124919616|NCT03090152|449336138|FG002|Overall Study|Epidural catheter could not be placed|0|||
124919617|NCT03958955|449336139|FG000|Overall Study|Adverse Event|1|||
124919618|NCT04673929|449336140|FG000|Overall Study|Death|73|||
124919619|NCT04673929|449336140|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
124919620|NCT02927769|449336142|FG000|Induction Phase|Study drug toxicity|1|||
124919621|NCT02927769|449336143|FG001|Induction Phase|Study drug toxicity|1|||
124919622|NCT02927769|449336142|FG000|Induction Phase|Disease progression|0|||
124919623|NCT02927769|449336143|FG001|Induction Phase|Disease progression|1|||
124919624|NCT02927769|449336142|FG000|Intensification Phase|Study drug toxicity|1|||
124919625|NCT02927769|449336143|FG001|Intensification Phase|Study drug toxicity|0|||
124919626|NCT02807636|449336144|FG000|Overall Study|Lost to Follow-up|10|||
124919627|NCT02807636|449336145|FG001|Overall Study|Lost to Follow-up|13|||
124919628|NCT02807636|449336146|FG002|Overall Study|Lost to Follow-up|6|||
124919629|NCT02807636|449336144|FG000|Overall Study|Protocol Deviation|1|||
124919630|NCT02807636|449336145|FG001|Overall Study|Protocol Deviation|0|||
124762133|NCT05051579|448753588|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
124762134|NCT05051579|448753589|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
124762135|NCT05051579|448753590|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
124762136|NCT05051579|448753591|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
124762137|NCT05051579|448753592|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
124762138|NCT00990106|448753593|FG000|Overall Study|"too busy to continue"|1|||
124762139|NCT00990106|448753594|FG001|Overall Study|"too busy to continue"|2|||
124762140|NCT00990106|448753593|FG000|Overall Study|Lost to Follow-up|1|||
124762141|NCT00990106|448753594|FG001|Overall Study|Lost to Follow-up|3|||
124762142|NCT00990106|448753593|FG000|Overall Study|Withdrawal by Subject|2|||
124919631|NCT02807636|449336146|FG002|Overall Study|Protocol Deviation|0|||
124919632|NCT02807636|449336144|FG000|Overall Study|Symptomatic Deterioration|0|||
124919633|NCT02807636|449336145|FG001|Overall Study|Symptomatic Deterioration|1|||
124919634|NCT02807636|449336146|FG002|Overall Study|Symptomatic Deterioration|0|||
124919635|NCT02807636|449336144|FG000|Overall Study|Withdrawal by Subject|39|||
124919636|NCT02807636|449336145|FG001|Overall Study|Withdrawal by Subject|28|||
124919637|NCT02807636|449336146|FG002|Overall Study|Withdrawal by Subject|24|||
124919638|NCT02807636|449336144|FG000|Overall Study|Death|303|||
124919639|NCT02807636|449336145|FG001|Overall Study|Death|332|||
124919640|NCT02807636|449336146|FG002|Overall Study|Death|272|||
124762143|NCT00990106|448753594|FG001|Overall Study|Withdrawal by Subject|1|||
124762144|NCT00990106|448753593|FG000|Overall Study|opted for open label prazosin|1|||
124762145|NCT00990106|448753594|FG001|Overall Study|opted for open label prazosin|1|||
124762146|NCT00990106|448753593|FG000|Overall Study|relocation/deployment|4|||
124762147|NCT00990106|448753594|FG001|Overall Study|relocation/deployment|1|||
124762148|NCT00990106|448753593|FG000|Overall Study|started exclusionary medication|0|||
124762149|NCT00990106|448753594|FG001|Overall Study|started exclusionary medication|1|||
124762150|NCT00990106|448753593|FG000|Overall Study|planned major surgery|0|||
124762151|NCT00990106|448753594|FG001|Overall Study|planned major surgery|1|||
124762152|NCT00990106|448753593|FG000|Overall Study|scheduling conflicts|0|||
124762153|NCT00990106|448753594|FG001|Overall Study|scheduling conflicts|2|||
124762154|NCT01650194|448753595|FG000|Overall Study|Progressive Disease (PD)|35|||
124762155|NCT01650194|448753595|FG000|Overall Study|Withdrawal by Subject|2|||
124762156|NCT01650194|448753595|FG000|Overall Study|Miscellaneous|10|||
124762157|NCT00880698|448753598|FG000|Overall Study|Death|0|||
124762158|NCT00880698|448753599|FG001|Overall Study|Death|0|||
124762159|NCT00880698|448753600|FG002|Overall Study|Death|1|||
124919641|NCT02807636|449336144|FG000|Overall Study|Study Terminated By Sponsor|47|||
124919642|NCT02807636|449336145|FG001|Overall Study|Study Terminated By Sponsor|76|||
124919643|NCT02807636|449336146|FG002|Overall Study|Study Terminated By Sponsor|60|||
124919644|NCT02807636|449336144|FG000|Overall Study|Physician Decision|0|||
124919645|NCT02807636|449336145|FG001|Overall Study|Physician Decision|1|||
124762160|NCT00880698|448753601|FG003|Overall Study|Death|2|||
124762161|NCT00880698|448753598|FG000|Overall Study|Lost to Follow-up|1|||
124762162|NCT00880698|448753599|FG001|Overall Study|Lost to Follow-up|3|||
124762163|NCT00880698|448753600|FG002|Overall Study|Lost to Follow-up|0|||
124919646|NCT02807636|449336146|FG002|Overall Study|Physician Decision|0|||
124919647|NCT04088630|449336147|FG000|Overall Study|Lost to Follow-up|3|||
124919648|NCT04088630|449336148|FG001|Overall Study|Lost to Follow-up|2|||
124762164|NCT00880698|448753601|FG003|Overall Study|Lost to Follow-up|1|||
124762165|NCT04158583|448753604|FG000|Overall Study|Withdrawal by Subject|1|||
124919649|NCT04088630|449336149|FG002|Overall Study|Lost to Follow-up|6|||
124919650|NCT04088630|449336147|FG000|Overall Study|Death|3|||
124919651|NCT04088630|449336148|FG001|Overall Study|Death|1|||
124762166|NCT04158583|448753605|FG001|Overall Study|Withdrawal by Subject|1|||
124919652|NCT04088630|449336149|FG002|Overall Study|Death|1|||
124919653|NCT04088630|449336147|FG000|Overall Study|Physician Decision|0|||
124919654|NCT04088630|449336148|FG001|Overall Study|Physician Decision|1|||
124919655|NCT04088630|449336149|FG002|Overall Study|Physician Decision|1|||
124919656|NCT03315754|449336150|FG000|Overall Study|COVID-19 complications leading to death|1|||
124919657|NCT03315754|449336150|FG000|Overall Study|insurance coverage issue|1|||
124919658|NCT04024813|449336151|FG000|Overall Study|Study terminated by Sponsor|1|||
124919659|NCT05034952|449336152|FG000|Overall Study|Adverse Event|1|||
124919660|NCT05034952|449336153|FG001|Overall Study|Adverse Event|0|||
124919661|NCT05034952|449336154|FG002|Overall Study|Adverse Event|0|||
124919662|NCT05034952|449336155|FG003|Overall Study|Adverse Event|0|||
124919663|NCT05034952|449336152|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
124919664|NCT05034952|449336153|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
124919665|NCT05034952|449336154|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
124919666|NCT05034952|449336155|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
124919667|NCT05034952|449336152|FG000|Overall Study|Lost to Follow-up|1|||
124919668|NCT05034952|449336153|FG001|Overall Study|Lost to Follow-up|4|||
124919669|NCT05034952|449336154|FG002|Overall Study|Lost to Follow-up|3|||
124919670|NCT05034952|449336155|FG003|Overall Study|Lost to Follow-up|3|||
124919671|NCT05034952|449336152|FG000|Overall Study|Other|0|||
124919672|NCT05034952|449336153|FG001|Overall Study|Other|0|||
124919673|NCT05034952|449336154|FG002|Overall Study|Other|0|||
124919674|NCT05034952|449336155|FG003|Overall Study|Other|1|||
124919675|NCT04783935|449336172|FG000|Overall Study|Withdrawal by Subject|6|||
124919676|NCT04783935|449336172|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
124919677|NCT04783935|449336172|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
124919678|NCT04783935|449336172|FG000|Overall Study|Lost to Follow-up|3|||
124919679|NCT04783935|449336172|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
124919680|NCT02437318|449336174|FG000|Overall Study|Progressive disease|207|||
124919681|NCT02437318|449336175|FG001|Overall Study|Progressive disease|240|||
124919682|NCT02437318|449336174|FG000|Overall Study|Subject/guardian decision|24|||
124919683|NCT02437318|449336175|FG001|Overall Study|Subject/guardian decision|11|||
124919684|NCT02437318|449336174|FG000|Overall Study|Physician Decision|29|||
124919685|NCT02437318|449336175|FG001|Overall Study|Physician Decision|22|||
124919686|NCT02437318|449336174|FG000|Overall Study|Adverse Event|14|||
124919687|NCT02437318|449336175|FG001|Overall Study|Adverse Event|4|||
124919688|NCT02437318|449336174|FG000|Overall Study|Death|4|||
124919689|NCT02437318|449336175|FG001|Overall Study|Death|4|||
124919690|NCT02437318|449336174|FG000|Overall Study|Protocol deviation|5|||
124919691|NCT02437318|449336175|FG001|Overall Study|Protocol deviation|7|||
124919692|NCT02437318|449336174|FG000|Overall Study|Sponsor decision|1|||
124919693|NCT02437318|449336175|FG001|Overall Study|Sponsor decision|0|||
124919694|NCT00920621|449336178|FG000|Overall Study|Lost to Follow-up|16|||
124919695|NCT00920621|449336179|FG001|Overall Study|Lost to Follow-up|17|||
124919696|NCT00920621|449336180|FG002|Overall Study|Lost to Follow-up|19|||
124919697|NCT00920621|449336181|FG003|Overall Study|Lost to Follow-up|21|||
124919698|NCT00920621|449336178|FG000|Overall Study|Fetal/neonatal deaths|16|||
124919699|NCT00920621|449336179|FG001|Overall Study|Fetal/neonatal deaths|14|||
124919700|NCT00920621|449336180|FG002|Overall Study|Fetal/neonatal deaths|16|||
124919701|NCT00920621|449336181|FG003|Overall Study|Fetal/neonatal deaths|14|||
124919702|NCT00920621|449336178|FG000|Overall Study|Blood sample not collected|22|||
124919703|NCT00920621|449336179|FG001|Overall Study|Blood sample not collected|14|||
124919704|NCT00920621|449336180|FG002|Overall Study|Blood sample not collected|0|||
124919705|NCT00920621|449336181|FG003|Overall Study|Blood sample not collected|0|||
124919706|NCT04245501|449336182|FG000|Overall Study|Adverse Event|2|||
124919707|NCT04245501|449336183|FG001|Overall Study|Adverse Event|0|||
124919708|NCT04245501|449336182|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
124919709|NCT04245501|449336183|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
124919710|NCT00961571|449336184|FG000|Overall Study|Physician Decision|39|||
124919711|NCT05337748|449336191|FG000|Overall Study|Withdrawal by Subject|1|||
124919712|NCT05337748|449336192|FG001|Overall Study|Withdrawal by Subject|0|||
124919713|NCT05337748|449336191|FG000|Overall Study|Death|1|||
124919714|NCT05337748|449336192|FG001|Overall Study|Death|0|||
124919715|NCT04321031|449336195|FG000|Overall Study|Adverse Event|0|||
124919716|NCT04321031|449336196|FG001|Overall Study|Adverse Event|2|||
124919717|NCT04321031|449336197|FG002|Overall Study|Adverse Event|2|||
124919718|NCT04321031|449336198|FG003|Overall Study|Adverse Event|2|||
124919719|NCT04321031|449336199|FG004|Overall Study|Adverse Event|2|||
124919720|NCT04321031|449336200|FG005|Overall Study|Adverse Event|2|||
124919721|NCT04321031|449336201|FG006|Overall Study|Adverse Event|0|||
124919722|NCT04321031|449336195|FG000|Overall Study|Lost to Follow-up|0|||
124919723|NCT04321031|449336196|FG001|Overall Study|Lost to Follow-up|0|||
124919724|NCT04321031|449336197|FG002|Overall Study|Lost to Follow-up|0|||
124919725|NCT04321031|449336198|FG003|Overall Study|Lost to Follow-up|1|||
124919726|NCT04321031|449336199|FG004|Overall Study|Lost to Follow-up|0|||
124919727|NCT04321031|449336200|FG005|Overall Study|Lost to Follow-up|2|||
124919728|NCT04321031|449336201|FG006|Overall Study|Lost to Follow-up|1|||
124919729|NCT04321031|449336195|FG000|Overall Study|Withdrawal by Subject|2|||
124919730|NCT04321031|449336196|FG001|Overall Study|Withdrawal by Subject|2|||
124919731|NCT04321031|449336197|FG002|Overall Study|Withdrawal by Subject|1|||
124919732|NCT04321031|449336198|FG003|Overall Study|Withdrawal by Subject|3|||
124919733|NCT04321031|449336199|FG004|Overall Study|Withdrawal by Subject|1|||
124919734|NCT04321031|449336200|FG005|Overall Study|Withdrawal by Subject|0|||
124919735|NCT04321031|449336201|FG006|Overall Study|Withdrawal by Subject|1|||
124919736|NCT04321031|449336195|FG000|Overall Study|Non-compliance with study drug|0|||
124919737|NCT04321031|449336196|FG001|Overall Study|Non-compliance with study drug|0|||
124919738|NCT04321031|449336197|FG002|Overall Study|Non-compliance with study drug|0|||
124919739|NCT04321031|449336198|FG003|Overall Study|Non-compliance with study drug|0|||
124919740|NCT04321031|449336199|FG004|Overall Study|Non-compliance with study drug|0|||
124919741|NCT04321031|449336200|FG005|Overall Study|Non-compliance with study drug|1|||
124919742|NCT04321031|449336201|FG006|Overall Study|Non-compliance with study drug|0|||
124919743|NCT04321031|449336195|FG000|Overall Study|Other|0|||
124919744|NCT04321031|449336196|FG001|Overall Study|Other|0|||
124919745|NCT04321031|449336197|FG002|Overall Study|Other|0|||
124919746|NCT04321031|449336198|FG003|Overall Study|Other|1|||
124919747|NCT04321031|449336199|FG004|Overall Study|Other|0|||
124919748|NCT04321031|449336200|FG005|Overall Study|Other|0|||
124919749|NCT04321031|449336201|FG006|Overall Study|Other|0|||
124919750|NCT05536440|449336202|FG000|Overall Study|Adverse Event|0|||
124919751|NCT05536440|449336203|FG001|Overall Study|Adverse Event|0|||
124919752|NCT05536440|449336204|FG002|Overall Study|Adverse Event|0|||
124919753|NCT05536440|449336205|FG003|Overall Study|Adverse Event|0|||
124919754|NCT05536440|449336206|FG004|Overall Study|Adverse Event|0|||
124919755|NCT05536440|449336207|FG005|Overall Study|Adverse Event|0|||
124919756|NCT05536440|449336208|FG006|Overall Study|Adverse Event|0|||
124919757|NCT05536440|449336209|FG007|Overall Study|Adverse Event|0|||
124919758|NCT05536440|449336210|FG008|Overall Study|Adverse Event|1|||
124919759|NCT06283173|449336211|FG000|Overall Study|Did not show for first visit|10|||
124919760|NCT06283173|449336211|FG000|Overall Study|Lost to Follow-up|12|||
124919761|NCT06283173|449336211|FG000|Overall Study|Physician Decision|7|||
124919762|NCT04784559|449336213|FG000|Overall Study|Withdrawal by Subject|3|||
124919763|NCT04784559|449336214|FG001|Overall Study|Withdrawal by Subject|2|||
124919764|NCT04784559|449336215|FG002|Overall Study|Withdrawal by Subject|1|||
124919765|NCT04784559|449336213|FG000|Overall Study|Death|2|||
124919766|NCT04784559|449336214|FG001|Overall Study|Death|1|||
124919767|NCT04784559|449336215|FG002|Overall Study|Death|2|||
124919768|NCT04784559|449336213|FG000|Overall Study|Lost to Follow-up|0|||
124919769|NCT04784559|449336214|FG001|Overall Study|Lost to Follow-up|0|||
124762167|NCT04158583|448753606|FG002|Overall Study|Withdrawal by Subject|0|||
124762168|NCT04158583|448753607|FG003|Overall Study|Withdrawal by Subject|0|||
124762169|NCT04158583|448753608|FG004|Overall Study|Withdrawal by Subject|1|||
124762170|NCT04158583|448753609|FG005|Overall Study|Withdrawal by Subject|0|||
124919770|NCT04784559|449336215|FG002|Overall Study|Lost to Follow-up|2|||
124919771|NCT04784559|449336213|FG000|Overall Study|Participant worsened, PI decision|1|||
124919772|NCT04784559|449336214|FG001|Overall Study|Participant worsened, PI decision|0|||
124919773|NCT04784559|449336215|FG002|Overall Study|Participant worsened, PI decision|0|||
124919774|NCT04784559|449336213|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
124919775|NCT04784559|449336214|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
124919776|NCT04784559|449336215|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
124919777|NCT04784559|449336213|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
124919778|NCT04784559|449336214|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
124919779|NCT04784559|449336215|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
124919780|NCT04784559|449336213|FG000|Overall Study|Did not meet all inclusion criteria|0|||
124919781|NCT04784559|449336214|FG001|Overall Study|Did not meet all inclusion criteria|1|||
124919782|NCT04784559|449336215|FG002|Overall Study|Did not meet all inclusion criteria|0|||
124919783|NCT04784559|449336213|FG000|Overall Study|The participant was transferred to IRCU|0|||
124919784|NCT04784559|449336214|FG001|Overall Study|The participant was transferred to IRCU|1|||
124919785|NCT04784559|449336215|FG002|Overall Study|The participant was transferred to IRCU|0|||
124919786|NCT04784559|449336213|FG000|Overall Study|SAE|0|||
124919787|NCT04784559|449336214|FG001|Overall Study|SAE|1|||
124919788|NCT04784559|449336215|FG002|Overall Study|SAE|0|||
124919789|NCT04784559|449336213|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
124919790|NCT04784559|449336214|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
124919791|NCT04784559|449336215|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
124919792|NCT03138512|449336216|FG000|Randomization|Participants withdrew consent|0|||
124919793|NCT03138512|449336217|FG001|Randomization|Participants withdrew consent|1|||
124919794|NCT03138512|449336218|FG002|Randomization|Participants withdrew consent|1|||
124919795|NCT03138512|449336219|FG003|Randomization|Participants withdrew consent|0|||
124919796|NCT03138512|449336220|FG004|Randomization|Participants withdrew consent|0|||
124919797|NCT03138512|449336216|FG000|Randomization|Participant no longer meets study criteria|0|||
124919798|NCT03138512|449336217|FG001|Randomization|Participant no longer meets study criteria|3|||
124919799|NCT03138512|449336218|FG002|Randomization|Participant no longer meets study criteria|1|||
124919800|NCT03138512|449336219|FG003|Randomization|Participant no longer meets study criteria|1|||
124919801|NCT03138512|449336220|FG004|Randomization|Participant no longer meets study criteria|3|||
124762171|NCT04158583|448753610|FG006|Overall Study|Withdrawal by Subject|0|||
124919802|NCT03138512|449336216|FG000|Randomization|Other reasons|1|||
124919803|NCT03138512|449336217|FG001|Randomization|Other reasons|0|||
124762172|NCT04158583|448753611|FG007|Overall Study|Withdrawal by Subject|0|||
124762173|NCT04158583|448753612|FG008|Overall Study|Withdrawal by Subject|2|||
124762174|NCT04158583|448753613|FG009|Overall Study|Withdrawal by Subject|0|||
124762175|NCT04158583|448753604|FG000|Overall Study|Study Terminated by Sponsor|0|||
124762176|NCT04158583|448753605|FG001|Overall Study|Study Terminated by Sponsor|0|||
124762177|NCT04158583|448753606|FG002|Overall Study|Study Terminated by Sponsor|0|||
124762178|NCT04158583|448753607|FG003|Overall Study|Study Terminated by Sponsor|1|||
124762179|NCT04158583|448753608|FG004|Overall Study|Study Terminated by Sponsor|0|||
124762180|NCT04158583|448753609|FG005|Overall Study|Study Terminated by Sponsor|0|||
124762181|NCT04158583|448753610|FG006|Overall Study|Study Terminated by Sponsor|0|||
124762182|NCT04158583|448753611|FG007|Overall Study|Study Terminated by Sponsor|0|||
124762183|NCT04158583|448753612|FG008|Overall Study|Study Terminated by Sponsor|0|||
124762184|NCT04158583|448753613|FG009|Overall Study|Study Terminated by Sponsor|0|||
124762185|NCT04158583|448753604|FG000|Overall Study|Progressive Disease|1|||
124762186|NCT04158583|448753605|FG001|Overall Study|Progressive Disease|0|||
124919804|NCT03138512|449336218|FG002|Randomization|Other reasons|0|||
124919805|NCT03138512|449336219|FG003|Randomization|Other reasons|0|||
124919806|NCT03138512|449336220|FG004|Randomization|Other reasons|0|||
124919807|NCT03138512|449336216|FG000|Treatment Part A|Disease recurrence|10|||
124919808|NCT03138512|449336217|FG001|Treatment Part A|Disease recurrence|20|||
124919809|NCT03138512|449336218|FG002|Treatment Part A|Disease recurrence|0|||
124919810|NCT03138512|449336219|FG003|Treatment Part A|Disease recurrence|0|||
124919811|NCT03138512|449336220|FG004|Treatment Part A|Disease recurrence|0|||
124919812|NCT03138512|449336216|FG000|Treatment Part A|Study Drug Toxicity|132|||
124919813|NCT03138512|449336217|FG001|Treatment Part A|Study Drug Toxicity|5|||
124919814|NCT03138512|449336218|FG002|Treatment Part A|Study Drug Toxicity|0|||
124919815|NCT03138512|449336219|FG003|Treatment Part A|Study Drug Toxicity|0|||
124919816|NCT03138512|449336220|FG004|Treatment Part A|Study Drug Toxicity|0|||
124919817|NCT03138512|449336216|FG000|Treatment Part A|Death|1|||
124919818|NCT03138512|449336217|FG001|Treatment Part A|Death|0|||
124919819|NCT03138512|449336218|FG002|Treatment Part A|Death|0|||
124919820|NCT03138512|449336219|FG003|Treatment Part A|Death|0|||
124919821|NCT03138512|449336220|FG004|Treatment Part A|Death|0|||
124919822|NCT03138512|449336216|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
124919823|NCT03138512|449336217|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
124919824|NCT03138512|449336218|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
124919825|NCT03138512|449336219|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
124919826|NCT03138512|449336220|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
124919827|NCT03138512|449336216|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
124919828|NCT03138512|449336217|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
124919829|NCT03138512|449336218|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
124919830|NCT03138512|449336219|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
124762187|NCT04158583|448753606|FG002|Overall Study|Progressive Disease|3|||
124762188|NCT04158583|448753607|FG003|Overall Study|Progressive Disease|5|||
124762189|NCT04158583|448753608|FG004|Overall Study|Progressive Disease|0|||
124762190|NCT04158583|448753609|FG005|Overall Study|Progressive Disease|1|||
124762191|NCT04158583|448753610|FG006|Overall Study|Progressive Disease|6|||
124919831|NCT03138512|449336220|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
124919832|NCT03138512|449336216|FG000|Treatment Part A|Participant withdrew consent|2|||
124919833|NCT03138512|449336217|FG001|Treatment Part A|Participant withdrew consent|4|||
124919834|NCT03138512|449336218|FG002|Treatment Part A|Participant withdrew consent|0|||
124919835|NCT03138512|449336219|FG003|Treatment Part A|Participant withdrew consent|0|||
124919836|NCT03138512|449336220|FG004|Treatment Part A|Participant withdrew consent|0|||
124919837|NCT03138512|449336216|FG000|Treatment Part A|Lost to Follow-up|0|||
124919838|NCT03138512|449336217|FG001|Treatment Part A|Lost to Follow-up|1|||
124919839|NCT03138512|449336218|FG002|Treatment Part A|Lost to Follow-up|0|||
124919840|NCT03138512|449336219|FG003|Treatment Part A|Lost to Follow-up|0|||
124919841|NCT03138512|449336220|FG004|Treatment Part A|Lost to Follow-up|0|||
124919842|NCT03138512|449336216|FG000|Treatment Part A|Poor/non-compliance|1|||
124919843|NCT03138512|449336217|FG001|Treatment Part A|Poor/non-compliance|0|||
124919844|NCT03138512|449336218|FG002|Treatment Part A|Poor/non-compliance|0|||
124919845|NCT03138512|449336219|FG003|Treatment Part A|Poor/non-compliance|0|||
124919846|NCT03138512|449336220|FG004|Treatment Part A|Poor/non-compliance|0|||
124919847|NCT03138512|449336216|FG000|Treatment Part A|Pregnancy|0|||
124919848|NCT03138512|449336217|FG001|Treatment Part A|Pregnancy|1|||
124762192|NCT04158583|448753611|FG007|Overall Study|Progressive Disease|2|||
124919849|NCT03138512|449336218|FG002|Treatment Part A|Pregnancy|0|||
124919850|NCT03138512|449336219|FG003|Treatment Part A|Pregnancy|0|||
124919851|NCT03138512|449336220|FG004|Treatment Part A|Pregnancy|0|||
124762193|NCT04158583|448753612|FG008|Overall Study|Progressive Disease|1|||
124762194|NCT04158583|448753613|FG009|Overall Study|Progressive Disease|2|||
124762195|NCT04158583|448753604|FG000|Overall Study|Lost to Follow-up|0|||
124762196|NCT04158583|448753605|FG001|Overall Study|Lost to Follow-up|0|||
124762197|NCT04158583|448753606|FG002|Overall Study|Lost to Follow-up|1|||
124762198|NCT04158583|448753607|FG003|Overall Study|Lost to Follow-up|1|||
124762199|NCT04158583|448753608|FG004|Overall Study|Lost to Follow-up|1|||
124762200|NCT04158583|448753609|FG005|Overall Study|Lost to Follow-up|0|||
124762201|NCT04158583|448753610|FG006|Overall Study|Lost to Follow-up|0|||
124762202|NCT04158583|448753611|FG007|Overall Study|Lost to Follow-up|0|||
124762203|NCT04158583|448753612|FG008|Overall Study|Lost to Follow-up|0|||
124762204|NCT04158583|448753613|FG009|Overall Study|Lost to Follow-up|0|||
124762205|NCT04158583|448753604|FG000|Overall Study|Due To Patient Status|0|||
124762206|NCT04158583|448753605|FG001|Overall Study|Due To Patient Status|0|||
124762207|NCT04158583|448753606|FG002|Overall Study|Due To Patient Status|0|||
124762208|NCT04158583|448753607|FG003|Overall Study|Due To Patient Status|0|||
124762209|NCT04158583|448753608|FG004|Overall Study|Due To Patient Status|0|||
124762210|NCT04158583|448753609|FG005|Overall Study|Due To Patient Status|0|||
124762211|NCT04158583|448753610|FG006|Overall Study|Due To Patient Status|0|||
124762212|NCT04158583|448753611|FG007|Overall Study|Due To Patient Status|0|||
124762213|NCT04158583|448753612|FG008|Overall Study|Due To Patient Status|1|||
124762214|NCT04158583|448753613|FG009|Overall Study|Due To Patient Status|0|||
124762215|NCT04158583|448753604|FG000|Overall Study|Death|3|||
124762216|NCT04158583|448753605|FG001|Overall Study|Death|4|||
124762217|NCT04158583|448753606|FG002|Overall Study|Death|2|||
124762218|NCT04158583|448753607|FG003|Overall Study|Death|2|||
124762219|NCT04158583|448753608|FG004|Overall Study|Death|4|||
124762220|NCT04158583|448753609|FG005|Overall Study|Death|3|||
124762221|NCT04158583|448753610|FG006|Overall Study|Death|5|||
124762222|NCT04158583|448753611|FG007|Overall Study|Death|2|||
124919852|NCT03138512|449336216|FG000|Treatment Part A|Other reasons|11|||
124919853|NCT03138512|449336217|FG001|Treatment Part A|Other reasons|8|||
124919854|NCT03138512|449336218|FG002|Treatment Part A|Other reasons|0|||
124919855|NCT03138512|449336219|FG003|Treatment Part A|Other reasons|0|||
124919856|NCT03138512|449336220|FG004|Treatment Part A|Other reasons|0|||
124919857|NCT03138512|449336216|FG000|Treatment Part B|Disease recurrence|0|||
124919858|NCT03138512|449336217|FG001|Treatment Part B|Disease recurrence|0|||
124919859|NCT03138512|449336218|FG002|Treatment Part B|Disease recurrence|6|||
124919860|NCT03138512|449336219|FG003|Treatment Part B|Disease recurrence|12|||
124919861|NCT03138512|449336220|FG004|Treatment Part B|Disease recurrence|10|||
124919862|NCT03138512|449336216|FG000|Treatment Part B|Study drug toxicity|0|||
124919863|NCT03138512|449336217|FG001|Treatment Part B|Study drug toxicity|0|||
124919864|NCT03138512|449336218|FG002|Treatment Part B|Study drug toxicity|63|||
124919865|NCT03138512|449336219|FG003|Treatment Part B|Study drug toxicity|3|||
124919866|NCT03138512|449336220|FG004|Treatment Part B|Study drug toxicity|45|||
124919867|NCT03138512|449336216|FG000|Treatment Part B|Death|0|||
124919868|NCT03138512|449336217|FG001|Treatment Part B|Death|0|||
124919869|NCT03138512|449336218|FG002|Treatment Part B|Death|1|||
124919870|NCT03138512|449336219|FG003|Treatment Part B|Death|0|||
124919871|NCT03138512|449336220|FG004|Treatment Part B|Death|0|||
124919872|NCT03138512|449336216|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
124919873|NCT03138512|449336217|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
124919874|NCT03138512|449336218|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
124919875|NCT03138512|449336219|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
124919876|NCT03138512|449336220|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
124919877|NCT03138512|449336216|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
124919878|NCT03138512|449336217|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
124919879|NCT03138512|449336218|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
124919880|NCT03138512|449336219|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
124919881|NCT03138512|449336220|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
124919882|NCT03138512|449336216|FG000|Treatment Part B|Participant withdrew consent|0|||
124919883|NCT03138512|449336217|FG001|Treatment Part B|Participant withdrew consent|0|||
124919884|NCT03138512|449336218|FG002|Treatment Part B|Participant withdrew consent|1|||
124919885|NCT03138512|449336219|FG003|Treatment Part B|Participant withdrew consent|1|||
124919886|NCT03138512|449336220|FG004|Treatment Part B|Participant withdrew consent|2|||
124919887|NCT03138512|449336216|FG000|Treatment Part B|Lost to Follow-up|0|||
124919888|NCT03138512|449336217|FG001|Treatment Part B|Lost to Follow-up|0|||
124762223|NCT04158583|448753612|FG008|Overall Study|Death|0|||
124762224|NCT04158583|448753613|FG009|Overall Study|Death|1|||
124919889|NCT03138512|449336218|FG002|Treatment Part B|Lost to Follow-up|0|||
124762225|NCT04158583|448753604|FG000|Overall Study|Clinical Progression Disease|0|||
124762226|NCT04158583|448753605|FG001|Overall Study|Clinical Progression Disease|0|||
124762227|NCT04158583|448753606|FG002|Overall Study|Clinical Progression Disease|0|||
124762228|NCT04158583|448753607|FG003|Overall Study|Clinical Progression Disease|1|||
124762229|NCT04158583|448753608|FG004|Overall Study|Clinical Progression Disease|0|||
124762230|NCT04158583|448753609|FG005|Overall Study|Clinical Progression Disease|0|||
124762231|NCT04158583|448753610|FG006|Overall Study|Clinical Progression Disease|0|||
124762232|NCT04158583|448753611|FG007|Overall Study|Clinical Progression Disease|0|||
124762233|NCT04158583|448753612|FG008|Overall Study|Clinical Progression Disease|0|||
124762234|NCT04158583|448753613|FG009|Overall Study|Clinical Progression Disease|0|||
124762235|NCT04158583|448753604|FG000|Overall Study|Clinical Progression|0|||
124762236|NCT04158583|448753605|FG001|Overall Study|Clinical Progression|0|||
124762237|NCT04158583|448753606|FG002|Overall Study|Clinical Progression|0|||
124762238|NCT04158583|448753607|FG003|Overall Study|Clinical Progression|0|||
124762239|NCT04158583|448753608|FG004|Overall Study|Clinical Progression|1|||
124762240|NCT04158583|448753609|FG005|Overall Study|Clinical Progression|0|||
124762241|NCT04158583|448753610|FG006|Overall Study|Clinical Progression|2|||
124762242|NCT04158583|448753611|FG007|Overall Study|Clinical Progression|0|||
124762243|NCT04158583|448753612|FG008|Overall Study|Clinical Progression|0|||
124762244|NCT04158583|448753613|FG009|Overall Study|Clinical Progression|0|||
124762245|NCT04158583|448753604|FG000|Overall Study|Clinical Deterioration|0|||
124762246|NCT04158583|448753605|FG001|Overall Study|Clinical Deterioration|0|||
124762247|NCT04158583|448753606|FG002|Overall Study|Clinical Deterioration|0|||
124762248|NCT04158583|448753607|FG003|Overall Study|Clinical Deterioration|1|||
124762249|NCT04158583|448753608|FG004|Overall Study|Clinical Deterioration|0|||
124762250|NCT04158583|448753609|FG005|Overall Study|Clinical Deterioration|0|||
124762251|NCT04158583|448753610|FG006|Overall Study|Clinical Deterioration|0|||
124762252|NCT04158583|448753611|FG007|Overall Study|Clinical Deterioration|0|||
124762253|NCT04158583|448753612|FG008|Overall Study|Clinical Deterioration|0|||
124762254|NCT04158583|448753613|FG009|Overall Study|Clinical Deterioration|1|||
124762255|NCT00320515|448753614|FG000|Overall Study|Death|33|||
124762256|NCT00320515|448753614|FG000|Overall Study|Lost to Follow-up|6|||
124762257|NCT00320515|448753614|FG000|Overall Study|Physician Decision|2|||
124762258|NCT00320515|448753614|FG000|Overall Study|Withdrawal by Subject|8|||
124762259|NCT01777776|448753615|FG000|Overall Study|Adverse Event|2|||
124762260|NCT01777776|448753616|FG001|Overall Study|Adverse Event|4|||
124762261|NCT01777776|448753617|FG002|Overall Study|Adverse Event|0|||
124762262|NCT01777776|448753618|FG003|Overall Study|Adverse Event|0|||
124762263|NCT01777776|448753615|FG000|Overall Study|Disease Progression|4|||
124762264|NCT01777776|448753616|FG001|Overall Study|Disease Progression|8|||
124762265|NCT01777776|448753617|FG002|Overall Study|Disease Progression|6|||
124762266|NCT01777776|448753618|FG003|Overall Study|Disease Progression|3|||
124762267|NCT01777776|448753615|FG000|Overall Study|Withdrawal by Subject|0|||
124762268|NCT01777776|448753616|FG001|Overall Study|Withdrawal by Subject|0|||
124762269|NCT01777776|448753617|FG002|Overall Study|Withdrawal by Subject|0|||
124762270|NCT01777776|448753618|FG003|Overall Study|Withdrawal by Subject|1|||
124762271|NCT00851786|448753619|FG000|Overall Study|Withdrawal by Subject|0|||
124762272|NCT00851786|448753620|FG001|Overall Study|Withdrawal by Subject|1|||
124762273|NCT00851786|448753619|FG000|Overall Study|Protocol Violation|0|||
124762274|NCT00851786|448753620|FG001|Overall Study|Protocol Violation|1|||
124762275|NCT00851786|448753619|FG000|Overall Study|Lost to Follow-up|1|||
124762276|NCT00851786|448753620|FG001|Overall Study|Lost to Follow-up|0|||
124762277|NCT00851786|448753619|FG000|Overall Study|Incarceration|1|||
124762278|NCT00851786|448753620|FG001|Overall Study|Incarceration|0|||
124762279|NCT00851786|448753619|FG000|Overall Study|Site Closure|1|||
124762280|NCT00851786|448753620|FG001|Overall Study|Site Closure|0|||
124762281|NCT00851786|448753619|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
124762282|NCT00851786|448753620|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
124762283|NCT03737123|448755832|FG000|Study Treatment|Adverse Event|2|||
124762284|NCT03737123|448755833|FG001|Study Treatment|Adverse Event|0|||
124762285|NCT03737123|448755832|FG000|Study Treatment|Disease Progression|2|||
124762286|NCT03737123|448755833|FG001|Study Treatment|Disease Progression|0|||
124762287|NCT03737123|448755832|FG000|Study Treatment|Withdrawal by Subject|2|||
124762288|NCT03737123|448755833|FG001|Study Treatment|Withdrawal by Subject|0|||
124762289|NCT03737123|448755832|FG000|Follow up|Death|1|||
124762290|NCT03737123|448755833|FG001|Follow up|Death|0|||
124762291|NCT03737123|448755832|FG000|Follow up|Withdrawal by Subject|1|||
124762292|NCT03737123|448755833|FG001|Follow up|Withdrawal by Subject|0|||
124762293|NCT03737123|448755832|FG000|Follow up|Termination of study|4|||
124762294|NCT03737123|448755833|FG001|Follow up|Termination of study|0|||
124762295|NCT04233801|448755845|FG000|Overall Study|Other than listed|0|||
124762296|NCT04233801|448755846|FG001|Overall Study|Other than listed|0|||
124762297|NCT04233801|448755847|FG002|Overall Study|Other than listed|1|||
124762298|NCT04233801|448755845|FG000|Overall Study|Withdrawal by Subject|0|||
124762299|NCT04233801|448755846|FG001|Overall Study|Withdrawal by Subject|2|||
124762300|NCT04233801|448755847|FG002|Overall Study|Withdrawal by Subject|3|||
124762301|NCT02792231|448755852|FG000|Overall Study|Patient/guardian decision|32|||
124762302|NCT02792231|448755853|FG001|Overall Study|Patient/guardian decision|42|||
124762303|NCT02792231|448755852|FG000|Overall Study|Adverse Event|15|||
124762304|NCT02792231|448755853|FG001|Overall Study|Adverse Event|11|||
124762305|NCT02792231|448755852|FG000|Overall Study|Physician Decision|14|||
124762306|NCT02792231|448755853|FG001|Overall Study|Physician Decision|12|||
124762307|NCT02792231|448755852|FG000|Overall Study|Lack of Efficacy|7|||
124762308|NCT02792231|448755853|FG001|Overall Study|Lack of Efficacy|9|||
124919890|NCT03138512|449336219|FG003|Treatment Part B|Lost to Follow-up|1|||
124919891|NCT03138512|449336220|FG004|Treatment Part B|Lost to Follow-up|0|||
124919892|NCT03138512|449336216|FG000|Treatment Part B|Poor/non-compliance|0|||
124919893|NCT03138512|449336217|FG001|Treatment Part B|Poor/non-compliance|0|||
124919894|NCT03138512|449336218|FG002|Treatment Part B|Poor/non-compliance|1|||
124919895|NCT03138512|449336219|FG003|Treatment Part B|Poor/non-compliance|1|||
124919896|NCT03138512|449336220|FG004|Treatment Part B|Poor/non-compliance|1|||
124919897|NCT03138512|449336216|FG000|Treatment Part B|Other reasons|0|||
124919898|NCT03138512|449336217|FG001|Treatment Part B|Other reasons|0|||
124919899|NCT03138512|449336218|FG002|Treatment Part B|Other reasons|3|||
124919900|NCT03138512|449336219|FG003|Treatment Part B|Other reasons|1|||
124919901|NCT03138512|449336220|FG004|Treatment Part B|Other reasons|5|||
124919902|NCT03332017|449336221|FG000|Overall Study|Lost to Follow-up|1|||
124919903|NCT03332017|449336222|FG001|Overall Study|Lost to Follow-up|2|||
124919904|NCT03332017|449336221|FG000|Overall Study|Death|17|||
124919905|NCT03332017|449336222|FG001|Overall Study|Death|16|||
124919906|NCT03332017|449336221|FG000|Overall Study|Withdrawal by Subject|6|||
124919907|NCT03332017|449336222|FG001|Overall Study|Withdrawal by Subject|14|||
124919908|NCT03332017|449336221|FG000|Overall Study|Other|1|||
124919909|NCT03332017|449336222|FG001|Overall Study|Other|3|||
124919910|NCT03332017|449336221|FG000|Overall Study|Remained in Study (Ongoing)|47|||
124919911|NCT03332017|449336222|FG001|Overall Study|Remained in Study (Ongoing)|110|||
124919912|NCT01261312|449336223|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
124919913|NCT01261312|449336224|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
124919914|NCT01261312|449336225|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
124919915|NCT01261312|449336226|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919916|NCT01261312|449336227|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919917|NCT01261312|449336228|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919918|NCT01261312|449336229|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919919|NCT01261312|449336230|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919920|NCT01261312|449336231|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919921|NCT01261312|449336232|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919922|NCT01261312|449336233|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919923|NCT01261312|449336234|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919924|NCT01261312|449336235|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
124919925|NCT01261312|449336223|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
124919926|NCT01261312|449336224|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
124919927|NCT01261312|449336225|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919928|NCT01261312|449336226|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919929|NCT01261312|449336227|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919930|NCT01261312|449336228|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919931|NCT01261312|449336229|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919932|NCT01261312|449336230|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919933|NCT01261312|449336231|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919934|NCT01261312|449336232|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919935|NCT01261312|449336233|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919936|NCT01261312|449336234|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919937|NCT01261312|449336235|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
124919938|NCT01261312|449336223|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
124919939|NCT01261312|449336224|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
124919940|NCT01261312|449336225|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919941|NCT01261312|449336226|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919942|NCT01261312|449336227|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124451757|NCT01854645|447615165|FG001|Overall Study|Lack of Efficacy|12|||
124451758|NCT01854645|447615166|FG002|Overall Study|Lack of Efficacy|9|||
124451759|NCT01854645|447615167|FG003|Overall Study|Lack of Efficacy|3|||
124451760|NCT01854645|447615168|FG004|Overall Study|Lack of Efficacy|9|||
124451761|NCT01854645|447615164|FG000|Overall Study|Adverse Event|33|||
124451762|NCT01854645|447615165|FG001|Overall Study|Adverse Event|31|||
124451763|NCT01854645|447615166|FG002|Overall Study|Adverse Event|19|||
124451764|NCT01854645|447615167|FG003|Overall Study|Adverse Event|20|||
124451765|NCT01854645|447615168|FG004|Overall Study|Adverse Event|11|||
124451766|NCT01202279|447615171|FG000|Overall Study|Adverse Event|8|||
124451767|NCT01202279|447615172|FG001|Overall Study|Adverse Event|6|||
124451768|NCT01202279|447615171|FG000|Overall Study|Withdrawal by Subject|13|||
124451769|NCT01202279|447615172|FG001|Overall Study|Withdrawal by Subject|10|||
124451770|NCT01202279|447615171|FG000|Overall Study|Physician Decision|0|||
124451771|NCT01202279|447615172|FG001|Overall Study|Physician Decision|1|||
124762309|NCT02792231|448755852|FG000|Overall Study|Lost to Follow-up|9|||
124919943|NCT01261312|449336228|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919944|NCT01261312|449336229|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124695591|NCT00576407|448505906|FG000|Overall Study|Death|7|||
124695592|NCT00576407|448505906|FG000|Overall Study|Physician Decision|1|||
124695593|NCT00621322|448505907|FG000|Overall Study|Lost to Follow-up|0|||
124695594|NCT00621322|448505908|FG001|Overall Study|Lost to Follow-up|0|||
124695595|NCT00621322|448505909|FG002|Overall Study|Lost to Follow-up|0|||
124919945|NCT01261312|449336230|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919946|NCT01261312|449336231|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919947|NCT01261312|449336232|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919948|NCT01261312|449336233|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919949|NCT01261312|449336234|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919950|NCT01261312|449336235|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
124919951|NCT01261312|449336223|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
124919952|NCT01261312|449336224|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
124919953|NCT01261312|449336225|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919954|NCT01261312|449336226|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919955|NCT01261312|449336227|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919956|NCT01261312|449336228|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919957|NCT01261312|449336229|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919958|NCT01261312|449336230|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919959|NCT01261312|449336231|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919960|NCT01261312|449336232|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919961|NCT01261312|449336233|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919962|NCT01261312|449336234|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919963|NCT01261312|449336235|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
124919964|NCT01261312|449336223|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
124919965|NCT01261312|449336224|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
124919966|NCT01261312|449336225|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
124919967|NCT01261312|449336226|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919968|NCT01261312|449336227|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919969|NCT01261312|449336228|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919970|NCT01261312|449336229|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919971|NCT01261312|449336230|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919972|NCT01261312|449336231|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919973|NCT01261312|449336232|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919974|NCT01261312|449336233|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919975|NCT01261312|449336234|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919976|NCT01261312|449336235|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
124919977|NCT01261312|449336223|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
124919978|NCT01261312|449336224|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
124919979|NCT01261312|449336225|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
124919980|NCT01261312|449336226|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919981|NCT01261312|449336227|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919982|NCT01261312|449336228|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919983|NCT01261312|449336229|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919984|NCT01261312|449336230|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919985|NCT01261312|449336231|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919986|NCT01261312|449336232|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919987|NCT01261312|449336233|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919988|NCT01261312|449336234|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919989|NCT01261312|449336235|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
124919990|NCT01261312|449336223|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
124919991|NCT01261312|449336224|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124919992|NCT01261312|449336225|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
124919993|NCT01261312|449336226|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124919994|NCT01261312|449336227|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124919995|NCT01261312|449336228|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124919996|NCT01261312|449336229|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124919997|NCT01261312|449336230|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124919998|NCT01261312|449336231|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124919999|NCT01261312|449336232|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124920000|NCT01261312|449336233|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124920001|NCT01261312|449336234|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124695596|NCT00621322|448505910|FG003|Overall Study|Lost to Follow-up|0|||
124920002|NCT01261312|449336235|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
124920003|NCT01261312|449336223|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920004|NCT01261312|449336224|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920005|NCT01261312|449336225|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920006|NCT01261312|449336226|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
124920007|NCT01261312|449336227|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
124920008|NCT01261312|449336228|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
124920009|NCT01261312|449336229|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920010|NCT01261312|449336230|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920011|NCT01261312|449336231|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920012|NCT01261312|449336232|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920013|NCT01261312|449336233|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920014|NCT01261312|449336234|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920015|NCT01261312|449336235|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
124920016|NCT01261312|449336223|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920017|NCT01261312|449336224|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920018|NCT01261312|449336225|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920019|NCT01261312|449336226|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920020|NCT01261312|449336227|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
124920021|NCT01261312|449336228|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
124920022|NCT01261312|449336229|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920023|NCT01261312|449336230|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920024|NCT01261312|449336231|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920025|NCT01261312|449336232|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920026|NCT01261312|449336233|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920027|NCT01261312|449336234|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920028|NCT01261312|449336235|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
124920029|NCT01261312|449336223|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920030|NCT01261312|449336224|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920031|NCT01261312|449336225|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920032|NCT01261312|449336226|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920033|NCT01261312|449336227|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
124920034|NCT01261312|449336228|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
124920035|NCT01261312|449336229|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920036|NCT01261312|449336230|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920037|NCT01261312|449336231|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920038|NCT01261312|449336232|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920039|NCT01261312|449336233|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920040|NCT01261312|449336234|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920041|NCT01261312|449336235|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
124920042|NCT01261312|449336223|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920043|NCT01261312|449336224|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920044|NCT01261312|449336225|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920045|NCT01261312|449336226|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
124920046|NCT01261312|449336227|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
124920047|NCT01261312|449336228|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
124920048|NCT01261312|449336229|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920049|NCT01261312|449336230|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920050|NCT01261312|449336231|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920051|NCT01261312|449336232|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920052|NCT01261312|449336233|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920053|NCT01261312|449336234|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920054|NCT01261312|449336235|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
124920055|NCT01261312|449336223|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920056|NCT01261312|449336224|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920057|NCT01261312|449336225|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920058|NCT01261312|449336226|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920059|NCT01261312|449336227|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920060|NCT01261312|449336228|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
124920061|NCT01261312|449336229|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920062|NCT01261312|449336230|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920063|NCT01261312|449336231|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124762310|NCT02792231|448755853|FG001|Overall Study|Lost to Follow-up|5|||
124920064|NCT01261312|449336232|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124451772|NCT01202279|447615171|FG000|Overall Study|Lost to Follow-up|10|||
124762311|NCT02792231|448755852|FG000|Overall Study|Pregnancy|1|||
124920065|NCT01261312|449336233|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920066|NCT01261312|449336234|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920067|NCT01261312|449336235|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
124920068|NCT01261312|449336223|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920069|NCT01261312|449336224|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920070|NCT01261312|449336225|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920071|NCT01261312|449336226|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
124920072|NCT01261312|449336227|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
124920073|NCT01261312|449336228|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
124920074|NCT01261312|449336229|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920075|NCT01261312|449336230|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920076|NCT01261312|449336231|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920077|NCT01261312|449336232|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920078|NCT01261312|449336233|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920079|NCT01261312|449336234|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920080|NCT01261312|449336235|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
124920081|NCT01261312|449336223|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920082|NCT01261312|449336224|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920083|NCT01261312|449336225|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920084|NCT01261312|449336226|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
124920085|NCT01261312|449336227|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
124920086|NCT01261312|449336228|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
124920087|NCT01261312|449336229|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920088|NCT01261312|449336230|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920089|NCT01261312|449336231|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920090|NCT01261312|449336232|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920091|NCT01261312|449336233|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920092|NCT01261312|449336234|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920093|NCT01261312|449336235|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
124920094|NCT01261312|449336223|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920095|NCT01261312|449336224|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920096|NCT01261312|449336225|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920097|NCT01261312|449336226|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920098|NCT01261312|449336227|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920099|NCT01261312|449336228|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920100|NCT01261312|449336229|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
124920101|NCT01261312|449336230|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
124920102|NCT01261312|449336231|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
124920103|NCT01261312|449336232|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920104|NCT01261312|449336233|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920105|NCT01261312|449336234|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920106|NCT01261312|449336235|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
124920107|NCT01261312|449336223|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920108|NCT01261312|449336224|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920109|NCT01261312|449336225|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920110|NCT01261312|449336226|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920111|NCT01261312|449336227|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920112|NCT01261312|449336228|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920113|NCT01261312|449336229|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920114|NCT01261312|449336230|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
124920115|NCT01261312|449336231|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
124920116|NCT01261312|449336232|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920117|NCT01261312|449336233|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920118|NCT01261312|449336234|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920119|NCT01261312|449336235|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
124920120|NCT01261312|449336223|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920121|NCT01261312|449336224|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920122|NCT01261312|449336225|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920123|NCT01261312|449336226|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124695597|NCT00621322|448505911|FG004|Overall Study|Lost to Follow-up|1|||
124920124|NCT01261312|449336227|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920125|NCT01261312|449336228|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920126|NCT01261312|449336229|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
124920127|NCT01261312|449336230|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
124920128|NCT01261312|449336231|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
124695598|NCT00621322|448505912|FG005|Overall Study|Lost to Follow-up|0|||
124695599|NCT00621322|448505907|FG000|Overall Study|Physician Decision|0|||
124695600|NCT00621322|448505908|FG001|Overall Study|Physician Decision|0|||
124920129|NCT01261312|449336232|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920130|NCT01261312|449336233|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920131|NCT01261312|449336234|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124920132|NCT01261312|449336235|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
124695601|NCT00621322|448505909|FG002|Overall Study|Physician Decision|1|||
124920133|NCT01261312|449336223|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
124920134|NCT01261312|449336224|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
124920135|NCT01261312|449336225|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
124920136|NCT01261312|449336226|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
124920137|NCT01261312|449336227|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
124920138|NCT01261312|449336228|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
124920139|NCT01261312|449336229|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
124920140|NCT01261312|449336230|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
124920141|NCT01261312|449336231|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
124920142|NCT01261312|449336232|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
124920143|NCT01261312|449336233|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
124920144|NCT01261312|449336234|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
124920145|NCT01261312|449336235|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
124920146|NCT01261312|449336223|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920147|NCT01261312|449336224|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920148|NCT01261312|449336225|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920149|NCT01261312|449336226|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920150|NCT01261312|449336227|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920151|NCT01261312|449336228|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920152|NCT01261312|449336229|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
124920153|NCT01261312|449336230|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
124920154|NCT01261312|449336231|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
124920155|NCT01261312|449336232|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920156|NCT01261312|449336233|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920157|NCT01261312|449336234|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920158|NCT01261312|449336235|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
124920159|NCT01261312|449336223|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920160|NCT01261312|449336224|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920161|NCT01261312|449336225|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920162|NCT01261312|449336226|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920163|NCT01261312|449336227|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920164|NCT01261312|449336228|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920165|NCT01261312|449336229|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
124920166|NCT01261312|449336230|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
124920167|NCT01261312|449336231|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
124920168|NCT01261312|449336232|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920169|NCT01261312|449336233|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920170|NCT01261312|449336234|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920171|NCT01261312|449336235|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
124920172|NCT01261312|449336223|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920173|NCT01261312|449336224|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920174|NCT01261312|449336225|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920175|NCT01261312|449336226|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920176|NCT01261312|449336227|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124695602|NCT00621322|448505910|FG003|Overall Study|Physician Decision|1|||
124695603|NCT00621322|448505911|FG004|Overall Study|Physician Decision|0|||
124695604|NCT00621322|448505912|FG005|Overall Study|Physician Decision|0|||
124695605|NCT00621322|448505907|FG000|Overall Study|Withdrawal by Subject|0|||
124695606|NCT00621322|448505908|FG001|Overall Study|Withdrawal by Subject|0|||
124695607|NCT00621322|448505909|FG002|Overall Study|Withdrawal by Subject|0|||
124695608|NCT00621322|448505910|FG003|Overall Study|Withdrawal by Subject|1|||
124695609|NCT00621322|448505911|FG004|Overall Study|Withdrawal by Subject|0|||
124695610|NCT00621322|448505912|FG005|Overall Study|Withdrawal by Subject|2|||
124695611|NCT00621322|448505907|FG000|Overall Study|Migrated/moved from study area|1|||
124920177|NCT01261312|449336228|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920178|NCT01261312|449336229|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
124920179|NCT01261312|449336230|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
124920180|NCT01261312|449336231|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
124920181|NCT01261312|449336232|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920182|NCT01261312|449336233|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920183|NCT01261312|449336234|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920184|NCT01261312|449336235|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
124920185|NCT01261312|449336223|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124920186|NCT01261312|449336224|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124920187|NCT01261312|449336225|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124695612|NCT00621322|448505908|FG001|Overall Study|Migrated/moved from study area|0|||
124695613|NCT00621322|448505909|FG002|Overall Study|Migrated/moved from study area|1|||
124695614|NCT00621322|448505910|FG003|Overall Study|Migrated/moved from study area|1|||
124695615|NCT00621322|448505911|FG004|Overall Study|Migrated/moved from study area|0|||
124695616|NCT00621322|448505912|FG005|Overall Study|Migrated/moved from study area|2|||
124695617|NCT00756444|448505913|FG000|Overall Study|Adverse Event|1|||
124695618|NCT00756444|448505914|FG001|Overall Study|Adverse Event|1|||
124695619|NCT00756444|448505913|FG000|Overall Study|Withdrawal by Subject|6|||
124695620|NCT00756444|448505914|FG001|Overall Study|Withdrawal by Subject|8|||
124695621|NCT00756444|448505913|FG000|Overall Study|Lost to Follow-up|0|||
124695622|NCT00756444|448505914|FG001|Overall Study|Lost to Follow-up|1|||
124695623|NCT00756444|448505913|FG000|Overall Study|Death|5|||
124695624|NCT00756444|448505914|FG001|Overall Study|Death|4|||
124695625|NCT00756444|448505913|FG000|Overall Study|Disease Progression|2|||
124695626|NCT00756444|448505914|FG001|Overall Study|Disease Progression|7|||
124695627|NCT00756444|448505913|FG000|Overall Study|Ineligibility Determined|1|||
124695628|NCT00756444|448505914|FG001|Overall Study|Ineligibility Determined|0|||
124695629|NCT00564070|448505915|FG000|Overall Study|Lost to Follow-up|9|||
124695630|NCT00564070|448505916|FG001|Overall Study|Lost to Follow-up|7|||
124695631|NCT00564070|448505915|FG000|Overall Study|Worsening depression, referred to care|3|||
124695632|NCT00564070|448505916|FG001|Overall Study|Worsening depression, referred to care|0|||
124695633|NCT03142334|448505923|FG000|Overall Study|Death|18|||
124695634|NCT03142334|448505924|FG001|Overall Study|Death|33|||
124695635|NCT03142334|448505923|FG000|Overall Study|Withdrawal by Subject|15|||
124695636|NCT03142334|448505924|FG001|Overall Study|Withdrawal by Subject|11|||
124695637|NCT03142334|448505923|FG000|Overall Study|Ongoing on trial follow up|463|||
124920188|NCT01261312|449336226|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124920189|NCT01261312|449336227|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124920190|NCT01261312|449336228|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124920191|NCT01261312|449336229|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124920192|NCT01261312|449336230|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124920193|NCT01261312|449336231|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
124920194|NCT01261312|449336232|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
124920195|NCT01261312|449336233|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
124920196|NCT01261312|449336234|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
124920197|NCT01261312|449336235|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
124920198|NCT01261312|449336223|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920199|NCT01261312|449336224|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920200|NCT01261312|449336225|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920201|NCT01261312|449336226|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920202|NCT01261312|449336227|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920203|NCT01261312|449336228|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920204|NCT01261312|449336229|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920205|NCT01261312|449336230|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920206|NCT01261312|449336231|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920207|NCT01261312|449336232|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
124920208|NCT01261312|449336233|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
124920209|NCT01261312|449336234|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
124920210|NCT01261312|449336235|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
124920211|NCT01261312|449336223|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920212|NCT01261312|449336224|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920213|NCT01261312|449336225|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920214|NCT01261312|449336226|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920215|NCT01261312|449336227|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920216|NCT01261312|449336228|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920217|NCT01261312|449336229|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920218|NCT01261312|449336230|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920219|NCT01261312|449336231|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
124920220|NCT01261312|449336232|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
124920221|NCT01261312|449336233|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
124920222|NCT01261312|449336234|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
124920223|NCT01261312|449336235|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
124451773|NCT01202279|447615172|FG001|Overall Study|Lost to Follow-up|7|||
124451774|NCT01202279|447615171|FG000|Overall Study|Protocol Violation|1|||
124451775|NCT01202279|447615172|FG001|Overall Study|Protocol Violation|1|||
124451776|NCT01202279|447615171|FG000|Overall Study|study compliance|5|||
124451777|NCT01202279|447615172|FG001|Overall Study|study compliance|2|||
124695638|NCT03142334|448505924|FG001|Overall Study|Ongoing on trial follow up|454|||
124695639|NCT03071965|448505925|FG000|Overall Study|Adverse Event|0|||
124695640|NCT03071965|448505926|FG001|Overall Study|Adverse Event|0|||
124695641|NCT03071965|448505927|FG002|Overall Study|Adverse Event|1|||
124762312|NCT02792231|448755853|FG001|Overall Study|Pregnancy|3|||
124920224|NCT01261312|449336223|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920225|NCT01261312|449336224|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920226|NCT01261312|449336225|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920227|NCT01261312|449336226|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920228|NCT01261312|449336227|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920229|NCT01261312|449336228|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920230|NCT01261312|449336229|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920231|NCT01261312|449336230|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920232|NCT01261312|449336231|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
124920233|NCT01261312|449336232|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
124920234|NCT01261312|449336233|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
124920235|NCT01261312|449336234|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
124920236|NCT01261312|449336235|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
124920237|NCT01261312|449336223|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920238|NCT01261312|449336224|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920239|NCT01261312|449336225|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920240|NCT01261312|449336226|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920241|NCT01261312|449336227|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920242|NCT01261312|449336228|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920243|NCT01261312|449336229|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920244|NCT01261312|449336230|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920245|NCT01261312|449336231|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
124920246|NCT01261312|449336232|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
124920247|NCT01261312|449336233|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
124920248|NCT01261312|449336234|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
124920249|NCT01261312|449336235|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
124920250|NCT01261312|449336223|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920251|NCT01261312|449336224|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920252|NCT01261312|449336225|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920253|NCT01261312|449336226|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920254|NCT01261312|449336227|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920255|NCT01261312|449336228|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920256|NCT01261312|449336229|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920257|NCT01261312|449336230|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920258|NCT01261312|449336231|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
124920259|NCT01261312|449336232|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
124920260|NCT01261312|449336233|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
124920261|NCT01261312|449336234|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
124920262|NCT01261312|449336235|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
124920263|NCT01261312|449336223|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920264|NCT01261312|449336224|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920265|NCT01261312|449336225|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920266|NCT01261312|449336226|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920267|NCT01261312|449336227|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920268|NCT01261312|449336228|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920269|NCT01261312|449336229|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920270|NCT01261312|449336230|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920271|NCT01261312|449336231|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
124920272|NCT01261312|449336232|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
124920273|NCT01261312|449336233|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
124920274|NCT01261312|449336234|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
124920275|NCT01261312|449336235|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
124920276|NCT03436745|449336242|FG000|Overall Study|Ineligible|0|||
124920277|NCT03436745|449336243|FG001|Overall Study|Ineligible|0|||
124920278|NCT03436745|449336244|FG002|Overall Study|Ineligible|1|||
124920279|NCT03406871|449336248|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
124920280|NCT03406871|449336249|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
124920281|NCT03406871|449336250|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
124762313|NCT02792231|448755852|FG000|Overall Study|Non-compliance with study treatment|2|||
124762314|NCT02792231|448755853|FG001|Overall Study|Non-compliance with study treatment|1|||
124920282|NCT03406871|449336248|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
124920283|NCT03406871|449336249|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
124920284|NCT03406871|449336250|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
124920285|NCT03406871|449336248|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
124920286|NCT03406871|449336249|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
124920287|NCT03406871|449336250|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
124920288|NCT03406871|449336248|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
124920289|NCT03406871|449336249|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
124920290|NCT03406871|449336250|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
124920291|NCT03406871|449336248|FG000|Expansion Cohort(Final Analysis)|Death|0|||
124920292|NCT03406871|449336249|FG001|Expansion Cohort(Final Analysis)|Death|1|||
124920293|NCT03406871|449336250|FG002|Expansion Cohort(Final Analysis)|Death|0|||
124920294|NCT03406871|449336248|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
124920295|NCT03406871|449336249|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
124920296|NCT03406871|449336250|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
124920297|NCT04588298|449336251|FG000|Overall Study|Adverse Event|0|||
124920298|NCT04588298|449336252|FG001|Overall Study|Adverse Event|0|||
124920299|NCT04588298|449336253|FG002|Overall Study|Adverse Event|1|||
124920300|NCT04588298|449336254|FG003|Overall Study|Adverse Event|0|||
124920301|NCT04588298|449336255|FG004|Overall Study|Adverse Event|2|||
124920302|NCT04588298|449336251|FG000|Overall Study|Withdrawal by Subject|1|||
124920303|NCT04588298|449336252|FG001|Overall Study|Withdrawal by Subject|0|||
124920304|NCT04588298|449336253|FG002|Overall Study|Withdrawal by Subject|0|||
124920305|NCT04588298|449336254|FG003|Overall Study|Withdrawal by Subject|1|||
124920306|NCT04588298|449336255|FG004|Overall Study|Withdrawal by Subject|0|||
124920307|NCT02120456|449336262|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
124920308|NCT02120456|449336263|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
124920309|NCT02120456|449336264|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
124920310|NCT02120456|449336265|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
124920311|NCT02120456|449336266|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
124920312|NCT02120456|449336267|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
124920313|NCT02120456|449336268|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
124920314|NCT02120456|449336269|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
124920315|NCT02120456|449336270|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
124920316|NCT02120456|449336262|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
124920317|NCT02120456|449336263|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
124920318|NCT02120456|449336264|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
124920319|NCT02120456|449336265|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
124920320|NCT02120456|449336266|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
124920321|NCT02120456|449336267|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
124920322|NCT02120456|449336268|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
124920323|NCT02120456|449336269|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
124920324|NCT02120456|449336270|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
124920325|NCT02120456|449336262|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
124920326|NCT02120456|449336263|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
124920327|NCT02120456|449336264|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
124920328|NCT02120456|449336265|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
124920329|NCT02120456|449336266|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
124920330|NCT02120456|449336267|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
124920331|NCT02120456|449336268|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
124920332|NCT02120456|449336269|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
124920333|NCT02120456|449336270|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
124920334|NCT05520190|449336271|FG000|Overall Study|Lost to Follow-up|7|||
124920335|NCT05520190|449336271|FG000|Overall Study|Withdrawal by Subject|2|||
124920336|NCT03476187|449336273|FG000|Overall Study|Protocol Violation|7|||
124920337|NCT03476187|449336273|FG000|Overall Study|Physician Decision|5|||
124920338|NCT04060355|449337967|FG000|Overall Study|Lost to Follow-up|41|||
124920339|NCT04956861|449337973|FG000|Overall Study|Withdrawal by Subject|4|||
124920340|NCT04956861|449337974|FG001|Overall Study|Withdrawal by Subject|4|||
124920341|NCT04956861|449337975|FG002|Overall Study|Withdrawal by Subject|2|||
124920342|NCT04956861|449337973|FG000|Overall Study|Physician Decision|4|||
124451778|NCT00475722|447615175|FG000|Overall Study|Withdrawal by Subject|12|||
124451779|NCT00475722|447615176|FG001|Overall Study|Withdrawal by Subject|12|||
124451780|NCT00475722|447615175|FG000|Overall Study|Protocol Violation|3|||
124451781|NCT00475722|447615176|FG001|Overall Study|Protocol Violation|0|||
124451782|NCT00916279|447615177|FG000|Overall Study|Death|2|||
124451783|NCT00916279|447615177|FG000|Overall Study|Lost to Follow-up|2|||
124451784|NCT02109562|447615178|FG000|Overall Study|Insufficient clinical response|2|||
124451785|NCT02109562|447615179|FG001|Overall Study|Insufficient clinical response|0|||
124451786|NCT02109562|447615180|FG002|Overall Study|Insufficient clinical response|4|||
124920343|NCT04956861|449337974|FG001|Overall Study|Physician Decision|5|||
124920344|NCT04956861|449337975|FG002|Overall Study|Physician Decision|1|||
124920345|NCT05215314|449337976|FG000|Overall Study|Lost to Follow-up|2|||
124920346|NCT05215314|449337977|FG001|Overall Study|Lost to Follow-up|2|||
124920347|NCT05215314|449337976|FG000|Overall Study|Withdrawal by Subject|2|||
124920348|NCT05215314|449337977|FG001|Overall Study|Withdrawal by Subject|0|||
124920349|NCT05215314|449337976|FG000|Overall Study|Physician Decision|1|||
124920350|NCT05215314|449337977|FG001|Overall Study|Physician Decision|0|||
124920351|NCT04294225|449337978|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
124920352|NCT04294225|449337978|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
124920353|NCT04294225|449337978|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
124920354|NCT04294225|449337978|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
124920355|NCT04294225|449337978|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
124920356|NCT01580488|449337980|FG000|Overall Study|Withdrawal by Subject|1|||
124920357|NCT03738228|449337981|FG000|Overall Study|Never received study treatment|2|||
124920358|NCT03738228|449337982|FG001|Overall Study|Never received study treatment|2|||
124920359|NCT03338790|449337990|FG000|Overall Study|Disease Progression|65|||
124920360|NCT03338790|449337991|FG001|Overall Study|Disease Progression|43|||
124920361|NCT03338790|449337992|FG002|Overall Study|Disease Progression|50|||
124920362|NCT03338790|449337993|FG003|Overall Study|Disease Progression|37|||
124920363|NCT03338790|449337990|FG000|Overall Study|Study Drug Toxicity|9|||
124920364|NCT03338790|449337991|FG001|Overall Study|Study Drug Toxicity|8|||
124920365|NCT03338790|449337992|FG002|Overall Study|Study Drug Toxicity|15|||
124920366|NCT03338790|449337993|FG003|Overall Study|Study Drug Toxicity|0|||
124920367|NCT03338790|449337990|FG000|Overall Study|Death|1|||
124920368|NCT03338790|449337991|FG001|Overall Study|Death|1|||
124920369|NCT03338790|449337992|FG002|Overall Study|Death|1|||
124920370|NCT03338790|449337993|FG003|Overall Study|Death|0|||
124920371|NCT03338790|449337990|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
124920372|NCT03338790|449337991|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
124920373|NCT03338790|449337992|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
124920374|NCT03338790|449337993|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
124920375|NCT03338790|449337990|FG000|Overall Study|Participant request to discontinue study treatment|3|||
124920376|NCT03338790|449337991|FG001|Overall Study|Participant request to discontinue study treatment|3|||
124920377|NCT03338790|449337992|FG002|Overall Study|Participant request to discontinue study treatment|2|||
124920378|NCT03338790|449337993|FG003|Overall Study|Participant request to discontinue study treatment|1|||
124920379|NCT03338790|449337990|FG000|Overall Study|Poor/non-compliance|0|||
124920380|NCT03338790|449337991|FG001|Overall Study|Poor/non-compliance|1|||
124920381|NCT03338790|449337992|FG002|Overall Study|Poor/non-compliance|0|||
124920382|NCT03338790|449337993|FG003|Overall Study|Poor/non-compliance|0|||
124920383|NCT03338790|449337990|FG000|Overall Study|Participant withdrew consent|1|||
124920384|NCT03338790|449337991|FG001|Overall Study|Participant withdrew consent|0|||
124920385|NCT03338790|449337992|FG002|Overall Study|Participant withdrew consent|1|||
124920386|NCT03338790|449337993|FG003|Overall Study|Participant withdrew consent|1|||
124920387|NCT03338790|449337990|FG000|Overall Study|Other reasons|0|||
124920388|NCT03338790|449337991|FG001|Overall Study|Other reasons|5|||
124920389|NCT03338790|449337992|FG002|Overall Study|Other reasons|0|||
124920390|NCT03338790|449337993|FG003|Overall Study|Other reasons|2|||
124920391|NCT03338790|449337990|FG000|Overall Study|Not reported|0|||
124920392|NCT03338790|449337991|FG001|Overall Study|Not reported|0|||
124920393|NCT03338790|449337992|FG002|Overall Study|Not reported|1|||
124920394|NCT03338790|449337993|FG003|Overall Study|Not reported|0|||
124920395|NCT03338790|449337990|FG000|Overall Study|Completed treatment period|1|||
124920396|NCT03338790|449337991|FG001|Overall Study|Completed treatment period|2|||
124920397|NCT03338790|449337992|FG002|Overall Study|Completed treatment period|0|||
124920398|NCT03338790|449337993|FG003|Overall Study|Completed treatment period|0|||
124920399|NCT03366649|449337995|FG000|Overall Study|Failed preoperative screening|4|||
124920400|NCT03366649|449337996|FG001|Overall Study|Failed preoperative screening|0|||
124920401|NCT03366649|449337997|FG002|Overall Study|Failed preoperative screening|0|||
124920402|NCT03366649|449337995|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
124920403|NCT03366649|449337996|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
124920404|NCT03366649|449337997|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
124920405|NCT03673111|449337998|FG000|Overall Study|Protocol Violation|0|||
124920406|NCT03673111|449337999|FG001|Overall Study|Protocol Violation|0|||
124920407|NCT03673111|449338000|FG002|Overall Study|Protocol Violation|0|||
124920408|NCT03673111|449338001|FG003|Overall Study|Protocol Violation|0|||
124920409|NCT03673111|449338002|FG004|Overall Study|Protocol Violation|0|||
124920410|NCT03673111|449338003|FG005|Overall Study|Protocol Violation|0|||
124920411|NCT03673111|449338004|FG006|Overall Study|Protocol Violation|0|||
124920412|NCT03673111|449338005|FG007|Overall Study|Protocol Violation|0|||
124920413|NCT03673111|449338006|FG008|Overall Study|Protocol Violation|0|||
124920414|NCT03673111|449338007|FG009|Overall Study|Protocol Violation|0|||
124920415|NCT03673111|449338008|FG010|Overall Study|Protocol Violation|1|||
124920416|NCT03673111|449338009|FG011|Overall Study|Protocol Violation|0|||
124920417|NCT03673111|449338010|FG012|Overall Study|Protocol Violation|0|||
124920418|NCT03673111|449338011|FG013|Overall Study|Protocol Violation|0|||
124920419|NCT03673111|449337998|FG000|Overall Study|Adverse Event|1|||
124920420|NCT03673111|449337999|FG001|Overall Study|Adverse Event|0|||
124920421|NCT03673111|449338000|FG002|Overall Study|Adverse Event|0|||
124920422|NCT03673111|449338001|FG003|Overall Study|Adverse Event|0|||
124762315|NCT02792231|448755852|FG000|Overall Study|Protocol deviation|2|||
124762316|NCT02792231|448755853|FG001|Overall Study|Protocol deviation|0|||
124762317|NCT02792231|448755852|FG000|Overall Study|Technical problems|0|||
124762318|NCT02792231|448755853|FG001|Overall Study|Technical problems|1|||
124762319|NCT05196828|448755854|FG000|Overall Study|Withdrawal by Subject|2|||
124762320|NCT05196828|448755855|FG001|Overall Study|Withdrawal by Subject|0|||
124920423|NCT03673111|449338002|FG004|Overall Study|Adverse Event|0|||
124920424|NCT03673111|449338003|FG005|Overall Study|Adverse Event|0|||
124920425|NCT03673111|449338004|FG006|Overall Study|Adverse Event|0|||
124920426|NCT03673111|449338005|FG007|Overall Study|Adverse Event|0|||
124920427|NCT03673111|449338006|FG008|Overall Study|Adverse Event|0|||
124920428|NCT03673111|449338007|FG009|Overall Study|Adverse Event|0|||
124920429|NCT03673111|449338008|FG010|Overall Study|Adverse Event|0|||
124920430|NCT03673111|449338009|FG011|Overall Study|Adverse Event|0|||
124920431|NCT03673111|449338010|FG012|Overall Study|Adverse Event|0|||
124920432|NCT03673111|449338011|FG013|Overall Study|Adverse Event|0|||
124920433|NCT03846505|449338012|FG000|Treatment Phase|Withdrawal by Subject|9|||
124920434|NCT03846505|449338013|FG001|Treatment Phase|Withdrawal by Subject|11|||
124920435|NCT03846505|449338012|FG000|Treatment Phase|Lost to Follow-up|6|||
124920436|NCT03846505|449338013|FG001|Treatment Phase|Lost to Follow-up|2|||
124920437|NCT03846505|449338012|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
124920438|NCT03846505|449338013|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
124920439|NCT03846505|449338012|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
124451787|NCT02109562|447615178|FG000|Overall Study|Adverse Event|0|||
124762321|NCT05196828|448755854|FG000|Overall Study|Lost to Follow-up|0|||
124762322|NCT05196828|448755855|FG001|Overall Study|Lost to Follow-up|4|||
124762323|NCT05196828|448755854|FG000|Overall Study|Adverse Event|1|||
124762324|NCT05196828|448755855|FG001|Overall Study|Adverse Event|0|||
124920440|NCT03846505|449338013|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
124920441|NCT01744782|449338017|FG000|Overall Study|Death|1|||
124920442|NCT04649359|449338018|FG000|Overall Study|Withdrawal by Subject|7|||
124545424|NCT03792633|447951203|FG001|Overall Study|Screen fail|0|||
124545425|NCT03792633|447951202|FG000|Overall Study|Second malignancy|0|||
124762325|NCT02469623|448755856|FG000|Overall Study|Not consented for long-term follow-up|4|||
124920443|NCT04649359|449338019|FG001|Overall Study|Withdrawal by Subject|7|||
124920444|NCT04649359|449338018|FG000|Overall Study|Death|41|||
124920445|NCT04649359|449338019|FG001|Overall Study|Death|26|||
124920446|NCT04649359|449338018|FG000|Overall Study|Ongoing in the study|75|||
124920447|NCT04649359|449338019|FG001|Overall Study|Ongoing in the study|31|||
124920448|NCT02243709|449338020|FG000|Phase 1|Lost to Follow-up|0|||
124920449|NCT02243709|449338021|FG001|Phase 1|Lost to Follow-up|1|||
124920450|NCT02243709|449338020|FG000|Phase 1|Withdrawal by Subject|1|||
124920451|NCT02243709|449338021|FG001|Phase 1|Withdrawal by Subject|0|||
124920452|NCT02243709|449338020|FG000|Phase 1|Protocol Violation|0|||
124920453|NCT02243709|449338021|FG001|Phase 1|Protocol Violation|1|||
124920454|NCT02243709|449338020|FG000|Phase 1|Adverse Event|0|||
124920455|NCT02243709|449338021|FG001|Phase 1|Adverse Event|1|||
124920456|NCT03443323|449338024|FG000|Overall Study|Lost to Follow-up|2|||
124920457|NCT03443323|449338025|FG001|Overall Study|Lost to Follow-up|2|||
124920458|NCT03443323|449338024|FG000|Overall Study|PI withdrawal|1|||
124920459|NCT03443323|449338025|FG001|Overall Study|PI withdrawal|0|||
124920460|NCT04610892|449338026|FG000|Overall Study|Adverse Event|1|||
124920461|NCT04610892|449338027|FG001|Overall Study|Adverse Event|0|||
124920462|NCT04610892|449338028|FG002|Overall Study|Adverse Event|0|||
124920463|NCT04610892|449338029|FG003|Overall Study|Adverse Event|1|||
124920464|NCT04610892|449338030|FG004|Overall Study|Adverse Event|3|||
124920465|NCT04610892|449338026|FG000|Overall Study|Death|0|||
124920466|NCT04610892|449338027|FG001|Overall Study|Death|1|||
124920467|NCT04610892|449338028|FG002|Overall Study|Death|0|||
124920468|NCT04610892|449338029|FG003|Overall Study|Death|1|||
124920469|NCT04610892|449338030|FG004|Overall Study|Death|0|||
124920470|NCT04610892|449338026|FG000|Overall Study|Withdrawal by Subject|3|||
124920471|NCT04610892|449338027|FG001|Overall Study|Withdrawal by Subject|2|||
124920472|NCT04610892|449338028|FG002|Overall Study|Withdrawal by Subject|0|||
124920473|NCT04610892|449338029|FG003|Overall Study|Withdrawal by Subject|6|||
124920474|NCT04610892|449338030|FG004|Overall Study|Withdrawal by Subject|6|||
124920475|NCT04610892|449338026|FG000|Overall Study|Subjects who did not receive treatment|1|||
124920476|NCT04610892|449338027|FG001|Overall Study|Subjects who did not receive treatment|0|||
124920477|NCT04610892|449338028|FG002|Overall Study|Subjects who did not receive treatment|0|||
124920478|NCT04610892|449338029|FG003|Overall Study|Subjects who did not receive treatment|0|||
124920479|NCT04610892|449338030|FG004|Overall Study|Subjects who did not receive treatment|2|||
124920480|NCT03683719|449338031|FG000|Overall Study|Lack of Efficacy|1|||
124920481|NCT03683719|449338032|FG001|Overall Study|Lack of Efficacy|3|||
124920482|NCT03683719|449338033|FG002|Overall Study|Lack of Efficacy|4|||
124920483|NCT03683719|449338034|FG003|Overall Study|Lack of Efficacy|0|||
124920484|NCT03683719|449338035|FG004|Overall Study|Lack of Efficacy|4|||
124920485|NCT03683719|449338031|FG000|Overall Study|Adverse Event|6|||
124920486|NCT03683719|449338032|FG001|Overall Study|Adverse Event|6|||
124920487|NCT03683719|449338033|FG002|Overall Study|Adverse Event|0|||
124920488|NCT03683719|449338034|FG003|Overall Study|Adverse Event|1|||
124920489|NCT03683719|449338035|FG004|Overall Study|Adverse Event|3|||
124920490|NCT03683719|449338031|FG000|Overall Study|Withdrawal by Subject|4|||
124920491|NCT03683719|449338032|FG001|Overall Study|Withdrawal by Subject|4|||
124920492|NCT03683719|449338033|FG002|Overall Study|Withdrawal by Subject|3|||
124920493|NCT03683719|449338034|FG003|Overall Study|Withdrawal by Subject|5|||
124920494|NCT03683719|449338035|FG004|Overall Study|Withdrawal by Subject|5|||
124920495|NCT03683719|449338031|FG000|Overall Study|Lost to Follow-up|1|||
124920496|NCT03683719|449338032|FG001|Overall Study|Lost to Follow-up|0|||
124920497|NCT03683719|449338033|FG002|Overall Study|Lost to Follow-up|0|||
124920498|NCT03683719|449338034|FG003|Overall Study|Lost to Follow-up|1|||
124920499|NCT03683719|449338035|FG004|Overall Study|Lost to Follow-up|1|||
124920500|NCT03683719|449338031|FG000|Overall Study|Other personal reasons|0|||
124920501|NCT03683719|449338032|FG001|Overall Study|Other personal reasons|0|||
124920502|NCT03683719|449338033|FG002|Overall Study|Other personal reasons|1|||
124920503|NCT03683719|449338034|FG003|Overall Study|Other personal reasons|0|||
124920504|NCT03683719|449338035|FG004|Overall Study|Other personal reasons|1|||
124695642|NCT03071965|448505928|FG003|Overall Study|Adverse Event|0|||
124920505|NCT04896476|449338041|FG000|Overall Study|Withdrawal by Subject|1|||
124920506|NCT04896476|449338041|FG000|Overall Study|Lost to Follow-up|2|||
124920507|NCT03135548|449338042|FG000|Overall Study|Lost to Follow-up|3|||
124920508|NCT03135548|449338043|FG001|Overall Study|Lost to Follow-up|0|||
124920509|NCT03135548|449338044|FG002|Overall Study|Lost to Follow-up|0|||
124920510|NCT03135548|449338042|FG000|Overall Study|Withdrawal by Subject|2|||
124695643|NCT03071965|448505925|FG000|Overall Study|Death|0|||
124920511|NCT03135548|449338043|FG001|Overall Study|Withdrawal by Subject|2|||
124920512|NCT03135548|449338044|FG002|Overall Study|Withdrawal by Subject|1|||
124920513|NCT03135548|449338042|FG000|Overall Study|Other than listed|0|||
124920514|NCT03135548|449338043|FG001|Overall Study|Other than listed|2|||
124920515|NCT03135548|449338044|FG002|Overall Study|Other than listed|2|||
124920516|NCT03924986|449338045|FG000|Overall Study|Death|57|||
124920517|NCT03924986|449338046|FG001|Overall Study|Death|66|||
124920518|NCT03924986|449338045|FG000|Overall Study|Study Concluded by Sponsor|51|||
124920519|NCT03924986|449338046|FG001|Overall Study|Study Concluded by Sponsor|41|||
124920520|NCT03924986|449338045|FG000|Overall Study|Withdrawal by Subject|15|||
124920521|NCT03924986|449338046|FG001|Overall Study|Withdrawal by Subject|20|||
124920522|NCT03924986|449338045|FG000|Overall Study|Lost to Follow-up|7|||
124920523|NCT03924986|449338046|FG001|Overall Study|Lost to Follow-up|5|||
124920524|NCT03924986|449338045|FG000|Overall Study|Miscellaneous|1|||
124920525|NCT03924986|449338046|FG001|Overall Study|Miscellaneous|0|||
124920526|NCT03445988|449338049|FG000|Overall Study|Lost to Follow-up|14|||
124920527|NCT03445988|449338050|FG001|Overall Study|Lost to Follow-up|26|||
124920528|NCT03445988|449338051|FG002|Overall Study|Lost to Follow-up|27|||
124920529|NCT03445988|449338052|FG003|Overall Study|Lost to Follow-up|66|||
124920530|NCT03445988|449338049|FG000|Overall Study|Withdrawal by Subject|7|||
124920531|NCT03445988|449338050|FG001|Overall Study|Withdrawal by Subject|4|||
124920532|NCT03445988|449338051|FG002|Overall Study|Withdrawal by Subject|3|||
124920533|NCT03445988|449338052|FG003|Overall Study|Withdrawal by Subject|5|||
124920534|NCT03445988|449338049|FG000|Overall Study|Death (unrelated to study)|5|||
124920535|NCT03445988|449338050|FG001|Overall Study|Death (unrelated to study)|1|||
124920536|NCT03445988|449338051|FG002|Overall Study|Death (unrelated to study)|2|||
124920537|NCT03445988|449338052|FG003|Overall Study|Death (unrelated to study)|4|||
124920538|NCT03988608|449338053|FG000|Overall Study|Adverse Event|1|||
124920539|NCT03988608|449338053|FG000|Overall Study|Lost to Follow-up|1|||
124920540|NCT03988608|449338053|FG000|Overall Study|Withdrawal by Subject|3|||
124920541|NCT03988608|449338053|FG000|Overall Study|Death|1|||
124920542|NCT02689284|449338060|FG000|Overall Study|Adverse Event|1|||
124920543|NCT02689284|449338061|FG001|Overall Study|Adverse Event|8|||
124920544|NCT02689284|449338060|FG000|Overall Study|Death|0|||
124920545|NCT02689284|449338061|FG001|Overall Study|Death|1|||
124920546|NCT02689284|449338060|FG000|Overall Study|Physician Decision|1|||
124920547|NCT02689284|449338061|FG001|Overall Study|Physician Decision|2|||
124920548|NCT02689284|449338060|FG000|Overall Study|Withdrawal by Subject|0|||
124920549|NCT02689284|449338061|FG001|Overall Study|Withdrawal by Subject|1|||
124920550|NCT02689284|449338060|FG000|Overall Study|progression of cancer|1|||
124920551|NCT02689284|449338061|FG001|Overall Study|progression of cancer|72|||
124920552|NCT02689284|449338060|FG000|Overall Study|decreased heart function|0|||
124920553|NCT02689284|449338061|FG001|Overall Study|decreased heart function|1|||
124920554|NCT02689284|449338060|FG000|Overall Study|concern for anemia|0|||
124920555|NCT02689284|449338061|FG001|Overall Study|concern for anemia|1|||
124920556|NCT02689284|449338060|FG000|Overall Study|no measurable cancer for evaluation|0|||
124920557|NCT02689284|449338061|FG001|Overall Study|no measurable cancer for evaluation|1|||
124920558|NCT05592418|449338062|FG000|Overall Study|Adverse Event|1|||
124920559|NCT05592418|449338063|FG001|Overall Study|Adverse Event|0|||
124920560|NCT05592418|449338062|FG000|Overall Study|Lost to Follow-up|1|||
124920561|NCT05592418|449338063|FG001|Overall Study|Lost to Follow-up|3|||
124920562|NCT05592418|449338062|FG000|Overall Study|Withdrawal by Subject|2|||
124920563|NCT05592418|449338063|FG001|Overall Study|Withdrawal by Subject|7|||
124920564|NCT05569252|449338066|FG000|Overall Study|Adverse event (central vision loss)|1|||
124920565|NCT05569252|449338067|FG001|Overall Study|Adverse event (central vision loss)|0|||
124920566|NCT05569252|449338068|FG002|Overall Study|Adverse event (central vision loss)|0|||
124920567|NCT05569252|449338069|FG003|Overall Study|Adverse event (central vision loss)|0|||
124920568|NCT03665597|449338070|FG000|Period 1|Adverse Event|1|||
124920569|NCT03665597|449338071|FG001|Period 1|Adverse Event|0|||
124920570|NCT03665597|449338072|FG002|Period 1|Adverse Event|0|||
124920571|NCT03665597|449338073|FG003|Period 1|Adverse Event|1|||
124920572|NCT03665597|449338074|FG004|Period 1|Adverse Event|0|||
124920573|NCT03665597|449338075|FG005|Period 1|Adverse Event|0|||
124920574|NCT03665597|449338076|FG006|Period 1|Adverse Event|0|||
124920575|NCT03665597|449338070|FG000|Period 1|Screen Failure|0|||
124920576|NCT03665597|449338071|FG001|Period 1|Screen Failure|0|||
124920577|NCT03665597|449338072|FG002|Period 1|Screen Failure|0|||
124920578|NCT03665597|449338073|FG003|Period 1|Screen Failure|1|||
124920579|NCT03665597|449338074|FG004|Period 1|Screen Failure|0|||
124920580|NCT03665597|449338075|FG005|Period 1|Screen Failure|0|||
124920581|NCT03665597|449338076|FG006|Period 1|Screen Failure|0|||
124920582|NCT03665597|449338070|FG000|Period 1|Death|0|||
124920583|NCT03665597|449338071|FG001|Period 1|Death|0|||
124920584|NCT03665597|449338072|FG002|Period 1|Death|0|||
124920585|NCT03665597|449338073|FG003|Period 1|Death|0|||
124920586|NCT03665597|449338074|FG004|Period 1|Death|0|||
124920587|NCT03665597|449338075|FG005|Period 1|Death|0|||
124920588|NCT03665597|449338076|FG006|Period 1|Death|45|||
124920589|NCT03665597|449338070|FG000|Period 1|Withdrawal by Subject|0|||
124920590|NCT03665597|449338071|FG001|Period 1|Withdrawal by Subject|0|||
124920591|NCT03665597|449338072|FG002|Period 1|Withdrawal by Subject|0|||
124920592|NCT03665597|449338073|FG003|Period 1|Withdrawal by Subject|0|||
124920593|NCT03665597|449338074|FG004|Period 1|Withdrawal by Subject|0|||
124920594|NCT03665597|449338075|FG005|Period 1|Withdrawal by Subject|0|||
124920595|NCT03665597|449338076|FG006|Period 1|Withdrawal by Subject|5|||
124920596|NCT03665597|449338070|FG000|Period 2|Adverse Event|0|||
124920597|NCT03665597|449338071|FG001|Period 2|Adverse Event|0|||
124920598|NCT03665597|449338072|FG002|Period 2|Adverse Event|0|||
124920599|NCT03665597|449338073|FG003|Period 2|Adverse Event|0|||
124920600|NCT03665597|449338074|FG004|Period 2|Adverse Event|0|||
124920601|NCT03665597|449338075|FG005|Period 2|Adverse Event|1|||
124920602|NCT03665597|449338076|FG006|Period 2|Adverse Event|0|||
124920603|NCT03665597|449338070|FG000|Period 3|Adverse Event|0|||
124920604|NCT03665597|449338071|FG001|Period 3|Adverse Event|1|||
124920605|NCT03665597|449338072|FG002|Period 3|Adverse Event|0|||
124920606|NCT03665597|449338073|FG003|Period 3|Adverse Event|0|||
124920607|NCT03665597|449338074|FG004|Period 3|Adverse Event|0|||
124920608|NCT03665597|449338075|FG005|Period 3|Adverse Event|0|||
124920609|NCT03665597|449338076|FG006|Period 3|Adverse Event|0|||
124920610|NCT03665597|449338070|FG000|Period 3|Death|0|||
124920611|NCT03665597|449338071|FG001|Period 3|Death|0|||
124920612|NCT03665597|449338072|FG002|Period 3|Death|0|||
124920613|NCT03665597|449338073|FG003|Period 3|Death|0|||
124920614|NCT03665597|449338074|FG004|Period 3|Death|1|||
124920615|NCT03665597|449338075|FG005|Period 3|Death|0|||
124695644|NCT03071965|448505926|FG001|Overall Study|Death|0|||
124695645|NCT03071965|448505927|FG002|Overall Study|Death|1|||
124920616|NCT03665597|449338076|FG006|Period 3|Death|0|||
124920617|NCT03665597|449338070|FG000|Period 4|Adverse Event|2|||
124920618|NCT03665597|449338071|FG001|Period 4|Adverse Event|2|||
124920619|NCT03665597|449338072|FG002|Period 4|Adverse Event|2|||
124920620|NCT03665597|449338073|FG003|Period 4|Adverse Event|2|||
124920621|NCT03665597|449338074|FG004|Period 4|Adverse Event|1|||
124920622|NCT03665597|449338075|FG005|Period 4|Adverse Event|0|||
124920623|NCT03665597|449338076|FG006|Period 4|Adverse Event|0|||
124920624|NCT03665597|449338070|FG000|Period 4|Death|0|||
124920625|NCT03665597|449338071|FG001|Period 4|Death|0|||
124920626|NCT03665597|449338072|FG002|Period 4|Death|2|||
124920627|NCT03665597|449338073|FG003|Period 4|Death|0|||
124920628|NCT03665597|449338074|FG004|Period 4|Death|0|||
124920629|NCT03665597|449338075|FG005|Period 4|Death|0|||
124920630|NCT03665597|449338076|FG006|Period 4|Death|0|||
124920631|NCT03665597|449338070|FG000|Period 4|Physician Decision|1|||
124920632|NCT03665597|449338071|FG001|Period 4|Physician Decision|2|||
124920633|NCT03665597|449338072|FG002|Period 4|Physician Decision|0|||
124920634|NCT03665597|449338073|FG003|Period 4|Physician Decision|0|||
124920635|NCT03665597|449338074|FG004|Period 4|Physician Decision|0|||
124920636|NCT03665597|449338075|FG005|Period 4|Physician Decision|0|||
124920637|NCT03665597|449338076|FG006|Period 4|Physician Decision|0|||
124920638|NCT04739956|449338080|FG000|Overall Study|Withdrawal by Subject|1|||
124920639|NCT04739956|449338081|FG001|Overall Study|Withdrawal by Subject|1|||
124920640|NCT03519581|449338084|FG000|Overall Study|Lost to Follow-up|3|||
124920641|NCT03519581|449338085|FG001|Overall Study|Lost to Follow-up|2|||
124920642|NCT03519581|449338084|FG000|Overall Study|Adverse Event|5|||
124920643|NCT03519581|449338085|FG001|Overall Study|Adverse Event|2|||
124920644|NCT03519581|449338084|FG000|Overall Study|Withdrawal by Subject|2|||
124920645|NCT03519581|449338085|FG001|Overall Study|Withdrawal by Subject|0|||
124920646|NCT03519581|449338084|FG000|Overall Study|Change to insurance|2|||
124920647|NCT03519581|449338085|FG001|Overall Study|Change to insurance|1|||
124920648|NCT03519581|449338084|FG000|Overall Study|Other|2|||
124920649|NCT03519581|449338085|FG001|Overall Study|Other|4|||
124920650|NCT03396926|449338086|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
124920651|NCT03396926|449338087|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
124920652|NCT03110315|449338088|FG000|Overall Study|Withdrawal by Subject|1|||
124920653|NCT03110315|449338089|FG001|Overall Study|Withdrawal by Subject|0|||
124920654|NCT00450658|449338093|FG000|Overall Study|Adverse Event|24|||
124920655|NCT00450658|449338094|FG001|Overall Study|Adverse Event|15|||
124920656|NCT00450658|449338093|FG000|Overall Study|Withdrawal by Subject|43|||
124920657|NCT00450658|449338094|FG001|Overall Study|Withdrawal by Subject|26|||
124920658|NCT00450658|449338093|FG000|Overall Study|Lost to Follow-up|22|||
124920659|NCT00450658|449338094|FG001|Overall Study|Lost to Follow-up|5|||
124920660|NCT00450658|449338093|FG000|Overall Study|UGI ulcer|33|||
124920661|NCT00450658|449338094|FG001|Overall Study|UGI ulcer|34|||
124920662|NCT00450658|449338093|FG000|Overall Study|misc|21|||
124920663|NCT00450658|449338094|FG001|Overall Study|misc|10|||
124920664|NCT04727554|449338097|FG000|Overall Study|Lost to Follow-up|0|||
124920665|NCT04727554|449338098|FG001|Overall Study|Lost to Follow-up|1|||
124920666|NCT04727554|449338097|FG000|Overall Study|Death|2|||
124920667|NCT04727554|449338098|FG001|Overall Study|Death|6|||
124920668|NCT04727554|449338097|FG000|Overall Study|Withdrawal by Subject|1|||
124920669|NCT04727554|449338098|FG001|Overall Study|Withdrawal by Subject|0|||
124920670|NCT05763823|449338099|FG000|Overall Study|Death|6|||
124920671|NCT05763823|449338099|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
124920672|NCT05763823|449338099|FG000|Overall Study|Withdrawal by Subject|6|||
124920673|NCT05371652|449338103|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
124920674|NCT05371652|449338103|FG000|Overall Study|Withdrawal by Subject|12|||
124920675|NCT05371652|449338103|FG000|Overall Study|Adverse Event|1|||
124920676|NCT05371652|449338103|FG000|Overall Study|Other|11|||
124920677|NCT05134233|449338108|FG000|Overall Study|Pregnancy|1|||
124920678|NCT05134233|449338108|FG000|Overall Study|MEP value too low|2|||
124920679|NCT05134233|449338108|FG000|Overall Study|Lost to Follow-up|1|||
124920680|NCT01573442|449338109|FG000|Overall Study|Cancels|9|||
124920681|NCT01573442|449338110|FG001|Overall Study|Cancels|10|||
124920682|NCT02724631|449338113|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
124920683|NCT04763265|449338114|FG000|Overall Study|Adverse Event|1|||
124920684|NCT04763265|449338115|FG001|Overall Study|Adverse Event|0|||
124920685|NCT04763265|449338114|FG000|Overall Study|Lost to Follow-up|2|||
124920686|NCT04763265|449338115|FG001|Overall Study|Lost to Follow-up|4|||
124920687|NCT04763265|449338114|FG000|Overall Study|Withdrawal by Subject|0|||
124920688|NCT04763265|449338115|FG001|Overall Study|Withdrawal by Subject|1|||
124920689|NCT05609760|449338131|FG000|Overall Study|Lost to Follow-up|0|||
124920690|NCT05609760|449338132|FG001|Overall Study|Lost to Follow-up|1|||
124920691|NCT05609760|449338131|FG000|Overall Study|Withdrawal by Subject|1|||
124920692|NCT05609760|449338132|FG001|Overall Study|Withdrawal by Subject|0|||
124920693|NCT04049643|449338133|FG000|Overall Study|Lack of Efficacy|1|||
124920694|NCT04049643|449338134|FG001|Overall Study|Lack of Efficacy|1|||
124920695|NCT04049643|449338135|FG002|Overall Study|Lack of Efficacy|0|||
124920696|NCT04049643|449338133|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
124920697|NCT04049643|449338134|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
124920698|NCT04049643|449338135|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
124920699|NCT05089734|449338136|FG000|Overall Study|Still on study|122|||
124920700|NCT05089734|449338137|FG001|Overall Study|Still on study|101|||
124920701|NCT05089734|449338136|FG000|Overall Study|Death|161|||
124920702|NCT05089734|449338137|FG001|Overall Study|Death|179|||
124920703|NCT05089734|449338136|FG000|Overall Study|Withdrew consent|11|||
124920704|NCT05089734|449338137|FG001|Overall Study|Withdrew consent|24|||
124920705|NCT05089734|449338136|FG000|Overall Study|Lost to Follow-up|5|||
124920706|NCT05089734|449338137|FG001|Overall Study|Lost to Follow-up|0|||
124920707|NCT05302596|449338138|FG000|Overall Study|Withdrawal by Subject|1|||
124920708|NCT05302596|449338139|FG001|Overall Study|Withdrawal by Subject|1|||
124920709|NCT04353661|449339939|FG000|Overall Study|Protocol Violation|0|||
124920710|NCT04353661|449339940|FG001|Overall Study|Protocol Violation|0|||
124920711|NCT04353661|449339941|FG002|Overall Study|Protocol Violation|1|||
124920712|NCT04353661|449339939|FG000|Overall Study|Study termination by the Sponsor|1|||
124920713|NCT04353661|449339940|FG001|Overall Study|Study termination by the Sponsor|1|||
124920714|NCT04353661|449339941|FG002|Overall Study|Study termination by the Sponsor|1|||
124920715|NCT00667251|449339942|FG000|Overall Study|Disease progression|232|||
124920716|NCT00667251|449339943|FG001|Overall Study|Disease progression|203|||
124920717|NCT00667251|449339942|FG000|Overall Study|Toxicity|44|||
124920718|NCT00667251|449339943|FG001|Overall Study|Toxicity|23|||
124920719|NCT00667251|449339942|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
124920720|NCT00667251|449339943|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
124920721|NCT00667251|449339942|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
124920722|NCT00667251|449339943|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
124920723|NCT00667251|449339942|FG000|Overall Study|Symptomatic progression|8|||
124920724|NCT00667251|449339943|FG001|Overall Study|Symptomatic progression|4|||
124920725|NCT00667251|449339942|FG000|Overall Study|Death|6|||
124920726|NCT00667251|449339943|FG001|Overall Study|Death|11|||
124920727|NCT00667251|449339942|FG000|Overall Study|Intercurrent illness|5|||
124920728|NCT00667251|449339943|FG001|Overall Study|Intercurrent illness|6|||
124920729|NCT00667251|449339942|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
124920730|NCT00667251|449339943|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
124920731|NCT00667251|449339942|FG000|Overall Study|Randomized not Treated|4|||
124920732|NCT00667251|449339943|FG001|Overall Study|Randomized not Treated|1|||
124920733|NCT01140880|449339945|FG000|Overall Study|Death|0|||
124920734|NCT01140880|449339946|FG001|Overall Study|Death|1|||
124920735|NCT01140880|449339945|FG000|Overall Study|Withdrawal by Subject|6|||
124920736|NCT01140880|449339946|FG001|Overall Study|Withdrawal by Subject|3|||
124920737|NCT01140880|449339945|FG000|Overall Study|Lost to Follow-up|8|||
124920738|NCT01140880|449339946|FG001|Overall Study|Lost to Follow-up|10|||
124920739|NCT01140880|449339945|FG000|Overall Study|Protocol Violation|0|||
124920740|NCT01140880|449339946|FG001|Overall Study|Protocol Violation|30|||
124920741|NCT03131648|449339948|FG000|Initial Treatment Period|Not dosed|2|||
124920742|NCT03131648|449339949|FG001|Initial Treatment Period|Not dosed|2|||
124920743|NCT03131648|449339950|FG002|Initial Treatment Period|Not dosed|0|||
124920744|NCT03131648|449339951|FG003|Initial Treatment Period|Not dosed|0|||
124920745|NCT03131648|449339952|FG004|Initial Treatment Period|Not dosed|0|||
124920746|NCT03131648|449339953|FG005|Initial Treatment Period|Not dosed|0|||
124920747|NCT03131648|449339954|FG006|Initial Treatment Period|Not dosed|0|||
124920748|NCT03131648|449339955|FG007|Initial Treatment Period|Not dosed|0|||
124920749|NCT03131648|449339948|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
124920750|NCT03131648|449339949|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
124920751|NCT03131648|449339950|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124920752|NCT03131648|449339951|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124920753|NCT03131648|449339952|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124920754|NCT03131648|449339953|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124920755|NCT03131648|449339954|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124920756|NCT03131648|449339955|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124920757|NCT03131648|449339948|FG000|Open-label Treatment|Discontinued IMP|0|||
124920758|NCT03131648|449339949|FG001|Open-label Treatment|Discontinued IMP|0|||
124920759|NCT03131648|449339950|FG002|Open-label Treatment|Discontinued IMP|0|||
124920760|NCT03131648|449339951|FG003|Open-label Treatment|Discontinued IMP|0|||
124920761|NCT03131648|449339952|FG004|Open-label Treatment|Discontinued IMP|0|||
124920762|NCT03131648|449339953|FG005|Open-label Treatment|Discontinued IMP|0|||
124920763|NCT03131648|449339954|FG006|Open-label Treatment|Discontinued IMP|112|||
124920764|NCT03131648|449339955|FG007|Open-label Treatment|Discontinued IMP|0|||
124920765|NCT03131648|449339948|FG000|Open-label Treatment|Completed Week 50|0|||
124920766|NCT03131648|449339949|FG001|Open-label Treatment|Completed Week 50|0|||
124920767|NCT03131648|449339950|FG002|Open-label Treatment|Completed Week 50|0|||
124920768|NCT03131648|449339951|FG003|Open-label Treatment|Completed Week 50|0|||
124920769|NCT03131648|449339952|FG004|Open-label Treatment|Completed Week 50|0|||
124920770|NCT03131648|449339953|FG005|Open-label Treatment|Completed Week 50|0|||
124920771|NCT03131648|449339954|FG006|Open-label Treatment|Completed Week 50|6|||
124920772|NCT03131648|449339955|FG007|Open-label Treatment|Completed Week 50|0|||
124920773|NCT03131648|449339948|FG000|Maintenance Treatment Period|Not dosed|0|||
124920774|NCT03131648|449339949|FG001|Maintenance Treatment Period|Not dosed|0|||
124920775|NCT03131648|449339950|FG002|Maintenance Treatment Period|Not dosed|3|||
124920776|NCT03131648|449339951|FG003|Maintenance Treatment Period|Not dosed|2|||
124920777|NCT03131648|449339952|FG004|Maintenance Treatment Period|Not dosed|1|||
124920778|NCT03131648|449339953|FG005|Maintenance Treatment Period|Not dosed|0|||
124920779|NCT03131648|449339954|FG006|Maintenance Treatment Period|Not dosed|0|||
124920780|NCT03131648|449339955|FG007|Maintenance Treatment Period|Not dosed|0|||
124920781|NCT03131648|449339948|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
124920782|NCT03131648|449339949|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
124920783|NCT03131648|449339950|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
124920784|NCT03131648|449339951|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
124920785|NCT03131648|449339952|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
124920786|NCT03131648|449339953|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
124545426|NCT03792633|447951203|FG001|Overall Study|Second malignancy|1|||
124920787|NCT03131648|449339954|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
124920788|NCT03131648|449339955|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
124920789|NCT03131648|449339948|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
124920790|NCT03131648|449339949|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
124920791|NCT03131648|449339950|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
124920792|NCT03131648|449339951|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
124920793|NCT03131648|449339952|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
124920794|NCT03131648|449339953|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
124920795|NCT03131648|449339954|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
124920796|NCT03131648|449339955|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
124920797|NCT03131648|449339948|FG000|Maintenance Treatment Period|Completed Week 50|0|||
124920798|NCT03131648|449339949|FG001|Maintenance Treatment Period|Completed Week 50|0|||
124920799|NCT03131648|449339950|FG002|Maintenance Treatment Period|Completed Week 50|0|||
124920800|NCT03131648|449339951|FG003|Maintenance Treatment Period|Completed Week 50|0|||
124920801|NCT03131648|449339952|FG004|Maintenance Treatment Period|Completed Week 50|1|||
124920802|NCT03131648|449339953|FG005|Maintenance Treatment Period|Completed Week 50|0|||
124920803|NCT03131648|449339954|FG006|Maintenance Treatment Period|Completed Week 50|0|||
124920804|NCT03131648|449339955|FG007|Maintenance Treatment Period|Completed Week 50|0|||
124920805|NCT03131648|449339948|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
124920806|NCT03131648|449339949|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
124920807|NCT03131648|449339950|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
124920808|NCT03131648|449339951|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
124920809|NCT03131648|449339952|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
124920810|NCT03131648|449339953|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
124920811|NCT03131648|449339954|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
124920812|NCT03131648|449339955|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
124920813|NCT02671903|449339956|FG000|Period 0 (Run-In)|Death|0|||
124920814|NCT02671903|449339957|FG001|Period 0 (Run-In)|Death|0|||
124920815|NCT02671903|449339958|FG002|Period 0 (Run-In)|Death|3|||
124920816|NCT02671903|449339956|FG000|Period 0 (Run-In)|Physician Decision|0|||
124920817|NCT02671903|449339957|FG001|Period 0 (Run-In)|Physician Decision|0|||
124920818|NCT02671903|449339958|FG002|Period 0 (Run-In)|Physician Decision|4|||
124920819|NCT02671903|449339956|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
124920820|NCT02671903|449339957|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
124920821|NCT02671903|449339958|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
124920822|NCT02671903|449339956|FG000|Period 0 (Run-In)|Protocol Violation|0|||
124920823|NCT02671903|449339957|FG001|Period 0 (Run-In)|Protocol Violation|0|||
124920824|NCT02671903|449339958|FG002|Period 0 (Run-In)|Protocol Violation|1|||
124920825|NCT02671903|449339956|FG000|Period 0 (Run-In)|Adverse Event|0|||
124920826|NCT02671903|449339957|FG001|Period 0 (Run-In)|Adverse Event|0|||
124920827|NCT02671903|449339958|FG002|Period 0 (Run-In)|Adverse Event|1|||
124920828|NCT02671903|449339956|FG000|Period 0 (Run-In)|Implantation Failure|0|||
124920829|NCT02671903|449339957|FG001|Period 0 (Run-In)|Implantation Failure|0|||
124920830|NCT02671903|449339958|FG002|Period 0 (Run-In)|Implantation Failure|2|||
124920831|NCT02671903|449339956|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
124920832|NCT02671903|449339957|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
124920833|NCT02671903|449339958|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
124920834|NCT04258709|449339959|FG000|Overall Study|Lost to Follow-up|10|||
124920835|NCT04258709|449339960|FG001|Overall Study|Lost to Follow-up|4|||
124920836|NCT04258709|449339959|FG000|Overall Study|Withdrawal by Subject|1|||
124920837|NCT04258709|449339960|FG001|Overall Study|Withdrawal by Subject|0|||
124920838|NCT04258709|449339959|FG000|Overall Study|Fetal demise|0|||
124920839|NCT04258709|449339960|FG001|Overall Study|Fetal demise|1|||
124920840|NCT04258709|449339959|FG000|Overall Study|Protocol Violation|1|||
124920841|NCT04258709|449339960|FG001|Overall Study|Protocol Violation|1|||
124920842|NCT05633953|449339961|FG000|Overall Study|Adverse Event|7|||
124920843|NCT05633953|449339961|FG000|Overall Study|Death|30|||
124920844|NCT05633953|449339961|FG000|Overall Study|Lost to Follow-up|1|||
124920845|NCT05633953|449339961|FG000|Overall Study|Osilodrostat discontinued|4|||
124920846|NCT05633953|449339961|FG000|Overall Study|Physician Decision|1|||
124920847|NCT05633953|449339961|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
124920848|NCT05633953|449339961|FG000|Overall Study|Progressive disease|2|||
124920849|NCT03047928|449339962|FG000|Overall Study|Adverse Event|0|||
124920850|NCT03047928|449339963|FG001|Overall Study|Adverse Event|2|||
124920851|NCT03047928|449339964|FG002|Overall Study|Adverse Event|0|||
124920852|NCT03047928|449339962|FG000|Overall Study|Protocol Violation|0|||
124920853|NCT03047928|449339963|FG001|Overall Study|Protocol Violation|1|||
124920854|NCT03047928|449339964|FG002|Overall Study|Protocol Violation|0|||
124920855|NCT03047928|449339962|FG000|Overall Study|included in another protocol|0|||
124920856|NCT03047928|449339963|FG001|Overall Study|included in another protocol|1|||
124920857|NCT03047928|449339964|FG002|Overall Study|included in another protocol|0|||
124920858|NCT02729311|449339965|FG000|Overall Study|Withdrawal by Subject|8|||
124920859|NCT02729311|449339966|FG001|Overall Study|Withdrawal by Subject|2|||
124920860|NCT05324124|449339967|FG000|Period 1|Withdrawal by Subject|1|||
124920861|NCT05324124|449339968|FG001|Period 1|Withdrawal by Subject|0|||
124920862|NCT05324124|449339967|FG000|Period 1|Physician Decision|0|||
124920863|NCT05324124|449339968|FG001|Period 1|Physician Decision|1|||
124920864|NCT04034251|449339969|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
124920865|NCT04034251|449339970|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
124920866|NCT04034251|449339971|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
124920867|NCT02287610|449339972|FG000|Overall Study|Lost to Follow-up|3|||
124920868|NCT02287610|449339972|FG000|Overall Study|Withdrawal by Subject|8|||
124920869|NCT02287610|449339972|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
124920870|NCT05273749|449339974|FG000|Overall Study|Adverse Event|14|||
124920871|NCT05273749|449339975|FG001|Overall Study|Adverse Event|8|||
124920872|NCT05273749|449339974|FG000|Overall Study|Lack of Efficacy|2|||
124920873|NCT05273749|449339975|FG001|Overall Study|Lack of Efficacy|8|||
124920874|NCT05273749|449339974|FG000|Overall Study|Physician Decision|0|||
124920875|NCT05273749|449339975|FG001|Overall Study|Physician Decision|2|||
124920876|NCT05273749|449339974|FG000|Overall Study|Withdrawal by Subject|14|||
124920877|NCT05273749|449339975|FG001|Overall Study|Withdrawal by Subject|16|||
124920878|NCT05273749|449339974|FG000|Overall Study|Lost to Follow-up|10|||
124920879|NCT05273749|449339975|FG001|Overall Study|Lost to Follow-up|10|||
124920880|NCT05273749|449339974|FG000|Overall Study|Pregnancy|1|||
124920881|NCT05273749|449339975|FG001|Overall Study|Pregnancy|0|||
124920882|NCT05273749|449339974|FG000|Overall Study|Non-Compliance|3|||
124920883|NCT05273749|449339975|FG001|Overall Study|Non-Compliance|2|||
124920884|NCT05273749|449339974|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
124920885|NCT05273749|449339975|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
124920886|NCT05247489|449339978|FG000|Overall Study|Lost to Follow-up|5|||
124920887|NCT05247489|449339979|FG001|Overall Study|Lost to Follow-up|1|||
124920888|NCT05247489|449339978|FG000|Overall Study|Withdrawal by Subject|6|||
124920889|NCT05247489|449339979|FG001|Overall Study|Withdrawal by Subject|7|||
124920890|NCT05247489|449339978|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
124920891|NCT05247489|449339979|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
124920892|NCT05247489|449339978|FG000|Overall Study|Left Country|1|||
124920893|NCT05247489|449339979|FG001|Overall Study|Left Country|0|||
124920894|NCT05247489|449339978|FG000|Overall Study|Noncompliance with Investigational Product|1|||
124920895|NCT05247489|449339979|FG001|Overall Study|Noncompliance with Investigational Product|0|||
124920896|NCT05247489|449339978|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
124920897|NCT05247489|449339979|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
124920898|NCT03771898|449339980|FG000|Overall Study|Adverse Event|1|||
124920899|NCT03771898|449339981|FG001|Overall Study|Adverse Event|0|||
124920900|NCT03771898|449339982|FG002|Overall Study|Adverse Event|0|||
124920901|NCT03771898|449339983|FG003|Overall Study|Adverse Event|0|||
124920902|NCT03771898|449339984|FG004|Overall Study|Adverse Event|0|||
124920903|NCT03771898|449339980|FG000|Overall Study|Lost to Follow-up|1|||
124920904|NCT03771898|449339981|FG001|Overall Study|Lost to Follow-up|1|||
124920905|NCT03771898|449339982|FG002|Overall Study|Lost to Follow-up|1|||
124920906|NCT03771898|449339983|FG003|Overall Study|Lost to Follow-up|0|||
124920907|NCT03771898|449339984|FG004|Overall Study|Lost to Follow-up|0|||
124920908|NCT03771898|449339980|FG000|Overall Study|Withdrawal by parent/guardian|1|||
124920909|NCT03771898|449339981|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124920910|NCT03771898|449339982|FG002|Overall Study|Withdrawal by parent/guardian|0|||
124920911|NCT03771898|449339983|FG003|Overall Study|Withdrawal by parent/guardian|0|||
124920912|NCT03771898|449339984|FG004|Overall Study|Withdrawal by parent/guardian|0|||
124920913|NCT03771898|449339980|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
124920914|NCT03771898|449339981|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
124920915|NCT03771898|449339982|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
124920916|NCT03771898|449339983|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
124920917|NCT03771898|449339984|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
124920918|NCT04541706|449339985|FG000|Overall Study|Withdrawal by Subject|3|||
124920919|NCT04541706|449339985|FG000|Overall Study|Progressive disease|33|||
124920920|NCT04541706|449339985|FG000|Overall Study|Physician Decision|1|||
124920921|NCT04541706|449339985|FG000|Overall Study|Lost to Follow-up|2|||
124920922|NCT04541706|449339985|FG000|Overall Study|Death|5|||
124920923|NCT04541706|449339985|FG000|Overall Study|Adverse Event|1|||
124920924|NCT05563246|449339986|FG000|Overall Study|Withdrawal by Subject|1|||
124920925|NCT05563246|449339987|FG001|Overall Study|Withdrawal by Subject|2|||
124920926|NCT05563246|449339988|FG002|Overall Study|Withdrawal by Subject|0|||
124920927|NCT05563246|449339989|FG003|Overall Study|Withdrawal by Subject|0|||
124762326|NCT02469623|448755856|FG000|Overall Study|Lost to Follow-up|4|||
124762327|NCT02469623|448755856|FG000|Overall Study|Withdrawal by Subject|2|||
124762328|NCT02469623|448755856|FG000|Overall Study|Death|3|||
124920928|NCT05563246|449339986|FG000|Overall Study|Protocol Deviation|0|||
124920929|NCT05563246|449339987|FG001|Overall Study|Protocol Deviation|1|||
124920930|NCT05563246|449339988|FG002|Overall Study|Protocol Deviation|0|||
124920931|NCT05563246|449339989|FG003|Overall Study|Protocol Deviation|0|||
124920932|NCT05563246|449339986|FG000|Overall Study|Physician Decision|0|||
124920933|NCT05563246|449339987|FG001|Overall Study|Physician Decision|1|||
124920934|NCT05563246|449339988|FG002|Overall Study|Physician Decision|0|||
124920935|NCT05563246|449339989|FG003|Overall Study|Physician Decision|0|||
124920936|NCT05563246|449339986|FG000|Overall Study|Adverse Event|0|||
124920937|NCT05563246|449339987|FG001|Overall Study|Adverse Event|0|||
124920938|NCT05563246|449339988|FG002|Overall Study|Adverse Event|2|||
124920939|NCT05563246|449339989|FG003|Overall Study|Adverse Event|0|||
124920940|NCT05563246|449339986|FG000|Overall Study|Lost to Follow-up|0|||
124920941|NCT05563246|449339987|FG001|Overall Study|Lost to Follow-up|0|||
124920942|NCT05563246|449339988|FG002|Overall Study|Lost to Follow-up|1|||
124920943|NCT05563246|449339989|FG003|Overall Study|Lost to Follow-up|0|||
124920944|NCT01416831|449339992|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
124920945|NCT01416831|449339993|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
124920946|NCT04179500|449339994|FG000|Treatment|Withdrawal by Subject|1|||
124920947|NCT04179500|449339994|FG000|Treatment|Adverse Event|2|||
124920948|NCT04179500|449339994|FG000|Treatment|pyrazinamide resistance|1|||
124920949|NCT04812535|449339999|FG000|Overall Study|Withdrawal by Subject|0|||
124920950|NCT04812535|449340000|FG001|Overall Study|Withdrawal by Subject|0|||
124920951|NCT04812535|449340001|FG002|Overall Study|Withdrawal by Subject|0|||
124920952|NCT04812535|449340002|FG003|Overall Study|Withdrawal by Subject|1|||
124920953|NCT04812535|449339999|FG000|Overall Study|Death|7|||
124920954|NCT04812535|449340000|FG001|Overall Study|Death|2|||
124920955|NCT04812535|449340001|FG002|Overall Study|Death|4|||
124920956|NCT04812535|449340002|FG003|Overall Study|Death|1|||
124920957|NCT04812535|449339999|FG000|Overall Study|Due to premature study termination by sponsor|2|||
124920958|NCT04812535|449340000|FG001|Overall Study|Due to premature study termination by sponsor|0|||
124920959|NCT04812535|449340001|FG002|Overall Study|Due to premature study termination by sponsor|1|||
124920960|NCT04812535|449340002|FG003|Overall Study|Due to premature study termination by sponsor|3|||
124920961|NCT03336333|449340003|FG000|Overall Study|Remained on study at time of data cut-off|202|||
124920962|NCT03336333|449340004|FG001|Overall Study|Remained on study at time of data cut-off|219|||
124920963|NCT03336333|449340005|FG002|Overall Study|Remained on study at time of data cut-off|102|||
124920964|NCT03336333|449340003|FG000|Overall Study|Death|14|||
124920965|NCT03336333|449340004|FG001|Overall Study|Death|16|||
124920966|NCT03336333|449340005|FG002|Overall Study|Death|8|||
124920967|NCT03336333|449340003|FG000|Overall Study|Withdrawal by Subject|16|||
124920968|NCT03336333|449340004|FG001|Overall Study|Withdrawal by Subject|5|||
124920969|NCT03336333|449340005|FG002|Overall Study|Withdrawal by Subject|1|||
124920970|NCT03336333|449340003|FG000|Overall Study|Physician Decision|5|||
124920971|NCT03336333|449340004|FG001|Overall Study|Physician Decision|1|||
124920972|NCT03336333|449340005|FG002|Overall Study|Physician Decision|0|||
124920973|NCT03336333|449340003|FG000|Overall Study|Lost to Follow-up|1|||
124920974|NCT03336333|449340004|FG001|Overall Study|Lost to Follow-up|0|||
124920975|NCT03336333|449340005|FG002|Overall Study|Lost to Follow-up|0|||
124920976|NCT03623321|449340012|FG000|Overall Study|Adverse Event|32|||
124920977|NCT03623321|449340012|FG000|Overall Study|Death|9|||
124920978|NCT03623321|449340012|FG000|Overall Study|Lack of Efficacy|9|||
124920979|NCT03623321|449340012|FG000|Overall Study|Lost to Follow-up|6|||
124920980|NCT03623321|449340012|FG000|Overall Study|Noncompliance with study drug|6|||
124920981|NCT03623321|449340012|FG000|Overall Study|Use of prohibited medication|3|||
124920982|NCT03623321|449340012|FG000|Overall Study|Physician Decision|5|||
124920983|NCT03623321|449340012|FG000|Overall Study|Protocol Violation|1|||
124920984|NCT03623321|449340012|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
124920985|NCT03623321|449340012|FG000|Overall Study|Not further specified|43|||
124920986|NCT01785719|449340014|FG000|4-week Baseline Evaluation|Physician Decision|1|||
124920987|NCT01785719|449340015|FG001|4-week Baseline Evaluation|Physician Decision|0|||
124920988|NCT01785719|449340014|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
124920989|NCT01785719|449340015|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
124920990|NCT01785719|449340014|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
124920991|NCT01785719|449340015|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
124920992|NCT01785719|449340014|FG000|4-week Baseline Evaluation|Pregnancy|0|||
124920993|NCT01785719|449340015|FG001|4-week Baseline Evaluation|Pregnancy|2|||
124695646|NCT03071965|448505928|FG003|Overall Study|Death|1|||
124695647|NCT03071965|448505925|FG000|Overall Study|COVID-19|0|||
124695648|NCT03071965|448505926|FG001|Overall Study|COVID-19|1|||
124920994|NCT01785719|449340014|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
124920995|NCT01785719|449340015|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
124920996|NCT01785719|449340014|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
124695649|NCT03071965|448505927|FG002|Overall Study|COVID-19|0|||
124920997|NCT01785719|449340015|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
124920998|NCT01785719|449340014|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
124920999|NCT01785719|449340015|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
124921000|NCT01785719|449340014|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
124921001|NCT01785719|449340015|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
124921002|NCT01785719|449340014|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
124695650|NCT03071965|448505928|FG003|Overall Study|COVID-19|1|||
124921003|NCT01785719|449340015|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
124921004|NCT01785719|449340014|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
124921005|NCT01785719|449340015|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
124921006|NCT01785719|449340014|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
124921007|NCT01785719|449340015|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
124921008|NCT01785719|449340014|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
124921009|NCT01785719|449340015|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
124921010|NCT01785719|449340014|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
124921011|NCT01785719|449340015|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
124921012|NCT01785719|449340014|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
124921013|NCT01785719|449340015|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
124921014|NCT01785719|449340014|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
124921015|NCT01785719|449340015|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
124921016|NCT03699709|449340027|FG000|Overall Study|Death|1|||
124921017|NCT03699709|449340028|FG001|Overall Study|Death|2|||
124921018|NCT03699709|449340027|FG000|Overall Study|Lost to Follow-up|10|||
124921019|NCT03699709|449340028|FG001|Overall Study|Lost to Follow-up|3|||
124921020|NCT03699709|449340027|FG000|Overall Study|Withdrawal by Subject|5|||
124921021|NCT03699709|449340028|FG001|Overall Study|Withdrawal by Subject|0|||
124921022|NCT03699709|449340027|FG000|Overall Study|incarcerated|1|||
124921023|NCT03699709|449340028|FG001|Overall Study|incarcerated|0|||
124921024|NCT03699709|449340027|FG000|Overall Study|scheduled, but no show|0|||
124921025|NCT03699709|449340028|FG001|Overall Study|scheduled, but no show|1|||
124921026|NCT04562649|449340029|FG000|Overall Study|Withdrawal by Subject|11|||
124921027|NCT04562649|449340030|FG001|Overall Study|Withdrawal by Subject|8|||
124921028|NCT04562649|449340029|FG000|Overall Study|Lost to Follow-up|26|||
124921029|NCT04562649|449340030|FG001|Overall Study|Lost to Follow-up|20|||
124921036|NCT05368103|449340032|FG000|Overall Study|Withdrawal by Subject|4|||
124921037|NCT05368103|449340032|FG000|Overall Study|Lost to Follow-up|1|||
124921038|NCT05368103|449340032|FG000|Overall Study|Lack of Efficacy|3|||
124921039|NCT03039023|449340041|FG000|Overall Study|Withdrawal by Subject|1|||
124921040|NCT03039023|449340042|FG001|Overall Study|Withdrawal by Subject|0|||
124921041|NCT03039023|449340043|FG002|Overall Study|Withdrawal by Subject|1|||
124921042|NCT03039023|449340044|FG003|Overall Study|Withdrawal by Subject|1|||
124921043|NCT03039023|449340045|FG004|Overall Study|Withdrawal by Subject|0|||
124921044|NCT03039023|449340041|FG000|Overall Study|Physician Decision|0|||
124921045|NCT03039023|449340042|FG001|Overall Study|Physician Decision|0|||
124921046|NCT03039023|449340043|FG002|Overall Study|Physician Decision|0|||
124921047|NCT03039023|449340044|FG003|Overall Study|Physician Decision|1|||
124921048|NCT03039023|449340045|FG004|Overall Study|Physician Decision|0|||
124921049|NCT04130438|449340046|FG000|Overall Study|Lost to Follow-up|0|||
124921050|NCT04130438|449340047|FG001|Overall Study|Lost to Follow-up|0|||
124921051|NCT04130438|449340048|FG002|Overall Study|Lost to Follow-up|1|||
124921052|NCT05268393|449340049|FG000|Overall Study|Withdrawal by Subject|2|||
124921053|NCT05268393|449340050|FG001|Overall Study|Withdrawal by Subject|1|||
124921054|NCT05256706|449340052|FG000|Overall Study|Lost to Follow-up|9|||
124921055|NCT05256706|449340053|FG001|Overall Study|Lost to Follow-up|3|||
124921056|NCT05256706|449340052|FG000|Overall Study|Withdrawal by Subject|7|||
124921057|NCT05256706|449340053|FG001|Overall Study|Withdrawal by Subject|11|||
124921058|NCT05256706|449340052|FG000|Overall Study|Screen Failures|3|||
124921059|NCT05256706|449340053|FG001|Overall Study|Screen Failures|0|||
124921060|NCT04410042|449340054|FG000|Overall Study|Not Eligible|1|||
124921061|NCT04410042|449340055|FG001|Overall Study|Not Eligible|1|||
124921062|NCT03850678|449340058|FG000|Overall Study|Withdrawal by Subject|3|||
124921063|NCT03850678|449340059|FG001|Overall Study|Withdrawal by Subject|0|||
124921064|NCT03850678|449340058|FG000|Overall Study|Experimenter Error|1|||
124921065|NCT03850678|449340059|FG001|Overall Study|Experimenter Error|1|||
124921066|NCT03850678|449340058|FG000|Overall Study|Did Not Condition To Experiment|7|||
124921067|NCT03850678|449340059|FG001|Overall Study|Did Not Condition To Experiment|2|||
124921068|NCT03720795|449340060|FG000|Phase 1|Lost to Follow-up|4|||
124921069|NCT03720795|449340060|FG000|Phase 1|Withdrawal by Subject|6|||
124921070|NCT03720795|449340060|FG000|Phase 1|Protocol Violation|1|||
124921071|NCT03720795|449340060|FG000|Phase 1|Other|1|||
124921072|NCT03720795|449340060|FG000|Phase 2|Lost to Follow-up|5|||
124921073|NCT03720795|449340060|FG000|Phase 2|Withdrawal by Subject|10|||
124921074|NCT03720795|449340060|FG000|Phase 2|Protocol Violation|2|||
124921075|NCT03720795|449340060|FG000|3 Month Follow Up|Lost to Follow-up|2|||
124921076|NCT03891667|449340061|FG000|Overall Study|Physician Decision|1|||
124921077|NCT03891667|449340062|FG001|Overall Study|Physician Decision|1|||
124545427|NCT03179462|447951206|FG000|Overall Study|screening failure|1|||
124545428|NCT03179462|447951207|FG001|Overall Study|screening failure|2|||
124545429|NCT03179462|447951208|FG002|Overall Study|screening failure|0|||
124545430|NCT03743571|447951211|FG000|Overall Study|Withdrawal by Subject|1|||
124545431|NCT03743571|447951212|FG001|Overall Study|Withdrawal by Subject|1|||
124545432|NCT03743571|447951211|FG000|Overall Study|Lost to Follow-up|1|||
124545433|NCT03743571|447951212|FG001|Overall Study|Lost to Follow-up|2|||
124921078|NCT03891667|449340061|FG000|Overall Study|COVID related pause|1|||
124921079|NCT03891667|449340062|FG001|Overall Study|COVID related pause|0|||
124921080|NCT03891667|449340061|FG000|Overall Study|Withdrawal by Subject|0|||
124921081|NCT03891667|449340062|FG001|Overall Study|Withdrawal by Subject|1|||
124921082|NCT03891667|449340061|FG000|Overall Study|Adverse Event|0|||
124921083|NCT03891667|449340062|FG001|Overall Study|Adverse Event|1|||
124921084|NCT03302494|449340063|FG000|Overall Study|Other|7|||
124921085|NCT03302494|449340064|FG001|Overall Study|Other|4|||
124921086|NCT03302494|449340065|FG002|Overall Study|Other|6|||
124921087|NCT03302494|449340063|FG000|Overall Study|Withdrawal by Subject|10|||
124921088|NCT03302494|449340064|FG001|Overall Study|Withdrawal by Subject|2|||
124921089|NCT03302494|449340065|FG002|Overall Study|Withdrawal by Subject|9|||
124921090|NCT03302494|449340063|FG000|Overall Study|Study Terminated by Sponsor|32|||
124921091|NCT03302494|449340064|FG001|Overall Study|Study Terminated by Sponsor|29|||
124921092|NCT03302494|449340065|FG002|Overall Study|Study Terminated by Sponsor|30|||
124921093|NCT03302494|449340063|FG000|Overall Study|Physician Decision|1|||
124921094|NCT03302494|449340064|FG001|Overall Study|Physician Decision|0|||
124921095|NCT03302494|449340065|FG002|Overall Study|Physician Decision|1|||
124921096|NCT03302494|449340063|FG000|Overall Study|Lost to Follow-up|1|||
124921097|NCT03302494|449340064|FG001|Overall Study|Lost to Follow-up|3|||
124921098|NCT03302494|449340065|FG002|Overall Study|Lost to Follow-up|3|||
124921099|NCT03302494|449340063|FG000|Overall Study|Death|13|||
124921100|NCT03302494|449340064|FG001|Overall Study|Death|11|||
124921101|NCT03302494|449340065|FG002|Overall Study|Death|4|||
124921102|NCT03302494|449340063|FG000|Overall Study|Adverse Event|1|||
124921103|NCT03302494|449340064|FG001|Overall Study|Adverse Event|2|||
124921104|NCT03302494|449340065|FG002|Overall Study|Adverse Event|0|||
124921105|NCT03302494|449340063|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
124921106|NCT03302494|449340064|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
124921107|NCT03302494|449340065|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
124545434|NCT04115488|447951213|FG000|Overall Study|Adverse Event|8|||
124545435|NCT04115488|447951214|FG001|Overall Study|Adverse Event|4|||
124545436|NCT04115488|447951213|FG000|Overall Study|Withdrawal by Subject|3|||
124545437|NCT04115488|447951214|FG001|Overall Study|Withdrawal by Subject|6|||
124545438|NCT04115488|447951213|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
124545439|NCT04115488|447951214|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
124545440|NCT04115488|447951213|FG000|Overall Study|Patient 's location change|1|||
124545441|NCT04115488|447951214|FG001|Overall Study|Patient 's location change|0|||
124545442|NCT04115488|447951213|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
124545443|NCT04115488|447951214|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
124545444|NCT01058707|447951227|FG000|Overall Study|Disease Progression|15|||
124545445|NCT01058707|447951228|FG001|Overall Study|Disease Progression|20|||
124545446|NCT01058707|447951229|FG002|Overall Study|Disease Progression|20|||
124921108|NCT05076708|449340071|FG000|Overall Study|Withdrawal by Subject|4|||
124921109|NCT05076708|449340071|FG000|Overall Study|Lost to study during switch phase|8|||
124921110|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Other|0|||
124921111|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Other|0|||
124921112|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Other|0|||
124921113|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Other|0|||
124921114|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Other|0|||
124921115|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Other|0|||
124921116|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Other|0|||
124921117|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Other|0|||
124921118|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Other|0|||
124921119|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Other|0|||
124921120|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Other|1|||
124921121|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Other|1|||
124921122|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Other|1|||
124921123|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Other|0|||
124921124|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Other|3|||
124921125|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Other|1|||
124921126|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Other|1|||
124921127|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Other|0|||
124921128|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921129|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921130|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921131|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921132|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921133|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921134|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
124921135|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921136|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
124921137|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921138|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921139|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921140|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
124921141|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921142|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921143|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921144|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921145|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
124921146|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921147|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921148|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921149|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921150|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921151|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921152|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921153|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
124921154|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921155|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921156|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921157|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124545447|NCT01058707|447951230|FG003|Overall Study|Disease Progression|15|||
124545448|NCT01058707|447951231|FG004|Overall Study|Disease Progression|23|||
124695651|NCT03071965|448505925|FG000|Overall Study|Other Health Reason|0|||
124921158|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921159|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921160|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124545449|NCT01058707|447951232|FG005|Overall Study|Disease Progression|10|||
124545450|NCT01058707|447951233|FG006|Overall Study|Disease Progression|12|||
124545451|NCT01058707|447951227|FG000|Overall Study|Adverse Event|11|||
124545452|NCT01058707|447951228|FG001|Overall Study|Adverse Event|4|||
124695652|NCT03071965|448505926|FG001|Overall Study|Other Health Reason|0|||
124695653|NCT03071965|448505927|FG002|Overall Study|Other Health Reason|0|||
124695654|NCT03071965|448505928|FG003|Overall Study|Other Health Reason|1|||
124695655|NCT01217047|448505929|FG000|Overall Study|Lost to Follow-up|0|||
124921161|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921162|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921163|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
124921164|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921165|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921166|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921167|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921168|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921169|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921170|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921171|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921172|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921173|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
124921174|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921175|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921176|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921177|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921178|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921179|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921180|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921181|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
124921182|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Death|0|||
124921183|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Death|0|||
124921184|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Death|0|||
124921185|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Death|0|||
124921186|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Death|0|||
124921187|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Death|0|||
124921188|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Death|0|||
124921189|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Death|0|||
124921190|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Death|0|||
124921191|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Death|1|||
124921192|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Death|0|||
124921193|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Death|1|||
124921194|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Death|0|||
124921195|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Death|1|||
124921196|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Death|0|||
124921197|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Death|0|||
124921198|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Death|2|||
124921199|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Death|0|||
124921200|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
124921201|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
124921202|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
124921203|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
124921204|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
124921205|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
124921206|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
124921207|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
124921208|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
124921209|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
124921210|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
124921211|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
124921212|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
124921213|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
124921214|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
124921215|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
124545453|NCT01058707|447951229|FG002|Overall Study|Adverse Event|7|||
124695656|NCT01217047|448505930|FG001|Overall Study|Lost to Follow-up|1|||
124695657|NCT01217047|448505931|FG002|Overall Study|Lost to Follow-up|0|||
124695658|NCT06399471|448505932|FG000|Overall Study|Withdrawal by Subject|1|||
124695659|NCT05587998|448505933|FG000|Overall Study|Withdrawal by Subject|1|||
124921216|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
124921217|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
124921218|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Adverse Event|0|||
124921219|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Adverse Event|0|||
124921220|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Adverse Event|0|||
124921221|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Adverse Event|0|||
124695660|NCT05587998|448505934|FG001|Overall Study|Withdrawal by Subject|1|||
124695661|NCT05587998|448505933|FG000|Overall Study|Not treated|3|||
124921222|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Adverse Event|0|||
124921223|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Adverse Event|0|||
124921224|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Adverse Event|2|||
124921225|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Adverse Event|0|||
124921226|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Adverse Event|0|||
124921227|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Adverse Event|0|||
124921228|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Adverse Event|1|||
124921229|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Adverse Event|2|||
124921230|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Adverse Event|0|||
124921231|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Adverse Event|1|||
124921232|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Adverse Event|0|||
124921233|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Adverse Event|0|||
124921234|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Adverse Event|1|||
124921235|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Adverse Event|0|||
124921236|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
124921237|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
124921238|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
124921239|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
124921240|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
124921241|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
124921242|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
124921243|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
124921244|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
124921245|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
124921246|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
124921247|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
124921248|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
124921249|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
124921250|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
124921251|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
124921252|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
124921253|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
124921254|NCT03269136|449340075|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921255|NCT03269136|449340076|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921256|NCT03269136|449340077|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921257|NCT03269136|449340078|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921258|NCT03269136|449340079|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921259|NCT03269136|449340080|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921260|NCT03269136|449340081|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921261|NCT03269136|449340082|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921262|NCT03269136|449340083|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921263|NCT03269136|449340084|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921264|NCT03269136|449340085|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921265|NCT03269136|449340086|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921266|NCT03269136|449340087|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
124921267|NCT03269136|449340088|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
124921268|NCT03269136|449340089|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
124921269|NCT03269136|449340090|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921270|NCT03269136|449340091|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
124921271|NCT03269136|449340092|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124921272|NCT03269136|449340075|FG000|Part 2A: Dose Expansion|Other|0|||
124921273|NCT03269136|449340076|FG001|Part 2A: Dose Expansion|Other|0|||
124921274|NCT03269136|449340077|FG002|Part 2A: Dose Expansion|Other|0|||
124921275|NCT03269136|449340078|FG003|Part 2A: Dose Expansion|Other|0|||
124921276|NCT03269136|449340079|FG004|Part 2A: Dose Expansion|Other|0|||
124921277|NCT03269136|449340080|FG005|Part 2A: Dose Expansion|Other|0|||
124921278|NCT03269136|449340081|FG006|Part 2A: Dose Expansion|Other|0|||
124921279|NCT03269136|449340082|FG007|Part 2A: Dose Expansion|Other|0|||
124921280|NCT03269136|449340083|FG008|Part 2A: Dose Expansion|Other|0|||
124921281|NCT03269136|449340084|FG009|Part 2A: Dose Expansion|Other|0|||
124921282|NCT03269136|449340085|FG010|Part 2A: Dose Expansion|Other|0|||
124451788|NCT02109562|447615179|FG001|Overall Study|Adverse Event|2|||
124451789|NCT02109562|447615180|FG002|Overall Study|Adverse Event|3|||
124451790|NCT02109562|447615178|FG000|Overall Study|Lost to Follow-up|1|||
124451791|NCT02109562|447615179|FG001|Overall Study|Lost to Follow-up|0|||
124451792|NCT02109562|447615180|FG002|Overall Study|Lost to Follow-up|1|||
124769819|NCT01502293|448785206|FG002|Overall Study|Reason Not Specified|0|||
124921283|NCT03269136|449340086|FG011|Part 2A: Dose Expansion|Other|0|||
124921284|NCT03269136|449340087|FG012|Part 2A: Dose Expansion|Other|0|||
124921285|NCT03269136|449340088|FG013|Part 2A: Dose Expansion|Other|0|||
124921286|NCT03269136|449340089|FG014|Part 2A: Dose Expansion|Other|0|||
124921287|NCT03269136|449340090|FG015|Part 2A: Dose Expansion|Other|0|||
124921288|NCT03269136|449340091|FG016|Part 2A: Dose Expansion|Other|0|||
124921289|NCT03269136|449340092|FG017|Part 2A: Dose Expansion|Other|1|||
124451793|NCT02109562|447615178|FG000|Overall Study|Protocol Violation|0|||
124451794|NCT02109562|447615179|FG001|Overall Study|Protocol Violation|3|||
124921290|NCT03269136|449340075|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921291|NCT03269136|449340076|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124695662|NCT05587998|448505934|FG001|Overall Study|Not treated|1|||
124695663|NCT05587998|448505933|FG000|Overall Study|Non-compliance with study procedures|0|||
124695664|NCT05587998|448505934|FG001|Overall Study|Non-compliance with study procedures|1|||
124695665|NCT03892915|448505938|FG000|Overall Study|Lost to Follow-up|6|||
124695666|NCT03892915|448505939|FG001|Overall Study|Lost to Follow-up|12|||
124695667|NCT03892915|448505938|FG000|Overall Study|Death|0|||
124695668|NCT03892915|448505939|FG001|Overall Study|Death|2|||
124695669|NCT03892915|448505938|FG000|Overall Study|Withdrawal by Subject|1|||
124921292|NCT03269136|449340077|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921293|NCT03269136|449340078|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921294|NCT03269136|449340079|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921295|NCT03269136|449340080|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921296|NCT03269136|449340081|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921297|NCT03269136|449340082|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921298|NCT03269136|449340083|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921299|NCT03269136|449340084|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921300|NCT03269136|449340085|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921301|NCT03269136|449340086|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921302|NCT03269136|449340087|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921303|NCT03269136|449340088|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921304|NCT03269136|449340089|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921305|NCT03269136|449340090|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921306|NCT03269136|449340091|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
124921307|NCT03269136|449340092|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
124921308|NCT03269136|449340075|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
124921309|NCT03269136|449340076|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
124921310|NCT03269136|449340077|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
124921311|NCT03269136|449340078|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
124921312|NCT03269136|449340079|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
124921313|NCT03269136|449340080|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
124921314|NCT03269136|449340081|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
124921315|NCT03269136|449340082|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
124921316|NCT03269136|449340083|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
124921317|NCT03269136|449340084|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
124921318|NCT03269136|449340085|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
124921319|NCT03269136|449340086|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
124921320|NCT03269136|449340087|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
124921321|NCT03269136|449340088|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
124921322|NCT03269136|449340089|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
124921323|NCT03269136|449340090|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
124921324|NCT03269136|449340091|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
124921325|NCT03269136|449340092|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
124921326|NCT03269136|449340075|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
124921327|NCT03269136|449340076|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
124921328|NCT03269136|449340077|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
124921329|NCT03269136|449340078|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
124921330|NCT03269136|449340079|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
124921331|NCT03269136|449340080|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
124921332|NCT03269136|449340081|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
124921333|NCT03269136|449340082|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
124921334|NCT03269136|449340083|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
124921335|NCT03269136|449340084|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
124921336|NCT03269136|449340085|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
124921337|NCT03269136|449340086|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
124921338|NCT03269136|449340087|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
124921339|NCT03269136|449340088|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
124921340|NCT03269136|449340089|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
124921341|NCT03269136|449340090|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
124921342|NCT03269136|449340091|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
124921343|NCT03269136|449340092|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
124921344|NCT03269136|449340075|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
124921345|NCT03269136|449340076|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
124921346|NCT03269136|449340077|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
124921347|NCT03269136|449340078|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
124921348|NCT03269136|449340079|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
124921349|NCT03269136|449340080|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
124921350|NCT03269136|449340081|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
124921351|NCT03269136|449340082|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
124695670|NCT03892915|448505939|FG001|Overall Study|Withdrawal by Subject|1|||
124921352|NCT03269136|449340083|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
124695671|NCT03892915|448505938|FG000|Overall Study|unsuccessful delivery|13|||
124921353|NCT03269136|449340084|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
124695672|NCT03892915|448505939|FG001|Overall Study|unsuccessful delivery|18|||
124921354|NCT03269136|449340085|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
124921355|NCT03269136|449340086|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
124921356|NCT03269136|449340087|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
124921357|NCT03269136|449340088|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
124921358|NCT03269136|449340089|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
124921359|NCT03269136|449340090|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
124921360|NCT03269136|449340091|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
124921361|NCT03269136|449340092|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
124921362|NCT04456517|449340093|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
124921363|NCT04456517|449340094|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
124921364|NCT04055090|449340095|FG000|Overall Study|screen failure|1|||
124921365|NCT04055090|449340096|FG001|Overall Study|screen failure|0|||
124921366|NCT04055090|449340095|FG000|Overall Study|Withdrawal by Subject|1|||
124921367|NCT04055090|449340096|FG001|Overall Study|Withdrawal by Subject|0|||
124921368|NCT05282173|449340099|FG000|Overall Study|Missed|3|||
124921369|NCT05282173|449340100|FG001|Overall Study|Missed|2|||
124921370|NCT05282173|449340101|FG002|Overall Study|Missed|4|||
124921371|NCT05093829|449340102|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
124921372|NCT05093829|449340103|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
124921373|NCT05093829|449340104|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
124921374|NCT05093829|449340105|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
124921375|NCT05093829|449340106|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
124921376|NCT02727699|449341977|FG000|Overall Study|Adverse Event|2|||
124921377|NCT02727699|449341978|FG001|Overall Study|Adverse Event|0|||
124921378|NCT02727699|449341977|FG000|Overall Study|Withdrawal by Subject|5|||
124921379|NCT02727699|449341978|FG001|Overall Study|Withdrawal by Subject|3|||
124921380|NCT02727699|449341977|FG000|Overall Study|Protocol Violation|0|||
124921381|NCT02727699|449341978|FG001|Overall Study|Protocol Violation|1|||
124921382|NCT02727699|449341977|FG000|Overall Study|Physician Decision|0|||
124921383|NCT02727699|449341978|FG001|Overall Study|Physician Decision|1|||
124921384|NCT02727699|449341977|FG000|Overall Study|Lost to Follow-up|1|||
124921385|NCT02727699|449341978|FG001|Overall Study|Lost to Follow-up|0|||
124921386|NCT02727699|449341977|FG000|Overall Study|Sponsor Decision|1|||
124921387|NCT02727699|449341978|FG001|Overall Study|Sponsor Decision|0|||
124921388|NCT02995434|449341983|FG000|Overall Study|Adverse Event|1|||
124921389|NCT02995434|449341984|FG001|Overall Study|Adverse Event|0|||
124921390|NCT02995434|449341983|FG000|Overall Study|Withdrawal by Subject|6|||
124921391|NCT02995434|449341984|FG001|Overall Study|Withdrawal by Subject|3|||
124921392|NCT03779204|449341985|FG000|Overall Study|Lost to Follow-up|2|||
124921393|NCT03779204|449341986|FG001|Overall Study|Lost to Follow-up|0|||
124921394|NCT04318548|449341996|FG000|Overall Study|Adverse Event|0|||
124921395|NCT04318548|449341997|FG001|Overall Study|Adverse Event|0|||
124921396|NCT04318548|449341998|FG002|Overall Study|Adverse Event|1|||
124921397|NCT04318548|449341996|FG000|Overall Study|Lost to Follow-up|6|||
124921398|NCT04318548|449341997|FG001|Overall Study|Lost to Follow-up|13|||
124921399|NCT04318548|449341998|FG002|Overall Study|Lost to Follow-up|9|||
124921400|NCT04318548|449341996|FG000|Overall Study|Protocol Violation|1|||
124921401|NCT04318548|449341997|FG001|Overall Study|Protocol Violation|0|||
124921402|NCT04318548|449341998|FG002|Overall Study|Protocol Violation|2|||
124921403|NCT04318548|449341996|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
124921404|NCT04318548|449341997|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
124921405|NCT04318548|449341998|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
124921406|NCT04318548|449341996|FG000|Overall Study|Migrated / moved from the study area|0|||
124921407|NCT04318548|449341997|FG001|Overall Study|Migrated / moved from the study area|0|||
124921408|NCT04318548|449341998|FG002|Overall Study|Migrated / moved from the study area|1|||
124921409|NCT04318548|449341996|FG000|Overall Study|Other|1|||
124921410|NCT04318548|449341997|FG001|Overall Study|Other|2|||
124921411|NCT04318548|449341998|FG002|Overall Study|Other|3|||
124921412|NCT04927065|449341999|FG000|First Booster|Adverse Event|1|||
124921413|NCT04927065|449342000|FG001|First Booster|Adverse Event|0|||
124545454|NCT01058707|447951230|FG003|Overall Study|Adverse Event|6|||
124921414|NCT04927065|449342001|FG002|First Booster|Adverse Event|0|||
124921415|NCT04927065|449342002|FG003|First Booster|Adverse Event|0|||
124921416|NCT04927065|449342003|FG004|First Booster|Adverse Event|0|||
124921417|NCT04927065|449342004|FG005|First Booster|Adverse Event|0|||
124921418|NCT04927065|449342005|FG006|First Booster|Adverse Event|0|||
124921419|NCT04927065|449342006|FG007|First Booster|Adverse Event|1|||
124921420|NCT04927065|449342007|FG008|First Booster|Adverse Event|0|||
124921421|NCT04927065|449342008|FG009|First Booster|Adverse Event|0|||
124921422|NCT04927065|449342009|FG010|First Booster|Adverse Event|0|||
124921423|NCT04927065|449342010|FG011|First Booster|Adverse Event|0|||
124921424|NCT04927065|449342011|FG012|First Booster|Adverse Event|0|||
124921425|NCT04927065|449342012|FG013|First Booster|Adverse Event|0|||
124921426|NCT04927065|449342013|FG014|First Booster|Adverse Event|0|||
124921427|NCT04927065|449342014|FG015|First Booster|Adverse Event|0|||
124921428|NCT04927065|449341999|FG000|First Booster|Death|1|||
124921429|NCT04927065|449342000|FG001|First Booster|Death|0|||
124921430|NCT04927065|449342001|FG002|First Booster|Death|0|||
124921431|NCT04927065|449342002|FG003|First Booster|Death|1|||
124921432|NCT04927065|449342003|FG004|First Booster|Death|0|||
124921433|NCT04927065|449342004|FG005|First Booster|Death|1|||
124921434|NCT04927065|449342005|FG006|First Booster|Death|0|||
124921435|NCT04927065|449342006|FG007|First Booster|Death|0|||
124921436|NCT04927065|449342007|FG008|First Booster|Death|0|||
124921437|NCT04927065|449342008|FG009|First Booster|Death|0|||
124921438|NCT04927065|449342009|FG010|First Booster|Death|0|||
124921439|NCT04927065|449342010|FG011|First Booster|Death|0|||
124921440|NCT04927065|449342011|FG012|First Booster|Death|0|||
124921441|NCT04927065|449342012|FG013|First Booster|Death|0|||
124921442|NCT04927065|449342013|FG014|First Booster|Death|0|||
124921443|NCT04927065|449342014|FG015|First Booster|Death|0|||
124921444|NCT04927065|449341999|FG000|First Booster|Lost to Follow-up|8|||
124921445|NCT04927065|449342000|FG001|First Booster|Lost to Follow-up|20|||
124921446|NCT04927065|449342001|FG002|First Booster|Lost to Follow-up|0|||
124921447|NCT04927065|449342002|FG003|First Booster|Lost to Follow-up|11|||
124921448|NCT04927065|449342003|FG004|First Booster|Lost to Follow-up|43|||
124921449|NCT04927065|449342004|FG005|First Booster|Lost to Follow-up|30|||
124921450|NCT04927065|449342005|FG006|First Booster|Lost to Follow-up|28|||
124921451|NCT04927065|449342006|FG007|First Booster|Lost to Follow-up|23|||
124921452|NCT04927065|449342007|FG008|First Booster|Lost to Follow-up|4|||
124921453|NCT04927065|449342008|FG009|First Booster|Lost to Follow-up|15|||
124921454|NCT04927065|449342009|FG010|First Booster|Lost to Follow-up|0|||
124921455|NCT04927065|449342010|FG011|First Booster|Lost to Follow-up|0|||
124921456|NCT04927065|449342011|FG012|First Booster|Lost to Follow-up|0|||
124921457|NCT04927065|449342012|FG013|First Booster|Lost to Follow-up|0|||
124921458|NCT04927065|449342013|FG014|First Booster|Lost to Follow-up|0|||
124921459|NCT04927065|449342014|FG015|First Booster|Lost to Follow-up|0|||
124921460|NCT04927065|449341999|FG000|First Booster|Physician Decision|1|||
124921461|NCT04927065|449342000|FG001|First Booster|Physician Decision|0|||
124921462|NCT04927065|449342001|FG002|First Booster|Physician Decision|0|||
124921463|NCT04927065|449342002|FG003|First Booster|Physician Decision|3|||
124921464|NCT04927065|449342003|FG004|First Booster|Physician Decision|1|||
124921465|NCT04927065|449342004|FG005|First Booster|Physician Decision|1|||
124921466|NCT04927065|449342005|FG006|First Booster|Physician Decision|0|||
124921467|NCT04927065|449342006|FG007|First Booster|Physician Decision|3|||
124921468|NCT04927065|449342007|FG008|First Booster|Physician Decision|0|||
124921469|NCT04927065|449342008|FG009|First Booster|Physician Decision|0|||
124921470|NCT04927065|449342009|FG010|First Booster|Physician Decision|0|||
124921471|NCT04927065|449342010|FG011|First Booster|Physician Decision|0|||
124921472|NCT04927065|449342011|FG012|First Booster|Physician Decision|0|||
124921473|NCT04927065|449342012|FG013|First Booster|Physician Decision|0|||
124921474|NCT04927065|449342013|FG014|First Booster|Physician Decision|0|||
124921475|NCT04927065|449342014|FG015|First Booster|Physician Decision|0|||
124921476|NCT04927065|449341999|FG000|First Booster|Protocol Violation|4|||
124921477|NCT04927065|449342000|FG001|First Booster|Protocol Violation|4|||
124921478|NCT04927065|449342001|FG002|First Booster|Protocol Violation|0|||
124921479|NCT04927065|449342002|FG003|First Booster|Protocol Violation|3|||
124921480|NCT04927065|449342003|FG004|First Booster|Protocol Violation|0|||
124921481|NCT04927065|449342004|FG005|First Booster|Protocol Violation|0|||
124921482|NCT04927065|449342005|FG006|First Booster|Protocol Violation|0|||
124921483|NCT04927065|449342006|FG007|First Booster|Protocol Violation|2|||
124921484|NCT04927065|449342007|FG008|First Booster|Protocol Violation|0|||
124921485|NCT04927065|449342008|FG009|First Booster|Protocol Violation|0|||
124921486|NCT04927065|449342009|FG010|First Booster|Protocol Violation|0|||
124921487|NCT04927065|449342010|FG011|First Booster|Protocol Violation|0|||
124921488|NCT04927065|449342011|FG012|First Booster|Protocol Violation|0|||
124921489|NCT04927065|449342012|FG013|First Booster|Protocol Violation|0|||
124921490|NCT04927065|449342013|FG014|First Booster|Protocol Violation|0|||
124921491|NCT04927065|449342014|FG015|First Booster|Protocol Violation|0|||
124921492|NCT04927065|449341999|FG000|First Booster|Withdrawal by Subject|8|||
124921493|NCT04927065|449342000|FG001|First Booster|Withdrawal by Subject|23|||
124921494|NCT04927065|449342001|FG002|First Booster|Withdrawal by Subject|0|||
124921495|NCT04927065|449342002|FG003|First Booster|Withdrawal by Subject|19|||
124921496|NCT04927065|449342003|FG004|First Booster|Withdrawal by Subject|20|||
124921497|NCT04927065|449342004|FG005|First Booster|Withdrawal by Subject|15|||
124921498|NCT04927065|449342005|FG006|First Booster|Withdrawal by Subject|6|||
124921499|NCT04927065|449342006|FG007|First Booster|Withdrawal by Subject|24|||
124921500|NCT04927065|449342007|FG008|First Booster|Withdrawal by Subject|0|||
124921501|NCT04927065|449342008|FG009|First Booster|Withdrawal by Subject|4|||
124921502|NCT04927065|449342009|FG010|First Booster|Withdrawal by Subject|0|||
124921503|NCT04927065|449342010|FG011|First Booster|Withdrawal by Subject|0|||
124921504|NCT04927065|449342011|FG012|First Booster|Withdrawal by Subject|0|||
124921505|NCT04927065|449342012|FG013|First Booster|Withdrawal by Subject|0|||
124921506|NCT04927065|449342013|FG014|First Booster|Withdrawal by Subject|0|||
124921507|NCT04927065|449342014|FG015|First Booster|Withdrawal by Subject|0|||
124921508|NCT04927065|449341999|FG000|First Booster|Other Than Specified|1|||
124921509|NCT04927065|449342000|FG001|First Booster|Other Than Specified|1|||
124921510|NCT04927065|449342001|FG002|First Booster|Other Than Specified|0|||
124921511|NCT04927065|449342002|FG003|First Booster|Other Than Specified|1|||
124921512|NCT04927065|449342003|FG004|First Booster|Other Than Specified|2|||
124921513|NCT04927065|449342004|FG005|First Booster|Other Than Specified|3|||
124921514|NCT04927065|449342005|FG006|First Booster|Other Than Specified|2|||
124921515|NCT04927065|449342006|FG007|First Booster|Other Than Specified|6|||
124921516|NCT04927065|449342007|FG008|First Booster|Other Than Specified|0|||
124921517|NCT04927065|449342008|FG009|First Booster|Other Than Specified|4|||
124921518|NCT04927065|449342009|FG010|First Booster|Other Than Specified|0|||
124921519|NCT04927065|449342010|FG011|First Booster|Other Than Specified|0|||
124921520|NCT04927065|449342011|FG012|First Booster|Other Than Specified|0|||
124921521|NCT04927065|449342012|FG013|First Booster|Other Than Specified|0|||
124921522|NCT04927065|449342013|FG014|First Booster|Other Than Specified|0|||
124921523|NCT04927065|449342014|FG015|First Booster|Other Than Specified|0|||
124545455|NCT01058707|447951231|FG004|Overall Study|Adverse Event|7|||
124695673|NCT01181128|448505940|FG000|Overall Study|Withdrawal by Subject|2|||
124695674|NCT01181128|448505941|FG001|Overall Study|Withdrawal by Subject|2|||
124695675|NCT01181128|448505942|FG002|Overall Study|Withdrawal by Subject|0|||
124921524|NCT04927065|449341999|FG000|Second Booster|Death|0|||
124921525|NCT04927065|449342000|FG001|Second Booster|Death|0|||
124545456|NCT01058707|447951232|FG005|Overall Study|Adverse Event|3|||
124921526|NCT04927065|449342001|FG002|Second Booster|Death|0|||
124921527|NCT04927065|449342002|FG003|Second Booster|Death|0|||
124921528|NCT04927065|449342003|FG004|Second Booster|Death|0|||
124921529|NCT04927065|449342004|FG005|Second Booster|Death|0|||
124921530|NCT04927065|449342005|FG006|Second Booster|Death|0|||
124921531|NCT04927065|449342006|FG007|Second Booster|Death|0|||
124921532|NCT04927065|449342007|FG008|Second Booster|Death|0|||
124921533|NCT04927065|449342008|FG009|Second Booster|Death|0|||
124921534|NCT04927065|449342009|FG010|Second Booster|Death|2|||
124921535|NCT04927065|449342010|FG011|Second Booster|Death|0|||
124921536|NCT04927065|449342011|FG012|Second Booster|Death|2|||
124921537|NCT04927065|449342012|FG013|Second Booster|Death|2|||
124921538|NCT04927065|449342013|FG014|Second Booster|Death|0|||
124921539|NCT04927065|449342014|FG015|Second Booster|Death|0|||
124921540|NCT04927065|449341999|FG000|Second Booster|Lost to Follow-up|0|||
124921541|NCT04927065|449342000|FG001|Second Booster|Lost to Follow-up|0|||
124921542|NCT04927065|449342001|FG002|Second Booster|Lost to Follow-up|3|||
124921543|NCT04927065|449342002|FG003|Second Booster|Lost to Follow-up|0|||
124921544|NCT04927065|449342003|FG004|Second Booster|Lost to Follow-up|0|||
124921545|NCT04927065|449342004|FG005|Second Booster|Lost to Follow-up|0|||
124921546|NCT04927065|449342005|FG006|Second Booster|Lost to Follow-up|0|||
124921547|NCT04927065|449342006|FG007|Second Booster|Lost to Follow-up|0|||
124451795|NCT02109562|447615180|FG002|Overall Study|Protocol Violation|1|||
124451796|NCT02109562|447615178|FG000|Overall Study|Withdrawal by Subject|20|||
124451797|NCT02109562|447615179|FG001|Overall Study|Withdrawal by Subject|25|||
124451798|NCT02109562|447615180|FG002|Overall Study|Withdrawal by Subject|21|||
124451799|NCT02109562|447615178|FG000|Overall Study|Physician Decision|3|||
124451800|NCT02109562|447615179|FG001|Overall Study|Physician Decision|4|||
124451801|NCT02109562|447615180|FG002|Overall Study|Physician Decision|5|||
124451802|NCT00310804|447615181|FG000|Overall Study|Lost to Follow-up|2|||
124451803|NCT00310804|447615182|FG001|Overall Study|Lost to Follow-up|0|||
124451804|NCT00310804|447615181|FG000|Overall Study|Withdrawal by Subject|3|||
124451805|NCT00310804|447615182|FG001|Overall Study|Withdrawal by Subject|0|||
124921548|NCT04927065|449342007|FG008|Second Booster|Lost to Follow-up|0|||
124921549|NCT04927065|449342008|FG009|Second Booster|Lost to Follow-up|0|||
124921550|NCT04927065|449342009|FG010|Second Booster|Lost to Follow-up|14|||
124921551|NCT04927065|449342010|FG011|Second Booster|Lost to Follow-up|10|||
124921552|NCT04927065|449342011|FG012|Second Booster|Lost to Follow-up|13|||
124921553|NCT04927065|449342012|FG013|Second Booster|Lost to Follow-up|16|||
124921554|NCT04927065|449342013|FG014|Second Booster|Lost to Follow-up|0|||
124451806|NCT00688155|447615187|FG000|Overall Study|Withdrawal by Subject|2|||
124451807|NCT00688155|447615188|FG001|Overall Study|Withdrawal by Subject|2|||
124451808|NCT00688155|447615189|FG002|Overall Study|Withdrawal by Subject|1|||
124451809|NCT00688155|447615190|FG003|Overall Study|Withdrawal by Subject|1|||
124451810|NCT03318978|447615197|FG000|Overall Study|Withdrawal by Subject|1|||
124451811|NCT01200238|447615199|FG000|Overall Study|Adverse Event|2|||
124451812|NCT01200238|447615200|FG001|Overall Study|Adverse Event|1|||
124451813|NCT01200238|447615199|FG000|Overall Study|Progressive Disease|5|||
124451814|NCT01200238|447615200|FG001|Overall Study|Progressive Disease|8|||
124451815|NCT01200238|447615199|FG000|Overall Study|Withdrawal by Subject|0|||
124451816|NCT01200238|447615200|FG001|Overall Study|Withdrawal by Subject|1|||
124451817|NCT01005745|447615201|FG000|Overall Study|No TIL growth|1|||
124451818|NCT01005745|447615201|FG000|Overall Study|Disease progressed during TIL growth|3|||
124451819|NCT01005745|447615201|FG000|Overall Study|Death prior to treatment|1|||
124451820|NCT01005745|447615201|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
124451821|NCT03227471|447616880|FG000|Overall Study|Withdrawal by Subject|0|||
124451822|NCT03227471|447616881|FG001|Overall Study|Withdrawal by Subject|0|||
124451823|NCT03227471|447616882|FG002|Overall Study|Withdrawal by Subject|0|||
124451824|NCT03227471|447616883|FG003|Overall Study|Withdrawal by Subject|0|||
124451825|NCT03227471|447616884|FG004|Overall Study|Withdrawal by Subject|1|||
124451826|NCT03227471|447616885|FG005|Overall Study|Withdrawal by Subject|0|||
124451827|NCT03227471|447616886|FG006|Overall Study|Withdrawal by Subject|0|||
124451828|NCT03227471|447616887|FG007|Overall Study|Withdrawal by Subject|0|||
124451829|NCT03227471|447616888|FG008|Overall Study|Withdrawal by Subject|0|||
124921555|NCT04927065|449342014|FG015|Second Booster|Lost to Follow-up|0|||
124921556|NCT04927065|449341999|FG000|Second Booster|Physician Decision|0|||
124451830|NCT03227471|447616889|FG009|Overall Study|Withdrawal by Subject|0|||
124451831|NCT03227471|447616890|FG010|Overall Study|Withdrawal by Subject|0|||
124451832|NCT03227471|447616891|FG011|Overall Study|Withdrawal by Subject|0|||
124451833|NCT03227471|447616892|FG012|Overall Study|Withdrawal by Subject|1|||
124451834|NCT03227471|447616893|FG013|Overall Study|Withdrawal by Subject|0|||
124451835|NCT03227471|447616894|FG014|Overall Study|Withdrawal by Subject|0|||
124921557|NCT04927065|449342000|FG001|Second Booster|Physician Decision|0|||
124921558|NCT04927065|449342001|FG002|Second Booster|Physician Decision|0|||
124921559|NCT04927065|449342002|FG003|Second Booster|Physician Decision|0|||
124921560|NCT04927065|449342003|FG004|Second Booster|Physician Decision|0|||
124921561|NCT04927065|449342004|FG005|Second Booster|Physician Decision|0|||
124451836|NCT03227471|447616880|FG000|Overall Study|Randomized, Never Dosed|0|||
124921562|NCT04927065|449342005|FG006|Second Booster|Physician Decision|0|||
124921563|NCT04927065|449342006|FG007|Second Booster|Physician Decision|0|||
124921564|NCT04927065|449342007|FG008|Second Booster|Physician Decision|0|||
124451837|NCT03227471|447616881|FG001|Overall Study|Randomized, Never Dosed|0|||
124451838|NCT03227471|447616882|FG002|Overall Study|Randomized, Never Dosed|0|||
124451839|NCT03227471|447616883|FG003|Overall Study|Randomized, Never Dosed|0|||
124451840|NCT03227471|447616884|FG004|Overall Study|Randomized, Never Dosed|0|||
124451841|NCT03227471|447616885|FG005|Overall Study|Randomized, Never Dosed|0|||
124451842|NCT03227471|447616886|FG006|Overall Study|Randomized, Never Dosed|0|||
124451843|NCT03227471|447616887|FG007|Overall Study|Randomized, Never Dosed|0|||
124451844|NCT03227471|447616888|FG008|Overall Study|Randomized, Never Dosed|0|||
124451845|NCT03227471|447616889|FG009|Overall Study|Randomized, Never Dosed|0|||
124451846|NCT03227471|447616890|FG010|Overall Study|Randomized, Never Dosed|0|||
124451847|NCT03227471|447616891|FG011|Overall Study|Randomized, Never Dosed|0|||
124451848|NCT03227471|447616892|FG012|Overall Study|Randomized, Never Dosed|0|||
124451849|NCT03227471|447616893|FG013|Overall Study|Randomized, Never Dosed|0|||
124451850|NCT03227471|447616894|FG014|Overall Study|Randomized, Never Dosed|1|||
124451851|NCT00382720|447616895|FG000|Overall Study|Adverse Event|21|||
124451852|NCT00382720|447616896|FG001|Overall Study|Adverse Event|23|||
124451853|NCT00382720|447616897|FG002|Overall Study|Adverse Event|15|||
124451854|NCT00382720|447616895|FG000|Overall Study|Protocol Violation|2|||
124451855|NCT00382720|447616896|FG001|Overall Study|Protocol Violation|5|||
124451856|NCT00382720|447616897|FG002|Overall Study|Protocol Violation|1|||
124451857|NCT00382720|447616895|FG000|Overall Study|Death|0|||
124451858|NCT00382720|447616896|FG001|Overall Study|Death|1|||
124451859|NCT00382720|447616897|FG002|Overall Study|Death|2|||
124451860|NCT00382720|447616895|FG000|Overall Study|Progressive disease|37|||
124451861|NCT00382720|447616896|FG001|Overall Study|Progressive disease|28|||
124451862|NCT00382720|447616897|FG002|Overall Study|Progressive disease|38|||
124451863|NCT00382720|447616895|FG000|Overall Study|Withdrew consent|1|||
124451864|NCT00382720|447616896|FG001|Overall Study|Withdrew consent|1|||
124451865|NCT00382720|447616897|FG002|Overall Study|Withdrew consent|2|||
124451866|NCT00382720|447616895|FG000|Overall Study|Withdrawal by Subject|11|||
124451867|NCT00382720|447616896|FG001|Overall Study|Withdrawal by Subject|20|||
124451868|NCT00382720|447616897|FG002|Overall Study|Withdrawal by Subject|12|||
124451869|NCT00382720|447616895|FG000|Overall Study|Surgery|1|||
124451870|NCT00382720|447616896|FG001|Overall Study|Surgery|1|||
124451871|NCT00382720|447616897|FG002|Overall Study|Surgery|4|||
124451872|NCT00382720|447616895|FG000|Overall Study|Patient did not receive study medication|1|||
124451873|NCT00382720|447616896|FG001|Overall Study|Patient did not receive study medication|1|||
124451874|NCT00382720|447616897|FG002|Overall Study|Patient did not receive study medication|4|||
124451875|NCT00382720|447616895|FG000|Overall Study|Clinically progressive disease|0|||
124451876|NCT00382720|447616896|FG001|Overall Study|Clinically progressive disease|1|||
124451877|NCT00382720|447616897|FG002|Overall Study|Clinically progressive disease|0|||
124451878|NCT00382720|447616895|FG000|Overall Study|Good prognosis|0|||
124451879|NCT00382720|447616896|FG001|Overall Study|Good prognosis|1|||
124451880|NCT00382720|447616897|FG002|Overall Study|Good prognosis|0|||
124451881|NCT00382720|447616895|FG000|Overall Study|Investigator/Clinical decision|5|||
124451882|NCT00382720|447616896|FG001|Overall Study|Investigator/Clinical decision|6|||
124451883|NCT00382720|447616897|FG002|Overall Study|Investigator/Clinical decision|6|||
124451884|NCT00382720|447616895|FG000|Overall Study|Discontinued at end of study|0|||
124451885|NCT00382720|447616896|FG001|Overall Study|Discontinued at end of study|1|||
124451886|NCT00382720|447616897|FG002|Overall Study|Discontinued at end of study|2|||
124451887|NCT00682448|447616898|FG000|Overall Study|Adverse Event|1|||
124451888|NCT00682448|447616899|FG001|Overall Study|Adverse Event|2|||
124451889|NCT00682448|447616898|FG000|Overall Study|Lack of Efficacy|1|||
124451890|NCT00682448|447616899|FG001|Overall Study|Lack of Efficacy|0|||
124695676|NCT01181128|448505940|FG000|Overall Study|Death|1|||
124695677|NCT01181128|448505941|FG001|Overall Study|Death|0|||
124695678|NCT01181128|448505942|FG002|Overall Study|Death|0|||
124695679|NCT01181128|448505940|FG000|Overall Study|Physician Decision|2|||
124695680|NCT01181128|448505941|FG001|Overall Study|Physician Decision|0|||
124695681|NCT01181128|448505942|FG002|Overall Study|Physician Decision|0|||
124921565|NCT04927065|449342008|FG009|Second Booster|Physician Decision|0|||
124921566|NCT04927065|449342009|FG010|Second Booster|Physician Decision|0|||
124921567|NCT04927065|449342010|FG011|Second Booster|Physician Decision|3|||
124921568|NCT04927065|449342011|FG012|Second Booster|Physician Decision|0|||
124921569|NCT04927065|449342012|FG013|Second Booster|Physician Decision|1|||
124921570|NCT04927065|449342013|FG014|Second Booster|Physician Decision|0|||
124921571|NCT04927065|449342014|FG015|Second Booster|Physician Decision|0|||
124921572|NCT04927065|449341999|FG000|Second Booster|Withdrawal by Subject|0|||
124921573|NCT04927065|449342000|FG001|Second Booster|Withdrawal by Subject|0|||
124921574|NCT04927065|449342001|FG002|Second Booster|Withdrawal by Subject|4|||
124921575|NCT04927065|449342002|FG003|Second Booster|Withdrawal by Subject|0|||
124921576|NCT04927065|449342003|FG004|Second Booster|Withdrawal by Subject|0|||
124451891|NCT00682448|447616898|FG000|Overall Study|Lost to Follow-up|1|||
124451892|NCT00682448|447616899|FG001|Overall Study|Lost to Follow-up|3|||
124451893|NCT00682448|447616898|FG000|Overall Study|Pregnancy|0|||
124451894|NCT00682448|447616899|FG001|Overall Study|Pregnancy|1|||
124695682|NCT01181128|448505940|FG000|Overall Study|Adverse Event|0|||
124921577|NCT04927065|449342004|FG005|Second Booster|Withdrawal by Subject|0|||
124451895|NCT00682448|447616898|FG000|Overall Study|Withdrawal by Subject|2|||
124451896|NCT00682448|447616899|FG001|Overall Study|Withdrawal by Subject|0|||
124451897|NCT00257166|447616903|FG000|Overall Study|Adverse Event|18|||
124451898|NCT00257166|447616904|FG001|Overall Study|Adverse Event|13|||
124451899|NCT00257166|447616903|FG000|Overall Study|Laboratory abnormality|1|||
124451900|NCT00257166|447616904|FG001|Overall Study|Laboratory abnormality|0|||
124451901|NCT00257166|447616903|FG000|Overall Study|Lost to Follow-up|8|||
124451902|NCT00257166|447616904|FG001|Overall Study|Lost to Follow-up|1|||
124695683|NCT01181128|448505941|FG001|Overall Study|Adverse Event|2|||
124695684|NCT01181128|448505942|FG002|Overall Study|Adverse Event|0|||
124695685|NCT01181128|448505940|FG000|Overall Study|Other|1|||
124695686|NCT01181128|448505941|FG001|Overall Study|Other|1|||
124695687|NCT01181128|448505942|FG002|Overall Study|Other|1|||
124695688|NCT01362270|448505945|FG000|Overall Study|Withdrawal by Subject|1|||
124695689|NCT01362270|448505946|FG001|Overall Study|Withdrawal by Subject|0|||
124695690|NCT01362270|448505945|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
124695691|NCT01362270|448505946|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
124762329|NCT04073186|448755857|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
124762330|NCT04073186|448755857|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
124762331|NCT04073186|448755857|FG000|First Wearing Cycle|Protocol Violation|1|||
124762332|NCT04073186|448755857|FG000|First Wearing Cycle|Lens Discomfort|2|||
124762333|NCT04073186|448755857|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
124762334|NCT04073186|448755857|FG000|Second Wearing Cycle|Adverse Event|1|||
124762335|NCT01096316|448755858|FG000|Overall Study|Lost to Follow-up|15|||
124762336|NCT01096316|448755859|FG001|Overall Study|Lost to Follow-up|9|||
124762337|NCT02763644|448755860|FG000|Overall Study|Patient/guardian decision|1|||
124921578|NCT04927065|449342005|FG006|Second Booster|Withdrawal by Subject|0|||
124695692|NCT01362270|448505945|FG000|Overall Study|Met excl. criteria before 1st session|1|||
124695693|NCT01362270|448505946|FG001|Overall Study|Met excl. criteria before 1st session|1|||
124695694|NCT02318277|448505947|FG000|Overall Study|Physician Decision|0|||
124695695|NCT02318277|448505948|FG001|Overall Study|Physician Decision|0|||
124762338|NCT02763644|448755861|FG001|Overall Study|Patient/guardian decision|0|||
124921579|NCT04927065|449342006|FG007|Second Booster|Withdrawal by Subject|0|||
124921580|NCT04927065|449342007|FG008|Second Booster|Withdrawal by Subject|0|||
124921581|NCT04927065|449342008|FG009|Second Booster|Withdrawal by Subject|0|||
124921582|NCT04927065|449342009|FG010|Second Booster|Withdrawal by Subject|3|||
124921583|NCT04927065|449342010|FG011|Second Booster|Withdrawal by Subject|16|||
124921584|NCT04927065|449342011|FG012|Second Booster|Withdrawal by Subject|13|||
124921585|NCT04927065|449342012|FG013|Second Booster|Withdrawal by Subject|9|||
124921586|NCT04927065|449342013|FG014|Second Booster|Withdrawal by Subject|0|||
124921587|NCT04927065|449342014|FG015|Second Booster|Withdrawal by Subject|0|||
124921588|NCT04927065|449341999|FG000|Second Booster|Other Than Specified|0|||
124921589|NCT04927065|449342000|FG001|Second Booster|Other Than Specified|0|||
124921590|NCT04927065|449342001|FG002|Second Booster|Other Than Specified|0|||
124921591|NCT04927065|449342002|FG003|Second Booster|Other Than Specified|0|||
124921592|NCT04927065|449342003|FG004|Second Booster|Other Than Specified|0|||
124921593|NCT04927065|449342004|FG005|Second Booster|Other Than Specified|0|||
124921594|NCT04927065|449342005|FG006|Second Booster|Other Than Specified|0|||
124921595|NCT04927065|449342006|FG007|Second Booster|Other Than Specified|0|||
124921596|NCT04927065|449342007|FG008|Second Booster|Other Than Specified|0|||
124921597|NCT04927065|449342008|FG009|Second Booster|Other Than Specified|0|||
124921598|NCT04927065|449342009|FG010|Second Booster|Other Than Specified|1|||
124921599|NCT04927065|449342010|FG011|Second Booster|Other Than Specified|1|||
124921600|NCT04927065|449342011|FG012|Second Booster|Other Than Specified|4|||
124921601|NCT04927065|449342012|FG013|Second Booster|Other Than Specified|0|||
124921602|NCT04927065|449342013|FG014|Second Booster|Other Than Specified|0|||
124921603|NCT04927065|449342014|FG015|Second Booster|Other Than Specified|0|||
124921604|NCT04927065|449341999|FG000|Third Booster|Lost to Follow-up|0|||
124921605|NCT04927065|449342000|FG001|Third Booster|Lost to Follow-up|0|||
124921606|NCT04927065|449342001|FG002|Third Booster|Lost to Follow-up|0|||
124921607|NCT04927065|449342002|FG003|Third Booster|Lost to Follow-up|0|||
124921608|NCT04927065|449342003|FG004|Third Booster|Lost to Follow-up|0|||
124921609|NCT04927065|449342004|FG005|Third Booster|Lost to Follow-up|0|||
124921610|NCT04927065|449342005|FG006|Third Booster|Lost to Follow-up|0|||
124762339|NCT02763644|448755860|FG000|Overall Study|Death|1|||
124762340|NCT02763644|448755861|FG001|Overall Study|Death|1|||
124451903|NCT00257166|447616903|FG000|Overall Study|Withdrawal by Subject|9|||
124695696|NCT02318277|448505949|FG002|Overall Study|Physician Decision|0|||
124921611|NCT04927065|449342006|FG007|Third Booster|Lost to Follow-up|0|||
124921612|NCT04927065|449342007|FG008|Third Booster|Lost to Follow-up|0|||
124921613|NCT04927065|449342008|FG009|Third Booster|Lost to Follow-up|0|||
124451904|NCT00257166|447616904|FG001|Overall Study|Withdrawal by Subject|2|||
124695697|NCT02318277|448505950|FG003|Overall Study|Physician Decision|0|||
124695698|NCT02318277|448505951|FG004|Overall Study|Physician Decision|0|||
124695699|NCT02318277|448505952|FG005|Overall Study|Physician Decision|0|||
124762341|NCT02763644|448755860|FG000|Overall Study|Adverse Event|1|||
124921614|NCT04927065|449342009|FG010|Third Booster|Lost to Follow-up|0|||
124921615|NCT04927065|449342010|FG011|Third Booster|Lost to Follow-up|0|||
124921616|NCT04927065|449342011|FG012|Third Booster|Lost to Follow-up|0|||
124921617|NCT04927065|449342012|FG013|Third Booster|Lost to Follow-up|0|||
124921618|NCT04927065|449342013|FG014|Third Booster|Lost to Follow-up|0|||
124921619|NCT04927065|449342014|FG015|Third Booster|Lost to Follow-up|1|||
124921620|NCT04927065|449341999|FG000|Third Booster|Withdrawal by Subject|0|||
124921621|NCT04927065|449342000|FG001|Third Booster|Withdrawal by Subject|0|||
124921622|NCT04927065|449342001|FG002|Third Booster|Withdrawal by Subject|0|||
124921623|NCT04927065|449342002|FG003|Third Booster|Withdrawal by Subject|0|||
124921624|NCT04927065|449342003|FG004|Third Booster|Withdrawal by Subject|0|||
124921625|NCT04927065|449342004|FG005|Third Booster|Withdrawal by Subject|0|||
124921626|NCT04927065|449342005|FG006|Third Booster|Withdrawal by Subject|0|||
124921627|NCT04927065|449342006|FG007|Third Booster|Withdrawal by Subject|0|||
124921628|NCT04927065|449342007|FG008|Third Booster|Withdrawal by Subject|0|||
124921629|NCT04927065|449342008|FG009|Third Booster|Withdrawal by Subject|0|||
124921630|NCT04927065|449342009|FG010|Third Booster|Withdrawal by Subject|0|||
124921631|NCT04927065|449342010|FG011|Third Booster|Withdrawal by Subject|0|||
124921632|NCT04927065|449342011|FG012|Third Booster|Withdrawal by Subject|0|||
124921633|NCT04927065|449342012|FG013|Third Booster|Withdrawal by Subject|0|||
124921634|NCT04927065|449342013|FG014|Third Booster|Withdrawal by Subject|0|||
124921635|NCT04927065|449342014|FG015|Third Booster|Withdrawal by Subject|1|||
124921636|NCT04241068|449342017|FG000|Core Treatment Period|Adverse Event|91|||
124695700|NCT02318277|448505953|FG006|Overall Study|Physician Decision|0|||
124695701|NCT02318277|448505954|FG007|Overall Study|Physician Decision|1|||
124695702|NCT02318277|448505947|FG000|Overall Study|Other|0|||
124695703|NCT02318277|448505948|FG001|Overall Study|Other|0|||
124695704|NCT02318277|448505949|FG002|Overall Study|Other|0|||
124695705|NCT02318277|448505950|FG003|Overall Study|Other|0|||
124695706|NCT02318277|448505951|FG004|Overall Study|Other|0|||
124695707|NCT02318277|448505952|FG005|Overall Study|Other|0|||
124695708|NCT02318277|448505953|FG006|Overall Study|Other|1|||
124695709|NCT02318277|448505954|FG007|Overall Study|Other|0|||
124695710|NCT02318277|448505947|FG000|Overall Study|Withdrawal by Subject|0|||
124921637|NCT04241068|449342017|FG000|Core Treatment Period|Change of Treatment|4|||
124695711|NCT02318277|448505948|FG001|Overall Study|Withdrawal by Subject|0|||
124695712|NCT02318277|448505949|FG002|Overall Study|Withdrawal by Subject|1|||
124695713|NCT02318277|448505950|FG003|Overall Study|Withdrawal by Subject|0|||
124695714|NCT02318277|448505951|FG004|Overall Study|Withdrawal by Subject|1|||
124695715|NCT02318277|448505952|FG005|Overall Study|Withdrawal by Subject|1|||
124695716|NCT02318277|448505953|FG006|Overall Study|Withdrawal by Subject|6|||
124695717|NCT02318277|448505954|FG007|Overall Study|Withdrawal by Subject|14|||
124695718|NCT02318277|448505947|FG000|Overall Study|Participant trial terminated by sponsor|0|||
124695719|NCT02318277|448505948|FG001|Overall Study|Participant trial terminated by sponsor|0|||
124695720|NCT02318277|448505949|FG002|Overall Study|Participant trial terminated by sponsor|1|||
124695721|NCT02318277|448505950|FG003|Overall Study|Participant trial terminated by sponsor|0|||
124695722|NCT02318277|448505951|FG004|Overall Study|Participant trial terminated by sponsor|1|||
124695723|NCT02318277|448505952|FG005|Overall Study|Participant trial terminated by sponsor|2|||
124695724|NCT02318277|448505953|FG006|Overall Study|Participant trial terminated by sponsor|5|||
124695725|NCT02318277|448505954|FG007|Overall Study|Participant trial terminated by sponsor|16|||
124695726|NCT02318277|448505947|FG000|Overall Study|Lost to Follow-up|1|||
124695727|NCT02318277|448505948|FG001|Overall Study|Lost to Follow-up|0|||
124695728|NCT02318277|448505949|FG002|Overall Study|Lost to Follow-up|1|||
124695729|NCT02318277|448505950|FG003|Overall Study|Lost to Follow-up|0|||
124695730|NCT02318277|448505951|FG004|Overall Study|Lost to Follow-up|0|||
124695731|NCT02318277|448505952|FG005|Overall Study|Lost to Follow-up|0|||
124695732|NCT02318277|448505953|FG006|Overall Study|Lost to Follow-up|3|||
124695733|NCT02318277|448505954|FG007|Overall Study|Lost to Follow-up|4|||
124695734|NCT02318277|448505947|FG000|Overall Study|Death|5|||
124921638|NCT04241068|449342017|FG000|Core Treatment Period|Consent Withdrawn|143|||
124921639|NCT04241068|449342017|FG000|Core Treatment Period|Death|26|||
124921640|NCT04241068|449342017|FG000|Core Treatment Period|Disease Progression|67|||
124921641|NCT04241068|449342017|FG000|Core Treatment Period|Investigator Decision|40|||
124921642|NCT04241068|449342017|FG000|Core Treatment Period|Loss of Capacity|9|||
124921643|NCT04241068|449342017|FG000|Core Treatment Period|Lost to Follow-up|11|||
124451905|NCT00257166|447616903|FG000|Overall Study|Other|16|||
124451906|NCT00257166|447616904|FG001|Overall Study|Other|21|||
124451907|NCT00257166|447616903|FG000|Overall Study|Randomized, but not treated|1|||
124451908|NCT00257166|447616904|FG001|Overall Study|Randomized, but not treated|0|||
124451909|NCT03335163|447616913|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
124451910|NCT03335163|447616913|FG000|Overall Study|Withdrawal by Subject|18|||
124451911|NCT00525044|447616914|FG000|Overall Study|Lost to Follow-up|0|||
124451912|NCT00525044|447616915|FG001|Overall Study|Lost to Follow-up|1|||
124451913|NCT03713034|447616917|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
124451914|NCT03713034|447616918|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
124695735|NCT02318277|448505948|FG001|Overall Study|Death|3|||
124695736|NCT02318277|448505949|FG002|Overall Study|Death|1|||
124695737|NCT02318277|448505950|FG003|Overall Study|Death|4|||
124921644|NCT04241068|449342017|FG000|Core Treatment Period|Relocation|4|||
124921645|NCT04241068|449342017|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
124921646|NCT04241068|449342017|FG000|Core Treatment Period|Study Visit Burden|40|||
124921647|NCT04241068|449342017|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
124921648|NCT04241068|449342017|FG000|Core Treatment Period|Missing|2|||
124921649|NCT04241068|449342017|FG000|Core Treatment Period|Reason Not Specified|41|||
124921650|NCT04241068|449342017|FG000|LTE Period|Adverse Event|19|||
124921651|NCT04241068|449342017|FG000|LTE Period|Change of Treatment|1|||
124921652|NCT04241068|449342017|FG000|LTE Period|Consent Withdrawn|71|||
124921653|NCT04241068|449342017|FG000|LTE Period|Death|8|||
124921654|NCT04241068|449342017|FG000|LTE Period|Disease Progression|11|||
124921655|NCT04241068|449342017|FG000|LTE Period|Investigator Decision|12|||
124921656|NCT04241068|449342017|FG000|LTE Period|Loss of Capacity|2|||
124921657|NCT04241068|449342017|FG000|LTE Period|Lost to Follow-up|7|||
124921658|NCT04241068|449342017|FG000|LTE Period|Relocation|6|||
124921659|NCT04241068|449342017|FG000|LTE Period|Site Terminated by Sponsor|26|||
124921660|NCT04241068|449342017|FG000|LTE Period|Study Terminated by Sponsor|276|||
124921661|NCT04241068|449342017|FG000|LTE Period|Study Visit Burden|10|||
124921662|NCT04241068|449342017|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
124921663|NCT04241068|449342017|FG000|LTE Period|Reason Not Specified|65|||
124921664|NCT04492007|449342018|FG000|Overall Study|Lost to Follow-up|1|||
124921665|NCT04492007|449342019|FG001|Overall Study|Lost to Follow-up|1|||
124921666|NCT04492007|449342020|FG002|Overall Study|Lost to Follow-up|2|||
124921667|NCT04492007|449342021|FG003|Overall Study|Lost to Follow-up|2|||
124921668|NCT04492007|449342018|FG000|Overall Study|Protocol Violation|1|||
124921669|NCT04492007|449342019|FG001|Overall Study|Protocol Violation|1|||
124921670|NCT04492007|449342020|FG002|Overall Study|Protocol Violation|1|||
124921671|NCT04492007|449342021|FG003|Overall Study|Protocol Violation|1|||
124921672|NCT04492007|449342018|FG000|Overall Study|Withdrawal by Subject|0|||
124921673|NCT04492007|449342019|FG001|Overall Study|Withdrawal by Subject|0|||
124921674|NCT04492007|449342020|FG002|Overall Study|Withdrawal by Subject|1|||
124921675|NCT04492007|449342021|FG003|Overall Study|Withdrawal by Subject|1|||
124921676|NCT04347161|449342022|FG000|Overall Study|Death|0|||
124921677|NCT04347161|449342023|FG001|Overall Study|Death|2|||
124921678|NCT04347161|449342022|FG000|Overall Study|Withdrawal by Subject|1|||
124451915|NCT02023242|447616925|FG000|Overall Study|Lost to Follow-up|3|||
124451916|NCT02023242|447616926|FG001|Overall Study|Lost to Follow-up|1|||
124451917|NCT02023242|447616925|FG000|Overall Study|Death|0|||
124451918|NCT02023242|447616926|FG001|Overall Study|Death|1|||
124451919|NCT04854434|447616934|FG000|Overall Study|Death|1|||
124451920|NCT04854434|447616935|FG001|Overall Study|Death|3|||
124451921|NCT04854434|447616936|FG002|Overall Study|Death|4|||
124451922|NCT04854434|447616934|FG000|Overall Study|Study Terminated by Sponsor|2|||
124451923|NCT04854434|447616935|FG001|Overall Study|Study Terminated by Sponsor|0|||
124451924|NCT04854434|447616936|FG002|Overall Study|Study Terminated by Sponsor|0|||
124451925|NCT04854434|447616934|FG000|Overall Study|Other|1|||
124451926|NCT04854434|447616935|FG001|Overall Study|Other|1|||
124451927|NCT04854434|447616936|FG002|Overall Study|Other|0|||
124451928|NCT00514514|447616938|FG000|Pre-phase|Death|10|||
124451929|NCT00514514|447616939|FG001|Pre-phase|Death|0|||
124451930|NCT00514514|447616940|FG002|Pre-phase|Death|0|||
124451931|NCT00514514|447616938|FG000|Pre-phase|administrative problems|2|||
124451932|NCT00514514|447616939|FG001|Pre-phase|administrative problems|0|||
124451933|NCT00514514|447616940|FG002|Pre-phase|administrative problems|0|||
124451934|NCT00514514|447616938|FG000|Pre-phase|Protocol Violation|6|||
124451935|NCT00514514|447616939|FG001|Pre-phase|Protocol Violation|0|||
124451936|NCT00514514|447616940|FG002|Pre-phase|Protocol Violation|0|||
124451937|NCT00514514|447616938|FG000|Pre-phase|condition no longer requires study drug|7|||
124451938|NCT00514514|447616939|FG001|Pre-phase|condition no longer requires study drug|0|||
124451939|NCT00514514|447616940|FG002|Pre-phase|condition no longer requires study drug|0|||
124451940|NCT00514514|447616938|FG000|Pre-phase|abnormal test procedure results|15|||
124451941|NCT00514514|447616939|FG001|Pre-phase|abnormal test procedure results|0|||
124921679|NCT04347161|449342023|FG001|Overall Study|Withdrawal by Subject|0|||
124921680|NCT04347161|449342022|FG000|Overall Study|Lost to Follow-up|0|||
124921681|NCT04347161|449342023|FG001|Overall Study|Lost to Follow-up|1|||
124921682|NCT04347161|449342022|FG000|Overall Study|No longer on study medication|1|||
124921683|NCT04347161|449342023|FG001|Overall Study|No longer on study medication|1|||
124921684|NCT04169373|449342024|FG000|Week 1 to Week 14|Adverse Event|1|||
124921685|NCT04169373|449342025|FG001|Week 1 to Week 14|Adverse Event|0|||
124921686|NCT04169373|449342026|FG002|Week 1 to Week 14|Adverse Event|1|||
124921687|NCT04169373|449342027|FG003|Week 1 to Week 14|Adverse Event|2|||
124921688|NCT04169373|449342024|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
124451942|NCT00514514|447616940|FG002|Pre-phase|abnormal test procedure results|0|||
124451943|NCT00514514|447616938|FG000|Pre-phase|Lost to Follow-up|2|||
124451944|NCT00514514|447616939|FG001|Pre-phase|Lost to Follow-up|0|||
124451945|NCT00514514|447616940|FG002|Pre-phase|Lost to Follow-up|0|||
124451946|NCT00514514|447616938|FG000|Pre-phase|abnormal lab values|23|||
124451947|NCT00514514|447616939|FG001|Pre-phase|abnormal lab values|0|||
124695738|NCT02318277|448505951|FG004|Overall Study|Death|6|||
124921689|NCT04169373|449342025|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
124921690|NCT04169373|449342026|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
124921691|NCT04169373|449342027|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
124921692|NCT04169373|449342024|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
124921693|NCT04169373|449342025|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
124921694|NCT04169373|449342026|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
124921695|NCT04169373|449342027|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
124921696|NCT04169373|449342024|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
124921697|NCT04169373|449342025|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
124921698|NCT04169373|449342026|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
124921699|NCT04169373|449342027|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
124921700|NCT04169373|449342024|FG000|Week 1 to Week 14|Other|1|||
124921701|NCT04169373|449342025|FG001|Week 1 to Week 14|Other|3|||
124921702|NCT04169373|449342026|FG002|Week 1 to Week 14|Other|3|||
124921703|NCT04169373|449342027|FG003|Week 1 to Week 14|Other|5|||
124921704|NCT04169373|449342024|FG000|Week 14 to Week 52|Adverse Event|1|||
124921705|NCT04169373|449342025|FG001|Week 14 to Week 52|Adverse Event|0|||
124921706|NCT04169373|449342026|FG002|Week 14 to Week 52|Adverse Event|0|||
124921707|NCT04169373|449342027|FG003|Week 14 to Week 52|Adverse Event|1|||
124921708|NCT04169373|449342024|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
124921709|NCT04169373|449342025|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
124921710|NCT04169373|449342026|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
124921711|NCT04169373|449342027|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
124921712|NCT04169373|449342024|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
124921713|NCT04169373|449342025|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
124921714|NCT04169373|449342026|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
124921715|NCT04169373|449342027|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
124921716|NCT04169373|449342024|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
124921717|NCT04169373|449342025|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
124921718|NCT04169373|449342026|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
124921719|NCT04169373|449342027|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
124921720|NCT04169373|449342024|FG000|Week 14 to Week 52|Other|4|||
124921721|NCT04169373|449342025|FG001|Week 14 to Week 52|Other|5|||
124921722|NCT04169373|449342026|FG002|Week 14 to Week 52|Other|4|||
124451948|NCT00514514|447616940|FG002|Pre-phase|abnormal lab values|0|||
124451949|NCT00514514|447616938|FG000|Pre-phase|Lack of Efficacy|35|||
124451950|NCT00514514|447616939|FG001|Pre-phase|Lack of Efficacy|0|||
124451951|NCT00514514|447616940|FG002|Pre-phase|Lack of Efficacy|0|||
124451952|NCT00514514|447616938|FG000|Pre-phase|Adverse Event|137|||
124451953|NCT00514514|447616939|FG001|Pre-phase|Adverse Event|0|||
124451954|NCT00514514|447616940|FG002|Pre-phase|Adverse Event|0|||
124451955|NCT00514514|447616938|FG000|Pre-phase|Withdrawal by Subject|66|||
124451956|NCT00514514|447616939|FG001|Pre-phase|Withdrawal by Subject|0|||
124451957|NCT00514514|447616940|FG002|Pre-phase|Withdrawal by Subject|0|||
124451958|NCT00514514|447616938|FG000|Randomized - 9 Month|Death|3|||
124451959|NCT00514514|447616939|FG001|Randomized - 9 Month|Death|2|||
124451960|NCT00514514|447616940|FG002|Randomized - 9 Month|Death|2|||
124451961|NCT00514514|447616938|FG000|Randomized - 9 Month|Administrative problems|1|||
124451962|NCT00514514|447616939|FG001|Randomized - 9 Month|Administrative problems|1|||
124451963|NCT00514514|447616940|FG002|Randomized - 9 Month|Administrative problems|2|||
124451964|NCT00514514|447616938|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
124451965|NCT00514514|447616939|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
124451966|NCT00514514|447616940|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
124451967|NCT00514514|447616938|FG000|Randomized - 9 Month|Protocol Violation|1|||
124451968|NCT00514514|447616939|FG001|Randomized - 9 Month|Protocol Violation|1|||
124451969|NCT00514514|447616940|FG002|Randomized - 9 Month|Protocol Violation|0|||
124451970|NCT00514514|447616938|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
124451971|NCT00514514|447616939|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
124451972|NCT00514514|447616940|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
124451973|NCT00514514|447616938|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
124451974|NCT00514514|447616939|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
124451975|NCT00514514|447616940|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
124451976|NCT00514514|447616938|FG000|Randomized - 9 Month|Adverse Event|25|||
124921723|NCT04169373|449342027|FG003|Week 14 to Week 52|Other|5|||
124921724|NCT04169373|449342024|FG000|Week 14 to Week 52|Ongoing|0|||
124921725|NCT04169373|449342025|FG001|Week 14 to Week 52|Ongoing|1|||
124921726|NCT04169373|449342026|FG002|Week 14 to Week 52|Ongoing|0|||
124921727|NCT04169373|449342027|FG003|Week 14 to Week 52|Ongoing|0|||
124921728|NCT01999075|449342030|FG000|Overall Study|Lost to Follow-up|0|||
124921729|NCT01999075|449342031|FG001|Overall Study|Lost to Follow-up|2|||
124921730|NCT01999075|449342030|FG000|Overall Study|Withdrawal by Subject|2|||
124921731|NCT01999075|449342031|FG001|Overall Study|Withdrawal by Subject|7|||
124451977|NCT00514514|447616939|FG001|Randomized - 9 Month|Adverse Event|44|||
124451978|NCT00514514|447616940|FG002|Randomized - 9 Month|Adverse Event|27|||
124451979|NCT00514514|447616938|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
124762342|NCT02763644|448755861|FG001|Overall Study|Adverse Event|1|||
124921732|NCT01999075|449342030|FG000|Overall Study|Enrolled in drug trial|3|||
124921733|NCT01999075|449342031|FG001|Overall Study|Enrolled in drug trial|1|||
124921734|NCT01999075|449342030|FG000|Overall Study|Became ineligible|0|||
124921735|NCT01999075|449342031|FG001|Overall Study|Became ineligible|2|||
124921736|NCT01413100|449342033|FG000|Overall Study|Withdrawal by Subject|1|||
124921737|NCT05369403|449342034|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
124921738|NCT05369403|449342035|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
124921739|NCT05369403|449342036|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
124921740|NCT05369403|449342034|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
124921741|NCT05369403|449342035|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
124921742|NCT05369403|449342036|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
124921743|NCT05369403|449342034|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
124921744|NCT05369403|449342035|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
124921745|NCT05369403|449342036|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
124545457|NCT01058707|447951233|FG006|Overall Study|Adverse Event|1|||
124921746|NCT05369403|449342034|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
124921747|NCT05369403|449342035|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
124921748|NCT05369403|449342036|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
124921749|NCT05369403|449342034|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
124921750|NCT05369403|449342035|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
124921751|NCT05369403|449342036|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
124921752|NCT05369403|449342034|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
124921753|NCT05369403|449342035|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
124921754|NCT05369403|449342036|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
124921755|NCT05369403|449342034|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
124921756|NCT05369403|449342035|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
124921757|NCT05369403|449342036|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
124921758|NCT05369403|449342034|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
124921759|NCT05369403|449342035|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
124921760|NCT05369403|449342036|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
124921761|NCT05369403|449342034|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
124921762|NCT05369403|449342035|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
124921763|NCT05369403|449342036|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
124921764|NCT05369403|449342034|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
124921765|NCT05369403|449342035|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
124921766|NCT05369403|449342036|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
124921767|NCT05369403|449342034|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
124921768|NCT05369403|449342035|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
124921769|NCT05369403|449342036|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
124921770|NCT05948670|449342039|FG000|Overall Study|Protocol Violation|6|||
124921771|NCT05948670|449342040|FG001|Overall Study|Protocol Violation|8|||
124921772|NCT05948670|449342039|FG000|Overall Study|Withdrawal by Subject|0|||
124921773|NCT05948670|449342040|FG001|Overall Study|Withdrawal by Subject|1|||
124921774|NCT02907099|449342041|FG000|Overall Study|Adverse Event|1|||
124921775|NCT02907099|449342041|FG000|Overall Study|Withdrawal by Subject|2|||
124921776|NCT02907099|449342041|FG000|Overall Study|Screen Fail|2|||
124921777|NCT03675282|449342043|FG000|Overall Study|Lost to Follow-up|4|||
124921778|NCT03675282|449342044|FG001|Overall Study|Lost to Follow-up|8|||
124921779|NCT03675282|449342045|FG002|Overall Study|Lost to Follow-up|1|||
124921780|NCT03675282|449342046|FG003|Overall Study|Lost to Follow-up|0|||
124921781|NCT03675282|449342047|FG004|Overall Study|Lost to Follow-up|2|||
124921782|NCT03675282|449342048|FG005|Overall Study|Lost to Follow-up|7|||
124921783|NCT03675282|449342043|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
124921784|NCT03675282|449342044|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
124921785|NCT03675282|449342045|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
124921786|NCT03675282|449342046|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
124921787|NCT03675282|449342047|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
124921788|NCT03675282|449342048|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
124921789|NCT03675282|449342043|FG000|Overall Study|Physician Decision|1|||
124921790|NCT03675282|449342044|FG001|Overall Study|Physician Decision|0|||
124921791|NCT03675282|449342045|FG002|Overall Study|Physician Decision|0|||
124921792|NCT03675282|449342046|FG003|Overall Study|Physician Decision|0|||
124921793|NCT03675282|449342047|FG004|Overall Study|Physician Decision|0|||
124921794|NCT03675282|449342048|FG005|Overall Study|Physician Decision|0|||
124921795|NCT03056040|449342052|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
124762343|NCT02836652|448755862|FG000|Overall Study|Death|3|||
124921796|NCT03056040|449342053|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
124921797|NCT03056040|449342052|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
124921798|NCT03056040|449342053|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
124921799|NCT03056040|449342052|FG000|Primary Evaluation Period|Pregnancy|0|||
124921800|NCT03056040|449342053|FG001|Primary Evaluation Period|Pregnancy|1|||
124921801|NCT03056040|449342052|FG000|Primary Evaluation Period|Randomized, not treated|1|||
124921802|NCT03056040|449342053|FG001|Primary Evaluation Period|Randomized, not treated|1|||
124921803|NCT03056040|449342052|FG000|Extension Period|Physician Decision|3|||
124921804|NCT03056040|449342053|FG001|Extension Period|Physician Decision|3|||
124921805|NCT03056040|449342052|FG000|Extension Period|Lost to Follow-up|0|||
124921806|NCT03056040|449342053|FG001|Extension Period|Lost to Follow-up|1|||
124921807|NCT03056040|449342052|FG000|Extension Period|Death|0|||
124921808|NCT03056040|449342053|FG001|Extension Period|Death|3|||
124921809|NCT03056040|449342052|FG000|Extension Period|Withdrawal by Subject|1|||
124921810|NCT03056040|449342053|FG001|Extension Period|Withdrawal by Subject|0|||
124921811|NCT04977947|449342054|FG000|Overall Study|Lost to Follow-up|1|||
124921812|NCT04977947|449342055|FG001|Overall Study|Lost to Follow-up|1|||
124921813|NCT04029688|449342056|FG000|Overall Study|Death|8|||
124921814|NCT04029688|449342057|FG001|Overall Study|Death|3|||
124921815|NCT04029688|449342058|FG002|Overall Study|Death|6|||
124921816|NCT04029688|449342059|FG003|Overall Study|Death|2|||
124921817|NCT04029688|449342060|FG004|Overall Study|Death|5|||
124921818|NCT04029688|449342061|FG005|Overall Study|Death|0|||
124921819|NCT04029688|449342062|FG006|Overall Study|Death|2|||
124921820|NCT04029688|449342063|FG007|Overall Study|Death|3|||
124921821|NCT04029688|449342056|FG000|Overall Study|Study Terminated by Sponsor|0|||
124921822|NCT04029688|449342057|FG001|Overall Study|Study Terminated by Sponsor|0|||
124921823|NCT04029688|449342058|FG002|Overall Study|Study Terminated by Sponsor|0|||
124921824|NCT04029688|449342059|FG003|Overall Study|Study Terminated by Sponsor|0|||
124921825|NCT04029688|449342060|FG004|Overall Study|Study Terminated by Sponsor|1|||
124921826|NCT04029688|449342061|FG005|Overall Study|Study Terminated by Sponsor|3|||
124921827|NCT04029688|449342062|FG006|Overall Study|Study Terminated by Sponsor|1|||
124921828|NCT04029688|449342063|FG007|Overall Study|Study Terminated by Sponsor|3|||
124921829|NCT04029688|449342056|FG000|Overall Study|Withdrawal by Subject|0|||
124921830|NCT04029688|449342057|FG001|Overall Study|Withdrawal by Subject|0|||
124921831|NCT04029688|449342058|FG002|Overall Study|Withdrawal by Subject|0|||
124921832|NCT04029688|449342059|FG003|Overall Study|Withdrawal by Subject|1|||
124921833|NCT04029688|449342060|FG004|Overall Study|Withdrawal by Subject|0|||
124921834|NCT04029688|449342061|FG005|Overall Study|Withdrawal by Subject|0|||
124921835|NCT04029688|449342062|FG006|Overall Study|Withdrawal by Subject|0|||
124921836|NCT04029688|449342063|FG007|Overall Study|Withdrawal by Subject|0|||
124921837|NCT05875142|449342064|FG000|Overall Study|Lost to Follow-up|0|||
124921838|NCT05875142|449342065|FG001|Overall Study|Lost to Follow-up|1|||
124921839|NCT05875142|449342066|FG002|Overall Study|Lost to Follow-up|1|||
124921840|NCT05784662|449342067|FG000|Overall Study|Lost to Follow-up|21|||
124921841|NCT05784662|449342068|FG001|Overall Study|Lost to Follow-up|17|||
124921842|NCT04274764|449342069|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
124921843|NCT04274764|449342070|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
124921844|NCT02677298|449342071|FG000|Double Blind Phase|Adverse Event|2|||
124921845|NCT02677298|449342072|FG001|Double Blind Phase|Adverse Event|1|||
124921846|NCT02677298|449342073|FG002|Double Blind Phase|Adverse Event|0|||
124921847|NCT02677298|449342071|FG000|Double Blind Phase|Physician Decision|5|||
124921848|NCT02677298|449342072|FG001|Double Blind Phase|Physician Decision|0|||
124921849|NCT02677298|449342073|FG002|Double Blind Phase|Physician Decision|0|||
124921850|NCT02677298|449342071|FG000|Double Blind Phase|Lost to Follow-up|11|||
124921851|NCT02677298|449342072|FG001|Double Blind Phase|Lost to Follow-up|7|||
124921852|NCT02677298|449342073|FG002|Double Blind Phase|Lost to Follow-up|0|||
124921853|NCT02677298|449342071|FG000|Double Blind Phase|Withdrawal by Subject|11|||
124921854|NCT02677298|449342072|FG001|Double Blind Phase|Withdrawal by Subject|8|||
124921855|NCT02677298|449342073|FG002|Double Blind Phase|Withdrawal by Subject|0|||
124921856|NCT02677298|449342071|FG000|Double Blind Phase|No study drug available at site|0|||
124921857|NCT02677298|449342072|FG001|Double Blind Phase|No study drug available at site|1|||
124921858|NCT02677298|449342073|FG002|Double Blind Phase|No study drug available at site|0|||
124921859|NCT02677298|449342071|FG000|Open Label Phase|Adverse Event|0|||
124921860|NCT02677298|449342072|FG001|Open Label Phase|Adverse Event|0|||
124921861|NCT02677298|449342073|FG002|Open Label Phase|Adverse Event|4|||
124921862|NCT02677298|449342071|FG000|Open Label Phase|Physician Decision|0|||
124921863|NCT02677298|449342072|FG001|Open Label Phase|Physician Decision|0|||
124921864|NCT02677298|449342073|FG002|Open Label Phase|Physician Decision|1|||
124921865|NCT02677298|449342071|FG000|Open Label Phase|Lost to Follow-up|0|||
124921866|NCT02677298|449342072|FG001|Open Label Phase|Lost to Follow-up|0|||
124921867|NCT02677298|449342073|FG002|Open Label Phase|Lost to Follow-up|17|||
124921868|NCT02677298|449342071|FG000|Open Label Phase|Withdrawal by Subject|0|||
124921869|NCT02677298|449342072|FG001|Open Label Phase|Withdrawal by Subject|0|||
124451980|NCT00514514|447616939|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
124451981|NCT00514514|447616940|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
124451982|NCT00514514|447616938|FG000|Extension - 4 Years|Lost to Follow-up|12|||
124451983|NCT00514514|447616939|FG001|Extension - 4 Years|Lost to Follow-up|10|||
124451984|NCT00514514|447616940|FG002|Extension - 4 Years|Lost to Follow-up|9|||
124451985|NCT00514514|447616938|FG000|Extension - 4 Years|Administrative problems|3|||
124451986|NCT00514514|447616939|FG001|Extension - 4 Years|Administrative problems|1|||
124451987|NCT00514514|447616940|FG002|Extension - 4 Years|Administrative problems|1|||
124451988|NCT00514514|447616938|FG000|Extension - 4 Years|Death|8|||
124451989|NCT00514514|447616939|FG001|Extension - 4 Years|Death|3|||
124451990|NCT00514514|447616940|FG002|Extension - 4 Years|Death|6|||
124451991|NCT00514514|447616938|FG000|Extension - 4 Years|Adverse Event|9|||
124451992|NCT00514514|447616939|FG001|Extension - 4 Years|Adverse Event|6|||
124451993|NCT00514514|447616940|FG002|Extension - 4 Years|Adverse Event|3|||
124451994|NCT02667275|447616941|FG000|Overall Study|Protocol Violation|11|||
124451995|NCT02667275|447616942|FG001|Overall Study|Protocol Violation|7|||
124451996|NCT02667275|447616941|FG000|Overall Study|Lost to Follow-up|0|||
124451997|NCT02667275|447616942|FG001|Overall Study|Lost to Follow-up|2|||
124451998|NCT02667275|447616941|FG000|Overall Study|Withdrawal by Subject|0|||
124451999|NCT02667275|447616942|FG001|Overall Study|Withdrawal by Subject|5|||
124452000|NCT02667275|447616941|FG000|Overall Study|Discontinued early without completing|0|||
124452001|NCT02667275|447616942|FG001|Overall Study|Discontinued early without completing|1|||
124452002|NCT01274715|447616943|FG000|Overall Study|Lost to Follow-up|1|||
124452003|NCT01274715|447616943|FG000|Overall Study|After consent, met exclusion criteria.|1|||
124545458|NCT01058707|447951227|FG000|Overall Study|Subject Decision|5|||
124921870|NCT02677298|449342073|FG002|Open Label Phase|Withdrawal by Subject|38|||
124921871|NCT03611621|449342074|FG000|Overall Study|Graft loss|3|||
124921872|NCT03611621|449342074|FG000|Overall Study|Death|3|||
124921873|NCT03611621|449342074|FG000|Overall Study|Lost to Follow-up|1|||
124921874|NCT03920111|449342089|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
124921875|NCT03920111|449342090|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
124921876|NCT03920111|449342091|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
124921877|NCT04764448|449342092|FG000|Overall Study|Study terminated by sponsor|2|||
124921878|NCT04764448|449342093|FG001|Overall Study|Study terminated by sponsor|2|||
124921879|NCT04764448|449342094|FG002|Overall Study|Study terminated by sponsor|5|||
124921880|NCT04764448|449342092|FG000|Overall Study|Withdrawal by Subject|3|||
124921881|NCT04764448|449342093|FG001|Overall Study|Withdrawal by Subject|3|||
124921882|NCT04764448|449342094|FG002|Overall Study|Withdrawal by Subject|1|||
124921883|NCT01997840|449342095|FG000|Overall Study|Lost to Follow-up|0|||
124921884|NCT01997840|449342096|FG001|Overall Study|Lost to Follow-up|0|||
124921885|NCT01997840|449342097|FG002|Overall Study|Lost to Follow-up|1|||
124921886|NCT01997840|449342098|FG003|Overall Study|Lost to Follow-up|0|||
124921887|NCT01997840|449342095|FG000|Overall Study|Withdrawal by participant|0|||
124921888|NCT01997840|449342096|FG001|Overall Study|Withdrawal by participant|0|||
124921889|NCT01997840|449342097|FG002|Overall Study|Withdrawal by participant|8|||
124921890|NCT01997840|449342098|FG003|Overall Study|Withdrawal by participant|1|||
124452004|NCT01274715|447616943|FG000|Overall Study|After consent, met exclusion criteria.|1|||
124452005|NCT01274715|447616943|FG000|Overall Study|After consent, met exclusion criteria.|1|||
124452006|NCT02285920|447616946|FG000|Overall Study|Kidney transplantation|2|||
124452007|NCT02285920|447616947|FG001|Overall Study|Kidney transplantation|2|||
124545459|NCT01058707|447951228|FG001|Overall Study|Subject Decision|3|||
124921891|NCT01997840|449342095|FG000|Overall Study|Physician Decision|0|||
124921892|NCT01997840|449342096|FG001|Overall Study|Physician Decision|0|||
124921893|NCT01997840|449342097|FG002|Overall Study|Physician Decision|3|||
124921894|NCT01997840|449342098|FG003|Overall Study|Physician Decision|0|||
124921895|NCT01997840|449342095|FG000|Overall Study|Progressive disease|3|||
124921896|NCT01997840|449342096|FG001|Overall Study|Progressive disease|4|||
124921897|NCT01997840|449342097|FG002|Overall Study|Progressive disease|57|||
124921898|NCT01997840|449342098|FG003|Overall Study|Progressive disease|8|||
124921899|NCT01997840|449342095|FG000|Overall Study|Other reasons|0|||
124921900|NCT01997840|449342096|FG001|Overall Study|Other reasons|0|||
124921901|NCT01997840|449342097|FG002|Overall Study|Other reasons|1|||
124921902|NCT01997840|449342098|FG003|Overall Study|Other reasons|0|||
124921903|NCT01997840|449342095|FG000|Overall Study|Adverse Event|0|||
124921904|NCT01997840|449342096|FG001|Overall Study|Adverse Event|0|||
124921905|NCT01997840|449342097|FG002|Overall Study|Adverse Event|15|||
124921906|NCT01997840|449342098|FG003|Overall Study|Adverse Event|2|||
124921907|NCT01494662|449342106|FG000|Overall Study|Withdrawal by Subject|0|||
124921908|NCT01494662|449342107|FG001|Overall Study|Withdrawal by Subject|0|||
124921909|NCT01494662|449342108|FG002|Overall Study|Withdrawal by Subject|1|||
124921910|NCT01494662|449342109|FG003|Overall Study|Withdrawal by Subject|0|||
124921911|NCT01494662|449342110|FG004|Overall Study|Withdrawal by Subject|0|||
124921912|NCT01494662|449342111|FG005|Overall Study|Withdrawal by Subject|0|||
124921913|NCT01494662|449342112|FG006|Overall Study|Withdrawal by Subject|0|||
124921914|NCT01494662|449342106|FG000|Overall Study|Physician Decision|0|||
124921915|NCT01494662|449342107|FG001|Overall Study|Physician Decision|0|||
124921916|NCT01494662|449342108|FG002|Overall Study|Physician Decision|1|||
124921917|NCT01494662|449342109|FG003|Overall Study|Physician Decision|0|||
124921918|NCT01494662|449342110|FG004|Overall Study|Physician Decision|0|||
124921919|NCT01494662|449342111|FG005|Overall Study|Physician Decision|0|||
124921920|NCT01494662|449342112|FG006|Overall Study|Physician Decision|0|||
124921921|NCT05311384|449342113|FG000|Overall Study|Uncontrolled health conditions|2|||
124921922|NCT05311384|449342113|FG000|Overall Study|Withdrawal by Subject|1|||
124921923|NCT04322643|449342114|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
124921924|NCT05710107|449342124|FG000|Overall Study|Withdrawal by Subject|1|||
124921925|NCT05710107|449342125|FG001|Overall Study|Withdrawal by Subject|1|||
124921926|NCT05710107|449342124|FG000|Overall Study|Lost to Follow-up|8|||
124921927|NCT05710107|449342125|FG001|Overall Study|Lost to Follow-up|9|||
124921928|NCT05710107|449342124|FG000|Overall Study|Unable to place assigned block|2|||
124921929|NCT05710107|449342125|FG001|Overall Study|Unable to place assigned block|0|||
124921930|NCT05710107|449342124|FG000|Overall Study|Withdrawn by study team|0|||
124921931|NCT05710107|449342125|FG001|Overall Study|Withdrawn by study team|1|||
124921932|NCT04717492|449342126|FG000|Overall Study|Withdrawal by Subject|2|||
124921933|NCT04717492|449342127|FG001|Overall Study|Withdrawal by Subject|13|||
124921934|NCT04717492|449342126|FG000|Overall Study|Lost to Follow-up|2|||
124921935|NCT04717492|449342127|FG001|Overall Study|Lost to Follow-up|9|||
124921936|NCT05071807|449342128|FG000|Overall Study|Withdrawal by Subject|4|||
124921937|NCT05071807|449342129|FG001|Overall Study|Withdrawal by Subject|0|||
124921938|NCT05071807|449342128|FG000|Overall Study|Unrelated medical issues|3|||
124921939|NCT05071807|449342129|FG001|Overall Study|Unrelated medical issues|0|||
124921940|NCT05071807|449342128|FG000|Overall Study|Relocated|0|||
124921941|NCT05071807|449342129|FG001|Overall Study|Relocated|1|||
124921942|NCT04072380|449342131|FG000|Overall Study|Adverse Event|4|||
124921943|NCT04072380|449342132|FG001|Overall Study|Adverse Event|6|||
124921944|NCT04072380|449342133|FG002|Overall Study|Adverse Event|0|||
124921945|NCT04072380|449342131|FG000|Overall Study|Withdrawal by Subject|3|||
124921946|NCT04072380|449342132|FG001|Overall Study|Withdrawal by Subject|1|||
124452008|NCT02285920|447616948|FG002|Overall Study|Kidney transplantation|2|||
124452009|NCT02285920|447616949|FG003|Overall Study|Kidney transplantation|0|||
124452010|NCT02285920|447616946|FG000|Overall Study|Change to peritoneal dialysis|0|||
124452011|NCT02285920|447616947|FG001|Overall Study|Change to peritoneal dialysis|0|||
124452012|NCT02285920|447616948|FG002|Overall Study|Change to peritoneal dialysis|1|||
124452013|NCT02285920|447616949|FG003|Overall Study|Change to peritoneal dialysis|0|||
124452014|NCT02285920|447616946|FG000|Overall Study|Transfer to non-participating unit|0|||
124452015|NCT02285920|447616947|FG001|Overall Study|Transfer to non-participating unit|1|||
124452016|NCT02285920|447616948|FG002|Overall Study|Transfer to non-participating unit|0|||
124452017|NCT02285920|447616949|FG003|Overall Study|Transfer to non-participating unit|0|||
124452018|NCT02285920|447616946|FG000|Overall Study|Dialysis discontinuation|0|||
124452019|NCT02285920|447616947|FG001|Overall Study|Dialysis discontinuation|1|||
124452020|NCT02285920|447616948|FG002|Overall Study|Dialysis discontinuation|0|||
124452021|NCT02285920|447616949|FG003|Overall Study|Dialysis discontinuation|0|||
124452022|NCT02285920|447616946|FG000|Overall Study|Death|2|||
124452023|NCT02285920|447616947|FG001|Overall Study|Death|0|||
124452024|NCT02285920|447616948|FG002|Overall Study|Death|2|||
124452025|NCT02285920|447616949|FG003|Overall Study|Death|1|||
124452026|NCT01101438|447616950|FG000|Overall Study|Withdrawal by Subject|8|||
124452027|NCT01101438|447616951|FG001|Overall Study|Withdrawal by Subject|9|||
124452028|NCT02713542|447616952|FG000|Overall Study|Use of prohibited medication|14|||
124452029|NCT02713542|447616953|FG001|Overall Study|Use of prohibited medication|5|||
124452030|NCT02713542|447616952|FG000|Overall Study|Withdrawal by Subject|4|||
124452031|NCT02713542|447616953|FG001|Overall Study|Withdrawal by Subject|1|||
124452032|NCT00066742|447616954|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
124452033|NCT00066742|447616954|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
124452034|NCT00066742|447616954|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
124452035|NCT00066742|447616954|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
124452036|NCT00066742|447616954|FG000|Induction Chemoradiotherapy|Ineligible|3|||
124452037|NCT00066742|447616954|FG000|Consolidation Chemotherapy|not protocol specified|1|||
124452038|NCT00066742|447616954|FG000|Consolidation Chemotherapy|Ineligible|2|||
124545460|NCT01058707|447951229|FG002|Overall Study|Subject Decision|3|||
124695739|NCT02318277|448505952|FG005|Overall Study|Death|5|||
124695740|NCT02318277|448505953|FG006|Overall Study|Death|34|||
124695741|NCT02318277|448505954|FG007|Overall Study|Death|58|||
124695742|NCT02318277|448505947|FG000|Overall Study|Transitioned to Hospice|0|||
124695743|NCT02318277|448505948|FG001|Overall Study|Transitioned to Hospice|0|||
124695744|NCT02318277|448505949|FG002|Overall Study|Transitioned to Hospice|0|||
124695745|NCT02318277|448505950|FG003|Overall Study|Transitioned to Hospice|0|||
124695746|NCT02318277|448505951|FG004|Overall Study|Transitioned to Hospice|0|||
124695747|NCT02318277|448505952|FG005|Overall Study|Transitioned to Hospice|1|||
124695748|NCT02318277|448505953|FG006|Overall Study|Transitioned to Hospice|0|||
124695749|NCT02318277|448505954|FG007|Overall Study|Transitioned to Hospice|0|||
124695750|NCT01520714|448505955|FG000|Overall Study|Protocol Violation|0|||
124695751|NCT01520714|448505956|FG001|Overall Study|Protocol Violation|3|||
124695752|NCT01520714|448505955|FG000|Overall Study|Adverse Event|0|||
124695753|NCT01520714|448505956|FG001|Overall Study|Adverse Event|2|||
124695754|NCT01520714|448505955|FG000|Overall Study|Lack of Efficacy|0|||
124695755|NCT01520714|448505956|FG001|Overall Study|Lack of Efficacy|1|||
124695756|NCT00395512|448505957|FG000|Overall Study|Adverse Event|3|||
124695757|NCT00395512|448505958|FG001|Overall Study|Adverse Event|8|||
124695758|NCT00395512|448505959|FG002|Overall Study|Adverse Event|6|||
124695759|NCT00395512|448505960|FG003|Overall Study|Adverse Event|6|||
124695760|NCT00395512|448505957|FG000|Overall Study|Protocol Violation|2|||
124695761|NCT00395512|448505958|FG001|Overall Study|Protocol Violation|3|||
124695762|NCT00395512|448505959|FG002|Overall Study|Protocol Violation|6|||
124695763|NCT00395512|448505960|FG003|Overall Study|Protocol Violation|7|||
124695764|NCT00395512|448505957|FG000|Overall Study|Lost to Follow-up|2|||
124695765|NCT00395512|448505958|FG001|Overall Study|Lost to Follow-up|6|||
124695766|NCT00395512|448505959|FG002|Overall Study|Lost to Follow-up|5|||
124695767|NCT00395512|448505960|FG003|Overall Study|Lost to Follow-up|5|||
124695768|NCT00395512|448505957|FG000|Overall Study|Withdrawal by Subject|6|||
124695769|NCT00395512|448505958|FG001|Overall Study|Withdrawal by Subject|5|||
124695770|NCT00395512|448505959|FG002|Overall Study|Withdrawal by Subject|5|||
124695771|NCT00395512|448505960|FG003|Overall Study|Withdrawal by Subject|12|||
124695772|NCT00395512|448505957|FG000|Overall Study|Physician Decision|6|||
124695773|NCT00395512|448505958|FG001|Overall Study|Physician Decision|4|||
124695774|NCT00395512|448505959|FG002|Overall Study|Physician Decision|2|||
124695775|NCT00395512|448505960|FG003|Overall Study|Physician Decision|2|||
124695776|NCT00395512|448505957|FG000|Overall Study|Other|1|||
124695777|NCT00395512|448505958|FG001|Overall Study|Other|1|||
124695778|NCT00395512|448505959|FG002|Overall Study|Other|0|||
124695779|NCT00395512|448505960|FG003|Overall Study|Other|0|||
124695780|NCT00395512|448505957|FG000|Overall Study|Hyperglycemic Rescue|18|||
124695781|NCT00395512|448505958|FG001|Overall Study|Hyperglycemic Rescue|10|||
124695782|NCT00395512|448505959|FG002|Overall Study|Hyperglycemic Rescue|4|||
124695783|NCT00395512|448505960|FG003|Overall Study|Hyperglycemic Rescue|6|||
124695784|NCT00754559|448505963|FG000|Overall Study|Adverse Event|15|||
124695785|NCT00754559|448505963|FG000|Overall Study|Protocol Violation|11|||
124921947|NCT04072380|449342133|FG002|Overall Study|Withdrawal by Subject|1|||
124921948|NCT04072380|449342131|FG000|Overall Study|Physician Decision|2|||
124921949|NCT04072380|449342132|FG001|Overall Study|Physician Decision|0|||
124921950|NCT04072380|449342133|FG002|Overall Study|Physician Decision|0|||
124921951|NCT04072380|449342131|FG000|Overall Study|Protocol Violation|0|||
124921952|NCT04072380|449342132|FG001|Overall Study|Protocol Violation|2|||
124921953|NCT04072380|449342133|FG002|Overall Study|Protocol Violation|3|||
124921954|NCT04072380|449342131|FG000|Overall Study|Intercurrent Illness and Others|3|||
124921955|NCT04072380|449342132|FG001|Overall Study|Intercurrent Illness and Others|5|||
124452039|NCT03794583|447616956|FG000|Overall Study|Death|8|||
124695786|NCT00754559|448505963|FG000|Overall Study|Lack of Efficacy|10|||
124695787|NCT00754559|448505963|FG000|Overall Study|Lost to Follow-up|2|||
124695788|NCT00754559|448505963|FG000|Overall Study|Administrative reason|1|||
124695789|NCT00754559|448505963|FG000|Overall Study|Other|5|||
124695790|NCT00754559|448505963|FG000|Overall Study|Withdrawal by Subject|3|||
124695791|NCT01663987|448505964|FG000|Overall Study|Adverse Event|7|||
124695792|NCT01663987|448505965|FG001|Overall Study|Adverse Event|2|||
124695793|NCT01663987|448505964|FG000|Overall Study|Lost to Follow-up|1|||
124695794|NCT01663987|448505965|FG001|Overall Study|Lost to Follow-up|1|||
124695795|NCT01663987|448505964|FG000|Overall Study|Withdrawal by Subject|2|||
124695796|NCT01663987|448505965|FG001|Overall Study|Withdrawal by Subject|3|||
124695797|NCT01663987|448505964|FG000|Overall Study|Other reason not defined above|3|||
124695798|NCT01663987|448505965|FG001|Overall Study|Other reason not defined above|0|||
124921956|NCT04072380|449342133|FG002|Overall Study|Intercurrent Illness and Others|6|||
124695799|NCT03721965|448505967|FG000|Overall Study|Death|1|||
124695800|NCT03721965|448505967|FG000|Overall Study|Study Terminated by Sponsor|1|||
124695801|NCT04913675|448505968|FG000|Main Study (Up to Week 36)|Death|0|||
124695802|NCT04913675|448505969|FG001|Main Study (Up to Week 36)|Death|2|||
124695803|NCT04913675|448505970|FG002|Main Study (Up to Week 36)|Death|2|||
124695804|NCT04913675|448505971|FG003|Main Study (Up to Week 36)|Death|0|||
124695805|NCT04913675|448505968|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
124695806|NCT04913675|448505969|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
124695807|NCT04913675|448505970|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
124452040|NCT03794583|447616956|FG000|Overall Study|Study Terminated by Sponsor|24|||
124452041|NCT03794583|447616956|FG000|Overall Study|Withdrawal by Subject|9|||
124452042|NCT00233363|447616963|FG000|Overall Study|Adverse Event|1|||
124452043|NCT00233363|447616964|FG001|Overall Study|Adverse Event|2|||
124452044|NCT00233363|447616963|FG000|Overall Study|Lack of Efficacy|0|||
124452045|NCT00233363|447616964|FG001|Overall Study|Lack of Efficacy|2|||
124452046|NCT00233363|447616963|FG000|Overall Study|Withdrawal by Subject|1|||
124452047|NCT00233363|447616964|FG001|Overall Study|Withdrawal by Subject|1|||
124452048|NCT00233363|447616963|FG000|Overall Study|Aggravation of complication|1|||
124452049|NCT00233363|447616964|FG001|Overall Study|Aggravation of complication|0|||
124452050|NCT00873366|447616970|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
124452051|NCT00873366|447616970|FG000|Overall Study|Off tamoxifen due to side effects|2|||
124452052|NCT00873366|447616970|FG000|Overall Study|Refused to continue DM-BT testing|3|||
124452053|NCT01576172|447616971|FG000|Overall Study|Ineligible|2|||
124452054|NCT01576172|447616972|FG001|Overall Study|Ineligible|1|||
124452055|NCT01576172|447616971|FG000|Overall Study|Withdrawal by Subject|2|||
124452056|NCT01576172|447616972|FG001|Overall Study|Withdrawal by Subject|0|||
124452057|NCT01576172|447616971|FG000|Overall Study|Insurance issue|1|||
124452058|NCT01576172|447616972|FG001|Overall Study|Insurance issue|0|||
124452059|NCT01537198|447616979|FG000|Overall Study|RSV infection|2|||
124452060|NCT01537198|447616979|FG000|Overall Study|Adverse Event|4|||
124452061|NCT01537198|447616979|FG000|Overall Study|No Further Visits to the Clinic|37|||
124452062|NCT01537198|447616979|FG000|Overall Study|Other|111|||
124452063|NCT01231659|447616980|FG000|Overall Study|Adverse Event|9|||
124452064|NCT01231659|447616980|FG000|Overall Study|Disease Progression|48|||
124452065|NCT01231659|447616980|FG000|Overall Study|Death|2|||
124452066|NCT01231659|447616980|FG000|Overall Study|Patient refused to complete study visit|1|||
124452067|NCT01231659|447616980|FG000|Overall Study|Other protocol defined criteria|12|||
124452068|NCT00545402|447616983|FG000|Overall Study|Discontinuation of treatment|17|||
124452069|NCT00545402|447616984|FG001|Overall Study|Discontinuation of treatment|9|||
124452070|NCT00545402|447616983|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
124452071|NCT00545402|447616984|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
124452072|NCT00545402|447616983|FG000|Overall Study|Death|5|||
124452073|NCT00545402|447616984|FG001|Overall Study|Death|7|||
124452074|NCT00545402|447616983|FG000|Overall Study|Graft loss|2|||
124452075|NCT00545402|447616984|FG001|Overall Study|Graft loss|4|||
124452076|NCT00545402|447616983|FG000|Overall Study|Withdrawal by Subject|0|||
124452077|NCT00545402|447616984|FG001|Overall Study|Withdrawal by Subject|1|||
124452078|NCT00545402|447616983|FG000|Overall Study|Protocol Violation|1|||
124452079|NCT00545402|447616984|FG001|Overall Study|Protocol Violation|0|||
124452080|NCT00545402|447616983|FG000|Overall Study|Reason not specified|1|||
124452081|NCT00545402|447616984|FG001|Overall Study|Reason not specified|1|||
124452082|NCT03520959|447616985|FG000|Overall Study|Study terminated by Sponsor|0|||
124452083|NCT03520959|447616986|FG001|Overall Study|Study terminated by Sponsor|1|||
124452084|NCT03734016|447616987|FG000|Overall Study|Sponsor Ended Study|225|||
124452085|NCT03734016|447616988|FG001|Overall Study|Sponsor Ended Study|200|||
124452086|NCT03734016|447616987|FG000|Overall Study|Death|69|||
124452087|NCT03734016|447616988|FG001|Overall Study|Death|83|||
124452088|NCT03734016|447616987|FG000|Overall Study|Withdrawal by Subject|21|||
124452089|NCT03734016|447616988|FG001|Overall Study|Withdrawal by Subject|27|||
124452090|NCT03734016|447616987|FG000|Overall Study|Physician Decision|1|||
124452091|NCT03734016|447616988|FG001|Overall Study|Physician Decision|12|||
124921957|NCT05551637|449342134|FG000|Overall Study|Lack of Efficacy|0|||
124921958|NCT05551637|449342135|FG001|Overall Study|Lack of Efficacy|6|||
124921959|NCT05551637|449342134|FG000|Overall Study|Lost to Follow-up|1|||
124921960|NCT05551637|449342135|FG001|Overall Study|Lost to Follow-up|1|||
124921961|NCT05351554|449342137|FG000|Overall Study|Study terminated by sponsor|1|||
124921962|NCT03774082|449342138|FG000|Overall Study|Death|6|||
124921963|NCT03774082|449342139|FG001|Overall Study|Death|3|||
124921964|NCT03774082|449342140|FG002|Overall Study|Death|2|||
124452092|NCT03734016|447616987|FG000|Overall Study|Lost to Follow-up|6|||
124452093|NCT03734016|447616988|FG001|Overall Study|Lost to Follow-up|2|||
124452094|NCT03734016|447616987|FG000|Overall Study|Miscellaneous|5|||
124452095|NCT03734016|447616988|FG001|Overall Study|Miscellaneous|1|||
124452096|NCT01979835|447616989|FG000|Primary Outcome SA Measurment|failed insertion|18|||
124452097|NCT01979835|447616989|FG000|Follow-up|Lost to Follow-up|32|||
124452098|NCT02592018|447616992|FG000|Overall Study|Adverse Event|1|||
124452099|NCT02592018|447616992|FG000|Overall Study|Lost to Follow-up|1|||
124452100|NCT02710136|447616995|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
124452101|NCT02710136|447616996|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
124452102|NCT00418665|447616997|FG000|Treatment Period|Ineligibility determined|1|||
124452103|NCT00418665|447616998|FG001|Treatment Period|Ineligibility determined|1|||
124452104|NCT00418665|447616999|FG002|Treatment Period|Ineligibility determined|0|||
124452105|NCT00418665|447616997|FG000|Treatment Period|Adverse Event|2|||
124921965|NCT03774082|449342138|FG000|Overall Study|Subject decision|0|||
124921966|NCT03774082|449342139|FG001|Overall Study|Subject decision|3|||
124921967|NCT03774082|449342140|FG002|Overall Study|Subject decision|0|||
124695808|NCT04913675|448505971|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
124695809|NCT04913675|448505968|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
124921968|NCT03774082|449342138|FG000|Overall Study|Lost to Follow-up|2|||
124921969|NCT03774082|449342139|FG001|Overall Study|Lost to Follow-up|0|||
124921970|NCT03774082|449342140|FG002|Overall Study|Lost to Follow-up|0|||
124921971|NCT03774082|449342138|FG000|Overall Study|Guardian decision|0|||
124921972|NCT03774082|449342139|FG001|Overall Study|Guardian decision|0|||
124921973|NCT03774082|449342140|FG002|Overall Study|Guardian decision|1|||
124921974|NCT03774082|449342138|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
124921975|NCT03774082|449342139|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
124921976|NCT03774082|449342140|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
124921977|NCT03792256|449343733|FG000|Overall Study|Death|0|||
124921978|NCT03792256|449343734|FG001|Overall Study|Death|1|||
124921979|NCT03792256|449343733|FG000|Overall Study|Lack of Efficacy|0|||
124921980|NCT03792256|449343734|FG001|Overall Study|Lack of Efficacy|1|||
124921981|NCT03792256|449343733|FG000|Overall Study|Withdrawal by Subject|0|||
124921982|NCT03792256|449343734|FG001|Overall Study|Withdrawal by Subject|1|||
124921983|NCT04760678|449343735|FG000|Overall Study|Death|13|||
124921984|NCT04760678|449343735|FG000|Overall Study|Lost to Follow-up|48|||
124921985|NCT04760678|449343735|FG000|Overall Study|Withdrawal by Subject|1|||
124921986|NCT01748448|449343738|FG000|Treatment Period|Consent withdrawn by subject|1|||
124921987|NCT01748448|449343739|FG001|Treatment Period|Consent withdrawn by subject|0|||
124921988|NCT01748448|449343738|FG000|Treatment Period|Adverse Event|1|||
124921989|NCT01748448|449343739|FG001|Treatment Period|Adverse Event|0|||
124921990|NCT01748448|449343738|FG000|Treatment Period|Personal|0|||
124921991|NCT01748448|449343739|FG001|Treatment Period|Personal|1|||
124695810|NCT04913675|448505969|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
124695811|NCT04913675|448505970|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
124695812|NCT04913675|448505971|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
124921992|NCT03232138|449343755|FG000|Overall Study|Physician Decision|1|||
124921993|NCT03232138|449343756|FG001|Overall Study|Physician Decision|0|||
124921994|NCT03232138|449343755|FG000|Overall Study|Adverse Event|2|||
124921995|NCT03232138|449343756|FG001|Overall Study|Adverse Event|0|||
124921996|NCT03232138|449343755|FG000|Overall Study|Withdrawal by Subject|1|||
124695813|NCT04913675|448505968|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
124762344|NCT02836652|448755863|FG001|Overall Study|Death|3|||
124921997|NCT03232138|449343756|FG001|Overall Study|Withdrawal by Subject|2|||
124921998|NCT04142788|449343757|FG000|Overall Study|Trial terminated prematurely|2|||
124695814|NCT04913675|448505969|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
124695815|NCT04913675|448505970|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
124921999|NCT04142788|449343758|FG001|Overall Study|Trial terminated prematurely|2|||
124452106|NCT00418665|447616998|FG001|Treatment Period|Adverse Event|2|||
124452107|NCT00418665|447616999|FG002|Treatment Period|Adverse Event|0|||
124452108|NCT00418665|447616997|FG000|Treatment Period|Withdrawal by Subject|0|||
124452109|NCT00418665|447616998|FG001|Treatment Period|Withdrawal by Subject|3|||
124452110|NCT00418665|447616999|FG002|Treatment Period|Withdrawal by Subject|1|||
124452111|NCT00418665|447616997|FG000|Treatment Period|Requirement for alternative therapy|1|||
124452112|NCT00418665|447616998|FG001|Treatment Period|Requirement for alternative therapy|0|||
124452113|NCT00418665|447616999|FG002|Treatment Period|Requirement for alternative therapy|0|||
124452114|NCT00418665|447616997|FG000|Treatment Period|Physician Decision|1|||
124452115|NCT00418665|447616998|FG001|Treatment Period|Physician Decision|0|||
124452116|NCT00418665|447616999|FG002|Treatment Period|Physician Decision|3|||
124452117|NCT00418665|447616997|FG000|Treatment Extension|Adverse Event|1|||
124452118|NCT00418665|447616998|FG001|Treatment Extension|Adverse Event|0|||
124452119|NCT00418665|447616999|FG002|Treatment Extension|Adverse Event|0|||
124452120|NCT00418665|447616997|FG000|Treatment Extension|Withdrawal by Subject|1|||
124452121|NCT00418665|447616998|FG001|Treatment Extension|Withdrawal by Subject|0|||
124452122|NCT00418665|447616999|FG002|Treatment Extension|Withdrawal by Subject|0|||
124452123|NCT00418665|447616997|FG000|Treatment Extension|Requirement for alternative therapy|2|||
124452124|NCT00418665|447616998|FG001|Treatment Extension|Requirement for alternative therapy|2|||
124452125|NCT00418665|447616999|FG002|Treatment Extension|Requirement for alternative therapy|0|||
124452126|NCT00418665|447616997|FG000|Treatment Extension|Physician Decision|2|||
124452127|NCT00418665|447616998|FG001|Treatment Extension|Physician Decision|2|||
124452128|NCT00418665|447616999|FG002|Treatment Extension|Physician Decision|1|||
124452129|NCT00418665|447616997|FG000|Treatment Extension|Death|0|||
124452130|NCT00418665|447616998|FG001|Treatment Extension|Death|0|||
124452131|NCT00418665|447616999|FG002|Treatment Extension|Death|1|||
124452132|NCT01133379|447617002|FG000|Overall Study|Withdrawal by Subject|0|||
124452133|NCT01133379|447617003|FG001|Overall Study|Withdrawal by Subject|1|||
124452134|NCT01133379|447617004|FG002|Overall Study|Withdrawal by Subject|1|||
124452135|NCT01133379|447617002|FG000|Overall Study|Lost to Follow-up|1|||
124452136|NCT01133379|447617003|FG001|Overall Study|Lost to Follow-up|1|||
124452137|NCT01133379|447617004|FG002|Overall Study|Lost to Follow-up|1|||
124452138|NCT00591214|447617005|FG000|Overall Study|Physician Decision|7|||
124452139|NCT00591214|447617005|FG000|Overall Study|Withdrawal by Subject|1|||
124452140|NCT05050318|447618587|FG000|Overall Study|Protocol Deviation|1|||
124452141|NCT05050318|447618588|FG001|Overall Study|Protocol Deviation|0|||
124452142|NCT05050318|447618589|FG002|Overall Study|Protocol Deviation|0|||
124452143|NCT02142738|447618594|FG000|Overall Study|Adverse Event|13|||
124452144|NCT02142738|447618595|FG001|Overall Study|Adverse Event|9|||
124452145|NCT02142738|447618594|FG000|Overall Study|Death|92|||
124452146|NCT02142738|447618595|FG001|Overall Study|Death|112|||
124452147|NCT02142738|447618594|FG000|Overall Study|Lost to Follow-up|0|||
124452148|NCT02142738|447618595|FG001|Overall Study|Lost to Follow-up|3|||
124452149|NCT02142738|447618594|FG000|Overall Study|Withdrawal by Subject|6|||
124452150|NCT02142738|447618595|FG001|Overall Study|Withdrawal by Subject|7|||
124452151|NCT02142738|447618594|FG000|Overall Study|Follow up ended by sponsor|43|||
124452152|NCT02142738|447618595|FG001|Overall Study|Follow up ended by sponsor|20|||
124452153|NCT03688880|447618596|FG000|Overall Study|Withdrawal by Subject|0|||
124452154|NCT03688880|447618597|FG001|Overall Study|Withdrawal by Subject|2|||
124922000|NCT05516147|449343759|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
124922001|NCT03338933|449343761|FG000|Screening Visit|Lost to Follow-up|1|||
124922002|NCT03338933|449343762|FG001|Screening Visit|Lost to Follow-up|3|||
124922003|NCT03338933|449343763|FG002|Screening Visit|Lost to Follow-up|1|||
124922004|NCT03338933|449343764|FG003|Screening Visit|Lost to Follow-up|4|||
124922005|NCT03338933|449343761|FG000|Screening Visit|Screen fail after consent|2|||
124922006|NCT03338933|449343762|FG001|Screening Visit|Screen fail after consent|7|||
124922007|NCT03338933|449343763|FG002|Screening Visit|Screen fail after consent|1|||
124922008|NCT03338933|449343764|FG003|Screening Visit|Screen fail after consent|4|||
124922009|NCT03338933|449343761|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
124922010|NCT03338933|449343762|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
124922011|NCT03338933|449343763|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
124922012|NCT03338933|449343764|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
124922013|NCT03338933|449343761|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
124452155|NCT03688880|447618596|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
124452156|NCT03688880|447618597|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
124452157|NCT03688880|447618596|FG000|Overall Study|Lost to Follow-up|4|||
124452158|NCT03688880|447618597|FG001|Overall Study|Lost to Follow-up|7|||
124452159|NCT03688880|447618596|FG000|Overall Study|Adverse Event|0|||
124452160|NCT03688880|447618597|FG001|Overall Study|Adverse Event|2|||
124695816|NCT04913675|448505971|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
124969519|NCT03520075|449517413|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
124452161|NCT03688880|447618596|FG000|Overall Study|Device deficiencies|0|||
124452162|NCT03688880|447618597|FG001|Overall Study|Device deficiencies|2|||
124452163|NCT03688880|447618596|FG000|Overall Study|Other|10|||
124452164|NCT03688880|447618597|FG001|Overall Study|Other|16|||
124452165|NCT01704287|447618598|FG000|Initial Treatment Period|Death|139|||
124452166|NCT01704287|447618599|FG001|Initial Treatment Period|Death|129|||
124452167|NCT01704287|447618600|FG002|Initial Treatment Period|Death|71|||
124452168|NCT01704287|447618601|FG003|Initial Treatment Period|Death|0|||
124452169|NCT01704287|447618602|FG004|Initial Treatment Period|Death|0|||
124452170|NCT01704287|447618598|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
124452171|NCT01704287|447618599|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
124452172|NCT01704287|447618600|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
124452173|NCT01704287|447618601|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
124452174|NCT01704287|447618602|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
124695817|NCT04913675|448505968|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
124695818|NCT04913675|448505969|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
124695819|NCT04913675|448505970|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
124695820|NCT04913675|448505971|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
124452175|NCT01704287|447618598|FG000|Initial Treatment Period|Lost to Follow-up|5|||
124452176|NCT01704287|447618599|FG001|Initial Treatment Period|Lost to Follow-up|3|||
124452177|NCT01704287|447618600|FG002|Initial Treatment Period|Lost to Follow-up|0|||
124452178|NCT01704287|447618601|FG003|Initial Treatment Period|Lost to Follow-up|0|||
124452179|NCT01704287|447618602|FG004|Initial Treatment Period|Lost to Follow-up|0|||
124452180|NCT01704287|447618598|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
124762345|NCT02836652|448755862|FG000|Overall Study|Transplant/Explant|3|||
124922014|NCT03338933|449343762|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
124922015|NCT03338933|449343763|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
124922016|NCT03338933|449343764|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
124922017|NCT03338933|449343761|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
124922018|NCT03338933|449343762|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
124922019|NCT03338933|449343763|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
124922020|NCT03338933|449343764|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
124922021|NCT03853746|449343767|FG000|Overall Study|Withdrawal by Subject|1|||
124452181|NCT01704287|447618599|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
124452182|NCT01704287|447618600|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
124452183|NCT01704287|447618601|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
124452184|NCT01704287|447618602|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
124452185|NCT01704287|447618598|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
124452186|NCT01704287|447618599|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
124452187|NCT01704287|447618600|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
124452188|NCT01704287|447618601|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
124452189|NCT01704287|447618602|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
124452190|NCT01704287|447618598|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
124452191|NCT01704287|447618599|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
124452192|NCT01704287|447618600|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
124452193|NCT01704287|447618601|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
124452194|NCT01704287|447618602|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
124452195|NCT01704287|447618598|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
124452196|NCT01704287|447618599|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
124452197|NCT01704287|447618600|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
124452198|NCT01704287|447618601|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
124452199|NCT01704287|447618602|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
124452200|NCT04490395|447618603|FG000|Overall Study|Lost to Follow-up|0|||
124452201|NCT04490395|447618604|FG001|Overall Study|Lost to Follow-up|1|||
124452202|NCT02230254|447618605|FG000|Overall Study|Lost to Follow-up|3|||
124452203|NCT01462435|447618607|FG000|Overall Study|Lack of Efficacy|1|||
124452204|NCT01462435|447618608|FG001|Overall Study|Lack of Efficacy|0|||
124452205|NCT01462435|447618609|FG002|Overall Study|Lack of Efficacy|0|||
124452206|NCT01462435|447618610|FG003|Overall Study|Lack of Efficacy|3|||
124452207|NCT01462435|447618607|FG000|Overall Study|Physician Decision|0|||
124452208|NCT01462435|447618608|FG001|Overall Study|Physician Decision|0|||
124452209|NCT01462435|447618609|FG002|Overall Study|Physician Decision|1|||
124452210|NCT01462435|447618610|FG003|Overall Study|Physician Decision|0|||
124452211|NCT01462435|447618607|FG000|Overall Study|Withdrawal by Subject|0|||
124452212|NCT01462435|447618608|FG001|Overall Study|Withdrawal by Subject|0|||
124452213|NCT01462435|447618609|FG002|Overall Study|Withdrawal by Subject|0|||
124452214|NCT01462435|447618610|FG003|Overall Study|Withdrawal by Subject|1|||
124452215|NCT01462435|447618607|FG000|Overall Study|Lost to Follow-up|0|||
124452216|NCT01462435|447618608|FG001|Overall Study|Lost to Follow-up|0|||
124452217|NCT01462435|447618609|FG002|Overall Study|Lost to Follow-up|0|||
124452218|NCT01462435|447618610|FG003|Overall Study|Lost to Follow-up|1|||
124452219|NCT01942148|447618611|FG000|Overall Study|Adverse Event|4|||
124452220|NCT01942148|447618611|FG000|Overall Study|Lack of Efficacy|2|||
124452221|NCT01942148|447618611|FG000|Overall Study|Physician Decision|11|||
124452222|NCT01942148|447618611|FG000|Overall Study|Protocol Violation|1|||
124452223|NCT01942148|447618611|FG000|Overall Study|Withdrawal by Subject|8|||
124452224|NCT01942148|447618611|FG000|Overall Study|Use of the prohibition medicine|1|||
124452225|NCT00257725|447618613|FG000|Overall Study|Adverse Event|3|||
124452226|NCT02573870|447618614|FG000|Overall Study|Adverse Event|0|||
124452227|NCT02573870|447618615|FG001|Overall Study|Adverse Event|2|||
124452228|NCT02573870|447618614|FG000|Overall Study|Lack of Efficacy|0|||
124452229|NCT02573870|447618615|FG001|Overall Study|Lack of Efficacy|1|||
124452230|NCT02573870|447618614|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
124452231|NCT02573870|447618615|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
124452232|NCT02573870|447618614|FG000|Overall Study|Lost to Follow-up|0|||
124762346|NCT02836652|448755863|FG001|Overall Study|Transplant/Explant|4|||
124452233|NCT02573870|447618615|FG001|Overall Study|Lost to Follow-up|1|||
124452234|NCT02573870|447618614|FG000|Overall Study|Other: Fail to Meet Visit|0|||
124452235|NCT02573870|447618615|FG001|Overall Study|Other: Fail to Meet Visit|2|||
124452236|NCT01858532|447618616|FG000|Overall Study|Adverse Event|58|||
124452237|NCT01858532|447618617|FG001|Overall Study|Adverse Event|50|||
124452238|NCT01858532|447618618|FG002|Overall Study|Adverse Event|23|||
124452239|NCT01858532|447618619|FG003|Overall Study|Adverse Event|28|||
124452240|NCT01858532|447618616|FG000|Overall Study|Withdrew consent|71|||
124762347|NCT02836652|448755862|FG000|Overall Study|Withdrawn|9|||
124545461|NCT01058707|447951230|FG003|Overall Study|Subject Decision|1|||
124545462|NCT01058707|447951231|FG004|Overall Study|Subject Decision|2|||
124545463|NCT01058707|447951232|FG005|Overall Study|Subject Decision|3|||
124545464|NCT01058707|447951233|FG006|Overall Study|Subject Decision|6|||
124545465|NCT01058707|447951227|FG000|Overall Study|Lost to Follow-up|0|||
124545466|NCT01058707|447951228|FG001|Overall Study|Lost to Follow-up|0|||
124545467|NCT01058707|447951229|FG002|Overall Study|Lost to Follow-up|1|||
124545468|NCT01058707|447951230|FG003|Overall Study|Lost to Follow-up|0|||
124545469|NCT01058707|447951231|FG004|Overall Study|Lost to Follow-up|0|||
124545470|NCT01058707|447951232|FG005|Overall Study|Lost to Follow-up|0|||
124545471|NCT01058707|447951233|FG006|Overall Study|Lost to Follow-up|0|||
124545472|NCT01058707|447951227|FG000|Overall Study|Reason Not Specified|0|||
124545473|NCT01058707|447951228|FG001|Overall Study|Reason Not Specified|3|||
124545474|NCT01058707|447951229|FG002|Overall Study|Reason Not Specified|2|||
124545475|NCT01058707|447951230|FG003|Overall Study|Reason Not Specified|0|||
124545476|NCT01058707|447951231|FG004|Overall Study|Reason Not Specified|7|||
124545477|NCT01058707|447951232|FG005|Overall Study|Reason Not Specified|1|||
124545478|NCT01058707|447951233|FG006|Overall Study|Reason Not Specified|7|||
124545479|NCT01821391|447951236|FG000|Overall Study|Adverse Event|1|||
124545480|NCT01821391|447951237|FG001|Overall Study|Adverse Event|0|||
124545481|NCT00828009|447951239|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
124545482|NCT00828009|447951239|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
124545483|NCT00828009|447951239|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
124545484|NCT00828009|447951239|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
124545485|NCT00828009|447951239|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
124545486|NCT00828009|447951239|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
124545487|NCT00828009|447951239|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
124545488|NCT00828009|447951239|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
124545489|NCT00828009|447951239|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
124545490|NCT00828009|447951239|FG000|Step 2 - Maintenance Therapy|Death|1|||
124545491|NCT00828009|447951239|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
124545492|NCT00828009|447951239|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
124545493|NCT00828009|447951239|FG000|Step 2 - Maintenance Therapy|Other|1|||
124545494|NCT04880850|447951240|FG000|Overall Study|Death|2|||
124545495|NCT04880850|447951241|FG001|Overall Study|Death|1|||
124545496|NCT04880850|447951240|FG000|Overall Study|Lost to Follow-up|3|||
124545497|NCT04880850|447951241|FG001|Overall Study|Lost to Follow-up|6|||
124545498|NCT04880850|447951240|FG000|Overall Study|Physician Decision|2|||
124545499|NCT04880850|447951241|FG001|Overall Study|Physician Decision|1|||
124545500|NCT04880850|447951240|FG000|Overall Study|Withdrawal by Subject|9|||
124545501|NCT04880850|447951241|FG001|Overall Study|Withdrawal by Subject|10|||
124545502|NCT03417102|447951242|FG000|Overall Study|Adverse Event|0|||
124545503|NCT03417102|447951243|FG001|Overall Study|Adverse Event|1|||
124545504|NCT03417102|447951242|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
124922022|NCT00999804|449343768|FG000|Overall Study|Lack of Efficacy|9|||
124922023|NCT00999804|449343769|FG001|Overall Study|Lack of Efficacy|2|||
124922024|NCT00999804|449343768|FG000|Overall Study|Adverse Event|4|||
124922025|NCT00999804|449343769|FG001|Overall Study|Adverse Event|3|||
124922026|NCT00999804|449343768|FG000|Overall Study|Withdrawal by Subject|4|||
124922027|NCT00999804|449343769|FG001|Overall Study|Withdrawal by Subject|0|||
124922028|NCT00999804|449343768|FG000|Overall Study|Death|1|||
124922029|NCT00999804|449343769|FG001|Overall Study|Death|0|||
124922030|NCT00999804|449343768|FG000|Overall Study|Ineligible|3|||
124922031|NCT00999804|449343769|FG001|Overall Study|Ineligible|0|||
124922032|NCT04166773|449343775|FG000|Overall Study|Adverse Event|2|||
124922033|NCT04166773|449343776|FG001|Overall Study|Adverse Event|0|||
124922034|NCT04166773|449343777|FG002|Overall Study|Adverse Event|2|||
124922035|NCT04166773|449343778|FG003|Overall Study|Adverse Event|1|||
124922036|NCT04166773|449343775|FG000|Overall Study|Lost to Follow-up|4|||
124922037|NCT04166773|449343776|FG001|Overall Study|Lost to Follow-up|2|||
124922038|NCT04166773|449343777|FG002|Overall Study|Lost to Follow-up|1|||
124922039|NCT04166773|449343778|FG003|Overall Study|Lost to Follow-up|3|||
124545505|NCT03417102|447951243|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
124545506|NCT03417102|447951242|FG000|Overall Study|Other|0|||
124922040|NCT04166773|449343775|FG000|Overall Study|Physician Decision|0|||
124922041|NCT04166773|449343776|FG001|Overall Study|Physician Decision|0|||
124545507|NCT03417102|447951243|FG001|Overall Study|Other|1|||
124545508|NCT00526227|447951245|FG000|Overall Study|Device not implanted|1|||
124922042|NCT04166773|449343777|FG002|Overall Study|Physician Decision|0|||
124922043|NCT04166773|449343778|FG003|Overall Study|Physician Decision|1|||
124922044|NCT04166773|449343775|FG000|Overall Study|Withdrawal by Subject|1|||
124922045|NCT04166773|449343776|FG001|Overall Study|Withdrawal by Subject|1|||
124922046|NCT04166773|449343777|FG002|Overall Study|Withdrawal by Subject|2|||
124545509|NCT00526227|447951245|FG000|Overall Study|Death|1|||
124545510|NCT03222856|447951246|FG000|Overall Study|Adverse Event|6|||
124545511|NCT03222856|447951246|FG000|Overall Study|Death|1|||
124545512|NCT03280628|447952705|FG000|Overall Study|Lost to Follow-up|8|||
124695821|NCT01341990|448505972|FG000|Overall Study|Adverse Event|0|||
124695822|NCT01341990|448505973|FG001|Overall Study|Adverse Event|1|||
124452241|NCT01858532|447618617|FG001|Overall Study|Withdrew consent|93|||
124452242|NCT01858532|447618618|FG002|Overall Study|Withdrew consent|46|||
124452243|NCT01858532|447618619|FG003|Overall Study|Withdrew consent|27|||
124452244|NCT01858532|447618616|FG000|Overall Study|Lost to Follow-up|17|||
124452245|NCT01858532|447618617|FG001|Overall Study|Lost to Follow-up|26|||
124452246|NCT01858532|447618618|FG002|Overall Study|Lost to Follow-up|11|||
124452247|NCT01858532|447618619|FG003|Overall Study|Lost to Follow-up|14|||
124452248|NCT01858532|447618616|FG000|Overall Study|Deterioration of medical status|3|||
124452249|NCT01858532|447618617|FG001|Overall Study|Deterioration of medical status|4|||
124452250|NCT01858532|447618618|FG002|Overall Study|Deterioration of medical status|3|||
124452251|NCT01858532|447618619|FG003|Overall Study|Deterioration of medical status|7|||
124452252|NCT01858532|447618616|FG000|Overall Study|Investigator request|3|||
124452253|NCT01858532|447618617|FG001|Overall Study|Investigator request|4|||
124452254|NCT01858532|447618618|FG002|Overall Study|Investigator request|2|||
124452255|NCT01858532|447618619|FG003|Overall Study|Investigator request|6|||
124695823|NCT01341990|448505972|FG000|Overall Study|Torn Study Lens|1|||
124695824|NCT01341990|448505973|FG001|Overall Study|Torn Study Lens|0|||
124695825|NCT01341990|448505972|FG000|Overall Study|Withdrawal by Subject|2|||
124452256|NCT01858532|447618616|FG000|Overall Study|Other, not specified|29|||
124452257|NCT01858532|447618617|FG001|Overall Study|Other, not specified|15|||
124695826|NCT01341990|448505973|FG001|Overall Study|Withdrawal by Subject|0|||
124922047|NCT04166773|449343778|FG003|Overall Study|Withdrawal by Subject|5|||
124922048|NCT04952909|449343790|FG000|Overall Study|Death|3|||
124922049|NCT03575897|449343791|FG000|Overall Study|Lost to Follow-up|12|||
124922050|NCT03575897|449343792|FG001|Overall Study|Lost to Follow-up|13|||
124922051|NCT03150810|449343799|FG000|Overall Study|Death|4|||
124922052|NCT03150810|449343800|FG001|Overall Study|Death|8|||
124922053|NCT03150810|449343801|FG002|Overall Study|Death|7|||
124922054|NCT03150810|449343802|FG003|Overall Study|Death|2|||
124922055|NCT03150810|449343803|FG004|Overall Study|Death|2|||
124922056|NCT03150810|449343804|FG005|Overall Study|Death|10|||
124922057|NCT03150810|449343805|FG006|Overall Study|Death|8|||
124922058|NCT03150810|449343806|FG007|Overall Study|Death|6|||
124922059|NCT03150810|449343807|FG008|Overall Study|Death|18|||
124922060|NCT03150810|449343808|FG009|Overall Study|Death|3|||
124922061|NCT03150810|449343809|FG010|Overall Study|Death|19|||
124922062|NCT03150810|449343810|FG011|Overall Study|Death|1|||
124922063|NCT03150810|449343811|FG012|Overall Study|Death|19|||
124922064|NCT03150810|449343799|FG000|Overall Study|Withdrawal by Subject|0|||
124922065|NCT03150810|449343800|FG001|Overall Study|Withdrawal by Subject|1|||
124922066|NCT03150810|449343801|FG002|Overall Study|Withdrawal by Subject|1|||
124452258|NCT01858532|447618618|FG002|Overall Study|Other, not specified|13|||
124452259|NCT01858532|447618619|FG003|Overall Study|Other, not specified|11|||
124452260|NCT03785925|447618621|FG000|Overall Study|Withdrawal by Subject|15|||
124452261|NCT03785925|447618621|FG000|Overall Study|Lost to Follow-up|1|||
124452262|NCT00806195|447618623|FG000|Overall Study|Death|6|||
124452263|NCT00806195|447618624|FG001|Overall Study|Death|0|||
124452264|NCT00806195|447618625|FG002|Overall Study|Death|1|||
124452265|NCT00806195|447618626|FG003|Overall Study|Death|0|||
124452266|NCT00806195|447618623|FG000|Overall Study|Adverse Event|25|||
124452267|NCT00806195|447618624|FG001|Overall Study|Adverse Event|5|||
124452268|NCT00806195|447618625|FG002|Overall Study|Adverse Event|11|||
124452269|NCT00806195|447618626|FG003|Overall Study|Adverse Event|2|||
124452270|NCT00806195|447618623|FG000|Overall Study|Withdrawal by Subject|119|||
124452271|NCT00806195|447618624|FG001|Overall Study|Withdrawal by Subject|31|||
124452272|NCT00806195|447618625|FG002|Overall Study|Withdrawal by Subject|76|||
124452273|NCT00806195|447618626|FG003|Overall Study|Withdrawal by Subject|35|||
124452274|NCT00806195|447618623|FG000|Overall Study|Lost to Follow-up|217|||
124452275|NCT00806195|447618624|FG001|Overall Study|Lost to Follow-up|66|||
124452276|NCT00806195|447618625|FG002|Overall Study|Lost to Follow-up|90|||
124452277|NCT00806195|447618626|FG003|Overall Study|Lost to Follow-up|34|||
124452278|NCT00806195|447618623|FG000|Overall Study|Inappropriate Enrollment|0|||
124452279|NCT00806195|447618624|FG001|Overall Study|Inappropriate Enrollment|1|||
124452280|NCT00806195|447618625|FG002|Overall Study|Inappropriate Enrollment|0|||
124452281|NCT00806195|447618626|FG003|Overall Study|Inappropriate Enrollment|0|||
124452282|NCT00806195|447618623|FG000|Overall Study|Administrative Reason|113|||
124452283|NCT00806195|447618624|FG001|Overall Study|Administrative Reason|35|||
124452284|NCT00806195|447618625|FG002|Overall Study|Administrative Reason|66|||
124452285|NCT00806195|447618626|FG003|Overall Study|Administrative Reason|26|||
124452286|NCT00806195|447618623|FG000|Overall Study|Protocol Violation|34|||
124452287|NCT00806195|447618624|FG001|Overall Study|Protocol Violation|24|||
124452288|NCT00806195|447618625|FG002|Overall Study|Protocol Violation|26|||
124452289|NCT00806195|447618626|FG003|Overall Study|Protocol Violation|9|||
124452290|NCT02490475|447618627|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
124452291|NCT02490475|447618628|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
124452292|NCT02490475|447618629|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
124452293|NCT02490475|447618630|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
124452294|NCT02490475|447618627|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
124922067|NCT03150810|449343802|FG003|Overall Study|Withdrawal by Subject|1|||
124922068|NCT03150810|449343803|FG004|Overall Study|Withdrawal by Subject|0|||
124922069|NCT03150810|449343804|FG005|Overall Study|Withdrawal by Subject|0|||
124922070|NCT03150810|449343805|FG006|Overall Study|Withdrawal by Subject|2|||
124922071|NCT03150810|449343806|FG007|Overall Study|Withdrawal by Subject|0|||
124452295|NCT02490475|447618628|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
124452296|NCT02490475|447618629|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
124452297|NCT02490475|447618630|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
124452298|NCT02490475|447618627|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
124452299|NCT02490475|447618628|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
124452300|NCT02490475|447618629|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
124922072|NCT03150810|449343807|FG008|Overall Study|Withdrawal by Subject|2|||
124922073|NCT03150810|449343808|FG009|Overall Study|Withdrawal by Subject|0|||
124922074|NCT03150810|449343809|FG010|Overall Study|Withdrawal by Subject|1|||
124922075|NCT03150810|449343810|FG011|Overall Study|Withdrawal by Subject|0|||
124922076|NCT03150810|449343811|FG012|Overall Study|Withdrawal by Subject|1|||
124922077|NCT03150810|449343799|FG000|Overall Study|Sponsor Decision|0|||
124452301|NCT02490475|447618630|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
124452302|NCT02490475|447618627|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
124922078|NCT03150810|449343800|FG001|Overall Study|Sponsor Decision|2|||
124922079|NCT03150810|449343801|FG002|Overall Study|Sponsor Decision|0|||
124545513|NCT03280628|447952706|FG001|Overall Study|Lost to Follow-up|6|||
124545514|NCT03280628|447952707|FG002|Overall Study|Lost to Follow-up|11|||
124545515|NCT01361308|447952708|FG000|Overall Study|Withdrawal by Subject|9|||
124545516|NCT01361308|447952709|FG001|Overall Study|Withdrawal by Subject|13|||
124545517|NCT01361308|447952708|FG000|Overall Study|Physician Decision|3|||
124545518|NCT01361308|447952709|FG001|Overall Study|Physician Decision|3|||
124545519|NCT01361308|447952708|FG000|Overall Study|Lack of Efficacy|2|||
124545520|NCT01361308|447952709|FG001|Overall Study|Lack of Efficacy|0|||
124545521|NCT01361308|447952708|FG000|Overall Study|Protocol Violation|1|||
124545522|NCT01361308|447952709|FG001|Overall Study|Protocol Violation|0|||
124545523|NCT01361308|447952708|FG000|Overall Study|Lost to Follow-up|5|||
124545524|NCT01361308|447952709|FG001|Overall Study|Lost to Follow-up|4|||
124545525|NCT01361308|447952708|FG000|Overall Study|Adverse Event|8|||
124545526|NCT01361308|447952709|FG001|Overall Study|Adverse Event|4|||
124545527|NCT01361308|447952708|FG000|Overall Study|Eligibility Criteria Not Met|2|||
124545528|NCT01361308|447952709|FG001|Overall Study|Eligibility Criteria Not Met|3|||
124545529|NCT01361308|447952708|FG000|Overall Study|Failed C-SSRS|5|||
124545530|NCT01361308|447952709|FG001|Overall Study|Failed C-SSRS|2|||
124545531|NCT01361308|447952708|FG000|Overall Study|Other|0|||
124545532|NCT01361308|447952709|FG001|Overall Study|Other|1|||
124545533|NCT00700115|447952722|FG000|Overall Study|Withdrawal by Subject|1|||
124545534|NCT00700115|447952723|FG001|Overall Study|Withdrawal by Subject|0|||
124545535|NCT00700115|447952722|FG000|Overall Study|Lost to Follow-up|0|||
124922080|NCT03150810|449343802|FG003|Overall Study|Sponsor Decision|0|||
124922081|NCT03150810|449343803|FG004|Overall Study|Sponsor Decision|1|||
124922082|NCT03150810|449343804|FG005|Overall Study|Sponsor Decision|1|||
124922083|NCT03150810|449343805|FG006|Overall Study|Sponsor Decision|0|||
124922084|NCT03150810|449343806|FG007|Overall Study|Sponsor Decision|0|||
124922085|NCT03150810|449343807|FG008|Overall Study|Sponsor Decision|1|||
124922086|NCT03150810|449343808|FG009|Overall Study|Sponsor Decision|0|||
124922087|NCT03150810|449343809|FG010|Overall Study|Sponsor Decision|0|||
124922088|NCT03150810|449343810|FG011|Overall Study|Sponsor Decision|0|||
124922089|NCT03150810|449343811|FG012|Overall Study|Sponsor Decision|5|||
124922090|NCT03150810|449343799|FG000|Overall Study|Lost to Follow-up|0|||
124922091|NCT03150810|449343800|FG001|Overall Study|Lost to Follow-up|1|||
124922092|NCT03150810|449343801|FG002|Overall Study|Lost to Follow-up|1|||
124922093|NCT03150810|449343802|FG003|Overall Study|Lost to Follow-up|0|||
124922094|NCT03150810|449343803|FG004|Overall Study|Lost to Follow-up|0|||
124922095|NCT03150810|449343804|FG005|Overall Study|Lost to Follow-up|0|||
124922096|NCT03150810|449343805|FG006|Overall Study|Lost to Follow-up|1|||
124922097|NCT03150810|449343806|FG007|Overall Study|Lost to Follow-up|0|||
124922098|NCT03150810|449343807|FG008|Overall Study|Lost to Follow-up|0|||
124922099|NCT03150810|449343808|FG009|Overall Study|Lost to Follow-up|0|||
124922100|NCT03150810|449343809|FG010|Overall Study|Lost to Follow-up|1|||
124922101|NCT03150810|449343810|FG011|Overall Study|Lost to Follow-up|0|||
124922102|NCT03150810|449343811|FG012|Overall Study|Lost to Follow-up|0|||
124922103|NCT03150810|449343799|FG000|Overall Study|Physician Decision|0|||
124922104|NCT03150810|449343800|FG001|Overall Study|Physician Decision|0|||
124922105|NCT03150810|449343801|FG002|Overall Study|Physician Decision|0|||
124922106|NCT03150810|449343802|FG003|Overall Study|Physician Decision|0|||
124922107|NCT03150810|449343803|FG004|Overall Study|Physician Decision|0|||
124922108|NCT03150810|449343804|FG005|Overall Study|Physician Decision|1|||
124922109|NCT03150810|449343805|FG006|Overall Study|Physician Decision|1|||
124922110|NCT03150810|449343806|FG007|Overall Study|Physician Decision|0|||
124922111|NCT03150810|449343807|FG008|Overall Study|Physician Decision|0|||
124922112|NCT03150810|449343808|FG009|Overall Study|Physician Decision|0|||
124922113|NCT03150810|449343809|FG010|Overall Study|Physician Decision|0|||
124922114|NCT03150810|449343810|FG011|Overall Study|Physician Decision|0|||
124922115|NCT03150810|449343811|FG012|Overall Study|Physician Decision|0|||
124545536|NCT00700115|447952723|FG001|Overall Study|Lost to Follow-up|1|||
124545537|NCT02983305|447952728|FG000|Overall Study|incomplete data|2|||
124545538|NCT02983305|447952729|FG001|Overall Study|incomplete data|0|||
124545539|NCT00706901|447952730|FG000|Overall Study|Lost to Follow-up|2|||
124545540|NCT00706901|447952731|FG001|Overall Study|Lost to Follow-up|3|||
124922116|NCT03150810|449343799|FG000|Overall Study|Site withdrawal from study|0|||
124922117|NCT03150810|449343800|FG001|Overall Study|Site withdrawal from study|1|||
124922118|NCT03150810|449343801|FG002|Overall Study|Site withdrawal from study|0|||
124922119|NCT03150810|449343802|FG003|Overall Study|Site withdrawal from study|0|||
124922120|NCT03150810|449343803|FG004|Overall Study|Site withdrawal from study|0|||
124922121|NCT03150810|449343804|FG005|Overall Study|Site withdrawal from study|0|||
124922122|NCT03150810|449343805|FG006|Overall Study|Site withdrawal from study|0|||
124922123|NCT03150810|449343806|FG007|Overall Study|Site withdrawal from study|0|||
124922124|NCT03150810|449343807|FG008|Overall Study|Site withdrawal from study|0|||
124922125|NCT03150810|449343808|FG009|Overall Study|Site withdrawal from study|1|||
124922126|NCT03150810|449343809|FG010|Overall Study|Site withdrawal from study|1|||
124922127|NCT03150810|449343810|FG011|Overall Study|Site withdrawal from study|0|||
124922128|NCT03150810|449343811|FG012|Overall Study|Site withdrawal from study|0|||
124545541|NCT00706901|447952732|FG002|Overall Study|Lost to Follow-up|2|||
124545542|NCT00706901|447952730|FG000|Overall Study|Withdrawal by Subject|4|||
124922129|NCT03150810|449343799|FG000|Overall Study|Hospice|0|||
124452303|NCT02490475|447618628|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
124452304|NCT02490475|447618629|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
124452305|NCT02490475|447618630|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
124452306|NCT02490475|447618627|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
124452307|NCT02490475|447618628|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
124452308|NCT02490475|447618629|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
124452309|NCT02490475|447618630|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
124452310|NCT02490475|447618627|FG000|Period 2: Extension Phase|Refused Treatment|0|||
124452311|NCT02490475|447618628|FG001|Period 2: Extension Phase|Refused Treatment|0|||
124452312|NCT02490475|447618629|FG002|Period 2: Extension Phase|Refused Treatment|0|||
124452313|NCT02490475|447618630|FG003|Period 2: Extension Phase|Refused Treatment|1|||
124452314|NCT02490475|447618627|FG000|Period 2: Extension Phase|Adverse Event|0|||
124452315|NCT02490475|447618628|FG001|Period 2: Extension Phase|Adverse Event|0|||
124452316|NCT02490475|447618629|FG002|Period 2: Extension Phase|Adverse Event|1|||
124452317|NCT02490475|447618630|FG003|Period 2: Extension Phase|Adverse Event|0|||
124452318|NCT00139776|447618631|FG000|Period I|Did not enter Period II|575|||
124452319|NCT00139776|447618632|FG001|Period I|Did not enter Period II|0|||
124452320|NCT00139776|447618633|FG002|Period I|Did not enter Period II|0|||
124452321|NCT00139776|447618634|FG003|Period I|Did not enter Period II|0|||
124452322|NCT00139776|447618631|FG000|Period II|Not Randomized into Period III|0|||
124452323|NCT00139776|447618632|FG001|Period II|Not Randomized into Period III|322|||
124452324|NCT00139776|447618633|FG002|Period II|Not Randomized into Period III|0|||
124452325|NCT00139776|447618634|FG003|Period II|Not Randomized into Period III|0|||
124452326|NCT00139776|447618631|FG000|Period III|Adverse Event|0|||
124452327|NCT00139776|447618632|FG001|Period III|Adverse Event|0|||
124452328|NCT00139776|447618633|FG002|Period III|Adverse Event|22|||
124452329|NCT00139776|447618634|FG003|Period III|Adverse Event|23|||
124452330|NCT00139776|447618631|FG000|Period III|Other|0|||
124452331|NCT00139776|447618632|FG001|Period III|Other|0|||
124452332|NCT00139776|447618633|FG002|Period III|Other|23|||
124452333|NCT00139776|447618634|FG003|Period III|Other|34|||
124452334|NCT00139776|447618631|FG000|Period III|Lack of Efficacy|0|||
124452335|NCT00139776|447618632|FG001|Period III|Lack of Efficacy|0|||
124452336|NCT00139776|447618633|FG002|Period III|Lack of Efficacy|10|||
124452337|NCT00139776|447618634|FG003|Period III|Lack of Efficacy|24|||
124452338|NCT00139776|447618631|FG000|Period III|Lost to Follow-up|0|||
124452339|NCT00139776|447618632|FG001|Period III|Lost to Follow-up|0|||
124452340|NCT00139776|447618633|FG002|Period III|Lost to Follow-up|5|||
124452341|NCT00139776|447618634|FG003|Period III|Lost to Follow-up|4|||
124452342|NCT00139776|447618631|FG000|Period III|Withdrawal by Subject|0|||
124452343|NCT00139776|447618632|FG001|Period III|Withdrawal by Subject|0|||
124452344|NCT00139776|447618633|FG002|Period III|Withdrawal by Subject|16|||
124452345|NCT00139776|447618634|FG003|Period III|Withdrawal by Subject|21|||
124452346|NCT01519934|447618641|FG000|Overall Study|Lost to Follow-up|3|||
124452347|NCT01994382|447618642|FG000|Overall Study|Informed consent withdrawn|0|||
124452348|NCT01994382|447618643|FG001|Overall Study|Informed consent withdrawn|0|||
124452349|NCT01994382|447618644|FG002|Overall Study|Informed consent withdrawn|0|||
124452350|NCT01994382|447618645|FG003|Overall Study|Informed consent withdrawn|0|||
124452351|NCT01994382|447618646|FG004|Overall Study|Informed consent withdrawn|0|||
124545543|NCT00706901|447952731|FG001|Overall Study|Withdrawal by Subject|2|||
124545544|NCT00706901|447952732|FG002|Overall Study|Withdrawal by Subject|5|||
124545545|NCT00706901|447952730|FG000|Overall Study|In Jail|1|||
124545546|NCT00706901|447952731|FG001|Overall Study|In Jail|0|||
124545547|NCT00706901|447952732|FG002|Overall Study|In Jail|1|||
124545548|NCT00706901|447952730|FG000|Overall Study|Death|1|||
124545549|NCT00706901|447952731|FG001|Overall Study|Death|0|||
124545550|NCT00706901|447952732|FG002|Overall Study|Death|0|||
124545551|NCT03433482|447952733|FG000|Overall Study|Lost to Follow-up|1|||
124545552|NCT03433482|447952734|FG001|Overall Study|Lost to Follow-up|0|||
124545553|NCT03433482|447952735|FG002|Overall Study|Lost to Follow-up|1|||
124545554|NCT03433482|447952736|FG003|Overall Study|Lost to Follow-up|1|||
124545555|NCT03433482|447952733|FG000|Overall Study|Withdrawal by Subject|0|||
124545556|NCT03433482|447952734|FG001|Overall Study|Withdrawal by Subject|0|||
124545557|NCT03433482|447952735|FG002|Overall Study|Withdrawal by Subject|1|||
124545558|NCT03433482|447952736|FG003|Overall Study|Withdrawal by Subject|0|||
124545559|NCT03433482|447952733|FG000|Overall Study|Unknown reason|0|||
124545560|NCT03433482|447952734|FG001|Overall Study|Unknown reason|0|||
124545561|NCT03433482|447952735|FG002|Overall Study|Unknown reason|2|||
124545562|NCT03433482|447952736|FG003|Overall Study|Unknown reason|0|||
124545563|NCT01646268|447952737|FG000|Overall Study|Adverse Event|6|||
124545564|NCT01646268|447952738|FG001|Overall Study|Adverse Event|7|||
124545565|NCT01646268|447952737|FG000|Overall Study|Lack of Efficacy|1|||
124545566|NCT01646268|447952738|FG001|Overall Study|Lack of Efficacy|3|||
124545567|NCT01646268|447952737|FG000|Overall Study|Protocol Violation|0|||
124545568|NCT01646268|447952738|FG001|Overall Study|Protocol Violation|1|||
124545569|NCT01646268|447952737|FG000|Overall Study|Withdrawal by Subject|2|||
124545570|NCT01646268|447952738|FG001|Overall Study|Withdrawal by Subject|5|||
124545571|NCT01646268|447952737|FG000|Overall Study|Other|2|||
124545572|NCT01646268|447952738|FG001|Overall Study|Other|0|||
124545573|NCT01519635|447952743|FG000|Overall Study|Withdrawal by Subject|0|||
124545574|NCT01519635|447952744|FG001|Overall Study|Withdrawal by Subject|1|||
124545575|NCT01519635|447952743|FG000|Overall Study|No possibility to put a catheter|1|||
124545576|NCT01519635|447952744|FG001|Overall Study|No possibility to put a catheter|2|||
124545577|NCT01300741|447952745|FG000|Overall Study|Lens deposits|1|||
124922130|NCT03150810|449343800|FG001|Overall Study|Hospice|0|||
124922131|NCT03150810|449343801|FG002|Overall Study|Hospice|0|||
124922132|NCT03150810|449343802|FG003|Overall Study|Hospice|0|||
124452352|NCT01994382|447618647|FG005|Overall Study|Informed consent withdrawn|0|||
124452353|NCT01994382|447618648|FG006|Overall Study|Informed consent withdrawn|1|||
124452354|NCT01994382|447618649|FG007|Overall Study|Informed consent withdrawn|0|||
124452355|NCT01994382|447618650|FG008|Overall Study|Informed consent withdrawn|0|||
124452356|NCT01994382|447618651|FG009|Overall Study|Informed consent withdrawn|0|||
124452357|NCT01994382|447618652|FG010|Overall Study|Informed consent withdrawn|0|||
124452358|NCT01994382|447618653|FG011|Overall Study|Informed consent withdrawn|0|||
124452359|NCT01994382|447618654|FG012|Overall Study|Informed consent withdrawn|0|||
124452360|NCT01994382|447618655|FG013|Overall Study|Informed consent withdrawn|0|||
124452361|NCT01994382|447618656|FG014|Overall Study|Informed consent withdrawn|0|||
124452362|NCT01994382|447618657|FG015|Overall Study|Informed consent withdrawn|0|||
124452363|NCT01994382|447618658|FG016|Overall Study|Informed consent withdrawn|0|||
124452364|NCT01994382|447618642|FG000|Overall Study|Progressive disease|3|||
124452365|NCT01994382|447618643|FG001|Overall Study|Progressive disease|4|||
124452366|NCT01994382|447618644|FG002|Overall Study|Progressive disease|4|||
124922133|NCT03150810|449343803|FG004|Overall Study|Hospice|0|||
124922134|NCT03150810|449343804|FG005|Overall Study|Hospice|1|||
124922135|NCT03150810|449343805|FG006|Overall Study|Hospice|0|||
124922136|NCT03150810|449343806|FG007|Overall Study|Hospice|0|||
124922137|NCT03150810|449343807|FG008|Overall Study|Hospice|0|||
124922138|NCT03150810|449343808|FG009|Overall Study|Hospice|0|||
124922139|NCT03150810|449343809|FG010|Overall Study|Hospice|0|||
124922140|NCT03150810|449343810|FG011|Overall Study|Hospice|0|||
124452367|NCT01994382|447618645|FG003|Overall Study|Progressive disease|3|||
124545578|NCT01300741|447952745|FG000|Overall Study|Lost to Follow-up|1|||
124545579|NCT01300741|447952745|FG000|Overall Study|Discomfort|1|||
124545580|NCT02325414|447952746|FG000|Overall Study|Withdrawal by Subject|3|||
124545581|NCT02325414|447952747|FG001|Overall Study|Withdrawal by Subject|1|||
124545582|NCT02325414|447952746|FG000|Overall Study|Lost to Follow-up|5|||
124545583|NCT02325414|447952747|FG001|Overall Study|Lost to Follow-up|5|||
124545584|NCT00560573|447952749|FG000|Overall Study|Death|4|||
124922141|NCT03150810|449343811|FG012|Overall Study|Hospice|0|||
124452368|NCT01994382|447618646|FG004|Overall Study|Progressive disease|2|||
124545585|NCT00560573|447952750|FG001|Overall Study|Death|1|||
124922142|NCT03150810|449343799|FG000|Overall Study|Participant relocated abroad.|0|||
124545586|NCT00560573|447952751|FG002|Overall Study|Death|4|||
124545587|NCT00560573|447952752|FG003|Overall Study|Death|5|||
124545588|NCT00560573|447952753|FG004|Overall Study|Death|1|||
124545589|NCT00560573|447952754|FG005|Overall Study|Death|10|||
124545590|NCT00560573|447952749|FG000|Overall Study|Lost to Follow-up|0|||
124545591|NCT00560573|447952750|FG001|Overall Study|Lost to Follow-up|0|||
124545592|NCT00560573|447952751|FG002|Overall Study|Lost to Follow-up|0|||
124545593|NCT00560573|447952752|FG003|Overall Study|Lost to Follow-up|1|||
124545594|NCT00560573|447952753|FG004|Overall Study|Lost to Follow-up|1|||
124545595|NCT00560573|447952754|FG005|Overall Study|Lost to Follow-up|0|||
124545596|NCT00560573|447952749|FG000|Overall Study|Withdrawal by Subject|0|||
124545597|NCT00560573|447952750|FG001|Overall Study|Withdrawal by Subject|0|||
124922143|NCT03150810|449343800|FG001|Overall Study|Participant relocated abroad.|0|||
124922144|NCT03150810|449343801|FG002|Overall Study|Participant relocated abroad.|0|||
124922145|NCT03150810|449343802|FG003|Overall Study|Participant relocated abroad.|0|||
124922146|NCT03150810|449343803|FG004|Overall Study|Participant relocated abroad.|0|||
124922147|NCT03150810|449343804|FG005|Overall Study|Participant relocated abroad.|1|||
124452369|NCT01994382|447618647|FG005|Overall Study|Progressive disease|3|||
124452370|NCT01994382|447618648|FG006|Overall Study|Progressive disease|3|||
124452371|NCT01994382|447618649|FG007|Overall Study|Progressive disease|6|||
124452372|NCT01994382|447618650|FG008|Overall Study|Progressive disease|2|||
124452373|NCT01994382|447618651|FG009|Overall Study|Progressive disease|2|||
124452374|NCT01994382|447618652|FG010|Overall Study|Progressive disease|13|||
124452375|NCT01994382|447618653|FG011|Overall Study|Progressive disease|8|||
124452376|NCT01994382|447618654|FG012|Overall Study|Progressive disease|7|||
124452377|NCT01994382|447618655|FG013|Overall Study|Progressive disease|3|||
124452378|NCT01994382|447618656|FG014|Overall Study|Progressive disease|6|||
124452379|NCT01994382|447618657|FG015|Overall Study|Progressive disease|44|||
124452380|NCT01994382|447618658|FG016|Overall Study|Progressive disease|28|||
124452381|NCT01994382|447618642|FG000|Overall Study|Physician Decision|0|||
124452382|NCT01994382|447618643|FG001|Overall Study|Physician Decision|1|||
124452383|NCT01994382|447618644|FG002|Overall Study|Physician Decision|0|||
124452384|NCT01994382|447618645|FG003|Overall Study|Physician Decision|0|||
124452385|NCT01994382|447618646|FG004|Overall Study|Physician Decision|0|||
124545598|NCT00560573|447952751|FG002|Overall Study|Withdrawal by Subject|0|||
124545599|NCT00560573|447952752|FG003|Overall Study|Withdrawal by Subject|1|||
124545600|NCT00560573|447952753|FG004|Overall Study|Withdrawal by Subject|1|||
124545601|NCT00560573|447952754|FG005|Overall Study|Withdrawal by Subject|0|||
124545602|NCT00560573|447952749|FG000|Overall Study|Other|2|||
124545603|NCT00560573|447952750|FG001|Overall Study|Other|2|||
124545604|NCT00560573|447952751|FG002|Overall Study|Other|2|||
124545605|NCT00560573|447952752|FG003|Overall Study|Other|3|||
124545606|NCT00560573|447952753|FG004|Overall Study|Other|3|||
124545607|NCT00560573|447952754|FG005|Overall Study|Other|3|||
124545608|NCT00560573|447952749|FG000|Overall Study|Enrolled, not treated|0|||
124545609|NCT00560573|447952750|FG001|Overall Study|Enrolled, not treated|0|||
124545610|NCT00560573|447952751|FG002|Overall Study|Enrolled, not treated|0|||
124695827|NCT02489045|448505974|FG000|Overall Study|unable to collect usable data|53|||
124695828|NCT02489045|448505974|FG000|Follow-up|Lost to Follow-up|10|||
124695829|NCT01751685|448505976|FG000|6-mo Followup|Missed study visit|1|||
124695830|NCT01751685|448505977|FG001|6-mo Followup|Missed study visit|0|||
124695831|NCT01751685|448505976|FG000|6-mo Followup|Withdrawal by Subject|2|||
124695832|NCT01751685|448505977|FG001|6-mo Followup|Withdrawal by Subject|2|||
124545611|NCT00560573|447952752|FG003|Overall Study|Enrolled, not treated|0|||
124695833|NCT01751685|448505976|FG000|6-mo Followup|Lost to Follow-up|0|||
124695834|NCT01751685|448505977|FG001|6-mo Followup|Lost to Follow-up|1|||
124452386|NCT01994382|447618647|FG005|Overall Study|Physician Decision|0|||
124452387|NCT01994382|447618648|FG006|Overall Study|Physician Decision|0|||
124452388|NCT01994382|447618649|FG007|Overall Study|Physician Decision|0|||
124452389|NCT01994382|447618650|FG008|Overall Study|Physician Decision|0|||
124452390|NCT01994382|447618651|FG009|Overall Study|Physician Decision|0|||
124452391|NCT01994382|447618652|FG010|Overall Study|Physician Decision|3|||
124452392|NCT01994382|447618653|FG011|Overall Study|Physician Decision|1|||
124452393|NCT01994382|447618654|FG012|Overall Study|Physician Decision|1|||
124452394|NCT01994382|447618655|FG013|Overall Study|Physician Decision|0|||
124452395|NCT01994382|447618656|FG014|Overall Study|Physician Decision|1|||
124452396|NCT01994382|447618657|FG015|Overall Study|Physician Decision|4|||
124545612|NCT00560573|447952753|FG004|Overall Study|Enrolled, not treated|1|||
124762348|NCT02836652|448755863|FG001|Overall Study|Withdrawn|9|||
124545613|NCT00560573|447952754|FG005|Overall Study|Enrolled, not treated|0|||
124545614|NCT01339273|447952755|FG000|Overall Study|Lost to Follow-up|8|||
124762349|NCT02836652|448755862|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
124922148|NCT03150810|449343805|FG006|Overall Study|Participant relocated abroad.|0|||
124452397|NCT01994382|447618658|FG016|Overall Study|Physician Decision|2|||
124452398|NCT01994382|447618642|FG000|Overall Study|Death|0|||
124452399|NCT01994382|447618643|FG001|Overall Study|Death|0|||
124452400|NCT01994382|447618644|FG002|Overall Study|Death|0|||
124545615|NCT01339273|447952756|FG001|Overall Study|Lost to Follow-up|8|||
124545616|NCT00726882|447952757|FG000|Overall Study|Withdrawal by Subject|5|||
124695835|NCT01751685|448505976|FG000|12-mo Followup|Lost to Follow-up|5|||
124695836|NCT01751685|448505977|FG001|12-mo Followup|Lost to Follow-up|0|||
124922149|NCT03150810|449343806|FG007|Overall Study|Participant relocated abroad.|0|||
124922150|NCT03150810|449343807|FG008|Overall Study|Participant relocated abroad.|0|||
124922151|NCT03150810|449343808|FG009|Overall Study|Participant relocated abroad.|0|||
124922152|NCT03150810|449343809|FG010|Overall Study|Participant relocated abroad.|0|||
124922153|NCT03150810|449343810|FG011|Overall Study|Participant relocated abroad.|0|||
124922154|NCT03150810|449343811|FG012|Overall Study|Participant relocated abroad.|0|||
124922155|NCT03150810|449343799|FG000|Overall Study|Transferred care to oncologist|0|||
124922156|NCT03150810|449343800|FG001|Overall Study|Transferred care to oncologist|0|||
124922157|NCT03150810|449343801|FG002|Overall Study|Transferred care to oncologist|0|||
124922158|NCT03150810|449343802|FG003|Overall Study|Transferred care to oncologist|0|||
124922159|NCT03150810|449343803|FG004|Overall Study|Transferred care to oncologist|0|||
124922160|NCT03150810|449343804|FG005|Overall Study|Transferred care to oncologist|0|||
124922161|NCT03150810|449343805|FG006|Overall Study|Transferred care to oncologist|2|||
124922162|NCT03150810|449343806|FG007|Overall Study|Transferred care to oncologist|0|||
124922163|NCT03150810|449343807|FG008|Overall Study|Transferred care to oncologist|0|||
124922164|NCT03150810|449343808|FG009|Overall Study|Transferred care to oncologist|0|||
124922165|NCT03150810|449343809|FG010|Overall Study|Transferred care to oncologist|0|||
124922166|NCT03150810|449343810|FG011|Overall Study|Transferred care to oncologist|0|||
124922167|NCT03150810|449343811|FG012|Overall Study|Transferred care to oncologist|0|||
124922168|NCT05116787|449343812|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
124922169|NCT05116787|449343813|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
124922170|NCT05116787|449343812|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
124922171|NCT05116787|449343813|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
124922172|NCT05116787|449343812|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
124922173|NCT05116787|449343813|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
124922174|NCT05116787|449343812|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
124922175|NCT05116787|449343813|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
124922176|NCT03557697|449343815|FG000|Overall Study|Withdrawal by Subject|2|||
124922177|NCT03557697|449343816|FG001|Overall Study|Withdrawal by Subject|4|||
124922178|NCT03611491|449343817|FG000|Overall Study|Lost to Follow-up|1|||
124922179|NCT05478499|449343823|FG000|Overall Study|Adverse Event|4|||
124922180|NCT05478499|449343824|FG001|Overall Study|Adverse Event|2|||
124922181|NCT05478499|449343823|FG000|Overall Study|Withdrawal by Subject|3|||
124922182|NCT05478499|449343824|FG001|Overall Study|Withdrawal by Subject|2|||
124922183|NCT05478499|449343823|FG000|Overall Study|Lack of Efficacy|1|||
124695837|NCT01348490|448505984|FG000|Overall Study|Death|1|||
124695838|NCT01348490|448505984|FG000|Overall Study|Adverse Event|3|||
124452401|NCT01994382|447618645|FG003|Overall Study|Death|0|||
124452402|NCT01994382|447618646|FG004|Overall Study|Death|1|||
124452403|NCT01994382|447618647|FG005|Overall Study|Death|0|||
124452404|NCT01994382|447618648|FG006|Overall Study|Death|0|||
124452405|NCT01994382|447618649|FG007|Overall Study|Death|0|||
124452406|NCT01994382|447618650|FG008|Overall Study|Death|1|||
124452407|NCT01994382|447618651|FG009|Overall Study|Death|1|||
124452408|NCT01994382|447618652|FG010|Overall Study|Death|0|||
124452409|NCT01994382|447618653|FG011|Overall Study|Death|0|||
124452410|NCT01994382|447618654|FG012|Overall Study|Death|0|||
124452411|NCT01994382|447618655|FG013|Overall Study|Death|0|||
124452412|NCT01994382|447618656|FG014|Overall Study|Death|0|||
124452413|NCT01994382|447618657|FG015|Overall Study|Death|1|||
124452414|NCT01994382|447618658|FG016|Overall Study|Death|0|||
124452415|NCT01994382|447618642|FG000|Overall Study|Adverse Event|0|||
124452416|NCT01994382|447618643|FG001|Overall Study|Adverse Event|1|||
124452417|NCT01994382|447618644|FG002|Overall Study|Adverse Event|2|||
124452418|NCT01994382|447618645|FG003|Overall Study|Adverse Event|0|||
124452419|NCT01994382|447618646|FG004|Overall Study|Adverse Event|0|||
124452420|NCT01994382|447618647|FG005|Overall Study|Adverse Event|0|||
124452421|NCT01994382|447618648|FG006|Overall Study|Adverse Event|0|||
124452422|NCT01994382|447618649|FG007|Overall Study|Adverse Event|0|||
124452423|NCT01994382|447618650|FG008|Overall Study|Adverse Event|0|||
124452424|NCT01994382|447618651|FG009|Overall Study|Adverse Event|0|||
124452425|NCT01994382|447618652|FG010|Overall Study|Adverse Event|15|||
124452426|NCT01994382|447618653|FG011|Overall Study|Adverse Event|2|||
124452427|NCT01994382|447618654|FG012|Overall Study|Adverse Event|7|||
124452428|NCT01994382|447618655|FG013|Overall Study|Adverse Event|3|||
124452429|NCT01994382|447618656|FG014|Overall Study|Adverse Event|17|||
124452430|NCT01994382|447618657|FG015|Overall Study|Adverse Event|6|||
124452431|NCT01994382|447618658|FG016|Overall Study|Adverse Event|3|||
124452432|NCT01994382|447618642|FG000|Overall Study|Other than specified|0|||
124452433|NCT01994382|447618643|FG001|Overall Study|Other than specified|0|||
124452434|NCT01994382|447618644|FG002|Overall Study|Other than specified|0|||
124452435|NCT01994382|447618645|FG003|Overall Study|Other than specified|0|||
124452436|NCT01994382|447618646|FG004|Overall Study|Other than specified|0|||
124452437|NCT01994382|447618647|FG005|Overall Study|Other than specified|0|||
124452438|NCT01994382|447618648|FG006|Overall Study|Other than specified|0|||
124452439|NCT01994382|447618649|FG007|Overall Study|Other than specified|0|||
124452440|NCT01994382|447618650|FG008|Overall Study|Other than specified|0|||
124452441|NCT01994382|447618651|FG009|Overall Study|Other than specified|0|||
124452442|NCT01994382|447618652|FG010|Overall Study|Other than specified|2|||
124452443|NCT01994382|447618653|FG011|Overall Study|Other than specified|0|||
124452444|NCT01994382|447618654|FG012|Overall Study|Other than specified|2|||
124452445|NCT01994382|447618655|FG013|Overall Study|Other than specified|0|||
124452446|NCT01994382|447618656|FG014|Overall Study|Other than specified|0|||
124452447|NCT01994382|447618657|FG015|Overall Study|Other than specified|4|||
124452448|NCT01994382|447618658|FG016|Overall Study|Other than specified|4|||
124452449|NCT01994382|447618642|FG000|Overall Study|Withdrawal by Subject|0|||
124452450|NCT01994382|447618643|FG001|Overall Study|Withdrawal by Subject|0|||
124452451|NCT01994382|447618644|FG002|Overall Study|Withdrawal by Subject|0|||
124452452|NCT01994382|447618645|FG003|Overall Study|Withdrawal by Subject|0|||
124452453|NCT01994382|447618646|FG004|Overall Study|Withdrawal by Subject|0|||
124452454|NCT01994382|447618647|FG005|Overall Study|Withdrawal by Subject|0|||
124452455|NCT01994382|447618648|FG006|Overall Study|Withdrawal by Subject|0|||
124452456|NCT01994382|447618649|FG007|Overall Study|Withdrawal by Subject|0|||
124452457|NCT01994382|447618650|FG008|Overall Study|Withdrawal by Subject|0|||
124452458|NCT01994382|447618651|FG009|Overall Study|Withdrawal by Subject|0|||
124452459|NCT01994382|447618652|FG010|Overall Study|Withdrawal by Subject|6|||
124452460|NCT01994382|447618653|FG011|Overall Study|Withdrawal by Subject|0|||
124452461|NCT01994382|447618654|FG012|Overall Study|Withdrawal by Subject|2|||
124452462|NCT01994382|447618655|FG013|Overall Study|Withdrawal by Subject|0|||
124452463|NCT01994382|447618656|FG014|Overall Study|Withdrawal by Subject|4|||
124452464|NCT01994382|447618657|FG015|Overall Study|Withdrawal by Subject|3|||
124695839|NCT01348490|448505984|FG000|Overall Study|Consent withdrawn|7|||
124452465|NCT01994382|447618658|FG016|Overall Study|Withdrawal by Subject|0|||
124452466|NCT01994382|447618642|FG000|Overall Study|Lost to Follow-up|0|||
124452467|NCT01994382|447618643|FG001|Overall Study|Lost to Follow-up|0|||
124452468|NCT01994382|447618644|FG002|Overall Study|Lost to Follow-up|0|||
124545617|NCT00726882|447952757|FG000|Overall Study|Lost to Follow-up|7|||
124695840|NCT01348490|448505984|FG000|Overall Study|Disease progression|3|||
124695841|NCT01348490|448505984|FG000|Overall Study|Lost to Follow-up|1|||
124452469|NCT01994382|447618645|FG003|Overall Study|Lost to Follow-up|0|||
124695842|NCT01348490|448505984|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
124452470|NCT01994382|447618646|FG004|Overall Study|Lost to Follow-up|0|||
124452471|NCT01994382|447618647|FG005|Overall Study|Lost to Follow-up|0|||
124452472|NCT01994382|447618648|FG006|Overall Study|Lost to Follow-up|0|||
124695843|NCT01348490|448505984|FG000|Overall Study|Other Unspecified|8|||
124695844|NCT01117350|448505986|FG000|Comparative Period|Not Treated|5|||
124695845|NCT01117350|448505987|FG001|Comparative Period|Not Treated|8|||
124695846|NCT01117350|448505986|FG000|Comparative Period|Adverse Event|6|||
124695847|NCT01117350|448505987|FG001|Comparative Period|Adverse Event|33|||
124695848|NCT01117350|448505986|FG000|Comparative Period|Lost to Follow-up|11|||
124695849|NCT01117350|448505987|FG001|Comparative Period|Lost to Follow-up|7|||
124695850|NCT01117350|448505986|FG000|Comparative Period|Withdrawal by Subject|9|||
124695851|NCT01117350|448505987|FG001|Comparative Period|Withdrawal by Subject|13|||
124695852|NCT01117350|448505986|FG000|Comparative Period|Protocol Violation|8|||
124695853|NCT01117350|448505987|FG001|Comparative Period|Protocol Violation|12|||
124695854|NCT01117350|448505986|FG000|Comparative Period|Lack of Efficacy|1|||
124695855|NCT01117350|448505987|FG001|Comparative Period|Lack of Efficacy|0|||
124695856|NCT01117350|448505986|FG000|Comparative Period|Physician Decision|0|||
124695857|NCT01117350|448505987|FG001|Comparative Period|Physician Decision|1|||
124695858|NCT01117350|448505986|FG000|Comparative Period|Move to another city/country|2|||
124695859|NCT01117350|448505987|FG001|Comparative Period|Move to another city/country|1|||
124695860|NCT01117350|448505986|FG000|Extension Period|Not included in extension, not treated|0|||
124695861|NCT01117350|448505987|FG001|Extension Period|Not included in extension, not treated|50|||
124695862|NCT01117350|448505986|FG000|Extension Period|Adverse Event|0|||
124695863|NCT01117350|448505987|FG001|Extension Period|Adverse Event|2|||
124695864|NCT01117350|448505986|FG000|Extension Period|Protocol Violation|0|||
124695865|NCT01117350|448505987|FG001|Extension Period|Protocol Violation|2|||
124695866|NCT01117350|448505986|FG000|Extension Period|Lost to Follow-up|0|||
124695867|NCT01117350|448505987|FG001|Extension Period|Lost to Follow-up|2|||
124695868|NCT01117350|448505986|FG000|Extension Period|Withdrawal by Subject|0|||
124695869|NCT01117350|448505987|FG001|Extension Period|Withdrawal by Subject|3|||
124695870|NCT01117350|448505986|FG000|Extension Period|Lack of Efficacy|0|||
124695871|NCT01117350|448505987|FG001|Extension Period|Lack of Efficacy|2|||
124695872|NCT01117350|448505986|FG000|Extension Period|Inclusion criteria not respected|0|||
124695873|NCT01117350|448505987|FG001|Extension Period|Inclusion criteria not respected|1|||
124695874|NCT01117350|448505986|FG000|Extension Period|Prohibited medication|0|||
124695875|NCT01117350|448505987|FG001|Extension Period|Prohibited medication|1|||
124695876|NCT00800384|448505989|FG000|Overall Study|Withdrawal by Subject|24|||
124695877|NCT00800384|448505990|FG001|Overall Study|Withdrawal by Subject|17|||
124695878|NCT00800384|448505989|FG000|Overall Study|Lost to Follow-up|17|||
124695879|NCT00800384|448505990|FG001|Overall Study|Lost to Follow-up|26|||
124695880|NCT01027754|448507312|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
124695881|NCT01027754|448507313|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
124695882|NCT01027754|448507312|FG000|Overall Study|Withdrawal by Subject|0|||
124695883|NCT01027754|448507313|FG001|Overall Study|Withdrawal by Subject|5|||
124695884|NCT00326495|448507314|FG000|Overall Study|Switched to alternative treatment|1|||
124695885|NCT00326495|448507314|FG000|Overall Study|Disease progression before treatment|1|||
124695886|NCT00326495|448507314|FG000|Overall Study|Refused further treatment|2|||
124695887|NCT00326495|448507314|FG000|Overall Study|Subject off study before assessment|1|||
124695888|NCT00432991|448507315|FG000|Overall Study|Protocol Violation|7|||
124695889|NCT00432991|448507316|FG001|Overall Study|Protocol Violation|12|||
124695890|NCT01755156|448507326|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
124695891|NCT01755156|448507327|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
124695892|NCT01755156|448507326|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
124695893|NCT01755156|448507327|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
124695894|NCT01755156|448507326|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
124695895|NCT01755156|448507327|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
124695896|NCT01755156|448507326|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
124695897|NCT01755156|448507327|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
124695898|NCT01755156|448507326|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
124695899|NCT01755156|448507327|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
124695900|NCT01755156|448507326|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
124695901|NCT01755156|448507327|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
124695902|NCT01755156|448507326|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
124695903|NCT01755156|448507327|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
124695904|NCT01755156|448507326|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
124695905|NCT01755156|448507327|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
124695906|NCT01755156|448507326|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
124695907|NCT01755156|448507327|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
124695908|NCT01755156|448507326|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
124695909|NCT01755156|448507327|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
124695910|NCT01755156|448507326|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
124695911|NCT01755156|448507327|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
124695912|NCT03142451|448507328|FG000|Overall Study|Adverse Event|5|||
124695913|NCT03142451|448507329|FG001|Overall Study|Adverse Event|2|||
124695914|NCT03142451|448507328|FG000|Overall Study|Lost to Follow-up|25|||
124695915|NCT03142451|448507329|FG001|Overall Study|Lost to Follow-up|8|||
124695916|NCT03142451|448507328|FG000|Overall Study|Participant request|24|||
124695917|NCT03142451|448507329|FG001|Overall Study|Participant request|12|||
124695918|NCT03142451|448507328|FG000|Overall Study|Protocol Violation|3|||
124695919|NCT03142451|448507329|FG001|Overall Study|Protocol Violation|1|||
124695920|NCT03142451|448507328|FG000|Overall Study|Other|1|||
124695921|NCT03142451|448507329|FG001|Overall Study|Other|1|||
124695922|NCT03048019|448507333|FG000|Overall Study|Adverse Event|1|||
124695923|NCT03048019|448507334|FG001|Overall Study|Adverse Event|0|||
124695924|NCT01716559|448507342|FG000|Overall Study|Adverse Event|11|||
124695925|NCT01716559|448507342|FG000|Overall Study|Death|21|||
124695926|NCT01716559|448507342|FG000|Overall Study|Withdrawal by Subject|4|||
124695927|NCT01716559|448507342|FG000|Overall Study|Other withdrawal reason|75|||
124695928|NCT00662038|448507346|FG000|Overall Study|Reason not specified|3|||
124695929|NCT00662038|448507346|FG000|Overall Study|Withdrawn consent|22|||
124695930|NCT00662038|448507346|FG000|Overall Study|Withdrawal by Subject|83|||
124695931|NCT00662038|448507346|FG000|Overall Study|Sponsor decision|1|||
124695932|NCT00662038|448507346|FG000|Overall Study|Physician Decision|19|||
124695933|NCT00662038|448507346|FG000|Overall Study|Lung transplantation|44|||
124695934|NCT00662038|448507346|FG000|Overall Study|Lost to Follow-up|1|||
124695935|NCT00662038|448507346|FG000|Overall Study|Death|95|||
124695936|NCT00662038|448507346|FG000|Overall Study|Adverse Event|358|||
124695937|NCT00662038|448507346|FG000|Overall Study|Continued treatment|5|||
124695938|NCT00397046|448507351|FG000|Overall Study|Disease Progression|3|||
124695939|NCT00397046|448507352|FG001|Overall Study|Disease Progression|3|||
124695940|NCT00397046|448507353|FG002|Overall Study|Disease Progression|10|||
124695941|NCT00397046|448507354|FG003|Overall Study|Disease Progression|5|||
124695942|NCT04189588|448507356|FG000|Overall Study|Death|0|||
124695943|NCT04189588|448507357|FG001|Overall Study|Death|1|||
124695944|NCT04189588|448507356|FG000|Overall Study|Lost to Follow-up|0|||
124695945|NCT04189588|448507357|FG001|Overall Study|Lost to Follow-up|1|||
124695946|NCT01655069|448507358|FG000|Overall Study|Physician Decision|0|||
124695947|NCT01655069|448507359|FG001|Overall Study|Physician Decision|0|||
124695948|NCT01655069|448507360|FG002|Overall Study|Physician Decision|0|||
124695949|NCT01655069|448507361|FG003|Overall Study|Physician Decision|1|||
124695950|NCT01655069|448507358|FG000|Overall Study|Adverse Event|6|||
124695951|NCT01655069|448507359|FG001|Overall Study|Adverse Event|7|||
124695952|NCT01655069|448507360|FG002|Overall Study|Adverse Event|2|||
124695953|NCT01655069|448507361|FG003|Overall Study|Adverse Event|3|||
124695954|NCT01655069|448507358|FG000|Overall Study|Lack of Efficacy|0|||
124695955|NCT01655069|448507359|FG001|Overall Study|Lack of Efficacy|1|||
124695956|NCT01655069|448507360|FG002|Overall Study|Lack of Efficacy|0|||
124695957|NCT01655069|448507361|FG003|Overall Study|Lack of Efficacy|0|||
124695958|NCT01655069|448507358|FG000|Overall Study|No Treatment Needed|0|||
124695959|NCT01655069|448507359|FG001|Overall Study|No Treatment Needed|1|||
124695960|NCT01655069|448507360|FG002|Overall Study|No Treatment Needed|0|||
124695961|NCT01655069|448507361|FG003|Overall Study|No Treatment Needed|0|||
124695962|NCT01655069|448507358|FG000|Overall Study|Withdrawal by Subject|2|||
124695963|NCT01655069|448507359|FG001|Overall Study|Withdrawal by Subject|3|||
124695964|NCT01655069|448507360|FG002|Overall Study|Withdrawal by Subject|0|||
124695965|NCT01655069|448507361|FG003|Overall Study|Withdrawal by Subject|0|||
124695966|NCT04034056|448507362|FG000|Overall Study|Withdrawal by Subject|2|||
124695967|NCT04034056|448507362|FG000|Overall Study|Reason Not Specified|13|||
124695968|NCT04034056|448507362|FG000|Overall Study|Adverse Event|56|||
124695969|NCT03225989|448507363|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
124695970|NCT03225989|448507364|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
124695971|NCT03225989|448507365|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
124695972|NCT03225989|448507363|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
124695973|NCT03225989|448507364|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
124695974|NCT03225989|448507365|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
124695975|NCT03225989|448507363|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
124452473|NCT01994382|447618649|FG007|Overall Study|Lost to Follow-up|0|||
124452474|NCT01994382|447618650|FG008|Overall Study|Lost to Follow-up|0|||
124452475|NCT01994382|447618651|FG009|Overall Study|Lost to Follow-up|0|||
124452476|NCT01994382|447618652|FG010|Overall Study|Lost to Follow-up|1|||
124452477|NCT01994382|447618653|FG011|Overall Study|Lost to Follow-up|0|||
124452478|NCT01994382|447618654|FG012|Overall Study|Lost to Follow-up|0|||
124452479|NCT01994382|447618655|FG013|Overall Study|Lost to Follow-up|0|||
124452480|NCT01994382|447618656|FG014|Overall Study|Lost to Follow-up|0|||
124452481|NCT01994382|447618657|FG015|Overall Study|Lost to Follow-up|0|||
124452482|NCT01994382|447618658|FG016|Overall Study|Lost to Follow-up|0|||
124452483|NCT01994382|447618642|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
124452484|NCT01994382|447618643|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
124452485|NCT01994382|447618644|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
124452486|NCT01994382|447618645|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
124452487|NCT01994382|447618646|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
124452488|NCT01994382|447618647|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
124452489|NCT01994382|447618648|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
124452490|NCT01994382|447618649|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
124452491|NCT01994382|447618650|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
124452492|NCT01994382|447618651|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
124452493|NCT01994382|447618652|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
124452494|NCT01994382|447618653|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
124452495|NCT01994382|447618654|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
124452496|NCT01994382|447618655|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
124452497|NCT01994382|447618656|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
124452498|NCT01994382|447618657|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
124452499|NCT01994382|447618658|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
124452500|NCT01994382|447618642|FG000|Overall Study|Protocol violation/noncompliance|0|||
124452501|NCT01994382|447618643|FG001|Overall Study|Protocol violation/noncompliance|0|||
124452502|NCT01994382|447618644|FG002|Overall Study|Protocol violation/noncompliance|0|||
124452503|NCT01994382|447618645|FG003|Overall Study|Protocol violation/noncompliance|0|||
124452504|NCT01994382|447618646|FG004|Overall Study|Protocol violation/noncompliance|0|||
124452505|NCT01994382|447618647|FG005|Overall Study|Protocol violation/noncompliance|0|||
124452506|NCT01994382|447618648|FG006|Overall Study|Protocol violation/noncompliance|0|||
124452507|NCT01994382|447618649|FG007|Overall Study|Protocol violation/noncompliance|0|||
124452508|NCT01994382|447618650|FG008|Overall Study|Protocol violation/noncompliance|0|||
124452509|NCT01994382|447618651|FG009|Overall Study|Protocol violation/noncompliance|0|||
124452510|NCT01994382|447618652|FG010|Overall Study|Protocol violation/noncompliance|0|||
124452511|NCT01994382|447618653|FG011|Overall Study|Protocol violation/noncompliance|1|||
124452512|NCT01994382|447618654|FG012|Overall Study|Protocol violation/noncompliance|0|||
124452513|NCT01994382|447618655|FG013|Overall Study|Protocol violation/noncompliance|0|||
124452514|NCT01994382|447618656|FG014|Overall Study|Protocol violation/noncompliance|0|||
124452515|NCT01994382|447618657|FG015|Overall Study|Protocol violation/noncompliance|0|||
124452516|NCT01994382|447618658|FG016|Overall Study|Protocol violation/noncompliance|2|||
124452517|NCT01994382|447618642|FG000|Overall Study|Rolled over to Phase 2a|0|||
124452518|NCT01994382|447618643|FG001|Overall Study|Rolled over to Phase 2a|0|||
124452519|NCT01994382|447618644|FG002|Overall Study|Rolled over to Phase 2a|1|||
124452520|NCT01994382|447618645|FG003|Overall Study|Rolled over to Phase 2a|0|||
124452521|NCT01994382|447618646|FG004|Overall Study|Rolled over to Phase 2a|0|||
124452522|NCT01994382|447618647|FG005|Overall Study|Rolled over to Phase 2a|0|||
124452523|NCT01994382|447618648|FG006|Overall Study|Rolled over to Phase 2a|0|||
124452524|NCT01994382|447618649|FG007|Overall Study|Rolled over to Phase 2a|0|||
124452525|NCT01994382|447618650|FG008|Overall Study|Rolled over to Phase 2a|0|||
124452526|NCT01994382|447618651|FG009|Overall Study|Rolled over to Phase 2a|2|||
124452527|NCT01994382|447618652|FG010|Overall Study|Rolled over to Phase 2a|0|||
124452528|NCT01994382|447618653|FG011|Overall Study|Rolled over to Phase 2a|0|||
124452529|NCT01994382|447618654|FG012|Overall Study|Rolled over to Phase 2a|0|||
124452530|NCT01994382|447618655|FG013|Overall Study|Rolled over to Phase 2a|0|||
124452531|NCT01994382|447618656|FG014|Overall Study|Rolled over to Phase 2a|0|||
124452532|NCT01994382|447618657|FG015|Overall Study|Rolled over to Phase 2a|0|||
124452533|NCT01994382|447618658|FG016|Overall Study|Rolled over to Phase 2a|0|||
124452534|NCT01368536|447618661|FG000|Overall Study|Adverse Event|5|||
124452535|NCT01368536|447618662|FG001|Overall Study|Adverse Event|6|||
124452536|NCT01368536|447618663|FG002|Overall Study|Adverse Event|8|||
124452537|NCT01368536|447618661|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124452538|NCT01368536|447618662|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124695976|NCT03225989|448507364|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
124452539|NCT01368536|447618663|FG002|Overall Study|Abnormal laboratory value(s)|2|||
124922184|NCT05478499|449343824|FG001|Overall Study|Lack of Efficacy|0|||
124922185|NCT05478499|449343823|FG000|Overall Study|Lost to Follow-up|1|||
124922186|NCT05478499|449343824|FG001|Overall Study|Lost to Follow-up|0|||
124922187|NCT05478499|449343823|FG000|Overall Study|Other reasons|0|||
124922188|NCT05478499|449343824|FG001|Overall Study|Other reasons|1|||
124922189|NCT02962895|449343825|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
124452540|NCT01368536|447618661|FG000|Overall Study|Abnormal test procedure result(s)|0|||
124452541|NCT01368536|447618662|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124452542|NCT01368536|447618663|FG002|Overall Study|Abnormal test procedure result(s)|1|||
124922190|NCT02962895|449343826|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
124922191|NCT02962895|449343827|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
124922192|NCT02962895|449343828|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
124922193|NCT02962895|449343829|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
124922194|NCT02962895|449343830|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
124922195|NCT02962895|449343831|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
124922196|NCT02962895|449343825|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
124922197|NCT02962895|449343826|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
124922198|NCT02962895|449343827|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
124922199|NCT02962895|449343828|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
124922200|NCT02962895|449343829|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
124922201|NCT02962895|449343830|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
124922202|NCT02962895|449343831|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
124922203|NCT02962895|449343825|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
124922204|NCT02962895|449343826|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
124922205|NCT02962895|449343827|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
124922206|NCT02962895|449343828|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
124452543|NCT01368536|447618661|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
124452544|NCT01368536|447618662|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124452545|NCT01368536|447618663|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
124452546|NCT01368536|447618661|FG000|Overall Study|No longer required study medication|0|||
124452547|NCT01368536|447618662|FG001|Overall Study|No longer required study medication|0|||
124452548|NCT01368536|447618663|FG002|Overall Study|No longer required study medication|1|||
124452549|NCT01368536|447618661|FG000|Overall Study|Withdrawal by Subject|2|||
124452550|NCT01368536|447618662|FG001|Overall Study|Withdrawal by Subject|5|||
124452551|NCT01368536|447618663|FG002|Overall Study|Withdrawal by Subject|4|||
124452552|NCT01368536|447618661|FG000|Overall Study|Lost to Follow-up|3|||
124452553|NCT01368536|447618662|FG001|Overall Study|Lost to Follow-up|3|||
124452554|NCT01368536|447618663|FG002|Overall Study|Lost to Follow-up|5|||
124452555|NCT01368536|447618661|FG000|Overall Study|Administrative problems|34|||
124452556|NCT01368536|447618662|FG001|Overall Study|Administrative problems|39|||
124452557|NCT01368536|447618663|FG002|Overall Study|Administrative problems|35|||
124452558|NCT01368536|447618661|FG000|Overall Study|Protocol deviation|0|||
124452559|NCT01368536|447618662|FG001|Overall Study|Protocol deviation|3|||
124452560|NCT01368536|447618663|FG002|Overall Study|Protocol deviation|1|||
124452561|NCT03861936|447618664|FG000|Overall Study|Withdrawal by Subject|4|||
124452562|NCT03861936|447618665|FG001|Overall Study|Withdrawal by Subject|1|||
124452563|NCT03861936|447618666|FG002|Overall Study|Withdrawal by Subject|3|||
124452564|NCT03861936|447618664|FG000|Overall Study|Lost to Follow-up|5|||
124452565|NCT03861936|447618665|FG001|Overall Study|Lost to Follow-up|3|||
124452566|NCT03861936|447618666|FG002|Overall Study|Lost to Follow-up|3|||
124452567|NCT03861936|447618664|FG000|Overall Study|Physician Decision|0|||
124452568|NCT03861936|447618665|FG001|Overall Study|Physician Decision|1|||
124452569|NCT03861936|447618666|FG002|Overall Study|Physician Decision|0|||
124452570|NCT03861936|447618664|FG000|Overall Study|Protocol Deviation|0|||
124452571|NCT03861936|447618665|FG001|Overall Study|Protocol Deviation|0|||
124452572|NCT03861936|447618666|FG002|Overall Study|Protocol Deviation|1|||
124452573|NCT03861936|447618664|FG000|Overall Study|Reason not Specified|5|||
124452574|NCT03861936|447618665|FG001|Overall Study|Reason not Specified|5|||
124452575|NCT03861936|447618666|FG002|Overall Study|Reason not Specified|3|||
124695977|NCT03225989|448507365|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
124695978|NCT03225989|448507363|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
124695979|NCT03225989|448507364|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
124695980|NCT03225989|448507365|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
124695981|NCT03225989|448507363|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
124452576|NCT00359021|447618667|FG000|Overall Study|Adverse Event|26|||
124452577|NCT00359021|447618668|FG001|Overall Study|Adverse Event|8|||
124452578|NCT00359021|447618667|FG000|Overall Study|Subject Non-Compliant|1|||
124452579|NCT00359021|447618668|FG001|Overall Study|Subject Non-Compliant|2|||
124452580|NCT00359021|447618667|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
124452581|NCT00359021|447618668|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
124452582|NCT00359021|447618667|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
124452583|NCT00359021|447618668|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
124452584|NCT00359021|447618667|FG000|Overall Study|Withdrawal by Subject|2|||
124452585|NCT00359021|447618668|FG001|Overall Study|Withdrawal by Subject|9|||
124452586|NCT00359021|447618667|FG000|Overall Study|Lost to Follow-up|1|||
124452587|NCT00359021|447618668|FG001|Overall Study|Lost to Follow-up|0|||
124452588|NCT00359021|447618667|FG000|Overall Study|Other|4|||
124452589|NCT00359021|447618668|FG001|Overall Study|Other|1|||
124452590|NCT00359021|447618667|FG000|Overall Study|Pregnancy|1|||
124695982|NCT03225989|448507364|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
124695983|NCT03225989|448507365|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
124695984|NCT03225989|448507363|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
124695985|NCT03225989|448507364|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
124695986|NCT03225989|448507365|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
124695987|NCT03225989|448507363|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
124695988|NCT03225989|448507364|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
124695989|NCT03225989|448507365|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
124695990|NCT03225989|448507363|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
124695991|NCT03225989|448507364|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
124695992|NCT03225989|448507365|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
124695993|NCT03225989|448507363|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
124695994|NCT03225989|448507364|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
124695995|NCT03225989|448507365|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
124695996|NCT03225989|448507363|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
124695997|NCT03225989|448507364|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
124695998|NCT03225989|448507365|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
124695999|NCT03225989|448507363|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
124696000|NCT03225989|448507364|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
124696001|NCT03225989|448507365|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
124696002|NCT03225989|448507363|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
124696003|NCT03225989|448507364|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
124696004|NCT03225989|448507365|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
124696005|NCT00601107|448507366|FG000|Overall Study|Adverse Event|0|||
124696006|NCT00601107|448507367|FG001|Overall Study|Adverse Event|1|||
124696007|NCT00601107|448507368|FG002|Overall Study|Adverse Event|3|||
124696008|NCT00601107|448507369|FG003|Overall Study|Adverse Event|0|||
124696009|NCT00601107|448507366|FG000|Overall Study|Withdrawal by Subject|5|||
124696010|NCT00601107|448507367|FG001|Overall Study|Withdrawal by Subject|4|||
124696011|NCT00601107|448507368|FG002|Overall Study|Withdrawal by Subject|7|||
124696012|NCT00601107|448507369|FG003|Overall Study|Withdrawal by Subject|4|||
124696013|NCT00601107|448507366|FG000|Overall Study|Lost to Follow-up|3|||
124696014|NCT00601107|448507367|FG001|Overall Study|Lost to Follow-up|3|||
124696015|NCT00601107|448507368|FG002|Overall Study|Lost to Follow-up|0|||
124696016|NCT00601107|448507369|FG003|Overall Study|Lost to Follow-up|3|||
124696017|NCT00601107|448507366|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
124696018|NCT00601107|448507367|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
124696019|NCT00601107|448507368|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
124696020|NCT00601107|448507369|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
124696021|NCT00601107|448507366|FG000|Overall Study|Worsening of Psoriasis|4|||
124696022|NCT00601107|448507367|FG001|Overall Study|Worsening of Psoriasis|1|||
124696023|NCT00601107|448507368|FG002|Overall Study|Worsening of Psoriasis|1|||
124696024|NCT00601107|448507369|FG003|Overall Study|Worsening of Psoriasis|4|||
124696025|NCT00601107|448507366|FG000|Overall Study|Undefined|1|||
124696026|NCT00601107|448507367|FG001|Overall Study|Undefined|0|||
124696027|NCT00601107|448507368|FG002|Overall Study|Undefined|1|||
124696028|NCT00601107|448507369|FG003|Overall Study|Undefined|0|||
124696029|NCT03722030|448507371|FG000|Overall Study|Withdrawal by Subject|1|||
124696030|NCT03722030|448507372|FG001|Overall Study|Withdrawal by Subject|0|||
124696031|NCT00147537|448507373|FG000|Phase 1b|Death|0|||
124696032|NCT00147537|448507374|FG001|Phase 1b|Death|1|||
124696033|NCT00147537|448507375|FG002|Phase 1b|Death|2|||
124696034|NCT00147537|448507376|FG003|Phase 1b|Death|1|||
124696035|NCT00147537|448507377|FG004|Phase 1b|Death|2|||
124696036|NCT00147537|448507378|FG005|Phase 1b|Death|2|||
124696037|NCT00147537|448507379|FG006|Phase 1b|Death|1|||
124696038|NCT00147537|448507380|FG007|Phase 1b|Death|3|||
124696039|NCT00147537|448507381|FG008|Phase 1b|Death|9|||
124696040|NCT00147537|448507382|FG009|Phase 1b|Death|0|||
124696041|NCT00147537|448507383|FG010|Phase 1b|Death|0|||
124696042|NCT00147537|448507373|FG000|Phase 1b|Lost to Follow-up|2|||
124696043|NCT00147537|448507374|FG001|Phase 1b|Lost to Follow-up|1|||
124452591|NCT00359021|447618668|FG001|Overall Study|Pregnancy|0|||
124452592|NCT02234284|447618672|FG000|Overall Study|Death|4|||
124452593|NCT02234284|447618673|FG001|Overall Study|Death|2|||
124696044|NCT00147537|448507375|FG002|Phase 1b|Lost to Follow-up|0|||
124545618|NCT00726882|447952757|FG000|Overall Study|Other|10|||
124545619|NCT00347776|447952758|FG000|1.5 Month Follow-up|Death|2|||
124545620|NCT00347776|447952759|FG001|1.5 Month Follow-up|Death|0|||
124545621|NCT00347776|447952760|FG002|1.5 Month Follow-up|Death|0|||
124545622|NCT00347776|447952758|FG000|1.5 Month Follow-up|reached the endpoint|12|||
124545623|NCT00347776|447952759|FG001|1.5 Month Follow-up|reached the endpoint|8|||
124545624|NCT00347776|447952760|FG002|1.5 Month Follow-up|reached the endpoint|12|||
124545625|NCT00347776|447952758|FG000|6 Month Follow-up|Death|2|||
124545626|NCT00347776|447952759|FG001|6 Month Follow-up|Death|1|||
124545627|NCT00347776|447952760|FG002|6 Month Follow-up|Death|3|||
124545628|NCT00347776|447952758|FG000|6 Month Follow-up|reached endpont|20|||
124545629|NCT00347776|447952759|FG001|6 Month Follow-up|reached endpont|12|||
124545630|NCT00347776|447952760|FG002|6 Month Follow-up|reached endpont|15|||
124545631|NCT00347776|447952758|FG000|12 Month Follow-up|Lost to Follow-up|7|||
124696045|NCT00147537|448507376|FG003|Phase 1b|Lost to Follow-up|0|||
124696046|NCT00147537|448507377|FG004|Phase 1b|Lost to Follow-up|0|||
124922207|NCT02962895|449343829|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
124922208|NCT02962895|449343830|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
124922209|NCT02962895|449343831|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
124922210|NCT02962895|449343825|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
124922211|NCT02962895|449343826|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
124922212|NCT02962895|449343827|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
124922213|NCT02962895|449343828|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
124922214|NCT02962895|449343829|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
124922215|NCT02962895|449343830|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
124922216|NCT02962895|449343831|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
124922217|NCT02962895|449343825|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
124922218|NCT02962895|449343826|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
124922219|NCT02962895|449343827|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
124922220|NCT02962895|449343828|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
124922221|NCT02962895|449343829|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
124922222|NCT02962895|449343830|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
124922223|NCT02962895|449343831|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
124922224|NCT02962895|449343825|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
124922225|NCT02962895|449343826|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
124922226|NCT02962895|449343827|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
124922227|NCT02962895|449343828|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
124922228|NCT02962895|449343829|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
124922229|NCT02962895|449343830|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
124922230|NCT02962895|449343831|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
124922231|NCT02962895|449343825|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
124922232|NCT02962895|449343826|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
124922233|NCT02962895|449343827|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
124922234|NCT02962895|449343828|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
124922235|NCT02962895|449343829|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
124922236|NCT02962895|449343830|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
124922237|NCT02962895|449343831|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
124922238|NCT02962895|449343825|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
124545632|NCT00347776|447952759|FG001|12 Month Follow-up|Lost to Follow-up|6|||
124545633|NCT00347776|447952760|FG002|12 Month Follow-up|Lost to Follow-up|6|||
124696047|NCT00147537|448507378|FG005|Phase 1b|Lost to Follow-up|0|||
124696048|NCT00147537|448507379|FG006|Phase 1b|Lost to Follow-up|2|||
124545634|NCT00347776|447952758|FG000|12 Month Follow-up|Death|3|||
124696049|NCT00147537|448507380|FG007|Phase 1b|Lost to Follow-up|0|||
124696050|NCT00147537|448507381|FG008|Phase 1b|Lost to Follow-up|1|||
124696051|NCT00147537|448507382|FG009|Phase 1b|Lost to Follow-up|0|||
124696052|NCT00147537|448507383|FG010|Phase 1b|Lost to Follow-up|0|||
124696053|NCT00147537|448507373|FG000|Phase 1b|Other|0|||
124696054|NCT00147537|448507374|FG001|Phase 1b|Other|0|||
124696055|NCT00147537|448507375|FG002|Phase 1b|Other|2|||
124545635|NCT00347776|447952759|FG001|12 Month Follow-up|Death|4|||
124545636|NCT00347776|447952760|FG002|12 Month Follow-up|Death|4|||
124545637|NCT00347776|447952758|FG000|12 Month Follow-up|Reached endpoint|13|||
124545638|NCT00347776|447952759|FG001|12 Month Follow-up|Reached endpoint|6|||
124545639|NCT00347776|447952760|FG002|12 Month Follow-up|Reached endpoint|9|||
124696056|NCT00147537|448507376|FG003|Phase 1b|Other|1|||
124696057|NCT00147537|448507377|FG004|Phase 1b|Other|1|||
124696058|NCT00147537|448507378|FG005|Phase 1b|Other|1|||
124696059|NCT00147537|448507379|FG006|Phase 1b|Other|14|||
124696060|NCT00147537|448507380|FG007|Phase 1b|Other|4|||
124696061|NCT00147537|448507381|FG008|Phase 1b|Other|4|||
124922239|NCT02962895|449343826|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
124922240|NCT02962895|449343827|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
124922241|NCT02962895|449343828|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
124922242|NCT02962895|449343829|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
124922243|NCT02962895|449343830|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
124922244|NCT02962895|449343831|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
124922245|NCT02962895|449343825|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
124922246|NCT02962895|449343826|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
124922247|NCT02962895|449343827|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
124922248|NCT02962895|449343828|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
124922249|NCT02962895|449343829|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
124922250|NCT02962895|449343830|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
124922251|NCT02962895|449343831|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
124922252|NCT02962895|449343825|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
124922253|NCT02962895|449343826|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
124922254|NCT02962895|449343827|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
124922255|NCT02962895|449343828|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
124922256|NCT02962895|449343829|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
124922257|NCT02962895|449343830|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
124922258|NCT02962895|449343831|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
124922259|NCT02962895|449343825|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
124922260|NCT02962895|449343826|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
124922261|NCT02962895|449343827|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
124922262|NCT02962895|449343828|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
124922263|NCT02962895|449343829|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
124922264|NCT02962895|449343830|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
124922265|NCT02962895|449343831|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
124922266|NCT02962895|449343825|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
124922267|NCT02962895|449343826|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
124922268|NCT02962895|449343827|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
124922269|NCT02962895|449343828|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
124922270|NCT02962895|449343829|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
124922271|NCT02962895|449343830|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
124922272|NCT02962895|449343831|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
124452594|NCT02234284|447618672|FG000|Overall Study|Withdrawal by Subject|1|||
124452595|NCT02234284|447618673|FG001|Overall Study|Withdrawal by Subject|0|||
124922273|NCT02962895|449343825|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
124922274|NCT02962895|449343826|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
124922275|NCT02962895|449343827|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
124452596|NCT02234284|447618672|FG000|Overall Study|Lost to Follow-up|20|||
124452597|NCT02234284|447618673|FG001|Overall Study|Lost to Follow-up|7|||
124452598|NCT01835015|447618674|FG000|Overall Study|Adverse Event|0|||
124452599|NCT01835015|447618675|FG001|Overall Study|Adverse Event|0|||
124452600|NCT01835015|447618676|FG002|Overall Study|Adverse Event|1|||
124452601|NCT01835015|447618677|FG003|Overall Study|Adverse Event|0|||
124452602|NCT01835015|447618678|FG004|Overall Study|Adverse Event|0|||
124452603|NCT04569032|447618679|FG000|Overall Study|Death|10|||
124452604|NCT04569032|447618680|FG001|Overall Study|Death|13|||
124452605|NCT04569032|447618679|FG000|Overall Study|Withdrawal by Subject|2|||
124452606|NCT04569032|447618680|FG001|Overall Study|Withdrawal by Subject|0|||
124452607|NCT04569032|447618679|FG000|Overall Study|Lost to Follow-up|0|||
124452608|NCT04569032|447618680|FG001|Overall Study|Lost to Follow-up|1|||
124452609|NCT04569032|447618679|FG000|Overall Study|In long term follow up|22|||
124452610|NCT04569032|447618680|FG001|Overall Study|In long term follow up|34|||
124452611|NCT00701090|447618682|FG000|Overall Study|Adverse Event|11|||
124452612|NCT00701090|447618683|FG001|Overall Study|Adverse Event|2|||
124452613|NCT00701090|447618682|FG000|Overall Study|Death|0|||
124452614|NCT00701090|447618683|FG001|Overall Study|Death|1|||
124452615|NCT00701090|447618682|FG000|Overall Study|Lack of Efficacy|5|||
124452616|NCT00701090|447618683|FG001|Overall Study|Lack of Efficacy|4|||
124452617|NCT00701090|447618682|FG000|Overall Study|Lost to Follow-up|9|||
124452618|NCT00701090|447618683|FG001|Overall Study|Lost to Follow-up|9|||
124452619|NCT00701090|447618682|FG000|Overall Study|Physician Decision|3|||
124452620|NCT00701090|447618683|FG001|Overall Study|Physician Decision|4|||
124452621|NCT00701090|447618682|FG000|Overall Study|Protocol Violation|2|||
124452622|NCT00701090|447618683|FG001|Overall Study|Protocol Violation|3|||
124922276|NCT02962895|449343828|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
124922277|NCT02962895|449343829|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
124452623|NCT00701090|447618682|FG000|Overall Study|Withdrawal by Subject|11|||
124696062|NCT00147537|448507382|FG009|Phase 1b|Other|0|||
124452624|NCT00701090|447618683|FG001|Overall Study|Withdrawal by Subject|16|||
124452625|NCT00701090|447618682|FG000|Overall Study|Other|7|||
124545640|NCT00594568|447952761|FG000|Initial Treatment|Adverse Event|51|||
124545641|NCT00594568|447952762|FG001|Initial Treatment|Adverse Event|121|||
124545642|NCT00594568|447952763|FG002|Initial Treatment|Adverse Event|144|||
124545643|NCT00594568|447952761|FG000|Initial Treatment|Death|6|||
124545644|NCT00594568|447952762|FG001|Initial Treatment|Death|11|||
124545645|NCT00594568|447952763|FG002|Initial Treatment|Death|15|||
124545646|NCT00594568|447952761|FG000|Initial Treatment|Lost to Follow-up|4|||
124545647|NCT00594568|447952762|FG001|Initial Treatment|Lost to Follow-up|1|||
124545648|NCT00594568|447952763|FG002|Initial Treatment|Lost to Follow-up|4|||
124545649|NCT00594568|447952761|FG000|Initial Treatment|Physician Decision|3|||
124545650|NCT00594568|447952762|FG001|Initial Treatment|Physician Decision|2|||
124545651|NCT00594568|447952763|FG002|Initial Treatment|Physician Decision|4|||
124545652|NCT00594568|447952761|FG000|Initial Treatment|Protocol Violation|2|||
124545653|NCT00594568|447952762|FG001|Initial Treatment|Protocol Violation|2|||
124545654|NCT00594568|447952763|FG002|Initial Treatment|Protocol Violation|5|||
124545655|NCT00594568|447952761|FG000|Initial Treatment|Withdrawal by Subject|25|||
124545656|NCT00594568|447952762|FG001|Initial Treatment|Withdrawal by Subject|31|||
124545657|NCT00594568|447952763|FG002|Initial Treatment|Withdrawal by Subject|46|||
124545658|NCT00594568|447952761|FG000|Initial Treatment|Sponsor decision|193|||
124545659|NCT00594568|447952762|FG001|Initial Treatment|Sponsor decision|142|||
124545660|NCT00594568|447952763|FG002|Initial Treatment|Sponsor decision|147|||
124545661|NCT00594568|447952761|FG000|Initial Treatment|Caregiver decision|21|||
124545662|NCT00594568|447952762|FG001|Initial Treatment|Caregiver decision|36|||
124545663|NCT00594568|447952763|FG002|Initial Treatment|Caregiver decision|36|||
124545664|NCT00594568|447952761|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
124696063|NCT00147537|448507383|FG010|Phase 1b|Other|0|||
124696064|NCT00147537|448507373|FG000|Phase 1b|Withdrawal by Subject|0|||
124922278|NCT02962895|449343830|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
124922279|NCT02962895|449343831|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
124922280|NCT02962895|449343825|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
124922281|NCT02962895|449343826|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
124922282|NCT02962895|449343827|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
124922283|NCT02962895|449343828|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
124922284|NCT02962895|449343829|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
124922285|NCT02962895|449343830|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
124922286|NCT02962895|449343831|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
124545665|NCT00594568|447952762|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
124545666|NCT00594568|447952763|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
124545667|NCT00594568|447952761|FG000|Initial Treatment|Entry criteria exclusion|0|||
124545668|NCT00594568|447952762|FG001|Initial Treatment|Entry criteria exclusion|1|||
124696065|NCT00147537|448507374|FG001|Phase 1b|Withdrawal by Subject|0|||
124696066|NCT00147537|448507375|FG002|Phase 1b|Withdrawal by Subject|0|||
124452626|NCT00701090|447618683|FG001|Overall Study|Other|12|||
124452627|NCT00131469|447618686|FG000|Overall Study|Withdrawal by Subject|3|||
124452628|NCT00131469|447618687|FG001|Overall Study|Withdrawal by Subject|4|||
124452629|NCT00131469|447618686|FG000|Overall Study|Protocol Violation|3|||
124452630|NCT00131469|447618687|FG001|Overall Study|Protocol Violation|1|||
124452631|NCT00131469|447618686|FG000|Overall Study|Death|0|||
124452632|NCT00131469|447618687|FG001|Overall Study|Death|1|||
124452633|NCT00131469|447618686|FG000|Overall Study|Lost to Follow-up|0|||
124452634|NCT00131469|447618687|FG001|Overall Study|Lost to Follow-up|1|||
124452635|NCT00131469|447618686|FG000|Overall Study|scan not analyzable|3|||
124762350|NCT02836652|448755863|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
124762351|NCT00473434|448755864|FG000|Overall Study|Physician Decision|3|||
124762352|NCT00473434|448755864|FG000|Overall Study|Withdrawal by Subject|9|||
124762353|NCT00473434|448755864|FG000|Overall Study|Compliance|3|||
124762354|NCT00473434|448755864|FG000|Overall Study|Lack of Efficacy|3|||
124762355|NCT00473434|448755864|FG000|Overall Study|Adverse Event|3|||
124762356|NCT00473434|448755864|FG000|Overall Study|Patient was selling medication to others|1|||
124762357|NCT00473434|448755864|FG000|Overall Study|Safety evaluation|1|||
124762358|NCT00473434|448755864|FG000|Overall Study|Reason not specified|6|||
124762359|NCT00473434|448755864|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
124762360|NCT00473434|448755864|FG000|Overall Study|Switching to trial medication|1|||
124762361|NCT00473434|448755864|FG000|Overall Study|No longer required|1|||
124762362|NCT02349633|448755865|FG000|Overall Study|Death|0|||
124762363|NCT02349633|448755866|FG001|Overall Study|Death|1|||
124762364|NCT02349633|448755867|FG002|Overall Study|Death|0|||
124762365|NCT02349633|448755868|FG003|Overall Study|Death|0|||
124762366|NCT02349633|448755869|FG004|Overall Study|Death|0|||
124762367|NCT02349633|448755870|FG005|Overall Study|Death|1|||
124762368|NCT02349633|448755871|FG006|Overall Study|Death|1|||
124762369|NCT02349633|448755872|FG007|Overall Study|Death|1|||
124762370|NCT02349633|448755873|FG008|Overall Study|Death|0|||
124762371|NCT02349633|448755874|FG009|Overall Study|Death|1|||
124762372|NCT02349633|448755875|FG010|Overall Study|Death|0|||
124762373|NCT02349633|448755876|FG011|Overall Study|Death|0|||
124762374|NCT02349633|448755877|FG012|Overall Study|Death|0|||
124762375|NCT02349633|448755878|FG013|Overall Study|Death|0|||
124762376|NCT02349633|448755865|FG000|Overall Study|Withdrawal by Subject|0|||
124762377|NCT02349633|448755866|FG001|Overall Study|Withdrawal by Subject|0|||
124762378|NCT02349633|448755867|FG002|Overall Study|Withdrawal by Subject|0|||
124762379|NCT02349633|448755868|FG003|Overall Study|Withdrawal by Subject|1|||
124762380|NCT02349633|448755869|FG004|Overall Study|Withdrawal by Subject|0|||
124762381|NCT02349633|448755870|FG005|Overall Study|Withdrawal by Subject|0|||
124452636|NCT00131469|447618687|FG001|Overall Study|scan not analyzable|6|||
124762382|NCT02349633|448755871|FG006|Overall Study|Withdrawal by Subject|0|||
124762383|NCT02349633|448755872|FG007|Overall Study|Withdrawal by Subject|2|||
124762384|NCT02349633|448755873|FG008|Overall Study|Withdrawal by Subject|2|||
124762385|NCT02349633|448755874|FG009|Overall Study|Withdrawal by Subject|1|||
124762386|NCT02349633|448755875|FG010|Overall Study|Withdrawal by Subject|0|||
124762387|NCT02349633|448755876|FG011|Overall Study|Withdrawal by Subject|0|||
124769820|NCT01502293|448785204|FG000|Overall Study|Physician Decision|0|||
124696067|NCT00147537|448507376|FG003|Phase 1b|Withdrawal by Subject|0|||
124696068|NCT00147537|448507377|FG004|Phase 1b|Withdrawal by Subject|0|||
124696069|NCT00147537|448507378|FG005|Phase 1b|Withdrawal by Subject|0|||
124696070|NCT00147537|448507379|FG006|Phase 1b|Withdrawal by Subject|0|||
124922287|NCT05894577|449343832|FG000|Overall Study|No receipt of study drug|14|||
124922288|NCT05894577|449343833|FG001|Overall Study|No receipt of study drug|13|||
124922289|NCT05894577|449343832|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
124922290|NCT05894577|449343833|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
124922291|NCT05894577|449343832|FG000|Overall Study|Screen Fail|2|||
124922292|NCT05894577|449343833|FG001|Overall Study|Screen Fail|0|||
124922293|NCT05894577|449343832|FG000|Overall Study|Study drug recall|86|||
124922294|NCT05894577|449343833|FG001|Overall Study|Study drug recall|63|||
124922295|NCT05481320|449343834|FG000|Overall Study|Withdrawal by Subject|1|||
124922296|NCT05481320|449343835|FG001|Overall Study|Withdrawal by Subject|1|||
124922297|NCT05481320|449343834|FG000|Overall Study|Care recipent passed away|0|||
124922298|NCT05481320|449343835|FG001|Overall Study|Care recipent passed away|1|||
124922299|NCT05481320|449343834|FG000|Overall Study|Out-of-window assessment|0|||
124922300|NCT05481320|449343835|FG001|Overall Study|Out-of-window assessment|1|||
124922301|NCT05481320|449343834|FG000|Overall Study|No longer a primary caregiver|3|||
124922302|NCT05481320|449343835|FG001|Overall Study|No longer a primary caregiver|0|||
124922303|NCT05481320|449343834|FG000|Overall Study|Unable to contact|1|||
124922304|NCT05481320|449343835|FG001|Overall Study|Unable to contact|0|||
124922305|NCT04509674|449343837|FG000|Overall Study|Not treated|33|||
124922306|NCT04509674|449343838|FG001|Overall Study|Not treated|26|||
124922307|NCT04509674|449343837|FG000|Overall Study|Protocol Violation|9|||
124922308|NCT04509674|449343838|FG001|Overall Study|Protocol Violation|10|||
124922309|NCT04509674|449343837|FG000|Overall Study|Lost to Follow-up|31|||
124922310|NCT04509674|449343838|FG001|Overall Study|Lost to Follow-up|39|||
124922311|NCT04509674|449343837|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
124922312|NCT04509674|449343838|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
124922313|NCT04509674|449343837|FG000|Overall Study|Adverse event, serious fatal event|11|||
124922314|NCT04509674|449343838|FG001|Overall Study|Adverse event, serious fatal event|4|||
124922315|NCT04509674|449343837|FG000|Overall Study|Adverse event, non-fatal event|107|||
124922316|NCT04509674|449343838|FG001|Overall Study|Adverse event, non-fatal event|118|||
124922317|NCT04509674|449343837|FG000|Overall Study|Other reason than listed|106|||
124922318|NCT04509674|449343838|FG001|Overall Study|Other reason than listed|95|||
124922319|NCT03476460|449343843|FG000|Overall Study|Withdrawal by Subject|3|||
124922320|NCT03476460|449343844|FG001|Overall Study|Withdrawal by Subject|2|||
124922321|NCT03476460|449343843|FG000|Overall Study|Non-compliance with treatment|3|||
124922322|NCT03476460|449343844|FG001|Overall Study|Non-compliance with treatment|0|||
124922323|NCT03476460|449343843|FG000|Overall Study|Missing laboratory tests|5|||
124452637|NCT00574288|447618688|FG000|Overall Study|Adverse Event|2|||
124452638|NCT00574288|447618689|FG001|Overall Study|Adverse Event|0|||
124452639|NCT00574288|447618690|FG002|Overall Study|Adverse Event|0|||
124452640|NCT00574288|447618691|FG003|Overall Study|Adverse Event|0|||
124452641|NCT00574288|447618692|FG004|Overall Study|Adverse Event|1|||
124452642|NCT00574288|447618693|FG005|Overall Study|Adverse Event|0|||
124452643|NCT00574288|447618694|FG006|Overall Study|Adverse Event|0|||
124452644|NCT00574288|447618688|FG000|Overall Study|Death|0|||
124922324|NCT03476460|449343844|FG001|Overall Study|Missing laboratory tests|5|||
124922325|NCT03476460|449343843|FG000|Overall Study|Adverse Event|0|||
124696071|NCT00147537|448507380|FG007|Phase 1b|Withdrawal by Subject|0|||
124696072|NCT00147537|448507381|FG008|Phase 1b|Withdrawal by Subject|2|||
124696073|NCT00147537|448507382|FG009|Phase 1b|Withdrawal by Subject|0|||
124922326|NCT03476460|449343844|FG001|Overall Study|Adverse Event|1|||
124922327|NCT01606215|449343852|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
124922328|NCT01606215|449343853|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
124922329|NCT04592549|449343854|FG000|Overall Study|Withdrawal by Subject|0|||
124922330|NCT04592549|449343855|FG001|Overall Study|Withdrawal by Subject|1|||
124922331|NCT04592549|449343856|FG002|Overall Study|Withdrawal by Subject|0|||
124922332|NCT04592549|449343857|FG003|Overall Study|Withdrawal by Subject|1|||
124922333|NCT04592549|449343858|FG004|Overall Study|Withdrawal by Subject|1|||
124922334|NCT04592549|449343859|FG005|Overall Study|Withdrawal by Subject|0|||
124922335|NCT04592549|449343854|FG000|Overall Study|Lost to Follow-up|2|||
124452645|NCT00574288|447618689|FG001|Overall Study|Death|0|||
124922336|NCT04592549|449343855|FG001|Overall Study|Lost to Follow-up|0|||
124922337|NCT04592549|449343856|FG002|Overall Study|Lost to Follow-up|0|||
124922338|NCT04592549|449343857|FG003|Overall Study|Lost to Follow-up|1|||
124922339|NCT04592549|449343858|FG004|Overall Study|Lost to Follow-up|1|||
124922340|NCT04592549|449343859|FG005|Overall Study|Lost to Follow-up|1|||
124452646|NCT00574288|447618690|FG002|Overall Study|Death|0|||
124452647|NCT00574288|447618691|FG003|Overall Study|Death|0|||
124696074|NCT00147537|448507383|FG010|Phase 1b|Withdrawal by Subject|0|||
124696075|NCT00147537|448507373|FG000|Phase 1b|Randomized but not treated|0|||
124696076|NCT00147537|448507374|FG001|Phase 1b|Randomized but not treated|0|||
124922341|NCT05184192|449343860|FG000|Overall Study|Lost to Follow-up|4|||
124922342|NCT05184192|449343861|FG001|Overall Study|Lost to Follow-up|7|||
124922343|NCT05184192|449343860|FG000|Overall Study|Adverse Event|1|||
124922344|NCT05184192|449343861|FG001|Overall Study|Adverse Event|4|||
124922345|NCT05184192|449343860|FG000|Overall Study|PI withdrawal|1|||
124922346|NCT05184192|449343861|FG001|Overall Study|PI withdrawal|2|||
124922347|NCT05184192|449343860|FG000|Overall Study|Withdrew due to adverse effect|1|||
124922348|NCT05184192|449343861|FG001|Overall Study|Withdrew due to adverse effect|0|||
124922349|NCT05184192|449343860|FG000|Overall Study|Medication schedule|1|||
124922350|NCT05184192|449343861|FG001|Overall Study|Medication schedule|0|||
124762388|NCT02349633|448755877|FG012|Overall Study|Withdrawal by Subject|0|||
124922351|NCT05184192|449343860|FG000|Overall Study|Concern for adverse effects|0|||
124922352|NCT05184192|449343861|FG001|Overall Study|Concern for adverse effects|4|||
124922353|NCT03640312|449343870|FG000|Overall Study|Lost to Follow-up|3|||
124922354|NCT03640312|449343871|FG001|Overall Study|Lost to Follow-up|6|||
124922355|NCT04948697|449343872|FG000|Overall Study|Progressive disease|27|||
124922356|NCT04948697|449343873|FG001|Overall Study|Progressive disease|18|||
124922357|NCT04948697|449343872|FG000|Overall Study|Adverse Event|14|||
124922358|NCT04948697|449343873|FG001|Overall Study|Adverse Event|4|||
124922359|NCT04948697|449343872|FG000|Overall Study|Participant moved to long term extension study|7|||
124922360|NCT04948697|449343873|FG001|Overall Study|Participant moved to long term extension study|4|||
124922361|NCT04948697|449343872|FG000|Overall Study|Withdrawal by Subject|10|||
124922362|NCT04948697|449343873|FG001|Overall Study|Withdrawal by Subject|0|||
124922363|NCT04948697|449343872|FG000|Overall Study|Closed by Sponsor|3|||
124922364|NCT04948697|449343873|FG001|Overall Study|Closed by Sponsor|2|||
124922365|NCT04948697|449343872|FG000|Overall Study|Physician Decision|0|||
124922366|NCT04948697|449343873|FG001|Overall Study|Physician Decision|2|||
124922367|NCT04948697|449343872|FG000|Overall Study|Lost to Follow-up|0|||
124922368|NCT04948697|449343873|FG001|Overall Study|Lost to Follow-up|1|||
124922369|NCT04948697|449343872|FG000|Overall Study|Other-Miscellaneous|1|||
124922370|NCT04948697|449343873|FG001|Overall Study|Other-Miscellaneous|0|||
124922371|NCT04948697|449343872|FG000|Overall Study|Randomized but not treated|0|||
124922372|NCT04948697|449343873|FG001|Overall Study|Randomized but not treated|1|||
124969520|NCT03520075|449517414|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969521|NCT03520075|449517415|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124762389|NCT02349633|448755878|FG013|Overall Study|Withdrawal by Subject|0|||
124969522|NCT03520075|449517416|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969523|NCT03520075|449517417|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969524|NCT03520075|449517418|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969525|NCT03520075|449517419|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
124969526|NCT03520075|449517420|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969527|NCT03520075|449517421|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
124969528|NCT03520075|449517422|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969529|NCT03520075|449517423|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969530|NCT03520075|449517424|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969531|NCT03520075|449517425|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969532|NCT03520075|449517426|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969533|NCT03520075|449517427|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
124969534|NCT03520075|449517409|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969535|NCT03520075|449517410|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969536|NCT03520075|449517411|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969537|NCT03520075|449517412|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969538|NCT03520075|449517413|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969539|NCT03520075|449517414|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969540|NCT03520075|449517415|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969541|NCT03520075|449517416|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969542|NCT03520075|449517417|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969543|NCT03520075|449517418|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
124969544|NCT03520075|449517419|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969545|NCT03520075|449517420|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969546|NCT03520075|449517421|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
124969547|NCT03520075|449517422|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969548|NCT03520075|449517423|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969549|NCT03520075|449517424|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969550|NCT03520075|449517425|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969551|NCT03520075|449517426|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969552|NCT03520075|449517427|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
124969553|NCT03520075|449517409|FG000|Phase 2 (Dose Expansion)|Death|0|||
124969554|NCT03520075|449517410|FG001|Phase 2 (Dose Expansion)|Death|0|||
124969555|NCT03520075|449517411|FG002|Phase 2 (Dose Expansion)|Death|0|||
124969556|NCT03520075|449517412|FG003|Phase 2 (Dose Expansion)|Death|0|||
124922373|NCT04177823|449345355|FG000|Overall Study|Physician Decision|1|||
124922374|NCT04177823|449345355|FG000|Overall Study|Withdrawal by Subject|1|||
124922375|NCT04229992|449345356|FG000|Overall Study|Withdrawal by Subject|0|||
124922376|NCT04229992|449345357|FG001|Overall Study|Withdrawal by Subject|2|||
124922377|NCT04229992|449345358|FG002|Overall Study|Withdrawal by Subject|1|||
124922378|NCT04229992|449345359|FG003|Overall Study|Withdrawal by Subject|1|||
124922379|NCT04229992|449345356|FG000|Overall Study|Adverse Event|1|||
124922380|NCT04229992|449345357|FG001|Overall Study|Adverse Event|1|||
124922381|NCT04229992|449345358|FG002|Overall Study|Adverse Event|3|||
124922382|NCT04229992|449345359|FG003|Overall Study|Adverse Event|1|||
124922383|NCT04229992|449345356|FG000|Overall Study|Lost to Follow-up|0|||
124452648|NCT00574288|447618692|FG004|Overall Study|Death|0|||
124452649|NCT00574288|447618693|FG005|Overall Study|Death|25|||
124452650|NCT00574288|447618694|FG006|Overall Study|Death|21|||
124452651|NCT00574288|447618688|FG000|Overall Study|Lost to Follow-up|0|||
124452652|NCT00574288|447618689|FG001|Overall Study|Lost to Follow-up|0|||
124452653|NCT00574288|447618690|FG002|Overall Study|Lost to Follow-up|0|||
124452654|NCT00574288|447618691|FG003|Overall Study|Lost to Follow-up|0|||
124452655|NCT00574288|447618692|FG004|Overall Study|Lost to Follow-up|0|||
124452656|NCT00574288|447618693|FG005|Overall Study|Lost to Follow-up|1|||
124452657|NCT00574288|447618694|FG006|Overall Study|Lost to Follow-up|2|||
124452658|NCT00574288|447618688|FG000|Overall Study|Study Terminated By Sponsor|0|||
124452659|NCT00574288|447618689|FG001|Overall Study|Study Terminated By Sponsor|0|||
124452660|NCT00574288|447618690|FG002|Overall Study|Study Terminated By Sponsor|0|||
124452661|NCT00574288|447618691|FG003|Overall Study|Study Terminated By Sponsor|0|||
124452662|NCT00574288|447618692|FG004|Overall Study|Study Terminated By Sponsor|0|||
124452663|NCT00574288|447618693|FG005|Overall Study|Study Terminated By Sponsor|0|||
124452664|NCT00574288|447618694|FG006|Overall Study|Study Terminated By Sponsor|5|||
124452665|NCT00574288|447618688|FG000|Overall Study|Progressive Disease|17|||
124452666|NCT00574288|447618689|FG001|Overall Study|Progressive Disease|2|||
124452667|NCT00574288|447618690|FG002|Overall Study|Progressive Disease|3|||
124452668|NCT00574288|447618691|FG003|Overall Study|Progressive Disease|2|||
124452669|NCT00574288|447618692|FG004|Overall Study|Progressive Disease|1|||
124452670|NCT00574288|447618693|FG005|Overall Study|Progressive Disease|0|||
124452671|NCT00574288|447618694|FG006|Overall Study|Progressive Disease|0|||
124452672|NCT00574288|447618688|FG000|Overall Study|Other|1|||
124452673|NCT00574288|447618689|FG001|Overall Study|Other|1|||
124452674|NCT00574288|447618690|FG002|Overall Study|Other|0|||
124452675|NCT00574288|447618691|FG003|Overall Study|Other|0|||
124452676|NCT00574288|447618692|FG004|Overall Study|Other|0|||
124452677|NCT00574288|447618693|FG005|Overall Study|Other|0|||
124452678|NCT00574288|447618694|FG006|Overall Study|Other|0|||
124452679|NCT00702325|447618695|FG000|Overall Study|Adverse Event|1|||
124452680|NCT00702325|447618696|FG001|Overall Study|Adverse Event|0|||
124452681|NCT00702325|447618695|FG000|Overall Study|Withdrawal by Subject|7|||
124452682|NCT00702325|447618696|FG001|Overall Study|Withdrawal by Subject|7|||
124452683|NCT00702325|447618695|FG000|Overall Study|Lost to Follow-up|3|||
124452684|NCT00702325|447618696|FG001|Overall Study|Lost to Follow-up|4|||
124696077|NCT00147537|448507375|FG002|Phase 1b|Randomized but not treated|0|||
124922384|NCT04229992|449345357|FG001|Overall Study|Lost to Follow-up|0|||
124922385|NCT04229992|449345358|FG002|Overall Study|Lost to Follow-up|0|||
124452685|NCT00702325|447618695|FG000|Overall Study|Incorrect enrollment|5|||
124452686|NCT00702325|447618696|FG001|Overall Study|Incorrect enrollment|7|||
124452687|NCT00702325|447618695|FG000|Overall Study|Developed study discontinuation criteria|18|||
124769821|NCT01502293|448785205|FG001|Overall Study|Physician Decision|0|||
124922386|NCT04229992|449345359|FG003|Overall Study|Lost to Follow-up|1|||
124452688|NCT00702325|447618696|FG001|Overall Study|Developed study discontinuation criteria|28|||
124452689|NCT00702325|447618695|FG000|Overall Study|Severe noncompliance to protocol|3|||
124452690|NCT00702325|447618696|FG001|Overall Study|Severe noncompliance to protocol|3|||
124452691|NCT00702325|447618695|FG000|Overall Study|Termination due to lab results|1|||
124452692|NCT00702325|447618696|FG001|Overall Study|Termination due to lab results|0|||
124452693|NCT00702325|447618695|FG000|Overall Study|Didn't follow study medication dosage|0|||
124452694|NCT00702325|447618696|FG001|Overall Study|Didn't follow study medication dosage|2|||
124452695|NCT00702325|447618695|FG000|Overall Study|Withdrew consent|0|||
124452696|NCT00702325|447618696|FG001|Overall Study|Withdrew consent|1|||
124452697|NCT00702325|447618695|FG000|Overall Study|Incorrectly Discontinued|0|||
124452698|NCT00702325|447618696|FG001|Overall Study|Incorrectly Discontinued|1|||
124452699|NCT01022502|447618697|FG000|Overall Study|Adverse Event|1|||
124452700|NCT01022502|447618697|FG000|Overall Study|employment related reasons|1|||
124452701|NCT01022502|447618697|FG000|Overall Study|Withdrawal by Subject|1|||
124452702|NCT03123250|447618698|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
124452703|NCT01390272|447618699|FG000|Overall Study|Death|3|||
124452704|NCT01390272|447618700|FG001|Overall Study|Death|2|||
124452705|NCT01390272|447618699|FG000|Overall Study|Withdrawal by Subject|9|||
124452706|NCT01390272|447618700|FG001|Overall Study|Withdrawal by Subject|5|||
124452707|NCT01390272|447618699|FG000|Overall Study|Patient moved, no longer eligible|5|||
124452708|NCT01390272|447618700|FG001|Overall Study|Patient moved, no longer eligible|8|||
124452709|NCT02566577|447618702|FG000|Overall Study|Withdrawal by Subject|1|||
124452710|NCT02566577|447618703|FG001|Overall Study|Withdrawal by Subject|1|||
124452711|NCT02566577|447618702|FG000|Overall Study|Equipment failure|1|||
124452712|NCT02566577|447618703|FG001|Overall Study|Equipment failure|1|||
124452713|NCT02566577|447618702|FG000|Overall Study|Physical limitation|1|||
124452714|NCT02566577|447618703|FG001|Overall Study|Physical limitation|0|||
124452715|NCT00073528|447618711|FG000|Overall Study|Death|488|||
124452716|NCT00073528|447618712|FG001|Overall Study|Death|473|||
124452717|NCT00073528|447618711|FG000|Overall Study|Lost to Follow-up|52|||
124452718|NCT00073528|447618712|FG001|Overall Study|Lost to Follow-up|45|||
124922387|NCT05178316|449345360|FG000|Overall Study|Adverse Event|5|||
124452719|NCT00073528|447618711|FG000|Overall Study|Withdrawal by Subject|50|||
124452720|NCT00073528|447618712|FG001|Overall Study|Withdrawal by Subject|45|||
124452721|NCT00073528|447618711|FG000|Overall Study|Study terminated by Sponsor|10|||
124452722|NCT00073528|447618712|FG001|Overall Study|Study terminated by Sponsor|29|||
124452723|NCT00073528|447618711|FG000|Overall Study|Other|18|||
124452724|NCT00073528|447618712|FG001|Overall Study|Other|19|||
124452725|NCT00073528|447618711|FG000|Overall Study|Other|9|||
124452726|NCT00073528|447618712|FG001|Overall Study|Other|12|||
124452727|NCT00073528|447618711|FG000|Overall Study|Protocol Violation|3|||
124452728|NCT00073528|447618712|FG001|Overall Study|Protocol Violation|5|||
124452729|NCT03086057|447618713|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
124452730|NCT03086057|447618714|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
124452731|NCT03086057|447618715|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
124452732|NCT03086057|447618716|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
124452733|NCT03086057|447618713|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
124452734|NCT03086057|447618714|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
124452735|NCT03086057|447618715|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
124452736|NCT03086057|447618716|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
124452737|NCT03086057|447618713|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
124452738|NCT03086057|447618714|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
124452739|NCT03086057|447618715|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
124452740|NCT03086057|447618716|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
124452741|NCT03086057|447618713|FG000|Stage 1: PrEP Uptake|Death|1|||
124922388|NCT05178316|449345361|FG001|Overall Study|Adverse Event|4|||
124922389|NCT05178316|449345362|FG002|Overall Study|Adverse Event|9|||
124922390|NCT05178316|449345360|FG000|Overall Study|Enrolled in Error|1|||
124922391|NCT05178316|449345361|FG001|Overall Study|Enrolled in Error|2|||
124922392|NCT05178316|449345362|FG002|Overall Study|Enrolled in Error|1|||
124922393|NCT05178316|449345360|FG000|Overall Study|Lost to Follow-up|3|||
124922394|NCT05178316|449345361|FG001|Overall Study|Lost to Follow-up|15|||
124696078|NCT00147537|448507376|FG003|Phase 1b|Randomized but not treated|0|||
124696079|NCT00147537|448507377|FG004|Phase 1b|Randomized but not treated|0|||
124696080|NCT00147537|448507378|FG005|Phase 1b|Randomized but not treated|0|||
124696081|NCT00147537|448507379|FG006|Phase 1b|Randomized but not treated|1|||
124696082|NCT00147537|448507380|FG007|Phase 1b|Randomized but not treated|0|||
124696083|NCT00147537|448507381|FG008|Phase 1b|Randomized but not treated|1|||
124922395|NCT05178316|449345362|FG002|Overall Study|Lost to Follow-up|11|||
124922396|NCT05178316|449345360|FG000|Overall Study|Noncompliance|1|||
124922397|NCT05178316|449345361|FG001|Overall Study|Noncompliance|3|||
124452742|NCT03086057|447618714|FG001|Stage 1: PrEP Uptake|Death|0|||
124452743|NCT03086057|447618715|FG002|Stage 1: PrEP Uptake|Death|0|||
124452744|NCT03086057|447618716|FG003|Stage 1: PrEP Uptake|Death|0|||
124769822|NCT01502293|448785206|FG002|Overall Study|Physician Decision|1|||
124922398|NCT05178316|449345362|FG002|Overall Study|Noncompliance|1|||
124922399|NCT05178316|449345360|FG000|Overall Study|Other|0|||
124922400|NCT05178316|449345361|FG001|Overall Study|Other|1|||
124922401|NCT05178316|449345362|FG002|Overall Study|Other|0|||
124922402|NCT05178316|449345360|FG000|Overall Study|Physician Decision|0|||
124922403|NCT05178316|449345361|FG001|Overall Study|Physician Decision|3|||
124922404|NCT05178316|449345362|FG002|Overall Study|Physician Decision|2|||
124922405|NCT05178316|449345360|FG000|Overall Study|Protocol deviation|1|||
124922406|NCT05178316|449345361|FG001|Overall Study|Protocol deviation|0|||
124922407|NCT05178316|449345362|FG002|Overall Study|Protocol deviation|1|||
124922408|NCT05178316|449345360|FG000|Overall Study|Sponsor decision|1|||
124922409|NCT05178316|449345361|FG001|Overall Study|Sponsor decision|0|||
124922410|NCT05178316|449345362|FG002|Overall Study|Sponsor decision|1|||
124452745|NCT03086057|447618713|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
124452746|NCT03086057|447618714|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
124452747|NCT03086057|447618715|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
124452748|NCT03086057|447618716|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
124452749|NCT03086057|447618713|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
124452750|NCT03086057|447618714|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
124452751|NCT03086057|447618715|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
124452752|NCT03086057|447618716|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
124452753|NCT03086057|447618713|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
124452754|NCT03086057|447618714|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
124452755|NCT03086057|447618715|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
124452756|NCT03086057|447618716|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
124452757|NCT01770912|447618722|FG000|Overall Study|Lost to Follow-up|2|||
124452758|NCT01770912|447618723|FG001|Overall Study|Lost to Follow-up|0|||
124452759|NCT01536951|447618724|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
124452760|NCT01536951|447618725|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
124452761|NCT01536951|447618726|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
124452762|NCT01536951|447618727|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
124452763|NCT01536951|447618728|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
124452764|NCT01536951|447618729|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
124452765|NCT01536951|447618730|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
124452766|NCT01536951|447618731|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
124452767|NCT01536951|447618732|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
124452768|NCT01536951|447618724|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
124452769|NCT01536951|447618725|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
124452770|NCT01536951|447618726|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
124452771|NCT01536951|447618727|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
124452772|NCT01536951|447618728|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
124452773|NCT01536951|447618729|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
124452774|NCT01536951|447618730|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
124452775|NCT01536951|447618731|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
124452776|NCT01536951|447618732|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
124452777|NCT00430482|447618737|FG000|Completed Treatment|Insufficient Treatment|7|||
124452778|NCT00430482|447618738|FG001|Completed Treatment|Insufficient Treatment|11|||
124452779|NCT00555477|447618739|FG000|Overall Study|Adverse Event|0|||
124452780|NCT00555477|447618740|FG001|Overall Study|Adverse Event|9|||
124452781|NCT00555477|447618739|FG000|Overall Study|Withdrawal by Subject|1|||
124452782|NCT00555477|447618740|FG001|Overall Study|Withdrawal by Subject|2|||
124452783|NCT00555477|447618739|FG000|Overall Study|Physician Decision|1|||
124452784|NCT00555477|447618740|FG001|Overall Study|Physician Decision|2|||
124452785|NCT01817751|447618741|FG000|Overall Study|Physician Decision|1|||
124452786|NCT01721876|447618742|FG000|Overall Study|Not treated|1|||
124452787|NCT01721876|447618743|FG001|Overall Study|Not treated|4|||
124452788|NCT01721876|447618742|FG000|Overall Study|Disease progression / relapse|123|||
124452789|NCT01721876|447618743|FG001|Overall Study|Disease progression / relapse|156|||
124452790|NCT01721876|447618742|FG000|Overall Study|Death|6|||
124452791|NCT01721876|447618743|FG001|Overall Study|Death|13|||
124452792|NCT01721876|447618742|FG000|Overall Study|Adverse Event|41|||
124922411|NCT05178316|449345360|FG000|Overall Study|Withdrawal by Subject|5|||
124922412|NCT05178316|449345361|FG001|Overall Study|Withdrawal by Subject|11|||
124452793|NCT01721876|447618743|FG001|Overall Study|Adverse Event|165|||
124452794|NCT01721876|447618742|FG000|Overall Study|Protocol Violation|2|||
124452795|NCT01721876|447618743|FG001|Overall Study|Protocol Violation|1|||
124452796|NCT01721876|447618742|FG000|Overall Study|Withdrawal by Subject|15|||
124922413|NCT05178316|449345362|FG002|Overall Study|Withdrawal by Subject|5|||
124922414|NCT03457142|449345365|FG000|Overall Study|Death|1|||
124452797|NCT01721876|447618743|FG001|Overall Study|Withdrawal by Subject|38|||
124452798|NCT01721876|447618742|FG000|Overall Study|Reason not listed|34|||
124452799|NCT01721876|447618743|FG001|Overall Study|Reason not listed|63|||
124452800|NCT01721876|447618742|FG000|Overall Study|Sponsor terminated trial|0|||
124452801|NCT01721876|447618743|FG001|Overall Study|Sponsor terminated trial|4|||
124452802|NCT00382018|447618744|FG000|Overall Study|Progression|0|||
124922415|NCT03770273|449345366|FG000|Overall Study|Adverse Event|2|||
124922416|NCT03770273|449345367|FG001|Overall Study|Adverse Event|0|||
124922417|NCT03770273|449345366|FG000|Overall Study|Lost to Follow-up|1|||
124922418|NCT03770273|449345367|FG001|Overall Study|Lost to Follow-up|1|||
124922419|NCT00418886|449345368|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
124922420|NCT00418886|449345369|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
124922421|NCT00418886|449345368|FG000|Randomized Period|Death|122|||
124922422|NCT00418886|449345369|FG001|Randomized Period|Death|147|||
124922423|NCT00418886|449345368|FG000|Randomized Period|Withdrawal by Subject|9|||
124452803|NCT00382018|447618745|FG001|Overall Study|Progression|136|||
124452804|NCT00382018|447618746|FG002|Overall Study|Progression|51|||
124452805|NCT00382018|447618747|FG003|Overall Study|Progression|43|||
124452806|NCT00382018|447618744|FG000|Overall Study|Death|0|||
124452807|NCT00382018|447618745|FG001|Overall Study|Death|9|||
124452808|NCT00382018|447618746|FG002|Overall Study|Death|7|||
124452809|NCT00382018|447618747|FG003|Overall Study|Death|11|||
124452810|NCT00382018|447618744|FG000|Overall Study|Withdrawal by Subject|0|||
124452811|NCT00382018|447618745|FG001|Overall Study|Withdrawal by Subject|4|||
124452812|NCT00382018|447618746|FG002|Overall Study|Withdrawal by Subject|3|||
124452813|NCT00382018|447618747|FG003|Overall Study|Withdrawal by Subject|4|||
124452814|NCT00382018|447618744|FG000|Overall Study|Other, not protocol specified|0|||
124452815|NCT00382018|447618745|FG001|Overall Study|Other, not protocol specified|16|||
124452816|NCT00382018|447618746|FG002|Overall Study|Other, not protocol specified|3|||
124452817|NCT00382018|447618747|FG003|Overall Study|Other, not protocol specified|1|||
124452818|NCT01721057|447618748|FG000|Treatment Period|Withdrawal by Subject|11|||
124452819|NCT01721057|447618749|FG001|Treatment Period|Withdrawal by Subject|5|||
124452820|NCT01721057|447618750|FG002|Treatment Period|Withdrawal by Subject|8|||
124452821|NCT01721057|447618751|FG003|Treatment Period|Withdrawal by Subject|0|||
124452822|NCT01721057|447618752|FG004|Treatment Period|Withdrawal by Subject|0|||
124452823|NCT01721057|447618753|FG005|Treatment Period|Withdrawal by Subject|0|||
124452824|NCT01721057|447618754|FG006|Treatment Period|Withdrawal by Subject|0|||
124452825|NCT01721057|447618748|FG000|Treatment Period|Adverse Event|7|||
124452826|NCT01721057|447618749|FG001|Treatment Period|Adverse Event|10|||
124452827|NCT01721057|447618750|FG002|Treatment Period|Adverse Event|12|||
124452828|NCT01721057|447618751|FG003|Treatment Period|Adverse Event|0|||
124452829|NCT01721057|447618752|FG004|Treatment Period|Adverse Event|0|||
124452830|NCT01721057|447618753|FG005|Treatment Period|Adverse Event|0|||
124452831|NCT01721057|447618754|FG006|Treatment Period|Adverse Event|0|||
124452832|NCT01721057|447618748|FG000|Treatment Period|Lack of Efficacy|7|||
124452833|NCT01721057|447618749|FG001|Treatment Period|Lack of Efficacy|3|||
124452834|NCT01721057|447618750|FG002|Treatment Period|Lack of Efficacy|0|||
124452835|NCT01721057|447618751|FG003|Treatment Period|Lack of Efficacy|0|||
124452836|NCT01721057|447618752|FG004|Treatment Period|Lack of Efficacy|0|||
124452837|NCT01721057|447618753|FG005|Treatment Period|Lack of Efficacy|0|||
124452838|NCT01721057|447618754|FG006|Treatment Period|Lack of Efficacy|0|||
124452839|NCT01721057|447618748|FG000|Treatment Period|Lost to Follow-up|1|||
124452840|NCT01721057|447618749|FG001|Treatment Period|Lost to Follow-up|0|||
124452841|NCT01721057|447618750|FG002|Treatment Period|Lost to Follow-up|0|||
124452842|NCT01721057|447618751|FG003|Treatment Period|Lost to Follow-up|0|||
124452843|NCT01721057|447618752|FG004|Treatment Period|Lost to Follow-up|0|||
124452844|NCT01721057|447618753|FG005|Treatment Period|Lost to Follow-up|0|||
124452845|NCT01721057|447618754|FG006|Treatment Period|Lost to Follow-up|0|||
124452846|NCT01721057|447618748|FG000|Treatment Period|Physician Decision|0|||
124452847|NCT01721057|447618749|FG001|Treatment Period|Physician Decision|1|||
124696084|NCT00147537|448507382|FG009|Phase 1b|Randomized but not treated|0|||
124696085|NCT00147537|448507383|FG010|Phase 1b|Randomized but not treated|0|||
124696086|NCT00147537|448507373|FG000|Phase 2|Death|0|||
124696087|NCT00147537|448507374|FG001|Phase 2|Death|0|||
124696088|NCT00147537|448507375|FG002|Phase 2|Death|0|||
124696089|NCT00147537|448507376|FG003|Phase 2|Death|0|||
124696090|NCT00147537|448507377|FG004|Phase 2|Death|0|||
124696091|NCT00147537|448507378|FG005|Phase 2|Death|0|||
124696092|NCT00147537|448507379|FG006|Phase 2|Death|0|||
124696093|NCT00147537|448507380|FG007|Phase 2|Death|0|||
124696094|NCT00147537|448507381|FG008|Phase 2|Death|0|||
124696095|NCT00147537|448507382|FG009|Phase 2|Death|85|||
124696096|NCT00147537|448507383|FG010|Phase 2|Death|31|||
124696097|NCT00147537|448507373|FG000|Phase 2|Lost to Follow-up|0|||
124696098|NCT00147537|448507374|FG001|Phase 2|Lost to Follow-up|0|||
124696099|NCT00147537|448507375|FG002|Phase 2|Lost to Follow-up|0|||
124696100|NCT00147537|448507376|FG003|Phase 2|Lost to Follow-up|0|||
124696101|NCT00147537|448507377|FG004|Phase 2|Lost to Follow-up|0|||
124696102|NCT00147537|448507378|FG005|Phase 2|Lost to Follow-up|0|||
124696103|NCT00147537|448507379|FG006|Phase 2|Lost to Follow-up|0|||
124696104|NCT00147537|448507380|FG007|Phase 2|Lost to Follow-up|0|||
124696105|NCT00147537|448507381|FG008|Phase 2|Lost to Follow-up|0|||
124696106|NCT00147537|448507382|FG009|Phase 2|Lost to Follow-up|12|||
124696107|NCT00147537|448507383|FG010|Phase 2|Lost to Follow-up|4|||
124696108|NCT00147537|448507373|FG000|Phase 2|Other|0|||
124696109|NCT00147537|448507374|FG001|Phase 2|Other|0|||
124696110|NCT00147537|448507375|FG002|Phase 2|Other|0|||
124696111|NCT00147537|448507376|FG003|Phase 2|Other|0|||
124696112|NCT00147537|448507377|FG004|Phase 2|Other|0|||
124922424|NCT00418886|449345369|FG001|Randomized Period|Withdrawal by Subject|10|||
124922425|NCT00418886|449345368|FG000|Randomized Period|Lost to Follow-up|4|||
124922426|NCT00418886|449345369|FG001|Randomized Period|Lost to Follow-up|6|||
124922427|NCT00418886|449345368|FG000|Randomized Period|withdrawn due to other reason|1|||
124922428|NCT00418886|449345369|FG001|Randomized Period|withdrawn due to other reason|0|||
124922429|NCT00418886|449345368|FG000|Randomized Period|randomised but no treatment received|0|||
124922430|NCT00418886|449345369|FG001|Randomized Period|randomised but no treatment received|1|||
124922431|NCT04060654|449345370|FG000|Overall Study|Withdrawal by Subject|1|||
124922432|NCT04060654|449345370|FG000|Overall Study|Lost to Follow-up|5|||
124922433|NCT03707951|449345371|FG000|Overall Study|Lost to Follow-up|8|||
124922434|NCT03707951|449345372|FG001|Overall Study|Lost to Follow-up|17|||
124922435|NCT03707951|449345371|FG000|Overall Study|Withdrawal by Subject|6|||
124922436|NCT03707951|449345372|FG001|Overall Study|Withdrawal by Subject|6|||
124922437|NCT04887129|449345373|FG000|Overall Study|Lost to Follow-up|0|||
124922438|NCT04887129|449345374|FG001|Overall Study|Lost to Follow-up|24|||
124922439|NCT04887129|449345373|FG000|Overall Study|Withdrawal by Subject|9|||
124922440|NCT04887129|449345374|FG001|Overall Study|Withdrawal by Subject|57|||
124922441|NCT04887129|449345373|FG000|Overall Study|Other|2|||
124922442|NCT04887129|449345374|FG001|Overall Study|Other|9|||
124922443|NCT02921230|449345381|FG000|Overall Study|Withdrawal by Subject|20|||
124922444|NCT02921230|449345382|FG001|Overall Study|Withdrawal by Subject|8|||
124922445|NCT02921230|449345381|FG000|Overall Study|Death|12|||
124922446|NCT02921230|449345382|FG001|Overall Study|Death|3|||
124922447|NCT02921230|449345381|FG000|Overall Study|Protocol Violation|17|||
124922448|NCT02921230|449345382|FG001|Overall Study|Protocol Violation|6|||
124922449|NCT02921230|449345381|FG000|Overall Study|Early completion|5|||
124922450|NCT02921230|449345382|FG001|Overall Study|Early completion|1|||
124922451|NCT02921230|449345381|FG000|Overall Study|Pending data entry|1|||
124922452|NCT02921230|449345382|FG001|Overall Study|Pending data entry|0|||
124922453|NCT03436290|449345383|FG000|Overall Study|Post-randomization Exclusion|1|||
124922454|NCT03436290|449345384|FG001|Overall Study|Post-randomization Exclusion|0|||
124922455|NCT03436290|449345383|FG000|Overall Study|Death|6|||
124922456|NCT03436290|449345384|FG001|Overall Study|Death|0|||
124922457|NCT03436290|449345383|FG000|Overall Study|Withdrawal by Subject|4|||
124922458|NCT03436290|449345384|FG001|Overall Study|Withdrawal by Subject|0|||
124922459|NCT03436290|449345383|FG000|Overall Study|Protocol Violation|30|||
124922460|NCT03436290|449345384|FG001|Overall Study|Protocol Violation|0|||
124922461|NCT01084876|449345387|FG000|Main Study Treatment Period|Adverse Event|12|||
124922462|NCT01084876|449345388|FG001|Main Study Treatment Period|Adverse Event|7|||
124922463|NCT01084876|449345387|FG000|Main Study Treatment Period|Disease Progression|41|||
124922464|NCT01084876|449345388|FG001|Main Study Treatment Period|Disease Progression|24|||
124922465|NCT01084876|449345387|FG000|Main Study Treatment Period|Physician Decision|2|||
124922466|NCT01084876|449345388|FG001|Main Study Treatment Period|Physician Decision|0|||
124922467|NCT01084876|449345387|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
124922468|NCT01084876|449345388|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
124922469|NCT01084876|449345387|FG000|Main Study Treatment Period|Other Reason|0|||
124922470|NCT01084876|449345388|FG001|Main Study Treatment Period|Other Reason|1|||
124922471|NCT01084876|449345387|FG000|Main Study Treatment Period|Other|0|||
124922472|NCT01084876|449345388|FG001|Main Study Treatment Period|Other|1|||
124922473|NCT01084876|449345387|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
124922474|NCT01084876|449345388|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
124922475|NCT01084876|449345387|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
124922476|NCT01084876|449345388|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
124922477|NCT01084876|449345387|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
124922478|NCT01084876|449345388|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
124922479|NCT01084876|449345387|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
124922480|NCT01084876|449345388|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
124922481|NCT01084876|449345387|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
124922482|NCT01084876|449345388|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
124922483|NCT01084876|449345387|FG000|Treatment Period Beyond Cycle 8|Other|6|||
124922484|NCT01084876|449345388|FG001|Treatment Period Beyond Cycle 8|Other|9|||
124922485|NCT04971395|449345389|FG000|Overall Study|Withdrawal by Subject|0|||
124922486|NCT04971395|449345390|FG001|Overall Study|Withdrawal by Subject|1|||
124922487|NCT04971395|449345391|FG002|Overall Study|Withdrawal by Subject|0|||
124922488|NCT02924272|449345392|FG000|Overall Study|Site Terminated by Sponsor|4|||
124922489|NCT02924272|449345393|FG001|Overall Study|Site Terminated by Sponsor|1|||
124922490|NCT02924272|449345392|FG000|Overall Study|Withdrawal by Subject|2|||
124922491|NCT02924272|449345393|FG001|Overall Study|Withdrawal by Subject|0|||
124922492|NCT02924272|449345392|FG000|Overall Study|Adverse Event|3|||
124922493|NCT02924272|449345393|FG001|Overall Study|Adverse Event|0|||
124922494|NCT02924272|449345392|FG000|Overall Study|Progressive Disease|11|||
124922495|NCT02924272|449345393|FG001|Overall Study|Progressive Disease|8|||
124922496|NCT02924272|449345392|FG000|Overall Study|Clinical Deterioration|1|||
124922497|NCT02924272|449345393|FG001|Overall Study|Clinical Deterioration|0|||
124922498|NCT02924272|449345392|FG000|Overall Study|Death|1|||
124922499|NCT02924272|449345393|FG001|Overall Study|Death|0|||
124922500|NCT02924272|449345392|FG000|Overall Study|Reason Not Specified|1|||
124922501|NCT02924272|449345393|FG001|Overall Study|Reason Not Specified|0|||
124922502|NCT02100813|449345396|FG000|Overall Study|Adverse Event|0|||
124922503|NCT02100813|449345397|FG001|Overall Study|Adverse Event|0|||
124922504|NCT02100813|449345398|FG002|Overall Study|Adverse Event|0|||
124922505|NCT02100813|449345399|FG003|Overall Study|Adverse Event|0|||
124922506|NCT02100813|449345400|FG004|Overall Study|Adverse Event|0|||
124922507|NCT02100813|449345401|FG005|Overall Study|Adverse Event|0|||
124922508|NCT02100813|449345402|FG006|Overall Study|Adverse Event|0|||
124922509|NCT02100813|449345403|FG007|Overall Study|Adverse Event|1|||
124922510|NCT04359108|449345405|FG000|Overall Study|Withdrawal by Subject|1|||
124922511|NCT04359108|449345406|FG001|Overall Study|Withdrawal by Subject|0|||
124922512|NCT04359108|449345405|FG000|Overall Study|Unable or too feeble to walk independently|0|||
124922513|NCT04359108|449345406|FG001|Overall Study|Unable or too feeble to walk independently|2|||
124922514|NCT04359108|449345405|FG000|Overall Study|Argus II system stopped functioning|0|||
124922515|NCT04359108|449345406|FG001|Overall Study|Argus II system stopped functioning|1|||
124922516|NCT04359108|449345405|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
124922517|NCT04359108|449345406|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
124922518|NCT06393088|449345407|FG000|Overall Study|Withdrawal by Subject|0|||
124922519|NCT06393088|449345408|FG001|Overall Study|Withdrawal by Subject|2|||
124922520|NCT02515773|449345409|FG000|Overall Study|Withdrawal by Subject|12|||
124922521|NCT02515773|449345410|FG001|Overall Study|Withdrawal by Subject|2|||
124922522|NCT02515773|449345409|FG000|Overall Study|Lost to Follow-up|119|||
124922523|NCT02515773|449345410|FG001|Overall Study|Lost to Follow-up|126|||
124922524|NCT02515773|449345409|FG000|Overall Study|Discharged from Clinic Services|53|||
124922525|NCT02515773|449345410|FG001|Overall Study|Discharged from Clinic Services|84|||
124922526|NCT02515773|449345409|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
124922527|NCT02515773|449345410|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
124922528|NCT02515773|449345409|FG000|Overall Study|Follow-up at non-study site|8|||
124922529|NCT02515773|449345410|FG001|Overall Study|Follow-up at non-study site|16|||
124922530|NCT02515773|449345409|FG000|Overall Study|Moved from area|9|||
124922531|NCT02515773|449345410|FG001|Overall Study|Moved from area|14|||
124922532|NCT04176965|449345411|FG000|Overall Study|Death|1|||
124922533|NCT04176965|449345412|FG001|Overall Study|Death|2|||
124922534|NCT04176965|449345411|FG000|Overall Study|Lost to Follow-up|10|||
124922535|NCT04176965|449345412|FG001|Overall Study|Lost to Follow-up|2|||
124922536|NCT04176965|449345411|FG000|Overall Study|Withdrawal by Subject|6|||
124922537|NCT04176965|449345412|FG001|Overall Study|Withdrawal by Subject|1|||
124922538|NCT03903146|449345413|FG000|Overall Study|Lost to Follow-up|6|||
124922539|NCT03903146|449345414|FG001|Overall Study|Lost to Follow-up|4|||
124922540|NCT03903146|449345413|FG000|Overall Study|Withdrawal by Subject|0|||
124922541|NCT03903146|449345414|FG001|Overall Study|Withdrawal by Subject|1|||
124922542|NCT02919683|449345415|FG000|Post-Surgery Follow-Up|Death|2|||
124922543|NCT02919683|449345416|FG001|Post-Surgery Follow-Up|Death|2|||
124922544|NCT02919683|449345415|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
124922545|NCT02919683|449345416|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
124922546|NCT03652688|449345417|FG000|Baseline|Withdrawal by Subject|0|||
124922547|NCT03652688|449345418|FG001|Baseline|Withdrawal by Subject|3|||
124922548|NCT03652688|449345417|FG000|Follow-up|Lost to Follow-up|56|||
124922549|NCT03652688|449345418|FG001|Follow-up|Lost to Follow-up|54|||
124922550|NCT03468218|449345419|FG000|Overall Study|Adverse Event|5|||
124696113|NCT00147537|448507378|FG005|Phase 2|Other|0|||
124696114|NCT00147537|448507379|FG006|Phase 2|Other|0|||
124922551|NCT03468218|449345419|FG000|Overall Study|Progressive Disease|16|||
124922552|NCT03468218|449345419|FG000|Overall Study|Death|1|||
124922553|NCT03468218|449345419|FG000|Overall Study|Alternate therapy|1|||
124922554|NCT03468218|449345419|FG000|Overall Study|Withdrawal by Subject|2|||
124922555|NCT03829410|449345421|FG000|Overall Study|Adverse Event|1|||
124922556|NCT03829410|449345422|FG001|Overall Study|Adverse Event|0|||
124922557|NCT03829410|449345423|FG002|Overall Study|Adverse Event|1|||
124922558|NCT03829410|449345424|FG003|Overall Study|Adverse Event|4|||
124922559|NCT03829410|449345421|FG000|Overall Study|Physician Decision|0|||
124922560|NCT03829410|449345422|FG001|Overall Study|Physician Decision|0|||
124922561|NCT03829410|449345423|FG002|Overall Study|Physician Decision|0|||
124922562|NCT03829410|449345424|FG003|Overall Study|Physician Decision|2|||
124922563|NCT03829410|449345421|FG000|Overall Study|Disease Progressing|3|||
124922564|NCT03829410|449345422|FG001|Overall Study|Disease Progressing|4|||
124922565|NCT03829410|449345423|FG002|Overall Study|Disease Progressing|2|||
124922566|NCT03829410|449345424|FG003|Overall Study|Disease Progressing|31|||
124922567|NCT03829410|449345421|FG000|Overall Study|Miscellaneous|2|||
124922568|NCT03829410|449345422|FG001|Overall Study|Miscellaneous|4|||
124922569|NCT03829410|449345423|FG002|Overall Study|Miscellaneous|3|||
124922570|NCT03829410|449345424|FG003|Overall Study|Miscellaneous|10|||
124922571|NCT03033576|449345425|FG000|Overall Study|Ineligible|1|||
124922572|NCT03033576|449345426|FG001|Overall Study|Ineligible|1|||
124922573|NCT03033576|449345425|FG000|Overall Study|Adverse Event|4|||
124922574|NCT03033576|449345426|FG001|Overall Study|Adverse Event|20|||
124922575|NCT03033576|449345425|FG000|Overall Study|Progression/relapse|9|||
124922576|NCT03033576|449345426|FG001|Overall Study|Progression/relapse|36|||
124452848|NCT01721057|447618750|FG002|Treatment Period|Physician Decision|3|||
124452849|NCT01721057|447618751|FG003|Treatment Period|Physician Decision|0|||
124452850|NCT01721057|447618752|FG004|Treatment Period|Physician Decision|0|||
124452851|NCT01721057|447618753|FG005|Treatment Period|Physician Decision|0|||
124452852|NCT01721057|447618754|FG006|Treatment Period|Physician Decision|0|||
124452853|NCT01721057|447618748|FG000|Treatment Period|Death|2|||
124452854|NCT01721057|447618749|FG001|Treatment Period|Death|0|||
124452855|NCT01721057|447618750|FG002|Treatment Period|Death|0|||
124452856|NCT01721057|447618751|FG003|Treatment Period|Death|0|||
124452857|NCT01721057|447618752|FG004|Treatment Period|Death|0|||
124452858|NCT01721057|447618753|FG005|Treatment Period|Death|0|||
124452859|NCT01721057|447618754|FG006|Treatment Period|Death|0|||
124452860|NCT01721057|447618748|FG000|Rescue Period|Adverse Event|0|||
124452861|NCT01721057|447618749|FG001|Rescue Period|Adverse Event|0|||
124452862|NCT01721057|447618750|FG002|Rescue Period|Adverse Event|0|||
124452863|NCT01721057|447618751|FG003|Rescue Period|Adverse Event|1|||
124762390|NCT02349633|448755865|FG000|Overall Study|Withdrawal of informed consent|0|||
124762391|NCT02349633|448755866|FG001|Overall Study|Withdrawal of informed consent|0|||
124762392|NCT02349633|448755867|FG002|Overall Study|Withdrawal of informed consent|0|||
124762393|NCT02349633|448755868|FG003|Overall Study|Withdrawal of informed consent|1|||
124922577|NCT03033576|449345425|FG000|Overall Study|Death|1|||
124922578|NCT03033576|449345426|FG001|Overall Study|Death|1|||
124922579|NCT03033576|449345425|FG000|Overall Study|Patient refusal|1|||
124922580|NCT03033576|449345426|FG001|Overall Study|Patient refusal|6|||
124922581|NCT03033576|449345425|FG000|Overall Study|Other, unspecified reasons|0|||
124922582|NCT03033576|449345426|FG001|Overall Study|Other, unspecified reasons|4|||
124922583|NCT03033576|449345425|FG000|Overall Study|Currently on protocol therapy|0|||
124922584|NCT03033576|449345426|FG001|Overall Study|Currently on protocol therapy|2|||
124922585|NCT05179837|449345427|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
124922586|NCT05179837|449345427|FG000|Overall Study|Device malfunctioned|1|||
124922587|NCT05179837|449345427|FG000|Overall Study|Image quality too low|2|||
124922588|NCT03719443|449345428|FG000|Overall Study|Lost to Follow-up|0|||
124922589|NCT03719443|449345429|FG001|Overall Study|Lost to Follow-up|0|||
124922590|NCT03719443|449345430|FG002|Overall Study|Lost to Follow-up|1|||
124922591|NCT03719443|449345431|FG003|Overall Study|Lost to Follow-up|0|||
124922592|NCT03719443|449345432|FG004|Overall Study|Lost to Follow-up|1|||
124922593|NCT03719443|449345433|FG005|Overall Study|Lost to Follow-up|0|||
124922594|NCT03719443|449345434|FG006|Overall Study|Lost to Follow-up|1|||
124922595|NCT03719443|449345428|FG000|Overall Study|Withdrawal by Subject|0|||
124922596|NCT03719443|449345429|FG001|Overall Study|Withdrawal by Subject|0|||
124922597|NCT03719443|449345430|FG002|Overall Study|Withdrawal by Subject|1|||
124922598|NCT03719443|449345431|FG003|Overall Study|Withdrawal by Subject|0|||
124922599|NCT03719443|449345432|FG004|Overall Study|Withdrawal by Subject|0|||
124922600|NCT03719443|449345433|FG005|Overall Study|Withdrawal by Subject|0|||
124762394|NCT02349633|448755869|FG004|Overall Study|Withdrawal of informed consent|1|||
124922601|NCT03719443|449345434|FG006|Overall Study|Withdrawal by Subject|0|||
124922602|NCT05051124|449345435|FG000|Overall Study|Lost to Follow-up|2|||
124922603|NCT05051124|449345435|FG000|Overall Study|Withdrawal by Subject|1|||
124922604|NCT05051124|449345435|FG000|Overall Study|Residential relocation|2|||
124922605|NCT05051124|449345435|FG000|Overall Study|Death|1|||
124922606|NCT04782973|449345436|FG000|Overall Study|Withdrawal by Subject|5|||
124922607|NCT04782973|449345436|FG000|Overall Study|Protocol Violation|6|||
124452864|NCT01721057|447618752|FG004|Rescue Period|Adverse Event|0|||
124452865|NCT01721057|447618753|FG005|Rescue Period|Adverse Event|0|||
124452866|NCT01721057|447618754|FG006|Rescue Period|Adverse Event|0|||
124922608|NCT04782973|449345436|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
124922609|NCT04924660|449345437|FG000|United States|Death|29|||
124922610|NCT04924660|449345438|FG001|United States|Death|32|||
124452867|NCT01721057|447618748|FG000|Rescue Period|Lack of Efficacy|0|||
124922611|NCT04924660|449345439|FG002|United States|Death|34|||
124922612|NCT04924660|449345440|FG003|United States|Death|25|||
124922613|NCT04924660|449345441|FG004|United States|Death|26|||
124922614|NCT04924660|449345442|FG005|United States|Death|23|||
124452868|NCT01721057|447618749|FG001|Rescue Period|Lack of Efficacy|0|||
124696115|NCT00147537|448507380|FG007|Phase 2|Other|0|||
124922615|NCT04924660|449345437|FG000|United States|Lost to Follow-up|15|||
124922616|NCT04924660|449345438|FG001|United States|Lost to Follow-up|10|||
124922617|NCT04924660|449345439|FG002|United States|Lost to Follow-up|13|||
124922618|NCT04924660|449345440|FG003|United States|Lost to Follow-up|5|||
124922619|NCT04924660|449345441|FG004|United States|Lost to Follow-up|19|||
124922620|NCT04924660|449345442|FG005|United States|Lost to Follow-up|20|||
124922621|NCT04924660|449345437|FG000|United States|Withdrawal by Subject|8|||
124922622|NCT04924660|449345438|FG001|United States|Withdrawal by Subject|3|||
124922623|NCT04924660|449345439|FG002|United States|Withdrawal by Subject|3|||
124922624|NCT04924660|449345440|FG003|United States|Withdrawal by Subject|3|||
124922625|NCT04924660|449345441|FG004|United States|Withdrawal by Subject|8|||
124922626|NCT04924660|449345442|FG005|United States|Withdrawal by Subject|4|||
124922627|NCT04924660|449345437|FG000|Spain|Death|0|||
124922628|NCT04924660|449345438|FG001|Spain|Death|0|||
124922629|NCT04924660|449345439|FG002|Spain|Death|0|||
124922630|NCT04924660|449345440|FG003|Spain|Death|0|||
124922631|NCT04924660|449345441|FG004|Spain|Death|0|||
124922632|NCT04924660|449345442|FG005|Spain|Death|2|||
124922633|NCT04924660|449345437|FG000|Spain|Lost to Follow-up|0|||
124922634|NCT04924660|449345438|FG001|Spain|Lost to Follow-up|0|||
124922635|NCT04924660|449345439|FG002|Spain|Lost to Follow-up|0|||
124922636|NCT04924660|449345440|FG003|Spain|Lost to Follow-up|0|||
124922637|NCT04924660|449345441|FG004|Spain|Lost to Follow-up|1|||
124922638|NCT04924660|449345442|FG005|Spain|Lost to Follow-up|0|||
124922639|NCT04924660|449345437|FG000|Brazil|Death|0|||
124922640|NCT04924660|449345438|FG001|Brazil|Death|0|||
124922641|NCT04924660|449345439|FG002|Brazil|Death|0|||
124922642|NCT04924660|449345440|FG003|Brazil|Death|0|||
124922643|NCT04924660|449345441|FG004|Brazil|Death|1|||
124922644|NCT04924660|449345442|FG005|Brazil|Death|0|||
124922645|NCT04924660|449345437|FG000|Italy|Lost to Follow-up|0|||
124922646|NCT04924660|449345438|FG001|Italy|Lost to Follow-up|0|||
124922647|NCT04924660|449345439|FG002|Italy|Lost to Follow-up|0|||
124922648|NCT04924660|449345440|FG003|Italy|Lost to Follow-up|0|||
124922649|NCT04924660|449345441|FG004|Italy|Lost to Follow-up|0|||
124922650|NCT04924660|449345442|FG005|Italy|Lost to Follow-up|1|||
124922651|NCT04924660|449345437|FG000|South Africa|Death|0|||
124922652|NCT04924660|449345438|FG001|South Africa|Death|0|||
124922653|NCT04924660|449345439|FG002|South Africa|Death|0|||
124922654|NCT04924660|449345440|FG003|South Africa|Death|0|||
124922655|NCT04924660|449345441|FG004|South Africa|Death|0|||
124922656|NCT04924660|449345442|FG005|South Africa|Death|1|||
124922657|NCT04924660|449345437|FG000|South Africa|Lost to Follow-up|0|||
124922658|NCT04924660|449345438|FG001|South Africa|Lost to Follow-up|0|||
124922659|NCT04924660|449345439|FG002|South Africa|Lost to Follow-up|0|||
124922660|NCT04924660|449345440|FG003|South Africa|Lost to Follow-up|0|||
124922661|NCT04924660|449345441|FG004|South Africa|Lost to Follow-up|0|||
124922662|NCT04924660|449345442|FG005|South Africa|Lost to Follow-up|1|||
124922663|NCT06205407|449345443|FG000|Period 2|Withdrawal by Subject|0|||
124922664|NCT06205407|449345444|FG001|Period 2|Withdrawal by Subject|1|||
124922665|NCT06205407|449345443|FG000|Period 2|Adverse Event|2|||
124922666|NCT06205407|449345444|FG001|Period 2|Adverse Event|1|||
124922667|NCT06491433|449345445|FG000|Overall Study|Protocol Violation|51|||
124922668|NCT06491433|449345445|FG000|Overall Study|consent withdrawal|2|||
124922669|NCT06491433|449345445|FG000|Overall Study|screen failure|1|||
124922670|NCT04749615|449345447|FG000|Overall Study|Lost to Follow-up|6|||
124922671|NCT04749615|449345448|FG001|Overall Study|Lost to Follow-up|10|||
124922672|NCT04516967|449345449|FG000|Core Phase|Adverse Event|2|||
124922673|NCT04516967|449345450|FG001|Core Phase|Adverse Event|1|||
124922674|NCT04516967|449345451|FG002|Core Phase|Adverse Event|0|||
124922675|NCT04516967|449345449|FG000|Core Phase|Physician Decision|1|||
124922676|NCT04516967|449345450|FG001|Core Phase|Physician Decision|1|||
124922677|NCT04516967|449345451|FG002|Core Phase|Physician Decision|0|||
124922678|NCT04516967|449345449|FG000|Core Phase|Lack of Efficacy|7|||
124922679|NCT04516967|449345450|FG001|Core Phase|Lack of Efficacy|18|||
124922680|NCT04516967|449345451|FG002|Core Phase|Lack of Efficacy|0|||
124922681|NCT04676022|449345452|FG000|Overall Study|Screen Failure/|1|||
124922682|NCT04676022|449345453|FG001|Overall Study|Screen Failure/|1|||
124922683|NCT04676022|449345454|FG002|Overall Study|Screen Failure/|85|||
124922684|NCT04676022|449345452|FG000|Overall Study|Lost to Follow-up|1|||
124696116|NCT00147537|448507381|FG008|Phase 2|Other|0|||
124452869|NCT01721057|447618750|FG002|Rescue Period|Lack of Efficacy|0|||
124452870|NCT01721057|447618751|FG003|Rescue Period|Lack of Efficacy|2|||
124696117|NCT00147537|448507382|FG009|Phase 2|Other|47|||
124922685|NCT04676022|449345453|FG001|Overall Study|Lost to Follow-up|1|||
124922686|NCT04676022|449345454|FG002|Overall Study|Lost to Follow-up|0|||
124922687|NCT04676022|449345452|FG000|Overall Study|Adverse Event|2|||
124922688|NCT04676022|449345453|FG001|Overall Study|Adverse Event|0|||
124922689|NCT04676022|449345454|FG002|Overall Study|Adverse Event|1|||
124922690|NCT04676022|449345452|FG000|Overall Study|Physician Decision|2|||
124922691|NCT04676022|449345453|FG001|Overall Study|Physician Decision|0|||
124922692|NCT04676022|449345454|FG002|Overall Study|Physician Decision|1|||
124922693|NCT04676022|449345452|FG000|Overall Study|Withdrawal by Subject|3|||
124696118|NCT00147537|448507383|FG010|Phase 2|Other|12|||
124696119|NCT00147537|448507373|FG000|Phase 2|Withdrawal by Subject|0|||
124696120|NCT00147537|448507374|FG001|Phase 2|Withdrawal by Subject|0|||
124696121|NCT00147537|448507375|FG002|Phase 2|Withdrawal by Subject|0|||
124696122|NCT00147537|448507376|FG003|Phase 2|Withdrawal by Subject|0|||
124696123|NCT00147537|448507377|FG004|Phase 2|Withdrawal by Subject|0|||
124696124|NCT00147537|448507378|FG005|Phase 2|Withdrawal by Subject|0|||
124696125|NCT00147537|448507379|FG006|Phase 2|Withdrawal by Subject|0|||
124696126|NCT00147537|448507380|FG007|Phase 2|Withdrawal by Subject|0|||
124696127|NCT00147537|448507381|FG008|Phase 2|Withdrawal by Subject|0|||
124696128|NCT00147537|448507382|FG009|Phase 2|Withdrawal by Subject|16|||
124696129|NCT00147537|448507383|FG010|Phase 2|Withdrawal by Subject|4|||
124696130|NCT00147537|448507373|FG000|Phase 2|Randomized but not treated|0|||
124762395|NCT02349633|448755870|FG005|Overall Study|Withdrawal of informed consent|0|||
124762396|NCT02349633|448755871|FG006|Overall Study|Withdrawal of informed consent|0|||
124762397|NCT02349633|448755872|FG007|Overall Study|Withdrawal of informed consent|3|||
124762398|NCT02349633|448755873|FG008|Overall Study|Withdrawal of informed consent|0|||
124762399|NCT02349633|448755874|FG009|Overall Study|Withdrawal of informed consent|0|||
124762400|NCT02349633|448755875|FG010|Overall Study|Withdrawal of informed consent|0|||
124762401|NCT02349633|448755876|FG011|Overall Study|Withdrawal of informed consent|0|||
124762402|NCT02349633|448755877|FG012|Overall Study|Withdrawal of informed consent|0|||
124762403|NCT02349633|448755878|FG013|Overall Study|Withdrawal of informed consent|0|||
124696131|NCT00147537|448507374|FG001|Phase 2|Randomized but not treated|0|||
124696132|NCT00147537|448507375|FG002|Phase 2|Randomized but not treated|0|||
124696133|NCT00147537|448507376|FG003|Phase 2|Randomized but not treated|0|||
124696134|NCT00147537|448507377|FG004|Phase 2|Randomized but not treated|0|||
124696135|NCT00147537|448507378|FG005|Phase 2|Randomized but not treated|0|||
124696136|NCT00147537|448507379|FG006|Phase 2|Randomized but not treated|0|||
124696137|NCT00147537|448507380|FG007|Phase 2|Randomized but not treated|0|||
124696138|NCT00147537|448507381|FG008|Phase 2|Randomized but not treated|0|||
124696139|NCT00147537|448507382|FG009|Phase 2|Randomized but not treated|1|||
124696140|NCT00147537|448507383|FG010|Phase 2|Randomized but not treated|1|||
124696141|NCT02006654|448507385|FG000|Overall Study|Withdrawal before treatment|4|||
124696142|NCT02006654|448507386|FG001|Overall Study|Withdrawal before treatment|2|||
124696143|NCT02006654|448507385|FG000|Overall Study|Adverse Event|16|||
124696144|NCT02006654|448507386|FG001|Overall Study|Adverse Event|17|||
124696145|NCT02006654|448507385|FG000|Overall Study|Death|1|||
124762404|NCT02349633|448755865|FG000|Overall Study|Transition to compassionate use|0|||
124762405|NCT02349633|448755866|FG001|Overall Study|Transition to compassionate use|0|||
124762406|NCT02349633|448755867|FG002|Overall Study|Transition to compassionate use|0|||
124762407|NCT02349633|448755868|FG003|Overall Study|Transition to compassionate use|0|||
124762408|NCT02349633|448755869|FG004|Overall Study|Transition to compassionate use|1|||
124452871|NCT01721057|447618752|FG004|Rescue Period|Lack of Efficacy|0|||
124452872|NCT01721057|447618753|FG005|Rescue Period|Lack of Efficacy|0|||
124452873|NCT01721057|447618754|FG006|Rescue Period|Lack of Efficacy|0|||
124452874|NCT03805750|447618755|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
124452875|NCT03805750|447618756|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
124452876|NCT00789880|447618757|FG000|Overall Study|Adverse Event|0|||
124452877|NCT00789880|447618758|FG001|Overall Study|Adverse Event|0|||
124452878|NCT00789880|447618759|FG002|Overall Study|Adverse Event|0|||
124452879|NCT00789880|447618760|FG003|Overall Study|Adverse Event|0|||
124452880|NCT00789880|447618761|FG004|Overall Study|Adverse Event|1|||
124452881|NCT00789880|447618762|FG005|Overall Study|Adverse Event|0|||
124452882|NCT00789880|447618757|FG000|Overall Study|Protocol Violation|0|||
124452883|NCT00789880|447618758|FG001|Overall Study|Protocol Violation|1|||
124452884|NCT00789880|447618759|FG002|Overall Study|Protocol Violation|0|||
124452885|NCT00789880|447618760|FG003|Overall Study|Protocol Violation|1|||
124452886|NCT00789880|447618761|FG004|Overall Study|Protocol Violation|0|||
124452887|NCT00789880|447618762|FG005|Overall Study|Protocol Violation|0|||
124452888|NCT00789880|447618757|FG000|Overall Study|Withdrawal by Subject|1|||
124452889|NCT00789880|447618758|FG001|Overall Study|Withdrawal by Subject|0|||
124452890|NCT00789880|447618759|FG002|Overall Study|Withdrawal by Subject|0|||
124452891|NCT00789880|447618760|FG003|Overall Study|Withdrawal by Subject|0|||
124696146|NCT02006654|448507386|FG001|Overall Study|Death|0|||
124696147|NCT02006654|448507385|FG000|Overall Study|Withdrawal by Subject|14|||
124696148|NCT02006654|448507386|FG001|Overall Study|Withdrawal by Subject|12|||
124696149|NCT02006654|448507385|FG000|Overall Study|Protocol Violation|5|||
124696150|NCT02006654|448507386|FG001|Overall Study|Protocol Violation|8|||
124762409|NCT02349633|448755870|FG005|Overall Study|Transition to compassionate use|0|||
124762410|NCT02349633|448755871|FG006|Overall Study|Transition to compassionate use|0|||
124452892|NCT00789880|447618761|FG004|Overall Study|Withdrawal by Subject|2|||
124452893|NCT00789880|447618762|FG005|Overall Study|Withdrawal by Subject|0|||
124452894|NCT01177683|447618763|FG000|Study Treatment|Disease Progressions during treatment|2|||
124452895|NCT01177683|447618764|FG001|Study Treatment|Disease Progressions during treatment|0|||
124696151|NCT02006654|448507385|FG000|Overall Study|Lost to Follow-up|1|||
124696152|NCT02006654|448507386|FG001|Overall Study|Lost to Follow-up|0|||
124922694|NCT04676022|449345453|FG001|Overall Study|Withdrawal by Subject|1|||
124922695|NCT04676022|449345454|FG002|Overall Study|Withdrawal by Subject|6|||
124762411|NCT02349633|448755872|FG007|Overall Study|Transition to compassionate use|3|||
124762412|NCT02349633|448755873|FG008|Overall Study|Transition to compassionate use|0|||
124922696|NCT04676022|449345452|FG000|Overall Study|Will not move forward with permanent implant|6|||
124922697|NCT04676022|449345453|FG001|Overall Study|Will not move forward with permanent implant|0|||
124922698|NCT04676022|449345454|FG002|Overall Study|Will not move forward with permanent implant|0|||
124922699|NCT04676022|449345452|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
124922700|NCT04676022|449345453|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
124922701|NCT04676022|449345454|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
124922702|NCT03194217|449345469|FG000|Overall Study|Adverse Event|0|||
124762413|NCT02349633|448755874|FG009|Overall Study|Transition to compassionate use|1|||
124762414|NCT02349633|448755875|FG010|Overall Study|Transition to compassionate use|0|||
124762415|NCT02349633|448755876|FG011|Overall Study|Transition to compassionate use|0|||
124762416|NCT02349633|448755877|FG012|Overall Study|Transition to compassionate use|0|||
124922703|NCT03194217|449345470|FG001|Overall Study|Adverse Event|2|||
124922704|NCT03194217|449345471|FG002|Overall Study|Adverse Event|3|||
124922705|NCT03194217|449345472|FG003|Overall Study|Adverse Event|3|||
124922706|NCT03194217|449345469|FG000|Overall Study|Failure to meet randomisation criteria|0|||
124922707|NCT03194217|449345470|FG001|Overall Study|Failure to meet randomisation criteria|0|||
124922708|NCT03194217|449345471|FG002|Overall Study|Failure to meet randomisation criteria|0|||
124696153|NCT02006654|448507385|FG000|Overall Study|patient's will|2|||
124696154|NCT02006654|448507386|FG001|Overall Study|patient's will|1|||
124696155|NCT02006654|448507385|FG000|Overall Study|insufficient compliance|1|||
124696156|NCT02006654|448507386|FG001|Overall Study|insufficient compliance|0|||
124696157|NCT02006654|448507385|FG000|Overall Study|worsening cognitive condition|0|||
124696158|NCT02006654|448507386|FG001|Overall Study|worsening cognitive condition|1|||
124696159|NCT02006654|448507385|FG000|Overall Study|faecal incontinence|0|||
124696160|NCT02006654|448507386|FG001|Overall Study|faecal incontinence|1|||
124696161|NCT02006654|448507385|FG000|Overall Study|mood disorder|0|||
124696162|NCT02006654|448507386|FG001|Overall Study|mood disorder|1|||
124696163|NCT02006654|448507385|FG000|Overall Study|disallowed medication|1|||
124696164|NCT02006654|448507386|FG001|Overall Study|disallowed medication|0|||
124696165|NCT02006654|448507385|FG000|Overall Study|moving out of state|0|||
124696166|NCT02006654|448507386|FG001|Overall Study|moving out of state|1|||
124696167|NCT00478140|448507387|FG000|Overall Study|Clinical Disease Progression|1|||
124696168|NCT00676689|448507390|FG000|Overall Study|Screen Failure|2|||
124696169|NCT00676689|448507390|FG000|Overall Study|Death|2|||
124696170|NCT00676689|448507390|FG000|Overall Study|Lost to Follow-up|4|||
124696171|NCT00676689|448507390|FG000|Overall Study|Physician Decision|1|||
124696172|NCT00676689|448507390|FG000|Overall Study|Withdrawal by Subject|3|||
124696173|NCT00676689|448507390|FG000|Overall Study|Continuing FU|49|||
124696174|NCT03438656|448507391|FG000|Overall Study|Lost to Follow-up|2|||
124696175|NCT00563316|448507394|FG000|Overall Study|Adverse Event|2|||
124696176|NCT00563316|448507394|FG000|Overall Study|Physician Decision|1|||
124696177|NCT00563316|448507394|FG000|Overall Study|Lost to Follow-up|2|||
124696178|NCT00563316|448507394|FG000|Overall Study|Death|1|||
124696179|NCT00563316|448507394|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
124696180|NCT00563316|448507394|FG000|Overall Study|Other|1|||
124696181|NCT04401293|448507403|FG000|Overall Study|Withdrawal by Subject|1|||
124696182|NCT04401293|448507404|FG001|Overall Study|Withdrawal by Subject|3|||
124696183|NCT00694161|448507407|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
124696184|NCT00694161|448507407|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
124696185|NCT00694161|448507407|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
124696186|NCT03111732|448507408|FG000|Overall Study|Enrolled in different study|1|||
124696187|NCT03111732|448507408|FG000|Overall Study|Progressive disease|3|||
124696188|NCT03111732|448507408|FG000|Overall Study|Withdrawal by Subject|1|||
124696189|NCT01108055|448507409|FG000|Overall Study|Ineligible|11|||
124696190|NCT01108055|448507409|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
124696191|NCT03339453|448507411|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
124696192|NCT03339453|448507412|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
124696193|NCT00450749|448507416|FG000|Overall Study|Withdrawal by Subject|0|||
124922709|NCT03194217|449345472|FG003|Overall Study|Failure to meet randomisation criteria|1|||
124696194|NCT00450749|448507417|FG001|Overall Study|Withdrawal by Subject|0|||
124696195|NCT00450749|448507418|FG002|Overall Study|Withdrawal by Subject|2|||
124696196|NCT00450749|448507416|FG000|Overall Study|Noncompliant|0|||
124696197|NCT00450749|448507417|FG001|Overall Study|Noncompliant|1|||
124696198|NCT00450749|448507418|FG002|Overall Study|Noncompliant|0|||
124696199|NCT01245049|448507419|FG000|Overall Study|Migrated/moved from study area|0|||
124696200|NCT01245049|448507420|FG001|Overall Study|Migrated/moved from study area|1|||
124696201|NCT01245049|448507419|FG000|Overall Study|Withdrawal by Subject|0|||
124696202|NCT01245049|448507420|FG001|Overall Study|Withdrawal by Subject|1|||
124696203|NCT01245049|448507419|FG000|Overall Study|Lost to Follow-up|1|||
124696204|NCT01245049|448507420|FG001|Overall Study|Lost to Follow-up|2|||
124696205|NCT02151604|448507421|FG000|Overall Study|Lost to Follow-up|3|||
124696206|NCT02151604|448507421|FG000|Overall Study|Withdrawal by Subject|2|||
124696207|NCT02151604|448507421|FG000|Overall Study|Physician Decision|3|||
124696208|NCT02151604|448507421|FG000|Overall Study|Death|1|||
124696209|NCT04495478|448507422|FG000|Overall Study|Withdrawal by Subject|0|||
124696210|NCT04495478|448507423|FG001|Overall Study|Withdrawal by Subject|0|||
124696211|NCT04495478|448507424|FG002|Overall Study|Withdrawal by Subject|0|||
124696212|NCT04495478|448507425|FG003|Overall Study|Withdrawal by Subject|1|||
124696213|NCT04495478|448507426|FG004|Overall Study|Withdrawal by Subject|0|||
124696214|NCT04495478|448507427|FG005|Overall Study|Withdrawal by Subject|0|||
124696215|NCT04495478|448507428|FG006|Overall Study|Withdrawal by Subject|0|||
124696216|NCT04495478|448507422|FG000|Overall Study|Physician Decision|0|||
124696217|NCT04495478|448507423|FG001|Overall Study|Physician Decision|1|||
124696218|NCT04495478|448507424|FG002|Overall Study|Physician Decision|0|||
124696219|NCT04495478|448507425|FG003|Overall Study|Physician Decision|0|||
124696220|NCT04495478|448507426|FG004|Overall Study|Physician Decision|1|||
124696221|NCT04495478|448507427|FG005|Overall Study|Physician Decision|0|||
124696222|NCT04495478|448507428|FG006|Overall Study|Physician Decision|0|||
124696223|NCT03312114|448509399|FG000|Overall Study|All the five enrolled dropped out of the|5|||
124696224|NCT00944645|448509400|FG000|Period 2|Adverse Event|1|||
124696225|NCT00944645|448509401|FG001|Period 2|Adverse Event|0|||
124696226|NCT00944645|448509400|FG000|Period 2|Lost to Follow-up|0|||
124696227|NCT00944645|448509401|FG001|Period 2|Lost to Follow-up|3|||
124696228|NCT00944645|448509400|FG000|Period 2|Withdrawal by Subject|7|||
124696229|NCT00944645|448509401|FG001|Period 2|Withdrawal by Subject|6|||
124696230|NCT03537729|448509402|FG000|Overall Study|Death|2|||
124696231|NCT03537729|448509403|FG001|Overall Study|Death|2|||
124696232|NCT03537729|448509404|FG002|Overall Study|Death|7|||
124696233|NCT03537729|448509402|FG000|Overall Study|Withdrawal by Subject|3|||
124696234|NCT03537729|448509403|FG001|Overall Study|Withdrawal by Subject|3|||
124696235|NCT03537729|448509404|FG002|Overall Study|Withdrawal by Subject|0|||
124696236|NCT03537729|448509402|FG000|Overall Study|Subject Moved|8|||
124696237|NCT03537729|448509403|FG001|Overall Study|Subject Moved|5|||
124696238|NCT03537729|448509404|FG002|Overall Study|Subject Moved|4|||
124696239|NCT03537729|448509402|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
124696240|NCT03537729|448509403|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
124696241|NCT03537729|448509404|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
124696242|NCT03537729|448509402|FG000|Overall Study|COVID-19 Site Restrictions|11|||
124696243|NCT03537729|448509403|FG001|Overall Study|COVID-19 Site Restrictions|15|||
124696244|NCT03537729|448509404|FG002|Overall Study|COVID-19 Site Restrictions|18|||
124696245|NCT03537729|448509402|FG000|Overall Study|Decline in Health|5|||
124696246|NCT03537729|448509403|FG001|Overall Study|Decline in Health|9|||
124696247|NCT03537729|448509404|FG002|Overall Study|Decline in Health|4|||
124696248|NCT03537729|448509402|FG000|Overall Study|Determined Ineligible|0|||
124696249|NCT03537729|448509403|FG001|Overall Study|Determined Ineligible|0|||
124696250|NCT03537729|448509404|FG002|Overall Study|Determined Ineligible|1|||
124696251|NCT02562040|448509406|FG000|Overall Study|Lost to Follow-up|20|||
124696252|NCT02562040|448509407|FG001|Overall Study|Lost to Follow-up|28|||
124696253|NCT02562040|448509406|FG000|Overall Study|Withdrawal by Subject|8|||
124696254|NCT02562040|448509407|FG001|Overall Study|Withdrawal by Subject|7|||
124696255|NCT02562040|448509406|FG000|Overall Study|Adverse Event|1|||
124696256|NCT02562040|448509407|FG001|Overall Study|Adverse Event|0|||
124696257|NCT01654250|448509408|FG000|Overall Study|Lost to Follow-up|1|||
124696258|NCT01654250|448509409|FG001|Overall Study|Lost to Follow-up|0|||
124696259|NCT01862029|448509410|FG000|Overall Study|Physician Decision|1|||
124696260|NCT00504556|448509411|FG000|Overall Study|Adverse Event|11|||
124696261|NCT00504556|448509412|FG001|Overall Study|Adverse Event|11|||
124696262|NCT00504556|448509413|FG002|Overall Study|Adverse Event|14|||
124696263|NCT00504556|448509414|FG003|Overall Study|Adverse Event|13|||
124696264|NCT00504556|448509415|FG004|Overall Study|Adverse Event|5|||
124922710|NCT03194217|449345469|FG000|Overall Study|Other|0|||
124922711|NCT03194217|449345470|FG001|Overall Study|Other|1|||
124696265|NCT00504556|448509411|FG000|Overall Study|Death|3|||
124696266|NCT00504556|448509412|FG001|Overall Study|Death|3|||
124696267|NCT00504556|448509413|FG002|Overall Study|Death|1|||
124696268|NCT00504556|448509414|FG003|Overall Study|Death|0|||
124696269|NCT00504556|448509415|FG004|Overall Study|Death|2|||
124696270|NCT00504556|448509411|FG000|Overall Study|Protocol Violation|1|||
124696271|NCT00504556|448509412|FG001|Overall Study|Protocol Violation|3|||
124696272|NCT00504556|448509413|FG002|Overall Study|Protocol Violation|2|||
124696273|NCT00504556|448509414|FG003|Overall Study|Protocol Violation|1|||
124696274|NCT00504556|448509415|FG004|Overall Study|Protocol Violation|2|||
124696275|NCT00504556|448509411|FG000|Overall Study|Lost to Follow-up|0|||
124696276|NCT00504556|448509412|FG001|Overall Study|Lost to Follow-up|0|||
124696277|NCT00504556|448509413|FG002|Overall Study|Lost to Follow-up|1|||
124696278|NCT00504556|448509414|FG003|Overall Study|Lost to Follow-up|1|||
124696279|NCT00504556|448509415|FG004|Overall Study|Lost to Follow-up|1|||
124922712|NCT03194217|449345471|FG002|Overall Study|Other|1|||
124452896|NCT01177683|447618765|FG002|Study Treatment|Disease Progressions during treatment|3|||
124452897|NCT01177683|447618763|FG000|Study Treatment|Adverse Event|0|||
124452898|NCT01177683|447618764|FG001|Study Treatment|Adverse Event|1|||
124452899|NCT01177683|447618765|FG002|Study Treatment|Adverse Event|12|||
124452900|NCT01177683|447618763|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
124452901|NCT01177683|447618764|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
124452902|NCT01177683|447618765|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
124452903|NCT01177683|447618763|FG000|Study Treatment|Alternative therapy|0|||
124452904|NCT01177683|447618764|FG001|Study Treatment|Alternative therapy|0|||
124452905|NCT01177683|447618765|FG002|Study Treatment|Alternative therapy|4|||
124452906|NCT01177683|447618763|FG000|Study Treatment|Physician Decision|1|||
124452907|NCT01177683|447618764|FG001|Study Treatment|Physician Decision|0|||
124452908|NCT01177683|447618765|FG002|Study Treatment|Physician Decision|1|||
124452909|NCT01177683|447618763|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
124452910|NCT01177683|447618764|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
124452911|NCT01177683|447618765|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
124452912|NCT01177683|447618763|FG000|Study Treatment|Symptomatic Deterioration|0|||
124452913|NCT01177683|447618764|FG001|Study Treatment|Symptomatic Deterioration|0|||
124452914|NCT01177683|447618765|FG002|Study Treatment|Symptomatic Deterioration|1|||
124452915|NCT01177683|447618763|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
124452916|NCT01177683|447618764|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
124452917|NCT01177683|447618765|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
124452918|NCT01177683|447618763|FG000|Follow up|Patient lost to follow up|0|||
124452919|NCT01177683|447618764|FG001|Follow up|Patient lost to follow up|0|||
124452920|NCT01177683|447618765|FG002|Follow up|Patient lost to follow up|2|||
124452921|NCT01177683|447618763|FG000|Follow up|Death|2|||
124452922|NCT01177683|447618764|FG001|Follow up|Death|1|||
124452923|NCT01177683|447618765|FG002|Follow up|Death|7|||
124452924|NCT01177683|447618763|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
124452925|NCT01177683|447618764|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
124452926|NCT01177683|447618765|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
124452927|NCT01977820|447618770|FG000|Overall Study|Sponsor terminated the study|1|||
124452928|NCT01977820|447618771|FG001|Overall Study|Sponsor terminated the study|1|||
124452929|NCT02568475|447618772|FG000|Overall Study|Lost to Follow-up|40|||
124452930|NCT02568475|447618773|FG001|Overall Study|Lost to Follow-up|39|||
124696280|NCT00504556|448509411|FG000|Overall Study|Withdrawal by Subject|16|||
124696281|NCT00504556|448509412|FG001|Overall Study|Withdrawal by Subject|16|||
124696282|NCT00504556|448509413|FG002|Overall Study|Withdrawal by Subject|7|||
124696283|NCT00504556|448509414|FG003|Overall Study|Withdrawal by Subject|8|||
124696284|NCT00504556|448509415|FG004|Overall Study|Withdrawal by Subject|12|||
124452931|NCT02568475|447618772|FG000|Overall Study|Withdrawal by Subject|2|||
124452932|NCT02568475|447618773|FG001|Overall Study|Withdrawal by Subject|0|||
124452933|NCT02568475|447618772|FG000|Overall Study|Discharged home|4|||
124452934|NCT02568475|447618773|FG001|Overall Study|Discharged home|4|||
124696285|NCT00504556|448509411|FG000|Overall Study|administrative reasons|0|||
124696286|NCT00504556|448509412|FG001|Overall Study|administrative reasons|2|||
124696287|NCT00504556|448509413|FG002|Overall Study|administrative reasons|2|||
124696288|NCT00504556|448509414|FG003|Overall Study|administrative reasons|1|||
124696289|NCT00504556|448509415|FG004|Overall Study|administrative reasons|2|||
124922713|NCT03194217|449345472|FG003|Overall Study|Other|0|||
124922714|NCT03197662|449345473|FG000|Overall Study|Withdrawn by family|0|||
124452935|NCT02568475|447618772|FG000|Overall Study|Short-term: Discharge location unknown|4|||
124452936|NCT02568475|447618773|FG001|Overall Study|Short-term: Discharge location unknown|0|||
124452937|NCT02568475|447618772|FG000|Overall Study|Transferred to another facility|1|||
124452938|NCT02568475|447618773|FG001|Overall Study|Transferred to another facility|0|||
124452939|NCT01889238|447618776|FG000|Overall Study|Death|1|||
124452940|NCT01889238|447618776|FG000|Overall Study|Withdrawal by Subject|1|||
124452941|NCT01889238|447618776|FG000|Overall Study|Adverse Event|6|||
124452942|NCT01889238|447618776|FG000|Overall Study|Disease Progression|104|||
124452943|NCT01889238|447618776|FG000|Overall Study|Other|6|||
124452944|NCT04136184|447618777|FG000|Overall Study|Lost to Follow-up|0|||
124452945|NCT04136184|447618778|FG001|Overall Study|Lost to Follow-up|3|||
124452946|NCT04136184|447618777|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
124452947|NCT04136184|447618778|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
124452948|NCT02844816|447618779|FG000|Overall Study|No protocol treatment received|5|||
124452949|NCT02844816|447618780|FG001|Overall Study|No protocol treatment received|1|||
124452950|NCT02844816|447618779|FG000|Overall Study|Ineligible|22|||
124452951|NCT02844816|447618780|FG001|Overall Study|Ineligible|15|||
124452952|NCT02844816|447618779|FG000|Overall Study|Participant refusal|5|||
124452953|NCT02844816|447618780|FG001|Overall Study|Participant refusal|5|||
124452954|NCT02844816|447618779|FG000|Overall Study|Adverse Event|5|||
124452955|NCT02844816|447618780|FG001|Overall Study|Adverse Event|4|||
124452956|NCT02844816|447618779|FG000|Overall Study|Death|0|||
124452957|NCT02844816|447618780|FG001|Overall Study|Death|1|||
124452958|NCT02844816|447618779|FG000|Overall Study|Disease progression/recurrence|50|||
124452959|NCT02844816|447618780|FG001|Overall Study|Disease progression/recurrence|24|||
124452960|NCT02844816|447618779|FG000|Overall Study|Physician Decision|1|||
124452961|NCT02844816|447618780|FG001|Overall Study|Physician Decision|1|||
124452962|NCT02717754|447618783|FG000|Overall Study|Incorrect Infusion Duration|0|||
124452963|NCT02717754|447618784|FG001|Overall Study|Incorrect Infusion Duration|0|||
124452964|NCT02717754|447618785|FG002|Overall Study|Incorrect Infusion Duration|0|||
124452965|NCT02717754|447618786|FG003|Overall Study|Incorrect Infusion Duration|10|||
124452966|NCT02717754|447618787|FG004|Overall Study|Incorrect Infusion Duration|20|||
124452967|NCT02717754|447618788|FG005|Overall Study|Incorrect Infusion Duration|20|||
124452968|NCT00938717|447620224|FG000|Overall Study|Adverse Event|10|||
124452969|NCT00938717|447620225|FG001|Overall Study|Adverse Event|41|||
124452970|NCT00938717|447620224|FG000|Overall Study|Protocol Violation|11|||
124452971|NCT00938717|447620225|FG001|Overall Study|Protocol Violation|8|||
124452972|NCT00938717|447620224|FG000|Overall Study|Withdrawal by Subject|26|||
124452973|NCT00938717|447620225|FG001|Overall Study|Withdrawal by Subject|24|||
124452974|NCT00938717|447620224|FG000|Overall Study|Lost to Follow-up|13|||
124452975|NCT00938717|447620225|FG001|Overall Study|Lost to Follow-up|18|||
124452976|NCT00938717|447620224|FG000|Overall Study|Lack of Efficacy|33|||
124452977|NCT00938717|447620225|FG001|Overall Study|Lack of Efficacy|15|||
124452978|NCT00938717|447620224|FG000|Overall Study|Other reason|5|||
124452979|NCT00938717|447620225|FG001|Overall Study|Other reason|2|||
124452980|NCT05092919|447620227|FG000|Overall Study|Lost to Follow-up|7|||
124452981|NCT05092919|447620227|FG000|Overall Study|Withdrawal by Subject|2|||
124452982|NCT02248259|447620229|FG000|Treatment Period 1|Adverse Event|0|||
124452983|NCT02248259|447620230|FG001|Treatment Period 1|Adverse Event|0|||
124452984|NCT02248259|447620231|FG002|Treatment Period 1|Adverse Event|1|||
124452985|NCT02248259|447620232|FG003|Treatment Period 1|Adverse Event|0|||
124452986|NCT01848288|447620236|FG000|Overall Study|Death|1|||
124452987|NCT01848288|447620236|FG000|Overall Study|Protocol Violation|1|||
124452988|NCT01848288|447620236|FG000|Overall Study|Withdrawal by Subject|1|||
124452989|NCT00677820|447620238|FG000|Overall Study|Lost to Follow-up|1|||
124452990|NCT00677820|447620239|FG001|Overall Study|Lost to Follow-up|0|||
124452991|NCT02865018|447620263|FG000|Overall Study|Withdrawal by Subject|1|||
124922715|NCT03197662|449345474|FG001|Overall Study|Withdrawn by family|2|||
124922716|NCT04495894|449345484|FG000|Overall Study|Withdrawal by Subject|2|||
124452992|NCT00290290|447620264|FG000|Overall Study|Death|3|||
124452993|NCT00290290|447620265|FG001|Overall Study|Death|4|||
124452994|NCT00290290|447620264|FG000|Overall Study|Withdrawal by Subject|2|||
124452995|NCT00290290|447620265|FG001|Overall Study|Withdrawal by Subject|2|||
124452996|NCT00290290|447620264|FG000|Overall Study|Underwent clean surgical procedure|13|||
124452997|NCT00290290|447620265|FG001|Overall Study|Underwent clean surgical procedure|12|||
124452998|NCT00549939|447620273|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
124452999|NCT00549939|447620274|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
124453000|NCT00549939|447620275|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
124696290|NCT00504556|448509411|FG000|Overall Study|did not meet entry criteria|2|||
124696291|NCT00504556|448509412|FG001|Overall Study|did not meet entry criteria|0|||
124696292|NCT00504556|448509413|FG002|Overall Study|did not meet entry criteria|1|||
124762417|NCT02349633|448755878|FG013|Overall Study|Transition to compassionate use|0|||
124762418|NCT02349633|448755865|FG000|Overall Study|Early termination of survival follow-up|0|||
124762419|NCT02349633|448755866|FG001|Overall Study|Early termination of survival follow-up|0|||
124762420|NCT02349633|448755867|FG002|Overall Study|Early termination of survival follow-up|0|||
124762421|NCT02349633|448755868|FG003|Overall Study|Early termination of survival follow-up|0|||
124762422|NCT02349633|448755869|FG004|Overall Study|Early termination of survival follow-up|0|||
124762423|NCT02349633|448755870|FG005|Overall Study|Early termination of survival follow-up|0|||
124762424|NCT02349633|448755871|FG006|Overall Study|Early termination of survival follow-up|0|||
124762425|NCT02349633|448755872|FG007|Overall Study|Early termination of survival follow-up|4|||
124762426|NCT02349633|448755873|FG008|Overall Study|Early termination of survival follow-up|0|||
124762427|NCT02349633|448755874|FG009|Overall Study|Early termination of survival follow-up|0|||
124762428|NCT02349633|448755875|FG010|Overall Study|Early termination of survival follow-up|0|||
124762429|NCT02349633|448755876|FG011|Overall Study|Early termination of survival follow-up|0|||
124762430|NCT02349633|448755877|FG012|Overall Study|Early termination of survival follow-up|0|||
124762431|NCT02349633|448755878|FG013|Overall Study|Early termination of survival follow-up|0|||
124762432|NCT02349633|448755865|FG000|Overall Study|Termination by sponsor|0|||
124762433|NCT02349633|448755866|FG001|Overall Study|Termination by sponsor|0|||
124762434|NCT02349633|448755867|FG002|Overall Study|Termination by sponsor|0|||
124762435|NCT02349633|448755868|FG003|Overall Study|Termination by sponsor|0|||
124762436|NCT02349633|448755869|FG004|Overall Study|Termination by sponsor|0|||
124762437|NCT02349633|448755870|FG005|Overall Study|Termination by sponsor|0|||
124762438|NCT02349633|448755871|FG006|Overall Study|Termination by sponsor|0|||
124762439|NCT02349633|448755872|FG007|Overall Study|Termination by sponsor|1|||
124762440|NCT02349633|448755873|FG008|Overall Study|Termination by sponsor|0|||
124762441|NCT02349633|448755874|FG009|Overall Study|Termination by sponsor|2|||
124762442|NCT02349633|448755875|FG010|Overall Study|Termination by sponsor|0|||
124762443|NCT02349633|448755876|FG011|Overall Study|Termination by sponsor|0|||
124762444|NCT02349633|448755877|FG012|Overall Study|Termination by sponsor|0|||
124762445|NCT02349633|448755878|FG013|Overall Study|Termination by sponsor|0|||
124762446|NCT02349633|448755865|FG000|Overall Study|Other|0|||
124762447|NCT02349633|448755866|FG001|Overall Study|Other|0|||
124762448|NCT02349633|448755867|FG002|Overall Study|Other|0|||
124762449|NCT02349633|448755868|FG003|Overall Study|Other|0|||
124762450|NCT02349633|448755869|FG004|Overall Study|Other|0|||
124762451|NCT02349633|448755870|FG005|Overall Study|Other|0|||
124762452|NCT02349633|448755871|FG006|Overall Study|Other|0|||
124762453|NCT02349633|448755872|FG007|Overall Study|Other|2|||
124453001|NCT00549939|447620273|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
124453002|NCT00549939|447620274|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
124545669|NCT00594568|447952763|FG002|Initial Treatment|Entry criteria exclusion|1|||
124545670|NCT00594568|447952761|FG000|Delayed Start|Death|0|||
124545671|NCT00594568|447952762|FG001|Delayed Start|Death|0|||
124545672|NCT00594568|447952763|FG002|Delayed Start|Death|1|||
124545673|NCT00594568|447952761|FG000|Delayed Start|Adverse Event|12|||
124545674|NCT00594568|447952762|FG001|Delayed Start|Adverse Event|2|||
124545675|NCT00594568|447952763|FG002|Delayed Start|Adverse Event|2|||
124545676|NCT00594568|447952761|FG000|Delayed Start|Withdrawal by Subject|4|||
124545677|NCT00594568|447952762|FG001|Delayed Start|Withdrawal by Subject|3|||
124545678|NCT00594568|447952763|FG002|Delayed Start|Withdrawal by Subject|0|||
124545679|NCT00594568|447952761|FG000|Delayed Start|Physician Decision|0|||
124545680|NCT00594568|447952762|FG001|Delayed Start|Physician Decision|0|||
124545681|NCT00594568|447952763|FG002|Delayed Start|Physician Decision|1|||
124545682|NCT00594568|447952761|FG000|Delayed Start|Lost to Follow-up|0|||
124545683|NCT00594568|447952762|FG001|Delayed Start|Lost to Follow-up|0|||
124545684|NCT00594568|447952763|FG002|Delayed Start|Lost to Follow-up|1|||
124762454|NCT02349633|448755873|FG008|Overall Study|Other|0|||
124453003|NCT00549939|447620275|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
124453004|NCT00549939|447620273|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
124453005|NCT00549939|447620274|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
124453006|NCT00549939|447620275|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
124453007|NCT00549939|447620273|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
124453008|NCT00549939|447620274|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
124453009|NCT00549939|447620275|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
124453010|NCT00549939|447620273|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
124762455|NCT02349633|448755874|FG009|Overall Study|Other|0|||
124762456|NCT02349633|448755875|FG010|Overall Study|Other|0|||
124762457|NCT02349633|448755876|FG011|Overall Study|Other|0|||
124762458|NCT02349633|448755877|FG012|Overall Study|Other|0|||
124762459|NCT02349633|448755878|FG013|Overall Study|Other|0|||
124762460|NCT01008943|448755880|FG000|Overall Study|Withdrawal by Subject|1|||
124922717|NCT04495894|449345485|FG001|Overall Study|Withdrawal by Subject|0|||
124545685|NCT00594568|447952761|FG000|Delayed Start|Caregiver Decision|5|||
124545686|NCT00594568|447952762|FG001|Delayed Start|Caregiver Decision|6|||
124545687|NCT00594568|447952763|FG002|Delayed Start|Caregiver Decision|2|||
124545688|NCT00594568|447952761|FG000|Delayed Start|Sponsor Decision|77|||
124453011|NCT00549939|447620274|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
124453012|NCT00549939|447620275|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
124453013|NCT00549939|447620273|FG000|40-week Open Label Treatment Period|Other|0|||
124453014|NCT00549939|447620274|FG001|40-week Open Label Treatment Period|Other|1|||
124696293|NCT00504556|448509414|FG003|Overall Study|did not meet entry criteria|1|||
124696294|NCT00504556|448509415|FG004|Overall Study|did not meet entry criteria|0|||
124696295|NCT00504556|448509411|FG000|Overall Study|data monitor committee decision|0|||
124696296|NCT00504556|448509412|FG001|Overall Study|data monitor committee decision|0|||
124696297|NCT00504556|448509413|FG002|Overall Study|data monitor committee decision|0|||
124696298|NCT00504556|448509414|FG003|Overall Study|data monitor committee decision|100|||
124696299|NCT00504556|448509415|FG004|Overall Study|data monitor committee decision|0|||
124696300|NCT00504556|448509411|FG000|Overall Study|Other|2|||
124696301|NCT00504556|448509412|FG001|Overall Study|Other|2|||
124696302|NCT00504556|448509413|FG002|Overall Study|Other|2|||
124696303|NCT00504556|448509414|FG003|Overall Study|Other|3|||
124696304|NCT00504556|448509415|FG004|Overall Study|Other|0|||
124922718|NCT04495894|449345486|FG002|Overall Study|Withdrawal by Subject|2|||
124453015|NCT00549939|447620275|FG002|40-week Open Label Treatment Period|Other|4|||
124453016|NCT03677596|447620276|FG000|Overall Study|Adverse Event|0|||
124453017|NCT03677596|447620277|FG001|Overall Study|Adverse Event|1|||
124453018|NCT03677596|447620276|FG000|Overall Study|Death|10|||
124453019|NCT03677596|447620277|FG001|Overall Study|Death|6|||
124453020|NCT03677596|447620276|FG000|Overall Study|Lost to Follow-up|0|||
124453021|NCT03677596|447620277|FG001|Overall Study|Lost to Follow-up|1|||
124545689|NCT00594568|447952762|FG001|Delayed Start|Sponsor Decision|66|||
124922719|NCT04495894|449345487|FG003|Overall Study|Withdrawal by Subject|3|||
124922720|NCT04495894|449345484|FG000|Overall Study|Early termination|0|||
124922721|NCT04495894|449345485|FG001|Overall Study|Early termination|0|||
124922722|NCT04495894|449345486|FG002|Overall Study|Early termination|3|||
124922723|NCT04495894|449345487|FG003|Overall Study|Early termination|0|||
124922724|NCT05579899|449345489|FG000|Overall Study|Lost to Follow-up|3|||
124922725|NCT05579899|449345490|FG001|Overall Study|Lost to Follow-up|1|||
124922726|NCT05579899|449345489|FG000|Overall Study|Adverse Event|0|||
124922727|NCT05579899|449345490|FG001|Overall Study|Adverse Event|3|||
124922728|NCT05579899|449345489|FG000|Overall Study|Pregnancy|0|||
124922729|NCT05579899|449345490|FG001|Overall Study|Pregnancy|1|||
124922730|NCT05579899|449345489|FG000|Overall Study|Withdrawal by Subject|0|||
124922731|NCT05579899|449345490|FG001|Overall Study|Withdrawal by Subject|3|||
124922732|NCT03364647|449345491|FG000|Overall Study|Withdrawal by Subject|3|||
124922733|NCT03364647|449345492|FG001|Overall Study|Withdrawal by Subject|1|||
124922734|NCT04064164|449345495|FG000|Overall Study|Withdrawal by Subject|8|||
124922735|NCT04064164|449345496|FG001|Overall Study|Withdrawal by Subject|8|||
124922736|NCT01000961|449345498|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
124922737|NCT01000961|449345499|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
124922738|NCT01000961|449345498|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
124922739|NCT01000961|449345499|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
124922740|NCT05030233|449345507|FG000|Overall Study|withdrawn for transfer|1|||
124922741|NCT05030233|449345508|FG001|Overall Study|withdrawn for transfer|0|||
124922742|NCT03365882|449345509|FG000|Randomization|Still Receiving Protocol Treatment|2|||
124922743|NCT03365882|449345510|FG001|Randomization|Still Receiving Protocol Treatment|0|||
124922744|NCT03365882|449345509|FG000|Randomization|Adverse Event|1|||
124922745|NCT03365882|449345510|FG001|Randomization|Adverse Event|2|||
124922746|NCT03365882|449345509|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
124922747|NCT03365882|449345510|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
124922748|NCT03365882|449345509|FG000|Randomization|Progression/Relapse|21|||
124545690|NCT00594568|447952763|FG002|Delayed Start|Sponsor Decision|59|||
124545691|NCT00594568|447952761|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
124545692|NCT00594568|447952762|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
124922749|NCT03365882|449345510|FG001|Randomization|Progression/Relapse|3|||
124922750|NCT03365882|449345509|FG000|Randomization|Death|1|||
124922751|NCT03365882|449345510|FG001|Randomization|Death|0|||
124922752|NCT03365882|449345509|FG000|Randomization|Other - Not Protocol Specified|1|||
124922753|NCT03365882|449345510|FG001|Randomization|Other - Not Protocol Specified|1|||
124545693|NCT00594568|447952763|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
124545694|NCT00594568|447952761|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
124453022|NCT03677596|447620276|FG000|Overall Study|Progressive Disease|8|||
124453023|NCT03677596|447620277|FG001|Overall Study|Progressive Disease|8|||
124545695|NCT00594568|447952762|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
124696305|NCT00504556|448509411|FG000|Overall Study|not in safety analysis set|0|||
124696306|NCT00504556|448509412|FG001|Overall Study|not in safety analysis set|1|||
124696307|NCT00504556|448509413|FG002|Overall Study|not in safety analysis set|1|||
124696308|NCT00504556|448509414|FG003|Overall Study|not in safety analysis set|0|||
124922754|NCT03365882|449345509|FG000|Randomization|Major Protocol Deviation|0|||
124922755|NCT03365882|449345510|FG001|Randomization|Major Protocol Deviation|1|||
124922756|NCT03365882|449345509|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
124922757|NCT03365882|449345510|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
124922758|NCT03365882|449345509|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
124922759|NCT03365882|449345510|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
124922760|NCT03365882|449345509|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
124922761|NCT03365882|449345510|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
124922762|NCT03365882|449345509|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
124453024|NCT03677596|447620276|FG000|Overall Study|Withdrawal by Subject|3|||
124453025|NCT03677596|447620277|FG001|Overall Study|Withdrawal by Subject|0|||
124453026|NCT03677596|447620276|FG000|Overall Study|Disease Relapse|2|||
124453027|NCT03677596|447620277|FG001|Overall Study|Disease Relapse|2|||
124453028|NCT03677596|447620276|FG000|Overall Study|Other|0|||
124453029|NCT03677596|447620277|FG001|Overall Study|Other|1|||
124453030|NCT00003895|447620278|FG000|Overall Study|Adverse Event|4|||
124453031|NCT00003895|447620279|FG001|Overall Study|Adverse Event|0|||
124453032|NCT00003895|447620278|FG000|Overall Study|Lack of Efficacy|1|||
124453033|NCT00003895|447620279|FG001|Overall Study|Lack of Efficacy|1|||
124453034|NCT00003895|447620278|FG000|Overall Study|Patient Vacation|2|||
124453035|NCT00003895|447620279|FG001|Overall Study|Patient Vacation|0|||
124453036|NCT00003895|447620278|FG000|Overall Study|Withdrawal by Subject|0|||
124453037|NCT00003895|447620279|FG001|Overall Study|Withdrawal by Subject|3|||
124453038|NCT04912245|447620280|FG000|Overall Study|Withdrawal by Subject|21|||
124453039|NCT04912245|447620281|FG001|Overall Study|Withdrawal by Subject|4|||
124453040|NCT04912245|447620280|FG000|Overall Study|Lost to Follow-up|5|||
124453041|NCT04912245|447620281|FG001|Overall Study|Lost to Follow-up|11|||
124453042|NCT01134614|447620282|FG000|Overall Study|Still on treatment as of March 2013|21|||
124453043|NCT01134614|447620283|FG001|Overall Study|Still on treatment as of March 2013|13|||
124453044|NCT01134614|447620282|FG000|Overall Study|Progressive disease|60|||
124453045|NCT01134614|447620283|FG001|Overall Study|Progressive disease|54|||
124453046|NCT01134614|447620282|FG000|Overall Study|Adverse Event|26|||
124453047|NCT01134614|447620283|FG001|Overall Study|Adverse Event|39|||
124453048|NCT01134614|447620282|FG000|Overall Study|Death|5|||
124453049|NCT01134614|447620283|FG001|Overall Study|Death|8|||
124453050|NCT01134614|447620282|FG000|Overall Study|Withdrawal by Subject|3|||
124453051|NCT01134614|447620283|FG001|Overall Study|Withdrawal by Subject|2|||
124453052|NCT01134614|447620282|FG000|Overall Study|Alternative therapy|2|||
124453053|NCT01134614|447620283|FG001|Overall Study|Alternative therapy|0|||
124453054|NCT01134614|447620282|FG000|Overall Study|Complicating disease|2|||
124453055|NCT01134614|447620283|FG001|Overall Study|Complicating disease|1|||
124453056|NCT01134614|447620282|FG000|Overall Study|Physician's decision|0|||
124453057|NCT01134614|447620283|FG001|Overall Study|Physician's decision|1|||
124453058|NCT01134614|447620282|FG000|Overall Study|Never started treatment|4|||
124453059|NCT01134614|447620283|FG001|Overall Study|Never started treatment|1|||
124453060|NCT01134614|447620282|FG000|Overall Study|Pt received tx not allowed on study|0|||
124453061|NCT01134614|447620283|FG001|Overall Study|Pt received tx not allowed on study|1|||
124453062|NCT01134614|447620282|FG000|Overall Study|Symptomatic deterioration|0|||
124453063|NCT01134614|447620283|FG001|Overall Study|Symptomatic deterioration|1|||
124453064|NCT01134614|447620282|FG000|Overall Study|Patient in hospice care|0|||
124453065|NCT01134614|447620283|FG001|Overall Study|Patient in hospice care|1|||
124453066|NCT04534491|447620290|FG000|Overall Study|Not completed end-of-study interview|24|||
124453067|NCT04534491|447620290|FG000|Overall Study|Non-users|70|||
124453068|NCT04534491|447620290|FG000|Overall Study|Non-verifiable users|58|||
124453069|NCT00496730|447620291|FG000|Overall Study|Lost to Follow-up|4|||
124453070|NCT00496730|447620292|FG001|Overall Study|Lost to Follow-up|3|||
124453071|NCT00496730|447620291|FG000|Overall Study|Withdrawal by Subject|2|||
124453072|NCT00496730|447620292|FG001|Overall Study|Withdrawal by Subject|2|||
124453073|NCT00113074|447620293|FG000|Overall Study|Lost to Follow-up|10|||
124453074|NCT00113074|447620294|FG001|Overall Study|Lost to Follow-up|10|||
124453075|NCT00113074|447620295|FG002|Overall Study|Lost to Follow-up|14|||
124453076|NCT02114268|447620296|FG000|Overall Study|Lost to Follow-up|4|||
124453077|NCT02114268|447620297|FG001|Overall Study|Lost to Follow-up|1|||
124453078|NCT02114268|447620298|FG002|Overall Study|Lost to Follow-up|1|||
124453079|NCT02114268|447620299|FG003|Overall Study|Lost to Follow-up|0|||
124453080|NCT02114268|447620300|FG004|Overall Study|Lost to Follow-up|0|||
124922763|NCT03365882|449345510|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
124453081|NCT02114268|447620301|FG005|Overall Study|Lost to Follow-up|2|||
124453082|NCT02114268|447620296|FG000|Overall Study|Withdrawal by Subject|1|||
124453083|NCT02114268|447620297|FG001|Overall Study|Withdrawal by Subject|0|||
124453084|NCT02114268|447620298|FG002|Overall Study|Withdrawal by Subject|0|||
124453085|NCT02114268|447620299|FG003|Overall Study|Withdrawal by Subject|0|||
124453086|NCT02114268|447620300|FG004|Overall Study|Withdrawal by Subject|0|||
124453087|NCT02114268|447620301|FG005|Overall Study|Withdrawal by Subject|1|||
124453088|NCT02114268|447620296|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
124922764|NCT05177848|449348179|FG000|Overall Study|Lost to Follow-up|1|||
124453089|NCT02114268|447620297|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
124453090|NCT02114268|447620298|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
124453091|NCT02114268|447620299|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
124453092|NCT02114268|447620300|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
124696309|NCT00504556|448509415|FG004|Overall Study|not in safety analysis set|1|||
124696310|NCT01013870|448509416|FG000|Overall Study|Lost to Follow-up|1|||
124922765|NCT05177848|449348180|FG001|Overall Study|Lost to Follow-up|4|||
124922766|NCT05177848|449348179|FG000|Overall Study|Discontinued|2|||
124922767|NCT05177848|449348180|FG001|Overall Study|Discontinued|1|||
124696311|NCT01013870|448509417|FG001|Overall Study|Lost to Follow-up|3|||
124696312|NCT01386645|448509418|FG000|Overall Study|Physician Decision|0|||
124696313|NCT01386645|448509419|FG001|Overall Study|Physician Decision|0|||
124696314|NCT01386645|448509420|FG002|Overall Study|Physician Decision|1|||
124696315|NCT01386645|448509418|FG000|Overall Study|Withdrawal by Subject|0|||
124696316|NCT01386645|448509419|FG001|Overall Study|Withdrawal by Subject|1|||
124696317|NCT01386645|448509420|FG002|Overall Study|Withdrawal by Subject|1|||
124696318|NCT01052428|448509421|FG000|Overall Study|Death|1|||
124696319|NCT01052428|448509422|FG001|Overall Study|Death|0|||
124696320|NCT01052428|448509421|FG000|Overall Study|Withdrawal by Subject|0|||
124696321|NCT01052428|448509422|FG001|Overall Study|Withdrawal by Subject|1|||
124696322|NCT00871000|448509423|FG000|Overall Study|Withdrawal by Subject|1|||
124696323|NCT00871000|448509424|FG001|Overall Study|Withdrawal by Subject|0|||
124696324|NCT04432298|448509428|FG000|Overall Study|Other than specified|1|||
124696325|NCT04432298|448509429|FG001|Overall Study|Other than specified|0|||
124696326|NCT04432298|448509428|FG000|Overall Study|Lost to Follow-up|0|||
124696327|NCT04432298|448509429|FG001|Overall Study|Lost to Follow-up|1|||
124696328|NCT04432298|448509428|FG000|Overall Study|Death|3|||
124696329|NCT04432298|448509429|FG001|Overall Study|Death|2|||
124696330|NCT04432298|448509428|FG000|Overall Study|Withdrawal by Subject|2|||
124696331|NCT04432298|448509429|FG001|Overall Study|Withdrawal by Subject|0|||
124696332|NCT02365064|448509430|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
124696333|NCT02365064|448509431|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
124696334|NCT02365064|448509430|FG000|Overall Study|Withdrawal by Subject|6|||
124696335|NCT02365064|448509431|FG001|Overall Study|Withdrawal by Subject|9|||
124922768|NCT03771417|449348181|FG000|Overall Study|Withdrawal by Subject|1|||
124922769|NCT03771417|449348182|FG001|Overall Study|Withdrawal by Subject|0|||
124922770|NCT03771417|449348183|FG002|Overall Study|Withdrawal by Subject|0|||
124922771|NCT03771417|449348181|FG000|Overall Study|Covid-19 Shutdown|0|||
124922772|NCT03771417|449348182|FG001|Overall Study|Covid-19 Shutdown|1|||
124696336|NCT02365064|448509430|FG000|Overall Study|Treatment intolerance|2|||
124696337|NCT02365064|448509431|FG001|Overall Study|Treatment intolerance|4|||
124696338|NCT02451007|448509434|FG000|Overall Study|Withdrawal by Subject|4|||
124696339|NCT02451007|448509434|FG000|Overall Study|Adverse Event|1|||
124696340|NCT02451007|448509434|FG000|Overall Study|Disease Progression|2|||
124696341|NCT00348374|448509435|FG000|Overall Study|Adverse Event|1|||
124696342|NCT00348374|448509436|FG001|Overall Study|Adverse Event|4|||
124696343|NCT00348374|448509435|FG000|Overall Study|Lost to Follow-up|1|||
124922773|NCT03771417|449348183|FG002|Overall Study|Covid-19 Shutdown|0|||
124453093|NCT02114268|447620301|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
124922774|NCT04342494|449348185|FG000|Overall Study|Questionnaire partially completed|1|||
124922775|NCT04342494|449348186|FG001|Overall Study|Questionnaire partially completed|0|||
124922776|NCT04342494|449348187|FG002|Overall Study|Questionnaire partially completed|2|||
124922777|NCT04342494|449348188|FG003|Overall Study|Questionnaire partially completed|0|||
124922778|NCT04342494|449348189|FG004|Overall Study|Questionnaire partially completed|1|||
124922779|NCT04342494|449348185|FG000|Overall Study|Lost to Follow-up|49|||
124922780|NCT04342494|449348186|FG001|Overall Study|Lost to Follow-up|38|||
124922781|NCT04342494|449348187|FG002|Overall Study|Lost to Follow-up|34|||
124922782|NCT04342494|449348188|FG003|Overall Study|Lost to Follow-up|34|||
124922783|NCT04342494|449348189|FG004|Overall Study|Lost to Follow-up|35|||
124922784|NCT01214616|449348192|FG000|Overall Study|Progressive disease|2|||
124922785|NCT01214616|449348193|FG001|Overall Study|Progressive disease|2|||
124922786|NCT01214616|449348194|FG002|Overall Study|Progressive disease|2|||
124922787|NCT01214616|449348195|FG003|Overall Study|Progressive disease|4|||
124922788|NCT01214616|449348192|FG000|Overall Study|Dose limiting toxicity|0|||
124922789|NCT01214616|449348193|FG001|Overall Study|Dose limiting toxicity|2|||
124922790|NCT01214616|449348194|FG002|Overall Study|Dose limiting toxicity|0|||
124922791|NCT01214616|449348195|FG003|Overall Study|Dose limiting toxicity|0|||
124922792|NCT01214616|449348192|FG000|Overall Study|Other adverse events|0|||
124922793|NCT01214616|449348193|FG001|Overall Study|Other adverse events|1|||
124922794|NCT01214616|449348194|FG002|Overall Study|Other adverse events|1|||
124922795|NCT01214616|449348195|FG003|Overall Study|Other adverse events|1|||
124922796|NCT01214616|449348192|FG000|Overall Study|Withdrawal by Subject|1|||
124922797|NCT01214616|449348193|FG001|Overall Study|Withdrawal by Subject|0|||
124922798|NCT01214616|449348194|FG002|Overall Study|Withdrawal by Subject|0|||
124922799|NCT01214616|449348195|FG003|Overall Study|Withdrawal by Subject|1|||
124922800|NCT03721952|449348196|FG000|Overall Study|Lost to Follow-up|0|||
124922801|NCT03721952|449348197|FG001|Overall Study|Lost to Follow-up|0|||
124922802|NCT03721952|449348198|FG002|Overall Study|Lost to Follow-up|2|||
124922803|NCT03721952|449348199|FG003|Overall Study|Lost to Follow-up|0|||
124922804|NCT03721952|449348200|FG004|Overall Study|Lost to Follow-up|0|||
124922805|NCT03721952|449348196|FG000|Overall Study|Protocol Violation|0|||
124922806|NCT03721952|449348197|FG001|Overall Study|Protocol Violation|1|||
124922807|NCT03721952|449348198|FG002|Overall Study|Protocol Violation|0|||
124922808|NCT03721952|449348199|FG003|Overall Study|Protocol Violation|0|||
124922809|NCT03721952|449348200|FG004|Overall Study|Protocol Violation|0|||
124922810|NCT03721952|449348196|FG000|Overall Study|Withdrawal by Subject|1|||
124922811|NCT03721952|449348197|FG001|Overall Study|Withdrawal by Subject|0|||
124922812|NCT03721952|449348198|FG002|Overall Study|Withdrawal by Subject|40|||
124922813|NCT03721952|449348199|FG003|Overall Study|Withdrawal by Subject|28|||
124922814|NCT03721952|449348200|FG004|Overall Study|Withdrawal by Subject|0|||
124922815|NCT05292365|449348201|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
124922816|NCT05292365|449348202|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
124922817|NCT05292365|449348203|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
124922818|NCT05292365|449348204|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
124922819|NCT04633122|449348205|FG000|Overall Study|Remained on treatment|19|||
124922820|NCT04633122|449348206|FG001|Overall Study|Remained on treatment|14|||
124922821|NCT04633122|449348205|FG000|Overall Study|Survival follow-up stopped|22|||
124922822|NCT04633122|449348206|FG001|Overall Study|Survival follow-up stopped|25|||
124922823|NCT04185298|449348207|FG000|Overall Study|Lost to Follow-up|1|||
124453094|NCT03962738|447620302|FG000|Overall Study|Protocol Deviation|3|||
124922824|NCT04185298|449348208|FG001|Overall Study|Lost to Follow-up|3|||
124922825|NCT04185298|449348207|FG000|Overall Study|Withdrawal by Subject|0|||
124922826|NCT04185298|449348208|FG001|Overall Study|Withdrawal by Subject|3|||
124922827|NCT01798498|449348209|FG000|Overall Study|Lost to Follow-up|1|||
124922828|NCT03896789|449348210|FG000|Baseline|Lost to Follow-up|1|||
124922829|NCT03896789|449348211|FG001|Baseline|Lost to Follow-up|2|||
124922830|NCT03896789|449348210|FG000|Baseline|Death|3|||
124922831|NCT03896789|449348211|FG001|Baseline|Death|6|||
124922832|NCT03896789|449348210|FG000|Post-Randomization|Lost to Follow-up|12|||
124922833|NCT03896789|449348211|FG001|Post-Randomization|Lost to Follow-up|11|||
124922834|NCT03896789|449348210|FG000|Post-Randomization|Death|12|||
124922835|NCT03896789|449348211|FG001|Post-Randomization|Death|13|||
124922836|NCT00227344|449348217|FG000|Overall Study|study terminated early|12|||
124453095|NCT03962738|447620303|FG001|Overall Study|Protocol Deviation|0|||
124453096|NCT03962738|447620304|FG002|Overall Study|Protocol Deviation|1|||
124922837|NCT00227344|449348218|FG001|Overall Study|study terminated early|5|||
124922838|NCT01987895|449348219|FG000|Overall Study|Withdrawal by Subject|12|||
124922839|NCT01987895|449348220|FG001|Overall Study|Withdrawal by Subject|7|||
124762461|NCT01453140|448755883|FG000|Overall Study|Adverse Event|3|||
124922840|NCT01987895|449348219|FG000|Overall Study|Physician Decision|8|||
124922841|NCT01987895|449348220|FG001|Overall Study|Physician Decision|10|||
124922842|NCT01987895|449348219|FG000|Overall Study|Death|7|||
124922843|NCT01987895|449348220|FG001|Overall Study|Death|7|||
124922844|NCT01987895|449348219|FG000|Overall Study|Lost to Follow-up|3|||
124545696|NCT00594568|447952763|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
124545697|NCT00594568|447952761|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
124545698|NCT00594568|447952762|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
124545699|NCT00594568|447952763|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
124922845|NCT01987895|449348220|FG001|Overall Study|Lost to Follow-up|5|||
124696344|NCT00348374|448509436|FG001|Overall Study|Lost to Follow-up|3|||
124762462|NCT02611479|448755884|FG000|Baseline Enrollment|Exited study|13|||
124762463|NCT02611479|448755884|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
124922846|NCT01987895|449348219|FG000|Overall Study|randomized before giving IC|0|||
124922847|NCT01987895|449348220|FG001|Overall Study|randomized before giving IC|1|||
124922848|NCT05364671|449348221|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
124922849|NCT05364671|449348222|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
124922850|NCT05364671|449348221|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
124922851|NCT05364671|449348222|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
124922852|NCT05364671|449348221|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
124922853|NCT05364671|449348222|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
124922854|NCT05364671|449348221|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
124922855|NCT05364671|449348222|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
124922856|NCT05364671|449348221|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
124922857|NCT05364671|449348222|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
124922858|NCT02359890|449348223|FG000|Overall Study|Not meeting eligibility|4|||
124922859|NCT02359890|449348223|FG000|Overall Study|Never treated with study catheter|6|||
124922860|NCT05256017|449348224|FG000|Treatment Period|Withdrawal by Subject|1|||
124922861|NCT05256017|449348225|FG001|Treatment Period|Withdrawal by Subject|1|||
124922862|NCT05256017|449348224|FG000|Follow-up|Lost to Follow-up|7|||
124922863|NCT05256017|449348225|FG001|Follow-up|Lost to Follow-up|1|||
124922864|NCT05256017|449348224|FG000|Follow-up|Withdrawal by Subject|1|||
124922865|NCT05256017|449348225|FG001|Follow-up|Withdrawal by Subject|0|||
124922866|NCT05256017|449348224|FG000|Follow-up|Death|0|||
124922867|NCT05256017|449348225|FG001|Follow-up|Death|1|||
124922868|NCT05780437|449348228|FG000|Overall Study|Withdrawal by Subject|22|||
124922869|NCT05780437|449348229|FG001|Overall Study|Withdrawal by Subject|16|||
124922870|NCT04015167|449348230|FG000|Overall Study|Lost to Follow-up|40|||
124922871|NCT04015167|449348230|FG000|Overall Study|Adverse Event|5|||
124922872|NCT04015167|449348230|FG000|Overall Study|Withdrawal by Subject|2|||
124922873|NCT04015167|449348230|FG000|Overall Study|Subject went to jail|1|||
124922874|NCT03536754|449348231|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
124922875|NCT03536754|449348232|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
124922876|NCT03536754|449348233|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
124922877|NCT03536754|449348234|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
124922878|NCT03536754|449348235|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
124922879|NCT03536754|449348231|FG000|Open Label Extension|Other|0|||
124922880|NCT03536754|449348232|FG001|Open Label Extension|Other|0|||
124922881|NCT03536754|449348233|FG002|Open Label Extension|Other|0|||
124922882|NCT03536754|449348234|FG003|Open Label Extension|Other|0|||
124922883|NCT03536754|449348235|FG004|Open Label Extension|Other|1|||
124545700|NCT00594568|447952761|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
124545701|NCT00594568|447952762|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
124696345|NCT00348374|448509435|FG000|Overall Study|Withdrawal by Subject|5|||
124696346|NCT00348374|448509436|FG001|Overall Study|Withdrawal by Subject|5|||
124696347|NCT00348374|448509435|FG000|Overall Study|Other|11|||
124696348|NCT00348374|448509436|FG001|Overall Study|Other|12|||
124696349|NCT00348374|448509435|FG000|Overall Study|ongoing at date of cutoff|1|||
124696350|NCT00348374|448509436|FG001|Overall Study|ongoing at date of cutoff|1|||
124696351|NCT00348374|448509435|FG000|Overall Study|randomized but did not receive treatment|0|||
124696352|NCT00348374|448509436|FG001|Overall Study|randomized but did not receive treatment|7|||
124696353|NCT02595437|448509445|FG000|Triferic Via IV|Withdrawal by Subject|1|||
124696354|NCT02773537|448509456|FG000|Overall Study|Lost to Follow-up|0|||
124696355|NCT02773537|448509457|FG001|Overall Study|Lost to Follow-up|1|||
124696356|NCT02773537|448509458|FG002|Overall Study|Lost to Follow-up|4|||
124696357|NCT01840163|448509459|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
124696358|NCT01840163|448509460|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
124922884|NCT03452579|449348236|FG000|Overall Study|Death|0|||
124696359|NCT01840163|448509459|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
124922885|NCT03452579|449348237|FG001|Overall Study|Death|1|||
124922886|NCT03452579|449348236|FG000|Overall Study|Withdrawal by Subject|2|||
124922887|NCT03452579|449348237|FG001|Overall Study|Withdrawal by Subject|0|||
124922888|NCT03452579|449348236|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
124922889|NCT03452579|449348237|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
124696360|NCT01840163|448509460|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
124696361|NCT01840163|448509459|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
124922890|NCT03452579|449348236|FG000|Overall Study|Physician Decision|1|||
124696362|NCT01840163|448509460|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
124696363|NCT03636269|448509464|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
124696364|NCT03636269|448509465|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
124696365|NCT03636269|448509466|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
124922891|NCT03452579|449348237|FG001|Overall Study|Physician Decision|1|||
124922892|NCT03452579|449348236|FG000|Overall Study|Adverse Event|1|||
124922893|NCT03452579|449348237|FG001|Overall Study|Adverse Event|4|||
124922894|NCT03382652|449348241|FG000|Overall Study|Lost to Follow-up|6|||
124922895|NCT03382652|449348241|FG000|Overall Study|Death|4|||
124922896|NCT03382652|449348241|FG000|Overall Study|Revision|5|||
124922897|NCT03382652|449348241|FG000|Overall Study|Patient withdrew|3|||
124922898|NCT03382652|449348241|FG000|Overall Study|Other reasons|21|||
124922899|NCT04858321|449348242|FG000|Overall Study|Withdrawal by Subject|3|||
124922900|NCT04810650|449348243|FG000|Overall Study|Disenrolled in error|0|||
124922901|NCT04810650|449348244|FG001|Overall Study|Disenrolled in error|0|||
124922902|NCT04810650|449348245|FG002|Overall Study|Disenrolled in error|0|||
124922903|NCT04810650|449348246|FG003|Overall Study|Disenrolled in error|0|||
124922904|NCT04810650|449348247|FG004|Overall Study|Disenrolled in error|0|||
124922905|NCT04810650|449348248|FG005|Overall Study|Disenrolled in error|0|||
124922906|NCT04810650|449348249|FG006|Overall Study|Disenrolled in error|0|||
124922907|NCT04810650|449348250|FG007|Overall Study|Disenrolled in error|0|||
124922908|NCT04810650|449348251|FG008|Overall Study|Disenrolled in error|1|||
124922909|NCT04810650|449348252|FG009|Overall Study|Disenrolled in error|0|||
124922910|NCT04810650|449348253|FG010|Overall Study|Disenrolled in error|0|||
124922911|NCT04810650|449348254|FG011|Overall Study|Disenrolled in error|0|||
124922912|NCT04810650|449348255|FG012|Overall Study|Disenrolled in error|0|||
124922913|NCT04810650|449348256|FG013|Overall Study|Disenrolled in error|0|||
124922914|NCT04810650|449348243|FG000|Overall Study|Death|0|||
124922915|NCT04810650|449348244|FG001|Overall Study|Death|0|||
124922916|NCT04810650|449348245|FG002|Overall Study|Death|0|||
124922917|NCT04810650|449348246|FG003|Overall Study|Death|0|||
124922918|NCT04810650|449348247|FG004|Overall Study|Death|0|||
124922919|NCT04810650|449348248|FG005|Overall Study|Death|0|||
124922920|NCT04810650|449348249|FG006|Overall Study|Death|2|||
124922921|NCT04810650|449348250|FG007|Overall Study|Death|2|||
124922922|NCT04810650|449348251|FG008|Overall Study|Death|0|||
124922923|NCT04810650|449348252|FG009|Overall Study|Death|1|||
124922924|NCT04810650|449348253|FG010|Overall Study|Death|0|||
124922925|NCT04810650|449348254|FG011|Overall Study|Death|0|||
124922926|NCT04810650|449348255|FG012|Overall Study|Death|2|||
124922927|NCT04810650|449348256|FG013|Overall Study|Death|1|||
124922928|NCT04810650|449348243|FG000|Overall Study|Moved/transferred care|0|||
124922929|NCT04810650|449348244|FG001|Overall Study|Moved/transferred care|0|||
124922930|NCT04810650|449348245|FG002|Overall Study|Moved/transferred care|0|||
124922931|NCT04810650|449348246|FG003|Overall Study|Moved/transferred care|0|||
124922932|NCT04810650|449348247|FG004|Overall Study|Moved/transferred care|0|||
124922933|NCT04810650|449348248|FG005|Overall Study|Moved/transferred care|0|||
124922934|NCT04810650|449348249|FG006|Overall Study|Moved/transferred care|0|||
124922935|NCT04810650|449348250|FG007|Overall Study|Moved/transferred care|1|||
124922936|NCT04810650|449348251|FG008|Overall Study|Moved/transferred care|12|||
124922937|NCT04810650|449348252|FG009|Overall Study|Moved/transferred care|10|||
124922938|NCT04810650|449348253|FG010|Overall Study|Moved/transferred care|0|||
124922939|NCT04810650|449348254|FG011|Overall Study|Moved/transferred care|0|||
124922940|NCT04810650|449348255|FG012|Overall Study|Moved/transferred care|0|||
124922941|NCT04810650|449348256|FG013|Overall Study|Moved/transferred care|0|||
124922942|NCT04810650|449348243|FG000|Overall Study|Lost to Follow-up|15|||
124922943|NCT04810650|449348244|FG001|Overall Study|Lost to Follow-up|12|||
124922944|NCT04810650|449348245|FG002|Overall Study|Lost to Follow-up|7|||
124922945|NCT04810650|449348246|FG003|Overall Study|Lost to Follow-up|9|||
124922946|NCT04810650|449348247|FG004|Overall Study|Lost to Follow-up|10|||
124922947|NCT04810650|449348248|FG005|Overall Study|Lost to Follow-up|6|||
124922948|NCT04810650|449348249|FG006|Overall Study|Lost to Follow-up|0|||
124922949|NCT04810650|449348250|FG007|Overall Study|Lost to Follow-up|0|||
124922950|NCT04810650|449348251|FG008|Overall Study|Lost to Follow-up|0|||
124922951|NCT04810650|449348252|FG009|Overall Study|Lost to Follow-up|0|||
124922952|NCT04810650|449348253|FG010|Overall Study|Lost to Follow-up|1|||
124922953|NCT04810650|449348254|FG011|Overall Study|Lost to Follow-up|0|||
124922954|NCT04810650|449348255|FG012|Overall Study|Lost to Follow-up|3|||
124922955|NCT04810650|449348256|FG013|Overall Study|Lost to Follow-up|9|||
124922956|NCT04810650|449348243|FG000|Overall Study|Participant declined|0|||
124922957|NCT04810650|449348244|FG001|Overall Study|Participant declined|0|||
124922958|NCT04810650|449348245|FG002|Overall Study|Participant declined|0|||
124922959|NCT04810650|449348246|FG003|Overall Study|Participant declined|0|||
124696366|NCT03636269|448509464|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
124922960|NCT04810650|449348247|FG004|Overall Study|Participant declined|0|||
124453097|NCT03962738|447620305|FG003|Overall Study|Protocol Deviation|1|||
124453098|NCT03962738|447620302|FG000|Overall Study|Withdrawal by Subject|4|||
124453099|NCT03962738|447620303|FG001|Overall Study|Withdrawal by Subject|0|||
124453100|NCT03962738|447620304|FG002|Overall Study|Withdrawal by Subject|0|||
124545702|NCT00594568|447952763|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
124545703|NCT00594568|447952761|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
124545704|NCT00594568|447952762|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
124545705|NCT00594568|447952763|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
124545706|NCT00594568|447952761|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
124545707|NCT00594568|447952762|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
124545708|NCT00594568|447952763|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
124545709|NCT04478994|447952764|FG000|Overall Study|Withdrawal by Subject|1|||
124545710|NCT04478994|447952765|FG001|Overall Study|Withdrawal by Subject|1|||
124545711|NCT01100073|447952766|FG000|Overall Study|Lack of Efficacy|4|||
124545712|NCT01100073|447952766|FG000|Overall Study|Insufficient Tolerability|21|||
124545713|NCT01100073|447952766|FG000|Overall Study|Withdrawal by Subject|13|||
124545714|NCT01100073|447952766|FG000|Overall Study|Lost to Follow-up|39|||
124545715|NCT01100073|447952766|FG000|Overall Study|Lack of effect + patient's wish|2|||
124545716|NCT01100073|447952766|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
124545717|NCT01100073|447952766|FG000|Overall Study|Other|8|||
124545718|NCT01100073|447952766|FG000|Overall Study|Missing|5|||
124545719|NCT00518531|447952767|FG000|Treatment Period 1|Adverse Event|5|||
124545720|NCT00518531|447952768|FG001|Treatment Period 1|Adverse Event|0|||
124545721|NCT00518531|447952767|FG000|Treatment Period 1|Lost to Follow-up|5|||
124545722|NCT00518531|447952768|FG001|Treatment Period 1|Lost to Follow-up|3|||
124545723|NCT00518531|447952767|FG000|Treatment Period 1|Physician Decision|1|||
124453101|NCT03962738|447620305|FG003|Overall Study|Withdrawal by Subject|0|||
124453102|NCT03962738|447620302|FG000|Overall Study|Lost to Follow-up|0|||
124453103|NCT03962738|447620303|FG001|Overall Study|Lost to Follow-up|0|||
124453104|NCT03962738|447620304|FG002|Overall Study|Lost to Follow-up|1|||
124453105|NCT03962738|447620305|FG003|Overall Study|Lost to Follow-up|0|||
124453106|NCT00509067|447620306|FG000|Overall Study|Lost to Follow-up|1|||
124453107|NCT00509067|447620307|FG001|Overall Study|Lost to Follow-up|1|||
124453108|NCT00509067|447620306|FG000|Overall Study|Adverse Event|3|||
124453109|NCT00509067|447620307|FG001|Overall Study|Adverse Event|1|||
124453110|NCT00509067|447620306|FG000|Overall Study|Protocol Violation|0|||
124453111|NCT00509067|447620307|FG001|Overall Study|Protocol Violation|3|||
124453112|NCT02247960|447620309|FG000|Patient Consent and Randomization|Physician Decision|2|||
124453113|NCT02247960|447620310|FG001|Patient Consent and Randomization|Physician Decision|2|||
124453114|NCT02247960|447620309|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
124453115|NCT02247960|447620310|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
124453116|NCT02247960|447620309|FG000|Catheter Removed|Lost to Follow-up|7|||
124453117|NCT02247960|447620310|FG001|Catheter Removed|Lost to Follow-up|10|||
124453118|NCT00356889|447620311|FG000|Overall Study|Protocol Violation|2|||
124453119|NCT00356889|447620311|FG000|Overall Study|Adverse Event|1|||
124453120|NCT00736034|447620314|FG000|Overall Study|Adverse Event|2|||
124545724|NCT00518531|447952768|FG001|Treatment Period 1|Physician Decision|0|||
124545725|NCT00518531|447952767|FG000|Treatment Period 1|Protocol Violation|2|||
124696367|NCT03636269|448509465|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
124696368|NCT03636269|448509466|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
124696369|NCT03636269|448509464|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
124696370|NCT03636269|448509465|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
124696371|NCT03636269|448509466|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
124696372|NCT03636269|448509464|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
124696373|NCT03636269|448509465|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
124696374|NCT03636269|448509466|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
124696375|NCT03636269|448509464|FG000|Period 1: Double-blind Phase|Other|6|||
124696376|NCT03636269|448509465|FG001|Period 1: Double-blind Phase|Other|3|||
124696377|NCT03636269|448509466|FG002|Period 1: Double-blind Phase|Other|0|||
124696378|NCT03636269|448509464|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
124696379|NCT03636269|448509465|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
124696380|NCT03636269|448509466|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
124696381|NCT03636269|448509464|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
124696382|NCT03636269|448509465|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
124696383|NCT03636269|448509466|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
124696384|NCT03636269|448509464|FG000|Period 2: Open-label Phase|Adverse Event|0|||
124696385|NCT03636269|448509465|FG001|Period 2: Open-label Phase|Adverse Event|0|||
124453121|NCT03716050|447620318|FG000|Overall Study|Lost to Follow-up|0|||
124453122|NCT03716050|447620319|FG001|Overall Study|Lost to Follow-up|0|||
124453123|NCT03716050|447620320|FG002|Overall Study|Lost to Follow-up|1|||
124453124|NCT03716050|447620321|FG003|Overall Study|Lost to Follow-up|0|||
124545726|NCT00518531|447952768|FG001|Treatment Period 1|Protocol Violation|0|||
124696386|NCT03636269|448509466|FG002|Period 2: Open-label Phase|Adverse Event|21|||
124922961|NCT04810650|449348248|FG005|Overall Study|Participant declined|0|||
124922962|NCT04810650|449348249|FG006|Overall Study|Participant declined|0|||
124922963|NCT04810650|449348250|FG007|Overall Study|Participant declined|0|||
124922964|NCT04810650|449348251|FG008|Overall Study|Participant declined|0|||
124922965|NCT04810650|449348252|FG009|Overall Study|Participant declined|0|||
124922966|NCT04810650|449348253|FG010|Overall Study|Participant declined|2|||
124922967|NCT04810650|449348254|FG011|Overall Study|Participant declined|0|||
124922968|NCT04810650|449348255|FG012|Overall Study|Participant declined|0|||
124922969|NCT04810650|449348256|FG013|Overall Study|Participant declined|0|||
124922970|NCT05794243|449348257|FG000|Overall Study|Withdrawal by Subject|1|||
124922971|NCT05794243|449348258|FG001|Overall Study|Withdrawal by Subject|0|||
124922972|NCT05794243|449348259|FG002|Overall Study|Withdrawal by Subject|1|||
124922973|NCT05794243|449348257|FG000|Overall Study|Physician Decision|0|||
124922974|NCT05794243|449348258|FG001|Overall Study|Physician Decision|3|||
124922975|NCT05794243|449348259|FG002|Overall Study|Physician Decision|1|||
124922976|NCT05057247|449348263|FG000|Overall Study|Death|4|||
124922977|NCT05057247|449348263|FG000|Overall Study|Physician Decision|3|||
124922978|NCT05057247|449348263|FG000|Overall Study|Progressive Disease|7|||
124922979|NCT05057247|449348263|FG000|Overall Study|Withdrawal by Subject|3|||
124922980|NCT05057247|449348263|FG000|Overall Study|Adverse Event|6|||
124922981|NCT05057247|449348263|FG000|Overall Study|Subject Non-Compliance|1|||
124922982|NCT05057247|449348263|FG000|Overall Study|On treatment|2|||
124922983|NCT02761057|449348276|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
124922984|NCT02761057|449348277|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
124922985|NCT02761057|449348278|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
124453125|NCT03716050|447620322|FG004|Overall Study|Lost to Follow-up|0|||
124453126|NCT03716050|447620323|FG005|Overall Study|Lost to Follow-up|0|||
124453127|NCT03716050|447620324|FG006|Overall Study|Lost to Follow-up|0|||
124453128|NCT03716050|447620325|FG007|Overall Study|Lost to Follow-up|0|||
124453129|NCT03716050|447620318|FG000|Overall Study|Physician Decision|0|||
124453130|NCT03716050|447620319|FG001|Overall Study|Physician Decision|0|||
124453131|NCT03716050|447620320|FG002|Overall Study|Physician Decision|0|||
124453132|NCT03716050|447620321|FG003|Overall Study|Physician Decision|1|||
124453133|NCT03716050|447620322|FG004|Overall Study|Physician Decision|0|||
124453134|NCT03716050|447620323|FG005|Overall Study|Physician Decision|0|||
124453135|NCT03716050|447620324|FG006|Overall Study|Physician Decision|0|||
124453136|NCT03716050|447620325|FG007|Overall Study|Physician Decision|0|||
124453137|NCT03716050|447620318|FG000|Overall Study|Protocol Violation|0|||
124453138|NCT03716050|447620319|FG001|Overall Study|Protocol Violation|0|||
124453139|NCT03716050|447620320|FG002|Overall Study|Protocol Violation|0|||
124453140|NCT03716050|447620321|FG003|Overall Study|Protocol Violation|1|||
124453141|NCT03716050|447620322|FG004|Overall Study|Protocol Violation|0|||
124453142|NCT03716050|447620323|FG005|Overall Study|Protocol Violation|0|||
124453143|NCT03716050|447620324|FG006|Overall Study|Protocol Violation|0|||
124453144|NCT03716050|447620325|FG007|Overall Study|Protocol Violation|2|||
124453145|NCT02361944|447620326|FG000|Overall Study|surgery cancellation|0|||
124453146|NCT02361944|447620327|FG001|Overall Study|surgery cancellation|1|||
124453147|NCT04305275|447620328|FG000|Overall Study|Adverse Event|4|||
124453148|NCT04305275|447620329|FG001|Overall Study|Adverse Event|0|||
124453149|NCT04305275|447620328|FG000|Overall Study|Lost to Follow-up|1|||
124453150|NCT04305275|447620329|FG001|Overall Study|Lost to Follow-up|1|||
124453151|NCT04305275|447620328|FG000|Overall Study|Withdrawal by Participant|8|||
124453152|NCT04305275|447620329|FG001|Overall Study|Withdrawal by Participant|1|||
124453153|NCT03654976|447620333|FG000|Overall Study|Withdrawal by Subject|12|||
124453154|NCT03654976|447620334|FG001|Overall Study|Withdrawal by Subject|11|||
124453155|NCT03654976|447620333|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
124453156|NCT03654976|447620334|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
124453157|NCT03654976|447620333|FG000|Overall Study|Adverse Event|5|||
124762464|NCT02611479|448755884|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
124762465|NCT02611479|448755884|FG000|Data Cleaning|No baseline function or pain metrics|2|||
124762466|NCT00743249|448755885|FG000|Overall Study|Adverse Event|0|||
124922986|NCT02761057|449348279|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
124922987|NCT02761057|449348276|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
124922988|NCT02761057|449348277|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
124922989|NCT02761057|449348278|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
124453158|NCT03654976|447620334|FG001|Overall Study|Adverse Event|0|||
124922990|NCT02761057|449348279|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
124922991|NCT02761057|449348276|FG000|Overall Study|Currently On Study Treatment|0|||
124453159|NCT03654976|447620333|FG000|Overall Study|Lost to Follow-up|2|||
124453160|NCT03654976|447620334|FG001|Overall Study|Lost to Follow-up|0|||
124453161|NCT03654976|447620333|FG000|Overall Study|Lack of Efficacy|0|||
124453162|NCT03654976|447620334|FG001|Overall Study|Lack of Efficacy|1|||
124453163|NCT00117598|447620335|FG000|Prior to Treatment Cross Over|Death|40|||
124453164|NCT00117598|447620336|FG001|Prior to Treatment Cross Over|Death|41|||
124453165|NCT00117598|447620337|FG002|Prior to Treatment Cross Over|Death|37|||
124453166|NCT00117598|447620338|FG003|Prior to Treatment Cross Over|Death|0|||
124762467|NCT00743249|448755886|FG001|Overall Study|Adverse Event|4|||
124762468|NCT00743249|448755885|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
124762469|NCT00743249|448755886|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
124762470|NCT00743249|448755885|FG000|Overall Study|Unsuccessful insertion of stent|2|||
124762471|NCT00743249|448755886|FG001|Overall Study|Unsuccessful insertion of stent|1|||
124762472|NCT00423657|448755890|FG000|Overall Study|Withdrew consent|10|||
124762473|NCT00423657|448755891|FG001|Overall Study|Withdrew consent|8|||
124922992|NCT02761057|449348277|FG001|Overall Study|Currently On Study Treatment|3|||
124922993|NCT02761057|449348278|FG002|Overall Study|Currently On Study Treatment|0|||
124922994|NCT02761057|449348279|FG003|Overall Study|Currently On Study Treatment|0|||
124922995|NCT02761057|449348276|FG000|Overall Study|Adverse Event|11|||
124922996|NCT02761057|449348277|FG001|Overall Study|Adverse Event|9|||
124922997|NCT02761057|449348278|FG002|Overall Study|Adverse Event|5|||
124922998|NCT02761057|449348279|FG003|Overall Study|Adverse Event|3|||
124922999|NCT02761057|449348276|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
124923000|NCT02761057|449348277|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
124923001|NCT02761057|449348278|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
124923002|NCT02761057|449348279|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
124923003|NCT02761057|449348276|FG000|Overall Study|Progression/Relapse|29|||
124923004|NCT02761057|449348277|FG001|Overall Study|Progression/Relapse|27|||
124923005|NCT02761057|449348278|FG002|Overall Study|Progression/Relapse|20|||
124923006|NCT02761057|449348279|FG003|Overall Study|Progression/Relapse|23|||
124923007|NCT02761057|449348276|FG000|Overall Study|Death|2|||
124923008|NCT02761057|449348277|FG001|Overall Study|Death|2|||
124923009|NCT02761057|449348278|FG002|Overall Study|Death|1|||
124923010|NCT02761057|449348279|FG003|Overall Study|Death|1|||
124923011|NCT02761057|449348276|FG000|Overall Study|Other - Not Protocol Specified|2|||
124923012|NCT02761057|449348277|FG001|Overall Study|Other - Not Protocol Specified|1|||
124923013|NCT02761057|449348278|FG002|Overall Study|Other - Not Protocol Specified|2|||
124923014|NCT02761057|449348279|FG003|Overall Study|Other - Not Protocol Specified|0|||
124923015|NCT04788511|449348280|FG000|Overall Study|Withdrawal by Subject|2|||
124923016|NCT04788511|449348281|FG001|Overall Study|Withdrawal by Subject|1|||
124923017|NCT04788511|449348280|FG000|Overall Study|Lost to Follow-up|2|||
124923018|NCT04788511|449348281|FG001|Overall Study|Lost to Follow-up|7|||
124923019|NCT04788511|449348280|FG000|Overall Study|Death|3|||
124923020|NCT04788511|449348281|FG001|Overall Study|Death|4|||
124923021|NCT04652700|449348284|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
124923022|NCT04652700|449348285|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
124923023|NCT04652700|449348284|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
124923024|NCT04652700|449348285|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
124923025|NCT04652700|449348284|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
124923026|NCT04652700|449348285|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
124923027|NCT04652700|449348284|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
124923028|NCT04652700|449348285|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
124923029|NCT04652700|449348284|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
124923030|NCT04652700|449348285|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
124923031|NCT04652700|449348284|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
124923032|NCT04652700|449348285|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
124923033|NCT04652700|449348284|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
124923034|NCT04652700|449348285|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
124923035|NCT04652700|449348284|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
124923036|NCT04652700|449348285|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
124923037|NCT04652700|449348284|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
124762474|NCT00423657|448755890|FG000|Overall Study|Non-compliance|0|||
124923038|NCT04652700|449348285|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
124923039|NCT06037369|449348288|FG000|Overall Study|Lost to Follow-up|0|||
124923040|NCT06037369|449348289|FG001|Overall Study|Lost to Follow-up|1|||
124923041|NCT04209465|449348290|FG000|Overall Study|Adverse Event|0|||
124923042|NCT04209465|449348291|FG001|Overall Study|Adverse Event|0|||
124923043|NCT04209465|449348292|FG002|Overall Study|Adverse Event|0|||
124762475|NCT00423657|448755891|FG001|Overall Study|Non-compliance|1|||
124923044|NCT04209465|449348293|FG003|Overall Study|Adverse Event|0|||
124923045|NCT04209465|449348294|FG004|Overall Study|Adverse Event|0|||
124923046|NCT04209465|449348295|FG005|Overall Study|Adverse Event|1|||
124923047|NCT04209465|449348296|FG006|Overall Study|Adverse Event|0|||
124923048|NCT04209465|449348297|FG007|Overall Study|Adverse Event|0|||
124923049|NCT04209465|449348298|FG008|Overall Study|Adverse Event|1|||
124923050|NCT04209465|449348299|FG009|Overall Study|Adverse Event|0|||
124923051|NCT04209465|449348300|FG010|Overall Study|Adverse Event|2|||
124923052|NCT04209465|449348301|FG011|Overall Study|Adverse Event|1|||
124923053|NCT04209465|449348302|FG012|Overall Study|Adverse Event|1|||
124762476|NCT00423657|448755890|FG000|Overall Study|Other|15|||
124762477|NCT00423657|448755891|FG001|Overall Study|Other|16|||
124762478|NCT00423657|448755890|FG000|Overall Study|Request of sponsor/investigator|1|||
124762479|NCT00423657|448755891|FG001|Overall Study|Request of sponsor/investigator|0|||
124762480|NCT02653326|448755895|FG000|Overall Study|Lost to Follow-up|10|||
124762481|NCT02653326|448755896|FG001|Overall Study|Lost to Follow-up|7|||
124762482|NCT02422498|448755897|FG000|Overall Study|Inevaluable|4|||
124762483|NCT03206216|448755898|FG000|Overall Study|Withdrawal by Subject|0|||
124762484|NCT03206216|448755899|FG001|Overall Study|Withdrawal by Subject|1|||
124762485|NCT01582061|448755900|FG000|Overall Study|Lack of Efficacy|3|||
124762486|NCT01582061|448755901|FG001|Overall Study|Lack of Efficacy|23|||
124762487|NCT01582061|448755900|FG000|Overall Study|Adverse Event|12|||
124762488|NCT01582061|448755901|FG001|Overall Study|Adverse Event|8|||
124762489|NCT01582061|448755900|FG000|Overall Study|Withdrawal by Subject|10|||
124762490|NCT01582061|448755901|FG001|Overall Study|Withdrawal by Subject|4|||
124762491|NCT01582061|448755900|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124762492|NCT01582061|448755901|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124762493|NCT01582061|448755900|FG000|Overall Study|Death|0|||
124762494|NCT01582061|448755901|FG001|Overall Study|Death|1|||
124762495|NCT01582061|448755900|FG000|Overall Study|condition no longer requires study drug|1|||
124762496|NCT01582061|448755901|FG001|Overall Study|condition no longer requires study drug|0|||
124762497|NCT01582061|448755900|FG000|Overall Study|Lost to Follow-up|1|||
124923054|NCT04209465|449348290|FG000|Overall Study|Death|1|||
124923055|NCT04209465|449348291|FG001|Overall Study|Death|0|||
124923056|NCT04209465|449348292|FG002|Overall Study|Death|0|||
124923057|NCT04209465|449348293|FG003|Overall Study|Death|0|||
124923058|NCT04209465|449348294|FG004|Overall Study|Death|2|||
124923059|NCT04209465|449348295|FG005|Overall Study|Death|7|||
124453167|NCT00117598|447620339|FG004|Prior to Treatment Cross Over|Death|0|||
124453168|NCT00117598|447620335|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
124453169|NCT00117598|447620336|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
124453170|NCT00117598|447620337|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
124762498|NCT01582061|448755901|FG001|Overall Study|Lost to Follow-up|0|||
124762499|NCT04698343|448755904|FG000|Overall Study|Withdrawal by Subject|6|||
124762500|NCT04698343|448755904|FG000|Overall Study|Physician Decision|2|||
124762501|NCT04698343|448755904|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
124762502|NCT04698343|448755904|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
124762503|NCT04698343|448755904|FG000|Overall Study|Personal reasons|3|||
124762504|NCT04698343|448755904|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
124762505|NCT01054456|448755905|FG000|Overall Study|Other|1|||
124762506|NCT04621448|448755906|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
124923060|NCT04209465|449348296|FG006|Overall Study|Death|2|||
124923061|NCT04209465|449348297|FG007|Overall Study|Death|2|||
124923062|NCT04209465|449348298|FG008|Overall Study|Death|1|||
124923063|NCT04209465|449348299|FG009|Overall Study|Death|1|||
124923064|NCT04209465|449348300|FG010|Overall Study|Death|1|||
124923065|NCT04209465|449348301|FG011|Overall Study|Death|0|||
124923066|NCT04209465|449348302|FG012|Overall Study|Death|10|||
124923067|NCT04209465|449348290|FG000|Overall Study|Physician Decision|0|||
124923068|NCT04209465|449348291|FG001|Overall Study|Physician Decision|1|||
124923069|NCT04209465|449348292|FG002|Overall Study|Physician Decision|0|||
124923070|NCT04209465|449348293|FG003|Overall Study|Physician Decision|0|||
124923071|NCT04209465|449348294|FG004|Overall Study|Physician Decision|0|||
124923072|NCT04209465|449348295|FG005|Overall Study|Physician Decision|0|||
124923073|NCT04209465|449348296|FG006|Overall Study|Physician Decision|0|||
124923074|NCT04209465|449348297|FG007|Overall Study|Physician Decision|0|||
124923075|NCT04209465|449348298|FG008|Overall Study|Physician Decision|0|||
124923076|NCT04209465|449348299|FG009|Overall Study|Physician Decision|0|||
124923077|NCT04209465|449348300|FG010|Overall Study|Physician Decision|0|||
124923078|NCT04209465|449348301|FG011|Overall Study|Physician Decision|0|||
124923079|NCT04209465|449348302|FG012|Overall Study|Physician Decision|0|||
124923080|NCT04209465|449348290|FG000|Overall Study|Progressive Disease|0|||
124923081|NCT04209465|449348291|FG001|Overall Study|Progressive Disease|0|||
124923082|NCT04209465|449348292|FG002|Overall Study|Progressive Disease|1|||
124762507|NCT04621448|448755907|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
124923083|NCT04209465|449348293|FG003|Overall Study|Progressive Disease|2|||
124923084|NCT04209465|449348294|FG004|Overall Study|Progressive Disease|8|||
124923085|NCT04209465|449348295|FG005|Overall Study|Progressive Disease|5|||
124923086|NCT04209465|449348296|FG006|Overall Study|Progressive Disease|3|||
124453171|NCT00117598|447620338|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
124696387|NCT03636269|448509464|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
124696388|NCT03636269|448509465|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
124696389|NCT03636269|448509466|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
124696390|NCT03636269|448509464|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
124696391|NCT03636269|448509465|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
124696392|NCT03636269|448509466|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
124696393|NCT03636269|448509464|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
124696394|NCT03636269|448509465|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
124696395|NCT03636269|448509466|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
124696396|NCT03636269|448509464|FG000|Period 2: Open-label Phase|Administrative|0|||
124696397|NCT03636269|448509465|FG001|Period 2: Open-label Phase|Administrative|0|||
124696398|NCT03636269|448509466|FG002|Period 2: Open-label Phase|Administrative|36|||
124696399|NCT03636269|448509464|FG000|Period 2: Open-label Phase|Other|0|||
124696400|NCT03636269|448509465|FG001|Period 2: Open-label Phase|Other|0|||
124696401|NCT03636269|448509466|FG002|Period 2: Open-label Phase|Other|9|||
124696402|NCT03636269|448509464|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
124696403|NCT03636269|448509465|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
124696404|NCT03636269|448509466|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
124696405|NCT03774810|448509469|FG000|Phase 1|Lack of Efficacy|21|||
124696406|NCT03774810|448509470|FG001|Phase 1|Lack of Efficacy|0|||
124696407|NCT03774810|448509471|FG002|Phase 1|Lack of Efficacy|0|||
124696408|NCT03774810|448509472|FG003|Phase 1|Lack of Efficacy|0|||
124696409|NCT03774810|448509473|FG004|Phase 1|Lack of Efficacy|0|||
124696410|NCT03774810|448509469|FG000|Phase 1|Withdrawal by Subject|9|||
124696411|NCT03774810|448509470|FG001|Phase 1|Withdrawal by Subject|0|||
124696412|NCT03774810|448509471|FG002|Phase 1|Withdrawal by Subject|0|||
124696413|NCT03774810|448509472|FG003|Phase 1|Withdrawal by Subject|0|||
124696414|NCT03774810|448509473|FG004|Phase 1|Withdrawal by Subject|0|||
124696415|NCT03774810|448509469|FG000|Phase 1|Lost to Follow-up|2|||
124696416|NCT03774810|448509470|FG001|Phase 1|Lost to Follow-up|0|||
124696417|NCT03774810|448509471|FG002|Phase 1|Lost to Follow-up|0|||
124696418|NCT03774810|448509472|FG003|Phase 1|Lost to Follow-up|0|||
124696419|NCT03774810|448509473|FG004|Phase 1|Lost to Follow-up|0|||
124696420|NCT03774810|448509469|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
124696421|NCT03774810|448509470|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
124696422|NCT03774810|448509471|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
124696423|NCT03774810|448509472|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
124696424|NCT03774810|448509473|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
124696425|NCT03774810|448509469|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
124696426|NCT03774810|448509470|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
124696427|NCT03774810|448509471|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
124696428|NCT03774810|448509472|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
124696429|NCT03774810|448509473|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
124696430|NCT03774810|448509469|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
124696431|NCT03774810|448509470|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
124696432|NCT03774810|448509471|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
124696433|NCT03774810|448509472|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
124696434|NCT03774810|448509473|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
124696435|NCT03774810|448509469|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
124696436|NCT03774810|448509470|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
124696437|NCT03774810|448509471|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
124696438|NCT03774810|448509472|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
124696439|NCT03774810|448509473|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
124696440|NCT03774810|448509469|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
124696441|NCT03774810|448509470|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
124696442|NCT03774810|448509471|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
124696443|NCT03774810|448509472|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
124696444|NCT03774810|448509473|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
124696445|NCT03774810|448509469|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
124696446|NCT03774810|448509470|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
124696447|NCT03774810|448509471|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
124696448|NCT03774810|448509472|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
124696449|NCT03774810|448509473|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
124696450|NCT00290758|448509476|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
124696451|NCT00290758|448509477|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
124696452|NCT00290758|448509476|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
124696453|NCT00290758|448509477|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
124696454|NCT00290758|448509476|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
124696455|NCT00290758|448509477|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
124453172|NCT00117598|447620339|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
124762508|NCT04621448|448755908|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
124762509|NCT04621448|448755909|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
124762510|NCT04621448|448755906|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
124762511|NCT04621448|448755907|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
124762512|NCT04621448|448755908|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
124762513|NCT04621448|448755909|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
124762514|NCT04621448|448755906|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
124762515|NCT04621448|448755907|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
124762516|NCT04621448|448755908|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
124762517|NCT04621448|448755909|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
124762518|NCT04621448|448755906|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
124762519|NCT04621448|448755907|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
124762520|NCT04621448|448755908|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
124762521|NCT04621448|448755909|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
124762522|NCT04590014|448755912|FG000|Overall Study|Withdrawal by Subject|1|||
124762523|NCT04590014|448755913|FG001|Overall Study|Withdrawal by Subject|0|||
124762524|NCT01506271|448755914|FG000|Overall Study|Progressive disease|0|||
124762525|NCT01506271|448755915|FG001|Overall Study|Progressive disease|1|||
124762526|NCT01506271|448755916|FG002|Overall Study|Progressive disease|0|||
124696456|NCT00290758|448509476|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
124696457|NCT00290758|448509477|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
124762527|NCT01506271|448755914|FG000|Overall Study|Protocol Violation|3|||
124762528|NCT01506271|448755915|FG001|Overall Study|Protocol Violation|1|||
124762529|NCT01506271|448755916|FG002|Overall Study|Protocol Violation|0|||
124762530|NCT01506271|448755914|FG000|Overall Study|Death|0|||
124696458|NCT00290758|448509476|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
124696459|NCT00290758|448509477|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
124696460|NCT00290758|448509476|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
124696461|NCT00290758|448509477|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
124696462|NCT00290758|448509476|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
124696463|NCT00290758|448509477|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
124696464|NCT00290758|448509476|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
124696465|NCT00290758|448509477|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
124696466|NCT03436420|448509478|FG000|Overall Study|Lack of Efficacy|3|||
124696467|NCT04914000|448509479|FG000|Overall Study|Lost to Follow-up|8|||
124696468|NCT04914000|448509479|FG000|Overall Study|Withdrawal by Subject|1|||
124696469|NCT01429623|448509480|FG000|Overall Study|Death|1|||
124696470|NCT01429623|448509481|FG001|Overall Study|Death|0|||
124696471|NCT01429623|448509480|FG000|Overall Study|Adverse Event|7|||
124696472|NCT01429623|448509481|FG001|Overall Study|Adverse Event|14|||
124696473|NCT01429623|448509480|FG000|Overall Study|Withdrawal by Subject|19|||
124696474|NCT01429623|448509481|FG001|Overall Study|Withdrawal by Subject|13|||
124696475|NCT01429623|448509480|FG000|Overall Study|Physician Decision|2|||
124696476|NCT01429623|448509481|FG001|Overall Study|Physician Decision|3|||
124696477|NCT01429623|448509480|FG000|Overall Study|Protocol Violation|3|||
124696478|NCT01429623|448509481|FG001|Overall Study|Protocol Violation|2|||
124696479|NCT01429623|448509480|FG000|Overall Study|Assorted|1|||
124696480|NCT01429623|448509481|FG001|Overall Study|Assorted|2|||
124696481|NCT01429623|448509480|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
124696482|NCT01429623|448509481|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
124696483|NCT01429623|448509480|FG000|Overall Study|No post baseline data|4|||
124696484|NCT01429623|448509481|FG001|Overall Study|No post baseline data|4|||
124696485|NCT01896986|448509483|FG000|Overall Study|samples lost|14|||
124696486|NCT01896986|448509484|FG001|Overall Study|samples lost|23|||
124696487|NCT01061710|448509490|FG000|Overall Study|Protocol Violation|14|||
124696488|NCT03156621|448509491|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
124696489|NCT03156621|448509492|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
124696490|NCT03156621|448509491|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
124696491|NCT03156621|448509492|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
124762531|NCT01506271|448755915|FG001|Overall Study|Death|1|||
124762532|NCT01506271|448755916|FG002|Overall Study|Death|0|||
124762533|NCT01506271|448755914|FG000|Overall Study|Adverse Event|0|||
124762534|NCT01506271|448755915|FG001|Overall Study|Adverse Event|2|||
124923087|NCT04209465|449348297|FG007|Overall Study|Progressive Disease|4|||
124923088|NCT04209465|449348298|FG008|Overall Study|Progressive Disease|1|||
124923089|NCT04209465|449348299|FG009|Overall Study|Progressive Disease|3|||
124923090|NCT04209465|449348300|FG010|Overall Study|Progressive Disease|2|||
124923091|NCT04209465|449348301|FG011|Overall Study|Progressive Disease|1|||
124923092|NCT04209465|449348302|FG012|Overall Study|Progressive Disease|0|||
124923093|NCT04209465|449348290|FG000|Overall Study|Withdrawal by Subject|0|||
124923094|NCT04209465|449348291|FG001|Overall Study|Withdrawal by Subject|0|||
124923095|NCT04209465|449348292|FG002|Overall Study|Withdrawal by Subject|0|||
124923096|NCT04209465|449348293|FG003|Overall Study|Withdrawal by Subject|0|||
124923097|NCT04209465|449348294|FG004|Overall Study|Withdrawal by Subject|0|||
124923098|NCT04209465|449348295|FG005|Overall Study|Withdrawal by Subject|1|||
124923099|NCT04209465|449348296|FG006|Overall Study|Withdrawal by Subject|2|||
124923100|NCT04209465|449348297|FG007|Overall Study|Withdrawal by Subject|0|||
124923101|NCT04209465|449348298|FG008|Overall Study|Withdrawal by Subject|1|||
124923102|NCT04209465|449348299|FG009|Overall Study|Withdrawal by Subject|0|||
124923103|NCT04209465|449348300|FG010|Overall Study|Withdrawal by Subject|0|||
124923104|NCT04209465|449348301|FG011|Overall Study|Withdrawal by Subject|2|||
124923105|NCT04209465|449348302|FG012|Overall Study|Withdrawal by Subject|2|||
124923106|NCT04209465|449348290|FG000|Overall Study|Lost to Follow-up|0|||
124923107|NCT04209465|449348291|FG001|Overall Study|Lost to Follow-up|0|||
124923108|NCT04209465|449348292|FG002|Overall Study|Lost to Follow-up|0|||
124923109|NCT04209465|449348293|FG003|Overall Study|Lost to Follow-up|0|||
124923110|NCT04209465|449348294|FG004|Overall Study|Lost to Follow-up|0|||
124923111|NCT04209465|449348295|FG005|Overall Study|Lost to Follow-up|1|||
124923112|NCT04209465|449348296|FG006|Overall Study|Lost to Follow-up|0|||
124923113|NCT04209465|449348297|FG007|Overall Study|Lost to Follow-up|0|||
124923114|NCT04209465|449348298|FG008|Overall Study|Lost to Follow-up|1|||
124923115|NCT04209465|449348299|FG009|Overall Study|Lost to Follow-up|0|||
124923116|NCT04209465|449348300|FG010|Overall Study|Lost to Follow-up|0|||
124923117|NCT04209465|449348301|FG011|Overall Study|Lost to Follow-up|1|||
124923118|NCT04209465|449348302|FG012|Overall Study|Lost to Follow-up|0|||
124923119|NCT04209465|449348290|FG000|Overall Study|Started new therapy|0|||
124923120|NCT04209465|449348291|FG001|Overall Study|Started new therapy|0|||
124923121|NCT04209465|449348292|FG002|Overall Study|Started new therapy|0|||
124923122|NCT04209465|449348293|FG003|Overall Study|Started new therapy|0|||
124923123|NCT04209465|449348294|FG004|Overall Study|Started new therapy|0|||
124923124|NCT04209465|449348295|FG005|Overall Study|Started new therapy|1|||
124923125|NCT04209465|449348296|FG006|Overall Study|Started new therapy|0|||
124923126|NCT04209465|449348297|FG007|Overall Study|Started new therapy|0|||
124923127|NCT04209465|449348298|FG008|Overall Study|Started new therapy|0|||
124923128|NCT04209465|449348299|FG009|Overall Study|Started new therapy|0|||
124923129|NCT04209465|449348300|FG010|Overall Study|Started new therapy|0|||
124923130|NCT04209465|449348301|FG011|Overall Study|Started new therapy|0|||
124923131|NCT04209465|449348302|FG012|Overall Study|Started new therapy|0|||
124923132|NCT04209465|449348290|FG000|Overall Study|Study terminated early by sponsor|0|||
124923133|NCT04209465|449348291|FG001|Overall Study|Study terminated early by sponsor|0|||
124923134|NCT04209465|449348292|FG002|Overall Study|Study terminated early by sponsor|0|||
124923135|NCT04209465|449348293|FG003|Overall Study|Study terminated early by sponsor|0|||
124923136|NCT04209465|449348294|FG004|Overall Study|Study terminated early by sponsor|0|||
124923137|NCT04209465|449348295|FG005|Overall Study|Study terminated early by sponsor|0|||
124923138|NCT04209465|449348296|FG006|Overall Study|Study terminated early by sponsor|3|||
124923139|NCT04209465|449348297|FG007|Overall Study|Study terminated early by sponsor|0|||
124923140|NCT04209465|449348298|FG008|Overall Study|Study terminated early by sponsor|0|||
124923141|NCT04209465|449348299|FG009|Overall Study|Study terminated early by sponsor|0|||
124453173|NCT00117598|447620335|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
124453174|NCT00117598|447620336|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
124453175|NCT00117598|447620337|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
124923142|NCT04209465|449348300|FG010|Overall Study|Study terminated early by sponsor|0|||
124923143|NCT04209465|449348301|FG011|Overall Study|Study terminated early by sponsor|0|||
124923144|NCT04209465|449348302|FG012|Overall Study|Study terminated early by sponsor|3|||
124923145|NCT04209465|449348290|FG000|Overall Study|Other|0|||
124923146|NCT04209465|449348291|FG001|Overall Study|Other|0|||
124923147|NCT04209465|449348292|FG002|Overall Study|Other|0|||
124923148|NCT04209465|449348293|FG003|Overall Study|Other|0|||
124923149|NCT04209465|449348294|FG004|Overall Study|Other|0|||
124923150|NCT04209465|449348295|FG005|Overall Study|Other|0|||
124923151|NCT04209465|449348296|FG006|Overall Study|Other|0|||
124923152|NCT04209465|449348297|FG007|Overall Study|Other|0|||
124923153|NCT04209465|449348298|FG008|Overall Study|Other|1|||
124923154|NCT04209465|449348299|FG009|Overall Study|Other|0|||
124923155|NCT04209465|449348300|FG010|Overall Study|Other|0|||
124923156|NCT04209465|449348301|FG011|Overall Study|Other|0|||
124923157|NCT04209465|449348302|FG012|Overall Study|Other|0|||
124923158|NCT05008835|449348304|FG000|Overall Study|Adverse Event|5|||
124923159|NCT05008835|449348305|FG001|Overall Study|Adverse Event|2|||
124923160|NCT05008835|449348306|FG002|Overall Study|Adverse Event|1|||
124923161|NCT05008835|449348304|FG000|Overall Study|Lack of Efficacy|0|||
124923162|NCT05008835|449348305|FG001|Overall Study|Lack of Efficacy|0|||
124923163|NCT05008835|449348306|FG002|Overall Study|Lack of Efficacy|1|||
124923164|NCT05008835|449348304|FG000|Overall Study|Study terminated by sponsor|0|||
124923165|NCT05008835|449348305|FG001|Overall Study|Study terminated by sponsor|0|||
124923166|NCT05008835|449348306|FG002|Overall Study|Study terminated by sponsor|1|||
124923167|NCT05008835|449348304|FG000|Overall Study|Not further specified|3|||
124923168|NCT05008835|449348305|FG001|Overall Study|Not further specified|2|||
124923169|NCT05008835|449348306|FG002|Overall Study|Not further specified|1|||
124923170|NCT04171999|449348307|FG000|Overall Study|deemed ineligible after randomization|2|||
124923171|NCT04171999|449348308|FG001|Overall Study|deemed ineligible after randomization|1|||
124923172|NCT04505904|449348313|FG000|Overall Study|Withdrawal by Subject|1|||
124923173|NCT04505904|449348314|FG001|Overall Study|Withdrawal by Subject|2|||
124923174|NCT04505904|449348315|FG002|Overall Study|Withdrawal by Subject|0|||
124923175|NCT04505904|449348316|FG003|Overall Study|Withdrawal by Subject|0|||
124923176|NCT04505904|449348313|FG000|Overall Study|Physician Decision|1|||
124923177|NCT04505904|449348314|FG001|Overall Study|Physician Decision|0|||
124923178|NCT04505904|449348315|FG002|Overall Study|Physician Decision|0|||
124923179|NCT04505904|449348316|FG003|Overall Study|Physician Decision|0|||
124923180|NCT04505904|449348313|FG000|Overall Study|Adverse Event|0|||
124923181|NCT04505904|449348314|FG001|Overall Study|Adverse Event|1|||
124923182|NCT04505904|449348315|FG002|Overall Study|Adverse Event|0|||
124923183|NCT04505904|449348316|FG003|Overall Study|Adverse Event|0|||
124923184|NCT04277442|449348319|FG000|Overall Study|Death|1|||
124923185|NCT03544281|449348320|FG000|Main Study Phase|Death|3|||
124923186|NCT03544281|449348321|FG001|Main Study Phase|Death|2|||
124923187|NCT03544281|449348322|FG002|Main Study Phase|Death|6|||
124923188|NCT03544281|449348323|FG003|Main Study Phase|Death|8|||
124923189|NCT03544281|449348324|FG004|Main Study Phase|Death|4|||
124923190|NCT03544281|449348325|FG005|Main Study Phase|Death|2|||
124923191|NCT03544281|449348326|FG006|Main Study Phase|Death|4|||
124923192|NCT03544281|449348327|FG007|Main Study Phase|Death|5|||
124923193|NCT03544281|449348328|FG008|Main Study Phase|Death|5|||
124923194|NCT03544281|449348329|FG009|Main Study Phase|Death|8|||
124923195|NCT03544281|449348330|FG010|Main Study Phase|Death|6|||
124923196|NCT03544281|449348331|FG011|Main Study Phase|Death|4|||
124923197|NCT03544281|449348332|FG012|Main Study Phase|Death|0|||
124923198|NCT03544281|449348333|FG013|Main Study Phase|Death|0|||
124923199|NCT03544281|449348334|FG014|Main Study Phase|Death|0|||
124923200|NCT03544281|449348335|FG015|Main Study Phase|Death|0|||
124923201|NCT03544281|449348336|FG016|Main Study Phase|Death|0|||
124923202|NCT03544281|449348337|FG017|Main Study Phase|Death|0|||
124923203|NCT03544281|449348338|FG018|Main Study Phase|Death|0|||
124923204|NCT03544281|449348339|FG019|Main Study Phase|Death|0|||
124923205|NCT03544281|449348340|FG020|Main Study Phase|Death|0|||
124923206|NCT03544281|449348341|FG021|Main Study Phase|Death|0|||
124923207|NCT03544281|449348320|FG000|Main Study Phase|Lost to Follow-up|0|||
124923208|NCT03544281|449348321|FG001|Main Study Phase|Lost to Follow-up|0|||
124923209|NCT03544281|449348322|FG002|Main Study Phase|Lost to Follow-up|0|||
124923210|NCT03544281|449348323|FG003|Main Study Phase|Lost to Follow-up|0|||
124923211|NCT03544281|449348324|FG004|Main Study Phase|Lost to Follow-up|0|||
124923212|NCT03544281|449348325|FG005|Main Study Phase|Lost to Follow-up|0|||
124923213|NCT03544281|449348326|FG006|Main Study Phase|Lost to Follow-up|0|||
124923214|NCT03544281|449348327|FG007|Main Study Phase|Lost to Follow-up|0|||
124923215|NCT03544281|449348328|FG008|Main Study Phase|Lost to Follow-up|0|||
124923216|NCT03544281|449348329|FG009|Main Study Phase|Lost to Follow-up|0|||
124923217|NCT03544281|449348330|FG010|Main Study Phase|Lost to Follow-up|1|||
124923218|NCT03544281|449348331|FG011|Main Study Phase|Lost to Follow-up|0|||
124923219|NCT03544281|449348332|FG012|Main Study Phase|Lost to Follow-up|0|||
124923220|NCT03544281|449348333|FG013|Main Study Phase|Lost to Follow-up|0|||
124923221|NCT03544281|449348334|FG014|Main Study Phase|Lost to Follow-up|0|||
124923222|NCT03544281|449348335|FG015|Main Study Phase|Lost to Follow-up|0|||
124762535|NCT01506271|448755916|FG002|Overall Study|Adverse Event|0|||
124762536|NCT01506271|448755914|FG000|Overall Study|Insufficient supply of study drug|1|||
124762537|NCT01506271|448755915|FG001|Overall Study|Insufficient supply of study drug|0|||
124923223|NCT03544281|449348336|FG016|Main Study Phase|Lost to Follow-up|0|||
124762538|NCT01506271|448755916|FG002|Overall Study|Insufficient supply of study drug|0|||
124923224|NCT03544281|449348337|FG017|Main Study Phase|Lost to Follow-up|0|||
124923225|NCT03544281|449348338|FG018|Main Study Phase|Lost to Follow-up|0|||
124923226|NCT03544281|449348339|FG019|Main Study Phase|Lost to Follow-up|0|||
124923227|NCT03544281|449348340|FG020|Main Study Phase|Lost to Follow-up|0|||
124923228|NCT03544281|449348341|FG021|Main Study Phase|Lost to Follow-up|0|||
124923229|NCT03544281|449348320|FG000|Main Study Phase|Physician Decision|0|||
124923230|NCT03544281|449348321|FG001|Main Study Phase|Physician Decision|0|||
124923231|NCT03544281|449348322|FG002|Main Study Phase|Physician Decision|0|||
124923232|NCT03544281|449348323|FG003|Main Study Phase|Physician Decision|0|||
124923233|NCT03544281|449348324|FG004|Main Study Phase|Physician Decision|0|||
124923234|NCT03544281|449348325|FG005|Main Study Phase|Physician Decision|0|||
124923235|NCT03544281|449348326|FG006|Main Study Phase|Physician Decision|0|||
124923236|NCT03544281|449348327|FG007|Main Study Phase|Physician Decision|1|||
124923237|NCT03544281|449348328|FG008|Main Study Phase|Physician Decision|0|||
124923238|NCT03544281|449348329|FG009|Main Study Phase|Physician Decision|0|||
124923239|NCT03544281|449348330|FG010|Main Study Phase|Physician Decision|0|||
124923240|NCT03544281|449348331|FG011|Main Study Phase|Physician Decision|0|||
124923241|NCT03544281|449348332|FG012|Main Study Phase|Physician Decision|0|||
124923242|NCT03544281|449348333|FG013|Main Study Phase|Physician Decision|0|||
124923243|NCT03544281|449348334|FG014|Main Study Phase|Physician Decision|0|||
124923244|NCT03544281|449348335|FG015|Main Study Phase|Physician Decision|0|||
124923245|NCT03544281|449348336|FG016|Main Study Phase|Physician Decision|0|||
124923246|NCT03544281|449348337|FG017|Main Study Phase|Physician Decision|0|||
124923247|NCT03544281|449348338|FG018|Main Study Phase|Physician Decision|0|||
124923248|NCT03544281|449348339|FG019|Main Study Phase|Physician Decision|0|||
124923249|NCT03544281|449348340|FG020|Main Study Phase|Physician Decision|0|||
124923250|NCT03544281|449348341|FG021|Main Study Phase|Physician Decision|0|||
124923251|NCT03544281|449348320|FG000|Main Study Phase|Withdrawal by Subject|2|||
124923252|NCT03544281|449348321|FG001|Main Study Phase|Withdrawal by Subject|0|||
124923253|NCT03544281|449348322|FG002|Main Study Phase|Withdrawal by Subject|1|||
124923254|NCT03544281|449348323|FG003|Main Study Phase|Withdrawal by Subject|2|||
124923255|NCT03544281|449348324|FG004|Main Study Phase|Withdrawal by Subject|0|||
124923256|NCT03544281|449348325|FG005|Main Study Phase|Withdrawal by Subject|0|||
124923257|NCT03544281|449348326|FG006|Main Study Phase|Withdrawal by Subject|0|||
124923258|NCT03544281|449348327|FG007|Main Study Phase|Withdrawal by Subject|0|||
124923259|NCT03544281|449348328|FG008|Main Study Phase|Withdrawal by Subject|2|||
124923260|NCT03544281|449348329|FG009|Main Study Phase|Withdrawal by Subject|3|||
124923261|NCT03544281|449348330|FG010|Main Study Phase|Withdrawal by Subject|0|||
124923262|NCT03544281|449348331|FG011|Main Study Phase|Withdrawal by Subject|4|||
124923263|NCT03544281|449348332|FG012|Main Study Phase|Withdrawal by Subject|0|||
124923264|NCT03544281|449348333|FG013|Main Study Phase|Withdrawal by Subject|0|||
124923265|NCT03544281|449348334|FG014|Main Study Phase|Withdrawal by Subject|0|||
124923266|NCT03544281|449348335|FG015|Main Study Phase|Withdrawal by Subject|0|||
124923267|NCT03544281|449348336|FG016|Main Study Phase|Withdrawal by Subject|0|||
124923268|NCT03544281|449348337|FG017|Main Study Phase|Withdrawal by Subject|0|||
124923269|NCT03544281|449348338|FG018|Main Study Phase|Withdrawal by Subject|0|||
124923270|NCT03544281|449348339|FG019|Main Study Phase|Withdrawal by Subject|0|||
124923271|NCT03544281|449348340|FG020|Main Study Phase|Withdrawal by Subject|0|||
124923272|NCT03544281|449348341|FG021|Main Study Phase|Withdrawal by Subject|0|||
124923273|NCT03544281|449348320|FG000|Main Study Phase|Ongoing|3|||
124923274|NCT03544281|449348321|FG001|Main Study Phase|Ongoing|1|||
124923275|NCT03544281|449348322|FG002|Main Study Phase|Ongoing|2|||
124923276|NCT03544281|449348323|FG003|Main Study Phase|Ongoing|4|||
124923277|NCT03544281|449348324|FG004|Main Study Phase|Ongoing|2|||
124923278|NCT03544281|449348325|FG005|Main Study Phase|Ongoing|4|||
124923279|NCT03544281|449348326|FG006|Main Study Phase|Ongoing|4|||
124923280|NCT03544281|449348327|FG007|Main Study Phase|Ongoing|0|||
124923281|NCT03544281|449348328|FG008|Main Study Phase|Ongoing|2|||
124923282|NCT03544281|449348329|FG009|Main Study Phase|Ongoing|2|||
124923283|NCT03544281|449348330|FG010|Main Study Phase|Ongoing|1|||
124923284|NCT03544281|449348331|FG011|Main Study Phase|Ongoing|0|||
124923285|NCT03544281|449348332|FG012|Main Study Phase|Ongoing|0|||
124923286|NCT03544281|449348333|FG013|Main Study Phase|Ongoing|0|||
124923287|NCT03544281|449348334|FG014|Main Study Phase|Ongoing|0|||
124923288|NCT03544281|449348335|FG015|Main Study Phase|Ongoing|0|||
124923289|NCT03544281|449348336|FG016|Main Study Phase|Ongoing|0|||
124923290|NCT03544281|449348337|FG017|Main Study Phase|Ongoing|0|||
124923291|NCT03544281|449348338|FG018|Main Study Phase|Ongoing|0|||
124923292|NCT03544281|449348339|FG019|Main Study Phase|Ongoing|0|||
124923293|NCT03544281|449348340|FG020|Main Study Phase|Ongoing|0|||
124923294|NCT03544281|449348341|FG021|Main Study Phase|Ongoing|0|||
124923295|NCT03544281|449348320|FG000|Main Study Phase|Investigator Site Closed|0|||
124923296|NCT03544281|449348321|FG001|Main Study Phase|Investigator Site Closed|0|||
124923297|NCT03544281|449348322|FG002|Main Study Phase|Investigator Site Closed|0|||
124923298|NCT03544281|449348323|FG003|Main Study Phase|Investigator Site Closed|0|||
124923299|NCT03544281|449348324|FG004|Main Study Phase|Investigator Site Closed|0|||
124923300|NCT03544281|449348325|FG005|Main Study Phase|Investigator Site Closed|0|||
124923301|NCT03544281|449348326|FG006|Main Study Phase|Investigator Site Closed|0|||
124923302|NCT03544281|449348327|FG007|Main Study Phase|Investigator Site Closed|0|||
124923303|NCT03544281|449348328|FG008|Main Study Phase|Investigator Site Closed|0|||
124923304|NCT03544281|449348329|FG009|Main Study Phase|Investigator Site Closed|1|||
124923305|NCT03544281|449348330|FG010|Main Study Phase|Investigator Site Closed|0|||
124923306|NCT03544281|449348331|FG011|Main Study Phase|Investigator Site Closed|0|||
124923307|NCT03544281|449348332|FG012|Main Study Phase|Investigator Site Closed|0|||
124923308|NCT03544281|449348333|FG013|Main Study Phase|Investigator Site Closed|0|||
124923309|NCT03544281|449348334|FG014|Main Study Phase|Investigator Site Closed|0|||
124923310|NCT03544281|449348335|FG015|Main Study Phase|Investigator Site Closed|0|||
124923311|NCT03544281|449348336|FG016|Main Study Phase|Investigator Site Closed|0|||
124923312|NCT03544281|449348337|FG017|Main Study Phase|Investigator Site Closed|0|||
124923313|NCT03544281|449348338|FG018|Main Study Phase|Investigator Site Closed|0|||
124923314|NCT03544281|449348339|FG019|Main Study Phase|Investigator Site Closed|0|||
124923315|NCT03544281|449348340|FG020|Main Study Phase|Investigator Site Closed|0|||
124923316|NCT03544281|449348341|FG021|Main Study Phase|Investigator Site Closed|0|||
124923317|NCT03544281|449348320|FG000|Main Study Phase|Did not receive study treatment|0|||
124923318|NCT03544281|449348321|FG001|Main Study Phase|Did not receive study treatment|0|||
124923319|NCT03544281|449348322|FG002|Main Study Phase|Did not receive study treatment|0|||
124923320|NCT03544281|449348323|FG003|Main Study Phase|Did not receive study treatment|0|||
124923321|NCT03544281|449348324|FG004|Main Study Phase|Did not receive study treatment|0|||
124453176|NCT00117598|447620338|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
124453177|NCT00117598|447620339|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
124453178|NCT00117598|447620335|FG000|Prior to Treatment Cross Over|Other|15|||
124453179|NCT00117598|447620336|FG001|Prior to Treatment Cross Over|Other|9|||
124453180|NCT00117598|447620337|FG002|Prior to Treatment Cross Over|Other|9|||
124453181|NCT00117598|447620338|FG003|Prior to Treatment Cross Over|Other|0|||
124453182|NCT00117598|447620339|FG004|Prior to Treatment Cross Over|Other|0|||
124453183|NCT00117598|447620335|FG000|After Treament Cross Over|Death|0|||
124453184|NCT00117598|447620336|FG001|After Treament Cross Over|Death|0|||
124453185|NCT00117598|447620337|FG002|After Treament Cross Over|Death|0|||
124453186|NCT00117598|447620338|FG003|After Treament Cross Over|Death|1|||
124453187|NCT00117598|447620339|FG004|After Treament Cross Over|Death|2|||
124453188|NCT00117598|447620335|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
124453189|NCT00117598|447620336|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
124453190|NCT00117598|447620337|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
124453191|NCT00117598|447620338|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
124453192|NCT00117598|447620339|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
124453193|NCT00117598|447620335|FG000|After Treament Cross Over|Other|0|||
124453194|NCT00117598|447620336|FG001|After Treament Cross Over|Other|0|||
124453195|NCT00117598|447620337|FG002|After Treament Cross Over|Other|0|||
124453196|NCT00117598|447620338|FG003|After Treament Cross Over|Other|1|||
124453197|NCT00117598|447620339|FG004|After Treament Cross Over|Other|2|||
124453198|NCT04688775|447620342|FG000|Placebo-controlled Period|Randomized, not treated|1|||
124453199|NCT04688775|447620343|FG001|Placebo-controlled Period|Randomized, not treated|1|||
124453200|NCT04688775|447620344|FG002|Placebo-controlled Period|Randomized, not treated|0|||
124453201|NCT04688775|447620345|FG003|Placebo-controlled Period|Randomized, not treated|0|||
124453202|NCT04688775|447620342|FG000|Placebo-controlled Period|Adverse Event|2|||
124453203|NCT04688775|447620343|FG001|Placebo-controlled Period|Adverse Event|0|||
124453204|NCT04688775|447620344|FG002|Placebo-controlled Period|Adverse Event|0|||
124453205|NCT04688775|447620345|FG003|Placebo-controlled Period|Adverse Event|0|||
124453206|NCT04688775|447620342|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
124453207|NCT04688775|447620343|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
124453208|NCT04688775|447620344|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
124453209|NCT04688775|447620345|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
124453210|NCT04688775|447620342|FG000|Placebo-controlled Period|Protocol Violation|0|||
124453211|NCT04688775|447620343|FG001|Placebo-controlled Period|Protocol Violation|1|||
124453212|NCT04688775|447620344|FG002|Placebo-controlled Period|Protocol Violation|0|||
124453213|NCT04688775|447620345|FG003|Placebo-controlled Period|Protocol Violation|0|||
124453214|NCT04688775|447620342|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
124453215|NCT04688775|447620343|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
124453216|NCT04688775|447620344|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
124453217|NCT04688775|447620345|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
124453218|NCT04688775|447620342|FG000|Placebo-controlled Period|Other reasons|0|||
124453219|NCT04688775|447620343|FG001|Placebo-controlled Period|Other reasons|1|||
124453220|NCT04688775|447620344|FG002|Placebo-controlled Period|Other reasons|0|||
124453221|NCT04688775|447620345|FG003|Placebo-controlled Period|Other reasons|0|||
124453222|NCT04688775|447620342|FG000|Delayed Start Period|Adverse Event|0|||
124453223|NCT04688775|447620343|FG001|Delayed Start Period|Adverse Event|0|||
124453224|NCT04688775|447620344|FG002|Delayed Start Period|Adverse Event|1|||
124453225|NCT04688775|447620345|FG003|Delayed Start Period|Adverse Event|0|||
124453226|NCT04688775|447620342|FG000|Delayed Start Period|Lack of Efficacy|0|||
124453227|NCT04688775|447620343|FG001|Delayed Start Period|Lack of Efficacy|0|||
124453228|NCT04688775|447620344|FG002|Delayed Start Period|Lack of Efficacy|0|||
124453229|NCT04688775|447620345|FG003|Delayed Start Period|Lack of Efficacy|3|||
124453230|NCT04688775|447620342|FG000|Delayed Start Period|Withdrawal by Subject|0|||
124923322|NCT03544281|449348325|FG005|Main Study Phase|Did not receive study treatment|0|||
124453231|NCT04688775|447620343|FG001|Delayed Start Period|Withdrawal by Subject|0|||
124453232|NCT04688775|447620344|FG002|Delayed Start Period|Withdrawal by Subject|2|||
124453233|NCT04688775|447620345|FG003|Delayed Start Period|Withdrawal by Subject|4|||
124453234|NCT04688775|447620342|FG000|Delayed Start Period|Lost to Follow-up|0|||
124453235|NCT04688775|447620343|FG001|Delayed Start Period|Lost to Follow-up|0|||
124453236|NCT04688775|447620344|FG002|Delayed Start Period|Lost to Follow-up|2|||
124453237|NCT04688775|447620345|FG003|Delayed Start Period|Lost to Follow-up|1|||
124453238|NCT04688775|447620342|FG000|Delayed Start Period|other reasons|0|||
124696492|NCT03757715|448509493|FG000|Overall Study|Lost to Follow-up|4|||
124696493|NCT03757715|448509494|FG001|Overall Study|Lost to Follow-up|9|||
124696494|NCT03757715|448509493|FG000|Overall Study|Withdrawal by Subject|1|||
124696495|NCT03757715|448509494|FG001|Overall Study|Withdrawal by Subject|1|||
124696496|NCT03302936|448509495|FG000|Overall Study|Protocol Violation|3|||
124696497|NCT03302936|448509496|FG001|Overall Study|Protocol Violation|4|||
124696498|NCT01259024|448509500|FG000|Overall Study|Physician Decision|1|||
124696499|NCT01657500|448509501|FG000|Overall Study|set impropperly matched|3|||
124696500|NCT01657500|448509502|FG001|Overall Study|set impropperly matched|3|||
124696501|NCT01657500|448509501|FG000|Overall Study|Lost to Follow-up|2|||
124696502|NCT01657500|448509502|FG001|Overall Study|Lost to Follow-up|2|||
124696503|NCT00986102|448509506|FG000|Overall Study|Lost to Follow-up|0|||
124696504|NCT00986102|448509507|FG001|Overall Study|Lost to Follow-up|1|||
124696505|NCT00986102|448509508|FG002|Overall Study|Lost to Follow-up|0|||
124696506|NCT00986102|448509509|FG003|Overall Study|Lost to Follow-up|1|||
124696507|NCT00986102|448509506|FG000|Overall Study|Withdrawal by Subject|1|||
124696508|NCT00986102|448509507|FG001|Overall Study|Withdrawal by Subject|1|||
124696509|NCT00986102|448509508|FG002|Overall Study|Withdrawal by Subject|0|||
124696510|NCT00986102|448509509|FG003|Overall Study|Withdrawal by Subject|0|||
124696511|NCT06083493|448509510|FG000|Overall Study|Technical issues with the interventional device|2|||
124696512|NCT06083493|448509511|FG001|Overall Study|Technical issues with the interventional device|2|||
124696513|NCT06083493|448509510|FG000|Overall Study|Performed incorrect visual task|1|||
124696514|NCT06083493|448509511|FG001|Overall Study|Performed incorrect visual task|0|||
124696515|NCT06083493|448509510|FG000|Overall Study|Insufficient baseline performance|0|||
124696516|NCT06083493|448509511|FG001|Overall Study|Insufficient baseline performance|1|||
124696517|NCT03093870|448509512|FG000|Overall Study|Withdrawal by Subject|2|||
124696518|NCT03093870|448509513|FG001|Overall Study|Withdrawal by Subject|6|||
124696519|NCT03093870|448509514|FG002|Overall Study|Withdrawal by Subject|5|||
124696520|NCT03093870|448509512|FG000|Overall Study|Death|1|||
124696521|NCT03093870|448509513|FG001|Overall Study|Death|35|||
124696522|NCT03093870|448509514|FG002|Overall Study|Death|35|||
124696523|NCT03093870|448509512|FG000|Overall Study|Radiographic disease progression|10|||
124696524|NCT03093870|448509513|FG001|Overall Study|Radiographic disease progression|0|||
124696525|NCT03093870|448509514|FG002|Overall Study|Radiographic disease progression|0|||
124696526|NCT03093870|448509512|FG000|Overall Study|Clinical disease progression|1|||
124696527|NCT03093870|448509513|FG001|Overall Study|Clinical disease progression|0|||
124696528|NCT03093870|448509514|FG002|Overall Study|Clinical disease progression|0|||
124696529|NCT03093870|448509512|FG000|Overall Study|Physician Decision|2|||
124696530|NCT03093870|448509513|FG001|Overall Study|Physician Decision|0|||
124696531|NCT03093870|448509514|FG002|Overall Study|Physician Decision|0|||
124696532|NCT03093870|448509512|FG000|Overall Study|Adverse Event|7|||
124696533|NCT03093870|448509513|FG001|Overall Study|Adverse Event|0|||
124696534|NCT03093870|448509514|FG002|Overall Study|Adverse Event|0|||
124696535|NCT03093870|448509512|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
124696536|NCT03093870|448509513|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
124696537|NCT03093870|448509514|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
124696538|NCT03093870|448509512|FG000|Overall Study|Lost to Follow-up|0|||
124696539|NCT03093870|448509513|FG001|Overall Study|Lost to Follow-up|0|||
124696540|NCT03093870|448509514|FG002|Overall Study|Lost to Follow-up|1|||
124696541|NCT04008069|448509515|FG000|Open-Label Period|Adverse Event|1|||
124696542|NCT04008069|448509516|FG001|Open-Label Period|Adverse Event|0|||
124696543|NCT04008069|448509517|FG002|Open-Label Period|Adverse Event|0|||
124696544|NCT04008069|448509515|FG000|Open-Label Period|Lack of Efficacy|4|||
124696545|NCT04008069|448509516|FG001|Open-Label Period|Lack of Efficacy|0|||
124696546|NCT04008069|448509517|FG002|Open-Label Period|Lack of Efficacy|0|||
124696547|NCT04008069|448509515|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
124696548|NCT04008069|448509516|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
124696549|NCT04008069|448509517|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
124696550|NCT04008069|448509515|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
124696551|NCT04008069|448509516|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
124923323|NCT03544281|449348326|FG006|Main Study Phase|Did not receive study treatment|1|||
124923324|NCT03544281|449348327|FG007|Main Study Phase|Did not receive study treatment|0|||
124696552|NCT04008069|448509517|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
124696553|NCT02134028|448509518|FG000|Overall Study|Lack of Efficacy|1|||
124696554|NCT02134028|448509519|FG001|Overall Study|Lack of Efficacy|0|||
124696555|NCT02134028|448509520|FG002|Overall Study|Lack of Efficacy|3|||
124696556|NCT02134028|448509521|FG003|Overall Study|Lack of Efficacy|2|||
124696557|NCT02134028|448509522|FG004|Overall Study|Lack of Efficacy|1|||
124696558|NCT02134028|448509523|FG005|Overall Study|Lack of Efficacy|2|||
124696559|NCT02134028|448509524|FG006|Overall Study|Lack of Efficacy|1|||
124696560|NCT02134028|448509525|FG007|Overall Study|Lack of Efficacy|0|||
124696561|NCT02134028|448509518|FG000|Overall Study|Poor compliance to protocol|1|||
124696562|NCT02134028|448509519|FG001|Overall Study|Poor compliance to protocol|1|||
124696563|NCT02134028|448509520|FG002|Overall Study|Poor compliance to protocol|3|||
124923325|NCT03544281|449348328|FG008|Main Study Phase|Did not receive study treatment|0|||
124923326|NCT03544281|449348329|FG009|Main Study Phase|Did not receive study treatment|0|||
124923327|NCT03544281|449348330|FG010|Main Study Phase|Did not receive study treatment|0|||
124923328|NCT03544281|449348331|FG011|Main Study Phase|Did not receive study treatment|0|||
124923329|NCT03544281|449348332|FG012|Main Study Phase|Did not receive study treatment|0|||
124923330|NCT03544281|449348333|FG013|Main Study Phase|Did not receive study treatment|0|||
124923331|NCT03544281|449348334|FG014|Main Study Phase|Did not receive study treatment|0|||
124923332|NCT03544281|449348335|FG015|Main Study Phase|Did not receive study treatment|0|||
124923333|NCT03544281|449348336|FG016|Main Study Phase|Did not receive study treatment|0|||
124923334|NCT03544281|449348337|FG017|Main Study Phase|Did not receive study treatment|0|||
124923335|NCT03544281|449348338|FG018|Main Study Phase|Did not receive study treatment|0|||
124923336|NCT03544281|449348339|FG019|Main Study Phase|Did not receive study treatment|0|||
124545727|NCT00518531|447952767|FG000|Treatment Period 1|Withdrawal by Subject|4|||
124545728|NCT00518531|447952768|FG001|Treatment Period 1|Withdrawal by Subject|6|||
124545729|NCT00518531|447952767|FG000|Treatment Period 1|Early crossover|1|||
124545730|NCT00518531|447952768|FG001|Treatment Period 1|Early crossover|3|||
124545731|NCT00518531|447952767|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124545732|NCT00518531|447952768|FG001|Treatment Period 2|Withdrawal by Subject|8|||
124545733|NCT00518531|447952767|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
124545734|NCT00518531|447952768|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
124545735|NCT00518531|447952767|FG000|Treatment Period 2|Adverse Event|1|||
124545736|NCT00518531|447952768|FG001|Treatment Period 2|Adverse Event|7|||
124545737|NCT00518531|447952767|FG000|Treatment Period 2|Protocol-specified criteria|0|||
124545738|NCT00518531|447952768|FG001|Treatment Period 2|Protocol-specified criteria|1|||
124545739|NCT00518531|447952767|FG000|Treatment Period 2|Non-compliance|1|||
124545740|NCT00518531|447952768|FG001|Treatment Period 2|Non-compliance|2|||
124545741|NCT01656850|447952769|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
124545742|NCT01656850|447952770|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
124545743|NCT01118949|447952773|FG000|Overall Study|Adverse Event|5|||
124545744|NCT01118949|447952773|FG000|Overall Study|Withdrawal by Subject|4|||
124545745|NCT00602927|447952779|FG000|Period 1: 13 Days|Protocol Violation|2|||
124545746|NCT00602927|447952780|FG001|Period 1: 13 Days|Protocol Violation|4|||
124545747|NCT00602927|447952779|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
124545748|NCT00602927|447952780|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
124545749|NCT00602927|447952779|FG000|Period 1: 13 Days|Time|1|||
124696564|NCT02134028|448509521|FG003|Overall Study|Poor compliance to protocol|7|||
124696565|NCT02134028|448509522|FG004|Overall Study|Poor compliance to protocol|1|||
124696566|NCT02134028|448509523|FG005|Overall Study|Poor compliance to protocol|1|||
124696567|NCT02134028|448509524|FG006|Overall Study|Poor compliance to protocol|0|||
124696568|NCT02134028|448509525|FG007|Overall Study|Poor compliance to protocol|0|||
124696569|NCT02134028|448509518|FG000|Overall Study|Other unspecified|4|||
124545750|NCT00602927|447952780|FG001|Period 1: 13 Days|Time|0|||
124545751|NCT00602927|447952779|FG000|Period 1: 13 Days|Claustrophobia|0|||
124545752|NCT00602927|447952780|FG001|Period 1: 13 Days|Claustrophobia|1|||
124545753|NCT00602927|447952779|FG000|Period 2: 14 Days|Protocol Violation|0|||
124545754|NCT00602927|447952780|FG001|Period 2: 14 Days|Protocol Violation|2|||
124545755|NCT00602927|447952779|FG000|Period 3: 13 Days|Protocol Violation|0|||
124545756|NCT00602927|447952780|FG001|Period 3: 13 Days|Protocol Violation|1|||
124696570|NCT02134028|448509519|FG001|Overall Study|Other unspecified|22|||
124696571|NCT02134028|448509520|FG002|Overall Study|Other unspecified|33|||
124545757|NCT00602927|447952779|FG000|Period 3: 13 Days|MRI data quality|2|||
124545758|NCT00602927|447952780|FG001|Period 3: 13 Days|MRI data quality|2|||
124696572|NCT02134028|448509521|FG003|Overall Study|Other unspecified|64|||
124696573|NCT02134028|448509522|FG004|Overall Study|Other unspecified|8|||
124696574|NCT02134028|448509523|FG005|Overall Study|Other unspecified|6|||
124696575|NCT02134028|448509524|FG006|Overall Study|Other unspecified|2|||
124696576|NCT02134028|448509525|FG007|Overall Study|Other unspecified|1|||
124696577|NCT02134028|448509518|FG000|Overall Study|Adverse Event|3|||
124696578|NCT02134028|448509519|FG001|Overall Study|Adverse Event|19|||
124696579|NCT02134028|448509520|FG002|Overall Study|Adverse Event|13|||
124696580|NCT02134028|448509521|FG003|Overall Study|Adverse Event|32|||
124696581|NCT02134028|448509522|FG004|Overall Study|Adverse Event|4|||
124696582|NCT02134028|448509523|FG005|Overall Study|Adverse Event|5|||
124696583|NCT02134028|448509524|FG006|Overall Study|Adverse Event|1|||
124696584|NCT02134028|448509525|FG007|Overall Study|Adverse Event|2|||
124696585|NCT00819832|448509528|FG000|Overall Study|Sponsor Termination of Study|3|||
124696586|NCT00819832|448509529|FG001|Overall Study|Sponsor Termination of Study|0|||
124696587|NCT00819832|448509530|FG002|Overall Study|Sponsor Termination of Study|0|||
124696588|NCT00819832|448509531|FG003|Overall Study|Sponsor Termination of Study|0|||
124696589|NCT00819832|448509532|FG004|Overall Study|Sponsor Termination of Study|0|||
124696590|NCT00819832|448509533|FG005|Overall Study|Sponsor Termination of Study|0|||
124696591|NCT01260311|448509541|FG000|Overall Study|Adverse Event|11|||
124696592|NCT01260311|448509541|FG000|Overall Study|Lack of Efficacy|4|||
124696593|NCT01260311|448509541|FG000|Overall Study|Lost to Follow-up|25|||
124696594|NCT01260311|448509541|FG000|Overall Study|Withdrawal by Subject|6|||
124696595|NCT01260311|448509541|FG000|Overall Study|Financial Constraints|77|||
124696596|NCT01260311|448509541|FG000|Overall Study|Gone to Province|2|||
124696597|NCT01260311|448509541|FG000|Overall Study|Medication Stopped|1|||
124696598|NCT01260311|448509541|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
124696599|NCT01452789|448509542|FG000|Overall Study|Withdrawal by Subject|3|||
124696600|NCT01452789|448509543|FG001|Overall Study|Withdrawal by Subject|2|||
124696601|NCT00066170|448509544|FG000|Overall Study|Adverse Event|2|||
124696602|NCT00066170|448509545|FG001|Overall Study|Adverse Event|4|||
124696603|NCT00066170|448509546|FG002|Overall Study|Adverse Event|1|||
124696604|NCT00066170|448509547|FG003|Overall Study|Adverse Event|7|||
124696605|NCT00066170|448509544|FG000|Overall Study|Serious Adverse Event|0|||
124696606|NCT00066170|448509545|FG001|Overall Study|Serious Adverse Event|0|||
124696607|NCT00066170|448509546|FG002|Overall Study|Serious Adverse Event|1|||
124696608|NCT00066170|448509547|FG003|Overall Study|Serious Adverse Event|1|||
124696609|NCT00066170|448509544|FG000|Overall Study|Lost to Follow-up|0|||
124696610|NCT00066170|448509545|FG001|Overall Study|Lost to Follow-up|1|||
124696611|NCT00066170|448509546|FG002|Overall Study|Lost to Follow-up|0|||
124696612|NCT00066170|448509547|FG003|Overall Study|Lost to Follow-up|0|||
124696613|NCT00066170|448509544|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
124696614|NCT00066170|448509545|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
124696615|NCT00066170|448509546|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
124923337|NCT03544281|449348340|FG020|Main Study Phase|Did not receive study treatment|0|||
124923338|NCT03544281|449348341|FG021|Main Study Phase|Did not receive study treatment|0|||
124923339|NCT03544281|449348320|FG000|PACT Phase|Adverse Event|0|||
124923340|NCT03544281|449348321|FG001|PACT Phase|Adverse Event|0|||
124923341|NCT03544281|449348322|FG002|PACT Phase|Adverse Event|0|||
124923342|NCT03544281|449348323|FG003|PACT Phase|Adverse Event|0|||
124923343|NCT03544281|449348324|FG004|PACT Phase|Adverse Event|0|||
124923344|NCT03544281|449348325|FG005|PACT Phase|Adverse Event|0|||
124923345|NCT03544281|449348326|FG006|PACT Phase|Adverse Event|0|||
124923346|NCT03544281|449348327|FG007|PACT Phase|Adverse Event|0|||
124923347|NCT03544281|449348328|FG008|PACT Phase|Adverse Event|0|||
124923348|NCT03544281|449348329|FG009|PACT Phase|Adverse Event|0|||
124923349|NCT03544281|449348330|FG010|PACT Phase|Adverse Event|0|||
124923350|NCT03544281|449348331|FG011|PACT Phase|Adverse Event|0|||
124923351|NCT03544281|449348332|FG012|PACT Phase|Adverse Event|1|||
124923352|NCT03544281|449348333|FG013|PACT Phase|Adverse Event|0|||
124923353|NCT03544281|449348334|FG014|PACT Phase|Adverse Event|0|||
124923354|NCT03544281|449348335|FG015|PACT Phase|Adverse Event|0|||
124923355|NCT03544281|449348336|FG016|PACT Phase|Adverse Event|0|||
124923356|NCT03544281|449348337|FG017|PACT Phase|Adverse Event|1|||
124923357|NCT03544281|449348338|FG018|PACT Phase|Adverse Event|1|||
124923358|NCT03544281|449348339|FG019|PACT Phase|Adverse Event|0|||
124923359|NCT03544281|449348340|FG020|PACT Phase|Adverse Event|0|||
124923360|NCT03544281|449348341|FG021|PACT Phase|Adverse Event|0|||
124923361|NCT04876118|449348343|FG000|Overall Study|Pregnancy|1|||
124923362|NCT04876118|449348343|FG000|Overall Study|Withdrawal by Subject|14|||
124923363|NCT03092518|449348344|FG000|Overall Study|Ineligible|2|||
124923364|NCT02547987|449348347|FG000|Overall Study|Withdrawal by Subject|1|||
124923365|NCT02547987|449348347|FG000|Overall Study|Adverse Event|2|||
124923366|NCT04282148|449348348|FG000|Overall Study|Death|7|||
124923367|NCT04282148|449348348|FG000|Overall Study|Withdrawal by Subject|1|||
124923368|NCT04282148|449348348|FG000|Overall Study|Physician Decision|1|||
124923369|NCT04925986|449348349|FG000|Overall Study|Death|0|||
124923370|NCT04925986|449348350|FG001|Overall Study|Death|0|||
124923371|NCT04925986|449348351|FG002|Overall Study|Death|2|||
124923372|NCT04925986|449348352|FG003|Overall Study|Death|0|||
124923373|NCT04925986|449348349|FG000|Overall Study|Lack of Efficacy|1|||
124923374|NCT04925986|449348350|FG001|Overall Study|Lack of Efficacy|2|||
124923375|NCT04925986|449348351|FG002|Overall Study|Lack of Efficacy|0|||
124923376|NCT04925986|449348352|FG003|Overall Study|Lack of Efficacy|1|||
124923377|NCT04925986|449348349|FG000|Overall Study|Withdrawal by Subject|0|||
124923378|NCT04925986|449348350|FG001|Overall Study|Withdrawal by Subject|0|||
124923379|NCT04925986|449348351|FG002|Overall Study|Withdrawal by Subject|1|||
124923380|NCT04925986|449348352|FG003|Overall Study|Withdrawal by Subject|2|||
124923381|NCT06181760|449348353|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
124923382|NCT06181760|449348354|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
124696616|NCT00066170|448509547|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
124696617|NCT00066170|448509544|FG000|Overall Study|Protocol Violation|3|||
124696618|NCT00066170|448509545|FG001|Overall Study|Protocol Violation|0|||
124696619|NCT00066170|448509546|FG002|Overall Study|Protocol Violation|0|||
124923383|NCT06181760|449348355|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
124923384|NCT06181760|449348356|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
124923385|NCT04770532|449348357|FG000|Overall Study|Withdrawal by Subject|0|||
124923386|NCT04770532|449348358|FG001|Overall Study|Withdrawal by Subject|3|||
124696620|NCT00066170|448509547|FG003|Overall Study|Protocol Violation|0|||
124696621|NCT00066170|448509544|FG000|Overall Study|Other|1|||
124696622|NCT00066170|448509545|FG001|Overall Study|Other|5|||
124696623|NCT00066170|448509546|FG002|Overall Study|Other|2|||
124696624|NCT00066170|448509547|FG003|Overall Study|Other|0|||
124696625|NCT00098293|448509548|FG000|Double-blind (DB) Phase|Adverse Event|14|||
124696626|NCT00098293|448509549|FG001|Double-blind (DB) Phase|Adverse Event|27|||
124696627|NCT00098293|448509550|FG002|Double-blind (DB) Phase|Adverse Event|60|||
124696628|NCT00098293|448509551|FG003|Double-blind (DB) Phase|Adverse Event|0|||
124696629|NCT00098293|448509552|FG004|Double-blind (DB) Phase|Adverse Event|0|||
124696630|NCT00098293|448509548|FG000|Double-blind (DB) Phase|Pregnancy|0|||
124696631|NCT00098293|448509549|FG001|Double-blind (DB) Phase|Pregnancy|7|||
124696632|NCT00098293|448509550|FG002|Double-blind (DB) Phase|Pregnancy|9|||
124696633|NCT00098293|448509551|FG003|Double-blind (DB) Phase|Pregnancy|0|||
124696634|NCT00098293|448509552|FG004|Double-blind (DB) Phase|Pregnancy|0|||
124696635|NCT00098293|448509548|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
124696636|NCT00098293|448509549|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
124696637|NCT00098293|448509550|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
124696638|NCT00098293|448509551|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
124696639|NCT00098293|448509552|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
124696640|NCT00098293|448509548|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
124696641|NCT00098293|448509549|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
124696642|NCT00098293|448509550|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
124696643|NCT00098293|448509551|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
124696644|NCT00098293|448509552|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
124696645|NCT00098293|448509548|FG000|Double-blind (DB) Phase|Death|1|||
124696646|NCT00098293|448509549|FG001|Double-blind (DB) Phase|Death|2|||
124696647|NCT00098293|448509550|FG002|Double-blind (DB) Phase|Death|2|||
124696648|NCT00098293|448509551|FG003|Double-blind (DB) Phase|Death|0|||
124696649|NCT00098293|448509552|FG004|Double-blind (DB) Phase|Death|0|||
124923387|NCT04770532|449348357|FG000|Overall Study|Physician Decision|1|||
124923388|NCT04770532|449348358|FG001|Overall Study|Physician Decision|0|||
124923389|NCT04770532|449348357|FG000|Overall Study|Death|2|||
124923390|NCT04770532|449348358|FG001|Overall Study|Death|2|||
124923391|NCT04938492|449348359|FG000|Overall Study|Lost to Follow-up|17|||
124923392|NCT04938492|449348360|FG001|Overall Study|Lost to Follow-up|18|||
124696650|NCT00098293|448509548|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
124696651|NCT00098293|448509549|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
124696652|NCT00098293|448509550|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
124696653|NCT00098293|448509551|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
124696654|NCT00098293|448509552|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
124696655|NCT00098293|448509548|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
124696656|NCT00098293|448509549|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
124696657|NCT00098293|448509550|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
124696658|NCT00098293|448509551|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
124696659|NCT00098293|448509552|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
124696660|NCT00098293|448509548|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
124696661|NCT00098293|448509549|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
124696662|NCT00098293|448509550|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
124696663|NCT00098293|448509551|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
124696664|NCT00098293|448509552|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
124696665|NCT00098293|448509548|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
124923393|NCT04025554|449348361|FG000|Overall Study|Adverse Event|3|||
124696666|NCT00098293|448509549|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
124696667|NCT00098293|448509550|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
124696668|NCT00098293|448509551|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
124696669|NCT00098293|448509552|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
124696670|NCT00098293|448509548|FG000|Open-label (OL) Phase|Adverse Event|0|||
124923394|NCT04338061|449348364|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
124453239|NCT04688775|447620343|FG001|Delayed Start Period|other reasons|0|||
124453240|NCT04688775|447620344|FG002|Delayed Start Period|other reasons|1|||
124453241|NCT04688775|447620345|FG003|Delayed Start Period|other reasons|0|||
124453242|NCT00493220|447620346|FG000|Third Intervention|Withdrawal by Subject|1|||
124453243|NCT00493220|447620347|FG001|Third Intervention|Withdrawal by Subject|0|||
124923395|NCT04338061|449348365|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
124923396|NCT04338061|449348364|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
124545759|NCT01741259|447952786|FG000|Overall Study|Protocol Violation|6|||
124969557|NCT03520075|449517413|FG004|Phase 2 (Dose Expansion)|Death|0|||
124696671|NCT00098293|448509549|FG001|Open-label (OL) Phase|Adverse Event|3|||
124696672|NCT00098293|448509550|FG002|Open-label (OL) Phase|Adverse Event|7|||
124696673|NCT00098293|448509551|FG003|Open-label (OL) Phase|Adverse Event|6|||
124696674|NCT00098293|448509552|FG004|Open-label (OL) Phase|Adverse Event|0|||
124696675|NCT00098293|448509548|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
124696676|NCT00098293|448509549|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
124696677|NCT00098293|448509550|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
124453244|NCT00493220|447620348|FG002|Third Intervention|Withdrawal by Subject|0|||
124453245|NCT00493220|447620349|FG003|Third Intervention|Withdrawal by Subject|0|||
124453246|NCT00493220|447620350|FG004|Third Intervention|Withdrawal by Subject|0|||
124453247|NCT00493220|447620351|FG005|Third Intervention|Withdrawal by Subject|0|||
124453248|NCT02625233|447620352|FG000|Overall Study|Adverse Event|2|||
124453249|NCT02625233|447620353|FG001|Overall Study|Adverse Event|0|||
124453250|NCT01877915|447620356|FG000|Overall Study|Lost to Follow-up|10|||
124453251|NCT01877915|447620357|FG001|Overall Study|Lost to Follow-up|9|||
124453252|NCT01877915|447620356|FG000|Overall Study|Withdrawal by Subject|42|||
124453253|NCT01877915|447620357|FG001|Overall Study|Withdrawal by Subject|55|||
124453254|NCT01877915|447620356|FG000|Overall Study|Other|2|||
124453255|NCT01877915|447620357|FG001|Overall Study|Other|4|||
124453256|NCT01449461|447620358|FG000|Overall Study|Adverse Event|0|||
124453257|NCT01449461|447620359|FG001|Overall Study|Adverse Event|3|||
124453258|NCT01449461|447620360|FG002|Overall Study|Adverse Event|2|||
124453259|NCT01449461|447620361|FG003|Overall Study|Adverse Event|3|||
124453260|NCT01449461|447620362|FG004|Overall Study|Adverse Event|4|||
124453261|NCT01449461|447620363|FG005|Overall Study|Adverse Event|4|||
124453262|NCT01449461|447620358|FG000|Overall Study|Death|0|||
124453263|NCT01449461|447620359|FG001|Overall Study|Death|2|||
124453264|NCT01449461|447620360|FG002|Overall Study|Death|0|||
124453265|NCT01449461|447620361|FG003|Overall Study|Death|0|||
124453266|NCT01449461|447620362|FG004|Overall Study|Death|7|||
124453267|NCT01449461|447620363|FG005|Overall Study|Death|1|||
124453268|NCT01449461|447620358|FG000|Overall Study|Physician Decision|0|||
124453269|NCT01449461|447620359|FG001|Overall Study|Physician Decision|1|||
124453270|NCT01449461|447620360|FG002|Overall Study|Physician Decision|0|||
124453271|NCT01449461|447620361|FG003|Overall Study|Physician Decision|4|||
124453272|NCT01449461|447620362|FG004|Overall Study|Physician Decision|1|||
124453273|NCT01449461|447620363|FG005|Overall Study|Physician Decision|0|||
124453274|NCT01449461|447620358|FG000|Overall Study|Documented Progressive Disease|4|||
124453275|NCT01449461|447620359|FG001|Overall Study|Documented Progressive Disease|7|||
124453276|NCT01449461|447620360|FG002|Overall Study|Documented Progressive Disease|14|||
124453277|NCT01449461|447620361|FG003|Overall Study|Documented Progressive Disease|15|||
124453278|NCT01449461|447620362|FG004|Overall Study|Documented Progressive Disease|24|||
124453279|NCT01449461|447620363|FG005|Overall Study|Documented Progressive Disease|5|||
124453280|NCT01449461|447620358|FG000|Overall Study|Clinical Progressive Disease|2|||
124453281|NCT01449461|447620359|FG001|Overall Study|Clinical Progressive Disease|2|||
124453282|NCT01449461|447620360|FG002|Overall Study|Clinical Progressive Disease|0|||
124453283|NCT01449461|447620361|FG003|Overall Study|Clinical Progressive Disease|3|||
124453284|NCT01449461|447620362|FG004|Overall Study|Clinical Progressive Disease|4|||
124453285|NCT01449461|447620363|FG005|Overall Study|Clinical Progressive Disease|2|||
124453286|NCT01449461|447620358|FG000|Overall Study|Protocol Violation|0|||
124453287|NCT01449461|447620359|FG001|Overall Study|Protocol Violation|0|||
124453288|NCT01449461|447620360|FG002|Overall Study|Protocol Violation|0|||
124453289|NCT01449461|447620361|FG003|Overall Study|Protocol Violation|1|||
124453290|NCT01449461|447620362|FG004|Overall Study|Protocol Violation|0|||
124453291|NCT01449461|447620363|FG005|Overall Study|Protocol Violation|0|||
124453292|NCT01449461|447620358|FG000|Overall Study|Site Terminated by Sponsor|0|||
124453293|NCT01449461|447620359|FG001|Overall Study|Site Terminated by Sponsor|1|||
124453294|NCT01449461|447620360|FG002|Overall Study|Site Terminated by Sponsor|2|||
124453295|NCT01449461|447620361|FG003|Overall Study|Site Terminated by Sponsor|3|||
124453296|NCT01449461|447620362|FG004|Overall Study|Site Terminated by Sponsor|4|||
124453297|NCT01449461|447620363|FG005|Overall Study|Site Terminated by Sponsor|1|||
124453298|NCT01449461|447620358|FG000|Overall Study|Withdrawal by Subject|0|||
124453299|NCT01449461|447620359|FG001|Overall Study|Withdrawal by Subject|1|||
124453300|NCT01449461|447620360|FG002|Overall Study|Withdrawal by Subject|0|||
124453301|NCT01449461|447620361|FG003|Overall Study|Withdrawal by Subject|0|||
124453302|NCT01449461|447620362|FG004|Overall Study|Withdrawal by Subject|2|||
124453303|NCT01449461|447620363|FG005|Overall Study|Withdrawal by Subject|1|||
124453304|NCT01449461|447620358|FG000|Overall Study|Reason not Specified|0|||
124453305|NCT01449461|447620359|FG001|Overall Study|Reason not Specified|1|||
124453306|NCT01449461|447620360|FG002|Overall Study|Reason not Specified|0|||
124453307|NCT01449461|447620361|FG003|Overall Study|Reason not Specified|3|||
124453308|NCT01449461|447620362|FG004|Overall Study|Reason not Specified|2|||
124453309|NCT01449461|447620363|FG005|Overall Study|Reason not Specified|1|||
124453310|NCT00943579|447620364|FG000|Overall Study|Adverse Event|4|||
124453311|NCT00943579|447620365|FG001|Overall Study|Adverse Event|3|||
124453312|NCT00943579|447620364|FG000|Overall Study|Lack of Efficacy|2|||
124453313|NCT00943579|447620365|FG001|Overall Study|Lack of Efficacy|2|||
124453314|NCT01357577|447620366|FG000|Overall Study|Lost to Follow-up|20|||
124453315|NCT01357577|447620367|FG001|Overall Study|Lost to Follow-up|16|||
124453316|NCT01357577|447620366|FG000|Overall Study|Withdrawal by Subject|16|||
124453317|NCT01357577|447620367|FG001|Overall Study|Withdrawal by Subject|8|||
124453318|NCT01357577|447620366|FG000|Overall Study|look at data in database?|1|||
124453319|NCT01357577|447620367|FG001|Overall Study|look at data in database?|2|||
124453320|NCT01502709|447621559|FG000|Overall Study|Lost to Follow-up|4|||
124453321|NCT01502709|447621560|FG001|Overall Study|Lost to Follow-up|0|||
124923397|NCT04338061|449348365|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
124923398|NCT04338061|449348364|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
124923399|NCT04338061|449348365|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
124923400|NCT04338061|449348364|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
124923401|NCT04338061|449348365|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
124923402|NCT04338061|449348364|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
124923403|NCT04338061|449348365|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
124923404|NCT04338061|449348364|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
124923405|NCT04338061|449348365|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
124923406|NCT04338061|449348364|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
124923407|NCT04338061|449348365|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
124923408|NCT04338061|449348364|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
124923409|NCT04338061|449348365|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
124923410|NCT04338061|449348364|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
124923411|NCT04338061|449348365|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
124923412|NCT04338061|449348364|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
124923413|NCT04338061|449348365|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
124923414|NCT04338061|449348364|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
124923415|NCT04338061|449348365|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
124923416|NCT04338061|449348364|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
124923417|NCT04338061|449348365|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
124923418|NCT03631784|449348367|FG000|Overall Study|Participants Ongoing|1|||
124923419|NCT03631784|449348368|FG001|Overall Study|Participants Ongoing|0|||
124923420|NCT03631784|449348367|FG000|Overall Study|Withdrawal by Subject|3|||
124923421|NCT03631784|449348368|FG001|Overall Study|Withdrawal by Subject|3|||
124453322|NCT00937937|447621562|FG000|Overall Study|Adverse Event|6|||
124453323|NCT00937937|447621562|FG000|Overall Study|Withdrawal by Subject|2|||
124453324|NCT00937937|447621562|FG000|Overall Study|Progression/relapse|61|||
124453325|NCT00937937|447621562|FG000|Overall Study|Death|1|||
124453326|NCT00937937|447621562|FG000|Overall Study|Other|2|||
124453327|NCT02932410|447621564|FG000|Overall Study|Death|7|||
124453328|NCT02932410|447621565|FG001|Overall Study|Death|6|||
124453329|NCT02932410|447621566|FG002|Overall Study|Death|0|||
124453330|NCT02932410|447621567|FG003|Overall Study|Death|0|||
124453331|NCT02932410|447621564|FG000|Overall Study|Lost to Follow-up|1|||
124453332|NCT02932410|447621565|FG001|Overall Study|Lost to Follow-up|2|||
124453333|NCT02932410|447621566|FG002|Overall Study|Lost to Follow-up|0|||
124453334|NCT02932410|447621567|FG003|Overall Study|Lost to Follow-up|0|||
124453335|NCT02932410|447621564|FG000|Overall Study|Parent/Subjects decision|6|||
124453336|NCT02932410|447621565|FG001|Overall Study|Parent/Subjects decision|6|||
124453337|NCT02932410|447621566|FG002|Overall Study|Parent/Subjects decision|1|||
124453338|NCT02932410|447621567|FG003|Overall Study|Parent/Subjects decision|0|||
124453339|NCT02932410|447621564|FG000|Overall Study|Physician Decision|0|||
124453340|NCT02932410|447621565|FG001|Overall Study|Physician Decision|1|||
124453341|NCT02932410|447621566|FG002|Overall Study|Physician Decision|0|||
124453342|NCT02932410|447621567|FG003|Overall Study|Physician Decision|0|||
124453343|NCT01007032|447621573|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
124453344|NCT01007032|447621574|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
124453345|NCT01007032|447621575|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
124453346|NCT01007032|447621576|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
124453347|NCT01007032|447621573|FG000|Overall Study|Withdrawal by Subject|0|||
124453348|NCT01007032|447621574|FG001|Overall Study|Withdrawal by Subject|0|||
124453349|NCT01007032|447621575|FG002|Overall Study|Withdrawal by Subject|0|||
124453350|NCT01007032|447621576|FG003|Overall Study|Withdrawal by Subject|1|||
124453351|NCT01841749|447621577|FG000|Overall Study|Protocol Violation|1|||
124453352|NCT02752035|447621585|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
124923422|NCT03631784|449348367|FG000|Overall Study|Sponsor's Decision|36|||
124923423|NCT03631784|449348368|FG001|Overall Study|Sponsor's Decision|52|||
124923424|NCT03631784|449348367|FG000|Overall Study|Lost to Follow-up|1|||
124923425|NCT03631784|449348368|FG001|Overall Study|Lost to Follow-up|0|||
124923426|NCT03631784|449348367|FG000|Overall Study|Death|71|||
124923427|NCT03631784|449348368|FG001|Overall Study|Death|49|||
124923428|NCT04437615|449348372|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
124923429|NCT02035787|449350413|FG000|Overall Study- 12 Months|Adverse Event|3|||
124453353|NCT02752035|447621586|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
124453354|NCT02752035|447621587|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
124453355|NCT02752035|447621588|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
124453356|NCT02752035|447621585|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
124453357|NCT02752035|447621586|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
124453358|NCT02752035|447621587|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
124453359|NCT02752035|447621588|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
124453360|NCT02752035|447621585|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
124923430|NCT02035787|449350414|FG001|Overall Study- 12 Months|Adverse Event|0|||
124923431|NCT02035787|449350413|FG000|Overall Study- 12 Months|Complete response|4|||
124923432|NCT02035787|449350414|FG001|Overall Study- 12 Months|Complete response|1|||
124923433|NCT02035787|449350413|FG000|Overall Study- 12 Months|Protocol Violation|1|||
124923434|NCT02035787|449350414|FG001|Overall Study- 12 Months|Protocol Violation|1|||
124923435|NCT06414213|449350415|FG000|Overall Study|Lost to Follow-up|1|||
124923436|NCT06414213|449350416|FG001|Overall Study|Lost to Follow-up|1|||
124545760|NCT01741259|447952787|FG001|Overall Study|Protocol Violation|4|||
124545761|NCT01741259|447952786|FG000|Overall Study|Withdrawal by Subject|0|||
124545762|NCT01741259|447952787|FG001|Overall Study|Withdrawal by Subject|2|||
124545763|NCT00057330|447952788|FG000|Overall Study|Adverse Event|9|||
124545764|NCT00057330|447952789|FG001|Overall Study|Adverse Event|12|||
124545765|NCT00057330|447952788|FG000|Overall Study|Death|1|||
124545766|NCT00057330|447952789|FG001|Overall Study|Death|0|||
124545767|NCT00057330|447952788|FG000|Overall Study|Protocol Violation|1|||
124545768|NCT00057330|447952789|FG001|Overall Study|Protocol Violation|1|||
124545769|NCT00057330|447952788|FG000|Overall Study|Withdrawal by Subject|115|||
124923437|NCT06414213|449350417|FG002|Overall Study|Lost to Follow-up|3|||
124545770|NCT00057330|447952789|FG001|Overall Study|Withdrawal by Subject|84|||
124545771|NCT00057330|447952788|FG000|Overall Study|Lost to Follow-up|745|||
124696678|NCT00098293|448509551|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
124923438|NCT01396278|449350418|FG000|Overall Study|Adverse Event|0|||
124923439|NCT01396278|449350419|FG001|Overall Study|Adverse Event|0|||
124923440|NCT01396278|449350420|FG002|Overall Study|Adverse Event|0|||
124923441|NCT01396278|449350421|FG003|Overall Study|Adverse Event|2|||
124923442|NCT01396278|449350422|FG004|Overall Study|Adverse Event|0|||
124923443|NCT01396278|449350418|FG000|Overall Study|Withdraw due to trial termination|2|||
124923444|NCT01396278|449350419|FG001|Overall Study|Withdraw due to trial termination|1|||
124923445|NCT01396278|449350420|FG002|Overall Study|Withdraw due to trial termination|1|||
124923446|NCT01396278|449350421|FG003|Overall Study|Withdraw due to trial termination|0|||
124923447|NCT01396278|449350422|FG004|Overall Study|Withdraw due to trial termination|2|||
124923448|NCT04515576|449350425|FG000|Overall Study|Withdrawal by Subject|0|||
124923449|NCT04515576|449350426|FG001|Overall Study|Withdrawal by Subject|0|||
124923450|NCT04515576|449350427|FG002|Overall Study|Withdrawal by Subject|0|||
124923451|NCT04515576|449350428|FG003|Overall Study|Withdrawal by Subject|0|||
124923452|NCT04515576|449350429|FG004|Overall Study|Withdrawal by Subject|0|||
124923453|NCT04515576|449350430|FG005|Overall Study|Withdrawal by Subject|1|||
124923454|NCT05028634|449350431|FG000|Overall Study|Withdrawal by Subject|0|||
124923455|NCT05028634|449350432|FG001|Overall Study|Withdrawal by Subject|1|||
124923456|NCT04728347|449350433|FG000|Overall Study|Sponsor decision|0|||
124923457|NCT04728347|449350434|FG001|Overall Study|Sponsor decision|0|||
124923458|NCT04728347|449350435|FG002|Overall Study|Sponsor decision|1|||
124923459|NCT04728347|449350436|FG003|Overall Study|Sponsor decision|0|||
124923460|NCT03953508|449350437|FG000|Baseline|Lost to Follow-up|3|||
124923461|NCT03953508|449350438|FG001|Baseline|Lost to Follow-up|2|||
124923462|NCT03953508|449350437|FG000|6-month Follow-up|Lost to Follow-up|62|||
124923463|NCT03953508|449350438|FG001|6-month Follow-up|Lost to Follow-up|70|||
124923464|NCT05308004|449350443|FG000|Overall Study|Not seen by Palliative Care NP|0|||
124923465|NCT05308004|449350444|FG001|Overall Study|Not seen by Palliative Care NP|1|||
124923466|NCT01160211|449350447|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
124923467|NCT01160211|449350448|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
124923468|NCT01160211|449350449|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
124923469|NCT01160211|449350447|FG000|Overall Study|Lost to Follow-up|4|||
124923470|NCT01160211|449350448|FG001|Overall Study|Lost to Follow-up|8|||
124923471|NCT01160211|449350449|FG002|Overall Study|Lost to Follow-up|4|||
124923472|NCT01160211|449350447|FG000|Overall Study|Physician Decision|1|||
124545772|NCT00057330|447952789|FG001|Overall Study|Lost to Follow-up|617|||
124696679|NCT00098293|448509552|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
124453361|NCT02752035|447621586|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
124453362|NCT02752035|447621587|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
124453363|NCT02752035|447621588|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
124453364|NCT02752035|447621585|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
124453365|NCT02752035|447621586|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
124453366|NCT02752035|447621587|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
124453367|NCT02752035|447621588|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
124453368|NCT02752035|447621585|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
124453369|NCT02752035|447621586|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
124453370|NCT02752035|447621587|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
124453371|NCT02752035|447621588|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
124453372|NCT02752035|447621585|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
124453373|NCT02752035|447621586|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
124453374|NCT02752035|447621587|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
124453375|NCT02752035|447621588|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
124453376|NCT02752035|447621585|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
124453377|NCT02752035|447621586|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
124453378|NCT02752035|447621587|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
124453379|NCT02752035|447621588|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
124453380|NCT02752035|447621585|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
124453381|NCT02752035|447621586|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
124453382|NCT02752035|447621587|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
124453383|NCT02752035|447621588|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
124453384|NCT02752035|447621585|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
124453385|NCT02752035|447621586|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
124453386|NCT02752035|447621587|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
124453387|NCT02752035|447621588|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
124453388|NCT02752035|447621585|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
124453389|NCT02752035|447621586|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
124453390|NCT02752035|447621587|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
124453391|NCT02752035|447621588|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
124453392|NCT02752035|447621585|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
124453393|NCT02752035|447621586|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
124453394|NCT02752035|447621587|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
124453395|NCT02752035|447621588|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
124453396|NCT02752035|447621585|FG000|Randomization: Approximately 3 Years|Death|0|||
124453397|NCT02752035|447621586|FG001|Randomization: Approximately 3 Years|Death|25|||
124453398|NCT02752035|447621587|FG002|Randomization: Approximately 3 Years|Death|13|||
124453399|NCT02752035|447621588|FG003|Randomization: Approximately 3 Years|Death|4|||
124453400|NCT02752035|447621585|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
124453401|NCT02752035|447621586|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
124453402|NCT02752035|447621587|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
124453403|NCT02752035|447621588|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
124453404|NCT02752035|447621585|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
124453405|NCT02752035|447621586|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
124453406|NCT02752035|447621587|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
124453407|NCT02752035|447621588|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
124453408|NCT02752035|447621585|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
124453409|NCT02752035|447621586|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
124453410|NCT02752035|447621587|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
124453411|NCT02752035|447621588|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
124453412|NCT02752035|447621585|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
124453413|NCT02752035|447621586|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
124762539|NCT01506271|448755914|FG000|Overall Study|Withdrawal by Subject|0|||
124923473|NCT01160211|449350448|FG001|Overall Study|Physician Decision|0|||
124923474|NCT01160211|449350449|FG002|Overall Study|Physician Decision|0|||
124923475|NCT01160211|449350447|FG000|Overall Study|Withdrawal by Subject|4|||
124923476|NCT01160211|449350448|FG001|Overall Study|Withdrawal by Subject|2|||
124923477|NCT01160211|449350449|FG002|Overall Study|Withdrawal by Subject|2|||
124923478|NCT01160211|449350447|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
124923479|NCT01160211|449350448|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
124923480|NCT01160211|449350449|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
124923481|NCT02577835|449350450|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
124923482|NCT05409183|449350451|FG000|Complete Study|Adverse Event|1|||
124923483|NCT05409183|449350452|FG001|Complete Study|Adverse Event|2|||
124923484|NCT05409183|449350451|FG000|Complete Study|Withdrawal by Subject|3|||
124923485|NCT05409183|449350452|FG001|Complete Study|Withdrawal by Subject|0|||
124453414|NCT02752035|447621587|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
124453415|NCT02752035|447621588|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
124453416|NCT02752035|447621585|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
124453417|NCT02752035|447621586|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
124453418|NCT02752035|447621587|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
124453419|NCT02752035|447621588|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
124453420|NCT01161043|447621591|FG000|Overall Study|Withdrawal by Subject|3|||
124453421|NCT01236573|447621592|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
124453422|NCT01236573|447621593|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
124453423|NCT01236573|447621594|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
124453424|NCT01236573|447621595|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
124453425|NCT01236573|447621596|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
124453426|NCT01236573|447621597|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
124453427|NCT01236573|447621598|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
124453428|NCT01236573|447621599|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
124453429|NCT01236573|447621600|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
124453430|NCT01236573|447621601|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
124453431|NCT01236573|447621602|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
124453432|NCT01236573|447621592|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
124923486|NCT02274662|449350453|FG000|Overall Study|Death|1|||
124923487|NCT02274662|449350453|FG000|Overall Study|Lost to Follow-up|3|||
124923488|NCT04806451|449350454|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
124923489|NCT04806451|449350455|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
124923490|NCT04806451|449350454|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
124923491|NCT04806451|449350455|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
124923492|NCT04806451|449350454|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
124923493|NCT04806451|449350455|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
124923494|NCT05835336|449350456|FG000|Overall Study|Withdrawal by Subject|5|||
124923495|NCT05835336|449350456|FG000|Overall Study|Did not complete the personalization process|3|||
124923496|NCT02936752|449350457|FG000|Overall Study|Death|2|||
124923497|NCT02936752|449350458|FG001|Overall Study|Death|1|||
124923498|NCT02936752|449350457|FG000|Overall Study|Physician Decision|4|||
124923499|NCT02936752|449350458|FG001|Overall Study|Physician Decision|0|||
124923500|NCT02936752|449350457|FG000|Overall Study|Withdrawal by Subject|0|||
124923501|NCT02936752|449350458|FG001|Overall Study|Withdrawal by Subject|2|||
124923502|NCT04489771|449350461|FG000|Overall Study|Death|27|||
124923503|NCT04489771|449350462|FG001|Overall Study|Death|25|||
124923504|NCT04489771|449350461|FG000|Overall Study|Withdrawal by Subject|1|||
124923505|NCT04489771|449350462|FG001|Overall Study|Withdrawal by Subject|0|||
124923506|NCT04489771|449350461|FG000|Overall Study|Participants Ongoing in Study|50|||
124923507|NCT04489771|449350462|FG001|Overall Study|Participants Ongoing in Study|51|||
124923508|NCT02979522|449350467|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
124923509|NCT02979522|449350468|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
124923510|NCT02979522|449350467|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
124923511|NCT02979522|449350468|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
124923512|NCT04059484|449350472|FG000|Overall Study|Adverse Event|2|||
124923513|NCT04059484|449350473|FG001|Overall Study|Adverse Event|5|||
124923514|NCT04059484|449350472|FG000|Overall Study|Withdrawal by Subject|5|||
124923515|NCT04059484|449350473|FG001|Overall Study|Withdrawal by Subject|3|||
124923516|NCT04059484|449350472|FG000|Overall Study|Progressive disease|112|||
124923517|NCT04059484|449350473|FG001|Overall Study|Progressive disease|112|||
124923518|NCT04059484|449350472|FG000|Overall Study|Other|8|||
124923519|NCT04059484|449350473|FG001|Overall Study|Other|3|||
124923520|NCT04059484|449350472|FG000|Overall Study|Ongoing|20|||
124923521|NCT04059484|449350473|FG001|Overall Study|Ongoing|20|||
124923522|NCT02949362|449350474|FG000|Retrospective Period|Inform consent not signed by participant|4|||
124923523|NCT02949362|449350475|FG001|Retrospective Period|Inform consent not signed by participant|1|||
124923524|NCT02949362|449350476|FG002|Retrospective Period|Inform consent not signed by participant|0|||
124923525|NCT02949362|449350477|FG003|Retrospective Period|Inform consent not signed by participant|0|||
124453433|NCT01236573|447621593|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
124923526|NCT02949362|449350474|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
124923527|NCT02949362|449350475|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
124923528|NCT02949362|449350476|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
124545773|NCT00057330|447952788|FG000|Overall Study|Physician Decision|1|||
124923529|NCT02949362|449350477|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
124923530|NCT02949362|449350474|FG000|Prospective Period|Other|0|||
124923531|NCT02949362|449350475|FG001|Prospective Period|Other|0|||
124923532|NCT02949362|449350476|FG002|Prospective Period|Other|0|||
124923533|NCT02949362|449350477|FG003|Prospective Period|Other|4|||
124923534|NCT03199469|449350481|FG000|Overall Study|Randomized, not treated|0|||
124923535|NCT03199469|449350482|FG001|Overall Study|Randomized, not treated|3|||
124453434|NCT01236573|447621594|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
124453435|NCT01236573|447621595|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
124453436|NCT01236573|447621596|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
124453437|NCT01236573|447621597|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
124453438|NCT01236573|447621598|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
124453439|NCT01236573|447621599|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
124453440|NCT01236573|447621600|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
124453441|NCT01236573|447621601|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
124453442|NCT01236573|447621602|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
124453443|NCT01236573|447621592|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
124453444|NCT01236573|447621593|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
124453445|NCT01236573|447621594|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
124453446|NCT01236573|447621595|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
124453447|NCT01236573|447621596|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
124453448|NCT01236573|447621597|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
124453449|NCT01236573|447621598|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
124453450|NCT01236573|447621599|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
124453451|NCT01236573|447621600|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
124453452|NCT01236573|447621601|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
124453453|NCT01236573|447621602|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
124453454|NCT02164929|447621605|FG000|Overall Study|Converted to open procedure|1|||
124453455|NCT02164929|447621606|FG001|Overall Study|Converted to open procedure|0|||
124453456|NCT02164929|447621607|FG002|Overall Study|Converted to open procedure|0|||
124453457|NCT02164929|447621608|FG003|Overall Study|Converted to open procedure|2|||
124453458|NCT02164929|447621605|FG000|Overall Study|Failed regional block|0|||
124453459|NCT02164929|447621606|FG001|Overall Study|Failed regional block|0|||
124545774|NCT00057330|447952789|FG001|Overall Study|Physician Decision|0|||
124453460|NCT02164929|447621607|FG002|Overall Study|Failed regional block|1|||
124453461|NCT02164929|447621608|FG003|Overall Study|Failed regional block|0|||
124762540|NCT01506271|448755915|FG001|Overall Study|Withdrawal by Subject|1|||
124453462|NCT00971178|447621609|FG000|Overall Study|Lost to Follow-up|2|||
124453463|NCT00971178|447621610|FG001|Overall Study|Lost to Follow-up|2|||
124453464|NCT00971178|447621611|FG002|Overall Study|Lost to Follow-up|2|||
124453465|NCT02161575|447621613|FG000|Overall Study|Protocol Violation|8|||
124453466|NCT02161575|447621613|FG000|Overall Study|Lack of Efficacy|1|||
124453467|NCT02161575|447621613|FG000|Overall Study|Adverse Event|2|||
124453468|NCT00424749|447621615|FG000|Overall Study|Withdrawal by Subject|1|||
124453469|NCT04109222|447621620|FG000|Overall Study|Adverse Event|1|||
124453470|NCT04109222|447621621|FG001|Overall Study|Adverse Event|0|||
124453471|NCT04109222|447621622|FG002|Overall Study|Adverse Event|0|||
124453472|NCT02577406|447621623|FG000|Randomized Period|Death|1|||
124453473|NCT02577406|447621624|FG001|Randomized Period|Death|0|||
124453474|NCT02577406|447621623|FG000|Randomized Period|Other reasons|0|||
124453475|NCT02577406|447621624|FG001|Randomized Period|Other reasons|20|||
124453476|NCT02577406|447621623|FG000|Treatment Period|Death|38|||
124453477|NCT02577406|447621624|FG001|Treatment Period|Death|23|||
124453478|NCT02577406|447621623|FG000|Treatment Period|Adverse Event|17|||
124453479|NCT02577406|447621624|FG001|Treatment Period|Adverse Event|12|||
124453480|NCT02577406|447621623|FG000|Treatment Period|Progressive Disease|53|||
124453481|NCT02577406|447621624|FG001|Treatment Period|Progressive Disease|37|||
124453482|NCT02577406|447621623|FG000|Treatment Period|Withdrawal by Subject|10|||
124453483|NCT02577406|447621624|FG001|Treatment Period|Withdrawal by Subject|24|||
124453484|NCT02577406|447621623|FG000|Treatment Period|Lost to Follow-up|0|||
124453485|NCT02577406|447621624|FG001|Treatment Period|Lost to Follow-up|1|||
124453486|NCT02577406|447621623|FG000|Treatment Period|Transition to commercially available treatment|1|||
124453487|NCT02577406|447621624|FG001|Treatment Period|Transition to commercially available treatment|1|||
124453488|NCT02577406|447621623|FG000|Treatment Period|Physician Decision|1|||
124453489|NCT02577406|447621624|FG001|Treatment Period|Physician Decision|0|||
124453490|NCT02577406|447621623|FG000|Treatment Period|Disease Relapse|28|||
124453491|NCT02577406|447621624|FG001|Treatment Period|Disease Relapse|1|||
124453492|NCT02577406|447621623|FG000|Treatment Period|Protocol Violation|0|||
124453493|NCT02577406|447621624|FG001|Treatment Period|Protocol Violation|1|||
124453494|NCT02577406|447621623|FG000|Treatment Period|Other Reasons|3|||
124453495|NCT02577406|447621624|FG001|Treatment Period|Other Reasons|39|||
124453496|NCT02577406|447621623|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
124453497|NCT02577406|447621624|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
124453498|NCT03023059|447621625|FG000|Overall Study|Withdrawal by Subject|5|||
124453499|NCT02138617|447621626|FG000|Overall Study|Death|1|||
124453500|NCT02138617|447621627|FG001|Overall Study|Death|2|||
124453501|NCT02138617|447621628|FG002|Overall Study|Death|2|||
124453502|NCT02138617|447621626|FG000|Overall Study|Adverse Event|8|||
124453503|NCT02138617|447621627|FG001|Overall Study|Adverse Event|5|||
124453504|NCT02138617|447621628|FG002|Overall Study|Adverse Event|2|||
124453505|NCT02138617|447621626|FG000|Overall Study|Disease Progression|20|||
124453506|NCT02138617|447621627|FG001|Overall Study|Disease Progression|13|||
124453507|NCT02138617|447621628|FG002|Overall Study|Disease Progression|4|||
124453508|NCT02138617|447621626|FG000|Overall Study|Withdrawal by Subject|7|||
124453509|NCT02138617|447621627|FG001|Overall Study|Withdrawal by Subject|10|||
124453510|NCT02138617|447621628|FG002|Overall Study|Withdrawal by Subject|2|||
124453511|NCT02138617|447621626|FG000|Overall Study|other complicating disease|0|||
124453512|NCT02138617|447621627|FG001|Overall Study|other complicating disease|2|||
124453513|NCT02138617|447621628|FG002|Overall Study|other complicating disease|0|||
124453514|NCT02138617|447621626|FG000|Overall Study|Protocol Violation|1|||
124453515|NCT02138617|447621627|FG001|Overall Study|Protocol Violation|0|||
124453516|NCT02138617|447621628|FG002|Overall Study|Protocol Violation|0|||
124453517|NCT02138617|447621626|FG000|Overall Study|Physician Decision|7|||
124453518|NCT02138617|447621627|FG001|Overall Study|Physician Decision|6|||
124453519|NCT02138617|447621628|FG002|Overall Study|Physician Decision|0|||
124453520|NCT02138617|447621626|FG000|Overall Study|financial reason|0|||
124453521|NCT02138617|447621627|FG001|Overall Study|financial reason|1|||
124453522|NCT02138617|447621628|FG002|Overall Study|financial reason|0|||
124453523|NCT02138617|447621626|FG000|Overall Study|other therapy|3|||
124453524|NCT02138617|447621627|FG001|Overall Study|other therapy|4|||
124453525|NCT02138617|447621628|FG002|Overall Study|other therapy|0|||
124453526|NCT05500274|447621629|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
124453527|NCT05500274|447621630|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
124453528|NCT05500274|447621629|FG000|Overall Study|Lost to Follow-up|76|||
124453529|NCT05500274|447621630|FG001|Overall Study|Lost to Follow-up|51|||
124453530|NCT04451161|447621633|FG000|Overall Study|Lost to Follow-up|28|||
124453531|NCT04451161|447621634|FG001|Overall Study|Lost to Follow-up|37|||
124453532|NCT04451161|447621635|FG002|Overall Study|Lost to Follow-up|22|||
124453533|NCT04451161|447621636|FG003|Overall Study|Lost to Follow-up|13|||
124453534|NCT04451161|447621637|FG004|Overall Study|Lost to Follow-up|11|||
124453535|NCT04451161|447621638|FG005|Overall Study|Lost to Follow-up|14|||
124453536|NCT04451161|447621633|FG000|Overall Study|Withdrawal by Subject|3|||
124453537|NCT04451161|447621634|FG001|Overall Study|Withdrawal by Subject|0|||
124453538|NCT04451161|447621635|FG002|Overall Study|Withdrawal by Subject|0|||
124696680|NCT00098293|448509548|FG000|Open-label (OL) Phase|Pregnancy|0|||
124696681|NCT00098293|448509549|FG001|Open-label (OL) Phase|Pregnancy|1|||
124453539|NCT04451161|447621636|FG003|Overall Study|Withdrawal by Subject|0|||
124453540|NCT04451161|447621637|FG004|Overall Study|Withdrawal by Subject|2|||
124545775|NCT00057330|447952788|FG000|Overall Study|Other|260|||
124923536|NCT03199469|449350481|FG000|Overall Study|Withdrawal by Subject|1|||
124923537|NCT03199469|449350482|FG001|Overall Study|Withdrawal by Subject|0|||
124923538|NCT03199469|449350481|FG000|Overall Study|Death|1|||
124923539|NCT03199469|449350482|FG001|Overall Study|Death|3|||
124923540|NCT03199469|449350481|FG000|Overall Study|Ongoing|5|||
124923541|NCT03199469|449350482|FG001|Overall Study|Ongoing|14|||
124923542|NCT05453773|449350486|FG000|Overall Study|Withdrawal by Subject|3|||
124923543|NCT05453773|449350486|FG000|Overall Study|Lost to Follow-up|3|||
124923544|NCT05453773|449350486|FG000|Overall Study|Difficult Blood Draw|3|||
124923545|NCT02023866|449350487|FG000|Overall Study|Non-compliance|2|||
124923546|NCT02023866|449350487|FG000|Overall Study|Adverse Event|3|||
124923547|NCT02023866|449350487|FG000|Overall Study|Withdrawal by Subject|1|||
124923548|NCT02485938|449350488|FG000|Overall Study|Withdrawal of consent|2|||
124923549|NCT02485938|449350489|FG001|Overall Study|Withdrawal of consent|0|||
124923550|NCT03307343|449350490|FG000|Overall Study|Withdrawal by Subject|1|||
124923551|NCT03307343|449350491|FG001|Overall Study|Withdrawal by Subject|2|||
124923552|NCT03307343|449350490|FG000|Overall Study|Pregnancy|0|||
124923553|NCT03307343|449350491|FG001|Overall Study|Pregnancy|2|||
124923554|NCT03307343|449350490|FG000|Overall Study|Physician Decision|1|||
124923555|NCT03307343|449350491|FG001|Overall Study|Physician Decision|0|||
124923556|NCT03307343|449350490|FG000|Overall Study|Lost to Follow-up|0|||
124923557|NCT03307343|449350491|FG001|Overall Study|Lost to Follow-up|2|||
124923558|NCT04683744|449350492|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
124923559|NCT04683744|449350493|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
124923560|NCT04683744|449350494|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
124923561|NCT03447470|449350497|FG000|Overall Study|Death|0|||
124923562|NCT03447470|449350498|FG001|Overall Study|Death|1|||
124923563|NCT03447470|449350499|FG002|Overall Study|Death|3|||
124923564|NCT03447470|449350500|FG003|Overall Study|Death|0|||
124923565|NCT03447470|449350501|FG004|Overall Study|Death|1|||
124923566|NCT03447470|449350502|FG005|Overall Study|Death|0|||
124923567|NCT03447470|449350503|FG006|Overall Study|Death|3|||
124923568|NCT03447470|449350504|FG007|Overall Study|Death|3|||
124923569|NCT03447470|449350505|FG008|Overall Study|Death|1|||
124923570|NCT03447470|449350497|FG000|Overall Study|Withdrawal by Subject|1|||
124923571|NCT03447470|449350498|FG001|Overall Study|Withdrawal by Subject|0|||
124923572|NCT03447470|449350499|FG002|Overall Study|Withdrawal by Subject|0|||
124923573|NCT03447470|449350500|FG003|Overall Study|Withdrawal by Subject|0|||
124923574|NCT03447470|449350501|FG004|Overall Study|Withdrawal by Subject|1|||
124923575|NCT03447470|449350502|FG005|Overall Study|Withdrawal by Subject|0|||
124923576|NCT03447470|449350503|FG006|Overall Study|Withdrawal by Subject|1|||
124923577|NCT03447470|449350504|FG007|Overall Study|Withdrawal by Subject|1|||
124923578|NCT03447470|449350505|FG008|Overall Study|Withdrawal by Subject|3|||
124923579|NCT03447470|449350497|FG000|Overall Study|Treatment discontinued|3|||
124923580|NCT03447470|449350498|FG001|Overall Study|Treatment discontinued|2|||
124923581|NCT03447470|449350499|FG002|Overall Study|Treatment discontinued|4|||
124923582|NCT03447470|449350500|FG003|Overall Study|Treatment discontinued|6|||
124923583|NCT03447470|449350501|FG004|Overall Study|Treatment discontinued|2|||
124923584|NCT03447470|449350502|FG005|Overall Study|Treatment discontinued|1|||
124923585|NCT03447470|449350503|FG006|Overall Study|Treatment discontinued|2|||
124923586|NCT03447470|449350504|FG007|Overall Study|Treatment discontinued|4|||
124923587|NCT03447470|449350505|FG008|Overall Study|Treatment discontinued|3|||
124923588|NCT04624633|449350507|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
124923589|NCT04624633|449350508|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
124923590|NCT04624633|449350507|FG000|Overall Study|Death|1|||
124923591|NCT04624633|449350508|FG001|Overall Study|Death|0|||
124923592|NCT04316871|449350509|FG000|Overall Study|Protocol Violation|2|||
124923593|NCT04316871|449350510|FG001|Overall Study|Protocol Violation|2|||
124923594|NCT04316871|449350511|FG002|Overall Study|Protocol Violation|2|||
124923595|NCT04316871|449350512|FG003|Overall Study|Protocol Violation|2|||
124923596|NCT05087992|449350513|FG000|Overall Study|Adverse Event|0|||
124923597|NCT05087992|449350514|FG001|Overall Study|Adverse Event|1|||
124923598|NCT05087992|449350515|FG002|Overall Study|Adverse Event|0|||
124923599|NCT05087992|449350513|FG000|Overall Study|Withdrawal by Subject|2|||
124923600|NCT05087992|449350514|FG001|Overall Study|Withdrawal by Subject|0|||
124923601|NCT05087992|449350515|FG002|Overall Study|Withdrawal by Subject|0|||
124923602|NCT05087992|449350513|FG000|Overall Study|clinical disease progression|3|||
124923603|NCT05087992|449350514|FG001|Overall Study|clinical disease progression|1|||
124923604|NCT05087992|449350515|FG002|Overall Study|clinical disease progression|0|||
124923605|NCT05087992|449350513|FG000|Overall Study|objective disease progression|4|||
124923606|NCT05087992|449350514|FG001|Overall Study|objective disease progression|1|||
124923607|NCT05087992|449350515|FG002|Overall Study|objective disease progression|0|||
124923608|NCT04091750|449350516|FG000|Overall Study|Adverse Event|4|||
124923609|NCT04091750|449350516|FG000|Overall Study|Withdrawal by Subject|1|||
124923610|NCT01842542|449350517|FG000|Overall Study|Withdrawal by Subject|2|||
124923611|NCT01842542|449350517|FG000|Overall Study|Lack of Efficacy|1|||
124923612|NCT01842542|449350517|FG000|Overall Study|Protocol Non-compliance|2|||
124762541|NCT01506271|448755916|FG002|Overall Study|Withdrawal by Subject|1|||
124762542|NCT01506271|448755914|FG000|Overall Study|Lost to Follow-up|0|||
124762543|NCT01506271|448755915|FG001|Overall Study|Lost to Follow-up|1|||
124453541|NCT04451161|447621638|FG005|Overall Study|Withdrawal by Subject|4|||
124453542|NCT01555151|447621640|FG000|Overall Study|Withdrawal by Subject|6|||
124453543|NCT01555151|447621641|FG001|Overall Study|Withdrawal by Subject|2|||
124453544|NCT01555151|447621642|FG002|Overall Study|Withdrawal by Subject|0|||
124453545|NCT01555151|447621643|FG003|Overall Study|Withdrawal by Subject|2|||
124453546|NCT01555151|447621640|FG000|Overall Study|Administrative|3|||
124453547|NCT01555151|447621641|FG001|Overall Study|Administrative|1|||
124453548|NCT01555151|447621642|FG002|Overall Study|Administrative|2|||
124453549|NCT01555151|447621643|FG003|Overall Study|Administrative|0|||
124453550|NCT01555151|447621640|FG000|Overall Study|Protocol Violation|3|||
124453551|NCT01555151|447621641|FG001|Overall Study|Protocol Violation|3|||
124453552|NCT01555151|447621642|FG002|Overall Study|Protocol Violation|3|||
124453553|NCT01555151|447621643|FG003|Overall Study|Protocol Violation|5|||
124453554|NCT01555151|447621640|FG000|Overall Study|Adverse Event|1|||
124453555|NCT01555151|447621641|FG001|Overall Study|Adverse Event|2|||
124453556|NCT01555151|447621642|FG002|Overall Study|Adverse Event|1|||
124453557|NCT01555151|447621643|FG003|Overall Study|Adverse Event|2|||
124453558|NCT01555151|447621640|FG000|Overall Study|Lost to Follow-up|0|||
124453559|NCT01555151|447621641|FG001|Overall Study|Lost to Follow-up|0|||
124453560|NCT01555151|447621642|FG002|Overall Study|Lost to Follow-up|0|||
124453561|NCT01555151|447621643|FG003|Overall Study|Lost to Follow-up|1|||
124453562|NCT03596866|447621644|FG000|Overall Study|Site terminated by Sponsor|64|||
124453563|NCT03596866|447621645|FG001|Overall Study|Site terminated by Sponsor|65|||
124453564|NCT03596866|447621644|FG000|Overall Study|Death|37|||
124453565|NCT03596866|447621645|FG001|Overall Study|Death|24|||
124453566|NCT03596866|447621644|FG000|Overall Study|Withdrawal by Subject|4|||
124453567|NCT03596866|447621645|FG001|Overall Study|Withdrawal by Subject|6|||
124453568|NCT03596866|447621644|FG000|Overall Study|Missing|0|||
124453569|NCT03596866|447621645|FG001|Overall Study|Missing|6|||
124453570|NCT03596866|447621644|FG000|Overall Study|Lost to Follow-up|2|||
124453571|NCT03596866|447621645|FG001|Overall Study|Lost to Follow-up|3|||
124453572|NCT03596866|447621644|FG000|Overall Study|Protocol Violation|1|||
124453573|NCT03596866|447621645|FG001|Overall Study|Protocol Violation|0|||
124453574|NCT03596866|447621644|FG000|Overall Study|Reason Not Specified|14|||
124453575|NCT03596866|447621645|FG001|Overall Study|Reason Not Specified|13|||
124453576|NCT00596947|447621646|FG000|Overall Study|study halted due to low enrollment|5|||
124453577|NCT00596947|447621647|FG001|Overall Study|study halted due to low enrollment|3|||
124453578|NCT00596947|447621646|FG000|Overall Study|Lost to Follow-up|1|||
124453579|NCT00596947|447621647|FG001|Overall Study|Lost to Follow-up|0|||
124453580|NCT03098836|447621648|FG000|Overall Study|Adverse Event|1|||
124453581|NCT03098836|447621649|FG001|Overall Study|Adverse Event|3|||
124453582|NCT03098836|447621648|FG000|Overall Study|Lack of Efficacy|30|||
124453583|NCT03098836|447621649|FG001|Overall Study|Lack of Efficacy|15|||
124453584|NCT03098836|447621648|FG000|Overall Study|Physician Decision|2|||
124453585|NCT03098836|447621649|FG001|Overall Study|Physician Decision|1|||
124453586|NCT03098836|447621648|FG000|Overall Study|Withdrawal by Subject|3|||
124453587|NCT03098836|447621649|FG001|Overall Study|Withdrawal by Subject|2|||
124453588|NCT00898443|447621650|FG000|Overall Study|Withdrawal by Subject|1|||
124453589|NCT00898443|447621651|FG001|Overall Study|Withdrawal by Subject|0|||
124453590|NCT04695392|447621652|FG000|Overall Study|Withdrawn by parent/guardian|0|||
124453591|NCT04695392|447621653|FG001|Overall Study|Withdrawn by parent/guardian|1|||
124453592|NCT04695392|447621652|FG000|Overall Study|Withdrawn by physician|0|||
124453593|NCT04695392|447621653|FG001|Overall Study|Withdrawn by physician|1|||
124453594|NCT03472924|447621655|FG000|Overall Study|Adverse Event|1|||
124453595|NCT03472924|447621656|FG001|Overall Study|Adverse Event|0|||
124453596|NCT00427349|447621658|FG000|Overall Study|Lack of Efficacy|23|||
124453597|NCT00427349|447621658|FG000|Overall Study|Adverse Event|14|||
124453598|NCT00427349|447621658|FG000|Overall Study|Death|1|||
124453599|NCT00427349|447621658|FG000|Overall Study|Withdrawal by Subject|3|||
124453600|NCT00427349|447621658|FG000|Overall Study|Alternative therapy|1|||
124453601|NCT00427349|447621658|FG000|Overall Study|Other|2|||
124453602|NCT00427349|447621658|FG000|Overall Study|Ineligible|1|||
124453603|NCT00427349|447621658|FG000|Overall Study|Never started therapy|1|||
124453604|NCT00698997|447621660|FG000|Overall Study|Lost to Follow-up|3|||
124453605|NCT00698997|447621661|FG001|Overall Study|Lost to Follow-up|0|||
124453606|NCT00698997|447621660|FG000|Overall Study|Withdrawal by Subject|7|||
124453607|NCT00698997|447621661|FG001|Overall Study|Withdrawal by Subject|27|||
124453608|NCT05082376|447621664|FG000|Overall Study|Lost to Follow-up|2|||
124453609|NCT01436084|447621665|FG000|Overall Study|Disease Progression|2|||
124453610|NCT01436084|447621665|FG000|Overall Study|Withdrawal by Subject|1|||
124453611|NCT01436084|447621665|FG000|Overall Study|Early Closure of Study|1|||
124453612|NCT04425720|447621671|FG000|Overall Study|Withdrawal by Subject|0|||
124453613|NCT04425720|447621672|FG001|Overall Study|Withdrawal by Subject|20|||
124453614|NCT00290186|447621673|FG000|Overall Study|Adverse Event|1|||
124453615|NCT00290186|447621674|FG001|Overall Study|Adverse Event|1|||
124453616|NCT00290186|447621673|FG000|Overall Study|Lost to Follow-up|3|||
124453617|NCT00290186|447621674|FG001|Overall Study|Lost to Follow-up|2|||
124453618|NCT00290186|447621673|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
124453619|NCT00290186|447621674|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
124453620|NCT00290186|447621673|FG000|Overall Study|Withdrawal by Subject|0|||
124453621|NCT00290186|447621674|FG001|Overall Study|Withdrawal by Subject|1|||
124453622|NCT00445224|447621675|FG000|Specific Exercises|Withdrawal by Subject|3|||
124453623|NCT00445224|447621676|FG001|Specific Exercises|Withdrawal by Subject|3|||
124453624|NCT00445224|447621675|FG000|Specific Exercises|Withdrawal by Subject|1|||
124453625|NCT00445224|447621676|FG001|Specific Exercises|Withdrawal by Subject|0|||
124453626|NCT00262522|447621686|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
124453627|NCT00262522|447621687|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
124453628|NCT00262522|447621688|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
124453629|NCT00262522|447621689|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
124453630|NCT00262522|447621686|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
124453631|NCT00262522|447621687|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
124453632|NCT00262522|447621688|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
124453633|NCT00262522|447621689|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
124453634|NCT00262522|447621686|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
124453635|NCT00262522|447621687|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
124453636|NCT00262522|447621688|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
124453637|NCT00262522|447621689|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
124453638|NCT00262522|447621686|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
124453639|NCT00262522|447621687|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
124453640|NCT00262522|447621688|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
124453641|NCT00262522|447621689|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
124453642|NCT00262522|447621686|FG000|Study Start Through 8 Weeks|Death|1|||
124453643|NCT00262522|447621687|FG001|Study Start Through 8 Weeks|Death|0|||
124453644|NCT00262522|447621688|FG002|Study Start Through 8 Weeks|Death|0|||
124923613|NCT01842542|449350517|FG000|Overall Study|Lost to Follow-up|1|||
124923614|NCT04473222|449350518|FG000|Overall Study|Lost to Follow-up|13|||
124923615|NCT04473222|449350519|FG001|Overall Study|Lost to Follow-up|13|||
124923616|NCT04473222|449350518|FG000|Overall Study|Withdrawal by Subject|0|||
124923617|NCT04473222|449350519|FG001|Overall Study|Withdrawal by Subject|1|||
124923618|NCT04473222|449350518|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
124923619|NCT04473222|449350519|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
124923620|NCT01369355|449350526|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
124923621|NCT01369355|449350527|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
124923622|NCT01369355|449350528|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
124923623|NCT01369355|449350529|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
124923624|NCT01369355|449350530|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
124923625|NCT01369355|449350531|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
124923626|NCT01369355|449350532|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
124923627|NCT01369355|449350533|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
124923628|NCT01369355|449350534|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
124923629|NCT01369355|449350526|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
124923630|NCT01369355|449350527|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
124923631|NCT01369355|449350528|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
124923632|NCT01369355|449350529|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
124923633|NCT01369355|449350530|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
124923634|NCT01369355|449350531|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
124923635|NCT01369355|449350532|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
124923636|NCT01369355|449350533|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
124923637|NCT01369355|449350534|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
124923638|NCT01369355|449350526|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
124923639|NCT01369355|449350527|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
124923640|NCT01369355|449350528|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
124923641|NCT01369355|449350529|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
124923642|NCT01369355|449350530|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
124923643|NCT01369355|449350531|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
124923644|NCT01369355|449350532|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
124923645|NCT01369355|449350533|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
124923646|NCT01369355|449350534|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
124923647|NCT01369355|449350526|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
124923648|NCT01369355|449350527|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
124923649|NCT01369355|449350528|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
124923650|NCT01369355|449350529|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
124923651|NCT01369355|449350530|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
124923652|NCT01369355|449350531|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
124923653|NCT01369355|449350532|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
124923654|NCT01369355|449350533|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
124923655|NCT01369355|449350534|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
124923656|NCT01369355|449350526|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
124923657|NCT01369355|449350527|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
124923658|NCT01369355|449350528|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
124923659|NCT01369355|449350529|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
124923660|NCT01369355|449350530|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
124923661|NCT01369355|449350531|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
124923662|NCT01369355|449350532|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
124923663|NCT01369355|449350533|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
124923664|NCT01369355|449350534|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
124923665|NCT01369355|449350526|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
124923666|NCT01369355|449350527|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
124923667|NCT01369355|449350528|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
124923668|NCT01369355|449350529|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
124923669|NCT01369355|449350530|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
124923670|NCT01369355|449350531|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
124923671|NCT01369355|449350532|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
124923672|NCT01369355|449350533|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
124923673|NCT01369355|449350534|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
124923674|NCT01369355|449350526|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
124923675|NCT01369355|449350527|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
124923676|NCT01369355|449350528|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
124545776|NCT00057330|447952789|FG001|Overall Study|Other|206|||
124545777|NCT03722849|447952799|FG000|Overall Study|Withdrawal by Subject|1|||
124545778|NCT03722849|447952800|FG001|Overall Study|Withdrawal by Subject|1|||
124545779|NCT04633434|447952803|FG000|Overall Study|Lost to Follow-up|32|||
124545780|NCT04633434|447952804|FG001|Overall Study|Lost to Follow-up|32|||
124545781|NCT04882085|447952824|FG000|Overall Study|Death|6|||
124923677|NCT01369355|449350529|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
124923678|NCT01369355|449350530|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
124923679|NCT01369355|449350531|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
124923680|NCT01369355|449350532|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
124923681|NCT01369355|449350533|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
124923682|NCT01369355|449350534|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
124923683|NCT01369355|449350526|FG000|Long-term Extension (Week 44-272)|Death|0|||
124923684|NCT01369355|449350527|FG001|Long-term Extension (Week 44-272)|Death|0|||
124453645|NCT00262522|447621689|FG003|Study Start Through 8 Weeks|Death|0|||
124453646|NCT00262522|447621686|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
124453647|NCT00262522|447621687|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
124453648|NCT00262522|447621688|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
124453649|NCT00262522|447621689|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
124453650|NCT00262522|447621686|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
124453651|NCT00262522|447621687|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
124453652|NCT00262522|447621688|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
124453653|NCT00262522|447621689|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
124453654|NCT00262522|447621686|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
124453655|NCT00262522|447621687|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
124453656|NCT00262522|447621688|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
124453657|NCT00262522|447621689|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
124453658|NCT00262522|447621686|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
124453659|NCT00262522|447621687|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
124453660|NCT00262522|447621688|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
124453661|NCT00262522|447621689|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
124453662|NCT00262522|447621686|FG000|Study Start Through 48 Weeks|Death|2|||
124453663|NCT00262522|447621687|FG001|Study Start Through 48 Weeks|Death|0|||
124453664|NCT00262522|447621688|FG002|Study Start Through 48 Weeks|Death|1|||
124453665|NCT00262522|447621689|FG003|Study Start Through 48 Weeks|Death|0|||
124453666|NCT00262522|447621686|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
124453667|NCT00262522|447621687|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
124453668|NCT00262522|447621688|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
124453669|NCT00262522|447621689|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
124453670|NCT00262522|447621686|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
124453671|NCT00262522|447621687|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
124453672|NCT00262522|447621688|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
124453673|NCT00262522|447621689|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
124453674|NCT00262522|447621686|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
124453675|NCT00262522|447621687|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
124453676|NCT00262522|447621688|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
124453677|NCT00262522|447621689|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
124453678|NCT00262522|447621686|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
124453679|NCT00262522|447621687|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
124453680|NCT00262522|447621688|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
124453681|NCT00262522|447621689|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
124453682|NCT00262522|447621686|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
124453683|NCT00262522|447621687|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
124453684|NCT00262522|447621688|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
124453685|NCT00262522|447621689|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
124453686|NCT00262522|447621686|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
124453687|NCT00262522|447621687|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
124453688|NCT00262522|447621688|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
124453689|NCT00262522|447621689|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
124453690|NCT00262522|447621686|FG000|Study Start Through 96 Weeks|Death|2|||
124453691|NCT00262522|447621687|FG001|Study Start Through 96 Weeks|Death|0|||
124453692|NCT00262522|447621688|FG002|Study Start Through 96 Weeks|Death|2|||
124453693|NCT00262522|447621689|FG003|Study Start Through 96 Weeks|Death|0|||
124453694|NCT00262522|447621686|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
124453695|NCT00262522|447621687|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
124453696|NCT00262522|447621688|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
124453697|NCT00262522|447621689|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
124923685|NCT01369355|449350528|FG002|Long-term Extension (Week 44-272)|Death|0|||
124545782|NCT04882085|447952825|FG001|Overall Study|Death|9|||
124923686|NCT01369355|449350529|FG003|Long-term Extension (Week 44-272)|Death|0|||
124545783|NCT04882085|447952824|FG000|Overall Study|Withdrawal by Subject|0|||
124453698|NCT00262522|447621686|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
124545784|NCT04882085|447952825|FG001|Overall Study|Withdrawal by Subject|3|||
124762544|NCT01506271|448755916|FG002|Overall Study|Lost to Follow-up|2|||
124923687|NCT01369355|449350530|FG004|Long-term Extension (Week 44-272)|Death|0|||
124923688|NCT01369355|449350531|FG005|Long-term Extension (Week 44-272)|Death|0|||
124923689|NCT01369355|449350532|FG006|Long-term Extension (Week 44-272)|Death|0|||
124923690|NCT01369355|449350533|FG007|Long-term Extension (Week 44-272)|Death|1|||
124923691|NCT01369355|449350534|FG008|Long-term Extension (Week 44-272)|Death|3|||
124923692|NCT01369355|449350526|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
124923693|NCT01369355|449350527|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
124923694|NCT01369355|449350528|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
124923695|NCT01369355|449350529|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
124923696|NCT01369355|449350530|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
124923697|NCT01369355|449350531|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
124923698|NCT01369355|449350532|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
124923699|NCT01369355|449350533|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
124923700|NCT01369355|449350534|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
124923701|NCT01369355|449350526|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
124923702|NCT01369355|449350527|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
124923703|NCT01369355|449350528|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
124923704|NCT01369355|449350529|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
124923705|NCT01369355|449350530|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
124923706|NCT01369355|449350531|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
124923707|NCT01369355|449350532|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
124923708|NCT01369355|449350533|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
124923709|NCT01369355|449350534|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
124923710|NCT01369355|449350526|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
124923711|NCT01369355|449350527|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
124923712|NCT01369355|449350528|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
124923713|NCT01369355|449350529|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
124923714|NCT01369355|449350530|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
124923715|NCT01369355|449350531|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
124923716|NCT01369355|449350532|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
124923717|NCT01369355|449350533|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
124923718|NCT01369355|449350534|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
124923719|NCT01369355|449350526|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
124923720|NCT01369355|449350527|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
124923721|NCT01369355|449350528|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
124923722|NCT01369355|449350529|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
124923723|NCT01369355|449350530|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
124923724|NCT01369355|449350531|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
124923725|NCT01369355|449350532|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
124923726|NCT01369355|449350533|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
124923727|NCT01369355|449350534|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
124923728|NCT01369355|449350526|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
124923729|NCT01369355|449350527|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
124923730|NCT01369355|449350528|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
124923731|NCT01369355|449350529|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
124923732|NCT01369355|449350530|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
124923733|NCT01369355|449350531|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
124923734|NCT01369355|449350532|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
124923735|NCT01369355|449350533|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
124923736|NCT01369355|449350534|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
124923737|NCT01369355|449350526|FG000|Long-term Extension (Week 44-272)|Other|0|||
124923738|NCT01369355|449350527|FG001|Long-term Extension (Week 44-272)|Other|0|||
124923739|NCT01369355|449350528|FG002|Long-term Extension (Week 44-272)|Other|0|||
124923740|NCT01369355|449350529|FG003|Long-term Extension (Week 44-272)|Other|0|||
124923741|NCT01369355|449350530|FG004|Long-term Extension (Week 44-272)|Other|0|||
124923742|NCT01369355|449350531|FG005|Long-term Extension (Week 44-272)|Other|0|||
124923743|NCT01369355|449350532|FG006|Long-term Extension (Week 44-272)|Other|110|||
124923744|NCT01369355|449350533|FG007|Long-term Extension (Week 44-272)|Other|9|||
124923745|NCT01369355|449350534|FG008|Long-term Extension (Week 44-272)|Other|17|||
124923746|NCT06424236|449350539|FG000|Overall Study|Adverse Event|0|||
124923747|NCT06424236|449350540|FG001|Overall Study|Adverse Event|1|||
124923748|NCT06424236|449350541|FG002|Overall Study|Adverse Event|0|||
124923749|NCT06424236|449350539|FG000|Overall Study|Withdrawal by Subject|3|||
124923750|NCT06424236|449350540|FG001|Overall Study|Withdrawal by Subject|1|||
124923751|NCT06424236|449350541|FG002|Overall Study|Withdrawal by Subject|2|||
124923752|NCT06424236|449350539|FG000|Overall Study|Physician Decision|0|||
124923753|NCT06424236|449350540|FG001|Overall Study|Physician Decision|1|||
124923754|NCT06424236|449350541|FG002|Overall Study|Physician Decision|0|||
124923755|NCT06424236|449350539|FG000|Overall Study|Study Terminated by Sponsor|11|||
124923756|NCT06424236|449350540|FG001|Overall Study|Study Terminated by Sponsor|20|||
124923757|NCT06424236|449350541|FG002|Overall Study|Study Terminated by Sponsor|16|||
124923758|NCT06424236|449350539|FG000|Overall Study|Lost to Follow-up|0|||
124923759|NCT06424236|449350540|FG001|Overall Study|Lost to Follow-up|1|||
124923760|NCT06424236|449350541|FG002|Overall Study|Lost to Follow-up|0|||
124923761|NCT06424236|449350539|FG000|Overall Study|Disease Progression|0|||
124923762|NCT06424236|449350540|FG001|Overall Study|Disease Progression|1|||
124923763|NCT06424236|449350541|FG002|Overall Study|Disease Progression|2|||
124923764|NCT06424236|449350539|FG000|Overall Study|Other|0|||
124923765|NCT06424236|449350540|FG001|Overall Study|Other|0|||
124923766|NCT06424236|449350541|FG002|Overall Study|Other|1|||
124923767|NCT02817776|449350542|FG000|Overall Study|Excluded|33|||
124923768|NCT02817776|449350542|FG000|Overall Study|Lost to Follow-up|20|||
124923769|NCT02817776|449350542|FG000|Overall Study|Withdrawal by Subject|33|||
124923770|NCT02817776|449350542|FG000|Overall Study|Death|2|||
124923771|NCT01824394|449350543|FG000|Overall Study|Early Termination|1|||
124923772|NCT01824394|449350544|FG001|Overall Study|Early Termination|1|||
124923773|NCT01824394|449350545|FG002|Overall Study|Early Termination|3|||
124923774|NCT01824394|449350543|FG000|Overall Study|Withdrawn due to Study Termination|91|||
124923775|NCT01824394|449350544|FG001|Overall Study|Withdrawn due to Study Termination|83|||
124923776|NCT01824394|449350545|FG002|Overall Study|Withdrawn due to Study Termination|41|||
124923777|NCT01824394|449350543|FG000|Overall Study|Lost to Follow-up|0|||
124923778|NCT01824394|449350544|FG001|Overall Study|Lost to Follow-up|9|||
124923779|NCT01824394|449350545|FG002|Overall Study|Lost to Follow-up|3|||
124923780|NCT01824394|449350543|FG000|Overall Study|Death|3|||
124923781|NCT01824394|449350544|FG001|Overall Study|Death|2|||
124923782|NCT01824394|449350545|FG002|Overall Study|Death|4|||
124923783|NCT01824394|449350543|FG000|Overall Study|Discontinued Subjects|1|||
124923784|NCT01824394|449350544|FG001|Overall Study|Discontinued Subjects|1|||
124923785|NCT01824394|449350545|FG002|Overall Study|Discontinued Subjects|2|||
124923786|NCT01824394|449350543|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
124923787|NCT01824394|449350544|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
124923788|NCT01824394|449350545|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
124923789|NCT05603143|449350546|FG000|Overall Study|Withdrew consent|6|||
124923790|NCT05603143|449350547|FG001|Overall Study|Withdrew consent|2|||
124923791|NCT05603143|449350546|FG000|Overall Study|Randomized but never treated|0|||
124923792|NCT05603143|449350547|FG001|Overall Study|Randomized but never treated|3|||
124923793|NCT05603143|449350546|FG000|Overall Study|Adverse Event|2|||
124923794|NCT05603143|449350547|FG001|Overall Study|Adverse Event|0|||
124923795|NCT05603143|449350546|FG000|Overall Study|Death|0|||
124923796|NCT05603143|449350547|FG001|Overall Study|Death|1|||
124923797|NCT05603143|449350546|FG000|Overall Study|Investigator's discretion|1|||
124923798|NCT05603143|449350547|FG001|Overall Study|Investigator's discretion|0|||
124923799|NCT05603143|449350546|FG000|Overall Study|Lost to Follow-up|0|||
124923800|NCT05603143|449350547|FG001|Overall Study|Lost to Follow-up|1|||
124923801|NCT05603143|449350546|FG000|Overall Study|Protocol Violation|0|||
124923802|NCT05603143|449350547|FG001|Overall Study|Protocol Violation|1|||
124923803|NCT05783102|449350548|FG000|Overall Study|Lost to Follow-up|1|||
124923804|NCT05783102|449350548|FG000|Overall Study|Withdrawal by Subject|2|||
124923805|NCT05647304|449350549|FG000|Overall Study|Withdrawal by Subject|1|||
124923806|NCT05647304|449350550|FG001|Overall Study|Withdrawal by Subject|0|||
124923807|NCT02683447|449350556|FG000|Overall Study|Lost to Follow-up|2|||
124923808|NCT03448107|449350557|FG000|Overall Study|Lost to Follow-up|229|||
124923809|NCT03448107|449350558|FG001|Overall Study|Lost to Follow-up|258|||
124923810|NCT03115476|449350559|FG000|LP0084-1369|Death|1|||
124923811|NCT03115476|449350560|FG001|LP0084-1369|Death|0|||
124923812|NCT03115476|449350561|FG002|LP0084-1369|Death|2|||
124923813|NCT03115476|449350559|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
124923814|NCT03115476|449350560|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
124923815|NCT03115476|449350561|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
124923816|NCT02489903|449350562|FG000|Screening|Screen Failure|24|||
124923817|NCT02489903|449350563|FG001|Screening|Screen Failure|0|||
124923818|NCT02489903|449350564|FG002|Screening|Screen Failure|0|||
124923819|NCT02489903|449350565|FG003|Screening|Screen Failure|8|||
124923820|NCT02489903|449350562|FG000|Randomized and Received Treatment|Protocol Violation|0|||
124923821|NCT02489903|449350563|FG001|Randomized and Received Treatment|Protocol Violation|1|||
124923822|NCT02489903|449350564|FG002|Randomized and Received Treatment|Protocol Violation|0|||
124923823|NCT02489903|449350565|FG003|Randomized and Received Treatment|Protocol Violation|0|||
124923824|NCT02489903|449350562|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
124923825|NCT02489903|449350563|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
124923826|NCT02489903|449350564|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
124923827|NCT02489903|449350565|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
124923828|NCT02489903|449350562|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
124923829|NCT02489903|449350563|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
124453699|NCT00262522|447621687|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
124453700|NCT00262522|447621688|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
124453701|NCT00262522|447621689|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
124453702|NCT03159091|447621690|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
124453703|NCT03159091|447621691|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
124453704|NCT03159091|447621690|FG000|Overall Study|Patient has taken no dose of study drug|0|||
124453705|NCT03159091|447621691|FG001|Overall Study|Patient has taken no dose of study drug|1|||
124453706|NCT04814823|447621692|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
124453707|NCT04085523|447621693|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
124453708|NCT04085523|447621694|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
124453709|NCT04085523|447621695|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
124453710|NCT04085523|447621696|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
124545785|NCT04882085|447952824|FG000|Overall Study|Randomized not treated|1|||
124545786|NCT04882085|447952825|FG001|Overall Study|Randomized not treated|0|||
124923830|NCT02489903|449350564|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
124923831|NCT02489903|449350565|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
124923832|NCT02489903|449350562|FG000|Randomized and Received Treatment|Death|10|||
124923833|NCT02489903|449350563|FG001|Randomized and Received Treatment|Death|1|||
124923834|NCT02489903|449350564|FG002|Randomized and Received Treatment|Death|0|||
124923835|NCT02489903|449350565|FG003|Randomized and Received Treatment|Death|0|||
124923836|NCT05257486|449350569|FG000|Overall Study|Protocol Violation|3|||
124923837|NCT04542317|449350570|FG000|Overall Study|Care recipients passed away|18|||
124923838|NCT04542317|449350571|FG001|Overall Study|Care recipients passed away|13|||
124923839|NCT04542317|449350570|FG000|Overall Study|No longer a primary caregiver|5|||
124923840|NCT04542317|449350571|FG001|Overall Study|No longer a primary caregiver|1|||
124923841|NCT04542317|449350570|FG000|Overall Study|Withdrawal by Subject|4|||
124923842|NCT04542317|449350571|FG001|Overall Study|Withdrawal by Subject|2|||
124923843|NCT04542317|449350570|FG000|Overall Study|Caregivers passed away|0|||
124923844|NCT04542317|449350571|FG001|Overall Study|Caregivers passed away|2|||
124923845|NCT04700163|449350572|FG000|Overall Study|Lost to Follow-up|0|||
124923846|NCT04700163|449350573|FG001|Overall Study|Lost to Follow-up|0|||
124923847|NCT04700163|449350574|FG002|Overall Study|Lost to Follow-up|0|||
124923848|NCT04700163|449350575|FG003|Overall Study|Lost to Follow-up|0|||
124923849|NCT04700163|449350576|FG004|Overall Study|Lost to Follow-up|0|||
124923850|NCT04700163|449350577|FG005|Overall Study|Lost to Follow-up|1|||
124923851|NCT03976362|449350580|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
124923852|NCT03976362|449350581|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
124923853|NCT03976362|449350582|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
124923854|NCT03976362|449350580|FG000|Induction Phase|Death|62|||
124923855|NCT03976362|449350581|FG001|Induction Phase|Death|0|||
124923856|NCT03976362|449350582|FG002|Induction Phase|Death|0|||
124923857|NCT03976362|449350580|FG000|Maintenance Phase|Participants Ongoing|0|||
124923858|NCT03976362|449350581|FG001|Maintenance Phase|Participants Ongoing|106|||
124923859|NCT03976362|449350582|FG002|Maintenance Phase|Participants Ongoing|103|||
124923860|NCT03976362|449350580|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124923861|NCT03976362|449350581|FG001|Maintenance Phase|Withdrawal by Subject|4|||
124923862|NCT03976362|449350582|FG002|Maintenance Phase|Withdrawal by Subject|4|||
124923863|NCT03976362|449350580|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
124923864|NCT03976362|449350581|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
124923865|NCT03976362|449350582|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
124923866|NCT03976362|449350580|FG000|Maintenance Phase|Death|0|||
124923867|NCT03976362|449350581|FG001|Maintenance Phase|Death|186|||
124923868|NCT03976362|449350582|FG002|Maintenance Phase|Death|187|||
124923869|NCT00613106|449350583|FG000|Overall Study|Adverse Event|3|||
124923870|NCT00613106|449350584|FG001|Overall Study|Adverse Event|1|||
124923871|NCT00613106|449350583|FG000|Overall Study|Withdrawal by Subject|6|||
124923872|NCT00613106|449350584|FG001|Overall Study|Withdrawal by Subject|3|||
124923873|NCT00613106|449350583|FG000|Overall Study|Lost to Follow-up|7|||
124923874|NCT00613106|449350584|FG001|Overall Study|Lost to Follow-up|2|||
124923875|NCT00613106|449350583|FG000|Overall Study|misc|4|||
124923876|NCT00613106|449350584|FG001|Overall Study|misc|3|||
124923877|NCT05126433|449350589|FG000|Overall Study|Withdrawal by Subject|3|||
124923878|NCT05126433|449350590|FG001|Overall Study|Withdrawal by Subject|0|||
124453711|NCT04085523|447621697|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
124545787|NCT00965562|447952829|FG000|Overall Study|Lost to Follow-up|1|||
124762545|NCT03040141|448755917|FG000|Overall Study|Death|1|||
124923879|NCT05126433|449350591|FG002|Overall Study|Withdrawal by Subject|4|||
124923880|NCT05126433|449350589|FG000|Overall Study|Death|9|||
124923881|NCT05126433|449350590|FG001|Overall Study|Death|3|||
124923882|NCT05126433|449350591|FG002|Overall Study|Death|5|||
124923883|NCT05126433|449350589|FG000|Overall Study|Study Terminated by sponsor|0|||
124923884|NCT05126433|449350590|FG001|Overall Study|Study Terminated by sponsor|1|||
124923885|NCT05126433|449350591|FG002|Overall Study|Study Terminated by sponsor|2|||
124923886|NCT05126433|449350589|FG000|Overall Study|Progressive Disease|1|||
124453712|NCT04085523|447621698|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
124453713|NCT03977974|447621701|FG000|Period 2|Adverse Event|0|||
124453714|NCT03977974|447621702|FG001|Period 2|Adverse Event|0|||
124453715|NCT03977974|447621703|FG002|Period 2|Adverse Event|0|||
124453716|NCT03977974|447621704|FG003|Period 2|Adverse Event|0|||
124453717|NCT03977974|447621705|FG004|Period 2|Adverse Event|1|||
124453718|NCT03977974|447621706|FG005|Period 2|Adverse Event|0|||
124453719|NCT03977974|447621707|FG006|Period 2|Adverse Event|0|||
124453720|NCT03977974|447621708|FG007|Period 2|Adverse Event|0|||
124453721|NCT03977974|447621709|FG008|Period 2|Adverse Event|0|||
124453722|NCT03977974|447621710|FG009|Period 2|Adverse Event|0|||
124453723|NCT03977974|447621711|FG010|Period 2|Adverse Event|0|||
124453724|NCT03977974|447621712|FG011|Period 2|Adverse Event|0|||
124453725|NCT03977974|447621713|FG012|Period 2|Adverse Event|0|||
124453726|NCT04024228|447622541|FG000|Overall Study|Adverse Event|1|||
124453727|NCT04024228|447622542|FG001|Overall Study|Adverse Event|0|||
124453728|NCT04024228|447622541|FG000|Overall Study|Protocol Deviation|0|||
124453729|NCT04024228|447622542|FG001|Overall Study|Protocol Deviation|2|||
124453730|NCT04024228|447622541|FG000|Overall Study|Withdrawal by Subject|3|||
124453731|NCT04024228|447622542|FG001|Overall Study|Withdrawal by Subject|4|||
124453732|NCT05197049|447622543|FG000|Overall Study|Death|0|||
124453733|NCT05197049|447622544|FG001|Overall Study|Death|1|||
124453734|NCT05197049|447622545|FG002|Overall Study|Death|0|||
124453735|NCT05197049|447622543|FG000|Overall Study|Lost to Follow-up|3|||
124453736|NCT05197049|447622544|FG001|Overall Study|Lost to Follow-up|1|||
124453737|NCT05197049|447622545|FG002|Overall Study|Lost to Follow-up|0|||
124453738|NCT05197049|447622543|FG000|Overall Study|Withdrawal by Subject|15|||
124453739|NCT05197049|447622544|FG001|Overall Study|Withdrawal by Subject|3|||
124453740|NCT05197049|447622545|FG002|Overall Study|Withdrawal by Subject|1|||
124453741|NCT05197049|447622543|FG000|Overall Study|GCP non-compliance|1|||
124453742|NCT05197049|447622544|FG001|Overall Study|GCP non-compliance|2|||
124453743|NCT05197049|447622545|FG002|Overall Study|GCP non-compliance|0|||
124453744|NCT04033445|447622552|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
124453745|NCT04033445|447622553|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
124453746|NCT04033445|447622554|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
124453747|NCT04033445|447622555|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
124453748|NCT04033445|447622556|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
124453749|NCT04033445|447622557|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
124453750|NCT04033445|447622558|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
124453751|NCT04033445|447622559|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
124453752|NCT04033445|447622560|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
124453753|NCT04033445|447622561|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
124453754|NCT04033445|447622562|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
124453755|NCT04033445|447622563|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
124453756|NCT04033445|447622564|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
124453757|NCT04033445|447622565|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
124545788|NCT00965562|447952830|FG001|Overall Study|Lost to Follow-up|2|||
124696682|NCT00098293|448509550|FG002|Open-label (OL) Phase|Pregnancy|0|||
124696683|NCT00098293|448509551|FG003|Open-label (OL) Phase|Pregnancy|3|||
124923887|NCT05126433|449350590|FG001|Overall Study|Progressive Disease|4|||
124923888|NCT05126433|449350591|FG002|Overall Study|Progressive Disease|3|||
124923889|NCT05126433|449350589|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
124923890|NCT05126433|449350590|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
124923891|NCT05126433|449350591|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
124923892|NCT05084508|449350597|FG000|Overall Study|Lost to Follow-up|6|||
124923893|NCT05084508|449350598|FG001|Overall Study|Lost to Follow-up|3|||
124923894|NCT05084508|449350599|FG002|Overall Study|Lost to Follow-up|7|||
124923895|NCT05084508|449350600|FG003|Overall Study|Lost to Follow-up|3|||
124923896|NCT05084508|449350597|FG000|Overall Study|Withdrawal by Subject|0|||
124923897|NCT05084508|449350598|FG001|Overall Study|Withdrawal by Subject|2|||
124923898|NCT05084508|449350599|FG002|Overall Study|Withdrawal by Subject|3|||
124923899|NCT05084508|449350600|FG003|Overall Study|Withdrawal by Subject|1|||
124696684|NCT00098293|448509552|FG004|Open-label (OL) Phase|Pregnancy|0|||
124696685|NCT00098293|448509548|FG000|Open-label (OL) Phase|Protocol Violation|0|||
124696686|NCT00098293|448509549|FG001|Open-label (OL) Phase|Protocol Violation|6|||
124696687|NCT00098293|448509550|FG002|Open-label (OL) Phase|Protocol Violation|13|||
124923900|NCT05084508|449350597|FG000|Overall Study|Other|0|||
124923901|NCT05084508|449350598|FG001|Overall Study|Other|0|||
124923902|NCT05084508|449350599|FG002|Overall Study|Other|0|||
124923903|NCT05084508|449350600|FG003|Overall Study|Other|1|||
124453758|NCT04033445|447622552|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
124453759|NCT04033445|447622553|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
124453760|NCT04033445|447622554|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
124453761|NCT04033445|447622555|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
124696688|NCT00098293|448509551|FG003|Open-label (OL) Phase|Protocol Violation|16|||
124696689|NCT00098293|448509552|FG004|Open-label (OL) Phase|Protocol Violation|0|||
124923904|NCT05296525|449350601|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
124923905|NCT05296525|449350602|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
124923906|NCT05296525|449350603|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
124923907|NCT05296525|449350604|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
124923908|NCT04065841|449350609|FG000|Overall Study|Adverse Event|4|||
124923909|NCT04065841|449350610|FG001|Overall Study|Adverse Event|2|||
124923910|NCT04065841|449350611|FG002|Overall Study|Adverse Event|10|||
124923911|NCT04065841|449350612|FG003|Overall Study|Adverse Event|1|||
124923912|NCT04065841|449350609|FG000|Overall Study|Lost to Follow-up|1|||
124923913|NCT04065841|449350610|FG001|Overall Study|Lost to Follow-up|2|||
124923914|NCT04065841|449350611|FG002|Overall Study|Lost to Follow-up|2|||
124923915|NCT04065841|449350612|FG003|Overall Study|Lost to Follow-up|2|||
124923916|NCT04065841|449350609|FG000|Overall Study|Physician Decision|1|||
124923917|NCT04065841|449350610|FG001|Overall Study|Physician Decision|0|||
124923918|NCT04065841|449350611|FG002|Overall Study|Physician Decision|0|||
124923919|NCT04065841|449350612|FG003|Overall Study|Physician Decision|0|||
124923920|NCT04065841|449350609|FG000|Overall Study|Protocol Violation|0|||
124923921|NCT04065841|449350610|FG001|Overall Study|Protocol Violation|1|||
124923922|NCT04065841|449350611|FG002|Overall Study|Protocol Violation|0|||
124923923|NCT04065841|449350612|FG003|Overall Study|Protocol Violation|0|||
124923924|NCT04065841|449350609|FG000|Overall Study|Study terminated by Sponsor|22|||
124923925|NCT04065841|449350610|FG001|Overall Study|Study terminated by Sponsor|16|||
124923926|NCT04065841|449350611|FG002|Overall Study|Study terminated by Sponsor|28|||
124923927|NCT04065841|449350612|FG003|Overall Study|Study terminated by Sponsor|17|||
124923928|NCT04065841|449350609|FG000|Overall Study|Withdrawal by Subject|1|||
124923929|NCT04065841|449350610|FG001|Overall Study|Withdrawal by Subject|1|||
124453762|NCT04033445|447622556|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
124453763|NCT04033445|447622557|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
124453764|NCT04033445|447622558|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
124453765|NCT04033445|447622559|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
124453766|NCT04033445|447622560|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
124453767|NCT04033445|447622561|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
124453768|NCT04033445|447622562|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
124453769|NCT04033445|447622563|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
124453770|NCT04033445|447622564|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
124453771|NCT04033445|447622565|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
124453772|NCT04033445|447622552|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
124453773|NCT04033445|447622553|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
124453774|NCT04033445|447622554|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
124453775|NCT04033445|447622555|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
124453776|NCT04033445|447622556|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
124453777|NCT04033445|447622557|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
124453778|NCT04033445|447622558|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
124453779|NCT04033445|447622559|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
124453780|NCT04033445|447622560|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
124453781|NCT04033445|447622561|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
124453782|NCT04033445|447622562|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
124453783|NCT04033445|447622563|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
124453784|NCT04033445|447622564|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
124453785|NCT04033445|447622565|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
124453786|NCT04033445|447622552|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
124453787|NCT04033445|447622553|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
124453788|NCT04033445|447622554|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
124453789|NCT04033445|447622555|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
124453790|NCT04033445|447622556|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
124453791|NCT04033445|447622557|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
124453792|NCT04033445|447622558|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
124453793|NCT04033445|447622559|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
124453794|NCT04033445|447622560|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
124453795|NCT04033445|447622561|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
124453796|NCT04033445|447622562|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
124453797|NCT04033445|447622563|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
124453798|NCT04033445|447622564|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
124545789|NCT00965562|447952831|FG002|Overall Study|Lost to Follow-up|3|||
124923930|NCT04065841|449350611|FG002|Overall Study|Withdrawal by Subject|2|||
124923931|NCT04065841|449350612|FG003|Overall Study|Withdrawal by Subject|0|||
124923932|NCT01420237|449350613|FG000|Overall Study|Death|13|||
124923933|NCT01420237|449350613|FG000|Overall Study|Withdrawal by Subject|41|||
124923934|NCT01420237|449350613|FG000|Overall Study|Lost to Follow-up|32|||
124923935|NCT01420237|449350613|FG000|Overall Study|Adverse Event|10|||
124923936|NCT01420237|449350613|FG000|Overall Study|Investigative Site Termination|43|||
124453799|NCT04033445|447622565|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
124453800|NCT04033445|447622552|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
124453801|NCT04033445|447622553|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
124453802|NCT04033445|447622554|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
124453803|NCT04033445|447622555|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
124453804|NCT04033445|447622556|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
124453805|NCT04033445|447622557|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
124453806|NCT04033445|447622558|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
124453807|NCT04033445|447622559|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
124453808|NCT04033445|447622560|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
124453809|NCT04033445|447622561|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
124453810|NCT04033445|447622562|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
124453811|NCT04033445|447622563|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
124453812|NCT04033445|447622564|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
124453813|NCT04033445|447622565|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
124453814|NCT04033445|447622552|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
124453815|NCT04033445|447622553|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
124453816|NCT04033445|447622554|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
124453817|NCT04033445|447622555|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
124453818|NCT04033445|447622556|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
124453819|NCT04033445|447622557|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
124453820|NCT04033445|447622558|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
124453821|NCT04033445|447622559|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
124453822|NCT04033445|447622560|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
124453823|NCT04033445|447622561|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
124453824|NCT04033445|447622562|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
124453825|NCT04033445|447622563|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
124453826|NCT04033445|447622564|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
124453827|NCT04033445|447622565|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
124453828|NCT04033445|447622552|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
124453829|NCT04033445|447622553|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
124453830|NCT04033445|447622554|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
124453831|NCT04033445|447622555|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
124453832|NCT04033445|447622556|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
124453833|NCT04033445|447622557|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
124453834|NCT04033445|447622558|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
124453835|NCT04033445|447622559|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
124453836|NCT04033445|447622560|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
124453837|NCT04033445|447622561|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
124453838|NCT04033445|447622562|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
124453839|NCT04033445|447622563|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
124453840|NCT04033445|447622564|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
124453841|NCT04033445|447622565|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
124453842|NCT04033445|447622552|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
124453843|NCT04033445|447622553|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
124453844|NCT04033445|447622554|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
124453845|NCT04033445|447622555|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
124453846|NCT04033445|447622556|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
124453847|NCT04033445|447622557|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
124453848|NCT04033445|447622558|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
124453849|NCT04033445|447622559|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
124453850|NCT04033445|447622560|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
124453851|NCT04033445|447622561|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
124453852|NCT04033445|447622562|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
124453853|NCT04033445|447622563|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
124453854|NCT04033445|447622564|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
124453855|NCT04033445|447622565|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
124923937|NCT01420237|449350613|FG000|Overall Study|Censored because study device not implanted|21|||
124923938|NCT01420237|449350613|FG000|Overall Study|Censored because surgery not performed|2|||
124923939|NCT01420237|449350613|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
124923940|NCT01420237|449350613|FG000|Overall Study|Sponsor terminated study early|127|||
124923941|NCT05653427|449352374|FG000|Overall Study|Study Terminated by Sponsor|13|||
124923942|NCT04256941|449352382|FG000|Overall Study|Withdrawal by Subject|0|||
124923943|NCT04256941|449352383|FG001|Overall Study|Withdrawal by Subject|1|||
124453856|NCT04033445|447622552|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
124762546|NCT03040141|448755918|FG001|Overall Study|Death|2|||
124453857|NCT04033445|447622553|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
124453858|NCT04033445|447622554|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
124453859|NCT04033445|447622555|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
124453860|NCT04033445|447622556|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
124453861|NCT04033445|447622557|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
124453862|NCT04033445|447622558|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
124453863|NCT04033445|447622559|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
124453864|NCT04033445|447622560|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
124453865|NCT04033445|447622561|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
124453866|NCT04033445|447622562|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
124453867|NCT04033445|447622563|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
124453868|NCT04033445|447622564|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
124453869|NCT04033445|447622565|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
124453870|NCT04033445|447622552|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
124453871|NCT04033445|447622553|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
124453872|NCT04033445|447622554|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
124453873|NCT04033445|447622555|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
124453874|NCT04033445|447622556|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
124453875|NCT04033445|447622557|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
124453876|NCT04033445|447622558|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
124453877|NCT04033445|447622559|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
124453878|NCT04033445|447622560|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
124453879|NCT04033445|447622561|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
124453880|NCT04033445|447622562|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
124453881|NCT04033445|447622563|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
124453882|NCT04033445|447622564|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
124453883|NCT04033445|447622565|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
124453884|NCT04033445|447622552|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
124453885|NCT04033445|447622553|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
124453886|NCT04033445|447622554|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
124453887|NCT04033445|447622555|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
124453888|NCT04033445|447622556|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
124453889|NCT04033445|447622557|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
124453890|NCT04033445|447622558|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
124453891|NCT04033445|447622559|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
124453892|NCT04033445|447622560|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
124453893|NCT04033445|447622561|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
124453894|NCT04033445|447622562|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
124453895|NCT04033445|447622563|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
124453896|NCT04033445|447622564|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
124453897|NCT04033445|447622565|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
124453898|NCT04033445|447622552|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
124453899|NCT04033445|447622553|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
124453900|NCT04033445|447622554|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
124453901|NCT04033445|447622555|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
124453902|NCT04033445|447622556|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
124453903|NCT04033445|447622557|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
124453904|NCT04033445|447622558|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
124453905|NCT04033445|447622559|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
124453906|NCT04033445|447622560|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
124453907|NCT04033445|447622561|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
124453908|NCT04033445|447622562|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
124453909|NCT04033445|447622563|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
124453910|NCT04033445|447622564|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
124453911|NCT04033445|447622565|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
124453912|NCT04033445|447622552|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
124453913|NCT04033445|447622553|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
124453914|NCT04033445|447622554|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
124453915|NCT04033445|447622555|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
124453916|NCT04033445|447622556|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
124453917|NCT04033445|447622557|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
124545790|NCT00965562|447952829|FG000|Overall Study|Withdrawal by Subject|2|||
124545791|NCT00965562|447952830|FG001|Overall Study|Withdrawal by Subject|2|||
124545792|NCT00965562|447952831|FG002|Overall Study|Withdrawal by Subject|0|||
124545793|NCT00816166|447952832|FG000|Overall Study|Lost to Follow-up|6|||
124545794|NCT00816166|447952833|FG001|Overall Study|Lost to Follow-up|10|||
124453918|NCT04033445|447622558|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
124453919|NCT04033445|447622559|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
124453920|NCT04033445|447622560|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
124453921|NCT04033445|447622561|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
124453922|NCT04033445|447622562|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
124453923|NCT04033445|447622563|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
124453924|NCT04033445|447622564|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
124453925|NCT04033445|447622565|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
124453926|NCT04033445|447622552|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
124453927|NCT04033445|447622553|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
124453928|NCT04033445|447622554|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
124453929|NCT04033445|447622555|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
124453930|NCT04033445|447622556|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
124453931|NCT04033445|447622557|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
124453932|NCT04033445|447622558|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
124453933|NCT04033445|447622559|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
124453934|NCT04033445|447622560|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
124453935|NCT04033445|447622561|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
124453936|NCT04033445|447622562|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
124453937|NCT04033445|447622563|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
124453938|NCT04033445|447622564|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
124453939|NCT04033445|447622565|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
124453940|NCT04033445|447622552|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
124453941|NCT04033445|447622553|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
124923944|NCT04256941|449352382|FG000|Overall Study|Death|1|||
124923945|NCT04256941|449352383|FG001|Overall Study|Death|0|||
124923946|NCT04256941|449352382|FG000|Overall Study|Disease Progession|0|||
124453942|NCT04033445|447622554|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
124453943|NCT04033445|447622555|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
124453944|NCT04033445|447622556|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
124453945|NCT04033445|447622557|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
124453946|NCT04033445|447622558|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
124453947|NCT04033445|447622559|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
124923947|NCT04256941|449352383|FG001|Overall Study|Disease Progession|2|||
124923948|NCT02908477|449352390|FG000|Overall Study|Withdrawal by Subject|8|||
124923949|NCT02908477|449352391|FG001|Overall Study|Withdrawal by Subject|28|||
124453948|NCT04033445|447622560|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
124453949|NCT04033445|447622561|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
124453950|NCT04033445|447622562|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
124453951|NCT04033445|447622563|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
124453952|NCT04033445|447622564|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
124453953|NCT04033445|447622565|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
124453954|NCT04033445|447622552|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
124453955|NCT04033445|447622553|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
124453956|NCT04033445|447622554|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
124453957|NCT04033445|447622555|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
124453958|NCT04033445|447622556|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
124453959|NCT04033445|447622557|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
124453960|NCT04033445|447622558|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
124453961|NCT04033445|447622559|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
124453962|NCT04033445|447622560|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
124453963|NCT04033445|447622561|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
124453964|NCT04033445|447622562|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
124453965|NCT04033445|447622563|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
124453966|NCT04033445|447622564|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
124453967|NCT04033445|447622565|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
124453968|NCT04033445|447622552|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
124696690|NCT00098293|448509548|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
124923950|NCT02140554|449352392|FG000|Overall Study|Withdrawal of consent|1|||
124453969|NCT04033445|447622553|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
124923951|NCT02140554|449352393|FG001|Overall Study|Withdrawal of consent|0|||
124923952|NCT02140554|449352394|FG002|Overall Study|Withdrawal of consent|4|||
124923953|NCT02140554|449352392|FG000|Overall Study|Physician Decision|1|||
124923954|NCT02140554|449352393|FG001|Overall Study|Physician Decision|0|||
124453970|NCT04033445|447622554|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
124923955|NCT02140554|449352394|FG002|Overall Study|Physician Decision|2|||
124453971|NCT04033445|447622555|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
124453972|NCT04033445|447622556|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
124453973|NCT04033445|447622557|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
124453974|NCT04033445|447622558|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
124923956|NCT02140554|449352392|FG000|Overall Study|Death|0|||
124923957|NCT02140554|449352393|FG001|Overall Study|Death|0|||
124453975|NCT04033445|447622559|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
124453976|NCT04033445|447622560|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
124453977|NCT04033445|447622561|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
124453978|NCT04033445|447622562|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
124453979|NCT04033445|447622563|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
124453980|NCT04033445|447622564|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
124453981|NCT04033445|447622565|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
124453982|NCT04033445|447622552|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
124453983|NCT04033445|447622553|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
124453984|NCT04033445|447622554|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
124453985|NCT04033445|447622555|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
124453986|NCT04033445|447622556|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
124453987|NCT04033445|447622557|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
124453988|NCT04033445|447622558|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
124453989|NCT04033445|447622559|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
124453990|NCT04033445|447622560|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
124453991|NCT04033445|447622561|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
124453992|NCT04033445|447622562|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
124453993|NCT04033445|447622563|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
124453994|NCT04033445|447622564|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
124453995|NCT04033445|447622565|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
124453996|NCT04033445|447622552|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
124453997|NCT04033445|447622553|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
124453998|NCT04033445|447622554|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
124453999|NCT04033445|447622555|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
124454000|NCT04033445|447622556|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
124454001|NCT04033445|447622557|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
124454002|NCT04033445|447622558|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
124454003|NCT04033445|447622559|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
124454004|NCT04033445|447622560|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
124454005|NCT04033445|447622561|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
124454006|NCT04033445|447622562|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
124454007|NCT04033445|447622563|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
124454008|NCT04033445|447622564|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
124454009|NCT04033445|447622565|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
124454010|NCT04033445|447622552|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
124454011|NCT04033445|447622553|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
124454012|NCT04033445|447622554|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
124454013|NCT04033445|447622555|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
124454014|NCT04033445|447622556|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
124454015|NCT04033445|447622557|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
124454016|NCT04033445|447622558|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
124454017|NCT04033445|447622559|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
124454018|NCT04033445|447622560|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
124454019|NCT04033445|447622561|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
124454020|NCT04033445|447622562|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
124454021|NCT04033445|447622563|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
124454022|NCT04033445|447622564|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
124454023|NCT04033445|447622565|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
124923958|NCT02140554|449352394|FG002|Overall Study|Death|1|||
124923959|NCT02140554|449352392|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
124923960|NCT02140554|449352393|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
124923961|NCT02140554|449352394|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
124923962|NCT05590403|449352395|FG000|Overall Study|Lost to Follow-up|13|||
124466466|NCT02574637|447666416|FG000|Double-blind Period|Lack of Efficacy|0|||
124466467|NCT02574637|447666417|FG001|Double-blind Period|Lack of Efficacy|0|||
124466468|NCT02574637|447666418|FG002|Double-blind Period|Lack of Efficacy|2|||
124762547|NCT03040141|448755919|FG002|Overall Study|Death|3|||
124923963|NCT05590403|449352396|FG001|Overall Study|Lost to Follow-up|1|||
124923964|NCT05590403|449352397|FG002|Overall Study|Lost to Follow-up|7|||
124466469|NCT02574637|447666419|FG003|Double-blind Period|Lack of Efficacy|0|||
124454024|NCT04033445|447622552|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
124454025|NCT04033445|447622553|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
124454026|NCT04033445|447622554|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
124454027|NCT04033445|447622555|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
124454028|NCT04033445|447622556|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
124454029|NCT04033445|447622557|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
124454030|NCT04033445|447622558|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
124454031|NCT04033445|447622559|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
124454032|NCT04033445|447622560|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
124454033|NCT04033445|447622561|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
124454034|NCT04033445|447622562|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
124454035|NCT04033445|447622563|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
124454036|NCT04033445|447622564|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
124454037|NCT04033445|447622565|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
124454038|NCT04033445|447622552|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
124454039|NCT04033445|447622553|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
124454040|NCT04033445|447622554|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
124454041|NCT04033445|447622555|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
124454042|NCT04033445|447622556|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
124454043|NCT04033445|447622557|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
124454044|NCT04033445|447622558|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
124454045|NCT04033445|447622559|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
124454046|NCT04033445|447622560|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
124454047|NCT04033445|447622561|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
124454048|NCT04033445|447622562|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
124454049|NCT04033445|447622563|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
124454050|NCT04033445|447622564|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
124454051|NCT04033445|447622565|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
124454052|NCT04033445|447622552|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
124454053|NCT04033445|447622553|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
124454054|NCT04033445|447622554|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
124454055|NCT04033445|447622555|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
124454056|NCT04033445|447622556|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
124454057|NCT04033445|447622557|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
124454058|NCT04033445|447622558|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
124454059|NCT04033445|447622559|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
124454060|NCT04033445|447622560|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
124454061|NCT04033445|447622561|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
124696691|NCT00098293|448509549|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
124696692|NCT00098293|448509550|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
124696693|NCT00098293|448509551|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
124696694|NCT00098293|448509552|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
124696695|NCT00098293|448509548|FG000|Open-label (OL) Phase|Death|0|||
124696696|NCT00098293|448509549|FG001|Open-label (OL) Phase|Death|2|||
124696697|NCT00098293|448509550|FG002|Open-label (OL) Phase|Death|3|||
124923965|NCT05590403|449352398|FG003|Overall Study|Lost to Follow-up|3|||
124545795|NCT00816166|447952832|FG000|Overall Study|Death|4|||
124545796|NCT00816166|447952833|FG001|Overall Study|Death|2|||
124545797|NCT02756182|447952834|FG000|Overall Study|StudyTechnical Difficulties|4|||
124545798|NCT01608321|447952844|FG000|Overall Study|Withdrawal by Subject|1|||
124545799|NCT01608321|447952845|FG001|Overall Study|Withdrawal by Subject|0|||
124923966|NCT05590403|449352399|FG004|Overall Study|Lost to Follow-up|4|||
124923967|NCT05590403|449352395|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
124923968|NCT05590403|449352396|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
124923969|NCT05590403|449352397|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
124923970|NCT05590403|449352398|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
124454062|NCT04033445|447622562|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
124454063|NCT04033445|447622563|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
124454064|NCT04033445|447622564|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
124454065|NCT04033445|447622565|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
124545800|NCT02062385|447952846|FG000|Overall Study|Adverse Event|19|||
124545801|NCT02062385|447952847|FG001|Overall Study|Adverse Event|13|||
124545802|NCT02062385|447952848|FG002|Overall Study|Adverse Event|1|||
124545803|NCT02062385|447952849|FG003|Overall Study|Adverse Event|0|||
124923971|NCT05590403|449352399|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
124923972|NCT05590403|449352395|FG000|Overall Study|Other|2|||
124923973|NCT05590403|449352396|FG001|Overall Study|Other|0|||
124454066|NCT05807464|447622569|FG000|Overall Study|Adverse Event|1|||
124454067|NCT04754802|447622570|FG000|Overall Study|Lost to Follow-up|0|||
124454068|NCT04754802|447622571|FG001|Overall Study|Lost to Follow-up|2|||
124454069|NCT04754802|447622570|FG000|Overall Study|Withdrawal by Subject|2|||
124454070|NCT04754802|447622571|FG001|Overall Study|Withdrawal by Subject|0|||
124454071|NCT05525689|447622572|FG000|Overall Study|Lost to Follow-up|1|||
124454072|NCT05525689|447622573|FG001|Overall Study|Lost to Follow-up|0|||
124454073|NCT01671111|447622574|FG000|Overall Study|Adverse Event|2|||
124454074|NCT01671111|447622574|FG000|Overall Study|Lack of Efficacy|1|||
124454075|NCT01671111|447622574|FG000|Overall Study|Withdrawal by Subject|2|||
124454076|NCT01671111|447622574|FG000|Overall Study|Physician Decision|1|||
124454077|NCT01671111|447622574|FG000|Overall Study|Other|24|||
124454078|NCT03680911|447622575|FG000|At Home Treatment|Study Termination|3|||
124454079|NCT03680911|447622576|FG001|At Home Treatment|Study Termination|0|||
124454080|NCT03680911|447622575|FG000|At Home Treatment|Lost to Follow-up|0|||
124454081|NCT03680911|447622576|FG001|At Home Treatment|Lost to Follow-up|1|||
124454082|NCT03680911|447622575|FG000|At Home Treatment|Withdrawal by Subject|0|||
124454083|NCT03680911|447622576|FG001|At Home Treatment|Withdrawal by Subject|2|||
124454084|NCT03680911|447622575|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
124454085|NCT03680911|447622576|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
124454086|NCT04702737|447622585|FG000|Overall Study|Decision by Sponsor|1|||
124454087|NCT04702737|447622585|FG000|Overall Study|Withdrawal of Consent from Study|3|||
124454088|NCT04702737|447622585|FG000|Overall Study|Lost to Follow-up|1|||
124454089|NCT04702737|447622585|FG000|Overall Study|Death|35|||
124454090|NCT02811549|447622586|FG000|Overall Study|Lost to Follow-up|1|||
124454091|NCT02811549|447622586|FG000|Overall Study|Withdrawal by Subject|3|||
124454092|NCT02811549|447622586|FG000|Overall Study|Subject screen failed|4|||
124454093|NCT02811549|447622586|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
124454094|NCT05318937|447622589|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124454095|NCT05318937|447622590|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124454096|NCT05318937|447622589|FG000|Overall Study|Lost to Follow-up|0|||
124454097|NCT05318937|447622590|FG001|Overall Study|Lost to Follow-up|1|||
124454098|NCT05318937|447622589|FG000|Overall Study|Withdrawal by Subject|0|||
124454099|NCT05318937|447622590|FG001|Overall Study|Withdrawal by Subject|2|||
124454100|NCT05318937|447622589|FG000|Overall Study|Protocol Violation|0|||
124454101|NCT05318937|447622590|FG001|Overall Study|Protocol Violation|1|||
124454102|NCT05678257|447622598|FG000|Overall Study|Withdrawal by Subject|2|||
124454103|NCT05678257|447622599|FG001|Overall Study|Withdrawal by Subject|0|||
124454104|NCT05678257|447622600|FG002|Overall Study|Withdrawal by Subject|5|||
124923974|NCT05590403|449352397|FG002|Overall Study|Other|2|||
124923975|NCT05590403|449352398|FG003|Overall Study|Other|2|||
124923976|NCT05590403|449352399|FG004|Overall Study|Other|0|||
124923977|NCT05590403|449352395|FG000|Overall Study|Migrated / moved from the study area|1|||
124923978|NCT05590403|449352396|FG001|Overall Study|Migrated / moved from the study area|1|||
124923979|NCT05590403|449352397|FG002|Overall Study|Migrated / moved from the study area|0|||
124923980|NCT05590403|449352398|FG003|Overall Study|Migrated / moved from the study area|3|||
124923981|NCT05590403|449352399|FG004|Overall Study|Migrated / moved from the study area|1|||
124923982|NCT05590403|449352395|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
124923983|NCT05590403|449352396|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
124923984|NCT05590403|449352397|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
124923985|NCT05590403|449352398|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
124923986|NCT05590403|449352399|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
124923987|NCT05659537|449352400|FG000|Overall Study|Adverse Event|5|||
124923988|NCT05659537|449352400|FG000|Overall Study|Lost to Follow-up|4|||
124923989|NCT05659537|449352400|FG000|Overall Study|Withdrawal by Subject|13|||
124923990|NCT05659537|449352400|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
124923991|NCT05659537|449352400|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
124923992|NCT05659537|449352400|FG000|Overall Study|Participant was suffering from anaemia|1|||
124454105|NCT05678257|447622598|FG000|Overall Study|Physician Decision|1|||
124454106|NCT05678257|447622599|FG001|Overall Study|Physician Decision|0|||
124454107|NCT05678257|447622600|FG002|Overall Study|Physician Decision|1|||
124454108|NCT05678257|447622598|FG000|Overall Study|Adverse Event|1|||
124454109|NCT05678257|447622599|FG001|Overall Study|Adverse Event|3|||
124696698|NCT00098293|448509551|FG003|Open-label (OL) Phase|Death|0|||
124696699|NCT00098293|448509552|FG004|Open-label (OL) Phase|Death|0|||
124454110|NCT05678257|447622600|FG002|Overall Study|Adverse Event|1|||
124545804|NCT02062385|447952846|FG000|Overall Study|Protocol Violation|1|||
124696700|NCT00098293|448509548|FG000|Supplemental Phase (SP)|Death|0|||
124696701|NCT00098293|448509549|FG001|Supplemental Phase (SP)|Death|0|||
124454111|NCT05678257|447622598|FG000|Overall Study|Progressive disease|11|||
124454112|NCT05678257|447622599|FG001|Overall Study|Progressive disease|18|||
124454113|NCT05678257|447622600|FG002|Overall Study|Progressive disease|7|||
124454114|NCT05678257|447622598|FG000|Overall Study|No longer clinically benefitting|2|||
124454115|NCT05678257|447622599|FG001|Overall Study|No longer clinically benefitting|1|||
124696702|NCT00098293|448509550|FG002|Supplemental Phase (SP)|Death|0|||
124454116|NCT05678257|447622600|FG002|Overall Study|No longer clinically benefitting|0|||
124454117|NCT05678257|447622598|FG000|Overall Study|Sponsor decision|5|||
124454118|NCT05678257|447622599|FG001|Overall Study|Sponsor decision|9|||
124454119|NCT05678257|447622600|FG002|Overall Study|Sponsor decision|8|||
124454120|NCT05678257|447622598|FG000|Overall Study|Protocol Violation|0|||
124454121|NCT05678257|447622599|FG001|Overall Study|Protocol Violation|0|||
124454122|NCT05678257|447622600|FG002|Overall Study|Protocol Violation|1|||
124454123|NCT05678257|447622598|FG000|Overall Study|Patient non-compliance|0|||
124696703|NCT00098293|448509551|FG003|Supplemental Phase (SP)|Death|0|||
124696704|NCT00098293|448509552|FG004|Supplemental Phase (SP)|Death|1|||
124696705|NCT00098293|448509548|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
124696706|NCT00098293|448509549|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
124696707|NCT00098293|448509550|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
124696708|NCT00098293|448509551|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
124696709|NCT00098293|448509552|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
124696710|NCT00098293|448509548|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
124696711|NCT00098293|448509549|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
124696712|NCT00098293|448509550|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
124696713|NCT00098293|448509551|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
124696714|NCT00098293|448509552|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
124696715|NCT00098293|448509548|FG000|Supplemental Phase (SP)|Other|0|||
124696716|NCT00098293|448509549|FG001|Supplemental Phase (SP)|Other|0|||
124696717|NCT00098293|448509550|FG002|Supplemental Phase (SP)|Other|0|||
124696718|NCT00098293|448509551|FG003|Supplemental Phase (SP)|Other|0|||
124696719|NCT00098293|448509552|FG004|Supplemental Phase (SP)|Other|22|||
124696720|NCT01370642|448509553|FG000|Overall Study|Adverse Event|2|||
124696721|NCT01370642|448509554|FG001|Overall Study|Adverse Event|1|||
124696722|NCT01370642|448509555|FG002|Overall Study|Adverse Event|1|||
124696723|NCT01370642|448509553|FG000|Overall Study|Detectable HCV RNA|0|||
124696724|NCT01370642|448509554|FG001|Overall Study|Detectable HCV RNA|0|||
124696725|NCT01370642|448509555|FG002|Overall Study|Detectable HCV RNA|22|||
124696726|NCT01370642|448509553|FG000|Overall Study|Lost to Follow-up|0|||
124696727|NCT01370642|448509554|FG001|Overall Study|Lost to Follow-up|0|||
124696728|NCT01370642|448509555|FG002|Overall Study|Lost to Follow-up|1|||
124696729|NCT01370642|448509553|FG000|Overall Study|Physician Decision|4|||
124696730|NCT01370642|448509554|FG001|Overall Study|Physician Decision|1|||
124696731|NCT01370642|448509555|FG002|Overall Study|Physician Decision|2|||
124696732|NCT01370642|448509553|FG000|Overall Study|Withdrawal by Subject|2|||
124696733|NCT01370642|448509554|FG001|Overall Study|Withdrawal by Subject|4|||
124696734|NCT01370642|448509555|FG002|Overall Study|Withdrawal by Subject|3|||
124696735|NCT01796470|448509562|FG000|Overall Study|Adverse Event|4|||
124696736|NCT01796470|448509563|FG001|Overall Study|Adverse Event|2|||
124696737|NCT01796470|448509564|FG002|Overall Study|Adverse Event|2|||
124696738|NCT01796470|448509565|FG003|Overall Study|Adverse Event|1|||
124696739|NCT01796470|448509566|FG004|Overall Study|Adverse Event|3|||
124696740|NCT01796470|448509562|FG000|Overall Study|Death|2|||
124696741|NCT01796470|448509563|FG001|Overall Study|Death|0|||
124696742|NCT01796470|448509564|FG002|Overall Study|Death|0|||
124696743|NCT01796470|448509565|FG003|Overall Study|Death|0|||
124696744|NCT01796470|448509566|FG004|Overall Study|Death|1|||
124696745|NCT01796470|448509562|FG000|Overall Study|Initiated New Therapy|9|||
124696746|NCT01796470|448509563|FG001|Overall Study|Initiated New Therapy|0|||
124696747|NCT01796470|448509564|FG002|Overall Study|Initiated New Therapy|0|||
124696748|NCT01796470|448509565|FG003|Overall Study|Initiated New Therapy|0|||
124923993|NCT04856163|449352402|FG000|Overall Study|Lost to Follow-up|97|||
124923994|NCT04856163|449352403|FG001|Overall Study|Lost to Follow-up|100|||
124923995|NCT04526704|449352412|FG000|Overall Study|Adverse Event|1|||
124923996|NCT04526704|449352413|FG001|Overall Study|Adverse Event|0|||
124454124|NCT05678257|447622599|FG001|Overall Study|Patient non-compliance|0|||
124545805|NCT02062385|447952847|FG001|Overall Study|Protocol Violation|0|||
124696749|NCT01796470|448509566|FG004|Overall Study|Initiated New Therapy|2|||
124696750|NCT01796470|448509562|FG000|Overall Study|Lost to Follow-up|0|||
124696751|NCT01796470|448509563|FG001|Overall Study|Lost to Follow-up|1|||
124923997|NCT04526704|449352412|FG000|Overall Study|Physician Decision|1|||
124454125|NCT05678257|447622600|FG002|Overall Study|Patient non-compliance|3|||
124454126|NCT05314517|447622601|FG000|Double-blind Period|Adverse Event|4|||
124696752|NCT01796470|448509564|FG002|Overall Study|Lost to Follow-up|0|||
124696753|NCT01796470|448509565|FG003|Overall Study|Lost to Follow-up|0|||
124696754|NCT01796470|448509566|FG004|Overall Study|Lost to Follow-up|0|||
124696755|NCT01796470|448509562|FG000|Overall Study|Physician Decision|5|||
124696756|NCT01796470|448509563|FG001|Overall Study|Physician Decision|4|||
124696757|NCT01796470|448509564|FG002|Overall Study|Physician Decision|1|||
124454127|NCT05314517|447622602|FG001|Double-blind Period|Adverse Event|0|||
124696758|NCT01796470|448509565|FG003|Overall Study|Physician Decision|0|||
124696759|NCT01796470|448509566|FG004|Overall Study|Physician Decision|1|||
124696760|NCT01796470|448509562|FG000|Overall Study|Progressive Disease|7|||
124696761|NCT01796470|448509563|FG001|Overall Study|Progressive Disease|7|||
124696762|NCT01796470|448509564|FG002|Overall Study|Progressive Disease|3|||
124923998|NCT04526704|449352413|FG001|Overall Study|Physician Decision|0|||
124923999|NCT04526704|449352412|FG000|Overall Study|Withdrawal by Subject|2|||
124924000|NCT04526704|449352413|FG001|Overall Study|Withdrawal by Subject|0|||
124924001|NCT00881621|449352414|FG000|Overall Study|Physician Decision|34|||
124924002|NCT03936322|449352419|FG000|Overall Study|Lost to Follow-up|1|||
124924003|NCT03936322|449352419|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
124924004|NCT05434078|449352421|FG000|Overall Study|Lost to Follow-up|2|||
124924005|NCT05434078|449352422|FG001|Overall Study|Lost to Follow-up|1|||
124924006|NCT05434078|449352421|FG000|Overall Study|Withdrawal by Subject|1|||
124924007|NCT05434078|449352422|FG001|Overall Study|Withdrawal by Subject|0|||
124924008|NCT02734290|449352426|FG000|Overall Study|Adverse Event|1|||
124924009|NCT02734290|449352427|FG001|Overall Study|Adverse Event|0|||
124924010|NCT02734290|449352426|FG000|Overall Study|Death|1|||
124924011|NCT02734290|449352427|FG001|Overall Study|Death|0|||
124924012|NCT03158129|449352428|FG000|Overall Study|Adverse Event|0|||
124924013|NCT03158129|449352429|FG001|Overall Study|Adverse Event|1|||
124924014|NCT03158129|449352430|FG002|Overall Study|Adverse Event|0|||
124924015|NCT03158129|449352431|FG003|Overall Study|Adverse Event|0|||
124924016|NCT03158129|449352428|FG000|Overall Study|Death|0|||
124924017|NCT03158129|449352429|FG001|Overall Study|Death|0|||
124924018|NCT03158129|449352430|FG002|Overall Study|Death|0|||
124924019|NCT03158129|449352431|FG003|Overall Study|Death|1|||
124924020|NCT03158129|449352428|FG000|Overall Study|High surgical risk|1|||
124924021|NCT03158129|449352429|FG001|Overall Study|High surgical risk|1|||
124924022|NCT03158129|449352430|FG002|Overall Study|High surgical risk|0|||
124924023|NCT03158129|449352431|FG003|Overall Study|High surgical risk|0|||
124924024|NCT03158129|449352428|FG000|Overall Study|Progression|1|||
124924025|NCT03158129|449352429|FG001|Overall Study|Progression|1|||
124924026|NCT03158129|449352430|FG002|Overall Study|Progression|0|||
124924027|NCT03158129|449352431|FG003|Overall Study|Progression|0|||
124924028|NCT03158129|449352428|FG000|Overall Study|Lack of resectability|0|||
124924029|NCT03158129|449352429|FG001|Overall Study|Lack of resectability|1|||
124924030|NCT03158129|449352430|FG002|Overall Study|Lack of resectability|0|||
124924031|NCT03158129|449352431|FG003|Overall Study|Lack of resectability|0|||
124924032|NCT03158129|449352428|FG000|Overall Study|Declined surgery|0|||
124924033|NCT03158129|449352429|FG001|Overall Study|Declined surgery|1|||
124924034|NCT03158129|449352430|FG002|Overall Study|Declined surgery|0|||
124924035|NCT03158129|449352431|FG003|Overall Study|Declined surgery|0|||
124924036|NCT03158129|449352428|FG000|Overall Study|No longer surgical candidate|0|||
124924037|NCT03158129|449352429|FG001|Overall Study|No longer surgical candidate|0|||
124924038|NCT03158129|449352430|FG002|Overall Study|No longer surgical candidate|0|||
124924039|NCT03158129|449352431|FG003|Overall Study|No longer surgical candidate|1|||
124924040|NCT03867500|449352436|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
124924041|NCT00554788|449352437|FG000|Overall Study|Adverse Event|0|||
124924042|NCT00554788|449352438|FG001|Overall Study|Adverse Event|1|||
124924043|NCT00554788|449352439|FG002|Overall Study|Adverse Event|2|||
124924044|NCT00554788|449352437|FG000|Overall Study|Lost to Follow-up|4|||
124924045|NCT00554788|449352438|FG001|Overall Study|Lost to Follow-up|3|||
124924046|NCT00554788|449352439|FG002|Overall Study|Lost to Follow-up|3|||
124924047|NCT00554788|449352437|FG000|Overall Study|Physician Decision|1|||
124924048|NCT00554788|449352438|FG001|Overall Study|Physician Decision|1|||
124924049|NCT00554788|449352439|FG002|Overall Study|Physician Decision|3|||
124924050|NCT00554788|449352437|FG000|Overall Study|Withdrawal by Subject|0|||
124924051|NCT00554788|449352438|FG001|Overall Study|Withdrawal by Subject|0|||
124924052|NCT00554788|449352439|FG002|Overall Study|Withdrawal by Subject|1|||
124924053|NCT00554788|449352437|FG000|Overall Study|Refusal of further protocol therapy|0|||
124924054|NCT00554788|449352438|FG001|Overall Study|Refusal of further protocol therapy|1|||
124924055|NCT00554788|449352439|FG002|Overall Study|Refusal of further protocol therapy|1|||
124924056|NCT00554788|449352437|FG000|Overall Study|Progressive disease|0|||
124924057|NCT00554788|449352438|FG001|Overall Study|Progressive disease|0|||
124924058|NCT00554788|449352439|FG002|Overall Study|Progressive disease|3|||
124924059|NCT00554788|449352437|FG000|Overall Study|Ineligible|2|||
124924060|NCT00554788|449352438|FG001|Overall Study|Ineligible|0|||
124924061|NCT00554788|449352439|FG002|Overall Study|Ineligible|1|||
124454128|NCT05314517|447622603|FG002|Double-blind Period|Adverse Event|0|||
124454129|NCT05314517|447622604|FG003|Double-blind Period|Adverse Event|0|||
124454130|NCT05314517|447622601|FG000|Double-blind Period|Noncompliance|0|||
124924062|NCT03897465|449352441|FG000|Overall Study|Lost to Follow-up|2|||
124924063|NCT03897465|449352442|FG001|Overall Study|Lost to Follow-up|1|||
124924064|NCT03897465|449352441|FG000|Overall Study|Adverse Event|2|||
124924065|NCT03897465|449352442|FG001|Overall Study|Adverse Event|0|||
124924066|NCT03897465|449352441|FG000|Overall Study|complete healing by V2|1|||
124924067|NCT03897465|449352442|FG001|Overall Study|complete healing by V2|0|||
124924068|NCT03897465|449352441|FG000|Overall Study|occurence of exclusion criterion|1|||
124924069|NCT03897465|449352442|FG001|Overall Study|occurence of exclusion criterion|1|||
124924070|NCT03897465|449352441|FG000|Overall Study|Other|1|||
124924071|NCT03897465|449352442|FG001|Overall Study|Other|0|||
124924072|NCT05119023|449352443|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
124924073|NCT05119023|449352443|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
124454131|NCT05314517|447622602|FG001|Double-blind Period|Noncompliance|1|||
124454132|NCT05314517|447622603|FG002|Double-blind Period|Noncompliance|0|||
124924074|NCT05119023|449352443|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
124924075|NCT04719390|449352459|FG000|Overall Study|Withdrawal by Subject|1|||
124454133|NCT05314517|447622604|FG003|Double-blind Period|Noncompliance|0|||
124454134|NCT05314517|447622601|FG000|Double-blind Period|Randomized, not treated|1|||
124454135|NCT05314517|447622602|FG001|Double-blind Period|Randomized, not treated|0|||
124454136|NCT05314517|447622603|FG002|Double-blind Period|Randomized, not treated|0|||
124454137|NCT05314517|447622604|FG003|Double-blind Period|Randomized, not treated|0|||
124454138|NCT05314517|447622601|FG000|Open-label Extension|Adverse Event|0|||
124454139|NCT05314517|447622602|FG001|Open-label Extension|Adverse Event|0|||
124454140|NCT05314517|447622603|FG002|Open-label Extension|Adverse Event|1|||
124454141|NCT05314517|447622604|FG003|Open-label Extension|Adverse Event|2|||
124454142|NCT05314517|447622601|FG000|Open-label Extension|Investigator decision|0|||
124454143|NCT05314517|447622602|FG001|Open-label Extension|Investigator decision|0|||
124454144|NCT05314517|447622603|FG002|Open-label Extension|Investigator decision|1|||
124454145|NCT05314517|447622604|FG003|Open-label Extension|Investigator decision|0|||
124454146|NCT05314517|447622601|FG000|Open-label Extension|Lost to Follow-up|0|||
124454147|NCT05314517|447622602|FG001|Open-label Extension|Lost to Follow-up|0|||
124924076|NCT04292223|449352460|FG000|Overall Study|Adverse Event|1|||
124924077|NCT04292223|449352460|FG000|Overall Study|Lost to Follow-up|1|||
124924078|NCT04292223|449352460|FG000|Overall Study|Noncompliance with study drug|2|||
124924079|NCT04292223|449352460|FG000|Overall Study|Patient moved out of the state|1|||
124924080|NCT04963270|449352464|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
124924081|NCT04963270|449352465|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
124924082|NCT04963270|449352466|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
124924083|NCT04963270|449352467|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
124924084|NCT04963270|449352464|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
124924085|NCT04963270|449352465|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
124924086|NCT04963270|449352466|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
124924087|NCT04963270|449352467|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
124924088|NCT04963270|449352464|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
124924089|NCT04963270|449352465|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
124924090|NCT04963270|449352466|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
124924091|NCT04963270|449352467|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
124924092|NCT04963270|449352464|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
124924093|NCT04963270|449352465|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
124924094|NCT04963270|449352466|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
124924095|NCT04963270|449352467|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
124924096|NCT04963270|449352464|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
124924097|NCT04963270|449352465|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
124924098|NCT04963270|449352466|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
124924099|NCT04963270|449352467|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
124924100|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
124924101|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
124924102|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
124924103|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
124924104|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
124924105|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
124924106|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
124924107|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
124454148|NCT05314517|447622603|FG002|Open-label Extension|Lost to Follow-up|0|||
124454149|NCT05314517|447622604|FG003|Open-label Extension|Lost to Follow-up|1|||
124454150|NCT05314517|447622601|FG000|Open-label Extension|Withdrawal by Subject|0|||
124454151|NCT05314517|447622602|FG001|Open-label Extension|Withdrawal by Subject|0|||
124454152|NCT05314517|447622603|FG002|Open-label Extension|Withdrawal by Subject|1|||
124454153|NCT05314517|447622604|FG003|Open-label Extension|Withdrawal by Subject|2|||
124454154|NCT05314517|447622601|FG000|Open-label Extension|Use of prohibited medication|0|||
124454155|NCT05314517|447622602|FG001|Open-label Extension|Use of prohibited medication|0|||
124454156|NCT05314517|447622603|FG002|Open-label Extension|Use of prohibited medication|1|||
124924108|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
124454157|NCT05314517|447622604|FG003|Open-label Extension|Use of prohibited medication|0|||
124924109|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
124924110|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
124969558|NCT03520075|449517414|FG005|Phase 2 (Dose Expansion)|Death|0|||
124454158|NCT05314517|447622601|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
124454159|NCT05314517|447622602|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
124454160|NCT05314517|447622603|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
124454161|NCT05314517|447622604|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
124545806|NCT02062385|447952848|FG002|Overall Study|Protocol Violation|0|||
124545807|NCT02062385|447952849|FG003|Overall Study|Protocol Violation|0|||
124545808|NCT02062385|447952846|FG000|Overall Study|Incomplete EPI by database lock|2|||
124545809|NCT02062385|447952847|FG001|Overall Study|Incomplete EPI by database lock|0|||
124545810|NCT02062385|447952848|FG002|Overall Study|Incomplete EPI by database lock|0|||
124762548|NCT03040141|448755917|FG000|Overall Study|Withdrawal by Subject|3|||
124762549|NCT03040141|448755918|FG001|Overall Study|Withdrawal by Subject|1|||
124762550|NCT03040141|448755919|FG002|Overall Study|Withdrawal by Subject|1|||
124762551|NCT03040141|448755917|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
124762552|NCT03040141|448755918|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
124762553|NCT03040141|448755919|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
124762554|NCT03040141|448755917|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
124762555|NCT03040141|448755918|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
124762556|NCT03040141|448755919|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
124762557|NCT01391663|448755920|FG000|Overall Study|Withdrawal by Subject|0|||
124762558|NCT01391663|448755921|FG001|Overall Study|Withdrawal by Subject|0|||
124762559|NCT01391663|448755922|FG002|Overall Study|Withdrawal by Subject|1|||
124762560|NCT01391663|448755923|FG003|Overall Study|Withdrawal by Subject|0|||
124762561|NCT03515824|448755924|FG000|Overall Study|Death|3|||
124762562|NCT03515824|448755925|FG001|Overall Study|Death|2|||
124762563|NCT03515824|448755926|FG002|Overall Study|Death|6|||
124545811|NCT02062385|447952849|FG003|Overall Study|Incomplete EPI by database lock|0|||
124545812|NCT02062385|447952846|FG000|Overall Study|Moved|10|||
124545813|NCT02062385|447952847|FG001|Overall Study|Moved|11|||
124545814|NCT02062385|447952848|FG002|Overall Study|Moved|1|||
124545815|NCT02062385|447952849|FG003|Overall Study|Moved|0|||
124545816|NCT02062385|447952846|FG000|Overall Study|Withdrawn by parent/guardian|46|||
124545817|NCT02062385|447952847|FG001|Overall Study|Withdrawn by parent/guardian|41|||
124545818|NCT02062385|447952848|FG002|Overall Study|Withdrawn by parent/guardian|9|||
124545819|NCT02062385|447952849|FG003|Overall Study|Withdrawn by parent/guardian|8|||
124545820|NCT02062385|447952846|FG000|Overall Study|Death|0|||
124545821|NCT02062385|447952847|FG001|Overall Study|Death|0|||
124545822|NCT02062385|447952848|FG002|Overall Study|Death|0|||
124545823|NCT02062385|447952849|FG003|Overall Study|Death|1|||
124545824|NCT02062385|447952846|FG000|Overall Study|Lost to Follow-up|0|||
124545825|NCT02062385|447952847|FG001|Overall Study|Lost to Follow-up|0|||
124545826|NCT02062385|447952848|FG002|Overall Study|Lost to Follow-up|1|||
124545827|NCT02062385|447952849|FG003|Overall Study|Lost to Follow-up|0|||
124545828|NCT04502862|447952850|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
124545829|NCT04502862|447952851|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
124545830|NCT04502862|447952850|FG000|Overall Study|Withdrawal by Subject|1|||
124545831|NCT04502862|447952851|FG001|Overall Study|Withdrawal by Subject|0|||
124545832|NCT04502862|447952850|FG000|Overall Study|Adverse Event|1|||
124545833|NCT04502862|447952851|FG001|Overall Study|Adverse Event|1|||
124545834|NCT01319994|447954400|FG000|Overall Study|Protocol Violation|7|||
124545835|NCT01319994|447954401|FG001|Overall Study|Protocol Violation|6|||
124545836|NCT01340794|447954402|FG000|Overall Study|Withdrawal by Subject|0|||
124545837|NCT01340794|447954403|FG001|Overall Study|Withdrawal by Subject|1|||
124545838|NCT00685763|447954405|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
124545839|NCT00685763|447954405|FG000|Overall Study|Protocol Violation|1|||
124762564|NCT03515824|448755927|FG003|Overall Study|Death|0|||
124762565|NCT03515824|448755924|FG000|Overall Study|Lost to Follow-up|0|||
124762566|NCT03515824|448755925|FG001|Overall Study|Lost to Follow-up|1|||
124762567|NCT03515824|448755926|FG002|Overall Study|Lost to Follow-up|1|||
124762568|NCT03515824|448755927|FG003|Overall Study|Lost to Follow-up|0|||
124762569|NCT03515824|448755924|FG000|Overall Study|Study terminated by sponsor|0|||
124762570|NCT03515824|448755925|FG001|Overall Study|Study terminated by sponsor|1|||
124762571|NCT03515824|448755926|FG002|Overall Study|Study terminated by sponsor|6|||
124762572|NCT03515824|448755927|FG003|Overall Study|Study terminated by sponsor|0|||
124762573|NCT03515824|448755924|FG000|Overall Study|Status not recorded|0|||
124762574|NCT03515824|448755925|FG001|Overall Study|Status not recorded|0|||
124762575|NCT03515824|448755926|FG002|Overall Study|Status not recorded|2|||
124762576|NCT03515824|448755927|FG003|Overall Study|Status not recorded|0|||
124762577|NCT01384734|448755928|FG000|Overall Study|Adverse Event|0|||
124762578|NCT01384734|448755929|FG001|Overall Study|Adverse Event|3|||
124762579|NCT01384734|448755930|FG002|Overall Study|Adverse Event|0|||
124762580|NCT01384734|448755931|FG003|Overall Study|Adverse Event|2|||
124762581|NCT01384734|448755932|FG004|Overall Study|Adverse Event|7|||
124762582|NCT01384734|448755928|FG000|Overall Study|Death|1|||
124545840|NCT00698009|447954406|FG000|Overall Study|Withdrawal by Subject|1|||
124545841|NCT00471237|447954412|FG000|Overall Study|Adverse Event|6|||
124545842|NCT00471237|447954413|FG001|Overall Study|Adverse Event|5|||
124545843|NCT00471237|447954414|FG002|Overall Study|Adverse Event|4|||
124545844|NCT00471237|447954415|FG003|Overall Study|Adverse Event|8|||
124545845|NCT00471237|447954416|FG004|Overall Study|Adverse Event|7|||
124762583|NCT01384734|448755929|FG001|Overall Study|Death|0|||
124762584|NCT01384734|448755930|FG002|Overall Study|Death|1|||
124762585|NCT01384734|448755931|FG003|Overall Study|Death|0|||
124762586|NCT01384734|448755932|FG004|Overall Study|Death|0|||
124762587|NCT01384734|448755928|FG000|Overall Study|Continuation criteria not met|0|||
124762588|NCT01384734|448755929|FG001|Overall Study|Continuation criteria not met|0|||
124454162|NCT04969276|447622605|FG000|Overall Study|Protocol Deviation|0|||
124454163|NCT04969276|447622606|FG001|Overall Study|Protocol Deviation|1|||
124924111|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
124924112|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
124924113|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
124924114|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
124924115|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
124924116|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
124924117|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
124924118|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
124924119|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
124924120|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
124924121|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
124924122|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
124924123|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
124924124|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
124924125|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
124924126|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
124924127|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
124924128|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
124924129|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
124924130|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
124924131|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
124924132|NCT04963270|449352464|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
124924133|NCT04963270|449352465|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
124924134|NCT04963270|449352466|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
124924135|NCT04963270|449352467|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
124924136|NCT04927364|449352471|FG000|Overall Study|Withdrawal by Subject|3|||
124924137|NCT04927364|449352471|FG000|Overall Study|Unable to complete preassessment MRI|1|||
124924138|NCT02919306|449352474|FG000|Overall Study|Withdrawal by Subject|1|||
124924139|NCT02919306|449352475|FG001|Overall Study|Withdrawal by Subject|0|||
124924140|NCT02919306|449352474|FG000|Overall Study|Protocol Violation|1|||
124924141|NCT02919306|449352475|FG001|Overall Study|Protocol Violation|0|||
124924142|NCT03560609|449352476|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
124924143|NCT03560609|449352477|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
124924144|NCT04293055|449352478|FG000|Overall Study|Lost to Follow-up|1|||
124924145|NCT04293055|449352479|FG001|Overall Study|Lost to Follow-up|1|||
124924146|NCT04293055|449352478|FG000|Overall Study|Did not trigger randomization|6|||
124454164|NCT04969276|447622607|FG002|Overall Study|Protocol Deviation|0|||
124454165|NCT04969276|447622605|FG000|Overall Study|Withdrawal by Subject|1|||
124454166|NCT04969276|447622606|FG001|Overall Study|Withdrawal by Subject|10|||
124454167|NCT04969276|447622607|FG002|Overall Study|Withdrawal by Subject|0|||
124454168|NCT04969276|447622605|FG000|Overall Study|Lost to Follow-up|0|||
124454169|NCT04969276|447622606|FG001|Overall Study|Lost to Follow-up|1|||
124454170|NCT04969276|447622607|FG002|Overall Study|Lost to Follow-up|0|||
124454171|NCT04655144|447622611|FG000|Overall Study|Consumed THC|1|||
124454172|NCT04655144|447622612|FG001|Overall Study|Consumed THC|0|||
124454173|NCT04655144|447622611|FG000|Overall Study|Unilateral embolization|0|||
124545846|NCT00471237|447954417|FG005|Overall Study|Adverse Event|5|||
124762589|NCT01384734|448755930|FG002|Overall Study|Continuation criteria not met|1|||
124762590|NCT01384734|448755931|FG003|Overall Study|Continuation criteria not met|1|||
124762591|NCT01384734|448755932|FG004|Overall Study|Continuation criteria not met|0|||
124762592|NCT01384734|448755928|FG000|Overall Study|Lack of Efficacy|3|||
124762593|NCT01384734|448755929|FG001|Overall Study|Lack of Efficacy|7|||
124762594|NCT01384734|448755930|FG002|Overall Study|Lack of Efficacy|4|||
124762595|NCT01384734|448755931|FG003|Overall Study|Lack of Efficacy|4|||
124924147|NCT04293055|449352479|FG001|Overall Study|Did not trigger randomization|5|||
124924148|NCT04195698|449352488|FG000|Overall Study|Adverse Event|4|||
124924149|NCT04195698|449352489|FG001|Overall Study|Adverse Event|11|||
124924150|NCT04195698|449352488|FG000|Overall Study|Withdrawal by Subject|9|||
124924151|NCT04195698|449352489|FG001|Overall Study|Withdrawal by Subject|10|||
124924152|NCT04195698|449352488|FG000|Overall Study|Lost to Follow-up|5|||
124454174|NCT04655144|447622612|FG001|Overall Study|Unilateral embolization|1|||
124454175|NCT04490018|447622613|FG000|Overall Study|Protocol Violation|0|||
124762596|NCT01384734|448755932|FG004|Overall Study|Lack of Efficacy|2|||
124924153|NCT04195698|449352489|FG001|Overall Study|Lost to Follow-up|4|||
124924154|NCT04195698|449352488|FG000|Overall Study|Lack of Efficacy|2|||
124924155|NCT04195698|449352489|FG001|Overall Study|Lack of Efficacy|10|||
124762597|NCT01384734|448755928|FG000|Overall Study|Lost to Follow-up|5|||
124762598|NCT01384734|448755929|FG001|Overall Study|Lost to Follow-up|3|||
124924156|NCT04195698|449352488|FG000|Overall Study|Other|5|||
124924157|NCT04195698|449352489|FG001|Overall Study|Other|4|||
124924158|NCT05459688|449352490|FG000|Overall Study|Lost to Follow-up|6|||
124924159|NCT05459688|449352490|FG000|Overall Study|Physician Decision|1|||
124924160|NCT05459688|449352490|FG000|Overall Study|Withdrawal by Subject|19|||
124924161|NCT05459688|449352490|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
124924162|NCT01959425|449352491|FG000|Overall Study|Withdrawal by Subject|5|||
124924163|NCT01959425|449352492|FG001|Overall Study|Withdrawal by Subject|4|||
124924164|NCT01959425|449352491|FG000|Overall Study|Lost to Follow-up|1|||
124924165|NCT01959425|449352492|FG001|Overall Study|Lost to Follow-up|0|||
124924166|NCT01959425|449352491|FG000|Overall Study|Discontinued Subjects|6|||
124924167|NCT01959425|449352492|FG001|Overall Study|Discontinued Subjects|4|||
124924168|NCT04625283|449352493|FG000|Overall Study|post randomization exclusion|28|||
124924169|NCT04625283|449352494|FG001|Overall Study|post randomization exclusion|20|||
124924170|NCT04632992|449352498|FG000|Overall Study|Adverse Event|0|||
124924171|NCT04632992|449352499|FG001|Overall Study|Adverse Event|0|||
124924172|NCT04632992|449352500|FG002|Overall Study|Adverse Event|0|||
124924173|NCT04632992|449352501|FG003|Overall Study|Adverse Event|0|||
124545847|NCT00471237|447954418|FG006|Overall Study|Adverse Event|0|||
124762599|NCT01384734|448755930|FG002|Overall Study|Lost to Follow-up|3|||
124762600|NCT01384734|448755931|FG003|Overall Study|Lost to Follow-up|8|||
124762601|NCT01384734|448755932|FG004|Overall Study|Lost to Follow-up|5|||
124762602|NCT01384734|448755928|FG000|Overall Study|Non-compliance with study drug|1|||
124762603|NCT01384734|448755929|FG001|Overall Study|Non-compliance with study drug|2|||
124762604|NCT01384734|448755930|FG002|Overall Study|Non-compliance with study drug|6|||
124762605|NCT01384734|448755931|FG003|Overall Study|Non-compliance with study drug|0|||
124762606|NCT01384734|448755932|FG004|Overall Study|Non-compliance with study drug|2|||
124762607|NCT01384734|448755928|FG000|Overall Study|Pregnancy|0|||
124762608|NCT01384734|448755929|FG001|Overall Study|Pregnancy|1|||
124762609|NCT01384734|448755930|FG002|Overall Study|Pregnancy|0|||
124762610|NCT01384734|448755931|FG003|Overall Study|Pregnancy|0|||
124762611|NCT01384734|448755932|FG004|Overall Study|Pregnancy|1|||
124762612|NCT01384734|448755928|FG000|Overall Study|Sponsor terminated|0|||
124762613|NCT01384734|448755929|FG001|Overall Study|Sponsor terminated|0|||
124762614|NCT01384734|448755930|FG002|Overall Study|Sponsor terminated|0|||
124762615|NCT01384734|448755931|FG003|Overall Study|Sponsor terminated|0|||
124762616|NCT01384734|448755932|FG004|Overall Study|Sponsor terminated|1|||
124762617|NCT01384734|448755928|FG000|Overall Study|Withdrawal by Subject|5|||
124762618|NCT01384734|448755929|FG001|Overall Study|Withdrawal by Subject|5|||
124762619|NCT01384734|448755930|FG002|Overall Study|Withdrawal by Subject|6|||
124762620|NCT01384734|448755931|FG003|Overall Study|Withdrawal by Subject|7|||
124762621|NCT01384734|448755932|FG004|Overall Study|Withdrawal by Subject|9|||
124762622|NCT01384734|448755928|FG000|Overall Study|Investigator relocating|0|||
124762623|NCT01384734|448755929|FG001|Overall Study|Investigator relocating|2|||
124762624|NCT01384734|448755930|FG002|Overall Study|Investigator relocating|0|||
124762625|NCT01384734|448755931|FG003|Overall Study|Investigator relocating|3|||
124762626|NCT01384734|448755932|FG004|Overall Study|Investigator relocating|1|||
124762627|NCT01384734|448755928|FG000|Overall Study|Unable to come back for visit|1|||
124762628|NCT01384734|448755929|FG001|Overall Study|Unable to come back for visit|0|||
124762629|NCT01384734|448755930|FG002|Overall Study|Unable to come back for visit|1|||
124762630|NCT01384734|448755931|FG003|Overall Study|Unable to come back for visit|1|||
124762631|NCT01384734|448755932|FG004|Overall Study|Unable to come back for visit|0|||
124762632|NCT01384734|448755928|FG000|Overall Study|Prison|0|||
124762633|NCT01384734|448755929|FG001|Overall Study|Prison|0|||
124762634|NCT01384734|448755930|FG002|Overall Study|Prison|1|||
124762635|NCT01384734|448755931|FG003|Overall Study|Prison|0|||
124762636|NCT01384734|448755932|FG004|Overall Study|Prison|0|||
124762637|NCT01384734|448755928|FG000|Overall Study|As per Exclusion criteria|0|||
124762638|NCT01384734|448755929|FG001|Overall Study|As per Exclusion criteria|1|||
124924174|NCT04632992|449352502|FG004|Overall Study|Adverse Event|0|||
124924175|NCT04632992|449352503|FG005|Overall Study|Adverse Event|0|||
124924176|NCT04632992|449352504|FG006|Overall Study|Adverse Event|0|||
124545848|NCT00471237|447954412|FG000|Overall Study|Lost to Follow-up|1|||
124924177|NCT04632992|449352505|FG007|Overall Study|Adverse Event|0|||
124924178|NCT04632992|449352506|FG008|Overall Study|Adverse Event|0|||
124924179|NCT04632992|449352507|FG009|Overall Study|Adverse Event|0|||
124762639|NCT01384734|448755930|FG002|Overall Study|As per Exclusion criteria|0|||
124762640|NCT01384734|448755931|FG003|Overall Study|As per Exclusion criteria|0|||
124762641|NCT01384734|448755932|FG004|Overall Study|As per Exclusion criteria|0|||
124762642|NCT01384734|448755928|FG000|Overall Study|Missed End of treatment visit|0|||
124762643|NCT01384734|448755929|FG001|Overall Study|Missed End of treatment visit|0|||
124924180|NCT04632992|449352508|FG010|Overall Study|Adverse Event|0|||
124924181|NCT04632992|449352509|FG011|Overall Study|Adverse Event|0|||
124454176|NCT04490018|447622614|FG001|Overall Study|Protocol Violation|2|||
124454177|NCT04490018|447622615|FG002|Overall Study|Protocol Violation|1|||
124454178|NCT04490018|447622613|FG000|Overall Study|Lost to Follow-up|2|||
124454179|NCT04490018|447622614|FG001|Overall Study|Lost to Follow-up|2|||
124454180|NCT04490018|447622615|FG002|Overall Study|Lost to Follow-up|0|||
124454181|NCT04490018|447622613|FG000|Overall Study|Withdrawal by Subject|2|||
124454182|NCT04490018|447622614|FG001|Overall Study|Withdrawal by Subject|1|||
124454183|NCT04490018|447622615|FG002|Overall Study|Withdrawal by Subject|0|||
124454184|NCT04490018|447622613|FG000|Overall Study|Withdrawal by parent/guardian|2|||
124454185|NCT04490018|447622614|FG001|Overall Study|Withdrawal by parent/guardian|3|||
124454186|NCT04490018|447622615|FG002|Overall Study|Withdrawal by parent/guardian|0|||
124454187|NCT01401842|447622617|FG000|Overall Study|Withdrawal by Subject|3|||
124454188|NCT01401842|447622618|FG001|Overall Study|Withdrawal by Subject|2|||
124454189|NCT01401842|447622617|FG000|Overall Study|academic reason|4|||
124454190|NCT01401842|447622618|FG001|Overall Study|academic reason|1|||
124454191|NCT01401842|447622617|FG000|Overall Study|changed companies|20|||
124454192|NCT01401842|447622618|FG001|Overall Study|changed companies|34|||
124454193|NCT01401842|447622617|FG000|Overall Study|discharged from US Army|3|||
124454194|NCT01401842|447622618|FG001|Overall Study|discharged from US Army|4|||
124762644|NCT01384734|448755930|FG002|Overall Study|Missed End of treatment visit|0|||
124924182|NCT04632992|449352510|FG012|Overall Study|Adverse Event|1|||
124924183|NCT04632992|449352511|FG013|Overall Study|Adverse Event|0|||
124924184|NCT04632992|449352498|FG000|Overall Study|Death|17|||
124924185|NCT04632992|449352499|FG001|Overall Study|Death|1|||
124924186|NCT04632992|449352500|FG002|Overall Study|Death|14|||
124924187|NCT04632992|449352501|FG003|Overall Study|Death|14|||
124924188|NCT04632992|449352502|FG004|Overall Study|Death|13|||
124924189|NCT04632992|449352503|FG005|Overall Study|Death|6|||
124924190|NCT04632992|449352504|FG006|Overall Study|Death|7|||
124924191|NCT04632992|449352505|FG007|Overall Study|Death|12|||
124924192|NCT04632992|449352506|FG008|Overall Study|Death|15|||
124924193|NCT04632992|449352507|FG009|Overall Study|Death|20|||
124924194|NCT04632992|449352508|FG010|Overall Study|Death|8|||
124924195|NCT04632992|449352509|FG011|Overall Study|Death|2|||
124924196|NCT04632992|449352510|FG012|Overall Study|Death|10|||
124924197|NCT04632992|449352511|FG013|Overall Study|Death|1|||
124924198|NCT04632992|449352498|FG000|Overall Study|Lost to Follow-up|1|||
124924199|NCT04632992|449352499|FG001|Overall Study|Lost to Follow-up|0|||
124924200|NCT04632992|449352500|FG002|Overall Study|Lost to Follow-up|1|||
124924201|NCT04632992|449352501|FG003|Overall Study|Lost to Follow-up|0|||
124924202|NCT04632992|449352502|FG004|Overall Study|Lost to Follow-up|2|||
124924203|NCT04632992|449352503|FG005|Overall Study|Lost to Follow-up|0|||
124924204|NCT04632992|449352504|FG006|Overall Study|Lost to Follow-up|1|||
124924205|NCT04632992|449352505|FG007|Overall Study|Lost to Follow-up|1|||
124924206|NCT04632992|449352506|FG008|Overall Study|Lost to Follow-up|1|||
124924207|NCT04632992|449352507|FG009|Overall Study|Lost to Follow-up|1|||
124924208|NCT04632992|449352508|FG010|Overall Study|Lost to Follow-up|2|||
124924209|NCT04632992|449352509|FG011|Overall Study|Lost to Follow-up|0|||
124924210|NCT04632992|449352510|FG012|Overall Study|Lost to Follow-up|0|||
124924211|NCT04632992|449352511|FG013|Overall Study|Lost to Follow-up|0|||
124924212|NCT04632992|449352498|FG000|Overall Study|Reason not Specified|2|||
124924213|NCT04632992|449352499|FG001|Overall Study|Reason not Specified|0|||
124924214|NCT04632992|449352500|FG002|Overall Study|Reason not Specified|1|||
124924215|NCT04632992|449352501|FG003|Overall Study|Reason not Specified|1|||
124924216|NCT04632992|449352502|FG004|Overall Study|Reason not Specified|0|||
124924217|NCT04632992|449352503|FG005|Overall Study|Reason not Specified|0|||
124924218|NCT04632992|449352504|FG006|Overall Study|Reason not Specified|0|||
124924219|NCT04632992|449352505|FG007|Overall Study|Reason not Specified|0|||
124924220|NCT04632992|449352506|FG008|Overall Study|Reason not Specified|0|||
124454195|NCT01401842|447622617|FG000|Overall Study|invalid follow-up strength data|1|||
124924221|NCT04632992|449352507|FG009|Overall Study|Reason not Specified|0|||
124454196|NCT01401842|447622618|FG001|Overall Study|invalid follow-up strength data|4|||
124454197|NCT01401842|447622617|FG000|Overall Study|on profile|9|||
124762645|NCT01384734|448755931|FG003|Overall Study|Missed End of treatment visit|1|||
124924222|NCT04632992|449352508|FG010|Overall Study|Reason not Specified|1|||
124924223|NCT04632992|449352509|FG011|Overall Study|Reason not Specified|0|||
124924224|NCT04632992|449352510|FG012|Overall Study|Reason not Specified|0|||
124924225|NCT04632992|449352511|FG013|Overall Study|Reason not Specified|0|||
124924226|NCT04632992|449352498|FG000|Overall Study|Physician Decision|0|||
124454198|NCT01401842|447622618|FG001|Overall Study|on profile|5|||
124454199|NCT01401842|447622617|FG000|Overall Study|other/unknown|28|||
124454200|NCT01401842|447622618|FG001|Overall Study|other/unknown|17|||
124924227|NCT04632992|449352499|FG001|Overall Study|Physician Decision|0|||
124924228|NCT04632992|449352500|FG002|Overall Study|Physician Decision|0|||
124924229|NCT04632992|449352501|FG003|Overall Study|Physician Decision|2|||
124924230|NCT04632992|449352502|FG004|Overall Study|Physician Decision|1|||
124454201|NCT03337542|447622619|FG000|Overall Study|Withdrew Consent|17|||
124924231|NCT04632992|449352503|FG005|Overall Study|Physician Decision|0|||
124924232|NCT04632992|449352504|FG006|Overall Study|Physician Decision|0|||
124924233|NCT04632992|449352505|FG007|Overall Study|Physician Decision|0|||
124454202|NCT03337542|447622619|FG000|Overall Study|Allergic Adverse Event|1|||
124454203|NCT03337542|447622619|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
124454204|NCT03337542|447622619|FG000|Overall Study|Lost to Follow-up|1|||
124454205|NCT03337542|447622619|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
124454206|NCT00282295|447622620|FG000|Overall Study|Adverse Event|0|||
124454207|NCT00282295|447622621|FG001|Overall Study|Adverse Event|1|||
124454208|NCT00282295|447622622|FG002|Overall Study|Adverse Event|0|||
124454209|NCT00282295|447622620|FG000|Overall Study|Serious Adverse Events|0|||
124454210|NCT00282295|447622621|FG001|Overall Study|Serious Adverse Events|0|||
124454211|NCT00282295|447622622|FG002|Overall Study|Serious Adverse Events|1|||
124454212|NCT00282295|447622620|FG000|Overall Study|Protocol Violation|0|||
124454213|NCT00282295|447622621|FG001|Overall Study|Protocol Violation|2|||
124454214|NCT00282295|447622622|FG002|Overall Study|Protocol Violation|1|||
124454215|NCT00282295|447622620|FG000|Overall Study|Withdrawal by Subject|2|||
124454216|NCT00282295|447622621|FG001|Overall Study|Withdrawal by Subject|6|||
124454217|NCT00282295|447622622|FG002|Overall Study|Withdrawal by Subject|4|||
124454218|NCT00282295|447622620|FG000|Overall Study|Lost to Follow-up|1|||
124454219|NCT00282295|447622621|FG001|Overall Study|Lost to Follow-up|7|||
124454220|NCT00282295|447622622|FG002|Overall Study|Lost to Follow-up|2|||
124545849|NCT00471237|447954413|FG001|Overall Study|Lost to Follow-up|1|||
124545850|NCT00471237|447954414|FG002|Overall Study|Lost to Follow-up|0|||
124545851|NCT00471237|447954415|FG003|Overall Study|Lost to Follow-up|2|||
124545852|NCT00471237|447954416|FG004|Overall Study|Lost to Follow-up|3|||
124545853|NCT00471237|447954417|FG005|Overall Study|Lost to Follow-up|0|||
124545854|NCT00471237|447954418|FG006|Overall Study|Lost to Follow-up|0|||
124545855|NCT00471237|447954412|FG000|Overall Study|Protocol Violation|3|||
124545856|NCT00471237|447954413|FG001|Overall Study|Protocol Violation|6|||
124545857|NCT00471237|447954414|FG002|Overall Study|Protocol Violation|3|||
124924234|NCT04632992|449352506|FG008|Overall Study|Physician Decision|0|||
124924235|NCT04632992|449352507|FG009|Overall Study|Physician Decision|0|||
124924236|NCT04632992|449352508|FG010|Overall Study|Physician Decision|0|||
124924237|NCT04632992|449352509|FG011|Overall Study|Physician Decision|0|||
124924238|NCT04632992|449352510|FG012|Overall Study|Physician Decision|3|||
124924239|NCT04632992|449352511|FG013|Overall Study|Physician Decision|0|||
124924240|NCT04632992|449352498|FG000|Overall Study|Progressive Disease|0|||
124924241|NCT04632992|449352499|FG001|Overall Study|Progressive Disease|0|||
124924242|NCT04632992|449352500|FG002|Overall Study|Progressive Disease|0|||
124924243|NCT04632992|449352501|FG003|Overall Study|Progressive Disease|0|||
124924244|NCT04632992|449352502|FG004|Overall Study|Progressive Disease|1|||
124924245|NCT04632992|449352503|FG005|Overall Study|Progressive Disease|0|||
124924246|NCT04632992|449352504|FG006|Overall Study|Progressive Disease|0|||
124924247|NCT04632992|449352505|FG007|Overall Study|Progressive Disease|0|||
124924248|NCT04632992|449352506|FG008|Overall Study|Progressive Disease|0|||
124924249|NCT04632992|449352507|FG009|Overall Study|Progressive Disease|1|||
124924250|NCT04632992|449352508|FG010|Overall Study|Progressive Disease|1|||
124924251|NCT04632992|449352509|FG011|Overall Study|Progressive Disease|0|||
124924252|NCT04632992|449352510|FG012|Overall Study|Progressive Disease|2|||
124924253|NCT04632992|449352511|FG013|Overall Study|Progressive Disease|0|||
124924254|NCT04632992|449352498|FG000|Overall Study|Withdrawal by Subject|4|||
124924255|NCT04632992|449352499|FG001|Overall Study|Withdrawal by Subject|1|||
124545858|NCT00471237|447954415|FG003|Overall Study|Protocol Violation|2|||
124545859|NCT00471237|447954416|FG004|Overall Study|Protocol Violation|2|||
124924256|NCT04632992|449352500|FG002|Overall Study|Withdrawal by Subject|5|||
124454221|NCT00282295|447622620|FG000|Overall Study|Other|0|||
124454222|NCT00282295|447622621|FG001|Overall Study|Other|1|||
124454223|NCT00282295|447622622|FG002|Overall Study|Other|0|||
124454224|NCT00121108|447622625|FG000|Overall Study|Lost to Follow-up|10|||
124545860|NCT00471237|447954417|FG005|Overall Study|Protocol Violation|4|||
124545861|NCT00471237|447954418|FG006|Overall Study|Protocol Violation|1|||
124545862|NCT00471237|447954412|FG000|Overall Study|Withdrawal by Subject|8|||
124924257|NCT04632992|449352501|FG003|Overall Study|Withdrawal by Subject|4|||
124924258|NCT04632992|449352502|FG004|Overall Study|Withdrawal by Subject|3|||
124924259|NCT04632992|449352503|FG005|Overall Study|Withdrawal by Subject|3|||
124924260|NCT04632992|449352504|FG006|Overall Study|Withdrawal by Subject|0|||
124924261|NCT04632992|449352505|FG007|Overall Study|Withdrawal by Subject|5|||
124924262|NCT04632992|449352506|FG008|Overall Study|Withdrawal by Subject|0|||
124924263|NCT04632992|449352507|FG009|Overall Study|Withdrawal by Subject|2|||
124924264|NCT04632992|449352508|FG010|Overall Study|Withdrawal by Subject|8|||
124924265|NCT04632992|449352509|FG011|Overall Study|Withdrawal by Subject|0|||
124924266|NCT04632992|449352510|FG012|Overall Study|Withdrawal by Subject|1|||
124924267|NCT04632992|449352511|FG013|Overall Study|Withdrawal by Subject|1|||
124924268|NCT04187833|449352512|FG000|Overall Study|Withdrawal by Subject|1|||
124924269|NCT03097549|449352513|FG000|Overall Study|Withdrawal by Subject|1|||
124924270|NCT03097549|449352514|FG001|Overall Study|Withdrawal by Subject|0|||
124924271|NCT03097549|449352513|FG000|Overall Study|Lost to Follow-up|1|||
124924272|NCT03097549|449352514|FG001|Overall Study|Lost to Follow-up|0|||
124924273|NCT02547233|449352515|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
124924274|NCT02547233|449352516|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
124924275|NCT02547233|449352515|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
124454225|NCT00121108|447622626|FG001|Overall Study|Lost to Follow-up|22|||
124454226|NCT00121108|447622625|FG000|Overall Study|Withdrawal by Subject|106|||
124924276|NCT02547233|449352516|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
124924277|NCT02547233|449352515|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
124924278|NCT02547233|449352516|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
124924279|NCT02547233|449352515|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
124924280|NCT02547233|449352516|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
124924281|NCT02547233|449352515|FG000|12-month Follow-up|Withdrawal by Subject|10|||
124924282|NCT02547233|449352516|FG001|12-month Follow-up|Withdrawal by Subject|10|||
124924283|NCT02547233|449352515|FG000|12-month Follow-up|Lost to Follow-up|3|||
124454227|NCT00121108|447622626|FG001|Overall Study|Withdrawal by Subject|195|||
124454228|NCT00121108|447622625|FG000|Overall Study|Death|5|||
124454229|NCT00121108|447622626|FG001|Overall Study|Death|8|||
124454230|NCT01380379|447622627|FG000|Overall Study|Pregnancy|1|||
124924284|NCT02547233|449352516|FG001|12-month Follow-up|Lost to Follow-up|3|||
124924285|NCT02547233|449352515|FG000|12-month Follow-up|Lack of Efficacy|1|||
124924286|NCT02547233|449352516|FG001|12-month Follow-up|Lack of Efficacy|2|||
124924287|NCT02547233|449352515|FG000|12-month Follow-up|Protocol Violation|0|||
124924288|NCT02547233|449352516|FG001|12-month Follow-up|Protocol Violation|1|||
124924289|NCT02547233|449352515|FG000|12-month Follow-up|Other|0|||
124924290|NCT02547233|449352516|FG001|12-month Follow-up|Other|1|||
124924291|NCT02146378|449352517|FG000|Overall Study|No information of administration|2|||
124924292|NCT03603600|449352518|FG000|Overall Study|Withdrawal by Subject|5|||
124924293|NCT03603600|449352519|FG001|Overall Study|Withdrawal by Subject|7|||
124924294|NCT03603600|449352518|FG000|Overall Study|Lost to Follow-up|2|||
124924295|NCT03603600|449352519|FG001|Overall Study|Lost to Follow-up|3|||
124924296|NCT03603600|449352518|FG000|Overall Study|Death|3|||
124924297|NCT03603600|449352519|FG001|Overall Study|Death|1|||
124924298|NCT03603600|449352518|FG000|Overall Study|Physician Decision|2|||
124924299|NCT03603600|449352519|FG001|Overall Study|Physician Decision|1|||
124924300|NCT03603600|449352518|FG000|Overall Study|Other reason|1|||
124924301|NCT03603600|449352519|FG001|Overall Study|Other reason|0|||
124924302|NCT05170009|449352520|FG000|Overall Study|Physician Decision|0|||
124924303|NCT05170009|449352521|FG001|Overall Study|Physician Decision|1|||
124924304|NCT03524612|449352522|FG000|Overall Study|Lack of Efficacy|10|||
124924305|NCT03524612|449352522|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
124924306|NCT03524612|449352522|FG000|Overall Study|Adverse Event|10|||
124924307|NCT03524612|449352522|FG000|Overall Study|Withdrawal by Subject|7|||
124924308|NCT03524612|449352522|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
124924309|NCT03524612|449352522|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
124924310|NCT03524612|449352522|FG000|Overall Study|New therapy for study indication|6|||
124924311|NCT03524612|449352522|FG000|Overall Study|Death|3|||
124924312|NCT03524612|449352522|FG000|Overall Study|Lost to Follow-up|2|||
124924313|NCT03524612|449352522|FG000|Overall Study|Protocol Violation|1|||
124924314|NCT05457647|449352523|FG000|Overall Study|Lost to Follow-up|3|||
124924315|NCT04137289|449352526|FG000|Overall Study|Death|0|||
124924316|NCT04137289|449352527|FG001|Overall Study|Death|0|||
124924317|NCT04137289|449352528|FG002|Overall Study|Death|0|||
124924318|NCT04137289|449352529|FG003|Overall Study|Death|0|||
124924319|NCT04137289|449352530|FG004|Overall Study|Death|0|||
124924320|NCT04137289|449352531|FG005|Overall Study|Death|0|||
124924321|NCT04137289|449352532|FG006|Overall Study|Death|1|||
124924322|NCT04137289|449352533|FG007|Overall Study|Death|0|||
124924323|NCT04137289|449352534|FG008|Overall Study|Death|0|||
124924324|NCT04137289|449352526|FG000|Overall Study|Clinical disease progression|0|||
124924325|NCT04137289|449352527|FG001|Overall Study|Clinical disease progression|0|||
124924326|NCT04137289|449352528|FG002|Overall Study|Clinical disease progression|0|||
124924327|NCT04137289|449352529|FG003|Overall Study|Clinical disease progression|4|||
124924328|NCT04137289|449352530|FG004|Overall Study|Clinical disease progression|4|||
124924329|NCT04137289|449352531|FG005|Overall Study|Clinical disease progression|2|||
124924330|NCT04137289|449352532|FG006|Overall Study|Clinical disease progression|5|||
124924331|NCT04137289|449352533|FG007|Overall Study|Clinical disease progression|1|||
124924332|NCT04137289|449352534|FG008|Overall Study|Clinical disease progression|0|||
124454231|NCT03697720|447623749|FG000|Overall Study|Lost to Follow-up|7|||
124454232|NCT02322125|447623754|FG000|Overall Study|Withdrawal by Subject|2|||
124696763|NCT01796470|448509565|FG003|Overall Study|Progressive Disease|2|||
124924333|NCT04137289|449352526|FG000|Overall Study|Lost to Follow-up|0|||
124924334|NCT04137289|449352527|FG001|Overall Study|Lost to Follow-up|0|||
124924335|NCT04137289|449352528|FG002|Overall Study|Lost to Follow-up|0|||
124924336|NCT04137289|449352529|FG003|Overall Study|Lost to Follow-up|1|||
124924337|NCT04137289|449352530|FG004|Overall Study|Lost to Follow-up|0|||
124924338|NCT04137289|449352531|FG005|Overall Study|Lost to Follow-up|0|||
124924339|NCT04137289|449352532|FG006|Overall Study|Lost to Follow-up|0|||
124924340|NCT04137289|449352533|FG007|Overall Study|Lost to Follow-up|0|||
124924341|NCT04137289|449352534|FG008|Overall Study|Lost to Follow-up|0|||
124924342|NCT04137289|449352526|FG000|Overall Study|Adverse Event|0|||
124924343|NCT04137289|449352527|FG001|Overall Study|Adverse Event|0|||
124924344|NCT04137289|449352528|FG002|Overall Study|Adverse Event|1|||
124924345|NCT04137289|449352529|FG003|Overall Study|Adverse Event|0|||
124924346|NCT04137289|449352530|FG004|Overall Study|Adverse Event|0|||
124924347|NCT04137289|449352531|FG005|Overall Study|Adverse Event|1|||
124924348|NCT04137289|449352532|FG006|Overall Study|Adverse Event|0|||
124924349|NCT04137289|449352533|FG007|Overall Study|Adverse Event|0|||
124924350|NCT04137289|449352534|FG008|Overall Study|Adverse Event|0|||
124924351|NCT04137289|449352526|FG000|Overall Study|Lack of clinical benefit|0|||
124924352|NCT04137289|449352527|FG001|Overall Study|Lack of clinical benefit|0|||
124924353|NCT04137289|449352528|FG002|Overall Study|Lack of clinical benefit|0|||
124924354|NCT04137289|449352529|FG003|Overall Study|Lack of clinical benefit|0|||
124924355|NCT04137289|449352530|FG004|Overall Study|Lack of clinical benefit|0|||
124924356|NCT04137289|449352531|FG005|Overall Study|Lack of clinical benefit|0|||
124924357|NCT04137289|449352532|FG006|Overall Study|Lack of clinical benefit|0|||
124924358|NCT04137289|449352533|FG007|Overall Study|Lack of clinical benefit|0|||
124924359|NCT04137289|449352534|FG008|Overall Study|Lack of clinical benefit|1|||
124924360|NCT04137289|449352526|FG000|Overall Study|Objective disease progression|1|||
124924361|NCT04137289|449352527|FG001|Overall Study|Objective disease progression|1|||
124924362|NCT04137289|449352528|FG002|Overall Study|Objective disease progression|6|||
124924363|NCT04137289|449352529|FG003|Overall Study|Objective disease progression|18|||
124924364|NCT04137289|449352530|FG004|Overall Study|Objective disease progression|12|||
124924365|NCT04137289|449352531|FG005|Overall Study|Objective disease progression|20|||
124924366|NCT04137289|449352532|FG006|Overall Study|Objective disease progression|18|||
124924367|NCT04137289|449352533|FG007|Overall Study|Objective disease progression|7|||
124924368|NCT04137289|449352534|FG008|Overall Study|Objective disease progression|6|||
124924369|NCT04492722|449352535|FG000|Overall Study|Adverse Event|7|||
124924370|NCT04492722|449352536|FG001|Overall Study|Adverse Event|2|||
124924371|NCT04492722|449352537|FG002|Overall Study|Adverse Event|3|||
124924372|NCT04492722|449352538|FG003|Overall Study|Adverse Event|0|||
124924373|NCT04492722|449352535|FG000|Overall Study|Death|0|||
124924374|NCT04492722|449352536|FG001|Overall Study|Death|0|||
124924375|NCT04492722|449352537|FG002|Overall Study|Death|0|||
124924376|NCT04492722|449352538|FG003|Overall Study|Death|1|||
124924377|NCT04492722|449352535|FG000|Overall Study|Lost to Follow-up|0|||
124924378|NCT04492722|449352536|FG001|Overall Study|Lost to Follow-up|1|||
124924379|NCT04492722|449352537|FG002|Overall Study|Lost to Follow-up|0|||
124924380|NCT04492722|449352538|FG003|Overall Study|Lost to Follow-up|1|||
124924381|NCT04492722|449352535|FG000|Overall Study|Physician Decision|0|||
124924382|NCT04492722|449352536|FG001|Overall Study|Physician Decision|3|||
124924383|NCT04492722|449352537|FG002|Overall Study|Physician Decision|1|||
124924384|NCT04492722|449352538|FG003|Overall Study|Physician Decision|1|||
124924385|NCT04492722|449352535|FG000|Overall Study|Withdrawal by Subject|6|||
124924386|NCT04492722|449352536|FG001|Overall Study|Withdrawal by Subject|6|||
124924387|NCT04492722|449352537|FG002|Overall Study|Withdrawal by Subject|0|||
124924388|NCT04492722|449352538|FG003|Overall Study|Withdrawal by Subject|3|||
124924389|NCT04492722|449352535|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
124924390|NCT04492722|449352536|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
124924391|NCT04492722|449352537|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
124924392|NCT04492722|449352538|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
124924393|NCT04492722|449352535|FG000|Overall Study|Due to Covid-19 pandemic|7|||
124924394|NCT04492722|449352536|FG001|Overall Study|Due to Covid-19 pandemic|3|||
124924395|NCT04492722|449352537|FG002|Overall Study|Due to Covid-19 pandemic|7|||
124696764|NCT01796470|448509566|FG004|Overall Study|Progressive Disease|0|||
124696765|NCT01796470|448509562|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
124696766|NCT01796470|448509563|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
124924396|NCT04492722|449352538|FG003|Overall Study|Due to Covid-19 pandemic|6|||
124924397|NCT04492722|449352535|FG000|Overall Study|Failure to meet randomisation criteria|2|||
124924398|NCT04492722|449352536|FG001|Overall Study|Failure to meet randomisation criteria|3|||
124924399|NCT04492722|449352537|FG002|Overall Study|Failure to meet randomisation criteria|4|||
124924400|NCT04492722|449352538|FG003|Overall Study|Failure to meet randomisation criteria|2|||
124924401|NCT04492722|449352535|FG000|Overall Study|Early termination from the study|54|||
124924402|NCT04492722|449352536|FG001|Overall Study|Early termination from the study|51|||
124924403|NCT04492722|449352537|FG002|Overall Study|Early termination from the study|50|||
124924404|NCT04492722|449352538|FG003|Overall Study|Early termination from the study|50|||
124924405|NCT04492722|449352535|FG000|Overall Study|Missing|3|||
124696767|NCT01796470|448509564|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
124696768|NCT01796470|448509565|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
124696769|NCT01796470|448509566|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
124924406|NCT04492722|449352536|FG001|Overall Study|Missing|0|||
124924407|NCT04492722|449352537|FG002|Overall Study|Missing|0|||
124924408|NCT04492722|449352538|FG003|Overall Study|Missing|5|||
124924409|NCT04492722|449352535|FG000|Overall Study|Participants who did not receive treatment|0|||
124924410|NCT04492722|449352536|FG001|Overall Study|Participants who did not receive treatment|1|||
124924411|NCT04492722|449352537|FG002|Overall Study|Participants who did not receive treatment|4|||
124696770|NCT01796470|448509562|FG000|Overall Study|Withdrawal by Subject|7|||
124696771|NCT01796470|448509563|FG001|Overall Study|Withdrawal by Subject|0|||
124696772|NCT01796470|448509564|FG002|Overall Study|Withdrawal by Subject|0|||
124696773|NCT01796470|448509565|FG003|Overall Study|Withdrawal by Subject|0|||
124924412|NCT04492722|449352538|FG003|Overall Study|Participants who did not receive treatment|0|||
124924413|NCT05329220|449352539|FG000|Active Trial Period|Adverse Event|0|||
124924414|NCT05329220|449352540|FG001|Active Trial Period|Adverse Event|0|||
124924415|NCT05329220|449352541|FG002|Active Trial Period|Adverse Event|0|||
124924416|NCT05329220|449352542|FG003|Active Trial Period|Adverse Event|0|||
124924417|NCT05329220|449352543|FG004|Active Trial Period|Adverse Event|1|||
124924418|NCT05329220|449352544|FG005|Active Trial Period|Adverse Event|0|||
124924419|NCT05329220|449352539|FG000|Active Trial Period|Lost to Follow-up|0|||
124924420|NCT05329220|449352540|FG001|Active Trial Period|Lost to Follow-up|0|||
124924421|NCT05329220|449352541|FG002|Active Trial Period|Lost to Follow-up|0|||
124924422|NCT05329220|449352542|FG003|Active Trial Period|Lost to Follow-up|0|||
124924423|NCT05329220|449352543|FG004|Active Trial Period|Lost to Follow-up|32|||
124924424|NCT05329220|449352544|FG005|Active Trial Period|Lost to Follow-up|28|||
124924425|NCT05329220|449352539|FG000|Active Trial Period|Physician Decision|0|||
124924426|NCT05329220|449352540|FG001|Active Trial Period|Physician Decision|0|||
124924427|NCT05329220|449352541|FG002|Active Trial Period|Physician Decision|0|||
124924428|NCT05329220|449352542|FG003|Active Trial Period|Physician Decision|0|||
124924429|NCT05329220|449352543|FG004|Active Trial Period|Physician Decision|2|||
124924430|NCT05329220|449352544|FG005|Active Trial Period|Physician Decision|0|||
124924431|NCT05329220|449352539|FG000|Active Trial Period|Protocol Violation|0|||
124924432|NCT05329220|449352540|FG001|Active Trial Period|Protocol Violation|0|||
124924433|NCT05329220|449352541|FG002|Active Trial Period|Protocol Violation|0|||
124924434|NCT05329220|449352542|FG003|Active Trial Period|Protocol Violation|0|||
124924435|NCT05329220|449352543|FG004|Active Trial Period|Protocol Violation|1|||
124924436|NCT05329220|449352544|FG005|Active Trial Period|Protocol Violation|3|||
124924437|NCT05329220|449352539|FG000|Active Trial Period|Withdrawal by Subject|0|||
124924438|NCT05329220|449352540|FG001|Active Trial Period|Withdrawal by Subject|0|||
124924439|NCT05329220|449352541|FG002|Active Trial Period|Withdrawal by Subject|0|||
124924440|NCT05329220|449352542|FG003|Active Trial Period|Withdrawal by Subject|1|||
124924441|NCT05329220|449352543|FG004|Active Trial Period|Withdrawal by Subject|12|||
124924442|NCT05329220|449352544|FG005|Active Trial Period|Withdrawal by Subject|13|||
124924443|NCT05329220|449352539|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
124924444|NCT05329220|449352540|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
124924445|NCT05329220|449352541|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
124924446|NCT05329220|449352542|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
124924447|NCT05329220|449352543|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
124924448|NCT05329220|449352544|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
124924449|NCT05329220|449352539|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
124924450|NCT05329220|449352540|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
124924451|NCT05329220|449352541|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
124924452|NCT05329220|449352542|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
124924453|NCT05329220|449352543|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
124924454|NCT05329220|449352544|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
124924455|NCT05329220|449352539|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
124924456|NCT05329220|449352540|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
124924457|NCT05329220|449352541|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
124924458|NCT05329220|449352542|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
124924459|NCT05329220|449352543|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
124924460|NCT05329220|449352544|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
124924461|NCT05329220|449352539|FG000|Follow-up Period|Adverse Event|0|||
124924462|NCT05329220|449352540|FG001|Follow-up Period|Adverse Event|0|||
124924463|NCT05329220|449352541|FG002|Follow-up Period|Adverse Event|0|||
124924464|NCT05329220|449352542|FG003|Follow-up Period|Adverse Event|0|||
124924465|NCT05329220|449352543|FG004|Follow-up Period|Adverse Event|2|||
124924466|NCT05329220|449352544|FG005|Follow-up Period|Adverse Event|1|||
124924467|NCT05329220|449352539|FG000|Follow-up Period|Death|0|||
124924468|NCT05329220|449352540|FG001|Follow-up Period|Death|0|||
124696774|NCT01796470|448509566|FG004|Overall Study|Withdrawal by Subject|1|||
124696775|NCT01927861|448509567|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
124924469|NCT05329220|449352541|FG002|Follow-up Period|Death|1|||
124924470|NCT05329220|449352542|FG003|Follow-up Period|Death|1|||
124924471|NCT05329220|449352543|FG004|Follow-up Period|Death|0|||
124696776|NCT01927861|448509568|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
124696777|NCT01927861|448509567|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
124696778|NCT01927861|448509568|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
124696779|NCT00987935|448509569|FG000|Overall Study|Progressive disease|3|||
124696780|NCT00987935|448509570|FG001|Overall Study|Progressive disease|2|||
124696781|NCT00987935|448509571|FG002|Overall Study|Progressive disease|3|||
124924472|NCT05329220|449352544|FG005|Follow-up Period|Death|1|||
124924473|NCT05329220|449352539|FG000|Follow-up Period|Lost to Follow-up|0|||
124924474|NCT05329220|449352540|FG001|Follow-up Period|Lost to Follow-up|1|||
124924475|NCT05329220|449352541|FG002|Follow-up Period|Lost to Follow-up|2|||
124924476|NCT05329220|449352542|FG003|Follow-up Period|Lost to Follow-up|2|||
124924477|NCT05329220|449352543|FG004|Follow-up Period|Lost to Follow-up|113|||
124924478|NCT05329220|449352544|FG005|Follow-up Period|Lost to Follow-up|89|||
124924479|NCT05329220|449352539|FG000|Follow-up Period|Physician Decision|0|||
124924480|NCT05329220|449352540|FG001|Follow-up Period|Physician Decision|0|||
124924481|NCT05329220|449352541|FG002|Follow-up Period|Physician Decision|0|||
124924482|NCT05329220|449352542|FG003|Follow-up Period|Physician Decision|0|||
124924483|NCT05329220|449352543|FG004|Follow-up Period|Physician Decision|2|||
124924484|NCT05329220|449352544|FG005|Follow-up Period|Physician Decision|2|||
124924485|NCT05329220|449352539|FG000|Follow-up Period|Protocol Violation|0|||
124924486|NCT05329220|449352540|FG001|Follow-up Period|Protocol Violation|0|||
124924487|NCT05329220|449352541|FG002|Follow-up Period|Protocol Violation|0|||
124924488|NCT05329220|449352542|FG003|Follow-up Period|Protocol Violation|0|||
124924489|NCT05329220|449352543|FG004|Follow-up Period|Protocol Violation|0|||
124924490|NCT05329220|449352544|FG005|Follow-up Period|Protocol Violation|1|||
124924491|NCT05329220|449352539|FG000|Follow-up Period|Withdrawal by Subject|0|||
124924492|NCT05329220|449352540|FG001|Follow-up Period|Withdrawal by Subject|0|||
124924493|NCT05329220|449352541|FG002|Follow-up Period|Withdrawal by Subject|1|||
124924494|NCT05329220|449352542|FG003|Follow-up Period|Withdrawal by Subject|1|||
124924495|NCT05329220|449352543|FG004|Follow-up Period|Withdrawal by Subject|34|||
124924496|NCT05329220|449352544|FG005|Follow-up Period|Withdrawal by Subject|35|||
124924497|NCT05329220|449352539|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
124924498|NCT05329220|449352540|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
124924499|NCT05329220|449352541|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
124924500|NCT05329220|449352542|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
124924501|NCT05329220|449352543|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
124924502|NCT05329220|449352544|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
124924503|NCT05329220|449352539|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
124924504|NCT05329220|449352540|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
124924505|NCT05329220|449352541|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
124924506|NCT05329220|449352542|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
124924507|NCT05329220|449352543|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
124924508|NCT05329220|449352544|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
124924509|NCT05329220|449352539|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
124924510|NCT05329220|449352540|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
124924511|NCT05329220|449352541|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
124924512|NCT05329220|449352542|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
124924513|NCT05329220|449352543|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
124924514|NCT05329220|449352544|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
124696782|NCT00987935|448509572|FG003|Overall Study|Progressive disease|2|||
124924515|NCT05329220|449352539|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
124924516|NCT05329220|449352540|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
124924517|NCT05329220|449352541|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
124924518|NCT05329220|449352542|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
124924519|NCT05329220|449352543|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
124924520|NCT05329220|449352544|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
124924521|NCT05329220|449352539|FG000|Follow-up Period|EARLY TERMINATION|0|||
124924522|NCT05329220|449352540|FG001|Follow-up Period|EARLY TERMINATION|0|||
124924523|NCT05329220|449352541|FG002|Follow-up Period|EARLY TERMINATION|0|||
124924524|NCT05329220|449352542|FG003|Follow-up Period|EARLY TERMINATION|0|||
124924525|NCT05329220|449352543|FG004|Follow-up Period|EARLY TERMINATION|0|||
124924526|NCT05329220|449352544|FG005|Follow-up Period|EARLY TERMINATION|1|||
124924527|NCT05329220|449352539|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
124924528|NCT05329220|449352540|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
124924529|NCT05329220|449352541|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
124924530|NCT05329220|449352542|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
124924531|NCT05329220|449352543|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
124924532|NCT05329220|449352544|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
124545863|NCT00471237|447954413|FG001|Overall Study|Withdrawal by Subject|6|||
124696783|NCT00987935|448509573|FG004|Overall Study|Progressive disease|5|||
124696784|NCT00987935|448509574|FG005|Overall Study|Progressive disease|3|||
124696785|NCT00987935|448509575|FG006|Overall Study|Progressive disease|9|||
124696786|NCT00987935|448509576|FG007|Overall Study|Progressive disease|48|||
124696787|NCT00987935|448509577|FG008|Overall Study|Progressive disease|23|||
124696788|NCT00987935|448509569|FG000|Overall Study|Adverse Event|0|||
124696789|NCT00987935|448509570|FG001|Overall Study|Adverse Event|1|||
124696790|NCT00987935|448509571|FG002|Overall Study|Adverse Event|0|||
124696791|NCT00987935|448509572|FG003|Overall Study|Adverse Event|1|||
124696792|NCT00987935|448509573|FG004|Overall Study|Adverse Event|1|||
124696793|NCT00987935|448509574|FG005|Overall Study|Adverse Event|0|||
124696794|NCT00987935|448509575|FG006|Overall Study|Adverse Event|2|||
124696795|NCT00987935|448509576|FG007|Overall Study|Adverse Event|10|||
124696796|NCT00987935|448509577|FG008|Overall Study|Adverse Event|6|||
124696797|NCT00987935|448509569|FG000|Overall Study|Refused to continue taking trial med.|1|||
124696798|NCT00987935|448509570|FG001|Overall Study|Refused to continue taking trial med.|0|||
124696799|NCT00987935|448509571|FG002|Overall Study|Refused to continue taking trial med.|0|||
124696800|NCT00987935|448509572|FG003|Overall Study|Refused to continue taking trial med.|0|||
124696801|NCT00987935|448509573|FG004|Overall Study|Refused to continue taking trial med.|1|||
124696802|NCT00987935|448509574|FG005|Overall Study|Refused to continue taking trial med.|0|||
124696803|NCT00987935|448509575|FG006|Overall Study|Refused to continue taking trial med.|4|||
124696804|NCT00987935|448509576|FG007|Overall Study|Refused to continue taking trial med.|4|||
124696805|NCT00987935|448509577|FG008|Overall Study|Refused to continue taking trial med.|2|||
124696806|NCT00987935|448509569|FG000|Overall Study|Reason other than those specified above|0|||
124696807|NCT00987935|448509570|FG001|Overall Study|Reason other than those specified above|0|||
124696808|NCT00987935|448509571|FG002|Overall Study|Reason other than those specified above|0|||
124696809|NCT00987935|448509572|FG003|Overall Study|Reason other than those specified above|0|||
124696810|NCT00987935|448509573|FG004|Overall Study|Reason other than those specified above|0|||
124696811|NCT00987935|448509574|FG005|Overall Study|Reason other than those specified above|0|||
124696812|NCT00987935|448509575|FG006|Overall Study|Reason other than those specified above|0|||
124696813|NCT00987935|448509576|FG007|Overall Study|Reason other than those specified above|0|||
124696814|NCT00987935|448509577|FG008|Overall Study|Reason other than those specified above|1|||
124696815|NCT01089543|448509578|FG000|Overall Study|Withdrawal by Subject|2|||
124696816|NCT01089543|448509579|FG001|Overall Study|Withdrawal by Subject|3|||
124696817|NCT01089543|448509580|FG002|Overall Study|Withdrawal by Subject|3|||
124696818|NCT01089543|448509581|FG003|Overall Study|Withdrawal by Subject|1|||
124696819|NCT01089543|448509578|FG000|Overall Study|Physician Decision|1|||
124696820|NCT01089543|448509579|FG001|Overall Study|Physician Decision|0|||
124696821|NCT01089543|448509580|FG002|Overall Study|Physician Decision|0|||
124696822|NCT01089543|448509581|FG003|Overall Study|Physician Decision|1|||
124696823|NCT01089543|448509578|FG000|Overall Study|Adverse Event|0|||
124696824|NCT01089543|448509579|FG001|Overall Study|Adverse Event|1|||
124696825|NCT01089543|448509580|FG002|Overall Study|Adverse Event|0|||
124924533|NCT05329220|449352539|FG000|Follow-up Period|DROPPED|0|||
124924534|NCT05329220|449352540|FG001|Follow-up Period|DROPPED|0|||
124924535|NCT05329220|449352541|FG002|Follow-up Period|DROPPED|0|||
124924536|NCT05329220|449352542|FG003|Follow-up Period|DROPPED|0|||
124924537|NCT05329220|449352543|FG004|Follow-up Period|DROPPED|0|||
124924538|NCT05329220|449352544|FG005|Follow-up Period|DROPPED|1|||
124924539|NCT05329220|449352539|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
124924540|NCT05329220|449352540|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
124924541|NCT05329220|449352541|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
124924542|NCT05329220|449352542|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
124924543|NCT05329220|449352543|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
124924544|NCT05329220|449352544|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
124924545|NCT02601313|449352545|FG000|Overall Study|Death|2|||
124924546|NCT02601313|449352546|FG001|Overall Study|Death|41|||
124924547|NCT02601313|449352547|FG002|Overall Study|Death|6|||
124924548|NCT02601313|449352545|FG000|Overall Study|Enrolled but never treated|0|||
124924549|NCT02601313|449352546|FG001|Overall Study|Enrolled but never treated|6|||
124924550|NCT02601313|449352547|FG002|Overall Study|Enrolled but never treated|3|||
124924551|NCT02601313|449352545|FG000|Overall Study|Enrolled, did not initiate AC|4|||
124924552|NCT02601313|449352546|FG001|Overall Study|Enrolled, did not initiate AC|0|||
124924553|NCT02601313|449352547|FG002|Overall Study|Enrolled, did not initiate AC|0|||
124924554|NCT02601313|449352545|FG000|Overall Study|Full consent withdrawal|0|||
124924555|NCT02601313|449352546|FG001|Overall Study|Full consent withdrawal|3|||
124924556|NCT02601313|449352547|FG002|Overall Study|Full consent withdrawal|2|||
124924557|NCT02601313|449352545|FG000|Overall Study|Lost to Follow-up|0|||
124924558|NCT02601313|449352546|FG001|Overall Study|Lost to Follow-up|1|||
124924559|NCT02601313|449352547|FG002|Overall Study|Lost to Follow-up|1|||
124924560|NCT03766009|449354511|FG000|Usual Care|Death|0|||
124924561|NCT03766009|449354512|FG001|Usual Care|Death|0|||
124924562|NCT03766009|449354513|FG002|Usual Care|Death|0|||
124924563|NCT03766009|449354514|FG003|Usual Care|Death|1|||
124924564|NCT03766009|449354515|FG004|Usual Care|Death|0|||
124924565|NCT03766009|449354516|FG005|Usual Care|Death|0|||
124924566|NCT03766009|449354511|FG000|Usual Care|Lost to Follow-up|0|||
124924567|NCT03766009|449354512|FG001|Usual Care|Lost to Follow-up|0|||
124924568|NCT03766009|449354513|FG002|Usual Care|Lost to Follow-up|0|||
124454233|NCT00766038|447623758|FG000|Overall Study|Lost to Follow-up|15|||
124454234|NCT00766038|447623759|FG001|Overall Study|Lost to Follow-up|14|||
124454235|NCT00449670|447623760|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
124924569|NCT03766009|449354514|FG003|Usual Care|Lost to Follow-up|1|||
124924570|NCT03766009|449354515|FG004|Usual Care|Lost to Follow-up|0|||
124924571|NCT03766009|449354516|FG005|Usual Care|Lost to Follow-up|0|||
124924572|NCT03766009|449354511|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
124924573|NCT03766009|449354512|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
124924574|NCT03766009|449354513|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
124924575|NCT03766009|449354514|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
124924576|NCT03766009|449354515|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
124924577|NCT03766009|449354516|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
124924578|NCT03766009|449354511|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
124924579|NCT03766009|449354512|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
124924580|NCT03766009|449354513|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
124924581|NCT03766009|449354514|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
124924582|NCT03766009|449354515|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
124924583|NCT03766009|449354516|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
124924584|NCT03766009|449354511|FG000|Usual Care|No treatment or declined surgery|0|||
124924585|NCT03766009|449354512|FG001|Usual Care|No treatment or declined surgery|0|||
124924586|NCT03766009|449354513|FG002|Usual Care|No treatment or declined surgery|0|||
124924587|NCT03766009|449354514|FG003|Usual Care|No treatment or declined surgery|2|||
124454236|NCT00449670|447623761|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
124454237|NCT00449670|447623760|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
124454238|NCT00449670|447623761|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
124454239|NCT00449670|447623760|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
124454240|NCT00449670|447623761|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
124454241|NCT00449670|447623760|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
124454242|NCT00449670|447623761|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
124454243|NCT00449670|447623760|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
124454244|NCT00449670|447623761|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
124454245|NCT00449670|447623760|FG000|Booster Phase (Study no.109873)|Other|0|||
124454246|NCT00449670|447623761|FG001|Booster Phase (Study no.109873)|Other|2|||
124454247|NCT04183790|447623766|FG000|Overall Study|Participants did not rollover to Part B|12|||
124454248|NCT04183790|447623767|FG001|Overall Study|Participants did not rollover to Part B|0|||
124454249|NCT04183790|447623766|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
124454250|NCT04183790|447623767|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
124454251|NCT04183790|447623766|FG000|Overall Study|Commercial drug is available for participant|6|||
124696826|NCT01089543|448509581|FG003|Overall Study|Adverse Event|0|||
124924588|NCT03766009|449354515|FG004|Usual Care|No treatment or declined surgery|0|||
124924589|NCT03766009|449354516|FG005|Usual Care|No treatment or declined surgery|0|||
124924590|NCT03766009|449354511|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
124924591|NCT03766009|449354512|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
124924592|NCT03766009|449354513|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
124924593|NCT03766009|449354514|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
124924594|NCT03766009|449354515|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
124924595|NCT03766009|449354516|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
124924596|NCT03766009|449354511|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
124924597|NCT03766009|449354512|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
124924598|NCT03766009|449354513|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
124924599|NCT03766009|449354514|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
124924600|NCT03766009|449354515|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
124924601|NCT03766009|449354516|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
124924602|NCT03766009|449354511|FG000|Usual Care|Ineligible|0|||
124924603|NCT03766009|449354512|FG001|Usual Care|Ineligible|1|||
124924604|NCT03766009|449354513|FG002|Usual Care|Ineligible|0|||
124924605|NCT03766009|449354514|FG003|Usual Care|Ineligible|0|||
124924606|NCT03766009|449354515|FG004|Usual Care|Ineligible|0|||
124924607|NCT03766009|449354516|FG005|Usual Care|Ineligible|0|||
124924608|NCT03766009|449354511|FG000|Usual Care|Other: Staff turnover|0|||
124924609|NCT03766009|449354512|FG001|Usual Care|Other: Staff turnover|0|||
124924610|NCT03766009|449354513|FG002|Usual Care|Other: Staff turnover|0|||
124924611|NCT03766009|449354514|FG003|Usual Care|Other: Staff turnover|0|||
124924612|NCT03766009|449354515|FG004|Usual Care|Other: Staff turnover|0|||
124454252|NCT04183790|447623767|FG001|Overall Study|Commercial drug is available for participant|0|||
124454253|NCT04183790|447623766|FG000|Overall Study|Adverse Event|1|||
124924613|NCT03766009|449354516|FG005|Usual Care|Other: Staff turnover|2|||
124924614|NCT04552223|449354517|FG000|Overall Study|Withdrawal by Subject|1|||
124924615|NCT03869866|449354518|FG000|Overall Study|Protocol Violation|1|||
124924616|NCT03869866|449354518|FG000|Overall Study|Withdrawal by Subject|3|||
124924617|NCT00506519|449354520|FG000|Overall Study|Death|4|||
124924618|NCT00506519|449354521|FG001|Overall Study|Death|6|||
124924619|NCT00506519|449354522|FG002|Overall Study|Death|0|||
124924620|NCT00506519|449354520|FG000|Overall Study|Adverse Event|1|||
124924621|NCT00506519|449354521|FG001|Overall Study|Adverse Event|0|||
124924622|NCT00506519|449354522|FG002|Overall Study|Adverse Event|0|||
124454254|NCT04183790|447623767|FG001|Overall Study|Adverse Event|0|||
124454255|NCT04183790|447623766|FG000|Overall Study|Not enrolled in 107 study|0|||
124454256|NCT04183790|447623767|FG001|Overall Study|Not enrolled in 107 study|2|||
124454257|NCT01251653|447623768|FG000|Overall Study|Progressive Disease|1|||
124454258|NCT01251653|447623769|FG001|Overall Study|Progressive Disease|7|||
124454259|NCT01251653|447623770|FG002|Overall Study|Progressive Disease|16|||
124454260|NCT01251653|447623771|FG003|Overall Study|Progressive Disease|4|||
124454261|NCT01251653|447623772|FG004|Overall Study|Progressive Disease|0|||
124454262|NCT01251653|447623773|FG005|Overall Study|Progressive Disease|17|||
124454263|NCT01251653|447623774|FG006|Overall Study|Progressive Disease|14|||
124924623|NCT01186367|449354523|FG000|Overall Study|Lost to Follow-up|7|||
124924624|NCT01186367|449354524|FG001|Overall Study|Lost to Follow-up|4|||
124924625|NCT01186367|449354525|FG002|Overall Study|Lost to Follow-up|7|||
124924626|NCT01186367|449354523|FG000|Overall Study|Did not receive study treatment|0|||
124924627|NCT01186367|449354524|FG001|Overall Study|Did not receive study treatment|1|||
124924628|NCT01186367|449354525|FG002|Overall Study|Did not receive study treatment|0|||
124924629|NCT02975882|449354526|FG000|Overall Study|Adverse Event|1|||
124924630|NCT02975882|449354527|FG001|Overall Study|Adverse Event|2|||
124924631|NCT02975882|449354528|FG002|Overall Study|Adverse Event|1|||
124924632|NCT02975882|449354529|FG003|Overall Study|Adverse Event|1|||
124924633|NCT02975882|449354526|FG000|Overall Study|Death|0|||
124924634|NCT02975882|449354527|FG001|Overall Study|Death|1|||
124924635|NCT02975882|449354528|FG002|Overall Study|Death|0|||
124924636|NCT02975882|449354529|FG003|Overall Study|Death|0|||
124924637|NCT02975882|449354526|FG000|Overall Study|Lack of Efficacy|3|||
124924638|NCT02975882|449354527|FG001|Overall Study|Lack of Efficacy|7|||
124924639|NCT02975882|449354528|FG002|Overall Study|Lack of Efficacy|4|||
124924640|NCT02975882|449354529|FG003|Overall Study|Lack of Efficacy|3|||
124924641|NCT02975882|449354526|FG000|Overall Study|Physician Decision|0|||
124924642|NCT02975882|449354527|FG001|Overall Study|Physician Decision|2|||
124924643|NCT02975882|449354528|FG002|Overall Study|Physician Decision|4|||
124924644|NCT02975882|449354529|FG003|Overall Study|Physician Decision|2|||
124924645|NCT02975882|449354526|FG000|Overall Study|Ineligible|0|||
124454264|NCT01251653|447623775|FG007|Overall Study|Progressive Disease|7|||
124454265|NCT01251653|447623776|FG008|Overall Study|Progressive Disease|5|||
124454266|NCT01251653|447623768|FG000|Overall Study|Dose-limiting toxicity|0|||
124454267|NCT01251653|447623769|FG001|Overall Study|Dose-limiting toxicity|1|||
124454268|NCT01251653|447623770|FG002|Overall Study|Dose-limiting toxicity|1|||
124454269|NCT01251653|447623771|FG003|Overall Study|Dose-limiting toxicity|1|||
124454270|NCT01251653|447623772|FG004|Overall Study|Dose-limiting toxicity|0|||
124454271|NCT01251653|447623773|FG005|Overall Study|Dose-limiting toxicity|0|||
124454272|NCT01251653|447623774|FG006|Overall Study|Dose-limiting toxicity|2|||
124454273|NCT01251653|447623775|FG007|Overall Study|Dose-limiting toxicity|0|||
124454274|NCT01251653|447623776|FG008|Overall Study|Dose-limiting toxicity|0|||
124454275|NCT01251653|447623768|FG000|Overall Study|Adverse Event|1|||
124454276|NCT01251653|447623769|FG001|Overall Study|Adverse Event|0|||
124454277|NCT01251653|447623770|FG002|Overall Study|Adverse Event|2|||
124454278|NCT01251653|447623771|FG003|Overall Study|Adverse Event|1|||
124454279|NCT01251653|447623772|FG004|Overall Study|Adverse Event|1|||
124454280|NCT01251653|447623773|FG005|Overall Study|Adverse Event|0|||
124924646|NCT02975882|449354527|FG001|Overall Study|Ineligible|1|||
124454281|NCT01251653|447623774|FG006|Overall Study|Adverse Event|2|||
124454282|NCT01251653|447623775|FG007|Overall Study|Adverse Event|2|||
124924647|NCT02975882|449354528|FG002|Overall Study|Ineligible|0|||
124924648|NCT02975882|449354529|FG003|Overall Study|Ineligible|0|||
124454283|NCT01251653|447623776|FG008|Overall Study|Adverse Event|1|||
124924649|NCT02737436|449354530|FG000|Washout Period|Lost to Follow-up|5|||
124924650|NCT02737436|449354531|FG001|Washout Period|Lost to Follow-up|11|||
124924651|NCT02737436|449354530|FG000|Data Analysis|Scanning data problems|5|||
124924652|NCT02737436|449354531|FG001|Data Analysis|Scanning data problems|8|||
124924653|NCT02105766|449354532|FG000|Overall Study|Physician Decision|1|||
124924654|NCT02105766|449354533|FG001|Overall Study|Physician Decision|1|||
124454284|NCT01251653|447623768|FG000|Overall Study|Withdrawal by Subject|1|||
124454285|NCT01251653|447623769|FG001|Overall Study|Withdrawal by Subject|0|||
124924655|NCT02105766|449354534|FG002|Overall Study|Physician Decision|0|||
124924656|NCT02105766|449354532|FG000|Overall Study|Lost to Follow-up|2|||
124924657|NCT02105766|449354533|FG001|Overall Study|Lost to Follow-up|0|||
124924658|NCT02105766|449354534|FG002|Overall Study|Lost to Follow-up|0|||
124924659|NCT02105766|449354532|FG000|Overall Study|Death|1|||
124924660|NCT02105766|449354533|FG001|Overall Study|Death|1|||
124924661|NCT02105766|449354534|FG002|Overall Study|Death|0|||
124924662|NCT03701399|449354535|FG000|Overall Study|Adverse Event|3|||
124924663|NCT03701399|449354536|FG001|Overall Study|Adverse Event|5|||
124924664|NCT03701399|449354535|FG000|Overall Study|Withdrawal by Subject|6|||
124924665|NCT03701399|449354536|FG001|Overall Study|Withdrawal by Subject|3|||
124924666|NCT03701399|449354535|FG000|Overall Study|Investigators decision|1|||
124924667|NCT03701399|449354536|FG001|Overall Study|Investigators decision|2|||
124924668|NCT03701399|449354535|FG000|Overall Study|Lost to Follow-up|1|||
124924669|NCT03701399|449354536|FG001|Overall Study|Lost to Follow-up|2|||
124924670|NCT03701399|449354535|FG000|Overall Study|Death|1|||
124924671|NCT03701399|449354536|FG001|Overall Study|Death|1|||
124924672|NCT03701399|449354535|FG000|Overall Study|Randomized but not treated|1|||
124924673|NCT03701399|449354536|FG001|Overall Study|Randomized but not treated|0|||
124924674|NCT03134196|449354544|FG000|Overall Study|Death|2|||
124924675|NCT03134196|449354545|FG001|Overall Study|Death|1|||
124924676|NCT03134196|449354544|FG000|Overall Study|Lost to Follow-up|13|||
124924677|NCT03134196|449354545|FG001|Overall Study|Lost to Follow-up|15|||
124924678|NCT03134196|449354544|FG000|Overall Study|Physician Decision|0|||
124924679|NCT03134196|449354545|FG001|Overall Study|Physician Decision|1|||
124924680|NCT03134196|449354544|FG000|Overall Study|Withdrawal by Subject|19|||
124924681|NCT03134196|449354545|FG001|Overall Study|Withdrawal by Subject|12|||
124924682|NCT03134196|449354544|FG000|Overall Study|Site Unable to Contact Participant|2|||
124924683|NCT03134196|449354545|FG001|Overall Study|Site Unable to Contact Participant|0|||
124924684|NCT03134196|449354544|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
124924685|NCT03134196|449354545|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
124924686|NCT03134196|449354544|FG000|Overall Study|Scheduling Conflict|1|||
124924687|NCT03134196|449354545|FG001|Overall Study|Scheduling Conflict|0|||
124924688|NCT06516705|449354550|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
124924689|NCT06516705|449354551|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
124924690|NCT06516705|449354550|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
124924691|NCT06516705|449354551|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
124924692|NCT06516705|449354550|FG000|T3 ( 3 Month After Education)|covid-19|1|||
124924693|NCT06516705|449354551|FG001|T3 ( 3 Month After Education)|covid-19|2|||
124924694|NCT06516705|449354550|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
124924695|NCT06516705|449354551|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
124924696|NCT06516705|449354550|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
124924697|NCT06516705|449354551|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
124924698|NCT06516705|449354550|FG000|T4 ( 6 Month After Education)|covid-19|3|||
124924699|NCT06516705|449354551|FG001|T4 ( 6 Month After Education)|covid-19|2|||
124924700|NCT06516705|449354550|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
124924701|NCT06516705|449354551|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
124924702|NCT00753545|449354552|FG000|Overall Study|Death|98|||
124924703|NCT00753545|449354553|FG001|Overall Study|Death|112|||
124924704|NCT00753545|449354552|FG000|Overall Study|Lost to Follow-up|2|||
124924705|NCT00753545|449354553|FG001|Overall Study|Lost to Follow-up|3|||
124924706|NCT00753545|449354552|FG000|Overall Study|Protocol Violation|1|||
124924707|NCT00753545|449354553|FG001|Overall Study|Protocol Violation|0|||
124924708|NCT00753545|449354552|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
124924709|NCT00753545|449354553|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
124924710|NCT06190691|449354554|FG000|Overall Study|Adverse Event|2|||
124924711|NCT06190691|449354555|FG001|Overall Study|Adverse Event|0|||
124924712|NCT06190691|449354556|FG002|Overall Study|Adverse Event|0|||
124924713|NCT06190691|449354557|FG003|Overall Study|Adverse Event|0|||
124924714|NCT05746455|449354558|FG000|Overall Study|Discharged from Clinical Service|1|||
124924715|NCT05746455|449354558|FG000|Overall Study|Lost to Follow-up|1|||
124924716|NCT03016754|449354562|FG000|Overall Study|Death|5|||
124924717|NCT03016754|449354563|FG001|Overall Study|Death|4|||
124924718|NCT03016754|449354564|FG002|Overall Study|Death|5|||
124924719|NCT03016754|449354565|FG003|Overall Study|Death|1|||
124924720|NCT03016754|449354562|FG000|Overall Study|Lost to Follow-up|23|||
124924721|NCT03016754|449354563|FG001|Overall Study|Lost to Follow-up|17|||
124924722|NCT03016754|449354564|FG002|Overall Study|Lost to Follow-up|4|||
124924723|NCT03016754|449354565|FG003|Overall Study|Lost to Follow-up|2|||
124924724|NCT03016754|449354562|FG000|Overall Study|Withdrawal by Subject|6|||
124924725|NCT03016754|449354563|FG001|Overall Study|Withdrawal by Subject|6|||
124924726|NCT03016754|449354564|FG002|Overall Study|Withdrawal by Subject|2|||
124924727|NCT03016754|449354565|FG003|Overall Study|Withdrawal by Subject|2|||
124924728|NCT03016754|449354562|FG000|Overall Study|Other/Unknown|2|||
124924729|NCT03016754|449354563|FG001|Overall Study|Other/Unknown|4|||
124924730|NCT03016754|449354564|FG002|Overall Study|Other/Unknown|2|||
124924731|NCT03016754|449354565|FG003|Overall Study|Other/Unknown|1|||
124924732|NCT03016754|449354562|FG000|Overall Study|Protocol Violation|0|||
124924733|NCT03016754|449354563|FG001|Overall Study|Protocol Violation|0|||
124924734|NCT03016754|449354564|FG002|Overall Study|Protocol Violation|0|||
124924735|NCT03016754|449354565|FG003|Overall Study|Protocol Violation|4|||
124924736|NCT03839940|449354566|FG000|Overall Study|Withdrawal by Subject|3|||
124696827|NCT01248468|448509583|FG000|Overall Study|Administrative problem|1|||
124696828|NCT01248468|448509584|FG001|Overall Study|Administrative problem|0|||
124762646|NCT01384734|448755932|FG004|Overall Study|Missed End of treatment visit|0|||
124762647|NCT01384734|448755928|FG000|Overall Study|Adhesion problem|0|||
124762648|NCT01384734|448755929|FG001|Overall Study|Adhesion problem|0|||
124762649|NCT01384734|448755930|FG002|Overall Study|Adhesion problem|0|||
124762650|NCT01384734|448755931|FG003|Overall Study|Adhesion problem|1|||
124762651|NCT01384734|448755932|FG004|Overall Study|Adhesion problem|0|||
124762652|NCT01384734|448755928|FG000|Overall Study|Early termination|0|||
124762653|NCT01384734|448755929|FG001|Overall Study|Early termination|0|||
124762654|NCT01384734|448755930|FG002|Overall Study|Early termination|0|||
124762655|NCT01384734|448755931|FG003|Overall Study|Early termination|0|||
124762656|NCT01384734|448755932|FG004|Overall Study|Early termination|1|||
124762657|NCT01384734|448755928|FG000|Overall Study|Physician Decision|1|||
124696829|NCT01248468|448509585|FG002|Overall Study|Administrative problem|0|||
124696830|NCT01248468|448509583|FG000|Overall Study|Lost to Follow-up|9|||
124696831|NCT01248468|448509584|FG001|Overall Study|Lost to Follow-up|12|||
124762658|NCT01384734|448755929|FG001|Overall Study|Physician Decision|0|||
124762659|NCT01384734|448755930|FG002|Overall Study|Physician Decision|0|||
124762660|NCT01384734|448755931|FG003|Overall Study|Physician Decision|0|||
124762661|NCT01384734|448755932|FG004|Overall Study|Physician Decision|0|||
124762662|NCT00920855|448755933|FG000|Overall Study|Adverse Event|1|||
124762663|NCT00920855|448755934|FG001|Overall Study|Adverse Event|1|||
124762664|NCT00920855|448755935|FG002|Overall Study|Adverse Event|4|||
124762665|NCT00920855|448755933|FG000|Overall Study|Withdrawal by Subject|2|||
124696832|NCT01248468|448509585|FG002|Overall Study|Lost to Follow-up|4|||
124696833|NCT01248468|448509583|FG000|Overall Study|Pregnancy|1|||
124696834|NCT01248468|448509584|FG001|Overall Study|Pregnancy|0|||
124696835|NCT01248468|448509585|FG002|Overall Study|Pregnancy|0|||
124696836|NCT01248468|448509583|FG000|Overall Study|Withdrawal by Subject|4|||
124696837|NCT01248468|448509584|FG001|Overall Study|Withdrawal by Subject|2|||
124696838|NCT01248468|448509585|FG002|Overall Study|Withdrawal by Subject|0|||
124696839|NCT00345592|448509586|FG000|Overall Study|Death|14|||
124696840|NCT00345592|448509587|FG001|Overall Study|Death|16|||
124696841|NCT00345592|448509586|FG000|Overall Study|Withdrawal by Subject|11|||
124696842|NCT00345592|448509587|FG001|Overall Study|Withdrawal by Subject|8|||
124696843|NCT02176525|448509589|FG000|Overall Study|Adverse Event|0|||
124696844|NCT02176525|448509590|FG001|Overall Study|Adverse Event|0|||
124696845|NCT02176525|448509591|FG002|Overall Study|Adverse Event|0|||
124696846|NCT02176525|448509592|FG003|Overall Study|Adverse Event|1|||
124696847|NCT02176525|448509593|FG004|Overall Study|Adverse Event|1|||
124696848|NCT02176525|448509594|FG005|Overall Study|Adverse Event|0|||
124696849|NCT02176525|448509595|FG006|Overall Study|Adverse Event|1|||
124696850|NCT02176525|448509596|FG007|Overall Study|Adverse Event|0|||
124696851|NCT02176525|448509589|FG000|Overall Study|not treated|1|||
124696852|NCT02176525|448509590|FG001|Overall Study|not treated|0|||
124696853|NCT02176525|448509591|FG002|Overall Study|not treated|0|||
124696854|NCT02176525|448509592|FG003|Overall Study|not treated|0|||
124696855|NCT02176525|448509593|FG004|Overall Study|not treated|0|||
124696856|NCT02176525|448509594|FG005|Overall Study|not treated|1|||
124696857|NCT02176525|448509595|FG006|Overall Study|not treated|0|||
124696858|NCT02176525|448509596|FG007|Overall Study|not treated|0|||
124696859|NCT00468546|448509597|FG000|Week 24 Analysis|Lack of Efficacy|83|||
124696860|NCT00468546|448509598|FG001|Week 24 Analysis|Lack of Efficacy|37|||
124696861|NCT00468546|448509597|FG000|Week 24 Analysis|Refused treatment|5|||
124696862|NCT00468546|448509598|FG001|Week 24 Analysis|Refused treatment|5|||
124696863|NCT00468546|448509597|FG000|Week 24 Analysis|Adverse Event|1|||
124696864|NCT00468546|448509598|FG001|Week 24 Analysis|Adverse Event|8|||
124696865|NCT00468546|448509597|FG000|Week 24 Analysis|Failure to return|3|||
124696866|NCT00468546|448509598|FG001|Week 24 Analysis|Failure to return|4|||
124696867|NCT00468546|448509597|FG000|Week 24 Analysis|Rescue therapy|2|||
124696868|NCT00468546|448509598|FG001|Week 24 Analysis|Rescue therapy|0|||
124696869|NCT00468546|448509597|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
124696870|NCT00468546|448509598|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
124696871|NCT00468546|448509597|FG000|Week 24 Analysis|Due to clinical hold|1|||
124762666|NCT00920855|448755934|FG001|Overall Study|Withdrawal by Subject|1|||
124762667|NCT00920855|448755935|FG002|Overall Study|Withdrawal by Subject|6|||
124762668|NCT00920855|448755933|FG000|Overall Study|Disease progression|2|||
124762669|NCT00920855|448755934|FG001|Overall Study|Disease progression|1|||
124696872|NCT00468546|448509598|FG001|Week 24 Analysis|Due to clinical hold|0|||
124696873|NCT00468546|448509597|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
124762670|NCT00920855|448755935|FG002|Overall Study|Disease progression|10|||
124969559|NCT03520075|449517415|FG006|Phase 2 (Dose Expansion)|Death|0|||
124969560|NCT03520075|449517416|FG007|Phase 2 (Dose Expansion)|Death|0|||
124969561|NCT03520075|449517417|FG008|Phase 2 (Dose Expansion)|Death|0|||
124969562|NCT03520075|449517418|FG009|Phase 2 (Dose Expansion)|Death|0|||
124969563|NCT03520075|449517419|FG010|Phase 2 (Dose Expansion)|Death|0|||
124969564|NCT03520075|449517420|FG011|Phase 2 (Dose Expansion)|Death|0|||
124969565|NCT03520075|449517421|FG012|Phase 2 (Dose Expansion)|Death|0|||
124969566|NCT03520075|449517422|FG013|Phase 2 (Dose Expansion)|Death|20|||
124924737|NCT03839940|449354567|FG001|Overall Study|Withdrawal by Subject|0|||
124924738|NCT03839940|449354566|FG000|Overall Study|Protocol Violation|0|||
124924739|NCT03839940|449354567|FG001|Overall Study|Protocol Violation|1|||
124924740|NCT03839940|449354566|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
124924741|NCT03839940|449354567|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
124924742|NCT03241745|449354568|FG000|Overall Study|Adverse Event|7|||
124924743|NCT03241745|449354568|FG000|Overall Study|Death|1|||
124924744|NCT03241745|449354568|FG000|Overall Study|Withdrawal by Subject|5|||
124924745|NCT03241745|449354568|FG000|Overall Study|Treatment delay >28 days|2|||
124924746|NCT03241745|449354568|FG000|Overall Study|Lack of Efficacy|14|||
124924747|NCT03023410|449354569|FG000|Overall Study|study termination|0|||
124924748|NCT03023410|449354570|FG001|Overall Study|study termination|1|||
124924749|NCT04799899|449354572|FG000|Overall Study|Lost to Follow-up|2|||
124924750|NCT04799899|449354573|FG001|Overall Study|Lost to Follow-up|4|||
124924751|NCT00470704|449354574|FG000|Overall Study|Withdrawal by Subject|4|||
124924752|NCT00470704|449354575|FG001|Overall Study|Withdrawal by Subject|3|||
124924753|NCT00470704|449354574|FG000|Overall Study|Relapse/Progression|37|||
124924754|NCT00470704|449354575|FG001|Overall Study|Relapse/Progression|42|||
124924755|NCT00470704|449354574|FG000|Overall Study|toxicity|0|||
124924756|NCT00470704|449354575|FG001|Overall Study|toxicity|1|||
124924757|NCT04019873|449354576|FG000|Overall Study|Discontinued from the treatment|1|||
124924758|NCT04019873|449354577|FG001|Overall Study|Discontinued from the treatment|39|||
124924759|NCT04019873|449354578|FG002|Overall Study|Discontinued from the treatment|2|||
124924760|NCT04908722|449354587|FG000|Overall Study|Protocol deviation|1|||
124924761|NCT04908722|449354588|FG001|Overall Study|Protocol deviation|0|||
124924762|NCT04908722|449354589|FG002|Overall Study|Protocol deviation|0|||
124924763|NCT04908722|449354590|FG003|Overall Study|Protocol deviation|0|||
124924764|NCT04908722|449354591|FG004|Overall Study|Protocol deviation|0|||
124924765|NCT04908722|449354592|FG005|Overall Study|Protocol deviation|1|||
124924766|NCT04908722|449354587|FG000|Overall Study|Lost to Follow-up|33|||
124924767|NCT04908722|449354588|FG001|Overall Study|Lost to Follow-up|33|||
124924768|NCT04908722|449354589|FG002|Overall Study|Lost to Follow-up|36|||
124924769|NCT04908722|449354590|FG003|Overall Study|Lost to Follow-up|30|||
124924770|NCT04908722|449354591|FG004|Overall Study|Lost to Follow-up|32|||
124924771|NCT04908722|449354592|FG005|Overall Study|Lost to Follow-up|34|||
124924772|NCT04908722|449354587|FG000|Overall Study|Physician Decision|1|||
124924773|NCT04908722|449354588|FG001|Overall Study|Physician Decision|1|||
124924774|NCT04908722|449354589|FG002|Overall Study|Physician Decision|1|||
124924775|NCT04908722|449354590|FG003|Overall Study|Physician Decision|2|||
124924776|NCT04908722|449354591|FG004|Overall Study|Physician Decision|0|||
124924777|NCT04908722|449354592|FG005|Overall Study|Physician Decision|0|||
124924778|NCT04908722|449354587|FG000|Overall Study|Death|1|||
124924779|NCT04908722|449354588|FG001|Overall Study|Death|0|||
124924780|NCT04908722|449354589|FG002|Overall Study|Death|0|||
124924781|NCT04908722|449354590|FG003|Overall Study|Death|0|||
124924782|NCT04908722|449354591|FG004|Overall Study|Death|0|||
124924783|NCT04908722|449354592|FG005|Overall Study|Death|1|||
124924784|NCT04908722|449354587|FG000|Overall Study|Withdrawal by Subject|12|||
124924785|NCT04908722|449354588|FG001|Overall Study|Withdrawal by Subject|8|||
124924786|NCT04908722|449354589|FG002|Overall Study|Withdrawal by Subject|7|||
124924787|NCT04908722|449354590|FG003|Overall Study|Withdrawal by Subject|6|||
124924788|NCT04908722|449354591|FG004|Overall Study|Withdrawal by Subject|12|||
124924789|NCT04908722|449354592|FG005|Overall Study|Withdrawal by Subject|14|||
124924790|NCT04908722|449354587|FG000|Overall Study|Other|3|||
124924791|NCT04908722|449354588|FG001|Overall Study|Other|1|||
124924792|NCT04908722|449354589|FG002|Overall Study|Other|3|||
124924793|NCT04908722|449354590|FG003|Overall Study|Other|2|||
124924794|NCT04908722|449354591|FG004|Overall Study|Other|4|||
124924795|NCT04908722|449354592|FG005|Overall Study|Other|1|||
124924796|NCT04908722|449354587|FG000|Overall Study|Initiated prohibited medication|0|||
124924797|NCT04908722|449354588|FG001|Overall Study|Initiated prohibited medication|0|||
124924798|NCT04908722|449354589|FG002|Overall Study|Initiated prohibited medication|0|||
124454286|NCT01251653|447623770|FG002|Overall Study|Withdrawal by Subject|1|||
124924799|NCT04908722|449354590|FG003|Overall Study|Initiated prohibited medication|1|||
124924800|NCT04908722|449354591|FG004|Overall Study|Initiated prohibited medication|0|||
124924801|NCT04908722|449354592|FG005|Overall Study|Initiated prohibited medication|1|||
124924802|NCT04908722|449354587|FG000|Overall Study|Randomized but not vaccinated|3|||
124924803|NCT04908722|449354588|FG001|Overall Study|Randomized but not vaccinated|1|||
124924804|NCT04908722|449354589|FG002|Overall Study|Randomized but not vaccinated|2|||
124924805|NCT04908722|449354590|FG003|Overall Study|Randomized but not vaccinated|2|||
124924806|NCT04908722|449354591|FG004|Overall Study|Randomized but not vaccinated|3|||
124924807|NCT04908722|449354592|FG005|Overall Study|Randomized but not vaccinated|4|||
124924808|NCT02319759|449354593|FG000|Week 0 - 16|Lack of Efficacy|1|||
124454287|NCT01251653|447623771|FG003|Overall Study|Withdrawal by Subject|0|||
124454288|NCT01251653|447623772|FG004|Overall Study|Withdrawal by Subject|1|||
124924809|NCT02319759|449354594|FG001|Week 0 - 16|Lack of Efficacy|0|||
124924810|NCT02319759|449354595|FG002|Week 0 - 16|Lack of Efficacy|0|||
124924811|NCT02319759|449354596|FG003|Week 0 - 16|Lack of Efficacy|0|||
124924812|NCT02319759|449354597|FG004|Week 0 - 16|Lack of Efficacy|0|||
124924813|NCT02319759|449354593|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
124924814|NCT02319759|449354594|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
124924815|NCT02319759|449354595|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
124924816|NCT02319759|449354596|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
124924817|NCT02319759|449354597|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
124924818|NCT02319759|449354593|FG000|Week 16 - 24|Lack of Efficacy|1|||
124696874|NCT00468546|448509598|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
124696875|NCT00468546|448509597|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
124696876|NCT00468546|448509598|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
124696877|NCT00468546|448509597|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
124924819|NCT02319759|449354594|FG001|Week 16 - 24|Lack of Efficacy|0|||
124924820|NCT02319759|449354595|FG002|Week 16 - 24|Lack of Efficacy|1|||
124924821|NCT02319759|449354596|FG003|Week 16 - 24|Lack of Efficacy|0|||
124924822|NCT02319759|449354597|FG004|Week 16 - 24|Lack of Efficacy|0|||
124924823|NCT02319759|449354593|FG000|Week 16 - 24|Lost to Follow-up|1|||
124924824|NCT02319759|449354594|FG001|Week 16 - 24|Lost to Follow-up|0|||
124454289|NCT01251653|447623773|FG005|Overall Study|Withdrawal by Subject|1|||
124454290|NCT01251653|447623774|FG006|Overall Study|Withdrawal by Subject|0|||
124454291|NCT01251653|447623775|FG007|Overall Study|Withdrawal by Subject|1|||
124454292|NCT01251653|447623776|FG008|Overall Study|Withdrawal by Subject|0|||
124454293|NCT01251653|447623768|FG000|Overall Study|Other reason not mentioned above|0|||
124454294|NCT01251653|447623769|FG001|Overall Study|Other reason not mentioned above|0|||
124454295|NCT01251653|447623770|FG002|Overall Study|Other reason not mentioned above|0|||
124454296|NCT01251653|447623771|FG003|Overall Study|Other reason not mentioned above|0|||
124454297|NCT01251653|447623772|FG004|Overall Study|Other reason not mentioned above|0|||
124454298|NCT01251653|447623773|FG005|Overall Study|Other reason not mentioned above|0|||
124454299|NCT01251653|447623774|FG006|Overall Study|Other reason not mentioned above|0|||
124924825|NCT02319759|449354595|FG002|Week 16 - 24|Lost to Follow-up|0|||
124924826|NCT02319759|449354596|FG003|Week 16 - 24|Lost to Follow-up|0|||
124924827|NCT02319759|449354597|FG004|Week 16 - 24|Lost to Follow-up|0|||
124924828|NCT02319759|449354593|FG000|Week 16 - 24|Withdrawal by Subject|0|||
124924829|NCT02319759|449354594|FG001|Week 16 - 24|Withdrawal by Subject|0|||
124924830|NCT02319759|449354595|FG002|Week 16 - 24|Withdrawal by Subject|2|||
124924831|NCT02319759|449354596|FG003|Week 16 - 24|Withdrawal by Subject|0|||
124924832|NCT02319759|449354597|FG004|Week 16 - 24|Withdrawal by Subject|0|||
124924833|NCT02319759|449354593|FG000|Week 24 - 56|Adverse Event|0|||
124924834|NCT02319759|449354594|FG001|Week 24 - 56|Adverse Event|0|||
124924835|NCT02319759|449354595|FG002|Week 24 - 56|Adverse Event|2|||
124924836|NCT02319759|449354596|FG003|Week 24 - 56|Adverse Event|0|||
124924837|NCT02319759|449354597|FG004|Week 24 - 56|Adverse Event|0|||
124924838|NCT02319759|449354593|FG000|Week 24 - 56|Lack of Efficacy|0|||
124924839|NCT02319759|449354594|FG001|Week 24 - 56|Lack of Efficacy|0|||
124924840|NCT02319759|449354595|FG002|Week 24 - 56|Lack of Efficacy|0|||
124924841|NCT02319759|449354596|FG003|Week 24 - 56|Lack of Efficacy|2|||
124924842|NCT02319759|449354597|FG004|Week 24 - 56|Lack of Efficacy|1|||
124924843|NCT02319759|449354593|FG000|Week 24 - 56|Withdrawal by Subject|0|||
124924844|NCT02319759|449354594|FG001|Week 24 - 56|Withdrawal by Subject|1|||
124924845|NCT02319759|449354595|FG002|Week 24 - 56|Withdrawal by Subject|0|||
124454300|NCT01251653|447623775|FG007|Overall Study|Other reason not mentioned above|2|||
124454301|NCT01251653|447623776|FG008|Overall Study|Other reason not mentioned above|0|||
124454302|NCT00847145|447623777|FG000|Overall Study|AE or Death|0|||
124454303|NCT00847145|447623778|FG001|Overall Study|AE or Death|1|||
124696878|NCT00468546|448509598|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
124696879|NCT00468546|448509597|FG000|Week 24 to Week 104 Analysis|Death|1|||
124696880|NCT00468546|448509598|FG001|Week 24 to Week 104 Analysis|Death|0|||
124696881|NCT00468546|448509597|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
124696882|NCT00468546|448509598|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
124696883|NCT00468546|448509597|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
124696884|NCT00468546|448509598|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
124696885|NCT00468546|448509597|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
124696886|NCT00468546|448509598|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
124696887|NCT00468546|448509597|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
124696888|NCT00468546|448509598|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
124696889|NCT00468546|448509597|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
124696890|NCT00468546|448509598|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
124696891|NCT00468546|448509597|FG000|Week 24 to Week 104 Analysis|Other|17|||
124696892|NCT00468546|448509598|FG001|Week 24 to Week 104 Analysis|Other|14|||
124696893|NCT00472641|448509599|FG000|Overall Study|Lack of Efficacy|3|||
124924846|NCT02319759|449354596|FG003|Week 24 - 56|Withdrawal by Subject|0|||
124924847|NCT02319759|449354597|FG004|Week 24 - 56|Withdrawal by Subject|0|||
124924848|NCT02319759|449354593|FG000|Week 24 - 56|Lost to Follow-up|0|||
124924849|NCT02319759|449354594|FG001|Week 24 - 56|Lost to Follow-up|0|||
124924850|NCT02319759|449354595|FG002|Week 24 - 56|Lost to Follow-up|0|||
124924851|NCT02319759|449354596|FG003|Week 24 - 56|Lost to Follow-up|0|||
124924852|NCT02319759|449354597|FG004|Week 24 - 56|Lost to Follow-up|1|||
124454304|NCT00847145|447623779|FG002|Overall Study|AE or Death|1|||
124454305|NCT00847145|447623780|FG003|Overall Study|AE or Death|0|||
124454306|NCT00847145|447623781|FG004|Overall Study|AE or Death|0|||
124924853|NCT03339713|449354599|FG000|Overall Study|Lost to Follow-up|2|||
124924854|NCT03339713|449354600|FG001|Overall Study|Lost to Follow-up|1|||
124924855|NCT03339713|449354599|FG000|Overall Study|Protocol Violation|1|||
124924856|NCT03339713|449354600|FG001|Overall Study|Protocol Violation|0|||
124924857|NCT03339713|449354599|FG000|Overall Study|Withdrawal by Subject|1|||
124924858|NCT03339713|449354600|FG001|Overall Study|Withdrawal by Subject|1|||
124924859|NCT01902173|449354601|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
124924860|NCT01902173|449354602|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
124924861|NCT01902173|449354603|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
124924862|NCT01902173|449354604|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
124924863|NCT01902173|449354605|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
124924864|NCT01902173|449354606|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
124924865|NCT01902173|449354601|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
124924866|NCT01902173|449354602|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
124924867|NCT01902173|449354603|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
124924868|NCT01902173|449354604|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
124924869|NCT01902173|449354605|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
124924870|NCT01902173|449354606|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
124924871|NCT01902173|449354601|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
124924872|NCT01902173|449354602|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
124924873|NCT01902173|449354603|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
124924874|NCT01902173|449354604|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
124924875|NCT01902173|449354605|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
124924876|NCT01902173|449354606|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
124924877|NCT01902173|449354601|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
124924878|NCT01902173|449354602|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
124924879|NCT01902173|449354603|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
124924880|NCT01902173|449354604|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
124924881|NCT01902173|449354605|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
124924882|NCT01902173|449354606|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
124924883|NCT01902173|449354601|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
124924884|NCT01902173|449354602|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
124924885|NCT01902173|449354603|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
124924886|NCT01902173|449354604|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
124924887|NCT01902173|449354605|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
124924888|NCT01902173|449354606|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
124924889|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
124924890|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
124924891|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
124924892|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
124924893|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
124924894|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
124924895|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
124924896|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
124924897|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
124454307|NCT00847145|447623782|FG005|Overall Study|AE or Death|0|||
124454308|NCT00847145|447623783|FG006|Overall Study|AE or Death|0|||
124454309|NCT00847145|447623784|FG007|Overall Study|AE or Death|0|||
124454310|NCT00847145|447623777|FG000|Overall Study|Withdrawal by Subject|3|||
124454311|NCT00847145|447623778|FG001|Overall Study|Withdrawal by Subject|4|||
124454312|NCT00847145|447623779|FG002|Overall Study|Withdrawal by Subject|6|||
124454313|NCT00847145|447623780|FG003|Overall Study|Withdrawal by Subject|1|||
124454314|NCT00847145|447623781|FG004|Overall Study|Withdrawal by Subject|0|||
124454315|NCT00847145|447623782|FG005|Overall Study|Withdrawal by Subject|0|||
124454316|NCT00847145|447623783|FG006|Overall Study|Withdrawal by Subject|1|||
124454317|NCT00847145|447623784|FG007|Overall Study|Withdrawal by Subject|1|||
124454318|NCT00847145|447623777|FG000|Overall Study|Lost to Follow-up|3|||
124454319|NCT00847145|447623778|FG001|Overall Study|Lost to Follow-up|1|||
124454320|NCT00847145|447623779|FG002|Overall Study|Lost to Follow-up|1|||
124454321|NCT00847145|447623780|FG003|Overall Study|Lost to Follow-up|0|||
124454322|NCT00847145|447623781|FG004|Overall Study|Lost to Follow-up|4|||
124454323|NCT00847145|447623782|FG005|Overall Study|Lost to Follow-up|4|||
124762671|NCT00920855|448755933|FG000|Overall Study|Noncompliance to study medication|0|||
124924898|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
124924899|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
124454324|NCT00847145|447623783|FG006|Overall Study|Lost to Follow-up|8|||
124454325|NCT00847145|447623784|FG007|Overall Study|Lost to Follow-up|2|||
124454326|NCT00847145|447623777|FG000|Overall Study|Inappropriate enrollment|0|||
124454327|NCT00847145|447623778|FG001|Overall Study|Inappropriate enrollment|0|||
124924900|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
124924901|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
124454328|NCT00847145|447623779|FG002|Overall Study|Inappropriate enrollment|0|||
124454329|NCT00847145|447623780|FG003|Overall Study|Inappropriate enrollment|0|||
124454330|NCT00847145|447623781|FG004|Overall Study|Inappropriate enrollment|1|||
124454331|NCT00847145|447623782|FG005|Overall Study|Inappropriate enrollment|0|||
124454332|NCT00847145|447623783|FG006|Overall Study|Inappropriate enrollment|0|||
124454333|NCT00847145|447623784|FG007|Overall Study|Inappropriate enrollment|0|||
124454334|NCT00847145|447623777|FG000|Overall Study|Protocol Violation|0|||
124454335|NCT00847145|447623778|FG001|Overall Study|Protocol Violation|0|||
124454336|NCT00847145|447623779|FG002|Overall Study|Protocol Violation|3|||
124454337|NCT00847145|447623780|FG003|Overall Study|Protocol Violation|0|||
124454338|NCT00847145|447623781|FG004|Overall Study|Protocol Violation|1|||
124454339|NCT00847145|447623782|FG005|Overall Study|Protocol Violation|0|||
124454340|NCT00847145|447623783|FG006|Overall Study|Protocol Violation|0|||
124454341|NCT00847145|447623784|FG007|Overall Study|Protocol Violation|1|||
124454342|NCT02833974|447623786|FG000|Overall Study|Lost to Follow-up|1|||
124454343|NCT02833974|447623787|FG001|Overall Study|Lost to Follow-up|0|||
124454344|NCT02833974|447623786|FG000|Overall Study|Adverse Event|0|||
124454345|NCT02833974|447623787|FG001|Overall Study|Adverse Event|3|||
124454346|NCT01524198|447623788|FG000|Overall Study|Protocol Violation|8|||
124454347|NCT01524198|447623789|FG001|Overall Study|Protocol Violation|6|||
124454348|NCT01524198|447623788|FG000|Overall Study|Withdrawal by Subject|15|||
124454349|NCT01524198|447623789|FG001|Overall Study|Withdrawal by Subject|10|||
124454350|NCT04419610|447623790|FG000|Overall Study|Withdrawal by Subject|3|||
124454351|NCT04419610|447623791|FG001|Overall Study|Withdrawal by Subject|1|||
124454352|NCT04419610|447623790|FG000|Overall Study|Adverse Event|1|||
124454353|NCT04419610|447623791|FG001|Overall Study|Adverse Event|0|||
124454354|NCT04419610|447623790|FG000|Overall Study|discharged early|1|||
124454355|NCT04419610|447623791|FG001|Overall Study|discharged early|1|||
124454356|NCT01439282|447623792|FG000|Overall Study|Adverse Event|5|||
124924902|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
124924903|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
124924904|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
124924905|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
124924906|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
124924907|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
124924908|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
124924909|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
124924910|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
124924911|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
124924912|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
124924913|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
124924914|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
124924915|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
124924916|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
124924917|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
124924918|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
124924919|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
124924920|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
124924921|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
124924922|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
124924923|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
124924924|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
124924925|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
124924926|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
124924927|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
124924928|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
124924929|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
124454357|NCT01439282|447623793|FG001|Overall Study|Adverse Event|0|||
124454358|NCT01439282|447623792|FG000|Overall Study|Withdrawal by Subject|2|||
124454359|NCT01439282|447623793|FG001|Overall Study|Withdrawal by Subject|0|||
124454360|NCT01439282|447623792|FG000|Overall Study|Other|1|||
124454361|NCT01439282|447623793|FG001|Overall Study|Other|1|||
124696894|NCT00472641|448509599|FG000|Overall Study|Adverse Event|3|||
124696895|NCT00472641|448509599|FG000|Overall Study|Lost to Follow-up|1|||
124696896|NCT03721107|448509600|FG000|Overall Study|Adverse Event|1|||
124696897|NCT03721107|448509601|FG001|Overall Study|Adverse Event|1|||
124454362|NCT02232802|447623794|FG000|Period 1|Sponsor request|1|||
124454363|NCT02232802|447623795|FG001|Period 1|Sponsor request|0|||
124696898|NCT03721107|448509602|FG002|Overall Study|Adverse Event|6|||
124924930|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
124924931|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
124924932|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
124762672|NCT00920855|448755934|FG001|Overall Study|Noncompliance to study medication|0|||
124762673|NCT00920855|448755935|FG002|Overall Study|Noncompliance to study medication|1|||
124762674|NCT00920855|448755933|FG000|Overall Study|Response plateau; started maintenance|0|||
124762675|NCT00920855|448755934|FG001|Overall Study|Response plateau; started maintenance|0|||
124762676|NCT00920855|448755935|FG002|Overall Study|Response plateau; started maintenance|1|||
124762677|NCT01290523|448755936|FG000|Overall Study|Death|3|||
124762678|NCT00539994|448755937|FG000|Overall Study|Lost to Follow-up|2|||
124762679|NCT00539994|448755938|FG001|Overall Study|Lost to Follow-up|1|||
124762680|NCT00539994|448755939|FG002|Overall Study|Lost to Follow-up|0|||
124762681|NCT00539994|448755937|FG000|Overall Study|Withdrawal by Subject|1|||
124762682|NCT00539994|448755938|FG001|Overall Study|Withdrawal by Subject|0|||
124762683|NCT00539994|448755939|FG002|Overall Study|Withdrawal by Subject|1|||
124762684|NCT00539994|448755937|FG000|Overall Study|Physician Decision|0|||
124762685|NCT00539994|448755938|FG001|Overall Study|Physician Decision|0|||
124762686|NCT00539994|448755939|FG002|Overall Study|Physician Decision|1|||
124762687|NCT03071263|448755940|FG000|Overall Study|Adverse Event|1|||
124762688|NCT03071263|448755941|FG001|Overall Study|Adverse Event|3|||
124696899|NCT03721107|448509603|FG003|Overall Study|Adverse Event|5|||
124696900|NCT03721107|448509600|FG000|Overall Study|Lost to Follow-up|2|||
124696901|NCT03721107|448509601|FG001|Overall Study|Lost to Follow-up|0|||
124696902|NCT03721107|448509602|FG002|Overall Study|Lost to Follow-up|3|||
124696903|NCT03721107|448509603|FG003|Overall Study|Lost to Follow-up|0|||
124696904|NCT03721107|448509600|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
124696905|NCT03721107|448509601|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
124696906|NCT03721107|448509602|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
124696907|NCT03721107|448509603|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
124696908|NCT03721107|448509600|FG000|Overall Study|Physician Decision|0|||
124696909|NCT03721107|448509601|FG001|Overall Study|Physician Decision|1|||
124696910|NCT03721107|448509602|FG002|Overall Study|Physician Decision|0|||
124696911|NCT03721107|448509603|FG003|Overall Study|Physician Decision|0|||
124696912|NCT03721107|448509600|FG000|Overall Study|Pregnancy|0|||
124696913|NCT03721107|448509601|FG001|Overall Study|Pregnancy|0|||
124696914|NCT03721107|448509602|FG002|Overall Study|Pregnancy|1|||
124696915|NCT03721107|448509603|FG003|Overall Study|Pregnancy|0|||
124762689|NCT03071263|448755940|FG000|Overall Study|Withdrawal by Subject|1|||
124762690|NCT03071263|448755941|FG001|Overall Study|Withdrawal by Subject|3|||
124696916|NCT03721107|448509600|FG000|Overall Study|Withdrawal by Subject|1|||
124762691|NCT03071263|448755940|FG000|Overall Study|Physician Decision|1|||
124454364|NCT02232802|447623794|FG000|Period 1|Adverse Event|1|||
124454365|NCT02232802|447623795|FG001|Period 1|Adverse Event|1|||
124454366|NCT00885703|447623803|FG000|Overall Study|Death|9|||
124454367|NCT00885703|447623804|FG001|Overall Study|Death|7|||
124454368|NCT00885703|447623805|FG002|Overall Study|Death|8|||
124454369|NCT00885703|447623806|FG003|Overall Study|Death|7|||
124454370|NCT00885703|447623807|FG004|Overall Study|Death|7|||
124454371|NCT00885703|447623808|FG005|Overall Study|Death|8|||
124454372|NCT00885703|447623809|FG006|Overall Study|Death|4|||
124454373|NCT00885703|447623803|FG000|Overall Study|Lost to Follow-up|0|||
124454374|NCT00885703|447623804|FG001|Overall Study|Lost to Follow-up|0|||
124454375|NCT00885703|447623805|FG002|Overall Study|Lost to Follow-up|1|||
124454376|NCT00885703|447623806|FG003|Overall Study|Lost to Follow-up|0|||
124454377|NCT00885703|447623807|FG004|Overall Study|Lost to Follow-up|0|||
124454378|NCT00885703|447623808|FG005|Overall Study|Lost to Follow-up|1|||
124454379|NCT00885703|447623809|FG006|Overall Study|Lost to Follow-up|0|||
124454380|NCT00885703|447623803|FG000|Overall Study|Withdrawal by Subject|0|||
124454381|NCT00885703|447623804|FG001|Overall Study|Withdrawal by Subject|0|||
124454382|NCT00885703|447623805|FG002|Overall Study|Withdrawal by Subject|0|||
124454383|NCT00885703|447623806|FG003|Overall Study|Withdrawal by Subject|1|||
124454384|NCT00885703|447623807|FG004|Overall Study|Withdrawal by Subject|3|||
124454385|NCT00885703|447623808|FG005|Overall Study|Withdrawal by Subject|1|||
124454386|NCT00885703|447623809|FG006|Overall Study|Withdrawal by Subject|1|||
124454387|NCT00885703|447623803|FG000|Overall Study|Ineligible (no CM)|1|||
124454388|NCT00885703|447623804|FG001|Overall Study|Ineligible (no CM)|3|||
124762692|NCT03071263|448755941|FG001|Overall Study|Physician Decision|0|||
124454389|NCT00885703|447623805|FG002|Overall Study|Ineligible (no CM)|2|||
124454390|NCT00885703|447623806|FG003|Overall Study|Ineligible (no CM)|1|||
124454391|NCT00885703|447623807|FG004|Overall Study|Ineligible (no CM)|2|||
124454392|NCT00885703|447623808|FG005|Overall Study|Ineligible (no CM)|3|||
124454393|NCT00885703|447623809|FG006|Overall Study|Ineligible (no CM)|1|||
124454394|NCT01183143|447623810|FG000|Overall Study|Protocol Violation|115|||
124454395|NCT01183143|447623810|FG000|Overall Study|Withdrawal by Subject|19|||
124924933|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
124924934|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
124924935|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
124924936|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
124924937|NCT01902173|449354601|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
124924938|NCT01902173|449354602|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
124924939|NCT01902173|449354603|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
124545864|NCT00471237|447954414|FG002|Overall Study|Withdrawal by Subject|5|||
124545865|NCT00471237|447954415|FG003|Overall Study|Withdrawal by Subject|8|||
124545866|NCT00471237|447954416|FG004|Overall Study|Withdrawal by Subject|7|||
124924940|NCT01902173|449354604|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
124924941|NCT01902173|449354605|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
124924942|NCT01902173|449354606|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
124924943|NCT02262728|449354608|FG000|Follow-up Phase (3 Years)|Death|0|||
124924944|NCT02262728|449354609|FG001|Follow-up Phase (3 Years)|Death|1|||
124924945|NCT02262728|449354608|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
124924946|NCT02262728|449354609|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
124924947|NCT02262728|449354608|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
124924948|NCT02262728|449354609|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
124924949|NCT05540665|449354610|FG000|Overall Study|Study terminated by sponsor|6|||
124924950|NCT05540665|449354611|FG001|Overall Study|Study terminated by sponsor|6|||
124924951|NCT05540665|449354612|FG002|Overall Study|Study terminated by sponsor|7|||
124924952|NCT02619838|449354613|FG000|Overall Study|Lost to Follow-up|9|||
124924953|NCT02619838|449354613|FG000|Overall Study|Withdrawal by Subject|15|||
124924954|NCT04066244|449354616|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
124924955|NCT04066244|449354617|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
124924956|NCT04066244|449354618|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
124924957|NCT04066244|449354619|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
124924958|NCT04066244|449354620|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
124924959|NCT04066244|449354621|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
124924960|NCT04066244|449354616|FG000|Part 2 (Cohort 5)|Death|0|||
124924961|NCT04066244|449354617|FG001|Part 2 (Cohort 5)|Death|0|||
124924962|NCT04066244|449354618|FG002|Part 2 (Cohort 5)|Death|0|||
124924963|NCT04066244|449354619|FG003|Part 2 (Cohort 5)|Death|0|||
124924964|NCT04066244|449354620|FG004|Part 2 (Cohort 5)|Death|0|||
124924965|NCT04066244|449354621|FG005|Part 2 (Cohort 5)|Death|2|||
124924966|NCT04066244|449354616|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
124924967|NCT04066244|449354617|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
124924968|NCT04066244|449354618|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
124924969|NCT04066244|449354619|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
124924970|NCT04066244|449354620|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
124924971|NCT04066244|449354621|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
124924972|NCT04066244|449354616|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
124924973|NCT04066244|449354617|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
124924974|NCT04066244|449354618|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
124924975|NCT04066244|449354619|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
124924976|NCT04066244|449354620|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
124924977|NCT04066244|449354621|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
124924978|NCT01073566|449354622|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
124924979|NCT01073566|449354623|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
124924980|NCT05006872|449354645|FG000|Overall Study|Lost to Follow-up|37|||
124924981|NCT05006872|449354646|FG001|Overall Study|Lost to Follow-up|31|||
124924982|NCT04149704|449354648|FG000|Three Month Follow-up|Death|2|||
124924983|NCT04149704|449354649|FG001|Three Month Follow-up|Death|0|||
124924984|NCT04149704|449354650|FG002|Three Month Follow-up|Death|0|||
124924985|NCT04149704|449354651|FG003|Three Month Follow-up|Death|0|||
124924986|NCT04149704|449354648|FG000|Three Month Follow-up|Lost to Follow-up|1|||
124924987|NCT04149704|449354649|FG001|Three Month Follow-up|Lost to Follow-up|4|||
124924988|NCT04149704|449354650|FG002|Three Month Follow-up|Lost to Follow-up|5|||
124924989|NCT04149704|449354651|FG003|Three Month Follow-up|Lost to Follow-up|5|||
124924990|NCT04149704|449354648|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
124924991|NCT04149704|449354649|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
124924992|NCT04149704|449354650|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
124924993|NCT04149704|449354651|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
124924994|NCT04149704|449354648|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
124924995|NCT04149704|449354649|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
124924996|NCT04149704|449354650|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
124924997|NCT04149704|449354651|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
124924998|NCT02268253|449354654|FG000|Stage 1|Withdrawal by Subject|1|||
124924999|NCT02268253|449354655|FG001|Stage 1|Withdrawal by Subject|0|||
124925000|NCT02268253|449354656|FG002|Stage 1|Withdrawal by Subject|0|||
124925001|NCT02268253|449354657|FG003|Stage 1|Withdrawal by Subject|0|||
124925002|NCT02268253|449354658|FG004|Stage 1|Withdrawal by Subject|0|||
124925003|NCT02268253|449354659|FG005|Stage 1|Withdrawal by Subject|0|||
124925004|NCT02268253|449354660|FG006|Stage 1|Withdrawal by Subject|0|||
124925005|NCT02268253|449354654|FG000|Stage 1|Death|0|||
124925006|NCT02268253|449354655|FG001|Stage 1|Death|2|||
124925007|NCT02268253|449354656|FG002|Stage 1|Death|2|||
124925008|NCT02268253|449354657|FG003|Stage 1|Death|2|||
124925009|NCT02268253|449354658|FG004|Stage 1|Death|1|||
124925010|NCT02268253|449354659|FG005|Stage 1|Death|1|||
124925011|NCT02268253|449354660|FG006|Stage 1|Death|0|||
124925012|NCT02268253|449354654|FG000|Stage 2|Disease Recurrence/ Progression|0|||
124925013|NCT02268253|449354655|FG001|Stage 2|Disease Recurrence/ Progression|0|||
124925014|NCT02268253|449354656|FG002|Stage 2|Disease Recurrence/ Progression|1|||
124925015|NCT02268253|449354657|FG003|Stage 2|Disease Recurrence/ Progression|0|||
124925016|NCT02268253|449354658|FG004|Stage 2|Disease Recurrence/ Progression|0|||
124925017|NCT02268253|449354659|FG005|Stage 2|Disease Recurrence/ Progression|0|||
124925018|NCT02268253|449354660|FG006|Stage 2|Disease Recurrence/ Progression|0|||
124925019|NCT02268253|449354654|FG000|Stage 2|Withdrawal by Subject|0|||
124925020|NCT02268253|449354655|FG001|Stage 2|Withdrawal by Subject|0|||
124925021|NCT02268253|449354656|FG002|Stage 2|Withdrawal by Subject|2|||
124925022|NCT02268253|449354657|FG003|Stage 2|Withdrawal by Subject|0|||
124925023|NCT02268253|449354658|FG004|Stage 2|Withdrawal by Subject|0|||
124925024|NCT02268253|449354659|FG005|Stage 2|Withdrawal by Subject|2|||
124925025|NCT02268253|449354660|FG006|Stage 2|Withdrawal by Subject|0|||
124925026|NCT02268253|449354654|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
124925027|NCT02268253|449354655|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
124925028|NCT02268253|449354656|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
124925029|NCT02268253|449354657|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
124925030|NCT02268253|449354658|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
124925031|NCT02268253|449354659|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
124925032|NCT02268253|449354660|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
124925033|NCT02268253|449354654|FG000|Stage 2|Death|0|||
124925034|NCT02268253|449354655|FG001|Stage 2|Death|0|||
124925035|NCT02268253|449354656|FG002|Stage 2|Death|19|||
124925036|NCT02268253|449354657|FG003|Stage 2|Death|0|||
124925037|NCT02268253|449354658|FG004|Stage 2|Death|0|||
124925038|NCT02268253|449354659|FG005|Stage 2|Death|20|||
124925039|NCT02268253|449354660|FG006|Stage 2|Death|1|||
124925040|NCT02268253|449354654|FG000|Stage 2|Lost to Follow-up|0|||
124925041|NCT02268253|449354655|FG001|Stage 2|Lost to Follow-up|0|||
124925042|NCT02268253|449354656|FG002|Stage 2|Lost to Follow-up|0|||
124925043|NCT02268253|449354657|FG003|Stage 2|Lost to Follow-up|0|||
124925044|NCT02268253|449354658|FG004|Stage 2|Lost to Follow-up|0|||
124925045|NCT02268253|449354659|FG005|Stage 2|Lost to Follow-up|4|||
124925046|NCT02268253|449354660|FG006|Stage 2|Lost to Follow-up|0|||
124925047|NCT02268253|449354654|FG000|Stage 2|Transferred to Hospice|0|||
124925048|NCT02268253|449354655|FG001|Stage 2|Transferred to Hospice|0|||
124925049|NCT02268253|449354656|FG002|Stage 2|Transferred to Hospice|0|||
124925050|NCT02268253|449354657|FG003|Stage 2|Transferred to Hospice|0|||
124925051|NCT02268253|449354658|FG004|Stage 2|Transferred to Hospice|0|||
124925052|NCT02268253|449354659|FG005|Stage 2|Transferred to Hospice|2|||
124925053|NCT02268253|449354660|FG006|Stage 2|Transferred to Hospice|0|||
124925054|NCT02268253|449354654|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
124925055|NCT02268253|449354655|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
124925056|NCT02268253|449354656|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
124925057|NCT02268253|449354657|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
124925058|NCT02268253|449354658|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
124925059|NCT02268253|449354659|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
124925060|NCT02268253|449354660|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
124925061|NCT02268253|449354654|FG000|Stage 3A|Withdrawal by Subject|0|||
124925062|NCT02268253|449354655|FG001|Stage 3A|Withdrawal by Subject|0|||
124925063|NCT02268253|449354656|FG002|Stage 3A|Withdrawal by Subject|2|||
124925064|NCT02268253|449354657|FG003|Stage 3A|Withdrawal by Subject|0|||
124925065|NCT02268253|449354658|FG004|Stage 3A|Withdrawal by Subject|0|||
124925066|NCT02268253|449354659|FG005|Stage 3A|Withdrawal by Subject|0|||
124925067|NCT02268253|449354660|FG006|Stage 3A|Withdrawal by Subject|0|||
124925068|NCT02268253|449354654|FG000|Stage 3A|Physician Decision|0|||
124925069|NCT02268253|449354655|FG001|Stage 3A|Physician Decision|0|||
124925070|NCT02268253|449354656|FG002|Stage 3A|Physician Decision|2|||
124925071|NCT02268253|449354657|FG003|Stage 3A|Physician Decision|0|||
124925072|NCT02268253|449354658|FG004|Stage 3A|Physician Decision|0|||
124925073|NCT02268253|449354659|FG005|Stage 3A|Physician Decision|0|||
124925074|NCT02268253|449354660|FG006|Stage 3A|Physician Decision|0|||
124925075|NCT02268253|449354654|FG000|Stage 3A|Study Terminated by Sponsor|0|||
124925076|NCT02268253|449354655|FG001|Stage 3A|Study Terminated by Sponsor|0|||
124925077|NCT02268253|449354656|FG002|Stage 3A|Study Terminated by Sponsor|2|||
124925078|NCT02268253|449354657|FG003|Stage 3A|Study Terminated by Sponsor|0|||
124925079|NCT02268253|449354658|FG004|Stage 3A|Study Terminated by Sponsor|0|||
124925080|NCT02268253|449354659|FG005|Stage 3A|Study Terminated by Sponsor|0|||
124925081|NCT02268253|449354660|FG006|Stage 3A|Study Terminated by Sponsor|0|||
124925082|NCT02268253|449354654|FG000|Stage 3A|Lost to Follow-up|0|||
124925083|NCT02268253|449354655|FG001|Stage 3A|Lost to Follow-up|0|||
124454396|NCT01183143|447623810|FG000|Overall Study|Subject Questionnaires not returned|5|||
124454397|NCT01183143|447623810|FG000|Overall Study|Subjects enrolled, but not treated|11|||
124454398|NCT03197493|447623813|FG000|Overall Study|Withdrawal by Subject|5|||
124454399|NCT02163187|447623816|FG000|Overall Study|Device removed|1|||
124454400|NCT02163187|447623817|FG001|Overall Study|Device removed|0|||
124454401|NCT02163187|447623816|FG000|Overall Study|Progressive disease|1|||
124454402|NCT02163187|447623817|FG001|Overall Study|Progressive disease|0|||
124454403|NCT03281668|447623819|FG000|Overall Study|Physician Decision|1|||
124454404|NCT03281668|447623819|FG000|Overall Study|scheduling conflict, family circumstance|2|||
124454405|NCT03281668|447623819|FG000|Overall Study|Withdrawal by Subject|4|||
124696917|NCT03721107|448509601|FG001|Overall Study|Withdrawal by Subject|1|||
124696918|NCT03721107|448509602|FG002|Overall Study|Withdrawal by Subject|5|||
124696919|NCT03721107|448509603|FG003|Overall Study|Withdrawal by Subject|5|||
124696920|NCT03721107|448509600|FG000|Overall Study|Other|1|||
124696921|NCT03721107|448509601|FG001|Overall Study|Other|0|||
124925084|NCT02268253|449354656|FG002|Stage 3A|Lost to Follow-up|1|||
124925085|NCT02268253|449354657|FG003|Stage 3A|Lost to Follow-up|0|||
124925086|NCT02268253|449354658|FG004|Stage 3A|Lost to Follow-up|0|||
124925087|NCT02268253|449354659|FG005|Stage 3A|Lost to Follow-up|0|||
124925088|NCT02268253|449354660|FG006|Stage 3A|Lost to Follow-up|0|||
124925089|NCT02268253|449354654|FG000|Stage 3A|Death|0|||
124925090|NCT02268253|449354655|FG001|Stage 3A|Death|0|||
124925091|NCT02268253|449354656|FG002|Stage 3A|Death|5|||
124454406|NCT03281668|447623819|FG000|Overall Study|Lost to Follow-up|1|||
124454407|NCT01785160|447623820|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
124454408|NCT01785160|447623820|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
124454409|NCT00957528|447623822|FG000|Overall Study|Protocol Violation|0|||
124454410|NCT00957528|447623823|FG001|Overall Study|Protocol Violation|1|||
124454411|NCT00957528|447623824|FG002|Overall Study|Protocol Violation|0|||
124454412|NCT00957528|447623822|FG000|Overall Study|Withdrawal by Subject|0|||
124454413|NCT00957528|447623823|FG001|Overall Study|Withdrawal by Subject|0|||
124454414|NCT00957528|447623824|FG002|Overall Study|Withdrawal by Subject|1|||
124454415|NCT02234479|447623829|FG000|Overall Study|Withdrawal by Subject|1|||
124454416|NCT02234479|447623830|FG001|Overall Study|Withdrawal by Subject|3|||
124454417|NCT02318667|447623831|FG000|Overall Study|Adverse Event|1|||
124454418|NCT02318667|447623831|FG000|Overall Study|Lack of Efficacy|6|||
124454419|NCT02318667|447623831|FG000|Overall Study|Protocol Violation|2|||
124454420|NCT02289742|447623832|FG000|First Wear Period|Adverse event prior to treatment|0|||
124454421|NCT02289742|447623833|FG001|First Wear Period|Adverse event prior to treatment|1|||
124454422|NCT02289742|447623834|FG002|First Wear Period|Adverse event prior to treatment|0|||
124454423|NCT02289742|447623835|FG003|First Wear Period|Adverse event prior to treatment|0|||
124454424|NCT02289742|447623832|FG000|First Wear Period|Adverse Event|0|||
124454425|NCT02289742|447623833|FG001|First Wear Period|Adverse Event|0|||
124454426|NCT02289742|447623834|FG002|First Wear Period|Adverse Event|1|||
124454427|NCT02289742|447623835|FG003|First Wear Period|Adverse Event|0|||
124454428|NCT02289742|447623832|FG000|First Wear Period|Other prior to treatment|0|||
124454429|NCT02289742|447623833|FG001|First Wear Period|Other prior to treatment|0|||
124454430|NCT02289742|447623834|FG002|First Wear Period|Other prior to treatment|0|||
124454431|NCT02289742|447623835|FG003|First Wear Period|Other prior to treatment|1|||
124454432|NCT02289742|447623832|FG000|Third Wear Period|Adverse Event|0|||
124454433|NCT02289742|447623833|FG001|Third Wear Period|Adverse Event|1|||
124454434|NCT02289742|447623834|FG002|Third Wear Period|Adverse Event|0|||
124454435|NCT02289742|447623835|FG003|Third Wear Period|Adverse Event|0|||
124454436|NCT02289742|447623832|FG000|Third Wear Period|Reason not given|0|||
124454437|NCT02289742|447623833|FG001|Third Wear Period|Reason not given|0|||
124454438|NCT02289742|447623834|FG002|Third Wear Period|Reason not given|0|||
124454439|NCT02289742|447623835|FG003|Third Wear Period|Reason not given|1|||
124696922|NCT03721107|448509602|FG002|Overall Study|Other|0|||
124696923|NCT03721107|448509603|FG003|Overall Study|Other|1|||
124696924|NCT01189227|448509604|FG000|Overall Study|Study terminated due to low accrual|6|||
124696925|NCT01189227|448509605|FG001|Overall Study|Study terminated due to low accrual|3|||
124696926|NCT01213251|448511830|FG000|Overall Study|Death|2|||
124696927|NCT01213251|448511831|FG001|Overall Study|Death|1|||
124696928|NCT01213251|448511832|FG002|Overall Study|Death|2|||
124696929|NCT01213251|448511830|FG000|Overall Study|Exit|3|||
124696930|NCT01213251|448511831|FG001|Overall Study|Exit|2|||
124696931|NCT01213251|448511832|FG002|Overall Study|Exit|8|||
124696932|NCT01213251|448511830|FG000|Overall Study|Protocol Violation|1|||
124696933|NCT01213251|448511831|FG001|Overall Study|Protocol Violation|1|||
124696934|NCT01213251|448511832|FG002|Overall Study|Protocol Violation|0|||
124696935|NCT01213251|448511830|FG000|Overall Study|Missed 18-Month Follow-up|0|||
124696936|NCT01213251|448511831|FG001|Overall Study|Missed 18-Month Follow-up|0|||
124696937|NCT01213251|448511832|FG002|Overall Study|Missed 18-Month Follow-up|1|||
124696938|NCT02529488|448511833|FG000|Overall Study|Adverse Event|1|||
124696939|NCT02529488|448511833|FG000|Overall Study|Death|3|||
124696940|NCT01557244|448511838|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
124696941|NCT01557244|448511839|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
124925092|NCT02268253|449354657|FG003|Stage 3A|Death|0|||
124925093|NCT02268253|449354658|FG004|Stage 3A|Death|0|||
124925094|NCT02268253|449354659|FG005|Stage 3A|Death|0|||
124925095|NCT02268253|449354660|FG006|Stage 3A|Death|0|||
124925096|NCT05362487|449354663|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
124925097|NCT06215521|449354672|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
124925098|NCT06215521|449354673|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
124925099|NCT06215521|449354674|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
124925100|NCT06215521|449354675|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
124925101|NCT06215521|449354676|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
124925102|NCT06215521|449354677|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
124925103|NCT04096040|449354678|FG000|Overall Study|Protocol Violation|12|||
124925104|NCT04096040|449354678|FG000|Overall Study|Non-compliant site|4|||
124925105|NCT04973254|449354681|FG000|Overall Study|Not adherent|0|||
124925106|NCT04973254|449354682|FG001|Overall Study|Not adherent|1|||
124925107|NCT04973254|449354683|FG002|Overall Study|Not adherent|0|||
124925108|NCT03808818|449354691|FG000|Overall Study|Death|6|||
124925109|NCT03808818|449354692|FG001|Overall Study|Death|6|||
124925110|NCT03808818|449354691|FG000|Overall Study|Withdrawal by Subject|7|||
124925111|NCT03808818|449354692|FG001|Overall Study|Withdrawal by Subject|18|||
124925112|NCT03808818|449354691|FG000|Overall Study|Lost to Follow-up|31|||
124925113|NCT03808818|449354692|FG001|Overall Study|Lost to Follow-up|33|||
124925114|NCT05415722|449354694|FG000|Overall Study|Lost to Follow-up|0|||
124925115|NCT05415722|449354695|FG001|Overall Study|Lost to Follow-up|2|||
124925116|NCT05415722|449354696|FG002|Overall Study|Lost to Follow-up|0|||
124925117|NCT05415722|449354697|FG003|Overall Study|Lost to Follow-up|1|||
124925118|NCT05415722|449354698|FG004|Overall Study|Lost to Follow-up|0|||
124925119|NCT05415722|449354699|FG005|Overall Study|Lost to Follow-up|0|||
124925120|NCT05415722|449354700|FG006|Overall Study|Lost to Follow-up|1|||
124925121|NCT05415722|449354694|FG000|Overall Study|Physician Decision|0|||
124925122|NCT05415722|449354695|FG001|Overall Study|Physician Decision|0|||
124925123|NCT05415722|449354696|FG002|Overall Study|Physician Decision|0|||
124925124|NCT05415722|449354697|FG003|Overall Study|Physician Decision|1|||
124925125|NCT05415722|449354698|FG004|Overall Study|Physician Decision|0|||
124925126|NCT05415722|449354699|FG005|Overall Study|Physician Decision|0|||
124925127|NCT05415722|449354700|FG006|Overall Study|Physician Decision|1|||
124925128|NCT05415722|449354694|FG000|Overall Study|Protocol Violation|0|||
124925129|NCT05415722|449354695|FG001|Overall Study|Protocol Violation|0|||
124925130|NCT05415722|449354696|FG002|Overall Study|Protocol Violation|0|||
124925131|NCT05415722|449354697|FG003|Overall Study|Protocol Violation|1|||
124925132|NCT05415722|449354698|FG004|Overall Study|Protocol Violation|0|||
124925133|NCT05415722|449354699|FG005|Overall Study|Protocol Violation|0|||
124925134|NCT05415722|449354700|FG006|Overall Study|Protocol Violation|0|||
124925135|NCT05415722|449354694|FG000|Overall Study|Sponsor Discretion|0|||
124925136|NCT05415722|449354695|FG001|Overall Study|Sponsor Discretion|0|||
124925137|NCT05415722|449354696|FG002|Overall Study|Sponsor Discretion|0|||
124454440|NCT01365039|447623837|FG000|Overall Study|Study related symptoms and complaints|1|||
124454441|NCT01365039|447623838|FG001|Overall Study|Study related symptoms and complaints|0|||
124696942|NCT01557244|448511840|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
124696943|NCT01557244|448511841|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
124696944|NCT01557244|448511842|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
124696945|NCT01557244|448511843|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
124696946|NCT01557244|448511844|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
124696947|NCT01557244|448511838|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
124696948|NCT01557244|448511839|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
124696949|NCT01557244|448511840|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
124696950|NCT01557244|448511841|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
124696951|NCT01557244|448511842|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
124696952|NCT01557244|448511843|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
124696953|NCT01557244|448511844|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
124696954|NCT01557244|448511838|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
124696955|NCT01557244|448511839|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
124762693|NCT03071263|448755940|FG000|Overall Study|Participant moved to another city|0|||
124925138|NCT05415722|449354697|FG003|Overall Study|Sponsor Discretion|0|||
124925139|NCT05415722|449354698|FG004|Overall Study|Sponsor Discretion|1|||
124925140|NCT05415722|449354699|FG005|Overall Study|Sponsor Discretion|1|||
124925141|NCT05415722|449354700|FG006|Overall Study|Sponsor Discretion|0|||
124925142|NCT05415722|449354694|FG000|Overall Study|Withdrawal by Subject|0|||
124454442|NCT01961349|447623848|FG000|Overall Study|Withdrawal by Subject|1|||
124925143|NCT05415722|449354695|FG001|Overall Study|Withdrawal by Subject|1|||
124925144|NCT05415722|449354696|FG002|Overall Study|Withdrawal by Subject|0|||
124925145|NCT05415722|449354697|FG003|Overall Study|Withdrawal by Subject|1|||
124925146|NCT05415722|449354698|FG004|Overall Study|Withdrawal by Subject|1|||
124925147|NCT05415722|449354699|FG005|Overall Study|Withdrawal by Subject|0|||
124925148|NCT05415722|449354700|FG006|Overall Study|Withdrawal by Subject|1|||
124925149|NCT04629716|449354701|FG000|Overall Study|Lost to Follow-up|7|||
124696956|NCT01557244|448511840|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
124696957|NCT01557244|448511841|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
124696958|NCT01557244|448511842|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
124696959|NCT01557244|448511843|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
124696960|NCT01557244|448511844|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
124696961|NCT01557244|448511838|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
124696962|NCT01557244|448511839|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
124696963|NCT01557244|448511840|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
124696964|NCT01557244|448511841|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
124696965|NCT01557244|448511842|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
124696966|NCT01557244|448511843|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
124696967|NCT01557244|448511844|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
124696968|NCT01557244|448511838|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
124696969|NCT01557244|448511839|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
124696970|NCT01557244|448511840|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
124696971|NCT01557244|448511841|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
124696972|NCT01557244|448511842|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
124696973|NCT01557244|448511843|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
124696974|NCT01557244|448511844|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
124696975|NCT01557244|448511838|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
124696976|NCT01557244|448511839|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
124696977|NCT01557244|448511840|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
124696978|NCT01557244|448511841|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
124696979|NCT01557244|448511842|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
124696980|NCT01557244|448511843|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
124696981|NCT01557244|448511844|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
124696982|NCT01557244|448511838|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
124696983|NCT01557244|448511839|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
124696984|NCT01557244|448511840|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
124696985|NCT01557244|448511841|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
124696986|NCT01557244|448511842|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
124696987|NCT01557244|448511843|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
124696988|NCT01557244|448511844|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
124696989|NCT01557244|448511838|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
124696990|NCT01557244|448511839|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
124696991|NCT01557244|448511840|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
124696992|NCT01557244|448511841|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
124696993|NCT01557244|448511842|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
124696994|NCT01557244|448511843|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
124696995|NCT01557244|448511844|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
124696996|NCT01557244|448511838|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
124696997|NCT01557244|448511839|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
124696998|NCT01557244|448511840|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
124696999|NCT01557244|448511841|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
124697000|NCT01557244|448511842|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
124697001|NCT01557244|448511843|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
124697002|NCT01557244|448511844|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
124697003|NCT01557244|448511838|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
124697004|NCT01557244|448511839|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
124697005|NCT01557244|448511840|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
124697006|NCT01557244|448511841|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
124925150|NCT04629716|449354702|FG001|Overall Study|Lost to Follow-up|3|||
124925151|NCT04537715|449354703|FG000|Overall Study|Death|3|||
124925152|NCT04537715|449354704|FG001|Overall Study|Death|1|||
124925153|NCT04537715|449354703|FG000|Overall Study|Withdrawal by Subject|3|||
124697007|NCT01557244|448511842|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
124697008|NCT01557244|448511843|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
124697009|NCT01557244|448511844|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
124762694|NCT03071263|448755941|FG001|Overall Study|Participant moved to another city|1|||
124925154|NCT04537715|449354704|FG001|Overall Study|Withdrawal by Subject|1|||
124925155|NCT04537715|449354703|FG000|Overall Study|Other|4|||
124925156|NCT04537715|449354704|FG001|Overall Study|Other|3|||
124925157|NCT04537715|449354703|FG000|Overall Study|Progressive disease|1|||
124925158|NCT04537715|449354704|FG001|Overall Study|Progressive disease|0|||
124925159|NCT03031470|449354705|FG000|Overall Study|Adverse Event|3|||
124925160|NCT03031470|449354706|FG001|Overall Study|Adverse Event|0|||
124925161|NCT03031470|449354705|FG000|Overall Study|Death|3|||
124925162|NCT03031470|449354706|FG001|Overall Study|Death|1|||
124925163|NCT03031470|449354705|FG000|Overall Study|Lost to Follow-up|1|||
124925164|NCT03031470|449354706|FG001|Overall Study|Lost to Follow-up|1|||
124925165|NCT03031470|449354705|FG000|Overall Study|Withdrawal by Subject|1|||
124925166|NCT03031470|449354706|FG001|Overall Study|Withdrawal by Subject|0|||
124925167|NCT03031470|449354705|FG000|Overall Study|Protocol entry criteria not met|0|||
124925168|NCT03031470|449354706|FG001|Overall Study|Protocol entry criteria not met|1|||
124925169|NCT03031470|449354705|FG000|Overall Study|Cancel the operation|0|||
124925170|NCT03031470|449354706|FG001|Overall Study|Cancel the operation|1|||
124925171|NCT03461276|449354707|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
124925172|NCT03461276|449354708|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
124925173|NCT03461276|449354707|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
124925174|NCT03461276|449354708|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
124925175|NCT03461276|449354707|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
124925176|NCT03461276|449354708|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
124925177|NCT03461276|449354707|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
124925178|NCT03461276|449354708|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
124925179|NCT03461276|449354707|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
124925180|NCT03461276|449354708|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
124925181|NCT03461276|449354707|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
124925182|NCT03461276|449354708|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
124925183|NCT03461276|449354707|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
124925184|NCT03461276|449354708|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
124925185|NCT03461276|449354707|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
124925186|NCT03461276|449354708|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
124925187|NCT03461276|449354707|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
124925188|NCT03461276|449354708|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
124925189|NCT03461276|449354707|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
124925190|NCT03461276|449354708|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
124925191|NCT02310646|449354710|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
124925192|NCT02310646|449354711|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
124925193|NCT02310646|449354710|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
124925194|NCT02310646|449354711|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
124925195|NCT03865498|449354712|FG000|Overall Study|Lack of Efficacy|12|||
124925196|NCT03865498|449354713|FG001|Overall Study|Lack of Efficacy|11|||
124925197|NCT03865498|449354712|FG000|Overall Study|Lost to Follow-up|125|||
124925198|NCT03865498|449354713|FG001|Overall Study|Lost to Follow-up|133|||
124925199|NCT03865498|449354712|FG000|Overall Study|Withdrawal by Subject|2|||
124925200|NCT03865498|449354713|FG001|Overall Study|Withdrawal by Subject|4|||
124925201|NCT05869383|449354716|FG000|Overall Study|Withdrawal by Subject|2|||
124925202|NCT05869383|449354717|FG001|Overall Study|Withdrawal by Subject|0|||
124925203|NCT03270501|449354720|FG000|Overall Study|Screen failure|6|||
124697010|NCT01557244|448511838|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
124697011|NCT01557244|448511839|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
124697012|NCT01557244|448511840|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
124697013|NCT01557244|448511841|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
124697014|NCT01557244|448511842|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
124925204|NCT03270501|449354720|FG000|Overall Study|Lost to Follow-up|2|||
124925205|NCT03270501|449354720|FG000|Overall Study|Adverse Event|1|||
124925206|NCT03812679|449356713|FG000|Overall Study|Adverse Event|2|||
124925207|NCT03812679|449356713|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
124925208|NCT03812679|449356713|FG000|Overall Study|Renal transplant|1|||
124925209|NCT03812679|449356713|FG000|Overall Study|Withdrawal by Subject|1|||
124925210|NCT03812679|449356713|FG000|Overall Study|Termination of study|2|||
124925211|NCT03812679|449356713|FG000|Overall Study|Water device replacement|1|||
124925212|NCT05486078|449356714|FG000|Overall Study|4 drop out and one withdrawn|5|||
124925213|NCT02985957|449356715|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124925214|NCT02985957|449356716|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124925215|NCT02985957|449356717|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124925216|NCT02985957|449356718|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124925217|NCT02985957|449356719|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
124925218|NCT02985957|449356720|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124925219|NCT02985957|449356721|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124925220|NCT02985957|449356715|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
124697015|NCT01557244|448511843|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
124925221|NCT02985957|449356716|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
124925222|NCT02985957|449356717|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
124925223|NCT02985957|449356718|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
124925224|NCT02985957|449356719|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
124925225|NCT02985957|449356720|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
124925226|NCT02985957|449356721|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
124925227|NCT02985957|449356715|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
124925228|NCT02985957|449356716|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
124925229|NCT02985957|449356717|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
124925230|NCT02985957|449356718|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
124925231|NCT02985957|449356719|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
124925232|NCT02985957|449356720|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
124925233|NCT02985957|449356721|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
124925234|NCT02985957|449356715|FG000|Treatment Period|Death|0|||
124925235|NCT02985957|449356716|FG001|Treatment Period|Death|0|||
124925236|NCT02985957|449356717|FG002|Treatment Period|Death|0|||
124925237|NCT02985957|449356718|FG003|Treatment Period|Death|0|||
124925238|NCT02985957|449356719|FG004|Treatment Period|Death|1|||
124925239|NCT02985957|449356720|FG005|Treatment Period|Death|0|||
124925240|NCT02985957|449356721|FG006|Treatment Period|Death|0|||
124925241|NCT02985957|449356715|FG000|Treatment Period|Participant withdrew consent|0|||
124925242|NCT02985957|449356716|FG001|Treatment Period|Participant withdrew consent|0|||
124925243|NCT02985957|449356717|FG002|Treatment Period|Participant withdrew consent|0|||
124925244|NCT02985957|449356718|FG003|Treatment Period|Participant withdrew consent|1|||
124925245|NCT02985957|449356719|FG004|Treatment Period|Participant withdrew consent|3|||
124925246|NCT02985957|449356720|FG005|Treatment Period|Participant withdrew consent|0|||
124925247|NCT02985957|449356721|FG006|Treatment Period|Participant withdrew consent|1|||
124925248|NCT02985957|449356715|FG000|Treatment Period|Lost to Follow-up|0|||
124925249|NCT02985957|449356716|FG001|Treatment Period|Lost to Follow-up|0|||
124925250|NCT02985957|449356717|FG002|Treatment Period|Lost to Follow-up|0|||
124925251|NCT02985957|449356718|FG003|Treatment Period|Lost to Follow-up|0|||
124925252|NCT02985957|449356719|FG004|Treatment Period|Lost to Follow-up|1|||
124925253|NCT02985957|449356720|FG005|Treatment Period|Lost to Follow-up|0|||
124925254|NCT02985957|449356721|FG006|Treatment Period|Lost to Follow-up|0|||
124925255|NCT02985957|449356715|FG000|Treatment Period|Other reasons|0|||
124925256|NCT02985957|449356716|FG001|Treatment Period|Other reasons|0|||
124925257|NCT02985957|449356717|FG002|Treatment Period|Other reasons|1|||
124925258|NCT02985957|449356718|FG003|Treatment Period|Other reasons|3|||
124925259|NCT02985957|449356719|FG004|Treatment Period|Other reasons|6|||
124925260|NCT02985957|449356720|FG005|Treatment Period|Other reasons|0|||
124925261|NCT02985957|449356721|FG006|Treatment Period|Other reasons|1|||
124925262|NCT02985957|449356715|FG000|Treatment Period|Not reported|0|||
124925263|NCT02985957|449356716|FG001|Treatment Period|Not reported|1|||
124454443|NCT01961349|447623849|FG001|Overall Study|Withdrawal by Subject|4|||
124454444|NCT01961349|447623850|FG002|Overall Study|Withdrawal by Subject|0|||
124454445|NCT01961349|447623848|FG000|Overall Study|Adverse Event|0|||
124454446|NCT01961349|447623849|FG001|Overall Study|Adverse Event|0|||
124454447|NCT01961349|447623850|FG002|Overall Study|Adverse Event|1|||
124454448|NCT01961349|447623848|FG000|Overall Study|registration error, personal reason etc|2|||
124454449|NCT01961349|447623849|FG001|Overall Study|registration error, personal reason etc|2|||
124454450|NCT01961349|447623850|FG002|Overall Study|registration error, personal reason etc|1|||
124454451|NCT00829179|447623853|FG000|Overall Study|Withdrawal by Subject|1|||
124454452|NCT01075412|447623854|FG000|Overall Study|Withdrawal by Subject|0|||
124454453|NCT01075412|447623855|FG001|Overall Study|Withdrawal by Subject|1|||
124454454|NCT00916149|447623856|FG000|Overall Study|Lost to Follow-up|3|||
124454455|NCT00916149|447623857|FG001|Overall Study|Lost to Follow-up|2|||
124454456|NCT00916149|447623858|FG002|Overall Study|Lost to Follow-up|0|||
124454457|NCT00916149|447623856|FG000|Overall Study|Unable to place scalp EEG leads|1|||
124762695|NCT03084796|448755942|FG000|Overall Study|Adverse Event|4|||
124454458|NCT00916149|447623857|FG001|Overall Study|Unable to place scalp EEG leads|0|||
124454459|NCT00916149|447623858|FG002|Overall Study|Unable to place scalp EEG leads|0|||
124454460|NCT00589420|447623861|FG000|Overall Study|screen failure|1|||
124925264|NCT02985957|449356717|FG002|Treatment Period|Not reported|2|||
124925265|NCT02985957|449356718|FG003|Treatment Period|Not reported|5|||
124925266|NCT02985957|449356719|FG004|Treatment Period|Not reported|0|||
124925267|NCT02985957|449356720|FG005|Treatment Period|Not reported|0|||
124925268|NCT02985957|449356721|FG006|Treatment Period|Not reported|0|||
124925269|NCT02985957|449356715|FG000|Treatment Period|Maximum clinical benefit|0|||
124925270|NCT02985957|449356716|FG001|Treatment Period|Maximum clinical benefit|0|||
124925271|NCT02985957|449356717|FG002|Treatment Period|Maximum clinical benefit|1|||
124925272|NCT02985957|449356718|FG003|Treatment Period|Maximum clinical benefit|1|||
124925273|NCT02985957|449356719|FG004|Treatment Period|Maximum clinical benefit|0|||
124925274|NCT02985957|449356720|FG005|Treatment Period|Maximum clinical benefit|0|||
124925275|NCT02985957|449356721|FG006|Treatment Period|Maximum clinical benefit|2|||
124969567|NCT03520075|449517423|FG014|Phase 2 (Dose Expansion)|Death|13|||
124762696|NCT03084796|448755943|FG001|Overall Study|Adverse Event|5|||
124762697|NCT03084796|448755944|FG002|Overall Study|Adverse Event|6|||
124762698|NCT03084796|448755945|FG003|Overall Study|Adverse Event|2|||
124762699|NCT03084796|448755946|FG004|Overall Study|Adverse Event|3|||
124762700|NCT03084796|448755947|FG005|Overall Study|Adverse Event|5|||
124762701|NCT03084796|448755942|FG000|Overall Study|Withdrawal by Subject|3|||
124762702|NCT03084796|448755943|FG001|Overall Study|Withdrawal by Subject|5|||
124762703|NCT03084796|448755944|FG002|Overall Study|Withdrawal by Subject|2|||
124762704|NCT03084796|448755945|FG003|Overall Study|Withdrawal by Subject|1|||
124762705|NCT03084796|448755946|FG004|Overall Study|Withdrawal by Subject|3|||
124762706|NCT03084796|448755947|FG005|Overall Study|Withdrawal by Subject|0|||
124762707|NCT03084796|448755942|FG000|Overall Study|Protocol Violation|0|||
124762708|NCT03084796|448755943|FG001|Overall Study|Protocol Violation|0|||
124762709|NCT03084796|448755944|FG002|Overall Study|Protocol Violation|1|||
124762710|NCT03084796|448755945|FG003|Overall Study|Protocol Violation|0|||
124762711|NCT03084796|448755946|FG004|Overall Study|Protocol Violation|1|||
124762712|NCT03084796|448755947|FG005|Overall Study|Protocol Violation|1|||
124762713|NCT03084796|448755942|FG000|Overall Study|Lack of Efficacy|0|||
124762714|NCT03084796|448755943|FG001|Overall Study|Lack of Efficacy|0|||
124762715|NCT03084796|448755944|FG002|Overall Study|Lack of Efficacy|1|||
124762716|NCT03084796|448755945|FG003|Overall Study|Lack of Efficacy|0|||
124762717|NCT03084796|448755946|FG004|Overall Study|Lack of Efficacy|1|||
124925276|NCT02985957|449356715|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
124925277|NCT02985957|449356716|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
124925278|NCT02985957|449356717|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
124925279|NCT02985957|449356718|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
124925280|NCT02985957|449356719|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
124925281|NCT02985957|449356720|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
124925282|NCT02985957|449356721|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
124925283|NCT02985957|449356715|FG000|Treatment Period|Study drug toxicity|1|||
124925284|NCT02985957|449356716|FG001|Treatment Period|Study drug toxicity|23|||
124925285|NCT02985957|449356717|FG002|Treatment Period|Study drug toxicity|20|||
124925286|NCT02985957|449356718|FG003|Treatment Period|Study drug toxicity|11|||
124925287|NCT02985957|449356719|FG004|Treatment Period|Study drug toxicity|19|||
124925288|NCT02985957|449356720|FG005|Treatment Period|Study drug toxicity|3|||
124925289|NCT02985957|449356721|FG006|Treatment Period|Study drug toxicity|5|||
124925290|NCT02985957|449356715|FG000|Treatment Period|Disease progression|0|||
124925291|NCT02985957|449356716|FG001|Treatment Period|Disease progression|16|||
124925292|NCT02985957|449356717|FG002|Treatment Period|Disease progression|20|||
124925293|NCT02985957|449356718|FG003|Treatment Period|Disease progression|39|||
124925294|NCT02985957|449356719|FG004|Treatment Period|Disease progression|29|||
124925295|NCT02985957|449356720|FG005|Treatment Period|Disease progression|11|||
124925296|NCT02985957|449356721|FG006|Treatment Period|Disease progression|28|||
124925297|NCT02985957|449356715|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
124925298|NCT02985957|449356716|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
124925299|NCT02985957|449356717|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
124925300|NCT02985957|449356718|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
124925301|NCT02985957|449356719|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
124925302|NCT02985957|449356720|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
124925303|NCT02985957|449356721|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
124925304|NCT02985957|449356715|FG000|Treatment Period|Poor/Non-Compliance|0|||
124925305|NCT02985957|449356716|FG001|Treatment Period|Poor/Non-Compliance|0|||
124925306|NCT02985957|449356717|FG002|Treatment Period|Poor/Non-Compliance|0|||
124925307|NCT02985957|449356718|FG003|Treatment Period|Poor/Non-Compliance|0|||
124925308|NCT02985957|449356719|FG004|Treatment Period|Poor/Non-Compliance|1|||
124925309|NCT02985957|449356720|FG005|Treatment Period|Poor/Non-Compliance|1|||
124454461|NCT01940471|447623862|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
124454462|NCT01940471|447623863|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
124454463|NCT01940471|447623864|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
124454464|NCT01940471|447623865|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
124454465|NCT01940471|447623862|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
124454466|NCT01940471|447623863|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
124454467|NCT01940471|447623864|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
124762718|NCT03084796|448755947|FG005|Overall Study|Lack of Efficacy|0|||
124762719|NCT03084796|448755942|FG000|Overall Study|Lost to Follow-up|0|||
124762720|NCT03084796|448755943|FG001|Overall Study|Lost to Follow-up|0|||
124762721|NCT03084796|448755944|FG002|Overall Study|Lost to Follow-up|1|||
124762722|NCT03084796|448755945|FG003|Overall Study|Lost to Follow-up|1|||
124925310|NCT02985957|449356721|FG006|Treatment Period|Poor/Non-Compliance|0|||
124925311|NCT02985957|449356715|FG000|Treatment Period|Continuing in Treatment Period|0|||
124925312|NCT02985957|449356716|FG001|Treatment Period|Continuing in Treatment Period|1|||
124762723|NCT03084796|448755946|FG004|Overall Study|Lost to Follow-up|3|||
124762724|NCT03084796|448755947|FG005|Overall Study|Lost to Follow-up|1|||
124697016|NCT01557244|448511844|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
124697017|NCT01557244|448511838|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
124697018|NCT01557244|448511839|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
124697019|NCT01557244|448511840|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
124697020|NCT01557244|448511841|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
124697021|NCT01557244|448511842|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
124697022|NCT01557244|448511843|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
124697023|NCT01557244|448511844|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
124697024|NCT01428713|448511845|FG000|Overall Study|Non-compliance|2|||
124697025|NCT01428713|448511846|FG001|Overall Study|Non-compliance|2|||
124697026|NCT01428713|448511845|FG000|Overall Study|Withdrawal by Subject|1|||
124697027|NCT01428713|448511846|FG001|Overall Study|Withdrawal by Subject|1|||
124697028|NCT01428713|448511845|FG000|Overall Study|Adverse Event|0|||
124697029|NCT01428713|448511846|FG001|Overall Study|Adverse Event|2|||
124697030|NCT00862277|448511847|FG000|Overall Study|Protocol Violation|1|||
124697031|NCT00862277|448511848|FG001|Overall Study|Protocol Violation|2|||
124697032|NCT00862277|448511849|FG002|Overall Study|Protocol Violation|5|||
124697033|NCT03400787|448511850|FG000|Overall Study|Lost to Follow-up|1|||
124697034|NCT03400787|448511851|FG001|Overall Study|Lost to Follow-up|0|||
124697035|NCT03400787|448511850|FG000|Overall Study|Death|1|||
124697036|NCT03400787|448511851|FG001|Overall Study|Death|0|||
124697037|NCT03400787|448511850|FG000|Overall Study|Protocol Violation|0|||
124697038|NCT03400787|448511851|FG001|Overall Study|Protocol Violation|2|||
124697039|NCT03400787|448511850|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
124697040|NCT03400787|448511851|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
124697041|NCT02070380|448511856|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
124697042|NCT02070380|448511857|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
124697043|NCT02070380|448511858|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
124697044|NCT02070380|448511859|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
124697045|NCT02070380|448511856|FG000|Second Injection|Image sets missing or technically inadeq|0|||
124697046|NCT02070380|448511857|FG001|Second Injection|Image sets missing or technically inadeq|1|||
124697047|NCT02070380|448511858|FG002|Second Injection|Image sets missing or technically inadeq|0|||
124697048|NCT02070380|448511859|FG003|Second Injection|Image sets missing or technically inadeq|0|||
124697049|NCT02070380|448511856|FG000|Second Injection|Protocol Violation|0|||
124697050|NCT02070380|448511857|FG001|Second Injection|Protocol Violation|1|||
124697051|NCT02070380|448511858|FG002|Second Injection|Protocol Violation|1|||
124697052|NCT02070380|448511859|FG003|Second Injection|Protocol Violation|5|||
124697053|NCT02242903|448511863|FG000|Overall Study|Withdrawal by Subject|1|||
124697054|NCT02242903|448511864|FG001|Overall Study|Withdrawal by Subject|0|||
124697055|NCT02242903|448511865|FG002|Overall Study|Withdrawal by Subject|0|||
124697056|NCT02242903|448511866|FG003|Overall Study|Withdrawal by Subject|0|||
124697057|NCT02242903|448511867|FG004|Overall Study|Withdrawal by Subject|0|||
124697058|NCT02242903|448511868|FG005|Overall Study|Withdrawal by Subject|0|||
124697059|NCT02242903|448511869|FG006|Overall Study|Withdrawal by Subject|0|||
124697060|NCT02105012|448511872|FG000|Overall Study|Withdrawal by Subject|11|||
124697061|NCT02105012|448511872|FG000|Overall Study|Protocol Specified Criteria|9|||
124697062|NCT02105012|448511872|FG000|Overall Study|Lost to Follow-up|4|||
124697063|NCT02105012|448511872|FG000|Overall Study|Protocol Violation|4|||
124697064|NCT02105012|448511872|FG000|Overall Study|Physician Decision|3|||
124697065|NCT02105012|448511872|FG000|Overall Study|Adverse Event|1|||
124697066|NCT02105012|448511872|FG000|Overall Study|Lack of Efficacy|1|||
124697067|NCT00493285|448511873|FG000|Overall Study|Lost to Follow-up|0|||
124697068|NCT00493285|448511874|FG001|Overall Study|Lost to Follow-up|0|||
124697069|NCT00493285|448511875|FG002|Overall Study|Lost to Follow-up|0|||
124697070|NCT00493285|448511876|FG003|Overall Study|Lost to Follow-up|0|||
124697071|NCT00493285|448511877|FG004|Overall Study|Lost to Follow-up|1|||
124697072|NCT00493285|448511878|FG005|Overall Study|Lost to Follow-up|0|||
124697073|NCT04535362|448511879|FG000|Overall Study|Lost to Follow-up|3|||
124697074|NCT04535362|448511880|FG001|Overall Study|Lost to Follow-up|1|||
124697075|NCT03791060|448511881|FG000|Overall Study|Withdrawal by Subject|1|||
124697076|NCT02619812|448511886|FG000|Overall Study|Withdrawal by Subject|0|||
124697077|NCT02619812|448511887|FG001|Overall Study|Withdrawal by Subject|0|||
124969568|NCT03520075|449517424|FG015|Phase 2 (Dose Expansion)|Death|9|||
124697078|NCT02619812|448511888|FG002|Overall Study|Withdrawal by Subject|1|||
124697079|NCT02619812|448511889|FG003|Overall Study|Withdrawal by Subject|2|||
124697080|NCT00981175|448511890|FG000|Primary Dose Vaccination|Adverse Event|1|||
124697081|NCT00981175|448511891|FG001|Primary Dose Vaccination|Adverse Event|0|||
124697082|NCT00981175|448511890|FG000|Primary Dose Vaccination|Protocol Violation|0|||
124697083|NCT00981175|448511891|FG001|Primary Dose Vaccination|Protocol Violation|1|||
124697084|NCT00981175|448511890|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
124697085|NCT00981175|448511891|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
124697086|NCT00981175|448511890|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
124762725|NCT03084796|448755942|FG000|Overall Study|Randomization error|0|||
124762726|NCT03084796|448755943|FG001|Overall Study|Randomization error|0|||
124969569|NCT03520075|449517425|FG016|Phase 2 (Dose Expansion)|Death|5|||
124697087|NCT00981175|448511891|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
124697088|NCT01658735|448511894|FG000|Overall Study|Lack of Efficacy|1|||
124697089|NCT01658735|448511895|FG001|Overall Study|Lack of Efficacy|0|||
124697090|NCT01658735|448511896|FG002|Overall Study|Lack of Efficacy|1|||
124697091|NCT01658735|448511894|FG000|Overall Study|Lost to Follow-up|1|||
124697092|NCT01658735|448511895|FG001|Overall Study|Lost to Follow-up|1|||
124697093|NCT01658735|448511896|FG002|Overall Study|Lost to Follow-up|0|||
124697094|NCT01658735|448511894|FG000|Overall Study|Protocol Violation|0|||
124697095|NCT01658735|448511895|FG001|Overall Study|Protocol Violation|1|||
124697096|NCT01658735|448511896|FG002|Overall Study|Protocol Violation|0|||
124697097|NCT01658735|448511894|FG000|Overall Study|Withdrawal by Subject|3|||
124697098|NCT01658735|448511895|FG001|Overall Study|Withdrawal by Subject|5|||
124697099|NCT01658735|448511896|FG002|Overall Study|Withdrawal by Subject|3|||
124697100|NCT01379937|448511897|FG000|Overall Study|Protocol Violation|0|||
124697101|NCT01379937|448511898|FG001|Overall Study|Protocol Violation|0|||
124697102|NCT01379937|448511899|FG002|Overall Study|Protocol Violation|0|||
124697103|NCT01379937|448511900|FG003|Overall Study|Protocol Violation|1|||
124697104|NCT01379937|448511897|FG000|Overall Study|Consent withdrawal|0|||
124697105|NCT01379937|448511898|FG001|Overall Study|Consent withdrawal|1|||
124697106|NCT01379937|448511899|FG002|Overall Study|Consent withdrawal|0|||
124697107|NCT01379937|448511900|FG003|Overall Study|Consent withdrawal|0|||
124697108|NCT01379937|448511897|FG000|Overall Study|Lost to Follow-up|1|||
124697109|NCT01379937|448511898|FG001|Overall Study|Lost to Follow-up|2|||
124697110|NCT01379937|448511899|FG002|Overall Study|Lost to Follow-up|2|||
124697111|NCT01379937|448511900|FG003|Overall Study|Lost to Follow-up|0|||
124697112|NCT01104870|448511901|FG000|Overall Study|Adverse Event|1|||
124697113|NCT01104870|448511902|FG001|Overall Study|Adverse Event|1|||
124697114|NCT01104870|448511903|FG002|Overall Study|Adverse Event|0|||
124697115|NCT01104870|448511901|FG000|Overall Study|Death|0|||
124697116|NCT01104870|448511902|FG001|Overall Study|Death|0|||
124697117|NCT01104870|448511903|FG002|Overall Study|Death|1|||
124697118|NCT01104870|448511901|FG000|Overall Study|Withdrawal by Subject|0|||
124697119|NCT01104870|448511902|FG001|Overall Study|Withdrawal by Subject|0|||
124697120|NCT01104870|448511903|FG002|Overall Study|Withdrawal by Subject|1|||
124697121|NCT00079781|448511915|FG000|Pre-implant Period|Withdrawal by Subject|2|||
124697122|NCT00079781|448511916|FG001|Pre-implant Period|Withdrawal by Subject|0|||
124697123|NCT00079781|448511917|FG002|Pre-implant Period|Withdrawal by Subject|0|||
124697124|NCT00079781|448511915|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
124697125|NCT00079781|448511916|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
124697126|NCT00079781|448511917|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
124697127|NCT00079781|448511915|FG000|Follow-up Period|Withdrawal by Subject|3|||
124697128|NCT00079781|448511916|FG001|Follow-up Period|Withdrawal by Subject|0|||
124697129|NCT00079781|448511917|FG002|Follow-up Period|Withdrawal by Subject|1|||
124697130|NCT00079781|448511915|FG000|Follow-up Period|Lost to Follow-up|1|||
124697131|NCT00079781|448511916|FG001|Follow-up Period|Lost to Follow-up|0|||
124697132|NCT00079781|448511917|FG002|Follow-up Period|Lost to Follow-up|0|||
124697133|NCT00079781|448511915|FG000|Follow-up Period|Death|0|||
124697134|NCT00079781|448511916|FG001|Follow-up Period|Death|0|||
124697135|NCT00079781|448511917|FG002|Follow-up Period|Death|1|||
124697136|NCT04641975|448511918|FG000|Overall Study|Protocol Violation|1|||
124697137|NCT04641975|448511919|FG001|Overall Study|Protocol Violation|2|||
124697138|NCT04641975|448511920|FG002|Overall Study|Protocol Violation|0|||
124697139|NCT04641975|448511921|FG003|Overall Study|Protocol Violation|0|||
124697140|NCT04641975|448511918|FG000|Overall Study|Adverse Event|0|||
124697141|NCT04641975|448511919|FG001|Overall Study|Adverse Event|0|||
124697142|NCT04641975|448511920|FG002|Overall Study|Adverse Event|1|||
124697143|NCT04641975|448511921|FG003|Overall Study|Adverse Event|1|||
124697144|NCT04641975|448511918|FG000|Overall Study|Withdrawal by Subject|1|||
124697145|NCT04641975|448511919|FG001|Overall Study|Withdrawal by Subject|0|||
124697146|NCT04641975|448511920|FG002|Overall Study|Withdrawal by Subject|0|||
124697147|NCT04641975|448511921|FG003|Overall Study|Withdrawal by Subject|0|||
124697148|NCT02067156|448511924|FG000|Overall Study|Lost to Follow-up|4|||
124697149|NCT03596983|448511925|FG000|Overall Study|Withdrawal by Subject|3|||
124697150|NCT05287685|448511926|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
124697151|NCT05287685|448511927|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
124697152|NCT05287685|448511926|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
124697153|NCT05287685|448511927|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
124697154|NCT01340170|448511934|FG000|Overall Study|Lost to Follow-up|2|||
124697155|NCT01340170|448511935|FG001|Overall Study|Lost to Follow-up|4|||
124697156|NCT01340170|448511936|FG002|Overall Study|Lost to Follow-up|0|||
124697157|NCT01340170|448511934|FG000|Overall Study|Implant failure|1|||
124697158|NCT01340170|448511935|FG001|Overall Study|Implant failure|3|||
124697159|NCT01340170|448511936|FG002|Overall Study|Implant failure|0|||
124697160|NCT00452530|448511938|FG000|Overall Study|Death|1|||
124697161|NCT00452530|448511939|FG001|Overall Study|Death|0|||
124697162|NCT00452530|448511938|FG000|Overall Study|Adverse Event|40|||
124697163|NCT00452530|448511939|FG001|Overall Study|Adverse Event|44|||
124697164|NCT00452530|448511938|FG000|Overall Study|Withdrawal by Subject|68|||
124545867|NCT00471237|447954417|FG005|Overall Study|Withdrawal by Subject|4|||
124545868|NCT00471237|447954418|FG006|Overall Study|Withdrawal by Subject|2|||
124925313|NCT02985957|449356717|FG002|Treatment Period|Continuing in Treatment Period|0|||
124925314|NCT02985957|449356718|FG003|Treatment Period|Continuing in Treatment Period|4|||
124925315|NCT02985957|449356719|FG004|Treatment Period|Continuing in Treatment Period|4|||
124925316|NCT02985957|449356720|FG005|Treatment Period|Continuing in Treatment Period|0|||
124925317|NCT02985957|449356721|FG006|Treatment Period|Continuing in Treatment Period|0|||
124925318|NCT04802967|449356728|FG000|Part B|Withdrawal by Subject|0|||
124925319|NCT04802967|449356729|FG001|Part B|Withdrawal by Subject|0|||
124925320|NCT04802967|449356730|FG002|Part B|Withdrawal by Subject|0|||
124925321|NCT04802967|449356731|FG003|Part B|Withdrawal by Subject|0|||
124925322|NCT04802967|449356732|FG004|Part B|Withdrawal by Subject|0|||
124925323|NCT04802967|449356733|FG005|Part B|Withdrawal by Subject|1|||
124925324|NCT04802967|449356734|FG006|Part B|Withdrawal by Subject|0|||
124925325|NCT04802967|449356735|FG007|Part B|Withdrawal by Subject|0|||
124925326|NCT04802967|449356736|FG008|Part B|Withdrawal by Subject|0|||
124925327|NCT04802967|449356737|FG009|Part B|Withdrawal by Subject|0|||
124925328|NCT03945292|449356740|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
124925329|NCT03945292|449356741|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
124925330|NCT03945292|449356742|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
124925331|NCT03945292|449356743|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
124925332|NCT03945292|449356744|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
124925333|NCT03945292|449356745|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
124925334|NCT03945292|449356746|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
124925335|NCT03945292|449356747|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
124925336|NCT03945292|449356740|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
124925337|NCT03945292|449356741|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
124925338|NCT03945292|449356742|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
124925339|NCT03945292|449356743|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
124925340|NCT03945292|449356744|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
124925341|NCT03945292|449356745|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
124925342|NCT03945292|449356746|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
124925343|NCT03945292|449356747|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
124925344|NCT03945292|449356740|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
124925345|NCT03945292|449356741|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
124925346|NCT03945292|449356742|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
124925347|NCT03945292|449356743|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
124925348|NCT03945292|449356744|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
124925349|NCT03945292|449356745|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
124925350|NCT03945292|449356746|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
124925351|NCT03945292|449356747|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
124925352|NCT04295798|449356751|FG000|Overall Study|Lost to Follow-up|1|||
124925353|NCT03524118|449356756|FG000|Overall Study|Lost to Follow-up|0|||
124925354|NCT03524118|449356757|FG001|Overall Study|Lost to Follow-up|0|||
124925355|NCT03524118|449356758|FG002|Overall Study|Lost to Follow-up|0|||
124925356|NCT03524118|449356759|FG003|Overall Study|Lost to Follow-up|0|||
124925357|NCT03524118|449356760|FG004|Overall Study|Lost to Follow-up|1|||
124925358|NCT03524118|449356761|FG005|Overall Study|Lost to Follow-up|0|||
124925359|NCT03524118|449356756|FG000|Overall Study|Other|0|||
124925360|NCT03524118|449356757|FG001|Overall Study|Other|1|||
124925361|NCT03524118|449356758|FG002|Overall Study|Other|0|||
124925362|NCT03524118|449356759|FG003|Overall Study|Other|0|||
124925363|NCT03524118|449356760|FG004|Overall Study|Other|1|||
124925364|NCT03524118|449356761|FG005|Overall Study|Other|1|||
124925365|NCT03524118|449356756|FG000|Overall Study|Physician Decision|0|||
124925366|NCT03524118|449356757|FG001|Overall Study|Physician Decision|0|||
124925367|NCT03524118|449356758|FG002|Overall Study|Physician Decision|0|||
124925368|NCT03524118|449356759|FG003|Overall Study|Physician Decision|0|||
124925369|NCT03524118|449356760|FG004|Overall Study|Physician Decision|1|||
124925370|NCT03524118|449356761|FG005|Overall Study|Physician Decision|0|||
124925371|NCT03524118|449356756|FG000|Overall Study|Protocol Violation|0|||
124925372|NCT03524118|449356757|FG001|Overall Study|Protocol Violation|0|||
124925373|NCT03524118|449356758|FG002|Overall Study|Protocol Violation|1|||
124925374|NCT03524118|449356759|FG003|Overall Study|Protocol Violation|0|||
124925375|NCT03524118|449356760|FG004|Overall Study|Protocol Violation|1|||
124925376|NCT03524118|449356761|FG005|Overall Study|Protocol Violation|0|||
124925377|NCT03524118|449356756|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124925378|NCT03524118|449356757|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
124925379|NCT03524118|449356758|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
124925380|NCT03524118|449356759|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
124925381|NCT03524118|449356760|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
124925382|NCT03524118|449356761|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
124925383|NCT04650269|449356767|FG000|Overall Study|Death|3|||
124925384|NCT04650269|449356767|FG000|Overall Study|Lost to Follow-up|6|||
124925385|NCT04987320|449356768|FG000|Overall Study|Withdrawal by Subject|0|||
124925386|NCT04987320|449356769|FG001|Overall Study|Withdrawal by Subject|1|||
124925387|NCT01437709|449356770|FG000|Overall Study|Adverse Event|0|||
124925388|NCT01437709|449356771|FG001|Overall Study|Adverse Event|1|||
124925389|NCT01437709|449356772|FG002|Overall Study|Adverse Event|0|||
124925390|NCT01437709|449356770|FG000|Overall Study|Pt trasnferred care|0|||
124925391|NCT01437709|449356771|FG001|Overall Study|Pt trasnferred care|1|||
124925392|NCT01437709|449356772|FG002|Overall Study|Pt trasnferred care|0|||
124925393|NCT00085735|449356773|FG000|Overall Study|Adverse Event|1|||
124925394|NCT00085735|449356774|FG001|Overall Study|Adverse Event|0|||
124925395|NCT00085735|449356775|FG002|Overall Study|Adverse Event|0|||
124925396|NCT00085735|449356776|FG003|Overall Study|Adverse Event|0|||
124925397|NCT00085735|449356777|FG004|Overall Study|Adverse Event|0|||
124925398|NCT00085735|449356778|FG005|Overall Study|Adverse Event|0|||
124925399|NCT00085735|449356773|FG000|Overall Study|Lack of Efficacy|2|||
124925400|NCT00085735|449356774|FG001|Overall Study|Lack of Efficacy|4|||
124925401|NCT00085735|449356775|FG002|Overall Study|Lack of Efficacy|6|||
124925402|NCT00085735|449356776|FG003|Overall Study|Lack of Efficacy|3|||
124925403|NCT00085735|449356777|FG004|Overall Study|Lack of Efficacy|4|||
124925404|NCT00085735|449356778|FG005|Overall Study|Lack of Efficacy|3|||
124925405|NCT00085735|449356773|FG000|Overall Study|Lost to Follow-up|0|||
124925406|NCT00085735|449356774|FG001|Overall Study|Lost to Follow-up|1|||
124925407|NCT00085735|449356775|FG002|Overall Study|Lost to Follow-up|0|||
124925408|NCT00085735|449356776|FG003|Overall Study|Lost to Follow-up|0|||
124925409|NCT00085735|449356777|FG004|Overall Study|Lost to Follow-up|1|||
124925410|NCT00085735|449356778|FG005|Overall Study|Lost to Follow-up|0|||
124925411|NCT00085735|449356773|FG000|Overall Study|Physician Decision|2|||
124925412|NCT00085735|449356774|FG001|Overall Study|Physician Decision|3|||
124925413|NCT00085735|449356775|FG002|Overall Study|Physician Decision|2|||
124925414|NCT00085735|449356776|FG003|Overall Study|Physician Decision|3|||
124925415|NCT00085735|449356777|FG004|Overall Study|Physician Decision|11|||
124925416|NCT00085735|449356778|FG005|Overall Study|Physician Decision|8|||
124925417|NCT00085735|449356773|FG000|Overall Study|Protocol Violation|1|||
124925418|NCT00085735|449356774|FG001|Overall Study|Protocol Violation|0|||
124925419|NCT00085735|449356775|FG002|Overall Study|Protocol Violation|0|||
124925420|NCT00085735|449356776|FG003|Overall Study|Protocol Violation|0|||
124925421|NCT00085735|449356777|FG004|Overall Study|Protocol Violation|0|||
124925422|NCT00085735|449356778|FG005|Overall Study|Protocol Violation|0|||
124925423|NCT00085735|449356773|FG000|Overall Study|Withdrawal by Subject|1|||
124925424|NCT00085735|449356774|FG001|Overall Study|Withdrawal by Subject|0|||
124925425|NCT00085735|449356775|FG002|Overall Study|Withdrawal by Subject|4|||
124925426|NCT00085735|449356776|FG003|Overall Study|Withdrawal by Subject|5|||
124925427|NCT00085735|449356777|FG004|Overall Study|Withdrawal by Subject|7|||
124762727|NCT03084796|448755944|FG002|Overall Study|Randomization error|1|||
124925428|NCT00085735|449356778|FG005|Overall Study|Withdrawal by Subject|8|||
124925429|NCT00085735|449356773|FG000|Overall Study|Patient ineligible|1|||
124925430|NCT00085735|449356774|FG001|Overall Study|Patient ineligible|0|||
124925431|NCT00085735|449356775|FG002|Overall Study|Patient ineligible|3|||
124925432|NCT00085735|449356776|FG003|Overall Study|Patient ineligible|7|||
124925433|NCT00085735|449356777|FG004|Overall Study|Patient ineligible|17|||
124925434|NCT00085735|449356778|FG005|Overall Study|Patient ineligible|8|||
124925435|NCT00085735|449356773|FG000|Overall Study|Excess residual disease|2|||
124925436|NCT00085735|449356774|FG001|Overall Study|Excess residual disease|2|||
124925437|NCT00085735|449356775|FG002|Overall Study|Excess residual disease|1|||
124925438|NCT00085735|449356776|FG003|Overall Study|Excess residual disease|1|||
124925439|NCT00085735|449356777|FG004|Overall Study|Excess residual disease|1|||
124925440|NCT00085735|449356778|FG005|Overall Study|Excess residual disease|4|||
124925441|NCT00085735|449356773|FG000|Overall Study|Reason not documented|1|||
124925442|NCT00085735|449356774|FG001|Overall Study|Reason not documented|0|||
124925443|NCT00085735|449356775|FG002|Overall Study|Reason not documented|1|||
124925444|NCT00085735|449356776|FG003|Overall Study|Reason not documented|0|||
124925445|NCT00085735|449356777|FG004|Overall Study|Reason not documented|1|||
124925446|NCT00085735|449356778|FG005|Overall Study|Reason not documented|0|||
124925447|NCT00085735|449356773|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
124925448|NCT00085735|449356774|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
124925449|NCT00085735|449356775|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
124925450|NCT00085735|449356776|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
124925451|NCT00085735|449356777|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
124925452|NCT00085735|449356778|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
124925453|NCT01824875|449356779|FG000|Overall Study|Disease progression|22|||
124925454|NCT01824875|449356780|FG001|Overall Study|Disease progression|15|||
124925455|NCT01824875|449356779|FG000|Overall Study|Withdrawal by Subject|5|||
124925456|NCT01824875|449356780|FG001|Overall Study|Withdrawal by Subject|4|||
124925457|NCT01824875|449356779|FG000|Overall Study|Adverse Event|4|||
124925458|NCT01824875|449356780|FG001|Overall Study|Adverse Event|10|||
124925459|NCT01824875|449356779|FG000|Overall Study|Alternative therapy|3|||
124925460|NCT01824875|449356780|FG001|Overall Study|Alternative therapy|0|||
124925461|NCT01824875|449356779|FG000|Overall Study|Complicating disease|1|||
124925462|NCT01824875|449356780|FG001|Overall Study|Complicating disease|0|||
124925463|NCT01824875|449356779|FG000|Overall Study|Physician Decision|0|||
124925464|NCT01824875|449356780|FG001|Overall Study|Physician Decision|1|||
124925465|NCT01824875|449356779|FG000|Overall Study|Non-compliance|1|||
124925466|NCT01824875|449356780|FG001|Overall Study|Non-compliance|1|||
124925467|NCT01824875|449356779|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
124925468|NCT01824875|449356780|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
124925469|NCT01824875|449356779|FG000|Overall Study|Administrative issues|0|||
124925470|NCT01824875|449356780|FG001|Overall Study|Administrative issues|2|||
124925471|NCT01824875|449356779|FG000|Overall Study|Ineligible or never started treatment|9|||
124925472|NCT01824875|449356780|FG001|Overall Study|Ineligible or never started treatment|5|||
124925473|NCT01824875|449356779|FG000|Overall Study|Other|0|||
124925474|NCT01824875|449356780|FG001|Overall Study|Other|2|||
124925475|NCT00433329|449356783|FG000|Overall Study|Adverse Event|9|||
124925476|NCT00433329|449356783|FG000|Overall Study|Death|4|||
124925477|NCT00433329|449356783|FG000|Overall Study|Withdrew consent|3|||
124925478|NCT00433329|449356783|FG000|Overall Study|Discontinued sildenafil|2|||
124925479|NCT00433329|449356783|FG000|Overall Study|Moved out of state|1|||
124925480|NCT00433329|449356783|FG000|Overall Study|Lost to Follow-up|1|||
124925481|NCT00433329|449356783|FG000|Overall Study|Physician Decision|1|||
124925482|NCT01098812|449356784|FG000|Overall Study|Death|2|||
124925483|NCT01098812|449356785|FG001|Overall Study|Death|0|||
124925484|NCT01098812|449356786|FG002|Overall Study|Death|1|||
124925485|NCT01098812|449356784|FG000|Overall Study|Lost to Follow-up|0|||
124925486|NCT01098812|449356785|FG001|Overall Study|Lost to Follow-up|1|||
124925487|NCT01098812|449356786|FG002|Overall Study|Lost to Follow-up|0|||
124925488|NCT01129102|449356787|FG000|Overall Study|No study drug treatment|2|||
124925489|NCT01129102|449356788|FG001|Overall Study|No study drug treatment|3|||
124925490|NCT01129102|449356789|FG002|Overall Study|No study drug treatment|1|||
124925491|NCT01129102|449356787|FG000|Overall Study|Withdrawal by Subject|2|||
124925492|NCT01129102|449356788|FG001|Overall Study|Withdrawal by Subject|0|||
124925493|NCT01129102|449356789|FG002|Overall Study|Withdrawal by Subject|3|||
124925494|NCT01129102|449356787|FG000|Overall Study|Protocol Violation|0|||
124925495|NCT01129102|449356788|FG001|Overall Study|Protocol Violation|1|||
124925496|NCT01129102|449356789|FG002|Overall Study|Protocol Violation|1|||
124925497|NCT01129102|449356787|FG000|Overall Study|Pregnancy|0|||
124762728|NCT03084796|448755945|FG003|Overall Study|Randomization error|0|||
124762729|NCT03084796|448755946|FG004|Overall Study|Randomization error|0|||
124762730|NCT03084796|448755947|FG005|Overall Study|Randomization error|0|||
124762731|NCT05470985|448755948|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
124925498|NCT01129102|449356788|FG001|Overall Study|Pregnancy|0|||
124925499|NCT01129102|449356789|FG002|Overall Study|Pregnancy|1|||
124925500|NCT01129102|449356787|FG000|Overall Study|Adverse Event|2|||
124925501|NCT01129102|449356788|FG001|Overall Study|Adverse Event|2|||
124925502|NCT01129102|449356789|FG002|Overall Study|Adverse Event|1|||
124925503|NCT01129102|449356787|FG000|Overall Study|Lost to Follow-up|2|||
124925504|NCT01129102|449356788|FG001|Overall Study|Lost to Follow-up|0|||
124925505|NCT01129102|449356789|FG002|Overall Study|Lost to Follow-up|0|||
124925506|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
124925507|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
124925508|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
124925509|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
124925510|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
124925511|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
124925512|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
124925513|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
124925514|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
124925515|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
124925516|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
124925517|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
124925518|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
124925519|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
124925520|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
124925521|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
124925522|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
124925523|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
124925524|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
124925525|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
124925526|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
124925527|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
124925528|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
124925529|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
124925530|NCT01715285|449356790|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
124925531|NCT01715285|449356791|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
124925532|NCT01715285|449356792|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
124925533|NCT01715285|449356790|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
124925534|NCT01715285|449356791|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
124925535|NCT01715285|449356792|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
124925536|NCT01715285|449356790|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
124925537|NCT01715285|449356791|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
124925538|NCT01715285|449356792|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
124925539|NCT01715285|449356790|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
124925540|NCT01715285|449356791|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
124925541|NCT01715285|449356792|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
124925542|NCT01715285|449356790|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
124925543|NCT01715285|449356791|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
124925544|NCT01715285|449356792|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
124925545|NCT01715285|449356790|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
124925546|NCT01715285|449356791|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
124925547|NCT01715285|449356792|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
124925548|NCT02598388|449356793|FG000|Overall Study|Lost to Follow-up|1|||
124925549|NCT02598388|449356794|FG001|Overall Study|Lost to Follow-up|0|||
124925550|NCT02598388|449356795|FG002|Overall Study|Lost to Follow-up|1|||
124925551|NCT02598388|449356796|FG003|Overall Study|Lost to Follow-up|0|||
124925552|NCT02598388|449356797|FG004|Overall Study|Lost to Follow-up|5|||
124925553|NCT02598388|449356798|FG005|Overall Study|Lost to Follow-up|1|||
124925554|NCT02598388|449356799|FG006|Overall Study|Lost to Follow-up|2|||
124925555|NCT02598388|449356800|FG007|Overall Study|Lost to Follow-up|1|||
124925556|NCT02598388|449356801|FG008|Overall Study|Lost to Follow-up|0|||
124925557|NCT02598388|449356802|FG009|Overall Study|Lost to Follow-up|0|||
124925558|NCT02598388|449356803|FG010|Overall Study|Lost to Follow-up|1|||
124925559|NCT02598388|449356804|FG011|Overall Study|Lost to Follow-up|0|||
124925560|NCT02598388|449356793|FG000|Overall Study|Withdrawal by Subject|0|||
124925561|NCT02598388|449356794|FG001|Overall Study|Withdrawal by Subject|0|||
124925562|NCT02598388|449356795|FG002|Overall Study|Withdrawal by Subject|0|||
124925563|NCT02598388|449356796|FG003|Overall Study|Withdrawal by Subject|0|||
124925564|NCT02598388|449356797|FG004|Overall Study|Withdrawal by Subject|2|||
124925565|NCT02598388|449356798|FG005|Overall Study|Withdrawal by Subject|0|||
124925566|NCT02598388|449356799|FG006|Overall Study|Withdrawal by Subject|2|||
124925567|NCT02598388|449356800|FG007|Overall Study|Withdrawal by Subject|0|||
124925568|NCT02598388|449356801|FG008|Overall Study|Withdrawal by Subject|0|||
124925569|NCT02598388|449356802|FG009|Overall Study|Withdrawal by Subject|1|||
124925570|NCT02598388|449356803|FG010|Overall Study|Withdrawal by Subject|0|||
124454468|NCT01940471|447623865|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
124925571|NCT02598388|449356804|FG011|Overall Study|Withdrawal by Subject|0|||
124925572|NCT02598388|449356793|FG000|Overall Study|Other|0|||
124925573|NCT02598388|449356794|FG001|Overall Study|Other|0|||
124925574|NCT02598388|449356795|FG002|Overall Study|Other|1|||
124925575|NCT02598388|449356796|FG003|Overall Study|Other|0|||
124925576|NCT02598388|449356797|FG004|Overall Study|Other|3|||
124925577|NCT02598388|449356798|FG005|Overall Study|Other|0|||
124925578|NCT02598388|449356799|FG006|Overall Study|Other|1|||
124925579|NCT02598388|449356800|FG007|Overall Study|Other|0|||
124925580|NCT02598388|449356801|FG008|Overall Study|Other|0|||
124454469|NCT01940471|447623862|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
124454470|NCT01940471|447623863|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
124454471|NCT01940471|447623864|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
124925581|NCT02598388|449356802|FG009|Overall Study|Other|0|||
124925582|NCT02598388|449356803|FG010|Overall Study|Other|0|||
124925583|NCT02598388|449356804|FG011|Overall Study|Other|0|||
124925584|NCT05020249|449356805|FG000|Overall Study|Protocol Violation|1|||
124925585|NCT05020249|449356806|FG001|Overall Study|Protocol Violation|0|||
124925586|NCT03628924|449356808|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
124925587|NCT03628924|449356809|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
124697165|NCT00452530|448511939|FG001|Overall Study|Withdrawal by Subject|57|||
124697166|NCT00452530|448511938|FG000|Overall Study|Lost to Follow-up|1|||
124697167|NCT00452530|448511939|FG001|Overall Study|Lost to Follow-up|0|||
124697168|NCT00452530|448511938|FG000|Overall Study|Poor compliance/noncompliance|1|||
124697169|NCT00452530|448511939|FG001|Overall Study|Poor compliance/noncompliance|2|||
124697170|NCT00452530|448511938|FG000|Overall Study|No longer met study criteria|18|||
124697171|NCT00452530|448511939|FG001|Overall Study|No longer met study criteria|22|||
124697172|NCT00452530|448511938|FG000|Overall Study|Other|7|||
124697173|NCT00452530|448511939|FG001|Overall Study|Other|11|||
124697174|NCT01608308|448511942|FG000|Overall Study|pretreatment medical and billing reasons|0|||
124697175|NCT01608308|448511943|FG001|Overall Study|pretreatment medical and billing reasons|2|||
124697176|NCT04648241|448511944|FG000|Overall Study|Lost to Follow-up|1|||
124697177|NCT04648241|448511945|FG001|Overall Study|Lost to Follow-up|0|||
124697178|NCT02057666|448511946|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
124697179|NCT02057666|448511947|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
124697180|NCT02057666|448511946|FG000|Double Blind Treatment Period|Poor tolerability|7|||
124697181|NCT02057666|448511947|FG001|Double Blind Treatment Period|Poor tolerability|2|||
124697182|NCT02057666|448511946|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
124697183|NCT02057666|448511947|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
124697184|NCT02057666|448511946|FG000|Double Blind Treatment Period|Physician Decision|1|||
124697185|NCT02057666|448511947|FG001|Double Blind Treatment Period|Physician Decision|0|||
124697186|NCT02057666|448511946|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
124697187|NCT02057666|448511947|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
124697188|NCT02057666|448511946|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
124697189|NCT02057666|448511947|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
124697190|NCT02057666|448511946|FG000|Double Blind Treatment Period|Sponsor's request|70|||
124697191|NCT02057666|448511947|FG001|Double Blind Treatment Period|Sponsor's request|34|||
124697192|NCT02057666|448511946|FG000|Open-Label Treatment Period|Poor tolerability|0|||
124697193|NCT02057666|448511947|FG001|Open-Label Treatment Period|Poor tolerability|1|||
124697194|NCT02057666|448511946|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
124697195|NCT02057666|448511947|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
124697196|NCT02057666|448511946|FG000|Open-Label Treatment Period|Sponsor's request|0|||
124697197|NCT02057666|448511947|FG001|Open-Label Treatment Period|Sponsor's request|4|||
124697198|NCT05259722|448511948|FG000|Overall Study|Adverse Event|2|||
124697199|NCT05259722|448511949|FG001|Overall Study|Adverse Event|24|||
124697200|NCT05259722|448511948|FG000|Overall Study|Lost to Follow-up|5|||
124697201|NCT05259722|448511949|FG001|Overall Study|Lost to Follow-up|1|||
124697202|NCT05259722|448511948|FG000|Overall Study|Lack of Efficacy|8|||
124697203|NCT05259722|448511949|FG001|Overall Study|Lack of Efficacy|26|||
124697204|NCT05259722|448511948|FG000|Overall Study|Withdrawal by Subject|15|||
124697205|NCT05259722|448511949|FG001|Overall Study|Withdrawal by Subject|33|||
124697206|NCT05259722|448511948|FG000|Overall Study|Various reasons|3|||
124697207|NCT05259722|448511949|FG001|Overall Study|Various reasons|9|||
124697208|NCT05259722|448511948|FG000|Overall Study|Not exposed to IMP|1|||
124697209|NCT05259722|448511949|FG001|Overall Study|Not exposed to IMP|12|||
124697210|NCT05259722|448511948|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
124697211|NCT05259722|448511949|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
124697212|NCT00962650|448511950|FG000|Overall Study|Transgastric DP was not completed|2|||
124697213|NCT00498485|448511956|FG000|Overall Study|Adverse Event|1|||
124697214|NCT00498485|448511957|FG001|Overall Study|Adverse Event|5|||
124697215|NCT01539525|448511958|FG000|Overall Study|Lost to Follow-up|19|||
124697216|NCT01539525|448511959|FG001|Overall Study|Lost to Follow-up|12|||
124697217|NCT01539525|448511960|FG002|Overall Study|Lost to Follow-up|11|||
124697218|NCT01539525|448511958|FG000|Overall Study|Withdrawal by Subject|0|||
124697219|NCT01539525|448511959|FG001|Overall Study|Withdrawal by Subject|3|||
124697220|NCT01539525|448511960|FG002|Overall Study|Withdrawal by Subject|2|||
124697221|NCT01539525|448511958|FG000|Overall Study|Protocol Violation|1|||
124697222|NCT01539525|448511959|FG001|Overall Study|Protocol Violation|1|||
124697223|NCT01539525|448511960|FG002|Overall Study|Protocol Violation|4|||
124697224|NCT01712074|448511961|FG000|Placebo Run-in Period|Adverse Event|2|||
124697225|NCT01712074|448511962|FG001|Placebo Run-in Period|Adverse Event|0|||
124454472|NCT01940471|447623865|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
124697226|NCT01712074|448511963|FG002|Placebo Run-in Period|Adverse Event|0|||
124697227|NCT01712074|448511961|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
124697228|NCT01712074|448511962|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
124697229|NCT01712074|448511963|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
124697230|NCT01712074|448511961|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
124697231|NCT01712074|448511962|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
124697232|NCT01712074|448511963|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
124697233|NCT01712074|448511961|FG000|Placebo Run-in Period|Other|1|||
124762732|NCT05470985|448755949|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
124762733|NCT05470985|448755948|FG000|Double Blind Treatment Period|Physician Decision|0|||
124762734|NCT05470985|448755949|FG001|Double Blind Treatment Period|Physician Decision|1|||
124762735|NCT05470985|448755948|FG000|Long Term Extension|Adverse Event|0|||
124762736|NCT05470985|448755949|FG001|Long Term Extension|Adverse Event|1|||
124762737|NCT05470985|448755948|FG000|Long Term Extension|Study terminated by sponsor|2|||
124762738|NCT05470985|448755949|FG001|Long Term Extension|Study terminated by sponsor|0|||
124762739|NCT01917747|448755950|FG000|Overall Study|Withdrawal by Subject|1|||
124762740|NCT01917747|448755951|FG001|Overall Study|Withdrawal by Subject|2|||
124762741|NCT01917747|448755950|FG000|Overall Study|Lost to Follow-up|18|||
124762742|NCT01917747|448755951|FG001|Overall Study|Lost to Follow-up|9|||
124762743|NCT02741245|448755952|FG000|Overall Study|Adverse Event|0|||
124762744|NCT02741245|448755953|FG001|Overall Study|Adverse Event|0|||
124925588|NCT03628924|449356810|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
124925589|NCT03628924|449356811|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
124925590|NCT03628924|449356812|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
124925591|NCT03628924|449356813|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
124925592|NCT03628924|449356814|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
124925593|NCT03628924|449356808|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
124925594|NCT03628924|449356809|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
124925595|NCT03628924|449356810|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
124925596|NCT03628924|449356811|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
124925597|NCT03628924|449356812|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
124925598|NCT03628924|449356813|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
124925599|NCT03628924|449356814|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
124925600|NCT03628924|449356808|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
124925601|NCT03628924|449356809|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
124925602|NCT03628924|449356810|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
124925603|NCT03628924|449356811|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
124925604|NCT03628924|449356812|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
124925605|NCT03628924|449356813|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
124697234|NCT01712074|448511962|FG001|Placebo Run-in Period|Other|0|||
124697235|NCT01712074|448511963|FG002|Placebo Run-in Period|Other|0|||
124697236|NCT01712074|448511961|FG000|Placebo Run-in Period|No longer willing to participate|1|||
124697237|NCT01712074|448511962|FG001|Placebo Run-in Period|No longer willing to participate|0|||
124697238|NCT01712074|448511963|FG002|Placebo Run-in Period|No longer willing to participate|0|||
124697239|NCT01712074|448511961|FG000|Double Blind Period|Adverse Event|0|||
124697240|NCT01712074|448511962|FG001|Double Blind Period|Adverse Event|2|||
124697241|NCT01712074|448511963|FG002|Double Blind Period|Adverse Event|1|||
124697242|NCT01712074|448511961|FG000|Double Blind Period|No longer willing to participate|0|||
124697243|NCT01712074|448511962|FG001|Double Blind Period|No longer willing to participate|2|||
124697244|NCT01712074|448511963|FG002|Double Blind Period|No longer willing to participate|4|||
124697245|NCT01712074|448511961|FG000|Double Blind Period|Death|0|||
124697246|NCT01712074|448511962|FG001|Double Blind Period|Death|1|||
124697247|NCT01712074|448511963|FG002|Double Blind Period|Death|0|||
124697248|NCT01712074|448511961|FG000|Double Blind Period|Lost to Follow-up|0|||
124697249|NCT01712074|448511962|FG001|Double Blind Period|Lost to Follow-up|2|||
124762745|NCT02741245|448755954|FG002|Overall Study|Adverse Event|0|||
124762746|NCT02741245|448755955|FG003|Overall Study|Adverse Event|2|||
124697250|NCT01712074|448511963|FG002|Double Blind Period|Lost to Follow-up|1|||
124697251|NCT01712074|448511961|FG000|Double Blind Period|Other|0|||
124762747|NCT02741245|448755956|FG004|Overall Study|Adverse Event|2|||
124697252|NCT01712074|448511962|FG001|Double Blind Period|Other|4|||
124697253|NCT01712074|448511963|FG002|Double Blind Period|Other|1|||
124762748|NCT02741245|448755952|FG000|Overall Study|Protocol Violation|0|||
124762749|NCT02741245|448755953|FG001|Overall Study|Protocol Violation|1|||
124762750|NCT02741245|448755954|FG002|Overall Study|Protocol Violation|0|||
124762751|NCT02741245|448755955|FG003|Overall Study|Protocol Violation|1|||
124762752|NCT02741245|448755956|FG004|Overall Study|Protocol Violation|0|||
124925606|NCT03628924|449356814|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
124925607|NCT03628924|449356808|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
124925608|NCT03628924|449356809|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
124925609|NCT03628924|449356810|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
124925610|NCT03628924|449356811|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
124925611|NCT03628924|449356812|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
124925612|NCT03628924|449356813|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
124925613|NCT03628924|449356814|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
124925614|NCT03628924|449356808|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
124925615|NCT03628924|449356809|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
124925616|NCT03628924|449356810|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
124925617|NCT03628924|449356811|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
124925618|NCT03628924|449356812|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
124925619|NCT03628924|449356813|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
124925620|NCT03628924|449356814|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
124925621|NCT03628924|449356808|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
124925622|NCT03628924|449356809|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
124925623|NCT03628924|449356810|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
124762753|NCT02741245|448755952|FG000|Overall Study|Withdrawal by Subject|0|||
124762754|NCT02741245|448755953|FG001|Overall Study|Withdrawal by Subject|0|||
124762755|NCT02741245|448755954|FG002|Overall Study|Withdrawal by Subject|0|||
124925624|NCT03628924|449356811|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
124925625|NCT03628924|449356812|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
124925626|NCT03628924|449356813|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
124925627|NCT03628924|449356814|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
124925628|NCT03628924|449356808|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
124925629|NCT03628924|449356809|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
124925630|NCT03628924|449356810|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
124925631|NCT03628924|449356811|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
124925632|NCT03628924|449356812|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
124925633|NCT03628924|449356813|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
124925634|NCT03628924|449356814|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
124925635|NCT03628924|449356808|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
124925636|NCT03628924|449356809|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
124762756|NCT02741245|448755955|FG003|Overall Study|Withdrawal by Subject|1|||
124762757|NCT02741245|448755956|FG004|Overall Study|Withdrawal by Subject|0|||
124762758|NCT01787461|448755959|FG000|Overall Study|Adverse Event|4|||
124762759|NCT01787461|448755960|FG001|Overall Study|Adverse Event|3|||
124762760|NCT01787461|448755959|FG000|Overall Study|Lost to Follow-up|3|||
124762761|NCT01787461|448755960|FG001|Overall Study|Lost to Follow-up|2|||
124762762|NCT01787461|448755959|FG000|Overall Study|No longer met eligibility criteria|1|||
124762763|NCT01787461|448755960|FG001|Overall Study|No longer met eligibility criteria|0|||
124762764|NCT01787461|448755959|FG000|Overall Study|Withdrawal by Subject|3|||
124762765|NCT01787461|448755960|FG001|Overall Study|Withdrawal by Subject|4|||
124762766|NCT01787461|448755959|FG000|Overall Study|Protocol Violation|3|||
124762767|NCT01787461|448755960|FG001|Overall Study|Protocol Violation|0|||
124762768|NCT00152503|448755961|FG000|Overall Study|Adverse Event|4|||
124762769|NCT02922725|448755962|FG000|Overall Study|Withdrawal by Subject|1|||
124762770|NCT02922725|448755963|FG001|Overall Study|Withdrawal by Subject|0|||
124762771|NCT02922725|448755964|FG002|Overall Study|Withdrawal by Subject|0|||
124762772|NCT01300234|448755965|FG000|Overall Study|Adverse Event|1|||
124762773|NCT01300234|448755966|FG001|Overall Study|Adverse Event|1|||
124762774|NCT01300234|448755965|FG000|Overall Study|Protocol Violation|2|||
124762775|NCT01300234|448755966|FG001|Overall Study|Protocol Violation|3|||
124762776|NCT01300234|448755965|FG000|Overall Study|Withdrawal by Subject|5|||
124925637|NCT03628924|449356810|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
124925638|NCT03628924|449356811|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
124925639|NCT03628924|449356812|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
124925640|NCT03628924|449356813|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
124762777|NCT01300234|448755966|FG001|Overall Study|Withdrawal by Subject|9|||
124762778|NCT01300234|448755965|FG000|Overall Study|Lost to Follow-up|14|||
124762779|NCT01300234|448755966|FG001|Overall Study|Lost to Follow-up|12|||
124762780|NCT01300234|448755965|FG000|Overall Study|Pregnancy|2|||
124762781|NCT01300234|448755966|FG001|Overall Study|Pregnancy|1|||
124762782|NCT01300234|448755965|FG000|Overall Study|Participant reached stopping critera|2|||
124925641|NCT03628924|449356814|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
124925642|NCT03628924|449356808|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
124925643|NCT03628924|449356809|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
124925644|NCT03628924|449356810|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
124925645|NCT03628924|449356811|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
124925646|NCT03628924|449356812|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
124925647|NCT03628924|449356813|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
124925648|NCT03628924|449356814|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
124925649|NCT03628924|449356808|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
124925650|NCT03628924|449356809|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
124925651|NCT03628924|449356810|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
124925652|NCT03628924|449356811|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
124925653|NCT03628924|449356812|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
124925654|NCT03628924|449356813|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
124925655|NCT03628924|449356814|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
124925656|NCT03474679|449356821|FG000|Overall Study|Death|7|||
124925657|NCT03474679|449356821|FG000|Overall Study|Withdrawal by Subject|1|||
124925658|NCT04971681|449356830|FG000|Followup|Lost to Follow-up|1|||
124925659|NCT04971681|449356831|FG001|Followup|Lost to Follow-up|0|||
124925660|NCT00686335|449356832|FG000|Run-in Period|Adverse Event|1|||
124697254|NCT01712074|448511961|FG000|Double Blind Period|Protocol Violation|0|||
124925661|NCT00686335|449356832|FG000|Run-in Period|asthma exacerbation|1|||
124925662|NCT00686335|449356832|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
124925663|NCT04332926|449356833|FG000|Overall Study|Withdrawal by Subject|6|||
124925664|NCT04332926|449356833|FG000|Overall Study|Physician Decision|6|||
124925665|NCT04350463|449356840|FG000|Overall Study|Other reason|0|||
124925666|NCT04350463|449356841|FG001|Overall Study|Other reason|0|||
124925667|NCT04350463|449356842|FG002|Overall Study|Other reason|0|||
124925668|NCT04350463|449356843|FG003|Overall Study|Other reason|1|||
124925669|NCT04350463|449356840|FG000|Overall Study|Lost to Follow-up|0|||
124925670|NCT04350463|449356841|FG001|Overall Study|Lost to Follow-up|0|||
124925671|NCT04350463|449356842|FG002|Overall Study|Lost to Follow-up|0|||
124925672|NCT04350463|449356843|FG003|Overall Study|Lost to Follow-up|2|||
124925673|NCT04350463|449356840|FG000|Overall Study|Withdrawal by Subject|4|||
124925674|NCT04350463|449356841|FG001|Overall Study|Withdrawal by Subject|0|||
124925675|NCT04350463|449356842|FG002|Overall Study|Withdrawal by Subject|1|||
124925676|NCT04350463|449356843|FG003|Overall Study|Withdrawal by Subject|4|||
124925677|NCT04350463|449356840|FG000|Overall Study|Adverse Event|0|||
124925678|NCT04350463|449356841|FG001|Overall Study|Adverse Event|0|||
124925679|NCT04350463|449356842|FG002|Overall Study|Adverse Event|0|||
124925680|NCT04350463|449356843|FG003|Overall Study|Adverse Event|2|||
124925681|NCT04350463|449356840|FG000|Overall Study|Death|27|||
124925682|NCT04350463|449356841|FG001|Overall Study|Death|2|||
124925683|NCT04350463|449356842|FG002|Overall Study|Death|13|||
124925684|NCT04350463|449356843|FG003|Overall Study|Death|26|||
124925685|NCT04111536|449356844|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
124925686|NCT04111536|449356845|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
124925687|NCT04111536|449356844|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
124925688|NCT04111536|449356845|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
124925689|NCT04111536|449356844|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
124925690|NCT04111536|449356845|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
124925691|NCT04111536|449356844|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
124925692|NCT04111536|449356845|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
124925693|NCT05672069|449356847|FG000|Overall Study|Implant removal|1|||
124925694|NCT05672069|449356847|FG000|Overall Study|Lost to Follow-up|2|||
124925695|NCT06019559|449356848|FG000|Overall Study|Withdrawal by Subject|7|||
124925696|NCT06019559|449356849|FG001|Overall Study|Withdrawal by Subject|6|||
124925697|NCT06019559|449356850|FG002|Overall Study|Withdrawal by Subject|5|||
124925698|NCT06019559|449356848|FG000|Overall Study|Lost to Follow-up|2|||
124925699|NCT06019559|449356849|FG001|Overall Study|Lost to Follow-up|0|||
124925700|NCT06019559|449356850|FG002|Overall Study|Lost to Follow-up|3|||
124925701|NCT05949788|449356851|FG000|Overall Study|severe birth deformity|2|||
124925702|NCT05949788|449356852|FG001|Overall Study|severe birth deformity|7|||
124925703|NCT05949788|449356851|FG000|Overall Study|twin-twin transfusion syndrome|2|||
124925704|NCT05949788|449356852|FG001|Overall Study|twin-twin transfusion syndrome|7|||
124925705|NCT05949788|449356851|FG000|Overall Study|neonatal hemolytic disease|3|||
124925706|NCT05949788|449356852|FG001|Overall Study|neonatal hemolytic disease|8|||
124925707|NCT05949788|449356851|FG000|Overall Study|death within 14 days after birth|2|||
124925708|NCT05949788|449356852|FG001|Overall Study|death within 14 days after birth|6|||
124925709|NCT05949788|449356851|FG000|Overall Study|transfer to another hospital|2|||
124925710|NCT05949788|449356852|FG001|Overall Study|transfer to another hospital|6|||
124925711|NCT05213390|449356853|FG000|Overall Study|Withdrawal by Subject|2|||
124925712|NCT05213390|449356853|FG000|Overall Study|Lost to Follow-up|12|||
124925713|NCT05213390|449356853|FG000|Overall Study|Protocol Violation|9|||
124925714|NCT01824537|449356854|FG000|Overall Study|Lost to Follow-up|78|||
124925715|NCT01824537|449356855|FG001|Overall Study|Lost to Follow-up|87|||
124925716|NCT03858634|449356856|FG000|Overall Study|Withdrawal by Subject|1|||
124925717|NCT03858634|449356857|FG001|Overall Study|Withdrawal by Subject|0|||
124925718|NCT03858634|449356856|FG000|Overall Study|Adverse Event|1|||
124925719|NCT03858634|449356857|FG001|Overall Study|Adverse Event|0|||
124925720|NCT03858634|449356856|FG000|Overall Study|Lost to Follow-up|0|||
124925721|NCT03858634|449356857|FG001|Overall Study|Lost to Follow-up|1|||
124925722|NCT03858634|449356856|FG000|Overall Study|Other, Not Specified|1|||
124925723|NCT03858634|449356857|FG001|Overall Study|Other, Not Specified|1|||
124925724|NCT04676763|449356858|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
124925725|NCT04676763|449356859|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
124925726|NCT04676763|449356860|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
124925727|NCT04676763|449356858|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
124925728|NCT04676763|449356859|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
124925729|NCT04676763|449356860|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
124925730|NCT04676763|449356858|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
124925731|NCT04676763|449356859|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
124925732|NCT04676763|449356860|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
124925733|NCT04623671|449356864|FG000|Overall Study|Adverse Event|0|||
124925734|NCT04623671|449356865|FG001|Overall Study|Adverse Event|1|||
124925735|NCT04623671|449356864|FG000|Overall Study|Lost to Follow-up|2|||
124925736|NCT04623671|449356865|FG001|Overall Study|Lost to Follow-up|1|||
124925737|NCT04623671|449356864|FG000|Overall Study|Death|5|||
124925738|NCT04623671|449356865|FG001|Overall Study|Death|5|||
124925739|NCT04663737|449356866|FG000|Overall Study|Withdrawal by Subject|2|||
124925740|NCT04663737|449356867|FG001|Overall Study|Withdrawal by Subject|0|||
124925741|NCT01943409|449356871|FG000|Overall Study|resumed oral/entral|24|||
124925742|NCT01943409|449356872|FG001|Overall Study|resumed oral/entral|20|||
124925743|NCT01943409|449356871|FG000|Overall Study|Protocol Violation|14|||
124925744|NCT01943409|449356872|FG001|Overall Study|Protocol Violation|24|||
124925745|NCT01943409|449356871|FG000|Overall Study|Death|3|||
124925746|NCT01943409|449356872|FG001|Overall Study|Death|1|||
124925747|NCT01943409|449356871|FG000|Overall Study|Withdrawal by Subject|4|||
124925748|NCT01943409|449356872|FG001|Overall Study|Withdrawal by Subject|3|||
124925749|NCT03848065|449356873|FG000|Overall Study|Death|0|||
124925750|NCT03848065|449356874|FG001|Overall Study|Death|1|||
124925751|NCT03848065|449356875|FG002|Overall Study|Death|0|||
124925752|NCT03848065|449356873|FG000|Overall Study|Lost to Follow-up|0|||
124925753|NCT03848065|449356874|FG001|Overall Study|Lost to Follow-up|0|||
124925754|NCT03848065|449356875|FG002|Overall Study|Lost to Follow-up|1|||
124925755|NCT03848065|449356873|FG000|Overall Study|Physician Decision|0|||
124925756|NCT03848065|449356874|FG001|Overall Study|Physician Decision|0|||
124925757|NCT03848065|449356875|FG002|Overall Study|Physician Decision|1|||
124925758|NCT03496168|449356882|FG000|Overall Study|Other Reasons|1|||
124925759|NCT03496168|449356882|FG000|Overall Study|Adverse Event|1|||
124925760|NCT04137367|449356883|FG000|Overall Study|Lost to Follow-up|8|||
124925761|NCT04137367|449356884|FG001|Overall Study|Lost to Follow-up|6|||
124925762|NCT04137367|449356885|FG002|Overall Study|Lost to Follow-up|4|||
124925763|NCT03907878|449356886|FG000|Treatment Period|Withdrawal by Subject|5|||
124925764|NCT03907878|449356886|FG000|Treatment Period|Adverse Event|4|||
124925765|NCT03907878|449356886|FG000|Treatment Period|Lack of Efficacy|1|||
124925766|NCT03907878|449356886|FG000|Treatment Period|Protocol Violation|1|||
124925767|NCT03907878|449356886|FG000|Follow-up Period|Adverse Event|3|||
124925768|NCT03907878|449356886|FG000|Follow-up Period|Withdrawal by Subject|3|||
124925769|NCT05144009|449356887|FG000|Overall Study|Lost to Follow-up|0|||
124925770|NCT05144009|449356888|FG001|Overall Study|Lost to Follow-up|1|||
124925771|NCT05144009|449356887|FG000|Overall Study|Study Termination by the Sponsor|11|||
124925772|NCT05144009|449356888|FG001|Overall Study|Study Termination by the Sponsor|11|||
124454473|NCT01940471|447623862|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
124454474|NCT01940471|447623863|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
124454475|NCT01940471|447623864|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
124454476|NCT01940471|447623865|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
124454477|NCT01940471|447623862|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
124454478|NCT01940471|447623863|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
124925773|NCT05144009|449356887|FG000|Overall Study|Disease Progression|1|||
124925774|NCT05144009|449356888|FG001|Overall Study|Disease Progression|0|||
124925775|NCT05144009|449356887|FG000|Overall Study|Participant Decision|0|||
124925776|NCT05144009|449356888|FG001|Overall Study|Participant Decision|2|||
124925777|NCT05144009|449356887|FG000|Overall Study|Death|5|||
124925778|NCT05144009|449356888|FG001|Overall Study|Death|10|||
124925779|NCT04499924|449356889|FG000|Overall Study|Study termination by sponsor|4|||
124925780|NCT04499924|449356890|FG001|Overall Study|Study termination by sponsor|6|||
124925781|NCT04499924|449356889|FG000|Overall Study|Withdrawal by Subject|1|||
124925782|NCT04499924|449356890|FG001|Overall Study|Withdrawal by Subject|3|||
124925783|NCT01648023|449356891|FG000|Overall Study|Screen Fail Post Randomization|1|||
124925784|NCT01648023|449356892|FG001|Overall Study|Screen Fail Post Randomization|2|||
124925785|NCT03379675|449358950|FG000|Overall Study|Lost to Follow-up|0|||
124925786|NCT03379675|449358951|FG001|Overall Study|Lost to Follow-up|1|||
124762783|NCT01300234|448755966|FG001|Overall Study|Participant reached stopping critera|0|||
124762784|NCT01300234|448755965|FG000|Overall Study|Participant stopped medication|1|||
124762785|NCT01300234|448755966|FG001|Overall Study|Participant stopped medication|1|||
124762786|NCT01300234|448755965|FG000|Overall Study|Participant refused return to hospital|1|||
124762787|NCT01300234|448755966|FG001|Overall Study|Participant refused return to hospital|0|||
124762788|NCT03253679|448755967|FG000|Overall Study|Screen Failure|1|||
124762789|NCT04816214|448755968|FG000|Overall Study|Progressive Disease|4|||
124762790|NCT04816214|448755969|FG001|Overall Study|Progressive Disease|0|||
124762791|NCT04816214|448755970|FG002|Overall Study|Progressive Disease|0|||
124762792|NCT04816214|448755968|FG000|Overall Study|Death|1|||
124762793|NCT04816214|448755969|FG001|Overall Study|Death|0|||
124762794|NCT04816214|448755970|FG002|Overall Study|Death|0|||
124762795|NCT04816214|448755968|FG000|Overall Study|Study Terminated by Sponsor|1|||
124762796|NCT04816214|448755969|FG001|Overall Study|Study Terminated by Sponsor|0|||
124762797|NCT04816214|448755970|FG002|Overall Study|Study Terminated by Sponsor|0|||
124762798|NCT00550407|448755971|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
124762799|NCT00550407|448755972|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
124762800|NCT00550407|448755973|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
124762801|NCT00550407|448755971|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
124762802|NCT00550407|448755972|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
124762803|NCT00550407|448755973|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
124762804|NCT00550407|448755971|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
124762805|NCT00550407|448755972|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
124762806|NCT00550407|448755973|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
124762807|NCT00550407|448755971|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
124762808|NCT00550407|448755972|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
124762809|NCT00550407|448755973|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
124762810|NCT00550407|448755971|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
124762811|NCT00550407|448755972|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
124762812|NCT00550407|448755973|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
124762813|NCT00550407|448755971|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
124762814|NCT00550407|448755972|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
124762815|NCT00550407|448755973|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
124762816|NCT00550407|448755971|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
124762817|NCT00550407|448755972|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
124762818|NCT00550407|448755973|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
124762819|NCT00550407|448755971|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
124762820|NCT00550407|448755972|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
124762821|NCT00550407|448755973|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
124762822|NCT00550407|448755971|FG000|26-Week Randomized Phase|Adverse Event|0|||
124762823|NCT00550407|448755972|FG001|26-Week Randomized Phase|Adverse Event|5|||
124762824|NCT00550407|448755973|FG002|26-Week Randomized Phase|Adverse Event|2|||
124762825|NCT00550407|448755971|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
124925787|NCT03379675|449358952|FG002|Overall Study|Lost to Follow-up|0|||
124925788|NCT03379675|449358950|FG000|Overall Study|Adverse Event|2|||
124925789|NCT03379675|449358951|FG001|Overall Study|Adverse Event|0|||
124925790|NCT03379675|449358952|FG002|Overall Study|Adverse Event|0|||
124925791|NCT03379675|449358950|FG000|Overall Study|Withdrawal by Subject|2|||
124925792|NCT03379675|449358951|FG001|Overall Study|Withdrawal by Subject|1|||
124925793|NCT03379675|449358952|FG002|Overall Study|Withdrawal by Subject|2|||
124925794|NCT03462030|449358955|FG000|Overall Study|Withdrawal by Subject|1|||
124454479|NCT01940471|447623864|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
124454480|NCT01940471|447623865|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
124454481|NCT01940471|447623862|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
124454482|NCT01940471|447623863|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
124454483|NCT01940471|447623864|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
124454484|NCT01940471|447623865|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
124454485|NCT01940471|447623862|FG000|Period 1: Double-blind Phase|Death|2|||
124454486|NCT01940471|447623863|FG001|Period 1: Double-blind Phase|Death|1|||
124454487|NCT01940471|447623864|FG002|Period 1: Double-blind Phase|Death|0|||
124454488|NCT01940471|447623865|FG003|Period 1: Double-blind Phase|Death|0|||
124454489|NCT01940471|447623862|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
124454490|NCT01940471|447623863|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
124454491|NCT01940471|447623864|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
124454492|NCT01940471|447623865|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
124454493|NCT01940471|447623862|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
124454494|NCT01940471|447623863|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
124454495|NCT01940471|447623864|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
124545869|NCT00471237|447954412|FG000|Overall Study|Sponsor terminated study|20|||
124925795|NCT03462030|449358956|FG001|Overall Study|Withdrawal by Subject|1|||
124925796|NCT03381196|449358957|FG000|Overall Study|Withdrawal by Subject|7|||
124925797|NCT03381196|449358958|FG001|Overall Study|Withdrawal by Subject|7|||
124925798|NCT03381196|449358957|FG000|Overall Study|Other|0|||
124925799|NCT03381196|449358958|FG001|Overall Study|Other|1|||
124925800|NCT03381196|449358957|FG000|Overall Study|Lost to Follow-up|5|||
124925801|NCT03381196|449358958|FG001|Overall Study|Lost to Follow-up|4|||
124925802|NCT03381196|449358957|FG000|Overall Study|Death|0|||
124925803|NCT03381196|449358958|FG001|Overall Study|Death|1|||
124925804|NCT03381196|449358957|FG000|Overall Study|Adverse Event|1|||
124925805|NCT03381196|449358958|FG001|Overall Study|Adverse Event|0|||
124925806|NCT03381196|449358957|FG000|Overall Study|Randomized, not treated|3|||
124925807|NCT03381196|449358958|FG001|Overall Study|Randomized, not treated|6|||
124925808|NCT02675751|449358959|FG000|Overall Study|Lost to Follow-up|16|||
124925809|NCT03371381|449358960|FG000|Overall Study|Death|5|||
124925810|NCT03371381|449358960|FG000|Overall Study|Study terminated by sponsor|3|||
124925811|NCT03371381|449358960|FG000|Overall Study|Other|4|||
124925812|NCT02979327|449358961|FG000|First Intervention|Protocol Violation|1|||
124925813|NCT02979327|449358962|FG001|First Intervention|Protocol Violation|0|||
124925814|NCT01539083|449358970|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
124925815|NCT01539083|449358971|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
124925816|NCT01539083|449358972|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
124925817|NCT01539083|449358970|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
124925818|NCT01539083|449358971|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
124925819|NCT01539083|449358972|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
124925820|NCT01539083|449358970|FG000|Before Randomization (VCD Induction)|Death|6|||
124925821|NCT01539083|449358971|FG001|Before Randomization (VCD Induction)|Death|0|||
124925822|NCT01539083|449358972|FG002|Before Randomization (VCD Induction)|Death|0|||
124925823|NCT01539083|449358970|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
124925824|NCT01539083|449358971|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
124925825|NCT01539083|449358972|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
124925826|NCT01539083|449358970|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
124925827|NCT01539083|449358971|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
124925828|NCT01539083|449358972|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
124925829|NCT01539083|449358970|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
124925830|NCT01539083|449358971|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
124925831|NCT01539083|449358972|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
124925832|NCT01539083|449358970|FG000|Before Randomization (VCD Induction)|Other|5|||
124925833|NCT01539083|449358971|FG001|Before Randomization (VCD Induction)|Other|0|||
124925834|NCT01539083|449358972|FG002|Before Randomization (VCD Induction)|Other|0|||
124925835|NCT01539083|449358970|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
124925836|NCT01539083|449358971|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
124925837|NCT01539083|449358972|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
124925838|NCT01539083|449358970|FG000|After Randomization (TP and VTP)|Other|0|||
124925839|NCT01539083|449358971|FG001|After Randomization (TP and VTP)|Other|1|||
124925840|NCT01539083|449358972|FG002|After Randomization (TP and VTP)|Other|1|||
124925841|NCT01539083|449358970|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
124925842|NCT01539083|449358971|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
124925843|NCT01539083|449358972|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
124925844|NCT01539083|449358970|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
124925845|NCT01539083|449358971|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
124925846|NCT01539083|449358972|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
124697255|NCT01712074|448511962|FG001|Double Blind Period|Protocol Violation|0|||
124925847|NCT01539083|449358970|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
124545870|NCT00471237|447954413|FG001|Overall Study|Sponsor terminated study|23|||
124925848|NCT01539083|449358971|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
124925849|NCT01539083|449358972|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
124925850|NCT01539083|449358970|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
124969570|NCT03520075|449517426|FG017|Phase 2 (Dose Expansion)|Death|14|||
124969571|NCT03520075|449517427|FG018|Phase 2 (Dose Expansion)|Death|12|||
124969572|NCT03520075|449517409|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969573|NCT03520075|449517410|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969574|NCT03520075|449517411|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969575|NCT03520075|449517412|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969576|NCT03520075|449517413|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969577|NCT03520075|449517414|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969578|NCT03520075|449517415|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969579|NCT03520075|449517416|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969580|NCT03520075|449517417|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124697256|NCT01712074|448511963|FG002|Double Blind Period|Protocol Violation|1|||
124697257|NCT01712074|448511961|FG000|Double Blind Period|No longer met eligibility criteria|0|||
124697258|NCT01712074|448511962|FG001|Double Blind Period|No longer met eligibility criteria|3|||
124697259|NCT01712074|448511963|FG002|Double Blind Period|No longer met eligibility criteria|0|||
124697260|NCT02268851|448511964|FG000|Overall Study|Death|0|||
124697261|NCT02268851|448511965|FG001|Overall Study|Death|0|||
124697262|NCT02268851|448511966|FG002|Overall Study|Death|0|||
124697263|NCT02268851|448511967|FG003|Overall Study|Death|1|||
124697264|NCT02268851|448511968|FG004|Overall Study|Death|2|||
124697265|NCT02268851|448511969|FG005|Overall Study|Death|1|||
124697266|NCT02268851|448511964|FG000|Overall Study|Adverse Event|0|||
124697267|NCT02268851|448511965|FG001|Overall Study|Adverse Event|0|||
124697268|NCT02268851|448511966|FG002|Overall Study|Adverse Event|0|||
124697269|NCT02268851|448511967|FG003|Overall Study|Adverse Event|0|||
124697270|NCT02268851|448511968|FG004|Overall Study|Adverse Event|2|||
124697271|NCT02268851|448511969|FG005|Overall Study|Adverse Event|2|||
124697272|NCT02268851|448511964|FG000|Overall Study|Withdrawal by Subject|0|||
124697273|NCT02268851|448511965|FG001|Overall Study|Withdrawal by Subject|0|||
124697274|NCT02268851|448511966|FG002|Overall Study|Withdrawal by Subject|0|||
124697275|NCT02268851|448511967|FG003|Overall Study|Withdrawal by Subject|2|||
124697276|NCT02268851|448511968|FG004|Overall Study|Withdrawal by Subject|0|||
124697277|NCT02268851|448511969|FG005|Overall Study|Withdrawal by Subject|1|||
124697278|NCT02268851|448511964|FG000|Overall Study|Progressive Disease|1|||
124697279|NCT02268851|448511965|FG001|Overall Study|Progressive Disease|3|||
124697280|NCT02268851|448511966|FG002|Overall Study|Progressive Disease|0|||
124697281|NCT02268851|448511967|FG003|Overall Study|Progressive Disease|0|||
124697282|NCT02268851|448511968|FG004|Overall Study|Progressive Disease|1|||
124697283|NCT02268851|448511969|FG005|Overall Study|Progressive Disease|4|||
124697284|NCT02268851|448511964|FG000|Overall Study|Physician Decision|0|||
124697285|NCT02268851|448511965|FG001|Overall Study|Physician Decision|0|||
124697286|NCT02268851|448511966|FG002|Overall Study|Physician Decision|1|||
124697287|NCT02268851|448511967|FG003|Overall Study|Physician Decision|0|||
124697288|NCT02268851|448511968|FG004|Overall Study|Physician Decision|0|||
124697289|NCT02268851|448511969|FG005|Overall Study|Physician Decision|1|||
124697290|NCT02268851|448511964|FG000|Overall Study|Patient Compliance|0|||
124697291|NCT02268851|448511965|FG001|Overall Study|Patient Compliance|0|||
124697292|NCT02268851|448511966|FG002|Overall Study|Patient Compliance|0|||
124697293|NCT02268851|448511967|FG003|Overall Study|Patient Compliance|0|||
124697294|NCT02268851|448511968|FG004|Overall Study|Patient Compliance|1|||
124697295|NCT02268851|448511969|FG005|Overall Study|Patient Compliance|1|||
124697296|NCT02268851|448511964|FG000|Overall Study|Co-Morbid Condition|0|||
124697297|NCT02268851|448511965|FG001|Overall Study|Co-Morbid Condition|0|||
124697298|NCT02268851|448511966|FG002|Overall Study|Co-Morbid Condition|0|||
124697299|NCT02268851|448511967|FG003|Overall Study|Co-Morbid Condition|0|||
124697300|NCT02268851|448511968|FG004|Overall Study|Co-Morbid Condition|1|||
124697301|NCT02268851|448511969|FG005|Overall Study|Co-Morbid Condition|1|||
124697302|NCT02539394|448511972|FG000|Overall Study|Protocol Violation|1|||
124697303|NCT02539394|448511973|FG001|Overall Study|Protocol Violation|3|||
124697304|NCT02539394|448511972|FG000|Overall Study|Lost to Follow-up|1|||
124697305|NCT02539394|448511973|FG001|Overall Study|Lost to Follow-up|2|||
124697306|NCT02539394|448511972|FG000|Overall Study|Incomplete dataset|6|||
124697307|NCT02539394|448511973|FG001|Overall Study|Incomplete dataset|6|||
124697308|NCT01472835|448511974|FG000|Overall Study|Lost to Follow-up|2|||
124697309|NCT01472835|448511975|FG001|Overall Study|Lost to Follow-up|0|||
124697310|NCT02205359|448511977|FG000|Overall Study|Death|293|||
124697311|NCT02205359|448511978|FG001|Overall Study|Death|327|||
124697312|NCT02205359|448511977|FG000|Overall Study|Lost to Follow-up|182|||
124697313|NCT02205359|448511978|FG001|Overall Study|Lost to Follow-up|162|||
124697314|NCT02205359|448511977|FG000|Overall Study|Physician Decision|51|||
124697315|NCT02205359|448511978|FG001|Overall Study|Physician Decision|53|||
124697316|NCT02205359|448511977|FG000|Overall Study|Withdrawal by Subject|167|||
124697317|NCT02205359|448511978|FG001|Overall Study|Withdrawal by Subject|169|||
124697318|NCT00236197|448511979|FG000|Overall Study|Withdrawal by Subject|3|||
124697319|NCT00236197|448511980|FG001|Overall Study|Withdrawal by Subject|2|||
124697320|NCT00236197|448511979|FG000|Overall Study|Lost to Follow-up|1|||
124697321|NCT00236197|448511980|FG001|Overall Study|Lost to Follow-up|5|||
124697322|NCT00236197|448511979|FG000|Overall Study|Protocol Violation|0|||
124697323|NCT00236197|448511980|FG001|Overall Study|Protocol Violation|3|||
124697324|NCT00236197|448511979|FG000|Overall Study|Medication non-compliance|1|||
124697325|NCT00236197|448511980|FG001|Overall Study|Medication non-compliance|2|||
124697326|NCT00236197|448511979|FG000|Overall Study|Other|0|||
124697327|NCT00236197|448511980|FG001|Overall Study|Other|2|||
124697328|NCT02792257|448511985|FG000|Overall Study|Lost to Follow-up|3|||
124697329|NCT02792257|448511986|FG001|Overall Study|Lost to Follow-up|4|||
124697330|NCT02792257|448511985|FG000|Overall Study|Allergy|0|||
124697331|NCT02792257|448511986|FG001|Overall Study|Allergy|1|||
124925851|NCT01539083|449358971|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
124925852|NCT01539083|449358972|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
124925853|NCT01539083|449358970|FG000|After Randomization (TP and VTP)|Death|0|||
124925854|NCT01539083|449358971|FG001|After Randomization (TP and VTP)|Death|6|||
124925855|NCT01539083|449358972|FG002|After Randomization (TP and VTP)|Death|11|||
124925856|NCT05499377|449358973|FG000|Overall Study|Withdrawal by Subject|2|||
124925857|NCT05499377|449358974|FG001|Overall Study|Withdrawal by Subject|0|||
124925858|NCT05499377|449358973|FG000|Overall Study|Physician Decision|1|||
124925859|NCT05499377|449358974|FG001|Overall Study|Physician Decision|0|||
124925860|NCT02573493|449358975|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
124925861|NCT02573493|449358976|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
124925862|NCT02573493|449358977|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
124925863|NCT02573493|449358978|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
124925864|NCT02677805|449358984|FG000|Double Blind Phase|Lost to Follow-up|8|||
124925865|NCT02677805|449358985|FG001|Double Blind Phase|Lost to Follow-up|3|||
124925866|NCT02677805|449358986|FG002|Double Blind Phase|Lost to Follow-up|0|||
124925867|NCT02677805|449358984|FG000|Double Blind Phase|Withdrawal by Subject|5|||
124925868|NCT02677805|449358985|FG001|Double Blind Phase|Withdrawal by Subject|2|||
124925869|NCT02677805|449358986|FG002|Double Blind Phase|Withdrawal by Subject|0|||
124925870|NCT02677805|449358984|FG000|Open Label Phase|Lost to Follow-up|0|||
124925871|NCT02677805|449358985|FG001|Open Label Phase|Lost to Follow-up|0|||
124925872|NCT02677805|449358986|FG002|Open Label Phase|Lost to Follow-up|10|||
124925873|NCT02677805|449358984|FG000|Open Label Phase|Withdrawal by Subject|0|||
124925874|NCT02677805|449358985|FG001|Open Label Phase|Withdrawal by Subject|0|||
124925875|NCT02677805|449358986|FG002|Open Label Phase|Withdrawal by Subject|6|||
124925876|NCT05714761|449358987|FG000|Overall Study|Lost to Follow-up|3|||
124925877|NCT05714761|449358987|FG000|Overall Study|Withdrawal by Subject|3|||
124925878|NCT05714761|449358987|FG000|Overall Study|unblinding of sensor data|1|||
124925879|NCT05714761|449358987|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
124925880|NCT05714761|449358987|FG000|Overall Study|did not return second CGM sensor|4|||
124925881|NCT03150173|449358988|FG000|Overall Study|Lost to Follow-up|13|||
124925882|NCT03150173|449358989|FG001|Overall Study|Lost to Follow-up|5|||
124925883|NCT02191618|449358996|FG000|Overall Study|Withdrawal by Subject|3|||
124925884|NCT02191618|449358996|FG000|Overall Study|Missed Visit|4|||
124925885|NCT01802788|449358999|FG000|Overall Study|Withdrawal by Subject|102|||
124925886|NCT01802788|449359000|FG001|Overall Study|Withdrawal by Subject|5|||
124925887|NCT01802788|449358999|FG000|Overall Study|Death|382|||
124925888|NCT01802788|449359000|FG001|Overall Study|Death|18|||
124925889|NCT01802788|449358999|FG000|Overall Study|Lost to Follow-up|31|||
124925890|NCT01802788|449359000|FG001|Overall Study|Lost to Follow-up|2|||
124925891|NCT01802788|449358999|FG000|Overall Study|Physician Decision|3|||
124925892|NCT01802788|449359000|FG001|Overall Study|Physician Decision|0|||
124925893|NCT01802788|449358999|FG000|Overall Study|Patient Non-Compliance|1|||
124925894|NCT01802788|449359000|FG001|Overall Study|Patient Non-Compliance|0|||
124925895|NCT01802788|449358999|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
124925896|NCT01802788|449359000|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
124697332|NCT02792257|448511985|FG000|Overall Study|Protocol Violation|2|||
124925897|NCT01802788|449358999|FG000|Overall Study|Other Reasons|19|||
124925898|NCT01802788|449359000|FG001|Overall Study|Other Reasons|0|||
124925899|NCT03011333|449359007|FG000|Overall Study|Lost to Follow-up|0|||
124925900|NCT03011333|449359008|FG001|Overall Study|Lost to Follow-up|1|||
124925901|NCT03011333|449359009|FG002|Overall Study|Lost to Follow-up|0|||
124925902|NCT03011333|449359010|FG003|Overall Study|Lost to Follow-up|1|||
124925903|NCT03011333|449359011|FG004|Overall Study|Lost to Follow-up|4|||
124925904|NCT03011333|449359012|FG005|Overall Study|Lost to Follow-up|4|||
124925905|NCT03011333|449359013|FG006|Overall Study|Lost to Follow-up|5|||
124697333|NCT02792257|448511986|FG001|Overall Study|Protocol Violation|0|||
124925906|NCT05269667|449359018|FG000|Overall Study|Study Terminated by Sponsor|4|||
124925907|NCT04599062|449359024|FG000|Overall Study|Physician Decision|1|||
124925908|NCT04599062|449359025|FG001|Overall Study|Physician Decision|0|||
124925909|NCT04074759|449359027|FG000|Overall Study|Withdrawal by Subject|0|||
124925910|NCT04074759|449359028|FG001|Overall Study|Withdrawal by Subject|0|||
124925911|NCT04074759|449359029|FG002|Overall Study|Withdrawal by Subject|0|||
124925912|NCT04074759|449359030|FG003|Overall Study|Withdrawal by Subject|0|||
124925913|NCT04074759|449359031|FG004|Overall Study|Withdrawal by Subject|0|||
124925914|NCT04074759|449359032|FG005|Overall Study|Withdrawal by Subject|2|||
124454496|NCT01940471|447623865|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
124454497|NCT01940471|447623862|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
124454498|NCT01940471|447623863|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
124454499|NCT01940471|447623864|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
124454500|NCT01940471|447623865|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
124454501|NCT01940471|447623862|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
124454502|NCT01940471|447623863|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
124454503|NCT01940471|447623864|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
124454504|NCT01940471|447623865|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
124925915|NCT04074759|449359033|FG006|Overall Study|Withdrawal by Subject|0|||
124925916|NCT04074759|449359034|FG007|Overall Study|Withdrawal by Subject|2|||
124925917|NCT04074759|449359035|FG008|Overall Study|Withdrawal by Subject|1|||
124925918|NCT04074759|449359036|FG009|Overall Study|Withdrawal by Subject|2|||
124925919|NCT04074759|449359037|FG010|Overall Study|Withdrawal by Subject|9|||
124925920|NCT04074759|449359038|FG011|Overall Study|Withdrawal by Subject|2|||
124925921|NCT04074759|449359039|FG012|Overall Study|Withdrawal by Subject|1|||
124925922|NCT04074759|449359040|FG013|Overall Study|Withdrawal by Subject|3|||
124925923|NCT04074759|449359041|FG014|Overall Study|Withdrawal by Subject|2|||
124925924|NCT04074759|449359042|FG015|Overall Study|Withdrawal by Subject|0|||
124925925|NCT04074759|449359043|FG016|Overall Study|Withdrawal by Subject|0|||
124925926|NCT04074759|449359044|FG017|Overall Study|Withdrawal by Subject|3|||
124925927|NCT04074759|449359045|FG018|Overall Study|Withdrawal by Subject|1|||
124925928|NCT04074759|449359027|FG000|Overall Study|Death|1|||
124925929|NCT04074759|449359028|FG001|Overall Study|Death|0|||
124925930|NCT04074759|449359029|FG002|Overall Study|Death|1|||
124925931|NCT04074759|449359030|FG003|Overall Study|Death|1|||
124925932|NCT04074759|449359031|FG004|Overall Study|Death|2|||
124925933|NCT04074759|449359032|FG005|Overall Study|Death|0|||
124925934|NCT04074759|449359033|FG006|Overall Study|Death|1|||
124925935|NCT04074759|449359034|FG007|Overall Study|Death|0|||
124925936|NCT04074759|449359035|FG008|Overall Study|Death|3|||
124697334|NCT02792257|448511985|FG000|Overall Study|Excessive Agitation|0|||
124697335|NCT02792257|448511986|FG001|Overall Study|Excessive Agitation|1|||
124697336|NCT02792257|448511985|FG000|Overall Study|Not Feeling Well|0|||
124697337|NCT02792257|448511986|FG001|Overall Study|Not Feeling Well|1|||
124697338|NCT00553475|448511987|FG000|Overall Study|Adverse Event|7|||
124697339|NCT00553475|448511988|FG001|Overall Study|Adverse Event|17|||
124697340|NCT00553475|448511989|FG002|Overall Study|Adverse Event|13|||
124925937|NCT04074759|449359036|FG009|Overall Study|Death|2|||
124925938|NCT04074759|449359037|FG010|Overall Study|Death|4|||
124925939|NCT04074759|449359038|FG011|Overall Study|Death|1|||
124925940|NCT04074759|449359039|FG012|Overall Study|Death|0|||
124925941|NCT04074759|449359040|FG013|Overall Study|Death|2|||
124925942|NCT04074759|449359041|FG014|Overall Study|Death|1|||
124925943|NCT04074759|449359042|FG015|Overall Study|Death|0|||
124925944|NCT04074759|449359043|FG016|Overall Study|Death|1|||
124925945|NCT04074759|449359044|FG017|Overall Study|Death|0|||
124925946|NCT04074759|449359045|FG018|Overall Study|Death|1|||
124925947|NCT04074759|449359027|FG000|Overall Study|Lost to Follow-up|0|||
124925948|NCT04074759|449359028|FG001|Overall Study|Lost to Follow-up|0|||
124925949|NCT04074759|449359029|FG002|Overall Study|Lost to Follow-up|0|||
124925950|NCT04074759|449359030|FG003|Overall Study|Lost to Follow-up|0|||
124925951|NCT04074759|449359031|FG004|Overall Study|Lost to Follow-up|0|||
124925952|NCT04074759|449359032|FG005|Overall Study|Lost to Follow-up|0|||
124925953|NCT04074759|449359033|FG006|Overall Study|Lost to Follow-up|0|||
124925954|NCT04074759|449359034|FG007|Overall Study|Lost to Follow-up|0|||
124925955|NCT04074759|449359035|FG008|Overall Study|Lost to Follow-up|0|||
124925956|NCT04074759|449359036|FG009|Overall Study|Lost to Follow-up|0|||
124925957|NCT04074759|449359037|FG010|Overall Study|Lost to Follow-up|1|||
124925958|NCT04074759|449359038|FG011|Overall Study|Lost to Follow-up|0|||
124925959|NCT04074759|449359039|FG012|Overall Study|Lost to Follow-up|0|||
124925960|NCT04074759|449359040|FG013|Overall Study|Lost to Follow-up|0|||
124925961|NCT04074759|449359041|FG014|Overall Study|Lost to Follow-up|0|||
124925962|NCT04074759|449359042|FG015|Overall Study|Lost to Follow-up|0|||
124925963|NCT04074759|449359043|FG016|Overall Study|Lost to Follow-up|1|||
124925964|NCT04074759|449359044|FG017|Overall Study|Lost to Follow-up|0|||
124925965|NCT04074759|449359045|FG018|Overall Study|Lost to Follow-up|1|||
124925966|NCT04074759|449359027|FG000|Overall Study|Other|0|||
124925967|NCT04074759|449359028|FG001|Overall Study|Other|1|||
124925968|NCT04074759|449359029|FG002|Overall Study|Other|1|||
124925969|NCT04074759|449359030|FG003|Overall Study|Other|0|||
124925970|NCT04074759|449359031|FG004|Overall Study|Other|2|||
124925971|NCT04074759|449359032|FG005|Overall Study|Other|1|||
124697341|NCT00553475|448511987|FG000|Overall Study|Lack of Efficacy|7|||
124697342|NCT00553475|448511988|FG001|Overall Study|Lack of Efficacy|1|||
124697343|NCT00553475|448511989|FG002|Overall Study|Lack of Efficacy|0|||
124697344|NCT00553475|448511987|FG000|Overall Study|Withdrawal by Subject|1|||
124697345|NCT00553475|448511988|FG001|Overall Study|Withdrawal by Subject|1|||
124697346|NCT00553475|448511989|FG002|Overall Study|Withdrawal by Subject|0|||
124697347|NCT00553475|448511987|FG000|Overall Study|Physician Decision|1|||
124697348|NCT00553475|448511988|FG001|Overall Study|Physician Decision|0|||
124697349|NCT00553475|448511989|FG002|Overall Study|Physician Decision|0|||
124697350|NCT00553475|448511987|FG000|Overall Study|Due to moving|0|||
124697351|NCT00553475|448511988|FG001|Overall Study|Due to moving|1|||
124697352|NCT00553475|448511989|FG002|Overall Study|Due to moving|0|||
124697353|NCT00992394|448511994|FG000|Overall Study|Lack of Efficacy|6|||
124697354|NCT00992394|448511995|FG001|Overall Study|Lack of Efficacy|3|||
124697355|NCT00992394|448511994|FG000|Overall Study|Adverse Event|4|||
124697356|NCT00992394|448511995|FG001|Overall Study|Adverse Event|5|||
124697357|NCT00992394|448511994|FG000|Overall Study|Withdrawal by Subject|8|||
124697358|NCT00992394|448511995|FG001|Overall Study|Withdrawal by Subject|2|||
124697359|NCT00992394|448511994|FG000|Overall Study|Physician Decision|1|||
124697360|NCT00992394|448511995|FG001|Overall Study|Physician Decision|0|||
124697361|NCT00992394|448511994|FG000|Overall Study|Protocol Violation|2|||
124925972|NCT04074759|449359033|FG006|Overall Study|Other|2|||
124925973|NCT04074759|449359034|FG007|Overall Study|Other|1|||
124925974|NCT04074759|449359035|FG008|Overall Study|Other|1|||
124925975|NCT04074759|449359036|FG009|Overall Study|Other|4|||
124925976|NCT04074759|449359037|FG010|Overall Study|Other|4|||
124925977|NCT04074759|449359038|FG011|Overall Study|Other|2|||
124925978|NCT04074759|449359039|FG012|Overall Study|Other|0|||
124925979|NCT04074759|449359040|FG013|Overall Study|Other|0|||
124925980|NCT04074759|449359041|FG014|Overall Study|Other|0|||
124697362|NCT00992394|448511995|FG001|Overall Study|Protocol Violation|4|||
124697363|NCT00992394|448511994|FG000|Overall Study|Lost to Follow-up|2|||
124697364|NCT00992394|448511995|FG001|Overall Study|Lost to Follow-up|0|||
124697365|NCT00992394|448511994|FG000|Overall Study|Other event|1|||
124697366|NCT00992394|448511995|FG001|Overall Study|Other event|0|||
124697367|NCT01905683|448511996|FG000|Overall Study|Protocol Violation|1|||
124925981|NCT04074759|449359042|FG015|Overall Study|Other|1|||
124925982|NCT04074759|449359043|FG016|Overall Study|Other|0|||
124925983|NCT04074759|449359044|FG017|Overall Study|Other|0|||
124925984|NCT04074759|449359045|FG018|Overall Study|Other|0|||
124925985|NCT04074759|449359027|FG000|Overall Study|Missing end of study status|0|||
124925986|NCT04074759|449359028|FG001|Overall Study|Missing end of study status|0|||
124454505|NCT01940471|447623862|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
124454506|NCT01940471|447623863|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
124454507|NCT01940471|447623864|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
124454508|NCT01940471|447623865|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
124454509|NCT01940471|447623862|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
124454510|NCT01940471|447623863|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
124454511|NCT01940471|447623864|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
124454512|NCT01940471|447623865|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
124454513|NCT01940471|447623862|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
124454514|NCT01940471|447623863|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
124454515|NCT01940471|447623864|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
124925987|NCT04074759|449359029|FG002|Overall Study|Missing end of study status|0|||
124925988|NCT04074759|449359030|FG003|Overall Study|Missing end of study status|0|||
124925989|NCT04074759|449359031|FG004|Overall Study|Missing end of study status|0|||
124925990|NCT04074759|449359032|FG005|Overall Study|Missing end of study status|0|||
124925991|NCT04074759|449359033|FG006|Overall Study|Missing end of study status|0|||
124925992|NCT04074759|449359034|FG007|Overall Study|Missing end of study status|0|||
124925993|NCT04074759|449359035|FG008|Overall Study|Missing end of study status|0|||
124925994|NCT04074759|449359036|FG009|Overall Study|Missing end of study status|0|||
124925995|NCT04074759|449359037|FG010|Overall Study|Missing end of study status|2|||
124925996|NCT04074759|449359038|FG011|Overall Study|Missing end of study status|0|||
124925997|NCT04074759|449359039|FG012|Overall Study|Missing end of study status|0|||
124925998|NCT04074759|449359040|FG013|Overall Study|Missing end of study status|0|||
124925999|NCT04074759|449359041|FG014|Overall Study|Missing end of study status|0|||
124926000|NCT04074759|449359042|FG015|Overall Study|Missing end of study status|0|||
124926001|NCT04074759|449359043|FG016|Overall Study|Missing end of study status|1|||
124926002|NCT04074759|449359044|FG017|Overall Study|Missing end of study status|0|||
124926003|NCT04074759|449359045|FG018|Overall Study|Missing end of study status|0|||
124926004|NCT05399459|449359054|FG000|Overall Study|Randomized but not treated|29|||
124926005|NCT05399459|449359055|FG001|Overall Study|Randomized but not treated|30|||
124926006|NCT05399459|449359056|FG002|Overall Study|Randomized but not treated|38|||
124926007|NCT05399459|449359054|FG000|Overall Study|Lost to Follow-up|1|||
124926008|NCT05399459|449359055|FG001|Overall Study|Lost to Follow-up|0|||
124926009|NCT05399459|449359056|FG002|Overall Study|Lost to Follow-up|0|||
124926010|NCT02231164|449359057|FG000|Overall Study|Adverse Event|1|||
124926011|NCT02231164|449359058|FG001|Overall Study|Adverse Event|1|||
124926012|NCT02231164|449359057|FG000|Overall Study|Lack of Efficacy|4|||
124926013|NCT02231164|449359058|FG001|Overall Study|Lack of Efficacy|3|||
124926014|NCT02231164|449359057|FG000|Overall Study|Withdrawal by Subject|1|||
124926015|NCT02231164|449359058|FG001|Overall Study|Withdrawal by Subject|2|||
124926016|NCT01210807|449359059|FG000|Overall Study|Lost to Follow-up|1|||
124926017|NCT01210807|449359060|FG001|Overall Study|Lost to Follow-up|2|||
124926018|NCT01210807|449359059|FG000|Overall Study|Not implanted bilaterally|2|||
124926019|NCT01210807|449359060|FG001|Overall Study|Not implanted bilaterally|1|||
124926020|NCT04436276|449359061|FG000|Overall Study|Adverse Event|0|||
124926021|NCT04436276|449359062|FG001|Overall Study|Adverse Event|0|||
124926022|NCT04436276|449359063|FG002|Overall Study|Adverse Event|0|||
124926023|NCT04436276|449359064|FG003|Overall Study|Adverse Event|0|||
124926024|NCT04436276|449359065|FG004|Overall Study|Adverse Event|0|||
124926025|NCT04436276|449359066|FG005|Overall Study|Adverse Event|0|||
124926026|NCT04436276|449359067|FG006|Overall Study|Adverse Event|0|||
124926027|NCT04436276|449359068|FG007|Overall Study|Adverse Event|0|||
124926028|NCT04436276|449359069|FG008|Overall Study|Adverse Event|0|||
124926029|NCT04436276|449359070|FG009|Overall Study|Adverse Event|0|||
124926030|NCT04436276|449359071|FG010|Overall Study|Adverse Event|0|||
124926031|NCT04436276|449359072|FG011|Overall Study|Adverse Event|0|||
124926032|NCT04436276|449359073|FG012|Overall Study|Adverse Event|0|||
124926033|NCT04436276|449359074|FG013|Overall Study|Adverse Event|0|||
124926034|NCT04436276|449359075|FG014|Overall Study|Adverse Event|0|||
124926035|NCT04436276|449359076|FG015|Overall Study|Adverse Event|0|||
124926036|NCT04436276|449359077|FG016|Overall Study|Adverse Event|1|||
124926037|NCT04436276|449359078|FG017|Overall Study|Adverse Event|0|||
124926038|NCT04436276|449359079|FG018|Overall Study|Adverse Event|0|||
124926039|NCT04436276|449359080|FG019|Overall Study|Adverse Event|0|||
124454516|NCT01940471|447623865|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
124926040|NCT04436276|449359081|FG020|Overall Study|Adverse Event|0|||
124926041|NCT04436276|449359082|FG021|Overall Study|Adverse Event|0|||
124926042|NCT04436276|449359083|FG022|Overall Study|Adverse Event|0|||
124926043|NCT04436276|449359061|FG000|Overall Study|Death|0|||
124926044|NCT04436276|449359062|FG001|Overall Study|Death|0|||
124926045|NCT04436276|449359063|FG002|Overall Study|Death|0|||
124926046|NCT04436276|449359064|FG003|Overall Study|Death|0|||
124926047|NCT04436276|449359065|FG004|Overall Study|Death|0|||
124926048|NCT04436276|449359066|FG005|Overall Study|Death|0|||
124926049|NCT04436276|449359067|FG006|Overall Study|Death|0|||
124926050|NCT04436276|449359068|FG007|Overall Study|Death|0|||
124697368|NCT01905683|448511996|FG000|Overall Study|Re-injection criteria not met; others|13|||
124697369|NCT01905683|448511996|FG000|Overall Study|Physician Decision|1|||
124697370|NCT01905683|448511996|FG000|Overall Study|Lack of Efficacy|8|||
124697371|NCT01905683|448511996|FG000|Overall Study|Withdrawal by Subject|20|||
124697372|NCT01905683|448511996|FG000|Overall Study|Adverse Event|4|||
124697373|NCT01905683|448511996|FG000|Overall Study|Lost to Follow-up|4|||
124697374|NCT00537082|448511998|FG000|Overall Study|Adverse Event|6|||
124697375|NCT00537082|448511999|FG001|Overall Study|Adverse Event|6|||
124697376|NCT00537082|448512000|FG002|Overall Study|Adverse Event|3|||
124697377|NCT00537082|448511998|FG000|Overall Study|Protocol Violation|0|||
124697378|NCT00537082|448511999|FG001|Overall Study|Protocol Violation|2|||
124697379|NCT00537082|448512000|FG002|Overall Study|Protocol Violation|1|||
124697380|NCT00537082|448511998|FG000|Overall Study|Lack of Efficacy|0|||
124697381|NCT00537082|448511999|FG001|Overall Study|Lack of Efficacy|0|||
124697382|NCT00537082|448512000|FG002|Overall Study|Lack of Efficacy|2|||
124697383|NCT00537082|448511998|FG000|Overall Study|Withdrawal by Subject|0|||
124697384|NCT00537082|448511999|FG001|Overall Study|Withdrawal by Subject|1|||
124697385|NCT00537082|448512000|FG002|Overall Study|Withdrawal by Subject|0|||
124697386|NCT00537082|448511998|FG000|Overall Study|Discontinued before initiating treatment|3|||
124697387|NCT00537082|448511999|FG001|Overall Study|Discontinued before initiating treatment|0|||
124697388|NCT00537082|448512000|FG002|Overall Study|Discontinued before initiating treatment|0|||
124697389|NCT02568254|448512001|FG000|Period 2|Adverse Event|0|||
124697390|NCT02568254|448512002|FG001|Period 2|Adverse Event|0|||
124697391|NCT02568254|448512003|FG002|Period 2|Adverse Event|1|||
124697392|NCT02568254|448512004|FG003|Period 2|Adverse Event|0|||
124697393|NCT02568254|448512005|FG004|Period 2|Adverse Event|0|||
124697394|NCT02568254|448512006|FG005|Period 2|Adverse Event|0|||
124697395|NCT02568254|448512001|FG000|Period 3|Unstatisfactory Lens fitting|0|||
124697396|NCT02568254|448512002|FG001|Period 3|Unstatisfactory Lens fitting|0|||
124697397|NCT02568254|448512003|FG002|Period 3|Unstatisfactory Lens fitting|0|||
124697398|NCT02568254|448512004|FG003|Period 3|Unstatisfactory Lens fitting|0|||
124697399|NCT02568254|448512005|FG004|Period 3|Unstatisfactory Lens fitting|1|||
124697400|NCT02568254|448512006|FG005|Period 3|Unstatisfactory Lens fitting|0|||
124697401|NCT00655746|448512007|FG000|Overall Study|Withdrawal by Subject|1|||
124697402|NCT01793129|448513893|FG000|Overall Study|Lost to Follow-up|3|||
124697403|NCT01793129|448513894|FG001|Overall Study|Lost to Follow-up|7|||
124697404|NCT01793129|448513893|FG000|Overall Study|Withdrawal by Subject|0|||
124697405|NCT01793129|448513894|FG001|Overall Study|Withdrawal by Subject|2|||
124697406|NCT01926509|448513897|FG000|Overall Study|vital sign met discontinuation criteria|1|||
124697407|NCT01926509|448513898|FG001|Overall Study|vital sign met discontinuation criteria|0|||
124697408|NCT01926509|448513899|FG002|Overall Study|vital sign met discontinuation criteria|0|||
124697409|NCT01926509|448513900|FG003|Overall Study|vital sign met discontinuation criteria|0|||
124697410|NCT03004183|448513901|FG000|Overall Study|Adverse Event|7|||
124697411|NCT03004183|448513901|FG000|Overall Study|Lost to Follow-up|1|||
124697412|NCT03004183|448513901|FG000|Overall Study|Physician Decision|40|||
124697413|NCT03004183|448513901|FG000|Overall Study|Withdrawal by Subject|1|||
124697414|NCT03004183|448513901|FG000|Overall Study|COVID-19|1|||
124697415|NCT03681093|448513902|FG000|Overall Study|Subject decision|0|||
124697416|NCT03681093|448513903|FG001|Overall Study|Subject decision|2|||
124697417|NCT03681093|448513904|FG002|Overall Study|Subject decision|1|||
124697418|NCT02698787|448513905|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
124697419|NCT02698787|448513906|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
124697420|NCT01882829|448513910|FG000|Overall Study|Adverse Event|4|||
124697421|NCT01882829|448513910|FG000|Overall Study|Protocol Violation|1|||
124697422|NCT01882829|448513910|FG000|Overall Study|Withdrawal by Subject|1|||
124697423|NCT01313676|448513913|FG000|Overall Study|Adverse Event|395|||
124697424|NCT01313676|448513914|FG001|Overall Study|Adverse Event|365|||
124697425|NCT01313676|448513915|FG002|Overall Study|Adverse Event|372|||
124697426|NCT01313676|448513916|FG003|Overall Study|Adverse Event|333|||
124697427|NCT01313676|448513913|FG000|Overall Study|Lack of Efficacy|98|||
124697428|NCT01313676|448513914|FG001|Overall Study|Lack of Efficacy|90|||
124697429|NCT01313676|448513915|FG002|Overall Study|Lack of Efficacy|65|||
124697430|NCT01313676|448513916|FG003|Overall Study|Lack of Efficacy|46|||
124697431|NCT01313676|448513913|FG000|Overall Study|Protocol Violation|37|||
124697432|NCT01313676|448513914|FG001|Overall Study|Protocol Violation|44|||
124697433|NCT01313676|448513915|FG002|Overall Study|Protocol Violation|46|||
124697434|NCT01313676|448513916|FG003|Overall Study|Protocol Violation|44|||
124697435|NCT01313676|448513913|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
124697436|NCT01313676|448513914|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
124545871|NCT00471237|447954414|FG002|Overall Study|Sponsor terminated study|19|||
124545872|NCT00471237|447954415|FG003|Overall Study|Sponsor terminated study|22|||
124545873|NCT00471237|447954416|FG004|Overall Study|Sponsor terminated study|18|||
124545874|NCT00471237|447954417|FG005|Overall Study|Sponsor terminated study|24|||
124545875|NCT00471237|447954418|FG006|Overall Study|Sponsor terminated study|0|||
124545876|NCT00471237|447954412|FG000|Overall Study|Non-compliance|0|||
124545877|NCT00471237|447954413|FG001|Overall Study|Non-compliance|1|||
124545878|NCT00471237|447954414|FG002|Overall Study|Non-compliance|0|||
124545879|NCT00471237|447954415|FG003|Overall Study|Non-compliance|1|||
124545880|NCT00471237|447954416|FG004|Overall Study|Non-compliance|0|||
124545881|NCT00471237|447954417|FG005|Overall Study|Non-compliance|0|||
124545882|NCT00471237|447954418|FG006|Overall Study|Non-compliance|0|||
124545883|NCT00471237|447954412|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
124545884|NCT00471237|447954413|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
124545885|NCT00471237|447954414|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
124545886|NCT00471237|447954415|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
124454517|NCT01940471|447623862|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
124454518|NCT01940471|447623863|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
124454519|NCT01940471|447623864|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
124454520|NCT01940471|447623865|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
124454521|NCT01940471|447623862|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
124454522|NCT01940471|447623863|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
124545887|NCT00471237|447954416|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
124926051|NCT04436276|449359069|FG008|Overall Study|Death|0|||
124926052|NCT04436276|449359070|FG009|Overall Study|Death|0|||
124926053|NCT04436276|449359071|FG010|Overall Study|Death|0|||
124926054|NCT04436276|449359072|FG011|Overall Study|Death|0|||
124926055|NCT04436276|449359073|FG012|Overall Study|Death|1|||
124926056|NCT04436276|449359074|FG013|Overall Study|Death|0|||
124926057|NCT04436276|449359075|FG014|Overall Study|Death|1|||
124926058|NCT04436276|449359076|FG015|Overall Study|Death|0|||
124926059|NCT04436276|449359077|FG016|Overall Study|Death|0|||
124926060|NCT04436276|449359078|FG017|Overall Study|Death|0|||
124926061|NCT04436276|449359079|FG018|Overall Study|Death|0|||
124926062|NCT04436276|449359080|FG019|Overall Study|Death|2|||
124926063|NCT04436276|449359081|FG020|Overall Study|Death|0|||
124926064|NCT04436276|449359082|FG021|Overall Study|Death|1|||
124926065|NCT04436276|449359083|FG022|Overall Study|Death|0|||
124926066|NCT04436276|449359061|FG000|Overall Study|Lost to Follow-up|0|||
124926067|NCT04436276|449359062|FG001|Overall Study|Lost to Follow-up|2|||
124926068|NCT04436276|449359063|FG002|Overall Study|Lost to Follow-up|2|||
124926069|NCT04436276|449359064|FG003|Overall Study|Lost to Follow-up|1|||
124926070|NCT04436276|449359065|FG004|Overall Study|Lost to Follow-up|4|||
124926071|NCT04436276|449359066|FG005|Overall Study|Lost to Follow-up|1|||
124926072|NCT04436276|449359067|FG006|Overall Study|Lost to Follow-up|0|||
124926073|NCT04436276|449359068|FG007|Overall Study|Lost to Follow-up|0|||
124926074|NCT04436276|449359069|FG008|Overall Study|Lost to Follow-up|1|||
124926075|NCT04436276|449359070|FG009|Overall Study|Lost to Follow-up|0|||
124926076|NCT04436276|449359071|FG010|Overall Study|Lost to Follow-up|5|||
124926077|NCT04436276|449359072|FG011|Overall Study|Lost to Follow-up|5|||
124926078|NCT04436276|449359073|FG012|Overall Study|Lost to Follow-up|4|||
124926079|NCT04436276|449359074|FG013|Overall Study|Lost to Follow-up|1|||
124926080|NCT04436276|449359075|FG014|Overall Study|Lost to Follow-up|7|||
124926081|NCT04436276|449359076|FG015|Overall Study|Lost to Follow-up|7|||
124926082|NCT04436276|449359077|FG016|Overall Study|Lost to Follow-up|1|||
124926083|NCT04436276|449359078|FG017|Overall Study|Lost to Follow-up|0|||
124926084|NCT04436276|449359079|FG018|Overall Study|Lost to Follow-up|1|||
124926085|NCT04436276|449359080|FG019|Overall Study|Lost to Follow-up|1|||
124926086|NCT04436276|449359081|FG020|Overall Study|Lost to Follow-up|2|||
124926087|NCT04436276|449359082|FG021|Overall Study|Lost to Follow-up|1|||
124926088|NCT04436276|449359083|FG022|Overall Study|Lost to Follow-up|1|||
124926089|NCT04436276|449359061|FG000|Overall Study|Physician Decision|1|||
124926090|NCT04436276|449359062|FG001|Overall Study|Physician Decision|0|||
124926091|NCT04436276|449359063|FG002|Overall Study|Physician Decision|2|||
124926092|NCT04436276|449359064|FG003|Overall Study|Physician Decision|1|||
124926093|NCT04436276|449359065|FG004|Overall Study|Physician Decision|0|||
124545888|NCT00471237|447954417|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
124545889|NCT00471237|447954418|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
124926094|NCT04436276|449359066|FG005|Overall Study|Physician Decision|0|||
124545890|NCT00471237|447954412|FG000|Overall Study|Early stopping due to non-efficacy|1|||
124545891|NCT00471237|447954413|FG001|Overall Study|Early stopping due to non-efficacy|0|||
124926095|NCT04436276|449359067|FG006|Overall Study|Physician Decision|0|||
124926096|NCT04436276|449359068|FG007|Overall Study|Physician Decision|0|||
124926097|NCT04436276|449359069|FG008|Overall Study|Physician Decision|0|||
124926098|NCT04436276|449359070|FG009|Overall Study|Physician Decision|0|||
124926099|NCT04436276|449359071|FG010|Overall Study|Physician Decision|0|||
124926100|NCT04436276|449359072|FG011|Overall Study|Physician Decision|1|||
124926101|NCT04436276|449359073|FG012|Overall Study|Physician Decision|2|||
124926102|NCT04436276|449359074|FG013|Overall Study|Physician Decision|0|||
124926103|NCT04436276|449359075|FG014|Overall Study|Physician Decision|0|||
124926104|NCT04436276|449359076|FG015|Overall Study|Physician Decision|0|||
124926105|NCT04436276|449359077|FG016|Overall Study|Physician Decision|0|||
124926106|NCT04436276|449359078|FG017|Overall Study|Physician Decision|0|||
124926107|NCT04436276|449359079|FG018|Overall Study|Physician Decision|0|||
124926108|NCT04436276|449359080|FG019|Overall Study|Physician Decision|0|||
124926109|NCT04436276|449359081|FG020|Overall Study|Physician Decision|1|||
124926110|NCT04436276|449359082|FG021|Overall Study|Physician Decision|2|||
124926111|NCT04436276|449359083|FG022|Overall Study|Physician Decision|0|||
124926112|NCT04436276|449359061|FG000|Overall Study|Protocol Violation|0|||
124926113|NCT04436276|449359062|FG001|Overall Study|Protocol Violation|0|||
124926114|NCT04436276|449359063|FG002|Overall Study|Protocol Violation|0|||
124926115|NCT04436276|449359064|FG003|Overall Study|Protocol Violation|0|||
124926116|NCT04436276|449359065|FG004|Overall Study|Protocol Violation|0|||
124926117|NCT04436276|449359066|FG005|Overall Study|Protocol Violation|0|||
124926118|NCT04436276|449359067|FG006|Overall Study|Protocol Violation|0|||
124926119|NCT04436276|449359068|FG007|Overall Study|Protocol Violation|0|||
124926120|NCT04436276|449359069|FG008|Overall Study|Protocol Violation|0|||
124926121|NCT04436276|449359070|FG009|Overall Study|Protocol Violation|0|||
124926122|NCT04436276|449359071|FG010|Overall Study|Protocol Violation|0|||
124926123|NCT04436276|449359072|FG011|Overall Study|Protocol Violation|0|||
124926124|NCT04436276|449359073|FG012|Overall Study|Protocol Violation|0|||
124926125|NCT04436276|449359074|FG013|Overall Study|Protocol Violation|1|||
124926126|NCT04436276|449359075|FG014|Overall Study|Protocol Violation|0|||
124926127|NCT04436276|449359076|FG015|Overall Study|Protocol Violation|1|||
124926128|NCT04436276|449359077|FG016|Overall Study|Protocol Violation|0|||
124926129|NCT04436276|449359078|FG017|Overall Study|Protocol Violation|0|||
124926130|NCT04436276|449359079|FG018|Overall Study|Protocol Violation|0|||
124926131|NCT04436276|449359080|FG019|Overall Study|Protocol Violation|0|||
124926132|NCT04436276|449359081|FG020|Overall Study|Protocol Violation|0|||
124926133|NCT04436276|449359082|FG021|Overall Study|Protocol Violation|0|||
124926134|NCT04436276|449359083|FG022|Overall Study|Protocol Violation|0|||
124926135|NCT04436276|449359061|FG000|Overall Study|Withdrawal by Subject|25|||
124926136|NCT04436276|449359062|FG001|Overall Study|Withdrawal by Subject|22|||
124926137|NCT04436276|449359063|FG002|Overall Study|Withdrawal by Subject|24|||
124926138|NCT04436276|449359064|FG003|Overall Study|Withdrawal by Subject|23|||
124926139|NCT04436276|449359065|FG004|Overall Study|Withdrawal by Subject|14|||
124926140|NCT04436276|449359066|FG005|Overall Study|Withdrawal by Subject|0|||
124926141|NCT04436276|449359067|FG006|Overall Study|Withdrawal by Subject|0|||
124926142|NCT04436276|449359068|FG007|Overall Study|Withdrawal by Subject|1|||
124926143|NCT04436276|449359069|FG008|Overall Study|Withdrawal by Subject|0|||
124926144|NCT04436276|449359070|FG009|Overall Study|Withdrawal by Subject|1|||
124926145|NCT04436276|449359071|FG010|Overall Study|Withdrawal by Subject|17|||
124926146|NCT04436276|449359072|FG011|Overall Study|Withdrawal by Subject|7|||
124926147|NCT04436276|449359073|FG012|Overall Study|Withdrawal by Subject|10|||
124926148|NCT04436276|449359074|FG013|Overall Study|Withdrawal by Subject|6|||
124926149|NCT04436276|449359075|FG014|Overall Study|Withdrawal by Subject|20|||
124926150|NCT04436276|449359076|FG015|Overall Study|Withdrawal by Subject|6|||
124926151|NCT04436276|449359077|FG016|Overall Study|Withdrawal by Subject|11|||
124926152|NCT04436276|449359078|FG017|Overall Study|Withdrawal by Subject|4|||
124926153|NCT04436276|449359079|FG018|Overall Study|Withdrawal by Subject|14|||
124926154|NCT04436276|449359080|FG019|Overall Study|Withdrawal by Subject|24|||
124926155|NCT04436276|449359081|FG020|Overall Study|Withdrawal by Subject|24|||
124926156|NCT04436276|449359082|FG021|Overall Study|Withdrawal by Subject|16|||
124926157|NCT04436276|449359083|FG022|Overall Study|Withdrawal by Subject|14|||
124926158|NCT04436276|449359061|FG000|Overall Study|Other|3|||
124545892|NCT00471237|447954414|FG002|Overall Study|Early stopping due to non-efficacy|0|||
124545893|NCT00471237|447954415|FG003|Overall Study|Early stopping due to non-efficacy|0|||
124545894|NCT00471237|447954416|FG004|Overall Study|Early stopping due to non-efficacy|1|||
124545895|NCT00471237|447954417|FG005|Overall Study|Early stopping due to non-efficacy|0|||
124926159|NCT04436276|449359062|FG001|Overall Study|Other|2|||
124926160|NCT04436276|449359063|FG002|Overall Study|Other|5|||
124926161|NCT04436276|449359064|FG003|Overall Study|Other|9|||
124926162|NCT04436276|449359065|FG004|Overall Study|Other|23|||
124926163|NCT04436276|449359066|FG005|Overall Study|Other|1|||
124926164|NCT04436276|449359067|FG006|Overall Study|Other|0|||
124926165|NCT04436276|449359068|FG007|Overall Study|Other|0|||
124926166|NCT04436276|449359069|FG008|Overall Study|Other|0|||
124545896|NCT00471237|447954418|FG006|Overall Study|Early stopping due to non-efficacy|0|||
124926167|NCT04436276|449359070|FG009|Overall Study|Other|0|||
124926168|NCT04436276|449359071|FG010|Overall Study|Other|3|||
124926169|NCT04436276|449359072|FG011|Overall Study|Other|1|||
124926170|NCT04436276|449359073|FG012|Overall Study|Other|1|||
124926171|NCT04436276|449359074|FG013|Overall Study|Other|2|||
124926172|NCT04436276|449359075|FG014|Overall Study|Other|3|||
124926173|NCT04436276|449359076|FG015|Overall Study|Other|0|||
124926174|NCT04436276|449359077|FG016|Overall Study|Other|0|||
124926175|NCT04436276|449359078|FG017|Overall Study|Other|6|||
124926176|NCT04436276|449359079|FG018|Overall Study|Other|1|||
124926177|NCT04436276|449359080|FG019|Overall Study|Other|0|||
124926178|NCT04436276|449359081|FG020|Overall Study|Other|2|||
124926179|NCT04436276|449359082|FG021|Overall Study|Other|2|||
124926180|NCT04436276|449359083|FG022|Overall Study|Other|60|||
124926181|NCT00324805|449359084|FG000|Overall Study|Adverse Event|62|||
124926182|NCT00324805|449359085|FG001|Overall Study|Adverse Event|203|||
124926183|NCT00324805|449359084|FG000|Overall Study|Progression|7|||
124926184|NCT00324805|449359085|FG001|Overall Study|Progression|35|||
124926185|NCT00324805|449359084|FG000|Overall Study|Withdrawal by Subject|51|||
124926186|NCT00324805|449359085|FG001|Overall Study|Withdrawal by Subject|174|||
124926187|NCT00324805|449359084|FG000|Overall Study|Death|6|||
124926188|NCT00324805|449359085|FG001|Overall Study|Death|9|||
124926189|NCT00324805|449359084|FG000|Overall Study|Alternative therapy|4|||
124926190|NCT00324805|449359085|FG001|Overall Study|Alternative therapy|8|||
124926191|NCT00324805|449359084|FG000|Overall Study|Other complicating disease|1|||
124926192|NCT00324805|449359085|FG001|Overall Study|Other complicating disease|9|||
124926193|NCT00324805|449359084|FG000|Overall Study|Other reasons|7|||
124926194|NCT00324805|449359085|FG001|Overall Study|Other reasons|26|||
124926195|NCT00324805|449359084|FG000|Overall Study|Other|0|||
124926196|NCT00324805|449359085|FG001|Overall Study|Other|2|||
124926197|NCT00324805|449359084|FG000|Overall Study|Did not start therapy|12|||
124926198|NCT00324805|449359085|FG001|Overall Study|Did not start therapy|17|||
124926199|NCT03931174|449359086|FG000|Providers|Staff left organization|26|||
124926200|NCT03931174|449359087|FG001|Providers|Staff left organization|25|||
124454523|NCT01940471|447623864|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
124454524|NCT01940471|447623865|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
124454525|NCT01940471|447623862|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
124454526|NCT01940471|447623863|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
124454527|NCT01940471|447623864|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
124454528|NCT01940471|447623865|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
124545897|NCT00471237|447954412|FG000|Overall Study|Participant planned to travel to abraod|1|||
124545898|NCT00471237|447954413|FG001|Overall Study|Participant planned to travel to abraod|0|||
124545899|NCT00471237|447954414|FG002|Overall Study|Participant planned to travel to abraod|0|||
124926201|NCT03931174|449359086|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
124926202|NCT03931174|449359087|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
124926203|NCT03931174|449359086|FG000|Providers|Lost to Follow-up|4|||
124926204|NCT03931174|449359087|FG001|Providers|Lost to Follow-up|4|||
124926205|NCT03931174|449359086|FG000|Patients|Post-consent screening failure|1|||
124926206|NCT03931174|449359087|FG001|Patients|Post-consent screening failure|1|||
124926207|NCT03931174|449359086|FG000|Patients|Death|1|||
124926208|NCT03931174|449359087|FG001|Patients|Death|1|||
124926209|NCT03931174|449359086|FG000|Patients|Lost to Follow-up|60|||
124926210|NCT03931174|449359087|FG001|Patients|Lost to Follow-up|89|||
124926211|NCT03322267|449359088|FG000|Overall Study|Lack of Efficacy|11|||
124926212|NCT03322267|449359088|FG000|Overall Study|Adverse Event|1|||
124926213|NCT03322267|449359088|FG000|Overall Study|Withdrawal by Subject|2|||
124926214|NCT03852472|449359098|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
124926215|NCT03852472|449359099|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
124926216|NCT03852472|449359100|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
124926217|NCT03852472|449359101|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
124926218|NCT03852472|449359102|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
124926219|NCT03852472|449359098|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
124926220|NCT03852472|449359099|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
124926221|NCT03852472|449359100|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
124926222|NCT03852472|449359101|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
124926223|NCT03852472|449359102|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
124926224|NCT03852472|449359098|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
124926225|NCT03852472|449359099|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
124926226|NCT03852472|449359100|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
124926227|NCT03852472|449359101|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
124926228|NCT03852472|449359102|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
124926229|NCT03852472|449359098|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
124926230|NCT03852472|449359099|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
124926231|NCT03852472|449359100|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
124926232|NCT03852472|449359101|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
124926233|NCT03852472|449359102|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
124926234|NCT03852472|449359098|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
124926235|NCT03852472|449359099|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
124926236|NCT03852472|449359100|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
124926237|NCT03852472|449359101|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
124969581|NCT03520075|449517418|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124926238|NCT03852472|449359102|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
124926239|NCT03852472|449359098|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
124926240|NCT03852472|449359099|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
124926241|NCT03852472|449359100|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
124926242|NCT03852472|449359101|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
124926243|NCT03852472|449359102|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
124926244|NCT03852472|449359098|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
124926245|NCT03852472|449359099|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
124926246|NCT03852472|449359100|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
124926247|NCT03852472|449359101|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
124926248|NCT03852472|449359102|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
124926249|NCT03852472|449359098|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
124926250|NCT03852472|449359099|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
124926251|NCT03852472|449359100|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
124926252|NCT03852472|449359101|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
124926253|NCT03852472|449359102|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
124926254|NCT03852472|449359098|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
124926255|NCT03852472|449359099|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
124926256|NCT03852472|449359100|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
124926257|NCT03852472|449359101|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
124926258|NCT03852472|449359102|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
124926259|NCT03852472|449359098|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
124926260|NCT03852472|449359099|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
124926261|NCT03852472|449359100|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
124926262|NCT03852472|449359101|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
124926263|NCT03852472|449359102|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
124926264|NCT03852472|449359098|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
124926265|NCT03852472|449359099|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
124926266|NCT03852472|449359100|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
124926267|NCT03852472|449359101|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
124926268|NCT03852472|449359102|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
124926269|NCT03852472|449359098|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
124926270|NCT03852472|449359099|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
124926271|NCT03852472|449359100|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
124926272|NCT03852472|449359101|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
124926273|NCT03852472|449359102|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
124926274|NCT03852472|449359098|FG000|Period 2 - Week 44|Adverse Event|0|||
124926275|NCT03852472|449359099|FG001|Period 2 - Week 44|Adverse Event|3|||
124926276|NCT03852472|449359100|FG002|Period 2 - Week 44|Adverse Event|1|||
124926277|NCT03852472|449359101|FG003|Period 2 - Week 44|Adverse Event|2|||
124926278|NCT03852472|449359102|FG004|Period 2 - Week 44|Adverse Event|2|||
124926279|NCT03852472|449359098|FG000|Period 2 - Week 44|COVID-19 Related|0|||
124926280|NCT03852472|449359099|FG001|Period 2 - Week 44|COVID-19 Related|0|||
124926281|NCT03852472|449359100|FG002|Period 2 - Week 44|COVID-19 Related|0|||
124926282|NCT03852472|449359101|FG003|Period 2 - Week 44|COVID-19 Related|1|||
124926283|NCT03852472|449359102|FG004|Period 2 - Week 44|COVID-19 Related|0|||
124926284|NCT03852472|449359098|FG000|Period 2 - Week 44|Reason not stated|0|||
124926285|NCT03852472|449359099|FG001|Period 2 - Week 44|Reason not stated|0|||
124926286|NCT03852472|449359100|FG002|Period 2 - Week 44|Reason not stated|0|||
124926287|NCT03852472|449359101|FG003|Period 2 - Week 44|Reason not stated|0|||
124926288|NCT03852472|449359102|FG004|Period 2 - Week 44|Reason not stated|1|||
124926289|NCT01919554|449359103|FG000|Overall Study|Withdrawal by Subject|0|||
124926290|NCT01919554|449359104|FG001|Overall Study|Withdrawal by Subject|0|||
124926291|NCT01919554|449359105|FG002|Overall Study|Withdrawal by Subject|1|||
124926292|NCT01919554|449359106|FG003|Overall Study|Withdrawal by Subject|1|||
124926293|NCT05977530|449359107|FG000|Overall Study|Withdrawal by Subject|1|||
124926294|NCT05977530|449359107|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
124926295|NCT06457802|449359108|FG000|Overall Study|Early termination of study prior to participant completion|2|||
124926296|NCT06457802|449359109|FG001|Overall Study|Early termination of study prior to participant completion|2|||
124926297|NCT01467427|449359110|FG000|Overall Study|Withdrawal by Subject|1|||
124926298|NCT01467427|449359111|FG001|Overall Study|Withdrawal by Subject|0|||
124926299|NCT01467427|449359110|FG000|Overall Study|Not continuing in extension phase|0|||
124926300|NCT01467427|449359111|FG001|Overall Study|Not continuing in extension phase|2|||
124926301|NCT01467427|449359110|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
124926302|NCT01467427|449359111|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
124926303|NCT01467427|449359110|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
124545900|NCT00471237|447954415|FG003|Overall Study|Participant planned to travel to abraod|0|||
124545901|NCT00471237|447954416|FG004|Overall Study|Participant planned to travel to abraod|0|||
124762826|NCT00550407|448755972|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
124762827|NCT00550407|448755973|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
124762828|NCT00550407|448755971|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
124762829|NCT00550407|448755972|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
124762830|NCT00550407|448755973|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
124762831|NCT00550407|448755971|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
124762832|NCT00550407|448755972|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
124762833|NCT00550407|448755973|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
124762834|NCT00584415|448755974|FG000|Overall Study|Adverse Event|7|||
124762835|NCT00717249|448755977|FG000|Overall Study|Lens Discomfort|4|||
124762836|NCT00717249|448755978|FG001|Overall Study|Lens Discomfort|1|||
124762837|NCT00717249|448755977|FG000|Overall Study|Unsatisfactory visual Response|0|||
124762838|NCT00717249|448755978|FG001|Overall Study|Unsatisfactory visual Response|2|||
124762839|NCT00717249|448755977|FG000|Overall Study|Adverse Event|4|||
124762840|NCT00717249|448755978|FG001|Overall Study|Adverse Event|2|||
124762841|NCT00717249|448755977|FG000|Overall Study|Lost to Follow-up|2|||
124762842|NCT00717249|448755978|FG001|Overall Study|Lost to Follow-up|0|||
124762843|NCT00717249|448755977|FG000|Overall Study|Withdrawal by Subject|1|||
124762844|NCT00717249|448755978|FG001|Overall Study|Withdrawal by Subject|2|||
124762845|NCT00717249|448755977|FG000|Overall Study|Pregnancy|6|||
124762846|NCT00717249|448755978|FG001|Overall Study|Pregnancy|3|||
124762847|NCT00717249|448755977|FG000|Overall Study|Protocol Violation|0|||
124762848|NCT00717249|448755978|FG001|Overall Study|Protocol Violation|2|||
124762849|NCT00717249|448755977|FG000|Overall Study|Subject became Ineligible|1|||
124762850|NCT00717249|448755978|FG001|Overall Study|Subject became Ineligible|1|||
124762851|NCT00717249|448755977|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
124762852|NCT00717249|448755978|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
124762853|NCT00717249|448755977|FG000|Overall Study|Gastric Surgery|0|||
124762854|NCT00717249|448755978|FG001|Overall Study|Gastric Surgery|1|||
124454529|NCT01940471|447623862|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
124454530|NCT01940471|447623863|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
124762855|NCT00717249|448755977|FG000|Overall Study|Diagnosed with Diabetes|1|||
124762856|NCT00717249|448755978|FG001|Overall Study|Diagnosed with Diabetes|0|||
124762857|NCT00717249|448755977|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
124762858|NCT00717249|448755978|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
124762859|NCT00717249|448755977|FG000|Overall Study|Subject relocated|1|||
124762860|NCT00717249|448755978|FG001|Overall Study|Subject relocated|0|||
124762861|NCT00717249|448755977|FG000|Overall Study|Headaches|1|||
124762862|NCT00717249|448755978|FG001|Overall Study|Headaches|0|||
124762863|NCT00360412|448755979|FG000|Overall Study|Adverse Event|37|||
124762864|NCT00360412|448755980|FG001|Overall Study|Adverse Event|65|||
124762865|NCT00360412|448755979|FG000|Overall Study|Protocol Violation|2|||
124762866|NCT00360412|448755980|FG001|Overall Study|Protocol Violation|5|||
124454531|NCT01940471|447623864|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
124454532|NCT01940471|447623865|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
124454533|NCT01940471|447623862|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
124454534|NCT01940471|447623863|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
124454535|NCT01940471|447623864|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
124454536|NCT01940471|447623865|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
124454537|NCT01940471|447623862|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
124454538|NCT01940471|447623863|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
124926304|NCT01467427|449359111|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
124926305|NCT01467427|449359110|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
124926306|NCT01467427|449359111|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
124926307|NCT01467427|449359110|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
124926308|NCT01467427|449359111|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
124926309|NCT03161028|449359112|FG000|Overall Study|Withdrawal by Subject|6|||
124926310|NCT03161028|449359113|FG001|Overall Study|Withdrawal by Subject|4|||
124926311|NCT03161028|449359112|FG000|Overall Study|Adverse Event|5|||
124926312|NCT03161028|449359113|FG001|Overall Study|Adverse Event|1|||
124926313|NCT03161028|449359112|FG000|Overall Study|Study drug side effects|2|||
124926314|NCT03161028|449359113|FG001|Overall Study|Study drug side effects|2|||
124926315|NCT03161028|449359112|FG000|Overall Study|Administrative PD/UP|4|||
124926316|NCT03161028|449359113|FG001|Overall Study|Administrative PD/UP|2|||
124926317|NCT03161028|449359112|FG000|Overall Study|Lost to Follow-up|2|||
124926318|NCT03161028|449359113|FG001|Overall Study|Lost to Follow-up|0|||
124926319|NCT03161028|449359112|FG000|Overall Study|Unable to comply with procedures|1|||
124926320|NCT03161028|449359113|FG001|Overall Study|Unable to comply with procedures|1|||
124926321|NCT00736723|449359114|FG000|Overall Study|Withdrawal by Subject|4|||
124926322|NCT00736723|449359115|FG001|Overall Study|Withdrawal by Subject|3|||
124926323|NCT03492216|449359116|FG000|Overall Study|Death|1|||
124926324|NCT03492216|449359117|FG001|Overall Study|Death|0|||
124926325|NCT03492216|449359118|FG002|Overall Study|Death|4|||
124926326|NCT03492216|449359119|FG003|Overall Study|Death|0|||
124926327|NCT03492216|449359116|FG000|Overall Study|Withdrawal by Subject|5|||
124926328|NCT03492216|449359117|FG001|Overall Study|Withdrawal by Subject|3|||
124926329|NCT03492216|449359118|FG002|Overall Study|Withdrawal by Subject|1|||
124926330|NCT03492216|449359119|FG003|Overall Study|Withdrawal by Subject|1|||
124926331|NCT03492216|449359116|FG000|Overall Study|Lost to Follow-up|9|||
124926332|NCT03492216|449359117|FG001|Overall Study|Lost to Follow-up|2|||
124926333|NCT03492216|449359118|FG002|Overall Study|Lost to Follow-up|7|||
124926334|NCT03492216|449359119|FG003|Overall Study|Lost to Follow-up|8|||
124926335|NCT03492216|449359116|FG000|Overall Study|Moved|5|||
124926336|NCT03492216|449359117|FG001|Overall Study|Moved|3|||
124926337|NCT03492216|449359118|FG002|Overall Study|Moved|3|||
124926338|NCT03492216|449359119|FG003|Overall Study|Moved|5|||
124926339|NCT03492216|449359116|FG000|Overall Study|Too ill|0|||
124926340|NCT03492216|449359117|FG001|Overall Study|Too ill|1|||
124926341|NCT03492216|449359118|FG002|Overall Study|Too ill|0|||
124926342|NCT03492216|449359119|FG003|Overall Study|Too ill|0|||
124926343|NCT03492216|449359116|FG000|Overall Study|Incarcerated|0|||
124926344|NCT03492216|449359117|FG001|Overall Study|Incarcerated|0|||
124926345|NCT03492216|449359118|FG002|Overall Study|Incarcerated|2|||
124926346|NCT03492216|449359119|FG003|Overall Study|Incarcerated|0|||
124926347|NCT04016662|449360791|FG000|Run-In Phase|Death|1|||
124926348|NCT04016662|449360791|FG000|Run-In Phase|Withdrawal by Subject|11|||
124697437|NCT01313676|448513915|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
124697438|NCT01313676|448513916|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
124697439|NCT01313676|448513913|FG000|Overall Study|Study Closed/terminated|7|||
124697440|NCT01313676|448513914|FG001|Overall Study|Study Closed/terminated|6|||
124697441|NCT01313676|448513915|FG002|Overall Study|Study Closed/terminated|9|||
124697442|NCT01313676|448513916|FG003|Overall Study|Study Closed/terminated|9|||
124926349|NCT04016662|449360791|FG000|Run-In Phase|Not meeting screening eligibility|9|||
124926350|NCT04016662|449360791|FG000|Run-In Phase|Physician Decision|3|||
124697443|NCT01313676|448513913|FG000|Overall Study|Lost to Follow-up|0|||
124697444|NCT01313676|448513914|FG001|Overall Study|Lost to Follow-up|0|||
124697445|NCT01313676|448513915|FG002|Overall Study|Lost to Follow-up|1|||
124926351|NCT04016662|449360791|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
124926352|NCT04016662|449360791|FG000|PLGS (12 Weeks)|Death|1|||
124926353|NCT04016662|449360791|FG000|SAP (12 Weeks)|Death|1|||
124926354|NCT03021096|449360792|FG000|Overall Study|Lost to Follow-up|4|||
124926355|NCT03021096|449360792|FG000|Overall Study|Protocol Violation|2|||
124926356|NCT00764751|449360802|FG000|Overall Study|Adverse Event|1|||
124926357|NCT00764751|449360803|FG001|Overall Study|Adverse Event|1|||
124926358|NCT00764751|449360802|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
124926359|NCT00764751|449360803|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
124697446|NCT01313676|448513916|FG003|Overall Study|Lost to Follow-up|0|||
124697447|NCT01313676|448513913|FG000|Overall Study|Physician Decision|53|||
124926360|NCT02998268|449360809|FG000|Overall Study|Adverse Event|0|||
124926361|NCT02998268|449360810|FG001|Overall Study|Adverse Event|2|||
124926362|NCT02998268|449360809|FG000|Overall Study|Withdrawal by Subject|0|||
124926363|NCT02998268|449360810|FG001|Overall Study|Withdrawal by Subject|1|||
124926364|NCT01175356|449360811|FG000|Overall Study|Death|1|||
124926365|NCT01175356|449360811|FG000|Overall Study|Lack of Efficacy|12|||
124926366|NCT01175356|449360811|FG000|Overall Study|Lost to Follow-up|1|||
124926367|NCT01175356|449360811|FG000|Overall Study|Physician Decision|23|||
124926368|NCT01175356|449360811|FG000|Overall Study|Ineligible|1|||
124926369|NCT01175356|449360811|FG000|Overall Study|Treatment Slot Not Available|18|||
124926370|NCT01175356|449360811|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
124926371|NCT01175356|449360811|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
124697448|NCT01313676|448513914|FG001|Overall Study|Physician Decision|64|||
124697449|NCT01313676|448513915|FG002|Overall Study|Physician Decision|62|||
124697450|NCT01313676|448513916|FG003|Overall Study|Physician Decision|48|||
124697451|NCT01313676|448513913|FG000|Overall Study|Decision by Participant or Proxy|643|||
124697452|NCT01313676|448513914|FG001|Overall Study|Decision by Participant or Proxy|527|||
124697453|NCT01313676|448513915|FG002|Overall Study|Decision by Participant or Proxy|515|||
124697454|NCT01313676|448513916|FG003|Overall Study|Decision by Participant or Proxy|492|||
124697455|NCT01313676|448513913|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
124697456|NCT01313676|448513914|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
124697457|NCT01313676|448513915|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
124697458|NCT01313676|448513916|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
124697459|NCT01313676|448513913|FG000|Overall Study|Investigator Site Closed|12|||
124697460|NCT01313676|448513914|FG001|Overall Study|Investigator Site Closed|11|||
124697461|NCT01313676|448513915|FG002|Overall Study|Investigator Site Closed|15|||
124762867|NCT00360412|448755979|FG000|Overall Study|Patient withdrew consent|27|||
124762868|NCT00360412|448755980|FG001|Overall Study|Patient withdrew consent|52|||
124762869|NCT00360412|448755979|FG000|Overall Study|Lack of therapeutic efficacy|46|||
124762870|NCT00360412|448755980|FG001|Overall Study|Lack of therapeutic efficacy|61|||
124762871|NCT00360412|448755979|FG000|Overall Study|Physician Decision|2|||
124762872|NCT00360412|448755980|FG001|Overall Study|Physician Decision|4|||
124762873|NCT00360412|448755979|FG000|Overall Study|Other|5|||
124762874|NCT00360412|448755980|FG001|Overall Study|Other|6|||
124762875|NCT00360412|448755979|FG000|Overall Study|Study termination by Sponsor|214|||
124926372|NCT01175356|449360811|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
124697462|NCT01313676|448513916|FG003|Overall Study|Investigator Site Closed|10|||
124697463|NCT01313676|448513913|FG000|Overall Study|Missing|1|||
124697464|NCT01313676|448513914|FG001|Overall Study|Missing|1|||
124697465|NCT01313676|448513915|FG002|Overall Study|Missing|1|||
124697466|NCT01313676|448513916|FG003|Overall Study|Missing|0|||
124697467|NCT02469961|448513918|FG000|Overall Study|Physician Decision|4|||
124697468|NCT02469961|448513919|FG001|Overall Study|Physician Decision|1|||
124697469|NCT05130281|448513923|FG000|Overall Study|Withdrawal by Subject|0|||
124697470|NCT05130281|448513924|FG001|Overall Study|Withdrawal by Subject|0|||
124697471|NCT05130281|448513925|FG002|Overall Study|Withdrawal by Subject|1|||
124697472|NCT06844812|448513926|FG000|Overall Study|Lost to Follow-up|5|||
124697473|NCT06844812|448513926|FG000|Overall Study|stigmatization concerns|2|||
124697474|NCT06844812|448513926|FG000|Overall Study|medication refusal|2|||
124697475|NCT06844812|448513926|FG000|Overall Study|concerns about possible side effects|2|||
124697476|NCT06844812|448513926|FG000|Overall Study|wanting to seek another specialist opinion|2|||
124697477|NCT06844812|448513926|FG000|Overall Study|side effects (dizziness)|1|||
124697478|NCT00368849|448513929|FG000|Overall Study|Withdrawal by Subject|0|||
124697479|NCT00368849|448513930|FG001|Overall Study|Withdrawal by Subject|1|||
124697480|NCT00368849|448513929|FG000|Overall Study|Physician Decision|0|||
124697481|NCT00368849|448513930|FG001|Overall Study|Physician Decision|1|||
124697482|NCT01699685|448513934|FG000|Period 1|Adverse Event|1|||
124697483|NCT01699685|448513935|FG001|Period 1|Adverse Event|1|||
124697484|NCT01699685|448513934|FG000|Period 1|Medical or ethical, noncompliance|2|||
124697485|NCT01699685|448513935|FG001|Period 1|Medical or ethical, noncompliance|0|||
124926373|NCT01175356|449360811|FG000|Overall Study|Inadequate stem cell for transplant|1|||
124926374|NCT01175356|449360811|FG000|Overall Study|Initiation other tx prior to completion|9|||
124926375|NCT03020199|449360816|FG000|Treatment Period|Adverse Event|0|||
124926376|NCT03020199|449360817|FG001|Treatment Period|Adverse Event|2|||
124926377|NCT03020199|449360816|FG000|Treatment Period|Lack of Efficacy|1|||
124926378|NCT03020199|449360817|FG001|Treatment Period|Lack of Efficacy|6|||
124697486|NCT01699685|448513934|FG000|Period 1|Other|0|||
124762876|NCT00360412|448755980|FG001|Overall Study|Study termination by Sponsor|469|||
124762877|NCT00871871|448755981|FG000|Part I|Adverse Event|0|||
124762878|NCT00871871|448755982|FG001|Part I|Adverse Event|2|||
124697487|NCT01699685|448513935|FG001|Period 1|Other|1|||
124697488|NCT01699685|448513934|FG000|Period 1|Patient request|0|||
124697489|NCT01699685|448513935|FG001|Period 1|Patient request|1|||
124762879|NCT00871871|448755983|FG002|Part I|Adverse Event|0|||
124926379|NCT03020199|449360816|FG000|Treatment Period|Lost to Follow-up|1|||
124926380|NCT03020199|449360817|FG001|Treatment Period|Lost to Follow-up|6|||
124762880|NCT00871871|448755984|FG003|Part I|Adverse Event|0|||
124762881|NCT00871871|448755981|FG000|Part I|Withdrawal by Subject|3|||
124926381|NCT03020199|449360816|FG000|Treatment Period|Physician Decision|0|||
124926382|NCT03020199|449360817|FG001|Treatment Period|Physician Decision|1|||
124926383|NCT03020199|449360816|FG000|Treatment Period|Subject/guardian decision|8|||
124926384|NCT03020199|449360817|FG001|Treatment Period|Subject/guardian decision|15|||
124926385|NCT03020199|449360816|FG000|Treatment Period|Subjects not treated|3|||
124926386|NCT03020199|449360817|FG001|Treatment Period|Subjects not treated|4|||
124926387|NCT03020199|449360816|FG000|Follow-up Period|Disease relapse|32|||
124926388|NCT03020199|449360817|FG001|Follow-up Period|Disease relapse|7|||
124926389|NCT03020199|449360816|FG000|Follow-up Period|Lack of Efficacy|1|||
124926390|NCT03020199|449360817|FG001|Follow-up Period|Lack of Efficacy|2|||
124926391|NCT03020199|449360816|FG000|Follow-up Period|Lost to Follow-up|4|||
124926392|NCT03020199|449360817|FG001|Follow-up Period|Lost to Follow-up|6|||
124926393|NCT03020199|449360816|FG000|Follow-up Period|Physician Decision|2|||
124926394|NCT03020199|449360817|FG001|Follow-up Period|Physician Decision|2|||
124926395|NCT03020199|449360816|FG000|Follow-up Period|Protocol Violation|1|||
124926396|NCT03020199|449360817|FG001|Follow-up Period|Protocol Violation|2|||
124926397|NCT03020199|449360816|FG000|Follow-up Period|Study terminated by Sponsor|6|||
124926398|NCT03020199|449360817|FG001|Follow-up Period|Study terminated by Sponsor|3|||
124926399|NCT03020199|449360816|FG000|Follow-up Period|Subject/guardian decision|14|||
124926400|NCT03020199|449360817|FG001|Follow-up Period|Subject/guardian decision|9|||
124926401|NCT05583578|449360818|FG000|Overall Study|Withdrawal by Subject|2|||
124926402|NCT05583578|449360819|FG001|Overall Study|Withdrawal by Subject|0|||
124926403|NCT04005794|449360822|FG000|Overall Study|Lost to Follow-up|0|||
124926404|NCT04005794|449360823|FG001|Overall Study|Lost to Follow-up|4|||
124926405|NCT04005794|449360824|FG002|Overall Study|Lost to Follow-up|0|||
124926406|NCT04313972|449360825|FG000|Overall Study|Withdrawal by Subject|0|||
124926407|NCT04313972|449360826|FG001|Overall Study|Withdrawal by Subject|1|||
124926408|NCT02547363|449360827|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
124926409|NCT02547363|449360828|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
124926410|NCT02547363|449360827|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
124926411|NCT02547363|449360828|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
124926412|NCT02547363|449360827|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
124926413|NCT02547363|449360828|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
124926414|NCT02547363|449360827|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
124926415|NCT02547363|449360828|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
124926416|NCT02547363|449360827|FG000|12-month Follow-up|Withdrawal by Subject|4|||
124926417|NCT02547363|449360828|FG001|12-month Follow-up|Withdrawal by Subject|3|||
124926418|NCT02547363|449360827|FG000|12-month Follow-up|Lost to Follow-up|4|||
124926419|NCT02547363|449360828|FG001|12-month Follow-up|Lost to Follow-up|1|||
124926420|NCT02547363|449360827|FG000|12-month Follow-up|Lack of Efficacy|1|||
124926421|NCT02547363|449360828|FG001|12-month Follow-up|Lack of Efficacy|1|||
124762882|NCT00871871|448755982|FG001|Part I|Withdrawal by Subject|0|||
124762883|NCT00871871|448755983|FG002|Part I|Withdrawal by Subject|0|||
124762884|NCT00871871|448755984|FG003|Part I|Withdrawal by Subject|0|||
124762885|NCT00871871|448755981|FG000|Part I|Laboratory abnormality|0|||
124926422|NCT02547363|449360827|FG000|12-month Follow-up|Other|1|||
124926423|NCT02547363|449360828|FG001|12-month Follow-up|Other|0|||
124926424|NCT05201079|449360841|FG000|Overall Study|Adverse Event|7|||
124926425|NCT05201079|449360842|FG001|Overall Study|Adverse Event|11|||
124926426|NCT05201079|449360841|FG000|Overall Study|Death|1|||
124926427|NCT05201079|449360842|FG001|Overall Study|Death|1|||
124926428|NCT05201079|449360841|FG000|Overall Study|Lack of Efficacy|0|||
124926429|NCT05201079|449360842|FG001|Overall Study|Lack of Efficacy|2|||
124926430|NCT05201079|449360841|FG000|Overall Study|Lost to Follow-up|0|||
124926431|NCT05201079|449360842|FG001|Overall Study|Lost to Follow-up|1|||
124926432|NCT05201079|449360841|FG000|Overall Study|Physician Decision|1|||
124926433|NCT05201079|449360842|FG001|Overall Study|Physician Decision|1|||
124926434|NCT05201079|449360841|FG000|Overall Study|Protocol Violation|1|||
124926435|NCT05201079|449360842|FG001|Overall Study|Protocol Violation|0|||
124926436|NCT05201079|449360841|FG000|Overall Study|Withdrawal by Subject|1|||
124762886|NCT00871871|448755982|FG001|Part I|Laboratory abnormality|1|||
124762887|NCT00871871|448755983|FG002|Part I|Laboratory abnormality|0|||
124762888|NCT00871871|448755984|FG003|Part I|Laboratory abnormality|0|||
124926437|NCT05201079|449360842|FG001|Overall Study|Withdrawal by Subject|0|||
124926438|NCT05201079|449360841|FG000|Overall Study|Forbidden medication|9|||
124926439|NCT05201079|449360842|FG001|Overall Study|Forbidden medication|5|||
124926440|NCT05201079|449360841|FG000|Overall Study|Transfer to another hospital|0|||
124926441|NCT05201079|449360842|FG001|Overall Study|Transfer to another hospital|1|||
124926442|NCT05201079|449360841|FG000|Overall Study|Clinical condition|1|||
124926443|NCT05201079|449360842|FG001|Overall Study|Clinical condition|0|||
124926444|NCT05201079|449360841|FG000|Overall Study|SAE and sepsis|1|||
124926445|NCT05201079|449360842|FG001|Overall Study|SAE and sepsis|0|||
124926446|NCT05808257|449360845|FG000|Overall Study|Lost to Follow-up|8|||
124926447|NCT05808257|449360846|FG001|Overall Study|Lost to Follow-up|8|||
124454539|NCT01940471|447623864|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
124454540|NCT01940471|447623865|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
124454541|NCT01940471|447623862|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
124454542|NCT01940471|447623863|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
124454543|NCT01940471|447623864|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
124454544|NCT01940471|447623865|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
124454545|NCT01846624|447623866|FG000|Overall Study|Died during induction, no midostaurin|1|||
124454546|NCT03574753|447623867|FG000|Overall Study|Adverse Event|3|||
124454547|NCT03574753|447623867|FG000|Overall Study|Progression/relapse|19|||
124454548|NCT03574753|447623867|FG000|Overall Study|Death|1|||
124454549|NCT03462719|447623870|FG000|Overall Study|Withdrawal by Subject|4|||
124454550|NCT03462719|447623871|FG001|Overall Study|Withdrawal by Subject|3|||
124454551|NCT03462719|447623870|FG000|Overall Study|Ongoing|87|||
124454552|NCT03462719|447623871|FG001|Overall Study|Ongoing|72|||
124454553|NCT03740165|447623872|FG000|Overall Study|Death|232|||
124454554|NCT03740165|447623873|FG001|Overall Study|Death|242|||
124454555|NCT03740165|447623874|FG002|Overall Study|Death|229|||
124454556|NCT03740165|447623872|FG000|Overall Study|Lost to Follow-up|0|||
124454557|NCT03740165|447623873|FG001|Overall Study|Lost to Follow-up|0|||
124454558|NCT03740165|447623874|FG002|Overall Study|Lost to Follow-up|1|||
124454559|NCT03740165|447623872|FG000|Overall Study|Withdrawal by Subject|7|||
124454560|NCT03740165|447623873|FG001|Overall Study|Withdrawal by Subject|4|||
124454561|NCT03740165|447623874|FG002|Overall Study|Withdrawal by Subject|3|||
124454562|NCT03740165|447623872|FG000|Overall Study|Ongoing in Study|216|||
124454563|NCT03740165|447623873|FG001|Overall Study|Ongoing in Study|212|||
124454564|NCT03740165|447623874|FG002|Overall Study|Ongoing in Study|221|||
124454565|NCT02044133|447623875|FG000|Overall Study|Lost to Follow-up|1|||
124454566|NCT02044133|447623876|FG001|Overall Study|Lost to Follow-up|1|||
124454567|NCT02044133|447623875|FG000|Overall Study|Death|1|||
124454568|NCT02044133|447623876|FG001|Overall Study|Death|0|||
124454569|NCT02044133|447623875|FG000|Overall Study|Release|3|||
124454570|NCT02044133|447623876|FG001|Overall Study|Release|4|||
124454571|NCT02044133|447623875|FG000|Overall Study|Transfer|1|||
124454572|NCT02044133|447623876|FG001|Overall Study|Transfer|0|||
124454573|NCT02044133|447623875|FG000|Overall Study|refusal of blood sampling|0|||
124697490|NCT01699685|448513934|FG000|Period 2|Lost to Follow-up|1|||
124697491|NCT01699685|448513935|FG001|Period 2|Lost to Follow-up|0|||
124697492|NCT03635996|448513936|FG000|Overall Study|Study terminated by Sponsor|94|||
124697493|NCT03635996|448513936|FG000|Overall Study|Withdrawal by Subject|20|||
124697494|NCT03635996|448513936|FG000|Overall Study|Ablation|26|||
124697495|NCT03635996|448513936|FG000|Overall Study|Adverse Event|7|||
124697496|NCT03635996|448513936|FG000|Overall Study|Physician Decision|3|||
124697497|NCT03635996|448513936|FG000|Overall Study|Prohibited medication|5|||
124697498|NCT03635996|448513936|FG000|Overall Study|Did not meet eligibility criteria|5|||
124697499|NCT03635996|448513936|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
124697500|NCT03635996|448513936|FG000|Overall Study|Protocol Violation|1|||
124697501|NCT03635996|448513936|FG000|Overall Study|Lost to Follow-up|1|||
124697502|NCT05058456|448513937|FG000|Overall Study|Death|1|||
124697503|NCT05058456|448513937|FG000|Overall Study|End of Study data not yet due for release|34|||
124697504|NCT02933151|448513938|FG000|Overall Study|Lost to Follow-up|19|||
124697505|NCT02933151|448513939|FG001|Overall Study|Lost to Follow-up|18|||
124697506|NCT02933151|448513938|FG000|Overall Study|Death|1732|||
124697507|NCT02933151|448513939|FG001|Overall Study|Death|1827|||
124697508|NCT02933151|448513938|FG000|Overall Study|Transplant|210|||
124697509|NCT02933151|448513939|FG001|Overall Study|Transplant|278|||
124697510|NCT02933151|448513938|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
124697511|NCT02933151|448513939|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
124697512|NCT02933151|448513938|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
124697513|NCT02933151|448513939|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
124697514|NCT02933151|448513938|FG000|Overall Study|Recovered Kidney Function|47|||
124697515|NCT02933151|448513939|FG001|Overall Study|Recovered Kidney Function|29|||
124697516|NCT01034657|448513953|FG000|Core Phase|Withdrawal by Subject|1|||
124697517|NCT01034657|448513954|FG001|Core Phase|Withdrawal by Subject|0|||
124697518|NCT01034657|448513955|FG002|Core Phase|Withdrawal by Subject|0|||
124697519|NCT01034657|448513953|FG000|Core Phase|Lack of Efficacy|2|||
124454574|NCT02044133|447623876|FG001|Overall Study|refusal of blood sampling|1|||
124697520|NCT01034657|448513954|FG001|Core Phase|Lack of Efficacy|0|||
124697521|NCT01034657|448513955|FG002|Core Phase|Lack of Efficacy|0|||
124697522|NCT01034657|448513953|FG000|Core Phase|Abnormal laboratory value|1|||
124697523|NCT01034657|448513954|FG001|Core Phase|Abnormal laboratory value|0|||
124697524|NCT01034657|448513955|FG002|Core Phase|Abnormal laboratory value|0|||
124697525|NCT01034657|448513953|FG000|Core Phase|Adverse Event|8|||
124697526|NCT01034657|448513954|FG001|Core Phase|Adverse Event|0|||
124697527|NCT01034657|448513955|FG002|Core Phase|Adverse Event|0|||
124697528|NCT01034657|448513953|FG000|Core Phase|Protocol Violation|2|||
124697529|NCT01034657|448513954|FG001|Core Phase|Protocol Violation|0|||
124697530|NCT01034657|448513955|FG002|Core Phase|Protocol Violation|0|||
124545902|NCT00471237|447954417|FG005|Overall Study|Participant planned to travel to abraod|1|||
124545903|NCT00471237|447954418|FG006|Overall Study|Participant planned to travel to abraod|0|||
124545904|NCT00471237|447954412|FG000|Overall Study|High parathyroid hormone|0|||
124545905|NCT00471237|447954413|FG001|Overall Study|High parathyroid hormone|0|||
124545906|NCT00471237|447954414|FG002|Overall Study|High parathyroid hormone|1|||
124545907|NCT00471237|447954415|FG003|Overall Study|High parathyroid hormone|0|||
124545908|NCT00471237|447954416|FG004|Overall Study|High parathyroid hormone|0|||
124545909|NCT00471237|447954417|FG005|Overall Study|High parathyroid hormone|0|||
124545910|NCT00471237|447954418|FG006|Overall Study|High parathyroid hormone|0|||
124545911|NCT00471237|447954412|FG000|Overall Study|Participant lost medication|0|||
124545912|NCT00471237|447954413|FG001|Overall Study|Participant lost medication|0|||
124545913|NCT00471237|447954414|FG002|Overall Study|Participant lost medication|0|||
124545914|NCT00471237|447954415|FG003|Overall Study|Participant lost medication|0|||
124545915|NCT00471237|447954416|FG004|Overall Study|Participant lost medication|1|||
124545916|NCT00471237|447954417|FG005|Overall Study|Participant lost medication|0|||
124545917|NCT00471237|447954418|FG006|Overall Study|Participant lost medication|0|||
124545918|NCT00471237|447954412|FG000|Overall Study|Administration of prohibited medicine|0|||
124545919|NCT00471237|447954413|FG001|Overall Study|Administration of prohibited medicine|0|||
124545920|NCT00471237|447954414|FG002|Overall Study|Administration of prohibited medicine|0|||
124545921|NCT00471237|447954415|FG003|Overall Study|Administration of prohibited medicine|0|||
124545922|NCT00471237|447954416|FG004|Overall Study|Administration of prohibited medicine|1|||
124545923|NCT00471237|447954417|FG005|Overall Study|Administration of prohibited medicine|0|||
124545924|NCT00471237|447954418|FG006|Overall Study|Administration of prohibited medicine|0|||
124545925|NCT00471237|447954412|FG000|Overall Study|Participant shifted residence|0|||
124545926|NCT00471237|447954413|FG001|Overall Study|Participant shifted residence|0|||
124545927|NCT00471237|447954414|FG002|Overall Study|Participant shifted residence|0|||
124545928|NCT00471237|447954415|FG003|Overall Study|Participant shifted residence|0|||
124545929|NCT00471237|447954416|FG004|Overall Study|Participant shifted residence|1|||
124545930|NCT00471237|447954417|FG005|Overall Study|Participant shifted residence|0|||
124545931|NCT00471237|447954418|FG006|Overall Study|Participant shifted residence|0|||
124545932|NCT00471237|447954412|FG000|Overall Study|Participant's decision|0|||
124545933|NCT00471237|447954413|FG001|Overall Study|Participant's decision|0|||
124545934|NCT00471237|447954414|FG002|Overall Study|Participant's decision|0|||
124545935|NCT00471237|447954415|FG003|Overall Study|Participant's decision|0|||
124545936|NCT00471237|447954416|FG004|Overall Study|Participant's decision|0|||
124545937|NCT00471237|447954417|FG005|Overall Study|Participant's decision|1|||
124545938|NCT00471237|447954418|FG006|Overall Study|Participant's decision|0|||
124762889|NCT00871871|448755981|FG000|Part II|Lack of Efficacy|0|||
124762890|NCT00871871|448755982|FG001|Part II|Lack of Efficacy|0|||
124762891|NCT00871871|448755983|FG002|Part II|Lack of Efficacy|1|||
124762892|NCT00871871|448755984|FG003|Part II|Lack of Efficacy|0|||
124762893|NCT00871871|448755981|FG000|Part II|Withdrawal by Subject|0|||
124762894|NCT00871871|448755982|FG001|Part II|Withdrawal by Subject|0|||
124762895|NCT00871871|448755983|FG002|Part II|Withdrawal by Subject|2|||
124762896|NCT00871871|448755984|FG003|Part II|Withdrawal by Subject|1|||
124762897|NCT00871871|448755981|FG000|Part II|Adverse Event|0|||
124926448|NCT04568486|449360847|FG000|Overall Study|Withdrawal by Subject|26|||
124926449|NCT04568486|449360847|FG000|Overall Study|Lost to Follow-up|7|||
124926450|NCT04042233|449360848|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
124926451|NCT04042233|449360849|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
124926452|NCT04042233|449360848|FG000|Overall Study|Protocol Violation|0|||
124926453|NCT04042233|449360849|FG001|Overall Study|Protocol Violation|2|||
124926454|NCT04907851|449360852|FG000|Overall Study|Consent withdrawn|1|||
124926455|NCT04907851|449360853|FG001|Overall Study|Consent withdrawn|2|||
124926456|NCT04907851|449360854|FG002|Overall Study|Consent withdrawn|0|||
124926457|NCT04907851|449360852|FG000|Overall Study|Death|5|||
124926458|NCT04907851|449360853|FG001|Overall Study|Death|15|||
124926459|NCT04907851|449360854|FG002|Overall Study|Death|10|||
124926460|NCT05281562|449360862|FG000|Overall Study|Ineligible patient|1|||
124926461|NCT05281562|449360863|FG001|Overall Study|Ineligible patient|0|||
124926462|NCT05477186|449360867|FG000|Overall Study|Vaccine not administered|0|||
124926463|NCT05477186|449360868|FG001|Overall Study|Vaccine not administered|2|||
124926464|NCT05477186|449360869|FG002|Overall Study|Vaccine not administered|1|||
124926465|NCT05477186|449360870|FG003|Overall Study|Vaccine not administered|0|||
124926466|NCT05477186|449360871|FG004|Overall Study|Vaccine not administered|1|||
124545939|NCT01605370|447954423|FG000|Overall Study|Adverse Event|1|||
124545940|NCT01605370|447954424|FG001|Overall Study|Adverse Event|0|||
124762898|NCT00871871|448755982|FG001|Part II|Adverse Event|0|||
124545941|NCT00627094|447954425|FG000|Overall Study|Adverse Event|8|||
124762899|NCT00871871|448755983|FG002|Part II|Adverse Event|1|||
124762900|NCT00871871|448755984|FG003|Part II|Adverse Event|2|||
124926467|NCT05477186|449360872|FG005|Overall Study|Vaccine not administered|0|||
124926468|NCT05477186|449360873|FG006|Overall Study|Vaccine not administered|0|||
124926469|NCT05477186|449360867|FG000|Overall Study|Withdrawal by Subject|1|||
124697531|NCT01034657|448513953|FG000|Randomized Phase|Withdrawal by Subject|0|||
124926470|NCT05477186|449360868|FG001|Overall Study|Withdrawal by Subject|0|||
124926471|NCT05477186|449360869|FG002|Overall Study|Withdrawal by Subject|0|||
124926472|NCT05477186|449360870|FG003|Overall Study|Withdrawal by Subject|0|||
124926473|NCT05477186|449360871|FG004|Overall Study|Withdrawal by Subject|0|||
124926474|NCT05477186|449360872|FG005|Overall Study|Withdrawal by Subject|1|||
124926475|NCT05477186|449360873|FG006|Overall Study|Withdrawal by Subject|0|||
124926476|NCT05477186|449360867|FG000|Overall Study|Lost to Follow-up|1|||
124926477|NCT05477186|449360868|FG001|Overall Study|Lost to Follow-up|0|||
124926478|NCT05477186|449360869|FG002|Overall Study|Lost to Follow-up|2|||
124926479|NCT05477186|449360870|FG003|Overall Study|Lost to Follow-up|1|||
124926480|NCT05477186|449360871|FG004|Overall Study|Lost to Follow-up|1|||
124926481|NCT05477186|449360872|FG005|Overall Study|Lost to Follow-up|0|||
124926482|NCT05477186|449360873|FG006|Overall Study|Lost to Follow-up|2|||
124926483|NCT05792085|449360876|FG000|Overall Study|Death|0|||
124926484|NCT05792085|449360877|FG001|Overall Study|Death|0|||
124926485|NCT05792085|449360878|FG002|Overall Study|Death|0|||
124926486|NCT05792085|449360879|FG003|Overall Study|Death|0|||
124926487|NCT05792085|449360880|FG004|Overall Study|Death|1|||
124926488|NCT04719832|449360885|FG000|Overall Study|Adverse Event|2|||
124926489|NCT04719832|449360886|FG001|Overall Study|Adverse Event|0|||
124926490|NCT04719832|449360885|FG000|Overall Study|Lack of Efficacy|2|||
124926491|NCT04719832|449360886|FG001|Overall Study|Lack of Efficacy|4|||
124926492|NCT04719832|449360885|FG000|Overall Study|Lost to Follow-up|0|||
124926493|NCT04719832|449360886|FG001|Overall Study|Lost to Follow-up|2|||
124926494|NCT04719832|449360885|FG000|Overall Study|Physician Decision|0|||
124926495|NCT04719832|449360886|FG001|Overall Study|Physician Decision|1|||
124926496|NCT04719832|449360885|FG000|Overall Study|Pregnancy|1|||
124926497|NCT04719832|449360886|FG001|Overall Study|Pregnancy|1|||
124926498|NCT04719832|449360885|FG000|Overall Study|Withdrawal by Subject|5|||
124926499|NCT04719832|449360886|FG001|Overall Study|Withdrawal by Subject|5|||
124926500|NCT04719832|449360885|FG000|Overall Study|Randomized, not treated|0|||
124926501|NCT04719832|449360886|FG001|Overall Study|Randomized, not treated|2|||
124926502|NCT04719832|449360885|FG000|Overall Study|GCP violations|4|||
124926503|NCT04719832|449360886|FG001|Overall Study|GCP violations|7|||
124926504|NCT04880863|449360889|FG000|Overall Study|Adverse Event|1|||
124926505|NCT04880863|449360889|FG000|Overall Study|Patient decision|2|||
124926506|NCT04880863|449360889|FG000|Overall Study|Confirmed Disease Progression|15|||
124926507|NCT04880863|449360889|FG000|Overall Study|Death|3|||
124926508|NCT04880863|449360889|FG000|Overall Study|Physician Decision|4|||
124926509|NCT04880863|449360889|FG000|Overall Study|Unconfirmed Disease Progression|4|||
124926510|NCT04880863|449360889|FG000|Overall Study|Withdrawal by Subject|2|||
124926511|NCT04880863|449360889|FG000|Overall Study|Study discontinuation by the sponsor|4|||
124926512|NCT04880863|449360889|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
124926513|NCT04880863|449360889|FG000|Overall Study|Not received study drug NAP|2|||
124926514|NCT04898673|449360892|FG000|Overall Study|Screenfail|1|||
124926515|NCT04898673|449360893|FG001|Overall Study|Screenfail|0|||
124926516|NCT03899259|449360894|FG000|Overall Study|Adverse Event|5|||
124926517|NCT03899259|449360895|FG001|Overall Study|Adverse Event|4|||
124926518|NCT03899259|449360896|FG002|Overall Study|Adverse Event|6|||
124926519|NCT03899259|449360894|FG000|Overall Study|Lack of Efficacy|5|||
124926520|NCT03899259|449360895|FG001|Overall Study|Lack of Efficacy|0|||
124926521|NCT03899259|449360896|FG002|Overall Study|Lack of Efficacy|2|||
124926522|NCT03899259|449360894|FG000|Overall Study|Pregnancy|3|||
124926523|NCT03899259|449360895|FG001|Overall Study|Pregnancy|0|||
124926524|NCT03899259|449360896|FG002|Overall Study|Pregnancy|1|||
124926525|NCT03899259|449360894|FG000|Overall Study|Physician Decision|0|||
124926526|NCT03899259|449360895|FG001|Overall Study|Physician Decision|1|||
124926527|NCT03899259|449360896|FG002|Overall Study|Physician Decision|0|||
124926528|NCT03899259|449360894|FG000|Overall Study|Protocol Deviation|1|||
124697532|NCT01034657|448513954|FG001|Randomized Phase|Withdrawal by Subject|2|||
124697533|NCT01034657|448513955|FG002|Randomized Phase|Withdrawal by Subject|0|||
124697534|NCT01034657|448513953|FG000|Randomized Phase|Lack of Efficacy|5|||
124697535|NCT01034657|448513954|FG001|Randomized Phase|Lack of Efficacy|1|||
124926529|NCT03899259|449360895|FG001|Overall Study|Protocol Deviation|1|||
124926530|NCT03899259|449360896|FG002|Overall Study|Protocol Deviation|1|||
124926531|NCT03899259|449360894|FG000|Overall Study|Withdrawal by Subject|8|||
124926532|NCT03899259|449360895|FG001|Overall Study|Withdrawal by Subject|10|||
124926533|NCT03899259|449360896|FG002|Overall Study|Withdrawal by Subject|12|||
124926534|NCT03899259|449360894|FG000|Overall Study|Lost to Follow-up|5|||
124926535|NCT03899259|449360895|FG001|Overall Study|Lost to Follow-up|6|||
124926536|NCT03899259|449360896|FG002|Overall Study|Lost to Follow-up|2|||
124926537|NCT03899259|449360894|FG000|Overall Study|Lack of Adherence|1|||
124926538|NCT03899259|449360895|FG001|Overall Study|Lack of Adherence|0|||
124926539|NCT03899259|449360896|FG002|Overall Study|Lack of Adherence|0|||
124545942|NCT00627094|447954426|FG001|Overall Study|Adverse Event|7|||
124926540|NCT03899259|449360894|FG000|Overall Study|Screen Failure|1|||
124926541|NCT03899259|449360895|FG001|Overall Study|Screen Failure|0|||
124926542|NCT03899259|449360896|FG002|Overall Study|Screen Failure|0|||
124926543|NCT03899259|449360894|FG000|Overall Study|Ongoing Study Participation|127|||
124762901|NCT00871871|448755981|FG000|Part II|Protocol Violation|0|||
124762902|NCT00871871|448755982|FG001|Part II|Protocol Violation|0|||
124762903|NCT00871871|448755983|FG002|Part II|Protocol Violation|0|||
124762904|NCT00871871|448755984|FG003|Part II|Protocol Violation|1|||
124762905|NCT03064490|448755990|FG000|Overall Study|Physician Decision|5|||
124762906|NCT01928927|448755991|FG000|Overall Study|Lost to Follow-up|1|||
124762907|NCT01928927|448755992|FG001|Overall Study|Lost to Follow-up|0|||
124545943|NCT00627094|447954425|FG000|Overall Study|Lost to Follow-up|1|||
124545944|NCT00627094|447954426|FG001|Overall Study|Lost to Follow-up|0|||
124545945|NCT00627094|447954425|FG000|Overall Study|Withdrawal by Subject|1|||
124545946|NCT00627094|447954426|FG001|Overall Study|Withdrawal by Subject|1|||
124545947|NCT00627094|447954425|FG000|Overall Study|ulcer healed|1|||
124545948|NCT00627094|447954426|FG001|Overall Study|ulcer healed|7|||
124545949|NCT00627094|447954425|FG000|Overall Study|Other reason|1|||
124545950|NCT00627094|447954426|FG001|Overall Study|Other reason|0|||
124697536|NCT01034657|448513955|FG002|Randomized Phase|Lack of Efficacy|0|||
124697537|NCT01034657|448513953|FG000|Randomized Phase|Abnormal laboratory value|0|||
124697538|NCT01034657|448513954|FG001|Randomized Phase|Abnormal laboratory value|1|||
124697539|NCT01034657|448513955|FG002|Randomized Phase|Abnormal laboratory value|0|||
124697540|NCT01034657|448513953|FG000|Randomized Phase|Adverse Event|0|||
124697541|NCT01034657|448513954|FG001|Randomized Phase|Adverse Event|2|||
124697542|NCT01034657|448513955|FG002|Randomized Phase|Adverse Event|1|||
124697543|NCT01791205|448513956|FG000|Phase II|Lack of Efficacy|6|||
124697544|NCT01791205|448513957|FG001|Phase II|Lack of Efficacy|0|||
124697545|NCT01791205|448513956|FG000|Phase II|Adverse Event|2|||
124697546|NCT01791205|448513957|FG001|Phase II|Adverse Event|0|||
124697547|NCT01791205|448513956|FG000|Phase II|Safety|1|||
124697548|NCT01791205|448513957|FG001|Phase II|Safety|0|||
124697549|NCT01791205|448513956|FG000|Phase II|Lost to Follow-up|1|||
124697550|NCT01791205|448513957|FG001|Phase II|Lost to Follow-up|0|||
124697551|NCT01791205|448513956|FG000|Phase II|Remission of disease|1|||
124697552|NCT01791205|448513957|FG001|Phase II|Remission of disease|0|||
124697553|NCT01791205|448513956|FG000|Phase II|Physician's decision|1|||
124697554|NCT01791205|448513957|FG001|Phase II|Physician's decision|0|||
124697555|NCT04985682|448513960|FG000|Overall Study|Withdrawal by Subject|1|||
124697556|NCT01546987|448513963|FG000|Overall Study|Protocol Violation|3|||
124697557|NCT01546987|448513964|FG001|Overall Study|Protocol Violation|4|||
124697558|NCT03878602|448513969|FG000|Overall Study|cord blood donation|7|||
124697559|NCT03878602|448513970|FG001|Overall Study|cord blood donation|1|||
124697560|NCT03878602|448513969|FG000|Overall Study|incomplete data collection|2|||
124697561|NCT03878602|448513970|FG001|Overall Study|incomplete data collection|0|||
124697562|NCT02191397|448513971|FG000|Overall Study|Adverse Event|28|||
124697563|NCT02191397|448513972|FG001|Overall Study|Adverse Event|17|||
124697564|NCT02191397|448513971|FG000|Overall Study|Lack of Efficacy|10|||
124697565|NCT02191397|448513972|FG001|Overall Study|Lack of Efficacy|5|||
124697566|NCT02191397|448513971|FG000|Overall Study|Protocol Violation|0|||
124697567|NCT02191397|448513972|FG001|Overall Study|Protocol Violation|3|||
124697568|NCT02191397|448513971|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
124697569|NCT02191397|448513972|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
124697570|NCT02191397|448513971|FG000|Overall Study|Lost to Follow-up|10|||
124697571|NCT02191397|448513972|FG001|Overall Study|Lost to Follow-up|11|||
124697572|NCT02191397|448513971|FG000|Overall Study|Physician Decision|8|||
124762908|NCT01928927|448755991|FG000|Overall Study|Withdrawal by Subject|1|||
124926544|NCT03899259|449360895|FG001|Overall Study|Ongoing Study Participation|134|||
124926545|NCT03899259|449360896|FG002|Overall Study|Ongoing Study Participation|210|||
124926546|NCT04797897|449360897|FG000|Overall Study|Study Termination by Sponsor|1|||
124926547|NCT04797897|449360898|FG001|Overall Study|Study Termination by Sponsor|1|||
124926548|NCT05670587|449360899|FG000|Overall Study|Withdrawal by Subject|3|||
124926549|NCT01197378|449360900|FG000|Overall Study|Adverse Event|3|||
124926550|NCT01197378|449360900|FG000|Overall Study|Withdrawal by Subject|1|||
124926551|NCT01197378|449360900|FG000|Overall Study|Physician Decision|1|||
124926552|NCT01197378|449360900|FG000|Overall Study|Other|2|||
124926553|NCT01544114|449360904|FG000|Overall Study|Withdrawal by Subject|0|||
124926554|NCT01544114|449360905|FG001|Overall Study|Withdrawal by Subject|0|||
124926555|NCT01544114|449360906|FG002|Overall Study|Withdrawal by Subject|3|||
124926556|NCT01544114|449360904|FG000|Overall Study|Lost to Follow-up|0|||
124926557|NCT01544114|449360905|FG001|Overall Study|Lost to Follow-up|2|||
124926558|NCT01544114|449360906|FG002|Overall Study|Lost to Follow-up|0|||
124926559|NCT01544114|449360904|FG000|Overall Study|Adverse Event|1|||
124545951|NCT00585468|447954429|FG000|First Intervention|Withdrawal by Subject|1|||
124697573|NCT02191397|448513972|FG001|Overall Study|Physician Decision|3|||
124697574|NCT02191397|448513971|FG000|Overall Study|Withdrawal by Subject|22|||
124697575|NCT02191397|448513972|FG001|Overall Study|Withdrawal by Subject|27|||
124697576|NCT04629521|448513973|FG000|Overall Study|Death|1|||
124697577|NCT04629521|448513973|FG000|Overall Study|Lost to Follow-up|3|||
124697578|NCT04629521|448513973|FG000|Overall Study|Subject withdrew consent|3|||
124697579|NCT04629521|448513973|FG000|Overall Study|Enrolled in error|1|||
124697580|NCT01618708|448513974|FG000|Overall Study|Adverse Event|10|||
124762909|NCT01928927|448755992|FG001|Overall Study|Withdrawal by Subject|1|||
124697581|NCT01618708|448513975|FG001|Overall Study|Adverse Event|10|||
124697582|NCT01618708|448513974|FG000|Overall Study|Lost to Follow-up|3|||
124697583|NCT01618708|448513975|FG001|Overall Study|Lost to Follow-up|3|||
124697584|NCT01618708|448513974|FG000|Overall Study|Withdrawal by Subject|17|||
124697585|NCT01618708|448513975|FG001|Overall Study|Withdrawal by Subject|22|||
124926560|NCT01544114|449360905|FG001|Overall Study|Adverse Event|1|||
124926561|NCT01544114|449360906|FG002|Overall Study|Adverse Event|2|||
124926562|NCT01544114|449360904|FG000|Overall Study|Protocol Violation|0|||
124926563|NCT01544114|449360905|FG001|Overall Study|Protocol Violation|1|||
124926564|NCT01544114|449360906|FG002|Overall Study|Protocol Violation|0|||
124926565|NCT03024437|449360921|FG000|Overall Study|Adverse Event|0|||
124926566|NCT03024437|449360922|FG001|Overall Study|Adverse Event|1|||
124926567|NCT03024437|449360923|FG002|Overall Study|Adverse Event|3|||
124926568|NCT03024437|449360924|FG003|Overall Study|Adverse Event|5|||
124926569|NCT03024437|449360925|FG004|Overall Study|Adverse Event|0|||
124926570|NCT03024437|449360921|FG000|Overall Study|Physician Decision|1|||
124926571|NCT03024437|449360922|FG001|Overall Study|Physician Decision|0|||
124926572|NCT03024437|449360923|FG002|Overall Study|Physician Decision|0|||
124926573|NCT03024437|449360924|FG003|Overall Study|Physician Decision|1|||
124926574|NCT03024437|449360925|FG004|Overall Study|Physician Decision|0|||
124926575|NCT03024437|449360921|FG000|Overall Study|Disease progression, relapse|1|||
124926576|NCT03024437|449360922|FG001|Overall Study|Disease progression, relapse|0|||
124926577|NCT03024437|449360923|FG002|Overall Study|Disease progression, relapse|0|||
124926578|NCT03024437|449360924|FG003|Overall Study|Disease progression, relapse|3|||
124926579|NCT03024437|449360925|FG004|Overall Study|Disease progression, relapse|0|||
124926580|NCT03024437|449360921|FG000|Overall Study|Disease progression, refractory disease|4|||
124926581|NCT03024437|449360922|FG001|Overall Study|Disease progression, refractory disease|4|||
124926582|NCT03024437|449360923|FG002|Overall Study|Disease progression, refractory disease|2|||
124926583|NCT03024437|449360924|FG003|Overall Study|Disease progression, refractory disease|2|||
124926584|NCT03024437|449360925|FG004|Overall Study|Disease progression, refractory disease|1|||
124926585|NCT03024437|449360921|FG000|Overall Study|Newly diagnosed cancer|0|||
124926586|NCT03024437|449360922|FG001|Overall Study|Newly diagnosed cancer|0|||
124926587|NCT03024437|449360923|FG002|Overall Study|Newly diagnosed cancer|0|||
124926588|NCT03024437|449360924|FG003|Overall Study|Newly diagnosed cancer|1|||
124926589|NCT03024437|449360925|FG004|Overall Study|Newly diagnosed cancer|0|||
124926590|NCT03024437|449360921|FG000|Overall Study|Moved out of state|0|||
124926591|NCT03024437|449360922|FG001|Overall Study|Moved out of state|1|||
124926592|NCT03024437|449360923|FG002|Overall Study|Moved out of state|0|||
124926593|NCT03024437|449360924|FG003|Overall Study|Moved out of state|0|||
124926594|NCT03024437|449360925|FG004|Overall Study|Moved out of state|0|||
124926595|NCT03024437|449360921|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
124926596|NCT03024437|449360922|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
124926597|NCT03024437|449360923|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
124926598|NCT03024437|449360924|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
124926599|NCT03024437|449360925|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
124926600|NCT04625465|449360926|FG000|Overall Study|Lost to Follow-up|2|||
124926601|NCT04625465|449360927|FG001|Overall Study|Lost to Follow-up|2|||
124926602|NCT04625465|449360928|FG002|Overall Study|Lost to Follow-up|1|||
124926603|NCT04625465|449360929|FG003|Overall Study|Lost to Follow-up|0|||
124926604|NCT04625465|449360930|FG004|Overall Study|Lost to Follow-up|0|||
124926605|NCT04625465|449360931|FG005|Overall Study|Lost to Follow-up|2|||
124926606|NCT04625465|449360932|FG006|Overall Study|Lost to Follow-up|0|||
124926607|NCT04625465|449360933|FG007|Overall Study|Lost to Follow-up|0|||
124926608|NCT04625465|449360926|FG000|Overall Study|Death|1|||
124926609|NCT04625465|449360927|FG001|Overall Study|Death|0|||
124926610|NCT04625465|449360928|FG002|Overall Study|Death|0|||
124926611|NCT04625465|449360929|FG003|Overall Study|Death|0|||
124926612|NCT04625465|449360930|FG004|Overall Study|Death|0|||
124926613|NCT04625465|449360931|FG005|Overall Study|Death|0|||
124697586|NCT01618708|448513974|FG000|Overall Study|Lack of Efficacy|8|||
124697587|NCT01618708|448513975|FG001|Overall Study|Lack of Efficacy|8|||
124762910|NCT02421172|448757844|FG000|Period 1|Adverse Event|1|||
124762911|NCT02421172|448757845|FG001|Period 1|Adverse Event|0|||
124697588|NCT01618708|448513974|FG000|Overall Study|Technical problems|2|||
124697589|NCT01618708|448513975|FG001|Overall Study|Technical problems|0|||
124926614|NCT04625465|449360932|FG006|Overall Study|Death|0|||
124926615|NCT04625465|449360933|FG007|Overall Study|Death|0|||
124926616|NCT04625465|449360926|FG000|Overall Study|Withdrawal by Subject|1|||
124926617|NCT04625465|449360927|FG001|Overall Study|Withdrawal by Subject|0|||
124926618|NCT04625465|449360928|FG002|Overall Study|Withdrawal by Subject|4|||
124926619|NCT04625465|449360929|FG003|Overall Study|Withdrawal by Subject|4|||
124926620|NCT04625465|449360930|FG004|Overall Study|Withdrawal by Subject|4|||
124926621|NCT04625465|449360931|FG005|Overall Study|Withdrawal by Subject|0|||
124697590|NCT01618708|448513974|FG000|Overall Study|Other than specified above|1|||
124762912|NCT02421172|448757846|FG002|Period 1|Adverse Event|0|||
124697591|NCT01618708|448513975|FG001|Overall Study|Other than specified above|1|||
124697592|NCT01618708|448513974|FG000|Overall Study|Randomized but not treated|3|||
124697593|NCT01618708|448513975|FG001|Overall Study|Randomized but not treated|2|||
124454582|NCT03496012|447625306|FG000|Overall Study|Withdrawal by Subject|2|||
124454583|NCT03496012|447625307|FG001|Overall Study|Withdrawal by Subject|0|||
124454584|NCT03496012|447625308|FG002|Overall Study|Withdrawal by Subject|2|||
124454585|NCT03496012|447625306|FG000|Overall Study|Adverse Event|0|||
124454586|NCT03496012|447625307|FG001|Overall Study|Adverse Event|0|||
124454587|NCT03496012|447625308|FG002|Overall Study|Adverse Event|1|||
124454588|NCT03496012|447625306|FG000|Overall Study|Reason Not Specified|2|||
124454589|NCT03496012|447625307|FG001|Overall Study|Reason Not Specified|0|||
124454590|NCT03496012|447625308|FG002|Overall Study|Reason Not Specified|1|||
124454591|NCT04096274|447625312|FG000|Phase I|Lost to Follow-up|5|||
124454592|NCT04096274|447625313|FG001|Phase I|Lost to Follow-up|5|||
124454593|NCT04096274|447625312|FG000|Phase II|Lost to Follow-up|11|||
124454594|NCT04096274|447625313|FG001|Phase II|Lost to Follow-up|11|||
124454595|NCT00516048|447625317|FG000|Overall Study|Death|0|||
124454596|NCT00516048|447625318|FG001|Overall Study|Death|0|||
124454597|NCT00516048|447625319|FG002|Overall Study|Death|1|||
124454598|NCT00516048|447625317|FG000|Overall Study|Subject Decision|0|||
124697594|NCT02554474|448513978|FG000|Overall Study|Protocol Violation|1|||
124697595|NCT02554474|448513979|FG001|Overall Study|Protocol Violation|1|||
124697596|NCT02554474|448513978|FG000|Overall Study|Health issue not related to the study|1|||
124697597|NCT02554474|448513979|FG001|Overall Study|Health issue not related to the study|0|||
124697598|NCT02554474|448513978|FG000|Overall Study|Withdrawal by Subject|1|||
124697599|NCT02554474|448513979|FG001|Overall Study|Withdrawal by Subject|1|||
124697600|NCT03211832|448513980|FG000|Overall Study|No longer with agency|32|||
124697601|NCT03211832|448513981|FG001|Overall Study|No longer with agency|49|||
124697602|NCT03211832|448513982|FG002|Overall Study|No longer with agency|30|||
124697603|NCT03211832|448513980|FG000|Overall Study|Declined survey|3|||
124697604|NCT03211832|448513981|FG001|Overall Study|Declined survey|3|||
124697605|NCT03211832|448513982|FG002|Overall Study|Declined survey|2|||
124762913|NCT02421172|448757847|FG003|Period 1|Adverse Event|0|||
124926622|NCT04625465|449360932|FG006|Overall Study|Withdrawal by Subject|0|||
124926623|NCT04625465|449360933|FG007|Overall Study|Withdrawal by Subject|0|||
124926624|NCT04501614|449360934|FG000|Overall Study|Study Terminated by Sponsor|6|||
124926625|NCT04501614|449360935|FG001|Overall Study|Study Terminated by Sponsor|3|||
124926626|NCT04501614|449360934|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
124926627|NCT04501614|449360935|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
124926628|NCT05566639|449360936|FG000|Overall Study|Adverse Event|1|||
124926629|NCT05566639|449360937|FG001|Overall Study|Adverse Event|1|||
124926630|NCT05566639|449360936|FG000|Overall Study|Serious Adverse Event|1|||
124926631|NCT05566639|449360937|FG001|Overall Study|Serious Adverse Event|3|||
124926632|NCT05566639|449360936|FG000|Overall Study|Death|44|||
124926633|NCT05566639|449360937|FG001|Overall Study|Death|45|||
124926634|NCT05566639|449360936|FG000|Overall Study|Lost to Follow-up|467|||
124926635|NCT05566639|449360937|FG001|Overall Study|Lost to Follow-up|461|||
124926636|NCT05566639|449360936|FG000|Overall Study|Physician Decision|45|||
124926637|NCT05566639|449360937|FG001|Overall Study|Physician Decision|44|||
124926638|NCT05566639|449360936|FG000|Overall Study|Protocol Deviation|4|||
124926639|NCT05566639|449360937|FG001|Overall Study|Protocol Deviation|4|||
124926640|NCT05566639|449360936|FG000|Overall Study|Withdrawal by Subject|277|||
124926641|NCT05566639|449360937|FG001|Overall Study|Withdrawal by Subject|271|||
124926642|NCT05566639|449360936|FG000|Overall Study|Other Than Specified|52|||
124926643|NCT05566639|449360937|FG001|Overall Study|Other Than Specified|64|||
124926644|NCT05239455|449360939|FG000|Overall Study|Adverse Event|1|||
124926645|NCT05239455|449360939|FG000|Overall Study|Sponsor Decision|5|||
124926646|NCT05239455|449360939|FG000|Overall Study|Incomplete Blood Collection|1|||
124926647|NCT02589522|449360940|FG000|Overall Study|Physician Decision|1|||
124926648|NCT02589522|449360941|FG001|Overall Study|Physician Decision|2|||
124454599|NCT00516048|447625318|FG001|Overall Study|Subject Decision|2|||
124697606|NCT03211832|448513980|FG000|Overall Study|Not available during data collection|1|||
124926649|NCT02589522|449360942|FG002|Overall Study|Physician Decision|0|||
124454600|NCT00516048|447625319|FG002|Overall Study|Subject Decision|0|||
124454601|NCT02807480|447625320|FG000|Overall Study|Withdrawal by Subject|14|||
124454602|NCT02807480|447625321|FG001|Overall Study|Withdrawal by Subject|10|||
124454603|NCT00054704|447625322|FG000|Overall Study|Lack of Efficacy|2|||
124454604|NCT00054704|447625323|FG001|Overall Study|Lack of Efficacy|3|||
124454605|NCT00054704|447625322|FG000|Overall Study|Adverse Event|3|||
124454606|NCT00054704|447625323|FG001|Overall Study|Adverse Event|1|||
124926650|NCT02589522|449360940|FG000|Overall Study|Did not start treatment|1|||
124926651|NCT02589522|449360941|FG001|Overall Study|Did not start treatment|0|||
124454607|NCT00054704|447625322|FG000|Overall Study|Lost to Follow-up|0|||
124454608|NCT00054704|447625323|FG001|Overall Study|Lost to Follow-up|1|||
124697607|NCT03211832|448513981|FG001|Overall Study|Not available during data collection|0|||
124762914|NCT02421172|448757848|FG004|Period 1|Adverse Event|0|||
124926652|NCT02589522|449360942|FG002|Overall Study|Did not start treatment|0|||
124926653|NCT03800654|449360943|FG000|Overall Study|Time constraints|3|||
124926654|NCT03800654|449360944|FG001|Overall Study|Time constraints|3|||
124926655|NCT03800654|449360945|FG002|Overall Study|Time constraints|3|||
124926656|NCT03800654|449360943|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
124926657|NCT03800654|449360944|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
124926658|NCT03800654|449360945|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
124926659|NCT03800654|449360943|FG000|Overall Study|Lost to Follow-up|2|||
124926660|NCT03800654|449360944|FG001|Overall Study|Lost to Follow-up|1|||
124926661|NCT03800654|449360945|FG002|Overall Study|Lost to Follow-up|6|||
124926662|NCT03800654|449360943|FG000|Overall Study|Medical Health Issue|0|||
124926663|NCT03800654|449360944|FG001|Overall Study|Medical Health Issue|0|||
124926664|NCT03800654|449360945|FG002|Overall Study|Medical Health Issue|1|||
124926665|NCT03800654|449360943|FG000|Overall Study|Personal Issues|0|||
124926666|NCT03800654|449360944|FG001|Overall Study|Personal Issues|2|||
124926667|NCT03800654|449360945|FG002|Overall Study|Personal Issues|0|||
124926668|NCT03800654|449360943|FG000|Overall Study|Protocol Violation|0|||
124926669|NCT03800654|449360944|FG001|Overall Study|Protocol Violation|1|||
124926670|NCT03800654|449360945|FG002|Overall Study|Protocol Violation|0|||
124926671|NCT04159415|449360946|FG000|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
124926672|NCT04159415|449360947|FG001|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
124926673|NCT04159415|449360948|FG002|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
124926674|NCT04159415|449360949|FG003|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
124926675|NCT04159415|449360950|FG004|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
124926676|NCT04159415|449360951|FG005|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
124926677|NCT04159415|449360952|FG006|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
124926678|NCT04159415|449360953|FG007|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
124926679|NCT01799265|449360954|FG000|Overall Study|Lost to Follow-up|1|||
124926680|NCT01799265|449360955|FG001|Overall Study|Lost to Follow-up|0|||
124926681|NCT01799265|449360954|FG000|Overall Study|Protocol Violation|2|||
124926682|NCT01799265|449360955|FG001|Overall Study|Protocol Violation|1|||
124926683|NCT01799265|449360954|FG000|Overall Study|inadequate sleep study|0|||
124926684|NCT01799265|449360955|FG001|Overall Study|inadequate sleep study|2|||
124926685|NCT03459729|449360956|FG000|Overall Study|Physician Decision|2|||
124926686|NCT06182033|449360957|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
124926687|NCT06182033|449360958|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
124926688|NCT06182033|449360957|FG000|Overall Study|Target child relocation|1|||
124926689|NCT06182033|449360958|FG001|Overall Study|Target child relocation|1|||
124926690|NCT06182033|449360957|FG000|Overall Study|Withdrawal by Subject|1|||
124926691|NCT06182033|449360958|FG001|Overall Study|Withdrawal by Subject|0|||
124926692|NCT02364557|449360959|FG000|Overall Study|Protocol Violation|3|||
124926693|NCT02364557|449360960|FG001|Overall Study|Protocol Violation|1|||
124926694|NCT04200456|449360965|FG000|Overall Study|Physician Decision|0|||
124926695|NCT04200456|449360966|FG001|Overall Study|Physician Decision|1|||
124926696|NCT04200456|449360965|FG000|Overall Study|Withdrawal by Subject|2|||
124926697|NCT04200456|449360966|FG001|Overall Study|Withdrawal by Subject|2|||
124926698|NCT04200456|449360965|FG000|Overall Study|Lack of Efficacy|1|||
124926699|NCT04200456|449360966|FG001|Overall Study|Lack of Efficacy|1|||
124926700|NCT04200456|449360965|FG000|Overall Study|Adverse event, non-fatal|0|||
124926701|NCT04200456|449360966|FG001|Overall Study|Adverse event, non-fatal|1|||
124926702|NCT04200456|449360965|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
124926703|NCT04200456|449360966|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
124926704|NCT04828005|449360967|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
124926705|NCT04828005|449360968|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
124926706|NCT04828005|449360969|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
124926707|NCT04828005|449360970|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
124926708|NCT04828005|449360967|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
124926709|NCT04828005|449360968|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
124926710|NCT04828005|449360969|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
124926711|NCT04828005|449360970|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
124926712|NCT04828005|449360967|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
124454609|NCT00362414|447625324|FG000|Overall Study|Death|2|||
124454610|NCT00362414|447625324|FG000|Overall Study|Adverse Event|1|||
124454611|NCT02369848|447625325|FG000|Overall Study|Death|1|||
124454612|NCT02369848|447625325|FG000|Overall Study|Withdrawal by Subject|2|||
124454613|NCT02369848|447625325|FG000|Overall Study|Lost to Follow-up|1|||
124926713|NCT04828005|449360968|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
124926714|NCT04828005|449360969|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
124926715|NCT04828005|449360970|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
124926716|NCT04828005|449360967|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
124454614|NCT01543152|447625326|FG000|Overall Study|Withdrawal by Subject|0|||
124454615|NCT01543152|447625327|FG001|Overall Study|Withdrawal by Subject|2|||
124926717|NCT04828005|449360968|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
124926718|NCT04828005|449360969|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
124926719|NCT04828005|449360970|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
124762915|NCT02421172|448757844|FG000|Period 1|Lost to Follow-up|3|||
124762916|NCT02421172|448757845|FG001|Period 1|Lost to Follow-up|1|||
124762917|NCT02421172|448757846|FG002|Period 1|Lost to Follow-up|0|||
124762918|NCT02421172|448757847|FG003|Period 1|Lost to Follow-up|0|||
124762919|NCT02421172|448757848|FG004|Period 1|Lost to Follow-up|0|||
124762920|NCT02421172|448757844|FG000|Period 1|Patient/guardian decision|0|||
124762921|NCT02421172|448757845|FG001|Period 1|Patient/guardian decision|1|||
124762922|NCT02421172|448757846|FG002|Period 1|Patient/guardian decision|0|||
124697608|NCT03211832|448513982|FG002|Overall Study|Not available during data collection|2|||
124697609|NCT02991859|448513986|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
124697610|NCT02991859|448513987|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
124697611|NCT02991859|448513988|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
124697612|NCT02991859|448513989|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
124697613|NCT02991859|448513990|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
124762923|NCT02421172|448757847|FG003|Period 1|Patient/guardian decision|0|||
124762924|NCT02421172|448757848|FG004|Period 1|Patient/guardian decision|0|||
124762925|NCT02421172|448757844|FG000|Period 2|Adverse Event|0|||
124762926|NCT02421172|448757845|FG001|Period 2|Adverse Event|0|||
124762927|NCT02421172|448757846|FG002|Period 2|Adverse Event|4|||
124762928|NCT02421172|448757847|FG003|Period 2|Adverse Event|0|||
124762929|NCT02421172|448757848|FG004|Period 2|Adverse Event|0|||
124762930|NCT02421172|448757844|FG000|Period 2|Lost to Follow-up|0|||
124762931|NCT02421172|448757845|FG001|Period 2|Lost to Follow-up|0|||
124762932|NCT02421172|448757846|FG002|Period 2|Lost to Follow-up|0|||
124762933|NCT02421172|448757847|FG003|Period 2|Lost to Follow-up|1|||
124762934|NCT02421172|448757848|FG004|Period 2|Lost to Follow-up|0|||
124762935|NCT02421172|448757844|FG000|Period 2|Patient/guardian decision|0|||
124762936|NCT02421172|448757845|FG001|Period 2|Patient/guardian decision|0|||
124762937|NCT02421172|448757846|FG002|Period 2|Patient/guardian decision|3|||
124762938|NCT02421172|448757847|FG003|Period 2|Patient/guardian decision|2|||
124762939|NCT02421172|448757848|FG004|Period 2|Patient/guardian decision|1|||
124762940|NCT00683878|448757852|FG000|Overall Study|Lack of Efficacy|3|||
124762941|NCT00683878|448757853|FG001|Overall Study|Lack of Efficacy|0|||
124762942|NCT00683878|448757854|FG002|Overall Study|Lack of Efficacy|1|||
124762943|NCT00683878|448757852|FG000|Overall Study|Adverse Event|4|||
124762944|NCT00683878|448757853|FG001|Overall Study|Adverse Event|3|||
124454616|NCT01543152|447625328|FG002|Overall Study|Withdrawal by Subject|0|||
124454617|NCT01543152|447625329|FG003|Overall Study|Withdrawal by Subject|0|||
124697614|NCT02991859|448513991|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
124697615|NCT02991859|448513992|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
124697616|NCT02991859|448513993|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
124697617|NCT02991859|448513994|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
124697618|NCT02991859|448513995|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
124697619|NCT02991859|448513996|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
124697620|NCT02991859|448513997|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
124697621|NCT02991859|448513998|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
124697622|NCT02991859|448513999|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
124697623|NCT02991859|448514000|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
124697624|NCT02991859|448514001|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
124697625|NCT02991859|448514002|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
124697626|NCT02991859|448513986|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
124697627|NCT02991859|448513987|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
124697628|NCT02991859|448513988|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
124697629|NCT02991859|448513989|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
124697630|NCT02991859|448513990|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
124454618|NCT01543152|447625330|FG004|Overall Study|Withdrawal by Subject|0|||
124454619|NCT02053168|447625331|FG000|Overall Study|Withdrawal by Subject|1|||
124454620|NCT02053168|447625331|FG000|Overall Study|Physician Decision|1|||
124454621|NCT02053168|447625331|FG000|Overall Study|Lost to Follow-up|1|||
124454622|NCT00636675|447625332|FG000|Overall Study|Lost to Follow-up|121|||
124454623|NCT00636675|447625333|FG001|Overall Study|Lost to Follow-up|31|||
124454624|NCT00636675|447625332|FG000|Overall Study|Withdrawal by Subject|19|||
124454625|NCT00636675|447625333|FG001|Overall Study|Withdrawal by Subject|10|||
124454626|NCT00096785|447625334|FG000|Overall Study|Lost to Follow-up|1|||
124454627|NCT00096785|447625335|FG001|Overall Study|Lost to Follow-up|0|||
124545952|NCT00585468|447954430|FG001|First Intervention|Withdrawal by Subject|1|||
124762945|NCT00683878|448757854|FG002|Overall Study|Adverse Event|3|||
124762946|NCT00683878|448757852|FG000|Overall Study|Withdrawal by Subject|9|||
124762947|NCT00683878|448757853|FG001|Overall Study|Withdrawal by Subject|8|||
124762948|NCT00683878|448757854|FG002|Overall Study|Withdrawal by Subject|6|||
124454628|NCT00096785|447625334|FG000|Overall Study|Withdrawal by Subject|0|||
124454629|NCT00096785|447625335|FG001|Overall Study|Withdrawal by Subject|1|||
124926720|NCT04828005|449360967|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
124926721|NCT04828005|449360968|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
124926722|NCT04828005|449360969|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
124926723|NCT04828005|449360970|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
124926724|NCT04828005|449360967|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
124926725|NCT04828005|449360968|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
124926726|NCT04828005|449360969|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
124926727|NCT04828005|449360970|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
124926728|NCT04828005|449360967|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
124926729|NCT04828005|449360968|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
124926730|NCT04828005|449360969|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
124926731|NCT04828005|449360970|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
124926732|NCT04828005|449360967|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
124926733|NCT04828005|449360968|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
124926734|NCT04828005|449360969|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
124926735|NCT04828005|449360970|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
124926736|NCT04828005|449360967|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
124926737|NCT04828005|449360968|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
124926738|NCT04828005|449360969|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
124926739|NCT04828005|449360970|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
124926740|NCT02043678|449362644|FG000|Overall Study|Never treated|11|||
124926741|NCT02043678|449362645|FG001|Overall Study|Never treated|9|||
124926742|NCT02043678|449362644|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
124926743|NCT02043678|449362645|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
124926744|NCT02043678|449362644|FG000|Overall Study|AE without clinical PD|54|||
124926745|NCT02043678|449362645|FG001|Overall Study|AE without clinical PD|36|||
124926746|NCT02043678|449362644|FG000|Overall Study|Lost to Follow-up|1|||
124926747|NCT02043678|449362645|FG001|Overall Study|Lost to Follow-up|1|||
124926748|NCT02043678|449362644|FG000|Overall Study|Other|10|||
124926749|NCT02043678|449362645|FG001|Overall Study|Other|14|||
124926750|NCT02043678|449362644|FG000|Overall Study|Clinical PD|114|||
124926751|NCT02043678|449362645|FG001|Overall Study|Clinical PD|148|||
124926752|NCT02043678|449362644|FG000|Overall Study|Radiological PD|100|||
124926753|NCT02043678|449362645|FG001|Overall Study|Radiological PD|90|||
124926754|NCT02043678|449362644|FG000|Overall Study|Protocol-driven decision point|59|||
124926755|NCT02043678|449362645|FG001|Overall Study|Protocol-driven decision point|58|||
124926756|NCT02043678|449362644|FG000|Overall Study|Withdrawal by Subject|16|||
124926757|NCT02043678|449362645|FG001|Overall Study|Withdrawal by Subject|20|||
124926758|NCT02043678|449362644|FG000|Overall Study|Protocol Violation|1|||
124926759|NCT02043678|449362645|FG001|Overall Study|Protocol Violation|0|||
124926760|NCT02043678|449362644|FG000|Overall Study|Deterioration of general conditions|1|||
124926761|NCT02043678|449362645|FG001|Overall Study|Deterioration of general conditions|1|||
124926762|NCT02043678|449362644|FG000|Overall Study|Logistical difficulties|2|||
124926763|NCT02043678|449362645|FG001|Overall Study|Logistical difficulties|0|||
124926764|NCT02043678|449362644|FG000|Overall Study|Non-compliance with study drug|3|||
124926765|NCT02043678|449362645|FG001|Overall Study|Non-compliance with study drug|1|||
124926766|NCT02043678|449362644|FG000|Overall Study|Physician Decision|4|||
124926767|NCT02043678|449362645|FG001|Overall Study|Physician Decision|3|||
124926768|NCT02043678|449362644|FG000|Overall Study|Subject decision|0|||
124926769|NCT02043678|449362645|FG001|Overall Study|Subject decision|1|||
124926770|NCT02043678|449362644|FG000|Overall Study|Switching to other therapy|3|||
124926771|NCT02043678|449362645|FG001|Overall Study|Switching to other therapy|2|||
124926772|NCT02043678|449362644|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
124926773|NCT02043678|449362645|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
124926774|NCT02043678|449362644|FG000|Overall Study|Missing|1|||
124926775|NCT02043678|449362645|FG001|Overall Study|Missing|0|||
124926776|NCT02043678|449362644|FG000|Overall Study|Adverse Event|0|||
124926777|NCT02043678|449362645|FG001|Overall Study|Adverse Event|1|||
124926778|NCT05543629|449362646|FG000|Overall Study|Death|1|||
124926779|NCT05543629|449362647|FG001|Overall Study|Death|0|||
124926780|NCT05543629|449362648|FG002|Overall Study|Death|1|||
124926781|NCT05543629|449362649|FG003|Overall Study|Death|0|||
124926782|NCT05543629|449362650|FG004|Overall Study|Death|0|||
124926783|NCT05543629|449362651|FG005|Overall Study|Death|1|||
124926784|NCT05543629|449362652|FG006|Overall Study|Death|2|||
124926785|NCT05543629|449362653|FG007|Overall Study|Death|2|||
124926786|NCT05543629|449362646|FG000|Overall Study|Other Reasons|0|||
124926787|NCT05543629|449362647|FG001|Overall Study|Other Reasons|0|||
124926788|NCT05543629|449362648|FG002|Overall Study|Other Reasons|0|||
124762949|NCT00683878|448757852|FG000|Overall Study|Death|0|||
124762950|NCT00683878|448757853|FG001|Overall Study|Death|1|||
124762951|NCT00683878|448757854|FG002|Overall Study|Death|0|||
124762952|NCT00683878|448757852|FG000|Overall Study|Lost to Follow-up|4|||
124762953|NCT00683878|448757853|FG001|Overall Study|Lost to Follow-up|2|||
124762954|NCT00683878|448757854|FG002|Overall Study|Lost to Follow-up|4|||
124762955|NCT00683878|448757852|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
124762956|NCT00683878|448757853|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
124762957|NCT00683878|448757854|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
124762958|NCT02869633|448757858|FG000|Overall Study|Death|2|||
124762959|NCT02869633|448757859|FG001|Overall Study|Death|1|||
124454630|NCT00096785|447625334|FG000|Overall Study|Relocated|1|||
124454631|NCT00096785|447625335|FG001|Overall Study|Relocated|0|||
124454632|NCT04053868|447625336|FG000|Overall Study|Withdrawal by Subject|1|||
124454633|NCT04053868|447625337|FG001|Overall Study|Withdrawal by Subject|0|||
124454634|NCT00833053|447625341|FG000|Overall Study|Adverse Event|4|||
124454635|NCT00833053|447625342|FG001|Overall Study|Adverse Event|0|||
124454636|NCT00833053|447625341|FG000|Overall Study|Treatment Failure|3|||
124454637|NCT00833053|447625342|FG001|Overall Study|Treatment Failure|1|||
124454638|NCT00833053|447625341|FG000|Overall Study|Withdrawal by Subject|0|||
124454639|NCT00833053|447625342|FG001|Overall Study|Withdrawal by Subject|1|||
124454640|NCT00833053|447625341|FG000|Overall Study|Protocol Violation|2|||
124454641|NCT00833053|447625342|FG001|Overall Study|Protocol Violation|1|||
124454642|NCT02187471|447625344|FG000|Overall Study|Protocol Violation|4|||
124454643|NCT02187471|447625345|FG001|Overall Study|Protocol Violation|5|||
124454644|NCT02187471|447625346|FG002|Overall Study|Protocol Violation|4|||
124454645|NCT02187471|447625347|FG003|Overall Study|Protocol Violation|4|||
124454646|NCT02187471|447625344|FG000|Overall Study|Missing|0|||
124454647|NCT02187471|447625345|FG001|Overall Study|Missing|0|||
124454648|NCT02187471|447625346|FG002|Overall Study|Missing|0|||
124454649|NCT02187471|447625347|FG003|Overall Study|Missing|1|||
124454650|NCT02187471|447625344|FG000|Overall Study|Lack of Efficacy|18|||
124454651|NCT02187471|447625345|FG001|Overall Study|Lack of Efficacy|9|||
124454652|NCT02187471|447625346|FG002|Overall Study|Lack of Efficacy|13|||
124454653|NCT02187471|447625347|FG003|Overall Study|Lack of Efficacy|11|||
124454654|NCT02187471|447625344|FG000|Overall Study|Adverse Event|24|||
124454655|NCT02187471|447625345|FG001|Overall Study|Adverse Event|34|||
124454656|NCT02187471|447625346|FG002|Overall Study|Adverse Event|44|||
124454657|NCT02187471|447625347|FG003|Overall Study|Adverse Event|36|||
124697631|NCT02991859|448513991|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
124697632|NCT02991859|448513992|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
124697633|NCT02991859|448513993|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
124697634|NCT02991859|448513994|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
124697635|NCT02991859|448513995|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
124697636|NCT02991859|448513996|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
124697637|NCT02991859|448513997|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
124697638|NCT02991859|448513998|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
124697639|NCT02991859|448513999|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
124697640|NCT02991859|448514000|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
124697641|NCT02991859|448514001|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
124697642|NCT02991859|448514002|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
124697643|NCT02991859|448513986|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
124697644|NCT02991859|448513987|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
124697645|NCT02991859|448513988|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
124697646|NCT02991859|448513989|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
124697647|NCT02991859|448513990|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
124697648|NCT02991859|448513991|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
124762960|NCT02869633|448757858|FG000|Overall Study|Patient refused follow-up|1|||
124762961|NCT02869633|448757859|FG001|Overall Study|Patient refused follow-up|0|||
124454658|NCT02187471|447625344|FG000|Overall Study|Withdrawal by Subject|23|||
124454659|NCT02187471|447625345|FG001|Overall Study|Withdrawal by Subject|29|||
124454660|NCT02187471|447625346|FG002|Overall Study|Withdrawal by Subject|22|||
124454661|NCT02187471|447625347|FG003|Overall Study|Withdrawal by Subject|24|||
124762962|NCT02869633|448757858|FG000|Overall Study|Provider discretion|1|||
124762963|NCT02869633|448757859|FG001|Overall Study|Provider discretion|0|||
124762964|NCT02869633|448757858|FG000|Overall Study|Investigator decision|1|||
124762965|NCT02869633|448757859|FG001|Overall Study|Investigator decision|0|||
124762966|NCT02869633|448757858|FG000|Overall Study|Lost to Follow-up|0|||
124762967|NCT02869633|448757859|FG001|Overall Study|Lost to Follow-up|1|||
124762968|NCT02869633|448757858|FG000|Overall Study|Not eligible|6|||
124762969|NCT02869633|448757859|FG001|Overall Study|Not eligible|1|||
124762970|NCT02869633|448757858|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
124762971|NCT02869633|448757859|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
124762972|NCT02869633|448757858|FG000|Overall Study|Withdrawal by Subject|0|||
124762973|NCT02869633|448757859|FG001|Overall Study|Withdrawal by Subject|1|||
124762974|NCT04024891|448757860|FG000|Overall Study|Pregnancy|0|||
124762975|NCT04024891|448757861|FG001|Overall Study|Pregnancy|1|||
124762976|NCT01421017|448757862|FG000|Overall Study|Withdrawal by Subject|2|||
124762977|NCT01421017|448757863|FG001|Overall Study|Withdrawal by Subject|0|||
124762978|NCT01421017|448757864|FG002|Overall Study|Withdrawal by Subject|0|||
124762979|NCT01421017|448757862|FG000|Overall Study|POD|0|||
124762980|NCT01421017|448757863|FG001|Overall Study|POD|6|||
124762981|NCT01421017|448757864|FG002|Overall Study|POD|3|||
124762982|NCT03489863|448757865|FG000|Overall Study|Withdrawal by Subject|0|||
124926789|NCT05543629|449362649|FG003|Overall Study|Other Reasons|0|||
124926790|NCT05543629|449362650|FG004|Overall Study|Other Reasons|1|||
124926791|NCT05543629|449362651|FG005|Overall Study|Other Reasons|0|||
124926792|NCT05543629|449362652|FG006|Overall Study|Other Reasons|0|||
124926793|NCT05543629|449362653|FG007|Overall Study|Other Reasons|0|||
124926794|NCT05543629|449362646|FG000|Overall Study|Physician Decision|0|||
124926795|NCT05543629|449362647|FG001|Overall Study|Physician Decision|0|||
124926796|NCT05543629|449362648|FG002|Overall Study|Physician Decision|3|||
124926797|NCT05543629|449362649|FG003|Overall Study|Physician Decision|0|||
124926798|NCT05543629|449362650|FG004|Overall Study|Physician Decision|0|||
124926799|NCT05543629|449362651|FG005|Overall Study|Physician Decision|0|||
124926800|NCT05543629|449362652|FG006|Overall Study|Physician Decision|1|||
124454662|NCT02187471|447625344|FG000|Overall Study|Other|7|||
124454663|NCT02187471|447625345|FG001|Overall Study|Other|5|||
124454664|NCT02187471|447625346|FG002|Overall Study|Other|3|||
124454665|NCT02187471|447625347|FG003|Overall Study|Other|4|||
124454666|NCT02236520|447625348|FG000|Overall Study|Physician Decision|0|||
124454667|NCT02236520|447625349|FG001|Overall Study|Physician Decision|5|||
124454668|NCT02236520|447625350|FG002|Overall Study|Physician Decision|0|||
124454669|NCT02236520|447625351|FG003|Overall Study|Physician Decision|0|||
124454670|NCT02236520|447625348|FG000|Overall Study|Withdrawal by Subject|1|||
124454671|NCT02236520|447625349|FG001|Overall Study|Withdrawal by Subject|0|||
124454672|NCT02236520|447625350|FG002|Overall Study|Withdrawal by Subject|0|||
124454673|NCT02236520|447625351|FG003|Overall Study|Withdrawal by Subject|1|||
124454674|NCT02236520|447625348|FG000|Overall Study|Pregnancy|1|||
124454675|NCT02236520|447625349|FG001|Overall Study|Pregnancy|0|||
124454676|NCT02236520|447625350|FG002|Overall Study|Pregnancy|0|||
124454677|NCT02236520|447625351|FG003|Overall Study|Pregnancy|0|||
124454678|NCT02081534|447625352|FG000|Overall Study|Adverse Event|5|||
124454679|NCT02081534|447625353|FG001|Overall Study|Adverse Event|4|||
124454680|NCT02081534|447625354|FG002|Overall Study|Adverse Event|3|||
124454681|NCT02081534|447625355|FG003|Overall Study|Adverse Event|10|||
124454682|NCT02081534|447625356|FG004|Overall Study|Adverse Event|2|||
124454683|NCT02081534|447625357|FG005|Overall Study|Adverse Event|8|||
124454684|NCT02081534|447625358|FG006|Overall Study|Adverse Event|2|||
124454685|NCT02081534|447625352|FG000|Overall Study|Withdrawal by Subject|0|||
124454686|NCT02081534|447625353|FG001|Overall Study|Withdrawal by Subject|1|||
124454687|NCT02081534|447625354|FG002|Overall Study|Withdrawal by Subject|1|||
124454688|NCT02081534|447625355|FG003|Overall Study|Withdrawal by Subject|1|||
124454689|NCT02081534|447625356|FG004|Overall Study|Withdrawal by Subject|1|||
124454690|NCT02081534|447625357|FG005|Overall Study|Withdrawal by Subject|0|||
124926801|NCT05543629|449362653|FG007|Overall Study|Physician Decision|0|||
124926802|NCT05543629|449362646|FG000|Overall Study|Study terminated by Sponsor|1|||
124926803|NCT05543629|449362647|FG001|Overall Study|Study terminated by Sponsor|0|||
124454691|NCT02081534|447625358|FG006|Overall Study|Withdrawal by Subject|1|||
124454692|NCT02081534|447625352|FG000|Overall Study|Protocol Violation|0|||
124454693|NCT02081534|447625353|FG001|Overall Study|Protocol Violation|3|||
124454694|NCT02081534|447625354|FG002|Overall Study|Protocol Violation|0|||
124454695|NCT02081534|447625355|FG003|Overall Study|Protocol Violation|0|||
124454696|NCT02081534|447625356|FG004|Overall Study|Protocol Violation|0|||
124454697|NCT02081534|447625357|FG005|Overall Study|Protocol Violation|0|||
124454698|NCT02081534|447625358|FG006|Overall Study|Protocol Violation|1|||
124454699|NCT02081534|447625352|FG000|Overall Study|Lost to Follow-up|0|||
124762983|NCT03489863|448757866|FG001|Overall Study|Withdrawal by Subject|1|||
124762984|NCT00962208|448757868|FG000|Overall Study|Could not achieve good vision|9|||
124762985|NCT00962208|448757869|FG001|Overall Study|Could not achieve good vision|0|||
124454700|NCT02081534|447625353|FG001|Overall Study|Lost to Follow-up|0|||
124926804|NCT05543629|449362648|FG002|Overall Study|Study terminated by Sponsor|0|||
124926805|NCT05543629|449362649|FG003|Overall Study|Study terminated by Sponsor|1|||
124762986|NCT00962208|448757868|FG000|Overall Study|Contraindicated to continue study|5|||
124762987|NCT00962208|448757869|FG001|Overall Study|Contraindicated to continue study|1|||
124762988|NCT00962208|448757868|FG000|Overall Study|Lost to Follow-up|0|||
124762989|NCT00962208|448757869|FG001|Overall Study|Lost to Follow-up|9|||
124762990|NCT00791388|448757870|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
124762991|NCT00791388|448757871|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
124762992|NCT00791388|448757872|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
124926806|NCT05543629|449362650|FG004|Overall Study|Study terminated by Sponsor|0|||
124926807|NCT05543629|449362651|FG005|Overall Study|Study terminated by Sponsor|4|||
124926808|NCT05543629|449362652|FG006|Overall Study|Study terminated by Sponsor|1|||
124926809|NCT05543629|449362653|FG007|Overall Study|Study terminated by Sponsor|0|||
124926810|NCT05543629|449362646|FG000|Overall Study|Withdrawal by Subject|1|||
124926811|NCT05543629|449362647|FG001|Overall Study|Withdrawal by Subject|1|||
124926812|NCT05543629|449362648|FG002|Overall Study|Withdrawal by Subject|0|||
124926813|NCT05543629|449362649|FG003|Overall Study|Withdrawal by Subject|2|||
124926814|NCT05543629|449362650|FG004|Overall Study|Withdrawal by Subject|1|||
124926815|NCT05543629|449362651|FG005|Overall Study|Withdrawal by Subject|1|||
124926816|NCT05543629|449362652|FG006|Overall Study|Withdrawal by Subject|1|||
124926817|NCT05543629|449362653|FG007|Overall Study|Withdrawal by Subject|1|||
124926818|NCT05543629|449362646|FG000|Overall Study|Not Reported|2|||
124926819|NCT05543629|449362647|FG001|Overall Study|Not Reported|2|||
124926820|NCT05543629|449362648|FG002|Overall Study|Not Reported|0|||
124926821|NCT05543629|449362649|FG003|Overall Study|Not Reported|0|||
124926822|NCT05543629|449362650|FG004|Overall Study|Not Reported|1|||
124926823|NCT05543629|449362651|FG005|Overall Study|Not Reported|1|||
124926824|NCT05543629|449362652|FG006|Overall Study|Not Reported|3|||
124926825|NCT05543629|449362653|FG007|Overall Study|Not Reported|0|||
124926826|NCT04568603|449362654|FG000|Overall Study|Physician Decision|1|||
124926827|NCT03313076|449362657|FG000|Overall Study|Withdrawal by Subject|2|||
124454701|NCT02081534|447625354|FG002|Overall Study|Lost to Follow-up|0|||
124454702|NCT02081534|447625355|FG003|Overall Study|Lost to Follow-up|2|||
124454703|NCT02081534|447625356|FG004|Overall Study|Lost to Follow-up|1|||
124454704|NCT02081534|447625357|FG005|Overall Study|Lost to Follow-up|1|||
124926828|NCT03313076|449362658|FG001|Overall Study|Withdrawal by Subject|0|||
124926829|NCT03313076|449362659|FG002|Overall Study|Withdrawal by Subject|0|||
124926830|NCT03313076|449362660|FG003|Overall Study|Withdrawal by Subject|0|||
124926831|NCT03313076|449362657|FG000|Overall Study|Lost to Follow-up|0|||
124545953|NCT01353586|447954431|FG000|Overall Study|Procedure terminated prior to ablation|3|||
124926832|NCT03313076|449362658|FG001|Overall Study|Lost to Follow-up|2|||
124926833|NCT03313076|449362659|FG002|Overall Study|Lost to Follow-up|2|||
124926834|NCT03313076|449362660|FG003|Overall Study|Lost to Follow-up|2|||
124926835|NCT04119843|449362661|FG000|Overall Study|Adverse Event|3|||
124926836|NCT04119843|449362661|FG000|Overall Study|Death|1|||
124926837|NCT03904147|449362662|FG000|Overall Study|Death|15|||
124697649|NCT02991859|448513992|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
124697650|NCT02991859|448513993|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
124697651|NCT02991859|448513994|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
124697652|NCT02991859|448513995|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
124697653|NCT02991859|448513996|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
124697654|NCT02991859|448513997|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
124697655|NCT02991859|448513998|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
124697656|NCT02991859|448513999|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
124926838|NCT03904147|449362663|FG001|Overall Study|Death|13|||
124926839|NCT03904147|449362664|FG002|Overall Study|Death|15|||
124926840|NCT03904147|449362662|FG000|Overall Study|Withdrawal by Subject|7|||
124926841|NCT03904147|449362663|FG001|Overall Study|Withdrawal by Subject|12|||
124926842|NCT03904147|449362664|FG002|Overall Study|Withdrawal by Subject|1|||
124926843|NCT03904147|449362662|FG000|Overall Study|1Y visit completed after 365 days|1|||
124926844|NCT03904147|449362663|FG001|Overall Study|1Y visit completed after 365 days|1|||
124926845|NCT03904147|449362664|FG002|Overall Study|1Y visit completed after 365 days|0|||
124926846|NCT04233216|449362673|FG000|Overall Study|Lost to Follow-up|1|||
124926847|NCT04233216|449362674|FG001|Overall Study|Lost to Follow-up|0|||
124926848|NCT04233216|449362675|FG002|Overall Study|Lost to Follow-up|2|||
124926849|NCT04233216|449362676|FG003|Overall Study|Lost to Follow-up|0|||
124926850|NCT04233216|449362673|FG000|Overall Study|Physician Decision|0|||
124926851|NCT04233216|449362674|FG001|Overall Study|Physician Decision|3|||
124926852|NCT04233216|449362675|FG002|Overall Study|Physician Decision|0|||
124926853|NCT04233216|449362676|FG003|Overall Study|Physician Decision|2|||
124926854|NCT04233216|449362673|FG000|Overall Study|Withdrawal by Subject|0|||
124926855|NCT04233216|449362674|FG001|Overall Study|Withdrawal by Subject|2|||
124926856|NCT04233216|449362675|FG002|Overall Study|Withdrawal by Subject|1|||
124926857|NCT04233216|449362676|FG003|Overall Study|Withdrawal by Subject|0|||
124926858|NCT04307355|449362677|FG000|Overall Study|Non-Compliance|3|||
124926859|NCT04307355|449362678|FG001|Overall Study|Non-Compliance|3|||
124926860|NCT04307355|449362679|FG002|Overall Study|Non-Compliance|0|||
124926861|NCT04225273|449362681|FG000|Overall Study|Lost to Follow-up|3|||
124926862|NCT03652389|449362682|FG000|Overall Study|Lost to Follow-up|1|||
124926863|NCT03652389|449362683|FG001|Overall Study|Lost to Follow-up|5|||
124926864|NCT03652389|449362682|FG000|Overall Study|Withdrawal by Subject|5|||
124926865|NCT03652389|449362683|FG001|Overall Study|Withdrawal by Subject|1|||
124926866|NCT03652389|449362682|FG000|Overall Study|New diagnosis|2|||
124926867|NCT03652389|449362683|FG001|Overall Study|New diagnosis|0|||
124926868|NCT04413708|449362685|FG000|Overall Study|Lost to Follow-up|1|||
124926869|NCT04413708|449362686|FG001|Overall Study|Lost to Follow-up|2|||
124926870|NCT03768505|449362687|FG000|Overall Study|sponsor decision|76|||
124926871|NCT03768505|449362687|FG000|Overall Study|Death|35|||
124926872|NCT03768505|449362687|FG000|Overall Study|Other -Various|30|||
124926873|NCT03768505|449362687|FG000|Overall Study|Withdrawal by Subject|22|||
124926874|NCT03768505|449362687|FG000|Overall Study|Lost to Follow-up|6|||
124926875|NCT04032704|449362688|FG000|Part A|Withdrawal by Subject|0|||
124926876|NCT04032704|449362689|FG001|Part A|Withdrawal by Subject|0|||
124545954|NCT01353586|447954432|FG001|Overall Study|Procedure terminated prior to ablation|0|||
124697657|NCT02991859|448514000|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
124926877|NCT04032704|449362690|FG002|Part A|Withdrawal by Subject|3|||
124926878|NCT04032704|449362691|FG003|Part A|Withdrawal by Subject|0|||
124926879|NCT04032704|449362692|FG004|Part A|Withdrawal by Subject|1|||
124926880|NCT04032704|449362693|FG005|Part A|Withdrawal by Subject|7|||
124926881|NCT04032704|449362694|FG006|Part A|Withdrawal by Subject|0|||
124926882|NCT04032704|449362695|FG007|Part A|Withdrawal by Subject|0|||
124926883|NCT04032704|449362696|FG008|Part A|Withdrawal by Subject|0|||
124926884|NCT04032704|449362697|FG009|Part A|Withdrawal by Subject|0|||
124926885|NCT04032704|449362698|FG010|Part A|Withdrawal by Subject|0|||
124926886|NCT04032704|449362699|FG011|Part A|Withdrawal by Subject|0|||
124926887|NCT04032704|449362700|FG012|Part A|Withdrawal by Subject|0|||
124926888|NCT04032704|449362701|FG013|Part A|Withdrawal by Subject|0|||
124926889|NCT04032704|449362702|FG014|Part A|Withdrawal by Subject|0|||
124926890|NCT04032704|449362703|FG015|Part A|Withdrawal by Subject|0|||
124926891|NCT04032704|449362704|FG016|Part A|Withdrawal by Subject|0|||
124926892|NCT04032704|449362705|FG017|Part A|Withdrawal by Subject|0|||
124926893|NCT04032704|449362688|FG000|Part A|Lost to Follow-up|1|||
124926894|NCT04032704|449362689|FG001|Part A|Lost to Follow-up|0|||
124926895|NCT04032704|449362690|FG002|Part A|Lost to Follow-up|0|||
124926896|NCT04032704|449362691|FG003|Part A|Lost to Follow-up|0|||
124926897|NCT04032704|449362692|FG004|Part A|Lost to Follow-up|0|||
124926898|NCT04032704|449362693|FG005|Part A|Lost to Follow-up|0|||
124926899|NCT04032704|449362694|FG006|Part A|Lost to Follow-up|0|||
124926900|NCT04032704|449362695|FG007|Part A|Lost to Follow-up|0|||
124926901|NCT04032704|449362696|FG008|Part A|Lost to Follow-up|0|||
124926902|NCT04032704|449362697|FG009|Part A|Lost to Follow-up|0|||
124926903|NCT04032704|449362698|FG010|Part A|Lost to Follow-up|0|||
124926904|NCT04032704|449362699|FG011|Part A|Lost to Follow-up|0|||
124926905|NCT04032704|449362700|FG012|Part A|Lost to Follow-up|0|||
124926906|NCT04032704|449362701|FG013|Part A|Lost to Follow-up|0|||
124926907|NCT04032704|449362702|FG014|Part A|Lost to Follow-up|0|||
124926908|NCT04032704|449362703|FG015|Part A|Lost to Follow-up|0|||
124926909|NCT04032704|449362704|FG016|Part A|Lost to Follow-up|0|||
124926910|NCT04032704|449362705|FG017|Part A|Lost to Follow-up|0|||
124926911|NCT04032704|449362688|FG000|Part A|Death|9|||
124926912|NCT04032704|449362689|FG001|Part A|Death|2|||
124926913|NCT04032704|449362690|FG002|Part A|Death|10|||
124926914|NCT04032704|449362691|FG003|Part A|Death|7|||
124926915|NCT04032704|449362692|FG004|Part A|Death|4|||
124926916|NCT04032704|449362693|FG005|Part A|Death|5|||
124926917|NCT04032704|449362694|FG006|Part A|Death|0|||
124926918|NCT04032704|449362695|FG007|Part A|Death|0|||
124926919|NCT04032704|449362696|FG008|Part A|Death|0|||
124926920|NCT04032704|449362697|FG009|Part A|Death|0|||
124926921|NCT04032704|449362698|FG010|Part A|Death|0|||
124926922|NCT04032704|449362699|FG011|Part A|Death|0|||
124926923|NCT04032704|449362700|FG012|Part A|Death|0|||
124926924|NCT04032704|449362701|FG013|Part A|Death|0|||
124926925|NCT04032704|449362702|FG014|Part A|Death|0|||
124926926|NCT04032704|449362703|FG015|Part A|Death|0|||
124926927|NCT04032704|449362704|FG016|Part A|Death|0|||
124926928|NCT04032704|449362705|FG017|Part A|Death|0|||
124926929|NCT04032704|449362688|FG000|Part B|Other|0|||
124926930|NCT04032704|449362689|FG001|Part B|Other|0|||
124926931|NCT04032704|449362690|FG002|Part B|Other|0|||
124926932|NCT04032704|449362691|FG003|Part B|Other|0|||
124926933|NCT04032704|449362692|FG004|Part B|Other|0|||
124926934|NCT04032704|449362693|FG005|Part B|Other|0|||
124926935|NCT04032704|449362694|FG006|Part B|Other|0|||
124926936|NCT04032704|449362695|FG007|Part B|Other|1|||
124926937|NCT04032704|449362696|FG008|Part B|Other|2|||
124926938|NCT04032704|449362697|FG009|Part B|Other|1|||
124926939|NCT04032704|449362698|FG010|Part B|Other|1|||
124926940|NCT04032704|449362699|FG011|Part B|Other|1|||
124926941|NCT04032704|449362700|FG012|Part B|Other|5|||
124926942|NCT04032704|449362701|FG013|Part B|Other|13|||
124926943|NCT04032704|449362702|FG014|Part B|Other|0|||
124926944|NCT04032704|449362703|FG015|Part B|Other|0|||
124926945|NCT04032704|449362704|FG016|Part B|Other|0|||
124926946|NCT04032704|449362705|FG017|Part B|Other|0|||
124926947|NCT04032704|449362688|FG000|Part B|Study termination by Sponsor|0|||
124926948|NCT04032704|449362689|FG001|Part B|Study termination by Sponsor|0|||
124926949|NCT04032704|449362690|FG002|Part B|Study termination by Sponsor|0|||
124926950|NCT04032704|449362691|FG003|Part B|Study termination by Sponsor|0|||
124926951|NCT04032704|449362692|FG004|Part B|Study termination by Sponsor|0|||
124926952|NCT04032704|449362693|FG005|Part B|Study termination by Sponsor|0|||
124926953|NCT04032704|449362694|FG006|Part B|Study termination by Sponsor|0|||
124926954|NCT04032704|449362695|FG007|Part B|Study termination by Sponsor|0|||
124926955|NCT04032704|449362696|FG008|Part B|Study termination by Sponsor|1|||
124926956|NCT04032704|449362697|FG009|Part B|Study termination by Sponsor|0|||
124926957|NCT04032704|449362698|FG010|Part B|Study termination by Sponsor|0|||
124926958|NCT04032704|449362699|FG011|Part B|Study termination by Sponsor|0|||
124926959|NCT04032704|449362700|FG012|Part B|Study termination by Sponsor|0|||
124926960|NCT04032704|449362701|FG013|Part B|Study termination by Sponsor|0|||
124926961|NCT04032704|449362702|FG014|Part B|Study termination by Sponsor|0|||
124926962|NCT04032704|449362703|FG015|Part B|Study termination by Sponsor|0|||
124926963|NCT04032704|449362704|FG016|Part B|Study termination by Sponsor|0|||
124926964|NCT04032704|449362705|FG017|Part B|Study termination by Sponsor|0|||
124926965|NCT04032704|449362688|FG000|Part B|Withdrawal by Subject|0|||
124926966|NCT04032704|449362689|FG001|Part B|Withdrawal by Subject|0|||
124926967|NCT04032704|449362690|FG002|Part B|Withdrawal by Subject|0|||
124926968|NCT04032704|449362691|FG003|Part B|Withdrawal by Subject|0|||
124926969|NCT04032704|449362692|FG004|Part B|Withdrawal by Subject|0|||
124926970|NCT04032704|449362693|FG005|Part B|Withdrawal by Subject|0|||
124926971|NCT04032704|449362694|FG006|Part B|Withdrawal by Subject|3|||
124926972|NCT04032704|449362695|FG007|Part B|Withdrawal by Subject|2|||
124926973|NCT04032704|449362696|FG008|Part B|Withdrawal by Subject|2|||
124926974|NCT04032704|449362697|FG009|Part B|Withdrawal by Subject|1|||
124926975|NCT04032704|449362698|FG010|Part B|Withdrawal by Subject|4|||
124926976|NCT04032704|449362699|FG011|Part B|Withdrawal by Subject|6|||
124926977|NCT04032704|449362700|FG012|Part B|Withdrawal by Subject|2|||
124926978|NCT04032704|449362701|FG013|Part B|Withdrawal by Subject|1|||
124926979|NCT04032704|449362702|FG014|Part B|Withdrawal by Subject|0|||
124926980|NCT04032704|449362703|FG015|Part B|Withdrawal by Subject|1|||
124926981|NCT04032704|449362704|FG016|Part B|Withdrawal by Subject|0|||
124926982|NCT04032704|449362705|FG017|Part B|Withdrawal by Subject|0|||
124926983|NCT04032704|449362688|FG000|Part B|Lost to Follow-up|0|||
124926984|NCT04032704|449362689|FG001|Part B|Lost to Follow-up|0|||
124926985|NCT04032704|449362690|FG002|Part B|Lost to Follow-up|0|||
124926986|NCT04032704|449362691|FG003|Part B|Lost to Follow-up|0|||
124926987|NCT04032704|449362692|FG004|Part B|Lost to Follow-up|0|||
124926988|NCT04032704|449362693|FG005|Part B|Lost to Follow-up|0|||
124545955|NCT01353586|447954431|FG000|Overall Study|Never had insertion of study catheter|4|||
124545956|NCT01353586|447954432|FG001|Overall Study|Never had insertion of study catheter|1|||
124545957|NCT01353586|447954431|FG000|Overall Study|Neurological exam not done|0|||
124926989|NCT04032704|449362694|FG006|Part B|Lost to Follow-up|0|||
124926990|NCT04032704|449362695|FG007|Part B|Lost to Follow-up|0|||
124926991|NCT04032704|449362696|FG008|Part B|Lost to Follow-up|0|||
124926992|NCT04032704|449362697|FG009|Part B|Lost to Follow-up|0|||
124926993|NCT04032704|449362698|FG010|Part B|Lost to Follow-up|0|||
124926994|NCT04032704|449362699|FG011|Part B|Lost to Follow-up|1|||
124926995|NCT04032704|449362700|FG012|Part B|Lost to Follow-up|0|||
124926996|NCT04032704|449362701|FG013|Part B|Lost to Follow-up|0|||
124926997|NCT04032704|449362702|FG014|Part B|Lost to Follow-up|0|||
124926998|NCT04032704|449362703|FG015|Part B|Lost to Follow-up|0|||
124926999|NCT04032704|449362704|FG016|Part B|Lost to Follow-up|0|||
124927000|NCT04032704|449362705|FG017|Part B|Lost to Follow-up|0|||
124927001|NCT04032704|449362688|FG000|Part B|Death|0|||
124927002|NCT04032704|449362689|FG001|Part B|Death|0|||
124927003|NCT04032704|449362690|FG002|Part B|Death|0|||
124927004|NCT04032704|449362691|FG003|Part B|Death|0|||
124927005|NCT04032704|449362692|FG004|Part B|Death|0|||
124927006|NCT04032704|449362693|FG005|Part B|Death|0|||
124927007|NCT04032704|449362694|FG006|Part B|Death|13|||
124927008|NCT04032704|449362695|FG007|Part B|Death|13|||
124927009|NCT04032704|449362696|FG008|Part B|Death|14|||
124927010|NCT04032704|449362697|FG009|Part B|Death|12|||
124545958|NCT01353586|447954432|FG001|Overall Study|Neurological exam not done|1|||
124697658|NCT02991859|448514001|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
124697659|NCT02991859|448514002|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
124927011|NCT04032704|449362698|FG010|Part B|Death|12|||
124927012|NCT04032704|449362699|FG011|Part B|Death|13|||
124927013|NCT04032704|449362700|FG012|Part B|Death|7|||
124927014|NCT04032704|449362701|FG013|Part B|Death|17|||
124927015|NCT04032704|449362702|FG014|Part B|Death|2|||
124927016|NCT04032704|449362703|FG015|Part B|Death|1|||
124927017|NCT04032704|449362704|FG016|Part B|Death|2|||
124927018|NCT04032704|449362705|FG017|Part B|Death|2|||
124927019|NCT02861300|449362706|FG000|Overall Study|Death|0|||
124927020|NCT02861300|449362707|FG001|Overall Study|Death|0|||
124927021|NCT02861300|449362708|FG002|Overall Study|Death|0|||
124927022|NCT02861300|449362709|FG003|Overall Study|Death|0|||
124927023|NCT02861300|449362710|FG004|Overall Study|Death|0|||
124927024|NCT02861300|449362711|FG005|Overall Study|Death|0|||
124927025|NCT02861300|449362712|FG006|Overall Study|Death|24|||
124927026|NCT02861300|449362706|FG000|Overall Study|Delay in treatment|0|||
124927027|NCT02861300|449362707|FG001|Overall Study|Delay in treatment|0|||
124927028|NCT02861300|449362708|FG002|Overall Study|Delay in treatment|0|||
124927029|NCT02861300|449362709|FG003|Overall Study|Delay in treatment|0|||
124927030|NCT02861300|449362710|FG004|Overall Study|Delay in treatment|0|||
124927031|NCT02861300|449362711|FG005|Overall Study|Delay in treatment|1|||
124927032|NCT02861300|449362712|FG006|Overall Study|Delay in treatment|0|||
124927033|NCT02861300|449362706|FG000|Overall Study|Disease Progression|0|||
124927034|NCT02861300|449362707|FG001|Overall Study|Disease Progression|1|||
124927035|NCT02861300|449362708|FG002|Overall Study|Disease Progression|0|||
124927036|NCT02861300|449362709|FG003|Overall Study|Disease Progression|0|||
124927037|NCT02861300|449362710|FG004|Overall Study|Disease Progression|0|||
124927038|NCT02861300|449362711|FG005|Overall Study|Disease Progression|0|||
124927039|NCT02861300|449362712|FG006|Overall Study|Disease Progression|2|||
124927040|NCT02861300|449362706|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
124927041|NCT02861300|449362707|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
124927042|NCT02861300|449362708|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
124927043|NCT02861300|449362709|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
124927044|NCT02861300|449362710|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
124927045|NCT02861300|449362711|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
124927046|NCT02861300|449362712|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
124927047|NCT02861300|449362706|FG000|Overall Study|Clinical Complications|0|||
124927048|NCT02861300|449362707|FG001|Overall Study|Clinical Complications|0|||
124927049|NCT02861300|449362708|FG002|Overall Study|Clinical Complications|0|||
124927050|NCT02861300|449362709|FG003|Overall Study|Clinical Complications|0|||
124927051|NCT02861300|449362710|FG004|Overall Study|Clinical Complications|0|||
124927052|NCT02861300|449362711|FG005|Overall Study|Clinical Complications|0|||
124927053|NCT02861300|449362712|FG006|Overall Study|Clinical Complications|1|||
124927054|NCT03133546|449362713|FG000|Overall Study|Death|46|||
124927055|NCT03133546|449362714|FG001|Overall Study|Death|43|||
124927056|NCT03133546|449362713|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
124927057|NCT03133546|449362714|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
124927058|NCT06103188|449362716|FG000|Overall Study|Lost to Follow-up|1|||
124927059|NCT06103188|449362717|FG001|Overall Study|Lost to Follow-up|6|||
124927060|NCT06103188|449362718|FG002|Overall Study|Lost to Follow-up|4|||
124927061|NCT05386030|449362723|FG000|Overall Study|Death|1|||
124927062|NCT05386030|449362724|FG001|Overall Study|Death|0|||
124927063|NCT05386030|449362723|FG000|Overall Study|Physician Decision|2|||
124927064|NCT05386030|449362724|FG001|Overall Study|Physician Decision|1|||
124927065|NCT05386030|449362723|FG000|Overall Study|Lost to Follow-up|19|||
124927066|NCT05386030|449362724|FG001|Overall Study|Lost to Follow-up|7|||
124927067|NCT05386030|449362723|FG000|Overall Study|Withdrawal by Subject|20|||
124927068|NCT05386030|449362724|FG001|Overall Study|Withdrawal by Subject|10|||
124927069|NCT05386030|449362723|FG000|Overall Study|Eligibility criteria violation|1|||
124927070|NCT05386030|449362724|FG001|Overall Study|Eligibility criteria violation|1|||
124927071|NCT05386030|449362723|FG000|Overall Study|Personal Reasons|1|||
124927072|NCT05386030|449362724|FG001|Overall Study|Personal Reasons|0|||
124927073|NCT01733316|449362729|FG000|RP103 Phase|Non-compliance|1|||
124927074|NCT01733316|449362729|FG000|Long Term Extension Phase|Adverse Event|1|||
124927075|NCT01733316|449362729|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
124927076|NCT01733316|449362729|FG000|Long Term Extension Phase|Sponsor Decision|2|||
124927077|NCT03058289|449362730|FG000|Overall Study|Radiographic Deterioration|0|||
124927078|NCT03058289|449362731|FG001|Overall Study|Radiographic Deterioration|3|||
124927079|NCT03058289|449362732|FG002|Overall Study|Radiographic Deterioration|1|||
124927080|NCT03058289|449362733|FG003|Overall Study|Radiographic Deterioration|2|||
124927081|NCT03058289|449362734|FG004|Overall Study|Radiographic Deterioration|6|||
124927082|NCT03058289|449362735|FG005|Overall Study|Radiographic Deterioration|3|||
124927083|NCT03058289|449362736|FG006|Overall Study|Radiographic Deterioration|0|||
124927084|NCT03058289|449362737|FG007|Overall Study|Radiographic Deterioration|4|||
124927085|NCT03058289|449362738|FG008|Overall Study|Radiographic Deterioration|2|||
124927086|NCT03058289|449362730|FG000|Overall Study|Adverse Event|2|||
124927087|NCT03058289|449362731|FG001|Overall Study|Adverse Event|0|||
124927088|NCT03058289|449362732|FG002|Overall Study|Adverse Event|1|||
124927089|NCT03058289|449362733|FG003|Overall Study|Adverse Event|3|||
124927090|NCT03058289|449362734|FG004|Overall Study|Adverse Event|1|||
124927091|NCT03058289|449362735|FG005|Overall Study|Adverse Event|0|||
124927092|NCT03058289|449362736|FG006|Overall Study|Adverse Event|1|||
124927093|NCT03058289|449362737|FG007|Overall Study|Adverse Event|3|||
124927094|NCT03058289|449362738|FG008|Overall Study|Adverse Event|0|||
124927095|NCT03058289|449362730|FG000|Overall Study|Withdrawal by Subject|0|||
124927096|NCT03058289|449362731|FG001|Overall Study|Withdrawal by Subject|0|||
124927097|NCT03058289|449362732|FG002|Overall Study|Withdrawal by Subject|0|||
124927098|NCT03058289|449362733|FG003|Overall Study|Withdrawal by Subject|2|||
124927099|NCT03058289|449362734|FG004|Overall Study|Withdrawal by Subject|0|||
124927100|NCT03058289|449362735|FG005|Overall Study|Withdrawal by Subject|2|||
124927101|NCT03058289|449362736|FG006|Overall Study|Withdrawal by Subject|0|||
124927102|NCT03058289|449362737|FG007|Overall Study|Withdrawal by Subject|4|||
124927103|NCT03058289|449362738|FG008|Overall Study|Withdrawal by Subject|1|||
124927104|NCT03058289|449362730|FG000|Overall Study|Physician Decision|1|||
124927105|NCT03058289|449362731|FG001|Overall Study|Physician Decision|0|||
124927106|NCT03058289|449362732|FG002|Overall Study|Physician Decision|0|||
124927107|NCT03058289|449362733|FG003|Overall Study|Physician Decision|2|||
124927108|NCT03058289|449362734|FG004|Overall Study|Physician Decision|1|||
124927109|NCT03058289|449362735|FG005|Overall Study|Physician Decision|0|||
124927110|NCT03058289|449362736|FG006|Overall Study|Physician Decision|2|||
124927111|NCT03058289|449362737|FG007|Overall Study|Physician Decision|3|||
124927112|NCT03058289|449362738|FG008|Overall Study|Physician Decision|0|||
124927113|NCT03058289|449362730|FG000|Overall Study|Clinical Deterioration|2|||
124927114|NCT03058289|449362731|FG001|Overall Study|Clinical Deterioration|0|||
124927115|NCT03058289|449362732|FG002|Overall Study|Clinical Deterioration|0|||
124927116|NCT03058289|449362733|FG003|Overall Study|Clinical Deterioration|2|||
124927117|NCT03058289|449362734|FG004|Overall Study|Clinical Deterioration|1|||
124697660|NCT02991859|448513986|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
124927118|NCT03058289|449362735|FG005|Overall Study|Clinical Deterioration|1|||
124927119|NCT03058289|449362736|FG006|Overall Study|Clinical Deterioration|0|||
124927120|NCT03058289|449362737|FG007|Overall Study|Clinical Deterioration|3|||
124927121|NCT03058289|449362738|FG008|Overall Study|Clinical Deterioration|2|||
124927122|NCT03058289|449362730|FG000|Overall Study|Lost to Follow-up|0|||
124927123|NCT03058289|449362731|FG001|Overall Study|Lost to Follow-up|0|||
124927124|NCT03058289|449362732|FG002|Overall Study|Lost to Follow-up|0|||
124927125|NCT03058289|449362733|FG003|Overall Study|Lost to Follow-up|0|||
124454705|NCT02081534|447625358|FG006|Overall Study|Lost to Follow-up|0|||
124454706|NCT00762892|447625359|FG000|Overall Study|Lost to Follow-up|2|||
124927126|NCT03058289|449362734|FG004|Overall Study|Lost to Follow-up|1|||
124927127|NCT03058289|449362735|FG005|Overall Study|Lost to Follow-up|0|||
124927128|NCT03058289|449362736|FG006|Overall Study|Lost to Follow-up|0|||
124927129|NCT03058289|449362737|FG007|Overall Study|Lost to Follow-up|0|||
124927130|NCT03058289|449362738|FG008|Overall Study|Lost to Follow-up|0|||
124927131|NCT03058289|449362730|FG000|Overall Study|Refused Further Treatment|0|||
124927132|NCT03058289|449362731|FG001|Overall Study|Refused Further Treatment|0|||
124927133|NCT03058289|449362732|FG002|Overall Study|Refused Further Treatment|1|||
124927134|NCT03058289|449362733|FG003|Overall Study|Refused Further Treatment|0|||
124927135|NCT03058289|449362734|FG004|Overall Study|Refused Further Treatment|1|||
124927136|NCT03058289|449362735|FG005|Overall Study|Refused Further Treatment|0|||
124927137|NCT03058289|449362736|FG006|Overall Study|Refused Further Treatment|0|||
124927138|NCT03058289|449362737|FG007|Overall Study|Refused Further Treatment|0|||
124927139|NCT03058289|449362738|FG008|Overall Study|Refused Further Treatment|0|||
124927140|NCT03058289|449362730|FG000|Overall Study|Rapid Progression of Disease|0|||
124927141|NCT03058289|449362731|FG001|Overall Study|Rapid Progression of Disease|0|||
124927142|NCT03058289|449362732|FG002|Overall Study|Rapid Progression of Disease|0|||
124927143|NCT03058289|449362733|FG003|Overall Study|Rapid Progression of Disease|1|||
124927144|NCT03058289|449362734|FG004|Overall Study|Rapid Progression of Disease|0|||
124927145|NCT03058289|449362735|FG005|Overall Study|Rapid Progression of Disease|0|||
124927146|NCT03058289|449362736|FG006|Overall Study|Rapid Progression of Disease|0|||
124927147|NCT03058289|449362737|FG007|Overall Study|Rapid Progression of Disease|0|||
124927148|NCT03058289|449362738|FG008|Overall Study|Rapid Progression of Disease|0|||
124927149|NCT05546411|449362741|FG000|Overall Study|Progressive Disease|1|||
124927150|NCT05546411|449362742|FG001|Overall Study|Progressive Disease|0|||
124927151|NCT05546411|449362741|FG000|Overall Study|Adverse Event|0|||
124927152|NCT05546411|449362742|FG001|Overall Study|Adverse Event|1|||
124927153|NCT05546411|449362741|FG000|Overall Study|Metastatic disease|1|||
124927154|NCT05546411|449362742|FG001|Overall Study|Metastatic disease|0|||
124927155|NCT02606422|449362743|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
124927156|NCT02606422|449362744|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
124927157|NCT02606422|449362743|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
124927158|NCT02606422|449362744|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
124927159|NCT02606422|449362743|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
124927160|NCT02606422|449362744|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
124927161|NCT02606422|449362743|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
124927162|NCT02606422|449362744|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
124927163|NCT02151981|449362748|FG000|Overall Study|Death|184|||
124927164|NCT02151981|449362749|FG001|Overall Study|Death|88|||
124927165|NCT02151981|449362748|FG000|Overall Study|Lost to Follow-up|7|||
124927166|NCT02151981|449362749|FG001|Overall Study|Lost to Follow-up|1|||
124927167|NCT02151981|449362748|FG000|Overall Study|Withdrawal by Subject|27|||
124927168|NCT02151981|449362749|FG001|Overall Study|Withdrawal by Subject|21|||
124927169|NCT02151981|449362748|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124927170|NCT02151981|449362749|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
124927171|NCT02151981|449362748|FG000|Overall Study|Other reasons|1|||
124927172|NCT02151981|449362749|FG001|Overall Study|Other reasons|2|||
124927173|NCT01946789|449362753|FG000|Overall Study|Death|0|||
124927174|NCT01946789|449362754|FG001|Overall Study|Death|2|||
124927175|NCT01946789|449362755|FG002|Overall Study|Death|1|||
124927176|NCT01946789|449362756|FG003|Overall Study|Death|1|||
124927177|NCT01946789|449362757|FG004|Overall Study|Death|1|||
124927178|NCT01946789|449362758|FG005|Overall Study|Death|1|||
124927179|NCT01946789|449362759|FG006|Overall Study|Death|3|||
124927180|NCT01946789|449362760|FG007|Overall Study|Death|1|||
124927181|NCT01946789|449362761|FG008|Overall Study|Death|2|||
124927182|NCT01946789|449362753|FG000|Overall Study|Progressive Disease|0|||
124927183|NCT01946789|449362754|FG001|Overall Study|Progressive Disease|0|||
124927184|NCT01946789|449362755|FG002|Overall Study|Progressive Disease|1|||
124927185|NCT01946789|449362756|FG003|Overall Study|Progressive Disease|0|||
124927186|NCT01946789|449362757|FG004|Overall Study|Progressive Disease|0|||
124927187|NCT01946789|449362758|FG005|Overall Study|Progressive Disease|2|||
124927188|NCT01946789|449362759|FG006|Overall Study|Progressive Disease|0|||
124927189|NCT01946789|449362760|FG007|Overall Study|Progressive Disease|0|||
124927190|NCT01946789|449362761|FG008|Overall Study|Progressive Disease|0|||
124454707|NCT00762892|447625360|FG001|Overall Study|Lost to Follow-up|5|||
124927191|NCT01946789|449362753|FG000|Overall Study|Withdrawal by Subject|0|||
124927192|NCT01946789|449362754|FG001|Overall Study|Withdrawal by Subject|0|||
124454708|NCT00762892|447625359|FG000|Overall Study|Withdrawal by Subject|0|||
124927193|NCT01946789|449362755|FG002|Overall Study|Withdrawal by Subject|0|||
124927194|NCT01946789|449362756|FG003|Overall Study|Withdrawal by Subject|2|||
124927195|NCT01946789|449362757|FG004|Overall Study|Withdrawal by Subject|1|||
124927196|NCT01946789|449362758|FG005|Overall Study|Withdrawal by Subject|0|||
124927197|NCT01946789|449362759|FG006|Overall Study|Withdrawal by Subject|1|||
124454709|NCT00762892|447625360|FG001|Overall Study|Withdrawal by Subject|1|||
124927198|NCT01946789|449362760|FG007|Overall Study|Withdrawal by Subject|0|||
124927199|NCT01946789|449362761|FG008|Overall Study|Withdrawal by Subject|0|||
124927200|NCT05374798|449362762|FG000|Overall Study|Lost to Follow-up|2|||
124927201|NCT05374798|449362762|FG000|Overall Study|Withdrawal by Subject|2|||
124927202|NCT05374798|449362762|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
124927203|NCT05576155|449362763|FG000|Overall Study|Withdrawal by Subject|1|||
124927204|NCT05576155|449362764|FG001|Overall Study|Withdrawal by Subject|1|||
124927205|NCT01275677|449362768|FG000|Overall Study|Not at risk for recurrence.|1|||
124927206|NCT01275677|449362769|FG001|Overall Study|Not at risk for recurrence.|1|||
124927207|NCT01275677|449362768|FG000|Overall Study|No follow-up|26|||
124927208|NCT01275677|449362769|FG001|Overall Study|No follow-up|37|||
124927209|NCT01275677|449362768|FG000|Overall Study|No clinical follow up.|1|||
124927210|NCT01275677|449362769|FG001|Overall Study|No clinical follow up.|4|||
124927211|NCT04409353|449362775|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
124927212|NCT04409353|449362776|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
124927213|NCT04409353|449362777|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
124927214|NCT04409353|449362775|FG000|Overall Study|Lost to Follow-up|6|||
124927215|NCT04409353|449362776|FG001|Overall Study|Lost to Follow-up|8|||
124927216|NCT04409353|449362777|FG002|Overall Study|Lost to Follow-up|7|||
124927217|NCT04409353|449362775|FG000|Overall Study|Major surgery during participation window|4|||
124927218|NCT04409353|449362776|FG001|Overall Study|Major surgery during participation window|3|||
124927219|NCT04409353|449362777|FG002|Overall Study|Major surgery during participation window|3|||
124927220|NCT04409353|449362775|FG000|Overall Study|Life event occurred during participation window|3|||
124927221|NCT04409353|449362776|FG001|Overall Study|Life event occurred during participation window|2|||
124927222|NCT04409353|449362777|FG002|Overall Study|Life event occurred during participation window|4|||
124927223|NCT04409353|449362775|FG000|Overall Study|Lack of Efficacy|4|||
124927224|NCT04409353|449362776|FG001|Overall Study|Lack of Efficacy|1|||
124927225|NCT04409353|449362777|FG002|Overall Study|Lack of Efficacy|3|||
124927226|NCT04409353|449362775|FG000|Overall Study|Adverse Event|2|||
124927227|NCT04409353|449362776|FG001|Overall Study|Adverse Event|1|||
124927228|NCT04409353|449362777|FG002|Overall Study|Adverse Event|1|||
124927229|NCT04409353|449362775|FG000|Overall Study|Disease burden - unable to participate|0|||
124927230|NCT04409353|449362776|FG001|Overall Study|Disease burden - unable to participate|1|||
124927231|NCT04409353|449362777|FG002|Overall Study|Disease burden - unable to participate|1|||
124927232|NCT04409353|449362775|FG000|Overall Study|Intervention too complicated|1|||
124927233|NCT04409353|449362776|FG001|Overall Study|Intervention too complicated|0|||
124927234|NCT04409353|449362777|FG002|Overall Study|Intervention too complicated|1|||
124927235|NCT04081103|449362778|FG000|Overall Study|Adverse Event|1|||
124927236|NCT04081103|449362779|FG001|Overall Study|Adverse Event|1|||
124927237|NCT04081103|449362780|FG002|Overall Study|Adverse Event|1|||
124927238|NCT04081103|449362778|FG000|Overall Study|Physician Decision|0|||
124927239|NCT04081103|449362779|FG001|Overall Study|Physician Decision|0|||
124927240|NCT04081103|449362780|FG002|Overall Study|Physician Decision|1|||
124927241|NCT05309291|449362781|FG000|Overall Study|Adverse Event|0|||
124927242|NCT05309291|449362782|FG001|Overall Study|Adverse Event|1|||
124927243|NCT05209152|449362785|FG000|Overall Study|Sponsor decision|1|||
124927244|NCT05209152|449362786|FG001|Overall Study|Sponsor decision|2|||
124927245|NCT05209152|449362785|FG000|Overall Study|Death|3|||
124927246|NCT05209152|449362786|FG001|Overall Study|Death|1|||
124927247|NCT03287817|449364526|FG000|Overall Study|Progressive disease|4|||
124927248|NCT03287817|449364527|FG001|Overall Study|Progressive disease|2|||
124927249|NCT03287817|449364528|FG002|Overall Study|Progressive disease|3|||
124927250|NCT03287817|449364529|FG003|Overall Study|Progressive disease|10|||
124927251|NCT03287817|449364530|FG004|Overall Study|Progressive disease|8|||
124927252|NCT03287817|449364526|FG000|Overall Study|Death|0|||
124927253|NCT03287817|449364527|FG001|Overall Study|Death|0|||
124927254|NCT03287817|449364528|FG002|Overall Study|Death|2|||
124927255|NCT03287817|449364529|FG003|Overall Study|Death|3|||
124927256|NCT03287817|449364530|FG004|Overall Study|Death|4|||
124927257|NCT03287817|449364526|FG000|Overall Study|Physician Decision|0|||
124927258|NCT03287817|449364527|FG001|Overall Study|Physician Decision|0|||
124927259|NCT03287817|449364528|FG002|Overall Study|Physician Decision|0|||
124927260|NCT03287817|449364529|FG003|Overall Study|Physician Decision|1|||
124927261|NCT03287817|449364530|FG004|Overall Study|Physician Decision|0|||
124927262|NCT03287817|449364526|FG000|Overall Study|Withdrawal by Subject|0|||
124927263|NCT03287817|449364527|FG001|Overall Study|Withdrawal by Subject|0|||
124927264|NCT03287817|449364528|FG002|Overall Study|Withdrawal by Subject|0|||
124927265|NCT03287817|449364529|FG003|Overall Study|Withdrawal by Subject|0|||
124927266|NCT03287817|449364530|FG004|Overall Study|Withdrawal by Subject|4|||
124927267|NCT06181227|449364531|FG000|Overall Study|Study terminated by sponsor|7|||
124927268|NCT06181227|449364532|FG001|Overall Study|Study terminated by sponsor|9|||
124927269|NCT03854227|449364536|FG000|Overall Study|Adverse Event|0|||
124927270|NCT03854227|449364537|FG001|Overall Study|Adverse Event|0|||
124927271|NCT03854227|449364538|FG002|Overall Study|Adverse Event|0|||
124927272|NCT03854227|449364539|FG003|Overall Study|Adverse Event|1|||
124927273|NCT03854227|449364540|FG004|Overall Study|Adverse Event|0|||
124927274|NCT03854227|449364541|FG005|Overall Study|Adverse Event|0|||
124927275|NCT03854227|449364542|FG006|Overall Study|Adverse Event|1|||
124927276|NCT03854227|449364543|FG007|Overall Study|Adverse Event|0|||
124927277|NCT03854227|449364544|FG008|Overall Study|Adverse Event|0|||
124927278|NCT03854227|449364545|FG009|Overall Study|Adverse Event|3|||
124927279|NCT03854227|449364546|FG010|Overall Study|Adverse Event|0|||
124927280|NCT03854227|449364547|FG011|Overall Study|Adverse Event|1|||
124927281|NCT03854227|449364536|FG000|Overall Study|Death|0|||
124927282|NCT03854227|449364537|FG001|Overall Study|Death|0|||
124927283|NCT03854227|449364538|FG002|Overall Study|Death|0|||
124927284|NCT03854227|449364539|FG003|Overall Study|Death|0|||
124927285|NCT03854227|449364540|FG004|Overall Study|Death|0|||
124927286|NCT03854227|449364541|FG005|Overall Study|Death|1|||
124927287|NCT03854227|449364542|FG006|Overall Study|Death|0|||
124927288|NCT03854227|449364543|FG007|Overall Study|Death|0|||
124927289|NCT03854227|449364544|FG008|Overall Study|Death|0|||
124927290|NCT03854227|449364545|FG009|Overall Study|Death|1|||
124927291|NCT03854227|449364546|FG010|Overall Study|Death|0|||
124927292|NCT03854227|449364547|FG011|Overall Study|Death|1|||
124927293|NCT03854227|449364536|FG000|Overall Study|Physician Decision|0|||
124927294|NCT03854227|449364537|FG001|Overall Study|Physician Decision|0|||
124927295|NCT03854227|449364538|FG002|Overall Study|Physician Decision|0|||
124927296|NCT03854227|449364539|FG003|Overall Study|Physician Decision|0|||
124927297|NCT03854227|449364540|FG004|Overall Study|Physician Decision|0|||
124927298|NCT03854227|449364541|FG005|Overall Study|Physician Decision|1|||
124927299|NCT03854227|449364542|FG006|Overall Study|Physician Decision|0|||
124927300|NCT03854227|449364543|FG007|Overall Study|Physician Decision|0|||
124927301|NCT03854227|449364544|FG008|Overall Study|Physician Decision|1|||
124927302|NCT03854227|449364545|FG009|Overall Study|Physician Decision|1|||
124927303|NCT03854227|449364546|FG010|Overall Study|Physician Decision|0|||
124927304|NCT03854227|449364547|FG011|Overall Study|Physician Decision|1|||
124927305|NCT03854227|449364536|FG000|Overall Study|Progressive disease|1|||
124927306|NCT03854227|449364537|FG001|Overall Study|Progressive disease|1|||
124927307|NCT03854227|449364538|FG002|Overall Study|Progressive disease|1|||
124927308|NCT03854227|449364539|FG003|Overall Study|Progressive disease|2|||
124927309|NCT03854227|449364540|FG004|Overall Study|Progressive disease|3|||
124927310|NCT03854227|449364541|FG005|Overall Study|Progressive disease|1|||
124927311|NCT03854227|449364542|FG006|Overall Study|Progressive disease|2|||
124927312|NCT03854227|449364543|FG007|Overall Study|Progressive disease|5|||
124927313|NCT03854227|449364544|FG008|Overall Study|Progressive disease|2|||
124927314|NCT03854227|449364545|FG009|Overall Study|Progressive disease|5|||
124927315|NCT03854227|449364546|FG010|Overall Study|Progressive disease|1|||
124927316|NCT03854227|449364547|FG011|Overall Study|Progressive disease|6|||
124927317|NCT03854227|449364536|FG000|Overall Study|Study terminated by sponsor|0|||
124927318|NCT03854227|449364537|FG001|Overall Study|Study terminated by sponsor|0|||
124927319|NCT03854227|449364538|FG002|Overall Study|Study terminated by sponsor|0|||
124927320|NCT03854227|449364539|FG003|Overall Study|Study terminated by sponsor|0|||
124454710|NCT00762892|447625359|FG000|Overall Study|Death|1|||
124454711|NCT00762892|447625360|FG001|Overall Study|Death|0|||
124454712|NCT00762892|447625359|FG000|Overall Study|Pregnancy|1|||
124454713|NCT00762892|447625360|FG001|Overall Study|Pregnancy|0|||
124927321|NCT03854227|449364540|FG004|Overall Study|Study terminated by sponsor|0|||
124927322|NCT03854227|449364541|FG005|Overall Study|Study terminated by sponsor|0|||
124927323|NCT03854227|449364542|FG006|Overall Study|Study terminated by sponsor|0|||
124927324|NCT03854227|449364543|FG007|Overall Study|Study terminated by sponsor|0|||
124927325|NCT03854227|449364544|FG008|Overall Study|Study terminated by sponsor|0|||
124927326|NCT03854227|449364545|FG009|Overall Study|Study terminated by sponsor|1|||
124927327|NCT03854227|449364546|FG010|Overall Study|Study terminated by sponsor|0|||
124927328|NCT03854227|449364547|FG011|Overall Study|Study terminated by sponsor|0|||
124927329|NCT03854227|449364536|FG000|Overall Study|Withdrawal by Subject|0|||
124927330|NCT03854227|449364537|FG001|Overall Study|Withdrawal by Subject|0|||
124927331|NCT03854227|449364538|FG002|Overall Study|Withdrawal by Subject|1|||
124927332|NCT03854227|449364539|FG003|Overall Study|Withdrawal by Subject|0|||
124927333|NCT03854227|449364540|FG004|Overall Study|Withdrawal by Subject|0|||
124927334|NCT03854227|449364541|FG005|Overall Study|Withdrawal by Subject|0|||
124927335|NCT03854227|449364542|FG006|Overall Study|Withdrawal by Subject|0|||
124927336|NCT03854227|449364543|FG007|Overall Study|Withdrawal by Subject|0|||
124454714|NCT00762892|447625359|FG000|Overall Study|Incarceration|1|||
124454715|NCT00762892|447625360|FG001|Overall Study|Incarceration|0|||
124454716|NCT00383084|447625361|FG000|Overall Study|Withdrawal by Subject|12|||
124927337|NCT03854227|449364544|FG008|Overall Study|Withdrawal by Subject|0|||
124927338|NCT03854227|449364545|FG009|Overall Study|Withdrawal by Subject|1|||
124927339|NCT03854227|449364546|FG010|Overall Study|Withdrawal by Subject|1|||
124927340|NCT03854227|449364547|FG011|Overall Study|Withdrawal by Subject|0|||
124927341|NCT03854227|449364536|FG000|Overall Study|Disease relapse|0|||
124927342|NCT03854227|449364537|FG001|Overall Study|Disease relapse|0|||
124927343|NCT03854227|449364538|FG002|Overall Study|Disease relapse|0|||
124927344|NCT03854227|449364539|FG003|Overall Study|Disease relapse|0|||
124454717|NCT00383084|447625362|FG001|Overall Study|Withdrawal by Subject|10|||
124927345|NCT03854227|449364540|FG004|Overall Study|Disease relapse|0|||
124927346|NCT03854227|449364541|FG005|Overall Study|Disease relapse|0|||
124927347|NCT03854227|449364542|FG006|Overall Study|Disease relapse|0|||
124927348|NCT03854227|449364543|FG007|Overall Study|Disease relapse|0|||
124927349|NCT03854227|449364544|FG008|Overall Study|Disease relapse|1|||
124927350|NCT03854227|449364545|FG009|Overall Study|Disease relapse|0|||
124927351|NCT03854227|449364546|FG010|Overall Study|Disease relapse|0|||
124927352|NCT03854227|449364547|FG011|Overall Study|Disease relapse|0|||
124927353|NCT03854227|449364536|FG000|Overall Study|Global deterioration of health status|0|||
124927354|NCT03854227|449364537|FG001|Overall Study|Global deterioration of health status|0|||
124927355|NCT03854227|449364538|FG002|Overall Study|Global deterioration of health status|0|||
124927356|NCT03854227|449364539|FG003|Overall Study|Global deterioration of health status|0|||
124927357|NCT03854227|449364540|FG004|Overall Study|Global deterioration of health status|0|||
124927358|NCT03854227|449364541|FG005|Overall Study|Global deterioration of health status|1|||
124927359|NCT03854227|449364542|FG006|Overall Study|Global deterioration of health status|0|||
124927360|NCT03854227|449364543|FG007|Overall Study|Global deterioration of health status|1|||
124927361|NCT03854227|449364544|FG008|Overall Study|Global deterioration of health status|0|||
124927362|NCT03854227|449364545|FG009|Overall Study|Global deterioration of health status|0|||
124927363|NCT03854227|449364546|FG010|Overall Study|Global deterioration of health status|0|||
124927364|NCT03854227|449364547|FG011|Overall Study|Global deterioration of health status|0|||
124927365|NCT03854227|449364536|FG000|Overall Study|Refused further treatment|0|||
124927366|NCT03854227|449364537|FG001|Overall Study|Refused further treatment|0|||
124927367|NCT03854227|449364538|FG002|Overall Study|Refused further treatment|0|||
124927368|NCT03854227|449364539|FG003|Overall Study|Refused further treatment|0|||
124927369|NCT03854227|449364540|FG004|Overall Study|Refused further treatment|0|||
124927370|NCT03854227|449364541|FG005|Overall Study|Refused further treatment|0|||
124927371|NCT03854227|449364542|FG006|Overall Study|Refused further treatment|0|||
124927372|NCT03854227|449364543|FG007|Overall Study|Refused further treatment|0|||
124927373|NCT03854227|449364544|FG008|Overall Study|Refused further treatment|0|||
124927374|NCT03854227|449364545|FG009|Overall Study|Refused further treatment|1|||
124927375|NCT03854227|449364546|FG010|Overall Study|Refused further treatment|0|||
124927376|NCT03854227|449364547|FG011|Overall Study|Refused further treatment|1|||
124927377|NCT03854227|449364536|FG000|Overall Study|Other|0|||
124927378|NCT03854227|449364537|FG001|Overall Study|Other|0|||
124927379|NCT03854227|449364538|FG002|Overall Study|Other|0|||
124927380|NCT03854227|449364539|FG003|Overall Study|Other|0|||
124927381|NCT03854227|449364540|FG004|Overall Study|Other|0|||
124927382|NCT03854227|449364541|FG005|Overall Study|Other|0|||
124927383|NCT03854227|449364542|FG006|Overall Study|Other|0|||
124927384|NCT03854227|449364543|FG007|Overall Study|Other|0|||
124927385|NCT03854227|449364544|FG008|Overall Study|Other|1|||
124927386|NCT03854227|449364545|FG009|Overall Study|Other|1|||
124927387|NCT03854227|449364546|FG010|Overall Study|Other|0|||
124927388|NCT03854227|449364547|FG011|Overall Study|Other|0|||
124927389|NCT03668236|449364548|FG000|90-day Follow-up|Withdrawal by Subject|3|||
124927390|NCT03668236|449364549|FG001|90-day Follow-up|Withdrawal by Subject|2|||
124927391|NCT03668236|449364548|FG000|90-day Follow-up|Lost to Follow-up|3|||
124927392|NCT03668236|449364549|FG001|90-day Follow-up|Lost to Follow-up|1|||
124927393|NCT03668236|449364548|FG000|Baseline Characteristics|Lost to Follow-up|9|||
124927394|NCT03668236|449364549|FG001|Baseline Characteristics|Lost to Follow-up|5|||
124927395|NCT03668236|449364548|FG000|1-year Follow-up|Withdrawal by Subject|17|||
124927396|NCT03668236|449364549|FG001|1-year Follow-up|Withdrawal by Subject|15|||
124927397|NCT06132282|449364555|FG000|Overall Study|Lost to Follow-up|31|||
124927398|NCT04376502|449364561|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
124927399|NCT03748953|449364562|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
124927400|NCT03748953|449364563|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
124927401|NCT03748953|449364562|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
124927402|NCT03748953|449364563|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
124927403|NCT03748953|449364562|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
124927404|NCT03748953|449364563|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
124927405|NCT03748953|449364562|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
124927406|NCT03748953|449364563|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
124927407|NCT03748953|449364562|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
124927408|NCT03748953|449364563|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
124927409|NCT04044768|449364565|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
124927410|NCT04044768|449364566|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
124927411|NCT01574274|449364567|FG000|Overall Study|Ineligible|0|||
124927412|NCT01574274|449364568|FG001|Overall Study|Ineligible|1|||
124927413|NCT01574274|449364567|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
124927414|NCT01574274|449364568|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
124927415|NCT01574274|449364567|FG000|Overall Study|Ph+ B-ALL|3|||
124927416|NCT01574274|449364568|FG001|Overall Study|Ph+ B-ALL|4|||
124927417|NCT01574274|449364567|FG000|Overall Study|Induction Death|2|||
124927418|NCT01574274|449364568|FG001|Overall Study|Induction Death|0|||
124927419|NCT01574274|449364567|FG000|Overall Study|Induction Failure|4|||
124927420|NCT01574274|449364568|FG001|Overall Study|Induction Failure|1|||
124927421|NCT01574274|449364567|FG000|Overall Study|Adverse Event|16|||
124927422|NCT01574274|449364568|FG001|Overall Study|Adverse Event|13|||
124927423|NCT01574274|449364567|FG000|Overall Study|Remission Death|1|||
124927424|NCT01574274|449364568|FG001|Overall Study|Remission Death|0|||
124927425|NCT01574274|449364567|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
124927426|NCT01574274|449364568|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
124927427|NCT01574274|449364567|FG000|Overall Study|Other, unknown|3|||
124927428|NCT01574274|449364568|FG001|Overall Study|Other, unknown|2|||
124927429|NCT05089019|449364569|FG000|Period 1|Withdrawal by Subject|0|||
124927430|NCT05089019|449364570|FG001|Period 1|Withdrawal by Subject|1|||
124927431|NCT05089019|449364569|FG000|Washout Period|Adverse Event|3|||
124927432|NCT05089019|449364570|FG001|Washout Period|Adverse Event|4|||
124927433|NCT05089019|449364569|FG000|Washout Period|Lost to Follow-up|1|||
124927434|NCT05089019|449364570|FG001|Washout Period|Lost to Follow-up|0|||
124927435|NCT05089019|449364569|FG000|Washout Period|Physician Decision|2|||
124927436|NCT05089019|449364570|FG001|Washout Period|Physician Decision|0|||
124927437|NCT05089019|449364569|FG000|Washout Period|Withdrawal by Subject|6|||
124927438|NCT05089019|449364570|FG001|Washout Period|Withdrawal by Subject|3|||
124927439|NCT05089019|449364569|FG000|Period 2|Adverse Event|4|||
124927440|NCT05089019|449364570|FG001|Period 2|Adverse Event|2|||
124927441|NCT05089019|449364569|FG000|Period 2|Lost to Follow-up|1|||
124927442|NCT05089019|449364570|FG001|Period 2|Lost to Follow-up|0|||
124927443|NCT05089019|449364569|FG000|Period 2|Withdrawal by Subject|0|||
124927444|NCT05089019|449364570|FG001|Period 2|Withdrawal by Subject|1|||
124927445|NCT01593917|449364575|FG000|Overall Study|Death|67|||
124927446|NCT01593917|449364575|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
124927447|NCT01593917|449364575|FG000|Overall Study|Withdrawal by Subject|23|||
124927448|NCT01593917|449364575|FG000|Overall Study|Lost to Follow-up|12|||
124927449|NCT01593917|449364575|FG000|Overall Study|Protocol Violation|5|||
124927450|NCT01593917|449364575|FG000|Overall Study|Physician Decision|3|||
124927451|NCT03216057|449364576|FG000|Overall Study|Lost to Follow-up|2|||
124927452|NCT03216057|449364577|FG001|Overall Study|Lost to Follow-up|2|||
124927453|NCT04564742|449364578|FG000|Overall Study|Lost to Follow-up|1|||
124927454|NCT04564742|449364579|FG001|Overall Study|Lost to Follow-up|0|||
124927455|NCT04564742|449364578|FG000|Overall Study|Consent Withdrawal|4|||
124927456|NCT04564742|449364579|FG001|Overall Study|Consent Withdrawal|4|||
124927457|NCT02841579|449364581|FG000|Overall Study|Death|1|||
124927458|NCT02841579|449364581|FG000|Overall Study|Adverse Event|1|||
124927459|NCT02841579|449364581|FG000|Overall Study|Lack of Efficacy|9|||
124927460|NCT05270408|449364582|FG000|Started Treatment|Withdrawal by Subject|0|||
124927461|NCT05270408|449364583|FG001|Started Treatment|Withdrawal by Subject|0|||
124927462|NCT05270408|449364584|FG002|Started Treatment|Withdrawal by Subject|3|||
124927463|NCT05270408|449364582|FG000|Started Treatment|Adverse Event|0|||
124927464|NCT05270408|449364583|FG001|Started Treatment|Adverse Event|0|||
124927465|NCT05270408|449364584|FG002|Started Treatment|Adverse Event|1|||
124927466|NCT05270408|449364582|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
124927467|NCT05270408|449364583|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
124927468|NCT05270408|449364584|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
124927469|NCT02465268|449364589|FG000|Overall Study|Withdrawal by Subject|4|||
124927470|NCT02465268|449364590|FG001|Overall Study|Withdrawal by Subject|3|||
124927471|NCT02465268|449364591|FG002|Overall Study|Withdrawal by Subject|1|||
124927472|NCT02465268|449364589|FG000|Overall Study|Not evaluable per protocol criteria|3|||
124927473|NCT02465268|449364590|FG001|Overall Study|Not evaluable per protocol criteria|2|||
124927474|NCT02465268|449364591|FG002|Overall Study|Not evaluable per protocol criteria|1|||
124927475|NCT02465268|449364589|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
124927476|NCT02465268|449364590|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
124927477|NCT02465268|449364591|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
124927478|NCT02465268|449364589|FG000|Overall Study|Study drug did not pass QA/QC|1|||
124927479|NCT02465268|449364590|FG001|Overall Study|Study drug did not pass QA/QC|0|||
124927480|NCT02465268|449364591|FG002|Overall Study|Study drug did not pass QA/QC|0|||
124927481|NCT02465268|449364589|FG000|Overall Study|Adverse Event|0|||
124927482|NCT02465268|449364590|FG001|Overall Study|Adverse Event|1|||
124927483|NCT02465268|449364591|FG002|Overall Study|Adverse Event|0|||
124927484|NCT02465268|449364589|FG000|Overall Study|Physician Decision|0|||
124927485|NCT02465268|449364590|FG001|Overall Study|Physician Decision|1|||
124927486|NCT02465268|449364591|FG002|Overall Study|Physician Decision|0|||
124927487|NCT01501955|449364594|FG000|Overall Study|Withdrawal by Subject|1|||
124927488|NCT01501955|449364595|FG001|Overall Study|Withdrawal by Subject|0|||
124927489|NCT01501955|449364594|FG000|Overall Study|Adverse Event|1|||
124927490|NCT01501955|449364595|FG001|Overall Study|Adverse Event|3|||
124927491|NCT02993159|449364596|FG000|Overall Study|Withdrawal by Subject|1|||
124927492|NCT02993159|449364597|FG001|Overall Study|Withdrawal by Subject|3|||
124927493|NCT02993159|449364596|FG000|Overall Study|Protocol Violation|1|||
124927494|NCT02993159|449364597|FG001|Overall Study|Protocol Violation|0|||
124927495|NCT02993159|449364596|FG000|Overall Study|Opted out of surgery|2|||
124697661|NCT02991859|448513987|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
124697662|NCT02991859|448513988|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
124697663|NCT02991859|448513989|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
124697664|NCT02991859|448513990|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
124697665|NCT02991859|448513991|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
124697666|NCT02991859|448513992|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
124454718|NCT02159729|447625363|FG000|Overall Study|Adverse Event|0|||
124454719|NCT02159729|447625364|FG001|Overall Study|Adverse Event|1|||
124454720|NCT02159729|447625363|FG000|Overall Study|Subject's Request|13|||
124454721|NCT02159729|447625364|FG001|Overall Study|Subject's Request|10|||
124454722|NCT02159729|447625363|FG000|Overall Study|Lost to Follow-up|24|||
124454723|NCT02159729|447625364|FG001|Overall Study|Lost to Follow-up|9|||
124454724|NCT02159729|447625363|FG000|Overall Study|Non compliance|2|||
124454725|NCT02159729|447625364|FG001|Overall Study|Non compliance|0|||
124454726|NCT02159729|447625363|FG000|Overall Study|Other Unspecified|3|||
124454727|NCT02159729|447625364|FG001|Overall Study|Other Unspecified|1|||
124927496|NCT02993159|449364597|FG001|Overall Study|Opted out of surgery|0|||
124927497|NCT02993159|449364596|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
124927498|NCT02993159|449364597|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
124927499|NCT02993159|449364596|FG000|Overall Study|Physician Decision|0|||
124927500|NCT02993159|449364597|FG001|Overall Study|Physician Decision|1|||
124927501|NCT04992520|449364601|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
124927502|NCT04992520|449364602|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
124927503|NCT04992520|449364603|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
124927504|NCT04992520|449364604|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
124927505|NCT04992520|449364605|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
124927506|NCT04992520|449364606|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
124927507|NCT04992520|449364601|FG000|Part A: First Challenge|Non-compliance|0|||
124927508|NCT04992520|449364602|FG001|Part A: First Challenge|Non-compliance|0|||
124927509|NCT04992520|449364603|FG002|Part A: First Challenge|Non-compliance|0|||
124927510|NCT04992520|449364604|FG003|Part A: First Challenge|Non-compliance|1|||
124927511|NCT04992520|449364605|FG004|Part A: First Challenge|Non-compliance|0|||
124927512|NCT04992520|449364606|FG005|Part A: First Challenge|Non-compliance|0|||
124927513|NCT04992520|449364601|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
124927514|NCT04992520|449364602|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
124927515|NCT04992520|449364603|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
124927516|NCT04992520|449364604|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
124927517|NCT04992520|449364605|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
124927518|NCT04992520|449364606|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
124927519|NCT04992520|449364601|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
124927520|NCT04992520|449364602|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
124927521|NCT04992520|449364603|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
124927522|NCT04992520|449364604|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
124927523|NCT04992520|449364605|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
124927524|NCT04992520|449364606|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
124927525|NCT03625167|449364609|FG000|Overall Study|Protocol Violation|5|||
124927526|NCT00248287|449364612|FG000|Overall Study|Adverse Event|11|||
124927527|NCT00248287|449364613|FG001|Overall Study|Adverse Event|10|||
124927528|NCT00248287|449364612|FG000|Overall Study|Death|1|||
124927529|NCT00248287|449364613|FG001|Overall Study|Death|0|||
124927530|NCT00248287|449364612|FG000|Overall Study|Lost to Follow-up|0|||
124927531|NCT00248287|449364613|FG001|Overall Study|Lost to Follow-up|1|||
124927532|NCT00248287|449364612|FG000|Overall Study|Investigator Request|4|||
124927533|NCT00248287|449364613|FG001|Overall Study|Investigator Request|3|||
124927534|NCT00248287|449364612|FG000|Overall Study|Patient Request|5|||
124927535|NCT00248287|449364613|FG001|Overall Study|Patient Request|3|||
124927536|NCT00248287|449364612|FG000|Overall Study|Other|3|||
124927537|NCT00248287|449364613|FG001|Overall Study|Other|2|||
124927538|NCT04524442|449364626|FG000|Overall Study|Subject Decision|1|||
124927539|NCT05228457|449364634|FG000|Overall Study|Withdrawal by Subject|1|||
124927540|NCT05228457|449364635|FG001|Overall Study|Withdrawal by Subject|1|||
124927541|NCT03213691|449364644|FG000|Overall Study|Adverse Event|2|||
124927542|NCT03213691|449364644|FG000|Overall Study|Death|3|||
124927543|NCT03213691|449364644|FG000|Overall Study|Physician Decision|1|||
124927544|NCT03213691|449364644|FG000|Overall Study|Progressive Disease|14|||
124927545|NCT03213691|449364644|FG000|Overall Study|Ineligible|1|||
124927546|NCT01152450|449364647|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
124927547|NCT01152450|449364648|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
124927548|NCT01152450|449364649|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
124454728|NCT02636582|447625365|FG000|Overall Study|Surgical Pathology|1|||
124454729|NCT02636582|447625366|FG001|Overall Study|Surgical Pathology|0|||
124545959|NCT00943826|447954442|FG000|Concurrent Phase|Adverse Event|50|||
124927549|NCT01152450|449364650|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
124927550|NCT01152450|449364651|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
124927551|NCT01152450|449364652|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
124927552|NCT01152450|449364647|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
124927553|NCT01152450|449364648|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
124927554|NCT01152450|449364649|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
124927555|NCT01152450|449364650|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
124927556|NCT01152450|449364651|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
124927557|NCT01152450|449364652|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
124927558|NCT01152450|449364647|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
124927559|NCT01152450|449364648|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
124927560|NCT01152450|449364649|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
124927561|NCT01152450|449364650|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
124927562|NCT01152450|449364651|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
124927563|NCT01152450|449364652|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
124927564|NCT05139810|449364653|FG000|Overall Study|Voluntary Withdrawal|2|||
124927565|NCT05139810|449364654|FG001|Overall Study|Voluntary Withdrawal|1|||
124927566|NCT05139810|449364655|FG002|Overall Study|Voluntary Withdrawal|0|||
124927567|NCT05139810|449364653|FG000|Overall Study|Pregnancy|1|||
124927568|NCT05139810|449364654|FG001|Overall Study|Pregnancy|0|||
124927569|NCT05139810|449364655|FG002|Overall Study|Pregnancy|0|||
124927570|NCT05139810|449364653|FG000|Overall Study|Roll Over to CS7|19|||
124927571|NCT05139810|449364654|FG001|Overall Study|Roll Over to CS7|44|||
124927572|NCT05139810|449364655|FG002|Overall Study|Roll Over to CS7|20|||
124927573|NCT02966873|449364656|FG000|Overall Study|Lost to Follow-up|16|||
124927574|NCT02966873|449364657|FG001|Overall Study|Lost to Follow-up|15|||
124927575|NCT04753697|449364660|FG000|Induction Phase|Withdrawal by Subject|12|||
124927576|NCT04753697|449364661|FG001|Induction Phase|Withdrawal by Subject|5|||
124927577|NCT04753697|449364662|FG002|Induction Phase|Withdrawal by Subject|6|||
124927578|NCT04753697|449364660|FG000|Induction Phase|Physician Decision|1|||
124927579|NCT04753697|449364661|FG001|Induction Phase|Physician Decision|0|||
124927580|NCT04753697|449364662|FG002|Induction Phase|Physician Decision|0|||
124927581|NCT04753697|449364660|FG000|Induction Phase|Lost to Follow-up|2|||
124927582|NCT04753697|449364661|FG001|Induction Phase|Lost to Follow-up|2|||
124927583|NCT04753697|449364662|FG002|Induction Phase|Lost to Follow-up|1|||
124927584|NCT04753697|449364660|FG000|Induction Phase|Lack of Efficacy|1|||
124927585|NCT04753697|449364661|FG001|Induction Phase|Lack of Efficacy|0|||
124927586|NCT04753697|449364662|FG002|Induction Phase|Lack of Efficacy|0|||
124927587|NCT04753697|449364660|FG000|Maintenance Phase|Physician Decision|0|||
124927588|NCT04753697|449364661|FG001|Maintenance Phase|Physician Decision|0|||
124927589|NCT04753697|449364662|FG002|Maintenance Phase|Physician Decision|1|||
124927590|NCT04753697|449364660|FG000|Maintenance Phase|Withdrawal by Subject|3|||
124927591|NCT04753697|449364661|FG001|Maintenance Phase|Withdrawal by Subject|4|||
124927592|NCT04753697|449364662|FG002|Maintenance Phase|Withdrawal by Subject|6|||
124927593|NCT04753697|449364660|FG000|Maintenance Phase|Lost to Follow-up|2|||
124927594|NCT04753697|449364661|FG001|Maintenance Phase|Lost to Follow-up|2|||
124927595|NCT04753697|449364662|FG002|Maintenance Phase|Lost to Follow-up|0|||
124927596|NCT04753697|449364660|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
124454730|NCT01263483|447625367|FG000|Overall Study|Adverse Event|4|||
124454731|NCT01263483|447625368|FG001|Overall Study|Adverse Event|0|||
124454732|NCT01263483|447625369|FG002|Overall Study|Adverse Event|3|||
124454733|NCT01263483|447625367|FG000|Overall Study|Withdrawal by Subject|1|||
124927597|NCT04753697|449364661|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
124927598|NCT04753697|449364662|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
124927599|NCT04753697|449364660|FG000|Maintenance Phase|Adverse Event|0|||
124927600|NCT04753697|449364661|FG001|Maintenance Phase|Adverse Event|1|||
124927601|NCT04753697|449364662|FG002|Maintenance Phase|Adverse Event|1|||
124927602|NCT04753697|449364660|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
124927603|NCT04753697|449364661|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
124927604|NCT04753697|449364662|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
124927605|NCT02626533|449364663|FG000|Overall Study|Protocol Violation|14|||
124927606|NCT02626533|449364663|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
124927607|NCT02626533|449364663|FG000|Overall Study|Withdrawal by Subject|1|||
124927608|NCT02723591|449364666|FG000|Overall Study|Adverse Event|48|||
124927609|NCT02723591|449364667|FG001|Overall Study|Adverse Event|40|||
124927610|NCT02723591|449364666|FG000|Overall Study|Death|2|||
124927611|NCT02723591|449364667|FG001|Overall Study|Death|2|||
124927612|NCT02723591|449364666|FG000|Overall Study|Lack of Efficacy|4|||
124927613|NCT02723591|449364667|FG001|Overall Study|Lack of Efficacy|3|||
124927614|NCT02723591|449364666|FG000|Overall Study|Lost to Follow-up|1|||
124927615|NCT02723591|449364667|FG001|Overall Study|Lost to Follow-up|7|||
124927616|NCT02723591|449364666|FG000|Overall Study|Protocol Violation|20|||
124927617|NCT02723591|449364667|FG001|Overall Study|Protocol Violation|23|||
124927618|NCT02723591|449364666|FG000|Overall Study|Withdrawal by Subject|4|||
124927619|NCT02723591|449364667|FG001|Overall Study|Withdrawal by Subject|8|||
124927620|NCT02723591|449364666|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
124927621|NCT02723591|449364667|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
124927622|NCT02723591|449364666|FG000|Overall Study|Miscellaneous|5|||
124927623|NCT02723591|449364667|FG001|Overall Study|Miscellaneous|6|||
124927624|NCT03691935|449364668|FG000|Overall Study|Physician Decision|2|||
124927625|NCT03691935|449364669|FG001|Overall Study|Physician Decision|1|||
124927626|NCT03691935|449364668|FG000|Overall Study|Adverse Event|3|||
124927627|NCT03691935|449364669|FG001|Overall Study|Adverse Event|0|||
124927628|NCT03034356|449364681|FG000|Baseline|Lost to Follow-up|2|||
124927629|NCT03034356|449364682|FG001|Baseline|Lost to Follow-up|4|||
124927630|NCT03034356|449364681|FG000|Baseline|Withdrawal by Subject|2|||
124927631|NCT03034356|449364682|FG001|Baseline|Withdrawal by Subject|0|||
124927632|NCT03034356|449364681|FG000|Baseline|Physician Decision|0|||
124927633|NCT03034356|449364682|FG001|Baseline|Physician Decision|1|||
124927634|NCT03034356|449364681|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
124927635|NCT03034356|449364682|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
124927636|NCT03034356|449364681|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
124927637|NCT03034356|449364682|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
124927638|NCT03034356|449364681|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
124927639|NCT03034356|449364682|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
124927640|NCT03034356|449364681|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
124927641|NCT03034356|449364682|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
124927642|NCT02823145|449364683|FG000|Enrollment|Other|1|||
124927643|NCT02823145|449364684|FG001|Enrollment|Other|0|||
124927644|NCT02823145|449364683|FG000|Treatment|Adverse Event|0|||
124927645|NCT02823145|449364684|FG001|Treatment|Adverse Event|11|||
124927646|NCT02823145|449364683|FG000|Treatment|Death|0|||
124927647|NCT02823145|449364684|FG001|Treatment|Death|3|||
124454734|NCT01263483|447625368|FG001|Overall Study|Withdrawal by Subject|0|||
124454735|NCT01263483|447625369|FG002|Overall Study|Withdrawal by Subject|0|||
124454736|NCT01263483|447625367|FG000|Overall Study|Lack of Efficacy|2|||
124454737|NCT01263483|447625368|FG001|Overall Study|Lack of Efficacy|0|||
124454738|NCT01263483|447625369|FG002|Overall Study|Lack of Efficacy|0|||
124927648|NCT02823145|449364683|FG000|Treatment|Family Decision|0|||
124927649|NCT02823145|449364684|FG001|Treatment|Family Decision|1|||
124927650|NCT02823145|449364683|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
124927651|NCT02823145|449364684|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
124927652|NCT02823145|449364683|FG000|Treatment|Lack of Efficacy|0|||
124927653|NCT02823145|449364684|FG001|Treatment|Lack of Efficacy|48|||
124454739|NCT01263483|447625367|FG000|Overall Study|Protocol Violation|0|||
124454740|NCT01263483|447625368|FG001|Overall Study|Protocol Violation|1|||
124927654|NCT02823145|449364683|FG000|Treatment|Non-Compliance With E-Diary|0|||
124927655|NCT02823145|449364684|FG001|Treatment|Non-Compliance With E-Diary|1|||
124927656|NCT02823145|449364683|FG000|Treatment|Physician Decision|0|||
124927657|NCT02823145|449364684|FG001|Treatment|Physician Decision|2|||
124927658|NCT02823145|449364683|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
124927659|NCT02823145|449364684|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
124927660|NCT02823145|449364683|FG000|Treatment|Subject needed to take prohibited medication|0|||
124927661|NCT02823145|449364684|FG001|Treatment|Subject needed to take prohibited medication|1|||
124927662|NCT02823145|449364683|FG000|Treatment|Subject transferred to direct access programme|0|||
124927663|NCT02823145|449364684|FG001|Treatment|Subject transferred to direct access programme|1|||
124927664|NCT02823145|449364683|FG000|Treatment|Switching to commercially available drug|0|||
124927665|NCT02823145|449364684|FG001|Treatment|Switching to commercially available drug|11|||
124927666|NCT02823145|449364683|FG000|Treatment|Transitioned to commercial supply of medication|0|||
124927667|NCT02823145|449364684|FG001|Treatment|Transitioned to commercial supply of medication|1|||
124927668|NCT02823145|449364683|FG000|Treatment|Withdrawal By Caregiver|0|||
124927669|NCT02823145|449364684|FG001|Treatment|Withdrawal By Caregiver|1|||
124927670|NCT02823145|449364683|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
124927671|NCT02823145|449364684|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
124927672|NCT02823145|449364683|FG000|Treatment|Withdrawal by Subject|0|||
124927673|NCT02823145|449364684|FG001|Treatment|Withdrawal by Subject|16|||
124927674|NCT02823145|449364683|FG000|Treatment|Reason unknown|0|||
124927675|NCT02823145|449364684|FG001|Treatment|Reason unknown|1|||
124927676|NCT05292391|449364685|FG000|Overall Study|Lost to Follow-up|0|||
124927677|NCT05292391|449364686|FG001|Overall Study|Lost to Follow-up|0|||
124927678|NCT05292391|449364687|FG002|Overall Study|Lost to Follow-up|0|||
124927679|NCT05292391|449364688|FG003|Overall Study|Lost to Follow-up|1|||
124927680|NCT05292391|449364689|FG004|Overall Study|Lost to Follow-up|0|||
124927681|NCT05809453|449366173|FG000|Overall Study|Withdrawal by Subject|1|||
124927682|NCT05809453|449366174|FG001|Overall Study|Withdrawal by Subject|0|||
124927683|NCT05809453|449366175|FG002|Overall Study|Withdrawal by Subject|0|||
124927684|NCT05809453|449366176|FG003|Overall Study|Withdrawal by Subject|0|||
124927685|NCT02696707|449366177|FG000|Per Protocol Population|Physician Decision|2|||
124927686|NCT02696707|449366178|FG001|Per Protocol Population|Physician Decision|1|||
124927687|NCT02696707|449366177|FG000|Per Protocol Population|Participant Decision|0|||
124927688|NCT02696707|449366178|FG001|Per Protocol Population|Participant Decision|2|||
124927689|NCT02696707|449366177|FG000|Completed Study as Planned|Reason = LVEF|2|||
124927690|NCT02696707|449366178|FG001|Completed Study as Planned|Reason = LVEF|2|||
124927691|NCT02696707|449366177|FG000|Completed Study as Planned|Protocol Violation|2|||
124927692|NCT02696707|449366178|FG001|Completed Study as Planned|Protocol Violation|6|||
124927693|NCT02696707|449366177|FG000|Completed Study as Planned|Metastatic disease|3|||
124927694|NCT02696707|449366178|FG001|Completed Study as Planned|Metastatic disease|0|||
124927695|NCT02696707|449366177|FG000|Completed Study as Planned|Location|1|||
124927696|NCT02696707|449366178|FG001|Completed Study as Planned|Location|1|||
124927697|NCT05251909|449366183|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
124927698|NCT05251909|449366184|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
124927699|NCT05543915|449366185|FG000|Overall Study|Lost to Follow-up|0|||
124927700|NCT05543915|449366186|FG001|Overall Study|Lost to Follow-up|1|||
124927701|NCT02815566|449366191|FG000|Overall Study|Adverse Event|1|||
124927702|NCT02815566|449366192|FG001|Overall Study|Adverse Event|1|||
124927703|NCT02815566|449366191|FG000|Overall Study|Withdrawal by Subject|1|||
124927704|NCT02815566|449366192|FG001|Overall Study|Withdrawal by Subject|0|||
124927705|NCT02815566|449366191|FG000|Overall Study|Lost to Follow-up|0|||
124454741|NCT01263483|447625369|FG002|Overall Study|Protocol Violation|1|||
124454742|NCT01263483|447625367|FG000|Overall Study|Participant Unavailability|0|||
124454743|NCT01263483|447625368|FG001|Overall Study|Participant Unavailability|1|||
124454744|NCT01263483|447625369|FG002|Overall Study|Participant Unavailability|1|||
124454745|NCT00326209|447625370|FG000|Overall Study|Adverse Event|28|||
124454746|NCT00326209|447625370|FG000|Overall Study|Withdrawal by Subject|22|||
124454747|NCT00326209|447625370|FG000|Overall Study|Lack of Efficacy|31|||
124697667|NCT02991859|448513993|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
124697668|NCT02991859|448513994|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
124697669|NCT02991859|448513995|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
124927706|NCT02815566|449366192|FG001|Overall Study|Lost to Follow-up|1|||
124927707|NCT03252847|449366195|FG000|Overall Study|Withdrawal by Subject|0|||
124927708|NCT03252847|449366196|FG001|Overall Study|Withdrawal by Subject|0|||
124927709|NCT03252847|449366197|FG002|Overall Study|Withdrawal by Subject|1|||
124927710|NCT03252847|449366198|FG003|Overall Study|Withdrawal by Subject|0|||
124927711|NCT03252847|449366199|FG004|Overall Study|Withdrawal by Subject|0|||
124454748|NCT00326209|447625370|FG000|Overall Study|Lost to Follow-up|18|||
124927712|NCT03252847|449366200|FG005|Overall Study|Withdrawal by Subject|0|||
124927713|NCT03252847|449366201|FG006|Overall Study|Withdrawal by Subject|0|||
124454749|NCT00326209|447625370|FG000|Overall Study|Participant non-compliant|6|||
124454750|NCT00326209|447625370|FG000|Overall Study|Sponsor closed study|173|||
124545960|NCT00943826|447954443|FG001|Concurrent Phase|Adverse Event|27|||
124762993|NCT00791388|448757873|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
124927714|NCT03252847|449366195|FG000|Overall Study|Other: Patient decision|0|||
124927715|NCT03252847|449366196|FG001|Overall Study|Other: Patient decision|0|||
124927716|NCT03252847|449366197|FG002|Overall Study|Other: Patient decision|0|||
124927717|NCT03252847|449366198|FG003|Overall Study|Other: Patient decision|0|||
124927718|NCT03252847|449366199|FG004|Overall Study|Other: Patient decision|1|||
124927719|NCT03252847|449366200|FG005|Overall Study|Other: Patient decision|0|||
124927720|NCT03252847|449366201|FG006|Overall Study|Other: Patient decision|0|||
124927721|NCT05034328|449366202|FG000|Overall Study|Protocol Violation|1|||
124927722|NCT05034328|449366203|FG001|Overall Study|Protocol Violation|0|||
124927723|NCT05034328|449366202|FG000|Overall Study|Lost to Follow-up|0|||
124927724|NCT05034328|449366203|FG001|Overall Study|Lost to Follow-up|10|||
124927725|NCT02969707|449366206|FG000|Overall Study|Withdrawal by Subject|6|||
124927726|NCT02969707|449366207|FG001|Overall Study|Withdrawal by Subject|5|||
124927727|NCT02969707|449366206|FG000|Overall Study|Severe anxiety|0|||
124927728|NCT02969707|449366207|FG001|Overall Study|Severe anxiety|1|||
124927729|NCT02969707|449366206|FG000|Overall Study|Positive toxicology screen|0|||
124927730|NCT02969707|449366207|FG001|Overall Study|Positive toxicology screen|2|||
124927731|NCT02969707|449366206|FG000|Overall Study|Claustrophobia|2|||
124927732|NCT02969707|449366207|FG001|Overall Study|Claustrophobia|2|||
124927733|NCT02969707|449366206|FG000|Overall Study|Non-compliance|1|||
124927734|NCT02969707|449366207|FG001|Overall Study|Non-compliance|2|||
124927735|NCT02427464|449366211|FG000|Overall Study|Adverse Event|6|||
124927736|NCT02427464|449366212|FG001|Overall Study|Adverse Event|1|||
124927737|NCT02427464|449366211|FG000|Overall Study|Lost to Follow-up|16|||
124927738|NCT02427464|449366212|FG001|Overall Study|Lost to Follow-up|5|||
124927739|NCT02427464|449366211|FG000|Overall Study|Physician Decision|2|||
124927740|NCT02427464|449366212|FG001|Overall Study|Physician Decision|0|||
124927741|NCT02427464|449366211|FG000|Overall Study|Withdrawal by Subject|10|||
124927742|NCT02427464|449366212|FG001|Overall Study|Withdrawal by Subject|8|||
124927743|NCT02427464|449366211|FG000|Overall Study|Noncompliance|16|||
124927744|NCT02427464|449366212|FG001|Overall Study|Noncompliance|10|||
124927745|NCT02714257|449366213|FG000|Overall Study|Withdrawal by Subject|6|||
124927746|NCT02714257|449366214|FG001|Overall Study|Withdrawal by Subject|11|||
124927747|NCT02714257|449366213|FG000|Overall Study|Death|3|||
124927748|NCT02714257|449366214|FG001|Overall Study|Death|4|||
124927749|NCT02714257|449366213|FG000|Overall Study|Lost to Follow-up|1|||
124927750|NCT02714257|449366214|FG001|Overall Study|Lost to Follow-up|6|||
124927751|NCT04103580|449366215|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
124927752|NCT04103580|449366216|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
124927753|NCT04103580|449366215|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
124927754|NCT04103580|449366216|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
124927755|NCT04103580|449366215|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
124927756|NCT04103580|449366216|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
124927757|NCT04103580|449366215|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
124927758|NCT04103580|449366216|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
124927759|NCT04103580|449366215|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
124927760|NCT04103580|449366216|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
124927761|NCT04103580|449366215|FG000|Phase 1 Active Caregiving|Other|3|||
124927762|NCT04103580|449366216|FG001|Phase 1 Active Caregiving|Other|3|||
124927763|NCT04103580|449366215|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
124927764|NCT04103580|449366216|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
124927765|NCT04103580|449366215|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
124927766|NCT04103580|449366216|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
124927767|NCT04103580|449366215|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
124927768|NCT04103580|449366216|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
124927769|NCT04103580|449366215|FG000|Phase 2 Bereavement|Other|8|||
124927770|NCT04103580|449366216|FG001|Phase 2 Bereavement|Other|6|||
124927771|NCT04145440|449366217|FG000|Overall Study|Physician Decision|3|||
124927772|NCT04145440|449366218|FG001|Overall Study|Physician Decision|0|||
124927773|NCT04145440|449366217|FG000|Overall Study|Use of prohibited therapy|2|||
124927774|NCT04145440|449366218|FG001|Overall Study|Use of prohibited therapy|3|||
124927775|NCT00104676|449366219|FG000|Overall Study|Death|3|||
124927776|NCT00104676|449366220|FG001|Overall Study|Death|2|||
124927777|NCT00104676|449366219|FG000|Overall Study|Withdrawal by Subject|0|||
124927778|NCT00104676|449366220|FG001|Overall Study|Withdrawal by Subject|2|||
124927779|NCT00104676|449366219|FG000|Overall Study|treatment interruption|4|||
124927780|NCT00104676|449366220|FG001|Overall Study|treatment interruption|10|||
124927781|NCT03766685|449366234|FG000|Overall Study|Lost to Follow-up|1|||
124927782|NCT03766685|449366235|FG001|Overall Study|Lost to Follow-up|1|||
124927783|NCT03766685|449366236|FG002|Overall Study|Lost to Follow-up|0|||
124927784|NCT03766685|449366237|FG003|Overall Study|Lost to Follow-up|0|||
124927785|NCT03766685|449366234|FG000|Overall Study|Adverse Event, not fatal|0|||
124927786|NCT03766685|449366235|FG001|Overall Study|Adverse Event, not fatal|1|||
124927787|NCT03766685|449366236|FG002|Overall Study|Adverse Event, not fatal|0|||
124927788|NCT03766685|449366237|FG003|Overall Study|Adverse Event, not fatal|1|||
124927789|NCT03766685|449366234|FG000|Overall Study|Withdrawal by Subject|0|||
124927790|NCT03766685|449366235|FG001|Overall Study|Withdrawal by Subject|2|||
124927791|NCT03766685|449366236|FG002|Overall Study|Withdrawal by Subject|0|||
124927792|NCT03766685|449366237|FG003|Overall Study|Withdrawal by Subject|0|||
124927793|NCT03766685|449366234|FG000|Overall Study|Protocol Violation|0|||
124762994|NCT00791388|448757874|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
124927794|NCT03766685|449366235|FG001|Overall Study|Protocol Violation|1|||
124927795|NCT03766685|449366236|FG002|Overall Study|Protocol Violation|0|||
124927796|NCT03766685|449366237|FG003|Overall Study|Protocol Violation|0|||
124927797|NCT03766685|449366234|FG000|Overall Study|Non-compliance|0|||
124927798|NCT03766685|449366235|FG001|Overall Study|Non-compliance|2|||
124927799|NCT03766685|449366236|FG002|Overall Study|Non-compliance|0|||
124927800|NCT03766685|449366237|FG003|Overall Study|Non-compliance|0|||
124927801|NCT05297565|449366240|FG000|Overall Study|Other Reasons|0|||
124927802|NCT05297565|449366241|FG001|Overall Study|Other Reasons|1|||
124927803|NCT05297565|449366240|FG000|Overall Study|Physician Decision|0|||
124927804|NCT05297565|449366241|FG001|Overall Study|Physician Decision|1|||
124927805|NCT05297565|449366240|FG000|Overall Study|Disease recurrence|1|||
124927806|NCT05297565|449366241|FG001|Overall Study|Disease recurrence|0|||
124927807|NCT04054193|449366253|FG000|Cycle 1|Physician Decision|1|||
124927808|NCT04054193|449366253|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
124927809|NCT04054193|449366253|FG000|Cycle 1|Allocated but not treated|3|||
124927810|NCT04054193|449366253|FG000|Cycles 2-3|Physician Decision|2|||
124927811|NCT04054193|449366253|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
124927812|NCT04054193|449366253|FG000|Cycles 2-3|Various reasons|17|||
124927813|NCT03084536|449366254|FG000|Overall Study|Determined to be ineligible|0|||
124927814|NCT03084536|449366255|FG001|Overall Study|Determined to be ineligible|0|||
124927815|NCT03084536|449366256|FG002|Overall Study|Determined to be ineligible|16|||
124927816|NCT03084536|449366254|FG000|Overall Study|Withdrawal by Subject|0|||
124927817|NCT03084536|449366255|FG001|Overall Study|Withdrawal by Subject|0|||
124927818|NCT03084536|449366256|FG002|Overall Study|Withdrawal by Subject|4|||
124927819|NCT03084536|449366254|FG000|Overall Study|Physician Decision|0|||
124927820|NCT03084536|449366255|FG001|Overall Study|Physician Decision|0|||
124927821|NCT03084536|449366256|FG002|Overall Study|Physician Decision|3|||
124927822|NCT03084536|449366254|FG000|Overall Study|Death|0|||
124927823|NCT03084536|449366255|FG001|Overall Study|Death|0|||
124927824|NCT03084536|449366256|FG002|Overall Study|Death|1|||
124927825|NCT03084536|449366254|FG000|Overall Study|Lost to Follow-up|0|||
124927826|NCT03084536|449366255|FG001|Overall Study|Lost to Follow-up|0|||
124927827|NCT03084536|449366256|FG002|Overall Study|Lost to Follow-up|1|||
124927828|NCT03084536|449366254|FG000|Overall Study|Protocol Violation|0|||
124927829|NCT03084536|449366255|FG001|Overall Study|Protocol Violation|0|||
124927830|NCT03084536|449366256|FG002|Overall Study|Protocol Violation|1|||
124927831|NCT03084536|449366254|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
124927832|NCT03084536|449366255|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
124927833|NCT03084536|449366256|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
124927834|NCT05704543|449366257|FG000|Overall Study|Withdrawal by Subject|1|||
124927835|NCT05704543|449366258|FG001|Overall Study|Withdrawal by Subject|1|||
124927836|NCT05704543|449366259|FG002|Overall Study|Withdrawal by Subject|0|||
124927837|NCT05704543|449366260|FG003|Overall Study|Withdrawal by Subject|2|||
124927838|NCT05704543|449366257|FG000|Overall Study|Lost to Follow-up|1|||
124927839|NCT05704543|449366258|FG001|Overall Study|Lost to Follow-up|2|||
124927840|NCT05704543|449366259|FG002|Overall Study|Lost to Follow-up|0|||
124927841|NCT05704543|449366260|FG003|Overall Study|Lost to Follow-up|0|||
124927842|NCT05073458|449366261|FG000|24-week Double-blind Period|Adverse Event|1|||
124927843|NCT05073458|449366262|FG001|24-week Double-blind Period|Adverse Event|0|||
124927844|NCT05073458|449366261|FG000|24-week Double-blind Period|Physician Decision|1|||
124927845|NCT05073458|449366262|FG001|24-week Double-blind Period|Physician Decision|0|||
124927846|NCT05073458|449366261|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
124927847|NCT05073458|449366262|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
124927848|NCT05073458|449366261|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
124927849|NCT05073458|449366262|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
124927850|NCT05073458|449366261|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
124927851|NCT05073458|449366262|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
124927852|NCT05073458|449366261|FG000|24-week Open-label Period|Adverse Event|1|||
124927853|NCT05073458|449366262|FG001|24-week Open-label Period|Adverse Event|2|||
124927854|NCT04830800|449366269|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
124927855|NCT04830800|449366270|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
124927856|NCT04830800|449366271|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
124927857|NCT04830800|449366272|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
124927858|NCT04830800|449366273|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
124927859|NCT03816332|449366276|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
124927860|NCT03816332|449366276|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
124927861|NCT03710603|449366277|FG000|Overall Study|Adverse Event|1|||
124927862|NCT03710603|449366278|FG001|Overall Study|Adverse Event|0|||
124927863|NCT03710603|449366277|FG000|Overall Study|Death|44|||
124927864|NCT03710603|449366278|FG001|Overall Study|Death|34|||
124927865|NCT03710603|449366277|FG000|Overall Study|Lost to Follow-up|3|||
124927866|NCT03710603|449366278|FG001|Overall Study|Lost to Follow-up|5|||
124927867|NCT03710603|449366277|FG000|Overall Study|Withdrawal by Subject|11|||
124927868|NCT03710603|449366278|FG001|Overall Study|Withdrawal by Subject|10|||
124927869|NCT01456949|449366279|FG000|Enrollment|PI death- incomplete data|6|||
124927870|NCT01456949|449366279|FG000|Enrollment|Death|1|||
124927871|NCT01456949|449366279|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
124927872|NCT01456949|449366279|FG000|Enrollment|Physician Decision|10|||
124927873|NCT01456949|449366279|FG000|Enrollment|Withdrawal by Subject|7|||
124927874|NCT01456949|449366279|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
124927875|NCT01456949|449366279|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
124927876|NCT01456949|449366279|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
124927877|NCT01456949|449366279|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
124927878|NCT01456949|449366279|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
124927879|NCT01456949|449366279|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
124927880|NCT01456949|449366279|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
124927881|NCT01456949|449366279|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
124927882|NCT03785964|449366280|FG000|Overall Study|Adverse Event|14|||
124927883|NCT03785964|449366281|FG001|Overall Study|Adverse Event|1|||
124927884|NCT03785964|449366280|FG000|Overall Study|Unqualified Clinical Progression|1|||
124927885|NCT03785964|449366281|FG001|Overall Study|Unqualified Clinical Progression|1|||
124927886|NCT03785964|449366280|FG000|Overall Study|Participant non-compliance|1|||
124927887|NCT03785964|449366281|FG001|Overall Study|Participant non-compliance|1|||
124927888|NCT03785964|449366280|FG000|Overall Study|Not treated|1|||
124927889|NCT03785964|449366281|FG001|Overall Study|Not treated|0|||
124927890|NCT03785964|449366280|FG000|Overall Study|Other reason|5|||
124927891|NCT03785964|449366281|FG001|Overall Study|Other reason|11|||
124927892|NCT03785964|449366280|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
124927893|NCT03785964|449366281|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
124927894|NCT04201262|449366292|FG000|Overall Study|Adverse Event|1|||
124927895|NCT04201262|449366293|FG001|Overall Study|Adverse Event|2|||
124927896|NCT04201262|449366292|FG000|Overall Study|Continuing in the study|57|||
124927897|NCT04201262|449366293|FG001|Overall Study|Continuing in the study|0|||
124927898|NCT04201262|449366292|FG000|Overall Study|Withdrawal by Subject|0|||
124927899|NCT04201262|449366293|FG001|Overall Study|Withdrawal by Subject|1|||
124927900|NCT05446168|449366296|FG000|Overall Study|Physician Decision|0|||
124927901|NCT05446168|449366297|FG001|Overall Study|Physician Decision|1|||
124927902|NCT03511664|449366301|FG000|Overall Study|Death|457|||
124927903|NCT03511664|449366302|FG001|Overall Study|Death|201|||
124927904|NCT03511664|449366303|FG002|Overall Study|Death|21|||
124927905|NCT03511664|449366301|FG000|Overall Study|Withdrew consent|40|||
124927906|NCT03511664|449366302|FG001|Overall Study|Withdrew consent|63|||
124927907|NCT03511664|449366303|FG002|Overall Study|Withdrew consent|3|||
124927908|NCT03511664|449366301|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
124927909|NCT03511664|449366302|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
124697670|NCT02991859|448513996|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
124927910|NCT03511664|449366303|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
124927911|NCT03511664|449366301|FG000|Overall Study|Lost to Follow-up|8|||
124927912|NCT03511664|449366302|FG001|Overall Study|Lost to Follow-up|5|||
124927913|NCT03511664|449366303|FG002|Overall Study|Lost to Follow-up|0|||
124927914|NCT03511664|449366301|FG000|Overall Study|Physician Decision|2|||
124927915|NCT03511664|449366302|FG001|Overall Study|Physician Decision|1|||
124927916|NCT03511664|449366303|FG002|Overall Study|Physician Decision|0|||
124927917|NCT03511664|449366301|FG000|Overall Study|Patient non-compliance|1|||
124927918|NCT03511664|449366302|FG001|Overall Study|Patient non-compliance|0|||
124927919|NCT03511664|449366303|FG002|Overall Study|Patient non-compliance|0|||
124927920|NCT04577963|449366310|FG000|Part 2|Death|0|||
124927921|NCT04577963|449366311|FG001|Part 2|Death|1|||
124927922|NCT04577963|449366312|FG002|Part 2|Death|8|||
124927923|NCT04577963|449366313|FG003|Part 2|Death|0|||
124927924|NCT04577963|449366314|FG004|Part 2|Death|20|||
124927925|NCT04577963|449366310|FG000|Part 2|Lost to Follow-up|0|||
124927926|NCT04577963|449366311|FG001|Part 2|Lost to Follow-up|0|||
124927927|NCT04577963|449366312|FG002|Part 2|Lost to Follow-up|0|||
124927928|NCT04577963|449366313|FG003|Part 2|Lost to Follow-up|0|||
124927929|NCT04577963|449366314|FG004|Part 2|Lost to Follow-up|2|||
124927930|NCT04577963|449366310|FG000|Part 2|Withdrawal by Subject|0|||
124927931|NCT04577963|449366311|FG001|Part 2|Withdrawal by Subject|0|||
124927932|NCT04577963|449366312|FG002|Part 2|Withdrawal by Subject|0|||
124927933|NCT04577963|449366313|FG003|Part 2|Withdrawal by Subject|0|||
124927934|NCT04577963|449366314|FG004|Part 2|Withdrawal by Subject|10|||
124927935|NCT04577963|449366310|FG000|Part 2|Progressive disease|0|||
124927936|NCT04577963|449366311|FG001|Part 2|Progressive disease|0|||
124927937|NCT04577963|449366312|FG002|Part 2|Progressive disease|0|||
124927938|NCT04577963|449366313|FG003|Part 2|Progressive disease|0|||
124927939|NCT04577963|449366314|FG004|Part 2|Progressive disease|2|||
124927940|NCT04577963|449366310|FG000|Part 2|Investigator decision|0|||
124927941|NCT04577963|449366311|FG001|Part 2|Investigator decision|0|||
124927942|NCT04577963|449366312|FG002|Part 2|Investigator decision|0|||
124927943|NCT04577963|449366313|FG003|Part 2|Investigator decision|0|||
124927944|NCT04577963|449366314|FG004|Part 2|Investigator decision|1|||
124927945|NCT04577963|449366310|FG000|Part 2|Sponsor terminated study|0|||
124927946|NCT04577963|449366311|FG001|Part 2|Sponsor terminated study|0|||
124927947|NCT04577963|449366312|FG002|Part 2|Sponsor terminated study|3|||
124927948|NCT04577963|449366313|FG003|Part 2|Sponsor terminated study|1|||
124927949|NCT04577963|449366314|FG004|Part 2|Sponsor terminated study|4|||
124927950|NCT04857723|449366317|FG000|Overall Study|Withdrawal by Subject|2|||
124927951|NCT03221426|449366318|FG000|Overall Study|Ongoing in study|212|||
124927952|NCT03221426|449366319|FG001|Overall Study|Ongoing in study|193|||
124927953|NCT03221426|449366320|FG002|Overall Study|Ongoing in study|61|||
124927954|NCT03221426|449366321|FG003|Overall Study|Ongoing in study|55|||
124927955|NCT03221426|449366318|FG000|Overall Study|Withdrawal by Subject|12|||
124927956|NCT03221426|449366319|FG001|Overall Study|Withdrawal by Subject|4|||
124927957|NCT03221426|449366320|FG002|Overall Study|Withdrawal by Subject|2|||
124927958|NCT03221426|449366321|FG003|Overall Study|Withdrawal by Subject|3|||
124927959|NCT03221426|449366318|FG000|Overall Study|Lost to Follow-up|4|||
124927960|NCT03221426|449366319|FG001|Overall Study|Lost to Follow-up|1|||
124927961|NCT03221426|449366320|FG002|Overall Study|Lost to Follow-up|1|||
124927962|NCT03221426|449366321|FG003|Overall Study|Lost to Follow-up|0|||
124927963|NCT03221426|449366318|FG000|Overall Study|Death|174|||
124927964|NCT03221426|449366319|FG001|Overall Study|Death|204|||
124927965|NCT03221426|449366320|FG002|Overall Study|Death|36|||
124927966|NCT03221426|449366321|FG003|Overall Study|Death|45|||
124927967|NCT03257410|449368237|FG000|Overall Study|Adverse Event|2|||
124927968|NCT03257410|449368238|FG001|Overall Study|Adverse Event|3|||
124927969|NCT03257410|449368237|FG000|Overall Study|Protocol Violation|1|||
124927970|NCT03257410|449368238|FG001|Overall Study|Protocol Violation|2|||
124927971|NCT03257410|449368237|FG000|Overall Study|Lost to Follow-up|1|||
124927972|NCT03257410|449368238|FG001|Overall Study|Lost to Follow-up|0|||
124927973|NCT03257410|449368237|FG000|Overall Study|Withdrawal by Subject|1|||
124927974|NCT03257410|449368238|FG001|Overall Study|Withdrawal by Subject|2|||
124927975|NCT03257410|449368237|FG000|Overall Study|Physician Decision|1|||
124927976|NCT03257410|449368238|FG001|Overall Study|Physician Decision|1|||
124927977|NCT03257410|449368237|FG000|Overall Study|Renal transplantation|2|||
124927978|NCT03257410|449368238|FG001|Overall Study|Renal transplantation|0|||
124927979|NCT03257410|449368237|FG000|Overall Study|Switch to peritoneal dialysis|1|||
124927980|NCT03257410|449368238|FG001|Overall Study|Switch to peritoneal dialysis|0|||
124927981|NCT03257410|449368237|FG000|Overall Study|Death|3|||
124927982|NCT03257410|449368238|FG001|Overall Study|Death|2|||
124927983|NCT03257410|449368237|FG000|Overall Study|Change to another dialysis center|2|||
124927984|NCT03257410|449368238|FG001|Overall Study|Change to another dialysis center|2|||
124927985|NCT03257410|449368237|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
124927986|NCT03257410|449368238|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
124927987|NCT03257410|449368237|FG000|Overall Study|Miscellaneous|2|||
124927988|NCT03257410|449368238|FG001|Overall Study|Miscellaneous|2|||
124927989|NCT03257410|449368237|FG000|Overall Study|Other|0|||
124927990|NCT03257410|449368238|FG001|Overall Study|Other|1|||
124697671|NCT02991859|448513997|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
124697672|NCT02991859|448513998|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
124927991|NCT02561247|449368239|FG000|Overall Study|Protocol Violation|1|||
124927992|NCT02561247|449368239|FG000|Overall Study|Withdrawal by Subject|1|||
124927993|NCT02561247|449368239|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
124927994|NCT02276885|449368240|FG000|Overall Study|Withdrawal by Subject|2|||
124927995|NCT02276885|449368241|FG001|Overall Study|Withdrawal by Subject|0|||
124927996|NCT02276885|449368240|FG000|Overall Study|Lost to Follow-up|5|||
124927997|NCT02276885|449368241|FG001|Overall Study|Lost to Follow-up|2|||
124927998|NCT04171141|449368244|FG000|Overall Study|Adverse Event|0|||
124697673|NCT02991859|448513999|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
124927999|NCT04171141|449368245|FG001|Overall Study|Adverse Event|0|||
124928000|NCT04171141|449368246|FG002|Overall Study|Adverse Event|2|||
124928001|NCT04171141|449368247|FG003|Overall Study|Adverse Event|0|||
124928002|NCT04171141|449368248|FG004|Overall Study|Adverse Event|0|||
124928003|NCT04171141|449368249|FG005|Overall Study|Adverse Event|0|||
124928004|NCT04171141|449368250|FG006|Overall Study|Adverse Event|0|||
124928005|NCT04171141|449368251|FG007|Overall Study|Adverse Event|0|||
124928006|NCT04171141|449368252|FG008|Overall Study|Adverse Event|0|||
124928007|NCT04171141|449368253|FG009|Overall Study|Adverse Event|0|||
124928008|NCT04171141|449368254|FG010|Overall Study|Adverse Event|0|||
124928009|NCT04171141|449368255|FG011|Overall Study|Adverse Event|0|||
124928010|NCT04171141|449368256|FG012|Overall Study|Adverse Event|0|||
124928011|NCT04171141|449368257|FG013|Overall Study|Adverse Event|2|||
124928012|NCT04171141|449368258|FG014|Overall Study|Adverse Event|0|||
124928013|NCT04171141|449368259|FG015|Overall Study|Adverse Event|0|||
124928014|NCT04171141|449368244|FG000|Overall Study|Physician Decision|0|||
124928015|NCT04171141|449368245|FG001|Overall Study|Physician Decision|0|||
124928016|NCT04171141|449368246|FG002|Overall Study|Physician Decision|0|||
124928017|NCT04171141|449368247|FG003|Overall Study|Physician Decision|0|||
124928018|NCT04171141|449368248|FG004|Overall Study|Physician Decision|1|||
124928019|NCT04171141|449368249|FG005|Overall Study|Physician Decision|0|||
124928020|NCT04171141|449368250|FG006|Overall Study|Physician Decision|0|||
124928021|NCT04171141|449368251|FG007|Overall Study|Physician Decision|0|||
124928022|NCT04171141|449368252|FG008|Overall Study|Physician Decision|0|||
124928023|NCT04171141|449368253|FG009|Overall Study|Physician Decision|0|||
124928024|NCT04171141|449368254|FG010|Overall Study|Physician Decision|0|||
124928025|NCT04171141|449368255|FG011|Overall Study|Physician Decision|0|||
124928026|NCT04171141|449368256|FG012|Overall Study|Physician Decision|0|||
124928027|NCT04171141|449368257|FG013|Overall Study|Physician Decision|0|||
124928028|NCT04171141|449368258|FG014|Overall Study|Physician Decision|0|||
124928029|NCT04171141|449368259|FG015|Overall Study|Physician Decision|1|||
124928030|NCT04171141|449368244|FG000|Overall Study|Progressive disease|2|||
124928031|NCT04171141|449368245|FG001|Overall Study|Progressive disease|3|||
124928032|NCT04171141|449368246|FG002|Overall Study|Progressive disease|4|||
124928033|NCT04171141|449368247|FG003|Overall Study|Progressive disease|7|||
124928034|NCT04171141|449368248|FG004|Overall Study|Progressive disease|1|||
124928035|NCT04171141|449368249|FG005|Overall Study|Progressive disease|8|||
124928036|NCT04171141|449368250|FG006|Overall Study|Progressive disease|4|||
124928037|NCT04171141|449368251|FG007|Overall Study|Progressive disease|6|||
124928038|NCT04171141|449368252|FG008|Overall Study|Progressive disease|7|||
124928039|NCT04171141|449368253|FG009|Overall Study|Progressive disease|3|||
124928040|NCT04171141|449368254|FG010|Overall Study|Progressive disease|4|||
124928041|NCT04171141|449368255|FG011|Overall Study|Progressive disease|3|||
124928042|NCT04171141|449368256|FG012|Overall Study|Progressive disease|4|||
124928043|NCT04171141|449368257|FG013|Overall Study|Progressive disease|2|||
124928044|NCT04171141|449368258|FG014|Overall Study|Progressive disease|4|||
124928045|NCT04171141|449368259|FG015|Overall Study|Progressive disease|1|||
124928046|NCT04171141|449368244|FG000|Overall Study|Withdrawal by Subject|0|||
124928047|NCT04171141|449368245|FG001|Overall Study|Withdrawal by Subject|0|||
124928048|NCT04171141|449368246|FG002|Overall Study|Withdrawal by Subject|0|||
124928049|NCT04171141|449368247|FG003|Overall Study|Withdrawal by Subject|1|||
124928050|NCT04171141|449368248|FG004|Overall Study|Withdrawal by Subject|0|||
124928051|NCT04171141|449368249|FG005|Overall Study|Withdrawal by Subject|0|||
124928052|NCT04171141|449368250|FG006|Overall Study|Withdrawal by Subject|1|||
124928053|NCT04171141|449368251|FG007|Overall Study|Withdrawal by Subject|0|||
124928054|NCT04171141|449368252|FG008|Overall Study|Withdrawal by Subject|0|||
124928055|NCT04171141|449368253|FG009|Overall Study|Withdrawal by Subject|1|||
124928056|NCT04171141|449368254|FG010|Overall Study|Withdrawal by Subject|0|||
124928057|NCT04171141|449368255|FG011|Overall Study|Withdrawal by Subject|0|||
124928058|NCT04171141|449368256|FG012|Overall Study|Withdrawal by Subject|0|||
124928059|NCT04171141|449368257|FG013|Overall Study|Withdrawal by Subject|0|||
124928060|NCT04171141|449368258|FG014|Overall Study|Withdrawal by Subject|0|||
124928061|NCT04171141|449368259|FG015|Overall Study|Withdrawal by Subject|0|||
124928062|NCT04171141|449368244|FG000|Overall Study|Global deterioration of health status|0|||
124928063|NCT04171141|449368245|FG001|Overall Study|Global deterioration of health status|0|||
124928064|NCT04171141|449368246|FG002|Overall Study|Global deterioration of health status|0|||
124928065|NCT04171141|449368247|FG003|Overall Study|Global deterioration of health status|1|||
124928066|NCT04171141|449368248|FG004|Overall Study|Global deterioration of health status|0|||
124928067|NCT04171141|449368249|FG005|Overall Study|Global deterioration of health status|2|||
124928068|NCT04171141|449368250|FG006|Overall Study|Global deterioration of health status|1|||
124928069|NCT04171141|449368251|FG007|Overall Study|Global deterioration of health status|0|||
124928070|NCT04171141|449368252|FG008|Overall Study|Global deterioration of health status|1|||
124928071|NCT04171141|449368253|FG009|Overall Study|Global deterioration of health status|0|||
124928072|NCT04171141|449368254|FG010|Overall Study|Global deterioration of health status|0|||
124928073|NCT04171141|449368255|FG011|Overall Study|Global deterioration of health status|0|||
124928074|NCT04171141|449368256|FG012|Overall Study|Global deterioration of health status|0|||
124928075|NCT04171141|449368257|FG013|Overall Study|Global deterioration of health status|0|||
124928076|NCT04171141|449368258|FG014|Overall Study|Global deterioration of health status|1|||
124928077|NCT04171141|449368259|FG015|Overall Study|Global deterioration of health status|1|||
124928078|NCT04858451|449368262|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
124928079|NCT04858451|449368263|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
124928080|NCT04858451|449368264|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
124928081|NCT04858451|449368265|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
124928082|NCT04858451|449368266|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
124928083|NCT04858451|449368267|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
124928084|NCT04858451|449368268|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
124928085|NCT04858451|449368269|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
124928086|NCT04858451|449368270|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
124928087|NCT04858451|449368262|FG000|Part 2|Discontinued|0|||
124928088|NCT04858451|449368263|FG001|Part 2|Discontinued|0|||
124928089|NCT04858451|449368264|FG002|Part 2|Discontinued|0|||
124928090|NCT04858451|449368265|FG003|Part 2|Discontinued|0|||
124928091|NCT04858451|449368266|FG004|Part 2|Discontinued|0|||
124928092|NCT04858451|449368267|FG005|Part 2|Discontinued|0|||
124928093|NCT04858451|449368268|FG006|Part 2|Discontinued|0|||
124928094|NCT04858451|449368269|FG007|Part 2|Discontinued|0|||
124928095|NCT04858451|449368270|FG008|Part 2|Discontinued|63|||
124928096|NCT03314454|449368271|FG000|Overall Study|Protocol Violation|1|||
124928097|NCT04314713|449368273|FG000|Overall Study|Lost to Follow-up|0|||
124928098|NCT04314713|449368274|FG001|Overall Study|Lost to Follow-up|0|||
124928099|NCT04314713|449368275|FG002|Overall Study|Lost to Follow-up|0|||
124928100|NCT04314713|449368276|FG003|Overall Study|Lost to Follow-up|1|||
124928101|NCT04314713|449368277|FG004|Overall Study|Lost to Follow-up|0|||
124928102|NCT04314713|449368278|FG005|Overall Study|Lost to Follow-up|0|||
124928103|NCT02927236|449368281|FG000|Characterization Phase|Physician Decision|0|||
124928104|NCT02927236|449368282|FG001|Characterization Phase|Physician Decision|3|||
124928105|NCT02927236|449368283|FG002|Characterization Phase|Physician Decision|0|||
124928106|NCT02927236|449368284|FG003|Characterization Phase|Physician Decision|2|||
124928107|NCT02927236|449368281|FG000|Characterization Phase|Lost to Follow-up|0|||
124928108|NCT02927236|449368282|FG001|Characterization Phase|Lost to Follow-up|0|||
124928109|NCT02927236|449368283|FG002|Characterization Phase|Lost to Follow-up|0|||
124928110|NCT02927236|449368284|FG003|Characterization Phase|Lost to Follow-up|3|||
124928111|NCT02927236|449368281|FG000|Characterization Phase|Withdrawal by Subject|1|||
124928112|NCT02927236|449368282|FG001|Characterization Phase|Withdrawal by Subject|0|||
124928113|NCT02927236|449368283|FG002|Characterization Phase|Withdrawal by Subject|0|||
124928114|NCT02927236|449368284|FG003|Characterization Phase|Withdrawal by Subject|1|||
124928115|NCT02927236|449368281|FG000|Treatment Phase|Adverse Event|1|||
124928116|NCT02927236|449368282|FG001|Treatment Phase|Adverse Event|0|||
124928117|NCT02927236|449368283|FG002|Treatment Phase|Adverse Event|1|||
124928118|NCT02927236|449368284|FG003|Treatment Phase|Adverse Event|1|||
124928119|NCT02927236|449368281|FG000|Treatment Phase|Protocol Violation|3|||
124928120|NCT02927236|449368282|FG001|Treatment Phase|Protocol Violation|0|||
124928121|NCT02927236|449368283|FG002|Treatment Phase|Protocol Violation|0|||
124928122|NCT02927236|449368284|FG003|Treatment Phase|Protocol Violation|1|||
124928123|NCT02927236|449368281|FG000|Treatment Phase|Lost to Follow-up|1|||
124928124|NCT02927236|449368282|FG001|Treatment Phase|Lost to Follow-up|0|||
124928125|NCT02927236|449368283|FG002|Treatment Phase|Lost to Follow-up|0|||
124928126|NCT02927236|449368284|FG003|Treatment Phase|Lost to Follow-up|0|||
124928127|NCT02927236|449368281|FG000|Follow-up Phase|Lost to Follow-up|1|||
124928128|NCT02927236|449368282|FG001|Follow-up Phase|Lost to Follow-up|0|||
124928129|NCT02927236|449368283|FG002|Follow-up Phase|Lost to Follow-up|1|||
124928130|NCT02927236|449368284|FG003|Follow-up Phase|Lost to Follow-up|0|||
124928131|NCT03656510|449368286|FG000|Overall Study|Lost to Follow-up|1|||
124928132|NCT03656510|449368287|FG001|Overall Study|Lost to Follow-up|0|||
124928133|NCT03656510|449368288|FG002|Overall Study|Lost to Follow-up|0|||
124928134|NCT03656510|449368289|FG003|Overall Study|Lost to Follow-up|0|||
124928135|NCT03656510|449368290|FG004|Overall Study|Lost to Follow-up|0|||
124928136|NCT03656510|449368291|FG005|Overall Study|Lost to Follow-up|0|||
124928137|NCT03656510|449368286|FG000|Overall Study|Withdrawal by Subject|1|||
124928138|NCT03656510|449368287|FG001|Overall Study|Withdrawal by Subject|1|||
124928139|NCT03656510|449368288|FG002|Overall Study|Withdrawal by Subject|0|||
124928140|NCT03656510|449368289|FG003|Overall Study|Withdrawal by Subject|1|||
124928141|NCT03656510|449368290|FG004|Overall Study|Withdrawal by Subject|0|||
124928142|NCT03656510|449368291|FG005|Overall Study|Withdrawal by Subject|0|||
124928143|NCT05496231|449368295|FG000|Overall Study|Adverse Event|1|||
124928144|NCT05496231|449368296|FG001|Overall Study|Adverse Event|1|||
124928145|NCT05496231|449368297|FG002|Overall Study|Adverse Event|0|||
124454751|NCT00326209|447625370|FG000|Overall Study|Prohibited medication use|1|||
124454752|NCT00326209|447625370|FG000|Overall Study|Violation of entry criteria|1|||
124454753|NCT00326209|447625370|FG000|Overall Study|Withdrawn in error|1|||
124454754|NCT00326209|447625370|FG000|Overall Study|Pregnancy|1|||
124454755|NCT00714285|447625371|FG000|Overall Study|Lost to Follow-up|0|||
124928146|NCT05496231|449368298|FG003|Overall Study|Adverse Event|4|||
124928147|NCT05496231|449368295|FG000|Overall Study|Withdrawal by Subject|5|||
124928148|NCT05496231|449368296|FG001|Overall Study|Withdrawal by Subject|5|||
124928149|NCT05496231|449368297|FG002|Overall Study|Withdrawal by Subject|4|||
124928150|NCT05496231|449368298|FG003|Overall Study|Withdrawal by Subject|11|||
124928151|NCT05496231|449368295|FG000|Overall Study|Migrated/moved from the study area|3|||
124928152|NCT05496231|449368296|FG001|Overall Study|Migrated/moved from the study area|5|||
124762995|NCT00791388|448757870|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
124762996|NCT00791388|448757871|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
124928153|NCT05496231|449368297|FG002|Overall Study|Migrated/moved from the study area|3|||
124928154|NCT05496231|449368298|FG003|Overall Study|Migrated/moved from the study area|3|||
124928155|NCT05496231|449368295|FG000|Overall Study|Lost to Follow-up|13|||
124928156|NCT05496231|449368296|FG001|Overall Study|Lost to Follow-up|6|||
124928157|NCT05496231|449368297|FG002|Overall Study|Lost to Follow-up|11|||
124928158|NCT05496231|449368298|FG003|Overall Study|Lost to Follow-up|6|||
124928159|NCT05496231|449368295|FG000|Overall Study|Other|9|||
124928160|NCT05496231|449368296|FG001|Overall Study|Other|7|||
124928161|NCT05496231|449368297|FG002|Overall Study|Other|7|||
124928162|NCT05496231|449368298|FG003|Overall Study|Other|8|||
124928163|NCT06232590|449368306|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
124928164|NCT06232590|449368307|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
124928165|NCT05940194|449368308|FG000|Overall Study|Adverse Event|0|||
124928166|NCT05940194|449368309|FG001|Overall Study|Adverse Event|1|||
124928167|NCT05940194|449368310|FG002|Overall Study|Adverse Event|0|||
124928168|NCT05940194|449368308|FG000|Overall Study|Migrated/Moved from the study area|2|||
124928169|NCT05940194|449368309|FG001|Overall Study|Migrated/Moved from the study area|2|||
124928170|NCT05940194|449368310|FG002|Overall Study|Migrated/Moved from the study area|4|||
124928171|NCT03085810|449368311|FG000|Main Study|Withdrawal by Subject|77|||
124928172|NCT03085810|449368312|FG001|Main Study|Withdrawal by Subject|0|||
124928173|NCT03085810|449368313|FG002|Main Study|Withdrawal by Subject|0|||
124928174|NCT03085810|449368311|FG000|Main Study|Terminated By Sponsor|14|||
124928175|NCT03085810|449368312|FG001|Main Study|Terminated By Sponsor|0|||
124928176|NCT03085810|449368313|FG002|Main Study|Terminated By Sponsor|0|||
124928177|NCT03085810|449368311|FG000|Main Study|Protocol Violation|15|||
124928178|NCT03085810|449368312|FG001|Main Study|Protocol Violation|0|||
124928179|NCT03085810|449368313|FG002|Main Study|Protocol Violation|0|||
124928180|NCT03085810|449368311|FG000|Main Study|Physician Decision|13|||
124928181|NCT03085810|449368312|FG001|Main Study|Physician Decision|0|||
124928182|NCT03085810|449368313|FG002|Main Study|Physician Decision|0|||
124928183|NCT03085810|449368311|FG000|Main Study|Lost to Follow-up|17|||
124928184|NCT03085810|449368312|FG001|Main Study|Lost to Follow-up|0|||
124928185|NCT03085810|449368313|FG002|Main Study|Lost to Follow-up|0|||
124928186|NCT03085810|449368311|FG000|Main Study|Adverse Event|25|||
124928187|NCT03085810|449368312|FG001|Main Study|Adverse Event|0|||
124928188|NCT03085810|449368313|FG002|Main Study|Adverse Event|0|||
124928189|NCT03085810|449368311|FG000|Main Study|Pregnancy|7|||
124928190|NCT03085810|449368312|FG001|Main Study|Pregnancy|0|||
124928191|NCT03085810|449368313|FG002|Main Study|Pregnancy|0|||
124928192|NCT03085810|449368311|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
124928193|NCT03085810|449368312|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
124928194|NCT03085810|449368313|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
124928195|NCT03085810|449368311|FG000|Main Study|Lack of Efficacy|10|||
124928196|NCT03085810|449368312|FG001|Main Study|Lack of Efficacy|0|||
124928197|NCT03085810|449368313|FG002|Main Study|Lack of Efficacy|0|||
124928198|NCT03085810|449368311|FG000|Main Study|Death|12|||
124928199|NCT03085810|449368312|FG001|Main Study|Death|0|||
124928200|NCT03085810|449368313|FG002|Main Study|Death|0|||
124928201|NCT03085810|449368311|FG000|Main Study|Disease progression|1|||
124928202|NCT03085810|449368312|FG001|Main Study|Disease progression|0|||
124928203|NCT03085810|449368313|FG002|Main Study|Disease progression|0|||
124928204|NCT03085810|449368311|FG000|Main Study|Site Closure|3|||
124928205|NCT03085810|449368312|FG001|Main Study|Site Closure|0|||
124928206|NCT03085810|449368313|FG002|Main Study|Site Closure|0|||
124928207|NCT03085810|449368311|FG000|Main Study|Planned pregnancy|17|||
124928208|NCT03085810|449368312|FG001|Main Study|Planned pregnancy|0|||
124928209|NCT03085810|449368313|FG002|Main Study|Planned pregnancy|0|||
124928210|NCT03085810|449368311|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
124928211|NCT03085810|449368312|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
124928212|NCT03085810|449368313|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
124928213|NCT03085810|449368311|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
124928214|NCT03085810|449368312|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
124928215|NCT03085810|449368313|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
124928216|NCT03085810|449368311|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
124928217|NCT03085810|449368312|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
124928218|NCT03085810|449368313|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
124928219|NCT03085810|449368311|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
124928220|NCT03085810|449368312|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
124928221|NCT03085810|449368313|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
124928222|NCT01959607|449368316|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
124928223|NCT01959607|449368317|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
124928224|NCT01959607|449368318|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
124928225|NCT01959607|449368319|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
124762997|NCT00791388|448757872|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
124928226|NCT03235544|449368324|FG000|Overall Study|Death|11|||
124928227|NCT03235544|449368325|FG001|Overall Study|Death|31|||
124928228|NCT03235544|449368326|FG002|Overall Study|Death|19|||
124928229|NCT03235544|449368327|FG003|Overall Study|Death|34|||
124928230|NCT03235544|449368324|FG000|Overall Study|Lost to Follow-up|0|||
124928231|NCT03235544|449368325|FG001|Overall Study|Lost to Follow-up|1|||
124928232|NCT03235544|449368326|FG002|Overall Study|Lost to Follow-up|1|||
124928233|NCT03235544|449368327|FG003|Overall Study|Lost to Follow-up|1|||
124928234|NCT03235544|449368324|FG000|Overall Study|Withdrawal by Subject|0|||
124928235|NCT03235544|449368325|FG001|Overall Study|Withdrawal by Subject|3|||
124928236|NCT03235544|449368326|FG002|Overall Study|Withdrawal by Subject|1|||
124928237|NCT03235544|449368327|FG003|Overall Study|Withdrawal by Subject|5|||
124928238|NCT03235544|449368324|FG000|Overall Study|Disease Progression|0|||
124928239|NCT03235544|449368325|FG001|Overall Study|Disease Progression|1|||
124928240|NCT03235544|449368326|FG002|Overall Study|Disease Progression|0|||
124928241|NCT03235544|449368327|FG003|Overall Study|Disease Progression|2|||
124928242|NCT03235544|449368324|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
124928243|NCT03235544|449368325|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
124928244|NCT03235544|449368326|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
124928245|NCT03235544|449368327|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
124928246|NCT03235544|449368324|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
124928247|NCT03235544|449368325|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
124928248|NCT03235544|449368326|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
124928249|NCT03235544|449368327|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
124928250|NCT00950742|449368328|FG000|Overall Study|Other Adverse Event|1|||
124928251|NCT00950742|449368329|FG001|Overall Study|Other Adverse Event|0|||
124697674|NCT02991859|448514000|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
124697675|NCT02991859|448514001|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
124697676|NCT02991859|448514002|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
124697677|NCT02991859|448513986|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
124762998|NCT00791388|448757873|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
124762999|NCT00791388|448757874|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
124763000|NCT00791388|448757870|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
124763001|NCT00791388|448757871|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
124763002|NCT00791388|448757872|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
124763003|NCT00791388|448757873|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
124763004|NCT00791388|448757874|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
124697678|NCT02991859|448513987|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
124697679|NCT02991859|448513988|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
124763005|NCT02995980|448757875|FG000|Overall Study|Lost to Follow-up|14|||
124763006|NCT00657540|448757877|FG000|Overall Study|Lost to Follow-up|1|||
124763007|NCT00657540|448757878|FG001|Overall Study|Lost to Follow-up|4|||
124697680|NCT02991859|448513989|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
124697681|NCT02991859|448513990|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
124697682|NCT02991859|448513991|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
124697683|NCT02991859|448513992|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
124697684|NCT02991859|448513993|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
124697685|NCT02991859|448513994|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
124697686|NCT02991859|448513995|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
124697687|NCT02991859|448513996|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
124697688|NCT02991859|448513997|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
124697689|NCT02991859|448513998|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
124697690|NCT02991859|448513999|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
124697691|NCT02991859|448514000|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
124697692|NCT02991859|448514001|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
124697693|NCT02991859|448514002|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
124697694|NCT01065766|448514003|FG000|Overall Study|Assessed before the contracted date|1|||
124697695|NCT01065766|448514003|FG000|Overall Study|Contraindication to administration|6|||
124697696|NCT01065766|448514003|FG000|Overall Study|Violated dosage/administration|25|||
124697697|NCT04223687|448514010|FG000|Overall Study|Missing primary outcome|1|||
124697698|NCT04223687|448514011|FG001|Overall Study|Missing primary outcome|0|||
124697699|NCT00425854|448514012|FG000|Overall Study|Progressive Disease|19|||
124697700|NCT00425854|448514013|FG001|Overall Study|Progressive Disease|12|||
124928252|NCT00950742|449368328|FG000|Overall Study|Withdrawal by Subject|3|||
124928253|NCT00950742|449368329|FG001|Overall Study|Withdrawal by Subject|0|||
124697701|NCT00425854|448514012|FG000|Overall Study|Dose reduction toxicity AE|8|||
124697702|NCT00425854|448514013|FG001|Overall Study|Dose reduction toxicity AE|7|||
124697703|NCT00425854|448514012|FG000|Overall Study|Other Adverse Event|2|||
124697704|NCT00425854|448514013|FG001|Overall Study|Other Adverse Event|2|||
124697705|NCT05652140|448514019|FG000|Overall Study|Lost to Follow-up|7|||
124697706|NCT05652140|448514020|FG001|Overall Study|Lost to Follow-up|16|||
124697707|NCT05652140|448514021|FG002|Overall Study|Lost to Follow-up|22|||
124697708|NCT05652140|448514022|FG003|Overall Study|Lost to Follow-up|31|||
124697709|NCT06048705|448514023|FG000|Overall Study|Physician Decision|1|||
124697710|NCT06048705|448514024|FG001|Overall Study|Physician Decision|0|||
124697711|NCT06048705|448514025|FG002|Overall Study|Physician Decision|0|||
124697712|NCT06048705|448514023|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
124697713|NCT06048705|448514024|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
124697714|NCT06048705|448514025|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
124697715|NCT06048705|448514023|FG000|Overall Study|Death prior to lymphodepletion|0|||
124697716|NCT06048705|448514024|FG001|Overall Study|Death prior to lymphodepletion|0|||
124697717|NCT06048705|448514025|FG002|Overall Study|Death prior to lymphodepletion|1|||
124697718|NCT01016015|448514026|FG000|Overall Study|Not Treated|3|||
124697719|NCT01016015|448514026|FG000|Overall Study|Withdrawal by Subject|1|||
124697720|NCT01016015|448514026|FG000|Overall Study|Adverse Event|15|||
124697721|NCT01602666|448514027|FG000|Induction Chemotherapy|Death|2|||
124697722|NCT01602666|448514028|FG001|Induction Chemotherapy|Death|1|||
124697723|NCT01602666|448514027|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
124697724|NCT01602666|448514028|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
124697725|NCT01602666|448514027|FG000|Induction Chemotherapy|Physician Decision|12|||
124697726|NCT01602666|448514028|FG001|Induction Chemotherapy|Physician Decision|5|||
124697727|NCT01602666|448514027|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
124697728|NCT01602666|448514028|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
124697729|NCT01602666|448514027|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
124697730|NCT01602666|448514028|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
124697731|NCT01602666|448514027|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
124697732|NCT01602666|448514028|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
124697733|NCT01602666|448514027|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
124697734|NCT01602666|448514028|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
124697735|NCT01602666|448514027|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
124697736|NCT01602666|448514028|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
124697737|NCT01602666|448514027|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
124697738|NCT01602666|448514028|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
124697739|NCT01602666|448514027|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
124697740|NCT01602666|448514028|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
124697741|NCT01602666|448514027|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
124697742|NCT01602666|448514028|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
124697743|NCT03069937|448514033|FG000|Overall Study|Second primary malignancy noted|1|||
124697744|NCT03624036|448514034|FG000|Overall Study|Death|2|||
124697745|NCT03624036|448514035|FG001|Overall Study|Death|3|||
124697746|NCT03624036|448514036|FG002|Overall Study|Death|0|||
124697747|NCT03624036|448514037|FG003|Overall Study|Death|1|||
124697748|NCT03624036|448514034|FG000|Overall Study|Withdrawal by Subject|1|||
124697749|NCT03624036|448514035|FG001|Overall Study|Withdrawal by Subject|0|||
124697750|NCT03624036|448514036|FG002|Overall Study|Withdrawal by Subject|1|||
124697751|NCT03624036|448514037|FG003|Overall Study|Withdrawal by Subject|0|||
124697752|NCT03624036|448514034|FG000|Overall Study|Enrolled but Never Treated|1|||
124697753|NCT03624036|448514035|FG001|Overall Study|Enrolled but Never Treated|0|||
124697754|NCT03624036|448514036|FG002|Overall Study|Enrolled but Never Treated|0|||
124697755|NCT03624036|448514037|FG003|Overall Study|Enrolled but Never Treated|0|||
124697756|NCT03624036|448514034|FG000|Overall Study|Reason not Specified|3|||
124697757|NCT03624036|448514035|FG001|Overall Study|Reason not Specified|0|||
124697758|NCT03624036|448514036|FG002|Overall Study|Reason not Specified|2|||
124697759|NCT03624036|448514037|FG003|Overall Study|Reason not Specified|2|||
124697760|NCT02774278|448514038|FG000|Overall Study|Lack of Efficacy|199|||
124454756|NCT00714285|447625372|FG001|Overall Study|Lost to Follow-up|2|||
124697761|NCT02774278|448514038|FG000|Overall Study|Death|29|||
124697762|NCT02774278|448514038|FG000|Overall Study|Adverse event/intercurrent illness|16|||
124697763|NCT02774278|448514038|FG000|Overall Study|Refused treatment/did not cooperate|9|||
124697764|NCT02774278|448514038|FG000|Overall Study|Administrative reasons|6|||
124454757|NCT00714285|447625373|FG002|Overall Study|Lost to Follow-up|0|||
124697765|NCT02774278|448514038|FG000|Overall Study|Withdrawal by Subject|3|||
124697766|NCT02774278|448514038|FG000|Overall Study|Protocol Violation|2|||
124697767|NCT00127933|448514041|FG000|Overall Study|Randomized but not dosed|1|||
124697768|NCT00127933|448514042|FG001|Overall Study|Randomized but not dosed|0|||
124697769|NCT01783938|448514044|FG000|Overall Study|Disease Progression|18|||
124697770|NCT01783938|448514045|FG001|Overall Study|Disease Progression|41|||
124697771|NCT01783938|448514044|FG000|Overall Study|Study Drug Toxicity|27|||
124697772|NCT01783938|448514045|FG001|Overall Study|Study Drug Toxicity|14|||
124697773|NCT01783938|448514044|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
124697774|NCT01783938|448514045|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
124697775|NCT01783938|448514044|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
124697776|NCT01783938|448514045|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
124697777|NCT01783938|448514044|FG000|Overall Study|Participant Withdrew Consent|2|||
124697778|NCT01783938|448514045|FG001|Overall Study|Participant Withdrew Consent|0|||
124697779|NCT01783938|448514044|FG000|Overall Study|Maximum Clinical Benefit|1|||
124697780|NCT01783938|448514045|FG001|Overall Study|Maximum Clinical Benefit|0|||
124697781|NCT01783938|448514044|FG000|Overall Study|Other Reasons|3|||
124697782|NCT01783938|448514045|FG001|Overall Study|Other Reasons|1|||
124697783|NCT03478787|448514046|FG000|Overall Study|Adverse Event|5|||
124697784|NCT03478787|448514047|FG001|Overall Study|Adverse Event|1|||
124697785|NCT03478787|448514046|FG000|Overall Study|Protocol Violation|3|||
124697786|NCT03478787|448514047|FG001|Overall Study|Protocol Violation|0|||
124697787|NCT03478787|448514046|FG000|Overall Study|Lack of Efficacy|7|||
124697788|NCT03478787|448514047|FG001|Overall Study|Lack of Efficacy|1|||
124697789|NCT03478787|448514046|FG000|Overall Study|Lost to Follow-up|9|||
124697790|NCT03478787|448514047|FG001|Overall Study|Lost to Follow-up|5|||
124697791|NCT03478787|448514046|FG000|Overall Study|Withdrawal by Subject|2|||
124697792|NCT03478787|448514047|FG001|Overall Study|Withdrawal by Subject|6|||
124697793|NCT03478787|448514046|FG000|Overall Study|Other, Not Specified|3|||
124697794|NCT03478787|448514047|FG001|Overall Study|Other, Not Specified|0|||
124697795|NCT00089583|448514048|FG000|Overall Study|Adverse Event|0|||
124697796|NCT00089583|448514049|FG001|Overall Study|Adverse Event|3|||
124697797|NCT00089583|448514048|FG000|Overall Study|Insufficient Viral Load Response|5|||
124697798|NCT00089583|448514049|FG001|Overall Study|Insufficient Viral Load Response|5|||
124697799|NCT00089583|448514048|FG000|Overall Study|Withdrawal by Subject|0|||
124697800|NCT00089583|448514049|FG001|Overall Study|Withdrawal by Subject|4|||
124697801|NCT00089583|448514048|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
124697802|NCT00089583|448514049|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
124697803|NCT00089583|448514048|FG000|Overall Study|Participant Refused Study Medication|0|||
124697804|NCT00089583|448514049|FG001|Overall Study|Participant Refused Study Medication|2|||
124697805|NCT00089583|448514048|FG000|Overall Study|Non-Compliance|0|||
124697806|NCT00089583|448514049|FG001|Overall Study|Non-Compliance|4|||
124697807|NCT00089583|448514048|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
124697808|NCT00089583|448514049|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
124697809|NCT00089583|448514048|FG000|Overall Study|Participant Management Criteria Met|0|||
124697810|NCT00089583|448514049|FG001|Overall Study|Participant Management Criteria Met|1|||
124697811|NCT00089583|448514048|FG000|Overall Study|Reason Not Provided|0|||
124697812|NCT00089583|448514049|FG001|Overall Study|Reason Not Provided|1|||
124697813|NCT00089583|448514048|FG000|Overall Study|Protocol Violation|0|||
124697814|NCT00089583|448514049|FG001|Overall Study|Protocol Violation|3|||
124697815|NCT00089583|448514048|FG000|Overall Study|Principal Investigator Decision|0|||
124697816|NCT00089583|448514049|FG001|Overall Study|Principal Investigator Decision|10|||
124697817|NCT00089583|448514048|FG000|Overall Study|Start of Disallowed Medication|0|||
124697818|NCT00089583|448514049|FG001|Overall Study|Start of Disallowed Medication|1|||
124697819|NCT00089583|448514048|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
124697820|NCT00089583|448514049|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
124697821|NCT00089583|448514048|FG000|Overall Study|Participant Incarcerated|0|||
124697822|NCT00089583|448514049|FG001|Overall Study|Participant Incarcerated|1|||
124697823|NCT00954538|448514050|FG000|Part III|Withdrawal by Subject|0|||
124697824|NCT00954538|448514051|FG001|Part III|Withdrawal by Subject|0|||
124697825|NCT00954538|448514052|FG002|Part III|Withdrawal by Subject|0|||
124697826|NCT00954538|448514053|FG003|Part III|Withdrawal by Subject|0|||
124697827|NCT00954538|448514054|FG004|Part III|Withdrawal by Subject|1|||
124697828|NCT00954538|448514055|FG005|Part III|Withdrawal by Subject|0|||
124697829|NCT03178942|448514059|FG000|Overall Study|Withdrawal by Subject|2|||
124697830|NCT03178942|448514060|FG001|Overall Study|Withdrawal by Subject|0|||
124697831|NCT03178942|448514059|FG000|Overall Study|Lost to Follow-up|1|||
124697832|NCT03178942|448514060|FG001|Overall Study|Lost to Follow-up|2|||
124697833|NCT01657942|448514061|FG000|Overall Study|Alternative Treatment|7|||
124697834|NCT01657942|448514061|FG000|Overall Study|Lost to Follow-up|1|||
124545961|NCT00943826|447954442|FG000|Concurrent Phase|Withdrew consent|3|||
124697835|NCT03061214|448514063|FG000|Overall Study|Withdrawal by Subject|21|||
124697836|NCT03061214|448514064|FG001|Overall Study|Withdrawal by Subject|26|||
124697837|NCT03061214|448514065|FG002|Overall Study|Withdrawal by Subject|9|||
124697838|NCT03061214|448514063|FG000|Overall Study|Lost to Follow-up|3|||
124697839|NCT03061214|448514064|FG001|Overall Study|Lost to Follow-up|1|||
124697840|NCT03061214|448514065|FG002|Overall Study|Lost to Follow-up|1|||
124697841|NCT03061214|448514063|FG000|Overall Study|Death|1|||
124928254|NCT00950742|449368328|FG000|Overall Study|Progressive Disease|6|||
124697842|NCT03061214|448514064|FG001|Overall Study|Death|1|||
124928255|NCT00950742|449368329|FG001|Overall Study|Progressive Disease|2|||
124697843|NCT03061214|448514065|FG002|Overall Study|Death|0|||
124928256|NCT00950742|449368328|FG000|Overall Study|Dose limiting toxicity|6|||
124928257|NCT00950742|449368329|FG001|Overall Study|Dose limiting toxicity|0|||
124697844|NCT01832038|448515923|FG000|Overall Study|Death|5|||
124697845|NCT01832038|448515923|FG000|Overall Study|Adverse Event|50|||
124697846|NCT01832038|448515923|FG000|Overall Study|Lack of Efficacy|81|||
124697847|NCT01832038|448515923|FG000|Overall Study|Protocol Violation|7|||
124697848|NCT01832038|448515923|FG000|Overall Study|Lost to Follow-up|10|||
124697849|NCT01832038|448515923|FG000|Overall Study|Withdrawal by Subject|49|||
124697850|NCT01832038|448515923|FG000|Overall Study|Visit non-compliance|2|||
124697851|NCT01832038|448515923|FG000|Overall Study|Subject refused to return visit|2|||
124697852|NCT01832038|448515923|FG000|Overall Study|Not convenient to come back to site|2|||
124697853|NCT01832038|448515923|FG000|Overall Study|Participant was asked to quit|5|||
124697854|NCT01832038|448515923|FG000|Overall Study|Back home|1|||
124697855|NCT01832038|448515923|FG000|Overall Study|Pregnancy|1|||
124697856|NCT01832038|448515923|FG000|Overall Study|Low compliance|3|||
124697857|NCT01832038|448515923|FG000|Overall Study|Prohibit procedure|2|||
124697858|NCT01832038|448515923|FG000|Overall Study|Not possible to visit the hospital|1|||
124697859|NCT01832038|448515923|FG000|Overall Study|Changes of implementation system|3|||
124697860|NCT01832038|448515923|FG000|Overall Study|Plan to pregnancy|7|||
124697861|NCT01832038|448515923|FG000|Overall Study|Bad mood and has suicidal thought|1|||
124697862|NCT01832038|448515923|FG000|Overall Study|Prohibited concomitant medication|1|||
124697863|NCT01832038|448515923|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
124697864|NCT01832038|448515923|FG000|Overall Study|Subject considered the efficacy was poor|1|||
124697865|NCT00101400|448515928|FG000|Survival Follow-Up|Alive|7|||
124697866|NCT05333965|448515949|FG000|First Intervention|Adverse Event|0|||
124697867|NCT05333965|448515950|FG001|First Intervention|Adverse Event|1|||
124697868|NCT05333965|448515949|FG000|First Intervention|Withdrawal by Subject|0|||
124697869|NCT05333965|448515950|FG001|First Intervention|Withdrawal by Subject|1|||
124697870|NCT00382863|448515951|FG000|Overall Study|Death|9|||
124697871|NCT00382863|448515952|FG001|Overall Study|Death|9|||
124697872|NCT00382863|448515951|FG000|Overall Study|Lost to Follow-up|1|||
124697873|NCT00382863|448515952|FG001|Overall Study|Lost to Follow-up|2|||
124697874|NCT00382863|448515951|FG000|Overall Study|Withdrawal by Subject|5|||
124697875|NCT00382863|448515952|FG001|Overall Study|Withdrawal by Subject|25|||
124697876|NCT02168439|448515953|FG000|Overall Study|Protocol Violation|0|||
124697877|NCT02168439|448515954|FG001|Overall Study|Protocol Violation|2|||
124697878|NCT00605657|448515956|FG000|Overall Study|Adverse Event|1|||
124697879|NCT00605657|448515956|FG000|Overall Study|Protocol Violation|1|||
124697880|NCT02180672|448515957|FG000|Overall Study|Lost to Follow-up|5|||
124697881|NCT02180672|448515958|FG001|Overall Study|Lost to Follow-up|7|||
124545962|NCT00943826|447954443|FG001|Concurrent Phase|Withdrew consent|7|||
124545963|NCT00943826|447954442|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
124545964|NCT00943826|447954443|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
124545965|NCT00943826|447954442|FG000|Concurrent Phase|Administrative reasons|2|||
124545966|NCT00943826|447954443|FG001|Concurrent Phase|Administrative reasons|1|||
124545967|NCT00943826|447954442|FG000|Concurrent Phase|Protocol Violation|1|||
124545968|NCT00943826|447954443|FG001|Concurrent Phase|Protocol Violation|0|||
124545969|NCT00943826|447954442|FG000|Maintenance Phase|Adverse Event|31|||
124545970|NCT00943826|447954443|FG001|Maintenance Phase|Adverse Event|30|||
124545971|NCT00943826|447954442|FG000|Maintenance Phase|Withdrew consent|2|||
124545972|NCT00943826|447954443|FG001|Maintenance Phase|Withdrew consent|4|||
124545973|NCT00943826|447954442|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
124545974|NCT00943826|447954443|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
124545975|NCT00943826|447954442|FG000|Maintenance Phase|Administrative reasons|4|||
124545976|NCT00943826|447954443|FG001|Maintenance Phase|Administrative reasons|1|||
124545977|NCT00943826|447954442|FG000|Maintenance Phase|Failure to return|0|||
124545978|NCT00943826|447954443|FG001|Maintenance Phase|Failure to return|1|||
124545979|NCT00943826|447954442|FG000|Monotherapy Phase|Adverse Event|42|||
124697882|NCT02837952|448515959|FG000|Overall Study|Adverse Event|0|||
124545980|NCT00943826|447954443|FG001|Monotherapy Phase|Adverse Event|5|||
124545981|NCT00943826|447954442|FG000|Monotherapy Phase|Administrative reasons|11|||
124545982|NCT00943826|447954443|FG001|Monotherapy Phase|Administrative reasons|5|||
124697883|NCT02837952|448515960|FG001|Overall Study|Adverse Event|1|||
124697884|NCT02837952|448515959|FG000|Overall Study|Withdrawal by Subject|4|||
124697885|NCT02837952|448515960|FG001|Overall Study|Withdrawal by Subject|5|||
124928258|NCT04447755|449368330|FG000|Overall Study|Death|8|||
124928259|NCT04447755|449368331|FG001|Overall Study|Death|14|||
124928260|NCT04447755|449368332|FG002|Overall Study|Death|8|||
124928261|NCT04447755|449368333|FG003|Overall Study|Death|9|||
124928262|NCT04447755|449368334|FG004|Overall Study|Death|7|||
124545983|NCT00943826|447954442|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
124545984|NCT00943826|447954443|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
124697886|NCT02837952|448515959|FG000|Overall Study|Medication Error|1|||
124697887|NCT02837952|448515960|FG001|Overall Study|Medication Error|0|||
124697888|NCT01362530|448515961|FG000|Base Study (Cycle 1)|Adverse Event|2|||
124697889|NCT01362530|448515962|FG001|Base Study (Cycle 1)|Adverse Event|0|||
124697890|NCT01362530|448515961|FG000|Base Study (Cycle 1)|Physician Decision|0|||
124697891|NCT01362530|448515962|FG001|Base Study (Cycle 1)|Physician Decision|1|||
124928263|NCT04447755|449368335|FG005|Overall Study|Death|7|||
124697892|NCT01362530|448515961|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
124697893|NCT01362530|448515962|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
124697894|NCT01362530|448515961|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
124545985|NCT00943826|447954442|FG000|Monotherapy Phase|Withdrew Consent|2|||
124454758|NCT00714285|447625374|FG003|Overall Study|Lost to Follow-up|1|||
124454759|NCT00714285|447625371|FG000|Overall Study|Migrated/moved from study area|0|||
124454760|NCT00714285|447625372|FG001|Overall Study|Migrated/moved from study area|1|||
124454761|NCT00714285|447625373|FG002|Overall Study|Migrated/moved from study area|0|||
124454762|NCT00714285|447625374|FG003|Overall Study|Migrated/moved from study area|0|||
124454763|NCT01372384|447625375|FG000|Overall Study|Progression of disease|3|||
124454764|NCT01131676|447625380|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
124454765|NCT01131676|447625381|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
124454766|NCT01131676|447625382|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
124454767|NCT01131676|447625380|FG000|Discontinuation From Treatment|Not treated|4|||
124454768|NCT01131676|447625381|FG001|Discontinuation From Treatment|Not treated|2|||
124454769|NCT01131676|447625382|FG002|Discontinuation From Treatment|Not treated|2|||
124454770|NCT01131676|447625380|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
124454771|NCT01131676|447625381|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
124454772|NCT01131676|447625382|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
124454773|NCT01131676|447625380|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
124454774|NCT01131676|447625381|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
124454775|NCT01131676|447625382|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
124454776|NCT01131676|447625380|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
124454777|NCT01131676|447625381|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
124454778|NCT01131676|447625382|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
124454779|NCT01131676|447625380|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
124454780|NCT01131676|447625381|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
124454781|NCT01131676|447625382|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
124454782|NCT01131676|447625380|FG000|Discontinuation From Treatment|Other than those specified|162|||
124454783|NCT01131676|447625381|FG001|Discontinuation From Treatment|Other than those specified|142|||
124454784|NCT01131676|447625382|FG002|Discontinuation From Treatment|Other than those specified|125|||
124454785|NCT01131676|447625380|FG000|Discontinuation From Treatment|Adverse Event|303|||
124454786|NCT01131676|447625381|FG001|Discontinuation From Treatment|Adverse Event|267|||
124454787|NCT01131676|447625382|FG002|Discontinuation From Treatment|Adverse Event|273|||
124454788|NCT01131676|447625380|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
124454789|NCT01131676|447625381|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
124454790|NCT01131676|447625382|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
124454791|NCT01131676|447625380|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
124454792|NCT01131676|447625381|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
124454793|NCT01131676|447625382|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
124454794|NCT01131676|447625380|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
124454795|NCT01131676|447625381|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
124454796|NCT01131676|447625382|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
124454797|NCT01131676|447625380|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
124454798|NCT01131676|447625381|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
124454799|NCT01131676|447625382|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
124454800|NCT01131676|447625380|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
124454801|NCT01131676|447625381|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
124454802|NCT01131676|447625382|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
124454803|NCT01131676|447625380|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
124454804|NCT01131676|447625381|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
124454805|NCT01131676|447625382|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
124454806|NCT03000179|447625383|FG000|Overall Study|Lost to Follow-up|2|||
124545986|NCT00943826|447954443|FG001|Monotherapy Phase|Withdrew Consent|3|||
124545987|NCT00943826|447954442|FG000|Monotherapy Phase|Failure to return|2|||
124545988|NCT00943826|447954443|FG001|Monotherapy Phase|Failure to return|1|||
124697895|NCT01362530|448515962|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
124697896|NCT01362530|448515961|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
124697897|NCT01362530|448515962|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
124697898|NCT01362530|448515961|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
124697899|NCT01362530|448515962|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
124928264|NCT04447755|449368336|FG006|Overall Study|Death|40|||
124928265|NCT04447755|449368330|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124928266|NCT04447755|449368331|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
124697900|NCT01362530|448515961|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
124697901|NCT01362530|448515962|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
124697902|NCT01362530|448515961|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
124697903|NCT01362530|448515962|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
124697904|NCT01362530|448515961|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
124697905|NCT01362530|448515962|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
124697906|NCT01362530|448515961|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
124697907|NCT01362530|448515962|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
124697908|NCT01362530|448515961|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
124697909|NCT01362530|448515962|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
124697910|NCT01362530|448515961|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
124697911|NCT01362530|448515962|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
124697912|NCT01362530|448515961|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
124697913|NCT01362530|448515962|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
124697914|NCT01772693|448515964|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
124697915|NCT01772693|448515965|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
124697916|NCT01772693|448515964|FG000|Overall Study|Withdrawal by Subject|2|||
124697917|NCT01772693|448515965|FG001|Overall Study|Withdrawal by Subject|0|||
124697918|NCT01772693|448515964|FG000|Overall Study|Alternative Treatment|2|||
124697919|NCT01772693|448515965|FG001|Overall Study|Alternative Treatment|0|||
124697920|NCT03021005|448515976|FG000|Overall Study|Lost to Follow-up|39|||
124697921|NCT03021005|448515977|FG001|Overall Study|Lost to Follow-up|26|||
124697922|NCT00276380|448515978|FG000|Overall Study|Adverse Event|5|||
124697923|NCT00276380|448515979|FG001|Overall Study|Adverse Event|3|||
124697924|NCT00276380|448515978|FG000|Overall Study|Lost to Follow-up|1|||
124697925|NCT00276380|448515979|FG001|Overall Study|Lost to Follow-up|1|||
124697926|NCT00276380|448515978|FG000|Overall Study|Withdrawal by Subject|3|||
124697927|NCT00276380|448515979|FG001|Overall Study|Withdrawal by Subject|6|||
124697928|NCT00276380|448515978|FG000|Overall Study|Death|5|||
124697929|NCT00276380|448515979|FG001|Overall Study|Death|3|||
124697930|NCT00276380|448515978|FG000|Overall Study|Abnormal aPPT Levels|0|||
124697931|NCT00276380|448515979|FG001|Overall Study|Abnormal aPPT Levels|1|||
124697932|NCT03473301|448515980|FG000|Overall Study|Protocol Violation|4|||
124697933|NCT03473301|448515981|FG001|Overall Study|Protocol Violation|0|||
124697934|NCT03473301|448515982|FG002|Overall Study|Protocol Violation|0|||
124697935|NCT03473301|448515980|FG000|Overall Study|Withdrawal by Subject|0|||
124697936|NCT03473301|448515981|FG001|Overall Study|Withdrawal by Subject|1|||
124697937|NCT03473301|448515982|FG002|Overall Study|Withdrawal by Subject|0|||
124697938|NCT03473301|448515980|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
124697939|NCT03473301|448515981|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
124697940|NCT03473301|448515982|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
124697941|NCT04829214|448515983|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
124697942|NCT04829214|448515984|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
124697943|NCT04829214|448515983|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
124697944|NCT04829214|448515984|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
124697945|NCT05071027|448515985|FG000|Overall Study|Lost to Follow-up|1|||
124697946|NCT05071027|448515986|FG001|Overall Study|Lost to Follow-up|4|||
124697947|NCT04135352|448515988|FG000|Overall Study|Not treated-randomization error|0|||
124697948|NCT04135352|448515989|FG001|Overall Study|Not treated-randomization error|0|||
124697949|NCT04135352|448515990|FG002|Overall Study|Not treated-randomization error|1|||
124697950|NCT04135352|448515991|FG003|Overall Study|Not treated-randomization error|0|||
124697951|NCT04135352|448515992|FG004|Overall Study|Not treated-randomization error|0|||
124697952|NCT04135352|448515993|FG005|Overall Study|Not treated-randomization error|0|||
124697953|NCT04135352|448515994|FG006|Overall Study|Not treated-randomization error|0|||
124697954|NCT04135352|448515995|FG007|Overall Study|Not treated-randomization error|0|||
124697955|NCT04135352|448515988|FG000|Overall Study|Withdrawal by Subject|0|||
124697956|NCT04135352|448515989|FG001|Overall Study|Withdrawal by Subject|0|||
124697957|NCT04135352|448515990|FG002|Overall Study|Withdrawal by Subject|2|||
124697958|NCT04135352|448515991|FG003|Overall Study|Withdrawal by Subject|0|||
124697959|NCT04135352|448515992|FG004|Overall Study|Withdrawal by Subject|0|||
124697960|NCT04135352|448515993|FG005|Overall Study|Withdrawal by Subject|0|||
124697961|NCT04135352|448515994|FG006|Overall Study|Withdrawal by Subject|0|||
124697962|NCT04135352|448515995|FG007|Overall Study|Withdrawal by Subject|0|||
124697963|NCT04135352|448515988|FG000|Overall Study|Sponsor Decision|0|||
124697964|NCT04135352|448515989|FG001|Overall Study|Sponsor Decision|0|||
124697965|NCT04135352|448515990|FG002|Overall Study|Sponsor Decision|2|||
124697966|NCT04135352|448515991|FG003|Overall Study|Sponsor Decision|5|||
124697967|NCT04135352|448515992|FG004|Overall Study|Sponsor Decision|1|||
124697968|NCT04135352|448515993|FG005|Overall Study|Sponsor Decision|4|||
124697969|NCT04135352|448515994|FG006|Overall Study|Sponsor Decision|0|||
124697970|NCT04135352|448515995|FG007|Overall Study|Sponsor Decision|0|||
124697971|NCT04135352|448515988|FG000|Overall Study|Physician Decision|0|||
124697972|NCT04135352|448515989|FG001|Overall Study|Physician Decision|0|||
124697973|NCT04135352|448515990|FG002|Overall Study|Physician Decision|1|||
124697974|NCT04135352|448515991|FG003|Overall Study|Physician Decision|0|||
124763008|NCT03010527|448757880|FG000|Overall Study|Death|0|||
124763009|NCT03010527|448757881|FG001|Overall Study|Death|0|||
124763010|NCT03010527|448757882|FG002|Overall Study|Death|1|||
124763011|NCT03010527|448757880|FG000|Overall Study|Adverse Event|0|||
124763012|NCT03010527|448757881|FG001|Overall Study|Adverse Event|4|||
124763013|NCT03010527|448757882|FG002|Overall Study|Adverse Event|2|||
124763014|NCT03010527|448757880|FG000|Overall Study|Protocol Violation|0|||
124697975|NCT04135352|448515992|FG004|Overall Study|Physician Decision|1|||
124697976|NCT04135352|448515993|FG005|Overall Study|Physician Decision|0|||
124697977|NCT04135352|448515994|FG006|Overall Study|Physician Decision|0|||
124697978|NCT04135352|448515995|FG007|Overall Study|Physician Decision|0|||
124697979|NCT04135352|448515988|FG000|Overall Study|Death|3|||
124697980|NCT04135352|448515989|FG001|Overall Study|Death|4|||
124697981|NCT04135352|448515990|FG002|Overall Study|Death|7|||
124697982|NCT04135352|448515991|FG003|Overall Study|Death|0|||
124697983|NCT04135352|448515992|FG004|Overall Study|Death|3|||
124697984|NCT04135352|448515993|FG005|Overall Study|Death|1|||
124697985|NCT04135352|448515994|FG006|Overall Study|Death|0|||
124697986|NCT04135352|448515995|FG007|Overall Study|Death|0|||
124697987|NCT00511199|448515996|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
124697988|NCT00511199|448515997|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
124697989|NCT00511199|448515996|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
124697990|NCT00511199|448515997|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
124697991|NCT00511199|448515996|FG000|Overall Study|Withdrawal of Informed Consent|19|||
124697992|NCT00511199|448515997|FG001|Overall Study|Withdrawal of Informed Consent|4|||
124697993|NCT00511199|448515996|FG000|Overall Study|Pregnancy|6|||
124697994|NCT00511199|448515997|FG001|Overall Study|Pregnancy|3|||
124697995|NCT00511199|448515996|FG000|Overall Study|Pregnancy Wish|16|||
124697996|NCT00511199|448515997|FG001|Overall Study|Pregnancy Wish|8|||
124697997|NCT00511199|448515996|FG000|Overall Study|Lost to Follow-up|40|||
124763015|NCT03010527|448757881|FG001|Overall Study|Protocol Violation|1|||
124763016|NCT03010527|448757882|FG002|Overall Study|Protocol Violation|0|||
124763017|NCT03010527|448757880|FG000|Overall Study|Lost to Follow-up|0|||
124454807|NCT00865904|447625387|FG000|Overall Study|Randomized but not Treated|2|||
124763018|NCT03010527|448757881|FG001|Overall Study|Lost to Follow-up|2|||
124763019|NCT03010527|448757882|FG002|Overall Study|Lost to Follow-up|1|||
124454808|NCT00865904|447625388|FG001|Overall Study|Randomized but not Treated|0|||
124697998|NCT00511199|448515997|FG001|Overall Study|Lost to Follow-up|17|||
124697999|NCT00511199|448515996|FG000|Overall Study|Other Reason|78|||
124763020|NCT03010527|448757880|FG000|Overall Study|Withdrawal by Subject|0|||
124763021|NCT03010527|448757881|FG001|Overall Study|Withdrawal by Subject|3|||
124698000|NCT00511199|448515997|FG001|Overall Study|Other Reason|37|||
124454809|NCT00865904|447625389|FG002|Overall Study|Randomized but not Treated|0|||
124454810|NCT00865904|447625390|FG003|Overall Study|Randomized but not Treated|1|||
124454811|NCT00865904|447625391|FG004|Overall Study|Randomized but not Treated|1|||
124454812|NCT03625687|447625392|FG000|Overall Study|Death|1|||
124454813|NCT01431274|447625393|FG000|Overall Study|Adverse Event|51|||
124454814|NCT01431274|447625394|FG001|Overall Study|Adverse Event|37|||
124454815|NCT01431274|447625395|FG002|Overall Study|Adverse Event|43|||
124454816|NCT01431274|447625396|FG003|Overall Study|Adverse Event|30|||
124454817|NCT01431274|447625397|FG004|Overall Study|Adverse Event|37|||
124454818|NCT01431274|447625393|FG000|Overall Study|Consent withdrawn not due to AE|29|||
124454819|NCT01431274|447625394|FG001|Overall Study|Consent withdrawn not due to AE|20|||
124698001|NCT02739828|448516003|FG000|Overall Study|Adverse Event|1|||
124698002|NCT02739828|448516003|FG000|Overall Study|Lost to Follow-up|4|||
124698003|NCT02314247|448516004|FG000|Overall Study|Adverse Event|2|||
124698004|NCT02314247|448516005|FG001|Overall Study|Adverse Event|1|||
124698005|NCT02314247|448516006|FG002|Overall Study|Adverse Event|0|||
124698006|NCT02314247|448516004|FG000|Overall Study|Withdrawal by Subject|1|||
124698007|NCT02314247|448516005|FG001|Overall Study|Withdrawal by Subject|3|||
124698008|NCT02314247|448516006|FG002|Overall Study|Withdrawal by Subject|1|||
124698009|NCT02314247|448516004|FG000|Overall Study|Progression of Disease|6|||
124698010|NCT02314247|448516005|FG001|Overall Study|Progression of Disease|2|||
124698011|NCT02314247|448516006|FG002|Overall Study|Progression of Disease|0|||
124698012|NCT01953354|448516007|FG000|Overall Study|Withdrawal by Subject|0|||
124698013|NCT01953354|448516008|FG001|Overall Study|Withdrawal by Subject|1|||
124698014|NCT01953354|448516007|FG000|Overall Study|Decision of Sponsor|0|||
124698015|NCT01953354|448516008|FG001|Overall Study|Decision of Sponsor|1|||
124698016|NCT01953354|448516007|FG000|Overall Study|Disease Exacerbation|1|||
124698017|NCT01953354|448516008|FG001|Overall Study|Disease Exacerbation|0|||
124698018|NCT01392495|448516009|FG000|Overall Study|Death|3|||
124698019|NCT01392495|448516009|FG000|Overall Study|Administrative problems|8|||
124698020|NCT01392495|448516009|FG000|Overall Study|Withdrawal by Subject|2|||
124698021|NCT01392495|448516009|FG000|Overall Study|Adverse Event|3|||
124698022|NCT02571244|448516010|FG000|Overall Study|Lost to Follow-up|0|||
124698023|NCT02571244|448516011|FG001|Overall Study|Lost to Follow-up|1|||
124698024|NCT02571244|448516010|FG000|Overall Study|Unable to reach out post discharge|3|||
124698025|NCT02571244|448516011|FG001|Overall Study|Unable to reach out post discharge|0|||
124698026|NCT01696214|448516013|FG000|Overall Study|Lost to Follow-up|1|||
124698027|NCT01696214|448516014|FG001|Overall Study|Lost to Follow-up|0|||
124698028|NCT01696214|448516015|FG002|Overall Study|Lost to Follow-up|0|||
124698029|NCT01696214|448516016|FG003|Overall Study|Lost to Follow-up|0|||
124698030|NCT01570192|448516017|FG000|Overall Study|no qualifying organism|6|||
124698031|NCT01570192|448516018|FG001|Overall Study|no qualifying organism|12|||
124698032|NCT01570192|448516017|FG000|Overall Study|changed to palliative care|1|||
124698033|NCT01570192|448516018|FG001|Overall Study|changed to palliative care|0|||
124698034|NCT01570192|448516017|FG000|Overall Study|Physician Decision|0|||
124698035|NCT01570192|448516018|FG001|Overall Study|Physician Decision|1|||
124698036|NCT02965976|448516019|FG000|Overall Study|Withdrawal by Subject|2|||
124698037|NCT02965976|448516020|FG001|Overall Study|Withdrawal by Subject|0|||
124698038|NCT00806026|448516021|FG000|Overall Study|Death|0|||
124698039|NCT00806026|448516022|FG001|Overall Study|Death|0|||
124698040|NCT00806026|448516023|FG002|Overall Study|Death|0|||
124698041|NCT00806026|448516024|FG003|Overall Study|Death|1|||
124698042|NCT00806026|448516025|FG004|Overall Study|Death|0|||
124698043|NCT00806026|448516026|FG005|Overall Study|Death|0|||
124698044|NCT00806026|448516021|FG000|Overall Study|Did not meet entrance criteria|4|||
124698045|NCT00806026|448516022|FG001|Overall Study|Did not meet entrance criteria|1|||
124698046|NCT00806026|448516023|FG002|Overall Study|Did not meet entrance criteria|2|||
124698047|NCT00806026|448516024|FG003|Overall Study|Did not meet entrance criteria|1|||
124698048|NCT00806026|448516025|FG004|Overall Study|Did not meet entrance criteria|0|||
124698049|NCT00806026|448516026|FG005|Overall Study|Did not meet entrance criteria|0|||
124698050|NCT00806026|448516021|FG000|Overall Study|Lack of Efficacy|5|||
124698051|NCT00806026|448516022|FG001|Overall Study|Lack of Efficacy|18|||
124698052|NCT00806026|448516023|FG002|Overall Study|Lack of Efficacy|13|||
124698053|NCT00806026|448516024|FG003|Overall Study|Lack of Efficacy|4|||
124698054|NCT00806026|448516025|FG004|Overall Study|Lack of Efficacy|8|||
124698055|NCT00806026|448516026|FG005|Overall Study|Lack of Efficacy|7|||
124454820|NCT01431274|447625395|FG002|Overall Study|Consent withdrawn not due to AE|17|||
124454821|NCT01431274|447625396|FG003|Overall Study|Consent withdrawn not due to AE|20|||
124454822|NCT01431274|447625397|FG004|Overall Study|Consent withdrawn not due to AE|11|||
124454823|NCT01431274|447625393|FG000|Overall Study|Non compliant with protocol|5|||
124454824|NCT01431274|447625394|FG001|Overall Study|Non compliant with protocol|8|||
124698056|NCT00806026|448516021|FG000|Overall Study|Lost to Follow-up|8|||
124698057|NCT00806026|448516022|FG001|Overall Study|Lost to Follow-up|15|||
124698058|NCT00806026|448516023|FG002|Overall Study|Lost to Follow-up|8|||
124698059|NCT00806026|448516024|FG003|Overall Study|Lost to Follow-up|2|||
124698060|NCT00806026|448516025|FG004|Overall Study|Lost to Follow-up|6|||
124698061|NCT00806026|448516026|FG005|Overall Study|Lost to Follow-up|6|||
124698062|NCT00806026|448516021|FG000|Overall Study|Withdrawal by Subject|14|||
124698063|NCT00806026|448516022|FG001|Overall Study|Withdrawal by Subject|17|||
124698064|NCT00806026|448516023|FG002|Overall Study|Withdrawal by Subject|9|||
124698065|NCT00806026|448516024|FG003|Overall Study|Withdrawal by Subject|2|||
124698066|NCT00806026|448516025|FG004|Overall Study|Withdrawal by Subject|5|||
124698067|NCT00806026|448516026|FG005|Overall Study|Withdrawal by Subject|3|||
124698068|NCT00806026|448516021|FG000|Overall Study|Other|3|||
124698069|NCT00806026|448516022|FG001|Overall Study|Other|6|||
124698070|NCT00806026|448516023|FG002|Overall Study|Other|8|||
124698071|NCT00806026|448516024|FG003|Overall Study|Other|2|||
124698072|NCT00806026|448516025|FG004|Overall Study|Other|0|||
124698073|NCT00806026|448516026|FG005|Overall Study|Other|4|||
124698074|NCT00806026|448516021|FG000|Overall Study|Protocol Violation|6|||
124698075|NCT00806026|448516022|FG001|Overall Study|Protocol Violation|9|||
124698076|NCT00806026|448516023|FG002|Overall Study|Protocol Violation|9|||
124698077|NCT00806026|448516024|FG003|Overall Study|Protocol Violation|0|||
124698078|NCT00806026|448516025|FG004|Overall Study|Protocol Violation|2|||
124698079|NCT00806026|448516026|FG005|Overall Study|Protocol Violation|3|||
124698080|NCT00806026|448516021|FG000|Overall Study|Adverse Event|52|||
124698081|NCT00806026|448516022|FG001|Overall Study|Adverse Event|35|||
124698082|NCT00806026|448516023|FG002|Overall Study|Adverse Event|44|||
124698083|NCT00806026|448516024|FG003|Overall Study|Adverse Event|17|||
124698084|NCT00806026|448516025|FG004|Overall Study|Adverse Event|9|||
124698085|NCT00806026|448516026|FG005|Overall Study|Adverse Event|9|||
124698086|NCT01687595|448516027|FG000|Overall Study|Withdrawal by Subject|8|||
124698087|NCT01687595|448516028|FG001|Overall Study|Withdrawal by Subject|0|||
124698088|NCT01687595|448516027|FG000|Overall Study|Lost to Follow-up|3|||
124698089|NCT01687595|448516028|FG001|Overall Study|Lost to Follow-up|1|||
124698090|NCT01687595|448516027|FG000|Overall Study|Investigator's decision|1|||
124698091|NCT01687595|448516028|FG001|Overall Study|Investigator's decision|0|||
124698092|NCT01687595|448516027|FG000|Overall Study|Sponsor's decision|1|||
124698093|NCT01687595|448516028|FG001|Overall Study|Sponsor's decision|0|||
124698094|NCT01687595|448516027|FG000|Overall Study|Noncompliance|1|||
124698095|NCT01687595|448516028|FG001|Overall Study|Noncompliance|2|||
124698096|NCT01687595|448516027|FG000|Overall Study|Other than specified|56|||
124698097|NCT01687595|448516028|FG001|Overall Study|Other than specified|7|||
124698098|NCT03180138|448516031|FG000|Overall Study|Mobile-phone could not be verified|2|||
124698099|NCT03180138|448516032|FG001|Overall Study|Mobile-phone could not be verified|13|||
124698100|NCT03180138|448516033|FG002|Overall Study|Mobile-phone could not be verified|15|||
124698101|NCT03180138|448516031|FG000|Overall Study|No prior immunization records|17|||
124698102|NCT03180138|448516032|FG001|Overall Study|No prior immunization records|0|||
124698103|NCT03180138|448516033|FG002|Overall Study|No prior immunization records|6|||
124698104|NCT03180138|448516031|FG000|Overall Study|Found to be >24 mon after randomization|3|||
124698105|NCT03180138|448516032|FG001|Overall Study|Found to be >24 mon after randomization|0|||
124698106|NCT03180138|448516033|FG002|Overall Study|Found to be >24 mon after randomization|3|||
124698107|NCT01905267|448516035|FG000|Overall Study|Physician Decision|2|||
124698108|NCT01905267|448516036|FG001|Overall Study|Physician Decision|2|||
124698109|NCT03888482|448516037|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
124698110|NCT03888482|448516038|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
124698111|NCT03888482|448516037|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
124698112|NCT03888482|448516038|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
124698113|NCT01630811|448516043|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
124698114|NCT01630811|448516044|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
124698115|NCT04818086|448516045|FG000|Overall Study|Physician Decision|1|||
124698116|NCT04818086|448516046|FG001|Overall Study|Physician Decision|0|||
124698117|NCT04818086|448516045|FG000|Overall Study|Withdrawal by Subject|0|||
124698118|NCT04818086|448516046|FG001|Overall Study|Withdrawal by Subject|1|||
124698119|NCT01725308|448516048|FG000|Treatment Period I|Did Not Receive Drug|1|||
124698120|NCT01725308|448516049|FG001|Treatment Period I|Did Not Receive Drug|0|||
124698121|NCT01725308|448516050|FG002|Treatment Period I|Did Not Receive Drug|0|||
124698122|NCT01725308|448516048|FG000|Treatment Period I|Adverse Event|5|||
124454825|NCT01431274|447625395|FG002|Overall Study|Non compliant with protocol|4|||
124454826|NCT01431274|447625396|FG003|Overall Study|Non compliant with protocol|4|||
124454827|NCT01431274|447625397|FG004|Overall Study|Non compliant with protocol|4|||
124454828|NCT01431274|447625393|FG000|Overall Study|Lost to Follow-up|6|||
124698123|NCT01725308|448516049|FG001|Treatment Period I|Adverse Event|4|||
124698124|NCT01725308|448516050|FG002|Treatment Period I|Adverse Event|21|||
124698125|NCT01725308|448516048|FG000|Treatment Period I|Insufficient Response|7|||
124698126|NCT01725308|448516049|FG001|Treatment Period I|Insufficient Response|0|||
124698127|NCT01725308|448516050|FG002|Treatment Period I|Insufficient Response|5|||
124698128|NCT01725308|448516048|FG000|Treatment Period I|Worsening of the Target Disease|8|||
124698129|NCT01725308|448516049|FG001|Treatment Period I|Worsening of the Target Disease|0|||
124698130|NCT01725308|448516050|FG002|Treatment Period I|Worsening of the Target Disease|2|||
124698131|NCT01725308|448516048|FG000|Treatment Period I|Changes in the Episodes|3|||
124698132|NCT01725308|448516049|FG001|Treatment Period I|Changes in the Episodes|0|||
124698133|NCT01725308|448516050|FG002|Treatment Period I|Changes in the Episodes|2|||
124454829|NCT01431274|447625394|FG001|Overall Study|Lost to Follow-up|7|||
124698134|NCT01725308|448516048|FG000|Treatment Period I|Withdrawal of Consent|12|||
124698135|NCT01725308|448516049|FG001|Treatment Period I|Withdrawal of Consent|7|||
124698136|NCT01725308|448516050|FG002|Treatment Period I|Withdrawal of Consent|5|||
124698137|NCT01725308|448516048|FG000|Treatment Period I|Lost to Follow-up|3|||
124698138|NCT01725308|448516049|FG001|Treatment Period I|Lost to Follow-up|2|||
124698139|NCT01725308|448516050|FG002|Treatment Period I|Lost to Follow-up|2|||
124698140|NCT01725308|448516048|FG000|Treatment Period I|Protocol Deviations|3|||
124698141|NCT01725308|448516049|FG001|Treatment Period I|Protocol Deviations|1|||
124698142|NCT01725308|448516050|FG002|Treatment Period I|Protocol Deviations|1|||
124698143|NCT01725308|448516048|FG000|Treatment Period I|Miscellaneous|2|||
124698144|NCT01725308|448516049|FG001|Treatment Period I|Miscellaneous|0|||
124698145|NCT01725308|448516050|FG002|Treatment Period I|Miscellaneous|3|||
124698146|NCT01725308|448516048|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
124698147|NCT01725308|448516049|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
124698148|NCT01725308|448516050|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
124698149|NCT01725308|448516048|FG000|Treatment Period II|Did Not Receive Drug|4|||
124698150|NCT01725308|448516049|FG001|Treatment Period II|Did Not Receive Drug|0|||
124698151|NCT01725308|448516050|FG002|Treatment Period II|Did Not Receive Drug|0|||
124698152|NCT01725308|448516048|FG000|Treatment Period II|Adverse Event|13|||
124698153|NCT01725308|448516049|FG001|Treatment Period II|Adverse Event|8|||
124698154|NCT01725308|448516050|FG002|Treatment Period II|Adverse Event|20|||
124698155|NCT01725308|448516048|FG000|Treatment Period II|Insufficient Response|2|||
124698156|NCT01725308|448516049|FG001|Treatment Period II|Insufficient Response|4|||
124698157|NCT01725308|448516050|FG002|Treatment Period II|Insufficient Response|6|||
124698158|NCT01725308|448516048|FG000|Treatment Period II|Worsening of the Target Disease|1|||
124698159|NCT01725308|448516049|FG001|Treatment Period II|Worsening of the Target Disease|4|||
124698160|NCT01725308|448516050|FG002|Treatment Period II|Worsening of the Target Disease|2|||
124698161|NCT01725308|448516048|FG000|Treatment Period II|Changes in the Episodes|1|||
124698162|NCT01725308|448516049|FG001|Treatment Period II|Changes in the Episodes|0|||
124698163|NCT01725308|448516050|FG002|Treatment Period II|Changes in the Episodes|5|||
124698164|NCT01725308|448516048|FG000|Treatment Period II|Withdrawal of Consent|28|||
124698165|NCT01725308|448516049|FG001|Treatment Period II|Withdrawal of Consent|2|||
124698166|NCT01725308|448516050|FG002|Treatment Period II|Withdrawal of Consent|16|||
124698167|NCT01725308|448516048|FG000|Treatment Period II|Lost to Follow-up|1|||
124698168|NCT01725308|448516049|FG001|Treatment Period II|Lost to Follow-up|5|||
124698169|NCT01725308|448516050|FG002|Treatment Period II|Lost to Follow-up|3|||
124698170|NCT01725308|448516048|FG000|Treatment Period II|Protocol Deviations|0|||
124698171|NCT01725308|448516049|FG001|Treatment Period II|Protocol Deviations|0|||
124698172|NCT01725308|448516050|FG002|Treatment Period II|Protocol Deviations|1|||
124698173|NCT01725308|448516048|FG000|Treatment Period II|Miscellaneous|5|||
124698174|NCT01725308|448516049|FG001|Treatment Period II|Miscellaneous|3|||
124698175|NCT01725308|448516050|FG002|Treatment Period II|Miscellaneous|7|||
124698176|NCT04128228|448516054|FG000|Overall Study|Withdrawal by Subject|3|||
124698177|NCT04128228|448516055|FG001|Overall Study|Withdrawal by Subject|3|||
124698178|NCT04128228|448516056|FG002|Overall Study|Withdrawal by Subject|0|||
124698179|NCT04128228|448516057|FG003|Overall Study|Withdrawal by Subject|0|||
124698180|NCT04128228|448516054|FG000|Overall Study|noncompliance|2|||
124454830|NCT01431274|447625395|FG002|Overall Study|Lost to Follow-up|1|||
124698181|NCT04128228|448516055|FG001|Overall Study|noncompliance|2|||
124698182|NCT04128228|448516056|FG002|Overall Study|noncompliance|0|||
124698183|NCT04128228|448516057|FG003|Overall Study|noncompliance|0|||
124698184|NCT03511209|448516058|FG000|Overall Study|Withdrawal by Subject|2|||
124698185|NCT03511209|448516059|FG001|Overall Study|Withdrawal by Subject|4|||
124698186|NCT03511209|448516058|FG000|Overall Study|Death|1|||
124698187|NCT03511209|448516059|FG001|Overall Study|Death|0|||
124698188|NCT03511209|448516058|FG000|Overall Study|Lost to Follow-up|0|||
124698189|NCT03511209|448516059|FG001|Overall Study|Lost to Follow-up|2|||
124698190|NCT03163264|448516060|FG000|Overall Study|Withdrawal by Subject|13|||
124698191|NCT03163264|448516061|FG001|Overall Study|Withdrawal by Subject|3|||
124698192|NCT03163264|448516062|FG002|Overall Study|Withdrawal by Subject|4|||
124698193|NCT03163264|448516063|FG003|Overall Study|Withdrawal by Subject|2|||
124698194|NCT03163264|448516060|FG000|Overall Study|Lost to Follow-up|17|||
124454831|NCT01431274|447625396|FG003|Overall Study|Lost to Follow-up|4|||
124698195|NCT03163264|448516061|FG001|Overall Study|Lost to Follow-up|20|||
124698196|NCT03163264|448516062|FG002|Overall Study|Lost to Follow-up|0|||
124698197|NCT03163264|448516063|FG003|Overall Study|Lost to Follow-up|0|||
124698198|NCT03163264|448516060|FG000|Overall Study|Death|0|||
124698199|NCT03163264|448516061|FG001|Overall Study|Death|2|||
124698200|NCT03163264|448516062|FG002|Overall Study|Death|0|||
124698201|NCT03163264|448516063|FG003|Overall Study|Death|0|||
124698202|NCT00215657|448516066|FG000|Overall Study|Adverse Event|5|||
124698203|NCT00215657|448516067|FG001|Overall Study|Adverse Event|1|||
124698204|NCT00215657|448516068|FG002|Overall Study|Adverse Event|3|||
124698205|NCT00215657|448516069|FG003|Overall Study|Adverse Event|0|||
124698206|NCT00215657|448516070|FG004|Overall Study|Adverse Event|3|||
124454832|NCT01431274|447625397|FG004|Overall Study|Lost to Follow-up|0|||
124698207|NCT00215657|448516071|FG005|Overall Study|Adverse Event|1|||
124698208|NCT00215657|448516072|FG006|Overall Study|Adverse Event|0|||
124698209|NCT00215657|448516073|FG007|Overall Study|Adverse Event|3|||
124698210|NCT00215657|448516066|FG000|Overall Study|Withdrawal by Subject|6|||
124698211|NCT00215657|448516067|FG001|Overall Study|Withdrawal by Subject|3|||
124698212|NCT00215657|448516068|FG002|Overall Study|Withdrawal by Subject|3|||
124698213|NCT00215657|448516069|FG003|Overall Study|Withdrawal by Subject|1|||
124698214|NCT00215657|448516070|FG004|Overall Study|Withdrawal by Subject|6|||
124698215|NCT00215657|448516071|FG005|Overall Study|Withdrawal by Subject|1|||
124698216|NCT00215657|448516072|FG006|Overall Study|Withdrawal by Subject|10|||
124698217|NCT00215657|448516073|FG007|Overall Study|Withdrawal by Subject|3|||
124698218|NCT00215657|448516066|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
124698219|NCT00215657|448516067|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
124698220|NCT00215657|448516068|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
124698221|NCT00215657|448516069|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
124698222|NCT00215657|448516070|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
124698223|NCT00215657|448516071|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
124698224|NCT00215657|448516072|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
124698225|NCT00215657|448516073|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
124698226|NCT00215657|448516066|FG000|Overall Study|Insufficient testosterone response|5|||
124698227|NCT00215657|448516067|FG001|Overall Study|Insufficient testosterone response|4|||
124698228|NCT00215657|448516068|FG002|Overall Study|Insufficient testosterone response|1|||
124698229|NCT00215657|448516069|FG003|Overall Study|Insufficient testosterone response|12|||
124698230|NCT00215657|448516070|FG004|Overall Study|Insufficient testosterone response|8|||
124698231|NCT00215657|448516071|FG005|Overall Study|Insufficient testosterone response|12|||
124698232|NCT00215657|448516072|FG006|Overall Study|Insufficient testosterone response|4|||
124698233|NCT00215657|448516073|FG007|Overall Study|Insufficient testosterone response|7|||
124698234|NCT00215657|448516066|FG000|Overall Study|Other|3|||
124698235|NCT00215657|448516067|FG001|Overall Study|Other|1|||
124698236|NCT00215657|448516068|FG002|Overall Study|Other|2|||
124698237|NCT00215657|448516069|FG003|Overall Study|Other|3|||
124698238|NCT00215657|448516070|FG004|Overall Study|Other|5|||
124698239|NCT00215657|448516071|FG005|Overall Study|Other|4|||
124698240|NCT00215657|448516072|FG006|Overall Study|Other|6|||
124698241|NCT00215657|448516073|FG007|Overall Study|Other|1|||
124698242|NCT03769467|448516074|FG000|Overall Study|Adverse Event|1|||
124698243|NCT03769467|448516075|FG001|Overall Study|Adverse Event|1|||
124698244|NCT03769467|448516076|FG002|Overall Study|Adverse Event|0|||
124698245|NCT03769467|448516074|FG000|Overall Study|Death|3|||
124698246|NCT03769467|448516075|FG001|Overall Study|Death|3|||
124698247|NCT03769467|448516076|FG002|Overall Study|Death|0|||
124698248|NCT03769467|448516074|FG000|Overall Study|Study Terminated By Sponsor|2|||
124698249|NCT03769467|448516075|FG001|Overall Study|Study Terminated By Sponsor|1|||
124698250|NCT03769467|448516076|FG002|Overall Study|Study Terminated By Sponsor|0|||
124698251|NCT03769467|448516074|FG000|Overall Study|Withdrawal by Subject|0|||
124698252|NCT03769467|448516075|FG001|Overall Study|Withdrawal by Subject|1|||
124698253|NCT03769467|448516076|FG002|Overall Study|Withdrawal by Subject|0|||
124698254|NCT02614066|448516077|FG000|Overall Study|Death|6|||
124698255|NCT02614066|448516078|FG001|Overall Study|Death|14|||
124698256|NCT02614066|448516079|FG002|Overall Study|Death|11|||
124698257|NCT02614066|448516080|FG003|Overall Study|Death|29|||
124698258|NCT02614066|448516077|FG000|Overall Study|Full consent withdrawn|0|||
124698259|NCT02614066|448516078|FG001|Overall Study|Full consent withdrawn|1|||
124698260|NCT02614066|448516079|FG002|Overall Study|Full consent withdrawn|0|||
124698261|NCT02614066|448516080|FG003|Overall Study|Full consent withdrawn|8|||
124454833|NCT01431274|447625393|FG000|Overall Study|Other reason not stated above|6|||
124454834|NCT01431274|447625394|FG001|Overall Study|Other reason not stated above|5|||
124454835|NCT01431274|447625395|FG002|Overall Study|Other reason not stated above|7|||
124698262|NCT02614066|448516077|FG000|Overall Study|Lost to Follow-up|0|||
124698263|NCT02614066|448516078|FG001|Overall Study|Lost to Follow-up|2|||
124698264|NCT02614066|448516079|FG002|Overall Study|Lost to Follow-up|2|||
124698265|NCT02614066|448516080|FG003|Overall Study|Lost to Follow-up|2|||
124698266|NCT02614066|448516077|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
124698267|NCT02614066|448516078|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
124698268|NCT02614066|448516079|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
124698269|NCT02614066|448516080|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
124698270|NCT02614066|448516077|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
124698271|NCT02614066|448516078|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
124698272|NCT02614066|448516079|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
124454836|NCT01431274|447625396|FG003|Overall Study|Other reason not stated above|2|||
124454837|NCT01431274|447625397|FG004|Overall Study|Other reason not stated above|4|||
124698273|NCT02614066|448516080|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
124698274|NCT02614066|448516077|FG000|Overall Study|Reason not specified|0|||
124698275|NCT02614066|448516078|FG001|Overall Study|Reason not specified|2|||
124698276|NCT02614066|448516079|FG002|Overall Study|Reason not specified|1|||
124698277|NCT02614066|448516080|FG003|Overall Study|Reason not specified|1|||
124698278|NCT04565756|448516081|FG000|Overall Study|Withdrawal by Subject|0|||
124698279|NCT04565756|448516082|FG001|Overall Study|Withdrawal by Subject|0|||
124698280|NCT04565756|448516083|FG002|Overall Study|Withdrawal by Subject|0|||
124698281|NCT04565756|448516084|FG003|Overall Study|Withdrawal by Subject|0|||
124698282|NCT04565756|448516085|FG004|Overall Study|Withdrawal by Subject|1|||
124698283|NCT04565756|448516086|FG005|Overall Study|Withdrawal by Subject|0|||
124698284|NCT04565756|448516081|FG000|Overall Study|Protocol Violation|0|||
124698285|NCT04565756|448516082|FG001|Overall Study|Protocol Violation|0|||
124698286|NCT04565756|448516083|FG002|Overall Study|Protocol Violation|0|||
124698287|NCT04565756|448516084|FG003|Overall Study|Protocol Violation|0|||
124698288|NCT04565756|448516085|FG004|Overall Study|Protocol Violation|0|||
124698289|NCT04565756|448516086|FG005|Overall Study|Protocol Violation|1|||
124698290|NCT00968968|448516093|FG000|Overall Study|Study closed/terminated|10|||
124698291|NCT00968968|448516094|FG001|Overall Study|Study closed/terminated|10|||
124698292|NCT00968968|448516093|FG000|Overall Study|Protocol defined stopping criteria|3|||
124698293|NCT00968968|448516094|FG001|Overall Study|Protocol defined stopping criteria|1|||
124698294|NCT00968968|448516093|FG000|Overall Study|Withdrawal by Subject|2|||
124698295|NCT00968968|448516094|FG001|Overall Study|Withdrawal by Subject|0|||
124698296|NCT00968968|448516093|FG000|Overall Study|Physician Decision|1|||
124698297|NCT00968968|448516094|FG001|Overall Study|Physician Decision|2|||
124698298|NCT00968968|448516093|FG000|Overall Study|Lost to Follow-up|0|||
124698299|NCT00968968|448516094|FG001|Overall Study|Lost to Follow-up|1|||
124698300|NCT01185366|448516095|FG000|First Line Therapy|Insurance Coverage Denied|1|||
124698301|NCT01185366|448516096|FG001|First Line Therapy|Insurance Coverage Denied|1|||
124698302|NCT01185366|448516095|FG000|First Line Therapy|Withdrawal by Subject|1|||
124698303|NCT01185366|448516096|FG001|First Line Therapy|Withdrawal by Subject|0|||
124698304|NCT01185366|448516095|FG000|First Line Therapy|Lack of Metastatic Site|1|||
124698305|NCT01185366|448516096|FG001|First Line Therapy|Lack of Metastatic Site|0|||
124698306|NCT01185366|448516095|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
124698307|NCT01185366|448516096|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
124698308|NCT01185366|448516095|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
124698309|NCT01185366|448516096|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
124698310|NCT01185366|448516095|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
124698311|NCT01185366|448516096|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
124698312|NCT01185366|448516095|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
124698313|NCT01185366|448516096|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
124698314|NCT00025233|448516101|FG000|Overall Study|Ineligible: wrong cell type|1|||
124698315|NCT00025233|448516101|FG000|Overall Study|Ineligible: wrong primary|1|||
124698316|NCT00025233|448516101|FG000|Overall Study|Ineligible: improper prior treatment|1|||
124698317|NCT00025233|448516101|FG000|Overall Study|Never treated|1|||
124698318|NCT03072875|448516106|FG000|Overall Study|Lost to Follow-up|1|||
124698319|NCT01720602|448516107|FG000|Overall Study|Adverse Event|3|||
124698320|NCT01720602|448516107|FG000|Overall Study|Progressive disease on therapy|2|||
124698321|NCT02413346|448516110|FG000|Overall Study|Adverse Event|6|||
124698322|NCT02413346|448516111|FG001|Overall Study|Adverse Event|6|||
124698323|NCT02413346|448516110|FG000|Overall Study|Withdrawal by Subject|30|||
124698324|NCT02413346|448516111|FG001|Overall Study|Withdrawal by Subject|40|||
124698325|NCT02413346|448516110|FG000|Overall Study|Lost to Follow-up|17|||
124698326|NCT02413346|448516111|FG001|Overall Study|Lost to Follow-up|21|||
124698327|NCT02413346|448516110|FG000|Overall Study|Protocol Violation|2|||
124698328|NCT02413346|448516111|FG001|Overall Study|Protocol Violation|0|||
124698329|NCT02413346|448516110|FG000|Overall Study|Other Miscellaneous Reasons|4|||
124698330|NCT02413346|448516111|FG001|Overall Study|Other Miscellaneous Reasons|3|||
124698331|NCT01316900|448516130|FG000|Overall Study|Adverse Event|10|||
124698332|NCT01316900|448516131|FG001|Overall Study|Adverse Event|10|||
124698333|NCT01316900|448516132|FG002|Overall Study|Adverse Event|15|||
124698334|NCT01316900|448516133|FG003|Overall Study|Adverse Event|9|||
124698335|NCT01316900|448516130|FG000|Overall Study|Lack of Efficacy|17|||
124698336|NCT01316900|448516131|FG001|Overall Study|Lack of Efficacy|9|||
124698337|NCT01316900|448516132|FG002|Overall Study|Lack of Efficacy|5|||
124698338|NCT01316900|448516133|FG003|Overall Study|Lack of Efficacy|7|||
124698339|NCT01316900|448516130|FG000|Overall Study|Protocol Violation|7|||
124698340|NCT01316900|448516131|FG001|Overall Study|Protocol Violation|1|||
124698341|NCT01316900|448516132|FG002|Overall Study|Protocol Violation|4|||
124698342|NCT01316900|448516133|FG003|Overall Study|Protocol Violation|0|||
124698343|NCT01316900|448516130|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
124698344|NCT01316900|448516131|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
124698345|NCT01316900|448516132|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
124698346|NCT01316900|448516133|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
124698347|NCT01316900|448516130|FG000|Overall Study|Lost to Follow-up|1|||
124698348|NCT01316900|448516131|FG001|Overall Study|Lost to Follow-up|0|||
124698349|NCT01316900|448516132|FG002|Overall Study|Lost to Follow-up|1|||
124698350|NCT01316900|448516133|FG003|Overall Study|Lost to Follow-up|1|||
124698351|NCT01316900|448516130|FG000|Overall Study|Withdrawal by Subject|7|||
124698352|NCT01316900|448516131|FG001|Overall Study|Withdrawal by Subject|8|||
124698353|NCT01316900|448516132|FG002|Overall Study|Withdrawal by Subject|6|||
124698354|NCT01316900|448516133|FG003|Overall Study|Withdrawal by Subject|9|||
124698355|NCT01684033|448516136|FG000|Period 1, First 30 Days|Adverse Event|1|||
124698356|NCT01684033|448516137|FG001|Period 1, First 30 Days|Adverse Event|1|||
124698357|NCT01684033|448516136|FG000|Period 1, First 30 Days|Noncompliance|1|||
124698358|NCT01684033|448516137|FG001|Period 1, First 30 Days|Noncompliance|0|||
124698359|NCT01684033|448516136|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
124698360|NCT01684033|448516137|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
124698361|NCT01684033|448516136|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
124698362|NCT01684033|448516137|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
124698363|NCT01684033|448516136|FG000|Period 2, Second 30 Days|Adverse Event|1|||
124698364|NCT01684033|448516137|FG001|Period 2, Second 30 Days|Adverse Event|0|||
124698365|NCT00507507|448516140|FG000|Treatment Period|Lost to Follow-up|0|||
124698366|NCT00507507|448516141|FG001|Treatment Period|Lost to Follow-up|2|||
124698367|NCT00507507|448516140|FG000|Treatment Period|Physician Decision|4|||
124698368|NCT00507507|448516141|FG001|Treatment Period|Physician Decision|1|||
124698369|NCT00507507|448516140|FG000|Treatment Period|Protocol Violation|1|||
124698370|NCT00507507|448516141|FG001|Treatment Period|Protocol Violation|2|||
124698371|NCT00507507|448516140|FG000|Treatment Period|Adverse Event|1|||
124698372|NCT00507507|448516141|FG001|Treatment Period|Adverse Event|1|||
124698373|NCT00507507|448516140|FG000|Treatment Period|Withdrawal by Subject|46|||
124698374|NCT00507507|448516141|FG001|Treatment Period|Withdrawal by Subject|47|||
124698375|NCT00507507|448516140|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
124698376|NCT00507507|448516141|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
124698377|NCT00507507|448516140|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
124698378|NCT00507507|448516141|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
124698379|NCT00507507|448516140|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
124698380|NCT00507507|448516141|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
124698381|NCT02916433|448516142|FG000|Overall Study|Withdrawal by Subject|1|||
124698382|NCT02916433|448516143|FG001|Overall Study|Withdrawal by Subject|0|||
124698383|NCT02916433|448516142|FG000|Overall Study|Physician Decision|1|||
124698384|NCT02916433|448516143|FG001|Overall Study|Physician Decision|0|||
124698385|NCT01623154|448516144|FG000|Overall Study|Did not drink Pranactin Citric|4|||
124698386|NCT01412983|448516145|FG000|1st Period|Ineligible|0|||
124698387|NCT01412983|448516146|FG001|1st Period|Ineligible|1|||
124698388|NCT01412983|448516145|FG000|1st Period|Positive slit lamp finding|0|||
124698389|NCT01412983|448516146|FG001|1st Period|Positive slit lamp finding|1|||
124698390|NCT01412983|448516145|FG000|1st Period|Unacceptable lens movement|0|||
124698391|NCT01412983|448516146|FG001|1st Period|Unacceptable lens movement|1|||
124698392|NCT01412983|448516145|FG000|1st Period|Inability to maintain wear|0|||
124698393|NCT01412983|448516146|FG001|1st Period|Inability to maintain wear|1|||
124698394|NCT00890097|448516147|FG000|Overall Study|Adverse Event|21|||
124698395|NCT00890097|448516148|FG001|Overall Study|Adverse Event|32|||
124698396|NCT00890097|448516149|FG002|Overall Study|Adverse Event|28|||
124698397|NCT00890097|448516147|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
124698398|NCT00890097|448516148|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
124698399|NCT00890097|448516149|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
124698400|NCT00890097|448516147|FG000|Overall Study|Withdrew Consent|9|||
124698401|NCT00890097|448516148|FG001|Overall Study|Withdrew Consent|6|||
124698402|NCT00890097|448516149|FG002|Overall Study|Withdrew Consent|9|||
124698403|NCT00890097|448516147|FG000|Overall Study|Lost to Follow-up|5|||
124698404|NCT00890097|448516148|FG001|Overall Study|Lost to Follow-up|5|||
124698405|NCT00890097|448516149|FG002|Overall Study|Lost to Follow-up|5|||
124698406|NCT00890097|448516147|FG000|Overall Study|Noncompliance|0|||
124698407|NCT00890097|448516148|FG001|Overall Study|Noncompliance|4|||
124698408|NCT00890097|448516149|FG002|Overall Study|Noncompliance|4|||
124698409|NCT00890097|448516147|FG000|Overall Study|Sponsor Decision|7|||
124698410|NCT00890097|448516148|FG001|Overall Study|Sponsor Decision|11|||
124698411|NCT00890097|448516149|FG002|Overall Study|Sponsor Decision|7|||
124698412|NCT00890097|448516147|FG000|Overall Study|Did not attend final visit|2|||
124698413|NCT00890097|448516148|FG001|Overall Study|Did not attend final visit|3|||
124698414|NCT00890097|448516149|FG002|Overall Study|Did not attend final visit|0|||
124698415|NCT00890097|448516147|FG000|Overall Study|Subject Decision|3|||
124698416|NCT00890097|448516148|FG001|Overall Study|Subject Decision|2|||
124698417|NCT00890097|448516149|FG002|Overall Study|Subject Decision|6|||
124698418|NCT00890097|448516147|FG000|Overall Study|Randomization Error|2|||
124698419|NCT00890097|448516148|FG001|Overall Study|Randomization Error|0|||
124698420|NCT00890097|448516149|FG002|Overall Study|Randomization Error|0|||
124698421|NCT00890097|448516147|FG000|Overall Study|Failed inclusion criteria|3|||
124698422|NCT00890097|448516148|FG001|Overall Study|Failed inclusion criteria|4|||
124698423|NCT00890097|448516149|FG002|Overall Study|Failed inclusion criteria|0|||
124698424|NCT00890097|448516147|FG000|Overall Study|Transportation|0|||
124698425|NCT00890097|448516148|FG001|Overall Study|Transportation|2|||
124698426|NCT00890097|448516149|FG002|Overall Study|Transportation|0|||
124698427|NCT00890097|448516147|FG000|Overall Study|Subject Moved|0|||
124698428|NCT00890097|448516148|FG001|Overall Study|Subject Moved|4|||
124698429|NCT00890097|448516149|FG002|Overall Study|Subject Moved|0|||
124698430|NCT00890097|448516147|FG000|Overall Study|Protocol Deviation|1|||
124698431|NCT00890097|448516148|FG001|Overall Study|Protocol Deviation|1|||
124698432|NCT00890097|448516149|FG002|Overall Study|Protocol Deviation|1|||
124698433|NCT00185614|448517962|FG000|Inter-treatment Period|Physician Decision|1|||
124698434|NCT00185614|448517962|FG000|Inter-treatment Period|Relapse|2|||
124698435|NCT00185614|448517962|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
124698436|NCT00107614|448517963|FG000|Overall Study|Physician Decision|10|||
124698437|NCT00107614|448517963|FG000|Overall Study|Death|2|||
124698438|NCT02715856|448517967|FG000|Overall Study|Software Issues|12|||
124698439|NCT02715856|448517968|FG001|Overall Study|Software Issues|7|||
124698440|NCT02715856|448517967|FG000|Overall Study|Death|6|||
124698441|NCT02715856|448517968|FG001|Overall Study|Death|5|||
124698442|NCT02715856|448517967|FG000|Overall Study|Non- Compliant|0|||
124698443|NCT02715856|448517968|FG001|Overall Study|Non- Compliant|40|||
124698444|NCT02462057|448517969|FG000|Overall Study|Left Vitality|32|||
124698445|NCT02462057|448517970|FG001|Overall Study|Left Vitality|27|||
124698446|NCT02462057|448517971|FG002|Overall Study|Left Vitality|23|||
124698447|NCT02462057|448517972|FG003|Overall Study|Left Vitality|35|||
124698448|NCT02462057|448517973|FG004|Overall Study|Left Vitality|33|||
124698449|NCT02462057|448517969|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
124698450|NCT02462057|448517970|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
124698451|NCT02462057|448517971|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
124698452|NCT02462057|448517972|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
124698453|NCT02462057|448517973|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
124698454|NCT02336555|448517974|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124698455|NCT02336555|448517975|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
124698456|NCT02336555|448517974|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
124698457|NCT02336555|448517975|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
124698458|NCT02336555|448517974|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
124698459|NCT02336555|448517975|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
124698460|NCT01633112|448517976|FG000|Overall Study|Lack of Efficacy|1|||
124698461|NCT01633112|448517977|FG001|Overall Study|Lack of Efficacy|6|||
124698462|NCT01633112|448517978|FG002|Overall Study|Lack of Efficacy|13|||
124698463|NCT01633112|448517976|FG000|Overall Study|Abnormal laboratory value(s)|3|||
124698464|NCT01633112|448517977|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124698465|NCT01633112|448517978|FG002|Overall Study|Abnormal laboratory value(s)|0|||
124698466|NCT01633112|448517976|FG000|Overall Study|Abnormal test procedure result(s)|0|||
124698467|NCT01633112|448517977|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124698468|NCT01633112|448517978|FG002|Overall Study|Abnormal test procedure result(s)|0|||
124698469|NCT01633112|448517976|FG000|Overall Study|Administrative problems|1|||
124698470|NCT01633112|448517977|FG001|Overall Study|Administrative problems|2|||
124698471|NCT01633112|448517978|FG002|Overall Study|Administrative problems|5|||
124698472|NCT01633112|448517976|FG000|Overall Study|Adverse Event|16|||
124698473|NCT01633112|448517977|FG001|Overall Study|Adverse Event|18|||
124698474|NCT01633112|448517978|FG002|Overall Study|Adverse Event|20|||
124698475|NCT01633112|448517976|FG000|Overall Study|Lost to Follow-up|7|||
124698476|NCT01633112|448517977|FG001|Overall Study|Lost to Follow-up|19|||
124698477|NCT01633112|448517978|FG002|Overall Study|Lost to Follow-up|6|||
124698478|NCT01633112|448517976|FG000|Overall Study|Protocol Violation|4|||
124698479|NCT01633112|448517977|FG001|Overall Study|Protocol Violation|0|||
124698480|NCT01633112|448517978|FG002|Overall Study|Protocol Violation|2|||
124698481|NCT01633112|448517976|FG000|Overall Study|Subject no longer requires study drug|0|||
124454838|NCT00711425|447625402|FG000|Overall Study|Protocol Violation|1|||
124698482|NCT01633112|448517977|FG001|Overall Study|Subject no longer requires study drug|0|||
124698483|NCT01633112|448517978|FG002|Overall Study|Subject no longer requires study drug|1|||
124698484|NCT01633112|448517976|FG000|Overall Study|Withdrawal by Subject|20|||
124698485|NCT01633112|448517977|FG001|Overall Study|Withdrawal by Subject|12|||
124698486|NCT01633112|448517978|FG002|Overall Study|Withdrawal by Subject|41|||
124698487|NCT01633112|448517976|FG000|Overall Study|missing Study Completion CRF|1|||
124698488|NCT01633112|448517977|FG001|Overall Study|missing Study Completion CRF|1|||
124698489|NCT01633112|448517978|FG002|Overall Study|missing Study Completion CRF|4|||
124698490|NCT01908699|448517979|FG000|Overall Study|Adverse Event|8|||
124698491|NCT01908699|448517980|FG001|Overall Study|Adverse Event|12|||
124698492|NCT01908699|448517979|FG000|Overall Study|Lack of Efficacy|2|||
124698493|NCT01908699|448517980|FG001|Overall Study|Lack of Efficacy|2|||
124698494|NCT01908699|448517979|FG000|Overall Study|Lost to Follow-up|2|||
124698495|NCT01908699|448517980|FG001|Overall Study|Lost to Follow-up|4|||
124698496|NCT01908699|448517979|FG000|Overall Study|Physician Decision|8|||
124698497|NCT01908699|448517980|FG001|Overall Study|Physician Decision|8|||
124698498|NCT01908699|448517979|FG000|Overall Study|Withdrawal by Subject|15|||
124698499|NCT01908699|448517980|FG001|Overall Study|Withdrawal by Subject|10|||
124698500|NCT01908699|448517979|FG000|Overall Study|Pregnancy|0|||
124698501|NCT01908699|448517980|FG001|Overall Study|Pregnancy|1|||
124698502|NCT01908699|448517979|FG000|Overall Study|Randomized in Error|1|||
124545989|NCT00943826|447954442|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
124545990|NCT00943826|447954443|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
124698503|NCT01908699|448517980|FG001|Overall Study|Randomized in Error|0|||
124698504|NCT01908699|448517979|FG000|Overall Study|Death|9|||
124698505|NCT01908699|448517980|FG001|Overall Study|Death|12|||
124698506|NCT01908699|448517979|FG000|Overall Study|Progressive Disease|30|||
124698507|NCT01908699|448517980|FG001|Overall Study|Progressive Disease|29|||
124698508|NCT01697501|448517981|FG000|Overall Study|Protocol Violation|2|||
124698509|NCT02094885|448517984|FG000|Overall Study|Death|1|||
124698510|NCT02094885|448517985|FG001|Overall Study|Death|5|||
124698511|NCT02094885|448517984|FG000|Overall Study|Withdrawn due to age|1|||
124698512|NCT02094885|448517985|FG001|Overall Study|Withdrawn due to age|0|||
124698513|NCT00889005|448517988|FG000|Overall Study|Lost to Follow-up|4|||
124698514|NCT00889005|448517989|FG001|Overall Study|Lost to Follow-up|2|||
124698515|NCT00889005|448517988|FG000|Overall Study|Withdrawal by Subject|4|||
124698516|NCT00889005|448517989|FG001|Overall Study|Withdrawal by Subject|0|||
124698517|NCT00215553|448517996|FG000|Overall Study|Adverse Event|0|||
124698518|NCT00215553|448517997|FG001|Overall Study|Adverse Event|1|||
124698519|NCT00215553|448517998|FG002|Overall Study|Adverse Event|2|||
124698520|NCT00215553|448517999|FG003|Overall Study|Adverse Event|1|||
124698521|NCT00215553|448518000|FG004|Overall Study|Adverse Event|2|||
124698522|NCT00215553|448518001|FG005|Overall Study|Adverse Event|6|||
124698523|NCT00215553|448518002|FG006|Overall Study|Adverse Event|0|||
124698524|NCT00756314|448518003|FG000|Overall Study|Lost to Follow-up|2|||
124698525|NCT00756314|448518004|FG001|Overall Study|Lost to Follow-up|59|||
124698526|NCT02605967|448518006|FG000|Overall Study|subject / guardian decision|1|||
124698527|NCT02605967|448518007|FG001|Overall Study|subject / guardian decision|2|||
124698528|NCT02605967|448518006|FG000|Overall Study|Physician Decision|10|||
124698529|NCT02605967|448518007|FG001|Overall Study|Physician Decision|1|||
124698530|NCT02605967|448518006|FG000|Overall Study|Death|4|||
124698531|NCT02605967|448518007|FG001|Overall Study|Death|2|||
124698532|NCT02605967|448518006|FG000|Overall Study|Adverse Event|1|||
124698533|NCT02605967|448518007|FG001|Overall Study|Adverse Event|0|||
124698534|NCT02605967|448518006|FG000|Overall Study|progressive disease|66|||
124698535|NCT02605967|448518007|FG001|Overall Study|progressive disease|35|||
124698536|NCT00159874|448518012|FG000|Overall Study|Adverse Event|2|||
124698537|NCT00159874|448518013|FG001|Overall Study|Adverse Event|2|||
124698538|NCT00159874|448518014|FG002|Overall Study|Adverse Event|5|||
124698539|NCT00159874|448518015|FG003|Overall Study|Adverse Event|1|||
124698540|NCT00159874|448518016|FG004|Overall Study|Adverse Event|1|||
124698541|NCT00159874|448518017|FG005|Overall Study|Adverse Event|2|||
124698542|NCT00159874|448518018|FG006|Overall Study|Adverse Event|0|||
124698543|NCT00159874|448518012|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
124698544|NCT00159874|448518013|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
124698545|NCT00159874|448518014|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
124698546|NCT00159874|448518015|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
124698547|NCT00159874|448518016|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
124698548|NCT00159874|448518017|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
124698549|NCT00159874|448518018|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
124698550|NCT00159874|448518012|FG000|Overall Study|Lack of Efficacy|2|||
124698551|NCT00159874|448518013|FG001|Overall Study|Lack of Efficacy|0|||
124698552|NCT00159874|448518014|FG002|Overall Study|Lack of Efficacy|1|||
124698553|NCT00159874|448518015|FG003|Overall Study|Lack of Efficacy|1|||
124698554|NCT00159874|448518016|FG004|Overall Study|Lack of Efficacy|0|||
124698555|NCT00159874|448518017|FG005|Overall Study|Lack of Efficacy|3|||
124698556|NCT00159874|448518018|FG006|Overall Study|Lack of Efficacy|0|||
124698557|NCT00159874|448518012|FG000|Overall Study|Lost to Follow-up|1|||
124698558|NCT00159874|448518013|FG001|Overall Study|Lost to Follow-up|0|||
124698559|NCT00159874|448518014|FG002|Overall Study|Lost to Follow-up|3|||
124698560|NCT00159874|448518015|FG003|Overall Study|Lost to Follow-up|0|||
124698561|NCT00159874|448518016|FG004|Overall Study|Lost to Follow-up|1|||
124698562|NCT00159874|448518017|FG005|Overall Study|Lost to Follow-up|2|||
124698563|NCT00159874|448518018|FG006|Overall Study|Lost to Follow-up|1|||
124698564|NCT00159874|448518012|FG000|Overall Study|Other|8|||
124698565|NCT00159874|448518013|FG001|Overall Study|Other|8|||
124698566|NCT00159874|448518014|FG002|Overall Study|Other|8|||
124698567|NCT00159874|448518015|FG003|Overall Study|Other|0|||
124698568|NCT00159874|448518016|FG004|Overall Study|Other|2|||
124698569|NCT00159874|448518017|FG005|Overall Study|Other|1|||
124698570|NCT00159874|448518018|FG006|Overall Study|Other|3|||
124928267|NCT04447755|449368332|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
124698571|NCT00159874|448518012|FG000|Overall Study|Protocol Violation|0|||
124698572|NCT00159874|448518013|FG001|Overall Study|Protocol Violation|5|||
124698573|NCT00159874|448518014|FG002|Overall Study|Protocol Violation|2|||
124698574|NCT00159874|448518015|FG003|Overall Study|Protocol Violation|0|||
124698575|NCT00159874|448518016|FG004|Overall Study|Protocol Violation|0|||
124698576|NCT00159874|448518017|FG005|Overall Study|Protocol Violation|0|||
124698577|NCT00159874|448518018|FG006|Overall Study|Protocol Violation|0|||
124698578|NCT00159874|448518012|FG000|Overall Study|Death|3|||
124698579|NCT00159874|448518013|FG001|Overall Study|Death|8|||
124698580|NCT00159874|448518014|FG002|Overall Study|Death|15|||
124698581|NCT00159874|448518015|FG003|Overall Study|Death|0|||
124698582|NCT00159874|448518016|FG004|Overall Study|Death|1|||
124698583|NCT00159874|448518017|FG005|Overall Study|Death|2|||
124698584|NCT00159874|448518018|FG006|Overall Study|Death|0|||
124698585|NCT00159874|448518012|FG000|Overall Study|Withdrawal by Subject|2|||
124698586|NCT00159874|448518013|FG001|Overall Study|Withdrawal by Subject|6|||
124698587|NCT00159874|448518014|FG002|Overall Study|Withdrawal by Subject|8|||
124698588|NCT00159874|448518015|FG003|Overall Study|Withdrawal by Subject|4|||
124698589|NCT00159874|448518016|FG004|Overall Study|Withdrawal by Subject|3|||
124698590|NCT00159874|448518017|FG005|Overall Study|Withdrawal by Subject|2|||
124698591|NCT00159874|448518018|FG006|Overall Study|Withdrawal by Subject|1|||
124698592|NCT00159874|448518012|FG000|Overall Study|Pregnancy|1|||
124698593|NCT00159874|448518013|FG001|Overall Study|Pregnancy|1|||
124698594|NCT00159874|448518014|FG002|Overall Study|Pregnancy|0|||
124698595|NCT00159874|448518015|FG003|Overall Study|Pregnancy|0|||
124698596|NCT00159874|448518016|FG004|Overall Study|Pregnancy|0|||
124698597|NCT00159874|448518017|FG005|Overall Study|Pregnancy|0|||
124698598|NCT00159874|448518018|FG006|Overall Study|Pregnancy|0|||
124698599|NCT01475825|448518022|FG000|Overall Study|Adverse Event|41|||
124698600|NCT01475825|448518023|FG001|Overall Study|Adverse Event|15|||
124698601|NCT01475825|448518024|FG002|Overall Study|Adverse Event|27|||
124698602|NCT01475825|448518025|FG003|Overall Study|Adverse Event|11|||
124698603|NCT01475825|448518022|FG000|Overall Study|Death|1|||
124698604|NCT01475825|448518023|FG001|Overall Study|Death|0|||
124698605|NCT01475825|448518024|FG002|Overall Study|Death|1|||
124698606|NCT01475825|448518025|FG003|Overall Study|Death|0|||
124698607|NCT01475825|448518022|FG000|Overall Study|Lack of Efficacy|0|||
124698608|NCT01475825|448518023|FG001|Overall Study|Lack of Efficacy|0|||
124698609|NCT01475825|448518024|FG002|Overall Study|Lack of Efficacy|1|||
124698610|NCT01475825|448518025|FG003|Overall Study|Lack of Efficacy|0|||
124698611|NCT01475825|448518022|FG000|Overall Study|Lost to Follow-up|0|||
124698612|NCT01475825|448518023|FG001|Overall Study|Lost to Follow-up|0|||
124698613|NCT01475825|448518024|FG002|Overall Study|Lost to Follow-up|3|||
124698614|NCT01475825|448518025|FG003|Overall Study|Lost to Follow-up|1|||
124698615|NCT01475825|448518022|FG000|Overall Study|Non-compliance with Study Drug|1|||
124698616|NCT01475825|448518023|FG001|Overall Study|Non-compliance with Study Drug|2|||
124698617|NCT01475825|448518024|FG002|Overall Study|Non-compliance with Study Drug|4|||
124698618|NCT01475825|448518025|FG003|Overall Study|Non-compliance with Study Drug|0|||
124698619|NCT01475825|448518022|FG000|Overall Study|Other: Not available|0|||
124698620|NCT01475825|448518023|FG001|Overall Study|Other: Not available|0|||
124698621|NCT01475825|448518024|FG002|Overall Study|Other: Not available|2|||
124698622|NCT01475825|448518025|FG003|Overall Study|Other: Not available|0|||
124698623|NCT01475825|448518022|FG000|Overall Study|Protocol Violation|1|||
124698624|NCT01475825|448518023|FG001|Overall Study|Protocol Violation|0|||
124698625|NCT01475825|448518024|FG002|Overall Study|Protocol Violation|0|||
124698626|NCT01475825|448518025|FG003|Overall Study|Protocol Violation|0|||
124698627|NCT01475825|448518022|FG000|Overall Study|Physician Decision|0|||
124698628|NCT01475825|448518023|FG001|Overall Study|Physician Decision|1|||
124698629|NCT01475825|448518024|FG002|Overall Study|Physician Decision|0|||
124698630|NCT01475825|448518025|FG003|Overall Study|Physician Decision|0|||
124698631|NCT01475825|448518022|FG000|Overall Study|Withdrawal by Subject|8|||
124698632|NCT01475825|448518023|FG001|Overall Study|Withdrawal by Subject|3|||
124698633|NCT01475825|448518024|FG002|Overall Study|Withdrawal by Subject|11|||
124698634|NCT01475825|448518025|FG003|Overall Study|Withdrawal by Subject|7|||
124698635|NCT01475825|448518022|FG000|Overall Study|Did not enter OLC|15|||
124698636|NCT01475825|448518023|FG001|Overall Study|Did not enter OLC|11|||
124698637|NCT01475825|448518024|FG002|Overall Study|Did not enter OLC|15|||
124698638|NCT01475825|448518025|FG003|Overall Study|Did not enter OLC|11|||
124698639|NCT00309946|448518028|FG000|Overall Study|Withdrawal by Subject|1|||
124698640|NCT01347086|448518032|FG000|Overall Study|failed screening visit|0|||
124698641|NCT01347086|448518033|FG001|Overall Study|failed screening visit|0|||
124698642|NCT01347086|448518034|FG002|Overall Study|failed screening visit|1|||
124698643|NCT01347086|448518035|FG003|Overall Study|failed screening visit|0|||
124698644|NCT01347086|448518036|FG004|Overall Study|failed screening visit|0|||
124698645|NCT01347086|448518037|FG005|Overall Study|failed screening visit|0|||
124698646|NCT01347086|448518038|FG006|Overall Study|failed screening visit|1|||
124698647|NCT01347086|448518039|FG007|Overall Study|failed screening visit|1|||
124698648|NCT01347086|448518040|FG008|Overall Study|failed screening visit|0|||
124698649|NCT01347086|448518041|FG009|Overall Study|failed screening visit|1|||
124698650|NCT00395447|448518043|FG000|Overall Study|Death|37|||
124698651|NCT00395447|448518044|FG001|Overall Study|Death|32|||
124698652|NCT00395447|448518043|FG000|Overall Study|Lost to Follow-up|52|||
124698653|NCT00395447|448518044|FG001|Overall Study|Lost to Follow-up|43|||
124698654|NCT00395447|448518043|FG000|Overall Study|Withdrawal by Subject|24|||
124698655|NCT00395447|448518044|FG001|Overall Study|Withdrawal by Subject|19|||
124698656|NCT00395447|448518043|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
124698657|NCT00395447|448518044|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
124698658|NCT02264821|448518046|FG000|Overall Study|Protocol Violation|1|||
124698659|NCT02264821|448518047|FG001|Overall Study|Protocol Violation|3|||
124698660|NCT02264821|448518048|FG002|Overall Study|Protocol Violation|6|||
124698661|NCT00489359|448518049|FG000|Overall Study|Death|0|||
124698662|NCT00489359|448518050|FG001|Overall Study|Death|2|||
124698663|NCT00489359|448518049|FG000|Overall Study|Progressive Disease|5|||
124698664|NCT00489359|448518050|FG001|Overall Study|Progressive Disease|6|||
124698665|NCT00489359|448518049|FG000|Overall Study|Lost to Follow-up|1|||
124698666|NCT00489359|448518050|FG001|Overall Study|Lost to Follow-up|0|||
124698667|NCT00489359|448518049|FG000|Overall Study|Withdrawal by Subject|1|||
124698668|NCT00489359|448518050|FG001|Overall Study|Withdrawal by Subject|5|||
124698669|NCT00489359|448518049|FG000|Overall Study|Adverse Event|0|||
124698670|NCT00489359|448518050|FG001|Overall Study|Adverse Event|16|||
124698671|NCT02100644|448518052|FG000|LTG Escalation Phase|Adverse Event|9|||
124698672|NCT02100644|448518053|FG001|LTG Escalation Phase|Adverse Event|0|||
124698673|NCT02100644|448518054|FG002|LTG Escalation Phase|Adverse Event|0|||
124698674|NCT02100644|448518052|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
124698675|NCT02100644|448518053|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
124698676|NCT02100644|448518054|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
124698677|NCT02100644|448518052|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
124698678|NCT02100644|448518053|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
124698679|NCT02100644|448518054|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
124698680|NCT00728182|448518055|FG000|Overall Study|Adverse Event|1|||
124698681|NCT00728182|448518056|FG001|Overall Study|Adverse Event|0|||
124698682|NCT00728182|448518055|FG000|Overall Study|Lost to Follow-up|2|||
124698683|NCT00728182|448518056|FG001|Overall Study|Lost to Follow-up|0|||
124698684|NCT00728182|448518055|FG000|Overall Study|Death|0|||
124698685|NCT00728182|448518056|FG001|Overall Study|Death|2|||
124698686|NCT00728182|448518055|FG000|Overall Study|Protocol Noncompliance|0|||
124698687|NCT00728182|448518056|FG001|Overall Study|Protocol Noncompliance|1|||
124698688|NCT01898091|448518058|FG000|Overall Study|Lost to Follow-up|1|||
124698689|NCT01898091|448518059|FG001|Overall Study|Lost to Follow-up|1|||
124698690|NCT01898091|448518058|FG000|Overall Study|Withdrawal by Subject|1|||
124698691|NCT01898091|448518059|FG001|Overall Study|Withdrawal by Subject|5|||
124698692|NCT04754399|448518060|FG000|Overall Study|Adverse Event|5|||
124698693|NCT04754399|448518060|FG000|Overall Study|Withdrawal by Subject|6|||
124698694|NCT00231465|448518061|FG000|Overall Study|Completed only one cycle|1|||
124698695|NCT00231465|448518061|FG000|Overall Study|Did not have follow up CT scans|1|||
124698696|NCT00930176|448518063|FG000|Overall Study|Death|1|||
124698697|NCT00401830|448518067|FG000|Overall Study|Adverse Event|10|||
124698698|NCT00401830|448518068|FG001|Overall Study|Adverse Event|18|||
124698699|NCT00401830|448518067|FG000|Overall Study|Lack of Efficacy|11|||
124698700|NCT00401830|448518068|FG001|Overall Study|Lack of Efficacy|5|||
124698701|NCT00401830|448518067|FG000|Overall Study|Withdrawal by Subject|4|||
124698702|NCT00401830|448518068|FG001|Overall Study|Withdrawal by Subject|3|||
124698703|NCT00401830|448518067|FG000|Overall Study|Protocol Violation|3|||
124698704|NCT00401830|448518068|FG001|Overall Study|Protocol Violation|3|||
124454839|NCT00711425|447625402|FG000|Overall Study|Death|2|||
124454840|NCT00711425|447625402|FG000|Overall Study|Lost to Follow-up|1|||
124698705|NCT00401830|448518067|FG000|Overall Study|Non-compliance with drug study|1|||
124698706|NCT00401830|448518068|FG001|Overall Study|Non-compliance with drug study|0|||
124698707|NCT00401830|448518067|FG000|Overall Study|Lost to Follow-up|1|||
124698708|NCT00401830|448518068|FG001|Overall Study|Lost to Follow-up|3|||
124698709|NCT00401830|448518067|FG000|Overall Study|Other: Personal / Family problems|1|||
124698710|NCT00401830|448518068|FG001|Overall Study|Other: Personal / Family problems|0|||
124698711|NCT01943825|448518069|FG000|Overall Study|Lost to Follow-up|9|||
124698712|NCT01943825|448518070|FG001|Overall Study|Lost to Follow-up|3|||
124698713|NCT01943825|448518071|FG002|Overall Study|Lost to Follow-up|12|||
124698714|NCT01943825|448518072|FG003|Overall Study|Lost to Follow-up|8|||
124698715|NCT01943825|448518069|FG000|Overall Study|Withdrawal by Subject|1|||
124698716|NCT01943825|448518070|FG001|Overall Study|Withdrawal by Subject|0|||
124698717|NCT01943825|448518071|FG002|Overall Study|Withdrawal by Subject|3|||
124698718|NCT01943825|448518072|FG003|Overall Study|Withdrawal by Subject|2|||
124698719|NCT01943825|448518069|FG000|Overall Study|Other than specified above|0|||
124698720|NCT01943825|448518070|FG001|Overall Study|Other than specified above|1|||
124454841|NCT04607148|447625405|FG000|Overall Study|Withdrawal by Subject|0|||
124454842|NCT04607148|447625406|FG001|Overall Study|Withdrawal by Subject|4|||
124698721|NCT01943825|448518071|FG002|Overall Study|Other than specified above|0|||
124698722|NCT01943825|448518072|FG003|Overall Study|Other than specified above|1|||
124698723|NCT00452400|448518073|FG000|Overall Study|Adverse Event|1|||
124763022|NCT03010527|448757882|FG002|Overall Study|Withdrawal by Subject|4|||
124763023|NCT03010527|448757880|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
124763024|NCT03010527|448757881|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
124763025|NCT03010527|448757882|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
124763026|NCT03010527|448757880|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
124763027|NCT03010527|448757881|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
124763028|NCT03010527|448757882|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
124763029|NCT03010527|448757880|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
124763030|NCT03010527|448757881|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
124763031|NCT03010527|448757882|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
124763032|NCT02656017|448757883|FG000|Overall Study|Study burden|3|||
124763033|NCT02656017|448757884|FG001|Overall Study|Study burden|3|||
124763034|NCT02656017|448757883|FG000|Overall Study|Adverse Event|2|||
124763035|NCT02656017|448757884|FG001|Overall Study|Adverse Event|1|||
124763036|NCT02656017|448757883|FG000|Overall Study|Unable/unwilling to take study medication|2|||
124763037|NCT02656017|448757884|FG001|Overall Study|Unable/unwilling to take study medication|1|||
124763038|NCT02656017|448757883|FG000|Overall Study|Began Tolvaptan|1|||
124763039|NCT02656017|448757884|FG001|Overall Study|Began Tolvaptan|1|||
124763040|NCT02656017|448757883|FG000|Overall Study|Withdrawal by Subject|1|||
124763041|NCT02656017|448757884|FG001|Overall Study|Withdrawal by Subject|0|||
124763042|NCT04245111|448757888|FG000|Overall Study|Lost to Follow-up|5|||
124763043|NCT04245111|448757889|FG001|Overall Study|Lost to Follow-up|1|||
124763044|NCT04245111|448757890|FG002|Overall Study|Lost to Follow-up|1|||
124763045|NCT03309878|448757894|FG000|Overall Study|Adverse Event|1|||
124763046|NCT03309878|448757895|FG001|Overall Study|Adverse Event|0|||
124763047|NCT03309878|448757896|FG002|Overall Study|Adverse Event|0|||
124763048|NCT03309878|448757897|FG003|Overall Study|Adverse Event|0|||
124763049|NCT03309878|448757894|FG000|Overall Study|Did not maintain eligibility|2|||
124763050|NCT03309878|448757895|FG001|Overall Study|Did not maintain eligibility|1|||
124763051|NCT03309878|448757896|FG002|Overall Study|Did not maintain eligibility|0|||
124763052|NCT03309878|448757897|FG003|Overall Study|Did not maintain eligibility|0|||
124763053|NCT03309878|448757894|FG000|Overall Study|Withdrawal by Subject|0|||
124763054|NCT03309878|448757895|FG001|Overall Study|Withdrawal by Subject|1|||
124763055|NCT03309878|448757896|FG002|Overall Study|Withdrawal by Subject|0|||
124763056|NCT03309878|448757897|FG003|Overall Study|Withdrawal by Subject|0|||
124763057|NCT03192176|448757899|FG000|Overall Study|Adverse Event|1|||
124763058|NCT03192176|448757900|FG001|Overall Study|Adverse Event|0|||
124763059|NCT03192176|448757901|FG002|Overall Study|Adverse Event|4|||
124763060|NCT03192176|448757902|FG003|Overall Study|Adverse Event|5|||
124763061|NCT03192176|448757903|FG004|Overall Study|Adverse Event|3|||
124763062|NCT03192176|448757904|FG005|Overall Study|Adverse Event|2|||
124763063|NCT03192176|448757905|FG006|Overall Study|Adverse Event|3|||
124763064|NCT03192176|448757906|FG007|Overall Study|Adverse Event|3|||
124763065|NCT03192176|448757899|FG000|Overall Study|Lost to Follow-up|0|||
124763066|NCT03192176|448757900|FG001|Overall Study|Lost to Follow-up|0|||
124763067|NCT03192176|448757901|FG002|Overall Study|Lost to Follow-up|1|||
124763068|NCT03192176|448757902|FG003|Overall Study|Lost to Follow-up|2|||
124763069|NCT03192176|448757903|FG004|Overall Study|Lost to Follow-up|3|||
124763070|NCT03192176|448757904|FG005|Overall Study|Lost to Follow-up|1|||
124763071|NCT03192176|448757905|FG006|Overall Study|Lost to Follow-up|1|||
124763072|NCT03192176|448757906|FG007|Overall Study|Lost to Follow-up|1|||
124763073|NCT03192176|448757899|FG000|Overall Study|Physician Decision|1|||
124763074|NCT03192176|448757900|FG001|Overall Study|Physician Decision|0|||
124763075|NCT03192176|448757901|FG002|Overall Study|Physician Decision|0|||
124763076|NCT03192176|448757902|FG003|Overall Study|Physician Decision|0|||
124763077|NCT03192176|448757903|FG004|Overall Study|Physician Decision|0|||
124763078|NCT03192176|448757904|FG005|Overall Study|Physician Decision|2|||
124763079|NCT03192176|448757905|FG006|Overall Study|Physician Decision|1|||
124763080|NCT03192176|448757906|FG007|Overall Study|Physician Decision|0|||
124763081|NCT03192176|448757899|FG000|Overall Study|Protocol Deviation|1|||
124763082|NCT03192176|448757900|FG001|Overall Study|Protocol Deviation|1|||
124763083|NCT03192176|448757901|FG002|Overall Study|Protocol Deviation|0|||
124763084|NCT03192176|448757902|FG003|Overall Study|Protocol Deviation|0|||
124763085|NCT03192176|448757903|FG004|Overall Study|Protocol Deviation|2|||
124763086|NCT03192176|448757904|FG005|Overall Study|Protocol Deviation|0|||
124763087|NCT03192176|448757905|FG006|Overall Study|Protocol Deviation|0|||
124763088|NCT03192176|448757906|FG007|Overall Study|Protocol Deviation|0|||
124763089|NCT03192176|448757899|FG000|Overall Study|Withdrawal by Subject|3|||
124763090|NCT03192176|448757900|FG001|Overall Study|Withdrawal by Subject|4|||
124763091|NCT03192176|448757901|FG002|Overall Study|Withdrawal by Subject|0|||
124763092|NCT03192176|448757902|FG003|Overall Study|Withdrawal by Subject|4|||
124763093|NCT03192176|448757903|FG004|Overall Study|Withdrawal by Subject|3|||
124763094|NCT03192176|448757904|FG005|Overall Study|Withdrawal by Subject|4|||
124763095|NCT03192176|448757905|FG006|Overall Study|Withdrawal by Subject|4|||
124763096|NCT03192176|448757906|FG007|Overall Study|Withdrawal by Subject|2|||
124763097|NCT03192176|448757899|FG000|Overall Study|Miscellaneous|1|||
124763098|NCT03192176|448757900|FG001|Overall Study|Miscellaneous|0|||
124763099|NCT03192176|448757901|FG002|Overall Study|Miscellaneous|1|||
124698724|NCT00452400|448518074|FG001|Overall Study|Adverse Event|1|||
124698725|NCT00452400|448518075|FG002|Overall Study|Adverse Event|5|||
124698726|NCT00452400|448518076|FG003|Overall Study|Adverse Event|0|||
124698727|NCT00452400|448518077|FG004|Overall Study|Adverse Event|2|||
124698728|NCT00452400|448518073|FG000|Overall Study|Protocol Violation|0|||
124698729|NCT00452400|448518074|FG001|Overall Study|Protocol Violation|0|||
124698730|NCT00452400|448518075|FG002|Overall Study|Protocol Violation|1|||
124698731|NCT00452400|448518076|FG003|Overall Study|Protocol Violation|0|||
124698732|NCT00452400|448518077|FG004|Overall Study|Protocol Violation|0|||
124698733|NCT00452400|448518073|FG000|Overall Study|Lost to Follow-up|1|||
124698734|NCT00452400|448518074|FG001|Overall Study|Lost to Follow-up|0|||
124698735|NCT00452400|448518075|FG002|Overall Study|Lost to Follow-up|0|||
124698736|NCT00452400|448518076|FG003|Overall Study|Lost to Follow-up|0|||
124698737|NCT00452400|448518077|FG004|Overall Study|Lost to Follow-up|0|||
124698738|NCT00452400|448518073|FG000|Overall Study|Withdrawal by Subject|1|||
124698739|NCT00452400|448518074|FG001|Overall Study|Withdrawal by Subject|0|||
124698740|NCT00452400|448518075|FG002|Overall Study|Withdrawal by Subject|1|||
124698741|NCT00452400|448518076|FG003|Overall Study|Withdrawal by Subject|0|||
124698742|NCT00452400|448518077|FG004|Overall Study|Withdrawal by Subject|0|||
124698743|NCT00452400|448518073|FG000|Overall Study|Lack of Efficacy|2|||
124698744|NCT00452400|448518074|FG001|Overall Study|Lack of Efficacy|0|||
124698745|NCT00452400|448518075|FG002|Overall Study|Lack of Efficacy|0|||
124454843|NCT04607148|447625407|FG002|Overall Study|Withdrawal by Subject|2|||
124454844|NCT04607148|447625408|FG003|Overall Study|Withdrawal by Subject|8|||
124454845|NCT04607148|447625405|FG000|Overall Study|Study Terminated by Sponsor|14|||
124454846|NCT04607148|447625406|FG001|Overall Study|Study Terminated by Sponsor|59|||
124454847|NCT04607148|447625407|FG002|Overall Study|Study Terminated by Sponsor|9|||
124454848|NCT04607148|447625408|FG003|Overall Study|Study Terminated by Sponsor|39|||
124454849|NCT04607148|447625405|FG000|Overall Study|Sponsor Decision|0|||
124454850|NCT04607148|447625406|FG001|Overall Study|Sponsor Decision|0|||
124454851|NCT04607148|447625407|FG002|Overall Study|Sponsor Decision|1|||
124454852|NCT04607148|447625408|FG003|Overall Study|Sponsor Decision|0|||
124454853|NCT04607148|447625405|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124454854|NCT04607148|447625406|FG001|Overall Study|Non-Compliance With Study Drug|1|||
124454855|NCT04607148|447625407|FG002|Overall Study|Non-Compliance With Study Drug|0|||
124454856|NCT04607148|447625408|FG003|Overall Study|Non-Compliance With Study Drug|0|||
124454857|NCT04607148|447625405|FG000|Overall Study|Lost to Follow-up|0|||
124454858|NCT04607148|447625406|FG001|Overall Study|Lost to Follow-up|2|||
124454859|NCT04607148|447625407|FG002|Overall Study|Lost to Follow-up|0|||
124454860|NCT04607148|447625408|FG003|Overall Study|Lost to Follow-up|0|||
124454861|NCT04607148|447625405|FG000|Overall Study|Death|0|||
124454862|NCT04607148|447625406|FG001|Overall Study|Death|3|||
124454863|NCT04607148|447625407|FG002|Overall Study|Death|0|||
124454864|NCT04607148|447625408|FG003|Overall Study|Death|1|||
124454865|NCT04607148|447625405|FG000|Overall Study|Adverse Event|0|||
124454866|NCT04607148|447625406|FG001|Overall Study|Adverse Event|1|||
124454867|NCT04607148|447625407|FG002|Overall Study|Adverse Event|0|||
124454868|NCT04607148|447625408|FG003|Overall Study|Adverse Event|0|||
124454869|NCT02973087|447625411|FG000|Overall Study|Withdrawal by Subject|2|||
124454870|NCT02973087|447625412|FG001|Overall Study|Withdrawal by Subject|1|||
124454871|NCT02973087|447625411|FG000|Overall Study|Adverse Event|1|||
124454872|NCT02973087|447625412|FG001|Overall Study|Adverse Event|0|||
124454873|NCT02973087|447625411|FG000|Overall Study|other|1|||
124454874|NCT02973087|447625412|FG001|Overall Study|other|1|||
124454875|NCT00932360|447625415|FG000|Washout (One Week)|Withdrawal by Subject|0|||
124454876|NCT00932360|447625416|FG001|Washout (One Week)|Withdrawal by Subject|0|||
124454877|NCT00932360|447625417|FG002|Washout (One Week)|Withdrawal by Subject|0|||
124698746|NCT00452400|448518076|FG003|Overall Study|Lack of Efficacy|0|||
124698747|NCT00452400|448518077|FG004|Overall Study|Lack of Efficacy|0|||
124698748|NCT00452400|448518073|FG000|Overall Study|Other reasons not listed above|0|||
124698749|NCT00452400|448518074|FG001|Overall Study|Other reasons not listed above|0|||
124698750|NCT00452400|448518075|FG002|Overall Study|Other reasons not listed above|0|||
124698751|NCT00452400|448518076|FG003|Overall Study|Other reasons not listed above|1|||
124698752|NCT00452400|448518077|FG004|Overall Study|Other reasons not listed above|1|||
124454878|NCT00932360|447625418|FG003|Washout (One Week)|Withdrawal by Subject|0|||
124454879|NCT00932360|447625419|FG004|Washout (One Week)|Withdrawal by Subject|2|||
124454880|NCT00932360|447625420|FG005|Washout (One Week)|Withdrawal by Subject|0|||
124454881|NCT01924182|447625421|FG000|Overall Study|Withdrawal by Subject|1|||
124454882|NCT01924182|447625422|FG001|Overall Study|Withdrawal by Subject|0|||
124454883|NCT00993265|447625423|FG000|Overall Study|Adverse Event|1|||
124454884|NCT00993265|447625424|FG001|Overall Study|Adverse Event|0|||
124454885|NCT00993265|447625423|FG000|Overall Study|Changed dose of concomitant drug|2|||
124454886|NCT00993265|447625424|FG001|Overall Study|Changed dose of concomitant drug|0|||
124454887|NCT00993265|447625423|FG000|Overall Study|Non-compliant with study medication|1|||
124454888|NCT00993265|447625424|FG001|Overall Study|Non-compliant with study medication|0|||
124763100|NCT03192176|448757902|FG003|Overall Study|Miscellaneous|1|||
124454889|NCT01744665|447625425|FG000|Monitoring Phase|Adverse Event|4|||
124454890|NCT01744665|447625425|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
124698753|NCT03378635|448518079|FG000|Overall Study|Adverse Event|1|||
124698754|NCT03378635|448518080|FG001|Overall Study|Adverse Event|0|||
124698755|NCT03378635|448518081|FG002|Overall Study|Adverse Event|0|||
124698756|NCT03378635|448518079|FG000|Overall Study|Withdrawal by Subject|1|||
124698757|NCT03378635|448518080|FG001|Overall Study|Withdrawal by Subject|0|||
124698758|NCT03378635|448518081|FG002|Overall Study|Withdrawal by Subject|0|||
124698759|NCT03425188|448518083|FG000|Overall Study|Withdrawal by Subject|1|||
124698760|NCT00562861|448518086|FG000|Overall Study|Adverse Event|1|||
124698761|NCT00562861|448518087|FG001|Overall Study|Adverse Event|1|||
124698762|NCT00562861|448518086|FG000|Overall Study|Lack of Efficacy|5|||
124698763|NCT00562861|448518087|FG001|Overall Study|Lack of Efficacy|5|||
124698764|NCT00562861|448518086|FG000|Overall Study|noncompliance, moved|7|||
124698765|NCT00562861|448518087|FG001|Overall Study|noncompliance, moved|2|||
124698766|NCT00562861|448518086|FG000|Overall Study|Lost to Follow-up|7|||
124698767|NCT00562861|448518087|FG001|Overall Study|Lost to Follow-up|3|||
124698768|NCT01694771|448518088|FG000|Overall Study|Adverse Event|18|||
124698769|NCT01694771|448518089|FG001|Overall Study|Adverse Event|16|||
124698770|NCT01694771|448518088|FG000|Overall Study|Lack of Efficacy|1|||
124698771|NCT01694771|448518089|FG001|Overall Study|Lack of Efficacy|0|||
124698772|NCT01694771|448518088|FG000|Overall Study|Non compliance protocol|7|||
124698773|NCT01694771|448518089|FG001|Overall Study|Non compliance protocol|6|||
124698774|NCT01694771|448518088|FG000|Overall Study|Lost to Follow-up|2|||
124698775|NCT01694771|448518089|FG001|Overall Study|Lost to Follow-up|3|||
124698776|NCT01694771|448518088|FG000|Overall Study|Consent withdrawn|7|||
124698777|NCT01694771|448518089|FG001|Overall Study|Consent withdrawn|9|||
124698778|NCT01694771|448518088|FG000|Overall Study|Other reasons|5|||
124698779|NCT01694771|448518089|FG001|Overall Study|Other reasons|6|||
124698780|NCT00289900|448518093|FG000|Overall Study|Adverse Event|28|||
124698781|NCT00289900|448518094|FG001|Overall Study|Adverse Event|40|||
124698782|NCT00289900|448518095|FG002|Overall Study|Adverse Event|13|||
124698783|NCT00289900|448518096|FG003|Overall Study|Adverse Event|19|||
124698784|NCT00289900|448518097|FG004|Overall Study|Adverse Event|20|||
124698785|NCT00289900|448518098|FG005|Overall Study|Adverse Event|33|||
124698786|NCT00289900|448518093|FG000|Overall Study|Lost to Follow-up|7|||
124698787|NCT00289900|448518094|FG001|Overall Study|Lost to Follow-up|7|||
124698788|NCT00289900|448518095|FG002|Overall Study|Lost to Follow-up|8|||
124698789|NCT00289900|448518096|FG003|Overall Study|Lost to Follow-up|8|||
124698790|NCT00289900|448518097|FG004|Overall Study|Lost to Follow-up|4|||
124698791|NCT00289900|448518098|FG005|Overall Study|Lost to Follow-up|8|||
124698792|NCT00289900|448518093|FG000|Overall Study|Participant had flushing|18|||
124698793|NCT00289900|448518094|FG001|Overall Study|Participant had flushing|42|||
124698794|NCT00289900|448518095|FG002|Overall Study|Participant had flushing|1|||
124698795|NCT00289900|448518096|FG003|Overall Study|Participant had flushing|2|||
124698796|NCT00289900|448518097|FG004|Overall Study|Participant had flushing|0|||
124698797|NCT00289900|448518098|FG005|Overall Study|Participant had flushing|4|||
124698798|NCT00289900|448518093|FG000|Overall Study|Other|0|||
124698799|NCT00289900|448518094|FG001|Overall Study|Other|0|||
124698800|NCT00289900|448518095|FG002|Overall Study|Other|0|||
124698801|NCT00289900|448518096|FG003|Overall Study|Other|5|||
124698802|NCT00289900|448518097|FG004|Overall Study|Other|1|||
124698803|NCT00289900|448518098|FG005|Overall Study|Other|0|||
124698804|NCT00289900|448518093|FG000|Overall Study|Participant moved|1|||
124698805|NCT00289900|448518094|FG001|Overall Study|Participant moved|0|||
124698806|NCT00289900|448518095|FG002|Overall Study|Participant moved|0|||
124698807|NCT00289900|448518096|FG003|Overall Study|Participant moved|1|||
124698808|NCT00289900|448518097|FG004|Overall Study|Participant moved|1|||
124698809|NCT00289900|448518098|FG005|Overall Study|Participant moved|1|||
124698810|NCT00289900|448518093|FG000|Overall Study|Withdrawal by Subject|10|||
124698811|NCT00289900|448518094|FG001|Overall Study|Withdrawal by Subject|21|||
124698812|NCT00289900|448518095|FG002|Overall Study|Withdrawal by Subject|8|||
124698813|NCT00289900|448518096|FG003|Overall Study|Withdrawal by Subject|18|||
124698814|NCT00289900|448518097|FG004|Overall Study|Withdrawal by Subject|12|||
124698815|NCT00289900|448518098|FG005|Overall Study|Withdrawal by Subject|11|||
124698816|NCT00289900|448518093|FG000|Overall Study|Protocol Violation|3|||
124698817|NCT00289900|448518094|FG001|Overall Study|Protocol Violation|9|||
124698818|NCT00289900|448518095|FG002|Overall Study|Protocol Violation|2|||
124698819|NCT00289900|448518096|FG003|Overall Study|Protocol Violation|6|||
124698820|NCT00289900|448518097|FG004|Overall Study|Protocol Violation|7|||
124698821|NCT00289900|448518098|FG005|Overall Study|Protocol Violation|4|||
124698822|NCT00289900|448518093|FG000|Overall Study|site terminated|1|||
124698823|NCT00289900|448518094|FG001|Overall Study|site terminated|0|||
124698824|NCT00289900|448518095|FG002|Overall Study|site terminated|1|||
124698825|NCT00289900|448518096|FG003|Overall Study|site terminated|0|||
124698826|NCT00289900|448518097|FG004|Overall Study|site terminated|0|||
124698827|NCT00289900|448518098|FG005|Overall Study|site terminated|0|||
124698828|NCT00289900|448518093|FG000|Overall Study|Not treated|0|||
124698829|NCT00289900|448518094|FG001|Overall Study|Not treated|1|||
124698830|NCT00289900|448518095|FG002|Overall Study|Not treated|0|||
124698831|NCT00289900|448518096|FG003|Overall Study|Not treated|0|||
124698832|NCT00289900|448518097|FG004|Overall Study|Not treated|0|||
124698833|NCT00289900|448518098|FG005|Overall Study|Not treated|0|||
124698834|NCT01152385|448518099|FG000|Overall Study|Withdrawal by Subject|3|||
124698835|NCT01152385|448518100|FG001|Overall Study|Withdrawal by Subject|1|||
124698836|NCT01152385|448518101|FG002|Overall Study|Withdrawal by Subject|1|||
124698837|NCT01152385|448518102|FG003|Overall Study|Withdrawal by Subject|1|||
124698838|NCT01152385|448518099|FG000|Overall Study|Protocol Violation|0|||
124698839|NCT01152385|448518100|FG001|Overall Study|Protocol Violation|0|||
124698840|NCT01152385|448518101|FG002|Overall Study|Protocol Violation|0|||
124698841|NCT01152385|448518102|FG003|Overall Study|Protocol Violation|1|||
124698842|NCT01152385|448518099|FG000|Overall Study|Adverse Event|1|||
124698843|NCT01152385|448518100|FG001|Overall Study|Adverse Event|1|||
124698844|NCT01152385|448518101|FG002|Overall Study|Adverse Event|0|||
124698845|NCT01152385|448518102|FG003|Overall Study|Adverse Event|0|||
124698846|NCT01152385|448518099|FG000|Overall Study|Study-specific withdrawal criteria|1|||
124698847|NCT01152385|448518100|FG001|Overall Study|Study-specific withdrawal criteria|1|||
124698848|NCT01152385|448518101|FG002|Overall Study|Study-specific withdrawal criteria|2|||
124698849|NCT01152385|448518102|FG003|Overall Study|Study-specific withdrawal criteria|0|||
124698850|NCT01152385|448518099|FG000|Overall Study|Other|4|||
124698851|NCT01152385|448518100|FG001|Overall Study|Other|3|||
124698852|NCT01152385|448518101|FG002|Overall Study|Other|2|||
124698853|NCT01152385|448518102|FG003|Overall Study|Other|3|||
124698854|NCT02656173|448518103|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
124698855|NCT02656173|448518104|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
124698856|NCT02656173|448518103|FG000|Overall Study|Adverse Event|7|||
124698857|NCT02656173|448518104|FG001|Overall Study|Adverse Event|5|||
124698858|NCT02656173|448518103|FG000|Overall Study|Withdrawal by Subject|1|||
124698859|NCT02656173|448518104|FG001|Overall Study|Withdrawal by Subject|3|||
124698860|NCT02656173|448518103|FG000|Overall Study|Protocol Violation|0|||
124698861|NCT02656173|448518104|FG001|Overall Study|Protocol Violation|1|||
124698862|NCT02656173|448518103|FG000|Overall Study|Miscellaneous|2|||
124698863|NCT02656173|448518104|FG001|Overall Study|Miscellaneous|0|||
124698864|NCT01064622|448518105|FG000|Randomized Phase II|Withdrawal by Subject|2|||
124698865|NCT01064622|448518106|FG001|Randomized Phase II|Withdrawal by Subject|2|||
124698866|NCT01064622|448518105|FG000|Randomized Phase II|Protocol Violation|0|||
124698867|NCT01064622|448518106|FG001|Randomized Phase II|Protocol Violation|1|||
124698868|NCT03927846|448518112|FG000|Overall Study|Lost to Follow-up|10|||
124698869|NCT03927846|448518113|FG001|Overall Study|Lost to Follow-up|11|||
124698870|NCT03289741|448518114|FG000|Overall Study|Adverse Event|1|||
124698871|NCT03289741|448518115|FG001|Overall Study|Adverse Event|1|||
124698872|NCT03289741|448518114|FG000|Overall Study|Physician Decision|2|||
124698873|NCT03289741|448518115|FG001|Overall Study|Physician Decision|2|||
124698874|NCT03289741|448518114|FG000|Overall Study|Withdrawal by Subject|1|||
124698875|NCT03289741|448518115|FG001|Overall Study|Withdrawal by Subject|0|||
124698876|NCT02037984|448518120|FG000|Overall Study|Lack of Efficacy|0|||
124698877|NCT02037984|448518121|FG001|Overall Study|Lack of Efficacy|0|||
124698878|NCT02037984|448518122|FG002|Overall Study|Lack of Efficacy|3|||
124698879|NCT02037984|448518123|FG003|Overall Study|Lack of Efficacy|10|||
124698880|NCT02037984|448518124|FG004|Overall Study|Lack of Efficacy|2|||
124698881|NCT02037984|448518125|FG005|Overall Study|Lack of Efficacy|2|||
124698882|NCT02037984|448518126|FG006|Overall Study|Lack of Efficacy|4|||
124763101|NCT03192176|448757903|FG004|Overall Study|Miscellaneous|1|||
124698883|NCT02037984|448518127|FG007|Overall Study|Lack of Efficacy|3|||
124698884|NCT02037984|448518120|FG000|Overall Study|Lost to Follow-up|1|||
124698885|NCT02037984|448518121|FG001|Overall Study|Lost to Follow-up|0|||
124698886|NCT02037984|448518122|FG002|Overall Study|Lost to Follow-up|3|||
124698887|NCT02037984|448518123|FG003|Overall Study|Lost to Follow-up|5|||
124698888|NCT02037984|448518124|FG004|Overall Study|Lost to Follow-up|2|||
124698889|NCT02037984|448518125|FG005|Overall Study|Lost to Follow-up|2|||
124698890|NCT02037984|448518126|FG006|Overall Study|Lost to Follow-up|2|||
124698891|NCT02037984|448518127|FG007|Overall Study|Lost to Follow-up|4|||
124698892|NCT02037984|448518120|FG000|Overall Study|Physician Decision|0|||
124698893|NCT02037984|448518121|FG001|Overall Study|Physician Decision|0|||
124698894|NCT02037984|448518122|FG002|Overall Study|Physician Decision|0|||
124698895|NCT02037984|448518123|FG003|Overall Study|Physician Decision|0|||
124698896|NCT02037984|448518124|FG004|Overall Study|Physician Decision|0|||
124698897|NCT02037984|448518125|FG005|Overall Study|Physician Decision|0|||
124698898|NCT02037984|448518126|FG006|Overall Study|Physician Decision|1|||
124698899|NCT02037984|448518127|FG007|Overall Study|Physician Decision|0|||
124698900|NCT02037984|448518120|FG000|Overall Study|Protocol Violation|0|||
124698901|NCT02037984|448518121|FG001|Overall Study|Protocol Violation|0|||
124698902|NCT02037984|448518122|FG002|Overall Study|Protocol Violation|0|||
124698903|NCT02037984|448518123|FG003|Overall Study|Protocol Violation|0|||
124698904|NCT02037984|448518124|FG004|Overall Study|Protocol Violation|0|||
124698905|NCT02037984|448518125|FG005|Overall Study|Protocol Violation|1|||
124763102|NCT03192176|448757904|FG005|Overall Study|Miscellaneous|2|||
124698906|NCT02037984|448518126|FG006|Overall Study|Protocol Violation|2|||
124698907|NCT02037984|448518127|FG007|Overall Study|Protocol Violation|0|||
124698908|NCT02037984|448518120|FG000|Overall Study|Technical Problems|0|||
124698909|NCT02037984|448518121|FG001|Overall Study|Technical Problems|0|||
124698910|NCT02037984|448518122|FG002|Overall Study|Technical Problems|3|||
124698911|NCT02037984|448518123|FG003|Overall Study|Technical Problems|3|||
124698912|NCT02037984|448518124|FG004|Overall Study|Technical Problems|2|||
124698913|NCT02037984|448518125|FG005|Overall Study|Technical Problems|3|||
124698914|NCT02037984|448518126|FG006|Overall Study|Technical Problems|4|||
124698915|NCT02037984|448518127|FG007|Overall Study|Technical Problems|2|||
124698916|NCT02037984|448518120|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124698917|NCT02037984|448518121|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124698918|NCT02037984|448518122|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
124698919|NCT02037984|448518123|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
124698920|NCT02037984|448518124|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
124698921|NCT02037984|448518125|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
124698922|NCT02037984|448518126|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
124698923|NCT02037984|448518127|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
124698924|NCT02037984|448518120|FG000|Overall Study|Withdrawal by Subject|0|||
124698925|NCT02037984|448518121|FG001|Overall Study|Withdrawal by Subject|0|||
124698926|NCT02037984|448518122|FG002|Overall Study|Withdrawal by Subject|0|||
124698927|NCT02037984|448518123|FG003|Overall Study|Withdrawal by Subject|1|||
124698928|NCT02037984|448518124|FG004|Overall Study|Withdrawal by Subject|1|||
124698929|NCT02037984|448518125|FG005|Overall Study|Withdrawal by Subject|3|||
124698930|NCT02037984|448518126|FG006|Overall Study|Withdrawal by Subject|0|||
124698931|NCT02037984|448518127|FG007|Overall Study|Withdrawal by Subject|1|||
124698932|NCT00974233|448518128|FG000|Induction Chemoimmunotherapy|Death|2|||
124698933|NCT00974233|448518128|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
124698934|NCT00974233|448518128|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
124698935|NCT00974233|448518128|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
124698936|NCT00974233|448518128|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
124698937|NCT00974233|448518128|FG000|Maintenance Lenalidomide|Adverse Event|8|||
124698938|NCT01691092|448518129|FG000|Overall Study|Lost to Follow-up|10|||
124698939|NCT01691092|448518129|FG000|Overall Study|Physician Decision|4|||
124698940|NCT01691092|448518129|FG000|Overall Study|Withdrawal by Subject|3|||
124698941|NCT01691092|448518129|FG000|Overall Study|non-compliance|3|||
124698942|NCT01691092|448518129|FG000|Overall Study|used for different study|2|||
124698943|NCT01691092|448518129|FG000|Overall Study|screen fail|19|||
124698944|NCT01569763|448519753|FG000|Overall Study|Lack of Efficacy|2|||
124698945|NCT01569763|448519754|FG001|Overall Study|Lack of Efficacy|7|||
124698946|NCT01569763|448519753|FG000|Overall Study|Adverse Event|1|||
124698947|NCT01569763|448519754|FG001|Overall Study|Adverse Event|0|||
124698948|NCT03211858|448519755|FG000|Overall Study|Adverse Event|8|||
124698949|NCT03211858|448519756|FG001|Overall Study|Adverse Event|6|||
124698950|NCT03211858|448519755|FG000|Overall Study|Lack of Efficacy|0|||
124698951|NCT03211858|448519756|FG001|Overall Study|Lack of Efficacy|4|||
124698952|NCT03211858|448519755|FG000|Overall Study|Poor compliance to protocol|6|||
124698953|NCT03211858|448519756|FG001|Overall Study|Poor compliance to protocol|2|||
124698954|NCT03211858|448519755|FG000|Overall Study|Non-serious Hypoglycemia|1|||
124698955|NCT03211858|448519756|FG001|Overall Study|Non-serious Hypoglycemia|0|||
124698956|NCT03211858|448519755|FG000|Overall Study|Other than specified above|22|||
124698957|NCT03211858|448519756|FG001|Overall Study|Other than specified above|21|||
124698958|NCT03810365|448519758|FG000|Overall Study|Lost to Follow-up|2|||
124698959|NCT03810365|448519759|FG001|Overall Study|Lost to Follow-up|2|||
124698960|NCT03810365|448519758|FG000|Overall Study|Withdrawal by Subject|4|||
124698961|NCT03810365|448519759|FG001|Overall Study|Withdrawal by Subject|5|||
124698962|NCT03160573|448519762|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
124698963|NCT03160573|448519763|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
124698964|NCT03160573|448519764|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
124698965|NCT03160573|448519765|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
124698966|NCT02402907|448519769|FG000|Overall Study|Delivered vaginally|9|||
124698967|NCT02402907|448519770|FG001|Overall Study|Delivered vaginally|3|||
124698968|NCT02402907|448519769|FG000|Overall Study|Delivered outside of Sinai|1|||
124698969|NCT02402907|448519770|FG001|Overall Study|Delivered outside of Sinai|1|||
124698970|NCT02402907|448519769|FG000|Overall Study|Lost to follow up after C-Section|10|||
124698971|NCT02402907|448519770|FG001|Overall Study|Lost to follow up after C-Section|23|||
124698972|NCT01423084|448519773|FG000|Overall Study|Adverse Event|0|||
124698973|NCT01423084|448519774|FG001|Overall Study|Adverse Event|1|||
124698974|NCT01423084|448519773|FG000|Overall Study|Withdrawal by Subject|2|||
124698975|NCT01423084|448519774|FG001|Overall Study|Withdrawal by Subject|3|||
124698976|NCT00661687|448519775|FG000|Overall Study|Study related symptoms and complaints|5|||
124698977|NCT00661687|448519775|FG000|Overall Study|Positive slit lamp findings|4|||
124698978|NCT00661687|448519775|FG000|Overall Study|Inability to maintain wearing schedule|3|||
124698979|NCT00661687|448519775|FG000|Overall Study|Physician Decision|1|||
124698980|NCT00661687|448519775|FG000|Overall Study|Adverse Event|2|||
124698981|NCT01682603|448519776|FG000|Overall Study|Lost to Follow-up|3|||
124698982|NCT01959919|448519777|FG000|Overall Study|Did not meet the eligibility criteria|2|||
124698983|NCT03707821|448519780|FG000|Overall Study|Protocol Violation|0|||
124698984|NCT03707821|448519781|FG001|Overall Study|Protocol Violation|1|||
124763103|NCT03192176|448757905|FG006|Overall Study|Miscellaneous|0|||
124698985|NCT03707821|448519780|FG000|Overall Study|Unsatisfactory Visual Response|1|||
124698986|NCT03707821|448519781|FG001|Overall Study|Unsatisfactory Visual Response|0|||
124698987|NCT03707821|448519780|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
124698988|NCT03707821|448519781|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
124698989|NCT00128492|448519782|FG000|Overall Study|AE unrelated to study|2|||
124698990|NCT00128492|448519783|FG001|Overall Study|AE unrelated to study|9|||
124698991|NCT00128492|448519782|FG000|Overall Study|Study drug intolerance (AE)|2|||
124698992|NCT00128492|448519783|FG001|Overall Study|Study drug intolerance (AE)|8|||
124698993|NCT00128492|448519782|FG000|Overall Study|AE related to study|1|||
124698994|NCT00128492|448519783|FG001|Overall Study|AE related to study|4|||
124698995|NCT00128492|448519782|FG000|Overall Study|Death|1|||
124698996|NCT00128492|448519783|FG001|Overall Study|Death|0|||
124698997|NCT00128492|448519782|FG000|Overall Study|Lost to Follow-up|1|||
124698998|NCT00128492|448519783|FG001|Overall Study|Lost to Follow-up|5|||
124698999|NCT00128492|448519782|FG000|Overall Study|Noncompliance|0|||
124699000|NCT00128492|448519783|FG001|Overall Study|Noncompliance|5|||
124699001|NCT00128492|448519782|FG000|Overall Study|Personal or administrative|10|||
124699002|NCT00128492|448519783|FG001|Overall Study|Personal or administrative|22|||
124699003|NCT00128492|448519782|FG000|Overall Study|Withdrawal by Subject|3|||
124699004|NCT00128492|448519783|FG001|Overall Study|Withdrawal by Subject|5|||
124699005|NCT00128492|448519782|FG000|Overall Study|Pregnancy|0|||
124699006|NCT00128492|448519783|FG001|Overall Study|Pregnancy|1|||
124699007|NCT00692237|448519787|FG000|Overall Study|Withdrawal by Subject|1|||
124699008|NCT00692237|448519788|FG001|Overall Study|Withdrawal by Subject|3|||
124699009|NCT00692237|448519787|FG000|Overall Study|Adverse Event|0|||
124699010|NCT00692237|448519788|FG001|Overall Study|Adverse Event|1|||
124699011|NCT03111108|448519789|FG000|Overall Study|Death|0|||
124699012|NCT03111108|448519790|FG001|Overall Study|Death|1|||
124699013|NCT03111108|448519789|FG000|Overall Study|Withdrawal by Subject|1|||
124699014|NCT03111108|448519790|FG001|Overall Study|Withdrawal by Subject|0|||
124699015|NCT02771145|448519791|FG000|Overall Study|Adverse Event|3|||
124699016|NCT02771145|448519791|FG000|Overall Study|Lost to Follow-up|1|||
124699017|NCT02662582|448519792|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
124699018|NCT02662582|448519793|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
124699019|NCT02662582|448519792|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
124699020|NCT02662582|448519793|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
124699021|NCT02662582|448519792|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
124699022|NCT02662582|448519793|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
124699023|NCT02662582|448519792|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
124699024|NCT02662582|448519793|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
124699025|NCT05463952|448519794|FG000|Treatment|Progressive disease|4|||
124699026|NCT05463952|448519794|FG000|Treatment|Ongoing|2|||
124699027|NCT01903733|448519795|FG000|Overall Study|Death|23|||
124699028|NCT01903733|448519796|FG001|Overall Study|Death|54|||
124699029|NCT01903733|448519797|FG002|Overall Study|Death|30|||
124699030|NCT01903733|448519798|FG003|Overall Study|Death|98|||
124699031|NCT01903733|448519795|FG000|Overall Study|Participant refused further follow-up|35|||
124699032|NCT01903733|448519796|FG001|Overall Study|Participant refused further follow-up|38|||
124699033|NCT01903733|448519797|FG002|Overall Study|Participant refused further follow-up|13|||
124699034|NCT01903733|448519798|FG003|Overall Study|Participant refused further follow-up|9|||
124699035|NCT01903733|448519795|FG000|Overall Study|Lost to Follow-up|18|||
124699036|NCT01903733|448519796|FG001|Overall Study|Lost to Follow-up|19|||
124928268|NCT04447755|449368333|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
124545991|NCT00943826|447954442|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
124545992|NCT00943826|447954443|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
124699037|NCT01903733|448519797|FG002|Overall Study|Lost to Follow-up|6|||
124699038|NCT01903733|448519798|FG003|Overall Study|Lost to Follow-up|9|||
124699039|NCT01903733|448519795|FG000|Overall Study|Other|10|||
124699040|NCT01903733|448519796|FG001|Overall Study|Other|15|||
124699041|NCT01903733|448519797|FG002|Overall Study|Other|12|||
124699042|NCT01903733|448519798|FG003|Overall Study|Other|3|||
124699043|NCT01903733|448519795|FG000|Overall Study|Missing|2|||
124699044|NCT01903733|448519796|FG001|Overall Study|Missing|0|||
124699045|NCT01903733|448519797|FG002|Overall Study|Missing|0|||
124699046|NCT01903733|448519798|FG003|Overall Study|Missing|0|||
124699047|NCT01903733|448519795|FG000|Overall Study|Investigator request|18|||
124699048|NCT01903733|448519796|FG001|Overall Study|Investigator request|0|||
124699049|NCT01903733|448519797|FG002|Overall Study|Investigator request|0|||
124699050|NCT01903733|448519798|FG003|Overall Study|Investigator request|0|||
124699051|NCT02395627|448519799|FG000|Overall Study|Withdrawal by Subject|0|||
124699052|NCT02395627|448519800|FG001|Overall Study|Withdrawal by Subject|2|||
124699053|NCT02395627|448519801|FG002|Overall Study|Withdrawal by Subject|0|||
124699054|NCT02395627|448519799|FG000|Overall Study|Did not receive pembrolizumab|3|||
124699055|NCT02395627|448519800|FG001|Overall Study|Did not receive pembrolizumab|1|||
124699056|NCT02395627|448519801|FG002|Overall Study|Did not receive pembrolizumab|0|||
124699057|NCT02852005|448519803|FG000|Overall Study|Lost to Follow-up|0|||
124699058|NCT02852005|448519804|FG001|Overall Study|Lost to Follow-up|0|||
124699059|NCT02852005|448519805|FG002|Overall Study|Lost to Follow-up|0|||
124699060|NCT02852005|448519806|FG003|Overall Study|Lost to Follow-up|0|||
124699061|NCT02852005|448519807|FG004|Overall Study|Lost to Follow-up|1|||
124699062|NCT02852005|448519803|FG000|Overall Study|Withdrawal by Subject|1|||
124699063|NCT02852005|448519804|FG001|Overall Study|Withdrawal by Subject|0|||
124699064|NCT02852005|448519805|FG002|Overall Study|Withdrawal by Subject|0|||
124699065|NCT02852005|448519806|FG003|Overall Study|Withdrawal by Subject|0|||
124699066|NCT02852005|448519807|FG004|Overall Study|Withdrawal by Subject|0|||
124699067|NCT02294019|448519809|FG000|Overall Study|Adverse Event|2|||
124699068|NCT02294019|448519809|FG000|Overall Study|Protocol Violation|68|||
124699069|NCT02294019|448519809|FG000|Overall Study|Lost to Follow-up|31|||
124699070|NCT02294019|448519809|FG000|Overall Study|Other|1|||
124699071|NCT02294019|448519809|FG000|Overall Study|Withdrawal by Subject|1|||
124699072|NCT02369159|448519810|FG000|Overall Study|Adverse Event|0|||
124699073|NCT02369159|448519811|FG001|Overall Study|Adverse Event|1|||
124699074|NCT02369159|448519810|FG000|Overall Study|Lost to Follow-up|1|||
124699075|NCT02369159|448519811|FG001|Overall Study|Lost to Follow-up|1|||
124699076|NCT02369159|448519810|FG000|Overall Study|Withdrawal by Subject|7|||
124699077|NCT02369159|448519811|FG001|Overall Study|Withdrawal by Subject|0|||
124699078|NCT03769116|448519812|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
124699079|NCT03769116|448519813|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
124699080|NCT03769116|448519812|FG000|Part 3 - Open Label|Physician Decision|1|||
124699081|NCT03769116|448519813|FG001|Part 3 - Open Label|Physician Decision|0|||
124699082|NCT03769116|448519812|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
124699083|NCT03769116|448519813|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
124699084|NCT01887600|448519821|FG000|Overall Study|Death|39|||
124699085|NCT01887600|448519822|FG001|Overall Study|Death|16|||
124699086|NCT01887600|448519821|FG000|Overall Study|Lack of Efficacy|3|||
124699087|NCT01887600|448519822|FG001|Overall Study|Lack of Efficacy|26|||
124699088|NCT01887600|448519821|FG000|Overall Study|Lost to Follow-up|5|||
124699089|NCT01887600|448519822|FG001|Overall Study|Lost to Follow-up|1|||
124699090|NCT01887600|448519821|FG000|Overall Study|Physician Decision|7|||
124699091|NCT01887600|448519822|FG001|Overall Study|Physician Decision|8|||
124699092|NCT01887600|448519821|FG000|Overall Study|Protocol Deviation|3|||
124699093|NCT01887600|448519822|FG001|Overall Study|Protocol Deviation|0|||
124699094|NCT01887600|448519821|FG000|Overall Study|Withdrawal by Subject|58|||
124699095|NCT01887600|448519822|FG001|Overall Study|Withdrawal by Subject|52|||
124699096|NCT01887600|448519821|FG000|Overall Study|Adverse Event|21|||
124699097|NCT01887600|448519822|FG001|Overall Study|Adverse Event|9|||
124699098|NCT01887600|448519821|FG000|Overall Study|Non-compliance with study drug|3|||
124699099|NCT01887600|448519822|FG001|Overall Study|Non-compliance with study drug|0|||
124699100|NCT01887600|448519821|FG000|Overall Study|Miscellaneous|6|||
124699101|NCT01887600|448519822|FG001|Overall Study|Miscellaneous|2|||
124699102|NCT01887600|448519821|FG000|Overall Study|Progressive Disease|1|||
124699103|NCT01887600|448519822|FG001|Overall Study|Progressive Disease|0|||
124699104|NCT03688139|448519823|FG000|Overall Study|Lost to Follow-up|2|||
124699105|NCT03688139|448519824|FG001|Overall Study|Lost to Follow-up|0|||
124699106|NCT03688139|448519823|FG000|Overall Study|Physician Decision|0|||
124699107|NCT03688139|448519824|FG001|Overall Study|Physician Decision|1|||
124699108|NCT03688139|448519823|FG000|Overall Study|Withdrawal by Subject|2|||
124928269|NCT04447755|449368334|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
124454891|NCT01744665|447625425|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
124454892|NCT01744665|447625425|FG000|Monitoring Phase|Withdrawal by Subject|5|||
124454893|NCT01744665|447625425|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
124454894|NCT01744665|447625425|FG000|Consolidation Phase|Adverse Event|2|||
124454895|NCT01744665|447625425|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
124454896|NCT01744665|447625425|FG000|Consolidation Phase|Withdrawal by Subject|4|||
124454897|NCT01744665|447625425|FG000|Consolidation Phase|Administrative problems|9|||
124454898|NCT01744665|447625425|FG000|Re-initiation Phase|Administrative problems|10|||
124454899|NCT01744665|447625425|FG000|Re-initiation Phase|Adverse Event|1|||
124454900|NCT01744665|447625425|FG000|Re-initiation Phase|No longer required treatment|1|||
124454901|NCT01744665|447625425|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
124454902|NCT01357655|447625426|FG000|Overall Study|Administrative Reason by Sponsor|45|||
124454903|NCT01357655|447625427|FG001|Overall Study|Administrative Reason by Sponsor|0|||
124699109|NCT03688139|448519824|FG001|Overall Study|Withdrawal by Subject|3|||
124699110|NCT00420056|448519825|FG000|Overall Study|Objective progression or relapse|17|||
124699111|NCT01390584|448519834|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
124699112|NCT01390584|448519835|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
124699113|NCT01390584|448519836|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
124699114|NCT01835431|448519841|FG000|Overall Study|Adverse Event|1|||
124699115|NCT01835431|448519842|FG001|Overall Study|Adverse Event|0|||
124699116|NCT01835431|448519841|FG000|Overall Study|other|0|||
124699117|NCT01835431|448519842|FG001|Overall Study|other|2|||
124699118|NCT01835431|448519841|FG000|Overall Study|Withdrawal by Subject|6|||
124699119|NCT01835431|448519842|FG001|Overall Study|Withdrawal by Subject|10|||
124699120|NCT01835431|448519841|FG000|Overall Study|Protocol Violation|1|||
124699121|NCT01835431|448519842|FG001|Overall Study|Protocol Violation|0|||
124454904|NCT01357655|447625426|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
124454905|NCT01357655|447625427|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
124699122|NCT00655356|448519845|FG000|Overall Study|Withdrawal by Subject|3|||
124699123|NCT00655356|448519846|FG001|Overall Study|Withdrawal by Subject|4|||
124699124|NCT00655356|448519845|FG000|Overall Study|Sponsor Request|10|||
124699125|NCT00655356|448519846|FG001|Overall Study|Sponsor Request|4|||
124699126|NCT00655356|448519845|FG000|Overall Study|Adverse Event|1|||
124699127|NCT00655356|448519846|FG001|Overall Study|Adverse Event|1|||
124699128|NCT00655356|448519845|FG000|Overall Study|Protocol Violation|2|||
124699129|NCT00655356|448519846|FG001|Overall Study|Protocol Violation|1|||
124699130|NCT00655356|448519845|FG000|Overall Study|Other Reason|1|||
124699131|NCT00655356|448519846|FG001|Overall Study|Other Reason|0|||
124699132|NCT00480025|448519847|FG000|Overall Study|Protocol Violation|12|||
124699133|NCT00480025|448519848|FG001|Overall Study|Protocol Violation|7|||
124699134|NCT00480025|448519847|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
124699135|NCT00480025|448519848|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
124699136|NCT00480025|448519847|FG000|Overall Study|Disease Progression / Recurrence|449|||
124699137|NCT00480025|448519848|FG001|Overall Study|Disease Progression / Recurrence|224|||
124699138|NCT00480025|448519847|FG000|Overall Study|Adverse Event|44|||
124699139|NCT00480025|448519848|FG001|Overall Study|Adverse Event|12|||
124699140|NCT00480025|448519847|FG000|Overall Study|Other|70|||
124699141|NCT00480025|448519848|FG001|Overall Study|Other|29|||
124699142|NCT00480025|448519847|FG000|Overall Study|SAE including intercurrent illness|76|||
124699143|NCT00480025|448519848|FG001|Overall Study|SAE including intercurrent illness|42|||
124699144|NCT04634331|448519849|FG000|Overall Study|Withdrawal by Subject|2|||
124699145|NCT04634331|448519850|FG001|Overall Study|Withdrawal by Subject|2|||
124699146|NCT02766478|448519852|FG000|Overall Study|Withdrawal by Subject|1|||
124699147|NCT02766478|448519853|FG001|Overall Study|Withdrawal by Subject|1|||
124699148|NCT02496156|448519854|FG000|Overall Study|Lost to Follow-up|5|||
124699149|NCT02496156|448519855|FG001|Overall Study|Lost to Follow-up|0|||
124699150|NCT02496156|448519854|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
124699151|NCT02496156|448519855|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
124699152|NCT03760666|448519856|FG000|Overall Study|Adverse Event|2|||
124699153|NCT03760666|448519857|FG001|Overall Study|Adverse Event|4|||
124699154|NCT03760666|448519858|FG002|Overall Study|Adverse Event|1|||
124699155|NCT03760666|448519856|FG000|Overall Study|AML Disease Progression|3|||
124699156|NCT03760666|448519857|FG001|Overall Study|AML Disease Progression|3|||
124699157|NCT03760666|448519858|FG002|Overall Study|AML Disease Progression|0|||
124699158|NCT03760666|448519856|FG000|Overall Study|Physician Decision|0|||
124699159|NCT03760666|448519857|FG001|Overall Study|Physician Decision|3|||
124699160|NCT03760666|448519858|FG002|Overall Study|Physician Decision|0|||
124699161|NCT03760666|448519856|FG000|Overall Study|Withdrawal by Subject|0|||
124699162|NCT03760666|448519857|FG001|Overall Study|Withdrawal by Subject|1|||
124699163|NCT03760666|448519858|FG002|Overall Study|Withdrawal by Subject|0|||
124699164|NCT04349098|448519860|FG000|Overall Study|Death|16|||
124699165|NCT04349098|448519861|FG001|Overall Study|Death|8|||
124699166|NCT04349098|448519860|FG000|Overall Study|Lost to Follow-up|11|||
124699167|NCT04349098|448519861|FG001|Overall Study|Lost to Follow-up|8|||
124699168|NCT04349098|448519860|FG000|Overall Study|Withdrawal by Subject|8|||
124699169|NCT04349098|448519861|FG001|Overall Study|Withdrawal by Subject|5|||
124699170|NCT04349098|448519860|FG000|Overall Study|Other|3|||
124699171|NCT04349098|448519861|FG001|Overall Study|Other|5|||
124699172|NCT01703221|448519862|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
124699173|NCT01703221|448519863|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
124454906|NCT01357655|447625426|FG000|Overall Study|Disease Progression|1|||
124454907|NCT01357655|447625427|FG001|Overall Study|Disease Progression|0|||
124454908|NCT01357655|447625426|FG000|Overall Study|Lost to Follow-up|2|||
124454909|NCT01357655|447625427|FG001|Overall Study|Lost to Follow-up|0|||
124454910|NCT01357655|447625426|FG000|Overall Study|Maximum Clinical Benefit|2|||
124454911|NCT01357655|447625427|FG001|Overall Study|Maximum Clinical Benefit|0|||
124454912|NCT01357655|447625426|FG000|Overall Study|Reason Unspecified|1|||
124454913|NCT01357655|447625427|FG001|Overall Study|Reason Unspecified|0|||
124454914|NCT01357655|447625426|FG000|Overall Study|Study Drug Toxicity|11|||
124454915|NCT01357655|447625427|FG001|Overall Study|Study Drug Toxicity|0|||
124454916|NCT01357655|447625426|FG000|Overall Study|Subject Withdrew Consent|1|||
124454917|NCT01357655|447625427|FG001|Overall Study|Subject Withdrew Consent|0|||
124699174|NCT01703221|448519864|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
124699175|NCT01703221|448519862|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
124699176|NCT01703221|448519863|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
124699177|NCT01703221|448519864|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
124699178|NCT01703221|448519862|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
124699179|NCT01703221|448519863|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124699180|NCT01703221|448519864|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124699181|NCT01703221|448519862|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
124699182|NCT01703221|448519863|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
124454918|NCT03184077|447625429|FG000|Overall Study|Lost to Follow-up|21|||
124454919|NCT03184077|447625430|FG001|Overall Study|Lost to Follow-up|21|||
124545993|NCT00943826|447954442|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
124545994|NCT00943826|447954443|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
124545995|NCT00943826|447954442|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
124545996|NCT00943826|447954443|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
124545997|NCT00625846|447954448|FG000|Overall Study|Withdrawal by Subject|2|||
124545998|NCT00625846|447954449|FG001|Overall Study|Withdrawal by Subject|0|||
124545999|NCT00625846|447954450|FG002|Overall Study|Withdrawal by Subject|1|||
124546000|NCT00625846|447954451|FG003|Overall Study|Withdrawal by Subject|2|||
124546001|NCT00807040|447954452|FG000|Overall Study|Death|24|||
124546002|NCT00807040|447954453|FG001|Overall Study|Death|29|||
124546003|NCT00807040|447954452|FG000|Overall Study|Withdrawal by Subject|8|||
124546004|NCT00807040|447954453|FG001|Overall Study|Withdrawal by Subject|6|||
124546005|NCT00807040|447954452|FG000|Overall Study|Lost to Follow-up|4|||
124546006|NCT00807040|447954453|FG001|Overall Study|Lost to Follow-up|6|||
124546007|NCT01870921|447954457|FG000|Overall Study|Subject decision|80|||
124546008|NCT01870921|447954457|FG000|Overall Study|Severe non-compliance to protocol|7|||
124546009|NCT01870921|447954457|FG000|Overall Study|Subject Lost to Follow up|2|||
124546010|NCT01870921|447954457|FG000|Overall Study|Other|1|||
124546011|NCT04409509|447954458|FG000|Overall Study|Failure to meet randomization requirement|1|||
124546012|NCT04409509|447954459|FG001|Overall Study|Failure to meet randomization requirement|0|||
124546013|NCT04409509|447954458|FG000|Overall Study|Adverse Event|0|||
124546014|NCT04409509|447954459|FG001|Overall Study|Adverse Event|1|||
124546015|NCT04409509|447954458|FG000|Overall Study|Death|11|||
124546016|NCT04409509|447954459|FG001|Overall Study|Death|10|||
124546017|NCT04409509|447954458|FG000|Overall Study|Non-compliance with study drug|0|||
124546018|NCT04409509|447954459|FG001|Overall Study|Non-compliance with study drug|1|||
124546019|NCT04409509|447954458|FG000|Overall Study|Lost to Follow-up|0|||
124546020|NCT04409509|447954459|FG001|Overall Study|Lost to Follow-up|3|||
124546021|NCT04409509|447954458|FG000|Overall Study|Withdrawal by Subject|0|||
124546022|NCT04409509|447954459|FG001|Overall Study|Withdrawal by Subject|3|||
124546023|NCT04409509|447954458|FG000|Overall Study|Randomized by mistake|0|||
124546024|NCT04409509|447954459|FG001|Overall Study|Randomized by mistake|1|||
124546025|NCT04409509|447954458|FG000|Overall Study|Other|1|||
124546026|NCT04409509|447954459|FG001|Overall Study|Other|1|||
124546027|NCT02279888|447954460|FG000|Overall Study|Death|326|||
124546028|NCT02279888|447954460|FG000|Overall Study|Withdrawal by Subject|38|||
124546029|NCT02279888|447954460|FG000|Overall Study|Lost to Follow-up|21|||
124546030|NCT02279888|447954460|FG000|Overall Study|Physician Decision|62|||
124546031|NCT02279888|447954460|FG000|Overall Study|Subject Non-compliance|43|||
124546032|NCT02279888|447954460|FG000|Overall Study|Not implanted|14|||
124546033|NCT02279888|447954460|FG000|Overall Study|Visit not performed|26|||
124546034|NCT00227591|447954461|FG000|Overall Study|Withdrawal by Subject|1|||
124546035|NCT02335411|447954462|FG000|Overall Study|Death|223|||
124546036|NCT02335411|447954463|FG001|Overall Study|Death|22|||
124546037|NCT02335411|447954464|FG002|Overall Study|Death|26|||
124546038|NCT02335411|447954462|FG000|Overall Study|Physician Decision|3|||
124546039|NCT02335411|447954463|FG001|Overall Study|Physician Decision|0|||
124546040|NCT02335411|447954464|FG002|Overall Study|Physician Decision|0|||
124546041|NCT02335411|447954462|FG000|Overall Study|Protocol Violation|1|||
124546042|NCT02335411|447954463|FG001|Overall Study|Protocol Violation|0|||
124546043|NCT02335411|447954464|FG002|Overall Study|Protocol Violation|0|||
124546044|NCT02335411|447954462|FG000|Overall Study|Withdrawal by Subject|11|||
124546045|NCT02335411|447954463|FG001|Overall Study|Withdrawal by Subject|0|||
124546046|NCT02335411|447954464|FG002|Overall Study|Withdrawal by Subject|3|||
124546047|NCT02335411|447954462|FG000|Overall Study|Sponsor Decision|12|||
124763104|NCT03192176|448757906|FG007|Overall Study|Miscellaneous|1|||
124763105|NCT00667628|448757907|FG000|Overall Study|Lost to Follow-up|1|||
124546048|NCT02335411|447954463|FG001|Overall Study|Sponsor Decision|3|||
124546049|NCT02335411|447954464|FG002|Overall Study|Sponsor Decision|2|||
124546050|NCT02335411|447954462|FG000|Overall Study|Adverse Event|9|||
124546051|NCT02335411|447954463|FG001|Overall Study|Adverse Event|0|||
124546052|NCT02335411|447954464|FG002|Overall Study|Adverse Event|0|||
124546053|NCT01891669|447954467|FG000|Overall Study|Death|0|||
124546054|NCT01891669|447954468|FG001|Overall Study|Death|0|||
124546055|NCT01891669|447954469|FG002|Overall Study|Death|0|||
124546056|NCT01891669|447954470|FG003|Overall Study|Death|0|||
124546057|NCT01891669|447954471|FG004|Overall Study|Death|0|||
124546058|NCT01891669|447954472|FG005|Overall Study|Death|0|||
124546059|NCT01891669|447954473|FG006|Overall Study|Death|0|||
124546060|NCT01891669|447954474|FG007|Overall Study|Death|1|||
124546061|NCT01891669|447954475|FG008|Overall Study|Death|0|||
124546062|NCT01891669|447954476|FG009|Overall Study|Death|1|||
124546063|NCT01891669|447954467|FG000|Overall Study|Withdrawal by Subject|1|||
124546064|NCT01891669|447954468|FG001|Overall Study|Withdrawal by Subject|1|||
124546065|NCT01891669|447954469|FG002|Overall Study|Withdrawal by Subject|0|||
124546066|NCT01891669|447954470|FG003|Overall Study|Withdrawal by Subject|0|||
124546067|NCT01891669|447954471|FG004|Overall Study|Withdrawal by Subject|0|||
124546068|NCT01891669|447954472|FG005|Overall Study|Withdrawal by Subject|0|||
124546069|NCT01891669|447954473|FG006|Overall Study|Withdrawal by Subject|1|||
124699183|NCT01703221|448519864|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
124699184|NCT01703221|448519862|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124699185|NCT01703221|448519863|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124699186|NCT01703221|448519864|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
124699187|NCT01703221|448519862|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
124699188|NCT01703221|448519863|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
124699189|NCT01703221|448519864|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
124699190|NCT01703221|448519862|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
124699191|NCT01703221|448519863|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
124699192|NCT01703221|448519864|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
124699193|NCT01703221|448519862|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
124699194|NCT01703221|448519863|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
124699195|NCT01703221|448519864|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
124699196|NCT05486065|448519865|FG000|Overall Study|Withdrawal by Subject|1|||
124699197|NCT05486065|448519866|FG001|Overall Study|Withdrawal by Subject|5|||
124699198|NCT05486065|448519867|FG002|Overall Study|Withdrawal by Subject|4|||
124699199|NCT05486065|448519868|FG003|Overall Study|Withdrawal by Subject|3|||
124699200|NCT05486065|448519865|FG000|Overall Study|Lost to Follow-up|4|||
124699201|NCT05486065|448519866|FG001|Overall Study|Lost to Follow-up|2|||
124699202|NCT05486065|448519867|FG002|Overall Study|Lost to Follow-up|2|||
124699203|NCT05486065|448519868|FG003|Overall Study|Lost to Follow-up|2|||
124699204|NCT05486065|448519865|FG000|Overall Study|Physician Decision|0|||
124699205|NCT05486065|448519866|FG001|Overall Study|Physician Decision|1|||
124699206|NCT05486065|448519867|FG002|Overall Study|Physician Decision|1|||
124699207|NCT05486065|448519868|FG003|Overall Study|Physician Decision|0|||
124699208|NCT05486065|448519865|FG000|Overall Study|Failure to meet randomization criteria|0|||
124699209|NCT05486065|448519866|FG001|Overall Study|Failure to meet randomization criteria|0|||
124699210|NCT05486065|448519867|FG002|Overall Study|Failure to meet randomization criteria|0|||
124699211|NCT05486065|448519868|FG003|Overall Study|Failure to meet randomization criteria|1|||
124699212|NCT03878069|448519869|FG000|Overall Study|Death|0|||
124699213|NCT03878069|448519870|FG001|Overall Study|Death|1|||
124699214|NCT03878069|448519871|FG002|Overall Study|Death|0|||
124699215|NCT00834587|448519872|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
124699216|NCT00834587|448519873|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
124699217|NCT00176254|448519874|FG000|Overall Study|Lost to Follow-up|1|||
124699218|NCT03810495|448519875|FG000|Overall Study|Lost to Follow-up|2|||
124699219|NCT03810495|448519875|FG000|Overall Study|Withdrawal by Subject|1|||
124699220|NCT02536339|448519877|FG000|Overall Study|Death|20|||
124699221|NCT02536339|448519877|FG000|Overall Study|Withdrawal by Subject|3|||
124699222|NCT02536339|448519877|FG000|Overall Study|Lost to Follow-up|2|||
124699223|NCT02536339|448519877|FG000|Overall Study|Treatment discontinued|2|||
124699224|NCT02536339|448519877|FG000|Overall Study|Physician Decision|1|||
124699225|NCT03449147|448519878|FG000|52-week Treatment Period|Death|0|||
124699226|NCT03449147|448519879|FG001|52-week Treatment Period|Death|1|||
124699227|NCT03449147|448519880|FG002|52-week Treatment Period|Death|0|||
124699228|NCT03449147|448519878|FG000|52-week Treatment Period|Lost to Follow-up|6|||
124699229|NCT03449147|448519879|FG001|52-week Treatment Period|Lost to Follow-up|2|||
124699230|NCT03449147|448519880|FG002|52-week Treatment Period|Lost to Follow-up|5|||
124699231|NCT03449147|448519878|FG000|52-week Treatment Period|Other|0|||
124699232|NCT03449147|448519879|FG001|52-week Treatment Period|Other|1|||
124699233|NCT03449147|448519880|FG002|52-week Treatment Period|Other|2|||
124763106|NCT00667628|448757908|FG001|Overall Study|Lost to Follow-up|0|||
124454920|NCT01045798|447625431|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
124454921|NCT01045798|447625432|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
124454922|NCT01045798|447625431|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
124454923|NCT01045798|447625432|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
124454924|NCT01045798|447625431|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
124454925|NCT01045798|447625432|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
124454926|NCT01045798|447625431|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
124454927|NCT01045798|447625432|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
124454928|NCT05321069|447625436|FG000|Overall Study|Adverse Event|52|||
124454929|NCT05321069|447625437|FG001|Overall Study|Adverse Event|52|||
124454930|NCT05321069|447625438|FG002|Overall Study|Adverse Event|64|||
124546070|NCT01891669|447954474|FG007|Overall Study|Withdrawal by Subject|2|||
124699234|NCT03449147|448519878|FG000|52-week Treatment Period|Physician Decision|1|||
124699235|NCT03449147|448519879|FG001|52-week Treatment Period|Physician Decision|0|||
124699236|NCT03449147|448519880|FG002|52-week Treatment Period|Physician Decision|3|||
124699237|NCT03449147|448519878|FG000|52-week Treatment Period|Screen Failure|1|||
124699238|NCT03449147|448519879|FG001|52-week Treatment Period|Screen Failure|2|||
124699239|NCT03449147|448519880|FG002|52-week Treatment Period|Screen Failure|0|||
124699240|NCT03449147|448519878|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
124699241|NCT03449147|448519879|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
124699242|NCT03449147|448519880|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
124699243|NCT03449147|448519878|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
124699244|NCT03449147|448519879|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
124699245|NCT03449147|448519880|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
124699246|NCT03449147|448519878|FG000|12-Week Off-Treatment Durability Period|Other|0|||
124699247|NCT03449147|448519879|FG001|12-Week Off-Treatment Durability Period|Other|1|||
124699248|NCT03449147|448519880|FG002|12-Week Off-Treatment Durability Period|Other|0|||
124699249|NCT02931539|448519883|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
124699250|NCT02931539|448519884|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
124699251|NCT02931539|448519885|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
124699252|NCT02931539|448519883|FG000|Period 1: Treatment Phase|Adverse Event|5|||
124699253|NCT02931539|448519884|FG001|Period 1: Treatment Phase|Adverse Event|1|||
124699254|NCT02931539|448519885|FG002|Period 1: Treatment Phase|Adverse Event|0|||
124699255|NCT02931539|448519883|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
124699256|NCT02931539|448519884|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
124699257|NCT02931539|448519885|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
124699258|NCT02931539|448519883|FG000|Period 1: Treatment Phase|Death|8|||
124699259|NCT02931539|448519884|FG001|Period 1: Treatment Phase|Death|24|||
124699260|NCT02931539|448519885|FG002|Period 1: Treatment Phase|Death|0|||
124699261|NCT02931539|448519883|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
124699262|NCT02931539|448519884|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
124699263|NCT02931539|448519885|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
124699264|NCT02931539|448519883|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
124699265|NCT02931539|448519884|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
124699266|NCT02931539|448519885|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
124699267|NCT02931539|448519883|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
124699268|NCT02931539|448519884|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
124699269|NCT02931539|448519885|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
124699270|NCT02931539|448519883|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
124699271|NCT02931539|448519884|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
124699272|NCT02931539|448519885|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
124699273|NCT02730169|448521382|FG000|Overall Study|Protocol Violation|1|||
124699274|NCT02730169|448521383|FG001|Overall Study|Protocol Violation|0|||
124699275|NCT02730169|448521384|FG002|Overall Study|Protocol Violation|0|||
124699276|NCT02730169|448521385|FG003|Overall Study|Protocol Violation|1|||
124699277|NCT02730169|448521382|FG000|Overall Study|Adverse Event|2|||
124699278|NCT02730169|448521383|FG001|Overall Study|Adverse Event|3|||
124699279|NCT02730169|448521384|FG002|Overall Study|Adverse Event|3|||
124699280|NCT02730169|448521385|FG003|Overall Study|Adverse Event|0|||
124699281|NCT02730169|448521382|FG000|Overall Study|Adverse Event of Special Interest|0|||
124699282|NCT02730169|448521383|FG001|Overall Study|Adverse Event of Special Interest|1|||
124699283|NCT02730169|448521384|FG002|Overall Study|Adverse Event of Special Interest|2|||
124699284|NCT02730169|448521385|FG003|Overall Study|Adverse Event of Special Interest|0|||
124699285|NCT02730169|448521382|FG000|Overall Study|Withdrawal by Subject|6|||
124699286|NCT02730169|448521383|FG001|Overall Study|Withdrawal by Subject|11|||
124699287|NCT02730169|448521384|FG002|Overall Study|Withdrawal by Subject|6|||
124699288|NCT02730169|448521385|FG003|Overall Study|Withdrawal by Subject|8|||
124699289|NCT02730169|448521382|FG000|Overall Study|Lost to Follow-up|5|||
124699290|NCT02730169|448521383|FG001|Overall Study|Lost to Follow-up|6|||
124699291|NCT02730169|448521384|FG002|Overall Study|Lost to Follow-up|5|||
124699292|NCT02730169|448521385|FG003|Overall Study|Lost to Follow-up|6|||
124699293|NCT02730169|448521382|FG000|Overall Study|Other|0|||
124699294|NCT02730169|448521383|FG001|Overall Study|Other|0|||
124699295|NCT02730169|448521384|FG002|Overall Study|Other|1|||
124699296|NCT02730169|448521385|FG003|Overall Study|Other|1|||
124699297|NCT02144337|448521392|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
124699298|NCT02144337|448521393|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
124699299|NCT02144337|448521392|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
124699300|NCT02144337|448521393|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
124699301|NCT02144337|448521392|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
124699302|NCT02144337|448521393|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
124699303|NCT02144337|448521392|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
124699304|NCT02144337|448521393|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
124699305|NCT02144337|448521392|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
124699306|NCT02144337|448521393|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
124699307|NCT01730729|448521394|FG000|Overall Study|Adverse Event|1|||
124454931|NCT05321069|447625436|FG000|Overall Study|Protocol Violation|1|||
124699308|NCT01730729|448521394|FG000|Overall Study|Death|1|||
124699309|NCT01730729|448521394|FG000|Overall Study|Progressive Disease|12|||
124699310|NCT00449787|448521395|FG000|Overall Study|Lost to Follow-up|10|||
124699311|NCT00449787|448521396|FG001|Overall Study|Lost to Follow-up|8|||
124699312|NCT00449787|448521395|FG000|Overall Study|Did not require medication|95|||
124699313|NCT00449787|448521396|FG001|Overall Study|Did not require medication|92|||
124699314|NCT03701074|448521397|FG000|Overall Study|Physician Decision|1|||
124699315|NCT03701074|448521398|FG001|Overall Study|Physician Decision|0|||
124699316|NCT03574389|448521402|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
124699317|NCT03574389|448521403|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
124699318|NCT03574389|448521404|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
124699319|NCT03574389|448521405|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
124699320|NCT03574389|448521406|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
124699321|NCT03574389|448521407|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
124699322|NCT03574389|448521408|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
124699323|NCT03574389|448521402|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
124699324|NCT03574389|448521403|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
124699325|NCT03574389|448521404|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
124699326|NCT03574389|448521405|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
124699327|NCT03574389|448521406|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
124699328|NCT03574389|448521407|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
124699329|NCT03574389|448521408|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
124699330|NCT03574389|448521402|FG000|Vaccination Period|Other|6|||
124699331|NCT03574389|448521403|FG001|Vaccination Period|Other|0|||
124699332|NCT03574389|448521404|FG002|Vaccination Period|Other|0|||
124699333|NCT03574389|448521405|FG003|Vaccination Period|Other|0|||
124699334|NCT03574389|448521406|FG004|Vaccination Period|Other|0|||
124699335|NCT03574389|448521407|FG005|Vaccination Period|Other|0|||
124699336|NCT03574389|448521408|FG006|Vaccination Period|Other|0|||
124699337|NCT03574389|448521402|FG000|Vaccination Period|Adverse Event|0|||
124699338|NCT03574389|448521403|FG001|Vaccination Period|Adverse Event|1|||
124699339|NCT03574389|448521404|FG002|Vaccination Period|Adverse Event|0|||
124699340|NCT03574389|448521405|FG003|Vaccination Period|Adverse Event|0|||
124699341|NCT03574389|448521406|FG004|Vaccination Period|Adverse Event|0|||
124699342|NCT03574389|448521407|FG005|Vaccination Period|Adverse Event|0|||
124699343|NCT03574389|448521408|FG006|Vaccination Period|Adverse Event|0|||
124699344|NCT03574389|448521402|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
124699345|NCT03574389|448521403|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
124699346|NCT03574389|448521404|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
124699347|NCT03574389|448521405|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
124699348|NCT03574389|448521406|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
124699349|NCT03574389|448521407|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
124699350|NCT03574389|448521408|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
124699351|NCT00993473|448521409|FG000|Overall Study|Adverse Event|0|||
124699352|NCT00993473|448521410|FG001|Overall Study|Adverse Event|2|||
124699353|NCT00993473|448521409|FG000|Overall Study|Protocol Violation|1|||
124699354|NCT00993473|448521410|FG001|Overall Study|Protocol Violation|2|||
124699355|NCT00993473|448521409|FG000|Overall Study|Lost to Follow-up|1|||
124699356|NCT00993473|448521410|FG001|Overall Study|Lost to Follow-up|0|||
124699357|NCT00993473|448521409|FG000|Overall Study|Withdrawal by Subject|1|||
124699358|NCT00993473|448521410|FG001|Overall Study|Withdrawal by Subject|5|||
124699359|NCT00993473|448521409|FG000|Overall Study|Technical problem with CGM device|0|||
124699360|NCT00993473|448521410|FG001|Overall Study|Technical problem with CGM device|1|||
124699361|NCT00993473|448521409|FG000|Overall Study|Family event|1|||
124699362|NCT00993473|448521410|FG001|Overall Study|Family event|0|||
124699363|NCT05122143|448521411|FG000|Overall Study|Adverse Event|1|||
124699364|NCT05122143|448521412|FG001|Overall Study|Adverse Event|0|||
124699365|NCT05122143|448521413|FG002|Overall Study|Adverse Event|0|||
124699366|NCT05122143|448521414|FG003|Overall Study|Adverse Event|0|||
124699367|NCT05122143|448521415|FG004|Overall Study|Adverse Event|1|||
124699368|NCT05122143|448521416|FG005|Overall Study|Adverse Event|0|||
124699369|NCT05122143|448521411|FG000|Overall Study|Protocol non-compliance|0|||
124699370|NCT05122143|448521412|FG001|Overall Study|Protocol non-compliance|0|||
124699371|NCT05122143|448521413|FG002|Overall Study|Protocol non-compliance|1|||
124699372|NCT05122143|448521414|FG003|Overall Study|Protocol non-compliance|0|||
124699373|NCT05122143|448521415|FG004|Overall Study|Protocol non-compliance|0|||
124699374|NCT05122143|448521416|FG005|Overall Study|Protocol non-compliance|0|||
124699375|NCT05122143|448521411|FG000|Overall Study|Covid contact|0|||
124454932|NCT05321069|447625437|FG001|Overall Study|Protocol Violation|1|||
124454933|NCT05321069|447625438|FG002|Overall Study|Protocol Violation|0|||
124454934|NCT05321069|447625436|FG000|Overall Study|Withdrawal by Subject|23|||
124454935|NCT05321069|447625437|FG001|Overall Study|Withdrawal by Subject|18|||
124454936|NCT05321069|447625438|FG002|Overall Study|Withdrawal by Subject|12|||
124699376|NCT05122143|448521412|FG001|Overall Study|Covid contact|0|||
124699377|NCT05122143|448521413|FG002|Overall Study|Covid contact|0|||
124699378|NCT05122143|448521414|FG003|Overall Study|Covid contact|0|||
124699379|NCT05122143|448521415|FG004|Overall Study|Covid contact|1|||
124699380|NCT05122143|448521416|FG005|Overall Study|Covid contact|0|||
124699381|NCT03766906|448521417|FG000|Overall Study|Withdrawal by Subject|6|||
124699382|NCT02624687|448521418|FG000|Overall Study|Withdrawal by Subject|1|||
124699383|NCT02624687|448521419|FG001|Overall Study|Withdrawal by Subject|1|||
124699384|NCT02624687|448521418|FG000|Overall Study|medical leave from work|0|||
124699385|NCT02624687|448521419|FG001|Overall Study|medical leave from work|1|||
124699386|NCT00552279|448521420|FG000|Overall Study|Adverse Event|0|||
124699387|NCT00552279|448521421|FG001|Overall Study|Adverse Event|1|||
124699388|NCT00552279|448521420|FG000|Overall Study|Withdrawal by Subject|12|||
124699389|NCT00552279|448521421|FG001|Overall Study|Withdrawal by Subject|1|||
124699390|NCT00552279|448521420|FG000|Overall Study|Lost to Follow-up|1|||
124699391|NCT00552279|448521421|FG001|Overall Study|Lost to Follow-up|0|||
124699392|NCT00552279|448521420|FG000|Overall Study|Other|1|||
124699393|NCT00552279|448521421|FG001|Overall Study|Other|1|||
124699394|NCT01651208|448521423|FG000|Overall Study|Lost to Follow-up|14|||
124699395|NCT01651208|448521424|FG001|Overall Study|Lost to Follow-up|16|||
124699396|NCT00836901|448521425|FG000|First Intervention|Withdrawal by Subject|1|||
124699397|NCT00836901|448521426|FG001|First Intervention|Withdrawal by Subject|0|||
124699398|NCT00830336|448521427|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
124699399|NCT00830336|448521428|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
124699400|NCT01853280|448521431|FG000|Overall Study|Lack of Efficacy|2|||
124699401|NCT01853280|448521432|FG001|Overall Study|Lack of Efficacy|2|||
124699402|NCT01853280|448521431|FG000|Overall Study|Lost to Follow-up|0|||
124699403|NCT01853280|448521432|FG001|Overall Study|Lost to Follow-up|1|||
124699404|NCT01853280|448521431|FG000|Overall Study|Physician Decision|0|||
124699405|NCT01853280|448521432|FG001|Overall Study|Physician Decision|1|||
124699406|NCT01853280|448521431|FG000|Overall Study|Withdrawal by Subject|0|||
124699407|NCT01853280|448521432|FG001|Overall Study|Withdrawal by Subject|1|||
124699408|NCT01853280|448521431|FG000|Overall Study|Ineligible|0|||
124699409|NCT01853280|448521432|FG001|Overall Study|Ineligible|1|||
124699410|NCT03032484|448521433|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
124699411|NCT03032484|448521434|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
124699412|NCT03032484|448521433|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
124699413|NCT03032484|448521434|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
124699414|NCT01229111|448521435|FG000|Overall Study|Death|1|||
124699415|NCT01689649|448521436|FG000|Overall Study|Lack of Efficacy|3|||
124699416|NCT01689649|448521436|FG000|Overall Study|Non-compliance|11|||
124699417|NCT01689649|448521436|FG000|Overall Study|Protocol Violation|3|||
124699418|NCT01689649|448521436|FG000|Overall Study|Lost to Follow-up|5|||
124699419|NCT03760081|448521440|FG000|Overall Study|Miscellaneous|0|||
124699420|NCT03760081|448521441|FG001|Overall Study|Miscellaneous|1|||
124699421|NCT03760081|448521440|FG000|Overall Study|Progressive Disease|5|||
124699422|NCT03760081|448521441|FG001|Overall Study|Progressive Disease|10|||
124699423|NCT03760081|448521440|FG000|Overall Study|Death|1|||
124699424|NCT03760081|448521441|FG001|Overall Study|Death|1|||
124699425|NCT03533491|448521442|FG000|Overall Study|Lost to Follow-up|2|||
124699426|NCT04576481|448521449|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
124699427|NCT04576481|448521450|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
124699428|NCT04576481|448521451|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
124699429|NCT04576481|448521452|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
124699430|NCT05261490|448521453|FG000|Overall Study|Other|1|||
124699431|NCT05261490|448521454|FG001|Overall Study|Other|0|||
124699432|NCT05261490|448521455|FG002|Overall Study|Other|0|||
124699433|NCT05261490|448521453|FG000|Overall Study|Study Terminated by Sponsor|1|||
124699434|NCT05261490|448521454|FG001|Overall Study|Study Terminated by Sponsor|1|||
124699435|NCT05261490|448521455|FG002|Overall Study|Study Terminated by Sponsor|4|||
124699436|NCT05261490|448521453|FG000|Overall Study|Death|1|||
124699437|NCT05261490|448521454|FG001|Overall Study|Death|2|||
124699438|NCT05261490|448521455|FG002|Overall Study|Death|0|||
124699439|NCT01682720|448521468|FG000|Overall Study|Randomized but Not Treated|0|||
124699440|NCT01682720|448521469|FG001|Overall Study|Randomized but Not Treated|1|||
124699441|NCT01682720|448521470|FG002|Overall Study|Randomized but Not Treated|1|||
124699442|NCT01682720|448521471|FG003|Overall Study|Randomized but Not Treated|0|||
124699443|NCT01682720|448521468|FG000|Overall Study|Terminated by Sponsor|83|||
124699444|NCT01682720|448521469|FG001|Overall Study|Terminated by Sponsor|0|||
124699445|NCT01682720|448521470|FG002|Overall Study|Terminated by Sponsor|0|||
124699446|NCT01682720|448521471|FG003|Overall Study|Terminated by Sponsor|0|||
124699447|NCT01682720|448521468|FG000|Overall Study|Efficacy Failure|0|||
124699448|NCT01682720|448521469|FG001|Overall Study|Efficacy Failure|3|||
124699449|NCT01682720|448521470|FG002|Overall Study|Efficacy Failure|3|||
124699450|NCT01682720|448521471|FG003|Overall Study|Efficacy Failure|30|||
124699451|NCT01682720|448521468|FG000|Overall Study|Lost to Follow-up|1|||
124699452|NCT01682720|448521469|FG001|Overall Study|Lost to Follow-up|1|||
124699453|NCT01682720|448521470|FG002|Overall Study|Lost to Follow-up|0|||
124699454|NCT01682720|448521471|FG003|Overall Study|Lost to Follow-up|6|||
124699455|NCT01682720|448521468|FG000|Overall Study|Subject Withdrew Consent|0|||
124699456|NCT01682720|448521469|FG001|Overall Study|Subject Withdrew Consent|0|||
124699457|NCT01682720|448521470|FG002|Overall Study|Subject Withdrew Consent|2|||
124699458|NCT01682720|448521471|FG003|Overall Study|Subject Withdrew Consent|2|||
124699459|NCT01682720|448521468|FG000|Overall Study|Adverse Event|1|||
124699460|NCT01682720|448521469|FG001|Overall Study|Adverse Event|0|||
124699461|NCT01682720|448521470|FG002|Overall Study|Adverse Event|1|||
124699462|NCT01682720|448521471|FG003|Overall Study|Adverse Event|1|||
124699463|NCT04204902|448521472|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
124763107|NCT00667628|448757907|FG000|Overall Study|Death|6|||
124699464|NCT04204902|448521473|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
124699465|NCT04191733|448521476|FG000|Overall Study|Withdrawn due to study closure|13|||
124699466|NCT04191733|448521477|FG001|Overall Study|Withdrawn due to study closure|14|||
124699467|NCT04191733|448521476|FG000|Overall Study|Withdrawal by Subject|2|||
124699468|NCT04191733|448521477|FG001|Overall Study|Withdrawal by Subject|4|||
124699469|NCT04191733|448521476|FG000|Overall Study|Physician Decision|1|||
124699470|NCT04191733|448521477|FG001|Overall Study|Physician Decision|1|||
124699471|NCT04191733|448521476|FG000|Overall Study|Lost to Follow-up|5|||
124699472|NCT04191733|448521477|FG001|Overall Study|Lost to Follow-up|6|||
124699473|NCT04191733|448521476|FG000|Overall Study|Death|0|||
124699474|NCT04191733|448521477|FG001|Overall Study|Death|1|||
124699475|NCT01714063|448521483|FG000|Overall Study|Equipment malfunction|2|||
124699476|NCT01646216|448521484|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
124699477|NCT01646216|448521485|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
124699478|NCT01646216|448521484|FG000|Overall Study|Did not complete training|0|||
124699479|NCT01646216|448521485|FG001|Overall Study|Did not complete training|2|||
124699480|NCT01646216|448521484|FG000|Overall Study|Investigator decision|1|||
124699481|NCT01646216|448521485|FG001|Overall Study|Investigator decision|1|||
124699482|NCT02633527|448521486|FG000|Overall Study|Failed to meet eligibility|0|||
124699483|NCT02633527|448521487|FG001|Overall Study|Failed to meet eligibility|1|||
124699484|NCT02633527|448521488|FG002|Overall Study|Failed to meet eligibility|1|||
124699485|NCT02633527|448521489|FG003|Overall Study|Failed to meet eligibility|0|||
124699486|NCT02633527|448521490|FG004|Overall Study|Failed to meet eligibility|1|||
124699487|NCT02633527|448521486|FG000|Overall Study|Adverse Event|0|||
124699488|NCT02633527|448521487|FG001|Overall Study|Adverse Event|4|||
124699489|NCT02633527|448521488|FG002|Overall Study|Adverse Event|3|||
124699490|NCT02633527|448521489|FG003|Overall Study|Adverse Event|1|||
124699491|NCT02633527|448521490|FG004|Overall Study|Adverse Event|5|||
124699492|NCT02633527|448521486|FG000|Overall Study|Lost to Follow-up|1|||
124699493|NCT02633527|448521487|FG001|Overall Study|Lost to Follow-up|2|||
124699494|NCT02633527|448521488|FG002|Overall Study|Lost to Follow-up|5|||
124699495|NCT02633527|448521489|FG003|Overall Study|Lost to Follow-up|5|||
124699496|NCT02633527|448521490|FG004|Overall Study|Lost to Follow-up|4|||
124699497|NCT02633527|448521486|FG000|Overall Study|Withdrawal by Subject|0|||
124699498|NCT02633527|448521487|FG001|Overall Study|Withdrawal by Subject|3|||
124699499|NCT02633527|448521488|FG002|Overall Study|Withdrawal by Subject|5|||
124699500|NCT02633527|448521489|FG003|Overall Study|Withdrawal by Subject|4|||
124699501|NCT02633527|448521490|FG004|Overall Study|Withdrawal by Subject|4|||
124699502|NCT02633527|448521486|FG000|Overall Study|Protocol Violation|0|||
124699503|NCT02633527|448521487|FG001|Overall Study|Protocol Violation|1|||
124699504|NCT02633527|448521488|FG002|Overall Study|Protocol Violation|1|||
124699505|NCT02633527|448521489|FG003|Overall Study|Protocol Violation|1|||
124699506|NCT02633527|448521490|FG004|Overall Study|Protocol Violation|1|||
124699507|NCT02633527|448521486|FG000|Overall Study|Physician Decision|0|||
124699508|NCT02633527|448521487|FG001|Overall Study|Physician Decision|0|||
124454937|NCT05321069|447625436|FG000|Overall Study|Lost to Follow-up|1|||
124454938|NCT05321069|447625437|FG001|Overall Study|Lost to Follow-up|0|||
124454939|NCT05321069|447625438|FG002|Overall Study|Lost to Follow-up|1|||
124454940|NCT05321069|447625436|FG000|Overall Study|No reason stated by the participants|23|||
124454941|NCT05321069|447625437|FG001|Overall Study|No reason stated by the participants|22|||
124454942|NCT05321069|447625438|FG002|Overall Study|No reason stated by the participants|16|||
124454943|NCT05321069|447625436|FG000|Overall Study|Lack of Efficacy|1|||
124454944|NCT05321069|447625437|FG001|Overall Study|Lack of Efficacy|1|||
124454945|NCT05321069|447625438|FG002|Overall Study|Lack of Efficacy|0|||
124454946|NCT06156215|447625441|FG000|Overall Study|Withdrawal by Subject|2|||
124454947|NCT06156215|447625442|FG001|Overall Study|Withdrawal by Subject|4|||
124454948|NCT06156215|447625443|FG002|Overall Study|Withdrawal by Subject|4|||
124454949|NCT06156215|447625444|FG003|Overall Study|Withdrawal by Subject|0|||
124454950|NCT06156215|447625445|FG004|Overall Study|Withdrawal by Subject|2|||
124454951|NCT06156215|447625446|FG005|Overall Study|Withdrawal by Subject|2|||
124454952|NCT06156215|447625441|FG000|Overall Study|Left ED without completing study|9|||
124454953|NCT06156215|447625442|FG001|Overall Study|Left ED without completing study|3|||
124454954|NCT06156215|447625443|FG002|Overall Study|Left ED without completing study|9|||
124699509|NCT02633527|448521488|FG002|Overall Study|Physician Decision|0|||
124454955|NCT06156215|447625444|FG003|Overall Study|Left ED without completing study|0|||
124454956|NCT06156215|447625445|FG004|Overall Study|Left ED without completing study|8|||
124454957|NCT06156215|447625446|FG005|Overall Study|Left ED without completing study|16|||
124699510|NCT02633527|448521489|FG003|Overall Study|Physician Decision|0|||
124699511|NCT02633527|448521490|FG004|Overall Study|Physician Decision|1|||
124699512|NCT02633527|448521486|FG000|Overall Study|Administrative reason|1|||
124699513|NCT02633527|448521487|FG001|Overall Study|Administrative reason|0|||
124699514|NCT02633527|448521488|FG002|Overall Study|Administrative reason|0|||
124699515|NCT02633527|448521489|FG003|Overall Study|Administrative reason|1|||
124699516|NCT02633527|448521490|FG004|Overall Study|Administrative reason|0|||
124699517|NCT02633527|448521486|FG000|Overall Study|Multiple reasons|1|||
124699518|NCT02633527|448521487|FG001|Overall Study|Multiple reasons|0|||
124546071|NCT01891669|447954475|FG008|Overall Study|Withdrawal by Subject|1|||
124546072|NCT01891669|447954476|FG009|Overall Study|Withdrawal by Subject|1|||
124546073|NCT01891669|447954467|FG000|Overall Study|Other|1|||
124546074|NCT01891669|447954468|FG001|Overall Study|Other|0|||
124546075|NCT01891669|447954469|FG002|Overall Study|Other|0|||
124546076|NCT01891669|447954470|FG003|Overall Study|Other|0|||
124546077|NCT01891669|447954471|FG004|Overall Study|Other|0|||
124546078|NCT01891669|447954472|FG005|Overall Study|Other|0|||
124546079|NCT01891669|447954473|FG006|Overall Study|Other|0|||
124546080|NCT01891669|447954474|FG007|Overall Study|Other|1|||
124699519|NCT02633527|448521488|FG002|Overall Study|Multiple reasons|2|||
124699520|NCT02633527|448521489|FG003|Overall Study|Multiple reasons|2|||
124699521|NCT02633527|448521490|FG004|Overall Study|Multiple reasons|1|||
124699522|NCT01681849|448521493|FG000|Overall Study|Protocol Violation|2|||
124699523|NCT01681849|448521494|FG001|Overall Study|Protocol Violation|0|||
124699524|NCT01681849|448521495|FG002|Overall Study|Protocol Violation|0|||
124699525|NCT01681849|448521493|FG000|Overall Study|Withdrawal by Subject|3|||
124699526|NCT01681849|448521494|FG001|Overall Study|Withdrawal by Subject|5|||
124699527|NCT01681849|448521495|FG002|Overall Study|Withdrawal by Subject|33|||
124699528|NCT01681849|448521493|FG000|Overall Study|Lost to Follow-up|3|||
124699529|NCT01681849|448521494|FG001|Overall Study|Lost to Follow-up|2|||
124699530|NCT01681849|448521495|FG002|Overall Study|Lost to Follow-up|6|||
124699531|NCT00979407|448521498|FG000|Overall Study|Withdrawal by Subject|3|||
124699532|NCT00979407|448521499|FG001|Overall Study|Withdrawal by Subject|4|||
124699533|NCT00979407|448521498|FG000|Overall Study|Lost to Follow-up|3|||
124699534|NCT00979407|448521499|FG001|Overall Study|Lost to Follow-up|3|||
124699535|NCT01166646|448521500|FG000|Overall Study|Protocol Violation|0|||
124699536|NCT01166646|448521501|FG001|Overall Study|Protocol Violation|1|||
124699537|NCT01166646|448521500|FG000|Overall Study|Adverse Event|1|||
124699538|NCT01166646|448521501|FG001|Overall Study|Adverse Event|0|||
124699539|NCT02420314|448521502|FG000|Overall Study|Withdrawal by Subject|1|||
124699540|NCT02420314|448521502|FG000|Overall Study|Protocol Violation|1|||
124699541|NCT03760068|448521503|FG000|Overall Study|Withdrawal by Subject|7|||
124699542|NCT03760068|448521504|FG001|Overall Study|Withdrawal by Subject|8|||
124699543|NCT03760068|448521503|FG000|Overall Study|Adverse Event|1|||
124699544|NCT03760068|448521504|FG001|Overall Study|Adverse Event|2|||
124699545|NCT03760068|448521503|FG000|Overall Study|Administrative Decision by Sponsor|0|||
124699546|NCT03760068|448521504|FG001|Overall Study|Administrative Decision by Sponsor|2|||
124699547|NCT03760068|448521503|FG000|Overall Study|Physician Decision|1|||
124699548|NCT03760068|448521504|FG001|Overall Study|Physician Decision|2|||
124699549|NCT03760068|448521503|FG000|Overall Study|Lost to Follow-up|4|||
124699550|NCT03760068|448521504|FG001|Overall Study|Lost to Follow-up|9|||
124699551|NCT03760068|448521503|FG000|Overall Study|Subject Moved Out of State|1|||
124699552|NCT03760068|448521504|FG001|Overall Study|Subject Moved Out of State|0|||
124699553|NCT03777020|448521508|FG000|Overall Study|Withdrawal by Subject|4|||
124699554|NCT03777020|448521509|FG001|Overall Study|Withdrawal by Subject|4|||
124699555|NCT03777020|448521508|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
124699556|NCT03777020|448521509|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
124699557|NCT00489476|448521510|FG000|Overall Study|Lost to Follow-up|0|||
124699558|NCT00489476|448521511|FG001|Overall Study|Lost to Follow-up|1|||
124699559|NCT00489476|448521512|FG002|Overall Study|Lost to Follow-up|0|||
124699560|NCT00489476|448521513|FG003|Overall Study|Lost to Follow-up|0|||
124699561|NCT03460704|448521514|FG000|Overall Study|Withdrawal by Subject|11|||
124699562|NCT03460704|448521515|FG001|Overall Study|Withdrawal by Subject|14|||
124699563|NCT03460704|448521514|FG000|Overall Study|Study terminated by the Sponsor|29|||
124699564|NCT03460704|448521515|FG001|Overall Study|Study terminated by the Sponsor|19|||
124699565|NCT03460704|448521514|FG000|Overall Study|Adverse Event|10|||
124699566|NCT03460704|448521515|FG001|Overall Study|Adverse Event|5|||
124699567|NCT03460704|448521514|FG000|Overall Study|Death|3|||
124454958|NCT06156215|447625441|FG000|Overall Study|Physician Decision|1|||
124454959|NCT06156215|447625442|FG001|Overall Study|Physician Decision|0|||
124454960|NCT06156215|447625443|FG002|Overall Study|Physician Decision|0|||
124454961|NCT06156215|447625444|FG003|Overall Study|Physician Decision|0|||
124454962|NCT06156215|447625445|FG004|Overall Study|Physician Decision|0|||
124454963|NCT06156215|447625446|FG005|Overall Study|Physician Decision|0|||
124454964|NCT06156215|447625441|FG000|Overall Study|Became or found ineligible|2|||
124454965|NCT06156215|447625442|FG001|Overall Study|Became or found ineligible|0|||
124454966|NCT06156215|447625443|FG002|Overall Study|Became or found ineligible|2|||
124454967|NCT06156215|447625444|FG003|Overall Study|Became or found ineligible|0|||
124454968|NCT06156215|447625445|FG004|Overall Study|Became or found ineligible|1|||
124454969|NCT06156215|447625446|FG005|Overall Study|Became or found ineligible|2|||
124454970|NCT03451851|447625447|FG000|PCP: Week 0 -16|Adverse Event|1|||
124546081|NCT01891669|447954475|FG008|Overall Study|Other|0|||
124546082|NCT01891669|447954476|FG009|Overall Study|Other|0|||
124546083|NCT04150107|447954479|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
124699568|NCT03460704|448521515|FG001|Overall Study|Death|2|||
124699569|NCT03460704|448521514|FG000|Overall Study|Non-Compliance with Study Drug|3|||
124699570|NCT03460704|448521515|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124763108|NCT00667628|448757908|FG001|Overall Study|Death|6|||
124699571|NCT03460704|448521514|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
124699572|NCT03460704|448521515|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
124699573|NCT03460704|448521514|FG000|Overall Study|Other|2|||
124699574|NCT03460704|448521515|FG001|Overall Study|Other|1|||
124699575|NCT02913326|448521520|FG000|Overall Study|Reason not listed|0|||
124699576|NCT02913326|448521521|FG001|Overall Study|Reason not listed|1|||
124699577|NCT02913326|448521520|FG000|Overall Study|Lost to Follow-up|0|||
124699578|NCT02913326|448521521|FG001|Overall Study|Lost to Follow-up|1|||
124699579|NCT02913326|448521520|FG000|Overall Study|Adverse Event|1|||
124699580|NCT02913326|448521521|FG001|Overall Study|Adverse Event|0|||
124699581|NCT01767857|448521522|FG000|Overall Study|Adverse Event|27|||
124699582|NCT01767857|448521523|FG001|Overall Study|Adverse Event|7|||
124699583|NCT01767857|448521522|FG000|Overall Study|Death|28|||
124699584|NCT01767857|448521523|FG001|Overall Study|Death|13|||
124699585|NCT01767857|448521522|FG000|Overall Study|Lack of Efficacy|299|||
124699586|NCT01767857|448521523|FG001|Overall Study|Lack of Efficacy|151|||
124699587|NCT01767857|448521522|FG000|Overall Study|Lost to Follow-up|1|||
124699588|NCT01767857|448521523|FG001|Overall Study|Lost to Follow-up|1|||
124699589|NCT01767857|448521522|FG000|Overall Study|Withdrawal by Subject|38|||
124699590|NCT01767857|448521523|FG001|Overall Study|Withdrawal by Subject|18|||
124699591|NCT01767857|448521522|FG000|Overall Study|Physician Decision|17|||
124699592|NCT01767857|448521523|FG001|Overall Study|Physician Decision|10|||
124699593|NCT01767857|448521522|FG000|Overall Study|Protocol Terminated|1|||
124699594|NCT01767857|448521523|FG001|Overall Study|Protocol Terminated|0|||
124699595|NCT01767857|448521522|FG000|Overall Study|Randomized But Never Treated|19|||
124699596|NCT01767857|448521523|FG001|Overall Study|Randomized But Never Treated|13|||
124699597|NCT04126174|448521524|FG000|Overall Study|Lost to Follow-up|3|||
124699598|NCT04126174|448521525|FG001|Overall Study|Lost to Follow-up|3|||
124699599|NCT01514422|448521528|FG000|Overall Study|Lost to Follow-up|1|||
124699600|NCT01044459|448521541|FG000|Overall Study|Withdrawal by Subject|21|||
124699601|NCT01044459|448521542|FG001|Overall Study|Withdrawal by Subject|28|||
124699602|NCT01044459|448521541|FG000|Overall Study|Terminated by Sponsor|22|||
124699603|NCT01044459|448521542|FG001|Overall Study|Terminated by Sponsor|21|||
124699604|NCT01044459|448521541|FG000|Overall Study|Adverse Event|22|||
124699605|NCT01044459|448521542|FG001|Overall Study|Adverse Event|20|||
124699606|NCT01044459|448521541|FG000|Overall Study|Lack of Efficacy|23|||
124699607|NCT01044459|448521542|FG001|Overall Study|Lack of Efficacy|12|||
124699608|NCT01044459|448521541|FG000|Overall Study|Protocol Violation|11|||
124699609|NCT01044459|448521542|FG001|Overall Study|Protocol Violation|16|||
124699610|NCT01044459|448521541|FG000|Overall Study|Other Reason|7|||
124699611|NCT01044459|448521542|FG001|Overall Study|Other Reason|14|||
124699612|NCT01044459|448521541|FG000|Overall Study|COPD exacerbation|9|||
124699613|NCT01044459|448521542|FG001|Overall Study|COPD exacerbation|8|||
124699614|NCT01044459|448521541|FG000|Overall Study|Lost to Follow-up|18|||
124699615|NCT01044459|448521542|FG001|Overall Study|Lost to Follow-up|12|||
124699616|NCT04105725|448521543|FG000|Primary Intervention|Lost to Follow-up|0|||
124699617|NCT04105725|448521544|FG001|Primary Intervention|Lost to Follow-up|2|||
124699618|NCT04105725|448521543|FG000|Primary Intervention|Withdrawal by Subject|0|||
124699619|NCT04105725|448521544|FG001|Primary Intervention|Withdrawal by Subject|1|||
124699620|NCT03726879|448521548|FG000|Overall Study|Death|11|||
124699621|NCT03726879|448521549|FG001|Overall Study|Death|13|||
124699622|NCT03726879|448521548|FG000|Overall Study|Physician Decision|0|||
124699623|NCT03726879|448521549|FG001|Overall Study|Physician Decision|2|||
124699624|NCT03726879|448521548|FG000|Overall Study|Protocol Violation|0|||
124699625|NCT03726879|448521549|FG001|Overall Study|Protocol Violation|1|||
124699626|NCT03726879|448521548|FG000|Overall Study|Withdrawal by Subject|5|||
124699627|NCT03726879|448521549|FG001|Overall Study|Withdrawal by Subject|6|||
124699628|NCT03726879|448521548|FG000|Overall Study|TSH result is unstable|0|||
124699629|NCT03726879|448521549|FG001|Overall Study|TSH result is unstable|1|||
124699630|NCT03726879|448521548|FG000|Overall Study|Disease relapse|1|||
124699631|NCT03726879|448521549|FG001|Overall Study|Disease relapse|0|||
124699632|NCT03726879|448521548|FG000|Overall Study|Lost to Follow-up|3|||
124699633|NCT03726879|448521549|FG001|Overall Study|Lost to Follow-up|0|||
124454971|NCT03451851|447625448|FG001|PCP: Week 0 -16|Adverse Event|0|||
124454972|NCT03451851|447625449|FG002|PCP: Week 0 -16|Adverse Event|0|||
124454973|NCT03451851|447625450|FG003|PCP: Week 0 -16|Adverse Event|0|||
124454974|NCT03451851|447625451|FG004|PCP: Week 0 -16|Adverse Event|0|||
124454975|NCT03451851|447625452|FG005|PCP: Week 0 -16|Adverse Event|0|||
124454976|NCT03451851|447625453|FG006|PCP: Week 0 -16|Adverse Event|1|||
124699634|NCT01093573|448521550|FG000|Overall Study|Physician Decision|0|||
124699635|NCT01093573|448521551|FG001|Overall Study|Physician Decision|0|||
124699636|NCT01093573|448521552|FG002|Overall Study|Physician Decision|1|||
124699637|NCT01093573|448521550|FG000|Overall Study|Insurance Denied|0|||
124699638|NCT01093573|448521551|FG001|Overall Study|Insurance Denied|0|||
124699639|NCT01093573|448521552|FG002|Overall Study|Insurance Denied|1|||
124699640|NCT05626686|448521553|FG000|Overall Study|Protocol Violation|3|||
124699641|NCT05626686|448521553|FG000|Overall Study|Withdrawal by Subject|3|||
124699642|NCT00581100|448523207|FG000|Overall Study|Death|1|||
124699643|NCT00581100|448523208|FG001|Overall Study|Death|0|||
124699644|NCT00581100|448523207|FG000|Overall Study|Adverse Event|2|||
124546084|NCT04150107|447954480|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
124546085|NCT04150107|447954479|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
124546086|NCT04150107|447954480|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
124546087|NCT03075826|447954482|FG000|Overall Study|Withdrawal by Subject|1|||
124546088|NCT03075826|447954482|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
124546089|NCT00650806|447954483|FG000|Overall Study|Adverse Event|0|||
124546090|NCT00650806|447954484|FG001|Overall Study|Adverse Event|5|||
124546091|NCT00650806|447954485|FG002|Overall Study|Adverse Event|3|||
124546092|NCT00650806|447954486|FG003|Overall Study|Adverse Event|4|||
124546093|NCT00650806|447954483|FG000|Overall Study|Lost to Follow-up|7|||
124546094|NCT00650806|447954484|FG001|Overall Study|Lost to Follow-up|6|||
124546095|NCT00650806|447954485|FG002|Overall Study|Lost to Follow-up|11|||
124546096|NCT00650806|447954486|FG003|Overall Study|Lost to Follow-up|10|||
124546097|NCT00650806|447954483|FG000|Overall Study|Protocol Violation|0|||
124546098|NCT00650806|447954484|FG001|Overall Study|Protocol Violation|0|||
124546099|NCT00650806|447954485|FG002|Overall Study|Protocol Violation|0|||
124546100|NCT00650806|447954486|FG003|Overall Study|Protocol Violation|1|||
124546101|NCT00650806|447954483|FG000|Overall Study|Pregnancy|0|||
124546102|NCT00650806|447954484|FG001|Overall Study|Pregnancy|0|||
124546103|NCT00650806|447954485|FG002|Overall Study|Pregnancy|0|||
124546104|NCT00650806|447954486|FG003|Overall Study|Pregnancy|1|||
124546105|NCT00650806|447954483|FG000|Overall Study|Withdrawal by Subject|7|||
124546106|NCT00650806|447954484|FG001|Overall Study|Withdrawal by Subject|5|||
124546107|NCT00650806|447954485|FG002|Overall Study|Withdrawal by Subject|8|||
124546108|NCT00650806|447954486|FG003|Overall Study|Withdrawal by Subject|6|||
124546109|NCT00650806|447954483|FG000|Overall Study|Noncompliance with study drug regimen|1|||
124546110|NCT00650806|447954484|FG001|Overall Study|Noncompliance with study drug regimen|1|||
124546111|NCT00650806|447954485|FG002|Overall Study|Noncompliance with study drug regimen|0|||
124546112|NCT00650806|447954486|FG003|Overall Study|Noncompliance with study drug regimen|0|||
124546113|NCT00650806|447954483|FG000|Overall Study|Study terminated by sponsor|2|||
124546114|NCT00650806|447954484|FG001|Overall Study|Study terminated by sponsor|3|||
124546115|NCT00650806|447954485|FG002|Overall Study|Study terminated by sponsor|5|||
124546116|NCT00650806|447954486|FG003|Overall Study|Study terminated by sponsor|4|||
124546117|NCT00650806|447954483|FG000|Overall Study|Other|1|||
124546118|NCT00650806|447954484|FG001|Overall Study|Other|1|||
124546119|NCT00650806|447954485|FG002|Overall Study|Other|2|||
124454977|NCT03451851|447625454|FG007|PCP: Week 0 -16|Adverse Event|0|||
124454978|NCT03451851|447625447|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
124454979|NCT03451851|447625448|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
124454980|NCT03451851|447625449|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
124454981|NCT03451851|447625450|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
124454982|NCT03451851|447625451|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
124454983|NCT03451851|447625452|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
124454984|NCT03451851|447625453|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
124454985|NCT03451851|447625454|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
124454986|NCT03451851|447625447|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
124454987|NCT03451851|447625448|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
124454988|NCT03451851|447625449|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
124454989|NCT03451851|447625450|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
124454990|NCT03451851|447625451|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
124454991|NCT03451851|447625452|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
124454992|NCT03451851|447625453|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
124454993|NCT03451851|447625454|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
124454994|NCT03451851|447625447|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
124454995|NCT03451851|447625448|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
124546120|NCT00650806|447954486|FG003|Overall Study|Other|0|||
124546121|NCT03707145|447954487|FG000|Overall Study|Lost to Follow-up|0|||
124699645|NCT00581100|448523208|FG001|Overall Study|Adverse Event|1|||
124699646|NCT00581100|448523207|FG000|Overall Study|Withdrawal by Subject|1|||
124699647|NCT00581100|448523208|FG001|Overall Study|Withdrawal by Subject|4|||
124699648|NCT00581100|448523207|FG000|Overall Study|Other|3|||
124699649|NCT00581100|448523208|FG001|Overall Study|Other|0|||
124699650|NCT04744831|448523209|FG000|Overall Study|Progressive Disease|31|||
124454996|NCT03451851|447625449|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
124454997|NCT03451851|447625450|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
124546122|NCT03707145|447954488|FG001|Overall Study|Lost to Follow-up|1|||
124546123|NCT03707145|447954489|FG002|Overall Study|Lost to Follow-up|1|||
124546124|NCT03707145|447954490|FG003|Overall Study|Lost to Follow-up|0|||
124546125|NCT04636437|447954492|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
124546126|NCT04636437|447954493|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
124546127|NCT04636437|447954494|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
124546128|NCT04636437|447954492|FG000|Overall Study|Started weight loss drug/program|2|||
124699651|NCT04744831|448523210|FG001|Overall Study|Progressive Disease|27|||
124699652|NCT04744831|448523211|FG002|Overall Study|Progressive Disease|25|||
124699653|NCT04744831|448523209|FG000|Overall Study|Adverse Event|3|||
124699654|NCT04744831|448523210|FG001|Overall Study|Adverse Event|3|||
124699655|NCT04744831|448523211|FG002|Overall Study|Adverse Event|3|||
124699656|NCT04744831|448523209|FG000|Overall Study|Clinical Progression|3|||
124699657|NCT04744831|448523210|FG001|Overall Study|Clinical Progression|2|||
124699658|NCT04744831|448523211|FG002|Overall Study|Clinical Progression|5|||
124699659|NCT04744831|448523209|FG000|Overall Study|Other|0|||
124699660|NCT04744831|448523210|FG001|Overall Study|Other|2|||
124699661|NCT04744831|448523211|FG002|Overall Study|Other|1|||
124699662|NCT04744831|448523209|FG000|Overall Study|Death|0|||
124699663|NCT04744831|448523210|FG001|Overall Study|Death|2|||
124699664|NCT04744831|448523211|FG002|Overall Study|Death|1|||
124699665|NCT04616196|448523221|FG000|Overall Study|Progressive Disease|3|||
124699666|NCT04616196|448523222|FG001|Overall Study|Progressive Disease|0|||
124699667|NCT04616196|448523223|FG002|Overall Study|Progressive Disease|4|||
124699668|NCT04616196|448523224|FG003|Overall Study|Progressive Disease|1|||
124699669|NCT04616196|448523221|FG000|Overall Study|Death|2|||
124699670|NCT04616196|448523222|FG001|Overall Study|Death|4|||
124699671|NCT04616196|448523223|FG002|Overall Study|Death|1|||
124699672|NCT04616196|448523224|FG003|Overall Study|Death|0|||
124699673|NCT04616196|448523221|FG000|Overall Study|Withdrawal by Subject|0|||
124699674|NCT04616196|448523222|FG001|Overall Study|Withdrawal by Subject|2|||
124699675|NCT04616196|448523223|FG002|Overall Study|Withdrawal by Subject|0|||
124699676|NCT04616196|448523224|FG003|Overall Study|Withdrawal by Subject|0|||
124699677|NCT04616196|448523221|FG000|Overall Study|Lost to Follow-up|1|||
124699678|NCT04616196|448523222|FG001|Overall Study|Lost to Follow-up|0|||
124699679|NCT04616196|448523223|FG002|Overall Study|Lost to Follow-up|0|||
124699680|NCT04616196|448523224|FG003|Overall Study|Lost to Follow-up|0|||
124699681|NCT04616196|448523221|FG000|Overall Study|Sponsor request|2|||
124699682|NCT04616196|448523222|FG001|Overall Study|Sponsor request|1|||
124699683|NCT04616196|448523223|FG002|Overall Study|Sponsor request|1|||
124699684|NCT04616196|448523224|FG003|Overall Study|Sponsor request|2|||
124699685|NCT05401409|448523225|FG000|Overall Study|Lost to Follow-up|1|||
124699686|NCT05401409|448523226|FG001|Overall Study|Lost to Follow-up|0|||
124699687|NCT02371889|448523227|FG000|Overall Study|Adverse medication effect|11|||
124699688|NCT02371889|448523228|FG001|Overall Study|Adverse medication effect|2|||
124699689|NCT02371889|448523227|FG000|Overall Study|Lost to Follow-up|6|||
124699690|NCT02371889|448523228|FG001|Overall Study|Lost to Follow-up|5|||
124699691|NCT02371889|448523227|FG000|Overall Study|Personal time constraints|2|||
124699692|NCT02371889|448523228|FG001|Overall Study|Personal time constraints|4|||
124454998|NCT03451851|447625451|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
124454999|NCT03451851|447625452|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
124455000|NCT03451851|447625453|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
124455001|NCT03451851|447625454|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
124455002|NCT03451851|447625447|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
124455003|NCT03451851|447625448|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
124455004|NCT03451851|447625449|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
124455005|NCT03451851|447625450|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
124455006|NCT03451851|447625451|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
124455007|NCT03451851|447625452|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
124455008|NCT03451851|447625453|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
124455009|NCT03451851|447625454|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
124455010|NCT03451851|447625447|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
124455011|NCT03451851|447625448|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
124455012|NCT03451851|447625449|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
124455013|NCT03451851|447625450|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
124455014|NCT03451851|447625451|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
124455015|NCT03451851|447625452|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
124455016|NCT03451851|447625453|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
124699693|NCT02371889|448523227|FG000|Overall Study|Lack of Efficacy|0|||
124455017|NCT03451851|447625454|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
124699694|NCT02371889|448523228|FG001|Overall Study|Lack of Efficacy|2|||
124699695|NCT02371889|448523227|FG000|Overall Study|Relapse|0|||
124699696|NCT02371889|448523228|FG001|Overall Study|Relapse|1|||
124699697|NCT05520333|448523229|FG000|Overall Study|Lost to Follow-up|3|||
124699698|NCT05520333|448523230|FG001|Overall Study|Lost to Follow-up|6|||
124699699|NCT02579759|448523231|FG000|Overall Study|Protocol Violation|2|||
124699700|NCT02579759|448523232|FG001|Overall Study|Protocol Violation|0|||
124699701|NCT02579759|448523233|FG002|Overall Study|Protocol Violation|0|||
124699702|NCT02579759|448523231|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
124699703|NCT02579759|448523232|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
124699704|NCT02579759|448523233|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
124699705|NCT02579759|448523231|FG000|Overall Study|BfArM hold|13|||
124699706|NCT02579759|448523232|FG001|Overall Study|BfArM hold|12|||
124455018|NCT05885737|447625455|FG000|DB Period|Adverse Event|4|||
124455019|NCT05885737|447625456|FG001|DB Period|Adverse Event|4|||
124455020|NCT05885737|447625455|FG000|DB Period|Lost to Follow-up|0|||
124455021|NCT05885737|447625456|FG001|DB Period|Lost to Follow-up|1|||
124455022|NCT05885737|447625455|FG000|DB Period|Physician Decision|2|||
124455023|NCT05885737|447625456|FG001|DB Period|Physician Decision|0|||
124455024|NCT05885737|447625455|FG000|DB Period|Withdrawal by Subject|12|||
124455025|NCT05885737|447625456|FG001|DB Period|Withdrawal by Subject|6|||
124455026|NCT05885737|447625455|FG000|DB Period|Other: Unspecified|2|||
124455027|NCT05885737|447625456|FG001|DB Period|Other: Unspecified|2|||
124455028|NCT05885737|447625455|FG000|OLE Period|Adverse Event|3|||
124455029|NCT05885737|447625456|FG001|OLE Period|Adverse Event|2|||
124455030|NCT05885737|447625455|FG000|OLE Period|Physician Decision|1|||
124455031|NCT05885737|447625456|FG001|OLE Period|Physician Decision|0|||
124455032|NCT05885737|447625455|FG000|OLE Period|Withdrawal by Subject|5|||
124455033|NCT05885737|447625456|FG001|OLE Period|Withdrawal by Subject|5|||
124455034|NCT05885737|447625455|FG000|OLE Period|Other: Unspecified|2|||
124455035|NCT05885737|447625456|FG001|OLE Period|Other: Unspecified|1|||
124455036|NCT00307151|447627100|FG000|Overall Study|Death|4|||
124455037|NCT00307151|447627101|FG001|Overall Study|Death|3|||
124455038|NCT00307151|447627102|FG002|Overall Study|Death|10|||
124455039|NCT00307151|447627103|FG003|Overall Study|Death|3|||
124455040|NCT00307151|447627100|FG000|Overall Study|Severe debilitation, unable to continue|1|||
124455041|NCT00307151|447627101|FG001|Overall Study|Severe debilitation, unable to continue|0|||
124455042|NCT00307151|447627102|FG002|Overall Study|Severe debilitation, unable to continue|0|||
124455043|NCT00307151|447627103|FG003|Overall Study|Severe debilitation, unable to continue|0|||
124455044|NCT00307151|447627100|FG000|Overall Study|Subject unable to get to clinic|1|||
124455045|NCT00307151|447627101|FG001|Overall Study|Subject unable to get to clinic|0|||
124455046|NCT00307151|447627102|FG002|Overall Study|Subject unable to get to clinic|6|||
124455047|NCT00307151|447627103|FG003|Overall Study|Subject unable to get to clinic|2|||
124455048|NCT00307151|447627100|FG000|Overall Study|Withdrew consent|0|||
124455049|NCT00307151|447627101|FG001|Overall Study|Withdrew consent|1|||
124455050|NCT00307151|447627102|FG002|Overall Study|Withdrew consent|1|||
124455051|NCT00307151|447627103|FG003|Overall Study|Withdrew consent|3|||
124455052|NCT00307151|447627100|FG000|Overall Study|Not willing to adhere to study reqs|2|||
124455053|NCT00307151|447627101|FG001|Overall Study|Not willing to adhere to study reqs|0|||
124455054|NCT00307151|447627102|FG002|Overall Study|Not willing to adhere to study reqs|2|||
124455055|NCT00307151|447627103|FG003|Overall Study|Not willing to adhere to study reqs|2|||
124455056|NCT00307151|447627100|FG000|Overall Study|Clinic unable to contact subject|3|||
124455057|NCT00307151|447627101|FG001|Overall Study|Clinic unable to contact subject|3|||
124455058|NCT00307151|447627102|FG002|Overall Study|Clinic unable to contact subject|1|||
124455059|NCT00307151|447627103|FG003|Overall Study|Clinic unable to contact subject|1|||
124455060|NCT02966509|447627104|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
124455061|NCT02966509|447627105|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
124455062|NCT02966509|447627104|FG000|Baseline Satisfaction Survey|Death|0|||
124455063|NCT02966509|447627105|FG001|Baseline Satisfaction Survey|Death|1|||
124455064|NCT02966509|447627104|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
124455065|NCT02966509|447627105|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
124455066|NCT02966509|447627104|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
124455067|NCT02966509|447627105|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
124455068|NCT02966509|447627104|FG000|6 Month Satisfaction Decision Survey|Death|22|||
124455069|NCT02966509|447627105|FG001|6 Month Satisfaction Decision Survey|Death|25|||
124455070|NCT02966509|447627104|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
124455071|NCT02966509|447627105|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
124455072|NCT02966509|447627104|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
124455073|NCT02966509|447627105|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
124455074|NCT02966509|447627104|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
124455075|NCT02966509|447627105|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
124455076|NCT02966509|447627104|FG000|6 Month Satisfaction Survey|Death|36|||
124455077|NCT02966509|447627105|FG001|6 Month Satisfaction Survey|Death|33|||
124455078|NCT02966509|447627104|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
124455079|NCT02966509|447627105|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
124455080|NCT02966509|447627104|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
124455081|NCT02966509|447627105|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
124455082|NCT02966509|447627104|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
124455083|NCT02966509|447627105|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
124455084|NCT02966509|447627104|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
124455085|NCT02966509|447627105|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
124455086|NCT02966509|447627104|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
124455087|NCT02966509|447627105|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
124455088|NCT01717287|447627106|FG000|Overall Study|Lost to Follow-up|0|||
124455089|NCT01717287|447627107|FG001|Overall Study|Lost to Follow-up|2|||
124455090|NCT01717287|447627106|FG000|Overall Study|Protocol Violation|0|||
124699707|NCT02579759|448523233|FG002|Overall Study|BfArM hold|12|||
124455091|NCT01717287|447627107|FG001|Overall Study|Protocol Violation|1|||
124455092|NCT01490450|447627108|FG000|Period 1|Lack of Efficacy|2|||
124455093|NCT01490450|447627109|FG001|Period 1|Lack of Efficacy|0|||
124455094|NCT01490450|447627110|FG002|Period 1|Lack of Efficacy|3|||
124455095|NCT01490450|447627111|FG003|Period 1|Lack of Efficacy|0|||
124455096|NCT01490450|447627108|FG000|Period 1|Adverse Event|0|||
124455097|NCT01490450|447627109|FG001|Period 1|Adverse Event|0|||
124455098|NCT01490450|447627110|FG002|Period 1|Adverse Event|0|||
124455099|NCT01490450|447627111|FG003|Period 1|Adverse Event|5|||
124455100|NCT01490450|447627108|FG000|Period 1|Request to discontinue treatment|1|||
124455101|NCT01490450|447627109|FG001|Period 1|Request to discontinue treatment|0|||
124455102|NCT01490450|447627110|FG002|Period 1|Request to discontinue treatment|0|||
124455103|NCT01490450|447627111|FG003|Period 1|Request to discontinue treatment|0|||
124455104|NCT01490450|447627108|FG000|Period 1|Withdrawal by Subject|0|||
124455105|NCT01490450|447627109|FG001|Period 1|Withdrawal by Subject|0|||
124455106|NCT01490450|447627110|FG002|Period 1|Withdrawal by Subject|0|||
124455107|NCT01490450|447627111|FG003|Period 1|Withdrawal by Subject|3|||
124455108|NCT01490450|447627108|FG000|Period 1|No longer met study criteria|0|||
124455109|NCT01490450|447627109|FG001|Period 1|No longer met study criteria|1|||
124455110|NCT01490450|447627110|FG002|Period 1|No longer met study criteria|1|||
124455111|NCT01490450|447627111|FG003|Period 1|No longer met study criteria|0|||
124699708|NCT02579759|448523231|FG000|Overall Study|Sponsor stopped Dose 2|0|||
124699709|NCT02579759|448523232|FG001|Overall Study|Sponsor stopped Dose 2|41|||
124699710|NCT02579759|448523233|FG002|Overall Study|Sponsor stopped Dose 2|0|||
124455112|NCT01490450|447627108|FG000|Period 2|Lack of Efficacy|0|||
124455113|NCT01490450|447627109|FG001|Period 2|Lack of Efficacy|0|||
124455114|NCT01490450|447627110|FG002|Period 2|Lack of Efficacy|0|||
124455115|NCT01490450|447627111|FG003|Period 2|Lack of Efficacy|1|||
124455116|NCT01490450|447627108|FG000|Period 2|Adverse Event|1|||
124455117|NCT01490450|447627109|FG001|Period 2|Adverse Event|1|||
124455118|NCT01490450|447627110|FG002|Period 2|Adverse Event|0|||
124455119|NCT01490450|447627111|FG003|Period 2|Adverse Event|1|||
124455120|NCT01490450|447627108|FG000|Period 2|Withdrawal by Subject|1|||
124455121|NCT01490450|447627109|FG001|Period 2|Withdrawal by Subject|0|||
124455122|NCT01490450|447627110|FG002|Period 2|Withdrawal by Subject|0|||
124455123|NCT01490450|447627111|FG003|Period 2|Withdrawal by Subject|0|||
124455124|NCT01490450|447627108|FG000|Period 2|Lost to Follow-up|0|||
124455125|NCT01490450|447627109|FG001|Period 2|Lost to Follow-up|0|||
124455126|NCT01490450|447627110|FG002|Period 2|Lost to Follow-up|0|||
124455127|NCT01490450|447627111|FG003|Period 2|Lost to Follow-up|2|||
124455128|NCT00404820|447627112|FG000|Overall Study|Adverse Event|4|||
124455129|NCT00404820|447627113|FG001|Overall Study|Adverse Event|16|||
124455130|NCT00404820|447627112|FG000|Overall Study|Withdrawal by Subject|5|||
124455131|NCT00404820|447627113|FG001|Overall Study|Withdrawal by Subject|3|||
124455132|NCT00404820|447627112|FG000|Overall Study|Lost to Follow-up|7|||
124455133|NCT00404820|447627113|FG001|Overall Study|Lost to Follow-up|3|||
124455134|NCT00404820|447627112|FG000|Overall Study|Administrative problems|2|||
124455135|NCT00404820|447627113|FG001|Overall Study|Administrative problems|0|||
124455136|NCT00404820|447627112|FG000|Overall Study|Death|1|||
124455137|NCT00404820|447627113|FG001|Overall Study|Death|0|||
124455138|NCT00404820|447627112|FG000|Overall Study|Other|0|||
124455139|NCT00404820|447627113|FG001|Overall Study|Other|2|||
124455140|NCT01469182|447627118|FG000|Overall Study|Adverse Event|21|||
124455141|NCT01469182|447627119|FG001|Overall Study|Adverse Event|3|||
124455142|NCT01469182|447627118|FG000|Overall Study|Lost to Follow-up|3|||
124455143|NCT01469182|447627119|FG001|Overall Study|Lost to Follow-up|0|||
124455144|NCT01469182|447627118|FG000|Overall Study|Withdrawal by Subject|4|||
124455145|NCT01469182|447627119|FG001|Overall Study|Withdrawal by Subject|1|||
124455146|NCT01469182|447627118|FG000|Overall Study|Protocol Violation|4|||
124455147|NCT01469182|447627119|FG001|Overall Study|Protocol Violation|2|||
124455148|NCT01469182|447627118|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
124455149|NCT01469182|447627119|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
124455150|NCT02687542|447627120|FG000|Overall Study|Medication error without associated AEs|0|||
124455151|NCT02687542|447627121|FG001|Overall Study|Medication error without associated AEs|0|||
124455152|NCT02687542|447627122|FG002|Overall Study|Medication error without associated AEs|0|||
124455153|NCT02687542|447627123|FG003|Overall Study|Medication error without associated AEs|0|||
124455154|NCT02687542|447627124|FG004|Overall Study|Medication error without associated AEs|1|||
124455155|NCT02687542|447627120|FG000|Overall Study|Lost to Follow-up|0|||
124455156|NCT02687542|447627121|FG001|Overall Study|Lost to Follow-up|0|||
124455157|NCT02687542|447627122|FG002|Overall Study|Lost to Follow-up|0|||
124455158|NCT02687542|447627123|FG003|Overall Study|Lost to Follow-up|0|||
124455159|NCT02687542|447627124|FG004|Overall Study|Lost to Follow-up|1|||
124455160|NCT02687542|447627120|FG000|Overall Study|Protocol Violation|0|||
124455161|NCT02687542|447627121|FG001|Overall Study|Protocol Violation|1|||
124455162|NCT02687542|447627122|FG002|Overall Study|Protocol Violation|0|||
124455163|NCT02687542|447627123|FG003|Overall Study|Protocol Violation|0|||
124455164|NCT02687542|447627124|FG004|Overall Study|Protocol Violation|0|||
124455165|NCT02687542|447627120|FG000|Overall Study|Other|5|||
124455166|NCT02687542|447627121|FG001|Overall Study|Other|9|||
124699711|NCT02579759|448523231|FG000|Overall Study|Non compliance|0|||
124699712|NCT02579759|448523232|FG001|Overall Study|Non compliance|1|||
124699713|NCT02579759|448523233|FG002|Overall Study|Non compliance|0|||
124699714|NCT02579759|448523231|FG000|Overall Study|Pregnancy|0|||
124699715|NCT02579759|448523232|FG001|Overall Study|Pregnancy|1|||
124699716|NCT02579759|448523233|FG002|Overall Study|Pregnancy|0|||
124699717|NCT02579759|448523231|FG000|Overall Study|Inclusion/exclusion criteria|0|||
124699718|NCT02579759|448523232|FG001|Overall Study|Inclusion/exclusion criteria|0|||
124699719|NCT02579759|448523233|FG002|Overall Study|Inclusion/exclusion criteria|1|||
124699720|NCT02579759|448523231|FG000|Overall Study|Adverse Event|4|||
124699721|NCT02579759|448523232|FG001|Overall Study|Adverse Event|3|||
124699722|NCT02579759|448523233|FG002|Overall Study|Adverse Event|1|||
124699723|NCT02579759|448523231|FG000|Overall Study|Withdrawal by Subject|3|||
124699724|NCT02579759|448523232|FG001|Overall Study|Withdrawal by Subject|3|||
124699725|NCT02579759|448523233|FG002|Overall Study|Withdrawal by Subject|5|||
124699726|NCT02579759|448523231|FG000|Overall Study|Lost to Follow-up|2|||
124699727|NCT02579759|448523232|FG001|Overall Study|Lost to Follow-up|2|||
124699728|NCT02579759|448523233|FG002|Overall Study|Lost to Follow-up|2|||
124699729|NCT02410200|448523236|FG000|Overall Study|Adverse Event|2|||
124699730|NCT02457546|448523237|FG000|Overall Study|Other reasons|4|||
124699731|NCT02457546|448523238|FG001|Overall Study|Other reasons|1|||
124699732|NCT02457546|448523237|FG000|Overall Study|Refused to complete study/procedures|1|||
124699733|NCT02457546|448523238|FG001|Overall Study|Refused to complete study/procedures|1|||
124699734|NCT02457546|448523237|FG000|Overall Study|Lost to Follow-up|4|||
124699735|NCT02457546|448523238|FG001|Overall Study|Lost to Follow-up|1|||
124699736|NCT02457546|448523237|FG000|Overall Study|Adverse Event|0|||
124699737|NCT02457546|448523238|FG001|Overall Study|Adverse Event|1|||
124699738|NCT05069415|448523239|FG000|Overall Study|Withdrawal by Subject|2|||
124699739|NCT05069415|448523240|FG001|Overall Study|Withdrawal by Subject|0|||
124699740|NCT05069415|448523239|FG000|Overall Study|Adverse Event|2|||
124699741|NCT05069415|448523240|FG001|Overall Study|Adverse Event|0|||
124699742|NCT00203242|448523243|FG000|Overall Study|Lost to Follow-up|1|||
124699743|NCT00866775|448523244|FG000|Overall Study|Adverse Event|5|||
124699744|NCT00866775|448523245|FG001|Overall Study|Adverse Event|19|||
124699745|NCT00866775|448523244|FG000|Overall Study|Death|1|||
124699746|NCT00866775|448523245|FG001|Overall Study|Death|0|||
124699747|NCT00866775|448523244|FG000|Overall Study|Lost to Follow-up|0|||
124699748|NCT00866775|448523245|FG001|Overall Study|Lost to Follow-up|4|||
124699749|NCT00866775|448523244|FG000|Overall Study|Physician Decision|0|||
124699750|NCT00866775|448523245|FG001|Overall Study|Physician Decision|3|||
124699751|NCT00866775|448523244|FG000|Overall Study|Protocol Violation|3|||
124699752|NCT00866775|448523245|FG001|Overall Study|Protocol Violation|4|||
124699753|NCT00866775|448523244|FG000|Overall Study|Withdrawal by Subject|4|||
124699754|NCT00866775|448523245|FG001|Overall Study|Withdrawal by Subject|4|||
124699755|NCT00866775|448523244|FG000|Overall Study|met exit criteria|23|||
124699756|NCT00866775|448523245|FG001|Overall Study|met exit criteria|17|||
124699757|NCT00866775|448523244|FG000|Overall Study|discontinued due to communication error|0|||
124699758|NCT00866775|448523245|FG001|Overall Study|discontinued due to communication error|1|||
124699759|NCT01661595|448523246|FG000|Phase 1: Week 0-4|Adverse Event|1|||
124699760|NCT01661595|448523247|FG001|Phase 1: Week 0-4|Adverse Event|0|||
124699761|NCT01661595|448523248|FG002|Phase 1: Week 0-4|Adverse Event|0|||
124699762|NCT01661595|448523249|FG003|Phase 1: Week 0-4|Adverse Event|0|||
124699763|NCT01661595|448523246|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
124699764|NCT01661595|448523247|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
124699765|NCT01661595|448523248|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
124699766|NCT01661595|448523249|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
124699767|NCT01500135|448523250|FG000|Overall Study|Withdrawal of Consent|4|||
124763109|NCT00667628|448757907|FG000|Overall Study|Investigator Considers in Best Interest|1|||
124763110|NCT00667628|448757908|FG001|Overall Study|Investigator Considers in Best Interest|0|||
124699768|NCT01500135|448523251|FG001|Overall Study|Withdrawal of Consent|0|||
124699769|NCT01500135|448523250|FG000|Overall Study|Lost to Follow-up|6|||
124699770|NCT01500135|448523251|FG001|Overall Study|Lost to Follow-up|4|||
124699771|NCT01500135|448523250|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
124699772|NCT01500135|448523251|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
124699773|NCT01500135|448523250|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
124763111|NCT00667628|448757907|FG000|Overall Study|Sponsor Terminated Study|17|||
124699774|NCT01500135|448523251|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
124699775|NCT01500135|448523250|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
124699776|NCT01500135|448523251|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
124699777|NCT01500135|448523250|FG000|Overall Study|Participant was a Safety Concern|1|||
124699778|NCT01500135|448523251|FG001|Overall Study|Participant was a Safety Concern|0|||
124699779|NCT01500135|448523250|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
124699780|NCT01500135|448523251|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
124699781|NCT00912509|448523252|FG000|Overall Study|Lost to Follow-up|1|||
124699782|NCT00912509|448523253|FG001|Overall Study|Lost to Follow-up|0|||
124763112|NCT00667628|448757908|FG001|Overall Study|Sponsor Terminated Study|21|||
124763113|NCT04244253|448757909|FG000|Overall Study|Adverse Event|2|||
124763114|NCT04244253|448757910|FG001|Overall Study|Adverse Event|2|||
124763115|NCT04244253|448757911|FG002|Overall Study|Adverse Event|4|||
124763116|NCT04244253|448757909|FG000|Overall Study|Protocol Violation|1|||
124763117|NCT04244253|448757910|FG001|Overall Study|Protocol Violation|2|||
124763118|NCT04244253|448757911|FG002|Overall Study|Protocol Violation|1|||
124763119|NCT04244253|448757909|FG000|Overall Study|Withdrawal by Subject|0|||
124763120|NCT04244253|448757910|FG001|Overall Study|Withdrawal by Subject|1|||
124763121|NCT04244253|448757911|FG002|Overall Study|Withdrawal by Subject|6|||
124763122|NCT04244253|448757909|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124763123|NCT04244253|448757910|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124763124|NCT04244253|448757911|FG002|Overall Study|Non-Compliance With Study Drug|1|||
124763125|NCT04663321|448757912|FG000|Overall Study|Study terminated by Sponsor|2|||
124763126|NCT04663321|448757913|FG001|Overall Study|Study terminated by Sponsor|1|||
124763127|NCT04663321|448757914|FG002|Overall Study|Study terminated by Sponsor|2|||
124763128|NCT04663321|448757912|FG000|Overall Study|Withdrawal by Subject|10|||
124763129|NCT04663321|448757913|FG001|Overall Study|Withdrawal by Subject|3|||
124763130|NCT04663321|448757914|FG002|Overall Study|Withdrawal by Subject|2|||
124763131|NCT04663321|448757912|FG000|Overall Study|Not provided|0|||
124763132|NCT04663321|448757913|FG001|Overall Study|Not provided|0|||
124763133|NCT04663321|448757914|FG002|Overall Study|Not provided|1|||
124763134|NCT03532542|448757917|FG000|Overall Study|Death|1|||
124763135|NCT03532542|448757918|FG001|Overall Study|Death|0|||
124763136|NCT03532542|448757917|FG000|Overall Study|Study Terminated by Sponsor|41|||
124763137|NCT03532542|448757918|FG001|Overall Study|Study Terminated by Sponsor|65|||
124763138|NCT03532542|448757917|FG000|Overall Study|Withdrawal by Subject|6|||
124763139|NCT03532542|448757918|FG001|Overall Study|Withdrawal by Subject|5|||
124763140|NCT01962441|448757919|FG000|Randomized Period|Randomized but Never Treated|4|||
124763141|NCT01962441|448757920|FG001|Randomized Period|Randomized but Never Treated|2|||
124763142|NCT01962441|448757921|FG002|Randomized Period|Randomized but Never Treated|3|||
124763143|NCT01962441|448757919|FG000|Randomized Period|Lost to Follow-up|2|||
124763144|NCT01962441|448757920|FG001|Randomized Period|Lost to Follow-up|4|||
124763145|NCT01962441|448757921|FG002|Randomized Period|Lost to Follow-up|4|||
124763146|NCT01962441|448757919|FG000|Randomized Period|Withdrew Consent|3|||
124763147|NCT01962441|448757920|FG001|Randomized Period|Withdrew Consent|3|||
124763148|NCT01962441|448757921|FG002|Randomized Period|Withdrew Consent|2|||
124763149|NCT01962441|448757919|FG000|Randomized Period|Adverse Event|1|||
124763150|NCT01962441|448757920|FG001|Randomized Period|Adverse Event|1|||
124763151|NCT01962441|448757921|FG002|Randomized Period|Adverse Event|0|||
124763152|NCT01962441|448757919|FG000|Randomized Period|Death|0|||
124763153|NCT01962441|448757920|FG001|Randomized Period|Death|0|||
124763154|NCT01962441|448757921|FG002|Randomized Period|Death|2|||
124763155|NCT01962441|448757919|FG000|Randomized Period|Protocol Violation|0|||
124763156|NCT01962441|448757920|FG001|Randomized Period|Protocol Violation|1|||
124763157|NCT01962441|448757921|FG002|Randomized Period|Protocol Violation|0|||
124763158|NCT01962441|448757919|FG000|Retreatment Substudy|Lack of Efficacy|1|||
124763159|NCT01962441|448757920|FG001|Retreatment Substudy|Lack of Efficacy|0|||
124763160|NCT01962441|448757921|FG002|Retreatment Substudy|Lack of Efficacy|0|||
124763161|NCT01962441|448757919|FG000|Retreatment Substudy|Lost to Follow-up|1|||
124763162|NCT01962441|448757920|FG001|Retreatment Substudy|Lost to Follow-up|0|||
124763163|NCT01962441|448757921|FG002|Retreatment Substudy|Lost to Follow-up|0|||
124763164|NCT02055898|448757922|FG000|First Intervention (5 Days)|Physician Decision|2|||
124763165|NCT02055898|448757923|FG001|First Intervention (5 Days)|Physician Decision|0|||
124763166|NCT02055898|448757922|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
124763167|NCT02055898|448757923|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
124763168|NCT02314052|448757927|FG000|Cycle One|Adverse Event|0|||
124763169|NCT02314052|448757928|FG001|Cycle One|Adverse Event|0|||
124763170|NCT02314052|448757929|FG002|Cycle One|Adverse Event|0|||
124763171|NCT02314052|448757930|FG003|Cycle One|Adverse Event|1|||
124763172|NCT02314052|448757931|FG004|Cycle One|Adverse Event|0|||
124763173|NCT02314052|448757932|FG005|Cycle One|Adverse Event|0|||
124763174|NCT00117637|448757933|FG000|First Intervention (Period 1)|Adverse Event|11|||
124763175|NCT00117637|448757934|FG001|First Intervention (Period 1)|Adverse Event|16|||
124763176|NCT00117637|448757933|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
124763177|NCT00117637|448757934|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
124763178|NCT00117637|448757933|FG000|First Intervention (Period 1)|Protocol Violation|1|||
124763179|NCT00117637|448757934|FG001|First Intervention (Period 1)|Protocol Violation|0|||
124763180|NCT00117637|448757933|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
124763181|NCT00117637|448757934|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
124763182|NCT00117637|448757933|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
124763183|NCT00117637|448757934|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
124763184|NCT00117637|448757933|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
124546129|NCT04636437|447954493|FG001|Overall Study|Started weight loss drug/program|1|||
124546130|NCT04636437|447954494|FG002|Overall Study|Started weight loss drug/program|1|||
124546131|NCT04636437|447954492|FG000|Overall Study|Lost to Follow-up|3|||
124546132|NCT04636437|447954493|FG001|Overall Study|Lost to Follow-up|1|||
124546133|NCT04636437|447954494|FG002|Overall Study|Lost to Follow-up|4|||
124546134|NCT04636437|447954492|FG000|Overall Study|Participant or physician decision|3|||
124546135|NCT04636437|447954493|FG001|Overall Study|Participant or physician decision|1|||
124546136|NCT04636437|447954494|FG002|Overall Study|Participant or physician decision|1|||
124699783|NCT00912509|448523252|FG000|Overall Study|Lack of Efficacy|4|||
124699784|NCT00912509|448523253|FG001|Overall Study|Lack of Efficacy|3|||
124699785|NCT03439072|448523254|FG000|Overall Study|Withdrawal by Subject|2|||
124699786|NCT03439072|448523255|FG001|Overall Study|Withdrawal by Subject|3|||
124699787|NCT03439072|448523254|FG000|Overall Study|Physician Decision|0|||
124699788|NCT03439072|448523255|FG001|Overall Study|Physician Decision|1|||
124699789|NCT01537432|448523257|FG000|Overall Study|Lost to Follow-up|3|||
124699790|NCT01537432|448523258|FG001|Overall Study|Lost to Follow-up|1|||
124699791|NCT01537432|448523257|FG000|Overall Study|Withdrawal by Subject|0|||
124699792|NCT01537432|448523258|FG001|Overall Study|Withdrawal by Subject|1|||
124699793|NCT01537432|448523257|FG000|Overall Study|Administrative problems|1|||
124699794|NCT01537432|448523258|FG001|Overall Study|Administrative problems|0|||
124699795|NCT01537432|448523257|FG000|Overall Study|Adverse Event|1|||
124699796|NCT01537432|448523258|FG001|Overall Study|Adverse Event|0|||
124699797|NCT01537432|448523257|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124699798|NCT01537432|448523258|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124699799|NCT05166902|448523259|FG000|First Intervention|Lost to Follow-up|0|||
124699800|NCT05166902|448523260|FG001|First Intervention|Lost to Follow-up|1|||
124699801|NCT01998477|448523261|FG000|Overall Study|Lost to Follow-up|4|||
124699802|NCT01998477|448523262|FG001|Overall Study|Lost to Follow-up|5|||
124699803|NCT01998477|448523261|FG000|Overall Study|Withdrawal by Subject|6|||
124699804|NCT01998477|448523262|FG001|Overall Study|Withdrawal by Subject|0|||
124699805|NCT00779909|448523263|FG000|Overall Study|Lost to Follow-up|1|||
124699806|NCT00779909|448523264|FG001|Overall Study|Lost to Follow-up|0|||
124699807|NCT00779909|448523265|FG002|Overall Study|Lost to Follow-up|0|||
124699808|NCT00779909|448523266|FG003|Overall Study|Lost to Follow-up|1|||
124699809|NCT00779909|448523263|FG000|Overall Study|Withdrawal by Subject|0|||
124699810|NCT00779909|448523264|FG001|Overall Study|Withdrawal by Subject|1|||
124699811|NCT00779909|448523265|FG002|Overall Study|Withdrawal by Subject|0|||
124699812|NCT00779909|448523266|FG003|Overall Study|Withdrawal by Subject|0|||
124699813|NCT03523585|448523267|FG000|Overall Study|Progressive Disease|174|||
124699814|NCT03523585|448523268|FG001|Overall Study|Progressive Disease|64|||
124699815|NCT03523585|448523269|FG002|Overall Study|Progressive Disease|77|||
124699816|NCT03523585|448523267|FG000|Overall Study|Adverse Event|74|||
124699817|NCT03523585|448523268|FG001|Overall Study|Adverse Event|5|||
124699818|NCT03523585|448523269|FG002|Overall Study|Adverse Event|9|||
124699819|NCT03523585|448523267|FG000|Overall Study|Withdrawal by Subject|30|||
124699820|NCT03523585|448523268|FG001|Overall Study|Withdrawal by Subject|11|||
124699821|NCT03523585|448523269|FG002|Overall Study|Withdrawal by Subject|6|||
124699822|NCT03523585|448523267|FG000|Overall Study|Clinical Progression|23|||
124699823|NCT03523585|448523268|FG001|Overall Study|Clinical Progression|5|||
124699824|NCT03523585|448523269|FG002|Overall Study|Clinical Progression|10|||
124699825|NCT03523585|448523267|FG000|Overall Study|Death|4|||
124699826|NCT03523585|448523268|FG001|Overall Study|Death|0|||
124699827|NCT03523585|448523269|FG002|Overall Study|Death|1|||
124699828|NCT03523585|448523267|FG000|Overall Study|Physician Decision|2|||
124699829|NCT03523585|448523268|FG001|Overall Study|Physician Decision|1|||
124699830|NCT03523585|448523269|FG002|Overall Study|Physician Decision|0|||
124699831|NCT03523585|448523267|FG000|Overall Study|Lost to Follow-up|1|||
124699832|NCT03523585|448523268|FG001|Overall Study|Lost to Follow-up|0|||
124699833|NCT03523585|448523269|FG002|Overall Study|Lost to Follow-up|0|||
124699834|NCT03523585|448523267|FG000|Overall Study|Miscellaneous|1|||
124699835|NCT03523585|448523268|FG001|Overall Study|Miscellaneous|0|||
124699836|NCT03523585|448523269|FG002|Overall Study|Miscellaneous|0|||
124699837|NCT03523585|448523267|FG000|Overall Study|Protocol Deviation|1|||
124699838|NCT03523585|448523268|FG001|Overall Study|Protocol Deviation|0|||
124699839|NCT03523585|448523269|FG002|Overall Study|Protocol Deviation|1|||
124699840|NCT03523585|448523267|FG000|Overall Study|Randomized But Not Treated|2|||
124699841|NCT03523585|448523268|FG001|Overall Study|Randomized But Not Treated|4|||
124699842|NCT03523585|448523269|FG002|Overall Study|Randomized But Not Treated|3|||
124699843|NCT05345405|448523270|FG000|Overall Study|Withdrawal by Subject|2|||
124699844|NCT05345405|448523271|FG001|Overall Study|Withdrawal by Subject|0|||
124699845|NCT05345405|448523272|FG002|Overall Study|Withdrawal by Subject|0|||
124546137|NCT02851069|447954495|FG000|Overall Study|Failure to Return|3|||
124546138|NCT02851069|447954495|FG000|Overall Study|Other|3|||
124699846|NCT05345405|448523270|FG000|Overall Study|Did not meet eligibility criteria|0|||
124699847|NCT05345405|448523271|FG001|Overall Study|Did not meet eligibility criteria|2|||
124699848|NCT05345405|448523272|FG002|Overall Study|Did not meet eligibility criteria|0|||
124546139|NCT00352664|447954500|FG000|Overall Study|Withdrawal by Subject|7|||
124546140|NCT00352664|447954501|FG001|Overall Study|Withdrawal by Subject|0|||
124546141|NCT03075215|447954504|FG000|12-Month Primary Endpoint|Death|152|||
124546142|NCT03075215|447954504|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
124546143|NCT03075215|447954504|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
124546144|NCT03075215|447954504|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
124546145|NCT02146365|447954505|FG000|Overall Study|Lost to Follow-up|2|||
124546146|NCT02146365|447954506|FG001|Overall Study|Lost to Follow-up|1|||
124546147|NCT02146365|447954507|FG002|Overall Study|Lost to Follow-up|3|||
124546148|NCT02146365|447954508|FG003|Overall Study|Lost to Follow-up|3|||
124546149|NCT02146365|447954509|FG004|Overall Study|Lost to Follow-up|1|||
124546150|NCT02146365|447954510|FG005|Overall Study|Lost to Follow-up|1|||
124546151|NCT02146365|447954511|FG006|Overall Study|Lost to Follow-up|0|||
124546152|NCT02146365|447954512|FG007|Overall Study|Lost to Follow-up|1|||
124546153|NCT02146365|447954505|FG000|Overall Study|Withdrawal by Subject|1|||
124546154|NCT02146365|447954506|FG001|Overall Study|Withdrawal by Subject|2|||
124546155|NCT02146365|447954507|FG002|Overall Study|Withdrawal by Subject|1|||
124546156|NCT02146365|447954508|FG003|Overall Study|Withdrawal by Subject|5|||
124546157|NCT02146365|447954509|FG004|Overall Study|Withdrawal by Subject|1|||
124546158|NCT02146365|447954510|FG005|Overall Study|Withdrawal by Subject|0|||
124699849|NCT05345405|448523270|FG000|Overall Study|Lost to Follow-up|0|||
124699850|NCT05345405|448523271|FG001|Overall Study|Lost to Follow-up|0|||
124699851|NCT05345405|448523272|FG002|Overall Study|Lost to Follow-up|1|||
124699852|NCT02872142|448523282|FG000|Overall Study|Adverse Event|2|||
124699853|NCT02872142|448523282|FG000|Overall Study|Death|1|||
124699854|NCT02872142|448523282|FG000|Overall Study|Participant Decision|3|||
124699855|NCT01903720|448523283|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
124699856|NCT01903720|448523283|FG000|Overall Study|Adverse Event|1|||
124699857|NCT01903720|448523283|FG000|Overall Study|Rescinding of informed consent|2|||
124699858|NCT01903720|448523283|FG000|Overall Study|Lost to Follow-up|2|||
124699859|NCT01903720|448523283|FG000|Overall Study|Treatment with alternative drug|1|||
124699860|NCT02244957|448523284|FG000|Overall Study|Lack of Efficacy|1|||
124699861|NCT02244957|448523285|FG001|Overall Study|Lack of Efficacy|0|||
124699862|NCT02150863|448523286|FG000|Overall Study|Lost to Follow-up|0|||
124699863|NCT02150863|448523287|FG001|Overall Study|Lost to Follow-up|1|||
124699864|NCT02150863|448523288|FG002|Overall Study|Lost to Follow-up|0|||
124699865|NCT00104884|448523293|FG000|Overall Study|Disease progression|4|||
124699866|NCT04893811|448523296|FG000|Vaccination Phase|Death|1|||
124699867|NCT04893811|448523297|FG001|Vaccination Phase|Death|0|||
124699868|NCT04893811|448523296|FG000|Vaccination Phase|Lost to Follow-up|1|||
124699869|NCT04893811|448523297|FG001|Vaccination Phase|Lost to Follow-up|1|||
124699870|NCT04893811|448523296|FG000|Vaccination Phase|Protocol Violation|2|||
124699871|NCT04893811|448523297|FG001|Vaccination Phase|Protocol Violation|0|||
124699872|NCT04893811|448523296|FG000|Vaccination Phase|Withdrawal by Subject|2|||
124699873|NCT04893811|448523297|FG001|Vaccination Phase|Withdrawal by Subject|1|||
124699874|NCT04893811|448523296|FG000|Vaccination Phase|Other|0|||
124699875|NCT04893811|448523297|FG001|Vaccination Phase|Other|1|||
124699876|NCT04893811|448523296|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
124699877|NCT04893811|448523297|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
124699878|NCT04893811|448523296|FG000|Follow-up Phase|Lost to Follow-up|0|||
124699879|NCT04893811|448523297|FG001|Follow-up Phase|Lost to Follow-up|1|||
124699880|NCT03268499|448523298|FG000|Overall Study|Withdrawal by Subject|2|||
124699881|NCT03268499|448523299|FG001|Overall Study|Withdrawal by Subject|1|||
124699882|NCT01725282|448523300|FG000|Overall Study|Adverse Event|1|||
124699883|NCT01725282|448523301|FG001|Overall Study|Adverse Event|3|||
124699884|NCT01725282|448523302|FG002|Overall Study|Adverse Event|6|||
124699885|NCT01725282|448523303|FG003|Overall Study|Adverse Event|4|||
124699886|NCT01725282|448523300|FG000|Overall Study|Exacerbation of Target Disease|1|||
124699887|NCT01725282|448523301|FG001|Overall Study|Exacerbation of Target Disease|0|||
124699888|NCT01725282|448523302|FG002|Overall Study|Exacerbation of Target Disease|0|||
124546159|NCT02146365|447954511|FG006|Overall Study|Withdrawal by Subject|0|||
124699889|NCT01725282|448523303|FG003|Overall Study|Exacerbation of Target Disease|1|||
124546160|NCT02146365|447954512|FG007|Overall Study|Withdrawal by Subject|0|||
124546161|NCT02146365|447954505|FG000|Overall Study|Unable to Comply with Protocol|0|||
124699890|NCT01725282|448523300|FG000|Overall Study|Met Exclusion Criteria|0|||
124699891|NCT01725282|448523301|FG001|Overall Study|Met Exclusion Criteria|0|||
124699892|NCT01725282|448523302|FG002|Overall Study|Met Exclusion Criteria|1|||
124699893|NCT01725282|448523303|FG003|Overall Study|Met Exclusion Criteria|0|||
124699894|NCT01725282|448523300|FG000|Overall Study|Study Site Withdrawal|0|||
124699895|NCT01725282|448523301|FG001|Overall Study|Study Site Withdrawal|1|||
124699896|NCT01725282|448523302|FG002|Overall Study|Study Site Withdrawal|0|||
124699897|NCT01725282|448523303|FG003|Overall Study|Study Site Withdrawal|0|||
124699898|NCT01725282|448523300|FG000|Overall Study|Withdrawal by Subject|0|||
124699899|NCT01725282|448523301|FG001|Overall Study|Withdrawal by Subject|0|||
124546162|NCT02146365|447954506|FG001|Overall Study|Unable to Comply with Protocol|1|||
124546163|NCT02146365|447954507|FG002|Overall Study|Unable to Comply with Protocol|1|||
124699900|NCT01725282|448523302|FG002|Overall Study|Withdrawal by Subject|1|||
124699901|NCT01725282|448523303|FG003|Overall Study|Withdrawal by Subject|1|||
124699902|NCT01725282|448523300|FG000|Overall Study|Lack of Efficacy|0|||
124699903|NCT01725282|448523301|FG001|Overall Study|Lack of Efficacy|1|||
124699904|NCT01725282|448523302|FG002|Overall Study|Lack of Efficacy|0|||
124699905|NCT01725282|448523303|FG003|Overall Study|Lack of Efficacy|1|||
124699906|NCT04064567|448523304|FG000|Overall Study|Lost to Follow-up|23|||
124699907|NCT04064567|448523305|FG001|Overall Study|Lost to Follow-up|22|||
124699908|NCT04064567|448523304|FG000|Overall Study|Withdrawal by Subject|0|||
124699909|NCT04064567|448523305|FG001|Overall Study|Withdrawal by Subject|1|||
124699910|NCT04064567|448523304|FG000|Overall Study|Reincarcerated|7|||
124699911|NCT04064567|448523305|FG001|Overall Study|Reincarcerated|10|||
124699912|NCT04064567|448523304|FG000|Overall Study|Moved out of U.S.|0|||
124699913|NCT04064567|448523305|FG001|Overall Study|Moved out of U.S.|1|||
124699914|NCT00595075|448523306|FG000|Overall Study|Withdrawal by Subject|1|||
124699915|NCT00595075|448523307|FG001|Overall Study|Withdrawal by Subject|0|||
124699916|NCT01946880|448523308|FG000|Overall Study|Lost to Follow-up|1|||
124699917|NCT01946880|448523309|FG001|Overall Study|Lost to Follow-up|0|||
124699918|NCT01946880|448523308|FG000|Overall Study|Physician Decision|1|||
124699919|NCT01946880|448523309|FG001|Overall Study|Physician Decision|1|||
124699920|NCT01946880|448523308|FG000|Overall Study|Withdrawal by Subject|3|||
124699921|NCT01946880|448523309|FG001|Overall Study|Withdrawal by Subject|2|||
124699922|NCT01946880|448523308|FG000|Overall Study|Met Primary Endpoint|1|||
124699923|NCT01946880|448523309|FG001|Overall Study|Met Primary Endpoint|0|||
124699924|NCT01946880|448523308|FG000|Overall Study|Personal and Family Issues|1|||
124699925|NCT01946880|448523309|FG001|Overall Study|Personal and Family Issues|0|||
124699926|NCT02034565|448523312|FG000|Overall Study|Adverse Event|1|||
124699927|NCT02034565|448523313|FG001|Overall Study|Adverse Event|0|||
124699928|NCT00113373|448523314|FG000|Overall Study|Ineligible: wrong primary|1|||
124699929|NCT00113373|448523314|FG000|Overall Study|Ineligible: second primary|1|||
124699930|NCT00113373|448523314|FG000|Overall Study|Never Treated|1|||
124699931|NCT06091956|448523316|FG000|Overall Study|Withdrawal by Subject|1|||
124699932|NCT06091956|448523316|FG000|Overall Study|Complicating Disease|1|||
124699933|NCT04525183|448523325|FG000|Overall Study|Withdrawal by Subject|0|||
124928270|NCT04447755|449368335|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
124928271|NCT04447755|449368336|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
124928272|NCT04447755|449368330|FG000|Overall Study|Ongoing in Study|1|||
124928273|NCT04447755|449368331|FG001|Overall Study|Ongoing in Study|2|||
124928274|NCT04447755|449368332|FG002|Overall Study|Ongoing in Study|0|||
124928275|NCT04447755|449368333|FG003|Overall Study|Ongoing in Study|0|||
124928276|NCT04447755|449368334|FG004|Overall Study|Ongoing in Study|2|||
124928277|NCT04447755|449368335|FG005|Overall Study|Ongoing in Study|2|||
124928278|NCT04447755|449368336|FG006|Overall Study|Ongoing in Study|26|||
124928279|NCT03701763|449368340|FG000|Placebo-controlled Phase|Adverse Event|1|||
124928280|NCT03701763|449368341|FG001|Placebo-controlled Phase|Adverse Event|5|||
124928281|NCT03701763|449368342|FG002|Placebo-controlled Phase|Adverse Event|0|||
124928282|NCT03701763|449368343|FG003|Placebo-controlled Phase|Adverse Event|0|||
124928283|NCT03701763|449368340|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
124928284|NCT03701763|449368341|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
124928285|NCT03701763|449368342|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
124928286|NCT03701763|449368343|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
124928287|NCT03701763|449368340|FG000|Placebo-controlled Phase|Miscellaneous|2|||
124928288|NCT03701763|449368341|FG001|Placebo-controlled Phase|Miscellaneous|0|||
124928289|NCT03701763|449368342|FG002|Placebo-controlled Phase|Miscellaneous|0|||
124928290|NCT03701763|449368343|FG003|Placebo-controlled Phase|Miscellaneous|0|||
124928291|NCT03701763|449368340|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
124928292|NCT03701763|449368341|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
124928293|NCT03701763|449368342|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
124928294|NCT03701763|449368343|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
124928295|NCT03701763|449368340|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
124455167|NCT02687542|447627122|FG002|Overall Study|Other|10|||
124455168|NCT02687542|447627123|FG003|Overall Study|Other|6|||
124455169|NCT02687542|447627124|FG004|Overall Study|Other|5|||
124455170|NCT02687542|447627120|FG000|Overall Study|Adverse Event|3|||
124455171|NCT02687542|447627121|FG001|Overall Study|Adverse Event|1|||
124455172|NCT02687542|447627122|FG002|Overall Study|Adverse Event|3|||
124455173|NCT02687542|447627123|FG003|Overall Study|Adverse Event|2|||
124455174|NCT02687542|447627124|FG004|Overall Study|Adverse Event|9|||
124455175|NCT02687542|447627120|FG000|Overall Study|Withdrawal by Subject|0|||
124455176|NCT02687542|447627121|FG001|Overall Study|Withdrawal by Subject|1|||
124699934|NCT04525183|448523326|FG001|Overall Study|Withdrawal by Subject|0|||
124699935|NCT04525183|448523327|FG002|Overall Study|Withdrawal by Subject|3|||
124699936|NCT04525183|448523325|FG000|Overall Study|Study non-compliance|0|||
124699937|NCT04525183|448523326|FG001|Overall Study|Study non-compliance|0|||
124699938|NCT04525183|448523327|FG002|Overall Study|Study non-compliance|1|||
124928296|NCT03701763|449368341|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
124928297|NCT03701763|449368342|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
124763185|NCT00117637|448757934|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
124763186|NCT00117637|448757933|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
124763187|NCT00117637|448757934|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
124763188|NCT00117637|448757933|FG000|First Intervention (Period 1)|reason not reported|0|||
124763189|NCT00117637|448757934|FG001|First Intervention (Period 1)|reason not reported|1|||
124763190|NCT00117637|448757933|FG000|Second Intervention (Period 2)|Adverse Event|0|||
124763191|NCT00117637|448757934|FG001|Second Intervention (Period 2)|Adverse Event|9|||
124763192|NCT00117637|448757933|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
124763193|NCT00117637|448757934|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
124763194|NCT00117637|448757933|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
124763195|NCT00117637|448757934|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
124763196|NCT00117637|448757933|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
124763197|NCT00117637|448757934|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
124763198|NCT00117637|448757933|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
124763199|NCT00117637|448757934|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
124763200|NCT00117637|448757933|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
124763201|NCT00117637|448757934|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
124763202|NCT00117637|448757933|FG000|Second Intervention (Period 2)|reason not reported|1|||
124763203|NCT00117637|448757934|FG001|Second Intervention (Period 2)|reason not reported|0|||
124763204|NCT01620060|448757935|FG000|Overall Study|Adverse Event|9|||
124763205|NCT01620060|448757935|FG000|Overall Study|Protocol Violation|1|||
124763206|NCT01620060|448757935|FG000|Overall Study|Withdrawal by Subject|1|||
124763207|NCT01620060|448757935|FG000|Overall Study|Did not comply with Study Produre|1|||
124763208|NCT01620060|448757935|FG000|Overall Study|Family emergency|1|||
124763209|NCT01620060|448757935|FG000|Overall Study|Per Sponsor Decision|2|||
124763210|NCT00231777|448757936|FG000|Overall Study|Lost to Follow-up|3|||
124763211|NCT00231777|448757937|FG001|Overall Study|Lost to Follow-up|0|||
124763212|NCT00231777|448757936|FG000|Overall Study|Other|3|||
124763213|NCT00231777|448757937|FG001|Overall Study|Other|2|||
124763214|NCT04551989|448757940|FG000|Overall Study|Adverse Event|4|||
124763215|NCT04551989|448757940|FG000|Overall Study|Protocol Violation|3|||
124763216|NCT04551989|448757940|FG000|Overall Study|Lost to Follow-up|1|||
124763217|NCT04551989|448757940|FG000|Overall Study|Physician Decision|3|||
124763218|NCT02756338|448757941|FG000|Overall Study|Withdrawn by Investigator|1|||
124763219|NCT02756338|448757941|FG000|Overall Study|Device Replaced with Pacemaker|4|||
124763220|NCT00088530|448757944|FG000|Overall Study|Progressive/Relapsed Disease|28|||
124763221|NCT00088530|448757945|FG001|Overall Study|Progressive/Relapsed Disease|39|||
124763222|NCT00088530|448757944|FG000|Overall Study|Adverse Event|15|||
124763223|NCT00088530|448757945|FG001|Overall Study|Adverse Event|9|||
124763224|NCT00088530|448757944|FG000|Overall Study|Withdrawal by Subject|2|||
124763225|NCT00088530|448757945|FG001|Overall Study|Withdrawal by Subject|5|||
124763226|NCT00088530|448757944|FG000|Overall Study|Lost to Follow-up|2|||
124763227|NCT00088530|448757945|FG001|Overall Study|Lost to Follow-up|0|||
124763228|NCT00088530|448757944|FG000|Overall Study|Physician Decision|2|||
124763229|NCT00088530|448757945|FG001|Overall Study|Physician Decision|0|||
124763230|NCT00088530|448757944|FG000|Overall Study|Sponsor decision|0|||
124763231|NCT00088530|448757945|FG001|Overall Study|Sponsor decision|1|||
124763232|NCT00088530|448757944|FG000|Overall Study|Patient never treated|1|||
124763233|NCT00088530|448757945|FG001|Overall Study|Patient never treated|0|||
124763234|NCT00300755|448757948|FG000|Overall Study|Adverse Event|1|||
124763235|NCT00300755|448757949|FG001|Overall Study|Adverse Event|2|||
124763236|NCT00300755|448757950|FG002|Overall Study|Adverse Event|1|||
124763237|NCT00300755|448757948|FG000|Overall Study|Withdrawal by Subject|0|||
124763238|NCT00300755|448757949|FG001|Overall Study|Withdrawal by Subject|2|||
124763239|NCT00300755|448757950|FG002|Overall Study|Withdrawal by Subject|0|||
124763240|NCT00300755|448757948|FG000|Overall Study|Protocol Violation|0|||
124763241|NCT00300755|448757949|FG001|Overall Study|Protocol Violation|0|||
124763242|NCT00300755|448757950|FG002|Overall Study|Protocol Violation|1|||
124763243|NCT02694744|448757954|FG000|Overall Study|Adverse Event|2|||
124763244|NCT02694744|448757955|FG001|Overall Study|Adverse Event|1|||
124763245|NCT02694744|448757954|FG000|Overall Study|Withdrawal by Subject|2|||
124763246|NCT02694744|448757955|FG001|Overall Study|Withdrawal by Subject|1|||
124763247|NCT02694744|448757954|FG000|Overall Study|Physician Decision|1|||
124455177|NCT02687542|447627122|FG002|Overall Study|Withdrawal by Subject|1|||
124455178|NCT02687542|447627123|FG003|Overall Study|Withdrawal by Subject|2|||
124455179|NCT02687542|447627124|FG004|Overall Study|Withdrawal by Subject|4|||
124455180|NCT00003535|447627127|FG000|Overall Study|Not evaluable|5|||
124455181|NCT02181816|447627128|FG000|Overall Study|Case Report Forms Uncollected|38|||
124455182|NCT02181816|447627128|FG000|Overall Study|Protocol Deviation|21|||
124455183|NCT03807349|447627129|FG000|Overall Study|Early Study Termination|9|||
124763248|NCT02694744|448757955|FG001|Overall Study|Physician Decision|2|||
124763249|NCT02694744|448757954|FG000|Overall Study|Lost to Follow-up|1|||
124455184|NCT00294060|447627130|FG000|Overall Study|Death|225|||
124763250|NCT02694744|448757955|FG001|Overall Study|Lost to Follow-up|0|||
124763251|NCT02694744|448757954|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
124763252|NCT02694744|448757955|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
124763253|NCT00686777|448757956|FG000|Overall Study|Adverse Event|2|||
124763254|NCT00686777|448757956|FG000|Overall Study|Pregnancy|1|||
124763255|NCT00686777|448757956|FG000|Overall Study|Withdrawal by Subject|2|||
124763256|NCT00686777|448757956|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
124763257|NCT00686777|448757956|FG000|Overall Study|No Visit|1|||
124763258|NCT01945021|448757957|FG000|Overall Study|Adverse Event|1|||
124763259|NCT01945021|448757957|FG000|Overall Study|Withdrawal of consent|12|||
124763260|NCT01945021|448757957|FG000|Overall Study|Lost to Follow-up|5|||
124763261|NCT01945021|448757957|FG000|Overall Study|Death|65|||
124763262|NCT03582215|448757958|FG000|Overall Study|Adverse Event|1|||
124763263|NCT03582215|448757959|FG001|Overall Study|Adverse Event|0|||
124928298|NCT03701763|449368343|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
124763264|NCT03582215|448757960|FG002|Overall Study|Adverse Event|0|||
124763265|NCT03582215|448757961|FG003|Overall Study|Adverse Event|0|||
124763266|NCT03582215|448757962|FG004|Overall Study|Adverse Event|0|||
124928299|NCT03701763|449368340|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
124928300|NCT03701763|449368341|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
124928301|NCT03701763|449368342|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
124928302|NCT03701763|449368343|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
124928303|NCT03701763|449368340|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
124928304|NCT03701763|449368341|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
124928305|NCT03701763|449368342|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
124928306|NCT03701763|449368343|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
124928307|NCT03701763|449368340|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
124928308|NCT03701763|449368341|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
124928309|NCT03701763|449368342|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
124928310|NCT03701763|449368343|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
124928311|NCT03701763|449368340|FG000|Apremilast Extension Phase|Adverse Event|0|||
124928312|NCT03701763|449368341|FG001|Apremilast Extension Phase|Adverse Event|0|||
124928313|NCT03701763|449368342|FG002|Apremilast Extension Phase|Adverse Event|3|||
124928314|NCT03701763|449368343|FG003|Apremilast Extension Phase|Adverse Event|1|||
124928315|NCT03701763|449368340|FG000|Apremilast Extension Phase|Miscellaneous|0|||
124928316|NCT03701763|449368341|FG001|Apremilast Extension Phase|Miscellaneous|0|||
124928317|NCT03701763|449368342|FG002|Apremilast Extension Phase|Miscellaneous|2|||
124928318|NCT03701763|449368343|FG003|Apremilast Extension Phase|Miscellaneous|1|||
124928319|NCT03701763|449368340|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
124928320|NCT03701763|449368341|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
124928321|NCT03701763|449368342|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
124928322|NCT03701763|449368343|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
124928323|NCT03701763|449368340|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
124928324|NCT03701763|449368341|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
124928325|NCT03701763|449368342|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
124928326|NCT03701763|449368343|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
124928327|NCT03701763|449368340|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
124928328|NCT03701763|449368341|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
124928329|NCT03701763|449368342|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
124928330|NCT03701763|449368343|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
124928331|NCT03701763|449368340|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
124928332|NCT03701763|449368341|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
124928333|NCT03701763|449368342|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
124928334|NCT03701763|449368343|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
124928335|NCT03701763|449368340|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
124928336|NCT03701763|449368341|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
124928337|NCT03701763|449368342|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
124928338|NCT03701763|449368343|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
124928339|NCT03701763|449368340|FG000|14-Week Observational Follow-up Phase|Other|0|||
124928340|NCT03701763|449368341|FG001|14-Week Observational Follow-up Phase|Other|0|||
124928341|NCT03701763|449368342|FG002|14-Week Observational Follow-up Phase|Other|1|||
124928342|NCT03701763|449368343|FG003|14-Week Observational Follow-up Phase|Other|0|||
124928343|NCT03701763|449368340|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
124928344|NCT03701763|449368341|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
124928345|NCT03701763|449368342|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
124928346|NCT03701763|449368343|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
124928347|NCT03701763|449368340|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
124928348|NCT03701763|449368341|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
124928349|NCT03701763|449368342|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
124928350|NCT03701763|449368343|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
124928351|NCT00592852|449368345|FG000|Overall Study|Non-compliance|1|||
124928352|NCT00592852|449368345|FG000|Overall Study|Adverse Event|3|||
124928353|NCT00592852|449368345|FG000|Overall Study|Found ineligible|1|||
124928354|NCT00592852|449368345|FG000|Overall Study|Withdrawal by Subject|1|||
124928355|NCT02589795|449368349|FG000|Overall Study|Lost to Follow-up|1|||
124928356|NCT02589795|449368350|FG001|Overall Study|Lost to Follow-up|0|||
124928357|NCT02589795|449368351|FG002|Overall Study|Lost to Follow-up|0|||
124928358|NCT02589795|449368349|FG000|Overall Study|Withdrawal by Subject|0|||
124928359|NCT02589795|449368350|FG001|Overall Study|Withdrawal by Subject|0|||
124928360|NCT02589795|449368351|FG002|Overall Study|Withdrawal by Subject|2|||
124928361|NCT02589795|449368349|FG000|Overall Study|Protocol Violation|0|||
124928362|NCT02589795|449368350|FG001|Overall Study|Protocol Violation|0|||
124928363|NCT02589795|449368351|FG002|Overall Study|Protocol Violation|1|||
124928364|NCT03599661|449368353|FG000|Overall Study|Lost to Follow-up|9|||
124928365|NCT04909801|449368354|FG000|Overall Study|Lack of Efficacy|2|||
124928366|NCT04909801|449368355|FG001|Overall Study|Lack of Efficacy|1|||
124928367|NCT04909801|449368354|FG000|Overall Study|Adverse Event|1|||
124928368|NCT04909801|449368355|FG001|Overall Study|Adverse Event|2|||
124928369|NCT04909801|449368354|FG000|Overall Study|Participant request to discontinue study treatment|1|||
124928370|NCT04909801|449368355|FG001|Overall Study|Participant request to discontinue study treatment|2|||
124928371|NCT04909801|449368354|FG000|Overall Study|Withdrawal by Subject|2|||
124928372|NCT04909801|449368355|FG001|Overall Study|Withdrawal by Subject|1|||
124928373|NCT04909801|449368354|FG000|Overall Study|other reasons|1|||
124928374|NCT04909801|449368355|FG001|Overall Study|other reasons|1|||
124928375|NCT04117347|449368358|FG000|Overall Study|Adverse Event|0|||
124928376|NCT04117347|449368359|FG001|Overall Study|Adverse Event|0|||
124928377|NCT04117347|449368360|FG002|Overall Study|Adverse Event|1|||
124928378|NCT04117347|449368358|FG000|Overall Study|No time for study|0|||
124928379|NCT04117347|449368359|FG001|Overall Study|No time for study|2|||
124928380|NCT04117347|449368360|FG002|Overall Study|No time for study|0|||
124928381|NCT04117347|449368358|FG000|Overall Study|Family emergency|1|||
124928382|NCT04117347|449368359|FG001|Overall Study|Family emergency|0|||
124928383|NCT04117347|449368360|FG002|Overall Study|Family emergency|0|||
124928384|NCT03687086|449368361|FG000|Overall Study|Withdrawal by Subject|3|||
124928385|NCT03687086|449368362|FG001|Overall Study|Withdrawal by Subject|4|||
124928386|NCT03687086|449368361|FG000|Overall Study|Lost to Follow-up|1|||
124928387|NCT03687086|449368362|FG001|Overall Study|Lost to Follow-up|1|||
124928388|NCT03687086|449368361|FG000|Overall Study|Death|1|||
124928389|NCT03687086|449368362|FG001|Overall Study|Death|0|||
124928390|NCT03687086|449368361|FG000|Overall Study|Incomplete assessment|0|||
124928391|NCT03687086|449368362|FG001|Overall Study|Incomplete assessment|2|||
124928392|NCT02505984|449368363|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
124928393|NCT02505984|449368364|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
124928394|NCT02505984|449368363|FG000|Overall Study|Unreliable self-report data|1|||
124928395|NCT02505984|449368364|FG001|Overall Study|Unreliable self-report data|0|||
124928396|NCT02505984|449368363|FG000|Overall Study|Study blind opened during assessment|0|||
124928397|NCT02505984|449368364|FG001|Overall Study|Study blind opened during assessment|1|||
124928398|NCT02505984|449368363|FG000|Overall Study|Noncompliance with study protocol|0|||
124928399|NCT02505984|449368364|FG001|Overall Study|Noncompliance with study protocol|1|||
124928400|NCT05194956|449368365|FG000|Washout Period|Withdrawal by Subject|0|||
124928401|NCT05194956|449368366|FG001|Washout Period|Withdrawal by Subject|2|||
124928402|NCT05192109|449368385|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
124928403|NCT05192109|449368386|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
124455185|NCT00294060|447627130|FG000|Overall Study|Other|59|||
124455186|NCT00294060|447627130|FG000|Overall Study|Lost to Follow-up|55|||
124455187|NCT00294060|447627130|FG000|Overall Study|Withdrawal by Subject|11|||
124455188|NCT00294060|447627130|FG000|Overall Study|Physician Decision|797|||
124455189|NCT00294060|447627130|FG000|Overall Study|Medical condition|3|||
124455190|NCT00294060|447627130|FG000|Overall Study|Device explanted/not replaced|23|||
124928404|NCT05192109|449368387|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
124928405|NCT05192109|449368388|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
124928406|NCT05192109|449368385|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
124928407|NCT05192109|449368386|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
124928408|NCT05192109|449368387|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
124455191|NCT01360554|447627131|FG000|Overall Study|Death|359|||
124928409|NCT05192109|449368388|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
124928410|NCT04498390|449368389|FG000|Overall Study|Adverse Event|0|||
124928411|NCT04498390|449368390|FG001|Overall Study|Adverse Event|0|||
124928412|NCT04498390|449368391|FG002|Overall Study|Adverse Event|1|||
124928413|NCT04498390|449368392|FG003|Overall Study|Adverse Event|0|||
124928414|NCT04498390|449368393|FG004|Overall Study|Adverse Event|0|||
124928415|NCT04498390|449368389|FG000|Overall Study|Withdrawal by Subject|0|||
124928416|NCT04498390|449368390|FG001|Overall Study|Withdrawal by Subject|0|||
124928417|NCT04498390|449368391|FG002|Overall Study|Withdrawal by Subject|0|||
124928418|NCT04498390|449368392|FG003|Overall Study|Withdrawal by Subject|1|||
124928419|NCT04498390|449368393|FG004|Overall Study|Withdrawal by Subject|0|||
124928420|NCT04971109|449368396|FG000|Overall Study|Adverse Event|4|||
124928421|NCT04971109|449368397|FG001|Overall Study|Adverse Event|3|||
124928422|NCT04971109|449368396|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
124928423|NCT04971109|449368397|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
124928424|NCT04971109|449368396|FG000|Overall Study|Lost to Follow-up|8|||
124928425|NCT04971109|449368397|FG001|Overall Study|Lost to Follow-up|2|||
124928426|NCT04971109|449368396|FG000|Overall Study|Physician Decision|5|||
124928427|NCT04971109|449368397|FG001|Overall Study|Physician Decision|0|||
124928428|NCT04971109|449368396|FG000|Overall Study|Protocol Violation|0|||
124928429|NCT04971109|449368397|FG001|Overall Study|Protocol Violation|1|||
124928430|NCT04971109|449368396|FG000|Overall Study|Withdrawal by Subject|18|||
124928431|NCT04971109|449368397|FG001|Overall Study|Withdrawal by Subject|3|||
124928432|NCT04971109|449368396|FG000|Overall Study|Subject was randomized in error|1|||
124928433|NCT04971109|449368397|FG001|Overall Study|Subject was randomized in error|0|||
124928434|NCT02709161|449368400|FG000|Overall Study|Withdrawal by Subject|1|||
124928435|NCT02709161|449368401|FG001|Overall Study|Withdrawal by Subject|0|||
124928436|NCT04231149|449370125|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
124928437|NCT04231149|449370126|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
124928438|NCT04231149|449370127|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
124928439|NCT04231149|449370128|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
124928440|NCT04231149|449370129|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
124928441|NCT04979442|449370131|FG000|Overall Study|Death|43|||
124928442|NCT04979442|449370132|FG001|Overall Study|Death|30|||
124928443|NCT04979442|449370131|FG000|Overall Study|Withdrawal by Subject|8|||
124928444|NCT04979442|449370132|FG001|Overall Study|Withdrawal by Subject|13|||
124928445|NCT04979442|449370131|FG000|Overall Study|Physician Decision|1|||
124928446|NCT04979442|449370132|FG001|Overall Study|Physician Decision|1|||
124928447|NCT04979442|449370131|FG000|Overall Study|Lost to Follow-up|0|||
124928448|NCT04979442|449370132|FG001|Overall Study|Lost to Follow-up|2|||
124928449|NCT04979442|449370131|FG000|Overall Study|do not want to continue|0|||
124928450|NCT04979442|449370132|FG001|Overall Study|do not want to continue|1|||
124928451|NCT04298983|449370135|FG000|Overall Study|Adverse Event|4|||
124928452|NCT04298983|449370135|FG000|Overall Study|Lack of Efficacy|3|||
124928453|NCT02116530|449370137|FG000|Overall Study|Withdrawal by Subject|1|||
124928454|NCT02116530|449370138|FG001|Overall Study|Withdrawal by Subject|2|||
124928455|NCT02116530|449370137|FG000|Overall Study|Adverse Event|4|||
124928456|NCT02116530|449370138|FG001|Overall Study|Adverse Event|0|||
124928457|NCT02116530|449370137|FG000|Overall Study|Physician Decision|1|||
124928458|NCT02116530|449370138|FG001|Overall Study|Physician Decision|0|||
124928459|NCT02116530|449370137|FG000|Overall Study|Lost to Follow-up|1|||
124928460|NCT02116530|449370138|FG001|Overall Study|Lost to Follow-up|0|||
124928461|NCT02116530|449370137|FG000|Overall Study|Other Medical Problems|2|||
124928462|NCT02116530|449370138|FG001|Overall Study|Other Medical Problems|2|||
124928463|NCT05029622|449370141|FG000|Overall Study|Lost to Follow-up|1|||
124928464|NCT05671653|449370142|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
124928465|NCT05671653|449370143|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
124928466|NCT05671653|449370144|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
124928467|NCT05671653|449370145|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
124928468|NCT05671653|449370146|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
124928469|NCT05671653|449370147|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
124928470|NCT05671653|449370148|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
124928471|NCT05671653|449370149|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
124928472|NCT05671653|449370150|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
124928473|NCT05671653|449370151|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
124928474|NCT05671653|449370152|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
124928475|NCT05671653|449370153|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
124928476|NCT05671653|449370154|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
124928477|NCT05671653|449370142|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928478|NCT05671653|449370143|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928479|NCT05671653|449370144|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928480|NCT05671653|449370145|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928481|NCT05671653|449370146|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928482|NCT05671653|449370147|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
124928483|NCT05671653|449370148|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928484|NCT05671653|449370149|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928485|NCT05671653|449370150|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928486|NCT05671653|449370151|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928487|NCT05671653|449370152|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124455192|NCT01360554|447627132|FG001|Overall Study|Death|371|||
124928488|NCT05671653|449370153|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928489|NCT05671653|449370154|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
124928490|NCT05671653|449370142|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928491|NCT05671653|449370143|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928492|NCT05671653|449370144|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928493|NCT05671653|449370145|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928494|NCT05671653|449370146|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928495|NCT05671653|449370147|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
124928496|NCT05671653|449370148|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928497|NCT05671653|449370149|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928498|NCT05671653|449370150|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928499|NCT05671653|449370151|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928500|NCT05671653|449370152|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928501|NCT05671653|449370153|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928502|NCT05671653|449370154|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
124928503|NCT05671653|449370142|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928504|NCT05671653|449370143|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928505|NCT05671653|449370144|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928506|NCT05671653|449370145|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124763267|NCT03582215|448757963|FG005|Overall Study|Adverse Event|0|||
124763268|NCT03582215|448757964|FG006|Overall Study|Adverse Event|2|||
124763269|NCT03582215|448757965|FG007|Overall Study|Adverse Event|2|||
124763270|NCT02163902|448757966|FG000|Overall Study|Subject's Request|3|||
124763271|NCT02163902|448757967|FG001|Overall Study|Subject's Request|4|||
124763272|NCT02163902|448757966|FG000|Overall Study|Lost to Follow-up|6|||
124763273|NCT02163902|448757967|FG001|Overall Study|Lost to Follow-up|7|||
124763274|NCT02163902|448757966|FG000|Overall Study|Administrative Decision|2|||
124763275|NCT02163902|448757967|FG001|Overall Study|Administrative Decision|2|||
124763276|NCT03119259|448757968|FG000|Overall Study|Withdrawn as no longer eligible|1|||
124763277|NCT03119259|448757969|FG001|Overall Study|Withdrawn as no longer eligible|0|||
124763278|NCT03119259|448757968|FG000|Overall Study|Withdrawal by Subject|4|||
124763279|NCT03119259|448757969|FG001|Overall Study|Withdrawal by Subject|2|||
124763280|NCT03119259|448757968|FG000|Overall Study|Lost to Follow-up|0|||
124763281|NCT03119259|448757969|FG001|Overall Study|Lost to Follow-up|1|||
124763282|NCT02903160|448757972|FG000|Overall Study|Adverse Event|2|||
124763283|NCT02903160|448757972|FG000|Overall Study|Death|1|||
124763284|NCT02903160|448757972|FG000|Overall Study|Lost to Follow-up|2|||
124763285|NCT02903160|448757972|FG000|Overall Study|Withdrawal by Subject|1|||
124763286|NCT02903160|448757972|FG000|Overall Study|Medical Insurance Barriers|1|||
124763287|NCT01664910|448757975|FG000|Overall Study|Adverse Event|0|||
124763288|NCT01664910|448757976|FG001|Overall Study|Adverse Event|0|||
124763289|NCT01664910|448757977|FG002|Overall Study|Adverse Event|1|||
124763290|NCT00730158|448757981|FG000|Overall Study|Withdrawal by Subject|1|||
124763291|NCT00730158|448757982|FG001|Overall Study|Withdrawal by Subject|1|||
124763292|NCT04678115|448757983|FG000|Overall Study|Lost to Follow-up|1|||
124763293|NCT04678115|448757984|FG001|Overall Study|Lost to Follow-up|0|||
124763294|NCT01168349|448757985|FG000|Overall Study|Death|157|||
124763295|NCT01168349|448757985|FG000|Overall Study|Lost to Follow-up|34|||
124763296|NCT01168349|448757985|FG000|Overall Study|Withdrawal by Subject|9|||
124763297|NCT01168349|448757985|FG000|Overall Study|Kidney transplantation|3|||
124763298|NCT01168349|448757985|FG000|Overall Study|Other|22|||
124763299|NCT01168349|448757985|FG000|Overall Study|Protocol Violation|76|||
124763300|NCT04059549|448757986|FG000|Overall Study|Withdrawal by Subject|2|||
124763301|NCT04059549|448757987|FG001|Overall Study|Withdrawal by Subject|0|||
124928507|NCT05671653|449370146|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928508|NCT05671653|449370147|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928509|NCT05671653|449370148|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928510|NCT05671653|449370149|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928511|NCT05671653|449370150|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
124928512|NCT05671653|449370151|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928513|NCT05671653|449370152|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928514|NCT05671653|449370153|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928515|NCT05671653|449370154|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
124928516|NCT05671653|449370142|FG000|Cohort 2 Period 2|Adverse Event|0|||
124763302|NCT00988884|448757989|FG000|Overall Study|Adverse Event|0|||
124763303|NCT00988884|448757990|FG001|Overall Study|Adverse Event|1|||
124763304|NCT00988884|448757989|FG000|Overall Study|Lost to Follow-up|20|||
124763305|NCT00988884|448757990|FG001|Overall Study|Lost to Follow-up|16|||
124763306|NCT00988884|448757989|FG000|Overall Study|Protocol Violation|0|||
124763307|NCT00988884|448757990|FG001|Overall Study|Protocol Violation|1|||
124928517|NCT05671653|449370143|FG001|Cohort 2 Period 2|Adverse Event|0|||
124928518|NCT05671653|449370144|FG002|Cohort 2 Period 2|Adverse Event|0|||
124928519|NCT05671653|449370145|FG003|Cohort 2 Period 2|Adverse Event|0|||
124928520|NCT05671653|449370146|FG004|Cohort 2 Period 2|Adverse Event|0|||
124928521|NCT05671653|449370147|FG005|Cohort 2 Period 2|Adverse Event|0|||
124928522|NCT05671653|449370148|FG006|Cohort 2 Period 2|Adverse Event|0|||
124928523|NCT05671653|449370149|FG007|Cohort 2 Period 2|Adverse Event|0|||
124928524|NCT05671653|449370150|FG008|Cohort 2 Period 2|Adverse Event|0|||
124928525|NCT05671653|449370151|FG009|Cohort 2 Period 2|Adverse Event|0|||
124928526|NCT05671653|449370152|FG010|Cohort 2 Period 2|Adverse Event|1|||
124928527|NCT05671653|449370153|FG011|Cohort 2 Period 2|Adverse Event|0|||
124928528|NCT05671653|449370154|FG012|Cohort 2 Period 2|Adverse Event|0|||
124928529|NCT05671653|449370142|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
124928530|NCT05671653|449370143|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
124928531|NCT05671653|449370144|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
124928532|NCT05671653|449370145|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
124928533|NCT05671653|449370146|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
124928534|NCT05671653|449370147|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
124928535|NCT05671653|449370148|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
124928536|NCT05671653|449370149|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
124928537|NCT05671653|449370150|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
124928538|NCT05671653|449370151|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
124928539|NCT05671653|449370152|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
124928540|NCT05671653|449370153|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
124928541|NCT05671653|449370154|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
124928542|NCT05671653|449370142|FG000|Cohort 2 Period 2|Pregnancy|0|||
124546164|NCT02146365|447954508|FG003|Overall Study|Unable to Comply with Protocol|0|||
124546165|NCT02146365|447954509|FG004|Overall Study|Unable to Comply with Protocol|0|||
124546166|NCT02146365|447954510|FG005|Overall Study|Unable to Comply with Protocol|0|||
124546167|NCT02146365|447954511|FG006|Overall Study|Unable to Comply with Protocol|0|||
124546168|NCT02146365|447954512|FG007|Overall Study|Unable to Comply with Protocol|0|||
124546169|NCT02146365|447954505|FG000|Overall Study|Other|1|||
124546170|NCT02146365|447954506|FG001|Overall Study|Other|0|||
124546171|NCT02146365|447954507|FG002|Overall Study|Other|2|||
124546172|NCT02146365|447954508|FG003|Overall Study|Other|1|||
124546173|NCT02146365|447954509|FG004|Overall Study|Other|0|||
124546174|NCT02146365|447954510|FG005|Overall Study|Other|0|||
124546175|NCT02146365|447954511|FG006|Overall Study|Other|0|||
124546176|NCT02146365|447954512|FG007|Overall Study|Other|0|||
124546177|NCT01843660|447954513|FG000|Overall Study|Other|30|||
124546178|NCT01977482|447954514|FG000|Overall Study|Adverse Event|0|||
124546179|NCT01977482|447954515|FG001|Overall Study|Adverse Event|1|||
124546180|NCT01977482|447954516|FG002|Overall Study|Adverse Event|1|||
124546181|NCT01977482|447954517|FG003|Overall Study|Adverse Event|0|||
124546182|NCT01977482|447954518|FG004|Overall Study|Adverse Event|2|||
124546183|NCT01977482|447954519|FG005|Overall Study|Adverse Event|0|||
124546184|NCT01977482|447954514|FG000|Overall Study|Lost to Follow-up|1|||
124546185|NCT01977482|447954515|FG001|Overall Study|Lost to Follow-up|0|||
124546186|NCT01977482|447954516|FG002|Overall Study|Lost to Follow-up|0|||
124546187|NCT01977482|447954517|FG003|Overall Study|Lost to Follow-up|0|||
124546188|NCT01977482|447954518|FG004|Overall Study|Lost to Follow-up|0|||
124699939|NCT04525183|448523325|FG000|Overall Study|Recurrent disease before starting on study|0|||
124699940|NCT04525183|448523326|FG001|Overall Study|Recurrent disease before starting on study|0|||
124928543|NCT05671653|449370143|FG001|Cohort 2 Period 2|Pregnancy|0|||
124928544|NCT05671653|449370144|FG002|Cohort 2 Period 2|Pregnancy|0|||
124928545|NCT05671653|449370145|FG003|Cohort 2 Period 2|Pregnancy|0|||
124928546|NCT05671653|449370146|FG004|Cohort 2 Period 2|Pregnancy|0|||
124928547|NCT05671653|449370147|FG005|Cohort 2 Period 2|Pregnancy|0|||
124928548|NCT05671653|449370148|FG006|Cohort 2 Period 2|Pregnancy|0|||
124928549|NCT05671653|449370149|FG007|Cohort 2 Period 2|Pregnancy|0|||
124928550|NCT05671653|449370150|FG008|Cohort 2 Period 2|Pregnancy|0|||
124928551|NCT05671653|449370151|FG009|Cohort 2 Period 2|Pregnancy|0|||
124928552|NCT05671653|449370152|FG010|Cohort 2 Period 2|Pregnancy|1|||
124928553|NCT05671653|449370153|FG011|Cohort 2 Period 2|Pregnancy|0|||
124928554|NCT05671653|449370154|FG012|Cohort 2 Period 2|Pregnancy|0|||
124928555|NCT05671653|449370142|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928556|NCT05671653|449370143|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928557|NCT05671653|449370144|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928558|NCT05671653|449370145|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928559|NCT05671653|449370146|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928560|NCT05671653|449370147|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
124546189|NCT01977482|447954519|FG005|Overall Study|Lost to Follow-up|0|||
124546190|NCT01977482|447954514|FG000|Overall Study|Physician Decision|0|||
124546191|NCT01977482|447954515|FG001|Overall Study|Physician Decision|1|||
124928561|NCT05671653|449370148|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928562|NCT05671653|449370149|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928563|NCT05671653|449370150|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928564|NCT05671653|449370151|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928565|NCT05671653|449370152|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
124928566|NCT05671653|449370153|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928567|NCT05671653|449370154|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
124928568|NCT05671653|449370142|FG000|Cohort 2 Period 2|Other|0|||
124928569|NCT05671653|449370143|FG001|Cohort 2 Period 2|Other|0|||
124928570|NCT05671653|449370144|FG002|Cohort 2 Period 2|Other|0|||
124928571|NCT05671653|449370145|FG003|Cohort 2 Period 2|Other|0|||
124928572|NCT05671653|449370146|FG004|Cohort 2 Period 2|Other|0|||
124928573|NCT05671653|449370147|FG005|Cohort 2 Period 2|Other|0|||
124546192|NCT01977482|447954516|FG002|Overall Study|Physician Decision|0|||
124546193|NCT01977482|447954517|FG003|Overall Study|Physician Decision|0|||
124546194|NCT01977482|447954518|FG004|Overall Study|Physician Decision|0|||
124546195|NCT01977482|447954519|FG005|Overall Study|Physician Decision|0|||
124546196|NCT01977482|447954514|FG000|Overall Study|Protocol Violation|0|||
124546197|NCT01977482|447954515|FG001|Overall Study|Protocol Violation|0|||
124546198|NCT01977482|447954516|FG002|Overall Study|Protocol Violation|1|||
124546199|NCT01977482|447954517|FG003|Overall Study|Protocol Violation|0|||
124546200|NCT01977482|447954518|FG004|Overall Study|Protocol Violation|0|||
124546201|NCT01977482|447954519|FG005|Overall Study|Protocol Violation|0|||
124546202|NCT01977482|447954514|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
124546203|NCT01977482|447954515|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
124546204|NCT01977482|447954516|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
124546205|NCT01977482|447954517|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
124546206|NCT01977482|447954518|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
124546207|NCT01977482|447954519|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
124546208|NCT01977482|447954514|FG000|Overall Study|Withdrawal by Subject|2|||
124546209|NCT01977482|447954515|FG001|Overall Study|Withdrawal by Subject|4|||
124546210|NCT01977482|447954516|FG002|Overall Study|Withdrawal by Subject|1|||
124546211|NCT01977482|447954517|FG003|Overall Study|Withdrawal by Subject|3|||
124546212|NCT01977482|447954518|FG004|Overall Study|Withdrawal by Subject|1|||
124546213|NCT01977482|447954519|FG005|Overall Study|Withdrawal by Subject|5|||
124546214|NCT00209560|447954520|FG000|Overall Study|Lack of Efficacy|1|||
124546215|NCT00209560|447954521|FG001|Overall Study|Lack of Efficacy|0|||
124546216|NCT00795886|447954522|FG000|Overall Study|Death|10|||
124546217|NCT05554471|447954532|FG000|Overall Study|Physician Decision|2|||
124546218|NCT05554471|447954533|FG001|Overall Study|Physician Decision|1|||
124546219|NCT05554471|447954532|FG000|Overall Study|Lost to Follow-up|2|||
124546220|NCT05554471|447954533|FG001|Overall Study|Lost to Follow-up|1|||
124546221|NCT05554471|447954532|FG000|Overall Study|Death|0|||
124546222|NCT05554471|447954533|FG001|Overall Study|Death|1|||
124546223|NCT03188991|447954534|FG000|Overall Study|Withdrawal by Subject|0|||
124546224|NCT03188991|447954535|FG001|Overall Study|Withdrawal by Subject|0|||
124546225|NCT03188991|447954536|FG002|Overall Study|Withdrawal by Subject|0|||
124928574|NCT05671653|449370148|FG006|Cohort 2 Period 2|Other|0|||
124928575|NCT05671653|449370149|FG007|Cohort 2 Period 2|Other|0|||
124928576|NCT05671653|449370150|FG008|Cohort 2 Period 2|Other|0|||
124928577|NCT05671653|449370151|FG009|Cohort 2 Period 2|Other|0|||
124928578|NCT05671653|449370152|FG010|Cohort 2 Period 2|Other|1|||
124928579|NCT05671653|449370153|FG011|Cohort 2 Period 2|Other|0|||
124928580|NCT05671653|449370154|FG012|Cohort 2 Period 2|Other|0|||
124928581|NCT05671653|449370142|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928582|NCT05671653|449370143|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928583|NCT05671653|449370144|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928584|NCT05671653|449370145|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928585|NCT05671653|449370146|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928586|NCT05671653|449370147|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928587|NCT05671653|449370148|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928588|NCT05671653|449370149|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928589|NCT05671653|449370150|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928590|NCT05671653|449370151|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928591|NCT05671653|449370152|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124546226|NCT03188991|447954537|FG003|Overall Study|Withdrawal by Subject|1|||
124928592|NCT05671653|449370153|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
124546227|NCT00848965|447955837|FG000|Overall Study|Adverse Event|1|||
124546228|NCT00848965|447955837|FG000|Overall Study|Withdrawal by Subject|1|||
124546229|NCT01976104|447955838|FG000|Overall Study|Adverse Event|0|||
124546230|NCT01976104|447955839|FG001|Overall Study|Adverse Event|0|||
124763308|NCT00988884|448757989|FG000|Overall Study|Withdrawal by Subject|15|||
124928593|NCT05671653|449370154|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
124928594|NCT03974178|449370155|FG000|Overall Study|Death|0|||
124928595|NCT03974178|449370156|FG001|Overall Study|Death|1|||
124928596|NCT05526430|449370157|FG000|Overall Study|Withdrawal by Subject|0|||
124928597|NCT05526430|449370158|FG001|Overall Study|Withdrawal by Subject|2|||
124546231|NCT01976104|447955840|FG002|Overall Study|Adverse Event|1|||
124546232|NCT01976104|447955841|FG003|Overall Study|Adverse Event|0|||
124546233|NCT01976104|447955838|FG000|Overall Study|Lost to Follow-up|3|||
124928598|NCT05526430|449370159|FG002|Overall Study|Withdrawal by Subject|0|||
124928599|NCT05526430|449370160|FG003|Overall Study|Withdrawal by Subject|0|||
124546234|NCT01976104|447955839|FG001|Overall Study|Lost to Follow-up|0|||
124546235|NCT01976104|447955840|FG002|Overall Study|Lost to Follow-up|1|||
124546236|NCT01976104|447955841|FG003|Overall Study|Lost to Follow-up|1|||
124546237|NCT01976104|447955838|FG000|Overall Study|Subject Choice|0|||
124546238|NCT01976104|447955839|FG001|Overall Study|Subject Choice|1|||
124546239|NCT01976104|447955840|FG002|Overall Study|Subject Choice|0|||
124546240|NCT01976104|447955841|FG003|Overall Study|Subject Choice|1|||
124546241|NCT01976104|447955838|FG000|Overall Study|Withdrawal by Subject|3|||
124546242|NCT01976104|447955839|FG001|Overall Study|Withdrawal by Subject|0|||
124546243|NCT01976104|447955840|FG002|Overall Study|Withdrawal by Subject|0|||
124546244|NCT01976104|447955841|FG003|Overall Study|Withdrawal by Subject|1|||
124546245|NCT01976104|447955838|FG000|Overall Study|Other|0|||
124546246|NCT01976104|447955839|FG001|Overall Study|Other|1|||
124546247|NCT01976104|447955840|FG002|Overall Study|Other|0|||
124546248|NCT01976104|447955841|FG003|Overall Study|Other|0|||
124546249|NCT01317199|447955842|FG000|Dose-escalation Phase 1|Physician Decision|5|||
124546250|NCT01317199|447955843|FG001|Dose-escalation Phase 1|Physician Decision|0|||
124546251|NCT01317199|447955844|FG002|Dose-escalation Phase 1|Physician Decision|0|||
124546252|NCT01317199|447955845|FG003|Dose-escalation Phase 1|Physician Decision|0|||
124546253|NCT01317199|447955842|FG000|Dose-escalation Phase 1|Disease progression|1|||
124546254|NCT01317199|447955843|FG001|Dose-escalation Phase 1|Disease progression|0|||
124546255|NCT01317199|447955844|FG002|Dose-escalation Phase 1|Disease progression|0|||
124546256|NCT01317199|447955845|FG003|Dose-escalation Phase 1|Disease progression|0|||
124546257|NCT01317199|447955842|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
124546258|NCT01317199|447955843|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
124546259|NCT01317199|447955844|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
124546260|NCT01317199|447955845|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
124546261|NCT01317199|447955842|FG000|Randomized Phase 2|Disease progression|0|||
124546262|NCT01317199|447955843|FG001|Randomized Phase 2|Disease progression|3|||
124546263|NCT01317199|447955844|FG002|Randomized Phase 2|Disease progression|7|||
124546264|NCT01317199|447955845|FG003|Randomized Phase 2|Disease progression|5|||
124546265|NCT01317199|447955842|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
124546266|NCT01317199|447955843|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
124546267|NCT01317199|447955844|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
124546268|NCT01317199|447955845|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
124546269|NCT01317199|447955842|FG000|Randomized Phase 2|Adverse Event|0|||
124546270|NCT01317199|447955843|FG001|Randomized Phase 2|Adverse Event|0|||
124546271|NCT01317199|447955844|FG002|Randomized Phase 2|Adverse Event|0|||
124546272|NCT01317199|447955845|FG003|Randomized Phase 2|Adverse Event|1|||
124546273|NCT01317199|447955842|FG000|Randomized Phase 2|Comorbidities|0|||
124546274|NCT01317199|447955843|FG001|Randomized Phase 2|Comorbidities|2|||
124546275|NCT01317199|447955844|FG002|Randomized Phase 2|Comorbidities|2|||
124546276|NCT01317199|447955845|FG003|Randomized Phase 2|Comorbidities|2|||
124546277|NCT01317199|447955842|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
124546278|NCT01317199|447955843|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
124546279|NCT01317199|447955844|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
124546280|NCT01317199|447955845|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
124546281|NCT01317199|447955842|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
124546282|NCT01317199|447955843|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
124546283|NCT01317199|447955844|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
124699941|NCT04525183|448523327|FG002|Overall Study|Recurrent disease before starting on study|1|||
124699942|NCT01335685|448523331|FG000|Overall Study|Study Terminated by Sponsor|2|||
124699943|NCT01335685|448523332|FG001|Overall Study|Study Terminated by Sponsor|1|||
124699944|NCT01335685|448523333|FG002|Overall Study|Study Terminated by Sponsor|1|||
124928600|NCT04508309|449370161|FG000|Overall Study|Death|0|||
124928601|NCT04508309|449370162|FG001|Overall Study|Death|0|||
124928602|NCT04508309|449370163|FG002|Overall Study|Death|0|||
124928603|NCT04508309|449370164|FG003|Overall Study|Death|0|||
124928604|NCT04508309|449370165|FG004|Overall Study|Death|1|||
124699945|NCT01335685|448523334|FG003|Overall Study|Study Terminated by Sponsor|10|||
124699946|NCT01335685|448523335|FG004|Overall Study|Study Terminated by Sponsor|0|||
124928605|NCT04508309|449370161|FG000|Overall Study|Lost to Follow-up|0|||
124928606|NCT04508309|449370162|FG001|Overall Study|Lost to Follow-up|0|||
124928607|NCT04508309|449370163|FG002|Overall Study|Lost to Follow-up|1|||
124928608|NCT04508309|449370164|FG003|Overall Study|Lost to Follow-up|1|||
124546284|NCT01317199|447955845|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
124546285|NCT01317199|447955842|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
124546286|NCT01317199|447955843|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
124699947|NCT01335685|448523336|FG005|Overall Study|Study Terminated by Sponsor|4|||
124546287|NCT01317199|447955844|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
124699948|NCT01335685|448523337|FG006|Overall Study|Study Terminated by Sponsor|2|||
124928609|NCT04508309|449370165|FG004|Overall Study|Lost to Follow-up|0|||
124928610|NCT04508309|449370161|FG000|Overall Study|Withdrawal by Subject|0|||
124928611|NCT04508309|449370162|FG001|Overall Study|Withdrawal by Subject|0|||
124928612|NCT04508309|449370163|FG002|Overall Study|Withdrawal by Subject|0|||
124928613|NCT04508309|449370164|FG003|Overall Study|Withdrawal by Subject|0|||
124928614|NCT04508309|449370165|FG004|Overall Study|Withdrawal by Subject|1|||
124928615|NCT02305888|449370166|FG000|Overall Study|Lost to Follow-up|0|||
124928616|NCT02305888|449370167|FG001|Overall Study|Lost to Follow-up|0|||
124928617|NCT02305888|449370168|FG002|Overall Study|Lost to Follow-up|1|||
124928618|NCT02305888|449370166|FG000|Overall Study|Adverse Event|0|||
124928619|NCT02305888|449370167|FG001|Overall Study|Adverse Event|1|||
124928620|NCT02305888|449370168|FG002|Overall Study|Adverse Event|0|||
124928621|NCT04914676|449370169|FG000|Overall Study|Study termination|3|||
124928622|NCT04914676|449370170|FG001|Overall Study|Study termination|0|||
124928623|NCT05200403|449370171|FG000|Overall Study|Withdrawal by Subject|4|||
124928624|NCT05200403|449370172|FG001|Overall Study|Withdrawal by Subject|2|||
124928625|NCT05200403|449370173|FG002|Overall Study|Withdrawal by Subject|6|||
124928626|NCT03913442|449370174|FG000|Overall Study|Adverse Event|0|||
124928627|NCT03913442|449370175|FG001|Overall Study|Adverse Event|3|||
124928628|NCT03913442|449370174|FG000|Overall Study|Withdrawal by Subject|5|||
124928629|NCT03913442|449370175|FG001|Overall Study|Withdrawal by Subject|5|||
124928630|NCT03913442|449370174|FG000|Overall Study|Terminations|2|||
124928631|NCT03913442|449370175|FG001|Overall Study|Terminations|1|||
124928632|NCT03913442|449370174|FG000|Overall Study|Lost to Follow-up|2|||
124928633|NCT03913442|449370175|FG001|Overall Study|Lost to Follow-up|2|||
124928634|NCT02460458|449370176|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
124928635|NCT02460458|449370176|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
124928636|NCT02460458|449370176|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
124928637|NCT02460458|449370176|FG000|First Prospective Phase|Lost to Follow-up|84|||
124928638|NCT02460458|449370176|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
124928639|NCT05436262|449370177|FG000|Pre-Randomization|Withdrawal by Subject|1|||
124928640|NCT05436262|449370178|FG001|Pre-Randomization|Withdrawal by Subject|0|||
124928641|NCT05436262|449370179|FG002|Pre-Randomization|Withdrawal by Subject|0|||
124928642|NCT05436262|449370177|FG000|Randomization|Withdrawal by Subject|0|||
124928643|NCT05436262|449370178|FG001|Randomization|Withdrawal by Subject|1|||
124928644|NCT05436262|449370179|FG002|Randomization|Withdrawal by Subject|0|||
124928645|NCT05299073|449370180|FG000|Overall Study|Withdrawal by Subject|0|||
124928646|NCT05299073|449370181|FG001|Overall Study|Withdrawal by Subject|0|||
124928647|NCT05299073|449370182|FG002|Overall Study|Withdrawal by Subject|1|||
124928648|NCT05299073|449370180|FG000|Overall Study|Adverse Event|0|||
124928649|NCT05299073|449370181|FG001|Overall Study|Adverse Event|1|||
124928650|NCT05299073|449370182|FG002|Overall Study|Adverse Event|0|||
124928651|NCT05299073|449370180|FG000|Overall Study|Lost to Follow-up|0|||
124928652|NCT05299073|449370181|FG001|Overall Study|Lost to Follow-up|1|||
124455193|NCT01360554|447627131|FG000|Overall Study|Lost to Follow-up|4|||
124455194|NCT01360554|447627132|FG001|Overall Study|Lost to Follow-up|4|||
124455195|NCT01360554|447627131|FG000|Overall Study|Withdrawal by Subject|23|||
124455196|NCT01360554|447627132|FG001|Overall Study|Withdrawal by Subject|24|||
124455197|NCT01360554|447627131|FG000|Overall Study|Study terminated by sponsor|49|||
124455198|NCT01360554|447627132|FG001|Overall Study|Study terminated by sponsor|37|||
124455199|NCT01360554|447627131|FG000|Overall Study|Other, not specified|1|||
124455200|NCT01360554|447627132|FG001|Overall Study|Other, not specified|0|||
124455201|NCT01360554|447627131|FG000|Overall Study|Randomized but not treated.|3|||
124455202|NCT01360554|447627132|FG001|Overall Study|Randomized but not treated.|3|||
124455203|NCT00187096|447627134|FG000|Overall Study|unacceptable toxicity|0|||
124455204|NCT00187096|447627135|FG001|Overall Study|unacceptable toxicity|0|||
124455205|NCT00187096|447627136|FG002|Overall Study|unacceptable toxicity|1|||
124455206|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
124455207|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
124455208|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
124455209|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
124455210|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
124546288|NCT01317199|447955845|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
124546289|NCT01317199|447955842|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
124699949|NCT01335685|448523338|FG007|Overall Study|Study Terminated by Sponsor|3|||
124699950|NCT01335685|448523331|FG000|Overall Study|Withdrawal by Subject|1|||
124699951|NCT01335685|448523332|FG001|Overall Study|Withdrawal by Subject|0|||
124928653|NCT05299073|449370182|FG002|Overall Study|Lost to Follow-up|0|||
124928654|NCT03952338|449370183|FG000|Overall Study|Lost to Follow-up|11|||
124928655|NCT03952338|449370184|FG001|Overall Study|Lost to Follow-up|17|||
124928656|NCT03952338|449370183|FG000|Overall Study|Withdrawal by Subject|1|||
124928657|NCT03952338|449370184|FG001|Overall Study|Withdrawal by Subject|1|||
124928658|NCT03952338|449370183|FG000|Overall Study|Protocol Violation|1|||
124928659|NCT03952338|449370184|FG001|Overall Study|Protocol Violation|0|||
124928660|NCT04850898|449370185|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
124928661|NCT04850898|449370186|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
124928662|NCT05002088|449370187|FG000|Overall Study|Withdrawal by Subject|9|||
124928663|NCT05002088|449370188|FG001|Overall Study|Withdrawal by Subject|0|||
124928664|NCT05002088|449370187|FG000|Overall Study|Lost to Follow-up|0|||
124928665|NCT05002088|449370188|FG001|Overall Study|Lost to Follow-up|1|||
124928666|NCT05002088|449370187|FG000|Overall Study|Death|16|||
124928667|NCT05002088|449370188|FG001|Overall Study|Death|2|||
124928668|NCT05002088|449370187|FG000|Overall Study|Protocol Violation|25|||
124928669|NCT05002088|449370188|FG001|Overall Study|Protocol Violation|7|||
124928670|NCT04068181|449370189|FG000|Overall Study|Death|17|||
124928671|NCT04068181|449370190|FG001|Overall Study|Death|12|||
124928672|NCT04068181|449370191|FG002|Overall Study|Death|4|||
124928673|NCT04068181|449370192|FG003|Overall Study|Death|7|||
124928674|NCT04068181|449370189|FG000|Overall Study|Lost to Follow-up|1|||
124928675|NCT04068181|449370190|FG001|Overall Study|Lost to Follow-up|0|||
124928676|NCT04068181|449370191|FG002|Overall Study|Lost to Follow-up|0|||
124928677|NCT04068181|449370192|FG003|Overall Study|Lost to Follow-up|0|||
124928678|NCT04068181|449370189|FG000|Overall Study|Withdrawal of consent from study|3|||
124928679|NCT04068181|449370190|FG001|Overall Study|Withdrawal of consent from study|0|||
124928680|NCT04068181|449370191|FG002|Overall Study|Withdrawal of consent from study|0|||
124928681|NCT04068181|449370192|FG003|Overall Study|Withdrawal of consent from study|0|||
124928682|NCT05070728|449370193|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
124928683|NCT05070728|449370194|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
124928684|NCT04770402|449370201|FG000|Overall Study|Lost to Follow-up|1|||
124928685|NCT04770402|449370202|FG001|Overall Study|Lost to Follow-up|2|||
124928686|NCT04770402|449370201|FG000|Overall Study|Non-compliance|1|||
124928687|NCT04770402|449370202|FG001|Overall Study|Non-compliance|0|||
124928688|NCT04770402|449370201|FG000|Overall Study|Withdrawal by Subject|0|||
124928689|NCT04770402|449370202|FG001|Overall Study|Withdrawal by Subject|1|||
124928690|NCT04550221|449370204|FG000|Overall Study|Lost to Follow-up|0|||
124928691|NCT04550221|449370205|FG001|Overall Study|Lost to Follow-up|4|||
124928692|NCT04550221|449370204|FG000|Overall Study|Withdrawn|3|||
124928693|NCT04550221|449370205|FG001|Overall Study|Withdrawn|0|||
124928694|NCT04550221|449370204|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
124928695|NCT04550221|449370205|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
124928696|NCT04811040|449370206|FG000|Overall Study|Lost to Follow-up|2|||
124928697|NCT04811040|449370207|FG001|Overall Study|Lost to Follow-up|0|||
124928698|NCT04811040|449370208|FG002|Overall Study|Lost to Follow-up|0|||
124928699|NCT04811040|449370209|FG003|Overall Study|Lost to Follow-up|0|||
124928700|NCT04811040|449370206|FG000|Overall Study|Withdrew consent|1|||
124928701|NCT04811040|449370207|FG001|Overall Study|Withdrew consent|1|||
124928702|NCT04811040|449370208|FG002|Overall Study|Withdrew consent|0|||
124928703|NCT04811040|449370209|FG003|Overall Study|Withdrew consent|0|||
124928704|NCT05274074|449370210|FG000|Overall Study|Lost to Follow-up|2|||
124928705|NCT05274074|449370211|FG001|Overall Study|Lost to Follow-up|3|||
124928706|NCT05274074|449370210|FG000|Overall Study|Withdrawal by Subject|1|||
124928707|NCT05274074|449370211|FG001|Overall Study|Withdrawal by Subject|2|||
124928708|NCT01828099|449370212|FG000|Treatment Period|Adverse Event|24|||
124928709|NCT01828099|449370213|FG001|Treatment Period|Adverse Event|23|||
124928710|NCT01828099|449370212|FG000|Treatment Period|Death|10|||
124928711|NCT01828099|449370213|FG001|Treatment Period|Death|12|||
124928712|NCT01828099|449370212|FG000|Treatment Period|Lost to Follow-up|2|||
124928713|NCT01828099|449370213|FG001|Treatment Period|Lost to Follow-up|1|||
124928714|NCT01828099|449370212|FG000|Treatment Period|Non-compliance with study treatment|1|||
124928715|NCT01828099|449370213|FG001|Treatment Period|Non-compliance with study treatment|0|||
124928716|NCT01828099|449370212|FG000|Treatment Period|Physician Decision|17|||
124928717|NCT01828099|449370213|FG001|Treatment Period|Physician Decision|16|||
124928718|NCT01828099|449370212|FG000|Treatment Period|Progressive disease|99|||
124455211|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
124763309|NCT00988884|448757990|FG001|Overall Study|Withdrawal by Subject|18|||
124763310|NCT01632020|448757991|FG000|Overall Study|Withdrawal by Subject|1|||
124763311|NCT01632020|448757992|FG001|Overall Study|Withdrawal by Subject|0|||
124928719|NCT01828099|449370213|FG001|Treatment Period|Progressive disease|107|||
124928720|NCT01828099|449370212|FG000|Treatment Period|Subject/guardian decision|22|||
124928721|NCT01828099|449370213|FG001|Treatment Period|Subject/guardian decision|26|||
124928722|NCT01828099|449370212|FG000|Treatment Period|Study terminated by Sponsor|13|||
124928723|NCT01828099|449370213|FG001|Treatment Period|Study terminated by Sponsor|1|||
124928724|NCT01828099|449370212|FG000|Treatment Period|Protocol deviation|1|||
124928725|NCT01828099|449370213|FG001|Treatment Period|Protocol deviation|0|||
124928726|NCT01828099|449370212|FG000|Treatment Period|No longer requires treatment|0|||
124928727|NCT01828099|449370213|FG001|Treatment Period|No longer requires treatment|1|||
124763312|NCT01632020|448757991|FG000|Overall Study|Adverse Event|1|||
124928728|NCT01828099|449370212|FG000|Extension-treatment Phase|Adverse Event|0|||
124928729|NCT01828099|449370213|FG001|Extension-treatment Phase|Adverse Event|17|||
124928730|NCT01828099|449370212|FG000|Extension-treatment Phase|Death|0|||
124928731|NCT01828099|449370213|FG001|Extension-treatment Phase|Death|11|||
124928732|NCT01828099|449370212|FG000|Extension-treatment Phase|Physician Decision|0|||
124928733|NCT01828099|449370213|FG001|Extension-treatment Phase|Physician Decision|5|||
124928734|NCT01828099|449370212|FG000|Extension-treatment Phase|Progressive disease|0|||
124928735|NCT01828099|449370213|FG001|Extension-treatment Phase|Progressive disease|54|||
124928736|NCT01828099|449370212|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
124928737|NCT01828099|449370213|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
124928738|NCT01828099|449370212|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
124928739|NCT01828099|449370213|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
124928740|NCT04568434|449370218|FG000|Overall Study|Voluntary Withdrawal|0|||
124928741|NCT04568434|449370219|FG001|Overall Study|Voluntary Withdrawal|1|||
124928742|NCT04568434|449370220|FG002|Overall Study|Voluntary Withdrawal|1|||
124928743|NCT04568434|449370218|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
124928744|NCT04568434|449370219|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
124928745|NCT04568434|449370220|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
124928746|NCT04568434|449370218|FG000|Overall Study|Investigator Judgement|1|||
124928747|NCT04568434|449370219|FG001|Overall Study|Investigator Judgement|0|||
124928748|NCT04568434|449370220|FG002|Overall Study|Investigator Judgement|0|||
124928749|NCT03905798|449370221|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
124928750|NCT05446870|449370222|FG000|Overall Study|Death|6|||
124928751|NCT05446870|449370223|FG001|Overall Study|Death|2|||
124928752|NCT05446870|449370222|FG000|Overall Study|Lost to Follow-up|0|||
124928753|NCT05446870|449370223|FG001|Overall Study|Lost to Follow-up|1|||
124928754|NCT05446870|449370222|FG000|Overall Study|Physician Decision|27|||
124928755|NCT05446870|449370223|FG001|Overall Study|Physician Decision|25|||
124928756|NCT05446870|449370222|FG000|Overall Study|Withdrawal by Subject|3|||
124928757|NCT05446870|449370223|FG001|Overall Study|Withdrawal by Subject|2|||
124928758|NCT05446870|449370222|FG000|Overall Study|Study Ongoing|37|||
124928759|NCT05446870|449370223|FG001|Overall Study|Study Ongoing|43|||
124928760|NCT05485779|449370224|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928761|NCT05485779|449370225|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928762|NCT05485779|449370226|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928763|NCT05485779|449370227|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928764|NCT05485779|449370228|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928765|NCT05485779|449370229|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928766|NCT05485779|449370230|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928767|NCT05485779|449370231|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
124928768|NCT05485779|449370232|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
124928769|NCT05485779|449370233|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928770|NCT05485779|449370234|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
124928771|NCT05485779|449370224|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928772|NCT05485779|449370225|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928773|NCT05485779|449370226|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928774|NCT05485779|449370227|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928775|NCT05485779|449370228|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928776|NCT05485779|449370229|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928777|NCT05485779|449370230|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928778|NCT05485779|449370231|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928779|NCT05485779|449370232|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928780|NCT05485779|449370233|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
124928781|NCT05485779|449370234|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
124928782|NCT05485779|449370224|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928783|NCT05485779|449370225|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928784|NCT05485779|449370226|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928785|NCT05485779|449370227|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
124928786|NCT05485779|449370228|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928787|NCT05485779|449370229|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928788|NCT05485779|449370230|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928789|NCT05485779|449370231|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928790|NCT05485779|449370232|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928791|NCT05485779|449370233|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928792|NCT05485779|449370234|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
124928793|NCT04515849|449370237|FG000|Overall Study|Adverse Event|0|||
124928794|NCT04515849|449370238|FG001|Overall Study|Adverse Event|0|||
124928795|NCT04515849|449370239|FG002|Overall Study|Adverse Event|0|||
124928796|NCT04515849|449370240|FG003|Overall Study|Adverse Event|1|||
124928797|NCT04515849|449370241|FG004|Overall Study|Adverse Event|2|||
124928798|NCT04515849|449370237|FG000|Overall Study|Death|2|||
124928799|NCT04515849|449370238|FG001|Overall Study|Death|0|||
124928800|NCT04515849|449370239|FG002|Overall Study|Death|0|||
124928801|NCT04515849|449370240|FG003|Overall Study|Death|0|||
124928802|NCT04515849|449370241|FG004|Overall Study|Death|0|||
124928803|NCT04515849|449370237|FG000|Overall Study|Other:family emergency|0|||
124928804|NCT04515849|449370238|FG001|Overall Study|Other:family emergency|0|||
124928805|NCT04515849|449370239|FG002|Overall Study|Other:family emergency|0|||
124928806|NCT04515849|449370240|FG003|Overall Study|Other:family emergency|1|||
124928807|NCT04515849|449370241|FG004|Overall Study|Other:family emergency|0|||
124928808|NCT04515849|449370237|FG000|Overall Study|Other:randomised by error|0|||
124928809|NCT04515849|449370238|FG001|Overall Study|Other:randomised by error|1|||
124928810|NCT04515849|449370239|FG002|Overall Study|Other:randomised by error|0|||
124928811|NCT04515849|449370240|FG003|Overall Study|Other:randomised by error|0|||
124928812|NCT04515849|449370241|FG004|Overall Study|Other:randomised by error|0|||
124928813|NCT04515849|449370237|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
124928814|NCT04515849|449370238|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
124928815|NCT04515849|449370239|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
124928816|NCT04515849|449370240|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
124928817|NCT04515849|449370241|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
124928818|NCT04515849|449370237|FG000|Overall Study|Physician Decision|0|||
124928819|NCT04515849|449370238|FG001|Overall Study|Physician Decision|1|||
124928820|NCT04515849|449370239|FG002|Overall Study|Physician Decision|0|||
124928821|NCT04515849|449370240|FG003|Overall Study|Physician Decision|0|||
124928822|NCT04515849|449370241|FG004|Overall Study|Physician Decision|0|||
124928823|NCT04515849|449370237|FG000|Overall Study|Withdrawal by Subject|1|||
124928824|NCT04515849|449370238|FG001|Overall Study|Withdrawal by Subject|2|||
124928825|NCT04515849|449370239|FG002|Overall Study|Withdrawal by Subject|1|||
124928826|NCT04515849|449370240|FG003|Overall Study|Withdrawal by Subject|0|||
124928827|NCT04515849|449370241|FG004|Overall Study|Withdrawal by Subject|0|||
124928828|NCT05370040|449370242|FG000|Overall Study|Lost to Follow-up|0|||
124928829|NCT05370040|449370243|FG001|Overall Study|Lost to Follow-up|0|||
124928830|NCT05370040|449370244|FG002|Overall Study|Lost to Follow-up|1|||
124928831|NCT05370040|449370245|FG003|Overall Study|Lost to Follow-up|0|||
124928832|NCT05370040|449370246|FG004|Overall Study|Lost to Follow-up|1|||
124928833|NCT05370040|449370247|FG005|Overall Study|Lost to Follow-up|0|||
124928834|NCT05093842|449370253|FG000|Overall Study|Pregnancy loss|1|||
124928835|NCT05093842|449370254|FG001|Overall Study|Pregnancy loss|1|||
124928836|NCT05093842|449370253|FG000|Overall Study|Lost to Follow-up|6|||
124928837|NCT05093842|449370254|FG001|Overall Study|Lost to Follow-up|0|||
124928838|NCT05093842|449370253|FG000|Overall Study|Physician Decision|0|||
124928839|NCT05093842|449370254|FG001|Overall Study|Physician Decision|1|||
124928840|NCT03987022|449370256|FG000|Overall Study|Lost to Follow-up|2|||
124928841|NCT03987022|449370257|FG001|Overall Study|Lost to Follow-up|2|||
124928842|NCT03987022|449370256|FG000|Overall Study|Withdrawal by Subject|1|||
124928843|NCT03987022|449370257|FG001|Overall Study|Withdrawal by Subject|0|||
124928844|NCT02887521|449370260|FG000|Overall Study|Withdrawal by Subject|0|||
124928845|NCT02887521|449370261|FG001|Overall Study|Withdrawal by Subject|3|||
124928846|NCT03571581|449370264|FG000|Overall Study|Death|2|||
124928847|NCT03571581|449370264|FG000|Overall Study|Withdrawal by Subject|2|||
124928848|NCT03663569|449371872|FG000|Overall Study|Discontinuation of study|11|||
124928849|NCT03663569|449371872|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
124928850|NCT03663569|449371872|FG000|Overall Study|Deceased patient|6|||
124928851|NCT03663569|449371872|FG000|Overall Study|Lost to Follow-up|18|||
124928852|NCT03663569|449371872|FG000|Overall Study|Withdrawal of consent|5|||
124928853|NCT03663569|449371872|FG000|Overall Study|Patient's request|11|||
124928854|NCT03663569|449371872|FG000|Overall Study|Adverse Event|4|||
124928855|NCT03663569|449371872|FG000|Overall Study|Not come to second visit|3|||
124928856|NCT03663569|449371872|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
124699952|NCT01335685|448523333|FG002|Overall Study|Withdrawal by Subject|0|||
124699953|NCT01335685|448523334|FG003|Overall Study|Withdrawal by Subject|1|||
124699954|NCT01335685|448523335|FG004|Overall Study|Withdrawal by Subject|0|||
124699955|NCT01335685|448523336|FG005|Overall Study|Withdrawal by Subject|0|||
124699956|NCT01335685|448523337|FG006|Overall Study|Withdrawal by Subject|0|||
124699957|NCT01335685|448523338|FG007|Overall Study|Withdrawal by Subject|0|||
124699958|NCT01335685|448523331|FG000|Overall Study|Reason not Specified|0|||
124699959|NCT01335685|448523332|FG001|Overall Study|Reason not Specified|0|||
124928857|NCT03663569|449371872|FG000|Overall Study|Serious adverse event|1|||
124928858|NCT05877976|449371873|FG000|Overall Study|Lost to Follow-up|31|||
124928859|NCT04248725|449371874|FG000|Post-Treatment|Lost to Follow-up|6|||
124928860|NCT04248725|449371875|FG001|Post-Treatment|Lost to Follow-up|5|||
124928861|NCT04248725|449371874|FG000|6-Month Follow Up|Lost to Follow-up|9|||
124928862|NCT04248725|449371875|FG001|6-Month Follow Up|Lost to Follow-up|8|||
124928863|NCT05622812|449371876|FG000|Overall Study|Withdrawal by Subject|1|||
124928864|NCT05622812|449371877|FG001|Overall Study|Withdrawal by Subject|4|||
124928865|NCT05622812|449371876|FG000|Overall Study|Lost to Follow-up|2|||
124928866|NCT05622812|449371877|FG001|Overall Study|Lost to Follow-up|1|||
124928867|NCT02844465|449371878|FG000|Overall Study|Screen Failure|36|||
124928868|NCT02844465|449371878|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
124928869|NCT02844465|449371878|FG000|Overall Study|Withdrawal by Subject|5|||
124928870|NCT02844465|449371878|FG000|Overall Study|Lost to Follow-up|1|||
124928871|NCT02844465|449371878|FG000|Overall Study|Retreatment|1|||
124928872|NCT03819153|449371880|FG000|Overall Study|Withdrawal by Subject|20|||
124928873|NCT03819153|449371881|FG001|Overall Study|Withdrawal by Subject|28|||
124928874|NCT03819153|449371880|FG000|Overall Study|Lost to Follow-up|23|||
124928875|NCT03819153|449371881|FG001|Overall Study|Lost to Follow-up|30|||
124928876|NCT03240016|449371883|FG000|Overall Study|Adverse Event|9|||
124928877|NCT03240016|449371883|FG000|Overall Study|Withdrawal by Subject|7|||
124928878|NCT03240016|449371883|FG000|Overall Study|Death|1|||
124928879|NCT03240016|449371883|FG000|Overall Study|Physician Decision|2|||
124928880|NCT05452460|449371891|FG000|Overall Study|Lost to Follow-up|3|||
124928881|NCT05452460|449371892|FG001|Overall Study|Lost to Follow-up|3|||
124928882|NCT05452460|449371891|FG000|Overall Study|Did not receive intervention|1|||
124928883|NCT05452460|449371892|FG001|Overall Study|Did not receive intervention|0|||
124928884|NCT04362254|449371897|FG000|Overall Study|Adverse Event|1|||
124928885|NCT04362254|449371897|FG000|Overall Study|Protocol Violation|1|||
124928886|NCT04362254|449371897|FG000|Overall Study|Due to early termination of the trial|10|||
124928887|NCT05469464|449371900|FG000|Overall Study|Withdrawal by Subject|8|||
124928888|NCT05469464|449371901|FG001|Overall Study|Withdrawal by Subject|7|||
124928889|NCT05469464|449371902|FG002|Overall Study|Withdrawal by Subject|4|||
124928890|NCT05469464|449371903|FG003|Overall Study|Withdrawal by Subject|5|||
124928891|NCT05469464|449371900|FG000|Overall Study|Adverse Event|8|||
124928892|NCT05469464|449371901|FG001|Overall Study|Adverse Event|14|||
124928893|NCT05469464|449371902|FG002|Overall Study|Adverse Event|13|||
124928894|NCT05469464|449371903|FG003|Overall Study|Adverse Event|2|||
124928895|NCT05469464|449371900|FG000|Overall Study|Lost to Follow-up|2|||
124928896|NCT05469464|449371901|FG001|Overall Study|Lost to Follow-up|5|||
124928897|NCT05469464|449371902|FG002|Overall Study|Lost to Follow-up|3|||
124928898|NCT05469464|449371903|FG003|Overall Study|Lost to Follow-up|3|||
124928899|NCT05469464|449371900|FG000|Overall Study|Lack of Efficacy|4|||
124928900|NCT05469464|449371901|FG001|Overall Study|Lack of Efficacy|1|||
124928901|NCT05469464|449371902|FG002|Overall Study|Lack of Efficacy|2|||
124928902|NCT05469464|449371903|FG003|Overall Study|Lack of Efficacy|2|||
124928903|NCT05469464|449371900|FG000|Overall Study|Physician Decision|0|||
124928904|NCT05469464|449371901|FG001|Overall Study|Physician Decision|0|||
124928905|NCT05469464|449371902|FG002|Overall Study|Physician Decision|0|||
124928906|NCT05469464|449371903|FG003|Overall Study|Physician Decision|1|||
124928907|NCT01208662|449371904|FG000|Induction and Consolidation|Disease Progression|23|||
124928908|NCT01208662|449371905|FG001|Induction and Consolidation|Disease Progression|13|||
124928909|NCT01208662|449371906|FG002|Induction and Consolidation|Disease Progression|0|||
124928910|NCT01208662|449371904|FG000|Induction and Consolidation|Adverse Event|16|||
124928911|NCT01208662|449371905|FG001|Induction and Consolidation|Adverse Event|18|||
124928912|NCT01208662|449371906|FG002|Induction and Consolidation|Adverse Event|2|||
124928913|NCT01208662|449371904|FG000|Induction and Consolidation|MD or Participant Decision|16|||
124928914|NCT01208662|449371905|FG001|Induction and Consolidation|MD or Participant Decision|34|||
124928915|NCT01208662|449371906|FG002|Induction and Consolidation|MD or Participant Decision|4|||
124928916|NCT01208662|449371904|FG000|Induction and Consolidation|Death|1|||
124928917|NCT01208662|449371905|FG001|Induction and Consolidation|Death|3|||
124928918|NCT01208662|449371906|FG002|Induction and Consolidation|Death|1|||
124928919|NCT01208662|449371904|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
124928920|NCT01208662|449371905|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
124928921|NCT01208662|449371906|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
124928922|NCT01208662|449371904|FG000|Maintenance|Disease Progression|156|||
124928923|NCT01208662|449371905|FG001|Maintenance|Disease Progression|102|||
124928924|NCT01208662|449371906|FG002|Maintenance|Disease Progression|0|||
124546290|NCT01317199|447955843|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
124928925|NCT01208662|449371904|FG000|Maintenance|Adverse Event|12|||
124928926|NCT01208662|449371905|FG001|Maintenance|Adverse Event|28|||
124928927|NCT01208662|449371906|FG002|Maintenance|Adverse Event|0|||
124928928|NCT01208662|449371904|FG000|Maintenance|MD or Participant Decision|24|||
124928929|NCT01208662|449371905|FG001|Maintenance|MD or Participant Decision|36|||
124928930|NCT01208662|449371906|FG002|Maintenance|MD or Participant Decision|0|||
124928931|NCT01208662|449371904|FG000|Maintenance|Death|0|||
124928932|NCT01208662|449371905|FG001|Maintenance|Death|3|||
124928933|NCT01208662|449371906|FG002|Maintenance|Death|0|||
124928934|NCT01208662|449371904|FG000|Maintenance|Discontinued for other reasons|21|||
124928935|NCT01208662|449371905|FG001|Maintenance|Discontinued for other reasons|31|||
124928936|NCT01208662|449371906|FG002|Maintenance|Discontinued for other reasons|0|||
124928937|NCT01208662|449371904|FG000|Maintenance|Still on Treatment|78|||
124928938|NCT01208662|449371905|FG001|Maintenance|Still on Treatment|89|||
124763313|NCT01632020|448757992|FG001|Overall Study|Adverse Event|0|||
124763314|NCT01362348|448757994|FG000|Overall Study|Protocol-defined stopping criteria|9|||
124763315|NCT01362348|448757994|FG000|Overall Study|Study closed/terminated|5|||
124763316|NCT00647296|448757997|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
124763317|NCT00647296|448757998|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
124763318|NCT00647296|448757999|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
124763319|NCT00647296|448758000|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
124763320|NCT00647296|448757997|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
124763321|NCT00647296|448757998|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
124763322|NCT00647296|448757999|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
124763323|NCT00647296|448758000|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
124763324|NCT00647296|448757997|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
124763325|NCT00647296|448757998|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
124763326|NCT00647296|448757999|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
124763327|NCT00647296|448758000|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
124763328|NCT00647296|448757997|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
124763329|NCT00647296|448757998|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
124763330|NCT00647296|448757999|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
124763331|NCT00647296|448758000|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
124763332|NCT00647296|448757997|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
124763333|NCT00647296|448757998|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
124763334|NCT00647296|448757999|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
124763335|NCT00647296|448758000|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
124763336|NCT00647296|448757997|FG000|Part 2: 4-week Placebo Washout|Death|3|||
124763337|NCT00647296|448757998|FG001|Part 2: 4-week Placebo Washout|Death|0|||
124763338|NCT00647296|448757999|FG002|Part 2: 4-week Placebo Washout|Death|0|||
124763339|NCT00647296|448758000|FG003|Part 2: 4-week Placebo Washout|Death|0|||
124763340|NCT00647296|448757997|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
124763341|NCT00647296|448757998|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
124763342|NCT00647296|448757999|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
124763343|NCT00647296|448758000|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
124763344|NCT00647296|448757997|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
124763345|NCT00647296|448757998|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
124763346|NCT00647296|448757999|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
124763347|NCT00647296|448758000|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
124763348|NCT00647296|448757997|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
124455212|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
124455213|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
124455214|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
124455215|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
124455216|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
124455217|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
124763349|NCT00647296|448757998|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
124763350|NCT00647296|448757999|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
124763351|NCT00647296|448758000|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
124763352|NCT00647296|448757997|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
124763353|NCT00647296|448757998|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
124763354|NCT00647296|448757999|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
124763355|NCT00647296|448758000|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
124763356|NCT00647296|448757997|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
124928939|NCT01208662|449371906|FG002|Maintenance|Still on Treatment|0|||
124928940|NCT00321048|449371907|FG000|Overall Study|Withdrawal by Subject|6|||
124928941|NCT00321048|449371908|FG001|Overall Study|Withdrawal by Subject|8|||
124455218|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
124455219|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
124928942|NCT04707625|449371909|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
124928943|NCT06473662|449371910|FG000|Overall Study|Withdrawal by Subject|1|||
124928944|NCT06473662|449371911|FG001|Overall Study|Withdrawal by Subject|6|||
124928945|NCT06473662|449371912|FG002|Overall Study|Withdrawal by Subject|5|||
124928946|NCT06473662|449371910|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
124928947|NCT06473662|449371911|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
124928948|NCT06473662|449371912|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
124928949|NCT06473662|449371910|FG000|Overall Study|Starting HbA1c below 7%|0|||
124928950|NCT06473662|449371911|FG001|Overall Study|Starting HbA1c below 7%|1|||
124928951|NCT06473662|449371912|FG002|Overall Study|Starting HbA1c below 7%|1|||
124928952|NCT06473662|449371910|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
124928953|NCT06473662|449371911|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
124928954|NCT06473662|449371912|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
124699960|NCT01335685|448523333|FG002|Overall Study|Reason not Specified|1|||
124699961|NCT01335685|448523334|FG003|Overall Study|Reason not Specified|0|||
124699962|NCT01335685|448523335|FG004|Overall Study|Reason not Specified|0|||
124699963|NCT01335685|448523336|FG005|Overall Study|Reason not Specified|1|||
124699964|NCT01335685|448523337|FG006|Overall Study|Reason not Specified|0|||
124699965|NCT01335685|448523338|FG007|Overall Study|Reason not Specified|0|||
124699966|NCT02801578|448524878|FG000|Overall Study|Adverse Event|2|||
124699967|NCT00668642|448524879|FG000|First Off-cycle|Cancer progression|1|||
124699968|NCT00668642|448524880|FG001|First Off-cycle|Cancer progression|0|||
124699969|NCT00668642|448524879|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
124699970|NCT00668642|448524880|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
124699971|NCT02003898|448524881|FG000|Overall Study|Death|3|||
124699972|NCT02003898|448524881|FG000|Overall Study|Lost to Follow-up|12|||
124699973|NCT02003898|448524881|FG000|Overall Study|Withdrawal by Subject|52|||
124699974|NCT03412591|448524882|FG000|Overall Study|Withdrawal by Subject|1|||
124699975|NCT03412591|448524883|FG001|Overall Study|Withdrawal by Subject|8|||
124699976|NCT03412591|448524882|FG000|Overall Study|Adverse Event|0|||
124699977|NCT03412591|448524883|FG001|Overall Study|Adverse Event|1|||
124699978|NCT02272985|448524884|FG000|Overall Study|Withdrawal by Subject|1|||
124699979|NCT02272985|448524884|FG000|Overall Study|hip fracture|1|||
124699980|NCT02272985|448524884|FG000|Overall Study|kidney transplantation|1|||
124699981|NCT00770679|448524885|FG000|Overall Study|Lost to Follow-up|3|||
124699982|NCT00770679|448524885|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
124699983|NCT00814983|448524886|FG000|Overall Study|Screen failure|1|||
124699984|NCT00814983|448524887|FG001|Overall Study|Screen failure|0|||
124699985|NCT00814983|448524886|FG000|Overall Study|Withdrawal by Subject|1|||
124699986|NCT00814983|448524887|FG001|Overall Study|Withdrawal by Subject|0|||
124699987|NCT00814983|448524886|FG000|Overall Study|Graft failure|1|||
124699988|NCT00814983|448524887|FG001|Overall Study|Graft failure|0|||
124699989|NCT03627468|448524888|FG000|Overall Study|Adverse Event|5|||
124699990|NCT03627468|448524889|FG001|Overall Study|Adverse Event|33|||
124699991|NCT03627468|448524888|FG000|Overall Study|Withdrawal by Subject|13|||
124699992|NCT03627468|448524889|FG001|Overall Study|Withdrawal by Subject|23|||
124546291|NCT01317199|447955844|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
124546292|NCT01317199|447955845|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
124546293|NCT01353209|447955846|FG000|Overall Study|Adverse Event|1|||
124763357|NCT00647296|448757998|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
124763358|NCT00647296|448757999|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
124928955|NCT06473662|449371910|FG000|Overall Study|Did not take medication|2|||
124928956|NCT06473662|449371911|FG001|Overall Study|Did not take medication|3|||
124928957|NCT06473662|449371912|FG002|Overall Study|Did not take medication|2|||
124928958|NCT03463044|449371913|FG000|Overall Study|Lost to Follow-up|0|||
124928959|NCT03463044|449371914|FG001|Overall Study|Lost to Follow-up|0|||
124928960|NCT03463044|449371915|FG002|Overall Study|Lost to Follow-up|0|||
124928961|NCT03463044|449371916|FG003|Overall Study|Lost to Follow-up|0|||
124928962|NCT03463044|449371917|FG004|Overall Study|Lost to Follow-up|0|||
124928963|NCT03463044|449371918|FG005|Overall Study|Lost to Follow-up|0|||
124928964|NCT03463044|449371919|FG006|Overall Study|Lost to Follow-up|0|||
124928965|NCT03463044|449371920|FG007|Overall Study|Lost to Follow-up|1|||
124928966|NCT03463044|449371921|FG008|Overall Study|Lost to Follow-up|0|||
124928967|NCT05764525|449371922|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
124928968|NCT05764525|449371923|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
124928969|NCT05764525|449371922|FG000|Overall Study|Withdrawal by Subject|4|||
124928970|NCT05764525|449371923|FG001|Overall Study|Withdrawal by Subject|8|||
124928971|NCT05764525|449371922|FG000|Overall Study|Physician Decision|1|||
124928972|NCT05764525|449371923|FG001|Overall Study|Physician Decision|0|||
124928973|NCT03334630|449371924|FG000|Overall Study|Withdrawal by Subject|7|||
124928974|NCT03334630|449371925|FG001|Overall Study|Withdrawal by Subject|7|||
124928975|NCT03334630|449371924|FG000|Overall Study|Lost to Follow-up|3|||
124928976|NCT03334630|449371925|FG001|Overall Study|Lost to Follow-up|1|||
124928977|NCT03334630|449371924|FG000|Overall Study|Adverse Event|0|||
124928978|NCT03334630|449371925|FG001|Overall Study|Adverse Event|1|||
124928979|NCT03334630|449371924|FG000|Overall Study|Physician Decision|1|||
124928980|NCT03334630|449371925|FG001|Overall Study|Physician Decision|1|||
124928981|NCT03334630|449371924|FG000|Overall Study|Enrollment closed|2|||
124928982|NCT03334630|449371925|FG001|Overall Study|Enrollment closed|1|||
124928983|NCT03334630|449371924|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
124928984|NCT03334630|449371925|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
124928985|NCT03334630|449371924|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
124928986|NCT03334630|449371925|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
124928987|NCT03030261|449371930|FG000|Overall Study|Still receiving continuation therapy|5|||
124928988|NCT03910478|449371934|FG000|Overall Study|Death|13|||
124928989|NCT03910478|449371935|FG001|Overall Study|Death|6|||
124928990|NCT03910478|449371934|FG000|Overall Study|Withdrawal by Subject|23|||
124928991|NCT03910478|449371935|FG001|Overall Study|Withdrawal by Subject|2|||
124928992|NCT03910478|449371934|FG000|Overall Study|Physician Decision|5|||
124928993|NCT03910478|449371935|FG001|Overall Study|Physician Decision|0|||
124928994|NCT03910478|449371934|FG000|Overall Study|Protocol Violation|1|||
124928995|NCT03910478|449371935|FG001|Overall Study|Protocol Violation|0|||
124928996|NCT03910478|449371934|FG000|Overall Study|Failure to meet continuation criteria|2|||
124928997|NCT03910478|449371935|FG001|Overall Study|Failure to meet continuation criteria|0|||
124928998|NCT03910478|449371934|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
124928999|NCT03910478|449371935|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
124929000|NCT05293171|449371936|FG000|Washout 5 to 7 Days|Adverse Event|1|||
124929001|NCT05293171|449371937|FG001|Washout 5 to 7 Days|Adverse Event|1|||
124763359|NCT00647296|448758000|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
124763360|NCT01519323|448759695|FG000|Overall Study|Death|3|||
124763361|NCT01519323|448759696|FG001|Overall Study|Death|2|||
124763362|NCT01519323|448759695|FG000|Overall Study|Study terminated by sponsor|0|||
124929002|NCT05293171|449371938|FG002|Washout 5 to 7 Days|Adverse Event|0|||
124929003|NCT05293171|449371939|FG003|Washout 5 to 7 Days|Adverse Event|0|||
124929004|NCT05293171|449371940|FG004|Washout 5 to 7 Days|Adverse Event|0|||
124929005|NCT05293171|449371941|FG005|Washout 5 to 7 Days|Adverse Event|0|||
124929006|NCT05293171|449371942|FG006|Washout 5 to 7 Days|Adverse Event|0|||
124929007|NCT05293171|449371943|FG007|Washout 5 to 7 Days|Adverse Event|0|||
124929008|NCT05293171|449371944|FG008|Washout 5 to 7 Days|Adverse Event|0|||
124929009|NCT05293171|449371945|FG009|Washout 5 to 7 Days|Adverse Event|0|||
124929010|NCT05293171|449371946|FG010|Washout 5 to 7 Days|Adverse Event|0|||
124929011|NCT05293171|449371947|FG011|Washout 5 to 7 Days|Adverse Event|0|||
124929012|NCT05293171|449371936|FG000|Washout 5 to 7 Days|Adverse Event|0|||
124929013|NCT05293171|449371937|FG001|Washout 5 to 7 Days|Adverse Event|0|||
124929014|NCT05293171|449371938|FG002|Washout 5 to 7 Days|Adverse Event|0|||
124929015|NCT05293171|449371939|FG003|Washout 5 to 7 Days|Adverse Event|0|||
124929016|NCT05293171|449371940|FG004|Washout 5 to 7 Days|Adverse Event|0|||
124699993|NCT03627468|448524888|FG000|Overall Study|Physician Decision|1|||
124699994|NCT03627468|448524889|FG001|Overall Study|Physician Decision|0|||
124699995|NCT03627468|448524888|FG000|Overall Study|Protocol Violation|0|||
124699996|NCT03627468|448524889|FG001|Overall Study|Protocol Violation|2|||
124699997|NCT03627468|448524888|FG000|Overall Study|Lost to Follow-up|10|||
124699998|NCT03627468|448524889|FG001|Overall Study|Lost to Follow-up|16|||
124699999|NCT03627468|448524888|FG000|Overall Study|Death|1|||
124700000|NCT03627468|448524889|FG001|Overall Study|Death|0|||
124700001|NCT03627468|448524888|FG000|Overall Study|Pregnancy|1|||
124700002|NCT03627468|448524889|FG001|Overall Study|Pregnancy|1|||
124700003|NCT03627468|448524888|FG000|Overall Study|Lack of Efficacy|0|||
124700004|NCT03627468|448524889|FG001|Overall Study|Lack of Efficacy|2|||
124700005|NCT03627468|448524888|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
124700006|NCT03627468|448524889|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
124700007|NCT04157738|448524890|FG000|Overall Study|Moved out of state|0|||
124700008|NCT04157738|448524891|FG001|Overall Study|Moved out of state|2|||
124700009|NCT04157738|448524890|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
124700010|NCT04157738|448524891|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
124700011|NCT00160563|448524892|FG000|Overall Study|Adverse Event|1|||
124700012|NCT00160563|448524893|FG001|Overall Study|Adverse Event|1|||
124700013|NCT00160563|448524894|FG002|Overall Study|Adverse Event|1|||
124700014|NCT00160563|448524892|FG000|Overall Study|Lost to Follow-up|1|||
124700015|NCT00160563|448524893|FG001|Overall Study|Lost to Follow-up|1|||
124700016|NCT00160563|448524894|FG002|Overall Study|Lost to Follow-up|2|||
124700017|NCT00160563|448524892|FG000|Overall Study|Protocol Violation|0|||
124700018|NCT00160563|448524893|FG001|Overall Study|Protocol Violation|0|||
124700019|NCT00160563|448524894|FG002|Overall Study|Protocol Violation|3|||
124700020|NCT00160563|448524892|FG000|Overall Study|Withdrawal by Subject|1|||
124700021|NCT00160563|448524893|FG001|Overall Study|Withdrawal by Subject|2|||
124929017|NCT05293171|449371941|FG005|Washout 5 to 7 Days|Adverse Event|1|||
124929018|NCT05293171|449371942|FG006|Washout 5 to 7 Days|Adverse Event|0|||
124929019|NCT05293171|449371943|FG007|Washout 5 to 7 Days|Adverse Event|0|||
124929020|NCT05293171|449371944|FG008|Washout 5 to 7 Days|Adverse Event|0|||
124929021|NCT05293171|449371945|FG009|Washout 5 to 7 Days|Adverse Event|0|||
124929022|NCT05293171|449371946|FG010|Washout 5 to 7 Days|Adverse Event|0|||
124929023|NCT05293171|449371947|FG011|Washout 5 to 7 Days|Adverse Event|0|||
124929024|NCT04066205|449371950|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
124929025|NCT04066205|449371951|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
124929026|NCT04066205|449371950|FG000|T2 Immediate Post-Intervention|did not respond|5|||
124929027|NCT04066205|449371951|FG001|T2 Immediate Post-Intervention|did not respond|3|||
124929028|NCT04766892|449371955|FG000|Overall Study|Withdrawal by Subject|1|||
124929029|NCT04766892|449371955|FG000|Overall Study|Lost to Follow-up|1|||
124929030|NCT04766892|449371955|FG000|Overall Study|Adverse Event|3|||
124929031|NCT04766892|449371955|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
124929032|NCT01712490|449371956|FG000|Overall Study|Ongoing|601|||
124929033|NCT01712490|449371957|FG001|Overall Study|Ongoing|586|||
124929034|NCT01712490|449371956|FG000|Overall Study|Other|11|||
124929035|NCT01712490|449371957|FG001|Overall Study|Other|11|||
124929036|NCT01712490|449371956|FG000|Overall Study|Withdrawal by Subject|36|||
124929037|NCT01712490|449371957|FG001|Overall Study|Withdrawal by Subject|44|||
124929038|NCT01712490|449371956|FG000|Overall Study|Lost to Follow-up|16|||
124929039|NCT01712490|449371957|FG001|Overall Study|Lost to Follow-up|29|||
124929040|NCT03478956|449371958|FG000|Randomized Treatment Period|Adverse Event|1|||
124929041|NCT03478956|449371959|FG001|Randomized Treatment Period|Adverse Event|0|||
124929042|NCT03478956|449371960|FG002|Randomized Treatment Period|Adverse Event|0|||
124929043|NCT03478956|449371961|FG003|Randomized Treatment Period|Adverse Event|0|||
124929044|NCT03478956|449371958|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
124929045|NCT03478956|449371959|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
124929046|NCT03478956|449371960|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
124700022|NCT00160563|448524894|FG002|Overall Study|Withdrawal by Subject|3|||
124700023|NCT00160563|448524892|FG000|Overall Study|Other (listed in the study report)|48|||
124700024|NCT00160563|448524893|FG001|Overall Study|Other (listed in the study report)|40|||
124763363|NCT01519323|448759696|FG001|Overall Study|Study terminated by sponsor|1|||
124546294|NCT01353209|447955847|FG001|Overall Study|Adverse Event|1|||
124546295|NCT01301625|447955860|FG000|Overall Study|Death|5|||
124700025|NCT00160563|448524894|FG002|Overall Study|Other (listed in the study report)|81|||
124700026|NCT00160563|448524892|FG000|Overall Study|Missing reason|0|||
124700027|NCT00160563|448524893|FG001|Overall Study|Missing reason|1|||
124700028|NCT00160563|448524894|FG002|Overall Study|Missing reason|0|||
124700029|NCT00347269|448524900|FG000|Overall Study|Lost to Follow-up|74|||
124700030|NCT00347269|448524901|FG001|Overall Study|Lost to Follow-up|65|||
124700031|NCT00347269|448524900|FG000|Overall Study|Withdrawal by Subject|18|||
124929047|NCT03478956|449371961|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
124929048|NCT03478956|449371958|FG000|Open Label Extension Period|Adverse Event|0|||
124929049|NCT03478956|449371959|FG001|Open Label Extension Period|Adverse Event|0|||
124929050|NCT03478956|449371960|FG002|Open Label Extension Period|Adverse Event|4|||
124929051|NCT03478956|449371961|FG003|Open Label Extension Period|Adverse Event|0|||
124455220|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
124929052|NCT03478956|449371958|FG000|Open Label Extension Period|Lack of Efficacy|0|||
124929053|NCT03478956|449371959|FG001|Open Label Extension Period|Lack of Efficacy|0|||
124929054|NCT03478956|449371960|FG002|Open Label Extension Period|Lack of Efficacy|8|||
124929055|NCT03478956|449371961|FG003|Open Label Extension Period|Lack of Efficacy|0|||
124929056|NCT03478956|449371958|FG000|Open Label Extension Period|Reason Not Provided|0|||
124929057|NCT03478956|449371959|FG001|Open Label Extension Period|Reason Not Provided|0|||
124929058|NCT03478956|449371960|FG002|Open Label Extension Period|Reason Not Provided|1|||
124929059|NCT03478956|449371961|FG003|Open Label Extension Period|Reason Not Provided|0|||
124929060|NCT03478956|449371958|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
124929061|NCT03478956|449371959|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
124929062|NCT03478956|449371960|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
124929063|NCT03478956|449371961|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
124929064|NCT03478956|449371958|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
124929065|NCT03478956|449371959|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
124929066|NCT03478956|449371960|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
124929067|NCT03478956|449371961|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
124929068|NCT03478956|449371958|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
124929069|NCT03478956|449371959|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
124929070|NCT03478956|449371960|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
124929071|NCT03478956|449371961|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
124929072|NCT04800211|449371962|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
124929073|NCT04800211|449371963|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
124929074|NCT04800211|449371964|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
124929075|NCT04800211|449371962|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
124929076|NCT04800211|449371963|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
124929077|NCT04800211|449371964|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
124929078|NCT04800211|449371962|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
124929079|NCT04800211|449371963|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
124929080|NCT04800211|449371964|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
124929081|NCT04800211|449371962|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
124455221|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
124455222|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
124455223|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
124455224|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
124455225|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
124455226|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
124455227|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
124455228|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
124455229|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
124455230|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
124455231|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
124455232|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
124455233|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
124455234|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
124455235|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
124546296|NCT01301625|447955860|FG000|Overall Study|Not Due|21|||
124546297|NCT01301625|447955860|FG000|Overall Study|Expected|8|||
124546298|NCT01301625|447955860|FG000|Overall Study|Lost to Follow-up|1|||
124546299|NCT03237325|447955863|FG000|Overall Study|Lost to Follow-up|3|||
124546300|NCT03237325|447955864|FG001|Overall Study|Lost to Follow-up|5|||
124546301|NCT03237325|447955863|FG000|Overall Study|Physician Decision|2|||
124700032|NCT00347269|448524901|FG001|Overall Study|Withdrawal by Subject|38|||
124700033|NCT00347269|448524900|FG000|Overall Study|Death|2|||
124700034|NCT00347269|448524901|FG001|Overall Study|Death|3|||
124700035|NCT00456365|448524915|FG000|Overall Study|Lost to Follow-up|1|||
124700036|NCT00456365|448524916|FG001|Overall Study|Lost to Follow-up|3|||
124700037|NCT00456365|448524915|FG000|Overall Study|Withdrawal by Subject|4|||
124700038|NCT00456365|448524916|FG001|Overall Study|Withdrawal by Subject|7|||
124700039|NCT00456365|448524915|FG000|Overall Study|Pregnancy|1|||
124700040|NCT00456365|448524916|FG001|Overall Study|Pregnancy|1|||
124700041|NCT00456365|448524915|FG000|Overall Study|oncologic diagnosis|1|||
124700042|NCT00456365|448524916|FG001|Overall Study|oncologic diagnosis|1|||
124700043|NCT05451329|448524917|FG000|Overall Study|Adverse Event|1|||
124700044|NCT05451329|448524918|FG001|Overall Study|Adverse Event|1|||
124700045|NCT05451329|448524919|FG002|Overall Study|Adverse Event|0|||
124700046|NCT05451329|448524917|FG000|Overall Study|Withdrawal by Subject|1|||
124763364|NCT00383552|448759699|FG000|Overall Study|Adverse Event|7|||
124929082|NCT04800211|449371963|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
124929083|NCT04800211|449371964|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
124929084|NCT04800211|449371962|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
124700047|NCT05451329|448524918|FG001|Overall Study|Withdrawal by Subject|0|||
124700048|NCT05451329|448524919|FG002|Overall Study|Withdrawal by Subject|0|||
124700049|NCT05451329|448524917|FG000|Overall Study|Investigational Product Lot exchange|1|||
124700050|NCT05451329|448524918|FG001|Overall Study|Investigational Product Lot exchange|1|||
124700051|NCT05451329|448524919|FG002|Overall Study|Investigational Product Lot exchange|0|||
124700052|NCT02202577|448524920|FG000|Overall Study|Lost to Follow-up|6|||
124700053|NCT02202577|448524921|FG001|Overall Study|Lost to Follow-up|16|||
124700054|NCT02202577|448524920|FG000|Overall Study|Protocol Violation|7|||
124700055|NCT02202577|448524921|FG001|Overall Study|Protocol Violation|3|||
124700056|NCT00069953|448524922|FG000|Overall Study|Protocol Violation|2|||
124700057|NCT00829868|448524923|FG000|Washout|Physician Decision|1|||
124700058|NCT00829868|448524924|FG001|Washout|Physician Decision|0|||
124700059|NCT02799043|448524925|FG000|Overall Study|Adverse Event|0|||
124700060|NCT02799043|448524926|FG001|Overall Study|Adverse Event|1|||
124700061|NCT02799043|448524925|FG000|Overall Study|Death|1|||
124700062|NCT02799043|448524926|FG001|Overall Study|Death|1|||
124700063|NCT02799043|448524925|FG000|Overall Study|Lost to Follow-up|3|||
124700064|NCT02799043|448524926|FG001|Overall Study|Lost to Follow-up|6|||
124700065|NCT02799043|448524925|FG000|Overall Study|Withdrawal by Subject|4|||
124700066|NCT02799043|448524926|FG001|Overall Study|Withdrawal by Subject|4|||
124700067|NCT02799043|448524925|FG000|Overall Study|Moved to different country|0|||
124700068|NCT02799043|448524926|FG001|Overall Study|Moved to different country|1|||
124700069|NCT02799043|448524925|FG000|Overall Study|Trial Screen Failure|1|||
124700070|NCT02799043|448524926|FG001|Overall Study|Trial Screen Failure|0|||
124700071|NCT02799043|448524925|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
124929085|NCT04800211|449371963|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
124929086|NCT04800211|449371964|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
124700072|NCT02799043|448524926|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
124700073|NCT00855166|448524929|FG000|Overall Study|Adverse Event|0|||
124700074|NCT00855166|448524930|FG001|Overall Study|Adverse Event|2|||
124700075|NCT00855166|448524929|FG000|Overall Study|Death|0|||
124700076|NCT00855166|448524930|FG001|Overall Study|Death|1|||
124700077|NCT00855166|448524929|FG000|Overall Study|Withdrawal by Subject|1|||
124700078|NCT00855166|448524930|FG001|Overall Study|Withdrawal by Subject|4|||
124929087|NCT04800211|449371962|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
124929088|NCT04800211|449371963|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
124929089|NCT04800211|449371964|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
124929090|NCT04800211|449371962|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
124929091|NCT04800211|449371963|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
124929092|NCT04800211|449371964|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
124929093|NCT04800211|449371962|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
124929094|NCT04800211|449371963|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
124929095|NCT04800211|449371964|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
124929096|NCT04800211|449371962|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
124700079|NCT00855166|448524929|FG000|Overall Study|Poor/non-compliance|2|||
124700080|NCT00855166|448524930|FG001|Overall Study|Poor/non-compliance|0|||
124700081|NCT00855166|448524929|FG000|Overall Study|Administrative reasons by sponsor|1|||
124700082|NCT00855166|448524930|FG001|Overall Study|Administrative reasons by sponsor|0|||
124700083|NCT00855166|448524929|FG000|Overall Study|Subject no longer meets study criteria|1|||
124700084|NCT00855166|448524930|FG001|Overall Study|Subject no longer meets study criteria|1|||
124700085|NCT01848457|448524933|FG000|Overall Study|Death|1|||
124700086|NCT01848457|448524934|FG001|Overall Study|Death|0|||
124700087|NCT01848457|448524935|FG002|Overall Study|Death|0|||
124700088|NCT01848457|448524936|FG003|Overall Study|Death|0|||
124700089|NCT00803049|448524937|FG000|Overall Study|Adverse Event|21|||
124700090|NCT00803049|448524938|FG001|Overall Study|Adverse Event|33|||
124700091|NCT00803049|448524939|FG002|Overall Study|Adverse Event|13|||
124700092|NCT00803049|448524940|FG003|Overall Study|Adverse Event|27|||
124700093|NCT00803049|448524937|FG000|Overall Study|Lack of Efficacy|10|||
124700094|NCT00803049|448524938|FG001|Overall Study|Lack of Efficacy|19|||
124700095|NCT00803049|448524939|FG002|Overall Study|Lack of Efficacy|6|||
124700096|NCT00803049|448524940|FG003|Overall Study|Lack of Efficacy|13|||
124700097|NCT00803049|448524937|FG000|Overall Study|Lost to Follow-up|0|||
124700098|NCT00803049|448524938|FG001|Overall Study|Lost to Follow-up|2|||
124700099|NCT00803049|448524939|FG002|Overall Study|Lost to Follow-up|0|||
124700100|NCT00803049|448524940|FG003|Overall Study|Lost to Follow-up|3|||
124700101|NCT00803049|448524937|FG000|Overall Study|Death|2|||
124700102|NCT00803049|448524938|FG001|Overall Study|Death|1|||
124700103|NCT00803049|448524939|FG002|Overall Study|Death|0|||
124700104|NCT00803049|448524940|FG003|Overall Study|Death|2|||
124700105|NCT00803049|448524937|FG000|Overall Study|Progressive Disease|6|||
124700106|NCT00803049|448524938|FG001|Overall Study|Progressive Disease|10|||
124700107|NCT00803049|448524939|FG002|Overall Study|Progressive Disease|6|||
124700108|NCT00803049|448524940|FG003|Overall Study|Progressive Disease|6|||
124700109|NCT00803049|448524937|FG000|Overall Study|Withdrawal by Subject|19|||
124700110|NCT00803049|448524938|FG001|Overall Study|Withdrawal by Subject|43|||
124929097|NCT04800211|449371963|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
124763365|NCT00383552|448759700|FG001|Overall Study|Adverse Event|6|||
124763366|NCT00383552|448759701|FG002|Overall Study|Adverse Event|9|||
124763367|NCT00383552|448759702|FG003|Overall Study|Adverse Event|6|||
124546302|NCT03237325|447955864|FG001|Overall Study|Physician Decision|4|||
124546303|NCT03237325|447955863|FG000|Overall Study|Withdrawal by Subject|9|||
124546304|NCT03237325|447955864|FG001|Overall Study|Withdrawal by Subject|12|||
124546305|NCT03237325|447955863|FG000|Overall Study|Noncompliance with Study Procedures|1|||
124546306|NCT03237325|447955864|FG001|Overall Study|Noncompliance with Study Procedures|1|||
124546307|NCT03237325|447955863|FG000|Overall Study|Termination by Sponsor|0|||
124546308|NCT03237325|447955864|FG001|Overall Study|Termination by Sponsor|1|||
124546309|NCT03237325|447955863|FG000|Overall Study|Reason other than described|0|||
124546310|NCT03237325|447955864|FG001|Overall Study|Reason other than described|2|||
124546311|NCT02684370|447955865|FG000|Part A|Adverse Event|2|||
124546312|NCT02684370|447955866|FG001|Part A|Adverse Event|0|||
124546313|NCT02684370|447955867|FG002|Part A|Adverse Event|1|||
124546314|NCT02684370|447955868|FG003|Part A|Adverse Event|0|||
124546315|NCT02684370|447955869|FG004|Part A|Adverse Event|0|||
124546316|NCT02684370|447955870|FG005|Part A|Adverse Event|0|||
124546317|NCT02684370|447955865|FG000|Part A|Lost to Follow-up|1|||
124546318|NCT02684370|447955866|FG001|Part A|Lost to Follow-up|1|||
124546319|NCT02684370|447955867|FG002|Part A|Lost to Follow-up|0|||
124546320|NCT02684370|447955868|FG003|Part A|Lost to Follow-up|0|||
124546321|NCT02684370|447955869|FG004|Part A|Lost to Follow-up|0|||
124546322|NCT02684370|447955870|FG005|Part A|Lost to Follow-up|0|||
124546323|NCT02684370|447955865|FG000|Part A|Subject Withdrawal|1|||
124546324|NCT02684370|447955866|FG001|Part A|Subject Withdrawal|0|||
124546325|NCT02684370|447955867|FG002|Part A|Subject Withdrawal|3|||
124546326|NCT02684370|447955868|FG003|Part A|Subject Withdrawal|0|||
124546327|NCT02684370|447955869|FG004|Part A|Subject Withdrawal|0|||
124546328|NCT02684370|447955870|FG005|Part A|Subject Withdrawal|0|||
124546329|NCT02684370|447955865|FG000|Part A|Other|0|||
124763368|NCT00383552|448759699|FG000|Overall Study|Lack of Efficacy|4|||
124763369|NCT00383552|448759700|FG001|Overall Study|Lack of Efficacy|13|||
124763370|NCT00383552|448759701|FG002|Overall Study|Lack of Efficacy|29|||
124763371|NCT00383552|448759702|FG003|Overall Study|Lack of Efficacy|42|||
124546330|NCT02684370|447955866|FG001|Part A|Other|0|||
124546331|NCT02684370|447955867|FG002|Part A|Other|1|||
124763372|NCT00383552|448759699|FG000|Overall Study|Lost to Follow-up|0|||
124546332|NCT02684370|447955868|FG003|Part A|Other|0|||
124546333|NCT02684370|447955869|FG004|Part A|Other|0|||
124546334|NCT02684370|447955870|FG005|Part A|Other|0|||
124546335|NCT02684370|447955865|FG000|Part B|Adverse Event|0|||
124546336|NCT02684370|447955866|FG001|Part B|Adverse Event|0|||
124546337|NCT02684370|447955867|FG002|Part B|Adverse Event|0|||
124700111|NCT00803049|448524939|FG002|Overall Study|Withdrawal by Subject|16|||
124700112|NCT00803049|448524940|FG003|Overall Study|Withdrawal by Subject|44|||
124700113|NCT00803049|448524937|FG000|Overall Study|Protocol Violation|0|||
124700114|NCT00803049|448524938|FG001|Overall Study|Protocol Violation|1|||
124700115|NCT00803049|448524939|FG002|Overall Study|Protocol Violation|1|||
124700116|NCT00803049|448524940|FG003|Overall Study|Protocol Violation|0|||
124700117|NCT00803049|448524937|FG000|Overall Study|Randomized and Not Treated|0|||
124700118|NCT00803049|448524938|FG001|Overall Study|Randomized and Not Treated|0|||
124700119|NCT00803049|448524939|FG002|Overall Study|Randomized and Not Treated|0|||
124700120|NCT00803049|448524940|FG003|Overall Study|Randomized and Not Treated|2|||
124700121|NCT00803049|448524937|FG000|Overall Study|Other than Specified Above|3|||
124700122|NCT00803049|448524938|FG001|Overall Study|Other than Specified Above|9|||
124700123|NCT00803049|448524939|FG002|Overall Study|Other than Specified Above|2|||
124700124|NCT00803049|448524940|FG003|Overall Study|Other than Specified Above|5|||
124700125|NCT01421459|448524941|FG000|Overall Study|Adverse Event|6|||
124700126|NCT01421459|448524942|FG001|Overall Study|Adverse Event|10|||
124700127|NCT01421459|448524941|FG000|Overall Study|Death|1|||
124700128|NCT01421459|448524942|FG001|Overall Study|Death|1|||
124700129|NCT01421459|448524941|FG000|Overall Study|Lack of Efficacy|1|||
124700130|NCT01421459|448524942|FG001|Overall Study|Lack of Efficacy|2|||
124700131|NCT01421459|448524941|FG000|Overall Study|Lost to Follow-up|8|||
124700132|NCT01421459|448524942|FG001|Overall Study|Lost to Follow-up|9|||
124700133|NCT01421459|448524941|FG000|Overall Study|Physician Decision|9|||
124700134|NCT01421459|448524942|FG001|Overall Study|Physician Decision|9|||
124700135|NCT01421459|448524941|FG000|Overall Study|Protocol Violation|8|||
124700136|NCT01421459|448524942|FG001|Overall Study|Protocol Violation|5|||
124700137|NCT01421459|448524941|FG000|Overall Study|Withdrawal by Subject|12|||
124700138|NCT01421459|448524942|FG001|Overall Study|Withdrawal by Subject|16|||
124700139|NCT01272219|448524953|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
124700140|NCT01272219|448524954|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
124700141|NCT01272219|448524955|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
124700142|NCT01272219|448524956|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
124700143|NCT01272219|448524957|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
124700144|NCT01272219|448524958|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
124700145|NCT01272219|448524953|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
124929098|NCT04800211|449371964|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
124929099|NCT04800211|449371962|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
124929100|NCT04800211|449371963|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
124929101|NCT04800211|449371964|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
124929102|NCT04800211|449371962|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
124929103|NCT04800211|449371963|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
124929104|NCT04800211|449371964|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
124546338|NCT02684370|447955868|FG003|Part B|Adverse Event|0|||
124546339|NCT02684370|447955869|FG004|Part B|Adverse Event|2|||
124546340|NCT02684370|447955870|FG005|Part B|Adverse Event|1|||
124546341|NCT02684370|447955865|FG000|Part B|Lost to Follow-up|0|||
124546342|NCT02684370|447955866|FG001|Part B|Lost to Follow-up|0|||
124546343|NCT02684370|447955867|FG002|Part B|Lost to Follow-up|0|||
124546344|NCT02684370|447955868|FG003|Part B|Lost to Follow-up|1|||
124546345|NCT02684370|447955869|FG004|Part B|Lost to Follow-up|2|||
124546346|NCT02684370|447955870|FG005|Part B|Lost to Follow-up|5|||
124546347|NCT02684370|447955865|FG000|Part B|Subject Withdrawal|0|||
124546348|NCT02684370|447955866|FG001|Part B|Subject Withdrawal|0|||
124546349|NCT02684370|447955867|FG002|Part B|Subject Withdrawal|0|||
124546350|NCT02684370|447955868|FG003|Part B|Subject Withdrawal|1|||
124546351|NCT02684370|447955869|FG004|Part B|Subject Withdrawal|1|||
124546352|NCT02684370|447955870|FG005|Part B|Subject Withdrawal|2|||
124546353|NCT04221373|447955871|FG000|Overall Study|Physician Decision|4|||
124546354|NCT04221373|447955872|FG001|Overall Study|Physician Decision|0|||
124546355|NCT00183170|447955881|FG000|First Intervention|Did not complete study|1|||
124546356|NCT00183170|447955882|FG001|First Intervention|Did not complete study|0|||
124700146|NCT01272219|448524954|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
124700147|NCT01272219|448524955|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
124700148|NCT01272219|448524956|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
124700149|NCT01272219|448524957|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
124700150|NCT01272219|448524958|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
124700151|NCT01272219|448524953|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
124546357|NCT00183170|447955881|FG000|First Intervention|Did not meet targeted BrAC|1|||
124546358|NCT00183170|447955882|FG001|First Intervention|Did not meet targeted BrAC|0|||
124546359|NCT00183170|447955881|FG000|Washout 1 Week|Did not complete study|6|||
124546360|NCT00183170|447955882|FG001|Washout 1 Week|Did not complete study|8|||
124546361|NCT00183170|447955881|FG000|Second Intervention|Did not complete study|1|||
124700152|NCT01272219|448524954|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
124700153|NCT01272219|448524955|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
124700154|NCT01272219|448524956|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
124700155|NCT01272219|448524957|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
124700156|NCT01272219|448524958|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
124700157|NCT01272219|448524953|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
124700158|NCT01272219|448524954|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
124700159|NCT01272219|448524955|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
124700160|NCT01272219|448524956|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
124700161|NCT01272219|448524957|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
124700162|NCT01272219|448524958|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
124700163|NCT01272219|448524953|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
124700164|NCT01272219|448524954|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
124700165|NCT01272219|448524955|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
124700166|NCT01272219|448524956|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
124700167|NCT01272219|448524957|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
124700168|NCT01272219|448524958|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
124700169|NCT01272219|448524953|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
124700170|NCT01272219|448524954|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
124700171|NCT01272219|448524955|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
124700172|NCT01272219|448524956|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
124700173|NCT01272219|448524957|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
124700174|NCT01272219|448524958|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
124700175|NCT01272219|448524953|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
124700176|NCT01272219|448524954|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
124700177|NCT01272219|448524955|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
124700178|NCT01272219|448524956|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
124700179|NCT01272219|448524957|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
124700180|NCT01272219|448524958|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
124700181|NCT01272219|448524953|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
124700182|NCT01272219|448524954|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
124700183|NCT01272219|448524955|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
124700184|NCT01272219|448524956|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
124700185|NCT01272219|448524957|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
124700186|NCT01272219|448524958|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
124700187|NCT01272219|448524953|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
124700188|NCT01272219|448524954|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
124700189|NCT01272219|448524955|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
124700190|NCT01272219|448524956|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
124700191|NCT01272219|448524957|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
124700192|NCT01272219|448524958|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
124700193|NCT01272219|448524953|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
124700194|NCT01272219|448524954|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
124700195|NCT01272219|448524955|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
124700196|NCT01272219|448524956|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
124700197|NCT01272219|448524957|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
124700198|NCT01272219|448524958|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
124700199|NCT01272219|448524953|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
124700200|NCT01272219|448524954|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
124700201|NCT01272219|448524955|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
124700202|NCT01272219|448524956|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
124700203|NCT01272219|448524957|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
124700204|NCT01272219|448524958|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
124700205|NCT01272219|448524953|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
124700206|NCT01272219|448524954|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
124700207|NCT01272219|448524955|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
124700208|NCT01272219|448524956|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
124700209|NCT01272219|448524957|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
124700210|NCT01272219|448524958|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
124700211|NCT01272219|448524953|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
124929111|NCT04730739|449371967|FG000|Overall Study|Death|1|||
124929112|NCT05170841|449371968|FG000|Single Dose Phase|Adverse Event|1|||
124929113|NCT05170841|449371969|FG001|Single Dose Phase|Adverse Event|2|||
124929114|NCT05170841|449371970|FG002|Single Dose Phase|Adverse Event|0|||
124546362|NCT00183170|447955882|FG001|Second Intervention|Did not complete study|0|||
124546363|NCT00183170|447955881|FG000|Second Intervention|Did not meet targeted BrAC|0|||
124546364|NCT00183170|447955882|FG001|Second Intervention|Did not meet targeted BrAC|2|||
124546365|NCT00924820|447955883|FG000|Overall Study|Death|2|||
124546366|NCT00924820|447955883|FG000|Overall Study|Ineligible, Screen Failure|5|||
124546367|NCT04983589|447955884|FG000|Overall Study|Withdrawal by Subject|0|||
124546368|NCT04983589|447955885|FG001|Overall Study|Withdrawal by Subject|3|||
124546369|NCT04983589|447955884|FG000|Overall Study|COVID-19 Infection|1|||
124546370|NCT04983589|447955885|FG001|Overall Study|COVID-19 Infection|0|||
124546371|NCT04983589|447955884|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
124546372|NCT04983589|447955885|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
124929115|NCT05170841|449371971|FG003|Single Dose Phase|Adverse Event|2|||
124929116|NCT05170841|449371968|FG000|Multiple Dose Phase|Adverse Event|1|||
124929117|NCT05170841|449371969|FG001|Multiple Dose Phase|Adverse Event|2|||
124929118|NCT05170841|449371970|FG002|Multiple Dose Phase|Adverse Event|1|||
124929119|NCT05170841|449371971|FG003|Multiple Dose Phase|Adverse Event|4|||
124929120|NCT05170841|449371968|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
124929121|NCT05170841|449371969|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
124929122|NCT05170841|449371970|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
124929123|NCT05170841|449371971|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
124929124|NCT05123586|449371974|FG000|Overall Study|Physician Decision|1|||
124929125|NCT05123586|449371975|FG001|Overall Study|Physician Decision|1|||
124929126|NCT05123586|449371974|FG000|Overall Study|Withdrawal by Subject|0|||
124929127|NCT05123586|449371975|FG001|Overall Study|Withdrawal by Subject|3|||
124929128|NCT04865289|449371976|FG000|Overall Study|Participant ongoing in study|47|||
124546373|NCT00761969|447955886|FG000|Overall Study|Death|112|||
124546374|NCT00761969|447955887|FG001|Overall Study|Death|47|||
124546375|NCT00761969|447955886|FG000|Overall Study|Lost to Follow-up|88|||
124929129|NCT04865289|449371977|FG001|Overall Study|Participant ongoing in study|35|||
124546376|NCT00761969|447955887|FG001|Overall Study|Lost to Follow-up|93|||
124546377|NCT00978120|447955888|FG000|Overall Study|Death|0|||
124546378|NCT00978120|447955889|FG001|Overall Study|Death|0|||
124546379|NCT00978120|447955890|FG002|Overall Study|Death|0|||
124546380|NCT00978120|447955891|FG003|Overall Study|Death|1|||
124546381|NCT00978120|447955888|FG000|Overall Study|Lost to Follow-up|0|||
124546382|NCT00978120|447955889|FG001|Overall Study|Lost to Follow-up|0|||
124546383|NCT00978120|447955890|FG002|Overall Study|Lost to Follow-up|3|||
124546384|NCT00978120|447955891|FG003|Overall Study|Lost to Follow-up|0|||
124700212|NCT01272219|448524954|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
124700213|NCT01272219|448524955|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
124700214|NCT01272219|448524956|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
124700215|NCT01272219|448524957|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
124700216|NCT01272219|448524958|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
124700217|NCT01272219|448524953|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
124700218|NCT01272219|448524954|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
124700219|NCT01272219|448524955|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
124700220|NCT01272219|448524956|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
124700221|NCT01272219|448524957|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
124700222|NCT01272219|448524958|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
124700223|NCT01272219|448524953|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
124700224|NCT01272219|448524954|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
124700225|NCT01272219|448524955|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
124700226|NCT01272219|448524956|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
124700227|NCT01272219|448524957|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
124700228|NCT01272219|448524958|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
124700229|NCT01272219|448524953|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
124700230|NCT01272219|448524954|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
124700231|NCT01272219|448524955|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
124700232|NCT01272219|448524956|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
124700233|NCT01272219|448524957|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
124700234|NCT01272219|448524958|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
124929130|NCT04865289|449371976|FG000|Overall Study|Death|27|||
124929131|NCT04865289|449371977|FG001|Overall Study|Death|21|||
124929132|NCT04677738|449371978|FG000|Overall Study|Withdrawal by Subject|4|||
124546385|NCT00978120|447955888|FG000|Overall Study|Withdrawal by Subject|2|||
124546386|NCT00978120|447955889|FG001|Overall Study|Withdrawal by Subject|0|||
124546387|NCT00978120|447955890|FG002|Overall Study|Withdrawal by Subject|0|||
124546388|NCT00978120|447955891|FG003|Overall Study|Withdrawal by Subject|0|||
124929133|NCT04677738|449371979|FG001|Overall Study|Withdrawal by Subject|2|||
124929134|NCT04707469|449371980|FG000|Overall Study|Site closure|0|||
124929135|NCT04707469|449371981|FG001|Overall Study|Site closure|2|||
124929136|NCT04707469|449371982|FG002|Overall Study|Site closure|0|||
124929137|NCT04707469|449371980|FG000|Overall Study|Physician Decision|2|||
124929138|NCT04707469|449371981|FG001|Overall Study|Physician Decision|2|||
124929139|NCT04707469|449371982|FG002|Overall Study|Physician Decision|2|||
124929140|NCT04707469|449371980|FG000|Overall Study|Death|1|||
124929141|NCT04707469|449371981|FG001|Overall Study|Death|6|||
124929142|NCT04707469|449371982|FG002|Overall Study|Death|2|||
124929143|NCT04707469|449371980|FG000|Overall Study|Lost to Follow-up|9|||
124929144|NCT04707469|449371981|FG001|Overall Study|Lost to Follow-up|19|||
124929145|NCT04707469|449371982|FG002|Overall Study|Lost to Follow-up|14|||
124929146|NCT04707469|449371980|FG000|Overall Study|Withdrawal by Subject|17|||
124929147|NCT04707469|449371981|FG001|Overall Study|Withdrawal by Subject|16|||
124929148|NCT04707469|449371982|FG002|Overall Study|Withdrawal by Subject|12|||
124929149|NCT02733159|449371983|FG000|Overall Study|Adverse Event|1|||
124929150|NCT02733159|449371983|FG000|Overall Study|Lack of disease progression|1|||
124929151|NCT06122194|449371986|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
124929152|NCT06122194|449371987|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
124929153|NCT06122194|449371988|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
124929154|NCT06122194|449371989|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
124929155|NCT02724969|449371996|FG000|Overall Study|Lost to Follow-up|12|||
124929156|NCT02724969|449371997|FG001|Overall Study|Lost to Follow-up|6|||
124929157|NCT02724969|449371996|FG000|Overall Study|Withdrawal by Subject|3|||
124929158|NCT02724969|449371997|FG001|Overall Study|Withdrawal by Subject|3|||
124929159|NCT02724969|449371996|FG000|Overall Study|Infant demise|0|||
124929160|NCT02724969|449371997|FG001|Overall Study|Infant demise|2|||
124929161|NCT01309672|449372000|FG000|Overall Study|Lack of Efficacy|20|||
124929162|NCT01309672|449372000|FG000|Overall Study|Other|9|||
124929163|NCT01309672|449372000|FG000|Overall Study|Adverse Event|5|||
124929164|NCT01309672|449372000|FG000|Overall Study|Withdrawal by Subject|3|||
124929165|NCT03626220|449372002|FG000|Overall Study|Withdrawal by Subject|2|||
124929166|NCT03626220|449372003|FG001|Overall Study|Withdrawal by Subject|0|||
124929167|NCT03916185|449373160|FG000|Overall Study|Lost to Follow-up|0|||
124929168|NCT03916185|449373161|FG001|Overall Study|Lost to Follow-up|1|||
124929169|NCT03916185|449373162|FG002|Overall Study|Lost to Follow-up|0|||
124929170|NCT03916185|449373163|FG003|Overall Study|Lost to Follow-up|0|||
124929171|NCT03916185|449373160|FG000|Overall Study|Moved|1|||
124929172|NCT03916185|449373161|FG001|Overall Study|Moved|0|||
124929173|NCT03916185|449373162|FG002|Overall Study|Moved|0|||
124455236|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
124455237|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
124455238|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
124455239|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
124455240|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
124455241|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
124546389|NCT00978120|447955888|FG000|Overall Study|Moved out of state|0|||
124700235|NCT03131479|448524959|FG000|Overall Study|Adverse Event|0|||
124700236|NCT03131479|448524960|FG001|Overall Study|Adverse Event|0|||
124700237|NCT03131479|448524961|FG002|Overall Study|Adverse Event|1|||
124700238|NCT03131479|448524962|FG003|Overall Study|Adverse Event|1|||
124700239|NCT03131479|448524963|FG004|Overall Study|Adverse Event|0|||
124700240|NCT03131479|448524959|FG000|Overall Study|Subject/Guardian Decision|0|||
124700241|NCT03131479|448524960|FG001|Overall Study|Subject/Guardian Decision|0|||
124700242|NCT03131479|448524961|FG002|Overall Study|Subject/Guardian Decision|0|||
124700243|NCT03131479|448524962|FG003|Overall Study|Subject/Guardian Decision|1|||
124700244|NCT03131479|448524963|FG004|Overall Study|Subject/Guardian Decision|0|||
124700245|NCT04439903|448524966|FG000|Overall Study|Withdrawal by Subject|2|||
124700246|NCT04439903|448524966|FG000|Overall Study|Screen Failure|1|||
124700247|NCT02899754|448524967|FG000|Overall Study|Lost to Follow-up|7|||
124700248|NCT02899754|448524968|FG001|Overall Study|Lost to Follow-up|9|||
124700249|NCT03186378|448524969|FG000|Overall Study|Lost to Follow-up|1|||
124700250|NCT03186378|448524970|FG001|Overall Study|Lost to Follow-up|0|||
124700251|NCT02181413|448524971|FG000|Overall Study|Withdrawal by Subject|45|||
124700252|NCT02181413|448524972|FG001|Overall Study|Withdrawal by Subject|61|||
124700253|NCT02181413|448524971|FG000|Overall Study|Reason Not Specified|2|||
124700254|NCT02181413|448524972|FG001|Overall Study|Reason Not Specified|5|||
124929174|NCT03916185|449373163|FG003|Overall Study|Moved|1|||
124929175|NCT03916185|449373160|FG000|Overall Study|Not Able to Get to Clinic|1|||
124929176|NCT03916185|449373161|FG001|Overall Study|Not Able to Get to Clinic|0|||
124929177|NCT03916185|449373162|FG002|Overall Study|Not Able to Get to Clinic|0|||
124929178|NCT03916185|449373163|FG003|Overall Study|Not Able to Get to Clinic|0|||
124929179|NCT02593773|449373177|FG000|Overall Study|Voluntary Withdrawal|3|||
124929180|NCT02593773|449373177|FG000|Overall Study|Study Terminated by Sponsor|31|||
124929181|NCT02593773|449373177|FG000|Overall Study|Death|1|||
124929182|NCT05934942|449373183|FG000|Run-in Period|Not treated|1|||
124929183|NCT05934942|449373183|FG000|Run-in Period|Withdrawal by Subject|1|||
124455242|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
124455243|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
124455244|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
124763373|NCT00383552|448759700|FG001|Overall Study|Lost to Follow-up|1|||
124763374|NCT00383552|448759701|FG002|Overall Study|Lost to Follow-up|5|||
124763375|NCT00383552|448759702|FG003|Overall Study|Lost to Follow-up|1|||
124763376|NCT00383552|448759699|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
124763377|NCT00383552|448759700|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
124763378|NCT00383552|448759701|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
124763379|NCT00383552|448759702|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
124763380|NCT00383552|448759699|FG000|Overall Study|Did not wish to continue (related)|1|||
124763381|NCT00383552|448759700|FG001|Overall Study|Did not wish to continue (related)|0|||
124763382|NCT00383552|448759701|FG002|Overall Study|Did not wish to continue (related)|2|||
124763383|NCT00383552|448759702|FG003|Overall Study|Did not wish to continue (related)|3|||
124763384|NCT00383552|448759699|FG000|Overall Study|Noncompliance with the protocol|11|||
124763385|NCT00383552|448759700|FG001|Overall Study|Noncompliance with the protocol|6|||
124763386|NCT00383552|448759701|FG002|Overall Study|Noncompliance with the protocol|8|||
124763387|NCT00383552|448759702|FG003|Overall Study|Noncompliance with the protocol|10|||
124763388|NCT00383552|448759699|FG000|Overall Study|Did not meet protocol eligibility|8|||
124763389|NCT00383552|448759700|FG001|Overall Study|Did not meet protocol eligibility|6|||
124763390|NCT00383552|448759701|FG002|Overall Study|Did not meet protocol eligibility|2|||
124763391|NCT00383552|448759702|FG003|Overall Study|Did not meet protocol eligibility|3|||
124763392|NCT00383552|448759699|FG000|Overall Study|Administrative|1|||
124763393|NCT00383552|448759700|FG001|Overall Study|Administrative|0|||
124763394|NCT00383552|448759701|FG002|Overall Study|Administrative|1|||
124763395|NCT00383552|448759702|FG003|Overall Study|Administrative|1|||
124763396|NCT03096834|448759703|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
124763397|NCT03096834|448759704|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
124763398|NCT03096834|448759705|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
124763399|NCT03096834|448759706|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
124763400|NCT03096834|448759703|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
124763401|NCT03096834|448759704|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
124763402|NCT03096834|448759705|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
124763403|NCT03096834|448759706|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
124763404|NCT03096834|448759703|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
124763405|NCT03096834|448759704|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
124763406|NCT03096834|448759705|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
124763407|NCT03096834|448759706|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
124763408|NCT03096834|448759703|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
124763409|NCT03096834|448759704|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
124763410|NCT03096834|448759705|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
124763411|NCT03096834|448759706|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
124763412|NCT03096834|448759703|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
124763413|NCT03096834|448759704|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
124763414|NCT03096834|448759705|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
124763415|NCT03096834|448759706|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
124455245|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
124455246|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
124455247|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
124455248|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
124455249|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
124455250|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
124763416|NCT03096834|448759703|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
124763417|NCT03096834|448759704|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
124763418|NCT03096834|448759705|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
124763419|NCT03096834|448759706|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
124929184|NCT04471246|449373186|FG000|Overall Study|Lost to Follow-up|2|||
124929185|NCT04471246|449373187|FG001|Overall Study|Lost to Follow-up|2|||
124929186|NCT03386578|449373189|FG000|PK Component|Lost to Follow-up|0|||
124929187|NCT03386578|449373190|FG001|PK Component|Lost to Follow-up|1|||
124929188|NCT03386578|449373191|FG002|PK Component|Lost to Follow-up|0|||
124929189|NCT03386578|449373192|FG003|PK Component|Lost to Follow-up|0|||
124929190|NCT03386578|449373193|FG004|PK Component|Lost to Follow-up|0|||
124929191|NCT03386578|449373194|FG005|PK Component|Lost to Follow-up|0|||
124929192|NCT03386578|449373195|FG006|PK Component|Lost to Follow-up|1|||
124929193|NCT03386578|449373196|FG007|PK Component|Lost to Follow-up|0|||
124929194|NCT03386578|449373197|FG008|PK Component|Lost to Follow-up|0|||
124929195|NCT03386578|449373198|FG009|PK Component|Lost to Follow-up|0|||
124929196|NCT03386578|449373189|FG000|PK Component|Stillbirth/Abortion|0|||
124929197|NCT03386578|449373190|FG001|PK Component|Stillbirth/Abortion|0|||
124929198|NCT03386578|449373191|FG002|PK Component|Stillbirth/Abortion|0|||
124929199|NCT03386578|449373192|FG003|PK Component|Stillbirth/Abortion|0|||
124929200|NCT03386578|449373193|FG004|PK Component|Stillbirth/Abortion|0|||
124929201|NCT03386578|449373194|FG005|PK Component|Stillbirth/Abortion|2|||
124929202|NCT03386578|449373195|FG006|PK Component|Stillbirth/Abortion|0|||
124929203|NCT03386578|449373196|FG007|PK Component|Stillbirth/Abortion|0|||
124929204|NCT03386578|449373197|FG008|PK Component|Stillbirth/Abortion|0|||
124929205|NCT03386578|449373198|FG009|PK Component|Stillbirth/Abortion|0|||
124929206|NCT03386578|449373189|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
124929207|NCT03386578|449373190|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
124929208|NCT03386578|449373191|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
124929209|NCT03386578|449373192|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
124929210|NCT03386578|449373193|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
124929211|NCT03386578|449373194|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
124455251|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
124455252|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
124455253|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
124455254|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
124455255|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
124455256|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
124455257|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
124455258|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
124929212|NCT03386578|449373195|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
124929213|NCT03386578|449373196|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
124929214|NCT03386578|449373197|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
124929215|NCT03386578|449373198|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
124929216|NCT03386578|449373189|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
124929217|NCT03386578|449373190|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
124929218|NCT03386578|449373191|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
124929219|NCT03386578|449373192|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
124929220|NCT03386578|449373193|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
124455259|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
124455260|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
124455261|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
124455262|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
124455263|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
124455264|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
124455265|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
124455266|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
124455267|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
124455268|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
124455269|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
124455270|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
124700255|NCT02181413|448524971|FG000|Overall Study|Lost to Follow-up|8|||
124929221|NCT03386578|449373194|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
124929222|NCT03386578|449373195|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
124929223|NCT03386578|449373196|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
124929224|NCT03386578|449373197|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
124929225|NCT03386578|449373198|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
124700256|NCT02181413|448524972|FG001|Overall Study|Lost to Follow-up|7|||
124929226|NCT03386578|449373189|FG000|PrEP Comparison Component Step 1|Death|0|||
124929227|NCT03386578|449373190|FG001|PrEP Comparison Component Step 1|Death|0|||
124929228|NCT03386578|449373191|FG002|PrEP Comparison Component Step 1|Death|1|||
124929229|NCT03386578|449373192|FG003|PrEP Comparison Component Step 1|Death|0|||
124929230|NCT03386578|449373193|FG004|PrEP Comparison Component Step 1|Death|0|||
124929231|NCT03386578|449373194|FG005|PrEP Comparison Component Step 1|Death|0|||
124929232|NCT03386578|449373195|FG006|PrEP Comparison Component Step 1|Death|0|||
124929233|NCT03386578|449373196|FG007|PrEP Comparison Component Step 1|Death|9|||
124929234|NCT03386578|449373197|FG008|PrEP Comparison Component Step 1|Death|5|||
124929235|NCT03386578|449373198|FG009|PrEP Comparison Component Step 1|Death|0|||
124929236|NCT03386578|449373189|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
124929237|NCT03386578|449373190|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
124929238|NCT03386578|449373191|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
124929239|NCT03386578|449373192|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
124929240|NCT03386578|449373193|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
124929241|NCT03386578|449373194|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
124929242|NCT03386578|449373195|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
124929243|NCT03386578|449373196|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
124929244|NCT03386578|449373197|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
124929245|NCT03386578|449373198|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
124929246|NCT03386578|449373189|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
124929247|NCT03386578|449373190|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
124929248|NCT03386578|449373191|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
124929249|NCT03386578|449373192|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
124929250|NCT03386578|449373193|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
124455271|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
124455272|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
124455273|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
124455274|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
124455275|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
124700257|NCT02514746|448524975|FG000|Overall Study|Chronically Ill|1|||
124700258|NCT02514746|448524976|FG001|Overall Study|Chronically Ill|2|||
124700259|NCT02514746|448524975|FG000|Overall Study|Physician Decision|4|||
124700260|NCT02514746|448524976|FG001|Overall Study|Physician Decision|2|||
124700261|NCT02514746|448524975|FG000|Overall Study|Withdrawal by Subject|12|||
124700262|NCT02514746|448524976|FG001|Overall Study|Withdrawal by Subject|10|||
124700263|NCT02514746|448524975|FG000|Overall Study|Other|5|||
124700264|NCT02514746|448524976|FG001|Overall Study|Other|1|||
124700265|NCT00050011|448524978|FG000|Overall Study|Adverse Event|41|||
124700266|NCT00050011|448524979|FG001|Overall Study|Adverse Event|46|||
124700267|NCT00050011|448524978|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124700268|NCT00050011|448524979|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124700269|NCT00050011|448524978|FG000|Overall Study|Abnormal test procedure results|0|||
124700270|NCT00050011|448524979|FG001|Overall Study|Abnormal test procedure results|1|||
124700271|NCT00050011|448524978|FG000|Overall Study|Lack of Efficacy|16|||
124700272|NCT00050011|448524979|FG001|Overall Study|Lack of Efficacy|21|||
124700273|NCT00050011|448524978|FG000|Overall Study|Participant condition no longer required|1|||
124700274|NCT00050011|448524979|FG001|Overall Study|Participant condition no longer required|0|||
124700275|NCT00050011|448524978|FG000|Overall Study|Protocol Violation|4|||
124700276|NCT00050011|448524979|FG001|Overall Study|Protocol Violation|10|||
124700277|NCT00050011|448524978|FG000|Overall Study|Withdrawal by Subject|34|||
124700278|NCT00050011|448524979|FG001|Overall Study|Withdrawal by Subject|26|||
124700279|NCT00050011|448524978|FG000|Overall Study|Lost to Follow-up|7|||
124700280|NCT00050011|448524979|FG001|Overall Study|Lost to Follow-up|9|||
124700281|NCT00050011|448524978|FG000|Overall Study|Administrative problems|10|||
124700282|NCT00050011|448524979|FG001|Overall Study|Administrative problems|6|||
124700283|NCT00050011|448524978|FG000|Overall Study|Death|7|||
124700284|NCT00050011|448524979|FG001|Overall Study|Death|4|||
124700285|NCT00050011|448524978|FG000|Overall Study|Unknown - Reason is missing|0|||
124700286|NCT00050011|448524979|FG001|Overall Study|Unknown - Reason is missing|2|||
124700287|NCT04003142|448524982|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
124700288|NCT04003142|448524983|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
124700289|NCT04003142|448524984|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
124700290|NCT04003142|448524985|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
124700291|NCT04003142|448524986|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
124700292|NCT04003142|448524982|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
124700293|NCT04003142|448524983|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
124700294|NCT04003142|448524984|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
124700295|NCT04003142|448524985|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
124700296|NCT04003142|448524986|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
124700297|NCT04003142|448524982|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
124700298|NCT04003142|448524983|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
124700299|NCT04003142|448524984|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
124700300|NCT04003142|448524985|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
124700301|NCT04003142|448524986|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
124546390|NCT00978120|447955889|FG001|Overall Study|Moved out of state|0|||
124700302|NCT04003142|448524982|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
124700303|NCT04003142|448524983|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
124700304|NCT04003142|448524984|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
124700305|NCT04003142|448524985|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
124700306|NCT04003142|448524986|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
124700307|NCT04003142|448524982|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
124700308|NCT04003142|448524983|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
124700309|NCT04003142|448524984|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
124700310|NCT04003142|448524985|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
124700311|NCT04003142|448524986|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
124700312|NCT04003142|448524982|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
124700313|NCT04003142|448524983|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
124700314|NCT04003142|448524984|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
124700315|NCT04003142|448524985|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
124700316|NCT04003142|448524986|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
124700317|NCT04003142|448524982|FG000|Extension Period (40 Weeks)|Death|0|||
124700318|NCT04003142|448524983|FG001|Extension Period (40 Weeks)|Death|0|||
124700319|NCT04003142|448524984|FG002|Extension Period (40 Weeks)|Death|0|||
124700320|NCT04003142|448524985|FG003|Extension Period (40 Weeks)|Death|0|||
124700321|NCT04003142|448524986|FG004|Extension Period (40 Weeks)|Death|1|||
124700322|NCT04003142|448524982|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
124700323|NCT04003142|448524983|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
124700324|NCT04003142|448524984|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
124700325|NCT04003142|448524985|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
124700326|NCT04003142|448524986|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
124700327|NCT04003142|448524982|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
124700328|NCT04003142|448524983|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
124700329|NCT04003142|448524984|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
124700330|NCT04003142|448524985|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
124700331|NCT04003142|448524986|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
124700332|NCT04003142|448524982|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
124700333|NCT04003142|448524983|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
124700334|NCT04003142|448524984|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
124700335|NCT04003142|448524985|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
124700336|NCT04003142|448524986|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
124700337|NCT04003142|448524982|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
124700338|NCT04003142|448524983|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
124700339|NCT04003142|448524984|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
124700340|NCT04003142|448524985|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
124700341|NCT04003142|448524986|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
124700342|NCT04042311|448524987|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
124700343|NCT04042311|448524987|FG000|Overall Study|Unable to tolerate|4|||
124700344|NCT04042311|448524987|FG000|Overall Study|Concurrent illness|2|||
124700345|NCT04042311|448524987|FG000|Overall Study|Adverse Event|2|||
124700346|NCT04042311|448524987|FG000|Overall Study|No longer meeting inclusion criteria|2|||
124700347|NCT04042311|448524987|FG000|Overall Study|No reason given|1|||
124700348|NCT04042311|448524987|FG000|Overall Study|Withdrawal by Subject|4|||
124700349|NCT03382873|448524988|FG000|Overall Study|Lost to Follow-up|9|||
124700350|NCT03382873|448524989|FG001|Overall Study|Lost to Follow-up|10|||
124700351|NCT03382873|448524988|FG000|Overall Study|Withdrawal by Subject|6|||
124700352|NCT03382873|448524989|FG001|Overall Study|Withdrawal by Subject|11|||
124700353|NCT03382873|448524988|FG000|Overall Study|Visit not completed due to pandemic|16|||
124700354|NCT03382873|448524989|FG001|Overall Study|Visit not completed due to pandemic|41|||
124700355|NCT03996395|448524992|FG000|Overall Study|Lost to Follow-up|4|||
124700356|NCT03996395|448524992|FG000|Overall Study|Withdrawal by Subject|1|||
124700357|NCT03996395|448524992|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
124700358|NCT02061085|448524995|FG000|Overall Study|Adverse Event|8|||
124700359|NCT03247673|448524996|FG000|Overall Study|Withdrawal by Subject|1|||
124700360|NCT03247673|448524997|FG001|Overall Study|Withdrawal by Subject|0|||
124700361|NCT03247673|448524998|FG002|Overall Study|Withdrawal by Subject|3|||
124763420|NCT03096834|448759703|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
124763421|NCT03096834|448759704|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
124763422|NCT03096834|448759705|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
124763423|NCT03096834|448759706|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
124763424|NCT03096834|448759703|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
124763425|NCT03096834|448759704|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
124763426|NCT03096834|448759705|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
124763427|NCT03096834|448759706|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
124763428|NCT03096834|448759703|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
124763429|NCT03096834|448759704|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
124763430|NCT03096834|448759705|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
124763431|NCT03096834|448759706|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
124763432|NCT03096834|448759703|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
124763433|NCT03096834|448759704|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
124763434|NCT03096834|448759705|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
124763435|NCT03096834|448759706|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
124763436|NCT03096834|448759703|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
124763437|NCT03096834|448759704|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
124763438|NCT03096834|448759705|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
124763439|NCT03096834|448759706|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
124763440|NCT03096834|448759703|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
124763441|NCT03096834|448759704|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
124763442|NCT03096834|448759705|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
124763443|NCT03096834|448759706|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
124763444|NCT00966654|448759707|FG000|Overall Study|Study was terminated,PI left institution|12|||
124763445|NCT04416204|448759710|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
124763446|NCT04416204|448759711|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
124763447|NCT04416204|448759712|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
124763448|NCT04416204|448759713|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
124763449|NCT03858049|448759714|FG000|Overall Study|Adverse Event|16|||
124763450|NCT03858049|448759715|FG001|Overall Study|Adverse Event|9|||
124763451|NCT03858049|448759714|FG000|Overall Study|Other|1|||
124763452|NCT03858049|448759715|FG001|Overall Study|Other|1|||
124763453|NCT04456504|448759716|FG000|Overall Study|Lost to Follow-up|2|||
124763454|NCT04617782|448759717|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
124763455|NCT04617782|448759717|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
124763456|NCT04617782|448759717|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
124763457|NCT04617782|448759717|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
124763458|NCT04617782|448759717|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
124763459|NCT04617782|448759717|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
124763460|NCT01405768|448759718|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
124763461|NCT01405768|448759719|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
124763462|NCT01690052|448759722|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
124763463|NCT01690052|448759723|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
124763464|NCT01474317|448759733|FG000|Overall Study|Adverse Event|1|||
124763465|NCT01474317|448759733|FG000|Overall Study|Subject ineligible for study|1|||
124763466|NCT01381016|448759736|FG000|Overall Study|Lost to Follow-up|1|||
124763467|NCT01381016|448759737|FG001|Overall Study|Lost to Follow-up|1|||
124763468|NCT01381016|448759736|FG000|Overall Study|Screen Failure|2|||
124763469|NCT01381016|448759737|FG001|Overall Study|Screen Failure|2|||
124763470|NCT01381016|448759736|FG000|Overall Study|Withdrawal by Subject|0|||
124763471|NCT01381016|448759737|FG001|Overall Study|Withdrawal by Subject|1|||
124763472|NCT01381016|448759736|FG000|Overall Study|Physician Decision|0|||
124763473|NCT01381016|448759737|FG001|Overall Study|Physician Decision|2|||
124763474|NCT01693029|448759738|FG000|Overall Study|Withdrawal by Subject|15|||
124763475|NCT01693029|448759739|FG001|Overall Study|Withdrawal by Subject|22|||
124763476|NCT01693029|448759738|FG000|Overall Study|Kidney transplantation|7|||
124763477|NCT01693029|448759739|FG001|Overall Study|Kidney transplantation|7|||
124763478|NCT01693029|448759738|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
124763479|NCT01693029|448759739|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
124763480|NCT01693029|448759738|FG000|Overall Study|Protocol Violation|6|||
124763481|NCT01693029|448759739|FG001|Overall Study|Protocol Violation|7|||
124763482|NCT01693029|448759738|FG000|Overall Study|Change in dialysis modality|2|||
124763483|NCT01693029|448759739|FG001|Overall Study|Change in dialysis modality|1|||
124763484|NCT01693029|448759738|FG000|Overall Study|Physician Decision|0|||
124763485|NCT01693029|448759739|FG001|Overall Study|Physician Decision|2|||
124763486|NCT01693029|448759738|FG000|Overall Study|Lost to Follow-up|0|||
124763487|NCT01693029|448759739|FG001|Overall Study|Lost to Follow-up|1|||
124763488|NCT01693029|448759738|FG000|Overall Study|Adverse Event|1|||
124763489|NCT01693029|448759739|FG001|Overall Study|Adverse Event|6|||
124763490|NCT01693029|448759738|FG000|Overall Study|Death|5|||
124763491|NCT01693029|448759739|FG001|Overall Study|Death|8|||
124763492|NCT01693029|448759738|FG000|Overall Study|Non-compliance|2|||
124763493|NCT01693029|448759739|FG001|Overall Study|Non-compliance|1|||
124763494|NCT02647281|448759740|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
124763495|NCT02647281|448759741|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
124763496|NCT02647281|448759742|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
124763497|NCT02647281|448759743|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
124763498|NCT02647281|448759744|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
124763499|NCT02647281|448759745|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
124929251|NCT03386578|449373194|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
124929252|NCT03386578|449373195|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
124929253|NCT03386578|449373196|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
124929254|NCT03386578|449373197|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
124929255|NCT03386578|449373198|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
124929256|NCT03386578|449373189|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
124929257|NCT03386578|449373190|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
124929258|NCT03386578|449373191|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
124929259|NCT03386578|449373192|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
124929260|NCT03386578|449373193|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
124929261|NCT03386578|449373194|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
124929262|NCT03386578|449373195|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
124929263|NCT03386578|449373196|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
124929264|NCT03386578|449373197|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
124929265|NCT03386578|449373198|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
124929266|NCT05907174|449373199|FG000|3-Month Assessment|Withdrawal by Subject|0|||
124929267|NCT05907174|449373200|FG001|3-Month Assessment|Withdrawal by Subject|0|||
124929268|NCT05907174|449373201|FG002|3-Month Assessment|Withdrawal by Subject|0|||
124929269|NCT05907174|449373202|FG003|3-Month Assessment|Withdrawal by Subject|1|||
124929270|NCT05907174|449373199|FG000|3-Month Assessment|Lost to Follow-up|1|||
124929271|NCT05907174|449373200|FG001|3-Month Assessment|Lost to Follow-up|1|||
124929272|NCT05907174|449373201|FG002|3-Month Assessment|Lost to Follow-up|1|||
124929273|NCT05907174|449373202|FG003|3-Month Assessment|Lost to Follow-up|1|||
124929274|NCT05907174|449373199|FG000|6-Month Assessment|Death|0|||
124929275|NCT05907174|449373200|FG001|6-Month Assessment|Death|0|||
124929276|NCT05907174|449373201|FG002|6-Month Assessment|Death|3|||
124929277|NCT05907174|449373202|FG003|6-Month Assessment|Death|0|||
124929278|NCT05907174|449373199|FG000|6-Month Assessment|Withdrawal by Subject|0|||
124929279|NCT05907174|449373200|FG001|6-Month Assessment|Withdrawal by Subject|0|||
124929280|NCT05907174|449373201|FG002|6-Month Assessment|Withdrawal by Subject|1|||
124929281|NCT05907174|449373202|FG003|6-Month Assessment|Withdrawal by Subject|1|||
124929282|NCT05907174|449373199|FG000|6-Month Assessment|Lost to Follow-up|0|||
124929283|NCT05907174|449373200|FG001|6-Month Assessment|Lost to Follow-up|1|||
124929284|NCT05907174|449373201|FG002|6-Month Assessment|Lost to Follow-up|1|||
124929285|NCT05907174|449373202|FG003|6-Month Assessment|Lost to Follow-up|1|||
124929286|NCT02668692|449373206|FG000|Overall Study|Adverse Event|1|||
124929287|NCT02668692|449373207|FG001|Overall Study|Adverse Event|0|||
124929288|NCT01627574|449373212|FG000|Overall Study|Withdrawal by Subject|8|||
124929289|NCT01627574|449373213|FG001|Overall Study|Withdrawal by Subject|5|||
124929290|NCT01627574|449373212|FG000|Overall Study|Lost to Follow-up|13|||
124929291|NCT01627574|449373213|FG001|Overall Study|Lost to Follow-up|13|||
124929292|NCT03734679|449373222|FG000|Overall Study|Missed Visit|1|||
124929293|NCT03249090|449373224|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
124929294|NCT03249090|449373225|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
124929295|NCT03249090|449373224|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
124929296|NCT03249090|449373225|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
124929297|NCT03249090|449373224|FG000|3 Month Time Point|Voluntary withdrawal|6|||
124929298|NCT03249090|449373225|FG001|3 Month Time Point|Voluntary withdrawal|3|||
124929299|NCT03249090|449373224|FG000|3 Month Time Point|Changed oncology practice|4|||
124929300|NCT03249090|449373225|FG001|3 Month Time Point|Changed oncology practice|2|||
124929301|NCT03249090|449373224|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
124929302|NCT03249090|449373225|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
124929303|NCT03249090|449373224|FG000|12 Month Time Point|Voluntary withdrawal|35|||
124929304|NCT03249090|449373225|FG001|12 Month Time Point|Voluntary withdrawal|4|||
124929305|NCT03249090|449373224|FG000|12 Month Time Point|Changed oncology practice|20|||
124929306|NCT03249090|449373225|FG001|12 Month Time Point|Changed oncology practice|9|||
124929307|NCT03362476|449373233|FG000|Overall Study|Withdrawal by Subject|0|||
124929308|NCT03362476|449373234|FG001|Overall Study|Withdrawal by Subject|1|||
124929309|NCT05974501|449373235|FG000|Overall Study|Physician Decision|0|||
124929310|NCT05974501|449373236|FG001|Overall Study|Physician Decision|1|||
124929311|NCT04270942|449373237|FG000|Overall Study|Death|1|||
124929312|NCT04295512|449373247|FG000|Overall Study|Lack of family response to schedule assessment|0|||
124929313|NCT04295512|449373248|FG001|Overall Study|Lack of family response to schedule assessment|0|||
124700362|NCT03247673|448524996|FG000|Overall Study|Lost to Follow-up|0|||
124700363|NCT03247673|448524997|FG001|Overall Study|Lost to Follow-up|0|||
124700364|NCT03247673|448524998|FG002|Overall Study|Lost to Follow-up|1|||
124700365|NCT02097225|448524999|FG000|Dose Level 4|Adverse Event|0|||
124700366|NCT02097225|448525000|FG001|Dose Level 4|Adverse Event|0|||
124700367|NCT02097225|448525001|FG002|Dose Level 4|Adverse Event|0|||
124700368|NCT02097225|448525002|FG003|Dose Level 4|Adverse Event|0|||
124700369|NCT02097225|448525003|FG004|Dose Level 4|Adverse Event|1|||
124546391|NCT00978120|447955890|FG002|Overall Study|Moved out of state|0|||
124700370|NCT01027351|448525005|FG000|Overall Study|Withdrawal by Subject|1|||
124700371|NCT01027351|448525006|FG001|Overall Study|Withdrawal by Subject|0|||
124700372|NCT01027351|448525007|FG002|Overall Study|Withdrawal by Subject|1|||
124700373|NCT01027351|448525008|FG003|Overall Study|Withdrawal by Subject|0|||
124700374|NCT01027351|448525009|FG004|Overall Study|Withdrawal by Subject|3|||
124700375|NCT01027351|448525010|FG005|Overall Study|Withdrawal by Subject|5|||
124700376|NCT01027351|448525005|FG000|Overall Study|Lost to Follow-up|1|||
124700377|NCT01027351|448525006|FG001|Overall Study|Lost to Follow-up|1|||
124700378|NCT01027351|448525007|FG002|Overall Study|Lost to Follow-up|0|||
124700379|NCT01027351|448525008|FG003|Overall Study|Lost to Follow-up|1|||
124700380|NCT01027351|448525009|FG004|Overall Study|Lost to Follow-up|6|||
124700381|NCT01027351|448525010|FG005|Overall Study|Lost to Follow-up|0|||
124700382|NCT01027351|448525005|FG000|Overall Study|Inappropriate enrollment|0|||
124700383|NCT01027351|448525006|FG001|Overall Study|Inappropriate enrollment|0|||
124700384|NCT01027351|448525007|FG002|Overall Study|Inappropriate enrollment|0|||
124700385|NCT01027351|448525008|FG003|Overall Study|Inappropriate enrollment|0|||
124700386|NCT01027351|448525009|FG004|Overall Study|Inappropriate enrollment|1|||
124700387|NCT01027351|448525010|FG005|Overall Study|Inappropriate enrollment|0|||
124700388|NCT01027351|448525005|FG000|Overall Study|Protocol Violation|1|||
124700389|NCT01027351|448525006|FG001|Overall Study|Protocol Violation|0|||
124700390|NCT01027351|448525007|FG002|Overall Study|Protocol Violation|0|||
124700391|NCT01027351|448525008|FG003|Overall Study|Protocol Violation|1|||
124700392|NCT01027351|448525009|FG004|Overall Study|Protocol Violation|1|||
124700393|NCT01027351|448525010|FG005|Overall Study|Protocol Violation|0|||
124700394|NCT02971137|448525011|FG000|Overall Study|Lost to Follow-up|44|||
124546392|NCT00978120|447955891|FG003|Overall Study|Moved out of state|1|||
124763500|NCT02647281|448759746|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
124763501|NCT02647281|448759747|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
124763502|NCT02647281|448759748|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
124763503|NCT05801991|448759749|FG000|Overall Study|Lost to Follow-up|1|||
124763504|NCT05801991|448759750|FG001|Overall Study|Lost to Follow-up|0|||
124763505|NCT01451723|448759752|FG000|Overall Study|study halted|6|||
124763506|NCT01451723|448759753|FG001|Overall Study|study halted|5|||
124763507|NCT01631435|448759754|FG000|Overall Study|Adverse Event|2|||
124763508|NCT01631435|448759754|FG000|Overall Study|Withdrawal by Subject|2|||
124763509|NCT01631435|448759754|FG000|Overall Study|incomplete study procedure|5|||
124763510|NCT01005251|448759763|FG000|Overall Study|Withdrawal by Subject|2|||
124763511|NCT01005251|448759764|FG001|Overall Study|Withdrawal by Subject|5|||
124763512|NCT01005251|448759765|FG002|Overall Study|Withdrawal by Subject|3|||
124763513|NCT01005251|448759766|FG003|Overall Study|Withdrawal by Subject|4|||
124763514|NCT01005251|448759767|FG004|Overall Study|Withdrawal by Subject|9|||
124763515|NCT01005251|448759763|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
124763516|NCT01005251|448759764|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124763517|NCT01005251|448759765|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
124763518|NCT01005251|448759766|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
124763519|NCT01005251|448759767|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
124763520|NCT01005251|448759763|FG000|Overall Study|Adverse Event|2|||
124763521|NCT01005251|448759764|FG001|Overall Study|Adverse Event|6|||
124763522|NCT01005251|448759765|FG002|Overall Study|Adverse Event|8|||
124763523|NCT01005251|448759766|FG003|Overall Study|Adverse Event|5|||
124763524|NCT01005251|448759767|FG004|Overall Study|Adverse Event|4|||
124763525|NCT01005251|448759763|FG000|Overall Study|Protocol Violation|1|||
124763526|NCT01005251|448759764|FG001|Overall Study|Protocol Violation|0|||
124763527|NCT01005251|448759765|FG002|Overall Study|Protocol Violation|0|||
124763528|NCT01005251|448759766|FG003|Overall Study|Protocol Violation|0|||
124763529|NCT01005251|448759767|FG004|Overall Study|Protocol Violation|2|||
124763530|NCT01005251|448759763|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
124763531|NCT01005251|448759764|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
124763532|NCT01005251|448759765|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
124763533|NCT01005251|448759766|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
124763534|NCT01005251|448759767|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
124763535|NCT01005251|448759763|FG000|Overall Study|Lost to Follow-up|1|||
124763536|NCT01005251|448759764|FG001|Overall Study|Lost to Follow-up|4|||
124763537|NCT01005251|448759765|FG002|Overall Study|Lost to Follow-up|2|||
124763538|NCT01005251|448759766|FG003|Overall Study|Lost to Follow-up|0|||
124763539|NCT01005251|448759767|FG004|Overall Study|Lost to Follow-up|0|||
124763540|NCT01005251|448759763|FG000|Overall Study|Physician Decision|0|||
124763541|NCT01005251|448759764|FG001|Overall Study|Physician Decision|0|||
124763542|NCT01005251|448759765|FG002|Overall Study|Physician Decision|0|||
124763543|NCT01005251|448759766|FG003|Overall Study|Physician Decision|0|||
124763544|NCT01005251|448759767|FG004|Overall Study|Physician Decision|2|||
124763545|NCT01005251|448759763|FG000|Overall Study|Patient moved|1|||
124763546|NCT01005251|448759764|FG001|Overall Study|Patient moved|0|||
124763547|NCT01005251|448759765|FG002|Overall Study|Patient moved|0|||
124763548|NCT01005251|448759766|FG003|Overall Study|Patient moved|0|||
124763549|NCT01005251|448759767|FG004|Overall Study|Patient moved|0|||
124763550|NCT01005251|448759763|FG000|Overall Study|Wrong drug dispensed|0|||
124763551|NCT01005251|448759764|FG001|Overall Study|Wrong drug dispensed|1|||
124763552|NCT01005251|448759765|FG002|Overall Study|Wrong drug dispensed|0|||
124763553|NCT01005251|448759766|FG003|Overall Study|Wrong drug dispensed|0|||
124763554|NCT01005251|448759767|FG004|Overall Study|Wrong drug dispensed|0|||
124929314|NCT04295512|449373249|FG002|Overall Study|Lack of family response to schedule assessment|0|||
124929315|NCT04295512|449373250|FG003|Overall Study|Lack of family response to schedule assessment|2|||
124929316|NCT04295512|449373247|FG000|Overall Study|Therapist did not refer eligible family|7|||
124929317|NCT04295512|449373248|FG001|Overall Study|Therapist did not refer eligible family|7|||
124929318|NCT04295512|449373249|FG002|Overall Study|Therapist did not refer eligible family|0|||
124929319|NCT04295512|449373250|FG003|Overall Study|Therapist did not refer eligible family|0|||
124763555|NCT01005251|448759763|FG000|Overall Study|Randomized in error|0|||
124763556|NCT01005251|448759764|FG001|Overall Study|Randomized in error|0|||
124763557|NCT01005251|448759765|FG002|Overall Study|Randomized in error|1|||
124929320|NCT05623228|449373257|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
124929321|NCT05623228|449373258|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
124763558|NCT01005251|448759766|FG003|Overall Study|Randomized in error|1|||
124763559|NCT01005251|448759767|FG004|Overall Study|Randomized in error|0|||
124763560|NCT01005251|448759763|FG000|Overall Study|Lack of Efficacy|0|||
124763561|NCT01005251|448759764|FG001|Overall Study|Lack of Efficacy|0|||
124763562|NCT01005251|448759765|FG002|Overall Study|Lack of Efficacy|1|||
124763563|NCT01005251|448759766|FG003|Overall Study|Lack of Efficacy|1|||
124763564|NCT01005251|448759767|FG004|Overall Study|Lack of Efficacy|0|||
124763565|NCT00443040|448759770|FG000|Overall Study|Withdrawal by Subject|1|||
124763566|NCT00443040|448759771|FG001|Overall Study|Withdrawal by Subject|0|||
124763567|NCT00443040|448759772|FG002|Overall Study|Withdrawal by Subject|0|||
124763568|NCT00443040|448759770|FG000|Overall Study|Converted to an open laparotomy|3|||
124763569|NCT00443040|448759771|FG001|Overall Study|Converted to an open laparotomy|0|||
124763570|NCT00443040|448759772|FG002|Overall Study|Converted to an open laparotomy|1|||
124763571|NCT00435409|448759773|FG000|Overall Study|Protocol Violation|1|||
124763572|NCT00435409|448759774|FG001|Overall Study|Protocol Violation|2|||
124763573|NCT00435409|448759775|FG002|Overall Study|Protocol Violation|0|||
124763574|NCT00435409|448759773|FG000|Overall Study|Lost to Follow-up|1|||
124763575|NCT00435409|448759774|FG001|Overall Study|Lost to Follow-up|2|||
124763576|NCT00435409|448759775|FG002|Overall Study|Lost to Follow-up|0|||
124763577|NCT00435409|448759773|FG000|Overall Study|Death|8|||
124763578|NCT00435409|448759774|FG001|Overall Study|Death|6|||
124763579|NCT00435409|448759775|FG002|Overall Study|Death|6|||
124763580|NCT00435409|448759773|FG000|Overall Study|Objective progression or relapse|158|||
124763581|NCT00435409|448759774|FG001|Overall Study|Objective progression or relapse|93|||
124763582|NCT00435409|448759775|FG002|Overall Study|Objective progression or relapse|58|||
124763583|NCT00435409|448759773|FG000|Overall Study|Global deterioration of health status|0|||
124763584|NCT00435409|448759774|FG001|Overall Study|Global deterioration of health status|0|||
124763585|NCT00435409|448759775|FG002|Overall Study|Global deterioration of health status|4|||
124763586|NCT00435409|448759773|FG000|Overall Study|Withdrawal by Subject|8|||
124763587|NCT00435409|448759774|FG001|Overall Study|Withdrawal by Subject|7|||
124763588|NCT00435409|448759775|FG002|Overall Study|Withdrawal by Subject|1|||
124763589|NCT00435409|448759773|FG000|Overall Study|Other|45|||
124763590|NCT00435409|448759774|FG001|Overall Study|Other|30|||
124763591|NCT00435409|448759775|FG002|Overall Study|Other|1|||
124763592|NCT00435409|448759773|FG000|Overall Study|Adverse Event|0|||
124763593|NCT00435409|448759774|FG001|Overall Study|Adverse Event|0|||
124763594|NCT00435409|448759775|FG002|Overall Study|Adverse Event|8|||
124763595|NCT00435409|448759773|FG000|Overall Study|Sponsor decision|0|||
124763596|NCT00435409|448759774|FG001|Overall Study|Sponsor decision|3|||
124763597|NCT00435409|448759775|FG002|Overall Study|Sponsor decision|0|||
124763598|NCT03661723|448759778|FG000|Overall Study|Disease Progression|4|||
124763599|NCT03661723|448759779|FG001|Overall Study|Disease Progression|24|||
124763600|NCT03661723|448759780|FG002|Overall Study|Disease Progression|4|||
124763601|NCT03661723|448759781|FG003|Overall Study|Disease Progression|19|||
124763602|NCT03661723|448759778|FG000|Overall Study|Withdrawal by Subject|1|||
124763603|NCT03661723|448759779|FG001|Overall Study|Withdrawal by Subject|0|||
124763604|NCT03661723|448759780|FG002|Overall Study|Withdrawal by Subject|2|||
124763605|NCT03661723|448759781|FG003|Overall Study|Withdrawal by Subject|4|||
124763606|NCT03661723|448759778|FG000|Overall Study|Physician Decision|1|||
124763607|NCT03661723|448759779|FG001|Overall Study|Physician Decision|0|||
124763608|NCT03661723|448759780|FG002|Overall Study|Physician Decision|0|||
124763609|NCT03661723|448759781|FG003|Overall Study|Physician Decision|0|||
124763610|NCT03661723|448759778|FG000|Overall Study|Clinical Deterioration|0|||
124763611|NCT03661723|448759779|FG001|Overall Study|Clinical Deterioration|0|||
124763612|NCT03661723|448759780|FG002|Overall Study|Clinical Deterioration|0|||
124763613|NCT03661723|448759781|FG003|Overall Study|Clinical Deterioration|1|||
124763614|NCT00883779|448759782|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
124763615|NCT00883779|448759783|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
124763616|NCT00883779|448759782|FG000|Primary Study Treatment Phase|Disease progression|75|||
124763617|NCT00883779|448759783|FG001|Primary Study Treatment Phase|Disease progression|59|||
124763618|NCT00883779|448759782|FG000|Primary Study Treatment Phase|Adverse Event|16|||
124763619|NCT00883779|448759783|FG001|Primary Study Treatment Phase|Adverse Event|16|||
124763620|NCT00883779|448759782|FG000|Primary Study Treatment Phase|Death|2|||
124763621|NCT00883779|448759783|FG001|Primary Study Treatment Phase|Death|3|||
124763622|NCT00883779|448759782|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
124763623|NCT00883779|448759783|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
124763624|NCT00883779|448759782|FG000|Primary Study Treatment Phase|Other|3|||
124763625|NCT00883779|448759783|FG001|Primary Study Treatment Phase|Other|0|||
124763626|NCT00883779|448759782|FG000|Post-Study Treatment Phase|Adverse Event|2|||
124763627|NCT00883779|448759783|FG001|Post-Study Treatment Phase|Adverse Event|3|||
124763628|NCT00883779|448759782|FG000|Post-Study Treatment Phase|Death|1|||
124763629|NCT00883779|448759783|FG001|Post-Study Treatment Phase|Death|3|||
124763630|NCT00883779|448759782|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
124763631|NCT00883779|448759783|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
124763632|NCT00883779|448759782|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
124763633|NCT00883779|448759783|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
124546393|NCT01068418|447955900|FG000|Overall Study|Physician Decision|12|||
124763634|NCT00883779|448759782|FG000|Post-Study Treatment Phase|Disease progression|103|||
124763635|NCT00883779|448759783|FG001|Post-Study Treatment Phase|Disease progression|122|||
124763636|NCT00883779|448759782|FG000|Post-Study Treatment Phase|Other|3|||
124763637|NCT00883779|448759783|FG001|Post-Study Treatment Phase|Other|0|||
124763638|NCT00883779|448759782|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
124700395|NCT02971137|448525012|FG001|Overall Study|Lost to Follow-up|56|||
124700396|NCT02757963|448525013|FG000|Overall Study|Adverse Event|3|||
124700397|NCT02757963|448525013|FG000|Overall Study|Reached Stopping Criteria|1054|||
124700398|NCT02757963|448525013|FG000|Overall Study|Lost to Follow-up|5|||
124700399|NCT02757963|448525013|FG000|Overall Study|Physician Decision|1|||
124700400|NCT02757963|448525013|FG000|Overall Study|Withdrawal by Subject|34|||
124700401|NCT00911157|448525014|FG000|Overall Study|Adverse Event|4|||
124700402|NCT00911157|448525015|FG001|Overall Study|Adverse Event|1|||
124700403|NCT00911157|448525014|FG000|Overall Study|Withdrawal by Subject|1|||
124700404|NCT00911157|448525015|FG001|Overall Study|Withdrawal by Subject|1|||
124700405|NCT00911157|448525014|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
124700406|NCT00911157|448525015|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
124700407|NCT00911157|448525014|FG000|Overall Study|Need to treat for lung cancer|1|||
124700408|NCT00911157|448525015|FG001|Overall Study|Need to treat for lung cancer|0|||
124763639|NCT00883779|448759783|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
124763640|NCT00883779|448759782|FG000|Off-study Phase|Death|185|||
124763641|NCT00883779|448759783|FG001|Off-study Phase|Death|174|||
124763642|NCT00883779|448759782|FG000|Off-study Phase|Refused treatment|1|||
124763643|NCT00883779|448759783|FG001|Off-study Phase|Refused treatment|1|||
124763644|NCT00883779|448759782|FG000|Off-study Phase|Failure to return|5|||
124763645|NCT00883779|448759783|FG001|Off-study Phase|Failure to return|6|||
124763646|NCT00883779|448759782|FG000|Off-study Phase|Other|18|||
124763647|NCT00883779|448759783|FG001|Off-study Phase|Other|21|||
124763648|NCT00499681|448759784|FG000|Overall Study|toxicity|0|||
124763649|NCT00499681|448759785|FG001|Overall Study|toxicity|1|||
124763650|NCT00499681|448759784|FG000|Overall Study|disease progression|0|||
124763651|NCT00499681|448759785|FG001|Overall Study|disease progression|1|||
124763652|NCT02174731|448759786|FG000|Overall Study|Participant decision|67|||
124763653|NCT02174731|448759787|FG001|Overall Study|Participant decision|64|||
124763654|NCT02174731|448759786|FG000|Overall Study|Incorrect enrolment before randomization|0|||
124763655|NCT02174731|448759787|FG001|Overall Study|Incorrect enrolment before randomization|1|||
124763656|NCT02174731|448759786|FG000|Overall Study|Missing|2|||
124763657|NCT02174731|448759787|FG001|Overall Study|Missing|0|||
124763658|NCT00079040|448759788|FG000|Overall Study|Withdrew before treatment|1|||
124763659|NCT00079040|448759788|FG000|Overall Study|Ineligible|1|||
124763660|NCT00739401|448759791|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
124763661|NCT00739401|448759791|FG000|Overall Study|Death|3|||
124763662|NCT00739401|448759791|FG000|Overall Study|Withdrawal by Subject|4|||
124763663|NCT04575155|448759792|FG000|2 Month|Withdrawal by Subject|1|||
124763664|NCT04575155|448759793|FG001|2 Month|Withdrawal by Subject|1|||
124763665|NCT04575155|448759792|FG000|2 Month|Lost to Follow-up|5|||
124763666|NCT04575155|448759793|FG001|2 Month|Lost to Follow-up|3|||
124763667|NCT04575155|448759792|FG000|2 Month|Ineligible|1|||
124763668|NCT04575155|448759793|FG001|2 Month|Ineligible|0|||
124763669|NCT00467740|448759796|FG000|Overall Study|Adverse Event|0|||
124763670|NCT00467740|448759797|FG001|Overall Study|Adverse Event|0|||
124763671|NCT00467740|448759798|FG002|Overall Study|Adverse Event|1|||
124763672|NCT00467740|448759799|FG003|Overall Study|Adverse Event|0|||
124763673|NCT00467740|448759800|FG004|Overall Study|Adverse Event|0|||
124763674|NCT00467740|448759796|FG000|Overall Study|Protocol Violation|0|||
124763675|NCT00467740|448759797|FG001|Overall Study|Protocol Violation|0|||
124763676|NCT00467740|448759798|FG002|Overall Study|Protocol Violation|1|||
124763677|NCT00467740|448759799|FG003|Overall Study|Protocol Violation|0|||
124763678|NCT00467740|448759800|FG004|Overall Study|Protocol Violation|0|||
124763679|NCT00467740|448759796|FG000|Overall Study|Lost to Follow-up|0|||
124763680|NCT00467740|448759797|FG001|Overall Study|Lost to Follow-up|1|||
124763681|NCT00467740|448759798|FG002|Overall Study|Lost to Follow-up|0|||
124763682|NCT00467740|448759799|FG003|Overall Study|Lost to Follow-up|0|||
124700409|NCT04755231|448525016|FG000|Overall Study|Lost to Follow-up|5|||
124700410|NCT04755231|448525016|FG000|Overall Study|Withdrawal by Subject|5|||
124763683|NCT00467740|448759800|FG004|Overall Study|Lost to Follow-up|0|||
124763684|NCT00467740|448759796|FG000|Overall Study|Withdrawal by Subject|1|||
124763685|NCT00467740|448759797|FG001|Overall Study|Withdrawal by Subject|1|||
124763686|NCT00467740|448759798|FG002|Overall Study|Withdrawal by Subject|0|||
124763687|NCT00467740|448759799|FG003|Overall Study|Withdrawal by Subject|1|||
124929322|NCT05623228|449373259|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
124700411|NCT04650893|448525017|FG000|Overall Study|Lost to Follow-up|11|||
124700412|NCT04650893|448525018|FG001|Overall Study|Lost to Follow-up|10|||
124700413|NCT04650893|448525019|FG002|Overall Study|Lost to Follow-up|11|||
124700414|NCT05346640|448525027|FG000|Overall Study|Lack of Efficacy|2|||
124700415|NCT05346640|448525027|FG000|Overall Study|Lost to Follow-up|14|||
124700416|NCT05346640|448525027|FG000|Overall Study|Protocol Violation|4|||
124700417|NCT05346640|448525027|FG000|Overall Study|Withdrawal by Subject|2|||
124929323|NCT05623228|449373260|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
124455276|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
124455277|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
124455278|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
124455279|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
124455280|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
124455281|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
124455282|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
124455283|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
124455284|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
124455285|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
124455286|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
124455287|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
124455288|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
124455289|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
124455290|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
124546394|NCT02181673|447955901|FG000|Up to Week 24|Adverse Event|2|||
124700418|NCT05346640|448525027|FG000|Overall Study|Physiological Complications|3|||
124700419|NCT05346640|448525027|FG000|Overall Study|Other Reason|3|||
124700420|NCT02613507|448525038|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
124700421|NCT02613507|448525039|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
124700422|NCT02613507|448525038|FG000|Pre-Treamtent|Participant withdrew consent|0|||
124700423|NCT02613507|448525039|FG001|Pre-Treamtent|Participant withdrew consent|4|||
124700424|NCT02613507|448525038|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
124700425|NCT02613507|448525039|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
124700426|NCT02613507|448525038|FG000|Treatment|Not reported|3|||
124700427|NCT02613507|448525039|FG001|Treatment|Not reported|0|||
124700428|NCT02613507|448525038|FG000|Treatment|Other reasons|8|||
124700429|NCT02613507|448525039|FG001|Treatment|Other reasons|0|||
124700430|NCT02613507|448525038|FG000|Treatment|Participant no longer meets criteria|3|||
124700431|NCT02613507|448525039|FG001|Treatment|Participant no longer meets criteria|0|||
124700432|NCT02613507|448525038|FG000|Treatment|Maximum clinical benefit|5|||
124700433|NCT02613507|448525039|FG001|Treatment|Maximum clinical benefit|10|||
124700434|NCT02613507|448525038|FG000|Treatment|Lost to Follow-up|1|||
124700435|NCT02613507|448525039|FG001|Treatment|Lost to Follow-up|0|||
124700436|NCT02613507|448525038|FG000|Treatment|Participant withdrew consent|0|||
124700437|NCT02613507|448525039|FG001|Treatment|Participant withdrew consent|2|||
124700438|NCT02613507|448525038|FG000|Treatment|Participant request to discontinue study treatment|13|||
124700439|NCT02613507|448525039|FG001|Treatment|Participant request to discontinue study treatment|17|||
124700440|NCT02613507|448525038|FG000|Treatment|Adverse event unrelated to study drug|20|||
124700441|NCT02613507|448525039|FG001|Treatment|Adverse event unrelated to study drug|3|||
124700442|NCT02613507|448525038|FG000|Treatment|Death|2|||
124700443|NCT02613507|448525039|FG001|Treatment|Death|0|||
124700444|NCT02613507|448525038|FG000|Treatment|Study drug toxicity|19|||
124700445|NCT02613507|448525039|FG001|Treatment|Study drug toxicity|14|||
124700446|NCT02613507|448525038|FG000|Treatment|Disease progression|263|||
124700447|NCT02613507|448525039|FG001|Treatment|Disease progression|110|||
124700448|NCT03941093|448525040|FG000|Overall Study|Protocol Violation|0|||
124700449|NCT03941093|448525041|FG001|Overall Study|Protocol Violation|1|||
124700450|NCT03941093|448525040|FG000|Overall Study|Withdrawal by Subject|9|||
124700451|NCT03941093|448525041|FG001|Overall Study|Withdrawal by Subject|6|||
124700452|NCT01197300|448526522|FG000|Overall Study|Lost to Follow-up|0|||
124700453|NCT01197300|448526523|FG001|Overall Study|Lost to Follow-up|1|||
124700454|NCT01197300|448526522|FG000|Overall Study|Protocol Violation|0|||
124700455|NCT01197300|448526523|FG001|Overall Study|Protocol Violation|1|||
124700456|NCT02113878|448526524|FG000|Overall Study|Adverse Event|1|||
124700457|NCT02113878|448526525|FG001|Overall Study|Adverse Event|0|||
124700458|NCT02113878|448526524|FG000|Overall Study|Withdrawal by Subject|1|||
124700459|NCT02113878|448526525|FG001|Overall Study|Withdrawal by Subject|0|||
124700460|NCT02113878|448526524|FG000|Overall Study|patient non-compliance|1|||
124700461|NCT02113878|448526525|FG001|Overall Study|patient non-compliance|0|||
124700462|NCT04129398|448526528|FG000|Overall Study|Physician Decision|2|||
124700463|NCT03058952|448526529|FG000|Overall Study|Adverse Event|1|||
124700464|NCT03058952|448526530|FG001|Overall Study|Adverse Event|0|||
124700465|NCT03058952|448526529|FG000|Overall Study|Lost to Follow-up|15|||
124763688|NCT00467740|448759800|FG004|Overall Study|Withdrawal by Subject|0|||
124763689|NCT00467740|448759796|FG000|Overall Study|Lack of Efficacy|0|||
124763690|NCT00467740|448759797|FG001|Overall Study|Lack of Efficacy|1|||
124763691|NCT00467740|448759798|FG002|Overall Study|Lack of Efficacy|0|||
124763692|NCT00467740|448759799|FG003|Overall Study|Lack of Efficacy|0|||
124763693|NCT00467740|448759800|FG004|Overall Study|Lack of Efficacy|0|||
124763694|NCT03535974|448759801|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
124763695|NCT03535974|448759802|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
124455291|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
124455292|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
124455293|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
124455294|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
124455295|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
124455296|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
124455297|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
124455298|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
124763696|NCT03535974|448759803|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
124455299|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
124455300|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
124455301|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
124455302|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
124763697|NCT03535974|448759801|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
124763698|NCT03535974|448759802|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
124763699|NCT03535974|448759803|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
124763700|NCT02678351|448759804|FG000|Overall Study|Withdrawal by Subject|1|||
124763701|NCT01919229|448759805|FG000|Overall Study|Subject/guardian decision|0|||
124455303|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
124455304|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
124455305|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
124455306|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
124455307|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
124455308|NCT00111800|447627137|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
124455309|NCT00111800|447627138|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
124455310|NCT00111800|447627139|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
124455311|NCT00111800|447627140|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
124455312|NCT00111800|447627141|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
124700466|NCT03058952|448526530|FG001|Overall Study|Lost to Follow-up|15|||
124700467|NCT03058952|448526529|FG000|Overall Study|Withdrawal by Subject|7|||
124700468|NCT03058952|448526530|FG001|Overall Study|Withdrawal by Subject|11|||
124700469|NCT03837509|448526533|FG000|Phase 1|Death|5|||
124700470|NCT03837509|448526534|FG001|Phase 1|Death|2|||
124700471|NCT03837509|448526535|FG002|Phase 1|Death|0|||
124700472|NCT03837509|448526536|FG003|Phase 1|Death|0|||
124700473|NCT03837509|448526537|FG004|Phase 1|Death|0|||
124700474|NCT03837509|448526533|FG000|Phase 2|Death|0|||
124700475|NCT03837509|448526534|FG001|Phase 2|Death|0|||
124700476|NCT03837509|448526535|FG002|Phase 2|Death|0|||
124700477|NCT03837509|448526536|FG003|Phase 2|Death|1|||
124700478|NCT03837509|448526537|FG004|Phase 2|Death|1|||
124700479|NCT01251965|448526538|FG000|Overall Study|Participant/physician decision|1|||
124700480|NCT01251965|448526539|FG001|Overall Study|Participant/physician decision|2|||
124700481|NCT01251965|448526540|FG002|Overall Study|Participant/physician decision|0|||
124700482|NCT01251965|448526538|FG000|Overall Study|Death|0|||
124700483|NCT01251965|448526539|FG001|Overall Study|Death|0|||
124700484|NCT01251965|448526540|FG002|Overall Study|Death|11|||
124700485|NCT02363283|448526541|FG000|Overall Study|Withdrawal by Subject|1|||
124700486|NCT02363283|448526541|FG000|Overall Study|Not eligible due to transaminitis|1|||
124700487|NCT00530257|448526547|FG000|Overall Study|Lost to Follow-up|1|||
124700488|NCT01897896|448526548|FG000|Overall Study|Death|1|||
124700489|NCT01897896|448526549|FG001|Overall Study|Death|0|||
124700490|NCT01897896|448526548|FG000|Overall Study|Adverse Event|11|||
124700491|NCT01897896|448526549|FG001|Overall Study|Adverse Event|1|||
124700492|NCT01897896|448526548|FG000|Overall Study|Lost to Follow-up|1|||
124700493|NCT01897896|448526549|FG001|Overall Study|Lost to Follow-up|0|||
124700494|NCT01897896|448526548|FG000|Overall Study|Non-compliance with study drug dosing|1|||
124700495|NCT01897896|448526549|FG001|Overall Study|Non-compliance with study drug dosing|1|||
124700496|NCT01897896|448526548|FG000|Overall Study|Withdrawal by Subject|7|||
124700497|NCT01897896|448526549|FG001|Overall Study|Withdrawal by Subject|1|||
124700498|NCT01897896|448526548|FG000|Overall Study|Require drug that interfere with study|1|||
124700499|NCT01897896|448526549|FG001|Overall Study|Require drug that interfere with study|4|||
124763702|NCT01919229|448759806|FG001|Overall Study|Subject/guardian decision|0|||
124700500|NCT01897896|448526548|FG000|Overall Study|Protocol Violation|1|||
124700501|NCT01897896|448526549|FG001|Overall Study|Protocol Violation|1|||
124700502|NCT01897896|448526548|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
124700503|NCT01897896|448526549|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
124700504|NCT01897896|448526548|FG000|Overall Study|Caregiver can no longer participate|0|||
124700505|NCT01897896|448526549|FG001|Overall Study|Caregiver can no longer participate|2|||
124700506|NCT01897896|448526548|FG000|Overall Study|Other than specified|2|||
124700507|NCT01897896|448526549|FG001|Overall Study|Other than specified|1|||
124700508|NCT00003907|448526556|FG000|Overall Study|Adverse Event|2|||
124700509|NCT00003907|448526557|FG001|Overall Study|Adverse Event|11|||
124700510|NCT00003907|448526556|FG000|Overall Study|Death|2|||
124700511|NCT00003907|448526557|FG001|Overall Study|Death|0|||
124700512|NCT00003907|448526556|FG000|Overall Study|Withdrawal by Subject|1|||
124700513|NCT00003907|448526557|FG001|Overall Study|Withdrawal by Subject|3|||
124700514|NCT00003907|448526556|FG000|Overall Study|Progressive disease|4|||
124700515|NCT00003907|448526557|FG001|Overall Study|Progressive disease|4|||
124700516|NCT00003907|448526556|FG000|Overall Study|Complicating disease|1|||
124700517|NCT00003907|448526557|FG001|Overall Study|Complicating disease|0|||
124700518|NCT00003907|448526556|FG000|Overall Study|Other|1|||
124700519|NCT00003907|448526557|FG001|Overall Study|Other|3|||
124700520|NCT00003907|448526556|FG000|Overall Study|ineligible or not treated|2|||
124700521|NCT00003907|448526557|FG001|Overall Study|ineligible or not treated|2|||
124700522|NCT01517178|448526558|FG000|Period 1|Adverse Event|1|||
124700523|NCT01517178|448526559|FG001|Period 1|Adverse Event|2|||
124700524|NCT01517178|448526558|FG000|Period 1|Lack of Efficacy|0|||
124700525|NCT01517178|448526559|FG001|Period 1|Lack of Efficacy|1|||
124700526|NCT01517178|448526558|FG000|Period 1|E.g. study termination|3|||
124700527|NCT01517178|448526559|FG001|Period 1|E.g. study termination|1|||
124700528|NCT01517178|448526558|FG000|Period 1|Withdrawal by Subject|0|||
124700529|NCT01517178|448526559|FG001|Period 1|Withdrawal by Subject|1|||
124700530|NCT01517178|448526558|FG000|Period 2|Adverse Event|1|||
124700531|NCT01517178|448526559|FG001|Period 2|Adverse Event|0|||
124700532|NCT01517178|448526558|FG000|Period 2|Withdrawal by Subject|3|||
124700533|NCT01517178|448526559|FG001|Period 2|Withdrawal by Subject|0|||
124700534|NCT01517178|448526558|FG000|Period 2|E.g. study termination|2|||
124700535|NCT01517178|448526559|FG001|Period 2|E.g. study termination|2|||
124700536|NCT01050218|448526566|FG000|Overall Study|Adverse Event|37|||
124700537|NCT01050218|448526566|FG000|Overall Study|Lack of Efficacy|8|||
124700538|NCT01050218|448526566|FG000|Overall Study|Protocol Violation|3|||
124700539|NCT01050218|448526566|FG000|Overall Study|Withdrawal by Subject|18|||
124700540|NCT01050218|448526566|FG000|Overall Study|Discontinued by sponsor|18|||
124700541|NCT01050218|448526566|FG000|Overall Study|Compliance|2|||
124700542|NCT01050218|448526566|FG000|Overall Study|Failed to return|7|||
124700543|NCT01050218|448526566|FG000|Overall Study|Serious Adverse Event|1|||
124700544|NCT01050218|448526566|FG000|Overall Study|Family emergency|1|||
124700545|NCT01149460|448526567|FG000|Overall Study|Withdrawal by Subject|0|||
124700546|NCT01149460|448526568|FG001|Overall Study|Withdrawal by Subject|2|||
124700547|NCT03682367|448526589|FG000|Overall Study|Protocol Violation|2|||
124700548|NCT03682367|448526590|FG001|Overall Study|Protocol Violation|1|||
124700549|NCT03682367|448526589|FG000|Overall Study|Closed Study Early|0|||
124700550|NCT03682367|448526590|FG001|Overall Study|Closed Study Early|3|||
124700551|NCT00129974|448526591|FG000|Overall Study|Other|1|||
124546395|NCT02181673|447955902|FG001|Up to Week 24|Adverse Event|0|||
124763703|NCT01919229|448759807|FG002|Overall Study|Subject/guardian decision|1|||
124763704|NCT04999839|448759816|FG000|Overall Study|Adverse Event|1|||
124763705|NCT04999839|448759817|FG001|Overall Study|Adverse Event|1|||
124763706|NCT04999839|448759818|FG002|Overall Study|Adverse Event|1|||
124763707|NCT04999839|448759819|FG003|Overall Study|Adverse Event|1|||
124763708|NCT04999839|448759820|FG004|Overall Study|Adverse Event|1|||
124763709|NCT04999839|448759816|FG000|Overall Study|Lost to Follow-up|2|||
124763710|NCT04999839|448759817|FG001|Overall Study|Lost to Follow-up|0|||
124763711|NCT04999839|448759818|FG002|Overall Study|Lost to Follow-up|2|||
124763712|NCT04999839|448759819|FG003|Overall Study|Lost to Follow-up|4|||
124763713|NCT04999839|448759820|FG004|Overall Study|Lost to Follow-up|1|||
124763714|NCT04999839|448759816|FG000|Overall Study|Withdrawal by Subject|6|||
124763715|NCT04999839|448759817|FG001|Overall Study|Withdrawal by Subject|5|||
124763716|NCT04999839|448759818|FG002|Overall Study|Withdrawal by Subject|3|||
124763717|NCT04999839|448759819|FG003|Overall Study|Withdrawal by Subject|2|||
124763718|NCT04999839|448759820|FG004|Overall Study|Withdrawal by Subject|2|||
124763719|NCT04999839|448759816|FG000|Overall Study|Lack of Efficacy|0|||
124763720|NCT04999839|448759817|FG001|Overall Study|Lack of Efficacy|1|||
124763721|NCT04999839|448759818|FG002|Overall Study|Lack of Efficacy|0|||
124763722|NCT04999839|448759819|FG003|Overall Study|Lack of Efficacy|0|||
124763723|NCT04999839|448759820|FG004|Overall Study|Lack of Efficacy|0|||
124763724|NCT04999839|448759816|FG000|Overall Study|Physician Decision|0|||
124763725|NCT04999839|448759817|FG001|Overall Study|Physician Decision|0|||
124763726|NCT04999839|448759818|FG002|Overall Study|Physician Decision|0|||
124763727|NCT04999839|448759819|FG003|Overall Study|Physician Decision|0|||
124763728|NCT04999839|448759820|FG004|Overall Study|Physician Decision|1|||
124763729|NCT04999839|448759816|FG000|Overall Study|Sponsor request|0|||
124763730|NCT04999839|448759817|FG001|Overall Study|Sponsor request|1|||
124763731|NCT04999839|448759818|FG002|Overall Study|Sponsor request|0|||
124763732|NCT04999839|448759819|FG003|Overall Study|Sponsor request|0|||
124763733|NCT04999839|448759820|FG004|Overall Study|Sponsor request|0|||
124763734|NCT04999839|448759816|FG000|Overall Study|Other|0|||
124763735|NCT04999839|448759817|FG001|Overall Study|Other|0|||
124763736|NCT04999839|448759818|FG002|Overall Study|Other|1|||
124763737|NCT04999839|448759819|FG003|Overall Study|Other|0|||
124763738|NCT04999839|448759820|FG004|Overall Study|Other|0|||
124763739|NCT00399516|448759821|FG000|Overall Study|Lost to Follow-up|2|||
124763740|NCT00982735|448759822|FG000|Overall Study|Lost to Follow-up|6|||
124763741|NCT00982735|448759822|FG000|Overall Study|Patient ineligible for trial|224|||
124763742|NCT02675907|448759832|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
124763743|NCT02675907|448759833|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
124763744|NCT02675907|448759832|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
124763745|NCT02675907|448759833|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
124763746|NCT02675907|448759832|FG000|Study Overall|Lack of Efficacy|1|||
124763747|NCT02675907|448759833|FG001|Study Overall|Lack of Efficacy|0|||
124763748|NCT02675907|448759832|FG000|Study Overall|Withdrawal by Subject|2|||
124763749|NCT02675907|448759833|FG001|Study Overall|Withdrawal by Subject|2|||
124763750|NCT02675907|448759832|FG000|Study Overall|Lost to Follow-up|0|||
124763751|NCT02675907|448759833|FG001|Study Overall|Lost to Follow-up|2|||
124763752|NCT00539981|448759834|FG000|Overall Study|Adverse events (AE)|3|||
124546396|NCT02181673|447955903|FG002|Up to Week 24|Adverse Event|3|||
124763753|NCT00539981|448759835|FG001|Overall Study|Adverse events (AE)|3|||
124763754|NCT00539981|448759834|FG000|Overall Study|Lost to Follow-up|260|||
124763755|NCT00539981|448759835|FG001|Overall Study|Lost to Follow-up|251|||
124763756|NCT00539981|448759834|FG000|Overall Study|Withdrew consent|22|||
124763757|NCT00539981|448759835|FG001|Overall Study|Withdrew consent|14|||
124763758|NCT00539981|448759834|FG000|Overall Study|Death|1|||
124763759|NCT00539981|448759835|FG001|Overall Study|Death|1|||
124763760|NCT00539981|448759834|FG000|Overall Study|Other reason-unspecified|9|||
124763761|NCT00539981|448759835|FG001|Overall Study|Other reason-unspecified|13|||
124763762|NCT01611792|448759836|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
124546397|NCT02181673|447955901|FG000|Up to Week 24|Death|1|||
124700552|NCT00414609|448526592|FG000|Core Study|Adverse Event|9|||
124700553|NCT00414609|448526593|FG001|Core Study|Adverse Event|11|||
124700554|NCT00414609|448526594|FG002|Core Study|Adverse Event|0|||
124700555|NCT00414609|448526592|FG000|Core Study|Abnormal laboratory values|0|||
124700556|NCT00414609|448526593|FG001|Core Study|Abnormal laboratory values|1|||
124700557|NCT00414609|448526594|FG002|Core Study|Abnormal laboratory values|0|||
124700558|NCT00414609|448526592|FG000|Core Study|Abnormal test procedure results|1|||
124700559|NCT00414609|448526593|FG001|Core Study|Abnormal test procedure results|1|||
124700560|NCT00414609|448526594|FG002|Core Study|Abnormal test procedure results|0|||
124700561|NCT00414609|448526592|FG000|Core Study|Protocol deviation|0|||
124700562|NCT00414609|448526593|FG001|Core Study|Protocol deviation|1|||
124700563|NCT00414609|448526594|FG002|Core Study|Protocol deviation|0|||
124700564|NCT00414609|448526592|FG000|Core Study|Patient withdrew consent|10|||
124700565|NCT00414609|448526593|FG001|Core Study|Patient withdrew consent|11|||
124700566|NCT00414609|448526594|FG002|Core Study|Patient withdrew consent|0|||
124700567|NCT00414609|448526592|FG000|Core Study|Lost to Follow-up|7|||
124700568|NCT00414609|448526593|FG001|Core Study|Lost to Follow-up|4|||
124700569|NCT00414609|448526594|FG002|Core Study|Lost to Follow-up|0|||
124700570|NCT00414609|448526592|FG000|Core Study|Administrative problems|0|||
124700571|NCT00414609|448526593|FG001|Core Study|Administrative problems|2|||
124700572|NCT00414609|448526594|FG002|Core Study|Administrative problems|0|||
124700573|NCT00414609|448526592|FG000|Core Study|Death|7|||
124700574|NCT00414609|448526593|FG001|Core Study|Death|14|||
124929324|NCT05623228|449373261|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
124929325|NCT05623228|449373262|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
124700575|NCT00414609|448526594|FG002|Core Study|Death|0|||
124700576|NCT00414609|448526592|FG000|Extension Study|Adverse Event|0|||
124700577|NCT00414609|448526593|FG001|Extension Study|Adverse Event|0|||
124700578|NCT00414609|448526594|FG002|Extension Study|Adverse Event|14|||
124700579|NCT00414609|448526592|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
124700580|NCT00414609|448526593|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
124700581|NCT00414609|448526594|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
124700582|NCT00414609|448526592|FG000|Extension Study|Withdrawal by Subject|0|||
124700583|NCT00414609|448526593|FG001|Extension Study|Withdrawal by Subject|0|||
124700584|NCT00414609|448526594|FG002|Extension Study|Withdrawal by Subject|13|||
124700585|NCT00414609|448526592|FG000|Extension Study|Lost to Follow-up|0|||
124700586|NCT00414609|448526593|FG001|Extension Study|Lost to Follow-up|0|||
124700587|NCT00414609|448526594|FG002|Extension Study|Lost to Follow-up|10|||
124700588|NCT00414609|448526592|FG000|Extension Study|Administrative problems|0|||
124700589|NCT00414609|448526593|FG001|Extension Study|Administrative problems|0|||
124700590|NCT00414609|448526594|FG002|Extension Study|Administrative problems|1|||
124700591|NCT00414609|448526592|FG000|Extension Study|Death|0|||
124700592|NCT00414609|448526593|FG001|Extension Study|Death|0|||
124700593|NCT00414609|448526594|FG002|Extension Study|Death|17|||
124700594|NCT01047540|448526599|FG000|Overall Study|Protocol Violation|1|||
124700595|NCT01047540|448526600|FG001|Overall Study|Protocol Violation|0|||
124700596|NCT01047540|448526601|FG002|Overall Study|Protocol Violation|0|||
124700597|NCT01047540|448526602|FG003|Overall Study|Protocol Violation|0|||
124700598|NCT01047540|448526603|FG004|Overall Study|Protocol Violation|0|||
124700599|NCT01047540|448526599|FG000|Overall Study|Lost to Follow-up|1|||
124700600|NCT01047540|448526600|FG001|Overall Study|Lost to Follow-up|0|||
124700601|NCT01047540|448526601|FG002|Overall Study|Lost to Follow-up|0|||
124700602|NCT01047540|448526602|FG003|Overall Study|Lost to Follow-up|0|||
124700603|NCT01047540|448526603|FG004|Overall Study|Lost to Follow-up|0|||
124700604|NCT01047540|448526599|FG000|Overall Study|Withdrawal by Subject|1|||
124700605|NCT01047540|448526600|FG001|Overall Study|Withdrawal by Subject|0|||
124700606|NCT01047540|448526601|FG002|Overall Study|Withdrawal by Subject|3|||
124700607|NCT01047540|448526602|FG003|Overall Study|Withdrawal by Subject|0|||
124700608|NCT01047540|448526603|FG004|Overall Study|Withdrawal by Subject|1|||
124700609|NCT01047540|448526599|FG000|Overall Study|Pregnancy|1|||
124700610|NCT01047540|448526600|FG001|Overall Study|Pregnancy|0|||
124700611|NCT01047540|448526601|FG002|Overall Study|Pregnancy|0|||
124929326|NCT05623228|449373263|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
124929327|NCT05623228|449373264|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
124700612|NCT01047540|448526602|FG003|Overall Study|Pregnancy|0|||
124700613|NCT01047540|448526603|FG004|Overall Study|Pregnancy|0|||
124700614|NCT01047540|448526599|FG000|Overall Study|Adverse Event|1|||
124700615|NCT01047540|448526600|FG001|Overall Study|Adverse Event|0|||
124700616|NCT01047540|448526601|FG002|Overall Study|Adverse Event|0|||
124700617|NCT01047540|448526602|FG003|Overall Study|Adverse Event|0|||
124700618|NCT01047540|448526603|FG004|Overall Study|Adverse Event|0|||
124700619|NCT01437189|448526607|FG000|Overall Study|Adverse Event|3|||
124700620|NCT01437189|448526607|FG000|Overall Study|Lack of Efficacy|4|||
124929328|NCT05623228|449373257|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
124700621|NCT01437189|448526607|FG000|Overall Study|Withdrawal by Subject|8|||
124929329|NCT05623228|449373258|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
124929330|NCT05623228|449373259|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
124929331|NCT05623228|449373260|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
124455313|NCT00111800|447627142|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
124455314|NCT00111800|447627137|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
124455315|NCT00111800|447627138|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
124455316|NCT00111800|447627139|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
124455317|NCT00111800|447627140|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
124455318|NCT00111800|447627141|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
124455319|NCT00111800|447627142|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
124455320|NCT00111800|447627137|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
124455321|NCT00111800|447627138|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
124455322|NCT00111800|447627139|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
124455323|NCT00111800|447627140|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
124455324|NCT00111800|447627141|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
124455325|NCT00111800|447627142|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
124700622|NCT03654326|448526608|FG000|Overall Study|Withdrawal by Subject|5|||
124700623|NCT03654326|448526609|FG001|Overall Study|Withdrawal by Subject|3|||
124700624|NCT03654326|448526608|FG000|Overall Study|Physician Decision|0|||
124700625|NCT03654326|448526609|FG001|Overall Study|Physician Decision|1|||
124700626|NCT03654326|448526608|FG000|Overall Study|Unable to adhere to study schedule|0|||
124700627|NCT03654326|448526609|FG001|Overall Study|Unable to adhere to study schedule|1|||
124700628|NCT03654326|448526608|FG000|Overall Study|Lost to Follow-up|1|||
124700629|NCT03654326|448526609|FG001|Overall Study|Lost to Follow-up|1|||
124700630|NCT04102514|448526610|FG000|Overall Study|Death|3|||
124700631|NCT04102514|448526611|FG001|Overall Study|Death|0|||
124700632|NCT04102514|448526612|FG002|Overall Study|Death|0|||
124700633|NCT04102514|448526613|FG003|Overall Study|Death|0|||
124700634|NCT04102514|448526610|FG000|Overall Study|Lost to Follow-up|0|||
124700635|NCT04102514|448526611|FG001|Overall Study|Lost to Follow-up|0|||
124700636|NCT04102514|448526612|FG002|Overall Study|Lost to Follow-up|3|||
124700637|NCT04102514|448526613|FG003|Overall Study|Lost to Follow-up|0|||
124700638|NCT04102514|448526610|FG000|Overall Study|Physician Decision|0|||
124700639|NCT04102514|448526611|FG001|Overall Study|Physician Decision|0|||
124700640|NCT04102514|448526612|FG002|Overall Study|Physician Decision|1|||
124700641|NCT04102514|448526613|FG003|Overall Study|Physician Decision|0|||
124700642|NCT04102514|448526610|FG000|Overall Study|Withdrawal by Subject|7|||
124700643|NCT04102514|448526611|FG001|Overall Study|Withdrawal by Subject|13|||
124700644|NCT04102514|448526612|FG002|Overall Study|Withdrawal by Subject|7|||
124700645|NCT04102514|448526613|FG003|Overall Study|Withdrawal by Subject|14|||
124700646|NCT04102514|448526610|FG000|Overall Study|Moved to longterm care facility|6|||
124700647|NCT04102514|448526611|FG001|Overall Study|Moved to longterm care facility|0|||
124700648|NCT04102514|448526612|FG002|Overall Study|Moved to longterm care facility|4|||
124700649|NCT04102514|448526613|FG003|Overall Study|Moved to longterm care facility|0|||
124700650|NCT00835549|448526614|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
124700651|NCT00835549|448526615|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
124700652|NCT00835042|448526616|FG000|First Intervention|Withdrawal by Subject|3|||
124700653|NCT00835042|448526617|FG001|First Intervention|Withdrawal by Subject|0|||
124700654|NCT00835042|448526616|FG000|First Intervention|Adverse Event|1|||
124700655|NCT00835042|448526617|FG001|First Intervention|Adverse Event|2|||
124700656|NCT00835042|448526616|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
124700657|NCT00835042|448526617|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
124700658|NCT00619918|448526618|FG000|Overall Study|Withdrawal by Subject|4|||
124700659|NCT00619918|448526619|FG001|Overall Study|Withdrawal by Subject|3|||
124700660|NCT00619918|448526618|FG000|Overall Study|Physician Decision|2|||
124700661|NCT00619918|448526619|FG001|Overall Study|Physician Decision|4|||
124700662|NCT00619918|448526618|FG000|Overall Study|Transfer to outside facility|3|||
124700663|NCT00619918|448526619|FG001|Overall Study|Transfer to outside facility|3|||
124700664|NCT00619918|448526618|FG000|Overall Study|Left before receiving first dose|7|||
124700665|NCT00619918|448526619|FG001|Overall Study|Left before receiving first dose|6|||
124700666|NCT00619918|448526618|FG000|Overall Study|ICU admission|4|||
124700667|NCT00619918|448526619|FG001|Overall Study|ICU admission|6|||
124700668|NCT05524948|448526639|FG000|Overall Study|Withdrawal by Subject|1|||
124700669|NCT05524948|448526640|FG001|Overall Study|Withdrawal by Subject|0|||
124700670|NCT05524948|448526639|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
124700671|NCT05524948|448526640|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
124700672|NCT04661839|448526645|FG000|Overall Study|Not Treated|0|||
124546398|NCT02181673|447955902|FG001|Up to Week 24|Death|0|||
124546399|NCT02181673|447955903|FG002|Up to Week 24|Death|0|||
124700673|NCT04661839|448526646|FG001|Overall Study|Not Treated|0|||
124700674|NCT04661839|448526647|FG002|Overall Study|Not Treated|1|||
124700675|NCT04661839|448526648|FG003|Overall Study|Not Treated|0|||
124700676|NCT04661839|448526645|FG000|Overall Study|Lost to Follow-up|1|||
124763763|NCT01611792|448759837|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
124700677|NCT04661839|448526646|FG001|Overall Study|Lost to Follow-up|0|||
124700678|NCT04661839|448526647|FG002|Overall Study|Lost to Follow-up|0|||
124700679|NCT04661839|448526648|FG003|Overall Study|Lost to Follow-up|1|||
124763764|NCT01611792|448759836|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
124700680|NCT02758626|448526650|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
124700681|NCT02758626|448526651|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
124700682|NCT02758626|448526650|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
124700683|NCT02758626|448526651|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
124700684|NCT02758626|448526650|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
124700685|NCT02758626|448526651|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
124700686|NCT02758626|448526650|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
124700687|NCT02758626|448526651|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
124700688|NCT04818229|448526652|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
124700689|NCT04818229|448526653|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
124700690|NCT04818229|448526654|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
124700691|NCT04818229|448526652|FG000|Overall Study|Adverse Event|3|||
124700692|NCT04818229|448526653|FG001|Overall Study|Adverse Event|1|||
124700693|NCT04818229|448526654|FG002|Overall Study|Adverse Event|1|||
124700694|NCT04818229|448526652|FG000|Overall Study|Withdrawal by Subject|0|||
124700695|NCT04818229|448526653|FG001|Overall Study|Withdrawal by Subject|0|||
124763765|NCT01611792|448759837|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
124763766|NCT02898454|448759840|FG000|Overall Study|Adverse Event|4|||
124763767|NCT02898454|448759841|FG001|Overall Study|Adverse Event|1|||
124763768|NCT02898454|448759842|FG002|Overall Study|Adverse Event|2|||
124763769|NCT02898454|448759840|FG000|Overall Study|Protocol Violation|1|||
124763770|NCT02898454|448759841|FG001|Overall Study|Protocol Violation|0|||
124763771|NCT02898454|448759842|FG002|Overall Study|Protocol Violation|1|||
124763772|NCT02898454|448759840|FG000|Overall Study|Lack of Efficacy|4|||
124929332|NCT05623228|449373261|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
124929333|NCT05623228|449373262|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
124929334|NCT05623228|449373263|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
124929335|NCT05623228|449373264|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
124929336|NCT04737330|449373265|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
124929337|NCT04737330|449373266|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
124929338|NCT04737330|449373265|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
124929339|NCT04737330|449373266|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
124929340|NCT04737330|449373265|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
124929341|NCT04737330|449373266|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
124929342|NCT04737330|449373265|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
124929343|NCT04737330|449373266|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
124929344|NCT04737330|449373265|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
124929345|NCT04737330|449373266|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
124929346|NCT04737330|449373265|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
124929347|NCT04737330|449373266|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
124929348|NCT04625725|449373267|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
124929349|NCT04625725|449373268|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
124929350|NCT04625725|449373269|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
124929351|NCT04625725|449373270|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
124929352|NCT04625725|449373271|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
124929353|NCT04625725|449373272|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
124929354|NCT04625725|449373267|FG000|Provent Main Study|Withdrawal by Subject|242|||
124929355|NCT04625725|449373268|FG001|Provent Main Study|Withdrawal by Subject|144|||
124929356|NCT04625725|449373269|FG002|Provent Main Study|Withdrawal by Subject|0|||
124929357|NCT04625725|449373270|FG003|Provent Main Study|Withdrawal by Subject|0|||
124763773|NCT02898454|448759841|FG001|Overall Study|Lack of Efficacy|1|||
124763774|NCT02898454|448759842|FG002|Overall Study|Lack of Efficacy|0|||
124763775|NCT02898454|448759840|FG000|Overall Study|Withdrawal by Subject|6|||
124763776|NCT02898454|448759841|FG001|Overall Study|Withdrawal by Subject|3|||
124763777|NCT02898454|448759842|FG002|Overall Study|Withdrawal by Subject|3|||
124763778|NCT02898454|448759840|FG000|Overall Study|Lost to Follow-up|1|||
124763779|NCT02898454|448759841|FG001|Overall Study|Lost to Follow-up|0|||
124763780|NCT02898454|448759842|FG002|Overall Study|Lost to Follow-up|0|||
124763781|NCT02898454|448759840|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
124763782|NCT02898454|448759841|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
124763783|NCT02898454|448759842|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
124763784|NCT01601535|448759843|FG000|Phase 1|Adverse Event|1|||
124763785|NCT01601535|448759844|FG001|Phase 1|Adverse Event|0|||
124763786|NCT01601535|448759845|FG002|Phase 1|Adverse Event|2|||
124763787|NCT01601535|448759846|FG003|Phase 1|Adverse Event|1|||
124763788|NCT01601535|448759847|FG004|Phase 1|Adverse Event|0|||
124763789|NCT01601535|448759848|FG005|Phase 1|Adverse Event|0|||
124763790|NCT01601535|448759843|FG000|Phase 1|Withdrawal by Subject|2|||
124763791|NCT01601535|448759844|FG001|Phase 1|Withdrawal by Subject|1|||
124763792|NCT01601535|448759845|FG002|Phase 1|Withdrawal by Subject|1|||
124763793|NCT01601535|448759846|FG003|Phase 1|Withdrawal by Subject|2|||
124763794|NCT01601535|448759847|FG004|Phase 1|Withdrawal by Subject|0|||
124763795|NCT01601535|448759848|FG005|Phase 1|Withdrawal by Subject|0|||
124763796|NCT01601535|448759843|FG000|Phase 1|Progressive Disease|2|||
124763797|NCT01601535|448759844|FG001|Phase 1|Progressive Disease|3|||
124763798|NCT01601535|448759845|FG002|Phase 1|Progressive Disease|2|||
124763799|NCT01601535|448759846|FG003|Phase 1|Progressive Disease|1|||
124763800|NCT01601535|448759847|FG004|Phase 1|Progressive Disease|0|||
124763801|NCT01601535|448759848|FG005|Phase 1|Progressive Disease|0|||
124763802|NCT01601535|448759843|FG000|Phase 1|Started Another Treatment|1|||
124763803|NCT01601535|448759844|FG001|Phase 1|Started Another Treatment|2|||
124763804|NCT01601535|448759845|FG002|Phase 1|Started Another Treatment|0|||
124763805|NCT01601535|448759846|FG003|Phase 1|Started Another Treatment|0|||
124763806|NCT01601535|448759847|FG004|Phase 1|Started Another Treatment|0|||
124763807|NCT01601535|448759848|FG005|Phase 1|Started Another Treatment|0|||
124763808|NCT01601535|448759843|FG000|Phase 2|Adverse Event|0|||
124763809|NCT01601535|448759844|FG001|Phase 2|Adverse Event|0|||
124763810|NCT01601535|448759845|FG002|Phase 2|Adverse Event|0|||
124455326|NCT00111800|447627137|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
124763811|NCT01601535|448759846|FG003|Phase 2|Adverse Event|0|||
124455327|NCT00111800|447627138|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
124455328|NCT00111800|447627139|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
124455329|NCT00111800|447627140|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
124455330|NCT00111800|447627141|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
124455331|NCT00111800|447627142|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
124455332|NCT00111800|447627137|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
124455333|NCT00111800|447627138|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
124455334|NCT00111800|447627139|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
124455335|NCT00111800|447627140|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
124455336|NCT00111800|447627141|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
124455337|NCT00111800|447627142|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
124455338|NCT00111800|447627137|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
124546400|NCT02181673|447955901|FG000|Up to Week 24|Lack of Efficacy|1|||
124546401|NCT02181673|447955902|FG001|Up to Week 24|Lack of Efficacy|0|||
124763812|NCT01601535|448759847|FG004|Phase 2|Adverse Event|5|||
124763813|NCT01601535|448759848|FG005|Phase 2|Adverse Event|1|||
124763814|NCT01601535|448759843|FG000|Phase 2|Withdrawal by Subject|0|||
124763815|NCT01601535|448759844|FG001|Phase 2|Withdrawal by Subject|0|||
124763816|NCT01601535|448759845|FG002|Phase 2|Withdrawal by Subject|0|||
124763817|NCT01601535|448759846|FG003|Phase 2|Withdrawal by Subject|0|||
124763818|NCT01601535|448759847|FG004|Phase 2|Withdrawal by Subject|8|||
124763819|NCT01601535|448759848|FG005|Phase 2|Withdrawal by Subject|2|||
124763820|NCT01601535|448759843|FG000|Phase 2|Progressive Disease|0|||
124763821|NCT01601535|448759844|FG001|Phase 2|Progressive Disease|0|||
124763822|NCT01601535|448759845|FG002|Phase 2|Progressive Disease|0|||
124763823|NCT01601535|448759846|FG003|Phase 2|Progressive Disease|0|||
124763824|NCT01601535|448759847|FG004|Phase 2|Progressive Disease|5|||
124546402|NCT02181673|447955903|FG002|Up to Week 24|Lack of Efficacy|0|||
124546403|NCT02181673|447955901|FG000|Up to Week 24|Lost to Follow-up|1|||
124763825|NCT01601535|448759848|FG005|Phase 2|Progressive Disease|7|||
124763826|NCT01601535|448759843|FG000|Phase 2|Started Another Treatment|0|||
124763827|NCT01601535|448759844|FG001|Phase 2|Started Another Treatment|0|||
124763828|NCT01601535|448759845|FG002|Phase 2|Started Another Treatment|0|||
124763829|NCT01601535|448759846|FG003|Phase 2|Started Another Treatment|0|||
124763830|NCT01601535|448759847|FG004|Phase 2|Started Another Treatment|1|||
124763831|NCT01601535|448759848|FG005|Phase 2|Started Another Treatment|2|||
124763832|NCT03649074|448759849|FG000|Overall Study|Lost to Follow-up|2|||
124763833|NCT03649074|448759850|FG001|Overall Study|Lost to Follow-up|1|||
124700696|NCT04818229|448526654|FG002|Overall Study|Withdrawal by Subject|2|||
124700697|NCT04818229|448526652|FG000|Overall Study|Lost to Follow-up|0|||
124700698|NCT04818229|448526653|FG001|Overall Study|Lost to Follow-up|0|||
124700699|NCT04818229|448526654|FG002|Overall Study|Lost to Follow-up|1|||
124700700|NCT04903093|448526661|FG000|Overall Study|Withdrawal by Subject|0|||
124700701|NCT04903093|448526662|FG001|Overall Study|Withdrawal by Subject|0|||
124700702|NCT04903093|448526663|FG002|Overall Study|Withdrawal by Subject|0|||
124700703|NCT04903093|448526664|FG003|Overall Study|Withdrawal by Subject|1|||
124700704|NCT04903093|448526665|FG004|Overall Study|Withdrawal by Subject|0|||
124700705|NCT04903093|448526666|FG005|Overall Study|Withdrawal by Subject|0|||
124700706|NCT03973489|448526672|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
124700707|NCT03973489|448526673|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
124700708|NCT03973489|448526674|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
124700709|NCT03973489|448526675|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
124700710|NCT03973489|448526676|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
124700711|NCT03973489|448526677|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
124700712|NCT03973489|448526678|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
124700713|NCT03973489|448526679|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
124700714|NCT03973489|448526672|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
124700715|NCT03973489|448526673|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
124700716|NCT03973489|448526674|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
124700717|NCT03973489|448526675|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
124700718|NCT03973489|448526676|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
124700719|NCT03973489|448526677|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
124700720|NCT03973489|448526678|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
124700721|NCT03973489|448526679|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
124700722|NCT03973489|448526672|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
124700723|NCT03973489|448526673|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
124700724|NCT03973489|448526674|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
124700725|NCT03973489|448526675|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
124700726|NCT03973489|448526676|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
124700727|NCT03973489|448526677|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
124700728|NCT03973489|448526678|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
124700729|NCT03973489|448526679|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
124700730|NCT03973489|448526672|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
124700731|NCT03973489|448526673|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
124700732|NCT03973489|448526674|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
124700733|NCT03973489|448526675|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
124700734|NCT03973489|448526676|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
124700735|NCT03973489|448526677|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
124700736|NCT03973489|448526678|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
124700737|NCT03973489|448526679|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
124700738|NCT03973489|448526672|FG000|Second Intervention (1 Day)|Adverse Event|0|||
124700739|NCT03973489|448526673|FG001|Second Intervention (1 Day)|Adverse Event|0|||
124763834|NCT03649074|448759849|FG000|Overall Study|Adverse Event|1|||
124763835|NCT03649074|448759850|FG001|Overall Study|Adverse Event|0|||
124763836|NCT03649074|448759849|FG000|Overall Study|Physician Decision|1|||
124763837|NCT03649074|448759850|FG001|Overall Study|Physician Decision|0|||
124763838|NCT03649074|448759849|FG000|Overall Study|Withdrawal by Subject|0|||
124763839|NCT03649074|448759850|FG001|Overall Study|Withdrawal by Subject|2|||
124763840|NCT03649074|448759849|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
124763841|NCT03649074|448759850|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
124763842|NCT03649074|448759849|FG000|Overall Study|Other|1|||
124763843|NCT03649074|448759850|FG001|Overall Study|Other|0|||
124763844|NCT00795704|448759851|FG000|Overall Study|Withdrawal by Subject|3|||
124763845|NCT00795704|448759852|FG001|Overall Study|Withdrawal by Subject|2|||
124763846|NCT00795704|448759851|FG000|Overall Study|Adverse Event|1|||
124929358|NCT04625725|449373271|FG004|Provent Main Study|Withdrawal by Subject|0|||
124929359|NCT04625725|449373272|FG005|Provent Main Study|Withdrawal by Subject|0|||
124929360|NCT04625725|449373267|FG000|Provent Main Study|Physician Decision|5|||
124929361|NCT04625725|449373268|FG001|Provent Main Study|Physician Decision|0|||
124700740|NCT03973489|448526674|FG002|Second Intervention (1 Day)|Adverse Event|0|||
124700741|NCT03973489|448526675|FG003|Second Intervention (1 Day)|Adverse Event|1|||
124700742|NCT03973489|448526676|FG004|Second Intervention (1 Day)|Adverse Event|0|||
124700743|NCT03973489|448526677|FG005|Second Intervention (1 Day)|Adverse Event|0|||
124763847|NCT00795704|448759852|FG001|Overall Study|Adverse Event|1|||
124929362|NCT04625725|449373269|FG002|Provent Main Study|Physician Decision|0|||
124763848|NCT03980730|448759853|FG000|Overall Study|Study Terminated by Sponsor|0|||
124763849|NCT03980730|448759854|FG001|Overall Study|Study Terminated by Sponsor|3|||
124763850|NCT03980730|448759853|FG000|Overall Study|Adverse Event|2|||
124929363|NCT04625725|449373270|FG003|Provent Main Study|Physician Decision|0|||
124763851|NCT03980730|448759854|FG001|Overall Study|Adverse Event|0|||
124763852|NCT03980730|448759853|FG000|Overall Study|Sponsor Request|0|||
124763853|NCT03980730|448759854|FG001|Overall Study|Sponsor Request|1|||
124763854|NCT00556894|448759855|FG000|Overall Study|Adverse Event|2|||
124763855|NCT00556894|448759856|FG001|Overall Study|Adverse Event|3|||
124763856|NCT00556894|448759857|FG002|Overall Study|Adverse Event|3|||
124763857|NCT00556894|448759855|FG000|Overall Study|Death|1|||
124763858|NCT00556894|448759856|FG001|Overall Study|Death|0|||
124763859|NCT00556894|448759857|FG002|Overall Study|Death|0|||
124763860|NCT00556894|448759855|FG000|Overall Study|regulatory decision in Bulgaria|10|||
124763861|NCT00556894|448759856|FG001|Overall Study|regulatory decision in Bulgaria|14|||
124763862|NCT00556894|448759857|FG002|Overall Study|regulatory decision in Bulgaria|13|||
124763863|NCT00556894|448759855|FG000|Overall Study|Change in therapy|2|||
124763864|NCT00556894|448759856|FG001|Overall Study|Change in therapy|1|||
124763865|NCT00556894|448759857|FG002|Overall Study|Change in therapy|2|||
124763866|NCT00556894|448759855|FG000|Overall Study|Withdrawal by Subject|1|||
124763867|NCT00556894|448759856|FG001|Overall Study|Withdrawal by Subject|1|||
124763868|NCT00556894|448759857|FG002|Overall Study|Withdrawal by Subject|1|||
124763869|NCT00880620|448759858|FG000|Overall Study|Adverse Event|4|||
124763870|NCT00880620|448759859|FG001|Overall Study|Adverse Event|5|||
124763871|NCT00880620|448759860|FG002|Overall Study|Adverse Event|15|||
124763872|NCT00880620|448759861|FG003|Overall Study|Adverse Event|15|||
124763873|NCT00880620|448759858|FG000|Overall Study|Death|0|||
124763874|NCT00880620|448759859|FG001|Overall Study|Death|0|||
124763875|NCT00880620|448759860|FG002|Overall Study|Death|1|||
124763876|NCT00880620|448759861|FG003|Overall Study|Death|0|||
124763877|NCT00880620|448759858|FG000|Overall Study|Lack of Efficacy|12|||
124763878|NCT00880620|448759859|FG001|Overall Study|Lack of Efficacy|4|||
124763879|NCT00880620|448759860|FG002|Overall Study|Lack of Efficacy|0|||
124763880|NCT00880620|448759861|FG003|Overall Study|Lack of Efficacy|1|||
124929364|NCT04625725|449373271|FG004|Provent Main Study|Physician Decision|0|||
124929365|NCT04625725|449373272|FG005|Provent Main Study|Physician Decision|0|||
124929366|NCT04625725|449373267|FG000|Provent Main Study|Protocol Violation|1|||
124929367|NCT04625725|449373268|FG001|Provent Main Study|Protocol Violation|0|||
124929368|NCT04625725|449373269|FG002|Provent Main Study|Protocol Violation|0|||
124929369|NCT04625725|449373270|FG003|Provent Main Study|Protocol Violation|0|||
124929370|NCT04625725|449373271|FG004|Provent Main Study|Protocol Violation|0|||
124929371|NCT04625725|449373272|FG005|Provent Main Study|Protocol Violation|0|||
124929372|NCT04625725|449373267|FG000|Provent Main Study|Lost to Follow-up|357|||
124929373|NCT04625725|449373268|FG001|Provent Main Study|Lost to Follow-up|200|||
124929374|NCT04625725|449373269|FG002|Provent Main Study|Lost to Follow-up|0|||
124929375|NCT04625725|449373270|FG003|Provent Main Study|Lost to Follow-up|0|||
124929376|NCT04625725|449373271|FG004|Provent Main Study|Lost to Follow-up|0|||
124929377|NCT04625725|449373272|FG005|Provent Main Study|Lost to Follow-up|0|||
124929378|NCT04625725|449373267|FG000|Provent Main Study|Death|22|||
124929379|NCT04625725|449373268|FG001|Provent Main Study|Death|10|||
124929380|NCT04625725|449373269|FG002|Provent Main Study|Death|0|||
124929381|NCT04625725|449373270|FG003|Provent Main Study|Death|0|||
124929382|NCT04625725|449373271|FG004|Provent Main Study|Death|0|||
124929383|NCT04625725|449373272|FG005|Provent Main Study|Death|0|||
124929384|NCT04625725|449373267|FG000|Provent Main Study|Adverse Event|2|||
124929385|NCT04625725|449373268|FG001|Provent Main Study|Adverse Event|1|||
124929386|NCT04625725|449373269|FG002|Provent Main Study|Adverse Event|0|||
124929387|NCT04625725|449373270|FG003|Provent Main Study|Adverse Event|0|||
124929388|NCT04625725|449373271|FG004|Provent Main Study|Adverse Event|0|||
124929389|NCT04625725|449373272|FG005|Provent Main Study|Adverse Event|0|||
124700744|NCT03973489|448526678|FG006|Second Intervention (1 Day)|Adverse Event|0|||
124700745|NCT03973489|448526679|FG007|Second Intervention (1 Day)|Adverse Event|0|||
124700746|NCT00392288|448526680|FG000|Overall Study|Adverse Event|17|||
124700747|NCT00392288|448526681|FG001|Overall Study|Adverse Event|7|||
124700748|NCT00392288|448526682|FG002|Overall Study|Adverse Event|8|||
124700749|NCT00392288|448526680|FG000|Overall Study|Lack of Efficacy|8|||
124700750|NCT00392288|448526681|FG001|Overall Study|Lack of Efficacy|5|||
124700751|NCT00392288|448526682|FG002|Overall Study|Lack of Efficacy|3|||
124700752|NCT00392288|448526680|FG000|Overall Study|Protocol Violation|1|||
124700753|NCT00392288|448526681|FG001|Overall Study|Protocol Violation|3|||
124700754|NCT00392288|448526682|FG002|Overall Study|Protocol Violation|1|||
124700755|NCT00392288|448526680|FG000|Overall Study|Lost to Follow-up|1|||
124700756|NCT00392288|448526681|FG001|Overall Study|Lost to Follow-up|1|||
124700757|NCT00392288|448526682|FG002|Overall Study|Lost to Follow-up|1|||
124700758|NCT00392288|448526680|FG000|Overall Study|Withdrawal by Subject|1|||
124700759|NCT00392288|448526681|FG001|Overall Study|Withdrawal by Subject|0|||
124700760|NCT00392288|448526682|FG002|Overall Study|Withdrawal by Subject|2|||
124700761|NCT00392288|448526680|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
124700762|NCT00392288|448526681|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
124700763|NCT00392288|448526682|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
124700764|NCT00392288|448526680|FG000|Overall Study|Other|3|||
124929390|NCT04625725|449373267|FG000|Provent Main Study|Participants dosed in sub-study|310|||
124929391|NCT04625725|449373268|FG001|Provent Main Study|Participants dosed in sub-study|193|||
124929392|NCT04625725|449373269|FG002|Provent Main Study|Participants dosed in sub-study|0|||
124929393|NCT04625725|449373270|FG003|Provent Main Study|Participants dosed in sub-study|0|||
124929394|NCT04625725|449373271|FG004|Provent Main Study|Participants dosed in sub-study|0|||
124929395|NCT04625725|449373272|FG005|Provent Main Study|Participants dosed in sub-study|0|||
124929396|NCT04625725|449373267|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
124929397|NCT04625725|449373268|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
124929398|NCT04625725|449373269|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
124929399|NCT04625725|449373270|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
124929400|NCT04625725|449373271|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
124929401|NCT04625725|449373272|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
124929402|NCT04625725|449373267|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
124929403|NCT04625725|449373268|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
124929404|NCT04625725|449373269|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
124929405|NCT04625725|449373270|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
124929406|NCT04625725|449373271|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
124929407|NCT04625725|449373272|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
124929408|NCT04625725|449373267|FG000|Provent Main Study|INCARCERATION|3|||
124929409|NCT04625725|449373268|FG001|Provent Main Study|INCARCERATION|0|||
124929410|NCT04625725|449373269|FG002|Provent Main Study|INCARCERATION|0|||
124929411|NCT04625725|449373270|FG003|Provent Main Study|INCARCERATION|0|||
124929412|NCT04625725|449373271|FG004|Provent Main Study|INCARCERATION|0|||
124929413|NCT04625725|449373272|FG005|Provent Main Study|INCARCERATION|0|||
124700765|NCT00392288|448526681|FG001|Overall Study|Other|4|||
124700766|NCT00392288|448526682|FG002|Overall Study|Other|1|||
124700767|NCT02544763|448526683|FG000|Overall Study|Adverse Event|8|||
124700768|NCT02544763|448526684|FG001|Overall Study|Adverse Event|8|||
124700769|NCT02544763|448526685|FG002|Overall Study|Adverse Event|0|||
124700770|NCT02544763|448526683|FG000|Overall Study|Withdrawn by parent/guardian|1|||
124700771|NCT02544763|448526684|FG001|Overall Study|Withdrawn by parent/guardian|1|||
124700772|NCT02544763|448526685|FG002|Overall Study|Withdrawn by parent/guardian|1|||
124700773|NCT02544763|448526683|FG000|Overall Study|Met withdrawal criteria|0|||
124929414|NCT04625725|449373267|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
124929415|NCT04625725|449373268|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
124929416|NCT04625725|449373269|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
124929417|NCT04625725|449373270|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
124700774|NCT02544763|448526684|FG001|Overall Study|Met withdrawal criteria|2|||
124700775|NCT02544763|448526685|FG002|Overall Study|Met withdrawal criteria|0|||
124700776|NCT02544763|448526683|FG000|Overall Study|Physician Decision|0|||
124700777|NCT02544763|448526684|FG001|Overall Study|Physician Decision|1|||
124700778|NCT02544763|448526685|FG002|Overall Study|Physician Decision|0|||
124700779|NCT02544763|448526683|FG000|Overall Study|Difficulties taking IMP|1|||
124929418|NCT04625725|449373271|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
124929419|NCT04625725|449373272|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
124929420|NCT04625725|449373267|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
124929421|NCT04625725|449373268|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
124929422|NCT04625725|449373269|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
124929423|NCT04625725|449373270|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
124700780|NCT02544763|448526684|FG001|Overall Study|Difficulties taking IMP|0|||
124700781|NCT02544763|448526685|FG002|Overall Study|Difficulties taking IMP|0|||
124712015|NCT01343888|448570709|FG002|Overall Study|other than stated above|1|||
124929424|NCT04625725|449373271|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
124700782|NCT00590317|448528023|FG000|Overall Study|Lack of Efficacy|1|||
124700783|NCT00590317|448528024|FG001|Overall Study|Lack of Efficacy|5|||
124700784|NCT00266032|448528025|FG000|Treatment|Adverse Event|42|||
124700785|NCT00266032|448528026|FG001|Treatment|Adverse Event|26|||
124700786|NCT00266032|448528027|FG002|Treatment|Adverse Event|10|||
124700787|NCT00266032|448528025|FG000|Treatment|Lost to Follow-up|19|||
124700788|NCT00266032|448528026|FG001|Treatment|Lost to Follow-up|4|||
124700789|NCT00266032|448528027|FG002|Treatment|Lost to Follow-up|2|||
124700790|NCT00266032|448528025|FG000|Treatment|Pregnancy|3|||
124763881|NCT00880620|448759858|FG000|Overall Study|Lost to Follow-up|0|||
124763882|NCT00880620|448759859|FG001|Overall Study|Lost to Follow-up|1|||
124763883|NCT00880620|448759860|FG002|Overall Study|Lost to Follow-up|1|||
124763884|NCT00880620|448759861|FG003|Overall Study|Lost to Follow-up|0|||
124763885|NCT00880620|448759858|FG000|Overall Study|Protocol Violation|0|||
124763886|NCT00880620|448759859|FG001|Overall Study|Protocol Violation|1|||
124763887|NCT00880620|448759860|FG002|Overall Study|Protocol Violation|0|||
124763888|NCT00880620|448759861|FG003|Overall Study|Protocol Violation|2|||
124763889|NCT00880620|448759858|FG000|Overall Study|Withdrawal by Subject|4|||
124763890|NCT00880620|448759859|FG001|Overall Study|Withdrawal by Subject|3|||
124763891|NCT00880620|448759860|FG002|Overall Study|Withdrawal by Subject|1|||
124763892|NCT00880620|448759861|FG003|Overall Study|Withdrawal by Subject|3|||
124763893|NCT00880620|448759858|FG000|Overall Study|Noncompliance|0|||
124763894|NCT00880620|448759859|FG001|Overall Study|Noncompliance|0|||
124763895|NCT00880620|448759860|FG002|Overall Study|Noncompliance|1|||
124763896|NCT00880620|448759861|FG003|Overall Study|Noncompliance|1|||
124763897|NCT00880620|448759858|FG000|Overall Study|Other|1|||
124763898|NCT00880620|448759859|FG001|Overall Study|Other|1|||
124929425|NCT04625725|449373272|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
124929426|NCT04625725|449373267|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
124763899|NCT00880620|448759860|FG002|Overall Study|Other|2|||
124763900|NCT00880620|448759861|FG003|Overall Study|Other|2|||
124763901|NCT03883581|448759863|FG000|Overall Study|Withdrawal by Subject|4|||
124763902|NCT04612725|448759864|FG000|Overall Study|Adverse Event|1|||
124763903|NCT04612725|448759865|FG001|Overall Study|Adverse Event|3|||
124763904|NCT04612725|448759866|FG002|Overall Study|Adverse Event|1|||
124763905|NCT04612725|448759867|FG003|Overall Study|Adverse Event|0|||
124763906|NCT04612725|448759868|FG004|Overall Study|Adverse Event|1|||
124763907|NCT04612725|448759864|FG000|Overall Study|Lost to Follow-up|0|||
124763908|NCT04612725|448759865|FG001|Overall Study|Lost to Follow-up|1|||
124763909|NCT04612725|448759866|FG002|Overall Study|Lost to Follow-up|0|||
124763910|NCT04612725|448759867|FG003|Overall Study|Lost to Follow-up|0|||
124763911|NCT04612725|448759868|FG004|Overall Study|Lost to Follow-up|0|||
124763912|NCT04612725|448759864|FG000|Overall Study|Physician Decision|2|||
124763913|NCT04612725|448759865|FG001|Overall Study|Physician Decision|0|||
124763914|NCT04612725|448759866|FG002|Overall Study|Physician Decision|0|||
124929427|NCT04625725|449373268|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
124929428|NCT04625725|449373269|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
124929429|NCT04625725|449373270|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
124929430|NCT04625725|449373271|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
124929431|NCT04625725|449373272|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
124929432|NCT04625725|449373267|FG000|Provent Main Study|MISSING REASON|0|||
124929433|NCT04625725|449373268|FG001|Provent Main Study|MISSING REASON|1|||
124455339|NCT00111800|447627138|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
124929434|NCT04625725|449373269|FG002|Provent Main Study|MISSING REASON|0|||
124455340|NCT00111800|447627139|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
124455341|NCT00111800|447627140|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
124455342|NCT00111800|447627141|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
124455343|NCT00111800|447627142|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
124455344|NCT00111800|447627137|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
124455345|NCT00111800|447627138|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
124455346|NCT00111800|447627139|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
124455347|NCT00111800|447627140|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
124455348|NCT00111800|447627141|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
124700791|NCT00266032|448528026|FG001|Treatment|Pregnancy|2|||
124700792|NCT00266032|448528027|FG002|Treatment|Pregnancy|2|||
124700793|NCT00266032|448528025|FG000|Treatment|Protocol Violation|6|||
124700794|NCT00266032|448528026|FG001|Treatment|Protocol Violation|14|||
124763915|NCT04612725|448759867|FG003|Overall Study|Physician Decision|0|||
124763916|NCT04612725|448759868|FG004|Overall Study|Physician Decision|0|||
124763917|NCT04612725|448759864|FG000|Overall Study|Study terminated by sponsor|3|||
124763918|NCT04612725|448759865|FG001|Overall Study|Study terminated by sponsor|1|||
124763919|NCT04612725|448759866|FG002|Overall Study|Study terminated by sponsor|2|||
124763920|NCT04612725|448759867|FG003|Overall Study|Study terminated by sponsor|4|||
124763921|NCT04612725|448759868|FG004|Overall Study|Study terminated by sponsor|5|||
124929435|NCT04625725|449373270|FG003|Provent Main Study|MISSING REASON|0|||
124763922|NCT04612725|448759864|FG000|Overall Study|Withdrawal by Subject|8|||
124929436|NCT04625725|449373271|FG004|Provent Main Study|MISSING REASON|0|||
124929437|NCT04625725|449373272|FG005|Provent Main Study|MISSING REASON|0|||
124929438|NCT04625725|449373267|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
124929439|NCT04625725|449373268|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
124929440|NCT04625725|449373269|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
124929441|NCT04625725|449373270|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
124929442|NCT04625725|449373271|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
124929443|NCT04625725|449373272|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
124929444|NCT04625725|449373267|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
124929445|NCT04625725|449373268|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
124929446|NCT04625725|449373269|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
124929447|NCT04625725|449373270|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
124929448|NCT04625725|449373271|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
124929449|NCT04625725|449373272|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
124929450|NCT04625725|449373267|FG000|Provent Sub Study|Lost to Follow-up|0|||
124929451|NCT04625725|449373268|FG001|Provent Sub Study|Lost to Follow-up|0|||
124929452|NCT04625725|449373269|FG002|Provent Sub Study|Lost to Follow-up|20|||
124700795|NCT00266032|448528027|FG002|Treatment|Protocol Violation|13|||
124700796|NCT00266032|448528025|FG000|Treatment|Withdrawal by Subject|28|||
124700797|NCT00266032|448528026|FG001|Treatment|Withdrawal by Subject|13|||
124700798|NCT00266032|448528027|FG002|Treatment|Withdrawal by Subject|12|||
124700799|NCT00266032|448528025|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
124700800|NCT00266032|448528026|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
124700801|NCT00266032|448528027|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
124700802|NCT00266032|448528025|FG000|Open-label Safety Extension|Adverse Event|5|||
124700803|NCT00266032|448528026|FG001|Open-label Safety Extension|Adverse Event|0|||
124700804|NCT00266032|448528027|FG002|Open-label Safety Extension|Adverse Event|4|||
124700805|NCT00266032|448528025|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
124700806|NCT00266032|448528026|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
124700807|NCT00266032|448528027|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
124700808|NCT00266032|448528025|FG000|Open-label Safety Extension|Pregnancy|4|||
124700809|NCT00266032|448528026|FG001|Open-label Safety Extension|Pregnancy|1|||
124700810|NCT00266032|448528027|FG002|Open-label Safety Extension|Pregnancy|2|||
124700811|NCT00266032|448528025|FG000|Open-label Safety Extension|Protocol Violation|1|||
124700812|NCT00266032|448528026|FG001|Open-label Safety Extension|Protocol Violation|3|||
124700813|NCT00266032|448528027|FG002|Open-label Safety Extension|Protocol Violation|2|||
124700814|NCT00266032|448528025|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
124700815|NCT00266032|448528026|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
124700816|NCT00266032|448528027|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
124700817|NCT00266032|448528025|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
124700818|NCT00266032|448528026|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
124700819|NCT00266032|448528027|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
124700820|NCT01514357|448528031|FG000|Overall Study|Screen failure|2|||
124700821|NCT01514357|448528032|FG001|Overall Study|Screen failure|0|||
124700822|NCT01514357|448528031|FG000|Overall Study|Withdrawal by Subject|2|||
124700823|NCT01514357|448528032|FG001|Overall Study|Withdrawal by Subject|0|||
124700824|NCT00752219|448528033|FG000|Overall Study|Clinical failure|0|||
124700825|NCT00752219|448528034|FG001|Overall Study|Clinical failure|1|||
124700826|NCT00752219|448528033|FG000|Overall Study|Adverse Event|5|||
124700827|NCT00752219|448528034|FG001|Overall Study|Adverse Event|3|||
124700828|NCT00752219|448528033|FG000|Overall Study|Protocol deviation|1|||
124700829|NCT00752219|448528034|FG001|Overall Study|Protocol deviation|0|||
124700830|NCT00752219|448528033|FG000|Overall Study|Lost to Follow-up|1|||
124700831|NCT00752219|448528034|FG001|Overall Study|Lost to Follow-up|2|||
124700832|NCT00752219|448528033|FG000|Overall Study|Randomized but not treated|1|||
124700833|NCT00752219|448528034|FG001|Overall Study|Randomized but not treated|0|||
124700834|NCT00752219|448528033|FG000|Overall Study|Other|3|||
124700835|NCT00752219|448528034|FG001|Overall Study|Other|0|||
124700836|NCT04691115|448528037|FG000|Overall Study|Withdrawal by Subject|0|||
124700837|NCT04691115|448528038|FG001|Overall Study|Withdrawal by Subject|0|||
124700838|NCT04691115|448528039|FG002|Overall Study|Withdrawal by Subject|0|||
124929453|NCT04625725|449373270|FG003|Provent Sub Study|Lost to Follow-up|10|||
124546404|NCT02181673|447955902|FG001|Up to Week 24|Lost to Follow-up|0|||
124700839|NCT04691115|448528040|FG003|Overall Study|Withdrawal by Subject|0|||
124700840|NCT04691115|448528041|FG004|Overall Study|Withdrawal by Subject|0|||
124700841|NCT04691115|448528042|FG005|Overall Study|Withdrawal by Subject|1|||
124700842|NCT04691115|448528043|FG006|Overall Study|Withdrawal by Subject|0|||
124700843|NCT04691115|448528044|FG007|Overall Study|Withdrawal by Subject|0|||
124700844|NCT04691115|448528045|FG008|Overall Study|Withdrawal by Subject|0|||
124700845|NCT04691115|448528046|FG009|Overall Study|Withdrawal by Subject|0|||
124700846|NCT04691115|448528047|FG010|Overall Study|Withdrawal by Subject|0|||
124929454|NCT04625725|449373271|FG004|Provent Sub Study|Lost to Follow-up|6|||
124929455|NCT04625725|449373272|FG005|Provent Sub Study|Lost to Follow-up|4|||
124700847|NCT04691115|448528048|FG011|Overall Study|Withdrawal by Subject|0|||
124700848|NCT04691115|448528049|FG012|Overall Study|Withdrawal by Subject|0|||
124700849|NCT04691115|448528050|FG013|Overall Study|Withdrawal by Subject|0|||
124700850|NCT02096354|448528055|FG000|Overall Study|Physician Decision|4|||
124700851|NCT02096354|448528056|FG001|Overall Study|Physician Decision|5|||
124700852|NCT02096354|448528057|FG002|Overall Study|Physician Decision|0|||
124700853|NCT02096354|448528055|FG000|Overall Study|Withdrawal by Subject|3|||
124700854|NCT02096354|448528056|FG001|Overall Study|Withdrawal by Subject|1|||
124700855|NCT02096354|448528057|FG002|Overall Study|Withdrawal by Subject|0|||
124700856|NCT02096354|448528055|FG000|Overall Study|Adverse Event|7|||
124700857|NCT02096354|448528056|FG001|Overall Study|Adverse Event|4|||
124700858|NCT02096354|448528057|FG002|Overall Study|Adverse Event|0|||
124700859|NCT02096354|448528055|FG000|Overall Study|Ineligible|0|||
124700860|NCT02096354|448528056|FG001|Overall Study|Ineligible|0|||
124700861|NCT02096354|448528057|FG002|Overall Study|Ineligible|11|||
124700862|NCT03715829|448528058|FG000|Dose Ranging Period|Adverse Event|2|||
124700863|NCT03715829|448528059|FG001|Dose Ranging Period|Adverse Event|4|||
124700864|NCT03715829|448528060|FG002|Dose Ranging Period|Adverse Event|5|||
124700865|NCT03715829|448528061|FG003|Dose Ranging Period|Adverse Event|2|||
124700866|NCT03715829|448528062|FG004|Dose Ranging Period|Adverse Event|3|||
124700867|NCT03715829|448528063|FG005|Dose Ranging Period|Adverse Event|3|||
124700868|NCT03715829|448528064|FG006|Dose Ranging Period|Adverse Event|0|||
124700869|NCT03715829|448528065|FG007|Dose Ranging Period|Adverse Event|0|||
124700870|NCT03715829|448528066|FG008|Dose Ranging Period|Adverse Event|0|||
124700871|NCT03715829|448528067|FG009|Dose Ranging Period|Adverse Event|0|||
124700872|NCT03715829|448528068|FG010|Dose Ranging Period|Adverse Event|0|||
124700873|NCT03715829|448528058|FG000|Dose Ranging Period|Lack of Efficacy|0|||
124700874|NCT03715829|448528059|FG001|Dose Ranging Period|Lack of Efficacy|1|||
124700875|NCT03715829|448528060|FG002|Dose Ranging Period|Lack of Efficacy|0|||
124700876|NCT03715829|448528061|FG003|Dose Ranging Period|Lack of Efficacy|1|||
124700877|NCT03715829|448528062|FG004|Dose Ranging Period|Lack of Efficacy|0|||
124700878|NCT03715829|448528063|FG005|Dose Ranging Period|Lack of Efficacy|0|||
124700879|NCT03715829|448528064|FG006|Dose Ranging Period|Lack of Efficacy|0|||
124700880|NCT03715829|448528065|FG007|Dose Ranging Period|Lack of Efficacy|0|||
124700881|NCT03715829|448528066|FG008|Dose Ranging Period|Lack of Efficacy|0|||
124700882|NCT03715829|448528067|FG009|Dose Ranging Period|Lack of Efficacy|0|||
124700883|NCT03715829|448528068|FG010|Dose Ranging Period|Lack of Efficacy|0|||
124700884|NCT03715829|448528058|FG000|Dose Ranging Period|Lost to Follow-up|2|||
124700885|NCT03715829|448528059|FG001|Dose Ranging Period|Lost to Follow-up|0|||
124700886|NCT03715829|448528060|FG002|Dose Ranging Period|Lost to Follow-up|1|||
124700887|NCT03715829|448528061|FG003|Dose Ranging Period|Lost to Follow-up|1|||
124700888|NCT03715829|448528062|FG004|Dose Ranging Period|Lost to Follow-up|1|||
124700889|NCT03715829|448528063|FG005|Dose Ranging Period|Lost to Follow-up|2|||
124700890|NCT03715829|448528064|FG006|Dose Ranging Period|Lost to Follow-up|0|||
124700891|NCT03715829|448528065|FG007|Dose Ranging Period|Lost to Follow-up|0|||
124700892|NCT03715829|448528066|FG008|Dose Ranging Period|Lost to Follow-up|0|||
124700893|NCT03715829|448528067|FG009|Dose Ranging Period|Lost to Follow-up|0|||
124700894|NCT03715829|448528068|FG010|Dose Ranging Period|Lost to Follow-up|0|||
124700895|NCT03715829|448528058|FG000|Dose Ranging Period|Protocol Violation|0|||
124700896|NCT03715829|448528059|FG001|Dose Ranging Period|Protocol Violation|0|||
124700897|NCT03715829|448528060|FG002|Dose Ranging Period|Protocol Violation|0|||
124700898|NCT03715829|448528061|FG003|Dose Ranging Period|Protocol Violation|1|||
124700899|NCT03715829|448528062|FG004|Dose Ranging Period|Protocol Violation|0|||
124700900|NCT03715829|448528063|FG005|Dose Ranging Period|Protocol Violation|0|||
124700901|NCT03715829|448528064|FG006|Dose Ranging Period|Protocol Violation|0|||
124700902|NCT03715829|448528065|FG007|Dose Ranging Period|Protocol Violation|0|||
124700903|NCT03715829|448528066|FG008|Dose Ranging Period|Protocol Violation|0|||
124700904|NCT03715829|448528067|FG009|Dose Ranging Period|Protocol Violation|0|||
124700905|NCT03715829|448528068|FG010|Dose Ranging Period|Protocol Violation|0|||
124700906|NCT03715829|448528058|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
124700907|NCT03715829|448528059|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
124700908|NCT03715829|448528060|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
124700909|NCT03715829|448528061|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
124700910|NCT03715829|448528062|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
124700911|NCT03715829|448528063|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
124700912|NCT03715829|448528064|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
124700913|NCT03715829|448528065|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
124700914|NCT03715829|448528066|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
124700915|NCT03715829|448528067|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
124700916|NCT03715829|448528068|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
124700917|NCT03715829|448528058|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
124700918|NCT03715829|448528059|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
124700919|NCT03715829|448528060|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
124455349|NCT00111800|447627142|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
124700920|NCT03715829|448528061|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
124929456|NCT04625725|449373267|FG000|Provent Sub Study|Death|0|||
124455350|NCT00111800|447627137|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
124455351|NCT00111800|447627138|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
124455352|NCT00111800|447627139|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
124455353|NCT00111800|447627140|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
124455354|NCT00111800|447627141|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
124455355|NCT00111800|447627142|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
124455356|NCT00111800|447627137|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
124455357|NCT00111800|447627138|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
124700921|NCT03715829|448528062|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
124700922|NCT03715829|448528063|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
124700923|NCT03715829|448528064|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
124700924|NCT03715829|448528065|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
124700925|NCT03715829|448528066|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
124700926|NCT03715829|448528067|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
124700927|NCT03715829|448528068|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
124700928|NCT03715829|448528058|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
124700929|NCT03715829|448528059|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
124700930|NCT03715829|448528060|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
124700931|NCT03715829|448528061|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
124700932|NCT03715829|448528062|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
124700933|NCT03715829|448528063|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
124700934|NCT03715829|448528064|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
124700935|NCT03715829|448528065|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
124700936|NCT03715829|448528066|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
124700937|NCT03715829|448528067|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
124700938|NCT03715829|448528068|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
124700939|NCT03715829|448528058|FG000|Dose Ranging Period|Other|0|||
124700940|NCT03715829|448528059|FG001|Dose Ranging Period|Other|0|||
124700941|NCT03715829|448528060|FG002|Dose Ranging Period|Other|2|||
124700942|NCT03715829|448528061|FG003|Dose Ranging Period|Other|0|||
124700943|NCT03715829|448528062|FG004|Dose Ranging Period|Other|0|||
124700944|NCT03715829|448528063|FG005|Dose Ranging Period|Other|3|||
124700945|NCT03715829|448528064|FG006|Dose Ranging Period|Other|0|||
124700946|NCT03715829|448528065|FG007|Dose Ranging Period|Other|0|||
124700947|NCT03715829|448528066|FG008|Dose Ranging Period|Other|0|||
124700948|NCT03715829|448528067|FG009|Dose Ranging Period|Other|0|||
124700949|NCT03715829|448528068|FG010|Dose Ranging Period|Other|0|||
124700950|NCT03715829|448528058|FG000|Extension Period|Adverse Event|0|||
124700951|NCT03715829|448528059|FG001|Extension Period|Adverse Event|0|||
124700952|NCT03715829|448528060|FG002|Extension Period|Adverse Event|0|||
124700953|NCT03715829|448528061|FG003|Extension Period|Adverse Event|0|||
124700954|NCT03715829|448528062|FG004|Extension Period|Adverse Event|0|||
124700955|NCT03715829|448528063|FG005|Extension Period|Adverse Event|0|||
124700956|NCT03715829|448528064|FG006|Extension Period|Adverse Event|3|||
124700957|NCT03715829|448528065|FG007|Extension Period|Adverse Event|1|||
124700958|NCT03715829|448528066|FG008|Extension Period|Adverse Event|6|||
124700959|NCT03715829|448528067|FG009|Extension Period|Adverse Event|0|||
124700960|NCT03715829|448528068|FG010|Extension Period|Adverse Event|0|||
124700961|NCT03715829|448528058|FG000|Extension Period|Lack of Efficacy|0|||
124700962|NCT03715829|448528059|FG001|Extension Period|Lack of Efficacy|0|||
124700963|NCT03715829|448528060|FG002|Extension Period|Lack of Efficacy|0|||
124700964|NCT03715829|448528061|FG003|Extension Period|Lack of Efficacy|0|||
124700965|NCT03715829|448528062|FG004|Extension Period|Lack of Efficacy|0|||
124700966|NCT03715829|448528063|FG005|Extension Period|Lack of Efficacy|0|||
124700967|NCT03715829|448528064|FG006|Extension Period|Lack of Efficacy|1|||
124700968|NCT03715829|448528065|FG007|Extension Period|Lack of Efficacy|9|||
124700969|NCT03715829|448528066|FG008|Extension Period|Lack of Efficacy|2|||
124700970|NCT03715829|448528067|FG009|Extension Period|Lack of Efficacy|0|||
124700971|NCT03715829|448528068|FG010|Extension Period|Lack of Efficacy|0|||
124700972|NCT03715829|448528058|FG000|Extension Period|Lost to Follow-up|0|||
124700973|NCT03715829|448528059|FG001|Extension Period|Lost to Follow-up|0|||
124700974|NCT03715829|448528060|FG002|Extension Period|Lost to Follow-up|0|||
124700975|NCT03715829|448528061|FG003|Extension Period|Lost to Follow-up|0|||
124700976|NCT03715829|448528062|FG004|Extension Period|Lost to Follow-up|0|||
124700977|NCT03715829|448528063|FG005|Extension Period|Lost to Follow-up|0|||
124700978|NCT03715829|448528064|FG006|Extension Period|Lost to Follow-up|0|||
124700979|NCT03715829|448528065|FG007|Extension Period|Lost to Follow-up|0|||
124700980|NCT03715829|448528066|FG008|Extension Period|Lost to Follow-up|2|||
124700981|NCT03715829|448528067|FG009|Extension Period|Lost to Follow-up|0|||
124700982|NCT03715829|448528068|FG010|Extension Period|Lost to Follow-up|0|||
124700983|NCT03715829|448528058|FG000|Extension Period|Protocol Violation|0|||
124763923|NCT04612725|448759865|FG001|Overall Study|Withdrawal by Subject|3|||
124929457|NCT04625725|449373268|FG001|Provent Sub Study|Death|0|||
124455358|NCT00111800|447627139|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
124455359|NCT00111800|447627140|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
124455360|NCT00111800|447627141|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
124455361|NCT00111800|447627142|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
124455362|NCT00253643|447627143|FG000|Overall Study|Withdrawal by Subject|0|||
124455363|NCT00253643|447627144|FG001|Overall Study|Withdrawal by Subject|0|||
124455364|NCT00253643|447627145|FG002|Overall Study|Withdrawal by Subject|1|||
124455365|NCT00253643|447627146|FG003|Overall Study|Withdrawal by Subject|1|||
124455366|NCT00253643|447627143|FG000|Overall Study|Non-Compliance|0|||
124455367|NCT00253643|447627144|FG001|Overall Study|Non-Compliance|0|||
124455368|NCT00253643|447627145|FG002|Overall Study|Non-Compliance|0|||
124455369|NCT00253643|447627146|FG003|Overall Study|Non-Compliance|2|||
124455370|NCT01549275|447627147|FG000|Overall Study|Lost to Follow-up|1|||
124455371|NCT01549275|447627148|FG001|Overall Study|Lost to Follow-up|0|||
124455372|NCT01486927|447627153|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
124455373|NCT01486927|447627153|FG000|Overall Study|Physician Decision|1|||
124455374|NCT01486927|447627153|FG000|Overall Study|50 Exposure days not reached|2|||
124455375|NCT01486927|447627153|FG000|Overall Study|Withdrawal by Subject|8|||
124455376|NCT01486927|447627153|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
124455377|NCT03668600|447627154|FG000|Overall Study|Study Terminated by the Sponsor|157|||
124455378|NCT03668600|447627154|FG000|Overall Study|Protocol Violation|1|||
124455379|NCT03668600|447627154|FG000|Overall Study|Pregnancy|1|||
124455380|NCT03668600|447627154|FG000|Overall Study|Lost to Follow-up|7|||
124455381|NCT03668600|447627154|FG000|Overall Study|Withdrawal by Subject|56|||
124455382|NCT03668600|447627154|FG000|Overall Study|Lack of Efficacy|7|||
124455383|NCT03668600|447627154|FG000|Overall Study|Adverse Event|1|||
124455384|NCT01476475|447627155|FG000|Overall Study|Adverse Event|6|||
124455385|NCT01476475|447627156|FG001|Overall Study|Adverse Event|0|||
124455386|NCT01476475|447627155|FG000|Overall Study|Poor compliance to protocol|1|||
124455387|NCT01476475|447627156|FG001|Overall Study|Poor compliance to protocol|1|||
124700984|NCT03715829|448528059|FG001|Extension Period|Protocol Violation|0|||
124700985|NCT03715829|448528060|FG002|Extension Period|Protocol Violation|0|||
124700986|NCT03715829|448528061|FG003|Extension Period|Protocol Violation|0|||
124700987|NCT03715829|448528062|FG004|Extension Period|Protocol Violation|0|||
124700988|NCT03715829|448528063|FG005|Extension Period|Protocol Violation|0|||
124700989|NCT03715829|448528064|FG006|Extension Period|Protocol Violation|0|||
124700990|NCT03715829|448528065|FG007|Extension Period|Protocol Violation|0|||
124700991|NCT03715829|448528066|FG008|Extension Period|Protocol Violation|1|||
124700992|NCT03715829|448528067|FG009|Extension Period|Protocol Violation|0|||
124700993|NCT03715829|448528068|FG010|Extension Period|Protocol Violation|0|||
124700994|NCT03715829|448528058|FG000|Extension Period|Withdrawal by Subject|0|||
124700995|NCT03715829|448528059|FG001|Extension Period|Withdrawal by Subject|0|||
124700996|NCT03715829|448528060|FG002|Extension Period|Withdrawal by Subject|0|||
124700997|NCT03715829|448528061|FG003|Extension Period|Withdrawal by Subject|0|||
124700998|NCT03715829|448528062|FG004|Extension Period|Withdrawal by Subject|0|||
124700999|NCT03715829|448528063|FG005|Extension Period|Withdrawal by Subject|0|||
124701000|NCT03715829|448528064|FG006|Extension Period|Withdrawal by Subject|3|||
124701001|NCT03715829|448528065|FG007|Extension Period|Withdrawal by Subject|3|||
124701002|NCT03715829|448528066|FG008|Extension Period|Withdrawal by Subject|12|||
124701003|NCT03715829|448528067|FG009|Extension Period|Withdrawal by Subject|3|||
124701004|NCT03715829|448528068|FG010|Extension Period|Withdrawal by Subject|0|||
124763924|NCT04612725|448759866|FG002|Overall Study|Withdrawal by Subject|5|||
124763925|NCT04612725|448759867|FG003|Overall Study|Withdrawal by Subject|1|||
124929458|NCT04625725|449373269|FG002|Provent Sub Study|Death|8|||
124929459|NCT04625725|449373270|FG003|Provent Sub Study|Death|5|||
124929460|NCT04625725|449373271|FG004|Provent Sub Study|Death|0|||
124929461|NCT04625725|449373272|FG005|Provent Sub Study|Death|1|||
124929462|NCT04625725|449373267|FG000|Provent Sub Study|Adverse Event|0|||
124929463|NCT04625725|449373268|FG001|Provent Sub Study|Adverse Event|0|||
124929464|NCT04625725|449373269|FG002|Provent Sub Study|Adverse Event|0|||
124929465|NCT04625725|449373270|FG003|Provent Sub Study|Adverse Event|0|||
124929466|NCT04625725|449373271|FG004|Provent Sub Study|Adverse Event|0|||
124929467|NCT04625725|449373272|FG005|Provent Sub Study|Adverse Event|1|||
124455388|NCT01476475|447627155|FG000|Overall Study|Other reasons|4|||
124455389|NCT01476475|447627156|FG001|Overall Study|Other reasons|2|||
124455390|NCT01278745|447627157|FG000|Overall Study|Death|2|||
124455391|NCT01278745|447627158|FG001|Overall Study|Death|5|||
124455392|NCT01278745|447627159|FG002|Overall Study|Death|7|||
124701005|NCT03715829|448528058|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
124701006|NCT03715829|448528059|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
124701007|NCT03715829|448528060|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
124701008|NCT03715829|448528061|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
124929468|NCT04625725|449373267|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
124763926|NCT04612725|448759868|FG004|Overall Study|Withdrawal by Subject|9|||
124763927|NCT04612725|448759864|FG000|Overall Study|Other|0|||
124763928|NCT04612725|448759865|FG001|Overall Study|Other|0|||
124763929|NCT04612725|448759866|FG002|Overall Study|Other|0|||
124763930|NCT04612725|448759867|FG003|Overall Study|Other|0|||
124763931|NCT04612725|448759868|FG004|Overall Study|Other|1|||
124763932|NCT02354235|448759869|FG000|Overall Study|Adverse Event|2|||
124763933|NCT02354235|448759870|FG001|Overall Study|Adverse Event|2|||
124763934|NCT02354235|448759869|FG000|Overall Study|Physician Decision|0|||
124763935|NCT02354235|448759870|FG001|Overall Study|Physician Decision|1|||
124763936|NCT02354235|448759869|FG000|Overall Study|Withdrawal by Subject|1|||
124763937|NCT02354235|448759870|FG001|Overall Study|Withdrawal by Subject|3|||
124763938|NCT02354235|448759869|FG000|Overall Study|Conflict with the stopping criteria|0|||
124763939|NCT02354235|448759870|FG001|Overall Study|Conflict with the stopping criteria|1|||
124763940|NCT04750642|448759873|FG000|Overall Study|Adverse Event|1|||
124763941|NCT04750642|448759874|FG001|Overall Study|Adverse Event|0|||
124763942|NCT04750642|448759873|FG000|Overall Study|Withdrawal by Subject|0|||
124763943|NCT04750642|448759874|FG001|Overall Study|Withdrawal by Subject|1|||
124763944|NCT04750642|448759873|FG000|Overall Study|Protocol Violation|0|||
124455393|NCT01278745|447627160|FG003|Overall Study|Death|0|||
124455394|NCT01278745|447627157|FG000|Overall Study|Physician Decision|1|||
124455395|NCT01278745|447627158|FG001|Overall Study|Physician Decision|0|||
124455396|NCT01278745|447627159|FG002|Overall Study|Physician Decision|0|||
124455397|NCT01278745|447627160|FG003|Overall Study|Physician Decision|9|||
124701009|NCT03715829|448528062|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
124701010|NCT03715829|448528063|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
124701011|NCT03715829|448528064|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
124455398|NCT01278745|447627157|FG000|Overall Study|Withdrawal by Subject|1|||
124455399|NCT01278745|447627158|FG001|Overall Study|Withdrawal by Subject|1|||
124455400|NCT01278745|447627159|FG002|Overall Study|Withdrawal by Subject|5|||
124455401|NCT01278745|447627160|FG003|Overall Study|Withdrawal by Subject|1|||
124455402|NCT01278745|447627157|FG000|Overall Study|Sponsor Decision|1|||
124701012|NCT03715829|448528065|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
124701013|NCT03715829|448528066|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
124701014|NCT03715829|448528067|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
124701015|NCT03715829|448528068|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
124701016|NCT03715829|448528058|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
124701017|NCT03715829|448528059|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
124701018|NCT03715829|448528060|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
124701019|NCT03715829|448528061|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
124701020|NCT03715829|448528062|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
124763945|NCT04750642|448759874|FG001|Overall Study|Protocol Violation|1|||
124763946|NCT02926638|448759875|FG000|Overall Study|Progression|2|||
124763947|NCT02926638|448759876|FG001|Overall Study|Progression|5|||
124455403|NCT01278745|447627158|FG001|Overall Study|Sponsor Decision|0|||
124455404|NCT01278745|447627159|FG002|Overall Study|Sponsor Decision|62|||
124455405|NCT01278745|447627160|FG003|Overall Study|Sponsor Decision|6|||
124763948|NCT02926638|448759875|FG000|Overall Study|Ineligible|1|||
124763949|NCT02926638|448759876|FG001|Overall Study|Ineligible|0|||
124763950|NCT02926638|448759875|FG000|Overall Study|Not protocol specified|1|||
124455406|NCT01278745|447627157|FG000|Overall Study|Ineligible|0|||
124701021|NCT03715829|448528063|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
124455407|NCT01278745|447627158|FG001|Overall Study|Ineligible|0|||
124701022|NCT03715829|448528064|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
124701023|NCT03715829|448528065|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
124701024|NCT03715829|448528066|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
124701025|NCT03715829|448528067|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
124701026|NCT03715829|448528068|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
124701027|NCT03715829|448528058|FG000|Extension Period|Other|0|||
124701028|NCT03715829|448528059|FG001|Extension Period|Other|0|||
124701029|NCT03715829|448528060|FG002|Extension Period|Other|0|||
124701030|NCT03715829|448528061|FG003|Extension Period|Other|0|||
124701031|NCT03715829|448528062|FG004|Extension Period|Other|0|||
124701032|NCT03715829|448528063|FG005|Extension Period|Other|0|||
124701033|NCT03715829|448528064|FG006|Extension Period|Other|1|||
124701034|NCT03715829|448528065|FG007|Extension Period|Other|2|||
124701035|NCT03715829|448528066|FG008|Extension Period|Other|4|||
124701036|NCT03715829|448528067|FG009|Extension Period|Other|0|||
124701037|NCT03715829|448528068|FG010|Extension Period|Other|0|||
124701038|NCT03579719|448528069|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
124701039|NCT03253627|448528072|FG000|Overall Study|Lost to Follow-up|1|||
124701040|NCT03253627|448528073|FG001|Overall Study|Lost to Follow-up|2|||
124701041|NCT03253627|448528072|FG000|Overall Study|Withdrawal by Subject|0|||
124701042|NCT03253627|448528073|FG001|Overall Study|Withdrawal by Subject|2|||
124701043|NCT03253627|448528072|FG000|Overall Study|Inability to complete MRI|1|||
124701044|NCT03253627|448528073|FG001|Overall Study|Inability to complete MRI|0|||
124701045|NCT01922895|448528077|FG000|Overall Study|Death|0|||
124701046|NCT01922895|448528078|FG001|Overall Study|Death|1|||
124701047|NCT01922895|448528077|FG000|Overall Study|Withdrawal by Subject|1|||
124701048|NCT01922895|448528078|FG001|Overall Study|Withdrawal by Subject|2|||
124701049|NCT01922895|448528077|FG000|Overall Study|Lost to Follow-up|5|||
124701050|NCT01922895|448528078|FG001|Overall Study|Lost to Follow-up|11|||
124701051|NCT01916226|448528079|FG000|Overall Study|Adverse Event|1|||
124701052|NCT01916226|448528080|FG001|Overall Study|Adverse Event|0|||
124701053|NCT01916226|448528081|FG002|Overall Study|Adverse Event|1|||
124701054|NCT01916226|448528082|FG003|Overall Study|Adverse Event|1|||
124701055|NCT01916226|448528079|FG000|Overall Study|Lack of Efficacy|0|||
124701056|NCT01916226|448528080|FG001|Overall Study|Lack of Efficacy|0|||
124701057|NCT01916226|448528081|FG002|Overall Study|Lack of Efficacy|2|||
124701058|NCT01916226|448528082|FG003|Overall Study|Lack of Efficacy|1|||
124701059|NCT01916226|448528079|FG000|Overall Study|Protocol Violation|0|||
124701060|NCT01916226|448528080|FG001|Overall Study|Protocol Violation|1|||
124701061|NCT01916226|448528081|FG002|Overall Study|Protocol Violation|0|||
124701062|NCT01916226|448528082|FG003|Overall Study|Protocol Violation|1|||
124701063|NCT01916226|448528079|FG000|Overall Study|Physician Decision|0|||
124701064|NCT01916226|448528080|FG001|Overall Study|Physician Decision|0|||
124701065|NCT01916226|448528081|FG002|Overall Study|Physician Decision|0|||
124701066|NCT01916226|448528082|FG003|Overall Study|Physician Decision|1|||
124701067|NCT03163667|448528083|FG000|Overall Study|Death|15|||
124701068|NCT03163667|448528084|FG001|Overall Study|Death|27|||
124701069|NCT03163667|448528083|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
124701070|NCT03163667|448528084|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
124701071|NCT02940223|448528090|FG000|Overall Study|Failed Requirement|2|||
124701072|NCT02940223|448528091|FG001|Overall Study|Failed Requirement|0|||
124701073|NCT01422382|448528095|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
124929469|NCT04625725|449373268|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
124929470|NCT04625725|449373269|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
124929471|NCT04625725|449373270|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
124929472|NCT04625725|449373271|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
124929473|NCT04625725|449373272|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
124929474|NCT04625725|449373267|FG000|Provent Sub Study|Withdrawal by Subject|0|||
124929475|NCT04625725|449373268|FG001|Provent Sub Study|Withdrawal by Subject|0|||
124929476|NCT04625725|449373269|FG002|Provent Sub Study|Withdrawal by Subject|11|||
124929477|NCT04625725|449373270|FG003|Provent Sub Study|Withdrawal by Subject|13|||
124929478|NCT04625725|449373271|FG004|Provent Sub Study|Withdrawal by Subject|5|||
124455408|NCT01278745|447627159|FG002|Overall Study|Ineligible|42|||
124701074|NCT01813357|448528096|FG000|Overall Study|Lost to Follow-up|5|||
124701075|NCT01813357|448528097|FG001|Overall Study|Lost to Follow-up|6|||
124701076|NCT03773562|448528098|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
124701077|NCT03773562|448528098|FG000|Overall Study|Lost to Follow-up|10|||
124701078|NCT03773562|448528098|FG000|Overall Study|Withdrawal by Subject|1|||
124701079|NCT04082364|448528101|FG000|Overall Study|Death|23|||
124455409|NCT01278745|447627160|FG003|Overall Study|Ineligible|61|||
124701080|NCT04082364|448528102|FG001|Overall Study|Death|1|||
124701081|NCT04082364|448528103|FG002|Overall Study|Death|1|||
124701082|NCT04082364|448528104|FG003|Overall Study|Death|2|||
124701083|NCT04082364|448528105|FG004|Overall Study|Death|1|||
124701084|NCT04082364|448528101|FG000|Overall Study|Lost to Follow-up|1|||
124701085|NCT04082364|448528102|FG001|Overall Study|Lost to Follow-up|0|||
124701086|NCT04082364|448528103|FG002|Overall Study|Lost to Follow-up|0|||
124701087|NCT04082364|448528104|FG003|Overall Study|Lost to Follow-up|0|||
124701088|NCT04082364|448528105|FG004|Overall Study|Lost to Follow-up|1|||
124701089|NCT04082364|448528101|FG000|Overall Study|Physician Decision|1|||
124701090|NCT04082364|448528102|FG001|Overall Study|Physician Decision|1|||
124701091|NCT04082364|448528103|FG002|Overall Study|Physician Decision|0|||
124701092|NCT04082364|448528104|FG003|Overall Study|Physician Decision|2|||
124701093|NCT04082364|448528105|FG004|Overall Study|Physician Decision|1|||
124701094|NCT04082364|448528101|FG000|Overall Study|Withdrawal by Subject|1|||
124701095|NCT04082364|448528102|FG001|Overall Study|Withdrawal by Subject|1|||
124701096|NCT04082364|448528103|FG002|Overall Study|Withdrawal by Subject|0|||
124701097|NCT04082364|448528104|FG003|Overall Study|Withdrawal by Subject|0|||
124701098|NCT04082364|448528105|FG004|Overall Study|Withdrawal by Subject|1|||
124701099|NCT04082364|448528101|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
124701100|NCT04082364|448528102|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
124701101|NCT04082364|448528103|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
124701102|NCT04082364|448528104|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
124701103|NCT04082364|448528105|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
124701104|NCT04082364|448528101|FG000|Overall Study|Disease progression|0|||
124701105|NCT04082364|448528102|FG001|Overall Study|Disease progression|0|||
124701106|NCT04082364|448528103|FG002|Overall Study|Disease progression|0|||
124701107|NCT04082364|448528104|FG003|Overall Study|Disease progression|1|||
124701108|NCT04082364|448528105|FG004|Overall Study|Disease progression|0|||
124701109|NCT04806373|448528107|FG000|Overall Study|Withdrawal by Subject|1|||
124701110|NCT04806373|448528108|FG001|Overall Study|Withdrawal by Subject|1|||
124701111|NCT03301415|448528111|FG000|Overall Study|Lost to Follow-up|2|||
124701112|NCT03301415|448528111|FG000|Overall Study|Unable to comply with visit schedule|2|||
124701113|NCT02412436|448528112|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
124701114|NCT02412436|448528112|FG000|Overall Study|Lost to Follow-up|6|||
124701115|NCT02412436|448528112|FG000|Overall Study|Unable to get to clinic|3|||
124701116|NCT02412436|448528112|FG000|Overall Study|Death|1|||
124701117|NCT02412436|448528112|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
124701118|NCT04090749|448528116|FG000|Open Label Pilot|Lost to Follow-up|1|||
124701119|NCT04090749|448528117|FG001|Open Label Pilot|Lost to Follow-up|0|||
124701120|NCT04090749|448528118|FG002|Open Label Pilot|Lost to Follow-up|0|||
124701121|NCT04090749|448528116|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
124701122|NCT04090749|448528117|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
124701123|NCT04090749|448528118|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
124701124|NCT04090749|448528116|FG000|Pilot Trial|Lost to Follow-up|0|||
124701125|NCT04090749|448528117|FG001|Pilot Trial|Lost to Follow-up|1|||
124701126|NCT04090749|448528118|FG002|Pilot Trial|Lost to Follow-up|1|||
124701127|NCT02528305|448528119|FG000|Overall Study|Withdrawal by Subject|1|||
124701128|NCT02528305|448528119|FG000|Overall Study|Adverse Event|1|||
124701129|NCT02528305|448528119|FG000|Overall Study|Physician Decision|1|||
124701130|NCT02184442|448528120|FG000|Overall Study|Death|61|||
124701131|NCT02184442|448528121|FG001|Overall Study|Death|65|||
124701132|NCT02184442|448528120|FG000|Overall Study|Withdrawal by Subject|3|||
124701133|NCT02184442|448528121|FG001|Overall Study|Withdrawal by Subject|11|||
124701134|NCT01852214|448528122|FG000|Period 1|Adverse Event|1|||
124701135|NCT01852214|448528123|FG001|Period 1|Adverse Event|2|||
124701136|NCT01852214|448528122|FG000|Period 1|Withdrawal by Subject|0|||
124701137|NCT01852214|448528123|FG001|Period 1|Withdrawal by Subject|1|||
124701138|NCT01852214|448528122|FG000|Washout Period|Withdrawal by Subject|0|||
124701139|NCT01852214|448528123|FG001|Washout Period|Withdrawal by Subject|1|||
124701140|NCT04091438|448528124|FG000|Treatment Period 1 (1 Day)|Other|1|||
124701141|NCT04091438|448528125|FG001|Treatment Period 1 (1 Day)|Other|0|||
124701142|NCT04091438|448528124|FG000|Washout Period (1 Day)|Protocol deviation|0|||
124701143|NCT04091438|448528125|FG001|Washout Period (1 Day)|Protocol deviation|1|||
124701144|NCT04091438|448528124|FG000|Washout Period (1 Day)|Other|0|||
124701145|NCT04091438|448528125|FG001|Washout Period (1 Day)|Other|1|||
124701146|NCT00421408|448528126|FG000|Overall Study|Lost to Follow-up|30|||
124701147|NCT00421408|448528127|FG001|Overall Study|Lost to Follow-up|20|||
124701148|NCT00421408|448528126|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
124701149|NCT00421408|448528127|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
124701150|NCT00787800|448528131|FG000|Overall Study|Withdrawal by Subject|3|||
124701151|NCT00787800|448528132|FG001|Overall Study|Withdrawal by Subject|5|||
124701152|NCT00787800|448528131|FG000|Overall Study|Death|0|||
124701153|NCT00787800|448528132|FG001|Overall Study|Death|2|||
124701154|NCT04309500|448528135|FG000|Overall Study|Lost to Follow-up|1|||
124701155|NCT04309500|448528136|FG001|Overall Study|Lost to Follow-up|0|||
124701156|NCT04309500|448528137|FG002|Overall Study|Lost to Follow-up|0|||
124701157|NCT04309500|448528138|FG003|Overall Study|Lost to Follow-up|0|||
124701158|NCT00913835|448528139|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
124701159|NCT00913835|448528140|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
124701160|NCT00913835|448528139|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
124701161|NCT00913835|448528140|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
124701162|NCT00913835|448528139|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
124701163|NCT00913835|448528140|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
124701164|NCT00913835|448528139|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
124701165|NCT00913835|448528140|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
124701166|NCT00913835|448528139|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
124701167|NCT00913835|448528140|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
124701168|NCT01308788|448528141|FG000|2-year Treatment|medication change by treating physician|4|||
124701169|NCT01308788|448528142|FG001|2-year Treatment|medication change by treating physician|11|||
124701170|NCT02414841|448528143|FG000|Overall Study|Withdrawal by Subject|7|||
124701171|NCT02414841|448528144|FG001|Overall Study|Withdrawal by Subject|5|||
124701172|NCT02414841|448528143|FG000|Overall Study|Lost to Follow-up|13|||
124701173|NCT02414841|448528144|FG001|Overall Study|Lost to Follow-up|6|||
124701174|NCT02414841|448528143|FG000|Overall Study|Death|17|||
124701175|NCT02414841|448528144|FG001|Overall Study|Death|14|||
124701176|NCT02414841|448528143|FG000|Overall Study|Received a Kidney Transplant|13|||
124701177|NCT02414841|448528144|FG001|Overall Study|Received a Kidney Transplant|4|||
124701178|NCT02414841|448528143|FG000|Overall Study|Randomized But Not Treated|6|||
124701179|NCT02414841|448528144|FG001|Overall Study|Randomized But Not Treated|4|||
124701180|NCT03249558|448528147|FG000|Overall Study|Lost to Follow-up|2|||
124701181|NCT03249558|448528148|FG001|Overall Study|Lost to Follow-up|1|||
124701182|NCT03249558|448528149|FG002|Overall Study|Lost to Follow-up|4|||
124701183|NCT03249558|448528147|FG000|Overall Study|Physician Decision|1|||
124701184|NCT03249558|448528148|FG001|Overall Study|Physician Decision|0|||
124701185|NCT03249558|448528149|FG002|Overall Study|Physician Decision|0|||
124701186|NCT03249558|448528147|FG000|Overall Study|Withdrawal by Subject|6|||
124701187|NCT03249558|448528148|FG001|Overall Study|Withdrawal by Subject|5|||
124701188|NCT03249558|448528149|FG002|Overall Study|Withdrawal by Subject|7|||
124701189|NCT03249558|448528147|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
124701190|NCT03249558|448528148|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
124701191|NCT03249558|448528149|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
124701192|NCT03249558|448528147|FG000|Overall Study|Protocol Violation|1|||
124701193|NCT03249558|448528148|FG001|Overall Study|Protocol Violation|1|||
124701194|NCT03249558|448528149|FG002|Overall Study|Protocol Violation|2|||
124701195|NCT00964678|448528150|FG000|Overall Study|Physician Decision|4|||
124701196|NCT03164356|448528151|FG000|Overall Study|Lost to Follow-up|1|||
124701197|NCT03164356|448528152|FG001|Overall Study|Lost to Follow-up|1|||
124701198|NCT03164356|448528153|FG002|Overall Study|Lost to Follow-up|2|||
124701199|NCT03164356|448528154|FG003|Overall Study|Lost to Follow-up|1|||
124701200|NCT03164356|448528151|FG000|Overall Study|Physician Decision|0|||
124701201|NCT03164356|448528152|FG001|Overall Study|Physician Decision|0|||
124701202|NCT03164356|448528153|FG002|Overall Study|Physician Decision|3|||
124701203|NCT03164356|448528154|FG003|Overall Study|Physician Decision|0|||
124701204|NCT03164356|448528151|FG000|Overall Study|Protocol Violation|2|||
124701205|NCT03164356|448528152|FG001|Overall Study|Protocol Violation|1|||
124701206|NCT03164356|448528153|FG002|Overall Study|Protocol Violation|0|||
124701207|NCT03164356|448528154|FG003|Overall Study|Protocol Violation|0|||
124701208|NCT03164356|448528151|FG000|Overall Study|Withdrawal by Subject|1|||
124701209|NCT03164356|448528152|FG001|Overall Study|Withdrawal by Subject|0|||
124701210|NCT03164356|448528153|FG002|Overall Study|Withdrawal by Subject|0|||
124701211|NCT03164356|448528154|FG003|Overall Study|Withdrawal by Subject|0|||
124701212|NCT03164356|448528151|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
124701213|NCT03164356|448528152|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
124701214|NCT03164356|448528153|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
124701215|NCT03164356|448528154|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
124701216|NCT03164356|448528151|FG000|Overall Study|Subject Incarcerated|0|||
124701217|NCT03164356|448528152|FG001|Overall Study|Subject Incarcerated|1|||
124701218|NCT03164356|448528153|FG002|Overall Study|Subject Incarcerated|0|||
124701219|NCT03164356|448528154|FG003|Overall Study|Subject Incarcerated|0|||
124701220|NCT03164356|448528151|FG000|Overall Study|Prosthetist unable to participate|0|||
124701221|NCT03164356|448528152|FG001|Overall Study|Prosthetist unable to participate|2|||
124701222|NCT03164356|448528153|FG002|Overall Study|Prosthetist unable to participate|1|||
124701223|NCT03164356|448528154|FG003|Overall Study|Prosthetist unable to participate|0|||
124701224|NCT05943990|448528155|FG000|Overall Study|Study Terminated by Sponsor|0|||
124701225|NCT05943990|448528156|FG001|Overall Study|Study Terminated by Sponsor|0|||
124701226|NCT05943990|448528157|FG002|Overall Study|Study Terminated by Sponsor|1|||
124701227|NCT02657356|448529201|FG000|Overall Study|Death|1|||
124701228|NCT02657356|448529202|FG001|Overall Study|Death|0|||
124701229|NCT02657356|448529201|FG000|Overall Study|Withdrawal by Subject|5|||
124701230|NCT02657356|448529202|FG001|Overall Study|Withdrawal by Subject|6|||
124701231|NCT02657356|448529201|FG000|Overall Study|Terminated by Sponsor|8|||
124763951|NCT02926638|448759876|FG001|Overall Study|Not protocol specified|0|||
124763952|NCT00644423|448761275|FG000|Overall Study|Lost to Follow-up|1|||
124763953|NCT00644423|448761276|FG001|Overall Study|Lost to Follow-up|1|||
124763954|NCT02426580|448761277|FG000|Overall Study|Death|2|||
124763955|NCT02426580|448761278|FG001|Overall Study|Death|2|||
124763956|NCT02426580|448761277|FG000|Overall Study|Lost to Follow-up|0|||
124763957|NCT02426580|448761278|FG001|Overall Study|Lost to Follow-up|9|||
124763958|NCT02426580|448761277|FG000|Overall Study|transfer to hemodialysis|5|||
124763959|NCT02426580|448761278|FG001|Overall Study|transfer to hemodialysis|5|||
124763960|NCT02426580|448761277|FG000|Overall Study|Kidney transplant|3|||
124763961|NCT02426580|448761278|FG001|Overall Study|Kidney transplant|0|||
124763962|NCT02426580|448761277|FG000|Overall Study|Allergic to egg white|1|||
124763963|NCT02426580|448761278|FG001|Overall Study|Allergic to egg white|0|||
124763964|NCT00445549|448761279|FG000|Overall Study|progressive disease|12|||
124763965|NCT00768989|448761280|FG000|Prior to Week 24|Withdrawal by Subject|1|||
124763966|NCT00768989|448761281|FG001|Prior to Week 24|Withdrawal by Subject|0|||
124763967|NCT00768989|448761280|FG000|Prior to Week 24|Adverse Event|3|||
124763968|NCT00768989|448761281|FG001|Prior to Week 24|Adverse Event|0|||
124763969|NCT00768989|448761280|FG000|Prior to Week 24|Lost to Follow-up|0|||
124763970|NCT00768989|448761281|FG001|Prior to Week 24|Lost to Follow-up|1|||
124763971|NCT00768989|448761280|FG000|Prior to Week 24|Protocol Violation|0|||
124763972|NCT00768989|448761281|FG001|Prior to Week 24|Protocol Violation|2|||
124763973|NCT00768989|448761280|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
124763974|NCT00768989|448761281|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
124763975|NCT00768989|448761280|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
124763976|NCT00768989|448761281|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
124763977|NCT00768989|448761280|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
124763978|NCT00768989|448761281|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
124763979|NCT00768989|448761280|FG000|On or After Week 36|Lack of Efficacy|1|||
124763980|NCT00768989|448761281|FG001|On or After Week 36|Lack of Efficacy|0|||
124763981|NCT00768989|448761280|FG000|On or After Week 36|Adverse Event|0|||
124763982|NCT00768989|448761281|FG001|On or After Week 36|Adverse Event|1|||
124763983|NCT00768989|448761280|FG000|On or After Week 36|Lost to Follow-up|1|||
124763984|NCT00768989|448761281|FG001|On or After Week 36|Lost to Follow-up|0|||
124763985|NCT00768989|448761280|FG000|On or After Week 36|Poor Compliance|1|||
124763986|NCT00768989|448761281|FG001|On or After Week 36|Poor Compliance|0|||
124763987|NCT00768989|448761280|FG000|On or After Week 36|Protocol Violation|1|||
124763988|NCT00768989|448761281|FG001|On or After Week 36|Protocol Violation|0|||
124763989|NCT00768989|448761280|FG000|On or After Week 36|Did not attend termination visit|2|||
124763990|NCT00768989|448761281|FG001|On or After Week 36|Did not attend termination visit|0|||
124763991|NCT00768989|448761280|FG000|On or After Week 36|Sponsor Termination|45|||
124763992|NCT00768989|448761281|FG001|On or After Week 36|Sponsor Termination|26|||
124763993|NCT00718510|448761288|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
124763994|NCT00718510|448761289|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
124763995|NCT00718510|448761288|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
124763996|NCT00718510|448761289|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
124763997|NCT00844376|448761295|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
124763998|NCT00844376|448761296|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
124763999|NCT01011673|448761297|FG000|Randomized|Secondary headache|2|||
124764000|NCT01011673|448761298|FG001|Randomized|Secondary headache|1|||
124929479|NCT04625725|449373272|FG005|Provent Sub Study|Withdrawal by Subject|6|||
124929480|NCT04625725|449373267|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
124929481|NCT04625725|449373268|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
124929482|NCT04625725|449373269|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
124929483|NCT04625725|449373270|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
124929484|NCT04625725|449373271|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
124929485|NCT04625725|449373272|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
124929486|NCT03298451|449373276|FG000|Overall Study|Death|275|||
124929487|NCT03298451|449373277|FG001|Overall Study|Death|260|||
124764001|NCT01011673|448761297|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
124929488|NCT03298451|449373278|FG002|Overall Study|Death|122|||
124764002|NCT01011673|448761298|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
124764003|NCT00549640|448761299|FG000|Overall Study|Withdrawal by Subject|6|||
124764004|NCT00549640|448761300|FG001|Overall Study|Withdrawal by Subject|12|||
124764005|NCT00549640|448761299|FG000|Overall Study|Adverse Event|5|||
124764006|NCT00549640|448761300|FG001|Overall Study|Adverse Event|0|||
124764007|NCT00549640|448761299|FG000|Overall Study|Lost to Follow-up|7|||
124764008|NCT00549640|448761300|FG001|Overall Study|Lost to Follow-up|4|||
124764009|NCT00660192|448761301|FG000|Overall Study|Lost to Follow-up|2|||
124929489|NCT03298451|449373279|FG003|Overall Study|Death|280|||
124929490|NCT03298451|449373276|FG000|Overall Study|Lost to Follow-up|1|||
124929491|NCT03298451|449373277|FG001|Overall Study|Lost to Follow-up|1|||
124929492|NCT03298451|449373278|FG002|Overall Study|Lost to Follow-up|0|||
124929493|NCT03298451|449373279|FG003|Overall Study|Lost to Follow-up|7|||
124929494|NCT03298451|449373276|FG000|Overall Study|Withdrawal by Subject|9|||
124929495|NCT03298451|449373277|FG001|Overall Study|Withdrawal by Subject|7|||
124929496|NCT03298451|449373278|FG002|Overall Study|Withdrawal by Subject|1|||
124929497|NCT03298451|449373279|FG003|Overall Study|Withdrawal by Subject|20|||
124929498|NCT01651403|449373282|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
124929499|NCT01651403|449373283|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
124929500|NCT01651403|449373282|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
124929501|NCT01651403|449373283|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
124929502|NCT01651403|449373282|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
124929503|NCT01651403|449373283|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
124929504|NCT01651403|449373282|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
124929505|NCT01651403|449373283|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
124929506|NCT01651403|449373282|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
124929507|NCT01651403|449373283|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
124929508|NCT01651403|449373282|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
124929509|NCT01651403|449373283|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
124929510|NCT05873556|449373284|FG000|Overall Study|Lost to Follow-up|4|||
124929511|NCT05873556|449373285|FG001|Overall Study|Lost to Follow-up|1|||
124929512|NCT03381586|449373286|FG000|Overall Study|Adverse Event|1|||
124929513|NCT03381586|449373287|FG001|Overall Study|Adverse Event|1|||
124929514|NCT03381586|449373286|FG000|Overall Study|Protocol Violation|1|||
124701232|NCT02657356|448529202|FG001|Overall Study|Terminated by Sponsor|5|||
124701233|NCT02657356|448529201|FG000|Overall Study|Rolled over to EAP study|6|||
124701234|NCT02657356|448529202|FG001|Overall Study|Rolled over to EAP study|4|||
124701235|NCT03379870|448529203|FG000|Overall Study|Lost to Follow-up|1|||
124701236|NCT03379870|448529204|FG001|Overall Study|Lost to Follow-up|0|||
124701237|NCT03379870|448529203|FG000|Overall Study|Protocol Violation|1|||
124701238|NCT03379870|448529204|FG001|Overall Study|Protocol Violation|1|||
124701239|NCT01394185|448529205|FG000|Overall Study|Withdrawal by Subject|2|||
124701240|NCT01394185|448529206|FG001|Overall Study|Withdrawal by Subject|0|||
124701241|NCT01394185|448529207|FG002|Overall Study|Withdrawal by Subject|0|||
124701242|NCT01394185|448529208|FG003|Overall Study|Withdrawal by Subject|0|||
124701243|NCT01394185|448529209|FG004|Overall Study|Withdrawal by Subject|1|||
124701244|NCT01394185|448529210|FG005|Overall Study|Withdrawal by Subject|0|||
124701245|NCT01394185|448529205|FG000|Overall Study|Change in protocol|3|||
124701246|NCT01394185|448529206|FG001|Overall Study|Change in protocol|0|||
124701247|NCT01394185|448529207|FG002|Overall Study|Change in protocol|0|||
124701248|NCT01394185|448529208|FG003|Overall Study|Change in protocol|0|||
124701249|NCT01394185|448529209|FG004|Overall Study|Change in protocol|3|||
124701250|NCT01394185|448529210|FG005|Overall Study|Change in protocol|0|||
124701251|NCT01394185|448529205|FG000|Overall Study|Protocol Violation|1|||
124701252|NCT01394185|448529206|FG001|Overall Study|Protocol Violation|0|||
124701253|NCT01394185|448529207|FG002|Overall Study|Protocol Violation|0|||
124701254|NCT01394185|448529208|FG003|Overall Study|Protocol Violation|1|||
124701255|NCT01394185|448529209|FG004|Overall Study|Protocol Violation|0|||
124701256|NCT01394185|448529210|FG005|Overall Study|Protocol Violation|1|||
124701257|NCT02904265|448529211|FG000|Overall Study|Physician Decision|1|||
124701258|NCT02904265|448529212|FG001|Overall Study|Physician Decision|2|||
124701259|NCT01557569|448529217|FG000|Overall Study|Adverse Event|2|||
124701260|NCT01557569|448529218|FG001|Overall Study|Adverse Event|0|||
124701261|NCT01557569|448529217|FG000|Overall Study|high blood pressure|0|||
124701262|NCT01557569|448529218|FG001|Overall Study|high blood pressure|1|||
124701263|NCT01557569|448529217|FG000|Overall Study|Withdrawal by Subject|3|||
124701264|NCT01557569|448529218|FG001|Overall Study|Withdrawal by Subject|5|||
124701265|NCT01557569|448529217|FG000|Overall Study|noncompliance with rules of residential|0|||
124701266|NCT01557569|448529218|FG001|Overall Study|noncompliance with rules of residential|1|||
124701267|NCT00267488|448529219|FG000|Overall Study|Sponsor Terminated Study|9|||
124701268|NCT00267488|448529219|FG000|Overall Study|Protocol Violation|1|||
124701269|NCT00267488|448529219|FG000|Overall Study|Other (Disease Progression)|1|||
124929515|NCT03381586|449373287|FG001|Overall Study|Protocol Violation|0|||
124701270|NCT02254460|448529220|FG000|Overall Study|Adverse Event|1|||
124701271|NCT02254460|448529221|FG001|Overall Study|Adverse Event|0|||
124701272|NCT01817777|448529224|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
124701273|NCT01817777|448529225|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
124701274|NCT01817777|448529226|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
124701275|NCT01817777|448529224|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
124701276|NCT01817777|448529225|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
124701277|NCT01817777|448529226|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
124929516|NCT03381586|449373286|FG000|Overall Study|Withdrawal by Subject|1|||
124929517|NCT03381586|449373287|FG001|Overall Study|Withdrawal by Subject|2|||
124701278|NCT01817777|448529224|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
124455410|NCT01278745|447627157|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
124455411|NCT01278745|447627158|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
124455412|NCT01278745|447627159|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
124455413|NCT01278745|447627160|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
124455414|NCT01111851|447627161|FG000|Overall Study|All planned PET scans were not obtained.|2|||
124455415|NCT01111851|447627162|FG001|Overall Study|All planned PET scans were not obtained.|0|||
124455416|NCT01471015|447627163|FG000|Overall Study|Death|0|||
124455417|NCT01471015|447627164|FG001|Overall Study|Death|1|||
124455418|NCT01471015|447627165|FG002|Overall Study|Death|1|||
124455419|NCT02576444|447627166|FG000|Overall Study|Death|1|||
124455420|NCT02576444|447627167|FG001|Overall Study|Death|1|||
124455421|NCT02576444|447627168|FG002|Overall Study|Death|0|||
124701279|NCT01817777|448529225|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
124764010|NCT00660192|448761302|FG001|Overall Study|Lost to Follow-up|3|||
124764011|NCT02734693|448761303|FG000|Overall Study|Adverse Event|1|||
124929518|NCT05299723|449374609|FG000|Overall Study|Withdrawal by Subject|0|||
124929519|NCT05299723|449374610|FG001|Overall Study|Withdrawal by Subject|2|||
124929520|NCT05299723|449374611|FG002|Overall Study|Withdrawal by Subject|0|||
124929521|NCT03220035|449374612|FG000|Overall Study|Adverse Event|1|||
124929522|NCT03220035|449374612|FG000|Overall Study|Protocol Violation|1|||
124929523|NCT03220035|449374612|FG000|Overall Study|Progressive Disease|2|||
124929524|NCT00696111|449374613|FG000|Overall Study|Withdrawal by Subject|17|||
124929525|NCT04447040|449374619|FG000|Overall Study|Lost to Follow-up|2|||
124929526|NCT04447040|449374620|FG001|Overall Study|Lost to Follow-up|1|||
124929527|NCT04447040|449374621|FG002|Overall Study|Lost to Follow-up|3|||
124929528|NCT04447040|449374622|FG003|Overall Study|Lost to Follow-up|3|||
124929529|NCT04447040|449374623|FG004|Overall Study|Lost to Follow-up|1|||
124929530|NCT04447040|449374624|FG005|Overall Study|Lost to Follow-up|3|||
124929531|NCT04447040|449374619|FG000|Overall Study|Withdrawal by Subject|0|||
124929532|NCT04447040|449374620|FG001|Overall Study|Withdrawal by Subject|1|||
124929533|NCT04447040|449374621|FG002|Overall Study|Withdrawal by Subject|1|||
124929534|NCT04447040|449374622|FG003|Overall Study|Withdrawal by Subject|1|||
124929535|NCT04447040|449374623|FG004|Overall Study|Withdrawal by Subject|0|||
124929536|NCT04447040|449374624|FG005|Overall Study|Withdrawal by Subject|0|||
124929537|NCT04076618|449374625|FG000|Overall Study|Lost to Follow-up|2|||
124929538|NCT04076618|449374626|FG001|Overall Study|Lost to Follow-up|1|||
124929539|NCT04076618|449374627|FG002|Overall Study|Lost to Follow-up|3|||
124929540|NCT04076618|449374625|FG000|Overall Study|Withdrawal by Subject|3|||
124929541|NCT04076618|449374626|FG001|Overall Study|Withdrawal by Subject|1|||
124929542|NCT04076618|449374627|FG002|Overall Study|Withdrawal by Subject|2|||
124929543|NCT04076618|449374625|FG000|Overall Study|Relocated out of state|0|||
124929544|NCT04076618|449374626|FG001|Overall Study|Relocated out of state|2|||
124929545|NCT04076618|449374627|FG002|Overall Study|Relocated out of state|0|||
124929546|NCT04076618|449374625|FG000|Overall Study|COVID concerns|0|||
124929547|NCT04076618|449374626|FG001|Overall Study|COVID concerns|1|||
124929548|NCT04076618|449374627|FG002|Overall Study|COVID concerns|0|||
124929549|NCT04076618|449374625|FG000|Overall Study|Adverse Event|0|||
124455422|NCT02576444|447627169|FG003|Overall Study|Death|0|||
124455423|NCT02576444|447627166|FG000|Overall Study|Withdrawal by Subject|0|||
124455424|NCT02576444|447627167|FG001|Overall Study|Withdrawal by Subject|0|||
124701280|NCT01817777|448529226|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
124701281|NCT01817777|448529224|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
124701282|NCT01817777|448529225|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
124701283|NCT01817777|448529226|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
124701284|NCT01817777|448529224|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
124701285|NCT01817777|448529225|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
124701286|NCT01817777|448529226|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
124701287|NCT00557440|448529227|FG000|Treatment Period 1|Adverse Event|0|||
124701288|NCT00557440|448529228|FG001|Treatment Period 1|Adverse Event|0|||
124701289|NCT00557440|448529229|FG002|Treatment Period 1|Adverse Event|1|||
124701290|NCT03524157|448529230|FG000|Overall Study|cytology not readable|0|||
124701291|NCT03524157|448529231|FG001|Overall Study|cytology not readable|0|||
124701292|NCT03524157|448529232|FG002|Overall Study|cytology not readable|1|||
124701293|NCT01592747|448529233|FG000|Overall Study|Loss of Therapeutic Response|107|||
124701294|NCT01592747|448529234|FG001|Overall Study|Loss of Therapeutic Response|108|||
124701295|NCT01592747|448529235|FG002|Overall Study|Loss of Therapeutic Response|100|||
124701296|NCT01592747|448529233|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
124701297|NCT01592747|448529234|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
124929550|NCT04076618|449374626|FG001|Overall Study|Adverse Event|0|||
124929551|NCT04076618|449374627|FG002|Overall Study|Adverse Event|2|||
124764012|NCT02734693|448761304|FG001|Overall Study|Adverse Event|3|||
124929552|NCT01928394|449374628|FG000|Treatment Period|Disease progression|17|||
124929553|NCT01928394|449374629|FG001|Treatment Period|Disease progression|2|||
124929554|NCT01928394|449374630|FG002|Treatment Period|Disease progression|12|||
124929555|NCT01928394|449374631|FG003|Treatment Period|Disease progression|48|||
124929556|NCT01928394|449374632|FG004|Treatment Period|Disease progression|3|||
124701298|NCT01592747|448529235|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
124701299|NCT01592747|448529233|FG000|Overall Study|Adverse Event|1|||
124701300|NCT01592747|448529234|FG001|Overall Study|Adverse Event|0|||
124701301|NCT01592747|448529235|FG002|Overall Study|Adverse Event|0|||
124701302|NCT01592747|448529233|FG000|Overall Study|Protocol Violation|4|||
124701303|NCT01592747|448529234|FG001|Overall Study|Protocol Violation|0|||
124701304|NCT01592747|448529235|FG002|Overall Study|Protocol Violation|4|||
124701305|NCT01592747|448529233|FG000|Overall Study|Lack of Efficacy|0|||
124701306|NCT01592747|448529234|FG001|Overall Study|Lack of Efficacy|1|||
124701307|NCT01592747|448529235|FG002|Overall Study|Lack of Efficacy|0|||
124701308|NCT01592747|448529233|FG000|Overall Study|Withdrawal by Subject|2|||
124701309|NCT01592747|448529234|FG001|Overall Study|Withdrawal by Subject|0|||
124701310|NCT01592747|448529235|FG002|Overall Study|Withdrawal by Subject|2|||
124701311|NCT01592747|448529233|FG000|Overall Study|Lost to Follow-up|1|||
124701312|NCT01592747|448529234|FG001|Overall Study|Lost to Follow-up|0|||
124701313|NCT01592747|448529235|FG002|Overall Study|Lost to Follow-up|1|||
124701314|NCT01592747|448529233|FG000|Overall Study|Other Reasons|1|||
124701315|NCT01592747|448529234|FG001|Overall Study|Other Reasons|1|||
124701316|NCT01592747|448529235|FG002|Overall Study|Other Reasons|0|||
124701317|NCT02853136|448529236|FG000|Wash-out|Adverse Event|0|||
124701318|NCT02853136|448529237|FG001|Wash-out|Adverse Event|0|||
124701319|NCT02853136|448529238|FG002|Wash-out|Adverse Event|0|||
124701320|NCT02853136|448529239|FG003|Wash-out|Adverse Event|1|||
124701321|NCT00867334|448529240|FG000|Overall Study|Withdrawal by Subject|0|||
124701322|NCT00867334|448529241|FG001|Overall Study|Withdrawal by Subject|1|||
124701323|NCT00867334|448529240|FG000|Overall Study|Withdrawal by Subject|1|||
124701324|NCT00867334|448529241|FG001|Overall Study|Withdrawal by Subject|0|||
124701325|NCT00867334|448529240|FG000|Overall Study|Withdrawal by Subject|1|||
124701326|NCT00867334|448529241|FG001|Overall Study|Withdrawal by Subject|0|||
124701327|NCT05418426|448529243|FG000|Overall Study|Adverse Event|0|||
124701328|NCT05418426|448529244|FG001|Overall Study|Adverse Event|1|||
124701329|NCT05418426|448529245|FG002|Overall Study|Adverse Event|0|||
124701330|NCT05418426|448529243|FG000|Overall Study|Withdrawal by Subject|0|||
124701331|NCT05418426|448529244|FG001|Overall Study|Withdrawal by Subject|1|||
124701332|NCT05418426|448529245|FG002|Overall Study|Withdrawal by Subject|0|||
124701333|NCT05418426|448529243|FG000|Overall Study|Protocol Violation|0|||
124701334|NCT05418426|448529244|FG001|Overall Study|Protocol Violation|0|||
124701335|NCT05418426|448529245|FG002|Overall Study|Protocol Violation|1|||
124701336|NCT04620668|448529246|FG000|Overall Study|Withdrawal by Subject|2|||
124701337|NCT04620668|448529247|FG001|Overall Study|Withdrawal by Subject|0|||
124701338|NCT04620668|448529246|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
124701339|NCT04620668|448529247|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
124701340|NCT04620668|448529246|FG000|Overall Study|Removed before analysis: missing data|2|||
124701341|NCT04620668|448529247|FG001|Overall Study|Removed before analysis: missing data|0|||
124701342|NCT04620668|448529246|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
124701343|NCT04620668|448529247|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
124701344|NCT04620668|448529246|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
124701345|NCT04620668|448529247|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
124701346|NCT02951819|448529252|FG000|Overall Study|Death|9|||
124701347|NCT02951819|448529253|FG001|Overall Study|Death|7|||
124701348|NCT02951819|448529252|FG000|Overall Study|Withdrawal by Subject|3|||
124701349|NCT02951819|448529253|FG001|Overall Study|Withdrawal by Subject|0|||
124929557|NCT01928394|449374633|FG005|Treatment Period|Disease progression|25|||
124929558|NCT01928394|449374634|FG006|Treatment Period|Disease progression|38|||
124929559|NCT01928394|449374635|FG007|Treatment Period|Disease progression|16|||
124929560|NCT01928394|449374636|FG008|Treatment Period|Disease progression|3|||
124929561|NCT01928394|449374637|FG009|Treatment Period|Disease progression|11|||
124929562|NCT01928394|449374638|FG010|Treatment Period|Disease progression|22|||
124929563|NCT01928394|449374639|FG011|Treatment Period|Disease progression|73|||
124929564|NCT01928394|449374640|FG012|Treatment Period|Disease progression|38|||
124929565|NCT01928394|449374641|FG013|Treatment Period|Disease progression|118|||
124929566|NCT01928394|449374642|FG014|Treatment Period|Disease progression|59|||
124701350|NCT02951819|448529252|FG000|Overall Study|Adverse Event|1|||
124701351|NCT02951819|448529253|FG001|Overall Study|Adverse Event|0|||
124701352|NCT02951819|448529252|FG000|Overall Study|Lack of Efficacy|4|||
124701353|NCT02951819|448529253|FG001|Overall Study|Lack of Efficacy|0|||
124701354|NCT02951819|448529252|FG000|Overall Study|Lost to Follow-up|1|||
124701355|NCT02951819|448529253|FG001|Overall Study|Lost to Follow-up|0|||
124701356|NCT02951819|448529252|FG000|Overall Study|Progressive Disease|1|||
124701357|NCT02951819|448529253|FG001|Overall Study|Progressive Disease|0|||
124701358|NCT02951819|448529252|FG000|Overall Study|Other|9|||
124701359|NCT02951819|448529253|FG001|Overall Study|Other|0|||
124701360|NCT05810597|448529256|FG000|Period 1|Adverse Event|2|||
124701361|NCT05810597|448529257|FG001|Period 1|Adverse Event|0|||
124701362|NCT05810597|448529256|FG000|Period 1|Physician Decision|1|||
124929567|NCT01928394|449374643|FG015|Treatment Period|Disease progression|1|||
124929568|NCT01928394|449374644|FG016|Treatment Period|Disease progression|43|||
124701363|NCT05810597|448529257|FG001|Period 1|Physician Decision|0|||
124929569|NCT01928394|449374645|FG017|Treatment Period|Disease progression|56|||
124701364|NCT05021224|448529258|FG000|Overall Study|Did not complete all survey items|4|||
124929570|NCT01928394|449374646|FG018|Treatment Period|Disease progression|50|||
124929571|NCT01928394|449374647|FG019|Treatment Period|Disease progression|71|||
124929572|NCT01928394|449374648|FG020|Treatment Period|Disease progression|30|||
124929573|NCT01928394|449374649|FG021|Treatment Period|Disease progression|31|||
124929574|NCT01928394|449374650|FG022|Treatment Period|Disease progression|31|||
124929575|NCT01928394|449374628|FG000|Treatment Period|Study drug toxicity|1|||
124929576|NCT01928394|449374629|FG001|Treatment Period|Study drug toxicity|1|||
124929577|NCT01928394|449374630|FG002|Treatment Period|Study drug toxicity|3|||
124929578|NCT01928394|449374631|FG003|Treatment Period|Study drug toxicity|3|||
124929579|NCT01928394|449374632|FG004|Treatment Period|Study drug toxicity|0|||
124929580|NCT01928394|449374633|FG005|Treatment Period|Study drug toxicity|9|||
124929581|NCT01928394|449374634|FG006|Treatment Period|Study drug toxicity|7|||
124929582|NCT01928394|449374635|FG007|Treatment Period|Study drug toxicity|1|||
124929583|NCT01928394|449374636|FG008|Treatment Period|Study drug toxicity|0|||
124929584|NCT01928394|449374637|FG009|Treatment Period|Study drug toxicity|5|||
124929585|NCT01928394|449374638|FG010|Treatment Period|Study drug toxicity|2|||
124929586|NCT01928394|449374639|FG011|Treatment Period|Study drug toxicity|3|||
124929587|NCT01928394|449374640|FG012|Treatment Period|Study drug toxicity|7|||
124929588|NCT01928394|449374641|FG013|Treatment Period|Study drug toxicity|5|||
124929589|NCT01928394|449374642|FG014|Treatment Period|Study drug toxicity|12|||
124929590|NCT01928394|449374643|FG015|Treatment Period|Study drug toxicity|0|||
124929591|NCT01928394|449374644|FG016|Treatment Period|Study drug toxicity|3|||
124929592|NCT01928394|449374645|FG017|Treatment Period|Study drug toxicity|3|||
124929593|NCT01928394|449374646|FG018|Treatment Period|Study drug toxicity|12|||
124929594|NCT01928394|449374647|FG019|Treatment Period|Study drug toxicity|15|||
124929595|NCT01928394|449374648|FG020|Treatment Period|Study drug toxicity|4|||
124929596|NCT01928394|449374649|FG021|Treatment Period|Study drug toxicity|7|||
124929597|NCT01928394|449374650|FG022|Treatment Period|Study drug toxicity|4|||
124929598|NCT01928394|449374628|FG000|Treatment Period|AE unrelated to study drug|0|||
124929599|NCT01928394|449374629|FG001|Treatment Period|AE unrelated to study drug|0|||
124929600|NCT01928394|449374630|FG002|Treatment Period|AE unrelated to study drug|2|||
124929601|NCT01928394|449374631|FG003|Treatment Period|AE unrelated to study drug|3|||
124929602|NCT01928394|449374632|FG004|Treatment Period|AE unrelated to study drug|0|||
124929603|NCT01928394|449374633|FG005|Treatment Period|AE unrelated to study drug|5|||
124929604|NCT01928394|449374634|FG006|Treatment Period|AE unrelated to study drug|1|||
124929605|NCT01928394|449374635|FG007|Treatment Period|AE unrelated to study drug|0|||
124929606|NCT01928394|449374636|FG008|Treatment Period|AE unrelated to study drug|0|||
124929607|NCT01928394|449374637|FG009|Treatment Period|AE unrelated to study drug|2|||
124929608|NCT01928394|449374638|FG010|Treatment Period|AE unrelated to study drug|0|||
124929609|NCT01928394|449374639|FG011|Treatment Period|AE unrelated to study drug|12|||
124929610|NCT01928394|449374640|FG012|Treatment Period|AE unrelated to study drug|6|||
124929611|NCT01928394|449374641|FG013|Treatment Period|AE unrelated to study drug|13|||
124929612|NCT01928394|449374642|FG014|Treatment Period|AE unrelated to study drug|6|||
124929613|NCT01928394|449374643|FG015|Treatment Period|AE unrelated to study drug|1|||
124929614|NCT01928394|449374644|FG016|Treatment Period|AE unrelated to study drug|1|||
124929615|NCT01928394|449374645|FG017|Treatment Period|AE unrelated to study drug|6|||
124929616|NCT01928394|449374646|FG018|Treatment Period|AE unrelated to study drug|3|||
124929617|NCT01928394|449374647|FG019|Treatment Period|AE unrelated to study drug|5|||
124929618|NCT01928394|449374648|FG020|Treatment Period|AE unrelated to study drug|1|||
124929619|NCT01928394|449374649|FG021|Treatment Period|AE unrelated to study drug|1|||
124929620|NCT01928394|449374650|FG022|Treatment Period|AE unrelated to study drug|0|||
124929621|NCT01928394|449374628|FG000|Treatment Period|Participant request to stop therapy|0|||
124929622|NCT01928394|449374629|FG001|Treatment Period|Participant request to stop therapy|0|||
124455425|NCT02576444|447627168|FG002|Overall Study|Withdrawal by Subject|2|||
124701365|NCT05021224|448529259|FG001|Overall Study|Did not complete all survey items|1|||
124701366|NCT05021224|448529260|FG002|Overall Study|Did not complete all survey items|0|||
124701367|NCT05021224|448529261|FG003|Overall Study|Did not complete all survey items|2|||
124701368|NCT01111552|448529266|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
124701369|NCT01111552|448529267|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
124701370|NCT01111552|448529268|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
124701371|NCT01111552|448529269|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
124929623|NCT01928394|449374630|FG002|Treatment Period|Participant request to stop therapy|0|||
124929624|NCT01928394|449374631|FG003|Treatment Period|Participant request to stop therapy|0|||
124929625|NCT01928394|449374632|FG004|Treatment Period|Participant request to stop therapy|0|||
124929626|NCT01928394|449374633|FG005|Treatment Period|Participant request to stop therapy|3|||
124929627|NCT01928394|449374634|FG006|Treatment Period|Participant request to stop therapy|3|||
124546405|NCT02181673|447955903|FG002|Up to Week 24|Lost to Follow-up|0|||
124929628|NCT01928394|449374635|FG007|Treatment Period|Participant request to stop therapy|0|||
124929629|NCT01928394|449374636|FG008|Treatment Period|Participant request to stop therapy|0|||
124701372|NCT01111552|448529270|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
124764013|NCT02734693|448761305|FG002|Overall Study|Adverse Event|3|||
124764014|NCT02734693|448761303|FG000|Overall Study|Lack of Efficacy|1|||
124764015|NCT02734693|448761304|FG001|Overall Study|Lack of Efficacy|0|||
124764016|NCT02734693|448761305|FG002|Overall Study|Lack of Efficacy|0|||
124764017|NCT02734693|448761303|FG000|Overall Study|Lost to Follow-up|2|||
124764018|NCT02734693|448761304|FG001|Overall Study|Lost to Follow-up|0|||
124764019|NCT02734693|448761305|FG002|Overall Study|Lost to Follow-up|0|||
124764020|NCT02734693|448761303|FG000|Overall Study|Protocol Violation|1|||
124764021|NCT02734693|448761304|FG001|Overall Study|Protocol Violation|0|||
124764022|NCT02734693|448761305|FG002|Overall Study|Protocol Violation|0|||
124764023|NCT02734693|448761303|FG000|Overall Study|Withdrawal by Subject|1|||
124764024|NCT02734693|448761304|FG001|Overall Study|Withdrawal by Subject|0|||
124764025|NCT02734693|448761305|FG002|Overall Study|Withdrawal by Subject|0|||
124764026|NCT03740048|448761307|FG000|Overall Study|Withdrawal by Subject|1|||
124764027|NCT03740048|448761308|FG001|Overall Study|Withdrawal by Subject|1|||
124764028|NCT03740048|448761307|FG000|Overall Study|Death|1|||
124764029|NCT03740048|448761308|FG001|Overall Study|Death|6|||
124764030|NCT03740048|448761307|FG000|Overall Study|Switched to thrice-weekly HD|2|||
124764031|NCT03740048|448761308|FG001|Overall Study|Switched to thrice-weekly HD|0|||
124764032|NCT03740048|448761307|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
124764033|NCT03740048|448761308|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
124764034|NCT03740048|448761307|FG000|Overall Study|Lost to Follow-up|0|||
124764035|NCT03740048|448761308|FG001|Overall Study|Lost to Follow-up|1|||
124764036|NCT03740048|448761307|FG000|Overall Study|Non-compliance with HD|0|||
124764037|NCT03740048|448761308|FG001|Overall Study|Non-compliance with HD|1|||
124764038|NCT01476722|448761309|FG000|Overall Study|Adverse Event|1|||
124764039|NCT03261336|448761310|FG000|Overall Study|Adverse Event|1|||
124764040|NCT01069484|448761312|FG000|Overall Study|Death-in-near-family|1|||
124764041|NCT01069484|448761313|FG001|Overall Study|Death-in-near-family|0|||
124764042|NCT01069484|448761312|FG000|Overall Study|No specific reason|8|||
124764043|NCT01069484|448761313|FG001|Overall Study|No specific reason|2|||
124764044|NCT01069484|448761312|FG000|Overall Study|Illness mother or child|3|||
124764045|NCT01069484|448761313|FG001|Overall Study|Illness mother or child|1|||
124764046|NCT00292942|448761315|FG000|Overall Study|Withdrawal by Subject|0|||
124764047|NCT00292942|448761316|FG001|Overall Study|Withdrawal by Subject|0|||
124764048|NCT00292942|448761317|FG002|Overall Study|Withdrawal by Subject|1|||
124764049|NCT00292942|448761318|FG003|Overall Study|Withdrawal by Subject|0|||
124764050|NCT00292942|448761315|FG000|Overall Study|Adverse Event|0|||
124764051|NCT00292942|448761316|FG001|Overall Study|Adverse Event|0|||
124764052|NCT00292942|448761317|FG002|Overall Study|Adverse Event|0|||
124764053|NCT00292942|448761318|FG003|Overall Study|Adverse Event|1|||
124764054|NCT00644358|448761319|FG000|Overall Study|Adverse Event|124|||
124764055|NCT00644358|448761319|FG000|Overall Study|Lost to Follow-up|105|||
124764056|NCT00644358|448761319|FG000|Overall Study|Consent Withdrawal|64|||
124764057|NCT00644358|448761319|FG000|Overall Study|Lack of Effectiveness|39|||
124764058|NCT00644358|448761319|FG000|Overall Study|Protocol Violation|5|||
124764059|NCT00644358|448761319|FG000|Overall Study|Noncompliance|14|||
124764060|NCT00644358|448761319|FG000|Overall Study|Other Unspecified|11|||
124701373|NCT01111552|448529266|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
124701374|NCT01111552|448529267|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
124701375|NCT01111552|448529268|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
124701376|NCT01111552|448529269|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
124701377|NCT01111552|448529270|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
124701378|NCT01111552|448529266|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
124701379|NCT01111552|448529267|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
124701380|NCT01111552|448529268|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
124701381|NCT01111552|448529269|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
124701382|NCT01111552|448529270|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
124701383|NCT01111552|448529266|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
124764061|NCT00651924|448761326|FG000|Overall Study|Withdrawal by PI|0|||
124764062|NCT00651924|448761327|FG001|Overall Study|Withdrawal by PI|2|||
124764063|NCT00651924|448761326|FG000|Overall Study|Withdrawal by Subject|0|||
124764064|NCT00651924|448761327|FG001|Overall Study|Withdrawal by Subject|5|||
124764065|NCT00758771|448761328|FG000|Overall Study|Withdrawal by Subject|1|||
124929630|NCT01928394|449374637|FG009|Treatment Period|Participant request to stop therapy|0|||
124764066|NCT00758771|448761329|FG001|Overall Study|Withdrawal by Subject|1|||
124764067|NCT00758771|448761328|FG000|Overall Study|Did not meet eligibility criteria|2|||
124764068|NCT00758771|448761329|FG001|Overall Study|Did not meet eligibility criteria|4|||
124764069|NCT00960063|448761330|FG000|Overall Study|Adverse Event|1|||
124764070|NCT00960063|448761331|FG001|Overall Study|Adverse Event|0|||
124764071|NCT00960063|448761332|FG002|Overall Study|Adverse Event|0|||
124764072|NCT00960063|448761330|FG000|Overall Study|Progression of Disease|0|||
124764073|NCT00960063|448761331|FG001|Overall Study|Progression of Disease|0|||
124764074|NCT00960063|448761332|FG002|Overall Study|Progression of Disease|3|||
124764075|NCT00771914|448761333|FG000|Overall Study|Physician Decision|0|||
124764076|NCT00771914|448761334|FG001|Overall Study|Physician Decision|0|||
124929631|NCT01928394|449374638|FG010|Treatment Period|Participant request to stop therapy|3|||
124929632|NCT01928394|449374639|FG011|Treatment Period|Participant request to stop therapy|2|||
124929633|NCT01928394|449374640|FG012|Treatment Period|Participant request to stop therapy|1|||
124929634|NCT01928394|449374641|FG013|Treatment Period|Participant request to stop therapy|2|||
124929635|NCT01928394|449374642|FG014|Treatment Period|Participant request to stop therapy|4|||
124929636|NCT01928394|449374643|FG015|Treatment Period|Participant request to stop therapy|0|||
124929637|NCT01928394|449374644|FG016|Treatment Period|Participant request to stop therapy|1|||
124929638|NCT01928394|449374645|FG017|Treatment Period|Participant request to stop therapy|3|||
124929639|NCT01928394|449374646|FG018|Treatment Period|Participant request to stop therapy|1|||
124929640|NCT01928394|449374647|FG019|Treatment Period|Participant request to stop therapy|1|||
124929641|NCT01928394|449374648|FG020|Treatment Period|Participant request to stop therapy|3|||
124929642|NCT01928394|449374649|FG021|Treatment Period|Participant request to stop therapy|1|||
124929643|NCT01928394|449374650|FG022|Treatment Period|Participant request to stop therapy|3|||
124929644|NCT01928394|449374628|FG000|Treatment Period|Participant withdrew consent|0|||
124546406|NCT02181673|447955901|FG000|Up to Week 24|Physician Decision|0|||
124764077|NCT00771914|448761335|FG002|Overall Study|Physician Decision|0|||
124764078|NCT00771914|448761336|FG003|Overall Study|Physician Decision|1|||
124764079|NCT00771914|448761333|FG000|Overall Study|Lost to Follow-up|0|||
124764080|NCT00771914|448761334|FG001|Overall Study|Lost to Follow-up|0|||
124764081|NCT00771914|448761335|FG002|Overall Study|Lost to Follow-up|0|||
124764082|NCT00771914|448761336|FG003|Overall Study|Lost to Follow-up|1|||
124764083|NCT02978417|448761340|FG000|Overall Study|Lost to Follow-up|2|||
124764084|NCT02978417|448761341|FG001|Overall Study|Lost to Follow-up|2|||
124764085|NCT05083351|448761346|FG000|Overall Study|Adverse Event|3|||
124764086|NCT05083351|448761346|FG000|Overall Study|Did not meet data inclusion criteria|8|||
124764087|NCT05083351|448761346|FG000|Overall Study|Did not meet eligibility criteria|19|||
124764088|NCT05083351|448761346|FG000|Overall Study|Study Staff Decision|19|||
124764089|NCT01759420|448761352|FG000|Overall Study|Screen failure|5|||
124764090|NCT01759420|448761352|FG000|Overall Study|Inaccurate EKG machine readings|1|||
124764091|NCT01129622|448761355|FG000|Overall Study|Withdrawal by Subject|2|||
124764092|NCT00960375|448761358|FG000|Overall Study|Lost to Follow-up|20|||
124764093|NCT00960375|448761359|FG001|Overall Study|Lost to Follow-up|22|||
124764094|NCT00591006|448761360|FG000|Overall Study|Withdrawal by Subject|0|||
124764095|NCT00591006|448761361|FG001|Overall Study|Withdrawal by Subject|0|||
124764096|NCT00591006|448761362|FG002|Overall Study|Withdrawal by Subject|0|||
124764097|NCT00591006|448761363|FG003|Overall Study|Withdrawal by Subject|0|||
124764098|NCT00591006|448761364|FG004|Overall Study|Withdrawal by Subject|0|||
124764099|NCT00591006|448761365|FG005|Overall Study|Withdrawal by Subject|0|||
124764100|NCT00591006|448761366|FG006|Overall Study|Withdrawal by Subject|0|||
124764101|NCT00591006|448761367|FG007|Overall Study|Withdrawal by Subject|0|||
124764102|NCT00591006|448761368|FG008|Overall Study|Withdrawal by Subject|0|||
124764103|NCT00591006|448761369|FG009|Overall Study|Withdrawal by Subject|0|||
124764104|NCT00591006|448761370|FG010|Overall Study|Withdrawal by Subject|0|||
124764105|NCT00591006|448761371|FG011|Overall Study|Withdrawal by Subject|0|||
124764106|NCT00591006|448761372|FG012|Overall Study|Withdrawal by Subject|0|||
124764107|NCT00591006|448761373|FG013|Overall Study|Withdrawal by Subject|0|||
124764108|NCT00591006|448761374|FG014|Overall Study|Withdrawal by Subject|0|||
124764109|NCT00591006|448761375|FG015|Overall Study|Withdrawal by Subject|1|||
124764110|NCT00591006|448761376|FG016|Overall Study|Withdrawal by Subject|0|||
124764111|NCT00591006|448761377|FG017|Overall Study|Withdrawal by Subject|0|||
124764112|NCT00591006|448761378|FG018|Overall Study|Withdrawal by Subject|0|||
124764113|NCT00591006|448761379|FG019|Overall Study|Withdrawal by Subject|0|||
124929645|NCT01928394|449374629|FG001|Treatment Period|Participant withdrew consent|0|||
124929646|NCT01928394|449374630|FG002|Treatment Period|Participant withdrew consent|1|||
124929647|NCT01928394|449374631|FG003|Treatment Period|Participant withdrew consent|1|||
124764114|NCT00591006|448761380|FG020|Overall Study|Withdrawal by Subject|0|||
124764115|NCT00591006|448761381|FG021|Overall Study|Withdrawal by Subject|0|||
124929648|NCT01928394|449374632|FG004|Treatment Period|Participant withdrew consent|0|||
124764116|NCT00591006|448761382|FG022|Overall Study|Withdrawal by Subject|0|||
124764117|NCT00591006|448761383|FG023|Overall Study|Withdrawal by Subject|1|||
124764118|NCT00591006|448761360|FG000|Overall Study|Adverse Event|0|||
124764119|NCT00591006|448761361|FG001|Overall Study|Adverse Event|0|||
124701384|NCT01111552|448529267|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
124701385|NCT01111552|448529268|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
124701386|NCT01111552|448529269|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
124701387|NCT01111552|448529270|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
124701388|NCT01111552|448529266|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
124701389|NCT01111552|448529267|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
124701390|NCT01111552|448529268|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
124701391|NCT01111552|448529269|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
124701392|NCT01111552|448529270|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
124701393|NCT01111552|448529266|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
124701394|NCT01111552|448529267|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
124701395|NCT01111552|448529268|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
124701396|NCT01111552|448529269|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
124701397|NCT01111552|448529270|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
124701398|NCT01111552|448529266|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
124701399|NCT01111552|448529267|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
124701400|NCT01111552|448529268|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
124701401|NCT01111552|448529269|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
124701402|NCT01111552|448529270|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
124701403|NCT01111552|448529266|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
124701404|NCT01111552|448529267|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
124701405|NCT01111552|448529268|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
124701406|NCT01111552|448529269|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
124701407|NCT01111552|448529270|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
124701408|NCT01111552|448529266|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
124701409|NCT01111552|448529267|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
124701410|NCT01111552|448529268|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
124701411|NCT01111552|448529269|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
124701412|NCT01111552|448529270|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
124701413|NCT01111552|448529266|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
124701414|NCT01111552|448529267|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
124701415|NCT01111552|448529268|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
124701416|NCT01111552|448529269|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
124764120|NCT00591006|448761362|FG002|Overall Study|Adverse Event|0|||
124764121|NCT00591006|448761363|FG003|Overall Study|Adverse Event|0|||
124764122|NCT00591006|448761364|FG004|Overall Study|Adverse Event|0|||
124764123|NCT00591006|448761365|FG005|Overall Study|Adverse Event|0|||
124764124|NCT00591006|448761366|FG006|Overall Study|Adverse Event|0|||
124764125|NCT00591006|448761367|FG007|Overall Study|Adverse Event|0|||
124764126|NCT00591006|448761368|FG008|Overall Study|Adverse Event|0|||
124764127|NCT00591006|448761369|FG009|Overall Study|Adverse Event|0|||
124764128|NCT00591006|448761370|FG010|Overall Study|Adverse Event|0|||
124764129|NCT00591006|448761371|FG011|Overall Study|Adverse Event|0|||
124764130|NCT00591006|448761372|FG012|Overall Study|Adverse Event|0|||
124764131|NCT00591006|448761373|FG013|Overall Study|Adverse Event|0|||
124764132|NCT00591006|448761374|FG014|Overall Study|Adverse Event|0|||
124764133|NCT00591006|448761375|FG015|Overall Study|Adverse Event|0|||
124764134|NCT00591006|448761376|FG016|Overall Study|Adverse Event|0|||
124764135|NCT00591006|448761377|FG017|Overall Study|Adverse Event|0|||
124764136|NCT00591006|448761378|FG018|Overall Study|Adverse Event|0|||
124764137|NCT00591006|448761379|FG019|Overall Study|Adverse Event|0|||
124764138|NCT00591006|448761380|FG020|Overall Study|Adverse Event|0|||
124764139|NCT00591006|448761381|FG021|Overall Study|Adverse Event|0|||
124764140|NCT00591006|448761382|FG022|Overall Study|Adverse Event|1|||
124764141|NCT00591006|448761383|FG023|Overall Study|Adverse Event|0|||
124764142|NCT00689390|448761384|FG000|Overall Study|Adverse Event|19|||
124764143|NCT00689390|448761385|FG001|Overall Study|Adverse Event|0|||
124764144|NCT00689390|448761384|FG000|Overall Study|Lost to Follow-up|179|||
124764145|NCT00689390|448761385|FG001|Overall Study|Lost to Follow-up|7|||
124764146|NCT00689390|448761384|FG000|Overall Study|Withdrawal by Subject|117|||
124764147|NCT00689390|448761385|FG001|Overall Study|Withdrawal by Subject|3|||
124455426|NCT02576444|447627169|FG003|Overall Study|Withdrawal by Subject|0|||
124455427|NCT02576444|447627166|FG000|Overall Study|Adverse Event|0|||
124701417|NCT01111552|448529270|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
124764148|NCT00689390|448761384|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
124764149|NCT00689390|448761385|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
124764150|NCT00689390|448761384|FG000|Overall Study|Non-Compliance With Protocol|21|||
124764151|NCT00689390|448761385|FG001|Overall Study|Non-Compliance With Protocol|0|||
124764152|NCT00689390|448761384|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
124764153|NCT00689390|448761385|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
124764154|NCT00689390|448761384|FG000|Overall Study|Administrative|37|||
124764155|NCT00689390|448761385|FG001|Overall Study|Administrative|0|||
124764156|NCT02343263|448761386|FG000|Overall Study|Physician Decision|5|||
124764157|NCT02343263|448761387|FG001|Overall Study|Physician Decision|3|||
124764158|NCT02343263|448761388|FG002|Overall Study|Physician Decision|1|||
124764159|NCT00525512|448761402|FG000|Double-Blind Phase|Adverse Event|48|||
124764160|NCT00525512|448761403|FG001|Double-Blind Phase|Adverse Event|28|||
124764161|NCT00525512|448761404|FG002|Double-Blind Phase|Adverse Event|0|||
124764162|NCT00525512|448761405|FG003|Double-Blind Phase|Adverse Event|0|||
124764163|NCT00525512|448761402|FG000|Double-Blind Phase|Protocol Violation|3|||
124764164|NCT00525512|448761403|FG001|Double-Blind Phase|Protocol Violation|1|||
124764165|NCT00525512|448761404|FG002|Double-Blind Phase|Protocol Violation|0|||
124764166|NCT00525512|448761405|FG003|Double-Blind Phase|Protocol Violation|0|||
124929649|NCT01928394|449374633|FG005|Treatment Period|Participant withdrew consent|1|||
124929650|NCT01928394|449374634|FG006|Treatment Period|Participant withdrew consent|0|||
124929651|NCT01928394|449374635|FG007|Treatment Period|Participant withdrew consent|1|||
124929652|NCT01928394|449374636|FG008|Treatment Period|Participant withdrew consent|0|||
124929653|NCT01928394|449374637|FG009|Treatment Period|Participant withdrew consent|0|||
124929654|NCT01928394|449374638|FG010|Treatment Period|Participant withdrew consent|1|||
124929655|NCT01928394|449374639|FG011|Treatment Period|Participant withdrew consent|1|||
124929656|NCT01928394|449374640|FG012|Treatment Period|Participant withdrew consent|1|||
124929657|NCT01928394|449374641|FG013|Treatment Period|Participant withdrew consent|0|||
124929658|NCT01928394|449374642|FG014|Treatment Period|Participant withdrew consent|2|||
124929659|NCT01928394|449374643|FG015|Treatment Period|Participant withdrew consent|0|||
124929660|NCT01928394|449374644|FG016|Treatment Period|Participant withdrew consent|2|||
124929661|NCT01928394|449374645|FG017|Treatment Period|Participant withdrew consent|1|||
124929662|NCT01928394|449374646|FG018|Treatment Period|Participant withdrew consent|1|||
124929663|NCT01928394|449374647|FG019|Treatment Period|Participant withdrew consent|1|||
124929664|NCT01928394|449374648|FG020|Treatment Period|Participant withdrew consent|0|||
124929665|NCT01928394|449374649|FG021|Treatment Period|Participant withdrew consent|2|||
124929666|NCT01928394|449374650|FG022|Treatment Period|Participant withdrew consent|0|||
124929667|NCT01928394|449374628|FG000|Treatment Period|Poor/non-compliance|0|||
124929668|NCT01928394|449374629|FG001|Treatment Period|Poor/non-compliance|0|||
124929669|NCT01928394|449374630|FG002|Treatment Period|Poor/non-compliance|0|||
124929670|NCT01928394|449374631|FG003|Treatment Period|Poor/non-compliance|1|||
124929671|NCT01928394|449374632|FG004|Treatment Period|Poor/non-compliance|0|||
124929672|NCT01928394|449374633|FG005|Treatment Period|Poor/non-compliance|0|||
124929673|NCT01928394|449374634|FG006|Treatment Period|Poor/non-compliance|0|||
124929674|NCT01928394|449374635|FG007|Treatment Period|Poor/non-compliance|0|||
124929675|NCT01928394|449374636|FG008|Treatment Period|Poor/non-compliance|0|||
124929676|NCT01928394|449374637|FG009|Treatment Period|Poor/non-compliance|0|||
124929677|NCT01928394|449374638|FG010|Treatment Period|Poor/non-compliance|0|||
124929678|NCT01928394|449374639|FG011|Treatment Period|Poor/non-compliance|0|||
124929679|NCT01928394|449374640|FG012|Treatment Period|Poor/non-compliance|1|||
124929680|NCT01928394|449374641|FG013|Treatment Period|Poor/non-compliance|0|||
124929681|NCT01928394|449374642|FG014|Treatment Period|Poor/non-compliance|1|||
124929682|NCT01928394|449374643|FG015|Treatment Period|Poor/non-compliance|0|||
124929683|NCT01928394|449374644|FG016|Treatment Period|Poor/non-compliance|0|||
124929684|NCT01928394|449374645|FG017|Treatment Period|Poor/non-compliance|1|||
124929685|NCT01928394|449374646|FG018|Treatment Period|Poor/non-compliance|0|||
124929686|NCT01928394|449374647|FG019|Treatment Period|Poor/non-compliance|1|||
124929687|NCT01928394|449374648|FG020|Treatment Period|Poor/non-compliance|0|||
124929688|NCT01928394|449374649|FG021|Treatment Period|Poor/non-compliance|0|||
124929689|NCT01928394|449374650|FG022|Treatment Period|Poor/non-compliance|0|||
124929690|NCT01928394|449374628|FG000|Treatment Period|other reason|0|||
124929691|NCT01928394|449374629|FG001|Treatment Period|other reason|0|||
124929692|NCT01928394|449374630|FG002|Treatment Period|other reason|0|||
124929693|NCT01928394|449374631|FG003|Treatment Period|other reason|0|||
124929694|NCT01928394|449374632|FG004|Treatment Period|other reason|0|||
124929695|NCT01928394|449374633|FG005|Treatment Period|other reason|0|||
124929696|NCT01928394|449374634|FG006|Treatment Period|other reason|0|||
124929697|NCT01928394|449374635|FG007|Treatment Period|other reason|0|||
124929698|NCT01928394|449374636|FG008|Treatment Period|other reason|0|||
124929699|NCT01928394|449374637|FG009|Treatment Period|other reason|0|||
124929700|NCT01928394|449374638|FG010|Treatment Period|other reason|1|||
124764167|NCT00525512|448761402|FG000|Double-Blind Phase|Lost to Follow-up|3|||
124764168|NCT00525512|448761403|FG001|Double-Blind Phase|Lost to Follow-up|7|||
124764169|NCT00525512|448761404|FG002|Double-Blind Phase|Lost to Follow-up|0|||
124764170|NCT00525512|448761405|FG003|Double-Blind Phase|Lost to Follow-up|0|||
124929701|NCT01928394|449374639|FG011|Treatment Period|other reason|1|||
124929702|NCT01928394|449374640|FG012|Treatment Period|other reason|1|||
124929703|NCT01928394|449374641|FG013|Treatment Period|other reason|0|||
124929704|NCT01928394|449374642|FG014|Treatment Period|other reason|1|||
124929705|NCT01928394|449374643|FG015|Treatment Period|other reason|0|||
124929706|NCT01928394|449374644|FG016|Treatment Period|other reason|0|||
124764171|NCT00525512|448761402|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
124764172|NCT00525512|448761403|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
124764173|NCT00525512|448761404|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
124764174|NCT00525512|448761405|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
124764175|NCT00525512|448761402|FG000|Double-Blind Phase|Lack of Efficacy|13|||
124764176|NCT00525512|448761403|FG001|Double-Blind Phase|Lack of Efficacy|5|||
124764177|NCT00525512|448761404|FG002|Double-Blind Phase|Lack of Efficacy|0|||
124764178|NCT00525512|448761405|FG003|Double-Blind Phase|Lack of Efficacy|0|||
124764179|NCT00525512|448761402|FG000|Double-Blind Phase|Other reason (not specified)|12|||
124764180|NCT00525512|448761403|FG001|Double-Blind Phase|Other reason (not specified)|13|||
124764181|NCT00525512|448761404|FG002|Double-Blind Phase|Other reason (not specified)|0|||
124764182|NCT00525512|448761405|FG003|Double-Blind Phase|Other reason (not specified)|0|||
124764183|NCT00525512|448761402|FG000|Open-Label Phase|Adverse Event|0|||
124764184|NCT00525512|448761403|FG001|Open-Label Phase|Adverse Event|0|||
124764185|NCT00525512|448761404|FG002|Open-Label Phase|Adverse Event|1|||
124764186|NCT00525512|448761405|FG003|Open-Label Phase|Adverse Event|0|||
124764187|NCT00525512|448761402|FG000|Open-Label Phase|Lost to Follow-up|0|||
124764188|NCT00525512|448761403|FG001|Open-Label Phase|Lost to Follow-up|0|||
124764189|NCT00525512|448761404|FG002|Open-Label Phase|Lost to Follow-up|1|||
124764190|NCT00525512|448761405|FG003|Open-Label Phase|Lost to Follow-up|0|||
124764191|NCT00525512|448761402|FG000|Open-Label Phase|Other reason (not specified)|0|||
124546407|NCT02181673|447955902|FG001|Up to Week 24|Physician Decision|0|||
124546408|NCT02181673|447955903|FG002|Up to Week 24|Physician Decision|3|||
124546409|NCT02181673|447955901|FG000|Up to Week 24|Withdrawal by Subject|10|||
124546410|NCT02181673|447955902|FG001|Up to Week 24|Withdrawal by Subject|0|||
124764192|NCT00525512|448761403|FG001|Open-Label Phase|Other reason (not specified)|0|||
124764193|NCT00525512|448761404|FG002|Open-Label Phase|Other reason (not specified)|4|||
124764194|NCT00525512|448761405|FG003|Open-Label Phase|Other reason (not specified)|5|||
124764195|NCT04258423|448761410|FG000|Overall Study|Study Closure|2|||
124764196|NCT04258423|448761411|FG001|Overall Study|Study Closure|2|||
124764197|NCT03289208|448761412|FG000|Overall Study|Adverse Event|1|||
124764198|NCT03289208|448761413|FG001|Overall Study|Adverse Event|0|||
124764199|NCT03289208|448761414|FG002|Overall Study|Adverse Event|0|||
124764200|NCT03353675|448761418|FG000|Overall Study|Adverse Event|4|||
124764201|NCT02362724|448761421|FG000|Overall Study|Withdrawal by Subject|3|||
124764202|NCT02362724|448761422|FG001|Overall Study|Withdrawal by Subject|1|||
124764203|NCT02362724|448761421|FG000|Overall Study|Adverse Event|3|||
124764204|NCT02362724|448761422|FG001|Overall Study|Adverse Event|0|||
124764205|NCT02025179|448761423|FG000|Overall Study|Lost to Follow-up|0|||
124764206|NCT02025179|448761424|FG001|Overall Study|Lost to Follow-up|0|||
124929707|NCT01928394|449374645|FG017|Treatment Period|other reason|0|||
124929708|NCT01928394|449374646|FG018|Treatment Period|other reason|2|||
124929709|NCT01928394|449374647|FG019|Treatment Period|other reason|2|||
124929710|NCT01928394|449374648|FG020|Treatment Period|other reason|0|||
124929711|NCT01928394|449374649|FG021|Treatment Period|other reason|0|||
124929712|NCT01928394|449374650|FG022|Treatment Period|other reason|0|||
124929713|NCT01928394|449374628|FG000|Treatment Period|Maximum clinical benefit|0|||
124929714|NCT01928394|449374629|FG001|Treatment Period|Maximum clinical benefit|0|||
124929715|NCT01928394|449374630|FG002|Treatment Period|Maximum clinical benefit|0|||
124929716|NCT01928394|449374631|FG003|Treatment Period|Maximum clinical benefit|0|||
124929717|NCT01928394|449374632|FG004|Treatment Period|Maximum clinical benefit|0|||
124929718|NCT01928394|449374633|FG005|Treatment Period|Maximum clinical benefit|0|||
124929719|NCT01928394|449374634|FG006|Treatment Period|Maximum clinical benefit|0|||
124929720|NCT01928394|449374635|FG007|Treatment Period|Maximum clinical benefit|0|||
124929721|NCT01928394|449374636|FG008|Treatment Period|Maximum clinical benefit|0|||
124929722|NCT01928394|449374637|FG009|Treatment Period|Maximum clinical benefit|0|||
124929723|NCT01928394|449374638|FG010|Treatment Period|Maximum clinical benefit|1|||
124929724|NCT01928394|449374639|FG011|Treatment Period|Maximum clinical benefit|1|||
124929725|NCT01928394|449374640|FG012|Treatment Period|Maximum clinical benefit|0|||
124929726|NCT01928394|449374641|FG013|Treatment Period|Maximum clinical benefit|0|||
124929727|NCT01928394|449374642|FG014|Treatment Period|Maximum clinical benefit|1|||
124929728|NCT01928394|449374643|FG015|Treatment Period|Maximum clinical benefit|0|||
124929729|NCT01928394|449374644|FG016|Treatment Period|Maximum clinical benefit|0|||
124929730|NCT01928394|449374645|FG017|Treatment Period|Maximum clinical benefit|1|||
124929731|NCT01928394|449374646|FG018|Treatment Period|Maximum clinical benefit|1|||
124929732|NCT01928394|449374647|FG019|Treatment Period|Maximum clinical benefit|0|||
124929733|NCT01928394|449374648|FG020|Treatment Period|Maximum clinical benefit|2|||
124929734|NCT01928394|449374649|FG021|Treatment Period|Maximum clinical benefit|0|||
124929735|NCT01928394|449374650|FG022|Treatment Period|Maximum clinical benefit|0|||
124929736|NCT01928394|449374628|FG000|Treatment Period|Lost to Follow-up|0|||
124764207|NCT02025179|448761425|FG002|Overall Study|Lost to Follow-up|1|||
124764208|NCT00402168|448761426|FG000|Randomized|Lost to Follow-up|1|||
124929737|NCT01928394|449374629|FG001|Treatment Period|Lost to Follow-up|0|||
124929738|NCT01928394|449374630|FG002|Treatment Period|Lost to Follow-up|0|||
124929739|NCT01928394|449374631|FG003|Treatment Period|Lost to Follow-up|0|||
124929740|NCT01928394|449374632|FG004|Treatment Period|Lost to Follow-up|0|||
124546411|NCT02181673|447955903|FG002|Up to Week 24|Withdrawal by Subject|1|||
124764209|NCT00402168|448761427|FG001|Randomized|Lost to Follow-up|0|||
124764210|NCT00402168|448761426|FG000|Randomized|Withdrawal by Subject|0|||
124764211|NCT00402168|448761427|FG001|Randomized|Withdrawal by Subject|1|||
124764212|NCT00402168|448761426|FG000|Treatment (up to 12 Months)|Death|0|||
124764213|NCT00402168|448761427|FG001|Treatment (up to 12 Months)|Death|1|||
124764214|NCT00402168|448761426|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
124764215|NCT00402168|448761427|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
124764216|NCT00402168|448761426|FG000|Treatment (up to 12 Months)|non-specified|0|||
124764217|NCT00402168|448761427|FG001|Treatment (up to 12 Months)|non-specified|1|||
124764218|NCT00402168|448761426|FG000|Long Term (LT)|Adverse Event|1|||
124764219|NCT00402168|448761427|FG001|Long Term (LT)|Adverse Event|5|||
124764220|NCT00402168|448761426|FG000|Long Term (LT)|Withdrawal by Subject|4|||
124764221|NCT00402168|448761427|FG001|Long Term (LT)|Withdrawal by Subject|7|||
124764222|NCT00402168|448761426|FG000|Long Term (LT)|Pregnancy|0|||
124764223|NCT00402168|448761427|FG001|Long Term (LT)|Pregnancy|1|||
124764224|NCT00402168|448761426|FG000|Long Term (LT)|Lost to Follow-up|1|||
124764225|NCT00402168|448761427|FG001|Long Term (LT)|Lost to Follow-up|0|||
124764226|NCT00402168|448761426|FG000|Long Term (LT)|Death|4|||
124764227|NCT00402168|448761427|FG001|Long Term (LT)|Death|0|||
124764228|NCT00402168|448761426|FG000|Long Term (LT)|Lack of Efficacy|0|||
124764229|NCT00402168|448761427|FG001|Long Term (LT)|Lack of Efficacy|2|||
124764230|NCT00402168|448761426|FG000|Long Term (LT)|non-specified|1|||
124764231|NCT00402168|448761427|FG001|Long Term (LT)|non-specified|2|||
124764232|NCT00402168|448761426|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
124764233|NCT00402168|448761427|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
124764234|NCT00402168|448761426|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
124764235|NCT00402168|448761427|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
124764236|NCT00395746|448761433|FG000|Overall Study|Adverse Event|5|||
124764237|NCT00395746|448761434|FG001|Overall Study|Adverse Event|2|||
124764238|NCT00395746|448761435|FG002|Overall Study|Adverse Event|2|||
124764239|NCT00395746|448761433|FG000|Overall Study|Protocol Violation|0|||
124764240|NCT00395746|448761434|FG001|Overall Study|Protocol Violation|1|||
124764241|NCT00395746|448761435|FG002|Overall Study|Protocol Violation|0|||
124764242|NCT00395746|448761433|FG000|Overall Study|Lack of Efficacy|2|||
124764243|NCT00395746|448761434|FG001|Overall Study|Lack of Efficacy|0|||
124764244|NCT00395746|448761435|FG002|Overall Study|Lack of Efficacy|17|||
124764245|NCT00395746|448761433|FG000|Overall Study|Hypoglycaemia|2|||
124764246|NCT00395746|448761434|FG001|Overall Study|Hypoglycaemia|1|||
124764247|NCT00395746|448761435|FG002|Overall Study|Hypoglycaemia|0|||
124764248|NCT00395746|448761433|FG000|Overall Study|Subject decision|0|||
124764249|NCT00395746|448761434|FG001|Overall Study|Subject decision|0|||
124764250|NCT00395746|448761435|FG002|Overall Study|Subject decision|1|||
124764251|NCT00395746|448761433|FG000|Overall Study|Withdrawal of consent|0|||
124764252|NCT00395746|448761434|FG001|Overall Study|Withdrawal of consent|0|||
124764253|NCT00395746|448761435|FG002|Overall Study|Withdrawal of consent|1|||
124764254|NCT00395746|448761433|FG000|Overall Study|Difficultulty in use of device|0|||
124764255|NCT00395746|448761434|FG001|Overall Study|Difficultulty in use of device|0|||
124764256|NCT00395746|448761435|FG002|Overall Study|Difficultulty in use of device|1|||
124764257|NCT00395746|448761433|FG000|Overall Study|Unable to visit site on schedule|1|||
124764258|NCT00395746|448761434|FG001|Overall Study|Unable to visit site on schedule|0|||
124764259|NCT00395746|448761435|FG002|Overall Study|Unable to visit site on schedule|0|||
124764260|NCT03137992|448761440|FG000|Washout Period 1|Adverse Event|1|||
124929741|NCT01928394|449374633|FG005|Treatment Period|Lost to Follow-up|0|||
124929742|NCT01928394|449374634|FG006|Treatment Period|Lost to Follow-up|0|||
124929743|NCT01928394|449374635|FG007|Treatment Period|Lost to Follow-up|0|||
124929744|NCT01928394|449374636|FG008|Treatment Period|Lost to Follow-up|0|||
124929745|NCT01928394|449374637|FG009|Treatment Period|Lost to Follow-up|0|||
124929746|NCT01928394|449374638|FG010|Treatment Period|Lost to Follow-up|0|||
124929747|NCT01928394|449374639|FG011|Treatment Period|Lost to Follow-up|0|||
124929748|NCT01928394|449374640|FG012|Treatment Period|Lost to Follow-up|0|||
124929749|NCT01928394|449374641|FG013|Treatment Period|Lost to Follow-up|0|||
124929750|NCT01928394|449374642|FG014|Treatment Period|Lost to Follow-up|0|||
124929751|NCT01928394|449374643|FG015|Treatment Period|Lost to Follow-up|0|||
124929752|NCT01928394|449374644|FG016|Treatment Period|Lost to Follow-up|0|||
124929753|NCT01928394|449374645|FG017|Treatment Period|Lost to Follow-up|0|||
124764261|NCT03137992|448761441|FG001|Washout Period 1|Adverse Event|1|||
124764262|NCT03137992|448761442|FG002|Washout Period 1|Adverse Event|0|||
124929754|NCT01928394|449374646|FG018|Treatment Period|Lost to Follow-up|0|||
124929755|NCT01928394|449374647|FG019|Treatment Period|Lost to Follow-up|0|||
124929756|NCT01928394|449374648|FG020|Treatment Period|Lost to Follow-up|0|||
124764263|NCT03137992|448761443|FG003|Washout Period 1|Adverse Event|0|||
124764264|NCT03137992|448761444|FG004|Washout Period 1|Adverse Event|0|||
124764265|NCT03137992|448761445|FG005|Washout Period 1|Adverse Event|1|||
124764266|NCT03137992|448761440|FG000|Washout Period 1|Withdrawal by Subject|0|||
124764267|NCT03137992|448761441|FG001|Washout Period 1|Withdrawal by Subject|1|||
124764268|NCT03137992|448761442|FG002|Washout Period 1|Withdrawal by Subject|1|||
124764269|NCT03137992|448761443|FG003|Washout Period 1|Withdrawal by Subject|0|||
124929757|NCT01928394|449374649|FG021|Treatment Period|Lost to Follow-up|0|||
124929758|NCT01928394|449374650|FG022|Treatment Period|Lost to Follow-up|1|||
124929759|NCT01928394|449374628|FG000|Treatment Period|Death|0|||
124929760|NCT01928394|449374629|FG001|Treatment Period|Death|0|||
124929761|NCT01928394|449374630|FG002|Treatment Period|Death|0|||
124929762|NCT01928394|449374631|FG003|Treatment Period|Death|0|||
124929763|NCT01928394|449374632|FG004|Treatment Period|Death|0|||
124929764|NCT01928394|449374633|FG005|Treatment Period|Death|0|||
124929765|NCT01928394|449374634|FG006|Treatment Period|Death|0|||
124929766|NCT01928394|449374635|FG007|Treatment Period|Death|0|||
124929767|NCT01928394|449374636|FG008|Treatment Period|Death|0|||
124929768|NCT01928394|449374637|FG009|Treatment Period|Death|0|||
124929769|NCT01928394|449374638|FG010|Treatment Period|Death|0|||
124929770|NCT01928394|449374639|FG011|Treatment Period|Death|0|||
124929771|NCT01928394|449374640|FG012|Treatment Period|Death|0|||
124929772|NCT01928394|449374641|FG013|Treatment Period|Death|1|||
124929773|NCT01928394|449374642|FG014|Treatment Period|Death|2|||
124929774|NCT01928394|449374643|FG015|Treatment Period|Death|0|||
124929775|NCT01928394|449374644|FG016|Treatment Period|Death|0|||
124929776|NCT01928394|449374645|FG017|Treatment Period|Death|0|||
124929777|NCT01928394|449374646|FG018|Treatment Period|Death|0|||
124929778|NCT01928394|449374647|FG019|Treatment Period|Death|0|||
124929779|NCT01928394|449374648|FG020|Treatment Period|Death|0|||
124929780|NCT01928394|449374649|FG021|Treatment Period|Death|0|||
124929781|NCT01928394|449374650|FG022|Treatment Period|Death|0|||
124929782|NCT01928394|449374628|FG000|Follow-up Period|Participant withdrew consent|3|||
124929783|NCT01928394|449374629|FG001|Follow-up Period|Participant withdrew consent|0|||
124929784|NCT01928394|449374630|FG002|Follow-up Period|Participant withdrew consent|1|||
124929785|NCT01928394|449374631|FG003|Follow-up Period|Participant withdrew consent|4|||
124929786|NCT01928394|449374632|FG004|Follow-up Period|Participant withdrew consent|0|||
124929787|NCT01928394|449374633|FG005|Follow-up Period|Participant withdrew consent|2|||
124929788|NCT01928394|449374634|FG006|Follow-up Period|Participant withdrew consent|5|||
124929789|NCT01928394|449374635|FG007|Follow-up Period|Participant withdrew consent|1|||
124929790|NCT01928394|449374636|FG008|Follow-up Period|Participant withdrew consent|0|||
124929791|NCT01928394|449374637|FG009|Follow-up Period|Participant withdrew consent|0|||
124929792|NCT01928394|449374638|FG010|Follow-up Period|Participant withdrew consent|5|||
124929793|NCT01928394|449374639|FG011|Follow-up Period|Participant withdrew consent|8|||
124929794|NCT01928394|449374640|FG012|Follow-up Period|Participant withdrew consent|2|||
124929795|NCT01928394|449374641|FG013|Follow-up Period|Participant withdrew consent|12|||
124929796|NCT01928394|449374642|FG014|Follow-up Period|Participant withdrew consent|7|||
124929797|NCT01928394|449374643|FG015|Follow-up Period|Participant withdrew consent|0|||
124929798|NCT01928394|449374644|FG016|Follow-up Period|Participant withdrew consent|5|||
124764270|NCT03137992|448761444|FG004|Washout Period 1|Withdrawal by Subject|0|||
124764271|NCT03137992|448761445|FG005|Washout Period 1|Withdrawal by Subject|0|||
124764272|NCT03137992|448761440|FG000|Washout Period 1|Principal Investigator Discretion|0|||
124764273|NCT03137992|448761441|FG001|Washout Period 1|Principal Investigator Discretion|1|||
124764274|NCT03137992|448761442|FG002|Washout Period 1|Principal Investigator Discretion|0|||
124764275|NCT03137992|448761443|FG003|Washout Period 1|Principal Investigator Discretion|0|||
124764276|NCT03137992|448761444|FG004|Washout Period 1|Principal Investigator Discretion|0|||
124764277|NCT03137992|448761445|FG005|Washout Period 1|Principal Investigator Discretion|0|||
124764278|NCT03137992|448761440|FG000|Washout Period 1|COPD Exacerbation|1|||
124764279|NCT03137992|448761441|FG001|Washout Period 1|COPD Exacerbation|1|||
124764280|NCT03137992|448761442|FG002|Washout Period 1|COPD Exacerbation|1|||
124764281|NCT03137992|448761443|FG003|Washout Period 1|COPD Exacerbation|0|||
124764282|NCT03137992|448761444|FG004|Washout Period 1|COPD Exacerbation|1|||
124764283|NCT03137992|448761445|FG005|Washout Period 1|COPD Exacerbation|1|||
124764284|NCT03137992|448761440|FG000|Washout Period 1|Subject Noncompliance|1|||
124764285|NCT03137992|448761441|FG001|Washout Period 1|Subject Noncompliance|0|||
124764286|NCT03137992|448761442|FG002|Washout Period 1|Subject Noncompliance|0|||
124764287|NCT03137992|448761443|FG003|Washout Period 1|Subject Noncompliance|0|||
124929799|NCT01928394|449374645|FG017|Follow-up Period|Participant withdrew consent|3|||
124929800|NCT01928394|449374646|FG018|Follow-up Period|Participant withdrew consent|2|||
124929801|NCT01928394|449374647|FG019|Follow-up Period|Participant withdrew consent|7|||
124929802|NCT01928394|449374648|FG020|Follow-up Period|Participant withdrew consent|4|||
124929803|NCT01928394|449374649|FG021|Follow-up Period|Participant withdrew consent|6|||
124929804|NCT01928394|449374650|FG022|Follow-up Period|Participant withdrew consent|2|||
124929805|NCT01928394|449374628|FG000|Follow-up Period|Death|0|||
124929806|NCT01928394|449374629|FG001|Follow-up Period|Death|0|||
124929807|NCT01928394|449374630|FG002|Follow-up Period|Death|2|||
124929808|NCT01928394|449374631|FG003|Follow-up Period|Death|6|||
124929809|NCT01928394|449374632|FG004|Follow-up Period|Death|0|||
124929810|NCT01928394|449374633|FG005|Follow-up Period|Death|6|||
124929811|NCT01928394|449374634|FG006|Follow-up Period|Death|6|||
124929812|NCT01928394|449374635|FG007|Follow-up Period|Death|2|||
124764288|NCT03137992|448761444|FG004|Washout Period 1|Subject Noncompliance|1|||
124764289|NCT03137992|448761445|FG005|Washout Period 1|Subject Noncompliance|0|||
124929813|NCT01928394|449374636|FG008|Follow-up Period|Death|1|||
124929814|NCT01928394|449374637|FG009|Follow-up Period|Death|2|||
124929815|NCT01928394|449374638|FG010|Follow-up Period|Death|4|||
124929816|NCT01928394|449374639|FG011|Follow-up Period|Death|12|||
124929817|NCT01928394|449374640|FG012|Follow-up Period|Death|11|||
124929818|NCT01928394|449374641|FG013|Follow-up Period|Death|25|||
124929819|NCT01928394|449374642|FG014|Follow-up Period|Death|18|||
124929820|NCT01928394|449374643|FG015|Follow-up Period|Death|0|||
124929821|NCT01928394|449374644|FG016|Follow-up Period|Death|6|||
124764290|NCT03137992|448761440|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
124764291|NCT03137992|448761441|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
124764292|NCT03137992|448761442|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
124764293|NCT03137992|448761443|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
124764294|NCT03137992|448761444|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
124764295|NCT03137992|448761445|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
124764296|NCT03137992|448761440|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
124764297|NCT03137992|448761441|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
124764298|NCT03137992|448761442|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
124764299|NCT03137992|448761443|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
124764300|NCT03137992|448761444|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
124764301|NCT03137992|448761445|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
124764302|NCT03137992|448761440|FG000|Period 2 (Visit 3)|Adverse Event|0|||
124764303|NCT03137992|448761441|FG001|Period 2 (Visit 3)|Adverse Event|1|||
124764304|NCT03137992|448761442|FG002|Period 2 (Visit 3)|Adverse Event|0|||
124764305|NCT03137992|448761443|FG003|Period 2 (Visit 3)|Adverse Event|0|||
124764306|NCT03137992|448761444|FG004|Period 2 (Visit 3)|Adverse Event|0|||
124929822|NCT01928394|449374645|FG017|Follow-up Period|Death|5|||
124929823|NCT01928394|449374646|FG018|Follow-up Period|Death|13|||
124929824|NCT01928394|449374647|FG019|Follow-up Period|Death|13|||
124929825|NCT01928394|449374648|FG020|Follow-up Period|Death|5|||
124929826|NCT01928394|449374649|FG021|Follow-up Period|Death|3|||
124929827|NCT01928394|449374650|FG022|Follow-up Period|Death|2|||
124929828|NCT01928394|449374628|FG000|Follow-up Period|other reason|0|||
124929829|NCT01928394|449374629|FG001|Follow-up Period|other reason|0|||
124929830|NCT01928394|449374630|FG002|Follow-up Period|other reason|0|||
124929831|NCT01928394|449374631|FG003|Follow-up Period|other reason|0|||
124929832|NCT01928394|449374632|FG004|Follow-up Period|other reason|0|||
124929833|NCT01928394|449374633|FG005|Follow-up Period|other reason|0|||
124929834|NCT01928394|449374634|FG006|Follow-up Period|other reason|1|||
124929835|NCT01928394|449374635|FG007|Follow-up Period|other reason|3|||
124929836|NCT01928394|449374636|FG008|Follow-up Period|other reason|0|||
124764307|NCT03137992|448761445|FG005|Period 2 (Visit 3)|Adverse Event|0|||
124764308|NCT03137992|448761440|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
124764309|NCT03137992|448761441|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
124764310|NCT03137992|448761442|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
124764311|NCT03137992|448761443|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
124764312|NCT03137992|448761444|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
124764313|NCT03137992|448761445|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
124764314|NCT03137992|448761440|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
124764315|NCT03137992|448761441|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
124764316|NCT03137992|448761442|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
124764317|NCT03137992|448761443|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
124764318|NCT03137992|448761444|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
124764319|NCT03137992|448761445|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
124764320|NCT03137992|448761440|FG000|Washout Period 2|COPD Exacerbation|1|||
124764321|NCT03137992|448761441|FG001|Washout Period 2|COPD Exacerbation|1|||
124764322|NCT03137992|448761442|FG002|Washout Period 2|COPD Exacerbation|0|||
124764323|NCT03137992|448761443|FG003|Washout Period 2|COPD Exacerbation|0|||
124764324|NCT03137992|448761444|FG004|Washout Period 2|COPD Exacerbation|1|||
124764325|NCT03137992|448761445|FG005|Washout Period 2|COPD Exacerbation|0|||
124764326|NCT03137992|448761440|FG000|Washout Period 2|Subject Non-compliance|0|||
124764327|NCT03137992|448761441|FG001|Washout Period 2|Subject Non-compliance|1|||
124764328|NCT03137992|448761442|FG002|Washout Period 2|Subject Non-compliance|0|||
124764329|NCT03137992|448761443|FG003|Washout Period 2|Subject Non-compliance|0|||
124764330|NCT03137992|448761444|FG004|Washout Period 2|Subject Non-compliance|0|||
124764331|NCT03137992|448761445|FG005|Washout Period 2|Subject Non-compliance|0|||
124764332|NCT03137992|448761440|FG000|Washout Period 2|Adverse Event|0|||
124764333|NCT03137992|448761441|FG001|Washout Period 2|Adverse Event|0|||
124929837|NCT01928394|449374637|FG009|Follow-up Period|other reason|0|||
124929838|NCT01928394|449374638|FG010|Follow-up Period|other reason|2|||
124929839|NCT01928394|449374639|FG011|Follow-up Period|other reason|1|||
124929840|NCT01928394|449374640|FG012|Follow-up Period|other reason|0|||
124764334|NCT03137992|448761442|FG002|Washout Period 2|Adverse Event|0|||
124764335|NCT03137992|448761443|FG003|Washout Period 2|Adverse Event|1|||
124929841|NCT01928394|449374641|FG013|Follow-up Period|other reason|1|||
124929842|NCT01928394|449374642|FG014|Follow-up Period|other reason|4|||
124929843|NCT01928394|449374643|FG015|Follow-up Period|other reason|0|||
124929844|NCT01928394|449374644|FG016|Follow-up Period|other reason|2|||
124929845|NCT01928394|449374645|FG017|Follow-up Period|other reason|0|||
124929846|NCT01928394|449374646|FG018|Follow-up Period|other reason|1|||
124929847|NCT01928394|449374647|FG019|Follow-up Period|other reason|1|||
124929848|NCT01928394|449374648|FG020|Follow-up Period|other reason|0|||
124929849|NCT01928394|449374649|FG021|Follow-up Period|other reason|0|||
124929850|NCT01928394|449374650|FG022|Follow-up Period|other reason|1|||
124929851|NCT01928394|449374628|FG000|Follow-up Period|Lost to Follow-up|0|||
124929852|NCT01928394|449374629|FG001|Follow-up Period|Lost to Follow-up|0|||
124929853|NCT01928394|449374630|FG002|Follow-up Period|Lost to Follow-up|0|||
124929854|NCT01928394|449374631|FG003|Follow-up Period|Lost to Follow-up|0|||
124929855|NCT01928394|449374632|FG004|Follow-up Period|Lost to Follow-up|0|||
124929856|NCT01928394|449374633|FG005|Follow-up Period|Lost to Follow-up|0|||
124929857|NCT01928394|449374634|FG006|Follow-up Period|Lost to Follow-up|0|||
124929858|NCT01928394|449374635|FG007|Follow-up Period|Lost to Follow-up|0|||
124929859|NCT01928394|449374636|FG008|Follow-up Period|Lost to Follow-up|0|||
124929860|NCT01928394|449374637|FG009|Follow-up Period|Lost to Follow-up|0|||
124929861|NCT01928394|449374638|FG010|Follow-up Period|Lost to Follow-up|0|||
124929862|NCT01928394|449374639|FG011|Follow-up Period|Lost to Follow-up|1|||
124929863|NCT01928394|449374640|FG012|Follow-up Period|Lost to Follow-up|1|||
124701418|NCT01111552|448529266|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
124701419|NCT01111552|448529267|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
124701420|NCT01111552|448529268|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
124701421|NCT01111552|448529269|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
124701422|NCT01111552|448529270|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
124701423|NCT01111552|448529266|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
124701424|NCT01111552|448529267|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
124701425|NCT01111552|448529268|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
124701426|NCT01111552|448529269|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
124701427|NCT01111552|448529270|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
124701428|NCT01111552|448529266|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
124701429|NCT01111552|448529267|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
124701430|NCT01111552|448529268|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
124701431|NCT01111552|448529269|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
124701432|NCT01111552|448529270|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
124701433|NCT01111552|448529266|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
124701434|NCT01111552|448529267|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
124701435|NCT01111552|448529268|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
124701436|NCT01111552|448529269|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
124701437|NCT01111552|448529270|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
124701438|NCT02691494|448529276|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
124701439|NCT02691494|448529277|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
124701440|NCT02691494|448529278|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
124701441|NCT02691494|448529276|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
124929864|NCT01928394|449374641|FG013|Follow-up Period|Lost to Follow-up|0|||
124929865|NCT01928394|449374642|FG014|Follow-up Period|Lost to Follow-up|1|||
124929866|NCT01928394|449374643|FG015|Follow-up Period|Lost to Follow-up|0|||
124929867|NCT01928394|449374644|FG016|Follow-up Period|Lost to Follow-up|1|||
124929868|NCT01928394|449374645|FG017|Follow-up Period|Lost to Follow-up|0|||
124929869|NCT01928394|449374646|FG018|Follow-up Period|Lost to Follow-up|0|||
124929870|NCT01928394|449374647|FG019|Follow-up Period|Lost to Follow-up|0|||
124764336|NCT03137992|448761444|FG004|Washout Period 2|Adverse Event|1|||
124764337|NCT03137992|448761445|FG005|Washout Period 2|Adverse Event|0|||
124764338|NCT03137992|448761440|FG000|Washout Period 2|Withdrawal by Subject|1|||
124764339|NCT03137992|448761441|FG001|Washout Period 2|Withdrawal by Subject|0|||
124764340|NCT03137992|448761442|FG002|Washout Period 2|Withdrawal by Subject|0|||
124929871|NCT01928394|449374648|FG020|Follow-up Period|Lost to Follow-up|0|||
124929872|NCT01928394|449374649|FG021|Follow-up Period|Lost to Follow-up|0|||
124929873|NCT01928394|449374650|FG022|Follow-up Period|Lost to Follow-up|1|||
124929874|NCT04433208|449374651|FG000|Overall Study|Withdrawal by Subject|0|||
124929875|NCT04433208|449374652|FG001|Overall Study|Withdrawal by Subject|1|||
124929876|NCT04433208|449374653|FG002|Overall Study|Withdrawal by Subject|1|||
124929877|NCT04433208|449374654|FG003|Overall Study|Withdrawal by Subject|0|||
124929878|NCT04433208|449374655|FG004|Overall Study|Withdrawal by Subject|2|||
124929879|NCT04433208|449374656|FG005|Overall Study|Withdrawal by Subject|1|||
124929880|NCT04433208|449374651|FG000|Overall Study|Lost to Follow-up|0|||
124929881|NCT04433208|449374652|FG001|Overall Study|Lost to Follow-up|0|||
124929882|NCT04433208|449374653|FG002|Overall Study|Lost to Follow-up|0|||
124929883|NCT04433208|449374654|FG003|Overall Study|Lost to Follow-up|0|||
124929884|NCT04433208|449374655|FG004|Overall Study|Lost to Follow-up|0|||
124929885|NCT04433208|449374656|FG005|Overall Study|Lost to Follow-up|1|||
124929886|NCT04299464|449374661|FG000|Overall Study|Adverse Event|1|||
124929887|NCT04299464|449374662|FG001|Overall Study|Adverse Event|0|||
124929888|NCT04299464|449374663|FG002|Overall Study|Adverse Event|2|||
124929889|NCT04299464|449374661|FG000|Overall Study|Non-compliance with Study Drug|1|||
124929890|NCT04299464|449374662|FG001|Overall Study|Non-compliance with Study Drug|0|||
124929891|NCT04299464|449374663|FG002|Overall Study|Non-compliance with Study Drug|0|||
124929892|NCT04299464|449374661|FG000|Overall Study|Reason not Specified|0|||
124929893|NCT04299464|449374662|FG001|Overall Study|Reason not Specified|1|||
124929894|NCT04299464|449374663|FG002|Overall Study|Reason not Specified|3|||
124929895|NCT04299464|449374661|FG000|Overall Study|Physician Decision|0|||
124929896|NCT04299464|449374662|FG001|Overall Study|Physician Decision|1|||
124929897|NCT04299464|449374663|FG002|Overall Study|Physician Decision|1|||
124929898|NCT04299464|449374661|FG000|Overall Study|Withdrawal by Subject|0|||
124929899|NCT04299464|449374662|FG001|Overall Study|Withdrawal by Subject|2|||
124929900|NCT04299464|449374663|FG002|Overall Study|Withdrawal by Subject|1|||
124929901|NCT03676192|449374664|FG000|Induction Study Period|Adverse Event|21|||
124929902|NCT03676192|449374665|FG001|Induction Study Period|Adverse Event|20|||
124929903|NCT03676192|449374664|FG000|Induction Study Period|Death|23|||
124929904|NCT03676192|449374665|FG001|Induction Study Period|Death|20|||
124929905|NCT03676192|449374664|FG000|Induction Study Period|Lost to Follow-up|3|||
124929906|NCT03676192|449374665|FG001|Induction Study Period|Lost to Follow-up|3|||
124929907|NCT03676192|449374664|FG000|Induction Study Period|Physician Decision|6|||
124929908|NCT03676192|449374665|FG001|Induction Study Period|Physician Decision|3|||
124929909|NCT03676192|449374664|FG000|Induction Study Period|Progressive Disease|32|||
124929910|NCT03676192|449374665|FG001|Induction Study Period|Progressive Disease|21|||
124929911|NCT03676192|449374664|FG000|Induction Study Period|Protocol Violation|1|||
124929912|NCT03676192|449374665|FG001|Induction Study Period|Protocol Violation|2|||
124929913|NCT03676192|449374664|FG000|Induction Study Period|Withdrawal by Subject|20|||
124929914|NCT03676192|449374665|FG001|Induction Study Period|Withdrawal by Subject|15|||
124929915|NCT04079218|449374666|FG000|Overall Study|Death|1|||
124929916|NCT04079218|449374667|FG001|Overall Study|Death|0|||
124929917|NCT04079218|449374666|FG000|Overall Study|Withdrawal by Subject|3|||
124929918|NCT04079218|449374667|FG001|Overall Study|Withdrawal by Subject|0|||
124929919|NCT04079218|449374666|FG000|Overall Study|Physician Decision|4|||
124929920|NCT04079218|449374667|FG001|Overall Study|Physician Decision|0|||
124929921|NCT04079218|449374666|FG000|Overall Study|Lost to Follow-up|0|||
124929922|NCT04079218|449374667|FG001|Overall Study|Lost to Follow-up|1|||
124929923|NCT02694822|449374668|FG000|Phase 1|Death|2|||
124929924|NCT02694822|449374669|FG001|Phase 1|Death|1|||
124929925|NCT02694822|449374670|FG002|Phase 1|Death|6|||
124929926|NCT02694822|449374671|FG003|Phase 1|Death|6|||
124929927|NCT02694822|449374672|FG004|Phase 1|Death|3|||
124929928|NCT02694822|449374673|FG005|Phase 1|Death|0|||
124764341|NCT03137992|448761443|FG003|Washout Period 2|Withdrawal by Subject|0|||
124764342|NCT03137992|448761444|FG004|Washout Period 2|Withdrawal by Subject|1|||
124764343|NCT03137992|448761445|FG005|Washout Period 2|Withdrawal by Subject|0|||
124929929|NCT02694822|449374668|FG000|Phase 1|Withdrawal by Subject|2|||
124929930|NCT02694822|449374669|FG001|Phase 1|Withdrawal by Subject|2|||
124764344|NCT03137992|448761440|FG000|Washout Period 2|Sponsor Decision|0|||
124764345|NCT03137992|448761441|FG001|Washout Period 2|Sponsor Decision|0|||
124929931|NCT02694822|449374670|FG002|Phase 1|Withdrawal by Subject|4|||
124929932|NCT02694822|449374671|FG003|Phase 1|Withdrawal by Subject|8|||
124929933|NCT02694822|449374672|FG004|Phase 1|Withdrawal by Subject|1|||
124929934|NCT02694822|449374673|FG005|Phase 1|Withdrawal by Subject|0|||
124929935|NCT02694822|449374668|FG000|Phase 2|Death|0|||
124929936|NCT02694822|449374669|FG001|Phase 2|Death|0|||
124929937|NCT02694822|449374670|FG002|Phase 2|Death|0|||
124929938|NCT02694822|449374671|FG003|Phase 2|Death|0|||
124929939|NCT02694822|449374672|FG004|Phase 2|Death|0|||
124929940|NCT02694822|449374673|FG005|Phase 2|Death|26|||
124929941|NCT02694822|449374668|FG000|Phase 2|Withdrawal by Subject|0|||
124929942|NCT02694822|449374669|FG001|Phase 2|Withdrawal by Subject|0|||
124929943|NCT02694822|449374670|FG002|Phase 2|Withdrawal by Subject|0|||
124929944|NCT02694822|449374671|FG003|Phase 2|Withdrawal by Subject|0|||
124929945|NCT02694822|449374672|FG004|Phase 2|Withdrawal by Subject|0|||
124929946|NCT02694822|449374673|FG005|Phase 2|Withdrawal by Subject|13|||
124455428|NCT02576444|447627167|FG001|Overall Study|Adverse Event|0|||
124701442|NCT02691494|448529277|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
124701443|NCT02691494|448529278|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
124701444|NCT02691494|448529276|FG000|Post-Treatment Follow-Up Period|Other|2|||
124701445|NCT02691494|448529277|FG001|Post-Treatment Follow-Up Period|Other|1|||
124701446|NCT02691494|448529278|FG002|Post-Treatment Follow-Up Period|Other|1|||
124701447|NCT02691494|448529276|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
124701448|NCT02691494|448529277|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
124701449|NCT02691494|448529278|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
124701450|NCT02691494|448529276|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
124701451|NCT02691494|448529277|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
124701452|NCT02691494|448529278|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
124701453|NCT00637156|448529281|FG000|Overall Study|Withdrawal by Subject|0|||
124701454|NCT00637156|448529282|FG001|Overall Study|Withdrawal by Subject|7|||
124701455|NCT00637156|448529281|FG000|Overall Study|Death|0|||
124701456|NCT00637156|448529282|FG001|Overall Study|Death|1|||
124701457|NCT00637156|448529281|FG000|Overall Study|Lost to Follow-up|10|||
124701458|NCT00637156|448529282|FG001|Overall Study|Lost to Follow-up|16|||
124701459|NCT00461812|448529283|FG000|Overall Study|study terminated|10|||
124701460|NCT03193437|448529284|FG000|Overall Study|Adverse Event|4|||
124701461|NCT03193437|448529284|FG000|Overall Study|Withdrawal by Subject|2|||
124701462|NCT03193437|448529284|FG000|Overall Study|Disease Progression|2|||
124701463|NCT05487378|448529285|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
124701464|NCT05487378|448529286|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
124701465|NCT05487378|448529285|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
124701466|NCT05487378|448529286|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
124701467|NCT01385995|448529288|FG000|Period 1, 2 Months|Physician Decision|1|||
124701468|NCT01385995|448529289|FG001|Period 1, 2 Months|Physician Decision|0|||
124701469|NCT00112385|448529290|FG000|Overall Study|Lost to Follow-up|1|||
124701470|NCT00112385|448529291|FG001|Overall Study|Lost to Follow-up|0|||
124701471|NCT00112385|448529290|FG000|Overall Study|Withdrawal by Subject|0|||
124701472|NCT00112385|448529291|FG001|Overall Study|Withdrawal by Subject|1|||
124701473|NCT03359395|448529315|FG000|First Intervention A / B|Withdrawal by Subject|1|||
124701474|NCT03359395|448529316|FG001|First Intervention A / B|Withdrawal by Subject|0|||
124701475|NCT03359395|448529315|FG000|First Intervention A / B|Lost to Follow-up|2|||
124701476|NCT03359395|448529316|FG001|First Intervention A / B|Lost to Follow-up|3|||
124701477|NCT03359395|448529315|FG000|Second Intervention B/A|Exclusion criteria|0|||
124701478|NCT03359395|448529316|FG001|Second Intervention B/A|Exclusion criteria|1|||
124701479|NCT03359395|448529315|FG000|Second Intervention B/A|Lost to Follow-up|3|||
124701480|NCT03359395|448529316|FG001|Second Intervention B/A|Lost to Follow-up|2|||
124701481|NCT00561821|448529317|FG000|Overall Study|Not treated|0|||
124701482|NCT00561821|448529318|FG001|Overall Study|Not treated|0|||
124701483|NCT00561821|448529319|FG002|Overall Study|Not treated|1|||
124701484|NCT00561821|448529320|FG003|Overall Study|Not treated|0|||
124701485|NCT00561821|448529317|FG000|Overall Study|Withdrawal by Subject|0|||
124701486|NCT00561821|448529318|FG001|Overall Study|Withdrawal by Subject|1|||
124701487|NCT00561821|448529319|FG002|Overall Study|Withdrawal by Subject|0|||
124701488|NCT00561821|448529320|FG003|Overall Study|Withdrawal by Subject|2|||
124701489|NCT00561821|448529317|FG000|Overall Study|Reasons not related to trial|2|||
124701490|NCT00561821|448529318|FG001|Overall Study|Reasons not related to trial|1|||
124701491|NCT00561821|448529319|FG002|Overall Study|Reasons not related to trial|0|||
124701492|NCT00561821|448529320|FG003|Overall Study|Reasons not related to trial|0|||
124701493|NCT00561821|448529317|FG000|Overall Study|Other (reason not specified)|1|||
124701494|NCT00561821|448529318|FG001|Overall Study|Other (reason not specified)|1|||
124701495|NCT00561821|448529319|FG002|Overall Study|Other (reason not specified)|0|||
124701496|NCT00561821|448529320|FG003|Overall Study|Other (reason not specified)|0|||
124701497|NCT00561821|448529317|FG000|Overall Study|Adverse Event|2|||
124701498|NCT00561821|448529318|FG001|Overall Study|Adverse Event|3|||
124701499|NCT00561821|448529319|FG002|Overall Study|Adverse Event|1|||
124701500|NCT00561821|448529320|FG003|Overall Study|Adverse Event|1|||
124701501|NCT02520154|448529322|FG000|Overall Study|Death|1|||
124701502|NCT02520154|448529322|FG000|Overall Study|Withdrawal by Subject|2|||
124701503|NCT02520154|448529322|FG000|Overall Study|Physician Decision|2|||
124701504|NCT03443401|448531058|FG000|Overall Study|Lost to Follow-up|13|||
124701505|NCT03443401|448531058|FG000|Overall Study|Influential outlier|1|||
124701506|NCT00137449|448531059|FG000|Overall Study|Disease Progression|8|||
124701507|NCT00137449|448531060|FG001|Overall Study|Disease Progression|13|||
124701508|NCT00137449|448531059|FG000|Overall Study|Death|4|||
124929947|NCT02694822|449374668|FG000|Phase 2|Administrative Study Closure|0|||
124764346|NCT03137992|448761442|FG002|Washout Period 2|Sponsor Decision|0|||
124764347|NCT03137992|448761443|FG003|Washout Period 2|Sponsor Decision|0|||
124764348|NCT03137992|448761444|FG004|Washout Period 2|Sponsor Decision|0|||
124764349|NCT03137992|448761445|FG005|Washout Period 2|Sponsor Decision|1|||
124764350|NCT03137992|448761440|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
124764351|NCT03137992|448761441|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
124764352|NCT03137992|448761442|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
124764353|NCT03137992|448761443|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
124764354|NCT03137992|448761444|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
124764355|NCT03137992|448761445|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
124764356|NCT03137992|448761440|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
124764357|NCT03137992|448761441|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
124764358|NCT03137992|448761442|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
124764359|NCT03137992|448761443|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
124764360|NCT03137992|448761444|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
124764361|NCT03137992|448761445|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
124764362|NCT03137992|448761440|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
124764363|NCT03137992|448761441|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
124764364|NCT03137992|448761442|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
124764365|NCT03137992|448761443|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
124764366|NCT03137992|448761444|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
124764367|NCT03137992|448761445|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
124764368|NCT03137992|448761440|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
124764369|NCT03137992|448761441|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
124764370|NCT03137992|448761442|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
124764371|NCT03137992|448761443|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
124764372|NCT03137992|448761444|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
124764373|NCT03137992|448761445|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
124764374|NCT03137992|448761440|FG000|Part 2 (Open-label Extension)|Per study team|1|||
124764375|NCT03137992|448761441|FG001|Part 2 (Open-label Extension)|Per study team|0|||
124764376|NCT03137992|448761442|FG002|Part 2 (Open-label Extension)|Per study team|0|||
124764377|NCT03137992|448761443|FG003|Part 2 (Open-label Extension)|Per study team|0|||
124764378|NCT03137992|448761444|FG004|Part 2 (Open-label Extension)|Per study team|0|||
124764379|NCT03137992|448761445|FG005|Part 2 (Open-label Extension)|Per study team|0|||
124764380|NCT03137992|448761440|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
124764381|NCT03137992|448761441|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
124764382|NCT03137992|448761442|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
124764383|NCT03137992|448761443|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
124764384|NCT03137992|448761444|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
124764385|NCT03137992|448761445|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
124764386|NCT02370420|448761446|FG000|Overall Study|Physician Decision|3|||
124764387|NCT02370420|448761447|FG001|Overall Study|Physician Decision|3|||
124764388|NCT02370420|448761446|FG000|Overall Study|Lost to Follow-up|11|||
124764389|NCT02370420|448761447|FG001|Overall Study|Lost to Follow-up|9|||
124764390|NCT03077542|448761448|FG000|Overall Study|Death|4|||
124764391|NCT03077542|448761449|FG001|Overall Study|Death|0|||
124764392|NCT03077542|448761448|FG000|Overall Study|Physician Decision|6|||
124764393|NCT03077542|448761449|FG001|Overall Study|Physician Decision|1|||
124764394|NCT03077542|448761448|FG000|Overall Study|Withdrawal by Subject|0|||
124764395|NCT03077542|448761449|FG001|Overall Study|Withdrawal by Subject|1|||
124764396|NCT01300728|448761450|FG000|Overall Study|Withdrawal by Subject|1|||
124764397|NCT01300728|448761451|FG001|Overall Study|Withdrawal by Subject|1|||
124764398|NCT01300728|448761450|FG000|Overall Study|Physician Decision|1|||
124764399|NCT01300728|448761451|FG001|Overall Study|Physician Decision|0|||
124764400|NCT00301808|448761454|FG000|Overall Study|Adverse Event|5|||
124764401|NCT00301808|448761454|FG000|Overall Study|Death|3|||
124764402|NCT00301808|448761454|FG000|Overall Study|Lack of Efficacy|4|||
124764403|NCT05893862|448761458|FG000|Overall Study|Physician Decision|0|||
124764404|NCT05893862|448761459|FG001|Overall Study|Physician Decision|1|||
124929948|NCT02694822|449374669|FG001|Phase 2|Administrative Study Closure|0|||
124929949|NCT02694822|449374670|FG002|Phase 2|Administrative Study Closure|0|||
124929950|NCT02694822|449374671|FG003|Phase 2|Administrative Study Closure|0|||
124701509|NCT00137449|448531060|FG001|Overall Study|Death|3|||
124701510|NCT00137449|448531059|FG000|Overall Study|Adverse Event|3|||
124929951|NCT02694822|449374672|FG004|Phase 2|Administrative Study Closure|0|||
124929952|NCT02694822|449374673|FG005|Phase 2|Administrative Study Closure|2|||
124929953|NCT02694822|449374668|FG000|Phase 2|Lost to Follow-up|0|||
124929954|NCT02694822|449374669|FG001|Phase 2|Lost to Follow-up|0|||
124929955|NCT02694822|449374670|FG002|Phase 2|Lost to Follow-up|0|||
124929956|NCT02694822|449374671|FG003|Phase 2|Lost to Follow-up|0|||
124929957|NCT02694822|449374672|FG004|Phase 2|Lost to Follow-up|0|||
124929958|NCT02694822|449374673|FG005|Phase 2|Lost to Follow-up|1|||
124929959|NCT02694822|449374668|FG000|Phase 2|Participant Transferred to Another Site|0|||
124929960|NCT02694822|449374669|FG001|Phase 2|Participant Transferred to Another Site|0|||
124929961|NCT02694822|449374670|FG002|Phase 2|Participant Transferred to Another Site|0|||
124929962|NCT02694822|449374671|FG003|Phase 2|Participant Transferred to Another Site|0|||
124929963|NCT02694822|449374672|FG004|Phase 2|Participant Transferred to Another Site|0|||
124929964|NCT02694822|449374673|FG005|Phase 2|Participant Transferred to Another Site|1|||
124929965|NCT02424617|449374674|FG000|Overall Study|Adverse Event|0|||
124929966|NCT02424617|449374675|FG001|Overall Study|Adverse Event|1|||
124929967|NCT02424617|449374676|FG002|Overall Study|Adverse Event|0|||
124929968|NCT02424617|449374677|FG003|Overall Study|Adverse Event|0|||
124929969|NCT02424617|449374674|FG000|Overall Study|Investigator Decision|0|||
124929970|NCT02424617|449374675|FG001|Overall Study|Investigator Decision|0|||
124929971|NCT02424617|449374676|FG002|Overall Study|Investigator Decision|0|||
124929972|NCT02424617|449374677|FG003|Overall Study|Investigator Decision|1|||
124929973|NCT02424617|449374674|FG000|Overall Study|Withdrawal by Subject|1|||
124929974|NCT02424617|449374675|FG001|Overall Study|Withdrawal by Subject|1|||
124929975|NCT02424617|449374676|FG002|Overall Study|Withdrawal by Subject|0|||
124929976|NCT02424617|449374677|FG003|Overall Study|Withdrawal by Subject|1|||
124929977|NCT02424617|449374674|FG000|Overall Study|Progressive Disease|7|||
124929978|NCT02424617|449374675|FG001|Overall Study|Progressive Disease|6|||
124929979|NCT02424617|449374676|FG002|Overall Study|Progressive Disease|11|||
124929980|NCT02424617|449374677|FG003|Overall Study|Progressive Disease|10|||
124929981|NCT02424617|449374674|FG000|Overall Study|Other|0|||
124929982|NCT02424617|449374675|FG001|Overall Study|Other|0|||
124929983|NCT02424617|449374676|FG002|Overall Study|Other|0|||
124929984|NCT02424617|449374677|FG003|Overall Study|Other|1|||
124929985|NCT01868997|449374680|FG000|Overall Study|Adverse Event|2|||
124929986|NCT01868997|449374681|FG001|Overall Study|Adverse Event|5|||
124929987|NCT01868997|449374680|FG000|Overall Study|Lack of Efficacy|2|||
124929988|NCT01868997|449374681|FG001|Overall Study|Lack of Efficacy|0|||
124929989|NCT01868997|449374680|FG000|Overall Study|Other|3|||
124929990|NCT01868997|449374681|FG001|Overall Study|Other|1|||
124929991|NCT02052882|449374682|FG000|Overall Study|Not treated|11|||
124929992|NCT02052882|449374682|FG000|Overall Study|Protocol Violation|1|||
124701511|NCT00137449|448531060|FG001|Overall Study|Adverse Event|1|||
124701512|NCT00137449|448531059|FG000|Overall Study|Withdrawal by Subject|1|||
124701513|NCT00137449|448531060|FG001|Overall Study|Withdrawal by Subject|1|||
124701514|NCT01356940|448531061|FG000|First Intervention (28 Days)|Adverse Event|1|||
124701515|NCT01356940|448531062|FG001|First Intervention (28 Days)|Adverse Event|0|||
124701516|NCT01356940|448531061|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
124701517|NCT01356940|448531062|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
124701518|NCT00505687|448531065|FG000|Overall Study|Important protocol violation|2|||
124701519|NCT00505687|448531065|FG000|Overall Study|Lack of Efficacy|15|||
124701520|NCT00505687|448531065|FG000|Overall Study|Adverse Event|48|||
124701521|NCT00505687|448531065|FG000|Overall Study|Subject withdrew consent|15|||
124701522|NCT00505687|448531065|FG000|Overall Study|Lost to Follow-up|1|||
124701523|NCT00505687|448531065|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
124701524|NCT00505687|448531065|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
124701525|NCT00505687|448531065|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
124929993|NCT02052882|449374682|FG000|Overall Study|Inadequate testing|1|||
124929994|NCT04778397|449374683|FG000|Overall Study|Death|59|||
124929995|NCT04778397|449374684|FG001|Overall Study|Death|54|||
124701526|NCT00505687|448531065|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
124701527|NCT00505687|448531065|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
124701528|NCT00505687|448531065|FG000|Overall Study|Other: Disease Progression|1|||
124929996|NCT04778397|449374685|FG002|Overall Study|Death|11|||
124929997|NCT04778397|449374686|FG003|Overall Study|Death|9|||
124929998|NCT04778397|449374683|FG000|Overall Study|Study Terminated by Sponsor|34|||
124929999|NCT04778397|449374684|FG001|Overall Study|Study Terminated by Sponsor|42|||
124930000|NCT04778397|449374685|FG002|Overall Study|Study Terminated by Sponsor|15|||
124930001|NCT04778397|449374686|FG003|Overall Study|Study Terminated by Sponsor|12|||
124930002|NCT04778397|449374683|FG000|Overall Study|Withdrew Consent|5|||
124930003|NCT04778397|449374684|FG001|Overall Study|Withdrew Consent|4|||
124764405|NCT05893862|448761460|FG002|Overall Study|Physician Decision|0|||
124764406|NCT05893862|448761461|FG003|Overall Study|Physician Decision|0|||
124764407|NCT05893862|448761462|FG004|Overall Study|Physician Decision|1|||
124764408|NCT05893862|448761463|FG005|Overall Study|Physician Decision|0|||
124764409|NCT05893862|448761458|FG000|Overall Study|Withdrawal by Subject|1|||
124764410|NCT05893862|448761459|FG001|Overall Study|Withdrawal by Subject|7|||
124764411|NCT05893862|448761460|FG002|Overall Study|Withdrawal by Subject|1|||
124764412|NCT05893862|448761461|FG003|Overall Study|Withdrawal by Subject|3|||
124764413|NCT05893862|448761462|FG004|Overall Study|Withdrawal by Subject|3|||
124764414|NCT05893862|448761463|FG005|Overall Study|Withdrawal by Subject|2|||
124764415|NCT05893862|448761458|FG000|Overall Study|Adverse Event|1|||
124764416|NCT05893862|448761459|FG001|Overall Study|Adverse Event|4|||
124764417|NCT05893862|448761460|FG002|Overall Study|Adverse Event|2|||
124764418|NCT05893862|448761461|FG003|Overall Study|Adverse Event|2|||
124764419|NCT05893862|448761462|FG004|Overall Study|Adverse Event|1|||
124764420|NCT05893862|448761463|FG005|Overall Study|Adverse Event|0|||
124764421|NCT02429830|448761464|FG000|Overall Study|Lost to Follow-up|1|||
124764422|NCT02429830|448761464|FG000|Overall Study|Device Explant|2|||
124764423|NCT01908426|448763654|FG000|Overall Study|Adverse Event|98|||
124764424|NCT01908426|448763655|FG001|Overall Study|Adverse Event|11|||
124764425|NCT01908426|448763654|FG000|Overall Study|Clinical Deterioration|72|||
124764426|NCT01908426|448763655|FG001|Overall Study|Clinical Deterioration|38|||
124764427|NCT01908426|448763654|FG000|Overall Study|Lack of Efficacy|3|||
124764428|NCT01908426|448763655|FG001|Overall Study|Lack of Efficacy|0|||
124764429|NCT01908426|448763654|FG000|Overall Study|Lost to Follow-up|0|||
124764430|NCT01908426|448763655|FG001|Overall Study|Lost to Follow-up|1|||
124764431|NCT01908426|448763654|FG000|Overall Study|Physician Decision|3|||
124764432|NCT01908426|448763655|FG001|Overall Study|Physician Decision|3|||
124764433|NCT01908426|448763654|FG000|Overall Study|Withdrawal by Subject|11|||
124764434|NCT01908426|448763655|FG001|Overall Study|Withdrawal by Subject|6|||
124764435|NCT01908426|448763654|FG000|Overall Study|Progressive Disease|206|||
124764436|NCT01908426|448763655|FG001|Overall Study|Progressive Disease|152|||
124764437|NCT01908426|448763654|FG000|Overall Study|Protocol Violation|1|||
124764438|NCT01908426|448763655|FG001|Overall Study|Protocol Violation|0|||
124764439|NCT01908426|448763654|FG000|Overall Study|No Study Treatment Given|3|||
124764440|NCT01908426|448763655|FG001|Overall Study|No Study Treatment Given|0|||
124764441|NCT03346434|448763656|FG000|Overall Study|Randomized in Error|0|||
124764442|NCT03346434|448763657|FG001|Overall Study|Randomized in Error|0|||
124764443|NCT03346434|448763658|FG002|Overall Study|Randomized in Error|0|||
124764444|NCT03346434|448763659|FG003|Overall Study|Randomized in Error|0|||
124764445|NCT03346434|448763660|FG004|Overall Study|Randomized in Error|1|||
124764446|NCT03346434|448763661|FG005|Overall Study|Randomized in Error|0|||
124764447|NCT03346434|448763656|FG000|Overall Study|Withdrawal by Subject|0|||
124764448|NCT03346434|448763657|FG001|Overall Study|Withdrawal by Subject|0|||
124764449|NCT03346434|448763658|FG002|Overall Study|Withdrawal by Subject|1|||
124764450|NCT03346434|448763659|FG003|Overall Study|Withdrawal by Subject|0|||
124764451|NCT03346434|448763660|FG004|Overall Study|Withdrawal by Subject|1|||
124764452|NCT03346434|448763661|FG005|Overall Study|Withdrawal by Subject|0|||
124764453|NCT03346434|448763656|FG000|Overall Study|Lost to Follow-up|0|||
124764454|NCT03346434|448763657|FG001|Overall Study|Lost to Follow-up|0|||
124764455|NCT03346434|448763658|FG002|Overall Study|Lost to Follow-up|0|||
124764456|NCT03346434|448763659|FG003|Overall Study|Lost to Follow-up|0|||
124764457|NCT03346434|448763660|FG004|Overall Study|Lost to Follow-up|1|||
124764458|NCT03346434|448763661|FG005|Overall Study|Lost to Follow-up|1|||
124930004|NCT04778397|449374685|FG002|Overall Study|Withdrew Consent|1|||
124930005|NCT04778397|449374686|FG003|Overall Study|Withdrew Consent|1|||
124930006|NCT04778397|449374683|FG000|Overall Study|Reason Not Specified|1|||
124930007|NCT04778397|449374684|FG001|Overall Study|Reason Not Specified|3|||
124930008|NCT04778397|449374685|FG002|Overall Study|Reason Not Specified|0|||
124930009|NCT04778397|449374686|FG003|Overall Study|Reason Not Specified|2|||
124930010|NCT04778397|449374683|FG000|Overall Study|Lost to Follow-up|2|||
124930011|NCT04778397|449374684|FG001|Overall Study|Lost to Follow-up|1|||
124930012|NCT04778397|449374685|FG002|Overall Study|Lost to Follow-up|0|||
124930013|NCT04778397|449374686|FG003|Overall Study|Lost to Follow-up|1|||
124930014|NCT05906784|449374688|FG000|Overall Study|Lost to Follow-up|2|||
124930015|NCT05906784|449374689|FG001|Overall Study|Lost to Follow-up|1|||
124930016|NCT05906784|449374690|FG002|Overall Study|Lost to Follow-up|1|||
124930017|NCT05906784|449374691|FG003|Overall Study|Lost to Follow-up|1|||
124930018|NCT01346540|449374697|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
124930019|NCT01346540|449374698|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
124930020|NCT01346540|449374697|FG000|Overall Study|Adverse Event|0|||
124930021|NCT01346540|449374698|FG001|Overall Study|Adverse Event|4|||
124930022|NCT05147116|449374700|FG000|Overall Study|Withdrawal by Subject|0|||
124930023|NCT05147116|449374701|FG001|Overall Study|Withdrawal by Subject|1|||
124930024|NCT03672916|449374702|FG000|Overall Study|Death|6|||
124930025|NCT03672916|449374702|FG000|Overall Study|Lost to Follow-up|29|||
124930026|NCT03672916|449374702|FG000|Overall Study|Adverse Event|6|||
124930027|NCT03672916|449374702|FG000|Overall Study|Withdrawal by Subject|11|||
124930028|NCT04197336|449374703|FG000|Overall Study|Withdrawal by Subject|1|||
124930029|NCT04585815|449374704|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
124930030|NCT04585815|449374705|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
124930031|NCT04585815|449374706|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
124930032|NCT04585815|449374707|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
124930033|NCT04585815|449374708|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
124546412|NCT02181673|447955901|FG000|Up to Week 24|Other|2|||
124546413|NCT02181673|447955902|FG001|Up to Week 24|Other|0|||
124546414|NCT02181673|447955903|FG002|Up to Week 24|Other|3|||
124701529|NCT00505687|448531065|FG000|Overall Study|Other: As Per Sponsor|8|||
124701530|NCT00586157|448531066|FG000|First Intervention|Worsening behavior|1|||
124701531|NCT00586157|448531067|FG001|First Intervention|Worsening behavior|0|||
124701532|NCT00586157|448531066|FG000|Second Intervention|Withdrawal by Subject|1|||
124701533|NCT00586157|448531067|FG001|Second Intervention|Withdrawal by Subject|0|||
124701534|NCT00586157|448531066|FG000|Second Intervention|Worsening behavior|1|||
124701535|NCT00586157|448531067|FG001|Second Intervention|Worsening behavior|0|||
124701536|NCT00586157|448531066|FG000|Second Intervention|Adverse Event|0|||
124701537|NCT00586157|448531067|FG001|Second Intervention|Adverse Event|1|||
124701538|NCT02014467|448531070|FG000|Overall Study|Adverse Event|4|||
124701539|NCT02014467|448531071|FG001|Overall Study|Adverse Event|0|||
124701540|NCT02014467|448531070|FG000|Overall Study|Protocol Violation|3|||
124701541|NCT02014467|448531071|FG001|Overall Study|Protocol Violation|0|||
124701542|NCT02014467|448531070|FG000|Overall Study|Physician Decision|2|||
124701543|NCT02014467|448531071|FG001|Overall Study|Physician Decision|3|||
124701544|NCT02014467|448531070|FG000|Overall Study|Withdrawal by Subject|16|||
124701545|NCT02014467|448531071|FG001|Overall Study|Withdrawal by Subject|4|||
124701546|NCT00831389|448531073|FG000|Overall Study|Withdrawal by Subject|0|||
124701547|NCT00831389|448531074|FG001|Overall Study|Withdrawal by Subject|1|||
124701548|NCT00278161|448531076|FG000|Overall Study|Death|11|||
124701549|NCT00443456|448531077|FG000|Overall Study|Adverse Event|16|||
124701550|NCT00443456|448531077|FG000|Overall Study|Move|1|||
124701551|NCT00443456|448531077|FG000|Overall Study|Withdrawal by Subject|1|||
124701552|NCT02157610|448531078|FG000|Overall Study|Death|4|||
124701553|NCT02157610|448531079|FG001|Overall Study|Death|4|||
124701554|NCT00124657|448531080|FG000|Overall Study|Toxicity|0|||
124701555|NCT00124657|448531081|FG001|Overall Study|Toxicity|0|||
124701556|NCT00124657|448531082|FG002|Overall Study|Toxicity|1|||
124701557|NCT00124657|448531080|FG000|Overall Study|Non-compliance|1|||
124701558|NCT00124657|448531081|FG001|Overall Study|Non-compliance|0|||
124701559|NCT00124657|448531082|FG002|Overall Study|Non-compliance|4|||
124701560|NCT00124657|448531080|FG000|Overall Study|Progressive disease|14|||
124701561|NCT00124657|448531081|FG001|Overall Study|Progressive disease|5|||
124701562|NCT00124657|448531082|FG002|Overall Study|Progressive disease|27|||
124701563|NCT00124657|448531080|FG000|Overall Study|Intercurrent illness|1|||
124701564|NCT00124657|448531081|FG001|Overall Study|Intercurrent illness|0|||
124701565|NCT00124657|448531082|FG002|Overall Study|Intercurrent illness|0|||
124701566|NCT01935947|448531083|FG000|Overall Study|Adverse Event|0|||
124701567|NCT01935947|448531084|FG001|Overall Study|Adverse Event|2|||
124701568|NCT01935947|448531085|FG002|Overall Study|Adverse Event|0|||
124701569|NCT01935947|448531083|FG000|Overall Study|Diease Progression|2|||
124701570|NCT01935947|448531084|FG001|Overall Study|Diease Progression|2|||
124701571|NCT01935947|448531085|FG002|Overall Study|Diease Progression|2|||
124701572|NCT01935947|448531083|FG000|Overall Study|Death|1|||
124701573|NCT01935947|448531084|FG001|Overall Study|Death|0|||
124701574|NCT01935947|448531085|FG002|Overall Study|Death|0|||
124701575|NCT04507763|448531086|FG000|Overall Study|Participants did not meet entrance criteria|201|||
124701576|NCT03427619|448531087|FG000|Overall Study|Physician Decision|3|||
124701577|NCT03427619|448531087|FG000|Overall Study|Withdrawal by Subject|4|||
124701578|NCT03427619|448531087|FG000|Overall Study|Lost to Follow-up|5|||
124701579|NCT03427619|448531087|FG000|Overall Study|Administrative|4|||
124701580|NCT03427619|448531087|FG000|Overall Study|Other|2|||
124701581|NCT03427619|448531087|FG000|Overall Study|Unknown or Missing Completion Status|48|||
124701582|NCT00425555|448531088|FG000|Overall Study|Withdrawal by Subject|11|||
124701583|NCT00425555|448531089|FG001|Overall Study|Withdrawal by Subject|8|||
124701584|NCT00425555|448531088|FG000|Overall Study|Lost to Follow-up|0|||
124701585|NCT00425555|448531089|FG001|Overall Study|Lost to Follow-up|1|||
124701586|NCT00425555|448531088|FG000|Overall Study|Administrative problems|3|||
124701587|NCT00425555|448531089|FG001|Overall Study|Administrative problems|0|||
124701588|NCT00425555|448531088|FG000|Overall Study|Death|1|||
124701589|NCT00425555|448531089|FG001|Overall Study|Death|2|||
124701590|NCT00425555|448531088|FG000|Overall Study|New cancer therapy|2|||
124701591|NCT00425555|448531089|FG001|Overall Study|New cancer therapy|1|||
124701592|NCT00425555|448531088|FG000|Overall Study|Disease progression|36|||
124701593|NCT00425555|448531089|FG001|Overall Study|Disease progression|33|||
124701594|NCT00425555|448531088|FG000|Overall Study|Adverse Event|25|||
124701595|NCT00425555|448531089|FG001|Overall Study|Adverse Event|15|||
124701596|NCT00425555|448531088|FG000|Overall Study|Protocol Violation|1|||
124701597|NCT00425555|448531089|FG001|Overall Study|Protocol Violation|0|||
124930034|NCT04585815|449374709|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
124764459|NCT03346434|448763656|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
124764460|NCT03346434|448763657|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
124764461|NCT03346434|448763658|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
124764462|NCT03346434|448763659|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
124764463|NCT03346434|448763660|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
124764464|NCT03346434|448763661|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
124764465|NCT01419236|448763677|FG000|Overall Study|Adverse Event|1|||
124764466|NCT01419236|448763678|FG001|Overall Study|Adverse Event|0|||
124764467|NCT01419236|448763677|FG000|Overall Study|Lack of Efficacy|0|||
124764468|NCT01419236|448763678|FG001|Overall Study|Lack of Efficacy|1|||
124764469|NCT01419236|448763677|FG000|Overall Study|Lost to Follow-up|1|||
124764470|NCT01419236|448763678|FG001|Overall Study|Lost to Follow-up|0|||
124764471|NCT01419236|448763677|FG000|Overall Study|Physician Decision|1|||
124764472|NCT01419236|448763678|FG001|Overall Study|Physician Decision|0|||
124764473|NCT01419236|448763677|FG000|Overall Study|Withdrawal by Subject|1|||
124764474|NCT01419236|448763678|FG001|Overall Study|Withdrawal by Subject|4|||
124764475|NCT01419236|448763677|FG000|Overall Study|Entry Criteria Not Met|1|||
124764476|NCT01419236|448763678|FG001|Overall Study|Entry Criteria Not Met|0|||
124764477|NCT00762359|448763685|FG000|Overall Study|Adverse Event|20|||
124764478|NCT00762359|448763686|FG001|Overall Study|Adverse Event|23|||
124764479|NCT00762359|448763685|FG000|Overall Study|Protocol Violation|21|||
124764480|NCT00762359|448763686|FG001|Overall Study|Protocol Violation|13|||
124764481|NCT00762359|448763685|FG000|Overall Study|Withdrawal by Subject|13|||
124764482|NCT00762359|448763686|FG001|Overall Study|Withdrawal by Subject|10|||
124764483|NCT00762359|448763685|FG000|Overall Study|Lack of Efficacy|0|||
124764484|NCT00762359|448763686|FG001|Overall Study|Lack of Efficacy|4|||
124764485|NCT00762359|448763685|FG000|Overall Study|Institution closed|2|||
124764486|NCT00762359|448763686|FG001|Overall Study|Institution closed|3|||
124764487|NCT00762359|448763685|FG000|Overall Study|Physician Decision|2|||
124764488|NCT00762359|448763686|FG001|Overall Study|Physician Decision|3|||
124764489|NCT00762359|448763685|FG000|Overall Study|Removal|0|||
124764490|NCT00762359|448763686|FG001|Overall Study|Removal|1|||
124764491|NCT00762359|448763685|FG000|Overall Study|Withdrew consent|1|||
124764492|NCT00762359|448763686|FG001|Overall Study|Withdrew consent|0|||
124764493|NCT01453049|448763687|FG000|Overall Study|Protocol Violation|2|||
124764494|NCT01453049|448763688|FG001|Overall Study|Protocol Violation|5|||
124764495|NCT01453049|448763687|FG000|Overall Study|Lost to Follow-up|2|||
124764496|NCT01453049|448763688|FG001|Overall Study|Lost to Follow-up|1|||
124764497|NCT01453049|448763687|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
124764498|NCT01453049|448763688|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
124764499|NCT01453049|448763687|FG000|Overall Study|Withdrawal by Subject|1|||
124764500|NCT01453049|448763688|FG001|Overall Study|Withdrawal by Subject|0|||
124764501|NCT01453049|448763687|FG000|Overall Study|Randomized in Error|1|||
124764502|NCT01453049|448763688|FG001|Overall Study|Randomized in Error|0|||
124764503|NCT00882440|448763689|FG000|Overall Study|Adverse Event|2|||
124764504|NCT00882440|448763690|FG001|Overall Study|Adverse Event|2|||
124764505|NCT00882440|448763691|FG002|Overall Study|Adverse Event|2|||
124764506|NCT00882440|448763692|FG003|Overall Study|Adverse Event|1|||
124764507|NCT00882440|448763693|FG004|Overall Study|Adverse Event|1|||
124764508|NCT00882440|448763694|FG005|Overall Study|Adverse Event|4|||
124764509|NCT00882440|448763695|FG006|Overall Study|Adverse Event|2|||
124764510|NCT00882440|448763689|FG000|Overall Study|Lack of Efficacy|3|||
124764511|NCT00882440|448763690|FG001|Overall Study|Lack of Efficacy|5|||
124764512|NCT00882440|448763691|FG002|Overall Study|Lack of Efficacy|2|||
124764513|NCT00882440|448763692|FG003|Overall Study|Lack of Efficacy|0|||
124764514|NCT00882440|448763693|FG004|Overall Study|Lack of Efficacy|0|||
124764515|NCT00882440|448763694|FG005|Overall Study|Lack of Efficacy|3|||
124930035|NCT04585815|449374710|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
124930036|NCT04585815|449374704|FG000|Sub-study A- Treatment Phase|Death|0|||
124930037|NCT04585815|449374705|FG001|Sub-study A- Treatment Phase|Death|1|||
124930038|NCT04585815|449374706|FG002|Sub-study A- Treatment Phase|Death|0|||
124930039|NCT04585815|449374707|FG003|Sub-study A- Treatment Phase|Death|0|||
124930040|NCT04585815|449374708|FG004|Sub-study A- Treatment Phase|Death|0|||
124930041|NCT04585815|449374709|FG005|Sub-study A- Treatment Phase|Death|0|||
124930042|NCT04585815|449374710|FG006|Sub-study A- Treatment Phase|Death|0|||
124930043|NCT04585815|449374704|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
124764516|NCT00882440|448763695|FG006|Overall Study|Lack of Efficacy|0|||
124764517|NCT00882440|448763689|FG000|Overall Study|Lost to Follow-up|2|||
124764518|NCT00882440|448763690|FG001|Overall Study|Lost to Follow-up|0|||
124764519|NCT00882440|448763691|FG002|Overall Study|Lost to Follow-up|1|||
124764520|NCT00882440|448763692|FG003|Overall Study|Lost to Follow-up|1|||
124764521|NCT00882440|448763693|FG004|Overall Study|Lost to Follow-up|1|||
124764522|NCT00882440|448763694|FG005|Overall Study|Lost to Follow-up|0|||
124764523|NCT00882440|448763695|FG006|Overall Study|Lost to Follow-up|1|||
124764524|NCT00882440|448763689|FG000|Overall Study|Protocol Violation|0|||
124764525|NCT00882440|448763690|FG001|Overall Study|Protocol Violation|0|||
124764526|NCT00882440|448763691|FG002|Overall Study|Protocol Violation|1|||
124455429|NCT02576444|447627168|FG002|Overall Study|Adverse Event|1|||
124455430|NCT02576444|447627169|FG003|Overall Study|Adverse Event|0|||
124455431|NCT02576444|447627166|FG000|Overall Study|Physician Decision|0|||
124455432|NCT02576444|447627167|FG001|Overall Study|Physician Decision|0|||
124701598|NCT05763381|448531090|FG000|Overall Study|Lost to Follow-up|2|||
124701599|NCT05763381|448531091|FG001|Overall Study|Lost to Follow-up|3|||
124930044|NCT04585815|449374705|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
124930045|NCT04585815|449374706|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
124930046|NCT04585815|449374707|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
124930047|NCT04585815|449374708|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
124930048|NCT04585815|449374709|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
124930049|NCT04585815|449374710|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
124455433|NCT02576444|447627168|FG002|Overall Study|Physician Decision|1|||
124701600|NCT05763381|448531090|FG000|Overall Study|Withdrawal by Subject|1|||
124701601|NCT05763381|448531091|FG001|Overall Study|Withdrawal by Subject|2|||
124701602|NCT01674062|448531092|FG000|Overall Study|Insufficient Therapeutic Response|56|||
124701603|NCT01674062|448531093|FG001|Overall Study|Insufficient Therapeutic Response|26|||
124701604|NCT01674062|448531092|FG000|Overall Study|Other|8|||
124701605|NCT01674062|448531093|FG001|Overall Study|Other|1|||
124701606|NCT01674062|448531092|FG000|Overall Study|Adverse Event|1|||
124701607|NCT01674062|448531093|FG001|Overall Study|Adverse Event|1|||
124701608|NCT01674062|448531092|FG000|Overall Study|Death|0|||
124701609|NCT01674062|448531093|FG001|Overall Study|Death|1|||
124701610|NCT01674062|448531092|FG000|Overall Study|Programming Error|1|||
124930050|NCT04585815|449374704|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
124930051|NCT04585815|449374705|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
124930052|NCT04585815|449374706|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
124930053|NCT04585815|449374707|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
124930054|NCT04585815|449374708|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
124701611|NCT01674062|448531093|FG001|Overall Study|Programming Error|0|||
124701612|NCT01443026|448531097|FG000|Overall Study|Physician Decision|1|||
124701613|NCT01443026|448531098|FG001|Overall Study|Physician Decision|0|||
124701614|NCT01443026|448531097|FG000|Overall Study|Death|0|||
124701615|NCT01443026|448531098|FG001|Overall Study|Death|1|||
124701616|NCT01443026|448531097|FG000|Overall Study|Withdrawal by Subject|0|||
124701617|NCT01443026|448531098|FG001|Overall Study|Withdrawal by Subject|3|||
124701618|NCT01443026|448531097|FG000|Overall Study|Lost to Follow-up|2|||
124701619|NCT01443026|448531098|FG001|Overall Study|Lost to Follow-up|1|||
124701620|NCT00581919|448531099|FG000|Overall Study|Adverse Event|8|||
124701621|NCT00581919|448531099|FG000|Overall Study|Death|1|||
124701622|NCT00581919|448531099|FG000|Overall Study|Disease Progression|10|||
124701623|NCT00581919|448531099|FG000|Overall Study|Physician Decision|1|||
124701624|NCT00581919|448531099|FG000|Overall Study|Other Complicating Disease|1|||
124701625|NCT00581919|448531099|FG000|Overall Study|Started Non-Protocol Therapy|2|||
124701626|NCT00581919|448531099|FG000|Overall Study|Withdrawal by Subject|1|||
124701627|NCT02655601|448531100|FG000|Overall Study|Adverse Event|0|||
124701628|NCT02655601|448531101|FG001|Overall Study|Adverse Event|0|||
124701629|NCT02655601|448531102|FG002|Overall Study|Adverse Event|0|||
124701630|NCT02655601|448531103|FG003|Overall Study|Adverse Event|1|||
124701631|NCT02655601|448531104|FG004|Overall Study|Adverse Event|1|||
124701632|NCT02655601|448531105|FG005|Overall Study|Adverse Event|0|||
124701633|NCT02655601|448531100|FG000|Overall Study|Physician Decision|0|||
124701634|NCT02655601|448531101|FG001|Overall Study|Physician Decision|0|||
124701635|NCT02655601|448531102|FG002|Overall Study|Physician Decision|0|||
124701636|NCT02655601|448531103|FG003|Overall Study|Physician Decision|0|||
124701637|NCT02655601|448531104|FG004|Overall Study|Physician Decision|1|||
124701638|NCT02655601|448531105|FG005|Overall Study|Physician Decision|1|||
124701639|NCT02655601|448531100|FG000|Overall Study|Withdrawal by Subject|0|||
124701640|NCT02655601|448531101|FG001|Overall Study|Withdrawal by Subject|0|||
124930055|NCT04585815|449374709|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
124455434|NCT02576444|447627169|FG003|Overall Study|Physician Decision|0|||
124455435|NCT01843842|447627174|FG000|Overall Study|Do not meet inclusion criteria|1|||
124701641|NCT02655601|448531102|FG002|Overall Study|Withdrawal by Subject|0|||
124701642|NCT02655601|448531103|FG003|Overall Study|Withdrawal by Subject|0|||
124701643|NCT02655601|448531104|FG004|Overall Study|Withdrawal by Subject|4|||
124701644|NCT02655601|448531105|FG005|Overall Study|Withdrawal by Subject|8|||
124701645|NCT02655601|448531100|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
124701646|NCT02655601|448531101|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
124701647|NCT02655601|448531102|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
124701648|NCT02655601|448531103|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
124701649|NCT02655601|448531104|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
124701650|NCT02655601|448531105|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
124455436|NCT01843842|447627175|FG001|Overall Study|Do not meet inclusion criteria|1|||
124930056|NCT04585815|449374710|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
124930057|NCT04585815|449374704|FG000|Sub-study A- Treatment Phase|Other|1|||
124930058|NCT04585815|449374705|FG001|Sub-study A- Treatment Phase|Other|0|||
124930059|NCT04585815|449374706|FG002|Sub-study A- Treatment Phase|Other|0|||
124930060|NCT04585815|449374707|FG003|Sub-study A- Treatment Phase|Other|0|||
124930061|NCT04585815|449374708|FG004|Sub-study A- Treatment Phase|Other|0|||
124930062|NCT04585815|449374709|FG005|Sub-study A- Treatment Phase|Other|0|||
124930063|NCT04585815|449374710|FG006|Sub-study A- Treatment Phase|Other|0|||
124930064|NCT04585815|449374704|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
124930065|NCT04585815|449374705|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
124930066|NCT04585815|449374706|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
124930067|NCT04585815|449374707|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
124930068|NCT04585815|449374708|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
124930069|NCT04585815|449374709|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
124930070|NCT04585815|449374710|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
124930071|NCT04585815|449374704|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
124930072|NCT04585815|449374705|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
124930073|NCT04585815|449374706|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
124930074|NCT04585815|449374707|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
124930075|NCT04585815|449374708|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
124930076|NCT04585815|449374709|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
124930077|NCT04585815|449374710|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
124930078|NCT04585815|449374704|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
124930079|NCT04585815|449374705|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
124930080|NCT04585815|449374706|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
124930081|NCT04585815|449374707|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
124930082|NCT04585815|449374708|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
124930083|NCT04585815|449374709|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
124930084|NCT04585815|449374710|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
124930085|NCT04585815|449374704|FG000|Sub-study B- Treatment Phase|Death|0|||
124930086|NCT04585815|449374705|FG001|Sub-study B- Treatment Phase|Death|0|||
124930087|NCT04585815|449374706|FG002|Sub-study B- Treatment Phase|Death|0|||
124701651|NCT03829683|448531110|FG000|Overall Study|Lost to Follow-up|1|||
124701652|NCT03829683|448531111|FG001|Overall Study|Lost to Follow-up|0|||
124701653|NCT03829683|448531110|FG000|Overall Study|Physician Decision|3|||
124701654|NCT03829683|448531111|FG001|Overall Study|Physician Decision|1|||
124701655|NCT03829683|448531110|FG000|Overall Study|Withdrawal by Subject|0|||
124701656|NCT03829683|448531111|FG001|Overall Study|Withdrawal by Subject|1|||
124701657|NCT03829683|448531110|FG000|Overall Study|Discharge from hospital|1|||
124701658|NCT03829683|448531111|FG001|Overall Study|Discharge from hospital|0|||
124701659|NCT02796651|448531115|FG000|Overall Study|Adverse Event|6|||
124701660|NCT02796651|448531115|FG000|Overall Study|Lost to Follow-up|1|||
124701661|NCT02796651|448531115|FG000|Overall Study|Withdrawal by Subject|4|||
124930088|NCT04585815|449374707|FG003|Sub-study B- Treatment Phase|Death|1|||
124930089|NCT04585815|449374708|FG004|Sub-study B- Treatment Phase|Death|0|||
124930090|NCT04585815|449374709|FG005|Sub-study B- Treatment Phase|Death|0|||
124930091|NCT04585815|449374710|FG006|Sub-study B- Treatment Phase|Death|0|||
124930092|NCT04585815|449374704|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
124930093|NCT04585815|449374705|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
124930094|NCT04585815|449374706|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
124701662|NCT02796651|448531115|FG000|Overall Study|Protocol Violation|4|||
124701663|NCT02796651|448531115|FG000|Overall Study|Lack of Efficacy|1|||
124701664|NCT02796651|448531115|FG000|Overall Study|Other|10|||
124701665|NCT05142306|448531119|FG000|Overall Study|Withdrawal by Subject|0|||
124701666|NCT05142306|448531120|FG001|Overall Study|Withdrawal by Subject|0|||
124701667|NCT05142306|448531121|FG002|Overall Study|Withdrawal by Subject|1|||
124701668|NCT05430919|448531122|FG000|Overall Study|Protocol Violation|0|||
124930095|NCT04585815|449374707|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
124930096|NCT04585815|449374708|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
124930097|NCT04585815|449374709|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
124930098|NCT04585815|449374710|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
124930099|NCT04585815|449374704|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
124930100|NCT04585815|449374705|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
124701669|NCT05430919|448531123|FG001|Overall Study|Protocol Violation|0|||
124701670|NCT05430919|448531124|FG002|Overall Study|Protocol Violation|1|||
124701671|NCT05430919|448531125|FG003|Overall Study|Protocol Violation|0|||
124701672|NCT05430919|448531122|FG000|Overall Study|Lost to Follow-up|0|||
124701673|NCT05430919|448531123|FG001|Overall Study|Lost to Follow-up|1|||
124701674|NCT05430919|448531124|FG002|Overall Study|Lost to Follow-up|0|||
124930101|NCT04585815|449374706|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
124930102|NCT04585815|449374707|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
124930103|NCT04585815|449374708|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
124930104|NCT04585815|449374709|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
124930105|NCT04585815|449374710|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
124930106|NCT04585815|449374704|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
124930107|NCT04585815|449374705|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
124930108|NCT04585815|449374706|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
124930109|NCT04585815|449374707|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
124930110|NCT04585815|449374708|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
124764527|NCT00882440|448763692|FG003|Overall Study|Protocol Violation|1|||
124764528|NCT00882440|448763693|FG004|Overall Study|Protocol Violation|1|||
124764529|NCT00882440|448763694|FG005|Overall Study|Protocol Violation|0|||
124764530|NCT00882440|448763695|FG006|Overall Study|Protocol Violation|0|||
124764531|NCT00882440|448763689|FG000|Overall Study|Withdrawal by Subject|2|||
124764532|NCT00882440|448763690|FG001|Overall Study|Withdrawal by Subject|1|||
124764533|NCT00882440|448763691|FG002|Overall Study|Withdrawal by Subject|1|||
124764534|NCT00882440|448763692|FG003|Overall Study|Withdrawal by Subject|0|||
124764535|NCT00882440|448763693|FG004|Overall Study|Withdrawal by Subject|6|||
124764536|NCT00882440|448763694|FG005|Overall Study|Withdrawal by Subject|0|||
124764537|NCT00882440|448763695|FG006|Overall Study|Withdrawal by Subject|1|||
124764538|NCT00882440|448763689|FG000|Overall Study|Patient Uncooperative|2|||
124764539|NCT00882440|448763690|FG001|Overall Study|Patient Uncooperative|0|||
124764540|NCT00882440|448763691|FG002|Overall Study|Patient Uncooperative|0|||
124764541|NCT00882440|448763692|FG003|Overall Study|Patient Uncooperative|0|||
124764542|NCT00882440|448763693|FG004|Overall Study|Patient Uncooperative|1|||
124764543|NCT00882440|448763694|FG005|Overall Study|Patient Uncooperative|0|||
124764544|NCT00882440|448763695|FG006|Overall Study|Patient Uncooperative|0|||
124764545|NCT03287791|448763696|FG000|Overall Study|Insufficient Therapeutic Response|0|||
124764546|NCT03287791|448763697|FG001|Overall Study|Insufficient Therapeutic Response|0|||
124764547|NCT03287791|448763698|FG002|Overall Study|Insufficient Therapeutic Response|1|||
124764548|NCT03287791|448763696|FG000|Overall Study|Adverse Event|0|||
124764549|NCT03287791|448763697|FG001|Overall Study|Adverse Event|4|||
124764550|NCT03287791|448763698|FG002|Overall Study|Adverse Event|3|||
124764551|NCT03287791|448763696|FG000|Overall Study|Withdrawal by Subject|12|||
124764552|NCT03287791|448763697|FG001|Overall Study|Withdrawal by Subject|12|||
124764553|NCT03287791|448763698|FG002|Overall Study|Withdrawal by Subject|17|||
124764554|NCT03287791|448763696|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
124764555|NCT03287791|448763697|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
124764556|NCT03287791|448763698|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
124764557|NCT03287791|448763696|FG000|Overall Study|Lost to Follow-up|8|||
124764558|NCT03287791|448763697|FG001|Overall Study|Lost to Follow-up|14|||
124764559|NCT03287791|448763698|FG002|Overall Study|Lost to Follow-up|11|||
124764560|NCT03287791|448763696|FG000|Overall Study|Protocol Violation|7|||
124930111|NCT04585815|449374709|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
124930112|NCT04585815|449374710|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
124930113|NCT04585815|449374704|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
124930114|NCT04585815|449374705|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
124930115|NCT04585815|449374706|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
124930116|NCT04585815|449374707|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
124930117|NCT04585815|449374708|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
124930118|NCT04585815|449374709|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
124764561|NCT03287791|448763697|FG001|Overall Study|Protocol Violation|2|||
124764562|NCT03287791|448763698|FG002|Overall Study|Protocol Violation|1|||
124764563|NCT03287791|448763696|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
124764564|NCT03287791|448763697|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
124764565|NCT03287791|448763698|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
124764566|NCT03287791|448763696|FG000|Overall Study|Too much time between 2 visits|0|||
124764567|NCT03287791|448763697|FG001|Overall Study|Too much time between 2 visits|1|||
124764568|NCT03287791|448763698|FG002|Overall Study|Too much time between 2 visits|0|||
124930119|NCT04585815|449374710|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
124930120|NCT04585815|449374704|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
124930121|NCT04585815|449374705|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
124930122|NCT04585815|449374706|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
124930123|NCT04585815|449374707|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
124764569|NCT03287791|448763696|FG000|Overall Study|Non-compliance|0|||
124764570|NCT03287791|448763697|FG001|Overall Study|Non-compliance|1|||
124764571|NCT03287791|448763698|FG002|Overall Study|Non-compliance|0|||
124764572|NCT03287791|448763696|FG000|Overall Study|Did not meet inclusion criteria|1|||
124764573|NCT03287791|448763697|FG001|Overall Study|Did not meet inclusion criteria|0|||
124764574|NCT03287791|448763698|FG002|Overall Study|Did not meet inclusion criteria|0|||
124764575|NCT05482308|448763703|FG000|Overall Study|Withdrawal by Subject|1|||
124764576|NCT05482308|448763704|FG001|Overall Study|Withdrawal by Subject|0|||
124764577|NCT05482308|448763703|FG000|Overall Study|No longer meets eligibility criteria|0|||
124764578|NCT05482308|448763704|FG001|Overall Study|No longer meets eligibility criteria|1|||
124764579|NCT02250326|448763708|FG000|Treatment|Death|1|||
124764580|NCT02250326|448763709|FG001|Treatment|Death|13|||
124764581|NCT02250326|448763710|FG002|Treatment|Death|2|||
124764582|NCT02250326|448763708|FG000|Treatment|Adverse Event|8|||
124764583|NCT02250326|448763709|FG001|Treatment|Adverse Event|8|||
124764584|NCT02250326|448763710|FG002|Treatment|Adverse Event|9|||
124764585|NCT02250326|448763708|FG000|Treatment|Progressive Disease|42|||
124764586|NCT02250326|448763709|FG001|Treatment|Progressive Disease|40|||
124764587|NCT02250326|448763710|FG002|Treatment|Progressive Disease|47|||
124764588|NCT02250326|448763708|FG000|Treatment|Symptomatic Deterioration|9|||
124764589|NCT02250326|448763709|FG001|Treatment|Symptomatic Deterioration|4|||
124764590|NCT02250326|448763710|FG002|Treatment|Symptomatic Deterioration|10|||
124764591|NCT02250326|448763708|FG000|Treatment|Withdrawal by Subject|11|||
124764592|NCT02250326|448763709|FG001|Treatment|Withdrawal by Subject|6|||
124930124|NCT04585815|449374708|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
124930125|NCT04585815|449374709|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
124930126|NCT04585815|449374710|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
124930127|NCT04585815|449374704|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
124930128|NCT04585815|449374705|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
124930129|NCT04585815|449374706|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
124930130|NCT04585815|449374707|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
124930131|NCT04585815|449374708|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
124930132|NCT04585815|449374709|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
124930133|NCT04585815|449374710|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
124930134|NCT04585815|449374704|FG000|Sub-study B- Follow-up Phase|Death|0|||
124930135|NCT04585815|449374705|FG001|Sub-study B- Follow-up Phase|Death|0|||
124930136|NCT04585815|449374706|FG002|Sub-study B- Follow-up Phase|Death|1|||
124930137|NCT04585815|449374707|FG003|Sub-study B- Follow-up Phase|Death|3|||
124930138|NCT04585815|449374708|FG004|Sub-study B- Follow-up Phase|Death|0|||
124930139|NCT04585815|449374709|FG005|Sub-study B- Follow-up Phase|Death|0|||
124930140|NCT04585815|449374710|FG006|Sub-study B- Follow-up Phase|Death|1|||
124930141|NCT04587453|449374716|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
124930142|NCT04587453|449374717|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
124930143|NCT04141891|449374720|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
124930144|NCT04141891|449374721|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
124930145|NCT04141891|449374720|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
124930146|NCT04141891|449374721|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
124930147|NCT04141891|449374720|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
124930148|NCT04141891|449374721|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
124930149|NCT04141891|449374720|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
124930150|NCT04141891|449374721|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
124930151|NCT04141891|449374720|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
124930152|NCT04141891|449374721|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
124930153|NCT04141891|449374720|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
124455437|NCT02953340|447627176|FG000|Overall Study|Death|0|||
124455438|NCT02953340|447627177|FG001|Overall Study|Death|1|||
124455439|NCT02953340|447627176|FG000|Overall Study|Investigator Decision|3|||
124930154|NCT04141891|449374721|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
124930155|NCT04141891|449374720|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
124930156|NCT04141891|449374721|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
124930157|NCT04141891|449374720|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
124930158|NCT04141891|449374721|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
124930159|NCT04141891|449374720|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
124930160|NCT04141891|449374721|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
124930161|NCT04141891|449374720|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
124930162|NCT04141891|449374721|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
124930163|NCT04141891|449374720|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
124455440|NCT02953340|447627177|FG001|Overall Study|Investigator Decision|3|||
124930164|NCT04141891|449374721|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
124930165|NCT04141891|449374720|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
124930166|NCT04141891|449374721|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
124455441|NCT02953340|447627176|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
124455442|NCT02953340|447627177|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
124764593|NCT02250326|448763710|FG002|Treatment|Withdrawal by Subject|4|||
124764594|NCT02250326|448763708|FG000|Treatment|Other reasons|8|||
124764595|NCT02250326|448763709|FG001|Treatment|Other reasons|7|||
124764596|NCT02250326|448763710|FG002|Treatment|Other reasons|7|||
124930167|NCT04141891|449374720|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
124930168|NCT04141891|449374721|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
124930169|NCT04141891|449374720|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
124930170|NCT04141891|449374721|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
124930171|NCT05090683|449374729|FG000|Overall Study|Lost to Follow-up|10|||
124930172|NCT05090683|449374730|FG001|Overall Study|Lost to Follow-up|2|||
124930173|NCT05090683|449374729|FG000|Overall Study|Withdrawal by Subject|15|||
124930174|NCT05090683|449374730|FG001|Overall Study|Withdrawal by Subject|0|||
124930175|NCT04032847|449374733|FG000|Overall Study|Study termination by sponsor|8|||
124701675|NCT05430919|448531125|FG003|Overall Study|Lost to Follow-up|0|||
124701676|NCT05430919|448531122|FG000|Overall Study|Withdrawal by Subject|3|||
124701677|NCT05430919|448531123|FG001|Overall Study|Withdrawal by Subject|0|||
124701678|NCT05430919|448531124|FG002|Overall Study|Withdrawal by Subject|0|||
124701679|NCT05430919|448531125|FG003|Overall Study|Withdrawal by Subject|1|||
124701680|NCT05014919|448531126|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
124701681|NCT05014919|448531127|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
124701682|NCT05014919|448531128|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
124701683|NCT05014919|448531126|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
124701684|NCT05014919|448531127|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
124701685|NCT05014919|448531128|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
124701686|NCT05014919|448531126|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
124701687|NCT05014919|448531127|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
124701688|NCT05014919|448531128|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
124701689|NCT05014919|448531126|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
124701690|NCT05014919|448531127|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
124701691|NCT05014919|448531128|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
124701692|NCT05014919|448531126|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
124701693|NCT05014919|448531127|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
124701694|NCT05014919|448531128|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
124701695|NCT05014919|448531126|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
124701696|NCT05014919|448531127|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
124701697|NCT05014919|448531128|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
124701698|NCT05014919|448531126|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
124701699|NCT05014919|448531127|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
124701700|NCT05014919|448531128|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
124701701|NCT05014919|448531126|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
124701702|NCT05014919|448531127|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
124701703|NCT05014919|448531128|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
124701704|NCT02971163|448531131|FG000|Overall Study|Lost to Follow-up|4|||
124701705|NCT02971163|448531132|FG001|Overall Study|Lost to Follow-up|2|||
124701706|NCT01299961|448531135|FG000|Overall Study|Adverse Event|3|||
124701707|NCT01299961|448531135|FG000|Overall Study|Lack of Efficacy|2|||
124701708|NCT01299961|448531135|FG000|Overall Study|Lost to Follow-up|1|||
124701709|NCT02904096|448531136|FG000|Overall Study|Adverse Event|1|||
124701710|NCT02904096|448531137|FG001|Overall Study|Adverse Event|0|||
124701711|NCT02904096|448531136|FG000|Overall Study|Withdrawal by Subject|4|||
124701712|NCT02904096|448531137|FG001|Overall Study|Withdrawal by Subject|3|||
124701713|NCT02904096|448531136|FG000|Overall Study|Lost to Follow-up|10|||
124701714|NCT02904096|448531137|FG001|Overall Study|Lost to Follow-up|17|||
124701715|NCT02904096|448531136|FG000|Overall Study|Non-compliant|3|||
124701716|NCT02904096|448531137|FG001|Overall Study|Non-compliant|1|||
124701717|NCT02904096|448531136|FG000|Overall Study|Sponsor instructed|1|||
124701718|NCT02904096|448531137|FG001|Overall Study|Sponsor instructed|0|||
124701719|NCT01491919|448531138|FG000|Overall Study|Insufficient PK sampling|1|||
124701720|NCT01491919|448531139|FG001|Overall Study|Insufficient PK sampling|2|||
124701721|NCT01491919|448531140|FG002|Overall Study|Insufficient PK sampling|1|||
124701722|NCT02871219|448531141|FG000|Overall Study|Adverse Event|15|||
124701723|NCT02871219|448531141|FG000|Overall Study|Death|3|||
124701724|NCT02871219|448531141|FG000|Overall Study|Progression|3|||
124701725|NCT02871219|448531141|FG000|Overall Study|Infections|7|||
124701726|NCT02871219|448531141|FG000|Overall Study|Infusion Related|4|||
124701727|NCT02298946|448531145|FG000|Overall Study|Did not receive treatment|2|||
124701728|NCT02298946|448531146|FG001|Overall Study|Did not receive treatment|0|||
124930176|NCT04032847|449374734|FG001|Overall Study|Study termination by sponsor|0|||
124701729|NCT02298946|448531145|FG000|Overall Study|Unevaluable|2|||
124701730|NCT02298946|448531146|FG001|Overall Study|Unevaluable|1|||
124701731|NCT01450631|448531153|FG000|Overall Study|Lost to Follow-up|2|||
124701732|NCT01450631|448531154|FG001|Overall Study|Lost to Follow-up|4|||
124701733|NCT01450631|448531153|FG000|Overall Study|Withdrawal by Subject|1|||
124701734|NCT01450631|448531154|FG001|Overall Study|Withdrawal by Subject|0|||
124701735|NCT00835354|448531155|FG000|First Intervention|Adverse Event|0|||
124701736|NCT00835354|448531156|FG001|First Intervention|Adverse Event|1|||
124701737|NCT04551053|448531157|FG000|Overall Study|Death|9|||
124701738|NCT04551053|448531158|FG001|Overall Study|Death|9|||
124701739|NCT04551053|448531157|FG000|Overall Study|Lost to Follow-up|0|||
124701740|NCT04551053|448531158|FG001|Overall Study|Lost to Follow-up|2|||
124701741|NCT04551053|448531157|FG000|Overall Study|Study Terminated by Sponsor|53|||
124701742|NCT04551053|448531158|FG001|Overall Study|Study Terminated by Sponsor|63|||
124701743|NCT04551053|448531157|FG000|Overall Study|Withdrawal by Subject|12|||
124701744|NCT04551053|448531158|FG001|Overall Study|Withdrawal by Subject|5|||
124701745|NCT04551053|448531157|FG000|Overall Study|Adverse Event|1|||
124701746|NCT04551053|448531158|FG001|Overall Study|Adverse Event|0|||
124701747|NCT04551053|448531157|FG000|Overall Study|Lack of Efficacy|2|||
124701748|NCT04551053|448531158|FG001|Overall Study|Lack of Efficacy|0|||
124701749|NCT04551053|448531157|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
124701750|NCT04551053|448531158|FG001|Overall Study|Transitioned to Rollover per Protocol|3|||
124701751|NCT04551053|448531157|FG000|Overall Study|Splenapendectomi|1|||
124701752|NCT04551053|448531158|FG001|Overall Study|Splenapendectomi|0|||
124701753|NCT04551053|448531157|FG000|Overall Study|Cytomegalovirus pneumonia|1|||
124701754|NCT04551053|448531158|FG001|Overall Study|Cytomegalovirus pneumonia|0|||
124701755|NCT04551053|448531157|FG000|Overall Study|Medical Decision|0|||
124701756|NCT04551053|448531158|FG001|Overall Study|Medical Decision|1|||
124701757|NCT04551053|448531157|FG000|Overall Study|Ongoing|6|||
124701758|NCT04551053|448531158|FG001|Overall Study|Ongoing|4|||
124701759|NCT05375929|448531159|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
124701760|NCT05375929|448531160|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
124701761|NCT05375929|448531161|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
124701762|NCT05375929|448531162|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
124701763|NCT05375929|448531159|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
124701764|NCT05375929|448531160|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
124701765|NCT05375929|448531161|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
124701766|NCT05375929|448531162|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
124701767|NCT05375929|448531159|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
124701768|NCT05375929|448531160|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
124701769|NCT05375929|448531161|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
124701770|NCT05375929|448531162|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
124701771|NCT05375929|448531159|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
124701772|NCT05375929|448531160|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
124701773|NCT05375929|448531161|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
124701774|NCT05375929|448531162|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
124701775|NCT05375929|448531159|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
124701776|NCT05375929|448531160|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
124701777|NCT05375929|448531161|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
124701778|NCT05375929|448531162|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
124701779|NCT05375929|448531159|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
124701780|NCT05375929|448531160|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
124701781|NCT05375929|448531161|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
124701782|NCT05375929|448531162|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
124701783|NCT05375929|448531159|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
124701784|NCT05375929|448531160|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
124701785|NCT05375929|448531161|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
124701786|NCT05375929|448531162|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
124701787|NCT05375929|448531159|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
124701788|NCT05375929|448531160|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
124701789|NCT05375929|448531161|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
124701790|NCT05375929|448531162|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
124701791|NCT05375929|448531159|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
124701792|NCT05375929|448531160|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
124701793|NCT05375929|448531161|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
124701794|NCT05375929|448531162|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
124701795|NCT05375929|448531159|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
124701796|NCT05375929|448531160|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
124701797|NCT05375929|448531161|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
124701798|NCT05375929|448531162|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
124701799|NCT03204812|448531163|FG000|Overall Study|Adverse Event|3|||
124701800|NCT00773461|448531165|FG000|Overall Study|Adverse Event|1|||
124701801|NCT00773461|448531166|FG001|Overall Study|Adverse Event|3|||
124701802|NCT00773461|448531165|FG000|Overall Study|Withdrawal by Subject|4|||
124930177|NCT04032847|449374735|FG002|Overall Study|Study termination by sponsor|4|||
124930178|NCT04032847|449374733|FG000|Overall Study|Death|12|||
124701803|NCT00773461|448531166|FG001|Overall Study|Withdrawal by Subject|1|||
124701804|NCT00322218|448531167|FG000|Overall Study|Death|3|||
124701805|NCT00322218|448531168|FG001|Overall Study|Death|6|||
124930179|NCT04032847|449374734|FG001|Overall Study|Death|0|||
124930180|NCT04032847|449374735|FG002|Overall Study|Death|0|||
124930181|NCT04032847|449374733|FG000|Overall Study|Progressive disease|2|||
124930182|NCT04032847|449374734|FG001|Overall Study|Progressive disease|0|||
124764597|NCT02250326|448763708|FG000|Extension Period|Progressive Disease|0|||
124764598|NCT02250326|448763709|FG001|Extension Period|Progressive Disease|2|||
124764599|NCT02250326|448763710|FG002|Extension Period|Progressive Disease|0|||
124764600|NCT02250326|448763708|FG000|Extension Period|Withdrawal by Subject|0|||
124764601|NCT02250326|448763709|FG001|Extension Period|Withdrawal by Subject|1|||
124764602|NCT02250326|448763710|FG002|Extension Period|Withdrawal by Subject|0|||
124764603|NCT02250326|448763708|FG000|Extension Period|Withdrawal by investigator|0|||
124764604|NCT02250326|448763709|FG001|Extension Period|Withdrawal by investigator|1|||
124764605|NCT02250326|448763710|FG002|Extension Period|Withdrawal by investigator|0|||
124764606|NCT00416624|448763711|FG000|Overall Study|Withdrawal by Subject|1|||
124764607|NCT00416624|448763712|FG001|Overall Study|Withdrawal by Subject|6|||
124764608|NCT00416624|448763713|FG002|Overall Study|Withdrawal by Subject|4|||
124930183|NCT04032847|449374735|FG002|Overall Study|Progressive disease|1|||
124930184|NCT03213665|449374736|FG000|Overall Study|Adverse Event|1|||
124930185|NCT03213665|449374736|FG000|Overall Study|Physician Decision|2|||
124930186|NCT03213665|449374736|FG000|Overall Study|Withdrawal by Subject|3|||
124930187|NCT03213665|449374736|FG000|Overall Study|Progressive Disease|13|||
124764609|NCT00416624|448763714|FG003|Overall Study|Withdrawal by Subject|9|||
124764610|NCT00416624|448763711|FG000|Overall Study|Death|4|||
124764611|NCT00416624|448763712|FG001|Overall Study|Death|7|||
124764612|NCT00416624|448763713|FG002|Overall Study|Death|7|||
124764613|NCT00416624|448763714|FG003|Overall Study|Death|1|||
124764614|NCT00416624|448763711|FG000|Overall Study|Adverse Event|8|||
124764615|NCT00416624|448763712|FG001|Overall Study|Adverse Event|3|||
124764616|NCT00416624|448763713|FG002|Overall Study|Adverse Event|2|||
124764617|NCT00416624|448763714|FG003|Overall Study|Adverse Event|2|||
124764618|NCT00416624|448763711|FG000|Overall Study|Other|8|||
124764619|NCT00416624|448763712|FG001|Overall Study|Other|11|||
124764620|NCT00416624|448763713|FG002|Overall Study|Other|5|||
124764621|NCT00416624|448763714|FG003|Overall Study|Other|5|||
124764622|NCT00416624|448763711|FG000|Overall Study|Cancel|1|||
124764623|NCT00416624|448763712|FG001|Overall Study|Cancel|0|||
124764624|NCT00416624|448763713|FG002|Overall Study|Cancel|0|||
124764625|NCT00416624|448763714|FG003|Overall Study|Cancel|0|||
124764626|NCT03924622|448763715|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
124764627|NCT03924622|448763716|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
124764628|NCT03924622|448763717|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
124764629|NCT03924622|448763718|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
124764630|NCT03924622|448763719|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
124764631|NCT03924622|448763720|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
124764632|NCT00141453|448763723|FG000|Overall Study|Protocol Violation|6|||
124764633|NCT00141453|448763724|FG001|Overall Study|Protocol Violation|5|||
124764634|NCT00866177|448763729|FG000|Overall Study|Withdrawal by Subject|1|||
124764635|NCT00866177|448763729|FG000|Overall Study|Not Treated|151|||
124764636|NCT03585660|448763730|FG000|Overall Study|operator error|1|||
124764637|NCT03585660|448763730|FG000|Overall Study|technical error|2|||
124764638|NCT03585660|448763730|FG000|Overall Study|hip prosthesis|2|||
124930188|NCT03056573|449374737|FG000|Overall Study|Death|2|||
124930189|NCT03056573|449374738|FG001|Overall Study|Death|4|||
124930190|NCT03056573|449374737|FG000|Overall Study|Withdrawal by Subject|2|||
124930191|NCT03056573|449374738|FG001|Overall Study|Withdrawal by Subject|0|||
124930192|NCT03056573|449374737|FG000|Overall Study|Lost to Follow-up|1|||
124930193|NCT03056573|449374738|FG001|Overall Study|Lost to Follow-up|1|||
124764639|NCT03585660|448763730|FG000|Overall Study|did not undergo biopsy|8|||
124764640|NCT03585660|448763730|FG000|Overall Study|scanner problem|2|||
124764641|NCT05635461|448763735|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
124764642|NCT05635461|448763736|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
124764643|NCT05635461|448763737|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
124930194|NCT04689256|449374739|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
124930195|NCT04689256|449374740|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
124764644|NCT05635461|448763738|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
124764645|NCT05635461|448763739|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
124764646|NCT05635461|448763740|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
124764647|NCT05635461|448763735|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
124764648|NCT05635461|448763736|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
124764649|NCT05635461|448763737|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
124764650|NCT05635461|448763738|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
124764651|NCT05635461|448763739|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
124764652|NCT05635461|448763740|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
124764653|NCT05635461|448763735|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
124764654|NCT05635461|448763736|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
124764655|NCT05635461|448763737|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
124764656|NCT05635461|448763738|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
124764657|NCT05635461|448763739|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
124764658|NCT05635461|448763740|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
124764659|NCT03760029|448763743|FG000|Overall Study|Death|1|||
124764660|NCT03760029|448763744|FG001|Overall Study|Death|0|||
124764661|NCT03760029|448763745|FG002|Overall Study|Death|0|||
124764662|NCT03760029|448763743|FG000|Overall Study|Lost to Follow-up|0|||
124764663|NCT03760029|448763744|FG001|Overall Study|Lost to Follow-up|2|||
124764664|NCT03760029|448763745|FG002|Overall Study|Lost to Follow-up|1|||
124764665|NCT03760029|448763743|FG000|Overall Study|Withdrawal by Subject|1|||
124764666|NCT03760029|448763744|FG001|Overall Study|Withdrawal by Subject|4|||
124764667|NCT03760029|448763745|FG002|Overall Study|Withdrawal by Subject|1|||
124764668|NCT03760029|448763743|FG000|Overall Study|Withdrawal by parent/guardian|4|||
124764669|NCT03760029|448763744|FG001|Overall Study|Withdrawal by parent/guardian|4|||
124764670|NCT03760029|448763745|FG002|Overall Study|Withdrawal by parent/guardian|1|||
124764671|NCT03760029|448763743|FG000|Overall Study|Other|2|||
124764672|NCT03760029|448763744|FG001|Overall Study|Other|1|||
124764673|NCT03760029|448763745|FG002|Overall Study|Other|0|||
124764674|NCT04890652|448763749|FG000|Overall Study|Withdrawal by Subject|2|||
124764675|NCT00524485|448763750|FG000|Overall Study|Withdrawal by Subject|5|||
124764676|NCT00286442|448763755|FG000|Overall Study|Hyperglycemic Rescue|19|||
124764677|NCT00286442|448763756|FG001|Overall Study|Hyperglycemic Rescue|17|||
124764678|NCT00286442|448763757|FG002|Overall Study|Hyperglycemic Rescue|25|||
124764679|NCT00286442|448763755|FG000|Overall Study|Adverse Event|7|||
124764680|NCT00286442|448763756|FG001|Overall Study|Adverse Event|6|||
124764681|NCT00286442|448763757|FG002|Overall Study|Adverse Event|1|||
124764682|NCT00286442|448763755|FG000|Overall Study|Protocol Violation|2|||
124764683|NCT00286442|448763756|FG001|Overall Study|Protocol Violation|4|||
124764684|NCT00286442|448763757|FG002|Overall Study|Protocol Violation|2|||
124764685|NCT00286442|448763755|FG000|Overall Study|Lost to Follow-up|5|||
124764686|NCT00286442|448763756|FG001|Overall Study|Lost to Follow-up|2|||
124764687|NCT00286442|448763757|FG002|Overall Study|Lost to Follow-up|1|||
124764688|NCT00286442|448763755|FG000|Overall Study|Physician Decision|1|||
124764689|NCT00286442|448763756|FG001|Overall Study|Physician Decision|1|||
124764690|NCT00286442|448763757|FG002|Overall Study|Physician Decision|1|||
124764691|NCT00286442|448763755|FG000|Overall Study|Administrative Error|1|||
124764692|NCT00286442|448763756|FG001|Overall Study|Administrative Error|1|||
124764693|NCT00286442|448763757|FG002|Overall Study|Administrative Error|0|||
124764694|NCT00286442|448763755|FG000|Overall Study|Withdrawal by Subject|2|||
124764695|NCT00286442|448763756|FG001|Overall Study|Withdrawal by Subject|14|||
124764696|NCT00286442|448763757|FG002|Overall Study|Withdrawal by Subject|2|||
124764697|NCT01339689|448763760|FG000|Overall Study|Adverse Event|1|||
124764698|NCT01339689|448763761|FG001|Overall Study|Adverse Event|2|||
124764699|NCT01339689|448763760|FG000|Overall Study|Lost to Follow-up|9|||
124764700|NCT01339689|448763761|FG001|Overall Study|Lost to Follow-up|3|||
124764701|NCT01339689|448763760|FG000|Overall Study|Withdrawal by Subject|3|||
124455443|NCT02953340|447627176|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
124455444|NCT02953340|447627177|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
124455445|NCT02953340|447627176|FG000|Overall Study|Withdrawal by Subject|9|||
124455446|NCT02953340|447627177|FG001|Overall Study|Withdrawal by Subject|9|||
124764702|NCT01339689|448763761|FG001|Overall Study|Withdrawal by Subject|0|||
124764703|NCT01339689|448763760|FG000|Overall Study|Noncompliance|1|||
124764704|NCT01339689|448763761|FG001|Overall Study|Noncompliance|0|||
124764705|NCT01339689|448763760|FG000|Overall Study|Relocated out of area|0|||
124764706|NCT01339689|448763761|FG001|Overall Study|Relocated out of area|1|||
124764707|NCT01339689|448763760|FG000|Overall Study|Other|2|||
124764708|NCT01339689|448763761|FG001|Overall Study|Other|2|||
124764709|NCT01339689|448763760|FG000|Overall Study|multiple reasons|1|||
124764710|NCT01339689|448763761|FG001|Overall Study|multiple reasons|1|||
124764711|NCT04571944|448763762|FG000|Overall Study|Death|1|||
124764712|NCT04571944|448763763|FG001|Overall Study|Death|0|||
124764713|NCT04571944|448763762|FG000|Overall Study|Withdrawal by Subject|3|||
124764714|NCT04571944|448763763|FG001|Overall Study|Withdrawal by Subject|0|||
124764715|NCT04571944|448763762|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
124930196|NCT05104463|449374743|FG000|Overall Study|Adverse Event|1|||
124930197|NCT05104463|449374744|FG001|Overall Study|Adverse Event|1|||
124930198|NCT05104463|449374743|FG000|Overall Study|Lost to Follow-up|1|||
124930199|NCT05104463|449374744|FG001|Overall Study|Lost to Follow-up|1|||
124930200|NCT05104463|449374743|FG000|Overall Study|Physician Decision|1|||
124930201|NCT05104463|449374744|FG001|Overall Study|Physician Decision|0|||
124930202|NCT05104463|449374743|FG000|Overall Study|Protocol Violation|0|||
124930203|NCT05104463|449374744|FG001|Overall Study|Protocol Violation|2|||
124930204|NCT05104463|449374743|FG000|Overall Study|Withdrawal by Subject|1|||
124930205|NCT05104463|449374744|FG001|Overall Study|Withdrawal by Subject|1|||
124930206|NCT05267470|449374748|FG000|Overall Study|Decision by sponsor|0|||
124930207|NCT05267470|449374749|FG001|Overall Study|Decision by sponsor|3|||
124930208|NCT05267470|449374750|FG002|Overall Study|Decision by sponsor|19|||
124930209|NCT05267470|449374751|FG003|Overall Study|Decision by sponsor|7|||
124930210|NCT05267470|449374752|FG004|Overall Study|Decision by sponsor|3|||
124455447|NCT02953340|447627176|FG000|Overall Study|Sponsor decision|0|||
124701806|NCT00908141|448531173|FG000|Overall Study|Withdrawal by Subject|0|||
124701807|NCT00908141|448531174|FG001|Overall Study|Withdrawal by Subject|1|||
124701808|NCT03648372|448531175|FG000|Overall Study|Withdrawal by Subject|2|||
124701809|NCT03648372|448531176|FG001|Overall Study|Withdrawal by Subject|0|||
124701810|NCT03648372|448531177|FG002|Overall Study|Withdrawal by Subject|0|||
124701811|NCT03648372|448531178|FG003|Overall Study|Withdrawal by Subject|0|||
124701812|NCT03648372|448531179|FG004|Overall Study|Withdrawal by Subject|0|||
124701813|NCT03648372|448531180|FG005|Overall Study|Withdrawal by Subject|1|||
124701814|NCT03648372|448531181|FG006|Overall Study|Withdrawal by Subject|2|||
124701815|NCT03648372|448531182|FG007|Overall Study|Withdrawal by Subject|0|||
124701816|NCT03648372|448531183|FG008|Overall Study|Withdrawal by Subject|0|||
124701817|NCT03648372|448531184|FG009|Overall Study|Withdrawal by Subject|0|||
124701818|NCT03648372|448531185|FG010|Overall Study|Withdrawal by Subject|2|||
124701819|NCT03648372|448531186|FG011|Overall Study|Withdrawal by Subject|0|||
124701820|NCT03648372|448531187|FG012|Overall Study|Withdrawal by Subject|2|||
124701821|NCT03648372|448531188|FG013|Overall Study|Withdrawal by Subject|0|||
124701822|NCT03648372|448531189|FG014|Overall Study|Withdrawal by Subject|0|||
124701823|NCT03648372|448531190|FG015|Overall Study|Withdrawal by Subject|0|||
124701824|NCT03648372|448531191|FG016|Overall Study|Withdrawal by Subject|1|||
124701825|NCT03648372|448531192|FG017|Overall Study|Withdrawal by Subject|0|||
124701826|NCT03648372|448531193|FG018|Overall Study|Withdrawal by Subject|0|||
124701827|NCT03648372|448531194|FG019|Overall Study|Withdrawal by Subject|0|||
124701828|NCT03648372|448531195|FG020|Overall Study|Withdrawal by Subject|0|||
124701829|NCT03648372|448531175|FG000|Overall Study|Progressive Disease|2|||
124701830|NCT03648372|448531176|FG001|Overall Study|Progressive Disease|3|||
124701831|NCT03648372|448531177|FG002|Overall Study|Progressive Disease|4|||
124701832|NCT03648372|448531178|FG003|Overall Study|Progressive Disease|3|||
124701833|NCT03648372|448531179|FG004|Overall Study|Progressive Disease|2|||
124701834|NCT03648372|448531180|FG005|Overall Study|Progressive Disease|2|||
124701835|NCT03648372|448531181|FG006|Overall Study|Progressive Disease|3|||
124701836|NCT03648372|448531182|FG007|Overall Study|Progressive Disease|3|||
124701837|NCT03648372|448531183|FG008|Overall Study|Progressive Disease|5|||
124701838|NCT03648372|448531184|FG009|Overall Study|Progressive Disease|5|||
124701839|NCT03648372|448531185|FG010|Overall Study|Progressive Disease|2|||
124701840|NCT03648372|448531186|FG011|Overall Study|Progressive Disease|3|||
124701841|NCT03648372|448531187|FG012|Overall Study|Progressive Disease|3|||
124701842|NCT03648372|448531188|FG013|Overall Study|Progressive Disease|3|||
124701843|NCT03648372|448531189|FG014|Overall Study|Progressive Disease|6|||
124701844|NCT03648372|448531190|FG015|Overall Study|Progressive Disease|0|||
124701845|NCT03648372|448531191|FG016|Overall Study|Progressive Disease|0|||
124701846|NCT03648372|448531192|FG017|Overall Study|Progressive Disease|0|||
124701847|NCT03648372|448531193|FG018|Overall Study|Progressive Disease|0|||
124701848|NCT03648372|448531194|FG019|Overall Study|Progressive Disease|0|||
124701849|NCT03648372|448531195|FG020|Overall Study|Progressive Disease|0|||
124701850|NCT03648372|448531175|FG000|Overall Study|Other|0|||
124701851|NCT03648372|448531176|FG001|Overall Study|Other|0|||
124701852|NCT03648372|448531177|FG002|Overall Study|Other|0|||
124701853|NCT03648372|448531178|FG003|Overall Study|Other|0|||
124701854|NCT03648372|448531179|FG004|Overall Study|Other|1|||
124764716|NCT04571944|448763763|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
124930211|NCT05267470|449374748|FG000|Overall Study|Withdrawal by Subject|1|||
124701855|NCT03648372|448531180|FG005|Overall Study|Other|0|||
124701856|NCT03648372|448531181|FG006|Overall Study|Other|0|||
124701857|NCT03648372|448531182|FG007|Overall Study|Other|0|||
124701858|NCT03648372|448531183|FG008|Overall Study|Other|0|||
124701859|NCT03648372|448531184|FG009|Overall Study|Other|0|||
124701860|NCT03648372|448531185|FG010|Overall Study|Other|1|||
124701861|NCT03648372|448531186|FG011|Overall Study|Other|2|||
124701862|NCT03648372|448531187|FG012|Overall Study|Other|1|||
124701863|NCT03648372|448531188|FG013|Overall Study|Other|3|||
124701864|NCT03648372|448531189|FG014|Overall Study|Other|0|||
124930212|NCT05267470|449374749|FG001|Overall Study|Withdrawal by Subject|1|||
124930213|NCT05267470|449374750|FG002|Overall Study|Withdrawal by Subject|2|||
124455448|NCT02953340|447627177|FG001|Overall Study|Sponsor decision|2|||
124455449|NCT02953340|447627176|FG000|Overall Study|Lost to Follow-up|3|||
124455450|NCT02953340|447627177|FG001|Overall Study|Lost to Follow-up|2|||
124764717|NCT00667888|448763764|FG000|Overall Study|Death|1|||
124764718|NCT00667888|448763765|FG001|Overall Study|Death|1|||
124764719|NCT00667888|448763764|FG000|Overall Study|Withdrawal by Subject|6|||
124764720|NCT00667888|448763765|FG001|Overall Study|Withdrawal by Subject|3|||
124764721|NCT00667888|448763764|FG000|Overall Study|Proceed with other treatment|3|||
124764722|NCT00667888|448763765|FG001|Overall Study|Proceed with other treatment|3|||
124764723|NCT00667888|448763764|FG000|Overall Study|Ineligible after SIM|0|||
124764724|NCT00667888|448763765|FG001|Overall Study|Ineligible after SIM|2|||
124764725|NCT02140047|448763766|FG000|Overall Study|Withdrawal by parent/guardian|1|||
124764726|NCT02140047|448763767|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124764727|NCT02140047|448763768|FG002|Overall Study|Withdrawal by parent/guardian|0|||
124764728|NCT00659061|448763769|FG000|Overall Study|Migration due to political unrest|21|||
124764729|NCT00659061|448763770|FG001|Overall Study|Migration due to political unrest|15|||
124764730|NCT01277744|448763771|FG000|Overall Study|Physician Decision|2|||
124764731|NCT00325897|448763772|FG000|Overall Study|Lost to Follow-up|12|||
124764732|NCT00325897|448763773|FG001|Overall Study|Lost to Follow-up|13|||
124764733|NCT03915717|448763774|FG000|Overall Study|EchoMark Not Implanted|6|||
124764734|NCT03748823|448763776|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
124764735|NCT03748823|448763777|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
124764736|NCT03748823|448763776|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
124764737|NCT03748823|448763777|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
124764738|NCT03748823|448763776|FG000|Extension Period|Withdrawal by Subject|9|||
124764739|NCT03748823|448763777|FG001|Extension Period|Withdrawal by Subject|12|||
124764740|NCT03748823|448763776|FG000|Extension Period|Death|2|||
124764741|NCT03748823|448763777|FG001|Extension Period|Death|2|||
124764742|NCT03748823|448763776|FG000|Extension Period|Other than Specified|0|||
124764743|NCT03748823|448763777|FG001|Extension Period|Other than Specified|1|||
124764744|NCT03748823|448763776|FG000|Extension Period|Protocol Violation|1|||
124764745|NCT03748823|448763777|FG001|Extension Period|Protocol Violation|0|||
124764746|NCT03748823|448763776|FG000|Extension Period|Lost to Follow-up|0|||
124764747|NCT03748823|448763777|FG001|Extension Period|Lost to Follow-up|1|||
124764748|NCT03748823|448763776|FG000|Extension Period|Lack of Efficacy|0|||
124764749|NCT03748823|448763777|FG001|Extension Period|Lack of Efficacy|1|||
124764750|NCT03748823|448763776|FG000|Extension Period|Physician Decision|1|||
124764751|NCT03748823|448763777|FG001|Extension Period|Physician Decision|2|||
124764752|NCT00626275|448763778|FG000|Part A - Treatment Period 1|Adverse Event|1|||
124764753|NCT00626275|448763779|FG001|Part A - Treatment Period 1|Adverse Event|0|||
124764754|NCT00626275|448763780|FG002|Part A - Treatment Period 1|Adverse Event|0|||
124764755|NCT00626275|448763781|FG003|Part A - Treatment Period 1|Adverse Event|0|||
124764756|NCT00626275|448763782|FG004|Part A - Treatment Period 1|Adverse Event|0|||
124764757|NCT00626275|448763783|FG005|Part A - Treatment Period 1|Adverse Event|0|||
124764758|NCT00626275|448763784|FG006|Part A - Treatment Period 1|Adverse Event|0|||
124764759|NCT00626275|448763785|FG007|Part A - Treatment Period 1|Adverse Event|0|||
124764760|NCT00626275|448763778|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
124764761|NCT00626275|448763779|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
124764762|NCT00626275|448763780|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
124764763|NCT00626275|448763781|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
124764764|NCT00626275|448763782|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
124764765|NCT00626275|448763783|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
124764766|NCT00626275|448763784|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
124764767|NCT00626275|448763785|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
124764768|NCT00626275|448763778|FG000|Part B|Lost to Follow-up|0|||
124764769|NCT00626275|448763779|FG001|Part B|Lost to Follow-up|0|||
124930214|NCT05267470|449374751|FG003|Overall Study|Withdrawal by Subject|2|||
124930215|NCT05267470|449374752|FG004|Overall Study|Withdrawal by Subject|0|||
124930216|NCT05267470|449374748|FG000|Overall Study|Death|3|||
124455451|NCT02953340|447627176|FG000|Overall Study|Reason not specified|2|||
124455452|NCT02953340|447627177|FG001|Overall Study|Reason not specified|2|||
124764770|NCT00626275|448763780|FG002|Part B|Lost to Follow-up|0|||
124930217|NCT05267470|449374749|FG001|Overall Study|Death|5|||
124455453|NCT00928889|447627179|FG000|Overall Study|Lost to Follow-up|3|||
124764771|NCT00626275|448763781|FG003|Part B|Lost to Follow-up|0|||
124764772|NCT00626275|448763782|FG004|Part B|Lost to Follow-up|0|||
124764773|NCT00626275|448763783|FG005|Part B|Lost to Follow-up|0|||
124764774|NCT00626275|448763784|FG006|Part B|Lost to Follow-up|1|||
124764775|NCT00626275|448763785|FG007|Part B|Lost to Follow-up|0|||
124455454|NCT00928889|447627180|FG001|Overall Study|Lost to Follow-up|1|||
124764776|NCT00626275|448763778|FG000|Part B|Withdrawal by Subject|0|||
124764777|NCT00626275|448763779|FG001|Part B|Withdrawal by Subject|0|||
124764778|NCT00626275|448763780|FG002|Part B|Withdrawal by Subject|0|||
124764779|NCT00626275|448763781|FG003|Part B|Withdrawal by Subject|0|||
124764780|NCT00626275|448763782|FG004|Part B|Withdrawal by Subject|0|||
124764781|NCT00626275|448763783|FG005|Part B|Withdrawal by Subject|0|||
124930218|NCT05267470|449374750|FG002|Overall Study|Death|8|||
124764782|NCT00626275|448763784|FG006|Part B|Withdrawal by Subject|0|||
124930219|NCT05267470|449374751|FG003|Overall Study|Death|18|||
124930220|NCT05267470|449374752|FG004|Overall Study|Death|1|||
124930221|NCT05267470|449374748|FG000|Overall Study|Lost to Follow-up|0|||
124930222|NCT05267470|449374749|FG001|Overall Study|Lost to Follow-up|0|||
124930223|NCT05267470|449374750|FG002|Overall Study|Lost to Follow-up|0|||
124930224|NCT05267470|449374751|FG003|Overall Study|Lost to Follow-up|1|||
124930225|NCT05267470|449374752|FG004|Overall Study|Lost to Follow-up|0|||
124930226|NCT04230681|449374757|FG000|Overall Study|Physician Decision|2|||
124930227|NCT04230681|449374758|FG001|Overall Study|Physician Decision|3|||
124930228|NCT04230681|449374757|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
124930229|NCT04230681|449374758|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
124930230|NCT04230681|449374757|FG000|Overall Study|IV inadvertently removed|0|||
124930231|NCT04230681|449374758|FG001|Overall Study|IV inadvertently removed|1|||
124930232|NCT02433379|449376822|FG000|Overall Study|Screen Failures|55|||
124930233|NCT02433379|449376822|FG000|Overall Study|Death|57|||
124930234|NCT02433379|449376822|FG000|Overall Study|Total Withdrawals|209|||
124930235|NCT02038777|449376823|FG000|Overall Study|Death|0|||
124930236|NCT02038777|449376824|FG001|Overall Study|Death|2|||
124930237|NCT02038777|449376825|FG002|Overall Study|Death|0|||
124930238|NCT02038777|449376826|FG003|Overall Study|Death|1|||
124930239|NCT02038777|449376827|FG004|Overall Study|Death|2|||
124930240|NCT02038777|449376828|FG005|Overall Study|Death|4|||
124455455|NCT00928889|447627179|FG000|Overall Study|Protocol Violation|0|||
124455456|NCT00928889|447627180|FG001|Overall Study|Protocol Violation|1|||
124455457|NCT00928889|447627179|FG000|Overall Study|Adverse Event|1|||
124455458|NCT00928889|447627180|FG001|Overall Study|Adverse Event|0|||
124455459|NCT00928889|447627179|FG000|Overall Study|Other|1|||
124455460|NCT00928889|447627180|FG001|Overall Study|Other|0|||
124455461|NCT01299376|447627186|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
124455462|NCT01299376|447627187|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
124455463|NCT01299376|447627186|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
124455464|NCT01299376|447627187|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
124546415|NCT02181673|447955901|FG000|Up to Week 24|Randomized not Treated|0|||
124930241|NCT02038777|449376829|FG006|Overall Study|Death|0|||
124930242|NCT02038777|449376830|FG007|Overall Study|Death|11|||
124930243|NCT02038777|449376823|FG000|Overall Study|Lost to Follow-up|0|||
124930244|NCT02038777|449376824|FG001|Overall Study|Lost to Follow-up|0|||
124930245|NCT02038777|449376825|FG002|Overall Study|Lost to Follow-up|0|||
124930246|NCT02038777|449376826|FG003|Overall Study|Lost to Follow-up|1|||
124930247|NCT02038777|449376827|FG004|Overall Study|Lost to Follow-up|0|||
124930248|NCT02038777|449376828|FG005|Overall Study|Lost to Follow-up|0|||
124930249|NCT02038777|449376829|FG006|Overall Study|Lost to Follow-up|0|||
124455465|NCT01299376|447627186|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
124701865|NCT03648372|448531190|FG015|Overall Study|Other|5|||
124701866|NCT03648372|448531191|FG016|Overall Study|Other|1|||
124701867|NCT03648372|448531192|FG017|Overall Study|Other|5|||
124701868|NCT03648372|448531193|FG018|Overall Study|Other|0|||
124701869|NCT03648372|448531194|FG019|Overall Study|Other|1|||
124701870|NCT03648372|448531195|FG020|Overall Study|Other|0|||
124701871|NCT03648372|448531175|FG000|Overall Study|Lost to Follow-up|0|||
124701872|NCT03648372|448531176|FG001|Overall Study|Lost to Follow-up|0|||
124701873|NCT03648372|448531177|FG002|Overall Study|Lost to Follow-up|0|||
124701874|NCT03648372|448531178|FG003|Overall Study|Lost to Follow-up|0|||
124701875|NCT03648372|448531179|FG004|Overall Study|Lost to Follow-up|0|||
124701876|NCT03648372|448531180|FG005|Overall Study|Lost to Follow-up|0|||
124701877|NCT03648372|448531181|FG006|Overall Study|Lost to Follow-up|0|||
124701878|NCT03648372|448531182|FG007|Overall Study|Lost to Follow-up|0|||
124701879|NCT03648372|448531183|FG008|Overall Study|Lost to Follow-up|0|||
124701880|NCT03648372|448531184|FG009|Overall Study|Lost to Follow-up|0|||
124701881|NCT03648372|448531185|FG010|Overall Study|Lost to Follow-up|0|||
124701882|NCT03648372|448531186|FG011|Overall Study|Lost to Follow-up|0|||
124764783|NCT00626275|448763785|FG007|Part B|Withdrawal by Subject|1|||
124764784|NCT01046565|448763786|FG000|Overall Study|Adverse Event|2|||
124764785|NCT01046565|448763786|FG000|Overall Study|Withdrawal by Subject|7|||
124455466|NCT01299376|447627187|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
124455467|NCT01299376|447627186|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
124455468|NCT01299376|447627187|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
124701883|NCT03648372|448531187|FG012|Overall Study|Lost to Follow-up|0|||
124701884|NCT03648372|448531188|FG013|Overall Study|Lost to Follow-up|1|||
124701885|NCT03648372|448531189|FG014|Overall Study|Lost to Follow-up|0|||
124701886|NCT03648372|448531190|FG015|Overall Study|Lost to Follow-up|1|||
124930250|NCT02038777|449376830|FG007|Overall Study|Lost to Follow-up|0|||
124930251|NCT02038777|449376823|FG000|Overall Study|Other|0|||
124930252|NCT02038777|449376824|FG001|Overall Study|Other|1|||
124930253|NCT02038777|449376825|FG002|Overall Study|Other|0|||
124930254|NCT02038777|449376826|FG003|Overall Study|Other|2|||
124930255|NCT02038777|449376827|FG004|Overall Study|Other|1|||
124930256|NCT02038777|449376828|FG005|Overall Study|Other|0|||
124455469|NCT01299376|447627186|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
124455470|NCT01299376|447627187|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
124701887|NCT03648372|448531191|FG016|Overall Study|Lost to Follow-up|0|||
124701888|NCT03648372|448531192|FG017|Overall Study|Lost to Follow-up|1|||
124701889|NCT03648372|448531193|FG018|Overall Study|Lost to Follow-up|0|||
124701890|NCT03648372|448531194|FG019|Overall Study|Lost to Follow-up|0|||
124701891|NCT03648372|448531195|FG020|Overall Study|Lost to Follow-up|0|||
124701892|NCT03648372|448531175|FG000|Overall Study|Start of a New Systemic Treatment|0|||
124701893|NCT03648372|448531176|FG001|Overall Study|Start of a New Systemic Treatment|0|||
124701894|NCT03648372|448531177|FG002|Overall Study|Start of a New Systemic Treatment|0|||
124701895|NCT03648372|448531178|FG003|Overall Study|Start of a New Systemic Treatment|0|||
124701896|NCT03648372|448531179|FG004|Overall Study|Start of a New Systemic Treatment|0|||
124701897|NCT03648372|448531180|FG005|Overall Study|Start of a New Systemic Treatment|0|||
124701898|NCT03648372|448531181|FG006|Overall Study|Start of a New Systemic Treatment|0|||
124701899|NCT03648372|448531182|FG007|Overall Study|Start of a New Systemic Treatment|2|||
124701900|NCT03648372|448531183|FG008|Overall Study|Start of a New Systemic Treatment|0|||
124701901|NCT03648372|448531184|FG009|Overall Study|Start of a New Systemic Treatment|0|||
124701902|NCT03648372|448531185|FG010|Overall Study|Start of a New Systemic Treatment|1|||
124701903|NCT03648372|448531186|FG011|Overall Study|Start of a New Systemic Treatment|0|||
124701904|NCT03648372|448531187|FG012|Overall Study|Start of a New Systemic Treatment|0|||
124701905|NCT03648372|448531188|FG013|Overall Study|Start of a New Systemic Treatment|0|||
124701906|NCT03648372|448531189|FG014|Overall Study|Start of a New Systemic Treatment|0|||
124701907|NCT03648372|448531190|FG015|Overall Study|Start of a New Systemic Treatment|0|||
124701908|NCT03648372|448531191|FG016|Overall Study|Start of a New Systemic Treatment|0|||
124701909|NCT03648372|448531192|FG017|Overall Study|Start of a New Systemic Treatment|0|||
124701910|NCT03648372|448531193|FG018|Overall Study|Start of a New Systemic Treatment|0|||
124701911|NCT03648372|448531194|FG019|Overall Study|Start of a New Systemic Treatment|0|||
124701912|NCT03648372|448531195|FG020|Overall Study|Start of a New Systemic Treatment|0|||
124701913|NCT00980044|448532135|FG000|Overall Study|Withdrawal by Subject|5|||
124701914|NCT00980044|448532136|FG001|Overall Study|Withdrawal by Subject|7|||
124701915|NCT00980044|448532137|FG002|Overall Study|Withdrawal by Subject|3|||
124701916|NCT00980044|448532135|FG000|Overall Study|Protocol Violation|0|||
124701917|NCT00980044|448532136|FG001|Overall Study|Protocol Violation|0|||
124701918|NCT00980044|448532137|FG002|Overall Study|Protocol Violation|2|||
124701919|NCT02254291|448532138|FG000|Overall Study|Withdrawal by Subject|0|||
124701920|NCT02254291|448532139|FG001|Overall Study|Withdrawal by Subject|3|||
124701921|NCT02254291|448532140|FG002|Overall Study|Withdrawal by Subject|1|||
124701922|NCT02254291|448532138|FG000|Overall Study|Missing follow-up information|0|||
124701923|NCT02254291|448532139|FG001|Overall Study|Missing follow-up information|0|||
124701924|NCT02254291|448532140|FG002|Overall Study|Missing follow-up information|1|||
124701925|NCT00833703|448532152|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
124701926|NCT00833703|448532153|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
124701927|NCT05538728|448532154|FG000|Overall Study|Withdrawal by Subject|1|||
124701928|NCT05538728|448532155|FG001|Overall Study|Withdrawal by Subject|1|||
124701929|NCT01904279|448532156|FG000|Overall Study|Lack of Efficacy|2|||
124701930|NCT01904279|448532157|FG001|Overall Study|Lack of Efficacy|3|||
124701931|NCT01904279|448532156|FG000|Overall Study|Withdrawal by Subject|1|||
124701932|NCT01904279|448532157|FG001|Overall Study|Withdrawal by Subject|0|||
124701933|NCT02489279|448532160|FG000|Overall Study|Lost to Follow-up|12|||
124701934|NCT02489279|448532161|FG001|Overall Study|Lost to Follow-up|10|||
124701935|NCT02263547|448532162|FG000|Overall Study|Adverse Event|1|||
124701936|NCT02263547|448532162|FG000|Overall Study|Lost to Follow-up|2|||
124701937|NCT01344356|448532163|FG000|Overall Study|Physician Decision|0|||
124701938|NCT01344356|448532164|FG001|Overall Study|Physician Decision|3|||
124701939|NCT01344356|448532163|FG000|Overall Study|Lost to Follow-up|0|||
124701940|NCT01344356|448532164|FG001|Overall Study|Lost to Follow-up|6|||
124701941|NCT00095576|448532165|FG000|Overall Study|Adverse Event|5|||
124701942|NCT00095576|448532166|FG001|Overall Study|Adverse Event|3|||
124701943|NCT00095576|448532165|FG000|Overall Study|Lost to Follow-up|233|||
124701944|NCT00095576|448532166|FG001|Overall Study|Lost to Follow-up|229|||
124701945|NCT00095576|448532165|FG000|Overall Study|Protocol Violation|1|||
124701946|NCT00095576|448532166|FG001|Overall Study|Protocol Violation|0|||
124701947|NCT00095576|448532165|FG000|Overall Study|Withdrawal by Subject|34|||
124701948|NCT00095576|448532166|FG001|Overall Study|Withdrawal by Subject|47|||
124701949|NCT00095576|448532165|FG000|Overall Study|Option to switch to a rollover study|1097|||
124701950|NCT00095576|448532166|FG001|Overall Study|Option to switch to a rollover study|1099|||
124701951|NCT00095576|448532165|FG000|Overall Study|Site terminated|75|||
124701952|NCT00095576|448532166|FG001|Overall Study|Site terminated|67|||
124701953|NCT00095576|448532165|FG000|Overall Study|Subject moved|30|||
124701954|NCT00095576|448532166|FG001|Overall Study|Subject moved|36|||
124701955|NCT03663582|448532167|FG000|Overall Study|Physician Decision|1|||
124701956|NCT03242434|448532179|FG000|Overall Study|Death|0|||
124701957|NCT03242434|448532180|FG001|Overall Study|Death|2|||
124701958|NCT02367885|448532181|FG000|Overall Study|Lost to Follow-up|1|||
124701959|NCT02367885|448532182|FG001|Overall Study|Lost to Follow-up|0|||
124455471|NCT01299376|447627186|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
124455472|NCT01299376|447627187|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
124455473|NCT01299376|447627186|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
124455474|NCT01299376|447627187|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
124455475|NCT01299376|447627186|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
124455476|NCT01299376|447627187|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
124455477|NCT01299376|447627186|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
124455478|NCT01299376|447627187|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
124455479|NCT01299376|447627186|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
124455480|NCT01299376|447627187|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
124455481|NCT01299376|447627186|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
124455482|NCT01299376|447627187|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
124455483|NCT02343159|447627188|FG000|Overall Study|Early Study Termination|16|||
124455484|NCT02343159|447627189|FG001|Overall Study|Early Study Termination|19|||
124455485|NCT02343159|447627190|FG002|Overall Study|Early Study Termination|23|||
124455486|NCT02343159|447627188|FG000|Overall Study|Physician Decision|2|||
124455487|NCT02343159|447627189|FG001|Overall Study|Physician Decision|0|||
124455488|NCT02343159|447627190|FG002|Overall Study|Physician Decision|1|||
124455489|NCT02343159|447627188|FG000|Overall Study|Withdrawal by Subject|3|||
124455490|NCT02343159|447627189|FG001|Overall Study|Withdrawal by Subject|0|||
124455491|NCT02343159|447627190|FG002|Overall Study|Withdrawal by Subject|2|||
124455492|NCT02343159|447627188|FG000|Overall Study|Lost to Follow-up|0|||
124455493|NCT02343159|447627189|FG001|Overall Study|Lost to Follow-up|2|||
124455494|NCT02343159|447627190|FG002|Overall Study|Lost to Follow-up|2|||
124455495|NCT02343159|447627188|FG000|Overall Study|Adverse Event|4|||
124455496|NCT02343159|447627189|FG001|Overall Study|Adverse Event|4|||
124455497|NCT02343159|447627190|FG002|Overall Study|Adverse Event|2|||
124455498|NCT02343159|447627188|FG000|Overall Study|Sponsor Decision|0|||
124455499|NCT02343159|447627189|FG001|Overall Study|Sponsor Decision|1|||
124455500|NCT02343159|447627190|FG002|Overall Study|Sponsor Decision|0|||
124455501|NCT02343159|447627188|FG000|Overall Study|Enrollment Error|1|||
124455502|NCT02343159|447627189|FG001|Overall Study|Enrollment Error|0|||
124455503|NCT02343159|447627190|FG002|Overall Study|Enrollment Error|0|||
124455504|NCT04712110|447627191|FG000|Overall Study|Lost to Follow-up|0|||
124455505|NCT04712110|447627192|FG001|Overall Study|Lost to Follow-up|1|||
124455506|NCT04712110|447627191|FG000|Overall Study|Withdrawal by Subject|0|||
124455507|NCT04712110|447627192|FG001|Overall Study|Withdrawal by Subject|4|||
124455508|NCT04712110|447627191|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
124455509|NCT04712110|447627192|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
124455510|NCT02285777|447627195|FG000|Overall Study|Withdrawal by Subject|1|||
124455511|NCT02285777|447627196|FG001|Overall Study|Withdrawal by Subject|1|||
124455512|NCT02285777|447627195|FG000|Overall Study|Lost to Follow-up|4|||
124455513|NCT02285777|447627196|FG001|Overall Study|Lost to Follow-up|2|||
124455514|NCT03962101|447627200|FG000|Overall Study|Adverse Event|1|||
124455515|NCT03962101|447627200|FG000|Overall Study|Physician Decision|2|||
124701960|NCT02367885|448532183|FG002|Overall Study|Lost to Follow-up|0|||
124701961|NCT02367885|448532181|FG000|Overall Study|Withdrawal by Subject|1|||
124701962|NCT02367885|448532182|FG001|Overall Study|Withdrawal by Subject|0|||
124701963|NCT02367885|448532183|FG002|Overall Study|Withdrawal by Subject|0|||
124701964|NCT01602484|448532184|FG000|Overall Study|Airway issues unrelated to study|0|||
124701965|NCT01602484|448532185|FG001|Overall Study|Airway issues unrelated to study|1|||
124701966|NCT01378195|448532186|FG000|Overall Study|Lost to Follow-up|29|||
124701967|NCT01378195|448532187|FG001|Overall Study|Lost to Follow-up|18|||
124701968|NCT00841815|448532194|FG000|Washout|Withdrawal by Subject|0|||
124701969|NCT00841815|448532195|FG001|Washout|Withdrawal by Subject|1|||
124701970|NCT01148771|448532197|FG000|Washout Period|Withdrawal by Subject|0|||
124701971|NCT01148771|448532198|FG001|Washout Period|Withdrawal by Subject|1|||
124701972|NCT03787615|448532199|FG000|Overall Study|Withdrawal by Subject|2|||
124701973|NCT03787615|448532199|FG000|Overall Study|Lost to Follow-up|2|||
124701974|NCT03464461|448532200|FG000|Overall Study|exclusionary medication given ,|1|||
124701975|NCT03464461|448532201|FG001|Overall Study|exclusionary medication given ,|2|||
124701976|NCT03464461|448532202|FG002|Overall Study|exclusionary medication given ,|0|||
124701977|NCT03464461|448532200|FG000|Overall Study|Physician Decision|0|||
124701978|NCT03464461|448532201|FG001|Overall Study|Physician Decision|1|||
124701979|NCT03464461|448532202|FG002|Overall Study|Physician Decision|0|||
124455516|NCT03962101|447627200|FG000|Overall Study|Not related to medical events|1|||
124701980|NCT03685149|448532204|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
124701981|NCT03685149|448532205|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
124701982|NCT03685149|448532204|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
124455517|NCT00271596|447627203|FG000|Overall Study|Protocol Violation|1|||
124455518|NCT00271596|447627204|FG001|Overall Study|Protocol Violation|0|||
124455519|NCT00271596|447627203|FG000|Overall Study|Withdrawal by Subject|0|||
124701983|NCT03685149|448532205|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
124701984|NCT03685149|448532204|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
124455520|NCT00271596|447627204|FG001|Overall Study|Withdrawal by Subject|1|||
124455521|NCT04315181|447627205|FG000|Overall Study|Non-responsive to drug conditions.|1|||
124701985|NCT03685149|448532205|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
124701986|NCT02609503|448532206|FG000|Overall Study|Adverse Event|1|||
124701987|NCT02609503|448532206|FG000|Overall Study|Death|1|||
124701988|NCT02609503|448532206|FG000|Overall Study|Withdrawal by Subject|1|||
124701989|NCT02609503|448532206|FG000|Overall Study|Disease progression|1|||
124701990|NCT03647137|448532207|FG000|Overall Study|Scan Limitation|2|||
124701991|NCT03647137|448532208|FG001|Overall Study|Scan Limitation|1|||
124701992|NCT03647137|448532209|FG002|Overall Study|Scan Limitation|1|||
124701993|NCT03647137|448532210|FG003|Overall Study|Scan Limitation|2|||
124701994|NCT02226653|448532211|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
124701995|NCT02226653|448532212|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
124701996|NCT02226653|448532211|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
124701997|NCT02226653|448532212|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
124701998|NCT04876391|448532214|FG000|Overall Study|Withdrawal by Subject|1|||
124701999|NCT04876391|448532215|FG001|Overall Study|Withdrawal by Subject|10|||
124702000|NCT04876391|448532214|FG000|Overall Study|Lost to Follow-up|2|||
124702001|NCT04876391|448532215|FG001|Overall Study|Lost to Follow-up|4|||
124702002|NCT04876391|448532214|FG000|Overall Study|Lack of Efficacy|0|||
124702003|NCT04876391|448532215|FG001|Overall Study|Lack of Efficacy|2|||
124702004|NCT04876391|448532214|FG000|Overall Study|Adverse Event|3|||
124702005|NCT04876391|448532215|FG001|Overall Study|Adverse Event|1|||
124702006|NCT04876391|448532214|FG000|Overall Study|Patient non-compliance|0|||
124702007|NCT04876391|448532215|FG001|Overall Study|Patient non-compliance|1|||
124702008|NCT04876391|448532214|FG000|Overall Study|Personal reasons|0|||
124702009|NCT04876391|448532215|FG001|Overall Study|Personal reasons|1|||
124702010|NCT04876391|448532214|FG000|Overall Study|Withdrawn as per protocol|2|||
124702011|NCT04876391|448532215|FG001|Overall Study|Withdrawn as per protocol|2|||
124702012|NCT00209131|448532221|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
124702013|NCT00209131|448532222|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
124702014|NCT05360784|448532223|FG000|Overall Study|Discontinued|25|||
124702015|NCT05360784|448532224|FG001|Overall Study|Discontinued|11|||
124702016|NCT00437073|448532225|FG000|Overall Study|Sponsor Terminated Study|1|||
124702017|NCT00437073|448532226|FG001|Overall Study|Sponsor Terminated Study|0|||
124702018|NCT00437073|448532225|FG000|Overall Study|Physician Decision|0|||
124702019|NCT00437073|448532226|FG001|Overall Study|Physician Decision|1|||
124702020|NCT02251041|448532227|FG000|Overall Study|Did not receive intervention|15|||
124702021|NCT02251041|448532228|FG001|Overall Study|Did not receive intervention|4|||
124702022|NCT04079920|448532229|FG000|Overall Study|Adverse event, not related to study drug|2|||
124702023|NCT04079920|448532229|FG000|Overall Study|Adverse event related to study drug|10|||
124702024|NCT04079920|448532229|FG000|Overall Study|Death|2|||
124702025|NCT04079920|448532229|FG000|Overall Study|Lost to Follow-up|22|||
124702026|NCT04079920|448532229|FG000|Overall Study|Physician Decision|1|||
124702027|NCT04079920|448532229|FG000|Overall Study|Withdrawal by Subject|11|||
124702028|NCT04918771|448532230|FG000|Overall Study|Withdrawal by Subject|4|||
124702029|NCT04918771|448532231|FG001|Overall Study|Withdrawal by Subject|5|||
124702030|NCT04918771|448532230|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
124702031|NCT04918771|448532231|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
124702032|NCT00680914|448532236|FG000|Overall Study|Consent withdrawal|6|||
124702033|NCT00680914|448532237|FG001|Overall Study|Consent withdrawal|3|||
124702034|NCT00680914|448532236|FG000|Overall Study|Lost to Follow-up|4|||
124702035|NCT00680914|448532237|FG001|Overall Study|Lost to Follow-up|0|||
124702036|NCT00680914|448532236|FG000|Overall Study|serious adverse event (SAE)|0|||
124702037|NCT00680914|448532237|FG001|Overall Study|serious adverse event (SAE)|1|||
124702038|NCT00539500|448532238|FG000|Overall Study|Disease Progression|1|||
124702039|NCT00539500|448532238|FG000|Overall Study|Lost to Follow-up|2|||
124702040|NCT05305651|448532239|FG000|Overall Study|Death|1|||
124702041|NCT05305651|448532239|FG000|Overall Study|Withdrawal by Subject|4|||
124702042|NCT05305651|448532239|FG000|Overall Study|Lost to Follow-up|4|||
124702043|NCT00526799|448532240|FG000|Overall Study|Withdrawal by Subject|1|||
124702044|NCT00526799|448532241|FG001|Overall Study|Withdrawal by Subject|0|||
124702045|NCT00526799|448532240|FG000|Overall Study|Intercurrent Complicating Disease|0|||
124702046|NCT00526799|448532241|FG001|Overall Study|Intercurrent Complicating Disease|1|||
124702047|NCT04003389|448532242|FG000|Overall Study|Adverse Event|27|||
124702048|NCT04003389|448532243|FG001|Overall Study|Adverse Event|34|||
124702049|NCT04003389|448532244|FG002|Overall Study|Adverse Event|28|||
124702050|NCT04003389|448532242|FG000|Overall Study|Lost to Follow-up|39|||
124764786|NCT01650558|448763787|FG000|Overall Study|Migration out of study area|61|||
124764787|NCT01650558|448763788|FG001|Overall Study|Migration out of study area|71|||
124764788|NCT01650558|448763789|FG002|Overall Study|Migration out of study area|56|||
124764789|NCT01650558|448763787|FG000|Overall Study|Lost to Follow-up|10|||
124764790|NCT01650558|448763788|FG001|Overall Study|Lost to Follow-up|13|||
124764791|NCT01650558|448763789|FG002|Overall Study|Lost to Follow-up|6|||
124764792|NCT01650558|448763787|FG000|Overall Study|Death|10|||
124764793|NCT01650558|448763788|FG001|Overall Study|Death|6|||
124764794|NCT01650558|448763789|FG002|Overall Study|Death|8|||
124764795|NCT01650558|448763787|FG000|Overall Study|Withdrawal by Subject|1|||
124764796|NCT01650558|448763788|FG001|Overall Study|Withdrawal by Subject|1|||
124764797|NCT01650558|448763789|FG002|Overall Study|Withdrawal by Subject|3|||
124764798|NCT01650558|448763787|FG000|Overall Study|Non-compliant participant|1|||
124764799|NCT01650558|448763788|FG001|Overall Study|Non-compliant participant|0|||
124764800|NCT01650558|448763789|FG002|Overall Study|Non-compliant participant|2|||
124764801|NCT01650558|448763787|FG000|Overall Study|Physician Decision|0|||
124764802|NCT01650558|448763788|FG001|Overall Study|Physician Decision|1|||
124764803|NCT01650558|448763789|FG002|Overall Study|Physician Decision|0|||
124764804|NCT00528957|448763792|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
124546416|NCT02181673|447955902|FG001|Up to Week 24|Randomized not Treated|0|||
124546417|NCT02181673|447955903|FG002|Up to Week 24|Randomized not Treated|1|||
124546418|NCT02181673|447955901|FG000|Week 24-Week 60|Adverse Event|0|||
124546419|NCT02181673|447955902|FG001|Week 24-Week 60|Adverse Event|4|||
124546420|NCT02181673|447955903|FG002|Week 24-Week 60|Adverse Event|10|||
124546421|NCT02181673|447955901|FG000|Week 24-Week 60|Other|0|||
124546422|NCT02181673|447955902|FG001|Week 24-Week 60|Other|2|||
124546423|NCT02181673|447955903|FG002|Week 24-Week 60|Other|1|||
124702051|NCT04003389|448532243|FG001|Overall Study|Lost to Follow-up|30|||
124702052|NCT04003389|448532244|FG002|Overall Study|Lost to Follow-up|33|||
124702053|NCT04003389|448532242|FG000|Overall Study|Protocol Violation|1|||
124702054|NCT04003389|448532243|FG001|Overall Study|Protocol Violation|6|||
124764805|NCT00528957|448763793|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
124764806|NCT00528957|448763792|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
124764807|NCT00528957|448763793|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
124764808|NCT00528957|448763792|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
124764809|NCT00528957|448763793|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
124764810|NCT00528957|448763792|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
124764811|NCT00528957|448763793|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
124764812|NCT00528957|448763792|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
124764813|NCT00528957|448763793|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
124764814|NCT00528957|448763792|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
124764815|NCT00528957|448763793|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
124702055|NCT04003389|448532244|FG002|Overall Study|Protocol Violation|5|||
124702056|NCT04003389|448532242|FG000|Overall Study|Withdrawal by Subject|119|||
124702057|NCT04003389|448532243|FG001|Overall Study|Withdrawal by Subject|79|||
124702058|NCT04003389|448532244|FG002|Overall Study|Withdrawal by Subject|85|||
124764816|NCT00528957|448763792|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
124764817|NCT00528957|448763793|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
124764818|NCT00528957|448763792|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
124764819|NCT00528957|448763793|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
124764820|NCT00528957|448763792|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
124764821|NCT00528957|448763793|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
124764822|NCT00528957|448763792|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
124764823|NCT00528957|448763793|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
124764824|NCT00528957|448763792|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
124764825|NCT00528957|448763793|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
124930257|NCT02038777|449376829|FG006|Overall Study|Other|0|||
124702059|NCT04003389|448532242|FG000|Overall Study|Miscellaneous|14|||
124764826|NCT00528957|448763792|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
124764827|NCT00528957|448763793|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
124769823|NCT03694353|448785213|FG000|Overall Study|Withdrawal by Subject|1|||
124546424|NCT02181673|447955901|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
124546425|NCT02181673|447955902|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
124702060|NCT04003389|448532243|FG001|Overall Study|Miscellaneous|11|||
124702061|NCT04003389|448532244|FG002|Overall Study|Miscellaneous|14|||
124930258|NCT02038777|449376830|FG007|Overall Study|Other|0|||
124930259|NCT02038777|449376823|FG000|Overall Study|Randomized but not treated|0|||
124930260|NCT02038777|449376824|FG001|Overall Study|Randomized but not treated|1|||
124930261|NCT02038777|449376825|FG002|Overall Study|Randomized but not treated|0|||
124930262|NCT02038777|449376826|FG003|Overall Study|Randomized but not treated|0|||
124930263|NCT02038777|449376827|FG004|Overall Study|Randomized but not treated|0|||
124930264|NCT02038777|449376828|FG005|Overall Study|Randomized but not treated|0|||
124930265|NCT02038777|449376829|FG006|Overall Study|Randomized but not treated|0|||
124930266|NCT02038777|449376830|FG007|Overall Study|Randomized but not treated|0|||
124930267|NCT02038777|449376823|FG000|Overall Study|Started Chemotherapy|1|||
124930268|NCT02038777|449376824|FG001|Overall Study|Started Chemotherapy|0|||
124930269|NCT02038777|449376825|FG002|Overall Study|Started Chemotherapy|3|||
124930270|NCT02038777|449376826|FG003|Overall Study|Started Chemotherapy|0|||
124930271|NCT02038777|449376827|FG004|Overall Study|Started Chemotherapy|0|||
124930272|NCT02038777|449376828|FG005|Overall Study|Started Chemotherapy|0|||
124702062|NCT04003389|448532242|FG000|Overall Study|Participant did not receive study drug|1|||
124702063|NCT04003389|448532243|FG001|Overall Study|Participant did not receive study drug|0|||
124702064|NCT04003389|448532244|FG002|Overall Study|Participant did not receive study drug|0|||
124702065|NCT04629196|448532245|FG000|Overall Study|Subject discontinued study drug|1|||
124764828|NCT00528957|448763792|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
124702066|NCT04629196|448532246|FG001|Overall Study|Subject discontinued study drug|0|||
124702067|NCT04629196|448532245|FG000|Overall Study|Subject study drug dosing increased|1|||
124702068|NCT04629196|448532246|FG001|Overall Study|Subject study drug dosing increased|1|||
124702069|NCT04629196|448532245|FG000|Overall Study|Withdrawal by Subject|1|||
124702070|NCT04629196|448532246|FG001|Overall Study|Withdrawal by Subject|2|||
124702071|NCT04280783|448534107|FG000|Overall Study|Family issues unrelated to the study.|1|||
124702072|NCT04280783|448534108|FG001|Overall Study|Family issues unrelated to the study.|0|||
124702073|NCT04280783|448534107|FG000|Overall Study|Withdrawal by Subject|0|||
124702074|NCT04280783|448534108|FG001|Overall Study|Withdrawal by Subject|1|||
124702075|NCT05654181|448534109|FG000|Overall Study|Adverse Event|1|||
124702076|NCT05654181|448534110|FG001|Overall Study|Adverse Event|0|||
124702077|NCT05654181|448534111|FG002|Overall Study|Adverse Event|0|||
124702078|NCT05654181|448534112|FG003|Overall Study|Adverse Event|0|||
124702079|NCT05654181|448534113|FG004|Overall Study|Adverse Event|0|||
124702080|NCT05654181|448534114|FG005|Overall Study|Adverse Event|0|||
124702081|NCT05654181|448534115|FG006|Overall Study|Adverse Event|0|||
124702082|NCT05654181|448534116|FG007|Overall Study|Adverse Event|1|||
124702083|NCT05654181|448534117|FG008|Overall Study|Adverse Event|0|||
124702084|NCT05654181|448534118|FG009|Overall Study|Adverse Event|0|||
124702085|NCT05654181|448534109|FG000|Overall Study|Withdrawal by Subject|0|||
124702086|NCT05654181|448534110|FG001|Overall Study|Withdrawal by Subject|0|||
124702087|NCT05654181|448534111|FG002|Overall Study|Withdrawal by Subject|0|||
124702088|NCT05654181|448534112|FG003|Overall Study|Withdrawal by Subject|0|||
124702089|NCT05654181|448534113|FG004|Overall Study|Withdrawal by Subject|0|||
124702090|NCT05654181|448534114|FG005|Overall Study|Withdrawal by Subject|0|||
124702091|NCT05654181|448534115|FG006|Overall Study|Withdrawal by Subject|0|||
124702092|NCT05654181|448534116|FG007|Overall Study|Withdrawal by Subject|1|||
124702093|NCT05654181|448534117|FG008|Overall Study|Withdrawal by Subject|0|||
124702094|NCT05654181|448534118|FG009|Overall Study|Withdrawal by Subject|0|||
124702095|NCT05654181|448534109|FG000|Overall Study|Other|0|||
124702096|NCT05654181|448534110|FG001|Overall Study|Other|0|||
124702097|NCT05654181|448534111|FG002|Overall Study|Other|0|||
124702098|NCT05654181|448534112|FG003|Overall Study|Other|0|||
124702099|NCT05654181|448534113|FG004|Overall Study|Other|1|||
124702100|NCT05654181|448534114|FG005|Overall Study|Other|1|||
124702101|NCT05654181|448534115|FG006|Overall Study|Other|0|||
124702102|NCT05654181|448534116|FG007|Overall Study|Other|0|||
124702103|NCT05654181|448534117|FG008|Overall Study|Other|0|||
124702104|NCT05654181|448534118|FG009|Overall Study|Other|0|||
124702105|NCT04101331|448534119|FG000|Overall Study|Adverse Event|9|||
124702106|NCT04101331|448534119|FG000|Overall Study|Disease progression|82|||
124702107|NCT04101331|448534119|FG000|Overall Study|Withdrawal by Subject|1|||
124702108|NCT04101331|448534119|FG000|Overall Study|Investigator decision|6|||
124702109|NCT04101331|448534119|FG000|Overall Study|Death|6|||
124930273|NCT02038777|449376829|FG006|Overall Study|Started Chemotherapy|0|||
124702110|NCT04101331|448534119|FG000|Overall Study|Allogenic transplant|1|||
124702111|NCT04110145|448534120|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
124702112|NCT04110145|448534121|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
124930274|NCT02038777|449376830|FG007|Overall Study|Started Chemotherapy|0|||
124930275|NCT02038777|449376823|FG000|Overall Study|participation terminated by sponsor|0|||
124702113|NCT04110145|448534122|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
124702114|NCT04110145|448534123|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
124930276|NCT02038777|449376824|FG001|Overall Study|participation terminated by sponsor|0|||
124930277|NCT02038777|449376825|FG002|Overall Study|participation terminated by sponsor|0|||
124930278|NCT02038777|449376826|FG003|Overall Study|participation terminated by sponsor|0|||
124930279|NCT02038777|449376827|FG004|Overall Study|participation terminated by sponsor|0|||
124930280|NCT02038777|449376828|FG005|Overall Study|participation terminated by sponsor|0|||
124930281|NCT02038777|449376829|FG006|Overall Study|participation terminated by sponsor|1|||
124930282|NCT02038777|449376830|FG007|Overall Study|participation terminated by sponsor|1|||
124930283|NCT04294641|449376840|FG000|Overall Study|Screen failure|4|||
124930284|NCT04314778|449376857|FG000|Overall Study|Lost to Follow-up|5|||
124930285|NCT04314778|449376858|FG001|Overall Study|Lost to Follow-up|3|||
124930286|NCT04024020|449376861|FG000|Overall Study|Withdrawal by Subject|2|||
124930287|NCT04024020|449376862|FG001|Overall Study|Withdrawal by Subject|2|||
124930288|NCT05646355|449376863|FG000|Overall Study|Lost to Follow-up|1|||
124930289|NCT05646355|449376864|FG001|Overall Study|Lost to Follow-up|0|||
124930290|NCT05646355|449376863|FG000|Overall Study|translated materials not available for pilot|2|||
124930291|NCT05646355|449376864|FG001|Overall Study|translated materials not available for pilot|0|||
124930292|NCT05646355|449376863|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
124930293|NCT05646355|449376864|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
124930294|NCT03523572|449376867|FG000|Dose Escalation|Progressive disease|1|||
124930295|NCT03523572|449376868|FG001|Dose Escalation|Progressive disease|0|||
124930296|NCT03523572|449376869|FG002|Dose Escalation|Progressive disease|0|||
124930297|NCT03523572|449376870|FG003|Dose Escalation|Progressive disease|0|||
124930298|NCT03523572|449376871|FG004|Dose Escalation|Progressive disease|0|||
124930299|NCT03523572|449376872|FG005|Dose Escalation|Progressive disease|0|||
124930300|NCT03523572|449376867|FG000|Dose Escalation|Clinical Progression|0|||
124930301|NCT03523572|449376868|FG001|Dose Escalation|Clinical Progression|1|||
124930302|NCT03523572|449376869|FG002|Dose Escalation|Clinical Progression|0|||
124930303|NCT03523572|449376870|FG003|Dose Escalation|Clinical Progression|0|||
124930304|NCT03523572|449376871|FG004|Dose Escalation|Clinical Progression|0|||
124930305|NCT03523572|449376872|FG005|Dose Escalation|Clinical Progression|0|||
124930306|NCT03523572|449376867|FG000|Dose Escalation|Adverse Event|2|||
124930307|NCT03523572|449376868|FG001|Dose Escalation|Adverse Event|0|||
124930308|NCT03523572|449376869|FG002|Dose Escalation|Adverse Event|0|||
124930309|NCT03523572|449376870|FG003|Dose Escalation|Adverse Event|0|||
124930310|NCT03523572|449376871|FG004|Dose Escalation|Adverse Event|0|||
124930311|NCT03523572|449376872|FG005|Dose Escalation|Adverse Event|0|||
124930312|NCT03523572|449376867|FG000|Dose Escalation|Physician Decision|1|||
124930313|NCT03523572|449376868|FG001|Dose Escalation|Physician Decision|1|||
124930314|NCT03523572|449376869|FG002|Dose Escalation|Physician Decision|0|||
124930315|NCT03523572|449376870|FG003|Dose Escalation|Physician Decision|0|||
124930316|NCT03523572|449376871|FG004|Dose Escalation|Physician Decision|0|||
124930317|NCT03523572|449376872|FG005|Dose Escalation|Physician Decision|0|||
124930318|NCT03523572|449376867|FG000|Dose Expansion|Progressive Disease|0|||
124930319|NCT03523572|449376868|FG001|Dose Expansion|Progressive Disease|0|||
124930320|NCT03523572|449376869|FG002|Dose Expansion|Progressive Disease|9|||
124930321|NCT03523572|449376870|FG003|Dose Expansion|Progressive Disease|11|||
124930322|NCT03523572|449376871|FG004|Dose Expansion|Progressive Disease|15|||
124930323|NCT03523572|449376872|FG005|Dose Expansion|Progressive Disease|2|||
124930324|NCT03523572|449376867|FG000|Dose Expansion|Clinical Progression|0|||
124930325|NCT03523572|449376868|FG001|Dose Expansion|Clinical Progression|0|||
124930326|NCT03523572|449376869|FG002|Dose Expansion|Clinical Progression|2|||
124930327|NCT03523572|449376870|FG003|Dose Expansion|Clinical Progression|2|||
124930328|NCT03523572|449376871|FG004|Dose Expansion|Clinical Progression|2|||
124930329|NCT03523572|449376872|FG005|Dose Expansion|Clinical Progression|0|||
124930330|NCT03523572|449376867|FG000|Dose Expansion|Adverse Event|0|||
124930331|NCT03523572|449376868|FG001|Dose Expansion|Adverse Event|0|||
124930332|NCT03523572|449376869|FG002|Dose Expansion|Adverse Event|10|||
124702115|NCT04110145|448534124|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
124702116|NCT00488293|448534128|FG000|Overall Study|Lost to Follow-up|28|||
124702117|NCT00488293|448534129|FG001|Overall Study|Lost to Follow-up|25|||
124702118|NCT00488293|448534128|FG000|Overall Study|Withdrawal by Subject|5|||
124702119|NCT00488293|448534129|FG001|Overall Study|Withdrawal by Subject|3|||
124702120|NCT00488293|448534128|FG000|Overall Study|Death|2|||
124702121|NCT00488293|448534129|FG001|Overall Study|Death|1|||
124702122|NCT00488293|448534128|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
124702123|NCT00488293|448534129|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
124930333|NCT03523572|449376870|FG003|Dose Expansion|Adverse Event|1|||
124930334|NCT03523572|449376871|FG004|Dose Expansion|Adverse Event|5|||
124930335|NCT03523572|449376872|FG005|Dose Expansion|Adverse Event|2|||
124930336|NCT03523572|449376867|FG000|Dose Expansion|Withdrawal by Subject|0|||
124930337|NCT03523572|449376868|FG001|Dose Expansion|Withdrawal by Subject|0|||
124930338|NCT03523572|449376869|FG002|Dose Expansion|Withdrawal by Subject|1|||
124930339|NCT03523572|449376870|FG003|Dose Expansion|Withdrawal by Subject|1|||
124930340|NCT03523572|449376871|FG004|Dose Expansion|Withdrawal by Subject|0|||
124930341|NCT03523572|449376872|FG005|Dose Expansion|Withdrawal by Subject|0|||
124930342|NCT03523572|449376867|FG000|Dose Expansion|Physician Decision|0|||
124702124|NCT00500331|448534130|FG000|Overall Study|Adverse Event|0|||
124702125|NCT00500331|448534131|FG001|Overall Study|Adverse Event|2|||
124702126|NCT00500331|448534132|FG002|Overall Study|Adverse Event|0|||
124930343|NCT03523572|449376868|FG001|Dose Expansion|Physician Decision|0|||
124930344|NCT03523572|449376869|FG002|Dose Expansion|Physician Decision|1|||
124930345|NCT03523572|449376870|FG003|Dose Expansion|Physician Decision|0|||
124930346|NCT03523572|449376871|FG004|Dose Expansion|Physician Decision|1|||
124930347|NCT03523572|449376872|FG005|Dose Expansion|Physician Decision|0|||
124930348|NCT03523572|449376867|FG000|Dose Expansion|Miscellaneous|0|||
124930349|NCT03523572|449376868|FG001|Dose Expansion|Miscellaneous|0|||
124930350|NCT03523572|449376869|FG002|Dose Expansion|Miscellaneous|0|||
124930351|NCT03523572|449376870|FG003|Dose Expansion|Miscellaneous|0|||
124930352|NCT03523572|449376871|FG004|Dose Expansion|Miscellaneous|3|||
124930353|NCT03523572|449376872|FG005|Dose Expansion|Miscellaneous|0|||
124930354|NCT05269966|449376873|FG000|Overall Study|Adverse Event|4|||
124930355|NCT05269966|449376873|FG000|Overall Study|Withdrawal by Subject|1|||
124930356|NCT05269966|449376873|FG000|Overall Study|Lost to Follow-up|4|||
124930357|NCT05269966|449376873|FG000|Overall Study|Physician Decision|1|||
124930358|NCT04685135|449376876|FG000|Overall Study|Death|126|||
124930359|NCT04685135|449376877|FG001|Overall Study|Death|53|||
124930360|NCT04685135|449376876|FG000|Overall Study|Withdrawal by Subject|12|||
124930361|NCT04685135|449376877|FG001|Overall Study|Withdrawal by Subject|16|||
124930362|NCT03519178|449376878|FG000|PF-06873600 Treatment|Adverse Event|0|||
124930363|NCT03519178|449376879|FG001|PF-06873600 Treatment|Adverse Event|0|||
124930364|NCT03519178|449376880|FG002|PF-06873600 Treatment|Adverse Event|0|||
124930365|NCT03519178|449376881|FG003|PF-06873600 Treatment|Adverse Event|0|||
124930366|NCT03519178|449376882|FG004|PF-06873600 Treatment|Adverse Event|0|||
124930367|NCT03519178|449376883|FG005|PF-06873600 Treatment|Adverse Event|0|||
124930368|NCT03519178|449376884|FG006|PF-06873600 Treatment|Adverse Event|0|||
124930369|NCT03519178|449376885|FG007|PF-06873600 Treatment|Adverse Event|2|||
124930370|NCT03519178|449376886|FG008|PF-06873600 Treatment|Adverse Event|1|||
124930371|NCT03519178|449376887|FG009|PF-06873600 Treatment|Adverse Event|0|||
124930372|NCT03519178|449376888|FG010|PF-06873600 Treatment|Adverse Event|0|||
124930373|NCT03519178|449376889|FG011|PF-06873600 Treatment|Adverse Event|0|||
124930374|NCT03519178|449376890|FG012|PF-06873600 Treatment|Adverse Event|1|||
124930375|NCT03519178|449376891|FG013|PF-06873600 Treatment|Adverse Event|3|||
124930376|NCT03519178|449376892|FG014|PF-06873600 Treatment|Adverse Event|2|||
124930377|NCT03519178|449376878|FG000|PF-06873600 Treatment|Death|0|||
124930378|NCT03519178|449376879|FG001|PF-06873600 Treatment|Death|0|||
124930379|NCT03519178|449376880|FG002|PF-06873600 Treatment|Death|0|||
124930380|NCT03519178|449376881|FG003|PF-06873600 Treatment|Death|0|||
124930381|NCT03519178|449376882|FG004|PF-06873600 Treatment|Death|0|||
124930382|NCT03519178|449376883|FG005|PF-06873600 Treatment|Death|0|||
124930383|NCT03519178|449376884|FG006|PF-06873600 Treatment|Death|0|||
124930384|NCT03519178|449376885|FG007|PF-06873600 Treatment|Death|0|||
124930385|NCT03519178|449376886|FG008|PF-06873600 Treatment|Death|1|||
124930386|NCT03519178|449376887|FG009|PF-06873600 Treatment|Death|1|||
124930387|NCT03519178|449376888|FG010|PF-06873600 Treatment|Death|0|||
124930388|NCT03519178|449376889|FG011|PF-06873600 Treatment|Death|0|||
124930389|NCT03519178|449376890|FG012|PF-06873600 Treatment|Death|0|||
124930390|NCT03519178|449376891|FG013|PF-06873600 Treatment|Death|0|||
124930391|NCT03519178|449376892|FG014|PF-06873600 Treatment|Death|1|||
124930392|NCT03519178|449376878|FG000|PF-06873600 Treatment|Physician Decision|0|||
124930393|NCT03519178|449376879|FG001|PF-06873600 Treatment|Physician Decision|0|||
124930394|NCT03519178|449376880|FG002|PF-06873600 Treatment|Physician Decision|0|||
124930395|NCT03519178|449376881|FG003|PF-06873600 Treatment|Physician Decision|0|||
124930396|NCT03519178|449376882|FG004|PF-06873600 Treatment|Physician Decision|0|||
124930397|NCT03519178|449376883|FG005|PF-06873600 Treatment|Physician Decision|0|||
124930398|NCT03519178|449376884|FG006|PF-06873600 Treatment|Physician Decision|0|||
124930399|NCT03519178|449376885|FG007|PF-06873600 Treatment|Physician Decision|1|||
124930400|NCT03519178|449376886|FG008|PF-06873600 Treatment|Physician Decision|0|||
124930401|NCT03519178|449376887|FG009|PF-06873600 Treatment|Physician Decision|0|||
124702127|NCT00500331|448534133|FG003|Overall Study|Adverse Event|1|||
124702128|NCT00500331|448534134|FG004|Overall Study|Adverse Event|2|||
124702129|NCT00500331|448534135|FG005|Overall Study|Adverse Event|2|||
124930402|NCT03519178|449376888|FG010|PF-06873600 Treatment|Physician Decision|1|||
124930403|NCT03519178|449376889|FG011|PF-06873600 Treatment|Physician Decision|0|||
124930404|NCT03519178|449376890|FG012|PF-06873600 Treatment|Physician Decision|0|||
124930405|NCT03519178|449376891|FG013|PF-06873600 Treatment|Physician Decision|4|||
124930406|NCT03519178|449376892|FG014|PF-06873600 Treatment|Physician Decision|1|||
124930407|NCT03519178|449376878|FG000|PF-06873600 Treatment|Progressive disease|1|||
124930408|NCT03519178|449376879|FG001|PF-06873600 Treatment|Progressive disease|1|||
124930409|NCT03519178|449376880|FG002|PF-06873600 Treatment|Progressive disease|1|||
124930410|NCT03519178|449376881|FG003|PF-06873600 Treatment|Progressive disease|1|||
124930411|NCT03519178|449376882|FG004|PF-06873600 Treatment|Progressive disease|6|||
124930412|NCT03519178|449376883|FG005|PF-06873600 Treatment|Progressive disease|7|||
124930413|NCT03519178|449376884|FG006|PF-06873600 Treatment|Progressive disease|3|||
124930414|NCT03519178|449376885|FG007|PF-06873600 Treatment|Progressive disease|7|||
124702130|NCT00500331|448534136|FG006|Overall Study|Adverse Event|0|||
124702131|NCT00500331|448534130|FG000|Overall Study|Lost to Follow-up|1|||
124702132|NCT00500331|448534131|FG001|Overall Study|Lost to Follow-up|1|||
124702133|NCT00500331|448534132|FG002|Overall Study|Lost to Follow-up|1|||
124702134|NCT00500331|448534133|FG003|Overall Study|Lost to Follow-up|2|||
124702135|NCT00500331|448534134|FG004|Overall Study|Lost to Follow-up|1|||
124702136|NCT00500331|448534135|FG005|Overall Study|Lost to Follow-up|0|||
124702137|NCT00500331|448534136|FG006|Overall Study|Lost to Follow-up|0|||
124930415|NCT03519178|449376886|FG008|PF-06873600 Treatment|Progressive disease|3|||
124930416|NCT03519178|449376887|FG009|PF-06873600 Treatment|Progressive disease|5|||
124930417|NCT03519178|449376888|FG010|PF-06873600 Treatment|Progressive disease|4|||
124930418|NCT03519178|449376889|FG011|PF-06873600 Treatment|Progressive disease|3|||
124930419|NCT03519178|449376890|FG012|PF-06873600 Treatment|Progressive disease|4|||
124930420|NCT03519178|449376891|FG013|PF-06873600 Treatment|Progressive disease|28|||
124930421|NCT03519178|449376892|FG014|PF-06873600 Treatment|Progressive disease|7|||
124930422|NCT03519178|449376878|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
124930423|NCT03519178|449376879|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
124930424|NCT03519178|449376880|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
124930425|NCT03519178|449376881|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
124930426|NCT03519178|449376882|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
124930427|NCT03519178|449376883|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
124930428|NCT03519178|449376884|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
124930429|NCT03519178|449376885|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
124930430|NCT03519178|449376886|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
124930431|NCT03519178|449376887|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
124930432|NCT03519178|449376888|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
124930433|NCT03519178|449376889|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
124930434|NCT03519178|449376890|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
124930435|NCT03519178|449376891|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
124930436|NCT03519178|449376892|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
124930437|NCT03519178|449376878|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
124930438|NCT03519178|449376879|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
124930439|NCT03519178|449376880|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
124930440|NCT03519178|449376881|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
124930441|NCT03519178|449376882|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
124930442|NCT03519178|449376883|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
124930443|NCT03519178|449376884|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
124930444|NCT03519178|449376885|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
124930445|NCT03519178|449376886|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
124930446|NCT03519178|449376887|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
124930447|NCT03519178|449376888|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
124930448|NCT03519178|449376889|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
124930449|NCT03519178|449376890|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
124930450|NCT03519178|449376891|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
124930451|NCT03519178|449376892|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
124930452|NCT03519178|449376878|FG000|PF-06873600 Treatment|Refused further treatment|0|||
124930453|NCT03519178|449376879|FG001|PF-06873600 Treatment|Refused further treatment|1|||
124930454|NCT03519178|449376880|FG002|PF-06873600 Treatment|Refused further treatment|0|||
124930455|NCT03519178|449376881|FG003|PF-06873600 Treatment|Refused further treatment|0|||
124930456|NCT03519178|449376882|FG004|PF-06873600 Treatment|Refused further treatment|1|||
124930457|NCT03519178|449376883|FG005|PF-06873600 Treatment|Refused further treatment|0|||
124930458|NCT03519178|449376884|FG006|PF-06873600 Treatment|Refused further treatment|0|||
124930459|NCT03519178|449376885|FG007|PF-06873600 Treatment|Refused further treatment|0|||
124930460|NCT03519178|449376886|FG008|PF-06873600 Treatment|Refused further treatment|0|||
124764829|NCT00528957|448763793|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
124764830|NCT00528957|448763792|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
124764831|NCT00528957|448763793|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
124702138|NCT00500331|448534130|FG000|Overall Study|Protocol Violation|3|||
124702139|NCT00500331|448534131|FG001|Overall Study|Protocol Violation|1|||
124764832|NCT00528957|448763792|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
124702140|NCT00500331|448534132|FG002|Overall Study|Protocol Violation|1|||
124702141|NCT00500331|448534133|FG003|Overall Study|Protocol Violation|0|||
124764833|NCT00528957|448763793|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
124764834|NCT00528957|448763792|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
124764835|NCT00528957|448763793|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
124930461|NCT03519178|449376887|FG009|PF-06873600 Treatment|Refused further treatment|0|||
124702142|NCT00500331|448534134|FG004|Overall Study|Protocol Violation|1|||
124702143|NCT00500331|448534135|FG005|Overall Study|Protocol Violation|1|||
124702144|NCT00500331|448534136|FG006|Overall Study|Protocol Violation|1|||
124764836|NCT03624881|448763794|FG000|Overall Study|Screen Failure|14|||
124764837|NCT03624881|448763795|FG001|Overall Study|Screen Failure|0|||
124764838|NCT03624881|448763794|FG000|Overall Study|No Catheter Inserted|6|||
124764839|NCT03624881|448763795|FG001|Overall Study|No Catheter Inserted|1|||
124764840|NCT03624881|448763794|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
124702145|NCT00500331|448534130|FG000|Overall Study|Withdrawal by Subject|4|||
124702146|NCT00500331|448534131|FG001|Overall Study|Withdrawal by Subject|0|||
124702147|NCT00500331|448534132|FG002|Overall Study|Withdrawal by Subject|1|||
124702148|NCT00500331|448534133|FG003|Overall Study|Withdrawal by Subject|5|||
124702149|NCT00500331|448534134|FG004|Overall Study|Withdrawal by Subject|0|||
124702150|NCT00500331|448534135|FG005|Overall Study|Withdrawal by Subject|1|||
124702151|NCT00500331|448534136|FG006|Overall Study|Withdrawal by Subject|1|||
124702152|NCT00500331|448534130|FG000|Overall Study|Lack of Efficacy|3|||
124702153|NCT00500331|448534131|FG001|Overall Study|Lack of Efficacy|1|||
124702154|NCT00500331|448534132|FG002|Overall Study|Lack of Efficacy|0|||
124702155|NCT00500331|448534133|FG003|Overall Study|Lack of Efficacy|0|||
124702156|NCT00500331|448534134|FG004|Overall Study|Lack of Efficacy|0|||
124702157|NCT00500331|448534135|FG005|Overall Study|Lack of Efficacy|0|||
124702158|NCT00500331|448534136|FG006|Overall Study|Lack of Efficacy|0|||
124702159|NCT00500331|448534130|FG000|Overall Study|Liver function test abnormality|0|||
124702160|NCT00500331|448534131|FG001|Overall Study|Liver function test abnormality|0|||
124764841|NCT03624881|448763795|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
124764842|NCT03624881|448763794|FG000|Overall Study|Death|2|||
124930462|NCT03519178|449376888|FG010|PF-06873600 Treatment|Refused further treatment|0|||
124930463|NCT03519178|449376889|FG011|PF-06873600 Treatment|Refused further treatment|0|||
124930464|NCT03519178|449376890|FG012|PF-06873600 Treatment|Refused further treatment|0|||
124930465|NCT03519178|449376891|FG013|PF-06873600 Treatment|Refused further treatment|0|||
124930466|NCT03519178|449376892|FG014|PF-06873600 Treatment|Refused further treatment|1|||
124930467|NCT03519178|449376878|FG000|PF-06873600 Treatment|Other|0|||
124930468|NCT03519178|449376879|FG001|PF-06873600 Treatment|Other|0|||
124930469|NCT03519178|449376880|FG002|PF-06873600 Treatment|Other|0|||
124930470|NCT03519178|449376881|FG003|PF-06873600 Treatment|Other|0|||
124930471|NCT03519178|449376882|FG004|PF-06873600 Treatment|Other|0|||
124930472|NCT03519178|449376883|FG005|PF-06873600 Treatment|Other|0|||
124930473|NCT03519178|449376884|FG006|PF-06873600 Treatment|Other|0|||
124930474|NCT03519178|449376885|FG007|PF-06873600 Treatment|Other|0|||
124930475|NCT03519178|449376886|FG008|PF-06873600 Treatment|Other|1|||
124930476|NCT03519178|449376887|FG009|PF-06873600 Treatment|Other|0|||
124930477|NCT03519178|449376888|FG010|PF-06873600 Treatment|Other|0|||
124930478|NCT03519178|449376889|FG011|PF-06873600 Treatment|Other|0|||
124930479|NCT03519178|449376890|FG012|PF-06873600 Treatment|Other|0|||
124930480|NCT03519178|449376891|FG013|PF-06873600 Treatment|Other|1|||
124930481|NCT03519178|449376892|FG014|PF-06873600 Treatment|Other|3|||
124930482|NCT03519178|449376878|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
124930483|NCT03519178|449376879|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
124930484|NCT03519178|449376880|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
124930485|NCT03519178|449376881|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
124930486|NCT03519178|449376882|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
124930487|NCT03519178|449376883|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
124930488|NCT03519178|449376884|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
124930489|NCT03519178|449376885|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
124930490|NCT03519178|449376886|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
124930491|NCT03519178|449376887|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
124930492|NCT03519178|449376888|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
124930493|NCT03519178|449376889|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
124930494|NCT03519178|449376890|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
124930495|NCT03519178|449376891|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
124930496|NCT03519178|449376892|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
124930497|NCT03519178|449376878|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930498|NCT03519178|449376879|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930499|NCT03519178|449376880|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930500|NCT03519178|449376881|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930501|NCT03519178|449376882|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930502|NCT03519178|449376883|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930503|NCT03519178|449376884|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930504|NCT03519178|449376885|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930505|NCT03519178|449376886|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930506|NCT03519178|449376887|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
124702161|NCT00500331|448534132|FG002|Overall Study|Liver function test abnormality|1|||
124702162|NCT00500331|448534133|FG003|Overall Study|Liver function test abnormality|0|||
124702163|NCT00500331|448534134|FG004|Overall Study|Liver function test abnormality|0|||
124702164|NCT00500331|448534135|FG005|Overall Study|Liver function test abnormality|0|||
124702165|NCT00500331|448534136|FG006|Overall Study|Liver function test abnormality|0|||
124702166|NCT00500331|448534130|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
124930507|NCT03519178|449376888|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930508|NCT03519178|449376889|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930509|NCT03519178|449376890|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
124930510|NCT03519178|449376891|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
124930511|NCT03519178|449376892|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
124930512|NCT03519178|449376878|FG000|PF-06873600 Treatment|Ongoing|0|||
124930513|NCT03519178|449376879|FG001|PF-06873600 Treatment|Ongoing|0|||
124930514|NCT03519178|449376880|FG002|PF-06873600 Treatment|Ongoing|0|||
124930515|NCT03519178|449376881|FG003|PF-06873600 Treatment|Ongoing|0|||
124930516|NCT03519178|449376882|FG004|PF-06873600 Treatment|Ongoing|0|||
124930517|NCT03519178|449376883|FG005|PF-06873600 Treatment|Ongoing|0|||
124930518|NCT03519178|449376884|FG006|PF-06873600 Treatment|Ongoing|0|||
124930519|NCT03519178|449376885|FG007|PF-06873600 Treatment|Ongoing|0|||
124930520|NCT03519178|449376886|FG008|PF-06873600 Treatment|Ongoing|0|||
124930521|NCT03519178|449376887|FG009|PF-06873600 Treatment|Ongoing|0|||
124930522|NCT03519178|449376888|FG010|PF-06873600 Treatment|Ongoing|0|||
124930523|NCT03519178|449376889|FG011|PF-06873600 Treatment|Ongoing|0|||
124930524|NCT03519178|449376890|FG012|PF-06873600 Treatment|Ongoing|0|||
124930525|NCT03519178|449376891|FG013|PF-06873600 Treatment|Ongoing|1|||
124930526|NCT03519178|449376892|FG014|PF-06873600 Treatment|Ongoing|6|||
124930527|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930528|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930529|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930530|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930531|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930532|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930533|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930534|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930535|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930536|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930537|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930538|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930539|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930540|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
124930541|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
124930542|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Death|0|||
124930543|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Death|0|||
124930544|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Death|0|||
124930545|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Death|0|||
124930546|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Death|0|||
124930547|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Death|0|||
124930548|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Death|0|||
124930549|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Death|0|||
124930550|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Death|0|||
124930551|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Death|1|||
124930552|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Death|0|||
124930553|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Death|0|||
124930554|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Death|0|||
124930555|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Death|0|||
124930556|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Death|1|||
124930557|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930558|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930559|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930560|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930561|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930562|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930563|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930564|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930565|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930566|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930567|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124702167|NCT00500331|448534131|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
124930568|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930569|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930570|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
124930571|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
124930572|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124455522|NCT05879107|447627208|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
124702168|NCT00500331|448534132|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
124455523|NCT05879107|447627209|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
124455524|NCT05879107|447627208|FG000|Overall Study|Migrated / moved from the study area|1|||
124455525|NCT05879107|447627209|FG001|Overall Study|Migrated / moved from the study area|1|||
124455526|NCT05879107|447627208|FG000|Overall Study|Lost to Follow-up|8|||
124455527|NCT05879107|447627209|FG001|Overall Study|Lost to Follow-up|13|||
124455528|NCT05879107|447627208|FG000|Overall Study|Death|0|||
124764843|NCT03624881|448763795|FG001|Overall Study|Death|0|||
124930573|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930574|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930575|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930576|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930577|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930578|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930579|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930580|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930581|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930582|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930583|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930584|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
124930585|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
124930586|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
124930587|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930588|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930589|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930590|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930591|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930592|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930593|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930594|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930595|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930596|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
124930597|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930598|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930599|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
124930600|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
124930601|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
124930602|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930603|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930604|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930605|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930606|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930607|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930608|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930609|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930610|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930611|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930612|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930613|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930614|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
124930615|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
124930616|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
124930617|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930618|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930619|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930620|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930621|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930622|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930623|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930624|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930625|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930626|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
124930627|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930628|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124455529|NCT05879107|447627209|FG001|Overall Study|Death|2|||
124930629|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
124930630|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
124930631|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
124930632|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930633|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930634|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930635|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930636|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930637|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930638|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930639|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930640|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930641|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
124930642|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930643|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930644|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930645|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
124930646|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
124930647|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930648|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930649|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930650|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930651|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930652|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930653|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930654|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930655|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930656|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930657|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930658|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930659|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930660|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
124930661|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
124930662|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Other|0|||
124930663|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Other|0|||
124930664|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Other|0|||
124930665|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Other|0|||
124930666|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Other|0|||
124930667|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Other|0|||
124930668|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Other|0|||
124930669|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Other|0|||
124930670|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Other|0|||
124930671|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Other|0|||
124930672|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Other|0|||
124930673|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Other|0|||
124930674|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Other|0|||
124930675|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Other|1|||
124930676|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Other|3|||
124930677|NCT03519178|449376878|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930678|NCT03519178|449376879|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930679|NCT03519178|449376880|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930680|NCT03519178|449376881|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930681|NCT03519178|449376882|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930682|NCT03519178|449376883|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
124455530|NCT05879107|447627208|FG000|Overall Study|Other|0|||
124455531|NCT05879107|447627209|FG001|Overall Study|Other|3|||
124455532|NCT03901079|447627210|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
124455533|NCT00843518|447627211|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
124455534|NCT00843518|447627212|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
124702169|NCT00500331|448534133|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
124702170|NCT00500331|448534134|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
124455535|NCT00843518|447627211|FG000|Period 2 (Double-blind Treatment)|Death|0|||
124702171|NCT00500331|448534135|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
124930683|NCT03519178|449376884|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930684|NCT03519178|449376885|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930685|NCT03519178|449376886|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930686|NCT03519178|449376887|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930687|NCT03519178|449376888|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930688|NCT03519178|449376889|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930689|NCT03519178|449376890|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
124930690|NCT03519178|449376891|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
124930691|NCT03519178|449376892|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
124930692|NCT03519178|449376878|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
124930693|NCT03519178|449376879|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
124930694|NCT03519178|449376880|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
124930695|NCT03519178|449376881|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
124930696|NCT03519178|449376882|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
124930697|NCT03519178|449376883|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
124930698|NCT03519178|449376884|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
124930699|NCT03519178|449376885|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
124930700|NCT03519178|449376886|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
124930701|NCT03519178|449376887|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
124930702|NCT03519178|449376888|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
124930703|NCT03519178|449376889|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
124930704|NCT03519178|449376890|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
124930705|NCT03519178|449376891|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
124930706|NCT03519178|449376892|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
124930707|NCT03519178|449376878|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
124930708|NCT03519178|449376879|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
124930709|NCT03519178|449376880|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
124930710|NCT03519178|449376881|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
124930711|NCT03519178|449376882|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
124930712|NCT03519178|449376883|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
124930713|NCT03519178|449376884|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
124930714|NCT03519178|449376885|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
124930715|NCT03519178|449376886|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
124930716|NCT03519178|449376887|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
124930717|NCT03519178|449376888|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
124930718|NCT03519178|449376889|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
124930719|NCT03519178|449376890|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
124930720|NCT03519178|449376891|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
124930721|NCT03519178|449376892|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
124930722|NCT03519178|449376878|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930723|NCT03519178|449376879|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930724|NCT03519178|449376880|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930725|NCT03519178|449376881|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930726|NCT03519178|449376882|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930727|NCT03519178|449376883|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930728|NCT03519178|449376884|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930729|NCT03519178|449376885|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930730|NCT03519178|449376886|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930731|NCT03519178|449376887|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930732|NCT03519178|449376888|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
124930733|NCT03519178|449376889|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930734|NCT03519178|449376890|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930735|NCT03519178|449376891|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930736|NCT03519178|449376892|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
124930737|NCT03519178|449376878|FG000|Follow-Up|Death|0|||
124930738|NCT03519178|449376879|FG001|Follow-Up|Death|0|||
124455536|NCT00843518|447627212|FG001|Period 2 (Double-blind Treatment)|Death|1|||
124455537|NCT00843518|447627211|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
124455538|NCT00843518|447627212|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
124455539|NCT00843518|447627211|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
124455540|NCT00843518|447627212|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
124930739|NCT03519178|449376880|FG002|Follow-Up|Death|1|||
124930740|NCT03519178|449376881|FG003|Follow-Up|Death|0|||
124930741|NCT03519178|449376882|FG004|Follow-Up|Death|0|||
124455541|NCT00843518|447627211|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
124455542|NCT00843518|447627212|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
124455543|NCT00843518|447627211|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
124455544|NCT00843518|447627212|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
124455545|NCT00843518|447627211|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
124455546|NCT00843518|447627212|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
124455547|NCT00912028|447627215|FG000|Overall Study|Lost to Follow-up|2|||
124455548|NCT00912028|447627216|FG001|Overall Study|Lost to Follow-up|3|||
124455549|NCT00912028|447627217|FG002|Overall Study|Lost to Follow-up|0|||
124455550|NCT00912028|447627218|FG003|Overall Study|Lost to Follow-up|1|||
124546426|NCT02181673|447955903|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
124546427|NCT02181673|447955901|FG000|Week 24-Week 60|Pregnancy|0|||
124930742|NCT03519178|449376883|FG005|Follow-Up|Death|0|||
124930743|NCT03519178|449376884|FG006|Follow-Up|Death|0|||
124930744|NCT03519178|449376885|FG007|Follow-Up|Death|0|||
124930745|NCT03519178|449376886|FG008|Follow-Up|Death|3|||
124930746|NCT03519178|449376887|FG009|Follow-Up|Death|1|||
124930747|NCT03519178|449376888|FG010|Follow-Up|Death|0|||
124930748|NCT03519178|449376889|FG011|Follow-Up|Death|0|||
124930749|NCT03519178|449376890|FG012|Follow-Up|Death|2|||
124930750|NCT03519178|449376891|FG013|Follow-Up|Death|0|||
124930751|NCT03519178|449376892|FG014|Follow-Up|Death|0|||
124930752|NCT03519178|449376878|FG000|Follow-Up|Lost to Follow-up|0|||
124930753|NCT03519178|449376879|FG001|Follow-Up|Lost to Follow-up|0|||
124930754|NCT03519178|449376880|FG002|Follow-Up|Lost to Follow-up|0|||
124930755|NCT03519178|449376881|FG003|Follow-Up|Lost to Follow-up|0|||
124930756|NCT03519178|449376882|FG004|Follow-Up|Lost to Follow-up|0|||
124930757|NCT03519178|449376883|FG005|Follow-Up|Lost to Follow-up|3|||
124930758|NCT03519178|449376884|FG006|Follow-Up|Lost to Follow-up|1|||
124930759|NCT03519178|449376885|FG007|Follow-Up|Lost to Follow-up|4|||
124930760|NCT03519178|449376886|FG008|Follow-Up|Lost to Follow-up|1|||
124930761|NCT03519178|449376887|FG009|Follow-Up|Lost to Follow-up|0|||
124930762|NCT03519178|449376888|FG010|Follow-Up|Lost to Follow-up|0|||
124930763|NCT03519178|449376889|FG011|Follow-Up|Lost to Follow-up|0|||
124930764|NCT03519178|449376890|FG012|Follow-Up|Lost to Follow-up|0|||
124930765|NCT03519178|449376891|FG013|Follow-Up|Lost to Follow-up|0|||
124930766|NCT03519178|449376892|FG014|Follow-Up|Lost to Follow-up|0|||
124930767|NCT03519178|449376878|FG000|Follow-Up|Withdrawal by Subject|1|||
124930768|NCT03519178|449376879|FG001|Follow-Up|Withdrawal by Subject|2|||
124930769|NCT03519178|449376880|FG002|Follow-Up|Withdrawal by Subject|2|||
124930770|NCT03519178|449376881|FG003|Follow-Up|Withdrawal by Subject|3|||
124930771|NCT03519178|449376882|FG004|Follow-Up|Withdrawal by Subject|5|||
124930772|NCT03519178|449376883|FG005|Follow-Up|Withdrawal by Subject|1|||
124930773|NCT03519178|449376884|FG006|Follow-Up|Withdrawal by Subject|2|||
124930774|NCT03519178|449376885|FG007|Follow-Up|Withdrawal by Subject|6|||
124930775|NCT03519178|449376886|FG008|Follow-Up|Withdrawal by Subject|5|||
124930776|NCT03519178|449376887|FG009|Follow-Up|Withdrawal by Subject|2|||
124930777|NCT03519178|449376888|FG010|Follow-Up|Withdrawal by Subject|3|||
124930778|NCT03519178|449376889|FG011|Follow-Up|Withdrawal by Subject|5|||
124930779|NCT03519178|449376890|FG012|Follow-Up|Withdrawal by Subject|2|||
124930780|NCT03519178|449376891|FG013|Follow-Up|Withdrawal by Subject|0|||
124930781|NCT03519178|449376892|FG014|Follow-Up|Withdrawal by Subject|0|||
124930782|NCT03519178|449376878|FG000|Follow-Up|Other|0|||
124930783|NCT03519178|449376879|FG001|Follow-Up|Other|0|||
124930784|NCT03519178|449376880|FG002|Follow-Up|Other|0|||
124930785|NCT03519178|449376881|FG003|Follow-Up|Other|0|||
124930786|NCT03519178|449376882|FG004|Follow-Up|Other|0|||
124930787|NCT03519178|449376883|FG005|Follow-Up|Other|0|||
124455551|NCT00912028|447627219|FG004|Overall Study|Lost to Follow-up|3|||
124455552|NCT00912028|447627215|FG000|Overall Study|Withdrawal by Subject|3|||
124455553|NCT00912028|447627216|FG001|Overall Study|Withdrawal by Subject|0|||
124546428|NCT02181673|447955902|FG001|Week 24-Week 60|Pregnancy|0|||
124930788|NCT03519178|449376884|FG006|Follow-Up|Other|0|||
124930789|NCT03519178|449376885|FG007|Follow-Up|Other|1|||
124930790|NCT03519178|449376886|FG008|Follow-Up|Other|0|||
124930791|NCT03519178|449376887|FG009|Follow-Up|Other|0|||
124930792|NCT03519178|449376888|FG010|Follow-Up|Other|0|||
124930793|NCT03519178|449376889|FG011|Follow-Up|Other|0|||
124930794|NCT03519178|449376890|FG012|Follow-Up|Other|0|||
124930795|NCT03519178|449376891|FG013|Follow-Up|Other|0|||
124930796|NCT03519178|449376892|FG014|Follow-Up|Other|0|||
124930797|NCT03519178|449376878|FG000|Long-term Follow-up|Death|0|||
124930798|NCT03519178|449376879|FG001|Long-term Follow-up|Death|0|||
124930799|NCT03519178|449376880|FG002|Long-term Follow-up|Death|0|||
124930800|NCT03519178|449376881|FG003|Long-term Follow-up|Death|0|||
124930801|NCT03519178|449376882|FG004|Long-term Follow-up|Death|0|||
124930802|NCT03519178|449376883|FG005|Long-term Follow-up|Death|0|||
124930803|NCT03519178|449376884|FG006|Long-term Follow-up|Death|0|||
124930804|NCT03519178|449376885|FG007|Long-term Follow-up|Death|0|||
124930805|NCT03519178|449376886|FG008|Long-term Follow-up|Death|0|||
124930806|NCT03519178|449376887|FG009|Long-term Follow-up|Death|0|||
124930807|NCT03519178|449376888|FG010|Long-term Follow-up|Death|0|||
124930808|NCT03519178|449376889|FG011|Long-term Follow-up|Death|0|||
124930809|NCT03519178|449376890|FG012|Long-term Follow-up|Death|0|||
124930810|NCT03519178|449376891|FG013|Long-term Follow-up|Death|4|||
124930811|NCT03519178|449376892|FG014|Long-term Follow-up|Death|4|||
124930812|NCT03519178|449376878|FG000|Long-term Follow-up|Lost to Follow-up|0|||
124930813|NCT03519178|449376879|FG001|Long-term Follow-up|Lost to Follow-up|0|||
124930814|NCT03519178|449376880|FG002|Long-term Follow-up|Lost to Follow-up|0|||
124930815|NCT03519178|449376881|FG003|Long-term Follow-up|Lost to Follow-up|0|||
124930816|NCT03519178|449376882|FG004|Long-term Follow-up|Lost to Follow-up|0|||
124930817|NCT03519178|449376883|FG005|Long-term Follow-up|Lost to Follow-up|0|||
124930818|NCT03519178|449376884|FG006|Long-term Follow-up|Lost to Follow-up|0|||
124930819|NCT03519178|449376885|FG007|Long-term Follow-up|Lost to Follow-up|0|||
124930820|NCT03519178|449376886|FG008|Long-term Follow-up|Lost to Follow-up|0|||
124930821|NCT03519178|449376887|FG009|Long-term Follow-up|Lost to Follow-up|0|||
124930822|NCT03519178|449376888|FG010|Long-term Follow-up|Lost to Follow-up|0|||
124930823|NCT03519178|449376889|FG011|Long-term Follow-up|Lost to Follow-up|0|||
124930824|NCT03519178|449376890|FG012|Long-term Follow-up|Lost to Follow-up|0|||
124930825|NCT03519178|449376891|FG013|Long-term Follow-up|Lost to Follow-up|1|||
124930826|NCT03519178|449376892|FG014|Long-term Follow-up|Lost to Follow-up|1|||
124930827|NCT03519178|449376878|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
124930828|NCT03519178|449376879|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
124930829|NCT03519178|449376880|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
124930830|NCT03519178|449376881|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
124930831|NCT03519178|449376882|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
124930832|NCT03519178|449376883|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
124930833|NCT03519178|449376884|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
124930834|NCT03519178|449376885|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
124930835|NCT03519178|449376886|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
124930836|NCT03519178|449376887|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
124930837|NCT03519178|449376888|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
124930838|NCT03519178|449376889|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
124930839|NCT03519178|449376890|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
124930840|NCT03519178|449376891|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
124930841|NCT03519178|449376892|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
124930842|NCT03519178|449376878|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
124930843|NCT03519178|449376879|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
124930844|NCT03519178|449376880|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
124930845|NCT03519178|449376881|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
124930846|NCT03519178|449376882|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
124930847|NCT03519178|449376883|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
124930848|NCT03519178|449376884|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
124930849|NCT03519178|449376885|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
124930850|NCT03519178|449376886|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
124930851|NCT03519178|449376887|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
124930852|NCT03519178|449376888|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
124930853|NCT03519178|449376889|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
124930854|NCT03519178|449376890|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
124930855|NCT03519178|449376891|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
124930856|NCT03519178|449376892|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
124930857|NCT03519178|449376878|FG000|Long-term Follow-up|Other|0|||
124930858|NCT03519178|449376879|FG001|Long-term Follow-up|Other|0|||
124930859|NCT03519178|449376880|FG002|Long-term Follow-up|Other|0|||
124930860|NCT03519178|449376881|FG003|Long-term Follow-up|Other|0|||
124930861|NCT03519178|449376882|FG004|Long-term Follow-up|Other|0|||
124930862|NCT03519178|449376883|FG005|Long-term Follow-up|Other|0|||
124930863|NCT03519178|449376884|FG006|Long-term Follow-up|Other|0|||
124930864|NCT03519178|449376885|FG007|Long-term Follow-up|Other|0|||
124930865|NCT03519178|449376886|FG008|Long-term Follow-up|Other|0|||
124930866|NCT03519178|449376887|FG009|Long-term Follow-up|Other|0|||
124930867|NCT03519178|449376888|FG010|Long-term Follow-up|Other|0|||
124930868|NCT03519178|449376889|FG011|Long-term Follow-up|Other|0|||
124930869|NCT03519178|449376890|FG012|Long-term Follow-up|Other|0|||
124930870|NCT03519178|449376891|FG013|Long-term Follow-up|Other|0|||
124930871|NCT03519178|449376892|FG014|Long-term Follow-up|Other|1|||
124930872|NCT03519178|449376878|FG000|Long-term Follow-up|Ongoing|0|||
124930873|NCT03519178|449376879|FG001|Long-term Follow-up|Ongoing|0|||
124930874|NCT03519178|449376880|FG002|Long-term Follow-up|Ongoing|0|||
124930875|NCT03519178|449376881|FG003|Long-term Follow-up|Ongoing|0|||
124930876|NCT03519178|449376882|FG004|Long-term Follow-up|Ongoing|0|||
124930877|NCT03519178|449376883|FG005|Long-term Follow-up|Ongoing|0|||
124930878|NCT03519178|449376884|FG006|Long-term Follow-up|Ongoing|0|||
124930879|NCT03519178|449376885|FG007|Long-term Follow-up|Ongoing|0|||
124930880|NCT03519178|449376886|FG008|Long-term Follow-up|Ongoing|0|||
124930881|NCT03519178|449376887|FG009|Long-term Follow-up|Ongoing|0|||
124930882|NCT03519178|449376888|FG010|Long-term Follow-up|Ongoing|0|||
124930883|NCT03519178|449376889|FG011|Long-term Follow-up|Ongoing|0|||
124930884|NCT03519178|449376890|FG012|Long-term Follow-up|Ongoing|0|||
124930885|NCT03519178|449376891|FG013|Long-term Follow-up|Ongoing|1|||
124930886|NCT03519178|449376892|FG014|Long-term Follow-up|Ongoing|0|||
124930887|NCT02315703|449376905|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
124930888|NCT02315703|449376906|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
124930889|NCT02315703|449376907|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
124930890|NCT02315703|449376908|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
124930891|NCT02315703|449376909|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
124930892|NCT02315703|449376910|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
124930893|NCT02315703|449376911|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
124930894|NCT02315703|449376912|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
124455554|NCT00912028|447627217|FG002|Overall Study|Withdrawal by Subject|0|||
124455555|NCT00912028|447627218|FG003|Overall Study|Withdrawal by Subject|0|||
124455556|NCT00912028|447627219|FG004|Overall Study|Withdrawal by Subject|0|||
124455557|NCT04143009|447627220|FG000|Pilot Trial|Lost to Follow-up|0|||
124455558|NCT04143009|447627221|FG001|Pilot Trial|Lost to Follow-up|1|||
124455559|NCT04143009|447627222|FG002|Pilot Trial|Lost to Follow-up|1|||
124455560|NCT05003622|447627223|FG000|Overall Study|Progressive disease|2|||
124455561|NCT05003622|447627223|FG000|Overall Study|Withdrawal by Subject|1|||
124455562|NCT00609986|447627224|FG000|Overall Study|Did not receive transplant or treatment|8|||
124455563|NCT00609986|447627225|FG001|Overall Study|Did not receive transplant or treatment|3|||
124455564|NCT02046096|447627234|FG000|Overall Study|Death|28|||
124455565|NCT02046096|447627235|FG001|Overall Study|Death|45|||
124455566|NCT02046096|447627234|FG000|Overall Study|Lost to Follow-up|9|||
124455567|NCT02046096|447627235|FG001|Overall Study|Lost to Follow-up|20|||
124455568|NCT02046096|447627234|FG000|Overall Study|Withdrawal by Subject|5|||
124455569|NCT02046096|447627235|FG001|Overall Study|Withdrawal by Subject|17|||
124455570|NCT02046096|447627234|FG000|Overall Study|Other endpoint|2|||
124455571|NCT02046096|447627235|FG001|Overall Study|Other endpoint|19|||
124455572|NCT02090413|447627236|FG000|Overall Study|Adverse Event|11|||
124455573|NCT02090413|447627237|FG001|Overall Study|Adverse Event|15|||
124455574|NCT02090413|447627238|FG002|Overall Study|Adverse Event|20|||
124455575|NCT02090413|447627236|FG000|Overall Study|Flushing event|2|||
124455576|NCT02090413|447627237|FG001|Overall Study|Flushing event|0|||
124455577|NCT02090413|447627238|FG002|Overall Study|Flushing event|1|||
124455578|NCT02090413|447627236|FG000|Overall Study|Withdrawal by Subject|2|||
124455579|NCT02090413|447627237|FG001|Overall Study|Withdrawal by Subject|2|||
124455580|NCT02090413|447627238|FG002|Overall Study|Withdrawal by Subject|2|||
124455581|NCT02090413|447627236|FG000|Overall Study|Investigator Decision|1|||
124455582|NCT02090413|447627237|FG001|Overall Study|Investigator Decision|1|||
124455583|NCT02090413|447627238|FG002|Overall Study|Investigator Decision|0|||
124455584|NCT02090413|447627236|FG000|Overall Study|Other|2|||
124455585|NCT02090413|447627237|FG001|Overall Study|Other|1|||
124455586|NCT02090413|447627238|FG002|Overall Study|Other|0|||
124455587|NCT02090413|447627236|FG000|Overall Study|Lost to Follow-up|1|||
124455588|NCT02090413|447627237|FG001|Overall Study|Lost to Follow-up|1|||
124455589|NCT02090413|447627238|FG002|Overall Study|Lost to Follow-up|0|||
124455590|NCT00597753|447627244|FG000|Overall Study|Adverse Event|6|||
124455591|NCT00597753|447627245|FG001|Overall Study|Adverse Event|2|||
124455592|NCT00597753|447627244|FG000|Overall Study|Death|55|||
124455593|NCT00597753|447627245|FG001|Overall Study|Death|29|||
124455594|NCT00597753|447627244|FG000|Overall Study|Lack of Efficacy|2|||
124455595|NCT00597753|447627245|FG001|Overall Study|Lack of Efficacy|0|||
124455596|NCT00597753|447627244|FG000|Overall Study|Lost to Follow-up|10|||
124455597|NCT00597753|447627245|FG001|Overall Study|Lost to Follow-up|3|||
124455598|NCT00597753|447627244|FG000|Overall Study|Physician Decision|5|||
124455599|NCT00597753|447627245|FG001|Overall Study|Physician Decision|1|||
124455600|NCT00597753|447627244|FG000|Overall Study|Pregnancy|1|||
124930895|NCT02315703|449376905|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
124930896|NCT02315703|449376906|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
124455601|NCT00597753|447627245|FG001|Overall Study|Pregnancy|0|||
124455602|NCT00597753|447627244|FG000|Overall Study|Withdrawal by Subject|35|||
124455603|NCT00597753|447627245|FG001|Overall Study|Withdrawal by Subject|12|||
124455604|NCT00597753|447627244|FG000|Overall Study|Discontinued Dialysis|0|||
124455605|NCT00597753|447627245|FG001|Overall Study|Discontinued Dialysis|1|||
124455606|NCT00597753|447627244|FG000|Overall Study|Never dosed|2|||
124455607|NCT00597753|447627245|FG001|Overall Study|Never dosed|0|||
124455608|NCT00597753|447627244|FG000|Overall Study|Noncompliance|2|||
124455609|NCT00597753|447627245|FG001|Overall Study|Noncompliance|1|||
124455610|NCT00597753|447627244|FG000|Overall Study|Relocation|17|||
124455611|NCT00597753|447627245|FG001|Overall Study|Relocation|6|||
124455612|NCT00597753|447627244|FG000|Overall Study|Renal transplant|10|||
124455613|NCT00597753|447627245|FG001|Overall Study|Renal transplant|3|||
124455614|NCT00597753|447627244|FG000|Overall Study|Site closed by sponsor|19|||
124764844|NCT03624881|448763794|FG000|Overall Study|Lost to Follow-up|10|||
124764845|NCT03624881|448763795|FG001|Overall Study|Lost to Follow-up|4|||
124764846|NCT03624881|448763794|FG000|Overall Study|Withdrawal by Subject|12|||
124764847|NCT03624881|448763795|FG001|Overall Study|Withdrawal by Subject|1|||
124764848|NCT03284710|448765022|FG000|Overall Study|Withdrawal by Subject|1|||
124764849|NCT03284710|448765023|FG001|Overall Study|Withdrawal by Subject|0|||
124764850|NCT03284710|448765024|FG002|Overall Study|Withdrawal by Subject|1|||
124764851|NCT03284710|448765025|FG003|Overall Study|Withdrawal by Subject|6|||
124764852|NCT03284710|448765022|FG000|Overall Study|Lost to Follow-up|3|||
124764853|NCT03284710|448765023|FG001|Overall Study|Lost to Follow-up|3|||
124764854|NCT03284710|448765024|FG002|Overall Study|Lost to Follow-up|1|||
124764855|NCT03284710|448765025|FG003|Overall Study|Lost to Follow-up|0|||
124764856|NCT03284710|448765022|FG000|Overall Study|Physician Decision|1|||
124764857|NCT03284710|448765023|FG001|Overall Study|Physician Decision|0|||
124764858|NCT03284710|448765024|FG002|Overall Study|Physician Decision|0|||
124764859|NCT03284710|448765025|FG003|Overall Study|Physician Decision|0|||
124764860|NCT03284710|448765022|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
124455615|NCT00597753|447627245|FG001|Overall Study|Site closed by sponsor|7|||
124455616|NCT00597753|447627244|FG000|Overall Study|Site elected to close|2|||
124455617|NCT00597753|447627245|FG001|Overall Study|Site elected to close|4|||
124455618|NCT00736255|447628809|FG000|Overall Study|Adverse Event|1|||
124455619|NCT00736255|447628810|FG001|Overall Study|Adverse Event|0|||
124455620|NCT00736255|447628809|FG000|Overall Study|Physician Decision|1|||
124455621|NCT00736255|447628810|FG001|Overall Study|Physician Decision|0|||
124455622|NCT00736255|447628809|FG000|Overall Study|Non-compliance|1|||
124455623|NCT00736255|447628810|FG001|Overall Study|Non-compliance|1|||
124455624|NCT01838616|447628816|FG000|Titration Period|Adverse Event|18|||
124455625|NCT01838616|447628817|FG001|Titration Period|Adverse Event|48|||
124455626|NCT01838616|447628816|FG000|Titration Period|Lack of Efficacy|5|||
124455627|NCT01838616|447628817|FG001|Titration Period|Lack of Efficacy|12|||
124455628|NCT01838616|447628816|FG000|Titration Period|Withdrawal by Subject|5|||
124455629|NCT01838616|447628817|FG001|Titration Period|Withdrawal by Subject|5|||
124455630|NCT01838616|447628816|FG000|Titration Period|Technical problems|1|||
124455631|NCT01838616|447628817|FG001|Titration Period|Technical problems|0|||
124455632|NCT01838616|447628816|FG000|Titration Period|Other|1|||
124455633|NCT01838616|447628817|FG001|Titration Period|Other|0|||
124455634|NCT01838616|447628816|FG000|Titration Period|Protocol Violation|0|||
124455635|NCT01838616|447628817|FG001|Titration Period|Protocol Violation|1|||
124455636|NCT01838616|447628816|FG000|Continuation Period|Lack of Efficacy|3|||
124930897|NCT02315703|449376907|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
124930898|NCT02315703|449376908|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
124930899|NCT02315703|449376909|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
124930900|NCT02315703|449376910|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
124930901|NCT02315703|449376911|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
124930902|NCT02315703|449376912|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
124930903|NCT02315703|449376905|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
124930904|NCT02315703|449376906|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
124930905|NCT02315703|449376907|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
124930906|NCT02315703|449376908|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
124930907|NCT02315703|449376909|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
124930908|NCT02315703|449376910|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
124930909|NCT02315703|449376911|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
124930910|NCT02315703|449376912|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
124930911|NCT02315703|449376905|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
124930912|NCT02315703|449376906|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
124930913|NCT02315703|449376907|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
124930914|NCT02315703|449376908|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
124930915|NCT02315703|449376909|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
124455637|NCT01838616|447628817|FG001|Continuation Period|Lack of Efficacy|5|||
124930916|NCT02315703|449376910|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
124455638|NCT01838616|447628816|FG000|Continuation Period|Adverse Event|8|||
124455639|NCT01838616|447628817|FG001|Continuation Period|Adverse Event|4|||
124455640|NCT01838616|447628816|FG000|Continuation Period|Protocol Violation|2|||
124764861|NCT03284710|448765023|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
124764862|NCT03284710|448765024|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
124764863|NCT03284710|448765025|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
124930917|NCT02315703|449376911|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
124930918|NCT02315703|449376912|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
124455641|NCT01838616|447628817|FG001|Continuation Period|Protocol Violation|0|||
124455642|NCT01838616|447628816|FG000|Continuation Period|Lost to Follow-up|1|||
124455643|NCT01838616|447628817|FG001|Continuation Period|Lost to Follow-up|0|||
124455644|NCT01838616|447628816|FG000|Continuation Period|Withdrawal by Subject|0|||
124455645|NCT01838616|447628817|FG001|Continuation Period|Withdrawal by Subject|4|||
124546429|NCT02181673|447955903|FG002|Week 24-Week 60|Pregnancy|1|||
124455646|NCT01838616|447628816|FG000|Continuation Period|Technical problems|0|||
124455647|NCT01838616|447628817|FG001|Continuation Period|Technical problems|1|||
124455648|NCT01838616|447628816|FG000|Pick-up Arm|Lack of Efficacy|4|||
124455649|NCT01838616|447628817|FG001|Pick-up Arm|Lack of Efficacy|0|||
124455650|NCT01838616|447628816|FG000|Pick-up Arm|Adverse Event|9|||
124702172|NCT00500331|448534136|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
124702173|NCT00500331|448534130|FG000|Overall Study|Didn't return for continuation of study|1|||
124702174|NCT00500331|448534131|FG001|Overall Study|Didn't return for continuation of study|0|||
124702175|NCT00500331|448534132|FG002|Overall Study|Didn't return for continuation of study|0|||
124702176|NCT00500331|448534133|FG003|Overall Study|Didn't return for continuation of study|0|||
124702177|NCT00500331|448534134|FG004|Overall Study|Didn't return for continuation of study|0|||
124702178|NCT00500331|448534135|FG005|Overall Study|Didn't return for continuation of study|0|||
124702179|NCT00500331|448534136|FG006|Overall Study|Didn't return for continuation of study|0|||
124702180|NCT00500331|448534130|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
124702181|NCT00500331|448534131|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
124702182|NCT00500331|448534132|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
124702183|NCT00500331|448534133|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
124702184|NCT00500331|448534134|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
124702185|NCT00500331|448534135|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
124702186|NCT00500331|448534136|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
124702187|NCT00500331|448534130|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
124702188|NCT00500331|448534131|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
124702189|NCT00500331|448534132|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
124702190|NCT00500331|448534133|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
124702191|NCT00500331|448534134|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
124702192|NCT00500331|448534135|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
124702193|NCT00500331|448534136|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
124702194|NCT00500331|448534130|FG000|Overall Study|Participant was randomized by mistake|1|||
124702195|NCT00500331|448534131|FG001|Overall Study|Participant was randomized by mistake|0|||
124702196|NCT00500331|448534132|FG002|Overall Study|Participant was randomized by mistake|0|||
124702197|NCT00500331|448534133|FG003|Overall Study|Participant was randomized by mistake|0|||
124702198|NCT00500331|448534134|FG004|Overall Study|Participant was randomized by mistake|0|||
124702199|NCT00500331|448534135|FG005|Overall Study|Participant was randomized by mistake|0|||
124702200|NCT00500331|448534136|FG006|Overall Study|Participant was randomized by mistake|0|||
124702201|NCT00500331|448534130|FG000|Overall Study|Diabetologist nurse in the study|0|||
124702202|NCT00500331|448534131|FG001|Overall Study|Diabetologist nurse in the study|0|||
124702203|NCT00500331|448534132|FG002|Overall Study|Diabetologist nurse in the study|1|||
124702204|NCT00500331|448534133|FG003|Overall Study|Diabetologist nurse in the study|0|||
124702205|NCT00500331|448534134|FG004|Overall Study|Diabetologist nurse in the study|0|||
124702206|NCT00500331|448534135|FG005|Overall Study|Diabetologist nurse in the study|0|||
124702207|NCT00500331|448534136|FG006|Overall Study|Diabetologist nurse in the study|0|||
124702208|NCT00500331|448534130|FG000|Overall Study|State ban of biological samples export|0|||
124702209|NCT00500331|448534131|FG001|Overall Study|State ban of biological samples export|0|||
124702210|NCT00500331|448534132|FG002|Overall Study|State ban of biological samples export|0|||
124702211|NCT00500331|448534133|FG003|Overall Study|State ban of biological samples export|1|||
124702212|NCT00500331|448534134|FG004|Overall Study|State ban of biological samples export|0|||
124702213|NCT00500331|448534135|FG005|Overall Study|State ban of biological samples export|0|||
124702214|NCT00500331|448534136|FG006|Overall Study|State ban of biological samples export|0|||
124702215|NCT00500331|448534130|FG000|Overall Study|Protocol violated|0|||
124455651|NCT01838616|447628817|FG001|Pick-up Arm|Adverse Event|0|||
124455652|NCT01838616|447628816|FG000|Pick-up Arm|Withdrawal by Subject|1|||
124455653|NCT01838616|447628817|FG001|Pick-up Arm|Withdrawal by Subject|0|||
124455654|NCT01838616|447628816|FG000|Pick-up Arm|Technical problems|1|||
124930919|NCT02315703|449376905|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
124930920|NCT02315703|449376906|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
124930921|NCT02315703|449376907|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
124930922|NCT02315703|449376908|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
124930923|NCT02315703|449376909|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
124930924|NCT02315703|449376910|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
124930925|NCT02315703|449376911|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
124930926|NCT02315703|449376912|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
124930927|NCT02315703|449376905|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
124930928|NCT02315703|449376906|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
124930929|NCT02315703|449376907|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
124930930|NCT02315703|449376908|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
124930931|NCT02315703|449376909|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
124930932|NCT02315703|449376910|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
124930933|NCT02315703|449376911|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
124930934|NCT02315703|449376912|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
124930935|NCT02315703|449376905|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
124930936|NCT02315703|449376906|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
124930937|NCT02315703|449376907|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
124930938|NCT02315703|449376908|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
124930939|NCT02315703|449376909|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
124930940|NCT02315703|449376910|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
124930941|NCT02315703|449376911|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
124930942|NCT02315703|449376912|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
124930943|NCT02315703|449376905|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
124930944|NCT02315703|449376906|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
124930945|NCT02315703|449376907|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
124930946|NCT02315703|449376908|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
124930947|NCT02315703|449376909|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
124930948|NCT02315703|449376910|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
124930949|NCT02315703|449376911|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
124930950|NCT02315703|449376912|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
124930951|NCT02315703|449376905|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
124930952|NCT02315703|449376906|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
124930953|NCT02315703|449376907|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
124930954|NCT02315703|449376908|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
124930955|NCT02315703|449376909|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
124930956|NCT02315703|449376910|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
124930957|NCT02315703|449376911|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
124930958|NCT02315703|449376912|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
124930959|NCT02240238|449376913|FG000|Phase 1|Adverse Event|0|||
124930960|NCT02240238|449376914|FG001|Phase 1|Adverse Event|0|||
124930961|NCT02240238|449376915|FG002|Phase 1|Adverse Event|0|||
124930962|NCT02240238|449376916|FG003|Phase 1|Adverse Event|0|||
124930963|NCT02240238|449376917|FG004|Phase 1|Adverse Event|0|||
124930964|NCT02240238|449376918|FG005|Phase 1|Adverse Event|0|||
124930965|NCT02240238|449376919|FG006|Phase 1|Adverse Event|3|||
124930966|NCT02240238|449376920|FG007|Phase 1|Adverse Event|1|||
124930967|NCT02240238|449376921|FG008|Phase 1|Adverse Event|0|||
124930968|NCT02240238|449376922|FG009|Phase 1|Adverse Event|0|||
124930969|NCT02240238|449376923|FG010|Phase 1|Adverse Event|0|||
124930970|NCT02240238|449376924|FG011|Phase 1|Adverse Event|0|||
124930971|NCT02240238|449376913|FG000|Phase 1|Death|0|||
124930972|NCT02240238|449376914|FG001|Phase 1|Death|0|||
124930973|NCT02240238|449376915|FG002|Phase 1|Death|0|||
124930974|NCT02240238|449376916|FG003|Phase 1|Death|0|||
124930975|NCT02240238|449376917|FG004|Phase 1|Death|0|||
124930976|NCT02240238|449376918|FG005|Phase 1|Death|1|||
124455655|NCT01838616|447628817|FG001|Pick-up Arm|Technical problems|0|||
124930977|NCT02240238|449376919|FG006|Phase 1|Death|0|||
124930978|NCT02240238|449376920|FG007|Phase 1|Death|0|||
124930979|NCT02240238|449376921|FG008|Phase 1|Death|0|||
124930980|NCT02240238|449376922|FG009|Phase 1|Death|0|||
124930981|NCT02240238|449376923|FG010|Phase 1|Death|0|||
124930982|NCT02240238|449376924|FG011|Phase 1|Death|0|||
124930983|NCT02240238|449376913|FG000|Phase 1|Sponsor termination|0|||
124930984|NCT02240238|449376914|FG001|Phase 1|Sponsor termination|0|||
124930985|NCT02240238|449376915|FG002|Phase 1|Sponsor termination|0|||
124930986|NCT02240238|449376916|FG003|Phase 1|Sponsor termination|0|||
124930987|NCT02240238|449376917|FG004|Phase 1|Sponsor termination|0|||
124930988|NCT02240238|449376918|FG005|Phase 1|Sponsor termination|1|||
124930989|NCT02240238|449376919|FG006|Phase 1|Sponsor termination|0|||
124930990|NCT02240238|449376920|FG007|Phase 1|Sponsor termination|0|||
124930991|NCT02240238|449376921|FG008|Phase 1|Sponsor termination|0|||
124930992|NCT02240238|449376922|FG009|Phase 1|Sponsor termination|0|||
124930993|NCT02240238|449376923|FG010|Phase 1|Sponsor termination|0|||
124930994|NCT02240238|449376924|FG011|Phase 1|Sponsor termination|0|||
124930995|NCT02240238|449376913|FG000|Phase 1|Withdrawal by Subject|0|||
124930996|NCT02240238|449376914|FG001|Phase 1|Withdrawal by Subject|0|||
124930997|NCT02240238|449376915|FG002|Phase 1|Withdrawal by Subject|0|||
124930998|NCT02240238|449376916|FG003|Phase 1|Withdrawal by Subject|0|||
124930999|NCT02240238|449376917|FG004|Phase 1|Withdrawal by Subject|0|||
124931000|NCT02240238|449376918|FG005|Phase 1|Withdrawal by Subject|2|||
124931001|NCT02240238|449376919|FG006|Phase 1|Withdrawal by Subject|0|||
124931002|NCT02240238|449376920|FG007|Phase 1|Withdrawal by Subject|0|||
124931003|NCT02240238|449376921|FG008|Phase 1|Withdrawal by Subject|0|||
124931004|NCT02240238|449376922|FG009|Phase 1|Withdrawal by Subject|0|||
124931005|NCT02240238|449376923|FG010|Phase 1|Withdrawal by Subject|0|||
124931006|NCT02240238|449376924|FG011|Phase 1|Withdrawal by Subject|0|||
124931007|NCT02240238|449376913|FG000|Phase 1|Physician Decision|0|||
124931008|NCT02240238|449376914|FG001|Phase 1|Physician Decision|0|||
124931009|NCT02240238|449376915|FG002|Phase 1|Physician Decision|0|||
124931010|NCT02240238|449376916|FG003|Phase 1|Physician Decision|0|||
124931011|NCT02240238|449376917|FG004|Phase 1|Physician Decision|0|||
124931012|NCT02240238|449376918|FG005|Phase 1|Physician Decision|2|||
124931013|NCT02240238|449376919|FG006|Phase 1|Physician Decision|0|||
124931014|NCT02240238|449376920|FG007|Phase 1|Physician Decision|0|||
124931015|NCT02240238|449376921|FG008|Phase 1|Physician Decision|0|||
124931016|NCT02240238|449376922|FG009|Phase 1|Physician Decision|0|||
124931017|NCT02240238|449376923|FG010|Phase 1|Physician Decision|0|||
124931018|NCT02240238|449376924|FG011|Phase 1|Physician Decision|0|||
124931019|NCT02240238|449376913|FG000|Phase 2|Adverse Event|0|||
124931020|NCT02240238|449376914|FG001|Phase 2|Adverse Event|0|||
124931021|NCT02240238|449376915|FG002|Phase 2|Adverse Event|0|||
124931022|NCT02240238|449376916|FG003|Phase 2|Adverse Event|0|||
124931023|NCT02240238|449376917|FG004|Phase 2|Adverse Event|0|||
124931024|NCT02240238|449376918|FG005|Phase 2|Adverse Event|0|||
124931025|NCT02240238|449376919|FG006|Phase 2|Adverse Event|0|||
124931026|NCT02240238|449376920|FG007|Phase 2|Adverse Event|0|||
124931027|NCT02240238|449376921|FG008|Phase 2|Adverse Event|0|||
124931028|NCT02240238|449376922|FG009|Phase 2|Adverse Event|7|||
124931029|NCT02240238|449376923|FG010|Phase 2|Adverse Event|14|||
124931030|NCT02240238|449376924|FG011|Phase 2|Adverse Event|2|||
124931031|NCT02240238|449376913|FG000|Phase 2|Death|0|||
124931032|NCT02240238|449376914|FG001|Phase 2|Death|0|||
124931033|NCT02240238|449376915|FG002|Phase 2|Death|0|||
124931034|NCT02240238|449376916|FG003|Phase 2|Death|0|||
124931035|NCT02240238|449376917|FG004|Phase 2|Death|0|||
124931036|NCT02240238|449376918|FG005|Phase 2|Death|0|||
124931037|NCT02240238|449376919|FG006|Phase 2|Death|0|||
124455656|NCT00840086|447628818|FG000|Overall Study|Adverse Event|1|||
124455657|NCT00840086|447628818|FG000|Overall Study|Protocol Violation|2|||
124931038|NCT02240238|449376920|FG007|Phase 2|Death|0|||
124931039|NCT02240238|449376921|FG008|Phase 2|Death|0|||
124931040|NCT02240238|449376922|FG009|Phase 2|Death|3|||
124931041|NCT02240238|449376923|FG010|Phase 2|Death|2|||
124931042|NCT02240238|449376924|FG011|Phase 2|Death|1|||
124931043|NCT02240238|449376913|FG000|Phase 2|Disease progression|0|||
124931044|NCT02240238|449376914|FG001|Phase 2|Disease progression|0|||
124931045|NCT02240238|449376915|FG002|Phase 2|Disease progression|0|||
124931046|NCT02240238|449376916|FG003|Phase 2|Disease progression|0|||
124931047|NCT02240238|449376917|FG004|Phase 2|Disease progression|0|||
124931048|NCT02240238|449376918|FG005|Phase 2|Disease progression|0|||
124931049|NCT02240238|449376919|FG006|Phase 2|Disease progression|0|||
124931050|NCT02240238|449376920|FG007|Phase 2|Disease progression|0|||
124931051|NCT02240238|449376921|FG008|Phase 2|Disease progression|0|||
124931052|NCT02240238|449376922|FG009|Phase 2|Disease progression|5|||
124931053|NCT02240238|449376923|FG010|Phase 2|Disease progression|11|||
124931054|NCT02240238|449376924|FG011|Phase 2|Disease progression|1|||
124931055|NCT02240238|449376913|FG000|Phase 2|Withdrawal by Subject|0|||
124931056|NCT02240238|449376914|FG001|Phase 2|Withdrawal by Subject|0|||
124931057|NCT02240238|449376915|FG002|Phase 2|Withdrawal by Subject|0|||
124931058|NCT02240238|449376916|FG003|Phase 2|Withdrawal by Subject|0|||
124931059|NCT02240238|449376917|FG004|Phase 2|Withdrawal by Subject|0|||
124931060|NCT02240238|449376918|FG005|Phase 2|Withdrawal by Subject|0|||
124931061|NCT02240238|449376919|FG006|Phase 2|Withdrawal by Subject|0|||
124931062|NCT02240238|449376920|FG007|Phase 2|Withdrawal by Subject|0|||
124931063|NCT02240238|449376921|FG008|Phase 2|Withdrawal by Subject|0|||
124931064|NCT02240238|449376922|FG009|Phase 2|Withdrawal by Subject|1|||
124931065|NCT02240238|449376923|FG010|Phase 2|Withdrawal by Subject|1|||
124931066|NCT02240238|449376924|FG011|Phase 2|Withdrawal by Subject|0|||
124931067|NCT02240238|449376913|FG000|Phase 2|Physician Decision|0|||
124931068|NCT02240238|449376914|FG001|Phase 2|Physician Decision|0|||
124931069|NCT02240238|449376915|FG002|Phase 2|Physician Decision|0|||
124931070|NCT02240238|449376916|FG003|Phase 2|Physician Decision|0|||
124931071|NCT02240238|449376917|FG004|Phase 2|Physician Decision|0|||
124931072|NCT02240238|449376918|FG005|Phase 2|Physician Decision|0|||
124931073|NCT02240238|449376919|FG006|Phase 2|Physician Decision|0|||
124931074|NCT02240238|449376920|FG007|Phase 2|Physician Decision|0|||
124931075|NCT02240238|449376921|FG008|Phase 2|Physician Decision|0|||
124931076|NCT02240238|449376922|FG009|Phase 2|Physician Decision|1|||
124931077|NCT02240238|449376923|FG010|Phase 2|Physician Decision|3|||
124931078|NCT02240238|449376924|FG011|Phase 2|Physician Decision|0|||
124931079|NCT02240238|449376913|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931080|NCT02240238|449376914|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931081|NCT02240238|449376915|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931082|NCT02240238|449376916|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931083|NCT02240238|449376917|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931084|NCT02240238|449376918|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931085|NCT02240238|449376919|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931086|NCT02240238|449376920|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931087|NCT02240238|449376921|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931088|NCT02240238|449376922|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
124931089|NCT02240238|449376923|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931090|NCT02240238|449376924|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
124931091|NCT02240238|449376913|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931092|NCT02240238|449376914|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931093|NCT02240238|449376915|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931094|NCT02240238|449376916|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931095|NCT02240238|449376917|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931096|NCT02240238|449376918|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931097|NCT02240238|449376919|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931098|NCT02240238|449376920|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931099|NCT02240238|449376921|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931100|NCT02240238|449376922|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
124931101|NCT02240238|449376923|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931102|NCT02240238|449376924|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
124931103|NCT02240238|449376913|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931104|NCT02240238|449376914|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931105|NCT02240238|449376915|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931106|NCT02240238|449376916|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931107|NCT02240238|449376917|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931108|NCT02240238|449376918|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931109|NCT02240238|449376919|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931110|NCT02240238|449376920|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931111|NCT02240238|449376921|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931112|NCT02240238|449376922|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124931113|NCT02240238|449376923|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
124931114|NCT02240238|449376924|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
124455658|NCT00840086|447628818|FG000|Overall Study|Lost to Follow-up|1|||
124455659|NCT03332498|447628819|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
124455660|NCT03332498|447628820|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
124455661|NCT03332498|447628821|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
124455662|NCT01566773|447628822|FG000|Overall Study|Protocol specified criteria|4|||
124455663|NCT01566773|447628822|FG000|Overall Study|Protocol Violation|4|||
124931115|NCT02240238|449376913|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931116|NCT02240238|449376914|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931117|NCT02240238|449376915|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931118|NCT02240238|449376916|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931119|NCT02240238|449376917|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931120|NCT02240238|449376918|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931121|NCT02240238|449376919|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931122|NCT02240238|449376920|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931123|NCT02240238|449376921|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931124|NCT02240238|449376922|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931125|NCT02240238|449376923|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
124764864|NCT03284710|448765022|FG000|Overall Study|HIV Infection|0|||
124764865|NCT03284710|448765023|FG001|Overall Study|HIV Infection|2|||
124764866|NCT03284710|448765024|FG002|Overall Study|HIV Infection|2|||
124931126|NCT02240238|449376924|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
124931127|NCT02240238|449376913|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931128|NCT02240238|449376914|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931129|NCT02240238|449376915|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931130|NCT02240238|449376916|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931131|NCT02240238|449376917|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931132|NCT02240238|449376918|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931133|NCT02240238|449376919|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931134|NCT02240238|449376920|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931135|NCT02240238|449376921|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931136|NCT02240238|449376922|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931137|NCT02240238|449376923|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
124931138|NCT02240238|449376924|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
124931139|NCT02240238|449376913|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931140|NCT02240238|449376914|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931141|NCT02240238|449376915|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931142|NCT02240238|449376916|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931143|NCT02240238|449376917|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931144|NCT02240238|449376918|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931145|NCT02240238|449376919|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931146|NCT02240238|449376920|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931147|NCT02240238|449376921|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931148|NCT02240238|449376922|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931149|NCT02240238|449376923|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
124931150|NCT02240238|449376924|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
124931151|NCT02240238|449376913|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931152|NCT02240238|449376914|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931153|NCT02240238|449376915|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931154|NCT02240238|449376916|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931155|NCT02240238|449376917|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931156|NCT02240238|449376918|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931157|NCT02240238|449376919|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931158|NCT02240238|449376920|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931159|NCT02240238|449376921|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931160|NCT02240238|449376922|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931161|NCT02240238|449376923|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
124931162|NCT02240238|449376924|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
124931163|NCT02240238|449376913|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931164|NCT02240238|449376914|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931165|NCT02240238|449376915|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931166|NCT02240238|449376916|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931167|NCT02240238|449376917|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931168|NCT02240238|449376918|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931169|NCT02240238|449376919|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931170|NCT02240238|449376920|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931171|NCT02240238|449376921|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931172|NCT02240238|449376922|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124764867|NCT03284710|448765025|FG003|Overall Study|HIV Infection|1|||
124764868|NCT02412306|448765028|FG000|Overall Study|Lost to Follow-up|0|||
124931173|NCT02240238|449376923|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
124931174|NCT02240238|449376924|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
124931175|NCT03476343|449376934|FG000|Overall Study|Clinical exam moved to another scanner|7|||
124931176|NCT03476343|449376934|FG000|Overall Study|Clinical order cancelled|4|||
124931177|NCT03476343|449376934|FG000|Overall Study|Neonate did not settle down for the scan|1|||
124931178|NCT03088878|449376935|FG000|Overall Study|Adverse Event|0|||
124931179|NCT03088878|449376936|FG001|Overall Study|Adverse Event|0|||
124931180|NCT03088878|449376937|FG002|Overall Study|Adverse Event|0|||
124931181|NCT03088878|449376938|FG003|Overall Study|Adverse Event|0|||
124931182|NCT03088878|449376939|FG004|Overall Study|Adverse Event|4|||
124931183|NCT03088878|449376940|FG005|Overall Study|Adverse Event|2|||
124931184|NCT03088878|449376941|FG006|Overall Study|Adverse Event|1|||
124931185|NCT03088878|449376942|FG007|Overall Study|Adverse Event|0|||
124931186|NCT03088878|449376943|FG008|Overall Study|Adverse Event|0|||
124931187|NCT03088878|449376944|FG009|Overall Study|Adverse Event|0|||
124931188|NCT03088878|449376945|FG010|Overall Study|Adverse Event|0|||
124931189|NCT03088878|449376946|FG011|Overall Study|Adverse Event|0|||
124931190|NCT03088878|449376947|FG012|Overall Study|Adverse Event|5|||
124931191|NCT03088878|449376948|FG013|Overall Study|Adverse Event|3|||
124931192|NCT03088878|449376935|FG000|Overall Study|Clinical Progression|0|||
124931193|NCT03088878|449376936|FG001|Overall Study|Clinical Progression|0|||
124931194|NCT03088878|449376937|FG002|Overall Study|Clinical Progression|0|||
124931195|NCT03088878|449376938|FG003|Overall Study|Clinical Progression|0|||
124931196|NCT03088878|449376939|FG004|Overall Study|Clinical Progression|2|||
124931197|NCT03088878|449376940|FG005|Overall Study|Clinical Progression|0|||
124931198|NCT03088878|449376941|FG006|Overall Study|Clinical Progression|0|||
124931199|NCT03088878|449376942|FG007|Overall Study|Clinical Progression|0|||
124931200|NCT03088878|449376943|FG008|Overall Study|Clinical Progression|0|||
124931201|NCT03088878|449376944|FG009|Overall Study|Clinical Progression|0|||
124931202|NCT03088878|449376945|FG010|Overall Study|Clinical Progression|0|||
124931203|NCT03088878|449376946|FG011|Overall Study|Clinical Progression|0|||
124931204|NCT03088878|449376947|FG012|Overall Study|Clinical Progression|0|||
124931205|NCT03088878|449376948|FG013|Overall Study|Clinical Progression|0|||
124931206|NCT03088878|449376935|FG000|Overall Study|Death|0|||
124931207|NCT03088878|449376936|FG001|Overall Study|Death|0|||
124931208|NCT03088878|449376937|FG002|Overall Study|Death|0|||
124931209|NCT03088878|449376938|FG003|Overall Study|Death|0|||
124931210|NCT03088878|449376939|FG004|Overall Study|Death|2|||
124931211|NCT03088878|449376940|FG005|Overall Study|Death|0|||
124931212|NCT03088878|449376941|FG006|Overall Study|Death|0|||
124931213|NCT03088878|449376942|FG007|Overall Study|Death|0|||
124931214|NCT03088878|449376943|FG008|Overall Study|Death|0|||
124931215|NCT03088878|449376944|FG009|Overall Study|Death|0|||
124931216|NCT03088878|449376945|FG010|Overall Study|Death|0|||
124931217|NCT03088878|449376946|FG011|Overall Study|Death|1|||
124931218|NCT03088878|449376947|FG012|Overall Study|Death|0|||
124931219|NCT03088878|449376948|FG013|Overall Study|Death|0|||
124931220|NCT03088878|449376935|FG000|Overall Study|Disease Progression|1|||
124931221|NCT03088878|449376936|FG001|Overall Study|Disease Progression|2|||
124931222|NCT03088878|449376937|FG002|Overall Study|Disease Progression|3|||
124931223|NCT03088878|449376938|FG003|Overall Study|Disease Progression|0|||
124931224|NCT03088878|449376939|FG004|Overall Study|Disease Progression|3|||
124931225|NCT03088878|449376940|FG005|Overall Study|Disease Progression|0|||
124931226|NCT03088878|449376941|FG006|Overall Study|Disease Progression|0|||
124931227|NCT03088878|449376942|FG007|Overall Study|Disease Progression|0|||
124931228|NCT03088878|449376943|FG008|Overall Study|Disease Progression|0|||
124931229|NCT03088878|449376944|FG009|Overall Study|Disease Progression|0|||
124931230|NCT03088878|449376945|FG010|Overall Study|Disease Progression|0|||
124931231|NCT03088878|449376946|FG011|Overall Study|Disease Progression|0|||
124931232|NCT03088878|449376947|FG012|Overall Study|Disease Progression|1|||
124931233|NCT03088878|449376948|FG013|Overall Study|Disease Progression|1|||
124931234|NCT03088878|449376935|FG000|Overall Study|Initiation of Alternative Treatment|0|||
124931235|NCT03088878|449376936|FG001|Overall Study|Initiation of Alternative Treatment|0|||
124931236|NCT03088878|449376937|FG002|Overall Study|Initiation of Alternative Treatment|0|||
124931237|NCT03088878|449376938|FG003|Overall Study|Initiation of Alternative Treatment|1|||
124931238|NCT03088878|449376939|FG004|Overall Study|Initiation of Alternative Treatment|0|||
124931239|NCT03088878|449376940|FG005|Overall Study|Initiation of Alternative Treatment|0|||
124931240|NCT03088878|449376941|FG006|Overall Study|Initiation of Alternative Treatment|0|||
124931241|NCT03088878|449376942|FG007|Overall Study|Initiation of Alternative Treatment|1|||
124931242|NCT03088878|449376943|FG008|Overall Study|Initiation of Alternative Treatment|1|||
124931243|NCT03088878|449376944|FG009|Overall Study|Initiation of Alternative Treatment|0|||
124931244|NCT03088878|449376945|FG010|Overall Study|Initiation of Alternative Treatment|0|||
124931245|NCT03088878|449376946|FG011|Overall Study|Initiation of Alternative Treatment|0|||
124931246|NCT03088878|449376947|FG012|Overall Study|Initiation of Alternative Treatment|0|||
124931247|NCT03088878|449376948|FG013|Overall Study|Initiation of Alternative Treatment|0|||
124931248|NCT03088878|449376935|FG000|Overall Study|Withdrawal by Subject|0|||
124931249|NCT03088878|449376936|FG001|Overall Study|Withdrawal by Subject|0|||
124931250|NCT03088878|449376937|FG002|Overall Study|Withdrawal by Subject|0|||
124931251|NCT03088878|449376938|FG003|Overall Study|Withdrawal by Subject|1|||
124931252|NCT03088878|449376939|FG004|Overall Study|Withdrawal by Subject|4|||
124931253|NCT03088878|449376940|FG005|Overall Study|Withdrawal by Subject|1|||
124931254|NCT03088878|449376941|FG006|Overall Study|Withdrawal by Subject|1|||
124931255|NCT03088878|449376942|FG007|Overall Study|Withdrawal by Subject|0|||
124931256|NCT03088878|449376943|FG008|Overall Study|Withdrawal by Subject|1|||
124931257|NCT03088878|449376944|FG009|Overall Study|Withdrawal by Subject|2|||
124931258|NCT03088878|449376945|FG010|Overall Study|Withdrawal by Subject|0|||
124931259|NCT03088878|449376946|FG011|Overall Study|Withdrawal by Subject|2|||
124931260|NCT03088878|449376947|FG012|Overall Study|Withdrawal by Subject|1|||
124931261|NCT03088878|449376948|FG013|Overall Study|Withdrawal by Subject|0|||
124931262|NCT03088878|449376935|FG000|Overall Study|Terminated by Sponsor|2|||
124931263|NCT03088878|449376936|FG001|Overall Study|Terminated by Sponsor|1|||
124931264|NCT03088878|449376937|FG002|Overall Study|Terminated by Sponsor|0|||
124931265|NCT03088878|449376938|FG003|Overall Study|Terminated by Sponsor|1|||
124931266|NCT03088878|449376939|FG004|Overall Study|Terminated by Sponsor|6|||
124931267|NCT03088878|449376940|FG005|Overall Study|Terminated by Sponsor|0|||
124931268|NCT03088878|449376941|FG006|Overall Study|Terminated by Sponsor|0|||
124931269|NCT03088878|449376942|FG007|Overall Study|Terminated by Sponsor|0|||
124931270|NCT03088878|449376943|FG008|Overall Study|Terminated by Sponsor|0|||
124931271|NCT03088878|449376944|FG009|Overall Study|Terminated by Sponsor|0|||
124931272|NCT03088878|449376945|FG010|Overall Study|Terminated by Sponsor|3|||
124931273|NCT03088878|449376946|FG011|Overall Study|Terminated by Sponsor|13|||
124931274|NCT03088878|449376947|FG012|Overall Study|Terminated by Sponsor|2|||
124931275|NCT03088878|449376948|FG013|Overall Study|Terminated by Sponsor|1|||
124931276|NCT03088878|449376935|FG000|Overall Study|Completed 2 years of Treatment|0|||
124931277|NCT03088878|449376936|FG001|Overall Study|Completed 2 years of Treatment|0|||
124931278|NCT03088878|449376937|FG002|Overall Study|Completed 2 years of Treatment|0|||
124931279|NCT03088878|449376938|FG003|Overall Study|Completed 2 years of Treatment|0|||
124931280|NCT03088878|449376939|FG004|Overall Study|Completed 2 years of Treatment|0|||
124931281|NCT03088878|449376940|FG005|Overall Study|Completed 2 years of Treatment|0|||
124931282|NCT03088878|449376941|FG006|Overall Study|Completed 2 years of Treatment|1|||
124931283|NCT03088878|449376942|FG007|Overall Study|Completed 2 years of Treatment|0|||
124931284|NCT03088878|449376943|FG008|Overall Study|Completed 2 years of Treatment|0|||
124931285|NCT03088878|449376944|FG009|Overall Study|Completed 2 years of Treatment|1|||
124931286|NCT03088878|449376945|FG010|Overall Study|Completed 2 years of Treatment|0|||
124931287|NCT03088878|449376946|FG011|Overall Study|Completed 2 years of Treatment|0|||
124931288|NCT03088878|449376947|FG012|Overall Study|Completed 2 years of Treatment|8|||
124931289|NCT03088878|449376948|FG013|Overall Study|Completed 2 years of Treatment|3|||
124931290|NCT03088878|449376935|FG000|Overall Study|Physician Decision|0|||
124931291|NCT03088878|449376936|FG001|Overall Study|Physician Decision|0|||
124931292|NCT03088878|449376937|FG002|Overall Study|Physician Decision|0|||
124931293|NCT03088878|449376938|FG003|Overall Study|Physician Decision|0|||
124931294|NCT03088878|449376939|FG004|Overall Study|Physician Decision|0|||
124931295|NCT03088878|449376940|FG005|Overall Study|Physician Decision|0|||
124931296|NCT03088878|449376941|FG006|Overall Study|Physician Decision|0|||
124931297|NCT03088878|449376942|FG007|Overall Study|Physician Decision|2|||
124931298|NCT03088878|449376943|FG008|Overall Study|Physician Decision|1|||
124931299|NCT03088878|449376944|FG009|Overall Study|Physician Decision|0|||
124931300|NCT03088878|449376945|FG010|Overall Study|Physician Decision|0|||
124931301|NCT03088878|449376946|FG011|Overall Study|Physician Decision|0|||
124931302|NCT03088878|449376947|FG012|Overall Study|Physician Decision|0|||
124931303|NCT03088878|449376948|FG013|Overall Study|Physician Decision|1|||
124931304|NCT03088878|449376935|FG000|Overall Study|COVID Related noncompliance|0|||
124931305|NCT03088878|449376936|FG001|Overall Study|COVID Related noncompliance|0|||
124931306|NCT03088878|449376937|FG002|Overall Study|COVID Related noncompliance|0|||
124931307|NCT03088878|449376938|FG003|Overall Study|COVID Related noncompliance|0|||
124931308|NCT03088878|449376939|FG004|Overall Study|COVID Related noncompliance|0|||
124931309|NCT03088878|449376940|FG005|Overall Study|COVID Related noncompliance|0|||
124931310|NCT03088878|449376941|FG006|Overall Study|COVID Related noncompliance|0|||
124931311|NCT03088878|449376942|FG007|Overall Study|COVID Related noncompliance|0|||
124931312|NCT03088878|449376943|FG008|Overall Study|COVID Related noncompliance|0|||
124931313|NCT03088878|449376944|FG009|Overall Study|COVID Related noncompliance|0|||
124931314|NCT03088878|449376945|FG010|Overall Study|COVID Related noncompliance|0|||
124931315|NCT03088878|449376946|FG011|Overall Study|COVID Related noncompliance|0|||
124931316|NCT03088878|449376947|FG012|Overall Study|COVID Related noncompliance|0|||
124931317|NCT03088878|449376948|FG013|Overall Study|COVID Related noncompliance|1|||
124931318|NCT03088878|449376935|FG000|Overall Study|Drug or Study Noncompliance|0|||
124931319|NCT03088878|449376936|FG001|Overall Study|Drug or Study Noncompliance|0|||
124931320|NCT03088878|449376937|FG002|Overall Study|Drug or Study Noncompliance|0|||
124931321|NCT03088878|449376938|FG003|Overall Study|Drug or Study Noncompliance|0|||
124931322|NCT03088878|449376939|FG004|Overall Study|Drug or Study Noncompliance|0|||
124931323|NCT03088878|449376940|FG005|Overall Study|Drug or Study Noncompliance|0|||
124931324|NCT03088878|449376941|FG006|Overall Study|Drug or Study Noncompliance|0|||
124931325|NCT03088878|449376942|FG007|Overall Study|Drug or Study Noncompliance|0|||
124931326|NCT03088878|449376943|FG008|Overall Study|Drug or Study Noncompliance|0|||
124931327|NCT03088878|449376944|FG009|Overall Study|Drug or Study Noncompliance|0|||
124931328|NCT03088878|449376945|FG010|Overall Study|Drug or Study Noncompliance|0|||
124931329|NCT03088878|449376946|FG011|Overall Study|Drug or Study Noncompliance|0|||
124931330|NCT03088878|449376947|FG012|Overall Study|Drug or Study Noncompliance|1|||
124931331|NCT03088878|449376948|FG013|Overall Study|Drug or Study Noncompliance|0|||
124931332|NCT01221948|449376967|FG000|Overall Study|Physician Decision|5|||
124931333|NCT01221948|449376967|FG000|Overall Study|Withdrawal by Subject|2|||
124931334|NCT01221948|449376967|FG000|Overall Study|not disclosed|2|||
124931335|NCT01221948|449376967|FG000|Overall Study|Death|1|||
124931336|NCT01221948|449376967|FG000|Overall Study|Protocol Violation|4|||
124931337|NCT00746096|449376968|FG000|Overall Study|Adverse Event|1|||
124931338|NCT00746096|449376969|FG001|Overall Study|Adverse Event|0|||
124931339|NCT00746096|449376968|FG000|Overall Study|Withdrawal by Subject|5|||
124931340|NCT00746096|449376969|FG001|Overall Study|Withdrawal by Subject|1|||
124931341|NCT00746096|449376968|FG000|Overall Study|Lost to Follow-up|2|||
124931342|NCT00746096|449376969|FG001|Overall Study|Lost to Follow-up|1|||
124931343|NCT00746096|449376968|FG000|Overall Study|Protocol Violation|1|||
124931344|NCT00746096|449376969|FG001|Overall Study|Protocol Violation|0|||
124931345|NCT00746096|449376968|FG000|Overall Study|No study drug treatment|1|||
124931346|NCT00746096|449376969|FG001|Overall Study|No study drug treatment|1|||
124931347|NCT04059185|449376970|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
124931348|NCT04059185|449376971|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
124931349|NCT04059185|449376972|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
124931350|NCT04059185|449376970|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
124931351|NCT04059185|449376971|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
124931352|NCT04059185|449376972|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
124931353|NCT04059185|449376970|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
124931354|NCT04059185|449376971|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
124931355|NCT04059185|449376972|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
124931356|NCT04059185|449376970|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
124931357|NCT04059185|449376971|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
124931358|NCT04059185|449376972|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
124931359|NCT04059185|449376970|FG000|Longitudinal Assessment-Adults Only|Death|4|||
124931360|NCT04059185|449376971|FG001|Longitudinal Assessment-Adults Only|Death|4|||
124931361|NCT04059185|449376972|FG002|Longitudinal Assessment-Adults Only|Death|3|||
124931362|NCT03756662|449376973|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
124931363|NCT03295721|449376981|FG000|Overall Study|Adverse Event|1|||
124931364|NCT03295721|449376982|FG001|Overall Study|Adverse Event|0|||
124931365|NCT03295721|449376983|FG002|Overall Study|Adverse Event|0|||
124931366|NCT03295721|449376981|FG000|Overall Study|Lost to Follow-up|1|||
124931367|NCT03295721|449376982|FG001|Overall Study|Lost to Follow-up|1|||
124455664|NCT01566773|447628822|FG000|Overall Study|Withdrawal by Subject|9|||
124455665|NCT01566773|447628822|FG000|Overall Study|Administrative reason|1|||
124455666|NCT01566773|447628822|FG000|Overall Study|Adverse Event|10|||
124455667|NCT01566773|447628822|FG000|Overall Study|Physician Decision|2|||
124455668|NCT04036708|447628823|FG000|Overall Study|Lost to Follow-up|14|||
124455669|NCT04036708|447628824|FG001|Overall Study|Lost to Follow-up|4|||
124455670|NCT04036708|447628825|FG002|Overall Study|Lost to Follow-up|14|||
124455671|NCT04036708|447628826|FG003|Overall Study|Lost to Follow-up|4|||
124455672|NCT01033734|447628827|FG000|Overall Study|Withdrawal by Subject|1|||
124455673|NCT01444742|447628830|FG000|Overall Study|Death|1|||
124455674|NCT02535715|447628831|FG000|Overall Study|Withdrawal by Subject|0|||
124455675|NCT02535715|447628832|FG001|Overall Study|Withdrawal by Subject|0|||
124455676|NCT02535715|447628833|FG002|Overall Study|Withdrawal by Subject|1|||
124455677|NCT00909181|447628834|FG000|Overall Study|Lost to Follow-up|39|||
124455678|NCT00909181|447628835|FG001|Overall Study|Lost to Follow-up|18|||
124455679|NCT00909181|447628836|FG002|Overall Study|Lost to Follow-up|33|||
124455680|NCT02349048|447628840|FG000|Overall Study|Withdrawal by Subject|4|||
124455681|NCT02349048|447628841|FG001|Overall Study|Withdrawal by Subject|0|||
124455682|NCT02349048|447628840|FG000|Overall Study|Lost to Follow-up|1|||
124455683|NCT02349048|447628841|FG001|Overall Study|Lost to Follow-up|0|||
124455684|NCT00094770|447628844|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
124455685|NCT00094770|447628845|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
124455686|NCT00094770|447628844|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
124455687|NCT00094770|447628845|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
124455688|NCT00094770|447628844|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
124455689|NCT00094770|447628845|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
124455690|NCT00094770|447628844|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
124455691|NCT00094770|447628845|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
124455692|NCT00094770|447628844|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
124455693|NCT00094770|447628845|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
124455694|NCT00094770|447628844|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
124455695|NCT00094770|447628845|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
124931368|NCT03295721|449376983|FG002|Overall Study|Lost to Follow-up|1|||
124931369|NCT03295721|449376981|FG000|Overall Study|Withdrawal by Subject|1|||
124931370|NCT03295721|449376982|FG001|Overall Study|Withdrawal by Subject|0|||
124931371|NCT03295721|449376983|FG002|Overall Study|Withdrawal by Subject|1|||
124931372|NCT03295721|449376981|FG000|Overall Study|Death|0|||
124931373|NCT03295721|449376982|FG001|Overall Study|Death|0|||
124931374|NCT03295721|449376983|FG002|Overall Study|Death|1|||
124931375|NCT03325985|449376986|FG000|Overall Study|Lost to Follow-up|122|||
124931376|NCT03325985|449376987|FG001|Overall Study|Lost to Follow-up|26|||
124931377|NCT03325985|449376988|FG002|Overall Study|Lost to Follow-up|141|||
124931378|NCT03325985|449376989|FG003|Overall Study|Lost to Follow-up|28|||
124931379|NCT03325985|449376986|FG000|Overall Study|Death|99|||
124931380|NCT03325985|449376987|FG001|Overall Study|Death|36|||
124931381|NCT03325985|449376988|FG002|Overall Study|Death|94|||
124931382|NCT03325985|449376989|FG003|Overall Study|Death|32|||
124931383|NCT02684227|449376991|FG000|Overall Study|Adverse Event|1|||
124931384|NCT02684227|449376992|FG001|Overall Study|Adverse Event|7|||
124931385|NCT02684227|449376991|FG000|Overall Study|Death|0|||
124931386|NCT02684227|449376992|FG001|Overall Study|Death|2|||
124931387|NCT02684227|449376991|FG000|Overall Study|Withdrawal by Subject|0|||
124931388|NCT02684227|449376992|FG001|Overall Study|Withdrawal by Subject|1|||
124931389|NCT02684227|449376991|FG000|Overall Study|Progressive Disease|0|||
124931390|NCT02684227|449376992|FG001|Overall Study|Progressive Disease|2|||
124931391|NCT03606408|449376993|FG000|Overall Study|Adverse Event|13|||
124931392|NCT03606408|449376993|FG000|Overall Study|Withdrawal by Subject|7|||
124931393|NCT03606408|449376993|FG000|Overall Study|Physician Decision|4|||
124455696|NCT00094770|447628844|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
124455697|NCT00094770|447628845|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
124455698|NCT00094770|447628844|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
124455699|NCT00094770|447628845|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
124455700|NCT00094770|447628844|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
124455701|NCT00094770|447628845|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
124455702|NCT00094770|447628844|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
124455703|NCT00094770|447628845|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
124455704|NCT00094770|447628844|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
124455705|NCT00094770|447628845|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
124931394|NCT03606408|449376993|FG000|Overall Study|Lack of Efficacy|2|||
124931395|NCT03606408|449376993|FG000|Overall Study|Death|1|||
124931396|NCT03606408|449376993|FG000|Overall Study|new therapy for study indication|1|||
124931397|NCT03556293|449376994|FG000|Overall Study|Ineligible for analysis|1904|||
124931398|NCT03556293|449376995|FG001|Overall Study|Ineligible for analysis|1471|||
124931399|NCT03556293|449376996|FG002|Overall Study|Ineligible for analysis|1091|||
124931400|NCT03556293|449376997|FG003|Overall Study|Ineligible for analysis|1269|||
124931401|NCT05828017|449377004|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
124931402|NCT05012163|449377005|FG000|Overall Study|Protocol Violation|0|||
124931403|NCT05012163|449377006|FG001|Overall Study|Protocol Violation|0|||
124931404|NCT05012163|449377007|FG002|Overall Study|Protocol Violation|1|||
124931405|NCT05012163|449377008|FG003|Overall Study|Protocol Violation|1|||
124931406|NCT04132518|449377015|FG000|Overall Study|Prematurely withdrawn from the study|0|||
124931407|NCT04132518|449377016|FG001|Overall Study|Prematurely withdrawn from the study|9|||
124931408|NCT04132518|449377017|FG002|Overall Study|Prematurely withdrawn from the study|1|||
124931409|NCT05524402|449377019|FG000|Overall Study|Withdrawal by Subject|3|||
124931410|NCT05524402|449377020|FG001|Overall Study|Withdrawal by Subject|1|||
124931411|NCT05524402|449377019|FG000|Overall Study|Lost to Follow-up|2|||
124931412|NCT05524402|449377020|FG001|Overall Study|Lost to Follow-up|1|||
124931413|NCT04428203|449377021|FG000|Overall Study|Adverse Event|1|||
124931414|NCT04428203|449377022|FG001|Overall Study|Adverse Event|0|||
124931415|NCT04428203|449377023|FG002|Overall Study|Adverse Event|0|||
124931416|NCT04428203|449377021|FG000|Overall Study|Withdrawal by Subject|1|||
124931417|NCT04428203|449377022|FG001|Overall Study|Withdrawal by Subject|0|||
124931418|NCT04428203|449377023|FG002|Overall Study|Withdrawal by Subject|1|||
124931419|NCT03308877|449378296|FG000|Overall Study|Lost to Follow-up|32|||
124931420|NCT03308877|449378297|FG001|Overall Study|Lost to Follow-up|28|||
124931421|NCT04359654|449378306|FG000|Overall Study|Withdrawal by Subject|1|||
124931422|NCT04359654|449378307|FG001|Overall Study|Withdrawal by Subject|0|||
124931423|NCT04359654|449378306|FG000|Overall Study|Adverse Event|0|||
124931424|NCT04359654|449378307|FG001|Overall Study|Adverse Event|1|||
124931425|NCT05863156|449378309|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
124931426|NCT05863156|449378310|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
124931427|NCT05863156|449378311|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
124931428|NCT05216406|449378312|FG000|Overall Study|Lost to Follow-up|8|||
124931429|NCT05216406|449378313|FG001|Overall Study|Lost to Follow-up|9|||
124931430|NCT04690582|449378316|FG000|Overall Study|Withdrawal by Subject|6|||
124931431|NCT04690582|449378317|FG001|Overall Study|Withdrawal by Subject|4|||
124931432|NCT03711474|449378318|FG000|Overall Study|Physician Decision|2|||
124931433|NCT03711474|449378319|FG001|Overall Study|Physician Decision|0|||
124931434|NCT03625115|449378322|FG000|Overall Study|Withdrawal by Subject|4|||
124931435|NCT03625115|449378323|FG001|Overall Study|Withdrawal by Subject|7|||
124931436|NCT03625115|449378322|FG000|Overall Study|Lost to Follow-up|17|||
124931437|NCT03625115|449378323|FG001|Overall Study|Lost to Follow-up|24|||
124931438|NCT04101357|449378325|FG000|Overall Study|Death|1|||
124931439|NCT04101357|449378326|FG001|Overall Study|Death|1|||
124931440|NCT04101357|449378327|FG002|Overall Study|Death|1|||
124931441|NCT04101357|449378328|FG003|Overall Study|Death|2|||
124455706|NCT00094770|447628844|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
124455707|NCT00094770|447628845|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
124931442|NCT04101357|449378329|FG004|Overall Study|Death|4|||
124931443|NCT04101357|449378330|FG005|Overall Study|Death|11|||
124931444|NCT04101357|449378331|FG006|Overall Study|Death|4|||
124931445|NCT04101357|449378332|FG007|Overall Study|Death|4|||
124931446|NCT04101357|449378333|FG008|Overall Study|Death|5|||
124931447|NCT04101357|449378334|FG009|Overall Study|Death|2|||
124931448|NCT04101357|449378335|FG010|Overall Study|Death|3|||
124931449|NCT04101357|449378325|FG000|Overall Study|Trial closure|0|||
124931450|NCT04101357|449378326|FG001|Overall Study|Trial closure|0|||
124931451|NCT04101357|449378327|FG002|Overall Study|Trial closure|0|||
124931452|NCT04101357|449378328|FG003|Overall Study|Trial closure|0|||
124931453|NCT04101357|449378329|FG004|Overall Study|Trial closure|0|||
124931454|NCT04101357|449378330|FG005|Overall Study|Trial closure|2|||
124931455|NCT04101357|449378331|FG006|Overall Study|Trial closure|2|||
124931456|NCT04101357|449378332|FG007|Overall Study|Trial closure|0|||
124931457|NCT04101357|449378333|FG008|Overall Study|Trial closure|0|||
124931458|NCT04101357|449378334|FG009|Overall Study|Trial closure|0|||
124931459|NCT04101357|449378335|FG010|Overall Study|Trial closure|1|||
124931460|NCT04101357|449378325|FG000|Overall Study|Lost to Follow-up|0|||
124931461|NCT04101357|449378326|FG001|Overall Study|Lost to Follow-up|0|||
124931462|NCT04101357|449378327|FG002|Overall Study|Lost to Follow-up|0|||
124931463|NCT04101357|449378328|FG003|Overall Study|Lost to Follow-up|1|||
124931464|NCT04101357|449378329|FG004|Overall Study|Lost to Follow-up|0|||
124931465|NCT04101357|449378330|FG005|Overall Study|Lost to Follow-up|0|||
124931466|NCT04101357|449378331|FG006|Overall Study|Lost to Follow-up|0|||
124931467|NCT04101357|449378332|FG007|Overall Study|Lost to Follow-up|1|||
124931468|NCT04101357|449378333|FG008|Overall Study|Lost to Follow-up|0|||
124455708|NCT00094770|447628844|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
124455709|NCT00094770|447628845|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
124455710|NCT00094770|447628844|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
124455711|NCT00094770|447628845|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
124455712|NCT00094770|447628844|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
124455713|NCT00094770|447628845|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
124455714|NCT00094770|447628844|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
124455715|NCT00094770|447628845|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
124455716|NCT00094770|447628844|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
124931469|NCT04101357|449378334|FG009|Overall Study|Lost to Follow-up|0|||
124931470|NCT04101357|449378335|FG010|Overall Study|Lost to Follow-up|0|||
124931471|NCT04101357|449378325|FG000|Overall Study|Withdrawal by Subject|1|||
124931472|NCT04101357|449378326|FG001|Overall Study|Withdrawal by Subject|0|||
124931473|NCT04101357|449378327|FG002|Overall Study|Withdrawal by Subject|0|||
124931474|NCT04101357|449378328|FG003|Overall Study|Withdrawal by Subject|0|||
124931475|NCT04101357|449378329|FG004|Overall Study|Withdrawal by Subject|0|||
124931476|NCT04101357|449378330|FG005|Overall Study|Withdrawal by Subject|0|||
124931477|NCT04101357|449378331|FG006|Overall Study|Withdrawal by Subject|0|||
124931478|NCT04101357|449378332|FG007|Overall Study|Withdrawal by Subject|0|||
124931479|NCT04101357|449378333|FG008|Overall Study|Withdrawal by Subject|1|||
124931480|NCT04101357|449378334|FG009|Overall Study|Withdrawal by Subject|1|||
124931481|NCT04101357|449378335|FG010|Overall Study|Withdrawal by Subject|0|||
124931482|NCT04101357|449378325|FG000|Overall Study|Other|0|||
124931483|NCT04101357|449378326|FG001|Overall Study|Other|0|||
124931484|NCT04101357|449378327|FG002|Overall Study|Other|0|||
124931485|NCT04101357|449378328|FG003|Overall Study|Other|0|||
124931486|NCT04101357|449378329|FG004|Overall Study|Other|0|||
124931487|NCT04101357|449378330|FG005|Overall Study|Other|1|||
124931488|NCT04101357|449378331|FG006|Overall Study|Other|2|||
124931489|NCT04101357|449378332|FG007|Overall Study|Other|1|||
124931490|NCT04101357|449378333|FG008|Overall Study|Other|0|||
124931491|NCT04101357|449378334|FG009|Overall Study|Other|0|||
124931492|NCT04101357|449378335|FG010|Overall Study|Other|0|||
124931493|NCT04101357|449378325|FG000|Overall Study|Enrolled but not treated|0|||
124931494|NCT04101357|449378326|FG001|Overall Study|Enrolled but not treated|0|||
124931495|NCT04101357|449378327|FG002|Overall Study|Enrolled but not treated|0|||
124931496|NCT04101357|449378328|FG003|Overall Study|Enrolled but not treated|0|||
124931497|NCT04101357|449378329|FG004|Overall Study|Enrolled but not treated|0|||
124931498|NCT04101357|449378330|FG005|Overall Study|Enrolled but not treated|1|||
124931499|NCT04101357|449378331|FG006|Overall Study|Enrolled but not treated|1|||
124931500|NCT04101357|449378332|FG007|Overall Study|Enrolled but not treated|0|||
124931501|NCT04101357|449378333|FG008|Overall Study|Enrolled but not treated|0|||
124931502|NCT04101357|449378334|FG009|Overall Study|Enrolled but not treated|0|||
124931503|NCT04101357|449378335|FG010|Overall Study|Enrolled but not treated|0|||
124931504|NCT05868382|449378336|FG000|Overall Study|Lost to Follow-up|5|||
124931505|NCT05868382|449378337|FG001|Overall Study|Lost to Follow-up|0|||
124931506|NCT05868382|449378338|FG002|Overall Study|Lost to Follow-up|6|||
124931507|NCT05868382|449378339|FG003|Overall Study|Lost to Follow-up|4|||
124931508|NCT05868382|449378340|FG004|Overall Study|Lost to Follow-up|2|||
124931509|NCT05868382|449378341|FG005|Overall Study|Lost to Follow-up|6|||
124931510|NCT05868382|449378336|FG000|Overall Study|Withdrawal by Subject|1|||
124931511|NCT05868382|449378337|FG001|Overall Study|Withdrawal by Subject|0|||
124931512|NCT05868382|449378338|FG002|Overall Study|Withdrawal by Subject|0|||
124931513|NCT05868382|449378339|FG003|Overall Study|Withdrawal by Subject|0|||
124931514|NCT05868382|449378340|FG004|Overall Study|Withdrawal by Subject|1|||
124931515|NCT05868382|449378341|FG005|Overall Study|Withdrawal by Subject|0|||
124455717|NCT00094770|447628845|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
124455718|NCT00094770|447628844|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
124455719|NCT00094770|447628845|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
124455720|NCT00914927|447628846|FG000|Overall Study|Adverse Event|0|||
124455721|NCT00914927|447628847|FG001|Overall Study|Adverse Event|0|||
124455722|NCT00914927|447628848|FG002|Overall Study|Adverse Event|0|||
124455723|NCT00914927|447628849|FG003|Overall Study|Adverse Event|0|||
124455724|NCT00914927|447628850|FG004|Overall Study|Adverse Event|1|||
124931516|NCT02497950|449378342|FG000|Overall Study|Death|209|||
124931517|NCT02497950|449378342|FG000|Overall Study|Transplanted|85|||
124931518|NCT02497950|449378342|FG000|Overall Study|Explanted|8|||
124931519|NCT02497950|449378342|FG000|Overall Study|Device Permanently Deactivated|4|||
124931520|NCT02497950|449378342|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
124931521|NCT02497950|449378342|FG000|Overall Study|Lost to Follow-up|6|||
124931522|NCT02497950|449378342|FG000|Overall Study|Withdrawal by Subject|2|||
124931523|NCT02497950|449378342|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
124931524|NCT02497950|449378342|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
124931525|NCT01236781|449378343|FG000|Overall Study|Ineligible|2|||
124931526|NCT01236781|449378344|FG001|Overall Study|Ineligible|1|||
124931527|NCT01236781|449378343|FG000|Overall Study|Did not complete study imaging|5|||
124931528|NCT01236781|449378344|FG001|Overall Study|Did not complete study imaging|0|||
124931529|NCT01009788|449378357|FG000|Overall Study|Withdrawal by Subject|1|||
124931530|NCT01009788|449378358|FG001|Overall Study|Withdrawal by Subject|0|||
124931531|NCT04308681|449378359|FG000|Pre-Treatment|Not reported|1|||
124931532|NCT04308681|449378360|FG001|Pre-Treatment|Not reported|1|||
124931533|NCT04308681|449378361|FG002|Pre-Treatment|Not reported|0|||
124931534|NCT04308681|449378362|FG003|Pre-Treatment|Not reported|0|||
124931535|NCT04308681|449378363|FG004|Pre-Treatment|Not reported|0|||
124931536|NCT04308681|449378364|FG005|Pre-Treatment|Not reported|2|||
124931537|NCT04308681|449378365|FG006|Pre-Treatment|Not reported|0|||
124931538|NCT04308681|449378366|FG007|Pre-Treatment|Not reported|0|||
124931539|NCT04308681|449378359|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
124931540|NCT04308681|449378360|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
124931541|NCT04308681|449378361|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
124931542|NCT04308681|449378362|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
124931543|NCT04308681|449378363|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
124931544|NCT04308681|449378364|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
124931545|NCT04308681|449378365|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
124931546|NCT04308681|449378366|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
124931547|NCT04308681|449378359|FG000|Treatment up to Week 26|Other reasons|2|||
124931548|NCT04308681|449378360|FG001|Treatment up to Week 26|Other reasons|0|||
124931549|NCT04308681|449378361|FG002|Treatment up to Week 26|Other reasons|0|||
124931550|NCT04308681|449378362|FG003|Treatment up to Week 26|Other reasons|0|||
124931551|NCT04308681|449378363|FG004|Treatment up to Week 26|Other reasons|1|||
124931552|NCT04308681|449378364|FG005|Treatment up to Week 26|Other reasons|1|||
124931553|NCT04308681|449378365|FG006|Treatment up to Week 26|Other reasons|0|||
124931554|NCT04308681|449378366|FG007|Treatment up to Week 26|Other reasons|0|||
124931555|NCT04308681|449378359|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
124931556|NCT04308681|449378360|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
124931557|NCT04308681|449378361|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
124931558|NCT04308681|449378362|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
124931559|NCT04308681|449378363|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
124931560|NCT04308681|449378364|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
124931561|NCT04308681|449378365|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
124931562|NCT04308681|449378366|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
124931563|NCT04308681|449378359|FG000|Treatment up to Week 26|Adverse Event|6|||
124931564|NCT04308681|449378360|FG001|Treatment up to Week 26|Adverse Event|5|||
124455725|NCT00914927|447628851|FG005|Overall Study|Adverse Event|0|||
124931565|NCT04308681|449378361|FG002|Treatment up to Week 26|Adverse Event|5|||
124455726|NCT00914927|447628852|FG006|Overall Study|Adverse Event|0|||
124455727|NCT00914927|447628846|FG000|Overall Study|Withdrawal by Subject|0|||
124546430|NCT02181673|447955901|FG000|Week 24-Week 60|Lack of Efficacy|0|||
124931566|NCT04308681|449378362|FG003|Treatment up to Week 26|Adverse Event|0|||
124931567|NCT04308681|449378363|FG004|Treatment up to Week 26|Adverse Event|6|||
124931568|NCT04308681|449378364|FG005|Treatment up to Week 26|Adverse Event|1|||
124931569|NCT04308681|449378365|FG006|Treatment up to Week 26|Adverse Event|0|||
124931570|NCT04308681|449378366|FG007|Treatment up to Week 26|Adverse Event|0|||
124764869|NCT02412306|448765029|FG001|Overall Study|Lost to Follow-up|1|||
124764870|NCT02412306|448765030|FG002|Overall Study|Lost to Follow-up|0|||
124764871|NCT02412306|448765031|FG003|Overall Study|Lost to Follow-up|0|||
124764872|NCT02412306|448765032|FG004|Overall Study|Lost to Follow-up|0|||
124764873|NCT02412306|448765028|FG000|Overall Study|Withdrawal by Subject|0|||
124764874|NCT02412306|448765029|FG001|Overall Study|Withdrawal by Subject|0|||
124764875|NCT02412306|448765030|FG002|Overall Study|Withdrawal by Subject|1|||
124764876|NCT02412306|448765031|FG003|Overall Study|Withdrawal by Subject|0|||
124764877|NCT02412306|448765032|FG004|Overall Study|Withdrawal by Subject|0|||
124764878|NCT02412306|448765028|FG000|Overall Study|Death|5|||
124764879|NCT02412306|448765029|FG001|Overall Study|Death|7|||
124764880|NCT02412306|448765030|FG002|Overall Study|Death|15|||
124764881|NCT02412306|448765031|FG003|Overall Study|Death|0|||
124764882|NCT02412306|448765032|FG004|Overall Study|Death|2|||
124764883|NCT01706458|448765036|FG000|Overall Study|Physician Decision|3|||
124764884|NCT01706458|448765037|FG001|Overall Study|Physician Decision|4|||
124764885|NCT04349891|448765043|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
124764886|NCT04349891|448765044|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
124764887|NCT04349891|448765043|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
124764888|NCT04349891|448765044|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
124764889|NCT04349891|448765043|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
124931571|NCT04308681|449378359|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
124931572|NCT04308681|449378360|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
124931573|NCT04308681|449378361|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
124931574|NCT04308681|449378362|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
124931575|NCT04308681|449378363|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
124931576|NCT04308681|449378364|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
124931577|NCT04308681|449378365|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
124931578|NCT04308681|449378366|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
124931579|NCT04308681|449378359|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
124931580|NCT04308681|449378360|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
124931581|NCT04308681|449378361|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
124931582|NCT04308681|449378362|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
124931583|NCT04308681|449378363|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
124931584|NCT04308681|449378364|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
124931585|NCT04308681|449378365|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
124931586|NCT04308681|449378366|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
124931587|NCT04308681|449378359|FG000|OTE - 26 Weeks|Death|0|||
124931588|NCT04308681|449378360|FG001|OTE - 26 Weeks|Death|1|||
124931589|NCT04308681|449378361|FG002|OTE - 26 Weeks|Death|0|||
124931590|NCT04308681|449378362|FG003|OTE - 26 Weeks|Death|0|||
124931591|NCT04308681|449378363|FG004|OTE - 26 Weeks|Death|0|||
124931592|NCT04308681|449378364|FG005|OTE - 26 Weeks|Death|0|||
124931593|NCT04308681|449378365|FG006|OTE - 26 Weeks|Death|1|||
124931594|NCT04308681|449378366|FG007|OTE - 26 Weeks|Death|0|||
124931595|NCT04308681|449378359|FG000|OTE - 26 Weeks|Adverse Event|0|||
124931596|NCT04308681|449378360|FG001|OTE - 26 Weeks|Adverse Event|2|||
124931597|NCT04308681|449378361|FG002|OTE - 26 Weeks|Adverse Event|8|||
124931598|NCT04308681|449378362|FG003|OTE - 26 Weeks|Adverse Event|3|||
124931599|NCT04308681|449378363|FG004|OTE - 26 Weeks|Adverse Event|0|||
124931600|NCT04308681|449378364|FG005|OTE - 26 Weeks|Adverse Event|1|||
124931601|NCT04308681|449378365|FG006|OTE - 26 Weeks|Adverse Event|2|||
124931602|NCT04308681|449378366|FG007|OTE - 26 Weeks|Adverse Event|0|||
124931603|NCT04308681|449378359|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
124931604|NCT04308681|449378360|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
124931605|NCT04308681|449378361|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
124931606|NCT04308681|449378362|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
124931607|NCT04308681|449378363|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
124931608|NCT04308681|449378364|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
124764890|NCT04349891|448765044|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
124764891|NCT04349891|448765043|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
124764892|NCT04349891|448765044|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
124764893|NCT02927301|448765047|FG000|Overall Study|Death|39|||
124764894|NCT02927301|448765047|FG000|Overall Study|Lost to Follow-up|8|||
124764895|NCT02927301|448765047|FG000|Overall Study|Physician Decision|2|||
124931609|NCT04308681|449378365|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
124931610|NCT04308681|449378366|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
124931611|NCT05565820|449378367|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
124931612|NCT05565820|449378368|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
124455728|NCT00914927|447628847|FG001|Overall Study|Withdrawal by Subject|1|||
124455729|NCT00914927|447628848|FG002|Overall Study|Withdrawal by Subject|0|||
124455730|NCT00914927|447628849|FG003|Overall Study|Withdrawal by Subject|1|||
124931613|NCT05565820|449378367|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
124931614|NCT05565820|449378368|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
124931615|NCT00429364|449378370|FG000|Overall Study|Withdrawal by Subject|11|||
124931616|NCT00429364|449378371|FG001|Overall Study|Withdrawal by Subject|5|||
124931617|NCT00429364|449378370|FG000|Overall Study|Physician Decision|4|||
124931618|NCT00429364|449378371|FG001|Overall Study|Physician Decision|2|||
124931619|NCT00429364|449378370|FG000|Overall Study|Lost to Follow-up|7|||
124931620|NCT00429364|449378371|FG001|Overall Study|Lost to Follow-up|6|||
124931621|NCT00429364|449378370|FG000|Overall Study|Death|0|||
124931622|NCT00429364|449378371|FG001|Overall Study|Death|1|||
124931623|NCT00429364|449378370|FG000|Overall Study|Underwent aortic root surgery|10|||
124931624|NCT00429364|449378371|FG001|Overall Study|Underwent aortic root surgery|18|||
124931625|NCT00429364|449378370|FG000|Overall Study|Pregnancy|0|||
124931626|NCT00429364|449378371|FG001|Overall Study|Pregnancy|1|||
124931627|NCT04871529|449378372|FG000|Overall Study|Withdrawal by Subject|0|||
124931628|NCT04871529|449378373|FG001|Overall Study|Withdrawal by Subject|1|||
124931629|NCT04871529|449378372|FG000|Overall Study|Death|0|||
124931630|NCT04871529|449378373|FG001|Overall Study|Death|1|||
124931631|NCT04871529|449378372|FG000|Overall Study|Not protocol specified|0|||
124931632|NCT04871529|449378373|FG001|Overall Study|Not protocol specified|1|||
124931633|NCT04003246|449378376|FG000|Overall Study|Death|9|||
124931634|NCT05237284|449378382|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
124931635|NCT05237284|449378383|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
124931636|NCT05237284|449378384|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
124931637|NCT05237284|449378385|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
124931638|NCT05237284|449378382|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
124931639|NCT05237284|449378383|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
124931640|NCT05237284|449378384|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
124931641|NCT05237284|449378385|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
124931642|NCT05237284|449378382|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
124931643|NCT05237284|449378383|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
124931644|NCT05237284|449378384|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
124931645|NCT05237284|449378385|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
124931646|NCT05237284|449378382|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
124931647|NCT05237284|449378383|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
124931648|NCT05237284|449378384|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
124931649|NCT05237284|449378385|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
124931650|NCT05237284|449378382|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
124931651|NCT05237284|449378383|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
124931652|NCT05237284|449378384|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
124931653|NCT05237284|449378385|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
124931654|NCT05237284|449378382|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
124931655|NCT05237284|449378383|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
124931656|NCT05237284|449378384|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
124931657|NCT05237284|449378385|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
124931658|NCT05237284|449378382|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
124931659|NCT05237284|449378383|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
124931660|NCT05237284|449378384|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
124931661|NCT05237284|449378385|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
124931662|NCT05237284|449378382|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
124931663|NCT05237284|449378383|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
124931664|NCT05237284|449378384|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
124931665|NCT05237284|449378385|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
124931666|NCT05237284|449378382|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
124931667|NCT05237284|449378383|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
124931668|NCT05237284|449378384|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
124931669|NCT05237284|449378385|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
124931670|NCT03733925|449378389|FG000|Overall Study|Lost to Follow-up|1|||
124931671|NCT03733925|449378389|FG000|Overall Study|Withdrawal by Subject|2|||
124931672|NCT03733925|449378389|FG000|Overall Study|Adverse Event|2|||
124931673|NCT03733925|449378389|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124931674|NCT03213873|449378390|FG000|Overall Study|Withdrawal by Subject|8|||
124931675|NCT03213873|449378391|FG001|Overall Study|Withdrawal by Subject|9|||
124931676|NCT03213873|449378390|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
124931677|NCT03213873|449378391|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
124931678|NCT03213873|449378390|FG000|Overall Study|Lost to Follow-up|0|||
124931679|NCT03213873|449378391|FG001|Overall Study|Lost to Follow-up|2|||
124931680|NCT02852655|449378397|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
124931681|NCT02852655|449378398|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
124931682|NCT02852655|449378399|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
124931683|NCT02852655|449378397|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
124931684|NCT02852655|449378398|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
124931685|NCT02852655|449378399|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
124931686|NCT02852655|449378397|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
124931687|NCT02852655|449378398|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
124931688|NCT02852655|449378399|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
124931689|NCT02852655|449378397|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
124931690|NCT02852655|449378398|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
124931691|NCT02852655|449378399|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
124931692|NCT02852655|449378397|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
124931693|NCT02852655|449378398|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
124931694|NCT02852655|449378399|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
124931695|NCT02852655|449378397|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
124931696|NCT02852655|449378398|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
124455731|NCT00914927|447628850|FG004|Overall Study|Withdrawal by Subject|0|||
124455732|NCT00914927|447628851|FG005|Overall Study|Withdrawal by Subject|0|||
124455733|NCT00914927|447628852|FG006|Overall Study|Withdrawal by Subject|0|||
124455734|NCT00914927|447628846|FG000|Overall Study|Lost to Follow-up|0|||
124931697|NCT02852655|449378399|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
124931698|NCT02852655|449378397|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
124931699|NCT02852655|449378398|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
124931700|NCT02852655|449378399|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
124931701|NCT02852655|449378397|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
124931702|NCT02852655|449378398|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
124931703|NCT02852655|449378399|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
124931704|NCT02852655|449378397|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
124931705|NCT02852655|449378398|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
124931706|NCT02852655|449378399|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
124931707|NCT02834390|449378403|FG000|Induction Phase|Progressive disease|0|||
124931708|NCT02834390|449378404|FG001|Induction Phase|Progressive disease|1|||
124931709|NCT02834390|449378403|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
124931710|NCT02834390|449378404|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
124931711|NCT02834390|449378403|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
124931712|NCT02834390|449378404|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
124931713|NCT02834390|449378403|FG000|Consolidation Phase|Physician Decision|1|||
124931714|NCT02834390|449378404|FG001|Consolidation Phase|Physician Decision|1|||
124931715|NCT04544007|449378405|FG000|Overall Study|Withdrawal by Subject|1|||
124931716|NCT04544007|449378405|FG000|Overall Study|Confirmed Progressive Disease|1|||
124931717|NCT02998528|449378406|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
124931718|NCT02998528|449378407|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
124931719|NCT02998528|449378408|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
124931720|NCT02998528|449378406|FG000|Randomization Period|Participant withdrew consent|0|||
124931721|NCT02998528|449378407|FG001|Randomization Period|Participant withdrew consent|3|||
124931722|NCT02998528|449378408|FG002|Randomization Period|Participant withdrew consent|0|||
124931723|NCT02998528|449378406|FG000|Randomization Period|Participant no longer meets study criteria|1|||
124931724|NCT02998528|449378407|FG001|Randomization Period|Participant no longer meets study criteria|3|||
124931725|NCT02998528|449378408|FG002|Randomization Period|Participant no longer meets study criteria|2|||
124931726|NCT02998528|449378406|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
124931727|NCT02998528|449378407|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
124931728|NCT02998528|449378408|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
124931729|NCT02998528|449378406|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
124931730|NCT02998528|449378407|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
124931731|NCT02998528|449378408|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
124931732|NCT02998528|449378406|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
124931733|NCT02998528|449378407|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
124931734|NCT02998528|449378408|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
124931735|NCT02998528|449378406|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
124931736|NCT02998528|449378407|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
124455735|NCT00914927|447628847|FG001|Overall Study|Lost to Follow-up|0|||
124455736|NCT00914927|447628848|FG002|Overall Study|Lost to Follow-up|0|||
124455737|NCT00914927|447628849|FG003|Overall Study|Lost to Follow-up|1|||
124702216|NCT00500331|448534131|FG001|Overall Study|Protocol violated|0|||
124702217|NCT00500331|448534132|FG002|Overall Study|Protocol violated|0|||
124702218|NCT00500331|448534133|FG003|Overall Study|Protocol violated|1|||
124931737|NCT02998528|449378408|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
124931738|NCT02998528|449378406|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
124931739|NCT02998528|449378407|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
124931740|NCT02998528|449378408|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
124931741|NCT02998528|449378406|FG000|Neoadjuvant Treatment Period|Death|1|||
124931742|NCT02998528|449378407|FG001|Neoadjuvant Treatment Period|Death|0|||
124931743|NCT02998528|449378408|FG002|Neoadjuvant Treatment Period|Death|0|||
124931744|NCT02998528|449378406|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
124931745|NCT02998528|449378407|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
124931746|NCT02998528|449378408|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
124931747|NCT02998528|449378406|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
124931748|NCT02998528|449378407|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
124931749|NCT02998528|449378408|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
124931750|NCT02998528|449378406|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
124931751|NCT02998528|449378407|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
124931752|NCT02998528|449378408|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
124931753|NCT02998528|449378406|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
124931754|NCT02998528|449378407|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
124931755|NCT02998528|449378408|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
124931756|NCT02998528|449378406|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
124931757|NCT02998528|449378407|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
124931758|NCT02998528|449378408|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
124931759|NCT02998528|449378406|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
124931760|NCT02998528|449378407|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
124931761|NCT02998528|449378408|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
124931762|NCT02413489|449378411|FG000|Overall Study|Death|11|||
124931763|NCT02413489|449378412|FG001|Overall Study|Death|3|||
124931764|NCT02413489|449378413|FG002|Overall Study|Death|4|||
124931765|NCT02413489|449378411|FG000|Overall Study|Withdrawal by Subject|2|||
124931766|NCT02413489|449378412|FG001|Overall Study|Withdrawal by Subject|0|||
124931767|NCT02413489|449378413|FG002|Overall Study|Withdrawal by Subject|0|||
124931768|NCT02413489|449378411|FG000|Overall Study|Study Terminated By Sponsor|2|||
124931769|NCT02413489|449378412|FG001|Overall Study|Study Terminated By Sponsor|13|||
124931770|NCT02413489|449378413|FG002|Overall Study|Study Terminated By Sponsor|1|||
124931771|NCT04247802|449378414|FG000|Overall Study|Withdrawal by Subject|1|||
124931772|NCT04247802|449378415|FG001|Overall Study|Withdrawal by Subject|3|||
124931773|NCT04247802|449378414|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
124931774|NCT04247802|449378415|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
124931775|NCT02575950|449378416|FG000|Overall Study|Withdrawal by Subject|0|||
124931776|NCT02575950|449378417|FG001|Overall Study|Withdrawal by Subject|0|||
124931777|NCT02575950|449378418|FG002|Overall Study|Withdrawal by Subject|0|||
124931778|NCT02575950|449378419|FG003|Overall Study|Withdrawal by Subject|2|||
124931779|NCT02575950|449378416|FG000|Overall Study|Lost to Follow-up|0|||
124931780|NCT02575950|449378417|FG001|Overall Study|Lost to Follow-up|1|||
124931781|NCT02575950|449378418|FG002|Overall Study|Lost to Follow-up|0|||
124931782|NCT02575950|449378419|FG003|Overall Study|Lost to Follow-up|3|||
124931783|NCT03209973|449379694|FG000|Overall Study|Withdrawal by Subject|7|||
124931784|NCT03209973|449379694|FG000|Overall Study|Lost to Follow-up|2|||
124931785|NCT03209973|449379694|FG000|Overall Study|Death|8|||
124931786|NCT03209973|449379694|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
124931787|NCT03209973|449379694|FG000|Overall Study|Sponsor Decision|18|||
124931788|NCT03209973|449379694|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
124931789|NCT03209973|449379694|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
124931790|NCT05218096|449379695|FG000|Primary Evaluation|Withdrawal by Subject|0|||
124931791|NCT05218096|449379696|FG001|Primary Evaluation|Withdrawal by Subject|0|||
124931792|NCT05218096|449379697|FG002|Primary Evaluation|Withdrawal by Subject|2|||
124931793|NCT05218096|449379698|FG003|Primary Evaluation|Withdrawal by Subject|0|||
124931794|NCT05218096|449379699|FG004|Primary Evaluation|Withdrawal by Subject|0|||
124931795|NCT05218096|449379695|FG000|Primary Evaluation|Physician Decision|1|||
124931796|NCT05218096|449379696|FG001|Primary Evaluation|Physician Decision|0|||
124931797|NCT05218096|449379697|FG002|Primary Evaluation|Physician Decision|0|||
124931798|NCT05218096|449379698|FG003|Primary Evaluation|Physician Decision|0|||
124931799|NCT05218096|449379699|FG004|Primary Evaluation|Physician Decision|0|||
124702219|NCT00500331|448534134|FG004|Overall Study|Protocol violated|0|||
124702220|NCT00500331|448534135|FG005|Overall Study|Protocol violated|0|||
124931800|NCT05218096|449379695|FG000|Extended Treatment|Clinical Deterioration|1|||
124931801|NCT05218096|449379696|FG001|Extended Treatment|Clinical Deterioration|1|||
124702221|NCT00500331|448534136|FG006|Overall Study|Protocol violated|0|||
124931802|NCT05218096|449379697|FG002|Extended Treatment|Clinical Deterioration|0|||
124931803|NCT05218096|449379698|FG003|Extended Treatment|Clinical Deterioration|0|||
124931804|NCT05218096|449379699|FG004|Extended Treatment|Clinical Deterioration|0|||
124931805|NCT05218096|449379695|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
124931806|NCT05218096|449379696|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
124931807|NCT05218096|449379697|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
124931808|NCT05218096|449379698|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
124931809|NCT05218096|449379699|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
124931810|NCT05218096|449379695|FG000|Extended Treatment|Withdrawal by Subject|1|||
124931811|NCT05218096|449379696|FG001|Extended Treatment|Withdrawal by Subject|3|||
124931812|NCT05218096|449379697|FG002|Extended Treatment|Withdrawal by Subject|0|||
124931813|NCT05218096|449379698|FG003|Extended Treatment|Withdrawal by Subject|2|||
124931814|NCT05218096|449379699|FG004|Extended Treatment|Withdrawal by Subject|2|||
124931815|NCT05218096|449379695|FG000|Extended Treatment|Lack of Efficacy|3|||
124931816|NCT05218096|449379696|FG001|Extended Treatment|Lack of Efficacy|0|||
124931817|NCT05218096|449379697|FG002|Extended Treatment|Lack of Efficacy|0|||
124931818|NCT05218096|449379698|FG003|Extended Treatment|Lack of Efficacy|0|||
124931819|NCT05218096|449379699|FG004|Extended Treatment|Lack of Efficacy|0|||
124546431|NCT02181673|447955902|FG001|Week 24-Week 60|Lack of Efficacy|0|||
124546432|NCT02181673|447955903|FG002|Week 24-Week 60|Lack of Efficacy|1|||
124546433|NCT02181673|447955901|FG000|Week 24-Week 60|Lost to Follow-up|0|||
124764896|NCT02927301|448765047|FG000|Overall Study|Withdrawal by Subject|12|||
124931820|NCT05218096|449379695|FG000|Extended Treatment|Physician Decision|0|||
124931821|NCT05218096|449379696|FG001|Extended Treatment|Physician Decision|1|||
124931822|NCT05218096|449379697|FG002|Extended Treatment|Physician Decision|0|||
124931823|NCT05218096|449379698|FG003|Extended Treatment|Physician Decision|0|||
124931824|NCT05218096|449379699|FG004|Extended Treatment|Physician Decision|0|||
124931825|NCT05218096|449379695|FG000|Open-label Extension|Adverse Event|1|||
124931826|NCT05218096|449379696|FG001|Open-label Extension|Adverse Event|0|||
124931827|NCT05218096|449379697|FG002|Open-label Extension|Adverse Event|0|||
124931828|NCT05218096|449379698|FG003|Open-label Extension|Adverse Event|0|||
124931829|NCT05218096|449379699|FG004|Open-label Extension|Adverse Event|1|||
124931830|NCT05218096|449379695|FG000|Open-label Extension|Pregnancy|0|||
124931831|NCT05218096|449379696|FG001|Open-label Extension|Pregnancy|0|||
124931832|NCT05218096|449379697|FG002|Open-label Extension|Pregnancy|0|||
124931833|NCT05218096|449379698|FG003|Open-label Extension|Pregnancy|0|||
124931834|NCT05218096|449379699|FG004|Open-label Extension|Pregnancy|1|||
124931835|NCT05218096|449379695|FG000|Open-label Extension|Lack of Efficacy|1|||
124931836|NCT05218096|449379696|FG001|Open-label Extension|Lack of Efficacy|2|||
124931837|NCT05218096|449379697|FG002|Open-label Extension|Lack of Efficacy|0|||
124931838|NCT05218096|449379698|FG003|Open-label Extension|Lack of Efficacy|0|||
124931839|NCT05218096|449379699|FG004|Open-label Extension|Lack of Efficacy|0|||
124931840|NCT05218096|449379695|FG000|Open-label Extension|Lost to Follow-up|1|||
124931841|NCT05218096|449379696|FG001|Open-label Extension|Lost to Follow-up|0|||
124931842|NCT05218096|449379697|FG002|Open-label Extension|Lost to Follow-up|0|||
124931843|NCT05218096|449379698|FG003|Open-label Extension|Lost to Follow-up|0|||
124931844|NCT05218096|449379699|FG004|Open-label Extension|Lost to Follow-up|0|||
124931845|NCT05218096|449379695|FG000|Open-label Extension|Death|0|||
124931846|NCT05218096|449379696|FG001|Open-label Extension|Death|0|||
124931847|NCT05218096|449379697|FG002|Open-label Extension|Death|0|||
124931848|NCT05218096|449379698|FG003|Open-label Extension|Death|1|||
124931849|NCT05218096|449379699|FG004|Open-label Extension|Death|0|||
124931850|NCT05218096|449379695|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
124931851|NCT05218096|449379696|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
124931852|NCT05218096|449379697|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
124931853|NCT05218096|449379698|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
124931854|NCT05218096|449379699|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
124931855|NCT04797195|449379708|FG000|Overall Study|Death|8|||
124931856|NCT04797195|449379709|FG001|Overall Study|Death|15|||
124931857|NCT04797195|449379708|FG000|Overall Study|Change from PD|15|||
124931858|NCT04797195|449379709|FG001|Overall Study|Change from PD|15|||
124931859|NCT04797195|449379708|FG000|Overall Study|Withdrawal by Subject|3|||
124931860|NCT04797195|449379709|FG001|Overall Study|Withdrawal by Subject|2|||
124931861|NCT04660539|449379712|FG000|Overall Study|Adverse Event|10|||
124764897|NCT02927301|448765047|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
124764898|NCT04247347|448765052|FG000|Overall Study|Withdrawal by Subject|2|||
124764899|NCT04247347|448765053|FG001|Overall Study|Withdrawal by Subject|3|||
124764900|NCT04247347|448765054|FG002|Overall Study|Withdrawal by Subject|3|||
124764901|NCT04247347|448765052|FG000|Overall Study|Lost to Follow-up|1|||
124764902|NCT04247347|448765053|FG001|Overall Study|Lost to Follow-up|1|||
124931862|NCT04660539|449379712|FG000|Overall Study|Lack of Efficacy|4|||
124931863|NCT04660539|449379712|FG000|Overall Study|Lost to Follow-up|5|||
124931864|NCT04660539|449379712|FG000|Overall Study|Non-Compliance With Study Drug|3|||
124931865|NCT04660539|449379712|FG000|Overall Study|Reason not Specified|12|||
124931866|NCT04660539|449379712|FG000|Overall Study|Pregnancy|2|||
124764903|NCT04247347|448765054|FG002|Overall Study|Lost to Follow-up|1|||
124455738|NCT00914927|447628850|FG004|Overall Study|Lost to Follow-up|0|||
124455739|NCT00914927|447628851|FG005|Overall Study|Lost to Follow-up|0|||
124455740|NCT00914927|447628852|FG006|Overall Study|Lost to Follow-up|0|||
124455741|NCT00914927|447628846|FG000|Overall Study|Administrative/Other|2|||
124455742|NCT00914927|447628847|FG001|Overall Study|Administrative/Other|1|||
124455743|NCT00914927|447628848|FG002|Overall Study|Administrative/Other|0|||
124455744|NCT00914927|447628849|FG003|Overall Study|Administrative/Other|0|||
124455745|NCT00914927|447628850|FG004|Overall Study|Administrative/Other|1|||
124455746|NCT00914927|447628851|FG005|Overall Study|Administrative/Other|0|||
124764904|NCT03562195|448765055|FG000|Overall Study|Adverse Event|0|||
124764905|NCT03562195|448765056|FG001|Overall Study|Adverse Event|6|||
124764906|NCT03562195|448765055|FG000|Overall Study|Lack of Efficacy|0|||
124764907|NCT03562195|448765056|FG001|Overall Study|Lack of Efficacy|5|||
124764908|NCT03562195|448765055|FG000|Overall Study|Protocol Violation|0|||
124764909|NCT03562195|448765056|FG001|Overall Study|Protocol Violation|1|||
124764910|NCT03562195|448765055|FG000|Overall Study|Lost to Follow-up|0|||
124931867|NCT04660539|449379712|FG000|Overall Study|Protocol Violation|2|||
124931868|NCT04660539|449379712|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
124931869|NCT04660539|449379712|FG000|Overall Study|Withdrawal by Subject|21|||
124931870|NCT05256654|449379713|FG000|Overall Study|Adverse Event|0|||
124931871|NCT05256654|449379714|FG001|Overall Study|Adverse Event|0|||
124931872|NCT05256654|449379715|FG002|Overall Study|Adverse Event|1|||
124931873|NCT05256654|449379716|FG003|Overall Study|Adverse Event|0|||
124931874|NCT05256654|449379713|FG000|Overall Study|Lost to Follow-up|0|||
124931875|NCT05256654|449379714|FG001|Overall Study|Lost to Follow-up|0|||
124931876|NCT05256654|449379715|FG002|Overall Study|Lost to Follow-up|0|||
124931877|NCT05256654|449379716|FG003|Overall Study|Lost to Follow-up|1|||
124931878|NCT05256654|449379713|FG000|Overall Study|Withdrawal by Subject|1|||
124931879|NCT05256654|449379714|FG001|Overall Study|Withdrawal by Subject|2|||
124931880|NCT05256654|449379715|FG002|Overall Study|Withdrawal by Subject|1|||
124931881|NCT05256654|449379716|FG003|Overall Study|Withdrawal by Subject|3|||
124931882|NCT05256654|449379713|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
124931883|NCT05256654|449379714|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
124931884|NCT05256654|449379715|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
124931885|NCT05256654|449379716|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
124931886|NCT05256654|449379713|FG000|Overall Study|Other|0|||
124931887|NCT05256654|449379714|FG001|Overall Study|Other|0|||
124931888|NCT05256654|449379715|FG002|Overall Study|Other|0|||
124931889|NCT05256654|449379716|FG003|Overall Study|Other|1|||
124455747|NCT00914927|447628852|FG006|Overall Study|Administrative/Other|0|||
124931890|NCT05167864|449379717|FG000|Overall Study|Lost to Follow-up|7|||
124931891|NCT05167864|449379718|FG001|Overall Study|Lost to Follow-up|6|||
124931892|NCT05167864|449379719|FG002|Overall Study|Lost to Follow-up|7|||
124931893|NCT05167864|449379720|FG003|Overall Study|Lost to Follow-up|9|||
124931894|NCT03852550|449379723|FG000|Overall Study|Lost to Follow-up|4|||
124931895|NCT03852550|449379724|FG001|Overall Study|Lost to Follow-up|3|||
124764911|NCT03562195|448765056|FG001|Overall Study|Lost to Follow-up|1|||
124764912|NCT03562195|448765055|FG000|Overall Study|Physician Decision|1|||
124931896|NCT03852550|449379723|FG000|Overall Study|Only parent outcomes completed|0|||
124931897|NCT03852550|449379724|FG001|Overall Study|Only parent outcomes completed|1|||
124931898|NCT03852550|449379723|FG000|Overall Study|Withdrawal by Subject|1|||
124931899|NCT03852550|449379724|FG001|Overall Study|Withdrawal by Subject|0|||
124931900|NCT05204654|449379725|FG000|Overall Study|Study terminated due to time restraint|2|||
124931901|NCT05204654|449379726|FG001|Overall Study|Study terminated due to time restraint|2|||
124931902|NCT05207956|449379741|FG000|Overall Study|Lost to follow up|1|||
124931903|NCT05207956|449379742|FG001|Overall Study|Lost to follow up|2|||
124931904|NCT02296684|449379743|FG000|Overall Study|Withdrawal by Subject|0|||
124931905|NCT02296684|449379744|FG001|Overall Study|Withdrawal by Subject|1|||
124931906|NCT02296684|449379745|FG002|Overall Study|Withdrawal by Subject|1|||
124931907|NCT02296684|449379743|FG000|Overall Study|Death|2|||
124931908|NCT02296684|449379744|FG001|Overall Study|Death|0|||
124931909|NCT02296684|449379745|FG002|Overall Study|Death|0|||
124931910|NCT01254864|449379746|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
124931911|NCT01254864|449379747|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
124931912|NCT01254864|449379748|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
124931913|NCT01254864|449379746|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
124931914|NCT01254864|449379747|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
124931915|NCT01254864|449379748|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
124931916|NCT01254864|449379746|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
124931917|NCT01254864|449379747|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
124455748|NCT02113436|447628853|FG000|Period 1: 8 Weeks|Adverse Event|1|||
124455749|NCT02113436|447628854|FG001|Period 1: 8 Weeks|Adverse Event|0|||
124455750|NCT02113436|447628855|FG002|Period 1: 8 Weeks|Adverse Event|0|||
124455751|NCT02113436|447628856|FG003|Period 1: 8 Weeks|Adverse Event|0|||
124455752|NCT02113436|447628853|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
124455753|NCT02113436|447628854|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
124455754|NCT02113436|447628855|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
124455755|NCT02113436|447628856|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
124455756|NCT02113436|447628853|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
124764913|NCT03562195|448765056|FG001|Overall Study|Physician Decision|0|||
124764914|NCT03562195|448765055|FG000|Overall Study|Withdrawal by Subject|3|||
124764915|NCT03562195|448765056|FG001|Overall Study|Withdrawal by Subject|0|||
124764916|NCT02529852|448765059|FG000|Overall Study|Withdrawal by Subject|2|||
124931918|NCT01254864|449379748|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
124931919|NCT01254864|449379746|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
124931920|NCT01254864|449379747|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
124931921|NCT01254864|449379748|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
124702222|NCT03436732|448534137|FG000|Overall Study|Not treated-enrolled in different study|1|||
124702223|NCT03436732|448534138|FG001|Overall Study|Not treated-enrolled in different study|0|||
124931922|NCT01254864|449379746|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
124931923|NCT01254864|449379747|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
124931924|NCT01254864|449379748|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
124931925|NCT01254864|449379746|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
124931926|NCT01254864|449379747|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
124931927|NCT01254864|449379748|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
124931928|NCT01254864|449379746|FG000|Randomization Phase|Adverse Event|0|||
124931929|NCT01254864|449379747|FG001|Randomization Phase|Adverse Event|5|||
124931930|NCT01254864|449379748|FG002|Randomization Phase|Adverse Event|17|||
124931931|NCT01254864|449379746|FG000|Randomization Phase|Death|0|||
124931932|NCT01254864|449379747|FG001|Randomization Phase|Death|1|||
124931933|NCT01254864|449379748|FG002|Randomization Phase|Death|0|||
124931934|NCT01254864|449379746|FG000|Randomization Phase|Lost to Follow-up|0|||
124931935|NCT01254864|449379747|FG001|Randomization Phase|Lost to Follow-up|0|||
124931936|NCT01254864|449379748|FG002|Randomization Phase|Lost to Follow-up|1|||
124931937|NCT01254864|449379746|FG000|Randomization Phase|Physician Decision|0|||
124931938|NCT01254864|449379747|FG001|Randomization Phase|Physician Decision|20|||
124931939|NCT01254864|449379748|FG002|Randomization Phase|Physician Decision|25|||
124931940|NCT01254864|449379746|FG000|Randomization Phase|Withdrawal by Subject|0|||
124931941|NCT01254864|449379747|FG001|Randomization Phase|Withdrawal by Subject|4|||
124931942|NCT01254864|449379748|FG002|Randomization Phase|Withdrawal by Subject|2|||
124931943|NCT01254864|449379746|FG000|Randomization Phase|Non-Compliance|0|||
124931944|NCT01254864|449379747|FG001|Randomization Phase|Non-Compliance|1|||
124931945|NCT01254864|449379748|FG002|Randomization Phase|Non-Compliance|0|||
124931946|NCT01254864|449379746|FG000|Randomization Phase|Comorbidities|0|||
124931947|NCT01254864|449379747|FG001|Randomization Phase|Comorbidities|2|||
124931948|NCT01254864|449379748|FG002|Randomization Phase|Comorbidities|1|||
124931949|NCT01828112|449379753|FG000|Treatment Phase|Adverse Event|7|||
124702224|NCT03436732|448534137|FG000|Overall Study|Off study after cycle 1|1|||
124702225|NCT03436732|448534138|FG001|Overall Study|Off study after cycle 1|0|||
124931950|NCT01828112|449379754|FG001|Treatment Phase|Adverse Event|8|||
124931951|NCT01828112|449379755|FG002|Treatment Phase|Adverse Event|0|||
124931952|NCT01828112|449379753|FG000|Treatment Phase|Death|9|||
124931953|NCT01828112|449379754|FG001|Treatment Phase|Death|5|||
124931954|NCT01828112|449379755|FG002|Treatment Phase|Death|0|||
124931955|NCT01828112|449379753|FG000|Treatment Phase|No longer required treatment|0|||
124931956|NCT01828112|449379754|FG001|Treatment Phase|No longer required treatment|1|||
124931957|NCT01828112|449379755|FG002|Treatment Phase|No longer required treatment|0|||
124931958|NCT01828112|449379753|FG000|Treatment Phase|Physician Decision|6|||
124931959|NCT01828112|449379754|FG001|Treatment Phase|Physician Decision|7|||
124931960|NCT01828112|449379755|FG002|Treatment Phase|Physician Decision|0|||
124931961|NCT01828112|449379753|FG000|Treatment Phase|Pregnancy|1|||
124931962|NCT01828112|449379754|FG001|Treatment Phase|Pregnancy|0|||
124931963|NCT01828112|449379755|FG002|Treatment Phase|Pregnancy|0|||
124931964|NCT01828112|449379753|FG000|Treatment Phase|Progressive disease|79|||
124931965|NCT01828112|449379754|FG001|Treatment Phase|Progressive disease|87|||
124931966|NCT01828112|449379755|FG002|Treatment Phase|Progressive disease|0|||
124931967|NCT01828112|449379753|FG000|Treatment Phase|Study terminated by sponsor|1|||
124931968|NCT01828112|449379754|FG001|Treatment Phase|Study terminated by sponsor|0|||
124931969|NCT01828112|449379755|FG002|Treatment Phase|Study terminated by sponsor|0|||
124931970|NCT01828112|449379753|FG000|Treatment Phase|Subject/guardian decision|12|||
124931971|NCT01828112|449379754|FG001|Treatment Phase|Subject/guardian decision|8|||
124702226|NCT03436732|448534137|FG000|Overall Study|Adverse Event|2|||
124702227|NCT03436732|448534138|FG001|Overall Study|Adverse Event|0|||
124931972|NCT01828112|449379755|FG002|Treatment Phase|Subject/guardian decision|0|||
124931973|NCT01828112|449379753|FG000|Extension Treatment Phase|Adverse Event|0|||
124931974|NCT01828112|449379754|FG001|Extension Treatment Phase|Adverse Event|0|||
124931975|NCT01828112|449379755|FG002|Extension Treatment Phase|Adverse Event|6|||
124931976|NCT01828112|449379753|FG000|Extension Treatment Phase|Death|0|||
124931977|NCT01828112|449379754|FG001|Extension Treatment Phase|Death|0|||
124931978|NCT01828112|449379755|FG002|Extension Treatment Phase|Death|17|||
124931979|NCT01828112|449379753|FG000|Extension Treatment Phase|Physician Decision|0|||
124764917|NCT02269124|448765065|FG000|Overall Study|Lost to Follow-up|1|||
124931980|NCT01828112|449379754|FG001|Extension Treatment Phase|Physician Decision|0|||
124931981|NCT01828112|449379755|FG002|Extension Treatment Phase|Physician Decision|5|||
124931982|NCT01828112|449379753|FG000|Extension Treatment Phase|Progressive disease|0|||
124931983|NCT01828112|449379754|FG001|Extension Treatment Phase|Progressive disease|0|||
124931984|NCT01828112|449379755|FG002|Extension Treatment Phase|Progressive disease|46|||
124931985|NCT01828112|449379753|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
124931986|NCT01828112|449379754|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
124931987|NCT01828112|449379755|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
124931988|NCT01828112|449379753|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
124931989|NCT01828112|449379754|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
124931990|NCT01828112|449379755|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
124931991|NCT02446236|449379765|FG000|Overall Study|Screen Failure|1|||
124931992|NCT02446236|449379766|FG001|Overall Study|Screen Failure|0|||
124931993|NCT02446236|449379767|FG002|Overall Study|Screen Failure|1|||
124931994|NCT02446236|449379765|FG000|Overall Study|Actively Receiving Therapy|0|||
124764918|NCT02269124|448765066|FG001|Overall Study|Lost to Follow-up|0|||
124931995|NCT02446236|449379766|FG001|Overall Study|Actively Receiving Therapy|0|||
124931996|NCT02446236|449379767|FG002|Overall Study|Actively Receiving Therapy|1|||
124931997|NCT05184452|449379768|FG000|Overall Study|Lost to Follow-up|0|||
124931998|NCT05184452|449379769|FG001|Overall Study|Lost to Follow-up|0|||
124931999|NCT05184452|449379770|FG002|Overall Study|Lost to Follow-up|0|||
124932000|NCT05184452|449379771|FG003|Overall Study|Lost to Follow-up|0|||
124932001|NCT05184452|449379772|FG004|Overall Study|Lost to Follow-up|0|||
124932002|NCT05184452|449379773|FG005|Overall Study|Lost to Follow-up|2|||
124932003|NCT05184452|449379774|FG006|Overall Study|Lost to Follow-up|0|||
124932004|NCT05184452|449379775|FG007|Overall Study|Lost to Follow-up|0|||
124932005|NCT05184452|449379776|FG008|Overall Study|Lost to Follow-up|0|||
124932006|NCT05184452|449379777|FG009|Overall Study|Lost to Follow-up|1|||
124932007|NCT05184452|449379768|FG000|Overall Study|Withdrawal by Subject|0|||
124932008|NCT05184452|449379769|FG001|Overall Study|Withdrawal by Subject|0|||
124932009|NCT05184452|449379770|FG002|Overall Study|Withdrawal by Subject|0|||
124932010|NCT05184452|449379771|FG003|Overall Study|Withdrawal by Subject|0|||
124932011|NCT05184452|449379772|FG004|Overall Study|Withdrawal by Subject|0|||
124932012|NCT05184452|449379773|FG005|Overall Study|Withdrawal by Subject|1|||
124932013|NCT05184452|449379774|FG006|Overall Study|Withdrawal by Subject|0|||
124932014|NCT05184452|449379775|FG007|Overall Study|Withdrawal by Subject|0|||
124932015|NCT05184452|449379776|FG008|Overall Study|Withdrawal by Subject|0|||
124932016|NCT05184452|449379777|FG009|Overall Study|Withdrawal by Subject|1|||
124932017|NCT05586490|449379778|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
124932018|NCT05586490|449379779|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
124932019|NCT05586490|449379780|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
124932020|NCT05586490|449379781|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
124932021|NCT05586490|449379782|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
124932022|NCT05586490|449379778|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
124932023|NCT05586490|449379779|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
124932024|NCT05586490|449379780|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
124932025|NCT05586490|449379781|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
124932026|NCT05586490|449379782|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
124932027|NCT05586490|449379778|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
124932028|NCT05586490|449379779|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
124932029|NCT05586490|449379780|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
124932030|NCT05586490|449379781|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
124932031|NCT05586490|449379782|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
124932032|NCT04786119|449379783|FG000|Overall Study|Withdrawal by Subject|2|||
124932033|NCT05076266|449379784|FG000|Overall Study|Survey not complete - Participant refusal|2|||
124932034|NCT05076266|449379785|FG001|Overall Study|Survey not complete - Participant refusal|0|||
124932035|NCT05425420|449379786|FG000|Overall Study|Physician Decision|1|||
124932036|NCT05425420|449379786|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
124932037|NCT05280574|449379787|FG000|Overall Study|Withdrawal by Subject|0|||
124932038|NCT05280574|449379788|FG001|Overall Study|Withdrawal by Subject|2|||
124932039|NCT05280574|449379789|FG002|Overall Study|Withdrawal by Subject|0|||
124932040|NCT02361216|449379797|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
124932041|NCT02361216|449379798|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
124932042|NCT02361216|449379797|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
124932043|NCT02361216|449379798|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
124932044|NCT02361216|449379797|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
124932045|NCT02361216|449379798|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
124932046|NCT02361216|449379797|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
124932047|NCT02361216|449379798|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
124932048|NCT02361216|449379797|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
124932049|NCT02361216|449379798|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
124932050|NCT02361216|449379797|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
124932051|NCT02361216|449379798|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
124932052|NCT03505008|449379799|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
124932053|NCT03505008|449379800|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
124932054|NCT03505008|449379801|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
124932055|NCT03505008|449379802|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
124932056|NCT03505008|449379799|FG000|Before Week 24 Randomization|Adverse Event|10|||
124932057|NCT03505008|449379800|FG001|Before Week 24 Randomization|Adverse Event|0|||
124932058|NCT03505008|449379801|FG002|Before Week 24 Randomization|Adverse Event|0|||
124932059|NCT03505008|449379802|FG003|Before Week 24 Randomization|Adverse Event|0|||
124932060|NCT03505008|449379799|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
124932061|NCT03505008|449379800|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
124932062|NCT03505008|449379801|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
124932063|NCT03505008|449379802|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
124932064|NCT03505008|449379799|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
124932065|NCT03505008|449379800|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
124932066|NCT03505008|449379801|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
124932067|NCT03505008|449379802|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
124932068|NCT03505008|449379799|FG000|Before Week 24 Randomization|Physician Decision|2|||
124932069|NCT03505008|449379800|FG001|Before Week 24 Randomization|Physician Decision|0|||
124932070|NCT03505008|449379801|FG002|Before Week 24 Randomization|Physician Decision|0|||
124932071|NCT03505008|449379802|FG003|Before Week 24 Randomization|Physician Decision|0|||
124932072|NCT03505008|449379799|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
124932073|NCT03505008|449379800|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
124932074|NCT03505008|449379801|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
124932075|NCT03505008|449379802|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
124932076|NCT03505008|449379799|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
124932077|NCT03505008|449379800|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
124932078|NCT03505008|449379801|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
124932079|NCT03505008|449379802|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
124932080|NCT03505008|449379799|FG000|Before Week 24 Randomization|Complication|1|||
124932081|NCT03505008|449379800|FG001|Before Week 24 Randomization|Complication|0|||
124932082|NCT03505008|449379801|FG002|Before Week 24 Randomization|Complication|0|||
124932083|NCT03505008|449379802|FG003|Before Week 24 Randomization|Complication|0|||
124932084|NCT03505008|449379799|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
124932085|NCT03505008|449379800|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
124932086|NCT03505008|449379801|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
124932087|NCT03505008|449379802|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
124932088|NCT03505008|449379799|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
124932089|NCT03505008|449379800|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
124932090|NCT03505008|449379801|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
124932091|NCT03505008|449379802|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
124932092|NCT03505008|449379799|FG000|After Week 24 Randomization|Adverse Event|0|||
124932093|NCT03505008|449379800|FG001|After Week 24 Randomization|Adverse Event|1|||
124932094|NCT03505008|449379801|FG002|After Week 24 Randomization|Adverse Event|2|||
124932095|NCT03505008|449379802|FG003|After Week 24 Randomization|Adverse Event|2|||
124932096|NCT03505008|449379799|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
124932097|NCT03505008|449379800|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
124932098|NCT03505008|449379801|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
124932099|NCT03505008|449379802|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
124932100|NCT03505008|449379799|FG000|After Week 24 Randomization|Protocol Violation|0|||
124932101|NCT03505008|449379800|FG001|After Week 24 Randomization|Protocol Violation|0|||
124932102|NCT03505008|449379801|FG002|After Week 24 Randomization|Protocol Violation|1|||
124932103|NCT03505008|449379802|FG003|After Week 24 Randomization|Protocol Violation|0|||
124932104|NCT01730937|449379803|FG000|Overall Study|Protocol Violation|5|||
124932105|NCT01730937|449379804|FG001|Overall Study|Protocol Violation|11|||
124932106|NCT02988661|449379813|FG000|Overall Study|Death|2|||
124932107|NCT02988661|449379814|FG001|Overall Study|Death|18|||
124932108|NCT02988661|449379813|FG000|Overall Study|Lost to Follow-up|0|||
124932109|NCT02988661|449379814|FG001|Overall Study|Lost to Follow-up|33|||
124932110|NCT02988661|449379813|FG000|Overall Study|Withdrawal by Subject|0|||
124932111|NCT02988661|449379814|FG001|Overall Study|Withdrawal by Subject|6|||
124932112|NCT02988661|449379813|FG000|Overall Study|Unable to complete the 18-month survey|1|||
124932113|NCT02988661|449379814|FG001|Overall Study|Unable to complete the 18-month survey|27|||
124932114|NCT03213678|449379822|FG000|Overall Study|Death|1|||
124932115|NCT03213678|449379822|FG000|Overall Study|Physician Decision|1|||
124932116|NCT03213678|449379822|FG000|Overall Study|Progressive disease|16|||
124932117|NCT04218851|449379823|FG000|Overall Study|Death|1|||
124932118|NCT04218851|449379824|FG001|Overall Study|Death|3|||
124932119|NCT05645757|449382277|FG000|Overall Study|Enrolled but treatment not administered|0|||
124932120|NCT05645757|449382278|FG001|Overall Study|Enrolled but treatment not administered|0|||
124932121|NCT05645757|449382279|FG002|Overall Study|Enrolled but treatment not administered|0|||
124932122|NCT05645757|449382280|FG003|Overall Study|Enrolled but treatment not administered|0|||
124932123|NCT05645757|449382281|FG004|Overall Study|Enrolled but treatment not administered|1|||
124932124|NCT05645757|449382282|FG005|Overall Study|Enrolled but treatment not administered|1|||
124932125|NCT05645757|449382283|FG006|Overall Study|Enrolled but treatment not administered|0|||
124932126|NCT05645757|449382284|FG007|Overall Study|Enrolled but treatment not administered|0|||
124932127|NCT03924635|449382285|FG000|Overall Study|Withdrawal by Subject|2|||
124932128|NCT03924635|449382286|FG001|Overall Study|Withdrawal by Subject|4|||
124932129|NCT00539591|449382287|FG000|Overall Study|Toxicity|3|||
124932130|NCT00539591|449382288|FG001|Overall Study|Toxicity|0|||
124932131|NCT00539591|449382289|FG002|Overall Study|Toxicity|0|||
124932132|NCT00539591|449382287|FG000|Overall Study|Disease progression|2|||
124932133|NCT00539591|449382288|FG001|Overall Study|Disease progression|2|||
124932134|NCT00539591|449382289|FG002|Overall Study|Disease progression|3|||
124932135|NCT01960452|449382290|FG000|Overall Study|Withdrawal by Subject|2|||
124932136|NCT01960452|449382291|FG001|Overall Study|Withdrawal by Subject|1|||
124932137|NCT01960452|449382290|FG000|Overall Study|Sleep apnea in Night 1|1|||
124932138|NCT01960452|449382291|FG001|Overall Study|Sleep apnea in Night 1|0|||
124932139|NCT01960452|449382290|FG000|Overall Study|Poor Sleep in Night 1|0|||
124932140|NCT01960452|449382291|FG001|Overall Study|Poor Sleep in Night 1|2|||
124932141|NCT01960452|449382290|FG000|Overall Study|No Sex/Age Match Night 1|1|||
124932142|NCT01960452|449382291|FG001|Overall Study|No Sex/Age Match Night 1|0|||
124932143|NCT01960452|449382290|FG000|Overall Study|No Sex/Age Match Night 2|0|||
124932144|NCT01960452|449382291|FG001|Overall Study|No Sex/Age Match Night 2|2|||
124932145|NCT01960452|449382290|FG000|Overall Study|Technical Difficulties Night 2|2|||
124932146|NCT01960452|449382291|FG001|Overall Study|Technical Difficulties Night 2|0|||
124932147|NCT04414722|449382292|FG000|Overall Study|Lost to Follow-up|3|||
124932148|NCT04414722|449382293|FG001|Overall Study|Lost to Follow-up|4|||
124932149|NCT04414722|449382294|FG002|Overall Study|Lost to Follow-up|3|||
124932150|NCT04414722|449382295|FG003|Overall Study|Lost to Follow-up|2|||
124932151|NCT04414722|449382296|FG004|Overall Study|Lost to Follow-up|3|||
124455757|NCT02113436|447628854|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
124455758|NCT02113436|447628855|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
124455759|NCT02113436|447628856|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
124455760|NCT02113436|447628853|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
124455761|NCT02113436|447628854|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
124932152|NCT04414722|449382292|FG000|Overall Study|Withdrawal by Subject|6|||
124932153|NCT04414722|449382293|FG001|Overall Study|Withdrawal by Subject|3|||
124932154|NCT04414722|449382294|FG002|Overall Study|Withdrawal by Subject|1|||
124932155|NCT04414722|449382295|FG003|Overall Study|Withdrawal by Subject|5|||
124932156|NCT04414722|449382296|FG004|Overall Study|Withdrawal by Subject|1|||
124455762|NCT02113436|447628855|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
124455763|NCT02113436|447628856|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
124932157|NCT04414722|449382292|FG000|Overall Study|Physician Decision|0|||
124932158|NCT04414722|449382293|FG001|Overall Study|Physician Decision|1|||
124932159|NCT04414722|449382294|FG002|Overall Study|Physician Decision|2|||
124932160|NCT04414722|449382295|FG003|Overall Study|Physician Decision|0|||
124932161|NCT04414722|449382296|FG004|Overall Study|Physician Decision|0|||
124932162|NCT04414722|449382292|FG000|Overall Study|Non-participatory|0|||
124702228|NCT03436732|448534137|FG000|Overall Study|Death|0|||
124702229|NCT03436732|448534138|FG001|Overall Study|Death|1|||
124702230|NCT03345550|448534139|FG000|Overall Study|Withdrawal by Subject|1|||
124702231|NCT03345550|448534140|FG001|Overall Study|Withdrawal by Subject|0|||
124702232|NCT03345550|448534139|FG000|Overall Study|Lost to Follow-up|4|||
124702233|NCT03345550|448534140|FG001|Overall Study|Lost to Follow-up|5|||
124702234|NCT00959049|448534141|FG000|Overall Study|Adverse Event|1|||
124702235|NCT00959049|448534142|FG001|Overall Study|Adverse Event|0|||
124702236|NCT00959049|448534143|FG002|Overall Study|Adverse Event|0|||
124932163|NCT04414722|449382293|FG001|Overall Study|Non-participatory|1|||
124932164|NCT04414722|449382294|FG002|Overall Study|Non-participatory|1|||
124932165|NCT04414722|449382295|FG003|Overall Study|Non-participatory|0|||
124932166|NCT04414722|449382296|FG004|Overall Study|Non-participatory|0|||
124932167|NCT03655028|449382299|FG000|12-weeks Follow up|Death|1|||
124932168|NCT03655028|449382300|FG001|12-weeks Follow up|Death|0|||
124702237|NCT00959049|448534144|FG003|Overall Study|Adverse Event|0|||
124932169|NCT03655028|449382299|FG000|12-weeks Follow up|Physician Decision|3|||
124932170|NCT03655028|449382300|FG001|12-weeks Follow up|Physician Decision|3|||
124932171|NCT03655028|449382299|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
124932172|NCT03655028|449382300|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
124932173|NCT03655028|449382299|FG000|12-weeks Follow up|Lost to Follow-up|4|||
124932174|NCT03655028|449382300|FG001|12-weeks Follow up|Lost to Follow-up|4|||
124932175|NCT03655028|449382299|FG000|24-weeks|Lost to Follow-up|1|||
124932176|NCT03655028|449382300|FG001|24-weeks|Lost to Follow-up|1|||
124932177|NCT03655028|449382299|FG000|24-weeks|Death|0|||
124932178|NCT03655028|449382300|FG001|24-weeks|Death|1|||
124932179|NCT03513302|449382301|FG000|First Intervention (14 Days)|Screen failure|15|||
124932180|NCT03513302|449382302|FG001|First Intervention (14 Days)|Screen failure|16|||
124932181|NCT05618587|449382303|FG000|Overall Study|Lost to Follow-up|2|||
124932182|NCT05618587|449382304|FG001|Overall Study|Lost to Follow-up|0|||
124932183|NCT03442309|449382309|FG000|Overall Study|Lost to Follow-up|1676|||
124932184|NCT03442309|449382310|FG001|Overall Study|Lost to Follow-up|1642|||
124932185|NCT04862416|449382311|FG000|Overall Study|Withdrawal by Subject|0|||
124932186|NCT04862416|449382312|FG001|Overall Study|Withdrawal by Subject|1|||
124932187|NCT04862416|449382313|FG002|Overall Study|Withdrawal by Subject|0|||
124932188|NCT04862416|449382314|FG003|Overall Study|Withdrawal by Subject|1|||
124932189|NCT04862416|449382315|FG004|Overall Study|Withdrawal by Subject|0|||
124932190|NCT04862416|449382316|FG005|Overall Study|Withdrawal by Subject|0|||
124932191|NCT04862416|449382317|FG006|Overall Study|Withdrawal by Subject|0|||
124932192|NCT04862416|449382318|FG007|Overall Study|Withdrawal by Subject|0|||
124702238|NCT00959049|448534145|FG004|Overall Study|Adverse Event|0|||
124702239|NCT00959049|448534146|FG005|Overall Study|Adverse Event|0|||
124702240|NCT00959049|448534141|FG000|Overall Study|Lost to Follow-up|17|||
124932193|NCT04862234|449382319|FG000|Overall Study|Surgery cancellation|1|||
124932194|NCT04862234|449382320|FG001|Overall Study|Surgery cancellation|2|||
124932195|NCT04862234|449382319|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
124932196|NCT04862234|449382320|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
124932197|NCT04862234|449382319|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
124932198|NCT04862234|449382320|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
124932199|NCT03292484|449382326|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
124932200|NCT03292484|449382326|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
124702241|NCT00959049|448534142|FG001|Overall Study|Lost to Follow-up|5|||
124702242|NCT00959049|448534143|FG002|Overall Study|Lost to Follow-up|1|||
124932201|NCT03292484|449382326|FG000|Overall Study|Protocol Violation|2|||
124702243|NCT00959049|448534144|FG003|Overall Study|Lost to Follow-up|10|||
124932202|NCT03292484|449382326|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
124932203|NCT03292484|449382326|FG000|Overall Study|Sponsor decision|349|||
124932204|NCT03292484|449382326|FG000|Overall Study|Lost to Follow-up|7|||
124932205|NCT03292484|449382326|FG000|Overall Study|Coronavirus Disease 2019|1|||
124932206|NCT03292484|449382326|FG000|Overall Study|Other|20|||
124932207|NCT05290493|449382327|FG000|Overall Study|Withdrawal by Subject|2|||
124932208|NCT05290493|449382328|FG001|Overall Study|Withdrawal by Subject|2|||
124932209|NCT05290493|449382327|FG000|Overall Study|Adverse Event|1|||
124932210|NCT05290493|449382328|FG001|Overall Study|Adverse Event|0|||
124932211|NCT03677141|449382332|FG000|Overall Study|Death|2|||
124932212|NCT03677141|449382333|FG001|Overall Study|Death|1|||
124932213|NCT03677141|449382334|FG002|Overall Study|Death|6|||
124932214|NCT03677141|449382335|FG003|Overall Study|Death|9|||
124932215|NCT03677141|449382336|FG004|Overall Study|Death|5|||
124932216|NCT03677141|449382337|FG005|Overall Study|Death|3|||
124932217|NCT03677141|449382332|FG000|Overall Study|Lost to Follow-up|0|||
124932218|NCT03677141|449382333|FG001|Overall Study|Lost to Follow-up|0|||
124932219|NCT03677141|449382334|FG002|Overall Study|Lost to Follow-up|0|||
124932220|NCT03677141|449382335|FG003|Overall Study|Lost to Follow-up|2|||
124932221|NCT03677141|449382336|FG004|Overall Study|Lost to Follow-up|0|||
124932222|NCT03677141|449382337|FG005|Overall Study|Lost to Follow-up|0|||
124932223|NCT03677141|449382332|FG000|Overall Study|Screen failure or enrolled in error|0|||
124932224|NCT03677141|449382333|FG001|Overall Study|Screen failure or enrolled in error|0|||
124932225|NCT03677141|449382334|FG002|Overall Study|Screen failure or enrolled in error|0|||
124932226|NCT03677141|449382335|FG003|Overall Study|Screen failure or enrolled in error|0|||
124932227|NCT03677141|449382336|FG004|Overall Study|Screen failure or enrolled in error|2|||
124932228|NCT03677141|449382337|FG005|Overall Study|Screen failure or enrolled in error|0|||
124932229|NCT03677141|449382332|FG000|Overall Study|Physician Decision|0|||
124932230|NCT03677141|449382333|FG001|Overall Study|Physician Decision|0|||
124932231|NCT03677141|449382334|FG002|Overall Study|Physician Decision|0|||
124932232|NCT03677141|449382335|FG003|Overall Study|Physician Decision|0|||
124932233|NCT03677141|449382336|FG004|Overall Study|Physician Decision|1|||
124932234|NCT03677141|449382337|FG005|Overall Study|Physician Decision|0|||
124932235|NCT03677141|449382332|FG000|Overall Study|Withdrawal by Subject|0|||
124932236|NCT03677141|449382333|FG001|Overall Study|Withdrawal by Subject|0|||
124932237|NCT03677141|449382334|FG002|Overall Study|Withdrawal by Subject|1|||
124932238|NCT03677141|449382335|FG003|Overall Study|Withdrawal by Subject|1|||
124932239|NCT03677141|449382336|FG004|Overall Study|Withdrawal by Subject|1|||
124932240|NCT03677141|449382337|FG005|Overall Study|Withdrawal by Subject|0|||
124932241|NCT05838027|449382341|FG000|Overall Study|Lost to Follow-up|5|||
124932242|NCT05838027|449382342|FG001|Overall Study|Lost to Follow-up|1|||
124932243|NCT05838027|449382341|FG000|Overall Study|Withdrawal by Subject|1|||
124932244|NCT05838027|449382342|FG001|Overall Study|Withdrawal by Subject|0|||
124932245|NCT04056611|449382346|FG000|Overall Study|Physician Decision|1|||
124702244|NCT00959049|448534145|FG004|Overall Study|Lost to Follow-up|9|||
124932246|NCT02631746|449382349|FG000|Overall Study|Lack of Efficacy|3|||
124932247|NCT04571619|449382350|FG000|Phase 1|Death|22|||
124932248|NCT04571619|449382351|FG001|Phase 1|Death|18|||
124932249|NCT04571619|449382350|FG000|Phase 1|Withdrawal by Subject|7|||
124932250|NCT04571619|449382351|FG001|Phase 1|Withdrawal by Subject|2|||
124932251|NCT04571619|449382350|FG000|Phase 2|Death|13|||
124932252|NCT04571619|449382351|FG001|Phase 2|Death|16|||
124932253|NCT04571619|449382350|FG000|Phase 2|Withdrawal by Subject|6|||
124932254|NCT04571619|449382351|FG001|Phase 2|Withdrawal by Subject|4|||
124932255|NCT04709419|449382353|FG000|Overall Study|Physician Decision|1|||
124932256|NCT04709419|449382354|FG001|Overall Study|Physician Decision|0|||
124932257|NCT05683340|449382355|FG000|Overall Study|Adverse Event|1|||
124932258|NCT05683340|449382356|FG001|Overall Study|Adverse Event|1|||
124932259|NCT05683340|449382355|FG000|Overall Study|Protocol Violation|1|||
124932260|NCT05683340|449382356|FG001|Overall Study|Protocol Violation|0|||
124932261|NCT05683340|449382355|FG000|Overall Study|Withdrawal by Subject|0|||
124932262|NCT05683340|449382356|FG001|Overall Study|Withdrawal by Subject|2|||
124932263|NCT02224144|449382357|FG000|Overall Study|Lost to Follow-up|3|||
124932264|NCT02224144|449382358|FG001|Overall Study|Lost to Follow-up|1|||
124932265|NCT02224144|449382357|FG000|Overall Study|Death|2|||
124932266|NCT02224144|449382358|FG001|Overall Study|Death|0|||
124932267|NCT02224144|449382357|FG000|Overall Study|Withdrawal by Subject|0|||
124932268|NCT02224144|449382358|FG001|Overall Study|Withdrawal by Subject|1|||
124932269|NCT02962076|449382361|FG000|Overall Study|MHED tracer not available|5|||
124932270|NCT02962076|449382361|FG000|Overall Study|Protocol Violation|1|||
124932271|NCT02962076|449382361|FG000|Overall Study|Physician Decision|1|||
124932272|NCT04741776|449382362|FG000|Overall Study|Withdrawal by Subject|7|||
124932273|NCT04741776|449382363|FG001|Overall Study|Withdrawal by Subject|10|||
124932274|NCT04741776|449382364|FG002|Overall Study|Withdrawal by Subject|10|||
124932275|NCT04741776|449382365|FG003|Overall Study|Withdrawal by Subject|17|||
124932276|NCT04741776|449382362|FG000|Overall Study|Death|0|||
124932277|NCT04741776|449382363|FG001|Overall Study|Death|0|||
124932278|NCT04741776|449382364|FG002|Overall Study|Death|1|||
124932279|NCT04741776|449382365|FG003|Overall Study|Death|0|||
124932280|NCT04089865|449382366|FG000|Overall Study|Withdrawal by Subject|2|||
124932281|NCT04089865|449382367|FG001|Overall Study|Withdrawal by Subject|2|||
124932282|NCT04089865|449382368|FG002|Overall Study|Withdrawal by Subject|7|||
124932283|NCT04089865|449382369|FG003|Overall Study|Withdrawal by Subject|2|||
124932284|NCT02780700|449382379|FG000|Overall Study|Progressive disease|1|||
124932285|NCT03824366|449382394|FG000|Overall Study|Death|1|||
124932286|NCT03824366|449382394|FG000|Overall Study|Previously unidentified metal artifact|1|||
124932287|NCT03824366|449382394|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
124932288|NCT03824366|449382394|FG000|Overall Study|Withdrawal by Subject|1|||
124932289|NCT05069896|449382401|FG000|Overall Study|Adverse Event|0|||
124932290|NCT05069896|449382402|FG001|Overall Study|Adverse Event|1|||
124932291|NCT05069896|449382403|FG002|Overall Study|Adverse Event|1|||
124932292|NCT05069896|449382404|FG003|Overall Study|Adverse Event|0|||
124932293|NCT05069896|449382405|FG004|Overall Study|Adverse Event|0|||
124932294|NCT05069896|449382406|FG005|Overall Study|Adverse Event|0|||
124932295|NCT05069896|449382401|FG000|Overall Study|Lost to Follow-up|0|||
124932296|NCT05069896|449382402|FG001|Overall Study|Lost to Follow-up|0|||
124932297|NCT05069896|449382403|FG002|Overall Study|Lost to Follow-up|1|||
124932298|NCT05069896|449382404|FG003|Overall Study|Lost to Follow-up|0|||
124932299|NCT05069896|449382405|FG004|Overall Study|Lost to Follow-up|1|||
124932300|NCT05069896|449382406|FG005|Overall Study|Lost to Follow-up|2|||
124932301|NCT04068831|449382407|FG000|Overall Study|Disease Progression|10|||
124932302|NCT04068831|449382408|FG001|Overall Study|Disease Progression|8|||
124932303|NCT04820322|449382409|FG000|Overall Study|Adverse Event|1|||
124932304|NCT04820322|449382410|FG001|Overall Study|Adverse Event|0|||
124932305|NCT00323856|449382414|FG000|Overall Study|Withdrawal by Subject|1|||
124932306|NCT00323856|449382414|FG000|Overall Study|Was uncooperative and noncompliant|1|||
124932307|NCT00323856|449382414|FG000|Overall Study|Reason not specified|1|||
124932308|NCT00323856|449382414|FG000|Overall Study|Missing|2|||
124932309|NCT03156465|449382420|FG000|Overall Study|Withdrawal by Subject|2|||
124932310|NCT05715528|449382430|FG000|Overall Study|Randomized but never treated|11|||
124702245|NCT00959049|448534146|FG005|Overall Study|Lost to Follow-up|1|||
124702246|NCT00959049|448534141|FG000|Overall Study|Contraindicated medication|0|||
124702247|NCT00959049|448534142|FG001|Overall Study|Contraindicated medication|0|||
124932311|NCT05715528|449382431|FG001|Overall Study|Randomized but never treated|13|||
124702248|NCT00959049|448534143|FG002|Overall Study|Contraindicated medication|0|||
124932312|NCT05715528|449382430|FG000|Overall Study|Withdrew consent|7|||
124932313|NCT05715528|449382431|FG001|Overall Study|Withdrew consent|15|||
124932314|NCT05715528|449382430|FG000|Overall Study|Lost to Follow-up|5|||
124932315|NCT05715528|449382431|FG001|Overall Study|Lost to Follow-up|13|||
124932316|NCT05715528|449382430|FG000|Overall Study|Investigator's discretion|3|||
124932317|NCT05715528|449382431|FG001|Overall Study|Investigator's discretion|1|||
124932318|NCT05715528|449382430|FG000|Overall Study|Protocol Violation|2|||
124932319|NCT05715528|449382431|FG001|Overall Study|Protocol Violation|0|||
124932320|NCT05715528|449382430|FG000|Overall Study|Non-compliance with study drug|0|||
124932321|NCT05715528|449382431|FG001|Overall Study|Non-compliance with study drug|1|||
124932322|NCT03485729|449382435|FG000|Overall Study|Withdrawal by Subject|0|||
124932323|NCT03485729|449382436|FG001|Overall Study|Withdrawal by Subject|0|||
124932324|NCT03485729|449382437|FG002|Overall Study|Withdrawal by Subject|1|||
124932325|NCT03485729|449382435|FG000|Overall Study|Disease progression|8|||
124932326|NCT03485729|449382436|FG001|Overall Study|Disease progression|13|||
124932327|NCT03485729|449382437|FG002|Overall Study|Disease progression|1|||
124932328|NCT03485729|449382435|FG000|Overall Study|Hospice care|1|||
124932329|NCT03485729|449382436|FG001|Overall Study|Hospice care|0|||
124932330|NCT03485729|449382437|FG002|Overall Study|Hospice care|0|||
124932331|NCT03485729|449382435|FG000|Overall Study|Poor performance status|1|||
124932332|NCT03485729|449382436|FG001|Overall Study|Poor performance status|0|||
124932333|NCT03485729|449382437|FG002|Overall Study|Poor performance status|0|||
124932334|NCT03485729|449382435|FG000|Overall Study|Illness|0|||
124932335|NCT03485729|449382436|FG001|Overall Study|Illness|1|||
124932336|NCT03485729|449382437|FG002|Overall Study|Illness|0|||
124932337|NCT05035654|449382439|FG000|Overall Study|Physician Decision|0|||
124932338|NCT05035654|449382440|FG001|Overall Study|Physician Decision|1|||
124932339|NCT05035654|449382441|FG002|Overall Study|Physician Decision|0|||
124932340|NCT05035654|449382439|FG000|Overall Study|Adverse Event|0|||
124932341|NCT05035654|449382440|FG001|Overall Study|Adverse Event|1|||
124932342|NCT05035654|449382441|FG002|Overall Study|Adverse Event|0|||
124932343|NCT05035654|449382439|FG000|Overall Study|Withdrawal by Subject|0|||
124932344|NCT05035654|449382440|FG001|Overall Study|Withdrawal by Subject|0|||
124932345|NCT05035654|449382441|FG002|Overall Study|Withdrawal by Subject|4|||
124932346|NCT05035654|449382439|FG000|Overall Study|Bilateral Dislodgement|1|||
124932347|NCT05035654|449382440|FG001|Overall Study|Bilateral Dislodgement|0|||
124932348|NCT05035654|449382441|FG002|Overall Study|Bilateral Dislodgement|0|||
124932349|NCT04880733|449382442|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
124932350|NCT04880733|449382443|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
124932351|NCT04880733|449382444|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
124932352|NCT04880733|449382442|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
124932353|NCT04880733|449382443|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
124932354|NCT04880733|449382444|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
124932355|NCT04880733|449382442|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
124932356|NCT04880733|449382443|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
124932357|NCT04880733|449382444|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
124932358|NCT04880733|449382442|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
124932359|NCT04880733|449382443|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
124932360|NCT04880733|449382444|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
124932361|NCT04880733|449382442|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
124932362|NCT04880733|449382443|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
124932363|NCT04880733|449382444|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
124932364|NCT04934072|449382446|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
124932365|NCT04934072|449382447|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
124932366|NCT04934072|449382448|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
124932367|NCT04934072|449382449|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
124932368|NCT04934072|449382450|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
124932369|NCT04934072|449382446|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
124932370|NCT04934072|449382447|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
124932371|NCT04934072|449382448|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
124932372|NCT04934072|449382449|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
124932373|NCT04934072|449382450|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
124932374|NCT04934072|449382446|FG000|Day 0 to Week 52|Other|3|||
124932375|NCT04934072|449382447|FG001|Day 0 to Week 52|Other|1|||
124932376|NCT04934072|449382448|FG002|Day 0 to Week 52|Other|0|||
124932377|NCT04934072|449382449|FG003|Day 0 to Week 52|Other|0|||
124932378|NCT04934072|449382450|FG004|Day 0 to Week 52|Other|0|||
124932379|NCT04934072|449382446|FG000|Day 0 to Week 52|Adverse Event|1|||
124932380|NCT04934072|449382447|FG001|Day 0 to Week 52|Adverse Event|3|||
124702249|NCT00959049|448534144|FG003|Overall Study|Contraindicated medication|1|||
124702250|NCT00959049|448534145|FG004|Overall Study|Contraindicated medication|0|||
124932381|NCT04934072|449382448|FG002|Day 0 to Week 52|Adverse Event|0|||
124932382|NCT04934072|449382449|FG003|Day 0 to Week 52|Adverse Event|0|||
124932383|NCT04934072|449382450|FG004|Day 0 to Week 52|Adverse Event|0|||
124932384|NCT04934072|449382446|FG000|Week 52 to Week 78|Adverse Event|0|||
124932385|NCT04934072|449382447|FG001|Week 52 to Week 78|Adverse Event|0|||
124932386|NCT04934072|449382448|FG002|Week 52 to Week 78|Adverse Event|0|||
124932387|NCT04934072|449382449|FG003|Week 52 to Week 78|Adverse Event|1|||
124932388|NCT04934072|449382450|FG004|Week 52 to Week 78|Adverse Event|1|||
124932389|NCT04934072|449382446|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
124932390|NCT04934072|449382447|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
124932391|NCT04934072|449382448|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
124702251|NCT00959049|448534146|FG005|Overall Study|Contraindicated medication|0|||
124932392|NCT04934072|449382449|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
124932393|NCT04934072|449382450|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
124932394|NCT04934072|449382446|FG000|Week 52 to Week 78|Other|0|||
124932395|NCT04934072|449382447|FG001|Week 52 to Week 78|Other|0|||
124932396|NCT04934072|449382448|FG002|Week 52 to Week 78|Other|1|||
124932397|NCT04934072|449382449|FG003|Week 52 to Week 78|Other|0|||
124932398|NCT04934072|449382450|FG004|Week 52 to Week 78|Other|0|||
124932399|NCT03174275|449382452|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
124932400|NCT03174275|449382452|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
124932401|NCT03174275|449382452|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
124932402|NCT03174275|449382452|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
124932403|NCT03174275|449382452|FG000|Adjuvant Chemotherapy|Progression|1|||
124932404|NCT03174275|449382452|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
124932405|NCT03174275|449382452|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
124932406|NCT03174275|449382452|FG000|Adjuvant Durvalumab|Progression|1|||
124932407|NCT03174275|449382452|FG000|Adjuvant Durvalumab|Adverse Event|3|||
124932408|NCT03174275|449382452|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
124932409|NCT03174275|449382452|FG000|Adjuvant Radiotherapy|Progression|1|||
124932410|NCT03174275|449382452|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
124932411|NCT04456296|449382453|FG000|Overall Study|Withdrawal by Subject|14|||
124932412|NCT04456296|449382454|FG001|Overall Study|Withdrawal by Subject|21|||
124932413|NCT04456296|449382455|FG002|Overall Study|Withdrawal by Subject|21|||
124932414|NCT04456296|449382453|FG000|Overall Study|Adverse Event|2|||
124932415|NCT04456296|449382454|FG001|Overall Study|Adverse Event|2|||
124932416|NCT04456296|449382455|FG002|Overall Study|Adverse Event|2|||
124932417|NCT04456296|449382453|FG000|Overall Study|Death|1|||
124932418|NCT04456296|449382454|FG001|Overall Study|Death|0|||
124932419|NCT04456296|449382455|FG002|Overall Study|Death|0|||
124932420|NCT04456296|449382453|FG000|Overall Study|Lost to Follow-up|3|||
124932421|NCT04456296|449382454|FG001|Overall Study|Lost to Follow-up|5|||
124932422|NCT04456296|449382455|FG002|Overall Study|Lost to Follow-up|6|||
124932423|NCT04456296|449382453|FG000|Overall Study|Other than specified|0|||
124932424|NCT04456296|449382454|FG001|Overall Study|Other than specified|1|||
124932425|NCT04456296|449382455|FG002|Overall Study|Other than specified|4|||
124932426|NCT04456296|449382453|FG000|Overall Study|Randomized, not treated|2|||
124932427|NCT04456296|449382454|FG001|Overall Study|Randomized, not treated|1|||
124932428|NCT04456296|449382455|FG002|Overall Study|Randomized, not treated|0|||
124932429|NCT02997202|449382456|FG000|Overall Study|Miscellaneous|2|||
124932430|NCT02997202|449382457|FG001|Overall Study|Miscellaneous|2|||
124932431|NCT02997202|449382456|FG000|Overall Study|Withdrawal by Subject|8|||
124932432|NCT02997202|449382457|FG001|Overall Study|Withdrawal by Subject|12|||
124932433|NCT02997202|449382456|FG000|Overall Study|Lost to Follow-up|5|||
124932434|NCT02997202|449382457|FG001|Overall Study|Lost to Follow-up|3|||
124932435|NCT02997202|449382456|FG000|Overall Study|Death|41|||
124932436|NCT02997202|449382457|FG001|Overall Study|Death|45|||
124932437|NCT04271046|449382459|FG000|Overall Study|Death|0|||
124932438|NCT04271046|449382460|FG001|Overall Study|Death|2|||
124932439|NCT04271046|449382461|FG002|Overall Study|Death|0|||
124932440|NCT04271046|449382462|FG003|Overall Study|Death|2|||
124932441|NCT04271046|449382459|FG000|Overall Study|Lost to Follow-up|12|||
124932442|NCT04271046|449382460|FG001|Overall Study|Lost to Follow-up|12|||
124932443|NCT04271046|449382461|FG002|Overall Study|Lost to Follow-up|11|||
124932444|NCT04271046|449382462|FG003|Overall Study|Lost to Follow-up|11|||
124932445|NCT04271046|449382459|FG000|Overall Study|Patient with Dementia Died|2|||
124932446|NCT04271046|449382460|FG001|Overall Study|Patient with Dementia Died|0|||
124932447|NCT04271046|449382461|FG002|Overall Study|Patient with Dementia Died|2|||
124932448|NCT04271046|449382462|FG003|Overall Study|Patient with Dementia Died|0|||
124932449|NCT04271046|449382459|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
124932450|NCT04271046|449382460|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
124932451|NCT04271046|449382461|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
124932452|NCT04271046|449382462|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
124932453|NCT00303459|449382463|FG000|Overall Study|Death|33|||
124932454|NCT00303459|449382464|FG001|Overall Study|Death|44|||
124932455|NCT00303459|449382463|FG000|Overall Study|Withdrawal of consent|32|||
124932456|NCT00303459|449382464|FG001|Overall Study|Withdrawal of consent|26|||
124932457|NCT00303459|449382463|FG000|Overall Study|Lost to Follow-up|5|||
124932458|NCT00303459|449382464|FG001|Overall Study|Lost to Follow-up|4|||
124932459|NCT00303459|449382463|FG000|Overall Study|Administrative reason|7|||
124932460|NCT00303459|449382464|FG001|Overall Study|Administrative reason|7|||
124932461|NCT00303459|449382463|FG000|Overall Study|Decision by the investigator|5|||
124932462|NCT00303459|449382464|FG001|Overall Study|Decision by the investigator|7|||
124932463|NCT00303459|449382463|FG000|Overall Study|Lung transplantation|1|||
124932464|NCT00303459|449382464|FG001|Overall Study|Lung transplantation|1|||
124932465|NCT01570361|449382465|FG000|Overall Study|Subject discontinued|1|||
124932466|NCT01570361|449382466|FG001|Overall Study|Subject discontinued|2|||
124932467|NCT01570361|449382465|FG000|Overall Study|Sponsor closing the study|51|||
124932468|NCT01570361|449382466|FG001|Overall Study|Sponsor closing the study|50|||
124702252|NCT00959049|448534141|FG000|Overall Study|Withdrawal by Subject|0|||
124455764|NCT02113436|447628853|FG000|Period 2: 16 Weeks|Adverse Event|0|||
124455765|NCT02113436|447628854|FG001|Period 2: 16 Weeks|Adverse Event|0|||
124455766|NCT02113436|447628855|FG002|Period 2: 16 Weeks|Adverse Event|4|||
124455767|NCT02113436|447628856|FG003|Period 2: 16 Weeks|Adverse Event|5|||
124455768|NCT02113436|447628853|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
124455769|NCT02113436|447628854|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
124455770|NCT02113436|447628855|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
124455771|NCT02113436|447628856|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
124455772|NCT02113436|447628853|FG000|Period 2: 16 Weeks|Physician Decision|0|||
124455773|NCT02113436|447628854|FG001|Period 2: 16 Weeks|Physician Decision|0|||
124455774|NCT02113436|447628855|FG002|Period 2: 16 Weeks|Physician Decision|2|||
124455775|NCT02113436|447628856|FG003|Period 2: 16 Weeks|Physician Decision|0|||
124455776|NCT02113436|447628853|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
124455777|NCT02113436|447628854|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
124455778|NCT02113436|447628855|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
124455779|NCT02113436|447628856|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
124455780|NCT01648790|447628857|FG000|Treatment 3|Withdrawal by Subject|0|||
124455781|NCT01648790|447628858|FG001|Treatment 3|Withdrawal by Subject|0|||
124455782|NCT01648790|447628859|FG002|Treatment 3|Withdrawal by Subject|0|||
124455783|NCT01648790|447628860|FG003|Treatment 3|Withdrawal by Subject|1|||
124455784|NCT01648790|447628861|FG004|Treatment 3|Withdrawal by Subject|0|||
124455785|NCT02969187|447628864|FG000|Overall Study|Physician Decision|12|||
124455786|NCT02969187|447628865|FG001|Overall Study|Physician Decision|13|||
124455787|NCT00365456|447628866|FG000|Trial Period I (12 Months)|Adverse Event|84|||
124455788|NCT00365456|447628867|FG001|Trial Period I (12 Months)|Adverse Event|0|||
124455789|NCT00365456|447628866|FG000|Trial Period I (12 Months)|Non-compliance|3|||
124455790|NCT00365456|447628867|FG001|Trial Period I (12 Months)|Non-compliance|0|||
124455791|NCT00365456|447628866|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
124455792|NCT00365456|447628867|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
124455793|NCT00365456|447628866|FG000|Trial Period I (12 Months)|Other|11|||
124455794|NCT00365456|447628867|FG001|Trial Period I (12 Months)|Other|0|||
124455795|NCT00365456|447628866|FG000|Trial Period II (12 Months)|Adverse Event|0|||
124455796|NCT00365456|447628867|FG001|Trial Period II (12 Months)|Adverse Event|6|||
124455797|NCT00365456|447628866|FG000|Trial Period II (12 Months)|Non-compliance|0|||
124455798|NCT00365456|447628867|FG001|Trial Period II (12 Months)|Non-compliance|2|||
124455799|NCT00365456|447628866|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
124455800|NCT00365456|447628867|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
124455801|NCT00365456|447628866|FG000|Trial Period II (12 Months)|Other|0|||
124702253|NCT00959049|448534142|FG001|Overall Study|Withdrawal by Subject|2|||
124702254|NCT00959049|448534143|FG002|Overall Study|Withdrawal by Subject|0|||
124702255|NCT00959049|448534144|FG003|Overall Study|Withdrawal by Subject|0|||
124455802|NCT00365456|447628867|FG001|Trial Period II (12 Months)|Other|1|||
124455803|NCT00365456|447628866|FG000|Trial Period III (12 Months)|Adverse Event|13|||
124455804|NCT00365456|447628867|FG001|Trial Period III (12 Months)|Adverse Event|3|||
124702256|NCT00959049|448534145|FG004|Overall Study|Withdrawal by Subject|0|||
124455805|NCT00365456|447628866|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
124455806|NCT00365456|447628867|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
124455807|NCT00365456|447628866|FG000|Trial Period III (12 Months)|Other|1|||
124455808|NCT00365456|447628867|FG001|Trial Period III (12 Months)|Other|1|||
124455809|NCT01816061|447628871|FG000|Overall Study|Lost to Follow-up|13|||
124455810|NCT01816061|447628872|FG001|Overall Study|Lost to Follow-up|24|||
124455811|NCT01265615|447628873|FG000|Overall Study|Protocol Violation|2|||
124455812|NCT01265615|447628874|FG001|Overall Study|Protocol Violation|2|||
124702257|NCT00959049|448534146|FG005|Overall Study|Withdrawal by Subject|0|||
124702258|NCT00567502|448534147|FG000|Overall Study|Lost to Follow-up|91|||
124702259|NCT00567502|448534148|FG001|Overall Study|Lost to Follow-up|14|||
124702260|NCT00567502|448534149|FG002|Overall Study|Lost to Follow-up|351|||
124702261|NCT00567502|448534150|FG003|Overall Study|Lost to Follow-up|2|||
124702262|NCT00567502|448534147|FG000|Overall Study|Death|65|||
124932469|NCT01570361|449382465|FG000|Overall Study|Subject excluded|5|||
124932470|NCT01570361|449382466|FG001|Overall Study|Subject excluded|3|||
124932471|NCT01570361|449382465|FG000|Overall Study|Subject withdrew consent|14|||
124932472|NCT01570361|449382466|FG001|Overall Study|Subject withdrew consent|9|||
124932473|NCT01570361|449382465|FG000|Overall Study|Adverse Event|2|||
124932474|NCT01570361|449382466|FG001|Overall Study|Adverse Event|1|||
124932475|NCT01570361|449382465|FG000|Overall Study|Lost to Follow-up|4|||
124932476|NCT01570361|449382466|FG001|Overall Study|Lost to Follow-up|4|||
124932477|NCT01570361|449382465|FG000|Overall Study|Death|5|||
124932478|NCT01570361|449382466|FG001|Overall Study|Death|4|||
124932479|NCT01570361|449382465|FG000|Overall Study|Other|0|||
124932480|NCT01570361|449382466|FG001|Overall Study|Other|2|||
124932481|NCT04129554|449382467|FG000|Overall Study|Withdrawal by Subject|4|||
124932482|NCT04129554|449382468|FG001|Overall Study|Withdrawal by Subject|3|||
124932483|NCT04129554|449382467|FG000|Overall Study|Other|0|||
124932484|NCT04129554|449382468|FG001|Overall Study|Other|2|||
124932485|NCT03993392|449382476|FG000|Overall Study|Withdrawal by Subject|3|||
124932486|NCT03993392|449382476|FG000|Overall Study|Lost to Follow-up|2|||
124932487|NCT03993392|449382476|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
124932488|NCT05962814|449382481|FG000|Overall Study|failed eligibility|1|||
124932489|NCT04826471|449384461|FG000|Overall Study|Lost to Follow-up|2|||
124932490|NCT04826471|449384461|FG000|Overall Study|Protocol Violation|3|||
124932491|NCT04826471|449384461|FG000|Overall Study|Withdrawal by Subject|1|||
124932492|NCT04304144|449384463|FG000|DLT Observation Period|Physician Decision|0|||
124932493|NCT04304144|449384464|FG001|DLT Observation Period|Physician Decision|1|||
124932494|NCT04304144|449384465|FG002|DLT Observation Period|Physician Decision|0|||
124932495|NCT04304144|449384466|FG003|DLT Observation Period|Physician Decision|0|||
124932496|NCT04304144|449384463|FG000|Continued Treatment Period|Adverse Event|0|||
124932497|NCT04304144|449384464|FG001|Continued Treatment Period|Adverse Event|1|||
124932498|NCT04304144|449384465|FG002|Continued Treatment Period|Adverse Event|0|||
124932499|NCT04304144|449384466|FG003|Continued Treatment Period|Adverse Event|0|||
124932500|NCT04304144|449384463|FG000|Continued Treatment Period|Death|0|||
124932501|NCT04304144|449384464|FG001|Continued Treatment Period|Death|0|||
124932502|NCT04304144|449384465|FG002|Continued Treatment Period|Death|1|||
124932503|NCT04304144|449384466|FG003|Continued Treatment Period|Death|2|||
124932504|NCT04304144|449384463|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
124932505|NCT04304144|449384464|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
124932506|NCT04304144|449384465|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
124932507|NCT04304144|449384466|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
124932508|NCT04304144|449384463|FG000|Continued Treatment Period|Other than specified|2|||
124932509|NCT04304144|449384464|FG001|Continued Treatment Period|Other than specified|0|||
124932510|NCT04304144|449384465|FG002|Continued Treatment Period|Other than specified|1|||
124932511|NCT04304144|449384466|FG003|Continued Treatment Period|Other than specified|1|||
124932512|NCT04615273|449384469|FG000|Overall Study|Withdrawal by Subject|3|||
124932513|NCT04615273|449384470|FG001|Overall Study|Withdrawal by Subject|1|||
124932514|NCT04615273|449384471|FG002|Overall Study|Withdrawal by Subject|2|||
124932515|NCT04615273|449384469|FG000|Overall Study|Adverse Event|1|||
124932516|NCT04615273|449384470|FG001|Overall Study|Adverse Event|0|||
124932517|NCT04615273|449384471|FG002|Overall Study|Adverse Event|1|||
124932518|NCT04615273|449384469|FG000|Overall Study|Lost to Follow-up|0|||
124932519|NCT04615273|449384470|FG001|Overall Study|Lost to Follow-up|1|||
124932520|NCT04615273|449384471|FG002|Overall Study|Lost to Follow-up|0|||
124932521|NCT04615273|449384469|FG000|Overall Study|Physician Decision|0|||
124932522|NCT04615273|449384470|FG001|Overall Study|Physician Decision|0|||
124932523|NCT04615273|449384471|FG002|Overall Study|Physician Decision|1|||
124932524|NCT04615273|449384469|FG000|Overall Study|Other|0|||
124932525|NCT04615273|449384470|FG001|Overall Study|Other|1|||
124932526|NCT04615273|449384471|FG002|Overall Study|Other|0|||
124932527|NCT04615273|449384469|FG000|Overall Study|Randomized but not treated|1|||
124932528|NCT04615273|449384470|FG001|Overall Study|Randomized but not treated|3|||
124932529|NCT04615273|449384471|FG002|Overall Study|Randomized but not treated|1|||
124932530|NCT03673501|449384474|FG000|Overall Study|Participants ongoing.|36|||
124932531|NCT03673501|449384475|FG001|Overall Study|Participants ongoing.|24|||
124932532|NCT04599634|449384476|FG000|Overall Study|Dose limiting toxicity|0|||
124455813|NCT01265615|447628875|FG002|Overall Study|Protocol Violation|4|||
124702263|NCT00567502|448534148|FG001|Overall Study|Death|16|||
124702264|NCT00567502|448534149|FG002|Overall Study|Death|360|||
124932533|NCT04599634|449384477|FG001|Overall Study|Dose limiting toxicity|0|||
124932534|NCT04599634|449384478|FG002|Overall Study|Dose limiting toxicity|2|||
124932535|NCT04599634|449384479|FG003|Overall Study|Dose limiting toxicity|0|||
124932536|NCT03714815|449384480|FG000|Overall Study|Physician Decision|2|||
124932537|NCT03714815|449384480|FG000|Overall Study|Withdrawal by Subject|2|||
124932538|NCT03714815|449384480|FG000|Overall Study|Death|11|||
124932539|NCT04999111|449384481|FG000|Overall Study|Lost to Follow-up|21|||
124932540|NCT04999111|449384482|FG001|Overall Study|Lost to Follow-up|16|||
124932541|NCT04999111|449384483|FG002|Overall Study|Lost to Follow-up|2|||
124932542|NCT04999111|449384484|FG003|Overall Study|Lost to Follow-up|26|||
124932543|NCT04999111|449384485|FG004|Overall Study|Lost to Follow-up|30|||
124932544|NCT04999111|449384486|FG005|Overall Study|Lost to Follow-up|6|||
124932545|NCT04999111|449384481|FG000|Overall Study|Physician Decision|1|||
124932546|NCT04999111|449384482|FG001|Overall Study|Physician Decision|3|||
124932547|NCT04999111|449384483|FG002|Overall Study|Physician Decision|0|||
124932548|NCT04999111|449384484|FG003|Overall Study|Physician Decision|1|||
124932549|NCT04999111|449384485|FG004|Overall Study|Physician Decision|2|||
124932550|NCT04999111|449384486|FG005|Overall Study|Physician Decision|0|||
124932551|NCT04999111|449384481|FG000|Overall Study|Withdrawal by Subject|23|||
124932552|NCT04999111|449384482|FG001|Overall Study|Withdrawal by Subject|29|||
124932553|NCT04999111|449384483|FG002|Overall Study|Withdrawal by Subject|15|||
124932554|NCT04999111|449384484|FG003|Overall Study|Withdrawal by Subject|30|||
124932555|NCT04999111|449384485|FG004|Overall Study|Withdrawal by Subject|35|||
124932556|NCT04999111|449384486|FG005|Overall Study|Withdrawal by Subject|10|||
124932557|NCT04999111|449384481|FG000|Overall Study|Other|6|||
124932558|NCT04999111|449384482|FG001|Overall Study|Other|6|||
124932559|NCT04999111|449384483|FG002|Overall Study|Other|3|||
124932560|NCT04999111|449384484|FG003|Overall Study|Other|8|||
124932561|NCT04999111|449384485|FG004|Overall Study|Other|8|||
124932562|NCT04999111|449384486|FG005|Overall Study|Other|5|||
124932563|NCT04999111|449384481|FG000|Overall Study|Non-compliance with study schedule|1|||
124932564|NCT04999111|449384482|FG001|Overall Study|Non-compliance with study schedule|0|||
124932565|NCT04999111|449384483|FG002|Overall Study|Non-compliance with study schedule|0|||
124932566|NCT04999111|449384484|FG003|Overall Study|Non-compliance with study schedule|1|||
124932567|NCT04999111|449384485|FG004|Overall Study|Non-compliance with study schedule|1|||
124932568|NCT04999111|449384486|FG005|Overall Study|Non-compliance with study schedule|1|||
124932569|NCT04999111|449384481|FG000|Overall Study|Randomized but not vaccinated|1|||
124932570|NCT04999111|449384482|FG001|Overall Study|Randomized but not vaccinated|2|||
124932571|NCT04999111|449384483|FG002|Overall Study|Randomized but not vaccinated|0|||
124932572|NCT04999111|449384484|FG003|Overall Study|Randomized but not vaccinated|3|||
124932573|NCT04999111|449384485|FG004|Overall Study|Randomized but not vaccinated|3|||
124932574|NCT04999111|449384486|FG005|Overall Study|Randomized but not vaccinated|0|||
124932575|NCT04999111|449384481|FG000|Overall Study|Adverse Event|1|||
124932576|NCT04999111|449384482|FG001|Overall Study|Adverse Event|1|||
124932577|NCT04999111|449384483|FG002|Overall Study|Adverse Event|0|||
124932578|NCT04999111|449384484|FG003|Overall Study|Adverse Event|0|||
124932579|NCT04999111|449384485|FG004|Overall Study|Adverse Event|0|||
124932580|NCT04999111|449384486|FG005|Overall Study|Adverse Event|0|||
124932581|NCT04999111|449384481|FG000|Overall Study|Initiated prohibited medication|0|||
124932582|NCT04999111|449384482|FG001|Overall Study|Initiated prohibited medication|0|||
124932583|NCT04999111|449384483|FG002|Overall Study|Initiated prohibited medication|0|||
124932584|NCT04999111|449384484|FG003|Overall Study|Initiated prohibited medication|0|||
124932585|NCT04999111|449384485|FG004|Overall Study|Initiated prohibited medication|1|||
124932586|NCT04999111|449384486|FG005|Overall Study|Initiated prohibited medication|0|||
124932587|NCT01314105|449384490|FG000|Overall Study|Progressive Disease|6|||
124932588|NCT01314105|449384491|FG001|Overall Study|Progressive Disease|10|||
124932589|NCT01314105|449384490|FG000|Overall Study|Refused to continue taking medication|0|||
124932590|NCT01314105|449384491|FG001|Overall Study|Refused to continue taking medication|1|||
124455814|NCT01265615|447628876|FG003|Overall Study|Protocol Violation|3|||
124455815|NCT03370120|447628878|FG000|Overall Study|Adverse event, non-fatal|24|||
124455816|NCT03370120|447628878|FG000|Overall Study|Withdrawal by Subject|6|||
124455817|NCT03370120|447628878|FG000|Overall Study|Lost to Follow-up|1|||
124932591|NCT01314105|449384490|FG000|Overall Study|Other Adverse Event|1|||
124932592|NCT01314105|449384491|FG001|Overall Study|Other Adverse Event|1|||
124932593|NCT02056834|449384492|FG000|Overall Study|Lost to Follow-up|7|||
124932594|NCT06106022|449384493|FG000|Overall Study|Lost to Follow-up|1|||
124932595|NCT06106022|449384494|FG001|Overall Study|Lost to Follow-up|0|||
124932596|NCT06106022|449384493|FG000|Overall Study|Voluntary Withdrawal|0|||
124932597|NCT06106022|449384494|FG001|Overall Study|Voluntary Withdrawal|2|||
124455818|NCT03370120|447628878|FG000|Overall Study|Lack of Efficacy|37|||
124932598|NCT03276676|449384496|FG000|Overall Study|Withdrawal by Subject|2|||
124932599|NCT03276676|449384497|FG001|Overall Study|Withdrawal by Subject|1|||
124932600|NCT03926130|449384500|FG000|Overall Study|Adverse Event|9|||
124455819|NCT03370120|447628878|FG000|Overall Study|Per sponsor's instructions|1|||
124932601|NCT03926130|449384501|FG001|Overall Study|Adverse Event|11|||
124932602|NCT03926130|449384502|FG002|Overall Study|Adverse Event|2|||
124932603|NCT03926130|449384503|FG003|Overall Study|Adverse Event|0|||
124932604|NCT03926130|449384500|FG000|Overall Study|Death|2|||
124932605|NCT03926130|449384501|FG001|Overall Study|Death|0|||
124932606|NCT03926130|449384502|FG002|Overall Study|Death|1|||
124932607|NCT03926130|449384503|FG003|Overall Study|Death|0|||
124932608|NCT03926130|449384500|FG000|Overall Study|Lack of Efficacy|14|||
124932609|NCT03926130|449384501|FG001|Overall Study|Lack of Efficacy|11|||
124932610|NCT03926130|449384502|FG002|Overall Study|Lack of Efficacy|7|||
124932611|NCT03926130|449384503|FG003|Overall Study|Lack of Efficacy|1|||
124932612|NCT03926130|449384500|FG000|Overall Study|Lost to Follow-up|0|||
124932613|NCT03926130|449384501|FG001|Overall Study|Lost to Follow-up|7|||
124932614|NCT03926130|449384502|FG002|Overall Study|Lost to Follow-up|1|||
124932615|NCT03926130|449384503|FG003|Overall Study|Lost to Follow-up|0|||
124932616|NCT03926130|449384500|FG000|Overall Study|As Reported by Investigator|2|||
124932617|NCT03926130|449384501|FG001|Overall Study|As Reported by Investigator|6|||
124932618|NCT03926130|449384502|FG002|Overall Study|As Reported by Investigator|6|||
124932619|NCT03926130|449384503|FG003|Overall Study|As Reported by Investigator|0|||
124932620|NCT03926130|449384500|FG000|Overall Study|Physician Decision|3|||
124932621|NCT03926130|449384501|FG001|Overall Study|Physician Decision|2|||
124932622|NCT03926130|449384502|FG002|Overall Study|Physician Decision|1|||
124932623|NCT03926130|449384503|FG003|Overall Study|Physician Decision|0|||
124932624|NCT03926130|449384500|FG000|Overall Study|Pregnancy|2|||
124932625|NCT03926130|449384501|FG001|Overall Study|Pregnancy|2|||
124932626|NCT03926130|449384502|FG002|Overall Study|Pregnancy|1|||
124932627|NCT03926130|449384503|FG003|Overall Study|Pregnancy|0|||
124932628|NCT03926130|449384500|FG000|Overall Study|Withdrawal by Subject|20|||
124455820|NCT03370120|447628878|FG000|Overall Study|Study was terminated by parent company UCB|2|||
124455821|NCT03370120|447628878|FG000|Overall Study|The study was ended by the promoter|3|||
124455822|NCT03370120|447628878|FG000|Overall Study|Discontinuation of drug development|3|||
124455823|NCT03370120|447628878|FG000|Overall Study|End of project|2|||
124455824|NCT03370120|447628878|FG000|Overall Study|Premature study closure|2|||
124455825|NCT03370120|447628878|FG000|Overall Study|Premature program termination|1|||
124455826|NCT03370120|447628878|FG000|Overall Study|Premature study termination|7|||
124455827|NCT03370120|447628878|FG000|Overall Study|Trial terminated by sponsor|2|||
124455828|NCT03370120|447628878|FG000|Overall Study|Trial discontinued by sponsor|2|||
124702265|NCT00567502|448534150|FG003|Overall Study|Death|5|||
124702266|NCT00567502|448534147|FG000|Overall Study|Other|64|||
124702267|NCT00567502|448534148|FG001|Overall Study|Other|2|||
124702268|NCT00567502|448534149|FG002|Overall Study|Other|134|||
124702269|NCT00567502|448534150|FG003|Overall Study|Other|6|||
124702270|NCT00567502|448534147|FG000|Overall Study|Participant request|12|||
124702271|NCT00567502|448534148|FG001|Overall Study|Participant request|1|||
124702272|NCT00567502|448534149|FG002|Overall Study|Participant request|33|||
124702273|NCT00567502|448534150|FG003|Overall Study|Participant request|1|||
124702274|NCT00567502|448534147|FG000|Overall Study|Sponsor request|9|||
124702275|NCT00567502|448534148|FG001|Overall Study|Sponsor request|0|||
124702276|NCT00567502|448534149|FG002|Overall Study|Sponsor request|30|||
124932629|NCT03926130|449384501|FG001|Overall Study|Withdrawal by Subject|28|||
124932630|NCT03926130|449384502|FG002|Overall Study|Withdrawal by Subject|18|||
124932631|NCT03926130|449384503|FG003|Overall Study|Withdrawal by Subject|1|||
124932632|NCT03926130|449384500|FG000|Overall Study|Non-Compliance|1|||
124932633|NCT03926130|449384501|FG001|Overall Study|Non-Compliance|1|||
124932634|NCT03926130|449384502|FG002|Overall Study|Non-Compliance|0|||
124932635|NCT03926130|449384503|FG003|Overall Study|Non-Compliance|0|||
124932636|NCT03926130|449384500|FG000|Overall Study|Disposition Not Captured|0|||
124932637|NCT03926130|449384501|FG001|Overall Study|Disposition Not Captured|2|||
124702277|NCT00567502|448534150|FG003|Overall Study|Sponsor request|1|||
124702278|NCT00567502|448534147|FG000|Overall Study|Never Initiated Treatment|0|||
124702279|NCT00567502|448534148|FG001|Overall Study|Never Initiated Treatment|0|||
124932638|NCT03926130|449384502|FG002|Overall Study|Disposition Not Captured|1|||
124932639|NCT03926130|449384503|FG003|Overall Study|Disposition Not Captured|0|||
124932640|NCT03583333|449384504|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
124969582|NCT03520075|449517419|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969583|NCT03520075|449517420|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969584|NCT03520075|449517421|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969585|NCT03520075|449517422|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
124969586|NCT03520075|449517423|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
124969587|NCT03520075|449517424|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
124969588|NCT03520075|449517425|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
124969589|NCT03520075|449517426|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
124969590|NCT03520075|449517427|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
124969591|NCT03520075|449517409|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969592|NCT03520075|449517410|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969593|NCT03520075|449517411|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969594|NCT03520075|449517412|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969595|NCT03520075|449517413|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969596|NCT03520075|449517414|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969597|NCT03520075|449517415|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124932641|NCT03583333|449384505|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
124932642|NCT03583333|449384504|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
124932643|NCT03583333|449384505|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
124932644|NCT03583333|449384504|FG000|Overall Study|Withdrawal by Subject|9|||
124932645|NCT03583333|449384505|FG001|Overall Study|Withdrawal by Subject|5|||
124932646|NCT03583333|449384504|FG000|Overall Study|Physician Decision|3|||
124932647|NCT03583333|449384505|FG001|Overall Study|Physician Decision|2|||
124932648|NCT03583333|449384504|FG000|Overall Study|Death|12|||
124932649|NCT03583333|449384505|FG001|Overall Study|Death|7|||
124932650|NCT04469270|449384506|FG000|Overall Study|Adverse Event|2|||
124932651|NCT04469270|449384507|FG001|Overall Study|Adverse Event|0|||
124932652|NCT04469270|449384506|FG000|Overall Study|Lost to Follow-up|4|||
124932653|NCT04469270|449384507|FG001|Overall Study|Lost to Follow-up|3|||
124932654|NCT04469270|449384506|FG000|Overall Study|Withdrawal by Subject|7|||
124932655|NCT04469270|449384507|FG001|Overall Study|Withdrawal by Subject|3|||
124932656|NCT04469270|449384506|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
124932657|NCT04469270|449384507|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
124932658|NCT04469270|449384506|FG000|Overall Study|missing|1|||
124932659|NCT04469270|449384507|FG001|Overall Study|missing|0|||
124932660|NCT04086121|449384513|FG000|Overall Study|Other than listed|8|||
124932661|NCT04086121|449384513|FG000|Overall Study|Withdrawal by Subject|3|||
124932662|NCT04086121|449384513|FG000|Overall Study|Lost to Follow-up|2|||
124932663|NCT04086121|449384513|FG000|Overall Study|Adverse Event|1|||
124932664|NCT04580914|449384516|FG000|Overall Study|Withdrawal by Subject|6|||
124932665|NCT04580914|449384516|FG000|Overall Study|Lost to Follow-up|2|||
124932666|NCT03580356|449384517|FG000|Treatment Period|Withdrawal by Subject|13|||
124932667|NCT03580356|449384518|FG001|Treatment Period|Withdrawal by Subject|0|||
124932668|NCT03580356|449384519|FG002|Treatment Period|Withdrawal by Subject|13|||
124932669|NCT03580356|449384520|FG003|Treatment Period|Withdrawal by Subject|1|||
124932670|NCT03580356|449384521|FG004|Treatment Period|Withdrawal by Subject|17|||
124932671|NCT03580356|449384522|FG005|Treatment Period|Withdrawal by Subject|0|||
124932672|NCT03580356|449384523|FG006|Treatment Period|Withdrawal by Subject|5|||
124932673|NCT03580356|449384524|FG007|Treatment Period|Withdrawal by Subject|0|||
124932674|NCT03580356|449384517|FG000|Treatment Period|Adverse Event|10|||
124932675|NCT03580356|449384518|FG001|Treatment Period|Adverse Event|0|||
124932676|NCT03580356|449384519|FG002|Treatment Period|Adverse Event|13|||
124932677|NCT03580356|449384520|FG003|Treatment Period|Adverse Event|0|||
124932678|NCT03580356|449384521|FG004|Treatment Period|Adverse Event|5|||
124932679|NCT03580356|449384522|FG005|Treatment Period|Adverse Event|0|||
124932680|NCT03580356|449384523|FG006|Treatment Period|Adverse Event|8|||
124932681|NCT03580356|449384524|FG007|Treatment Period|Adverse Event|0|||
124932682|NCT03580356|449384517|FG000|Treatment Period|Protocol Violation|5|||
124932683|NCT03580356|449384518|FG001|Treatment Period|Protocol Violation|0|||
124932684|NCT03580356|449384519|FG002|Treatment Period|Protocol Violation|6|||
124932685|NCT03580356|449384520|FG003|Treatment Period|Protocol Violation|1|||
124932686|NCT03580356|449384521|FG004|Treatment Period|Protocol Violation|9|||
124932687|NCT03580356|449384522|FG005|Treatment Period|Protocol Violation|1|||
124932688|NCT03580356|449384523|FG006|Treatment Period|Protocol Violation|1|||
124932689|NCT03580356|449384524|FG007|Treatment Period|Protocol Violation|0|||
124932690|NCT03580356|449384517|FG000|Treatment Period|Lack of Efficacy|6|||
124932691|NCT03580356|449384518|FG001|Treatment Period|Lack of Efficacy|0|||
124932692|NCT03580356|449384519|FG002|Treatment Period|Lack of Efficacy|2|||
124932693|NCT03580356|449384520|FG003|Treatment Period|Lack of Efficacy|0|||
124932694|NCT03580356|449384521|FG004|Treatment Period|Lack of Efficacy|3|||
124932695|NCT03580356|449384522|FG005|Treatment Period|Lack of Efficacy|0|||
124932696|NCT03580356|449384523|FG006|Treatment Period|Lack of Efficacy|3|||
124932697|NCT03580356|449384524|FG007|Treatment Period|Lack of Efficacy|0|||
124932698|NCT03580356|449384517|FG000|Treatment Period|Pregnancy|1|||
124932699|NCT03580356|449384518|FG001|Treatment Period|Pregnancy|0|||
124932700|NCT03580356|449384519|FG002|Treatment Period|Pregnancy|7|||
124932701|NCT03580356|449384520|FG003|Treatment Period|Pregnancy|0|||
124932702|NCT03580356|449384521|FG004|Treatment Period|Pregnancy|2|||
124932703|NCT03580356|449384522|FG005|Treatment Period|Pregnancy|0|||
124932704|NCT03580356|449384523|FG006|Treatment Period|Pregnancy|1|||
124932705|NCT03580356|449384524|FG007|Treatment Period|Pregnancy|0|||
124932706|NCT03580356|449384517|FG000|Treatment Period|Physician Decision|2|||
124932707|NCT03580356|449384518|FG001|Treatment Period|Physician Decision|0|||
124932708|NCT03580356|449384519|FG002|Treatment Period|Physician Decision|1|||
124932709|NCT03580356|449384520|FG003|Treatment Period|Physician Decision|0|||
124932710|NCT03580356|449384521|FG004|Treatment Period|Physician Decision|4|||
124932711|NCT03580356|449384522|FG005|Treatment Period|Physician Decision|0|||
124932712|NCT03580356|449384523|FG006|Treatment Period|Physician Decision|2|||
124932713|NCT03580356|449384524|FG007|Treatment Period|Physician Decision|0|||
124932714|NCT03580356|449384517|FG000|Treatment Period|Lost to Follow-up|1|||
124932715|NCT03580356|449384518|FG001|Treatment Period|Lost to Follow-up|1|||
124932716|NCT03580356|449384519|FG002|Treatment Period|Lost to Follow-up|1|||
124932717|NCT03580356|449384520|FG003|Treatment Period|Lost to Follow-up|0|||
124932718|NCT03580356|449384521|FG004|Treatment Period|Lost to Follow-up|3|||
124932719|NCT03580356|449384522|FG005|Treatment Period|Lost to Follow-up|0|||
124932720|NCT03580356|449384523|FG006|Treatment Period|Lost to Follow-up|1|||
124932721|NCT03580356|449384524|FG007|Treatment Period|Lost to Follow-up|0|||
124932722|NCT03580356|449384517|FG000|Treatment Period|Death|0|||
124932723|NCT03580356|449384518|FG001|Treatment Period|Death|0|||
124932724|NCT03580356|449384519|FG002|Treatment Period|Death|1|||
124932725|NCT03580356|449384520|FG003|Treatment Period|Death|0|||
124932726|NCT03580356|449384521|FG004|Treatment Period|Death|0|||
124932727|NCT03580356|449384522|FG005|Treatment Period|Death|0|||
124932728|NCT03580356|449384523|FG006|Treatment Period|Death|0|||
124932729|NCT03580356|449384524|FG007|Treatment Period|Death|0|||
124932730|NCT03580356|449384517|FG000|Treatment Period|Technical problems|0|||
124932731|NCT03580356|449384518|FG001|Treatment Period|Technical problems|0|||
124932732|NCT03580356|449384519|FG002|Treatment Period|Technical problems|0|||
124932733|NCT03580356|449384520|FG003|Treatment Period|Technical problems|0|||
124932734|NCT03580356|449384521|FG004|Treatment Period|Technical problems|1|||
124932735|NCT03580356|449384522|FG005|Treatment Period|Technical problems|0|||
124932736|NCT03580356|449384523|FG006|Treatment Period|Technical problems|0|||
124932737|NCT03580356|449384524|FG007|Treatment Period|Technical problems|0|||
124932738|NCT03580356|449384517|FG000|Treatment Period|Misrandomized, no treatment|0|||
124932739|NCT03580356|449384518|FG001|Treatment Period|Misrandomized, no treatment|0|||
124932740|NCT03580356|449384519|FG002|Treatment Period|Misrandomized, no treatment|1|||
124932741|NCT03580356|449384520|FG003|Treatment Period|Misrandomized, no treatment|0|||
124932742|NCT03580356|449384521|FG004|Treatment Period|Misrandomized, no treatment|2|||
124932743|NCT03580356|449384522|FG005|Treatment Period|Misrandomized, no treatment|0|||
124932744|NCT03580356|449384523|FG006|Treatment Period|Misrandomized, no treatment|0|||
124932745|NCT03580356|449384524|FG007|Treatment Period|Misrandomized, no treatment|0|||
124932746|NCT03580356|449384517|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
124932747|NCT03580356|449384518|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
124932748|NCT03580356|449384519|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
124932749|NCT03580356|449384520|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
124932750|NCT03580356|449384521|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
124932751|NCT03580356|449384522|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
124932752|NCT03580356|449384523|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
124932753|NCT03580356|449384524|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
124932754|NCT03580356|449384517|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
124932755|NCT03580356|449384518|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
124932756|NCT03580356|449384519|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
124932757|NCT03580356|449384520|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
124932758|NCT03580356|449384521|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
124932759|NCT03580356|449384522|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
124932760|NCT03580356|449384523|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
124702280|NCT00567502|448534149|FG002|Overall Study|Never Initiated Treatment|0|||
124702281|NCT00567502|448534150|FG003|Overall Study|Never Initiated Treatment|72|||
124702282|NCT00337168|448534151|FG000|Overall Study|Death|5|||
124702283|NCT00337168|448534151|FG000|Overall Study|Not protocol specified|2|||
124702284|NCT00337168|448534151|FG000|Overall Study|Did not start therapy|1|||
124702285|NCT00666263|448534154|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
124455829|NCT03370120|447628878|FG000|Overall Study|Study ended|15|||
124455830|NCT03370120|447628878|FG000|Overall Study|Clinical trial has been cancelled|1|||
124455831|NCT03370120|447628878|FG000|Overall Study|End of study per sponsor decision|2|||
124455832|NCT03370120|447628878|FG000|Overall Study|Promoter's decision|2|||
124455833|NCT03370120|447628878|FG000|Overall Study|The trial has been suspended|3|||
124455834|NCT03370120|447628878|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
124455835|NCT03370120|447628878|FG000|Overall Study|Early termination by order of sponsor|2|||
124455836|NCT03370120|447628878|FG000|Overall Study|Discontinuation of the study|5|||
124455837|NCT03370120|447628878|FG000|Overall Study|End of clinical trial discontinuation|1|||
124455838|NCT03370120|447628878|FG000|Overall Study|Because the clinical trial ended halfway|4|||
124455839|NCT03370120|447628878|FG000|Overall Study|Development discontinued|5|||
124455840|NCT03370120|447628878|FG000|Overall Study|Padsenovil program closed|3|||
124455841|NCT03370120|447628878|FG000|Overall Study|End of project|2|||
124455842|NCT03370120|447628878|FG000|Overall Study|Termination of project|1|||
124455843|NCT03370120|447628878|FG000|Overall Study|The study was interrupted by sponsor|4|||
124455844|NCT03370120|447628878|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
124455845|NCT03370120|447628878|FG000|Overall Study|End of sponsor decision|1|||
124455846|NCT03370120|447628878|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
124455847|NCT03370120|447628878|FG000|Overall Study|Early termination of studies|5|||
124455848|NCT03370120|447628878|FG000|Overall Study|This study is ended early|1|||
124455849|NCT03370120|447628878|FG000|Overall Study|End of padsevonil program|2|||
124455850|NCT03370120|447628878|FG000|Overall Study|Decision of sponsor|6|||
124455851|NCT03370120|447628878|FG000|Overall Study|Asked by the sponsor|3|||
124455852|NCT03370120|447628878|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
124455853|NCT03370120|447628878|FG000|Overall Study|PI decision poor compliance from participant|1|||
124455854|NCT03370120|447628878|FG000|Overall Study|Promoter ended the study|3|||
124455855|NCT03370120|447628878|FG000|Overall Study|Premature study close by sponsor's decision|4|||
124455856|NCT03370120|447628878|FG000|Overall Study|Study terminated by sponsor|33|||
124702286|NCT00666263|448534155|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
124702287|NCT00666263|448534154|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
124702288|NCT00666263|448534155|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
124702289|NCT00666263|448534154|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
124702290|NCT00666263|448534155|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
124702291|NCT02439957|448534156|FG000|Overall Study|Study Terminated|3|||
124455857|NCT03370120|447628878|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
124455858|NCT03370120|447628878|FG000|Overall Study|Sponsor decision to terminate study|63|||
124455859|NCT03370120|447628878|FG000|Overall Study|Program closure|3|||
124455860|NCT03370120|447628878|FG000|Overall Study|Study ended prematurely|1|||
124455861|NCT03370120|447628878|FG000|Overall Study|Study stopped by sponsor|2|||
124455862|NCT03370120|447628878|FG000|Overall Study|Program termination|55|||
124455863|NCT03370120|447628878|FG000|Overall Study|Sponsor decision|62|||
124455864|NCT03370120|447628878|FG000|Overall Study|Sponsor study closure|10|||
124702292|NCT02439957|448534157|FG001|Overall Study|Study Terminated|3|||
124702293|NCT01225952|448534159|FG000|Overall Study|Lost to Follow-up|1|||
124702294|NCT01225952|448534160|FG001|Overall Study|Lost to Follow-up|0|||
124702295|NCT01225952|448534161|FG002|Overall Study|Lost to Follow-up|0|||
124702296|NCT01225952|448534159|FG000|Overall Study|Study Eye Explanted|0|||
124702297|NCT01225952|448534160|FG001|Overall Study|Study Eye Explanted|0|||
124702298|NCT01225952|448534161|FG002|Overall Study|Study Eye Explanted|1|||
124702299|NCT01225952|448534159|FG000|Overall Study|Withdrawal by Subject|4|||
124702300|NCT01225952|448534160|FG001|Overall Study|Withdrawal by Subject|4|||
124932761|NCT03580356|449384524|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
124932762|NCT03580356|449384517|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
124932763|NCT03580356|449384518|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
124932764|NCT03580356|449384519|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
124932765|NCT03580356|449384520|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
124932766|NCT03580356|449384521|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
124932767|NCT03580356|449384522|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
124932768|NCT03580356|449384523|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
124932769|NCT03580356|449384524|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
124932770|NCT03580356|449384517|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
124932771|NCT03580356|449384518|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
124932772|NCT03580356|449384519|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
124932773|NCT03580356|449384520|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
124932774|NCT03580356|449384521|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
124932775|NCT03580356|449384522|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
124932776|NCT03580356|449384523|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
124932777|NCT03580356|449384524|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
124932778|NCT03580356|449384517|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
124932779|NCT03580356|449384518|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
124932780|NCT03580356|449384519|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
124932781|NCT03580356|449384520|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
124932782|NCT03580356|449384521|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
124932783|NCT03580356|449384522|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
124932784|NCT03580356|449384523|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
124932785|NCT03580356|449384524|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
124932786|NCT03580356|449384517|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
124932787|NCT03580356|449384518|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
124932788|NCT03580356|449384519|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
124932789|NCT03580356|449384520|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
124932790|NCT03580356|449384521|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
124932791|NCT03580356|449384522|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
124932792|NCT03580356|449384523|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
124932793|NCT03580356|449384524|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
124932794|NCT03580356|449384517|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
124932795|NCT03580356|449384518|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
124932796|NCT03580356|449384519|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
124932797|NCT03580356|449384520|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
124932798|NCT03580356|449384521|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
124932799|NCT03580356|449384522|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
124932800|NCT03580356|449384523|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
124932801|NCT03580356|449384524|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
124932802|NCT03118518|449384526|FG000|Overall Study|Early Exit after treatment|2|||
124932803|NCT03118518|449384527|FG001|Overall Study|Early Exit after treatment|8|||
124932804|NCT03118518|449384526|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
124932805|NCT03118518|449384527|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
124932806|NCT03536884|449384531|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
124932807|NCT03536884|449384532|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
124932808|NCT03536884|449384533|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932809|NCT03536884|449384534|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932810|NCT03536884|449384535|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932811|NCT03536884|449384536|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932812|NCT03536884|449384537|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932813|NCT03536884|449384538|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932814|NCT03536884|449384539|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932815|NCT03536884|449384540|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124702301|NCT01225952|448534161|FG002|Overall Study|Withdrawal by Subject|5|||
124932816|NCT03536884|449384541|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932817|NCT03536884|449384542|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
124932818|NCT03536884|449384531|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932819|NCT03536884|449384532|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
124702302|NCT01225952|448534159|FG000|Overall Study|Surgical complications|1|||
124702303|NCT01225952|448534160|FG001|Overall Study|Surgical complications|0|||
124932820|NCT03536884|449384533|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932821|NCT03536884|449384534|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932822|NCT03536884|449384535|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932823|NCT03536884|449384536|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932824|NCT03536884|449384537|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932825|NCT03536884|449384538|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932826|NCT03536884|449384539|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932827|NCT03536884|449384540|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932828|NCT03536884|449384541|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932829|NCT03536884|449384542|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
124932830|NCT03536884|449384531|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
124932831|NCT03536884|449384532|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
124932832|NCT03536884|449384533|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932833|NCT03536884|449384534|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932834|NCT03536884|449384535|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932835|NCT03536884|449384536|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932836|NCT03536884|449384537|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932837|NCT03536884|449384538|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932838|NCT03536884|449384539|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932839|NCT03536884|449384540|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932840|NCT03536884|449384541|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932841|NCT03536884|449384542|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
124932842|NCT03536884|449384531|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932843|NCT03536884|449384532|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
124932844|NCT03536884|449384533|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932845|NCT03536884|449384534|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932846|NCT03536884|449384535|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932847|NCT03536884|449384536|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932848|NCT03536884|449384537|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932849|NCT03536884|449384538|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932850|NCT03536884|449384539|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932851|NCT03536884|449384540|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932852|NCT03536884|449384541|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932853|NCT03536884|449384542|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
124932854|NCT03536884|449384531|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932855|NCT03536884|449384532|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
124932856|NCT03536884|449384533|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932857|NCT03536884|449384534|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932858|NCT03536884|449384535|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932859|NCT03536884|449384536|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932860|NCT03536884|449384537|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932861|NCT03536884|449384538|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932862|NCT03536884|449384539|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932863|NCT03536884|449384540|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932864|NCT03536884|449384541|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932865|NCT03536884|449384542|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
124932866|NCT03536884|449384531|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932867|NCT03536884|449384532|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
124932868|NCT03536884|449384533|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932869|NCT03536884|449384534|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932870|NCT03536884|449384535|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932871|NCT03536884|449384536|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124455865|NCT01376778|447628879|FG000|Overall Study|Lost to Follow-up|3|||
124932872|NCT03536884|449384537|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932873|NCT03536884|449384538|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932874|NCT03536884|449384539|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932875|NCT03536884|449384540|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124455866|NCT01376778|447628880|FG001|Overall Study|Lost to Follow-up|2|||
124702304|NCT01225952|448534161|FG002|Overall Study|Surgical complications|0|||
124702305|NCT01230060|448534165|FG000|Overall Study|Withdrawal by Subject|1|||
124702306|NCT01052779|448534167|FG000|Overall Study|Adverse Event|1|||
124702307|NCT01052779|448534168|FG001|Overall Study|Adverse Event|4|||
124702308|NCT01052779|448534167|FG000|Overall Study|Withdrawal by Subject|1|||
124702309|NCT01052779|448534168|FG001|Overall Study|Withdrawal by Subject|2|||
124702310|NCT01052779|448534167|FG000|Overall Study|Other-Protocol Violation|1|||
124702311|NCT01052779|448534168|FG001|Overall Study|Other-Protocol Violation|1|||
124702312|NCT01052779|448534167|FG000|Overall Study|Other-Surgery|0|||
124702313|NCT01052779|448534168|FG001|Overall Study|Other-Surgery|2|||
124702314|NCT01052779|448534167|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
124702315|NCT01052779|448534168|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
124702316|NCT03802916|448534169|FG000|Overall Study|Adverse Event|0|||
124702317|NCT03802916|448534170|FG001|Overall Study|Adverse Event|1|||
124702318|NCT03802916|448534169|FG000|Overall Study|Withdrawal by Subject|0|||
124702319|NCT03802916|448534170|FG001|Overall Study|Withdrawal by Subject|1|||
124702320|NCT00480532|448534171|FG000|Overall Study|Withdrawal by Subject|2|||
124702321|NCT00480532|448534172|FG001|Overall Study|Withdrawal by Subject|4|||
124702322|NCT00480532|448534173|FG002|Overall Study|Withdrawal by Subject|3|||
124702323|NCT00480532|448534174|FG003|Overall Study|Withdrawal by Subject|1|||
124702324|NCT00480532|448534171|FG000|Overall Study|Protocol Violation|0|||
124702325|NCT00480532|448534172|FG001|Overall Study|Protocol Violation|0|||
124702326|NCT00480532|448534173|FG002|Overall Study|Protocol Violation|1|||
124702327|NCT00480532|448534174|FG003|Overall Study|Protocol Violation|0|||
124702328|NCT03729609|448534175|FG000|Overall Study|Protocol Violation|1|||
124932876|NCT03536884|449384541|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932877|NCT03536884|449384542|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
124932878|NCT03536884|449384531|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932879|NCT03536884|449384532|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932880|NCT03536884|449384533|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
124932881|NCT03536884|449384534|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932882|NCT03536884|449384535|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
124932883|NCT03536884|449384536|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932884|NCT03536884|449384537|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932885|NCT03536884|449384538|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932886|NCT03536884|449384539|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932887|NCT03536884|449384540|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932888|NCT03536884|449384541|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932889|NCT03536884|449384542|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
124932890|NCT03536884|449384531|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124932891|NCT03536884|449384532|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124932892|NCT03536884|449384533|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
124932893|NCT03536884|449384534|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
124932894|NCT03536884|449384535|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
124932895|NCT03536884|449384536|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124932896|NCT03536884|449384537|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124932897|NCT03536884|449384538|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124932898|NCT03536884|449384539|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124932899|NCT03536884|449384540|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124932900|NCT03536884|449384541|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124455867|NCT00454857|447628881|FG000|Overall Study|Withdrawal by Subject|15|||
124932901|NCT03536884|449384542|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
124932902|NCT03536884|449384531|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124932903|NCT03536884|449384532|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124932904|NCT03536884|449384533|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124932905|NCT03536884|449384534|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
124932906|NCT03536884|449384535|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
124932907|NCT03536884|449384536|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124455868|NCT00454857|447628881|FG000|Overall Study|Lost to Follow-up|16|||
124702329|NCT00605189|448534182|FG000|Overall Study|Adverse Event|1|||
124702330|NCT00605189|448534183|FG001|Overall Study|Adverse Event|0|||
124702331|NCT00605189|448534184|FG002|Overall Study|Adverse Event|0|||
124932908|NCT03536884|449384537|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124702332|NCT00605189|448534182|FG000|Overall Study|Other|2|||
124702333|NCT00605189|448534183|FG001|Overall Study|Other|2|||
124702334|NCT00605189|448534184|FG002|Overall Study|Other|0|||
124702335|NCT02697448|448534185|FG000|Overall Study|Protocol Violation|2|||
124455869|NCT00454857|447628881|FG000|Overall Study|Noncompliance|6|||
124455870|NCT00454857|447628881|FG000|Overall Study|Death|5|||
124455871|NCT00454857|447628881|FG000|Overall Study|Other|11|||
124455872|NCT00454857|447628881|FG000|Overall Study|Reason unknown|1|||
124455873|NCT04206020|447628885|FG000|Overall Study|Adverse Event|1|||
124455874|NCT04206020|447628886|FG001|Overall Study|Adverse Event|4|||
124455875|NCT04206020|447628885|FG000|Overall Study|Protocol Violation|2|||
124455876|NCT04206020|447628886|FG001|Overall Study|Protocol Violation|0|||
124455877|NCT04206020|447628885|FG000|Overall Study|Withdrawal by Subject|2|||
124455878|NCT04206020|447628886|FG001|Overall Study|Withdrawal by Subject|0|||
124455879|NCT04206020|447628885|FG000|Overall Study|Lost to Follow-up|2|||
124455880|NCT04206020|447628886|FG001|Overall Study|Lost to Follow-up|0|||
124455881|NCT04206020|447628885|FG000|Overall Study|Pregnancy|0|||
124455882|NCT04206020|447628886|FG001|Overall Study|Pregnancy|1|||
124455883|NCT04206020|447628885|FG000|Overall Study|Unable to attend visits|1|||
124455884|NCT04206020|447628886|FG001|Overall Study|Unable to attend visits|2|||
124455885|NCT02375724|447628889|FG000|Overall Study|Lack of Efficacy|1|||
124455886|NCT02375724|447628890|FG001|Overall Study|Lack of Efficacy|1|||
124455887|NCT02375724|447628889|FG000|Overall Study|Withdrawal by Subject|1|||
124455888|NCT02375724|447628890|FG001|Overall Study|Withdrawal by Subject|1|||
124455889|NCT02375724|447628889|FG000|Overall Study|Lost to Follow-up|1|||
124455890|NCT02375724|447628890|FG001|Overall Study|Lost to Follow-up|0|||
124455891|NCT02375724|447628889|FG000|Overall Study|Protocol Violation|1|||
124455892|NCT02375724|447628890|FG001|Overall Study|Protocol Violation|0|||
124455893|NCT02375724|447628889|FG000|Overall Study|Adverse Event|2|||
124702336|NCT02697448|448534186|FG001|Overall Study|Protocol Violation|4|||
124702337|NCT02697448|448534185|FG000|Overall Study|Clinical concerns during ablation|1|||
124702338|NCT02697448|448534186|FG001|Overall Study|Clinical concerns during ablation|1|||
124702339|NCT02697448|448534185|FG000|Overall Study|No data collected|2|||
124702340|NCT02697448|448534186|FG001|Overall Study|No data collected|0|||
124455894|NCT02375724|447628890|FG001|Overall Study|Adverse Event|4|||
124455895|NCT01517893|447628893|FG000|Overall Study|Withdrawal by Subject|3|||
124455896|NCT01517893|447628894|FG001|Overall Study|Withdrawal by Subject|0|||
124455897|NCT01309659|447628895|FG000|Overall Study|Protocol Violation|0|||
124455898|NCT01309659|447628896|FG001|Overall Study|Protocol Violation|1|||
124455899|NCT03462576|447628897|FG000|Overall Study|Protocol Violation|5|||
124455900|NCT03462576|447628898|FG001|Overall Study|Protocol Violation|11|||
124455901|NCT03462576|447628899|FG002|Overall Study|Protocol Violation|7|||
124455902|NCT03462576|447628897|FG000|Overall Study|Device Malfunction|0|||
124455903|NCT03462576|447628898|FG001|Overall Study|Device Malfunction|0|||
124455904|NCT03462576|447628899|FG002|Overall Study|Device Malfunction|1|||
124546434|NCT02181673|447955902|FG001|Week 24-Week 60|Lost to Follow-up|0|||
124932909|NCT03536884|449384538|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124932910|NCT03536884|449384539|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124932911|NCT03536884|449384540|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124932912|NCT03536884|449384541|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124932913|NCT03536884|449384542|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
124932914|NCT03536884|449384531|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932915|NCT03536884|449384532|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932916|NCT03536884|449384533|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
124932917|NCT03536884|449384534|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
124932918|NCT03536884|449384535|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
124932919|NCT03536884|449384536|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932920|NCT03536884|449384537|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932921|NCT03536884|449384538|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932922|NCT03536884|449384539|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932923|NCT03536884|449384540|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932924|NCT03536884|449384541|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932925|NCT03536884|449384542|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
124932926|NCT03536884|449384531|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932927|NCT03536884|449384532|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932928|NCT03536884|449384533|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
124932929|NCT03536884|449384534|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
124932930|NCT03536884|449384535|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
124932931|NCT03536884|449384536|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932932|NCT03536884|449384537|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932933|NCT03536884|449384538|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932934|NCT03536884|449384539|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932935|NCT03536884|449384540|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932936|NCT03536884|449384541|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932937|NCT03536884|449384542|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
124932938|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
124932939|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
124932940|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
124932941|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
124932942|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
124932943|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
124932944|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
124932945|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
124932946|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
124932947|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
124932948|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
124932949|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
124932950|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
124932951|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
124932952|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
124932953|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
124932954|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
124932955|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
124932956|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
124932957|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
124932958|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
124932959|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
124932960|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
124932961|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
124932962|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932963|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932964|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932965|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932966|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932967|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
124932968|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932969|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
124932970|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932971|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932972|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932973|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
124932974|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124932975|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124932976|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124932977|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124932978|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124702341|NCT05473715|448534187|FG000|Overall Study|Trial terminate|2|||
124702342|NCT05473715|448534188|FG001|Overall Study|Trial terminate|1|||
124932979|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
124932980|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124932981|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
124932982|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
124932983|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124932984|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124932985|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
124932986|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
124932987|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
124932988|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
124932989|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
124932990|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
124932991|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
124932992|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
124932993|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
124932994|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
124932995|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
124932996|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
124932997|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
124932998|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124932999|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933000|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933001|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933002|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933003|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
124933004|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933005|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933006|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933007|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933008|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933009|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
124933010|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933011|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933012|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933013|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933014|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933015|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933016|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
124933017|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933018|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933019|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933020|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933021|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
124933022|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933023|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933024|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933025|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933026|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933027|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933028|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
124933029|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933030|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933031|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933032|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933033|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
124933034|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933035|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933036|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933037|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
124702343|NCT02919618|448534192|FG000|Overall Study|Death|1|||
124546435|NCT02181673|447955903|FG002|Week 24-Week 60|Lost to Follow-up|1|||
124933038|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933039|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
124933040|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933041|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933042|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933043|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933044|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933045|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
124933046|NCT03536884|449384531|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933047|NCT03536884|449384532|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933048|NCT03536884|449384533|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933049|NCT03536884|449384534|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933050|NCT03536884|449384535|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933051|NCT03536884|449384536|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933052|NCT03536884|449384537|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933053|NCT03536884|449384538|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933054|NCT03536884|449384539|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
124933055|NCT03536884|449384540|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933056|NCT03536884|449384541|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933057|NCT03536884|449384542|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
124933058|NCT03536884|449384531|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933059|NCT03536884|449384532|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933060|NCT03536884|449384533|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933061|NCT03536884|449384534|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933062|NCT03536884|449384535|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933063|NCT03536884|449384536|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933064|NCT03536884|449384537|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933065|NCT03536884|449384538|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933066|NCT03536884|449384539|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124933067|NCT03536884|449384540|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
124933068|NCT03536884|449384541|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
124933069|NCT03536884|449384542|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
124455905|NCT01069172|447628911|FG000|Overall Study|Withdrawal by Subject|1|||
124455906|NCT01069172|447628912|FG001|Overall Study|Withdrawal by Subject|0|||
124455907|NCT04206605|447628913|FG000|Overall Study|Adverse Event|0|||
124455908|NCT04206605|447628914|FG001|Overall Study|Adverse Event|1|||
124455909|NCT04206605|447628913|FG000|Overall Study|Withdrawal by Subject|1|||
124933070|NCT03536884|449384531|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124933071|NCT03536884|449384532|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124933072|NCT03536884|449384533|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124455910|NCT04206605|447628914|FG001|Overall Study|Withdrawal by Subject|0|||
124933073|NCT03536884|449384534|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124933074|NCT03536884|449384535|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124933075|NCT03536884|449384536|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124933076|NCT03536884|449384537|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124933077|NCT03536884|449384538|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124933078|NCT03536884|449384539|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124933079|NCT03536884|449384540|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
124933080|NCT03536884|449384541|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
124933081|NCT03536884|449384542|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
124933082|NCT03536884|449384531|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933083|NCT03536884|449384532|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933084|NCT03536884|449384533|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933085|NCT03536884|449384534|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933086|NCT03536884|449384535|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933087|NCT03536884|449384536|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933088|NCT03536884|449384537|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933089|NCT03536884|449384538|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933090|NCT03536884|449384539|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933091|NCT03536884|449384540|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933092|NCT03536884|449384541|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
124933093|NCT03536884|449384542|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
124933094|NCT03536884|449384531|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933095|NCT03536884|449384532|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933096|NCT03536884|449384533|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933097|NCT03536884|449384534|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933098|NCT03536884|449384535|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933099|NCT03536884|449384536|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933100|NCT03536884|449384537|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933101|NCT03536884|449384538|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933102|NCT03536884|449384539|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933103|NCT03536884|449384540|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933104|NCT03536884|449384541|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
124933105|NCT03536884|449384542|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
124933106|NCT03536884|449384531|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933107|NCT03536884|449384532|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933108|NCT03536884|449384533|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933109|NCT03536884|449384534|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933110|NCT03536884|449384535|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933111|NCT03536884|449384536|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933112|NCT03536884|449384537|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933113|NCT03536884|449384538|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933114|NCT03536884|449384539|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933115|NCT03536884|449384540|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933116|NCT03536884|449384541|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
124933117|NCT03536884|449384542|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
124933118|NCT02367040|449384564|FG000|Overall Study|Lost to Follow-up|1|||
124933119|NCT02367040|449384565|FG001|Overall Study|Lost to Follow-up|1|||
124933120|NCT02367040|449384564|FG000|Overall Study|Lack of Efficacy|1|||
124933121|NCT02367040|449384565|FG001|Overall Study|Lack of Efficacy|0|||
124933122|NCT02367040|449384564|FG000|Overall Study|Additional primary malignancy|0|||
124933123|NCT02367040|449384565|FG001|Overall Study|Additional primary malignancy|1|||
124933124|NCT02367040|449384564|FG000|Overall Study|AE not associated with clinical disease progression|114|||
124933125|NCT02367040|449384565|FG001|Overall Study|AE not associated with clinical disease progression|11|||
124933126|NCT02367040|449384564|FG000|Overall Study|AE associated with clinical disease progression|1|||
124702344|NCT02592863|448534193|FG000|Overall Study|Withdrawal by Subject|2|||
124702345|NCT02592863|448534194|FG001|Overall Study|Withdrawal by Subject|2|||
124702346|NCT02592863|448534193|FG000|Overall Study|Lost to Follow-up|1|||
124702347|NCT02592863|448534194|FG001|Overall Study|Lost to Follow-up|1|||
124702348|NCT02743221|448534195|FG000|Overall Study|Progressive disease|29|||
124702349|NCT02743221|448534196|FG001|Overall Study|Progressive disease|38|||
124933127|NCT02367040|449384565|FG001|Overall Study|AE associated with clinical disease progression|3|||
124933128|NCT02367040|449384564|FG000|Overall Study|Physician Decision|2|||
124933129|NCT02367040|449384565|FG001|Overall Study|Physician Decision|8|||
124933130|NCT02367040|449384564|FG000|Overall Study|Non-compliance with study drug|1|||
124933131|NCT02367040|449384565|FG001|Overall Study|Non-compliance with study drug|0|||
124933132|NCT02367040|449384564|FG000|Overall Study|Failure to meet continuation criteria|1|||
124933133|NCT02367040|449384565|FG001|Overall Study|Failure to meet continuation criteria|0|||
124933134|NCT02367040|449384564|FG000|Overall Study|Switching to other therapy|2|||
124933135|NCT02367040|449384565|FG001|Overall Study|Switching to other therapy|0|||
124933136|NCT02367040|449384564|FG000|Overall Study|Withdrawal by Subject|46|||
124933137|NCT02367040|449384565|FG001|Overall Study|Withdrawal by Subject|16|||
124933138|NCT02367040|449384564|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
124933139|NCT02367040|449384565|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
124933140|NCT02367040|449384564|FG000|Overall Study|Patient decision|39|||
124933141|NCT02367040|449384565|FG001|Overall Study|Patient decision|14|||
124933142|NCT02367040|449384564|FG000|Overall Study|Required procedure failed|1|||
124933143|NCT02367040|449384565|FG001|Overall Study|Required procedure failed|0|||
124933144|NCT02367040|449384564|FG000|Overall Study|Randomized by mistake with study treatment|1|||
124933145|NCT02367040|449384565|FG001|Overall Study|Randomized by mistake with study treatment|0|||
124933146|NCT02367040|449384564|FG000|Overall Study|Protocol Violation|1|||
124933147|NCT02367040|449384565|FG001|Overall Study|Protocol Violation|0|||
124933148|NCT02367040|449384564|FG000|Overall Study|Progressive disease - radiological progression|51|||
124933149|NCT02367040|449384565|FG001|Overall Study|Progressive disease - radiological progression|78|||
124933150|NCT02367040|449384564|FG000|Overall Study|Progressive disease - clinical progression|6|||
124933151|NCT02367040|449384565|FG001|Overall Study|Progressive disease - clinical progression|6|||
124933152|NCT02367040|449384564|FG000|Overall Study|Drug not administered|3|||
124933153|NCT02367040|449384565|FG001|Overall Study|Drug not administered|2|||
124933154|NCT02367040|449384564|FG000|Overall Study|Progressive disease|0|||
124933155|NCT02367040|449384565|FG001|Overall Study|Progressive disease|1|||
124933156|NCT02367040|449384564|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
124933157|NCT02367040|449384565|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
124933158|NCT02367040|449384564|FG000|Overall Study|Death|2|||
124933159|NCT02367040|449384565|FG001|Overall Study|Death|0|||
124933160|NCT05856435|449384579|FG000|Overall Study|Lost to Follow-up|6|||
124933161|NCT02323880|449384580|FG000|Overall Study|Adverse Event|2|||
124933162|NCT02323880|449384581|FG001|Overall Study|Adverse Event|0|||
124933163|NCT02323880|449384582|FG002|Overall Study|Adverse Event|1|||
124933164|NCT02323880|449384583|FG003|Overall Study|Adverse Event|1|||
124933165|NCT02323880|449384584|FG004|Overall Study|Adverse Event|1|||
124933166|NCT02323880|449384585|FG005|Overall Study|Adverse Event|0|||
124933167|NCT02323880|449384586|FG006|Overall Study|Adverse Event|1|||
124933168|NCT02323880|449384587|FG007|Overall Study|Adverse Event|0|||
124933169|NCT02323880|449384580|FG000|Overall Study|Death|0|||
124933170|NCT02323880|449384581|FG001|Overall Study|Death|0|||
124933171|NCT02323880|449384582|FG002|Overall Study|Death|0|||
124933172|NCT02323880|449384583|FG003|Overall Study|Death|0|||
124933173|NCT02323880|449384584|FG004|Overall Study|Death|0|||
124933174|NCT02323880|449384585|FG005|Overall Study|Death|1|||
124933175|NCT02323880|449384586|FG006|Overall Study|Death|0|||
124933176|NCT02323880|449384587|FG007|Overall Study|Death|0|||
124933177|NCT02323880|449384580|FG000|Overall Study|Lack of Efficacy|4|||
124933178|NCT02323880|449384581|FG001|Overall Study|Lack of Efficacy|11|||
124933179|NCT02323880|449384582|FG002|Overall Study|Lack of Efficacy|5|||
124933180|NCT02323880|449384583|FG003|Overall Study|Lack of Efficacy|5|||
124933181|NCT02323880|449384584|FG004|Overall Study|Lack of Efficacy|4|||
124933182|NCT02323880|449384585|FG005|Overall Study|Lack of Efficacy|8|||
124933183|NCT02323880|449384586|FG006|Overall Study|Lack of Efficacy|4|||
124933184|NCT02323880|449384587|FG007|Overall Study|Lack of Efficacy|6|||
124933185|NCT02323880|449384580|FG000|Overall Study|Physician Decision|0|||
124933186|NCT02323880|449384581|FG001|Overall Study|Physician Decision|0|||
124933187|NCT02323880|449384582|FG002|Overall Study|Physician Decision|0|||
124933188|NCT02323880|449384583|FG003|Overall Study|Physician Decision|0|||
124933189|NCT02323880|449384584|FG004|Overall Study|Physician Decision|1|||
124933190|NCT02323880|449384585|FG005|Overall Study|Physician Decision|1|||
124933191|NCT02323880|449384586|FG006|Overall Study|Physician Decision|1|||
124933192|NCT02323880|449384587|FG007|Overall Study|Physician Decision|0|||
124933193|NCT02323880|449384580|FG000|Overall Study|Withdrawal by Subject|0|||
124933194|NCT02323880|449384581|FG001|Overall Study|Withdrawal by Subject|2|||
124933195|NCT02323880|449384582|FG002|Overall Study|Withdrawal by Subject|0|||
124933196|NCT02323880|449384583|FG003|Overall Study|Withdrawal by Subject|0|||
124933197|NCT02323880|449384584|FG004|Overall Study|Withdrawal by Subject|0|||
124933198|NCT02323880|449384585|FG005|Overall Study|Withdrawal by Subject|0|||
124933199|NCT02323880|449384586|FG006|Overall Study|Withdrawal by Subject|0|||
124933200|NCT02323880|449384587|FG007|Overall Study|Withdrawal by Subject|0|||
124933201|NCT05660434|449384590|FG000|Overall Study|Never obtained study materials|2|||
124933202|NCT05660434|449384591|FG001|Overall Study|Never obtained study materials|1|||
124933203|NCT05424380|449384592|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
124702350|NCT02743221|448534195|FG000|Overall Study|Adverse Event|17|||
124702351|NCT02743221|448534196|FG001|Overall Study|Adverse Event|14|||
124702352|NCT02743221|448534195|FG000|Overall Study|non medical reason|8|||
124702353|NCT02743221|448534196|FG001|Overall Study|non medical reason|2|||
124702354|NCT02743221|448534195|FG000|Overall Study|Physician Decision|2|||
124702355|NCT02743221|448534196|FG001|Overall Study|Physician Decision|5|||
124702356|NCT02743221|448534195|FG000|Overall Study|Patient not eligible, not treated|0|||
124702357|NCT02743221|448534196|FG001|Overall Study|Patient not eligible, not treated|1|||
124702358|NCT04770285|448534198|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
124933204|NCT05424380|449384593|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
124933205|NCT05424380|449384594|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
124933206|NCT05424380|449384595|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
124933207|NCT05424380|449384596|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
124933208|NCT05424380|449384597|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
124933209|NCT05424380|449384592|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
124933210|NCT05424380|449384593|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
124933211|NCT05424380|449384594|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
124933212|NCT05424380|449384595|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
124933213|NCT05424380|449384596|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
124933214|NCT05424380|449384597|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
124933215|NCT05424380|449384592|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
124933216|NCT05424380|449384593|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
124933217|NCT05424380|449384594|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
124933218|NCT05424380|449384595|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
124933219|NCT05424380|449384596|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
124933220|NCT05424380|449384597|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
124933221|NCT05424380|449384592|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
124933222|NCT05424380|449384593|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
124933223|NCT05424380|449384594|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
124933224|NCT05424380|449384595|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
124933225|NCT05424380|449384596|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
124933226|NCT05424380|449384597|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
124933227|NCT05424380|449384592|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
124933228|NCT05424380|449384593|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
124933229|NCT05424380|449384594|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
124933230|NCT05424380|449384595|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
124933231|NCT05424380|449384596|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
124933232|NCT05424380|449384597|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
124933233|NCT05424380|449384592|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
124933234|NCT05424380|449384593|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
124933235|NCT05424380|449384594|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
124933236|NCT05424380|449384595|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
124933237|NCT05424380|449384596|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
124933238|NCT05424380|449384597|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
124933239|NCT05424380|449384592|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
124933240|NCT05424380|449384593|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
124933241|NCT05424380|449384594|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
124933242|NCT05424380|449384595|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
124933243|NCT05424380|449384596|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
124702359|NCT04770285|448534199|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
124702360|NCT04770285|448534198|FG000|Overall Study|Lack of Efficacy|0|||
124764919|NCT02269124|448765065|FG000|Overall Study|Withdrawal by Subject|0|||
124933244|NCT05424380|449384597|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
124933245|NCT05424380|449384592|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
124933246|NCT05424380|449384593|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
124933247|NCT05424380|449384594|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
124933248|NCT05424380|449384595|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
124933249|NCT05424380|449384596|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
124933250|NCT05424380|449384597|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
124702361|NCT04770285|448534199|FG001|Overall Study|Lack of Efficacy|1|||
124933251|NCT05424380|449384592|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933252|NCT05424380|449384593|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933253|NCT05424380|449384594|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933254|NCT05424380|449384595|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
124933255|NCT05424380|449384596|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933256|NCT05424380|449384597|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933257|NCT05424380|449384592|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
124933258|NCT05424380|449384593|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
124933259|NCT05424380|449384594|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
124933260|NCT05424380|449384595|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
124933261|NCT05424380|449384596|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
124933262|NCT05424380|449384597|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
124933263|NCT05424380|449384592|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
124933264|NCT05424380|449384593|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
124933265|NCT05424380|449384594|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
124933266|NCT05424380|449384595|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
124933267|NCT05424380|449384596|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
124933268|NCT05424380|449384597|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
124933269|NCT05424380|449384592|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
124933270|NCT05424380|449384593|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
124933271|NCT05424380|449384594|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
124933272|NCT05424380|449384595|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
124933273|NCT05424380|449384596|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
124933274|NCT05424380|449384597|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
124933275|NCT05424380|449384592|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933276|NCT05424380|449384593|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933277|NCT05424380|449384594|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933278|NCT05424380|449384595|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933279|NCT05424380|449384596|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
124933280|NCT05424380|449384597|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
124933281|NCT05424380|449384592|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
124933282|NCT05424380|449384593|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
124933283|NCT05424380|449384594|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
124933284|NCT05424380|449384595|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
124933285|NCT05424380|449384596|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
124933286|NCT05424380|449384597|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
124933287|NCT02909686|449384598|FG000|Overall Study|Physician Decision|3|||
124933288|NCT02909686|449384598|FG000|Overall Study|Withdrawal by Subject|2|||
124933289|NCT03858517|449384599|FG000|Overall Study|Adverse Event|1|||
124933290|NCT03858517|449384599|FG000|Overall Study|Lost to Follow-up|1|||
124933291|NCT03858517|449384599|FG000|Overall Study|removed for being incarcerated|1|||
124933292|NCT03858517|449384599|FG000|Overall Study|Sponsor Closure|48|||
124933293|NCT01820611|449384604|FG000|Overall Study|Death|8|||
124933294|NCT01820611|449384604|FG000|Overall Study|Adverse Event|1|||
124933295|NCT01820611|449384604|FG000|Overall Study|Withdrawal by Subject|9|||
124933296|NCT05736458|449384605|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
124933297|NCT05736458|449384606|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
124933298|NCT05736458|449384607|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
124933299|NCT05736458|449384605|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
124933300|NCT05736458|449384606|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
124933301|NCT05736458|449384607|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
124933302|NCT05736458|449384605|FG000|TMS/fMRI #1|Physician Decision|0|||
124933303|NCT05736458|449384606|FG001|TMS/fMRI #1|Physician Decision|0|||
124933304|NCT05736458|449384607|FG002|TMS/fMRI #1|Physician Decision|2|||
124933305|NCT05736458|449384605|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
124933306|NCT05736458|449384606|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
124933307|NCT05736458|449384607|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
124933308|NCT02990338|449384608|FG000|Overall Study|Randomized and not treated|4|||
124933309|NCT02990338|449384609|FG001|Overall Study|Randomized and not treated|2|||
124933310|NCT02990338|449384608|FG000|Overall Study|Adverse Event|23|||
124933311|NCT02990338|449384609|FG001|Overall Study|Adverse Event|22|||
124455911|NCT00827606|447628917|FG000|Overall Study|Protocol Violation|4|||
124455912|NCT00827606|447628918|FG001|Overall Study|Protocol Violation|3|||
124702362|NCT04770285|448534198|FG000|Overall Study|Lost to Follow-up|11|||
124702363|NCT04770285|448534199|FG001|Overall Study|Lost to Follow-up|8|||
124702364|NCT04770285|448534198|FG000|Overall Study|Protocol Deviation|6|||
124702365|NCT04770285|448534199|FG001|Overall Study|Protocol Deviation|6|||
124933312|NCT02990338|449384608|FG000|Overall Study|Progressive disease|118|||
124933313|NCT02990338|449384609|FG001|Overall Study|Progressive disease|107|||
124933314|NCT02990338|449384608|FG000|Overall Study|Poor compliance to protocol|0|||
124933315|NCT02990338|449384609|FG001|Overall Study|Poor compliance to protocol|1|||
124933316|NCT02990338|449384608|FG000|Overall Study|Withdrawal by Subject|6|||
124933317|NCT02990338|449384609|FG001|Overall Study|Withdrawal by Subject|8|||
124933318|NCT02990338|449384608|FG000|Overall Study|Physician's decision|2|||
124933319|NCT02990338|449384609|FG001|Overall Study|Physician's decision|6|||
124933320|NCT02990338|449384608|FG000|Overall Study|Treatment extension study|0|||
124933321|NCT02990338|449384609|FG001|Overall Study|Treatment extension study|6|||
124933322|NCT02990338|449384608|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
124933323|NCT02990338|449384609|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
124933324|NCT02990338|449384608|FG000|Overall Study|Continue with therapy available commercially|0|||
124933325|NCT02990338|449384609|FG001|Overall Study|Continue with therapy available commercially|1|||
124933326|NCT04479761|449384611|FG000|Overall Study|could not perform the balance tasks|1|||
124933327|NCT04479761|449384612|FG001|Overall Study|could not perform the balance tasks|0|||
124933328|NCT04479761|449384613|FG002|Overall Study|could not perform the balance tasks|0|||
124933329|NCT04479761|449384611|FG000|Overall Study|Adverse Event|1|||
124933330|NCT04479761|449384612|FG001|Overall Study|Adverse Event|0|||
124933331|NCT04479761|449384613|FG002|Overall Study|Adverse Event|0|||
124933332|NCT04479761|449384611|FG000|Overall Study|one control did not meet screening criteria|0|||
124933333|NCT04479761|449384612|FG001|Overall Study|one control did not meet screening criteria|0|||
124933334|NCT04479761|449384613|FG002|Overall Study|one control did not meet screening criteria|1|||
124933335|NCT04479761|449384611|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
124933336|NCT04479761|449384612|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
124933337|NCT04479761|449384613|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
124933338|NCT04186819|449384614|FG000|Overall Study|Adverse Event|1|||
124933339|NCT04186819|449384614|FG000|Overall Study|Lost to Follow-up|1|||
124933340|NCT04186819|449384614|FG000|Overall Study|Opted for EBRT|1|||
124933341|NCT04186819|449384614|FG000|Overall Study|Opted SBRT|1|||
124933342|NCT04186819|449384614|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
124933343|NCT04186819|449384614|FG000|Overall Study|Physician Decision|1|||
124933344|NCT04186819|449384614|FG000|Overall Study|RP Delayed|1|||
124933345|NCT04186819|449384614|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
124933346|NCT04186819|449384614|FG000|Overall Study|Subject declined for financial reasons|1|||
124933347|NCT04186819|449384614|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
124933348|NCT04186819|449384614|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
124933349|NCT04186819|449384614|FG000|Overall Study|The subject opted for other treatment option|2|||
124933350|NCT04186819|449384614|FG000|Overall Study|The subject opted for other treatment options|1|||
124933351|NCT04186819|449384614|FG000|Overall Study|Withdrawal by Subject|3|||
124933352|NCT04186819|449384614|FG000|Overall Study|Reason not specified|1|||
124933353|NCT03252288|449384620|FG000|Overall Study|Death|1|||
124933354|NCT03252288|449384621|FG001|Overall Study|Death|0|||
124933355|NCT03252288|449384622|FG002|Overall Study|Death|0|||
124933356|NCT03252288|449384620|FG000|Overall Study|Death|11|||
124933357|NCT03252288|449384621|FG001|Overall Study|Death|0|||
124933358|NCT03252288|449384622|FG002|Overall Study|Death|0|||
124933359|NCT03252288|449384620|FG000|Overall Study|Withdrawal by Subject|2|||
124933360|NCT03252288|449384621|FG001|Overall Study|Withdrawal by Subject|0|||
124933361|NCT03252288|449384622|FG002|Overall Study|Withdrawal by Subject|0|||
124933362|NCT03252288|449384620|FG000|Overall Study|Lost to Follow-up|79|||
124933363|NCT03252288|449384621|FG001|Overall Study|Lost to Follow-up|0|||
124933364|NCT03252288|449384622|FG002|Overall Study|Lost to Follow-up|0|||
124933365|NCT03252288|449384620|FG000|Overall Study|Loss of baseline data on tablets|6|||
124933366|NCT03252288|449384621|FG001|Overall Study|Loss of baseline data on tablets|0|||
124933367|NCT03252288|449384622|FG002|Overall Study|Loss of baseline data on tablets|0|||
124933368|NCT05900154|449384626|FG000|Follow-Up Period|Lost to Follow-up|1|||
124933369|NCT05900154|449384627|FG001|Follow-Up Period|Lost to Follow-up|2|||
124702366|NCT04770285|448534198|FG000|Overall Study|Technical Problem|0|||
124455913|NCT00827606|447628917|FG000|Overall Study|Lost to Follow-up|3|||
124455914|NCT00827606|447628918|FG001|Overall Study|Lost to Follow-up|1|||
124702367|NCT04770285|448534199|FG001|Overall Study|Technical Problem|1|||
124702368|NCT04770285|448534198|FG000|Overall Study|Withdrawal by Subject|9|||
124933370|NCT05900154|449384628|FG002|Follow-Up Period|Lost to Follow-up|1|||
124933371|NCT05900154|449384629|FG003|Follow-Up Period|Lost to Follow-up|0|||
124933372|NCT05900154|449384630|FG004|Follow-Up Period|Lost to Follow-up|1|||
124933373|NCT05900154|449384631|FG005|Follow-Up Period|Lost to Follow-up|1|||
124933374|NCT02865538|449384635|FG000|Overall Study|Withdrawal by Subject|0|||
124933375|NCT02865538|449384636|FG001|Overall Study|Withdrawal by Subject|0|||
124933376|NCT02865538|449384637|FG002|Overall Study|Withdrawal by Subject|1|||
124933377|NCT02865538|449384638|FG003|Overall Study|Withdrawal by Subject|0|||
124933378|NCT02865538|449384639|FG004|Overall Study|Withdrawal by Subject|0|||
124933379|NCT02865538|449384635|FG000|Overall Study|Lost to Follow-up|1|||
124933380|NCT02865538|449384636|FG001|Overall Study|Lost to Follow-up|0|||
124933381|NCT02865538|449384637|FG002|Overall Study|Lost to Follow-up|0|||
124933382|NCT02865538|449384638|FG003|Overall Study|Lost to Follow-up|0|||
124933383|NCT02865538|449384639|FG004|Overall Study|Lost to Follow-up|0|||
124933384|NCT03106740|449385872|FG000|Overall Study|Lost to Follow-up|2|||
124933385|NCT03106740|449385873|FG001|Overall Study|Lost to Follow-up|2|||
124933386|NCT03106740|449385872|FG000|Overall Study|Withdrawal by Subject|2|||
124933387|NCT03106740|449385873|FG001|Overall Study|Withdrawal by Subject|4|||
124933388|NCT03106740|449385872|FG000|Overall Study|Physician Decision|0|||
124933389|NCT03106740|449385873|FG001|Overall Study|Physician Decision|1|||
124933390|NCT03106740|449385872|FG000|Overall Study|Partial data|1|||
124933391|NCT03106740|449385873|FG001|Overall Study|Partial data|0|||
124933392|NCT04565990|449385874|FG000|Overall Study|Death|5|||
124933393|NCT04565990|449385874|FG000|Overall Study|Lost to Follow-up|1|||
124933394|NCT04565990|449385874|FG000|Overall Study|Withdrawal by Subject|1|||
124933395|NCT04797858|449385875|FG000|Overall Study|Withdrawal by Subject|0|||
124933396|NCT04797858|449385876|FG001|Overall Study|Withdrawal by Subject|1|||
124933397|NCT04797858|449385875|FG000|Overall Study|Excluded due to administrative error|7|||
124933398|NCT04797858|449385876|FG001|Overall Study|Excluded due to administrative error|8|||
124933399|NCT05363163|449385886|FG000|Overall Study|Withdrawal by Subject|13|||
124933400|NCT04659603|449385890|FG000|Overall Study|Ongoing study treatment at the time of primary analysis completion|0|||
124933401|NCT04659603|449385891|FG001|Overall Study|Ongoing study treatment at the time of primary analysis completion|0|||
124933402|NCT04659603|449385892|FG002|Overall Study|Ongoing study treatment at the time of primary analysis completion|6|||
124933403|NCT04659603|449385890|FG000|Overall Study|Withdrawal by Subject|0|||
124933404|NCT04659603|449385891|FG001|Overall Study|Withdrawal by Subject|5|||
124933405|NCT04659603|449385892|FG002|Overall Study|Withdrawal by Subject|0|||
124933406|NCT04659603|449385890|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
124933407|NCT04659603|449385891|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
124933408|NCT04659603|449385892|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
124933409|NCT02839265|449385893|FG000|Overall Study|Screen Failure|2|||
124933410|NCT02839265|449385893|FG000|Overall Study|Death|1|||
124933411|NCT02839265|449385893|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
124933412|NCT05552508|449385894|FG000|Overall Study|Adverse Event|3|||
124933413|NCT06037668|449385895|FG000|Overall Study|Lost to Follow-up|1|||
124933414|NCT06037668|449385896|FG001|Overall Study|Lost to Follow-up|1|||
124933415|NCT06037668|449385895|FG000|Overall Study|Protocol Violation|1|||
124933416|NCT06037668|449385896|FG001|Overall Study|Protocol Violation|0|||
124933417|NCT06037668|449385895|FG000|Overall Study|Withdrawal by Subject|1|||
124933418|NCT06037668|449385896|FG001|Overall Study|Withdrawal by Subject|0|||
124933419|NCT06037668|449385895|FG000|Overall Study|Other Study Discontinuation Reason|1|||
124933420|NCT06037668|449385896|FG001|Overall Study|Other Study Discontinuation Reason|0|||
124933421|NCT05285137|449385898|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
124933422|NCT05285137|449385899|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
124933423|NCT05285137|449385900|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
124933424|NCT05285137|449385901|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
124933425|NCT05285137|449385902|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
124933426|NCT05285137|449385903|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
124933427|NCT05285137|449385904|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
124933428|NCT05285137|449385905|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
124933429|NCT05285137|449385906|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
124933430|NCT05285137|449385898|FG000|Overall Study|Lost to Follow-up|0|||
124933431|NCT05285137|449385899|FG001|Overall Study|Lost to Follow-up|0|||
124933432|NCT05285137|449385900|FG002|Overall Study|Lost to Follow-up|1|||
124455915|NCT00827606|447628917|FG000|Overall Study|Withdrawal by Subject|7|||
124455916|NCT00827606|447628918|FG001|Overall Study|Withdrawal by Subject|6|||
124933433|NCT05285137|449385901|FG003|Overall Study|Lost to Follow-up|3|||
124933434|NCT05285137|449385902|FG004|Overall Study|Lost to Follow-up|0|||
124933435|NCT05285137|449385903|FG005|Overall Study|Lost to Follow-up|0|||
124933436|NCT05285137|449385904|FG006|Overall Study|Lost to Follow-up|1|||
124933437|NCT05285137|449385905|FG007|Overall Study|Lost to Follow-up|0|||
124933438|NCT05285137|449385906|FG008|Overall Study|Lost to Follow-up|0|||
124933439|NCT05285137|449385898|FG000|Overall Study|Physician Decision|0|||
124933440|NCT05285137|449385899|FG001|Overall Study|Physician Decision|1|||
124455917|NCT00827606|447628917|FG000|Overall Study|Pregnancy|0|||
124455918|NCT00827606|447628918|FG001|Overall Study|Pregnancy|1|||
124933441|NCT05285137|449385900|FG002|Overall Study|Physician Decision|0|||
124933442|NCT05285137|449385901|FG003|Overall Study|Physician Decision|0|||
124702369|NCT04770285|448534199|FG001|Overall Study|Withdrawal by Subject|8|||
124702370|NCT04770285|448534198|FG000|Overall Study|Reason Not Specified|0|||
124702371|NCT04770285|448534199|FG001|Overall Study|Reason Not Specified|1|||
124933443|NCT05285137|449385902|FG004|Overall Study|Physician Decision|0|||
124933444|NCT05285137|449385903|FG005|Overall Study|Physician Decision|0|||
124933445|NCT05285137|449385904|FG006|Overall Study|Physician Decision|0|||
124933446|NCT05285137|449385905|FG007|Overall Study|Physician Decision|0|||
124933447|NCT05285137|449385906|FG008|Overall Study|Physician Decision|0|||
124933448|NCT05285137|449385898|FG000|Overall Study|Pregnancy|0|||
124933449|NCT05285137|449385899|FG001|Overall Study|Pregnancy|0|||
124933450|NCT05285137|449385900|FG002|Overall Study|Pregnancy|0|||
124933451|NCT05285137|449385901|FG003|Overall Study|Pregnancy|0|||
124933452|NCT05285137|449385902|FG004|Overall Study|Pregnancy|0|||
124933453|NCT05285137|449385903|FG005|Overall Study|Pregnancy|0|||
124933454|NCT05285137|449385904|FG006|Overall Study|Pregnancy|1|||
124933455|NCT05285137|449385905|FG007|Overall Study|Pregnancy|0|||
124933456|NCT05285137|449385906|FG008|Overall Study|Pregnancy|0|||
124933457|NCT05285137|449385898|FG000|Overall Study|Withdrawal by Subject|0|||
124933458|NCT05285137|449385899|FG001|Overall Study|Withdrawal by Subject|1|||
124933459|NCT05285137|449385900|FG002|Overall Study|Withdrawal by Subject|2|||
124933460|NCT05285137|449385901|FG003|Overall Study|Withdrawal by Subject|1|||
124933461|NCT05285137|449385902|FG004|Overall Study|Withdrawal by Subject|0|||
124933462|NCT05285137|449385903|FG005|Overall Study|Withdrawal by Subject|0|||
124933463|NCT05285137|449385904|FG006|Overall Study|Withdrawal by Subject|0|||
124933464|NCT05285137|449385905|FG007|Overall Study|Withdrawal by Subject|0|||
124933465|NCT05285137|449385906|FG008|Overall Study|Withdrawal by Subject|1|||
124933466|NCT03717935|449385907|FG000|Overall Study|Withdrawal by Subject|0|||
124933467|NCT03717935|449385908|FG001|Overall Study|Withdrawal by Subject|2|||
124933468|NCT03484819|449385913|FG000|Overall Study|Death|2|||
124933469|NCT03484819|449385913|FG000|Overall Study|Adverse Event|2|||
124933470|NCT03484819|449385913|FG000|Overall Study|Physician Decision|1|||
124933471|NCT03484819|449385913|FG000|Overall Study|Withdrawal by Subject|2|||
124933472|NCT03484819|449385913|FG000|Overall Study|Disease Progression|4|||
124933473|NCT03484819|449385913|FG000|Overall Study|Complicating Condition|1|||
124933474|NCT01199133|449385918|FG000|Year 1|Adverse Event|16|||
124933475|NCT01199133|449385919|FG001|Year 1|Adverse Event|4|||
124933476|NCT01199133|449385918|FG000|Year 1|Withdrawal by Subject|8|||
124933477|NCT01199133|449385919|FG001|Year 1|Withdrawal by Subject|4|||
124933478|NCT01199133|449385918|FG000|Year 1|Any other reason not above-mentioned|6|||
124933479|NCT01199133|449385919|FG001|Year 1|Any other reason not above-mentioned|7|||
124933480|NCT01199133|449385918|FG000|Year 2|Adverse Event|1|||
124933481|NCT01199133|449385919|FG001|Year 2|Adverse Event|0|||
124933482|NCT01199133|449385918|FG000|Year 2|Withdrawal by Subject|1|||
124933483|NCT01199133|449385919|FG001|Year 2|Withdrawal by Subject|1|||
124933484|NCT01199133|449385918|FG000|Year 2|Any other reason not above-mentioned|1|||
124933485|NCT01199133|449385919|FG001|Year 2|Any other reason not above-mentioned|2|||
124933486|NCT03988621|449385920|FG000|Overall Study|Lost to Follow-up|16|||
124933487|NCT03988621|449385921|FG001|Overall Study|Lost to Follow-up|17|||
124933488|NCT03988621|449385920|FG000|Overall Study|Withdrawal by Subject|14|||
124933489|NCT03988621|449385921|FG001|Overall Study|Withdrawal by Subject|7|||
124933490|NCT03988621|449385920|FG000|Overall Study|Patient Lost to Follow Up|15|||
124933491|NCT03988621|449385921|FG001|Overall Study|Patient Lost to Follow Up|15|||
124933492|NCT03988621|449385920|FG000|Overall Study|Patient death|1|||
124933493|NCT03988621|449385921|FG001|Overall Study|Patient death|5|||
124933494|NCT05013385|449385922|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
124933495|NCT04629339|449385925|FG000|Overall Study|Death|1|||
124933496|NCT04629339|449385926|FG001|Overall Study|Death|0|||
124933497|NCT04629339|449385927|FG002|Overall Study|Death|2|||
124933498|NCT04629339|449385928|FG003|Overall Study|Death|2|||
124933499|NCT04629339|449385929|FG004|Overall Study|Death|0|||
124933500|NCT04629339|449385925|FG000|Overall Study|Disease Progression|0|||
124933501|NCT04629339|449385926|FG001|Overall Study|Disease Progression|0|||
124933502|NCT04629339|449385927|FG002|Overall Study|Disease Progression|1|||
124933503|NCT04629339|449385928|FG003|Overall Study|Disease Progression|1|||
124933504|NCT04629339|449385929|FG004|Overall Study|Disease Progression|0|||
124933505|NCT04629339|449385925|FG000|Overall Study|Lost to Follow-up|0|||
124933506|NCT04629339|449385926|FG001|Overall Study|Lost to Follow-up|0|||
124933507|NCT04629339|449385927|FG002|Overall Study|Lost to Follow-up|0|||
124933508|NCT04629339|449385928|FG003|Overall Study|Lost to Follow-up|1|||
124933509|NCT04629339|449385929|FG004|Overall Study|Lost to Follow-up|0|||
124933510|NCT04629339|449385925|FG000|Overall Study|Physician Decision|0|||
124933511|NCT04629339|449385926|FG001|Overall Study|Physician Decision|1|||
124933512|NCT04629339|449385927|FG002|Overall Study|Physician Decision|0|||
124933513|NCT04629339|449385928|FG003|Overall Study|Physician Decision|0|||
124933514|NCT04629339|449385929|FG004|Overall Study|Physician Decision|0|||
124933515|NCT04629339|449385925|FG000|Overall Study|Study Terminated by Sponsor|0|||
124702372|NCT03766399|448534200|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
124702373|NCT03766399|448534201|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
124702374|NCT03766399|448534202|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
124702375|NCT03766399|448534203|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
124702376|NCT03766399|448534204|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
124933516|NCT04629339|449385926|FG001|Overall Study|Study Terminated by Sponsor|0|||
124933517|NCT04629339|449385927|FG002|Overall Study|Study Terminated by Sponsor|0|||
124933518|NCT04629339|449385928|FG003|Overall Study|Study Terminated by Sponsor|1|||
124933519|NCT04629339|449385929|FG004|Overall Study|Study Terminated by Sponsor|0|||
124933520|NCT04629339|449385925|FG000|Overall Study|Withdrawal by Subject|0|||
124933521|NCT04629339|449385926|FG001|Overall Study|Withdrawal by Subject|0|||
124933522|NCT04629339|449385927|FG002|Overall Study|Withdrawal by Subject|2|||
124933523|NCT04629339|449385928|FG003|Overall Study|Withdrawal by Subject|2|||
124933524|NCT04629339|449385929|FG004|Overall Study|Withdrawal by Subject|0|||
124933525|NCT01447719|449385932|FG000|Overall Study|Image acquisition failure|2|||
124933526|NCT01447719|449385932|FG000|Overall Study|Invalid image or not imaged|3|||
124933527|NCT01447719|449385932|FG000|Overall Study|Subject still living at end of study|79|||
124933528|NCT01447719|449385932|FG000|Overall Study|Withdrawal by Subject|2|||
124933529|NCT01447719|449385932|FG000|Overall Study|Family withdrew autopsy consent|7|||
124933530|NCT03914469|449385935|FG000|Overall Study|Lost to Follow-up|1|||
124933531|NCT03914469|449385936|FG001|Overall Study|Lost to Follow-up|4|||
124933532|NCT01121588|449385943|FG000|Overall Study|Death|5|||
124933533|NCT01121588|449385944|FG001|Overall Study|Death|3|||
124933534|NCT01121588|449385945|FG002|Overall Study|Death|13|||
124933535|NCT01121588|449385943|FG000|Overall Study|Study Terminated by Sponsor|1|||
124933536|NCT01121588|449385944|FG001|Overall Study|Study Terminated by Sponsor|1|||
124933537|NCT01121588|449385945|FG002|Overall Study|Study Terminated by Sponsor|0|||
124933538|NCT01121588|449385943|FG000|Overall Study|Participant Refused Further Followup|2|||
124933539|NCT01121588|449385944|FG001|Overall Study|Participant Refused Further Followup|0|||
124933540|NCT01121588|449385945|FG002|Overall Study|Participant Refused Further Followup|2|||
124933541|NCT01121588|449385943|FG000|Overall Study|Lost to Follow-up|0|||
124933542|NCT01121588|449385944|FG001|Overall Study|Lost to Follow-up|1|||
124933543|NCT01121588|449385945|FG002|Overall Study|Lost to Follow-up|1|||
124933544|NCT01121588|449385943|FG000|Overall Study|Non-Specified Reasons|9|||
124933545|NCT01121588|449385944|FG001|Overall Study|Non-Specified Reasons|4|||
124933546|NCT01121588|449385945|FG002|Overall Study|Non-Specified Reasons|2|||
124933547|NCT02938923|449385953|FG000|Overall Study|Death|1|||
124933548|NCT02938923|449385954|FG001|Overall Study|Death|0|||
124933549|NCT02938923|449385955|FG002|Overall Study|Death|0|||
124933550|NCT02938923|449385953|FG000|Overall Study|Physician Decision|0|||
124933551|NCT02938923|449385954|FG001|Overall Study|Physician Decision|2|||
124933552|NCT02938923|449385955|FG002|Overall Study|Physician Decision|0|||
124933553|NCT02938923|449385953|FG000|Overall Study|Withdrawal by Subject|0|||
124933554|NCT02938923|449385954|FG001|Overall Study|Withdrawal by Subject|1|||
124933555|NCT02938923|449385955|FG002|Overall Study|Withdrawal by Subject|1|||
124933556|NCT04583280|449385959|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
124933557|NCT04583280|449385960|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
124933558|NCT03606512|449385963|FG000|Overall Study|Lost to Follow-up|0|||
124933559|NCT03606512|449385964|FG001|Overall Study|Lost to Follow-up|1|||
124933560|NCT03606512|449385963|FG000|Overall Study|'moved from study area|0|||
124933561|NCT03606512|449385964|FG001|Overall Study|'moved from study area|1|||
124933562|NCT05513937|449385965|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
124933563|NCT05513937|449385966|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
124933564|NCT05513937|449385967|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
124933565|NCT05513937|449385968|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
124933566|NCT05513937|449385965|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
124933567|NCT05513937|449385966|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
124933568|NCT05513937|449385967|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
124933569|NCT05513937|449385968|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
124933570|NCT05513937|449385965|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
124933571|NCT05513937|449385966|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
124933572|NCT05513937|449385967|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
124933573|NCT05513937|449385968|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
124933574|NCT05513937|449385965|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
124933575|NCT05513937|449385966|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
124933576|NCT05513937|449385967|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
124933577|NCT05513937|449385968|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
124933578|NCT05513937|449385965|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
124933579|NCT05513937|449385966|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
124933580|NCT05513937|449385967|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
124933581|NCT05513937|449385968|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
124933582|NCT05513937|449385965|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
124933583|NCT05513937|449385966|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
124933584|NCT05513937|449385967|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
124933585|NCT05513937|449385968|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
124933586|NCT02846545|449385969|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
124933587|NCT02846545|449385970|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
124933588|NCT02846545|449385969|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
124933589|NCT02846545|449385970|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
124933590|NCT02846545|449385969|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
124933591|NCT02846545|449385970|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
124933592|NCT02846545|449385969|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
124933593|NCT02846545|449385970|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
124933594|NCT02846545|449385969|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
124933595|NCT02846545|449385970|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
124933596|NCT03691298|449385973|FG000|Overall Study|Lost to Follow-up|8|||
124933597|NCT03691298|449385973|FG000|Overall Study|Sponsor terminated study|2|||
124933598|NCT02492711|449385977|FG000|Overall Study|Adverse Event|9|||
124933599|NCT02492711|449385978|FG001|Overall Study|Adverse Event|9|||
124933600|NCT02492711|449385979|FG002|Overall Study|Adverse Event|2|||
124933601|NCT02492711|449385977|FG000|Overall Study|Death|3|||
124933602|NCT02492711|449385978|FG001|Overall Study|Death|3|||
124933603|NCT02492711|449385979|FG002|Overall Study|Death|0|||
124933604|NCT02492711|449385977|FG000|Overall Study|Withdrawal by Subject|10|||
124933605|NCT02492711|449385978|FG001|Overall Study|Withdrawal by Subject|16|||
124933606|NCT02492711|449385979|FG002|Overall Study|Withdrawal by Subject|5|||
124933607|NCT02492711|449385977|FG000|Overall Study|Physician Decision|10|||
124933608|NCT02492711|449385978|FG001|Overall Study|Physician Decision|6|||
124933609|NCT02492711|449385979|FG002|Overall Study|Physician Decision|4|||
124933610|NCT02492711|449385977|FG000|Overall Study|Lost to Follow-up|0|||
124933611|NCT02492711|449385978|FG001|Overall Study|Lost to Follow-up|0|||
124933612|NCT02492711|449385979|FG002|Overall Study|Lost to Follow-up|1|||
124933613|NCT02492711|449385977|FG000|Overall Study|study treatment delay|2|||
124933614|NCT02492711|449385978|FG001|Overall Study|study treatment delay|1|||
124933615|NCT02492711|449385979|FG002|Overall Study|study treatment delay|0|||
124933616|NCT02492711|449385977|FG000|Overall Study|change in chemotherapy|0|||
124933617|NCT02492711|449385978|FG001|Overall Study|change in chemotherapy|1|||
124933618|NCT02492711|449385979|FG002|Overall Study|change in chemotherapy|0|||
124933619|NCT02492711|449385977|FG000|Overall Study|never treated|2|||
124933620|NCT02492711|449385978|FG001|Overall Study|never treated|4|||
124933621|NCT02492711|449385979|FG002|Overall Study|never treated|0|||
124933622|NCT02492711|449385977|FG000|Overall Study|Other|0|||
124933623|NCT02492711|449385978|FG001|Overall Study|Other|0|||
124933624|NCT02492711|449385979|FG002|Overall Study|Other|1|||
124933625|NCT03245840|449385984|FG000|Overall Study|Adverse Event|6|||
124933626|NCT03245840|449385985|FG001|Overall Study|Adverse Event|0|||
124933627|NCT03245840|449385984|FG000|Overall Study|Death|2|||
124933628|NCT03245840|449385985|FG001|Overall Study|Death|0|||
124933629|NCT03245840|449385984|FG000|Overall Study|Withdrawal by Subject|31|||
124933630|NCT03245840|449385985|FG001|Overall Study|Withdrawal by Subject|1|||
124933631|NCT03245840|449385984|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
124933632|NCT03245840|449385985|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124933633|NCT03245840|449385984|FG000|Overall Study|Physician Decision|4|||
124933634|NCT03245840|449385985|FG001|Overall Study|Physician Decision|1|||
124933635|NCT03245840|449385984|FG000|Overall Study|Study Terminated by Sponsor|56|||
124933636|NCT03245840|449385985|FG001|Overall Study|Study Terminated by Sponsor|6|||
124933637|NCT03245840|449385984|FG000|Overall Study|Site Terminated by Sponsor|4|||
124933638|NCT03245840|449385985|FG001|Overall Study|Site Terminated by Sponsor|0|||
124933639|NCT03245840|449385984|FG000|Overall Study|Lost to Follow-up|12|||
124933640|NCT03245840|449385985|FG001|Overall Study|Lost to Follow-up|2|||
124933641|NCT03245840|449385984|FG000|Overall Study|Pregnancy|2|||
124933642|NCT03245840|449385985|FG001|Overall Study|Pregnancy|0|||
124933643|NCT03245840|449385984|FG000|Overall Study|Non-Compliance with Study Drug|2|||
124933644|NCT03245840|449385985|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124933645|NCT03245840|449385984|FG000|Overall Study|Not treated|1|||
124933646|NCT03245840|449385985|FG001|Overall Study|Not treated|1|||
124933647|NCT04505410|449385987|FG000|Overall Study|Adverse Event|2|||
124933648|NCT04505410|449385988|FG001|Overall Study|Adverse Event|0|||
124933649|NCT04505410|449385987|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
124933650|NCT04505410|449385988|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
124933651|NCT04505410|449385987|FG000|Overall Study|did not want to follow diet|1|||
124546436|NCT02181673|447955901|FG000|Week 24-Week 60|Physician Decision|0|||
124933652|NCT04505410|449385988|FG001|Overall Study|did not want to follow diet|0|||
124933653|NCT04505410|449385987|FG000|Overall Study|flare up of ulcerative colitis|0|||
124933654|NCT04505410|449385988|FG001|Overall Study|flare up of ulcerative colitis|1|||
124933655|NCT04505410|449385987|FG000|Overall Study|Lost to Follow-up|0|||
124546437|NCT02181673|447955902|FG001|Week 24-Week 60|Physician Decision|0|||
124546438|NCT02181673|447955903|FG002|Week 24-Week 60|Physician Decision|1|||
124546439|NCT03155269|447955904|FG000|Overall Study|Withdrawal by Subject|4|||
124546440|NCT03155269|447955905|FG001|Overall Study|Withdrawal by Subject|5|||
124546441|NCT03155269|447955904|FG000|Overall Study|Lost to Follow-up|1|||
124546442|NCT03155269|447955905|FG001|Overall Study|Lost to Follow-up|2|||
124546443|NCT00138658|447955906|FG000|Overall Study|Adverse Event|23|||
124546444|NCT00138658|447955906|FG000|Overall Study|Death|1|||
124546445|NCT00138658|447955906|FG000|Overall Study|Disease Progression|21|||
124546446|NCT00138658|447955906|FG000|Overall Study|Physician Decision|11|||
124546447|NCT00138658|447955906|FG000|Overall Study|Withdrawal by Subject|5|||
124546448|NCT03733301|447955909|FG000|Overall Study|Screen Fail|1|||
124546449|NCT03733301|447955910|FG001|Overall Study|Screen Fail|0|||
124546450|NCT03733301|447955911|FG002|Overall Study|Screen Fail|0|||
124546451|NCT03733301|447955909|FG000|Overall Study|Non-compliance|1|||
124546452|NCT03733301|447955910|FG001|Overall Study|Non-compliance|0|||
124546453|NCT03733301|447955911|FG002|Overall Study|Non-compliance|0|||
124546454|NCT03733301|447955909|FG000|Overall Study|Lack of Efficacy|2|||
124546455|NCT03733301|447955910|FG001|Overall Study|Lack of Efficacy|3|||
124546456|NCT03733301|447955911|FG002|Overall Study|Lack of Efficacy|0|||
124546457|NCT03733301|447955909|FG000|Overall Study|Adverse Event|0|||
124546458|NCT03733301|447955910|FG001|Overall Study|Adverse Event|1|||
124546459|NCT03733301|447955911|FG002|Overall Study|Adverse Event|3|||
124546460|NCT03733301|447955909|FG000|Overall Study|Withdrawal by Subject|3|||
124546461|NCT03733301|447955910|FG001|Overall Study|Withdrawal by Subject|5|||
124546462|NCT03733301|447955911|FG002|Overall Study|Withdrawal by Subject|1|||
124546463|NCT04637815|447955912|FG000|Overall Study|Death|1|||
124546464|NCT04637815|447955913|FG001|Overall Study|Death|0|||
124546465|NCT04637815|447955912|FG000|Overall Study|Lost to Follow-up|5|||
124546466|NCT04637815|447955913|FG001|Overall Study|Lost to Follow-up|2|||
124546467|NCT00337727|447955914|FG000|Overall Study|Adverse Event|5|||
124546468|NCT00337727|447955915|FG001|Overall Study|Adverse Event|3|||
124933656|NCT04505410|449385988|FG001|Overall Study|Lost to Follow-up|2|||
124933657|NCT04505410|449385987|FG000|Overall Study|Lost to Follow-up|1|||
124933658|NCT04505410|449385988|FG001|Overall Study|Lost to Follow-up|0|||
124933659|NCT04505410|449385987|FG000|Overall Study|initiated another diet on their own|0|||
124933660|NCT04505410|449385988|FG001|Overall Study|initiated another diet on their own|2|||
124933661|NCT01586910|449387154|FG000|Overall Study|Death|4|||
124933662|NCT01586910|449387155|FG001|Overall Study|Death|4|||
124933663|NCT01586910|449387154|FG000|Overall Study|Withdrawal by Subject|6|||
124933664|NCT01586910|449387155|FG001|Overall Study|Withdrawal by Subject|43|||
124933665|NCT01586910|449387154|FG000|Overall Study|Physician withdrew Subject|5|||
124933666|NCT01586910|449387155|FG001|Overall Study|Physician withdrew Subject|24|||
124933667|NCT02437136|449387160|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
124546469|NCT00337727|447955914|FG000|Overall Study|Lost to Follow-up|5|||
124546470|NCT00337727|447955915|FG001|Overall Study|Lost to Follow-up|4|||
124546471|NCT00337727|447955914|FG000|Overall Study|Physician Decision|1|||
124546472|NCT00337727|447955915|FG001|Overall Study|Physician Decision|0|||
124546473|NCT00337727|447955914|FG000|Overall Study|Protocol Violation|4|||
124933668|NCT02437136|449387161|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
124546474|NCT00337727|447955915|FG001|Overall Study|Protocol Violation|0|||
124546475|NCT00337727|447955914|FG000|Overall Study|Withdrawal by Subject|3|||
124546476|NCT00337727|447955915|FG001|Overall Study|Withdrawal by Subject|5|||
124546477|NCT00320801|447955916|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
124933669|NCT02437136|449387162|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
124546478|NCT00320801|447955917|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
124546479|NCT00320801|447955918|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
124933670|NCT02437136|449387163|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
124933671|NCT02437136|449387164|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
124933672|NCT02437136|449387165|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
124455919|NCT00827606|447628917|FG000|Overall Study|Other|5|||
124455920|NCT00827606|447628918|FG001|Overall Study|Other|13|||
124455921|NCT00827606|447628917|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
124455922|NCT00827606|447628918|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
124455923|NCT00827606|447628917|FG000|Overall Study|Adverse Event|4|||
124933673|NCT02437136|449387166|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
124933674|NCT02437136|449387160|FG000|Expansion (Phase 2)|Death|0|||
124933675|NCT02437136|449387161|FG001|Expansion (Phase 2)|Death|0|||
124933676|NCT02437136|449387162|FG002|Expansion (Phase 2)|Death|0|||
124933677|NCT02437136|449387163|FG003|Expansion (Phase 2)|Death|6|||
124933678|NCT02437136|449387164|FG004|Expansion (Phase 2)|Death|37|||
124933679|NCT02437136|449387165|FG005|Expansion (Phase 2)|Death|29|||
124933680|NCT02437136|449387166|FG006|Expansion (Phase 2)|Death|24|||
124933681|NCT02437136|449387160|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
124933682|NCT02437136|449387161|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
124933683|NCT02437136|449387162|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
124933684|NCT02437136|449387163|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
124933685|NCT02437136|449387164|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
124933686|NCT02437136|449387165|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
124933687|NCT02437136|449387166|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
124933688|NCT02437136|449387160|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
124933689|NCT02437136|449387161|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
124933690|NCT02437136|449387162|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
124933691|NCT02437136|449387163|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
124933692|NCT02437136|449387164|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
124933693|NCT02437136|449387165|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
124933694|NCT02437136|449387166|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
124933695|NCT03640286|449387174|FG000|Overall Study|Adverse Event|6|||
124933696|NCT03640286|449387175|FG001|Overall Study|Adverse Event|6|||
124933697|NCT03640286|449387174|FG000|Overall Study|Lost to Follow-up|3|||
124933698|NCT03640286|449387175|FG001|Overall Study|Lost to Follow-up|6|||
124933699|NCT03640286|449387174|FG000|Overall Study|Pregnancy|1|||
124933700|NCT03640286|449387175|FG001|Overall Study|Pregnancy|0|||
124933701|NCT03640286|449387174|FG000|Overall Study|Withdrawal by Subject|10|||
124933702|NCT03640286|449387175|FG001|Overall Study|Withdrawal by Subject|10|||
124933703|NCT03640286|449387174|FG000|Overall Study|Non-compliance|4|||
124933704|NCT03640286|449387175|FG001|Overall Study|Non-compliance|10|||
124933705|NCT03640286|449387174|FG000|Overall Study|Medication change|1|||
124933706|NCT03640286|449387175|FG001|Overall Study|Medication change|0|||
124933707|NCT03640286|449387174|FG000|Overall Study|Other|1|||
124933708|NCT03640286|449387175|FG001|Overall Study|Other|2|||
124933709|NCT03640286|449387174|FG000|Overall Study|Joined another lifestyle program|0|||
124933710|NCT03640286|449387175|FG001|Overall Study|Joined another lifestyle program|1|||
124933711|NCT05524116|449387176|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
124933712|NCT05524116|449387177|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
124933713|NCT05524116|449387176|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
124933714|NCT05524116|449387177|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
124933715|NCT05524116|449387176|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
124933716|NCT05524116|449387177|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
124933717|NCT05524116|449387176|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
124455924|NCT00827606|447628918|FG001|Overall Study|Adverse Event|2|||
124455925|NCT04037748|447628921|FG000|Treatment Period 1|Withdrawal by Subject|3|||
124933718|NCT05524116|449387177|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
124455926|NCT04037748|447628922|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124933719|NCT05524116|449387176|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
124933720|NCT05524116|449387177|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
124933721|NCT03181516|449387178|FG000|Overall Study|Withdrawal by Subject|14|||
124455927|NCT04037748|447628921|FG000|Treatment Period 1|Adverse Event|1|||
124933722|NCT03181516|449387179|FG001|Overall Study|Withdrawal by Subject|7|||
124933723|NCT03181516|449387178|FG000|Overall Study|Lost to Follow-up|2|||
124933724|NCT03181516|449387179|FG001|Overall Study|Lost to Follow-up|2|||
124933725|NCT05405985|449387180|FG000|Overall Study|Withdrawal by Subject|1|||
124933726|NCT05405985|449387181|FG001|Overall Study|Withdrawal by Subject|0|||
124933727|NCT03635424|449387182|FG000|Overall Study|Adverse Event|1|||
124933728|NCT03635424|449387182|FG000|Overall Study|Death|1|||
124933729|NCT03635424|449387182|FG000|Overall Study|Device not implanted|1|||
124933730|NCT05533190|449387183|FG000|Overall Study|Lost to Follow-up|19|||
124933731|NCT05533190|449387184|FG001|Overall Study|Lost to Follow-up|7|||
124933732|NCT05533190|449387183|FG000|Overall Study|Failed to download app|1|||
124933733|NCT05533190|449387184|FG001|Overall Study|Failed to download app|0|||
124933734|NCT05533190|449387183|FG000|Overall Study|Thought app was a scam|1|||
124933735|NCT05533190|449387184|FG001|Overall Study|Thought app was a scam|0|||
124933736|NCT05533190|449387183|FG000|Overall Study|Withdrawal by Subject|2|||
124933737|NCT05533190|449387184|FG001|Overall Study|Withdrawal by Subject|0|||
124933738|NCT01917084|449387185|FG000|Overall Study|Withdrawal by Subject|1|||
124933739|NCT04451772|449387193|FG000|Overall Study|Adverse Event|1|||
124933740|NCT04451772|449387194|FG001|Overall Study|Adverse Event|0|||
124933741|NCT04451772|449387195|FG002|Overall Study|Adverse Event|1|||
124933742|NCT04451772|449387196|FG003|Overall Study|Adverse Event|1|||
124933743|NCT04451772|449387197|FG004|Overall Study|Adverse Event|0|||
124933744|NCT04451772|449387198|FG005|Overall Study|Adverse Event|3|||
124933745|NCT04451772|449387193|FG000|Overall Study|Withdrawal by Subject|2|||
124933746|NCT04451772|449387194|FG001|Overall Study|Withdrawal by Subject|7|||
124933747|NCT04451772|449387195|FG002|Overall Study|Withdrawal by Subject|2|||
124933748|NCT04451772|449387196|FG003|Overall Study|Withdrawal by Subject|1|||
124933749|NCT04451772|449387197|FG004|Overall Study|Withdrawal by Subject|1|||
124933750|NCT04451772|449387198|FG005|Overall Study|Withdrawal by Subject|0|||
124933751|NCT04451772|449387193|FG000|Overall Study|Other, not specified|1|||
124933752|NCT04451772|449387194|FG001|Overall Study|Other, not specified|2|||
124933753|NCT04451772|449387195|FG002|Overall Study|Other, not specified|1|||
124933754|NCT04451772|449387196|FG003|Overall Study|Other, not specified|0|||
124933755|NCT04451772|449387197|FG004|Overall Study|Other, not specified|0|||
124933756|NCT04451772|449387198|FG005|Overall Study|Other, not specified|1|||
124933757|NCT04451772|449387193|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
124933758|NCT04451772|449387194|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
124933759|NCT04451772|449387195|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
124933760|NCT04451772|449387196|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
124933761|NCT04451772|449387197|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
124933762|NCT04451772|449387198|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
124933763|NCT04167553|449387199|FG000|Overall Study|Withdrawal by Subject|1|||
124933764|NCT04167553|449387200|FG001|Overall Study|Withdrawal by Subject|0|||
124933765|NCT04167553|449387201|FG002|Overall Study|Withdrawal by Subject|1|||
124933766|NCT04167553|449387202|FG003|Overall Study|Withdrawal by Subject|2|||
124933767|NCT04167553|449387203|FG004|Overall Study|Withdrawal by Subject|1|||
124455928|NCT04037748|447628922|FG001|Treatment Period 1|Adverse Event|1|||
124455929|NCT04037748|447628921|FG000|Treatment Period 1|Protocol Violation|4|||
124455930|NCT04037748|447628922|FG001|Treatment Period 1|Protocol Violation|5|||
124455931|NCT04037748|447628921|FG000|Treatment Period 2|Adverse Event|0|||
124455932|NCT04037748|447628922|FG001|Treatment Period 2|Adverse Event|1|||
124455933|NCT04037748|447628921|FG000|Treatment Period 2|Protocol Violation|2|||
124455934|NCT04037748|447628922|FG001|Treatment Period 2|Protocol Violation|0|||
124455935|NCT04544475|447628927|FG000|Overall Study|Withdrawal by Subject|1|||
124455936|NCT04544475|447628928|FG001|Overall Study|Withdrawal by Subject|3|||
124455937|NCT01378858|447628929|FG000|Overall Study|Withdrawal by Subject|4|||
124455938|NCT01378858|447628930|FG001|Overall Study|Withdrawal by Subject|4|||
124455939|NCT00942175|447628931|FG000|Overall Study|Adverse Event|2|||
124455940|NCT00942175|447628932|FG001|Overall Study|Adverse Event|1|||
124455941|NCT00942175|447628933|FG002|Overall Study|Adverse Event|0|||
124455942|NCT00942175|447628934|FG003|Overall Study|Adverse Event|0|||
124455943|NCT00942175|447628931|FG000|Overall Study|Protocol Violation|0|||
124455944|NCT00942175|447628932|FG001|Overall Study|Protocol Violation|1|||
124455945|NCT00942175|447628933|FG002|Overall Study|Protocol Violation|2|||
124455946|NCT00942175|447628934|FG003|Overall Study|Protocol Violation|0|||
124933768|NCT04167553|449387204|FG005|Overall Study|Withdrawal by Subject|0|||
124933769|NCT04167553|449387205|FG006|Overall Study|Withdrawal by Subject|0|||
124933770|NCT04167553|449387199|FG000|Overall Study|Physician Decision|0|||
124933771|NCT04167553|449387200|FG001|Overall Study|Physician Decision|0|||
124933772|NCT04167553|449387201|FG002|Overall Study|Physician Decision|0|||
124933773|NCT04167553|449387202|FG003|Overall Study|Physician Decision|0|||
124933774|NCT04167553|449387203|FG004|Overall Study|Physician Decision|2|||
124933775|NCT04167553|449387204|FG005|Overall Study|Physician Decision|2|||
124455947|NCT00942175|447628931|FG000|Overall Study|Pregnancy|0|||
124455948|NCT00942175|447628932|FG001|Overall Study|Pregnancy|0|||
124455949|NCT00942175|447628933|FG002|Overall Study|Pregnancy|0|||
124933776|NCT04167553|449387205|FG006|Overall Study|Physician Decision|0|||
124933777|NCT04167553|449387199|FG000|Overall Study|Lost to Follow-up|0|||
124455950|NCT00942175|447628934|FG003|Overall Study|Pregnancy|1|||
124455951|NCT00942175|447628931|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
124933778|NCT04167553|449387200|FG001|Overall Study|Lost to Follow-up|0|||
124933779|NCT04167553|449387201|FG002|Overall Study|Lost to Follow-up|2|||
124933780|NCT04167553|449387202|FG003|Overall Study|Lost to Follow-up|0|||
124933781|NCT04167553|449387203|FG004|Overall Study|Lost to Follow-up|0|||
124933782|NCT04167553|449387204|FG005|Overall Study|Lost to Follow-up|0|||
124933783|NCT04167553|449387205|FG006|Overall Study|Lost to Follow-up|0|||
124933784|NCT02828358|449387213|FG000|Overall Study|Physician Decision|7|||
124933785|NCT02828358|449387214|FG001|Overall Study|Physician Decision|1|||
124933786|NCT02828358|449387213|FG000|Overall Study|Treatment Failure|6|||
124933787|NCT02828358|449387214|FG001|Overall Study|Treatment Failure|0|||
124933788|NCT02828358|449387213|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
124933789|NCT02828358|449387214|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
124933790|NCT02828358|449387213|FG000|Overall Study|Refusal of further protocol therapy|2|||
124933791|NCT02828358|449387214|FG001|Overall Study|Refusal of further protocol therapy|0|||
124933792|NCT02828358|449387213|FG000|Overall Study|Relapse|25|||
124933793|NCT02828358|449387214|FG001|Overall Study|Relapse|0|||
124933794|NCT02828358|449387213|FG000|Overall Study|Still on therapy|5|||
124933795|NCT02828358|449387214|FG001|Overall Study|Still on therapy|0|||
124933796|NCT05224544|449387217|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
124933797|NCT05224544|449387218|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
124933798|NCT04804540|449387219|FG000|Overall Study|Adverse Event|26|||
124933799|NCT04804540|449387220|FG001|Overall Study|Adverse Event|13|||
124933800|NCT05172232|449387221|FG000|Overall Study|Lost to Follow-up|3|||
124933801|NCT01828021|449387222|FG000|Overall Study|Adverse Event|5|||
124933802|NCT01828021|449387222|FG000|Overall Study|Lack of Efficacy|17|||
124933803|NCT01828021|449387222|FG000|Overall Study|Withdrawal by Subject|2|||
124933804|NCT01828021|449387222|FG000|Overall Study|Ileal obstruction, unrelated|1|||
124933805|NCT00844415|449387223|FG000|Overall Study|Withdrawal by Subject|1|||
124933806|NCT02473445|449387224|FG000|Overall Study|Withdrawal by Subject|2|||
124933807|NCT02473445|449387224|FG000|Overall Study|Sponsor Decision|20|||
124933808|NCT04881461|449387225|FG000|Overall Study|Adverse Event|2|||
124933809|NCT04881461|449387226|FG001|Overall Study|Adverse Event|4|||
124933810|NCT04881461|449387225|FG000|Overall Study|Withdrawal by Subject|19|||
124933811|NCT04881461|449387226|FG001|Overall Study|Withdrawal by Subject|19|||
124933812|NCT04881461|449387225|FG000|Overall Study|Lost to Follow-up|4|||
124933813|NCT04881461|449387226|FG001|Overall Study|Lost to Follow-up|4|||
124933814|NCT04881461|449387225|FG000|Overall Study|Lack of Efficacy|1|||
124933815|NCT04881461|449387226|FG001|Overall Study|Lack of Efficacy|0|||
124933816|NCT04881461|449387225|FG000|Overall Study|"Reason stated as other in CRF"|1|||
124933817|NCT04881461|449387226|FG001|Overall Study|"Reason stated as other in CRF"|2|||
124933818|NCT03015532|449387227|FG000|Overall Study|Adverse Event|0|||
124933819|NCT03015532|449387228|FG001|Overall Study|Adverse Event|0|||
124933820|NCT03015532|449387229|FG002|Overall Study|Adverse Event|0|||
124933821|NCT03015532|449387230|FG003|Overall Study|Adverse Event|0|||
124933822|NCT03015532|449387231|FG004|Overall Study|Adverse Event|0|||
124933823|NCT03015532|449387232|FG005|Overall Study|Adverse Event|2|||
124933824|NCT03015532|449387233|FG006|Overall Study|Adverse Event|1|||
124933825|NCT03015532|449387234|FG007|Overall Study|Adverse Event|0|||
124933826|NCT03015532|449387227|FG000|Overall Study|Withdrawal by Subject|0|||
124933827|NCT03015532|449387228|FG001|Overall Study|Withdrawal by Subject|0|||
124933828|NCT03015532|449387229|FG002|Overall Study|Withdrawal by Subject|0|||
124933829|NCT03015532|449387230|FG003|Overall Study|Withdrawal by Subject|0|||
124933830|NCT03015532|449387231|FG004|Overall Study|Withdrawal by Subject|0|||
124933831|NCT03015532|449387232|FG005|Overall Study|Withdrawal by Subject|0|||
124933832|NCT03015532|449387233|FG006|Overall Study|Withdrawal by Subject|1|||
124933833|NCT03015532|449387234|FG007|Overall Study|Withdrawal by Subject|0|||
124933834|NCT05970861|449387235|FG000|Overall Study|Physician Decision|4|||
124933835|NCT05970861|449387236|FG001|Overall Study|Physician Decision|4|||
124933836|NCT05970861|449387235|FG000|Overall Study|Lost to Follow-up|4|||
124933837|NCT05970861|449387236|FG001|Overall Study|Lost to Follow-up|3|||
124933838|NCT05100628|449387237|FG000|Overall Study|Progressive Disease|1|||
124933839|NCT05100628|449387238|FG001|Overall Study|Progressive Disease|0|||
124933840|NCT05100628|449387239|FG002|Overall Study|Progressive Disease|0|||
124933841|NCT05100628|449387240|FG003|Overall Study|Progressive Disease|0|||
124455952|NCT00942175|447628932|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
124933842|NCT05100628|449387237|FG000|Overall Study|Study Terminated by Sponsor|0|||
124933843|NCT05100628|449387238|FG001|Overall Study|Study Terminated by Sponsor|0|||
124933844|NCT05100628|449387239|FG002|Overall Study|Study Terminated by Sponsor|3|||
124933845|NCT05100628|449387240|FG003|Overall Study|Study Terminated by Sponsor|0|||
124933846|NCT05100628|449387237|FG000|Overall Study|unkown|0|||
124933847|NCT05100628|449387238|FG001|Overall Study|unkown|1|||
124933848|NCT05100628|449387239|FG002|Overall Study|unkown|0|||
124933849|NCT05100628|449387240|FG003|Overall Study|unkown|0|||
124933850|NCT00677365|449387245|FG000|Overall Study|Adverse Event|2|||
124933851|NCT00677365|449387246|FG001|Overall Study|Adverse Event|1|||
124933852|NCT00677365|449387247|FG002|Overall Study|Adverse Event|1|||
124933853|NCT00677365|449387248|FG003|Overall Study|Adverse Event|2|||
124933854|NCT00677365|449387245|FG000|Overall Study|Withdrawal by Subject|0|||
124455953|NCT00942175|447628933|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
124455954|NCT00942175|447628934|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
124702377|NCT03766399|448534205|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
124702378|NCT03766399|448534206|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
124702379|NCT03766399|448534207|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
124933855|NCT00677365|449387246|FG001|Overall Study|Withdrawal by Subject|0|||
124933856|NCT00677365|449387247|FG002|Overall Study|Withdrawal by Subject|1|||
124933857|NCT00677365|449387248|FG003|Overall Study|Withdrawal by Subject|0|||
124933858|NCT00677365|449387245|FG000|Overall Study|Other reason|0|||
124933859|NCT00677365|449387246|FG001|Overall Study|Other reason|0|||
124933860|NCT00677365|449387247|FG002|Overall Study|Other reason|0|||
124933861|NCT00677365|449387248|FG003|Overall Study|Other reason|1|||
124933862|NCT05422885|449387249|FG000|Overall Study|Lost to Follow-up|1|||
124933863|NCT05422885|449387249|FG000|Overall Study|Withdrawal by Subject|2|||
124933864|NCT02542631|449387252|FG000|Overall Study|Adverse Event|1|||
124933865|NCT02542631|449387253|FG001|Overall Study|Adverse Event|1|||
124933866|NCT02542631|449387252|FG000|Overall Study|Sponsor Termination|1|||
124933867|NCT02542631|449387253|FG001|Overall Study|Sponsor Termination|0|||
124933868|NCT02542631|449387252|FG000|Overall Study|Withdrawal by Subject|11|||
124933869|NCT02542631|449387253|FG001|Overall Study|Withdrawal by Subject|16|||
124933870|NCT02542631|449387252|FG000|Overall Study|Protocol Violation|1|||
124933871|NCT02542631|449387253|FG001|Overall Study|Protocol Violation|1|||
124933872|NCT02542631|449387252|FG000|Overall Study|Physician Decision|6|||
124933873|NCT02542631|449387253|FG001|Overall Study|Physician Decision|4|||
124933874|NCT02542631|449387252|FG000|Overall Study|Lost to Follow-up|6|||
124933875|NCT02542631|449387253|FG001|Overall Study|Lost to Follow-up|5|||
124933876|NCT02542631|449387252|FG000|Overall Study|Death|1|||
124933877|NCT02542631|449387253|FG001|Overall Study|Death|2|||
124933878|NCT02542631|449387252|FG000|Overall Study|Other|2|||
124933879|NCT02542631|449387253|FG001|Overall Study|Other|1|||
124933880|NCT02542631|449387252|FG000|Overall Study|Used Prohibited Medication|2|||
124933881|NCT02542631|449387253|FG001|Overall Study|Used Prohibited Medication|1|||
124933882|NCT02641730|449387254|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
124933883|NCT02641730|449387255|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
124933884|NCT02641730|449387256|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
124933885|NCT02641730|449387257|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
124933886|NCT02641730|449387258|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
124933887|NCT02641730|449387254|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
124933888|NCT02641730|449387255|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
124933889|NCT02641730|449387256|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
124933890|NCT02641730|449387257|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
124933891|NCT02641730|449387258|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
124933892|NCT02641730|449387254|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
124933893|NCT02641730|449387255|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
124933894|NCT02641730|449387256|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
124933895|NCT02641730|449387257|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
124933896|NCT02641730|449387258|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
124933897|NCT02641730|449387254|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
124933898|NCT02641730|449387255|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
124933899|NCT02641730|449387256|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
124933900|NCT02641730|449387257|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
124933901|NCT02641730|449387258|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
124933902|NCT02641730|449387254|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
124933903|NCT02641730|449387255|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
124933904|NCT02641730|449387256|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
124933905|NCT02641730|449387257|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
124764920|NCT02269124|448765066|FG001|Overall Study|Withdrawal by Subject|2|||
124764921|NCT00614575|448765067|FG000|Overall Study|Adverse Event|106|||
124933906|NCT02641730|449387258|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
124933907|NCT02641730|449387254|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
124933908|NCT02641730|449387255|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
124933909|NCT02641730|449387256|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
124933910|NCT02641730|449387257|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
124933911|NCT02641730|449387258|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
124933912|NCT00319046|449387259|FG000|Overall Study|withdrawal of subject's consent|7|||
124933913|NCT00319046|449387259|FG000|Overall Study|administrative reason|1|||
124933914|NCT00721149|449387260|FG000|Overall Study|Physician Decision|1|||
124933915|NCT00631475|449387262|FG000|Overall Study|Death|18|||
124933916|NCT00631475|449387262|FG000|Overall Study|Adverse Event|14|||
124933917|NCT00631475|449387262|FG000|Overall Study|Withdrew consent|5|||
124933918|NCT00631475|449387262|FG000|Overall Study|Preparation for lung transplant|8|||
124933919|NCT05158504|449387263|FG000|Overall Study|Lost to Follow-up|2|||
124933920|NCT05158504|449387264|FG001|Overall Study|Lost to Follow-up|3|||
124933921|NCT05652010|449387265|FG000|First Intervention|Withdrawal by Subject|0|||
124933922|NCT05652010|449387266|FG001|First Intervention|Withdrawal by Subject|1|||
124933923|NCT05652010|449387265|FG000|Second Intervention|Withdrawal by Subject|1|||
124933924|NCT05652010|449387266|FG001|Second Intervention|Withdrawal by Subject|0|||
124933925|NCT04707768|449387270|FG000|Overall Study|Adverse Event|9|||
124933926|NCT04707768|449387271|FG001|Overall Study|Adverse Event|18|||
124933927|NCT04707768|449387272|FG002|Overall Study|Adverse Event|3|||
124933928|NCT04707768|449387270|FG000|Overall Study|Investigator's Discretion|8|||
124933929|NCT04707768|449387271|FG001|Overall Study|Investigator's Discretion|4|||
124933930|NCT04707768|449387272|FG002|Overall Study|Investigator's Discretion|3|||
124933931|NCT04707768|449387270|FG000|Overall Study|Withdrawal by Subject|6|||
124933932|NCT04707768|449387271|FG001|Overall Study|Withdrawal by Subject|8|||
124933933|NCT04707768|449387272|FG002|Overall Study|Withdrawal by Subject|2|||
124933934|NCT04707768|449387270|FG000|Overall Study|Lack of Efficacy|1|||
124933935|NCT04707768|449387271|FG001|Overall Study|Lack of Efficacy|3|||
124933936|NCT04707768|449387272|FG002|Overall Study|Lack of Efficacy|0|||
124933937|NCT04707768|449387270|FG000|Overall Study|Lost to Follow-up|0|||
124933938|NCT04707768|449387271|FG001|Overall Study|Lost to Follow-up|0|||
124933939|NCT04707768|449387272|FG002|Overall Study|Lost to Follow-up|3|||
124933940|NCT04707768|449387270|FG000|Overall Study|Death|13|||
124933941|NCT04707768|449387271|FG001|Overall Study|Death|11|||
124933942|NCT04707768|449387272|FG002|Overall Study|Death|13|||
124933943|NCT04707768|449387270|FG000|Overall Study|Protocol Violation|2|||
124933944|NCT04707768|449387271|FG001|Overall Study|Protocol Violation|1|||
124933945|NCT04707768|449387272|FG002|Overall Study|Protocol Violation|0|||
124933946|NCT04707768|449387270|FG000|Overall Study|Non Compliance with Study Drug|1|||
124933947|NCT04707768|449387271|FG001|Overall Study|Non Compliance with Study Drug|0|||
124933948|NCT04707768|449387272|FG002|Overall Study|Non Compliance with Study Drug|0|||
124933949|NCT04707768|449387270|FG000|Overall Study|Transplant|4|||
124933950|NCT04707768|449387271|FG001|Overall Study|Transplant|4|||
124933951|NCT04707768|449387272|FG002|Overall Study|Transplant|8|||
124933952|NCT04707768|449387270|FG000|Overall Study|Other|9|||
124933953|NCT04707768|449387271|FG001|Overall Study|Other|5|||
124933954|NCT04707768|449387272|FG002|Overall Study|Other|2|||
124933955|NCT02518048|449387273|FG000|Overall Study|Withdrawal by Subject|1|||
124933956|NCT04678856|449387274|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
124933957|NCT04678856|449387275|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
124933958|NCT04678856|449387274|FG000|Overall Study|Withdrawal by Subject|5|||
124933959|NCT04678856|449387275|FG001|Overall Study|Withdrawal by Subject|1|||
124933960|NCT04282980|449388604|FG000|Overall Study|Remained on treatment|6|||
124933961|NCT04282980|449388604|FG000|Overall Study|Survival follow-up|11|||
124933962|NCT04282980|449388604|FG000|Overall Study|Withdrawal of informed consent|1|||
124933963|NCT04282980|449388604|FG000|Overall Study|Lost to Follow-up|1|||
124933964|NCT03571386|449388606|FG000|Overall Study|scheduling conflict|4|||
124933965|NCT03571386|449388607|FG001|Overall Study|scheduling conflict|0|||
124933966|NCT03571386|449388606|FG000|Overall Study|Withdrawal by Subject|15|||
124933967|NCT03571386|449388607|FG001|Overall Study|Withdrawal by Subject|5|||
124933968|NCT04311632|449388608|FG000|Overall Study|Withdrawal by Subject|0|||
124933969|NCT04311632|449388609|FG001|Overall Study|Withdrawal by Subject|0|||
124933970|NCT04311632|449388610|FG002|Overall Study|Withdrawal by Subject|1|||
124933971|NCT04605159|449388611|FG000|Overall Study|Adverse Event|6|||
124933972|NCT04605159|449388612|FG001|Overall Study|Adverse Event|3|||
124933973|NCT04605159|449388613|FG002|Overall Study|Adverse Event|21|||
124933974|NCT04605159|449388614|FG003|Overall Study|Adverse Event|4|||
124933975|NCT04605159|449388611|FG000|Overall Study|Lost to Follow-up|74|||
124933976|NCT04605159|449388612|FG001|Overall Study|Lost to Follow-up|45|||
124764922|NCT00614575|448765067|FG000|Overall Study|Lost to Follow-up|55|||
124933977|NCT04605159|449388613|FG002|Overall Study|Lost to Follow-up|119|||
124764923|NCT00614575|448765067|FG000|Overall Study|Lack of Efficacy|14|||
124933978|NCT04605159|449388614|FG003|Overall Study|Lost to Follow-up|80|||
124933979|NCT04605159|449388611|FG000|Overall Study|Protocol Violation|4|||
124455955|NCT00942175|447628931|FG000|Overall Study|Low Platelet Count|0|||
124455956|NCT00942175|447628932|FG001|Overall Study|Low Platelet Count|2|||
124455957|NCT00942175|447628933|FG002|Overall Study|Low Platelet Count|0|||
124455958|NCT00942175|447628934|FG003|Overall Study|Low Platelet Count|0|||
124933980|NCT04605159|449388612|FG001|Overall Study|Protocol Violation|5|||
124933981|NCT04605159|449388613|FG002|Overall Study|Protocol Violation|2|||
124933982|NCT04605159|449388614|FG003|Overall Study|Protocol Violation|0|||
124933983|NCT04605159|449388611|FG000|Overall Study|Withdrawal by Subject|66|||
124933984|NCT04605159|449388612|FG001|Overall Study|Withdrawal by Subject|37|||
124933985|NCT04605159|449388613|FG002|Overall Study|Withdrawal by Subject|68|||
124933986|NCT04605159|449388614|FG003|Overall Study|Withdrawal by Subject|50|||
124933987|NCT04605159|449388611|FG000|Overall Study|Migrated / moved from the study area|32|||
124933988|NCT04605159|449388612|FG001|Overall Study|Migrated / moved from the study area|22|||
124933989|NCT04605159|449388613|FG002|Overall Study|Migrated / moved from the study area|41|||
124933990|NCT04605159|449388614|FG003|Overall Study|Migrated / moved from the study area|21|||
124933991|NCT04605159|449388611|FG000|Overall Study|Other|1|||
124933992|NCT04605159|449388612|FG001|Overall Study|Other|2|||
124933993|NCT04605159|449388613|FG002|Overall Study|Other|7|||
124933994|NCT04605159|449388614|FG003|Overall Study|Other|3|||
124933995|NCT02278211|449388615|FG000|Overall Study|Unable to analyse PET scan|2|||
124933996|NCT04158739|449388616|FG000|Overall Study|Adverse Event|1|||
124933997|NCT04158739|449388617|FG001|Overall Study|Adverse Event|0|||
124933998|NCT04158739|449388616|FG000|Overall Study|Death|0|||
124933999|NCT04158739|449388617|FG001|Overall Study|Death|1|||
124934000|NCT04158739|449388616|FG000|Overall Study|Lack of Efficacy|3|||
124934001|NCT04158739|449388617|FG001|Overall Study|Lack of Efficacy|7|||
124934002|NCT04158739|449388616|FG000|Overall Study|Physician Decision|0|||
124934003|NCT04158739|449388617|FG001|Overall Study|Physician Decision|1|||
124934004|NCT04158739|449388616|FG000|Overall Study|Withdrawal by Subject|3|||
124934005|NCT04158739|449388617|FG001|Overall Study|Withdrawal by Subject|0|||
124934006|NCT04778410|449388618|FG000|Safety Run-in Period|Death|5|||
124934007|NCT04778410|449388619|FG001|Safety Run-in Period|Death|6|||
124934008|NCT04778410|449388620|FG002|Safety Run-in Period|Death|0|||
124934009|NCT04778410|449388621|FG003|Safety Run-in Period|Death|0|||
124934010|NCT04778410|449388622|FG004|Safety Run-in Period|Death|0|||
124934011|NCT04778410|449388623|FG005|Safety Run-in Period|Death|0|||
124934012|NCT04778410|449388618|FG000|Phase 2 Period|Death|0|||
124934013|NCT04778410|449388619|FG001|Phase 2 Period|Death|0|||
124934014|NCT04778410|449388620|FG002|Phase 2 Period|Death|0|||
124934015|NCT04778410|449388621|FG003|Phase 2 Period|Death|5|||
124934016|NCT04778410|449388622|FG004|Phase 2 Period|Death|18|||
124934017|NCT04778410|449388623|FG005|Phase 2 Period|Death|0|||
124934018|NCT04778410|449388618|FG000|Phase 2 Period|Lost to Follow-up|0|||
124934019|NCT04778410|449388619|FG001|Phase 2 Period|Lost to Follow-up|0|||
124934020|NCT04778410|449388620|FG002|Phase 2 Period|Lost to Follow-up|0|||
124455959|NCT02664272|447628935|FG000|Overall Study|Fluoroscopic images not made available|2|||
124455960|NCT03073980|447628938|FG000|Overall Study|Lost to Follow-up|10|||
124455961|NCT03073980|447628939|FG001|Overall Study|Lost to Follow-up|2|||
124934021|NCT04778410|449388621|FG003|Phase 2 Period|Lost to Follow-up|1|||
124934022|NCT04778410|449388622|FG004|Phase 2 Period|Lost to Follow-up|1|||
124934023|NCT04778410|449388623|FG005|Phase 2 Period|Lost to Follow-up|0|||
124934024|NCT04778410|449388618|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
124934025|NCT04778410|449388619|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
124934026|NCT04778410|449388620|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
124934027|NCT04778410|449388621|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
124934028|NCT04778410|449388622|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
124934029|NCT04778410|449388623|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
124934030|NCT04778410|449388618|FG000|Phase 2 Period|Withdrew Consent|0|||
124934031|NCT04778410|449388619|FG001|Phase 2 Period|Withdrew Consent|0|||
124934032|NCT04778410|449388620|FG002|Phase 2 Period|Withdrew Consent|0|||
124934033|NCT04778410|449388621|FG003|Phase 2 Period|Withdrew Consent|0|||
124934034|NCT04778410|449388622|FG004|Phase 2 Period|Withdrew Consent|2|||
124934035|NCT04778410|449388623|FG005|Phase 2 Period|Withdrew Consent|0|||
124934036|NCT02944968|449388624|FG000|Overall Study|Subject excluded before study procedure|1|||
124934037|NCT02944968|449388624|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
124934038|NCT02905331|449388625|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
124934039|NCT02905331|449388626|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
124934040|NCT02905331|449388627|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
124934041|NCT02905331|449388625|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
124934042|NCT02905331|449388626|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
124934043|NCT02905331|449388627|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
124934044|NCT02905331|449388625|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
124934045|NCT02905331|449388626|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
124934046|NCT02905331|449388627|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
124934047|NCT02905331|449388625|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
124934048|NCT02905331|449388626|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
124934049|NCT02905331|449388627|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
124934050|NCT02905331|449388625|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
124934051|NCT02905331|449388626|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
124934052|NCT02905331|449388627|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
124934053|NCT01385202|449388628|FG000|Overall Study|Lost to Follow-up|6|||
124934054|NCT01385202|449388628|FG000|Overall Study|Not Eligible|11|||
124934055|NCT01385202|449388628|FG000|Overall Study|Withdrawn|1|||
124934056|NCT03681262|449388629|FG000|Overall Study|Continuing on study|3|||
124934057|NCT03681262|449388630|FG001|Overall Study|Continuing on study|3|||
124934058|NCT03681262|449388629|FG000|Overall Study|Lost to Follow-up|1|||
124934059|NCT03681262|449388630|FG001|Overall Study|Lost to Follow-up|0|||
124934060|NCT04102111|449388632|FG000|Overall Study|Withdrawal by Subject|2|||
124934061|NCT04102111|449388633|FG001|Overall Study|Withdrawal by Subject|3|||
124934062|NCT04102111|449388632|FG000|Overall Study|Adverse Event|1|||
124934063|NCT04102111|449388633|FG001|Overall Study|Adverse Event|1|||
124934064|NCT04102111|449388632|FG000|Overall Study|Study terminated by sponsor|1|||
124934065|NCT04102111|449388633|FG001|Overall Study|Study terminated by sponsor|3|||
124934066|NCT02782676|449388634|FG000|Overall Study|Lost to Follow-up|0|||
124934067|NCT02782676|449388635|FG001|Overall Study|Lost to Follow-up|1|||
124934068|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
124934069|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
124934070|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
124934071|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
124934072|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
124934073|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
124934074|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
124934075|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
124934076|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
124934077|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
124934078|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
124934079|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
124934080|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
124934081|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
124934082|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
124934083|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
124934084|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
124934085|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
124934086|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
124934087|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
124934088|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
124934089|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
124934090|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
124934091|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
124934092|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
124934093|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
124934094|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
124934095|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
124934096|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
124934097|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
124934098|NCT04614948|449388636|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
124934099|NCT04614948|449388637|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
124934100|NCT04614948|449388638|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
124934101|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
124934102|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
124934103|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
124934104|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
124934105|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
124934106|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
124934107|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
124934108|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
124934109|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
124934110|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
124934111|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
124934112|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
124934113|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
124934114|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
124934115|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
124934116|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
124934117|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
124934118|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
124934119|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
124934120|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
124934121|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
124934122|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
124934123|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
124934124|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
124934125|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
124934126|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
124934127|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
124934128|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
124934129|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
124934130|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
124934131|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
124934132|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
124934133|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
124934134|NCT04614948|449388636|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
124934135|NCT04614948|449388637|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
124934136|NCT04614948|449388638|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
124934137|NCT04055012|449388639|FG000|Overall Study|Withdrawal by Subject|1|||
124934138|NCT04055012|449388640|FG001|Overall Study|Withdrawal by Subject|3|||
124934139|NCT04055012|449388641|FG002|Overall Study|Withdrawal by Subject|1|||
124934140|NCT04055012|449388642|FG003|Overall Study|Withdrawal by Subject|0|||
124934141|NCT04055012|449388639|FG000|Overall Study|Metformin Recall|1|||
124934142|NCT04055012|449388640|FG001|Overall Study|Metformin Recall|1|||
124934143|NCT04055012|449388641|FG002|Overall Study|Metformin Recall|1|||
124934144|NCT04055012|449388642|FG003|Overall Study|Metformin Recall|0|||
124934145|NCT03663205|449388645|FG000|Overall Study|Death|144|||
124934146|NCT03663205|449388646|FG001|Overall Study|Death|69|||
124934147|NCT03663205|449388645|FG000|Overall Study|Sponsor decision|53|||
124934148|NCT03663205|449388646|FG001|Overall Study|Sponsor decision|19|||
124934149|NCT03663205|449388645|FG000|Overall Study|Withdrawal by Subject|8|||
124934150|NCT03663205|449388646|FG001|Overall Study|Withdrawal by Subject|11|||
124934151|NCT03663205|449388645|FG000|Overall Study|Lost to Follow-up|7|||
124934152|NCT03663205|449388646|FG001|Overall Study|Lost to Follow-up|9|||
124934153|NCT03663205|449388645|FG000|Overall Study|Transferred to long term extension study|11|||
124934154|NCT03663205|449388646|FG001|Overall Study|Transferred to long term extension study|3|||
124934155|NCT02326974|449388647|FG000|Overall Study|Withdrawal by Subject|2|||
124934156|NCT02326974|449388647|FG000|Overall Study|failed heterogenity evaluation|5|||
124934157|NCT02577354|449388648|FG000|Overall Study|Lack of Efficacy|4|||
124934158|NCT02577354|449388649|FG001|Overall Study|Lack of Efficacy|4|||
124934159|NCT02577354|449388648|FG000|Overall Study|Lost to Follow-up|3|||
124934160|NCT02577354|449388649|FG001|Overall Study|Lost to Follow-up|1|||
124934161|NCT02577354|449388648|FG000|Overall Study|Missed Visit|4|||
124934162|NCT02577354|449388649|FG001|Overall Study|Missed Visit|3|||
124934163|NCT02577354|449388648|FG000|Overall Study|Adverse Event|4|||
124934164|NCT02577354|449388649|FG001|Overall Study|Adverse Event|5|||
124934165|NCT04924400|449388653|FG000|Overall Study|Lost to Follow-up|3|||
124934166|NCT04924400|449388654|FG001|Overall Study|Lost to Follow-up|0|||
124934167|NCT04424316|449388655|FG000|Overall Study|Adverse Event|0|||
124934168|NCT04424316|449388656|FG001|Overall Study|Adverse Event|1|||
124934169|NCT04424316|449388657|FG002|Overall Study|Adverse Event|0|||
124934170|NCT04424316|449388658|FG003|Overall Study|Adverse Event|0|||
124934171|NCT04424316|449388655|FG000|Overall Study|Death|1|||
124934172|NCT04424316|449388656|FG001|Overall Study|Death|0|||
124934173|NCT04424316|449388657|FG002|Overall Study|Death|8|||
124934174|NCT04424316|449388658|FG003|Overall Study|Death|14|||
124934175|NCT04424316|449388655|FG000|Overall Study|Lost to Follow-up|93|||
124934176|NCT04424316|449388656|FG001|Overall Study|Lost to Follow-up|88|||
124934177|NCT04424316|449388657|FG002|Overall Study|Lost to Follow-up|224|||
124934178|NCT04424316|449388658|FG003|Overall Study|Lost to Follow-up|211|||
124934179|NCT04424316|449388655|FG000|Overall Study|No longer met eligibility criteria|1|||
124934180|NCT04424316|449388656|FG001|Overall Study|No longer met eligibility criteria|0|||
124934181|NCT04424316|449388657|FG002|Overall Study|No longer met eligibility criteria|0|||
124934182|NCT04424316|449388658|FG003|Overall Study|No longer met eligibility criteria|0|||
124934183|NCT04424316|449388655|FG000|Overall Study|Other|15|||
124934184|NCT04424316|449388656|FG001|Overall Study|Other|11|||
124934185|NCT04424316|449388657|FG002|Overall Study|Other|34|||
124934186|NCT04424316|449388658|FG003|Overall Study|Other|45|||
124934187|NCT04424316|449388655|FG000|Overall Study|Physician Decision|1|||
124934188|NCT04424316|449388656|FG001|Overall Study|Physician Decision|0|||
124934189|NCT04424316|449388657|FG002|Overall Study|Physician Decision|1|||
124934190|NCT04424316|449388658|FG003|Overall Study|Physician Decision|1|||
124934191|NCT04424316|449388655|FG000|Overall Study|Protocol Violation|0|||
124934192|NCT04424316|449388656|FG001|Overall Study|Protocol Violation|1|||
124934193|NCT04424316|449388657|FG002|Overall Study|Protocol Violation|0|||
124934194|NCT04424316|449388658|FG003|Overall Study|Protocol Violation|0|||
124934195|NCT04424316|449388655|FG000|Overall Study|Withdrawal by Subject|71|||
124934196|NCT04424316|449388656|FG001|Overall Study|Withdrawal by Subject|77|||
124934197|NCT04424316|449388657|FG002|Overall Study|Withdrawal by Subject|0|||
124934198|NCT04424316|449388658|FG003|Overall Study|Withdrawal by Subject|0|||
124934199|NCT04424316|449388655|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124934200|NCT04424316|449388656|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124934201|NCT04424316|449388657|FG002|Overall Study|Withdrawal by parent/guardian|74|||
124934202|NCT04424316|449388658|FG003|Overall Study|Withdrawal by parent/guardian|81|||
124934203|NCT04424316|449388655|FG000|Overall Study|Randomized but not vaccinated|13|||
124934204|NCT04424316|449388656|FG001|Overall Study|Randomized but not vaccinated|21|||
124934205|NCT04424316|449388657|FG002|Overall Study|Randomized but not vaccinated|0|||
124934206|NCT04424316|449388658|FG003|Overall Study|Randomized but not vaccinated|0|||
124934207|NCT04424316|449388655|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
124934208|NCT04424316|449388656|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
124934209|NCT04424316|449388657|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
124934210|NCT04424316|449388658|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
124934211|NCT00412607|449388661|FG000|Overall Study|Withdrawal by Subject|9|||
124934212|NCT00412607|449388661|FG000|Overall Study|Lost to Follow-up|19|||
124934213|NCT00412607|449388661|FG000|Overall Study|Death|61|||
124934214|NCT00412607|449388661|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
124934215|NCT04109066|449388663|FG000|Pre-treatment|Participant withdrew consent|2|||
124934216|NCT04109066|449388664|FG001|Pre-treatment|Participant withdrew consent|0|||
124934217|NCT04109066|449388663|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
124934218|NCT04109066|449388664|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
124934219|NCT04109066|449388663|FG000|Treatment|Lack of Efficacy|2|||
124934220|NCT04109066|449388664|FG001|Treatment|Lack of Efficacy|4|||
124934221|NCT04109066|449388663|FG000|Treatment|Adverse Event|23|||
124934222|NCT04109066|449388664|FG001|Treatment|Adverse Event|7|||
124934223|NCT04109066|449388663|FG000|Treatment|Participant request to discontinue Study treatment|15|||
124934224|NCT04109066|449388664|FG001|Treatment|Participant request to discontinue Study treatment|14|||
124934225|NCT04109066|449388663|FG000|Treatment|Withdrawal by Subject|8|||
124702380|NCT03766399|448534208|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
124702381|NCT03766399|448534209|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
124934226|NCT04109066|449388664|FG001|Treatment|Withdrawal by Subject|8|||
124934227|NCT04109066|449388663|FG000|Treatment|Death|3|||
124934228|NCT04109066|449388664|FG001|Treatment|Death|0|||
124934229|NCT04109066|449388663|FG000|Treatment|Participant no longer meets study criteria|2|||
124934230|NCT04109066|449388664|FG001|Treatment|Participant no longer meets study criteria|2|||
124934231|NCT04109066|449388663|FG000|Treatment|Administrative reasons by sponsor|2|||
124934232|NCT04109066|449388664|FG001|Treatment|Administrative reasons by sponsor|3|||
124934233|NCT04109066|449388663|FG000|Treatment|Other reasons|17|||
124934234|NCT04109066|449388664|FG001|Treatment|Other reasons|23|||
124934235|NCT04109066|449388663|FG000|Treatment|Disease Progression|4|||
124934236|NCT04109066|449388664|FG001|Treatment|Disease Progression|7|||
124934237|NCT04109066|449388663|FG000|Treatment|Study drug toxicity|12|||
124934238|NCT04109066|449388664|FG001|Treatment|Study drug toxicity|5|||
124934239|NCT04109066|449388663|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
124546480|NCT00320801|447955919|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
124934240|NCT04109066|449388664|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
124934241|NCT04109066|449388663|FG000|Treatment|Disease Recurrence|0|||
124934242|NCT04109066|449388664|FG001|Treatment|Disease Recurrence|2|||
124934243|NCT04109066|449388663|FG000|Treatment|Not reported|4|||
124934244|NCT04109066|449388664|FG001|Treatment|Not reported|8|||
124934245|NCT05741294|449388666|FG000|Overall Study|Lost to Follow-up|3|||
124934246|NCT05741294|449388666|FG000|Overall Study|Protocol deviation|3|||
124934247|NCT05741294|449388666|FG000|Overall Study|Withdrawal by Subject|1|||
124934248|NCT04675034|449388669|FG000|Overall Study|Lost to Follow-up|1|||
124934249|NCT04675034|449388670|FG001|Overall Study|Lost to Follow-up|1|||
124934250|NCT04675034|449388671|FG002|Overall Study|Lost to Follow-up|0|||
124934251|NCT04675034|449388672|FG003|Overall Study|Lost to Follow-up|2|||
124934252|NCT04675034|449388673|FG004|Overall Study|Lost to Follow-up|0|||
124934253|NCT04675034|449388669|FG000|Overall Study|Protocol Violation|1|||
124934254|NCT04675034|449388670|FG001|Overall Study|Protocol Violation|0|||
124934255|NCT04675034|449388671|FG002|Overall Study|Protocol Violation|0|||
124934256|NCT04675034|449388672|FG003|Overall Study|Protocol Violation|1|||
124934257|NCT04675034|449388673|FG004|Overall Study|Protocol Violation|3|||
124934258|NCT04675034|449388669|FG000|Overall Study|Withdrawal by Subject|9|||
124934259|NCT04675034|449388670|FG001|Overall Study|Withdrawal by Subject|3|||
124934260|NCT04675034|449388671|FG002|Overall Study|Withdrawal by Subject|4|||
124934261|NCT04675034|449388672|FG003|Overall Study|Withdrawal by Subject|8|||
124934262|NCT04675034|449388673|FG004|Overall Study|Withdrawal by Subject|6|||
124934263|NCT04163991|449388674|FG000|Overall Study|Adverse Event|0|||
124934264|NCT04163991|449388675|FG001|Overall Study|Adverse Event|0|||
124934265|NCT04163991|449388676|FG002|Overall Study|Adverse Event|0|||
124934266|NCT04163991|449388677|FG003|Overall Study|Adverse Event|1|||
124934267|NCT04163991|449388678|FG004|Overall Study|Adverse Event|0|||
124934268|NCT04163991|449388674|FG000|Overall Study|Death|0|||
124934269|NCT04163991|449388675|FG001|Overall Study|Death|0|||
124934270|NCT04163991|449388676|FG002|Overall Study|Death|1|||
124934271|NCT04163991|449388677|FG003|Overall Study|Death|0|||
124934272|NCT04163991|449388678|FG004|Overall Study|Death|0|||
124934273|NCT04163991|449388674|FG000|Overall Study|Lost to Follow-up|0|||
124934274|NCT04163991|449388675|FG001|Overall Study|Lost to Follow-up|1|||
124934275|NCT04163991|449388676|FG002|Overall Study|Lost to Follow-up|0|||
124934276|NCT04163991|449388677|FG003|Overall Study|Lost to Follow-up|0|||
124934277|NCT04163991|449388678|FG004|Overall Study|Lost to Follow-up|0|||
124934278|NCT04163991|449388674|FG000|Overall Study|Withdrawal by Subject|1|||
124934279|NCT04163991|449388675|FG001|Overall Study|Withdrawal by Subject|1|||
124934280|NCT04163991|449388676|FG002|Overall Study|Withdrawal by Subject|3|||
124934281|NCT04163991|449388677|FG003|Overall Study|Withdrawal by Subject|1|||
124934282|NCT04163991|449388678|FG004|Overall Study|Withdrawal by Subject|1|||
124934283|NCT04163991|449388674|FG000|Overall Study|Other, Not Specified|0|||
124934284|NCT04163991|449388675|FG001|Overall Study|Other, Not Specified|1|||
124934285|NCT04163991|449388676|FG002|Overall Study|Other, Not Specified|1|||
124934286|NCT04163991|449388677|FG003|Overall Study|Other, Not Specified|1|||
124934287|NCT04163991|449388678|FG004|Overall Study|Other, Not Specified|0|||
124934288|NCT04078152|449388679|FG000|Overall Study|Other|83|||
124934289|NCT04078152|449388680|FG001|Overall Study|Other|22|||
124934290|NCT04078152|449388681|FG002|Overall Study|Other|25|||
124934291|NCT04078152|449388679|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
124934292|NCT04078152|449388680|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
124934293|NCT04078152|449388681|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
124934294|NCT04078152|449388679|FG000|Overall Study|Withdrawal by Subject|5|||
124934295|NCT04078152|449388680|FG001|Overall Study|Withdrawal by Subject|0|||
124934296|NCT04078152|449388681|FG002|Overall Study|Withdrawal by Subject|1|||
124934297|NCT04078152|449388679|FG000|Overall Study|Death|10|||
124934298|NCT04078152|449388680|FG001|Overall Study|Death|2|||
124546481|NCT00320801|447955916|FG000|Open-label Run-in Period|Adverse Event|33|||
124546482|NCT00320801|447955917|FG001|Open-label Run-in Period|Adverse Event|0|||
124546483|NCT00320801|447955918|FG002|Open-label Run-in Period|Adverse Event|0|||
124934299|NCT04078152|449388681|FG002|Overall Study|Death|12|||
124934300|NCT04078152|449388679|FG000|Overall Study|Adverse Event|1|||
124934301|NCT04078152|449388680|FG001|Overall Study|Adverse Event|0|||
124934302|NCT04078152|449388681|FG002|Overall Study|Adverse Event|0|||
124934303|NCT02510235|449388682|FG000|Overall Study|Withdrawal by Subject|1|||
124934304|NCT02510235|449388683|FG001|Overall Study|Withdrawal by Subject|0|||
124934305|NCT05890105|449388684|FG000|Overall Study|Adverse Event|1|||
124934306|NCT05890105|449388685|FG001|Overall Study|Adverse Event|0|||
124934307|NCT05890105|449388686|FG002|Overall Study|Adverse Event|0|||
124934308|NCT05890105|449388684|FG000|Overall Study|Other|1|||
124934309|NCT05890105|449388685|FG001|Overall Study|Other|2|||
124934310|NCT05890105|449388686|FG002|Overall Study|Other|0|||
124934311|NCT03367156|449389724|FG000|Overall Study|Lack of interest|3|||
124934312|NCT03367156|449389725|FG001|Overall Study|Lack of interest|1|||
124934313|NCT03367156|449389724|FG000|Overall Study|Death|2|||
124934314|NCT03367156|449389725|FG001|Overall Study|Death|0|||
124934315|NCT03367156|449389724|FG000|Overall Study|Lost to Follow-up|2|||
124934316|NCT03367156|449389725|FG001|Overall Study|Lost to Follow-up|1|||
124934317|NCT03367156|449389724|FG000|Overall Study|Became ineligible|1|||
124934318|NCT03367156|449389725|FG001|Overall Study|Became ineligible|2|||
124934319|NCT03367156|449389724|FG000|Overall Study|Hospitalization|1|||
124934320|NCT03367156|449389725|FG001|Overall Study|Hospitalization|0|||
124934321|NCT03367156|449389724|FG000|Overall Study|Concerned about Treatment|11|||
124934322|NCT03367156|449389725|FG001|Overall Study|Concerned about Treatment|3|||
124702382|NCT03766399|448534210|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
124702383|NCT03766399|448534211|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
124702384|NCT03766399|448534212|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
124934323|NCT03367156|449389724|FG000|Overall Study|Started new treatment|4|||
124934324|NCT03367156|449389725|FG001|Overall Study|Started new treatment|1|||
124934325|NCT05507437|449389726|FG000|Overall Study|Withdrawal by Subject|1|||
124934326|NCT05507437|449389727|FG001|Overall Study|Withdrawal by Subject|1|||
124934327|NCT05507437|449389726|FG000|Overall Study|Death|3|||
124934328|NCT05507437|449389727|FG001|Overall Study|Death|0|||
124934329|NCT04084574|449389729|FG000|Overall Study|Lost to Follow-up|1|||
124934330|NCT04084574|449389730|FG001|Overall Study|Lost to Follow-up|0|||
124934331|NCT04084574|449389729|FG000|Overall Study|Physician Decision|1|||
124934332|NCT04084574|449389730|FG001|Overall Study|Physician Decision|0|||
124934333|NCT04084574|449389729|FG000|Overall Study|Relocated out of state|1|||
124934334|NCT04084574|449389730|FG001|Overall Study|Relocated out of state|0|||
124934335|NCT00942877|449389731|FG000|Overall Study|Refused further treatment|1|||
124934336|NCT00942877|449389732|FG001|Overall Study|Refused further treatment|1|||
124934337|NCT00942877|449389731|FG000|Overall Study|Patient was not treated|1|||
124934338|NCT00942877|449389732|FG001|Overall Study|Patient was not treated|0|||
124934339|NCT00942877|449389731|FG000|Overall Study|Adverse Event|1|||
124934340|NCT00942877|449389732|FG001|Overall Study|Adverse Event|0|||
124934341|NCT00942877|449389731|FG000|Overall Study|Progressive disease|42|||
124934342|NCT00942877|449389732|FG001|Overall Study|Progressive disease|3|||
124934343|NCT00887198|449389735|FG000|Randomized Period|Ongoing|42|||
124934344|NCT00887198|449389736|FG001|Randomized Period|Ongoing|0|||
124934345|NCT00887198|449389737|FG002|Randomized Period|Ongoing|0|||
124934346|NCT00887198|449389735|FG000|Randomized Period|Adverse Event|50|||
124934347|NCT00887198|449389736|FG001|Randomized Period|Adverse Event|33|||
124934348|NCT00887198|449389737|FG002|Randomized Period|Adverse Event|0|||
124934349|NCT00887198|449389735|FG000|Randomized Period|Lost to Follow-up|1|||
124934350|NCT00887198|449389736|FG001|Randomized Period|Lost to Follow-up|0|||
124934351|NCT00887198|449389737|FG002|Randomized Period|Lost to Follow-up|0|||
124934352|NCT00887198|449389735|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
124934353|NCT00887198|449389736|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
124934354|NCT00887198|449389737|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
124934355|NCT00887198|449389735|FG000|Randomized Period|Withdrawal by Subject|41|||
124934356|NCT00887198|449389736|FG001|Randomized Period|Withdrawal by Subject|56|||
124934357|NCT00887198|449389737|FG002|Randomized Period|Withdrawal by Subject|0|||
124934358|NCT00887198|449389735|FG000|Randomized Period|Progressive disease|366|||
124934359|NCT00887198|449389736|FG001|Randomized Period|Progressive disease|370|||
124934360|NCT00887198|449389737|FG002|Randomized Period|Progressive disease|0|||
124934361|NCT00887198|449389735|FG000|Randomized Period|Other|42|||
124934362|NCT00887198|449389736|FG001|Randomized Period|Other|30|||
124934363|NCT00887198|449389737|FG002|Randomized Period|Other|0|||
124934364|NCT00887198|449389735|FG000|Randomized Period|Randomized, Not treated|4|||
124934365|NCT00887198|449389736|FG001|Randomized Period|Randomized, Not treated|2|||
124934366|NCT00887198|449389737|FG002|Randomized Period|Randomized, Not treated|0|||
124934367|NCT00887198|449389735|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
124934368|NCT00887198|449389736|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
124934369|NCT00887198|449389737|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
124934370|NCT00887198|449389735|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
124934371|NCT00887198|449389736|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
124934372|NCT00887198|449389737|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
124934373|NCT00887198|449389735|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
124934374|NCT00887198|449389736|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
124934375|NCT00887198|449389737|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
124934376|NCT00887198|449389735|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
124934377|NCT00887198|449389736|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
124934378|NCT00887198|449389737|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
124934379|NCT00887198|449389735|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
124934380|NCT00887198|449389736|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
124934381|NCT00887198|449389737|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
124934382|NCT00887198|449389735|FG000|Cross Over (Placebo to AA)|Other|0|||
124934383|NCT00887198|449389736|FG001|Cross Over (Placebo to AA)|Other|0|||
124934384|NCT00887198|449389737|FG002|Cross Over (Placebo to AA)|Other|19|||
124934385|NCT03334695|449389738|FG000|Overall Study|Lost to Follow-up|3|||
124702385|NCT03766399|448534213|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
124934386|NCT03334695|449389739|FG001|Overall Study|Lost to Follow-up|3|||
124934387|NCT03334695|449389738|FG000|Overall Study|Physician Decision|1|||
124934388|NCT03334695|449389739|FG001|Overall Study|Physician Decision|2|||
124934389|NCT03334695|449389738|FG000|Overall Study|Protocol Violation|0|||
124934390|NCT03334695|449389739|FG001|Overall Study|Protocol Violation|1|||
124934391|NCT05007080|449389740|FG000|Overall Study|Lost to Follow-up|0|||
124702386|NCT03766399|448534214|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
124934392|NCT05007080|449389741|FG001|Overall Study|Lost to Follow-up|1|||
124934393|NCT05007080|449389742|FG002|Overall Study|Lost to Follow-up|0|||
124934394|NCT05007080|449389743|FG003|Overall Study|Lost to Follow-up|1|||
124934395|NCT05007080|449389744|FG004|Overall Study|Lost to Follow-up|1|||
124934396|NCT05007080|449389745|FG005|Overall Study|Lost to Follow-up|1|||
124934397|NCT05007080|449389740|FG000|Overall Study|Death|0|||
124934398|NCT05007080|449389741|FG001|Overall Study|Death|1|||
124934399|NCT05007080|449389742|FG002|Overall Study|Death|0|||
124934400|NCT05007080|449389743|FG003|Overall Study|Death|0|||
124934401|NCT05007080|449389744|FG004|Overall Study|Death|0|||
124934402|NCT05007080|449389745|FG005|Overall Study|Death|0|||
124934403|NCT05007080|449389740|FG000|Overall Study|Withdrawal by Subject|1|||
124934404|NCT05007080|449389741|FG001|Overall Study|Withdrawal by Subject|2|||
124934405|NCT05007080|449389742|FG002|Overall Study|Withdrawal by Subject|0|||
124934406|NCT05007080|449389743|FG003|Overall Study|Withdrawal by Subject|2|||
124934407|NCT05007080|449389744|FG004|Overall Study|Withdrawal by Subject|1|||
124934408|NCT05007080|449389745|FG005|Overall Study|Withdrawal by Subject|1|||
124934409|NCT05007080|449389740|FG000|Overall Study|Other|1|||
124934410|NCT05007080|449389741|FG001|Overall Study|Other|0|||
124934411|NCT05007080|449389742|FG002|Overall Study|Other|1|||
124934412|NCT05007080|449389743|FG003|Overall Study|Other|1|||
124934413|NCT05007080|449389744|FG004|Overall Study|Other|0|||
124934414|NCT05007080|449389745|FG005|Overall Study|Other|2|||
124934415|NCT05007080|449389740|FG000|Overall Study|Randomized not vaccinated|0|||
124934416|NCT05007080|449389741|FG001|Overall Study|Randomized not vaccinated|0|||
124934417|NCT05007080|449389742|FG002|Overall Study|Randomized not vaccinated|0|||
124934418|NCT05007080|449389743|FG003|Overall Study|Randomized not vaccinated|0|||
124934419|NCT05007080|449389744|FG004|Overall Study|Randomized not vaccinated|0|||
124934420|NCT05007080|449389745|FG005|Overall Study|Randomized not vaccinated|1|||
124934421|NCT02874742|449389746|FG000|Overall Study|Death|0|||
124934422|NCT02874742|449389747|FG001|Overall Study|Death|1|||
124934423|NCT02874742|449389748|FG002|Overall Study|Death|0|||
124934424|NCT02874742|449389746|FG000|Overall Study|Lost to Follow-up|5|||
124934425|NCT02874742|449389747|FG001|Overall Study|Lost to Follow-up|4|||
124934426|NCT02874742|449389748|FG002|Overall Study|Lost to Follow-up|1|||
124934427|NCT02874742|449389746|FG000|Overall Study|Withdrawal by Subject|17|||
124934428|NCT02874742|449389747|FG001|Overall Study|Withdrawal by Subject|8|||
124934429|NCT02874742|449389748|FG002|Overall Study|Withdrawal by Subject|0|||
124934430|NCT02874742|449389746|FG000|Overall Study|Other|4|||
124934431|NCT02874742|449389747|FG001|Overall Study|Other|1|||
124934432|NCT02874742|449389748|FG002|Overall Study|Other|0|||
124934433|NCT02874742|449389746|FG000|Overall Study|Progressive Disease|1|||
124934434|NCT02874742|449389747|FG001|Overall Study|Progressive Disease|0|||
124934435|NCT02874742|449389748|FG002|Overall Study|Progressive Disease|0|||
124934436|NCT02874742|449389746|FG000|Overall Study|Screen Failure|0|||
124934437|NCT02874742|449389747|FG001|Overall Study|Screen Failure|2|||
124934438|NCT02874742|449389748|FG002|Overall Study|Screen Failure|0|||
124934439|NCT05070741|449389758|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
124934440|NCT03582033|449389759|FG000|Part A|Other|0|||
124934441|NCT03582033|449389760|FG001|Part A|Other|0|||
124934442|NCT03582033|449389761|FG002|Part A|Other|0|||
124934443|NCT03582033|449389762|FG003|Part A|Other|0|||
124934444|NCT03582033|449389763|FG004|Part A|Other|2|||
124934445|NCT03582033|449389764|FG005|Part A|Other|0|||
124934446|NCT03582033|449389765|FG006|Part A|Other|0|||
124934447|NCT03582033|449389766|FG007|Part A|Other|0|||
124934448|NCT03582033|449389767|FG008|Part A|Other|0|||
124934449|NCT03582033|449389768|FG009|Part A|Other|0|||
124934450|NCT03582033|449389759|FG000|Part A|Death|1|||
124934451|NCT03582033|449389760|FG001|Part A|Death|1|||
124934452|NCT03582033|449389761|FG002|Part A|Death|2|||
124934453|NCT03582033|449389762|FG003|Part A|Death|4|||
124934454|NCT03582033|449389763|FG004|Part A|Death|11|||
124934455|NCT03582033|449389764|FG005|Part A|Death|0|||
124934456|NCT03582033|449389765|FG006|Part A|Death|0|||
124934457|NCT03582033|449389766|FG007|Part A|Death|0|||
124934458|NCT03582033|449389767|FG008|Part A|Death|0|||
124934459|NCT03582033|449389768|FG009|Part A|Death|0|||
124455962|NCT03073980|447628940|FG002|Overall Study|Lost to Follow-up|9|||
124455963|NCT03073980|447628938|FG000|Overall Study|No post-procedure data|0|||
124934460|NCT03582033|449389759|FG000|Part A|Lost to Follow-up|0|||
124934461|NCT03582033|449389760|FG001|Part A|Lost to Follow-up|0|||
124934462|NCT03582033|449389761|FG002|Part A|Lost to Follow-up|0|||
124934463|NCT03582033|449389762|FG003|Part A|Lost to Follow-up|0|||
124934464|NCT03582033|449389763|FG004|Part A|Lost to Follow-up|1|||
124934465|NCT03582033|449389764|FG005|Part A|Lost to Follow-up|0|||
124934466|NCT03582033|449389765|FG006|Part A|Lost to Follow-up|0|||
124934467|NCT03582033|449389766|FG007|Part A|Lost to Follow-up|0|||
124934468|NCT03582033|449389767|FG008|Part A|Lost to Follow-up|0|||
124934469|NCT03582033|449389768|FG009|Part A|Lost to Follow-up|0|||
124934470|NCT03582033|449389759|FG000|Part A|Study terminated by sponsor|0|||
124934471|NCT03582033|449389760|FG001|Part A|Study terminated by sponsor|0|||
124934472|NCT03582033|449389761|FG002|Part A|Study terminated by sponsor|0|||
124934473|NCT03582033|449389762|FG003|Part A|Study terminated by sponsor|2|||
124934474|NCT03582033|449389763|FG004|Part A|Study terminated by sponsor|1|||
124934475|NCT03582033|449389764|FG005|Part A|Study terminated by sponsor|0|||
124934476|NCT03582033|449389765|FG006|Part A|Study terminated by sponsor|0|||
124934477|NCT03582033|449389766|FG007|Part A|Study terminated by sponsor|0|||
124934478|NCT03582033|449389767|FG008|Part A|Study terminated by sponsor|0|||
124934479|NCT03582033|449389768|FG009|Part A|Study terminated by sponsor|0|||
124934480|NCT03582033|449389759|FG000|Part A|Withdrawal by Subject|1|||
124934481|NCT03582033|449389760|FG001|Part A|Withdrawal by Subject|1|||
124934482|NCT03582033|449389761|FG002|Part A|Withdrawal by Subject|0|||
124934483|NCT03582033|449389762|FG003|Part A|Withdrawal by Subject|1|||
124934484|NCT03582033|449389763|FG004|Part A|Withdrawal by Subject|7|||
124934485|NCT03582033|449389764|FG005|Part A|Withdrawal by Subject|0|||
124934486|NCT03582033|449389765|FG006|Part A|Withdrawal by Subject|0|||
124934487|NCT03582033|449389766|FG007|Part A|Withdrawal by Subject|0|||
124934488|NCT03582033|449389767|FG008|Part A|Withdrawal by Subject|0|||
124934489|NCT03582033|449389768|FG009|Part A|Withdrawal by Subject|0|||
124934490|NCT03582033|449389759|FG000|Part B|Death|0|||
124934491|NCT03582033|449389760|FG001|Part B|Death|0|||
124934492|NCT03582033|449389761|FG002|Part B|Death|0|||
124934493|NCT03582033|449389762|FG003|Part B|Death|0|||
124934494|NCT03582033|449389763|FG004|Part B|Death|0|||
124934495|NCT03582033|449389764|FG005|Part B|Death|2|||
124934496|NCT03582033|449389765|FG006|Part B|Death|0|||
124934497|NCT03582033|449389766|FG007|Part B|Death|0|||
124934498|NCT03582033|449389767|FG008|Part B|Death|0|||
124934499|NCT03582033|449389768|FG009|Part B|Death|0|||
124934500|NCT03582033|449389759|FG000|Part B|Study terminated by sponsor|0|||
124934501|NCT03582033|449389760|FG001|Part B|Study terminated by sponsor|0|||
124934502|NCT03582033|449389761|FG002|Part B|Study terminated by sponsor|0|||
124934503|NCT03582033|449389762|FG003|Part B|Study terminated by sponsor|0|||
124934504|NCT03582033|449389763|FG004|Part B|Study terminated by sponsor|0|||
124934505|NCT03582033|449389764|FG005|Part B|Study terminated by sponsor|12|||
124934506|NCT03582033|449389765|FG006|Part B|Study terminated by sponsor|0|||
124934507|NCT03582033|449389766|FG007|Part B|Study terminated by sponsor|0|||
124934508|NCT03582033|449389767|FG008|Part B|Study terminated by sponsor|0|||
124934509|NCT03582033|449389768|FG009|Part B|Study terminated by sponsor|0|||
124934510|NCT03582033|449389759|FG000|Part B|Withdrawal by Subject|0|||
124934511|NCT03582033|449389760|FG001|Part B|Withdrawal by Subject|0|||
124934512|NCT03582033|449389761|FG002|Part B|Withdrawal by Subject|0|||
124934513|NCT03582033|449389762|FG003|Part B|Withdrawal by Subject|0|||
124934514|NCT03582033|449389763|FG004|Part B|Withdrawal by Subject|0|||
124934515|NCT03582033|449389764|FG005|Part B|Withdrawal by Subject|6|||
124934516|NCT03582033|449389765|FG006|Part B|Withdrawal by Subject|0|||
124934517|NCT03582033|449389766|FG007|Part B|Withdrawal by Subject|0|||
124934518|NCT03582033|449389767|FG008|Part B|Withdrawal by Subject|0|||
124934519|NCT03582033|449389768|FG009|Part B|Withdrawal by Subject|0|||
124934520|NCT03582033|449389759|FG000|Part C|Other|0|||
124934521|NCT03582033|449389760|FG001|Part C|Other|0|||
124934522|NCT03582033|449389761|FG002|Part C|Other|0|||
124934523|NCT03582033|449389762|FG003|Part C|Other|0|||
124934524|NCT03582033|449389763|FG004|Part C|Other|0|||
124934525|NCT03582033|449389764|FG005|Part C|Other|0|||
124934526|NCT03582033|449389765|FG006|Part C|Other|2|||
124934527|NCT03582033|449389766|FG007|Part C|Other|0|||
124934528|NCT03582033|449389767|FG008|Part C|Other|0|||
124934529|NCT03582033|449389768|FG009|Part C|Other|0|||
124934530|NCT03582033|449389759|FG000|Part C|Death|0|||
124934531|NCT03582033|449389760|FG001|Part C|Death|0|||
124934532|NCT03582033|449389761|FG002|Part C|Death|0|||
124934533|NCT03582033|449389762|FG003|Part C|Death|0|||
124934534|NCT03582033|449389763|FG004|Part C|Death|0|||
124934535|NCT03582033|449389764|FG005|Part C|Death|0|||
124934536|NCT03582033|449389765|FG006|Part C|Death|6|||
124934537|NCT03582033|449389766|FG007|Part C|Death|1|||
124934538|NCT03582033|449389767|FG008|Part C|Death|2|||
124934539|NCT03582033|449389768|FG009|Part C|Death|0|||
124934540|NCT03582033|449389759|FG000|Part C|Study terminated by sponsor|0|||
124934541|NCT03582033|449389760|FG001|Part C|Study terminated by sponsor|0|||
124934542|NCT03582033|449389761|FG002|Part C|Study terminated by sponsor|0|||
124934543|NCT03582033|449389762|FG003|Part C|Study terminated by sponsor|0|||
124934544|NCT03582033|449389763|FG004|Part C|Study terminated by sponsor|0|||
124934545|NCT03582033|449389764|FG005|Part C|Study terminated by sponsor|0|||
124934546|NCT03582033|449389765|FG006|Part C|Study terminated by sponsor|3|||
124934547|NCT03582033|449389766|FG007|Part C|Study terminated by sponsor|3|||
124934548|NCT03582033|449389767|FG008|Part C|Study terminated by sponsor|2|||
124934549|NCT03582033|449389768|FG009|Part C|Study terminated by sponsor|0|||
124934550|NCT03582033|449389759|FG000|Part C|Withdrawal by Subject|0|||
124934551|NCT03582033|449389760|FG001|Part C|Withdrawal by Subject|0|||
124934552|NCT03582033|449389761|FG002|Part C|Withdrawal by Subject|0|||
124934553|NCT03582033|449389762|FG003|Part C|Withdrawal by Subject|0|||
124934554|NCT03582033|449389763|FG004|Part C|Withdrawal by Subject|0|||
124934555|NCT03582033|449389764|FG005|Part C|Withdrawal by Subject|0|||
124934556|NCT03582033|449389765|FG006|Part C|Withdrawal by Subject|1|||
124934557|NCT03582033|449389766|FG007|Part C|Withdrawal by Subject|2|||
124934558|NCT03582033|449389767|FG008|Part C|Withdrawal by Subject|1|||
124934559|NCT03582033|449389768|FG009|Part C|Withdrawal by Subject|0|||
124934560|NCT03582033|449389759|FG000|Part D|Death|0|||
124934561|NCT03582033|449389760|FG001|Part D|Death|0|||
124934562|NCT03582033|449389761|FG002|Part D|Death|0|||
124934563|NCT03582033|449389762|FG003|Part D|Death|0|||
124934564|NCT03582033|449389763|FG004|Part D|Death|0|||
124934565|NCT03582033|449389764|FG005|Part D|Death|0|||
124934566|NCT03582033|449389765|FG006|Part D|Death|0|||
124934567|NCT03582033|449389766|FG007|Part D|Death|0|||
124934568|NCT03582033|449389767|FG008|Part D|Death|0|||
124934569|NCT03582033|449389768|FG009|Part D|Death|1|||
124934570|NCT03582033|449389759|FG000|Part D|Study terminated by sponsor|0|||
124934571|NCT03582033|449389760|FG001|Part D|Study terminated by sponsor|0|||
124934572|NCT03582033|449389761|FG002|Part D|Study terminated by sponsor|0|||
124934573|NCT03582033|449389762|FG003|Part D|Study terminated by sponsor|0|||
124934574|NCT03582033|449389763|FG004|Part D|Study terminated by sponsor|0|||
124934575|NCT03582033|449389764|FG005|Part D|Study terminated by sponsor|0|||
124934576|NCT03582033|449389765|FG006|Part D|Study terminated by sponsor|0|||
124934577|NCT03582033|449389766|FG007|Part D|Study terminated by sponsor|0|||
124934578|NCT03582033|449389767|FG008|Part D|Study terminated by sponsor|0|||
124934579|NCT03582033|449389768|FG009|Part D|Study terminated by sponsor|4|||
124934580|NCT03812614|449389769|FG000|Intervention|Withdrawal by Subject|7|||
124934581|NCT03812614|449389770|FG001|Intervention|Withdrawal by Subject|2|||
124934582|NCT03812614|449389771|FG002|Intervention|Withdrawal by Subject|7|||
124934583|NCT03812614|449389772|FG003|Intervention|Withdrawal by Subject|2|||
124934584|NCT03812614|449389769|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
124934585|NCT03812614|449389770|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
124934586|NCT03812614|449389771|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
124934587|NCT03812614|449389772|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
124934588|NCT03812614|449389769|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
124934589|NCT03812614|449389770|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
124934590|NCT03812614|449389771|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
124934591|NCT03812614|449389772|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
124934592|NCT03812614|449389769|FG000|6-month Follow-up|Lost to Follow-up|0|||
124934593|NCT03812614|449389770|FG001|6-month Follow-up|Lost to Follow-up|0|||
124934594|NCT03812614|449389771|FG002|6-month Follow-up|Lost to Follow-up|12|||
124934595|NCT03812614|449389772|FG003|6-month Follow-up|Lost to Follow-up|8|||
124934596|NCT03812614|449389769|FG000|12-month Follow-up|Lost to Follow-up|18|||
124934597|NCT03812614|449389770|FG001|12-month Follow-up|Lost to Follow-up|17|||
124934598|NCT03812614|449389771|FG002|12-month Follow-up|Lost to Follow-up|5|||
124934599|NCT03812614|449389772|FG003|12-month Follow-up|Lost to Follow-up|2|||
124934600|NCT05205161|449389773|FG000|Overall Study|Study terminated by sponsor|3|||
124934601|NCT05205161|449389774|FG001|Overall Study|Study terminated by sponsor|3|||
124934602|NCT05205161|449389775|FG002|Overall Study|Study terminated by sponsor|1|||
124934603|NCT04214418|449389780|FG000|Overall Study|Withdrawal by Subject|1|||
124934604|NCT04214418|449389781|FG001|Overall Study|Withdrawal by Subject|0|||
124934605|NCT04214418|449389782|FG002|Overall Study|Withdrawal by Subject|0|||
124934606|NCT04214418|449389783|FG003|Overall Study|Withdrawal by Subject|0|||
124934607|NCT04214418|449389784|FG004|Overall Study|Withdrawal by Subject|0|||
124934608|NCT04214418|449389785|FG005|Overall Study|Withdrawal by Subject|0|||
124934609|NCT04214418|449389780|FG000|Overall Study|Adverse Event|0|||
124934610|NCT04214418|449389781|FG001|Overall Study|Adverse Event|2|||
124934611|NCT04214418|449389782|FG002|Overall Study|Adverse Event|0|||
124934612|NCT04214418|449389783|FG003|Overall Study|Adverse Event|0|||
124934613|NCT04214418|449389784|FG004|Overall Study|Adverse Event|0|||
124934614|NCT04214418|449389785|FG005|Overall Study|Adverse Event|0|||
124934615|NCT04214418|449389780|FG000|Overall Study|Death|1|||
124934616|NCT04214418|449389781|FG001|Overall Study|Death|0|||
124934617|NCT04214418|449389782|FG002|Overall Study|Death|0|||
124934618|NCT04214418|449389783|FG003|Overall Study|Death|0|||
124934619|NCT04214418|449389784|FG004|Overall Study|Death|0|||
124934620|NCT04214418|449389785|FG005|Overall Study|Death|0|||
124934621|NCT00450216|449389789|FG000|Overall Study|Adverse Event|38|||
124934622|NCT00450216|449389790|FG001|Overall Study|Adverse Event|23|||
124934623|NCT00450216|449389789|FG000|Overall Study|Withdrawal by Subject|48|||
124934624|NCT00450216|449389790|FG001|Overall Study|Withdrawal by Subject|26|||
124934625|NCT00450216|449389789|FG000|Overall Study|Lost to Follow-up|16|||
124934626|NCT00450216|449389790|FG001|Overall Study|Lost to Follow-up|9|||
124934627|NCT00450216|449389789|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
124934628|NCT00450216|449389790|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
124934629|NCT00450216|449389789|FG000|Overall Study|misc|21|||
124934630|NCT00450216|449389790|FG001|Overall Study|misc|20|||
124934631|NCT04206787|449389791|FG000|Overall Study|Other than listed|2|||
124934632|NCT04206787|449389791|FG000|Overall Study|Investigator decision|1|||
124934633|NCT04206787|449389791|FG000|Overall Study|Death|25|||
124934634|NCT04206787|449389791|FG000|Overall Study|Lost to Follow-up|9|||
124934635|NCT04206787|449389791|FG000|Overall Study|Withdrawal of consent|9|||
124934636|NCT05008055|449389792|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
124934637|NCT05008055|449389793|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
124934638|NCT05008055|449389794|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
124934639|NCT04635059|449389796|FG000|Overall Study|Study terminated early.|4|||
124934640|NCT03011034|449389797|FG000|Overall Study|Adverse Event|1|||
124934641|NCT03011034|449389798|FG001|Overall Study|Adverse Event|0|||
124934642|NCT05123027|449389805|FG000|Overall Study|Lost to Follow-up|17|||
124934643|NCT05123027|449389806|FG001|Overall Study|Lost to Follow-up|22|||
124934644|NCT05123027|449389805|FG000|Overall Study|Incarceration|3|||
124934645|NCT05123027|449389806|FG001|Overall Study|Incarceration|4|||
124934646|NCT05123027|449389805|FG000|Overall Study|Death|2|||
124934647|NCT05123027|449389806|FG001|Overall Study|Death|2|||
124934648|NCT05123027|449389805|FG000|Overall Study|Other|2|||
124934649|NCT05123027|449389806|FG001|Overall Study|Other|0|||
124934650|NCT03735979|449389807|FG000|Overall Study|Lost to Follow-up|1|||
124934651|NCT03735979|449389808|FG001|Overall Study|Lost to Follow-up|12|||
124934652|NCT03735979|449389809|FG002|Overall Study|Lost to Follow-up|14|||
124934653|NCT03735979|449389807|FG000|Overall Study|Withdrawal by Subject|1|||
124934654|NCT03735979|449389808|FG001|Overall Study|Withdrawal by Subject|5|||
124934655|NCT03735979|449389809|FG002|Overall Study|Withdrawal by Subject|2|||
124934656|NCT03735979|449389807|FG000|Overall Study|Not due to the above reasons|1|||
124934657|NCT03735979|449389808|FG001|Overall Study|Not due to the above reasons|0|||
124934658|NCT03735979|449389809|FG002|Overall Study|Not due to the above reasons|0|||
124934659|NCT00319111|449389812|FG000|Overall Study|Adverse Event|20|||
124934660|NCT00319111|449389812|FG000|Overall Study|Withdrawal of consent|11|||
124934661|NCT00319111|449389812|FG000|Overall Study|Death|9|||
124934662|NCT00319111|449389812|FG000|Overall Study|Lack of clinical improvement|4|||
124934663|NCT00319111|449389812|FG000|Overall Study|Administrative|2|||
124934664|NCT00319111|449389812|FG000|Overall Study|Treatment failure|1|||
124934665|NCT04743973|449389814|FG000|Overall Study|Withdrawal by Subject|5|||
124934666|NCT05654662|449389815|FG000|Overall Study|Withdrawal by Subject|1|||
124934667|NCT05654662|449389816|FG001|Overall Study|Withdrawal by Subject|0|||
124934668|NCT05654662|449389815|FG000|Overall Study|A death in the family|1|||
124934669|NCT05654662|449389816|FG001|Overall Study|A death in the family|0|||
124934670|NCT03165955|449389817|FG000|Treatment|Withdrawal by Subject|3|||
124934671|NCT03165955|449389817|FG000|Treatment|Death|1|||
124934672|NCT03165955|449389817|FG000|Treatment|Adverse Event|1|||
124934673|NCT03165955|449389817|FG000|Treatment|Progressive disease|3|||
124934674|NCT04499521|449389820|FG000|Overall Study|Disease Progression|1|||
124934675|NCT04499521|449389821|FG001|Overall Study|Disease Progression|0|||
124934676|NCT03990883|449389822|FG000|Blinded Treatment Phase|Adverse Event|1|||
124934677|NCT03990883|449389823|FG001|Blinded Treatment Phase|Adverse Event|1|||
124934678|NCT03990883|449389824|FG002|Blinded Treatment Phase|Adverse Event|0|||
124934679|NCT03990883|449389822|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
124934680|NCT03990883|449389823|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
124934681|NCT03990883|449389824|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
124934682|NCT03990883|449389822|FG000|Blinded Treatment Phase|Physician Decision|1|||
124934683|NCT03990883|449389823|FG001|Blinded Treatment Phase|Physician Decision|0|||
124934684|NCT03990883|449389824|FG002|Blinded Treatment Phase|Physician Decision|0|||
124934685|NCT03990883|449389822|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
124934686|NCT03990883|449389823|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
124934687|NCT03990883|449389824|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
124934688|NCT03990883|449389822|FG000|Blinded Treatment Phase|COVID-19|3|||
124934689|NCT03990883|449389823|FG001|Blinded Treatment Phase|COVID-19|2|||
124934690|NCT03990883|449389824|FG002|Blinded Treatment Phase|COVID-19|0|||
124934691|NCT03990883|449389822|FG000|Blinded Treatment Phase|Personal Reasons|6|||
124934692|NCT03990883|449389823|FG001|Blinded Treatment Phase|Personal Reasons|3|||
124934693|NCT03990883|449389824|FG002|Blinded Treatment Phase|Personal Reasons|0|||
124934694|NCT03990883|449389822|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
124934695|NCT03990883|449389823|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
124934696|NCT03990883|449389824|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
124934697|NCT03990883|449389822|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
124934698|NCT03990883|449389823|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
124934699|NCT03990883|449389824|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
124934700|NCT03990883|449389822|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
124934701|NCT03990883|449389823|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
124934702|NCT03990883|449389824|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
124934703|NCT04427007|449390714|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
124934704|NCT04427007|449390715|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
124934705|NCT04633278|449390716|FG000|Overall Study|Adverse Event|1|||
124934706|NCT04633278|449390717|FG001|Overall Study|Adverse Event|0|||
124934707|NCT04633278|449390716|FG000|Overall Study|Withdrawal by Subject|1|||
124934708|NCT04633278|449390717|FG001|Overall Study|Withdrawal by Subject|0|||
124934709|NCT04633278|449390716|FG000|Overall Study|Death|11|||
124934710|NCT04633278|449390717|FG001|Overall Study|Death|7|||
124934711|NCT04633278|449390716|FG000|Overall Study|Sponsor Decision|3|||
124934712|NCT04633278|449390717|FG001|Overall Study|Sponsor Decision|0|||
124934713|NCT04633278|449390716|FG000|Overall Study|Not Listed|1|||
124934714|NCT04633278|449390717|FG001|Overall Study|Not Listed|0|||
124934715|NCT05247034|449390718|FG000|Overall Study|Lost to Follow-up|3|||
124934716|NCT05247034|449390719|FG001|Overall Study|Lost to Follow-up|2|||
124934717|NCT05247034|449390718|FG000|Overall Study|Organizational problems when attending appointments|1|||
124934718|NCT05247034|449390719|FG001|Overall Study|Organizational problems when attending appointments|0|||
124934719|NCT03505710|449390720|FG000|Overall Study|Progressive Disease|24|||
124934720|NCT03505710|449390721|FG001|Overall Study|Progressive Disease|17|||
124934721|NCT03505710|449390722|FG002|Overall Study|Progressive Disease|43|||
124934722|NCT03505710|449390720|FG000|Overall Study|Clinical Progression|6|||
124934723|NCT03505710|449390721|FG001|Overall Study|Clinical Progression|8|||
124934724|NCT03505710|449390722|FG002|Overall Study|Clinical Progression|3|||
124934725|NCT03505710|449390720|FG000|Overall Study|Adverse Event|12|||
124934726|NCT03505710|449390721|FG001|Overall Study|Adverse Event|6|||
124934727|NCT03505710|449390722|FG002|Overall Study|Adverse Event|28|||
124934728|NCT03505710|449390720|FG000|Overall Study|Withdrawal by Subject|1|||
124934729|NCT03505710|449390721|FG001|Overall Study|Withdrawal by Subject|3|||
124455964|NCT03073980|447628939|FG001|Overall Study|No post-procedure data|0|||
124455965|NCT03073980|447628940|FG002|Overall Study|No post-procedure data|2|||
124455966|NCT00545064|447628941|FG000|Overall Study|Lost to Follow-up|3|||
124455967|NCT00545064|447628941|FG000|Overall Study|Withdrawal by Subject|2|||
124455968|NCT00545064|447628941|FG000|Overall Study|did not complete course of treatment|1|||
124455969|NCT00545064|447628941|FG000|Overall Study|cancel all appointments, no rebooking|1|||
124455970|NCT00545064|447628941|FG000|Overall Study|inclement weather|1|||
124455971|NCT00501007|447628942|FG000|Overall Study|Inclusion criteria not met.|29|||
124934730|NCT03505710|449390722|FG002|Overall Study|Withdrawal by Subject|7|||
124934731|NCT03505710|449390720|FG000|Overall Study|Physician Decision|1|||
124934732|NCT03505710|449390721|FG001|Overall Study|Physician Decision|1|||
124934733|NCT03505710|449390722|FG002|Overall Study|Physician Decision|2|||
124934734|NCT03505710|449390720|FG000|Overall Study|Death|4|||
124934735|NCT03505710|449390721|FG001|Overall Study|Death|5|||
124934736|NCT03505710|449390722|FG002|Overall Study|Death|6|||
124934737|NCT03505710|449390720|FG000|Overall Study|Other Reasons|1|||
124934738|NCT03505710|449390721|FG001|Overall Study|Other Reasons|1|||
124934739|NCT03505710|449390722|FG002|Overall Study|Other Reasons|1|||
124934740|NCT03505710|449390720|FG000|Overall Study|Study Terminated by Sponsor|0|||
124934741|NCT03505710|449390721|FG001|Overall Study|Study Terminated by Sponsor|0|||
124934742|NCT03505710|449390722|FG002|Overall Study|Study Terminated by Sponsor|1|||
124934743|NCT04389957|449390726|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
124934744|NCT04389957|449390727|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
124934745|NCT04389957|449390728|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
124934746|NCT04389957|449390729|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
124934747|NCT04389957|449390730|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
124934748|NCT06655818|449390738|FG000|Overall Study|Withdrawal by Subject|1|||
124934749|NCT05147584|449390739|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
124934750|NCT05460871|449390740|FG000|Overall Study|Withdrawal by Subject|1|||
124934751|NCT05460871|449390741|FG001|Overall Study|Withdrawal by Subject|2|||
124934752|NCT04623775|449390752|FG000|Randomization|No Longer Meets Study Criteria|2|||
124934753|NCT04623775|449390753|FG001|Randomization|No Longer Meets Study Criteria|1|||
124934754|NCT04623775|449390754|FG002|Randomization|No Longer Meets Study Criteria|0|||
124934755|NCT04623775|449390755|FG003|Randomization|No Longer Meets Study Criteria|0|||
124934756|NCT04623775|449390752|FG000|Randomization|Withdrew Consent|0|||
124934757|NCT04623775|449390753|FG001|Randomization|Withdrew Consent|0|||
124934758|NCT04623775|449390754|FG002|Randomization|Withdrew Consent|0|||
124934759|NCT04623775|449390755|FG003|Randomization|Withdrew Consent|1|||
124934760|NCT04623775|449390752|FG000|Randomization|Other Reasons|0|||
124934761|NCT04623775|449390753|FG001|Randomization|Other Reasons|0|||
124934762|NCT04623775|449390754|FG002|Randomization|Other Reasons|0|||
124934763|NCT04623775|449390755|FG003|Randomization|Other Reasons|1|||
124934764|NCT04623775|449390752|FG000|Treatment Period|participant withdrew consent|4|||
124934765|NCT04623775|449390753|FG001|Treatment Period|participant withdrew consent|0|||
124934766|NCT04623775|449390754|FG002|Treatment Period|participant withdrew consent|1|||
124934767|NCT04623775|449390755|FG003|Treatment Period|participant withdrew consent|2|||
124934768|NCT04623775|449390752|FG000|Treatment Period|Death|3|||
124934769|NCT04623775|449390753|FG001|Treatment Period|Death|1|||
124934770|NCT04623775|449390754|FG002|Treatment Period|Death|4|||
124934771|NCT04623775|449390755|FG003|Treatment Period|Death|2|||
124934772|NCT04623775|449390752|FG000|Treatment Period|Lost to Follow-up|0|||
124934773|NCT04623775|449390753|FG001|Treatment Period|Lost to Follow-up|2|||
124934774|NCT04623775|449390754|FG002|Treatment Period|Lost to Follow-up|0|||
124934775|NCT04623775|449390755|FG003|Treatment Period|Lost to Follow-up|0|||
124934776|NCT04623775|449390752|FG000|Treatment Period|poor/non compliance|0|||
124934777|NCT04623775|449390753|FG001|Treatment Period|poor/non compliance|0|||
124934778|NCT04623775|449390754|FG002|Treatment Period|poor/non compliance|1|||
124934779|NCT04623775|449390755|FG003|Treatment Period|poor/non compliance|0|||
124934780|NCT04623775|449390752|FG000|Treatment Period|participant no longer meets study criteria|0|||
124934781|NCT04623775|449390753|FG001|Treatment Period|participant no longer meets study criteria|1|||
124934782|NCT04623775|449390754|FG002|Treatment Period|participant no longer meets study criteria|0|||
124934783|NCT04623775|449390755|FG003|Treatment Period|participant no longer meets study criteria|0|||
124934784|NCT04623775|449390752|FG000|Treatment Period|administrative reasons by sponsor|3|||
124934785|NCT04623775|449390753|FG001|Treatment Period|administrative reasons by sponsor|2|||
124934786|NCT04623775|449390754|FG002|Treatment Period|administrative reasons by sponsor|0|||
124934787|NCT04623775|449390755|FG003|Treatment Period|administrative reasons by sponsor|0|||
124934788|NCT04623775|449390752|FG000|Treatment Period|other reasons|2|||
124934789|NCT04623775|449390753|FG001|Treatment Period|other reasons|0|||
124934790|NCT04623775|449390754|FG002|Treatment Period|other reasons|1|||
124934791|NCT04623775|449390755|FG003|Treatment Period|other reasons|1|||
124934792|NCT04623775|449390752|FG000|Treatment Period|disease progression|40|||
124934793|NCT04623775|449390753|FG001|Treatment Period|disease progression|35|||
124934794|NCT04623775|449390754|FG002|Treatment Period|disease progression|63|||
124934795|NCT04623775|449390755|FG003|Treatment Period|disease progression|63|||
124934796|NCT04623775|449390752|FG000|Treatment Period|study drug toxicity|12|||
124934797|NCT04623775|449390753|FG001|Treatment Period|study drug toxicity|15|||
124934798|NCT04623775|449390754|FG002|Treatment Period|study drug toxicity|13|||
124934799|NCT04623775|449390755|FG003|Treatment Period|study drug toxicity|12|||
124934800|NCT04623775|449390752|FG000|Treatment Period|AE unrelated to study drug|4|||
124934801|NCT04623775|449390753|FG001|Treatment Period|AE unrelated to study drug|9|||
124934802|NCT04623775|449390754|FG002|Treatment Period|AE unrelated to study drug|12|||
124934803|NCT04623775|449390755|FG003|Treatment Period|AE unrelated to study drug|9|||
124934804|NCT04623775|449390752|FG000|Treatment Period|participant request to discontinue treatment|0|||
124934805|NCT04623775|449390753|FG001|Treatment Period|participant request to discontinue treatment|2|||
124934806|NCT04623775|449390754|FG002|Treatment Period|participant request to discontinue treatment|2|||
124934807|NCT04623775|449390755|FG003|Treatment Period|participant request to discontinue treatment|0|||
124934808|NCT00964392|449390756|FG000|Overall Study|Withdrawal by Subject|4|||
124934809|NCT00964392|449390757|FG001|Overall Study|Withdrawal by Subject|6|||
124934810|NCT00964392|449390756|FG000|Overall Study|Lost to Follow-up|4|||
124934811|NCT00964392|449390757|FG001|Overall Study|Lost to Follow-up|10|||
124934812|NCT00964392|449390756|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
124934813|NCT00964392|449390757|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
124934814|NCT00964392|449390756|FG000|Overall Study|Not completed|44|||
124934815|NCT00964392|449390757|FG001|Overall Study|Not completed|168|||
124934816|NCT03652272|449390764|FG000|3 Month|Withdrawal by Subject|1|||
124934817|NCT03652272|449390765|FG001|3 Month|Withdrawal by Subject|1|||
124934818|NCT03652272|449390764|FG000|3 Month|Lost to Follow-up|16|||
124934819|NCT03652272|449390765|FG001|3 Month|Lost to Follow-up|14|||
124934820|NCT04173247|449390766|FG000|Overall Study|Withdrawal by Subject|0|||
124934821|NCT04173247|449390767|FG001|Overall Study|Withdrawal by Subject|2|||
124934822|NCT04173247|449390766|FG000|Overall Study|Death|1|||
124934823|NCT04173247|449390767|FG001|Overall Study|Death|0|||
124934824|NCT04173247|449390766|FG000|Overall Study|Physician Decision|1|||
124934825|NCT04173247|449390767|FG001|Overall Study|Physician Decision|0|||
124934826|NCT04214834|449390770|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
124934827|NCT04214834|449390771|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
124934828|NCT03884101|449390778|FG000|Overall Study|Participant Ongoing in Study|202|||
124934829|NCT03884101|449390779|FG001|Overall Study|Participant Ongoing in Study|186|||
124934830|NCT03884101|449390778|FG000|Overall Study|Death|212|||
124934831|NCT03884101|449390779|FG001|Overall Study|Death|224|||
124934832|NCT03884101|449390778|FG000|Overall Study|Lost to Follow-up|0|||
124934833|NCT03884101|449390779|FG001|Overall Study|Lost to Follow-up|1|||
124934834|NCT03884101|449390778|FG000|Overall Study|Withdrawal by Subject|6|||
124934835|NCT03884101|449390779|FG001|Overall Study|Withdrawal by Subject|11|||
124934836|NCT03370913|449390780|FG000|Overall Study|Death|1|||
124934837|NCT03370913|449390780|FG000|Overall Study|Lost to Follow-up|1|||
124934838|NCT03248479|449390790|FG000|Overall Study|Death|12|||
124934839|NCT03248479|449390791|FG001|Overall Study|Death|44|||
124934840|NCT03248479|449390792|FG002|Overall Study|Death|1|||
124934841|NCT03248479|449390793|FG003|Overall Study|Death|72|||
124934842|NCT03248479|449390794|FG004|Overall Study|Death|17|||
124934843|NCT03248479|449390795|FG005|Overall Study|Death|6|||
124934844|NCT03248479|449390796|FG006|Overall Study|Death|1|||
124934845|NCT03248479|449390797|FG007|Overall Study|Death|14|||
124934846|NCT03248479|449390798|FG008|Overall Study|Death|3|||
124934847|NCT03248479|449390799|FG009|Overall Study|Death|7|||
124934848|NCT03248479|449390800|FG010|Overall Study|Death|3|||
124934849|NCT03248479|449390801|FG011|Overall Study|Death|1|||
124934850|NCT03248479|449390802|FG012|Overall Study|Death|1|||
124934851|NCT03248479|449390790|FG000|Overall Study|Study terminated by sponsor|12|||
124934852|NCT03248479|449390791|FG001|Overall Study|Study terminated by sponsor|15|||
124934853|NCT03248479|449390792|FG002|Overall Study|Study terminated by sponsor|0|||
124934854|NCT03248479|449390793|FG003|Overall Study|Study terminated by sponsor|5|||
124934855|NCT03248479|449390794|FG004|Overall Study|Study terminated by sponsor|0|||
124934856|NCT03248479|449390795|FG005|Overall Study|Study terminated by sponsor|0|||
124934857|NCT03248479|449390796|FG006|Overall Study|Study terminated by sponsor|0|||
124934858|NCT03248479|449390797|FG007|Overall Study|Study terminated by sponsor|1|||
124934859|NCT03248479|449390798|FG008|Overall Study|Study terminated by sponsor|1|||
124934860|NCT03248479|449390799|FG009|Overall Study|Study terminated by sponsor|0|||
124934861|NCT03248479|449390800|FG010|Overall Study|Study terminated by sponsor|5|||
124934862|NCT03248479|449390801|FG011|Overall Study|Study terminated by sponsor|4|||
124934863|NCT03248479|449390802|FG012|Overall Study|Study terminated by sponsor|0|||
124934864|NCT03248479|449390790|FG000|Overall Study|Consent withdrawn|6|||
124934865|NCT03248479|449390791|FG001|Overall Study|Consent withdrawn|3|||
124934866|NCT03248479|449390792|FG002|Overall Study|Consent withdrawn|0|||
124934867|NCT03248479|449390793|FG003|Overall Study|Consent withdrawn|9|||
124934868|NCT03248479|449390794|FG004|Overall Study|Consent withdrawn|1|||
124934869|NCT03248479|449390795|FG005|Overall Study|Consent withdrawn|0|||
124934870|NCT03248479|449390796|FG006|Overall Study|Consent withdrawn|0|||
124934871|NCT03248479|449390797|FG007|Overall Study|Consent withdrawn|1|||
124934872|NCT03248479|449390798|FG008|Overall Study|Consent withdrawn|0|||
124934873|NCT03248479|449390799|FG009|Overall Study|Consent withdrawn|3|||
124934874|NCT03248479|449390800|FG010|Overall Study|Consent withdrawn|1|||
124934875|NCT03248479|449390801|FG011|Overall Study|Consent withdrawn|0|||
124934876|NCT03248479|449390802|FG012|Overall Study|Consent withdrawn|1|||
124934877|NCT03248479|449390790|FG000|Overall Study|Lost to Follow-up|2|||
124934878|NCT03248479|449390791|FG001|Overall Study|Lost to Follow-up|1|||
124934879|NCT03248479|449390792|FG002|Overall Study|Lost to Follow-up|0|||
124934880|NCT03248479|449390793|FG003|Overall Study|Lost to Follow-up|0|||
124934881|NCT03248479|449390794|FG004|Overall Study|Lost to Follow-up|0|||
124934882|NCT03248479|449390795|FG005|Overall Study|Lost to Follow-up|0|||
124934883|NCT03248479|449390796|FG006|Overall Study|Lost to Follow-up|0|||
124934884|NCT03248479|449390797|FG007|Overall Study|Lost to Follow-up|0|||
124934885|NCT03248479|449390798|FG008|Overall Study|Lost to Follow-up|0|||
124934886|NCT03248479|449390799|FG009|Overall Study|Lost to Follow-up|0|||
124934887|NCT03248479|449390800|FG010|Overall Study|Lost to Follow-up|0|||
124934888|NCT03248479|449390801|FG011|Overall Study|Lost to Follow-up|0|||
124934889|NCT03248479|449390802|FG012|Overall Study|Lost to Follow-up|1|||
124934890|NCT03248479|449390790|FG000|Overall Study|Not reported|0|||
124934891|NCT03248479|449390791|FG001|Overall Study|Not reported|0|||
124934892|NCT03248479|449390792|FG002|Overall Study|Not reported|0|||
124934893|NCT03248479|449390793|FG003|Overall Study|Not reported|1|||
124934894|NCT03248479|449390794|FG004|Overall Study|Not reported|1|||
124934895|NCT03248479|449390795|FG005|Overall Study|Not reported|0|||
124934896|NCT03248479|449390796|FG006|Overall Study|Not reported|0|||
124934897|NCT03248479|449390797|FG007|Overall Study|Not reported|1|||
124934898|NCT03248479|449390798|FG008|Overall Study|Not reported|1|||
124934899|NCT03248479|449390799|FG009|Overall Study|Not reported|0|||
124934900|NCT03248479|449390800|FG010|Overall Study|Not reported|0|||
124934901|NCT03248479|449390801|FG011|Overall Study|Not reported|0|||
124934902|NCT03248479|449390802|FG012|Overall Study|Not reported|0|||
124934903|NCT04679389|449390803|FG000|Overall Study|Adverse Event|1|||
124934904|NCT04679389|449390804|FG001|Overall Study|Adverse Event|0|||
124934905|NCT04679389|449390803|FG000|Overall Study|Protocol Violation|2|||
124934906|NCT04679389|449390804|FG001|Overall Study|Protocol Violation|0|||
124934907|NCT04679389|449390803|FG000|Overall Study|Physician Decision|3|||
124934908|NCT04679389|449390804|FG001|Overall Study|Physician Decision|5|||
124934909|NCT04679389|449390803|FG000|Overall Study|Withdrawal by Subject|5|||
124934910|NCT04679389|449390804|FG001|Overall Study|Withdrawal by Subject|7|||
124934911|NCT05112900|449390805|FG000|Overall Study|Withdrawal by Subject|960|||
124934912|NCT05112900|449390806|FG001|Overall Study|Withdrawal by Subject|921|||
124934913|NCT05112900|449390807|FG002|Overall Study|Withdrawal by Subject|968|||
124934914|NCT05541484|449390808|FG000|Overall Study|Withdrawal by Subject|1|||
124934915|NCT05541484|449390809|FG001|Overall Study|Withdrawal by Subject|0|||
124934916|NCT03279978|449390812|FG000|Overall Study|Withdrawal by Subject|0|||
124934917|NCT03279978|449390813|FG001|Overall Study|Withdrawal by Subject|1|||
124934918|NCT03279978|449390814|FG002|Overall Study|Withdrawal by Subject|0|||
124934919|NCT03279978|449390815|FG003|Overall Study|Withdrawal by Subject|0|||
124934920|NCT03279978|449390816|FG004|Overall Study|Withdrawal by Subject|0|||
124934921|NCT03279978|449390817|FG005|Overall Study|Withdrawal by Subject|0|||
124934922|NCT03279978|449390818|FG006|Overall Study|Withdrawal by Subject|0|||
124934923|NCT03279978|449390819|FG007|Overall Study|Withdrawal by Subject|0|||
124934924|NCT03279978|449390820|FG008|Overall Study|Withdrawal by Subject|0|||
124934925|NCT03279978|449390821|FG009|Overall Study|Withdrawal by Subject|1|||
124934926|NCT03279978|449390812|FG000|Overall Study|Lost to Follow-up|1|||
124934927|NCT03279978|449390813|FG001|Overall Study|Lost to Follow-up|0|||
124934928|NCT03279978|449390814|FG002|Overall Study|Lost to Follow-up|1|||
124934929|NCT03279978|449390815|FG003|Overall Study|Lost to Follow-up|0|||
124934930|NCT03279978|449390816|FG004|Overall Study|Lost to Follow-up|0|||
124934931|NCT03279978|449390817|FG005|Overall Study|Lost to Follow-up|0|||
124934932|NCT03279978|449390818|FG006|Overall Study|Lost to Follow-up|0|||
124702387|NCT03766399|448534215|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
124702388|NCT03766399|448534216|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
124702389|NCT03766399|448534217|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
124702390|NCT03411044|448534218|FG000|Overall Study|Death|30|||
124702391|NCT03411044|448534218|FG000|Overall Study|Withdrawal by Subject|48|||
124702392|NCT03411044|448534218|FG000|Overall Study|Lost to Follow-up|78|||
124702393|NCT03411044|448534218|FG000|Overall Study|Adverse Event|30|||
124702394|NCT03411044|448534218|FG000|Overall Study|Missing status|4|||
124702395|NCT01969409|448534219|FG000|Overall Study|Death|2|||
124702396|NCT01969409|448534220|FG001|Overall Study|Death|2|||
124702397|NCT01969409|448534219|FG000|Overall Study|Transplant|1|||
124702398|NCT01969409|448534220|FG001|Overall Study|Transplant|1|||
124702399|NCT01969409|448534219|FG000|Overall Study|Withdrawal by Subject|0|||
124702400|NCT01969409|448534220|FG001|Overall Study|Withdrawal by Subject|1|||
124934933|NCT03279978|449390819|FG007|Overall Study|Lost to Follow-up|0|||
124702401|NCT01051661|448534223|FG000|Overall Study|Adverse Event|1|||
124702402|NCT01051661|448534224|FG001|Overall Study|Adverse Event|1|||
124702403|NCT01051661|448534225|FG002|Overall Study|Adverse Event|1|||
124702404|NCT01051661|448534226|FG003|Overall Study|Adverse Event|1|||
124934934|NCT03279978|449390820|FG008|Overall Study|Lost to Follow-up|0|||
124934935|NCT03279978|449390821|FG009|Overall Study|Lost to Follow-up|0|||
124934936|NCT03279978|449390812|FG000|Overall Study|Other than stated above|0|||
124934937|NCT03279978|449390813|FG001|Overall Study|Other than stated above|0|||
124934938|NCT03279978|449390814|FG002|Overall Study|Other than stated above|0|||
124934939|NCT03279978|449390815|FG003|Overall Study|Other than stated above|0|||
124934940|NCT03279978|449390816|FG004|Overall Study|Other than stated above|0|||
124702405|NCT01051661|448534227|FG004|Overall Study|Adverse Event|0|||
124702406|NCT01051661|448534228|FG005|Overall Study|Adverse Event|0|||
124702407|NCT01051661|448534223|FG000|Overall Study|Lost to Follow-up|13|||
124934941|NCT03279978|449390817|FG005|Overall Study|Other than stated above|0|||
124934942|NCT03279978|449390818|FG006|Overall Study|Other than stated above|1|||
124934943|NCT03279978|449390819|FG007|Overall Study|Other than stated above|0|||
124934944|NCT03279978|449390820|FG008|Overall Study|Other than stated above|0|||
124934945|NCT03279978|449390821|FG009|Overall Study|Other than stated above|0|||
124934946|NCT05525104|449390822|FG000|Overall Study|Failed caudal analgesia|1|||
124934947|NCT05525104|449390823|FG001|Overall Study|Failed caudal analgesia|3|||
124934948|NCT05525104|449390822|FG000|Overall Study|Premedication needed|0|||
124934949|NCT05525104|449390823|FG001|Overall Study|Premedication needed|1|||
124934950|NCT05525104|449390822|FG000|Overall Study|Protocol Violation|10|||
124934951|NCT05525104|449390823|FG001|Overall Study|Protocol Violation|0|||
124934952|NCT05525104|449390822|FG000|Overall Study|Cancelled operation|1|||
124934953|NCT05525104|449390823|FG001|Overall Study|Cancelled operation|0|||
124934954|NCT03636490|449392046|FG000|Overall Study|Dropped out or incomplete data|141|||
124934955|NCT04464564|449392049|FG000|Period A (Placebo lead-in)|Other|5|||
124934956|NCT04464564|449392050|FG001|Period A (Placebo lead-in)|Other|0|||
124934957|NCT04464564|449392051|FG002|Period A (Placebo lead-in)|Other|0|||
124934958|NCT04464564|449392052|FG003|Period A (Placebo lead-in)|Other|0|||
124934959|NCT04464564|449392049|FG000|Period B (Randomization Period)|Adverse Event|0|||
124934960|NCT04464564|449392050|FG001|Period B (Randomization Period)|Adverse Event|1|||
124934961|NCT04464564|449392051|FG002|Period B (Randomization Period)|Adverse Event|2|||
124934962|NCT04464564|449392052|FG003|Period B (Randomization Period)|Adverse Event|8|||
124934963|NCT04464564|449392049|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
124934964|NCT04464564|449392050|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
124934965|NCT04464564|449392051|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
124934966|NCT04464564|449392052|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
124934967|NCT04464564|449392049|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
124934968|NCT04464564|449392050|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
124934969|NCT04464564|449392051|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
124934970|NCT04464564|449392052|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
124934971|NCT04464564|449392049|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
124934972|NCT04464564|449392050|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
124934973|NCT04464564|449392051|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
124934974|NCT04464564|449392052|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
124934975|NCT04464564|449392049|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
124934976|NCT04464564|449392050|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
124934977|NCT04464564|449392051|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
124934978|NCT04464564|449392052|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
124934979|NCT04464564|449392049|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
124934980|NCT04464564|449392050|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
124934981|NCT04464564|449392051|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
124934982|NCT04464564|449392052|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
124934983|NCT04464564|449392049|FG000|Period B (Randomization Period)|Reason not Specified|0|||
124934984|NCT04464564|449392050|FG001|Period B (Randomization Period)|Reason not Specified|3|||
124934985|NCT04464564|449392051|FG002|Period B (Randomization Period)|Reason not Specified|3|||
124934986|NCT04464564|449392052|FG003|Period B (Randomization Period)|Reason not Specified|3|||
124934987|NCT02095691|449392059|FG000|Overall Study|Physician Decision|1|||
124934988|NCT03498521|449392060|FG000|Overall Study|Death|191|||
124934989|NCT03498521|449392061|FG001|Overall Study|Death|64|||
124934990|NCT03498521|449392062|FG002|Overall Study|Death|72|||
124934991|NCT03498521|449392060|FG000|Overall Study|Exclusion criteria|1|||
124934992|NCT03498521|449392061|FG001|Overall Study|Exclusion criteria|0|||
124934993|NCT03498521|449392062|FG002|Overall Study|Exclusion criteria|0|||
124934994|NCT03498521|449392060|FG000|Overall Study|Lost to Follow-up|3|||
124934995|NCT03498521|449392061|FG001|Overall Study|Lost to Follow-up|3|||
124934996|NCT03498521|449392062|FG002|Overall Study|Lost to Follow-up|3|||
124702408|NCT01051661|448534224|FG001|Overall Study|Lost to Follow-up|22|||
124702409|NCT01051661|448534225|FG002|Overall Study|Lost to Follow-up|15|||
124702410|NCT01051661|448534226|FG003|Overall Study|Lost to Follow-up|17|||
124934997|NCT03498521|449392060|FG000|Overall Study|No profile due to technical failure|1|||
124934998|NCT03498521|449392061|FG001|Overall Study|No profile due to technical failure|0|||
124934999|NCT03498521|449392062|FG002|Overall Study|No profile due to technical failure|0|||
124702411|NCT01051661|448534227|FG004|Overall Study|Lost to Follow-up|10|||
124702412|NCT01051661|448534228|FG005|Overall Study|Lost to Follow-up|24|||
124935000|NCT03498521|449392060|FG000|Overall Study|Physician Decision|0|||
124935001|NCT03498521|449392061|FG001|Overall Study|Physician Decision|1|||
124935002|NCT03498521|449392062|FG002|Overall Study|Physician Decision|0|||
124935003|NCT03498521|449392060|FG000|Overall Study|Withdrawal by Subject|9|||
124702413|NCT01051661|448534223|FG000|Overall Study|Migrated/moved from study area|1|||
124935004|NCT03498521|449392061|FG001|Overall Study|Withdrawal by Subject|6|||
124935005|NCT03498521|449392062|FG002|Overall Study|Withdrawal by Subject|2|||
124935006|NCT03498521|449392060|FG000|Overall Study|Study ongoing|121|||
124935007|NCT03498521|449392061|FG001|Overall Study|Study ongoing|36|||
124935008|NCT03498521|449392062|FG002|Overall Study|Study ongoing|15|||
124935009|NCT02163694|449392064|FG000|Overall Study|Adverse event- related to progression|4|||
124935010|NCT02163694|449392065|FG001|Overall Study|Adverse event- related to progression|10|||
124935011|NCT02163694|449392064|FG000|Overall Study|Adverse event- not related to progression|7|||
124935012|NCT02163694|449392065|FG001|Overall Study|Adverse event- not related to progression|22|||
124935013|NCT02163694|449392064|FG000|Overall Study|Withdrew consent|13|||
124935014|NCT02163694|449392065|FG001|Overall Study|Withdrew consent|28|||
124935015|NCT02163694|449392064|FG000|Overall Study|Lost to Follow-up|2|||
124935016|NCT02163694|449392065|FG001|Overall Study|Lost to Follow-up|2|||
124935017|NCT02163694|449392064|FG000|Overall Study|Sponsor discontinued study|3|||
124935018|NCT02163694|449392065|FG001|Overall Study|Sponsor discontinued study|29|||
124935019|NCT02163694|449392064|FG000|Overall Study|Progressive disease per protocol|125|||
124935020|NCT02163694|449392065|FG001|Overall Study|Progressive disease per protocol|224|||
124935021|NCT02163694|449392064|FG000|Overall Study|Other, not specified|17|||
124935022|NCT02163694|449392065|FG001|Overall Study|Other, not specified|22|||
124935023|NCT02163694|449392064|FG000|Overall Study|Randomized but Not Treated|1|||
124935024|NCT02163694|449392065|FG001|Overall Study|Randomized but Not Treated|0|||
124935025|NCT02163694|449392064|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
124935026|NCT02163694|449392065|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
124935027|NCT04633538|449392066|FG000|Overall Study|Death|1|||
124935028|NCT04633538|449392066|FG000|Overall Study|Lost to Follow-up|3|||
124935029|NCT04633538|449392066|FG000|Overall Study|Withdrawal by Subject|1|||
124935030|NCT02938520|449392069|FG000|Overall Study|On-going at the time of analysis|258|||
124935031|NCT02938520|449392070|FG001|Overall Study|On-going at the time of analysis|261|||
124935032|NCT02938520|449392069|FG000|Overall Study|Physician Decision|2|||
124935033|NCT02938520|449392070|FG001|Overall Study|Physician Decision|5|||
124935034|NCT02938520|449392069|FG000|Overall Study|Lost to Follow-up|2|||
124935035|NCT02938520|449392070|FG001|Overall Study|Lost to Follow-up|2|||
124935036|NCT02938520|449392069|FG000|Overall Study|Withdrawal by Subject|7|||
124935037|NCT02938520|449392070|FG001|Overall Study|Withdrawal by Subject|7|||
124935038|NCT02938520|449392069|FG000|Overall Study|Protocol Violation|0|||
124935039|NCT02938520|449392070|FG001|Overall Study|Protocol Violation|1|||
124935040|NCT02938520|449392069|FG000|Overall Study|Lack of Efficacy|5|||
124935041|NCT02938520|449392070|FG001|Overall Study|Lack of Efficacy|3|||
124935042|NCT02938520|449392069|FG000|Overall Study|Adverse Event|9|||
124935043|NCT02938520|449392070|FG001|Overall Study|Adverse Event|4|||
124935044|NCT03372057|449392073|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
124935045|NCT03372057|449392074|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
124935046|NCT03372057|449392075|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
124935047|NCT03372057|449392073|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
124935048|NCT03372057|449392074|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
124935049|NCT03372057|449392075|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
124935050|NCT03372057|449392073|FG000|Dose Optimization Phase|Death|16|||
124935051|NCT03372057|449392074|FG001|Dose Optimization Phase|Death|11|||
124935052|NCT03372057|449392075|FG002|Dose Optimization Phase|Death|0|||
124935053|NCT03372057|449392073|FG000|Expansion Phase|Withdrawal by Subject|0|||
124935054|NCT03372057|449392074|FG001|Expansion Phase|Withdrawal by Subject|0|||
124935055|NCT03372057|449392075|FG002|Expansion Phase|Withdrawal by Subject|4|||
124935056|NCT03372057|449392073|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
124935057|NCT03372057|449392074|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
124935058|NCT03372057|449392075|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
124935059|NCT03372057|449392073|FG000|Expansion Phase|Death|0|||
124935060|NCT03372057|449392074|FG001|Expansion Phase|Death|0|||
124935061|NCT03372057|449392075|FG002|Expansion Phase|Death|78|||
124935062|NCT03372057|449392073|FG000|Expansion Phase|Progressive Disease|0|||
124935063|NCT03372057|449392074|FG001|Expansion Phase|Progressive Disease|0|||
124935064|NCT03372057|449392075|FG002|Expansion Phase|Progressive Disease|1|||
124935065|NCT03372057|449392073|FG000|Expansion Phase|Adverse Event|0|||
124935066|NCT03372057|449392074|FG001|Expansion Phase|Adverse Event|0|||
124935067|NCT03372057|449392075|FG002|Expansion Phase|Adverse Event|1|||
124935068|NCT05953740|449392076|FG000|Period 1|Physician Decision|0|||
124935069|NCT05953740|449392077|FG001|Period 1|Physician Decision|1|||
124702414|NCT01051661|448534224|FG001|Overall Study|Migrated/moved from study area|6|||
124702415|NCT01051661|448534225|FG002|Overall Study|Migrated/moved from study area|6|||
124702416|NCT01051661|448534226|FG003|Overall Study|Migrated/moved from study area|8|||
124935070|NCT05953740|449392078|FG002|Period 1|Physician Decision|0|||
124935071|NCT05953740|449392079|FG003|Period 1|Physician Decision|0|||
124935072|NCT05953740|449392080|FG004|Period 1|Physician Decision|0|||
124935073|NCT05953740|449392081|FG005|Period 1|Physician Decision|0|||
124935074|NCT05953740|449392082|FG006|Period 1|Physician Decision|0|||
124935075|NCT05953740|449392083|FG007|Period 1|Physician Decision|0|||
124935076|NCT05953740|449392076|FG000|Period 2|Withdrawal by Subject|0|||
124935077|NCT05953740|449392077|FG001|Period 2|Withdrawal by Subject|1|||
124935078|NCT05953740|449392078|FG002|Period 2|Withdrawal by Subject|1|||
124935079|NCT05953740|449392079|FG003|Period 2|Withdrawal by Subject|0|||
124935080|NCT05953740|449392080|FG004|Period 2|Withdrawal by Subject|0|||
124935081|NCT05953740|449392081|FG005|Period 2|Withdrawal by Subject|0|||
124935082|NCT05953740|449392082|FG006|Period 2|Withdrawal by Subject|0|||
124935083|NCT05953740|449392083|FG007|Period 2|Withdrawal by Subject|0|||
124935084|NCT03880955|449392084|FG000|Overall Study|Adverse Event|1|||
124935085|NCT03880955|449392084|FG000|Overall Study|Death|1|||
124935086|NCT03880955|449392084|FG000|Overall Study|Lost to Follow-up|12|||
124935087|NCT03880955|449392084|FG000|Overall Study|Withdrawal by Subject|4|||
124935088|NCT03880955|449392084|FG000|Overall Study|Missing- Study Site Closed|27|||
124935089|NCT01438853|449392112|FG000|Overall Study|Death|0|||
124935090|NCT01438853|449392113|FG001|Overall Study|Death|0|||
124935091|NCT01438853|449392114|FG002|Overall Study|Death|0|||
124935092|NCT01438853|449392115|FG003|Overall Study|Death|1|||
124935093|NCT01438853|449392112|FG000|Overall Study|Withdrawal by Subject|0|||
124935094|NCT01438853|449392113|FG001|Overall Study|Withdrawal by Subject|0|||
124935095|NCT01438853|449392114|FG002|Overall Study|Withdrawal by Subject|1|||
124935096|NCT01438853|449392115|FG003|Overall Study|Withdrawal by Subject|0|||
124935097|NCT02624050|449392116|FG000|Overall Study|Physician Decision|4|||
124935098|NCT02624050|449392117|FG001|Overall Study|Physician Decision|0|||
124935099|NCT02624050|449392116|FG000|Overall Study|Protocol Violation|2|||
124935100|NCT02624050|449392117|FG001|Overall Study|Protocol Violation|0|||
124935101|NCT05215054|449392118|FG000|Overall Study|Lost to Follow-up|1|||
124935102|NCT05215054|449392119|FG001|Overall Study|Lost to Follow-up|1|||
124935103|NCT05215054|449392118|FG000|Overall Study|Protocol Violation|1|||
124935104|NCT05215054|449392119|FG001|Overall Study|Protocol Violation|1|||
124935105|NCT05215054|449392118|FG000|Overall Study|Withdrawal by Subject|4|||
124935106|NCT05215054|449392119|FG001|Overall Study|Withdrawal by Subject|4|||
124935107|NCT04330040|449392123|FG000|Overall Study|Other: Adverse event|5|||
124935108|NCT04330040|449392124|FG001|Overall Study|Other: Adverse event|0|||
124935109|NCT04330040|449392125|FG002|Overall Study|Other: Adverse event|0|||
124935110|NCT04330040|449392123|FG000|Overall Study|Disease progression|38|||
124935111|NCT04330040|449392124|FG001|Overall Study|Disease progression|10|||
124935112|NCT04330040|449392125|FG002|Overall Study|Disease progression|0|||
124935113|NCT04330040|449392123|FG000|Overall Study|Physician Decision|5|||
124935114|NCT04330040|449392124|FG001|Overall Study|Physician Decision|3|||
124935115|NCT04330040|449392125|FG002|Overall Study|Physician Decision|0|||
124935116|NCT04330040|449392123|FG000|Overall Study|Lost to Follow-up|1|||
124935117|NCT04330040|449392124|FG001|Overall Study|Lost to Follow-up|1|||
124935118|NCT04330040|449392125|FG002|Overall Study|Lost to Follow-up|0|||
124935119|NCT04330040|449392123|FG000|Overall Study|Death|2|||
124935120|NCT04330040|449392124|FG001|Overall Study|Death|1|||
124935121|NCT04330040|449392125|FG002|Overall Study|Death|0|||
124935122|NCT04330040|449392123|FG000|Overall Study|Withdrawal by Subject|3|||
124935123|NCT04330040|449392124|FG001|Overall Study|Withdrawal by Subject|3|||
124935124|NCT04330040|449392125|FG002|Overall Study|Withdrawal by Subject|0|||
124935125|NCT04330040|449392123|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
124935126|NCT04330040|449392124|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
124935127|NCT04330040|449392125|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
124935128|NCT04330040|449392123|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
124935129|NCT04330040|449392124|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
124935130|NCT04330040|449392125|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
124935131|NCT04330040|449392123|FG000|Overall Study|Other: Disease progression|1|||
124935132|NCT04330040|449392124|FG001|Overall Study|Other: Disease progression|0|||
124935133|NCT04330040|449392125|FG002|Overall Study|Other: Disease progression|0|||
124935134|NCT04330040|449392123|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
124935135|NCT04330040|449392124|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
124935136|NCT04330040|449392125|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
124935137|NCT04330040|449392123|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
124935138|NCT04330040|449392124|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
124935139|NCT04330040|449392125|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
124935140|NCT04330040|449392123|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
124935141|NCT04330040|449392124|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
124935142|NCT04330040|449392125|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
124935143|NCT00626795|449392128|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
124935144|NCT00626795|449392129|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
124935145|NCT00626795|449392130|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
124935146|NCT00626795|449392128|FG000|Blinded Treatment|Lack of Efficacy|2|||
124455972|NCT00501007|447628943|FG001|Overall Study|Inclusion criteria not met.|25|||
124935147|NCT00626795|449392129|FG001|Blinded Treatment|Lack of Efficacy|0|||
124935148|NCT00626795|449392130|FG002|Blinded Treatment|Lack of Efficacy|0|||
124935149|NCT00626795|449392128|FG000|Blinded Treatment|Unacceptable adverse event|0|||
124935150|NCT00626795|449392129|FG001|Blinded Treatment|Unacceptable adverse event|0|||
124935151|NCT00626795|449392130|FG002|Blinded Treatment|Unacceptable adverse event|1|||
124935152|NCT00626795|449392128|FG000|Blinded Treatment|Protocol Violation|0|||
124935153|NCT00626795|449392129|FG001|Blinded Treatment|Protocol Violation|1|||
124935154|NCT00626795|449392130|FG002|Blinded Treatment|Protocol Violation|1|||
124935155|NCT00626795|449392128|FG000|Blinded Treatment|Withdrawal by Subject|1|||
124935156|NCT00626795|449392129|FG001|Blinded Treatment|Withdrawal by Subject|1|||
124935157|NCT00626795|449392130|FG002|Blinded Treatment|Withdrawal by Subject|0|||
124935158|NCT00626795|449392128|FG000|Blinded Treatment|Other reasons|2|||
124935159|NCT00626795|449392129|FG001|Blinded Treatment|Other reasons|0|||
124935160|NCT00626795|449392130|FG002|Blinded Treatment|Other reasons|2|||
124935161|NCT00626795|449392128|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
124935162|NCT00626795|449392129|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
124935163|NCT00626795|449392130|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
124935164|NCT04159519|449392131|FG000|Overall Study|Adverse Event|1|||
124935165|NCT04159519|449392132|FG001|Overall Study|Adverse Event|1|||
124935166|NCT04159519|449392131|FG000|Overall Study|Lack of Efficacy|1|||
124935167|NCT04159519|449392132|FG001|Overall Study|Lack of Efficacy|0|||
124935168|NCT04159519|449392131|FG000|Overall Study|Discontinued from study|1|||
124935169|NCT04159519|449392132|FG001|Overall Study|Discontinued from study|0|||
124935170|NCT04159519|449392131|FG000|Overall Study|Protocol Violation|1|||
124935171|NCT04159519|449392132|FG001|Overall Study|Protocol Violation|1|||
124935172|NCT04159519|449392131|FG000|Overall Study|Withdrawal by Subject|4|||
124935173|NCT04159519|449392132|FG001|Overall Study|Withdrawal by Subject|4|||
124935174|NCT02246127|449392905|FG000|First Course Treatment|Adverse Event|9|||
124935175|NCT02246127|449392906|FG001|First Course Treatment|Adverse Event|7|||
124935176|NCT02246127|449392905|FG000|First Course Treatment|Withdrawal by Subject|6|||
124935177|NCT02246127|449392906|FG001|First Course Treatment|Withdrawal by Subject|7|||
124935178|NCT02246127|449392905|FG000|First Course Treatment|Physician Decision|9|||
124935179|NCT02246127|449392906|FG001|First Course Treatment|Physician Decision|9|||
124935180|NCT02246127|449392905|FG000|First Course Treatment|Death|3|||
124935181|NCT02246127|449392906|FG001|First Course Treatment|Death|3|||
124935182|NCT02246127|449392905|FG000|First Course Treatment|Not reported reasons|6|||
124935183|NCT02246127|449392906|FG001|First Course Treatment|Not reported reasons|7|||
124935184|NCT02246127|449392905|FG000|First Course Treatment|Not treated|3|||
124935185|NCT02246127|449392906|FG001|First Course Treatment|Not treated|3|||
124935186|NCT05311176|449392909|FG000|Overall Study|Death|6|||
124935187|NCT05311176|449392909|FG000|Overall Study|Sponsor discontinued the study|1|||
124935188|NCT01880515|449392910|FG000|Overall Study|Lost to Follow-up|3|||
124935189|NCT01880515|449392911|FG001|Overall Study|Lost to Follow-up|2|||
124935190|NCT01880515|449392910|FG000|Overall Study|Disease Progression|5|||
124935191|NCT01880515|449392911|FG001|Overall Study|Disease Progression|7|||
124935192|NCT06262347|449392922|FG000|Overall Study|Lost to Follow-up|4|||
124935193|NCT06262347|449392923|FG001|Overall Study|Lost to Follow-up|3|||
124935194|NCT06262347|449392922|FG000|Overall Study|Withdrawal by Subject|0|||
124935195|NCT06262347|449392923|FG001|Overall Study|Withdrawal by Subject|1|||
124935196|NCT05830799|449392930|FG000|Overall Study|Withdrawal by Subject|1|||
124935197|NCT04560179|449392935|FG000|Overall Study|Physician Decision|1|||
124935198|NCT04560179|449392936|FG001|Overall Study|Physician Decision|0|||
124935199|NCT04560179|449392937|FG002|Overall Study|Physician Decision|0|||
124935200|NCT04560179|449392938|FG003|Overall Study|Physician Decision|0|||
124935201|NCT04560179|449392939|FG004|Overall Study|Physician Decision|0|||
124935202|NCT04560179|449392935|FG000|Overall Study|Adverse Event|0|||
124935203|NCT04560179|449392936|FG001|Overall Study|Adverse Event|0|||
124935204|NCT04560179|449392937|FG002|Overall Study|Adverse Event|0|||
124935205|NCT04560179|449392938|FG003|Overall Study|Adverse Event|1|||
124702417|NCT01051661|448534227|FG004|Overall Study|Migrated/moved from study area|7|||
124702418|NCT01051661|448534228|FG005|Overall Study|Migrated/moved from study area|3|||
124702419|NCT01051661|448534223|FG000|Overall Study|Refused blood sampling|0|||
124702420|NCT01051661|448534224|FG001|Overall Study|Refused blood sampling|0|||
124702421|NCT01051661|448534225|FG002|Overall Study|Refused blood sampling|0|||
124935206|NCT04560179|449392939|FG004|Overall Study|Adverse Event|0|||
124935207|NCT04631016|449392942|FG000|Overall Study|Adverse Event|3|||
124935208|NCT04631016|449392943|FG001|Overall Study|Adverse Event|0|||
124935209|NCT04631016|449392942|FG000|Overall Study|Withdrawal by Subject|5|||
124935210|NCT04631016|449392943|FG001|Overall Study|Withdrawal by Subject|4|||
124935211|NCT04631016|449392942|FG000|Overall Study|Reason unspecified|1|||
124935212|NCT04631016|449392943|FG001|Overall Study|Reason unspecified|0|||
124935213|NCT04631016|449392942|FG000|Overall Study|Failure to meet randomization criteria|2|||
124935214|NCT04631016|449392943|FG001|Overall Study|Failure to meet randomization criteria|1|||
124935215|NCT06010836|449392944|FG000|Overall Study|Lost to Follow-up|2|||
124935216|NCT06010836|449392945|FG001|Overall Study|Lost to Follow-up|2|||
124702422|NCT01051661|448534226|FG003|Overall Study|Refused blood sampling|0|||
124455973|NCT00258674|447628946|FG000|Overall Study|Death|32|||
124455974|NCT00258674|447628947|FG001|Overall Study|Death|53|||
124455975|NCT00258674|447628948|FG002|Overall Study|Death|34|||
124455976|NCT01358760|447628953|FG000|Overall Study|Adverse Event|3|||
124455977|NCT01358760|447628954|FG001|Overall Study|Adverse Event|4|||
124455978|NCT01358760|447628955|FG002|Overall Study|Adverse Event|3|||
124455979|NCT01358760|447628953|FG000|Overall Study|Lost to Follow-up|1|||
124455980|NCT01358760|447628954|FG001|Overall Study|Lost to Follow-up|1|||
124455981|NCT01358760|447628955|FG002|Overall Study|Lost to Follow-up|3|||
124455982|NCT01358760|447628953|FG000|Overall Study|Withdrawal by Subject|5|||
124455983|NCT01358760|447628954|FG001|Overall Study|Withdrawal by Subject|3|||
124455984|NCT01358760|447628955|FG002|Overall Study|Withdrawal by Subject|2|||
124455985|NCT01358760|447628953|FG000|Overall Study|Physician Decision|1|||
124455986|NCT01358760|447628954|FG001|Overall Study|Physician Decision|0|||
124455987|NCT01358760|447628955|FG002|Overall Study|Physician Decision|1|||
124455988|NCT01358760|447628953|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
124935217|NCT06010836|449392944|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
124935218|NCT06010836|449392945|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
124935219|NCT06010836|449392944|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
124935220|NCT06010836|449392945|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
124935221|NCT06010836|449392944|FG000|Overall Study|Did not receive intervention discussion|0|||
124935222|NCT06010836|449392945|FG001|Overall Study|Did not receive intervention discussion|4|||
124935223|NCT04496752|449392946|FG000|Second Assessment|Lost to Follow-up|3|||
124935224|NCT04496752|449392947|FG001|Second Assessment|Lost to Follow-up|3|||
124935225|NCT04496752|449392946|FG000|Second Assessment|Adverse Event|2|||
124935226|NCT04496752|449392947|FG001|Second Assessment|Adverse Event|0|||
124935227|NCT04524689|449392950|FG000|Overall Study|Withdrawal by Subject|1|||
124935228|NCT04524689|449392951|FG001|Overall Study|Withdrawal by Subject|1|||
124935229|NCT04524689|449392952|FG002|Overall Study|Withdrawal by Subject|0|||
124935230|NCT04524689|449392953|FG003|Overall Study|Withdrawal by Subject|0|||
124935231|NCT04524689|449392954|FG004|Overall Study|Withdrawal by Subject|1|||
124935232|NCT04524689|449392955|FG005|Overall Study|Withdrawal by Subject|0|||
124935233|NCT04524689|449392950|FG000|Overall Study|Not related to Coronavirus disease 2019|2|||
124935234|NCT04524689|449392951|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
124935235|NCT04524689|449392952|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
124935236|NCT04524689|449392953|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
124935237|NCT04524689|449392954|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
124935238|NCT04524689|449392955|FG005|Overall Study|Not related to Coronavirus disease 2019|0|||
124935239|NCT04524689|449392950|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|12|||
124935240|NCT04524689|449392951|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
124935241|NCT04524689|449392952|FG002|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
124935242|NCT04524689|449392953|FG003|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
124935243|NCT04524689|449392954|FG004|Overall Study|Ongoing study treatment at the time of primary analysis|5|||
124935244|NCT04524689|449392955|FG005|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
124935245|NCT04967599|449392956|FG000|Overall Study|Lost to Follow-up|35|||
124935246|NCT04967599|449392957|FG001|Overall Study|Lost to Follow-up|19|||
124935247|NCT04967599|449392958|FG002|Overall Study|Lost to Follow-up|23|||
124935248|NCT04369911|449392959|FG000|Overall Study|Lost to Follow-up|3|||
124935249|NCT04369911|449392960|FG001|Overall Study|Lost to Follow-up|3|||
124935250|NCT04369911|449392959|FG000|Overall Study|Withdrawal by Subject|1|||
124935251|NCT04369911|449392960|FG001|Overall Study|Withdrawal by Subject|2|||
124935252|NCT05451693|449392961|FG000|Overall Study|Withdrawal by Subject|1|||
124935253|NCT05451693|449392962|FG001|Overall Study|Withdrawal by Subject|1|||
124935254|NCT03662022|449392963|FG000|Year 1 2019|prevalent case|83|||
124935255|NCT03662022|449392964|FG001|Year 1 2019|prevalent case|116|||
124935256|NCT03662022|449392965|FG002|Year 1 2019|prevalent case|158|||
124935257|NCT03662022|449392966|FG003|Year 1 2019|prevalent case|99|||
124935258|NCT03662022|449392963|FG000|Year 2 2020|incident case|18|||
124935259|NCT03662022|449392964|FG001|Year 2 2020|incident case|18|||
124935260|NCT03662022|449392965|FG002|Year 2 2020|incident case|16|||
124935261|NCT03662022|449392966|FG003|Year 2 2020|incident case|26|||
124935262|NCT03662022|449392963|FG000|Year 2 2020|other case|18|||
124935263|NCT03662022|449392964|FG001|Year 2 2020|other case|16|||
124935264|NCT03662022|449392965|FG002|Year 2 2020|other case|16|||
124935265|NCT03662022|449392966|FG003|Year 2 2020|other case|24|||
124935266|NCT03662022|449392963|FG000|Year 2 2020|Lost to Follow-up|1633|||
124935267|NCT03662022|449392964|FG001|Year 2 2020|Lost to Follow-up|1183|||
124455989|NCT01358760|447628954|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
124455990|NCT01358760|447628955|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
124455991|NCT01506960|447628956|FG000|Overall Study|Did not meet angiographic criteria|47|||
124935268|NCT03662022|449392965|FG002|Year 2 2020|Lost to Follow-up|1381|||
124935269|NCT03662022|449392966|FG003|Year 2 2020|Lost to Follow-up|2858|||
124935270|NCT03662022|449392963|FG000|Year 3 2021|incident case|24|||
124935271|NCT03662022|449392964|FG001|Year 3 2021|incident case|27|||
124702423|NCT01051661|448534227|FG004|Overall Study|Refused blood sampling|0|||
124702424|NCT01051661|448534228|FG005|Overall Study|Refused blood sampling|1|||
124702425|NCT01051661|448534223|FG000|Overall Study|Data not reliable|1|||
124702426|NCT01051661|448534224|FG001|Overall Study|Data not reliable|0|||
124702427|NCT01051661|448534225|FG002|Overall Study|Data not reliable|0|||
124702428|NCT01051661|448534226|FG003|Overall Study|Data not reliable|0|||
124702429|NCT01051661|448534227|FG004|Overall Study|Data not reliable|0|||
124702430|NCT01051661|448534228|FG005|Overall Study|Data not reliable|1|||
124702431|NCT01051661|448534223|FG000|Overall Study|Unable to attend visit(s)|2|||
124702432|NCT01051661|448534224|FG001|Overall Study|Unable to attend visit(s)|4|||
124702433|NCT01051661|448534225|FG002|Overall Study|Unable to attend visit(s)|2|||
124702434|NCT01051661|448534226|FG003|Overall Study|Unable to attend visit(s)|1|||
124702435|NCT01051661|448534227|FG004|Overall Study|Unable to attend visit(s)|3|||
124702436|NCT01051661|448534228|FG005|Overall Study|Unable to attend visit(s)|2|||
124702437|NCT01051661|448534223|FG000|Overall Study|Consent not received from both parents|0|||
124702438|NCT01051661|448534224|FG001|Overall Study|Consent not received from both parents|0|||
124702439|NCT01051661|448534225|FG002|Overall Study|Consent not received from both parents|0|||
124702440|NCT01051661|448534226|FG003|Overall Study|Consent not received from both parents|0|||
124702441|NCT01051661|448534227|FG004|Overall Study|Consent not received from both parents|0|||
124702442|NCT01051661|448534228|FG005|Overall Study|Consent not received from both parents|1|||
124702443|NCT01051661|448534223|FG000|Overall Study|Failure to comply with protocol|0|||
124702444|NCT01051661|448534224|FG001|Overall Study|Failure to comply with protocol|0|||
124702445|NCT01051661|448534225|FG002|Overall Study|Failure to comply with protocol|2|||
124702446|NCT01051661|448534226|FG003|Overall Study|Failure to comply with protocol|0|||
124935272|NCT03662022|449392965|FG002|Year 3 2021|incident case|24|||
124935273|NCT03662022|449392966|FG003|Year 3 2021|incident case|11|||
124935274|NCT03662022|449392963|FG000|Year 3 2021|other case|4|||
124935275|NCT03662022|449392964|FG001|Year 3 2021|other case|15|||
124935276|NCT03662022|449392965|FG002|Year 3 2021|other case|10|||
124935277|NCT03662022|449392966|FG003|Year 3 2021|other case|14|||
124935278|NCT03662022|449392963|FG000|Year 3 2021|Lost to Follow-up|179|||
124935279|NCT03662022|449392964|FG001|Year 3 2021|Lost to Follow-up|244|||
124935280|NCT03662022|449392965|FG002|Year 3 2021|Lost to Follow-up|480|||
124935281|NCT03662022|449392966|FG003|Year 3 2021|Lost to Follow-up|477|||
124935282|NCT03662022|449392963|FG000|Year 4 2022|incident case|25|||
124935283|NCT03662022|449392964|FG001|Year 4 2022|incident case|41|||
124935284|NCT03662022|449392965|FG002|Year 4 2022|incident case|28|||
124935285|NCT03662022|449392966|FG003|Year 4 2022|incident case|7|||
124935286|NCT03662022|449392963|FG000|Year 4 2022|other case|8|||
124935287|NCT03662022|449392964|FG001|Year 4 2022|other case|19|||
124935288|NCT03662022|449392965|FG002|Year 4 2022|other case|13|||
124935289|NCT03662022|449392966|FG003|Year 4 2022|other case|7|||
124935290|NCT03662022|449392963|FG000|Year 4 2022|Lost to Follow-up|986|||
124935291|NCT03662022|449392964|FG001|Year 4 2022|Lost to Follow-up|1079|||
124935292|NCT03662022|449392965|FG002|Year 4 2022|Lost to Follow-up|1236|||
124935293|NCT03662022|449392966|FG003|Year 4 2022|Lost to Follow-up|1826|||
124935294|NCT04490109|449392977|FG000|Overall Study|Lost to Follow-up|3|||
124935295|NCT04490109|449392978|FG001|Overall Study|Lost to Follow-up|10|||
124935296|NCT04490109|449392979|FG002|Overall Study|Lost to Follow-up|4|||
124935297|NCT04490109|449392977|FG000|Overall Study|Withdrawal by Subject|8|||
124935298|NCT04490109|449392978|FG001|Overall Study|Withdrawal by Subject|6|||
124935299|NCT04490109|449392979|FG002|Overall Study|Withdrawal by Subject|9|||
124935300|NCT04490109|449392977|FG000|Overall Study|Physician Decision|0|||
124935301|NCT04490109|449392978|FG001|Overall Study|Physician Decision|2|||
124935302|NCT04490109|449392979|FG002|Overall Study|Physician Decision|3|||
124935303|NCT04490109|449392977|FG000|Overall Study|Adverse Event|2|||
124702447|NCT01051661|448534227|FG004|Overall Study|Failure to comply with protocol|0|||
124702448|NCT01051661|448534228|FG005|Overall Study|Failure to comply with protocol|0|||
124702449|NCT01051661|448534223|FG000|Overall Study|Subject lost legal representation|0|||
124702450|NCT01051661|448534224|FG001|Overall Study|Subject lost legal representation|0|||
124702451|NCT01051661|448534225|FG002|Overall Study|Subject lost legal representation|0|||
124702452|NCT01051661|448534226|FG003|Overall Study|Subject lost legal representation|0|||
124935304|NCT04490109|449392978|FG001|Overall Study|Adverse Event|1|||
124935305|NCT04490109|449392979|FG002|Overall Study|Adverse Event|0|||
124935306|NCT04490109|449392977|FG000|Overall Study|Significant Non-Compliance|2|||
124935307|NCT04490109|449392978|FG001|Overall Study|Significant Non-Compliance|4|||
124935308|NCT04490109|449392979|FG002|Overall Study|Significant Non-Compliance|4|||
124702453|NCT01051661|448534227|FG004|Overall Study|Subject lost legal representation|1|||
124702454|NCT01051661|448534228|FG005|Overall Study|Subject lost legal representation|0|||
124702455|NCT01051661|448534223|FG000|Overall Study|Protocol Violation|0|||
124702456|NCT01051661|448534224|FG001|Overall Study|Protocol Violation|0|||
124702457|NCT01051661|448534225|FG002|Overall Study|Protocol Violation|0|||
124702458|NCT01051661|448534226|FG003|Overall Study|Protocol Violation|1|||
124702459|NCT01051661|448534227|FG004|Overall Study|Protocol Violation|2|||
124702460|NCT01051661|448534228|FG005|Overall Study|Protocol Violation|1|||
124702461|NCT01051661|448534223|FG000|Overall Study|Withdrawal by Subject|16|||
124935309|NCT04490109|449392977|FG000|Overall Study|Significant Clinical Event|0|||
124935310|NCT04490109|449392978|FG001|Overall Study|Significant Clinical Event|1|||
124702462|NCT01051661|448534224|FG001|Overall Study|Withdrawal by Subject|30|||
124702463|NCT01051661|448534225|FG002|Overall Study|Withdrawal by Subject|13|||
124702464|NCT01051661|448534226|FG003|Overall Study|Withdrawal by Subject|28|||
124702465|NCT01051661|448534227|FG004|Overall Study|Withdrawal by Subject|12|||
124702466|NCT01051661|448534228|FG005|Overall Study|Withdrawal by Subject|34|||
124702467|NCT04642079|448534229|FG000|Overall Study|Lost to Follow-up|2|||
124702468|NCT04642079|448534230|FG001|Overall Study|Lost to Follow-up|5|||
124935311|NCT04490109|449392979|FG002|Overall Study|Significant Clinical Event|0|||
124935312|NCT04490109|449392977|FG000|Overall Study|Other Reason|4|||
124935313|NCT04490109|449392978|FG001|Overall Study|Other Reason|1|||
124935314|NCT04490109|449392979|FG002|Overall Study|Other Reason|1|||
124935315|NCT03884439|449392982|FG000|Overall Study|No informed consent for publication of study results|38|||
124935316|NCT03884439|449392982|FG000|Overall Study|Contract violation/deficiency|7|||
124935317|NCT03904576|449392983|FG000|Washout Period|Protocol Violation|1|||
124935318|NCT03904576|449392984|FG001|Washout Period|Protocol Violation|1|||
124935319|NCT04780581|449392985|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
124935320|NCT04780581|449392986|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
124935321|NCT04780581|449392985|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
124935322|NCT04780581|449392986|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
124935323|NCT01756300|449392987|FG000|Overall Study|Death|1|||
124935324|NCT01756300|449392987|FG000|Overall Study|Withdrawal by Subject|1|||
124935325|NCT05836012|449393834|FG000|Overall Study|Lost to Follow-up|1|||
124935326|NCT05836012|449393835|FG001|Overall Study|Lost to Follow-up|0|||
124935327|NCT05836012|449393834|FG000|Overall Study|Withdrawal by Subject|1|||
124935328|NCT05836012|449393835|FG001|Overall Study|Withdrawal by Subject|3|||
124935329|NCT05836012|449393834|FG000|Overall Study|Reason not included in pre-specified categories|2|||
124935330|NCT05836012|449393835|FG001|Overall Study|Reason not included in pre-specified categories|1|||
124935331|NCT03817983|449393836|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
124935332|NCT03817983|449393837|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
124935333|NCT03817983|449393838|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
124935334|NCT03744676|449393839|FG000|Pre-Treatment Phase|Disease related complications|2|||
124935335|NCT03744676|449393839|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
124935336|NCT03744676|449393839|FG000|Pre-Treatment Phase|Death|7|||
124935337|NCT03744676|449393839|FG000|Pre-Treatment Phase|Other Reasons|7|||
124935338|NCT03744676|449393839|FG000|Treatment Phase|Participant withdrew consent|8|||
124935339|NCT03744676|449393839|FG000|Treatment Phase|Death|33|||
124935340|NCT03744676|449393839|FG000|Treatment Phase|other reasons|6|||
124935341|NCT03333915|449393840|FG000|Overall Study|Lost to Follow-up|0|||
124935342|NCT03333915|449393841|FG001|Overall Study|Lost to Follow-up|0|||
124935343|NCT03333915|449393842|FG002|Overall Study|Lost to Follow-up|1|||
124935344|NCT03333915|449393843|FG003|Overall Study|Lost to Follow-up|0|||
124935345|NCT03333915|449393844|FG004|Overall Study|Lost to Follow-up|0|||
124935346|NCT03333915|449393840|FG000|Overall Study|Disease Progression|0|||
124935347|NCT03333915|449393841|FG001|Overall Study|Disease Progression|1|||
124764924|NCT00614575|448765067|FG000|Overall Study|Withdrawal by Subject|6|||
124764925|NCT00614575|448765067|FG000|Overall Study|Death|3|||
124764926|NCT00614575|448765067|FG000|Overall Study|Physician Decision|2|||
124764927|NCT00614575|448765067|FG000|Overall Study|No data were collected.|18|||
124935348|NCT03333915|449393842|FG002|Overall Study|Disease Progression|0|||
124935349|NCT03333915|449393843|FG003|Overall Study|Disease Progression|0|||
124935350|NCT03333915|449393844|FG004|Overall Study|Disease Progression|0|||
124935351|NCT03333915|449393840|FG000|Overall Study|Death|0|||
124935352|NCT03333915|449393841|FG001|Overall Study|Death|0|||
124935353|NCT03333915|449393842|FG002|Overall Study|Death|0|||
124935354|NCT03333915|449393843|FG003|Overall Study|Death|37|||
124702469|NCT04642079|448534231|FG002|Overall Study|Lost to Follow-up|2|||
124702470|NCT04642079|448534232|FG003|Overall Study|Lost to Follow-up|0|||
124764928|NCT00614575|448765067|FG000|Overall Study|Irregularly enrolled patients|23|||
124935355|NCT03333915|449393844|FG004|Overall Study|Death|18|||
124935356|NCT03333915|449393840|FG000|Overall Study|Sponsor's Decision|0|||
124935357|NCT03333915|449393841|FG001|Overall Study|Sponsor's Decision|0|||
124935358|NCT03333915|449393842|FG002|Overall Study|Sponsor's Decision|0|||
124764929|NCT00614575|448765067|FG000|Overall Study|No treatment|1|||
124935359|NCT03333915|449393843|FG003|Overall Study|Sponsor's Decision|48|||
124935360|NCT03333915|449393844|FG004|Overall Study|Sponsor's Decision|4|||
124935361|NCT03333915|449393840|FG000|Overall Study|Withdrawal by Subject|0|||
124935362|NCT03333915|449393841|FG001|Overall Study|Withdrawal by Subject|0|||
124935363|NCT03333915|449393842|FG002|Overall Study|Withdrawal by Subject|0|||
124935364|NCT03333915|449393843|FG003|Overall Study|Withdrawal by Subject|5|||
124935365|NCT03333915|449393844|FG004|Overall Study|Withdrawal by Subject|1|||
124935366|NCT05454514|449393848|FG000|Overall Study|Withdrawal by Subject|4|||
124935367|NCT05785130|449393849|FG000|Overall Study|Withdrawal by Subject|1|||
124702471|NCT04642079|448534229|FG000|Overall Study|Withdrawal by Subject|0|||
124702472|NCT04642079|448534230|FG001|Overall Study|Withdrawal by Subject|4|||
124702473|NCT04642079|448534231|FG002|Overall Study|Withdrawal by Subject|1|||
124764930|NCT03452540|448765069|FG000|Overall Study|Adverse Event|1|||
124702474|NCT04642079|448534232|FG003|Overall Study|Withdrawal by Subject|2|||
124702475|NCT04642079|448534229|FG000|Overall Study|Other|0|||
124702476|NCT04642079|448534230|FG001|Overall Study|Other|0|||
124702477|NCT04642079|448534231|FG002|Overall Study|Other|0|||
124702478|NCT04642079|448534232|FG003|Overall Study|Other|1|||
124702479|NCT04642079|448534229|FG000|Overall Study|No longer met eligibility criteria|1|||
124702480|NCT04642079|448534230|FG001|Overall Study|No longer met eligibility criteria|0|||
124702481|NCT04642079|448534231|FG002|Overall Study|No longer met eligibility criteria|1|||
124702482|NCT04642079|448534232|FG003|Overall Study|No longer met eligibility criteria|1|||
124702483|NCT03078868|448534235|FG000|Overall Study|Physician Decision|3|||
124702484|NCT03038620|448534236|FG000|Overall Study|Lost to Follow-up|18|||
124702485|NCT03038620|448534237|FG001|Overall Study|Lost to Follow-up|23|||
124702486|NCT03038620|448534236|FG000|Overall Study|Withdrawal by Subject|0|||
124702487|NCT03038620|448534237|FG001|Overall Study|Withdrawal by Subject|15|||
124702488|NCT03038620|448534236|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
124702489|NCT03038620|448534237|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
124702490|NCT01435356|448534243|FG000|Overall Study|Adverse Event|2|||
124935368|NCT05785130|449393850|FG001|Overall Study|Withdrawal by Subject|0|||
124935369|NCT05785130|449393849|FG000|Overall Study|Lack of Efficacy|0|||
124935370|NCT05785130|449393850|FG001|Overall Study|Lack of Efficacy|1|||
124935371|NCT02461134|449393855|FG000|Overall Study|Adverse Event|1|||
124935372|NCT04761198|449393856|FG000|Overall Study|Progressive Disease|1|||
124935373|NCT04761198|449393857|FG001|Overall Study|Progressive Disease|0|||
124935374|NCT04761198|449393858|FG002|Overall Study|Progressive Disease|0|||
124935375|NCT04761198|449393859|FG003|Overall Study|Progressive Disease|1|||
124935376|NCT04761198|449393860|FG004|Overall Study|Progressive Disease|4|||
124935377|NCT04761198|449393861|FG005|Overall Study|Progressive Disease|1|||
124935378|NCT04761198|449393862|FG006|Overall Study|Progressive Disease|2|||
124935379|NCT04761198|449393856|FG000|Overall Study|Protocol Violation|0|||
124935380|NCT04761198|449393857|FG001|Overall Study|Protocol Violation|0|||
124935381|NCT04761198|449393858|FG002|Overall Study|Protocol Violation|0|||
124935382|NCT04761198|449393859|FG003|Overall Study|Protocol Violation|0|||
124935383|NCT04761198|449393860|FG004|Overall Study|Protocol Violation|1|||
124935384|NCT04761198|449393861|FG005|Overall Study|Protocol Violation|0|||
124935385|NCT04761198|449393862|FG006|Overall Study|Protocol Violation|0|||
124935386|NCT04761198|449393856|FG000|Overall Study|Death|2|||
124935387|NCT04761198|449393857|FG001|Overall Study|Death|1|||
124935388|NCT04761198|449393858|FG002|Overall Study|Death|2|||
124935389|NCT04761198|449393859|FG003|Overall Study|Death|5|||
124935390|NCT04761198|449393860|FG004|Overall Study|Death|14|||
124935391|NCT04761198|449393861|FG005|Overall Study|Death|2|||
124935392|NCT04761198|449393862|FG006|Overall Study|Death|5|||
124935393|NCT04761198|449393856|FG000|Overall Study|Lost to Follow-up|0|||
124935394|NCT04761198|449393857|FG001|Overall Study|Lost to Follow-up|0|||
124935395|NCT04761198|449393858|FG002|Overall Study|Lost to Follow-up|0|||
124935396|NCT04761198|449393859|FG003|Overall Study|Lost to Follow-up|0|||
124935397|NCT04761198|449393860|FG004|Overall Study|Lost to Follow-up|1|||
124935398|NCT04761198|449393861|FG005|Overall Study|Lost to Follow-up|0|||
124935399|NCT04761198|449393862|FG006|Overall Study|Lost to Follow-up|0|||
124935400|NCT04761198|449393856|FG000|Overall Study|Withdrawal by Subject|2|||
124935401|NCT04761198|449393857|FG001|Overall Study|Withdrawal by Subject|0|||
124935402|NCT04761198|449393858|FG002|Overall Study|Withdrawal by Subject|1|||
124935403|NCT04761198|449393859|FG003|Overall Study|Withdrawal by Subject|0|||
124935404|NCT04761198|449393860|FG004|Overall Study|Withdrawal by Subject|2|||
124935405|NCT04761198|449393861|FG005|Overall Study|Withdrawal by Subject|0|||
124935406|NCT04761198|449393862|FG006|Overall Study|Withdrawal by Subject|1|||
124935407|NCT04761198|449393856|FG000|Overall Study|Study Terminated by Sponsor|6|||
124935408|NCT04761198|449393857|FG001|Overall Study|Study Terminated by Sponsor|0|||
124935409|NCT04761198|449393858|FG002|Overall Study|Study Terminated by Sponsor|5|||
124935410|NCT04761198|449393859|FG003|Overall Study|Study Terminated by Sponsor|3|||
124935411|NCT04761198|449393860|FG004|Overall Study|Study Terminated by Sponsor|10|||
124935412|NCT04761198|449393861|FG005|Overall Study|Study Terminated by Sponsor|1|||
124935413|NCT04761198|449393862|FG006|Overall Study|Study Terminated by Sponsor|2|||
124935414|NCT03533257|449393863|FG000|Overall Study|Adverse Event|4|||
124935415|NCT03533257|449393864|FG001|Overall Study|Adverse Event|2|||
124935416|NCT03533257|449393863|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
124935417|NCT03533257|449393864|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
124935418|NCT03250676|449393866|FG000|Overall Study|Adverse Event|0|||
124935419|NCT03250676|449393867|FG001|Overall Study|Adverse Event|0|||
124935420|NCT03250676|449393868|FG002|Overall Study|Adverse Event|0|||
124702491|NCT01435356|448534244|FG001|Overall Study|Adverse Event|0|||
124702492|NCT01435356|448534243|FG000|Overall Study|Disease progression/recurrence|17|||
124702493|NCT01435356|448534244|FG001|Overall Study|Disease progression/recurrence|10|||
124702494|NCT01435356|448534243|FG000|Overall Study|Protocol Violation|0|||
124702495|NCT01435356|448534244|FG001|Overall Study|Protocol Violation|1|||
124702496|NCT01435356|448534243|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
124702497|NCT01435356|448534244|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
124702498|NCT01435356|448534243|FG000|Overall Study|Withdrawal by Subject|1|||
124702499|NCT01435356|448534244|FG001|Overall Study|Withdrawal by Subject|1|||
124702500|NCT01435356|448534243|FG000|Overall Study|Facial palsy|1|||
124702501|NCT01435356|448534244|FG001|Overall Study|Facial palsy|0|||
124702502|NCT01435356|448534243|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
124702503|NCT01435356|448534244|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
124702504|NCT01435356|448534243|FG000|Overall Study|Physician Decision|1|||
124702505|NCT01435356|448534244|FG001|Overall Study|Physician Decision|0|||
124702506|NCT01435356|448534243|FG000|Overall Study|Patient decision|3|||
124702507|NCT01435356|448534244|FG001|Overall Study|Patient decision|0|||
124702508|NCT01435356|448534243|FG000|Overall Study|Patient moved to another city|1|||
124702509|NCT01435356|448534244|FG001|Overall Study|Patient moved to another city|1|||
124702510|NCT04221438|448534247|FG000|Overall Study|Adverse Event|1|||
124702511|NCT04221438|448534247|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
124702512|NCT03633058|448534250|FG000|Overall Study|Adverse Event|0|||
124702513|NCT03633058|448534251|FG001|Overall Study|Adverse Event|0|||
124702514|NCT03633058|448534252|FG002|Overall Study|Adverse Event|1|||
124702515|NCT03633058|448534253|FG003|Overall Study|Adverse Event|0|||
124702516|NCT03034044|448534254|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
124702517|NCT03312543|448534255|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
124702518|NCT03312543|448534256|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
124702519|NCT03312543|448534255|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
124702520|NCT03312543|448534256|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
124702521|NCT03312543|448534255|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
124702522|NCT03312543|448534256|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
124702523|NCT03312543|448534255|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
124702524|NCT03312543|448534256|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
124702525|NCT03312543|448534255|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
124702526|NCT03312543|448534256|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
124702527|NCT03312543|448534255|FG000|Regression (Week 12 to Week 24)|Death|0|||
124702528|NCT03312543|448534256|FG001|Regression (Week 12 to Week 24)|Death|1|||
124702529|NCT05535972|448534257|FG000|Overall Study|Withdrawal by Subject|31|||
124702530|NCT05535972|448534257|FG000|Overall Study|Lost to Follow-up|5|||
124702531|NCT05535972|448534257|FG000|Overall Study|Adverse Event|6|||
124702532|NCT05535972|448534257|FG000|Overall Study|Protocol Deviation|2|||
124702533|NCT04197583|448534260|FG000|Overall Study|Study Stent Replacement|34|||
124702534|NCT04197583|448534261|FG001|Overall Study|Study Stent Replacement|8|||
124702535|NCT04197583|448534260|FG000|Overall Study|Lost to Follow-up|14|||
124702536|NCT04197583|448534261|FG001|Overall Study|Lost to Follow-up|3|||
124702537|NCT04197583|448534260|FG000|Overall Study|Death|3|||
124702538|NCT04197583|448534261|FG001|Overall Study|Death|0|||
124702539|NCT04197583|448534260|FG000|Overall Study|Physician Decision|1|||
124702540|NCT04197583|448534261|FG001|Overall Study|Physician Decision|0|||
124702541|NCT04197583|448534260|FG000|Overall Study|Withdrawal by Subject|1|||
124702542|NCT04197583|448534261|FG001|Overall Study|Withdrawal by Subject|1|||
124702543|NCT04197583|448534260|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
124702544|NCT04197583|448534261|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
124702545|NCT04197583|448534260|FG000|Overall Study|Screen Failure|0|||
124702546|NCT04197583|448534261|FG001|Overall Study|Screen Failure|20|||
124702547|NCT01992757|448535643|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
124702548|NCT04992273|448535644|FG000|Overall Study|Lost to Follow-up|0|||
124702549|NCT04992273|448535645|FG001|Overall Study|Lost to Follow-up|1|||
124702550|NCT00856557|448535646|FG000|Overall Study|No patients with contextual flags|12|||
124702551|NCT00856557|448535647|FG001|Overall Study|No patients with contextual flags|16|||
124935421|NCT03250676|449393869|FG003|Overall Study|Adverse Event|1|||
124935422|NCT03250676|449393870|FG004|Overall Study|Adverse Event|2|||
124935423|NCT03250676|449393871|FG005|Overall Study|Adverse Event|9|||
124935424|NCT03250676|449393866|FG000|Overall Study|Withdrawal by Subject|1|||
124935425|NCT03250676|449393867|FG001|Overall Study|Withdrawal by Subject|0|||
124935426|NCT03250676|449393868|FG002|Overall Study|Withdrawal by Subject|0|||
124935427|NCT03250676|449393869|FG003|Overall Study|Withdrawal by Subject|1|||
124935428|NCT03250676|449393870|FG004|Overall Study|Withdrawal by Subject|1|||
124935429|NCT03250676|449393871|FG005|Overall Study|Withdrawal by Subject|2|||
124935430|NCT03250676|449393866|FG000|Overall Study|Physician Decision|0|||
124935431|NCT03250676|449393867|FG001|Overall Study|Physician Decision|0|||
124702552|NCT01432444|448535648|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
124702553|NCT01432444|448535649|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
124702554|NCT01432444|448535650|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
124702555|NCT01432444|448535648|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
124702556|NCT01432444|448535649|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
124702557|NCT01432444|448535650|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
124935432|NCT03250676|449393868|FG002|Overall Study|Physician Decision|0|||
124702558|NCT01432444|448535648|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
124702559|NCT01432444|448535649|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
124702560|NCT01432444|448535650|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
124702561|NCT01432444|448535648|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
124702562|NCT01432444|448535649|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
124702563|NCT01432444|448535650|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
124702564|NCT01432444|448535648|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
124702565|NCT01432444|448535649|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
124702566|NCT01432444|448535650|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
124702567|NCT01432444|448535648|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
124702568|NCT01432444|448535649|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
124702569|NCT01432444|448535650|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
124702570|NCT01432444|448535648|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
124702571|NCT01432444|448535649|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
124702572|NCT01432444|448535650|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
124702573|NCT01432444|448535648|FG000|Treatment Phase|Lost to Follow-up|0|||
124702574|NCT01432444|448535649|FG001|Treatment Phase|Lost to Follow-up|33|||
124702575|NCT01432444|448535650|FG002|Treatment Phase|Lost to Follow-up|0|||
124702576|NCT01432444|448535648|FG000|Treatment Phase|Adverse Event|0|||
124702577|NCT01432444|448535649|FG001|Treatment Phase|Adverse Event|37|||
124702578|NCT01432444|448535650|FG002|Treatment Phase|Adverse Event|0|||
124702579|NCT01432444|448535648|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
124702580|NCT01432444|448535649|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
124702581|NCT01432444|448535650|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
124702582|NCT01432444|448535648|FG000|Treatment Phase|Physician Decision|0|||
124702583|NCT01432444|448535649|FG001|Treatment Phase|Physician Decision|5|||
124702584|NCT01432444|448535650|FG002|Treatment Phase|Physician Decision|0|||
124702585|NCT01432444|448535648|FG000|Treatment Phase|Withdrawal by Subject|0|||
124702586|NCT01432444|448535649|FG001|Treatment Phase|Withdrawal by Subject|41|||
124702587|NCT01432444|448535650|FG002|Treatment Phase|Withdrawal by Subject|0|||
124702588|NCT01432444|448535648|FG000|Treatment Phase|Protocol Deviation|0|||
124702589|NCT01432444|448535649|FG001|Treatment Phase|Protocol Deviation|3|||
124702590|NCT01432444|448535650|FG002|Treatment Phase|Protocol Deviation|0|||
124702591|NCT01432444|448535648|FG000|Treatment Phase|Lack of Efficacy|0|||
124702592|NCT01432444|448535649|FG001|Treatment Phase|Lack of Efficacy|10|||
124702593|NCT01432444|448535650|FG002|Treatment Phase|Lack of Efficacy|0|||
124702594|NCT01432444|448535648|FG000|Extension Phase|Lost to Follow-up|0|||
124702595|NCT01432444|448535649|FG001|Extension Phase|Lost to Follow-up|0|||
124702596|NCT01432444|448535650|FG002|Extension Phase|Lost to Follow-up|17|||
124702597|NCT01432444|448535648|FG000|Extension Phase|Adverse Event|0|||
124702598|NCT01432444|448535649|FG001|Extension Phase|Adverse Event|0|||
124702599|NCT01432444|448535650|FG002|Extension Phase|Adverse Event|10|||
124702600|NCT01432444|448535648|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
124702601|NCT01432444|448535649|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
124702602|NCT01432444|448535650|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
124702603|NCT01432444|448535648|FG000|Extension Phase|Met Withdrawal Criteria|0|||
124702604|NCT01432444|448535649|FG001|Extension Phase|Met Withdrawal Criteria|0|||
124702605|NCT01432444|448535650|FG002|Extension Phase|Met Withdrawal Criteria|144|||
124935433|NCT03250676|449393869|FG003|Overall Study|Physician Decision|2|||
124935434|NCT03250676|449393870|FG004|Overall Study|Physician Decision|0|||
124935435|NCT03250676|449393871|FG005|Overall Study|Physician Decision|3|||
124935436|NCT03250676|449393866|FG000|Overall Study|Withdrawal of consent|0|||
124935437|NCT03250676|449393867|FG001|Overall Study|Withdrawal of consent|0|||
124935438|NCT03250676|449393868|FG002|Overall Study|Withdrawal of consent|2|||
124935439|NCT03250676|449393869|FG003|Overall Study|Withdrawal of consent|0|||
124935440|NCT03250676|449393870|FG004|Overall Study|Withdrawal of consent|0|||
124935441|NCT03250676|449393871|FG005|Overall Study|Withdrawal of consent|2|||
124935442|NCT03250676|449393866|FG000|Overall Study|Other|1|||
124935443|NCT03250676|449393867|FG001|Overall Study|Other|0|||
124935444|NCT03250676|449393868|FG002|Overall Study|Other|0|||
124702606|NCT01432444|448535648|FG000|Extension Phase|Physician Decision|0|||
124702607|NCT01432444|448535649|FG001|Extension Phase|Physician Decision|0|||
124702608|NCT01432444|448535650|FG002|Extension Phase|Physician Decision|1|||
124702609|NCT01432444|448535648|FG000|Extension Phase|Withdrawal by Subject|0|||
124935445|NCT03250676|449393869|FG003|Overall Study|Other|0|||
124935446|NCT03250676|449393870|FG004|Overall Study|Other|0|||
124702610|NCT01432444|448535649|FG001|Extension Phase|Withdrawal by Subject|0|||
124702611|NCT01432444|448535650|FG002|Extension Phase|Withdrawal by Subject|13|||
124702612|NCT02301897|448535651|FG000|Treatment Course 1|Non-Compliance|0|||
124702613|NCT02301897|448535652|FG001|Treatment Course 1|Non-Compliance|0|||
124702614|NCT02301897|448535653|FG002|Treatment Course 1|Non-Compliance|1|||
124702615|NCT02301897|448535651|FG000|Treatment Course 1|Adverse Event|1|||
124702616|NCT02301897|448535652|FG001|Treatment Course 1|Adverse Event|1|||
124935447|NCT03250676|449393871|FG005|Overall Study|Other|0|||
124935448|NCT03250676|449393866|FG000|Overall Study|Disease progression|4|||
124935449|NCT03250676|449393867|FG001|Overall Study|Disease progression|12|||
124935450|NCT03250676|449393868|FG002|Overall Study|Disease progression|9|||
124702617|NCT02301897|448535653|FG002|Treatment Course 1|Adverse Event|0|||
124702618|NCT02301897|448535651|FG000|Treatment Course 1|Lost to Follow-up|1|||
124702619|NCT02301897|448535652|FG001|Treatment Course 1|Lost to Follow-up|2|||
124702620|NCT02301897|448535653|FG002|Treatment Course 1|Lost to Follow-up|1|||
124702621|NCT02301897|448535651|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
124702622|NCT02301897|448535652|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
124702623|NCT02301897|448535653|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
124702624|NCT02301897|448535651|FG000|Treatment Course 1|Withdrawal by Subject|0|||
124702625|NCT02301897|448535652|FG001|Treatment Course 1|Withdrawal by Subject|0|||
124702626|NCT02301897|448535653|FG002|Treatment Course 1|Withdrawal by Subject|2|||
124935451|NCT03250676|449393869|FG003|Overall Study|Disease progression|7|||
124935452|NCT03250676|449393870|FG004|Overall Study|Disease progression|4|||
124935453|NCT03250676|449393871|FG005|Overall Study|Disease progression|88|||
124935454|NCT03587805|449393872|FG000|Overall Study|Adverse Event|72|||
124935455|NCT03587805|449393872|FG000|Overall Study|Death|1|||
124935456|NCT03587805|449393872|FG000|Overall Study|Lost to Follow-up|78|||
124935457|NCT03587805|449393872|FG000|Overall Study|Withdrawal by Subject|105|||
124935458|NCT03587805|449393872|FG000|Overall Study|Lack of Efficacy|119|||
124935459|NCT03587805|449393872|FG000|Overall Study|Reason unknown|26|||
124935460|NCT03587805|449393872|FG000|Overall Study|COVID_19 pandemic|4|||
124935461|NCT03587805|449393872|FG000|Overall Study|Various reasons|121|||
124935462|NCT03587805|449393872|FG000|Overall Study|Withdrawal by parent/guardian|3|||
124935463|NCT04626427|449393873|FG000|Overall Study|Death|1|||
124935464|NCT04626427|449393873|FG000|Overall Study|Withdrawal by Subject|1|||
124935465|NCT04626427|449393873|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
124935466|NCT04626427|449393873|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
124935467|NCT01651000|449393874|FG000|Overall Study|Adverse Event|2|||
124935468|NCT01651000|449393875|FG001|Overall Study|Adverse Event|8|||
124935469|NCT01651000|449393874|FG000|Overall Study|Lost to Follow-up|3|||
124935470|NCT01651000|449393875|FG001|Overall Study|Lost to Follow-up|2|||
124935471|NCT01651000|449393874|FG000|Overall Study|Protocol Violation|0|||
124935472|NCT01651000|449393875|FG001|Overall Study|Protocol Violation|3|||
124935473|NCT01651000|449393874|FG000|Overall Study|Withdrawal by Subject|2|||
124935474|NCT01651000|449393875|FG001|Overall Study|Withdrawal by Subject|10|||
124935475|NCT01651000|449393874|FG000|Overall Study|Subject noncompliance|0|||
124935476|NCT01651000|449393875|FG001|Overall Study|Subject noncompliance|3|||
124935477|NCT01651000|449393874|FG000|Overall Study|Lack of Efficacy|1|||
124935478|NCT01651000|449393875|FG001|Overall Study|Lack of Efficacy|1|||
124935479|NCT01651000|449393874|FG000|Overall Study|Physician Decision|1|||
124935480|NCT01651000|449393875|FG001|Overall Study|Physician Decision|0|||
124935481|NCT01651000|449393874|FG000|Overall Study|Administrative reason|1|||
124935482|NCT01651000|449393875|FG001|Overall Study|Administrative reason|0|||
124935483|NCT01651000|449393874|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
124935484|NCT01651000|449393875|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
124935485|NCT03982186|449393876|FG000|Overall Study|Lost to Follow-up|0|||
124935486|NCT03982186|449393877|FG001|Overall Study|Lost to Follow-up|1|||
124935487|NCT03982186|449393878|FG002|Overall Study|Lost to Follow-up|2|||
124935488|NCT03982186|449393879|FG003|Overall Study|Lost to Follow-up|1|||
124935489|NCT03982186|449393880|FG004|Overall Study|Lost to Follow-up|1|||
124935490|NCT03982186|449393881|FG005|Overall Study|Lost to Follow-up|0|||
124935491|NCT03982186|449393876|FG000|Overall Study|Physician Decision|0|||
124935492|NCT03982186|449393877|FG001|Overall Study|Physician Decision|1|||
124935493|NCT03982186|449393878|FG002|Overall Study|Physician Decision|0|||
124935494|NCT03982186|449393879|FG003|Overall Study|Physician Decision|0|||
124935495|NCT03982186|449393880|FG004|Overall Study|Physician Decision|0|||
124702627|NCT02301897|448535651|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
124935496|NCT03982186|449393881|FG005|Overall Study|Physician Decision|0|||
124935497|NCT03982186|449393876|FG000|Overall Study|Withdrawal by Subject|3|||
124935498|NCT03982186|449393877|FG001|Overall Study|Withdrawal by Subject|4|||
124935499|NCT03982186|449393878|FG002|Overall Study|Withdrawal by Subject|1|||
124935500|NCT03982186|449393879|FG003|Overall Study|Withdrawal by Subject|7|||
124702628|NCT02301897|448535652|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
124702629|NCT02301897|448535653|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
124702630|NCT02301897|448535651|FG000|Treatment Course 2|Lost to Follow-up|0|||
124702631|NCT02301897|448535652|FG001|Treatment Course 2|Lost to Follow-up|2|||
124702632|NCT02301897|448535653|FG002|Treatment Course 2|Lost to Follow-up|0|||
124702633|NCT02301897|448535651|FG000|Treatment Course 2|Pregnancy|0|||
124702634|NCT02301897|448535652|FG001|Treatment Course 2|Pregnancy|1|||
124935501|NCT03982186|449393880|FG004|Overall Study|Withdrawal by Subject|2|||
124935502|NCT03982186|449393881|FG005|Overall Study|Withdrawal by Subject|0|||
124935503|NCT03982186|449393876|FG000|Overall Study|Randomized and not treated|0|||
124935504|NCT03982186|449393877|FG001|Overall Study|Randomized and not treated|0|||
124935505|NCT03982186|449393878|FG002|Overall Study|Randomized and not treated|0|||
124935506|NCT03982186|449393879|FG003|Overall Study|Randomized and not treated|1|||
124935507|NCT03982186|449393880|FG004|Overall Study|Randomized and not treated|0|||
124935508|NCT03982186|449393881|FG005|Overall Study|Randomized and not treated|0|||
124935509|NCT02765412|449393882|FG000|Overall Study|Death|482|||
124935510|NCT02765412|449393883|FG001|Overall Study|Death|855|||
124935511|NCT04244175|449394788|FG000|Overall Study|Adverse Event|3|||
124935512|NCT04244175|449394789|FG001|Overall Study|Adverse Event|2|||
124935513|NCT04244175|449394790|FG002|Overall Study|Adverse Event|5|||
124935514|NCT04244175|449394788|FG000|Overall Study|Lack of Efficacy|1|||
124935515|NCT04244175|449394789|FG001|Overall Study|Lack of Efficacy|0|||
124935516|NCT04244175|449394790|FG002|Overall Study|Lack of Efficacy|1|||
124935517|NCT04244175|449394788|FG000|Overall Study|Lost to Follow-up|1|||
124935518|NCT04244175|449394789|FG001|Overall Study|Lost to Follow-up|0|||
124935519|NCT04244175|449394790|FG002|Overall Study|Lost to Follow-up|0|||
124935520|NCT04244175|449394788|FG000|Overall Study|Non-compliance with study drug|1|||
124935521|NCT04244175|449394789|FG001|Overall Study|Non-compliance with study drug|0|||
124935522|NCT04244175|449394790|FG002|Overall Study|Non-compliance with study drug|1|||
124935523|NCT04244175|449394788|FG000|Overall Study|Protocol deviation|0|||
124935524|NCT04244175|449394789|FG001|Overall Study|Protocol deviation|1|||
124935525|NCT04244175|449394790|FG002|Overall Study|Protocol deviation|0|||
124935526|NCT04244175|449394788|FG000|Overall Study|Withdrawal by Subject|1|||
124935527|NCT04244175|449394789|FG001|Overall Study|Withdrawal by Subject|3|||
124935528|NCT04244175|449394790|FG002|Overall Study|Withdrawal by Subject|1|||
124935529|NCT04244175|449394788|FG000|Overall Study|Other, not specified|0|||
124935530|NCT04244175|449394789|FG001|Overall Study|Other, not specified|1|||
124935531|NCT04244175|449394790|FG002|Overall Study|Other, not specified|2|||
124935532|NCT04595331|449394791|FG000|Overall Study|Withdrawal by Subject|0|||
124935533|NCT04595331|449394792|FG001|Overall Study|Withdrawal by Subject|1|||
124935534|NCT04595331|449394791|FG000|Overall Study|Lost to Follow-up|0|||
124935535|NCT04595331|449394792|FG001|Overall Study|Lost to Follow-up|5|||
124935536|NCT04595331|449394791|FG000|Overall Study|Medical reason|0|||
124935537|NCT04595331|449394792|FG001|Overall Study|Medical reason|1|||
124935538|NCT03781089|449394793|FG000|Overall Study|Constipation|1|||
124935539|NCT03781089|449394794|FG001|Overall Study|Constipation|0|||
124935540|NCT03781089|449394793|FG000|Overall Study|Positive pregnancy test|0|||
124935541|NCT03781089|449394794|FG001|Overall Study|Positive pregnancy test|1|||
124935542|NCT05020353|449394795|FG000|Overall Study|Protocol Violation|7|||
124935543|NCT05020353|449394795|FG000|Overall Study|Withdrawal by Subject|33|||
124935544|NCT05985395|449394804|FG000|Overall Study|Physician Decision|2|||
124935545|NCT05985395|449394805|FG001|Overall Study|Physician Decision|1|||
124935546|NCT05985395|449394804|FG000|Overall Study|Withdrawal by Subject|1|||
124935547|NCT05985395|449394805|FG001|Overall Study|Withdrawal by Subject|0|||
124935548|NCT02777593|449394817|FG000|Overall Study|Still in study|1|||
124935549|NCT02777593|449394818|FG001|Overall Study|Still in study|32|||
124935550|NCT02777593|449394819|FG002|Overall Study|Still in study|3|||
124935551|NCT02777593|449394820|FG003|Overall Study|Still in study|6|||
124935552|NCT02777593|449394821|FG004|Overall Study|Still in study|5|||
124935553|NCT02777593|449394817|FG000|Overall Study|Death|21|||
124935554|NCT02777593|449394818|FG001|Overall Study|Death|28|||
124702635|NCT02301897|448535653|FG002|Treatment Course 2|Pregnancy|1|||
124935555|NCT02777593|449394819|FG002|Overall Study|Death|0|||
124935556|NCT02777593|449394820|FG003|Overall Study|Death|5|||
124702636|NCT02301897|448535651|FG000|Treatment Course 2|Withdrawal by Subject|0|||
124935557|NCT02777593|449394821|FG004|Overall Study|Death|0|||
124935558|NCT02777593|449394817|FG000|Overall Study|Withdrawal by Subject|8|||
124935559|NCT02777593|449394818|FG001|Overall Study|Withdrawal by Subject|4|||
124455992|NCT00219284|447628958|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
124935560|NCT02777593|449394819|FG002|Overall Study|Withdrawal by Subject|1|||
124935561|NCT02777593|449394820|FG003|Overall Study|Withdrawal by Subject|1|||
124935562|NCT02777593|449394821|FG004|Overall Study|Withdrawal by Subject|0|||
124935563|NCT02777593|449394817|FG000|Overall Study|Lost to Follow-up|8|||
124935564|NCT02777593|449394818|FG001|Overall Study|Lost to Follow-up|16|||
124935565|NCT02777593|449394819|FG002|Overall Study|Lost to Follow-up|5|||
124935566|NCT02777593|449394820|FG003|Overall Study|Lost to Follow-up|0|||
124935567|NCT02777593|449394821|FG004|Overall Study|Lost to Follow-up|1|||
124702637|NCT02301897|448535652|FG001|Treatment Course 2|Withdrawal by Subject|2|||
124935568|NCT02777593|449394817|FG000|Overall Study|Physician Decision|2|||
124935569|NCT02777593|449394818|FG001|Overall Study|Physician Decision|2|||
124935570|NCT02777593|449394819|FG002|Overall Study|Physician Decision|0|||
124935571|NCT02777593|449394820|FG003|Overall Study|Physician Decision|0|||
124935572|NCT02777593|449394821|FG004|Overall Study|Physician Decision|0|||
124935573|NCT02777593|449394817|FG000|Overall Study|Discontinued due to Other|1|||
124935574|NCT02777593|449394818|FG001|Overall Study|Discontinued due to Other|0|||
124935575|NCT02777593|449394819|FG002|Overall Study|Discontinued due to Other|0|||
124935576|NCT02777593|449394820|FG003|Overall Study|Discontinued due to Other|0|||
124935577|NCT02777593|449394821|FG004|Overall Study|Discontinued due to Other|0|||
124935578|NCT03547271|449394824|FG000|Overall Study|Adverse Event|1|||
124935579|NCT03547271|449394825|FG001|Overall Study|Adverse Event|1|||
124935580|NCT03547271|449394826|FG002|Overall Study|Adverse Event|0|||
124935581|NCT03547271|449394827|FG003|Overall Study|Adverse Event|0|||
124935582|NCT03547271|449394824|FG000|Overall Study|Protocol deviation|5|||
124935583|NCT03547271|449394825|FG001|Overall Study|Protocol deviation|7|||
124935584|NCT03547271|449394826|FG002|Overall Study|Protocol deviation|3|||
124935585|NCT03547271|449394827|FG003|Overall Study|Protocol deviation|0|||
124935586|NCT03547271|449394824|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
124935587|NCT03547271|449394825|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
124935588|NCT03547271|449394826|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
124935589|NCT03547271|449394827|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
124935590|NCT03547271|449394824|FG000|Overall Study|Lost to Follow-up|3|||
124935591|NCT03547271|449394825|FG001|Overall Study|Lost to Follow-up|3|||
124935592|NCT03547271|449394826|FG002|Overall Study|Lost to Follow-up|1|||
124935593|NCT03547271|449394827|FG003|Overall Study|Lost to Follow-up|0|||
124935594|NCT06065735|449394832|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
124935595|NCT06065735|449394833|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
124935596|NCT06065735|449394834|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
124935597|NCT06065735|449394832|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
124935598|NCT06065735|449394833|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
124935599|NCT06065735|449394834|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
124935600|NCT06065735|449394832|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
124935601|NCT06065735|449394833|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
124935602|NCT06065735|449394834|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
124935603|NCT06065735|449394832|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
124935604|NCT06065735|449394833|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
124935605|NCT06065735|449394834|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
124935606|NCT06065735|449394832|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
124935607|NCT06065735|449394833|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
124935608|NCT06065735|449394834|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
124935609|NCT02532621|449394835|FG000|Overall Study|Death|3|||
124935610|NCT02532621|449394835|FG000|Overall Study|Lost to Follow-up|3|||
124935611|NCT02532621|449394835|FG000|Overall Study|Withdrawal by Subject|6|||
124935612|NCT02532621|449394835|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
124935613|NCT02532621|449394835|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
124935614|NCT03522298|449394836|FG000|Overall Study|Adverse Event|1|||
124935615|NCT03522298|449394837|FG001|Overall Study|Adverse Event|0|||
124935616|NCT03522298|449394838|FG002|Overall Study|Adverse Event|0|||
124935617|NCT03522298|449394839|FG003|Overall Study|Adverse Event|1|||
124935618|NCT03522298|449394836|FG000|Overall Study|Death|2|||
124935619|NCT03522298|449394837|FG001|Overall Study|Death|4|||
124935620|NCT03522298|449394838|FG002|Overall Study|Death|8|||
124702638|NCT02301897|448535653|FG002|Treatment Course 2|Withdrawal by Subject|0|||
124702639|NCT02301897|448535651|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
124702640|NCT02301897|448535652|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
124702641|NCT02301897|448535653|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
124702642|NCT03673176|448535654|FG000|Overall Study|Death prior to intervention|1|||
124702643|NCT03673176|448535654|FG000|Overall Study|Death following intervention|3|||
124702644|NCT03673176|448535654|FG000|Overall Study|Withdrawal by Subject|1|||
124702645|NCT03283241|448535655|FG000|Overall Study|Adverse Event|4|||
124702646|NCT03283241|448535656|FG001|Overall Study|Adverse Event|1|||
124702647|NCT03283241|448535655|FG000|Overall Study|Withdrawal by Subject|0|||
124702648|NCT03283241|448535656|FG001|Overall Study|Withdrawal by Subject|1|||
124702649|NCT03283241|448535655|FG000|Overall Study|Subject relocated to Finland|0|||
124702650|NCT03283241|448535656|FG001|Overall Study|Subject relocated to Finland|1|||
124935621|NCT03522298|449394839|FG003|Overall Study|Death|8|||
124935622|NCT03522298|449394836|FG000|Overall Study|Patient decision|0|||
124935623|NCT03522298|449394837|FG001|Overall Study|Patient decision|2|||
124935624|NCT03522298|449394838|FG002|Overall Study|Patient decision|2|||
124935625|NCT03522298|449394839|FG003|Overall Study|Patient decision|2|||
124935626|NCT04795245|449394842|FG000|Overall Study|Unkown reason|7|||
124935627|NCT04795245|449394842|FG000|Overall Study|Death|17|||
124935628|NCT04795245|449394842|FG000|Overall Study|Other than listed|19|||
124935629|NCT04795245|449394842|FG000|Overall Study|Adverse Event|143|||
124935630|NCT04795245|449394842|FG000|Overall Study|Progressive disease|512|||
124935631|NCT04795245|449394842|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
124935632|NCT02919917|449394843|FG000|Overall Study|Withdrawal by Subject|4|||
124935633|NCT02919917|449394844|FG001|Overall Study|Withdrawal by Subject|8|||
124935634|NCT03418740|449394845|FG000|Overall Study|Lost to Follow-up|13|||
124935635|NCT03418740|449394845|FG000|Overall Study|Scheduling Issues|7|||
124935636|NCT03418740|449394845|FG000|Overall Study|Withdrawal by Subject|2|||
124935637|NCT03418740|449394845|FG000|Overall Study|Unable to Continue Consent|1|||
124935638|NCT04157517|449394850|FG000|Overall Study|Death|1|||
124935639|NCT04157517|449394851|FG001|Overall Study|Death|2|||
124935640|NCT04157517|449394852|FG002|Overall Study|Death|2|||
124935641|NCT04157517|449394853|FG003|Overall Study|Death|3|||
124935642|NCT04157517|449394854|FG004|Overall Study|Death|3|||
124935643|NCT04157517|449394855|FG005|Overall Study|Death|4|||
124935644|NCT04157517|449394856|FG006|Overall Study|Death|1|||
124935645|NCT04157517|449394857|FG007|Overall Study|Death|2|||
124935646|NCT04157517|449394858|FG008|Overall Study|Death|4|||
124935647|NCT04157517|449394859|FG009|Overall Study|Death|0|||
124935648|NCT04157517|449394850|FG000|Overall Study|Withdrawal by Subject|1|||
124935649|NCT04157517|449394851|FG001|Overall Study|Withdrawal by Subject|1|||
124935650|NCT04157517|449394852|FG002|Overall Study|Withdrawal by Subject|1|||
124935651|NCT04157517|449394853|FG003|Overall Study|Withdrawal by Subject|0|||
124935652|NCT04157517|449394854|FG004|Overall Study|Withdrawal by Subject|0|||
124935653|NCT04157517|449394855|FG005|Overall Study|Withdrawal by Subject|1|||
124935654|NCT04157517|449394856|FG006|Overall Study|Withdrawal by Subject|0|||
124935655|NCT04157517|449394857|FG007|Overall Study|Withdrawal by Subject|0|||
124935656|NCT04157517|449394858|FG008|Overall Study|Withdrawal by Subject|1|||
124935657|NCT04157517|449394859|FG009|Overall Study|Withdrawal by Subject|0|||
124935658|NCT04157517|449394850|FG000|Overall Study|Other|1|||
124935659|NCT04157517|449394851|FG001|Overall Study|Other|0|||
124935660|NCT04157517|449394852|FG002|Overall Study|Other|0|||
124935661|NCT04157517|449394853|FG003|Overall Study|Other|0|||
124935662|NCT04157517|449394854|FG004|Overall Study|Other|0|||
124935663|NCT04157517|449394855|FG005|Overall Study|Other|1|||
124935664|NCT04157517|449394856|FG006|Overall Study|Other|2|||
124935665|NCT04157517|449394857|FG007|Overall Study|Other|7|||
124935666|NCT04157517|449394858|FG008|Overall Study|Other|7|||
124935667|NCT04157517|449394859|FG009|Overall Study|Other|0|||
124935668|NCT02933489|449394860|FG000|Overall Study|Ineligible|3|||
124702651|NCT02378480|448535657|FG000|Overall Study|Physician Decision|1|||
124764931|NCT03452540|448765069|FG000|Overall Study|Withdrawal by Subject|1|||
124764932|NCT03452540|448765069|FG000|Overall Study|Other SAE and AE|2|||
124764933|NCT04664153|448765072|FG000|Overall Study|Lack of Efficacy|0|||
124764934|NCT04664153|448765073|FG001|Overall Study|Lack of Efficacy|0|||
124935669|NCT02933489|449394861|FG001|Overall Study|Ineligible|3|||
124935670|NCT02933489|449394860|FG000|Overall Study|Withdrawal by Subject|27|||
124935671|NCT02933489|449394861|FG001|Overall Study|Withdrawal by Subject|18|||
124935672|NCT02933489|449394860|FG000|Overall Study|Unable to complete exams (other)|14|||
124935673|NCT02933489|449394861|FG001|Overall Study|Unable to complete exams (other)|7|||
124702652|NCT02378480|448535658|FG001|Overall Study|Physician Decision|1|||
124702653|NCT02378480|448535657|FG000|Overall Study|Death|1|||
124764935|NCT04664153|448765074|FG002|Overall Study|Lack of Efficacy|1|||
124764936|NCT04664153|448765075|FG003|Overall Study|Lack of Efficacy|0|||
124935674|NCT02994927|449394862|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124935675|NCT02994927|449394863|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124935676|NCT02994927|449394862|FG000|Overall Study|Did not meet eligibility criteria|0|||
124935677|NCT02994927|449394863|FG001|Overall Study|Did not meet eligibility criteria|1|||
124935678|NCT02994927|449394862|FG000|Overall Study|Physician Decision|4|||
124935679|NCT02994927|449394863|FG001|Overall Study|Physician Decision|3|||
124935680|NCT02994927|449394862|FG000|Overall Study|Death|4|||
124935681|NCT02994927|449394863|FG001|Overall Study|Death|2|||
124935682|NCT02994927|449394862|FG000|Overall Study|Adverse Event|2|||
124935683|NCT02994927|449394863|FG001|Overall Study|Adverse Event|1|||
124935684|NCT02994927|449394862|FG000|Overall Study|Withdrawal by Subject|3|||
124935685|NCT02994927|449394863|FG001|Overall Study|Withdrawal by Subject|6|||
124935686|NCT02994927|449394862|FG000|Overall Study|Lost to Follow-up|2|||
124935687|NCT02994927|449394863|FG001|Overall Study|Lost to Follow-up|1|||
124935688|NCT04281498|449394864|FG000|Overall Study|Progression of disease|1|||
124935689|NCT04281498|449394864|FG000|Overall Study|Planned SCT|1|||
124935690|NCT04281498|449394864|FG000|Overall Study|Alternative Treatment|1|||
124935691|NCT03417284|449395128|FG000|Overall Study|Inadequate supply on study drug|1|||
124935692|NCT03417284|449395129|FG001|Overall Study|Inadequate supply on study drug|0|||
124935693|NCT03417284|449395130|FG002|Overall Study|Inadequate supply on study drug|0|||
124935694|NCT03417284|449395131|FG003|Overall Study|Inadequate supply on study drug|0|||
124935695|NCT03417284|449395128|FG000|Overall Study|Disease Progression|0|||
124935696|NCT03417284|449395129|FG001|Overall Study|Disease Progression|0|||
124935697|NCT03417284|449395130|FG002|Overall Study|Disease Progression|1|||
124935698|NCT03417284|449395131|FG003|Overall Study|Disease Progression|0|||
124935699|NCT05132400|449395132|FG000|Overall Study|Withdrawal by Subject|14|||
124935700|NCT05132400|449395133|FG001|Overall Study|Withdrawal by Subject|8|||
124935701|NCT05132400|449395132|FG000|Overall Study|Lost to Follow-up|132|||
124935702|NCT05132400|449395133|FG001|Overall Study|Lost to Follow-up|121|||
124935703|NCT02076009|449395135|FG000|Overall Study|Death|172|||
124935704|NCT02076009|449395136|FG001|Overall Study|Death|153|||
124935705|NCT02076009|449395135|FG000|Overall Study|Withdrawal by Subject|16|||
124935706|NCT02076009|449395136|FG001|Overall Study|Withdrawal by Subject|12|||
124935707|NCT02076009|449395135|FG000|Overall Study|Lost to Follow-up|4|||
124935708|NCT02076009|449395136|FG001|Overall Study|Lost to Follow-up|2|||
124935709|NCT02076009|449395135|FG000|Overall Study|Progressive Disease|1|||
124935710|NCT02076009|449395136|FG001|Overall Study|Progressive Disease|0|||
124935711|NCT02076009|449395135|FG000|Overall Study|Physician Decision|0|||
124935712|NCT02076009|449395136|FG001|Overall Study|Physician Decision|1|||
124935713|NCT02076009|449395135|FG000|Overall Study|End of data collection|90|||
124935714|NCT02076009|449395136|FG001|Overall Study|End of data collection|118|||
124935715|NCT01897441|449395143|FG000|Overall Study|Lost to Follow-up|0|||
124935716|NCT01897441|449395144|FG001|Overall Study|Lost to Follow-up|0|||
124935717|NCT01897441|449395145|FG002|Overall Study|Lost to Follow-up|1|||
124935718|NCT01897441|449395146|FG003|Overall Study|Lost to Follow-up|0|||
124935719|NCT01897441|449395147|FG004|Overall Study|Lost to Follow-up|0|||
124935720|NCT01897441|449395148|FG005|Overall Study|Lost to Follow-up|0|||
124935721|NCT01897441|449395143|FG000|Overall Study|Withdrawal by Subject|0|||
124935722|NCT01897441|449395144|FG001|Overall Study|Withdrawal by Subject|0|||
124935723|NCT01897441|449395145|FG002|Overall Study|Withdrawal by Subject|0|||
124935724|NCT01897441|449395146|FG003|Overall Study|Withdrawal by Subject|0|||
124935725|NCT01897441|449395147|FG004|Overall Study|Withdrawal by Subject|1|||
124935726|NCT01897441|449395148|FG005|Overall Study|Withdrawal by Subject|0|||
124935727|NCT01897441|449395143|FG000|Overall Study|Withdrawn by Provider|0|||
124935728|NCT01897441|449395144|FG001|Overall Study|Withdrawn by Provider|2|||
124935729|NCT01897441|449395145|FG002|Overall Study|Withdrawn by Provider|0|||
124935730|NCT01897441|449395146|FG003|Overall Study|Withdrawn by Provider|0|||
124935731|NCT01897441|449395147|FG004|Overall Study|Withdrawn by Provider|0|||
124935732|NCT01897441|449395148|FG005|Overall Study|Withdrawn by Provider|0|||
124935733|NCT04093869|449395158|FG000|Overall Study|Death|0|||
124935734|NCT04093869|449395159|FG001|Overall Study|Death|1|||
124935735|NCT04093869|449395158|FG000|Overall Study|Withdrawal by Subject|1|||
124935736|NCT04093869|449395159|FG001|Overall Study|Withdrawal by Subject|0|||
124935737|NCT02806726|449395164|FG000|Overall Study|Lost to Follow-up|1|||
124935738|NCT05129501|449395165|FG000|Overall Study|Lost to Follow-up|54|||
124935739|NCT05129501|449395166|FG001|Overall Study|Lost to Follow-up|41|||
124935740|NCT04166513|449395167|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
124935741|NCT04166513|449395168|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
124935742|NCT04166513|449395169|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
124935743|NCT04166513|449395170|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
124935744|NCT04166513|449395167|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
124935745|NCT04166513|449395168|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
124935746|NCT04166513|449395169|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
124935747|NCT04166513|449395170|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
124935748|NCT04166513|449395167|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
124935749|NCT04166513|449395168|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
124935750|NCT04166513|449395169|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
124702654|NCT02378480|448535658|FG001|Overall Study|Death|2|||
124702655|NCT02378480|448535657|FG000|Overall Study|Randomized, but Not Treated|6|||
124702656|NCT02378480|448535658|FG001|Overall Study|Randomized, but Not Treated|4|||
124702657|NCT02378480|448535657|FG000|Overall Study|Adverse Event|0|||
124935751|NCT04166513|449395170|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
124935752|NCT04166513|449395167|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
124935753|NCT04166513|449395168|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
124935754|NCT04166513|449395169|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
124935755|NCT04166513|449395170|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
124935756|NCT04166513|449395167|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
124935757|NCT04166513|449395168|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
124935758|NCT04166513|449395169|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
124935759|NCT04166513|449395170|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
124935760|NCT05866926|449395171|FG000|Overall Study|Death|16|||
124935761|NCT05866926|449395172|FG001|Overall Study|Death|9|||
124935762|NCT05866926|449395171|FG000|Overall Study|Lost to Follow-up|0|||
124935763|NCT05866926|449395172|FG001|Overall Study|Lost to Follow-up|1|||
124935764|NCT05866926|449395171|FG000|Overall Study|Adverse Event|1|||
124935765|NCT05866926|449395172|FG001|Overall Study|Adverse Event|0|||
124935766|NCT05866926|449395171|FG000|Overall Study|Withdrawal by Subject|5|||
124935767|NCT05866926|449395172|FG001|Overall Study|Withdrawal by Subject|1|||
124935768|NCT05866926|449395171|FG000|Overall Study|Disease progression|1|||
124935769|NCT05866926|449395172|FG001|Overall Study|Disease progression|0|||
124935770|NCT05866926|449395171|FG000|Overall Study|other causes|2|||
124935771|NCT05866926|449395172|FG001|Overall Study|other causes|1|||
124935772|NCT05267639|449395533|FG000|Overall Study|Withdrawal by Subject|1|||
124935773|NCT05267639|449395534|FG001|Overall Study|Withdrawal by Subject|0|||
124935774|NCT03816397|449395541|FG000|Overall Study|Censored at interim analysis date.|13|||
124935775|NCT03816397|449395542|FG001|Overall Study|Censored at interim analysis date.|6|||
124935776|NCT03816397|449395541|FG000|Overall Study|Withdrawal by Subject|1|||
124935777|NCT03816397|449395542|FG001|Overall Study|Withdrawal by Subject|1|||
124935778|NCT05718687|449395547|FG000|Overall Study|Withdrawal by Subject|3|||
124935779|NCT03493542|449395548|FG000|Base Study|Withdrawal by Subject|0|||
124935780|NCT03493542|449395549|FG001|Base Study|Withdrawal by Subject|4|||
124935781|NCT03493542|449395550|FG002|Base Study|Withdrawal by Subject|0|||
124935782|NCT03493542|449395548|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
124935783|NCT03493542|449395549|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
124935784|NCT03493542|449395550|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
124935785|NCT03493542|449395548|FG000|Extension Study|Withdrawal by Subject|0|||
124935786|NCT03493542|449395549|FG001|Extension Study|Withdrawal by Subject|0|||
124935787|NCT03493542|449395550|FG002|Extension Study|Withdrawal by Subject|25|||
124935788|NCT05485935|449395551|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
124935789|NCT05485935|449395552|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
124935790|NCT05485935|449395551|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
124935791|NCT05485935|449395552|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
124935792|NCT05485935|449395551|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
124935793|NCT05485935|449395552|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
124935794|NCT05485935|449395551|FG000|Period 2 (T2 and V3)|loss of contact|0|||
124935795|NCT05485935|449395552|FG001|Period 2 (T2 and V3)|loss of contact|1|||
124935796|NCT01527188|449395558|FG000|Overall Study|Adverse Event|5|||
124935797|NCT01527188|449395559|FG001|Overall Study|Adverse Event|5|||
124935798|NCT01527188|449395560|FG002|Overall Study|Adverse Event|11|||
124935799|NCT01527188|449395561|FG003|Overall Study|Adverse Event|0|||
124935800|NCT01527188|449395558|FG000|Overall Study|Withdrawal by Subject|3|||
124935801|NCT01527188|449395559|FG001|Overall Study|Withdrawal by Subject|6|||
124935802|NCT01527188|449395560|FG002|Overall Study|Withdrawal by Subject|4|||
124935803|NCT01527188|449395561|FG003|Overall Study|Withdrawal by Subject|4|||
124935804|NCT01527188|449395558|FG000|Overall Study|Any other reason not above-mentioned|6|||
124935805|NCT01527188|449395559|FG001|Overall Study|Any other reason not above-mentioned|7|||
124935806|NCT01527188|449395560|FG002|Overall Study|Any other reason not above-mentioned|8|||
124935807|NCT01527188|449395561|FG003|Overall Study|Any other reason not above-mentioned|8|||
124935808|NCT01265537|449395563|FG000|Overall Study|Adverse Event|2|||
124935809|NCT01265537|449395564|FG001|Overall Study|Adverse Event|1|||
124935810|NCT01265537|449395563|FG000|Overall Study|Physician Decision|0|||
124935811|NCT01265537|449395564|FG001|Overall Study|Physician Decision|1|||
124935812|NCT03782116|449395565|FG000|Completed Intervetion|Lost to Follow-up|11|||
124935813|NCT03782116|449395566|FG001|Completed Intervetion|Lost to Follow-up|7|||
124702658|NCT02378480|448535658|FG001|Overall Study|Adverse Event|1|||
124702659|NCT02378480|448535657|FG000|Overall Study|Missed EOT/PTE Visit|1|||
124935814|NCT03782116|449395565|FG000|Completed Intervetion|Withdrawal by Subject|6|||
124935815|NCT03782116|449395566|FG001|Completed Intervetion|Withdrawal by Subject|5|||
124764937|NCT04664153|448765072|FG000|Overall Study|Physician Decision|0|||
124935816|NCT03782116|449395565|FG000|Included in Analysis|Protocol Violation|5|||
124935817|NCT03782116|449395566|FG001|Included in Analysis|Protocol Violation|5|||
124935818|NCT03512301|449396083|FG000|Overall Study|Protocol Violation|2|||
124935819|NCT03512301|449396083|FG000|Overall Study|Did Not Qualify|3|||
124935820|NCT03512301|449396083|FG000|Overall Study|Age-ineligible|1|||
124935821|NCT03512301|449396083|FG000|Overall Study|Inadequate fluency with the English language|3|||
124935822|NCT00447980|449396084|FG000|Overall Study|Withdrawal by Subject|1|||
124935823|NCT00447980|449396085|FG001|Overall Study|Withdrawal by Subject|1|||
124935824|NCT00447980|449396086|FG002|Overall Study|Withdrawal by Subject|4|||
124935825|NCT00447980|449396087|FG003|Overall Study|Withdrawal by Subject|4|||
124935826|NCT00447980|449396084|FG000|Overall Study|Lost to Follow-up|1|||
124935827|NCT00447980|449396085|FG001|Overall Study|Lost to Follow-up|1|||
124935828|NCT00447980|449396086|FG002|Overall Study|Lost to Follow-up|0|||
124935829|NCT00447980|449396087|FG003|Overall Study|Lost to Follow-up|0|||
124935830|NCT00447980|449396084|FG000|Overall Study|Did not proceed with surgery|3|||
124935831|NCT00447980|449396085|FG001|Overall Study|Did not proceed with surgery|3|||
124935832|NCT00447980|449396086|FG002|Overall Study|Did not proceed with surgery|2|||
124935833|NCT00447980|449396087|FG003|Overall Study|Did not proceed with surgery|2|||
124935834|NCT03635567|449396090|FG000|Overall Study|Lost to Follow-up|4|||
124935835|NCT03635567|449396091|FG001|Overall Study|Lost to Follow-up|1|||
124935836|NCT03635567|449396090|FG000|Overall Study|Withdrawal by Subject|11|||
124935837|NCT03635567|449396091|FG001|Overall Study|Withdrawal by Subject|16|||
124935838|NCT03635567|449396090|FG000|Overall Study|Sponsor Decision|99|||
124935839|NCT03635567|449396091|FG001|Overall Study|Sponsor Decision|57|||
124935840|NCT03635567|449396090|FG000|Overall Study|Death|194|||
124935841|NCT03635567|449396091|FG001|Overall Study|Death|235|||
124935842|NCT05157841|449396092|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
124935843|NCT05157841|449396093|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
124935844|NCT05157841|449396094|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
124935845|NCT05157841|449396092|FG000|Part A (14 Days)|Adverse Event|1|||
124935846|NCT05157841|449396093|FG001|Part A (14 Days)|Adverse Event|0|||
124935847|NCT05157841|449396094|FG002|Part A (14 Days)|Adverse Event|0|||
124935848|NCT05157841|449396092|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
124935849|NCT05157841|449396093|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
124935850|NCT05157841|449396094|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
124935851|NCT04933474|449396097|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
124935852|NCT04933474|449396098|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
124935853|NCT04933474|449396097|FG000|Overall Study|Lost to Follow-up|19|||
124935854|NCT04933474|449396098|FG001|Overall Study|Lost to Follow-up|9|||
124935855|NCT04933474|449396097|FG000|Overall Study|Life Burden - unable to participate|6|||
124935856|NCT04933474|449396098|FG001|Overall Study|Life Burden - unable to participate|2|||
124935857|NCT04933474|449396097|FG000|Overall Study|Disease Burden - unable to participate|4|||
124935858|NCT04933474|449396098|FG001|Overall Study|Disease Burden - unable to participate|1|||
124935859|NCT04933474|449396097|FG000|Overall Study|Surgery/Hospitalization|1|||
124935860|NCT04933474|449396098|FG001|Overall Study|Surgery/Hospitalization|2|||
124935861|NCT04933474|449396097|FG000|Overall Study|Dissatisfied with Intervention|1|||
124935862|NCT04933474|449396098|FG001|Overall Study|Dissatisfied with Intervention|1|||
124935863|NCT04933474|449396097|FG000|Overall Study|Withdrew interest in participation|1|||
124455993|NCT00219284|447628959|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
124455994|NCT00219284|447628958|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
124455995|NCT00219284|447628959|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
124455996|NCT00219284|447628958|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
124455997|NCT00219284|447628959|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
124455998|NCT00219284|447628958|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
124455999|NCT00219284|447628959|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
124456000|NCT00219284|447628958|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
124456001|NCT00219284|447628959|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
124456002|NCT00219284|447628958|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
124456003|NCT00219284|447628959|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
124456004|NCT00219284|447628958|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
124456005|NCT00219284|447628959|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
124456006|NCT00219284|447628958|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
124456007|NCT00219284|447628959|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
124456008|NCT00219284|447628958|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
124456009|NCT00219284|447628959|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
124456010|NCT02321930|447628963|FG000|Overall Study|Lost to Follow-up|1|||
124456011|NCT01293968|447628964|FG000|Overall Study|non-cooperation|3|||
124456012|NCT01293968|447628965|FG001|Overall Study|non-cooperation|3|||
124456013|NCT00853749|447628966|FG000|Overall Study|Lost to Follow-up|0|||
124456014|NCT00853749|447628967|FG001|Overall Study|Lost to Follow-up|1|||
124456015|NCT01392677|447628968|FG000|Overall Study|Adverse Event|3|||
124456016|NCT01392677|447628969|FG001|Overall Study|Adverse Event|1|||
124456017|NCT01392677|447628968|FG000|Overall Study|Withdrawal by Subject|0|||
124456018|NCT01392677|447628969|FG001|Overall Study|Withdrawal by Subject|2|||
124456019|NCT01392677|447628968|FG000|Overall Study|Incorrect enrollment|2|||
124456020|NCT01392677|447628969|FG001|Overall Study|Incorrect enrollment|3|||
124456021|NCT01392677|447628968|FG000|Overall Study|Other reason|3|||
124456022|NCT01392677|447628969|FG001|Overall Study|Other reason|2|||
124456023|NCT04360551|447630294|FG000|Overall Study|Withdrawal by Subject|1|||
124456024|NCT04360551|447630295|FG001|Overall Study|Withdrawal by Subject|0|||
124456025|NCT00388973|447630300|FG000|Overall Study|Adverse Event|16|||
124456026|NCT00388973|447630301|FG001|Overall Study|Adverse Event|6|||
124456027|NCT00388973|447630300|FG000|Overall Study|Lack of Efficacy|1|||
124456028|NCT00388973|447630301|FG001|Overall Study|Lack of Efficacy|12|||
124456029|NCT00388973|447630300|FG000|Overall Study|Protocol Violation|3|||
124456030|NCT00388973|447630301|FG001|Overall Study|Protocol Violation|0|||
124456031|NCT00388973|447630300|FG000|Overall Study|Withdrawal by Subject|14|||
124456032|NCT00388973|447630301|FG001|Overall Study|Withdrawal by Subject|17|||
124456033|NCT00388973|447630300|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
124456034|NCT00388973|447630301|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
124456035|NCT00388973|447630300|FG000|Overall Study|Did not complete 61 days of treatment|5|||
124456036|NCT00388973|447630301|FG001|Overall Study|Did not complete 61 days of treatment|4|||
124456037|NCT00388973|447630300|FG000|Overall Study|Left region|0|||
124456038|NCT00388973|447630301|FG001|Overall Study|Left region|1|||
124456039|NCT00388973|447630300|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
124456040|NCT00388973|447630301|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
124456041|NCT02700412|447630316|FG000|Overall Study|Adverse Event|6|||
124702660|NCT02378480|448535658|FG001|Overall Study|Missed EOT/PTE Visit|2|||
124702661|NCT02378480|448535657|FG000|Overall Study|Withdrawal by Subject|9|||
124702662|NCT02378480|448535658|FG001|Overall Study|Withdrawal by Subject|4|||
124702663|NCT02378480|448535657|FG000|Overall Study|Lost to Follow-up|10|||
124702664|NCT02378480|448535658|FG001|Overall Study|Lost to Follow-up|18|||
124702665|NCT01217892|448535659|FG000|Overall Study|Adverse Event|1|||
124456042|NCT02700412|447630316|FG000|Overall Study|Death|1|||
124456043|NCT02700412|447630316|FG000|Overall Study|Lack of Efficacy|19|||
124456044|NCT02700412|447630316|FG000|Overall Study|Protocol Violation|5|||
124456045|NCT02700412|447630316|FG000|Overall Study|Withdrawal by Subject|2|||
124456046|NCT04416555|447630317|FG000|Overall Study|Withdrawal by Subject|0|||
124702666|NCT01217892|448535660|FG001|Overall Study|Adverse Event|1|||
124702667|NCT01217892|448535661|FG002|Overall Study|Adverse Event|1|||
124456047|NCT04416555|447630318|FG001|Overall Study|Withdrawal by Subject|3|||
124456048|NCT03374189|447630327|FG000|Overall Study|Lost to Follow-up|1|||
124456049|NCT03374189|447630328|FG001|Overall Study|Lost to Follow-up|0|||
124456050|NCT01197521|447630331|FG000|Overall Study|Not reported|24|||
124456051|NCT01197521|447630332|FG001|Overall Study|Not reported|25|||
124702668|NCT01217892|448535662|FG003|Overall Study|Adverse Event|0|||
124702669|NCT01217892|448535659|FG000|Overall Study|Withdrawal by Subject|0|||
124702670|NCT01217892|448535660|FG001|Overall Study|Withdrawal by Subject|2|||
124702671|NCT01217892|448535661|FG002|Overall Study|Withdrawal by Subject|1|||
124702672|NCT01217892|448535662|FG003|Overall Study|Withdrawal by Subject|0|||
124702673|NCT01217892|448535659|FG000|Overall Study|Lab value|1|||
124702674|NCT01217892|448535660|FG001|Overall Study|Lab value|0|||
124702675|NCT01217892|448535661|FG002|Overall Study|Lab value|1|||
124702676|NCT01217892|448535662|FG003|Overall Study|Lab value|0|||
124702677|NCT01217892|448535659|FG000|Overall Study|Subject no longer meets study criteria|5|||
124702678|NCT01217892|448535660|FG001|Overall Study|Subject no longer meets study criteria|2|||
124702679|NCT01217892|448535661|FG002|Overall Study|Subject no longer meets study criteria|4|||
124702680|NCT01217892|448535662|FG003|Overall Study|Subject no longer meets study criteria|8|||
124702681|NCT01217892|448535659|FG000|Overall Study|Incorrect enrollment|0|||
124702682|NCT01217892|448535660|FG001|Overall Study|Incorrect enrollment|1|||
124702683|NCT01217892|448535661|FG002|Overall Study|Incorrect enrollment|1|||
124702684|NCT01217892|448535662|FG003|Overall Study|Incorrect enrollment|0|||
124702685|NCT01217892|448535659|FG000|Overall Study|Poor/Non-Compliance|0|||
124702686|NCT01217892|448535660|FG001|Overall Study|Poor/Non-Compliance|0|||
124702687|NCT01217892|448535661|FG002|Overall Study|Poor/Non-Compliance|1|||
124702688|NCT01217892|448535662|FG003|Overall Study|Poor/Non-Compliance|0|||
124702689|NCT01285102|448535663|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
124702690|NCT01905540|448535664|FG000|Period 3|Other|1|||
124702691|NCT01905540|448535665|FG001|Period 3|Other|0|||
124702692|NCT01905540|448535666|FG002|Period 3|Other|1|||
124702693|NCT01905540|448535667|FG003|Period 3|Other|1|||
124702694|NCT02743962|448535670|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
124702695|NCT02743962|448535671|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
124702696|NCT02327169|448535675|FG000|Overall Study|Progressive Disease|1|||
124702697|NCT02327169|448535676|FG001|Overall Study|Progressive Disease|3|||
124702698|NCT02327169|448535677|FG002|Overall Study|Progressive Disease|4|||
124702699|NCT02327169|448535678|FG003|Overall Study|Progressive Disease|3|||
124702700|NCT02327169|448535679|FG004|Overall Study|Progressive Disease|4|||
124702701|NCT02327169|448535680|FG005|Overall Study|Progressive Disease|3|||
124702702|NCT02327169|448535681|FG006|Overall Study|Progressive Disease|3|||
124702703|NCT02327169|448535682|FG007|Overall Study|Progressive Disease|3|||
124702704|NCT02327169|448535683|FG008|Overall Study|Progressive Disease|4|||
124702705|NCT02327169|448535684|FG009|Overall Study|Progressive Disease|4|||
124702706|NCT02327169|448535685|FG010|Overall Study|Progressive Disease|4|||
124702707|NCT02327169|448535686|FG011|Overall Study|Progressive Disease|3|||
124702708|NCT02327169|448535687|FG012|Overall Study|Progressive Disease|1|||
124702709|NCT02327169|448535688|FG013|Overall Study|Progressive Disease|3|||
124702710|NCT02327169|448535689|FG014|Overall Study|Progressive Disease|3|||
124702711|NCT02327169|448535675|FG000|Overall Study|Adverse Event|2|||
124702712|NCT02327169|448535676|FG001|Overall Study|Adverse Event|0|||
124702713|NCT02327169|448535677|FG002|Overall Study|Adverse Event|1|||
124702714|NCT02327169|448535678|FG003|Overall Study|Adverse Event|0|||
124702715|NCT02327169|448535679|FG004|Overall Study|Adverse Event|1|||
124702716|NCT02327169|448535680|FG005|Overall Study|Adverse Event|0|||
124702717|NCT02327169|448535681|FG006|Overall Study|Adverse Event|0|||
124702718|NCT02327169|448535682|FG007|Overall Study|Adverse Event|0|||
124702719|NCT02327169|448535683|FG008|Overall Study|Adverse Event|0|||
124702720|NCT02327169|448535684|FG009|Overall Study|Adverse Event|2|||
124702721|NCT02327169|448535685|FG010|Overall Study|Adverse Event|0|||
124702722|NCT02327169|448535686|FG011|Overall Study|Adverse Event|3|||
124702723|NCT02327169|448535687|FG012|Overall Study|Adverse Event|0|||
124456052|NCT01197521|447630333|FG002|Overall Study|Not reported|21|||
124456053|NCT01197521|447630331|FG000|Overall Study|Enrolment in long term extension|42|||
124702724|NCT02327169|448535688|FG013|Overall Study|Adverse Event|2|||
124702725|NCT02327169|448535689|FG014|Overall Study|Adverse Event|1|||
124702726|NCT02327169|448535675|FG000|Overall Study|Symptomatic Deterioration|0|||
124456054|NCT01197521|447630332|FG001|Overall Study|Enrolment in long term extension|36|||
124702727|NCT02327169|448535676|FG001|Overall Study|Symptomatic Deterioration|0|||
124702728|NCT02327169|448535677|FG002|Overall Study|Symptomatic Deterioration|1|||
124702729|NCT02327169|448535678|FG003|Overall Study|Symptomatic Deterioration|0|||
124702730|NCT02327169|448535679|FG004|Overall Study|Symptomatic Deterioration|1|||
124702731|NCT02327169|448535680|FG005|Overall Study|Symptomatic Deterioration|1|||
124702732|NCT02327169|448535681|FG006|Overall Study|Symptomatic Deterioration|0|||
124702733|NCT02327169|448535682|FG007|Overall Study|Symptomatic Deterioration|0|||
124702734|NCT02327169|448535683|FG008|Overall Study|Symptomatic Deterioration|2|||
124935864|NCT04933474|449396098|FG001|Overall Study|Withdrew interest in participation|0|||
124456055|NCT01197521|447630333|FG002|Overall Study|Enrolment in long term extension|87|||
124702735|NCT02327169|448535684|FG009|Overall Study|Symptomatic Deterioration|1|||
124702736|NCT02327169|448535685|FG010|Overall Study|Symptomatic Deterioration|0|||
124702737|NCT02327169|448535686|FG011|Overall Study|Symptomatic Deterioration|0|||
124702738|NCT02327169|448535687|FG012|Overall Study|Symptomatic Deterioration|0|||
124702739|NCT02327169|448535688|FG013|Overall Study|Symptomatic Deterioration|2|||
124702740|NCT02327169|448535689|FG014|Overall Study|Symptomatic Deterioration|1|||
124935865|NCT04933474|449396097|FG000|Overall Study|Had previously enrolled in the study|0|||
124935866|NCT04933474|449396098|FG001|Overall Study|Had previously enrolled in the study|1|||
124935867|NCT04174170|449396099|FG000|Placebo Run-in Period|Not Randomized|38|||
124935868|NCT04174170|449396100|FG001|Placebo Run-in Period|Not Randomized|0|||
124935869|NCT04174170|449396101|FG002|Placebo Run-in Period|Not Randomized|0|||
124935870|NCT04174170|449396102|FG003|Placebo Run-in Period|Not Randomized|0|||
124935871|NCT04174170|449396099|FG000|Double Blind Treatment Period|Adverse Event|0|||
124935872|NCT04174170|449396100|FG001|Double Blind Treatment Period|Adverse Event|9|||
124935873|NCT04174170|449396101|FG002|Double Blind Treatment Period|Adverse Event|9|||
124935874|NCT04174170|449396102|FG003|Double Blind Treatment Period|Adverse Event|8|||
124935875|NCT04174170|449396099|FG000|Double Blind Treatment Period|Death|0|||
124935876|NCT04174170|449396100|FG001|Double Blind Treatment Period|Death|1|||
124935877|NCT04174170|449396101|FG002|Double Blind Treatment Period|Death|0|||
124935878|NCT04174170|449396102|FG003|Double Blind Treatment Period|Death|0|||
124935879|NCT04174170|449396099|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
124935880|NCT04174170|449396100|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
124935881|NCT04174170|449396101|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
124935882|NCT04174170|449396102|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
124935883|NCT04174170|449396099|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
124935884|NCT04174170|449396100|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
124935885|NCT04174170|449396101|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
124935886|NCT04174170|449396102|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
124935887|NCT04174170|449396099|FG000|Double Blind Treatment Period|Physician Decision|0|||
124935888|NCT04174170|449396100|FG001|Double Blind Treatment Period|Physician Decision|1|||
124935889|NCT04174170|449396101|FG002|Double Blind Treatment Period|Physician Decision|0|||
124935890|NCT04174170|449396102|FG003|Double Blind Treatment Period|Physician Decision|1|||
124935891|NCT04174170|449396099|FG000|Double Blind Treatment Period|Pregnancy|0|||
124935892|NCT04174170|449396100|FG001|Double Blind Treatment Period|Pregnancy|1|||
124935893|NCT04174170|449396101|FG002|Double Blind Treatment Period|Pregnancy|0|||
124935894|NCT04174170|449396102|FG003|Double Blind Treatment Period|Pregnancy|1|||
124935895|NCT04174170|449396099|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
124935896|NCT04174170|449396100|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
124935897|NCT04174170|449396101|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
124935898|NCT04174170|449396102|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
124935899|NCT04174170|449396099|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
124935900|NCT04174170|449396100|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
124935901|NCT04174170|449396101|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
124935902|NCT04174170|449396102|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
124935903|NCT04174170|449396099|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
124935904|NCT04174170|449396100|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
124935905|NCT04174170|449396101|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
124935906|NCT04174170|449396102|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
124935907|NCT00942734|449396108|FG000|Overall Study|Adverse Event|2|||
124935908|NCT00942734|449396108|FG000|Overall Study|Protocol Violation|3|||
124935909|NCT00942734|449396108|FG000|Overall Study|Disease Progression|2|||
124935910|NCT00942734|449396108|FG000|Overall Study|Physician Decision|1|||
124935911|NCT04908930|449396117|FG000|Overall Study|Lost to Follow-up|1|||
124935912|NCT04908930|449396118|FG001|Overall Study|Lost to Follow-up|1|||
124935913|NCT04908930|449396119|FG002|Overall Study|Lost to Follow-up|0|||
124935914|NCT04908930|449396120|FG003|Overall Study|Lost to Follow-up|0|||
124935915|NCT04908930|449396121|FG004|Overall Study|Lost to Follow-up|0|||
124935916|NCT04908930|449396117|FG000|Overall Study|hardware in mouth|1|||
124935917|NCT04908930|449396118|FG001|Overall Study|hardware in mouth|1|||
124935918|NCT04908930|449396119|FG002|Overall Study|hardware in mouth|0|||
124935919|NCT04908930|449396120|FG003|Overall Study|hardware in mouth|0|||
124935920|NCT04908930|449396121|FG004|Overall Study|hardware in mouth|0|||
124935921|NCT04908930|449396117|FG000|Overall Study|wrong team|1|||
124935922|NCT04908930|449396118|FG001|Overall Study|wrong team|0|||
124935923|NCT04908930|449396119|FG002|Overall Study|wrong team|0|||
124935924|NCT04908930|449396120|FG003|Overall Study|wrong team|0|||
124935925|NCT04908930|449396121|FG004|Overall Study|wrong team|0|||
124935926|NCT04908930|449396117|FG000|Overall Study|quit team|2|||
124935927|NCT04908930|449396118|FG001|Overall Study|quit team|4|||
124935928|NCT04908930|449396119|FG002|Overall Study|quit team|0|||
124702741|NCT02327169|448535675|FG000|Overall Study|Reason Not Specified|0|||
124702742|NCT02327169|448535676|FG001|Overall Study|Reason Not Specified|0|||
124702743|NCT02327169|448535677|FG002|Overall Study|Reason Not Specified|1|||
124702744|NCT02327169|448535678|FG003|Overall Study|Reason Not Specified|0|||
124702745|NCT02327169|448535679|FG004|Overall Study|Reason Not Specified|0|||
124702746|NCT02327169|448535680|FG005|Overall Study|Reason Not Specified|0|||
124702747|NCT02327169|448535681|FG006|Overall Study|Reason Not Specified|0|||
124702748|NCT02327169|448535682|FG007|Overall Study|Reason Not Specified|0|||
124702749|NCT02327169|448535683|FG008|Overall Study|Reason Not Specified|0|||
124702750|NCT02327169|448535684|FG009|Overall Study|Reason Not Specified|1|||
124702751|NCT02327169|448535685|FG010|Overall Study|Reason Not Specified|2|||
124702752|NCT02327169|448535686|FG011|Overall Study|Reason Not Specified|1|||
124702753|NCT02327169|448535687|FG012|Overall Study|Reason Not Specified|0|||
124702754|NCT02327169|448535688|FG013|Overall Study|Reason Not Specified|0|||
124702755|NCT02327169|448535689|FG014|Overall Study|Reason Not Specified|2|||
124764938|NCT04664153|448765073|FG001|Overall Study|Physician Decision|0|||
124764939|NCT04664153|448765074|FG002|Overall Study|Physician Decision|1|||
124935929|NCT04908930|449396120|FG003|Overall Study|quit team|0|||
124935930|NCT04908930|449396121|FG004|Overall Study|quit team|0|||
124935931|NCT04908930|449396117|FG000|Overall Study|Withdrawal by Subject|1|||
124935932|NCT04908930|449396118|FG001|Overall Study|Withdrawal by Subject|2|||
124935933|NCT04908930|449396119|FG002|Overall Study|Withdrawal by Subject|0|||
124935934|NCT04908930|449396120|FG003|Overall Study|Withdrawal by Subject|0|||
124935935|NCT04908930|449396121|FG004|Overall Study|Withdrawal by Subject|0|||
124935936|NCT04908930|449396117|FG000|Overall Study|parent not liking program|0|||
124935937|NCT04908930|449396118|FG001|Overall Study|parent not liking program|1|||
124935938|NCT04908930|449396119|FG002|Overall Study|parent not liking program|0|||
124935939|NCT04908930|449396120|FG003|Overall Study|parent not liking program|0|||
124935940|NCT04908930|449396121|FG004|Overall Study|parent not liking program|0|||
124935941|NCT04586244|449396122|FG000|Overall Study|Lost to Follow-up|1|||
124935942|NCT04586244|449396123|FG001|Overall Study|Lost to Follow-up|0|||
124935943|NCT04586244|449396124|FG002|Overall Study|Lost to Follow-up|0|||
124935944|NCT04586244|449396125|FG003|Overall Study|Lost to Follow-up|1|||
124935945|NCT04586244|449396126|FG004|Overall Study|Lost to Follow-up|0|||
124935946|NCT04586244|449396122|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
124935947|NCT04586244|449396123|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
124935948|NCT04586244|449396124|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
124935949|NCT04586244|449396125|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
124935950|NCT04586244|449396126|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
124935951|NCT05771467|449396128|FG000|Overall Study|Lost to Follow-up|6|||
124935952|NCT05771467|449396129|FG001|Overall Study|Lost to Follow-up|3|||
124935953|NCT01220531|449396132|FG000|Overall Study|Death|7|||
124935954|NCT01220531|449396132|FG000|Overall Study|Lost to Follow-up|1|||
124935955|NCT04873232|449396133|FG000|Overall Study|Lost to Follow-up|1|||
124935956|NCT04873232|449396134|FG001|Overall Study|Lost to Follow-up|4|||
124935957|NCT04873232|449396133|FG000|Overall Study|Withdrawal by Subject|1|||
124935958|NCT04873232|449396134|FG001|Overall Study|Withdrawal by Subject|0|||
124935959|NCT02325154|449396137|FG000|Overall Study|Physician Decision|1|||
124935960|NCT00709956|449396138|FG000|Overall Study|Withdrawal by Subject|1|||
124935961|NCT00709956|449396139|FG001|Overall Study|Withdrawal by Subject|1|||
124935962|NCT00709956|449396138|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
124935963|NCT00709956|449396139|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
124935964|NCT03008382|449396140|FG000|Overall Study|Withdrawal by Subject|2|||
124935965|NCT03008382|449396141|FG001|Overall Study|Withdrawal by Subject|5|||
124935966|NCT03008382|449396142|FG002|Overall Study|Withdrawal by Subject|2|||
124935967|NCT03008382|449396143|FG003|Overall Study|Withdrawal by Subject|0|||
124702756|NCT02327169|448535675|FG000|Overall Study|Withdrawal by Subject|1|||
124702757|NCT02327169|448535676|FG001|Overall Study|Withdrawal by Subject|0|||
124702758|NCT02327169|448535677|FG002|Overall Study|Withdrawal by Subject|0|||
124702759|NCT02327169|448535678|FG003|Overall Study|Withdrawal by Subject|0|||
124702760|NCT02327169|448535679|FG004|Overall Study|Withdrawal by Subject|1|||
124702761|NCT02327169|448535680|FG005|Overall Study|Withdrawal by Subject|0|||
124935968|NCT03008382|449396140|FG000|Overall Study|Protocol Violation|1|||
124935969|NCT03008382|449396141|FG001|Overall Study|Protocol Violation|0|||
124935970|NCT03008382|449396142|FG002|Overall Study|Protocol Violation|0|||
124935971|NCT03008382|449396143|FG003|Overall Study|Protocol Violation|0|||
124935972|NCT03008382|449396140|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
124935973|NCT03008382|449396141|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
124935974|NCT03008382|449396142|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
124702762|NCT02327169|448535681|FG006|Overall Study|Withdrawal by Subject|0|||
124764940|NCT04664153|448765075|FG003|Overall Study|Physician Decision|0|||
124935975|NCT03008382|449396143|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
124702763|NCT02327169|448535682|FG007|Overall Study|Withdrawal by Subject|1|||
124702764|NCT02327169|448535683|FG008|Overall Study|Withdrawal by Subject|0|||
124702765|NCT02327169|448535684|FG009|Overall Study|Withdrawal by Subject|0|||
124702766|NCT02327169|448535685|FG010|Overall Study|Withdrawal by Subject|0|||
124702767|NCT02327169|448535686|FG011|Overall Study|Withdrawal by Subject|0|||
124702768|NCT02327169|448535687|FG012|Overall Study|Withdrawal by Subject|0|||
124702769|NCT02327169|448535688|FG013|Overall Study|Withdrawal by Subject|0|||
124702770|NCT02327169|448535689|FG014|Overall Study|Withdrawal by Subject|3|||
124702771|NCT02327169|448535675|FG000|Overall Study|Lost to Follow-up|0|||
124702772|NCT02327169|448535676|FG001|Overall Study|Lost to Follow-up|0|||
124702773|NCT02327169|448535677|FG002|Overall Study|Lost to Follow-up|0|||
124702774|NCT02327169|448535678|FG003|Overall Study|Lost to Follow-up|0|||
124702775|NCT02327169|448535679|FG004|Overall Study|Lost to Follow-up|1|||
124702776|NCT02327169|448535680|FG005|Overall Study|Lost to Follow-up|0|||
124702777|NCT02327169|448535681|FG006|Overall Study|Lost to Follow-up|0|||
124702778|NCT02327169|448535682|FG007|Overall Study|Lost to Follow-up|0|||
124702779|NCT02327169|448535683|FG008|Overall Study|Lost to Follow-up|0|||
124702780|NCT02327169|448535684|FG009|Overall Study|Lost to Follow-up|0|||
124702781|NCT02327169|448535685|FG010|Overall Study|Lost to Follow-up|0|||
124702782|NCT02327169|448535686|FG011|Overall Study|Lost to Follow-up|0|||
124702783|NCT02327169|448535687|FG012|Overall Study|Lost to Follow-up|0|||
124702784|NCT02327169|448535688|FG013|Overall Study|Lost to Follow-up|0|||
124702785|NCT02327169|448535689|FG014|Overall Study|Lost to Follow-up|0|||
124702786|NCT00478257|448535690|FG000|Overall Study|Withdrawal by Subject|8|||
124702787|NCT00478257|448535691|FG001|Overall Study|Withdrawal by Subject|3|||
124702788|NCT01381679|448535697|FG000|Overall Study|Adverse Event|3|||
124702789|NCT01381679|448535697|FG000|Overall Study|Lost to Follow-up|885|||
124702790|NCT04023487|448535698|FG000|Overall Study|Lost to Follow-up|5|||
124702791|NCT04023487|448535699|FG001|Overall Study|Lost to Follow-up|4|||
124702792|NCT04023487|448535698|FG000|Overall Study|Pregnancy|1|||
124702793|NCT04023487|448535699|FG001|Overall Study|Pregnancy|2|||
124702794|NCT04023487|448535698|FG000|Overall Study|Withdrawal by Subject|4|||
124702795|NCT04023487|448535699|FG001|Overall Study|Withdrawal by Subject|5|||
124702796|NCT04023487|448535698|FG000|Overall Study|Partially completed testing|8|||
124702797|NCT04023487|448535699|FG001|Overall Study|Partially completed testing|4|||
124702798|NCT02014376|448535702|FG000|Overall Study|Adverse Event|1|||
124935976|NCT03008382|449396140|FG000|Overall Study|Lost to Follow-up|0|||
124935977|NCT03008382|449396141|FG001|Overall Study|Lost to Follow-up|0|||
124935978|NCT03008382|449396142|FG002|Overall Study|Lost to Follow-up|1|||
124935979|NCT03008382|449396143|FG003|Overall Study|Lost to Follow-up|0|||
124935980|NCT03008382|449396140|FG000|Overall Study|Screenfail|0|||
124935981|NCT03008382|449396141|FG001|Overall Study|Screenfail|0|||
124935982|NCT03008382|449396142|FG002|Overall Study|Screenfail|2|||
124935983|NCT03008382|449396143|FG003|Overall Study|Screenfail|0|||
124935984|NCT02611687|449396799|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
124935985|NCT02611687|449396800|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
124935986|NCT03983382|449396804|FG000|Overall Study|Death|1|||
124935987|NCT03983382|449396804|FG000|Overall Study|Lost to Follow-up|3|||
124935988|NCT03983382|449396804|FG000|Overall Study|Physician Decision|2|||
124935989|NCT03983382|449396804|FG000|Overall Study|Withdrawal by Subject|10|||
124935990|NCT03983382|449396804|FG000|Overall Study|Change in cancer treatment|2|||
124935991|NCT04165213|449396805|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
124935992|NCT04165213|449396806|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
124935993|NCT04165213|449396805|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
124935994|NCT04165213|449396806|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
124935995|NCT04165213|449396805|FG000|Clinician Enrollment|Termination from site|0|||
124935996|NCT04165213|449396806|FG001|Clinician Enrollment|Termination from site|1|||
124935997|NCT04165213|449396805|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
124935998|NCT04165213|449396806|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
124702799|NCT02014376|448535703|FG001|Overall Study|Adverse Event|1|||
124702800|NCT02014376|448535704|FG002|Overall Study|Adverse Event|0|||
124702801|NCT02014376|448535702|FG000|Overall Study|Lost to Follow-up|2|||
124702802|NCT02014376|448535703|FG001|Overall Study|Lost to Follow-up|0|||
124702803|NCT02014376|448535704|FG002|Overall Study|Lost to Follow-up|0|||
124702804|NCT00759395|448535710|FG000|Overall Study|Adverse Event|1|||
124702805|NCT00759395|448535711|FG001|Overall Study|Adverse Event|0|||
124702806|NCT00759395|448535710|FG000|Overall Study|Withdrawal by Subject|1|||
124702807|NCT00759395|448535711|FG001|Overall Study|Withdrawal by Subject|0|||
124935999|NCT04165213|449396805|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
124702808|NCT00759395|448535710|FG000|Overall Study|Lack of Efficacy|0|||
124702809|NCT00759395|448535711|FG001|Overall Study|Lack of Efficacy|2|||
124702810|NCT04875533|448535712|FG000|Overall Study|Adverse Event|6|||
124702811|NCT04875533|448535713|FG001|Overall Study|Adverse Event|4|||
124702812|NCT04875533|448535712|FG000|Overall Study|Protocol Violation|4|||
124702813|NCT04875533|448535713|FG001|Overall Study|Protocol Violation|0|||
124702814|NCT04875533|448535712|FG000|Overall Study|Withdrawal by Subject|8|||
124936000|NCT04165213|449396806|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
124936001|NCT04165213|449396805|FG000|Caregiver Enrollment|Physician Decision|1|||
124936002|NCT04165213|449396806|FG001|Caregiver Enrollment|Physician Decision|0|||
124936003|NCT04165213|449396805|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
124936004|NCT04165213|449396806|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
124936005|NCT04165213|449396805|FG000|Caregiver Enrollment|PLWD death|2|||
124936006|NCT04165213|449396806|FG001|Caregiver Enrollment|PLWD death|0|||
124936007|NCT04165213|449396805|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
124936008|NCT04165213|449396806|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
124456056|NCT01197521|447630331|FG000|Overall Study|Severe non-compliance to protocol|1|||
124936009|NCT04165213|449396805|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
124936010|NCT04165213|449396806|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
124936011|NCT04165213|449396805|FG000|PLWD Enrollment|Lost to Follow-up|1|||
124936012|NCT04165213|449396806|FG001|PLWD Enrollment|Lost to Follow-up|1|||
124936013|NCT04165213|449396805|FG000|PLWD Enrollment|Physician Decision|1|||
124936014|NCT04165213|449396806|FG001|PLWD Enrollment|Physician Decision|0|||
124936015|NCT04165213|449396805|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
124936016|NCT04165213|449396806|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
124936017|NCT04165213|449396805|FG000|PLWD Enrollment|Death|2|||
124936018|NCT04165213|449396806|FG001|PLWD Enrollment|Death|0|||
124936019|NCT04165213|449396805|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
124936020|NCT04165213|449396806|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
124936021|NCT04772534|449396813|FG000|Overall Study|Physician Decision|1|||
124936022|NCT04772534|449396814|FG001|Overall Study|Physician Decision|0|||
124936023|NCT04772534|449396815|FG002|Overall Study|Physician Decision|0|||
124936024|NCT04772534|449396813|FG000|Overall Study|Withdrawal by Subject|3|||
124936025|NCT04772534|449396814|FG001|Overall Study|Withdrawal by Subject|0|||
124936026|NCT04772534|449396815|FG002|Overall Study|Withdrawal by Subject|1|||
124936027|NCT04194450|449396816|FG000|Overall Study|not eligible|1|||
124936028|NCT04194450|449396817|FG001|Overall Study|not eligible|0|||
124936029|NCT03242915|449396836|FG000|Overall Study|Adverse Event|5|||
124936030|NCT03242915|449396837|FG001|Overall Study|Adverse Event|1|||
124936031|NCT03242915|449396836|FG000|Overall Study|Withdrawal by Subject|0|||
124936032|NCT03242915|449396837|FG001|Overall Study|Withdrawal by Subject|2|||
124936033|NCT03242915|449396836|FG000|Overall Study|Physician Decision|4|||
124936034|NCT03242915|449396837|FG001|Overall Study|Physician Decision|1|||
124936035|NCT05988398|449396838|FG000|Overall Study|Lack of time|21|||
124936036|NCT05988398|449396839|FG001|Overall Study|Lack of time|0|||
124936037|NCT05988398|449396838|FG000|Overall Study|Absent from school|0|||
124936038|NCT05988398|449396839|FG001|Overall Study|Absent from school|38|||
124936039|NCT05988398|449396838|FG000|Overall Study|Chose not to participate|0|||
124936040|NCT05988398|449396839|FG001|Overall Study|Chose not to participate|42|||
124936041|NCT05988398|449396838|FG000|Overall Study|Other commitments (e.g., sports)|0|||
124936042|NCT05988398|449396839|FG001|Overall Study|Other commitments (e.g., sports)|25|||
124936043|NCT03872466|449396852|FG000|Overall Study|Withdrawal by Subject|1|||
124936044|NCT03872466|449396853|FG001|Overall Study|Withdrawal by Subject|0|||
124936045|NCT03872466|449396852|FG000|Overall Study|Physician Decision|2|||
124936046|NCT03872466|449396853|FG001|Overall Study|Physician Decision|0|||
124936047|NCT01778686|449396854|FG000|Overall Study|Adverse Event|0|||
124456057|NCT01197521|447630332|FG001|Overall Study|Severe non-compliance to protocol|3|||
124456058|NCT01197521|447630333|FG002|Overall Study|Severe non-compliance to protocol|3|||
124456059|NCT01197521|447630331|FG000|Overall Study|Lack of therapeutic response|2|||
124456060|NCT01197521|447630332|FG001|Overall Study|Lack of therapeutic response|3|||
124456061|NCT01197521|447630333|FG002|Overall Study|Lack of therapeutic response|4|||
124456062|NCT01197521|447630331|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
124456063|NCT01197521|447630332|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
124456064|NCT01197521|447630333|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
124456065|NCT01197521|447630331|FG000|Overall Study|Lost to Follow-up|3|||
124936048|NCT01778686|449396855|FG001|Overall Study|Adverse Event|0|||
124936049|NCT01778686|449396856|FG002|Overall Study|Adverse Event|1|||
124936050|NCT01499368|449396857|FG000|Overall Study|Did not meet I/E criteria|8|||
124936051|NCT01499368|449396858|FG001|Overall Study|Did not meet I/E criteria|4|||
124936052|NCT01499368|449396859|FG002|Overall Study|Did not meet I/E criteria|4|||
124936053|NCT01499368|449396857|FG000|Overall Study|Prohibited Concomitant medication|1|||
124936054|NCT01499368|449396858|FG001|Overall Study|Prohibited Concomitant medication|1|||
124936055|NCT01499368|449396859|FG002|Overall Study|Prohibited Concomitant medication|0|||
124456066|NCT01197521|447630332|FG001|Overall Study|Lost to Follow-up|2|||
124456067|NCT01197521|447630333|FG002|Overall Study|Lost to Follow-up|2|||
124456068|NCT01197521|447630331|FG000|Overall Study|Adverse Event|25|||
124456069|NCT01197521|447630332|FG001|Overall Study|Adverse Event|28|||
124456070|NCT01197521|447630333|FG002|Overall Study|Adverse Event|24|||
124456071|NCT00552175|447630334|FG000|Overall Study|Lack of Efficacy|2|||
124456072|NCT00552175|447630335|FG001|Overall Study|Lack of Efficacy|0|||
124456073|NCT00552175|447630336|FG002|Overall Study|Lack of Efficacy|1|||
124456074|NCT00552175|447630334|FG000|Overall Study|Adverse Event|9|||
124546484|NCT00320801|447955919|FG003|Open-label Run-in Period|Adverse Event|0|||
124702815|NCT04875533|448535713|FG001|Overall Study|Withdrawal by Subject|5|||
124702816|NCT04875533|448535712|FG000|Overall Study|No longer meets eligibility criteria|1|||
124936056|NCT01499368|449396857|FG000|Overall Study|Withdrawal by Subject|11|||
124936057|NCT01499368|449396858|FG001|Overall Study|Withdrawal by Subject|10|||
124936058|NCT01499368|449396859|FG002|Overall Study|Withdrawal by Subject|8|||
124936059|NCT01499368|449396857|FG000|Overall Study|Lost to Follow-up|3|||
124936060|NCT01499368|449396858|FG001|Overall Study|Lost to Follow-up|2|||
124936061|NCT01499368|449396859|FG002|Overall Study|Lost to Follow-up|5|||
124936062|NCT01499368|449396857|FG000|Overall Study|Adverse Event|4|||
124936063|NCT01499368|449396858|FG001|Overall Study|Adverse Event|0|||
124936064|NCT01499368|449396859|FG002|Overall Study|Adverse Event|2|||
124936065|NCT01499368|449396857|FG000|Overall Study|Physician Decision|0|||
124936066|NCT01499368|449396858|FG001|Overall Study|Physician Decision|1|||
124936067|NCT01499368|449396859|FG002|Overall Study|Physician Decision|0|||
124936068|NCT01499368|449396857|FG000|Overall Study|Deviation from visit window|0|||
124936069|NCT01499368|449396858|FG001|Overall Study|Deviation from visit window|0|||
124936070|NCT01499368|449396859|FG002|Overall Study|Deviation from visit window|1|||
124936071|NCT01499368|449396857|FG000|Overall Study|Error of Prescriptions|0|||
124936072|NCT01499368|449396858|FG001|Overall Study|Error of Prescriptions|0|||
124936073|NCT01499368|449396859|FG002|Overall Study|Error of Prescriptions|1|||
124936074|NCT06059443|449396860|FG000|Overall Study|Withdrawal by Subject|2|||
124936075|NCT06059443|449396861|FG001|Overall Study|Withdrawal by Subject|0|||
124936076|NCT06059443|449396860|FG000|Overall Study|Lost to Follow-up|2|||
124936077|NCT06059443|449396861|FG001|Overall Study|Lost to Follow-up|2|||
124936078|NCT03092674|449396862|FG000|Overall Study|Adverse Event or Side Effects|1|||
124936079|NCT03092674|449396863|FG001|Overall Study|Adverse Event or Side Effects|4|||
124936080|NCT03092674|449396864|FG002|Overall Study|Adverse Event or Side Effects|4|||
124936081|NCT03092674|449396862|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
124936082|NCT03092674|449396863|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
124936083|NCT03092674|449396864|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
124936084|NCT03092674|449396862|FG000|Overall Study|Progression/Relapse|5|||
124936085|NCT03092674|449396863|FG001|Overall Study|Progression/Relapse|4|||
124936086|NCT03092674|449396864|FG002|Overall Study|Progression/Relapse|8|||
124936087|NCT03092674|449396862|FG000|Overall Study|Death|4|||
124936088|NCT03092674|449396863|FG001|Overall Study|Death|8|||
124936089|NCT03092674|449396864|FG002|Overall Study|Death|2|||
124936090|NCT03092674|449396862|FG000|Overall Study|Other - Not Protocol Specified|11|||
124936091|NCT03092674|449396863|FG001|Overall Study|Other - Not Protocol Specified|8|||
124936092|NCT03092674|449396864|FG002|Overall Study|Other - Not Protocol Specified|8|||
124936093|NCT01105091|449396865|FG000|Overall Study|Death|2|||
124936094|NCT01105091|449396866|FG001|Overall Study|Death|0|||
124936095|NCT03934931|449397341|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
124936096|NCT03934931|449397342|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
124936097|NCT03934931|449397343|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
124936098|NCT04227899|449397345|FG000|Overall Study|Withdrawal by Subject|6|||
124936099|NCT04227899|449397346|FG001|Overall Study|Withdrawal by Subject|3|||
124936100|NCT04227899|449397345|FG000|Overall Study|Death|12|||
124936101|NCT04227899|449397346|FG001|Overall Study|Death|6|||
124936102|NCT04227899|449397345|FG000|Overall Study|Lost to Follow-up|2|||
124936103|NCT04227899|449397346|FG001|Overall Study|Lost to Follow-up|1|||
124936104|NCT02989662|449397349|FG000|Overall Study|Lost to Follow-up|0|||
124936105|NCT02989662|449397350|FG001|Overall Study|Lost to Follow-up|0|||
124936106|NCT02989662|449397351|FG002|Overall Study|Lost to Follow-up|0|||
124936107|NCT02989662|449397352|FG003|Overall Study|Lost to Follow-up|2|||
124936108|NCT02989662|449397349|FG000|Overall Study|Physician Decision|3|||
124936109|NCT02989662|449397350|FG001|Overall Study|Physician Decision|0|||
124936110|NCT02989662|449397351|FG002|Overall Study|Physician Decision|0|||
124936111|NCT02989662|449397352|FG003|Overall Study|Physician Decision|0|||
124936112|NCT02989662|449397349|FG000|Overall Study|Withdrawal by Subject|1|||
124936113|NCT02989662|449397350|FG001|Overall Study|Withdrawal by Subject|0|||
124936114|NCT02989662|449397351|FG002|Overall Study|Withdrawal by Subject|0|||
124936115|NCT02989662|449397352|FG003|Overall Study|Withdrawal by Subject|0|||
124936116|NCT00328783|449397353|FG000|Overall Study|Could not tolerate ABC|21|||
124702817|NCT04875533|448535713|FG001|Overall Study|No longer meets eligibility criteria|0|||
124702818|NCT04875533|448535712|FG000|Overall Study|Other|0|||
124702819|NCT04875533|448535713|FG001|Overall Study|Other|2|||
124702820|NCT02657343|448535717|FG000|Overall Study|Death|0|||
124936117|NCT00328783|449397353|FG000|Overall Study|No heart in RT field|4|||
124936118|NCT00328783|449397353|FG000|Overall Study|Withdrawal by Subject|1|||
124936119|NCT00357682|449397354|FG000|Overall Study|Did not receive allocated Treatment|10|||
124936120|NCT00357682|449397355|FG001|Overall Study|Did not receive allocated Treatment|9|||
124936121|NCT00357682|449397356|FG002|Overall Study|Did not receive allocated Treatment|9|||
124936122|NCT00357682|449397357|FG003|Overall Study|Did not receive allocated Treatment|10|||
124936123|NCT00357682|449397354|FG000|Overall Study|Withdrew consent|6|||
124936124|NCT00357682|449397355|FG001|Overall Study|Withdrew consent|6|||
124702821|NCT02657343|448535718|FG001|Overall Study|Death|2|||
124702822|NCT02657343|448535719|FG002|Overall Study|Death|0|||
124936125|NCT00357682|449397356|FG002|Overall Study|Withdrew consent|5|||
124936126|NCT00357682|449397357|FG003|Overall Study|Withdrew consent|5|||
124936127|NCT00357682|449397354|FG000|Overall Study|Lost to Follow-up|39|||
124936128|NCT00357682|449397355|FG001|Overall Study|Lost to Follow-up|33|||
124936129|NCT00357682|449397356|FG002|Overall Study|Lost to Follow-up|26|||
124936130|NCT00357682|449397357|FG003|Overall Study|Lost to Follow-up|35|||
124936131|NCT00357682|449397354|FG000|Overall Study|Adverse Event|24|||
124936132|NCT00357682|449397355|FG001|Overall Study|Adverse Event|32|||
124936133|NCT00357682|449397356|FG002|Overall Study|Adverse Event|22|||
124936134|NCT00357682|449397357|FG003|Overall Study|Adverse Event|27|||
124936135|NCT00357682|449397354|FG000|Overall Study|Physician Decision|32|||
124936136|NCT00357682|449397355|FG001|Overall Study|Physician Decision|20|||
124936137|NCT00357682|449397356|FG002|Overall Study|Physician Decision|24|||
124936138|NCT00357682|449397357|FG003|Overall Study|Physician Decision|30|||
124936139|NCT00357682|449397354|FG000|Overall Study|Patient decision|73|||
124936140|NCT00357682|449397355|FG001|Overall Study|Patient decision|80|||
124936141|NCT00357682|449397356|FG002|Overall Study|Patient decision|51|||
124936142|NCT00357682|449397357|FG003|Overall Study|Patient decision|59|||
124936143|NCT00357682|449397354|FG000|Overall Study|Other reason|157|||
124936144|NCT00357682|449397355|FG001|Overall Study|Other reason|130|||
124936145|NCT00357682|449397356|FG002|Overall Study|Other reason|114|||
124936146|NCT00357682|449397357|FG003|Overall Study|Other reason|99|||
124936147|NCT04408755|449397361|FG000|Period A (Placebo lead-in)|Other|11|||
124936148|NCT04408755|449397362|FG001|Period A (Placebo lead-in)|Other|0|||
124936149|NCT04408755|449397363|FG002|Period A (Placebo lead-in)|Other|0|||
124936150|NCT04408755|449397364|FG003|Period A (Placebo lead-in)|Other|0|||
124936151|NCT04408755|449397361|FG000|Period B (Randomization Period)|Adverse Event|0|||
124936152|NCT04408755|449397362|FG001|Period B (Randomization Period)|Adverse Event|3|||
124936153|NCT04408755|449397363|FG002|Period B (Randomization Period)|Adverse Event|0|||
124936154|NCT04408755|449397364|FG003|Period B (Randomization Period)|Adverse Event|1|||
124936155|NCT04408755|449397361|FG000|Period B (Randomization Period)|Death|0|||
124936156|NCT04408755|449397362|FG001|Period B (Randomization Period)|Death|0|||
124936157|NCT04408755|449397363|FG002|Period B (Randomization Period)|Death|1|||
124936158|NCT04408755|449397364|FG003|Period B (Randomization Period)|Death|0|||
124936159|NCT04408755|449397361|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
124936160|NCT04408755|449397362|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
124936161|NCT04408755|449397363|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
124936162|NCT04408755|449397364|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
124936163|NCT04408755|449397361|FG000|Period B (Randomization Period)|Physician Decision|0|||
124702823|NCT02657343|448535720|FG003|Overall Study|Death|0|||
124702824|NCT02657343|448535721|FG004|Overall Study|Death|0|||
124702825|NCT02657343|448535722|FG005|Overall Study|Death|0|||
124702826|NCT02657343|448535717|FG000|Overall Study|Patient went to hospice|1|||
124936164|NCT04408755|449397362|FG001|Period B (Randomization Period)|Physician Decision|0|||
124936165|NCT04408755|449397363|FG002|Period B (Randomization Period)|Physician Decision|1|||
124936166|NCT04408755|449397364|FG003|Period B (Randomization Period)|Physician Decision|0|||
124702827|NCT02657343|448535718|FG001|Overall Study|Patient went to hospice|0|||
124936167|NCT04408755|449397361|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
124764941|NCT04664153|448765072|FG000|Overall Study|Withdrawal by Subject|3|||
124764942|NCT04664153|448765073|FG001|Overall Study|Withdrawal by Subject|2|||
124764943|NCT04664153|448765074|FG002|Overall Study|Withdrawal by Subject|1|||
124764944|NCT04664153|448765075|FG003|Overall Study|Withdrawal by Subject|2|||
124764945|NCT04664153|448765072|FG000|Overall Study|Other|0|||
124764946|NCT04664153|448765073|FG001|Overall Study|Other|1|||
124764947|NCT04664153|448765074|FG002|Overall Study|Other|0|||
124764948|NCT04664153|448765075|FG003|Overall Study|Other|0|||
124936168|NCT04408755|449397362|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
124936169|NCT04408755|449397363|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
124936170|NCT04408755|449397364|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
124936171|NCT04408755|449397361|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
124936172|NCT04408755|449397362|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
124936173|NCT04408755|449397363|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
124936174|NCT04408755|449397364|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
124936175|NCT04408755|449397361|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
124936176|NCT04408755|449397362|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
124936177|NCT04408755|449397363|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
124936178|NCT04408755|449397364|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
124936179|NCT04408755|449397361|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
124936180|NCT04408755|449397362|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
124936181|NCT04408755|449397363|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
124936182|NCT04408755|449397364|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
124936183|NCT04408755|449397361|FG000|Period B (Randomization Period)|Reason not Specified|0|||
124936184|NCT04408755|449397362|FG001|Period B (Randomization Period)|Reason not Specified|1|||
124936185|NCT04408755|449397363|FG002|Period B (Randomization Period)|Reason not Specified|0|||
124936186|NCT04408755|449397364|FG003|Period B (Randomization Period)|Reason not Specified|2|||
124936187|NCT02726386|449397365|FG000|Overall Study|Adverse Event|17|||
124936188|NCT02726386|449397366|FG001|Overall Study|Adverse Event|20|||
124936189|NCT02726386|449397365|FG000|Overall Study|Withdrawal by Subject|14|||
124936190|NCT02726386|449397366|FG001|Overall Study|Withdrawal by Subject|28|||
124936191|NCT02726386|449397365|FG000|Overall Study|Other reasons|7|||
124936192|NCT02726386|449397366|FG001|Overall Study|Other reasons|8|||
124936193|NCT00308997|449397367|FG000|Overall Study|Subject feigned clinical data|0|||
124936194|NCT00308997|449397368|FG001|Overall Study|Subject feigned clinical data|1|||
124936195|NCT00308997|449397367|FG000|Overall Study|Unable to tolerate intervention|1|||
124936196|NCT00308997|449397368|FG001|Overall Study|Unable to tolerate intervention|0|||
124936197|NCT04490356|449397371|FG000|Overall Study|Lost to Follow-up|1|||
124936198|NCT03733626|449397372|FG000|Overall Study|Physician Decision|4|||
124936199|NCT03733626|449397373|FG001|Overall Study|Physician Decision|4|||
124936200|NCT05424718|449397376|FG000|Overall Study|Lost to Follow-up|5|||
124936201|NCT05424718|449397377|FG001|Overall Study|Lost to Follow-up|4|||
124936202|NCT03142009|449397378|FG000|Overall Study|Lost to Follow-up|45|||
124936203|NCT03142009|449397379|FG001|Overall Study|Lost to Follow-up|30|||
124936204|NCT01553149|449397382|FG000|Overall Study|Adverse Event|0|||
124936205|NCT01553149|449397383|FG001|Overall Study|Adverse Event|9|||
124936206|NCT01553149|449397382|FG000|Overall Study|Physician Decision|5|||
124936207|NCT01553149|449397383|FG001|Overall Study|Physician Decision|10|||
124936208|NCT01553149|449397382|FG000|Overall Study|Ineligible|0|||
124936209|NCT01553149|449397383|FG001|Overall Study|Ineligible|1|||
124936210|NCT03215706|449397389|FG000|Randomization|Adverse Event unrelated to study drug|1|||
124936211|NCT03215706|449397390|FG001|Randomization|Adverse Event unrelated to study drug|0|||
124936212|NCT03215706|449397389|FG000|Randomization|participant withdrew consent|1|||
124936213|NCT03215706|449397390|FG001|Randomization|participant withdrew consent|3|||
124936214|NCT03215706|449397389|FG000|Randomization|no longer meets study criteria|1|||
124936215|NCT03215706|449397390|FG001|Randomization|no longer meets study criteria|4|||
124936216|NCT03215706|449397389|FG000|Randomization|other reasons|0|||
124936217|NCT03215706|449397390|FG001|Randomization|other reasons|2|||
124936218|NCT03215706|449397389|FG000|Treatment Period|Disease Progression|150|||
124936219|NCT03215706|449397390|FG001|Treatment Period|Disease Progression|142|||
124936220|NCT03215706|449397389|FG000|Treatment Period|Study Drug Toxicity|53|||
124936221|NCT03215706|449397390|FG001|Treatment Period|Study Drug Toxicity|21|||
124936222|NCT03215706|449397389|FG000|Treatment Period|Death|2|||
124936223|NCT03215706|449397390|FG001|Treatment Period|Death|1|||
124936224|NCT03215706|449397389|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
124456075|NCT00552175|447630335|FG001|Overall Study|Adverse Event|9|||
124936225|NCT03215706|449397390|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
124936226|NCT03215706|449397389|FG000|Treatment Period|Request to D/C treatment|1|||
124936227|NCT03215706|449397390|FG001|Treatment Period|Request to D/C treatment|6|||
124936228|NCT03215706|449397389|FG000|Treatment Period|Participant withdrew consent|3|||
124764949|NCT04664153|448765072|FG000|Overall Study|Adverse Event|4|||
124456076|NCT00552175|447630336|FG002|Overall Study|Adverse Event|10|||
124702828|NCT02657343|448535719|FG002|Overall Study|Patient went to hospice|0|||
124702829|NCT02657343|448535720|FG003|Overall Study|Patient went to hospice|0|||
124702830|NCT02657343|448535721|FG004|Overall Study|Patient went to hospice|0|||
124936229|NCT03215706|449397390|FG001|Treatment Period|Participant withdrew consent|4|||
124936230|NCT03215706|449397389|FG000|Treatment Period|Lost to Follow-up|0|||
124936231|NCT03215706|449397390|FG001|Treatment Period|Lost to Follow-up|1|||
124936232|NCT03215706|449397389|FG000|Treatment Period|Other Reasons|4|||
124936233|NCT03215706|449397390|FG001|Treatment Period|Other Reasons|5|||
124936234|NCT03215706|449397389|FG000|Treatment Period|Ongoing in the treatment period|105|||
124936235|NCT03215706|449397390|FG001|Treatment Period|Ongoing in the treatment period|43|||
124936236|NCT00945724|449397391|FG000|Overall Study|Withdrawal by Subject|2|||
124936237|NCT00945724|449397391|FG000|Overall Study|Physician Decision|1|||
124936238|NCT00945724|449397391|FG000|Overall Study|Adverse Event|5|||
124936239|NCT00945724|449397391|FG000|Overall Study|Second malignancy|1|||
124936240|NCT00994643|449398336|FG000|Overall Study|Withdrawal by Subject|1|||
124936241|NCT05412004|449398338|FG000|Overall Study|Adverse Event|0|||
124936242|NCT05412004|449398339|FG001|Overall Study|Adverse Event|2|||
124936243|NCT05412004|449398340|FG002|Overall Study|Adverse Event|1|||
124936244|NCT05412004|449398341|FG003|Overall Study|Adverse Event|5|||
124936245|NCT05412004|449398338|FG000|Overall Study|Assigned Treatment by Mistake|5|||
124936246|NCT05412004|449398339|FG001|Overall Study|Assigned Treatment by Mistake|10|||
124936247|NCT05412004|449398340|FG002|Overall Study|Assigned Treatment by Mistake|2|||
124936248|NCT05412004|449398341|FG003|Overall Study|Assigned Treatment by Mistake|5|||
124936249|NCT05412004|449398338|FG000|Overall Study|Lost to Follow-up|3|||
124936250|NCT05412004|449398339|FG001|Overall Study|Lost to Follow-up|0|||
124936251|NCT05412004|449398340|FG002|Overall Study|Lost to Follow-up|0|||
124936252|NCT05412004|449398341|FG003|Overall Study|Lost to Follow-up|0|||
124936253|NCT05412004|449398338|FG000|Overall Study|Patient could not travel to site|0|||
124936254|NCT05412004|449398339|FG001|Overall Study|Patient could not travel to site|1|||
124936255|NCT05412004|449398340|FG002|Overall Study|Patient could not travel to site|0|||
124936256|NCT05412004|449398341|FG003|Overall Study|Patient could not travel to site|0|||
124936257|NCT05412004|449398338|FG000|Overall Study|Physician Decision|0|||
124936258|NCT05412004|449398339|FG001|Overall Study|Physician Decision|1|||
124936259|NCT05412004|449398340|FG002|Overall Study|Physician Decision|0|||
124936260|NCT05412004|449398341|FG003|Overall Study|Physician Decision|0|||
124936261|NCT05412004|449398338|FG000|Overall Study|Pregnancy|0|||
124936262|NCT05412004|449398339|FG001|Overall Study|Pregnancy|1|||
124936263|NCT05412004|449398340|FG002|Overall Study|Pregnancy|0|||
124936264|NCT05412004|449398341|FG003|Overall Study|Pregnancy|0|||
124936265|NCT05412004|449398338|FG000|Overall Study|Protocol Violation|1|||
124936266|NCT05412004|449398339|FG001|Overall Study|Protocol Violation|0|||
124936267|NCT05412004|449398340|FG002|Overall Study|Protocol Violation|0|||
124936268|NCT05412004|449398341|FG003|Overall Study|Protocol Violation|0|||
124936269|NCT05412004|449398338|FG000|Overall Study|Withdrawal by Subject|4|||
124936270|NCT05412004|449398339|FG001|Overall Study|Withdrawal by Subject|19|||
124936271|NCT05412004|449398340|FG002|Overall Study|Withdrawal by Subject|4|||
124936272|NCT05412004|449398341|FG003|Overall Study|Withdrawal by Subject|14|||
124936273|NCT05412004|449398338|FG000|Overall Study|Screen Failure|0|||
124936274|NCT05412004|449398339|FG001|Overall Study|Screen Failure|0|||
124936275|NCT05412004|449398340|FG002|Overall Study|Screen Failure|0|||
124936276|NCT05412004|449398341|FG003|Overall Study|Screen Failure|1|||
124936277|NCT05412004|449398338|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
124936278|NCT05412004|449398339|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
124936279|NCT05412004|449398340|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
124936280|NCT05412004|449398341|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
124936281|NCT00968149|449398342|FG000|Overall Study|Adverse Event|5|||
124936282|NCT00968149|449398343|FG001|Overall Study|Adverse Event|1|||
124936283|NCT00968149|449398342|FG000|Overall Study|Lack of Efficacy|0|||
124936284|NCT00968149|449398343|FG001|Overall Study|Lack of Efficacy|4|||
124936285|NCT00968149|449398342|FG000|Overall Study|Lost to Follow-up|0|||
124936286|NCT00968149|449398343|FG001|Overall Study|Lost to Follow-up|1|||
124936287|NCT00968149|449398342|FG000|Overall Study|Protocol Violation|4|||
124936288|NCT00968149|449398343|FG001|Overall Study|Protocol Violation|0|||
124936289|NCT00968149|449398342|FG000|Overall Study|Withdrawal by Subject|2|||
124936290|NCT00968149|449398343|FG001|Overall Study|Withdrawal by Subject|0|||
124936291|NCT02719574|449398344|FG000|Phase 1 (Dose Escalation)|Other|0|||
124936292|NCT02719574|449398345|FG001|Phase 1 (Dose Escalation)|Other|2|||
124936293|NCT02719574|449398346|FG002|Phase 1 (Dose Escalation)|Other|1|||
124936294|NCT02719574|449398347|FG003|Phase 1 (Dose Escalation)|Other|2|||
124936295|NCT02719574|449398348|FG004|Phase 1 (Dose Escalation)|Other|2|||
124936296|NCT02719574|449398349|FG005|Phase 1 (Dose Escalation)|Other|0|||
124936297|NCT02719574|449398350|FG006|Phase 1 (Dose Escalation)|Other|0|||
124936298|NCT02719574|449398351|FG007|Phase 1 (Dose Escalation)|Other|0|||
124936299|NCT02719574|449398352|FG008|Phase 1 (Dose Escalation)|Other|0|||
124936300|NCT02719574|449398353|FG009|Phase 1 (Dose Escalation)|Other|0|||
124936301|NCT02719574|449398354|FG010|Phase 1 (Dose Escalation)|Other|0|||
124936302|NCT02719574|449398355|FG011|Phase 1 (Dose Escalation)|Other|0|||
124936303|NCT02719574|449398356|FG012|Phase 1 (Dose Escalation)|Other|0|||
124936304|NCT02719574|449398357|FG013|Phase 1 (Dose Escalation)|Other|0|||
124702831|NCT02657343|448535722|FG005|Overall Study|Patient went to hospice|0|||
124702832|NCT02657343|448535717|FG000|Overall Study|Withdrawal by Subject|0|||
124702833|NCT02657343|448535718|FG001|Overall Study|Withdrawal by Subject|0|||
124702834|NCT02657343|448535719|FG002|Overall Study|Withdrawal by Subject|0|||
124702835|NCT02657343|448535720|FG003|Overall Study|Withdrawal by Subject|0|||
124936305|NCT02719574|449398358|FG014|Phase 1 (Dose Escalation)|Other|0|||
124936306|NCT02719574|449398359|FG015|Phase 1 (Dose Escalation)|Other|0|||
124936307|NCT02719574|449398360|FG016|Phase 1 (Dose Escalation)|Other|0|||
124936308|NCT02719574|449398344|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
124936309|NCT02719574|449398345|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
124936310|NCT02719574|449398346|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
124936311|NCT02719574|449398347|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
124936312|NCT02719574|449398348|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
124936313|NCT02719574|449398349|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
124936314|NCT02719574|449398350|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936315|NCT02719574|449398351|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936316|NCT02719574|449398352|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936317|NCT02719574|449398353|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936318|NCT02719574|449398354|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936319|NCT02719574|449398355|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936320|NCT02719574|449398356|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936321|NCT02719574|449398357|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936322|NCT02719574|449398358|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936323|NCT02719574|449398359|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936324|NCT02719574|449398360|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
124936325|NCT02719574|449398344|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936326|NCT02719574|449398345|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
124936327|NCT02719574|449398346|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
124936328|NCT02719574|449398347|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936329|NCT02719574|449398348|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
124936330|NCT02719574|449398349|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
124936331|NCT02719574|449398350|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936332|NCT02719574|449398351|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936333|NCT02719574|449398352|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936334|NCT02719574|449398353|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936335|NCT02719574|449398354|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936336|NCT02719574|449398355|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936337|NCT02719574|449398356|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936338|NCT02719574|449398357|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936339|NCT02719574|449398358|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936340|NCT02719574|449398359|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936341|NCT02719574|449398360|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
124936342|NCT02719574|449398344|FG000|Phase 1 (Dose Escalation)|Death|2|||
124936343|NCT02719574|449398345|FG001|Phase 1 (Dose Escalation)|Death|1|||
124936344|NCT02719574|449398346|FG002|Phase 1 (Dose Escalation)|Death|1|||
124936345|NCT02719574|449398347|FG003|Phase 1 (Dose Escalation)|Death|0|||
124936346|NCT02719574|449398348|FG004|Phase 1 (Dose Escalation)|Death|0|||
124936347|NCT02719574|449398349|FG005|Phase 1 (Dose Escalation)|Death|0|||
124936348|NCT02719574|449398350|FG006|Phase 1 (Dose Escalation)|Death|0|||
124936349|NCT02719574|449398351|FG007|Phase 1 (Dose Escalation)|Death|0|||
124936350|NCT02719574|449398352|FG008|Phase 1 (Dose Escalation)|Death|0|||
124936351|NCT02719574|449398353|FG009|Phase 1 (Dose Escalation)|Death|0|||
124936352|NCT02719574|449398354|FG010|Phase 1 (Dose Escalation)|Death|0|||
124936353|NCT02719574|449398355|FG011|Phase 1 (Dose Escalation)|Death|0|||
124936354|NCT02719574|449398356|FG012|Phase 1 (Dose Escalation)|Death|0|||
124936355|NCT02719574|449398357|FG013|Phase 1 (Dose Escalation)|Death|0|||
124936356|NCT02719574|449398358|FG014|Phase 1 (Dose Escalation)|Death|0|||
124936357|NCT02719574|449398359|FG015|Phase 1 (Dose Escalation)|Death|0|||
124936358|NCT02719574|449398360|FG016|Phase 1 (Dose Escalation)|Death|0|||
124702836|NCT02657343|448535721|FG004|Overall Study|Withdrawal by Subject|1|||
124702837|NCT02657343|448535722|FG005|Overall Study|Withdrawal by Subject|0|||
124702838|NCT02011542|448535724|FG000|Overall Study|Physician Decision|1|||
124702839|NCT00982280|448535730|FG000|Observation Period|Not eligible to be dosed|19|||
124702840|NCT00982280|448535730|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
124936359|NCT02719574|449398344|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936360|NCT02719574|449398345|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
124936361|NCT02719574|449398346|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936362|NCT02719574|449398347|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936363|NCT02719574|449398348|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
124936364|NCT02719574|449398349|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
124936365|NCT02719574|449398350|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936366|NCT02719574|449398351|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936367|NCT02719574|449398352|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936368|NCT02719574|449398353|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
124702841|NCT00982280|448535730|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
124936369|NCT02719574|449398354|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936370|NCT02719574|449398355|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936371|NCT02719574|449398356|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936372|NCT02719574|449398357|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936373|NCT02719574|449398358|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936374|NCT02719574|449398359|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936375|NCT02719574|449398360|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
124936376|NCT02719574|449398344|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936377|NCT02719574|449398345|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936378|NCT02719574|449398346|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936379|NCT02719574|449398347|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936380|NCT02719574|449398348|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
124936381|NCT02719574|449398349|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
124936382|NCT02719574|449398350|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936383|NCT02719574|449398351|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936384|NCT02719574|449398352|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936385|NCT02719574|449398353|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936386|NCT02719574|449398354|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936387|NCT02719574|449398355|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936388|NCT02719574|449398356|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936389|NCT02719574|449398357|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936390|NCT02719574|449398358|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936391|NCT02719574|449398359|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936392|NCT02719574|449398360|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
124936393|NCT02719574|449398344|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936394|NCT02719574|449398345|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936395|NCT02719574|449398346|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
124936396|NCT02719574|449398347|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936397|NCT02719574|449398348|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936398|NCT02719574|449398349|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936399|NCT02719574|449398350|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936400|NCT02719574|449398351|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936401|NCT02719574|449398352|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936402|NCT02719574|449398353|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936403|NCT02719574|449398354|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936404|NCT02719574|449398355|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936405|NCT02719574|449398356|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936406|NCT02719574|449398357|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936407|NCT02719574|449398358|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936408|NCT02719574|449398359|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936409|NCT02719574|449398360|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124936410|NCT02719574|449398344|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936411|NCT02719574|449398345|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936412|NCT02719574|449398346|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936413|NCT02719574|449398347|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936414|NCT02719574|449398348|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936415|NCT02719574|449398349|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936416|NCT02719574|449398350|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
124936417|NCT02719574|449398351|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
124936418|NCT02719574|449398352|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
124936419|NCT02719574|449398353|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936420|NCT02719574|449398354|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936421|NCT02719574|449398355|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936422|NCT02719574|449398356|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936423|NCT02719574|449398357|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936424|NCT02719574|449398358|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936425|NCT02719574|449398359|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936426|NCT02719574|449398360|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
124936427|NCT02719574|449398344|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936428|NCT02719574|449398345|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936429|NCT02719574|449398346|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936430|NCT02719574|449398347|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936431|NCT02719574|449398348|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936432|NCT02719574|449398349|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936433|NCT02719574|449398350|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
124936434|NCT02719574|449398351|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
124936435|NCT02719574|449398352|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936436|NCT02719574|449398353|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936437|NCT02719574|449398354|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936438|NCT02719574|449398355|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936439|NCT02719574|449398356|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936440|NCT02719574|449398357|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936441|NCT02719574|449398358|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936442|NCT02719574|449398359|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936443|NCT02719574|449398360|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
124936444|NCT02719574|449398344|FG000|Phase 1 (Dose Expansion)|Death|0|||
124936445|NCT02719574|449398345|FG001|Phase 1 (Dose Expansion)|Death|0|||
124936446|NCT02719574|449398346|FG002|Phase 1 (Dose Expansion)|Death|0|||
124936447|NCT02719574|449398347|FG003|Phase 1 (Dose Expansion)|Death|0|||
124936448|NCT02719574|449398348|FG004|Phase 1 (Dose Expansion)|Death|0|||
124936449|NCT02719574|449398349|FG005|Phase 1 (Dose Expansion)|Death|0|||
124936450|NCT02719574|449398350|FG006|Phase 1 (Dose Expansion)|Death|1|||
124936451|NCT02719574|449398351|FG007|Phase 1 (Dose Expansion)|Death|6|||
124936452|NCT02719574|449398352|FG008|Phase 1 (Dose Expansion)|Death|0|||
124936453|NCT02719574|449398353|FG009|Phase 1 (Dose Expansion)|Death|0|||
124936454|NCT02719574|449398354|FG010|Phase 1 (Dose Expansion)|Death|0|||
124936455|NCT02719574|449398355|FG011|Phase 1 (Dose Expansion)|Death|0|||
124936456|NCT02719574|449398356|FG012|Phase 1 (Dose Expansion)|Death|0|||
124936457|NCT02719574|449398357|FG013|Phase 1 (Dose Expansion)|Death|0|||
124936458|NCT02719574|449398358|FG014|Phase 1 (Dose Expansion)|Death|0|||
124936459|NCT02719574|449398359|FG015|Phase 1 (Dose Expansion)|Death|0|||
124936460|NCT02719574|449398360|FG016|Phase 1 (Dose Expansion)|Death|0|||
124936461|NCT02719574|449398344|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936462|NCT02719574|449398345|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936463|NCT02719574|449398346|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936464|NCT02719574|449398347|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936465|NCT02719574|449398348|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936466|NCT02719574|449398349|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936467|NCT02719574|449398350|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
124936468|NCT02719574|449398351|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
124936469|NCT02719574|449398352|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936470|NCT02719574|449398353|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936471|NCT02719574|449398354|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936472|NCT02719574|449398355|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936473|NCT02719574|449398356|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936474|NCT02719574|449398357|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936475|NCT02719574|449398358|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936476|NCT02719574|449398359|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936477|NCT02719574|449398360|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
124936478|NCT02719574|449398344|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936479|NCT02719574|449398345|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936480|NCT02719574|449398346|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936481|NCT02719574|449398347|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936482|NCT02719574|449398348|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936483|NCT02719574|449398349|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936484|NCT02719574|449398350|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
124936485|NCT02719574|449398351|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
124936486|NCT02719574|449398352|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936487|NCT02719574|449398353|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936488|NCT02719574|449398354|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936489|NCT02719574|449398355|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936490|NCT02719574|449398356|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936491|NCT02719574|449398357|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936492|NCT02719574|449398358|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936493|NCT02719574|449398359|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936494|NCT02719574|449398360|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
124936495|NCT02719574|449398344|FG000|Phase 1 (Dose Expansion)|Other|0|||
124936496|NCT02719574|449398345|FG001|Phase 1 (Dose Expansion)|Other|0|||
124456077|NCT00552175|447630334|FG000|Overall Study|Withdrawal by Subject|2|||
124456078|NCT00552175|447630335|FG001|Overall Study|Withdrawal by Subject|2|||
124456079|NCT00552175|447630336|FG002|Overall Study|Withdrawal by Subject|1|||
124456080|NCT00552175|447630334|FG000|Overall Study|Lost to Follow-up|0|||
124456081|NCT00552175|447630335|FG001|Overall Study|Lost to Follow-up|0|||
124456082|NCT00552175|447630336|FG002|Overall Study|Lost to Follow-up|1|||
124936497|NCT02719574|449398346|FG002|Phase 1 (Dose Expansion)|Other|0|||
124936498|NCT02719574|449398347|FG003|Phase 1 (Dose Expansion)|Other|0|||
124936499|NCT02719574|449398348|FG004|Phase 1 (Dose Expansion)|Other|0|||
124456083|NCT00552175|447630334|FG000|Overall Study|Entry Criteria Not Met|1|||
124456084|NCT00552175|447630335|FG001|Overall Study|Entry Criteria Not Met|1|||
124936500|NCT02719574|449398349|FG005|Phase 1 (Dose Expansion)|Other|0|||
124936501|NCT02719574|449398350|FG006|Phase 1 (Dose Expansion)|Other|1|||
124936502|NCT02719574|449398351|FG007|Phase 1 (Dose Expansion)|Other|7|||
124936503|NCT02719574|449398352|FG008|Phase 1 (Dose Expansion)|Other|0|||
124936504|NCT02719574|449398353|FG009|Phase 1 (Dose Expansion)|Other|0|||
124936505|NCT02719574|449398354|FG010|Phase 1 (Dose Expansion)|Other|0|||
124456085|NCT00552175|447630336|FG002|Overall Study|Entry Criteria Not Met|0|||
124936506|NCT02719574|449398355|FG011|Phase 1 (Dose Expansion)|Other|0|||
124936507|NCT02719574|449398356|FG012|Phase 1 (Dose Expansion)|Other|0|||
124936508|NCT02719574|449398357|FG013|Phase 1 (Dose Expansion)|Other|0|||
124936509|NCT02719574|449398358|FG014|Phase 1 (Dose Expansion)|Other|0|||
124936510|NCT02719574|449398359|FG015|Phase 1 (Dose Expansion)|Other|0|||
124936511|NCT02719574|449398360|FG016|Phase 1 (Dose Expansion)|Other|0|||
124936512|NCT02719574|449398344|FG000|Phase 2|Protocol Defined Disease Progression|0|||
124936513|NCT02719574|449398345|FG001|Phase 2|Protocol Defined Disease Progression|0|||
124936514|NCT02719574|449398346|FG002|Phase 2|Protocol Defined Disease Progression|0|||
124936515|NCT02719574|449398347|FG003|Phase 2|Protocol Defined Disease Progression|0|||
124936516|NCT02719574|449398348|FG004|Phase 2|Protocol Defined Disease Progression|0|||
124936517|NCT02719574|449398349|FG005|Phase 2|Protocol Defined Disease Progression|0|||
124936518|NCT02719574|449398350|FG006|Phase 2|Protocol Defined Disease Progression|0|||
124936519|NCT02719574|449398351|FG007|Phase 2|Protocol Defined Disease Progression|0|||
124936520|NCT02719574|449398352|FG008|Phase 2|Protocol Defined Disease Progression|0|||
124936521|NCT02719574|449398353|FG009|Phase 2|Protocol Defined Disease Progression|65|||
124936522|NCT02719574|449398354|FG010|Phase 2|Protocol Defined Disease Progression|8|||
124936523|NCT02719574|449398355|FG011|Phase 2|Protocol Defined Disease Progression|2|||
124936524|NCT02719574|449398356|FG012|Phase 2|Protocol Defined Disease Progression|4|||
124936525|NCT02719574|449398357|FG013|Phase 2|Protocol Defined Disease Progression|9|||
124936526|NCT02719574|449398358|FG014|Phase 2|Protocol Defined Disease Progression|11|||
124936527|NCT02719574|449398359|FG015|Phase 2|Protocol Defined Disease Progression|3|||
124936528|NCT02719574|449398360|FG016|Phase 2|Protocol Defined Disease Progression|4|||
124936529|NCT02719574|449398344|FG000|Phase 2|Adverse Event|0|||
124936530|NCT02719574|449398345|FG001|Phase 2|Adverse Event|0|||
124936531|NCT02719574|449398346|FG002|Phase 2|Adverse Event|0|||
124936532|NCT02719574|449398347|FG003|Phase 2|Adverse Event|0|||
124936533|NCT02719574|449398348|FG004|Phase 2|Adverse Event|0|||
124936534|NCT02719574|449398349|FG005|Phase 2|Adverse Event|0|||
124936535|NCT02719574|449398350|FG006|Phase 2|Adverse Event|0|||
124936536|NCT02719574|449398351|FG007|Phase 2|Adverse Event|0|||
124936537|NCT02719574|449398352|FG008|Phase 2|Adverse Event|0|||
124936538|NCT02719574|449398353|FG009|Phase 2|Adverse Event|27|||
124936539|NCT02719574|449398354|FG010|Phase 2|Adverse Event|0|||
124936540|NCT02719574|449398355|FG011|Phase 2|Adverse Event|1|||
124936541|NCT02719574|449398356|FG012|Phase 2|Adverse Event|1|||
124936542|NCT02719574|449398357|FG013|Phase 2|Adverse Event|1|||
124936543|NCT02719574|449398358|FG014|Phase 2|Adverse Event|2|||
124936544|NCT02719574|449398359|FG015|Phase 2|Adverse Event|2|||
124936545|NCT02719574|449398360|FG016|Phase 2|Adverse Event|3|||
124936546|NCT02719574|449398344|FG000|Phase 2|Other|0|||
124936547|NCT02719574|449398345|FG001|Phase 2|Other|0|||
124936548|NCT02719574|449398346|FG002|Phase 2|Other|0|||
124936549|NCT02719574|449398347|FG003|Phase 2|Other|0|||
124936550|NCT02719574|449398348|FG004|Phase 2|Other|0|||
124936551|NCT02719574|449398349|FG005|Phase 2|Other|0|||
124936552|NCT02719574|449398350|FG006|Phase 2|Other|0|||
124936553|NCT02719574|449398351|FG007|Phase 2|Other|0|||
124936554|NCT02719574|449398352|FG008|Phase 2|Other|0|||
124936555|NCT02719574|449398353|FG009|Phase 2|Other|20|||
124936556|NCT02719574|449398354|FG010|Phase 2|Other|7|||
124936557|NCT02719574|449398355|FG011|Phase 2|Other|0|||
124936558|NCT02719574|449398356|FG012|Phase 2|Other|5|||
124936559|NCT02719574|449398357|FG013|Phase 2|Other|7|||
124936560|NCT02719574|449398358|FG014|Phase 2|Other|0|||
124936561|NCT02719574|449398359|FG015|Phase 2|Other|1|||
124936562|NCT02719574|449398360|FG016|Phase 2|Other|4|||
124936563|NCT02719574|449398344|FG000|Phase 2|Transplant|0|||
124936564|NCT02719574|449398345|FG001|Phase 2|Transplant|0|||
124936565|NCT02719574|449398346|FG002|Phase 2|Transplant|0|||
124936566|NCT02719574|449398347|FG003|Phase 2|Transplant|0|||
124936567|NCT02719574|449398348|FG004|Phase 2|Transplant|0|||
124936568|NCT02719574|449398349|FG005|Phase 2|Transplant|0|||
124936569|NCT02719574|449398350|FG006|Phase 2|Transplant|0|||
124936570|NCT02719574|449398351|FG007|Phase 2|Transplant|0|||
124936571|NCT02719574|449398352|FG008|Phase 2|Transplant|0|||
124936572|NCT02719574|449398353|FG009|Phase 2|Transplant|15|||
124936573|NCT02719574|449398354|FG010|Phase 2|Transplant|2|||
124936574|NCT02719574|449398355|FG011|Phase 2|Transplant|0|||
124936575|NCT02719574|449398356|FG012|Phase 2|Transplant|6|||
124936576|NCT02719574|449398357|FG013|Phase 2|Transplant|1|||
124936577|NCT02719574|449398358|FG014|Phase 2|Transplant|1|||
124936578|NCT02719574|449398359|FG015|Phase 2|Transplant|0|||
124936579|NCT02719574|449398360|FG016|Phase 2|Transplant|0|||
124936580|NCT02719574|449398344|FG000|Phase 2|Death|0|||
124936581|NCT02719574|449398345|FG001|Phase 2|Death|0|||
124936582|NCT02719574|449398346|FG002|Phase 2|Death|0|||
124936583|NCT02719574|449398347|FG003|Phase 2|Death|0|||
124936584|NCT02719574|449398348|FG004|Phase 2|Death|0|||
124936585|NCT02719574|449398349|FG005|Phase 2|Death|0|||
124702842|NCT00982280|448535730|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
124936586|NCT02719574|449398350|FG006|Phase 2|Death|0|||
124936587|NCT02719574|449398351|FG007|Phase 2|Death|0|||
124936588|NCT02719574|449398352|FG008|Phase 2|Death|0|||
124936589|NCT02719574|449398353|FG009|Phase 2|Death|14|||
124936590|NCT02719574|449398354|FG010|Phase 2|Death|0|||
124936591|NCT02719574|449398355|FG011|Phase 2|Death|0|||
124936592|NCT02719574|449398356|FG012|Phase 2|Death|1|||
124936593|NCT02719574|449398357|FG013|Phase 2|Death|1|||
124936594|NCT02719574|449398358|FG014|Phase 2|Death|2|||
124936595|NCT02719574|449398359|FG015|Phase 2|Death|0|||
124936596|NCT02719574|449398360|FG016|Phase 2|Death|0|||
124936597|NCT02719574|449398344|FG000|Phase 2|Investigator Decision|0|||
124936598|NCT02719574|449398345|FG001|Phase 2|Investigator Decision|0|||
124936599|NCT02719574|449398346|FG002|Phase 2|Investigator Decision|0|||
124936600|NCT02719574|449398347|FG003|Phase 2|Investigator Decision|0|||
124936601|NCT02719574|449398348|FG004|Phase 2|Investigator Decision|0|||
124936602|NCT02719574|449398349|FG005|Phase 2|Investigator Decision|0|||
124936603|NCT02719574|449398350|FG006|Phase 2|Investigator Decision|0|||
124936604|NCT02719574|449398351|FG007|Phase 2|Investigator Decision|0|||
124936605|NCT02719574|449398352|FG008|Phase 2|Investigator Decision|0|||
124936606|NCT02719574|449398353|FG009|Phase 2|Investigator Decision|6|||
124936607|NCT02719574|449398354|FG010|Phase 2|Investigator Decision|1|||
124936608|NCT02719574|449398355|FG011|Phase 2|Investigator Decision|2|||
124936609|NCT02719574|449398356|FG012|Phase 2|Investigator Decision|3|||
124936610|NCT02719574|449398357|FG013|Phase 2|Investigator Decision|1|||
124936611|NCT02719574|449398358|FG014|Phase 2|Investigator Decision|3|||
124936612|NCT02719574|449398359|FG015|Phase 2|Investigator Decision|2|||
124936613|NCT02719574|449398360|FG016|Phase 2|Investigator Decision|0|||
124936614|NCT02719574|449398344|FG000|Phase 2|Withdrawal by Subject|0|||
124936615|NCT02719574|449398345|FG001|Phase 2|Withdrawal by Subject|0|||
124936616|NCT02719574|449398346|FG002|Phase 2|Withdrawal by Subject|0|||
124936617|NCT02719574|449398347|FG003|Phase 2|Withdrawal by Subject|0|||
124936618|NCT02719574|449398348|FG004|Phase 2|Withdrawal by Subject|0|||
124936619|NCT02719574|449398349|FG005|Phase 2|Withdrawal by Subject|0|||
124936620|NCT02719574|449398350|FG006|Phase 2|Withdrawal by Subject|0|||
124936621|NCT02719574|449398351|FG007|Phase 2|Withdrawal by Subject|0|||
124936622|NCT02719574|449398352|FG008|Phase 2|Withdrawal by Subject|0|||
124936623|NCT02719574|449398353|FG009|Phase 2|Withdrawal by Subject|5|||
124936624|NCT02719574|449398354|FG010|Phase 2|Withdrawal by Subject|0|||
124936625|NCT02719574|449398355|FG011|Phase 2|Withdrawal by Subject|0|||
124936626|NCT02719574|449398356|FG012|Phase 2|Withdrawal by Subject|0|||
124936627|NCT02719574|449398357|FG013|Phase 2|Withdrawal by Subject|1|||
124936628|NCT02719574|449398358|FG014|Phase 2|Withdrawal by Subject|1|||
124936629|NCT02719574|449398359|FG015|Phase 2|Withdrawal by Subject|2|||
124936630|NCT02719574|449398360|FG016|Phase 2|Withdrawal by Subject|0|||
124936631|NCT02719574|449398344|FG000|Phase 2|Protocol Violation|0|||
124936632|NCT02719574|449398345|FG001|Phase 2|Protocol Violation|0|||
124936633|NCT02719574|449398346|FG002|Phase 2|Protocol Violation|0|||
124936634|NCT02719574|449398347|FG003|Phase 2|Protocol Violation|0|||
124936635|NCT02719574|449398348|FG004|Phase 2|Protocol Violation|0|||
124936636|NCT02719574|449398349|FG005|Phase 2|Protocol Violation|0|||
124936637|NCT02719574|449398350|FG006|Phase 2|Protocol Violation|0|||
124936638|NCT02719574|449398351|FG007|Phase 2|Protocol Violation|0|||
124936639|NCT02719574|449398352|FG008|Phase 2|Protocol Violation|0|||
124936640|NCT02719574|449398353|FG009|Phase 2|Protocol Violation|1|||
124936641|NCT02719574|449398354|FG010|Phase 2|Protocol Violation|0|||
124936642|NCT02719574|449398355|FG011|Phase 2|Protocol Violation|0|||
124936643|NCT02719574|449398356|FG012|Phase 2|Protocol Violation|0|||
124936644|NCT02719574|449398357|FG013|Phase 2|Protocol Violation|0|||
124936645|NCT02719574|449398358|FG014|Phase 2|Protocol Violation|0|||
124936646|NCT02719574|449398359|FG015|Phase 2|Protocol Violation|0|||
124936647|NCT02719574|449398360|FG016|Phase 2|Protocol Violation|0|||
124936648|NCT02720068|449398364|FG000|Overall Study|Adverse Event|0|||
124936649|NCT02720068|449398365|FG001|Overall Study|Adverse Event|0|||
124936650|NCT02720068|449398366|FG002|Overall Study|Adverse Event|0|||
124936651|NCT02720068|449398367|FG003|Overall Study|Adverse Event|0|||
124936652|NCT02720068|449398368|FG004|Overall Study|Adverse Event|0|||
124936653|NCT02720068|449398369|FG005|Overall Study|Adverse Event|0|||
124936654|NCT02720068|449398370|FG006|Overall Study|Adverse Event|0|||
124936655|NCT02720068|449398371|FG007|Overall Study|Adverse Event|0|||
124936656|NCT02720068|449398372|FG008|Overall Study|Adverse Event|0|||
124936657|NCT02720068|449398373|FG009|Overall Study|Adverse Event|0|||
124936658|NCT02720068|449398374|FG010|Overall Study|Adverse Event|0|||
124936659|NCT02720068|449398375|FG011|Overall Study|Adverse Event|1|||
124936660|NCT02720068|449398376|FG012|Overall Study|Adverse Event|0|||
124936661|NCT02720068|449398377|FG013|Overall Study|Adverse Event|0|||
124936662|NCT02720068|449398378|FG014|Overall Study|Adverse Event|0|||
124936663|NCT02720068|449398379|FG015|Overall Study|Adverse Event|0|||
124936664|NCT02720068|449398380|FG016|Overall Study|Adverse Event|0|||
124936665|NCT02720068|449398381|FG017|Overall Study|Adverse Event|0|||
124936666|NCT02720068|449398364|FG000|Overall Study|Death|1|||
124936667|NCT02720068|449398365|FG001|Overall Study|Death|3|||
124702843|NCT00982280|448535730|FG000|Maintenance Period|Adverse Event|1|||
124702844|NCT01979185|448535731|FG000|Period 2|Other|0|||
124702845|NCT01979185|448535732|FG001|Period 2|Other|1|||
124702846|NCT00980798|448535733|FG000|Overall Study|Adverse Event|7|||
124702847|NCT00980798|448535734|FG001|Overall Study|Adverse Event|36|||
124936668|NCT02720068|449398366|FG002|Overall Study|Death|2|||
124936669|NCT02720068|449398367|FG003|Overall Study|Death|1|||
124936670|NCT02720068|449398368|FG004|Overall Study|Death|2|||
124936671|NCT02720068|449398369|FG005|Overall Study|Death|1|||
124936672|NCT02720068|449398370|FG006|Overall Study|Death|2|||
124936673|NCT02720068|449398371|FG007|Overall Study|Death|2|||
124936674|NCT02720068|449398372|FG008|Overall Study|Death|3|||
124936675|NCT02720068|449398373|FG009|Overall Study|Death|1|||
124936676|NCT02720068|449398374|FG010|Overall Study|Death|20|||
124936677|NCT02720068|449398375|FG011|Overall Study|Death|166|||
124936678|NCT02720068|449398376|FG012|Overall Study|Death|34|||
124936679|NCT02720068|449398377|FG013|Overall Study|Death|30|||
124936680|NCT02720068|449398378|FG014|Overall Study|Death|45|||
124936681|NCT02720068|449398379|FG015|Overall Study|Death|16|||
124936682|NCT02720068|449398380|FG016|Overall Study|Death|20|||
124936683|NCT02720068|449398381|FG017|Overall Study|Death|28|||
124936684|NCT02720068|449398364|FG000|Overall Study|Lost to Follow-up|0|||
124936685|NCT02720068|449398365|FG001|Overall Study|Lost to Follow-up|0|||
124936686|NCT02720068|449398366|FG002|Overall Study|Lost to Follow-up|0|||
124936687|NCT02720068|449398367|FG003|Overall Study|Lost to Follow-up|0|||
124936688|NCT02720068|449398368|FG004|Overall Study|Lost to Follow-up|0|||
124936689|NCT02720068|449398369|FG005|Overall Study|Lost to Follow-up|0|||
124936690|NCT02720068|449398370|FG006|Overall Study|Lost to Follow-up|0|||
124936691|NCT02720068|449398371|FG007|Overall Study|Lost to Follow-up|0|||
124936692|NCT02720068|449398372|FG008|Overall Study|Lost to Follow-up|0|||
124936693|NCT02720068|449398373|FG009|Overall Study|Lost to Follow-up|0|||
124936694|NCT02720068|449398374|FG010|Overall Study|Lost to Follow-up|0|||
124936695|NCT02720068|449398375|FG011|Overall Study|Lost to Follow-up|1|||
124936696|NCT02720068|449398376|FG012|Overall Study|Lost to Follow-up|0|||
124936697|NCT02720068|449398377|FG013|Overall Study|Lost to Follow-up|1|||
124936698|NCT02720068|449398378|FG014|Overall Study|Lost to Follow-up|2|||
124936699|NCT02720068|449398379|FG015|Overall Study|Lost to Follow-up|0|||
124936700|NCT02720068|449398380|FG016|Overall Study|Lost to Follow-up|0|||
124936701|NCT02720068|449398381|FG017|Overall Study|Lost to Follow-up|1|||
124936702|NCT02720068|449398364|FG000|Overall Study|Physician Decision|0|||
124936703|NCT02720068|449398365|FG001|Overall Study|Physician Decision|0|||
124936704|NCT02720068|449398366|FG002|Overall Study|Physician Decision|0|||
124936705|NCT02720068|449398367|FG003|Overall Study|Physician Decision|1|||
124936706|NCT02720068|449398368|FG004|Overall Study|Physician Decision|0|||
124936707|NCT02720068|449398369|FG005|Overall Study|Physician Decision|0|||
124936708|NCT02720068|449398370|FG006|Overall Study|Physician Decision|0|||
124936709|NCT02720068|449398371|FG007|Overall Study|Physician Decision|0|||
124936710|NCT02720068|449398372|FG008|Overall Study|Physician Decision|0|||
124936711|NCT02720068|449398373|FG009|Overall Study|Physician Decision|0|||
124936712|NCT02720068|449398374|FG010|Overall Study|Physician Decision|0|||
124936713|NCT02720068|449398375|FG011|Overall Study|Physician Decision|1|||
124936714|NCT02720068|449398376|FG012|Overall Study|Physician Decision|0|||
124936715|NCT02720068|449398377|FG013|Overall Study|Physician Decision|0|||
124936716|NCT02720068|449398378|FG014|Overall Study|Physician Decision|0|||
124936717|NCT02720068|449398379|FG015|Overall Study|Physician Decision|0|||
124936718|NCT02720068|449398380|FG016|Overall Study|Physician Decision|0|||
124936719|NCT02720068|449398381|FG017|Overall Study|Physician Decision|1|||
124936720|NCT02720068|449398364|FG000|Overall Study|Progressive Disease|2|||
124936721|NCT02720068|449398365|FG001|Overall Study|Progressive Disease|3|||
124936722|NCT02720068|449398366|FG002|Overall Study|Progressive Disease|1|||
124936723|NCT02720068|449398367|FG003|Overall Study|Progressive Disease|1|||
124936724|NCT02720068|449398368|FG004|Overall Study|Progressive Disease|1|||
124936725|NCT02720068|449398369|FG005|Overall Study|Progressive Disease|2|||
124702848|NCT00980798|448535733|FG000|Overall Study|Lack of Efficacy|16|||
124702849|NCT00980798|448535734|FG001|Overall Study|Lack of Efficacy|5|||
124702850|NCT00980798|448535733|FG000|Overall Study|Lost to Follow-up|0|||
124936726|NCT02720068|449398370|FG006|Overall Study|Progressive Disease|1|||
124702851|NCT00980798|448535734|FG001|Overall Study|Lost to Follow-up|1|||
124702852|NCT00980798|448535733|FG000|Overall Study|Physician Decision|2|||
124702853|NCT00980798|448535734|FG001|Overall Study|Physician Decision|1|||
124936727|NCT02720068|449398371|FG007|Overall Study|Progressive Disease|1|||
124936728|NCT02720068|449398372|FG008|Overall Study|Progressive Disease|0|||
124936729|NCT02720068|449398373|FG009|Overall Study|Progressive Disease|1|||
124936730|NCT02720068|449398374|FG010|Overall Study|Progressive Disease|0|||
124936731|NCT02720068|449398375|FG011|Overall Study|Progressive Disease|4|||
124936732|NCT02720068|449398376|FG012|Overall Study|Progressive Disease|1|||
124936733|NCT02720068|449398377|FG013|Overall Study|Progressive Disease|0|||
124936734|NCT02720068|449398378|FG014|Overall Study|Progressive Disease|0|||
124936735|NCT02720068|449398379|FG015|Overall Study|Progressive Disease|0|||
124456086|NCT00552175|447630334|FG000|Overall Study|Reason Not Specified|3|||
124456087|NCT00552175|447630335|FG001|Overall Study|Reason Not Specified|1|||
124456088|NCT00552175|447630336|FG002|Overall Study|Reason Not Specified|1|||
124456089|NCT00884273|447630337|FG000|Overall Study|Adverse Event|0|||
124456090|NCT00884273|447630338|FG001|Overall Study|Adverse Event|2|||
124456091|NCT00884273|447630337|FG000|Overall Study|Protocol Violation|1|||
124702854|NCT00980798|448535733|FG000|Overall Study|Withdrawal by Subject|8|||
124702855|NCT00980798|448535734|FG001|Overall Study|Withdrawal by Subject|11|||
124702856|NCT00980798|448535733|FG000|Overall Study|Other|0|||
124702857|NCT00980798|448535734|FG001|Overall Study|Other|1|||
124702858|NCT04724837|448535735|FG000|Overall Study|Other|4|||
124702859|NCT04724837|448535736|FG001|Overall Study|Other|16|||
124702860|NCT04724837|448535737|FG002|Overall Study|Other|0|||
124702861|NCT04724837|448535735|FG000|Overall Study|Withdrawal by Subject|2|||
124702862|NCT04724837|448535736|FG001|Overall Study|Withdrawal by Subject|9|||
124702863|NCT04724837|448535737|FG002|Overall Study|Withdrawal by Subject|9|||
124702864|NCT04724837|448535735|FG000|Overall Study|Adverse Event|2|||
124702865|NCT04724837|448535736|FG001|Overall Study|Adverse Event|7|||
124702866|NCT04724837|448535737|FG002|Overall Study|Adverse Event|4|||
124702867|NCT04724837|448535735|FG000|Overall Study|Lost to Follow-up|0|||
124702868|NCT04724837|448535736|FG001|Overall Study|Lost to Follow-up|1|||
124702869|NCT04724837|448535737|FG002|Overall Study|Lost to Follow-up|3|||
124702870|NCT04724837|448535735|FG000|Overall Study|Physician Decision|1|||
124702871|NCT04724837|448535736|FG001|Overall Study|Physician Decision|2|||
124702872|NCT04724837|448535737|FG002|Overall Study|Physician Decision|0|||
124702873|NCT04724837|448535735|FG000|Overall Study|Death|0|||
124702874|NCT04724837|448535736|FG001|Overall Study|Death|0|||
124702875|NCT04724837|448535737|FG002|Overall Study|Death|1|||
124702876|NCT04724837|448535735|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
124702877|NCT04724837|448535736|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
124702878|NCT04724837|448535737|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
124702879|NCT04724837|448535735|FG000|Overall Study|Study Terminated by Sponsor|0|||
124702880|NCT04724837|448535736|FG001|Overall Study|Study Terminated by Sponsor|1|||
124702881|NCT04724837|448535737|FG002|Overall Study|Study Terminated by Sponsor|0|||
124702882|NCT00522379|448535738|FG000|Overall Study|Adverse Event|12|||
124702883|NCT00522379|448535739|FG001|Overall Study|Adverse Event|15|||
124702884|NCT00522379|448535740|FG002|Overall Study|Adverse Event|12|||
124702885|NCT00522379|448535741|FG003|Overall Study|Adverse Event|5|||
124702886|NCT00522379|448535742|FG004|Overall Study|Adverse Event|17|||
124702887|NCT00522379|448535738|FG000|Overall Study|Lack of Efficacy|3|||
124702888|NCT00522379|448535739|FG001|Overall Study|Lack of Efficacy|0|||
124702889|NCT00522379|448535740|FG002|Overall Study|Lack of Efficacy|2|||
124702890|NCT00522379|448535741|FG003|Overall Study|Lack of Efficacy|2|||
124702891|NCT00522379|448535742|FG004|Overall Study|Lack of Efficacy|7|||
124702892|NCT00522379|448535738|FG000|Overall Study|Withdrawal by Subject|2|||
124702893|NCT00522379|448535739|FG001|Overall Study|Withdrawal by Subject|3|||
124702894|NCT00522379|448535740|FG002|Overall Study|Withdrawal by Subject|1|||
124702895|NCT00522379|448535741|FG003|Overall Study|Withdrawal by Subject|2|||
124702896|NCT00522379|448535742|FG004|Overall Study|Withdrawal by Subject|0|||
124936736|NCT02720068|449398380|FG016|Overall Study|Progressive Disease|0|||
124936737|NCT02720068|449398381|FG017|Overall Study|Progressive Disease|0|||
124936738|NCT02720068|449398364|FG000|Overall Study|Sponsor Decision|0|||
124936739|NCT02720068|449398365|FG001|Overall Study|Sponsor Decision|0|||
124936740|NCT02720068|449398366|FG002|Overall Study|Sponsor Decision|0|||
124936741|NCT02720068|449398367|FG003|Overall Study|Sponsor Decision|0|||
124936742|NCT02720068|449398368|FG004|Overall Study|Sponsor Decision|0|||
124936743|NCT02720068|449398369|FG005|Overall Study|Sponsor Decision|0|||
124936744|NCT02720068|449398370|FG006|Overall Study|Sponsor Decision|0|||
124936745|NCT02720068|449398371|FG007|Overall Study|Sponsor Decision|0|||
124936746|NCT02720068|449398372|FG008|Overall Study|Sponsor Decision|0|||
124936747|NCT02720068|449398373|FG009|Overall Study|Sponsor Decision|0|||
124936748|NCT02720068|449398374|FG010|Overall Study|Sponsor Decision|0|||
124936749|NCT02720068|449398375|FG011|Overall Study|Sponsor Decision|6|||
124702897|NCT00522379|448535738|FG000|Overall Study|Protocol Violation|1|||
124702898|NCT00522379|448535739|FG001|Overall Study|Protocol Violation|1|||
124702899|NCT00522379|448535740|FG002|Overall Study|Protocol Violation|2|||
124702900|NCT00522379|448535741|FG003|Overall Study|Protocol Violation|0|||
124702901|NCT00522379|448535742|FG004|Overall Study|Protocol Violation|0|||
124936750|NCT02720068|449398376|FG012|Overall Study|Sponsor Decision|3|||
124936751|NCT02720068|449398377|FG013|Overall Study|Sponsor Decision|2|||
124936752|NCT02720068|449398378|FG014|Overall Study|Sponsor Decision|4|||
124936753|NCT02720068|449398379|FG015|Overall Study|Sponsor Decision|4|||
124936754|NCT02720068|449398380|FG016|Overall Study|Sponsor Decision|0|||
124702902|NCT00522379|448535738|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
124702903|NCT00522379|448535739|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
124702904|NCT00522379|448535740|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
124702905|NCT00522379|448535741|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
124702906|NCT00522379|448535742|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
124702907|NCT00522379|448535738|FG000|Overall Study|Lost to Follow-up|1|||
124702908|NCT00522379|448535739|FG001|Overall Study|Lost to Follow-up|0|||
124702909|NCT00522379|448535740|FG002|Overall Study|Lost to Follow-up|4|||
124702910|NCT00522379|448535741|FG003|Overall Study|Lost to Follow-up|2|||
124702911|NCT00522379|448535742|FG004|Overall Study|Lost to Follow-up|2|||
124936755|NCT02720068|449398381|FG017|Overall Study|Sponsor Decision|8|||
124936756|NCT02720068|449398364|FG000|Overall Study|Withdrawal by Subject|0|||
124936757|NCT02720068|449398365|FG001|Overall Study|Withdrawal by Subject|0|||
124456092|NCT00884273|447630338|FG001|Overall Study|Protocol Violation|3|||
124456093|NCT00884273|447630337|FG000|Overall Study|Practical reasons|1|||
124456094|NCT00884273|447630338|FG001|Overall Study|Practical reasons|0|||
124456095|NCT03715153|447630339|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
124456096|NCT03715153|447630340|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
124456097|NCT03715153|447630339|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
124456098|NCT03715153|447630340|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
124456099|NCT03715153|447630339|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
124456100|NCT03715153|447630340|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
124456101|NCT03715153|447630339|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
124456102|NCT03715153|447630340|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
124456103|NCT03715153|447630339|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
124456104|NCT03715153|447630340|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
124456105|NCT03715153|447630339|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
124456106|NCT03715153|447630340|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
124456107|NCT00450723|447630344|FG000|Overall Study|Physician Decision|5|||
124456108|NCT00078325|447630345|FG000|Overall Study|Adverse Event|15|||
124456109|NCT00078325|447630346|FG001|Overall Study|Adverse Event|10|||
124456110|NCT00078325|447630347|FG002|Overall Study|Adverse Event|5|||
124456111|NCT00078325|447630345|FG000|Overall Study|Protocol Violation|2|||
124456112|NCT00078325|447630346|FG001|Overall Study|Protocol Violation|2|||
124456113|NCT00078325|447630347|FG002|Overall Study|Protocol Violation|0|||
124456114|NCT00078325|447630345|FG000|Overall Study|Withdrawal by Subject|1|||
124456115|NCT00078325|447630346|FG001|Overall Study|Withdrawal by Subject|5|||
124456116|NCT00078325|447630347|FG002|Overall Study|Withdrawal by Subject|3|||
124456117|NCT00078325|447630345|FG000|Overall Study|Lost to Follow-up|0|||
124456118|NCT00078325|447630346|FG001|Overall Study|Lost to Follow-up|1|||
124456119|NCT00078325|447630347|FG002|Overall Study|Lost to Follow-up|1|||
124546485|NCT00320801|447955916|FG000|Open-label Run-in Period|Administrative|10|||
124546486|NCT00320801|447955917|FG001|Open-label Run-in Period|Administrative|0|||
124546487|NCT00320801|447955918|FG002|Open-label Run-in Period|Administrative|0|||
124546488|NCT00320801|447955919|FG003|Open-label Run-in Period|Administrative|0|||
124936758|NCT02720068|449398366|FG002|Overall Study|Withdrawal by Subject|0|||
124936759|NCT02720068|449398367|FG003|Overall Study|Withdrawal by Subject|0|||
124936760|NCT02720068|449398368|FG004|Overall Study|Withdrawal by Subject|0|||
124936761|NCT02720068|449398369|FG005|Overall Study|Withdrawal by Subject|0|||
124936762|NCT02720068|449398370|FG006|Overall Study|Withdrawal by Subject|0|||
124936763|NCT02720068|449398371|FG007|Overall Study|Withdrawal by Subject|0|||
124936764|NCT02720068|449398372|FG008|Overall Study|Withdrawal by Subject|0|||
124936765|NCT02720068|449398373|FG009|Overall Study|Withdrawal by Subject|1|||
124936766|NCT02720068|449398374|FG010|Overall Study|Withdrawal by Subject|0|||
124936767|NCT02720068|449398375|FG011|Overall Study|Withdrawal by Subject|27|||
124936768|NCT02720068|449398376|FG012|Overall Study|Withdrawal by Subject|2|||
124936769|NCT02720068|449398377|FG013|Overall Study|Withdrawal by Subject|8|||
124936770|NCT02720068|449398378|FG014|Overall Study|Withdrawal by Subject|7|||
124936771|NCT02720068|449398379|FG015|Overall Study|Withdrawal by Subject|0|||
124936772|NCT02720068|449398380|FG016|Overall Study|Withdrawal by Subject|0|||
124702912|NCT00522379|448535738|FG000|Overall Study|Randomization error|0|||
124936773|NCT02720068|449398381|FG017|Overall Study|Withdrawal by Subject|2|||
124936774|NCT02720068|449398364|FG000|Overall Study|Protocol Violation|0|||
124936775|NCT02720068|449398365|FG001|Overall Study|Protocol Violation|0|||
124936776|NCT02720068|449398366|FG002|Overall Study|Protocol Violation|0|||
124936777|NCT02720068|449398367|FG003|Overall Study|Protocol Violation|0|||
124936778|NCT02720068|449398368|FG004|Overall Study|Protocol Violation|0|||
124936779|NCT02720068|449398369|FG005|Overall Study|Protocol Violation|0|||
124936780|NCT02720068|449398370|FG006|Overall Study|Protocol Violation|0|||
124936781|NCT02720068|449398371|FG007|Overall Study|Protocol Violation|0|||
124936782|NCT02720068|449398372|FG008|Overall Study|Protocol Violation|0|||
124936783|NCT02720068|449398373|FG009|Overall Study|Protocol Violation|0|||
124936784|NCT02720068|449398374|FG010|Overall Study|Protocol Violation|1|||
124936785|NCT02720068|449398375|FG011|Overall Study|Protocol Violation|0|||
124936786|NCT02720068|449398376|FG012|Overall Study|Protocol Violation|0|||
124546489|NCT00320801|447955916|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
124702913|NCT00522379|448535739|FG001|Overall Study|Randomization error|0|||
124936787|NCT02720068|449398377|FG013|Overall Study|Protocol Violation|0|||
124936788|NCT02720068|449398378|FG014|Overall Study|Protocol Violation|1|||
124936789|NCT02720068|449398379|FG015|Overall Study|Protocol Violation|0|||
124936790|NCT02720068|449398380|FG016|Overall Study|Protocol Violation|1|||
124936791|NCT02720068|449398381|FG017|Overall Study|Protocol Violation|0|||
124936792|NCT00495677|449398382|FG000|Stage 1 (25 Days)|Adverse Event|0|||
124936793|NCT00495677|449398383|FG001|Stage 1 (25 Days)|Adverse Event|0|||
124936794|NCT00495677|449398384|FG002|Stage 1 (25 Days)|Adverse Event|1|||
124936795|NCT00495677|449398385|FG003|Stage 1 (25 Days)|Adverse Event|0|||
124456120|NCT00078325|447630345|FG000|Overall Study|Physician Decision|2|||
124456121|NCT00078325|447630346|FG001|Overall Study|Physician Decision|0|||
124456122|NCT00078325|447630347|FG002|Overall Study|Physician Decision|1|||
124936796|NCT00495677|449398386|FG004|Stage 1 (25 Days)|Adverse Event|0|||
124936797|NCT00495677|449398387|FG005|Stage 1 (25 Days)|Adverse Event|0|||
124936798|NCT00495677|449398388|FG006|Stage 1 (25 Days)|Adverse Event|0|||
124936799|NCT03786926|449398391|FG000|Overall Study|Adverse Event|0|||
124936800|NCT03786926|449398392|FG001|Overall Study|Adverse Event|0|||
124936801|NCT03786926|449398393|FG002|Overall Study|Adverse Event|0|||
124936802|NCT03786926|449398394|FG003|Overall Study|Adverse Event|0|||
124936803|NCT03786926|449398395|FG004|Overall Study|Adverse Event|0|||
124936804|NCT03786926|449398396|FG005|Overall Study|Adverse Event|0|||
124936805|NCT03786926|449398397|FG006|Overall Study|Adverse Event|0|||
124936806|NCT03786926|449398398|FG007|Overall Study|Adverse Event|1|||
124936807|NCT03786926|449398399|FG008|Overall Study|Adverse Event|1|||
124936808|NCT03786926|449398400|FG009|Overall Study|Adverse Event|0|||
124936809|NCT03786926|449398401|FG010|Overall Study|Adverse Event|1|||
124936810|NCT03786926|449398391|FG000|Overall Study|Progressive disease|3|||
124936811|NCT03786926|449398392|FG001|Overall Study|Progressive disease|0|||
124936812|NCT03786926|449398393|FG002|Overall Study|Progressive disease|3|||
124936813|NCT03786926|449398394|FG003|Overall Study|Progressive disease|1|||
124936814|NCT03786926|449398395|FG004|Overall Study|Progressive disease|2|||
124936815|NCT03786926|449398396|FG005|Overall Study|Progressive disease|2|||
124936816|NCT03786926|449398397|FG006|Overall Study|Progressive disease|1|||
124936817|NCT03786926|449398398|FG007|Overall Study|Progressive disease|6|||
124936818|NCT03786926|449398399|FG008|Overall Study|Progressive disease|1|||
124936819|NCT03786926|449398400|FG009|Overall Study|Progressive disease|1|||
124936820|NCT03786926|449398401|FG010|Overall Study|Progressive disease|1|||
124936821|NCT03786926|449398391|FG000|Overall Study|Death|0|||
124456123|NCT00078325|447630345|FG000|Overall Study|Miscellaneous|1|||
124456124|NCT00078325|447630346|FG001|Overall Study|Miscellaneous|1|||
124456125|NCT00078325|447630347|FG002|Overall Study|Miscellaneous|1|||
124456126|NCT00578136|447630348|FG000|Overall Study|Not given intervention|1|||
124456127|NCT00578136|447630349|FG001|Overall Study|Not given intervention|1|||
124936822|NCT03786926|449398392|FG001|Overall Study|Death|1|||
124936823|NCT03786926|449398393|FG002|Overall Study|Death|1|||
124936824|NCT03786926|449398394|FG003|Overall Study|Death|0|||
124936825|NCT03786926|449398395|FG004|Overall Study|Death|0|||
124456128|NCT02047253|447630350|FG000|Overall Study|Lost to Follow-up|8|||
124936826|NCT03786926|449398396|FG005|Overall Study|Death|0|||
124702914|NCT00522379|448535740|FG002|Overall Study|Randomization error|0|||
124936827|NCT03786926|449398397|FG006|Overall Study|Death|0|||
124936828|NCT03786926|449398398|FG007|Overall Study|Death|0|||
124936829|NCT03786926|449398399|FG008|Overall Study|Death|0|||
124936830|NCT03786926|449398400|FG009|Overall Study|Death|1|||
124936831|NCT03786926|449398401|FG010|Overall Study|Death|2|||
124936832|NCT03786926|449398391|FG000|Overall Study|Physician Decision|0|||
124936833|NCT03786926|449398392|FG001|Overall Study|Physician Decision|1|||
124936834|NCT03786926|449398393|FG002|Overall Study|Physician Decision|0|||
124936835|NCT03786926|449398394|FG003|Overall Study|Physician Decision|1|||
124936836|NCT03786926|449398395|FG004|Overall Study|Physician Decision|2|||
124936837|NCT03786926|449398396|FG005|Overall Study|Physician Decision|0|||
124936838|NCT03786926|449398397|FG006|Overall Study|Physician Decision|0|||
124936839|NCT03786926|449398398|FG007|Overall Study|Physician Decision|2|||
124936840|NCT03786926|449398399|FG008|Overall Study|Physician Decision|1|||
124936841|NCT03786926|449398400|FG009|Overall Study|Physician Decision|1|||
124936842|NCT03786926|449398401|FG010|Overall Study|Physician Decision|0|||
124936843|NCT03786926|449398391|FG000|Overall Study|Withdrawal by Subject|0|||
124936844|NCT03786926|449398392|FG001|Overall Study|Withdrawal by Subject|1|||
124936845|NCT03786926|449398393|FG002|Overall Study|Withdrawal by Subject|1|||
124936846|NCT03786926|449398394|FG003|Overall Study|Withdrawal by Subject|0|||
124936847|NCT03786926|449398395|FG004|Overall Study|Withdrawal by Subject|0|||
124936848|NCT03786926|449398396|FG005|Overall Study|Withdrawal by Subject|0|||
124936849|NCT03786926|449398397|FG006|Overall Study|Withdrawal by Subject|1|||
124936850|NCT03786926|449398398|FG007|Overall Study|Withdrawal by Subject|0|||
124936851|NCT03786926|449398399|FG008|Overall Study|Withdrawal by Subject|1|||
124936852|NCT03786926|449398400|FG009|Overall Study|Withdrawal by Subject|0|||
124936853|NCT03786926|449398401|FG010|Overall Study|Withdrawal by Subject|1|||
124936854|NCT03786926|449398391|FG000|Overall Study|Study terminated by Sponsor|0|||
124936855|NCT03786926|449398392|FG001|Overall Study|Study terminated by Sponsor|0|||
124936856|NCT03786926|449398393|FG002|Overall Study|Study terminated by Sponsor|0|||
124936857|NCT03786926|449398394|FG003|Overall Study|Study terminated by Sponsor|0|||
124936858|NCT03786926|449398395|FG004|Overall Study|Study terminated by Sponsor|1|||
124936859|NCT03786926|449398396|FG005|Overall Study|Study terminated by Sponsor|0|||
124936860|NCT03786926|449398397|FG006|Overall Study|Study terminated by Sponsor|0|||
124936861|NCT03786926|449398398|FG007|Overall Study|Study terminated by Sponsor|4|||
124936862|NCT03786926|449398399|FG008|Overall Study|Study terminated by Sponsor|0|||
124936863|NCT03786926|449398400|FG009|Overall Study|Study terminated by Sponsor|0|||
124936864|NCT03786926|449398401|FG010|Overall Study|Study terminated by Sponsor|0|||
124936865|NCT03786926|449398391|FG000|Overall Study|Anti-neoplasm treatment|0|||
124936866|NCT03786926|449398392|FG001|Overall Study|Anti-neoplasm treatment|0|||
124936867|NCT03786926|449398393|FG002|Overall Study|Anti-neoplasm treatment|0|||
124936868|NCT03786926|449398394|FG003|Overall Study|Anti-neoplasm treatment|0|||
124936869|NCT03786926|449398395|FG004|Overall Study|Anti-neoplasm treatment|1|||
124936870|NCT03786926|449398396|FG005|Overall Study|Anti-neoplasm treatment|0|||
124936871|NCT03786926|449398397|FG006|Overall Study|Anti-neoplasm treatment|1|||
124936872|NCT03786926|449398398|FG007|Overall Study|Anti-neoplasm treatment|0|||
124936873|NCT03786926|449398399|FG008|Overall Study|Anti-neoplasm treatment|0|||
124936874|NCT03786926|449398400|FG009|Overall Study|Anti-neoplasm treatment|0|||
124936875|NCT03786926|449398401|FG010|Overall Study|Anti-neoplasm treatment|0|||
124936876|NCT03786926|449398391|FG000|Overall Study|Other|0|||
124936877|NCT03786926|449398392|FG001|Overall Study|Other|0|||
124936878|NCT03786926|449398393|FG002|Overall Study|Other|0|||
124936879|NCT03786926|449398394|FG003|Overall Study|Other|1|||
124936880|NCT03786926|449398395|FG004|Overall Study|Other|0|||
124936881|NCT03786926|449398396|FG005|Overall Study|Other|1|||
124936882|NCT03786926|449398397|FG006|Overall Study|Other|0|||
124936883|NCT03786926|449398398|FG007|Overall Study|Other|0|||
124936884|NCT03786926|449398399|FG008|Overall Study|Other|2|||
124456129|NCT03710486|447630352|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
124702915|NCT00522379|448535741|FG003|Overall Study|Randomization error|0|||
124702916|NCT00522379|448535742|FG004|Overall Study|Randomization error|1|||
124936885|NCT03786926|449398400|FG009|Overall Study|Other|0|||
124702917|NCT00522379|448535738|FG000|Overall Study|Dispensing error|1|||
124936886|NCT03786926|449398401|FG010|Overall Study|Other|0|||
124936887|NCT05875701|449398405|FG000|Overall Study|Lost to Follow-up|2|||
124936888|NCT05875701|449398406|FG001|Overall Study|Lost to Follow-up|0|||
124936889|NCT05875701|449398405|FG000|Overall Study|Withdrawal by Subject|1|||
124936890|NCT05875701|449398406|FG001|Overall Study|Withdrawal by Subject|1|||
124936891|NCT04174560|449398408|FG000|Overall Study|Lost to Follow-up|1|||
124936892|NCT04174560|449398409|FG001|Overall Study|Lost to Follow-up|0|||
124936893|NCT04174560|449398410|FG002|Overall Study|Lost to Follow-up|0|||
124936894|NCT04174560|449398411|FG003|Overall Study|Lost to Follow-up|0|||
124936895|NCT04174560|449398408|FG000|Overall Study|Withdrawal by Subject|0|||
124936896|NCT04174560|449398409|FG001|Overall Study|Withdrawal by Subject|0|||
124936897|NCT04174560|449398410|FG002|Overall Study|Withdrawal by Subject|2|||
124456130|NCT03710486|447630353|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
124456131|NCT03710486|447630352|FG000|Overall Study|Missing|0|||
124936898|NCT04174560|449398411|FG003|Overall Study|Withdrawal by Subject|0|||
124702918|NCT00522379|448535739|FG001|Overall Study|Dispensing error|0|||
124702919|NCT00522379|448535740|FG002|Overall Study|Dispensing error|0|||
124702920|NCT00522379|448535741|FG003|Overall Study|Dispensing error|1|||
124702921|NCT00522379|448535742|FG004|Overall Study|Dispensing error|0|||
124702922|NCT00522379|448535738|FG000|Overall Study|Subject Moved|1|||
124702923|NCT00522379|448535739|FG001|Overall Study|Subject Moved|1|||
124764950|NCT04664153|448765073|FG001|Overall Study|Adverse Event|0|||
124764951|NCT04664153|448765074|FG002|Overall Study|Adverse Event|1|||
124764952|NCT04664153|448765075|FG003|Overall Study|Adverse Event|0|||
124702924|NCT00522379|448535740|FG002|Overall Study|Subject Moved|0|||
124702925|NCT00522379|448535741|FG003|Overall Study|Subject Moved|0|||
124702926|NCT00522379|448535742|FG004|Overall Study|Subject Moved|0|||
124702927|NCT00522379|448535738|FG000|Overall Study|Sponsor Request|0|||
124702928|NCT00522379|448535739|FG001|Overall Study|Sponsor Request|1|||
124702929|NCT00522379|448535740|FG002|Overall Study|Sponsor Request|0|||
124702930|NCT00522379|448535741|FG003|Overall Study|Sponsor Request|0|||
124702931|NCT00522379|448535742|FG004|Overall Study|Sponsor Request|0|||
124702932|NCT00522379|448535738|FG000|Overall Study|Family Problem|0|||
124702933|NCT00522379|448535739|FG001|Overall Study|Family Problem|0|||
124702934|NCT00522379|448535740|FG002|Overall Study|Family Problem|1|||
124702935|NCT00522379|448535741|FG003|Overall Study|Family Problem|0|||
124702936|NCT00522379|448535742|FG004|Overall Study|Family Problem|0|||
124702937|NCT00522379|448535738|FG000|Overall Study|Site Closed|0|||
124702938|NCT00522379|448535739|FG001|Overall Study|Site Closed|0|||
124764953|NCT01045460|448765076|FG000|Overall Study|Physician Decision|3|||
124764954|NCT01045460|448765077|FG001|Overall Study|Physician Decision|2|||
124702939|NCT00522379|448535740|FG002|Overall Study|Site Closed|0|||
124702940|NCT00522379|448535741|FG003|Overall Study|Site Closed|1|||
124702941|NCT00522379|448535742|FG004|Overall Study|Site Closed|0|||
124702942|NCT00522379|448535738|FG000|Overall Study|Subject Withdrawal|0|||
124764955|NCT01045460|448765076|FG000|Overall Study|Lost to Follow-up|0|||
124764956|NCT01045460|448765077|FG001|Overall Study|Lost to Follow-up|1|||
124702943|NCT00522379|448535739|FG001|Overall Study|Subject Withdrawal|0|||
124764957|NCT01045460|448765076|FG000|Overall Study|Lack of Efficacy|3|||
124702944|NCT00522379|448535740|FG002|Overall Study|Subject Withdrawal|0|||
124702945|NCT00522379|448535741|FG003|Overall Study|Subject Withdrawal|1|||
124702946|NCT00522379|448535742|FG004|Overall Study|Subject Withdrawal|0|||
124702947|NCT00967499|448535747|FG000|Overall Study|Adverse Event|0|||
124702948|NCT00967499|448535748|FG001|Overall Study|Adverse Event|1|||
124702949|NCT00967499|448535747|FG000|Overall Study|Protocol Violation|1|||
124702950|NCT00967499|448535748|FG001|Overall Study|Protocol Violation|0|||
124936899|NCT04046549|449398415|FG000|Overall Study|Adverse Event|1|||
124936900|NCT04046549|449398415|FG000|Overall Study|Physician Decision|1|||
124936901|NCT04046549|449398415|FG000|Overall Study|Withdrawal by Subject|3|||
124936902|NCT04046549|449398415|FG000|Overall Study|Other, Not Specified|5|||
124702951|NCT00967499|448535747|FG000|Overall Study|Sponsor Decision|1|||
124702952|NCT00967499|448535748|FG001|Overall Study|Sponsor Decision|0|||
124702953|NCT00967499|448535747|FG000|Overall Study|Randomized but not treated|63|||
124702954|NCT00967499|448535748|FG001|Overall Study|Randomized but not treated|59|||
124936903|NCT04012567|449398416|FG000|Overall Study|Lost to Follow-up|0|||
124936904|NCT04012567|449398417|FG001|Overall Study|Lost to Follow-up|1|||
124936905|NCT04012567|449398416|FG000|Overall Study|Withdrawal by Subject|1|||
124936906|NCT04012567|449398417|FG001|Overall Study|Withdrawal by Subject|0|||
124936907|NCT03705793|449399202|FG000|Overall Study|Lost to Follow-up|3|||
124936908|NCT03705793|449399203|FG001|Overall Study|Lost to Follow-up|4|||
124936909|NCT03705793|449399202|FG000|Overall Study|Withdrawal by Subject|2|||
124936910|NCT03705793|449399203|FG001|Overall Study|Withdrawal by Subject|1|||
124936911|NCT00113360|449399207|FG000|Overall Study|Adverse Event|3|||
124936912|NCT00113360|449399207|FG000|Overall Study|Subject required surgery|1|||
124936913|NCT00113360|449399207|FG000|Overall Study|Did not meet eligibility criteria|3|||
124936914|NCT02467270|449399210|FG000|Overall Study|Participants Never Treated|0|||
124936915|NCT02467270|449399211|FG001|Overall Study|Participants Never Treated|1|||
124936916|NCT02467270|449399212|FG002|Overall Study|Participants Never Treated|0|||
124936917|NCT02467270|449399210|FG000|Overall Study|Ongoing|50|||
124936918|NCT02467270|449399211|FG001|Overall Study|Ongoing|41|||
124936919|NCT02467270|449399212|FG002|Overall Study|Ongoing|43|||
124936920|NCT02467270|449399210|FG000|Overall Study|Adverse Event|16|||
124936921|NCT02467270|449399211|FG001|Overall Study|Adverse Event|15|||
124936922|NCT02467270|449399212|FG002|Overall Study|Adverse Event|14|||
124936923|NCT02467270|449399210|FG000|Overall Study|Progressive Disease|7|||
124936924|NCT02467270|449399211|FG001|Overall Study|Progressive Disease|7|||
124936925|NCT02467270|449399212|FG002|Overall Study|Progressive Disease|4|||
124936926|NCT02467270|449399210|FG000|Overall Study|Death|2|||
124936927|NCT02467270|449399211|FG001|Overall Study|Death|0|||
124936928|NCT02467270|449399212|FG002|Overall Study|Death|2|||
124936929|NCT02467270|449399210|FG000|Overall Study|Lack of Efficacy|12|||
124936930|NCT02467270|449399211|FG001|Overall Study|Lack of Efficacy|18|||
124936931|NCT02467270|449399212|FG002|Overall Study|Lack of Efficacy|23|||
124936932|NCT02467270|449399210|FG000|Overall Study|Non-compliance With Study Drug|0|||
124936933|NCT02467270|449399211|FG001|Overall Study|Non-compliance With Study Drug|2|||
124936934|NCT02467270|449399212|FG002|Overall Study|Non-compliance With Study Drug|1|||
124936935|NCT02467270|449399210|FG000|Overall Study|Lost to Follow-up|2|||
124936936|NCT02467270|449399211|FG001|Overall Study|Lost to Follow-up|1|||
124936937|NCT02467270|449399212|FG002|Overall Study|Lost to Follow-up|0|||
124936938|NCT02467270|449399210|FG000|Overall Study|Pregnancy|0|||
124936939|NCT02467270|449399211|FG001|Overall Study|Pregnancy|1|||
124936940|NCT02467270|449399212|FG002|Overall Study|Pregnancy|0|||
124936941|NCT02467270|449399210|FG000|Overall Study|Physician Decision|0|||
124936942|NCT02467270|449399211|FG001|Overall Study|Physician Decision|4|||
124936943|NCT02467270|449399212|FG002|Overall Study|Physician Decision|1|||
124936944|NCT02467270|449399210|FG000|Overall Study|Withdrawal by Subject|4|||
124936945|NCT02467270|449399211|FG001|Overall Study|Withdrawal by Subject|3|||
124936946|NCT02467270|449399212|FG002|Overall Study|Withdrawal by Subject|5|||
124936947|NCT02467270|449399210|FG000|Overall Study|Reason not Specified|1|||
124936948|NCT02467270|449399211|FG001|Overall Study|Reason not Specified|2|||
124936949|NCT02467270|449399212|FG002|Overall Study|Reason not Specified|1|||
124936950|NCT04129164|449399219|FG000|Overall Study|Non-compliance with procedures|0|||
124936951|NCT04129164|449399220|FG001|Overall Study|Non-compliance with procedures|0|||
124936952|NCT04129164|449399221|FG002|Overall Study|Non-compliance with procedures|2|||
124936953|NCT04129164|449399222|FG003|Overall Study|Non-compliance with procedures|0|||
124936954|NCT04129164|449399219|FG000|Overall Study|Adverse Event|0|||
124936955|NCT04129164|449399220|FG001|Overall Study|Adverse Event|0|||
124936956|NCT04129164|449399221|FG002|Overall Study|Adverse Event|2|||
124936957|NCT04129164|449399222|FG003|Overall Study|Adverse Event|0|||
124936958|NCT04129164|449399219|FG000|Overall Study|Pregnancy|0|||
124936959|NCT04129164|449399220|FG001|Overall Study|Pregnancy|0|||
124702955|NCT02607722|448535750|FG000|Overall Study|No data reliability|1|||
124702956|NCT02607722|448535750|FG000|Overall Study|no patient visit|18|||
124702957|NCT02607722|448535750|FG000|Overall Study|missing info in CRF|13|||
124702958|NCT02607722|448535750|FG000|Overall Study|Withdrawal by Subject|616|||
124702959|NCT02607722|448535750|FG000|Overall Study|Lost to Follow-up|312|||
124936960|NCT04129164|449399221|FG002|Overall Study|Pregnancy|0|||
124936961|NCT04129164|449399222|FG003|Overall Study|Pregnancy|1|||
124936962|NCT04129164|449399219|FG000|Overall Study|Withdrawal by Subject|3|||
124936963|NCT04129164|449399220|FG001|Overall Study|Withdrawal by Subject|2|||
124936964|NCT04129164|449399221|FG002|Overall Study|Withdrawal by Subject|4|||
124936965|NCT04129164|449399222|FG003|Overall Study|Withdrawal by Subject|6|||
124936966|NCT04129164|449399219|FG000|Overall Study|Death|0|||
124936967|NCT04129164|449399220|FG001|Overall Study|Death|1|||
124936968|NCT04129164|449399221|FG002|Overall Study|Death|0|||
124936969|NCT04129164|449399222|FG003|Overall Study|Death|0|||
124936970|NCT04129164|449399219|FG000|Overall Study|Lost to Follow-up|0|||
124936971|NCT04129164|449399220|FG001|Overall Study|Lost to Follow-up|1|||
124936972|NCT04129164|449399221|FG002|Overall Study|Lost to Follow-up|0|||
124936973|NCT04129164|449399222|FG003|Overall Study|Lost to Follow-up|0|||
124936974|NCT03868930|449399223|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
124936975|NCT03868930|449399224|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
124702960|NCT02607722|448535750|FG000|Overall Study|Improved|22|||
124702961|NCT02607722|448535750|FG000|Overall Study|Lack of Efficacy|316|||
124936976|NCT03868930|449399223|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
124456132|NCT03710486|447630353|FG001|Overall Study|Missing|2|||
124456133|NCT01987960|447630354|FG000|Period 1|Adverse Event|24|||
124936977|NCT03868930|449399224|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
124936978|NCT03868930|449399223|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
124936979|NCT03868930|449399224|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
124936980|NCT03868930|449399223|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
124936981|NCT03868930|449399224|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
124936982|NCT03868930|449399223|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
124936983|NCT03868930|449399224|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
124936984|NCT03286114|449399227|FG000|Overall Study|Adverse Event|6|||
124936985|NCT03286114|449399227|FG000|Overall Study|Death|3|||
124936986|NCT01773993|449399229|FG000|Overall Study|No Visit After Treatment|35|||
124936987|NCT04664881|449399230|FG000|Overall Study|Withdrawal by Subject|1|||
124936988|NCT04664881|449399231|FG001|Overall Study|Withdrawal by Subject|8|||
124936989|NCT04664881|449399230|FG000|Overall Study|Physician Decision|0|||
124936990|NCT04664881|449399231|FG001|Overall Study|Physician Decision|5|||
124936991|NCT04664881|449399230|FG000|Overall Study|Lost to Follow-up|1|||
124936992|NCT04664881|449399231|FG001|Overall Study|Lost to Follow-up|0|||
124936993|NCT02231749|449399232|FG000|Overall Study|Disease progression|229|||
124936994|NCT02231749|449399233|FG001|Overall Study|Disease progression|297|||
124936995|NCT02231749|449399232|FG000|Overall Study|Study Drug Toxicity|134|||
124936996|NCT02231749|449399233|FG001|Overall Study|Study Drug Toxicity|63|||
124936997|NCT02231749|449399232|FG000|Overall Study|Death|1|||
124936998|NCT02231749|449399233|FG001|Overall Study|Death|1|||
124936999|NCT02231749|449399232|FG000|Overall Study|AE unrelated to Study drug|32|||
124937000|NCT02231749|449399233|FG001|Overall Study|AE unrelated to Study drug|31|||
124937001|NCT02231749|449399232|FG000|Overall Study|Participant's request to discontinue|10|||
124937002|NCT02231749|449399233|FG001|Overall Study|Participant's request to discontinue|21|||
124937003|NCT02231749|449399232|FG000|Overall Study|Participant withdrew Consent|8|||
124937004|NCT02231749|449399233|FG001|Overall Study|Participant withdrew Consent|15|||
124937005|NCT02231749|449399232|FG000|Overall Study|Lost to Follow-up|1|||
124937006|NCT02231749|449399233|FG001|Overall Study|Lost to Follow-up|2|||
124937007|NCT02231749|449399232|FG000|Overall Study|Maximum Clinical Benefit|5|||
124937008|NCT02231749|449399233|FG001|Overall Study|Maximum Clinical Benefit|8|||
124937009|NCT02231749|449399232|FG000|Overall Study|Poor/Non-Compliance|0|||
124937010|NCT02231749|449399233|FG001|Overall Study|Poor/Non-Compliance|3|||
124937011|NCT02231749|449399232|FG000|Overall Study|Pregnancy|1|||
124937012|NCT02231749|449399233|FG001|Overall Study|Pregnancy|0|||
124937013|NCT02231749|449399232|FG000|Overall Study|other|0|||
124937014|NCT02231749|449399233|FG001|Overall Study|other|8|||
124937015|NCT02231749|449399232|FG000|Overall Study|No longer meets Study Criteria|1|||
124937016|NCT02231749|449399233|FG001|Overall Study|No longer meets Study Criteria|0|||
124937017|NCT02656706|449399242|FG000|Overall Study|Insurance Denial|1|||
124937018|NCT03725332|449399243|FG000|Overall Study|Adverse Event|5|||
124937019|NCT03725332|449399244|FG001|Overall Study|Adverse Event|10|||
124937020|NCT03725332|449399243|FG000|Overall Study|Death|1|||
124937021|NCT03725332|449399244|FG001|Overall Study|Death|3|||
124937022|NCT03725332|449399243|FG000|Overall Study|Lost to Follow-up|43|||
124937023|NCT03725332|449399244|FG001|Overall Study|Lost to Follow-up|122|||
124937024|NCT03725332|449399243|FG000|Overall Study|Withdrawal by Subject|0|||
124937025|NCT03725332|449399244|FG001|Overall Study|Withdrawal by Subject|1|||
124937026|NCT03725332|449399243|FG000|Overall Study|Duplicate enrollment|0|||
124937027|NCT03725332|449399244|FG001|Overall Study|Duplicate enrollment|1|||
124937028|NCT03725332|449399243|FG000|Overall Study|Did not consent|0|||
124937029|NCT03725332|449399244|FG001|Overall Study|Did not consent|1|||
124937030|NCT05707351|449399247|FG000|Overall Study|Withdrawal by Subject|2|||
124937031|NCT05707351|449399247|FG000|Overall Study|Reason Not Specified|1|||
124937032|NCT02951052|449399251|FG000|Overall Study|Adverse Event|13|||
124937033|NCT02951052|449399252|FG001|Overall Study|Adverse Event|5|||
124937034|NCT02951052|449399251|FG000|Overall Study|Withdrawal by Subject|1|||
124937035|NCT02951052|449399252|FG001|Overall Study|Withdrawal by Subject|5|||
124456134|NCT01987960|447630355|FG001|Period 1|Adverse Event|0|||
124937036|NCT02951052|449399251|FG000|Overall Study|Physician Decision|2|||
124937037|NCT02951052|449399252|FG001|Overall Study|Physician Decision|0|||
124937038|NCT02951052|449399251|FG000|Overall Study|Lost to Follow-up|1|||
124937039|NCT02951052|449399252|FG001|Overall Study|Lost to Follow-up|1|||
124937040|NCT02951052|449399251|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
124937041|NCT02951052|449399252|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
124937042|NCT02951052|449399251|FG000|Overall Study|Protocol Violation|5|||
124456135|NCT01987960|447630356|FG002|Period 1|Adverse Event|0|||
124937043|NCT02951052|449399252|FG001|Overall Study|Protocol Violation|3|||
124937044|NCT02951052|449399251|FG000|Overall Study|Lack of Efficacy|3|||
124937045|NCT02951052|449399252|FG001|Overall Study|Lack of Efficacy|4|||
124937046|NCT02951052|449399251|FG000|Overall Study|Ongoing|1|||
124937047|NCT02951052|449399252|FG001|Overall Study|Ongoing|0|||
124937048|NCT03891758|449399259|FG000|Overall Study|Adverse Event|2|||
124937049|NCT03891758|449399260|FG001|Overall Study|Adverse Event|0|||
124456136|NCT01987960|447630357|FG003|Period 1|Adverse Event|0|||
124702962|NCT02607722|448535750|FG000|Overall Study|Adverse Event|2553|||
124702963|NCT02607722|448535750|FG000|Overall Study|Not treated|1|||
124937050|NCT03891758|449399259|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124937051|NCT03891758|449399260|FG001|Overall Study|Withdrawal by parent/guardian|2|||
124937052|NCT05795153|449399974|FG000|Overall Study|Adverse Event|2|||
124937053|NCT05795153|449399974|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124937054|NCT05795153|449399974|FG000|Overall Study|Lost to Follow-up|1|||
124937055|NCT05795153|449399974|FG000|Overall Study|Subject decision|2|||
124937056|NCT04644029|449399977|FG000|Overall Study|Death|1|||
124937057|NCT04644029|449399978|FG001|Overall Study|Death|0|||
124937058|NCT04644029|449399977|FG000|Overall Study|Physician Decision|1|||
124937059|NCT04644029|449399978|FG001|Overall Study|Physician Decision|2|||
124937060|NCT04644029|449399977|FG000|Overall Study|Withdrawal by Subject|21|||
124937061|NCT04644029|449399978|FG001|Overall Study|Withdrawal by Subject|19|||
124937062|NCT04644029|449399977|FG000|Overall Study|Lost to Follow-up|31|||
124937063|NCT04644029|449399978|FG001|Overall Study|Lost to Follow-up|34|||
124937064|NCT04644029|449399977|FG000|Overall Study|Study Terminated by Sponsor|308|||
124937065|NCT04644029|449399978|FG001|Overall Study|Study Terminated by Sponsor|309|||
124937066|NCT04644029|449399977|FG000|Overall Study|Randomized in Error|2|||
124937067|NCT04644029|449399978|FG001|Overall Study|Randomized in Error|1|||
124937068|NCT04644029|449399977|FG000|Overall Study|Other|0|||
124937069|NCT04644029|449399978|FG001|Overall Study|Other|1|||
124937070|NCT00739908|449399979|FG000|Overall Study|Adverse Event|5|||
124937071|NCT00739908|449399980|FG001|Overall Study|Adverse Event|6|||
124937072|NCT00739908|449399979|FG000|Overall Study|Withdrawal by Subject|4|||
124937073|NCT00739908|449399980|FG001|Overall Study|Withdrawal by Subject|2|||
124937074|NCT00739908|449399979|FG000|Overall Study|Lost to Follow-up|14|||
124937075|NCT00739908|449399980|FG001|Overall Study|Lost to Follow-up|9|||
124937076|NCT00739908|449399979|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
124937077|NCT00739908|449399980|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
124937078|NCT00739908|449399979|FG000|Overall Study|Non-Compliance With Study Medication|0|||
124937079|NCT00739908|449399980|FG001|Overall Study|Non-Compliance With Study Medication|3|||
124937080|NCT00739908|449399979|FG000|Overall Study|Lack of Efficacy|0|||
124937081|NCT00739908|449399980|FG001|Overall Study|Lack of Efficacy|1|||
124937082|NCT00739908|449399979|FG000|Overall Study|Relocation|0|||
124937083|NCT00739908|449399980|FG001|Overall Study|Relocation|1|||
124937084|NCT03875313|449399981|FG000|Overall Study|Withdrawal by Subject|1|||
124937085|NCT03875313|449399982|FG001|Overall Study|Withdrawal by Subject|3|||
124937086|NCT03875313|449399983|FG002|Overall Study|Withdrawal by Subject|0|||
124937087|NCT03875313|449399984|FG003|Overall Study|Withdrawal by Subject|0|||
124937088|NCT03875313|449399985|FG004|Overall Study|Withdrawal by Subject|0|||
124937089|NCT03875313|449399981|FG000|Overall Study|Death|0|||
124937090|NCT03875313|449399982|FG001|Overall Study|Death|0|||
124937091|NCT03875313|449399983|FG002|Overall Study|Death|0|||
124937092|NCT03875313|449399984|FG003|Overall Study|Death|0|||
124937093|NCT03875313|449399985|FG004|Overall Study|Death|1|||
124937094|NCT03875313|449399981|FG000|Overall Study|Lost to Follow-up|0|||
124937095|NCT03875313|449399982|FG001|Overall Study|Lost to Follow-up|0|||
124937096|NCT03875313|449399983|FG002|Overall Study|Lost to Follow-up|0|||
124937097|NCT03875313|449399984|FG003|Overall Study|Lost to Follow-up|0|||
124937098|NCT03875313|449399985|FG004|Overall Study|Lost to Follow-up|1|||
124937099|NCT03875313|449399981|FG000|Overall Study|Study Termination by Sponsor|0|||
124546490|NCT00320801|447955917|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
124546491|NCT00320801|447955918|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
124702964|NCT02607722|448535750|FG000|Overall Study|No CRF collected|138|||
124702965|NCT02607722|448535750|FG000|Overall Study|without CRF|4225|||
124702966|NCT02607722|448535750|FG000|Overall Study|Physician Decision|367|||
124702967|NCT04562090|448535751|FG000|Overall Study|Withdrawal by Subject|3|||
124937100|NCT03875313|449399982|FG001|Overall Study|Study Termination by Sponsor|1|||
124702968|NCT04562090|448535752|FG001|Overall Study|Withdrawal by Subject|4|||
124937101|NCT03875313|449399983|FG002|Overall Study|Study Termination by Sponsor|1|||
124702969|NCT04562090|448535751|FG000|Overall Study|Protocol Violation|2|||
124937102|NCT03875313|449399984|FG003|Overall Study|Study Termination by Sponsor|0|||
124937103|NCT03875313|449399985|FG004|Overall Study|Study Termination by Sponsor|1|||
124937104|NCT03875313|449399981|FG000|Overall Study|New Anticancer Treatment|0|||
124937105|NCT03875313|449399982|FG001|Overall Study|New Anticancer Treatment|1|||
124937106|NCT03875313|449399983|FG002|Overall Study|New Anticancer Treatment|2|||
124937107|NCT03875313|449399984|FG003|Overall Study|New Anticancer Treatment|1|||
124937108|NCT03875313|449399985|FG004|Overall Study|New Anticancer Treatment|0|||
124937109|NCT03875313|449399981|FG000|Overall Study|Other, Not Specified|2|||
124937110|NCT03875313|449399982|FG001|Overall Study|Other, Not Specified|11|||
124937111|NCT03875313|449399983|FG002|Overall Study|Other, Not Specified|3|||
124937112|NCT03875313|449399984|FG003|Overall Study|Other, Not Specified|3|||
124937113|NCT03875313|449399985|FG004|Overall Study|Other, Not Specified|1|||
124937114|NCT04121546|449399986|FG000|Overall Study|Lost to Follow-up|1|||
124937115|NCT04121546|449399987|FG001|Overall Study|Lost to Follow-up|3|||
124937116|NCT01046825|449399990|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
124764958|NCT01045460|448765077|FG001|Overall Study|Lack of Efficacy|0|||
124764959|NCT00097500|448765078|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
124937117|NCT01046825|449399991|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
124937118|NCT01046825|449399992|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
124937119|NCT01046825|449399993|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
124937120|NCT01046825|449399994|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
124937121|NCT01046825|449399990|FG000|Overall Study|Physician Decision|0|||
124937122|NCT01046825|449399991|FG001|Overall Study|Physician Decision|1|||
124937123|NCT01046825|449399992|FG002|Overall Study|Physician Decision|2|||
124937124|NCT01046825|449399993|FG003|Overall Study|Physician Decision|0|||
124937125|NCT01046825|449399994|FG004|Overall Study|Physician Decision|0|||
124937126|NCT01046825|449399990|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
124937127|NCT01046825|449399991|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
124937128|NCT01046825|449399992|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
124937129|NCT01046825|449399993|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
124937130|NCT01046825|449399994|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
124937131|NCT01046825|449399990|FG000|Overall Study|Found to be ineligible|0|||
124937132|NCT01046825|449399991|FG001|Overall Study|Found to be ineligible|1|||
124937133|NCT01046825|449399992|FG002|Overall Study|Found to be ineligible|0|||
124937134|NCT01046825|449399993|FG003|Overall Study|Found to be ineligible|0|||
124937135|NCT01046825|449399994|FG004|Overall Study|Found to be ineligible|0|||
124937136|NCT01046825|449399990|FG000|Overall Study|Death|0|||
124937137|NCT01046825|449399991|FG001|Overall Study|Death|0|||
124937138|NCT01046825|449399992|FG002|Overall Study|Death|0|||
124937139|NCT01046825|449399993|FG003|Overall Study|Death|1|||
124937140|NCT01046825|449399994|FG004|Overall Study|Death|0|||
124937141|NCT01046825|449399990|FG000|Overall Study|Did not submit biology samples|0|||
124937142|NCT01046825|449399991|FG001|Overall Study|Did not submit biology samples|0|||
124937143|NCT01046825|449399992|FG002|Overall Study|Did not submit biology samples|0|||
124937144|NCT01046825|449399993|FG003|Overall Study|Did not submit biology samples|0|||
124937145|NCT01046825|449399994|FG004|Overall Study|Did not submit biology samples|13|||
124937146|NCT02075554|449399996|FG000|Overall Study|Lost to Follow-up|7|||
124937147|NCT02075554|449399996|FG000|Overall Study|Withdrawal by Subject|5|||
124937148|NCT02075554|449399996|FG000|Overall Study|Physician Decision|3|||
124937149|NCT04993677|449400003|FG000|Overall Study|Lost to Follow-up|1|||
124937150|NCT04993677|449400004|FG001|Overall Study|Lost to Follow-up|0|||
124937151|NCT04993677|449400005|FG002|Overall Study|Lost to Follow-up|0|||
124937152|NCT04993677|449400006|FG003|Overall Study|Lost to Follow-up|0|||
124937153|NCT04993677|449400003|FG000|Overall Study|Death|11|||
124937154|NCT04993677|449400004|FG001|Overall Study|Death|8|||
124937155|NCT04993677|449400005|FG002|Overall Study|Death|3|||
124937156|NCT04993677|449400006|FG003|Overall Study|Death|1|||
124937157|NCT04993677|449400003|FG000|Overall Study|Subject withdrawal of consent|4|||
124937158|NCT04993677|449400004|FG001|Overall Study|Subject withdrawal of consent|3|||
124937159|NCT04993677|449400005|FG002|Overall Study|Subject withdrawal of consent|0|||
124937160|NCT04993677|449400006|FG003|Overall Study|Subject withdrawal of consent|2|||
124937161|NCT04993677|449400003|FG000|Overall Study|Study termination by sponsor|3|||
124937162|NCT04993677|449400004|FG001|Overall Study|Study termination by sponsor|25|||
124937163|NCT04993677|449400005|FG002|Overall Study|Study termination by sponsor|3|||
124937164|NCT04993677|449400006|FG003|Overall Study|Study termination by sponsor|3|||
124937165|NCT04993677|449400003|FG000|Overall Study|Other|2|||
124937166|NCT04993677|449400004|FG001|Overall Study|Other|3|||
124456137|NCT01987960|447630354|FG000|Period 1|Lack of Efficacy|4|||
124456138|NCT01987960|447630355|FG001|Period 1|Lack of Efficacy|0|||
124456139|NCT01987960|447630356|FG002|Period 1|Lack of Efficacy|0|||
124456140|NCT01987960|447630357|FG003|Period 1|Lack of Efficacy|0|||
124937167|NCT04993677|449400005|FG002|Overall Study|Other|3|||
124937168|NCT04993677|449400006|FG003|Overall Study|Other|2|||
124937169|NCT00003222|449400013|FG000|Overall Study|Physician Decision|0|||
124937170|NCT00003222|449400014|FG001|Overall Study|Physician Decision|1|||
124937171|NCT03248492|449400015|FG000|Overall Study|Progressive Disease|24|||
124937172|NCT03248492|449400016|FG001|Overall Study|Progressive Disease|23|||
124937173|NCT03248492|449400017|FG002|Overall Study|Progressive Disease|11|||
124937174|NCT03248492|449400018|FG003|Overall Study|Progressive Disease|66|||
124937175|NCT03248492|449400019|FG004|Overall Study|Progressive Disease|1|||
124937176|NCT03248492|449400015|FG000|Overall Study|Adverse Event|14|||
124937177|NCT03248492|449400016|FG001|Overall Study|Adverse Event|13|||
124456141|NCT01987960|447630354|FG000|Period 1|Non-compliance with IMP|6|||
124764960|NCT00097500|448765079|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
124937178|NCT03248492|449400017|FG002|Overall Study|Adverse Event|9|||
124937179|NCT03248492|449400018|FG003|Overall Study|Adverse Event|22|||
124937180|NCT03248492|449400019|FG004|Overall Study|Adverse Event|2|||
124937181|NCT03248492|449400015|FG000|Overall Study|Withdrawal by Subject|5|||
124937182|NCT03248492|449400016|FG001|Overall Study|Withdrawal by Subject|4|||
124937183|NCT03248492|449400017|FG002|Overall Study|Withdrawal by Subject|0|||
124456142|NCT01987960|447630355|FG001|Period 1|Non-compliance with IMP|0|||
124937184|NCT03248492|449400018|FG003|Overall Study|Withdrawal by Subject|8|||
124937185|NCT03248492|449400019|FG004|Overall Study|Withdrawal by Subject|1|||
124937186|NCT03248492|449400015|FG000|Overall Study|Physician Decision|1|||
124937187|NCT03248492|449400016|FG001|Overall Study|Physician Decision|1|||
124937188|NCT03248492|449400017|FG002|Overall Study|Physician Decision|1|||
124937189|NCT03248492|449400018|FG003|Overall Study|Physician Decision|7|||
124937190|NCT03248492|449400019|FG004|Overall Study|Physician Decision|0|||
124937191|NCT03248492|449400015|FG000|Overall Study|Death|1|||
124937192|NCT03248492|449400016|FG001|Overall Study|Death|1|||
124937193|NCT03248492|449400017|FG002|Overall Study|Death|0|||
124937194|NCT03248492|449400018|FG003|Overall Study|Death|6|||
124937195|NCT03248492|449400019|FG004|Overall Study|Death|0|||
124937196|NCT03248492|449400015|FG000|Overall Study|Study Terminated by Sponsor|3|||
124937197|NCT03248492|449400016|FG001|Overall Study|Study Terminated by Sponsor|1|||
124937198|NCT03248492|449400017|FG002|Overall Study|Study Terminated by Sponsor|0|||
124937199|NCT03248492|449400018|FG003|Overall Study|Study Terminated by Sponsor|7|||
124937200|NCT03248492|449400019|FG004|Overall Study|Study Terminated by Sponsor|0|||
124937201|NCT03248492|449400015|FG000|Overall Study|Other|2|||
124937202|NCT03248492|449400016|FG001|Overall Study|Other|5|||
124937203|NCT03248492|449400017|FG002|Overall Study|Other|0|||
124937204|NCT03248492|449400018|FG003|Overall Study|Other|14|||
124937205|NCT03248492|449400019|FG004|Overall Study|Other|0|||
124937206|NCT03767335|449400021|FG000|Overall Study|Physician Decision|1|||
124937207|NCT03767335|449400022|FG001|Overall Study|Physician Decision|1|||
124937208|NCT03767335|449400023|FG002|Overall Study|Physician Decision|0|||
124937209|NCT03767335|449400021|FG000|Overall Study|Withdrawal by Subject|0|||
124937210|NCT03767335|449400022|FG001|Overall Study|Withdrawal by Subject|0|||
124937211|NCT03767335|449400023|FG002|Overall Study|Withdrawal by Subject|6|||
124937212|NCT03767335|449400021|FG000|Overall Study|Participant excluded from efficacy population|0|||
124937213|NCT03767335|449400022|FG001|Overall Study|Participant excluded from efficacy population|0|||
124937214|NCT03767335|449400023|FG002|Overall Study|Participant excluded from efficacy population|1|||
124937215|NCT03767335|449400021|FG000|Overall Study|Death|0|||
124937216|NCT03767335|449400022|FG001|Overall Study|Death|0|||
124937217|NCT03767335|449400023|FG002|Overall Study|Death|2|||
124937218|NCT03767335|449400021|FG000|Overall Study|Progressive Disease|2|||
124937219|NCT03767335|449400022|FG001|Overall Study|Progressive Disease|2|||
124937220|NCT03767335|449400023|FG002|Overall Study|Progressive Disease|2|||
124937221|NCT03767335|449400021|FG000|Overall Study|Disease progression needing additional medication|0|||
124937222|NCT03767335|449400022|FG001|Overall Study|Disease progression needing additional medication|0|||
124937223|NCT03767335|449400023|FG002|Overall Study|Disease progression needing additional medication|17|||
124937224|NCT03767335|449400021|FG000|Overall Study|Sponsor decision|0|||
124937225|NCT03767335|449400022|FG001|Overall Study|Sponsor decision|0|||
124937226|NCT03767335|449400023|FG002|Overall Study|Sponsor decision|2|||
124937227|NCT03767335|449400021|FG000|Overall Study|Other Medical Reasons|0|||
124937228|NCT03767335|449400022|FG001|Overall Study|Other Medical Reasons|0|||
124937229|NCT03767335|449400023|FG002|Overall Study|Other Medical Reasons|3|||
124937230|NCT03705390|449400024|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
124937231|NCT03705390|449400024|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
124937232|NCT04495621|449400026|FG000|Overall Study|Withdrawal by Subject|0|||
124937233|NCT04495621|449400027|FG001|Overall Study|Withdrawal by Subject|3|||
124937234|NCT04495621|449400026|FG000|Overall Study|Death|7|||
124937235|NCT04495621|449400027|FG001|Overall Study|Death|11|||
124937236|NCT04495621|449400026|FG000|Overall Study|Investigator Decision|0|||
124937237|NCT04495621|449400027|FG001|Overall Study|Investigator Decision|7|||
124937238|NCT04495621|449400026|FG000|Overall Study|Lost to Follow-up|0|||
124937239|NCT04495621|449400027|FG001|Overall Study|Lost to Follow-up|1|||
124937240|NCT04757753|449400033|FG000|Overall Study|Lost to Follow-up|7|||
124937241|NCT04757753|449400034|FG001|Overall Study|Lost to Follow-up|7|||
124937242|NCT04757753|449400033|FG000|Overall Study|Withdrawal by Subject|0|||
124937243|NCT04757753|449400034|FG001|Overall Study|Withdrawal by Subject|3|||
124937244|NCT04757753|449400033|FG000|Overall Study|Endodontic treatment failure|1|||
124937245|NCT04757753|449400034|FG001|Overall Study|Endodontic treatment failure|2|||
124937246|NCT04757753|449400033|FG000|Overall Study|Tooth fracture/extraction|3|||
124937247|NCT04757753|449400034|FG001|Overall Study|Tooth fracture/extraction|0|||
124937248|NCT01313559|449400035|FG000|Overall Study|Withdrawal by Subject|1|||
124937249|NCT01313559|449400036|FG001|Overall Study|Withdrawal by Subject|2|||
124937250|NCT01313559|449400035|FG000|Overall Study|Disease progression|1|||
124937251|NCT01313559|449400036|FG001|Overall Study|Disease progression|0|||
124937252|NCT01313559|449400035|FG000|Overall Study|Rising PSA|2|||
124937253|NCT01313559|449400036|FG001|Overall Study|Rising PSA|0|||
124937254|NCT03201939|449400043|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
124937255|NCT03201939|449400044|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
124937256|NCT04908514|449400049|FG000|Overall Study|Lost to Follow-up|2|||
124937257|NCT04908514|449400049|FG000|Overall Study|Withdrawal by Subject|1|||
124937258|NCT05180539|449400568|FG000|Overall Study|Lost to Follow-up|27|||
124937259|NCT05180539|449400569|FG001|Overall Study|Lost to Follow-up|30|||
124937260|NCT02566889|449400572|FG000|Overall Study|Withdrawal by Subject|3|||
124937261|NCT02566889|449400573|FG001|Overall Study|Withdrawal by Subject|1|||
124937262|NCT02566889|449400572|FG000|Overall Study|Adverse Event|4|||
124937263|NCT02566889|449400573|FG001|Overall Study|Adverse Event|2|||
124937264|NCT02566889|449400572|FG000|Overall Study|Other|6|||
124937265|NCT02566889|449400573|FG001|Overall Study|Other|2|||
124937266|NCT04518943|449400574|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
124937267|NCT04518943|449400575|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
124937268|NCT04518943|449400576|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
124937269|NCT04518943|449400577|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
124937270|NCT04518943|449400578|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
124937271|NCT04518943|449400579|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
124937272|NCT04518943|449400580|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
124937273|NCT04518943|449400581|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
124937274|NCT04518943|449400582|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
124937275|NCT04518943|449400583|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
124937276|NCT04518943|449400584|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
124937277|NCT04518943|449400585|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
124937278|NCT04518943|449400586|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
124937279|NCT04518943|449400587|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
124937280|NCT04518943|449400588|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
124937281|NCT04518943|449400589|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
124937282|NCT03699163|449400590|FG000|Overall Study|Physician Decision|12|||
124937283|NCT03699163|449400591|FG001|Overall Study|Physician Decision|0|||
124937284|NCT03699163|449400590|FG000|Overall Study|failed QC measures|205|||
124937285|NCT03699163|449400591|FG001|Overall Study|failed QC measures|206|||
124937286|NCT02701283|449400609|FG000|Overall Study|Death|25|||
124937287|NCT02701283|449400610|FG001|Overall Study|Death|29|||
124937288|NCT02701283|449400611|FG002|Overall Study|Death|19|||
124937289|NCT02701283|449400609|FG000|Overall Study|Lost to Follow-up|3|||
124937290|NCT02701283|449400610|FG001|Overall Study|Lost to Follow-up|8|||
124937291|NCT02701283|449400611|FG002|Overall Study|Lost to Follow-up|1|||
124937292|NCT02701283|449400609|FG000|Overall Study|Withdrawal by Subject|12|||
124937293|NCT02701283|449400610|FG001|Overall Study|Withdrawal by Subject|41|||
124937294|NCT02701283|449400611|FG002|Overall Study|Withdrawal by Subject|1|||
124937295|NCT02701283|449400609|FG000|Overall Study|Missed 2-year visit|22|||
124937296|NCT02701283|449400610|FG001|Overall Study|Missed 2-year visit|27|||
124937297|NCT02701283|449400611|FG002|Overall Study|Missed 2-year visit|0|||
124937298|NCT02701283|449400609|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
124937299|NCT02701283|449400610|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
124937300|NCT02701283|449400611|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
124937301|NCT01830595|449400615|FG000|First Period|Withdrawal by Subject|1|||
124937302|NCT01830595|449400616|FG001|First Period|Withdrawal by Subject|3|||
124937303|NCT01830595|449400615|FG000|Washout|Withdrawal by Subject|2|||
124937304|NCT01830595|449400616|FG001|Washout|Withdrawal by Subject|2|||
124937305|NCT04940624|449400617|FG000|Overall Study|Adverse Event|4|||
124937306|NCT04940624|449400618|FG001|Overall Study|Adverse Event|11|||
124937307|NCT04940624|449400617|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
124937308|NCT04940624|449400618|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
124937309|NCT04940624|449400617|FG000|Overall Study|Physician Decision|1|||
124937310|NCT04940624|449400618|FG001|Overall Study|Physician Decision|0|||
124937311|NCT04940624|449400617|FG000|Overall Study|Lost to Follow-up|1|||
124937312|NCT04940624|449400618|FG001|Overall Study|Lost to Follow-up|0|||
124937313|NCT04940624|449400617|FG000|Overall Study|Reason Not Specified|1|||
124937314|NCT04940624|449400618|FG001|Overall Study|Reason Not Specified|0|||
124937315|NCT04479787|449400625|FG000|Through 6 Months|Withdrawal by Subject|16|||
124937316|NCT04479787|449400626|FG001|Through 6 Months|Withdrawal by Subject|14|||
124937317|NCT04479787|449400625|FG000|Through 6 Months|Unsuccessful Trial|17|||
124937318|NCT04479787|449400626|FG001|Through 6 Months|Unsuccessful Trial|0|||
124937319|NCT04479787|449400625|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
124937320|NCT04479787|449400626|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
124937321|NCT04479787|449400625|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
124937322|NCT04479787|449400626|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
124937323|NCT04479787|449400625|FG000|Through 6 Months|Lost to Follow-up|3|||
124937324|NCT04479787|449400626|FG001|Through 6 Months|Lost to Follow-up|2|||
124702970|NCT04562090|448535752|FG001|Overall Study|Protocol Violation|0|||
124702971|NCT04562090|448535751|FG000|Overall Study|Lack of Efficacy|0|||
124702972|NCT04562090|448535752|FG001|Overall Study|Lack of Efficacy|1|||
124702973|NCT04562090|448535751|FG000|Overall Study|Adverse Event|1|||
124702974|NCT04562090|448535752|FG001|Overall Study|Adverse Event|4|||
124702975|NCT04562090|448535751|FG000|Overall Study|Miscellaneous|0|||
124702976|NCT04562090|448535752|FG001|Overall Study|Miscellaneous|3|||
124702977|NCT02402647|448535753|FG000|Overall Study|Lost to Follow-up|13|||
124702978|NCT02402647|448535754|FG001|Overall Study|Lost to Follow-up|7|||
124702979|NCT02402647|448535753|FG000|Overall Study|Protocol Violation|1|||
124702980|NCT02402647|448535754|FG001|Overall Study|Protocol Violation|1|||
124702981|NCT02402647|448535753|FG000|Overall Study|scheduled and timed out|2|||
124702982|NCT02402647|448535754|FG001|Overall Study|scheduled and timed out|1|||
124702983|NCT02402647|448535753|FG000|Overall Study|medical illness|2|||
124702984|NCT02402647|448535754|FG001|Overall Study|medical illness|4|||
124702985|NCT02402647|448535753|FG000|Overall Study|Moved|2|||
124702986|NCT02402647|448535754|FG001|Overall Study|Moved|0|||
124456143|NCT01987960|447630356|FG002|Period 1|Non-compliance with IMP|0|||
124456144|NCT01987960|447630357|FG003|Period 1|Non-compliance with IMP|0|||
124702987|NCT02402647|448535753|FG000|Overall Study|loved one illness|1|||
124702988|NCT02402647|448535754|FG001|Overall Study|loved one illness|0|||
124702989|NCT02402647|448535753|FG000|Overall Study|deceased preexisting condition|2|||
124702990|NCT02402647|448535754|FG001|Overall Study|deceased preexisting condition|0|||
124702991|NCT02402647|448535753|FG000|Overall Study|Other|2|||
124937325|NCT04479787|449400625|FG000|Through 6 Months|Death|3|||
124456145|NCT01987960|447630354|FG000|Period 1|Protocol Violation|12|||
124456146|NCT01987960|447630355|FG001|Period 1|Protocol Violation|0|||
124456147|NCT01987960|447630356|FG002|Period 1|Protocol Violation|0|||
124456148|NCT01987960|447630357|FG003|Period 1|Protocol Violation|0|||
124456149|NCT01987960|447630354|FG000|Period 1|Withdrawal by Subject|21|||
124456150|NCT01987960|447630355|FG001|Period 1|Withdrawal by Subject|0|||
124456151|NCT01987960|447630356|FG002|Period 1|Withdrawal by Subject|0|||
124456152|NCT01987960|447630357|FG003|Period 1|Withdrawal by Subject|0|||
124456153|NCT01987960|447630354|FG000|Period 1|Lost to Follow-up|40|||
124456154|NCT01987960|447630355|FG001|Period 1|Lost to Follow-up|0|||
124702992|NCT02402647|448535754|FG001|Overall Study|Other|1|||
124702993|NCT05852470|448535756|FG000|Overall Study|Withdrawal by Subject|0|||
124702994|NCT05852470|448535757|FG001|Overall Study|Withdrawal by Subject|1|||
124702995|NCT04134936|448535758|FG000|Overall Study|Adverse Event|3|||
124937326|NCT04479787|449400626|FG001|Through 6 Months|Death|0|||
124937327|NCT04479787|449400625|FG000|Through 6 Months|Inclusion/Exclusion|2|||
124937328|NCT04479787|449400626|FG001|Through 6 Months|Inclusion/Exclusion|1|||
124937329|NCT04479787|449400625|FG000|Through 6 Months|Subject Became Pregnant|1|||
124937330|NCT04479787|449400626|FG001|Through 6 Months|Subject Became Pregnant|1|||
124937331|NCT04479787|449400625|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
124937332|NCT04479787|449400626|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
124937333|NCT04479787|449400625|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
124937334|NCT04479787|449400626|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
124937335|NCT04479787|449400625|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
124937336|NCT04479787|449400626|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
124937337|NCT04479787|449400625|FG000|After 6 Months|Withdrawal by Subject|3|||
124937338|NCT04479787|449400626|FG001|After 6 Months|Withdrawal by Subject|13|||
124937339|NCT04479787|449400625|FG000|After 6 Months|Unsuccessful Trial|0|||
124937340|NCT04479787|449400626|FG001|After 6 Months|Unsuccessful Trial|7|||
124937341|NCT04479787|449400625|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
124937342|NCT04479787|449400626|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
124937343|NCT04479787|449400625|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
124937344|NCT04479787|449400626|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
124937345|NCT04479787|449400625|FG000|After 6 Months|Death|2|||
124702996|NCT04134936|448535759|FG001|Overall Study|Adverse Event|2|||
124702997|NCT04134936|448535758|FG000|Overall Study|Withdrawal by Subject|2|||
124937346|NCT04479787|449400626|FG001|After 6 Months|Death|0|||
124937347|NCT04479787|449400625|FG000|After 6 Months|Lost to Follow-up|1|||
124937348|NCT04479787|449400626|FG001|After 6 Months|Lost to Follow-up|1|||
124937349|NCT04479787|449400625|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
124937350|NCT04479787|449400626|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
124937351|NCT04479787|449400625|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
124937352|NCT04479787|449400626|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
124456155|NCT01987960|447630356|FG002|Period 1|Lost to Follow-up|0|||
124456156|NCT01987960|447630357|FG003|Period 1|Lost to Follow-up|0|||
124702998|NCT04134936|448535759|FG001|Overall Study|Withdrawal by Subject|3|||
124702999|NCT04134936|448535758|FG000|Overall Study|Physician Decision|0|||
124703000|NCT04134936|448535759|FG001|Overall Study|Physician Decision|1|||
124703001|NCT04134936|448535758|FG000|Overall Study|Progressive disease, joined another trial|1|||
124703002|NCT04134936|448535759|FG001|Overall Study|Progressive disease, joined another trial|0|||
124703003|NCT04134936|448535758|FG000|Overall Study|Progressive disease|1|||
124937353|NCT04479787|449400625|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
124937354|NCT04479787|449400626|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
124937355|NCT04479787|449400625|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
124937356|NCT04479787|449400626|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
124937357|NCT05039021|449401349|FG000|Overall Study|Death|1|||
124937358|NCT05039021|449401349|FG000|Overall Study|Lost to Follow-up|3|||
124937359|NCT03653364|449401352|FG000|Overall Study|Withdrawal by Subject|1|||
124937360|NCT03653364|449401352|FG000|Overall Study|Enrolled in Error|1|||
124937361|NCT03653364|449401352|FG000|Overall Study|Death|1|||
124937362|NCT00686595|449401353|FG000|Overall Study|Adverse Event|3|||
124937363|NCT00686595|449401353|FG000|Overall Study|Protocol Violation|1|||
124937364|NCT00686595|449401353|FG000|Overall Study|Lost to Follow-up|1|||
124937365|NCT00686595|449401353|FG000|Overall Study|Lack of Efficacy|1|||
124937366|NCT00686595|449401353|FG000|Overall Study|Poor Compliance|1|||
124937367|NCT03213457|449401356|FG000|Screening Period|Withdrawal by Subject|0|||
124937368|NCT03213457|449401357|FG001|Screening Period|Withdrawal by Subject|1|||
124937369|NCT03213457|449401358|FG002|Screening Period|Withdrawal by Subject|0|||
124937370|NCT03213457|449401356|FG000|Screening Period|Other|1|||
124937371|NCT03213457|449401357|FG001|Screening Period|Other|0|||
124937372|NCT03213457|449401358|FG002|Screening Period|Other|0|||
124937373|NCT03213457|449401356|FG000|Double-Blind Period|Adverse Event|3|||
124937374|NCT03213457|449401357|FG001|Double-Blind Period|Adverse Event|2|||
124937375|NCT03213457|449401358|FG002|Double-Blind Period|Adverse Event|7|||
124937376|NCT03213457|449401356|FG000|Double-Blind Period|Withdrawal by Subject|14|||
124937377|NCT03213457|449401357|FG001|Double-Blind Period|Withdrawal by Subject|2|||
124937378|NCT03213457|449401358|FG002|Double-Blind Period|Withdrawal by Subject|14|||
124937379|NCT03213457|449401356|FG000|Double-Blind Period|Lost to Follow-up|2|||
124937380|NCT03213457|449401357|FG001|Double-Blind Period|Lost to Follow-up|3|||
124937381|NCT03213457|449401358|FG002|Double-Blind Period|Lost to Follow-up|9|||
124937382|NCT03213457|449401356|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
124937383|NCT03213457|449401357|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
124937384|NCT03213457|449401358|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
124937385|NCT03213457|449401356|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
124937386|NCT03213457|449401357|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
124937387|NCT03213457|449401358|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
124937388|NCT03213457|449401356|FG000|Double-Blind Period|Pregnancy|5|||
124937389|NCT03213457|449401357|FG001|Double-Blind Period|Pregnancy|0|||
124937390|NCT03213457|449401358|FG002|Double-Blind Period|Pregnancy|0|||
124937391|NCT03213457|449401356|FG000|Double-Blind Period|Other|10|||
124937392|NCT03213457|449401357|FG001|Double-Blind Period|Other|3|||
124937393|NCT03213457|449401358|FG002|Double-Blind Period|Other|17|||
124937394|NCT03213457|449401356|FG000|Open-Label Period|Adverse Event|1|||
124937395|NCT03213457|449401357|FG001|Open-Label Period|Adverse Event|2|||
124937396|NCT03213457|449401358|FG002|Open-Label Period|Adverse Event|2|||
124937397|NCT03213457|449401356|FG000|Open-Label Period|Withdrawal by Subject|12|||
124937398|NCT03213457|449401357|FG001|Open-Label Period|Withdrawal by Subject|5|||
124937399|NCT03213457|449401358|FG002|Open-Label Period|Withdrawal by Subject|24|||
124937400|NCT03213457|449401356|FG000|Open-Label Period|Lost to Follow-up|1|||
124937401|NCT03213457|449401357|FG001|Open-Label Period|Lost to Follow-up|2|||
124937402|NCT03213457|449401358|FG002|Open-Label Period|Lost to Follow-up|8|||
124937403|NCT03213457|449401356|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
124937404|NCT03213457|449401357|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
124937405|NCT03213457|449401358|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
124937406|NCT03213457|449401356|FG000|Open-Label Period|Non-compliance with study procedures|1|||
124937407|NCT03213457|449401357|FG001|Open-Label Period|Non-compliance with study procedures|1|||
124937408|NCT03213457|449401358|FG002|Open-Label Period|Non-compliance with study procedures|2|||
124937409|NCT03213457|449401356|FG000|Open-Label Period|Exclusionary medications|0|||
124937410|NCT03213457|449401357|FG001|Open-Label Period|Exclusionary medications|0|||
124937411|NCT03213457|449401358|FG002|Open-Label Period|Exclusionary medications|1|||
124937412|NCT03213457|449401356|FG000|Open-Label Period|Other|1|||
124937413|NCT03213457|449401357|FG001|Open-Label Period|Other|1|||
124937414|NCT03213457|449401358|FG002|Open-Label Period|Other|6|||
124937415|NCT03213457|449401356|FG000|Follow-Up Period|Adverse Event|16|||
124546492|NCT00320801|447955919|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
124937416|NCT03213457|449401357|FG001|Follow-Up Period|Adverse Event|8|||
124937417|NCT03213457|449401358|FG002|Follow-Up Period|Adverse Event|37|||
124937418|NCT03213457|449401356|FG000|Follow-Up Period|Withdrawal by Subject|18|||
124937419|NCT03213457|449401357|FG001|Follow-Up Period|Withdrawal by Subject|11|||
124937420|NCT03213457|449401358|FG002|Follow-Up Period|Withdrawal by Subject|55|||
124937421|NCT03213457|449401356|FG000|Follow-Up Period|Lost to Follow-up|28|||
124937422|NCT03213457|449401357|FG001|Follow-Up Period|Lost to Follow-up|15|||
124546493|NCT00320801|447955916|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
124703004|NCT04134936|448535759|FG001|Overall Study|Progressive disease|0|||
124703005|NCT00323622|448535762|FG000|Overall Study|Other|30|||
124703006|NCT00323622|448535763|FG001|Overall Study|Other|91|||
124703007|NCT00323622|448535764|FG002|Overall Study|Other|4|||
124703008|NCT00323622|448535765|FG003|Overall Study|Other|12|||
124703009|NCT00323622|448535766|FG004|Overall Study|Other|32|||
124703010|NCT00323622|448535767|FG005|Overall Study|Other|74|||
124937423|NCT03213457|449401358|FG002|Follow-Up Period|Lost to Follow-up|50|||
124937424|NCT03213457|449401356|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
124937425|NCT03213457|449401357|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
124937426|NCT03213457|449401358|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
124937427|NCT03213457|449401356|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
124937428|NCT03213457|449401357|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
124937429|NCT03213457|449401358|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
124937430|NCT03213457|449401356|FG000|Follow-Up Period|Pregnancy|7|||
124937431|NCT03213457|449401357|FG001|Follow-Up Period|Pregnancy|0|||
124937432|NCT03213457|449401358|FG002|Follow-Up Period|Pregnancy|18|||
124937433|NCT03213457|449401356|FG000|Follow-Up Period|Exclusionary medications|1|||
124937434|NCT03213457|449401357|FG001|Follow-Up Period|Exclusionary medications|1|||
124937435|NCT03213457|449401358|FG002|Follow-Up Period|Exclusionary medications|5|||
124937436|NCT03213457|449401356|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
124937437|NCT03213457|449401357|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
124937438|NCT03213457|449401358|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
124937439|NCT03213457|449401356|FG000|Follow-Up Period|Other|14|||
124937440|NCT03213457|449401357|FG001|Follow-Up Period|Other|10|||
124937441|NCT03213457|449401358|FG002|Follow-Up Period|Other|31|||
124937442|NCT05934292|449401360|FG000|Overall Study|Lost to Follow-up|0|||
124937443|NCT05934292|449401361|FG001|Overall Study|Lost to Follow-up|0|||
124937444|NCT05934292|449401362|FG002|Overall Study|Lost to Follow-up|1|||
124937445|NCT05934292|449401363|FG003|Overall Study|Lost to Follow-up|0|||
124937446|NCT05714059|449401366|FG000|Overall Study|Withdrawal by Subject|2|||
124937447|NCT05714059|449401367|FG001|Overall Study|Withdrawal by Subject|2|||
124937448|NCT05714059|449401366|FG000|Overall Study|Adverse Event|0|||
124937449|NCT05714059|449401367|FG001|Overall Study|Adverse Event|1|||
124937450|NCT05714059|449401366|FG000|Overall Study|Lost to Follow-up|0|||
124937451|NCT05714059|449401367|FG001|Overall Study|Lost to Follow-up|1|||
124937452|NCT05714059|449401366|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
124937453|NCT05714059|449401367|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
124937454|NCT05714059|449401366|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
124937455|NCT05714059|449401367|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
124937456|NCT04899674|449401368|FG000|Test|Adverse Event|1|||
124937457|NCT03774472|449401369|FG000|Overall Study|Physician Decision|1|||
124937458|NCT03774472|449401370|FG001|Overall Study|Physician Decision|0|||
124937459|NCT03774472|449401371|FG002|Overall Study|Physician Decision|0|||
124937460|NCT03774472|449401369|FG000|Overall Study|Progression prior to 4 weeks|0|||
124937461|NCT03774472|449401370|FG001|Overall Study|Progression prior to 4 weeks|1|||
124937462|NCT03774472|449401371|FG002|Overall Study|Progression prior to 4 weeks|0|||
124937463|NCT03774472|449401369|FG000|Overall Study|Withdrawal by Subject|0|||
124937464|NCT03774472|449401370|FG001|Overall Study|Withdrawal by Subject|1|||
124937465|NCT03774472|449401371|FG002|Overall Study|Withdrawal by Subject|0|||
124937466|NCT05155306|449401372|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
124937467|NCT05155306|449401373|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
124937468|NCT05155306|449401374|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
124937469|NCT05155306|449401375|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
124937470|NCT05155306|449401372|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
124937471|NCT05155306|449401373|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
124703011|NCT00323622|448535768|FG006|Overall Study|Other|5|||
124937472|NCT05155306|449401374|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
124937473|NCT05155306|449401375|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
124937474|NCT05116774|449401377|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
124937475|NCT05116774|449401378|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
124937476|NCT05116774|449401377|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
124937477|NCT05116774|449401378|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
124937478|NCT05116774|449401377|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
124937479|NCT05116774|449401378|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
124703012|NCT00323622|448535769|FG007|Overall Study|Other|13|||
124703013|NCT00323622|448535762|FG000|Overall Study|Death|1|||
124703014|NCT00323622|448535763|FG001|Overall Study|Death|1|||
124937480|NCT05116774|449401377|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
124937481|NCT05116774|449401378|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
124937482|NCT03150862|449401379|FG000|Overall Study|Death|2|||
124937483|NCT03150862|449401380|FG001|Overall Study|Death|7|||
124937484|NCT03150862|449401381|FG002|Overall Study|Death|8|||
124937485|NCT03150862|449401382|FG003|Overall Study|Death|27|||
124937486|NCT03150862|449401383|FG004|Overall Study|Death|4|||
124937487|NCT03150862|449401384|FG005|Overall Study|Death|8|||
124937488|NCT03150862|449401385|FG006|Overall Study|Death|6|||
124937489|NCT03150862|449401386|FG007|Overall Study|Death|21|||
124937490|NCT03150862|449401379|FG000|Overall Study|Withdrawal by Subject|1|||
124937491|NCT03150862|449401380|FG001|Overall Study|Withdrawal by Subject|1|||
124937492|NCT03150862|449401381|FG002|Overall Study|Withdrawal by Subject|0|||
124937493|NCT03150862|449401382|FG003|Overall Study|Withdrawal by Subject|3|||
124937494|NCT03150862|449401383|FG004|Overall Study|Withdrawal by Subject|1|||
124937495|NCT03150862|449401384|FG005|Overall Study|Withdrawal by Subject|1|||
124937496|NCT03150862|449401385|FG006|Overall Study|Withdrawal by Subject|1|||
124937497|NCT03150862|449401386|FG007|Overall Study|Withdrawal by Subject|3|||
124937498|NCT03150862|449401379|FG000|Overall Study|Lost to Follow-up|0|||
124937499|NCT03150862|449401380|FG001|Overall Study|Lost to Follow-up|0|||
124937500|NCT03150862|449401381|FG002|Overall Study|Lost to Follow-up|1|||
124937501|NCT03150862|449401382|FG003|Overall Study|Lost to Follow-up|0|||
124937502|NCT03150862|449401383|FG004|Overall Study|Lost to Follow-up|0|||
124937503|NCT03150862|449401384|FG005|Overall Study|Lost to Follow-up|0|||
124937504|NCT03150862|449401385|FG006|Overall Study|Lost to Follow-up|0|||
124937505|NCT03150862|449401386|FG007|Overall Study|Lost to Follow-up|2|||
124937506|NCT03150862|449401379|FG000|Overall Study|Sponsor's decision|0|||
124937507|NCT03150862|449401380|FG001|Overall Study|Sponsor's decision|0|||
124937508|NCT03150862|449401381|FG002|Overall Study|Sponsor's decision|0|||
124937509|NCT03150862|449401382|FG003|Overall Study|Sponsor's decision|10|||
124937510|NCT03150862|449401383|FG004|Overall Study|Sponsor's decision|3|||
124937511|NCT03150862|449401384|FG005|Overall Study|Sponsor's decision|0|||
124937512|NCT03150862|449401385|FG006|Overall Study|Sponsor's decision|1|||
124937513|NCT03150862|449401386|FG007|Overall Study|Sponsor's decision|1|||
124937514|NCT03150862|449401379|FG000|Overall Study|Change in Methylation status|0|||
124937515|NCT03150862|449401380|FG001|Overall Study|Change in Methylation status|0|||
124937516|NCT03150862|449401381|FG002|Overall Study|Change in Methylation status|0|||
124937517|NCT03150862|449401382|FG003|Overall Study|Change in Methylation status|0|||
124937518|NCT03150862|449401383|FG004|Overall Study|Change in Methylation status|1|||
124937519|NCT03150862|449401384|FG005|Overall Study|Change in Methylation status|0|||
124937520|NCT03150862|449401385|FG006|Overall Study|Change in Methylation status|0|||
124937521|NCT03150862|449401386|FG007|Overall Study|Change in Methylation status|0|||
124937522|NCT03150862|449401379|FG000|Overall Study|Roll over in to Long Term Extension|0|||
124937523|NCT03150862|449401380|FG001|Overall Study|Roll over in to Long Term Extension|0|||
124937524|NCT03150862|449401381|FG002|Overall Study|Roll over in to Long Term Extension|0|||
124937525|NCT03150862|449401382|FG003|Overall Study|Roll over in to Long Term Extension|0|||
124937526|NCT03150862|449401383|FG004|Overall Study|Roll over in to Long Term Extension|0|||
124937527|NCT03150862|449401384|FG005|Overall Study|Roll over in to Long Term Extension|0|||
124937528|NCT03150862|449401385|FG006|Overall Study|Roll over in to Long Term Extension|0|||
124937529|NCT03150862|449401386|FG007|Overall Study|Roll over in to Long Term Extension|1|||
124937530|NCT03150862|449401379|FG000|Overall Study|Progressive Disease|0|||
124937531|NCT03150862|449401380|FG001|Overall Study|Progressive Disease|0|||
124937532|NCT03150862|449401381|FG002|Overall Study|Progressive Disease|0|||
124937533|NCT03150862|449401382|FG003|Overall Study|Progressive Disease|0|||
124937534|NCT03150862|449401383|FG004|Overall Study|Progressive Disease|0|||
124937535|NCT03150862|449401384|FG005|Overall Study|Progressive Disease|0|||
124937536|NCT03150862|449401385|FG006|Overall Study|Progressive Disease|0|||
124937537|NCT03150862|449401386|FG007|Overall Study|Progressive Disease|2|||
124937538|NCT04158141|449401389|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
124937539|NCT04158141|449401390|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
124456157|NCT01987960|447630354|FG000|Period 1|administrative or other reason|75|||
124703015|NCT00323622|448535764|FG002|Overall Study|Death|0|||
124703016|NCT00323622|448535765|FG003|Overall Study|Death|0|||
124703017|NCT00323622|448535766|FG004|Overall Study|Death|7|||
124456158|NCT01987960|447630355|FG001|Period 1|administrative or other reason|0|||
124456159|NCT01987960|447630356|FG002|Period 1|administrative or other reason|0|||
124456160|NCT01987960|447630357|FG003|Period 1|administrative or other reason|0|||
124703018|NCT00323622|448535767|FG005|Overall Study|Death|0|||
124703019|NCT00323622|448535768|FG006|Overall Study|Death|0|||
124703020|NCT00323622|448535769|FG007|Overall Study|Death|2|||
124937540|NCT04158141|449401391|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
124937541|NCT04158141|449401389|FG000|Step 1: Registration|Adverse Event|1|||
124937542|NCT04158141|449401390|FG001|Step 1: Registration|Adverse Event|0|||
124937543|NCT04158141|449401391|FG002|Step 1: Registration|Adverse Event|0|||
124937544|NCT04158141|449401389|FG000|Step 1: Registration|Withdrawal by Subject|1|||
124937545|NCT04158141|449401390|FG001|Step 1: Registration|Withdrawal by Subject|0|||
124937546|NCT04158141|449401391|FG002|Step 1: Registration|Withdrawal by Subject|0|||
124937547|NCT04158141|449401389|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
124937548|NCT04158141|449401390|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
124937549|NCT04158141|449401391|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
124937550|NCT04505722|449401396|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
124937551|NCT04505722|449401397|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
124937552|NCT04505722|449401398|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
124937553|NCT04505722|449401396|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
124937554|NCT04505722|449401397|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
124937555|NCT04505722|449401398|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
124937556|NCT04505722|449401396|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
124937557|NCT04505722|449401397|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
124937558|NCT04505722|449401398|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
124937559|NCT04505722|449401396|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
124937560|NCT04505722|449401397|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
124937561|NCT04505722|449401398|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
124937562|NCT04505722|449401396|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
124937563|NCT04505722|449401397|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
124937564|NCT04505722|449401398|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
124937565|NCT04505722|449401396|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
124456161|NCT01987960|447630354|FG000|Period 1|Withdrawal of consent before treatment|4|||
124456162|NCT01987960|447630355|FG001|Period 1|Withdrawal of consent before treatment|0|||
124937566|NCT04505722|449401397|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
124937567|NCT04505722|449401398|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
124937568|NCT04505722|449401396|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
124937569|NCT04505722|449401397|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
124937570|NCT04505722|449401398|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
124937571|NCT04505722|449401396|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
124937572|NCT04505722|449401397|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
124937573|NCT04505722|449401398|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
124937574|NCT04505722|449401396|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
124937575|NCT04505722|449401397|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
124937576|NCT04505722|449401398|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
124937577|NCT04505722|449401396|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
124937578|NCT04505722|449401397|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
124937579|NCT04505722|449401398|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
124937580|NCT04505722|449401396|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
124937581|NCT04505722|449401397|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
124937582|NCT04505722|449401398|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
124937583|NCT04505722|449401396|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
124937584|NCT04505722|449401397|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
124937585|NCT04505722|449401398|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
124937586|NCT04505722|449401396|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
124937587|NCT04505722|449401397|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
124937588|NCT04505722|449401398|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
124937589|NCT04505722|449401396|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
124937590|NCT04505722|449401397|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
124937591|NCT04505722|449401398|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
124937592|NCT04505722|449401396|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
124937593|NCT04505722|449401397|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
124937594|NCT04505722|449401398|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
124937595|NCT04755595|449401399|FG000|Overall Study|Lost to Follow-up|1|||
124937596|NCT00319696|449401400|FG000|Overall Study|Adverse Event|36|||
124937597|NCT00319696|449401400|FG000|Overall Study|withdrawal of consent|14|||
124937598|NCT00319696|449401400|FG000|Overall Study|administrative|7|||
124937599|NCT00319696|449401400|FG000|Overall Study|Lost to Follow-up|3|||
124937600|NCT02206828|449401401|FG000|Overall Study|Lost to Follow-up|7|||
124937601|NCT04977583|449402046|FG000|Overall Study|Lost to Follow-up|8|||
124937602|NCT04977583|449402047|FG001|Overall Study|Lost to Follow-up|4|||
124937603|NCT04977583|449402048|FG002|Overall Study|Lost to Follow-up|13|||
124937604|NCT04977583|449402046|FG000|Overall Study|Withdrawal by Subject|3|||
124937605|NCT04977583|449402047|FG001|Overall Study|Withdrawal by Subject|2|||
124937606|NCT04977583|449402048|FG002|Overall Study|Withdrawal by Subject|1|||
124937607|NCT02422615|449402049|FG000|Treatment Period|Progressive disease|314|||
124937608|NCT02422615|449402050|FG001|Treatment Period|Progressive disease|200|||
124937609|NCT02422615|449402049|FG000|Treatment Period|Adverse Event|51|||
124937610|NCT02422615|449402050|FG001|Treatment Period|Adverse Event|9|||
124937611|NCT02422615|449402049|FG000|Treatment Period|Physician Decision|32|||
124937612|NCT02422615|449402050|FG001|Treatment Period|Physician Decision|8|||
124937613|NCT02422615|449402049|FG000|Treatment Period|Subject/guardian decision|38|||
124937614|NCT02422615|449402050|FG001|Treatment Period|Subject/guardian decision|8|||
124937615|NCT02422615|449402049|FG000|Treatment Period|Death|2|||
124937616|NCT02422615|449402050|FG001|Treatment Period|Death|1|||
124937617|NCT02422615|449402049|FG000|Treatment Period|Technical problems|0|||
124937618|NCT02422615|449402050|FG001|Treatment Period|Technical problems|1|||
124937619|NCT02422615|449402049|FG000|Treatment Period|Protocol deviation|1|||
124937620|NCT02422615|449402050|FG001|Treatment Period|Protocol deviation|1|||
124937621|NCT02422615|449402049|FG000|Treatment Period|Study terminated as per protocol|46|||
124937622|NCT02422615|449402050|FG001|Treatment Period|Study terminated as per protocol|14|||
124937623|NCT02422615|449402049|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
124937624|NCT02422615|449402050|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124937625|NCT02422615|449402049|FG000|Post-treatment Efficacy Follow-up|Death|2|||
124937626|NCT02422615|449402050|FG001|Post-treatment Efficacy Follow-up|Death|1|||
124937627|NCT02422615|449402049|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
124937628|NCT02422615|449402050|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
124937629|NCT02422615|449402049|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
124937630|NCT02422615|449402050|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
124937631|NCT02422615|449402049|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
124937632|NCT02422615|449402050|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
124937633|NCT02422615|449402049|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
124937634|NCT02422615|449402050|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
124937635|NCT01639131|449402051|FG000|Overall Study|Disease Progression|6|||
124937636|NCT01105975|449402058|FG000|Overall Study|Adverse Event|2|||
124937637|NCT01105975|449402059|FG001|Overall Study|Adverse Event|1|||
124937638|NCT01105975|449402060|FG002|Overall Study|Adverse Event|5|||
124937639|NCT01105975|449402061|FG003|Overall Study|Adverse Event|1|||
124937640|NCT01105975|449402062|FG004|Overall Study|Adverse Event|0|||
124937641|NCT01105975|449402063|FG005|Overall Study|Adverse Event|1|||
124937642|NCT01105975|449402064|FG006|Overall Study|Adverse Event|2|||
124937643|NCT01105975|449402065|FG007|Overall Study|Adverse Event|4|||
124937644|NCT01105975|449402066|FG008|Overall Study|Adverse Event|1|||
124937645|NCT01105975|449402067|FG009|Overall Study|Adverse Event|4|||
124937646|NCT01105975|449402058|FG000|Overall Study|Withdrawal by Subject|2|||
124937647|NCT01105975|449402059|FG001|Overall Study|Withdrawal by Subject|2|||
124937648|NCT01105975|449402060|FG002|Overall Study|Withdrawal by Subject|2|||
124937649|NCT01105975|449402061|FG003|Overall Study|Withdrawal by Subject|0|||
124937650|NCT01105975|449402062|FG004|Overall Study|Withdrawal by Subject|4|||
124937651|NCT01105975|449402063|FG005|Overall Study|Withdrawal by Subject|1|||
124937652|NCT01105975|449402064|FG006|Overall Study|Withdrawal by Subject|2|||
124937653|NCT01105975|449402065|FG007|Overall Study|Withdrawal by Subject|1|||
124937654|NCT01105975|449402066|FG008|Overall Study|Withdrawal by Subject|0|||
124937655|NCT01105975|449402067|FG009|Overall Study|Withdrawal by Subject|3|||
124937656|NCT01105975|449402058|FG000|Overall Study|Lost to Follow-up|1|||
124937657|NCT01105975|449402059|FG001|Overall Study|Lost to Follow-up|0|||
124937658|NCT01105975|449402060|FG002|Overall Study|Lost to Follow-up|0|||
124937659|NCT01105975|449402061|FG003|Overall Study|Lost to Follow-up|1|||
124937660|NCT01105975|449402062|FG004|Overall Study|Lost to Follow-up|1|||
124937661|NCT01105975|449402063|FG005|Overall Study|Lost to Follow-up|0|||
124937662|NCT01105975|449402064|FG006|Overall Study|Lost to Follow-up|0|||
124937663|NCT01105975|449402065|FG007|Overall Study|Lost to Follow-up|0|||
124456163|NCT01987960|447630356|FG002|Period 1|Withdrawal of consent before treatment|0|||
124456164|NCT01987960|447630357|FG003|Period 1|Withdrawal of consent before treatment|0|||
124456165|NCT01987960|447630354|FG000|Period 2|Adverse Event|0|||
124456166|NCT01987960|447630355|FG001|Period 2|Adverse Event|0|||
124456167|NCT01987960|447630356|FG002|Period 2|Adverse Event|1|||
124456168|NCT01987960|447630357|FG003|Period 2|Adverse Event|0|||
124456169|NCT01987960|447630354|FG000|Period 2|Withdrawal by Subject|0|||
124456170|NCT01987960|447630355|FG001|Period 2|Withdrawal by Subject|0|||
124456171|NCT01987960|447630356|FG002|Period 2|Withdrawal by Subject|1|||
124456172|NCT01987960|447630357|FG003|Period 2|Withdrawal by Subject|0|||
124456173|NCT01987960|447630354|FG000|Period 2|Administrative or other reason|0|||
124456174|NCT01987960|447630355|FG001|Period 2|Administrative or other reason|5|||
124456175|NCT01987960|447630356|FG002|Period 2|Administrative or other reason|7|||
124456176|NCT01987960|447630357|FG003|Period 2|Administrative or other reason|0|||
124456177|NCT01987960|447630354|FG000|Period 3|Adverse Event|0|||
124456178|NCT01987960|447630355|FG001|Period 3|Adverse Event|0|||
124456179|NCT01987960|447630356|FG002|Period 3|Adverse Event|0|||
124456180|NCT01987960|447630357|FG003|Period 3|Adverse Event|7|||
124456181|NCT01987960|447630354|FG000|Period 3|Non-compliance with IMP|0|||
124456182|NCT01987960|447630355|FG001|Period 3|Non-compliance with IMP|0|||
124456183|NCT01987960|447630356|FG002|Period 3|Non-compliance with IMP|0|||
124456184|NCT01987960|447630357|FG003|Period 3|Non-compliance with IMP|1|||
124703021|NCT02420717|448535770|FG000|Overall Study|Did not receive all study medication|2|||
124703022|NCT02420717|448535771|FG001|Overall Study|Did not receive all study medication|0|||
124703023|NCT02420717|448535772|FG002|Overall Study|Did not receive all study medication|0|||
124703024|NCT04191135|448535783|FG000|Induction Treatment|Not Treated|2|||
124937664|NCT01105975|449402066|FG008|Overall Study|Lost to Follow-up|1|||
124937665|NCT01105975|449402067|FG009|Overall Study|Lost to Follow-up|0|||
124937666|NCT01105975|449402058|FG000|Overall Study|Physician Decision|0|||
124456185|NCT01987960|447630354|FG000|Period 3|Protocol Violation|0|||
124456186|NCT01987960|447630355|FG001|Period 3|Protocol Violation|0|||
124456187|NCT01987960|447630356|FG002|Period 3|Protocol Violation|0|||
124456188|NCT01987960|447630357|FG003|Period 3|Protocol Violation|6|||
124456189|NCT01987960|447630354|FG000|Period 3|Withdrawal by Subject|0|||
124456190|NCT01987960|447630355|FG001|Period 3|Withdrawal by Subject|0|||
124456191|NCT01987960|447630356|FG002|Period 3|Withdrawal by Subject|0|||
124937667|NCT01105975|449402059|FG001|Overall Study|Physician Decision|0|||
124937668|NCT01105975|449402060|FG002|Overall Study|Physician Decision|0|||
124937669|NCT01105975|449402061|FG003|Overall Study|Physician Decision|0|||
124937670|NCT01105975|449402062|FG004|Overall Study|Physician Decision|0|||
124937671|NCT01105975|449402063|FG005|Overall Study|Physician Decision|0|||
124937672|NCT01105975|449402064|FG006|Overall Study|Physician Decision|2|||
124937673|NCT01105975|449402065|FG007|Overall Study|Physician Decision|0|||
124937674|NCT01105975|449402066|FG008|Overall Study|Physician Decision|0|||
124456192|NCT01987960|447630357|FG003|Period 3|Withdrawal by Subject|9|||
124456193|NCT01987960|447630354|FG000|Period 3|Lost to Follow-up|0|||
124456194|NCT01987960|447630355|FG001|Period 3|Lost to Follow-up|0|||
124456195|NCT01987960|447630356|FG002|Period 3|Lost to Follow-up|0|||
124456196|NCT01987960|447630357|FG003|Period 3|Lost to Follow-up|5|||
124456197|NCT01987960|447630354|FG000|Period 3|Administrative or other reason|0|||
124456198|NCT01987960|447630355|FG001|Period 3|Administrative or other reason|0|||
124456199|NCT01987960|447630356|FG002|Period 3|Administrative or other reason|0|||
124703025|NCT04191135|448535784|FG001|Induction Treatment|Not Treated|0|||
124937675|NCT01105975|449402067|FG009|Overall Study|Physician Decision|0|||
124937676|NCT01105975|449402058|FG000|Overall Study|Protocol Violation|0|||
124937677|NCT01105975|449402059|FG001|Overall Study|Protocol Violation|2|||
124937678|NCT01105975|449402060|FG002|Overall Study|Protocol Violation|2|||
124937679|NCT01105975|449402061|FG003|Overall Study|Protocol Violation|0|||
124937680|NCT01105975|449402062|FG004|Overall Study|Protocol Violation|1|||
124937681|NCT01105975|449402063|FG005|Overall Study|Protocol Violation|1|||
124937682|NCT01105975|449402064|FG006|Overall Study|Protocol Violation|1|||
124937683|NCT01105975|449402065|FG007|Overall Study|Protocol Violation|1|||
124937684|NCT01105975|449402066|FG008|Overall Study|Protocol Violation|2|||
124937685|NCT01105975|449402067|FG009|Overall Study|Protocol Violation|2|||
124937686|NCT01105975|449402058|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
124937687|NCT01105975|449402059|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
124937688|NCT01105975|449402060|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
124937689|NCT01105975|449402061|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
124937690|NCT01105975|449402062|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
124937691|NCT01105975|449402063|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
124937692|NCT01105975|449402064|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
124937693|NCT01105975|449402065|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
124937694|NCT01105975|449402066|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
124937695|NCT01105975|449402067|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
124937696|NCT00087685|449402077|FG000|Overall Study|Adverse Event|5|||
124937697|NCT00087685|449402077|FG000|Overall Study|Non-Compliance|1|||
124937698|NCT00087685|449402077|FG000|Overall Study|Progressive Disease|5|||
124937699|NCT00087685|449402077|FG000|Overall Study|Withdrawal by Subject|3|||
124937700|NCT05018143|449402078|FG000|Overall Study|Lost to Follow-up|5|||
124937701|NCT05018143|449402079|FG001|Overall Study|Lost to Follow-up|4|||
124937702|NCT05018143|449402078|FG000|Overall Study|Withdrawal by Subject|0|||
124937703|NCT05018143|449402079|FG001|Overall Study|Withdrawal by Subject|1|||
124937704|NCT04018495|449402080|FG000|Overall Study|Physician Decision|1|||
124937705|NCT04059406|449402081|FG000|Overall Study|Early Treatment Termination|5|||
124937706|NCT04059406|449402082|FG001|Overall Study|Early Treatment Termination|5|||
124937707|NCT04059406|449402083|FG002|Overall Study|Early Treatment Termination|15|||
124937708|NCT05601882|449402084|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
124937709|NCT05601882|449402085|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
124937710|NCT05601882|449402086|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
124937711|NCT05601882|449402087|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
124937712|NCT05601882|449402084|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
124937713|NCT05601882|449402085|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
124937714|NCT05601882|449402086|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
124937715|NCT05601882|449402087|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
124937716|NCT05601882|449402084|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
124937717|NCT05601882|449402085|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
124937718|NCT05601882|449402086|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
124937719|NCT05601882|449402087|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
124937720|NCT05601882|449402084|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
124937721|NCT05601882|449402085|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
124937722|NCT05601882|449402086|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
124937723|NCT05601882|449402087|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
124937724|NCT05601882|449402084|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
124937725|NCT05601882|449402085|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
124937726|NCT05601882|449402086|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
124937727|NCT05601882|449402087|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
124937728|NCT05601882|449402084|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
124937729|NCT05601882|449402085|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
124937730|NCT05601882|449402086|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
124937731|NCT05601882|449402087|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
124937732|NCT04121741|449402088|FG000|Overall Study|Protocol Violation|1|||
124937733|NCT04121741|449402089|FG001|Overall Study|Protocol Violation|0|||
124937734|NCT04121741|449402090|FG002|Overall Study|Protocol Violation|0|||
124937735|NCT04121741|449402091|FG003|Overall Study|Protocol Violation|0|||
124937736|NCT04121741|449402092|FG004|Overall Study|Protocol Violation|0|||
124937737|NCT04121741|449402093|FG005|Overall Study|Protocol Violation|0|||
124937738|NCT03473223|449402094|FG000|Overall Study|Lost to Follow-up|1|||
124937739|NCT03473223|449402095|FG001|Overall Study|Lost to Follow-up|1|||
124937740|NCT03473223|449402094|FG000|Overall Study|Withdrawal by Subject|47|||
124937741|NCT03473223|449402095|FG001|Overall Study|Withdrawal by Subject|42|||
124937742|NCT03473223|449402094|FG000|Overall Study|Indirect contact|32|||
124937743|NCT03473223|449402095|FG001|Overall Study|Indirect contact|29|||
124937744|NCT03473223|449402094|FG000|Overall Study|Other (Not specified)|32|||
124937745|NCT03473223|449402095|FG001|Overall Study|Other (Not specified)|20|||
124937746|NCT03524092|449402096|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
124937747|NCT03524092|449402097|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
124937748|NCT03524092|449402098|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
124937749|NCT03524092|449402099|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
124937750|NCT03524092|449402100|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
124937751|NCT03524092|449402101|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
124937752|NCT03524092|449402096|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
124937753|NCT03524092|449402097|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
124937754|NCT03524092|449402098|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
124937755|NCT03524092|449402099|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
124937756|NCT03524092|449402100|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
124937757|NCT03524092|449402101|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
124937758|NCT03524092|449402096|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
124937759|NCT03524092|449402097|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
124937760|NCT03524092|449402098|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
124937761|NCT03524092|449402099|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
124937762|NCT03524092|449402100|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
124937763|NCT03524092|449402101|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
124937764|NCT03524092|449402096|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
124937765|NCT03524092|449402097|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
124937766|NCT03524092|449402098|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
124937767|NCT03524092|449402099|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
124937768|NCT03524092|449402100|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
124937769|NCT03524092|449402101|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
124937770|NCT03524092|449402096|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
124937771|NCT03524092|449402097|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
124937772|NCT03524092|449402098|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
124937773|NCT03524092|449402099|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
124937774|NCT03524092|449402100|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
124937775|NCT03524092|449402101|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
124937776|NCT03524092|449402096|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
124937777|NCT03524092|449402097|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
124937778|NCT03524092|449402098|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
124937779|NCT03524092|449402099|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
124937780|NCT03524092|449402100|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
124937781|NCT03524092|449402101|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
124937782|NCT03524092|449402096|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
124937783|NCT03524092|449402097|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
124937784|NCT03524092|449402098|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
124937785|NCT03524092|449402099|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
124937786|NCT03524092|449402100|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
124937787|NCT03524092|449402101|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
124937788|NCT03524092|449402096|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
124937789|NCT03524092|449402097|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
124937790|NCT03524092|449402098|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
124937791|NCT03524092|449402099|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
124937792|NCT03524092|449402100|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
124937793|NCT03524092|449402101|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
124937794|NCT03524092|449402096|FG000|Loss of Response Rescue Period|Adverse Event|0|||
124937795|NCT03524092|449402097|FG001|Loss of Response Rescue Period|Adverse Event|0|||
124937796|NCT03524092|449402098|FG002|Loss of Response Rescue Period|Adverse Event|0|||
124937797|NCT03524092|449402099|FG003|Loss of Response Rescue Period|Adverse Event|2|||
124937798|NCT03524092|449402100|FG004|Loss of Response Rescue Period|Adverse Event|0|||
124937799|NCT03524092|449402101|FG005|Loss of Response Rescue Period|Adverse Event|0|||
124937800|NCT03524092|449402096|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
124937801|NCT03524092|449402097|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
124937802|NCT03524092|449402098|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
124937803|NCT03524092|449402099|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
124937804|NCT03524092|449402100|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
124937805|NCT03524092|449402101|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
124937806|NCT03524092|449402096|FG000|Loss of Response Rescue Period|Pregnancy|0|||
124937807|NCT03524092|449402097|FG001|Loss of Response Rescue Period|Pregnancy|0|||
124937808|NCT03524092|449402098|FG002|Loss of Response Rescue Period|Pregnancy|0|||
124937809|NCT03524092|449402099|FG003|Loss of Response Rescue Period|Pregnancy|1|||
124937810|NCT03524092|449402100|FG004|Loss of Response Rescue Period|Pregnancy|0|||
124703026|NCT04191135|448535785|FG002|Induction Treatment|Not Treated|0|||
124937811|NCT03524092|449402101|FG005|Loss of Response Rescue Period|Pregnancy|0|||
124937812|NCT03524092|449402096|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
124937813|NCT03524092|449402097|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
124937814|NCT03524092|449402098|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
124937815|NCT03524092|449402099|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
124937816|NCT03524092|449402100|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
124937817|NCT03524092|449402101|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
124937818|NCT03524092|449402096|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
124937819|NCT03524092|449402097|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
124937820|NCT03524092|449402098|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
124937821|NCT03524092|449402099|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
124937822|NCT03524092|449402100|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
124937823|NCT03524092|449402101|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
124937824|NCT03524092|449402096|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
124937825|NCT03524092|449402097|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
124937826|NCT03524092|449402098|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
124937827|NCT03524092|449402099|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
124937828|NCT03524092|449402100|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
124937829|NCT03524092|449402101|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
124937830|NCT03524092|449402096|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
124937831|NCT03524092|449402097|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
124937832|NCT03524092|449402098|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
124937833|NCT03524092|449402099|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
124937834|NCT03524092|449402100|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
124937835|NCT03524092|449402101|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
124937836|NCT03524092|449402096|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
124937837|NCT03524092|449402097|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
124937838|NCT03524092|449402098|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
124937839|NCT03524092|449402099|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
124937840|NCT03524092|449402100|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
124937841|NCT03524092|449402101|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
124937842|NCT03524092|449402096|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
124937843|NCT03524092|449402097|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
124937844|NCT03524092|449402098|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
124937845|NCT03524092|449402099|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
124937846|NCT03524092|449402100|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
124937847|NCT03524092|449402101|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
124937848|NCT03524092|449402096|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
124937849|NCT03524092|449402097|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
124937850|NCT03524092|449402098|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
124937851|NCT03524092|449402099|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
124937852|NCT03524092|449402100|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
124937853|NCT03524092|449402101|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
124937854|NCT03524092|449402096|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
124937855|NCT03524092|449402097|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
124937856|NCT03524092|449402098|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
124937857|NCT03524092|449402099|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
124937858|NCT03524092|449402100|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
124937859|NCT03524092|449402101|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
124937860|NCT03524092|449402096|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
124937861|NCT03524092|449402097|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
124937862|NCT03524092|449402098|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
124937863|NCT03524092|449402099|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
124937864|NCT03524092|449402100|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
124937865|NCT03524092|449402101|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
124937866|NCT03524092|449402096|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
124456200|NCT01987960|447630357|FG003|Period 3|Administrative or other reason|43|||
124456201|NCT01892163|447630364|FG000|Overall Study|Death|1|||
124937867|NCT03524092|449402097|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
124937868|NCT03524092|449402098|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
124456202|NCT01892163|447630365|FG001|Overall Study|Death|1|||
124456203|NCT01892163|447630364|FG000|Overall Study|Lost to Follow-up|1|||
124703027|NCT04191135|448535783|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
124937869|NCT03524092|449402099|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
124937870|NCT03524092|449402100|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
124937871|NCT03524092|449402101|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
124937872|NCT03524092|449402096|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
124937873|NCT03524092|449402097|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
124937874|NCT03524092|449402098|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
124937875|NCT03524092|449402099|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
124937876|NCT03524092|449402100|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
124937877|NCT03524092|449402101|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
124937878|NCT03524092|449402096|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
124937879|NCT03524092|449402097|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
124937880|NCT03524092|449402098|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
124937881|NCT03524092|449402099|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
124937882|NCT03524092|449402100|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
124937883|NCT03524092|449402101|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
124937884|NCT03834740|449402102|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
124937885|NCT03834740|449402103|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
124937886|NCT03834740|449402104|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
124937887|NCT00115934|449402105|FG000|Overall Study|Lost to Follow-up|1|||
124937888|NCT00115934|449402106|FG001|Overall Study|Lost to Follow-up|0|||
124937889|NCT00115934|449402105|FG000|Overall Study|Did not receive intervention|3|||
124937890|NCT00115934|449402106|FG001|Overall Study|Did not receive intervention|2|||
124937891|NCT03997474|449402107|FG000|Overall Study|Death|6|||
124937892|NCT03997474|449402108|FG001|Overall Study|Death|2|||
124937893|NCT03997474|449402109|FG002|Overall Study|Death|1|||
124937894|NCT03997474|449402107|FG000|Overall Study|Physician Decision|2|||
124937895|NCT03997474|449402108|FG001|Overall Study|Physician Decision|0|||
124937896|NCT03997474|449402109|FG002|Overall Study|Physician Decision|0|||
124937897|NCT03997474|449402107|FG000|Overall Study|study terminated by sponsor|1|||
124937898|NCT03997474|449402108|FG001|Overall Study|study terminated by sponsor|0|||
124937899|NCT03997474|449402109|FG002|Overall Study|study terminated by sponsor|1|||
124937900|NCT03183050|449403056|FG000|Overall Study|Lost to Follow-up|23|||
124937901|NCT00754065|449403057|FG000|Overall Study|Never received treatment|12|||
124937902|NCT00754065|449403058|FG001|Overall Study|Never received treatment|2|||
124937903|NCT00754065|449403057|FG000|Overall Study|Adverse Event|19|||
124937904|NCT00754065|449403058|FG001|Overall Study|Adverse Event|25|||
124937905|NCT00754065|449403057|FG000|Overall Study|Lost to Follow-up|7|||
124937906|NCT00754065|449403058|FG001|Overall Study|Lost to Follow-up|11|||
124937907|NCT00754065|449403057|FG000|Overall Study|Protocol Violation|12|||
124937908|NCT00754065|449403058|FG001|Overall Study|Protocol Violation|10|||
124937909|NCT00754065|449403057|FG000|Overall Study|Withdrawal by Subject|4|||
124937910|NCT00754065|449403058|FG001|Overall Study|Withdrawal by Subject|5|||
124937911|NCT00754065|449403057|FG000|Overall Study|Pregnancy|6|||
124937912|NCT00754065|449403058|FG001|Overall Study|Pregnancy|0|||
124937913|NCT00754065|449403057|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
124937914|NCT00754065|449403058|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
124937915|NCT03776812|449403059|FG000|Overall Study|Death|27|||
124937916|NCT03776812|449403060|FG001|Overall Study|Death|19|||
124937917|NCT03776812|449403061|FG002|Overall Study|Death|29|||
124937918|NCT03776812|449403059|FG000|Overall Study|Withdrawal by Subject|1|||
124937919|NCT03776812|449403060|FG001|Overall Study|Withdrawal by Subject|7|||
124937920|NCT03776812|449403061|FG002|Overall Study|Withdrawal by Subject|1|||
124937921|NCT03776812|449403059|FG000|Overall Study|Lost to Follow-up|0|||
124937922|NCT03776812|449403060|FG001|Overall Study|Lost to Follow-up|1|||
124937923|NCT03776812|449403061|FG002|Overall Study|Lost to Follow-up|0|||
124937924|NCT03776812|449403059|FG000|Overall Study|Still on study as of March 22, 2021 data cutoff date|30|||
124937925|NCT03776812|449403060|FG001|Overall Study|Still on study as of March 22, 2021 data cutoff date|33|||
124937926|NCT03776812|449403061|FG002|Overall Study|Still on study as of March 22, 2021 data cutoff date|30|||
124937927|NCT01171976|449403065|FG000|Overall Study|Protocol Violation|0|||
124937928|NCT01171976|449403066|FG001|Overall Study|Protocol Violation|0|||
124937929|NCT01171976|449403067|FG002|Overall Study|Protocol Violation|1|||
124937930|NCT01171976|449403065|FG000|Overall Study|Death|2|||
124703028|NCT04191135|448535784|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
124703029|NCT04191135|448535785|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
124937931|NCT01171976|449403066|FG001|Overall Study|Death|4|||
124937932|NCT01171976|449403067|FG002|Overall Study|Death|1|||
124937933|NCT01171976|449403065|FG000|Overall Study|Lost to Follow-up|4|||
124937934|NCT01171976|449403066|FG001|Overall Study|Lost to Follow-up|0|||
124937935|NCT01171976|449403067|FG002|Overall Study|Lost to Follow-up|2|||
124456204|NCT01892163|447630365|FG001|Overall Study|Lost to Follow-up|0|||
124456205|NCT03302975|447630367|FG000|Overall Study|Lost to Follow-up|4|||
124466470|NCT02574637|447666420|FG004|Double-blind Period|Lack of Efficacy|0|||
124937936|NCT01171976|449403065|FG000|Overall Study|Withdrawal by Subject|1|||
124937937|NCT01171976|449403066|FG001|Overall Study|Withdrawal by Subject|5|||
124937938|NCT01171976|449403067|FG002|Overall Study|Withdrawal by Subject|6|||
124937939|NCT01171976|449403065|FG000|Overall Study|Abnormal test result|1|||
124937940|NCT01171976|449403066|FG001|Overall Study|Abnormal test result|0|||
124937941|NCT01171976|449403067|FG002|Overall Study|Abnormal test result|0|||
124937942|NCT01171976|449403065|FG000|Overall Study|Adverse Event|6|||
124937943|NCT01171976|449403066|FG001|Overall Study|Adverse Event|2|||
124937944|NCT01171976|449403067|FG002|Overall Study|Adverse Event|5|||
124937945|NCT06688357|449403068|FG000|Overall Study|Adverse Event|0|||
124937946|NCT06688357|449403069|FG001|Overall Study|Adverse Event|1|||
124937947|NCT03222609|449403072|FG000|Overall Study|Withdrew consent|2|||
124937948|NCT03222609|449403073|FG001|Overall Study|Withdrew consent|3|||
124937949|NCT03222609|449403074|FG002|Overall Study|Withdrew consent|4|||
124937950|NCT03222609|449403075|FG003|Overall Study|Withdrew consent|2|||
124937951|NCT03222609|449403072|FG000|Overall Study|Lost to Follow-up|1|||
124937952|NCT03222609|449403073|FG001|Overall Study|Lost to Follow-up|0|||
124937953|NCT03222609|449403074|FG002|Overall Study|Lost to Follow-up|0|||
124937954|NCT03222609|449403075|FG003|Overall Study|Lost to Follow-up|0|||
124937955|NCT03222609|449403072|FG000|Overall Study|Death|16|||
124937956|NCT03222609|449403073|FG001|Overall Study|Death|13|||
124937957|NCT03222609|449403074|FG002|Overall Study|Death|9|||
124937958|NCT03222609|449403075|FG003|Overall Study|Death|6|||
124937959|NCT03222609|449403072|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
124937960|NCT03222609|449403073|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
124937961|NCT03222609|449403074|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
124937962|NCT03222609|449403075|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
124937963|NCT01084863|449403076|FG000|Main Study Treatment Period|Disease progression|11|||
124937964|NCT01084863|449403077|FG001|Main Study Treatment Period|Disease progression|7|||
124937965|NCT01084863|449403076|FG000|Main Study Treatment Period|Adverse Event|5|||
124937966|NCT01084863|449403077|FG001|Main Study Treatment Period|Adverse Event|3|||
124937967|NCT01084863|449403076|FG000|Main Study Treatment Period|Other Reason|0|||
124937968|NCT01084863|449403077|FG001|Main Study Treatment Period|Other Reason|1|||
124937969|NCT01084863|449403076|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
124937970|NCT01084863|449403077|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
124937971|NCT01084863|449403076|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
124937972|NCT01084863|449403077|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
124937973|NCT01084863|449403076|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
124937974|NCT01084863|449403077|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
124937975|NCT01084863|449403076|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
124937976|NCT01084863|449403077|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
124937977|NCT01084863|449403076|FG000|Treatment Period Beyond Cycle 8|Other|0|||
124937978|NCT01084863|449403077|FG001|Treatment Period Beyond Cycle 8|Other|1|||
124937979|NCT01084863|449403076|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
124937980|NCT01084863|449403077|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
124937981|NCT04305327|449403078|FG000|Overall Study|Study early termination|2|||
124937982|NCT04305327|449403079|FG001|Overall Study|Study early termination|5|||
124937983|NCT04305327|449403080|FG002|Overall Study|Study early termination|2|||
124937984|NCT04305327|449403081|FG003|Overall Study|Study early termination|2|||
124937985|NCT04305327|449403078|FG000|Overall Study|Withdrawal by Subject|0|||
124937986|NCT04305327|449403079|FG001|Overall Study|Withdrawal by Subject|1|||
124937987|NCT04305327|449403080|FG002|Overall Study|Withdrawal by Subject|0|||
124937988|NCT04305327|449403081|FG003|Overall Study|Withdrawal by Subject|0|||
124937989|NCT03275285|449403084|FG000|Overall Study|Ongoing|45|||
124937990|NCT03275285|449403085|FG001|Overall Study|Ongoing|69|||
124937991|NCT06191679|449403086|FG000|Baseline|Lost to Follow-up|1|||
124937992|NCT06191679|449403087|FG001|Baseline|Lost to Follow-up|0|||
124937993|NCT06191679|449403088|FG002|Baseline|Lost to Follow-up|1|||
124937994|NCT06191679|449403089|FG003|Baseline|Lost to Follow-up|0|||
124937995|NCT06191679|449403086|FG000|Allocation to Group|Withdrawal by Subject|0|||
124937996|NCT06191679|449403087|FG001|Allocation to Group|Withdrawal by Subject|1|||
124937997|NCT06191679|449403088|FG002|Allocation to Group|Withdrawal by Subject|2|||
124937998|NCT06191679|449403089|FG003|Allocation to Group|Withdrawal by Subject|0|||
124937999|NCT06191679|449403086|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
124456206|NCT02258451|447630370|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
124938000|NCT06191679|449403087|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
124938001|NCT06191679|449403088|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
124703030|NCT04191135|448535783|FG000|Induction Treatment|Adverse Event|25|||
124938002|NCT06191679|449403089|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
124938003|NCT06191679|449403086|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
124938004|NCT06191679|449403087|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
124938005|NCT06191679|449403088|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
124938006|NCT06191679|449403089|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
124938007|NCT06191679|449403086|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
124764961|NCT00097500|448765078|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
124764962|NCT00097500|448765079|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
124764963|NCT00097500|448765078|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
124938008|NCT06191679|449403087|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
124938009|NCT06191679|449403088|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
124938010|NCT06191679|449403089|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
124938011|NCT03656718|449403090|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
124938012|NCT03656718|449403091|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
124938013|NCT03656718|449403092|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
124938014|NCT03656718|449403093|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
124938015|NCT03656718|449403094|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
124938016|NCT03656718|449403095|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
124938017|NCT03656718|449403096|FG006|Treatment Period Parts A, B, D, and E|Disease progression|14|||
124938018|NCT03656718|449403090|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
124938019|NCT03656718|449403091|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
124938020|NCT03656718|449403092|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
124938021|NCT03656718|449403093|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
124938022|NCT03656718|449403094|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
124938023|NCT03656718|449403095|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
124938024|NCT03656718|449403096|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
124938025|NCT03656718|449403090|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
124938026|NCT03656718|449403091|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
124938027|NCT03656718|449403092|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
124938028|NCT03656718|449403093|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
124938029|NCT03656718|449403094|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
124938030|NCT03656718|449403095|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
124938031|NCT03656718|449403096|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
124938032|NCT03656718|449403090|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
124938033|NCT03656718|449403091|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
124938034|NCT03656718|449403092|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
124938035|NCT03656718|449403093|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
124938036|NCT03656718|449403094|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
124938037|NCT03656718|449403095|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
124938038|NCT03656718|449403096|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
124938039|NCT03656718|449403090|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
124938040|NCT03656718|449403091|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
124938041|NCT03656718|449403092|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
124938042|NCT03656718|449403093|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
124938043|NCT03656718|449403094|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
124938044|NCT03656718|449403095|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
124938045|NCT03656718|449403096|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
124938046|NCT03656718|449403090|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
124938047|NCT03656718|449403091|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
124938048|NCT03656718|449403092|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
124938049|NCT03656718|449403093|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
124938050|NCT03656718|449403094|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
124938051|NCT03656718|449403095|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
124938052|NCT03656718|449403096|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
124938053|NCT03656718|449403090|FG000|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
124938054|NCT03656718|449403091|FG001|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
124764964|NCT00097500|448765079|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
124764965|NCT00097500|448765078|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
124764966|NCT00097500|448765079|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
124764967|NCT00097500|448765078|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
124764968|NCT00097500|448765079|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
124764969|NCT00097500|448765078|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
124764970|NCT00097500|448765079|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
124764971|NCT00097500|448765078|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
124764972|NCT00097500|448765079|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
124938055|NCT03656718|449403092|FG002|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
124764973|NCT01600885|448765083|FG000|First Period|Adverse Event|1|||
124938056|NCT03656718|449403093|FG003|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
124938057|NCT03656718|449403094|FG004|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
124938058|NCT03656718|449403095|FG005|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
124938059|NCT03656718|449403096|FG006|Treatment Period Parts A, B, D, and E|Continuing study treatment|14|||
124938060|NCT03656718|449403090|FG000|Treatment Period Part C|Disease progression|0|||
124938061|NCT03656718|449403091|FG001|Treatment Period Part C|Disease progression|0|||
124938062|NCT03656718|449403092|FG002|Treatment Period Part C|Disease progression|0|||
124938063|NCT03656718|449403093|FG003|Treatment Period Part C|Disease progression|0|||
124938064|NCT03656718|449403094|FG004|Treatment Period Part C|Disease progression|12|||
124938065|NCT03656718|449403095|FG005|Treatment Period Part C|Disease progression|0|||
124938066|NCT03656718|449403096|FG006|Treatment Period Part C|Disease progression|0|||
124938067|NCT03656718|449403090|FG000|Treatment Period Part C|Death|0|||
124938068|NCT03656718|449403091|FG001|Treatment Period Part C|Death|0|||
124938069|NCT03656718|449403092|FG002|Treatment Period Part C|Death|0|||
124938070|NCT03656718|449403093|FG003|Treatment Period Part C|Death|0|||
124938071|NCT03656718|449403094|FG004|Treatment Period Part C|Death|1|||
124938072|NCT03656718|449403095|FG005|Treatment Period Part C|Death|0|||
124938073|NCT03656718|449403096|FG006|Treatment Period Part C|Death|0|||
124938074|NCT03656718|449403090|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
124938075|NCT03656718|449403091|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
124938076|NCT03656718|449403092|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
124938077|NCT03656718|449403093|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
124938078|NCT03656718|449403094|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
124938079|NCT03656718|449403095|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
124938080|NCT03656718|449403096|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
124938081|NCT03656718|449403090|FG000|Treatment Period Part C|Other reasons|0|||
124938082|NCT03656718|449403091|FG001|Treatment Period Part C|Other reasons|0|||
124938083|NCT03656718|449403092|FG002|Treatment Period Part C|Other reasons|0|||
124938084|NCT03656718|449403093|FG003|Treatment Period Part C|Other reasons|0|||
124938085|NCT03656718|449403094|FG004|Treatment Period Part C|Other reasons|1|||
124938086|NCT03656718|449403095|FG005|Treatment Period Part C|Other reasons|0|||
124938087|NCT03656718|449403096|FG006|Treatment Period Part C|Other reasons|0|||
124938088|NCT03656718|449403090|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
124938089|NCT03656718|449403091|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
124938090|NCT03656718|449403092|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
124938091|NCT03656718|449403093|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
124938092|NCT03656718|449403094|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
124938093|NCT03656718|449403095|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
124938094|NCT03656718|449403096|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
124938095|NCT03211247|449403097|FG000|Overall Study|Adverse Event|8|||
124938096|NCT03211247|449403098|FG001|Overall Study|Adverse Event|0|||
124938097|NCT03211247|449403099|FG002|Overall Study|Adverse Event|1|||
124938098|NCT03211247|449403100|FG003|Overall Study|Adverse Event|0|||
124938099|NCT03211247|449403101|FG004|Overall Study|Adverse Event|0|||
124938100|NCT03211247|449403097|FG000|Overall Study|Lost to Follow-up|2|||
124938101|NCT03211247|449403098|FG001|Overall Study|Lost to Follow-up|1|||
124938102|NCT03211247|449403099|FG002|Overall Study|Lost to Follow-up|0|||
124938103|NCT03211247|449403100|FG003|Overall Study|Lost to Follow-up|0|||
124938104|NCT03211247|449403101|FG004|Overall Study|Lost to Follow-up|0|||
124938105|NCT03211247|449403097|FG000|Overall Study|Physician Decision|1|||
124938106|NCT03211247|449403098|FG001|Overall Study|Physician Decision|2|||
124938107|NCT03211247|449403099|FG002|Overall Study|Physician Decision|0|||
124938108|NCT03211247|449403100|FG003|Overall Study|Physician Decision|0|||
124938109|NCT03211247|449403101|FG004|Overall Study|Physician Decision|0|||
124938110|NCT03211247|449403097|FG000|Overall Study|Non-compliance with study drug|2|||
124938111|NCT03211247|449403098|FG001|Overall Study|Non-compliance with study drug|0|||
124938112|NCT03211247|449403099|FG002|Overall Study|Non-compliance with study drug|0|||
124938113|NCT03211247|449403100|FG003|Overall Study|Non-compliance with study drug|0|||
124938114|NCT03211247|449403101|FG004|Overall Study|Non-compliance with study drug|0|||
124938115|NCT03211247|449403097|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
124938116|NCT03211247|449403098|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
124938117|NCT03211247|449403099|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
124938118|NCT03211247|449403100|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
124938119|NCT03211247|449403101|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
124938120|NCT03211247|449403097|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
124938121|NCT03211247|449403098|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
124938122|NCT03211247|449403099|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
124938123|NCT03211247|449403100|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
124938124|NCT03211247|449403101|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
124938125|NCT03211247|449403097|FG000|Overall Study|Protocol Violation|0|||
124938126|NCT03211247|449403098|FG001|Overall Study|Protocol Violation|1|||
124938127|NCT03211247|449403099|FG002|Overall Study|Protocol Violation|0|||
124938128|NCT03211247|449403100|FG003|Overall Study|Protocol Violation|0|||
124938129|NCT03211247|449403101|FG004|Overall Study|Protocol Violation|0|||
124938130|NCT02039401|449403102|FG000|Overall Study|Adverse Event|0|||
124938131|NCT02039401|449403103|FG001|Overall Study|Adverse Event|1|||
124938132|NCT05827068|449403107|FG000|Overall Study|Lost to Follow-up|1|||
124938133|NCT05827068|449403108|FG001|Overall Study|Lost to Follow-up|4|||
124938134|NCT05827068|449403109|FG002|Overall Study|Lost to Follow-up|1|||
124938135|NCT05827068|449403110|FG003|Overall Study|Lost to Follow-up|1|||
124938136|NCT05827068|449403111|FG004|Overall Study|Lost to Follow-up|2|||
124938137|NCT05827068|449403112|FG005|Overall Study|Lost to Follow-up|4|||
124938138|NCT05827068|449403113|FG006|Overall Study|Lost to Follow-up|1|||
124938139|NCT05827068|449403107|FG000|Overall Study|Withdrawal by Subject|4|||
124938140|NCT05827068|449403108|FG001|Overall Study|Withdrawal by Subject|0|||
124938141|NCT05827068|449403109|FG002|Overall Study|Withdrawal by Subject|1|||
124938142|NCT05827068|449403110|FG003|Overall Study|Withdrawal by Subject|2|||
124938143|NCT05827068|449403111|FG004|Overall Study|Withdrawal by Subject|3|||
124938144|NCT05827068|449403112|FG005|Overall Study|Withdrawal by Subject|0|||
124938145|NCT05827068|449403113|FG006|Overall Study|Withdrawal by Subject|1|||
124938146|NCT05827068|449403107|FG000|Overall Study|Physician Decision|0|||
124938147|NCT05827068|449403108|FG001|Overall Study|Physician Decision|0|||
124938148|NCT05827068|449403109|FG002|Overall Study|Physician Decision|0|||
124938149|NCT05827068|449403110|FG003|Overall Study|Physician Decision|0|||
124938150|NCT05827068|449403111|FG004|Overall Study|Physician Decision|1|||
124938151|NCT05827068|449403112|FG005|Overall Study|Physician Decision|0|||
124938152|NCT05827068|449403113|FG006|Overall Study|Physician Decision|1|||
124938153|NCT05827068|449403107|FG000|Overall Study|Other Than Specified|0|||
124938154|NCT05827068|449403108|FG001|Overall Study|Other Than Specified|1|||
124938155|NCT05827068|449403109|FG002|Overall Study|Other Than Specified|0|||
124938156|NCT05827068|449403110|FG003|Overall Study|Other Than Specified|0|||
124938157|NCT05827068|449403111|FG004|Overall Study|Other Than Specified|0|||
124938158|NCT05827068|449403112|FG005|Overall Study|Other Than Specified|0|||
124938159|NCT05827068|449403113|FG006|Overall Study|Other Than Specified|0|||
124703031|NCT04191135|448535784|FG001|Induction Treatment|Adverse Event|0|||
124703032|NCT04191135|448535785|FG002|Induction Treatment|Adverse Event|0|||
124703033|NCT04191135|448535783|FG000|Induction Treatment|Clinical Progression|8|||
124703034|NCT04191135|448535784|FG001|Induction Treatment|Clinical Progression|0|||
124703035|NCT04191135|448535785|FG002|Induction Treatment|Clinical Progression|0|||
124703036|NCT04191135|448535783|FG000|Induction Treatment|Excluded Medication|1|||
124703037|NCT04191135|448535784|FG001|Induction Treatment|Excluded Medication|0|||
124938160|NCT00353496|449403114|FG000|Overall Study|Adverse Event|1|||
124938161|NCT00353496|449403115|FG001|Overall Study|Adverse Event|0|||
124938162|NCT00353496|449403114|FG000|Overall Study|Protocol Violation|2|||
124938163|NCT00353496|449403115|FG001|Overall Study|Protocol Violation|2|||
124938164|NCT00353496|449403114|FG000|Overall Study|Withdrawal by Subject|3|||
124938165|NCT00353496|449403115|FG001|Overall Study|Withdrawal by Subject|4|||
124938166|NCT00353496|449403114|FG000|Overall Study|Physician Decision|6|||
124938167|NCT00353496|449403115|FG001|Overall Study|Physician Decision|9|||
124938168|NCT00353496|449403114|FG000|Overall Study|Not otherwise specified|4|||
124938169|NCT00353496|449403115|FG001|Overall Study|Not otherwise specified|2|||
124938170|NCT04980300|449403116|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
124938171|NCT04980300|449403117|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
124938172|NCT04980300|449403116|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
124938173|NCT04980300|449403117|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
124938174|NCT04980300|449403116|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
124938175|NCT04980300|449403117|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
124938176|NCT04980300|449403116|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
124938177|NCT04980300|449403117|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
124938178|NCT01470144|449403123|FG000|Overall Study|Adverse Event|2|||
124938179|NCT01470144|449403123|FG000|Overall Study|Death|1|||
124938180|NCT01470144|449403123|FG000|Overall Study|Lung transplant|6|||
124938181|NCT01470144|449403123|FG000|Overall Study|Patient's and investigator's decision|1|||
124938182|NCT03459196|449403738|FG000|Overall Study|Subject didn't receive study catheter|2|||
124938183|NCT02325466|449403739|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
124938184|NCT02325466|449403740|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
124938185|NCT02325466|449403741|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
124938186|NCT02325466|449403739|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
124938187|NCT02325466|449403740|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
124938188|NCT02325466|449403741|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
124938189|NCT02325466|449403739|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
124938190|NCT02325466|449403740|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
124703038|NCT04191135|448535785|FG002|Induction Treatment|Excluded Medication|0|||
124703039|NCT04191135|448535783|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
124703040|NCT04191135|448535784|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
124703041|NCT04191135|448535785|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
124703042|NCT04191135|448535783|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
124703043|NCT04191135|448535784|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
124703044|NCT04191135|448535785|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
124703045|NCT04191135|448535783|FG000|Induction Treatment|Physician Decision|2|||
124703046|NCT04191135|448535784|FG001|Induction Treatment|Physician Decision|0|||
124703047|NCT04191135|448535785|FG002|Induction Treatment|Physician Decision|0|||
124703048|NCT04191135|448535783|FG000|Induction Treatment|Progressive Disease|135|||
124703049|NCT04191135|448535784|FG001|Induction Treatment|Progressive Disease|0|||
124703050|NCT04191135|448535785|FG002|Induction Treatment|Progressive Disease|0|||
124703051|NCT04191135|448535783|FG000|Induction Treatment|Protocol Violation|10|||
124703052|NCT04191135|448535784|FG001|Induction Treatment|Protocol Violation|0|||
124703053|NCT04191135|448535785|FG002|Induction Treatment|Protocol Violation|0|||
124703054|NCT04191135|448535783|FG000|Induction Treatment|Withdrawal by Subject|4|||
124938191|NCT02325466|449403741|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
124938192|NCT02325466|449403739|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
124938193|NCT02325466|449403740|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
124938194|NCT02325466|449403741|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
124938195|NCT02325466|449403739|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
124938196|NCT02325466|449403740|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
124938197|NCT02325466|449403741|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
124938198|NCT02325466|449403739|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
124938199|NCT02325466|449403740|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
124938200|NCT02325466|449403741|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
124938201|NCT02325466|449403739|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
124938202|NCT02325466|449403740|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
124938203|NCT02325466|449403741|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
124938204|NCT02325466|449403739|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
124938205|NCT02325466|449403740|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
124938206|NCT02325466|449403741|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
124938207|NCT02325466|449403739|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
124938208|NCT02325466|449403740|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
124938209|NCT02325466|449403741|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
124938210|NCT01074294|449403742|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
124938211|NCT01074294|449403743|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
124938212|NCT01074294|449403744|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
124938213|NCT01074294|449403745|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
124938214|NCT01074294|449403742|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
124938215|NCT01074294|449403743|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
124938216|NCT01074294|449403744|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
124938217|NCT01074294|449403745|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
124938218|NCT01074294|449403742|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
124938219|NCT01074294|449403743|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
124938220|NCT01074294|449403744|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
124938221|NCT01074294|449403745|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
124938222|NCT01074294|449403742|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
124938223|NCT01074294|449403743|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
124938224|NCT01074294|449403744|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
124938225|NCT01074294|449403745|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
124938226|NCT01074294|449403742|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
124938227|NCT01074294|449403743|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
124938228|NCT01074294|449403744|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
124938229|NCT01074294|449403745|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
124938230|NCT01074294|449403742|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
124938231|NCT01074294|449403743|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
124938232|NCT01074294|449403744|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
124938233|NCT01074294|449403745|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
124938234|NCT01074294|449403742|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
124938235|NCT01074294|449403743|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
124938236|NCT01074294|449403744|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
124938237|NCT01074294|449403745|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
124938238|NCT01074294|449403742|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
124938239|NCT01074294|449403743|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
124938240|NCT01074294|449403744|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
124703055|NCT04191135|448535784|FG001|Induction Treatment|Withdrawal by Subject|0|||
124703056|NCT04191135|448535785|FG002|Induction Treatment|Withdrawal by Subject|0|||
124703057|NCT04191135|448535783|FG000|Randomized Treatment|Death|0|||
124703058|NCT04191135|448535784|FG001|Randomized Treatment|Death|50|||
124703059|NCT04191135|448535785|FG002|Randomized Treatment|Death|54|||
124703060|NCT04191135|448535783|FG000|Randomized Treatment|Lost to Follow-up|0|||
124703061|NCT04191135|448535784|FG001|Randomized Treatment|Lost to Follow-up|0|||
124703062|NCT04191135|448535785|FG002|Randomized Treatment|Lost to Follow-up|1|||
124703063|NCT04191135|448535783|FG000|Randomized Treatment|Withdrawal by Subject|0|||
124703064|NCT04191135|448535784|FG001|Randomized Treatment|Withdrawal by Subject|2|||
124703065|NCT04191135|448535785|FG002|Randomized Treatment|Withdrawal by Subject|0|||
124703066|NCT04191135|448535783|FG000|Randomized Treatment|Ongoing in Trial|0|||
124703067|NCT04191135|448535784|FG001|Randomized Treatment|Ongoing in Trial|83|||
124703068|NCT04191135|448535785|FG002|Randomized Treatment|Ongoing in Trial|81|||
124703069|NCT03514134|448537212|FG000|Overall Study|Lost to Follow-up|0|||
124703070|NCT03514134|448537213|FG001|Overall Study|Lost to Follow-up|1|||
124703071|NCT02471144|448537214|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
124703072|NCT02471144|448537215|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
124703073|NCT02471144|448537216|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
124703074|NCT02471144|448537217|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
124938241|NCT01074294|449403745|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
124938242|NCT01074294|449403742|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
124938243|NCT01074294|449403743|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
124938244|NCT01074294|449403744|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
124938245|NCT01074294|449403745|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
124938246|NCT01074294|449403742|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
124938247|NCT01074294|449403743|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
124938248|NCT01074294|449403744|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
124938249|NCT01074294|449403745|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
124938250|NCT01074294|449403742|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
124938251|NCT01074294|449403743|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
124938252|NCT01074294|449403744|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
124938253|NCT01074294|449403745|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
124938254|NCT01074294|449403742|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
124938255|NCT01074294|449403743|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
124938256|NCT01074294|449403744|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
124938257|NCT01074294|449403745|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
124938258|NCT01074294|449403742|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
124938259|NCT01074294|449403743|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
124938260|NCT01074294|449403744|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
124938261|NCT01074294|449403745|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
124938262|NCT02284113|449403747|FG000|Overall Study|Adverse Event|1|||
124938263|NCT02284113|449403748|FG001|Overall Study|Adverse Event|0|||
124938264|NCT02284113|449403747|FG000|Overall Study|non-compliance|0|||
124938265|NCT02284113|449403748|FG001|Overall Study|non-compliance|1|||
124938266|NCT02284113|449403747|FG000|Overall Study|Withdrawal by Subject|0|||
124938267|NCT02284113|449403748|FG001|Overall Study|Withdrawal by Subject|1|||
124938268|NCT02284113|449403747|FG000|Overall Study|not provided|0|||
124938269|NCT02284113|449403748|FG001|Overall Study|not provided|1|||
124938270|NCT02284113|449403747|FG000|Overall Study|surgery cancelled|2|||
124938271|NCT02284113|449403748|FG001|Overall Study|surgery cancelled|0|||
124938272|NCT03885232|449403749|FG000|Overall Study|Lost to Follow-up|74|||
124938273|NCT03885232|449403750|FG001|Overall Study|Lost to Follow-up|32|||
124938274|NCT03885232|449403749|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
124938275|NCT03885232|449403750|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
124938276|NCT01315132|449403751|FG000|Overall Study|not treated due to disease progression|1|||
124938277|NCT03840902|449403754|FG000|Overall Study|Randomized but not treated|1|||
124938278|NCT03840902|449403755|FG001|Overall Study|Randomized but not treated|1|||
124938279|NCT03660930|449403756|FG000|Overall Study|Adverse Event|0|||
124938280|NCT03660930|449403757|FG001|Overall Study|Adverse Event|0|||
124938281|NCT03660930|449403758|FG002|Overall Study|Adverse Event|0|||
124938282|NCT03660930|449403759|FG003|Overall Study|Adverse Event|2|||
124938283|NCT03660930|449403760|FG004|Overall Study|Adverse Event|0|||
124938284|NCT03660930|449403761|FG005|Overall Study|Adverse Event|1|||
124938285|NCT03660930|449403762|FG006|Overall Study|Adverse Event|0|||
124938286|NCT03660930|449403763|FG007|Overall Study|Adverse Event|0|||
124938287|NCT03660930|449403756|FG000|Overall Study|Withdrawal by Subject|0|||
124938288|NCT03660930|449403757|FG001|Overall Study|Withdrawal by Subject|0|||
124938289|NCT03660930|449403758|FG002|Overall Study|Withdrawal by Subject|0|||
124938290|NCT03660930|449403759|FG003|Overall Study|Withdrawal by Subject|0|||
124938291|NCT03660930|449403760|FG004|Overall Study|Withdrawal by Subject|0|||
124938292|NCT03660930|449403761|FG005|Overall Study|Withdrawal by Subject|1|||
124703075|NCT02471144|448537218|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
124938293|NCT03660930|449403762|FG006|Overall Study|Withdrawal by Subject|0|||
124938294|NCT03660930|449403763|FG007|Overall Study|Withdrawal by Subject|0|||
124938295|NCT03509909|449403764|FG000|Overall Study|Withdrawal by Subject|16|||
124938296|NCT03509909|449403765|FG001|Overall Study|Withdrawal by Subject|9|||
124938297|NCT03509909|449403764|FG000|Overall Study|Lost to Follow-up|3|||
124938298|NCT03509909|449403765|FG001|Overall Study|Lost to Follow-up|4|||
124938299|NCT03509909|449403764|FG000|Overall Study|Adverse Event|2|||
124938300|NCT03509909|449403765|FG001|Overall Study|Adverse Event|0|||
124938301|NCT05139992|449403771|FG000|Overall Study|Withdrawal by Subject|12|||
124938302|NCT05139992|449403771|FG000|Overall Study|Lost to Follow-up|6|||
124938303|NCT01208974|449403772|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
124938304|NCT01208974|449403773|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
124938305|NCT01208974|449403774|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
124938306|NCT01208974|449403775|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
124938307|NCT01208974|449403772|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
124938308|NCT01208974|449403773|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
124938309|NCT01208974|449403774|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
124938310|NCT01208974|449403775|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
124938311|NCT01208974|449403772|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
124938312|NCT01208974|449403773|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
124938313|NCT01208974|449403774|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
124938314|NCT01208974|449403775|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
124938315|NCT05521516|449403776|FG000|Overall Study|Withdrawal by Subject|1|||
124938316|NCT05521516|449403777|FG001|Overall Study|Withdrawal by Subject|1|||
124938317|NCT03777657|449403778|FG000|Overall Study|Death|397|||
124938318|NCT03777657|449403779|FG001|Overall Study|Death|431|||
124938319|NCT03777657|449403778|FG000|Overall Study|Study Closed by Sponsor|77|||
124938320|NCT03777657|449403779|FG001|Overall Study|Study Closed by Sponsor|38|||
124938321|NCT03777657|449403778|FG000|Overall Study|Withdrawal by Subject|20|||
124938322|NCT03777657|449403779|FG001|Overall Study|Withdrawal by Subject|17|||
124938323|NCT03777657|449403778|FG000|Overall Study|Lost to Follow-up|6|||
124938324|NCT03777657|449403779|FG001|Overall Study|Lost to Follow-up|10|||
124938325|NCT02500576|449403780|FG000|Overall Study|Adverse Event|0|||
124938326|NCT02500576|449403781|FG001|Overall Study|Adverse Event|1|||
124938327|NCT02500576|449403780|FG000|Overall Study|Death|2|||
124938328|NCT02500576|449403781|FG001|Overall Study|Death|1|||
124938329|NCT02500576|449403780|FG000|Overall Study|Lack of Efficacy|5|||
124938330|NCT02500576|449403781|FG001|Overall Study|Lack of Efficacy|5|||
124938331|NCT02500576|449403780|FG000|Overall Study|Withdrawal by Subject|1|||
124938332|NCT02500576|449403781|FG001|Overall Study|Withdrawal by Subject|1|||
124938333|NCT03691493|449403787|FG000|Overall Study|Withdrawal by Subject|1|||
124938334|NCT03867201|449403788|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
124938335|NCT03867201|449403789|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
124938336|NCT03867201|449403788|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
124938337|NCT03867201|449403789|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
124938338|NCT03867201|449403788|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
124938339|NCT03867201|449403789|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
124938340|NCT03867201|449403788|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
124938341|NCT03867201|449403789|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
124703076|NCT02471144|448537219|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
124703077|NCT02471144|448537220|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
124703078|NCT02471144|448537221|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
124703079|NCT02471144|448537222|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
124703080|NCT02471144|448537223|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
124703081|NCT02471144|448537224|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
124703082|NCT02471144|448537214|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
124703083|NCT02471144|448537215|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
124703084|NCT02471144|448537216|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
124703085|NCT02471144|448537217|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
124703086|NCT02471144|448537218|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
124703087|NCT02471144|448537219|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
124764974|NCT01600885|448765084|FG001|First Period|Adverse Event|1|||
124938342|NCT03867201|449403788|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
124938343|NCT03867201|449403789|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
124938344|NCT03867201|449403788|FG000|Open-Label Period From Week 12|Adverse Event|5|||
124938345|NCT03867201|449403789|FG001|Open-Label Period From Week 12|Adverse Event|11|||
124938346|NCT03867201|449403788|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
124703088|NCT02471144|448537220|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
124703089|NCT02471144|448537221|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
124938347|NCT03867201|449403789|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
124938348|NCT03867201|449403788|FG000|Open-Label Period From Week 12|Physician Decision|6|||
124938349|NCT03867201|449403789|FG001|Open-Label Period From Week 12|Physician Decision|3|||
124938350|NCT03867201|449403788|FG000|Open-Label Period From Week 12|Pregnancy|2|||
124938351|NCT03867201|449403789|FG001|Open-Label Period From Week 12|Pregnancy|2|||
124938352|NCT03867201|449403788|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
124938353|NCT03867201|449403789|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
124938354|NCT03867201|449403788|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
124938355|NCT03867201|449403789|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
124938356|NCT03867201|449403788|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
124938357|NCT03867201|449403789|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
124938358|NCT03867201|449403788|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
124938359|NCT03867201|449403789|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
124938360|NCT01983683|449403790|FG000|Overall Study|Withdrawal by Subject|14|||
124938361|NCT01983683|449403791|FG001|Overall Study|Withdrawal by Subject|18|||
124938362|NCT01983683|449403790|FG000|Overall Study|Death|11|||
124938363|NCT01983683|449403791|FG001|Overall Study|Death|15|||
124938364|NCT01983683|449403790|FG000|Overall Study|Physician Decision|8|||
124938365|NCT01983683|449403791|FG001|Overall Study|Physician Decision|9|||
124938366|NCT01983683|449403790|FG000|Overall Study|Lost to Follow-up|4|||
124938367|NCT01983683|449403791|FG001|Overall Study|Lost to Follow-up|8|||
124938368|NCT01983683|449403790|FG000|Overall Study|Sponsor Decision|1|||
124938369|NCT01983683|449403791|FG001|Overall Study|Sponsor Decision|1|||
124938370|NCT05464732|449403794|FG000|Overall Study|Lost to Follow-up|0|||
124938371|NCT05464732|449403795|FG001|Overall Study|Lost to Follow-up|1|||
124938372|NCT05464732|449403794|FG000|Overall Study|Adverse Event|1|||
124938373|NCT05464732|449403795|FG001|Overall Study|Adverse Event|0|||
124938374|NCT04039113|449403802|FG000|Overall Study|Withdrawal by Subject|8|||
124938375|NCT04039113|449403803|FG001|Overall Study|Withdrawal by Subject|11|||
124938376|NCT04039113|449403802|FG000|Overall Study|Lost to Follow-up|1|||
124938377|NCT04039113|449403803|FG001|Overall Study|Lost to Follow-up|1|||
124938378|NCT04039113|449403802|FG000|Overall Study|Adverse Event|2|||
124938379|NCT04039113|449403803|FG001|Overall Study|Adverse Event|2|||
124938380|NCT04039113|449403802|FG000|Overall Study|Death|2|||
124938381|NCT04039113|449403803|FG001|Overall Study|Death|4|||
124938382|NCT04039113|449403802|FG000|Overall Study|Site Closure|6|||
124938383|NCT04039113|449403803|FG001|Overall Study|Site Closure|0|||
124938384|NCT04039113|449403802|FG000|Overall Study|Failure to meet randomisation criteria|4|||
124938385|NCT04039113|449403803|FG001|Overall Study|Failure to meet randomisation criteria|0|||
124938386|NCT05786612|449403804|FG000|Overall Study|Adverse Event|1|||
124938387|NCT05786612|449403805|FG001|Overall Study|Adverse Event|2|||
124938388|NCT05786612|449403804|FG000|Overall Study|one screening failure|0|||
124938389|NCT05786612|449403805|FG001|Overall Study|one screening failure|2|||
124938390|NCT04926740|449403806|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
124938391|NCT04926740|449403807|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
124938392|NCT04926740|449403806|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
124938393|NCT04926740|449403807|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
124938394|NCT00655499|449404673|FG000|Overall Study|not eligible|4|||
124938395|NCT03140670|449404679|FG000|Overall Study|Withdrawal by Subject|2|||
124938396|NCT03140670|449404679|FG000|Overall Study|Lost to Follow-up|1|||
124938397|NCT03140670|449404679|FG000|Overall Study|Physician Decision|1|||
124938398|NCT00220805|449404680|FG000|Overall Study|Adverse Event|1|||
124938399|NCT00220805|449404681|FG001|Overall Study|Adverse Event|3|||
124938400|NCT00220805|449404680|FG000|Overall Study|Withdrawal by Subject|3|||
124938401|NCT00220805|449404681|FG001|Overall Study|Withdrawal by Subject|0|||
124938402|NCT00220805|449404680|FG000|Overall Study|Lack of Efficacy|1|||
124938403|NCT00220805|449404681|FG001|Overall Study|Lack of Efficacy|0|||
124938404|NCT00220805|449404680|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
124938405|NCT00220805|449404681|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
124938406|NCT00146172|449404682|FG000|Overall Study|Adverse Event|0|||
124938407|NCT00146172|449404683|FG001|Overall Study|Adverse Event|0|||
124703090|NCT02471144|448537222|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
124703091|NCT02471144|448537223|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
124703092|NCT02471144|448537224|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
124703093|NCT02471144|448537214|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
124703094|NCT02471144|448537215|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
124703095|NCT02471144|448537216|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
124703096|NCT02471144|448537217|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
124703097|NCT02471144|448537218|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
124938408|NCT00146172|449404684|FG002|Overall Study|Adverse Event|1|||
124938409|NCT00146172|449404685|FG003|Overall Study|Adverse Event|1|||
124938410|NCT00146172|449404686|FG004|Overall Study|Adverse Event|0|||
124938411|NCT00146172|449404687|FG005|Overall Study|Adverse Event|2|||
124938412|NCT00146172|449404688|FG006|Overall Study|Adverse Event|3|||
124938413|NCT00146172|449404689|FG007|Overall Study|Adverse Event|10|||
124938414|NCT00146172|449404682|FG000|Overall Study|Lost to Follow-up|0|||
124938415|NCT00146172|449404683|FG001|Overall Study|Lost to Follow-up|0|||
124938416|NCT00146172|449404684|FG002|Overall Study|Lost to Follow-up|0|||
124938417|NCT00146172|449404685|FG003|Overall Study|Lost to Follow-up|0|||
124938418|NCT00146172|449404686|FG004|Overall Study|Lost to Follow-up|0|||
124938419|NCT00146172|449404687|FG005|Overall Study|Lost to Follow-up|0|||
124938420|NCT00146172|449404688|FG006|Overall Study|Lost to Follow-up|0|||
124938421|NCT00146172|449404689|FG007|Overall Study|Lost to Follow-up|1|||
124456207|NCT02258451|447630371|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
124456208|NCT02258451|447630370|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
124456209|NCT02258451|447630371|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
124456210|NCT02258451|447630370|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
124456211|NCT02258451|447630371|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
124456212|NCT02258451|447630370|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
124456213|NCT02258451|447630371|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
124456214|NCT02258451|447630370|FG000|Overall Study|Discontinuation all treatment due to death|4|||
124456215|NCT02258451|447630371|FG001|Overall Study|Discontinuation all treatment due to death|3|||
124456216|NCT02258451|447630370|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
124456217|NCT02258451|447630371|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
124456218|NCT02258451|447630370|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
124456219|NCT02258451|447630371|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
124456220|NCT02258451|447630370|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
124456221|NCT02258451|447630371|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
124456222|NCT02258451|447630370|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
124456223|NCT02258451|447630371|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
124456224|NCT02258451|447630370|FG000|Overall Study|Other reason|1|||
124456225|NCT02258451|447630371|FG001|Overall Study|Other reason|1|||
124456226|NCT02258451|447630370|FG000|Overall Study|Never treated|2|||
124456227|NCT02258451|447630371|FG001|Overall Study|Never treated|3|||
124456228|NCT04722042|447630372|FG000|Overall Study|Withdrawal by Subject|2|||
124456229|NCT04722042|447630373|FG001|Overall Study|Withdrawal by Subject|1|||
124456230|NCT04722042|447630374|FG002|Overall Study|Withdrawal by Subject|0|||
124456231|NCT00517751|447630376|FG000|Overall Study|Death|3|||
124456232|NCT00517751|447630376|FG000|Overall Study|Withdrawal by Subject|37|||
124456233|NCT00517751|447630376|FG000|Overall Study|Lost to Follow-up|4|||
124456234|NCT00517751|447630376|FG000|Overall Study|patient not over due|6|||
124456235|NCT00517751|447630376|FG000|Overall Study|Patient not due for visit|76|||
124456236|NCT00517751|447630376|FG000|Overall Study|Missing|3|||
124456237|NCT01484977|447630383|FG000|Overall Study|Adverse Event|8|||
124456238|NCT01484977|447630383|FG000|Overall Study|Lack of Efficacy|4|||
124456239|NCT01484977|447630383|FG000|Overall Study|Protocol Violation|6|||
124456240|NCT01484977|447630383|FG000|Overall Study|Lost to Follow-up|1|||
124456241|NCT01484977|447630383|FG000|Overall Study|Withdrawal by Subject|4|||
124456242|NCT01484977|447630383|FG000|Overall Study|Subject Protocol Non-compliant|1|||
124456243|NCT01484977|447630383|FG000|Overall Study|Moving Overseas|1|||
124456244|NCT01484977|447630383|FG000|Overall Study|Low White Blood Cell Count|1|||
124456245|NCT01484977|447630383|FG000|Overall Study|Lack of Compliance|1|||
124456246|NCT02269787|447630386|FG000|Overall Study|Lost to Follow-up|20|||
124456247|NCT02269787|447630387|FG001|Overall Study|Lost to Follow-up|6|||
124456248|NCT02269787|447630386|FG000|Overall Study|Death|2|||
124456249|NCT02269787|447630387|FG001|Overall Study|Death|3|||
124456250|NCT02269787|447630386|FG000|Overall Study|Incapacitated|0|||
124456251|NCT02269787|447630387|FG001|Overall Study|Incapacitated|1|||
124456252|NCT00687440|447630388|FG000|Overall Study|Adverse Event|3|||
124456253|NCT00687440|447630388|FG000|Overall Study|Lost to Follow-up|3|||
124456254|NCT00687440|447630388|FG000|Overall Study|Lack of Efficacy|2|||
124456255|NCT00687440|447630388|FG000|Overall Study|Death|2|||
124456256|NCT00687440|447630388|FG000|Overall Study|Other|1|||
124456257|NCT00687440|447630388|FG000|Overall Study|Missing|1|||
124456258|NCT02228720|447630389|FG000|Open Label - Day 30|Lost to Follow-up|1|||
124456259|NCT03996876|447630394|FG000|Overall Study|Incomplete Data|2|||
124456260|NCT03996876|447630395|FG001|Overall Study|Incomplete Data|4|||
124456261|NCT05264740|447630400|FG000|Baseline|Withdrawal by Subject|0|||
124456262|NCT05264740|447630401|FG001|Baseline|Withdrawal by Subject|1|||
124456263|NCT05264740|447630400|FG000|Follow Up 1|Lost to Follow-up|1|||
124456264|NCT05264740|447630401|FG001|Follow Up 1|Lost to Follow-up|1|||
124456265|NCT05264740|447630400|FG000|Follow Up 1|Withdrawal by Subject|0|||
124456266|NCT05264740|447630401|FG001|Follow Up 1|Withdrawal by Subject|1|||
124456267|NCT05264740|447630400|FG000|Follow Up 2|Lost to Follow-up|1|||
124456268|NCT05264740|447630401|FG001|Follow Up 2|Lost to Follow-up|4|||
124938422|NCT00146172|449404682|FG000|Overall Study|Disease Progression|2|||
124938423|NCT00146172|449404683|FG001|Overall Study|Disease Progression|4|||
124938424|NCT00146172|449404684|FG002|Overall Study|Disease Progression|2|||
124764975|NCT01600885|448765083|FG000|First Period|moved out of area|1|||
124764976|NCT01600885|448765084|FG001|First Period|moved out of area|0|||
124764977|NCT00436332|448765085|FG000|Overall Study|Adverse Event|9|||
124764978|NCT00436332|448765085|FG000|Overall Study|Withdrawal by Subject|2|||
124764979|NCT00436332|448765085|FG000|Overall Study|Progression|59|||
124764980|NCT00436332|448765085|FG000|Overall Study|Death|2|||
124764981|NCT00436332|448765085|FG000|Overall Study|Not Protocol Specified|6|||
124764982|NCT00436332|448765085|FG000|Overall Study|Ineligible|2|||
124764983|NCT00436332|448765085|FG000|Overall Study|Never Received Treatment|3|||
124764984|NCT00472108|448765086|FG000|Overall Study|Lost to Follow-up|0|||
124764985|NCT00472108|448765087|FG001|Overall Study|Lost to Follow-up|1|||
124764986|NCT00642356|448765094|FG000|Overall Study|Adverse Event|1|||
124764987|NCT00642356|448765095|FG001|Overall Study|Adverse Event|0|||
124764988|NCT00642356|448765094|FG000|Overall Study|Protocol Violation|0|||
124764989|NCT00642356|448765095|FG001|Overall Study|Protocol Violation|3|||
124764990|NCT00642356|448765094|FG000|Overall Study|Lack of Efficacy|1|||
124764991|NCT00642356|448765095|FG001|Overall Study|Lack of Efficacy|0|||
124938425|NCT00146172|449404685|FG003|Overall Study|Disease Progression|5|||
124938426|NCT00146172|449404686|FG004|Overall Study|Disease Progression|2|||
124938427|NCT00146172|449404687|FG005|Overall Study|Disease Progression|2|||
124938428|NCT00146172|449404688|FG006|Overall Study|Disease Progression|1|||
124938429|NCT00146172|449404689|FG007|Overall Study|Disease Progression|22|||
124938430|NCT00146172|449404682|FG000|Overall Study|Death|0|||
124938431|NCT00146172|449404683|FG001|Overall Study|Death|0|||
124938432|NCT00146172|449404684|FG002|Overall Study|Death|0|||
124938433|NCT00146172|449404685|FG003|Overall Study|Death|0|||
124938434|NCT00146172|449404686|FG004|Overall Study|Death|0|||
124938435|NCT00146172|449404687|FG005|Overall Study|Death|0|||
124938436|NCT00146172|449404688|FG006|Overall Study|Death|1|||
124938437|NCT00146172|449404689|FG007|Overall Study|Death|0|||
124938438|NCT00146172|449404682|FG000|Overall Study|Physician Decision|0|||
124938439|NCT00146172|449404683|FG001|Overall Study|Physician Decision|0|||
124938440|NCT00146172|449404684|FG002|Overall Study|Physician Decision|0|||
124938441|NCT00146172|449404685|FG003|Overall Study|Physician Decision|0|||
124938442|NCT00146172|449404686|FG004|Overall Study|Physician Decision|0|||
124938443|NCT00146172|449404687|FG005|Overall Study|Physician Decision|0|||
124938444|NCT00146172|449404688|FG006|Overall Study|Physician Decision|0|||
124938445|NCT00146172|449404689|FG007|Overall Study|Physician Decision|1|||
124938446|NCT00146172|449404682|FG000|Overall Study|Withdrawal by Subject|0|||
124938447|NCT00146172|449404683|FG001|Overall Study|Withdrawal by Subject|0|||
124938448|NCT00146172|449404684|FG002|Overall Study|Withdrawal by Subject|0|||
124938449|NCT00146172|449404685|FG003|Overall Study|Withdrawal by Subject|0|||
124938450|NCT00146172|449404686|FG004|Overall Study|Withdrawal by Subject|0|||
124938451|NCT00146172|449404687|FG005|Overall Study|Withdrawal by Subject|1|||
124938452|NCT00146172|449404688|FG006|Overall Study|Withdrawal by Subject|1|||
124938453|NCT00146172|449404689|FG007|Overall Study|Withdrawal by Subject|4|||
124938454|NCT00146172|449404682|FG000|Overall Study|Symptomatic Deterioration|1|||
124938455|NCT00146172|449404683|FG001|Overall Study|Symptomatic Deterioration|0|||
124938456|NCT00146172|449404684|FG002|Overall Study|Symptomatic Deterioration|1|||
124938457|NCT00146172|449404685|FG003|Overall Study|Symptomatic Deterioration|0|||
124938458|NCT00146172|449404686|FG004|Overall Study|Symptomatic Deterioration|1|||
124938459|NCT00146172|449404687|FG005|Overall Study|Symptomatic Deterioration|2|||
124938460|NCT00146172|449404688|FG006|Overall Study|Symptomatic Deterioration|0|||
124938461|NCT00146172|449404689|FG007|Overall Study|Symptomatic Deterioration|2|||
124938462|NCT01288443|449404692|FG000|Overall Study|Adverse Event|0|||
124938463|NCT01288443|449404693|FG001|Overall Study|Adverse Event|0|||
124938464|NCT01288443|449404694|FG002|Overall Study|Adverse Event|1|||
124938465|NCT01288443|449404695|FG003|Overall Study|Adverse Event|1|||
124938466|NCT01288443|449404696|FG004|Overall Study|Adverse Event|3|||
124938467|NCT01288443|449404697|FG005|Overall Study|Adverse Event|1|||
124938468|NCT01288443|449404692|FG000|Overall Study|Poor compliance to protocol|0|||
124938469|NCT01288443|449404693|FG001|Overall Study|Poor compliance to protocol|0|||
124938470|NCT01288443|449404694|FG002|Overall Study|Poor compliance to protocol|0|||
124938471|NCT01288443|449404695|FG003|Overall Study|Poor compliance to protocol|0|||
124938472|NCT01288443|449404696|FG004|Overall Study|Poor compliance to protocol|0|||
124938473|NCT01288443|449404697|FG005|Overall Study|Poor compliance to protocol|1|||
124938474|NCT01288443|449404692|FG000|Overall Study|Participant Moved|0|||
124938475|NCT01288443|449404693|FG001|Overall Study|Participant Moved|0|||
124938476|NCT01288443|449404694|FG002|Overall Study|Participant Moved|0|||
124938477|NCT01288443|449404695|FG003|Overall Study|Participant Moved|1|||
124938478|NCT01288443|449404696|FG004|Overall Study|Participant Moved|2|||
124938479|NCT01288443|449404697|FG005|Overall Study|Participant Moved|1|||
124764992|NCT01009060|448765096|FG000|Overall Study|Adverse Event|1|||
124764993|NCT01009060|448765097|FG001|Overall Study|Adverse Event|2|||
124764994|NCT01009060|448765096|FG000|Overall Study|Protocol Violation|0|||
124764995|NCT01009060|448765097|FG001|Overall Study|Protocol Violation|1|||
124764996|NCT01009060|448765096|FG000|Overall Study|Lost to Follow-up|1|||
124764997|NCT01009060|448765097|FG001|Overall Study|Lost to Follow-up|0|||
124938480|NCT01288443|449404692|FG000|Overall Study|Consent withdrawn by Participant|0|||
124938481|NCT01288443|449404693|FG001|Overall Study|Consent withdrawn by Participant|0|||
124938482|NCT01288443|449404694|FG002|Overall Study|Consent withdrawn by Participant|0|||
124938483|NCT01288443|449404695|FG003|Overall Study|Consent withdrawn by Participant|0|||
124938484|NCT01288443|449404696|FG004|Overall Study|Consent withdrawn by Participant|0|||
124938485|NCT01288443|449404697|FG005|Overall Study|Consent withdrawn by Participant|1|||
124938486|NCT01288443|449404692|FG000|Overall Study|Lost to Follow-up|0|||
124938487|NCT01288443|449404693|FG001|Overall Study|Lost to Follow-up|1|||
124938488|NCT01288443|449404694|FG002|Overall Study|Lost to Follow-up|0|||
124938489|NCT01288443|449404695|FG003|Overall Study|Lost to Follow-up|0|||
124938490|NCT01288443|449404696|FG004|Overall Study|Lost to Follow-up|0|||
124764998|NCT01009060|448765096|FG000|Overall Study|Physician Decision|1|||
124938491|NCT01288443|449404697|FG005|Overall Study|Lost to Follow-up|0|||
124938492|NCT01288443|449404692|FG000|Overall Study|Study drug auto-injector administration|0|||
124938493|NCT01288443|449404693|FG001|Overall Study|Study drug auto-injector administration|0|||
124938494|NCT01288443|449404694|FG002|Overall Study|Study drug auto-injector administration|0|||
124938495|NCT01288443|449404695|FG003|Overall Study|Study drug auto-injector administration|0|||
124938496|NCT01288443|449404696|FG004|Overall Study|Study drug auto-injector administration|1|||
124938497|NCT01288443|449404697|FG005|Overall Study|Study drug auto-injector administration|1|||
124938498|NCT01288443|449404692|FG000|Overall Study|Other than above|0|||
124938499|NCT01288443|449404693|FG001|Overall Study|Other than above|0|||
124938500|NCT01288443|449404694|FG002|Overall Study|Other than above|0|||
124938501|NCT01288443|449404695|FG003|Overall Study|Other than above|2|||
124938502|NCT01288443|449404696|FG004|Overall Study|Other than above|1|||
124938503|NCT01288443|449404697|FG005|Overall Study|Other than above|0|||
124938504|NCT01596972|449404698|FG000|Overall Study|Physician Decision|1|||
124938505|NCT01596972|449404699|FG001|Overall Study|Physician Decision|9|||
124938506|NCT01596972|449404698|FG000|Overall Study|Lost to Follow-up|0|||
124938507|NCT01596972|449404699|FG001|Overall Study|Lost to Follow-up|4|||
124938508|NCT01596972|449404698|FG000|Overall Study|Withdrawal by Subject|0|||
124938509|NCT01596972|449404699|FG001|Overall Study|Withdrawal by Subject|1|||
124938510|NCT01964300|449404702|FG000|Overall Study|Ineligible after enrollment|0|||
124938511|NCT01964300|449404703|FG001|Overall Study|Ineligible after enrollment|1|||
124938512|NCT01964300|449404702|FG000|Overall Study|Adverse Event|1|||
124938513|NCT01964300|449404703|FG001|Overall Study|Adverse Event|1|||
124938514|NCT01964300|449404702|FG000|Overall Study|Lack of Efficacy|3|||
124938515|NCT01964300|449404703|FG001|Overall Study|Lack of Efficacy|5|||
124938516|NCT01964300|449404702|FG000|Overall Study|Withdrawal by Subject|0|||
124938517|NCT01964300|449404703|FG001|Overall Study|Withdrawal by Subject|1|||
124938518|NCT01964300|449404702|FG000|Overall Study|To receive alternative therapy|1|||
124938519|NCT01964300|449404703|FG001|Overall Study|To receive alternative therapy|2|||
124938520|NCT01964300|449404702|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
124938521|NCT01964300|449404703|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
124938522|NCT01964300|449404702|FG000|Overall Study|Weight criteria not met|0|||
124938523|NCT01964300|449404703|FG001|Overall Study|Weight criteria not met|1|||
124938524|NCT00557492|449404704|FG000|Overall Study|Change in health insurance|1|||
124938525|NCT02438137|449404705|FG000|Overall Study|Lost to Follow-up|3|||
124938526|NCT02438137|449404706|FG001|Overall Study|Lost to Follow-up|2|||
124938527|NCT02438137|449404705|FG000|Overall Study|Adverse Event|1|||
124938528|NCT02438137|449404706|FG001|Overall Study|Adverse Event|0|||
124938529|NCT02438137|449404705|FG000|Overall Study|Withdrawal by Subject|4|||
124938530|NCT02438137|449404706|FG001|Overall Study|Withdrawal by Subject|3|||
124938531|NCT02438137|449404705|FG000|Overall Study|Physician Decision|0|||
124938532|NCT02438137|449404706|FG001|Overall Study|Physician Decision|1|||
124938533|NCT02285270|449404707|FG000|Overall Study|Lost to Follow-up|1|||
124938534|NCT02285270|449404707|FG000|Overall Study|Physician Decision|3|||
124938535|NCT02285270|449404707|FG000|Overall Study|Determined to be ineligible|1|||
124938536|NCT04868617|449404708|FG000|Overall Study|Death|1|||
124938537|NCT04868617|449404709|FG001|Overall Study|Death|0|||
124938538|NCT04868617|449404708|FG000|Overall Study|Adverse Event|1|||
124938539|NCT04868617|449404709|FG001|Overall Study|Adverse Event|0|||
124938540|NCT04868617|449404708|FG000|Overall Study|Withdrawal by Subject|1|||
124938541|NCT04868617|449404709|FG001|Overall Study|Withdrawal by Subject|0|||
124938542|NCT04868617|449404708|FG000|Overall Study|Device deficiency|1|||
124938543|NCT04868617|449404709|FG001|Overall Study|Device deficiency|0|||
124938544|NCT00623194|449404710|FG000|Overall Study|Lack of Efficacy|1|||
124938545|NCT00623194|449404710|FG000|Overall Study|Protocol Violation|3|||
124938546|NCT00623194|449404710|FG000|Overall Study|Unclassified|1|||
124938547|NCT01260896|449404711|FG000|First Intervention|Withdrawn Due to Emesis|2|||
124938548|NCT01260896|449404712|FG001|First Intervention|Withdrawn Due to Emesis|0|||
124938549|NCT00312208|449404713|FG000|Overall Study|Adverse Event|97|||
124938550|NCT00312208|449404714|FG001|Overall Study|Adverse Event|61|||
124938551|NCT00312208|449404713|FG000|Overall Study|Protocol Violation|5|||
124703098|NCT02471144|448537219|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
124703099|NCT02471144|448537220|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
124703100|NCT02471144|448537221|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
124703101|NCT02471144|448537222|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
124703102|NCT02471144|448537223|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
124703103|NCT02471144|448537224|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
124938552|NCT00312208|449404714|FG001|Overall Study|Protocol Violation|3|||
124703104|NCT02471144|448537214|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
124938553|NCT00312208|449404713|FG000|Overall Study|Death|2|||
124938554|NCT00312208|449404714|FG001|Overall Study|Death|1|||
124938555|NCT00312208|449404713|FG000|Overall Study|Lack of Efficacy|7|||
124456269|NCT05264740|447630400|FG000|Follow Up 3|Lost to Follow-up|7|||
124456270|NCT05264740|447630401|FG001|Follow Up 3|Lost to Follow-up|4|||
124938556|NCT00312208|449404714|FG001|Overall Study|Lack of Efficacy|4|||
124938557|NCT00312208|449404713|FG000|Overall Study|Lost to Follow-up|3|||
124938558|NCT00312208|449404714|FG001|Overall Study|Lost to Follow-up|5|||
124938559|NCT00312208|449404713|FG000|Overall Study|Withdrawal by Subject|53|||
124938560|NCT00312208|449404714|FG001|Overall Study|Withdrawal by Subject|42|||
124938561|NCT00312208|449404713|FG000|Overall Study|Other|5|||
124938562|NCT00312208|449404714|FG001|Overall Study|Other|7|||
124938563|NCT00982644|449404717|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
124938564|NCT00982644|449404718|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
124938565|NCT00982644|449404717|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
124938566|NCT00982644|449404718|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
124938567|NCT00982644|449404717|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
124938568|NCT00982644|449404718|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
124938569|NCT00982644|449404717|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
124938570|NCT00982644|449404718|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
124938571|NCT00982644|449404717|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
124938572|NCT00982644|449404718|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
124938573|NCT00982644|449404717|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
124938574|NCT00982644|449404718|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
124938575|NCT00982644|449404717|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
124938576|NCT00982644|449404718|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
124938577|NCT00982644|449404717|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
124938578|NCT00982644|449404718|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
124938579|NCT00982644|449404717|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
124938580|NCT00982644|449404718|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
124938581|NCT00982644|449404717|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
124938582|NCT00982644|449404718|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
124938583|NCT00943917|449404721|FG000|Stage I|Adverse Event|1|||
124938584|NCT00943917|449404722|FG001|Stage I|Adverse Event|2|||
124938585|NCT00943917|449404723|FG002|Stage I|Adverse Event|2|||
124938586|NCT00943917|449404724|FG003|Stage I|Adverse Event|0|||
124938587|NCT00943917|449404725|FG004|Stage I|Adverse Event|0|||
124938588|NCT00943917|449404726|FG005|Stage I|Adverse Event|0|||
124938589|NCT00943917|449404727|FG006|Stage I|Adverse Event|0|||
124938590|NCT00943917|449404728|FG007|Stage I|Adverse Event|0|||
124938591|NCT00943917|449404729|FG008|Stage I|Adverse Event|0|||
124938592|NCT00943917|449404730|FG009|Stage I|Adverse Event|0|||
124938593|NCT00943917|449404731|FG010|Stage I|Adverse Event|0|||
124938594|NCT00943917|449404732|FG011|Stage I|Adverse Event|0|||
124938595|NCT00943917|449404733|FG012|Stage I|Adverse Event|0|||
124938596|NCT00943917|449404734|FG013|Stage I|Adverse Event|0|||
124938597|NCT00943917|449404735|FG014|Stage I|Adverse Event|0|||
124938598|NCT00943917|449404721|FG000|Stage I|Lost to Follow-up|0|||
124938599|NCT00943917|449404722|FG001|Stage I|Lost to Follow-up|0|||
124938600|NCT00943917|449404723|FG002|Stage I|Lost to Follow-up|1|||
124938601|NCT00943917|449404724|FG003|Stage I|Lost to Follow-up|0|||
124938602|NCT00943917|449404725|FG004|Stage I|Lost to Follow-up|0|||
124938603|NCT00943917|449404726|FG005|Stage I|Lost to Follow-up|0|||
124938604|NCT00943917|449404727|FG006|Stage I|Lost to Follow-up|0|||
124938605|NCT00943917|449404728|FG007|Stage I|Lost to Follow-up|0|||
124938606|NCT00943917|449404729|FG008|Stage I|Lost to Follow-up|0|||
124938607|NCT00943917|449404730|FG009|Stage I|Lost to Follow-up|0|||
124938608|NCT00943917|449404731|FG010|Stage I|Lost to Follow-up|0|||
124938609|NCT00943917|449404732|FG011|Stage I|Lost to Follow-up|0|||
124938610|NCT00943917|449404733|FG012|Stage I|Lost to Follow-up|0|||
124938611|NCT00943917|449404734|FG013|Stage I|Lost to Follow-up|0|||
124938612|NCT00943917|449404735|FG014|Stage I|Lost to Follow-up|0|||
124938613|NCT00943917|449404721|FG000|Stage I|hyperglycemia|0|||
124938614|NCT00943917|449404722|FG001|Stage I|hyperglycemia|0|||
124938615|NCT00943917|449404723|FG002|Stage I|hyperglycemia|1|||
124938616|NCT00943917|449404724|FG003|Stage I|hyperglycemia|0|||
124938617|NCT00943917|449404725|FG004|Stage I|hyperglycemia|0|||
124938618|NCT00943917|449404726|FG005|Stage I|hyperglycemia|0|||
124938619|NCT00943917|449404727|FG006|Stage I|hyperglycemia|0|||
124938620|NCT00943917|449404728|FG007|Stage I|hyperglycemia|0|||
124938621|NCT00943917|449404729|FG008|Stage I|hyperglycemia|0|||
124938622|NCT00943917|449404730|FG009|Stage I|hyperglycemia|0|||
124938623|NCT00943917|449404731|FG010|Stage I|hyperglycemia|0|||
124938624|NCT00943917|449404732|FG011|Stage I|hyperglycemia|0|||
124938625|NCT00943917|449404733|FG012|Stage I|hyperglycemia|0|||
124938626|NCT00943917|449404734|FG013|Stage I|hyperglycemia|0|||
124938627|NCT00943917|449404735|FG014|Stage I|hyperglycemia|0|||
124938628|NCT00943917|449404721|FG000|Stage I|A1C elevation|1|||
124938629|NCT00943917|449404722|FG001|Stage I|A1C elevation|0|||
124938630|NCT00943917|449404723|FG002|Stage I|A1C elevation|0|||
124938631|NCT00943917|449404724|FG003|Stage I|A1C elevation|0|||
124938632|NCT00943917|449404725|FG004|Stage I|A1C elevation|0|||
124938633|NCT00943917|449404726|FG005|Stage I|A1C elevation|0|||
124938634|NCT00943917|449404727|FG006|Stage I|A1C elevation|0|||
124938635|NCT00943917|449404728|FG007|Stage I|A1C elevation|0|||
124938636|NCT00943917|449404729|FG008|Stage I|A1C elevation|0|||
124938637|NCT00943917|449404730|FG009|Stage I|A1C elevation|0|||
124938638|NCT00943917|449404731|FG010|Stage I|A1C elevation|0|||
124938639|NCT00943917|449404732|FG011|Stage I|A1C elevation|0|||
124938640|NCT00943917|449404733|FG012|Stage I|A1C elevation|0|||
124938641|NCT00943917|449404734|FG013|Stage I|A1C elevation|0|||
124938642|NCT00943917|449404735|FG014|Stage I|A1C elevation|0|||
124703105|NCT02471144|448537215|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
124703106|NCT02471144|448537216|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
124938643|NCT00943917|449404721|FG000|Stage I|Withdrawal by Subject|2|||
124938644|NCT00943917|449404722|FG001|Stage I|Withdrawal by Subject|1|||
124938645|NCT00943917|449404723|FG002|Stage I|Withdrawal by Subject|2|||
124938646|NCT00943917|449404724|FG003|Stage I|Withdrawal by Subject|0|||
124938647|NCT00943917|449404725|FG004|Stage I|Withdrawal by Subject|0|||
124938648|NCT00943917|449404726|FG005|Stage I|Withdrawal by Subject|0|||
124938649|NCT00943917|449404727|FG006|Stage I|Withdrawal by Subject|0|||
124938650|NCT00943917|449404728|FG007|Stage I|Withdrawal by Subject|0|||
124938651|NCT00943917|449404729|FG008|Stage I|Withdrawal by Subject|0|||
124938652|NCT00943917|449404730|FG009|Stage I|Withdrawal by Subject|0|||
124938653|NCT00943917|449404731|FG010|Stage I|Withdrawal by Subject|0|||
124938654|NCT00943917|449404732|FG011|Stage I|Withdrawal by Subject|0|||
124938655|NCT00943917|449404733|FG012|Stage I|Withdrawal by Subject|0|||
124938656|NCT00943917|449404734|FG013|Stage I|Withdrawal by Subject|0|||
124938657|NCT00943917|449404735|FG014|Stage I|Withdrawal by Subject|0|||
124938658|NCT00943917|449404721|FG000|Stage II|Adverse Event|0|||
124938659|NCT00943917|449404722|FG001|Stage II|Adverse Event|0|||
124546494|NCT00320801|447955917|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
124938660|NCT00943917|449404723|FG002|Stage II|Adverse Event|0|||
124938661|NCT00943917|449404724|FG003|Stage II|Adverse Event|0|||
124938662|NCT00943917|449404725|FG004|Stage II|Adverse Event|0|||
124546495|NCT00320801|447955918|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
124703107|NCT02471144|448537217|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
124703108|NCT02471144|448537218|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
124703109|NCT02471144|448537219|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
124703110|NCT02471144|448537220|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
124703111|NCT02471144|448537221|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
124703112|NCT02471144|448537222|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
124703113|NCT02471144|448537223|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
124703114|NCT02471144|448537224|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
124703115|NCT02471144|448537214|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
124703116|NCT02471144|448537215|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
124703117|NCT02471144|448537216|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
124703118|NCT02471144|448537217|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
124938663|NCT00943917|449404726|FG005|Stage II|Adverse Event|1|||
124938664|NCT00943917|449404727|FG006|Stage II|Adverse Event|3|||
124938665|NCT00943917|449404728|FG007|Stage II|Adverse Event|0|||
124938666|NCT00943917|449404729|FG008|Stage II|Adverse Event|1|||
124938667|NCT00943917|449404730|FG009|Stage II|Adverse Event|0|||
124938668|NCT00943917|449404731|FG010|Stage II|Adverse Event|0|||
124938669|NCT00943917|449404732|FG011|Stage II|Adverse Event|0|||
124938670|NCT00943917|449404733|FG012|Stage II|Adverse Event|0|||
124938671|NCT00943917|449404734|FG013|Stage II|Adverse Event|0|||
124938672|NCT00943917|449404735|FG014|Stage II|Adverse Event|0|||
124938673|NCT00943917|449404721|FG000|Stage II|Withdrawal by Subject|0|||
124938674|NCT00943917|449404722|FG001|Stage II|Withdrawal by Subject|0|||
124938675|NCT00943917|449404723|FG002|Stage II|Withdrawal by Subject|0|||
124938676|NCT00943917|449404724|FG003|Stage II|Withdrawal by Subject|0|||
124938677|NCT00943917|449404725|FG004|Stage II|Withdrawal by Subject|0|||
124703119|NCT02471144|448537218|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
124703120|NCT02471144|448537219|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
124703121|NCT02471144|448537220|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
124703122|NCT02471144|448537221|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
124938678|NCT00943917|449404726|FG005|Stage II|Withdrawal by Subject|1|||
124938679|NCT00943917|449404727|FG006|Stage II|Withdrawal by Subject|0|||
124938680|NCT00943917|449404728|FG007|Stage II|Withdrawal by Subject|0|||
124938681|NCT00943917|449404729|FG008|Stage II|Withdrawal by Subject|0|||
124938682|NCT00943917|449404730|FG009|Stage II|Withdrawal by Subject|0|||
124938683|NCT00943917|449404731|FG010|Stage II|Withdrawal by Subject|0|||
124938684|NCT00943917|449404732|FG011|Stage II|Withdrawal by Subject|0|||
124938685|NCT00943917|449404733|FG012|Stage II|Withdrawal by Subject|0|||
124938686|NCT00943917|449404734|FG013|Stage II|Withdrawal by Subject|0|||
124938687|NCT00943917|449404735|FG014|Stage II|Withdrawal by Subject|0|||
124938688|NCT00943917|449404721|FG000|Stage II|Pregnancy|0|||
124938689|NCT00943917|449404722|FG001|Stage II|Pregnancy|0|||
124938690|NCT00943917|449404723|FG002|Stage II|Pregnancy|0|||
124938691|NCT00943917|449404724|FG003|Stage II|Pregnancy|0|||
124938692|NCT00943917|449404725|FG004|Stage II|Pregnancy|0|||
124938693|NCT00943917|449404726|FG005|Stage II|Pregnancy|1|||
124938694|NCT00943917|449404727|FG006|Stage II|Pregnancy|0|||
124938695|NCT00943917|449404728|FG007|Stage II|Pregnancy|0|||
124938696|NCT00943917|449404729|FG008|Stage II|Pregnancy|0|||
124938697|NCT00943917|449404730|FG009|Stage II|Pregnancy|0|||
124938698|NCT00943917|449404731|FG010|Stage II|Pregnancy|0|||
124938699|NCT00943917|449404732|FG011|Stage II|Pregnancy|0|||
124938700|NCT00943917|449404733|FG012|Stage II|Pregnancy|0|||
124938701|NCT00943917|449404734|FG013|Stage II|Pregnancy|0|||
124938702|NCT00943917|449404735|FG014|Stage II|Pregnancy|0|||
124938703|NCT00943917|449404721|FG000|Stage II Continuation|Adverse Event|0|||
124938704|NCT00943917|449404722|FG001|Stage II Continuation|Adverse Event|0|||
124938705|NCT00943917|449404723|FG002|Stage II Continuation|Adverse Event|0|||
124938706|NCT00943917|449404724|FG003|Stage II Continuation|Adverse Event|0|||
124938707|NCT00943917|449404725|FG004|Stage II Continuation|Adverse Event|0|||
124938708|NCT00943917|449404726|FG005|Stage II Continuation|Adverse Event|0|||
124938709|NCT00943917|449404727|FG006|Stage II Continuation|Adverse Event|0|||
124938710|NCT00943917|449404728|FG007|Stage II Continuation|Adverse Event|0|||
124938711|NCT00943917|449404729|FG008|Stage II Continuation|Adverse Event|0|||
124938712|NCT00943917|449404730|FG009|Stage II Continuation|Adverse Event|0|||
124938713|NCT00943917|449404731|FG010|Stage II Continuation|Adverse Event|0|||
124938714|NCT00943917|449404732|FG011|Stage II Continuation|Adverse Event|1|||
124938715|NCT00943917|449404733|FG012|Stage II Continuation|Adverse Event|2|||
124938716|NCT00943917|449404734|FG013|Stage II Continuation|Adverse Event|1|||
124938717|NCT00943917|449404735|FG014|Stage II Continuation|Adverse Event|1|||
124938718|NCT00943917|449404721|FG000|Stage II Continuation|Withdrawal by Subject|0|||
124938719|NCT00943917|449404722|FG001|Stage II Continuation|Withdrawal by Subject|0|||
124938720|NCT00943917|449404723|FG002|Stage II Continuation|Withdrawal by Subject|0|||
124938721|NCT00943917|449404724|FG003|Stage II Continuation|Withdrawal by Subject|0|||
124938722|NCT00943917|449404725|FG004|Stage II Continuation|Withdrawal by Subject|0|||
124938723|NCT00943917|449404726|FG005|Stage II Continuation|Withdrawal by Subject|0|||
124938724|NCT00943917|449404727|FG006|Stage II Continuation|Withdrawal by Subject|0|||
124938725|NCT00943917|449404728|FG007|Stage II Continuation|Withdrawal by Subject|0|||
124938726|NCT00943917|449404729|FG008|Stage II Continuation|Withdrawal by Subject|0|||
124938727|NCT00943917|449404730|FG009|Stage II Continuation|Withdrawal by Subject|0|||
124938728|NCT00943917|449404731|FG010|Stage II Continuation|Withdrawal by Subject|0|||
124938729|NCT00943917|449404732|FG011|Stage II Continuation|Withdrawal by Subject|0|||
124938730|NCT00943917|449404733|FG012|Stage II Continuation|Withdrawal by Subject|0|||
124938731|NCT00943917|449404734|FG013|Stage II Continuation|Withdrawal by Subject|1|||
124938732|NCT00943917|449404735|FG014|Stage II Continuation|Withdrawal by Subject|3|||
124938733|NCT00943917|449404721|FG000|Stage II Continuation|Protocol Violation|0|||
124938734|NCT00943917|449404722|FG001|Stage II Continuation|Protocol Violation|0|||
124938735|NCT00943917|449404723|FG002|Stage II Continuation|Protocol Violation|0|||
124938736|NCT00943917|449404724|FG003|Stage II Continuation|Protocol Violation|0|||
124938737|NCT00943917|449404725|FG004|Stage II Continuation|Protocol Violation|0|||
124938738|NCT00943917|449404726|FG005|Stage II Continuation|Protocol Violation|0|||
124938739|NCT00943917|449404727|FG006|Stage II Continuation|Protocol Violation|0|||
124938740|NCT00943917|449404728|FG007|Stage II Continuation|Protocol Violation|0|||
124703123|NCT02471144|448537222|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
124703124|NCT02471144|448537223|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
124938741|NCT00943917|449404729|FG008|Stage II Continuation|Protocol Violation|0|||
124938742|NCT00943917|449404730|FG009|Stage II Continuation|Protocol Violation|1|||
124938743|NCT00943917|449404731|FG010|Stage II Continuation|Protocol Violation|0|||
124938744|NCT00943917|449404732|FG011|Stage II Continuation|Protocol Violation|1|||
124938745|NCT00943917|449404733|FG012|Stage II Continuation|Protocol Violation|0|||
124938746|NCT00943917|449404734|FG013|Stage II Continuation|Protocol Violation|0|||
124938747|NCT00943917|449404735|FG014|Stage II Continuation|Protocol Violation|0|||
124938748|NCT00943917|449404721|FG000|Stage II Continuation|hypoglycemia|0|||
124938749|NCT00943917|449404722|FG001|Stage II Continuation|hypoglycemia|0|||
124938750|NCT00943917|449404723|FG002|Stage II Continuation|hypoglycemia|0|||
124938751|NCT00943917|449404724|FG003|Stage II Continuation|hypoglycemia|0|||
124938752|NCT00943917|449404725|FG004|Stage II Continuation|hypoglycemia|0|||
124938753|NCT00943917|449404726|FG005|Stage II Continuation|hypoglycemia|0|||
124938754|NCT00943917|449404727|FG006|Stage II Continuation|hypoglycemia|0|||
124938755|NCT00943917|449404728|FG007|Stage II Continuation|hypoglycemia|0|||
124938756|NCT00943917|449404729|FG008|Stage II Continuation|hypoglycemia|0|||
124938757|NCT00943917|449404730|FG009|Stage II Continuation|hypoglycemia|0|||
124938758|NCT00943917|449404731|FG010|Stage II Continuation|hypoglycemia|0|||
124938759|NCT00943917|449404732|FG011|Stage II Continuation|hypoglycemia|0|||
124938760|NCT00943917|449404733|FG012|Stage II Continuation|hypoglycemia|1|||
124938761|NCT00943917|449404734|FG013|Stage II Continuation|hypoglycemia|0|||
124938762|NCT00943917|449404735|FG014|Stage II Continuation|hypoglycemia|0|||
124938763|NCT00943917|449404721|FG000|Stage II Continuation|A1C elevation|0|||
124938764|NCT00943917|449404722|FG001|Stage II Continuation|A1C elevation|0|||
124938765|NCT00943917|449404723|FG002|Stage II Continuation|A1C elevation|0|||
124938766|NCT00943917|449404724|FG003|Stage II Continuation|A1C elevation|0|||
124938767|NCT00943917|449404725|FG004|Stage II Continuation|A1C elevation|0|||
124938768|NCT00943917|449404726|FG005|Stage II Continuation|A1C elevation|0|||
124938769|NCT00943917|449404727|FG006|Stage II Continuation|A1C elevation|0|||
124938770|NCT00943917|449404728|FG007|Stage II Continuation|A1C elevation|0|||
124938771|NCT00943917|449404729|FG008|Stage II Continuation|A1C elevation|0|||
124938772|NCT00943917|449404730|FG009|Stage II Continuation|A1C elevation|0|||
124938773|NCT00943917|449404731|FG010|Stage II Continuation|A1C elevation|0|||
124938774|NCT00943917|449404732|FG011|Stage II Continuation|A1C elevation|0|||
124938775|NCT00943917|449404733|FG012|Stage II Continuation|A1C elevation|0|||
124938776|NCT00943917|449404734|FG013|Stage II Continuation|A1C elevation|1|||
124938777|NCT00943917|449404735|FG014|Stage II Continuation|A1C elevation|0|||
124938778|NCT02844439|449404736|FG000|Overall Study|Withdrawal by Subject|1|||
124938779|NCT02844439|449404736|FG000|Overall Study|Lost to Follow-up|2|||
124938780|NCT02844439|449404736|FG000|Overall Study|Termination by Sponsor|4|||
124938781|NCT02844439|449404736|FG000|Overall Study|Death|28|||
124938782|NCT02844439|449404736|FG000|Overall Study|Other|5|||
124938783|NCT03170648|449404741|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
124938784|NCT03170648|449404741|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
124938785|NCT03500549|449404742|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
124938786|NCT03500549|449404743|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
124938787|NCT03500549|449404742|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
124938788|NCT03500549|449404743|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
124938789|NCT02754596|449404744|FG000|Overall Study|Withdrawal by Subject|3|||
124938790|NCT02754596|449404745|FG001|Overall Study|Withdrawal by Subject|4|||
124938791|NCT02754596|449404746|FG002|Overall Study|Withdrawal by Subject|0|||
124938792|NCT02754596|449404744|FG000|Overall Study|Physician Decision|1|||
124938793|NCT02754596|449404745|FG001|Overall Study|Physician Decision|1|||
124938794|NCT02754596|449404746|FG002|Overall Study|Physician Decision|1|||
124938795|NCT02754596|449404744|FG000|Overall Study|Lost to Follow-up|1|||
124938796|NCT02754596|449404745|FG001|Overall Study|Lost to Follow-up|1|||
124938797|NCT02754596|449404746|FG002|Overall Study|Lost to Follow-up|2|||
124938798|NCT02754596|449404744|FG000|Overall Study|Death|0|||
124938799|NCT02754596|449404745|FG001|Overall Study|Death|2|||
124938800|NCT02754596|449404746|FG002|Overall Study|Death|0|||
124938801|NCT02754596|449404744|FG000|Overall Study|Adverse Event|1|||
124938802|NCT02754596|449404745|FG001|Overall Study|Adverse Event|0|||
124703125|NCT02471144|448537224|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
124703126|NCT02471144|448537214|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
124938803|NCT02754596|449404746|FG002|Overall Study|Adverse Event|1|||
124938804|NCT02754596|449404744|FG000|Overall Study|Other|1|||
124938805|NCT02754596|449404745|FG001|Overall Study|Other|0|||
124938806|NCT02754596|449404746|FG002|Overall Study|Other|0|||
124938807|NCT02107261|449404747|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
124938808|NCT02107261|449404748|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
124938809|NCT02107261|449404747|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
124938810|NCT02107261|449404748|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
124938811|NCT04337931|449404749|FG000|Overall Study|Death|4|||
124938812|NCT04337931|449404750|FG001|Overall Study|Death|1|||
124703127|NCT02471144|448537215|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
124938813|NCT04337931|449404751|FG002|Overall Study|Death|7|||
124938814|NCT04337931|449404749|FG000|Overall Study|Withdrawal by Subject|0|||
124938815|NCT04337931|449404750|FG001|Overall Study|Withdrawal by Subject|1|||
124546496|NCT00320801|447955919|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
124546497|NCT00320801|447955916|FG000|Open-label Run-in Period|Did not qualify|1|||
124546498|NCT00320801|447955917|FG001|Open-label Run-in Period|Did not qualify|0|||
124546499|NCT00320801|447955918|FG002|Open-label Run-in Period|Did not qualify|0|||
124546500|NCT00320801|447955919|FG003|Open-label Run-in Period|Did not qualify|0|||
124546501|NCT00320801|447955916|FG000|Double-blind Phase|Withdrawal by Subject|0|||
124546502|NCT00320801|447955917|FG001|Double-blind Phase|Withdrawal by Subject|0|||
124546503|NCT00320801|447955918|FG002|Double-blind Phase|Withdrawal by Subject|1|||
124546504|NCT00320801|447955919|FG003|Double-blind Phase|Withdrawal by Subject|0|||
124546505|NCT00320801|447955916|FG000|Double-blind Phase|Adverse Event|0|||
124546506|NCT00320801|447955917|FG001|Double-blind Phase|Adverse Event|2|||
124938816|NCT04337931|449404751|FG002|Overall Study|Withdrawal by Subject|0|||
124938817|NCT04337931|449404749|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
124938818|NCT04337931|449404750|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
124938819|NCT04337931|449404751|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
124938820|NCT04337931|449404749|FG000|Overall Study|Study terminated by sponsor|3|||
124938821|NCT04337931|449404750|FG001|Overall Study|Study terminated by sponsor|6|||
124938822|NCT04337931|449404751|FG002|Overall Study|Study terminated by sponsor|2|||
124938823|NCT04337931|449404749|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
124938824|NCT04337931|449404750|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
124546507|NCT00320801|447955918|FG002|Double-blind Phase|Adverse Event|8|||
124546508|NCT00320801|447955919|FG003|Double-blind Phase|Adverse Event|0|||
124546509|NCT00320801|447955916|FG000|Double-blind Phase|Administrative|0|||
124546510|NCT00320801|447955917|FG001|Double-blind Phase|Administrative|0|||
124938825|NCT04337931|449404751|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
124938826|NCT04337931|449404749|FG000|Overall Study|Colorectal cancer treatment|1|||
124546511|NCT00320801|447955918|FG002|Double-blind Phase|Administrative|4|||
124546512|NCT00320801|447955919|FG003|Double-blind Phase|Administrative|0|||
124546513|NCT00320801|447955916|FG000|Double-blind Phase|Lack of Efficacy|0|||
124546514|NCT00320801|447955917|FG001|Double-blind Phase|Lack of Efficacy|9|||
124546515|NCT00320801|447955918|FG002|Double-blind Phase|Lack of Efficacy|1|||
124546516|NCT00320801|447955919|FG003|Double-blind Phase|Lack of Efficacy|0|||
124546517|NCT00320801|447955916|FG000|Extension Phase|Withdrawal by Subject|0|||
124546518|NCT00320801|447955917|FG001|Extension Phase|Withdrawal by Subject|0|||
124546519|NCT00320801|447955918|FG002|Extension Phase|Withdrawal by Subject|0|||
124546520|NCT00320801|447955919|FG003|Extension Phase|Withdrawal by Subject|6|||
124546521|NCT00320801|447955916|FG000|Extension Phase|Adverse Event|0|||
124546522|NCT00320801|447955917|FG001|Extension Phase|Adverse Event|0|||
124546523|NCT00320801|447955918|FG002|Extension Phase|Adverse Event|0|||
124546524|NCT00320801|447955919|FG003|Extension Phase|Adverse Event|8|||
124938827|NCT04337931|449404750|FG001|Overall Study|Colorectal cancer treatment|0|||
124938828|NCT04337931|449404751|FG002|Overall Study|Colorectal cancer treatment|0|||
124938829|NCT04337931|449404749|FG000|Overall Study|Participant decision|0|||
124938830|NCT04337931|449404750|FG001|Overall Study|Participant decision|1|||
124938831|NCT04337931|449404751|FG002|Overall Study|Participant decision|0|||
124938832|NCT04436289|449404753|FG000|Overall Study|Death prior to hospital discharge|8|||
124938833|NCT04436289|449404754|FG001|Overall Study|Death prior to hospital discharge|5|||
124938834|NCT04436289|449404755|FG002|Overall Study|Death prior to hospital discharge|0|||
124938835|NCT04436289|449404756|FG003|Overall Study|Death prior to hospital discharge|1|||
124938836|NCT04436289|449404753|FG000|Overall Study|Withdrawal by Subject|0|||
124938837|NCT04436289|449404754|FG001|Overall Study|Withdrawal by Subject|1|||
124938838|NCT04436289|449404755|FG002|Overall Study|Withdrawal by Subject|4|||
124938839|NCT04436289|449404756|FG003|Overall Study|Withdrawal by Subject|0|||
124938840|NCT04436289|449404753|FG000|Overall Study|Extended hospital stay|0|||
124938841|NCT04436289|449404754|FG001|Overall Study|Extended hospital stay|1|||
124938842|NCT04436289|449404755|FG002|Overall Study|Extended hospital stay|0|||
124938843|NCT04436289|449404756|FG003|Overall Study|Extended hospital stay|0|||
124938844|NCT04436289|449404753|FG000|Overall Study|Lost to Follow-up|0|||
124938845|NCT04436289|449404754|FG001|Overall Study|Lost to Follow-up|4|||
124938846|NCT04436289|449404755|FG002|Overall Study|Lost to Follow-up|1|||
124938847|NCT04436289|449404756|FG003|Overall Study|Lost to Follow-up|3|||
124938848|NCT03357952|449404759|FG000|Overall Study|Withdrawal by Subject|0|||
124938849|NCT03357952|449404760|FG001|Overall Study|Withdrawal by Subject|1|||
124938850|NCT03357952|449404759|FG000|Overall Study|Sponsor Decision|9|||
124938851|NCT03357952|449404760|FG001|Overall Study|Sponsor Decision|0|||
124938852|NCT01371994|449404761|FG000|Overall Study|Adverse Event|3|||
124938853|NCT01371994|449404762|FG001|Overall Study|Adverse Event|6|||
124938854|NCT01371994|449404761|FG000|Overall Study|Lack of Efficacy|3|||
124938855|NCT01371994|449404762|FG001|Overall Study|Lack of Efficacy|0|||
124938856|NCT01371994|449404761|FG000|Overall Study|Withdrawal by Subject|13|||
124938857|NCT01371994|449404762|FG001|Overall Study|Withdrawal by Subject|7|||
124938858|NCT01371994|449404761|FG000|Overall Study|Lost to Follow-up|1|||
124938859|NCT01371994|449404762|FG001|Overall Study|Lost to Follow-up|1|||
124938860|NCT01371994|449404761|FG000|Overall Study|Protocol Violation|24|||
124938861|NCT01371994|449404762|FG001|Overall Study|Protocol Violation|17|||
124938862|NCT01371994|449404761|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
124938863|NCT01371994|449404762|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
124546525|NCT00320801|447955916|FG000|Extension Phase|Administrative|0|||
124546526|NCT00320801|447955917|FG001|Extension Phase|Administrative|0|||
124546527|NCT00320801|447955918|FG002|Extension Phase|Administrative|0|||
124546528|NCT00320801|447955919|FG003|Extension Phase|Administrative|29|||
124546529|NCT00320801|447955916|FG000|Extension Phase|Lack of Efficacy|0|||
124546530|NCT00320801|447955917|FG001|Extension Phase|Lack of Efficacy|0|||
124938864|NCT01371994|449404761|FG000|Overall Study|Physician Decision|1|||
124938865|NCT01371994|449404762|FG001|Overall Study|Physician Decision|1|||
124938866|NCT01371994|449404761|FG000|Overall Study|Miscellaneous Reasons|6|||
124938867|NCT01371994|449404762|FG001|Overall Study|Miscellaneous Reasons|4|||
124938868|NCT03280030|449404763|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
124938869|NCT03280030|449404764|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
124938870|NCT03280030|449404765|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
124938871|NCT03280030|449404763|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
124938872|NCT03280030|449404764|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
124938873|NCT03280030|449404765|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
124938874|NCT03280030|449404763|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
124938875|NCT03280030|449404764|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
124938876|NCT03280030|449404765|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
124938877|NCT03280030|449404763|FG000|Part 2 - Efficacy|Adverse Event|0|||
124938878|NCT03280030|449404764|FG001|Part 2 - Efficacy|Adverse Event|4|||
124938879|NCT03280030|449404765|FG002|Part 2 - Efficacy|Adverse Event|6|||
124938880|NCT03280030|449404763|FG000|Part 2 - Efficacy|Death|0|||
124938881|NCT03280030|449404764|FG001|Part 2 - Efficacy|Death|3|||
124938882|NCT03280030|449404765|FG002|Part 2 - Efficacy|Death|0|||
124938883|NCT03280030|449404763|FG000|Part 2 - Efficacy|Physician Decision|0|||
124938884|NCT03280030|449404764|FG001|Part 2 - Efficacy|Physician Decision|10|||
124938885|NCT03280030|449404765|FG002|Part 2 - Efficacy|Physician Decision|16|||
124938886|NCT03280030|449404763|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
124938887|NCT03280030|449404764|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
124938888|NCT03280030|449404765|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
124938889|NCT03280030|449404763|FG000|Part 2 - Efficacy|Progressive disease|0|||
124938890|NCT03280030|449404764|FG001|Part 2 - Efficacy|Progressive disease|7|||
124938891|NCT03280030|449404765|FG002|Part 2 - Efficacy|Progressive disease|5|||
124938892|NCT00747565|449404766|FG000|Overall Study|Withdrawal by Subject|10|||
124938893|NCT00747565|449404767|FG001|Overall Study|Withdrawal by Subject|6|||
124938894|NCT00747565|449404766|FG000|Overall Study|Lost to Follow-up|4|||
124938895|NCT00747565|449404767|FG001|Overall Study|Lost to Follow-up|1|||
124938896|NCT00319020|449404770|FG000|Overall Study|Death|2|||
124456271|NCT01538628|447630402|FG000|Overall Study|Withdrawal by Subject|1|||
124456272|NCT01538628|447630403|FG001|Overall Study|Withdrawal by Subject|1|||
124456273|NCT01538628|447630402|FG000|Overall Study|Lost to Follow-up|0|||
124456274|NCT01538628|447630403|FG001|Overall Study|Lost to Follow-up|1|||
124456275|NCT01423851|447630404|FG000|Whole Study|Disease progression|2|||
124456276|NCT01423851|447630405|FG001|Whole Study|Disease progression|1|||
124456277|NCT01423851|447630406|FG002|Whole Study|Disease progression|1|||
124456278|NCT01423851|447630407|FG003|Whole Study|Disease progression|4|||
124456279|NCT01423851|447630408|FG004|Whole Study|Disease progression|1|||
124456280|NCT01423851|447630409|FG005|Whole Study|Disease progression|3|||
124456281|NCT01423851|447630410|FG006|Whole Study|Disease progression|1|||
124456282|NCT01423851|447630411|FG007|Whole Study|Disease progression|4|||
124456283|NCT01423851|447630412|FG008|Whole Study|Disease progression|0|||
124456284|NCT01423851|447630413|FG009|Whole Study|Disease progression|2|||
124456285|NCT01423851|447630414|FG010|Whole Study|Disease progression|10|||
124456286|NCT01423851|447630404|FG000|Whole Study|Physician Decision|0|||
124456287|NCT01423851|447630405|FG001|Whole Study|Physician Decision|1|||
124456288|NCT01423851|447630406|FG002|Whole Study|Physician Decision|2|||
124456289|NCT01423851|447630407|FG003|Whole Study|Physician Decision|0|||
124456290|NCT01423851|447630408|FG004|Whole Study|Physician Decision|2|||
124456291|NCT01423851|447630409|FG005|Whole Study|Physician Decision|0|||
124456292|NCT01423851|447630410|FG006|Whole Study|Physician Decision|2|||
124456293|NCT01423851|447630411|FG007|Whole Study|Physician Decision|1|||
124456294|NCT01423851|447630412|FG008|Whole Study|Physician Decision|3|||
124456295|NCT01423851|447630413|FG009|Whole Study|Physician Decision|4|||
124456296|NCT01423851|447630414|FG010|Whole Study|Physician Decision|12|||
124456297|NCT01423851|447630404|FG000|Whole Study|Withdrawal by Subject|1|||
124456298|NCT01423851|447630405|FG001|Whole Study|Withdrawal by Subject|1|||
124546531|NCT00320801|447955918|FG002|Extension Phase|Lack of Efficacy|0|||
124938897|NCT00319020|449404771|FG001|Overall Study|Death|2|||
124938898|NCT00319020|449404770|FG000|Overall Study|Withdrawal by Subject|4|||
124938899|NCT00319020|449404771|FG001|Overall Study|Withdrawal by Subject|1|||
124938900|NCT00319020|449404770|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
124938901|NCT00319020|449404771|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
124938902|NCT00319020|449404770|FG000|Overall Study|Administrative reason|0|||
124938903|NCT00319020|449404771|FG001|Overall Study|Administrative reason|5|||
124938904|NCT00319020|449404770|FG000|Overall Study|Disease progression|0|||
124938905|NCT00319020|449404771|FG001|Overall Study|Disease progression|2|||
124938906|NCT00319020|449404770|FG000|Overall Study|Transplant|0|||
124456299|NCT01423851|447630406|FG002|Whole Study|Withdrawal by Subject|0|||
124456300|NCT01423851|447630407|FG003|Whole Study|Withdrawal by Subject|0|||
124456301|NCT01423851|447630408|FG004|Whole Study|Withdrawal by Subject|0|||
124456302|NCT01423851|447630409|FG005|Whole Study|Withdrawal by Subject|0|||
124456303|NCT01423851|447630410|FG006|Whole Study|Withdrawal by Subject|0|||
124456304|NCT01423851|447630411|FG007|Whole Study|Withdrawal by Subject|0|||
124456305|NCT01423851|447630412|FG008|Whole Study|Withdrawal by Subject|2|||
124938907|NCT00319020|449404771|FG001|Overall Study|Transplant|1|||
124456306|NCT01423851|447630413|FG009|Whole Study|Withdrawal by Subject|0|||
124938908|NCT00319020|449404770|FG000|Overall Study|Treatment failure|0|||
124938909|NCT00319020|449404771|FG001|Overall Study|Treatment failure|1|||
124938910|NCT00319020|449404770|FG000|Overall Study|Adverse Event|0|||
124938911|NCT00319020|449404771|FG001|Overall Study|Adverse Event|1|||
124938912|NCT00227266|449404772|FG000|Overall Study|Withdrawal by Subject|0|||
124938913|NCT00227266|449404773|FG001|Overall Study|Withdrawal by Subject|0|||
124938914|NCT00227266|449404774|FG002|Overall Study|Withdrawal by Subject|1|||
124938915|NCT00227266|449404772|FG000|Overall Study|Protocol Violation|1|||
124938916|NCT00227266|449404773|FG001|Overall Study|Protocol Violation|0|||
124938917|NCT00227266|449404774|FG002|Overall Study|Protocol Violation|1|||
124938918|NCT00227266|449404772|FG000|Overall Study|Excessive weight gain|0|||
124938919|NCT00227266|449404773|FG001|Overall Study|Excessive weight gain|0|||
124938920|NCT00227266|449404774|FG002|Overall Study|Excessive weight gain|2|||
124938921|NCT04153890|449404775|FG000|Overall Study|Lost to Follow-up|9|||
124938922|NCT04153890|449404776|FG001|Overall Study|Lost to Follow-up|0|||
124938923|NCT04153890|449404777|FG002|Overall Study|Lost to Follow-up|9|||
124938924|NCT04153890|449404778|FG003|Overall Study|Lost to Follow-up|0|||
124938925|NCT04153890|449404775|FG000|Overall Study|Death|0|||
124938926|NCT04153890|449404776|FG001|Overall Study|Death|2|||
124938927|NCT04153890|449404777|FG002|Overall Study|Death|0|||
124938928|NCT04153890|449404778|FG003|Overall Study|Death|0|||
124938929|NCT04153890|449404775|FG000|Overall Study|Withdrawal by Subject|0|||
124938930|NCT04153890|449404776|FG001|Overall Study|Withdrawal by Subject|0|||
124938931|NCT04153890|449404777|FG002|Overall Study|Withdrawal by Subject|0|||
124938932|NCT04153890|449404778|FG003|Overall Study|Withdrawal by Subject|2|||
124938933|NCT00593840|449404779|FG000|Overall Study|Withdrawal by Subject|1|||
124938934|NCT01637402|449405997|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
124938935|NCT01637402|449405998|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
124938936|NCT01637402|449405997|FG000|Standard Dose Regimen|Adverse Event|1|||
124938937|NCT01637402|449405998|FG001|Standard Dose Regimen|Adverse Event|0|||
124938938|NCT01637402|449405997|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
124938939|NCT01637402|449405998|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
124456307|NCT01423851|447630414|FG010|Whole Study|Withdrawal by Subject|4|||
124456308|NCT01423851|447630404|FG000|Whole Study|Adverse Event|0|||
124456309|NCT01423851|447630405|FG001|Whole Study|Adverse Event|0|||
124456310|NCT01423851|447630406|FG002|Whole Study|Adverse Event|0|||
124456311|NCT01423851|447630407|FG003|Whole Study|Adverse Event|2|||
124456312|NCT01423851|447630408|FG004|Whole Study|Adverse Event|0|||
124456313|NCT01423851|447630409|FG005|Whole Study|Adverse Event|0|||
124456314|NCT01423851|447630410|FG006|Whole Study|Adverse Event|0|||
124456315|NCT01423851|447630411|FG007|Whole Study|Adverse Event|3|||
124456316|NCT01423851|447630412|FG008|Whole Study|Adverse Event|3|||
124456317|NCT01423851|447630413|FG009|Whole Study|Adverse Event|2|||
124456318|NCT01423851|447630414|FG010|Whole Study|Adverse Event|3|||
124456319|NCT03080883|447630415|FG000|Overall Study|Withdrawal by Subject|11|||
124456320|NCT03080883|447630416|FG001|Overall Study|Withdrawal by Subject|15|||
124456321|NCT03080883|447630415|FG000|Overall Study|Adverse Event|22|||
124456322|NCT03080883|447630416|FG001|Overall Study|Adverse Event|22|||
124456323|NCT03080883|447630415|FG000|Overall Study|Alternative Therapy|0|||
124456324|NCT03080883|447630416|FG001|Overall Study|Alternative Therapy|3|||
124456325|NCT03080883|447630415|FG000|Overall Study|Other Complicating Disease|9|||
124456326|NCT03080883|447630416|FG001|Overall Study|Other Complicating Disease|5|||
124456327|NCT03080883|447630415|FG000|Overall Study|Death|21|||
124456328|NCT03080883|447630416|FG001|Overall Study|Death|16|||
124456329|NCT03080883|447630415|FG000|Overall Study|Physician Decision|2|||
124456330|NCT03080883|447630416|FG001|Overall Study|Physician Decision|2|||
124456331|NCT03080883|447630415|FG000|Overall Study|Disease Progression|2|||
124456332|NCT03080883|447630416|FG001|Overall Study|Disease Progression|8|||
124456333|NCT03080883|447630415|FG000|Overall Study|Lost to Follow-up|1|||
124456334|NCT03080883|447630416|FG001|Overall Study|Lost to Follow-up|1|||
124456335|NCT00346073|447631676|FG000|Overall Study|Serious Adverse Event|2|||
124938940|NCT01637402|449405997|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
124938941|NCT01637402|449405998|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
124938942|NCT01637402|449405997|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
124938943|NCT01637402|449405998|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
124938944|NCT01637402|449405997|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
124938945|NCT01637402|449405998|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
124456336|NCT00346073|447631677|FG001|Overall Study|Serious Adverse Event|0|||
124456337|NCT00346073|447631676|FG000|Overall Study|Lost to Follow-up|39|||
124456338|NCT00346073|447631677|FG001|Overall Study|Lost to Follow-up|24|||
124456339|NCT00075023|447631680|FG000|Pilot Study|Physician Decision|1|||
124456340|NCT00075023|447631681|FG001|Pilot Study|Physician Decision|2|||
124456341|NCT00075023|447631680|FG000|Pilot Study|Withdrawal by Subject|1|||
124456342|NCT00075023|447631681|FG001|Pilot Study|Withdrawal by Subject|0|||
124456343|NCT04342871|447631682|FG000|Overall Study|Death|4|||
124456344|NCT04342871|447631682|FG000|Overall Study|Clinical deterioration/illness progression|2|||
124546532|NCT00320801|447955919|FG003|Extension Phase|Lack of Efficacy|2|||
124938946|NCT02111096|449405999|FG000|Overall Study|Adverse Event|4|||
124938947|NCT02111096|449406000|FG001|Overall Study|Adverse Event|1|||
124938948|NCT02111096|449406001|FG002|Overall Study|Adverse Event|2|||
124938949|NCT02111096|449405999|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124938950|NCT02111096|449406000|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124938951|NCT02111096|449406001|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124938952|NCT02111096|449405999|FG000|Overall Study|Lost to Follow Up|1|||
124938953|NCT02111096|449406000|FG001|Overall Study|Lost to Follow Up|1|||
124938954|NCT02111096|449406001|FG002|Overall Study|Lost to Follow Up|1|||
124938955|NCT02111096|449405999|FG000|Overall Study|Physician Decision|0|||
124456345|NCT04342871|447631682|FG000|Overall Study|Did not complete baseline assessments|5|||
124456346|NCT04342871|447631682|FG000|Overall Study|Lost to Follow-up|13|||
124456347|NCT04179734|447631683|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
124456348|NCT04179734|447631684|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
124456349|NCT04179734|447631683|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
124456350|NCT04179734|447631684|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
124456351|NCT01429584|447631686|FG000|Overall Study|Withdrawal by Subject|1|||
124456352|NCT01429584|447631687|FG001|Overall Study|Withdrawal by Subject|0|||
124456353|NCT01429584|447631686|FG000|Overall Study|Protocol Violation|0|||
124456354|NCT01429584|447631687|FG001|Overall Study|Protocol Violation|1|||
124456355|NCT02263079|447631688|FG000|Overall Study|Physician Decision|1|||
124456356|NCT02263079|447631689|FG001|Overall Study|Physician Decision|0|||
124456357|NCT02263079|447631690|FG002|Overall Study|Physician Decision|0|||
124456358|NCT02263079|447631688|FG000|Overall Study|Withdrawal by Subject|2|||
124456359|NCT02263079|447631689|FG001|Overall Study|Withdrawal by Subject|8|||
124456360|NCT02263079|447631690|FG002|Overall Study|Withdrawal by Subject|0|||
124456361|NCT02603120|447631691|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
124456362|NCT02603120|447631692|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
124456363|NCT02603120|447631691|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
124456364|NCT02603120|447631692|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
124456365|NCT02603120|447631691|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
124456366|NCT02603120|447631692|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
124456367|NCT02603120|447631691|FG000|Double-Blind Treatment Phase|Death|2|||
124456368|NCT02603120|447631692|FG001|Double-Blind Treatment Phase|Death|0|||
124456369|NCT02603120|447631691|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
124456370|NCT02603120|447631692|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
124456371|NCT02603120|447631691|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
124456372|NCT02603120|447631692|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
124456373|NCT02603120|447631691|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
124456374|NCT02603120|447631692|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
124456375|NCT02603120|447631691|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
124456376|NCT02603120|447631692|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
124456377|NCT02603120|447631691|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
124456378|NCT02603120|447631692|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
124456379|NCT02603120|447631691|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
124456380|NCT02603120|447631692|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
124456381|NCT02603120|447631691|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
124456382|NCT02603120|447631692|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
124456383|NCT02603120|447631691|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
124456384|NCT02603120|447631692|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
124456385|NCT02603120|447631691|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
124456386|NCT02603120|447631692|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
124456387|NCT02603120|447631691|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
124456388|NCT02603120|447631692|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
124456389|NCT00176605|447631697|FG000|Overall Study|Withdrawal by Subject|2|||
124456390|NCT01321710|447631700|FG000|Overall Study|Lost to Follow-up|4|||
124456391|NCT01321710|447631701|FG001|Overall Study|Lost to Follow-up|5|||
124456392|NCT01321710|447631702|FG002|Overall Study|Lost to Follow-up|0|||
124456393|NCT01227187|447631703|FG000|Overall Study|Physician Decision|0|||
124456394|NCT01227187|447631704|FG001|Overall Study|Physician Decision|0|||
124456395|NCT01227187|447631705|FG002|Overall Study|Physician Decision|0|||
124546533|NCT00320801|447955916|FG000|Extension Phase|Lost to Follow-up|0|||
124938956|NCT02111096|449406000|FG001|Overall Study|Physician Decision|1|||
124938957|NCT02111096|449406001|FG002|Overall Study|Physician Decision|0|||
124938958|NCT02111096|449405999|FG000|Overall Study|Protocol Violation|1|||
124938959|NCT02111096|449406000|FG001|Overall Study|Protocol Violation|0|||
124938960|NCT02111096|449406001|FG002|Overall Study|Protocol Violation|1|||
124938961|NCT02111096|449405999|FG000|Overall Study|Terminated by Sponsor|53|||
124938962|NCT02111096|449406000|FG001|Overall Study|Terminated by Sponsor|35|||
124456396|NCT01227187|447631706|FG003|Overall Study|Physician Decision|1|||
124456397|NCT01761292|447631707|FG000|Part 1|Adverse Event|1|||
124456398|NCT01761292|447631707|FG000|Part 1|not receiving treatment in Part 1|1|||
124546534|NCT00320801|447955917|FG001|Extension Phase|Lost to Follow-up|0|||
124546535|NCT00320801|447955918|FG002|Extension Phase|Lost to Follow-up|0|||
124546536|NCT00320801|447955919|FG003|Extension Phase|Lost to Follow-up|3|||
124546537|NCT00577031|447955920|FG000|Overall Study|Adverse Event|52|||
124546538|NCT00577031|447955920|FG000|Overall Study|Progression of disease|93|||
124546539|NCT00577031|447955920|FG000|Overall Study|Protocol Violation|5|||
124546540|NCT00577031|447955920|FG000|Overall Study|Participant withdrew consent|13|||
124546541|NCT00577031|447955920|FG000|Overall Study|Participant non-compliance|5|||
124546542|NCT00577031|447955920|FG000|Overall Study|Need for surgery|17|||
124546543|NCT00577031|447955920|FG000|Overall Study|Medical decision|14|||
124546544|NCT00577031|447955920|FG000|Overall Study|Death|6|||
124546545|NCT06067191|447955922|FG000|Overall Study|Withdrawal by Subject|0|||
124546546|NCT06067191|447955923|FG001|Overall Study|Withdrawal by Subject|1|||
124546547|NCT04764669|447955924|FG000|Overall Study|Adverse Event|1|||
124546548|NCT04764669|447955925|FG001|Overall Study|Adverse Event|0|||
124546549|NCT04764669|447955926|FG002|Overall Study|Adverse Event|1|||
124938963|NCT02111096|449406001|FG002|Overall Study|Terminated by Sponsor|54|||
124546550|NCT04764669|447955927|FG003|Overall Study|Adverse Event|0|||
124546551|NCT04764669|447955924|FG000|Overall Study|Subject Choice|0|||
124546552|NCT04764669|447955925|FG001|Overall Study|Subject Choice|0|||
124546553|NCT04764669|447955926|FG002|Overall Study|Subject Choice|1|||
124546554|NCT04764669|447955927|FG003|Overall Study|Subject Choice|0|||
124546555|NCT04764669|447955924|FG000|Overall Study|Withdrawal by Subject|2|||
124938964|NCT02111096|449405999|FG000|Overall Study|Withdrawal by Subject|4|||
124938965|NCT02111096|449406000|FG001|Overall Study|Withdrawal by Subject|2|||
124938966|NCT02111096|449406001|FG002|Overall Study|Withdrawal by Subject|8|||
124938967|NCT03709706|449406002|FG000|Overall Study|Adverse Event|0|||
124938968|NCT03709706|449406003|FG001|Overall Study|Adverse Event|1|||
124938969|NCT03709706|449406002|FG000|Overall Study|Physician Decision|14|||
124938970|NCT03709706|449406003|FG001|Overall Study|Physician Decision|8|||
124938971|NCT03709706|449406002|FG000|Overall Study|Withdrawal by Subject|2|||
124938972|NCT03709706|449406003|FG001|Overall Study|Withdrawal by Subject|1|||
124938973|NCT03709706|449406002|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
124938974|NCT03709706|449406003|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
124938975|NCT00609869|449406004|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
124938976|NCT00609869|449406004|FG000|Overall Study|Severe hematologic toxicity|1|||
124938977|NCT00609869|449406004|FG000|Overall Study|Withdrawal by Subject|1|||
124938978|NCT00609869|449406004|FG000|Overall Study|Seizures|1|||
124938979|NCT00609869|449406004|FG000|Overall Study|Severe tumor flare reaction|1|||
124938980|NCT00609869|449406004|FG000|Overall Study|Hepatitis B infection|1|||
124938981|NCT00609869|449406004|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
124938982|NCT00609869|449406004|FG000|Overall Study|Mantle cell: not evaluable|4|||
124938983|NCT01627561|449406005|FG000|Overall Study|Lost to Follow-up|1|||
124938984|NCT01627561|449406006|FG001|Overall Study|Lost to Follow-up|0|||
124938985|NCT01627561|449406005|FG000|Overall Study|Withdrawal by Subject|0|||
124938986|NCT01627561|449406006|FG001|Overall Study|Withdrawal by Subject|1|||
124938987|NCT01627561|449406005|FG000|Overall Study|Migrated/moved from study area|0|||
124938988|NCT01627561|449406006|FG001|Overall Study|Migrated/moved from study area|2|||
124456399|NCT01761292|447631707|FG000|Extension 1|Withdrawal by Subject|1|||
124456400|NCT02554019|447631708|FG000|Overall Study|Withdrawal by Subject|1|||
124456401|NCT02554019|447631709|FG001|Overall Study|Withdrawal by Subject|0|||
124456402|NCT02554019|447631710|FG002|Overall Study|Withdrawal by Subject|2|||
124456403|NCT02554019|447631708|FG000|Overall Study|Adverse Event|1|||
124456404|NCT02554019|447631709|FG001|Overall Study|Adverse Event|0|||
124456405|NCT02554019|447631710|FG002|Overall Study|Adverse Event|0|||
124456406|NCT02463409|447631711|FG000|Overall Study|Withdrawal by Subject|1|||
124456407|NCT02463409|447631711|FG000|Overall Study|Screen failure|1|||
124456408|NCT00772954|447631712|FG000|Overall Study|Adverse Event|0|||
124456409|NCT00772954|447631713|FG001|Overall Study|Adverse Event|0|||
124456410|NCT00772954|447631714|FG002|Overall Study|Adverse Event|1|||
124456411|NCT02495844|447631715|FG000|Overall Study|Lack of Efficacy|1|||
124456412|NCT02495844|447631716|FG001|Overall Study|Lack of Efficacy|2|||
124456413|NCT02495844|447631715|FG000|Overall Study|AE, non-fatal|0|||
124546556|NCT04764669|447955925|FG001|Overall Study|Withdrawal by Subject|0|||
124546557|NCT04764669|447955926|FG002|Overall Study|Withdrawal by Subject|0|||
124546558|NCT04764669|447955927|FG003|Overall Study|Withdrawal by Subject|0|||
124938989|NCT00890591|449406008|FG000|Overall Study|Lack of Efficacy|20|||
124938990|NCT01579318|449406011|FG000|Overall Study|Disease Progression|1|||
124938991|NCT02797132|449406012|FG000|Part A (15 Days)|Adverse Event|1|||
124938992|NCT02797132|449406012|FG000|Part B (24 Weeks)|Adverse Event|3|||
124938993|NCT02347332|449406013|FG000|Overall Study|Not treated|5|||
124938994|NCT02347332|449406014|FG001|Overall Study|Not treated|2|||
124456414|NCT02495844|447631716|FG001|Overall Study|AE, non-fatal|1|||
124456415|NCT02495844|447631715|FG000|Overall Study|Hepatitis Positivity|0|||
124456416|NCT02495844|447631716|FG001|Overall Study|Hepatitis Positivity|1|||
124456417|NCT02325219|447631717|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
124546559|NCT01067339|447955930|FG000|Overall Study|Withdrawal by Subject|6|||
124546560|NCT01067339|447955931|FG001|Overall Study|Withdrawal by Subject|5|||
124456418|NCT02325219|447631718|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
124456419|NCT02325219|447631719|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
124456420|NCT02325219|447631720|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
124456421|NCT02325219|447631721|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
124456422|NCT02325219|447631717|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
124456423|NCT02325219|447631718|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
124456424|NCT02325219|447631719|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
124703128|NCT02471144|448537216|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
124703129|NCT02471144|448537217|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
124703130|NCT02471144|448537218|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
124703131|NCT02471144|448537219|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
124703132|NCT02471144|448537220|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
124703133|NCT02471144|448537221|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
124703134|NCT02471144|448537222|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
124703135|NCT02471144|448537223|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
124703136|NCT02471144|448537224|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
124703137|NCT02471144|448537214|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
124703138|NCT02471144|448537215|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
124703139|NCT02471144|448537216|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
124703140|NCT02471144|448537217|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
124703141|NCT02471144|448537218|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
124703142|NCT02471144|448537219|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
124703143|NCT02471144|448537220|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
124703144|NCT02471144|448537221|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
124703145|NCT02471144|448537222|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
124703146|NCT02471144|448537223|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
124703147|NCT02471144|448537224|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
124703148|NCT02471144|448537214|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
124703149|NCT02471144|448537215|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
124703150|NCT02471144|448537216|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
124703151|NCT02471144|448537217|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
124703152|NCT02471144|448537218|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
124703153|NCT02471144|448537219|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
124703154|NCT02471144|448537220|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
124703155|NCT02471144|448537221|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
124703156|NCT02471144|448537222|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
124703157|NCT02471144|448537223|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
124703158|NCT02471144|448537224|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
124703159|NCT02471144|448537214|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
124703160|NCT02471144|448537215|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
124703161|NCT02471144|448537216|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
124703162|NCT02471144|448537217|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
124703163|NCT02471144|448537218|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
124703164|NCT02471144|448537219|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
124938995|NCT02347332|449406013|FG000|Overall Study|Progressive disease|141|||
124938996|NCT02347332|449406014|FG001|Overall Study|Progressive disease|159|||
124938997|NCT02347332|449406013|FG000|Overall Study|Adverse Event|50|||
124938998|NCT02347332|449406014|FG001|Overall Study|Adverse Event|41|||
124456425|NCT02325219|447631720|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
124456426|NCT02325219|447631721|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
124456427|NCT02325219|447631717|FG000|Controlled Period (Week 0 - 16)|Other|0|||
124456428|NCT02325219|447631718|FG001|Controlled Period (Week 0 - 16)|Other|0|||
124456429|NCT02325219|447631719|FG002|Controlled Period (Week 0 - 16)|Other|1|||
124456430|NCT02325219|447631720|FG003|Controlled Period (Week 0 - 16)|Other|0|||
124456431|NCT02325219|447631721|FG004|Controlled Period (Week 0 - 16)|Other|0|||
124456432|NCT02325219|447631717|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
124456433|NCT02325219|447631718|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
124456434|NCT02325219|447631719|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
124456435|NCT02325219|447631720|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
124456436|NCT02325219|447631721|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
124456437|NCT02325219|447631717|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
124456438|NCT02325219|447631718|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
124456439|NCT02325219|447631719|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
124456440|NCT02325219|447631720|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
124938999|NCT02347332|449406013|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
124939000|NCT02347332|449406014|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
124939001|NCT02347332|449406013|FG000|Overall Study|Protocol Violation|1|||
124703165|NCT02471144|448537220|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
124939002|NCT02347332|449406014|FG001|Overall Study|Protocol Violation|1|||
124939003|NCT02347332|449406013|FG000|Overall Study|Lost to Follow-up|2|||
124939004|NCT02347332|449406014|FG001|Overall Study|Lost to Follow-up|1|||
124939005|NCT02347332|449406013|FG000|Overall Study|Physician Decision|4|||
124939006|NCT02347332|449406014|FG001|Overall Study|Physician Decision|3|||
124939007|NCT02347332|449406013|FG000|Overall Study|Withdrawal by Subject|20|||
124939008|NCT02347332|449406014|FG001|Overall Study|Withdrawal by Subject|14|||
124939009|NCT02347332|449406013|FG000|Overall Study|Protocol requirement|1|||
124939010|NCT02347332|449406014|FG001|Overall Study|Protocol requirement|1|||
124939011|NCT02347332|449406013|FG000|Overall Study|Switch Post-Trial program|0|||
124939012|NCT02347332|449406014|FG001|Overall Study|Switch Post-Trial program|1|||
124939013|NCT01970007|449406015|FG000|Overall Study|Death|5|||
124939014|NCT01970007|449406015|FG000|Overall Study|Withdrawal by Subject|23|||
124939015|NCT01970007|449406015|FG000|Overall Study|Lost to Follow-up|24|||
124939016|NCT01970007|449406015|FG000|Overall Study|"Other endpoint"|3|||
124939017|NCT00112359|449406019|FG000|Overall Study|Unrelated adverse event|16|||
124939018|NCT00112359|449406020|FG001|Overall Study|Unrelated adverse event|8|||
124939019|NCT00112359|449406019|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
124939020|NCT00112359|449406020|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
124939021|NCT00112359|449406019|FG000|Overall Study|Related adverse event|5|||
124939022|NCT00112359|449406020|FG001|Overall Study|Related adverse event|3|||
124939023|NCT00112359|449406019|FG000|Overall Study|Lost to Follow-up|0|||
124939024|NCT00112359|449406020|FG001|Overall Study|Lost to Follow-up|1|||
124939025|NCT00112359|449406019|FG000|Overall Study|Personal/administrative|1|||
124939026|NCT00112359|449406020|FG001|Overall Study|Personal/administrative|1|||
124939027|NCT00112359|449406019|FG000|Overall Study|Other|3|||
124939028|NCT00112359|449406020|FG001|Overall Study|Other|0|||
124939029|NCT01961609|449406021|FG000|Initiation|Missing|3|||
124939030|NCT01961609|449406022|FG001|Initiation|Missing|2|||
124939031|NCT01961609|449406023|FG002|Initiation|Missing|0|||
124939032|NCT01961609|449406024|FG003|Initiation|Missing|0|||
124939033|NCT01961609|449406021|FG000|Initiation|Protocol deviation|1|||
124939034|NCT01961609|449406022|FG001|Initiation|Protocol deviation|0|||
124939035|NCT01961609|449406023|FG002|Initiation|Protocol deviation|0|||
124939036|NCT01961609|449406024|FG003|Initiation|Protocol deviation|0|||
124939037|NCT01961609|449406021|FG000|Initiation|Death|0|||
124939038|NCT01961609|449406022|FG001|Initiation|Death|1|||
124939039|NCT01961609|449406023|FG002|Initiation|Death|0|||
124939040|NCT01961609|449406024|FG003|Initiation|Death|0|||
124939041|NCT01961609|449406021|FG000|Initiation|Administrative problems|1|||
124939042|NCT01961609|449406022|FG001|Initiation|Administrative problems|0|||
124939043|NCT01961609|449406023|FG002|Initiation|Administrative problems|0|||
124939044|NCT01961609|449406024|FG003|Initiation|Administrative problems|0|||
124939045|NCT01961609|449406021|FG000|Initiation|Withdrawal by Subject|1|||
124939046|NCT01961609|449406022|FG001|Initiation|Withdrawal by Subject|2|||
124939047|NCT01961609|449406023|FG002|Initiation|Withdrawal by Subject|0|||
124939048|NCT01961609|449406024|FG003|Initiation|Withdrawal by Subject|0|||
124939049|NCT01961609|449406021|FG000|Initiation|Lack of Efficacy|2|||
124939050|NCT01961609|449406022|FG001|Initiation|Lack of Efficacy|1|||
124939051|NCT01961609|449406023|FG002|Initiation|Lack of Efficacy|0|||
124939052|NCT01961609|449406024|FG003|Initiation|Lack of Efficacy|0|||
124939053|NCT01961609|449406021|FG000|Initiation|Abnormal lab values|0|||
124939054|NCT01961609|449406022|FG001|Initiation|Abnormal lab values|1|||
124939055|NCT01961609|449406023|FG002|Initiation|Abnormal lab values|0|||
124939056|NCT01961609|449406024|FG003|Initiation|Abnormal lab values|0|||
124939057|NCT01961609|449406021|FG000|Initiation|Adverse Event|3|||
124939058|NCT01961609|449406022|FG001|Initiation|Adverse Event|5|||
124939059|NCT01961609|449406023|FG002|Initiation|Adverse Event|0|||
124939060|NCT01961609|449406024|FG003|Initiation|Adverse Event|0|||
124939061|NCT01961609|449406021|FG000|Initiation|Randomized but not treated|1|||
124939062|NCT01961609|449406022|FG001|Initiation|Randomized but not treated|1|||
124939063|NCT01961609|449406023|FG002|Initiation|Randomized but not treated|0|||
124939064|NCT01961609|449406024|FG003|Initiation|Randomized but not treated|0|||
124939065|NCT01961609|449406021|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
124939066|NCT01961609|449406022|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
124939067|NCT01961609|449406023|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
124939068|NCT01961609|449406024|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
124939069|NCT01961609|449406021|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
124703166|NCT02471144|448537221|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
124703167|NCT02471144|448537222|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
124703168|NCT02471144|448537223|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
124703169|NCT02471144|448537224|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
124703170|NCT02471144|448537214|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
124703171|NCT02471144|448537215|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
124703172|NCT02471144|448537216|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
124703173|NCT02471144|448537217|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
124703174|NCT02471144|448537218|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
124703175|NCT02471144|448537219|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
124703176|NCT02471144|448537220|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
124703177|NCT02471144|448537221|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
124703178|NCT02471144|448537222|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
124703179|NCT02471144|448537223|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
124703180|NCT02471144|448537224|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
124703181|NCT02471144|448537214|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
124703182|NCT02471144|448537215|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
124703183|NCT02471144|448537216|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
124703184|NCT02471144|448537217|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
124703185|NCT02471144|448537218|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
124703186|NCT02471144|448537219|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
124703187|NCT02471144|448537220|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
124703188|NCT02471144|448537221|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
124703189|NCT02471144|448537222|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
124703190|NCT02471144|448537223|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
124703191|NCT02471144|448537224|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
124546561|NCT00890409|447955932|FG000|Overall Study|Lost to Follow-up|20|||
124546562|NCT00890409|447955933|FG001|Overall Study|Lost to Follow-up|21|||
124546563|NCT00455923|447955936|FG000|Overall Study|Pregnancy|0|||
124546564|NCT00455923|447955937|FG001|Overall Study|Pregnancy|2|||
124703192|NCT02471144|448537214|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
124703193|NCT02471144|448537215|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
124703194|NCT02471144|448537216|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
124703195|NCT02471144|448537217|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
124703196|NCT02471144|448537218|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
124703197|NCT02471144|448537219|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
124703198|NCT02471144|448537220|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
124703199|NCT02471144|448537221|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
124703200|NCT02471144|448537222|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
124703201|NCT02471144|448537223|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
124703202|NCT02471144|448537224|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
124703203|NCT02471144|448537214|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
124703204|NCT02471144|448537215|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
124703205|NCT02471144|448537216|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
124703206|NCT02471144|448537217|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
124703207|NCT02471144|448537218|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
124703208|NCT02471144|448537219|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
124939070|NCT01961609|449406022|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
124939071|NCT01961609|449406023|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
124939072|NCT01961609|449406024|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
124939073|NCT01961609|449406021|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
124939074|NCT01961609|449406022|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
124939075|NCT01961609|449406023|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
124456441|NCT02325219|447631721|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
124456442|NCT02325219|447631717|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
124456443|NCT02325219|447631718|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
124456444|NCT02325219|447631719|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
124456445|NCT02325219|447631720|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
124456446|NCT02325219|447631721|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
124456447|NCT01911442|447631724|FG000|Overall Study|Adverse Event|2|||
124456448|NCT01911442|447631725|FG001|Overall Study|Adverse Event|2|||
124456449|NCT01911442|447631726|FG002|Overall Study|Adverse Event|4|||
124456450|NCT01911442|447631724|FG000|Overall Study|Lack of Efficacy|1|||
124456451|NCT01911442|447631725|FG001|Overall Study|Lack of Efficacy|1|||
124456452|NCT01911442|447631726|FG002|Overall Study|Lack of Efficacy|1|||
124456453|NCT01911442|447631724|FG000|Overall Study|Lost to Follow-up|2|||
124456454|NCT01911442|447631725|FG001|Overall Study|Lost to Follow-up|0|||
124456455|NCT01911442|447631726|FG002|Overall Study|Lost to Follow-up|1|||
124546565|NCT00455923|447955936|FG000|Overall Study|Other|3|||
124546566|NCT00455923|447955937|FG001|Overall Study|Other|1|||
124546567|NCT00769132|447955940|FG000|Period 1|Adverse Event|1|||
124546568|NCT00769132|447955941|FG001|Period 1|Adverse Event|0|||
124546569|NCT00769132|447955942|FG002|Period 1|Adverse Event|0|||
124546570|NCT00769132|447955943|FG003|Period 1|Adverse Event|1|||
124546571|NCT00769132|447955940|FG000|Period 2|Withdrawal by Subject|0|||
124546572|NCT00769132|447955941|FG001|Period 2|Withdrawal by Subject|0|||
124546573|NCT00769132|447955942|FG002|Period 2|Withdrawal by Subject|0|||
124546574|NCT00769132|447955943|FG003|Period 2|Withdrawal by Subject|1|||
124546575|NCT00769132|447955940|FG000|Period 3|Withdrawal by Subject|1|||
124546576|NCT00769132|447955941|FG001|Period 3|Withdrawal by Subject|0|||
124546577|NCT00769132|447955942|FG002|Period 3|Withdrawal by Subject|0|||
124546578|NCT00769132|447955943|FG003|Period 3|Withdrawal by Subject|0|||
124546579|NCT00769132|447955940|FG000|Period 4|Withdrawal by Subject|0|||
124546580|NCT00769132|447955941|FG001|Period 4|Withdrawal by Subject|1|||
124546581|NCT00769132|447955942|FG002|Period 4|Withdrawal by Subject|0|||
124546582|NCT00769132|447955943|FG003|Period 4|Withdrawal by Subject|0|||
124546583|NCT02230332|447955944|FG000|Overall Study|Adverse Event|2|||
124546584|NCT02230332|447955945|FG001|Overall Study|Adverse Event|1|||
124546585|NCT02230332|447955944|FG000|Overall Study|Lost to Follow-up|1|||
124546586|NCT02230332|447955945|FG001|Overall Study|Lost to Follow-up|0|||
124546587|NCT02230332|447955944|FG000|Overall Study|Protocol Violation|1|||
124546588|NCT02230332|447955945|FG001|Overall Study|Protocol Violation|0|||
124546589|NCT00877799|447955947|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
124546590|NCT00877799|447955948|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
124939076|NCT01961609|449406024|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
124939077|NCT01961609|449406021|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
124939078|NCT01961609|449406022|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
124939079|NCT01961609|449406023|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
124939080|NCT01961609|449406024|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
124939081|NCT01961609|449406021|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
124939082|NCT01961609|449406022|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
124939083|NCT01961609|449406023|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
124939084|NCT01961609|449406024|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
124939085|NCT01961609|449406021|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
124939086|NCT01961609|449406022|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
124939087|NCT01961609|449406023|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
124939088|NCT01961609|449406024|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
124939089|NCT01961609|449406021|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
124939090|NCT01961609|449406022|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
124939091|NCT01961609|449406023|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
124939092|NCT01961609|449406024|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
124939093|NCT01961609|449406021|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
124939094|NCT01961609|449406022|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
124939095|NCT01961609|449406023|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
124939096|NCT01961609|449406024|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
124939097|NCT01961609|449406021|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
124546591|NCT00877799|447955949|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
124546592|NCT00877799|447955950|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
124546593|NCT00877799|447955951|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
124546594|NCT00877799|447955947|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
124546595|NCT00877799|447955948|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
124546596|NCT00877799|447955949|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
124546597|NCT00877799|447955950|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
124546598|NCT00877799|447955951|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
124546599|NCT00877799|447955947|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
124546600|NCT00877799|447955948|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
124546601|NCT00877799|447955949|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
124546602|NCT00877799|447955950|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
124546603|NCT00877799|447955951|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
124546604|NCT00877799|447955947|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
124546605|NCT00877799|447955948|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
124546606|NCT00877799|447955949|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
124546607|NCT00877799|447955950|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
124546608|NCT00877799|447955951|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
124546609|NCT00877799|447955947|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
124546610|NCT00877799|447955948|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
124546611|NCT00877799|447955949|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
124546612|NCT00877799|447955950|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
124546613|NCT00877799|447955951|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
124546614|NCT04054011|447955952|FG000|Overall Study|COVID|3|||
124546615|NCT00557830|447955956|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
124546616|NCT00557830|447955957|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
124546617|NCT00557830|447955958|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
124546618|NCT00557830|447955956|FG000|Screening Treatment Phase|Adverse Event|2|||
124546619|NCT00557830|447955957|FG001|Screening Treatment Phase|Adverse Event|0|||
124546620|NCT00557830|447955958|FG002|Screening Treatment Phase|Adverse Event|0|||
124546621|NCT00557830|447955956|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
124546622|NCT00557830|447955957|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
124546623|NCT00557830|447955958|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
124703209|NCT02471144|448537220|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
124703210|NCT02471144|448537221|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
124703211|NCT02471144|448537222|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
124939098|NCT01961609|449406022|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
124939099|NCT01961609|449406023|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
124939100|NCT01961609|449406024|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
124939101|NCT01961609|449406021|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
124939102|NCT01961609|449406022|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
124939103|NCT01961609|449406023|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
124939104|NCT01961609|449406024|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
124939105|NCT01961609|449406021|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
124939106|NCT01961609|449406022|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
124939107|NCT01961609|449406023|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
124939108|NCT01961609|449406024|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
124939109|NCT01961609|449406021|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
124939110|NCT01961609|449406022|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
124939111|NCT01961609|449406023|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
124939112|NCT01961609|449406024|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
124939113|NCT01988402|449406025|FG000|Overall Study|Adverse Event|1|||
124939114|NCT01988402|449406026|FG001|Overall Study|Adverse Event|2|||
124939115|NCT01988402|449406025|FG000|Overall Study|Withdrawal by Subject|1|||
124939116|NCT01988402|449406026|FG001|Overall Study|Withdrawal by Subject|0|||
124939117|NCT00582972|449406028|FG000|Overall Study|Protocol Violation|2|||
124939118|NCT01566890|449406031|FG000|Overall Study|Adverse Event|1|||
124939119|NCT01566890|449406032|FG001|Overall Study|Adverse Event|0|||
124939120|NCT01566890|449406033|FG002|Overall Study|Adverse Event|0|||
124456456|NCT01911442|447631724|FG000|Overall Study|Withdrawal by Subject|1|||
124456457|NCT01911442|447631725|FG001|Overall Study|Withdrawal by Subject|0|||
124456458|NCT01911442|447631726|FG002|Overall Study|Withdrawal by Subject|6|||
124456459|NCT01911442|447631724|FG000|Overall Study|Mother's Work Schedule|0|||
124456460|NCT01911442|447631725|FG001|Overall Study|Mother's Work Schedule|1|||
124456461|NCT01911442|447631726|FG002|Overall Study|Mother's Work Schedule|0|||
124456462|NCT04773106|447631732|FG000|Overall Study|Withdrawal by Subject|3|||
124456463|NCT04773106|447631732|FG000|Overall Study|Death|1|||
124456464|NCT03200366|447631735|FG000|Patient Navigation Intervention Given|Death|0|||
124456465|NCT03200366|447631736|FG001|Patient Navigation Intervention Given|Death|2|||
124456466|NCT03200366|447631737|FG002|Patient Navigation Intervention Given|Death|0|||
124456467|NCT03200366|447631735|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
124456468|NCT03200366|447631736|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
124456469|NCT03200366|447631737|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
124456470|NCT03200366|447631735|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
124456471|NCT03200366|447631736|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
124456472|NCT03200366|447631737|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
124456473|NCT03200366|447631735|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
124456474|NCT03200366|447631736|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
124456475|NCT03200366|447631737|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
124456476|NCT03200366|447631735|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
124456477|NCT03200366|447631736|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
124456478|NCT03200366|447631737|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
124456479|NCT03200366|447631735|FG000|6 Month Post-Baseline Interview|Death|1|||
124456480|NCT03200366|447631736|FG001|6 Month Post-Baseline Interview|Death|1|||
124456481|NCT03200366|447631737|FG002|6 Month Post-Baseline Interview|Death|1|||
124456482|NCT03200366|447631735|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
124939121|NCT01566890|449406034|FG003|Overall Study|Adverse Event|0|||
124939122|NCT01566890|449406035|FG004|Overall Study|Adverse Event|0|||
124939123|NCT01566890|449406031|FG000|Overall Study|Withdrawal by Subject|3|||
124939124|NCT01566890|449406032|FG001|Overall Study|Withdrawal by Subject|1|||
124939125|NCT01566890|449406033|FG002|Overall Study|Withdrawal by Subject|1|||
124939126|NCT01566890|449406034|FG003|Overall Study|Withdrawal by Subject|1|||
124939127|NCT01566890|449406035|FG004|Overall Study|Withdrawal by Subject|0|||
124939128|NCT01566890|449406031|FG000|Overall Study|Screen failure|6|||
124939129|NCT01566890|449406032|FG001|Overall Study|Screen failure|0|||
124939130|NCT01566890|449406033|FG002|Overall Study|Screen failure|1|||
124939131|NCT01566890|449406034|FG003|Overall Study|Screen failure|1|||
124939132|NCT01566890|449406035|FG004|Overall Study|Screen failure|0|||
124939133|NCT01566890|449406031|FG000|Overall Study|Incomplete CEU data|1|||
124939134|NCT01566890|449406032|FG001|Overall Study|Incomplete CEU data|3|||
124939135|NCT01566890|449406033|FG002|Overall Study|Incomplete CEU data|5|||
124939136|NCT01566890|449406034|FG003|Overall Study|Incomplete CEU data|8|||
124939137|NCT01566890|449406035|FG004|Overall Study|Incomplete CEU data|0|||
124939138|NCT01566890|449406031|FG000|Overall Study|Lost to Follow-up|0|||
124939139|NCT01566890|449406032|FG001|Overall Study|Lost to Follow-up|0|||
124939140|NCT01566890|449406033|FG002|Overall Study|Lost to Follow-up|4|||
124939141|NCT01566890|449406034|FG003|Overall Study|Lost to Follow-up|4|||
124939142|NCT01566890|449406035|FG004|Overall Study|Lost to Follow-up|0|||
124939143|NCT01566890|449406031|FG000|Overall Study|Other|0|||
124939144|NCT01566890|449406032|FG001|Overall Study|Other|0|||
124939145|NCT01566890|449406033|FG002|Overall Study|Other|0|||
124939146|NCT01566890|449406034|FG003|Overall Study|Other|0|||
124939147|NCT01566890|449406035|FG004|Overall Study|Other|7|||
124939148|NCT01211184|449406045|FG000|Overall Study|Withdrawal by Subject|0|||
124939149|NCT01211184|449406046|FG001|Overall Study|Withdrawal by Subject|2|||
124939150|NCT01211184|449406047|FG002|Overall Study|Withdrawal by Subject|1|||
124939151|NCT00822120|449406048|FG000|Initial Registration|Adverse Event|1|||
124939152|NCT00822120|449406049|FG001|Initial Registration|Adverse Event|0|||
124939153|NCT00822120|449406050|FG002|Initial Registration|Adverse Event|0|||
124939154|NCT00822120|449406051|FG003|Initial Registration|Adverse Event|0|||
124939155|NCT00822120|449406052|FG004|Initial Registration|Adverse Event|0|||
124939156|NCT00822120|449406053|FG005|Initial Registration|Adverse Event|0|||
124939157|NCT00822120|449406048|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
124939158|NCT00822120|449406049|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
124939159|NCT00822120|449406050|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
124939160|NCT00822120|449406051|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
124939161|NCT00822120|449406052|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
124939162|NCT00822120|449406053|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
124939163|NCT00822120|449406048|FG000|Initial Registration|Reasons not Protocol Specified|2|||
124939164|NCT00822120|449406049|FG001|Initial Registration|Reasons not Protocol Specified|0|||
124939165|NCT00822120|449406050|FG002|Initial Registration|Reasons not Protocol Specified|0|||
124939166|NCT00822120|449406051|FG003|Initial Registration|Reasons not Protocol Specified|0|||
124939167|NCT00822120|449406052|FG004|Initial Registration|Reasons not Protocol Specified|0|||
124939168|NCT00822120|449406053|FG005|Initial Registration|Reasons not Protocol Specified|0|||
124939169|NCT00822120|449406048|FG000|Initial Registration|Ineligible|22|||
124939170|NCT00822120|449406049|FG001|Initial Registration|Ineligible|1|||
124939171|NCT00822120|449406050|FG002|Initial Registration|Ineligible|0|||
124939172|NCT00822120|449406051|FG003|Initial Registration|Ineligible|0|||
124939173|NCT00822120|449406052|FG004|Initial Registration|Ineligible|0|||
124939174|NCT00822120|449406053|FG005|Initial Registration|Ineligible|0|||
124939175|NCT00822120|449406048|FG000|PET-directed Therapy|Adverse Event|0|||
124939176|NCT00822120|449406049|FG001|PET-directed Therapy|Adverse Event|0|||
124939177|NCT00822120|449406050|FG002|PET-directed Therapy|Adverse Event|0|||
124939178|NCT00822120|449406051|FG003|PET-directed Therapy|Adverse Event|1|||
124939179|NCT00822120|449406052|FG004|PET-directed Therapy|Adverse Event|0|||
124939180|NCT00822120|449406053|FG005|PET-directed Therapy|Adverse Event|0|||
124939181|NCT00822120|449406048|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
124939182|NCT00822120|449406049|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
124939183|NCT00822120|449406050|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
124939184|NCT00822120|449406051|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
124939185|NCT00822120|449406052|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
124939186|NCT00822120|449406053|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
124939187|NCT00822120|449406048|FG000|PET-directed Therapy|Death|0|||
124939188|NCT00822120|449406049|FG001|PET-directed Therapy|Death|0|||
124939189|NCT00822120|449406050|FG002|PET-directed Therapy|Death|0|||
124939190|NCT00822120|449406051|FG003|PET-directed Therapy|Death|2|||
124939191|NCT00822120|449406052|FG004|PET-directed Therapy|Death|0|||
124939192|NCT00822120|449406053|FG005|PET-directed Therapy|Death|0|||
124939193|NCT00822120|449406048|FG000|PET-directed Therapy|Protocol Violation|0|||
124939194|NCT00822120|449406049|FG001|PET-directed Therapy|Protocol Violation|0|||
124939195|NCT00822120|449406050|FG002|PET-directed Therapy|Protocol Violation|0|||
124546624|NCT01833897|447955960|FG000|Overall Study|Lack of Efficacy|1|||
124546625|NCT00669110|447955961|FG000|Overall Study|Adverse Event|4|||
124546626|NCT00669110|447955962|FG001|Overall Study|Adverse Event|3|||
124546627|NCT00669110|447955961|FG000|Overall Study|Caregiver request|3|||
124546628|NCT00669110|447955962|FG001|Overall Study|Caregiver request|2|||
124546629|NCT00669110|447955961|FG000|Overall Study|Physician Decision|0|||
124546630|NCT00669110|447955962|FG001|Overall Study|Physician Decision|1|||
124546631|NCT00669110|447955961|FG000|Overall Study|Lost to Follow-up|1|||
124546632|NCT00669110|447955962|FG001|Overall Study|Lost to Follow-up|0|||
124546633|NCT00669110|447955961|FG000|Overall Study|Protocol Violation|0|||
124546634|NCT00669110|447955962|FG001|Overall Study|Protocol Violation|5|||
124546635|NCT00669110|447955961|FG000|Overall Study|Withdrawal by Subject|0|||
124546636|NCT00669110|447955962|FG001|Overall Study|Withdrawal by Subject|2|||
124546637|NCT00127192|447955963|FG000|Overall Study|Adverse Event|0|||
124546638|NCT00127192|447955964|FG001|Overall Study|Adverse Event|1|||
124546639|NCT00127192|447955965|FG002|Overall Study|Adverse Event|1|||
124546640|NCT00127192|447955966|FG003|Overall Study|Adverse Event|1|||
124546641|NCT00127192|447955967|FG004|Overall Study|Adverse Event|0|||
124546642|NCT00127192|447955963|FG000|Overall Study|Lack of Efficacy|2|||
124546643|NCT00127192|447955964|FG001|Overall Study|Lack of Efficacy|0|||
124546644|NCT00127192|447955965|FG002|Overall Study|Lack of Efficacy|0|||
124546645|NCT00127192|447955966|FG003|Overall Study|Lack of Efficacy|0|||
124546646|NCT00127192|447955967|FG004|Overall Study|Lack of Efficacy|2|||
124546647|NCT00127192|447955963|FG000|Overall Study|Withdrawal by Subject|0|||
124546648|NCT00127192|447955964|FG001|Overall Study|Withdrawal by Subject|0|||
124546649|NCT00127192|447955965|FG002|Overall Study|Withdrawal by Subject|1|||
124546650|NCT00127192|447955966|FG003|Overall Study|Withdrawal by Subject|0|||
124939196|NCT00822120|449406051|FG003|PET-directed Therapy|Protocol Violation|6|||
124939197|NCT00822120|449406052|FG004|PET-directed Therapy|Protocol Violation|0|||
124939198|NCT00822120|449406053|FG005|PET-directed Therapy|Protocol Violation|0|||
124939199|NCT01324310|449406054|FG000|Overall Study|Adverse Event|1|||
124939200|NCT01324310|449406054|FG000|Overall Study|Disease Progression|1|||
124939201|NCT04060212|449406056|FG000|Overall Study|Withdrawal by Subject|7|||
124939202|NCT02787005|449406077|FG000|Overall Study|Adverse Event|24|||
124939203|NCT02787005|449406078|FG001|Overall Study|Adverse Event|9|||
124939204|NCT02787005|449406079|FG002|Overall Study|Adverse Event|9|||
124939205|NCT02787005|449406080|FG003|Overall Study|Adverse Event|7|||
124939206|NCT02787005|449406081|FG004|Overall Study|Adverse Event|2|||
124939207|NCT02787005|449406077|FG000|Overall Study|Death|100|||
124939208|NCT02787005|449406078|FG001|Overall Study|Death|53|||
124939209|NCT02787005|449406079|FG002|Overall Study|Death|48|||
124939210|NCT02787005|449406080|FG003|Overall Study|Death|69|||
124939211|NCT02787005|449406081|FG004|Overall Study|Death|38|||
124939212|NCT02787005|449406077|FG000|Overall Study|Sponsor Decision|7|||
124939213|NCT02787005|449406078|FG001|Overall Study|Sponsor Decision|4|||
124939214|NCT02787005|449406079|FG002|Overall Study|Sponsor Decision|0|||
124939215|NCT02787005|449406080|FG003|Overall Study|Sponsor Decision|4|||
124939216|NCT02787005|449406081|FG004|Overall Study|Sponsor Decision|5|||
124939217|NCT02787005|449406077|FG000|Overall Study|Withdrawal by Subject|2|||
124939218|NCT02787005|449406078|FG001|Overall Study|Withdrawal by Subject|1|||
124939219|NCT02787005|449406079|FG002|Overall Study|Withdrawal by Subject|1|||
124939220|NCT02787005|449406080|FG003|Overall Study|Withdrawal by Subject|0|||
124939221|NCT02787005|449406081|FG004|Overall Study|Withdrawal by Subject|1|||
124939222|NCT02787005|449406077|FG000|Overall Study|Screen Failure|0|||
124939223|NCT02787005|449406078|FG001|Overall Study|Screen Failure|2|||
124939224|NCT02787005|449406079|FG002|Overall Study|Screen Failure|0|||
124939225|NCT02787005|449406080|FG003|Overall Study|Screen Failure|0|||
124939226|NCT02787005|449406081|FG004|Overall Study|Screen Failure|1|||
124546651|NCT00127192|447955967|FG004|Overall Study|Withdrawal by Subject|3|||
124546652|NCT00127192|447955963|FG000|Overall Study|Adverse event in pre-treatment period|1|||
124546653|NCT00127192|447955964|FG001|Overall Study|Adverse event in pre-treatment period|0|||
124546654|NCT00127192|447955965|FG002|Overall Study|Adverse event in pre-treatment period|0|||
124546655|NCT00127192|447955966|FG003|Overall Study|Adverse event in pre-treatment period|0|||
124546656|NCT00127192|447955967|FG004|Overall Study|Adverse event in pre-treatment period|0|||
124939227|NCT02787005|449406077|FG000|Overall Study|Lost to Follow-up|0|||
124546657|NCT00077766|447955970|FG000|Overall Study|Adverse Event|1|||
124546658|NCT00077766|447955971|FG001|Overall Study|Adverse Event|1|||
124939228|NCT02787005|449406078|FG001|Overall Study|Lost to Follow-up|0|||
124939229|NCT02787005|449406079|FG002|Overall Study|Lost to Follow-up|0|||
124939230|NCT02787005|449406080|FG003|Overall Study|Lost to Follow-up|1|||
124546659|NCT00077766|447955970|FG000|Overall Study|Withdrawal by Subject|4|||
124546660|NCT00077766|447955971|FG001|Overall Study|Withdrawal by Subject|3|||
124546661|NCT00077766|447955970|FG000|Overall Study|Death|12|||
124764999|NCT01009060|448765097|FG001|Overall Study|Physician Decision|1|||
124939231|NCT02787005|449406081|FG004|Overall Study|Lost to Follow-up|0|||
124939232|NCT02016872|449406085|FG000|Overall Study|Withdrawal by Subject|10|||
124546662|NCT00077766|447955971|FG001|Overall Study|Death|10|||
124546663|NCT00077766|447955970|FG000|Overall Study|Lost to Follow-up|2|||
124939233|NCT02016872|449406085|FG000|Overall Study|Death Progression|2|||
124456483|NCT03200366|447631736|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
124456484|NCT03200366|447631737|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
124456485|NCT03200366|447631735|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
124456486|NCT03200366|447631736|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
124456487|NCT03200366|447631737|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
124456488|NCT03200366|447631735|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
124456489|NCT03200366|447631736|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
124456490|NCT03200366|447631737|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
124703212|NCT02471144|448537223|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
124703213|NCT02471144|448537224|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
124703214|NCT02471144|448537214|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
124703215|NCT02471144|448537215|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
124703216|NCT02471144|448537216|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
124703217|NCT02471144|448537217|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
124703218|NCT02471144|448537218|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
124703219|NCT02471144|448537219|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
124703220|NCT02471144|448537220|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
124703221|NCT02471144|448537221|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
124703222|NCT02471144|448537222|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
124703223|NCT02471144|448537223|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
124939234|NCT02016872|449406085|FG000|Overall Study|No FMISO scan|1|||
124939235|NCT02016872|449406085|FG000|Overall Study|Ineligible|2|||
124939236|NCT03477175|449406088|FG000|Overall Study|Unable to travel due to COVID-19|0|||
124939237|NCT03477175|449406089|FG001|Overall Study|Unable to travel due to COVID-19|1|||
124939238|NCT03477175|449406088|FG000|Overall Study|Physician Decision|1|||
124939239|NCT03477175|449406089|FG001|Overall Study|Physician Decision|0|||
124939240|NCT03477175|449406088|FG000|Overall Study|Transitioned to commercial drug|6|||
124939241|NCT03477175|449406089|FG001|Overall Study|Transitioned to commercial drug|6|||
124939242|NCT03477175|449406088|FG000|Overall Study|Lost to Follow-up|1|||
124939243|NCT03477175|449406089|FG001|Overall Study|Lost to Follow-up|1|||
124939244|NCT03477175|449406088|FG000|Overall Study|Withdrawal by Subject|3|||
124939245|NCT03477175|449406089|FG001|Overall Study|Withdrawal by Subject|1|||
124939246|NCT03477175|449406088|FG000|Overall Study|Adverse Event|1|||
124939247|NCT03477175|449406089|FG001|Overall Study|Adverse Event|5|||
124939248|NCT03477175|449406088|FG000|Overall Study|Disease Progression|7|||
124939249|NCT03477175|449406089|FG001|Overall Study|Disease Progression|7|||
124939250|NCT03593226|449406090|FG000|Overall Study|Disease progression|6|||
124939251|NCT03593226|449406091|FG001|Overall Study|Disease progression|13|||
124939252|NCT03593226|449406092|FG002|Overall Study|Disease progression|5|||
124939253|NCT03593226|449406093|FG003|Overall Study|Disease progression|6|||
124939254|NCT03593226|449406090|FG000|Overall Study|Adverse Event|0|||
124939255|NCT03593226|449406091|FG001|Overall Study|Adverse Event|1|||
124939256|NCT03593226|449406092|FG002|Overall Study|Adverse Event|0|||
124939257|NCT03593226|449406093|FG003|Overall Study|Adverse Event|0|||
124939258|NCT03593226|449406090|FG000|Overall Study|Withdrawal by Subject|0|||
124939259|NCT03593226|449406091|FG001|Overall Study|Withdrawal by Subject|4|||
124939260|NCT03593226|449406092|FG002|Overall Study|Withdrawal by Subject|1|||
124939261|NCT03593226|449406093|FG003|Overall Study|Withdrawal by Subject|0|||
124939262|NCT03593226|449406090|FG000|Overall Study|Physician Decision|0|||
124939263|NCT03593226|449406091|FG001|Overall Study|Physician Decision|1|||
124939264|NCT03593226|449406092|FG002|Overall Study|Physician Decision|0|||
124939265|NCT03593226|449406093|FG003|Overall Study|Physician Decision|0|||
124939266|NCT03593226|449406090|FG000|Overall Study|Clinical disease progression|0|||
124939267|NCT03593226|449406091|FG001|Overall Study|Clinical disease progression|0|||
124939268|NCT03593226|449406092|FG002|Overall Study|Clinical disease progression|1|||
124939269|NCT03593226|449406093|FG003|Overall Study|Clinical disease progression|0|||
124939270|NCT00545545|449406094|FG000|Overall Study|Progressive Neoplastic Disease|1|||
124939271|NCT00545545|449406095|FG001|Overall Study|Progressive Neoplastic Disease|5|||
124939272|NCT00545545|449406096|FG002|Overall Study|Progressive Neoplastic Disease|0|||
124939273|NCT00545545|449406097|FG003|Overall Study|Progressive Neoplastic Disease|4|||
124939274|NCT00545545|449406098|FG004|Overall Study|Progressive Neoplastic Disease|8|||
124939275|NCT00545545|449406099|FG005|Overall Study|Progressive Neoplastic Disease|7|||
124939276|NCT00545545|449406094|FG000|Overall Study|Withdrawal by Subject|0|||
124939277|NCT00545545|449406095|FG001|Overall Study|Withdrawal by Subject|1|||
124939278|NCT00545545|449406096|FG002|Overall Study|Withdrawal by Subject|0|||
124456491|NCT03200366|447631735|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
124456492|NCT03200366|447631736|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
124456493|NCT03200366|447631737|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
124939279|NCT00545545|449406097|FG003|Overall Study|Withdrawal by Subject|0|||
124939280|NCT00545545|449406098|FG004|Overall Study|Withdrawal by Subject|0|||
124939281|NCT00545545|449406099|FG005|Overall Study|Withdrawal by Subject|0|||
124939282|NCT00545545|449406094|FG000|Overall Study|Physician Decision|1|||
124939283|NCT00545545|449406095|FG001|Overall Study|Physician Decision|0|||
124939284|NCT00545545|449406096|FG002|Overall Study|Physician Decision|0|||
124939285|NCT00545545|449406097|FG003|Overall Study|Physician Decision|0|||
124939286|NCT00545545|449406098|FG004|Overall Study|Physician Decision|0|||
124939287|NCT00545545|449406099|FG005|Overall Study|Physician Decision|1|||
124939288|NCT00545545|449406094|FG000|Overall Study|Irinotecan intolerance|1|||
124939289|NCT00545545|449406095|FG001|Overall Study|Irinotecan intolerance|1|||
124939290|NCT00545545|449406096|FG002|Overall Study|Irinotecan intolerance|0|||
124939291|NCT00545545|449406097|FG003|Overall Study|Irinotecan intolerance|0|||
124939292|NCT00545545|449406098|FG004|Overall Study|Irinotecan intolerance|0|||
124939293|NCT00545545|449406099|FG005|Overall Study|Irinotecan intolerance|0|||
124939294|NCT00545545|449406094|FG000|Overall Study|No target lesions to track post surgery|0|||
124939295|NCT00545545|449406095|FG001|Overall Study|No target lesions to track post surgery|0|||
124939296|NCT00545545|449406096|FG002|Overall Study|No target lesions to track post surgery|0|||
124939297|NCT00545545|449406097|FG003|Overall Study|No target lesions to track post surgery|0|||
124939298|NCT00545545|449406098|FG004|Overall Study|No target lesions to track post surgery|1|||
124939299|NCT00545545|449406099|FG005|Overall Study|No target lesions to track post surgery|1|||
124939300|NCT03978637|449406112|FG000|Overall Study|Death|0|||
124939301|NCT03978637|449406113|FG001|Overall Study|Death|2|||
124939302|NCT03978637|449406114|FG002|Overall Study|Death|2|||
124939303|NCT03978637|449406115|FG003|Overall Study|Death|0|||
124939304|NCT03978637|449406112|FG000|Overall Study|Withdrawal by Subject|0|||
124939305|NCT03978637|449406113|FG001|Overall Study|Withdrawal by Subject|0|||
124939306|NCT03978637|449406114|FG002|Overall Study|Withdrawal by Subject|1|||
124939307|NCT03978637|449406115|FG003|Overall Study|Withdrawal by Subject|0|||
124939308|NCT03978637|449406112|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
124939309|NCT03978637|449406113|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
124939310|NCT03978637|449406114|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
124939311|NCT03978637|449406115|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
124939312|NCT03959423|449406116|FG000|Overall Study|Withdrawal by Subject|2|||
124456494|NCT03200366|447631735|FG000|9 Month Post-Baseline Interview|Death|1|||
124456495|NCT03200366|447631736|FG001|9 Month Post-Baseline Interview|Death|1|||
124456496|NCT03200366|447631737|FG002|9 Month Post-Baseline Interview|Death|1|||
124456497|NCT03200366|447631735|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
124456498|NCT03200366|447631736|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
124456499|NCT03200366|447631737|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
124456500|NCT03200366|447631735|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
124456501|NCT03200366|447631736|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
124456502|NCT03200366|447631737|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
124456503|NCT03200366|447631735|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
124456504|NCT03200366|447631736|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
124456505|NCT03200366|447631737|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
124456506|NCT03201458|447631738|FG000|Overall Study|No longer eligible|2|||
124456507|NCT03201458|447631739|FG001|Overall Study|No longer eligible|5|||
124456508|NCT03201458|447631738|FG000|Overall Study|Health event before starting|1|||
124456509|NCT03201458|447631739|FG001|Overall Study|Health event before starting|0|||
124456510|NCT03201458|447631738|FG000|Overall Study|Physician Decision|1|||
124456511|NCT03201458|447631739|FG001|Overall Study|Physician Decision|0|||
124456512|NCT00750737|447631742|FG000|Overall Study|Withdrawal by Subject|3|||
124456513|NCT00750737|447631743|FG001|Overall Study|Withdrawal by Subject|3|||
124456514|NCT04707157|447631745|FG000|Overall Study|Adverse Event|12|||
124456515|NCT04707157|447631746|FG001|Overall Study|Adverse Event|3|||
124456516|NCT04707157|447631745|FG000|Overall Study|Lost to Follow-up|2|||
124456517|NCT04707157|447631746|FG001|Overall Study|Lost to Follow-up|0|||
124456518|NCT04707157|447631745|FG000|Overall Study|Sponsor's decision|1|||
124456519|NCT04707157|447631746|FG001|Overall Study|Sponsor's decision|0|||
124456520|NCT04707157|447631745|FG000|Overall Study|Physician Decision|8|||
124456521|NCT04707157|447631746|FG001|Overall Study|Physician Decision|5|||
124456522|NCT04707157|447631745|FG000|Overall Study|Protocol Deviation|1|||
124456523|NCT04707157|447631746|FG001|Overall Study|Protocol Deviation|0|||
124456524|NCT04707157|447631745|FG000|Overall Study|Withdrawal by Subject|1|||
124456525|NCT04707157|447631746|FG001|Overall Study|Withdrawal by Subject|1|||
124456526|NCT01543828|447631747|FG000|Treatment 2|Lost to Follow-up|1|||
124939313|NCT03959423|449406117|FG001|Overall Study|Withdrawal by Subject|3|||
124939314|NCT03959423|449406116|FG000|Overall Study|Physician Decision|0|||
124939315|NCT03959423|449406117|FG001|Overall Study|Physician Decision|1|||
124939316|NCT03959423|449406116|FG000|Overall Study|Lost to Follow-up|1|||
124939317|NCT03959423|449406117|FG001|Overall Study|Lost to Follow-up|0|||
124456527|NCT01543828|447631748|FG001|Treatment 2|Lost to Follow-up|0|||
124939318|NCT03959423|449406116|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
124456528|NCT03975920|447631749|FG000|Overall Study|Lost to Follow-up|1|||
124456529|NCT03975920|447631750|FG001|Overall Study|Lost to Follow-up|2|||
124456530|NCT03975920|447631749|FG000|Overall Study|Protocol Violation|1|||
124456531|NCT03975920|447631750|FG001|Overall Study|Protocol Violation|1|||
124939319|NCT03959423|449406117|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124546664|NCT00077766|447955971|FG001|Overall Study|Lost to Follow-up|0|||
124546665|NCT00077766|447955970|FG000|Overall Study|Protocol Violation|1|||
124546666|NCT00077766|447955971|FG001|Overall Study|Protocol Violation|0|||
124546667|NCT00077766|447955970|FG000|Overall Study|Kidney Transplantation|9|||
124546668|NCT00077766|447955971|FG001|Overall Study|Kidney Transplantation|5|||
124546669|NCT00077766|447955970|FG000|Overall Study|Transplantation|5|||
124546670|NCT00077766|447955971|FG001|Overall Study|Transplantation|1|||
124546671|NCT00077766|447955970|FG000|Overall Study|Investigators Discretion|1|||
124546672|NCT00077766|447955971|FG001|Overall Study|Investigators Discretion|0|||
124546673|NCT00077766|447955970|FG000|Overall Study|Participant's decision|1|||
124546674|NCT00077766|447955971|FG001|Overall Study|Participant's decision|0|||
124546675|NCT00077766|447955970|FG000|Overall Study|Dialysis Discontinued|1|||
124546676|NCT00077766|447955971|FG001|Overall Study|Dialysis Discontinued|0|||
124546677|NCT00077766|447955970|FG000|Overall Study|Dialysis|0|||
124546678|NCT00077766|447955971|FG001|Overall Study|Dialysis|1|||
124546679|NCT00077766|447955970|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
124546680|NCT00077766|447955971|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
124546681|NCT00077766|447955970|FG000|Overall Study|Started Nocturnal Dialysis|0|||
124546682|NCT00077766|447955971|FG001|Overall Study|Started Nocturnal Dialysis|1|||
124546683|NCT00077766|447955970|FG000|Overall Study|Stop Dialysis|0|||
124546684|NCT00077766|447955971|FG001|Overall Study|Stop Dialysis|1|||
124546685|NCT00077766|447955970|FG000|Overall Study|Participants Vacation|2|||
124546686|NCT00077766|447955971|FG001|Overall Study|Participants Vacation|1|||
124546687|NCT01886105|447955972|FG000|Overall Study|Lack of Efficacy|3|||
124546688|NCT03843775|447955973|FG000|Overall Study|Adverse Event|1|||
124546689|NCT03843775|447955974|FG001|Overall Study|Adverse Event|1|||
124546690|NCT03843775|447955973|FG000|Overall Study|Lack of Efficacy|2|||
124546691|NCT03843775|447955974|FG001|Overall Study|Lack of Efficacy|6|||
124546692|NCT03843775|447955973|FG000|Overall Study|Withdrawal by Subject|0|||
124546693|NCT03843775|447955974|FG001|Overall Study|Withdrawal by Subject|1|||
124546694|NCT04455620|447955975|FG000|Overall Study|Withdrawal by Subject|0|||
124546695|NCT04455620|447955976|FG001|Overall Study|Withdrawal by Subject|0|||
124546696|NCT04455620|447955977|FG002|Overall Study|Withdrawal by Subject|2|||
124939320|NCT02549352|449406118|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
124939321|NCT02549352|449406119|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
124939322|NCT02549352|449406118|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
124939323|NCT02549352|449406119|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
124939324|NCT02549352|449406118|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
124939325|NCT02549352|449406119|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
124939326|NCT02549352|449406118|FG000|12-month Follow-up|Withdrawal by Subject|4|||
124939327|NCT02549352|449406119|FG001|12-month Follow-up|Withdrawal by Subject|5|||
124939328|NCT02549352|449406118|FG000|12-month Follow-up|Lost to Follow-up|3|||
124939329|NCT02549352|449406119|FG001|12-month Follow-up|Lost to Follow-up|2|||
124939330|NCT02549352|449406118|FG000|12-month Follow-up|Death|0|||
124939331|NCT02549352|449406119|FG001|12-month Follow-up|Death|1|||
124939332|NCT02549352|449406118|FG000|12-month Follow-up|Protocol Violation|0|||
124939333|NCT02549352|449406119|FG001|12-month Follow-up|Protocol Violation|1|||
124939334|NCT02549352|449406118|FG000|12-month Follow-up|Other|1|||
124546697|NCT04455620|447955978|FG003|Overall Study|Withdrawal by Subject|0|||
124546698|NCT04455620|447955979|FG004|Overall Study|Withdrawal by Subject|1|||
124546699|NCT04455620|447955975|FG000|Overall Study|Lost to Follow-up|0|||
124546700|NCT04455620|447955976|FG001|Overall Study|Lost to Follow-up|0|||
124703224|NCT02471144|448537224|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
124939335|NCT02549352|449406119|FG001|12-month Follow-up|Other|3|||
124939336|NCT04530487|449407435|FG000|Overall Study|Death|1|||
124546701|NCT04455620|447955977|FG002|Overall Study|Lost to Follow-up|1|||
124546702|NCT04455620|447955978|FG003|Overall Study|Lost to Follow-up|1|||
124546703|NCT04455620|447955979|FG004|Overall Study|Lost to Follow-up|0|||
124939337|NCT03876457|449407436|FG000|Overall Study|Lost to Follow-up|1|||
124939338|NCT03876457|449407437|FG001|Overall Study|Lost to Follow-up|3|||
124939339|NCT01184326|449407438|FG000|Overall Study|Adverse Event|1|||
124939340|NCT01184326|449407439|FG001|Overall Study|Adverse Event|2|||
124939341|NCT01184326|449407440|FG002|Overall Study|Adverse Event|0|||
124939342|NCT01184326|449407438|FG000|Overall Study|Death|0|||
124939343|NCT01184326|449407439|FG001|Overall Study|Death|0|||
124939344|NCT01184326|449407440|FG002|Overall Study|Death|1|||
124939345|NCT01184326|449407438|FG000|Overall Study|Withdrawal by Subject|0|||
124939346|NCT01184326|449407439|FG001|Overall Study|Withdrawal by Subject|0|||
124939347|NCT01184326|449407440|FG002|Overall Study|Withdrawal by Subject|1|||
124939348|NCT01184326|449407438|FG000|Overall Study|Physician Decision|1|||
124939349|NCT01184326|449407439|FG001|Overall Study|Physician Decision|1|||
124939350|NCT01184326|449407440|FG002|Overall Study|Physician Decision|0|||
124939351|NCT01184326|449407438|FG000|Overall Study|Disease Progression|1|||
124939352|NCT01184326|449407439|FG001|Overall Study|Disease Progression|3|||
124939353|NCT01184326|449407440|FG002|Overall Study|Disease Progression|12|||
124939354|NCT01036724|449407441|FG000|Overall Study|Adverse Event|1|||
124939355|NCT01036724|449407442|FG001|Overall Study|Adverse Event|2|||
124546704|NCT04455620|447955975|FG000|Overall Study|Death|1|||
124546705|NCT04455620|447955976|FG001|Overall Study|Death|6|||
124546706|NCT04455620|447955977|FG002|Overall Study|Death|20|||
124546707|NCT04455620|447955978|FG003|Overall Study|Death|1|||
124546708|NCT04455620|447955979|FG004|Overall Study|Death|7|||
124546709|NCT04455620|447955975|FG000|Overall Study|Study Termination|0|||
124546710|NCT04455620|447955976|FG001|Overall Study|Study Termination|2|||
124546711|NCT04455620|447955977|FG002|Overall Study|Study Termination|1|||
124546712|NCT04455620|447955978|FG003|Overall Study|Study Termination|0|||
124546713|NCT04455620|447955979|FG004|Overall Study|Study Termination|6|||
124703225|NCT00003645|448537225|FG000|Overall Study|Death|4|||
124703226|NCT00003645|448537226|FG001|Overall Study|Death|1|||
124703227|NCT00003645|448537225|FG000|Overall Study|Lost to Follow-up|7|||
124703228|NCT00003645|448537226|FG001|Overall Study|Lost to Follow-up|8|||
124939356|NCT01036724|449407441|FG000|Overall Study|Lack of Efficacy|1|||
124939357|NCT01036724|449407442|FG001|Overall Study|Lack of Efficacy|1|||
124939358|NCT01036724|449407441|FG000|Overall Study|Protocol Violation|4|||
124939359|NCT01036724|449407442|FG001|Overall Study|Protocol Violation|5|||
124939360|NCT04213807|449407449|FG000|Overall Study|Physician Decision|0|||
124939361|NCT04213807|449407450|FG001|Overall Study|Physician Decision|0|||
124939362|NCT04213807|449407451|FG002|Overall Study|Physician Decision|1|||
124939363|NCT01574716|449407452|FG000|Part 1|Death|3|||
124939364|NCT01574716|449407453|FG001|Part 1|Death|1|||
124939365|NCT01574716|449407454|FG002|Part 1|Death|8|||
124939366|NCT01574716|449407455|FG003|Part 1|Death|0|||
124939367|NCT01574716|449407456|FG004|Part 1|Death|0|||
124939368|NCT01574716|449407452|FG000|Part 1|Discontinuation of study by sponsor|0|||
124939369|NCT01574716|449407453|FG001|Part 1|Discontinuation of study by sponsor|0|||
124939370|NCT01574716|449407454|FG002|Part 1|Discontinuation of study by sponsor|1|||
124939371|NCT01574716|449407455|FG003|Part 1|Discontinuation of study by sponsor|0|||
124939372|NCT01574716|449407456|FG004|Part 1|Discontinuation of study by sponsor|0|||
124939373|NCT01574716|449407452|FG000|Part 1|Withdrawal by Subject|0|||
124939374|NCT01574716|449407453|FG001|Part 1|Withdrawal by Subject|2|||
124939375|NCT01574716|449407454|FG002|Part 1|Withdrawal by Subject|0|||
124939376|NCT01574716|449407455|FG003|Part 1|Withdrawal by Subject|0|||
124939377|NCT01574716|449407456|FG004|Part 1|Withdrawal by Subject|0|||
124939378|NCT01574716|449407452|FG000|Part 1|Lost to Follow-up|0|||
124939379|NCT01574716|449407453|FG001|Part 1|Lost to Follow-up|1|||
124939380|NCT01574716|449407454|FG002|Part 1|Lost to Follow-up|0|||
124939381|NCT01574716|449407455|FG003|Part 1|Lost to Follow-up|0|||
124939382|NCT01574716|449407456|FG004|Part 1|Lost to Follow-up|0|||
124939383|NCT01574716|449407452|FG000|Part 2|Progressive disease|0|||
124939384|NCT01574716|449407453|FG001|Part 2|Progressive disease|0|||
124939385|NCT01574716|449407454|FG002|Part 2|Progressive disease|0|||
124939386|NCT01574716|449407455|FG003|Part 2|Progressive disease|1|||
124939387|NCT01574716|449407456|FG004|Part 2|Progressive disease|0|||
124939388|NCT01574716|449407452|FG000|Part 2|Death|0|||
124939389|NCT01574716|449407453|FG001|Part 2|Death|0|||
124939390|NCT01574716|449407454|FG002|Part 2|Death|0|||
124939391|NCT01574716|449407455|FG003|Part 2|Death|76|||
124939392|NCT01574716|449407456|FG004|Part 2|Death|35|||
124939393|NCT01574716|449407452|FG000|Part 2|Discontinuation of study by sponsor|0|||
124939394|NCT01574716|449407453|FG001|Part 2|Discontinuation of study by sponsor|0|||
124939395|NCT01574716|449407454|FG002|Part 2|Discontinuation of study by sponsor|0|||
124939396|NCT01574716|449407455|FG003|Part 2|Discontinuation of study by sponsor|51|||
124939397|NCT01574716|449407456|FG004|Part 2|Discontinuation of study by sponsor|31|||
124939398|NCT01574716|449407452|FG000|Part 2|Withdrawal by Subject|0|||
124939399|NCT01574716|449407453|FG001|Part 2|Withdrawal by Subject|0|||
124939400|NCT01574716|449407454|FG002|Part 2|Withdrawal by Subject|0|||
124939401|NCT01574716|449407455|FG003|Part 2|Withdrawal by Subject|5|||
124939402|NCT01574716|449407456|FG004|Part 2|Withdrawal by Subject|4|||
124939403|NCT01574716|449407452|FG000|Part 2|Brain metastases|0|||
124939404|NCT01574716|449407453|FG001|Part 2|Brain metastases|0|||
124939405|NCT01574716|449407454|FG002|Part 2|Brain metastases|0|||
124939406|NCT01574716|449407455|FG003|Part 2|Brain metastases|1|||
124939407|NCT01574716|449407456|FG004|Part 2|Brain metastases|0|||
124939408|NCT01574716|449407452|FG000|Part 2|Lost to Follow-up|0|||
124939409|NCT01574716|449407453|FG001|Part 2|Lost to Follow-up|0|||
124546714|NCT03539952|447955982|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
124546715|NCT03539952|447955983|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
124939410|NCT01574716|449407454|FG002|Part 2|Lost to Follow-up|0|||
124703229|NCT00003645|448537225|FG000|Overall Study|Withdrawal by Subject|1|||
124703230|NCT00003645|448537226|FG001|Overall Study|Withdrawal by Subject|3|||
124703231|NCT03768336|448537229|FG000|Overall Study|Lost to Follow-up|3|||
124939411|NCT01574716|449407455|FG003|Part 2|Lost to Follow-up|3|||
124939412|NCT01574716|449407456|FG004|Part 2|Lost to Follow-up|0|||
124939413|NCT00692913|449407458|FG000|Overall Study|Adverse Event|8|||
124939414|NCT00692913|449407459|FG001|Overall Study|Adverse Event|4|||
124939415|NCT00692913|449407458|FG000|Overall Study|Lost to Follow-up|3|||
124939416|NCT00692913|449407459|FG001|Overall Study|Lost to Follow-up|5|||
124939417|NCT00692913|449407458|FG000|Overall Study|Physician Decision|2|||
124939418|NCT00692913|449407459|FG001|Overall Study|Physician Decision|0|||
124546716|NCT03539952|447955982|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
124765000|NCT01009060|448765096|FG000|Overall Study|Withdrawal by Subject|1|||
124765001|NCT01009060|448765097|FG001|Overall Study|Withdrawal by Subject|1|||
124765002|NCT00005906|448765098|FG000|Overall Study|Lack of Efficacy|3|||
124765003|NCT02542865|448765105|FG000|Overall Study|Identified as screen failure|1|||
124765004|NCT02542865|448765106|FG001|Overall Study|Identified as screen failure|0|||
124765005|NCT02542865|448765105|FG000|Overall Study|Withdrawal by Subject|16|||
124765006|NCT02542865|448765106|FG001|Overall Study|Withdrawal by Subject|0|||
124765007|NCT04913610|448765109|FG000|Randomized Participants|Did Not Receive Treatment|0|||
124765008|NCT04913610|448765110|FG001|Randomized Participants|Did Not Receive Treatment|0|||
124546717|NCT03539952|447955983|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
124546718|NCT03539952|447955982|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
124546719|NCT03539952|447955983|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
124546720|NCT03539952|447955982|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
124546721|NCT03539952|447955983|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
124546722|NCT03539952|447955982|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
124546723|NCT03539952|447955983|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
124546724|NCT03539952|447955982|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
124546725|NCT03539952|447955983|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
124546726|NCT03539952|447955982|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
124546727|NCT03539952|447955983|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
124546728|NCT02087865|447957365|FG000|Overall Study|Withdrawal by Subject|6|||
124546729|NCT02087865|447957366|FG001|Overall Study|Withdrawal by Subject|0|||
124546730|NCT02087865|447957367|FG002|Overall Study|Withdrawal by Subject|1|||
124546731|NCT02087865|447957365|FG000|Overall Study|Lost to Follow-up|0|||
124546732|NCT02087865|447957366|FG001|Overall Study|Lost to Follow-up|0|||
124546733|NCT02087865|447957367|FG002|Overall Study|Lost to Follow-up|1|||
124546734|NCT02087865|447957365|FG000|Overall Study|Drug Non-compliance|0|||
124546735|NCT02087865|447957366|FG001|Overall Study|Drug Non-compliance|2|||
124546736|NCT02087865|447957367|FG002|Overall Study|Drug Non-compliance|0|||
124546737|NCT02087865|447957365|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
124546738|NCT02087865|447957366|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
124546739|NCT02087865|447957367|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
124765009|NCT04913610|448765111|FG002|Randomized Participants|Did Not Receive Treatment|1|||
124939419|NCT00692913|449407458|FG000|Overall Study|Protocol Violation|1|||
124939420|NCT00692913|449407459|FG001|Overall Study|Protocol Violation|1|||
124939421|NCT00692913|449407458|FG000|Overall Study|Withdrawal by Subject|15|||
124939422|NCT00692913|449407459|FG001|Overall Study|Withdrawal by Subject|20|||
124939423|NCT03801148|449407460|FG000|Period 1 (2 Days)|Adverse Event|1|||
124939424|NCT03801148|449407461|FG001|Period 1 (2 Days)|Adverse Event|1|||
124939425|NCT03801148|449407462|FG002|Period 1 (2 Days)|Adverse Event|0|||
124939426|NCT03801148|449407463|FG003|Period 1 (2 Days)|Adverse Event|0|||
124939427|NCT03801148|449407460|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
124939428|NCT03801148|449407461|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
124939429|NCT03801148|449407462|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
124939430|NCT03801148|449407463|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
124939431|NCT03801148|449407460|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
124939432|NCT03801148|449407461|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
124939433|NCT03801148|449407462|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
124939434|NCT03801148|449407463|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
124939435|NCT03801148|449407460|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
124939436|NCT03801148|449407461|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
124939437|NCT03801148|449407462|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
124939438|NCT03801148|449407463|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
124939439|NCT04334317|449407464|FG000|Overall Study|Adverse Event|1|||
124939440|NCT04334317|449407465|FG001|Overall Study|Adverse Event|2|||
124939441|NCT04334317|449407466|FG002|Overall Study|Adverse Event|0|||
124939442|NCT04334317|449407467|FG003|Overall Study|Adverse Event|0|||
124939443|NCT04334317|449407464|FG000|Overall Study|Protocol Deviation|0|||
124939444|NCT04334317|449407465|FG001|Overall Study|Protocol Deviation|1|||
124939445|NCT04334317|449407466|FG002|Overall Study|Protocol Deviation|0|||
124939446|NCT04334317|449407467|FG003|Overall Study|Protocol Deviation|0|||
124939447|NCT04334317|449407464|FG000|Overall Study|Withdrawal by Subject|2|||
124939448|NCT04334317|449407465|FG001|Overall Study|Withdrawal by Subject|2|||
124939449|NCT04334317|449407466|FG002|Overall Study|Withdrawal by Subject|0|||
124939450|NCT04334317|449407467|FG003|Overall Study|Withdrawal by Subject|0|||
124939451|NCT03621735|449407468|FG000|Overall Study|Withdrawal by Subject|13|||
124939452|NCT03621735|449407469|FG001|Overall Study|Withdrawal by Subject|13|||
124939453|NCT01128595|449407472|FG000|Treatment Period 3|Withdrawal by Subject|0|||
124939454|NCT01128595|449407473|FG001|Treatment Period 3|Withdrawal by Subject|1|||
124939455|NCT01128595|449407474|FG002|Treatment Period 3|Withdrawal by Subject|0|||
124939456|NCT01128595|449407475|FG003|Treatment Period 3|Withdrawal by Subject|0|||
124939457|NCT00605306|449407476|FG000|Overall Study|Adverse Event|0|||
124939458|NCT00605306|449407477|FG001|Overall Study|Adverse Event|1|||
124939459|NCT00372775|449407478|FG000|Overall Study|Adverse Event|8|||
124939460|NCT00372775|449407478|FG000|Overall Study|Death|15|||
124939461|NCT00372775|449407478|FG000|Overall Study|Objective progression or relapse|30|||
124939462|NCT00372775|449407478|FG000|Overall Study|Global deterioration of health status|6|||
124939463|NCT00372775|449407478|FG000|Overall Study|Withdrawal by Subject|1|||
124939464|NCT00372775|449407478|FG000|Overall Study|Other|1|||
124939465|NCT00372775|449407478|FG000|Overall Study|Not Treated|2|||
124939466|NCT00336505|449407484|FG000|Overall Study|Adverse Event|10|||
124939467|NCT00336505|449407485|FG001|Overall Study|Adverse Event|9|||
124939468|NCT00336505|449407484|FG000|Overall Study|Lack of Efficacy|8|||
124939469|NCT00336505|449407485|FG001|Overall Study|Lack of Efficacy|4|||
124939470|NCT00336505|449407484|FG000|Overall Study|Lost to Follow-up|7|||
124939471|NCT00336505|449407485|FG001|Overall Study|Lost to Follow-up|4|||
124939472|NCT00336505|449407484|FG000|Overall Study|Withdrawal by Subject|5|||
124939473|NCT00336505|449407485|FG001|Overall Study|Withdrawal by Subject|3|||
124939474|NCT00336505|449407484|FG000|Overall Study|Other|7|||
124939475|NCT00336505|449407485|FG001|Overall Study|Other|7|||
124939476|NCT01561300|449407486|FG000|Run in on Placebo|Adverse Event|1|||
124939477|NCT01561300|449407487|FG001|Run in on Placebo|Adverse Event|0|||
124939478|NCT00724126|449407490|FG000|Overall Study|Adverse Event|2|||
124939479|NCT00724126|449407491|FG001|Overall Study|Adverse Event|0|||
124939480|NCT00724126|449407490|FG000|Overall Study|Withdrawal by Subject|8|||
124939481|NCT00724126|449407491|FG001|Overall Study|Withdrawal by Subject|6|||
124939482|NCT00724126|449407490|FG000|Overall Study|Lost to Follow-up|6|||
124939483|NCT00724126|449407491|FG001|Overall Study|Lost to Follow-up|6|||
124939484|NCT00724126|449407490|FG000|Overall Study|Noncompliance|2|||
124939485|NCT00724126|449407491|FG001|Overall Study|Noncompliance|1|||
124456532|NCT03975920|447631749|FG000|Overall Study|Did not complete survey|2|||
124456533|NCT03975920|447631750|FG001|Overall Study|Did not complete survey|1|||
124456534|NCT01279850|447631754|FG000|Overall Study|Protocol Violation|50|||
124456535|NCT01279850|447631754|FG000|Overall Study|No Drug Administration Information|7|||
124456536|NCT01279850|447631754|FG000|Overall Study|No Visit After Treatment|34|||
124456537|NCT01131520|447631755|FG000|Overall Study|Computer problem|1|||
124456538|NCT01131520|447631756|FG001|Overall Study|Computer problem|0|||
124456539|NCT01131520|447631755|FG000|Overall Study|Counselor not available|0|||
124456540|NCT01131520|447631756|FG001|Overall Study|Counselor not available|3|||
124456541|NCT01131520|447631755|FG000|Overall Study|Subject changed history after enrollment|0|||
124456542|NCT01131520|447631756|FG001|Overall Study|Subject changed history after enrollment|1|||
124456543|NCT01147744|447631757|FG000|Overall Study|Protocol Violation|1|||
124456544|NCT01147744|447631758|FG001|Overall Study|Protocol Violation|0|||
124456545|NCT01147744|447631759|FG002|Overall Study|Protocol Violation|1|||
124456546|NCT01147744|447631760|FG003|Overall Study|Protocol Violation|0|||
124456547|NCT01147744|447631761|FG004|Overall Study|Protocol Violation|1|||
124456548|NCT01147744|447631762|FG005|Overall Study|Protocol Violation|3|||
124546740|NCT01392469|447957368|FG000|Overall Study|Adverse Event|2|||
124546741|NCT01392469|447957368|FG000|Overall Study|Withdrawal by Subject|1|||
124703232|NCT03768336|448537230|FG001|Overall Study|Lost to Follow-up|2|||
124939486|NCT00724126|449407490|FG000|Overall Study|Subject randomized although ineligible|1|||
124939487|NCT00724126|449407491|FG001|Overall Study|Subject randomized although ineligible|1|||
124939488|NCT00724126|449407490|FG000|Overall Study|Subject had to leave vicinity of site|0|||
124939489|NCT00724126|449407491|FG001|Overall Study|Subject had to leave vicinity of site|1|||
124456549|NCT01147744|447631763|FG006|Overall Study|Protocol Violation|1|||
124456550|NCT01147744|447631757|FG000|Overall Study|Physician Decision|0|||
124703233|NCT03768336|448537229|FG000|Overall Study|Became Ineligible|2|||
124939490|NCT02502526|449407493|FG000|Overall Study|Lost to Follow-up|2|||
124939491|NCT02502526|449407494|FG001|Overall Study|Lost to Follow-up|2|||
124939492|NCT02502526|449407495|FG002|Overall Study|Lost to Follow-up|3|||
124939493|NCT02502526|449407493|FG000|Overall Study|Withdrawal by Subject|0|||
124939494|NCT02502526|449407494|FG001|Overall Study|Withdrawal by Subject|1|||
124939495|NCT02502526|449407495|FG002|Overall Study|Withdrawal by Subject|1|||
124703234|NCT03768336|448537230|FG001|Overall Study|Became Ineligible|0|||
124703235|NCT03768336|448537229|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
124703236|NCT03768336|448537230|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
124703237|NCT03768336|448537229|FG000|Overall Study|Missed final survey (post-treatment|0|||
124703238|NCT03768336|448537230|FG001|Overall Study|Missed final survey (post-treatment|1|||
124703239|NCT03977155|448537231|FG000|Overall Study|Adverse Event|3|||
124703240|NCT03977155|448537232|FG001|Overall Study|Adverse Event|0|||
124703241|NCT03977155|448537233|FG002|Overall Study|Adverse Event|0|||
124703242|NCT03977155|448537231|FG000|Overall Study|Lost to Follow-up|0|||
124703243|NCT03977155|448537232|FG001|Overall Study|Lost to Follow-up|1|||
124703244|NCT03977155|448537233|FG002|Overall Study|Lost to Follow-up|0|||
124703245|NCT03977155|448537231|FG000|Overall Study|Withdrawal by Subject|1|||
124703246|NCT03977155|448537232|FG001|Overall Study|Withdrawal by Subject|1|||
124703247|NCT03977155|448537233|FG002|Overall Study|Withdrawal by Subject|2|||
124456551|NCT01147744|447631758|FG001|Overall Study|Physician Decision|1|||
124456552|NCT01147744|447631759|FG002|Overall Study|Physician Decision|1|||
124456553|NCT01147744|447631760|FG003|Overall Study|Physician Decision|0|||
124456554|NCT01147744|447631761|FG004|Overall Study|Physician Decision|0|||
124456555|NCT01147744|447631762|FG005|Overall Study|Physician Decision|0|||
124456556|NCT01147744|447631763|FG006|Overall Study|Physician Decision|1|||
124456557|NCT01147744|447631757|FG000|Overall Study|Lack of Efficacy|11|||
124456558|NCT01147744|447631758|FG001|Overall Study|Lack of Efficacy|11|||
124456559|NCT01147744|447631759|FG002|Overall Study|Lack of Efficacy|9|||
124456560|NCT01147744|447631760|FG003|Overall Study|Lack of Efficacy|11|||
124456561|NCT01147744|447631761|FG004|Overall Study|Lack of Efficacy|13|||
124456562|NCT01147744|447631762|FG005|Overall Study|Lack of Efficacy|8|||
124546742|NCT01392469|447957368|FG000|Overall Study|Protocol Violation|1|||
124546743|NCT03255226|447957371|FG000|Overall Study|Adverse Event|2|||
124546744|NCT03255226|447957371|FG000|Overall Study|Physician Decision|3|||
124546745|NCT03255226|447957371|FG000|Overall Study|Withdrawal by Subject|1|||
124703248|NCT03977155|448537231|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
124456563|NCT01147744|447631763|FG006|Overall Study|Lack of Efficacy|7|||
124456564|NCT01147744|447631757|FG000|Overall Study|Adverse Event|1|||
124703249|NCT03977155|448537232|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
124703250|NCT03977155|448537233|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
124703251|NCT00936936|448537234|FG000|Overall Study|Adverse Event|7|||
124703252|NCT00936936|448537235|FG001|Overall Study|Adverse Event|1|||
124703253|NCT00936936|448537234|FG000|Overall Study|Disease Progression|2|||
124703254|NCT00936936|448537235|FG001|Overall Study|Disease Progression|2|||
124703255|NCT00936936|448537234|FG000|Overall Study|Unrelated|3|||
124703256|NCT00936936|448537235|FG001|Overall Study|Unrelated|1|||
124703257|NCT01373281|448537236|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
124703258|NCT01373281|448537237|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
124703259|NCT01373281|448537236|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
124703260|NCT01373281|448537237|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
124703261|NCT01373281|448537236|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
124703262|NCT01373281|448537237|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
124703263|NCT01373281|448537236|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
124703264|NCT01373281|448537237|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
124703265|NCT01373281|448537236|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
124703266|NCT01373281|448537237|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
124703267|NCT01373281|448537236|FG000|Surveillance Expansion Period|Protocol Violation|9|||
124703268|NCT01373281|448537237|FG001|Surveillance Expansion Period|Protocol Violation|1|||
124703269|NCT01373281|448537236|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
124939496|NCT02502526|449407493|FG000|Overall Study|Disqualified due to cataract grading|0|||
124939497|NCT02502526|449407494|FG001|Overall Study|Disqualified due to cataract grading|0|||
124939498|NCT02502526|449407495|FG002|Overall Study|Disqualified due to cataract grading|1|||
124939499|NCT02502526|449407493|FG000|Overall Study|Enrollment suspension|4|||
124939500|NCT02502526|449407494|FG001|Overall Study|Enrollment suspension|1|||
124939501|NCT02502526|449407495|FG002|Overall Study|Enrollment suspension|1|||
124939502|NCT01952366|449407496|FG000|Overall Study|Death|22|||
124939503|NCT01952366|449407496|FG000|Overall Study|Withdrawal by Subject|9|||
124939504|NCT00571649|449407497|FG000|Treatment Period|Adverse Event|438|||
124939505|NCT00571649|449407498|FG001|Treatment Period|Adverse Event|385|||
124939506|NCT00571649|449407497|FG000|Treatment Period|Clinical endpoint reached|50|||
124939507|NCT00571649|449407498|FG001|Treatment Period|Clinical endpoint reached|56|||
124939508|NCT00571649|449407497|FG000|Treatment Period|Withdrawal by Subject|285|||
124939509|NCT00571649|449407498|FG001|Treatment Period|Withdrawal by Subject|255|||
124939510|NCT00571649|449407497|FG000|Treatment Period|Death|76|||
124939511|NCT00571649|449407498|FG001|Treatment Period|Death|59|||
124939512|NCT00571649|449407497|FG000|Treatment Period|Physician Decision|8|||
124939513|NCT00571649|449407498|FG001|Treatment Period|Physician Decision|9|||
124939514|NCT00571649|449407497|FG000|Treatment Period|Lost to Follow-up|43|||
124939515|NCT00571649|449407498|FG001|Treatment Period|Lost to Follow-up|41|||
124939516|NCT00571649|449407497|FG000|Treatment Period|Non-compliant with study medication|88|||
124939517|NCT00571649|449407498|FG001|Treatment Period|Non-compliant with study medication|89|||
124939518|NCT00571649|449407497|FG000|Treatment Period|Patient convenience|11|||
124939519|NCT00571649|449407498|FG001|Treatment Period|Patient convenience|13|||
124939520|NCT00571649|449407497|FG000|Treatment Period|Protocol Violation|90|||
124939521|NCT00571649|449407498|FG001|Treatment Period|Protocol Violation|92|||
124939522|NCT00571649|449407497|FG000|Treatment Period|Technical problems|3|||
124939523|NCT00571649|449407498|FG001|Treatment Period|Technical problems|5|||
124939524|NCT00571649|449407497|FG000|Follow-up Period|Adverse Event|46|||
124939525|NCT00571649|449407498|FG001|Follow-up Period|Adverse Event|40|||
124939526|NCT00571649|449407497|FG000|Follow-up Period|Clinical endpoint reached|5|||
124939527|NCT00571649|449407498|FG001|Follow-up Period|Clinical endpoint reached|2|||
124939528|NCT00571649|449407497|FG000|Follow-up Period|Withdrawal by Subject|119|||
124939529|NCT00571649|449407498|FG001|Follow-up Period|Withdrawal by Subject|115|||
124939530|NCT00571649|449407497|FG000|Follow-up Period|Death|132|||
124939531|NCT00571649|449407498|FG001|Follow-up Period|Death|133|||
124703270|NCT01373281|448537237|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
124703271|NCT01373281|448537236|FG000|Surveillance Expansion Period|Serious adverse event|3|||
124703272|NCT01373281|448537237|FG001|Surveillance Expansion Period|Serious adverse event|4|||
124703273|NCT03502681|448537240|FG000|Overall Study|Adverse Event|1|||
124703274|NCT03502681|448537241|FG001|Overall Study|Adverse Event|1|||
124939532|NCT00571649|449407497|FG000|Follow-up Period|Physician Decision|7|||
124939533|NCT00571649|449407498|FG001|Follow-up Period|Physician Decision|13|||
124939534|NCT00571649|449407497|FG000|Follow-up Period|Lost to Follow-up|95|||
124939535|NCT00571649|449407498|FG001|Follow-up Period|Lost to Follow-up|92|||
124939536|NCT00571649|449407497|FG000|Follow-up Period|Patient convenience|136|||
124703275|NCT03502681|448537240|FG000|Overall Study|Disease Progression|2|||
124703276|NCT03502681|448537241|FG001|Overall Study|Disease Progression|1|||
124939537|NCT00571649|449407498|FG001|Follow-up Period|Patient convenience|121|||
124939538|NCT00571649|449407497|FG000|Follow-up Period|Protocol Violation|5|||
124939539|NCT00571649|449407498|FG001|Follow-up Period|Protocol Violation|12|||
124939540|NCT01421667|449407499|FG000|Overall Study|Withdrawal by Subject|0|||
124939541|NCT01421667|449407500|FG001|Overall Study|Withdrawal by Subject|1|||
124939542|NCT01421667|449407501|FG002|Overall Study|Withdrawal by Subject|2|||
124939543|NCT01421667|449407502|FG003|Overall Study|Withdrawal by Subject|1|||
124939544|NCT01421667|449407499|FG000|Overall Study|Lost to Follow-up|0|||
124939545|NCT01421667|449407500|FG001|Overall Study|Lost to Follow-up|1|||
124939546|NCT01421667|449407501|FG002|Overall Study|Lost to Follow-up|0|||
124939547|NCT01421667|449407502|FG003|Overall Study|Lost to Follow-up|0|||
124939548|NCT00503906|449407503|FG000|Overall Study|Withdrawal by Subject|1|||
124939549|NCT01387516|449407504|FG000|Overall Study|Lost to Follow-up|4|||
124939550|NCT01387516|449407505|FG001|Overall Study|Lost to Follow-up|4|||
124939551|NCT01387516|449407506|FG002|Overall Study|Lost to Follow-up|2|||
124939552|NCT01387516|449407507|FG003|Overall Study|Lost to Follow-up|3|||
124939553|NCT01387516|449407504|FG000|Overall Study|Withdrawal by Subject|1|||
124939554|NCT01387516|449407505|FG001|Overall Study|Withdrawal by Subject|1|||
124939555|NCT01387516|449407506|FG002|Overall Study|Withdrawal by Subject|2|||
124939556|NCT01387516|449407507|FG003|Overall Study|Withdrawal by Subject|0|||
124939557|NCT01387516|449407504|FG000|Overall Study|Death|0|||
124939558|NCT01387516|449407505|FG001|Overall Study|Death|0|||
124939559|NCT01387516|449407506|FG002|Overall Study|Death|0|||
124939560|NCT01387516|449407507|FG003|Overall Study|Death|1|||
124456565|NCT01147744|447631758|FG001|Overall Study|Adverse Event|2|||
124456566|NCT01147744|447631759|FG002|Overall Study|Adverse Event|3|||
124456567|NCT01147744|447631760|FG003|Overall Study|Adverse Event|0|||
124456568|NCT01147744|447631761|FG004|Overall Study|Adverse Event|2|||
124456569|NCT01147744|447631762|FG005|Overall Study|Adverse Event|1|||
124456570|NCT01147744|447631763|FG006|Overall Study|Adverse Event|2|||
124456571|NCT01147744|447631757|FG000|Overall Study|Withdrawal by Subject|8|||
124456572|NCT01147744|447631758|FG001|Overall Study|Withdrawal by Subject|4|||
124456573|NCT01147744|447631759|FG002|Overall Study|Withdrawal by Subject|2|||
124456574|NCT01147744|447631760|FG003|Overall Study|Withdrawal by Subject|2|||
124456575|NCT01147744|447631761|FG004|Overall Study|Withdrawal by Subject|2|||
124456576|NCT01147744|447631762|FG005|Overall Study|Withdrawal by Subject|5|||
124456577|NCT01147744|447631763|FG006|Overall Study|Withdrawal by Subject|2|||
124456578|NCT01147744|447631757|FG000|Overall Study|Lost to Follow-up|0|||
124456579|NCT01147744|447631758|FG001|Overall Study|Lost to Follow-up|1|||
124456580|NCT01147744|447631759|FG002|Overall Study|Lost to Follow-up|0|||
124456581|NCT01147744|447631760|FG003|Overall Study|Lost to Follow-up|0|||
124456582|NCT01147744|447631761|FG004|Overall Study|Lost to Follow-up|0|||
124456583|NCT01147744|447631762|FG005|Overall Study|Lost to Follow-up|0|||
124456584|NCT01147744|447631763|FG006|Overall Study|Lost to Follow-up|0|||
124456585|NCT01147744|447631757|FG000|Overall Study|Sponsor decision to amend protocol|7|||
124456586|NCT01147744|447631758|FG001|Overall Study|Sponsor decision to amend protocol|4|||
124456587|NCT01147744|447631759|FG002|Overall Study|Sponsor decision to amend protocol|2|||
124456588|NCT01147744|447631760|FG003|Overall Study|Sponsor decision to amend protocol|5|||
124456589|NCT01147744|447631761|FG004|Overall Study|Sponsor decision to amend protocol|7|||
124456590|NCT01147744|447631762|FG005|Overall Study|Sponsor decision to amend protocol|2|||
124456591|NCT01147744|447631763|FG006|Overall Study|Sponsor decision to amend protocol|6|||
124456592|NCT01147744|447631757|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
124456593|NCT01147744|447631758|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
124456594|NCT01147744|447631759|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
124456595|NCT01147744|447631760|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
124456596|NCT01147744|447631761|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
124456597|NCT01147744|447631762|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
124456598|NCT01147744|447631763|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
124939561|NCT04517435|449407527|FG000|Overall Study|Withdrawal by Subject|0|||
124939562|NCT04517435|449407528|FG001|Overall Study|Withdrawal by Subject|0|||
124939563|NCT04517435|449407529|FG002|Overall Study|Withdrawal by Subject|1|||
124939564|NCT04517435|449407527|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
124939565|NCT04517435|449407528|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
124939566|NCT04517435|449407529|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
124939567|NCT02415127|449407530|FG000|Overall Study|Adverse Event|1|||
124939568|NCT02415127|449407531|FG001|Overall Study|Adverse Event|0|||
124939569|NCT04882917|449407535|FG000|Overall Study|Adverse Event|0|||
124939570|NCT04882917|449407536|FG001|Overall Study|Adverse Event|1|||
124939571|NCT04882917|449407537|FG002|Overall Study|Adverse Event|2|||
124939572|NCT04882917|449407538|FG003|Overall Study|Adverse Event|2|||
124939573|NCT04882917|449407535|FG000|Overall Study|Withdrawal by Subject|1|||
124939574|NCT04882917|449407536|FG001|Overall Study|Withdrawal by Subject|0|||
124939575|NCT04882917|449407537|FG002|Overall Study|Withdrawal by Subject|2|||
124939576|NCT04882917|449407538|FG003|Overall Study|Withdrawal by Subject|1|||
124939577|NCT04882917|449407535|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
124939578|NCT04882917|449407536|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
124939579|NCT04882917|449407537|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
124939580|NCT04882917|449407538|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
124939581|NCT02678689|449407539|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
124939582|NCT02678689|449407540|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
124939583|NCT03160885|449407541|FG000|Initial Treatment Period|Not dosed|2|||
124939584|NCT03160885|449407542|FG001|Initial Treatment Period|Not dosed|0|||
124939585|NCT03160885|449407543|FG002|Initial Treatment Period|Not dosed|0|||
124939586|NCT03160885|449407544|FG003|Initial Treatment Period|Not dosed|0|||
124939587|NCT03160885|449407545|FG004|Initial Treatment Period|Not dosed|0|||
124939588|NCT03160885|449407546|FG005|Initial Treatment Period|Not dosed|0|||
124939589|NCT03160885|449407547|FG006|Initial Treatment Period|Not dosed|0|||
124939590|NCT03160885|449407541|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
124939591|NCT03160885|449407542|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
124939592|NCT03160885|449407543|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124939593|NCT03160885|449407544|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124939594|NCT03160885|449407545|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124939595|NCT03160885|449407546|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124939596|NCT03160885|449407547|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
124939597|NCT03160885|449407541|FG000|Open-label Treatment|Not dosed|0|||
124939598|NCT03160885|449407542|FG001|Open-label Treatment|Not dosed|0|||
124939599|NCT03160885|449407543|FG002|Open-label Treatment|Not dosed|0|||
124939600|NCT03160885|449407544|FG003|Open-label Treatment|Not dosed|0|||
124939601|NCT03160885|449407545|FG004|Open-label Treatment|Not dosed|0|||
124939602|NCT03160885|449407546|FG005|Open-label Treatment|Not dosed|0|||
124939603|NCT03160885|449407547|FG006|Open-label Treatment|Not dosed|2|||
124939604|NCT03160885|449407541|FG000|Open-label Treatment|Discontinued IMP|0|||
124939605|NCT03160885|449407542|FG001|Open-label Treatment|Discontinued IMP|0|||
124939606|NCT03160885|449407543|FG002|Open-label Treatment|Discontinued IMP|0|||
124939607|NCT03160885|449407544|FG003|Open-label Treatment|Discontinued IMP|0|||
124939608|NCT03160885|449407545|FG004|Open-label Treatment|Discontinued IMP|0|||
124939609|NCT03160885|449407546|FG005|Open-label Treatment|Discontinued IMP|0|||
124939610|NCT03160885|449407547|FG006|Open-label Treatment|Discontinued IMP|131|||
124939611|NCT03160885|449407541|FG000|Open-label Treatment|Completed Week 50|0|||
124939612|NCT03160885|449407542|FG001|Open-label Treatment|Completed Week 50|0|||
124939613|NCT03160885|449407543|FG002|Open-label Treatment|Completed Week 50|0|||
124456599|NCT02536313|447631768|FG000|Overall Study|Lack of Efficacy|0|||
124456600|NCT02536313|447631769|FG001|Overall Study|Lack of Efficacy|1|||
124456601|NCT02437864|447631775|FG000|Overall Study|Protocol Violation|4|||
124456602|NCT02437864|447631776|FG001|Overall Study|Protocol Violation|0|||
124456603|NCT00807742|447631778|FG000|Overall Study|Death|9|||
124456604|NCT00807742|447631779|FG001|Overall Study|Death|2|||
124456605|NCT00807742|447631778|FG000|Overall Study|Withdrawal by Subject|2|||
124456606|NCT00807742|447631779|FG001|Overall Study|Withdrawal by Subject|1|||
124456607|NCT00807742|447631778|FG000|Overall Study|Lost to Follow-up|35|||
124456608|NCT00807742|447631779|FG001|Overall Study|Lost to Follow-up|51|||
124456609|NCT00492752|447631780|FG000|Double Blind Treatment|Death|13|||
124456610|NCT00492752|447631781|FG001|Double Blind Treatment|Death|0|||
124456611|NCT00492752|447631782|FG002|Double Blind Treatment|Death|2|||
124456612|NCT00492752|447631783|FG003|Double Blind Treatment|Death|0|||
124456613|NCT00492752|447631780|FG000|Double Blind Treatment|Adverse Event|1|||
124456614|NCT00492752|447631781|FG001|Double Blind Treatment|Adverse Event|0|||
124456615|NCT00492752|447631782|FG002|Double Blind Treatment|Adverse Event|0|||
124456616|NCT00492752|447631783|FG003|Double Blind Treatment|Adverse Event|0|||
124456617|NCT00492752|447631780|FG000|Double Blind Treatment|Protocol Violation|0|||
124456618|NCT00492752|447631781|FG001|Double Blind Treatment|Protocol Violation|0|||
124456619|NCT00492752|447631782|FG002|Double Blind Treatment|Protocol Violation|1|||
124546746|NCT03255226|447957371|FG000|Overall Study|Serum or blood sodium increased|4|||
124546747|NCT03255226|447957371|FG000|Overall Study|Serum or blood potassium increased|4|||
124939614|NCT03160885|449407544|FG003|Open-label Treatment|Completed Week 50|0|||
124939615|NCT03160885|449407545|FG004|Open-label Treatment|Completed Week 50|0|||
124456620|NCT00492752|447631783|FG003|Double Blind Treatment|Protocol Violation|0|||
124703277|NCT01444781|448537242|FG000|Overall Study|Lost to Follow-up|0|||
124703278|NCT01444781|448537243|FG001|Overall Study|Lost to Follow-up|3|||
124703279|NCT01444781|448537244|FG002|Overall Study|Lost to Follow-up|1|||
124703280|NCT01444781|448537242|FG000|Overall Study|Withdrawal by Subject|3|||
124703281|NCT01444781|448537243|FG001|Overall Study|Withdrawal by Subject|1|||
124703282|NCT01444781|448537244|FG002|Overall Study|Withdrawal by Subject|2|||
124703283|NCT06790303|448537245|FG000|Overall Study|Study Terminated by sponsor|4|||
124703284|NCT06790303|448537245|FG000|Overall Study|Death|4|||
124703285|NCT02374255|448537254|FG000|Overall Study|Withdrawal by Subject|2|||
124703286|NCT02374255|448537255|FG001|Overall Study|Withdrawal by Subject|0|||
124703287|NCT02374255|448537256|FG002|Overall Study|Withdrawal by Subject|0|||
124703288|NCT02374255|448537257|FG003|Overall Study|Withdrawal by Subject|0|||
124703289|NCT02093520|448537258|FG000|Overall Study|Not treated|6|||
124703290|NCT02093520|448537259|FG001|Overall Study|Not treated|22|||
124703291|NCT03014089|448537260|FG000|Overall Study|Withdrawal by Subject|0|||
124703292|NCT03014089|448537261|FG001|Overall Study|Withdrawal by Subject|1|||
124703293|NCT03014089|448537262|FG002|Overall Study|Withdrawal by Subject|1|||
124703294|NCT03014089|448537263|FG003|Overall Study|Withdrawal by Subject|1|||
124703295|NCT03014089|448537260|FG000|Overall Study|Lost to Follow-up|1|||
124703296|NCT03014089|448537261|FG001|Overall Study|Lost to Follow-up|0|||
124703297|NCT03014089|448537262|FG002|Overall Study|Lost to Follow-up|0|||
124703298|NCT03014089|448537263|FG003|Overall Study|Lost to Follow-up|0|||
124703299|NCT03014089|448537260|FG000|Overall Study|Adverse Event|1|||
124703300|NCT03014089|448537261|FG001|Overall Study|Adverse Event|0|||
124703301|NCT03014089|448537262|FG002|Overall Study|Adverse Event|1|||
124703302|NCT03014089|448537263|FG003|Overall Study|Adverse Event|0|||
124703303|NCT00321932|448537264|FG000|Overall Study|Death|3|||
124703304|NCT00321932|448537265|FG001|Overall Study|Death|6|||
124703305|NCT00321932|448537264|FG000|Overall Study|Withdrawal by Subject|3|||
124703306|NCT00321932|448537265|FG001|Overall Study|Withdrawal by Subject|6|||
124939616|NCT03160885|449407546|FG005|Open-label Treatment|Completed Week 50|0|||
124939617|NCT03160885|449407547|FG006|Open-label Treatment|Completed Week 50|4|||
124939618|NCT03160885|449407541|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
124939619|NCT03160885|449407542|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
124939620|NCT03160885|449407543|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
124939621|NCT03160885|449407544|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
124939622|NCT03160885|449407545|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
124939623|NCT03160885|449407546|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
124939624|NCT03160885|449407547|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
124939625|NCT03160885|449407541|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
124939626|NCT03160885|449407542|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
124939627|NCT03160885|449407543|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
124939628|NCT03160885|449407544|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
124939629|NCT03160885|449407545|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
124939630|NCT03160885|449407546|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
124939631|NCT03160885|449407547|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
124939632|NCT03160885|449407541|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
124939633|NCT03160885|449407542|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
124939634|NCT03160885|449407543|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
124939635|NCT03160885|449407544|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
124939636|NCT03160885|449407545|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
124939637|NCT03160885|449407546|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
124939638|NCT03160885|449407547|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
124939639|NCT03160885|449407541|FG000|Maintenance Treatment Period|Completed Week 50|0|||
124939640|NCT03160885|449407542|FG001|Maintenance Treatment Period|Completed Week 50|0|||
124939641|NCT03160885|449407543|FG002|Maintenance Treatment Period|Completed Week 50|1|||
124939642|NCT03160885|449407544|FG003|Maintenance Treatment Period|Completed Week 50|0|||
124939643|NCT03160885|449407545|FG004|Maintenance Treatment Period|Completed Week 50|0|||
124939644|NCT03160885|449407546|FG005|Maintenance Treatment Period|Completed Week 50|0|||
124939645|NCT03160885|449407547|FG006|Maintenance Treatment Period|Completed Week 50|0|||
124939646|NCT02761187|449407548|FG000|Overall Study|Too ill to Participate|13|||
124939647|NCT02761187|449407549|FG001|Overall Study|Too ill to Participate|8|||
124703307|NCT00321932|448537264|FG000|Overall Study|Early relapse|2|||
124703308|NCT00321932|448537265|FG001|Overall Study|Early relapse|8|||
124456621|NCT00492752|447631780|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
124456622|NCT00492752|447631781|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
124703309|NCT00321932|448537264|FG000|Overall Study|Missing data|2|||
124703310|NCT00321932|448537265|FG001|Overall Study|Missing data|1|||
124703311|NCT03257657|448537267|FG000|Overall Study|Lost to Follow-up|0|||
124703312|NCT03257657|448537268|FG001|Overall Study|Lost to Follow-up|3|||
124703313|NCT03257657|448537267|FG000|Overall Study|Withdrawn|0|||
124703314|NCT03257657|448537268|FG001|Overall Study|Withdrawn|1|||
124703315|NCT03257657|448537267|FG000|Overall Study|Noted not eligible right after enrolled|0|||
124939648|NCT02761187|449407548|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
124939649|NCT02761187|449407549|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
124939650|NCT02761187|449407548|FG000|Overall Study|Patient withdrew consent|64|||
124939651|NCT02761187|449407549|FG001|Overall Study|Patient withdrew consent|58|||
124939652|NCT02761187|449407548|FG000|Overall Study|Physician discretion|4|||
124939653|NCT02761187|449407549|FG001|Overall Study|Physician discretion|8|||
124939654|NCT02761187|449407548|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
124939655|NCT02761187|449407549|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
124939656|NCT02761187|449407548|FG000|Overall Study|On Hospice|20|||
124939657|NCT02761187|449407549|FG001|Overall Study|On Hospice|26|||
124939658|NCT02761187|449407548|FG000|Overall Study|Deceased|474|||
124939659|NCT02761187|449407549|FG001|Overall Study|Deceased|642|||
124939660|NCT02761187|449407548|FG000|Overall Study|Lost to Follow-up|73|||
124939661|NCT02761187|449407549|FG001|Overall Study|Lost to Follow-up|63|||
124939662|NCT02761187|449407548|FG000|Overall Study|Due to study discontinued at site|100|||
124939663|NCT02761187|449407549|FG001|Overall Study|Due to study discontinued at site|85|||
124939664|NCT02761187|449407548|FG000|Overall Study|Reason not Specified|1484|||
124939665|NCT02761187|449407549|FG001|Overall Study|Reason not Specified|937|||
124939666|NCT02307682|449407550|FG000|Overall Study|Adverse Event|9|||
124939667|NCT02307682|449407551|FG001|Overall Study|Adverse Event|8|||
124939668|NCT02307682|449407552|FG002|Overall Study|Adverse Event|12|||
124939669|NCT02307682|449407550|FG000|Overall Study|Lack of Efficacy|1|||
124939670|NCT02307682|449407551|FG001|Overall Study|Lack of Efficacy|0|||
124939671|NCT02307682|449407552|FG002|Overall Study|Lack of Efficacy|1|||
124939672|NCT02307682|449407550|FG000|Overall Study|Physician Decision|2|||
124939673|NCT02307682|449407551|FG001|Overall Study|Physician Decision|2|||
124939674|NCT02307682|449407552|FG002|Overall Study|Physician Decision|8|||
124939675|NCT02307682|449407550|FG000|Overall Study|Progressive Disease|1|||
124939676|NCT02307682|449407551|FG001|Overall Study|Progressive Disease|0|||
124939677|NCT02307682|449407552|FG002|Overall Study|Progressive Disease|0|||
124939678|NCT02307682|449407550|FG000|Overall Study|Withdrawal by Subject|26|||
124456623|NCT00492752|447631782|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
124456624|NCT00492752|447631783|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
124456625|NCT00492752|447631780|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
124456626|NCT00492752|447631781|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
124456627|NCT00492752|447631782|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
124456628|NCT00492752|447631783|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
124456629|NCT00492752|447631780|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
124456630|NCT00492752|447631781|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
124456631|NCT00492752|447631782|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
124456632|NCT00492752|447631783|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
124456633|NCT00492752|447631780|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
124456634|NCT00492752|447631781|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
124456635|NCT00492752|447631782|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
124456636|NCT00492752|447631783|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
124456637|NCT00492752|447631780|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
124456638|NCT00492752|447631781|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
124456639|NCT00492752|447631782|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
124546748|NCT01035229|447957372|FG000|Overall Study|Adverse Event|61|||
124939679|NCT02307682|449407551|FG001|Overall Study|Withdrawal by Subject|34|||
124939680|NCT02307682|449407552|FG002|Overall Study|Withdrawal by Subject|23|||
124939681|NCT02307682|449407550|FG000|Overall Study|Death|9|||
124939682|NCT02307682|449407551|FG001|Overall Study|Death|7|||
124939683|NCT02307682|449407552|FG002|Overall Study|Death|12|||
124939684|NCT02307682|449407550|FG000|Overall Study|Lost to Follow-up|1|||
124939685|NCT02307682|449407551|FG001|Overall Study|Lost to Follow-up|5|||
124456640|NCT00492752|447631783|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
124456641|NCT00492752|447631780|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
124456642|NCT00492752|447631781|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
124456643|NCT00492752|447631782|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
124456644|NCT00492752|447631783|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
124456645|NCT00492752|447631780|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
124456646|NCT00492752|447631781|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
124456647|NCT00492752|447631782|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
124456648|NCT00492752|447631783|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
124456649|NCT00492752|447631780|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
124765010|NCT04913610|448765112|FG003|Randomized Participants|Did Not Receive Treatment|1|||
124765011|NCT04913610|448765113|FG004|Randomized Participants|Did Not Receive Treatment|0|||
124765012|NCT04913610|448765109|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
124939686|NCT02307682|449407552|FG002|Overall Study|Lost to Follow-up|6|||
124939687|NCT02307682|449407550|FG000|Overall Study|Protocol Deviation|0|||
124939688|NCT02307682|449407551|FG001|Overall Study|Protocol Deviation|0|||
124939689|NCT02307682|449407552|FG002|Overall Study|Protocol Deviation|2|||
124939690|NCT02307682|449407550|FG000|Overall Study|Other|1|||
124939691|NCT02307682|449407551|FG001|Overall Study|Other|1|||
124939692|NCT02307682|449407552|FG002|Overall Study|Other|0|||
124939693|NCT05630833|449407553|FG000|Overall Study|Adverse Event|3|||
124939694|NCT05630833|449407554|FG001|Overall Study|Adverse Event|0|||
124939695|NCT05630833|449407553|FG000|Overall Study|Lack of Efficacy|0|||
124939696|NCT05630833|449407554|FG001|Overall Study|Lack of Efficacy|1|||
124939697|NCT05630833|449407553|FG000|Overall Study|Lost to Follow-up|1|||
124939698|NCT05630833|449407554|FG001|Overall Study|Lost to Follow-up|0|||
124939699|NCT05630833|449407553|FG000|Overall Study|Withdrawal by Subject|3|||
124939700|NCT05630833|449407554|FG001|Overall Study|Withdrawal by Subject|1|||
124939701|NCT03170349|449407556|FG000|From Implant to the 30-Day Visit|Death|1|||
124939702|NCT03170349|449407556|FG000|From 30-Day to 6-Month Visit|Death|3|||
124939703|NCT03170349|449407556|FG000|From 30-Day to 6-Month Visit|Withdrawal by Subject|1|||
124939704|NCT03170349|449407556|FG000|From 30-Day to 6-Month Visit|Exited for Other Reasons|5|||
124939705|NCT03170349|449407556|FG000|From 6-Month to 1-Year Visit|Death|6|||
124939706|NCT03170349|449407556|FG000|From 6-Month to 1-Year Visit|Exited for Other Reasons|2|||
124939707|NCT03170349|449407556|FG000|From 1-Year to 2-Year Visit|Death|13|||
124939708|NCT03170349|449407556|FG000|From 1-Year to 2-Year Visit|Withdrawal by Subject|1|||
124939709|NCT03170349|449407556|FG000|From 1-Year to 2-Year Visit|Missed Visit|4|||
124939710|NCT03170349|449407556|FG000|From 2-Year to 3-Year Visit|Death|10|||
124939711|NCT03170349|449407556|FG000|From 2-Year to 3-Year Visit|Lost to Follow-up|2|||
124939712|NCT03170349|449407556|FG000|From 2-Year to 3-Year Visit|Withdrawal by Subject|2|||
124939713|NCT03170349|449407556|FG000|From 2-Year to 3-Year Visit|Missed Visit|1|||
124939714|NCT04551066|449407557|FG000|Overall Study|Death|5|||
124939715|NCT04551066|449407558|FG001|Overall Study|Death|3|||
124939716|NCT04551066|449407557|FG000|Overall Study|Lost to Follow-up|1|||
124939717|NCT04551066|449407558|FG001|Overall Study|Lost to Follow-up|0|||
124939718|NCT04551066|449407557|FG000|Overall Study|Sponsor Decision|103|||
124939719|NCT04551066|449407558|FG001|Overall Study|Sponsor Decision|117|||
124939720|NCT04551066|449407557|FG000|Overall Study|Withdrawal by Subject|8|||
124939721|NCT04551066|449407558|FG001|Overall Study|Withdrawal by Subject|2|||
124939722|NCT04551066|449407557|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
124939723|NCT04551066|449407558|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
124939724|NCT04551066|449407557|FG000|Overall Study|Adverse Event|2|||
124939725|NCT04551066|449407558|FG001|Overall Study|Adverse Event|0|||
124939726|NCT04551066|449407557|FG000|Overall Study|Physician Decision|2|||
124939727|NCT04551066|449407558|FG001|Overall Study|Physician Decision|0|||
124939728|NCT04551066|449407557|FG000|Overall Study|Protocol Violation|1|||
124939729|NCT04551066|449407558|FG001|Overall Study|Protocol Violation|0|||
124939730|NCT04551066|449407557|FG000|Overall Study|Lack of Efficacy|0|||
124939731|NCT04551066|449407558|FG001|Overall Study|Lack of Efficacy|1|||
124939732|NCT04551066|449407557|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
124939733|NCT04551066|449407558|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
124939734|NCT05529992|449407559|FG000|Overall Study|Withdrawal by Subject|1|||
124939735|NCT00536120|449408498|FG000|Overall Study|Lost to Follow-up|1|||
124939736|NCT00536120|449408499|FG001|Overall Study|Lost to Follow-up|0|||
124939737|NCT00536120|449408498|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
124939738|NCT00536120|449408499|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
124939739|NCT00536120|449408498|FG000|Overall Study|Non-compliance|1|||
124939740|NCT00536120|449408499|FG001|Overall Study|Non-compliance|0|||
124939741|NCT00536120|449408498|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
124939742|NCT00536120|449408499|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
124939743|NCT00536120|449408498|FG000|Overall Study|Steroid Use|0|||
124939744|NCT00536120|449408499|FG001|Overall Study|Steroid Use|2|||
124939745|NCT00536120|449408498|FG000|Overall Study|Missed Study Visit|0|||
124939746|NCT00536120|449408499|FG001|Overall Study|Missed Study Visit|1|||
124939747|NCT02760654|449408500|FG000|Overall Study|Lost to Follow-up|3|||
124939748|NCT02760654|449408501|FG001|Overall Study|Lost to Follow-up|3|||
124939749|NCT02760654|449408500|FG000|Overall Study|Withdrawal by Subject|4|||
124939750|NCT02760654|449408501|FG001|Overall Study|Withdrawal by Subject|3|||
124939751|NCT01084694|449408503|FG000|Overall Study|Withdrawal by Subject|2|||
124939752|NCT01084694|449408504|FG001|Overall Study|Withdrawal by Subject|1|||
124939753|NCT01084694|449408503|FG000|Overall Study|Death|2|||
124939754|NCT01084694|449408504|FG001|Overall Study|Death|12|||
124939755|NCT01084694|449408503|FG000|Overall Study|eligibility not maintained|2|||
124939756|NCT01084694|449408504|FG001|Overall Study|eligibility not maintained|7|||
124939757|NCT00945321|449408507|FG000|Period 1|Adverse Event|0|||
124939758|NCT00945321|449408508|FG001|Period 1|Adverse Event|0|||
124939759|NCT00945321|449408509|FG002|Period 1|Adverse Event|0|||
124939760|NCT00945321|449408510|FG003|Period 1|Adverse Event|0|||
124939761|NCT00945321|449408511|FG004|Period 1|Adverse Event|1|||
124939762|NCT00945321|449408512|FG005|Period 1|Adverse Event|0|||
124939763|NCT00945321|449408507|FG000|Period 4|Lost to Follow-up|0|||
124939764|NCT00945321|449408508|FG001|Period 4|Lost to Follow-up|0|||
124939765|NCT00945321|449408509|FG002|Period 4|Lost to Follow-up|0|||
124939766|NCT00945321|449408510|FG003|Period 4|Lost to Follow-up|0|||
124939767|NCT00945321|449408511|FG004|Period 4|Lost to Follow-up|0|||
124939768|NCT00945321|449408512|FG005|Period 4|Lost to Follow-up|1|||
124939769|NCT02633215|449408513|FG000|Overall Study|Lost to Follow-up|2|||
124939770|NCT02633215|449408514|FG001|Overall Study|Lost to Follow-up|3|||
124939771|NCT04017611|449408515|FG000|Overall Study|Withdrawn prior to completion|1|||
124939772|NCT02291913|449408524|FG000|Overall Study|Progressive Disease|32|||
124939773|NCT02291913|449408524|FG000|Overall Study|Adverse Event|11|||
124939774|NCT02291913|449408524|FG000|Overall Study|Death|2|||
124939775|NCT02291913|449408524|FG000|Overall Study|Physician Decision|1|||
124939776|NCT02291913|449408524|FG000|Overall Study|Withdrawal by Subject|1|||
124939777|NCT02291913|449408524|FG000|Overall Study|Protocol Violation|1|||
124939778|NCT04876417|449408527|FG000|Overall Study|Lost to Follow-up|5|||
124939779|NCT04876417|449408528|FG001|Overall Study|Lost to Follow-up|8|||
124939780|NCT04876417|449408529|FG002|Overall Study|Lost to Follow-up|0|||
124939781|NCT04876417|449408530|FG003|Overall Study|Lost to Follow-up|0|||
124939782|NCT02866942|449408531|FG000|Overall Study|Invalid consent|1|||
124939783|NCT00439270|449408532|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
124939784|NCT00439270|449408533|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
124939785|NCT00439270|449408534|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
124939786|NCT00439270|449408535|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
124939787|NCT00439270|449408536|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
124939788|NCT00439270|449408532|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
124939789|NCT00439270|449408533|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
124939790|NCT00439270|449408534|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
124939791|NCT00439270|449408535|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
124939792|NCT00439270|449408536|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
124939793|NCT00439270|449408532|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
124939794|NCT00439270|449408533|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
124939795|NCT00439270|449408534|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
124939796|NCT00439270|449408535|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
124939797|NCT00439270|449408536|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
124939798|NCT00439270|449408532|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
124939799|NCT00439270|449408533|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
124939800|NCT00439270|449408534|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
124939801|NCT00439270|449408535|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
124939802|NCT00439270|449408536|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
124546749|NCT01035229|447957373|FG001|Overall Study|Adverse Event|14|||
124939803|NCT00439270|449408532|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
124939804|NCT00439270|449408533|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
124939805|NCT00439270|449408534|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
124703316|NCT03257657|448537268|FG001|Overall Study|Noted not eligible right after enrolled|1|||
124703317|NCT00688740|448537279|FG000|Overall Study|Adverse Event|45|||
124703318|NCT00688740|448537280|FG001|Overall Study|Adverse Event|8|||
124703319|NCT00688740|448537279|FG000|Overall Study|Death|2|||
124703320|NCT00688740|448537280|FG001|Overall Study|Death|2|||
124703321|NCT00688740|448537279|FG000|Overall Study|Lost to Follow-up|0|||
124703322|NCT00688740|448537280|FG001|Overall Study|Lost to Follow-up|1|||
124703323|NCT00688740|448537279|FG000|Overall Study|Consent Withdrawn|17|||
124939806|NCT00439270|449408535|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
124939807|NCT00439270|449408536|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
124939808|NCT00439270|449408532|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
124939809|NCT00439270|449408533|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
124939810|NCT00439270|449408534|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
124703324|NCT00688740|448537280|FG001|Overall Study|Consent Withdrawn|17|||
124939811|NCT00439270|449408535|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
124939812|NCT00439270|449408536|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
124939813|NCT00439270|449408532|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
124939814|NCT00439270|449408533|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
124939815|NCT00439270|449408534|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
124939816|NCT00439270|449408535|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
124939817|NCT00439270|449408536|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
124939818|NCT00439270|449408532|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
124939819|NCT00439270|449408533|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
124939820|NCT00439270|449408534|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
124939821|NCT00439270|449408535|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
124939822|NCT00439270|449408536|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
124939823|NCT00439270|449408532|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
124939824|NCT00439270|449408533|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
124939825|NCT00439270|449408534|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
124939826|NCT00439270|449408535|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
124939827|NCT00439270|449408536|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
124939828|NCT00439270|449408532|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
124939829|NCT00439270|449408533|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
124939830|NCT00439270|449408534|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
124939831|NCT00439270|449408535|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
124939832|NCT00439270|449408536|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
124939833|NCT01268306|449408537|FG000|Overall Study|Lost to Follow-up|1|||
124939834|NCT02568215|449408539|FG000|Overall Study|Death|1|||
124939835|NCT02568215|449408540|FG001|Overall Study|Death|2|||
124939836|NCT02568215|449408541|FG002|Overall Study|Death|0|||
124939837|NCT02568215|449408539|FG000|Overall Study|Physician Decision|2|||
124939838|NCT02568215|449408540|FG001|Overall Study|Physician Decision|2|||
124939839|NCT02568215|449408541|FG002|Overall Study|Physician Decision|2|||
124939840|NCT02568215|449408539|FG000|Overall Study|Lost to Follow-up|29|||
124939841|NCT02568215|449408540|FG001|Overall Study|Lost to Follow-up|32|||
124939842|NCT02568215|449408541|FG002|Overall Study|Lost to Follow-up|41|||
124939843|NCT02568215|449408539|FG000|Overall Study|Withdrawal by Subject|21|||
124939844|NCT02568215|449408540|FG001|Overall Study|Withdrawal by Subject|19|||
124939845|NCT02568215|449408541|FG002|Overall Study|Withdrawal by Subject|22|||
124939846|NCT02568215|449408539|FG000|Overall Study|Protocol Violation|1|||
124939847|NCT02568215|449408540|FG001|Overall Study|Protocol Violation|1|||
124939848|NCT02568215|449408541|FG002|Overall Study|Protocol Violation|0|||
124939849|NCT02568215|449408539|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
124939850|NCT02568215|449408540|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
124939851|NCT02568215|449408541|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
124939852|NCT02568215|449408539|FG000|Overall Study|Other|0|||
124939853|NCT02568215|449408540|FG001|Overall Study|Other|1|||
124939854|NCT02568215|449408541|FG002|Overall Study|Other|4|||
124939855|NCT00246805|449408542|FG000|Phase 1|Lost to Follow-up|1|||
124939856|NCT00246805|449408543|FG001|Phase 1|Lost to Follow-up|0|||
124939857|NCT00293397|449408544|FG000|Overall Study|Death|2|||
124939858|NCT01218009|449408545|FG000|Overall Study|Protocol Violation|2|||
124939859|NCT01218009|449408546|FG001|Overall Study|Protocol Violation|1|||
124939860|NCT01218009|449408545|FG000|Overall Study|Withdrawal by Subject|3|||
124939861|NCT01218009|449408546|FG001|Overall Study|Withdrawal by Subject|1|||
124939862|NCT01218009|449408545|FG000|Overall Study|Sponsor terminated study|161|||
124939863|NCT01218009|449408546|FG001|Overall Study|Sponsor terminated study|163|||
124939864|NCT00174252|449408547|FG000|Overall Study|Protocol Violation|2|||
124939865|NCT03170882|449408548|FG000|Overall Study|Death|17|||
124939866|NCT03170882|449408549|FG001|Overall Study|Death|29|||
124703325|NCT00688740|448537279|FG000|Overall Study|Breast Cancer Relapse|1|||
124703326|NCT00688740|448537280|FG001|Overall Study|Breast Cancer Relapse|4|||
124703327|NCT00688740|448537279|FG000|Overall Study|Violation of Inclusion Criteria|1|||
124703328|NCT00688740|448537280|FG001|Overall Study|Violation of Inclusion Criteria|3|||
124703329|NCT03931330|448537283|FG000|Overall Study|Physician Decision|1|||
124703330|NCT03412929|448537284|FG000|Overall Study|Protocol Violation|3|||
124703331|NCT00645658|448537287|FG000|Overall Study|Withdrawal by Subject|1|||
124703332|NCT00645658|448537288|FG001|Overall Study|Withdrawal by Subject|0|||
124703333|NCT00645658|448537287|FG000|Overall Study|Did not complete all assesments|0|||
124703334|NCT00645658|448537288|FG001|Overall Study|Did not complete all assesments|2|||
124703335|NCT00023595|448537291|FG000|5 Year Follow up|Lost to Follow-up|2|||
124939867|NCT03170882|449408548|FG000|Overall Study|Lost to Follow-up|0|||
124939868|NCT03170882|449408549|FG001|Overall Study|Lost to Follow-up|1|||
124939869|NCT03170882|449408548|FG000|Overall Study|Withdrawal by Subject|4|||
124703336|NCT00023595|448537292|FG001|5 Year Follow up|Lost to Follow-up|2|||
124939870|NCT03170882|449408549|FG001|Overall Study|Withdrawal by Subject|7|||
124939871|NCT03170882|449408548|FG000|Overall Study|Reason not Specified|28|||
124939872|NCT03170882|449408549|FG001|Overall Study|Reason not Specified|36|||
124939873|NCT03802994|449408550|FG000|Overall Study|Lost to Follow-up|0|||
124703337|NCT00023595|448537293|FG002|5 Year Follow up|Lost to Follow-up|1|||
124939874|NCT03802994|449408551|FG001|Overall Study|Lost to Follow-up|2|||
124939875|NCT03802994|449408552|FG002|Overall Study|Lost to Follow-up|3|||
124939876|NCT03802994|449408553|FG003|Overall Study|Lost to Follow-up|2|||
124939877|NCT03802994|449408554|FG004|Overall Study|Lost to Follow-up|2|||
124939878|NCT01753999|449408557|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
124939879|NCT01753999|449408558|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
124939880|NCT01753999|449408557|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
124939881|NCT01753999|449408558|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
124939882|NCT01753999|449408557|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
124456650|NCT00492752|447631781|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
124456651|NCT00492752|447631782|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
124456652|NCT00492752|447631783|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
124456653|NCT05419128|447631784|FG000|Overall Study|Withdrawal by Subject|1|||
124456654|NCT05419128|447631785|FG001|Overall Study|Withdrawal by Subject|1|||
124456655|NCT05419128|447631786|FG002|Overall Study|Withdrawal by Subject|0|||
124456656|NCT05419128|447631787|FG003|Overall Study|Withdrawal by Subject|1|||
124456657|NCT05419128|447631788|FG004|Overall Study|Withdrawal by Subject|1|||
124456658|NCT05419128|447631789|FG005|Overall Study|Withdrawal by Subject|0|||
124456659|NCT05419128|447631784|FG000|Overall Study|Lost to Follow-up|0|||
124456660|NCT05419128|447631785|FG001|Overall Study|Lost to Follow-up|0|||
124456661|NCT05419128|447631786|FG002|Overall Study|Lost to Follow-up|1|||
124456662|NCT05419128|447631787|FG003|Overall Study|Lost to Follow-up|0|||
124456663|NCT05419128|447631788|FG004|Overall Study|Lost to Follow-up|0|||
124456664|NCT05419128|447631789|FG005|Overall Study|Lost to Follow-up|1|||
124456665|NCT03834519|447631790|FG000|Overall Study|Lost to Follow-up|2|||
124456666|NCT03834519|447631791|FG001|Overall Study|Lost to Follow-up|1|||
124456667|NCT03834519|447631790|FG000|Overall Study|Withdrawal by Subject|5|||
124456668|NCT03834519|447631791|FG001|Overall Study|Withdrawal by Subject|8|||
124456669|NCT03834519|447631790|FG000|Overall Study|Death|368|||
124456670|NCT03834519|447631791|FG001|Overall Study|Death|174|||
124456671|NCT03834519|447631790|FG000|Overall Study|Physician Decision|5|||
124456672|NCT03834519|447631791|FG001|Overall Study|Physician Decision|1|||
124456673|NCT03834519|447631790|FG000|Overall Study|Sponsor decision|149|||
124456674|NCT03834519|447631791|FG001|Overall Study|Sponsor decision|80|||
124456675|NCT04066491|447631792|FG000|Overall Study|Randomized, not treated|0|||
124456676|NCT04066491|447631793|FG001|Overall Study|Randomized, not treated|0|||
124456677|NCT04066491|447631794|FG002|Overall Study|Randomized, not treated|2|||
124456678|NCT04506086|447631795|FG000|Overall Study|Withdrawal by Subject|2|||
124456679|NCT00495820|447631798|FG000|Overall Study|Adverse Event|1|||
124456680|NCT00495820|447631799|FG001|Overall Study|Adverse Event|1|||
124456681|NCT04857996|447631800|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
124456682|NCT04857996|447631801|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
124456683|NCT04857996|447631800|FG000|Overall Study|Lost to Follow-up|1|||
124456684|NCT04857996|447631801|FG001|Overall Study|Lost to Follow-up|3|||
124456685|NCT04857996|447631800|FG000|Overall Study|Site Closure|1|||
124456686|NCT04857996|447631801|FG001|Overall Study|Site Closure|0|||
124456687|NCT04857996|447631800|FG000|Overall Study|Withdrawal by Subject|1|||
124456688|NCT04857996|447631801|FG001|Overall Study|Withdrawal by Subject|0|||
124456689|NCT00820950|447631802|FG000|Overall Study|Scheduling Conflict|0|||
124939883|NCT01753999|449408558|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
124939884|NCT01753999|449408557|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
124939885|NCT01753999|449408558|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
124939886|NCT01753999|449408557|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
124939887|NCT01753999|449408558|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
124939888|NCT01753999|449408557|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
124939889|NCT01753999|449408558|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
124939890|NCT02392234|449408559|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
124939891|NCT02392234|449408560|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
124939892|NCT02392234|449408561|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
124939893|NCT02392234|449408562|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
124939894|NCT02392234|449408563|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
124939895|NCT02392234|449408564|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
124939896|NCT02392234|449408559|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
124939897|NCT02392234|449408560|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
124939898|NCT02392234|449408561|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
124456690|NCT00820950|447631803|FG001|Overall Study|Scheduling Conflict|0|||
124456691|NCT00820950|447631804|FG002|Overall Study|Scheduling Conflict|0|||
124456692|NCT00820950|447631805|FG003|Overall Study|Scheduling Conflict|0|||
124456693|NCT00820950|447631806|FG004|Overall Study|Scheduling Conflict|0|||
124456694|NCT00820950|447631807|FG005|Overall Study|Scheduling Conflict|0|||
124456695|NCT00820950|447631808|FG006|Overall Study|Scheduling Conflict|1|||
124456696|NCT00820950|447631809|FG007|Overall Study|Scheduling Conflict|1|||
124456697|NCT00820950|447631810|FG008|Overall Study|Scheduling Conflict|0|||
124703338|NCT00023595|448537294|FG003|5 Year Follow up|Lost to Follow-up|7|||
124703339|NCT00023595|448537295|FG004|5 Year Follow up|Lost to Follow-up|3|||
124703340|NCT00023595|448537291|FG000|10 Year Follow up|Lost to Follow-up|12|||
124703341|NCT00023595|448537292|FG001|10 Year Follow up|Lost to Follow-up|10|||
124939899|NCT02392234|449408562|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
124939900|NCT02392234|449408563|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
124939901|NCT02392234|449408564|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
124939902|NCT02392234|449408559|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
124939903|NCT02392234|449408560|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
124939904|NCT02392234|449408561|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
124939905|NCT02392234|449408562|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
124939906|NCT02392234|449408563|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
124939907|NCT02392234|449408564|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
124939908|NCT02392234|449408559|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
124939909|NCT02392234|449408560|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
124939910|NCT02392234|449408561|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
124939911|NCT02392234|449408562|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
124939912|NCT02392234|449408563|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
124939913|NCT02392234|449408564|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
124939914|NCT02392234|449408559|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
124939915|NCT02392234|449408560|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
124939916|NCT02392234|449408561|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
124939917|NCT02392234|449408562|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
124939918|NCT02392234|449408563|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
124939919|NCT02392234|449408564|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
124939920|NCT02392234|449408559|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
124939921|NCT02392234|449408560|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
124939922|NCT02392234|449408561|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
124939923|NCT02392234|449408562|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
124939924|NCT02392234|449408563|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
124939925|NCT02392234|449408564|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
124939926|NCT02392234|449408559|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
124939927|NCT02392234|449408560|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
124939928|NCT02392234|449408561|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
124939929|NCT02392234|449408562|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
124939930|NCT02392234|449408563|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
124939931|NCT02392234|449408564|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
124939932|NCT02392234|449408559|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
124939933|NCT02392234|449408560|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
124939934|NCT02392234|449408561|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
124939935|NCT02392234|449408562|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
124939936|NCT02392234|449408563|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
124939937|NCT02392234|449408564|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
124939938|NCT02029235|449408565|FG000|Overall Study|Non-compliance with study meds or diary|4|||
124939939|NCT02029235|449408566|FG001|Overall Study|Non-compliance with study meds or diary|1|||
124939940|NCT01738438|449408567|FG000|Overall Study|Disease Progression|32|||
124939941|NCT01738438|449408567|FG000|Overall Study|Adverse Event|3|||
124939942|NCT02928172|449408568|FG000|Overall Study|Device did not record data|1|||
124939943|NCT04066075|449408569|FG000|Overall Study|Lost to Follow-up|3|||
124939944|NCT04066075|449408570|FG001|Overall Study|Lost to Follow-up|3|||
124939945|NCT04066075|449408569|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
124939946|NCT04066075|449408570|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
124939947|NCT04066075|449408569|FG000|Overall Study|Withdrawal by Subject|2|||
124939948|NCT04066075|449408570|FG001|Overall Study|Withdrawal by Subject|2|||
124939949|NCT00309166|449408571|FG000|Overall Study|Adverse event, non-fatal|1|||
124939950|NCT00309166|449408572|FG001|Overall Study|Adverse event, non-fatal|0|||
124939951|NCT00309166|449408571|FG000|Overall Study|Withdrawal by Subject|4|||
124939952|NCT00309166|449408572|FG001|Overall Study|Withdrawal by Subject|3|||
124939953|NCT00701701|449408573|FG000|Overall Study|Withdrawal by Subject|0|||
124939954|NCT00701701|449408574|FG001|Overall Study|Withdrawal by Subject|1|||
124939955|NCT00701701|449408573|FG000|Overall Study|Adverse Event|0|||
124939956|NCT00701701|449408574|FG001|Overall Study|Adverse Event|1|||
124939957|NCT03789110|449408577|FG000|Overall Study|Adverse Event|2|||
124939958|NCT03789110|449408577|FG000|Overall Study|Physician Decision|1|||
124939959|NCT03789110|449408577|FG000|Overall Study|Withdrawal by Subject|2|||
124939960|NCT03789110|449408577|FG000|Overall Study|Lack of Efficacy|22|||
124939961|NCT03789110|449408577|FG000|Overall Study|still on treatment|3|||
124939962|NCT01855750|449408578|FG000|Overall Study|Death|78|||
124703342|NCT00023595|448537293|FG002|10 Year Follow up|Lost to Follow-up|3|||
124703343|NCT00023595|448537294|FG003|10 Year Follow up|Lost to Follow-up|0|||
124456698|NCT00820950|447631811|FG009|Overall Study|Scheduling Conflict|0|||
124456699|NCT00820950|447631802|FG000|Overall Study|Protocol Violation|1|||
124456700|NCT00820950|447631803|FG001|Overall Study|Protocol Violation|1|||
124939963|NCT01855750|449408579|FG001|Overall Study|Death|78|||
124939964|NCT01855750|449408578|FG000|Overall Study|Lost to Follow-up|9|||
124939965|NCT01855750|449408579|FG001|Overall Study|Lost to Follow-up|23|||
124939966|NCT01855750|449408578|FG000|Overall Study|Withdrawal by Subject|35|||
124939967|NCT01855750|449408579|FG001|Overall Study|Withdrawal by Subject|28|||
124939968|NCT01855750|449408578|FG000|Overall Study|Sponsor ends the study|297|||
124939969|NCT01855750|449408579|FG001|Overall Study|Sponsor ends the study|290|||
124939970|NCT04300023|449408580|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
124939971|NCT04300023|449408581|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
124939972|NCT05525572|449408582|FG000|Overall Study|Lost to Follow-up|2|||
124939973|NCT04057131|449408583|FG000|Overall Study|Protocol Violation|24|||
124456701|NCT00820950|447631804|FG002|Overall Study|Protocol Violation|0|||
124456702|NCT00820950|447631805|FG003|Overall Study|Protocol Violation|0|||
124456703|NCT00820950|447631806|FG004|Overall Study|Protocol Violation|0|||
124456704|NCT00820950|447631807|FG005|Overall Study|Protocol Violation|0|||
124456705|NCT00820950|447631808|FG006|Overall Study|Protocol Violation|0|||
124456706|NCT00820950|447631809|FG007|Overall Study|Protocol Violation|0|||
124456707|NCT00820950|447631810|FG008|Overall Study|Protocol Violation|0|||
124456708|NCT00820950|447631811|FG009|Overall Study|Protocol Violation|0|||
124456709|NCT00798135|447631812|FG000|Overall Study|Disease progression, relapse|11|||
124456710|NCT00798135|447631812|FG000|Overall Study|Disease progression, refractory|1|||
124456711|NCT00798135|447631812|FG000|Overall Study|Physician Decision|1|||
124456712|NCT03670953|447633547|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
124456713|NCT03670953|447633548|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
124456714|NCT03670953|447633549|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
124456715|NCT03670953|447633550|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
124456716|NCT03670953|447633547|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
124456717|NCT03670953|447633548|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
124456718|NCT03670953|447633549|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
124456719|NCT03670953|447633550|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
124456720|NCT03670953|447633547|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
124456721|NCT03670953|447633548|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
124456722|NCT03670953|447633549|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
124456723|NCT03670953|447633550|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
124456724|NCT03670953|447633547|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
124456725|NCT03670953|447633548|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
124456726|NCT03670953|447633549|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
124456727|NCT03670953|447633550|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
124456728|NCT03670953|447633547|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
124456729|NCT03670953|447633548|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
124456730|NCT03670953|447633549|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
124456731|NCT03670953|447633550|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
124456732|NCT03670953|447633547|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
124456733|NCT03670953|447633548|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
124456734|NCT03670953|447633549|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
124456735|NCT03670953|447633550|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
124456736|NCT03670953|447633547|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
124456737|NCT03670953|447633548|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
124456738|NCT03670953|447633549|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
124456739|NCT03670953|447633550|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
124456740|NCT03670953|447633547|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
124456741|NCT03670953|447633548|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
124456742|NCT03670953|447633549|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
124456743|NCT03670953|447633550|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
124456744|NCT03670953|447633547|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
124456745|NCT03670953|447633548|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
124456746|NCT03670953|447633549|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
124939974|NCT03425682|449408584|FG000|Overall Study|Lost to Follow-up|2|||
124939975|NCT03425682|449408585|FG001|Overall Study|Lost to Follow-up|4|||
124939976|NCT03425682|449408584|FG000|Overall Study|Withdrawal by Subject|0|||
124939977|NCT03425682|449408585|FG001|Overall Study|Withdrawal by Subject|3|||
124939978|NCT03425682|449408584|FG000|Overall Study|Subject did not meet I/E|4|||
124456747|NCT03670953|447633550|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
124456748|NCT03670953|447633547|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
124456749|NCT03670953|447633548|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
124456750|NCT03670953|447633549|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
124456751|NCT03670953|447633550|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
124939979|NCT03425682|449408585|FG001|Overall Study|Subject did not meet I/E|10|||
124939980|NCT03277989|449408589|FG000|Overall Study|Lost to Follow-up|6|||
124939981|NCT03277989|449408589|FG000|Overall Study|Adverse Event|6|||
124703344|NCT00023595|448537295|FG004|10 Year Follow up|Lost to Follow-up|0|||
124703345|NCT01472185|448537296|FG000|Overall Study|Randomized but Not Treated|0|||
124703346|NCT01472185|448537297|FG001|Overall Study|Randomized but Not Treated|1|||
124703347|NCT01472185|448537296|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
124703348|NCT01472185|448537297|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
124703349|NCT01472185|448537296|FG000|Overall Study|Hyperglycemia|5|||
124703350|NCT01472185|448537297|FG001|Overall Study|Hyperglycemia|2|||
124703351|NCT01472185|448537296|FG000|Overall Study|Investigator's Discretion|3|||
124703352|NCT01472185|448537297|FG001|Overall Study|Investigator's Discretion|1|||
124703353|NCT01472185|448537296|FG000|Overall Study|Lost to Follow-up|4|||
124703354|NCT01472185|448537297|FG001|Overall Study|Lost to Follow-up|1|||
124703355|NCT01472185|448537296|FG000|Overall Study|Protocol Violation|5|||
124703356|NCT01472185|448537297|FG001|Overall Study|Protocol Violation|1|||
124703357|NCT01472185|448537296|FG000|Overall Study|Subject Noncompliance|8|||
124703358|NCT01472185|448537297|FG001|Overall Study|Subject Noncompliance|15|||
124703359|NCT01472185|448537296|FG000|Overall Study|Subject Withdrew Consent|6|||
124703360|NCT01472185|448537297|FG001|Overall Study|Subject Withdrew Consent|3|||
124703361|NCT05889468|448537298|FG000|Overall Study|Lost to Follow-up|9|||
124703362|NCT05889468|448537299|FG001|Overall Study|Lost to Follow-up|2|||
124703363|NCT05889468|448537298|FG000|Overall Study|Withdrawal by Subject|2|||
124703364|NCT05889468|448537299|FG001|Overall Study|Withdrawal by Subject|2|||
124703365|NCT03900650|448537302|FG000|Overall Study|Withdrawal by Subject|1|||
124703366|NCT03900650|448537303|FG001|Overall Study|Withdrawal by Subject|1|||
124703367|NCT03900650|448537304|FG002|Overall Study|Withdrawal by Subject|0|||
124703368|NCT03900650|448537305|FG003|Overall Study|Withdrawal by Subject|0|||
124703369|NCT03900650|448537302|FG000|Overall Study|Withdrawn by staff|1|||
124765013|NCT04913610|448765110|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
124939982|NCT03277989|449408589|FG000|Overall Study|Withdrawal by Subject|3|||
124939983|NCT03277989|449408589|FG000|Overall Study|Didn't Receive Study Device|7|||
124939984|NCT03277989|449408589|FG000|Overall Study|Site Closure|26|||
124939985|NCT03277989|449408589|FG000|Overall Study|Sponsor Closure|107|||
124939986|NCT05704725|449408592|FG000|Overall Study|Lost to Follow-up|0|||
124939987|NCT05704725|449408593|FG001|Overall Study|Lost to Follow-up|1|||
124939988|NCT05704725|449408592|FG000|Overall Study|Withdrawal by Subject|1|||
124939989|NCT05704725|449408593|FG001|Overall Study|Withdrawal by Subject|0|||
124939990|NCT03227861|449408594|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
124939991|NCT03227861|449408594|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
124939992|NCT03227861|449408594|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
124456752|NCT03670953|447633547|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
124456753|NCT03670953|447633548|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
124456754|NCT03670953|447633549|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
124456755|NCT03670953|447633550|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
124456756|NCT03670953|447633547|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
124456757|NCT03670953|447633548|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
124456758|NCT03670953|447633549|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
124456759|NCT03670953|447633550|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
124456760|NCT03670953|447633547|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
124456761|NCT03670953|447633548|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
124456762|NCT03670953|447633549|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
124456763|NCT03670953|447633550|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
124456764|NCT03670953|447633547|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
124456765|NCT03670953|447633548|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
124456766|NCT03670953|447633549|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
124456767|NCT03670953|447633550|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
124456768|NCT03670953|447633547|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
124456769|NCT03670953|447633548|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
124456770|NCT03670953|447633549|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
124456771|NCT03670953|447633550|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
124456772|NCT03670953|447633547|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
124456773|NCT03670953|447633548|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
124456774|NCT03670953|447633549|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
124703370|NCT03900650|448537303|FG001|Overall Study|Withdrawn by staff|0|||
124703371|NCT03900650|448537304|FG002|Overall Study|Withdrawn by staff|0|||
124703372|NCT03900650|448537305|FG003|Overall Study|Withdrawn by staff|0|||
124765014|NCT04913610|448765111|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
124939993|NCT03227861|449408594|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
124939994|NCT03227861|449408594|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
124703373|NCT01554904|448537308|FG000|Overall Study|Withdrawal by Subject|3|||
124703374|NCT01554904|448537308|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
124703375|NCT00635050|448537311|FG000|Overall Study|Withdrawal by Subject|1|||
124703376|NCT00086515|448537312|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
124546750|NCT01035229|447957372|FG000|Overall Study|Withdrawal by Subject|20|||
124546751|NCT01035229|447957373|FG001|Overall Study|Withdrawal by Subject|7|||
124546752|NCT01035229|447957372|FG000|Overall Study|Lost to Follow-up|1|||
124546753|NCT01035229|447957373|FG001|Overall Study|Lost to Follow-up|0|||
124546754|NCT01035229|447957372|FG000|Overall Study|Administrative problems|1|||
124546755|NCT01035229|447957373|FG001|Overall Study|Administrative problems|1|||
124546756|NCT01035229|447957372|FG000|Overall Study|Death|13|||
124546757|NCT01035229|447957373|FG001|Overall Study|Death|5|||
124546758|NCT01035229|447957372|FG000|Overall Study|New cancer therapy|2|||
124546759|NCT01035229|447957373|FG001|Overall Study|New cancer therapy|0|||
124546760|NCT01035229|447957372|FG000|Overall Study|Protocol Violation|0|||
124546761|NCT01035229|447957373|FG001|Overall Study|Protocol Violation|2|||
124546762|NCT01035229|447957372|FG000|Overall Study|Sponsor's decision to end study|3|||
124546763|NCT01035229|447957373|FG001|Overall Study|Sponsor's decision to end study|3|||
124546764|NCT01035229|447957372|FG000|Overall Study|Disease Progression|261|||
124546765|NCT01035229|447957373|FG001|Overall Study|Disease Progression|152|||
124546766|NCT00564486|447957376|FG000|Overall Study|Adverse Event|0|||
124546767|NCT00564486|447957377|FG001|Overall Study|Adverse Event|1|||
124546768|NCT00564486|447957378|FG002|Overall Study|Adverse Event|0|||
124546769|NCT00564486|447957379|FG003|Overall Study|Adverse Event|0|||
124546770|NCT00564486|447957376|FG000|Overall Study|Withdrawal by Subject|4|||
124546771|NCT00564486|447957377|FG001|Overall Study|Withdrawal by Subject|0|||
124546772|NCT00564486|447957378|FG002|Overall Study|Withdrawal by Subject|0|||
124546773|NCT00564486|447957379|FG003|Overall Study|Withdrawal by Subject|5|||
124546774|NCT00564486|447957376|FG000|Overall Study|Subject refused to have blood drawn|0|||
124546775|NCT00564486|447957377|FG001|Overall Study|Subject refused to have blood drawn|0|||
124546776|NCT00564486|447957378|FG002|Overall Study|Subject refused to have blood drawn|1|||
124546777|NCT00564486|447957379|FG003|Overall Study|Subject refused to have blood drawn|0|||
124546778|NCT00564486|447957376|FG000|Overall Study|Lost to Follow-up|3|||
124546779|NCT00564486|447957377|FG001|Overall Study|Lost to Follow-up|0|||
124546780|NCT00564486|447957378|FG002|Overall Study|Lost to Follow-up|2|||
124546781|NCT00564486|447957379|FG003|Overall Study|Lost to Follow-up|2|||
124546782|NCT03862807|447957384|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
124546783|NCT04362761|447957385|FG000|Part A (48 Weeks)|Adverse Event|2|||
124546784|NCT04362761|447957385|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
124546785|NCT04362761|447957385|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
124546786|NCT04362761|447957385|FG000|Part A (48 Weeks)|Other|5|||
124546787|NCT04362761|447957385|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
124546788|NCT04362761|447957385|FG000|Part B (86 Weeks)|Other|4|||
124546789|NCT00684645|447957386|FG000|Overall Study|Death|2|||
124546790|NCT00684645|447957386|FG000|Overall Study|Progressive disease|67|||
124546791|NCT00684645|447957386|FG000|Overall Study|Adverse Event|27|||
124546792|NCT00684645|447957386|FG000|Overall Study|Lost to Follow-up|3|||
124546793|NCT00684645|447957386|FG000|Overall Study|Other|15|||
124546794|NCT02856282|447957395|FG000|Overall Study|Withdrawal by Subject|1|||
124546795|NCT02074982|447957396|FG000|Overall Study|Adverse Event|15|||
124546796|NCT02074982|447957397|FG001|Overall Study|Adverse Event|7|||
124546797|NCT02074982|447957396|FG000|Overall Study|Lack of Efficacy|6|||
124546798|NCT02074982|447957397|FG001|Overall Study|Lack of Efficacy|1|||
124546799|NCT02074982|447957396|FG000|Overall Study|Lost to Follow-up|9|||
124546800|NCT02074982|447957397|FG001|Overall Study|Lost to Follow-up|10|||
124546801|NCT02074982|447957396|FG000|Overall Study|Non-compliance with study treatment|0|||
124456775|NCT03670953|447633550|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
124456776|NCT03670953|447633547|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
124456777|NCT03670953|447633548|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
124456778|NCT03670953|447633549|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
124456779|NCT03670953|447633550|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
124456780|NCT03670953|447633547|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
124456781|NCT03670953|447633548|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
124456782|NCT03670953|447633549|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
124456783|NCT03670953|447633550|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
124456784|NCT01199042|447633551|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
124546802|NCT02074982|447957397|FG001|Overall Study|Non-compliance with study treatment|2|||
124546803|NCT02074982|447957396|FG000|Overall Study|Physician Decision|1|||
124546804|NCT02074982|447957397|FG001|Overall Study|Physician Decision|1|||
124546805|NCT02074982|447957396|FG000|Overall Study|Pregnancy|1|||
124703377|NCT00086515|448537313|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
124546806|NCT02074982|447957397|FG001|Overall Study|Pregnancy|2|||
124546807|NCT02074982|447957396|FG000|Overall Study|Protocol deviation|4|||
124546808|NCT02074982|447957397|FG001|Overall Study|Protocol deviation|3|||
124546809|NCT02074982|447957396|FG000|Overall Study|Technical problems|0|||
124546810|NCT02074982|447957397|FG001|Overall Study|Technical problems|2|||
124546811|NCT02074982|447957396|FG000|Overall Study|Subject/guardian decision|15|||
124703378|NCT00086515|448537312|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
124546812|NCT02074982|447957397|FG001|Overall Study|Subject/guardian decision|24|||
124939995|NCT03227861|449408594|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
124939996|NCT03227861|449408594|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
124939997|NCT03227861|449408594|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
124939998|NCT03227861|449408594|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
124939999|NCT03227861|449408594|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
124940000|NCT03516942|449408595|FG000|Registration Through Baseline Survey Com|Withdrawal by Subject|36|||
124940001|NCT03516942|449408595|FG000|Registration Through Baseline Survey Com|Death|8|||
124940002|NCT03516942|449408595|FG000|Registration Through Baseline Survey Com|Could not contact patient after enrollment|58|||
124546813|NCT02074982|447957396|FG000|Overall Study|Death|0|||
124546814|NCT02074982|447957397|FG001|Overall Study|Death|2|||
124546815|NCT00798707|447957405|FG000|Overall Study|Adverse Event|6|||
124546816|NCT00798707|447957406|FG001|Overall Study|Adverse Event|8|||
124546817|NCT00798707|447957407|FG002|Overall Study|Adverse Event|8|||
124546818|NCT00798707|447957405|FG000|Overall Study|Failed to return|2|||
124546819|NCT00798707|447957406|FG001|Overall Study|Failed to return|2|||
124546820|NCT00798707|447957407|FG002|Overall Study|Failed to return|0|||
124546821|NCT00798707|447957405|FG000|Overall Study|Investigator|0|||
124546822|NCT00798707|447957406|FG001|Overall Study|Investigator|1|||
124546823|NCT00798707|447957407|FG002|Overall Study|Investigator|2|||
124546824|NCT00798707|447957405|FG000|Overall Study|Lack of Efficacy|2|||
124546825|NCT00798707|447957406|FG001|Overall Study|Lack of Efficacy|2|||
124546826|NCT00798707|447957407|FG002|Overall Study|Lack of Efficacy|1|||
124546827|NCT00798707|447957405|FG000|Overall Study|Lost to Follow-up|5|||
124546828|NCT00798707|447957406|FG001|Overall Study|Lost to Follow-up|6|||
124546829|NCT00798707|447957407|FG002|Overall Study|Lost to Follow-up|6|||
124546830|NCT00798707|447957405|FG000|Overall Study|Other|0|||
124546831|NCT00798707|447957406|FG001|Overall Study|Other|1|||
124546832|NCT00798707|447957407|FG002|Overall Study|Other|0|||
124546833|NCT00798707|447957405|FG000|Overall Study|Protocol Violation|4|||
124546834|NCT00798707|447957406|FG001|Overall Study|Protocol Violation|0|||
124546835|NCT00798707|447957407|FG002|Overall Study|Protocol Violation|2|||
124546836|NCT00798707|447957405|FG000|Overall Study|Withdrawal by Subject|3|||
124546837|NCT00798707|447957406|FG001|Overall Study|Withdrawal by Subject|8|||
124546838|NCT00798707|447957407|FG002|Overall Study|Withdrawal by Subject|2|||
124546839|NCT00798707|447957405|FG000|Overall Study|Randomized not treated|4|||
124546840|NCT00798707|447957406|FG001|Overall Study|Randomized not treated|5|||
124546841|NCT00798707|447957407|FG002|Overall Study|Randomized not treated|1|||
124546842|NCT02525627|447957410|FG000|Overall Study|Revision|1|||
124546843|NCT02525627|447957411|FG001|Overall Study|Revision|1|||
124546844|NCT02525627|447957410|FG000|Overall Study|Withdrawal by Subject|1|||
124940003|NCT03516942|449408595|FG000|T0: Baseline|LOST|13|||
124940004|NCT03516942|449408595|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
124940005|NCT03516942|449408595|FG000|T1: 3 Months Survey|Death|10|||
124940006|NCT03516942|449408595|FG000|T1: 3 Months Survey|Lost|163|||
124940007|NCT03516942|449408595|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
124940008|NCT03516942|449408595|FG000|T2: 6 Month Survey|Death|14|||
124940009|NCT03516942|449408595|FG000|T2: 6 Month Survey|Lost|180|||
124940010|NCT03516942|449408595|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
124940011|NCT03516942|449408595|FG000|T3: 12 Month Survey|Death|19|||
124940012|NCT03516942|449408595|FG000|T3: 12 Month Survey|Lost|209|||
124940013|NCT00490139|449408597|FG000|Overall Study|Lost to Follow-up|249|||
124940014|NCT00490139|449408598|FG001|Overall Study|Lost to Follow-up|216|||
124940015|NCT00490139|449408599|FG002|Overall Study|Lost to Follow-up|205|||
124940016|NCT00490139|449408600|FG003|Overall Study|Lost to Follow-up|229|||
124940017|NCT00490139|449408597|FG000|Overall Study|Withdrawal by Subject|333|||
124940018|NCT00490139|449408598|FG001|Overall Study|Withdrawal by Subject|322|||
124940019|NCT00490139|449408599|FG002|Overall Study|Withdrawal by Subject|396|||
124940020|NCT00490139|449408600|FG003|Overall Study|Withdrawal by Subject|295|||
124940021|NCT00490139|449408597|FG000|Overall Study|Patient did not sign ICF 12|169|||
124456785|NCT01199042|447633551|FG000|At Home (3 Months)|Lost to Follow-up|1|||
124940022|NCT00490139|449408598|FG001|Overall Study|Patient did not sign ICF 12|176|||
124940023|NCT00490139|449408599|FG002|Overall Study|Patient did not sign ICF 12|139|||
124940024|NCT00490139|449408600|FG003|Overall Study|Patient did not sign ICF 12|167|||
124940025|NCT00490139|449408597|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
124940026|NCT00490139|449408598|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
124456786|NCT00880399|447633552|FG000|Overall Study|Adverse Event|4|||
124456787|NCT00880399|447633553|FG001|Overall Study|Adverse Event|6|||
124456788|NCT00880399|447633554|FG002|Overall Study|Adverse Event|5|||
124456789|NCT00880399|447633552|FG000|Overall Study|Lack of Efficacy|1|||
124456790|NCT00880399|447633553|FG001|Overall Study|Lack of Efficacy|4|||
124456791|NCT00880399|447633554|FG002|Overall Study|Lack of Efficacy|2|||
124456792|NCT00880399|447633552|FG000|Overall Study|Protocol Violation|4|||
124456793|NCT00880399|447633553|FG001|Overall Study|Protocol Violation|4|||
124546845|NCT02525627|447957411|FG001|Overall Study|Withdrawal by Subject|2|||
124546846|NCT02525627|447957410|FG000|Overall Study|Death|1|||
124546847|NCT02525627|447957411|FG001|Overall Study|Death|0|||
124546848|NCT02525627|447957410|FG000|Overall Study|Site terminated|11|||
124940027|NCT00490139|449408599|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
124703379|NCT00086515|448537313|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
124703380|NCT00086515|448537312|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
124703381|NCT00086515|448537313|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
124703382|NCT00086515|448537312|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
124940028|NCT00490139|449408600|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
124940029|NCT00490139|449408597|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
124940030|NCT00490139|449408598|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
124940031|NCT00490139|449408599|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
124940032|NCT00490139|449408600|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
124703383|NCT00086515|448537313|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
124703384|NCT00086515|448537312|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
124703385|NCT00086515|448537313|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
124703386|NCT00086515|448537312|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
124703387|NCT00086515|448537313|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
124703388|NCT00086515|448537312|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
124703389|NCT00086515|448537313|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
124703390|NCT00086515|448537312|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
124703391|NCT00086515|448537313|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
124703392|NCT00086515|448537312|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
124703393|NCT00086515|448537313|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
124703394|NCT00086515|448537312|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
124703395|NCT00086515|448537313|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
124703396|NCT00086515|448537312|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
124940033|NCT00490139|449408597|FG000|Overall Study|Other reasons as defined per protocol|98|||
124940034|NCT00490139|449408598|FG001|Overall Study|Other reasons as defined per protocol|84|||
124940035|NCT00490139|449408599|FG002|Overall Study|Other reasons as defined per protocol|82|||
124940036|NCT00490139|449408600|FG003|Overall Study|Other reasons as defined per protocol|105|||
124940037|NCT02798471|449408603|FG000|Overall Study|Adverse Event|7|||
124940038|NCT02798471|449408604|FG001|Overall Study|Adverse Event|2|||
124940039|NCT02798471|449408603|FG000|Overall Study|Physician Decision|3|||
124940040|NCT02798471|449408604|FG001|Overall Study|Physician Decision|7|||
124940041|NCT02798471|449408603|FG000|Overall Study|Death|2|||
124940042|NCT02798471|449408604|FG001|Overall Study|Death|3|||
124940043|NCT02798471|449408603|FG000|Overall Study|Lost to Follow-up|0|||
124940044|NCT02798471|449408604|FG001|Overall Study|Lost to Follow-up|1|||
124940045|NCT02798471|449408603|FG000|Overall Study|Other|5|||
124940046|NCT02798471|449408604|FG001|Overall Study|Other|3|||
124940047|NCT02798471|449408603|FG000|Overall Study|Subject withdrew consent|0|||
124940048|NCT02798471|449408604|FG001|Overall Study|Subject withdrew consent|6|||
124940049|NCT02798471|449408603|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
124940050|NCT02798471|449408604|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
124940051|NCT02798471|449408603|FG000|Overall Study|Randomized, but not treated|0|||
124940052|NCT02798471|449408604|FG001|Overall Study|Randomized, but not treated|2|||
124940053|NCT05293717|449408605|FG000|Overall Study|Physician Decision|1|||
124940054|NCT04989816|449409776|FG000|Overall Study|Death|77|||
124940055|NCT04989816|449409776|FG000|Overall Study|Lost to Follow-up|3|||
124940056|NCT01982682|449409777|FG000|Overall Study|Physician Decision|1|||
124940057|NCT00065182|449409779|FG000|Overall Study|Adverse Event|24|||
124940058|NCT00065182|449409780|FG001|Overall Study|Adverse Event|17|||
124940059|NCT00065182|449409779|FG000|Overall Study|Lost to Follow-up|0|||
124940060|NCT00065182|449409780|FG001|Overall Study|Lost to Follow-up|4|||
124940061|NCT00065182|449409779|FG000|Overall Study|Protocol Violation|3|||
124940062|NCT00065182|449409780|FG001|Overall Study|Protocol Violation|4|||
124940063|NCT00065182|449409779|FG000|Overall Study|Serious adverse events (SAE)|1|||
124940064|NCT00065182|449409780|FG001|Overall Study|Serious adverse events (SAE)|0|||
124940065|NCT00065182|449409779|FG000|Overall Study|Sponsor Decision|11|||
124940066|NCT00065182|449409780|FG001|Overall Study|Sponsor Decision|7|||
124940067|NCT00065182|449409779|FG000|Overall Study|Withdrawal by Subject|8|||
124940068|NCT00065182|449409780|FG001|Overall Study|Withdrawal by Subject|3|||
124940069|NCT00065182|449409779|FG000|Overall Study|No clinical benefit|1|||
124940070|NCT00065182|449409780|FG001|Overall Study|No clinical benefit|0|||
124940071|NCT00065182|449409779|FG000|Overall Study|Death|0|||
124940072|NCT00065182|449409780|FG001|Overall Study|Death|1|||
124940073|NCT00065182|449409779|FG000|Overall Study|Decline in Status|0|||
124940074|NCT00065182|449409780|FG001|Overall Study|Decline in Status|1|||
124940075|NCT00754325|449409781|FG000|Initial Treatment|Continuing Active Treatment|4|||
124940076|NCT00754325|449409782|FG001|Initial Treatment|Continuing Active Treatment|5|||
124940077|NCT00754325|449409781|FG000|Initial Treatment|Adverse Event|7|||
124940078|NCT00754325|449409782|FG001|Initial Treatment|Adverse Event|6|||
124940079|NCT00754325|449409781|FG000|Initial Treatment|Withdrawal by Subject|2|||
124940080|NCT00754325|449409782|FG001|Initial Treatment|Withdrawal by Subject|2|||
124546849|NCT02525627|447957411|FG001|Overall Study|Site terminated|10|||
124703397|NCT00086515|448537313|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
124703398|NCT00086515|448537312|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
124703399|NCT00086515|448537313|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
124703400|NCT00086515|448537312|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
124703401|NCT00086515|448537313|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
124703402|NCT00086515|448537312|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
124703403|NCT00086515|448537313|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
124703404|NCT00086515|448537312|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
124703405|NCT00086515|448537313|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
124703406|NCT00086515|448537312|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
124703407|NCT00086515|448537313|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
124703408|NCT00086515|448537312|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
124703409|NCT00086515|448537313|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
124703410|NCT00086515|448537312|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
124703411|NCT00086515|448537313|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
124703412|NCT00086515|448537312|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
124703413|NCT00086515|448537313|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
124703414|NCT00086515|448537312|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
124703415|NCT00086515|448537313|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
124703416|NCT00086515|448537312|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
124703417|NCT00086515|448537313|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
124703418|NCT00086515|448537312|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
124703419|NCT00086515|448537313|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
124703420|NCT00086515|448537312|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
124703421|NCT00086515|448537313|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
124703422|NCT00086515|448537312|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
124940081|NCT00754325|449409781|FG000|Initial Treatment|Physician Decision|2|||
124940082|NCT00754325|449409782|FG001|Initial Treatment|Physician Decision|0|||
124940083|NCT00754325|449409781|FG000|Initial Treatment|Sponsor Request|0|||
124940084|NCT00754325|449409782|FG001|Initial Treatment|Sponsor Request|1|||
124940085|NCT00754325|449409781|FG000|Initial Treatment|Disease Progression|35|||
124940086|NCT00754325|449409782|FG001|Initial Treatment|Disease Progression|35|||
124940087|NCT01750684|449409787|FG000|Overall Study|Death|1|||
124940088|NCT01750684|449409788|FG001|Overall Study|Death|0|||
124940089|NCT01750684|449409787|FG000|Overall Study|Non-compliance with Study Drug|0|||
124940090|NCT01750684|449409788|FG001|Overall Study|Non-compliance with Study Drug|1|||
124940091|NCT01750684|449409787|FG000|Overall Study|Withdrawn by Sponsor|0|||
124940092|NCT01750684|449409788|FG001|Overall Study|Withdrawn by Sponsor|1|||
124940093|NCT01750684|449409787|FG000|Overall Study|Protocol Violation|1|||
124940094|NCT01750684|449409788|FG001|Overall Study|Protocol Violation|0|||
124940095|NCT02185794|449409790|FG000|Overall Study|Enrolled but Never Dosed|1|||
124940096|NCT02185794|449409791|FG001|Overall Study|Enrolled but Never Dosed|6|||
124940097|NCT02185794|449409792|FG002|Overall Study|Enrolled but Never Dosed|3|||
124940098|NCT02185794|449409793|FG003|Overall Study|Enrolled but Never Dosed|1|||
124940099|NCT02185794|449409794|FG004|Overall Study|Enrolled but Never Dosed|1|||
124940100|NCT02185794|449409795|FG005|Overall Study|Enrolled but Never Dosed|0|||
124940101|NCT02185794|449409790|FG000|Overall Study|Investigator's Discretion|1|||
124940102|NCT02185794|449409791|FG001|Overall Study|Investigator's Discretion|0|||
124940103|NCT02185794|449409792|FG002|Overall Study|Investigator's Discretion|1|||
124940104|NCT02185794|449409793|FG003|Overall Study|Investigator's Discretion|2|||
124940105|NCT02185794|449409794|FG004|Overall Study|Investigator's Discretion|2|||
124940106|NCT02185794|449409795|FG005|Overall Study|Investigator's Discretion|15|||
124940107|NCT02185794|449409790|FG000|Overall Study|Withdrew Consent|2|||
124703423|NCT00086515|448537313|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
124703424|NCT00086515|448537312|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
124703425|NCT00086515|448537313|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
124940108|NCT02185794|449409791|FG001|Overall Study|Withdrew Consent|5|||
124940109|NCT02185794|449409792|FG002|Overall Study|Withdrew Consent|10|||
124940110|NCT02185794|449409793|FG003|Overall Study|Withdrew Consent|2|||
124940111|NCT02185794|449409794|FG004|Overall Study|Withdrew Consent|0|||
124456794|NCT00880399|447633554|FG002|Overall Study|Protocol Violation|6|||
124940112|NCT02185794|449409795|FG005|Overall Study|Withdrew Consent|0|||
124940113|NCT02185794|449409790|FG000|Overall Study|Lost to Follow-up|1|||
124940114|NCT02185794|449409791|FG001|Overall Study|Lost to Follow-up|2|||
124940115|NCT02185794|449409792|FG002|Overall Study|Lost to Follow-up|2|||
124456795|NCT00880399|447633552|FG000|Overall Study|Study closed/terminated|3|||
124456796|NCT00880399|447633553|FG001|Overall Study|Study closed/terminated|7|||
124456797|NCT00880399|447633554|FG002|Overall Study|Study closed/terminated|4|||
124456798|NCT00880399|447633552|FG000|Overall Study|Lost to Follow-up|8|||
124456799|NCT00880399|447633553|FG001|Overall Study|Lost to Follow-up|5|||
124940116|NCT02185794|449409793|FG003|Overall Study|Lost to Follow-up|3|||
124940117|NCT02185794|449409794|FG004|Overall Study|Lost to Follow-up|0|||
124940118|NCT02185794|449409795|FG005|Overall Study|Lost to Follow-up|1|||
124456800|NCT00880399|447633554|FG002|Overall Study|Lost to Follow-up|3|||
124703426|NCT00086515|448537312|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
124940119|NCT01092416|449409796|FG000|Enrollment|Atherectomy device not inserted|3|||
124703427|NCT00086515|448537313|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
124703428|NCT00086515|448537312|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
124703429|NCT00086515|448537313|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
124703430|NCT00086515|448537312|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
124703431|NCT00086515|448537313|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
124703432|NCT00086515|448537312|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
124703433|NCT00086515|448537313|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
124703434|NCT00086515|448537312|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
124703435|NCT00086515|448537313|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
124703436|NCT00086515|448537312|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
124703437|NCT00086515|448537313|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
124940120|NCT01092416|449409796|FG000|30-Day Follow-up|Death|2|||
124940121|NCT01092416|449409796|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
124940122|NCT01092416|449409796|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
124940123|NCT01092416|449409796|FG000|12-Month Follow-up|Death|16|||
124940124|NCT01092416|449409796|FG000|12-Month Follow-up|Lost to Follow-up|4|||
124940125|NCT01092416|449409796|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
124940126|NCT01092416|449409796|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
124940127|NCT01092416|449409796|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
124940128|NCT00366249|449409797|FG000|Overall Study|Adverse Event|53|||
124940129|NCT00366249|449409798|FG001|Overall Study|Adverse Event|28|||
124940130|NCT00366249|449409797|FG000|Overall Study|Death|0|||
124940131|NCT00366249|449409798|FG001|Overall Study|Death|1|||
124940132|NCT00366249|449409797|FG000|Overall Study|Physician Decision|5|||
124940133|NCT00366249|449409798|FG001|Overall Study|Physician Decision|2|||
124940134|NCT00366249|449409797|FG000|Overall Study|Lost to Follow-up|2|||
124940135|NCT00366249|449409798|FG001|Overall Study|Lost to Follow-up|0|||
124940136|NCT00366249|449409797|FG000|Overall Study|Protocol Violation|1|||
124940137|NCT00366249|449409798|FG001|Overall Study|Protocol Violation|2|||
124940138|NCT00366249|449409797|FG000|Overall Study|Withdrawal by Subject|18|||
124940139|NCT00366249|449409798|FG001|Overall Study|Withdrawal by Subject|4|||
124940140|NCT00366249|449409797|FG000|Overall Study|Lack of Efficacy|21|||
124940141|NCT00366249|449409798|FG001|Overall Study|Lack of Efficacy|21|||
124940142|NCT00366249|449409797|FG000|Overall Study|Most due to osteomylitis status|31|||
124940143|NCT00366249|449409798|FG001|Overall Study|Most due to osteomylitis status|20|||
124940144|NCT00777049|449409799|FG000|Overall Study|Withdrawal by Subject|1|||
124940145|NCT00777049|449409800|FG001|Overall Study|Withdrawal by Subject|0|||
124940146|NCT00777049|449409799|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
124940147|NCT00777049|449409800|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
124940148|NCT03478969|449409801|FG000|Overall Study|Withdrawal by Subject|4|||
124940149|NCT03478969|449409802|FG001|Overall Study|Withdrawal by Subject|7|||
124940150|NCT03478969|449409803|FG002|Overall Study|Withdrawal by Subject|6|||
124940151|NCT03478969|449409801|FG000|Overall Study|Adverse Event|2|||
124940152|NCT03478969|449409802|FG001|Overall Study|Adverse Event|0|||
124940153|NCT03478969|449409803|FG002|Overall Study|Adverse Event|1|||
124940154|NCT03478969|449409801|FG000|Overall Study|Pregnancy|1|||
124456801|NCT00880399|447633552|FG000|Overall Study|Physician Decision|5|||
124456802|NCT00880399|447633553|FG001|Overall Study|Physician Decision|0|||
124456803|NCT00880399|447633554|FG002|Overall Study|Physician Decision|3|||
124456804|NCT00880399|447633552|FG000|Overall Study|Withdrawal by Subject|6|||
124456805|NCT00880399|447633553|FG001|Overall Study|Withdrawal by Subject|3|||
124456806|NCT00880399|447633554|FG002|Overall Study|Withdrawal by Subject|3|||
124456807|NCT04353284|447633555|FG000|Overall Study|Adverse Event|1|||
124456808|NCT04353284|447633556|FG001|Overall Study|Adverse Event|1|||
124456809|NCT04353284|447633555|FG000|Overall Study|Lost to Follow-up|1|||
124456810|NCT04353284|447633556|FG001|Overall Study|Lost to Follow-up|0|||
124456811|NCT00122681|447633557|FG000|Overall Study|Adverse Event|20|||
124456812|NCT00122681|447633558|FG001|Overall Study|Adverse Event|16|||
124456813|NCT00122681|447633557|FG000|Overall Study|Lost to Follow-up|1080|||
124456814|NCT00122681|447633558|FG001|Overall Study|Lost to Follow-up|1097|||
124456815|NCT00122681|447633557|FG000|Overall Study|Protocol Violation|7|||
124456816|NCT00122681|447633558|FG001|Overall Study|Protocol Violation|10|||
124456817|NCT00122681|447633557|FG000|Overall Study|Withdrawal by Subject|257|||
124456818|NCT00122681|447633558|FG001|Overall Study|Withdrawal by Subject|251|||
124456819|NCT00122681|447633557|FG000|Overall Study|Personal reasons|150|||
124456820|NCT00122681|447633558|FG001|Overall Study|Personal reasons|147|||
124456821|NCT02819635|447633560|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
124456822|NCT02819635|447633561|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
124456823|NCT02819635|447633562|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
124456824|NCT02819635|447633563|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
124456825|NCT02819635|447633564|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
124546850|NCT03746080|447957412|FG000|Overall Study|In follow up|2|||
124546851|NCT03746080|447957412|FG000|Overall Study|Death|15|||
124456826|NCT02819635|447633565|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
124940155|NCT03478969|449409802|FG001|Overall Study|Pregnancy|0|||
124940156|NCT03478969|449409803|FG002|Overall Study|Pregnancy|0|||
124940157|NCT03478969|449409801|FG000|Overall Study|Personal Reasons|1|||
124940158|NCT03478969|449409802|FG001|Overall Study|Personal Reasons|0|||
124940159|NCT03478969|449409803|FG002|Overall Study|Personal Reasons|1|||
124940160|NCT03478969|449409801|FG000|Overall Study|Covid-19|1|||
124940161|NCT03478969|449409802|FG001|Overall Study|Covid-19|4|||
124940162|NCT03478969|449409803|FG002|Overall Study|Covid-19|3|||
124940163|NCT03478969|449409801|FG000|Overall Study|Multiple Reasons|0|||
124940164|NCT03478969|449409802|FG001|Overall Study|Multiple Reasons|1|||
124940165|NCT03478969|449409803|FG002|Overall Study|Multiple Reasons|1|||
124940166|NCT03478969|449409801|FG000|Overall Study|Eligibility Criteria|0|||
124940167|NCT03478969|449409802|FG001|Overall Study|Eligibility Criteria|0|||
124940168|NCT03478969|449409803|FG002|Overall Study|Eligibility Criteria|5|||
124940169|NCT03478969|449409801|FG000|Overall Study|Lost to Follow-up|0|||
124940170|NCT03478969|449409802|FG001|Overall Study|Lost to Follow-up|0|||
124940171|NCT03478969|449409803|FG002|Overall Study|Lost to Follow-up|1|||
124940172|NCT01185600|449409804|FG000|Overall Study|Adverse Event|1|||
124940173|NCT01185600|449409805|FG001|Overall Study|Adverse Event|1|||
124940174|NCT01185600|449409804|FG000|Overall Study|Death|0|||
124940175|NCT01185600|449409805|FG001|Overall Study|Death|1|||
124940176|NCT01185600|449409804|FG000|Overall Study|Lost to Follow-up|0|||
124940177|NCT01185600|449409805|FG001|Overall Study|Lost to Follow-up|5|||
124940178|NCT01185600|449409804|FG000|Overall Study|Physician Decision|29|||
124940179|NCT01185600|449409805|FG001|Overall Study|Physician Decision|35|||
124940180|NCT01185600|449409804|FG000|Overall Study|Withdrawal by Subject|1|||
124940181|NCT01185600|449409805|FG001|Overall Study|Withdrawal by Subject|1|||
124940182|NCT01185600|449409804|FG000|Overall Study|Hold by DSMB|1|||
124940183|NCT01185600|449409805|FG001|Overall Study|Hold by DSMB|2|||
124940184|NCT02941549|449409806|FG000|Overall Study|Adverse Event|1|||
124940185|NCT02941549|449409807|FG001|Overall Study|Adverse Event|0|||
124940186|NCT02941549|449409808|FG002|Overall Study|Adverse Event|0|||
124940187|NCT02941549|449409806|FG000|Overall Study|Withdrawal by Subject|2|||
124940188|NCT02941549|449409807|FG001|Overall Study|Withdrawal by Subject|1|||
124940189|NCT02941549|449409808|FG002|Overall Study|Withdrawal by Subject|2|||
124940190|NCT01436175|449409810|FG000|Overall Study|Adverse Event|111|||
124940191|NCT01436175|449409810|FG000|Overall Study|Protocol Violation|49|||
124456827|NCT02819635|447633566|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
124456828|NCT02819635|447633567|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
124456829|NCT02819635|447633568|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
124456830|NCT02819635|447633569|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
124456831|NCT02819635|447633570|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
124456832|NCT02819635|447633571|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
124456833|NCT02819635|447633560|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
124456834|NCT02819635|447633561|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
124456835|NCT02819635|447633562|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
124456836|NCT02819635|447633563|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
124456837|NCT02819635|447633564|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
124456838|NCT02819635|447633565|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
124456839|NCT02819635|447633566|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
124456840|NCT02819635|447633567|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
124456841|NCT02819635|447633568|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
124456842|NCT02819635|447633569|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
124456843|NCT02819635|447633570|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
124456844|NCT02819635|447633571|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
124456845|NCT02819635|447633560|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
124456846|NCT02819635|447633561|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
124456847|NCT02819635|447633562|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
124456848|NCT02819635|447633563|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
124456849|NCT02819635|447633564|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
124456850|NCT02819635|447633565|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
124456851|NCT02819635|447633566|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
124940192|NCT01436175|449409810|FG000|Overall Study|Withdrawal by Subject|108|||
124940193|NCT01436175|449409810|FG000|Overall Study|Lost to Follow-up|89|||
124940194|NCT01436175|449409810|FG000|Overall Study|Lack of Efficacy|24|||
124940195|NCT01436175|449409810|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
124940196|NCT01436175|449409810|FG000|Overall Study|Other|826|||
124940197|NCT03577106|449409813|FG000|Overall Study|Withdrawal by Subject|3|||
124940198|NCT03601715|449409816|FG000|Second Intervention|Lost to Follow-up|1|||
124940199|NCT03601715|449409817|FG001|Second Intervention|Lost to Follow-up|1|||
124940200|NCT03601715|449409818|FG002|Second Intervention|Lost to Follow-up|0|||
124456852|NCT02819635|447633567|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
124456853|NCT02819635|447633568|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
124546852|NCT02094573|447957413|FG000|Overall Study|Adverse Event|4|||
124940201|NCT00918333|449409821|FG000|Overall Study|Drug not taken per protocol|1|||
124940202|NCT00918333|449409822|FG001|Overall Study|Drug not taken per protocol|0|||
124940203|NCT00918333|449409821|FG000|Overall Study|Inadequate amount of drugs provided|1|||
124940204|NCT00918333|449409822|FG001|Overall Study|Inadequate amount of drugs provided|4|||
124940205|NCT00918333|449409821|FG000|Overall Study|Ineligible|1|||
124940206|NCT00918333|449409822|FG001|Overall Study|Ineligible|0|||
124940207|NCT00918333|449409821|FG000|Overall Study|Withdrawal by Subject|0|||
124940208|NCT00918333|449409822|FG001|Overall Study|Withdrawal by Subject|1|||
124940209|NCT01313884|449409824|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
124940210|NCT00263757|449409825|FG000|Overall Study|Withdrawal by Subject|5|||
124940211|NCT00263757|449409826|FG001|Overall Study|Withdrawal by Subject|4|||
124456854|NCT02819635|447633569|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
124456855|NCT02819635|447633570|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
124703438|NCT00049543|448537314|FG000|Overall Study|still on treatment|2|||
124703439|NCT00049543|448537315|FG001|Overall Study|still on treatment|9|||
124703440|NCT02106832|448537316|FG000|Overall Study|Adverse Event|1|||
124703441|NCT02106832|448537317|FG001|Overall Study|Adverse Event|2|||
124703442|NCT02106832|448537318|FG002|Overall Study|Adverse Event|3|||
124703443|NCT02106832|448537319|FG003|Overall Study|Adverse Event|0|||
124703444|NCT02106832|448537316|FG000|Overall Study|Death|4|||
124703445|NCT02106832|448537317|FG001|Overall Study|Death|4|||
124703446|NCT02106832|448537318|FG002|Overall Study|Death|1|||
124703447|NCT02106832|448537319|FG003|Overall Study|Death|4|||
124456856|NCT02819635|447633571|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
124703448|NCT02106832|448537316|FG000|Overall Study|Deterioration of general conditions|0|||
124703449|NCT02106832|448537317|FG001|Overall Study|Deterioration of general conditions|0|||
124703450|NCT02106832|448537318|FG002|Overall Study|Deterioration of general conditions|1|||
124456857|NCT02819635|447633560|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
124456858|NCT02819635|447633561|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
124456859|NCT02819635|447633562|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
124456860|NCT02819635|447633563|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
124456861|NCT02819635|447633564|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
124456862|NCT02819635|447633565|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
124456863|NCT02819635|447633566|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
124456864|NCT02819635|447633567|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
124456865|NCT02819635|447633568|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
124456866|NCT02819635|447633569|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
124456867|NCT02819635|447633570|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
124456868|NCT02819635|447633571|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
124456869|NCT02819635|447633560|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
124456870|NCT02819635|447633561|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
124456871|NCT02819635|447633562|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
124456872|NCT02819635|447633563|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
124456873|NCT02819635|447633564|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
124456874|NCT02819635|447633565|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
124456875|NCT02819635|447633566|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
124456876|NCT02819635|447633567|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
124456877|NCT02819635|447633568|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
124456878|NCT02819635|447633569|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
124456879|NCT02819635|447633570|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
124456880|NCT02819635|447633571|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
124456881|NCT02819635|447633560|FG000|Substudy 2, Part 2|Adverse Event|0|||
124456882|NCT02819635|447633561|FG001|Substudy 2, Part 2|Adverse Event|0|||
124456883|NCT02819635|447633562|FG002|Substudy 2, Part 2|Adverse Event|0|||
124456884|NCT02819635|447633563|FG003|Substudy 2, Part 2|Adverse Event|0|||
124703451|NCT02106832|448537319|FG003|Overall Study|Deterioration of general conditions|0|||
124703452|NCT02106832|448537316|FG000|Overall Study|Lost to Follow-up|0|||
124703453|NCT02106832|448537317|FG001|Overall Study|Lost to Follow-up|1|||
124703454|NCT02106832|448537318|FG002|Overall Study|Lost to Follow-up|1|||
124703455|NCT02106832|448537319|FG003|Overall Study|Lost to Follow-up|3|||
124456885|NCT02819635|447633564|FG004|Substudy 2, Part 2|Adverse Event|0|||
124456886|NCT02819635|447633565|FG005|Substudy 2, Part 2|Adverse Event|4|||
124456887|NCT02819635|447633566|FG006|Substudy 2, Part 2|Adverse Event|0|||
124456888|NCT02819635|447633567|FG007|Substudy 2, Part 2|Adverse Event|0|||
124456889|NCT02819635|447633568|FG008|Substudy 2, Part 2|Adverse Event|0|||
124703456|NCT02106832|448537316|FG000|Overall Study|Physician Decision|1|||
124703457|NCT02106832|448537317|FG001|Overall Study|Physician Decision|0|||
124703458|NCT02106832|448537318|FG002|Overall Study|Physician Decision|0|||
124703459|NCT02106832|448537319|FG003|Overall Study|Physician Decision|0|||
124703460|NCT02106832|448537316|FG000|Overall Study|Protocol Violation|0|||
124703461|NCT02106832|448537317|FG001|Overall Study|Protocol Violation|0|||
124940212|NCT00263757|449409825|FG000|Overall Study|Screen failure|0|||
124456890|NCT02819635|447633569|FG009|Substudy 2, Part 2|Adverse Event|0|||
124456891|NCT02819635|447633570|FG010|Substudy 2, Part 2|Adverse Event|0|||
124546853|NCT02094573|447957414|FG001|Overall Study|Adverse Event|14|||
124546854|NCT02094573|447957413|FG000|Overall Study|Clinical Progressive Disease|9|||
124546855|NCT02094573|447957414|FG001|Overall Study|Clinical Progressive Disease|13|||
124703462|NCT02106832|448537318|FG002|Overall Study|Protocol Violation|0|||
124703463|NCT02106832|448537319|FG003|Overall Study|Protocol Violation|1|||
124703464|NCT02106832|448537316|FG000|Overall Study|Withdrawal by Subject|17|||
124703465|NCT02106832|448537317|FG001|Overall Study|Withdrawal by Subject|17|||
124703466|NCT02106832|448537318|FG002|Overall Study|Withdrawal by Subject|10|||
124703467|NCT02106832|448537319|FG003|Overall Study|Withdrawal by Subject|7|||
124703468|NCT02106832|448537316|FG000|Overall Study|Technical problems|0|||
124703469|NCT02106832|448537317|FG001|Overall Study|Technical problems|1|||
124456892|NCT02819635|447633571|FG011|Substudy 2, Part 2|Adverse Event|0|||
124456893|NCT02819635|447633560|FG000|Substudy 2, Part 2|Withdrew consent|0|||
124456894|NCT02819635|447633561|FG001|Substudy 2, Part 2|Withdrew consent|0|||
124456895|NCT02819635|447633562|FG002|Substudy 2, Part 2|Withdrew consent|0|||
124456896|NCT02819635|447633563|FG003|Substudy 2, Part 2|Withdrew consent|0|||
124456897|NCT02819635|447633564|FG004|Substudy 2, Part 2|Withdrew consent|0|||
124456898|NCT02819635|447633565|FG005|Substudy 2, Part 2|Withdrew consent|3|||
124456899|NCT02819635|447633566|FG006|Substudy 2, Part 2|Withdrew consent|1|||
124456900|NCT02819635|447633567|FG007|Substudy 2, Part 2|Withdrew consent|0|||
124456901|NCT02819635|447633568|FG008|Substudy 2, Part 2|Withdrew consent|0|||
124456902|NCT02819635|447633569|FG009|Substudy 2, Part 2|Withdrew consent|0|||
124456903|NCT02819635|447633570|FG010|Substudy 2, Part 2|Withdrew consent|0|||
124456904|NCT02819635|447633571|FG011|Substudy 2, Part 2|Withdrew consent|0|||
124456905|NCT02819635|447633560|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
124456906|NCT02819635|447633561|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
124456907|NCT02819635|447633562|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
124456908|NCT02819635|447633563|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
124456909|NCT02819635|447633564|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
124456910|NCT02819635|447633565|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
124456911|NCT02819635|447633566|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
124456912|NCT02819635|447633567|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
124456913|NCT02819635|447633568|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
124456914|NCT02819635|447633569|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
124703470|NCT02106832|448537318|FG002|Overall Study|Technical problems|0|||
124703471|NCT02106832|448537319|FG003|Overall Study|Technical problems|0|||
124703472|NCT03485157|448537320|FG000|Double Blind Phase|Lost to Follow-up|4|||
124703473|NCT03485157|448537321|FG001|Double Blind Phase|Lost to Follow-up|4|||
124703474|NCT03485157|448537320|FG000|Double Blind Phase|Adverse Event|2|||
124703475|NCT03485157|448537321|FG001|Double Blind Phase|Adverse Event|1|||
124703476|NCT03485157|448537320|FG000|Double Blind Phase|Withdrawal by Subject|6|||
124703477|NCT03485157|448537321|FG001|Double Blind Phase|Withdrawal by Subject|9|||
124703478|NCT03485157|448537320|FG000|Double Blind Phase|Removal by PI|3|||
124703479|NCT03485157|448537321|FG001|Double Blind Phase|Removal by PI|7|||
124703480|NCT03485157|448537320|FG000|Open Label Phase|Lost to Follow-up|1|||
124703481|NCT03485157|448537321|FG001|Open Label Phase|Lost to Follow-up|2|||
124703482|NCT03485157|448537320|FG000|Open Label Phase|Adverse Event|0|||
124703483|NCT03485157|448537321|FG001|Open Label Phase|Adverse Event|1|||
124703484|NCT03485157|448537320|FG000|Open Label Phase|Withdrawal by Subject|1|||
124703485|NCT03485157|448537321|FG001|Open Label Phase|Withdrawal by Subject|2|||
124703486|NCT03485157|448537320|FG000|Open Label Phase|Removal by PI|2|||
124703487|NCT03485157|448537321|FG001|Open Label Phase|Removal by PI|0|||
124703488|NCT00265122|448537322|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
124940213|NCT00263757|449409826|FG001|Overall Study|Screen failure|1|||
124456915|NCT02819635|447633570|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
124456916|NCT02819635|447633571|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
124456917|NCT02819635|447633560|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
124456918|NCT02819635|447633561|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
124456919|NCT02819635|447633562|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
124456920|NCT02819635|447633563|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
124456921|NCT02819635|447633564|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
124456922|NCT02819635|447633565|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
124456923|NCT02819635|447633566|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
124456924|NCT02819635|447633567|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
124456925|NCT02819635|447633568|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
124546856|NCT02094573|447957413|FG000|Overall Study|Death|11|||
124703489|NCT00265122|448537323|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
124703490|NCT00265122|448537324|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
124703491|NCT00265122|448537325|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
124703492|NCT00265122|448537326|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
124703493|NCT00265122|448537327|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
124703494|NCT00265122|448537322|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
124703495|NCT00265122|448537323|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
124703496|NCT00265122|448537324|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
124940214|NCT00263757|449409825|FG000|Overall Study|Adverse Event|3|||
124940215|NCT00263757|449409826|FG001|Overall Study|Adverse Event|3|||
124940216|NCT01342367|449409827|FG000|Overall Study|Death|1|||
124940217|NCT01342367|449409828|FG001|Overall Study|Death|0|||
124940218|NCT01342367|449409827|FG000|Overall Study|Withdrawal by Subject|1|||
124940219|NCT01342367|449409828|FG001|Overall Study|Withdrawal by Subject|2|||
124940220|NCT02964741|449409829|FG000|Overall Study|Protocol Violation|1|||
124940221|NCT02964741|449409830|FG001|Overall Study|Protocol Violation|0|||
124940222|NCT02964741|449409831|FG002|Overall Study|Protocol Violation|0|||
124940223|NCT02964741|449409829|FG000|Overall Study|Withdrawal by Subject|0|||
124940224|NCT02964741|449409830|FG001|Overall Study|Withdrawal by Subject|1|||
124940225|NCT02964741|449409831|FG002|Overall Study|Withdrawal by Subject|0|||
124940226|NCT02964741|449409829|FG000|Overall Study|claustrophobia|1|||
124940227|NCT02964741|449409830|FG001|Overall Study|claustrophobia|0|||
124940228|NCT02964741|449409831|FG002|Overall Study|claustrophobia|0|||
124940229|NCT00640159|449409832|FG000|Overall Study|Lost to Follow-up|2|||
124940230|NCT01500200|449409833|FG000|Stage 1|Adverse Event|1|||
124940231|NCT01500200|449409834|FG001|Stage 1|Adverse Event|4|||
124940232|NCT01500200|449409835|FG002|Stage 1|Adverse Event|5|||
124940233|NCT01500200|449409836|FG003|Stage 1|Adverse Event|0|||
124940234|NCT01500200|449409837|FG004|Stage 1|Adverse Event|0|||
124940235|NCT01500200|449409838|FG005|Stage 1|Adverse Event|0|||
124940236|NCT01500200|449409833|FG000|Stage 1|Lost to Follow-up|2|||
124940237|NCT01500200|449409834|FG001|Stage 1|Lost to Follow-up|2|||
124940238|NCT01500200|449409835|FG002|Stage 1|Lost to Follow-up|1|||
124940239|NCT01500200|449409836|FG003|Stage 1|Lost to Follow-up|0|||
124940240|NCT01500200|449409837|FG004|Stage 1|Lost to Follow-up|0|||
124940241|NCT01500200|449409838|FG005|Stage 1|Lost to Follow-up|0|||
124940242|NCT01500200|449409833|FG000|Stage 1|Withdrawal by Subject|3|||
124940243|NCT01500200|449409834|FG001|Stage 1|Withdrawal by Subject|0|||
124940244|NCT01500200|449409835|FG002|Stage 1|Withdrawal by Subject|0|||
124940245|NCT01500200|449409836|FG003|Stage 1|Withdrawal by Subject|0|||
124940246|NCT01500200|449409837|FG004|Stage 1|Withdrawal by Subject|0|||
124940247|NCT01500200|449409838|FG005|Stage 1|Withdrawal by Subject|0|||
124940248|NCT01500200|449409833|FG000|Stage 1|Noncompliance with Study Drug|1|||
124940249|NCT01500200|449409834|FG001|Stage 1|Noncompliance with Study Drug|0|||
124940250|NCT01500200|449409835|FG002|Stage 1|Noncompliance with Study Drug|0|||
124940251|NCT01500200|449409836|FG003|Stage 1|Noncompliance with Study Drug|0|||
124940252|NCT01500200|449409837|FG004|Stage 1|Noncompliance with Study Drug|0|||
124940253|NCT01500200|449409838|FG005|Stage 1|Noncompliance with Study Drug|0|||
124940254|NCT01500200|449409833|FG000|Stage 1|Physician Decision|1|||
124940255|NCT01500200|449409834|FG001|Stage 1|Physician Decision|0|||
124940256|NCT01500200|449409835|FG002|Stage 1|Physician Decision|0|||
124940257|NCT01500200|449409836|FG003|Stage 1|Physician Decision|0|||
124940258|NCT01500200|449409837|FG004|Stage 1|Physician Decision|0|||
124940259|NCT01500200|449409838|FG005|Stage 1|Physician Decision|0|||
124940260|NCT01500200|449409833|FG000|Stage 2|Adverse Event|0|||
124940261|NCT01500200|449409834|FG001|Stage 2|Adverse Event|0|||
124940262|NCT01500200|449409835|FG002|Stage 2|Adverse Event|0|||
124940263|NCT01500200|449409836|FG003|Stage 2|Adverse Event|0|||
124940264|NCT01500200|449409837|FG004|Stage 2|Adverse Event|5|||
124940265|NCT01500200|449409838|FG005|Stage 2|Adverse Event|4|||
124940266|NCT04860505|449409845|FG000|Overall Study|Lost to Follow-up|2|||
124456926|NCT02819635|447633569|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
124456927|NCT02819635|447633570|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
124456928|NCT02819635|447633571|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
124456929|NCT02819635|447633560|FG000|Substudy 2, Part 2|Other, not specified|0|||
124456930|NCT02819635|447633561|FG001|Substudy 2, Part 2|Other, not specified|0|||
124456931|NCT02819635|447633562|FG002|Substudy 2, Part 2|Other, not specified|0|||
124456932|NCT02819635|447633563|FG003|Substudy 2, Part 2|Other, not specified|0|||
124456933|NCT02819635|447633564|FG004|Substudy 2, Part 2|Other, not specified|0|||
124703497|NCT00265122|448537325|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
124703498|NCT00265122|448537326|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
124703499|NCT00265122|448537327|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
124940267|NCT01212744|449409854|FG000|Overall Study|Withdrawal by Subject|1|||
124940268|NCT02167451|449409855|FG000|Overall Study|Withdrawal by Subject|1|||
124940269|NCT01218659|449409856|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
124940270|NCT01218659|449409857|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
124456934|NCT02819635|447633565|FG005|Substudy 2, Part 2|Other, not specified|4|||
124456935|NCT02819635|447633566|FG006|Substudy 2, Part 2|Other, not specified|8|||
124456936|NCT02819635|447633567|FG007|Substudy 2, Part 2|Other, not specified|0|||
124940271|NCT01218659|449409858|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
124940272|NCT01218659|449409856|FG000|18-Month Randomized Period|Did not receive study drug|0|||
124940273|NCT01218659|449409857|FG001|18-Month Randomized Period|Did not receive study drug|3|||
124940274|NCT01218659|449409858|FG002|18-Month Randomized Period|Did not receive study drug|0|||
124940275|NCT01218659|449409856|FG000|12-Month OLE|Withdrawal by Subject|0|||
124703500|NCT00265122|448537322|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
124703501|NCT00265122|448537323|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
124703502|NCT00265122|448537324|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
124703503|NCT00265122|448537325|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
124940276|NCT01218659|449409857|FG001|12-Month OLE|Withdrawal by Subject|0|||
124940277|NCT01218659|449409858|FG002|12-Month OLE|Withdrawal by Subject|2|||
124940278|NCT01218659|449409856|FG000|12-Month OLE|Physician Decision|0|||
124940279|NCT01218659|449409857|FG001|12-Month OLE|Physician Decision|0|||
124940280|NCT01218659|449409858|FG002|12-Month OLE|Physician Decision|1|||
124940281|NCT01218659|449409856|FG000|12-Month OLE|Lost to Follow-up|0|||
124940282|NCT01218659|449409857|FG001|12-Month OLE|Lost to Follow-up|0|||
124940283|NCT01218659|449409858|FG002|12-Month OLE|Lost to Follow-up|1|||
124940284|NCT01218659|449409856|FG000|12-Month OLE|Pregnancy|0|||
124940285|NCT01218659|449409857|FG001|12-Month OLE|Pregnancy|0|||
124940286|NCT01218659|449409858|FG002|12-Month OLE|Pregnancy|1|||
124940287|NCT01218659|449409856|FG000|12-Month OLE|Lack of Efficacy|0|||
124940288|NCT01218659|449409857|FG001|12-Month OLE|Lack of Efficacy|0|||
124940289|NCT01218659|449409858|FG002|12-Month OLE|Lack of Efficacy|1|||
124940290|NCT01218659|449409856|FG000|12-Month OLE|Declined to participate in the OLE|0|||
124940291|NCT01218659|449409857|FG001|12-Month OLE|Declined to participate in the OLE|0|||
124940292|NCT01218659|449409858|FG002|12-Month OLE|Declined to participate in the OLE|4|||
124940293|NCT03066609|449409863|FG000|INDUCTION|Pregnancy|0|||
124940294|NCT03066609|449409864|FG001|INDUCTION|Pregnancy|0|||
124940295|NCT03066609|449409865|FG002|INDUCTION|Pregnancy|1|||
124940296|NCT03066609|449409866|FG003|INDUCTION|Pregnancy|0|||
124940297|NCT03066609|449409863|FG000|INDUCTION|Lack of Efficacy|0|||
124940298|NCT03066609|449409864|FG001|INDUCTION|Lack of Efficacy|0|||
124940299|NCT03066609|449409865|FG002|INDUCTION|Lack of Efficacy|1|||
124940300|NCT03066609|449409866|FG003|INDUCTION|Lack of Efficacy|0|||
124940301|NCT03066609|449409863|FG000|INDUCTION|Adverse Event|2|||
124940302|NCT03066609|449409864|FG001|INDUCTION|Adverse Event|2|||
124940303|NCT03066609|449409865|FG002|INDUCTION|Adverse Event|0|||
124940304|NCT03066609|449409866|FG003|INDUCTION|Adverse Event|0|||
124456937|NCT02819635|447633568|FG008|Substudy 2, Part 2|Other, not specified|0|||
124456938|NCT02819635|447633569|FG009|Substudy 2, Part 2|Other, not specified|0|||
124456939|NCT02819635|447633570|FG010|Substudy 2, Part 2|Other, not specified|0|||
124456940|NCT02819635|447633571|FG011|Substudy 2, Part 2|Other, not specified|0|||
124456941|NCT02819635|447633560|FG000|Substudy 3|Adverse Event|0|||
124456942|NCT02819635|447633561|FG001|Substudy 3|Adverse Event|0|||
124456943|NCT02819635|447633562|FG002|Substudy 3|Adverse Event|0|||
124456944|NCT02819635|447633563|FG003|Substudy 3|Adverse Event|0|||
124456945|NCT02819635|447633564|FG004|Substudy 3|Adverse Event|0|||
124456946|NCT02819635|447633565|FG005|Substudy 3|Adverse Event|0|||
124456947|NCT02819635|447633566|FG006|Substudy 3|Adverse Event|0|||
124456948|NCT02819635|447633567|FG007|Substudy 3|Adverse Event|0|||
124456949|NCT02819635|447633568|FG008|Substudy 3|Adverse Event|32|||
124456950|NCT02819635|447633569|FG009|Substudy 3|Adverse Event|3|||
124456951|NCT02819635|447633570|FG010|Substudy 3|Adverse Event|12|||
124456952|NCT02819635|447633571|FG011|Substudy 3|Adverse Event|18|||
124456953|NCT02819635|447633560|FG000|Substudy 3|Withdrew consent|0|||
124456954|NCT02819635|447633561|FG001|Substudy 3|Withdrew consent|0|||
124456955|NCT02819635|447633562|FG002|Substudy 3|Withdrew consent|0|||
124456956|NCT02819635|447633563|FG003|Substudy 3|Withdrew consent|0|||
124456957|NCT02819635|447633564|FG004|Substudy 3|Withdrew consent|0|||
124456958|NCT02819635|447633565|FG005|Substudy 3|Withdrew consent|0|||
124456959|NCT02819635|447633566|FG006|Substudy 3|Withdrew consent|0|||
124456960|NCT02819635|447633567|FG007|Substudy 3|Withdrew consent|0|||
124456961|NCT02819635|447633568|FG008|Substudy 3|Withdrew consent|11|||
124456962|NCT02819635|447633569|FG009|Substudy 3|Withdrew consent|1|||
124456963|NCT02819635|447633570|FG010|Substudy 3|Withdrew consent|4|||
124456964|NCT02819635|447633571|FG011|Substudy 3|Withdrew consent|9|||
124456965|NCT02819635|447633560|FG000|Substudy 3|Lost to Follow-up|0|||
124456966|NCT02819635|447633561|FG001|Substudy 3|Lost to Follow-up|0|||
124456967|NCT02819635|447633562|FG002|Substudy 3|Lost to Follow-up|0|||
124456968|NCT02819635|447633563|FG003|Substudy 3|Lost to Follow-up|0|||
124456969|NCT02819635|447633564|FG004|Substudy 3|Lost to Follow-up|0|||
124703504|NCT00265122|448537326|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
124940305|NCT03066609|449409863|FG000|MAINTENANCE|Adverse Event|0|||
124703505|NCT00265122|448537327|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
124940306|NCT03066609|449409864|FG001|MAINTENANCE|Adverse Event|0|||
124940307|NCT03066609|449409865|FG002|MAINTENANCE|Adverse Event|0|||
124456970|NCT02819635|447633565|FG005|Substudy 3|Lost to Follow-up|0|||
124456971|NCT02819635|447633566|FG006|Substudy 3|Lost to Follow-up|0|||
124456972|NCT02819635|447633567|FG007|Substudy 3|Lost to Follow-up|0|||
124456973|NCT02819635|447633568|FG008|Substudy 3|Lost to Follow-up|1|||
124940308|NCT03066609|449409866|FG003|MAINTENANCE|Adverse Event|1|||
124456974|NCT02819635|447633569|FG009|Substudy 3|Lost to Follow-up|0|||
124456975|NCT02819635|447633570|FG010|Substudy 3|Lost to Follow-up|1|||
124456976|NCT02819635|447633571|FG011|Substudy 3|Lost to Follow-up|1|||
124456977|NCT02819635|447633560|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
124940309|NCT03066609|449409863|FG000|MAINTENANCE|Withdrawal by Subject|4|||
124456978|NCT02819635|447633561|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
124456979|NCT02819635|447633562|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
124456980|NCT02819635|447633563|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
124456981|NCT02819635|447633564|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
124456982|NCT02819635|447633565|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
124456983|NCT02819635|447633566|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
124456984|NCT02819635|447633567|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
124456985|NCT02819635|447633568|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
124456986|NCT02819635|447633569|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
124456987|NCT02819635|447633570|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
124456988|NCT02819635|447633571|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
124456989|NCT02819635|447633560|FG000|Substudy 3|Other, not specified|0|||
124456990|NCT02819635|447633561|FG001|Substudy 3|Other, not specified|0|||
124456991|NCT02819635|447633562|FG002|Substudy 3|Other, not specified|0|||
124456992|NCT02819635|447633563|FG003|Substudy 3|Other, not specified|0|||
124456993|NCT02819635|447633564|FG004|Substudy 3|Other, not specified|0|||
124456994|NCT02819635|447633565|FG005|Substudy 3|Other, not specified|0|||
124456995|NCT02819635|447633566|FG006|Substudy 3|Other, not specified|0|||
124456996|NCT02819635|447633567|FG007|Substudy 3|Other, not specified|0|||
124456997|NCT02819635|447633568|FG008|Substudy 3|Other, not specified|202|||
124456998|NCT02819635|447633569|FG009|Substudy 3|Other, not specified|5|||
124940310|NCT03066609|449409864|FG001|MAINTENANCE|Withdrawal by Subject|2|||
124940311|NCT03066609|449409865|FG002|MAINTENANCE|Withdrawal by Subject|1|||
124940312|NCT03066609|449409866|FG003|MAINTENANCE|Withdrawal by Subject|1|||
124940313|NCT03066609|449409863|FG000|MAINTENANCE|Lost to Follow-up|0|||
124940314|NCT03066609|449409864|FG001|MAINTENANCE|Lost to Follow-up|1|||
124940315|NCT03066609|449409865|FG002|MAINTENANCE|Lost to Follow-up|1|||
124940316|NCT03066609|449409866|FG003|MAINTENANCE|Lost to Follow-up|0|||
124940317|NCT03066609|449409863|FG000|MAINTENANCE|Pregnancy|1|||
124940318|NCT03066609|449409864|FG001|MAINTENANCE|Pregnancy|0|||
124940319|NCT03066609|449409865|FG002|MAINTENANCE|Pregnancy|0|||
124940320|NCT03066609|449409866|FG003|MAINTENANCE|Pregnancy|0|||
124940321|NCT03066609|449409863|FG000|MAINTENANCE|Lack of Efficacy|2|||
124940322|NCT03066609|449409864|FG001|MAINTENANCE|Lack of Efficacy|1|||
124940323|NCT03066609|449409865|FG002|MAINTENANCE|Lack of Efficacy|0|||
124940324|NCT03066609|449409866|FG003|MAINTENANCE|Lack of Efficacy|1|||
124940325|NCT03066609|449409863|FG000|OVERALL STUDY|Adverse Event|2|||
124940326|NCT03066609|449409864|FG001|OVERALL STUDY|Adverse Event|2|||
124940327|NCT03066609|449409865|FG002|OVERALL STUDY|Adverse Event|0|||
124940328|NCT03066609|449409866|FG003|OVERALL STUDY|Adverse Event|1|||
124940329|NCT03066609|449409863|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
124940330|NCT03066609|449409864|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
124940331|NCT03066609|449409865|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
124940332|NCT03066609|449409866|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
124940333|NCT03066609|449409863|FG000|OVERALL STUDY|Lost to Follow-up|1|||
124940334|NCT03066609|449409864|FG001|OVERALL STUDY|Lost to Follow-up|1|||
124940335|NCT03066609|449409865|FG002|OVERALL STUDY|Lost to Follow-up|1|||
124940336|NCT03066609|449409866|FG003|OVERALL STUDY|Lost to Follow-up|1|||
124940337|NCT03066609|449409863|FG000|OVERALL STUDY|Pregnancy|1|||
124940338|NCT03066609|449409864|FG001|OVERALL STUDY|Pregnancy|0|||
124940339|NCT03066609|449409865|FG002|OVERALL STUDY|Pregnancy|1|||
124940340|NCT03066609|449409866|FG003|OVERALL STUDY|Pregnancy|0|||
124940341|NCT03066609|449409863|FG000|OVERALL STUDY|Lack of Efficacy|2|||
124940342|NCT03066609|449409864|FG001|OVERALL STUDY|Lack of Efficacy|1|||
124940343|NCT03066609|449409865|FG002|OVERALL STUDY|Lack of Efficacy|1|||
124940344|NCT03066609|449409866|FG003|OVERALL STUDY|Lack of Efficacy|1|||
124940345|NCT03066609|449409863|FG000|OVERALL STUDY|discontinued follow up|0|||
124940346|NCT03066609|449409864|FG001|OVERALL STUDY|discontinued follow up|2|||
124940347|NCT03066609|449409865|FG002|OVERALL STUDY|discontinued follow up|0|||
124940348|NCT03066609|449409866|FG003|OVERALL STUDY|discontinued follow up|0|||
124940349|NCT00523419|449409871|FG000|Overall Study|Adverse Event|1|||
124456999|NCT02819635|447633570|FG010|Substudy 3|Other, not specified|89|||
124457000|NCT02819635|447633571|FG011|Substudy 3|Other, not specified|39|||
124457001|NCT03179891|447633575|FG000|First Intervention|Withdrawal by Subject|1|||
124457002|NCT03179891|447633576|FG001|First Intervention|Withdrawal by Subject|1|||
124457003|NCT03179891|447633575|FG000|First Intervention|Unspecified reason|1|||
124457004|NCT03179891|447633576|FG001|First Intervention|Unspecified reason|0|||
124940350|NCT00523419|449409871|FG000|Overall Study|Withdrawal by Subject|1|||
124940351|NCT00523419|449409871|FG000|Overall Study|Physician Decision|2|||
124940352|NCT00523419|449409871|FG000|Overall Study|Progressive Disease|22|||
124457005|NCT03179891|447633575|FG000|First Intervention|Protocol Violation|0|||
124457006|NCT03179891|447633576|FG001|First Intervention|Protocol Violation|1|||
124457007|NCT01349465|447633577|FG000|Overall Study|Adverse Event|1|||
124940353|NCT00523419|449409871|FG000|Overall Study|Death due to Study Disease|4|||
124940354|NCT00523419|449409871|FG000|Overall Study|Death due to Adverse Event|2|||
124940355|NCT01437319|449409874|FG000|Phase I|Lost to Follow-up|2|||
124940356|NCT01437319|449409875|FG001|Phase I|Lost to Follow-up|0|||
124940357|NCT01437319|449409876|FG002|Phase I|Lost to Follow-up|0|||
124940358|NCT01437319|449409874|FG000|Phase I|Protocol Violation|1|||
124940359|NCT01437319|449409875|FG001|Phase I|Protocol Violation|0|||
124940360|NCT01437319|449409876|FG002|Phase I|Protocol Violation|0|||
124940361|NCT01437319|449409874|FG000|Phase I|Study related symptoms/complaints|27|||
124940362|NCT01437319|449409875|FG001|Phase I|Study related symptoms/complaints|0|||
124940363|NCT01437319|449409876|FG002|Phase I|Study related symptoms/complaints|0|||
124940364|NCT01437319|449409874|FG000|Phase I|Withdrawal by Subject|25|||
124940365|NCT01437319|449409875|FG001|Phase I|Withdrawal by Subject|0|||
124940366|NCT01437319|449409876|FG002|Phase I|Withdrawal by Subject|0|||
124940367|NCT01437319|449409874|FG000|Phase II|Withdrawal by Subject|0|||
124940368|NCT01437319|449409875|FG001|Phase II|Withdrawal by Subject|8|||
124940369|NCT01437319|449409876|FG002|Phase II|Withdrawal by Subject|16|||
124940370|NCT01437319|449409874|FG000|Phase II|Lost to Follow-up|0|||
124940371|NCT01437319|449409875|FG001|Phase II|Lost to Follow-up|7|||
124940372|NCT01437319|449409876|FG002|Phase II|Lost to Follow-up|2|||
124940373|NCT01437319|449409874|FG000|Phase II|Study related symptoms/complaints|0|||
124940374|NCT01437319|449409875|FG001|Phase II|Study related symptoms/complaints|28|||
124940375|NCT01437319|449409876|FG002|Phase II|Study related symptoms/complaints|19|||
124940376|NCT01437319|449409874|FG000|Phase II|Protocol Violation|0|||
124940377|NCT01437319|449409875|FG001|Phase II|Protocol Violation|1|||
124940378|NCT01437319|449409876|FG002|Phase II|Protocol Violation|0|||
124940379|NCT01499849|449409877|FG000|Overall Study|Adverse Event|28|||
124940380|NCT01499849|449409878|FG001|Overall Study|Adverse Event|32|||
124940381|NCT01499849|449409877|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
124940382|NCT01499849|449409878|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
124940383|NCT01499849|449409877|FG000|Overall Study|Withdrawal by Subject|43|||
124940384|NCT01499849|449409878|FG001|Overall Study|Withdrawal by Subject|43|||
124940385|NCT01499849|449409877|FG000|Overall Study|Death|5|||
124940386|NCT01499849|449409878|FG001|Overall Study|Death|7|||
124940387|NCT01499849|449409877|FG000|Overall Study|Disease Progression|11|||
124940388|NCT01499849|449409878|FG001|Overall Study|Disease Progression|10|||
124940389|NCT01499849|449409877|FG000|Overall Study|Protocol Violation|11|||
124940390|NCT01499849|449409878|FG001|Overall Study|Protocol Violation|11|||
124940391|NCT01499849|449409877|FG000|Overall Study|Physician Decision|20|||
124940392|NCT01499849|449409878|FG001|Overall Study|Physician Decision|19|||
124940393|NCT01499849|449409877|FG000|Overall Study|Lack of Efficacy|3|||
124940394|NCT01499849|449409878|FG001|Overall Study|Lack of Efficacy|4|||
124940395|NCT01499849|449409877|FG000|Overall Study|Lost to Follow-up|6|||
124940396|NCT01499849|449409878|FG001|Overall Study|Lost to Follow-up|3|||
124940397|NCT01499849|449409877|FG000|Overall Study|Other Reasons|27|||
124940398|NCT01499849|449409878|FG001|Overall Study|Other Reasons|30|||
124940399|NCT00811941|449409879|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
124940400|NCT00811941|449409880|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
124940401|NCT00811941|449409879|FG000|All Treated Patients|Adverse Event|2|||
124940402|NCT00811941|449409880|FG001|All Treated Patients|Adverse Event|43|||
124940403|NCT00811941|449409879|FG000|All Treated Patients|Lack of Efficacy|2|||
124940404|NCT00811941|449409880|FG001|All Treated Patients|Lack of Efficacy|3|||
124940405|NCT00811941|449409879|FG000|All Treated Patients|Non-compliance|1|||
124703506|NCT00265122|448537322|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
124940406|NCT00811941|449409880|FG001|All Treated Patients|Non-compliance|8|||
124703507|NCT00265122|448537323|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
124703508|NCT00265122|448537324|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
124703509|NCT00265122|448537325|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
124703510|NCT00265122|448537326|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
124703511|NCT00265122|448537327|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
124703512|NCT00265122|448537322|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
124940407|NCT00811941|449409879|FG000|All Treated Patients|Protocol Violation|5|||
124940408|NCT00811941|449409880|FG001|All Treated Patients|Protocol Violation|17|||
124940409|NCT00811941|449409879|FG000|All Treated Patients|Withdrawal by Subject|35|||
124940410|NCT00811941|449409880|FG001|All Treated Patients|Withdrawal by Subject|94|||
124940411|NCT00811941|449409879|FG000|All Treated Patients|Lost to Follow-up|3|||
124940412|NCT00811941|449409880|FG001|All Treated Patients|Lost to Follow-up|12|||
124940413|NCT00811941|449409879|FG000|All Treated Patients|Other Reason|4|||
124940414|NCT00811941|449409880|FG001|All Treated Patients|Other Reason|14|||
124940415|NCT00622700|449409883|FG000|Core Treatment Period|Randomized but Not Treated|0|||
124940416|NCT00622700|449409884|FG001|Core Treatment Period|Randomized but Not Treated|2|||
124940417|NCT00622700|449409885|FG002|Core Treatment Period|Randomized but Not Treated|2|||
124940418|NCT00622700|449409886|FG003|Core Treatment Period|Randomized but Not Treated|0|||
124940419|NCT00622700|449409887|FG004|Core Treatment Period|Randomized but Not Treated|0|||
124940420|NCT00622700|449409888|FG005|Core Treatment Period|Randomized but Not Treated|0|||
124940421|NCT00622700|449409889|FG006|Core Treatment Period|Randomized but Not Treated|0|||
124940422|NCT00622700|449409883|FG000|Core Treatment Period|Adverse Event|18|||
124940423|NCT00622700|449409884|FG001|Core Treatment Period|Adverse Event|25|||
124940424|NCT00622700|449409885|FG002|Core Treatment Period|Adverse Event|18|||
124940425|NCT00622700|449409886|FG003|Core Treatment Period|Adverse Event|0|||
124940426|NCT00622700|449409887|FG004|Core Treatment Period|Adverse Event|0|||
124940427|NCT00622700|449409888|FG005|Core Treatment Period|Adverse Event|0|||
124940428|NCT00622700|449409889|FG006|Core Treatment Period|Adverse Event|0|||
124940429|NCT00622700|449409883|FG000|Core Treatment Period|Lack of Efficacy|19|||
124940430|NCT00622700|449409884|FG001|Core Treatment Period|Lack of Efficacy|6|||
124940431|NCT00622700|449409885|FG002|Core Treatment Period|Lack of Efficacy|12|||
124940432|NCT00622700|449409886|FG003|Core Treatment Period|Lack of Efficacy|0|||
124940433|NCT00622700|449409887|FG004|Core Treatment Period|Lack of Efficacy|0|||
124940434|NCT00622700|449409888|FG005|Core Treatment Period|Lack of Efficacy|0|||
124940435|NCT00622700|449409889|FG006|Core Treatment Period|Lack of Efficacy|0|||
124940436|NCT00622700|449409883|FG000|Core Treatment Period|Lost to Follow-up|1|||
124940437|NCT00622700|449409884|FG001|Core Treatment Period|Lost to Follow-up|1|||
124940438|NCT00622700|449409885|FG002|Core Treatment Period|Lost to Follow-up|1|||
124940439|NCT00622700|449409886|FG003|Core Treatment Period|Lost to Follow-up|0|||
124940440|NCT00622700|449409887|FG004|Core Treatment Period|Lost to Follow-up|0|||
124940441|NCT00622700|449409888|FG005|Core Treatment Period|Lost to Follow-up|0|||
124940442|NCT00622700|449409889|FG006|Core Treatment Period|Lost to Follow-up|0|||
124940443|NCT00622700|449409883|FG000|Core Treatment Period|Death|1|||
124940444|NCT00622700|449409884|FG001|Core Treatment Period|Death|0|||
124940445|NCT00622700|449409885|FG002|Core Treatment Period|Death|0|||
124940446|NCT00622700|449409886|FG003|Core Treatment Period|Death|0|||
124940447|NCT00622700|449409887|FG004|Core Treatment Period|Death|0|||
124940448|NCT00622700|449409888|FG005|Core Treatment Period|Death|0|||
124940449|NCT00622700|449409889|FG006|Core Treatment Period|Death|0|||
124940450|NCT00622700|449409883|FG000|Core Treatment Period|Progressive Disease|3|||
124940451|NCT00622700|449409884|FG001|Core Treatment Period|Progressive Disease|1|||
124457008|NCT01349465|447633578|FG001|Overall Study|Adverse Event|0|||
124457009|NCT01349465|447633577|FG000|Overall Study|Death|3|||
124457010|NCT01349465|447633578|FG001|Overall Study|Death|0|||
124457011|NCT01349465|447633577|FG000|Overall Study|Lost to Follow-up|10|||
124457012|NCT01349465|447633578|FG001|Overall Study|Lost to Follow-up|1|||
124457013|NCT01349465|447633577|FG000|Overall Study|Withdrawal by Subject|4|||
124457014|NCT01349465|447633578|FG001|Overall Study|Withdrawal by Subject|2|||
124457015|NCT01349465|447633577|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
124457016|NCT01349465|447633578|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
124457017|NCT00632099|447633579|FG000|Overall Study|Lost to Follow-up|3|||
124940452|NCT00622700|449409885|FG002|Core Treatment Period|Progressive Disease|0|||
124940453|NCT00622700|449409886|FG003|Core Treatment Period|Progressive Disease|0|||
124457018|NCT00632099|447633580|FG001|Overall Study|Lost to Follow-up|3|||
124457019|NCT02004262|447633583|FG000|Overall Study|Death|67|||
124457020|NCT02004262|447633584|FG001|Overall Study|Death|64|||
124940454|NCT00622700|449409887|FG004|Core Treatment Period|Progressive Disease|0|||
124940455|NCT00622700|449409888|FG005|Core Treatment Period|Progressive Disease|0|||
124940456|NCT00622700|449409889|FG006|Core Treatment Period|Progressive Disease|0|||
124940457|NCT00622700|449409883|FG000|Core Treatment Period|Withdrawal by Subject|12|||
124940458|NCT00622700|449409884|FG001|Core Treatment Period|Withdrawal by Subject|18|||
124940459|NCT00622700|449409885|FG002|Core Treatment Period|Withdrawal by Subject|15|||
124457021|NCT02004262|447633585|FG002|Overall Study|Death|66|||
124457022|NCT02004262|447633586|FG003|Overall Study|Death|28|||
124457023|NCT02004262|447633587|FG004|Overall Study|Death|29|||
124940460|NCT00622700|449409886|FG003|Core Treatment Period|Withdrawal by Subject|0|||
124940461|NCT00622700|449409887|FG004|Core Treatment Period|Withdrawal by Subject|0|||
124940462|NCT00622700|449409888|FG005|Core Treatment Period|Withdrawal by Subject|0|||
124940463|NCT00622700|449409889|FG006|Core Treatment Period|Withdrawal by Subject|0|||
124940464|NCT00622700|449409883|FG000|Core Treatment Period|Other than specified above|2|||
124940465|NCT00622700|449409884|FG001|Core Treatment Period|Other than specified above|2|||
124940466|NCT00622700|449409885|FG002|Core Treatment Period|Other than specified above|5|||
124940467|NCT00622700|449409886|FG003|Core Treatment Period|Other than specified above|0|||
124940468|NCT00622700|449409887|FG004|Core Treatment Period|Other than specified above|0|||
124940469|NCT00622700|449409888|FG005|Core Treatment Period|Other than specified above|0|||
124940470|NCT00622700|449409889|FG006|Core Treatment Period|Other than specified above|0|||
124940471|NCT00622700|449409883|FG000|Extension Treatment Period|Adverse Event|0|||
124940472|NCT00622700|449409884|FG001|Extension Treatment Period|Adverse Event|0|||
124940473|NCT00622700|449409885|FG002|Extension Treatment Period|Adverse Event|0|||
124940474|NCT00622700|449409886|FG003|Extension Treatment Period|Adverse Event|5|||
124940475|NCT00622700|449409887|FG004|Extension Treatment Period|Adverse Event|9|||
124940476|NCT00622700|449409888|FG005|Extension Treatment Period|Adverse Event|6|||
124940477|NCT00622700|449409889|FG006|Extension Treatment Period|Adverse Event|8|||
124940478|NCT00622700|449409883|FG000|Extension Treatment Period|Lack of Efficacy|0|||
124940479|NCT00622700|449409884|FG001|Extension Treatment Period|Lack of Efficacy|0|||
124940480|NCT00622700|449409885|FG002|Extension Treatment Period|Lack of Efficacy|0|||
124940481|NCT00622700|449409886|FG003|Extension Treatment Period|Lack of Efficacy|2|||
124940482|NCT00622700|449409887|FG004|Extension Treatment Period|Lack of Efficacy|8|||
124940483|NCT00622700|449409888|FG005|Extension Treatment Period|Lack of Efficacy|1|||
124940484|NCT00622700|449409889|FG006|Extension Treatment Period|Lack of Efficacy|9|||
124940485|NCT00622700|449409883|FG000|Extension Treatment Period|Protocol Violation|0|||
124940486|NCT00622700|449409884|FG001|Extension Treatment Period|Protocol Violation|0|||
124940487|NCT00622700|449409885|FG002|Extension Treatment Period|Protocol Violation|0|||
124940488|NCT00622700|449409886|FG003|Extension Treatment Period|Protocol Violation|0|||
124546857|NCT02094573|447957414|FG001|Overall Study|Death|3|||
124546858|NCT02094573|447957413|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
124546859|NCT02094573|447957414|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
124546860|NCT02094573|447957413|FG000|Overall Study|Non-compliance with Study Drug|1|||
124546861|NCT02094573|447957414|FG001|Overall Study|Non-compliance with Study Drug|1|||
124546862|NCT02094573|447957413|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
124546863|NCT02094573|447957414|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
124546864|NCT02094573|447957413|FG000|Overall Study|Physician Decision|4|||
124546865|NCT02094573|447957414|FG001|Overall Study|Physician Decision|4|||
124546866|NCT02094573|447957413|FG000|Overall Study|Site Terminated by Sponsor|10|||
124546867|NCT02094573|447957414|FG001|Overall Study|Site Terminated by Sponsor|17|||
124546868|NCT02094573|447957413|FG000|Overall Study|Withdrawal by Subject|6|||
124546869|NCT02094573|447957414|FG001|Overall Study|Withdrawal by Subject|8|||
124546870|NCT02094573|447957413|FG000|Overall Study|Randomized but not Treated|3|||
124546871|NCT02094573|447957414|FG001|Overall Study|Randomized but not Treated|0|||
124546872|NCT01473589|447957415|FG000|Overall Study|Adverse Event|1|||
124546873|NCT01473589|447957416|FG001|Overall Study|Adverse Event|1|||
124546874|NCT01473589|447957415|FG000|Overall Study|Death|2|||
124546875|NCT01473589|447957416|FG001|Overall Study|Death|0|||
124546876|NCT01473589|447957415|FG000|Overall Study|Lost to Follow-up|2|||
124546877|NCT01473589|447957416|FG001|Overall Study|Lost to Follow-up|2|||
124546878|NCT01473589|447957415|FG000|Overall Study|Protocol Violation|1|||
124546879|NCT01473589|447957416|FG001|Overall Study|Protocol Violation|0|||
124546880|NCT01473589|447957415|FG000|Overall Study|Withdrawal by Subject|5|||
124546881|NCT01473589|447957416|FG001|Overall Study|Withdrawal by Subject|11|||
124546882|NCT01473589|447957415|FG000|Overall Study|Physician Decision|0|||
124546883|NCT01473589|447957416|FG001|Overall Study|Physician Decision|1|||
124546884|NCT01473589|447957415|FG000|Overall Study|Entry criteria not met|0|||
124546885|NCT01473589|447957416|FG001|Overall Study|Entry criteria not met|1|||
124703513|NCT00265122|448537323|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
124703514|NCT00265122|448537324|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
124703515|NCT00265122|448537325|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
124940489|NCT00622700|449409887|FG004|Extension Treatment Period|Protocol Violation|0|||
124940490|NCT00622700|449409888|FG005|Extension Treatment Period|Protocol Violation|2|||
124940491|NCT00622700|449409889|FG006|Extension Treatment Period|Protocol Violation|0|||
124940492|NCT00622700|449409883|FG000|Extension Treatment Period|Lost to Follow-up|0|||
124546886|NCT03256526|447957417|FG000|Overall Study|Adverse Event|1|||
124546887|NCT03256526|447957418|FG001|Overall Study|Adverse Event|0|||
124546888|NCT03256526|447957419|FG002|Overall Study|Adverse Event|1|||
124546889|NCT03256526|447957417|FG000|Overall Study|Lost to Follow-up|1|||
124546890|NCT03256526|447957418|FG001|Overall Study|Lost to Follow-up|0|||
124546891|NCT03256526|447957419|FG002|Overall Study|Lost to Follow-up|2|||
124703516|NCT00265122|448537326|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
124703517|NCT00265122|448537327|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
124703518|NCT00265122|448537322|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
124703519|NCT00265122|448537323|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
124703520|NCT00265122|448537324|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
124703521|NCT00265122|448537325|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
124703522|NCT00265122|448537326|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
124703523|NCT00265122|448537327|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
124703524|NCT05205616|448537334|FG000|Overall Study|Lost to Follow-up|4|||
124703525|NCT05205616|448537335|FG001|Overall Study|Lost to Follow-up|4|||
124940493|NCT00622700|449409884|FG001|Extension Treatment Period|Lost to Follow-up|0|||
124940494|NCT00622700|449409885|FG002|Extension Treatment Period|Lost to Follow-up|0|||
124940495|NCT00622700|449409886|FG003|Extension Treatment Period|Lost to Follow-up|0|||
124940496|NCT00622700|449409887|FG004|Extension Treatment Period|Lost to Follow-up|1|||
124940497|NCT00622700|449409888|FG005|Extension Treatment Period|Lost to Follow-up|0|||
124940498|NCT00622700|449409889|FG006|Extension Treatment Period|Lost to Follow-up|0|||
124940499|NCT00622700|449409883|FG000|Extension Treatment Period|Progressive Disease|0|||
124940500|NCT00622700|449409884|FG001|Extension Treatment Period|Progressive Disease|0|||
124940501|NCT00622700|449409885|FG002|Extension Treatment Period|Progressive Disease|0|||
124940502|NCT00622700|449409886|FG003|Extension Treatment Period|Progressive Disease|1|||
124940503|NCT00622700|449409887|FG004|Extension Treatment Period|Progressive Disease|2|||
124940504|NCT00622700|449409888|FG005|Extension Treatment Period|Progressive Disease|0|||
124940505|NCT00622700|449409889|FG006|Extension Treatment Period|Progressive Disease|2|||
124940506|NCT00622700|449409883|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
124940507|NCT00622700|449409884|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
124940508|NCT00622700|449409885|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
124940509|NCT00622700|449409886|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
124940510|NCT00622700|449409887|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
124940511|NCT00622700|449409888|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
124940512|NCT00622700|449409889|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
124940513|NCT00622700|449409883|FG000|Extension Treatment Period|Missing|0|||
124940514|NCT00622700|449409884|FG001|Extension Treatment Period|Missing|0|||
124940515|NCT00622700|449409885|FG002|Extension Treatment Period|Missing|0|||
124940516|NCT00622700|449409886|FG003|Extension Treatment Period|Missing|2|||
124940517|NCT00622700|449409887|FG004|Extension Treatment Period|Missing|3|||
124940518|NCT00622700|449409888|FG005|Extension Treatment Period|Missing|1|||
124940519|NCT00622700|449409889|FG006|Extension Treatment Period|Missing|0|||
124940520|NCT00622700|449409883|FG000|Extension Treatment Period|Other than specified above|0|||
124940521|NCT00622700|449409884|FG001|Extension Treatment Period|Other than specified above|0|||
124940522|NCT00622700|449409885|FG002|Extension Treatment Period|Other than specified above|0|||
124940523|NCT00622700|449409886|FG003|Extension Treatment Period|Other than specified above|0|||
124940524|NCT00622700|449409887|FG004|Extension Treatment Period|Other than specified above|0|||
124940525|NCT00622700|449409888|FG005|Extension Treatment Period|Other than specified above|1|||
124940526|NCT00622700|449409889|FG006|Extension Treatment Period|Other than specified above|1|||
124940527|NCT03611556|449409890|FG000|Overall Study|Death|7|||
124940528|NCT03611556|449409891|FG001|Overall Study|Death|7|||
124940529|NCT03611556|449409892|FG002|Overall Study|Death|3|||
124940530|NCT03611556|449409893|FG003|Overall Study|Death|8|||
124940531|NCT03611556|449409894|FG004|Overall Study|Death|47|||
124940532|NCT03611556|449409895|FG005|Overall Study|Death|32|||
124940533|NCT03611556|449409896|FG006|Overall Study|Death|53|||
124940534|NCT03611556|449409890|FG000|Overall Study|Withdrawal by Subject|0|||
124940535|NCT03611556|449409891|FG001|Overall Study|Withdrawal by Subject|0|||
124940536|NCT03611556|449409892|FG002|Overall Study|Withdrawal by Subject|0|||
124940537|NCT03611556|449409893|FG003|Overall Study|Withdrawal by Subject|0|||
124940538|NCT03611556|449409894|FG004|Overall Study|Withdrawal by Subject|4|||
124940539|NCT03611556|449409895|FG005|Overall Study|Withdrawal by Subject|2|||
124940540|NCT03611556|449409896|FG006|Overall Study|Withdrawal by Subject|4|||
124940541|NCT03611556|449409890|FG000|Overall Study|Sponsor decision|0|||
124940542|NCT03611556|449409891|FG001|Overall Study|Sponsor decision|0|||
124940543|NCT03611556|449409892|FG002|Overall Study|Sponsor decision|0|||
124940544|NCT03611556|449409893|FG003|Overall Study|Sponsor decision|0|||
124940545|NCT03611556|449409894|FG004|Overall Study|Sponsor decision|9|||
124940546|NCT03611556|449409895|FG005|Overall Study|Sponsor decision|4|||
124940547|NCT03611556|449409896|FG006|Overall Study|Sponsor decision|12|||
124940548|NCT03611556|449409890|FG000|Overall Study|Reasons|0|||
124940549|NCT03611556|449409891|FG001|Overall Study|Reasons|0|||
124940550|NCT03611556|449409892|FG002|Overall Study|Reasons|0|||
124940551|NCT03611556|449409893|FG003|Overall Study|Reasons|0|||
124940552|NCT03611556|449409894|FG004|Overall Study|Reasons|2|||
124940553|NCT03611556|449409895|FG005|Overall Study|Reasons|0|||
124940554|NCT03611556|449409896|FG006|Overall Study|Reasons|1|||
124940555|NCT02078648|449409906|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
124457024|NCT02004262|447633588|FG005|Overall Study|Death|22|||
124940556|NCT02078648|449409907|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
124940557|NCT02078648|449409906|FG000|Overall Study|Adverse Event|0|||
124940558|NCT02078648|449409907|FG001|Overall Study|Adverse Event|1|||
124940559|NCT02078648|449409906|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
124940560|NCT02078648|449409907|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
124940561|NCT02078648|449409906|FG000|Overall Study|Withdrawal by Subject|3|||
124940562|NCT02078648|449409907|FG001|Overall Study|Withdrawal by Subject|1|||
124940563|NCT02078648|449409906|FG000|Overall Study|Investigator Decision|5|||
124940564|NCT02078648|449409907|FG001|Overall Study|Investigator Decision|7|||
124940565|NCT02078648|449409906|FG000|Overall Study|Death|1|||
124940566|NCT02078648|449409907|FG001|Overall Study|Death|1|||
124940567|NCT02078648|449409906|FG000|Overall Study|Undefined|0|||
124940568|NCT02078648|449409907|FG001|Overall Study|Undefined|1|||
124940569|NCT04088227|449409908|FG000|Overall Study|Withdrawal by Subject|1|||
124940570|NCT04088227|449409909|FG001|Overall Study|Withdrawal by Subject|0|||
124940571|NCT04088227|449409908|FG000|Overall Study|Surgery postponed >5weeks|1|||
124940572|NCT04088227|449409909|FG001|Overall Study|Surgery postponed >5weeks|0|||
124940573|NCT01675492|449409910|FG000|Overall Study|study completed early - product approval|42|||
124940574|NCT03762850|449411772|FG000|Overall Study|Death|0|||
124940575|NCT03762850|449411773|FG001|Overall Study|Death|1|||
124940576|NCT03762850|449411772|FG000|Overall Study|Lost to Follow-up|0|||
124940577|NCT03762850|449411773|FG001|Overall Study|Lost to Follow-up|1|||
124940578|NCT03762850|449411772|FG000|Overall Study|Physician Decision|0|||
124940579|NCT03762850|449411773|FG001|Overall Study|Physician Decision|1|||
124940580|NCT03762850|449411772|FG000|Overall Study|Withdrawal by Subject|4|||
124940581|NCT03762850|449411773|FG001|Overall Study|Withdrawal by Subject|9|||
124940582|NCT03083366|449411774|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
124940583|NCT03083366|449411775|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
124940584|NCT03083366|449411774|FG000|Enrollment Period|Lack of Efficacy|1|||
124940585|NCT03083366|449411775|FG001|Enrollment Period|Lack of Efficacy|0|||
124940586|NCT02036970|449411783|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
124940587|NCT02036970|449411784|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
124940588|NCT02036970|449411785|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
124940589|NCT02036970|449411786|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
124940590|NCT02036970|449411787|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
124940591|NCT02036970|449411788|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
124940592|NCT02036970|449411789|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
124940593|NCT02036970|449411790|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
124940594|NCT02036970|449411791|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
124940595|NCT02036970|449411792|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
124940596|NCT02036970|449411783|FG000|Part 1: Day 1 Through Week 16|Death|0|||
124940597|NCT02036970|449411784|FG001|Part 1: Day 1 Through Week 16|Death|0|||
124940598|NCT02036970|449411785|FG002|Part 1: Day 1 Through Week 16|Death|0|||
124940599|NCT02036970|449411786|FG003|Part 1: Day 1 Through Week 16|Death|0|||
124940600|NCT02036970|449411787|FG004|Part 1: Day 1 Through Week 16|Death|0|||
124940601|NCT02036970|449411788|FG005|Part 1: Day 1 Through Week 16|Death|0|||
124940602|NCT02036970|449411789|FG006|Part 1: Day 1 Through Week 16|Death|0|||
124940603|NCT02036970|449411790|FG007|Part 1: Day 1 Through Week 16|Death|0|||
124940604|NCT02036970|449411791|FG008|Part 1: Day 1 Through Week 16|Death|1|||
124457025|NCT02004262|447633583|FG000|Overall Study|Withdrawal by Subject|1|||
124457026|NCT02004262|447633584|FG001|Overall Study|Withdrawal by Subject|0|||
124457027|NCT02004262|447633585|FG002|Overall Study|Withdrawal by Subject|4|||
124457028|NCT02004262|447633586|FG003|Overall Study|Withdrawal by Subject|0|||
124457029|NCT02004262|447633587|FG004|Overall Study|Withdrawal by Subject|1|||
124457030|NCT02004262|447633588|FG005|Overall Study|Withdrawal by Subject|3|||
124457031|NCT02004262|447633583|FG000|Overall Study|Lost to Follow-up|1|||
124457032|NCT02004262|447633584|FG001|Overall Study|Lost to Follow-up|1|||
124457033|NCT02004262|447633585|FG002|Overall Study|Lost to Follow-up|0|||
124457034|NCT02004262|447633586|FG003|Overall Study|Lost to Follow-up|0|||
124457035|NCT02004262|447633587|FG004|Overall Study|Lost to Follow-up|0|||
124457036|NCT02004262|447633588|FG005|Overall Study|Lost to Follow-up|0|||
124457037|NCT02004262|447633583|FG000|Overall Study|Study Terminated by Sponsor|4|||
124457038|NCT02004262|447633584|FG001|Overall Study|Study Terminated by Sponsor|3|||
124546892|NCT01160770|447957420|FG000|Overall Study|Adverse Event|10|||
124940605|NCT02036970|449411792|FG009|Part 1: Day 1 Through Week 16|Death|0|||
124546893|NCT01160770|447957420|FG000|Overall Study|Protocol Violation|2|||
124940606|NCT02036970|449411783|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
124457039|NCT02004262|447633585|FG002|Overall Study|Study Terminated by Sponsor|2|||
124457040|NCT02004262|447633586|FG003|Overall Study|Study Terminated by Sponsor|1|||
124457041|NCT02004262|447633587|FG004|Overall Study|Study Terminated by Sponsor|1|||
124765015|NCT04913610|448765112|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
124940607|NCT02036970|449411784|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
124940608|NCT02036970|449411785|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
124457042|NCT02004262|447633588|FG005|Overall Study|Study Terminated by Sponsor|5|||
124703526|NCT00663260|448537341|FG000|Overall Study|Lack of Efficacy|2|||
124940609|NCT02036970|449411786|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
124940610|NCT02036970|449411787|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
124940611|NCT02036970|449411788|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
124940612|NCT02036970|449411789|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
124940613|NCT02036970|449411790|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
124940614|NCT02036970|449411791|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
124940615|NCT02036970|449411792|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
124940616|NCT02036970|449411783|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
124940617|NCT02036970|449411784|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
124940618|NCT02036970|449411785|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
124940619|NCT02036970|449411786|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
124940620|NCT02036970|449411787|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
124940621|NCT02036970|449411788|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
124940622|NCT02036970|449411789|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
124940623|NCT02036970|449411790|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
124940624|NCT02036970|449411791|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
124940625|NCT02036970|449411792|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
124940626|NCT02036970|449411783|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940627|NCT02036970|449411784|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940628|NCT02036970|449411785|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940629|NCT02036970|449411786|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
124940630|NCT02036970|449411787|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940631|NCT02036970|449411788|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940632|NCT02036970|449411789|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940633|NCT02036970|449411790|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940634|NCT02036970|449411791|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940635|NCT02036970|449411792|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
124940636|NCT02036970|449411783|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
124940637|NCT02036970|449411784|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
124940638|NCT02036970|449411785|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
124940639|NCT02036970|449411786|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
124940640|NCT02036970|449411787|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
124940641|NCT02036970|449411788|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
124940642|NCT02036970|449411789|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
124940643|NCT02036970|449411790|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
124940644|NCT02036970|449411791|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
124940645|NCT02036970|449411792|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
124940646|NCT02036970|449411783|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940647|NCT02036970|449411784|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940648|NCT02036970|449411785|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940649|NCT02036970|449411786|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940650|NCT02036970|449411787|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940651|NCT02036970|449411788|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940652|NCT02036970|449411789|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940653|NCT02036970|449411790|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
124940654|NCT02036970|449411791|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940655|NCT02036970|449411792|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
124940656|NCT02036970|449411783|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
124940657|NCT02036970|449411784|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
124940658|NCT02036970|449411785|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
124457043|NCT01923285|447633589|FG000|Overall Study|Withdrawal by Subject|7|||
124457044|NCT01923285|447633590|FG001|Overall Study|Withdrawal by Subject|6|||
124457045|NCT00804570|447633593|FG000|Overall Study|Adverse Event|14|||
124457046|NCT00804570|447633594|FG001|Overall Study|Adverse Event|7|||
124457047|NCT00804570|447633593|FG000|Overall Study|Lack of Efficacy|0|||
124457048|NCT00804570|447633594|FG001|Overall Study|Lack of Efficacy|1|||
124703527|NCT00663260|448537342|FG001|Overall Study|Lack of Efficacy|0|||
124703528|NCT00663260|448537343|FG002|Overall Study|Lack of Efficacy|0|||
124940659|NCT02036970|449411786|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
124940660|NCT02036970|449411787|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
124940661|NCT02036970|449411788|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
124457049|NCT00804570|447633593|FG000|Overall Study|Lost to Follow-up|18|||
124940662|NCT02036970|449411789|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
124940663|NCT02036970|449411790|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
124457050|NCT00804570|447633594|FG001|Overall Study|Lost to Follow-up|21|||
124457051|NCT00804570|447633593|FG000|Overall Study|Entry criteria not met|5|||
124457052|NCT00804570|447633594|FG001|Overall Study|Entry criteria not met|5|||
124457053|NCT00804570|447633593|FG000|Overall Study|Protocol Violation|12|||
124546894|NCT01160770|447957420|FG000|Overall Study|Subject/parent/caregiver request|33|||
124703529|NCT00663260|448537341|FG000|Overall Study|Adverse Event|12|||
124703530|NCT00663260|448537342|FG001|Overall Study|Adverse Event|7|||
124703531|NCT00663260|448537343|FG002|Overall Study|Adverse Event|6|||
124703532|NCT00663260|448537341|FG000|Overall Study|Withdrawal by Subject|3|||
124703533|NCT00663260|448537342|FG001|Overall Study|Withdrawal by Subject|1|||
124703534|NCT00663260|448537343|FG002|Overall Study|Withdrawal by Subject|6|||
124703535|NCT00663260|448537341|FG000|Overall Study|Death|1|||
124703536|NCT00663260|448537342|FG001|Overall Study|Death|0|||
124703537|NCT00663260|448537343|FG002|Overall Study|Death|1|||
124940664|NCT02036970|449411791|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
124940665|NCT02036970|449411792|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
124940666|NCT02036970|449411783|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
124940667|NCT02036970|449411784|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
124940668|NCT02036970|449411785|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
124940669|NCT02036970|449411786|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
124940670|NCT02036970|449411787|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
124940671|NCT02036970|449411788|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
124940672|NCT02036970|449411789|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
124940673|NCT02036970|449411790|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
124940674|NCT02036970|449411791|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
124940675|NCT02036970|449411792|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
124940676|NCT02386098|449411797|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
124940677|NCT02386098|449411798|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
124940678|NCT02386098|449411799|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
124940679|NCT02386098|449411800|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
124940680|NCT02386098|449411801|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
124940681|NCT02386098|449411797|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
124940682|NCT02386098|449411798|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
124940683|NCT02386098|449411799|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
124940684|NCT02386098|449411800|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
124940685|NCT02386098|449411801|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
124940686|NCT02386098|449411797|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
124940687|NCT02386098|449411798|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
124940688|NCT02386098|449411799|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
124940689|NCT02386098|449411800|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
124940690|NCT02386098|449411801|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
124940691|NCT02386098|449411797|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
124940692|NCT02386098|449411798|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
124940693|NCT02386098|449411799|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
124940694|NCT02386098|449411800|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
124940695|NCT02386098|449411801|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
124940696|NCT02386098|449411797|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
124940697|NCT02386098|449411798|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
124940698|NCT02386098|449411799|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
124940699|NCT02386098|449411800|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
124457054|NCT00804570|447633594|FG001|Overall Study|Protocol Violation|16|||
124457055|NCT00804570|447633593|FG000|Overall Study|Physician Decision|1|||
124457056|NCT00804570|447633594|FG001|Overall Study|Physician Decision|2|||
124457057|NCT00804570|447633593|FG000|Overall Study|Sponsor decision|1|||
124457058|NCT00804570|447633594|FG001|Overall Study|Sponsor decision|4|||
124457059|NCT00804570|447633593|FG000|Overall Study|Withdrawal by Subject|21|||
124457060|NCT00804570|447633594|FG001|Overall Study|Withdrawal by Subject|38|||
124457061|NCT00290342|447633595|FG000|Overall Study|Other|0|||
124457062|NCT00290342|447633596|FG001|Overall Study|Other|1|||
124457063|NCT00290342|447633595|FG000|Overall Study|Withdrawal by Subject|6|||
124457064|NCT00290342|447633596|FG001|Overall Study|Withdrawal by Subject|4|||
124457065|NCT00290342|447633595|FG000|Overall Study|Lost to Follow-up|1|||
124457066|NCT00290342|447633596|FG001|Overall Study|Lost to Follow-up|0|||
124457067|NCT01056510|447633599|FG000|Overall Study|Dropout Before Start of Treatment|1|||
124457068|NCT01056510|447633600|FG001|Overall Study|Dropout Before Start of Treatment|1|||
124457069|NCT01056510|447633599|FG000|Overall Study|Withdrawal by Subject|4|||
124457070|NCT01056510|447633600|FG001|Overall Study|Withdrawal by Subject|2|||
124457071|NCT01056510|447633599|FG000|Overall Study|Death|29|||
124457072|NCT01056510|447633600|FG001|Overall Study|Death|34|||
124457073|NCT01056510|447633599|FG000|Overall Study|Noncompliance|1|||
124457074|NCT01056510|447633600|FG001|Overall Study|Noncompliance|3|||
124457075|NCT01056510|447633599|FG000|Overall Study|Physician Decision|4|||
124703538|NCT00663260|448537341|FG000|Overall Study|Lost to Follow-up|0|||
124940700|NCT02386098|449411801|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
124940701|NCT02386098|449411797|FG000|Stage 1 (96 Weeks)|Other|1|||
124457076|NCT01056510|447633600|FG001|Overall Study|Physician Decision|5|||
124457077|NCT01056510|447633599|FG000|Overall Study|Lost to Follow-up|5|||
124457078|NCT01056510|447633600|FG001|Overall Study|Lost to Follow-up|6|||
124457079|NCT01056510|447633599|FG000|Overall Study|Other|10|||
124703539|NCT00663260|448537342|FG001|Overall Study|Lost to Follow-up|1|||
124703540|NCT00663260|448537343|FG002|Overall Study|Lost to Follow-up|0|||
124703541|NCT00663260|448537341|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
124703542|NCT00663260|448537342|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
124703543|NCT00663260|448537343|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
124703544|NCT02231580|448537350|FG000|Overall Study|Adverse Event|5|||
124703545|NCT02231580|448537351|FG001|Overall Study|Adverse Event|0|||
124703546|NCT03620981|448537352|FG000|Overall Study|Adverse Event|14|||
124703547|NCT03620981|448537353|FG001|Overall Study|Adverse Event|38|||
124703548|NCT03620981|448537354|FG002|Overall Study|Adverse Event|25|||
124703549|NCT03620981|448537352|FG000|Overall Study|Lack of Efficacy|2|||
124703550|NCT03620981|448537353|FG001|Overall Study|Lack of Efficacy|1|||
124703551|NCT03620981|448537354|FG002|Overall Study|Lack of Efficacy|1|||
124703552|NCT03620981|448537352|FG000|Overall Study|Physician Decision|7|||
124703553|NCT03620981|448537353|FG001|Overall Study|Physician Decision|4|||
124703554|NCT03620981|448537354|FG002|Overall Study|Physician Decision|4|||
124703555|NCT03620981|448537352|FG000|Overall Study|Protocol Violation|1|||
124703556|NCT03620981|448537353|FG001|Overall Study|Protocol Violation|2|||
124703557|NCT03620981|448537354|FG002|Overall Study|Protocol Violation|1|||
124703558|NCT03620981|448537352|FG000|Overall Study|Withdrawal by Legal Representative|2|||
124703559|NCT03620981|448537353|FG001|Overall Study|Withdrawal by Legal Representative|1|||
124703560|NCT03620981|448537354|FG002|Overall Study|Withdrawal by Legal Representative|1|||
124703561|NCT03620981|448537352|FG000|Overall Study|Withdrawal by Care Giver|2|||
124703562|NCT03620981|448537353|FG001|Overall Study|Withdrawal by Care Giver|0|||
124703563|NCT03620981|448537354|FG002|Overall Study|Withdrawal by Care Giver|1|||
124703564|NCT03620981|448537352|FG000|Overall Study|Non-compliance with Study Drug|1|||
124703565|NCT03620981|448537353|FG001|Overall Study|Non-compliance with Study Drug|1|||
124703566|NCT03620981|448537354|FG002|Overall Study|Non-compliance with Study Drug|0|||
124703567|NCT03238196|448537357|FG000|Overall Study|Adverse Event|3|||
124703568|NCT03238196|448537358|FG001|Overall Study|Adverse Event|0|||
124703569|NCT03238196|448537359|FG002|Overall Study|Adverse Event|2|||
124703570|NCT03238196|448537360|FG003|Overall Study|Adverse Event|2|||
124703571|NCT03238196|448537357|FG000|Overall Study|Withdrawal by Subject|4|||
124703572|NCT03238196|448537358|FG001|Overall Study|Withdrawal by Subject|1|||
124703573|NCT03238196|448537359|FG002|Overall Study|Withdrawal by Subject|1|||
124703574|NCT03238196|448537360|FG003|Overall Study|Withdrawal by Subject|0|||
124703575|NCT03238196|448537357|FG000|Overall Study|Disease progression|14|||
124703576|NCT03238196|448537358|FG001|Overall Study|Disease progression|2|||
124703577|NCT03238196|448537359|FG002|Overall Study|Disease progression|3|||
124703578|NCT03238196|448537360|FG003|Overall Study|Disease progression|2|||
124703579|NCT03238196|448537357|FG000|Overall Study|Still on treatment|1|||
124703580|NCT03238196|448537358|FG001|Overall Study|Still on treatment|0|||
124703581|NCT03238196|448537359|FG002|Overall Study|Still on treatment|0|||
124703582|NCT03238196|448537360|FG003|Overall Study|Still on treatment|0|||
124703583|NCT04938427|448537361|FG000|Overall Study|Adverse Event|5|||
124703584|NCT04938427|448537362|FG001|Overall Study|Adverse Event|19|||
124703585|NCT04938427|448537361|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
124703586|NCT04938427|448537362|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124703587|NCT04938427|448537361|FG000|Overall Study|Withdrawal by Subject|1|||
124703588|NCT04938427|448537362|FG001|Overall Study|Withdrawal by Subject|0|||
124703589|NCT04938427|448537361|FG000|Overall Study|Reason Not Specified|2|||
124940702|NCT02386098|449411798|FG001|Stage 1 (96 Weeks)|Other|0|||
124940703|NCT02386098|449411799|FG002|Stage 1 (96 Weeks)|Other|0|||
124940704|NCT02386098|449411800|FG003|Stage 1 (96 Weeks)|Other|0|||
124940705|NCT02386098|449411801|FG004|Stage 1 (96 Weeks)|Other|0|||
124940706|NCT02386098|449411797|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
124940707|NCT02386098|449411798|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
124940708|NCT02386098|449411799|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
124940709|NCT02386098|449411800|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
124940710|NCT02386098|449411801|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
124940711|NCT04503681|449411802|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
124940712|NCT04503681|449411803|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
124940713|NCT03352713|449411804|FG000|Overall Study|Lost to Follow-up|8|||
124703590|NCT04938427|448537362|FG001|Overall Study|Reason Not Specified|1|||
124703591|NCT01903863|448537363|FG000|Overall Study|Physician Decision|2|||
124703592|NCT01903863|448537364|FG001|Overall Study|Physician Decision|0|||
124940714|NCT03352713|449411804|FG000|Overall Study|Withdrawn by investigator|5|||
124703593|NCT03033784|448539169|FG000|Overall Study|Anxiety related to MRI scanner|0|||
124703594|NCT03033784|448539170|FG001|Overall Study|Anxiety related to MRI scanner|1|||
124703595|NCT03033784|448539171|FG002|Overall Study|Anxiety related to MRI scanner|0|||
124703596|NCT03033784|448539172|FG003|Overall Study|Anxiety related to MRI scanner|0|||
124703597|NCT03033784|448539173|FG004|Overall Study|Anxiety related to MRI scanner|0|||
124703598|NCT03033784|448539174|FG005|Overall Study|Anxiety related to MRI scanner|0|||
124703599|NCT03033784|448539175|FG006|Overall Study|Anxiety related to MRI scanner|0|||
124703600|NCT03033784|448539176|FG007|Overall Study|Anxiety related to MRI scanner|0|||
124703601|NCT03033784|448539177|FG008|Overall Study|Anxiety related to MRI scanner|0|||
124940715|NCT03352713|449411804|FG000|Overall Study|Completed 0 EMAs|8|||
124703602|NCT03033784|448539178|FG009|Overall Study|Anxiety related to MRI scanner|0|||
124703603|NCT03033784|448539179|FG010|Overall Study|Anxiety related to MRI scanner|0|||
124940716|NCT03352713|449411804|FG000|Overall Study|Device incompatible/stolen|5|||
124703604|NCT03033784|448539180|FG011|Overall Study|Anxiety related to MRI scanner|0|||
124703605|NCT03033784|448539181|FG012|Overall Study|Anxiety related to MRI scanner|0|||
124703606|NCT03033784|448539169|FG000|Overall Study|Withdrawal by Subject|0|||
124703607|NCT03033784|448539170|FG001|Overall Study|Withdrawal by Subject|0|||
124703608|NCT03033784|448539171|FG002|Overall Study|Withdrawal by Subject|0|||
124703609|NCT03033784|448539172|FG003|Overall Study|Withdrawal by Subject|0|||
124703610|NCT03033784|448539173|FG004|Overall Study|Withdrawal by Subject|0|||
124703611|NCT03033784|448539174|FG005|Overall Study|Withdrawal by Subject|0|||
124703612|NCT03033784|448539175|FG006|Overall Study|Withdrawal by Subject|0|||
124703613|NCT03033784|448539176|FG007|Overall Study|Withdrawal by Subject|0|||
124703614|NCT03033784|448539177|FG008|Overall Study|Withdrawal by Subject|0|||
124703615|NCT03033784|448539178|FG009|Overall Study|Withdrawal by Subject|0|||
124703616|NCT03033784|448539179|FG010|Overall Study|Withdrawal by Subject|0|||
124703617|NCT03033784|448539180|FG011|Overall Study|Withdrawal by Subject|0|||
124703618|NCT03033784|448539181|FG012|Overall Study|Withdrawal by Subject|2|||
124703619|NCT03332056|448539182|FG000|Overall Study|Incomplete questionnaires|8|||
124703620|NCT03332056|448539183|FG001|Overall Study|Incomplete questionnaires|9|||
124703621|NCT03332056|448539182|FG000|Overall Study|Passed stone prior to surgery date|1|||
124703622|NCT03332056|448539183|FG001|Overall Study|Passed stone prior to surgery date|0|||
124703623|NCT03332056|448539182|FG000|Overall Study|Did not require a ureteral stent|0|||
124703624|NCT03332056|448539183|FG001|Overall Study|Did not require a ureteral stent|1|||
124703625|NCT00851084|448539184|FG000|Overall Study|Randomized but not treated|1|||
124940717|NCT01812759|449411805|FG000|Overall Study|Physician Decision|0|||
124940718|NCT01812759|449411806|FG001|Overall Study|Physician Decision|0|||
124940719|NCT01812759|449411807|FG002|Overall Study|Physician Decision|1|||
124940720|NCT00360269|449411808|FG000|Overall Study|Lost to Follow-up|7|||
124940721|NCT00360269|449411809|FG001|Overall Study|Lost to Follow-up|9|||
124940722|NCT00360269|449411808|FG000|Overall Study|Physician Decision|1|||
124940723|NCT00360269|449411809|FG001|Overall Study|Physician Decision|2|||
124940724|NCT00360269|449411808|FG000|Overall Study|Adverse Event|1|||
124940725|NCT00360269|449411809|FG001|Overall Study|Adverse Event|0|||
124940726|NCT00360269|449411808|FG000|Overall Study|Withdrawal by Subject|1|||
124940727|NCT00360269|449411809|FG001|Overall Study|Withdrawal by Subject|1|||
124940728|NCT03437733|449411815|FG000|Overall Study|Eligibility criteria not met|0|||
124940729|NCT03437733|449411816|FG001|Overall Study|Eligibility criteria not met|3|||
124940730|NCT00210106|449411817|FG000|Overall Study|Death|1|||
124940731|NCT00210106|449411817|FG000|Overall Study|Protocol Violation|13|||
124940732|NCT05405244|449411825|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
124940733|NCT05405244|449411826|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
124940734|NCT05405244|449411825|FG000|Washout (2 Weeks)|Adverse Event|2|||
124940735|NCT05405244|449411826|FG001|Washout (2 Weeks)|Adverse Event|0|||
124940736|NCT05405244|449411825|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
124940737|NCT05405244|449411826|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
124940738|NCT00739934|449411827|FG000|Voriconazole IV|Adverse Event|6|||
124940739|NCT00739934|449411827|FG000|Voriconazole Oral|Other|3|||
124940740|NCT03418922|449411828|FG000|Overall Study|Withdrawal by Subject|0|||
124940741|NCT03418922|449411829|FG001|Overall Study|Withdrawal by Subject|2|||
124940742|NCT03418922|449411828|FG000|Overall Study|Adverse Event|2|||
124940743|NCT03418922|449411829|FG001|Overall Study|Adverse Event|2|||
124940744|NCT03418922|449411828|FG000|Overall Study|Death|0|||
124940745|NCT03418922|449411829|FG001|Overall Study|Death|1|||
124940746|NCT03418922|449411828|FG000|Overall Study|Physician Decision|0|||
124940747|NCT03418922|449411829|FG001|Overall Study|Physician Decision|1|||
124940748|NCT03451422|449411830|FG000|Overall Study|Lost to Follow-up|0|||
124940749|NCT03451422|449411831|FG001|Overall Study|Lost to Follow-up|0|||
124940750|NCT03451422|449411832|FG002|Overall Study|Lost to Follow-up|0|||
124940751|NCT03451422|449411833|FG003|Overall Study|Lost to Follow-up|0|||
124940752|NCT03451422|449411834|FG004|Overall Study|Lost to Follow-up|0|||
124940753|NCT03451422|449411835|FG005|Overall Study|Lost to Follow-up|1|||
124546895|NCT01160770|447957420|FG000|Overall Study|Physician Decision|1|||
124703626|NCT00851084|448539185|FG001|Overall Study|Randomized but not treated|0|||
124703627|NCT00851084|448539184|FG000|Overall Study|Adverse Event|26|||
124703628|NCT00851084|448539185|FG001|Overall Study|Adverse Event|36|||
124703629|NCT00851084|448539184|FG000|Overall Study|Disease progression|52|||
124703630|NCT00851084|448539185|FG001|Overall Study|Disease progression|47|||
124703631|NCT00851084|448539184|FG000|Overall Study|Poor compliance to protocol|1|||
124940754|NCT03451422|449411830|FG000|Overall Study|Decision by sponsor|1|||
124940755|NCT03451422|449411831|FG001|Overall Study|Decision by sponsor|0|||
124940756|NCT03451422|449411832|FG002|Overall Study|Decision by sponsor|1|||
124940757|NCT03451422|449411833|FG003|Overall Study|Decision by sponsor|0|||
124940758|NCT03451422|449411834|FG004|Overall Study|Decision by sponsor|0|||
124940759|NCT03451422|449411835|FG005|Overall Study|Decision by sponsor|0|||
124940760|NCT03451422|449411830|FG000|Overall Study|Withdrawal by Subject|0|||
124940761|NCT03451422|449411831|FG001|Overall Study|Withdrawal by Subject|0|||
124940762|NCT03451422|449411832|FG002|Overall Study|Withdrawal by Subject|2|||
124940763|NCT03451422|449411833|FG003|Overall Study|Withdrawal by Subject|3|||
124940764|NCT03451422|449411834|FG004|Overall Study|Withdrawal by Subject|2|||
124940765|NCT03451422|449411835|FG005|Overall Study|Withdrawal by Subject|1|||
124940766|NCT03355573|449411836|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
124940767|NCT03355573|449411836|FG000|Overall Study|Sponsor's decision|1|||
124940768|NCT03355573|449411836|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
124940769|NCT03355573|449411836|FG000|Overall Study|PI's decision|2|||
124940770|NCT03355573|449411836|FG000|Overall Study|Withdrawal by Subject|23|||
124940771|NCT03355573|449411836|FG000|Overall Study|Lost to Follow-up|4|||
124940772|NCT03355573|449411836|FG000|Overall Study|Lack of Efficacy|2|||
124940773|NCT03355573|449411836|FG000|Overall Study|Adverse Event, non-fatal|17|||
124940774|NCT03355573|449411836|FG000|Overall Study|Adverse Event, serious fatal|2|||
124940775|NCT04191824|449411841|FG000|Overall Study|Death|13|||
124940776|NCT04191824|449411842|FG001|Overall Study|Death|12|||
124940777|NCT04191824|449411841|FG000|Overall Study|Lost to Follow-up|456|||
124940778|NCT04191824|449411842|FG001|Overall Study|Lost to Follow-up|435|||
124940779|NCT04191824|449411841|FG000|Overall Study|Physician Decision|2|||
124940780|NCT04191824|449411842|FG001|Overall Study|Physician Decision|1|||
124940781|NCT04191824|449411841|FG000|Overall Study|Protocol Violation|0|||
124940782|NCT04191824|449411842|FG001|Overall Study|Protocol Violation|2|||
124940783|NCT04191824|449411841|FG000|Overall Study|Withdrawal by Subject|16|||
124940784|NCT04191824|449411842|FG001|Overall Study|Withdrawal by Subject|18|||
124940785|NCT04191824|449411841|FG000|Overall Study|Early site closure|24|||
124940786|NCT04191824|449411842|FG001|Overall Study|Early site closure|22|||
124940787|NCT03631407|449411843|FG000|Overall Study|Withdrawal by Subject|3|||
124940788|NCT03631407|449411844|FG001|Overall Study|Withdrawal by Subject|2|||
124940789|NCT03631407|449411843|FG000|Overall Study|Sponsor Decision|0|||
124940790|NCT03631407|449411844|FG001|Overall Study|Sponsor Decision|2|||
124940791|NCT03631407|449411843|FG000|Overall Study|Death|16|||
124940792|NCT03631407|449411844|FG001|Overall Study|Death|16|||
124940793|NCT03631407|449411843|FG000|Overall Study|Randomized by mistake without study treatment|1|||
124940794|NCT03631407|449411844|FG001|Overall Study|Randomized by mistake without study treatment|0|||
124940795|NCT02646618|449411849|FG000|Overall Study|Lost to Follow-up|10|||
124940796|NCT02646618|449411850|FG001|Overall Study|Lost to Follow-up|14|||
124940797|NCT00390884|449411851|FG000|Overall Study|Withdrawal by Subject|2|||
124940798|NCT00390884|449411852|FG001|Overall Study|Withdrawal by Subject|2|||
124940799|NCT03304587|449411853|FG000|Overall Study|Headache after intervention|0|||
124940800|NCT03304587|449411854|FG001|Overall Study|Headache after intervention|1|||
124940801|NCT03304587|449411853|FG000|Overall Study|Withdrawal by Subject|1|||
124940802|NCT03304587|449411854|FG001|Overall Study|Withdrawal by Subject|0|||
124940803|NCT01458366|449411856|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
124940804|NCT01458366|449411857|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
124940805|NCT01458366|449411858|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
124940806|NCT01458366|449411859|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
124940807|NCT01458366|449411860|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
124940808|NCT01458366|449411856|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
124940809|NCT01458366|449411857|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
124940810|NCT01458366|449411858|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
124940811|NCT01458366|449411859|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
124940812|NCT01458366|449411860|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
124940813|NCT02397096|449411861|FG000|Day 1 to Week 24|Adverse Event|7|||
124940814|NCT02397096|449411862|FG001|Day 1 to Week 24|Adverse Event|1|||
124940815|NCT02397096|449411861|FG000|Day 1 to Week 24|Death|1|||
124940816|NCT02397096|449411862|FG001|Day 1 to Week 24|Death|0|||
124940817|NCT02397096|449411861|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
124940818|NCT02397096|449411862|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
124940819|NCT02397096|449411861|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
124940820|NCT02397096|449411862|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
124940821|NCT02397096|449411861|FG000|Day 1 to Week 24|Physician Decision|2|||
124940822|NCT02397096|449411862|FG001|Day 1 to Week 24|Physician Decision|3|||
124940823|NCT02397096|449411861|FG000|Day 1 to Week 24|Protocol Violation|1|||
124940824|NCT02397096|449411862|FG001|Day 1 to Week 24|Protocol Violation|4|||
124940825|NCT02397096|449411861|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
124940826|NCT02397096|449411862|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
124940827|NCT02397096|449411861|FG000|Day 1 to Week 24|Randomized, not treated|3|||
124940828|NCT02397096|449411862|FG001|Day 1 to Week 24|Randomized, not treated|0|||
124940829|NCT02397096|449411861|FG000|Week 24 to Week 48|Adverse Event|6|||
124940830|NCT02397096|449411862|FG001|Week 24 to Week 48|Adverse Event|2|||
124940831|NCT02397096|449411861|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
124940832|NCT02397096|449411862|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
124940833|NCT02397096|449411861|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
124940834|NCT02397096|449411862|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
124940835|NCT02397096|449411861|FG000|Week 24 to Week 48|Physician Decision|2|||
124940836|NCT02397096|449411862|FG001|Week 24 to Week 48|Physician Decision|1|||
124940837|NCT02397096|449411861|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
124940838|NCT02397096|449411862|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
124940839|NCT02397096|449411861|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
124940840|NCT02397096|449411862|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
124940841|NCT02397096|449411861|FG000|Study Extension 1|Adverse Event|7|||
124940842|NCT02397096|449411862|FG001|Study Extension 1|Adverse Event|5|||
124940843|NCT02397096|449411861|FG000|Study Extension 1|Death|1|||
124940844|NCT02397096|449411862|FG001|Study Extension 1|Death|0|||
124940845|NCT02397096|449411861|FG000|Study Extension 1|Lack of Efficacy|2|||
124940846|NCT02397096|449411862|FG001|Study Extension 1|Lack of Efficacy|5|||
124940847|NCT02397096|449411861|FG000|Study Extension 1|Lost to Follow-up|2|||
124940848|NCT02397096|449411862|FG001|Study Extension 1|Lost to Follow-up|3|||
124940849|NCT02397096|449411861|FG000|Study Extension 1|Non-compliance with study drug|3|||
124940850|NCT02397096|449411862|FG001|Study Extension 1|Non-compliance with study drug|0|||
124940851|NCT02397096|449411861|FG000|Study Extension 1|Physician Decision|4|||
124940852|NCT02397096|449411862|FG001|Study Extension 1|Physician Decision|2|||
124940853|NCT02397096|449411861|FG000|Study Extension 1|Pregnancy|1|||
124940854|NCT02397096|449411862|FG001|Study Extension 1|Pregnancy|0|||
124940855|NCT02397096|449411861|FG000|Study Extension 1|Protocol Violation|0|||
124940856|NCT02397096|449411862|FG001|Study Extension 1|Protocol Violation|1|||
124940857|NCT02397096|449411861|FG000|Study Extension 1|Withdrawal by Subject|21|||
124940858|NCT02397096|449411862|FG001|Study Extension 1|Withdrawal by Subject|7|||
124940859|NCT02397096|449411861|FG000|Study Extension 2|Adverse Event|3|||
124940860|NCT02397096|449411862|FG001|Study Extension 2|Adverse Event|3|||
124940861|NCT02397096|449411861|FG000|Study Extension 2|Availability of study medication locally|152|||
124940862|NCT02397096|449411862|FG001|Study Extension 2|Availability of study medication locally|64|||
124940863|NCT02397096|449411861|FG000|Study Extension 2|Death|2|||
124940864|NCT02397096|449411862|FG001|Study Extension 2|Death|0|||
124940865|NCT02397096|449411861|FG000|Study Extension 2|Lack of Efficacy|1|||
124940866|NCT02397096|449411862|FG001|Study Extension 2|Lack of Efficacy|0|||
124940867|NCT02397096|449411861|FG000|Study Extension 2|Lost to Follow-up|2|||
124940868|NCT02397096|449411862|FG001|Study Extension 2|Lost to Follow-up|1|||
124940869|NCT02397096|449411861|FG000|Study Extension 2|Non-compliance with study drug|1|||
124457080|NCT01056510|447633600|FG001|Overall Study|Other|12|||
124457081|NCT01056510|447633599|FG000|Overall Study|Missing|0|||
124457082|NCT01056510|447633600|FG001|Overall Study|Missing|1|||
124457083|NCT00243386|447633601|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
124457084|NCT00243386|447633602|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
124457085|NCT00243386|447633603|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
124457086|NCT00243386|447633601|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
124457087|NCT00243386|447633602|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
124457088|NCT00243386|447633603|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
124457089|NCT00243386|447633601|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
124457090|NCT00243386|447633602|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
124457091|NCT00243386|447633603|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
124457092|NCT00243386|447633601|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
124457093|NCT00243386|447633602|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
124457094|NCT00243386|447633603|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
124457095|NCT00243386|447633601|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
124457096|NCT00243386|447633602|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
124457097|NCT00243386|447633603|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
124457098|NCT00243386|447633601|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
124940870|NCT02397096|449411862|FG001|Study Extension 2|Non-compliance with study drug|0|||
124940871|NCT02397096|449411861|FG000|Study Extension 2|Physician Decision|2|||
124940872|NCT02397096|449411862|FG001|Study Extension 2|Physician Decision|5|||
124940873|NCT02397096|449411861|FG000|Study Extension 2|Pregnancy|1|||
124940874|NCT02397096|449411862|FG001|Study Extension 2|Pregnancy|0|||
124940875|NCT02397096|449411861|FG000|Study Extension 2|Withdrawal by Subject|10|||
124940876|NCT02397096|449411862|FG001|Study Extension 2|Withdrawal by Subject|3|||
124940877|NCT02397096|449411861|FG000|Study Extension 3|Adverse Event|1|||
124457099|NCT00243386|447633602|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
124940878|NCT02397096|449411862|FG001|Study Extension 3|Adverse Event|0|||
124940879|NCT02397096|449411861|FG000|Study Extension 3|Availability of study medication locally|11|||
124457100|NCT00243386|447633603|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
124457101|NCT00243386|447633601|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
124457102|NCT00243386|447633602|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
124457103|NCT00243386|447633603|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
124457104|NCT00243386|447633601|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
124546896|NCT01160770|447957420|FG000|Overall Study|Lost to Follow-up|7|||
124940880|NCT02397096|449411862|FG001|Study Extension 3|Availability of study medication locally|3|||
124940881|NCT02397096|449411861|FG000|Study Extension 3|Lost to Follow-up|1|||
124703632|NCT00851084|448539185|FG001|Overall Study|Poor compliance to protocol|1|||
124703633|NCT00851084|448539184|FG000|Overall Study|Physician Decision|13|||
124703634|NCT00851084|448539185|FG001|Overall Study|Physician Decision|14|||
124940882|NCT02397096|449411862|FG001|Study Extension 3|Lost to Follow-up|0|||
124940883|NCT02397096|449411861|FG000|Study Extension 3|Withdrawal by Subject|2|||
124940884|NCT02397096|449411862|FG001|Study Extension 3|Withdrawal by Subject|1|||
124457105|NCT00243386|447633602|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
124457106|NCT00243386|447633603|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
124457107|NCT02285998|447633604|FG000|Overall Study|Adverse Event|9|||
124457108|NCT02285998|447633605|FG001|Overall Study|Adverse Event|8|||
124457109|NCT02285998|447633604|FG000|Overall Study|Physician Decision|1|||
124457110|NCT02285998|447633605|FG001|Overall Study|Physician Decision|2|||
124457111|NCT02285998|447633604|FG000|Overall Study|Lost to Follow-up|176|||
124457112|NCT02285998|447633605|FG001|Overall Study|Lost to Follow-up|172|||
124457113|NCT02285998|447633604|FG000|Overall Study|Withdrawal by Subject|53|||
124940885|NCT05580003|449411863|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940886|NCT05580003|449411864|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940887|NCT05580003|449411865|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940888|NCT05580003|449411866|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940889|NCT05580003|449411867|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940890|NCT05580003|449411868|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940891|NCT05580003|449411869|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
124940892|NCT05580003|449411870|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940893|NCT05580003|449411871|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940894|NCT05580003|449411872|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940895|NCT05580003|449411873|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940896|NCT05580003|449411874|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940897|NCT05580003|449411875|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940898|NCT05580003|449411876|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940899|NCT05580003|449411877|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940900|NCT05580003|449411878|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940901|NCT05580003|449411879|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940902|NCT05580003|449411880|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940903|NCT05580003|449411881|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940904|NCT05580003|449411882|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940905|NCT05580003|449411883|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940906|NCT05580003|449411884|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940907|NCT05580003|449411885|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940908|NCT05580003|449411886|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940909|NCT05580003|449411887|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940910|NCT05580003|449411888|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940911|NCT05580003|449411889|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940912|NCT05580003|449411890|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124940913|NCT05580003|449411863|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940914|NCT05580003|449411864|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940915|NCT05580003|449411865|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940916|NCT05580003|449411866|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124457114|NCT02285998|447633605|FG001|Overall Study|Withdrawal by Subject|61|||
124457115|NCT02285998|447633604|FG000|Overall Study|Other Reasons|7|||
124457116|NCT02285998|447633605|FG001|Overall Study|Other Reasons|10|||
124703635|NCT00851084|448539184|FG000|Overall Study|Consent withdrawn|0|||
124703636|NCT00851084|448539185|FG001|Overall Study|Consent withdrawn|2|||
124703637|NCT00851084|448539184|FG000|Overall Study|Withdrawal by Subject|11|||
124940917|NCT05580003|449411867|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940918|NCT05580003|449411868|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
124457117|NCT00545298|447633606|FG000|Overall Study|Issues with Standard of Care|2|||
124457118|NCT00545298|447633607|FG001|Overall Study|Issues with Standard of Care|0|||
124457119|NCT00545298|447633608|FG002|Overall Study|Issues with Standard of Care|1|||
124457120|NCT01793142|447633612|FG000|Overall Study|Randomized not treated|7|||
124457121|NCT01820364|447633617|FG000|Part I: LGX818|Death|1|||
124940919|NCT05580003|449411869|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940920|NCT05580003|449411870|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940921|NCT05580003|449411871|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940922|NCT05580003|449411872|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124457122|NCT01820364|447633618|FG001|Part I: LGX818|Death|0|||
124703638|NCT00851084|448539185|FG001|Overall Study|Withdrawal by Subject|12|||
124703639|NCT00851084|448539184|FG000|Overall Study|Metastatic surgery|6|||
124703640|NCT00851084|448539185|FG001|Overall Study|Metastatic surgery|6|||
124457123|NCT01820364|447633617|FG000|Part I: LGX818|Administrative Problems|3|||
124457124|NCT01820364|447633618|FG001|Part I: LGX818|Administrative Problems|0|||
124457125|NCT01820364|447633617|FG000|Part I: LGX818|Adverse Event|6|||
124457126|NCT01820364|447633618|FG001|Part I: LGX818|Adverse Event|0|||
124457127|NCT01820364|447633617|FG000|Part I: LGX818|Disease Progression|4|||
124940923|NCT05580003|449411873|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940924|NCT05580003|449411874|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940925|NCT05580003|449411875|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940926|NCT05580003|449411876|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940927|NCT05580003|449411877|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940928|NCT05580003|449411878|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940929|NCT05580003|449411879|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940930|NCT05580003|449411880|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940931|NCT05580003|449411881|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940932|NCT05580003|449411882|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940933|NCT05580003|449411883|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940934|NCT05580003|449411884|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940935|NCT05580003|449411885|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940936|NCT05580003|449411886|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940937|NCT05580003|449411887|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940938|NCT05580003|449411888|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940939|NCT05580003|449411889|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940940|NCT05580003|449411890|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
124940941|NCT05580003|449411863|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940942|NCT05580003|449411864|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940943|NCT05580003|449411865|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940944|NCT05580003|449411866|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
124940945|NCT05580003|449411867|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940946|NCT05580003|449411868|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940947|NCT05580003|449411869|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940948|NCT05580003|449411870|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940949|NCT05580003|449411871|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940950|NCT05580003|449411872|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940951|NCT05580003|449411873|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940952|NCT05580003|449411874|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940953|NCT05580003|449411875|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940954|NCT05580003|449411876|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940955|NCT05580003|449411877|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940956|NCT05580003|449411878|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940957|NCT05580003|449411879|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940958|NCT05580003|449411880|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940959|NCT05580003|449411881|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940960|NCT05580003|449411882|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940961|NCT05580003|449411883|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940962|NCT05580003|449411884|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940963|NCT05580003|449411885|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940964|NCT05580003|449411886|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940965|NCT05580003|449411887|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940966|NCT05580003|449411888|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940967|NCT05580003|449411889|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940968|NCT05580003|449411890|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
124940969|NCT05580003|449411863|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940970|NCT05580003|449411864|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
124940971|NCT05580003|449411865|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940972|NCT05580003|449411866|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940973|NCT05580003|449411867|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940974|NCT05580003|449411868|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940975|NCT05580003|449411869|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940976|NCT05580003|449411870|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940977|NCT05580003|449411871|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940978|NCT05580003|449411872|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940979|NCT05580003|449411873|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940980|NCT05580003|449411874|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124457128|NCT01820364|447633618|FG001|Part I: LGX818|Disease Progression|0|||
124457129|NCT01820364|447633617|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
124457130|NCT01820364|447633618|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
124457131|NCT03451084|447633622|FG000|Overall Study|Withdrawal by Subject|2|||
124457132|NCT03451084|447633623|FG001|Overall Study|Withdrawal by Subject|1|||
124457133|NCT03451084|447633624|FG002|Overall Study|Withdrawal by Subject|2|||
124457134|NCT03451084|447633625|FG003|Overall Study|Withdrawal by Subject|1|||
124940981|NCT05580003|449411875|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940982|NCT05580003|449411876|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940983|NCT05580003|449411877|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940984|NCT05580003|449411878|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940985|NCT05580003|449411879|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940986|NCT05580003|449411880|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940987|NCT05580003|449411881|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940988|NCT05580003|449411882|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940989|NCT05580003|449411883|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940990|NCT05580003|449411884|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940991|NCT05580003|449411885|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940992|NCT05580003|449411886|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940993|NCT05580003|449411887|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940994|NCT05580003|449411888|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940995|NCT05580003|449411889|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940996|NCT05580003|449411890|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
124940997|NCT05580003|449411863|FG000|Part 2 (up to 10 Days)|Other|0|||
124940998|NCT05580003|449411864|FG001|Part 2 (up to 10 Days)|Other|0|||
124940999|NCT05580003|449411865|FG002|Part 2 (up to 10 Days)|Other|0|||
124941000|NCT05580003|449411866|FG003|Part 2 (up to 10 Days)|Other|0|||
124941001|NCT05580003|449411867|FG004|Part 2 (up to 10 Days)|Other|0|||
124941002|NCT05580003|449411868|FG005|Part 2 (up to 10 Days)|Other|0|||
124941003|NCT05580003|449411869|FG006|Part 2 (up to 10 Days)|Other|0|||
124941004|NCT05580003|449411870|FG007|Part 2 (up to 10 Days)|Other|0|||
124941005|NCT05580003|449411871|FG008|Part 2 (up to 10 Days)|Other|0|||
124941006|NCT05580003|449411872|FG009|Part 2 (up to 10 Days)|Other|1|||
124941007|NCT05580003|449411873|FG010|Part 2 (up to 10 Days)|Other|0|||
124941008|NCT05580003|449411874|FG011|Part 2 (up to 10 Days)|Other|0|||
124941009|NCT05580003|449411875|FG012|Part 2 (up to 10 Days)|Other|0|||
124941010|NCT05580003|449411876|FG013|Part 2 (up to 10 Days)|Other|0|||
124941011|NCT05580003|449411877|FG014|Part 2 (up to 10 Days)|Other|0|||
124941012|NCT05580003|449411878|FG015|Part 2 (up to 10 Days)|Other|0|||
124941013|NCT05580003|449411879|FG016|Part 2 (up to 10 Days)|Other|0|||
124941014|NCT05580003|449411880|FG017|Part 2 (up to 10 Days)|Other|0|||
124941015|NCT05580003|449411881|FG018|Part 2 (up to 10 Days)|Other|0|||
124941016|NCT05580003|449411882|FG019|Part 2 (up to 10 Days)|Other|0|||
124941017|NCT05580003|449411883|FG020|Part 2 (up to 10 Days)|Other|0|||
124941018|NCT05580003|449411884|FG021|Part 2 (up to 10 Days)|Other|0|||
124941019|NCT05580003|449411885|FG022|Part 2 (up to 10 Days)|Other|0|||
124941020|NCT05580003|449411886|FG023|Part 2 (up to 10 Days)|Other|0|||
124941021|NCT05580003|449411887|FG024|Part 2 (up to 10 Days)|Other|0|||
124941022|NCT05580003|449411888|FG025|Part 2 (up to 10 Days)|Other|0|||
124941023|NCT05580003|449411889|FG026|Part 2 (up to 10 Days)|Other|0|||
124941024|NCT05580003|449411890|FG027|Part 2 (up to 10 Days)|Other|0|||
124941025|NCT05580003|449411863|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941026|NCT05580003|449411864|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941027|NCT05580003|449411865|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941028|NCT05580003|449411866|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941029|NCT05580003|449411867|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941030|NCT05580003|449411868|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941031|NCT05580003|449411869|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941032|NCT05580003|449411870|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941033|NCT05580003|449411871|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941034|NCT05580003|449411872|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941035|NCT05580003|449411873|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941036|NCT05580003|449411874|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941037|NCT05580003|449411875|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124765016|NCT04913610|448765113|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
124941038|NCT05580003|449411876|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941039|NCT05580003|449411877|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941040|NCT05580003|449411878|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124546897|NCT01160770|447957420|FG000|Overall Study|Study termination or sponsor request|1|||
124546898|NCT01160770|447957420|FG000|Overall Study|Death|9|||
124546899|NCT01160770|447957420|FG000|Overall Study|Lack of Efficacy|15|||
124546900|NCT01160770|447957420|FG000|Overall Study|Other Reasons|1|||
124546901|NCT01513759|447957424|FG000|Overall Study|Protocol Violation|4|||
124546902|NCT01513759|447957424|FG000|Overall Study|Death during catheter placement|1|||
124546903|NCT03606109|447957425|FG000|Overall Study|Lost to Follow-up|2|||
124546904|NCT03606109|447957426|FG001|Overall Study|Lost to Follow-up|1|||
124546905|NCT03669640|447957427|FG000|Overall Study|Study Terminated by Sponsor|0|||
124546906|NCT03669640|447957428|FG001|Overall Study|Study Terminated by Sponsor|0|||
124546907|NCT03669640|447957429|FG002|Overall Study|Study Terminated by Sponsor|0|||
124546908|NCT03669640|447957430|FG003|Overall Study|Study Terminated by Sponsor|0|||
124765017|NCT02358473|448765118|FG000|Overall Study|Disease Progession|6|||
124941041|NCT05580003|449411879|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941042|NCT05580003|449411880|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941043|NCT05580003|449411881|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941044|NCT05580003|449411882|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
124941045|NCT05580003|449411883|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941046|NCT05580003|449411884|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941047|NCT05580003|449411885|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941048|NCT05580003|449411886|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941049|NCT05580003|449411887|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941050|NCT05580003|449411888|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941051|NCT05580003|449411889|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941052|NCT05580003|449411890|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
124941053|NCT05580003|449411863|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941054|NCT05580003|449411864|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941055|NCT05580003|449411865|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941056|NCT05580003|449411866|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941057|NCT05580003|449411867|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941058|NCT05580003|449411868|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941059|NCT05580003|449411869|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941060|NCT05580003|449411870|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941061|NCT05580003|449411871|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941062|NCT05580003|449411872|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941063|NCT05580003|449411873|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941064|NCT05580003|449411874|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941065|NCT05580003|449411875|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941066|NCT05580003|449411876|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941067|NCT05580003|449411877|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941068|NCT05580003|449411878|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941069|NCT05580003|449411879|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941070|NCT05580003|449411880|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941071|NCT05580003|449411881|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941072|NCT05580003|449411882|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941073|NCT05580003|449411883|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
124941074|NCT05580003|449411884|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941075|NCT05580003|449411885|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941076|NCT05580003|449411886|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941077|NCT05580003|449411887|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941078|NCT05580003|449411888|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941079|NCT05580003|449411889|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124546909|NCT03669640|447957431|FG004|Overall Study|Study Terminated by Sponsor|1|||
124546910|NCT03669640|447957432|FG005|Overall Study|Study Terminated by Sponsor|0|||
124546911|NCT03669640|447957427|FG000|Overall Study|Lost to Follow-up|0|||
124546912|NCT03669640|447957428|FG001|Overall Study|Lost to Follow-up|0|||
124941080|NCT05580003|449411890|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
124941081|NCT05580003|449411863|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941082|NCT05580003|449411864|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941083|NCT05580003|449411865|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941084|NCT05580003|449411866|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941085|NCT05580003|449411867|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941086|NCT05580003|449411868|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941087|NCT05580003|449411869|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941088|NCT05580003|449411870|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941089|NCT05580003|449411871|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941090|NCT05580003|449411872|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941091|NCT05580003|449411873|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941092|NCT05580003|449411874|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941093|NCT05580003|449411875|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941094|NCT05580003|449411876|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941095|NCT05580003|449411877|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941096|NCT05580003|449411878|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941097|NCT05580003|449411879|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941098|NCT05580003|449411880|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941099|NCT05580003|449411881|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941100|NCT05580003|449411882|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941101|NCT05580003|449411883|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941102|NCT05580003|449411884|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
124941103|NCT05580003|449411885|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941104|NCT05580003|449411886|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941105|NCT05580003|449411887|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941106|NCT05580003|449411888|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941107|NCT05580003|449411889|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124546913|NCT03669640|447957429|FG002|Overall Study|Lost to Follow-up|2|||
124941108|NCT05580003|449411890|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
124941109|NCT05580003|449411863|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941110|NCT05580003|449411864|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941111|NCT05580003|449411865|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941112|NCT05580003|449411866|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941113|NCT05580003|449411867|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941114|NCT05580003|449411868|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941115|NCT05580003|449411869|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941116|NCT05580003|449411870|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941117|NCT05580003|449411871|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941118|NCT05580003|449411872|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941119|NCT05580003|449411873|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941120|NCT05580003|449411874|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941121|NCT05580003|449411875|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941122|NCT05580003|449411876|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941123|NCT05580003|449411877|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941124|NCT05580003|449411878|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941125|NCT05580003|449411879|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941126|NCT05580003|449411880|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941127|NCT05580003|449411881|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941128|NCT05580003|449411882|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941129|NCT05580003|449411883|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941130|NCT05580003|449411884|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124546914|NCT03669640|447957430|FG003|Overall Study|Lost to Follow-up|0|||
124546915|NCT03669640|447957431|FG004|Overall Study|Lost to Follow-up|0|||
124546916|NCT03669640|447957432|FG005|Overall Study|Lost to Follow-up|0|||
124546917|NCT03669640|447957427|FG000|Overall Study|Death|0|||
124546918|NCT03669640|447957428|FG001|Overall Study|Death|0|||
124703641|NCT00851084|448539184|FG000|Overall Study|Other|7|||
124703642|NCT00851084|448539185|FG001|Overall Study|Other|1|||
124941131|NCT05580003|449411885|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941132|NCT05580003|449411886|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941133|NCT05580003|449411887|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941134|NCT05580003|449411888|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124941135|NCT05580003|449411889|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
124546919|NCT03669640|447957429|FG002|Overall Study|Death|1|||
124546920|NCT03669640|447957430|FG003|Overall Study|Death|0|||
124941136|NCT05580003|449411890|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
124941137|NCT05580003|449411863|FG000|Part 6 Period 2 (Day 1)|Other|0|||
124941138|NCT05580003|449411864|FG001|Part 6 Period 2 (Day 1)|Other|0|||
124546921|NCT03669640|447957431|FG004|Overall Study|Death|0|||
124703643|NCT00734032|448539186|FG000|Overall Study|Adverse Event|0|||
124703644|NCT00734032|448539187|FG001|Overall Study|Adverse Event|1|||
124941139|NCT05580003|449411865|FG002|Part 6 Period 2 (Day 1)|Other|0|||
124941140|NCT05580003|449411866|FG003|Part 6 Period 2 (Day 1)|Other|0|||
124941141|NCT05580003|449411867|FG004|Part 6 Period 2 (Day 1)|Other|0|||
124941142|NCT05580003|449411868|FG005|Part 6 Period 2 (Day 1)|Other|0|||
124941143|NCT05580003|449411869|FG006|Part 6 Period 2 (Day 1)|Other|0|||
124941144|NCT05580003|449411870|FG007|Part 6 Period 2 (Day 1)|Other|0|||
124941145|NCT05580003|449411871|FG008|Part 6 Period 2 (Day 1)|Other|0|||
124941146|NCT05580003|449411872|FG009|Part 6 Period 2 (Day 1)|Other|0|||
124941147|NCT05580003|449411873|FG010|Part 6 Period 2 (Day 1)|Other|0|||
124941148|NCT05580003|449411874|FG011|Part 6 Period 2 (Day 1)|Other|0|||
124941149|NCT05580003|449411875|FG012|Part 6 Period 2 (Day 1)|Other|0|||
124941150|NCT05580003|449411876|FG013|Part 6 Period 2 (Day 1)|Other|0|||
124941151|NCT05580003|449411877|FG014|Part 6 Period 2 (Day 1)|Other|0|||
124941152|NCT05580003|449411878|FG015|Part 6 Period 2 (Day 1)|Other|0|||
124941153|NCT05580003|449411879|FG016|Part 6 Period 2 (Day 1)|Other|0|||
124941154|NCT05580003|449411880|FG017|Part 6 Period 2 (Day 1)|Other|0|||
124941155|NCT05580003|449411881|FG018|Part 6 Period 2 (Day 1)|Other|0|||
124941156|NCT05580003|449411882|FG019|Part 6 Period 2 (Day 1)|Other|0|||
124941157|NCT05580003|449411883|FG020|Part 6 Period 2 (Day 1)|Other|0|||
124941158|NCT05580003|449411884|FG021|Part 6 Period 2 (Day 1)|Other|0|||
124941159|NCT05580003|449411885|FG022|Part 6 Period 2 (Day 1)|Other|0|||
124941160|NCT05580003|449411886|FG023|Part 6 Period 2 (Day 1)|Other|0|||
124941161|NCT05580003|449411887|FG024|Part 6 Period 2 (Day 1)|Other|1|||
124941162|NCT05580003|449411888|FG025|Part 6 Period 2 (Day 1)|Other|0|||
124941163|NCT05580003|449411889|FG026|Part 6 Period 2 (Day 1)|Other|0|||
124941164|NCT05580003|449411890|FG027|Part 6 Period 2 (Day 1)|Other|0|||
124941165|NCT04795167|449411891|FG000|Overall Study|Death|1|||
124941166|NCT04795167|449411892|FG001|Overall Study|Death|18|||
124941167|NCT04795167|449411893|FG002|Overall Study|Death|1|||
124941168|NCT04795167|449411891|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
124941169|NCT04795167|449411892|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
124941170|NCT04795167|449411893|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
124941171|NCT02052440|449411894|FG000|Overall Study|Withdrawal by Subject|0|||
124941172|NCT02052440|449411895|FG001|Overall Study|Withdrawal by Subject|1|||
124941173|NCT03333109|449411898|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
124941174|NCT03333109|449411899|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
124941175|NCT03333109|449411900|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
124941176|NCT03333109|449411898|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
124941177|NCT03333109|449411899|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
124941178|NCT03333109|449411900|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
124941179|NCT03333109|449411898|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
124546922|NCT03669640|447957432|FG005|Overall Study|Death|0|||
124546923|NCT03669640|447957427|FG000|Overall Study|Withdrawal by Subject|1|||
124703645|NCT00734032|448539188|FG002|Overall Study|Adverse Event|0|||
124703646|NCT00734032|448539189|FG003|Overall Study|Adverse Event|0|||
124941180|NCT03333109|449411899|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
124941181|NCT03333109|449411900|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
124941182|NCT03333109|449411898|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
124941183|NCT03333109|449411899|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
124941184|NCT03333109|449411900|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
124941185|NCT03333109|449411898|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
124941186|NCT03333109|449411899|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
124941187|NCT03333109|449411900|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
124457135|NCT03451084|447633622|FG000|Overall Study|Disease recurrence|0|||
124457136|NCT03451084|447633623|FG001|Overall Study|Disease recurrence|2|||
124457137|NCT03451084|447633624|FG002|Overall Study|Disease recurrence|0|||
124457138|NCT03451084|447633625|FG003|Overall Study|Disease recurrence|0|||
124457139|NCT03451084|447633622|FG000|Overall Study|Lack of Efficacy|0|||
124457140|NCT03451084|447633623|FG001|Overall Study|Lack of Efficacy|3|||
124457141|NCT03451084|447633624|FG002|Overall Study|Lack of Efficacy|0|||
124457142|NCT03451084|447633625|FG003|Overall Study|Lack of Efficacy|1|||
124457143|NCT03451084|447633622|FG000|Overall Study|Death|1|||
124457144|NCT03451084|447633623|FG001|Overall Study|Death|0|||
124457145|NCT03451084|447633624|FG002|Overall Study|Death|2|||
124457146|NCT03451084|447633625|FG003|Overall Study|Death|0|||
124457147|NCT03451084|447633622|FG000|Overall Study|Physician Decision|0|||
124457148|NCT03451084|447633623|FG001|Overall Study|Physician Decision|0|||
124457149|NCT03451084|447633624|FG002|Overall Study|Physician Decision|2|||
124457150|NCT03451084|447633625|FG003|Overall Study|Physician Decision|2|||
124457151|NCT03451084|447633622|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
124457152|NCT03451084|447633623|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
124457153|NCT03451084|447633624|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
124457154|NCT03451084|447633625|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
124457155|NCT04995055|447633626|FG000|Period 1|COVID-19 Related|1|||
124457156|NCT04995055|447633627|FG001|Period 1|COVID-19 Related|0|||
124457157|NCT04995055|447633626|FG000|Period 1|Withdrawal by Subject|0|||
124457158|NCT04995055|447633627|FG001|Period 1|Withdrawal by Subject|1|||
124457159|NCT04995055|447633626|FG000|Period 1|Subject discontinued due to timing|4|||
124457160|NCT04995055|447633627|FG001|Period 1|Subject discontinued due to timing|4|||
124457161|NCT03418129|447633632|FG000|Overall Study|Lost to Follow-up|11|||
124457162|NCT03418129|447633633|FG001|Overall Study|Lost to Follow-up|20|||
124457163|NCT03418129|447633634|FG002|Overall Study|Lost to Follow-up|15|||
124457164|NCT03418129|447633632|FG000|Overall Study|Withdrawal by Subject|3|||
124457165|NCT03418129|447633633|FG001|Overall Study|Withdrawal by Subject|6|||
124457166|NCT03418129|447633634|FG002|Overall Study|Withdrawal by Subject|4|||
124457167|NCT01553188|447633638|FG000|Overall Study|Patient choice|1|||
124457168|NCT01553188|447633639|FG001|Overall Study|Patient choice|0|||
124457169|NCT01553188|447633640|FG002|Overall Study|Patient choice|0|||
124457170|NCT01553188|447633641|FG003|Overall Study|Patient choice|0|||
124457171|NCT01553188|447633638|FG000|Overall Study|Intercurrent illness and adverse event|0|||
124457172|NCT01553188|447633639|FG001|Overall Study|Intercurrent illness and adverse event|1|||
124457173|NCT01553188|447633640|FG002|Overall Study|Intercurrent illness and adverse event|2|||
124457174|NCT01553188|447633641|FG003|Overall Study|Intercurrent illness and adverse event|0|||
124457175|NCT04744207|447633645|FG000|Treatment|Withdrawal by Subject|2|||
124457176|NCT04744207|447633646|FG001|Treatment|Withdrawal by Subject|0|||
124457177|NCT04744207|447633645|FG000|Treatment|Adverse Event|1|||
124457178|NCT04744207|447633646|FG001|Treatment|Adverse Event|2|||
124457179|NCT01617070|447633655|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
124457180|NCT05289570|447633656|FG000|Overall Study|Physician Decision|1|||
124457181|NCT02230384|447633658|FG000|Phase 1|Lost to Follow-up|1|||
124457182|NCT02230384|447633659|FG001|Phase 1|Lost to Follow-up|0|||
124457183|NCT02230384|447633658|FG000|Phase 1|Physician Decision|0|||
124457184|NCT02230384|447633659|FG001|Phase 1|Physician Decision|1|||
124457185|NCT02230384|447633658|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
124457186|NCT02230384|447633659|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
124457187|NCT02230384|447633658|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
124457188|NCT02230384|447633659|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
124457189|NCT02230384|447633658|FG000|Phase 2 - Switch|Adverse Event|2|||
124457190|NCT02230384|447633659|FG001|Phase 2 - Switch|Adverse Event|0|||
124457191|NCT00808236|447633660|FG000|Overall Study|Was not resuscitated|50|||
124457192|NCT00808236|447633661|FG001|Overall Study|Was not resuscitated|56|||
124765018|NCT02358473|448765118|FG000|Overall Study|Adverse Event|3|||
124941188|NCT03333109|449411898|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
124941189|NCT03333109|449411899|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
124941190|NCT03333109|449411900|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
124941191|NCT03333109|449411898|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
124941192|NCT03333109|449411899|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
124941193|NCT03333109|449411900|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
124941194|NCT03333109|449411898|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
124941195|NCT03333109|449411899|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
124941196|NCT03333109|449411900|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
124941197|NCT00918203|449411904|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
124941198|NCT00918203|449411905|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
124941199|NCT00918203|449411906|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
124941200|NCT00918203|449411904|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
124941201|NCT00918203|449411905|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
124941202|NCT00918203|449411906|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
124941203|NCT00918203|449411904|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
124941204|NCT00918203|449411905|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
124941205|NCT00918203|449411906|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
124941206|NCT00918203|449411904|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
124941207|NCT00918203|449411905|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
124941208|NCT00918203|449411906|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
124941209|NCT00589875|449411909|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
124941210|NCT00589875|449411909|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
124941211|NCT03488719|449411912|FG000|Overall Study|Adverse Event|0|||
124941212|NCT03488719|449411913|FG001|Overall Study|Adverse Event|4|||
124941213|NCT03488719|449411914|FG002|Overall Study|Adverse Event|2|||
124941214|NCT03488719|449411912|FG000|Overall Study|Other|0|||
124941215|NCT03488719|449411913|FG001|Overall Study|Other|0|||
124941216|NCT03488719|449411914|FG002|Overall Study|Other|5|||
124941217|NCT05025384|449411915|FG000|Overall Study|Physician Decision|5|||
124941218|NCT05025384|449411916|FG001|Overall Study|Physician Decision|6|||
124941219|NCT03610581|449411917|FG000|Overall Study|Study terminated by sponsor|2|||
124941220|NCT03610581|449411918|FG001|Overall Study|Study terminated by sponsor|0|||
124941221|NCT03610581|449411917|FG000|Overall Study|Other|0|||
124941222|NCT03610581|449411918|FG001|Overall Study|Other|1|||
124941223|NCT03610581|449411917|FG000|Overall Study|Withdrawal by Subject|1|||
124941224|NCT03610581|449411918|FG001|Overall Study|Withdrawal by Subject|0|||
124941225|NCT05485805|449411927|FG000|Overall Study|Withdrawal by Subject|1|||
124941226|NCT05485805|449411928|FG001|Overall Study|Withdrawal by Subject|2|||
124941227|NCT05485805|449411929|FG002|Overall Study|Withdrawal by Subject|2|||
124941228|NCT05485805|449411930|FG003|Overall Study|Withdrawal by Subject|0|||
124941229|NCT05485805|449411931|FG004|Overall Study|Withdrawal by Subject|2|||
124941230|NCT05485805|449411927|FG000|Overall Study|Adverse Event|0|||
124941231|NCT05485805|449411928|FG001|Overall Study|Adverse Event|1|||
124941232|NCT05485805|449411929|FG002|Overall Study|Adverse Event|0|||
124941233|NCT05485805|449411930|FG003|Overall Study|Adverse Event|0|||
124941234|NCT05485805|449411931|FG004|Overall Study|Adverse Event|0|||
124941235|NCT05485805|449411927|FG000|Overall Study|Lost to Follow-up|1|||
124941236|NCT05485805|449411928|FG001|Overall Study|Lost to Follow-up|1|||
124941237|NCT05485805|449411929|FG002|Overall Study|Lost to Follow-up|3|||
124941238|NCT05485805|449411930|FG003|Overall Study|Lost to Follow-up|1|||
124941239|NCT05485805|449411931|FG004|Overall Study|Lost to Follow-up|0|||
124941240|NCT04218357|449411933|FG000|1st Allocation|Withdrawal by Subject|1|||
124941241|NCT04218357|449411934|FG001|1st Allocation|Withdrawal by Subject|0|||
124941242|NCT05349838|449411935|FG000|Overall Study|Virological Failure|1|||
124457193|NCT00808236|447633660|FG000|Overall Study|Pre-defined exclusion|13|||
124457194|NCT00808236|447633661|FG001|Overall Study|Pre-defined exclusion|3|||
124457195|NCT00808236|447633660|FG000|Overall Study|Lost to Follow-up|1|||
124457196|NCT00808236|447633661|FG001|Overall Study|Lost to Follow-up|1|||
124941243|NCT05349838|449411936|FG001|Overall Study|Virological Failure|2|||
124941244|NCT05349838|449411935|FG000|Overall Study|Withdrawal by Subject|2|||
124941245|NCT05349838|449411936|FG001|Overall Study|Withdrawal by Subject|3|||
124941246|NCT05349838|449411935|FG000|Overall Study|Adverse Event|3|||
124941247|NCT05349838|449411936|FG001|Overall Study|Adverse Event|1|||
124941248|NCT05349838|449411935|FG000|Overall Study|Lost to Follow-up|1|||
124941249|NCT05349838|449411936|FG001|Overall Study|Lost to Follow-up|2|||
124941250|NCT05349838|449411935|FG000|Overall Study|Other reasons|5|||
124941251|NCT05349838|449411936|FG001|Overall Study|Other reasons|1|||
124941252|NCT02488408|449411938|FG000|Part A|Adverse Event|2|||
124941253|NCT02488408|449411939|FG001|Part A|Adverse Event|0|||
124941254|NCT02488408|449411940|FG002|Part A|Adverse Event|0|||
124941255|NCT02488408|449411941|FG003|Part A|Adverse Event|0|||
124457197|NCT00808236|447633660|FG000|Overall Study|Physician Decision|0|||
124457198|NCT00808236|447633661|FG001|Overall Study|Physician Decision|1|||
124941256|NCT02488408|449411942|FG004|Part A|Adverse Event|0|||
124457199|NCT00808236|447633660|FG000|Overall Study|Death|18|||
124457200|NCT00808236|447633661|FG001|Overall Study|Death|30|||
124457201|NCT00777101|447633662|FG000|Overall Study|Death|48|||
124457202|NCT00777101|447633663|FG001|Overall Study|Death|43|||
124457203|NCT00777101|447633662|FG000|Overall Study|Withdrawal by Subject|11|||
124703647|NCT03360344|448539194|FG000|Overall Study|Withdrawal by Subject|0|||
124703648|NCT03360344|448539195|FG001|Overall Study|Withdrawal by Subject|1|||
124703649|NCT03360344|448539196|FG002|Overall Study|Withdrawal by Subject|1|||
124703650|NCT00133705|448539201|FG000|Overall Study|Withdrawal by Subject|2|||
124703651|NCT00133705|448539202|FG001|Overall Study|Withdrawal by Subject|3|||
124703652|NCT01892189|448539210|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
124703653|NCT01892189|448539211|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
124703654|NCT01892189|448539212|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
124703655|NCT01892189|448539213|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
124703656|NCT01892189|448539214|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
124703657|NCT01892189|448539215|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
124703658|NCT01892189|448539216|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
124703659|NCT01892189|448539217|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
124703660|NCT01892189|448539218|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
124703661|NCT01892189|448539210|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124703662|NCT01892189|448539211|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124703663|NCT01892189|448539212|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
124703664|NCT01892189|448539213|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
124703665|NCT01892189|448539214|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124703666|NCT01892189|448539215|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124703667|NCT01892189|448539216|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
124703668|NCT01892189|448539217|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124703669|NCT01892189|448539218|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
124703670|NCT01892189|448539210|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
124703671|NCT01892189|448539211|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
124703672|NCT01892189|448539212|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
124703673|NCT01892189|448539213|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
124703674|NCT01892189|448539214|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
124703675|NCT01892189|448539215|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
124703676|NCT01892189|448539216|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
124941257|NCT02488408|449411943|FG005|Part A|Adverse Event|0|||
124941258|NCT02488408|449411944|FG006|Part A|Adverse Event|0|||
124941259|NCT02488408|449411945|FG007|Part A|Adverse Event|0|||
124941260|NCT02488408|449411946|FG008|Part A|Adverse Event|0|||
124941261|NCT02488408|449411947|FG009|Part A|Adverse Event|0|||
124941262|NCT02488408|449411938|FG000|Part A|Death|1|||
124941263|NCT02488408|449411939|FG001|Part A|Death|5|||
124941264|NCT02488408|449411940|FG002|Part A|Death|0|||
124941265|NCT02488408|449411941|FG003|Part A|Death|0|||
124941266|NCT02488408|449411942|FG004|Part A|Death|3|||
124941267|NCT02488408|449411943|FG005|Part A|Death|0|||
124941268|NCT02488408|449411944|FG006|Part A|Death|0|||
124941269|NCT02488408|449411945|FG007|Part A|Death|0|||
124941270|NCT02488408|449411946|FG008|Part A|Death|0|||
124941271|NCT02488408|449411947|FG009|Part A|Death|0|||
124941272|NCT02488408|449411938|FG000|Part A|Disease Progression|2|||
124941273|NCT02488408|449411939|FG001|Part A|Disease Progression|8|||
124941274|NCT02488408|449411940|FG002|Part A|Disease Progression|2|||
124457204|NCT00777101|447633663|FG001|Overall Study|Withdrawal by Subject|6|||
124457205|NCT00777101|447633662|FG000|Overall Study|Lost to Follow-up|2|||
124457206|NCT00777101|447633663|FG001|Overall Study|Lost to Follow-up|1|||
124457207|NCT00777101|447633662|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
124457208|NCT00777101|447633663|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
124941275|NCT02488408|449411941|FG003|Part A|Disease Progression|3|||
124941276|NCT02488408|449411942|FG004|Part A|Disease Progression|4|||
124941277|NCT02488408|449411943|FG005|Part A|Disease Progression|0|||
124457209|NCT00777101|447633662|FG000|Overall Study|Failed to Return|0|||
124457210|NCT00777101|447633663|FG001|Overall Study|Failed to Return|1|||
124457211|NCT00961220|447633664|FG000|Overall Study|Adverse Event|3|||
124703677|NCT01892189|448539217|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
124703678|NCT01892189|448539218|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
124703679|NCT03440411|448539219|FG000|Overall Study|Adverse Event|0|||
124703680|NCT03440411|448539220|FG001|Overall Study|Adverse Event|0|||
124703681|NCT03440411|448539221|FG002|Overall Study|Adverse Event|1|||
124703682|NCT03440411|448539222|FG003|Overall Study|Adverse Event|0|||
124703683|NCT03440411|448539219|FG000|Overall Study|PD|2|||
124703684|NCT03440411|448539220|FG001|Overall Study|PD|1|||
124703685|NCT03440411|448539221|FG002|Overall Study|PD|1|||
124703686|NCT03440411|448539222|FG003|Overall Study|PD|1|||
124941278|NCT02488408|449411944|FG006|Part A|Disease Progression|0|||
124941279|NCT02488408|449411945|FG007|Part A|Disease Progression|0|||
124941280|NCT02488408|449411946|FG008|Part A|Disease Progression|0|||
124457212|NCT00961220|447633664|FG000|Overall Study|Lack of Efficacy|1|||
124941281|NCT02488408|449411947|FG009|Part A|Disease Progression|0|||
124941282|NCT02488408|449411938|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
124941283|NCT02488408|449411939|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
124941284|NCT02488408|449411940|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
124941285|NCT02488408|449411941|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
124941286|NCT02488408|449411942|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
124941287|NCT02488408|449411943|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
124941288|NCT02488408|449411944|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
124941289|NCT02488408|449411945|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
124941290|NCT02488408|449411946|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
124941291|NCT02488408|449411947|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
124941292|NCT02488408|449411938|FG000|Part A|Investigator Decision|0|||
124941293|NCT02488408|449411939|FG001|Part A|Investigator Decision|1|||
124457213|NCT00961220|447633664|FG000|Overall Study|No IV access for O6BG|1|||
124457214|NCT00961220|447633664|FG000|Overall Study|O6BG no longer supplied|1|||
124457215|NCT00961220|447633664|FG000|Overall Study|Complete Response prior to 12 courses|1|||
124457216|NCT05376215|447633665|FG000|Overall Study|Withdrawal by Subject|2|||
124457217|NCT05376215|447633666|FG001|Overall Study|Withdrawal by Subject|1|||
124457218|NCT05376215|447633665|FG000|Overall Study|Lost to Follow-up|0|||
124457219|NCT05376215|447633666|FG001|Overall Study|Lost to Follow-up|1|||
124457220|NCT01301950|447633673|FG000|Overall Study|Surgery was cancelled by patient|0|||
124457221|NCT01301950|447633674|FG001|Overall Study|Surgery was cancelled by patient|1|||
124457222|NCT01066585|447633677|FG000|Overall Study|Protocol Violation|1|||
124457223|NCT01066585|447633678|FG001|Overall Study|Protocol Violation|0|||
124457224|NCT01066585|447633677|FG000|Overall Study|Withdrawal by Subject|0|||
124457225|NCT01066585|447633678|FG001|Overall Study|Withdrawal by Subject|3|||
124457226|NCT04247061|447633686|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
124457227|NCT04247061|447633686|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
124457228|NCT04247061|447633686|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
124457229|NCT03610724|447633687|FG000|Overall Study|Death|17|||
124457230|NCT03610724|447633687|FG000|Overall Study|Lost to Follow-up|1|||
124457231|NCT03610724|447633687|FG000|Overall Study|Physician Decision|1|||
124457232|NCT03610724|447633687|FG000|Overall Study|Died prior to infusion|1|||
124457233|NCT01519765|447633688|FG000|Overall Study|Adverse Event|0|||
124457234|NCT01519765|447633689|FG001|Overall Study|Adverse Event|1|||
124457235|NCT01519765|447633688|FG000|Overall Study|Lack of Efficacy|2|||
124941294|NCT02488408|449411940|FG002|Part A|Investigator Decision|1|||
124941295|NCT02488408|449411941|FG003|Part A|Investigator Decision|0|||
124941296|NCT02488408|449411942|FG004|Part A|Investigator Decision|0|||
124941297|NCT02488408|449411943|FG005|Part A|Investigator Decision|0|||
124457236|NCT01519765|447633689|FG001|Overall Study|Lack of Efficacy|0|||
124457237|NCT01519765|447633688|FG000|Overall Study|Protocol Violation|1|||
124457238|NCT01519765|447633689|FG001|Overall Study|Protocol Violation|0|||
124457239|NCT01519765|447633688|FG000|Overall Study|Withdrawal by Subject|0|||
124457240|NCT01519765|447633689|FG001|Overall Study|Withdrawal by Subject|1|||
124457241|NCT01473563|447633690|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
124457242|NCT04126083|447633691|FG000|Overall Study|Withdrawal by Subject|1|||
124457243|NCT00786565|447633692|FG000|Enrollment Prior to Surgery|Site Closed|3|||
124457244|NCT00786565|447633692|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
124457245|NCT00786565|447633692|FG000|Post Surgery|Abnormal macular pucker|1|||
124457246|NCT00786565|447633692|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
124457247|NCT05248295|447633700|FG000|Overall Study|found ineligible|4|||
124457248|NCT05248295|447633701|FG001|Overall Study|found ineligible|1|||
124457249|NCT05248295|447633700|FG000|Overall Study|Withdrawal by Subject|0|||
124457250|NCT05248295|447633701|FG001|Overall Study|Withdrawal by Subject|1|||
124457251|NCT05248295|447633700|FG000|Overall Study|Data loss: audio recording error|1|||
124457252|NCT05248295|447633701|FG001|Overall Study|Data loss: audio recording error|1|||
124457253|NCT03021499|447633702|FG000|Overall Study|Adverse Event|1|||
124457254|NCT03021499|447633703|FG001|Overall Study|Adverse Event|0|||
124457255|NCT03021499|447633702|FG000|Overall Study|Death|1|||
124457256|NCT03021499|447633703|FG001|Overall Study|Death|5|||
124457257|NCT03021499|447633702|FG000|Overall Study|Lack of Efficacy|0|||
124457258|NCT03021499|447633703|FG001|Overall Study|Lack of Efficacy|1|||
124941298|NCT02488408|449411944|FG006|Part A|Investigator Decision|0|||
124457259|NCT03021499|447633702|FG000|Overall Study|Lost to Follow-up|1|||
124457260|NCT03021499|447633703|FG001|Overall Study|Lost to Follow-up|3|||
124457261|NCT03021499|447633702|FG000|Overall Study|Physician Decision|2|||
124457262|NCT03021499|447633703|FG001|Overall Study|Physician Decision|3|||
124457263|NCT03021499|447633702|FG000|Overall Study|Pregnancy|1|||
124457264|NCT03021499|447633703|FG001|Overall Study|Pregnancy|0|||
124457265|NCT03021499|447633702|FG000|Overall Study|Withdrawal by Subject|7|||
124457266|NCT03021499|447633703|FG001|Overall Study|Withdrawal by Subject|14|||
124457267|NCT03021499|447633702|FG000|Overall Study|Prohibited medication required|1|||
124457268|NCT03021499|447633703|FG001|Overall Study|Prohibited medication required|0|||
124941299|NCT02488408|449411945|FG007|Part A|Investigator Decision|0|||
124941300|NCT02488408|449411946|FG008|Part A|Investigator Decision|0|||
124941301|NCT02488408|449411947|FG009|Part A|Investigator Decision|0|||
124941302|NCT02488408|449411938|FG000|Part A|Withdrawal by Subject|0|||
124941303|NCT02488408|449411939|FG001|Part A|Withdrawal by Subject|0|||
124941304|NCT02488408|449411940|FG002|Part A|Withdrawal by Subject|2|||
124941305|NCT02488408|449411941|FG003|Part A|Withdrawal by Subject|0|||
124941306|NCT02488408|449411942|FG004|Part A|Withdrawal by Subject|0|||
124941307|NCT02488408|449411943|FG005|Part A|Withdrawal by Subject|0|||
124941308|NCT02488408|449411944|FG006|Part A|Withdrawal by Subject|0|||
124941309|NCT02488408|449411945|FG007|Part A|Withdrawal by Subject|0|||
124941310|NCT02488408|449411946|FG008|Part A|Withdrawal by Subject|0|||
124941311|NCT02488408|449411947|FG009|Part A|Withdrawal by Subject|0|||
124941312|NCT02488408|449411938|FG000|Part A|Other|1|||
124941313|NCT02488408|449411939|FG001|Part A|Other|0|||
124941314|NCT02488408|449411940|FG002|Part A|Other|0|||
124941315|NCT02488408|449411941|FG003|Part A|Other|0|||
124941316|NCT02488408|449411942|FG004|Part A|Other|0|||
124941317|NCT02488408|449411943|FG005|Part A|Other|0|||
124941318|NCT02488408|449411944|FG006|Part A|Other|0|||
124941319|NCT02488408|449411945|FG007|Part A|Other|0|||
124941320|NCT02488408|449411946|FG008|Part A|Other|0|||
124941321|NCT02488408|449411947|FG009|Part A|Other|0|||
124941322|NCT02488408|449411938|FG000|Part B|Adverse Event|0|||
124941323|NCT02488408|449411939|FG001|Part B|Adverse Event|0|||
124941324|NCT02488408|449411940|FG002|Part B|Adverse Event|0|||
124941325|NCT02488408|449411941|FG003|Part B|Adverse Event|0|||
124941326|NCT02488408|449411942|FG004|Part B|Adverse Event|0|||
124941327|NCT02488408|449411943|FG005|Part B|Adverse Event|2|||
124941328|NCT02488408|449411944|FG006|Part B|Adverse Event|2|||
124941329|NCT02488408|449411945|FG007|Part B|Adverse Event|7|||
124941330|NCT02488408|449411946|FG008|Part B|Adverse Event|2|||
124941331|NCT02488408|449411947|FG009|Part B|Adverse Event|2|||
124941332|NCT02488408|449411938|FG000|Part B|Death|0|||
124941333|NCT02488408|449411939|FG001|Part B|Death|0|||
124941334|NCT02488408|449411940|FG002|Part B|Death|0|||
124941335|NCT02488408|449411941|FG003|Part B|Death|0|||
124941336|NCT02488408|449411942|FG004|Part B|Death|0|||
124941337|NCT02488408|449411943|FG005|Part B|Death|3|||
124941338|NCT02488408|449411944|FG006|Part B|Death|1|||
124941339|NCT02488408|449411945|FG007|Part B|Death|2|||
124941340|NCT02488408|449411946|FG008|Part B|Death|2|||
124941341|NCT02488408|449411947|FG009|Part B|Death|2|||
124941342|NCT02488408|449411938|FG000|Part B|Death due to Disease Progression|0|||
124941343|NCT02488408|449411939|FG001|Part B|Death due to Disease Progression|0|||
124941344|NCT02488408|449411940|FG002|Part B|Death due to Disease Progression|0|||
124941345|NCT02488408|449411941|FG003|Part B|Death due to Disease Progression|0|||
124941346|NCT02488408|449411942|FG004|Part B|Death due to Disease Progression|0|||
124457269|NCT03021499|447633702|FG000|Overall Study|Protocol non-compliance|1|||
124457270|NCT03021499|447633703|FG001|Overall Study|Protocol non-compliance|1|||
124457271|NCT03021499|447633702|FG000|Overall Study|None of the above|0|||
124457272|NCT03021499|447633703|FG001|Overall Study|None of the above|4|||
124457273|NCT03021499|447633702|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
124457274|NCT03021499|447633703|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
124457275|NCT01210690|447633704|FG000|Overall Study|Adverse Event|7|||
124457276|NCT01210690|447633704|FG000|Overall Study|Lack of Efficacy|12|||
124457277|NCT01210690|447633704|FG000|Overall Study|Lost to Follow-up|3|||
124457278|NCT01210690|447633704|FG000|Overall Study|Disease Remission|1|||
124457279|NCT01210690|447633704|FG000|Overall Study|Withdrawal by Subject|1|||
124457280|NCT01210690|447633704|FG000|Overall Study|Patient refused to swallow|1|||
124457281|NCT01210690|447633704|FG000|Overall Study|Patient could not take glucose|1|||
124457282|NCT00470054|447633705|FG000|Overall Study|Ineligible|1|||
124546924|NCT03669640|447957428|FG001|Overall Study|Withdrawal by Subject|2|||
124546925|NCT03669640|447957429|FG002|Overall Study|Withdrawal by Subject|1|||
124546926|NCT03669640|447957430|FG003|Overall Study|Withdrawal by Subject|0|||
124941347|NCT02488408|449411943|FG005|Part B|Death due to Disease Progression|2|||
124941348|NCT02488408|449411944|FG006|Part B|Death due to Disease Progression|2|||
124457283|NCT04869345|447633712|FG000|Overall Study|Lost to Follow-up|8|||
124546927|NCT03669640|447957431|FG004|Overall Study|Withdrawal by Subject|1|||
124546928|NCT03669640|447957432|FG005|Overall Study|Withdrawal by Subject|3|||
124941349|NCT02488408|449411945|FG007|Part B|Death due to Disease Progression|1|||
124941350|NCT02488408|449411946|FG008|Part B|Death due to Disease Progression|1|||
124941351|NCT02488408|449411947|FG009|Part B|Death due to Disease Progression|1|||
124941352|NCT02488408|449411938|FG000|Part B|Disease Progression|0|||
124941353|NCT02488408|449411939|FG001|Part B|Disease Progression|0|||
124941354|NCT02488408|449411940|FG002|Part B|Disease Progression|0|||
124941355|NCT02488408|449411941|FG003|Part B|Disease Progression|0|||
124941356|NCT02488408|449411942|FG004|Part B|Disease Progression|0|||
124941357|NCT02488408|449411943|FG005|Part B|Disease Progression|6|||
124941358|NCT02488408|449411944|FG006|Part B|Disease Progression|9|||
124941359|NCT02488408|449411945|FG007|Part B|Disease Progression|7|||
124941360|NCT02488408|449411946|FG008|Part B|Disease Progression|9|||
124941361|NCT02488408|449411947|FG009|Part B|Disease Progression|11|||
124941362|NCT02488408|449411938|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
124941363|NCT02488408|449411939|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
124941364|NCT02488408|449411940|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
124941365|NCT02488408|449411941|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
124941366|NCT02488408|449411942|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
124941367|NCT02488408|449411943|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
124941368|NCT02488408|449411944|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
124941369|NCT02488408|449411945|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
124941370|NCT02488408|449411946|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
124941371|NCT02488408|449411947|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
124941372|NCT02488408|449411938|FG000|Part B|Investigator Decision|0|||
124941373|NCT02488408|449411939|FG001|Part B|Investigator Decision|0|||
124941374|NCT02488408|449411940|FG002|Part B|Investigator Decision|0|||
124941375|NCT02488408|449411941|FG003|Part B|Investigator Decision|0|||
124941376|NCT02488408|449411942|FG004|Part B|Investigator Decision|0|||
124941377|NCT02488408|449411943|FG005|Part B|Investigator Decision|0|||
124941378|NCT02488408|449411944|FG006|Part B|Investigator Decision|1|||
124941379|NCT02488408|449411945|FG007|Part B|Investigator Decision|0|||
124941380|NCT02488408|449411946|FG008|Part B|Investigator Decision|2|||
124941381|NCT02488408|449411947|FG009|Part B|Investigator Decision|1|||
124941382|NCT04701203|449411950|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
124941383|NCT04701203|449411951|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
124941384|NCT04701203|449411952|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
124941385|NCT04701203|449411950|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
124941386|NCT04701203|449411951|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
124941387|NCT04701203|449411952|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
124941388|NCT04701203|449411950|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
124941389|NCT04701203|449411951|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
124941390|NCT04701203|449411952|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
124941391|NCT04701203|449411950|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
124941392|NCT04701203|449411951|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
124941393|NCT04701203|449411952|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
124941394|NCT06140290|449411953|FG000|Period 1|Adverse Event|1|||
124941395|NCT06140290|449411954|FG001|Period 1|Adverse Event|0|||
124941396|NCT06140290|449411953|FG000|Period 2|Assigned but not treated|0|||
124941397|NCT06140290|449411954|FG001|Period 2|Assigned but not treated|1|||
124941398|NCT06140290|449411953|FG000|Period 2|Withdrawal by Subject|0|||
124941399|NCT06140290|449411954|FG001|Period 2|Withdrawal by Subject|1|||
124941400|NCT03752684|449413137|FG000|Overall Study|Lost to Follow-up|4|||
124941401|NCT02722434|449413140|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
124941402|NCT02722434|449413141|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
124941403|NCT02722434|449413140|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
124941404|NCT02722434|449413141|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
124941405|NCT02200705|449413142|FG000|Overall Study|Excluded|12|||
124941406|NCT02200705|449413142|FG000|Overall Study|Death|21|||
124941407|NCT02200705|449413142|FG000|Overall Study|Withdrawal by Subject|22|||
124457284|NCT04869345|447633713|FG001|Overall Study|Lost to Follow-up|3|||
124457285|NCT00528021|447633717|FG000|Overall Study|Lack of Efficacy|17|||
124457286|NCT00528021|447633718|FG001|Overall Study|Lack of Efficacy|13|||
124457287|NCT00528021|447633719|FG002|Overall Study|Lack of Efficacy|7|||
124703687|NCT03440411|448539219|FG000|Overall Study|Withdrawal by Subject|1|||
124703688|NCT03440411|448539220|FG001|Overall Study|Withdrawal by Subject|0|||
124703689|NCT03440411|448539221|FG002|Overall Study|Withdrawal by Subject|0|||
124703690|NCT03440411|448539222|FG003|Overall Study|Withdrawal by Subject|0|||
124703691|NCT03440411|448539219|FG000|Overall Study|Closed study by sponsor|0|||
124703692|NCT03440411|448539220|FG001|Overall Study|Closed study by sponsor|0|||
124703693|NCT03440411|448539221|FG002|Overall Study|Closed study by sponsor|0|||
124703694|NCT03440411|448539222|FG003|Overall Study|Closed study by sponsor|1|||
124703695|NCT04484857|448539232|FG000|Overall Study|Adverse Event|2|||
124703696|NCT04484857|448539232|FG000|Overall Study|Death|10|||
124703697|NCT04484857|448539232|FG000|Overall Study|Withdrawal by Subject|3|||
124703698|NCT04484857|448539232|FG000|Overall Study|Transferred/Relocation|5|||
124703699|NCT04484857|448539232|FG000|Overall Study|Kidney Transplant|7|||
124703700|NCT04484857|448539232|FG000|Overall Study|Other than specified|4|||
124703701|NCT04484857|448539232|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
124703702|NCT01358734|448539234|FG000|Overall Study|Adverse Event|4|||
124703703|NCT01358734|448539235|FG001|Overall Study|Adverse Event|7|||
124703704|NCT01358734|448539236|FG002|Overall Study|Adverse Event|3|||
124703705|NCT01358734|448539234|FG000|Overall Study|Lack of Efficacy|0|||
124703706|NCT01358734|448539235|FG001|Overall Study|Lack of Efficacy|1|||
124703707|NCT01358734|448539236|FG002|Overall Study|Lack of Efficacy|3|||
124703708|NCT01358734|448539234|FG000|Overall Study|Withdrawal by Subject|1|||
124703709|NCT01358734|448539235|FG001|Overall Study|Withdrawal by Subject|6|||
124703710|NCT01358734|448539236|FG002|Overall Study|Withdrawal by Subject|3|||
124703711|NCT01358734|448539234|FG000|Overall Study|Death|3|||
124703712|NCT01358734|448539235|FG001|Overall Study|Death|7|||
124703713|NCT01358734|448539236|FG002|Overall Study|Death|2|||
124703714|NCT01358734|448539234|FG000|Overall Study|Progressive Disease|5|||
124703715|NCT01358734|448539235|FG001|Overall Study|Progressive Disease|13|||
124703716|NCT01358734|448539236|FG002|Overall Study|Progressive Disease|16|||
124703717|NCT01358734|448539234|FG000|Overall Study|Non-compliance with study drug|0|||
124703718|NCT01358734|448539235|FG001|Overall Study|Non-compliance with study drug|0|||
124703719|NCT01358734|448539236|FG002|Overall Study|Non-compliance with study drug|1|||
124703720|NCT01358734|448539234|FG000|Overall Study|Other|2|||
124703721|NCT01358734|448539235|FG001|Overall Study|Other|5|||
124703722|NCT01358734|448539236|FG002|Overall Study|Other|4|||
124703723|NCT01358734|448539234|FG000|Overall Study|Protocol Violation|0|||
124703724|NCT01358734|448539235|FG001|Overall Study|Protocol Violation|0|||
124703725|NCT01358734|448539236|FG002|Overall Study|Protocol Violation|2|||
124703726|NCT03322566|448539238|FG000|Overall Study|Death|34|||
124703727|NCT03322566|448539239|FG001|Overall Study|Death|35|||
124703728|NCT03322566|448539240|FG002|Overall Study|Death|23|||
124703729|NCT03322566|448539238|FG000|Overall Study|Physician Decision|6|||
124703730|NCT03322566|448539239|FG001|Overall Study|Physician Decision|7|||
124703731|NCT03322566|448539240|FG002|Overall Study|Physician Decision|2|||
124703732|NCT03322566|448539238|FG000|Overall Study|Withdrawal by Subject|4|||
124703733|NCT03322566|448539239|FG001|Overall Study|Withdrawal by Subject|3|||
124703734|NCT03322566|448539240|FG002|Overall Study|Withdrawal by Subject|6|||
124703735|NCT03322566|448539238|FG000|Overall Study|Lost to Follow-up|0|||
124765019|NCT02358473|448765118|FG000|Overall Study|Withdrawal by Subject|2|||
124941408|NCT02200705|449413142|FG000|Overall Study|Lost to Follow-up|13|||
124941409|NCT02200705|449413142|FG000|Overall Study|Physician Decision|5|||
124941410|NCT02200705|449413142|FG000|Overall Study|Adverse Event|2|||
124941411|NCT00786864|449413143|FG000|Overall Study|Lost to Follow-up|0|||
124941412|NCT00786864|449413144|FG001|Overall Study|Lost to Follow-up|1|||
124941413|NCT00786864|449413143|FG000|Overall Study|Sustained serious back injury|1|||
124941414|NCT00786864|449413144|FG001|Overall Study|Sustained serious back injury|0|||
124941415|NCT03442777|449413148|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
124941416|NCT03442777|449413149|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
124941417|NCT03442777|449413150|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
124941418|NCT00442104|449413152|FG000|Overall Study|Adverse Event|5|||
124765020|NCT02358473|448765118|FG000|Overall Study|Physician Decision|2|||
124941419|NCT00442104|449413152|FG000|Overall Study|Death|2|||
124941420|NCT00442104|449413152|FG000|Overall Study|Lost to Follow-up|3|||
124703736|NCT03322566|448539239|FG001|Overall Study|Lost to Follow-up|0|||
124703737|NCT03322566|448539240|FG002|Overall Study|Lost to Follow-up|1|||
124703738|NCT03322566|448539238|FG000|Overall Study|Study terminated by sponsor|1|||
124703739|NCT03322566|448539239|FG001|Overall Study|Study terminated by sponsor|0|||
124703740|NCT03322566|448539240|FG002|Overall Study|Study terminated by sponsor|1|||
124703741|NCT03847519|448539245|FG000|Overall Study|Death|5|||
124703742|NCT03847519|448539246|FG001|Overall Study|Death|8|||
124703743|NCT03847519|448539247|FG002|Overall Study|Death|1|||
124703744|NCT03847519|448539245|FG000|Overall Study|Lost to Follow-up|1|||
124703745|NCT03847519|448539246|FG001|Overall Study|Lost to Follow-up|2|||
124703746|NCT03847519|448539247|FG002|Overall Study|Lost to Follow-up|0|||
124703747|NCT03847519|448539245|FG000|Overall Study|Study Terminated by Sponsor|0|||
124703748|NCT03847519|448539246|FG001|Overall Study|Study Terminated by Sponsor|3|||
124703749|NCT03847519|448539247|FG002|Overall Study|Study Terminated by Sponsor|2|||
124703750|NCT02314923|448539250|FG000|Overall Study|Death|0|||
124703751|NCT02314923|448539251|FG001|Overall Study|Death|0|||
124703752|NCT02314923|448539252|FG002|Overall Study|Death|0|||
124703753|NCT02314923|448539253|FG003|Overall Study|Death|1|||
124703754|NCT02314923|448539254|FG004|Overall Study|Death|0|||
124703755|NCT02314923|448539255|FG005|Overall Study|Death|0|||
124941421|NCT00442104|449413152|FG000|Overall Study|Withdrawal by Subject|5|||
124941422|NCT00442104|449413152|FG000|Overall Study|Insufficient Clinical Response|10|||
124941423|NCT00442104|449413152|FG000|Overall Study|Other|21|||
124941424|NCT00442104|449413152|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
124941425|NCT00463229|449413158|FG000|Overall Study|Lost to Follow-up|5|||
124941426|NCT00463229|449413159|FG001|Overall Study|Lost to Follow-up|7|||
124941427|NCT00463229|449413158|FG000|Overall Study|Death|4|||
124941428|NCT00463229|449413159|FG001|Overall Study|Death|3|||
124941429|NCT01932970|449413160|FG000|Overall Study|Withdrawal by Subject|5|||
124941430|NCT01932970|449413160|FG000|Overall Study|Death|1|||
124941431|NCT01932970|449413160|FG000|Overall Study|Lost to Follow-up|2|||
124941432|NCT01932970|449413160|FG000|Overall Study|Protocol Specified Criteria|10|||
124941433|NCT01767467|449413161|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
124941434|NCT01767467|449413162|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
124941435|NCT01767467|449413161|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
124703756|NCT02314923|448539256|FG006|Overall Study|Death|0|||
124703757|NCT02314923|448539257|FG007|Overall Study|Death|0|||
124703758|NCT02314923|448539258|FG008|Overall Study|Death|0|||
124941436|NCT01767467|449413162|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
124941437|NCT01767467|449413161|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
124941438|NCT01767467|449413162|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
124941439|NCT01767467|449413161|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
124703759|NCT02314923|448539259|FG009|Overall Study|Death|0|||
124703760|NCT02314923|448539250|FG000|Overall Study|Lost to Follow-up|2|||
124703761|NCT02314923|448539251|FG001|Overall Study|Lost to Follow-up|3|||
124703762|NCT02314923|448539252|FG002|Overall Study|Lost to Follow-up|1|||
124703763|NCT02314923|448539253|FG003|Overall Study|Lost to Follow-up|0|||
124941440|NCT01767467|449413162|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
124941441|NCT01767467|449413161|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
124941442|NCT01767467|449413162|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
124941443|NCT01767467|449413161|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
124941444|NCT01767467|449413162|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
124941445|NCT01767467|449413161|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
124457288|NCT00528021|447633720|FG003|Overall Study|Lack of Efficacy|9|||
124457289|NCT04050982|447633721|FG000|Overall Study|Did not meet eligibility criteria|0|||
124457290|NCT04050982|447633722|FG001|Overall Study|Did not meet eligibility criteria|1|||
124457291|NCT04050982|447633723|FG002|Overall Study|Did not meet eligibility criteria|0|||
124457292|NCT04050982|447633721|FG000|Overall Study|Withdrawal by Subject|1|||
124457293|NCT04050982|447633722|FG001|Overall Study|Withdrawal by Subject|0|||
124457294|NCT04050982|447633723|FG002|Overall Study|Withdrawal by Subject|0|||
124457295|NCT04050982|447633721|FG000|Overall Study|Unable to enroll on platform|1|||
124457296|NCT04050982|447633722|FG001|Overall Study|Unable to enroll on platform|0|||
124457297|NCT04050982|447633723|FG002|Overall Study|Unable to enroll on platform|0|||
124457298|NCT05054114|447633724|FG000|Overall Study|Protocol Violation|13|||
124457299|NCT05054114|447633725|FG001|Overall Study|Protocol Violation|1|||
124457300|NCT05054114|447633724|FG000|Overall Study|Pregnancy|0|||
124457301|NCT05054114|447633725|FG001|Overall Study|Pregnancy|1|||
124457302|NCT02186847|447633726|FG000|Overall Study|Protocol Violation|3|||
124457303|NCT02186847|447633727|FG001|Overall Study|Protocol Violation|0|||
124457304|NCT00733954|447633728|FG000|Overall Study|Lost to Follow-up|5|||
124457305|NCT00733954|447633729|FG001|Overall Study|Lost to Follow-up|2|||
124457306|NCT00733954|447633728|FG000|Overall Study|Protocol Violation|1|||
124457307|NCT00733954|447633729|FG001|Overall Study|Protocol Violation|0|||
124457308|NCT00733954|447633728|FG000|Overall Study|Withdrawal by Subject|2|||
124457309|NCT00733954|447633729|FG001|Overall Study|Withdrawal by Subject|0|||
124457310|NCT02663453|447633730|FG000|Overall Study|Death|4|||
124457311|NCT02663453|447633731|FG001|Overall Study|Death|4|||
124457312|NCT02663453|447633730|FG000|Overall Study|Withdrawal by Subject|1|||
124457313|NCT02663453|447633731|FG001|Overall Study|Withdrawal by Subject|0|||
124457314|NCT03416153|447633732|FG000|Overall Study|Physician Decision|1|||
124457315|NCT03416153|447633733|FG001|Overall Study|Physician Decision|1|||
124457316|NCT03416153|447633732|FG000|Overall Study|Withdrawal by Subject|1|||
124457317|NCT03416153|447633733|FG001|Overall Study|Withdrawal by Subject|0|||
124457318|NCT03703882|447634993|FG000|Overall Study|Adverse Event|1|||
124457319|NCT03703882|447634994|FG001|Overall Study|Adverse Event|0|||
124457320|NCT03703882|447634993|FG000|Overall Study|Lost to Follow-up|0|||
124457321|NCT03703882|447634994|FG001|Overall Study|Lost to Follow-up|2|||
124457322|NCT03703882|447634993|FG000|Overall Study|Non-compliance with study drug|0|||
124457323|NCT03703882|447634994|FG001|Overall Study|Non-compliance with study drug|1|||
124457324|NCT03703882|447634993|FG000|Overall Study|Physician Decision|0|||
124457325|NCT03703882|447634994|FG001|Overall Study|Physician Decision|1|||
124457326|NCT03703882|447634993|FG000|Overall Study|Progressive disease|1|||
124457327|NCT03703882|447634994|FG001|Overall Study|Progressive disease|0|||
124457328|NCT03703882|447634993|FG000|Overall Study|Withdrawal by parent/guardian|1|||
124457329|NCT03703882|447634994|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124457330|NCT03703882|447634993|FG000|Overall Study|Starting another treatment|0|||
124457331|NCT03703882|447634994|FG001|Overall Study|Starting another treatment|1|||
124457332|NCT03703882|447634993|FG000|Overall Study|noncompliance with study procedures|0|||
124457333|NCT03703882|447634994|FG001|Overall Study|noncompliance with study procedures|1|||
124457334|NCT01617460|447634995|FG000|Overall Study|Adverse Event|10|||
124457335|NCT01617460|447634995|FG000|Overall Study|Physician Decision|16|||
124457336|NCT01617460|447634995|FG000|Overall Study|Protocol Violation|5|||
124457337|NCT01617460|447634995|FG000|Overall Study|Withdrawal by Subject|9|||
124457338|NCT00666458|447635001|FG000|Overall Study|Adverse Event|8|||
124457339|NCT00666458|447635002|FG001|Overall Study|Adverse Event|7|||
124457340|NCT00666458|447635001|FG000|Overall Study|Withdrawal by Subject|5|||
124457341|NCT00666458|447635002|FG001|Overall Study|Withdrawal by Subject|4|||
124457342|NCT00666458|447635001|FG000|Overall Study|Lost to Follow-up|0|||
124457343|NCT00666458|447635002|FG001|Overall Study|Lost to Follow-up|3|||
124457344|NCT00666458|447635001|FG000|Overall Study|Administrative reason by sponsor|1|||
124457345|NCT00666458|447635002|FG001|Overall Study|Administrative reason by sponsor|1|||
124457346|NCT00666458|447635001|FG000|Overall Study|Incorrect enrollment|7|||
124457347|NCT00666458|447635002|FG001|Overall Study|Incorrect enrollment|1|||
124546929|NCT03669640|447957427|FG000|Overall Study|Protocol Violation|1|||
124941446|NCT01767467|449413162|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
124457348|NCT00666458|447635001|FG000|Overall Study|Study specific discontinuation criteria|14|||
124457349|NCT00666458|447635002|FG001|Overall Study|Study specific discontinuation criteria|7|||
124457350|NCT00666458|447635001|FG000|Overall Study|Severe non-compliance to the protocol|1|||
124457351|NCT00666458|447635002|FG001|Overall Study|Severe non-compliance to the protocol|1|||
124457352|NCT00666458|447635001|FG000|Overall Study|Safety reasons|1|||
124457353|NCT00666458|447635002|FG001|Overall Study|Safety reasons|0|||
124457354|NCT00666458|447635001|FG000|Overall Study|Medical history of anemia|1|||
124546930|NCT03669640|447957428|FG001|Overall Study|Protocol Violation|0|||
124546931|NCT03669640|447957429|FG002|Overall Study|Protocol Violation|0|||
124546932|NCT03669640|447957430|FG003|Overall Study|Protocol Violation|0|||
124546933|NCT03669640|447957431|FG004|Overall Study|Protocol Violation|0|||
124546934|NCT03669640|447957432|FG005|Overall Study|Protocol Violation|0|||
124546935|NCT03669640|447957427|FG000|Overall Study|Physician Decision|0|||
124546936|NCT03669640|447957428|FG001|Overall Study|Physician Decision|2|||
124546937|NCT03669640|447957429|FG002|Overall Study|Physician Decision|0|||
124546938|NCT03669640|447957430|FG003|Overall Study|Physician Decision|0|||
124546939|NCT03669640|447957431|FG004|Overall Study|Physician Decision|0|||
124546940|NCT03669640|447957432|FG005|Overall Study|Physician Decision|0|||
124546941|NCT03669640|447957427|FG000|Overall Study|Disease Relapse|1|||
124546942|NCT03669640|447957428|FG001|Overall Study|Disease Relapse|0|||
124546943|NCT03669640|447957429|FG002|Overall Study|Disease Relapse|0|||
124546944|NCT03669640|447957430|FG003|Overall Study|Disease Relapse|0|||
124546945|NCT03669640|447957431|FG004|Overall Study|Disease Relapse|0|||
124546946|NCT03669640|447957432|FG005|Overall Study|Disease Relapse|0|||
124546947|NCT03669640|447957427|FG000|Overall Study|Adverse Event|2|||
124546948|NCT03669640|447957428|FG001|Overall Study|Adverse Event|1|||
124546949|NCT03669640|447957429|FG002|Overall Study|Adverse Event|0|||
124546950|NCT03669640|447957430|FG003|Overall Study|Adverse Event|0|||
124546951|NCT03669640|447957431|FG004|Overall Study|Adverse Event|1|||
124546952|NCT03669640|447957432|FG005|Overall Study|Adverse Event|0|||
124546953|NCT05553600|447957433|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
124546954|NCT05553600|447957434|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
124546955|NCT05553600|447957435|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
124546956|NCT05553600|447957436|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
124546957|NCT05553600|447957433|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
124546958|NCT05553600|447957434|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
124546959|NCT05553600|447957435|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
124546960|NCT05553600|447957436|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
124546961|NCT05553600|447957433|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
124546962|NCT05553600|447957434|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
124546963|NCT05553600|447957435|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
124546964|NCT05553600|447957436|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
124546965|NCT05553600|447957433|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
124546966|NCT05553600|447957434|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
124546967|NCT05553600|447957435|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
124546968|NCT05553600|447957436|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
124546969|NCT05553600|447957433|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
124546970|NCT05553600|447957434|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
124546971|NCT05553600|447957435|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
124546972|NCT05553600|447957436|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
124546973|NCT05553600|447957433|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
124546974|NCT05553600|447957434|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
124546975|NCT05553600|447957435|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
124546976|NCT05553600|447957436|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
124546977|NCT05553600|447957433|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
124546978|NCT05553600|447957434|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
124546979|NCT05553600|447957435|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
124546980|NCT05553600|447957436|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
124546981|NCT05553600|447957433|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
124546982|NCT05553600|447957434|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
124546983|NCT05553600|447957435|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
124546984|NCT05553600|447957436|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
124546985|NCT05553600|447957433|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
124546986|NCT05553600|447957434|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
124546987|NCT05553600|447957435|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
124546988|NCT05553600|447957436|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
124546989|NCT05553600|447957433|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
124546990|NCT05553600|447957434|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
124546991|NCT05553600|447957435|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
124941447|NCT01767467|449413161|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
124941448|NCT01767467|449413162|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
124546992|NCT05553600|447957436|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
124546993|NCT05553600|447957433|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
124546994|NCT05553600|447957434|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
124941449|NCT01767467|449413161|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
124703764|NCT02314923|448539254|FG004|Overall Study|Lost to Follow-up|0|||
124546995|NCT05553600|447957435|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
124546996|NCT05553600|447957436|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
124546997|NCT05553600|447957433|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
124546998|NCT05553600|447957434|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
124546999|NCT05553600|447957435|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
124547000|NCT05553600|447957436|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
124547001|NCT04242264|447957438|FG000|Overall Study|Lost to Follow-up|2|||
124547002|NCT04242264|447957439|FG001|Overall Study|Lost to Follow-up|2|||
124547003|NCT04242264|447957440|FG002|Overall Study|Lost to Follow-up|1|||
124547004|NCT04242264|447957441|FG003|Overall Study|Lost to Follow-up|1|||
124703765|NCT02314923|448539255|FG005|Overall Study|Lost to Follow-up|0|||
124703766|NCT02314923|448539256|FG006|Overall Study|Lost to Follow-up|3|||
124703767|NCT02314923|448539257|FG007|Overall Study|Lost to Follow-up|4|||
124703768|NCT02314923|448539258|FG008|Overall Study|Lost to Follow-up|2|||
124703769|NCT02314923|448539259|FG009|Overall Study|Lost to Follow-up|0|||
124703770|NCT02314923|448539250|FG000|Overall Study|Withdrawal by Subject|0|||
124703771|NCT02314923|448539251|FG001|Overall Study|Withdrawal by Subject|0|||
124703772|NCT02314923|448539252|FG002|Overall Study|Withdrawal by Subject|1|||
124703773|NCT02314923|448539253|FG003|Overall Study|Withdrawal by Subject|0|||
124703774|NCT02314923|448539254|FG004|Overall Study|Withdrawal by Subject|1|||
124703775|NCT02314923|448539255|FG005|Overall Study|Withdrawal by Subject|0|||
124703776|NCT02314923|448539256|FG006|Overall Study|Withdrawal by Subject|1|||
124703777|NCT02314923|448539257|FG007|Overall Study|Withdrawal by Subject|0|||
124703778|NCT02314923|448539258|FG008|Overall Study|Withdrawal by Subject|0|||
124703779|NCT02314923|448539259|FG009|Overall Study|Withdrawal by Subject|0|||
124703780|NCT02314923|448539250|FG000|Overall Study|Physician Decision|0|||
124703781|NCT02314923|448539251|FG001|Overall Study|Physician Decision|1|||
124703782|NCT02314923|448539252|FG002|Overall Study|Physician Decision|0|||
124703783|NCT02314923|448539253|FG003|Overall Study|Physician Decision|0|||
124703784|NCT02314923|448539254|FG004|Overall Study|Physician Decision|0|||
124703785|NCT02314923|448539255|FG005|Overall Study|Physician Decision|0|||
124703786|NCT02314923|448539256|FG006|Overall Study|Physician Decision|0|||
124703787|NCT02314923|448539257|FG007|Overall Study|Physician Decision|0|||
124703788|NCT02314923|448539258|FG008|Overall Study|Physician Decision|0|||
124703789|NCT02314923|448539259|FG009|Overall Study|Physician Decision|0|||
124703790|NCT02314923|448539250|FG000|Overall Study|Participant unavailable|0|||
124703791|NCT02314923|448539251|FG001|Overall Study|Participant unavailable|0|||
124703792|NCT02314923|448539252|FG002|Overall Study|Participant unavailable|0|||
124703793|NCT02314923|448539253|FG003|Overall Study|Participant unavailable|0|||
124703794|NCT02314923|448539254|FG004|Overall Study|Participant unavailable|0|||
124703795|NCT02314923|448539255|FG005|Overall Study|Participant unavailable|1|||
124703796|NCT02314923|448539256|FG006|Overall Study|Participant unavailable|0|||
124703797|NCT02314923|448539257|FG007|Overall Study|Participant unavailable|0|||
124703798|NCT02314923|448539258|FG008|Overall Study|Participant unavailable|0|||
124703799|NCT02314923|448539259|FG009|Overall Study|Participant unavailable|0|||
124703800|NCT02314923|448539250|FG000|Overall Study|Screen failure|0|||
124703801|NCT02314923|448539251|FG001|Overall Study|Screen failure|0|||
124703802|NCT02314923|448539252|FG002|Overall Study|Screen failure|0|||
124703803|NCT02314923|448539253|FG003|Overall Study|Screen failure|0|||
124703804|NCT02314923|448539254|FG004|Overall Study|Screen failure|0|||
124703805|NCT02314923|448539255|FG005|Overall Study|Screen failure|0|||
124703806|NCT02314923|448539256|FG006|Overall Study|Screen failure|1|||
124703807|NCT02314923|448539257|FG007|Overall Study|Screen failure|0|||
124703808|NCT02314923|448539258|FG008|Overall Study|Screen failure|0|||
124703809|NCT02314923|448539259|FG009|Overall Study|Screen failure|0|||
124703810|NCT02314923|448539250|FG000|Overall Study|Participant relocation|1|||
124703811|NCT02314923|448539251|FG001|Overall Study|Participant relocation|0|||
124703812|NCT02314923|448539252|FG002|Overall Study|Participant relocation|0|||
124703813|NCT02314923|448539253|FG003|Overall Study|Participant relocation|0|||
124703814|NCT02314923|448539254|FG004|Overall Study|Participant relocation|0|||
124941450|NCT01767467|449413162|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
124941451|NCT01767467|449413161|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
124941452|NCT01767467|449413162|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
124941453|NCT01767467|449413161|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
124547005|NCT04242264|447957438|FG000|Overall Study|Withdrawal by Subject|1|||
124703815|NCT02314923|448539255|FG005|Overall Study|Participant relocation|0|||
124703816|NCT02314923|448539256|FG006|Overall Study|Participant relocation|0|||
124703817|NCT02314923|448539257|FG007|Overall Study|Participant relocation|1|||
124703818|NCT02314923|448539258|FG008|Overall Study|Participant relocation|0|||
124703819|NCT02314923|448539259|FG009|Overall Study|Participant relocation|0|||
124703820|NCT00725985|448539260|FG000|ITP- Treatment Disposition|Adverse Event|20|||
124703821|NCT00725985|448539261|FG001|ITP- Treatment Disposition|Adverse Event|10|||
124703822|NCT00725985|448539262|FG002|ITP- Treatment Disposition|Adverse Event|5|||
124703823|NCT00725985|448539263|FG003|ITP- Treatment Disposition|Adverse Event|0|||
124703824|NCT00725985|448539264|FG004|ITP- Treatment Disposition|Adverse Event|0|||
124941454|NCT01767467|449413162|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
124941455|NCT01767467|449413161|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
124941456|NCT01767467|449413162|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
124941457|NCT01767467|449413161|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
124941458|NCT01767467|449413162|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
124941459|NCT01767467|449413161|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
124941460|NCT01767467|449413162|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
124941461|NCT01787032|449413169|FG000|Overall Study|Protocol Violation|0|||
124941462|NCT01787032|449413170|FG001|Overall Study|Protocol Violation|0|||
124941463|NCT01787032|449413171|FG002|Overall Study|Protocol Violation|0|||
124941464|NCT01787032|449413172|FG003|Overall Study|Protocol Violation|0|||
124941465|NCT01787032|449413173|FG004|Overall Study|Protocol Violation|1|||
124941466|NCT01787032|449413174|FG005|Overall Study|Protocol Violation|1|||
124941467|NCT00776009|449413175|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
124941468|NCT00776009|449413176|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
124941469|NCT00776009|449413177|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
124941470|NCT00776009|449413178|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
124941471|NCT00776009|449413179|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
124941472|NCT00776009|449413180|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
124941473|NCT00776009|449413175|FG000|Period 1: First Intervention|Protocol Violation|0|||
124457355|NCT00666458|447635002|FG001|Overall Study|Medical history of anemia|0|||
124457356|NCT02222207|447635003|FG000|Overall Study|Death|1|||
124457357|NCT02222207|447635003|FG000|Overall Study|Other reasons|2|||
124457358|NCT02222207|447635003|FG000|Overall Study|Adverse Event|1|||
124457359|NCT02982954|447635004|FG000|Overall Study|Death|55|||
124457360|NCT02982954|447635005|FG001|Overall Study|Death|29|||
124457361|NCT02982954|447635006|FG002|Overall Study|Death|15|||
124457362|NCT02982954|447635007|FG003|Overall Study|Death|20|||
124457363|NCT02982954|447635004|FG000|Overall Study|Lost to Follow-up|2|||
124457364|NCT02982954|447635005|FG001|Overall Study|Lost to Follow-up|1|||
124457365|NCT02982954|447635006|FG002|Overall Study|Lost to Follow-up|0|||
124457366|NCT02982954|447635007|FG003|Overall Study|Lost to Follow-up|0|||
124457367|NCT02982954|447635004|FG000|Overall Study|Participant withdrew consent|7|||
124457368|NCT02982954|447635005|FG001|Overall Study|Participant withdrew consent|5|||
124457369|NCT02982954|447635006|FG002|Overall Study|Participant withdrew consent|1|||
124457370|NCT02982954|447635007|FG003|Overall Study|Participant withdrew consent|1|||
124457371|NCT02982954|447635004|FG000|Overall Study|Other reasons|42|||
124457372|NCT02982954|447635005|FG001|Overall Study|Other reasons|17|||
124457373|NCT02982954|447635006|FG002|Overall Study|Other reasons|12|||
124457374|NCT02982954|447635007|FG003|Overall Study|Other reasons|3|||
124457375|NCT02982954|447635004|FG000|Overall Study|Premature site closure|0|||
124457376|NCT02982954|447635005|FG001|Overall Study|Premature site closure|0|||
124457377|NCT02982954|447635006|FG002|Overall Study|Premature site closure|0|||
124457378|NCT02982954|447635007|FG003|Overall Study|Premature site closure|1|||
124457379|NCT00747643|447635011|FG000|Overall Study|Withdrawal by Subject|36|||
124457380|NCT00747643|447635012|FG001|Overall Study|Withdrawal by Subject|27|||
124457381|NCT00750698|447635013|FG000|Overall Study|Withdrawal by Subject|1|||
124457382|NCT00750698|447635014|FG001|Overall Study|Withdrawal by Subject|0|||
124457383|NCT00750698|447635013|FG000|Overall Study|Progressive disease|5|||
124457384|NCT00750698|447635014|FG001|Overall Study|Progressive disease|2|||
124457385|NCT01417195|447635015|FG000|Overall Study|Stimulation failure|1|||
124457386|NCT01417195|447635016|FG001|Overall Study|Stimulation failure|0|||
124457387|NCT01417195|447635015|FG000|Overall Study|No embryos for transfer|0|||
124457388|NCT01417195|447635016|FG001|Overall Study|No embryos for transfer|1|||
124457389|NCT01417195|447635015|FG000|Overall Study|No transfer due to risk of OHSS|1|||
124457390|NCT01417195|447635016|FG001|Overall Study|No transfer due to risk of OHSS|0|||
124457391|NCT01417195|447635015|FG000|Overall Study|No transfer due to elevated progesterone|1|||
124457392|NCT01417195|447635016|FG001|Overall Study|No transfer due to elevated progesterone|0|||
124457393|NCT03357731|447635017|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
124457394|NCT03357731|447635018|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
124457395|NCT03357731|447635019|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
124457396|NCT03357731|447635020|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
124457397|NCT03357731|447635021|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
124457398|NCT03357731|447635022|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
124457399|NCT03357731|447635017|FG000|Overall Study|Acute bradycardia and hypotension|0|||
124457400|NCT03357731|447635018|FG001|Overall Study|Acute bradycardia and hypotension|0|||
124941474|NCT00776009|449413176|FG001|Period 1: First Intervention|Protocol Violation|1|||
124941475|NCT00776009|449413177|FG002|Period 1: First Intervention|Protocol Violation|0|||
124941476|NCT00776009|449413178|FG003|Period 1: First Intervention|Protocol Violation|0|||
124941477|NCT00776009|449413179|FG004|Period 1: First Intervention|Protocol Violation|1|||
124457401|NCT03357731|447635019|FG002|Overall Study|Acute bradycardia and hypotension|0|||
124457402|NCT03357731|447635020|FG003|Overall Study|Acute bradycardia and hypotension|1|||
124457403|NCT03357731|447635021|FG004|Overall Study|Acute bradycardia and hypotension|0|||
124547006|NCT04242264|447957439|FG001|Overall Study|Withdrawal by Subject|0|||
124547007|NCT04242264|447957440|FG002|Overall Study|Withdrawal by Subject|0|||
124547008|NCT04242264|447957441|FG003|Overall Study|Withdrawal by Subject|0|||
124547009|NCT02116309|447957445|FG000|Overall Study|Lost to Follow-up|0|||
124547010|NCT02116309|447957446|FG001|Overall Study|Lost to Follow-up|1|||
124547011|NCT03710824|447957447|FG000|Overall Study|Withdrawal by Subject|1|||
124547012|NCT03710824|447957447|FG000|Overall Study|Lost to Follow-up|3|||
124547013|NCT03710824|447957447|FG000|Overall Study|Adverse Event|25|||
124547014|NCT03710824|447957447|FG000|Overall Study|Treatment discontinuation|2|||
124547015|NCT02329834|447957448|FG000|Overall Study|Physician Decision|1|||
124547016|NCT02329834|447957449|FG001|Overall Study|Physician Decision|0|||
124547017|NCT00578448|447957450|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
124547018|NCT00578448|447957450|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
124547019|NCT00578448|447957450|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
124547020|NCT00578448|447957450|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
124547021|NCT05102162|447957452|FG000|Overall Study|Withdrawal by Subject|3|||
124547022|NCT05102162|447957453|FG001|Overall Study|Withdrawal by Subject|0|||
124547023|NCT05102162|447957452|FG000|Overall Study|Baseline cultures negative|4|||
124547024|NCT05102162|447957453|FG001|Overall Study|Baseline cultures negative|2|||
124547025|NCT05102162|447957452|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
124547026|NCT05102162|447957453|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
124547027|NCT05102162|447957452|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
124547028|NCT05102162|447957453|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
124547029|NCT01165424|447957454|FG000|Overall Study|Clinical adverse experiences|1|||
124547030|NCT01165424|447957454|FG000|Overall Study|Laboratory adverse experiences|1|||
124547031|NCT01165424|447957454|FG000|Overall Study|Did not meet entry criteria|1|||
124547032|NCT01165424|447957454|FG000|Overall Study|Participant moved (relocated)|1|||
124547033|NCT00538473|447957455|FG000|Overall Study|Adverse Event|1|||
124547034|NCT00538473|447957456|FG001|Overall Study|Adverse Event|0|||
124547035|NCT00440193|447957457|FG000|Treatment Period|Adverse Event|74|||
124547036|NCT00440193|447957458|FG001|Treatment Period|Adverse Event|67|||
124547037|NCT00440193|447957457|FG000|Treatment Period|Death|19|||
124547038|NCT00440193|447957458|FG001|Treatment Period|Death|22|||
124547039|NCT00440193|447957457|FG000|Treatment Period|Lack of Efficacy|0|||
124547040|NCT00440193|447957458|FG001|Treatment Period|Lack of Efficacy|1|||
124547041|NCT00440193|447957457|FG000|Treatment Period|Lost to Follow-up|12|||
124547042|NCT00440193|447957458|FG001|Treatment Period|Lost to Follow-up|18|||
124547043|NCT00440193|447957457|FG000|Treatment Period|Physician Decision|3|||
124547044|NCT00440193|447957458|FG001|Treatment Period|Physician Decision|6|||
124547045|NCT00440193|447957457|FG000|Treatment Period|Protocol Violation|16|||
124547046|NCT00440193|447957458|FG001|Treatment Period|Protocol Violation|19|||
124547047|NCT00440193|447957457|FG000|Treatment Period|Withdrawal by Subject|36|||
124703825|NCT00725985|448539265|FG005|ITP- Treatment Disposition|Adverse Event|0|||
124703826|NCT00725985|448539266|FG006|ITP- Treatment Disposition|Adverse Event|0|||
124703827|NCT00725985|448539267|FG007|ITP- Treatment Disposition|Adverse Event|0|||
124703828|NCT00725985|448539268|FG008|ITP- Treatment Disposition|Adverse Event|0|||
124547048|NCT00440193|447957458|FG001|Treatment Period|Withdrawal by Subject|77|||
124547049|NCT00440193|447957457|FG000|Treatment Period|Clinical endpoint reached|28|||
124547050|NCT00440193|447957458|FG001|Treatment Period|Clinical endpoint reached|25|||
124547051|NCT00440193|447957457|FG000|Treatment Period|Study terminated by sponsor|102|||
124547052|NCT00440193|447957458|FG001|Treatment Period|Study terminated by sponsor|94|||
124547053|NCT00440193|447957457|FG000|Treatment Period|Protocol driven decision point|2|||
124547054|NCT00440193|447957458|FG001|Treatment Period|Protocol driven decision point|2|||
124547055|NCT00440193|447957457|FG000|Treatment Period|Switch to commercial drug|0|||
124547056|NCT00440193|447957458|FG001|Treatment Period|Switch to commercial drug|2|||
124547057|NCT00440193|447957457|FG000|Treatment Period|Technical problems|1|||
124703829|NCT00725985|448539269|FG009|ITP- Treatment Disposition|Adverse Event|0|||
124703830|NCT00725985|448539270|FG010|ITP- Treatment Disposition|Adverse Event|0|||
124703831|NCT00725985|448539271|FG011|ITP- Treatment Disposition|Adverse Event|0|||
124703832|NCT00725985|448539260|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
124703833|NCT00725985|448539261|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
124703834|NCT00725985|448539262|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
124703835|NCT00725985|448539263|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
124703836|NCT00725985|448539264|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
124703837|NCT00725985|448539265|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
124703838|NCT00725985|448539266|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
124703839|NCT00725985|448539267|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
124703840|NCT00725985|448539268|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
124703841|NCT00725985|448539269|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
124703842|NCT00725985|448539270|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
124703843|NCT00725985|448539271|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
124703844|NCT00725985|448539260|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
124703845|NCT00725985|448539261|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
124703846|NCT00725985|448539262|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
124703847|NCT00725985|448539263|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
124703848|NCT00725985|448539264|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
124703849|NCT00725985|448539265|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
124703850|NCT00725985|448539266|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
124703851|NCT00725985|448539267|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
124703852|NCT00725985|448539268|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
124703853|NCT00725985|448539269|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
124703854|NCT00725985|448539270|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
124703855|NCT00725985|448539271|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
124703856|NCT00725985|448539260|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
124703857|NCT00725985|448539261|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
124703858|NCT00725985|448539262|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
124703859|NCT00725985|448539263|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
124703860|NCT00725985|448539264|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
124703861|NCT00725985|448539265|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
124703862|NCT00725985|448539266|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
124703863|NCT00725985|448539267|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
124703864|NCT00725985|448539268|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
124703865|NCT00725985|448539269|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
124703866|NCT00725985|448539270|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
124703867|NCT00725985|448539271|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
124703868|NCT00725985|448539260|FG000|ITP- Treatment Disposition|Other|50|||
124703869|NCT00725985|448539261|FG001|ITP- Treatment Disposition|Other|38|||
124703870|NCT00725985|448539262|FG002|ITP- Treatment Disposition|Other|24|||
124703871|NCT00725985|448539263|FG003|ITP- Treatment Disposition|Other|0|||
124703872|NCT00725985|448539264|FG004|ITP- Treatment Disposition|Other|0|||
124703873|NCT00725985|448539265|FG005|ITP- Treatment Disposition|Other|0|||
124703874|NCT00725985|448539266|FG006|ITP- Treatment Disposition|Other|0|||
124703875|NCT00725985|448539267|FG007|ITP- Treatment Disposition|Other|0|||
124703876|NCT00725985|448539268|FG008|ITP- Treatment Disposition|Other|0|||
124703877|NCT00725985|448539269|FG009|ITP- Treatment Disposition|Other|0|||
124703878|NCT00725985|448539270|FG010|ITP- Treatment Disposition|Other|0|||
124703879|NCT00725985|448539271|FG011|ITP- Treatment Disposition|Other|0|||
124703880|NCT00725985|448539260|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
124703881|NCT00725985|448539261|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
124703882|NCT00725985|448539262|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
124703883|NCT00725985|448539263|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
124703884|NCT00725985|448539264|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
124703885|NCT00725985|448539265|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
124703886|NCT00725985|448539266|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
124941478|NCT00776009|449413180|FG005|Period 1: First Intervention|Protocol Violation|0|||
124941479|NCT00776009|449413175|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
124941480|NCT00776009|449413176|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
124941481|NCT00776009|449413177|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
124941482|NCT00776009|449413178|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
124941483|NCT00776009|449413179|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
124941484|NCT00776009|449413180|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
124941485|NCT00776009|449413175|FG000|Period 2: Second Intervention|Protocol Violation|1|||
124703887|NCT00725985|448539267|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
124703888|NCT00725985|448539268|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
124703889|NCT00725985|448539269|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
124703890|NCT00725985|448539270|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
124703891|NCT00725985|448539271|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
124703892|NCT00725985|448539260|FG000|OLMP (Up to 96 Weeks)|Death|0|||
124703893|NCT00725985|448539261|FG001|OLMP (Up to 96 Weeks)|Death|0|||
124941486|NCT00776009|449413176|FG001|Period 2: Second Intervention|Protocol Violation|0|||
124941487|NCT00776009|449413177|FG002|Period 2: Second Intervention|Protocol Violation|1|||
124941488|NCT00776009|449413178|FG003|Period 2: Second Intervention|Protocol Violation|0|||
124941489|NCT00776009|449413179|FG004|Period 2: Second Intervention|Protocol Violation|0|||
124941490|NCT00776009|449413180|FG005|Period 2: Second Intervention|Protocol Violation|0|||
124941491|NCT00776009|449413175|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
124941492|NCT00776009|449413176|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
124941493|NCT00776009|449413177|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
124941494|NCT00776009|449413178|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
124941495|NCT00776009|449413179|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
124941496|NCT00776009|449413180|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
124941497|NCT01640951|449413181|FG000|Overall Study|Adverse Event|8|||
124941498|NCT01640951|449413182|FG001|Overall Study|Adverse Event|3|||
124941499|NCT01640951|449413183|FG002|Overall Study|Adverse Event|10|||
124941500|NCT01640951|449413184|FG003|Overall Study|Adverse Event|6|||
124941501|NCT01640951|449413185|FG004|Overall Study|Adverse Event|1|||
124941502|NCT01640951|449413186|FG005|Overall Study|Adverse Event|11|||
124941503|NCT01640951|449413187|FG006|Overall Study|Adverse Event|1|||
124941504|NCT01640951|449413188|FG007|Overall Study|Adverse Event|3|||
124941505|NCT01640951|449413181|FG000|Overall Study|Lack of Efficacy|20|||
124941506|NCT01640951|449413182|FG001|Overall Study|Lack of Efficacy|1|||
124941507|NCT01640951|449413183|FG002|Overall Study|Lack of Efficacy|7|||
124941508|NCT01640951|449413184|FG003|Overall Study|Lack of Efficacy|14|||
124941509|NCT01640951|449413185|FG004|Overall Study|Lack of Efficacy|0|||
124941510|NCT01640951|449413186|FG005|Overall Study|Lack of Efficacy|6|||
124941511|NCT01640951|449413187|FG006|Overall Study|Lack of Efficacy|5|||
124941512|NCT01640951|449413188|FG007|Overall Study|Lack of Efficacy|6|||
124941513|NCT01640951|449413181|FG000|Overall Study|Lost to Follow-up|1|||
124941514|NCT01640951|449413182|FG001|Overall Study|Lost to Follow-up|0|||
124941515|NCT01640951|449413183|FG002|Overall Study|Lost to Follow-up|6|||
124941516|NCT01640951|449413184|FG003|Overall Study|Lost to Follow-up|2|||
124941517|NCT01640951|449413185|FG004|Overall Study|Lost to Follow-up|2|||
124941518|NCT01640951|449413186|FG005|Overall Study|Lost to Follow-up|3|||
124941519|NCT01640951|449413187|FG006|Overall Study|Lost to Follow-up|1|||
124941520|NCT01640951|449413188|FG007|Overall Study|Lost to Follow-up|1|||
124941521|NCT01640951|449413181|FG000|Overall Study|Non-compliance with study treatment|0|||
124941522|NCT01640951|449413182|FG001|Overall Study|Non-compliance with study treatment|0|||
124941523|NCT01640951|449413183|FG002|Overall Study|Non-compliance with study treatment|1|||
124941524|NCT01640951|449413184|FG003|Overall Study|Non-compliance with study treatment|1|||
124941525|NCT01640951|449413185|FG004|Overall Study|Non-compliance with study treatment|1|||
124941526|NCT01640951|449413186|FG005|Overall Study|Non-compliance with study treatment|4|||
124941527|NCT01640951|449413187|FG006|Overall Study|Non-compliance with study treatment|1|||
124941528|NCT01640951|449413188|FG007|Overall Study|Non-compliance with study treatment|0|||
124941529|NCT01640951|449413181|FG000|Overall Study|Physician Decision|2|||
124941530|NCT01640951|449413182|FG001|Overall Study|Physician Decision|5|||
124457404|NCT03357731|447635022|FG005|Overall Study|Acute bradycardia and hypotension|0|||
124457405|NCT03357731|447635017|FG000|Overall Study|Adverse Event|0|||
124457406|NCT03357731|447635018|FG001|Overall Study|Adverse Event|0|||
124457407|NCT03357731|447635019|FG002|Overall Study|Adverse Event|0|||
124457408|NCT03357731|447635020|FG003|Overall Study|Adverse Event|0|||
124457409|NCT03357731|447635021|FG004|Overall Study|Adverse Event|0|||
124457410|NCT03357731|447635022|FG005|Overall Study|Adverse Event|1|||
124457411|NCT03357731|447635017|FG000|Overall Study|Hypotension|0|||
124457412|NCT03357731|447635018|FG001|Overall Study|Hypotension|0|||
124457413|NCT03357731|447635019|FG002|Overall Study|Hypotension|1|||
124457414|NCT03357731|447635020|FG003|Overall Study|Hypotension|1|||
124457415|NCT03357731|447635021|FG004|Overall Study|Hypotension|0|||
124457416|NCT03357731|447635022|FG005|Overall Study|Hypotension|0|||
124457417|NCT03357731|447635017|FG000|Overall Study|Lost to Follow-up|0|||
124457418|NCT03357731|447635018|FG001|Overall Study|Lost to Follow-up|0|||
124457419|NCT03357731|447635019|FG002|Overall Study|Lost to Follow-up|0|||
124457420|NCT03357731|447635020|FG003|Overall Study|Lost to Follow-up|1|||
124457421|NCT03357731|447635021|FG004|Overall Study|Lost to Follow-up|0|||
124457422|NCT03357731|447635022|FG005|Overall Study|Lost to Follow-up|0|||
124457423|NCT01239342|447635023|FG000|Overall Study|Adverse Event|1|||
124457424|NCT01239342|447635024|FG001|Overall Study|Adverse Event|0|||
124457425|NCT01239342|447635023|FG000|Overall Study|Withdrawal by Subject|1|||
124457426|NCT01239342|447635024|FG001|Overall Study|Withdrawal by Subject|5|||
124457427|NCT01239342|447635023|FG000|Overall Study|Reason Unknown|1|||
124457428|NCT01239342|447635024|FG001|Overall Study|Reason Unknown|1|||
124457429|NCT02918864|447635027|FG000|Overall Study|Withdrawal by Subject|1|||
124457430|NCT02918864|447635028|FG001|Overall Study|Withdrawal by Subject|1|||
124457431|NCT02918864|447635027|FG000|Overall Study|Lost to Follow-up|3|||
124457432|NCT02918864|447635028|FG001|Overall Study|Lost to Follow-up|2|||
124457433|NCT03577730|447635031|FG000|Overall Study|Physician Decision|3|||
124457434|NCT03577730|447635032|FG001|Overall Study|Physician Decision|1|||
124457435|NCT03577730|447635031|FG000|Overall Study|Did not receive allocated intervention|1|||
124457436|NCT03577730|447635032|FG001|Overall Study|Did not receive allocated intervention|0|||
124457437|NCT02634151|447635033|FG000|Overall Study|Withdrawal by Subject|1|||
124457438|NCT02634151|447635034|FG001|Overall Study|Withdrawal by Subject|0|||
124457439|NCT02634151|447635033|FG000|Overall Study|Non-Compliance|0|||
124457440|NCT02634151|447635034|FG001|Overall Study|Non-Compliance|1|||
124457441|NCT02634151|447635033|FG000|Overall Study|Other|0|||
124457442|NCT02634151|447635034|FG001|Overall Study|Other|1|||
124457443|NCT04640272|447635035|FG000|Overall Study|Subject moved out of area|1|||
124457444|NCT00751400|447635040|FG000|Overall Study|Lost to Follow-up|10|||
124457445|NCT00441974|447635045|FG000|Overall Study|Adverse Event|6|||
124457446|NCT00441974|447635045|FG000|Overall Study|Consent Withdrawn|35|||
124941531|NCT01640951|449413183|FG002|Overall Study|Physician Decision|2|||
124941532|NCT01640951|449413184|FG003|Overall Study|Physician Decision|2|||
124941533|NCT01640951|449413185|FG004|Overall Study|Physician Decision|2|||
124457447|NCT00441974|447635045|FG000|Overall Study|Lost to Follow-up|80|||
124457448|NCT00441974|447635045|FG000|Overall Study|Protocol Violation|7|||
124457449|NCT02770547|447635046|FG000|Overall Study|Patient non-compliant|1|||
124457450|NCT02770547|447635047|FG001|Overall Study|Patient non-compliant|0|||
124457451|NCT02770547|447635046|FG000|Overall Study|Adverse Event|0|||
124457452|NCT02770547|447635047|FG001|Overall Study|Adverse Event|1|||
124941534|NCT01640951|449413186|FG005|Overall Study|Physician Decision|3|||
124941535|NCT01640951|449413187|FG006|Overall Study|Physician Decision|3|||
124941536|NCT01640951|449413188|FG007|Overall Study|Physician Decision|0|||
124547058|NCT00440193|447957458|FG001|Treatment Period|Technical problems|1|||
124941537|NCT01640951|449413181|FG000|Overall Study|Pregnancy|3|||
124941538|NCT01640951|449413182|FG001|Overall Study|Pregnancy|0|||
124941539|NCT01640951|449413183|FG002|Overall Study|Pregnancy|0|||
124941540|NCT01640951|449413184|FG003|Overall Study|Pregnancy|4|||
124941541|NCT01640951|449413185|FG004|Overall Study|Pregnancy|0|||
124941542|NCT01640951|449413186|FG005|Overall Study|Pregnancy|0|||
124941543|NCT01640951|449413187|FG006|Overall Study|Pregnancy|2|||
124941544|NCT01640951|449413188|FG007|Overall Study|Pregnancy|0|||
124941545|NCT01640951|449413181|FG000|Overall Study|Protocol Deviation|0|||
124941546|NCT01640951|449413182|FG001|Overall Study|Protocol Deviation|1|||
124941547|NCT01640951|449413183|FG002|Overall Study|Protocol Deviation|2|||
124941548|NCT01640951|449413184|FG003|Overall Study|Protocol Deviation|1|||
124941549|NCT01640951|449413185|FG004|Overall Study|Protocol Deviation|0|||
124941550|NCT01640951|449413186|FG005|Overall Study|Protocol Deviation|1|||
124941551|NCT01640951|449413187|FG006|Overall Study|Protocol Deviation|0|||
124941552|NCT01640951|449413188|FG007|Overall Study|Protocol Deviation|0|||
124941553|NCT01640951|449413181|FG000|Overall Study|Subject/Guardian decision|12|||
124941554|NCT01640951|449413182|FG001|Overall Study|Subject/Guardian decision|4|||
124941555|NCT01640951|449413183|FG002|Overall Study|Subject/Guardian decision|13|||
124941556|NCT01640951|449413184|FG003|Overall Study|Subject/Guardian decision|15|||
124941557|NCT01640951|449413185|FG004|Overall Study|Subject/Guardian decision|7|||
124941558|NCT01640951|449413186|FG005|Overall Study|Subject/Guardian decision|19|||
124941559|NCT01640951|449413187|FG006|Overall Study|Subject/Guardian decision|5|||
124941560|NCT01640951|449413188|FG007|Overall Study|Subject/Guardian decision|4|||
124941561|NCT01640951|449413181|FG000|Overall Study|Death|0|||
124941562|NCT01640951|449413182|FG001|Overall Study|Death|1|||
124941563|NCT01640951|449413183|FG002|Overall Study|Death|1|||
124941564|NCT01640951|449413184|FG003|Overall Study|Death|0|||
124941565|NCT01640951|449413185|FG004|Overall Study|Death|0|||
124941566|NCT01640951|449413186|FG005|Overall Study|Death|0|||
124941567|NCT01640951|449413187|FG006|Overall Study|Death|0|||
124547059|NCT00440193|447957457|FG000|Treatment Period|Participant convenience|5|||
124547060|NCT00440193|447957458|FG001|Treatment Period|Participant convenience|2|||
124547061|NCT00440193|447957457|FG000|Treatment Period|Participant did not receive treatment|7|||
124547062|NCT00440193|447957458|FG001|Treatment Period|Participant did not receive treatment|13|||
124547063|NCT00440193|447957457|FG000|Treatment Period|Site closed by investigator|0|||
124547064|NCT00440193|447957458|FG001|Treatment Period|Site closed by investigator|2|||
124941568|NCT01640951|449413188|FG007|Overall Study|Death|2|||
124941569|NCT02406092|449413189|FG000|Overall Study|Screen failure|10|||
124941570|NCT02406092|449413190|FG001|Overall Study|Screen failure|7|||
124941571|NCT02406092|449413189|FG000|Overall Study|Death|22|||
124941572|NCT02406092|449413190|FG001|Overall Study|Death|5|||
124547065|NCT00440193|447957457|FG000|Observational Period|Adverse Event|2|||
124547066|NCT00440193|447957458|FG001|Observational Period|Adverse Event|2|||
124547067|NCT00440193|447957457|FG000|Observational Period|Death|15|||
124547068|NCT00440193|447957458|FG001|Observational Period|Death|20|||
124547069|NCT00440193|447957457|FG000|Observational Period|Lost to Follow-up|12|||
124547070|NCT00440193|447957458|FG001|Observational Period|Lost to Follow-up|8|||
124547071|NCT00440193|447957457|FG000|Observational Period|Protocol Violation|1|||
124547072|NCT00440193|447957458|FG001|Observational Period|Protocol Violation|0|||
124941573|NCT02406092|449413189|FG000|Overall Study|Lost to Follow-up|4|||
124941574|NCT02406092|449413190|FG001|Overall Study|Lost to Follow-up|1|||
124941575|NCT02406092|449413189|FG000|Overall Study|Adverse Event|1|||
124941576|NCT02406092|449413190|FG001|Overall Study|Adverse Event|0|||
124941577|NCT02406092|449413189|FG000|Overall Study|Withdrawal by Subject|1|||
124941578|NCT02406092|449413190|FG001|Overall Study|Withdrawal by Subject|0|||
124941579|NCT03041233|449413193|FG000|Overall Study|Death|5|||
124941580|NCT03041233|449413193|FG000|Overall Study|Physician Decision|1|||
124941581|NCT03041233|449413193|FG000|Overall Study|Lost to Follow-up|16|||
124941582|NCT03041233|449413193|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
124703894|NCT00725985|448539262|FG002|OLMP (Up to 96 Weeks)|Death|0|||
124547073|NCT00440193|447957457|FG000|Observational Period|Withdrawal by Subject|11|||
124703895|NCT00725985|448539263|FG003|OLMP (Up to 96 Weeks)|Death|0|||
124941583|NCT03041233|449413193|FG000|Overall Study|Sponsor Request|1|||
124547074|NCT00440193|447957458|FG001|Observational Period|Withdrawal by Subject|8|||
124547075|NCT00440193|447957457|FG000|Observational Period|Physician Decision|1|||
124941584|NCT03041233|449413193|FG000|Overall Study|Duplicate subject|1|||
124941585|NCT03041233|449413193|FG000|Overall Study|Re-ablation|1|||
124941586|NCT00942266|449413194|FG000|Overall Study|Withdrawal by Subject|1|||
124941587|NCT00942266|449413195|FG001|Overall Study|Withdrawal by Subject|0|||
124941588|NCT00942266|449413194|FG000|Overall Study|Adverse Event|2|||
124941589|NCT00942266|449413195|FG001|Overall Study|Adverse Event|1|||
124941590|NCT00942266|449413194|FG000|Overall Study|Disease Progression|38|||
124941591|NCT00942266|449413195|FG001|Overall Study|Disease Progression|11|||
124941592|NCT00942266|449413194|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
124941593|NCT00942266|449413195|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
124941594|NCT00942266|449413194|FG000|Overall Study|Intercurrent illness|0|||
124941595|NCT00942266|449413195|FG001|Overall Study|Intercurrent illness|1|||
124547076|NCT00440193|447957458|FG001|Observational Period|Physician Decision|0|||
124547077|NCT00440193|447957457|FG000|Observational Period|Clinical endpoint reached|1|||
124547078|NCT00440193|447957458|FG001|Observational Period|Clinical endpoint reached|0|||
124547079|NCT00440193|447957457|FG000|Observational Period|Participant convenience|2|||
124547080|NCT00440193|447957458|FG001|Observational Period|Participant convenience|0|||
124547081|NCT02061293|447957464|FG000|Overall Study|Elevated Blood Pressure|1|||
124547082|NCT02061293|447957465|FG001|Overall Study|Elevated Blood Pressure|1|||
124547083|NCT02184988|447957466|FG000|Overall Study|Pregnancy|2|||
124547084|NCT02184988|447957466|FG000|Overall Study|Adverse Event|2|||
124547085|NCT02184988|447957466|FG000|Overall Study|moving away/travelling/unable to complet|6|||
124547086|NCT02184988|447957466|FG000|Overall Study|work scheduling issues|4|||
124547087|NCT02184988|447957466|FG000|Overall Study|various other reasons|9|||
124547088|NCT02184988|447957466|FG000|Overall Study|Lost to Follow-up|32|||
124547089|NCT00690573|447957476|FG000|Overall Study|Lack of Efficacy|8|||
124547090|NCT00690573|447957476|FG000|Overall Study|Withdrawal by Subject|1|||
124547091|NCT01283282|447957477|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
124547092|NCT01283282|447957478|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
124547093|NCT01283282|447957477|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
124547094|NCT01283282|447957478|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
124547095|NCT01283282|447957477|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
124547096|NCT01283282|447957478|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
124547097|NCT00777920|447957479|FG000|Overall Study|Adverse Event|39|||
124547098|NCT00777920|447957479|FG000|Overall Study|Withdrawal of Consent|4|||
124547099|NCT00777920|447957479|FG000|Overall Study|Lost to Follow-up|1|||
124547100|NCT00777920|447957479|FG000|Overall Study|Investigator's discretion|1|||
124547101|NCT00777920|447957479|FG000|Overall Study|Clinical status did not improve|1|||
124547102|NCT00777920|447957479|FG000|Overall Study|Other, not specified|4|||
124547103|NCT00483717|447957480|FG000|Overall Study|Protocol Violation|5|||
124547104|NCT00483717|447957481|FG001|Overall Study|Protocol Violation|7|||
124547105|NCT00483717|447957480|FG000|Overall Study|Time of dosing missing|1|||
124547106|NCT00483717|447957481|FG001|Overall Study|Time of dosing missing|1|||
124547107|NCT00483717|447957480|FG000|Overall Study|No treatment for migraine|16|||
124547108|NCT00483717|447957481|FG001|Overall Study|No treatment for migraine|13|||
124547109|NCT00483717|447957480|FG000|Overall Study|Lost to Follow-up|1|||
124547110|NCT00483717|447957481|FG001|Overall Study|Lost to Follow-up|0|||
124547111|NCT00483717|447957480|FG000|Overall Study|Withdrawal by Subject|1|||
124547112|NCT00483717|447957481|FG001|Overall Study|Withdrawal by Subject|0|||
124547113|NCT03878108|447957482|FG000|Overall Study|Adverse Event|1|||
124547114|NCT03878108|447957483|FG001|Overall Study|Adverse Event|0|||
124547115|NCT01682681|447957484|FG000|Overall Study|Lack of Efficacy|62|||
124547116|NCT01682681|447957484|FG000|Overall Study|Withdrawal by Subject|1|||
124547117|NCT01682681|447957484|FG000|Overall Study|Moved to other hospital|10|||
124547118|NCT01682681|447957484|FG000|Overall Study|Lost to Follow-up|174|||
124547119|NCT01682681|447957484|FG000|Overall Study|Adverse Event|46|||
124547120|NCT01682681|447957484|FG000|Overall Study|tapering of topiramate|5|||
124547121|NCT01682681|447957484|FG000|Overall Study|Other|21|||
124547122|NCT01682681|447957484|FG000|Overall Study|Low compliance|13|||
124547123|NCT00975000|447957485|FG000|Overall Study|Other|1|||
124547124|NCT00975000|447957486|FG001|Overall Study|Other|0|||
124547125|NCT00975000|447957485|FG000|Overall Study|Adverse Event|1|||
124547126|NCT00975000|447957486|FG001|Overall Study|Adverse Event|1|||
124547127|NCT00975000|447957485|FG000|Overall Study|Withdrawal by Subject|2|||
124547128|NCT00975000|447957486|FG001|Overall Study|Withdrawal by Subject|2|||
124547129|NCT00975000|447957485|FG000|Overall Study|Lost to Follow-up|0|||
124547130|NCT00975000|447957486|FG001|Overall Study|Lost to Follow-up|1|||
124547131|NCT00975000|447957485|FG000|Overall Study|Protocol-specified Criteria|1|||
124547132|NCT00975000|447957486|FG001|Overall Study|Protocol-specified Criteria|0|||
124547133|NCT00975000|447957485|FG000|Overall Study|Non-compliance|0|||
124547134|NCT00975000|447957486|FG001|Overall Study|Non-compliance|1|||
124547135|NCT01525407|447957487|FG000|Overall Study|Change in recipient treatment plan|2|||
124547136|NCT01525407|447957488|FG001|Overall Study|Change in recipient treatment plan|2|||
124547137|NCT01525407|447957487|FG000|Overall Study|Withdrawal by Subject|0|||
124547138|NCT01525407|447957488|FG001|Overall Study|Withdrawal by Subject|1|||
124547139|NCT01525407|447957487|FG000|Overall Study|Transplant was delayed|0|||
124547140|NCT01525407|447957488|FG001|Overall Study|Transplant was delayed|1|||
124547141|NCT01525407|447957487|FG000|Overall Study|Delay in Transplant|1|||
124547142|NCT01525407|447957488|FG001|Overall Study|Delay in Transplant|0|||
124547143|NCT01819467|447958803|FG000|Overall Study|Physician Decision|20|||
124547144|NCT01819467|447958804|FG001|Overall Study|Physician Decision|9|||
124547145|NCT02875340|447958806|FG000|Overall Study|Death|2|||
124547146|NCT02875340|447958806|FG000|Overall Study|Withdrawal by Subject|2|||
124547147|NCT02875340|447958806|FG000|Overall Study|Physician Decision|3|||
124547148|NCT02875340|447958806|FG000|Overall Study|Adverse Event|1|||
124547149|NCT01607398|447958809|FG000|Overall Study|Adverse Event|0|||
124547150|NCT01607398|447958810|FG001|Overall Study|Adverse Event|2|||
124547151|NCT01607398|447958809|FG000|Overall Study|Severe COPD|2|||
124547152|NCT01607398|447958810|FG001|Overall Study|Severe COPD|0|||
124941596|NCT00942266|449413194|FG000|Overall Study|Physician Decision|2|||
124941597|NCT00942266|449413195|FG001|Overall Study|Physician Decision|0|||
124941598|NCT00942266|449413194|FG000|Overall Study|medical deterioration (pneumonia)|0|||
124941599|NCT00942266|449413195|FG001|Overall Study|medical deterioration (pneumonia)|1|||
124941600|NCT00756574|449413199|FG000|Overall Study|Withdrawal by Subject|9|||
124941601|NCT00756574|449413200|FG001|Overall Study|Withdrawal by Subject|7|||
124941602|NCT00756574|449413199|FG000|Overall Study|Lost to Follow-up|4|||
124941603|NCT00756574|449413200|FG001|Overall Study|Lost to Follow-up|4|||
124941604|NCT04035447|449413201|FG000|Treatment Period|Lost to Follow-up|6|||
124941605|NCT04035447|449413202|FG001|Treatment Period|Lost to Follow-up|5|||
124941606|NCT04035447|449413201|FG000|Treatment Period|Physician Decision|0|||
124547153|NCT03457727|447958811|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
124547154|NCT03457727|447958812|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
124547155|NCT03457727|447958813|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
124547156|NCT03457727|447958814|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
124547157|NCT00929201|447958815|FG000|Period 1|Withdrawal by Subject|0|||
124547158|NCT00929201|447958816|FG001|Period 1|Withdrawal by Subject|1|||
124547159|NCT01299272|447958819|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
124547160|NCT01299272|447958820|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
124547161|NCT01299272|447958821|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
124547162|NCT01299272|447958822|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
124547163|NCT01299272|447958819|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
124547164|NCT01299272|447958820|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
124547165|NCT01299272|447958821|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
124547166|NCT01299272|447958822|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
124547167|NCT01299272|447958819|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
124547168|NCT01299272|447958820|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
124547169|NCT01299272|447958821|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
124547170|NCT01299272|447958822|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
124547171|NCT01299272|447958819|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
124547172|NCT01299272|447958820|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
124547173|NCT01299272|447958821|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
124547174|NCT01299272|447958822|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
124547175|NCT01299272|447958819|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
124547176|NCT01299272|447958820|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
124547177|NCT01299272|447958821|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
124547178|NCT01299272|447958822|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
124547179|NCT01299272|447958819|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
124547180|NCT01299272|447958820|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
124547181|NCT01299272|447958821|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
124547182|NCT01299272|447958822|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
124547183|NCT01299272|447958819|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
124547184|NCT01299272|447958820|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
124547185|NCT01299272|447958821|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
124547186|NCT01299272|447958822|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
124547187|NCT01299272|447958819|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
124547188|NCT01299272|447958820|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
124547189|NCT01299272|447958821|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
124547190|NCT01299272|447958822|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
124547191|NCT01299272|447958819|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
124547192|NCT01299272|447958820|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
124547193|NCT01299272|447958821|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
124547194|NCT01299272|447958822|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
124547195|NCT01299272|447958819|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
124547196|NCT01299272|447958820|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
124547197|NCT01299272|447958821|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
124547198|NCT01299272|447958822|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
124547199|NCT01299272|447958819|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
124547200|NCT01299272|447958820|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
124547201|NCT01299272|447958821|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
124547202|NCT01299272|447958822|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
124547203|NCT01299272|447958819|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
124547204|NCT01299272|447958820|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
124547205|NCT01299272|447958821|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
124547206|NCT01299272|447958822|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
124703896|NCT00725985|448539264|FG004|OLMP (Up to 96 Weeks)|Death|1|||
124941607|NCT04035447|449413202|FG001|Treatment Period|Physician Decision|2|||
124941608|NCT02816398|449413204|FG000|Overall Study|Death|5|||
124457453|NCT01148537|447635048|FG000|Overall Study|Withdrawal by Subject|1|||
124457454|NCT01148537|447635049|FG001|Overall Study|Withdrawal by Subject|0|||
124457455|NCT01148537|447635050|FG002|Overall Study|Withdrawal by Subject|2|||
124457456|NCT01148537|447635048|FG000|Overall Study|Adverse Event|2|||
124457457|NCT01148537|447635049|FG001|Overall Study|Adverse Event|0|||
124457458|NCT01148537|447635050|FG002|Overall Study|Adverse Event|1|||
124457459|NCT03134599|447635052|FG000|Week 1|Lost to Follow-up|0|||
124457460|NCT03134599|447635053|FG001|Week 1|Lost to Follow-up|0|||
124457461|NCT03134599|447635054|FG002|Week 1|Lost to Follow-up|0|||
124457462|NCT03134599|447635055|FG003|Week 1|Lost to Follow-up|0|||
124457463|NCT03134599|447635056|FG004|Week 1|Lost to Follow-up|1|||
124457464|NCT03134599|447635057|FG005|Week 1|Lost to Follow-up|0|||
124457465|NCT03134599|447635052|FG000|Week 2|Lost to Follow-up|1|||
124457466|NCT03134599|447635053|FG001|Week 2|Lost to Follow-up|0|||
124457467|NCT03134599|447635054|FG002|Week 2|Lost to Follow-up|0|||
124457468|NCT03134599|447635055|FG003|Week 2|Lost to Follow-up|1|||
124457469|NCT03134599|447635056|FG004|Week 2|Lost to Follow-up|1|||
124457470|NCT03134599|447635057|FG005|Week 2|Lost to Follow-up|0|||
124457471|NCT03134599|447635052|FG000|Week 3|Lost to Follow-up|0|||
124457472|NCT03134599|447635053|FG001|Week 3|Lost to Follow-up|0|||
124457473|NCT03134599|447635054|FG002|Week 3|Lost to Follow-up|0|||
124457474|NCT03134599|447635055|FG003|Week 3|Lost to Follow-up|1|||
124457475|NCT03134599|447635056|FG004|Week 3|Lost to Follow-up|0|||
124457476|NCT03134599|447635057|FG005|Week 3|Lost to Follow-up|1|||
124457477|NCT00393887|447635058|FG000|Overall Study|Physician Decision|5|||
124457478|NCT00393887|447635059|FG001|Overall Study|Physician Decision|0|||
124457479|NCT00393887|447635058|FG000|Overall Study|Lost to Follow-up|11|||
124457480|NCT00393887|447635059|FG001|Overall Study|Lost to Follow-up|9|||
124457481|NCT02018822|447635063|FG000|Overall Study|filling replaced by crown|0|||
124457482|NCT02018822|447635064|FG001|Overall Study|filling replaced by crown|1|||
124457483|NCT02018822|447635065|FG002|Overall Study|filling replaced by crown|0|||
124457484|NCT02018822|447635063|FG000|Overall Study|Physician Decision|0|||
124457485|NCT02018822|447635064|FG001|Overall Study|Physician Decision|1|||
124457486|NCT02018822|447635065|FG002|Overall Study|Physician Decision|1|||
124457487|NCT02018822|447635063|FG000|Overall Study|Lost to Follow-up|6|||
124457488|NCT02018822|447635064|FG001|Overall Study|Lost to Follow-up|6|||
124457489|NCT02018822|447635065|FG002|Overall Study|Lost to Follow-up|5|||
124457490|NCT00715026|447635066|FG000|Overall Study|Withdrawal by Subject|5|||
124457491|NCT00715026|447635066|FG000|Overall Study|Lost to Follow-up|3|||
124457492|NCT00715026|447635066|FG000|Overall Study|Protocol Violation|1|||
124457493|NCT00715026|447635066|FG000|Overall Study|Surgery done on non-study consented hip|1|||
124765021|NCT02051764|448765119|FG000|Overall Study|Study terminated by sponsor|0|||
124765022|NCT02051764|448765120|FG001|Overall Study|Study terminated by sponsor|7|||
124765023|NCT03557970|448765121|FG000|Overall Study|Study closure|1|||
124765024|NCT03557970|448765122|FG001|Overall Study|Study closure|0|||
124765025|NCT03557970|448765121|FG000|Overall Study|Physician Decision|0|||
124765026|NCT03557970|448765122|FG001|Overall Study|Physician Decision|1|||
124457494|NCT01389752|447635069|FG000|Study Period 1|Sponsor decision|0|||
124457495|NCT01389752|447635070|FG001|Study Period 1|Sponsor decision|2|||
124457496|NCT01389752|447635069|FG000|Study Period 2|Sponsor decision|1|||
124457497|NCT01389752|447635070|FG001|Study Period 2|Sponsor decision|0|||
124457498|NCT01157364|447635075|FG000|Overall Study|Other Reasons|1|||
124457499|NCT01157364|447635076|FG001|Overall Study|Other Reasons|1|||
124457500|NCT01157364|447635077|FG002|Overall Study|Other Reasons|2|||
124457501|NCT01157364|447635078|FG003|Overall Study|Other Reasons|1|||
124457502|NCT01157364|447635079|FG004|Overall Study|Other Reasons|0|||
124457503|NCT01157364|447635080|FG005|Overall Study|Other Reasons|0|||
124457504|NCT01157364|447635075|FG000|Overall Study|Personal Reasons|0|||
124457505|NCT01157364|447635076|FG001|Overall Study|Personal Reasons|2|||
124457506|NCT01157364|447635077|FG002|Overall Study|Personal Reasons|0|||
124457507|NCT01157364|447635078|FG003|Overall Study|Personal Reasons|0|||
124457508|NCT01157364|447635079|FG004|Overall Study|Personal Reasons|1|||
124457509|NCT01157364|447635080|FG005|Overall Study|Personal Reasons|1|||
124457510|NCT01157364|447635075|FG000|Overall Study|Lost to Follow-up|1|||
124457511|NCT01157364|447635076|FG001|Overall Study|Lost to Follow-up|0|||
124457512|NCT01157364|447635077|FG002|Overall Study|Lost to Follow-up|1|||
124457513|NCT01157364|447635078|FG003|Overall Study|Lost to Follow-up|0|||
124457514|NCT01157364|447635079|FG004|Overall Study|Lost to Follow-up|0|||
124457515|NCT01157364|447635080|FG005|Overall Study|Lost to Follow-up|0|||
124457516|NCT01157364|447635075|FG000|Overall Study|Lack of Efficacy|0|||
124457517|NCT01157364|447635076|FG001|Overall Study|Lack of Efficacy|0|||
124457518|NCT01157364|447635077|FG002|Overall Study|Lack of Efficacy|0|||
124457519|NCT01157364|447635078|FG003|Overall Study|Lack of Efficacy|1|||
124457520|NCT01157364|447635079|FG004|Overall Study|Lack of Efficacy|0|||
124457521|NCT01157364|447635080|FG005|Overall Study|Lack of Efficacy|0|||
124765027|NCT03557970|448765121|FG000|Overall Study|Death|0|||
124765028|NCT03557970|448765122|FG001|Overall Study|Death|1|||
124765029|NCT03155724|448765123|FG000|Overall Study|Death|3|||
124457522|NCT01157364|447635075|FG000|Overall Study|Adverse Event|0|||
124457523|NCT01157364|447635076|FG001|Overall Study|Adverse Event|1|||
124457524|NCT01157364|447635077|FG002|Overall Study|Adverse Event|1|||
124457525|NCT01157364|447635078|FG003|Overall Study|Adverse Event|0|||
124457526|NCT01157364|447635079|FG004|Overall Study|Adverse Event|1|||
124765030|NCT03155724|448765123|FG000|Overall Study|Physician Decision|1|||
124703897|NCT00725985|448539265|FG005|OLMP (Up to 96 Weeks)|Death|0|||
124703898|NCT00725985|448539266|FG006|OLMP (Up to 96 Weeks)|Death|0|||
124941609|NCT02816398|449413204|FG000|Overall Study|Lack of Efficacy|8|||
124941610|NCT02816398|449413204|FG000|Overall Study|Lost to Follow-up|1|||
124941611|NCT01588951|449413205|FG000|Overall Study|Ineligible in retrospect|0|||
124941612|NCT01588951|449413206|FG001|Overall Study|Ineligible in retrospect|0|||
124941613|NCT01588951|449413207|FG002|Overall Study|Ineligible in retrospect|1|||
124941614|NCT02130557|449413210|FG000|Overall Study|Withdrawal by Subject|12|||
124941615|NCT02130557|449413211|FG001|Overall Study|Withdrawal by Subject|12|||
124941616|NCT02130557|449413210|FG000|Overall Study|Investigator Request|0|||
124941617|NCT02130557|449413211|FG001|Overall Study|Investigator Request|2|||
124941618|NCT02130557|449413210|FG000|Overall Study|Deceased|14|||
124941619|NCT02130557|449413211|FG001|Overall Study|Deceased|14|||
124703899|NCT00725985|448539267|FG007|OLMP (Up to 96 Weeks)|Death|0|||
124703900|NCT00725985|448539268|FG008|OLMP (Up to 96 Weeks)|Death|0|||
124941620|NCT02130557|449413210|FG000|Overall Study|Lost to Follow-up|6|||
124941621|NCT02130557|449413211|FG001|Overall Study|Lost to Follow-up|7|||
124941622|NCT02130557|449413210|FG000|Overall Study|Other|2|||
124941623|NCT02130557|449413211|FG001|Overall Study|Other|1|||
124941624|NCT02130557|449413210|FG000|Overall Study|Missing|2|||
124941625|NCT02130557|449413211|FG001|Overall Study|Missing|1|||
124703901|NCT00725985|448539269|FG009|OLMP (Up to 96 Weeks)|Death|0|||
124703902|NCT00725985|448539270|FG010|OLMP (Up to 96 Weeks)|Death|0|||
124703903|NCT00725985|448539271|FG011|OLMP (Up to 96 Weeks)|Death|0|||
124703904|NCT00725985|448539260|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
124703905|NCT00725985|448539261|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
124703906|NCT00725985|448539262|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
124703907|NCT00725985|448539263|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
124703908|NCT00725985|448539264|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
124703909|NCT00725985|448539265|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
124703910|NCT00725985|448539266|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
124703911|NCT00725985|448539267|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
124703912|NCT00725985|448539268|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
124703913|NCT00725985|448539269|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
124703914|NCT00725985|448539270|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
124703915|NCT00725985|448539271|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
124703916|NCT00725985|448539260|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
124703917|NCT00725985|448539261|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
124703918|NCT00725985|448539262|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
124703919|NCT00725985|448539263|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
124703920|NCT00725985|448539264|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
124703921|NCT00725985|448539265|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
124703922|NCT00725985|448539266|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
124703923|NCT00725985|448539267|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
124941626|NCT02408887|449413212|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
124703924|NCT00725985|448539268|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
124703925|NCT00725985|448539269|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
124703926|NCT00725985|448539270|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
124703927|NCT00725985|448539271|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
124703928|NCT00725985|448539260|FG000|OLMP (Up to 96 Weeks)|Other|0|||
124703929|NCT00725985|448539261|FG001|OLMP (Up to 96 Weeks)|Other|0|||
124703930|NCT00725985|448539262|FG002|OLMP (Up to 96 Weeks)|Other|0|||
124457527|NCT01157364|447635080|FG005|Overall Study|Adverse Event|0|||
124457528|NCT04251910|447635084|FG000|Overall Study|Covid 19 lockdown|0|||
124457529|NCT04251910|447635085|FG001|Overall Study|Covid 19 lockdown|5|||
124457530|NCT04251910|447635086|FG002|Overall Study|Covid 19 lockdown|0|||
124457531|NCT04251910|447635087|FG003|Overall Study|Covid 19 lockdown|4|||
124457532|NCT04251910|447635088|FG004|Overall Study|Covid 19 lockdown|0|||
124457533|NCT04251910|447635089|FG005|Overall Study|Covid 19 lockdown|0|||
124457534|NCT04251910|447635084|FG000|Overall Study|Assisted living facility was closed|0|||
124457535|NCT04251910|447635085|FG001|Overall Study|Assisted living facility was closed|0|||
124457536|NCT04251910|447635086|FG002|Overall Study|Assisted living facility was closed|0|||
124457537|NCT04251910|447635087|FG003|Overall Study|Assisted living facility was closed|0|||
124457538|NCT04251910|447635088|FG004|Overall Study|Assisted living facility was closed|1|||
124457539|NCT04251910|447635089|FG005|Overall Study|Assisted living facility was closed|0|||
124457540|NCT00841568|447635092|FG000|Overall Study|Adverse Event|1|||
124457541|NCT00841568|447635092|FG000|Overall Study|Death|1|||
124457542|NCT00841568|447635092|FG000|Overall Study|Withdrawal by Subject|2|||
124457543|NCT00841568|447635092|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
124457544|NCT01087775|447635093|FG000|Overall Study|failed inclusion criteria|2|||
124457545|NCT00825162|447635100|FG000|Overall Study|Withdrawal by Subject|11|||
124457546|NCT00825162|447635101|FG001|Overall Study|Withdrawal by Subject|13|||
124457547|NCT00825162|447635102|FG002|Overall Study|Withdrawal by Subject|3|||
124457548|NCT00825162|447635100|FG000|Overall Study|Lost to Follow-up|9|||
124457549|NCT00825162|447635101|FG001|Overall Study|Lost to Follow-up|6|||
124457550|NCT00825162|447635102|FG002|Overall Study|Lost to Follow-up|3|||
124457551|NCT00825162|447635100|FG000|Overall Study|Physician Decision|2|||
124457552|NCT00825162|447635101|FG001|Overall Study|Physician Decision|0|||
124457553|NCT00825162|447635102|FG002|Overall Study|Physician Decision|0|||
124457554|NCT00825162|447635100|FG000|Overall Study|Move away from the study area|1|||
124457555|NCT00825162|447635101|FG001|Overall Study|Move away from the study area|0|||
124457556|NCT00825162|447635102|FG002|Overall Study|Move away from the study area|0|||
124457557|NCT00825162|447635100|FG000|Overall Study|Unable to attend the study visit|5|||
124457558|NCT00825162|447635101|FG001|Overall Study|Unable to attend the study visit|2|||
124457559|NCT00825162|447635102|FG002|Overall Study|Unable to attend the study visit|0|||
124457560|NCT00781911|447635103|FG000|Overall Study|Adverse Event|4|||
124457561|NCT00781911|447635104|FG001|Overall Study|Adverse Event|4|||
124457562|NCT00781911|447635103|FG000|Overall Study|Withdrawal by Subject|1|||
124457563|NCT00781911|447635104|FG001|Overall Study|Withdrawal by Subject|2|||
124457564|NCT00781911|447635103|FG000|Overall Study|Physician Decision|0|||
124457565|NCT00781911|447635104|FG001|Overall Study|Physician Decision|2|||
124703931|NCT00725985|448539263|FG003|OLMP (Up to 96 Weeks)|Other|15|||
124703932|NCT00725985|448539264|FG004|OLMP (Up to 96 Weeks)|Other|20|||
124457566|NCT00781911|447635103|FG000|Overall Study|Sponsor Decision|1|||
124457567|NCT00781911|447635104|FG001|Overall Study|Sponsor Decision|0|||
124457568|NCT03317795|447635107|FG000|Overall Study|IUD Expulsion|1|||
124457569|NCT03317795|447635108|FG001|Overall Study|IUD Expulsion|0|||
124457570|NCT03317795|447635107|FG000|Overall Study|Lost to Follow-up|1|||
124457571|NCT03317795|447635108|FG001|Overall Study|Lost to Follow-up|3|||
124457572|NCT03317795|447635107|FG000|Overall Study|Treatment change|0|||
124457573|NCT03317795|447635108|FG001|Overall Study|Treatment change|3|||
124457574|NCT03317795|447635107|FG000|Overall Study|Intolerance of medication|0|||
124457575|NCT03317795|447635108|FG001|Overall Study|Intolerance of medication|1|||
124457576|NCT00939783|447635109|FG000|Overall Study|Death|6|||
124457577|NCT00939783|447635109|FG000|Overall Study|Adverse Event|39|||
124457578|NCT00939783|447635109|FG000|Overall Study|Study Terminated by Sponsor|498|||
124457579|NCT00939783|447635109|FG000|Overall Study|Withdrawal by Subject|78|||
124457580|NCT00939783|447635109|FG000|Overall Study|Other|16|||
124457581|NCT00939783|447635109|FG000|Overall Study|Lost to Follow-up|8|||
124457582|NCT00939783|447635109|FG000|Overall Study|Protocol Violation|3|||
124547207|NCT01299272|447958819|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
124703933|NCT00725985|448539265|FG005|OLMP (Up to 96 Weeks)|Other|44|||
124457583|NCT00939783|447635109|FG000|Overall Study|Enrolled but not treated|1|||
124457584|NCT01549002|447635114|FG000|Overall Study|Excessive pain|0|||
124703934|NCT00725985|448539266|FG006|OLMP (Up to 96 Weeks)|Other|0|||
124457585|NCT01549002|447635115|FG001|Overall Study|Excessive pain|2|||
124457586|NCT01549002|447635114|FG000|Overall Study|Moderate sedation required|0|||
124547208|NCT01299272|447958820|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
124703935|NCT00725985|448539267|FG007|OLMP (Up to 96 Weeks)|Other|0|||
124703936|NCT00725985|448539268|FG008|OLMP (Up to 96 Weeks)|Other|0|||
124703937|NCT00725985|448539269|FG009|OLMP (Up to 96 Weeks)|Other|0|||
124703938|NCT00725985|448539270|FG010|OLMP (Up to 96 Weeks)|Other|0|||
124703939|NCT00725985|448539271|FG011|OLMP (Up to 96 Weeks)|Other|0|||
124703940|NCT00725985|448539260|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
124703941|NCT00725985|448539261|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
124703942|NCT00725985|448539262|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
124703943|NCT00725985|448539263|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
124703944|NCT00725985|448539264|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
124703945|NCT00725985|448539265|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
124703946|NCT00725985|448539266|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
124703947|NCT00725985|448539267|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
124703948|NCT00725985|448539268|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
124703949|NCT00725985|448539269|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
124703950|NCT00725985|448539270|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
124703951|NCT00725985|448539271|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
124703952|NCT00725985|448539260|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
124703953|NCT00725985|448539261|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
124703954|NCT00725985|448539262|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
124703955|NCT00725985|448539263|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
124703956|NCT00725985|448539264|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
124703957|NCT00725985|448539265|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
124703958|NCT00725985|448539266|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
124703959|NCT00725985|448539267|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
124703960|NCT00725985|448539268|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
124703961|NCT00725985|448539269|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
124703962|NCT00725985|448539270|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
124703963|NCT00725985|448539271|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
124703964|NCT00725985|448539260|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
124703965|NCT00725985|448539261|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
124703966|NCT00725985|448539262|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
124547209|NCT01299272|447958821|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
124547210|NCT01299272|447958822|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
124547211|NCT01299272|447958819|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
124765031|NCT03155724|448765123|FG000|Overall Study|Study closure|7|||
124703967|NCT00725985|448539263|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
124703968|NCT00725985|448539264|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
124547212|NCT01299272|447958820|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
124547213|NCT01299272|447958821|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
124547214|NCT01299272|447958822|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
124547215|NCT01299272|447958819|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
124547216|NCT01299272|447958820|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
124547217|NCT01299272|447958821|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
124547218|NCT01299272|447958822|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
124547219|NCT01299272|447958819|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
124547220|NCT01299272|447958820|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
124547221|NCT01299272|447958821|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
124547222|NCT01299272|447958822|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
124547223|NCT01299272|447958819|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
124547224|NCT01299272|447958820|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
124547225|NCT01299272|447958821|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
124547226|NCT01299272|447958822|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
124547227|NCT01299272|447958819|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
124547228|NCT01299272|447958820|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
124547229|NCT01299272|447958821|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
124547230|NCT01299272|447958822|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
124547231|NCT01299272|447958819|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
124547232|NCT01299272|447958820|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
124547233|NCT01299272|447958821|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
124547234|NCT01299272|447958822|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
124547235|NCT01299272|447958819|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
124547236|NCT01299272|447958820|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
124547237|NCT01299272|447958821|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
124765032|NCT00321789|448765127|FG000|Overall Study|Lost to Follow-up|4|||
124703969|NCT00725985|448539265|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
124547238|NCT01299272|447958822|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
124547239|NCT01299272|447958819|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
124703970|NCT00725985|448539266|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
124765033|NCT00321789|448765128|FG001|Overall Study|Lost to Follow-up|7|||
124703971|NCT00725985|448539267|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
124703972|NCT00725985|448539268|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
124703973|NCT00725985|448539269|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
124703974|NCT00725985|448539270|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
124703975|NCT00725985|448539271|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
124703976|NCT00725985|448539260|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
124703977|NCT00725985|448539261|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
124703978|NCT00725985|448539262|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
124703979|NCT00725985|448539263|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
124703980|NCT00725985|448539264|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
124703981|NCT00725985|448539265|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
124703982|NCT00725985|448539266|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
124703983|NCT00725985|448539267|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
124703984|NCT00725985|448539268|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
124703985|NCT00725985|448539269|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
124703986|NCT00725985|448539270|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
124703987|NCT00725985|448539271|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
124703988|NCT04476784|448539272|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
124703989|NCT04476784|448539273|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
124703990|NCT00863304|448539274|FG000|Overall Study|Adverse Event|10|||
124703991|NCT00863304|448539275|FG001|Overall Study|Adverse Event|4|||
124703992|NCT00863304|448539276|FG002|Overall Study|Adverse Event|14|||
124703993|NCT00863304|448539277|FG003|Overall Study|Adverse Event|16|||
124703994|NCT00863304|448539274|FG000|Overall Study|Lost to Follow-up|1|||
124703995|NCT00863304|448539275|FG001|Overall Study|Lost to Follow-up|5|||
124703996|NCT00863304|448539276|FG002|Overall Study|Lost to Follow-up|4|||
124703997|NCT00863304|448539277|FG003|Overall Study|Lost to Follow-up|2|||
124703998|NCT00863304|448539274|FG000|Overall Study|Lack of Efficacy|57|||
124703999|NCT00863304|448539275|FG001|Overall Study|Lack of Efficacy|26|||
124704000|NCT00863304|448539276|FG002|Overall Study|Lack of Efficacy|30|||
124704001|NCT00863304|448539277|FG003|Overall Study|Lack of Efficacy|28|||
124704002|NCT00863304|448539274|FG000|Overall Study|Withdrawal by Subject|19|||
124704003|NCT00863304|448539275|FG001|Overall Study|Withdrawal by Subject|14|||
124704004|NCT00863304|448539276|FG002|Overall Study|Withdrawal by Subject|20|||
124704005|NCT00863304|448539277|FG003|Overall Study|Withdrawal by Subject|18|||
124704006|NCT00863304|448539274|FG000|Overall Study|Other|1|||
124704007|NCT00863304|448539275|FG001|Overall Study|Other|0|||
124457587|NCT01549002|447635115|FG001|Overall Study|Moderate sedation required|2|||
124457588|NCT02255409|447635120|FG000|Overall Study|Administrative Reason|3|||
124457589|NCT02255409|447635121|FG001|Overall Study|Administrative Reason|7|||
124457590|NCT02255409|447635120|FG000|Overall Study|Withdrawal by Subject|1|||
124457591|NCT02255409|447635121|FG001|Overall Study|Withdrawal by Subject|5|||
124457592|NCT02255409|447635120|FG000|Overall Study|Lost to Follow-up|10|||
124457593|NCT02255409|447635121|FG001|Overall Study|Lost to Follow-up|19|||
124457594|NCT01251367|447635122|FG000|Overall Study|Protocol Violation|1|||
124457595|NCT01251367|447635122|FG000|Overall Study|Lack of Efficacy|2|||
124457596|NCT01251367|447635122|FG000|Overall Study|Adverse Event|19|||
124457597|NCT01251367|447635122|FG000|Overall Study|Withdrawal by Subject|36|||
124457598|NCT01251367|447635122|FG000|Overall Study|Lost to Follow-up|5|||
124457599|NCT01251367|447635122|FG000|Overall Study|Subject Required Alternative Treatment|7|||
124457600|NCT01251367|447635122|FG000|Overall Study|No Study Drug Available|1|||
124457601|NCT01251367|447635122|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
124457602|NCT01251367|447635122|FG000|Overall Study|End of Study Visit Performed in Error|1|||
124457603|NCT02016820|447635125|FG000|Overall Study|Lost to Follow-up|2|||
124457604|NCT02016820|447635126|FG001|Overall Study|Lost to Follow-up|4|||
124457605|NCT02424253|447635127|FG000|Overall Study|Other, unspecified|1|||
124457606|NCT02424253|447635128|FG001|Overall Study|Other, unspecified|0|||
124457607|NCT02424253|447635127|FG000|Overall Study|Compliance problems|1|||
124457608|NCT02424253|447635128|FG001|Overall Study|Compliance problems|0|||
124457609|NCT02424253|447635127|FG000|Overall Study|Physician Decision|2|||
124457610|NCT02424253|447635128|FG001|Overall Study|Physician Decision|0|||
124457611|NCT02424253|447635127|FG000|Overall Study|Lack of Efficacy|0|||
124457612|NCT02424253|447635128|FG001|Overall Study|Lack of Efficacy|7|||
124457613|NCT02424253|447635127|FG000|Overall Study|Adverse Event|2|||
124457614|NCT02424253|447635128|FG001|Overall Study|Adverse Event|0|||
124457615|NCT02424253|447635127|FG000|Overall Study|Consent withdrawn by subject|4|||
124457616|NCT02424253|447635128|FG001|Overall Study|Consent withdrawn by subject|1|||
124457617|NCT02424253|447635127|FG000|Overall Study|Lost to Follow-up|1|||
124457618|NCT02424253|447635128|FG001|Overall Study|Lost to Follow-up|1|||
124457619|NCT01136655|447635131|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
124457620|NCT01136655|447635131|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
124457621|NCT01136655|447635131|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
124457622|NCT01136655|447635131|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
124457623|NCT03557281|447636619|FG000|Overall Study|Investigator discretion|0|||
124457624|NCT03557281|447636620|FG001|Overall Study|Investigator discretion|0|||
124457625|NCT03557281|447636621|FG002|Overall Study|Investigator discretion|1|||
124704008|NCT00863304|448539276|FG002|Overall Study|Other|0|||
124704009|NCT00863304|448539277|FG003|Overall Study|Other|1|||
124941627|NCT02408887|449413213|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
124941628|NCT02408887|449413212|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
124941629|NCT02408887|449413213|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
124941630|NCT02517268|449413214|FG000|Overall Study|Withdrawal by Subject|1|||
124941631|NCT02517268|449413215|FG001|Overall Study|Withdrawal by Subject|0|||
124941632|NCT04912856|449413225|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
124941633|NCT04912856|449413226|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
124941634|NCT04912856|449413225|FG000|Overall Study|Not reported in synoptic CSR.|0|||
124941635|NCT04912856|449413226|FG001|Overall Study|Not reported in synoptic CSR.|1|||
124941636|NCT05613907|449413227|FG000|Overall Study|Lost to Follow-up|5|||
124941637|NCT05613907|449413227|FG000|Overall Study|Death|3|||
124941638|NCT05613907|449413227|FG000|Overall Study|Withdrawal by Subject|2|||
124941639|NCT00748709|449413230|FG000|Overall Study|Progressive disease|15|||
124941640|NCT00748709|449413230|FG000|Overall Study|Drug reducing Toxity|2|||
124941641|NCT00748709|449413230|FG000|Overall Study|Other Adverse Event|1|||
124941642|NCT00748709|449413230|FG000|Overall Study|Withdrawal by Subject|1|||
124941643|NCT00748709|449413230|FG000|Overall Study|Other Reasons|1|||
124704010|NCT00863304|448539274|FG000|Overall Study|Protocol Violation|2|||
124704011|NCT00863304|448539275|FG001|Overall Study|Protocol Violation|6|||
124704012|NCT00863304|448539276|FG002|Overall Study|Protocol Violation|2|||
124704013|NCT00863304|448539277|FG003|Overall Study|Protocol Violation|0|||
124704014|NCT00863304|448539274|FG000|Overall Study|Randomized, but not Treated|3|||
124704015|NCT00863304|448539275|FG001|Overall Study|Randomized, but not Treated|1|||
124704016|NCT00863304|448539276|FG002|Overall Study|Randomized, but not Treated|4|||
124704017|NCT00863304|448539277|FG003|Overall Study|Randomized, but not Treated|1|||
124704018|NCT00863304|448539274|FG000|Overall Study|Entered extension study|101|||
124704019|NCT00863304|448539275|FG001|Overall Study|Entered extension study|129|||
124704020|NCT00863304|448539276|FG002|Overall Study|Entered extension study|113|||
124704021|NCT00863304|448539277|FG003|Overall Study|Entered extension study|125|||
124704022|NCT06582732|448539278|FG000|Initial Study Period|Adverse Event|0|||
124704023|NCT06582732|448539279|FG001|Initial Study Period|Adverse Event|0|||
124704024|NCT06582732|448539280|FG002|Initial Study Period|Adverse Event|0|||
124704025|NCT06582732|448539281|FG003|Initial Study Period|Adverse Event|2|||
124704026|NCT06582732|448539282|FG004|Initial Study Period|Adverse Event|0|||
124704027|NCT06582732|448539283|FG005|Initial Study Period|Adverse Event|0|||
124704028|NCT06582732|448539284|FG006|Initial Study Period|Adverse Event|0|||
124704029|NCT06582732|448539278|FG000|Initial Study Period|Death|1|||
124704030|NCT06582732|448539279|FG001|Initial Study Period|Death|0|||
124457626|NCT03557281|447636622|FG003|Overall Study|Investigator discretion|0|||
124457627|NCT03557281|447636623|FG004|Overall Study|Investigator discretion|0|||
124457628|NCT03557281|447636619|FG000|Overall Study|Withdrawal by Subject|0|||
124457629|NCT03557281|447636620|FG001|Overall Study|Withdrawal by Subject|1|||
124457630|NCT03557281|447636621|FG002|Overall Study|Withdrawal by Subject|1|||
124457631|NCT03557281|447636622|FG003|Overall Study|Withdrawal by Subject|1|||
124457632|NCT03557281|447636623|FG004|Overall Study|Withdrawal by Subject|2|||
124457633|NCT03557281|447636619|FG000|Overall Study|Randomized, but did not receive treatment|0|||
124457634|NCT03557281|447636620|FG001|Overall Study|Randomized, but did not receive treatment|0|||
124457635|NCT03557281|447636621|FG002|Overall Study|Randomized, but did not receive treatment|0|||
124457636|NCT03557281|447636622|FG003|Overall Study|Randomized, but did not receive treatment|0|||
124457637|NCT03557281|447636623|FG004|Overall Study|Randomized, but did not receive treatment|1|||
124457638|NCT00402649|447636624|FG000|Overall Study|Lost to Follow-up|1|||
124457639|NCT00402649|447636624|FG000|Overall Study|Withdrawal by Subject|1|||
124457640|NCT01999465|447636625|FG000|Overall Study|Lost to Follow-up|0|||
124457641|NCT01999465|447636626|FG001|Overall Study|Lost to Follow-up|2|||
124457642|NCT01999465|447636625|FG000|Overall Study|Protocol Violation|0|||
124457643|NCT01999465|447636626|FG001|Overall Study|Protocol Violation|1|||
124457644|NCT01611974|447636635|FG000|Overall Study|Death|10|||
124457645|NCT01611974|447636636|FG001|Overall Study|Death|12|||
124457646|NCT01611974|447636637|FG002|Overall Study|Death|10|||
124457647|NCT01611974|447636635|FG000|Overall Study|Lost to Follow-up|0|||
124457648|NCT01611974|447636636|FG001|Overall Study|Lost to Follow-up|1|||
124457649|NCT01611974|447636637|FG002|Overall Study|Lost to Follow-up|0|||
124457650|NCT01611974|447636635|FG000|Overall Study|Physician Decision|5|||
124704031|NCT06582732|448539280|FG002|Initial Study Period|Death|0|||
124704032|NCT06582732|448539281|FG003|Initial Study Period|Death|0|||
124704033|NCT06582732|448539282|FG004|Initial Study Period|Death|1|||
124704034|NCT06582732|448539283|FG005|Initial Study Period|Death|0|||
124704035|NCT06582732|448539284|FG006|Initial Study Period|Death|0|||
124704036|NCT06582732|448539278|FG000|Initial Study Period|Lost to Follow-up|0|||
124704037|NCT06582732|448539279|FG001|Initial Study Period|Lost to Follow-up|0|||
124704038|NCT06582732|448539280|FG002|Initial Study Period|Lost to Follow-up|2|||
124704039|NCT06582732|448539281|FG003|Initial Study Period|Lost to Follow-up|0|||
124457651|NCT01611974|447636636|FG001|Overall Study|Physician Decision|1|||
124457652|NCT01611974|447636637|FG002|Overall Study|Physician Decision|2|||
124704040|NCT06582732|448539282|FG004|Initial Study Period|Lost to Follow-up|0|||
124704041|NCT06582732|448539283|FG005|Initial Study Period|Lost to Follow-up|0|||
124704042|NCT06582732|448539284|FG006|Initial Study Period|Lost to Follow-up|0|||
124704043|NCT06582732|448539278|FG000|Initial Study Period|Withdrawal by Subject|0|||
124704044|NCT06582732|448539279|FG001|Initial Study Period|Withdrawal by Subject|1|||
124704045|NCT06582732|448539280|FG002|Initial Study Period|Withdrawal by Subject|0|||
124704046|NCT06582732|448539281|FG003|Initial Study Period|Withdrawal by Subject|1|||
124704047|NCT06582732|448539282|FG004|Initial Study Period|Withdrawal by Subject|3|||
124704048|NCT06582732|448539283|FG005|Initial Study Period|Withdrawal by Subject|1|||
124704049|NCT06582732|448539284|FG006|Initial Study Period|Withdrawal by Subject|2|||
124704050|NCT06582732|448539278|FG000|Initial Study Period|Moved Away|0|||
124704051|NCT06582732|448539279|FG001|Initial Study Period|Moved Away|0|||
124704052|NCT06582732|448539280|FG002|Initial Study Period|Moved Away|0|||
124704053|NCT06582732|448539281|FG003|Initial Study Period|Moved Away|0|||
124704054|NCT06582732|448539282|FG004|Initial Study Period|Moved Away|1|||
124704055|NCT06582732|448539283|FG005|Initial Study Period|Moved Away|0|||
124704056|NCT06582732|448539284|FG006|Initial Study Period|Moved Away|0|||
124704057|NCT02507934|448539285|FG000|Overall Study|Lost to Follow-up|2|||
124704058|NCT02507934|448539286|FG001|Overall Study|Lost to Follow-up|0|||
124704059|NCT02507934|448539285|FG000|Overall Study|Withdrawal by Subject|2|||
124704060|NCT02507934|448539286|FG001|Overall Study|Withdrawal by Subject|0|||
124704061|NCT03528902|448539287|FG000|Overall Study|Adverse Event|1|||
124704062|NCT03528902|448539288|FG001|Overall Study|Adverse Event|0|||
124704063|NCT05030766|448539289|FG000|Phase 1 Participants|Lost to Follow-up|12|||
124704064|NCT05030766|448539290|FG001|Phase 1 Participants|Lost to Follow-up|22|||
124704065|NCT05030766|448539291|FG002|Phase 1 Participants|Lost to Follow-up|0|||
124704066|NCT05030766|448539292|FG003|Phase 1 Participants|Lost to Follow-up|0|||
124704067|NCT05030766|448539289|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
124704068|NCT05030766|448539290|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
124704069|NCT05030766|448539291|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
124704070|NCT05030766|448539292|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
124704071|NCT05030766|448539289|FG000|Phase 2 Participants|Lost to Follow-up|0|||
124704072|NCT05030766|448539290|FG001|Phase 2 Participants|Lost to Follow-up|0|||
124704073|NCT05030766|448539291|FG002|Phase 2 Participants|Lost to Follow-up|6|||
124704074|NCT05030766|448539292|FG003|Phase 2 Participants|Lost to Follow-up|2|||
124941644|NCT02751528|449413235|FG000|Overall Study|Withdrawal by Subject|1|||
124941645|NCT02751528|449413235|FG000|Overall Study|Adverse Event|1|||
124941646|NCT05071430|449413236|FG000|Overall Study|Adverse Event|1|||
124941647|NCT05071430|449413237|FG001|Overall Study|Adverse Event|2|||
124941648|NCT05071430|449413236|FG000|Overall Study|Lost to Follow-up|4|||
124941649|NCT05071430|449413237|FG001|Overall Study|Lost to Follow-up|4|||
124941650|NCT05071430|449413236|FG000|Overall Study|Protocol Violation|1|||
124941651|NCT05071430|449413237|FG001|Overall Study|Protocol Violation|0|||
124941652|NCT05071430|449413236|FG000|Overall Study|Withdrawal by Subject|3|||
124941653|NCT05071430|449413237|FG001|Overall Study|Withdrawal by Subject|2|||
124704075|NCT03605693|448539299|FG000|Overall Study|Lost to Follow-up|4|||
124704076|NCT03605693|448539300|FG001|Overall Study|Lost to Follow-up|0|||
124704077|NCT03605693|448539299|FG000|Overall Study|Physician Decision|1|||
124704078|NCT03605693|448539300|FG001|Overall Study|Physician Decision|0|||
124704079|NCT03895372|448539303|FG000|Investigational Treatment Period|Adverse Event|1|||
124704080|NCT03895372|448539304|FG001|Investigational Treatment Period|Adverse Event|0|||
124941654|NCT05071430|449413236|FG000|Overall Study|Other|1|||
124941655|NCT05071430|449413237|FG001|Overall Study|Other|1|||
124941656|NCT01958021|449413238|FG000|Treatment|Progressive disease|206|||
124941657|NCT01958021|449413239|FG001|Treatment|Progressive disease|265|||
124457653|NCT01611974|447636635|FG000|Overall Study|Withdrawal by Subject|0|||
124457654|NCT01611974|447636636|FG001|Overall Study|Withdrawal by Subject|1|||
124457655|NCT01611974|447636637|FG002|Overall Study|Withdrawal by Subject|4|||
124704081|NCT03895372|448539305|FG002|Investigational Treatment Period|Adverse Event|0|||
124704082|NCT03895372|448539306|FG003|Investigational Treatment Period|Adverse Event|0|||
124457656|NCT00916357|447636638|FG000|Period 1|Withdrawal by Subject|1|||
124457657|NCT00916357|447636639|FG001|Period 1|Withdrawal by Subject|0|||
124457658|NCT00916357|447636640|FG002|Period 1|Withdrawal by Subject|0|||
124457659|NCT00916357|447636641|FG003|Period 1|Withdrawal by Subject|0|||
124457660|NCT00916357|447636642|FG004|Period 1|Withdrawal by Subject|0|||
124457661|NCT00916357|447636643|FG005|Period 1|Withdrawal by Subject|0|||
124704083|NCT03895372|448539307|FG004|Investigational Treatment Period|Adverse Event|0|||
124704084|NCT03895372|448539308|FG005|Investigational Treatment Period|Adverse Event|0|||
124704085|NCT03895372|448539309|FG006|Investigational Treatment Period|Adverse Event|4|||
124704086|NCT03895372|448539310|FG007|Investigational Treatment Period|Adverse Event|3|||
124704087|NCT03895372|448539303|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
124704088|NCT03895372|448539304|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
124704089|NCT03895372|448539305|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
124704090|NCT03895372|448539306|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
124704091|NCT03895372|448539307|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
124704092|NCT03895372|448539308|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
124704093|NCT03895372|448539309|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
124704094|NCT03895372|448539310|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
124704095|NCT03895372|448539303|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
124704096|NCT03895372|448539304|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
124704097|NCT03895372|448539305|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
124704098|NCT03895372|448539306|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
124704099|NCT03895372|448539307|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
124704100|NCT03895372|448539308|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
124704101|NCT03895372|448539309|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
124704102|NCT03895372|448539310|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
124704103|NCT03895372|448539303|FG000|Investigational Treatment Period|Other|0|||
124704104|NCT03895372|448539304|FG001|Investigational Treatment Period|Other|0|||
124704105|NCT03895372|448539305|FG002|Investigational Treatment Period|Other|0|||
124704106|NCT03895372|448539306|FG003|Investigational Treatment Period|Other|0|||
124704107|NCT03895372|448539307|FG004|Investigational Treatment Period|Other|0|||
124704108|NCT03895372|448539308|FG005|Investigational Treatment Period|Other|1|||
124704109|NCT03895372|448539309|FG006|Investigational Treatment Period|Other|0|||
124704110|NCT03895372|448539310|FG007|Investigational Treatment Period|Other|2|||
124704111|NCT03895372|448539303|FG000|Investigational Treatment Period|Protocol Violation|0|||
124704112|NCT03895372|448539304|FG001|Investigational Treatment Period|Protocol Violation|0|||
124704113|NCT03895372|448539305|FG002|Investigational Treatment Period|Protocol Violation|0|||
124704114|NCT03895372|448539306|FG003|Investigational Treatment Period|Protocol Violation|1|||
124704115|NCT03895372|448539307|FG004|Investigational Treatment Period|Protocol Violation|0|||
124704116|NCT03895372|448539308|FG005|Investigational Treatment Period|Protocol Violation|0|||
124704117|NCT03895372|448539309|FG006|Investigational Treatment Period|Protocol Violation|0|||
124704118|NCT03895372|448539310|FG007|Investigational Treatment Period|Protocol Violation|0|||
124704119|NCT03895372|448539303|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
124704120|NCT03895372|448539304|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
124704121|NCT03895372|448539305|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
124704122|NCT03895372|448539306|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
124941658|NCT01958021|449413238|FG000|Treatment|Adverse Event|38|||
124941659|NCT01958021|449413239|FG001|Treatment|Adverse Event|10|||
124941660|NCT01958021|449413238|FG000|Treatment|Subject/guardian decision|29|||
124941661|NCT01958021|449413239|FG001|Treatment|Subject/guardian decision|25|||
124941662|NCT01958021|449413238|FG000|Treatment|Physician Decision|28|||
124941663|NCT01958021|449413239|FG001|Treatment|Physician Decision|21|||
124941664|NCT01958021|449413238|FG000|Treatment|Death|6|||
124941665|NCT01958021|449413239|FG001|Treatment|Death|1|||
124941666|NCT01958021|449413238|FG000|Treatment|Protocol deviation|3|||
124941667|NCT01958021|449413239|FG001|Treatment|Protocol deviation|1|||
124941668|NCT01958021|449413238|FG000|Treatment|Sponsor decision|24|||
124941669|NCT01958021|449413239|FG001|Treatment|Sponsor decision|11|||
124457662|NCT00916357|447636638|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
124457663|NCT00916357|447636639|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
124457664|NCT00916357|447636640|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
124704123|NCT03895372|448539307|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
124704124|NCT03895372|448539308|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
124704125|NCT03895372|448539309|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
124704126|NCT03895372|448539310|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
124941670|NCT01958021|449413238|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
124704127|NCT03895372|448539303|FG000|Extension Treatment Period|Adverse Event|0|||
124704128|NCT03895372|448539304|FG001|Extension Treatment Period|Adverse Event|1|||
124457665|NCT00916357|447636641|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
124704129|NCT03895372|448539305|FG002|Extension Treatment Period|Adverse Event|0|||
124704130|NCT03895372|448539306|FG003|Extension Treatment Period|Adverse Event|1|||
124704131|NCT03895372|448539307|FG004|Extension Treatment Period|Adverse Event|0|||
124457666|NCT00916357|447636642|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
124457667|NCT00916357|447636643|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
124457668|NCT01308008|447636644|FG000|4 Weeks|Illness, disinterest, time|9|||
124457669|NCT01308008|447636645|FG001|4 Weeks|Illness, disinterest, time|2|||
124765034|NCT00321789|448765127|FG000|Overall Study|Withdrawal by Subject|6|||
124765035|NCT00321789|448765128|FG001|Overall Study|Withdrawal by Subject|6|||
124765036|NCT00321789|448765127|FG000|Overall Study|Protocol Violation|5|||
124765037|NCT00321789|448765128|FG001|Overall Study|Protocol Violation|3|||
124765038|NCT03309020|448765130|FG000|Overall Study|Death|1|||
124765039|NCT03309020|448765131|FG001|Overall Study|Death|0|||
124765040|NCT03309020|448765130|FG000|Overall Study|Did not undergo surgery|2|||
124765041|NCT03309020|448765131|FG001|Overall Study|Did not undergo surgery|1|||
124765042|NCT02919761|448765134|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
124765043|NCT02919761|448765135|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
124765044|NCT02919761|448765136|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
124765045|NCT02919761|448765134|FG000|Part 1: Open Label|Adverse Event|1|||
124765046|NCT02919761|448765135|FG001|Part 1: Open Label|Adverse Event|0|||
124765047|NCT02919761|448765136|FG002|Part 1: Open Label|Adverse Event|0|||
124765048|NCT02919761|448765134|FG000|Part 1: Open Label|Lost to Follow-up|1|||
124765049|NCT02919761|448765135|FG001|Part 1: Open Label|Lost to Follow-up|0|||
124765050|NCT02919761|448765136|FG002|Part 1: Open Label|Lost to Follow-up|0|||
124765051|NCT02919761|448765134|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
124765052|NCT02919761|448765135|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
124765053|NCT02919761|448765136|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
124765054|NCT02919761|448765134|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
124765055|NCT02919761|448765135|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
124765056|NCT02919761|448765136|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
124765057|NCT02919761|448765134|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
124765058|NCT02919761|448765135|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
124765059|NCT02919761|448765136|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
124765060|NCT02919761|448765134|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
124765061|NCT02919761|448765135|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
124765062|NCT02919761|448765136|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
124765063|NCT02919761|448765134|FG000|Part 1: Open Label|Termination by Sponsor|1|||
124765064|NCT02919761|448765135|FG001|Part 1: Open Label|Termination by Sponsor|0|||
124765065|NCT02919761|448765136|FG002|Part 1: Open Label|Termination by Sponsor|0|||
124765066|NCT02919761|448765134|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
124765067|NCT02919761|448765135|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
124765068|NCT02919761|448765136|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
124765069|NCT02919761|448765134|FG000|Part 2: Double-blind|Adverse Event|0|||
124765070|NCT02919761|448765135|FG001|Part 2: Double-blind|Adverse Event|1|||
124765071|NCT02919761|448765136|FG002|Part 2: Double-blind|Adverse Event|0|||
124765072|NCT02919761|448765134|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
124765073|NCT02919761|448765135|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
124765074|NCT02919761|448765136|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
124765075|NCT02919761|448765134|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
124765076|NCT02919761|448765135|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
124765077|NCT02919761|448765136|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
124765078|NCT02919761|448765134|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
124765079|NCT02919761|448765135|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
124765080|NCT02919761|448765136|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
124765081|NCT02919761|448765134|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
124765082|NCT02919761|448765135|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
124765083|NCT02919761|448765136|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
124765084|NCT02919761|448765134|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
124765085|NCT02919761|448765135|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
124765086|NCT02919761|448765136|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
124704132|NCT03895372|448539308|FG005|Extension Treatment Period|Adverse Event|0|||
124704133|NCT03895372|448539309|FG006|Extension Treatment Period|Adverse Event|3|||
124704134|NCT03895372|448539310|FG007|Extension Treatment Period|Adverse Event|3|||
124704135|NCT03895372|448539303|FG000|Extension Treatment Period|Other|1|||
124457670|NCT04766021|447636646|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
124765087|NCT02919761|448765134|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
124765088|NCT02919761|448765135|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
124704136|NCT03895372|448539304|FG001|Extension Treatment Period|Other|3|||
124765089|NCT02919761|448765136|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
124765090|NCT03409796|448767302|FG000|Overall Study|Adverse Event|2|||
124765091|NCT03409796|448767303|FG001|Overall Study|Adverse Event|0|||
124704137|NCT03895372|448539305|FG002|Extension Treatment Period|Other|0|||
124704138|NCT03895372|448539306|FG003|Extension Treatment Period|Other|0|||
124704139|NCT03895372|448539307|FG004|Extension Treatment Period|Other|1|||
124704140|NCT03895372|448539308|FG005|Extension Treatment Period|Other|0|||
124704141|NCT03895372|448539309|FG006|Extension Treatment Period|Other|0|||
124704142|NCT03895372|448539310|FG007|Extension Treatment Period|Other|2|||
124704143|NCT03895372|448539303|FG000|Extension Treatment Period|Pregnancy|0|||
124704144|NCT03895372|448539304|FG001|Extension Treatment Period|Pregnancy|0|||
124704145|NCT03895372|448539305|FG002|Extension Treatment Period|Pregnancy|0|||
124704146|NCT03895372|448539306|FG003|Extension Treatment Period|Pregnancy|0|||
124704147|NCT03895372|448539307|FG004|Extension Treatment Period|Pregnancy|1|||
124704148|NCT03895372|448539308|FG005|Extension Treatment Period|Pregnancy|0|||
124704149|NCT03895372|448539309|FG006|Extension Treatment Period|Pregnancy|0|||
124704150|NCT03895372|448539310|FG007|Extension Treatment Period|Pregnancy|0|||
124704151|NCT03895372|448539303|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
124704152|NCT03895372|448539304|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
124704153|NCT03895372|448539305|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
124704154|NCT03895372|448539306|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
124704155|NCT03895372|448539307|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
124704156|NCT03895372|448539308|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
124704157|NCT03895372|448539309|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
124704158|NCT03895372|448539310|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
124704159|NCT03093415|448539311|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
124704160|NCT03093415|448539312|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
124704161|NCT03093415|448539313|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
124704162|NCT03093415|448539311|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
124704163|NCT03093415|448539312|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
124704164|NCT03093415|448539313|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
124704165|NCT03093415|448539311|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
124704166|NCT03093415|448539312|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
124704167|NCT03093415|448539313|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
124704168|NCT03093415|448539311|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
124704169|NCT03093415|448539312|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
124704170|NCT03093415|448539313|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
124704171|NCT03093415|448539311|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
124704172|NCT03093415|448539312|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
124704173|NCT03093415|448539313|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
124704174|NCT03093415|448539311|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
124704175|NCT03093415|448539312|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
124704176|NCT03093415|448539313|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
124704177|NCT03093415|448539311|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
124704178|NCT03093415|448539312|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
124704179|NCT03093415|448539313|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
124704180|NCT03093415|448539311|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
124704181|NCT03093415|448539312|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
124704182|NCT03093415|448539313|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
124704183|NCT03093415|448539311|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
124704184|NCT03093415|448539312|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
124941671|NCT01958021|449413239|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124941672|NCT01958021|449413238|FG000|Post-treatment Efficacy Follow-up|Death|1|||
124941673|NCT01958021|449413239|FG001|Post-treatment Efficacy Follow-up|Death|0|||
124941674|NCT01958021|449413238|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
124941675|NCT01958021|449413239|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124704185|NCT03093415|448539313|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
124704186|NCT03093415|448539311|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
124704187|NCT03093415|448539312|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
124704188|NCT03093415|448539313|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
124704189|NCT03093415|448539311|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
124704190|NCT03093415|448539312|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
124704191|NCT03093415|448539313|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
124704192|NCT03331354|448539316|FG000|Overall Study|Withdrawal by Subject|1|||
124704193|NCT03331354|448539317|FG001|Overall Study|Withdrawal by Subject|3|||
124704194|NCT03331354|448539316|FG000|Overall Study|Lost to Follow-up|3|||
124704195|NCT03331354|448539317|FG001|Overall Study|Lost to Follow-up|3|||
124704196|NCT03331354|448539316|FG000|Overall Study|Found employment before initiated active intervention|0|||
124704197|NCT03331354|448539317|FG001|Overall Study|Found employment before initiated active intervention|4|||
124704198|NCT01309230|448539324|FG000|Overall Study|Withdrawal by Subject|0|||
124704199|NCT01309230|448539325|FG001|Overall Study|Withdrawal by Subject|2|||
124704200|NCT01309230|448539324|FG000|Overall Study|Observation arm closed|0|||
124704201|NCT01309230|448539325|FG001|Overall Study|Observation arm closed|2|||
124704202|NCT00427700|448539328|FG000|Overall Study|Lost to Follow-up|2|||
124704203|NCT00427700|448539329|FG001|Overall Study|Lost to Follow-up|5|||
124704204|NCT00427700|448539328|FG000|Overall Study|no induction of menses|1|||
124704205|NCT00427700|448539329|FG001|Overall Study|no induction of menses|4|||
124704206|NCT00427700|448539328|FG000|Overall Study|Pregnancy|0|||
124704207|NCT00427700|448539329|FG001|Overall Study|Pregnancy|2|||
124704208|NCT04581395|448539330|FG000|Overall Study|Protocol Violation|4|||
124704209|NCT04581395|448539331|FG001|Overall Study|Protocol Violation|3|||
124941676|NCT01958021|449413238|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
124941677|NCT01958021|449413239|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
124941678|NCT01958021|449413238|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
124941679|NCT01958021|449413239|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
124941680|NCT01958021|449413238|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
124941681|NCT01958021|449413239|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
124941682|NCT01958021|449413238|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
124941683|NCT01958021|449413239|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
124941684|NCT04484623|449413241|FG000|Overall Study|Lost to Follow-up|0|||
124941685|NCT04484623|449413242|FG001|Overall Study|Lost to Follow-up|1|||
124941686|NCT04484623|449413241|FG000|Overall Study|Protocol Deviation|1|||
124941687|NCT04484623|449413242|FG001|Overall Study|Protocol Deviation|0|||
124941688|NCT04484623|449413241|FG000|Overall Study|Physician Decision|1|||
124941689|NCT04484623|449413242|FG001|Overall Study|Physician Decision|0|||
124941690|NCT04484623|449413241|FG000|Overall Study|Withdrawal by Subject|11|||
124941691|NCT04484623|449413242|FG001|Overall Study|Withdrawal by Subject|8|||
124941692|NCT04484623|449413241|FG000|Overall Study|Ongoing|94|||
124941693|NCT04484623|449413242|FG001|Overall Study|Ongoing|84|||
124941694|NCT04649047|449413243|FG000|Overall Study|Withdrawal by Subject|3|||
124941695|NCT00719888|449413244|FG000|Overall Study|Death|24|||
124941696|NCT00719888|449413245|FG001|Overall Study|Death|9|||
124941697|NCT00719888|449413244|FG000|Overall Study|Relapse|8|||
124941698|NCT00719888|449413245|FG001|Overall Study|Relapse|3|||
124941699|NCT00719888|449413244|FG000|Overall Study|Physician Decision|1|||
124941700|NCT00719888|449413245|FG001|Overall Study|Physician Decision|0|||
124704210|NCT04581395|448539332|FG002|Overall Study|Protocol Violation|2|||
124704211|NCT04581395|448539330|FG000|Overall Study|Physician Decision|0|||
124704212|NCT04581395|448539331|FG001|Overall Study|Physician Decision|1|||
124704213|NCT04581395|448539332|FG002|Overall Study|Physician Decision|0|||
124704214|NCT00815633|448539335|FG000|Overall Study|study terminated|1|||
124704215|NCT00721110|448539336|FG000|Overall Study|Ultram use|1|||
124704216|NCT00721110|448539337|FG001|Overall Study|Ultram use|0|||
124704217|NCT00721110|448539338|FG002|Overall Study|Ultram use|0|||
124941701|NCT00719888|449413244|FG000|Overall Study|Withdrawal by Subject|1|||
124941702|NCT00719888|449413245|FG001|Overall Study|Withdrawal by Subject|0|||
124941703|NCT05037513|449413246|FG000|Intervention Period|Lost to Follow-up|1|||
124941704|NCT05037513|449413247|FG001|Intervention Period|Lost to Follow-up|2|||
124941705|NCT05037513|449413246|FG000|Follow Up Period|Lost to Follow-up|16|||
124941706|NCT05037513|449413247|FG001|Follow Up Period|Lost to Follow-up|21|||
124941707|NCT05037513|449413246|FG000|Follow Up Period|Death|0|||
124941708|NCT05037513|449413247|FG001|Follow Up Period|Death|1|||
124941709|NCT05037513|449413246|FG000|Follow Up Period|Incarcerated|4|||
124547240|NCT01299272|447958820|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
124547241|NCT01299272|447958821|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
124547242|NCT01299272|447958822|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
124547243|NCT01299272|447958819|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
124547244|NCT01299272|447958820|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
124547245|NCT01299272|447958821|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
124547246|NCT01299272|447958822|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
124547247|NCT01299272|447958819|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
124547248|NCT01299272|447958820|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
124547249|NCT01299272|447958821|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
124547250|NCT01299272|447958822|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
124547251|NCT01299272|447958819|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
124547252|NCT01299272|447958820|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
124547253|NCT01299272|447958821|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
124547254|NCT01299272|447958822|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
124547255|NCT01299272|447958819|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
124547256|NCT01299272|447958820|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
124547257|NCT01299272|447958821|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
124547258|NCT01299272|447958822|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
124547259|NCT00464308|447958823|FG000|Overall Study|Adverse Event|22|||
124547260|NCT00464308|447958824|FG001|Overall Study|Adverse Event|27|||
124547261|NCT00464308|447958825|FG002|Overall Study|Adverse Event|16|||
124547262|NCT00464308|447958823|FG000|Overall Study|Lost to Follow-up|29|||
124547263|NCT00464308|447958824|FG001|Overall Study|Lost to Follow-up|19|||
124547264|NCT00464308|447958825|FG002|Overall Study|Lost to Follow-up|20|||
124547265|NCT00464308|447958823|FG000|Overall Study|Patient discontinued and other reasons|17|||
124547266|NCT00464308|447958824|FG001|Overall Study|Patient discontinued and other reasons|17|||
124547267|NCT00464308|447958825|FG002|Overall Study|Patient discontinued and other reasons|23|||
124547268|NCT00464308|447958823|FG000|Overall Study|Physician Decision|1|||
124547269|NCT00464308|447958824|FG001|Overall Study|Physician Decision|0|||
124547270|NCT00464308|447958825|FG002|Overall Study|Physician Decision|0|||
124547271|NCT00630994|447958826|FG000|Overall Study|Adverse Event|1|||
124547272|NCT00630994|447958826|FG000|Overall Study|Disease Progression|1|||
124547273|NCT00630994|447958826|FG000|Overall Study|Lack of Efficacy|1|||
124547274|NCT00630994|447958826|FG000|Overall Study|Other|1|||
124547275|NCT03533608|447958827|FG000|Overall Study|Withdrawal by Subject|3|||
124547276|NCT03533608|447958827|FG000|Overall Study|Physician Decision|2|||
124941710|NCT05037513|449413247|FG001|Follow Up Period|Incarcerated|2|||
124941711|NCT05886777|449413248|FG000|Overall Study|Lost to Follow-up|1|||
124941712|NCT05886777|449413249|FG001|Overall Study|Lost to Follow-up|0|||
124941713|NCT05886777|449413250|FG002|Overall Study|Lost to Follow-up|2|||
124941714|NCT05886777|449413251|FG003|Overall Study|Lost to Follow-up|1|||
124547277|NCT03286426|447958828|FG000|Overall Study|Physician Decision|3|||
124547278|NCT03514121|447958829|FG000|Overall Study|Withdrawal by Subject|0|||
124547279|NCT03514121|447958830|FG001|Overall Study|Withdrawal by Subject|0|||
124704218|NCT00721110|448539339|FG003|Overall Study|Ultram use|0|||
124704219|NCT00721110|448539336|FG000|Overall Study|vertical incision|0|||
124704220|NCT00721110|448539337|FG001|Overall Study|vertical incision|0|||
124941715|NCT05886777|449413252|FG004|Overall Study|Lost to Follow-up|0|||
124704221|NCT00721110|448539338|FG002|Overall Study|vertical incision|1|||
124704222|NCT00721110|448539339|FG003|Overall Study|vertical incision|0|||
124765092|NCT03409796|448767302|FG000|Overall Study|Other|0|||
124941716|NCT05886777|449413253|FG005|Overall Study|Lost to Follow-up|2|||
124765093|NCT03409796|448767303|FG001|Overall Study|Other|1|||
124941717|NCT05886777|449413254|FG006|Overall Study|Lost to Follow-up|0|||
124941718|NCT05886777|449413248|FG000|Overall Study|Other|0|||
124547280|NCT03514121|447958831|FG002|Overall Study|Withdrawal by Subject|0|||
124547281|NCT03514121|447958832|FG003|Overall Study|Withdrawal by Subject|0|||
124547282|NCT03514121|447958833|FG004|Overall Study|Withdrawal by Subject|1|||
124765094|NCT00740220|448767304|FG000|Overall Study|screen failures (non-COPD patients)|9|||
124765095|NCT01602224|448767305|FG000|Overall Study|Adverse Event|0|||
124765096|NCT01602224|448767306|FG001|Overall Study|Adverse Event|1|||
124765097|NCT01602224|448767307|FG002|Overall Study|Adverse Event|0|||
124765098|NCT01602224|448767305|FG000|Overall Study|Investigator Decison|1|||
124941719|NCT05886777|449413249|FG001|Overall Study|Other|2|||
124941720|NCT05886777|449413250|FG002|Overall Study|Other|1|||
124941721|NCT05886777|449413251|FG003|Overall Study|Other|0|||
124704223|NCT01605097|448539340|FG000|Overall Study|Protocol Violation|1|||
124704224|NCT02038647|448539341|FG000|Overall Study|Progressive Disease|50|||
124704225|NCT02038647|448539342|FG001|Overall Study|Progressive Disease|59|||
124704226|NCT02038647|448539341|FG000|Overall Study|Adverse Event|18|||
124704227|NCT02038647|448539342|FG001|Overall Study|Adverse Event|10|||
124704228|NCT02038647|448539341|FG000|Overall Study|Symptomatic Deterioration|7|||
124704229|NCT02038647|448539342|FG001|Overall Study|Symptomatic Deterioration|7|||
124704230|NCT02038647|448539341|FG000|Overall Study|Withdrawal by Subject|5|||
124704231|NCT02038647|448539342|FG001|Overall Study|Withdrawal by Subject|2|||
124704232|NCT02038647|448539341|FG000|Overall Study|Not Reported|0|||
124704233|NCT02038647|448539342|FG001|Overall Study|Not Reported|1|||
124704234|NCT02038647|448539341|FG000|Overall Study|Ongoing at Datacut|9|||
124704235|NCT02038647|448539342|FG001|Overall Study|Ongoing at Datacut|10|||
124704236|NCT02757430|448539343|FG000|Overall Study|Physician Decision|6|||
124704237|NCT02757430|448539343|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
124765099|NCT01602224|448767306|FG001|Overall Study|Investigator Decison|0|||
124941722|NCT05886777|449413252|FG004|Overall Study|Other|0|||
124941723|NCT05886777|449413253|FG005|Overall Study|Other|0|||
124941724|NCT05886777|449413254|FG006|Overall Study|Other|0|||
124941725|NCT05886777|449413248|FG000|Overall Study|Withdrawal by Subject|1|||
124941726|NCT05886777|449413249|FG001|Overall Study|Withdrawal by Subject|0|||
124941727|NCT05886777|449413250|FG002|Overall Study|Withdrawal by Subject|1|||
124941728|NCT05886777|449413251|FG003|Overall Study|Withdrawal by Subject|4|||
124941729|NCT05886777|449413252|FG004|Overall Study|Withdrawal by Subject|3|||
124941730|NCT05886777|449413253|FG005|Overall Study|Withdrawal by Subject|1|||
124941731|NCT05886777|449413254|FG006|Overall Study|Withdrawal by Subject|1|||
124941732|NCT05886777|449413248|FG000|Overall Study|Protocol Violation|0|||
124941733|NCT05886777|449413249|FG001|Overall Study|Protocol Violation|0|||
124941734|NCT05886777|449413250|FG002|Overall Study|Protocol Violation|1|||
124941735|NCT05886777|449413251|FG003|Overall Study|Protocol Violation|0|||
124941736|NCT05886777|449413252|FG004|Overall Study|Protocol Violation|0|||
124941737|NCT05886777|449413253|FG005|Overall Study|Protocol Violation|0|||
124941738|NCT05886777|449413254|FG006|Overall Study|Protocol Violation|0|||
124941739|NCT05886777|449413248|FG000|Overall Study|No longer met eligibility criteria|0|||
124941740|NCT05886777|449413249|FG001|Overall Study|No longer met eligibility criteria|1|||
124941741|NCT05886777|449413250|FG002|Overall Study|No longer met eligibility criteria|0|||
124941742|NCT05886777|449413251|FG003|Overall Study|No longer met eligibility criteria|0|||
124941743|NCT05886777|449413252|FG004|Overall Study|No longer met eligibility criteria|0|||
124941744|NCT05886777|449413253|FG005|Overall Study|No longer met eligibility criteria|0|||
124941745|NCT05886777|449413254|FG006|Overall Study|No longer met eligibility criteria|0|||
124941746|NCT03664804|449413256|FG000|Overall Study|Withdrawal by Subject|7|||
124941747|NCT03002194|449414784|FG000|Overall Study|Lost to Follow-up|6|||
124941748|NCT03002194|449414784|FG000|Overall Study|Adverse Event|1|||
124941749|NCT03002194|449414784|FG000|Overall Study|Lack of Efficacy|1|||
124941750|NCT03002194|449414784|FG000|Overall Study|Withdrawal by Subject|2|||
124941751|NCT00048932|449414785|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
124941752|NCT00048932|449414786|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
124941753|NCT00048932|449414787|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
124941754|NCT00048932|449414785|FG000|Double Blind Period (DB)|Adverse Event|51|||
124941755|NCT00048932|449414786|FG001|Double Blind Period (DB)|Adverse Event|19|||
124941756|NCT00048932|449414787|FG002|Double Blind Period (DB)|Adverse Event|0|||
124941757|NCT00048932|449414785|FG000|Double Blind Period (DB)|Death|5|||
124941758|NCT00048932|449414786|FG001|Double Blind Period (DB)|Death|3|||
124941759|NCT00048932|449414787|FG002|Double Blind Period (DB)|Death|0|||
124941760|NCT00048932|449414785|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
124941761|NCT00048932|449414786|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
124941762|NCT00048932|449414787|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
124941763|NCT00048932|449414785|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
124941764|NCT00048932|449414786|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
124941765|NCT00048932|449414787|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
124941766|NCT00048932|449414785|FG000|Double Blind Period (DB)|Relocation|1|||
124941767|NCT00048932|449414786|FG001|Double Blind Period (DB)|Relocation|0|||
124941768|NCT00048932|449414787|FG002|Double Blind Period (DB)|Relocation|0|||
124941769|NCT00048932|449414785|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
124704238|NCT02757430|448539343|FG000|Overall Study|No informed consent|1|||
124704239|NCT02757430|448539343|FG000|Overall Study|No procedure performed|2|||
124704240|NCT02082977|448539344|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
124704241|NCT02082977|448539345|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
124704242|NCT02082977|448539346|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
124704243|NCT02082977|448539347|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
124704244|NCT02082977|448539348|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
124704245|NCT02082977|448539349|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
124704246|NCT02082977|448539350|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
124704247|NCT02082977|448539351|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
124704248|NCT02082977|448539352|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
124704249|NCT02082977|448539353|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
124704250|NCT02082977|448539344|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
124704251|NCT02082977|448539345|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
124704252|NCT02082977|448539346|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
124704253|NCT02082977|448539347|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
124704254|NCT02082977|448539348|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
124704255|NCT02082977|448539349|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
124704256|NCT02082977|448539350|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
124704257|NCT02082977|448539351|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
124704258|NCT02082977|448539352|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
124704259|NCT02082977|448539353|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
124704260|NCT02082977|448539344|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
124704261|NCT02082977|448539345|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
124704262|NCT02082977|448539346|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
124704263|NCT02082977|448539347|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
124704264|NCT02082977|448539348|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
124704265|NCT02082977|448539349|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
124704266|NCT02082977|448539350|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
124704267|NCT02082977|448539351|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
124704268|NCT02082977|448539352|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
124704269|NCT02082977|448539353|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
124704270|NCT02082977|448539344|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
124704271|NCT02082977|448539345|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
124704272|NCT02082977|448539346|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
124704273|NCT02082977|448539347|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
124457671|NCT04766021|447636646|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
124457672|NCT00789529|447636648|FG000|Overall Study|Withdrawal by Subject|0|||
124704274|NCT02082977|448539348|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
124704275|NCT02082977|448539349|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
124704276|NCT02082977|448539350|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
124704277|NCT02082977|448539351|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
124704278|NCT02082977|448539352|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
124704279|NCT02082977|448539353|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
124704280|NCT02082977|448539344|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
124704281|NCT02082977|448539345|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
124704282|NCT02082977|448539346|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
124704283|NCT02082977|448539347|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
124704284|NCT02082977|448539348|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
124704285|NCT02082977|448539349|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
124704286|NCT02082977|448539350|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
124704287|NCT02082977|448539351|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
124704288|NCT02082977|448539352|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
124704289|NCT02082977|448539353|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
124704290|NCT05852340|448539354|FG000|Period 5|Not completing the meal|0|||
124704291|NCT05852340|448539355|FG001|Period 5|Not completing the meal|1|||
124457673|NCT00789529|447636649|FG001|Overall Study|Withdrawal by Subject|1|||
124457674|NCT00789529|447636648|FG000|Overall Study|Other Reason|1|||
124457675|NCT00789529|447636649|FG001|Overall Study|Other Reason|0|||
124457676|NCT00573430|447636658|FG000|Overall Study|Incorrect enrollment of randomization|0|||
124457677|NCT00573430|447636659|FG001|Overall Study|Incorrect enrollment of randomization|4|||
124457678|NCT00573430|447636660|FG002|Overall Study|Incorrect enrollment of randomization|3|||
124457679|NCT00573430|447636658|FG000|Overall Study|Adverse Event|0|||
124457680|NCT00573430|447636659|FG001|Overall Study|Adverse Event|0|||
124704292|NCT05852340|448539356|FG002|Period 5|Not completing the meal|0|||
124704293|NCT05852340|448539357|FG003|Period 5|Not completing the meal|0|||
124457681|NCT00573430|447636660|FG002|Overall Study|Adverse Event|2|||
124704294|NCT05852340|448539354|FG000|Period 5|Adverse Event|0|||
124704295|NCT05852340|448539355|FG001|Period 5|Adverse Event|0|||
124704296|NCT05852340|448539356|FG002|Period 5|Adverse Event|0|||
124704297|NCT05852340|448539357|FG003|Period 5|Adverse Event|1|||
124704298|NCT01397253|448540847|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
124704299|NCT01397253|448540848|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
124704300|NCT02546323|448540855|FG000|Overall Study|Withdrawal by Subject|36|||
124547283|NCT03514121|447958834|FG005|Overall Study|Withdrawal by Subject|2|||
124547284|NCT03514121|447958835|FG006|Overall Study|Withdrawal by Subject|1|||
124547285|NCT03514121|447958836|FG007|Overall Study|Withdrawal by Subject|1|||
124547286|NCT03514121|447958837|FG008|Overall Study|Withdrawal by Subject|7|||
124547287|NCT03514121|447958838|FG009|Overall Study|Withdrawal by Subject|2|||
124547288|NCT03514121|447958829|FG000|Overall Study|Death|0|||
124547289|NCT03514121|447958830|FG001|Overall Study|Death|0|||
124547290|NCT03514121|447958831|FG002|Overall Study|Death|0|||
124547291|NCT03514121|447958832|FG003|Overall Study|Death|0|||
124547292|NCT03514121|447958833|FG004|Overall Study|Death|0|||
124547293|NCT03514121|447958834|FG005|Overall Study|Death|3|||
124547294|NCT03514121|447958835|FG006|Overall Study|Death|2|||
124547295|NCT03514121|447958836|FG007|Overall Study|Death|1|||
124547296|NCT03514121|447958837|FG008|Overall Study|Death|26|||
124547297|NCT03514121|447958838|FG009|Overall Study|Death|3|||
124547298|NCT03514121|447958829|FG000|Overall Study|Lost to Follow-up|0|||
124547299|NCT03514121|447958830|FG001|Overall Study|Lost to Follow-up|0|||
124547300|NCT03514121|447958831|FG002|Overall Study|Lost to Follow-up|1|||
124547301|NCT03514121|447958832|FG003|Overall Study|Lost to Follow-up|0|||
124547302|NCT03514121|447958833|FG004|Overall Study|Lost to Follow-up|0|||
124547303|NCT03514121|447958834|FG005|Overall Study|Lost to Follow-up|0|||
124547304|NCT03514121|447958835|FG006|Overall Study|Lost to Follow-up|0|||
124547305|NCT03514121|447958836|FG007|Overall Study|Lost to Follow-up|0|||
124547306|NCT03514121|447958837|FG008|Overall Study|Lost to Follow-up|1|||
124547307|NCT03514121|447958838|FG009|Overall Study|Lost to Follow-up|0|||
124547308|NCT03514121|447958829|FG000|Overall Study|Adverse Event|0|||
124547309|NCT03514121|447958830|FG001|Overall Study|Adverse Event|0|||
124547310|NCT03514121|447958831|FG002|Overall Study|Adverse Event|0|||
124547311|NCT03514121|447958832|FG003|Overall Study|Adverse Event|0|||
124547312|NCT03514121|447958833|FG004|Overall Study|Adverse Event|0|||
124547313|NCT03514121|447958834|FG005|Overall Study|Adverse Event|0|||
124547314|NCT03514121|447958835|FG006|Overall Study|Adverse Event|1|||
124547315|NCT03514121|447958836|FG007|Overall Study|Adverse Event|0|||
124547316|NCT03514121|447958837|FG008|Overall Study|Adverse Event|0|||
124547317|NCT03514121|447958838|FG009|Overall Study|Adverse Event|0|||
124547318|NCT03514121|447958829|FG000|Overall Study|Other|0|||
124547319|NCT03514121|447958830|FG001|Overall Study|Other|1|||
124547320|NCT03514121|447958831|FG002|Overall Study|Other|1|||
124547321|NCT03514121|447958832|FG003|Overall Study|Other|0|||
124547322|NCT03514121|447958833|FG004|Overall Study|Other|1|||
124547323|NCT03514121|447958834|FG005|Overall Study|Other|2|||
124547324|NCT03514121|447958835|FG006|Overall Study|Other|3|||
124547325|NCT03514121|447958836|FG007|Overall Study|Other|2|||
124547326|NCT03514121|447958837|FG008|Overall Study|Other|7|||
124547327|NCT03514121|447958838|FG009|Overall Study|Other|3|||
124547328|NCT03514121|447958829|FG000|Overall Study|Study termination by Sponsor|0|||
124547329|NCT03514121|447958830|FG001|Overall Study|Study termination by Sponsor|0|||
124547330|NCT03514121|447958831|FG002|Overall Study|Study termination by Sponsor|0|||
124547331|NCT03514121|447958832|FG003|Overall Study|Study termination by Sponsor|0|||
124547332|NCT03514121|447958833|FG004|Overall Study|Study termination by Sponsor|0|||
124547333|NCT03514121|447958834|FG005|Overall Study|Study termination by Sponsor|0|||
124547334|NCT03514121|447958835|FG006|Overall Study|Study termination by Sponsor|0|||
124547335|NCT03514121|447958836|FG007|Overall Study|Study termination by Sponsor|0|||
124547336|NCT03514121|447958837|FG008|Overall Study|Study termination by Sponsor|11|||
124547337|NCT03514121|447958838|FG009|Overall Study|Study termination by Sponsor|3|||
124547338|NCT03514121|447958829|FG000|Overall Study|Investigator decision|0|||
124547339|NCT03514121|447958830|FG001|Overall Study|Investigator decision|0|||
124547340|NCT03514121|447958831|FG002|Overall Study|Investigator decision|0|||
124547341|NCT03514121|447958832|FG003|Overall Study|Investigator decision|0|||
124547342|NCT03514121|447958833|FG004|Overall Study|Investigator decision|0|||
124547343|NCT03514121|447958834|FG005|Overall Study|Investigator decision|0|||
124547344|NCT03514121|447958835|FG006|Overall Study|Investigator decision|0|||
124547345|NCT03514121|447958836|FG007|Overall Study|Investigator decision|0|||
124547346|NCT03514121|447958837|FG008|Overall Study|Investigator decision|1|||
124704301|NCT02546323|448540856|FG001|Overall Study|Withdrawal by Subject|33|||
124704302|NCT02546323|448540855|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
124704303|NCT02546323|448540856|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
124704304|NCT02546323|448540855|FG000|Overall Study|Adverse Event|17|||
124704305|NCT02546323|448540856|FG001|Overall Study|Adverse Event|11|||
124704306|NCT02546323|448540855|FG000|Overall Study|Patient Specific Reasons|1|||
124704307|NCT02546323|448540856|FG001|Overall Study|Patient Specific Reasons|2|||
124704308|NCT02546323|448540855|FG000|Overall Study|Lost to Follow-up|2|||
124704309|NCT02546323|448540856|FG001|Overall Study|Lost to Follow-up|3|||
124704310|NCT02546323|448540855|FG000|Overall Study|Non-compliance with Study Drug|2|||
124941770|NCT00048932|449414786|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
124941771|NCT00048932|449414787|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
124941772|NCT00048932|449414785|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
124941773|NCT00048932|449414786|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
124941774|NCT00048932|449414787|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
124941775|NCT00048932|449414785|FG000|Double Blind Period (DB)|Pregnancy|1|||
124941776|NCT00048932|449414786|FG001|Double Blind Period (DB)|Pregnancy|0|||
124704311|NCT02546323|448540856|FG001|Overall Study|Non-compliance with Study Drug|2|||
124704312|NCT02546323|448540855|FG000|Overall Study|Met Withdrawal Criteria|2|||
124704313|NCT02546323|448540856|FG001|Overall Study|Met Withdrawal Criteria|14|||
124704314|NCT01055028|448540857|FG000|Screening|Screen Failure|1|||
124704315|NCT01055028|448540858|FG001|Screening|Screen Failure|1|||
124704316|NCT01055028|448540857|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
124704317|NCT01055028|448540858|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
124704318|NCT01055028|448540857|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
124704319|NCT01055028|448540858|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
124704320|NCT01055028|448540857|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
124941777|NCT00048932|449414787|FG002|Double Blind Period (DB)|Pregnancy|0|||
124941778|NCT00048932|449414785|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
124704321|NCT01055028|448540858|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
124704322|NCT03559530|448540859|FG000|Overall Study|non-location of medical records|44|||
124704323|NCT03559530|448540860|FG001|Overall Study|non-location of medical records|0|||
124704324|NCT03559530|448540859|FG000|Overall Study|culture results not considered for treat|29|||
124704325|NCT03559530|448540860|FG001|Overall Study|culture results not considered for treat|0|||
124704326|NCT03559530|448540859|FG000|Overall Study|duplicate cases|8|||
124704327|NCT03559530|448540860|FG001|Overall Study|duplicate cases|0|||
124704328|NCT03559530|448540859|FG000|Overall Study|other species of Acinetobacte|7|||
124704329|NCT03559530|448540860|FG001|Overall Study|other species of Acinetobacte|0|||
124704330|NCT03559530|448540859|FG000|Overall Study|contamination / colonization|3|||
124704331|NCT03559530|448540860|FG001|Overall Study|contamination / colonization|0|||
124704332|NCT01362790|448540861|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
124704333|NCT01362790|448540862|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
124704334|NCT01362790|448540863|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
124704335|NCT01362790|448540864|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
124704336|NCT01362790|448540865|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
124704337|NCT01362790|448540866|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
124704338|NCT01362790|448540867|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
124704339|NCT01362790|448540861|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
124704340|NCT01362790|448540862|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
124704341|NCT01362790|448540863|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
124704342|NCT01362790|448540864|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
124704343|NCT01362790|448540865|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
124547347|NCT03514121|447958838|FG009|Overall Study|Investigator decision|0|||
124547348|NCT03286400|447958842|FG000|Overall Study|Death|10|||
124547349|NCT03286400|447958842|FG000|Overall Study|Lost to Follow-up|10|||
124547350|NCT03286400|447958842|FG000|Overall Study|Physician Decision|1|||
124547351|NCT03286400|447958842|FG000|Overall Study|Scheduling difficulty|4|||
124547352|NCT00826176|447958845|FG000|Overall Study|Lost to Follow-up|1|||
124547353|NCT00826176|447958846|FG001|Overall Study|Lost to Follow-up|0|||
124547354|NCT00826176|447958845|FG000|Overall Study|Subject Withdrew Consent|3|||
124547355|NCT00826176|447958846|FG001|Overall Study|Subject Withdrew Consent|0|||
124547356|NCT00826176|447958845|FG000|Overall Study|Administrative|9|||
124547357|NCT00826176|447958846|FG001|Overall Study|Administrative|0|||
124547358|NCT00297882|447958851|FG000|Day 14|Lack of Efficacy|12|||
124547359|NCT00297882|447958852|FG001|Day 14|Lack of Efficacy|49|||
124547360|NCT00297882|447958851|FG000|Day 28|Lost to Follow-up|13|||
124547361|NCT00297882|447958852|FG001|Day 28|Lost to Follow-up|23|||
124547362|NCT00297882|447958851|FG000|Day 28|Lack of Efficacy|3|||
124547363|NCT00297882|447958852|FG001|Day 28|Lack of Efficacy|0|||
124547364|NCT04484805|447958853|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
124547365|NCT04484805|447958854|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
124547366|NCT04484805|447958853|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
124704344|NCT01362790|448540866|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
124704345|NCT01362790|448540867|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
124941779|NCT00048932|449414786|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
124941780|NCT00048932|449414787|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
124941781|NCT00048932|449414785|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
124941782|NCT00048932|449414786|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
124941783|NCT00048932|449414787|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
124704346|NCT01362790|448540861|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
124704347|NCT01362790|448540862|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
124941784|NCT00048932|449414785|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
124941785|NCT00048932|449414786|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
124941786|NCT00048932|449414787|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
124941787|NCT00048932|449414785|FG000|Open Label Period (OL)|Death|0|||
124941788|NCT00048932|449414786|FG001|Open Label Period (OL)|Death|0|||
124941789|NCT00048932|449414787|FG002|Open Label Period (OL)|Death|25|||
124941790|NCT00048932|449414785|FG000|Open Label Period (OL)|Adverse Event|0|||
124704348|NCT01362790|448540863|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
124704349|NCT01362790|448540864|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
124704350|NCT01362790|448540865|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
124704351|NCT01362790|448540866|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
124704352|NCT01362790|448540867|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
124704353|NCT01362790|448540861|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
124704354|NCT01362790|448540862|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
124704355|NCT01362790|448540863|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
124704356|NCT01362790|448540864|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
124704357|NCT01362790|448540865|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
124704358|NCT01362790|448540866|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
124704359|NCT01362790|448540867|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
124704360|NCT01362790|448540861|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
124704361|NCT01362790|448540862|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
124704362|NCT01362790|448540863|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
124704363|NCT01362790|448540864|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
124704364|NCT01362790|448540865|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
124704365|NCT01362790|448540866|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
124704366|NCT01362790|448540867|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
124704367|NCT01362790|448540861|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
124704368|NCT01362790|448540862|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
124704369|NCT01362790|448540863|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
124704370|NCT01362790|448540864|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
124704371|NCT01362790|448540865|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
124547367|NCT04484805|447958854|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
124547368|NCT04139642|447958856|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
124704372|NCT01362790|448540866|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
124704373|NCT01362790|448540867|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
124704374|NCT01362790|448540861|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
124704375|NCT01362790|448540862|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
124704376|NCT01362790|448540863|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
124704377|NCT01362790|448540864|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
124704378|NCT01362790|448540865|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
124704379|NCT01362790|448540866|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
124704380|NCT01362790|448540867|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
124704381|NCT01362790|448540861|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
124704382|NCT01362790|448540862|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
124704383|NCT01362790|448540863|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
124704384|NCT01362790|448540864|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
124704385|NCT01362790|448540865|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
124704386|NCT01362790|448540866|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
124704387|NCT01362790|448540867|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
124704388|NCT01362790|448540861|FG000|Pilot Phase & Phase 2|Death on study|0|||
124704389|NCT01362790|448540862|FG001|Pilot Phase & Phase 2|Death on study|0|||
124704390|NCT01362790|448540863|FG002|Pilot Phase & Phase 2|Death on study|0|||
124704391|NCT01362790|448540864|FG003|Pilot Phase & Phase 2|Death on study|1|||
124704392|NCT01362790|448540865|FG004|Pilot Phase & Phase 2|Death on study|0|||
124704393|NCT01362790|448540866|FG005|Pilot Phase & Phase 2|Death on study|0|||
124704394|NCT01362790|448540867|FG006|Pilot Phase & Phase 2|Death on study|0|||
124704395|NCT01362790|448540861|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
124704396|NCT01362790|448540862|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
124704397|NCT01362790|448540863|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
124704398|NCT01362790|448540864|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
124704399|NCT01362790|448540865|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
124704400|NCT01362790|448540866|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
124704401|NCT01362790|448540867|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
124457682|NCT00573430|447636658|FG000|Overall Study|Withdrawal by Subject|1|||
124457683|NCT00573430|447636659|FG001|Overall Study|Withdrawal by Subject|0|||
124457684|NCT00573430|447636660|FG002|Overall Study|Withdrawal by Subject|1|||
124457685|NCT00573430|447636658|FG000|Overall Study|Protocol Violation|0|||
124457686|NCT00573430|447636659|FG001|Overall Study|Protocol Violation|1|||
124457687|NCT00573430|447636660|FG002|Overall Study|Protocol Violation|1|||
124457688|NCT00573430|447636658|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124457689|NCT00573430|447636659|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124457690|NCT00573430|447636660|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
124457691|NCT04962022|447636662|FG000|Period 1|Withdrawal by Subject|1|||
124457692|NCT04962022|447636663|FG001|Period 1|Withdrawal by Subject|0|||
124457693|NCT01146873|447636669|FG000|Overall Study|Transfer out|0|||
124457694|NCT01146873|447636670|FG001|Overall Study|Transfer out|6|||
124704402|NCT01362790|448540861|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
124457695|NCT01967628|447636671|FG000|Overall Study|Withdrawal by Subject|2|||
124457696|NCT01967628|447636672|FG001|Overall Study|Withdrawal by Subject|0|||
124457697|NCT01967628|447636671|FG000|Overall Study|Unable to complete bronchoscopy|4|||
124457698|NCT01967628|447636672|FG001|Overall Study|Unable to complete bronchoscopy|6|||
124457699|NCT01967628|447636671|FG000|Overall Study|Lost to Follow-up|1|||
124457700|NCT01967628|447636672|FG001|Overall Study|Lost to Follow-up|0|||
124457701|NCT01967628|447636671|FG000|Overall Study|Low protein concentration in sample|20|||
124457702|NCT01967628|447636672|FG001|Overall Study|Low protein concentration in sample|25|||
124457703|NCT01356407|447636673|FG000|Overall Study|Lost to Follow-up|2|||
124457704|NCT01356407|447636674|FG001|Overall Study|Lost to Follow-up|0|||
124457705|NCT01356407|447636673|FG000|Overall Study|Patient Withdrew Consent|2|||
124457706|NCT01356407|447636674|FG001|Overall Study|Patient Withdrew Consent|1|||
124457707|NCT01356407|447636673|FG000|Overall Study|Could not afford IMP administration|0|||
124457708|NCT01356407|447636674|FG001|Overall Study|Could not afford IMP administration|1|||
124457709|NCT01356407|447636673|FG000|Overall Study|Not complete Endoscopy|2|||
124457710|NCT01356407|447636674|FG001|Overall Study|Not complete Endoscopy|2|||
124457711|NCT02055820|447636675|FG000|Phase I: Dose-Finding|Death|1|||
124457712|NCT02055820|447636676|FG001|Phase I: Dose-Finding|Death|0|||
124457713|NCT02055820|447636677|FG002|Phase I: Dose-Finding|Death|1|||
124457714|NCT02055820|447636678|FG003|Phase I: Dose-Finding|Death|2|||
124457715|NCT02055820|447636679|FG004|Phase I: Dose-Finding|Death|0|||
124457716|NCT02055820|447636680|FG005|Phase I: Dose-Finding|Death|1|||
124457717|NCT02055820|447636681|FG006|Phase I: Dose-Finding|Death|1|||
124457718|NCT02055820|447636682|FG007|Phase I: Dose-Finding|Death|0|||
124457719|NCT02055820|447636683|FG008|Phase I: Dose-Finding|Death|0|||
124457720|NCT02055820|447636684|FG009|Phase I: Dose-Finding|Death|0|||
124457721|NCT02055820|447636675|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
124457722|NCT02055820|447636676|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
124547369|NCT04139642|447958857|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
124704403|NCT01362790|448540862|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
124704404|NCT01362790|448540863|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
124704405|NCT01362790|448540864|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
124704406|NCT01362790|448540865|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
124704407|NCT01362790|448540866|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
124704408|NCT01362790|448540867|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
124704409|NCT01362790|448540861|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
124704410|NCT01362790|448540862|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
124704411|NCT01362790|448540863|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
124704412|NCT01362790|448540864|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
124704413|NCT01362790|448540865|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
124704414|NCT01362790|448540866|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
124704415|NCT01362790|448540867|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
124704416|NCT02457065|448540868|FG000|Overall Study|Lost to Follow-up|9|||
124457723|NCT02055820|447636677|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
124457724|NCT02055820|447636678|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
124457725|NCT02055820|447636679|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
124457726|NCT02055820|447636680|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
124457727|NCT02055820|447636681|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
124457728|NCT02055820|447636682|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
124457729|NCT02055820|447636683|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
124457730|NCT02055820|447636684|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
124457731|NCT02055820|447636675|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
124457732|NCT02055820|447636676|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
124457733|NCT02055820|447636677|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
124457734|NCT02055820|447636678|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
124457735|NCT02055820|447636679|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
124704417|NCT02457065|448540869|FG001|Overall Study|Lost to Follow-up|11|||
124457736|NCT02055820|447636680|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
124547370|NCT00433771|447958859|FG000|Overall Study|screen fail|14|||
124704418|NCT05805150|448540871|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
124704419|NCT05805150|448540872|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
124704420|NCT01506726|448540878|FG000|Overall Study|Adverse Event|1|||
124704421|NCT01506726|448540879|FG001|Overall Study|Adverse Event|2|||
124704422|NCT04347538|448540883|FG000|Overall Study|Lost to Follow-up|4|||
124704423|NCT04347538|448540884|FG001|Overall Study|Lost to Follow-up|5|||
124704424|NCT04347538|448540885|FG002|Overall Study|Lost to Follow-up|7|||
124704425|NCT02135133|448540886|FG000|Overall Study|Adverse Event|10|||
124704426|NCT02135133|448540886|FG000|Overall Study|regulatory mandate|5|||
124704427|NCT02259231|448540887|FG000|Overall Study|Adverse Event|1|||
124704428|NCT02259231|448540888|FG001|Overall Study|Adverse Event|1|||
124704429|NCT02259231|448540889|FG002|Overall Study|Adverse Event|2|||
124704430|NCT02259231|448540890|FG003|Overall Study|Adverse Event|0|||
124704431|NCT02259231|448540891|FG004|Overall Study|Adverse Event|0|||
124704432|NCT02259231|448540892|FG005|Overall Study|Adverse Event|0|||
124704433|NCT02259231|448540893|FG006|Overall Study|Adverse Event|0|||
124704434|NCT02259231|448540887|FG000|Overall Study|Progressive Disease|4|||
124704435|NCT02259231|448540888|FG001|Overall Study|Progressive Disease|5|||
124704436|NCT02259231|448540889|FG002|Overall Study|Progressive Disease|4|||
124704437|NCT02259231|448540890|FG003|Overall Study|Progressive Disease|5|||
124704438|NCT02259231|448540891|FG004|Overall Study|Progressive Disease|4|||
124704439|NCT02259231|448540892|FG005|Overall Study|Progressive Disease|5|||
124704440|NCT02259231|448540893|FG006|Overall Study|Progressive Disease|4|||
124704441|NCT02259231|448540887|FG000|Overall Study|Sponsor termination of study|1|||
124704442|NCT02259231|448540888|FG001|Overall Study|Sponsor termination of study|0|||
124704443|NCT02259231|448540889|FG002|Overall Study|Sponsor termination of study|0|||
124704444|NCT02259231|448540890|FG003|Overall Study|Sponsor termination of study|1|||
124704445|NCT02259231|448540891|FG004|Overall Study|Sponsor termination of study|2|||
124704446|NCT02259231|448540892|FG005|Overall Study|Sponsor termination of study|1|||
124704447|NCT02259231|448540893|FG006|Overall Study|Sponsor termination of study|1|||
124704448|NCT05081843|448540894|FG000|Overall Study|Lost to Follow-up|135|||
124704449|NCT05081843|448540895|FG001|Overall Study|Lost to Follow-up|145|||
124704450|NCT02303821|448540896|FG000|Overall Study|Withdrawal by Subject|0|||
124704451|NCT02303821|448540897|FG001|Overall Study|Withdrawal by Subject|0|||
124704452|NCT02303821|448540898|FG002|Overall Study|Withdrawal by Subject|0|||
124704453|NCT02303821|448540899|FG003|Overall Study|Withdrawal by Subject|0|||
124704454|NCT02303821|448540900|FG004|Overall Study|Withdrawal by Subject|0|||
124704455|NCT02303821|448540901|FG005|Overall Study|Withdrawal by Subject|0|||
124704456|NCT02303821|448540902|FG006|Overall Study|Withdrawal by Subject|0|||
124704457|NCT02303821|448540903|FG007|Overall Study|Withdrawal by Subject|2|||
124704458|NCT02303821|448540896|FG000|Overall Study|Death|0|||
124704459|NCT02303821|448540897|FG001|Overall Study|Death|2|||
124704460|NCT02303821|448540898|FG002|Overall Study|Death|0|||
124704461|NCT02303821|448540899|FG003|Overall Study|Death|0|||
124704462|NCT02303821|448540900|FG004|Overall Study|Death|0|||
124704463|NCT02303821|448540901|FG005|Overall Study|Death|3|||
124704464|NCT02303821|448540902|FG006|Overall Study|Death|41|||
124704465|NCT02303821|448540903|FG007|Overall Study|Death|29|||
124704466|NCT02303821|448540896|FG000|Overall Study|Lost to Follow-up|0|||
124704467|NCT02303821|448540897|FG001|Overall Study|Lost to Follow-up|0|||
124704468|NCT02303821|448540898|FG002|Overall Study|Lost to Follow-up|0|||
124704469|NCT02303821|448540899|FG003|Overall Study|Lost to Follow-up|0|||
124704470|NCT02303821|448540900|FG004|Overall Study|Lost to Follow-up|0|||
124704471|NCT02303821|448540901|FG005|Overall Study|Lost to Follow-up|0|||
124704472|NCT02303821|448540902|FG006|Overall Study|Lost to Follow-up|1|||
124704473|NCT02303821|448540903|FG007|Overall Study|Lost to Follow-up|0|||
124704474|NCT02303821|448540896|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
124704475|NCT02303821|448540897|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
124704476|NCT02303821|448540898|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
124704477|NCT02303821|448540899|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
124941791|NCT00048932|449414786|FG001|Open Label Period (OL)|Adverse Event|0|||
124941792|NCT00048932|449414787|FG002|Open Label Period (OL)|Adverse Event|103|||
124941793|NCT00048932|449414785|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
124941794|NCT00048932|449414786|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
124941795|NCT00048932|449414787|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
124941796|NCT00048932|449414785|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
124941797|NCT00048932|449414786|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
124941798|NCT00048932|449414787|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
124704478|NCT02303821|448540900|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
124704479|NCT02303821|448540901|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
124704480|NCT02303821|448540902|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
124704481|NCT02303821|448540903|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
124704482|NCT02303821|448540896|FG000|Overall Study|Decision by sponsor|0|||
124704483|NCT02303821|448540897|FG001|Overall Study|Decision by sponsor|0|||
124704484|NCT02303821|448540898|FG002|Overall Study|Decision by sponsor|0|||
124704485|NCT02303821|448540899|FG003|Overall Study|Decision by sponsor|0|||
124547371|NCT00433771|447958859|FG000|Overall Study|Treated and later found to be ineligible|2|||
124547372|NCT00433771|447958859|FG000|Overall Study|Death|2|||
124547373|NCT00433771|447958859|FG000|Overall Study|Failure to deploy stent|1|||
124547374|NCT00539006|447958863|FG000|Pre-treatment|Other|0|||
124547375|NCT00539006|447958864|FG001|Pre-treatment|Other|1|||
124547376|NCT00539006|447958865|FG002|Pre-treatment|Other|0|||
124547377|NCT00539006|447958866|FG003|Pre-treatment|Other|0|||
124547378|NCT00539006|447958863|FG000|Treatment Period 1|Lost to Follow-up|0|||
124547379|NCT00539006|447958864|FG001|Treatment Period 1|Lost to Follow-up|0|||
124547380|NCT00539006|447958865|FG002|Treatment Period 1|Lost to Follow-up|1|||
124547381|NCT00539006|447958866|FG003|Treatment Period 1|Lost to Follow-up|0|||
124547382|NCT00539006|447958863|FG000|Treatment Period 1|Protocol Violation|0|||
124547383|NCT00539006|447958864|FG001|Treatment Period 1|Protocol Violation|0|||
124547384|NCT00539006|447958865|FG002|Treatment Period 1|Protocol Violation|1|||
124547385|NCT00539006|447958866|FG003|Treatment Period 1|Protocol Violation|0|||
124547386|NCT00539006|447958863|FG000|Treatment Period 1|Lack of Efficacy|0|||
124547387|NCT00539006|447958864|FG001|Treatment Period 1|Lack of Efficacy|0|||
124547388|NCT00539006|447958865|FG002|Treatment Period 1|Lack of Efficacy|0|||
124547389|NCT00539006|447958866|FG003|Treatment Period 1|Lack of Efficacy|1|||
124547390|NCT00539006|447958863|FG000|Washout|Adverse Event|2|||
124547391|NCT00539006|447958864|FG001|Washout|Adverse Event|1|||
124547392|NCT00539006|447958865|FG002|Washout|Adverse Event|0|||
124547393|NCT00539006|447958866|FG003|Washout|Adverse Event|0|||
124547394|NCT00539006|447958863|FG000|Washout|Protocol Violation|1|||
124547395|NCT00539006|447958864|FG001|Washout|Protocol Violation|1|||
124547396|NCT00539006|447958865|FG002|Washout|Protocol Violation|0|||
124547397|NCT00539006|447958866|FG003|Washout|Protocol Violation|0|||
124547398|NCT00539006|447958863|FG000|Washout|Withdrawal by Subject|0|||
124547399|NCT00539006|447958864|FG001|Washout|Withdrawal by Subject|2|||
124547400|NCT00539006|447958865|FG002|Washout|Withdrawal by Subject|0|||
124547401|NCT00539006|447958866|FG003|Washout|Withdrawal by Subject|0|||
124547402|NCT00539006|447958863|FG000|Washout|Failed to meet continuation criteria|16|||
124547403|NCT00539006|447958864|FG001|Washout|Failed to meet continuation criteria|5|||
124547404|NCT00539006|447958865|FG002|Washout|Failed to meet continuation criteria|14|||
124547405|NCT00539006|447958866|FG003|Washout|Failed to meet continuation criteria|6|||
124547406|NCT00539006|447958863|FG000|Washout|Other|1|||
124547407|NCT00539006|447958864|FG001|Washout|Other|1|||
124547408|NCT00539006|447958865|FG002|Washout|Other|2|||
124547409|NCT00539006|447958866|FG003|Washout|Other|3|||
124547410|NCT00539006|447958863|FG000|Treatment Period 2|Protocol Violation|1|||
124547411|NCT00539006|447958864|FG001|Treatment Period 2|Protocol Violation|0|||
124547412|NCT00539006|447958865|FG002|Treatment Period 2|Protocol Violation|0|||
124547413|NCT00539006|447958866|FG003|Treatment Period 2|Protocol Violation|0|||
124547414|NCT00539006|447958863|FG000|Treatment Period 2|Other|0|||
124547415|NCT00539006|447958864|FG001|Treatment Period 2|Other|1|||
124547416|NCT00539006|447958865|FG002|Treatment Period 2|Other|0|||
124547417|NCT00539006|447958866|FG003|Treatment Period 2|Other|0|||
124547418|NCT02353572|447958867|FG000|Overall Study|Withdrawal by Subject|1|||
124547419|NCT02353572|447958867|FG000|Overall Study|Study terminated|2|||
124547420|NCT01036594|447958875|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
124547421|NCT01036594|447958876|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
124547422|NCT01036594|447958875|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
124547423|NCT01036594|447958876|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
124547424|NCT01036594|447958875|FG000|Week 12 Evaluation|Adverse Event|5|||
124547425|NCT01036594|447958876|FG001|Week 12 Evaluation|Adverse Event|0|||
124547426|NCT01036594|447958875|FG000|Week 12 Evaluation|Physician Decision|1|||
124547427|NCT01036594|447958876|FG001|Week 12 Evaluation|Physician Decision|0|||
124547428|NCT01036594|447958875|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
124547429|NCT01036594|447958876|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
124547430|NCT01036594|447958875|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
124547431|NCT01036594|447958876|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
124547432|NCT01036594|447958875|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
124547433|NCT01036594|447958876|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
124547434|NCT01036594|447958875|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
124547435|NCT01036594|447958876|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
124547436|NCT01036594|447958875|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
124547437|NCT01036594|447958876|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
124547438|NCT01244516|447958879|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
124547439|NCT01244516|447958880|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
124704486|NCT02303821|448540900|FG004|Overall Study|Decision by sponsor|0|||
124547440|NCT01244516|447958881|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
124547441|NCT01244516|447958879|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
124704487|NCT02303821|448540901|FG005|Overall Study|Decision by sponsor|1|||
124547442|NCT01244516|447958880|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
124547443|NCT01244516|447958881|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
124704488|NCT02303821|448540902|FG006|Overall Study|Decision by sponsor|0|||
124457737|NCT02055820|447636681|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
124457738|NCT02055820|447636682|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
124457739|NCT02055820|447636683|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
124457740|NCT02055820|447636684|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
124457741|NCT02055820|447636675|FG000|Phase II: Expansion|Death|0|||
124457742|NCT02055820|447636676|FG001|Phase II: Expansion|Death|0|||
124457743|NCT02055820|447636677|FG002|Phase II: Expansion|Death|0|||
124457744|NCT02055820|447636678|FG003|Phase II: Expansion|Death|0|||
124457745|NCT02055820|447636679|FG004|Phase II: Expansion|Death|33|||
124457746|NCT02055820|447636680|FG005|Phase II: Expansion|Death|0|||
124457747|NCT02055820|447636681|FG006|Phase II: Expansion|Death|0|||
124457748|NCT02055820|447636682|FG007|Phase II: Expansion|Death|0|||
124457749|NCT02055820|447636683|FG008|Phase II: Expansion|Death|0|||
124457750|NCT02055820|447636684|FG009|Phase II: Expansion|Death|0|||
124457751|NCT02055820|447636675|FG000|Phase II: Expansion|Lost to Follow-up|0|||
124457752|NCT02055820|447636676|FG001|Phase II: Expansion|Lost to Follow-up|0|||
124457753|NCT02055820|447636677|FG002|Phase II: Expansion|Lost to Follow-up|0|||
124457754|NCT02055820|447636678|FG003|Phase II: Expansion|Lost to Follow-up|0|||
124457755|NCT02055820|447636679|FG004|Phase II: Expansion|Lost to Follow-up|4|||
124457756|NCT02055820|447636680|FG005|Phase II: Expansion|Lost to Follow-up|0|||
124457757|NCT02055820|447636681|FG006|Phase II: Expansion|Lost to Follow-up|0|||
124457758|NCT02055820|447636682|FG007|Phase II: Expansion|Lost to Follow-up|0|||
124457759|NCT02055820|447636683|FG008|Phase II: Expansion|Lost to Follow-up|0|||
124457760|NCT02055820|447636684|FG009|Phase II: Expansion|Lost to Follow-up|0|||
124457761|NCT02055820|447636675|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
124457762|NCT02055820|447636676|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
124457763|NCT02055820|447636677|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
124457764|NCT02055820|447636678|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
124457765|NCT02055820|447636679|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
124457766|NCT02055820|447636680|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
124457767|NCT02055820|447636681|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
124457768|NCT02055820|447636682|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
124457769|NCT02055820|447636683|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
124457770|NCT02055820|447636684|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
124457771|NCT02184195|447636695|FG000|Overall Study|Patient decision|5|||
124457772|NCT02184195|447636696|FG001|Overall Study|Patient decision|2|||
124457773|NCT02184195|447636695|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124457774|NCT02184195|447636696|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
124457775|NCT02184195|447636695|FG000|Overall Study|Death|67|||
124457776|NCT02184195|447636696|FG001|Overall Study|Death|44|||
124457777|NCT02184195|447636695|FG000|Overall Study|Lost to Follow-up|1|||
124457778|NCT02184195|447636696|FG001|Overall Study|Lost to Follow-up|5|||
124457779|NCT02184195|447636695|FG000|Overall Study|Other|0|||
124457780|NCT02184195|447636696|FG001|Overall Study|Other|3|||
124457781|NCT00133991|447636697|FG000|Overall Study|Death|4|||
124457782|NCT03002155|447636698|FG000|Overall Study|Lost to Follow-up|1|||
124457783|NCT03002155|447636699|FG001|Overall Study|Lost to Follow-up|2|||
124457784|NCT03002155|447636698|FG000|Overall Study|Withdrawal by Subject|1|||
124457785|NCT03002155|447636699|FG001|Overall Study|Withdrawal by Subject|0|||
124457786|NCT03002155|447636698|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
124457787|NCT03002155|447636699|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
124547444|NCT01244516|447958879|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
124547445|NCT01244516|447958880|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
124457788|NCT00978029|447636700|FG000|Overall Study|Adverse Event|1|||
124457789|NCT00978029|447636701|FG001|Overall Study|Adverse Event|2|||
124457790|NCT00978029|447636702|FG002|Overall Study|Adverse Event|5|||
124457791|NCT00978029|447636700|FG000|Overall Study|Withdrawal by Subject|0|||
124457792|NCT00978029|447636701|FG001|Overall Study|Withdrawal by Subject|0|||
124457793|NCT00978029|447636702|FG002|Overall Study|Withdrawal by Subject|1|||
124457794|NCT00978029|447636700|FG000|Overall Study|Protocol Violation|0|||
124457795|NCT00978029|447636701|FG001|Overall Study|Protocol Violation|1|||
124457796|NCT00978029|447636702|FG002|Overall Study|Protocol Violation|0|||
124457797|NCT00964743|447636703|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
124547446|NCT01244516|447958881|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
124457798|NCT01227044|447636706|FG000|Overall Study|Lost to Follow-up|5|||
124457799|NCT01227044|447636707|FG001|Overall Study|Lost to Follow-up|7|||
124457800|NCT01227044|447636706|FG000|Overall Study|Discontinued Intervention|1|||
124457801|NCT01227044|447636707|FG001|Overall Study|Discontinued Intervention|2|||
124457802|NCT00583362|447636708|FG000|Overall Study|Adverse Event|44|||
124457803|NCT00583362|447636708|FG000|Overall Study|Lack of Efficacy|22|||
124457804|NCT00583362|447636708|FG000|Overall Study|Lost to Follow-up|4|||
124457805|NCT00583362|447636708|FG000|Overall Study|Non-compliance with study drug|28|||
124457806|NCT00583362|447636708|FG000|Overall Study|Pregnancy|7|||
124457807|NCT00583362|447636708|FG000|Overall Study|Miscommunication of visit window|5|||
124547447|NCT01244516|447958879|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
124457808|NCT00583362|447636708|FG000|Overall Study|Current site closed|7|||
124457809|NCT00583362|447636708|FG000|Overall Study|Subject not dosed in LBSL99|1|||
124457810|NCT00583362|447636708|FG000|Overall Study|Subject moved out of the country/state|2|||
124457811|NCT00583362|447636708|FG000|Overall Study|Missed visits due to staff changes|1|||
124457812|NCT00583362|447636708|FG000|Overall Study|Misunderstanding of protocol|1|||
124457813|NCT00583362|447636708|FG000|Overall Study|Behavioral problems and non-compliance|1|||
124457814|NCT00583362|447636708|FG000|Overall Study|Sponsor request due to missed doses|1|||
124457815|NCT00583362|447636708|FG000|Overall Study|Physician Decision|19|||
124457816|NCT00583362|447636708|FG000|Overall Study|Protocol Violation|2|||
124457817|NCT00583362|447636708|FG000|Overall Study|Withdrawal by Subject|57|||
124457818|NCT00473343|447636709|FG000|Overall Study|Adverse Event|9|||
124457819|NCT00473343|447636709|FG000|Overall Study|Lost to Follow-up|8|||
124457820|NCT00473343|447636709|FG000|Overall Study|Treatment failure|27|||
124457821|NCT00473343|447636709|FG000|Overall Study|Withdrew consent|3|||
124457822|NCT00473343|447636709|FG000|Overall Study|Other un-specified reason|3|||
124457823|NCT02290873|447636714|FG000|Overall Study|Withdrawal by Subject|0|||
124457824|NCT02290873|447636715|FG001|Overall Study|Withdrawal by Subject|1|||
124457825|NCT02290873|447636716|FG002|Overall Study|Withdrawal by Subject|1|||
124457826|NCT02290873|447636714|FG000|Overall Study|Nellcor device error|1|||
124457827|NCT02290873|447636715|FG001|Overall Study|Nellcor device error|0|||
124457828|NCT02290873|447636716|FG002|Overall Study|Nellcor device error|0|||
124457829|NCT02290873|447636714|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
124457830|NCT02290873|447636715|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
124457831|NCT02290873|447636716|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
124457832|NCT02290873|447636714|FG000|Overall Study|Protocol Violation|0|||
124457833|NCT02290873|447636715|FG001|Overall Study|Protocol Violation|0|||
124457834|NCT02290873|447636716|FG002|Overall Study|Protocol Violation|1|||
124457835|NCT02370615|447636717|FG000|Overall Study|Adverse Event|1|||
124457836|NCT02370615|447636718|FG001|Overall Study|Adverse Event|0|||
124457837|NCT01378104|447636719|FG000|Overall Study|Adverse Event|8|||
124457838|NCT01378104|447636720|FG001|Overall Study|Adverse Event|8|||
124457839|NCT01378104|447636719|FG000|Overall Study|Lack of Efficacy|7|||
124457840|NCT01378104|447636720|FG001|Overall Study|Lack of Efficacy|5|||
124457841|NCT01378104|447636719|FG000|Overall Study|Withdrawal by Subject|12|||
124457842|NCT01378104|447636720|FG001|Overall Study|Withdrawal by Subject|13|||
124457843|NCT02287623|447636721|FG000|Overall Study|Protocol Violation|0|||
124457844|NCT02287623|447636722|FG001|Overall Study|Protocol Violation|1|||
124457845|NCT02700997|447636723|FG000|Overall Study|Did not undergo CT imaging|1|||
124457846|NCT02700997|447636723|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
124457847|NCT02354222|447636724|FG000|Overall Study|Adverse Event|0|||
124457848|NCT02354222|447636725|FG001|Overall Study|Adverse Event|3|||
124457849|NCT02354222|447636724|FG000|Overall Study|Physician Decision|1|||
124457850|NCT02354222|447636725|FG001|Overall Study|Physician Decision|1|||
124457851|NCT02354222|447636724|FG000|Overall Study|Pregnancy|1|||
124457852|NCT02354222|447636725|FG001|Overall Study|Pregnancy|0|||
124457853|NCT02354222|447636724|FG000|Overall Study|Withdrawal by Subject|2|||
124457854|NCT02354222|447636725|FG001|Overall Study|Withdrawal by Subject|3|||
124457855|NCT02354222|447636724|FG000|Overall Study|Conflict with the stopping criteria|0|||
124457856|NCT02354222|447636725|FG001|Overall Study|Conflict with the stopping criteria|4|||
124457857|NCT01342484|447636728|FG000|Overall Study|Other Reasons|1|||
124457858|NCT01342484|447636729|FG001|Overall Study|Other Reasons|0|||
124457859|NCT01342484|447636730|FG002|Overall Study|Other Reasons|0|||
124457860|NCT01342484|447636728|FG000|Overall Study|Protocol Violation|0|||
124457861|NCT01342484|447636729|FG001|Overall Study|Protocol Violation|0|||
124457862|NCT01342484|447636730|FG002|Overall Study|Protocol Violation|1|||
124457863|NCT01342484|447636728|FG000|Overall Study|Withdrawal by Subject|1|||
124457864|NCT01342484|447636729|FG001|Overall Study|Withdrawal by Subject|0|||
124457865|NCT01342484|447636730|FG002|Overall Study|Withdrawal by Subject|0|||
124457866|NCT01840579|447636731|FG000|Overall Study|Status not recorded|0|||
124457867|NCT01840579|447636732|FG001|Overall Study|Status not recorded|0|||
124457868|NCT01840579|447636733|FG002|Overall Study|Status not recorded|2|||
124457869|NCT01840579|447636734|FG003|Overall Study|Status not recorded|3|||
124457870|NCT01840579|447636735|FG004|Overall Study|Status not recorded|4|||
124457871|NCT01840579|447636736|FG005|Overall Study|Status not recorded|3|||
124457872|NCT01840579|447636737|FG006|Overall Study|Status not recorded|0|||
124457873|NCT01840579|447636738|FG007|Overall Study|Status not recorded|3|||
124457874|NCT01840579|447636739|FG008|Overall Study|Status not recorded|3|||
124457875|NCT01840579|447636740|FG009|Overall Study|Status not recorded|3|||
124457876|NCT01840579|447636731|FG000|Overall Study|Progressive disease|3|||
124457877|NCT01840579|447636732|FG001|Overall Study|Progressive disease|5|||
124457878|NCT01840579|447636733|FG002|Overall Study|Progressive disease|0|||
124457879|NCT01840579|447636734|FG003|Overall Study|Progressive disease|0|||
124457880|NCT01840579|447636735|FG004|Overall Study|Progressive disease|0|||
124457881|NCT01840579|447636736|FG005|Overall Study|Progressive disease|0|||
124457882|NCT01840579|447636737|FG006|Overall Study|Progressive disease|0|||
124457883|NCT01840579|447636738|FG007|Overall Study|Progressive disease|0|||
124457884|NCT01840579|447636739|FG008|Overall Study|Progressive disease|0|||
124457885|NCT01840579|447636740|FG009|Overall Study|Progressive disease|0|||
124457886|NCT01840579|447636731|FG000|Overall Study|Ongoing in study|0|||
124457887|NCT01840579|447636732|FG001|Overall Study|Ongoing in study|1|||
124457888|NCT01840579|447636733|FG002|Overall Study|Ongoing in study|0|||
124457889|NCT01840579|447636734|FG003|Overall Study|Ongoing in study|0|||
124457890|NCT01840579|447636735|FG004|Overall Study|Ongoing in study|0|||
124457891|NCT01840579|447636736|FG005|Overall Study|Ongoing in study|0|||
124457892|NCT01840579|447636737|FG006|Overall Study|Ongoing in study|0|||
124457893|NCT01840579|447636738|FG007|Overall Study|Ongoing in study|0|||
124457894|NCT01840579|447636739|FG008|Overall Study|Ongoing in study|0|||
124457895|NCT01840579|447636740|FG009|Overall Study|Ongoing in study|0|||
124704489|NCT02303821|448540903|FG007|Overall Study|Decision by sponsor|0|||
124457896|NCT01840579|447636731|FG000|Overall Study|Death|0|||
124457897|NCT01840579|447636732|FG001|Overall Study|Death|0|||
124457898|NCT01840579|447636733|FG002|Overall Study|Death|0|||
124457899|NCT01840579|447636734|FG003|Overall Study|Death|0|||
124457900|NCT01840579|447636735|FG004|Overall Study|Death|0|||
124457901|NCT01840579|447636736|FG005|Overall Study|Death|1|||
124457902|NCT01840579|447636737|FG006|Overall Study|Death|0|||
124457903|NCT01840579|447636738|FG007|Overall Study|Death|0|||
124547448|NCT01244516|447958880|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
124547449|NCT01244516|447958881|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
124547450|NCT01244516|447958879|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
124547451|NCT01244516|447958880|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
124547452|NCT01244516|447958881|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
124547453|NCT01244516|447958879|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
124547454|NCT01244516|447958880|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
124547455|NCT01244516|447958881|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
124547456|NCT01244516|447958879|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
124547457|NCT01244516|447958880|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
124547458|NCT01244516|447958881|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
124547459|NCT00244881|447958888|FG000|Overall Study|Withdrawal by Subject|3|||
124547460|NCT03664024|447958889|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
124547461|NCT03664024|447958889|FG000|Overall Study|Lost to Follow-up|2|||
124547462|NCT03664024|447958889|FG000|Overall Study|Withdrawal by Subject|2|||
124547463|NCT03664024|447958889|FG000|Overall Study|Death|80|||
124547464|NCT03159611|447958890|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
124547465|NCT03159611|447958891|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
124547466|NCT03159611|447958890|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
124547467|NCT03159611|447958891|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
124547468|NCT03159611|447958890|FG000|Overall Study|Protocol Violation|7|||
124547469|NCT03159611|447958891|FG001|Overall Study|Protocol Violation|4|||
124547470|NCT03159611|447958890|FG000|Overall Study|Adverse Event|1|||
124547471|NCT03159611|447958891|FG001|Overall Study|Adverse Event|0|||
124547472|NCT03159611|447958890|FG000|Overall Study|Withdrawal by Subject|1|||
124547473|NCT03159611|447958891|FG001|Overall Study|Withdrawal by Subject|1|||
124547474|NCT03159611|447958890|FG000|Overall Study|Non-compliance with protocol requirement|3|||
124547475|NCT03159611|447958891|FG001|Overall Study|Non-compliance with protocol requirement|2|||
124547476|NCT03159611|447958890|FG000|Overall Study|Inability to perform procedures|1|||
124547477|NCT03159611|447958891|FG001|Overall Study|Inability to perform procedures|0|||
124547478|NCT02057549|447958893|FG000|Overall Study|Lost to Follow-up|1|||
124547479|NCT02057549|447958894|FG001|Overall Study|Lost to Follow-up|0|||
124547480|NCT02057549|447958893|FG000|Overall Study|Physician Decision|1|||
124547481|NCT02057549|447958894|FG001|Overall Study|Physician Decision|0|||
124547482|NCT02057549|447958893|FG000|Overall Study|Withdrawal by Subject|1|||
124547483|NCT02057549|447958894|FG001|Overall Study|Withdrawal by Subject|0|||
124547484|NCT01418365|447958895|FG000|First Intervention|Withdrawal by Subject|0|||
124547485|NCT01418365|447958896|FG001|First Intervention|Withdrawal by Subject|1|||
124547486|NCT01418365|447958895|FG000|First Intervention|Non-compliance|1|||
124547487|NCT01418365|447958896|FG001|First Intervention|Non-compliance|0|||
124547488|NCT01418365|447958895|FG000|Second Intervention|Withdrawal by Subject|0|||
124547489|NCT01418365|447958896|FG001|Second Intervention|Withdrawal by Subject|1|||
124547490|NCT03319368|447958901|FG000|Overall Study|Discharge swabs not collected from resident|57|||
124547491|NCT03319368|447958902|FG001|Overall Study|Discharge swabs not collected from resident|46|||
124547492|NCT03000075|447958903|FG000|Part A|Adverse Event|4|||
124547493|NCT03000075|447958904|FG001|Part A|Adverse Event|0|||
124547494|NCT03000075|447958905|FG002|Part A|Adverse Event|0|||
124547495|NCT03000075|447958906|FG003|Part A|Adverse Event|0|||
124547496|NCT03000075|447958907|FG004|Part A|Adverse Event|0|||
124547497|NCT03000075|447958908|FG005|Part A|Adverse Event|0|||
124547498|NCT03000075|447958909|FG006|Part A|Adverse Event|0|||
124547499|NCT03000075|447958903|FG000|Part B|Not dosed due to AE|0|||
124547500|NCT03000075|447958904|FG001|Part B|Not dosed due to AE|0|||
124547501|NCT03000075|447958905|FG002|Part B|Not dosed due to AE|0|||
124547502|NCT03000075|447958906|FG003|Part B|Not dosed due to AE|0|||
124547503|NCT03000075|447958907|FG004|Part B|Not dosed due to AE|0|||
124547504|NCT03000075|447958908|FG005|Part B|Not dosed due to AE|2|||
124547505|NCT03000075|447958909|FG006|Part B|Not dosed due to AE|1|||
124547506|NCT03000075|447958903|FG000|Part B|Adverse Event|0|||
124547507|NCT03000075|447958904|FG001|Part B|Adverse Event|0|||
124704490|NCT02303821|448540896|FG000|Overall Study|Protocol-specified criteria|0|||
124704491|NCT02303821|448540897|FG001|Overall Study|Protocol-specified criteria|1|||
124704492|NCT02303821|448540898|FG002|Overall Study|Protocol-specified criteria|0|||
124704493|NCT02303821|448540899|FG003|Overall Study|Protocol-specified criteria|0|||
124704494|NCT02303821|448540900|FG004|Overall Study|Protocol-specified criteria|0|||
124941799|NCT00048932|449414785|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
124941800|NCT00048932|449414786|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
124941801|NCT00048932|449414787|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
124941802|NCT00048932|449414785|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
124941803|NCT00048932|449414786|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
124941804|NCT00048932|449414787|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
124547508|NCT03000075|447958905|FG002|Part B|Adverse Event|0|||
124547509|NCT03000075|447958906|FG003|Part B|Adverse Event|0|||
124941805|NCT00048932|449414785|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
124547510|NCT03000075|447958907|FG004|Part B|Adverse Event|1|||
124704495|NCT02303821|448540901|FG005|Overall Study|Protocol-specified criteria|1|||
124704496|NCT02303821|448540902|FG006|Overall Study|Protocol-specified criteria|0|||
124704497|NCT02303821|448540903|FG007|Overall Study|Protocol-specified criteria|0|||
124704498|NCT04116489|448540918|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
124704499|NCT04116489|448540918|FG000|Overall Study|Withdrawal by Subject|1|||
124704500|NCT03734536|448540919|FG000|Overall Study|Withdrew Consent|1|||
124704501|NCT03734536|448540920|FG001|Overall Study|Withdrew Consent|5|||
124704502|NCT03734536|448540919|FG000|Overall Study|Lost to Follow-up|10|||
124704503|NCT03734536|448540920|FG001|Overall Study|Lost to Follow-up|7|||
124704504|NCT04727151|448540921|FG000|Overall Study|Death|0|||
124704505|NCT04727151|448540922|FG001|Overall Study|Death|0|||
124704506|NCT04727151|448540923|FG002|Overall Study|Death|0|||
124704507|NCT04727151|448540924|FG003|Overall Study|Death|0|||
124704508|NCT04727151|448540925|FG004|Overall Study|Death|3|||
124704509|NCT04727151|448540921|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
124704510|NCT04727151|448540922|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
124704511|NCT04727151|448540923|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
124704512|NCT04727151|448540924|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
124704513|NCT04727151|448540925|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
124704514|NCT01346592|448540927|FG000|Overall Study|Lost to Follow-up|62|||
124704515|NCT01346592|448540928|FG001|Overall Study|Lost to Follow-up|29|||
124704516|NCT01346592|448540929|FG002|Overall Study|Lost to Follow-up|29|||
124704517|NCT01346592|448540927|FG000|Overall Study|Protocol Violation|2|||
124704518|NCT01346592|448540928|FG001|Overall Study|Protocol Violation|1|||
124704519|NCT01346592|448540929|FG002|Overall Study|Protocol Violation|0|||
124704520|NCT01346592|448540927|FG000|Overall Study|Death|1|||
124704521|NCT01346592|448540928|FG001|Overall Study|Death|3|||
124704522|NCT01346592|448540929|FG002|Overall Study|Death|4|||
124704523|NCT01346592|448540927|FG000|Overall Study|Adverse Event|0|||
124704524|NCT01346592|448540928|FG001|Overall Study|Adverse Event|1|||
124704525|NCT01346592|448540929|FG002|Overall Study|Adverse Event|0|||
124704526|NCT01346592|448540927|FG000|Overall Study|Withdrawal by Subject|77|||
124704527|NCT01346592|448540928|FG001|Overall Study|Withdrawal by Subject|51|||
124704528|NCT01346592|448540929|FG002|Overall Study|Withdrawal by Subject|38|||
124704529|NCT01346592|448540927|FG000|Overall Study|Inappropriate enrollment|3|||
124704530|NCT01346592|448540928|FG001|Overall Study|Inappropriate enrollment|1|||
124704531|NCT01346592|448540929|FG002|Overall Study|Inappropriate enrollment|1|||
124704532|NCT01346592|448540927|FG000|Overall Study|Administrative reason|1|||
124704533|NCT01346592|448540928|FG001|Overall Study|Administrative reason|0|||
124704534|NCT01346592|448540929|FG002|Overall Study|Administrative reason|0|||
124704535|NCT01346592|448540927|FG000|Overall Study|Unable to Classify|7|||
124704536|NCT01346592|448540928|FG001|Overall Study|Unable to Classify|3|||
124941806|NCT00048932|449414786|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
124941807|NCT00048932|449414787|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
124941808|NCT00048932|449414785|FG000|Open Label Period (OL)|Pregnancy|0|||
124941809|NCT00048932|449414786|FG001|Open Label Period (OL)|Pregnancy|0|||
124941810|NCT00048932|449414787|FG002|Open Label Period (OL)|Pregnancy|6|||
124941811|NCT00048932|449414785|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
124941812|NCT00048932|449414786|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
124941813|NCT00048932|449414787|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
124704537|NCT01346592|448540929|FG002|Overall Study|Unable to Classify|6|||
124704538|NCT02679274|448540930|FG000|Overall Study|Withdrawal by Subject|1|||
124704539|NCT02679274|448540931|FG001|Overall Study|Withdrawal by Subject|0|||
124704540|NCT02038036|448540936|FG000|Core Study|Adverse Event|7|||
124704541|NCT02038036|448540937|FG001|Core Study|Adverse Event|7|||
124704542|NCT02038036|448540936|FG000|Core Study|Death|1|||
124704543|NCT02038036|448540937|FG001|Core Study|Death|1|||
124704544|NCT02038036|448540936|FG000|Core Study|Disease progression|2|||
124704545|NCT02038036|448540937|FG001|Core Study|Disease progression|2|||
124704546|NCT02038036|448540936|FG000|Core Study|Lost to Follow-up|0|||
124704547|NCT02038036|448540937|FG001|Core Study|Lost to Follow-up|1|||
124704548|NCT02038036|448540936|FG000|Core Study|Physician Decision|2|||
124704549|NCT02038036|448540937|FG001|Core Study|Physician Decision|1|||
124704550|NCT02038036|448540936|FG000|Core Study|Subject/guardian decision|0|||
124941814|NCT00048932|449414785|FG000|Open Label Period (OL)|Investigator Retiring|0|||
124941815|NCT00048932|449414786|FG001|Open Label Period (OL)|Investigator Retiring|0|||
124941816|NCT00048932|449414787|FG002|Open Label Period (OL)|Investigator Retiring|2|||
124941817|NCT00048932|449414785|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
124941818|NCT00048932|449414786|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
124941819|NCT00048932|449414787|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
124941820|NCT00048932|449414785|FG000|Open Label Period (OL)|Participant Relocated|0|||
124941821|NCT00048932|449414786|FG001|Open Label Period (OL)|Participant Relocated|0|||
124941822|NCT00048932|449414787|FG002|Open Label Period (OL)|Participant Relocated|6|||
124941823|NCT00048932|449414785|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
124941824|NCT00048932|449414786|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
124941825|NCT00048932|449414787|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
124941826|NCT00048932|449414785|FG000|Open Label Period (OL)|Site Closure|0|||
124941827|NCT00048932|449414786|FG001|Open Label Period (OL)|Site Closure|0|||
124941828|NCT00048932|449414787|FG002|Open Label Period (OL)|Site Closure|3|||
124941829|NCT00048932|449414785|FG000|Open Label Period (OL)|Trial Terminated|0|||
124941830|NCT00048932|449414786|FG001|Open Label Period (OL)|Trial Terminated|0|||
124941831|NCT00048932|449414787|FG002|Open Label Period (OL)|Trial Terminated|1|||
124941832|NCT00048932|449414785|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
124941833|NCT00048932|449414786|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
124704551|NCT02038036|448540937|FG001|Core Study|Subject/guardian decision|1|||
124704552|NCT02038036|448540936|FG000|Core Study|Withdrawal by Subject|3|||
124704553|NCT02038036|448540937|FG001|Core Study|Withdrawal by Subject|1|||
124704554|NCT02038036|448540936|FG000|Crossover Period|Withdrawal by Subject|0|||
124704555|NCT02038036|448540937|FG001|Crossover Period|Withdrawal by Subject|3|||
124457904|NCT01840579|447636739|FG008|Overall Study|Death|0|||
124457905|NCT01840579|447636740|FG009|Overall Study|Death|0|||
124457906|NCT01840579|447636731|FG000|Overall Study|Adverse Event|0|||
124457907|NCT01840579|447636732|FG001|Overall Study|Adverse Event|1|||
124457908|NCT01840579|447636733|FG002|Overall Study|Adverse Event|0|||
124457909|NCT01840579|447636734|FG003|Overall Study|Adverse Event|0|||
124457910|NCT01840579|447636735|FG004|Overall Study|Adverse Event|0|||
124457911|NCT01840579|447636736|FG005|Overall Study|Adverse Event|0|||
124457912|NCT01840579|447636737|FG006|Overall Study|Adverse Event|0|||
124457913|NCT01840579|447636738|FG007|Overall Study|Adverse Event|0|||
124457914|NCT01840579|447636739|FG008|Overall Study|Adverse Event|0|||
124457915|NCT01840579|447636740|FG009|Overall Study|Adverse Event|0|||
124457916|NCT01840579|447636731|FG000|Overall Study|Follow-up ended by Sponsor|0|||
124457917|NCT01840579|447636732|FG001|Overall Study|Follow-up ended by Sponsor|0|||
124457918|NCT01840579|447636733|FG002|Overall Study|Follow-up ended by Sponsor|0|||
124457919|NCT01840579|447636734|FG003|Overall Study|Follow-up ended by Sponsor|0|||
124457920|NCT01840579|447636735|FG004|Overall Study|Follow-up ended by Sponsor|0|||
124457921|NCT01840579|447636736|FG005|Overall Study|Follow-up ended by Sponsor|0|||
124457922|NCT01840579|447636737|FG006|Overall Study|Follow-up ended by Sponsor|2|||
124457923|NCT01840579|447636738|FG007|Overall Study|Follow-up ended by Sponsor|0|||
124457924|NCT01840579|447636739|FG008|Overall Study|Follow-up ended by Sponsor|0|||
124457925|NCT01840579|447636740|FG009|Overall Study|Follow-up ended by Sponsor|0|||
124457926|NCT00432042|447636741|FG000|Overall Study|Protocol Violation|2|||
124457927|NCT00432042|447636742|FG001|Overall Study|Protocol Violation|0|||
124457928|NCT00432042|447636743|FG002|Overall Study|Protocol Violation|0|||
124457929|NCT00432042|447636741|FG000|Overall Study|Withdrawal by Subject|0|||
124457930|NCT00432042|447636742|FG001|Overall Study|Withdrawal by Subject|0|||
124457931|NCT00432042|447636743|FG002|Overall Study|Withdrawal by Subject|2|||
124457932|NCT00432042|447636741|FG000|Overall Study|Lost to Follow-up|5|||
124457933|NCT00432042|447636742|FG001|Overall Study|Lost to Follow-up|1|||
124457934|NCT00432042|447636743|FG002|Overall Study|Lost to Follow-up|0|||
124704556|NCT02038036|448540936|FG000|Crossover Period|Adverse Event|0|||
124704557|NCT02038036|448540937|FG001|Crossover Period|Adverse Event|9|||
124704558|NCT02038036|448540936|FG000|Crossover Period|Death|0|||
124457935|NCT01585272|447636745|FG000|Overall Study|Adverse Event|22|||
124457936|NCT01585272|447636745|FG000|Overall Study|Protocol Violation|7|||
124457937|NCT01585272|447636745|FG000|Overall Study|Withdrawal by Subject|10|||
124457938|NCT00645593|447636746|FG000|Overall Study|Later found to be ineligible|1|||
124457939|NCT00645593|447636747|FG001|Overall Study|Later found to be ineligible|0|||
124704559|NCT02038036|448540937|FG001|Crossover Period|Death|2|||
124704560|NCT02038036|448540936|FG000|Crossover Period|Disease progression|0|||
124704561|NCT02038036|448540937|FG001|Crossover Period|Disease progression|3|||
124704562|NCT02038036|448540936|FG000|Crossover Period|Lost to Follow-up|0|||
124704563|NCT02038036|448540937|FG001|Crossover Period|Lost to Follow-up|1|||
124457940|NCT02577146|447636752|FG000|Overall Study|Lost to Follow-up|8|||
124547511|NCT03000075|447958908|FG005|Part B|Adverse Event|0|||
124704564|NCT02038036|448540936|FG000|Crossover Period|Physician Decision|0|||
124704565|NCT02038036|448540937|FG001|Crossover Period|Physician Decision|2|||
124704566|NCT03537508|448540945|FG000|Overall Study|Adverse Event|2|||
124704567|NCT03537508|448540946|FG001|Overall Study|Adverse Event|1|||
124704568|NCT03537508|448540945|FG000|Overall Study|Protocol Violation|65|||
124704569|NCT03537508|448540946|FG001|Overall Study|Protocol Violation|48|||
124704570|NCT03537508|448540945|FG000|Overall Study|Lost to Follow-up|86|||
124704571|NCT03537508|448540946|FG001|Overall Study|Lost to Follow-up|60|||
124704572|NCT03537508|448540945|FG000|Overall Study|Withdrawal by parent/guardian|263|||
124941834|NCT00048932|449414787|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
124941835|NCT00048932|449414785|FG000|Open Label Period (OL)|Patient Decision|0|||
124941836|NCT00048932|449414786|FG001|Open Label Period (OL)|Patient Decision|0|||
124457941|NCT02577146|447636752|FG000|Overall Study|Physician Decision|3|||
124941837|NCT00048932|449414787|FG002|Open Label Period (OL)|Patient Decision|4|||
124941838|NCT00048932|449414785|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
124941839|NCT00048932|449414786|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
124941840|NCT00048932|449414787|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
124941841|NCT00048932|449414785|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
124941842|NCT00048932|449414786|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
124941843|NCT00048932|449414787|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
124941844|NCT00048932|449414785|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
124941845|NCT00048932|449414786|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
124941846|NCT00048932|449414787|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
124941847|NCT00048932|449414785|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
124941848|NCT00048932|449414786|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
124941849|NCT00048932|449414787|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
124941850|NCT00048932|449414785|FG000|Open Label Period (OL)|Investigator Decision|0|||
124941851|NCT00048932|449414786|FG001|Open Label Period (OL)|Investigator Decision|0|||
124941852|NCT00048932|449414787|FG002|Open Label Period (OL)|Investigator Decision|4|||
124941853|NCT00048932|449414785|FG000|Open Label Period (OL)|Site Staff Issues|0|||
124941854|NCT00048932|449414786|FG001|Open Label Period (OL)|Site Staff Issues|0|||
124941855|NCT00048932|449414787|FG002|Open Label Period (OL)|Site Staff Issues|2|||
124941856|NCT00048932|449414785|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
124941857|NCT00048932|449414786|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
124941858|NCT00048932|449414787|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
124941859|NCT00048932|449414785|FG000|Open Label Period (OL)|Participant Surgery|0|||
124941860|NCT00048932|449414786|FG001|Open Label Period (OL)|Participant Surgery|0|||
124941861|NCT00048932|449414787|FG002|Open Label Period (OL)|Participant Surgery|1|||
124941862|NCT02232737|449414788|FG000|Overall Study|Lost to Follow-up|18|||
124941863|NCT02232737|449414789|FG001|Overall Study|Lost to Follow-up|28|||
124941864|NCT02232737|449414790|FG002|Overall Study|Lost to Follow-up|33|||
124941865|NCT02232737|449414788|FG000|Overall Study|Personal reasons|7|||
124941866|NCT02232737|449414789|FG001|Overall Study|Personal reasons|8|||
124941867|NCT02232737|449414790|FG002|Overall Study|Personal reasons|14|||
124941868|NCT02232737|449414788|FG000|Overall Study|Adverse Event|6|||
124941869|NCT02232737|449414789|FG001|Overall Study|Adverse Event|3|||
124941870|NCT02232737|449414790|FG002|Overall Study|Adverse Event|8|||
124941871|NCT02232737|449414788|FG000|Overall Study|Incarcerated|2|||
124941872|NCT02232737|449414789|FG001|Overall Study|Incarcerated|1|||
124941873|NCT02232737|449414790|FG002|Overall Study|Incarcerated|2|||
124941874|NCT02232737|449414788|FG000|Overall Study|Withdrawal by Subject|0|||
124941875|NCT02232737|449414789|FG001|Overall Study|Withdrawal by Subject|1|||
124941876|NCT02232737|449414790|FG002|Overall Study|Withdrawal by Subject|2|||
124941877|NCT02232737|449414788|FG000|Overall Study|Death|0|||
124941878|NCT02232737|449414789|FG001|Overall Study|Death|1|||
124941879|NCT02232737|449414790|FG002|Overall Study|Death|1|||
124941880|NCT02232737|449414788|FG000|Overall Study|Physician Decision|1|||
124941881|NCT02232737|449414789|FG001|Overall Study|Physician Decision|3|||
124941882|NCT02232737|449414790|FG002|Overall Study|Physician Decision|1|||
124941883|NCT02232737|449414788|FG000|Overall Study|Protocol Violation|1|||
124941884|NCT02232737|449414789|FG001|Overall Study|Protocol Violation|0|||
124941885|NCT02232737|449414790|FG002|Overall Study|Protocol Violation|1|||
124941886|NCT02232737|449414788|FG000|Overall Study|Reason unknown|1|||
124941887|NCT02232737|449414789|FG001|Overall Study|Reason unknown|0|||
124941888|NCT02232737|449414790|FG002|Overall Study|Reason unknown|0|||
124941889|NCT04559698|449414800|FG000|Overall Study|Lost to Follow-up|14|||
124941890|NCT04559698|449414801|FG001|Overall Study|Lost to Follow-up|15|||
124941891|NCT04559698|449414800|FG000|Overall Study|Withdrawal by Subject|0|||
124941892|NCT04559698|449414801|FG001|Overall Study|Withdrawal by Subject|1|||
124941893|NCT01641900|449414806|FG000|Overall Study|Withdrawal by Subject|2|||
124941894|NCT01641900|449414807|FG001|Overall Study|Withdrawal by Subject|2|||
124941895|NCT03220724|449414813|FG000|Overall Study|Lost to Follow-up|2|||
124941896|NCT03220724|449414814|FG001|Overall Study|Lost to Follow-up|2|||
124941897|NCT03220724|449414815|FG002|Overall Study|Lost to Follow-up|0|||
124941898|NCT03220724|449414816|FG003|Overall Study|Lost to Follow-up|3|||
124941899|NCT03220724|449414817|FG004|Overall Study|Lost to Follow-up|1|||
124941900|NCT03220724|449414818|FG005|Overall Study|Lost to Follow-up|0|||
124941901|NCT03220724|449414819|FG006|Overall Study|Lost to Follow-up|2|||
124941902|NCT03220724|449414820|FG007|Overall Study|Lost to Follow-up|1|||
124704573|NCT03537508|448540946|FG001|Overall Study|Withdrawal by parent/guardian|149|||
124704574|NCT01972659|448540959|FG000|Overall Study|Protocol Violation|2|||
124704575|NCT01972659|448540960|FG001|Overall Study|Protocol Violation|2|||
124704576|NCT01972659|448540959|FG000|Overall Study|problems realted to acceleromyograph|2|||
124704577|NCT01972659|448540960|FG001|Overall Study|problems realted to acceleromyograph|1|||
124704578|NCT04144517|448540964|FG000|Overall Study|Physician Decision|0|||
124704579|NCT04144517|448540965|FG001|Overall Study|Physician Decision|1|||
124704580|NCT04144517|448540964|FG000|Overall Study|Other|2|||
124704581|NCT04144517|448540965|FG001|Overall Study|Other|2|||
124704582|NCT04144517|448540964|FG000|Overall Study|Death|6|||
124704583|NCT04144517|448540965|FG001|Overall Study|Death|3|||
124704584|NCT02757768|448540973|FG000|Overall Study|Randomized Never Received Study Drug|3|||
124941903|NCT03220724|449414821|FG008|Overall Study|Lost to Follow-up|0|||
124941904|NCT03220724|449414813|FG000|Overall Study|Withdrawal by Subject|1|||
124941905|NCT03220724|449414814|FG001|Overall Study|Withdrawal by Subject|0|||
124941906|NCT03220724|449414815|FG002|Overall Study|Withdrawal by Subject|1|||
124941907|NCT03220724|449414816|FG003|Overall Study|Withdrawal by Subject|0|||
124941908|NCT03220724|449414817|FG004|Overall Study|Withdrawal by Subject|0|||
124941909|NCT03220724|449414818|FG005|Overall Study|Withdrawal by Subject|0|||
124941910|NCT03220724|449414819|FG006|Overall Study|Withdrawal by Subject|0|||
124941911|NCT03220724|449414820|FG007|Overall Study|Withdrawal by Subject|0|||
124941912|NCT03220724|449414821|FG008|Overall Study|Withdrawal by Subject|0|||
124941913|NCT01478594|449414826|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
124941914|NCT01478594|449414827|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
124941915|NCT01478594|449414826|FG000|Overall Study|Death|45|||
124941916|NCT01478594|449414827|FG001|Overall Study|Death|18|||
124941917|NCT01478594|449414826|FG000|Overall Study|Lost to Follow-up|3|||
124941918|NCT01478594|449414827|FG001|Overall Study|Lost to Follow-up|1|||
124941919|NCT01478594|449414826|FG000|Overall Study|Withdrawal by Subject|9|||
124941920|NCT01478594|449414827|FG001|Overall Study|Withdrawal by Subject|3|||
124941921|NCT01478594|449414826|FG000|Overall Study|Study Closed by Sponsor|8|||
124941922|NCT01478594|449414827|FG001|Overall Study|Study Closed by Sponsor|5|||
124941923|NCT02463448|449414834|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
124941924|NCT02463448|449414834|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
124941925|NCT02463448|449414834|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
124941926|NCT02463448|449414834|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
124941927|NCT01359150|449414835|FG000|Overall Study|Lack of Efficacy|1|||
124941928|NCT01359150|449414836|FG001|Overall Study|Lack of Efficacy|1|||
124941929|NCT01359150|449414835|FG000|Overall Study|Withdrawal by Subject|1|||
124941930|NCT01359150|449414836|FG001|Overall Study|Withdrawal by Subject|1|||
124941931|NCT01359150|449414835|FG000|Overall Study|Adverse Event|4|||
124941932|NCT01359150|449414836|FG001|Overall Study|Adverse Event|3|||
124941933|NCT01359150|449414835|FG000|Overall Study|Other|1|||
124941934|NCT01359150|449414836|FG001|Overall Study|Other|0|||
124941935|NCT03113409|449414837|FG000|Overall Study|Withdrawal by Subject|5|||
124941936|NCT03113409|449414838|FG001|Overall Study|Withdrawal by Subject|0|||
124941937|NCT03113409|449414839|FG002|Overall Study|Withdrawal by Subject|0|||
124941938|NCT01536093|449414840|FG000|Overall Study|Death|1|||
124941939|NCT01536093|449414841|FG001|Overall Study|Death|2|||
124941940|NCT01536093|449414840|FG000|Overall Study|absence of maternal colostrum|2|||
124941941|NCT01536093|449414841|FG001|Overall Study|absence of maternal colostrum|0|||
124941942|NCT01536093|449414840|FG000|Overall Study|Withdrawal by Subject|0|||
124941943|NCT01536093|449414841|FG001|Overall Study|Withdrawal by Subject|1|||
124941944|NCT02275611|449414844|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
124941945|NCT02275611|449414845|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
124941946|NCT02275611|449414846|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
124941947|NCT02275611|449414847|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
124941948|NCT01759862|449414851|FG000|Overall Study|Physician Decision|3|||
124941949|NCT01759862|449414852|FG001|Overall Study|Physician Decision|1|||
124941950|NCT01759862|449414851|FG000|Overall Study|Adverse Event|0|||
124941951|NCT01759862|449414852|FG001|Overall Study|Adverse Event|1|||
124941952|NCT03890289|449414855|FG000|Overall Study|Adverse Event|1|||
124941953|NCT03890289|449414855|FG000|Overall Study|Physician Decision|1|||
124941954|NCT03890289|449414855|FG000|Overall Study|Lack of Efficacy|2|||
124941955|NCT00274261|449414858|FG000|Overall Study|Adverse Event|19|||
124941956|NCT00274261|449414859|FG001|Overall Study|Adverse Event|11|||
124941957|NCT00274261|449414858|FG000|Overall Study|Pregnancy|114|||
124941958|NCT00274261|449414859|FG001|Overall Study|Pregnancy|83|||
124941959|NCT00274261|449414858|FG000|Overall Study|Withdrawal by Subject|179|||
124941960|NCT00274261|449414859|FG001|Overall Study|Withdrawal by Subject|126|||
124941961|NCT00274261|449414858|FG000|Overall Study|Protocol Violation|71|||
124941962|NCT00274261|449414859|FG001|Overall Study|Protocol Violation|42|||
124941963|NCT00274261|449414858|FG000|Overall Study|Lost to Follow-up|106|||
124941964|NCT00274261|449414859|FG001|Overall Study|Lost to Follow-up|75|||
124941965|NCT02628626|449414868|FG000|Overall Study|Withdrawal by Subject|2|||
124704585|NCT02757768|448540974|FG001|Overall Study|Randomized Never Received Study Drug|4|||
124704586|NCT02757768|448540973|FG000|Overall Study|Adverse Event|5|||
124704587|NCT02757768|448540974|FG001|Overall Study|Adverse Event|3|||
124704588|NCT02757768|448540973|FG000|Overall Study|Lack of Efficacy|2|||
124704589|NCT02757768|448540974|FG001|Overall Study|Lack of Efficacy|1|||
124704590|NCT02757768|448540973|FG000|Overall Study|Lost to Follow-up|1|||
124704591|NCT02757768|448540974|FG001|Overall Study|Lost to Follow-up|0|||
124704592|NCT02757768|448540973|FG000|Overall Study|Protocol Deviation|2|||
124704593|NCT02757768|448540974|FG001|Overall Study|Protocol Deviation|9|||
124704594|NCT02757768|448540973|FG000|Overall Study|Withdrawal by Subject|16|||
124704595|NCT02757768|448540974|FG001|Overall Study|Withdrawal by Subject|9|||
124704596|NCT02757768|448540973|FG000|Overall Study|Miscellaneous|4|||
124704597|NCT02757768|448540974|FG001|Overall Study|Miscellaneous|2|||
124704598|NCT00835367|448540986|FG000|Washout|Adverse Event|2|||
124704599|NCT00835367|448540987|FG001|Washout|Adverse Event|0|||
124704600|NCT00835367|448540986|FG000|Washout|Withdrawal by Subject|1|||
124704601|NCT00835367|448540987|FG001|Washout|Withdrawal by Subject|0|||
124704602|NCT00835367|448540986|FG000|Second Intervention|Adverse Event|1|||
124704603|NCT00835367|448540987|FG001|Second Intervention|Adverse Event|1|||
124704604|NCT02495883|448540988|FG000|Overall Study|Excessive head motion|1|||
124704605|NCT02495883|448540989|FG001|Overall Study|Excessive head motion|0|||
124704606|NCT00791648|448542873|FG000|Overall Study|Physician Decision|0|||
124704607|NCT00791648|448542874|FG001|Overall Study|Physician Decision|1|||
124704608|NCT00791648|448542873|FG000|Overall Study|Withdrawal by Subject|0|||
124704609|NCT00791648|448542874|FG001|Overall Study|Withdrawal by Subject|1|||
124704610|NCT00462826|448542875|FG000|Overall Study|Ineligible - second primary|1|||
124704611|NCT00462826|448542875|FG000|Overall Study|Ineligible - wrong cell type|1|||
124704612|NCT00462826|448542875|FG000|Overall Study|Ineligible - wrong primary|2|||
124704613|NCT00462826|448542875|FG000|Overall Study|Never treated|1|||
124704614|NCT04976777|448542876|FG000|Overall Study|COVID-19 Infection|1|||
124704615|NCT04976777|448542877|FG001|Overall Study|COVID-19 Infection|0|||
124704616|NCT02278003|448542878|FG000|Overall Study|Withdrawal by Subject|11|||
124704617|NCT02278003|448542879|FG001|Overall Study|Withdrawal by Subject|0|||
124704618|NCT02278003|448542878|FG000|Overall Study|Not Treated|1|||
124704619|NCT02278003|448542879|FG001|Overall Study|Not Treated|0|||
124941966|NCT02628626|449414869|FG001|Overall Study|Withdrawal by Subject|2|||
124941967|NCT02972359|449414874|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
124941968|NCT02972359|449414874|FG000|Overall Study|Lack of Efficacy|1|||
124941969|NCT02972359|449414874|FG000|Overall Study|Adverse Event|4|||
124941970|NCT02972359|449414874|FG000|Overall Study|Death|1|||
124941971|NCT02972359|449414874|FG000|Overall Study|Withdrawal by Subject|30|||
124941972|NCT02972359|449414874|FG000|Overall Study|Protocol Violation|1|||
124941973|NCT02972359|449414874|FG000|Overall Study|Lost to Follow-up|26|||
124941974|NCT02972359|449414874|FG000|Overall Study|Other reasons|5|||
124941975|NCT02972359|449414874|FG000|Overall Study|Missing|1|||
124941976|NCT02063659|449414875|FG000|Double-Blind Treatment Period|Adverse Event|1|||
124547512|NCT03000075|447958909|FG006|Part B|Adverse Event|0|||
124547513|NCT00530621|447958915|FG000|Overall Study|Adverse Event|11|||
124547514|NCT00530621|447958916|FG001|Overall Study|Adverse Event|8|||
124547515|NCT00530621|447958915|FG000|Overall Study|Physician Decision|2|||
124547516|NCT00530621|447958916|FG001|Overall Study|Physician Decision|4|||
124547517|NCT00530621|447958915|FG000|Overall Study|Progressive Disease (PD)|47|||
124547518|NCT00530621|447958916|FG001|Overall Study|Progressive Disease (PD)|40|||
124547519|NCT00530621|447958915|FG000|Overall Study|Sponsor Decision|12|||
124941977|NCT02063659|449414876|FG001|Double-Blind Treatment Period|Adverse Event|2|||
124941978|NCT02063659|449414877|FG002|Double-Blind Treatment Period|Adverse Event|0|||
124941979|NCT02063659|449414878|FG003|Double-Blind Treatment Period|Adverse Event|0|||
124941980|NCT02063659|449414875|FG000|Double-Blind Treatment Period|Physician Decision|1|||
124941981|NCT02063659|449414876|FG001|Double-Blind Treatment Period|Physician Decision|0|||
124941982|NCT02063659|449414877|FG002|Double-Blind Treatment Period|Physician Decision|0|||
124941983|NCT02063659|449414878|FG003|Double-Blind Treatment Period|Physician Decision|0|||
124704620|NCT02278003|448542878|FG000|Overall Study|Recognition task improperly completed|7|||
124704621|NCT02278003|448542879|FG001|Overall Study|Recognition task improperly completed|0|||
124704622|NCT04123704|448542894|FG000|Overall Study|Disease progression|2|||
124704623|NCT03440385|448542895|FG000|Overall Study|Other Reason|4|||
124704624|NCT03440385|448542896|FG001|Overall Study|Other Reason|1|||
124704625|NCT03440385|448542895|FG000|Overall Study|Site Closed|1|||
124704626|NCT03440385|448542896|FG001|Overall Study|Site Closed|0|||
124704627|NCT03440385|448542895|FG000|Overall Study|Lost to Follow-up|2|||
124704628|NCT03440385|448542896|FG001|Overall Study|Lost to Follow-up|0|||
124704629|NCT03440385|448542895|FG000|Overall Study|Withdrawal by Subject|12|||
124704630|NCT03440385|448542896|FG001|Overall Study|Withdrawal by Subject|6|||
124704631|NCT03440385|448542895|FG000|Overall Study|Lack of Efficacy|9|||
124704632|NCT03440385|448542896|FG001|Overall Study|Lack of Efficacy|2|||
124704633|NCT03440385|448542895|FG000|Overall Study|Adverse Event|15|||
124704634|NCT03440385|448542896|FG001|Overall Study|Adverse Event|11|||
124704635|NCT00939185|448542897|FG000|Overall Study|Adverse Event|3|||
124704636|NCT00939185|448542897|FG000|Overall Study|Lack of Efficacy|1|||
124704637|NCT00939185|448542897|FG000|Overall Study|Lost to Follow-up|6|||
124704638|NCT00939185|448542897|FG000|Overall Study|Other|3|||
124704639|NCT00939185|448542897|FG000|Overall Study|Withdrawal by Subject|2|||
124704640|NCT00939185|448542897|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
124704641|NCT00363298|448542898|FG000|First Study Week|Lack of Efficacy|6|||
124704642|NCT00363298|448542899|FG001|First Study Week|Lack of Efficacy|5|||
124547520|NCT00530621|447958916|FG001|Overall Study|Sponsor Decision|15|||
124704643|NCT00363298|448542898|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
124704644|NCT00363298|448542899|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
124704645|NCT03552029|448542903|FG000|Overall Study|Death|3|||
124704646|NCT03552029|448542904|FG001|Overall Study|Death|0|||
124704647|NCT03552029|448542903|FG000|Overall Study|Adverse Event|1|||
124941984|NCT02063659|449414875|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
124941985|NCT02063659|449414876|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
124941986|NCT02063659|449414877|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
124941987|NCT02063659|449414878|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
124941988|NCT02063659|449414875|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
124941989|NCT02063659|449414876|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
124941990|NCT02063659|449414877|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
124941991|NCT02063659|449414878|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
124941992|NCT02063659|449414875|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
124941993|NCT02063659|449414876|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
124941994|NCT02063659|449414877|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
124941995|NCT02063659|449414878|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
124941996|NCT02063659|449414875|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
124941997|NCT02063659|449414876|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
124941998|NCT02063659|449414877|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
124941999|NCT02063659|449414878|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
124942000|NCT02063659|449414875|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
124942001|NCT02063659|449414876|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
124942002|NCT02063659|449414877|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
124942003|NCT02063659|449414878|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
124942004|NCT02063659|449414875|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
124942005|NCT02063659|449414876|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
124942006|NCT02063659|449414877|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
124942007|NCT02063659|449414878|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
124942008|NCT01532999|449414879|FG000|Overall Study|Lost to Follow-up|14|||
124457942|NCT02577146|447636752|FG000|Overall Study|Screen Failure|17|||
124457943|NCT03765138|447636753|FG000|Overall Study|Lost to Follow-up|1|||
124457944|NCT01970501|447636754|FG000|Overall Study|Discontinuation of study by sponsor|16|||
124457945|NCT01970501|447636755|FG001|Overall Study|Discontinuation of study by sponsor|14|||
124457946|NCT01970501|447636754|FG000|Overall Study|Withdrawal by Subject|6|||
124457947|NCT01970501|447636755|FG001|Overall Study|Withdrawal by Subject|7|||
124457948|NCT01970501|447636754|FG000|Overall Study|Adverse Event|2|||
124457949|NCT01970501|447636755|FG001|Overall Study|Adverse Event|4|||
124457950|NCT01970501|447636754|FG000|Overall Study|Death|1|||
124457951|NCT01970501|447636755|FG001|Overall Study|Death|3|||
124457952|NCT01970501|447636754|FG000|Overall Study|Physician Decision|2|||
124765100|NCT01602224|448767307|FG002|Overall Study|Investigator Decison|0|||
124765101|NCT01602224|448767305|FG000|Overall Study|Lost to Follow-up|0|||
124765102|NCT01602224|448767306|FG001|Overall Study|Lost to Follow-up|0|||
124765103|NCT01602224|448767307|FG002|Overall Study|Lost to Follow-up|1|||
124942009|NCT01532999|449414880|FG001|Overall Study|Lost to Follow-up|8|||
124942010|NCT01532999|449414879|FG000|Overall Study|Physician Decision|1|||
124942011|NCT01532999|449414880|FG001|Overall Study|Physician Decision|2|||
124942012|NCT01532999|449414879|FG000|Overall Study|Withdrawal by Subject|5|||
124942013|NCT01532999|449414880|FG001|Overall Study|Withdrawal by Subject|0|||
124942014|NCT01532999|449414879|FG000|Overall Study|Relocated|2|||
124942015|NCT01532999|449414880|FG001|Overall Study|Relocated|0|||
124942016|NCT01532999|449414879|FG000|Overall Study|should not have been randomized|1|||
124942017|NCT01532999|449414880|FG001|Overall Study|should not have been randomized|0|||
124942018|NCT01532999|449414879|FG000|Overall Study|substantial noncompliance|2|||
124942019|NCT01532999|449414880|FG001|Overall Study|substantial noncompliance|0|||
124942020|NCT01532999|449414879|FG000|Overall Study|no show for week 9 assessments|6|||
124942021|NCT01532999|449414880|FG001|Overall Study|no show for week 9 assessments|4|||
124942022|NCT01532999|449414879|FG000|Overall Study|Adverse Event|0|||
124942023|NCT01532999|449414880|FG001|Overall Study|Adverse Event|1|||
124942024|NCT01532999|449414879|FG000|Overall Study|incarcerated|0|||
124942025|NCT01532999|449414880|FG001|Overall Study|incarcerated|1|||
124942026|NCT01532999|449414879|FG000|Overall Study|New job|0|||
124942027|NCT01532999|449414880|FG001|Overall Study|New job|2|||
124942028|NCT00914966|449414881|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
124942029|NCT00914966|449414881|FG000|Step 1: 1500 Units|Physician Decision|1|||
124942030|NCT00914966|449414881|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
124942031|NCT03598907|449414888|FG000|Overall Study|Physician Decision|14|||
124942032|NCT03598907|449414889|FG001|Overall Study|Physician Decision|19|||
124457953|NCT01970501|447636755|FG001|Overall Study|Physician Decision|0|||
124457954|NCT03803059|447636757|FG000|Overall Study|Protocol Violation|2|||
124457955|NCT03803059|447636757|FG000|Overall Study|Lost to Follow-up|1|||
124942033|NCT04021862|449414890|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
124942034|NCT04021862|449414891|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
124942035|NCT04021862|449414892|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
124942036|NCT04021862|449414893|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
124942037|NCT04021862|449414894|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
124942038|NCT04021862|449414895|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
124942039|NCT04021862|449414890|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
124765104|NCT01602224|448767305|FG000|Overall Study|Protocol Violation|0|||
124457956|NCT04013529|447636760|FG000|Overall Study|Withdrawal by Subject|1|||
124457957|NCT04013529|447636761|FG001|Overall Study|Withdrawal by Subject|1|||
124942040|NCT04021862|449414891|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
124942041|NCT04021862|449414892|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
124942042|NCT04021862|449414893|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
124942043|NCT04021862|449414894|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
124942044|NCT04021862|449414895|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
124942045|NCT04021862|449414890|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
124704648|NCT03552029|448542904|FG001|Overall Study|Adverse Event|0|||
124704649|NCT03552029|448542903|FG000|Overall Study|Lack of Efficacy|0|||
124704650|NCT03552029|448542904|FG001|Overall Study|Lack of Efficacy|2|||
124704651|NCT03552029|448542903|FG000|Overall Study|Physician Decision|0|||
124704652|NCT03552029|448542904|FG001|Overall Study|Physician Decision|1|||
124765105|NCT01602224|448767306|FG001|Overall Study|Protocol Violation|1|||
124765106|NCT01602224|448767307|FG002|Overall Study|Protocol Violation|0|||
124765107|NCT01602224|448767305|FG000|Overall Study|Sponsor Decision|2|||
124765108|NCT01602224|448767306|FG001|Overall Study|Sponsor Decision|3|||
124765109|NCT01602224|448767307|FG002|Overall Study|Sponsor Decision|2|||
124765110|NCT01602224|448767305|FG000|Overall Study|Withdrawal by Subject|5|||
124704653|NCT03552029|448542903|FG000|Overall Study|Study terminated by Sponsor|0|||
124704654|NCT03552029|448542904|FG001|Overall Study|Study terminated by Sponsor|1|||
124704655|NCT03552029|448542903|FG000|Overall Study|Other|0|||
124704656|NCT03552029|448542904|FG001|Overall Study|Other|2|||
124704657|NCT03468998|448542907|FG000|Overall Study|Withdrawal by Subject|1|||
124704658|NCT03468998|448542908|FG001|Overall Study|Withdrawal by Subject|1|||
124704659|NCT03468998|448542909|FG002|Overall Study|Withdrawal by Subject|0|||
124765111|NCT01602224|448767306|FG001|Overall Study|Withdrawal by Subject|3|||
124765112|NCT01602224|448767307|FG002|Overall Study|Withdrawal by Subject|3|||
124765113|NCT01352117|448767308|FG000|Overall Study|Death|15|||
124704660|NCT03468998|448542910|FG003|Overall Study|Withdrawal by Subject|4|||
124704661|NCT03468998|448542911|FG004|Overall Study|Withdrawal by Subject|1|||
124704662|NCT03468998|448542912|FG005|Overall Study|Withdrawal by Subject|0|||
124704663|NCT00836706|448542915|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
124704664|NCT00836706|448542916|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
124704665|NCT00633126|448542919|FG000|Overall Study|Did not receive full dose|1|||
124704666|NCT02390076|448542924|FG000|Overall Study|Lost to Follow-up|2|||
124704667|NCT02390076|448542925|FG001|Overall Study|Lost to Follow-up|1|||
124765114|NCT01352117|448767309|FG001|Overall Study|Death|16|||
124765115|NCT01352117|448767308|FG000|Overall Study|Withdrawal by Subject|1|||
124765116|NCT01352117|448767309|FG001|Overall Study|Withdrawal by Subject|0|||
124765117|NCT01352117|448767308|FG000|Overall Study|Lost to Follow-up|2|||
124765118|NCT01352117|448767309|FG001|Overall Study|Lost to Follow-up|7|||
124765119|NCT01352117|448767308|FG000|Overall Study|Non-adherent to study requirements|1|||
124765120|NCT01352117|448767309|FG001|Overall Study|Non-adherent to study requirements|1|||
124765121|NCT01352117|448767308|FG000|Overall Study|Did not initiate study treatment|1|||
124704668|NCT02390076|448542926|FG002|Overall Study|Lost to Follow-up|4|||
124704669|NCT01822925|448542930|FG000|Overall Study|Adverse Event|1|||
124704670|NCT01822925|448542931|FG001|Overall Study|Adverse Event|1|||
124704671|NCT01822925|448542932|FG002|Overall Study|Adverse Event|1|||
124704672|NCT01822925|448542933|FG003|Overall Study|Adverse Event|1|||
124704673|NCT01822925|448542930|FG000|Overall Study|Lost to Follow-up|0|||
124704674|NCT01822925|448542931|FG001|Overall Study|Lost to Follow-up|1|||
124704675|NCT01822925|448542932|FG002|Overall Study|Lost to Follow-up|0|||
124704676|NCT01822925|448542933|FG003|Overall Study|Lost to Follow-up|0|||
124704677|NCT01822925|448542930|FG000|Overall Study|Protocol Violation|1|||
124704678|NCT01822925|448542931|FG001|Overall Study|Protocol Violation|0|||
124704679|NCT01822925|448542932|FG002|Overall Study|Protocol Violation|0|||
124704680|NCT01822925|448542933|FG003|Overall Study|Protocol Violation|1|||
124704681|NCT01822925|448542930|FG000|Overall Study|Withdrawal by Subject|2|||
124704682|NCT01822925|448542931|FG001|Overall Study|Withdrawal by Subject|0|||
124704683|NCT01822925|448542932|FG002|Overall Study|Withdrawal by Subject|2|||
124704684|NCT01822925|448542933|FG003|Overall Study|Withdrawal by Subject|2|||
124704685|NCT01822925|448542930|FG000|Overall Study|Taking prohibited medication|2|||
124765122|NCT01352117|448767309|FG001|Overall Study|Did not initiate study treatment|0|||
124765123|NCT01352117|448767308|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
124765124|NCT01352117|448767309|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
124765125|NCT00633477|448767310|FG000|Overall Study|Death|1|||
124765126|NCT00633477|448767311|FG001|Overall Study|Death|0|||
124704686|NCT01822925|448542931|FG001|Overall Study|Taking prohibited medication|0|||
124704687|NCT01822925|448542932|FG002|Overall Study|Taking prohibited medication|0|||
124704688|NCT01822925|448542933|FG003|Overall Study|Taking prohibited medication|1|||
124704689|NCT04617860|448542934|FG000|Overall Study|Adverse Event|0|||
124704690|NCT04617860|448542935|FG001|Overall Study|Adverse Event|2|||
124704691|NCT04617860|448542936|FG002|Overall Study|Adverse Event|2|||
124704692|NCT04617860|448542934|FG000|Overall Study|Withdrawal by Subject|0|||
124704693|NCT04617860|448542935|FG001|Overall Study|Withdrawal by Subject|0|||
124457958|NCT03116698|447636762|FG000|Overall Study|Adverse Event|1|||
124704694|NCT04617860|448542936|FG002|Overall Study|Withdrawal by Subject|2|||
124704695|NCT04617860|448542934|FG000|Overall Study|Physician Decision|0|||
124704696|NCT04617860|448542935|FG001|Overall Study|Physician Decision|1|||
124704697|NCT04617860|448542936|FG002|Overall Study|Physician Decision|0|||
124704698|NCT04617860|448542934|FG000|Overall Study|Sponsor Decision|0|||
124704699|NCT04617860|448542935|FG001|Overall Study|Sponsor Decision|3|||
124704700|NCT04617860|448542936|FG002|Overall Study|Sponsor Decision|1|||
124704701|NCT04617860|448542934|FG000|Overall Study|Termination of Study by Sponsor|8|||
124704702|NCT04617860|448542935|FG001|Overall Study|Termination of Study by Sponsor|4|||
124704703|NCT04617860|448542936|FG002|Overall Study|Termination of Study by Sponsor|13|||
124704704|NCT00833690|448542937|FG000|Overall Study|Withdrawal by Subject|1|||
124704705|NCT00833690|448542938|FG001|Overall Study|Withdrawal by Subject|0|||
124704706|NCT00833690|448542939|FG002|Overall Study|Withdrawal by Subject|0|||
124704707|NCT00833690|448542937|FG000|Overall Study|Discontinued study drug|3|||
124704708|NCT00833690|448542938|FG001|Overall Study|Discontinued study drug|2|||
124704709|NCT00833690|448542939|FG002|Overall Study|Discontinued study drug|0|||
124704710|NCT01182350|448542940|FG000|Overall Study|Adverse Event|5|||
124704711|NCT01182350|448542941|FG001|Overall Study|Adverse Event|0|||
124704712|NCT01182350|448542942|FG002|Overall Study|Adverse Event|0|||
124704713|NCT01182350|448542943|FG003|Overall Study|Adverse Event|0|||
124704714|NCT01182350|448542944|FG004|Overall Study|Adverse Event|0|||
124704715|NCT01182350|448542940|FG000|Overall Study|Disease Progression|15|||
124704716|NCT01182350|448542941|FG001|Overall Study|Disease Progression|12|||
124704717|NCT01182350|448542942|FG002|Overall Study|Disease Progression|0|||
124704718|NCT01182350|448542943|FG003|Overall Study|Disease Progression|1|||
124704719|NCT01182350|448542944|FG004|Overall Study|Disease Progression|0|||
124704720|NCT01182350|448542940|FG000|Overall Study|Death|0|||
124704721|NCT01182350|448542941|FG001|Overall Study|Death|1|||
124942046|NCT04021862|449414891|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
124942047|NCT04021862|449414892|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
124457959|NCT03116698|447636763|FG001|Overall Study|Adverse Event|1|||
124457960|NCT03116698|447636764|FG002|Overall Study|Adverse Event|1|||
124765127|NCT00633477|448767310|FG000|Overall Study|Randomized but not treated|1|||
124765128|NCT00633477|448767311|FG001|Overall Study|Randomized but not treated|0|||
124765129|NCT00770653|448767315|FG000|Overall Study|Adverse Event|13|||
124765130|NCT00770653|448767316|FG001|Overall Study|Adverse Event|5|||
124765131|NCT00770653|448767315|FG000|Overall Study|Protocol Violation|8|||
124765132|NCT00770653|448767316|FG001|Overall Study|Protocol Violation|6|||
124765133|NCT00770653|448767315|FG000|Overall Study|Withdrawal by Subject|4|||
124765134|NCT00770653|448767316|FG001|Overall Study|Withdrawal by Subject|7|||
124765135|NCT00770653|448767315|FG000|Overall Study|Lack of Compliance|1|||
124765136|NCT00770653|448767316|FG001|Overall Study|Lack of Compliance|4|||
124765137|NCT00770653|448767315|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
124765138|NCT00770653|448767316|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
124765139|NCT00770653|448767315|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
124765140|NCT00770653|448767316|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
124765141|NCT00770653|448767315|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
124765142|NCT00770653|448767316|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
124765143|NCT00770653|448767315|FG000|Overall Study|Lost to Follow-up|1|||
124765144|NCT00770653|448767316|FG001|Overall Study|Lost to Follow-up|2|||
124765145|NCT00770653|448767315|FG000|Overall Study|Physician Decision|1|||
124765146|NCT00770653|448767316|FG001|Overall Study|Physician Decision|0|||
124765147|NCT04906499|448767321|FG000|Overall Study|Lack of time|1|||
124765148|NCT03525444|448767327|FG000|Overall Study|Adverse Event|0|||
124765149|NCT03525444|448767328|FG001|Overall Study|Adverse Event|1|||
124765150|NCT03525444|448767327|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
124765151|NCT03525444|448767328|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
124765152|NCT03525444|448767327|FG000|Overall Study|Other|0|||
124765153|NCT03525444|448767328|FG001|Overall Study|Other|1|||
124765154|NCT00262860|448767329|FG000|Overall Study|Adverse Event|2|||
124765155|NCT02741128|448767330|FG000|Overall Study|Protocol Violation|4|||
124765156|NCT02741128|448767331|FG001|Overall Study|Protocol Violation|1|||
124765157|NCT02741128|448767330|FG000|Overall Study|Withdrawal by Subject|2|||
124765158|NCT02741128|448767331|FG001|Overall Study|Withdrawal by Subject|0|||
124765159|NCT02741128|448767330|FG000|Overall Study|Lost to Follow-up|1|||
124765160|NCT02741128|448767331|FG001|Overall Study|Lost to Follow-up|0|||
124765161|NCT01419769|448767332|FG000|Overall Study|Did not receive the AXIOS stent|3|||
124765162|NCT01419769|448767332|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
124765163|NCT00878501|448767333|FG000|Overall Study|Adverse Event|11|||
124942048|NCT04021862|449414893|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
124942049|NCT04021862|449414894|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
124942050|NCT04021862|449414895|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
124942051|NCT04021862|449414890|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
124942052|NCT04021862|449414891|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
124704722|NCT01182350|448542942|FG002|Overall Study|Death|1|||
124704723|NCT01182350|448542943|FG003|Overall Study|Death|0|||
124704724|NCT01182350|448542944|FG004|Overall Study|Death|0|||
124765164|NCT00878501|448767334|FG001|Overall Study|Adverse Event|3|||
124765165|NCT00878501|448767335|FG002|Overall Study|Adverse Event|3|||
124942053|NCT04021862|449414892|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
124942054|NCT04021862|449414893|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
124942055|NCT04021862|449414894|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
124942056|NCT04021862|449414895|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
124942057|NCT04021862|449414890|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
124942058|NCT04021862|449414891|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
124942059|NCT04021862|449414892|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
124942060|NCT04021862|449414893|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
124942061|NCT04021862|449414894|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
124942062|NCT04021862|449414895|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
124942063|NCT05251363|449414896|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
124942064|NCT05251363|449414896|FG000|Overall Study After Implant Period|Death|9|||
124942065|NCT05251363|449414896|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
124942066|NCT05251363|449414896|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
124942067|NCT05251363|449414896|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
124942068|NCT05251363|449414896|FG000|Overall Study After Implant Period|Physician Decision|1|||
124942069|NCT05251363|449414896|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
124942070|NCT03835754|449414899|FG000|Overall Study|Death|4|||
124942071|NCT02830204|449414900|FG000|Overall Study|Death|9|||
124942072|NCT02830204|449414900|FG000|Overall Study|Withdrawal by Subject|1|||
124942073|NCT01690624|449414903|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
124942074|NCT01690624|449414904|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
124942075|NCT01690624|449414905|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
124942076|NCT01690624|449414906|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
124942077|NCT01690624|449414903|FG000|Overall Study|Adverse event (other than DLT)|3|||
124942078|NCT01690624|449414904|FG001|Overall Study|Adverse event (other than DLT)|1|||
124942079|NCT01690624|449414905|FG002|Overall Study|Adverse event (other than DLT)|1|||
124942080|NCT01690624|449414906|FG003|Overall Study|Adverse event (other than DLT)|1|||
124942081|NCT01690624|449414903|FG000|Overall Study|Withdrawal by Subject|0|||
124942082|NCT01690624|449414904|FG001|Overall Study|Withdrawal by Subject|0|||
124942083|NCT01690624|449414905|FG002|Overall Study|Withdrawal by Subject|1|||
124942084|NCT01690624|449414906|FG003|Overall Study|Withdrawal by Subject|0|||
124942085|NCT01690624|449414903|FG000|Overall Study|Sponsor is ending trial|0|||
124457961|NCT03116698|447636765|FG003|Overall Study|Adverse Event|0|||
124457962|NCT03116698|447636762|FG000|Overall Study|Withdrawal by Subject|1|||
124457963|NCT03116698|447636763|FG001|Overall Study|Withdrawal by Subject|4|||
124457964|NCT03116698|447636764|FG002|Overall Study|Withdrawal by Subject|5|||
124457965|NCT03116698|447636765|FG003|Overall Study|Withdrawal by Subject|2|||
124457966|NCT03116698|447636762|FG000|Overall Study|Lost to Follow-up|2|||
124457967|NCT03116698|447636763|FG001|Overall Study|Lost to Follow-up|0|||
124457968|NCT03116698|447636764|FG002|Overall Study|Lost to Follow-up|0|||
124457969|NCT03116698|447636765|FG003|Overall Study|Lost to Follow-up|0|||
124457970|NCT03116698|447636762|FG000|Overall Study|Physician Decision|1|||
124457971|NCT03116698|447636763|FG001|Overall Study|Physician Decision|1|||
124457972|NCT03116698|447636764|FG002|Overall Study|Physician Decision|0|||
124457973|NCT03116698|447636765|FG003|Overall Study|Physician Decision|0|||
124457974|NCT03116698|447636762|FG000|Overall Study|Protocol Violation|1|||
124457975|NCT03116698|447636763|FG001|Overall Study|Protocol Violation|0|||
124457976|NCT03116698|447636764|FG002|Overall Study|Protocol Violation|0|||
124457977|NCT03116698|447636765|FG003|Overall Study|Protocol Violation|0|||
124457978|NCT03116698|447636762|FG000|Overall Study|Death|0|||
124457979|NCT03116698|447636763|FG001|Overall Study|Death|0|||
124457980|NCT03116698|447636764|FG002|Overall Study|Death|2|||
124457981|NCT03116698|447636765|FG003|Overall Study|Death|0|||
124457982|NCT00788372|447636766|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
124457983|NCT00788372|447636766|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
124457984|NCT00788372|447636766|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
124457985|NCT00788372|447636766|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
124457986|NCT00788372|447636766|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
124457987|NCT00788372|447636766|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
124457988|NCT00788372|447636766|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
124457989|NCT02116777|447636769|FG000|Overall Study|Adverse Event|0|||
124457990|NCT02116777|447636770|FG001|Overall Study|Adverse Event|0|||
124457991|NCT02116777|447636771|FG002|Overall Study|Adverse Event|0|||
124942086|NCT01690624|449414904|FG001|Overall Study|Sponsor is ending trial|0|||
124942087|NCT01690624|449414905|FG002|Overall Study|Sponsor is ending trial|0|||
124457992|NCT02116777|447636772|FG003|Overall Study|Adverse Event|0|||
124457993|NCT02116777|447636773|FG004|Overall Study|Adverse Event|2|||
124457994|NCT02116777|447636774|FG005|Overall Study|Adverse Event|2|||
124457995|NCT02116777|447636775|FG006|Overall Study|Adverse Event|0|||
124457996|NCT02116777|447636769|FG000|Overall Study|Death|0|||
124457997|NCT02116777|447636770|FG001|Overall Study|Death|0|||
124457998|NCT02116777|447636771|FG002|Overall Study|Death|0|||
124942088|NCT01690624|449414906|FG003|Overall Study|Sponsor is ending trial|1|||
124942089|NCT01690624|449414903|FG000|Overall Study|Physician Decision|0|||
124942090|NCT01690624|449414904|FG001|Overall Study|Physician Decision|0|||
124942091|NCT01690624|449414905|FG002|Overall Study|Physician Decision|0|||
124942092|NCT01690624|449414906|FG003|Overall Study|Physician Decision|1|||
124942093|NCT01690624|449414903|FG000|Overall Study|Withdrawal by Subject|0|||
124942094|NCT01690624|449414904|FG001|Overall Study|Withdrawal by Subject|1|||
124942095|NCT01690624|449414905|FG002|Overall Study|Withdrawal by Subject|0|||
124765166|NCT00878501|448767333|FG000|Overall Study|Lack of Efficacy|2|||
124765167|NCT00878501|448767334|FG001|Overall Study|Lack of Efficacy|1|||
124765168|NCT00878501|448767335|FG002|Overall Study|Lack of Efficacy|0|||
124765169|NCT00878501|448767333|FG000|Overall Study|Withdrawal by Subject|2|||
124765170|NCT00878501|448767334|FG001|Overall Study|Withdrawal by Subject|1|||
124765171|NCT00878501|448767335|FG002|Overall Study|Withdrawal by Subject|2|||
124765172|NCT00878501|448767333|FG000|Overall Study|Protocol Violation|0|||
124765173|NCT00878501|448767334|FG001|Overall Study|Protocol Violation|0|||
124765174|NCT00878501|448767335|FG002|Overall Study|Protocol Violation|1|||
124765175|NCT00878501|448767333|FG000|Overall Study|Incorrect enrolment|1|||
124765176|NCT00878501|448767334|FG001|Overall Study|Incorrect enrolment|2|||
124765177|NCT00878501|448767335|FG002|Overall Study|Incorrect enrolment|0|||
124765178|NCT00878501|448767333|FG000|Overall Study|Intake of prohibited concom. medication|0|||
124765179|NCT00878501|448767334|FG001|Overall Study|Intake of prohibited concom. medication|0|||
124765180|NCT00878501|448767335|FG002|Overall Study|Intake of prohibited concom. medication|1|||
124765181|NCT00878501|448767333|FG000|Overall Study|Mis-randomisation of patient|1|||
124765182|NCT00878501|448767334|FG001|Overall Study|Mis-randomisation of patient|0|||
124765183|NCT00878501|448767335|FG002|Overall Study|Mis-randomisation of patient|0|||
124765184|NCT00878501|448767333|FG000|Overall Study|Administrative|0|||
124765185|NCT00878501|448767334|FG001|Overall Study|Administrative|0|||
124765186|NCT00878501|448767335|FG002|Overall Study|Administrative|1|||
124765187|NCT00812708|448767336|FG000|Overall Study|Device could not be implanted|2|||
124765188|NCT00812708|448767336|FG000|Overall Study|Lack of medical insurance|1|||
124942096|NCT01690624|449414906|FG003|Overall Study|Withdrawal by Subject|0|||
124942097|NCT01690624|449414903|FG000|Overall Study|Lack of Efficacy|1|||
124942098|NCT01690624|449414904|FG001|Overall Study|Lack of Efficacy|1|||
124942099|NCT01690624|449414905|FG002|Overall Study|Lack of Efficacy|3|||
124942100|NCT01690624|449414906|FG003|Overall Study|Lack of Efficacy|0|||
124942101|NCT04686266|449414908|FG000|Overall Study|Withdrawal by Subject|0|||
124942102|NCT04686266|449414909|FG001|Overall Study|Withdrawal by Subject|1|||
124942103|NCT04306367|449414910|FG000|Overall Study|Progression of Disease|9|||
124942104|NCT04306367|449414910|FG000|Overall Study|Adverse Event|3|||
124942105|NCT04306367|449414910|FG000|Overall Study|Withdrawal by Subject|1|||
124942106|NCT02401815|449414911|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942107|NCT02401815|449414912|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942108|NCT02401815|449414913|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942109|NCT02401815|449414914|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
124942110|NCT02401815|449414915|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942111|NCT02401815|449414916|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942112|NCT02401815|449414917|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942113|NCT02401815|449414918|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942114|NCT02401815|449414919|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942115|NCT02401815|449414920|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
124942116|NCT02401815|449414911|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
124942117|NCT02401815|449414912|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
124942118|NCT02401815|449414913|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
124942119|NCT02401815|449414914|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
124942120|NCT02401815|449414915|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
124942121|NCT02401815|449414916|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
124942122|NCT02401815|449414917|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
124942123|NCT02401815|449414918|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
124942124|NCT02401815|449414919|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
124942125|NCT02401815|449414920|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
124942126|NCT02401815|449414911|FG000|Dose Escalation (up to 670 Days)|Death|1|||
124942127|NCT02401815|449414912|FG001|Dose Escalation (up to 670 Days)|Death|2|||
124942128|NCT02401815|449414913|FG002|Dose Escalation (up to 670 Days)|Death|3|||
124942129|NCT02401815|449414914|FG003|Dose Escalation (up to 670 Days)|Death|5|||
124942130|NCT02401815|449414915|FG004|Dose Escalation (up to 670 Days)|Death|4|||
124942131|NCT02401815|449414916|FG005|Dose Escalation (up to 670 Days)|Death|0|||
124547521|NCT00530621|447958915|FG000|Overall Study|Subject Decision|4|||
124765189|NCT00812708|448767336|FG000|Overall Study|Switched to another study|1|||
124765190|NCT00812708|448767336|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
124765191|NCT00812708|448767336|FG000|Overall Study|Signed consent but later withdrew|3|||
124942132|NCT02401815|449414917|FG006|Dose Escalation (up to 670 Days)|Death|0|||
124942133|NCT02401815|449414918|FG007|Dose Escalation (up to 670 Days)|Death|0|||
124765192|NCT01959503|448767337|FG000|Overall Study|Death|2|||
124547522|NCT00530621|447958916|FG001|Overall Study|Subject Decision|7|||
124547523|NCT00530621|447958915|FG000|Overall Study|Death|3|||
124547524|NCT00530621|447958916|FG001|Overall Study|Death|6|||
124547525|NCT00530621|447958915|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
124547526|NCT00530621|447958916|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
124547527|NCT03409328|447958917|FG000|Overall Study|Lost to Follow-up|6|||
124547528|NCT03409328|447958918|FG001|Overall Study|Lost to Follow-up|3|||
124547529|NCT02596009|447958919|FG000|Overall Study|Administrative problems|0|||
124547530|NCT02596009|447958920|FG001|Overall Study|Administrative problems|1|||
124547531|NCT02596009|447958921|FG002|Overall Study|Administrative problems|0|||
124547532|NCT02596009|447958922|FG003|Overall Study|Administrative problems|0|||
124547533|NCT02596009|447958923|FG004|Overall Study|Administrative problems|0|||
124547534|NCT02596009|447958924|FG005|Overall Study|Administrative problems|0|||
124547535|NCT00518011|447958925|FG000|Overall Study|Death|1|||
124547536|NCT00518011|447958926|FG001|Overall Study|Death|1|||
124547537|NCT00518011|447958925|FG000|Overall Study|Adverse Event|2|||
124547538|NCT00518011|447958926|FG001|Overall Study|Adverse Event|3|||
124547539|NCT00518011|447958925|FG000|Overall Study|Disease Progression|2|||
124547540|NCT00518011|447958926|FG001|Overall Study|Disease Progression|2|||
124547541|NCT00518011|447958925|FG000|Overall Study|Other Reasons|3|||
124547542|NCT00518011|447958926|FG001|Overall Study|Other Reasons|2|||
124547543|NCT00518011|447958925|FG000|Overall Study|Withdrawal by Subject|1|||
124547544|NCT00518011|447958926|FG001|Overall Study|Withdrawal by Subject|0|||
124547545|NCT03930615|447958927|FG000|Overall Study|Death|9|||
124547546|NCT03930615|447958928|FG001|Overall Study|Death|3|||
124547547|NCT03930615|447958927|FG000|Overall Study|Lost to Follow-up|1|||
124547548|NCT03930615|447958928|FG001|Overall Study|Lost to Follow-up|2|||
124547549|NCT03930615|447958927|FG000|Overall Study|Physician Decision|3|||
124942134|NCT02401815|449414919|FG008|Dose Escalation (up to 670 Days)|Death|0|||
124942135|NCT02401815|449414920|FG009|Dose Escalation (up to 670 Days)|Death|0|||
124942136|NCT02401815|449414911|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
124942137|NCT02401815|449414912|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
124942138|NCT02401815|449414913|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
124942139|NCT02401815|449414914|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
124942140|NCT02401815|449414915|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
124942141|NCT02401815|449414916|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
124942142|NCT02401815|449414917|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
124942143|NCT02401815|449414918|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
124942144|NCT02401815|449414919|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
124942145|NCT02401815|449414920|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
124942146|NCT02401815|449414911|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
124942147|NCT02401815|449414912|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
124942148|NCT02401815|449414913|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
124942149|NCT02401815|449414914|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
124942150|NCT02401815|449414915|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
124942151|NCT02401815|449414916|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
124942152|NCT02401815|449414917|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
124942153|NCT02401815|449414918|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
124942154|NCT02401815|449414919|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
124942155|NCT02401815|449414920|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
124942156|NCT02401815|449414911|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
124942157|NCT02401815|449414912|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
124942158|NCT02401815|449414913|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
124942159|NCT02401815|449414914|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
124942160|NCT02401815|449414915|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
124547550|NCT03930615|447958928|FG001|Overall Study|Physician Decision|4|||
124547551|NCT03930615|447958927|FG000|Overall Study|Withdrawal by Subject|13|||
124547552|NCT03930615|447958928|FG001|Overall Study|Withdrawal by Subject|2|||
124547553|NCT03930615|447958927|FG000|Overall Study|Not treated|1|||
124547554|NCT03930615|447958928|FG001|Overall Study|Not treated|1|||
124547555|NCT04797637|447958939|FG000|Overall Study|Lost to Follow-up|23|||
124547556|NCT04797637|447958940|FG001|Overall Study|Lost to Follow-up|32|||
124547557|NCT04797637|447958939|FG000|Overall Study|Withdrawal by Subject|0|||
124547558|NCT04797637|447958940|FG001|Overall Study|Withdrawal by Subject|1|||
124704725|NCT01182350|448542940|FG000|Overall Study|Withdrawal by Subject|3|||
124704726|NCT01182350|448542941|FG001|Overall Study|Withdrawal by Subject|1|||
124704727|NCT01182350|448542942|FG002|Overall Study|Withdrawal by Subject|0|||
124704728|NCT01182350|448542943|FG003|Overall Study|Withdrawal by Subject|1|||
124704729|NCT01182350|448542944|FG004|Overall Study|Withdrawal by Subject|0|||
124704730|NCT01182350|448542940|FG000|Overall Study|Alternative Therapy|2|||
124704731|NCT01182350|448542941|FG001|Overall Study|Alternative Therapy|0|||
124704732|NCT01182350|448542942|FG002|Overall Study|Alternative Therapy|1|||
124704733|NCT01182350|448542943|FG003|Overall Study|Alternative Therapy|0|||
124704734|NCT01182350|448542944|FG004|Overall Study|Alternative Therapy|0|||
124704735|NCT01182350|448542940|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
124704736|NCT01182350|448542941|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
124704737|NCT01182350|448542942|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
124704738|NCT01182350|448542943|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
124704739|NCT01182350|448542944|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
124704740|NCT01182350|448542940|FG000|Overall Study|Unevaluable for Biopsy|0|||
124704741|NCT01182350|448542941|FG001|Overall Study|Unevaluable for Biopsy|0|||
124704742|NCT01182350|448542942|FG002|Overall Study|Unevaluable for Biopsy|0|||
124704743|NCT01182350|448542943|FG003|Overall Study|Unevaluable for Biopsy|0|||
124704744|NCT01182350|448542944|FG004|Overall Study|Unevaluable for Biopsy|3|||
124704745|NCT03898180|448542945|FG000|Overall Study|Death|178|||
124704746|NCT03898180|448542946|FG001|Overall Study|Death|173|||
124704747|NCT03898180|448542945|FG000|Overall Study|Physician Decision|1|||
124704748|NCT03898180|448542946|FG001|Overall Study|Physician Decision|0|||
124704749|NCT03898180|448542945|FG000|Overall Study|Sponsor Decision|3|||
124704750|NCT03898180|448542946|FG001|Overall Study|Sponsor Decision|0|||
124765193|NCT01959503|448767338|FG001|Overall Study|Death|1|||
124942161|NCT02401815|449414916|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
124942162|NCT02401815|449414917|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
124942163|NCT02401815|449414918|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
124942164|NCT02401815|449414919|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
124942165|NCT02401815|449414920|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
124942166|NCT02401815|449414911|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942167|NCT02401815|449414912|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942168|NCT02401815|449414913|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942169|NCT02401815|449414914|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942170|NCT02401815|449414915|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942171|NCT02401815|449414916|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942172|NCT02401815|449414917|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
124942173|NCT02401815|449414918|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942174|NCT02401815|449414919|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942175|NCT02401815|449414920|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942176|NCT02401815|449414911|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
124942177|NCT02401815|449414912|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
124942178|NCT02401815|449414913|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
124942179|NCT02401815|449414914|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
124942180|NCT02401815|449414915|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
124942181|NCT02401815|449414916|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
124942182|NCT02401815|449414917|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
124942183|NCT02401815|449414918|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
124942184|NCT02401815|449414919|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
124942185|NCT02401815|449414920|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
124704751|NCT03898180|448542945|FG000|Overall Study|Lost to Follow-up|1|||
124704752|NCT03898180|448542946|FG001|Overall Study|Lost to Follow-up|0|||
124704753|NCT03898180|448542945|FG000|Overall Study|Withdrawal by Subject|5|||
124704754|NCT03898180|448542946|FG001|Overall Study|Withdrawal by Subject|4|||
124704755|NCT01646827|448542947|FG000|Overall Study|Lost to Follow-up|0|||
124704756|NCT01646827|448542948|FG001|Overall Study|Lost to Follow-up|3|||
124704757|NCT01646827|448542947|FG000|Overall Study|Physician Decision|1|||
124704758|NCT01646827|448542948|FG001|Overall Study|Physician Decision|2|||
124704759|NCT01646827|448542947|FG000|Overall Study|Withdrawal by Subject|1|||
124704760|NCT01646827|448542948|FG001|Overall Study|Withdrawal by Subject|0|||
124704761|NCT00928668|448542949|FG000|Overall Study|Adverse Event|1|||
124704762|NCT00928668|448542950|FG001|Overall Study|Adverse Event|0|||
124704763|NCT00928668|448542951|FG002|Overall Study|Adverse Event|0|||
124704764|NCT00928668|448542952|FG003|Overall Study|Adverse Event|0|||
124704765|NCT00928668|448542953|FG004|Overall Study|Adverse Event|0|||
124704766|NCT00928668|448542949|FG000|Overall Study|Protocol Violation|0|||
124704767|NCT00928668|448542950|FG001|Overall Study|Protocol Violation|0|||
124704768|NCT00928668|448542951|FG002|Overall Study|Protocol Violation|0|||
124547559|NCT00648739|447960256|FG000|Overall Study|Adverse Event|1|||
124547560|NCT00648739|447960257|FG001|Overall Study|Adverse Event|0|||
124547561|NCT00648739|447960258|FG002|Overall Study|Adverse Event|1|||
124547562|NCT00648739|447960259|FG003|Overall Study|Adverse Event|2|||
124547563|NCT00648739|447960260|FG004|Overall Study|Adverse Event|1|||
124547564|NCT00648739|447960261|FG005|Overall Study|Adverse Event|0|||
124547565|NCT00648739|447960262|FG006|Overall Study|Adverse Event|0|||
124547566|NCT00648739|447960256|FG000|Overall Study|Withdrawal by Subject|1|||
124547567|NCT00648739|447960257|FG001|Overall Study|Withdrawal by Subject|0|||
124547568|NCT00648739|447960258|FG002|Overall Study|Withdrawal by Subject|1|||
124547569|NCT00648739|447960259|FG003|Overall Study|Withdrawal by Subject|0|||
124547570|NCT00648739|447960260|FG004|Overall Study|Withdrawal by Subject|0|||
124547571|NCT00648739|447960261|FG005|Overall Study|Withdrawal by Subject|2|||
124547572|NCT00648739|447960262|FG006|Overall Study|Withdrawal by Subject|0|||
124547573|NCT00648739|447960256|FG000|Overall Study|Lack of Efficacy|0|||
124547574|NCT00648739|447960257|FG001|Overall Study|Lack of Efficacy|0|||
124547575|NCT00648739|447960258|FG002|Overall Study|Lack of Efficacy|0|||
124547576|NCT00648739|447960259|FG003|Overall Study|Lack of Efficacy|0|||
124547577|NCT00648739|447960260|FG004|Overall Study|Lack of Efficacy|1|||
124547578|NCT00648739|447960261|FG005|Overall Study|Lack of Efficacy|2|||
124547579|NCT00648739|447960262|FG006|Overall Study|Lack of Efficacy|0|||
124547580|NCT00648739|447960256|FG000|Overall Study|Investigator Considered it Advisable|0|||
124547581|NCT00648739|447960257|FG001|Overall Study|Investigator Considered it Advisable|0|||
124547582|NCT00648739|447960258|FG002|Overall Study|Investigator Considered it Advisable|0|||
124547583|NCT00648739|447960259|FG003|Overall Study|Investigator Considered it Advisable|0|||
124547584|NCT00648739|447960260|FG004|Overall Study|Investigator Considered it Advisable|0|||
124547585|NCT00648739|447960261|FG005|Overall Study|Investigator Considered it Advisable|1|||
124547586|NCT00648739|447960262|FG006|Overall Study|Investigator Considered it Advisable|1|||
124547587|NCT00648739|447960256|FG000|Overall Study|Death|0|||
124547588|NCT00648739|447960257|FG001|Overall Study|Death|1|||
124547589|NCT00648739|447960258|FG002|Overall Study|Death|0|||
124547590|NCT00648739|447960259|FG003|Overall Study|Death|0|||
124547591|NCT00648739|447960260|FG004|Overall Study|Death|0|||
124547592|NCT00648739|447960261|FG005|Overall Study|Death|0|||
124547593|NCT00648739|447960262|FG006|Overall Study|Death|0|||
124547594|NCT00648739|447960256|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
124547595|NCT00648739|447960257|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
124547596|NCT00648739|447960258|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
124547597|NCT00648739|447960259|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
124547598|NCT00648739|447960260|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
124547599|NCT00648739|447960261|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
124547600|NCT00648739|447960262|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
124547601|NCT00648739|447960256|FG000|Overall Study|Follow-up Visits Not Completed|0|||
124547602|NCT00648739|447960257|FG001|Overall Study|Follow-up Visits Not Completed|1|||
124547603|NCT00648739|447960258|FG002|Overall Study|Follow-up Visits Not Completed|0|||
124547604|NCT00648739|447960259|FG003|Overall Study|Follow-up Visits Not Completed|0|||
124547605|NCT00648739|447960260|FG004|Overall Study|Follow-up Visits Not Completed|0|||
124547606|NCT00648739|447960261|FG005|Overall Study|Follow-up Visits Not Completed|0|||
124547607|NCT00648739|447960262|FG006|Overall Study|Follow-up Visits Not Completed|0|||
124547608|NCT00242567|447960267|FG000|Overall Study|Adverse Event|70|||
124547609|NCT00242567|447960268|FG001|Overall Study|Adverse Event|43|||
124547610|NCT00242567|447960267|FG000|Overall Study|Disease Progression|17|||
124547611|NCT00242567|447960268|FG001|Overall Study|Disease Progression|22|||
124547612|NCT00242567|447960267|FG000|Overall Study|Symptomatic deterioration|9|||
124547613|NCT00242567|447960268|FG001|Overall Study|Symptomatic deterioration|3|||
124547614|NCT00242567|447960267|FG000|Overall Study|Lack of Efficacy|2|||
124547615|NCT00242567|447960268|FG001|Overall Study|Lack of Efficacy|2|||
124547616|NCT00242567|447960267|FG000|Overall Study|Lost to Follow-up|9|||
124547617|NCT00242567|447960268|FG001|Overall Study|Lost to Follow-up|19|||
124547618|NCT00242567|447960267|FG000|Overall Study|Withdrawal by Subject|33|||
124547619|NCT00242567|447960268|FG001|Overall Study|Withdrawal by Subject|28|||
124547620|NCT00242567|447960267|FG000|Overall Study|Protocol Violation|12|||
124547621|NCT00242567|447960268|FG001|Overall Study|Protocol Violation|12|||
124547622|NCT00242567|447960267|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
124547623|NCT00242567|447960268|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
124547624|NCT00242567|447960267|FG000|Overall Study|Other|14|||
124942186|NCT02401815|449414911|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
124547625|NCT00242567|447960268|FG001|Overall Study|Other|9|||
124547626|NCT01721200|447960269|FG000|Overall Study|Lost to Follow-up|3|||
124547627|NCT01721200|447960270|FG001|Overall Study|Lost to Follow-up|5|||
124547628|NCT02729545|447960273|FG000|Overall Study|Pregnancy|1|||
124547629|NCT02729545|447960274|FG001|Overall Study|Pregnancy|1|||
124547630|NCT02729545|447960273|FG000|Overall Study|Lost to Follow-up|0|||
124547631|NCT02729545|447960274|FG001|Overall Study|Lost to Follow-up|1|||
124547632|NCT02729545|447960273|FG000|Overall Study|Withdrawal by Subject|2|||
124547633|NCT02729545|447960274|FG001|Overall Study|Withdrawal by Subject|3|||
124942187|NCT02401815|449414912|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
124942188|NCT02401815|449414913|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
124942189|NCT02401815|449414914|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
124942190|NCT02401815|449414915|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
124942191|NCT02401815|449414916|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
124942192|NCT02401815|449414917|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
124942193|NCT02401815|449414918|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
124942194|NCT02401815|449414919|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
124942195|NCT02401815|449414920|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
124942196|NCT02401815|449414911|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
124942197|NCT02401815|449414912|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
124942198|NCT02401815|449414913|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
124942199|NCT02401815|449414914|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
124942200|NCT02401815|449414915|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
124942201|NCT02401815|449414916|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
124942202|NCT02401815|449414917|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
124942203|NCT02401815|449414918|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
124942204|NCT02401815|449414919|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
124942205|NCT02401815|449414920|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
124942206|NCT02401815|449414911|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942207|NCT02401815|449414912|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942208|NCT02401815|449414913|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942209|NCT02401815|449414914|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942210|NCT02401815|449414915|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124547634|NCT04930536|447960277|FG000|Overall Study|Adverse Event|1|||
124547635|NCT04930536|447960278|FG001|Overall Study|Adverse Event|0|||
124547636|NCT04930536|447960277|FG000|Overall Study|Disease Progression|2|||
124547637|NCT04930536|447960278|FG001|Overall Study|Disease Progression|0|||
124547638|NCT04930536|447960277|FG000|Overall Study|Patient Decision|4|||
124547639|NCT04930536|447960278|FG001|Overall Study|Patient Decision|2|||
124547640|NCT04930536|447960277|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
124547641|NCT04930536|447960278|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
124547642|NCT01432600|447960279|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
124547643|NCT01432600|447960280|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
124547644|NCT01432600|447960281|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
124547645|NCT03079869|447960290|FG000|Overall Study|Adverse Event|6|||
124547646|NCT03079869|447960291|FG001|Overall Study|Adverse Event|8|||
124547647|NCT03079869|447960290|FG000|Overall Study|Withdrawal by Subject|4|||
124547648|NCT03079869|447960291|FG001|Overall Study|Withdrawal by Subject|1|||
124942211|NCT02401815|449414916|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124547649|NCT03079869|447960290|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
124942212|NCT02401815|449414917|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942213|NCT02401815|449414918|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
124942214|NCT02401815|449414919|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
124942215|NCT02401815|449414920|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
124942216|NCT02401815|449414911|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942217|NCT02401815|449414912|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942218|NCT02401815|449414913|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942219|NCT02401815|449414914|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942220|NCT02401815|449414915|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942221|NCT02401815|449414916|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942222|NCT02401815|449414917|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942223|NCT02401815|449414918|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942224|NCT02401815|449414919|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
124942225|NCT02401815|449414920|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
124942226|NCT02401815|449414911|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
124942227|NCT02401815|449414912|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
124942228|NCT02401815|449414913|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
124942229|NCT02401815|449414914|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
124942230|NCT02401815|449414915|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
124547650|NCT03079869|447960291|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
124547651|NCT02411110|447960292|FG000|Treatment Period 1|Adverse Event|4|||
124547652|NCT02411110|447960293|FG001|Treatment Period 1|Adverse Event|2|||
124547653|NCT02411110|447960292|FG000|Treatment Period 1|Lost to Follow-up|1|||
124547654|NCT02411110|447960293|FG001|Treatment Period 1|Lost to Follow-up|0|||
124942231|NCT02401815|449414916|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
124942232|NCT02401815|449414917|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
124942233|NCT02401815|449414918|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
124942234|NCT02401815|449414919|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
124942235|NCT02401815|449414920|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
124942236|NCT02401815|449414911|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
124942237|NCT02401815|449414912|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
124942238|NCT02401815|449414913|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
124942239|NCT02401815|449414914|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
124942240|NCT02401815|449414915|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
124942241|NCT02401815|449414916|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
124942242|NCT02401815|449414917|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
124942243|NCT02401815|449414918|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
124942244|NCT02401815|449414919|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
124942245|NCT02401815|449414920|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
124942246|NCT03773107|449414934|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
124942247|NCT03773107|449414935|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
124942248|NCT03773107|449414936|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
124942249|NCT03773107|449414937|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
124942250|NCT05864209|449416618|FG000|Overall Study|Lost to Follow-up|2|||
124942251|NCT05864209|449416619|FG001|Overall Study|Lost to Follow-up|3|||
124942252|NCT00092534|449416622|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
124942253|NCT00092534|449416623|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
124942254|NCT00092534|449416624|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
124942255|NCT00092534|449416625|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
124942256|NCT00092534|449416626|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
124942257|NCT00092534|449416622|FG000|Base Study Vaccination Period|Adverse Event|3|||
124942258|NCT00092534|449416623|FG001|Base Study Vaccination Period|Adverse Event|1|||
124942259|NCT00092534|449416624|FG002|Base Study Vaccination Period|Adverse Event|0|||
124942260|NCT00092534|449416625|FG003|Base Study Vaccination Period|Adverse Event|0|||
124942261|NCT00092534|449416626|FG004|Base Study Vaccination Period|Adverse Event|0|||
124942262|NCT00092534|449416622|FG000|Base Study Vaccination Period|Death|5|||
124942263|NCT00092534|449416623|FG001|Base Study Vaccination Period|Death|4|||
124942264|NCT00092534|449416624|FG002|Base Study Vaccination Period|Death|0|||
124942265|NCT00092534|449416625|FG003|Base Study Vaccination Period|Death|0|||
124942266|NCT00092534|449416626|FG004|Base Study Vaccination Period|Death|0|||
124942267|NCT00092534|449416622|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
124942268|NCT00092534|449416623|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
124942269|NCT00092534|449416624|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
124942270|NCT00092534|449416625|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
124942271|NCT00092534|449416626|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
124942272|NCT00092534|449416622|FG000|Base Study Vaccination Period|Physician Decision|1|||
124942273|NCT00092534|449416623|FG001|Base Study Vaccination Period|Physician Decision|0|||
124942274|NCT00092534|449416624|FG002|Base Study Vaccination Period|Physician Decision|0|||
124942275|NCT00092534|449416625|FG003|Base Study Vaccination Period|Physician Decision|0|||
124942276|NCT00092534|449416626|FG004|Base Study Vaccination Period|Physician Decision|0|||
124942277|NCT00092534|449416622|FG000|Base Study Vaccination Period|Pregnancy|9|||
124942278|NCT00092534|449416623|FG001|Base Study Vaccination Period|Pregnancy|7|||
124942279|NCT00092534|449416624|FG002|Base Study Vaccination Period|Pregnancy|0|||
124942280|NCT00092534|449416625|FG003|Base Study Vaccination Period|Pregnancy|0|||
124942281|NCT00092534|449416626|FG004|Base Study Vaccination Period|Pregnancy|0|||
124942282|NCT00092534|449416622|FG000|Base Study Vaccination Period|Protocol Violation|2|||
124942283|NCT00092534|449416623|FG001|Base Study Vaccination Period|Protocol Violation|1|||
124942284|NCT00092534|449416624|FG002|Base Study Vaccination Period|Protocol Violation|0|||
124942285|NCT00092534|449416625|FG003|Base Study Vaccination Period|Protocol Violation|0|||
124942286|NCT00092534|449416626|FG004|Base Study Vaccination Period|Protocol Violation|0|||
124942287|NCT00092534|449416622|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
124942288|NCT00092534|449416623|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
124942289|NCT00092534|449416624|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
124942290|NCT00092534|449416625|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
124942291|NCT00092534|449416626|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
124942292|NCT00092534|449416622|FG000|Base Study Vaccination Period|Moved|14|||
124942293|NCT00092534|449416623|FG001|Base Study Vaccination Period|Moved|12|||
124942294|NCT00092534|449416624|FG002|Base Study Vaccination Period|Moved|0|||
124942295|NCT00092534|449416625|FG003|Base Study Vaccination Period|Moved|0|||
124942296|NCT00092534|449416626|FG004|Base Study Vaccination Period|Moved|0|||
124942297|NCT00092534|449416622|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
124704769|NCT00928668|448542952|FG003|Overall Study|Protocol Violation|0|||
124704770|NCT00928668|448542953|FG004|Overall Study|Protocol Violation|1|||
124704771|NCT00928668|448542949|FG000|Overall Study|Withdrawal by Subject|0|||
124704772|NCT00928668|448542950|FG001|Overall Study|Withdrawal by Subject|1|||
124704773|NCT00928668|448542951|FG002|Overall Study|Withdrawal by Subject|1|||
124704774|NCT00928668|448542952|FG003|Overall Study|Withdrawal by Subject|0|||
124704775|NCT00928668|448542953|FG004|Overall Study|Withdrawal by Subject|0|||
124704776|NCT00928668|448542949|FG000|Overall Study|Other reasons not listed above|0|||
124704777|NCT00928668|448542950|FG001|Overall Study|Other reasons not listed above|0|||
124704778|NCT00928668|448542951|FG002|Overall Study|Other reasons not listed above|0|||
124704779|NCT00928668|448542952|FG003|Overall Study|Other reasons not listed above|1|||
124704780|NCT00928668|448542953|FG004|Overall Study|Other reasons not listed above|0|||
124704781|NCT01767987|448542957|FG000|Overall Study|Physician Decision|4|||
124704782|NCT01767987|448542958|FG001|Overall Study|Physician Decision|1|||
124942298|NCT00092534|449416623|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
124942299|NCT00092534|449416624|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
124942300|NCT00092534|449416625|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
124942301|NCT00092534|449416626|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
124942302|NCT00092534|449416622|FG000|Base Study Vaccination Period|Travel|1|||
124942303|NCT00092534|449416623|FG001|Base Study Vaccination Period|Travel|0|||
124942304|NCT00092534|449416624|FG002|Base Study Vaccination Period|Travel|0|||
124942305|NCT00092534|449416625|FG003|Base Study Vaccination Period|Travel|0|||
124942306|NCT00092534|449416626|FG004|Base Study Vaccination Period|Travel|0|||
124942307|NCT00092534|449416622|FG000|Base Study Vaccination Period|Site Closed|0|||
124942308|NCT00092534|449416623|FG001|Base Study Vaccination Period|Site Closed|1|||
124942309|NCT00092534|449416624|FG002|Base Study Vaccination Period|Site Closed|0|||
124942310|NCT00092534|449416625|FG003|Base Study Vaccination Period|Site Closed|0|||
124942311|NCT00092534|449416626|FG004|Base Study Vaccination Period|Site Closed|0|||
124942312|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Adverse Event|2|||
124942313|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Adverse Event|4|||
124942314|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Adverse Event|0|||
124942315|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Adverse Event|0|||
124942316|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Adverse Event|0|||
124942317|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Death|2|||
124942318|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Death|1|||
124942319|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Death|0|||
124942320|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Death|0|||
124942321|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Death|0|||
124942322|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
124942323|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
124942324|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
124942325|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
124942326|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
124942327|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Pregnancy|6|||
124942328|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Pregnancy|10|||
124942329|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Pregnancy|0|||
124942330|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Pregnancy|0|||
124942331|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Pregnancy|0|||
124942332|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
124942333|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
124942334|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
124942335|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
124942336|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
124942337|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
124942338|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
124942339|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
124704783|NCT03232567|448542959|FG000|Overall Study|Withdrawal by Subject|0|||
124704784|NCT03232567|448542960|FG001|Overall Study|Withdrawal by Subject|1|||
124704785|NCT03232567|448542961|FG002|Overall Study|Withdrawal by Subject|0|||
124942340|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
124942341|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
124942342|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Moved|62|||
124942343|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Moved|58|||
124942344|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Moved|0|||
124942345|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Moved|0|||
124942346|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Moved|0|||
124942347|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Travel|10|||
124942348|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Travel|7|||
124704786|NCT03232567|448542962|FG003|Overall Study|Withdrawal by Subject|0|||
124704787|NCT05837481|448542963|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
124712016|NCT00800735|448570712|FG000|Overall Study|Administrative/Other|2|||
124942349|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Travel|0|||
124942350|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Travel|0|||
124704788|NCT05837481|448542964|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
124704789|NCT03038087|448542967|FG000|Overall Study|lost data|1|||
124704790|NCT02284893|448542976|FG000|26 Week (Short Term)|Adverse Event|1|||
124704791|NCT02284893|448542977|FG001|26 Week (Short Term)|Adverse Event|9|||
124704792|NCT02284893|448542976|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
124704793|NCT02284893|448542977|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
124704794|NCT02284893|448542976|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
124704795|NCT02284893|448542977|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
124704796|NCT02284893|448542976|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
124704797|NCT02284893|448542977|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
124704798|NCT02284893|448542976|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
124704799|NCT02284893|448542977|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
124704800|NCT02284893|448542976|FG000|26 Week (Short Term)|Other|1|||
124704801|NCT02284893|448542977|FG001|26 Week (Short Term)|Other|1|||
124765194|NCT01959503|448767337|FG000|Overall Study|Randomized but not treated|1|||
124942351|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Travel|0|||
124942352|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Site Closed|0|||
124942353|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Site Closed|2|||
124942354|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Site Closed|0|||
124942355|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Site Closed|0|||
124942356|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Site Closed|0|||
124942357|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
124942358|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
124942359|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
124765195|NCT01959503|448767338|FG001|Overall Study|Randomized but not treated|1|||
124765196|NCT01600326|448767339|FG000|Overall Study|Lost to Follow-up|1|||
124942360|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
124942361|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
124942362|NCT00092534|449416622|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
124942363|NCT00092534|449416623|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
124942364|NCT00092534|449416624|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
124942365|NCT00092534|449416625|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
124765197|NCT01600326|448767340|FG001|Overall Study|Lost to Follow-up|1|||
124765198|NCT01131507|448767342|FG000|Overall Study|Adverse Event|1|||
124765199|NCT01131507|448767342|FG000|Overall Study|Lost to Follow-up|1|||
124942366|NCT00092534|449416626|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
124942367|NCT00092534|449416622|FG000|Base Study EXT|Lost to Follow-up|0|||
124942368|NCT00092534|449416623|FG001|Base Study EXT|Lost to Follow-up|0|||
124942369|NCT00092534|449416624|FG002|Base Study EXT|Lost to Follow-up|41|||
124942370|NCT00092534|449416625|FG003|Base Study EXT|Lost to Follow-up|0|||
124765200|NCT01131507|448767342|FG000|Overall Study|Withdrawal by Subject|1|||
124765201|NCT01393158|448767343|FG000|Overall Study|Adverse Event|1|||
124765202|NCT01393158|448767344|FG001|Overall Study|Adverse Event|0|||
124765203|NCT03224130|448767345|FG000|Overall Study|consent issue|0|||
124765204|NCT03224130|448767346|FG001|Overall Study|consent issue|1|||
124765205|NCT03095651|448767349|FG000|Overall Study|Lost to Follow-up|1|||
124765206|NCT03095651|448767350|FG001|Overall Study|Lost to Follow-up|1|||
124765207|NCT03095651|448767351|FG002|Overall Study|Lost to Follow-up|0|||
124765208|NCT03095651|448767352|FG003|Overall Study|Lost to Follow-up|1|||
124765209|NCT03095651|448767353|FG004|Overall Study|Lost to Follow-up|0|||
124765210|NCT03095651|448767354|FG005|Overall Study|Lost to Follow-up|0|||
124765211|NCT03095651|448767355|FG006|Overall Study|Lost to Follow-up|0|||
124765212|NCT03095651|448767356|FG007|Overall Study|Lost to Follow-up|0|||
124765213|NCT03095651|448767349|FG000|Overall Study|Withdrawal by Subject|0|||
124765214|NCT03095651|448767350|FG001|Overall Study|Withdrawal by Subject|0|||
124765215|NCT03095651|448767351|FG002|Overall Study|Withdrawal by Subject|0|||
124942371|NCT00092534|449416626|FG004|Base Study EXT|Lost to Follow-up|0|||
124942372|NCT00092534|449416622|FG000|Base Study EXT|Physician Decision|0|||
124704802|NCT02284893|448542976|FG000|52 Week (Long Term)|Adverse Event|3|||
124704803|NCT02284893|448542977|FG001|52 Week (Long Term)|Adverse Event|1|||
124704804|NCT02284893|448542976|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
124765216|NCT03095651|448767352|FG003|Overall Study|Withdrawal by Subject|0|||
124765217|NCT03095651|448767353|FG004|Overall Study|Withdrawal by Subject|0|||
124765218|NCT03095651|448767354|FG005|Overall Study|Withdrawal by Subject|1|||
124765219|NCT03095651|448767355|FG006|Overall Study|Withdrawal by Subject|0|||
124765220|NCT03095651|448767356|FG007|Overall Study|Withdrawal by Subject|0|||
124765221|NCT02587520|448767362|FG000|Overall Study|Protocol Violation|2|||
124765222|NCT02587520|448767363|FG001|Overall Study|Protocol Violation|0|||
124765223|NCT02587520|448767364|FG002|Overall Study|Protocol Violation|0|||
124765224|NCT02587520|448767365|FG003|Overall Study|Protocol Violation|2|||
124942373|NCT00092534|449416623|FG001|Base Study EXT|Physician Decision|0|||
124942374|NCT00092534|449416624|FG002|Base Study EXT|Physician Decision|1|||
124765225|NCT02587520|448767366|FG004|Overall Study|Protocol Violation|0|||
124942375|NCT00092534|449416625|FG003|Base Study EXT|Physician Decision|0|||
124457999|NCT02116777|447636772|FG003|Overall Study|Death|1|||
124942376|NCT00092534|449416626|FG004|Base Study EXT|Physician Decision|0|||
124942377|NCT00092534|449416622|FG000|Base Study EXT|Pregnancy|0|||
124942378|NCT00092534|449416623|FG001|Base Study EXT|Pregnancy|0|||
124942379|NCT00092534|449416624|FG002|Base Study EXT|Pregnancy|12|||
124942380|NCT00092534|449416625|FG003|Base Study EXT|Pregnancy|0|||
124942381|NCT00092534|449416626|FG004|Base Study EXT|Pregnancy|0|||
124942382|NCT00092534|449416622|FG000|Base Study EXT|Withdrawal by Subject|0|||
124942383|NCT00092534|449416623|FG001|Base Study EXT|Withdrawal by Subject|0|||
124942384|NCT00092534|449416624|FG002|Base Study EXT|Withdrawal by Subject|18|||
124942385|NCT00092534|449416625|FG003|Base Study EXT|Withdrawal by Subject|0|||
124942386|NCT00092534|449416626|FG004|Base Study EXT|Withdrawal by Subject|0|||
124942387|NCT00092534|449416622|FG000|Base Study EXT|Participant moved|0|||
124942388|NCT00092534|449416623|FG001|Base Study EXT|Participant moved|0|||
124942389|NCT00092534|449416624|FG002|Base Study EXT|Participant moved|6|||
124942390|NCT00092534|449416625|FG003|Base Study EXT|Participant moved|0|||
124942391|NCT00092534|449416626|FG004|Base Study EXT|Participant moved|0|||
124942392|NCT00092534|449416622|FG000|Base Study EXT|Travel|0|||
124942393|NCT00092534|449416623|FG001|Base Study EXT|Travel|0|||
124942394|NCT00092534|449416624|FG002|Base Study EXT|Travel|2|||
124942395|NCT00092534|449416625|FG003|Base Study EXT|Travel|0|||
124942396|NCT00092534|449416626|FG004|Base Study EXT|Travel|0|||
124942397|NCT00092534|449416622|FG000|Base Study EXT|Site closed|0|||
124942398|NCT00092534|449416623|FG001|Base Study EXT|Site closed|0|||
124942399|NCT00092534|449416624|FG002|Base Study EXT|Site closed|21|||
124942400|NCT00092534|449416625|FG003|Base Study EXT|Site closed|0|||
124942401|NCT00092534|449416626|FG004|Base Study EXT|Site closed|0|||
124942402|NCT00092534|449416622|FG000|Base Study EXT|Study ended|0|||
124942403|NCT00092534|449416623|FG001|Base Study EXT|Study ended|0|||
124942404|NCT00092534|449416624|FG002|Base Study EXT|Study ended|29|||
124942405|NCT00092534|449416625|FG003|Base Study EXT|Study ended|0|||
124942406|NCT00092534|449416626|FG004|Base Study EXT|Study ended|0|||
124942407|NCT00092534|449416622|FG000|Base Study EXT|Protocol Violation|0|||
124942408|NCT00092534|449416623|FG001|Base Study EXT|Protocol Violation|0|||
124942409|NCT00092534|449416624|FG002|Base Study EXT|Protocol Violation|15|||
124942410|NCT00092534|449416625|FG003|Base Study EXT|Protocol Violation|0|||
124942411|NCT00092534|449416626|FG004|Base Study EXT|Protocol Violation|0|||
124942412|NCT00092534|449416622|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
124942413|NCT00092534|449416623|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
124942414|NCT00092534|449416624|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
124942415|NCT00092534|449416625|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
124942416|NCT00092534|449416626|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
124942417|NCT05029284|449416627|FG000|Overall Study|Lost to Follow-up|1|||
124942418|NCT04001829|449416628|FG000|Overall Study|Never start protocol therapy|5|||
124942419|NCT04001829|449416629|FG001|Overall Study|Never start protocol therapy|5|||
124942420|NCT04001829|449416628|FG000|Overall Study|Adverse Event|11|||
124942421|NCT04001829|449416629|FG001|Overall Study|Adverse Event|7|||
124942422|NCT04001829|449416628|FG000|Overall Study|Alternative therapy|1|||
124942423|NCT04001829|449416629|FG001|Overall Study|Alternative therapy|2|||
124942424|NCT04001829|449416628|FG000|Overall Study|Disease progression/relapse|2|||
124942425|NCT04001829|449416629|FG001|Overall Study|Disease progression/relapse|1|||
124942426|NCT04001829|449416628|FG000|Overall Study|Other complicating disease|1|||
124942427|NCT04001829|449416629|FG001|Overall Study|Other complicating disease|0|||
124942428|NCT04001829|449416628|FG000|Overall Study|Withdrawal by Subject|1|||
124942429|NCT04001829|449416629|FG001|Overall Study|Withdrawal by Subject|4|||
124942430|NCT04001829|449416628|FG000|Overall Study|Ineligible|2|||
124942431|NCT04001829|449416629|FG001|Overall Study|Ineligible|2|||
124942432|NCT04001829|449416628|FG000|Overall Study|Reason missing due to delinquent data|1|||
124942433|NCT04001829|449416629|FG001|Overall Study|Reason missing due to delinquent data|0|||
124765226|NCT02587520|448767367|FG005|Overall Study|Protocol Violation|1|||
124942434|NCT03678688|449416630|FG000|Overall Study|Reason not Specified|0|||
124942435|NCT03678688|449416631|FG001|Overall Study|Reason not Specified|0|||
124942436|NCT03678688|449416632|FG002|Overall Study|Reason not Specified|3|||
124942437|NCT03678688|449416633|FG003|Overall Study|Reason not Specified|0|||
124458000|NCT02116777|447636773|FG004|Overall Study|Death|0|||
124942438|NCT03678688|449416634|FG004|Overall Study|Reason not Specified|1|||
124942439|NCT03678688|449416635|FG005|Overall Study|Reason not Specified|0|||
124942440|NCT03678688|449416636|FG006|Overall Study|Reason not Specified|0|||
124942441|NCT03678688|449416637|FG007|Overall Study|Reason not Specified|0|||
124942442|NCT03678688|449416638|FG008|Overall Study|Reason not Specified|0|||
124942443|NCT03678688|449416630|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
124942444|NCT03678688|449416631|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
124942445|NCT03678688|449416632|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
124942446|NCT03678688|449416633|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
124942447|NCT03678688|449416634|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
124547655|NCT02411110|447960292|FG000|Treatment Period 1|Personal Reasons|2|||
124547656|NCT02411110|447960293|FG001|Treatment Period 1|Personal Reasons|5|||
124547657|NCT02411110|447960292|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
124547658|NCT02411110|447960293|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
124547659|NCT02411110|447960292|FG000|Treatment Period 2|Adverse Event|1|||
124547660|NCT02411110|447960293|FG001|Treatment Period 2|Adverse Event|0|||
124547661|NCT02411110|447960292|FG000|Treatment Period 2|Lost to Follow-up|0|||
124547662|NCT02411110|447960293|FG001|Treatment Period 2|Lost to Follow-up|2|||
124547663|NCT02411110|447960292|FG000|Treatment Period 2|Personal Reasons|0|||
124547664|NCT02411110|447960293|FG001|Treatment Period 2|Personal Reasons|2|||
124547665|NCT03292731|447960294|FG000|Overall Study|Protocol Violation|4|||
124547666|NCT03292731|447960295|FG001|Overall Study|Protocol Violation|11|||
124547667|NCT03292731|447960296|FG002|Overall Study|Protocol Violation|1|||
124547668|NCT03901352|447960300|FG000|Double-blind Phase|Adverse Event|6|||
124547669|NCT03901352|447960301|FG001|Double-blind Phase|Adverse Event|4|||
124547670|NCT03901352|447960300|FG000|Double-blind Phase|Death|1|||
124942448|NCT03678688|449416635|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
124942449|NCT03678688|449416636|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
124942450|NCT03678688|449416637|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
124942451|NCT03678688|449416638|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
124942452|NCT03678688|449416630|FG000|Overall Study|Covid Related Adverse Event|0|||
124942453|NCT03678688|449416631|FG001|Overall Study|Covid Related Adverse Event|0|||
124942454|NCT03678688|449416632|FG002|Overall Study|Covid Related Adverse Event|0|||
124942455|NCT03678688|449416633|FG003|Overall Study|Covid Related Adverse Event|0|||
124942456|NCT03678688|449416634|FG004|Overall Study|Covid Related Adverse Event|0|||
124942457|NCT03678688|449416635|FG005|Overall Study|Covid Related Adverse Event|3|||
124942458|NCT03678688|449416636|FG006|Overall Study|Covid Related Adverse Event|1|||
124942459|NCT03678688|449416637|FG007|Overall Study|Covid Related Adverse Event|1|||
124942460|NCT03678688|449416638|FG008|Overall Study|Covid Related Adverse Event|0|||
124704805|NCT02284893|448542977|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
124704806|NCT02284893|448542976|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
124704807|NCT02284893|448542977|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
124704808|NCT02284893|448542976|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
124704809|NCT02284893|448542977|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
124704810|NCT02284893|448542976|FG000|52 Week (Long Term)|Non-Compliance|2|||
124704811|NCT02284893|448542977|FG001|52 Week (Long Term)|Non-Compliance|3|||
124704812|NCT00105066|448542978|FG000|Overall Study|Adverse Event|2|||
124704813|NCT00105066|448542979|FG001|Overall Study|Adverse Event|5|||
124704814|NCT00847730|448543015|FG000|Overall Study|Multiple interruptions in therapy|8|||
124704815|NCT04507269|448543018|FG000|Overall Study|Withdrawal by Subject|1|||
124704816|NCT04507269|448543019|FG001|Overall Study|Withdrawal by Subject|1|||
124704817|NCT04507269|448543020|FG002|Overall Study|Withdrawal by Subject|0|||
124704818|NCT04507269|448543021|FG003|Overall Study|Withdrawal by Subject|0|||
124704819|NCT04507269|448543022|FG004|Overall Study|Withdrawal by Subject|0|||
124704820|NCT04507269|448543023|FG005|Overall Study|Withdrawal by Subject|0|||
124704821|NCT04507269|448543018|FG000|Overall Study|Lost to Follow-up|0|||
124704822|NCT04507269|448543019|FG001|Overall Study|Lost to Follow-up|0|||
124704823|NCT04507269|448543020|FG002|Overall Study|Lost to Follow-up|0|||
124704824|NCT04507269|448543021|FG003|Overall Study|Lost to Follow-up|0|||
124704825|NCT04507269|448543022|FG004|Overall Study|Lost to Follow-up|1|||
124704826|NCT04507269|448543023|FG005|Overall Study|Lost to Follow-up|0|||
124704827|NCT00071032|448543026|FG000|Overall Study|Lost to Follow-up|1|||
124704828|NCT00071032|448543027|FG001|Overall Study|Lost to Follow-up|1|||
124704829|NCT00071032|448543026|FG000|Overall Study|Withdrawal by Subject|8|||
124704830|NCT00071032|448543027|FG001|Overall Study|Withdrawal by Subject|6|||
124704831|NCT00071032|448543026|FG000|Overall Study|Missing Primary Outcome|0|||
124704832|NCT00071032|448543027|FG001|Overall Study|Missing Primary Outcome|1|||
124704833|NCT01889251|448543028|FG000|Overall Study|Adverse Event|1|||
124704834|NCT01889251|448543029|FG001|Overall Study|Adverse Event|0|||
124704835|NCT06071104|448543033|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
124704836|NCT03518060|448543034|FG000|Overall Study|Death|1|||
124704837|NCT03518060|448543034|FG000|Overall Study|Poor adherence|1|||
124704838|NCT03518060|448543034|FG000|Overall Study|Withdrawal of informed consent|2|||
124704839|NCT03518060|448543034|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
124942461|NCT03678688|449416630|FG000|Overall Study|Physician Decision|0|||
124942462|NCT03678688|449416631|FG001|Overall Study|Physician Decision|0|||
124704840|NCT03518060|448543034|FG000|Overall Study|Physician Decision|7|||
124704841|NCT03518060|448543034|FG000|Overall Study|Adverse drug reactions|23|||
124704842|NCT03518060|448543034|FG000|Overall Study|Withdrawal by Subject|25|||
124704843|NCT03518060|448543034|FG000|Overall Study|Lost to Follow-up|13|||
124942463|NCT03678688|449416632|FG002|Overall Study|Physician Decision|0|||
124942464|NCT03678688|449416633|FG003|Overall Study|Physician Decision|0|||
124547671|NCT03901352|447960301|FG001|Double-blind Phase|Death|0|||
124547672|NCT03901352|447960300|FG000|Double-blind Phase|Lack of Efficacy|0|||
124547673|NCT03901352|447960301|FG001|Double-blind Phase|Lack of Efficacy|1|||
124704844|NCT03211416|448543040|FG000|Overall Study|Adverse Event|7|||
124704845|NCT03211416|448543040|FG000|Overall Study|Lack of Efficacy|2|||
124704846|NCT03211416|448543040|FG000|Overall Study|Physician Decision|1|||
124704847|NCT01877278|448543041|FG000|Overall Study|Lost to Follow-up|3|||
124704848|NCT01877278|448543042|FG001|Overall Study|Lost to Follow-up|3|||
124704849|NCT04890509|448543043|FG000|Overall Study|Death|4|||
124704850|NCT04890509|448543044|FG001|Overall Study|Death|4|||
124704851|NCT00618787|448543047|FG000|Overall Study|Adverse Event|0|||
124704852|NCT00618787|448543048|FG001|Overall Study|Adverse Event|1|||
124704853|NCT00618787|448543047|FG000|Overall Study|Withdrawal by Subject|2|||
124704854|NCT00618787|448543048|FG001|Overall Study|Withdrawal by Subject|1|||
124704855|NCT00618787|448543047|FG000|Overall Study|Lost to Follow-up|1|||
124704856|NCT00618787|448543048|FG001|Overall Study|Lost to Follow-up|0|||
124704857|NCT01107886|448543049|FG000|Overall Study|Lost to Follow-up|15|||
124704858|NCT01107886|448543050|FG001|Overall Study|Lost to Follow-up|13|||
124704859|NCT01107886|448543049|FG000|Overall Study|Withdrawal by Subject|180|||
124704860|NCT01107886|448543050|FG001|Overall Study|Withdrawal by Subject|196|||
124704861|NCT01107886|448543049|FG000|Overall Study|Administrative withdrawal of consent|7|||
124704862|NCT01107886|448543050|FG001|Overall Study|Administrative withdrawal of consent|5|||
124704863|NCT01649869|448543055|FG000|Overall Study|Family member illness|1|||
124704864|NCT01649869|448543056|FG001|Overall Study|Family member illness|0|||
124704865|NCT01649869|448543055|FG000|Overall Study|Required treatment outside protocol|1|||
124704866|NCT01649869|448543056|FG001|Overall Study|Required treatment outside protocol|0|||
124704867|NCT01649869|448543055|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
124704868|NCT01649869|448543056|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
124704869|NCT02776735|448543057|FG000|Overall Study|Adverse Event|0|||
124704870|NCT02776735|448543058|FG001|Overall Study|Adverse Event|0|||
124704871|NCT02776735|448543059|FG002|Overall Study|Adverse Event|0|||
124704872|NCT02776735|448543060|FG003|Overall Study|Adverse Event|1|||
124704873|NCT02776735|448543061|FG004|Overall Study|Adverse Event|0|||
124704874|NCT02776735|448543062|FG005|Overall Study|Adverse Event|1|||
124704875|NCT02776735|448543057|FG000|Overall Study|Lost to Follow-up|0|||
124704876|NCT02776735|448543058|FG001|Overall Study|Lost to Follow-up|0|||
124704877|NCT02776735|448543059|FG002|Overall Study|Lost to Follow-up|0|||
124704878|NCT02776735|448543060|FG003|Overall Study|Lost to Follow-up|1|||
124704879|NCT02776735|448543061|FG004|Overall Study|Lost to Follow-up|0|||
124704880|NCT02776735|448543062|FG005|Overall Study|Lost to Follow-up|0|||
124704881|NCT02776735|448543057|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124704882|NCT02776735|448543058|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124704883|NCT02776735|448543059|FG002|Overall Study|Withdrawal by parent/guardian|2|||
124704884|NCT02776735|448543060|FG003|Overall Study|Withdrawal by parent/guardian|2|||
124704885|NCT02776735|448543061|FG004|Overall Study|Withdrawal by parent/guardian|0|||
124704886|NCT02776735|448543062|FG005|Overall Study|Withdrawal by parent/guardian|0|||
124704887|NCT02776735|448543057|FG000|Overall Study|Withdrawal by Subject|1|||
124704888|NCT02776735|448543058|FG001|Overall Study|Withdrawal by Subject|0|||
124704889|NCT02776735|448543059|FG002|Overall Study|Withdrawal by Subject|0|||
124704890|NCT02776735|448543060|FG003|Overall Study|Withdrawal by Subject|0|||
124704891|NCT02776735|448543061|FG004|Overall Study|Withdrawal by Subject|0|||
124704892|NCT02776735|448543062|FG005|Overall Study|Withdrawal by Subject|1|||
124704893|NCT02776735|448543057|FG000|Overall Study|Other|0|||
124704894|NCT02776735|448543058|FG001|Overall Study|Other|0|||
124704895|NCT02776735|448543059|FG002|Overall Study|Other|3|||
124704896|NCT02776735|448543060|FG003|Overall Study|Other|0|||
124704897|NCT02776735|448543061|FG004|Overall Study|Other|0|||
124704898|NCT02776735|448543062|FG005|Overall Study|Other|0|||
124704899|NCT03556891|448543065|FG000|Overall Study|Adverse Event|4|||
124704900|NCT03556891|448543065|FG000|Overall Study|MRI Need|3|||
124704901|NCT03556891|448543065|FG000|Overall Study|Device Failure|1|||
124704902|NCT03556891|448543065|FG000|Overall Study|Death|1|||
124704903|NCT03556891|448543065|FG000|Overall Study|Lost to Follow-up|1|||
124704904|NCT03556891|448543065|FG000|Overall Study|Missing at random|1|||
124704905|NCT03556891|448543065|FG000|Overall Study|Missing due to COVID|1|||
124704906|NCT03556891|448543065|FG000|Overall Study|Protocol Violation|1|||
124704907|NCT01168596|448544704|FG000|Overall Study|Withdrawal by Subject|3|||
124704908|NCT01168596|448544705|FG001|Overall Study|Withdrawal by Subject|1|||
124704909|NCT02297516|448544710|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
124704910|NCT02297516|448544711|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
124704911|NCT02297516|448544710|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
124704912|NCT02297516|448544711|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
124704913|NCT02297516|448544710|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
124704914|NCT02297516|448544711|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
124704915|NCT02332928|448544713|FG000|Overall Study|Withdrawal by Subject|0|||
124704916|NCT02332928|448544714|FG001|Overall Study|Withdrawal by Subject|2|||
124704917|NCT02332928|448544713|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
124704918|NCT02332928|448544714|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
124942465|NCT03678688|449416634|FG004|Overall Study|Physician Decision|0|||
124942466|NCT03678688|449416635|FG005|Overall Study|Physician Decision|1|||
124942467|NCT03678688|449416636|FG006|Overall Study|Physician Decision|0|||
124942468|NCT03678688|449416637|FG007|Overall Study|Physician Decision|0|||
124942469|NCT03678688|449416638|FG008|Overall Study|Physician Decision|0|||
124942470|NCT03678688|449416630|FG000|Overall Study|Withdrawal by Subject|0|||
124942471|NCT03678688|449416631|FG001|Overall Study|Withdrawal by Subject|0|||
124942472|NCT03678688|449416632|FG002|Overall Study|Withdrawal by Subject|0|||
124942473|NCT03678688|449416633|FG003|Overall Study|Withdrawal by Subject|0|||
124942474|NCT03678688|449416634|FG004|Overall Study|Withdrawal by Subject|0|||
124942475|NCT03678688|449416635|FG005|Overall Study|Withdrawal by Subject|0|||
124942476|NCT03678688|449416636|FG006|Overall Study|Withdrawal by Subject|2|||
124942477|NCT03678688|449416637|FG007|Overall Study|Withdrawal by Subject|1|||
124942478|NCT03678688|449416638|FG008|Overall Study|Withdrawal by Subject|0|||
124942479|NCT00985088|449416644|FG000|Overall Study|Serious Adverse Event|1|||
124942480|NCT00985088|449416645|FG001|Overall Study|Serious Adverse Event|1|||
124942481|NCT00985088|449416646|FG002|Overall Study|Serious Adverse Event|0|||
124942482|NCT00985088|449416647|FG003|Overall Study|Serious Adverse Event|0|||
124942483|NCT00985088|449416648|FG004|Overall Study|Serious Adverse Event|0|||
124942484|NCT00985088|449416649|FG005|Overall Study|Serious Adverse Event|0|||
124942485|NCT00985088|449416650|FG006|Overall Study|Serious Adverse Event|0|||
124942486|NCT00985088|449416651|FG007|Overall Study|Serious Adverse Event|1|||
124942487|NCT00985088|449416644|FG000|Overall Study|Adverse Event|0|||
124942488|NCT00985088|449416645|FG001|Overall Study|Adverse Event|0|||
124942489|NCT00985088|449416646|FG002|Overall Study|Adverse Event|1|||
124942490|NCT00985088|449416647|FG003|Overall Study|Adverse Event|0|||
124942491|NCT00985088|449416648|FG004|Overall Study|Adverse Event|0|||
124942492|NCT00985088|449416649|FG005|Overall Study|Adverse Event|0|||
124942493|NCT00985088|449416650|FG006|Overall Study|Adverse Event|0|||
124942494|NCT00985088|449416651|FG007|Overall Study|Adverse Event|0|||
124942495|NCT00985088|449416644|FG000|Overall Study|Withdrawal by Subject|4|||
124942496|NCT00985088|449416645|FG001|Overall Study|Withdrawal by Subject|0|||
124942497|NCT00985088|449416646|FG002|Overall Study|Withdrawal by Subject|0|||
124942498|NCT00985088|449416647|FG003|Overall Study|Withdrawal by Subject|1|||
124942499|NCT00985088|449416648|FG004|Overall Study|Withdrawal by Subject|3|||
124942500|NCT00985088|449416649|FG005|Overall Study|Withdrawal by Subject|2|||
124942501|NCT00985088|449416650|FG006|Overall Study|Withdrawal by Subject|1|||
124942502|NCT00985088|449416651|FG007|Overall Study|Withdrawal by Subject|2|||
124942503|NCT00985088|449416644|FG000|Overall Study|Migrated/moved from study area|0|||
124942504|NCT00985088|449416645|FG001|Overall Study|Migrated/moved from study area|0|||
124942505|NCT00985088|449416646|FG002|Overall Study|Migrated/moved from study area|1|||
124942506|NCT00985088|449416647|FG003|Overall Study|Migrated/moved from study area|0|||
124942507|NCT00985088|449416648|FG004|Overall Study|Migrated/moved from study area|0|||
124942508|NCT00985088|449416649|FG005|Overall Study|Migrated/moved from study area|0|||
124942509|NCT00985088|449416650|FG006|Overall Study|Migrated/moved from study area|0|||
124942510|NCT00985088|449416651|FG007|Overall Study|Migrated/moved from study area|1|||
124942511|NCT00985088|449416644|FG000|Overall Study|Lost to Follow-up|6|||
124942512|NCT00985088|449416645|FG001|Overall Study|Lost to Follow-up|1|||
124942513|NCT00985088|449416646|FG002|Overall Study|Lost to Follow-up|2|||
124942514|NCT00985088|449416647|FG003|Overall Study|Lost to Follow-up|6|||
124942515|NCT00985088|449416648|FG004|Overall Study|Lost to Follow-up|6|||
124942516|NCT00985088|449416649|FG005|Overall Study|Lost to Follow-up|5|||
124942517|NCT00985088|449416650|FG006|Overall Study|Lost to Follow-up|3|||
124942518|NCT00985088|449416651|FG007|Overall Study|Lost to Follow-up|2|||
124942519|NCT01278030|449416654|FG000|Overall Study|Withdrawal by Subject|8|||
124942520|NCT01278030|449416655|FG001|Overall Study|Withdrawal by Subject|4|||
124942521|NCT00458783|449416657|FG000|Overall Study|Protocol Violation|1228|||
124942522|NCT00458783|449416658|FG001|Overall Study|Protocol Violation|1220|||
124942523|NCT01737398|449416659|FG000|Overall Study|Adverse event or SAE|16|||
124942524|NCT01737398|449416660|FG001|Overall Study|Adverse event or SAE|1|||
124547674|NCT03901352|447960300|FG000|Double-blind Phase|Protocol Violation|0|||
124547675|NCT03901352|447960301|FG001|Double-blind Phase|Protocol Violation|1|||
124942525|NCT01737398|449416659|FG000|Overall Study|Stopping rule met|2|||
124942526|NCT01737398|449416660|FG001|Overall Study|Stopping rule met|1|||
124942527|NCT01737398|449416659|FG000|Overall Study|Voluntary withdrawal|2|||
124547676|NCT03901352|447960300|FG000|Double-blind Phase|Withdrawal by Subject|10|||
124547677|NCT03901352|447960301|FG001|Double-blind Phase|Withdrawal by Subject|8|||
124547678|NCT03901352|447960300|FG000|Open-label Extension Phase|Adverse Event|24|||
124942528|NCT01737398|449416660|FG001|Overall Study|Voluntary withdrawal|3|||
124942529|NCT01737398|449416659|FG000|Overall Study|Ineligibility|1|||
124942530|NCT01737398|449416660|FG001|Overall Study|Ineligibility|0|||
124942531|NCT01737398|449416659|FG000|Overall Study|Liver transplant|1|||
124942532|NCT01737398|449416660|FG001|Overall Study|Liver transplant|0|||
124942533|NCT01737398|449416659|FG000|Overall Study|Disease progression|2|||
124942534|NCT01737398|449416660|FG001|Overall Study|Disease progression|3|||
124942535|NCT01737398|449416659|FG000|Overall Study|Sponsor's decision|2|||
124704919|NCT01425814|448544715|FG000|Period 1|Stability criteria not fulfilled|0|||
124704920|NCT01425814|448544716|FG001|Period 1|Stability criteria not fulfilled|1|||
124704921|NCT01425814|448544717|FG002|Period 1|Stability criteria not fulfilled|0|||
124704922|NCT01425814|448544718|FG003|Period 1|Stability criteria not fulfilled|0|||
124942536|NCT01737398|449416660|FG001|Overall Study|Sponsor's decision|0|||
124942537|NCT02962284|449416662|FG000|Overall Study|Death|2|||
124942538|NCT02962284|449416663|FG001|Overall Study|Death|0|||
124942539|NCT02962284|449416662|FG000|Overall Study|Progressive disease|2|||
124942540|NCT02962284|449416663|FG001|Overall Study|Progressive disease|3|||
124942541|NCT02962284|449416662|FG000|Overall Study|Withdrawal by Subject|1|||
124942542|NCT02962284|449416663|FG001|Overall Study|Withdrawal by Subject|0|||
124942543|NCT00357994|449416666|FG000|Overall Study|Adverse Event|1|||
124942544|NCT00357994|449416667|FG001|Overall Study|Adverse Event|2|||
124942545|NCT00357994|449416666|FG000|Overall Study|Lack of Efficacy|0|||
124942546|NCT00357994|449416667|FG001|Overall Study|Lack of Efficacy|1|||
124942547|NCT00357994|449416666|FG000|Overall Study|Protocol Violation|1|||
124942548|NCT00357994|449416667|FG001|Overall Study|Protocol Violation|0|||
124942549|NCT04162210|449416672|FG000|Overall Study|Lost to Follow-up|4|||
124942550|NCT04162210|449416673|FG001|Overall Study|Lost to Follow-up|1|||
124942551|NCT04162210|449416672|FG000|Overall Study|Withdrawal by Subject|17|||
124942552|NCT04162210|449416673|FG001|Overall Study|Withdrawal by Subject|9|||
124942553|NCT04162210|449416672|FG000|Overall Study|Ongoing|113|||
124942554|NCT04162210|449416673|FG001|Overall Study|Ongoing|59|||
124942555|NCT03244800|449416674|FG000|Overall Study|Adverse Event|0|||
124942556|NCT03244800|449416675|FG001|Overall Study|Adverse Event|1|||
124942557|NCT03244800|449416676|FG002|Overall Study|Adverse Event|0|||
124942558|NCT03244800|449416677|FG003|Overall Study|Adverse Event|1|||
124942559|NCT03244800|449416674|FG000|Overall Study|Withdrew treatment|0|||
124942560|NCT03244800|449416675|FG001|Overall Study|Withdrew treatment|0|||
124942561|NCT03244800|449416676|FG002|Overall Study|Withdrew treatment|0|||
124942562|NCT03244800|449416677|FG003|Overall Study|Withdrew treatment|1|||
124942563|NCT00371345|449416680|FG000|Overall Study|Disease Progression|21|||
124942564|NCT00371345|449416681|FG001|Overall Study|Disease Progression|35|||
124942565|NCT00371345|449416680|FG000|Overall Study|Study Drug Toxicity|1|||
124942566|NCT00371345|449416681|FG001|Overall Study|Study Drug Toxicity|7|||
124942567|NCT00371345|449416680|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
124942568|NCT00371345|449416681|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
124942569|NCT00371345|449416680|FG000|Overall Study|Participant Request|1|||
124942570|NCT00371345|449416681|FG001|Overall Study|Participant Request|1|||
124942571|NCT00371345|449416680|FG000|Overall Study|Participant Withdrew Consent|0|||
124942572|NCT00371345|449416681|FG001|Overall Study|Participant Withdrew Consent|1|||
124942573|NCT00713596|449416682|FG000|Overall Study|Study was terminated|2|||
124942574|NCT00713596|449416683|FG001|Overall Study|Study was terminated|3|||
124942575|NCT00713596|449416684|FG002|Overall Study|Study was terminated|2|||
124942576|NCT04545619|449416685|FG000|Overall Study|due to equipment challenges|1|||
124942577|NCT03712371|449416686|FG000|Overall Study|Lack of Efficacy|0|||
124942578|NCT03712371|449416687|FG001|Overall Study|Lack of Efficacy|0|||
124942579|NCT03712371|449416688|FG002|Overall Study|Lack of Efficacy|0|||
124942580|NCT03712371|449416689|FG003|Overall Study|Lack of Efficacy|1|||
124942581|NCT02788981|449416690|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
124942582|NCT02788981|449416691|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
124942583|NCT00229658|449416692|FG000|Overall Study|Administrative|2|||
124942584|NCT00229658|449416693|FG001|Overall Study|Administrative|1|||
124942585|NCT00229658|449416692|FG000|Overall Study|Investigator decision|13|||
124942586|NCT00229658|449416693|FG001|Overall Study|Investigator decision|10|||
124942587|NCT00229658|449416692|FG000|Overall Study|Other|80|||
124942588|NCT00229658|449416693|FG001|Overall Study|Other|60|||
124942589|NCT00229658|449416692|FG000|Overall Study|Lost to Follow-up|82|||
124942590|NCT00229658|449416693|FG001|Overall Study|Lost to Follow-up|55|||
124704923|NCT01425814|448544719|FG004|Period 1|Stability criteria not fulfilled|0|||
124704924|NCT01425814|448544720|FG005|Period 1|Stability criteria not fulfilled|0|||
124704925|NCT01425814|448544715|FG000|Period 2|Stability criteria not fulfilled|0|||
124704926|NCT01425814|448544716|FG001|Period 2|Stability criteria not fulfilled|1|||
124704927|NCT01425814|448544717|FG002|Period 2|Stability criteria not fulfilled|0|||
124942591|NCT00229658|449416692|FG000|Overall Study|Serious Adverse Event|2|||
124942592|NCT00229658|449416693|FG001|Overall Study|Serious Adverse Event|2|||
124942593|NCT00229658|449416692|FG000|Overall Study|Withdrawal of consent|46|||
124942594|NCT00229658|449416693|FG001|Overall Study|Withdrawal of consent|39|||
124942595|NCT00249769|449416694|FG000|Overall Study|Withdrawal by Subject|1|||
124942596|NCT00249769|449416695|FG001|Overall Study|Withdrawal by Subject|10|||
124942597|NCT00249769|449416696|FG002|Overall Study|Withdrawal by Subject|6|||
124942598|NCT00249769|449416694|FG000|Overall Study|Migration from Study Area|1|||
124942599|NCT00249769|449416695|FG001|Overall Study|Migration from Study Area|3|||
124942600|NCT00249769|449416696|FG002|Overall Study|Migration from Study Area|14|||
124942601|NCT00249769|449416694|FG000|Overall Study|Miscellaneous|0|||
124942602|NCT00249769|449416695|FG001|Overall Study|Miscellaneous|2|||
124942603|NCT00249769|449416696|FG002|Overall Study|Miscellaneous|2|||
124942604|NCT00249769|449416694|FG000|Overall Study|Adverse Event|0|||
124942605|NCT00249769|449416695|FG001|Overall Study|Adverse Event|0|||
124942606|NCT00249769|449416696|FG002|Overall Study|Adverse Event|1|||
124942607|NCT00249769|449416694|FG000|Overall Study|Physician Decision|0|||
124942608|NCT00249769|449416695|FG001|Overall Study|Physician Decision|0|||
124942609|NCT00249769|449416696|FG002|Overall Study|Physician Decision|2|||
124942610|NCT00249769|449416694|FG000|Overall Study|Lost to Follow-up|0|||
124942611|NCT00249769|449416695|FG001|Overall Study|Lost to Follow-up|0|||
124942612|NCT00249769|449416696|FG002|Overall Study|Lost to Follow-up|3|||
124942613|NCT01953224|449416697|FG000|Overall Study|Lost to Follow-up|1|||
124942614|NCT01953224|449416698|FG001|Overall Study|Lost to Follow-up|1|||
124942615|NCT01953224|449416697|FG000|Overall Study|Withdrawal by Subject|1|||
124942616|NCT01953224|449416698|FG001|Overall Study|Withdrawal by Subject|2|||
124942617|NCT00857766|449416705|FG000|Overall Study|Adverse Event|13|||
124942618|NCT00857766|449416706|FG001|Overall Study|Adverse Event|12|||
124547679|NCT03901352|447960301|FG001|Open-label Extension Phase|Adverse Event|0|||
124547680|NCT03901352|447960300|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
124547681|NCT03901352|447960301|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
124547682|NCT03901352|447960300|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
124547683|NCT03901352|447960301|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
124547684|NCT03901352|447960300|FG000|Open-label Extension Phase|Other|1|||
124547685|NCT03901352|447960301|FG001|Open-label Extension Phase|Other|0|||
124547686|NCT02871921|447960306|FG000|Overall Study|Withdrawal by Subject|34|||
124547687|NCT02871921|447960307|FG001|Overall Study|Withdrawal by Subject|27|||
124547688|NCT02871921|447960308|FG002|Overall Study|Withdrawal by Subject|27|||
124547689|NCT02871921|447960309|FG003|Overall Study|Withdrawal by Subject|30|||
124547690|NCT00824993|447960315|FG000|Overall Study|Withdrawal by Subject|1|||
124547691|NCT00824993|447960316|FG001|Overall Study|Withdrawal by Subject|1|||
124547692|NCT00824993|447960315|FG000|Overall Study|Malignancy Relapse|9|||
124547693|NCT00824993|447960316|FG001|Overall Study|Malignancy Relapse|10|||
124547694|NCT00824993|447960315|FG000|Overall Study|Rapid Bone Loss|0|||
124547695|NCT00824993|447960316|FG001|Overall Study|Rapid Bone Loss|1|||
124547696|NCT00824993|447960315|FG000|Overall Study|Non-Compliant|2|||
124547697|NCT00824993|447960316|FG001|Overall Study|Non-Compliant|1|||
124547698|NCT00824993|447960315|FG000|Overall Study|Insurance Issue|2|||
124547699|NCT00824993|447960316|FG001|Overall Study|Insurance Issue|1|||
124547700|NCT00824993|447960315|FG000|Overall Study|Death|0|||
124547701|NCT00824993|447960316|FG001|Overall Study|Death|3|||
124547702|NCT02998645|447960317|FG000|Treatment Period 1|Adverse Event|6|||
124547703|NCT02998645|447960317|FG000|Treatment Period 1|Death|5|||
124547704|NCT02998645|447960317|FG000|Treatment Period 1|Technical Problems|4|||
124547705|NCT02998645|447960317|FG000|Treatment Period 1|Lack of Efficacy|2|||
124547706|NCT02998645|447960317|FG000|Treatment Period 1|Progressive disease|1|||
124547707|NCT02998645|447960317|FG000|Treatment Period 1|Subject/guardian decision|1|||
124547708|NCT02998645|447960317|FG000|Treatment Period 2|Lack of Efficacy|5|||
124547709|NCT02998645|447960317|FG000|Treatment Period 2|Adverse Event|2|||
124547710|NCT02998645|447960317|FG000|Treatment Period 2|Progressive disease|2|||
124547711|NCT02998645|447960317|FG000|Treatment Period 2|Physician Decision|1|||
124547712|NCT04611152|447960320|FG000|Overall Study|Adverse Event|9|||
124547713|NCT04611152|447960321|FG001|Overall Study|Adverse Event|8|||
124547714|NCT04611152|447960320|FG000|Overall Study|Non-compliance with study schedule|1|||
124547715|NCT04611152|447960321|FG001|Overall Study|Non-compliance with study schedule|3|||
124547716|NCT04611152|447960320|FG000|Overall Study|Withdrawal by Subject|5|||
124547717|NCT04611152|447960321|FG001|Overall Study|Withdrawal by Subject|6|||
124547718|NCT04611152|447960320|FG000|Overall Study|Lost to Follow-up|11|||
124547719|NCT04611152|447960321|FG001|Overall Study|Lost to Follow-up|2|||
124547720|NCT03644927|447960322|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
124547721|NCT03644927|447960323|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
124547722|NCT00956813|447960324|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
124547723|NCT00956813|447960325|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
124547724|NCT00956813|447960324|FG000|Flaxseed and Placebo|Ineligible|3|||
124547725|NCT00956813|447960325|FG001|Flaxseed and Placebo|Ineligible|1|||
124547726|NCT01275170|447960330|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
124547727|NCT01275170|447960331|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
124547728|NCT01275170|447960332|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
124547729|NCT01275170|447960333|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
124547730|NCT01275170|447960334|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
124547731|NCT01275170|447960335|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
124942619|NCT00857766|449416705|FG000|Overall Study|Protocol Violation|11|||
124942620|NCT00857766|449416706|FG001|Overall Study|Protocol Violation|11|||
124942621|NCT00857766|449416705|FG000|Overall Study|Lost to Follow-up|1|||
124942622|NCT00857766|449416706|FG001|Overall Study|Lost to Follow-up|0|||
124942623|NCT00857766|449416705|FG000|Overall Study|Investigator Discretion|2|||
124942624|NCT00857766|449416706|FG001|Overall Study|Investigator Discretion|3|||
124942625|NCT00857766|449416705|FG000|Overall Study|Participant Withdrew Consent|4|||
124942626|NCT00857766|449416706|FG001|Overall Study|Participant Withdrew Consent|4|||
124704928|NCT01425814|448544718|FG003|Period 2|Stability criteria not fulfilled|0|||
124704929|NCT01425814|448544719|FG004|Period 2|Stability criteria not fulfilled|0|||
124942627|NCT02040870|449416707|FG000|Overall Study|Completed treatment phase|6|||
124942628|NCT02040870|449416707|FG000|Overall Study|Adverse Event|7|||
124942629|NCT02040870|449416707|FG000|Overall Study|Progressive disease|58|||
124942630|NCT02040870|449416707|FG000|Overall Study|Physician Decision|6|||
124942631|NCT02040870|449416707|FG000|Overall Study|Subject/guardian decision|10|||
124942632|NCT02040870|449416707|FG000|Overall Study|Lost to Follow-up|3|||
124942633|NCT02040870|449416707|FG000|Overall Study|Death|13|||
124942634|NCT04971733|449416708|FG000|Overall Study|Adverse Event|1|||
124942635|NCT04971733|449416709|FG001|Overall Study|Adverse Event|1|||
124942636|NCT04971733|449416708|FG000|Overall Study|Subject choice|2|||
124942637|NCT04971733|449416709|FG001|Overall Study|Subject choice|0|||
124942638|NCT04971733|449416708|FG000|Overall Study|Withdrawal by Subject|1|||
124942639|NCT04971733|449416709|FG001|Overall Study|Withdrawal by Subject|0|||
124942640|NCT04971733|449416708|FG000|Overall Study|Other|1|||
124942641|NCT04971733|449416709|FG001|Overall Study|Other|0|||
124942642|NCT01367236|449416715|FG000|Overall Study|Withdrawal by Subject|3|||
124942643|NCT01367236|449416716|FG001|Overall Study|Withdrawal by Subject|1|||
124942644|NCT01593020|449416719|FG000|Overall Study|Adverse Event|1|||
124942645|NCT01593020|449416720|FG001|Overall Study|Adverse Event|1|||
124942646|NCT01593020|449416719|FG000|Overall Study|Death|0|||
124942647|NCT01593020|449416720|FG001|Overall Study|Death|1|||
124942648|NCT01593020|449416719|FG000|Overall Study|Ineligible|1|||
124942649|NCT01593020|449416720|FG001|Overall Study|Ineligible|0|||
124942650|NCT02350634|449416721|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
124942651|NCT01400958|449416730|FG000|Overall Study|Physician Decision|0|||
124942652|NCT01400958|449416731|FG001|Overall Study|Physician Decision|1|||
124942653|NCT01400958|449416730|FG000|Overall Study|Withdrawal by Subject|0|||
124942654|NCT01400958|449416731|FG001|Overall Study|Withdrawal by Subject|1|||
124942655|NCT01400958|449416730|FG000|Overall Study|Adverse Event|1|||
124942656|NCT01400958|449416731|FG001|Overall Study|Adverse Event|0|||
124942657|NCT04445831|449416735|FG000|Overall Study|Withdrawal by Subject|2|||
124942658|NCT04445831|449416736|FG001|Overall Study|Withdrawal by Subject|1|||
124942659|NCT04445831|449416737|FG002|Overall Study|Withdrawal by Subject|1|||
124942660|NCT04445831|449416738|FG003|Overall Study|Withdrawal by Subject|0|||
124942661|NCT04445831|449416739|FG004|Overall Study|Withdrawal by Subject|0|||
124942662|NCT04445831|449416740|FG005|Overall Study|Withdrawal by Subject|0|||
124942663|NCT04445831|449416741|FG006|Overall Study|Withdrawal by Subject|0|||
124942664|NCT04445831|449416735|FG000|Overall Study|Subject withdrawal by caregiver|0|||
124942665|NCT04445831|449416736|FG001|Overall Study|Subject withdrawal by caregiver|1|||
124942666|NCT04445831|449416737|FG002|Overall Study|Subject withdrawal by caregiver|0|||
124942667|NCT04445831|449416738|FG003|Overall Study|Subject withdrawal by caregiver|0|||
124942668|NCT04445831|449416739|FG004|Overall Study|Subject withdrawal by caregiver|0|||
124942669|NCT04445831|449416740|FG005|Overall Study|Subject withdrawal by caregiver|0|||
124942670|NCT04445831|449416741|FG006|Overall Study|Subject withdrawal by caregiver|0|||
124942671|NCT05810285|449416742|FG000|Overall Study|Death|4|||
124942672|NCT05810285|449416743|FG001|Overall Study|Death|21|||
124942673|NCT05810285|449416742|FG000|Overall Study|Adverse Event|18|||
124942674|NCT05810285|449416743|FG001|Overall Study|Adverse Event|16|||
124704930|NCT01425814|448544720|FG005|Period 2|Stability criteria not fulfilled|0|||
124704931|NCT01425814|448544715|FG000|Period 3|Adverse Event|0|||
124704932|NCT01425814|448544716|FG001|Period 3|Adverse Event|0|||
124704933|NCT01425814|448544717|FG002|Period 3|Adverse Event|0|||
124704934|NCT01425814|448544718|FG003|Period 3|Adverse Event|0|||
124704935|NCT01425814|448544719|FG004|Period 3|Adverse Event|0|||
124704936|NCT01425814|448544720|FG005|Period 3|Adverse Event|1|||
124704937|NCT01425814|448544715|FG000|Period 4|Adverse Event|1|||
124704938|NCT01425814|448544716|FG001|Period 4|Adverse Event|0|||
124704939|NCT01425814|448544717|FG002|Period 4|Adverse Event|1|||
124704940|NCT01425814|448544718|FG003|Period 4|Adverse Event|0|||
124765227|NCT02587520|448767368|FG006|Overall Study|Protocol Violation|1|||
124942675|NCT05470114|449416744|FG000|Overall Study|Withdrawal by Subject|1|||
124942676|NCT05470114|449416745|FG001|Overall Study|Withdrawal by Subject|0|||
124458001|NCT02116777|447636774|FG005|Overall Study|Death|0|||
124704941|NCT01425814|448544719|FG004|Period 4|Adverse Event|0|||
124942677|NCT05470114|449416744|FG000|Overall Study|Lost to Follow-up|1|||
124704942|NCT01425814|448544720|FG005|Period 4|Adverse Event|0|||
124765228|NCT02587520|448767369|FG007|Overall Study|Protocol Violation|1|||
124765229|NCT02587520|448767370|FG008|Overall Study|Protocol Violation|3|||
124942678|NCT05470114|449416745|FG001|Overall Study|Lost to Follow-up|0|||
124942679|NCT05325294|449416746|FG000|Overall Study|Adverse Event|3|||
124942680|NCT05325294|449416747|FG001|Overall Study|Adverse Event|3|||
124942681|NCT05325294|449416746|FG000|Overall Study|Physician Decision|0|||
124942682|NCT05325294|449416747|FG001|Overall Study|Physician Decision|1|||
124942683|NCT05325294|449416746|FG000|Overall Study|Withdrawal by Subject|0|||
124942684|NCT05325294|449416747|FG001|Overall Study|Withdrawal by Subject|3|||
124942685|NCT05325294|449416746|FG000|Overall Study|Lost to Follow-up|1|||
124458002|NCT02116777|447636775|FG006|Overall Study|Death|0|||
124458003|NCT02116777|447636769|FG000|Overall Study|Lack of Efficacy|3|||
124765230|NCT02587520|448767371|FG009|Overall Study|Protocol Violation|3|||
124942686|NCT05325294|449416747|FG001|Overall Study|Lost to Follow-up|0|||
124942687|NCT05325294|449416746|FG000|Overall Study|Sponsor Request|0|||
124942688|NCT05325294|449416747|FG001|Overall Study|Sponsor Request|2|||
124942689|NCT01563185|449416749|FG000|Overall Study|Withdrawal by Subject|1|||
124942690|NCT01563185|449416749|FG000|Overall Study|Non-Compliance with study drug|1|||
124942691|NCT04577651|449416750|FG000|Overall Study|Screen Failure|7|||
124942692|NCT04577651|449416750|FG000|Overall Study|Adverse Event|1|||
124942693|NCT04577651|449416750|FG000|Overall Study|Death|1|||
124942694|NCT04577651|449416750|FG000|Overall Study|Physician Decision|1|||
124942695|NCT04577651|449416750|FG000|Overall Study|Withdrawal by Subject|3|||
124942696|NCT03214081|449417863|FG000|Overall Study|Case Report Forms Uncollected|9|||
124942697|NCT03214081|449417863|FG000|Overall Study|Protocol Deviation|54|||
124942698|NCT01372085|449417866|FG000|Washout Period 2|Physician Decision|0|||
124942699|NCT01372085|449417867|FG001|Washout Period 2|Physician Decision|0|||
124942700|NCT01372085|449417868|FG002|Washout Period 2|Physician Decision|0|||
124942701|NCT01372085|449417869|FG003|Washout Period 2|Physician Decision|0|||
124942702|NCT01372085|449417870|FG004|Washout Period 2|Physician Decision|1|||
124942703|NCT01372085|449417871|FG005|Washout Period 2|Physician Decision|0|||
124942704|NCT01372085|449417872|FG006|Washout Period 2|Physician Decision|0|||
124942705|NCT01372085|449417873|FG007|Washout Period 2|Physician Decision|0|||
124942706|NCT01372085|449417874|FG008|Washout Period 2|Physician Decision|0|||
124942707|NCT01372085|449417875|FG009|Washout Period 2|Physician Decision|0|||
124942708|NCT01372085|449417866|FG000|Washout Period 3|Withdrawal by Subject|0|||
124942709|NCT01372085|449417867|FG001|Washout Period 3|Withdrawal by Subject|0|||
124942710|NCT01372085|449417868|FG002|Washout Period 3|Withdrawal by Subject|0|||
124942711|NCT01372085|449417869|FG003|Washout Period 3|Withdrawal by Subject|0|||
124942712|NCT01372085|449417870|FG004|Washout Period 3|Withdrawal by Subject|0|||
124942713|NCT01372085|449417871|FG005|Washout Period 3|Withdrawal by Subject|2|||
124942714|NCT01372085|449417872|FG006|Washout Period 3|Withdrawal by Subject|0|||
124942715|NCT01372085|449417873|FG007|Washout Period 3|Withdrawal by Subject|0|||
124942716|NCT01372085|449417874|FG008|Washout Period 3|Withdrawal by Subject|0|||
124942717|NCT01372085|449417875|FG009|Washout Period 3|Withdrawal by Subject|0|||
124942718|NCT00790569|449417876|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
124942719|NCT00790569|449417877|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
124765231|NCT02587520|448767372|FG010|Overall Study|Protocol Violation|1|||
124765232|NCT02587520|448767373|FG011|Overall Study|Protocol Violation|2|||
124765233|NCT02587520|448767374|FG012|Overall Study|Protocol Violation|0|||
124765234|NCT02587520|448767375|FG013|Overall Study|Protocol Violation|0|||
124765235|NCT02587520|448767376|FG014|Overall Study|Protocol Violation|0|||
124942720|NCT00790569|449417878|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
124942721|NCT00790569|449417876|FG000|End of Treatment (6 Month Interview)|Death|0|||
124942722|NCT00790569|449417877|FG001|End of Treatment (6 Month Interview)|Death|2|||
124942723|NCT00790569|449417878|FG002|End of Treatment (6 Month Interview)|Death|1|||
124942724|NCT00790569|449417876|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
124942725|NCT00790569|449417877|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
124942726|NCT00790569|449417878|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
124942727|NCT00790569|449417876|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
124942728|NCT00790569|449417877|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
124942729|NCT00790569|449417878|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
124942730|NCT00790569|449417876|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
124942731|NCT00790569|449417877|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
124942732|NCT00790569|449417878|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
124942733|NCT00790569|449417876|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
124942734|NCT00790569|449417877|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
124942735|NCT00790569|449417878|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
124942736|NCT00512252|449417882|FG000|Overall Study|Lost to Follow-up|0|||
124942737|NCT00512252|449417883|FG001|Overall Study|Lost to Follow-up|0|||
124942738|NCT00512252|449417884|FG002|Overall Study|Lost to Follow-up|1|||
124942739|NCT00512252|449417882|FG000|Overall Study|Protocol Violation|0|||
124942740|NCT00512252|449417883|FG001|Overall Study|Protocol Violation|0|||
124942741|NCT00512252|449417884|FG002|Overall Study|Protocol Violation|1|||
124547732|NCT01275170|447960336|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
124547733|NCT01275170|447960337|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
124765236|NCT02587520|448767377|FG015|Overall Study|Protocol Violation|0|||
124942742|NCT00512252|449417882|FG000|Overall Study|Death|0|||
124942743|NCT00512252|449417883|FG001|Overall Study|Death|0|||
124942744|NCT00512252|449417884|FG002|Overall Study|Death|1|||
124942745|NCT00705406|449417885|FG000|Overall Study|Lost to Follow-up|3|||
124942746|NCT00705406|449417886|FG001|Overall Study|Lost to Follow-up|3|||
124942747|NCT00705406|449417885|FG000|Overall Study|Did not receive study drug|1|||
124547734|NCT02864953|447960338|FG000|Overall Study|Adverse Event|22|||
124547735|NCT02864953|447960339|FG001|Overall Study|Adverse Event|19|||
124547736|NCT02864953|447960338|FG000|Overall Study|Withdrawal by Subject|1|||
124547737|NCT02864953|447960339|FG001|Overall Study|Withdrawal by Subject|0|||
124547738|NCT02864953|447960338|FG000|Overall Study|Physician Decision|4|||
124547739|NCT02864953|447960339|FG001|Overall Study|Physician Decision|2|||
124547740|NCT02864953|447960338|FG000|Overall Study|Death|3|||
124547741|NCT02864953|447960339|FG001|Overall Study|Death|13|||
124547742|NCT02864953|447960338|FG000|Overall Study|Reason not specified|14|||
124547743|NCT02864953|447960339|FG001|Overall Study|Reason not specified|12|||
124547744|NCT02864953|447960338|FG000|Overall Study|Withdrew Prior to Dosing|9|||
124547745|NCT02864953|447960339|FG001|Overall Study|Withdrew Prior to Dosing|8|||
124547746|NCT01023022|447960342|FG000|Overall Study|Death|5|||
124547747|NCT01023022|447960342|FG000|Overall Study|Lost to Follow-up|7|||
124547748|NCT01023022|447960342|FG000|Overall Study|due to technical issues|2|||
124547749|NCT03917654|447960343|FG000|Year 1|Withdrawal by Subject|1|||
124547750|NCT03917654|447960344|FG001|Year 1|Withdrawal by Subject|0|||
124765237|NCT02587520|448767378|FG016|Overall Study|Protocol Violation|0|||
124765238|NCT02587520|448767379|FG017|Overall Study|Protocol Violation|0|||
124942748|NCT00705406|449417886|FG001|Overall Study|Did not receive study drug|2|||
124942749|NCT01079806|449417887|FG000|Day 1 to Week 96|Adverse Event|0|||
124942750|NCT01079806|449417888|FG001|Day 1 to Week 96|Adverse Event|3|||
124942751|NCT01079806|449417887|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
124942752|NCT01079806|449417888|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
124942753|NCT01079806|449417887|FG000|Day 1 to Week 96|Pregnancy|0|||
124942754|NCT01079806|449417888|FG001|Day 1 to Week 96|Pregnancy|1|||
124942755|NCT01079806|449417887|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
124942756|NCT01079806|449417888|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
124942757|NCT01079806|449417887|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
124942758|NCT01079806|449417888|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
124942759|NCT01079806|449417887|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
124942760|NCT01079806|449417888|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
124942761|NCT01079806|449417887|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
124942762|NCT01079806|449417888|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
124942763|NCT01079806|449417887|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
124942764|NCT01079806|449417888|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
124942765|NCT01079806|449417887|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
124942766|NCT01079806|449417888|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
124942767|NCT01079806|449417887|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
124942768|NCT01079806|449417888|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
124942769|NCT03732807|449417889|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
124942770|NCT03732807|449417890|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
124942771|NCT03732807|449417891|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
124942772|NCT03732807|449417892|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
124942773|NCT03732807|449417893|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
124942774|NCT03732807|449417894|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
124942775|NCT03732807|449417895|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
124942776|NCT03732807|449417889|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
124942777|NCT03732807|449417890|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
124942778|NCT03732807|449417891|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
124942779|NCT03732807|449417892|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
124942780|NCT03732807|449417893|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
124547751|NCT03917654|447960345|FG002|Year 1|Withdrawal by Subject|0|||
124765239|NCT02587520|448767362|FG000|Overall Study|Adverse Event|0|||
124765240|NCT02587520|448767363|FG001|Overall Study|Adverse Event|0|||
124765241|NCT02587520|448767364|FG002|Overall Study|Adverse Event|0|||
124765242|NCT02587520|448767365|FG003|Overall Study|Adverse Event|0|||
124765243|NCT02587520|448767366|FG004|Overall Study|Adverse Event|0|||
124547752|NCT03917654|447960346|FG003|Year 1|Withdrawal by Subject|0|||
124547753|NCT03917654|447960347|FG004|Year 1|Withdrawal by Subject|0|||
124547754|NCT03917654|447960348|FG005|Year 1|Withdrawal by Subject|1|||
124547755|NCT03917654|447960349|FG006|Year 1|Withdrawal by Subject|6|||
124547756|NCT03917654|447960350|FG007|Year 1|Withdrawal by Subject|2|||
124547757|NCT03917654|447960351|FG008|Year 1|Withdrawal by Subject|5|||
124547758|NCT03917654|447960352|FG009|Year 1|Withdrawal by Subject|3|||
124547759|NCT03917654|447960353|FG010|Year 1|Withdrawal by Subject|1|||
124765244|NCT02587520|448767367|FG005|Overall Study|Adverse Event|0|||
124942781|NCT03732807|449417894|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
124942782|NCT03732807|449417895|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
124942783|NCT03732807|449417889|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
124942784|NCT03732807|449417890|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
124547760|NCT03917654|447960354|FG011|Year 1|Withdrawal by Subject|0|||
124942785|NCT03732807|449417891|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
124547761|NCT03917654|447960343|FG000|Year 1|Travel|0|||
124704943|NCT01425814|448544715|FG000|Period 5|Stability criteria not fulfilled|0|||
124704944|NCT01425814|448544716|FG001|Period 5|Stability criteria not fulfilled|0|||
124704945|NCT01425814|448544717|FG002|Period 5|Stability criteria not fulfilled|1|||
124704946|NCT01425814|448544718|FG003|Period 5|Stability criteria not fulfilled|0|||
124704947|NCT01425814|448544719|FG004|Period 5|Stability criteria not fulfilled|0|||
124704948|NCT01425814|448544720|FG005|Period 5|Stability criteria not fulfilled|1|||
124704949|NCT00573768|448544723|FG000|Overall Study|Adverse Event|1|||
124704950|NCT00573768|448544724|FG001|Overall Study|Adverse Event|1|||
124704951|NCT00573768|448544725|FG002|Overall Study|Adverse Event|2|||
124704952|NCT00573768|448544723|FG000|Overall Study|Protocol Violation|1|||
124704953|NCT00573768|448544724|FG001|Overall Study|Protocol Violation|0|||
124704954|NCT00573768|448544725|FG002|Overall Study|Protocol Violation|1|||
124704955|NCT00573768|448544723|FG000|Overall Study|Withdrawal by Subject|0|||
124704956|NCT00573768|448544724|FG001|Overall Study|Withdrawal by Subject|1|||
124704957|NCT00573768|448544725|FG002|Overall Study|Withdrawal by Subject|0|||
124704958|NCT00573768|448544723|FG000|Overall Study|Lost to Follow-up|0|||
124704959|NCT00573768|448544724|FG001|Overall Study|Lost to Follow-up|0|||
124704960|NCT00573768|448544725|FG002|Overall Study|Lost to Follow-up|1|||
124704961|NCT03243084|448544726|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
124704962|NCT03243084|448544727|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
124704963|NCT02090764|448544730|FG000|Overall Study|Adverse Event|1|||
124704964|NCT02090764|448544731|FG001|Overall Study|Adverse Event|3|||
124704965|NCT02090764|448544730|FG000|Overall Study|Lack of Efficacy|0|||
124942786|NCT03732807|449417892|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
124942787|NCT03732807|449417893|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
124942788|NCT03732807|449417894|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
124942789|NCT03732807|449417895|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
124942790|NCT03732807|449417889|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
124942791|NCT03732807|449417890|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
124942792|NCT03732807|449417891|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
124942793|NCT03732807|449417892|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
124942794|NCT03732807|449417893|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
124942795|NCT03732807|449417894|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
124942796|NCT03732807|449417895|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
124942797|NCT03732807|449417889|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
124942798|NCT03732807|449417890|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
124942799|NCT03732807|449417891|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
124942800|NCT03732807|449417892|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
124942801|NCT03732807|449417893|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
124942802|NCT03732807|449417894|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
124942803|NCT03732807|449417895|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
124942804|NCT03732807|449417889|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
124942805|NCT03732807|449417890|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
124942806|NCT03732807|449417891|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
124942807|NCT03732807|449417892|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
124942808|NCT03732807|449417893|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
124942809|NCT03732807|449417894|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
124942810|NCT03732807|449417895|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
124942811|NCT03732807|449417889|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
124942812|NCT03732807|449417890|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
124942813|NCT03732807|449417891|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
124942814|NCT03732807|449417892|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
124942815|NCT03732807|449417893|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
124704966|NCT02090764|448544731|FG001|Overall Study|Lack of Efficacy|13|||
124704967|NCT02090764|448544730|FG000|Overall Study|Withdrawal by Subject|2|||
124704968|NCT02090764|448544731|FG001|Overall Study|Withdrawal by Subject|1|||
124942816|NCT03732807|449417894|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
124942817|NCT03732807|449417895|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
124704969|NCT02090764|448544730|FG000|Overall Study|Intercurrent illness and other|1|||
124704970|NCT02090764|448544731|FG001|Overall Study|Intercurrent illness and other|1|||
124704971|NCT02090764|448544730|FG000|Overall Study|Lost to Follow-up|2|||
124942818|NCT03732807|449417889|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
124942819|NCT03732807|449417890|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
124942820|NCT03732807|449417891|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
124704972|NCT02090764|448544731|FG001|Overall Study|Lost to Follow-up|2|||
124704973|NCT02300233|448544733|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
124704974|NCT02300233|448544734|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
124704975|NCT02300233|448544735|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
124704976|NCT02300233|448544733|FG000|Overall Study|Withdrawal by Subject|1|||
124704977|NCT02300233|448544734|FG001|Overall Study|Withdrawal by Subject|0|||
124765245|NCT02587520|448767368|FG006|Overall Study|Adverse Event|0|||
124942821|NCT03732807|449417892|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
124942822|NCT03732807|449417893|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
124942823|NCT03732807|449417894|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
124942824|NCT03732807|449417895|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
124942825|NCT03732807|449417889|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
124942826|NCT03732807|449417890|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
124942827|NCT03732807|449417891|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
124942828|NCT03732807|449417892|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
124942829|NCT03732807|449417893|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
124942830|NCT03732807|449417894|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
124942831|NCT03732807|449417895|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
124942832|NCT03732807|449417889|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
124942833|NCT03732807|449417890|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
124942834|NCT03732807|449417891|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
124942835|NCT03732807|449417892|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
124942836|NCT03732807|449417893|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
124942837|NCT03732807|449417894|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
124942838|NCT03732807|449417895|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
124942839|NCT03732807|449417889|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
124942840|NCT03732807|449417890|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
124704978|NCT02300233|448544735|FG002|Overall Study|Withdrawal by Subject|3|||
124704979|NCT02300233|448544733|FG000|Overall Study|Investigator Judgement|0|||
124704980|NCT02300233|448544734|FG001|Overall Study|Investigator Judgement|0|||
124704981|NCT02300233|448544735|FG002|Overall Study|Investigator Judgement|1|||
124704982|NCT02300233|448544733|FG000|Overall Study|Reason Not Specified|0|||
124704983|NCT02300233|448544734|FG001|Overall Study|Reason Not Specified|0|||
124704984|NCT02300233|448544735|FG002|Overall Study|Reason Not Specified|5|||
124704985|NCT04752566|448544736|FG000|Overall Study|Protocol Violation|0|||
124704986|NCT04752566|448544737|FG001|Overall Study|Protocol Violation|1|||
124704987|NCT04752566|448544736|FG000|Overall Study|Death|1|||
124704988|NCT04752566|448544737|FG001|Overall Study|Death|0|||
124704989|NCT04752566|448544736|FG000|Overall Study|Adverse Event|1|||
124704990|NCT04752566|448544737|FG001|Overall Study|Adverse Event|0|||
124704991|NCT04752566|448544736|FG000|Overall Study|Withdrawal by Subject|2|||
124704992|NCT04752566|448544737|FG001|Overall Study|Withdrawal by Subject|0|||
124704993|NCT04752566|448544736|FG000|Overall Study|Physician Decision|1|||
124704994|NCT04752566|448544737|FG001|Overall Study|Physician Decision|1|||
124704995|NCT02661815|448544738|FG000|Overall Study|Withdrawal by Subject|1|||
124704996|NCT02661815|448544739|FG001|Overall Study|Withdrawal by Subject|0|||
124704997|NCT02661815|448544740|FG002|Overall Study|Withdrawal by Subject|0|||
124704998|NCT02661815|448544741|FG003|Overall Study|Withdrawal by Subject|0|||
124704999|NCT01153516|448544742|FG000|Overall Study|Both subjects refused surgery|2|||
124705000|NCT01153516|448544743|FG001|Overall Study|Both subjects refused surgery|0|||
124705001|NCT00654355|448544749|FG000|Overall Study|Lost to Follow-up|2|||
124705002|NCT00654355|448544750|FG001|Overall Study|Lost to Follow-up|2|||
124705003|NCT01728246|448544751|FG000|Overall Study|Participant needed rescue medication|1|||
124705004|NCT01728246|448544752|FG001|Overall Study|Participant needed rescue medication|5|||
124705005|NCT01728246|448544751|FG000|Overall Study|Protocol Violation|1|||
124705006|NCT01728246|448544752|FG001|Overall Study|Protocol Violation|0|||
124705007|NCT01728246|448544751|FG000|Overall Study|Withdrawal by Subject|2|||
124705008|NCT01728246|448544752|FG001|Overall Study|Withdrawal by Subject|3|||
124765246|NCT02587520|448767369|FG007|Overall Study|Adverse Event|0|||
124942841|NCT03732807|449417891|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
124942842|NCT03732807|449417892|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
124942843|NCT03732807|449417893|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
124705009|NCT01728246|448544751|FG000|Overall Study|Lost to Follow-up|23|||
124705010|NCT01728246|448544752|FG001|Overall Study|Lost to Follow-up|22|||
124705011|NCT01728246|448544751|FG000|Overall Study|Lack of Efficacy|1|||
124942844|NCT03732807|449417894|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
124942845|NCT03732807|449417895|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
124942846|NCT03732807|449417889|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
124942847|NCT03732807|449417890|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
124942848|NCT03732807|449417891|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
124942849|NCT03732807|449417892|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
124942850|NCT03732807|449417893|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
124942851|NCT03732807|449417894|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
124942852|NCT03732807|449417895|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
124942853|NCT03732807|449417889|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
124458004|NCT02116777|447636770|FG001|Overall Study|Lack of Efficacy|3|||
124458005|NCT02116777|447636771|FG002|Overall Study|Lack of Efficacy|3|||
124458006|NCT02116777|447636772|FG003|Overall Study|Lack of Efficacy|8|||
124458007|NCT02116777|447636773|FG004|Overall Study|Lack of Efficacy|4|||
124458008|NCT02116777|447636774|FG005|Overall Study|Lack of Efficacy|1|||
124458009|NCT02116777|447636775|FG006|Overall Study|Lack of Efficacy|9|||
124458010|NCT02116777|447636769|FG000|Overall Study|Physician Decision|0|||
124458011|NCT02116777|447636770|FG001|Overall Study|Physician Decision|0|||
124458012|NCT02116777|447636771|FG002|Overall Study|Physician Decision|0|||
124458013|NCT02116777|447636772|FG003|Overall Study|Physician Decision|2|||
124458014|NCT02116777|447636773|FG004|Overall Study|Physician Decision|0|||
124458015|NCT02116777|447636774|FG005|Overall Study|Physician Decision|0|||
124458016|NCT02116777|447636775|FG006|Overall Study|Physician Decision|0|||
124458017|NCT02116777|447636769|FG000|Overall Study|Protocol Violation|0|||
124458018|NCT02116777|447636770|FG001|Overall Study|Protocol Violation|0|||
124458019|NCT02116777|447636771|FG002|Overall Study|Protocol Violation|0|||
124458020|NCT02116777|447636772|FG003|Overall Study|Protocol Violation|1|||
124458021|NCT02116777|447636773|FG004|Overall Study|Protocol Violation|0|||
124458022|NCT02116777|447636774|FG005|Overall Study|Protocol Violation|0|||
124458023|NCT02116777|447636775|FG006|Overall Study|Protocol Violation|0|||
124458024|NCT02116777|447636769|FG000|Overall Study|Withdrawal by Subject|0|||
124458025|NCT02116777|447636770|FG001|Overall Study|Withdrawal by Subject|0|||
124458026|NCT02116777|447636771|FG002|Overall Study|Withdrawal by Subject|0|||
124458027|NCT02116777|447636772|FG003|Overall Study|Withdrawal by Subject|1|||
124458028|NCT02116777|447636773|FG004|Overall Study|Withdrawal by Subject|0|||
124458029|NCT02116777|447636774|FG005|Overall Study|Withdrawal by Subject|0|||
124458030|NCT02116777|447636775|FG006|Overall Study|Withdrawal by Subject|0|||
124458031|NCT00980200|447638105|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
124458032|NCT00980200|447638106|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
124458033|NCT00980200|447638107|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
124458034|NCT00980200|447638108|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
124458035|NCT00980200|447638109|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
124458036|NCT00980200|447638105|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
124458037|NCT00980200|447638106|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
124458038|NCT00980200|447638107|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
124458039|NCT00980200|447638108|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
124458040|NCT00980200|447638109|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
124458041|NCT00457015|447638110|FG000|Overall Study|Left study site against medical advice|0|||
124458042|NCT00457015|447638111|FG001|Overall Study|Left study site against medical advice|1|||
124458043|NCT01773109|447638112|FG000|Overall Study|Symptomatic Progression|2|||
124458044|NCT01773109|447638112|FG000|Overall Study|Death|1|||
124458045|NCT02257372|447638116|FG000|Overall Study|Adverse Event|3|||
124458046|NCT02257372|447638117|FG001|Overall Study|Adverse Event|7|||
124458047|NCT02257372|447638116|FG000|Overall Study|Lack of Efficacy|2|||
124458048|NCT02257372|447638117|FG001|Overall Study|Lack of Efficacy|1|||
124458049|NCT02257372|447638116|FG000|Overall Study|Protocol Violation|1|||
124458050|NCT02257372|447638117|FG001|Overall Study|Protocol Violation|1|||
124458051|NCT02257372|447638116|FG000|Overall Study|Lost to Follow-up|0|||
124458052|NCT02257372|447638117|FG001|Overall Study|Lost to Follow-up|1|||
124458053|NCT02257372|447638116|FG000|Overall Study|Withdrew consent|1|||
124458054|NCT02257372|447638117|FG001|Overall Study|Withdrew consent|0|||
124458055|NCT01230242|447638122|FG000|Overall Study|Physician Decision|2|||
124458056|NCT01230242|447638122|FG000|Overall Study|Withdrawal by Subject|1|||
124458057|NCT04329702|447638126|FG000|Overall Study|illness|3|||
124705012|NCT01728246|448544752|FG001|Overall Study|Lack of Efficacy|1|||
124458058|NCT04329702|447638127|FG001|Overall Study|illness|4|||
124458059|NCT04329702|447638128|FG002|Overall Study|illness|0|||
124458060|NCT04329702|447638126|FG000|Overall Study|Lost to Follow-up|0|||
124705013|NCT01728246|448544751|FG000|Overall Study|Adverse Event|8|||
124458061|NCT04329702|447638127|FG001|Overall Study|Lost to Follow-up|0|||
124765247|NCT02587520|448767370|FG008|Overall Study|Adverse Event|0|||
124942854|NCT03732807|449417890|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
124942855|NCT03732807|449417891|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
124942856|NCT03732807|449417892|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
124942857|NCT03732807|449417893|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
124942858|NCT03732807|449417894|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
124942859|NCT03732807|449417895|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
124942860|NCT03732807|449417889|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
124942861|NCT03732807|449417890|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
124942862|NCT03732807|449417891|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
124942863|NCT03732807|449417892|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
124942864|NCT03732807|449417893|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
124942865|NCT03732807|449417894|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
124942866|NCT03732807|449417895|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
124942867|NCT01779700|449417896|FG000|Overall Study|Adverse Event|4|||
124942868|NCT01779700|449417897|FG001|Overall Study|Adverse Event|3|||
124942869|NCT01779700|449417896|FG000|Overall Study|Withdrawal by Subject|0|||
124942870|NCT01779700|449417897|FG001|Overall Study|Withdrawal by Subject|2|||
124942871|NCT00683800|449417900|FG000|Overall Study|Adverse Event|195|||
124942872|NCT00683800|449417901|FG001|Overall Study|Adverse Event|102|||
124942873|NCT00683800|449417900|FG000|Overall Study|Death|0|||
124942874|NCT00683800|449417901|FG001|Overall Study|Death|1|||
124942875|NCT00683800|449417900|FG000|Overall Study|Lost to Follow-up|57|||
124942876|NCT00683800|449417901|FG001|Overall Study|Lost to Follow-up|44|||
124942877|NCT00683800|449417900|FG000|Overall Study|Other|5|||
124942878|NCT00683800|449417901|FG001|Overall Study|Other|2|||
124942879|NCT00683800|449417900|FG000|Overall Study|Protocol Violation|13|||
124705014|NCT01728246|448544752|FG001|Overall Study|Adverse Event|5|||
124705015|NCT01983111|448544753|FG000|Overall Study|Withdrawal by Subject|8|||
124705016|NCT01983111|448544754|FG001|Overall Study|Withdrawal by Subject|6|||
124705017|NCT01983111|448544753|FG000|Overall Study|Adverse Event|4|||
124705018|NCT01983111|448544754|FG001|Overall Study|Adverse Event|0|||
124705019|NCT01983111|448544753|FG000|Overall Study|Protocol Violation|0|||
124705020|NCT01983111|448544754|FG001|Overall Study|Protocol Violation|1|||
124705021|NCT03502200|448544755|FG000|Overall Study|Adverse Event|1|||
124705022|NCT03502200|448544756|FG001|Overall Study|Adverse Event|0|||
124705023|NCT03502200|448544755|FG000|Overall Study|Lost to Follow-up|36|||
124705024|NCT03502200|448544756|FG001|Overall Study|Lost to Follow-up|38|||
124705025|NCT03502200|448544755|FG000|Overall Study|Study Team Decision|1|||
124705026|NCT03502200|448544756|FG001|Overall Study|Study Team Decision|1|||
124705027|NCT03502200|448544755|FG000|Overall Study|Withdrawal by Subject|5|||
124705028|NCT03502200|448544756|FG001|Overall Study|Withdrawal by Subject|7|||
124705029|NCT03502200|448544755|FG000|Overall Study|Death|0|||
124705030|NCT03502200|448544756|FG001|Overall Study|Death|2|||
124705031|NCT00855335|448544757|FG000|Overall Study|Lost to Follow-up|0|||
124705032|NCT00855335|448544758|FG001|Overall Study|Lost to Follow-up|0|||
124705033|NCT00855335|448544759|FG002|Overall Study|Lost to Follow-up|3|||
124705034|NCT00855335|448544760|FG003|Overall Study|Lost to Follow-up|1|||
124705035|NCT00855335|448544761|FG004|Overall Study|Lost to Follow-up|0|||
124705036|NCT00855335|448544757|FG000|Overall Study|Withdrawal by Subject|0|||
124705037|NCT00855335|448544758|FG001|Overall Study|Withdrawal by Subject|0|||
124705038|NCT00855335|448544759|FG002|Overall Study|Withdrawal by Subject|0|||
124705039|NCT00855335|448544760|FG003|Overall Study|Withdrawal by Subject|1|||
124705040|NCT00855335|448544761|FG004|Overall Study|Withdrawal by Subject|0|||
124705041|NCT00855335|448544757|FG000|Overall Study|Adverse Event|2|||
124705042|NCT00855335|448544758|FG001|Overall Study|Adverse Event|0|||
124705043|NCT00855335|448544759|FG002|Overall Study|Adverse Event|0|||
124705044|NCT00855335|448544760|FG003|Overall Study|Adverse Event|0|||
124705045|NCT00855335|448544761|FG004|Overall Study|Adverse Event|0|||
124705046|NCT00855335|448544757|FG000|Overall Study|Physician Decision|1|||
124705047|NCT00855335|448544758|FG001|Overall Study|Physician Decision|1|||
124705048|NCT00855335|448544759|FG002|Overall Study|Physician Decision|0|||
124705049|NCT00855335|448544760|FG003|Overall Study|Physician Decision|0|||
124705050|NCT00855335|448544761|FG004|Overall Study|Physician Decision|0|||
124705051|NCT00855335|448544757|FG000|Overall Study|Other|2|||
124705052|NCT00855335|448544758|FG001|Overall Study|Other|1|||
124705053|NCT00855335|448544759|FG002|Overall Study|Other|2|||
124705054|NCT00855335|448544760|FG003|Overall Study|Other|5|||
124705055|NCT00855335|448544761|FG004|Overall Study|Other|1|||
124705056|NCT04380142|448544767|FG000|LD/CD Stabilization Period|Adverse Event|3|||
124705057|NCT04380142|448544768|FG001|LD/CD Stabilization Period|Adverse Event|0|||
124705058|NCT04380142|448544769|FG002|LD/CD Stabilization Period|Adverse Event|0|||
124705059|NCT04380142|448544767|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
124705060|NCT04380142|448544768|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
124705061|NCT04380142|448544769|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
124705062|NCT04380142|448544767|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
124705063|NCT04380142|448544768|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
124705064|NCT04380142|448544769|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
124705065|NCT04380142|448544767|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
124705066|NCT04380142|448544768|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
124705067|NCT04380142|448544769|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
124705068|NCT04380142|448544767|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
124705069|NCT04380142|448544768|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
124705070|NCT04380142|448544769|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
124705071|NCT04380142|448544767|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
124705072|NCT04380142|448544768|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
124705073|NCT04380142|448544769|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
124705074|NCT04380142|448544767|FG000|Double-Blind Treatment Period|Adverse Event|0|||
124705075|NCT04380142|448544768|FG001|Double-Blind Treatment Period|Adverse Event|1|||
124705076|NCT04380142|448544769|FG002|Double-Blind Treatment Period|Adverse Event|14|||
124705077|NCT04380142|448544767|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
124705078|NCT04380142|448544768|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
124705079|NCT04380142|448544769|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
124705080|NCT04380142|448544767|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
124705081|NCT04380142|448544768|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
124705082|NCT04380142|448544769|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
124705083|NCT04380142|448544767|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
124458062|NCT04329702|447638128|FG002|Overall Study|Lost to Follow-up|2|||
124705084|NCT04380142|448544768|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
124705085|NCT04380142|448544769|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
124705086|NCT04380142|448544767|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
124705087|NCT04380142|448544768|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
124942880|NCT00683800|449417901|FG001|Overall Study|Protocol Violation|16|||
124942881|NCT00683800|449417900|FG000|Overall Study|Withdrawal by Subject|66|||
124942882|NCT00683800|449417901|FG001|Overall Study|Withdrawal by Subject|64|||
124942883|NCT00683800|449417900|FG000|Overall Study|Lack of Efficacy|61|||
124942884|NCT00683800|449417901|FG001|Overall Study|Lack of Efficacy|104|||
124942885|NCT00683800|449417900|FG000|Overall Study|Randomized, not treated|35|||
124942886|NCT00683800|449417901|FG001|Overall Study|Randomized, not treated|33|||
124942887|NCT01700205|449417905|FG000|Overall Study|Withdrawal by Subject|13|||
124942888|NCT01700205|449417906|FG001|Overall Study|Withdrawal by Subject|13|||
124942889|NCT01700205|449417905|FG000|Overall Study|Protocol Violation|2|||
124942890|NCT01700205|449417906|FG001|Overall Study|Protocol Violation|2|||
124942891|NCT02251652|449417907|FG000|Overall Study|Withdrawal by Subject|1|||
124942892|NCT00983294|449417911|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
124942893|NCT00983294|449417911|FG000|Colchicine With Azithromycin|Adverse Event|1|||
124942894|NCT03229408|449417915|FG000|Overall Study|Withdrawal by Subject|4|||
124942895|NCT03229408|449417916|FG001|Overall Study|Withdrawal by Subject|1|||
124942896|NCT03229408|449417915|FG000|Overall Study|Adverse Event|2|||
124942897|NCT03229408|449417916|FG001|Overall Study|Adverse Event|0|||
124942898|NCT03229408|449417915|FG000|Overall Study|Pregnancy|0|||
124942899|NCT03229408|449417916|FG001|Overall Study|Pregnancy|1|||
124942900|NCT03229408|449417915|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
124942901|NCT03229408|449417916|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
124942902|NCT04200664|449417917|FG000|Overall Study|Withdrawal by Subject|1|||
124942903|NCT04200664|449417918|FG001|Overall Study|Withdrawal by Subject|0|||
124942904|NCT04200664|449417919|FG002|Overall Study|Withdrawal by Subject|0|||
124942905|NCT04541589|449417921|FG000|Treatment Period|Adverse Event|8|||
124942906|NCT04541589|449417922|FG001|Treatment Period|Adverse Event|2|||
124942907|NCT04541589|449417921|FG000|Treatment Period|Physician Decision|3|||
124942908|NCT04541589|449417922|FG001|Treatment Period|Physician Decision|1|||
124942909|NCT04541589|449417921|FG000|Treatment Period|Subject decision|7|||
124942910|NCT04541589|449417922|FG001|Treatment Period|Subject decision|4|||
124942911|NCT04541589|449417921|FG000|Treatment Period|Withdrawal by Subject|1|||
124942912|NCT04541589|449417922|FG001|Treatment Period|Withdrawal by Subject|0|||
124942913|NCT04541589|449417921|FG000|Safety Follow-up Period|Adverse Event|2|||
124942914|NCT04541589|449417922|FG001|Safety Follow-up Period|Adverse Event|1|||
124942915|NCT04541589|449417921|FG000|Safety Follow-up Period|Physician Decision|1|||
124942916|NCT04541589|449417922|FG001|Safety Follow-up Period|Physician Decision|0|||
124458063|NCT04329702|447638126|FG000|Overall Study|Death|0|||
124458064|NCT04329702|447638127|FG001|Overall Study|Death|2|||
124458065|NCT04329702|447638128|FG002|Overall Study|Death|0|||
124458066|NCT01438489|447638129|FG000|Overall Study|Lost to Follow-up|4|||
124458067|NCT01438489|447638130|FG001|Overall Study|Lost to Follow-up|2|||
124458068|NCT01438489|447638131|FG002|Overall Study|Lost to Follow-up|2|||
124458069|NCT01438489|447638129|FG000|Overall Study|Withdrawal by Subject|11|||
124458070|NCT01438489|447638130|FG001|Overall Study|Withdrawal by Subject|3|||
124458071|NCT01438489|447638131|FG002|Overall Study|Withdrawal by Subject|8|||
124458072|NCT01438489|447638129|FG000|Overall Study|Death|0|||
124458073|NCT01438489|447638130|FG001|Overall Study|Death|0|||
124458074|NCT01438489|447638131|FG002|Overall Study|Death|1|||
124458075|NCT01438489|447638129|FG000|Overall Study|Sponsor decision|4|||
124458076|NCT01438489|447638130|FG001|Overall Study|Sponsor decision|1|||
124458077|NCT01438489|447638131|FG002|Overall Study|Sponsor decision|4|||
124458078|NCT01438489|447638129|FG000|Overall Study|Subject choice/Subject moved|2|||
124458079|NCT01438489|447638130|FG001|Overall Study|Subject choice/Subject moved|1|||
124458080|NCT01438489|447638131|FG002|Overall Study|Subject choice/Subject moved|1|||
124458081|NCT01438489|447638129|FG000|Overall Study|Investigator decision|0|||
124458082|NCT01438489|447638130|FG001|Overall Study|Investigator decision|1|||
124458083|NCT01438489|447638131|FG002|Overall Study|Investigator decision|0|||
124458084|NCT01438489|447638129|FG000|Overall Study|AE/SAEs|2|||
124458085|NCT01438489|447638130|FG001|Overall Study|AE/SAEs|1|||
124458086|NCT01438489|447638131|FG002|Overall Study|AE/SAEs|1|||
124458087|NCT01438489|447638129|FG000|Overall Study|Received prohibited medication|1|||
124458088|NCT01438489|447638130|FG001|Overall Study|Received prohibited medication|0|||
124458089|NCT01438489|447638131|FG002|Overall Study|Received prohibited medication|0|||
124458090|NCT01438489|447638129|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
124458091|NCT01438489|447638130|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
124458092|NCT01438489|447638131|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
124458093|NCT01438489|447638129|FG000|Overall Study|Inadequate venous access|0|||
124458094|NCT01438489|447638130|FG001|Overall Study|Inadequate venous access|2|||
124942917|NCT04541589|449417921|FG000|Safety Follow-up Period|Subject decision|5|||
124942918|NCT04541589|449417922|FG001|Safety Follow-up Period|Subject decision|3|||
124458095|NCT01438489|447638131|FG002|Overall Study|Inadequate venous access|0|||
124458096|NCT00766532|447638132|FG000|Overall Study|Protocol Violation|2|||
124458097|NCT02037295|447638133|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
124458098|NCT02037295|447638134|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
124942919|NCT04541589|449417921|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
124942920|NCT04541589|449417922|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
124942921|NCT02426138|449417923|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
124942922|NCT02426138|449417924|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
124942923|NCT03582475|449417931|FG000|Treatment Period|Withdrawal by Subject|0|||
124942924|NCT03582475|449417932|FG001|Treatment Period|Withdrawal by Subject|1|||
124942925|NCT03582475|449417931|FG000|Follow-up Period|Withdrawal by Subject|0|||
124942926|NCT03582475|449417932|FG001|Follow-up Period|Withdrawal by Subject|1|||
124942927|NCT01706159|449417935|FG000|Overall Study|Withdrawal Criteria|2|||
124942928|NCT01706159|449417936|FG001|Overall Study|Withdrawal Criteria|1|||
124942929|NCT01706159|449417935|FG000|Overall Study|Unclassified|6|||
124942930|NCT01706159|449417936|FG001|Overall Study|Unclassified|1|||
124942931|NCT03362190|449417937|FG000|Overall Study|Adverse Event|0|||
124942932|NCT03362190|449417938|FG001|Overall Study|Adverse Event|0|||
124942933|NCT03362190|449417939|FG002|Overall Study|Adverse Event|0|||
124942934|NCT03362190|449417940|FG003|Overall Study|Adverse Event|1|||
124942935|NCT03362190|449417937|FG000|Overall Study|Withdrawal by Subject|0|||
124942936|NCT03362190|449417938|FG001|Overall Study|Withdrawal by Subject|0|||
124942937|NCT03362190|449417939|FG002|Overall Study|Withdrawal by Subject|0|||
124942938|NCT03362190|449417940|FG003|Overall Study|Withdrawal by Subject|1|||
124942939|NCT00687219|449417941|FG000|Overall Study|Adverse Event|8|||
124458099|NCT02037295|447638135|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
124458100|NCT02037295|447638136|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
124458101|NCT01140451|447638137|FG000|Overall Study|Withdrawal by Subject|26|||
124942940|NCT00687219|449417941|FG000|Overall Study|Discontinuance criteria met|7|||
124942941|NCT00687219|449417941|FG000|Overall Study|HCV-RNA positive conversion|34|||
124942942|NCT00687219|449417941|FG000|Overall Study|Withdrawal by Subject|1|||
124942943|NCT00687219|449417941|FG000|Overall Study|Lack of Efficacy|1|||
124942944|NCT03775486|449417946|FG000|Initial Therapy Phase|Other reason provided|0|||
124942945|NCT03775486|449417947|FG001|Initial Therapy Phase|Other reason provided|15|||
124942946|NCT03775486|449417946|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
124942947|NCT03775486|449417947|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
124942948|NCT03775486|449417946|FG000|Initial Therapy Phase|Protocol Violation|0|||
124942949|NCT03775486|449417947|FG001|Initial Therapy Phase|Protocol Violation|2|||
124942950|NCT03775486|449417946|FG000|Initial Therapy Phase|Adverse Event|0|||
124942951|NCT03775486|449417947|FG001|Initial Therapy Phase|Adverse Event|34|||
124942952|NCT03775486|449417946|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
124942953|NCT03775486|449417947|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
124942954|NCT03775486|449417946|FG000|Maintenance Phase|Withdrawal by Subject|13|||
124942955|NCT03775486|449417947|FG001|Maintenance Phase|Withdrawal by Subject|12|||
124942956|NCT03775486|449417946|FG000|Maintenance Phase|Death|44|||
124942957|NCT03775486|449417947|FG001|Maintenance Phase|Death|45|||
124942958|NCT02744066|449417953|FG000|Overall Study|Withdrawal by parent|0|||
124942959|NCT02744066|449417954|FG001|Overall Study|Withdrawal by parent|1|||
124942960|NCT02744066|449417953|FG000|Overall Study|Discharged from NICU prior to completion|0|||
124942961|NCT02744066|449417954|FG001|Overall Study|Discharged from NICU prior to completion|4|||
124942962|NCT02454959|449417955|FG000|Overall Study|Protocol-Specified Criteria|3|||
124942963|NCT02454959|449417955|FG000|Overall Study|Physician Decision|1|||
124942964|NCT02454959|449417955|FG000|Overall Study|Withdrawal by Subject|3|||
124942965|NCT02454959|449417955|FG000|Overall Study|Adverse Event|2|||
124942966|NCT00647387|449417966|FG000|Overall Study|Lost to Follow-up|6|||
124458102|NCT01140451|447638138|FG001|Overall Study|Withdrawal by Subject|33|||
124942967|NCT00647387|449417966|FG000|Overall Study|Unsuccessful implant|5|||
124942968|NCT00647387|449417966|FG000|Overall Study|Device explanted|3|||
124942969|NCT00647387|449417966|FG000|Overall Study|Other Reason|3|||
124942970|NCT00647387|449417966|FG000|Overall Study|Death|2|||
124942971|NCT02969356|449417968|FG000|Overall Study|Adverse Event|7|||
124458103|NCT01140451|447638137|FG000|Overall Study|Adverse Event|2|||
124942972|NCT02969356|449417968|FG000|Overall Study|Consent withdrawn|2|||
124942973|NCT02969356|449417968|FG000|Overall Study|Lost to Follow-up|3|||
124942974|NCT02969356|449417968|FG000|Overall Study|Did not need to be reinjected|6|||
124942975|NCT02969356|449417968|FG000|Overall Study|Personal reasons|5|||
124942976|NCT04172675|449419793|FG000|Overall Study|Withdrawal by Subject|7|||
124942977|NCT04172675|449419794|FG001|Overall Study|Withdrawal by Subject|5|||
124942978|NCT04172675|449419795|FG002|Overall Study|Withdrawal by Subject|1|||
124942979|NCT04172675|449419796|FG003|Overall Study|Withdrawal by Subject|4|||
124942980|NCT03945773|449419797|FG000|Overall Study|Consent Withdrawn|1|||
124942981|NCT03945773|449419798|FG001|Overall Study|Consent Withdrawn|1|||
124942982|NCT03945773|449419797|FG000|Overall Study|Lost to Follow-up|1|||
124942983|NCT03945773|449419798|FG001|Overall Study|Lost to Follow-up|0|||
124942984|NCT03945773|449419797|FG000|Overall Study|Death|46|||
124942985|NCT03945773|449419798|FG001|Overall Study|Death|22|||
124942986|NCT03945773|449419797|FG000|Overall Study|Physician Decision|1|||
124942987|NCT03945773|449419798|FG001|Overall Study|Physician Decision|0|||
124942988|NCT03945773|449419797|FG000|Overall Study|Other|1|||
124942989|NCT03945773|449419798|FG001|Overall Study|Other|0|||
124705088|NCT04380142|448544769|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
124705089|NCT04380142|448544767|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
124705090|NCT04380142|448544768|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
124705091|NCT04380142|448544769|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
124705092|NCT02706392|448544775|FG000|Overall Study|Death|1|||
124705093|NCT02706392|448544776|FG001|Overall Study|Death|0|||
124705094|NCT02706392|448544777|FG002|Overall Study|Death|2|||
124705095|NCT02706392|448544778|FG003|Overall Study|Death|2|||
124705096|NCT02706392|448544779|FG004|Overall Study|Death|5|||
124705097|NCT02706392|448544780|FG005|Overall Study|Death|2|||
124705098|NCT04716894|448544783|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
124705099|NCT04716894|448544783|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
124705100|NCT00787150|448544786|FG000|Overall Study|Adverse Event|4|||
124705101|NCT00787150|448544787|FG001|Overall Study|Adverse Event|4|||
124705102|NCT00787150|448544788|FG002|Overall Study|Adverse Event|4|||
124705103|NCT00787150|448544786|FG000|Overall Study|Physician Decision|1|||
124705104|NCT00787150|448544787|FG001|Overall Study|Physician Decision|2|||
124705105|NCT00787150|448544788|FG002|Overall Study|Physician Decision|1|||
124705106|NCT00787150|448544786|FG000|Overall Study|Withdrawal by Subject|2|||
124705107|NCT00787150|448544787|FG001|Overall Study|Withdrawal by Subject|1|||
124705108|NCT00787150|448544788|FG002|Overall Study|Withdrawal by Subject|0|||
124705109|NCT00787150|448544786|FG000|Overall Study|Dosing incorrect study durg|2|||
124705110|NCT00787150|448544787|FG001|Overall Study|Dosing incorrect study durg|0|||
124705111|NCT00787150|448544788|FG002|Overall Study|Dosing incorrect study durg|0|||
124705112|NCT00879398|448544795|FG000|Overall Study|Visit Stop|399|||
124705113|NCT00879398|448544795|FG000|Overall Study|Lack of Efficacy|64|||
124705114|NCT00879398|448544795|FG000|Overall Study|Adverse Event|41|||
124705115|NCT00879398|448544795|FG000|Overall Study|Other Reasons|171|||
124705116|NCT03773484|448544796|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
124705117|NCT01344226|448544798|FG000|Overall Study|Protocol Violation|2|||
124705118|NCT01344226|448544798|FG000|Overall Study|Withdrawal by Subject|3|||
124705119|NCT01344226|448544798|FG000|Overall Study|Lack of Efficacy|3|||
124705120|NCT02302222|448544800|FG000|Overall Study|Physician Decision|0|||
124705121|NCT02302222|448544801|FG001|Overall Study|Physician Decision|4|||
124705122|NCT02302222|448544800|FG000|Overall Study|Lost to Follow-up|1|||
124705123|NCT02302222|448544801|FG001|Overall Study|Lost to Follow-up|0|||
124705124|NCT02302222|448544800|FG000|Overall Study|Treatment discontinued before day 5|0|||
124942990|NCT03945773|449419797|FG000|Overall Study|Ongoing at the time of DCO|4|||
124942991|NCT03945773|449419798|FG001|Overall Study|Ongoing at the time of DCO|3|||
124942992|NCT05349721|449419799|FG000|Part A (24 Weeks)|Adverse Event|9|||
124942993|NCT05349721|449419800|FG001|Part A (24 Weeks)|Adverse Event|2|||
124942994|NCT05349721|449419799|FG000|Part A (24 Weeks)|Death|8|||
124942995|NCT05349721|449419800|FG001|Part A (24 Weeks)|Death|3|||
124942996|NCT05349721|449419799|FG000|Part A (24 Weeks)|Disease Progression|1|||
124942997|NCT05349721|449419800|FG001|Part A (24 Weeks)|Disease Progression|1|||
124942998|NCT05349721|449419799|FG000|Part A (24 Weeks)|Screen Failure|2|||
124942999|NCT05349721|449419800|FG001|Part A (24 Weeks)|Screen Failure|0|||
124943000|NCT05349721|449419799|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
124943001|NCT05349721|449419800|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
124943002|NCT05349721|449419799|FG000|Part A (24 Weeks)|Other Than Specified|5|||
124943003|NCT05349721|449419800|FG001|Part A (24 Weeks)|Other Than Specified|1|||
124943004|NCT05349721|449419799|FG000|Part B (28 Weeks)|Adverse Event|3|||
124943005|NCT05349721|449419800|FG001|Part B (28 Weeks)|Adverse Event|0|||
124943006|NCT05349721|449419799|FG000|Part B (28 Weeks)|Death|21|||
124943007|NCT05349721|449419800|FG001|Part B (28 Weeks)|Death|11|||
124943008|NCT05349721|449419799|FG000|Part B (28 Weeks)|Disease Progression|2|||
124943009|NCT05349721|449419800|FG001|Part B (28 Weeks)|Disease Progression|1|||
124705125|NCT02302222|448544801|FG001|Overall Study|Treatment discontinued before day 5|1|||
124705126|NCT02302222|448544800|FG000|Overall Study|Withdrawn prior to any treatment|0|||
124943010|NCT05349721|449419799|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
124943011|NCT05349721|449419800|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
124943012|NCT05349721|449419799|FG000|Part B (28 Weeks)|Physician Decision|1|||
124943013|NCT05349721|449419800|FG001|Part B (28 Weeks)|Physician Decision|0|||
124943014|NCT05349721|449419799|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
124705127|NCT02302222|448544801|FG001|Overall Study|Withdrawn prior to any treatment|1|||
124705128|NCT03781570|448544807|FG000|Overall Study|Technical Issues (equipment failure)|31|||
124705129|NCT03781570|448544807|FG000|Overall Study|Withdrawal by Subject|7|||
124705130|NCT03781570|448544807|FG000|Overall Study|Physical Constraints|11|||
124705131|NCT01107496|448544808|FG000|Overall Study|Adverse Event|1|||
124705132|NCT01107496|448544809|FG001|Overall Study|Adverse Event|0|||
124705133|NCT01107496|448544808|FG000|Overall Study|Lack of Efficacy|1|||
124705134|NCT01107496|448544809|FG001|Overall Study|Lack of Efficacy|0|||
124705135|NCT01107496|448544808|FG000|Overall Study|Protocol Violation|0|||
124943015|NCT05349721|449419800|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
124943016|NCT05349721|449419799|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
124943017|NCT05349721|449419800|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
124458104|NCT01140451|447638138|FG001|Overall Study|Adverse Event|6|||
124458105|NCT01140451|447638137|FG000|Overall Study|Physician Decision|5|||
124458106|NCT01140451|447638138|FG001|Overall Study|Physician Decision|3|||
124458107|NCT01140451|447638137|FG000|Overall Study|Lost to Follow-up|2|||
124765248|NCT02587520|448767371|FG009|Overall Study|Adverse Event|0|||
124458108|NCT01140451|447638138|FG001|Overall Study|Lost to Follow-up|0|||
124943018|NCT05349721|449419799|FG000|Part B (28 Weeks)|Other Than Specified|4|||
124943019|NCT05349721|449419800|FG001|Part B (28 Weeks)|Other Than Specified|2|||
124943020|NCT05349721|449419799|FG000|Part C (108 Weeks)|Death|0|||
124943021|NCT05349721|449419800|FG001|Part C (108 Weeks)|Death|1|||
124943022|NCT05349721|449419799|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
124943023|NCT05349721|449419800|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
124943024|NCT05349721|449419799|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
124943025|NCT05349721|449419800|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
124943026|NCT05349721|449419799|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
124943027|NCT05349721|449419800|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
124943028|NCT03070392|449419801|FG000|Overall Study|Not Treated|7|||
124943029|NCT03070392|449419802|FG001|Overall Study|Not Treated|0|||
124943030|NCT03070392|449419803|FG002|Overall Study|Not Treated|3|||
124943031|NCT03070392|449419804|FG003|Overall Study|Not Treated|12|||
124943032|NCT03070392|449419801|FG000|Overall Study|Death|3|||
124943033|NCT03070392|449419802|FG001|Overall Study|Death|0|||
124943034|NCT03070392|449419803|FG002|Overall Study|Death|0|||
124943035|NCT03070392|449419804|FG003|Overall Study|Death|1|||
124943036|NCT03070392|449419801|FG000|Overall Study|Withdrawal by Subject|7|||
124943037|NCT03070392|449419802|FG001|Overall Study|Withdrawal by Subject|0|||
124943038|NCT03070392|449419803|FG002|Overall Study|Withdrawal by Subject|0|||
124943039|NCT03070392|449419804|FG003|Overall Study|Withdrawal by Subject|3|||
124943040|NCT03070392|449419801|FG000|Overall Study|Physician Decision|1|||
124943041|NCT03070392|449419802|FG001|Overall Study|Physician Decision|0|||
124943042|NCT03070392|449419803|FG002|Overall Study|Physician Decision|0|||
124943043|NCT03070392|449419804|FG003|Overall Study|Physician Decision|2|||
124943044|NCT03070392|449419801|FG000|Overall Study|Progressive Disease|154|||
124943045|NCT03070392|449419802|FG001|Overall Study|Progressive Disease|6|||
124943046|NCT03070392|449419803|FG002|Overall Study|Progressive Disease|2|||
124943047|NCT03070392|449419804|FG003|Overall Study|Progressive Disease|70|||
124943048|NCT03070392|449419801|FG000|Overall Study|Adverse Event|6|||
124943049|NCT03070392|449419802|FG001|Overall Study|Adverse Event|1|||
124458109|NCT01140451|447638137|FG000|Overall Study|Participants Planning Pregnancy|3|||
124458110|NCT01140451|447638138|FG001|Overall Study|Participants Planning Pregnancy|0|||
124458111|NCT00960661|447638142|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
124458112|NCT00960661|447638143|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
124458113|NCT00960661|447638144|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
124458114|NCT00960661|447638142|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
124458115|NCT00960661|447638143|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
124458116|NCT00960661|447638144|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
124458117|NCT00960661|447638142|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
124458118|NCT00960661|447638143|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
124458119|NCT00960661|447638144|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
124458120|NCT00960661|447638142|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
124458121|NCT00960661|447638143|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
124458122|NCT00960661|447638144|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
124458123|NCT00960661|447638142|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
124458124|NCT00960661|447638143|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
124458125|NCT00960661|447638144|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
124458126|NCT00960661|447638142|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
124458127|NCT00960661|447638143|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
124458128|NCT00960661|447638144|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
124458129|NCT00960661|447638142|FG000|Interventional Phase|Adverse Event|0|||
124458130|NCT00960661|447638143|FG001|Interventional Phase|Adverse Event|17|||
124458131|NCT00960661|447638144|FG002|Interventional Phase|Adverse Event|8|||
124458132|NCT00960661|447638142|FG000|Interventional Phase|Death|0|||
124943050|NCT03070392|449419803|FG002|Overall Study|Adverse Event|1|||
124458133|NCT00960661|447638143|FG001|Interventional Phase|Death|1|||
124458134|NCT00960661|447638144|FG002|Interventional Phase|Death|0|||
124458135|NCT00960661|447638142|FG000|Interventional Phase|Lost to Follow-up|0|||
124943051|NCT03070392|449419804|FG003|Overall Study|Adverse Event|3|||
124943052|NCT03070392|449419801|FG000|Overall Study|Alternate anticancer treatment|1|||
124943053|NCT03070392|449419802|FG001|Overall Study|Alternate anticancer treatment|0|||
124943054|NCT03070392|449419803|FG002|Overall Study|Alternate anticancer treatment|0|||
124943055|NCT03070392|449419804|FG003|Overall Study|Alternate anticancer treatment|1|||
124943056|NCT03070392|449419801|FG000|Overall Study|Ongoing|73|||
124943057|NCT03070392|449419802|FG001|Overall Study|Ongoing|0|||
124943058|NCT03070392|449419803|FG002|Overall Study|Ongoing|0|||
124943059|NCT03070392|449419804|FG003|Overall Study|Ongoing|11|||
124943060|NCT02972034|449419805|FG000|Overall Study|Death|11|||
124943061|NCT02972034|449419806|FG001|Overall Study|Death|1|||
124943062|NCT02972034|449419807|FG002|Overall Study|Death|3|||
124943063|NCT02972034|449419808|FG003|Overall Study|Death|3|||
124943064|NCT02972034|449419809|FG004|Overall Study|Death|2|||
124943065|NCT02972034|449419810|FG005|Overall Study|Death|2|||
124943066|NCT02972034|449419811|FG006|Overall Study|Death|3|||
124943067|NCT02972034|449419812|FG007|Overall Study|Death|4|||
124943068|NCT02972034|449419813|FG008|Overall Study|Death|8|||
124943069|NCT02972034|449419814|FG009|Overall Study|Death|11|||
124943070|NCT02972034|449419815|FG010|Overall Study|Death|3|||
124943071|NCT02972034|449419816|FG011|Overall Study|Death|2|||
124943072|NCT02972034|449419817|FG012|Overall Study|Death|11|||
124943073|NCT02972034|449419818|FG013|Overall Study|Death|10|||
124943074|NCT02972034|449419819|FG014|Overall Study|Death|9|||
124943075|NCT02972034|449419805|FG000|Overall Study|Lost to Follow-up|0|||
124943076|NCT02972034|449419806|FG001|Overall Study|Lost to Follow-up|0|||
124943077|NCT02972034|449419807|FG002|Overall Study|Lost to Follow-up|0|||
124943078|NCT02972034|449419808|FG003|Overall Study|Lost to Follow-up|0|||
124943079|NCT02972034|449419809|FG004|Overall Study|Lost to Follow-up|1|||
124943080|NCT02972034|449419810|FG005|Overall Study|Lost to Follow-up|0|||
124943081|NCT02972034|449419811|FG006|Overall Study|Lost to Follow-up|0|||
124943082|NCT02972034|449419812|FG007|Overall Study|Lost to Follow-up|1|||
124943083|NCT02972034|449419813|FG008|Overall Study|Lost to Follow-up|0|||
124943084|NCT02972034|449419814|FG009|Overall Study|Lost to Follow-up|0|||
124943085|NCT02972034|449419815|FG010|Overall Study|Lost to Follow-up|0|||
124943086|NCT02972034|449419816|FG011|Overall Study|Lost to Follow-up|0|||
124943087|NCT02972034|449419817|FG012|Overall Study|Lost to Follow-up|0|||
124943088|NCT02972034|449419818|FG013|Overall Study|Lost to Follow-up|0|||
124943089|NCT02972034|449419819|FG014|Overall Study|Lost to Follow-up|1|||
124943090|NCT02972034|449419805|FG000|Overall Study|Physician Decision|0|||
124943091|NCT02972034|449419806|FG001|Overall Study|Physician Decision|0|||
124943092|NCT02972034|449419807|FG002|Overall Study|Physician Decision|0|||
124943093|NCT02972034|449419808|FG003|Overall Study|Physician Decision|0|||
124943094|NCT02972034|449419809|FG004|Overall Study|Physician Decision|0|||
124943095|NCT02972034|449419810|FG005|Overall Study|Physician Decision|0|||
124943096|NCT02972034|449419811|FG006|Overall Study|Physician Decision|0|||
124943097|NCT02972034|449419812|FG007|Overall Study|Physician Decision|1|||
124943098|NCT02972034|449419813|FG008|Overall Study|Physician Decision|0|||
124943099|NCT02972034|449419814|FG009|Overall Study|Physician Decision|0|||
124943100|NCT02972034|449419815|FG010|Overall Study|Physician Decision|1|||
124943101|NCT02972034|449419816|FG011|Overall Study|Physician Decision|0|||
124943102|NCT02972034|449419817|FG012|Overall Study|Physician Decision|0|||
124943103|NCT02972034|449419818|FG013|Overall Study|Physician Decision|0|||
124943104|NCT02972034|449419819|FG014|Overall Study|Physician Decision|0|||
124705136|NCT01107496|448544809|FG001|Overall Study|Protocol Violation|1|||
124705137|NCT01107496|448544808|FG000|Overall Study|Lost to Follow-up|0|||
124705138|NCT01107496|448544809|FG001|Overall Study|Lost to Follow-up|1|||
124705139|NCT03709472|448544810|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
124458136|NCT00960661|447638143|FG001|Interventional Phase|Lost to Follow-up|0|||
124458137|NCT00960661|447638144|FG002|Interventional Phase|Lost to Follow-up|2|||
124943105|NCT02972034|449419805|FG000|Overall Study|Sponsor Decision|0|||
124943106|NCT02972034|449419806|FG001|Overall Study|Sponsor Decision|0|||
124943107|NCT02972034|449419807|FG002|Overall Study|Sponsor Decision|0|||
124943108|NCT02972034|449419808|FG003|Overall Study|Sponsor Decision|1|||
124943109|NCT02972034|449419809|FG004|Overall Study|Sponsor Decision|0|||
124943110|NCT02972034|449419810|FG005|Overall Study|Sponsor Decision|0|||
124943111|NCT02972034|449419811|FG006|Overall Study|Sponsor Decision|1|||
124943112|NCT02972034|449419812|FG007|Overall Study|Sponsor Decision|1|||
124943113|NCT02972034|449419813|FG008|Overall Study|Sponsor Decision|1|||
124943114|NCT02972034|449419814|FG009|Overall Study|Sponsor Decision|2|||
124943115|NCT02972034|449419815|FG010|Overall Study|Sponsor Decision|2|||
124943116|NCT02972034|449419816|FG011|Overall Study|Sponsor Decision|0|||
124943117|NCT02972034|449419817|FG012|Overall Study|Sponsor Decision|1|||
124943118|NCT02972034|449419818|FG013|Overall Study|Sponsor Decision|0|||
124458138|NCT00960661|447638142|FG000|Interventional Phase|entry criteria not met|0|||
124458139|NCT00960661|447638143|FG001|Interventional Phase|entry criteria not met|3|||
124458140|NCT00960661|447638144|FG002|Interventional Phase|entry criteria not met|0|||
124458141|NCT00960661|447638142|FG000|Interventional Phase|Protocol Violation|0|||
124458142|NCT00960661|447638143|FG001|Interventional Phase|Protocol Violation|7|||
124458143|NCT00960661|447638144|FG002|Interventional Phase|Protocol Violation|2|||
124458144|NCT00960661|447638142|FG000|Interventional Phase|Withdrawal by Subject|0|||
124458145|NCT00960661|447638143|FG001|Interventional Phase|Withdrawal by Subject|18|||
124458146|NCT00960661|447638144|FG002|Interventional Phase|Withdrawal by Subject|29|||
124458147|NCT00960661|447638142|FG000|Interventional Phase|Physician Decision|0|||
124458148|NCT00960661|447638143|FG001|Interventional Phase|Physician Decision|3|||
124458149|NCT00960661|447638144|FG002|Interventional Phase|Physician Decision|5|||
124458150|NCT00960661|447638142|FG000|Interventional Phase|sponsor decision|0|||
124458151|NCT00960661|447638143|FG001|Interventional Phase|sponsor decision|1|||
124458152|NCT00960661|447638144|FG002|Interventional Phase|sponsor decision|0|||
124458153|NCT00960661|447638142|FG000|Interventional Phase|Lack of Efficacy|0|||
124458154|NCT00960661|447638143|FG001|Interventional Phase|Lack of Efficacy|2|||
124705140|NCT03709472|448544811|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
124943119|NCT02972034|449419819|FG014|Overall Study|Sponsor Decision|1|||
124943120|NCT02972034|449419805|FG000|Overall Study|Withdrawal by Subject|3|||
124943121|NCT02972034|449419806|FG001|Overall Study|Withdrawal by Subject|0|||
124943122|NCT02972034|449419807|FG002|Overall Study|Withdrawal by Subject|0|||
124458155|NCT00960661|447638144|FG002|Interventional Phase|Lack of Efficacy|0|||
124458156|NCT02699892|447638145|FG000|Overall Study|Other|36|||
124458157|NCT01324232|447638152|FG000|Overall Study|Protocol Violation|0|||
124458158|NCT01324232|447638153|FG001|Overall Study|Protocol Violation|0|||
124943123|NCT02972034|449419808|FG003|Overall Study|Withdrawal by Subject|0|||
124943124|NCT02972034|449419809|FG004|Overall Study|Withdrawal by Subject|1|||
124705141|NCT03709472|448544810|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
124705142|NCT03709472|448544811|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
124705143|NCT02496000|448544814|FG000|Overall Study|Withdrawal by Subject|1|||
124943125|NCT02972034|449419810|FG005|Overall Study|Withdrawal by Subject|1|||
124943126|NCT02972034|449419811|FG006|Overall Study|Withdrawal by Subject|0|||
124943127|NCT02972034|449419812|FG007|Overall Study|Withdrawal by Subject|0|||
124943128|NCT02972034|449419813|FG008|Overall Study|Withdrawal by Subject|1|||
124943129|NCT02972034|449419814|FG009|Overall Study|Withdrawal by Subject|1|||
124943130|NCT02972034|449419815|FG010|Overall Study|Withdrawal by Subject|2|||
124705144|NCT02496000|448544815|FG001|Overall Study|Withdrawal by Subject|2|||
124705145|NCT02496000|448544816|FG002|Overall Study|Withdrawal by Subject|0|||
124705146|NCT02496000|448544814|FG000|Overall Study|Lost to Follow-up|1|||
124705147|NCT02496000|448544815|FG001|Overall Study|Lost to Follow-up|0|||
124705148|NCT02496000|448544816|FG002|Overall Study|Lost to Follow-up|1|||
124705149|NCT02496000|448544814|FG000|Overall Study|Protocol Violation|0|||
124705150|NCT02496000|448544815|FG001|Overall Study|Protocol Violation|0|||
124705151|NCT02496000|448544816|FG002|Overall Study|Protocol Violation|1|||
124705152|NCT02496000|448544814|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
124705153|NCT02496000|448544815|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
124705154|NCT02496000|448544816|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
124705155|NCT02496000|448544814|FG000|Overall Study|undetermined|0|||
124705156|NCT02496000|448544815|FG001|Overall Study|undetermined|1|||
124705157|NCT02496000|448544816|FG002|Overall Study|undetermined|0|||
124705158|NCT02255656|448544817|FG000|Overall Study|Adverse Event|11|||
124705159|NCT02255656|448544817|FG000|Overall Study|Poor compliance to protocol|3|||
124705160|NCT02255656|448544817|FG000|Overall Study|Lost to Follow-up|30|||
124705161|NCT02255656|448544817|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
124705162|NCT02255656|448544817|FG000|Overall Study|Other|126|||
124705163|NCT01969058|448544818|FG000|Overall Study|Withdrawal by Subject|2|||
124705164|NCT01969058|448544819|FG001|Overall Study|Withdrawal by Subject|0|||
124705165|NCT01969058|448544818|FG000|Overall Study|Adverse Event|1|||
124705166|NCT01969058|448544819|FG001|Overall Study|Adverse Event|0|||
124705167|NCT04976855|448544820|FG000|Part I|Withdrawal by Subject|0|||
124705168|NCT04976855|448544821|FG001|Part I|Withdrawal by Subject|1|||
124705169|NCT04976855|448544822|FG002|Part I|Withdrawal by Subject|0|||
124705170|NCT04976855|448544823|FG003|Part I|Withdrawal by Subject|0|||
124705171|NCT04976855|448544824|FG004|Part I|Withdrawal by Subject|0|||
124705172|NCT04976855|448544825|FG005|Part I|Withdrawal by Subject|0|||
124705173|NCT04976855|448544826|FG006|Part I|Withdrawal by Subject|0|||
124705174|NCT04976855|448544820|FG000|Part II|Adverse Event|0|||
124705175|NCT04976855|448544821|FG001|Part II|Adverse Event|0|||
124705176|NCT04976855|448544822|FG002|Part II|Adverse Event|0|||
124705177|NCT04976855|448544823|FG003|Part II|Adverse Event|1|||
124705178|NCT04976855|448544824|FG004|Part II|Adverse Event|0|||
124705179|NCT04976855|448544825|FG005|Part II|Adverse Event|0|||
124705180|NCT04976855|448544826|FG006|Part II|Adverse Event|0|||
124705181|NCT04976855|448544820|FG000|Part II|Withdrawal by Subject|0|||
124705182|NCT04976855|448544821|FG001|Part II|Withdrawal by Subject|0|||
124705183|NCT04976855|448544822|FG002|Part II|Withdrawal by Subject|0|||
124705184|NCT04976855|448544823|FG003|Part II|Withdrawal by Subject|0|||
124705185|NCT04976855|448544824|FG004|Part II|Withdrawal by Subject|1|||
124705186|NCT04976855|448544825|FG005|Part II|Withdrawal by Subject|0|||
124705187|NCT04976855|448544826|FG006|Part II|Withdrawal by Subject|0|||
124705188|NCT04976855|448544820|FG000|Part II|Lost to Follow-up|0|||
124705189|NCT04976855|448544821|FG001|Part II|Lost to Follow-up|0|||
124705190|NCT04976855|448544822|FG002|Part II|Lost to Follow-up|0|||
124705191|NCT04976855|448544823|FG003|Part II|Lost to Follow-up|0|||
124705192|NCT04976855|448544824|FG004|Part II|Lost to Follow-up|0|||
124705193|NCT04976855|448544825|FG005|Part II|Lost to Follow-up|1|||
124705194|NCT04976855|448544826|FG006|Part II|Lost to Follow-up|0|||
124943131|NCT02972034|449419816|FG011|Overall Study|Withdrawal by Subject|1|||
124943132|NCT02972034|449419817|FG012|Overall Study|Withdrawal by Subject|1|||
124943133|NCT02972034|449419818|FG013|Overall Study|Withdrawal by Subject|1|||
124943134|NCT02972034|449419819|FG014|Overall Study|Withdrawal by Subject|0|||
124705195|NCT05318287|448544827|FG000|Overall Study|Lost to Follow-up|8|||
124705196|NCT05185453|448544828|FG000|Overall Study|Lost to Follow-up|13|||
124705197|NCT05185453|448544829|FG001|Overall Study|Lost to Follow-up|3|||
124705198|NCT05715827|448544836|FG000|Overall Study|Physician Decision|0|||
124705199|NCT05715827|448544837|FG001|Overall Study|Physician Decision|1|||
124705200|NCT05715827|448544836|FG000|Overall Study|console communication error|0|||
124705201|NCT05715827|448544837|FG001|Overall Study|console communication error|1|||
124705202|NCT02457793|448544838|FG000|Overall Study|Reason not specified|0|||
124705203|NCT02457793|448544839|FG001|Overall Study|Reason not specified|0|||
124943135|NCT02972034|449419805|FG000|Overall Study|Screen Failure|0|||
124943136|NCT02972034|449419806|FG001|Overall Study|Screen Failure|0|||
124705204|NCT02457793|448544840|FG002|Overall Study|Reason not specified|0|||
124705205|NCT02457793|448544841|FG003|Overall Study|Reason not specified|1|||
124705206|NCT02457793|448544842|FG004|Overall Study|Reason not specified|1|||
124705207|NCT02457793|448544843|FG005|Overall Study|Reason not specified|1|||
124943137|NCT02972034|449419807|FG002|Overall Study|Screen Failure|0|||
124943138|NCT02972034|449419808|FG003|Overall Study|Screen Failure|0|||
124943139|NCT02972034|449419809|FG004|Overall Study|Screen Failure|0|||
124943140|NCT02972034|449419810|FG005|Overall Study|Screen Failure|0|||
124705208|NCT02457793|448544838|FG000|Overall Study|Withdrawal by Subject|0|||
124705209|NCT02457793|448544839|FG001|Overall Study|Withdrawal by Subject|4|||
124705210|NCT02457793|448544840|FG002|Overall Study|Withdrawal by Subject|2|||
124705211|NCT02457793|448544841|FG003|Overall Study|Withdrawal by Subject|2|||
124705212|NCT02457793|448544842|FG004|Overall Study|Withdrawal by Subject|2|||
124705213|NCT02457793|448544843|FG005|Overall Study|Withdrawal by Subject|2|||
124705214|NCT02457793|448544838|FG000|Overall Study|Adverse Event|0|||
124705215|NCT02457793|448544839|FG001|Overall Study|Adverse Event|0|||
124705216|NCT02457793|448544840|FG002|Overall Study|Adverse Event|0|||
124705217|NCT02457793|448544841|FG003|Overall Study|Adverse Event|1|||
124705218|NCT02457793|448544842|FG004|Overall Study|Adverse Event|0|||
124705219|NCT02457793|448544843|FG005|Overall Study|Adverse Event|0|||
124705220|NCT02457793|448544838|FG000|Overall Study|Physician Decision|1|||
124705221|NCT02457793|448544839|FG001|Overall Study|Physician Decision|0|||
124705222|NCT02457793|448544840|FG002|Overall Study|Physician Decision|1|||
124705223|NCT02457793|448544841|FG003|Overall Study|Physician Decision|1|||
124705224|NCT02457793|448544842|FG004|Overall Study|Physician Decision|1|||
124705225|NCT02457793|448544843|FG005|Overall Study|Physician Decision|3|||
124705226|NCT03814044|448544848|FG000|Overall Study|Protocol deviation|1|||
124705227|NCT05929326|448544851|FG000|Overall Study|unqualified sample|2|||
124705228|NCT05929326|448544852|FG001|Overall Study|unqualified sample|3|||
124705229|NCT05929326|448544853|FG002|Overall Study|unqualified sample|7|||
124705230|NCT00835172|448544854|FG000|Washout|Protocol Violation|0|||
124705231|NCT00835172|448544855|FG001|Washout|Protocol Violation|1|||
124705232|NCT03274466|448544864|FG000|Overall Study|Withdrawal by Subject|7|||
124705233|NCT03274466|448544865|FG001|Overall Study|Withdrawal by Subject|3|||
124705234|NCT03274466|448544864|FG000|Overall Study|Protocol Specified Withdrawal|5|||
124705235|NCT03274466|448544865|FG001|Overall Study|Protocol Specified Withdrawal|11|||
124705236|NCT03274466|448544864|FG000|Overall Study|Lost to Follow-up|5|||
124705237|NCT03274466|448544865|FG001|Overall Study|Lost to Follow-up|7|||
124705238|NCT03274466|448544864|FG000|Overall Study|Subject Non-compliance|0|||
124705239|NCT03274466|448544865|FG001|Overall Study|Subject Non-compliance|1|||
124705240|NCT03274466|448544864|FG000|Overall Study|Adverse Event|3|||
124705241|NCT03274466|448544865|FG001|Overall Study|Adverse Event|3|||
124705242|NCT03274466|448544864|FG000|Overall Study|Physician Decision|0|||
124705243|NCT03274466|448544865|FG001|Overall Study|Physician Decision|1|||
124705244|NCT03274466|448544864|FG000|Overall Study|Protocol Violation|3|||
124705245|NCT03274466|448544865|FG001|Overall Study|Protocol Violation|3|||
124705246|NCT00730327|448547143|FG000|Overall Study|Lost to Follow-up|14|||
124705247|NCT00730327|448547144|FG001|Overall Study|Lost to Follow-up|16|||
124705248|NCT00730327|448547143|FG000|Overall Study|Adverse Event|8|||
124705249|NCT00730327|448547144|FG001|Overall Study|Adverse Event|1|||
124705250|NCT00730327|448547143|FG000|Overall Study|Withdrawal by Subject|3|||
124705251|NCT00730327|448547144|FG001|Overall Study|Withdrawal by Subject|13|||
124705252|NCT00730327|448547143|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
124705253|NCT00730327|448547144|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
124705254|NCT02552225|448547145|FG000|Overall Study|Withdrawal by Subject|1|||
124705255|NCT02552225|448547146|FG001|Overall Study|Withdrawal by Subject|0|||
124705256|NCT02989857|448547147|FG000|Randomization Phase|Not Treated|3|||
124705257|NCT02989857|448547148|FG001|Randomization Phase|Not Treated|2|||
124705258|NCT02989857|448547149|FG002|Randomization Phase|Not Treated|0|||
124705259|NCT00876447|448547156|FG000|Overall Study|Other miscellaneous reasons|3|||
124705260|NCT00876447|448547157|FG001|Overall Study|Other miscellaneous reasons|8|||
124705261|NCT00876447|448547156|FG000|Overall Study|Site closure|19|||
124705262|NCT00876447|448547157|FG001|Overall Study|Site closure|14|||
124705263|NCT00876447|448547156|FG000|Overall Study|Protocol Violation|9|||
124705264|NCT00876447|448547157|FG001|Overall Study|Protocol Violation|3|||
124943141|NCT02972034|449419811|FG006|Overall Study|Screen Failure|0|||
124943142|NCT02972034|449419812|FG007|Overall Study|Screen Failure|0|||
124705265|NCT00876447|448547156|FG000|Overall Study|Personal reasons|30|||
124705266|NCT00876447|448547157|FG001|Overall Study|Personal reasons|28|||
124705267|NCT00876447|448547156|FG000|Overall Study|Lost to Follow-up|6|||
124705268|NCT00876447|448547157|FG001|Overall Study|Lost to Follow-up|15|||
124705269|NCT00876447|448547156|FG000|Overall Study|Pregnancy|4|||
124705270|NCT00876447|448547157|FG001|Overall Study|Pregnancy|2|||
124705271|NCT00876447|448547156|FG000|Overall Study|Lack of Efficacy|5|||
124705272|NCT00876447|448547157|FG001|Overall Study|Lack of Efficacy|3|||
124705273|NCT00876447|448547156|FG000|Overall Study|Adverse Event|4|||
124705274|NCT00876447|448547157|FG001|Overall Study|Adverse Event|8|||
124943143|NCT02972034|449419813|FG008|Overall Study|Screen Failure|0|||
124943144|NCT02972034|449419814|FG009|Overall Study|Screen Failure|0|||
124765249|NCT02587520|448767372|FG010|Overall Study|Adverse Event|0|||
124705275|NCT00366457|448547161|FG000|Overall Study|never began study therapy|2|||
124705276|NCT02538614|448547162|FG000|Overall Study|Progressive Disease|2|||
124705277|NCT00189423|448547167|FG000|Overall Study|Death|746|||
124943145|NCT02972034|449419815|FG010|Overall Study|Screen Failure|0|||
124943146|NCT02972034|449419816|FG011|Overall Study|Screen Failure|0|||
124943147|NCT02972034|449419817|FG012|Overall Study|Screen Failure|1|||
124943148|NCT02972034|449419818|FG013|Overall Study|Screen Failure|0|||
124943149|NCT02972034|449419819|FG014|Overall Study|Screen Failure|0|||
124943150|NCT03861052|449419820|FG000|Overall Study|Adverse Event|1|||
124943151|NCT03861052|449419821|FG001|Overall Study|Adverse Event|1|||
124943152|NCT03861052|449419822|FG002|Overall Study|Adverse Event|2|||
124943153|NCT03861052|449419823|FG003|Overall Study|Adverse Event|4|||
124943154|NCT03861052|449419820|FG000|Overall Study|Lost to Follow-up|0|||
124943155|NCT03861052|449419821|FG001|Overall Study|Lost to Follow-up|0|||
124943156|NCT03861052|449419822|FG002|Overall Study|Lost to Follow-up|0|||
124943157|NCT03861052|449419823|FG003|Overall Study|Lost to Follow-up|1|||
124943158|NCT03861052|449419820|FG000|Overall Study|Physician Decision|0|||
124943159|NCT03861052|449419821|FG001|Overall Study|Physician Decision|1|||
124943160|NCT03861052|449419822|FG002|Overall Study|Physician Decision|0|||
124943161|NCT03861052|449419823|FG003|Overall Study|Physician Decision|0|||
124943162|NCT03861052|449419820|FG000|Overall Study|Withdrawal by Subject|2|||
124943163|NCT03861052|449419821|FG001|Overall Study|Withdrawal by Subject|5|||
124943164|NCT03861052|449419822|FG002|Overall Study|Withdrawal by Subject|3|||
124943165|NCT03861052|449419823|FG003|Overall Study|Withdrawal by Subject|0|||
124705278|NCT00189423|448547168|FG001|Overall Study|Death|747|||
124705279|NCT00189423|448547167|FG000|Overall Study|Withdrawal by Subject|9|||
124705280|NCT00189423|448547168|FG001|Overall Study|Withdrawal by Subject|9|||
124705281|NCT00189423|448547167|FG000|Overall Study|Lost to Follow-up|10|||
124705282|NCT00189423|448547168|FG001|Overall Study|Lost to Follow-up|10|||
124705283|NCT04622592|448547171|FG000|Overall Study|Death|0|||
124705284|NCT04622592|448547172|FG001|Overall Study|Death|0|||
124705285|NCT04622592|448547173|FG002|Overall Study|Death|1|||
124705286|NCT04622592|448547174|FG003|Overall Study|Death|0|||
124705287|NCT04622592|448547175|FG004|Overall Study|Death|0|||
124705288|NCT04622592|448547176|FG005|Overall Study|Death|0|||
124705289|NCT04622592|448547177|FG006|Overall Study|Death|0|||
124705290|NCT04622592|448547178|FG007|Overall Study|Death|1|||
124705291|NCT04622592|448547171|FG000|Overall Study|Lost to Follow-up|0|||
124705292|NCT04622592|448547172|FG001|Overall Study|Lost to Follow-up|0|||
124705293|NCT04622592|448547173|FG002|Overall Study|Lost to Follow-up|0|||
124705294|NCT04622592|448547174|FG003|Overall Study|Lost to Follow-up|3|||
124705295|NCT04622592|448547175|FG004|Overall Study|Lost to Follow-up|1|||
124705296|NCT04622592|448547176|FG005|Overall Study|Lost to Follow-up|0|||
124705297|NCT04622592|448547177|FG006|Overall Study|Lost to Follow-up|2|||
124705298|NCT04622592|448547178|FG007|Overall Study|Lost to Follow-up|2|||
124705299|NCT04622592|448547171|FG000|Overall Study|Physician Decision|0|||
124705300|NCT04622592|448547172|FG001|Overall Study|Physician Decision|0|||
124705301|NCT04622592|448547173|FG002|Overall Study|Physician Decision|0|||
124705302|NCT04622592|448547174|FG003|Overall Study|Physician Decision|0|||
124705303|NCT04622592|448547175|FG004|Overall Study|Physician Decision|1|||
124705304|NCT04622592|448547176|FG005|Overall Study|Physician Decision|0|||
124705305|NCT04622592|448547177|FG006|Overall Study|Physician Decision|0|||
124705306|NCT04622592|448547178|FG007|Overall Study|Physician Decision|0|||
124705307|NCT04622592|448547171|FG000|Overall Study|Withdrawal by Subject|1|||
124705308|NCT04622592|448547172|FG001|Overall Study|Withdrawal by Subject|0|||
124705309|NCT04622592|448547173|FG002|Overall Study|Withdrawal by Subject|2|||
124705310|NCT04622592|448547174|FG003|Overall Study|Withdrawal by Subject|0|||
124705311|NCT04622592|448547175|FG004|Overall Study|Withdrawal by Subject|0|||
124943166|NCT03861052|449419820|FG000|Overall Study|Relocation to other city|1|||
124943167|NCT03861052|449419821|FG001|Overall Study|Relocation to other city|0|||
124943168|NCT03861052|449419822|FG002|Overall Study|Relocation to other city|0|||
124943169|NCT03861052|449419823|FG003|Overall Study|Relocation to other city|0|||
124943170|NCT03823703|449419824|FG000|Overall Study|Sponsor request|0|||
124943171|NCT03823703|449419825|FG001|Overall Study|Sponsor request|3|||
124943172|NCT03823703|449419826|FG002|Overall Study|Sponsor request|4|||
124943173|NCT03823703|449419824|FG000|Overall Study|Adverse Event|3|||
124458159|NCT01324232|447638154|FG002|Overall Study|Protocol Violation|0|||
124705312|NCT04622592|448547176|FG005|Overall Study|Withdrawal by Subject|0|||
124705313|NCT04622592|448547177|FG006|Overall Study|Withdrawal by Subject|1|||
124705314|NCT04622592|448547178|FG007|Overall Study|Withdrawal by Subject|4|||
124705315|NCT04622592|448547171|FG000|Overall Study|Other than specified above|0|||
124705316|NCT04622592|448547172|FG001|Overall Study|Other than specified above|0|||
124705317|NCT04622592|448547173|FG002|Overall Study|Other than specified above|1|||
124705318|NCT04622592|448547174|FG003|Overall Study|Other than specified above|0|||
124943174|NCT03823703|449419825|FG001|Overall Study|Adverse Event|1|||
124943175|NCT03823703|449419826|FG002|Overall Study|Adverse Event|0|||
124943176|NCT03823703|449419824|FG000|Overall Study|Withdrawal by Subject|0|||
124943177|NCT03823703|449419825|FG001|Overall Study|Withdrawal by Subject|1|||
124943178|NCT03823703|449419826|FG002|Overall Study|Withdrawal by Subject|0|||
124458160|NCT01324232|447638155|FG003|Overall Study|Protocol Violation|2|||
124705319|NCT04622592|448547175|FG004|Overall Study|Other than specified above|0|||
124943179|NCT03137459|449419827|FG000|2-month Assessment|Withdrawal by Subject|13|||
124943180|NCT03137459|449419828|FG001|2-month Assessment|Withdrawal by Subject|3|||
124943181|NCT03137459|449419827|FG000|2-month Assessment|Unable to reach|42|||
124943182|NCT03137459|449419828|FG001|2-month Assessment|Unable to reach|32|||
124943183|NCT03137459|449419827|FG000|2-month Assessment|Refused assessment|7|||
124943184|NCT03137459|449419828|FG001|2-month Assessment|Refused assessment|5|||
124705320|NCT04622592|448547176|FG005|Overall Study|Other than specified above|0|||
124705321|NCT04622592|448547177|FG006|Overall Study|Other than specified above|0|||
124705322|NCT04622592|448547178|FG007|Overall Study|Other than specified above|0|||
124705323|NCT01497197|448547179|FG000|Overall Study|Lost to Follow-up|1|||
124705324|NCT01497197|448547180|FG001|Overall Study|Lost to Follow-up|0|||
124705325|NCT01497197|448547179|FG000|Overall Study|Protocol Violation|0|||
124705326|NCT01497197|448547180|FG001|Overall Study|Protocol Violation|2|||
124705327|NCT01497197|448547179|FG000|Overall Study|Withdrawal by Subject|2|||
124705328|NCT01497197|448547180|FG001|Overall Study|Withdrawal by Subject|1|||
124705329|NCT01497197|448547179|FG000|Overall Study|Excessive/lack of response to treatment|1|||
124705330|NCT01497197|448547180|FG001|Overall Study|Excessive/lack of response to treatment|0|||
124705331|NCT01497197|448547179|FG000|Overall Study|Risk of OHSS|1|||
124705332|NCT01497197|448547180|FG001|Overall Study|Risk of OHSS|0|||
124705333|NCT01497197|448547179|FG000|Overall Study|No oocytes retrieved|3|||
124705334|NCT01497197|448547180|FG001|Overall Study|No oocytes retrieved|2|||
124705335|NCT01497197|448547179|FG000|Overall Study|No fertilisation|6|||
124705336|NCT01497197|448547180|FG001|Overall Study|No fertilisation|5|||
124705337|NCT01497197|448547179|FG000|Overall Study|Intention to freeze all embryos|0|||
124705338|NCT01497197|448547180|FG001|Overall Study|Intention to freeze all embryos|1|||
124705339|NCT01497197|448547179|FG000|Overall Study|All embryos discarded|0|||
124705340|NCT01497197|448547180|FG001|Overall Study|All embryos discarded|3|||
124705341|NCT01497197|448547179|FG000|Overall Study|Other|3|||
124705342|NCT01497197|448547180|FG001|Overall Study|Other|1|||
124705343|NCT00565747|448547186|FG000|Overall Study|No embryo transfer|67|||
124705344|NCT00565747|448547187|FG001|Overall Study|No embryo transfer|73|||
124705345|NCT00183248|448547188|FG000|Overall Study|Lost to Follow-up|0|||
124705346|NCT00183248|448547189|FG001|Overall Study|Lost to Follow-up|1|||
124705347|NCT00183248|448547188|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
124705348|NCT00183248|448547189|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
124705349|NCT03309202|448547190|FG000|Overall Study|Lost to Follow-up|1|||
124705350|NCT03309202|448547191|FG001|Overall Study|Lost to Follow-up|0|||
124705351|NCT03309202|448547192|FG002|Overall Study|Lost to Follow-up|0|||
124705352|NCT03309202|448547193|FG003|Overall Study|Lost to Follow-up|0|||
124705353|NCT00415636|448547196|FG000|Overall Study|Symptomatic deterioration|1|||
124705354|NCT00415636|448547197|FG001|Overall Study|Symptomatic deterioration|0|||
124705355|NCT00415636|448547198|FG002|Overall Study|Symptomatic deterioration|1|||
124705356|NCT00415636|448547199|FG003|Overall Study|Symptomatic deterioration|2|||
124705357|NCT00415636|448547200|FG004|Overall Study|Symptomatic deterioration|0|||
124705358|NCT00415636|448547201|FG005|Overall Study|Symptomatic deterioration|1|||
124705359|NCT00415636|448547196|FG000|Overall Study|Adverse Event|0|||
124705360|NCT00415636|448547197|FG001|Overall Study|Adverse Event|0|||
124705361|NCT00415636|448547198|FG002|Overall Study|Adverse Event|0|||
124705362|NCT00415636|448547199|FG003|Overall Study|Adverse Event|1|||
124705363|NCT00415636|448547200|FG004|Overall Study|Adverse Event|1|||
124705364|NCT00415636|448547201|FG005|Overall Study|Adverse Event|0|||
124705365|NCT00415636|448547196|FG000|Overall Study|Withdrawal by Subject|0|||
124705366|NCT00415636|448547197|FG001|Overall Study|Withdrawal by Subject|0|||
124705367|NCT00415636|448547198|FG002|Overall Study|Withdrawal by Subject|0|||
124705368|NCT00415636|448547199|FG003|Overall Study|Withdrawal by Subject|0|||
124705369|NCT00415636|448547200|FG004|Overall Study|Withdrawal by Subject|1|||
124705370|NCT00415636|448547201|FG005|Overall Study|Withdrawal by Subject|0|||
124705371|NCT00415636|448547196|FG000|Overall Study|Disease progression|0|||
124705372|NCT00415636|448547197|FG001|Overall Study|Disease progression|0|||
124705373|NCT00415636|448547198|FG002|Overall Study|Disease progression|0|||
124705374|NCT00415636|448547199|FG003|Overall Study|Disease progression|3|||
124705375|NCT00415636|448547200|FG004|Overall Study|Disease progression|0|||
124705376|NCT00415636|448547201|FG005|Overall Study|Disease progression|1|||
124943185|NCT03137459|449419827|FG000|2-month Assessment|Acutely ill|6|||
124705377|NCT04734210|448547202|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
124705378|NCT04734210|448547203|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
124705379|NCT04734210|448547204|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
124705380|NCT04734210|448547202|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
124705381|NCT04734210|448547203|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
124705382|NCT04734210|448547204|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
124705383|NCT04734210|448547202|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
124705384|NCT04734210|448547203|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
124705385|NCT04734210|448547204|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
124943186|NCT03137459|449419828|FG001|2-month Assessment|Acutely ill|2|||
124943187|NCT03137459|449419827|FG000|4-month Assessment|Death|4|||
124705386|NCT04734210|448547202|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
124705387|NCT04734210|448547203|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
124705388|NCT04734210|448547204|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
124705389|NCT02684461|448547205|FG000|Overall Study|Adverse Event|1|||
124705390|NCT02684461|448547206|FG001|Overall Study|Adverse Event|0|||
124705391|NCT02684461|448547207|FG002|Overall Study|Adverse Event|0|||
124705392|NCT02684461|448547205|FG000|Overall Study|Lack of Efficacy|1|||
124705393|NCT02684461|448547206|FG001|Overall Study|Lack of Efficacy|2|||
124705394|NCT02684461|448547207|FG002|Overall Study|Lack of Efficacy|0|||
124705395|NCT02138825|448547208|FG000|Main Study Treatment|Adverse Event|11|||
124705396|NCT02138825|448547209|FG001|Main Study Treatment|Adverse Event|3|||
124705397|NCT02138825|448547208|FG000|Main Study Treatment|Death|1|||
124705398|NCT02138825|448547209|FG001|Main Study Treatment|Death|2|||
124705399|NCT02138825|448547208|FG000|Main Study Treatment|Protocol Violation|2|||
124705400|NCT02138825|448547209|FG001|Main Study Treatment|Protocol Violation|2|||
124705401|NCT02138825|448547208|FG000|Main Study Treatment|Sponsor decision|12|||
124705402|NCT02138825|448547209|FG001|Main Study Treatment|Sponsor decision|18|||
124705403|NCT02138825|448547208|FG000|Main Study Treatment|Study terminated by sponsor|10|||
124705404|NCT02138825|448547209|FG001|Main Study Treatment|Study terminated by sponsor|9|||
124705405|NCT02138825|448547208|FG000|Main Study Treatment|Withdrawal by Subject|3|||
124705406|NCT02138825|448547209|FG001|Main Study Treatment|Withdrawal by Subject|1|||
124705407|NCT02138825|448547208|FG000|Main Study Treatment|Medical decision|1|||
124705408|NCT02138825|448547209|FG001|Main Study Treatment|Medical decision|0|||
124705409|NCT02138825|448547208|FG000|Long-term Extension|Study termination by sponsor|32|||
124705410|NCT02138825|448547209|FG001|Long-term Extension|Study termination by sponsor|38|||
124705411|NCT02138825|448547208|FG000|Safety Follow-up|Adverse Event|4|||
124705412|NCT02138825|448547209|FG001|Safety Follow-up|Adverse Event|3|||
124705413|NCT02138825|448547208|FG000|Safety Follow-up|Death|11|||
124943188|NCT03137459|449419828|FG001|4-month Assessment|Death|2|||
124943189|NCT03137459|449419827|FG000|4-month Assessment|Withdrawal by Subject|4|||
124943190|NCT03137459|449419828|FG001|4-month Assessment|Withdrawal by Subject|2|||
124943191|NCT03137459|449419827|FG000|4-month Assessment|Unable to reach|44|||
124943192|NCT03137459|449419828|FG001|4-month Assessment|Unable to reach|29|||
124943193|NCT03137459|449419827|FG000|4-month Assessment|Refused assessment|24|||
124943194|NCT03137459|449419828|FG001|4-month Assessment|Refused assessment|10|||
124943195|NCT03137459|449419827|FG000|4-month Assessment|Acutely ill|2|||
124943196|NCT03137459|449419828|FG001|4-month Assessment|Acutely ill|3|||
124943197|NCT03137459|449419827|FG000|6-months|Lost to Follow-up|14|||
124943198|NCT03137459|449419828|FG001|6-months|Lost to Follow-up|11|||
124943199|NCT03137459|449419827|FG000|6-months|Death|0|||
124943200|NCT03137459|449419828|FG001|6-months|Death|2|||
124943201|NCT03137459|449419827|FG000|6-months|Refused assessment|6|||
124943202|NCT03137459|449419828|FG001|6-months|Refused assessment|3|||
124943203|NCT03137459|449419827|FG000|6-months|Acutely ill|1|||
124943204|NCT03137459|449419828|FG001|6-months|Acutely ill|1|||
124943205|NCT01970878|449419830|FG000|Overall Study|Withdrawal by Subject|11|||
124943206|NCT01970878|449419831|FG001|Overall Study|Withdrawal by Subject|10|||
124943207|NCT01970878|449419832|FG002|Overall Study|Withdrawal by Subject|14|||
124943208|NCT01970878|449419833|FG003|Overall Study|Withdrawal by Subject|7|||
124943209|NCT01970878|449419830|FG000|Overall Study|Lost to Follow-up|1|||
124943210|NCT01970878|449419831|FG001|Overall Study|Lost to Follow-up|3|||
124943211|NCT01970878|449419832|FG002|Overall Study|Lost to Follow-up|2|||
124943212|NCT01970878|449419833|FG003|Overall Study|Lost to Follow-up|4|||
124943213|NCT01970878|449419830|FG000|Overall Study|Administrative Reasons|1|||
124943214|NCT01970878|449419831|FG001|Overall Study|Administrative Reasons|0|||
124943215|NCT01970878|449419832|FG002|Overall Study|Administrative Reasons|0|||
124943216|NCT01970878|449419833|FG003|Overall Study|Administrative Reasons|4|||
124943217|NCT01970878|449419830|FG000|Overall Study|Lack of Efficacy|2|||
124943218|NCT01970878|449419831|FG001|Overall Study|Lack of Efficacy|1|||
124943219|NCT01970878|449419832|FG002|Overall Study|Lack of Efficacy|2|||
124943220|NCT01970878|449419833|FG003|Overall Study|Lack of Efficacy|0|||
124705414|NCT02138825|448547209|FG001|Safety Follow-up|Death|5|||
124943221|NCT01970878|449419830|FG000|Overall Study|Adverse Event|12|||
124943222|NCT01970878|449419831|FG001|Overall Study|Adverse Event|7|||
124705415|NCT02138825|448547208|FG000|Safety Follow-up|Withdrawal by Subject|5|||
124943223|NCT01970878|449419832|FG002|Overall Study|Adverse Event|4|||
124943224|NCT01970878|449419833|FG003|Overall Study|Adverse Event|3|||
124943225|NCT01970878|449419830|FG000|Overall Study|Protocol Specified Criteria|10|||
124943226|NCT01970878|449419831|FG001|Overall Study|Protocol Specified Criteria|4|||
124943227|NCT01970878|449419832|FG002|Overall Study|Protocol Specified Criteria|3|||
124943228|NCT01970878|449419833|FG003|Overall Study|Protocol Specified Criteria|6|||
124943229|NCT01970878|449419830|FG000|Overall Study|Physician Decision|0|||
124943230|NCT01970878|449419831|FG001|Overall Study|Physician Decision|1|||
124943231|NCT01970878|449419832|FG002|Overall Study|Physician Decision|1|||
124943232|NCT01970878|449419833|FG003|Overall Study|Physician Decision|0|||
124943233|NCT01970878|449419830|FG000|Overall Study|No Completion Status|0|||
124943234|NCT01970878|449419831|FG001|Overall Study|No Completion Status|1|||
124943235|NCT01970878|449419832|FG002|Overall Study|No Completion Status|0|||
124943236|NCT01970878|449419833|FG003|Overall Study|No Completion Status|0|||
124943237|NCT00925548|449419834|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
124943238|NCT00925548|449419835|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
124943239|NCT04921358|449419836|FG000|Overall Study|Withdrawal by Subject|6|||
124943240|NCT04921358|449419837|FG001|Overall Study|Withdrawal by Subject|13|||
124943241|NCT04921358|449419836|FG000|Overall Study|Lost to Follow-up|3|||
124943242|NCT04921358|449419837|FG001|Overall Study|Lost to Follow-up|6|||
124943243|NCT04921358|449419836|FG000|Overall Study|Study Terminated by Sponsor|86|||
124943244|NCT04921358|449419837|FG001|Overall Study|Study Terminated by Sponsor|89|||
124943245|NCT04921358|449419836|FG000|Overall Study|Death|92|||
124943246|NCT04921358|449419837|FG001|Overall Study|Death|82|||
124943247|NCT02278796|449419838|FG000|Overall Study|Death|2|||
124943248|NCT02278796|449419839|FG001|Overall Study|Death|3|||
124458161|NCT01324232|447638152|FG000|Overall Study|Missing|0|||
124458162|NCT01324232|447638153|FG001|Overall Study|Missing|0|||
124458163|NCT01324232|447638154|FG002|Overall Study|Missing|1|||
124458164|NCT01324232|447638155|FG003|Overall Study|Missing|0|||
124458165|NCT01324232|447638152|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
124458166|NCT01324232|447638153|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
124458167|NCT01324232|447638154|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
124458168|NCT01324232|447638155|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
124458169|NCT01324232|447638152|FG000|Overall Study|Lack of Efficacy|2|||
124943249|NCT04926857|449419840|FG000|Overall Study|Withdrawal by Subject|40|||
124943250|NCT04926857|449419840|FG000|Overall Study|Death|9|||
124943251|NCT04926857|449419840|FG000|Overall Study|Study product no longer in use|44|||
124943252|NCT04926857|449419840|FG000|Overall Study|Inadequate data to address primary objective|16|||
124943253|NCT02372799|449419845|FG000|Treatment Period|Adverse Event|3|||
124943254|NCT02372799|449419846|FG001|Treatment Period|Adverse Event|10|||
124943255|NCT02372799|449419847|FG002|Treatment Period|Adverse Event|6|||
124943256|NCT02372799|449419845|FG000|Treatment Period|Insufficient therapeutic response|2|||
124943257|NCT02372799|449419846|FG001|Treatment Period|Insufficient therapeutic response|2|||
124943258|NCT02372799|449419847|FG002|Treatment Period|Insufficient therapeutic response|0|||
124943259|NCT02372799|449419845|FG000|Treatment Period|Withdrawal by Subject|10|||
124943260|NCT02372799|449419846|FG001|Treatment Period|Withdrawal by Subject|10|||
124943261|NCT02372799|449419847|FG002|Treatment Period|Withdrawal by Subject|2|||
124943262|NCT02372799|449419845|FG000|Treatment Period|Lost to Follow-up|11|||
124943263|NCT02372799|449419846|FG001|Treatment Period|Lost to Follow-up|5|||
124943264|NCT02372799|449419847|FG002|Treatment Period|Lost to Follow-up|3|||
124943265|NCT02372799|449419845|FG000|Treatment Period|Protocol Violation|3|||
124943266|NCT02372799|449419846|FG001|Treatment Period|Protocol Violation|0|||
124943267|NCT02372799|449419847|FG002|Treatment Period|Protocol Violation|0|||
124943268|NCT02372799|449419845|FG000|Treatment Period|Non-compliance with study drug|4|||
124943269|NCT02372799|449419846|FG001|Treatment Period|Non-compliance with study drug|4|||
124943270|NCT02372799|449419847|FG002|Treatment Period|Non-compliance with study drug|4|||
124943271|NCT02372799|449419845|FG000|Treatment Period|Miscellaneous Reasons|1|||
124943272|NCT02372799|449419846|FG001|Treatment Period|Miscellaneous Reasons|1|||
124943273|NCT02372799|449419847|FG002|Treatment Period|Miscellaneous Reasons|0|||
124943274|NCT02372799|449419845|FG000|Down-taper Period|Lost to Follow-up|1|||
124943275|NCT02372799|449419846|FG001|Down-taper Period|Lost to Follow-up|2|||
124943276|NCT02372799|449419847|FG002|Down-taper Period|Lost to Follow-up|2|||
124943277|NCT02637063|449419849|FG000|Overall Study|Lost to Follow-up|3|||
124943278|NCT02637063|449419850|FG001|Overall Study|Lost to Follow-up|2|||
124943279|NCT02637063|449419851|FG002|Overall Study|Lost to Follow-up|3|||
124943280|NCT02637063|449419849|FG000|Overall Study|Withdrawal by Subject|2|||
124943281|NCT02637063|449419850|FG001|Overall Study|Withdrawal by Subject|2|||
124943282|NCT02637063|449419851|FG002|Overall Study|Withdrawal by Subject|3|||
124943283|NCT00491400|449419852|FG000|Overall Study|Withdrawal by Subject|5|||
124943284|NCT00491400|449419853|FG001|Overall Study|Withdrawal by Subject|4|||
124943285|NCT00747006|449419854|FG000|Overall Study|Adverse Event|1|||
124943286|NCT00747006|449419855|FG001|Overall Study|Adverse Event|0|||
124943287|NCT00747006|449419856|FG002|Overall Study|Adverse Event|0|||
124943288|NCT00747006|449419854|FG000|Overall Study|Lost to Follow-up|0|||
124943289|NCT00747006|449419855|FG001|Overall Study|Lost to Follow-up|1|||
124943290|NCT00747006|449419856|FG002|Overall Study|Lost to Follow-up|0|||
124943291|NCT00747006|449419854|FG000|Overall Study|Physician Decision|2|||
124943292|NCT00747006|449419855|FG001|Overall Study|Physician Decision|0|||
124943293|NCT00747006|449419856|FG002|Overall Study|Physician Decision|1|||
124458170|NCT01324232|447638153|FG001|Overall Study|Lack of Efficacy|1|||
124458171|NCT01324232|447638154|FG002|Overall Study|Lack of Efficacy|2|||
124458172|NCT01324232|447638155|FG003|Overall Study|Lack of Efficacy|2|||
124765250|NCT02587520|448767373|FG011|Overall Study|Adverse Event|1|||
124943294|NCT00345046|449419861|FG000|Overall Study|Protocol Violation|1|||
124943295|NCT00345046|449419862|FG001|Overall Study|Protocol Violation|1|||
124943296|NCT00345046|449419863|FG002|Overall Study|Protocol Violation|2|||
124943297|NCT02824198|449419864|FG000|Overall Study|Non-compliance with the protocol|5|||
124705416|NCT02138825|448547209|FG001|Safety Follow-up|Withdrawal by Subject|3|||
124705417|NCT02138825|448547208|FG000|Safety Follow-up|clinic worsening|1|||
124943298|NCT02824198|449419865|FG001|Overall Study|Non-compliance with the protocol|1|||
124943299|NCT02824198|449419864|FG000|Overall Study|Lost to Follow-up|5|||
124943300|NCT02824198|449419865|FG001|Overall Study|Lost to Follow-up|2|||
124943301|NCT02824198|449419864|FG000|Overall Study|Withdrawal by Subject|5|||
124943302|NCT02824198|449419865|FG001|Overall Study|Withdrawal by Subject|0|||
124943303|NCT00562094|449419866|FG000|Overall Study|Lost to Follow-up|62|||
124943304|NCT03689946|449419869|FG000|Overall Study|Withdrawal by Subject|3|||
124943305|NCT03689946|449419869|FG000|Overall Study|Lost to Follow-up|3|||
124943306|NCT03689946|449419869|FG000|Overall Study|Data corruption|2|||
124943307|NCT01555138|449419870|FG000|Overall Study|Death|0|||
124943308|NCT01555138|449419871|FG001|Overall Study|Death|1|||
124943309|NCT01555138|449419870|FG000|Overall Study|Lost to Follow-up|1|||
124943310|NCT01555138|449419871|FG001|Overall Study|Lost to Follow-up|0|||
124943311|NCT01555138|449419870|FG000|Overall Study|Abnormal Lab reults|1|||
124943312|NCT01555138|449419871|FG001|Overall Study|Abnormal Lab reults|3|||
124943313|NCT01555138|449419870|FG000|Overall Study|Lack of Efficacy|2|||
124943314|NCT01555138|449419871|FG001|Overall Study|Lack of Efficacy|2|||
124943315|NCT01555138|449419870|FG000|Overall Study|Protocol Violation|5|||
124943316|NCT01555138|449419871|FG001|Overall Study|Protocol Violation|3|||
124943317|NCT01555138|449419870|FG000|Overall Study|Administrative problems|8|||
124943318|NCT01555138|449419871|FG001|Overall Study|Administrative problems|0|||
124943319|NCT01555138|449419870|FG000|Overall Study|Withdrawal by Subject|16|||
124458173|NCT01324232|447638152|FG000|Overall Study|Participant Refused Medication|0|||
124458174|NCT01324232|447638153|FG001|Overall Study|Participant Refused Medication|1|||
124458175|NCT01324232|447638154|FG002|Overall Study|Participant Refused Medication|0|||
124458176|NCT01324232|447638155|FG003|Overall Study|Participant Refused Medication|0|||
124458177|NCT01324232|447638152|FG000|Overall Study|Intercurrent illness|0|||
124458178|NCT01324232|447638153|FG001|Overall Study|Intercurrent illness|0|||
124458179|NCT01324232|447638154|FG002|Overall Study|Intercurrent illness|0|||
124458180|NCT01324232|447638155|FG003|Overall Study|Intercurrent illness|1|||
124458181|NCT01324232|447638152|FG000|Overall Study|Adverse Event|2|||
124458182|NCT01324232|447638153|FG001|Overall Study|Adverse Event|5|||
124458183|NCT01324232|447638154|FG002|Overall Study|Adverse Event|6|||
124458184|NCT01324232|447638155|FG003|Overall Study|Adverse Event|6|||
124458185|NCT01324232|447638152|FG000|Overall Study|Withdrawal by Subject|0|||
124458186|NCT01324232|447638153|FG001|Overall Study|Withdrawal by Subject|3|||
124458187|NCT01324232|447638154|FG002|Overall Study|Withdrawal by Subject|4|||
124458188|NCT01324232|447638155|FG003|Overall Study|Withdrawal by Subject|0|||
124458189|NCT01324232|447638152|FG000|Overall Study|Lost to Follow-up|1|||
124458190|NCT01324232|447638153|FG001|Overall Study|Lost to Follow-up|0|||
124458191|NCT01324232|447638154|FG002|Overall Study|Lost to Follow-up|0|||
124458192|NCT01324232|447638155|FG003|Overall Study|Lost to Follow-up|0|||
124458193|NCT00661531|447638156|FG000|Overall Study|Withdrawal by Subject|3|||
124458194|NCT00530270|447638160|FG000|Overall Study|Protocol Violation|1|||
124705418|NCT02138825|448547209|FG001|Safety Follow-up|clinic worsening|0|||
124943320|NCT01555138|449419871|FG001|Overall Study|Withdrawal by Subject|15|||
124943321|NCT01555138|449419870|FG000|Overall Study|Adverse Event|14|||
124943322|NCT01555138|449419871|FG001|Overall Study|Adverse Event|14|||
124943323|NCT01613417|449419872|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
124943324|NCT01613417|449419873|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
124943325|NCT02357966|449419876|FG000|Overall Study|Death|0|||
124943326|NCT02357966|449419877|FG001|Overall Study|Death|0|||
124943327|NCT02357966|449419878|FG002|Overall Study|Death|1|||
124943328|NCT02357966|449419879|FG003|Overall Study|Death|0|||
124943329|NCT02357966|449419880|FG004|Overall Study|Death|2|||
124943330|NCT02357966|449419881|FG005|Overall Study|Death|0|||
124943331|NCT02357966|449419876|FG000|Overall Study|Physician Decision|1|||
124943332|NCT02357966|449419877|FG001|Overall Study|Physician Decision|0|||
124943333|NCT02357966|449419878|FG002|Overall Study|Physician Decision|0|||
124943334|NCT02357966|449419879|FG003|Overall Study|Physician Decision|0|||
124943335|NCT02357966|449419880|FG004|Overall Study|Physician Decision|1|||
124943336|NCT02357966|449419881|FG005|Overall Study|Physician Decision|0|||
124943337|NCT00019604|449419882|FG000|Overall Study|Death|1|||
124943338|NCT00019604|449419882|FG000|Overall Study|Progressive disease|23|||
124943339|NCT00019604|449419882|FG000|Overall Study|Refused treatment|1|||
124943340|NCT00019604|449419882|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
124943341|NCT00019604|449419882|FG000|Overall Study|Going to have liver transplant|1|||
124943342|NCT00019604|449419882|FG000|Overall Study|Move to a different study|1|||
124458195|NCT00530270|447638161|FG001|Overall Study|Protocol Violation|0|||
124458196|NCT02614859|447638165|FG000|Overall Study|Physician Decision|0|||
124458197|NCT02614859|447638166|FG001|Overall Study|Physician Decision|1|||
124943343|NCT00019604|449419882|FG000|Overall Study|Non compliant on systemic CH|1|||
124458198|NCT01399788|447638168|FG000|First Intervention Period|Adverse Event|1|||
124705419|NCT02138825|448547208|FG000|Safety Follow-up|withdrawal by PI|1|||
124943344|NCT00019604|449419882|FG000|Overall Study|Non compliant|1|||
124943345|NCT00019604|449419882|FG000|Overall Study|Resectable disease|1|||
124943346|NCT00019604|449419882|FG000|Overall Study|Started new chemo regimen|1|||
124458199|NCT01399788|447638169|FG001|First Intervention Period|Adverse Event|0|||
124458200|NCT02919436|447638170|FG000|Overall Study|Did not undergo surgery|16|||
124458201|NCT02919436|447638171|FG001|Overall Study|Did not undergo surgery|20|||
124458202|NCT02919436|447638170|FG000|Overall Study|Enrolled before trial registration|44|||
124458203|NCT02919436|447638171|FG001|Overall Study|Enrolled before trial registration|33|||
124458204|NCT03699007|447638173|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
124458205|NCT03699007|447638174|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
124458206|NCT03699007|447638173|FG000|6-month Follow Up|Lost to Follow-up|2|||
124458207|NCT03699007|447638174|FG001|6-month Follow Up|Lost to Follow-up|3|||
124458208|NCT04718974|447638175|FG000|Overall Study|Death|0|||
124458209|NCT04718974|447638176|FG001|Overall Study|Death|2|||
124458210|NCT04718974|447638175|FG000|Overall Study|Lost to Follow-up|10|||
124458211|NCT04718974|447638176|FG001|Overall Study|Lost to Follow-up|20|||
124458212|NCT04718974|447638175|FG000|Overall Study|Transferred out|2|||
124458213|NCT04718974|447638176|FG001|Overall Study|Transferred out|4|||
124458214|NCT03259074|447638177|FG000|Overall Study|Adverse Event|9|||
124458215|NCT03259074|447638178|FG001|Overall Study|Adverse Event|12|||
124458216|NCT03259074|447638179|FG002|Overall Study|Adverse Event|8|||
124458217|NCT03259074|447638177|FG000|Overall Study|Death|1|||
124458218|NCT03259074|447638178|FG001|Overall Study|Death|1|||
124458219|NCT03259074|447638179|FG002|Overall Study|Death|3|||
124458220|NCT03259074|447638177|FG000|Overall Study|Lost to Follow-up|2|||
124458221|NCT03259074|447638178|FG001|Overall Study|Lost to Follow-up|4|||
124458222|NCT03259074|447638179|FG002|Overall Study|Lost to Follow-up|3|||
124458223|NCT03259074|447638177|FG000|Overall Study|New Therapy For Study Indication|1|||
124458224|NCT03259074|447638178|FG001|Overall Study|New Therapy For Study Indication|2|||
124458225|NCT03259074|447638179|FG002|Overall Study|New Therapy For Study Indication|2|||
124458226|NCT03259074|447638177|FG000|Overall Study|Physician Decision|4|||
124458227|NCT03259074|447638178|FG001|Overall Study|Physician Decision|12|||
124458228|NCT03259074|447638179|FG002|Overall Study|Physician Decision|10|||
124458229|NCT03259074|447638177|FG000|Overall Study|Pregnancy|1|||
124458230|NCT03259074|447638178|FG001|Overall Study|Pregnancy|1|||
124458231|NCT03259074|447638179|FG002|Overall Study|Pregnancy|0|||
124458232|NCT03259074|447638177|FG000|Overall Study|Progressive Disease|1|||
124458233|NCT03259074|447638178|FG001|Overall Study|Progressive Disease|0|||
124458234|NCT03259074|447638179|FG002|Overall Study|Progressive Disease|0|||
124458235|NCT03259074|447638177|FG000|Overall Study|Protocol Deviation|1|||
124458236|NCT03259074|447638178|FG001|Overall Study|Protocol Deviation|1|||
124458237|NCT03259074|447638179|FG002|Overall Study|Protocol Deviation|3|||
124458238|NCT03259074|447638177|FG000|Overall Study|Subject/Guardian Decision|13|||
124458239|NCT03259074|447638178|FG001|Overall Study|Subject/Guardian Decision|16|||
124458240|NCT03259074|447638179|FG002|Overall Study|Subject/Guardian Decision|14|||
124458241|NCT01780662|447638180|FG000|Overall Study|Adverse Event|1|||
124458242|NCT01780662|447638181|FG001|Overall Study|Adverse Event|0|||
124458243|NCT01780662|447638182|FG002|Overall Study|Adverse Event|2|||
124458244|NCT01780662|447638180|FG000|Overall Study|Physician Decision|0|||
124458245|NCT01780662|447638181|FG001|Overall Study|Physician Decision|5|||
124458246|NCT01780662|447638182|FG002|Overall Study|Physician Decision|7|||
124458247|NCT01780662|447638180|FG000|Overall Study|Protocol Violation|0|||
124458248|NCT01780662|447638181|FG001|Overall Study|Protocol Violation|1|||
124458249|NCT01780662|447638182|FG002|Overall Study|Protocol Violation|0|||
124458250|NCT01780662|447638180|FG000|Overall Study|Ineligible|0|||
124458251|NCT01780662|447638181|FG001|Overall Study|Ineligible|0|||
124458252|NCT01780662|447638182|FG002|Overall Study|Ineligible|1|||
124458253|NCT00183274|447638185|FG000|Phase 1: Open-Label|Adverse Event|31|||
124458254|NCT00183274|447638186|FG001|Phase 1: Open-Label|Adverse Event|0|||
124458255|NCT00183274|447638187|FG002|Phase 1: Open-Label|Adverse Event|0|||
124458256|NCT00183274|447638188|FG003|Phase 1: Open-Label|Adverse Event|0|||
124458257|NCT00183274|447638189|FG004|Phase 1: Open-Label|Adverse Event|0|||
124458258|NCT00183274|447638190|FG005|Phase 1: Open-Label|Adverse Event|0|||
124458259|NCT00183274|447638185|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
124458260|NCT00183274|447638186|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
124458261|NCT00183274|447638187|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
124458262|NCT00183274|447638188|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
124458263|NCT00183274|447638189|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
124458264|NCT00183274|447638190|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
124458265|NCT00183274|447638185|FG000|Phase 1: Open-Label|Protocol Violation|11|||
124458266|NCT00183274|447638186|FG001|Phase 1: Open-Label|Protocol Violation|0|||
124458267|NCT00183274|447638187|FG002|Phase 1: Open-Label|Protocol Violation|0|||
124458268|NCT00183274|447638188|FG003|Phase 1: Open-Label|Protocol Violation|0|||
124458269|NCT00183274|447638189|FG004|Phase 1: Open-Label|Protocol Violation|0|||
124458270|NCT00183274|447638190|FG005|Phase 1: Open-Label|Protocol Violation|0|||
124458271|NCT00183274|447638185|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
124458272|NCT00183274|447638186|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
124458273|NCT00183274|447638187|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
124458274|NCT00183274|447638188|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
124458275|NCT00183274|447638189|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
124458276|NCT00183274|447638190|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
124547762|NCT03917654|447960344|FG001|Year 1|Travel|1|||
124943347|NCT00019604|449419882|FG000|Overall Study|Pt going to immunotherapy study|1|||
124547763|NCT03917654|447960345|FG002|Year 1|Travel|1|||
124547764|NCT03917654|447960346|FG003|Year 1|Travel|0|||
124547765|NCT03917654|447960347|FG004|Year 1|Travel|4|||
124547766|NCT03917654|447960348|FG005|Year 1|Travel|4|||
124943348|NCT00019604|449419882|FG000|Overall Study|Too much disease|1|||
124943349|NCT00019604|449419882|FG000|Overall Study|Unable to evaluate|1|||
124943350|NCT00019604|449419882|FG000|Overall Study|Details for other not available|4|||
124943351|NCT04608409|449419883|FG000|Overall Study|Physician Decision|1|||
124943352|NCT04608409|449419884|FG001|Overall Study|Physician Decision|1|||
124547767|NCT03917654|447960349|FG006|Year 1|Travel|10|||
124547768|NCT03917654|447960350|FG007|Year 1|Travel|8|||
124547769|NCT03917654|447960351|FG008|Year 1|Travel|2|||
124547770|NCT03917654|447960352|FG009|Year 1|Travel|5|||
124547771|NCT03917654|447960353|FG010|Year 1|Travel|3|||
124547772|NCT03917654|447960354|FG011|Year 1|Travel|3|||
124547773|NCT03917654|447960343|FG000|Year 1|Subject moved away from site|0|||
124547774|NCT03917654|447960344|FG001|Year 1|Subject moved away from site|1|||
124547775|NCT03917654|447960345|FG002|Year 1|Subject moved away from site|0|||
124547776|NCT03917654|447960346|FG003|Year 1|Subject moved away from site|0|||
124547777|NCT03917654|447960347|FG004|Year 1|Subject moved away from site|0|||
124547778|NCT03917654|447960348|FG005|Year 1|Subject moved away from site|0|||
124705420|NCT02138825|448547209|FG001|Safety Follow-up|withdrawal by PI|0|||
124705421|NCT02138825|448547208|FG000|Safety Follow-up|logistical difficulties|0|||
124705422|NCT02138825|448547209|FG001|Safety Follow-up|logistical difficulties|1|||
124705423|NCT02138825|448547208|FG000|Safety Follow-up|progressive disease|0|||
124705424|NCT02138825|448547209|FG001|Safety Follow-up|progressive disease|2|||
124705425|NCT02138825|448547208|FG000|Safety Follow-up|too unwell to attend the visit|0|||
124705426|NCT02138825|448547209|FG001|Safety Follow-up|too unwell to attend the visit|1|||
124705427|NCT02138825|448547208|FG000|Safety Follow-up|treatment unblinded|0|||
124705428|NCT02138825|448547209|FG001|Safety Follow-up|treatment unblinded|1|||
124705429|NCT02138825|448547208|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
124705430|NCT02138825|448547209|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
124705431|NCT05201807|448547213|FG000|Overall Study|Adverse Event|1|||
124705432|NCT05201807|448547213|FG000|Overall Study|COVID-19 Related|1|||
124705433|NCT01209767|448547214|FG000|Overall Study|Withdrawal by Subject|1|||
124705434|NCT01209767|448547214|FG000|Overall Study|Lost to Follow-up|3|||
124705435|NCT01702298|448547215|FG000|Overall Study|Withdrawal by Subject|1|||
124705436|NCT01206517|448547219|FG000|Overall Study|Withdrawal by Subject|0|||
124705437|NCT01206517|448547220|FG001|Overall Study|Withdrawal by Subject|0|||
124705438|NCT01206517|448547221|FG002|Overall Study|Withdrawal by Subject|2|||
124705439|NCT01206517|448547222|FG003|Overall Study|Withdrawal by Subject|0|||
124705440|NCT01206517|448547223|FG004|Overall Study|Withdrawal by Subject|1|||
124705441|NCT01206517|448547224|FG005|Overall Study|Withdrawal by Subject|0|||
124705442|NCT03493958|448547225|FG000|Overall Study|Withdrawal by Subject|6|||
124705443|NCT03493958|448547225|FG000|Overall Study|Lost to Follow-up|7|||
124705444|NCT03493958|448547225|FG000|Overall Study|Did not complete all required study procedures|2|||
124705445|NCT01029535|448547226|FG000|Overall Study|Lost to Follow-up|24|||
124705446|NCT01029535|448547226|FG000|Overall Study|Protocol Violation|2|||
124705447|NCT01029535|448547226|FG000|Overall Study|Participant Withdrew Consent|2|||
124705448|NCT01029535|448547226|FG000|Overall Study|Adverse Event|1|||
124705449|NCT01029535|448547226|FG000|Overall Study|Use of Another Treatment|1|||
124705450|NCT01029535|448547226|FG000|Overall Study|Death|1|||
124705451|NCT04047446|448547227|FG000|Overall Study|Physician Decision|1|||
124705452|NCT04047446|448547228|FG001|Overall Study|Physician Decision|0|||
124705453|NCT02367456|448547229|FG000|Overall Study|Death|8|||
124705454|NCT02367456|448547230|FG001|Overall Study|Death|24|||
124705455|NCT02367456|448547231|FG002|Overall Study|Death|17|||
124705456|NCT02367456|448547229|FG000|Overall Study|Lost to Follow-up|1|||
124705457|NCT02367456|448547230|FG001|Overall Study|Lost to Follow-up|3|||
124705458|NCT02367456|448547231|FG002|Overall Study|Lost to Follow-up|1|||
124705459|NCT02367456|448547229|FG000|Overall Study|Other reason|3|||
124705460|NCT02367456|448547230|FG001|Overall Study|Other reason|3|||
124705461|NCT02367456|448547231|FG002|Overall Study|Other reason|9|||
124705462|NCT02367456|448547229|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
124705463|NCT02367456|448547230|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
124705464|NCT02367456|448547231|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
124705465|NCT01198587|448547241|FG000|Overall Study|Lost to Follow-up|8|||
124705466|NCT01198587|448547242|FG001|Overall Study|Lost to Follow-up|0|||
124705467|NCT01198587|448547243|FG002|Overall Study|Lost to Follow-up|9|||
124705468|NCT01198587|448547244|FG003|Overall Study|Lost to Follow-up|0|||
124705469|NCT00904371|448547245|FG000|Overall Study|Adverse Event|2|||
124705470|NCT00904371|448547245|FG000|Overall Study|Lost to Follow-up|4|||
124705471|NCT00904371|448547245|FG000|Overall Study|Discontinued at target blood pressure|2|||
124705472|NCT00904371|448547245|FG000|Overall Study|Continued with Tritace|1|||
124547779|NCT03917654|447960349|FG006|Year 1|Subject moved away from site|1|||
124547780|NCT03917654|447960350|FG007|Year 1|Subject moved away from site|2|||
124705473|NCT00553254|448547248|FG000|Overall Study|Death|3|||
124705474|NCT00553254|448547249|FG001|Overall Study|Death|6|||
124705475|NCT00553254|448547250|FG002|Overall Study|Death|25|||
124705476|NCT00553254|448547248|FG000|Overall Study|Lost to Follow-up|0|||
124705477|NCT00553254|448547249|FG001|Overall Study|Lost to Follow-up|0|||
124705478|NCT00553254|448547250|FG002|Overall Study|Lost to Follow-up|2|||
124705479|NCT00553254|448547248|FG000|Overall Study|Withdrawal by Subject|2|||
124705480|NCT00553254|448547249|FG001|Overall Study|Withdrawal by Subject|0|||
124705481|NCT00553254|448547250|FG002|Overall Study|Withdrawal by Subject|2|||
124705482|NCT00553254|448547248|FG000|Overall Study|Study terminated by Sponsor|0|||
124705483|NCT00553254|448547249|FG001|Overall Study|Study terminated by Sponsor|0|||
124705484|NCT00553254|448547250|FG002|Overall Study|Study terminated by Sponsor|1|||
124705485|NCT00553254|448547248|FG000|Overall Study|Other|1|||
124705486|NCT00553254|448547249|FG001|Overall Study|Other|0|||
124705487|NCT00553254|448547250|FG002|Overall Study|Other|13|||
124705488|NCT00583219|448547258|FG000|Phase 2|Withdrawal by Subject|1|||
124705489|NCT00754572|448547259|FG000|Overall Study|Adverse Event|19|||
124705490|NCT00754572|448547259|FG000|Overall Study|Other|39|||
124705491|NCT00754572|448547259|FG000|Overall Study|Protocol Violation|3|||
124705492|NCT00754572|448547259|FG000|Overall Study|Withdrawal by Subject|3|||
124705493|NCT00754572|448547259|FG000|Overall Study|Lack of Efficacy|2|||
124705494|NCT00754572|448547259|FG000|Overall Study|Death|1|||
124705495|NCT00754572|448547259|FG000|Overall Study|Administrative Reason|3|||
124705496|NCT00754572|448547259|FG000|Overall Study|Lost to Follow-up|1|||
124705497|NCT05448950|448547263|FG000|Overall Study|Death|2|||
124705498|NCT05448950|448547263|FG000|Overall Study|Withdrawal by Subject|1|||
124705499|NCT05448950|448547263|FG000|Overall Study|AVG abandoned|4|||
124705500|NCT02836249|448547264|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
124705501|NCT02836249|448547265|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
124705502|NCT02836249|448547266|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
124705503|NCT02836249|448547267|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
124705504|NCT02836249|448547264|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
124705505|NCT02836249|448547265|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
124705506|NCT02836249|448547266|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
124705507|NCT02836249|448547267|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
124705508|NCT02836249|448547264|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
124705509|NCT02836249|448547265|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
124705510|NCT02836249|448547266|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
124705511|NCT02836249|448547267|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
124705512|NCT02836249|448547264|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
124705513|NCT02836249|448547265|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
124705514|NCT02836249|448547266|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
124705515|NCT02836249|448547267|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
124705516|NCT02836249|448547264|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
124705517|NCT02836249|448547265|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
124705518|NCT02836249|448547266|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
124705519|NCT02836249|448547267|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
124705520|NCT02836249|448547264|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
124705521|NCT02836249|448547265|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
124705522|NCT02836249|448547266|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
124705523|NCT02836249|448547267|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
124943353|NCT04608409|449419885|FG002|Overall Study|Physician Decision|2|||
124943354|NCT00599196|449419886|FG000|Overall Study|Lack of Efficacy|22|||
124943355|NCT00599196|449419886|FG000|Overall Study|Adverse Event|93|||
124943356|NCT00599196|449419886|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
124943357|NCT00599196|449419886|FG000|Overall Study|Subject withdrew consent|43|||
124943358|NCT00599196|449419886|FG000|Overall Study|Study ended per sponsor|197|||
124943359|NCT00599196|449419886|FG000|Overall Study|Lost to Follow-up|17|||
124705524|NCT02836249|448547264|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
124705525|NCT02836249|448547265|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
124705526|NCT02836249|448547266|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
124705527|NCT02836249|448547267|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
124943360|NCT00599196|449419886|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
124943361|NCT00599196|449419886|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
124943362|NCT00599196|449419886|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
124943363|NCT00599196|449419886|FG000|Overall Study|Other: Pt Moved To Australia|1|||
124943364|NCT00599196|449419886|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
124943365|NCT00599196|449419886|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
124943366|NCT04497415|449419904|FG000|Overall Study|Lost to Follow-up|43|||
124705528|NCT02836249|448547264|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
124705529|NCT02836249|448547265|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
124943367|NCT04497415|449419905|FG001|Overall Study|Lost to Follow-up|27|||
124943368|NCT00734578|449419908|FG000|Overall Study|Adverse Event|4|||
124705530|NCT02836249|448547266|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
124765251|NCT02587520|448767374|FG012|Overall Study|Adverse Event|0|||
124943369|NCT00734578|449419909|FG001|Overall Study|Adverse Event|6|||
124943370|NCT00734578|449419910|FG002|Overall Study|Adverse Event|1|||
124943371|NCT00734578|449419908|FG000|Overall Study|Protocol Violation|8|||
124943372|NCT00734578|449419909|FG001|Overall Study|Protocol Violation|6|||
124943373|NCT00734578|449419910|FG002|Overall Study|Protocol Violation|3|||
124943374|NCT00734578|449419908|FG000|Overall Study|Withdrawal by Subject|7|||
124943375|NCT00734578|449419909|FG001|Overall Study|Withdrawal by Subject|8|||
124943376|NCT00734578|449419910|FG002|Overall Study|Withdrawal by Subject|11|||
124943377|NCT00734578|449419908|FG000|Overall Study|Lost to Follow-up|9|||
124943378|NCT00734578|449419909|FG001|Overall Study|Lost to Follow-up|3|||
124943379|NCT00734578|449419910|FG002|Overall Study|Lost to Follow-up|5|||
124943380|NCT00734578|449419908|FG000|Overall Study|Lack of Efficacy|3|||
124943381|NCT00734578|449419909|FG001|Overall Study|Lack of Efficacy|2|||
124943382|NCT00734578|449419910|FG002|Overall Study|Lack of Efficacy|5|||
124943383|NCT00734578|449419908|FG000|Overall Study|Randomized in error|1|||
124943384|NCT00734578|449419909|FG001|Overall Study|Randomized in error|0|||
124943385|NCT00734578|449419910|FG002|Overall Study|Randomized in error|0|||
124943386|NCT00734578|449419908|FG000|Overall Study|Exclusion criteria|1|||
124943387|NCT00734578|449419909|FG001|Overall Study|Exclusion criteria|0|||
124943388|NCT00734578|449419910|FG002|Overall Study|Exclusion criteria|0|||
124943389|NCT02085941|449419914|FG000|Overall Study|Lack of Efficacy|1|||
124943390|NCT02085941|449419915|FG001|Overall Study|Lack of Efficacy|0|||
124943391|NCT02085941|449419914|FG000|Overall Study|Death|6|||
124943392|NCT02085941|449419915|FG001|Overall Study|Death|1|||
124943393|NCT02085941|449419914|FG000|Overall Study|Lost to Follow-up|1|||
124943394|NCT02085941|449419915|FG001|Overall Study|Lost to Follow-up|0|||
124943395|NCT02085941|449419914|FG000|Overall Study|Physician Decision|0|||
124943396|NCT02085941|449419915|FG001|Overall Study|Physician Decision|2|||
124943397|NCT04652726|449419920|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
124943398|NCT04652726|449419921|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
124943399|NCT04652726|449419922|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
124943400|NCT04652726|449419920|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
124943401|NCT04652726|449419921|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
124943402|NCT04652726|449419922|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
124943403|NCT02157116|449419923|FG000|Overall Study|Withdrawal by Subject|4|||
124943404|NCT02157116|449419923|FG000|Overall Study|Physician Decision|3|||
124943405|NCT02157116|449419923|FG000|Overall Study|Failed Screening|2|||
124943406|NCT00093496|449419924|FG000|Overall Study|Protocol Violation|1|||
124943407|NCT00093496|449419925|FG001|Overall Study|Protocol Violation|3|||
124943408|NCT03274076|449419927|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
124943409|NCT03274076|449419928|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
124943410|NCT03274076|449419929|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
124943411|NCT03274076|449419930|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
124943412|NCT03274076|449419927|FG000|24 Weeks Open Label|Adverse Event|0|||
124943413|NCT03274076|449419928|FG001|24 Weeks Open Label|Adverse Event|0|||
124943414|NCT03274076|449419929|FG002|24 Weeks Open Label|Adverse Event|2|||
124943415|NCT03274076|449419930|FG003|24 Weeks Open Label|Adverse Event|0|||
124943416|NCT03274076|449419927|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
124943417|NCT03274076|449419928|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
124943418|NCT03274076|449419929|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
124943419|NCT03274076|449419930|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
124943420|NCT00975585|449419931|FG000|Overall Study|Adverse Event|0|||
124943421|NCT00975585|449419932|FG001|Overall Study|Adverse Event|4|||
124943422|NCT00975585|449419931|FG000|Overall Study|Lost to Follow-up|3|||
124943423|NCT00975585|449419932|FG001|Overall Study|Lost to Follow-up|5|||
124943424|NCT00975585|449419931|FG000|Overall Study|Withdrawal by Subject|2|||
124943425|NCT00975585|449419932|FG001|Overall Study|Withdrawal by Subject|1|||
124943426|NCT00975585|449419931|FG000|Overall Study|Lens issue|2|||
124943427|NCT00975585|449419932|FG001|Overall Study|Lens issue|2|||
124943428|NCT00795184|449419933|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
124943429|NCT00795184|449419934|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
124943430|NCT00205179|449419937|FG000|Overall Study|Death|0|||
124943431|NCT00205179|449419938|FG001|Overall Study|Death|2|||
124943432|NCT00205179|449419937|FG000|Overall Study|Physician Decision|1|||
124943433|NCT00205179|449419938|FG001|Overall Study|Physician Decision|1|||
124943434|NCT00205179|449419937|FG000|Overall Study|Adverse Event|1|||
124705531|NCT02836249|448547267|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
124705532|NCT02836249|448547264|FG000|Open-Label TAF Treatment Phase|Death|0|||
124943435|NCT00205179|449419938|FG001|Overall Study|Adverse Event|1|||
124943436|NCT00586313|449419939|FG000|Overall Study|Lack of Efficacy|2|||
124943437|NCT02079649|449419940|FG000|Overall Study|Lost to Follow-up|0|||
124943438|NCT02079649|449419941|FG001|Overall Study|Lost to Follow-up|0|||
124943439|NCT02079649|449419942|FG002|Overall Study|Lost to Follow-up|0|||
124943440|NCT02079649|449419943|FG003|Overall Study|Lost to Follow-up|1|||
124943441|NCT02079649|449419940|FG000|Overall Study|Withdrawal by Subject|0|||
124943442|NCT02079649|449419941|FG001|Overall Study|Withdrawal by Subject|0|||
124943443|NCT02079649|449419942|FG002|Overall Study|Withdrawal by Subject|0|||
124705533|NCT02836249|448547265|FG001|Open-Label TAF Treatment Phase|Death|0|||
124943444|NCT02079649|449419943|FG003|Overall Study|Withdrawal by Subject|1|||
124943445|NCT02079649|449419940|FG000|Overall Study|Randomization error (prior to treatment)|1|||
124943446|NCT02079649|449419941|FG001|Overall Study|Randomization error (prior to treatment)|0|||
124943447|NCT02079649|449419942|FG002|Overall Study|Randomization error (prior to treatment)|1|||
124943448|NCT02079649|449419943|FG003|Overall Study|Randomization error (prior to treatment)|0|||
124943449|NCT00853580|449419965|FG000|Overall Study|Lost to Follow-up|3|||
124943450|NCT00853580|449419966|FG001|Overall Study|Lost to Follow-up|5|||
124943451|NCT00853580|449419965|FG000|Overall Study|Protocol Violation|2|||
124943452|NCT00853580|449419966|FG001|Overall Study|Protocol Violation|1|||
124943453|NCT00853580|449419965|FG000|Overall Study|Withdrawal by Subject|2|||
124943454|NCT00853580|449419966|FG001|Overall Study|Withdrawal by Subject|8|||
124943455|NCT00853580|449419965|FG000|Overall Study|Commenced contraindicated therapy|0|||
124943456|NCT00853580|449419966|FG001|Overall Study|Commenced contraindicated therapy|2|||
124943457|NCT01968967|449419969|FG000|Treatment Period|Other|22|||
124943458|NCT01968967|449419970|FG001|Treatment Period|Other|22|||
124943459|NCT01968967|449419971|FG002|Treatment Period|Other|0|||
124943460|NCT01968967|449419972|FG003|Treatment Period|Other|0|||
124943461|NCT01968967|449419973|FG004|Treatment Period|Other|0|||
124943462|NCT01968967|449419969|FG000|Treatment Period|Withdrawal by Subject|71|||
124943463|NCT01968967|449419970|FG001|Treatment Period|Withdrawal by Subject|61|||
124943464|NCT01968967|449419971|FG002|Treatment Period|Withdrawal by Subject|0|||
124943465|NCT01968967|449419972|FG003|Treatment Period|Withdrawal by Subject|0|||
124943466|NCT01968967|449419973|FG004|Treatment Period|Withdrawal by Subject|0|||
124943467|NCT01968967|449419969|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
124943468|NCT01968967|449419970|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
124943469|NCT01968967|449419971|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
124943470|NCT01968967|449419972|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
124943471|NCT01968967|449419973|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
124943472|NCT01968967|449419969|FG000|Treatment Period|Lost to Follow-up|26|||
124943473|NCT01968967|449419970|FG001|Treatment Period|Lost to Follow-up|31|||
124943474|NCT01968967|449419971|FG002|Treatment Period|Lost to Follow-up|0|||
124943475|NCT01968967|449419972|FG003|Treatment Period|Lost to Follow-up|0|||
124943476|NCT01968967|449419973|FG004|Treatment Period|Lost to Follow-up|0|||
124943477|NCT01968967|449419969|FG000|Treatment Period|Protocol Violation|1|||
124943478|NCT01968967|449419970|FG001|Treatment Period|Protocol Violation|2|||
124943479|NCT01968967|449419971|FG002|Treatment Period|Protocol Violation|0|||
124943480|NCT01968967|449419972|FG003|Treatment Period|Protocol Violation|0|||
124943481|NCT01968967|449419973|FG004|Treatment Period|Protocol Violation|0|||
124943482|NCT01968967|449419969|FG000|Treatment Period|Adverse Event|9|||
124943483|NCT01968967|449419970|FG001|Treatment Period|Adverse Event|8|||
124458277|NCT00183274|447638185|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
124458278|NCT00183274|447638186|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
124458279|NCT00183274|447638187|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
124458280|NCT00183274|447638188|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
124458281|NCT00183274|447638189|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
124458282|NCT00183274|447638190|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
124458283|NCT00183274|447638185|FG000|Phase 1: Open-Label|Other|9|||
124765252|NCT02587520|448767375|FG013|Overall Study|Adverse Event|0|||
124765253|NCT02587520|448767376|FG014|Overall Study|Adverse Event|0|||
124765254|NCT02587520|448767377|FG015|Overall Study|Adverse Event|0|||
124765255|NCT02587520|448767378|FG016|Overall Study|Adverse Event|0|||
124765256|NCT02587520|448767379|FG017|Overall Study|Adverse Event|0|||
124765257|NCT02587520|448767362|FG000|Overall Study|Withdrawal by Subject|0|||
124765258|NCT02587520|448767363|FG001|Overall Study|Withdrawal by Subject|0|||
124765259|NCT02587520|448767364|FG002|Overall Study|Withdrawal by Subject|1|||
124765260|NCT02587520|448767365|FG003|Overall Study|Withdrawal by Subject|1|||
124943484|NCT01968967|449419971|FG002|Treatment Period|Adverse Event|0|||
124943485|NCT01968967|449419972|FG003|Treatment Period|Adverse Event|0|||
124943486|NCT01968967|449419973|FG004|Treatment Period|Adverse Event|0|||
124765261|NCT02587520|448767366|FG004|Overall Study|Withdrawal by Subject|0|||
124943487|NCT01968967|449419969|FG000|Treatment Period|Death|9|||
124943488|NCT01968967|449419970|FG001|Treatment Period|Death|2|||
124943489|NCT01968967|449419971|FG002|Treatment Period|Death|0|||
124943490|NCT01968967|449419972|FG003|Treatment Period|Death|0|||
124458284|NCT00183274|447638186|FG001|Phase 1: Open-Label|Other|0|||
124458285|NCT00183274|447638187|FG002|Phase 1: Open-Label|Other|0|||
124458286|NCT00183274|447638188|FG003|Phase 1: Open-Label|Other|0|||
124458287|NCT00183274|447638189|FG004|Phase 1: Open-Label|Other|0|||
124765262|NCT02587520|448767367|FG005|Overall Study|Withdrawal by Subject|1|||
124943491|NCT01968967|449419973|FG004|Treatment Period|Death|0|||
124943492|NCT01968967|449419969|FG000|Treatment Period|Randomized Not Treated|6|||
124943493|NCT01968967|449419970|FG001|Treatment Period|Randomized Not Treated|5|||
124943494|NCT01968967|449419971|FG002|Treatment Period|Randomized Not Treated|0|||
124458288|NCT00183274|447638190|FG005|Phase 1: Open-Label|Other|0|||
124458289|NCT00183274|447638185|FG000|Phase 2: Double-Blind|Relapsed|0|||
124765263|NCT02587520|448767368|FG006|Overall Study|Withdrawal by Subject|1|||
124943495|NCT01968967|449419972|FG003|Treatment Period|Randomized Not Treated|0|||
124943496|NCT01968967|449419973|FG004|Treatment Period|Randomized Not Treated|0|||
124705534|NCT02836249|448547266|FG002|Open-Label TAF Treatment Phase|Death|1|||
124705535|NCT02836249|448547267|FG003|Open-Label TAF Treatment Phase|Death|0|||
124705536|NCT02836249|448547264|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
124705537|NCT02836249|448547265|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
124705538|NCT02836249|448547266|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
124705539|NCT02836249|448547267|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
124705540|NCT02836249|448547264|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
124705541|NCT02836249|448547265|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
124705542|NCT02836249|448547266|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
124705543|NCT02836249|448547267|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
124705544|NCT00619866|448547268|FG000|Weeks 1 - 12|Adverse Event|0|||
124705545|NCT00619866|448547269|FG001|Weeks 1 - 12|Adverse Event|1|||
124705546|NCT00619866|448547270|FG002|Weeks 1 - 12|Adverse Event|2|||
124943497|NCT01968967|449419969|FG000|Extension Period|Withdrew Consent|0|||
124943498|NCT01968967|449419970|FG001|Extension Period|Withdrew Consent|0|||
124705547|NCT00619866|448547271|FG003|Weeks 1 - 12|Adverse Event|0|||
124705548|NCT00619866|448547272|FG004|Weeks 1 - 12|Adverse Event|0|||
124705549|NCT00619866|448547268|FG000|Weeks 1 - 12|Non-compliance|0|||
124705550|NCT00619866|448547269|FG001|Weeks 1 - 12|Non-compliance|0|||
124705551|NCT00619866|448547270|FG002|Weeks 1 - 12|Non-compliance|1|||
124705552|NCT00619866|448547271|FG003|Weeks 1 - 12|Non-compliance|0|||
124705553|NCT00619866|448547272|FG004|Weeks 1 - 12|Non-compliance|0|||
124705554|NCT00619866|448547268|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
124705555|NCT00619866|448547269|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
124705556|NCT00619866|448547270|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
124705557|NCT00619866|448547271|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
124705558|NCT00619866|448547272|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
124705559|NCT00619866|448547268|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
124705560|NCT00619866|448547269|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
124705561|NCT00619866|448547270|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
124705562|NCT00619866|448547271|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
124705563|NCT00619866|448547272|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
124705564|NCT00619866|448547268|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
124705565|NCT00619866|448547269|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
124705566|NCT00619866|448547270|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
124943499|NCT01968967|449419971|FG002|Extension Period|Withdrew Consent|2|||
124943500|NCT01968967|449419972|FG003|Extension Period|Withdrew Consent|0|||
124943501|NCT01968967|449419973|FG004|Extension Period|Withdrew Consent|5|||
124943502|NCT01170208|449419974|FG000|Overall Study|Withdrawal by Subject|5|||
124943503|NCT01170208|449419975|FG001|Overall Study|Withdrawal by Subject|0|||
124943504|NCT01170208|449419976|FG002|Overall Study|Withdrawal by Subject|1|||
124943505|NCT01170208|449419974|FG000|Overall Study|Protocol Violation|1|||
124458290|NCT00183274|447638186|FG001|Phase 2: Double-Blind|Relapsed|8|||
124458291|NCT00183274|447638187|FG002|Phase 2: Double-Blind|Relapsed|29|||
124458292|NCT00183274|447638188|FG003|Phase 2: Double-Blind|Relapsed|0|||
124458293|NCT00183274|447638189|FG004|Phase 2: Double-Blind|Relapsed|0|||
124458294|NCT00183274|447638190|FG005|Phase 2: Double-Blind|Relapsed|0|||
124458295|NCT00183274|447638185|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
124458296|NCT00183274|447638186|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
124547781|NCT03917654|447960351|FG008|Year 1|Subject moved away from site|1|||
124943506|NCT01170208|449419975|FG001|Overall Study|Protocol Violation|0|||
124943507|NCT01170208|449419976|FG002|Overall Study|Protocol Violation|1|||
124943508|NCT01160354|449419987|FG000|Overall Study|Death|0|||
124943509|NCT01160354|449419988|FG001|Overall Study|Death|1|||
124943510|NCT01160354|449419989|FG002|Overall Study|Death|1|||
124943511|NCT02743819|449419992|FG000|Overall Study|Lack of Efficacy|5|||
124943512|NCT02743819|449419992|FG000|Overall Study|Death|2|||
124943513|NCT02743819|449419992|FG000|Overall Study|Adverse Event|1|||
124943514|NCT03683576|449420001|FG000|Overall Study|Withdrawal by Subject|2|||
124943515|NCT03683576|449420002|FG001|Overall Study|Withdrawal by Subject|0|||
124943516|NCT03683576|449420003|FG002|Overall Study|Withdrawal by Subject|8|||
124943517|NCT03683576|449420004|FG003|Overall Study|Withdrawal by Subject|3|||
124943518|NCT03683576|449420001|FG000|Overall Study|Adverse Event|3|||
124943519|NCT03683576|449420002|FG001|Overall Study|Adverse Event|0|||
124458297|NCT00183274|447638187|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
124705567|NCT00619866|448547271|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
124705568|NCT00619866|448547272|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
124705569|NCT00619866|448547268|FG000|Weeks 1 - 12|Sponsor Decision|0|||
124705570|NCT00619866|448547269|FG001|Weeks 1 - 12|Sponsor Decision|1|||
124705571|NCT00619866|448547270|FG002|Weeks 1 - 12|Sponsor Decision|0|||
124705572|NCT00619866|448547271|FG003|Weeks 1 - 12|Sponsor Decision|0|||
124943520|NCT03683576|449420003|FG002|Overall Study|Adverse Event|0|||
124943521|NCT03683576|449420004|FG003|Overall Study|Adverse Event|4|||
124943522|NCT03683576|449420001|FG000|Overall Study|Lack of Efficacy|1|||
124705573|NCT00619866|448547272|FG004|Weeks 1 - 12|Sponsor Decision|0|||
124705574|NCT00619866|448547268|FG000|Weeks 13 - 24|Adverse Event|0|||
124705575|NCT00619866|448547269|FG001|Weeks 13 - 24|Adverse Event|0|||
124705576|NCT00619866|448547270|FG002|Weeks 13 - 24|Adverse Event|2|||
124943523|NCT03683576|449420002|FG001|Overall Study|Lack of Efficacy|0|||
124943524|NCT03683576|449420003|FG002|Overall Study|Lack of Efficacy|1|||
124943525|NCT03683576|449420004|FG003|Overall Study|Lack of Efficacy|1|||
124943526|NCT03683576|449420001|FG000|Overall Study|Lost to Follow-up|0|||
124943527|NCT03683576|449420002|FG001|Overall Study|Lost to Follow-up|1|||
124943528|NCT03683576|449420003|FG002|Overall Study|Lost to Follow-up|2|||
124943529|NCT03683576|449420004|FG003|Overall Study|Lost to Follow-up|0|||
124943530|NCT03683576|449420001|FG000|Overall Study|Other, Not Specified|0|||
124943531|NCT03683576|449420002|FG001|Overall Study|Other, Not Specified|2|||
124943532|NCT03683576|449420003|FG002|Overall Study|Other, Not Specified|0|||
124943533|NCT03683576|449420004|FG003|Overall Study|Other, Not Specified|0|||
124943534|NCT03683576|449420001|FG000|Overall Study|Protocol Violation|0|||
124943535|NCT03683576|449420002|FG001|Overall Study|Protocol Violation|1|||
124943536|NCT03683576|449420003|FG002|Overall Study|Protocol Violation|1|||
124943537|NCT03683576|449420004|FG003|Overall Study|Protocol Violation|0|||
124943538|NCT01827839|449420005|FG000|Overall Study|Adverse Event|1|||
124943539|NCT01827839|449420005|FG000|Overall Study|Consent Withdrawal|2|||
124943540|NCT00491894|449420006|FG000|Overall Study|Adverse Event|14|||
124943541|NCT00491894|449420006|FG000|Overall Study|Withdrawal by Subject|5|||
124943542|NCT00491894|449420006|FG000|Overall Study|Death|3|||
124943543|NCT00491894|449420006|FG000|Overall Study|Lost to Follow-up|3|||
124943544|NCT00491894|449420006|FG000|Overall Study|Lack of Efficacy|2|||
124943545|NCT00491894|449420006|FG000|Overall Study|Other-Failed to meet any criteria|2|||
124943546|NCT00491894|449420006|FG000|Overall Study|Physician Decision|2|||
124943547|NCT00491894|449420006|FG000|Overall Study|Protocol Violation|2|||
124943548|NCT00491894|449420006|FG000|Overall Study|Other-Intake of prohibited medication|1|||
124943549|NCT03499964|449421914|FG000|Overall Study|Lack of Efficacy|6|||
124943550|NCT03499964|449421915|FG001|Overall Study|Lack of Efficacy|26|||
124943551|NCT03499964|449421914|FG000|Overall Study|Adverse Event|1|||
124943552|NCT03499964|449421915|FG001|Overall Study|Adverse Event|0|||
124943553|NCT03499964|449421914|FG000|Overall Study|Death|1|||
124943554|NCT03499964|449421915|FG001|Overall Study|Death|0|||
124943555|NCT03499964|449421914|FG000|Overall Study|Withdrawal by Subject|2|||
124943556|NCT03499964|449421915|FG001|Overall Study|Withdrawal by Subject|1|||
124943557|NCT03499964|449421914|FG000|Overall Study|Lost to Follow-up|1|||
124943558|NCT03499964|449421915|FG001|Overall Study|Lost to Follow-up|0|||
124943559|NCT03739866|449421919|FG000|Overall Study|Lost to Follow-up|0|||
124943560|NCT03739866|449421920|FG001|Overall Study|Lost to Follow-up|0|||
124943561|NCT03739866|449421921|FG002|Overall Study|Lost to Follow-up|0|||
124943562|NCT03739866|449421922|FG003|Overall Study|Lost to Follow-up|1|||
124943563|NCT03739866|449421923|FG004|Overall Study|Lost to Follow-up|0|||
124943564|NCT03739866|449421924|FG005|Overall Study|Lost to Follow-up|0|||
124943565|NCT03739866|449421925|FG006|Overall Study|Lost to Follow-up|0|||
124943566|NCT03739866|449421926|FG007|Overall Study|Lost to Follow-up|0|||
124943567|NCT03739866|449421919|FG000|Overall Study|Enrolled but not treated|0|||
124943568|NCT03739866|449421920|FG001|Overall Study|Enrolled but not treated|0|||
124943569|NCT03739866|449421921|FG002|Overall Study|Enrolled but not treated|1|||
124943570|NCT03739866|449421922|FG003|Overall Study|Enrolled but not treated|0|||
124943571|NCT03739866|449421923|FG004|Overall Study|Enrolled but not treated|1|||
124943572|NCT03739866|449421924|FG005|Overall Study|Enrolled but not treated|0|||
124943573|NCT03739866|449421925|FG006|Overall Study|Enrolled but not treated|0|||
124943574|NCT03739866|449421926|FG007|Overall Study|Enrolled but not treated|0|||
124943575|NCT01728324|449421927|FG000|Termination of DBV|Adverse Event|14|||
124943576|NCT01728324|449421928|FG001|Termination of DBV|Adverse Event|13|||
124458298|NCT00183274|447638188|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
124458299|NCT00183274|447638189|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
124458300|NCT00183274|447638190|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
124458301|NCT00183274|447638185|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
124458302|NCT00183274|447638186|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
124458303|NCT00183274|447638187|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
124458304|NCT00183274|447638188|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
124943577|NCT01728324|449421929|FG002|Termination of DBV|Adverse Event|4|||
124943578|NCT01728324|449421927|FG000|Termination of DBV|Lack of Efficacy|14|||
124943579|NCT01728324|449421928|FG001|Termination of DBV|Lack of Efficacy|12|||
124943580|NCT01728324|449421929|FG002|Termination of DBV|Lack of Efficacy|8|||
124943581|NCT01728324|449421927|FG000|Termination of DBV|Withdrawal by Subject|9|||
124943582|NCT01728324|449421928|FG001|Termination of DBV|Withdrawal by Subject|6|||
124943583|NCT01728324|449421929|FG002|Termination of DBV|Withdrawal by Subject|2|||
124943584|NCT01728324|449421927|FG000|Termination of DBV|Other than stated|1|||
124458305|NCT00183274|447638189|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
124943585|NCT01728324|449421928|FG001|Termination of DBV|Other than stated|3|||
124943586|NCT01728324|449421929|FG002|Termination of DBV|Other than stated|0|||
124943587|NCT01728324|449421927|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
124943588|NCT01728324|449421928|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
124943589|NCT01728324|449421929|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
124943590|NCT01728324|449421927|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
124943591|NCT01728324|449421928|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
124705577|NCT00619866|448547271|FG003|Weeks 13 - 24|Adverse Event|1|||
124943592|NCT01728324|449421929|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
124943593|NCT01728324|449421927|FG000|Termination of FDV|Adverse Event|14|||
124943594|NCT01728324|449421928|FG001|Termination of FDV|Adverse Event|13|||
124943595|NCT01728324|449421929|FG002|Termination of FDV|Adverse Event|4|||
124943596|NCT01728324|449421927|FG000|Termination of FDV|Lack of Efficacy|14|||
124943597|NCT01728324|449421928|FG001|Termination of FDV|Lack of Efficacy|12|||
124943598|NCT01728324|449421929|FG002|Termination of FDV|Lack of Efficacy|8|||
124943599|NCT01728324|449421927|FG000|Termination of FDV|Withdrawal by Subject|9|||
124943600|NCT01728324|449421928|FG001|Termination of FDV|Withdrawal by Subject|6|||
124943601|NCT01728324|449421929|FG002|Termination of FDV|Withdrawal by Subject|2|||
124458306|NCT00183274|447638190|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
124943602|NCT01728324|449421927|FG000|Termination of FDV|Other than stated|1|||
124943603|NCT01728324|449421928|FG001|Termination of FDV|Other than stated|3|||
124943604|NCT01728324|449421929|FG002|Termination of FDV|Other than stated|0|||
124943605|NCT01728324|449421927|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
124943606|NCT01728324|449421928|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
124943607|NCT01728324|449421929|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
124943608|NCT01728324|449421927|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
124943609|NCT01728324|449421928|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
124943610|NCT01728324|449421929|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
124943611|NCT01728324|449421927|FG000|Termination of RBV|Adverse Event|15|||
124943612|NCT01728324|449421928|FG001|Termination of RBV|Adverse Event|16|||
124943613|NCT01728324|449421929|FG002|Termination of RBV|Adverse Event|5|||
124943614|NCT01728324|449421927|FG000|Termination of RBV|Lack of Efficacy|14|||
124943615|NCT01728324|449421928|FG001|Termination of RBV|Lack of Efficacy|11|||
124943616|NCT01728324|449421929|FG002|Termination of RBV|Lack of Efficacy|7|||
124943617|NCT01728324|449421927|FG000|Termination of RBV|Withdrawal by Subject|9|||
124943618|NCT01728324|449421928|FG001|Termination of RBV|Withdrawal by Subject|5|||
124943619|NCT01728324|449421929|FG002|Termination of RBV|Withdrawal by Subject|2|||
124943620|NCT01728324|449421927|FG000|Termination of RBV|Other than stated|1|||
124943621|NCT01728324|449421928|FG001|Termination of RBV|Other than stated|3|||
124943622|NCT01728324|449421929|FG002|Termination of RBV|Other than stated|1|||
124943623|NCT01728324|449421927|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
124943624|NCT01728324|449421928|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
124943625|NCT01728324|449421929|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
124943626|NCT01728324|449421927|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
124943627|NCT01728324|449421928|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
124943628|NCT01728324|449421929|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
124943629|NCT03057600|449421932|FG000|Overall Study|Adverse Event|0|||
124943630|NCT03057600|449421933|FG001|Overall Study|Adverse Event|0|||
124943631|NCT03057600|449421934|FG002|Overall Study|Adverse Event|4|||
124943632|NCT03057600|449421935|FG003|Overall Study|Adverse Event|0|||
124943633|NCT03057600|449421932|FG000|Overall Study|Radiologic Disease Progression|8|||
124943634|NCT03057600|449421933|FG001|Overall Study|Radiologic Disease Progression|7|||
124943635|NCT03057600|449421934|FG002|Overall Study|Radiologic Disease Progression|13|||
124943636|NCT03057600|449421935|FG003|Overall Study|Radiologic Disease Progression|10|||
124943637|NCT03057600|449421932|FG000|Overall Study|Symptomatic Deterioration|0|||
124943638|NCT03057600|449421933|FG001|Overall Study|Symptomatic Deterioration|1|||
124943639|NCT03057600|449421934|FG002|Overall Study|Symptomatic Deterioration|1|||
124943640|NCT03057600|449421935|FG003|Overall Study|Symptomatic Deterioration|0|||
124943641|NCT03057600|449421932|FG000|Overall Study|Investigator Decision|0|||
124943642|NCT03057600|449421933|FG001|Overall Study|Investigator Decision|0|||
124943643|NCT03057600|449421934|FG002|Overall Study|Investigator Decision|1|||
124943644|NCT03057600|449421935|FG003|Overall Study|Investigator Decision|0|||
124943645|NCT03057600|449421932|FG000|Overall Study|Study Termination by Sponsor|0|||
124943646|NCT03057600|449421933|FG001|Overall Study|Study Termination by Sponsor|0|||
124943647|NCT03057600|449421934|FG002|Overall Study|Study Termination by Sponsor|0|||
124943648|NCT03057600|449421935|FG003|Overall Study|Study Termination by Sponsor|2|||
124943649|NCT03057600|449421932|FG000|Overall Study|Withdrawal by Subject|0|||
124943650|NCT03057600|449421933|FG001|Overall Study|Withdrawal by Subject|1|||
124943651|NCT03057600|449421934|FG002|Overall Study|Withdrawal by Subject|0|||
124943652|NCT03057600|449421935|FG003|Overall Study|Withdrawal by Subject|0|||
124943653|NCT03057600|449421932|FG000|Overall Study|Other, Not Specified|1|||
124943654|NCT03057600|449421933|FG001|Overall Study|Other, Not Specified|1|||
124943655|NCT03057600|449421934|FG002|Overall Study|Other, Not Specified|1|||
124943656|NCT03057600|449421935|FG003|Overall Study|Other, Not Specified|1|||
124943657|NCT03489369|449421936|FG000|Overall Study|Documented Progressive Disease|3|||
124943658|NCT03489369|449421937|FG001|Overall Study|Documented Progressive Disease|2|||
124458307|NCT00183274|447638185|FG000|Phase 3: Double-Blind|Relapsed|0|||
124458308|NCT00183274|447638186|FG001|Phase 3: Double-Blind|Relapsed|0|||
124943659|NCT03489369|449421938|FG002|Overall Study|Documented Progressive Disease|3|||
124458309|NCT00183274|447638187|FG002|Phase 3: Double-Blind|Relapsed|0|||
124943660|NCT03489369|449421939|FG003|Overall Study|Documented Progressive Disease|6|||
124943661|NCT03489369|449421936|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
124943662|NCT03489369|449421937|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
124943663|NCT03489369|449421938|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
124943664|NCT03489369|449421939|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
124943665|NCT03335488|449421944|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
124943666|NCT03335488|449421945|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
124943667|NCT03335488|449421944|FG000|Safety Extension Period|Adverse Event|1|||
124943668|NCT03335488|449421945|FG001|Safety Extension Period|Adverse Event|0|||
124943669|NCT03335488|449421944|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
124943670|NCT03335488|449421945|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
124943671|NCT00388726|449421946|FG000|Overall Study|Adverse Event|50|||
124943672|NCT00388726|449421947|FG001|Overall Study|Adverse Event|24|||
124943673|NCT00388726|449421946|FG000|Overall Study|Progressive Disease|336|||
124943674|NCT00388726|449421947|FG001|Overall Study|Progressive Disease|153|||
124943675|NCT00388726|449421946|FG000|Overall Study|Clinical Progression|61|||
124943676|NCT00388726|449421947|FG001|Overall Study|Clinical Progression|36|||
124943677|NCT00388726|449421946|FG000|Overall Study|Withdrawal by Subject|10|||
124943678|NCT00388726|449421947|FG001|Overall Study|Withdrawal by Subject|7|||
124943679|NCT00388726|449421946|FG000|Overall Study|Administrative|6|||
124943680|NCT00388726|449421947|FG001|Overall Study|Administrative|9|||
124943681|NCT00388726|449421946|FG000|Overall Study|Physician Decision|18|||
124943682|NCT00388726|449421947|FG001|Overall Study|Physician Decision|13|||
124943683|NCT00388726|449421946|FG000|Overall Study|Death|3|||
124943684|NCT00388726|449421947|FG001|Overall Study|Death|2|||
124943685|NCT01953692|449421948|FG000|Overall Study|Adverse Event|5|||
124943686|NCT01953692|449421949|FG001|Overall Study|Adverse Event|2|||
124943687|NCT01953692|449421950|FG002|Overall Study|Adverse Event|4|||
124943688|NCT01953692|449421951|FG003|Overall Study|Adverse Event|2|||
124943689|NCT01953692|449421952|FG004|Overall Study|Adverse Event|1|||
124943690|NCT01953692|449421953|FG005|Overall Study|Adverse Event|2|||
124943691|NCT01953692|449421954|FG006|Overall Study|Adverse Event|0|||
124943692|NCT01953692|449421955|FG007|Overall Study|Adverse Event|0|||
124943693|NCT01953692|449421956|FG008|Overall Study|Adverse Event|0|||
124547782|NCT03917654|447960352|FG009|Year 1|Subject moved away from site|0|||
124547783|NCT03917654|447960353|FG010|Year 1|Subject moved away from site|0|||
124547784|NCT03917654|447960354|FG011|Year 1|Subject moved away from site|3|||
124547785|NCT03917654|447960343|FG000|Year 1|Spouse/Family member request|0|||
124547786|NCT03917654|447960344|FG001|Year 1|Spouse/Family member request|0|||
124547787|NCT03917654|447960345|FG002|Year 1|Spouse/Family member request|1|||
124547788|NCT03917654|447960346|FG003|Year 1|Spouse/Family member request|0|||
124547789|NCT03917654|447960347|FG004|Year 1|Spouse/Family member request|1|||
124547790|NCT03917654|447960348|FG005|Year 1|Spouse/Family member request|0|||
124547791|NCT03917654|447960349|FG006|Year 1|Spouse/Family member request|0|||
124547792|NCT03917654|447960350|FG007|Year 1|Spouse/Family member request|2|||
124547793|NCT03917654|447960351|FG008|Year 1|Spouse/Family member request|0|||
124547794|NCT03917654|447960352|FG009|Year 1|Spouse/Family member request|0|||
124547795|NCT03917654|447960353|FG010|Year 1|Spouse/Family member request|0|||
124547796|NCT03917654|447960354|FG011|Year 1|Spouse/Family member request|1|||
124547797|NCT03917654|447960343|FG000|Year 1|Death|0|||
124547798|NCT03917654|447960344|FG001|Year 1|Death|0|||
124547799|NCT03917654|447960345|FG002|Year 1|Death|0|||
124547800|NCT03917654|447960346|FG003|Year 1|Death|0|||
124547801|NCT03917654|447960347|FG004|Year 1|Death|0|||
124547802|NCT03917654|447960348|FG005|Year 1|Death|0|||
124547803|NCT03917654|447960349|FG006|Year 1|Death|0|||
124547804|NCT03917654|447960350|FG007|Year 1|Death|0|||
124547805|NCT03917654|447960351|FG008|Year 1|Death|1|||
124547806|NCT03917654|447960352|FG009|Year 1|Death|1|||
124547807|NCT03917654|447960353|FG010|Year 1|Death|0|||
124547808|NCT03917654|447960354|FG011|Year 1|Death|0|||
124705578|NCT00619866|448547272|FG004|Weeks 13 - 24|Adverse Event|0|||
124705579|NCT00619866|448547268|FG000|Weeks 13 - 24|Protocol Deviation|0|||
124943694|NCT01953692|449421948|FG000|Overall Study|Clinical Progression|0|||
124943695|NCT01953692|449421949|FG001|Overall Study|Clinical Progression|15|||
124547809|NCT03917654|447960343|FG000|Year 1|Lost to Follow-up|0|||
124547810|NCT03917654|447960344|FG001|Year 1|Lost to Follow-up|0|||
124547811|NCT03917654|447960345|FG002|Year 1|Lost to Follow-up|0|||
124547812|NCT03917654|447960346|FG003|Year 1|Lost to Follow-up|0|||
124547813|NCT03917654|447960347|FG004|Year 1|Lost to Follow-up|0|||
124547814|NCT03917654|447960348|FG005|Year 1|Lost to Follow-up|0|||
124547815|NCT03917654|447960349|FG006|Year 1|Lost to Follow-up|2|||
124705580|NCT00619866|448547269|FG001|Weeks 13 - 24|Protocol Deviation|0|||
124943696|NCT01953692|449421950|FG002|Overall Study|Clinical Progression|7|||
124943697|NCT01953692|449421951|FG003|Overall Study|Clinical Progression|5|||
124547816|NCT03917654|447960350|FG007|Year 1|Lost to Follow-up|0|||
124547817|NCT03917654|447960351|FG008|Year 1|Lost to Follow-up|0|||
124547818|NCT03917654|447960352|FG009|Year 1|Lost to Follow-up|0|||
124547819|NCT03917654|447960353|FG010|Year 1|Lost to Follow-up|0|||
124547820|NCT03917654|447960354|FG011|Year 1|Lost to Follow-up|0|||
124547821|NCT03917654|447960343|FG000|Year 1|Missed visits|0|||
124547822|NCT03917654|447960344|FG001|Year 1|Missed visits|0|||
124547823|NCT03917654|447960345|FG002|Year 1|Missed visits|0|||
124547824|NCT03917654|447960346|FG003|Year 1|Missed visits|0|||
124547825|NCT03917654|447960347|FG004|Year 1|Missed visits|0|||
124547826|NCT03917654|447960348|FG005|Year 1|Missed visits|0|||
124547827|NCT03917654|447960349|FG006|Year 1|Missed visits|0|||
124547828|NCT03917654|447960350|FG007|Year 1|Missed visits|0|||
124547829|NCT03917654|447960351|FG008|Year 1|Missed visits|0|||
124547830|NCT03917654|447960352|FG009|Year 1|Missed visits|0|||
124547831|NCT03917654|447960353|FG010|Year 1|Missed visits|1|||
124547832|NCT03917654|447960354|FG011|Year 1|Missed visits|1|||
124547833|NCT03917654|447960343|FG000|Year 1|Pregnancy|0|||
124547834|NCT03917654|447960344|FG001|Year 1|Pregnancy|0|||
124547835|NCT03917654|447960345|FG002|Year 1|Pregnancy|0|||
124547836|NCT03917654|447960346|FG003|Year 1|Pregnancy|0|||
124547837|NCT03917654|447960347|FG004|Year 1|Pregnancy|0|||
124547838|NCT03917654|447960348|FG005|Year 1|Pregnancy|0|||
124547839|NCT03917654|447960349|FG006|Year 1|Pregnancy|0|||
124547840|NCT03917654|447960350|FG007|Year 1|Pregnancy|1|||
124547841|NCT03917654|447960351|FG008|Year 1|Pregnancy|0|||
124547842|NCT03917654|447960352|FG009|Year 1|Pregnancy|1|||
124547843|NCT03917654|447960353|FG010|Year 1|Pregnancy|0|||
124547844|NCT03917654|447960354|FG011|Year 1|Pregnancy|0|||
124547845|NCT03917654|447960343|FG000|Year 2|Travel|1|||
124547846|NCT03917654|447960344|FG001|Year 2|Travel|0|||
124547847|NCT03917654|447960345|FG002|Year 2|Travel|0|||
124547848|NCT03917654|447960346|FG003|Year 2|Travel|0|||
124547849|NCT03917654|447960347|FG004|Year 2|Travel|1|||
124547850|NCT03917654|447960348|FG005|Year 2|Travel|1|||
124547851|NCT03917654|447960349|FG006|Year 2|Travel|2|||
124547852|NCT03917654|447960350|FG007|Year 2|Travel|1|||
124547853|NCT03917654|447960351|FG008|Year 2|Travel|0|||
124547854|NCT03917654|447960352|FG009|Year 2|Travel|1|||
124705581|NCT00619866|448547270|FG002|Weeks 13 - 24|Protocol Deviation|0|||
124705582|NCT00619866|448547271|FG003|Weeks 13 - 24|Protocol Deviation|1|||
124458310|NCT00183274|447638188|FG003|Phase 3: Double-Blind|Relapsed|1|||
124458311|NCT00183274|447638189|FG004|Phase 3: Double-Blind|Relapsed|11|||
124458312|NCT00183274|447638190|FG005|Phase 3: Double-Blind|Relapsed|2|||
124458313|NCT04081363|447638193|FG000|Overall Study|Withdrawal by Subject|1|||
124458314|NCT04081363|447638194|FG001|Overall Study|Withdrawal by Subject|0|||
124458315|NCT02409290|447638195|FG000|Overall Study|Protocol Violation|3|||
124458316|NCT02409290|447638196|FG001|Overall Study|Protocol Violation|6|||
124458317|NCT02409290|447638197|FG002|Overall Study|Protocol Violation|9|||
124458318|NCT02409290|447638198|FG003|Overall Study|Protocol Violation|4|||
124458319|NCT02409290|447638195|FG000|Overall Study|No positive culture/no baseline sample|3|||
124458320|NCT02409290|447638196|FG001|Overall Study|No positive culture/no baseline sample|9|||
124458321|NCT02409290|447638197|FG002|Overall Study|No positive culture/no baseline sample|6|||
124458322|NCT02409290|447638198|FG003|Overall Study|No positive culture/no baseline sample|5|||
124458323|NCT02409290|447638195|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
124458324|NCT02409290|447638196|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
124458325|NCT02409290|447638197|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
124458326|NCT02409290|447638198|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
124458327|NCT00708500|447638199|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
124458328|NCT00708500|447638200|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
124458329|NCT00708500|447638201|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
124458330|NCT00708500|447638199|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
124458331|NCT00708500|447638200|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
124458332|NCT00708500|447638201|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
124458333|NCT00708500|447638199|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
124458334|NCT00708500|447638200|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
124458335|NCT00708500|447638201|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
124458336|NCT00708500|447638199|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
124458337|NCT00708500|447638200|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
124458338|NCT00708500|447638201|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
124547855|NCT03917654|447960353|FG010|Year 2|Travel|0|||
124547856|NCT03917654|447960354|FG011|Year 2|Travel|1|||
124547857|NCT03917654|447960343|FG000|Year 2|Married|1|||
124547858|NCT03917654|447960344|FG001|Year 2|Married|0|||
124547859|NCT03917654|447960345|FG002|Year 2|Married|0|||
124547860|NCT03917654|447960346|FG003|Year 2|Married|0|||
124547861|NCT03917654|447960347|FG004|Year 2|Married|0|||
124547862|NCT03917654|447960348|FG005|Year 2|Married|0|||
124547863|NCT03917654|447960349|FG006|Year 2|Married|1|||
124547864|NCT03917654|447960350|FG007|Year 2|Married|1|||
124547865|NCT03917654|447960351|FG008|Year 2|Married|0|||
124547866|NCT03917654|447960352|FG009|Year 2|Married|0|||
124547867|NCT03917654|447960353|FG010|Year 2|Married|0|||
124547868|NCT03917654|447960354|FG011|Year 2|Married|0|||
124547869|NCT03917654|447960343|FG000|Year 2|Subject moved away from site|1|||
124943698|NCT01953692|449421952|FG004|Overall Study|Clinical Progression|0|||
124943699|NCT01953692|449421953|FG005|Overall Study|Clinical Progression|7|||
124943700|NCT01953692|449421954|FG006|Overall Study|Clinical Progression|20|||
124943701|NCT01953692|449421955|FG007|Overall Study|Clinical Progression|3|||
124943702|NCT01953692|449421956|FG008|Overall Study|Clinical Progression|3|||
124943703|NCT01953692|449421948|FG000|Overall Study|Death|5|||
124943704|NCT01953692|449421949|FG001|Overall Study|Death|0|||
124943705|NCT01953692|449421950|FG002|Overall Study|Death|2|||
124943706|NCT01953692|449421951|FG003|Overall Study|Death|2|||
124943707|NCT01953692|449421952|FG004|Overall Study|Death|1|||
124943708|NCT01953692|449421953|FG005|Overall Study|Death|3|||
124943709|NCT01953692|449421954|FG006|Overall Study|Death|6|||
124943710|NCT01953692|449421955|FG007|Overall Study|Death|2|||
124943711|NCT01953692|449421956|FG008|Overall Study|Death|1|||
124943712|NCT01953692|449421948|FG000|Overall Study|Excluded Medication|1|||
124943713|NCT01953692|449421949|FG001|Overall Study|Excluded Medication|0|||
124943714|NCT01953692|449421950|FG002|Overall Study|Excluded Medication|0|||
124943715|NCT01953692|449421951|FG003|Overall Study|Excluded Medication|0|||
124943716|NCT01953692|449421952|FG004|Overall Study|Excluded Medication|0|||
124943717|NCT01953692|449421953|FG005|Overall Study|Excluded Medication|0|||
124943718|NCT01953692|449421954|FG006|Overall Study|Excluded Medication|0|||
124943719|NCT01953692|449421955|FG007|Overall Study|Excluded Medication|0|||
124943720|NCT01953692|449421956|FG008|Overall Study|Excluded Medication|0|||
124943721|NCT01953692|449421948|FG000|Overall Study|Lost to Follow-up|1|||
124943722|NCT01953692|449421949|FG001|Overall Study|Lost to Follow-up|0|||
124943723|NCT01953692|449421950|FG002|Overall Study|Lost to Follow-up|3|||
124943724|NCT01953692|449421951|FG003|Overall Study|Lost to Follow-up|1|||
124943725|NCT01953692|449421952|FG004|Overall Study|Lost to Follow-up|0|||
124943726|NCT01953692|449421953|FG005|Overall Study|Lost to Follow-up|1|||
124943727|NCT01953692|449421954|FG006|Overall Study|Lost to Follow-up|0|||
124943728|NCT01953692|449421955|FG007|Overall Study|Lost to Follow-up|0|||
124458339|NCT00708500|447638199|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
124458340|NCT00708500|447638200|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
124943729|NCT01953692|449421956|FG008|Overall Study|Lost to Follow-up|0|||
124943730|NCT01953692|449421948|FG000|Overall Study|Physician Decision|11|||
124943731|NCT01953692|449421949|FG001|Overall Study|Physician Decision|4|||
124943732|NCT01953692|449421950|FG002|Overall Study|Physician Decision|2|||
124943733|NCT01953692|449421951|FG003|Overall Study|Physician Decision|2|||
124943734|NCT01953692|449421952|FG004|Overall Study|Physician Decision|1|||
124943735|NCT01953692|449421953|FG005|Overall Study|Physician Decision|2|||
124943736|NCT01953692|449421954|FG006|Overall Study|Physician Decision|4|||
124943737|NCT01953692|449421955|FG007|Overall Study|Physician Decision|1|||
124943738|NCT01953692|449421956|FG008|Overall Study|Physician Decision|0|||
124943739|NCT01953692|449421948|FG000|Overall Study|Protocol Violation|0|||
124943740|NCT01953692|449421949|FG001|Overall Study|Protocol Violation|2|||
124943741|NCT01953692|449421950|FG002|Overall Study|Protocol Violation|1|||
124943742|NCT01953692|449421951|FG003|Overall Study|Protocol Violation|0|||
124943743|NCT01953692|449421952|FG004|Overall Study|Protocol Violation|0|||
124943744|NCT01953692|449421953|FG005|Overall Study|Protocol Violation|0|||
124943745|NCT01953692|449421954|FG006|Overall Study|Protocol Violation|0|||
124943746|NCT01953692|449421955|FG007|Overall Study|Protocol Violation|1|||
124943747|NCT01953692|449421956|FG008|Overall Study|Protocol Violation|0|||
124943748|NCT01953692|449421948|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
124943749|NCT01953692|449421949|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
124943750|NCT01953692|449421950|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
124943751|NCT01953692|449421951|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
124943752|NCT01953692|449421952|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
124943753|NCT01953692|449421953|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
124943754|NCT01953692|449421954|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
124943755|NCT01953692|449421955|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
124458341|NCT00708500|447638201|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
124458342|NCT00708500|447638199|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
124458343|NCT00708500|447638200|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
124943756|NCT01953692|449421956|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
124943757|NCT01953692|449421948|FG000|Overall Study|Withdrawal by Subject|4|||
124943758|NCT01953692|449421949|FG001|Overall Study|Withdrawal by Subject|2|||
124943759|NCT01953692|449421950|FG002|Overall Study|Withdrawal by Subject|1|||
124943760|NCT01953692|449421951|FG003|Overall Study|Withdrawal by Subject|2|||
124943761|NCT01953692|449421952|FG004|Overall Study|Withdrawal by Subject|0|||
124943762|NCT01953692|449421953|FG005|Overall Study|Withdrawal by Subject|3|||
124943763|NCT01953692|449421954|FG006|Overall Study|Withdrawal by Subject|2|||
124943764|NCT01953692|449421955|FG007|Overall Study|Withdrawal by Subject|1|||
124943765|NCT01953692|449421956|FG008|Overall Study|Withdrawal by Subject|1|||
124943766|NCT04638816|449421957|FG000|Overall Study|Withdrawal by Subject|0|||
124943767|NCT04638816|449421958|FG001|Overall Study|Withdrawal by Subject|1|||
124943768|NCT04638816|449421957|FG000|Overall Study|Lost to Follow-up|0|||
124943769|NCT04638816|449421958|FG001|Overall Study|Lost to Follow-up|1|||
124705583|NCT00619866|448547272|FG004|Weeks 13 - 24|Protocol Deviation|0|||
124705584|NCT00619866|448547268|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
124705585|NCT00619866|448547269|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
124705586|NCT00619866|448547270|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
124705587|NCT00619866|448547271|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
124705588|NCT00619866|448547272|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
124705589|NCT00619866|448547268|FG000|Weeks 13 - 24|Non-compliance|0|||
124705590|NCT00619866|448547269|FG001|Weeks 13 - 24|Non-compliance|1|||
124705591|NCT00619866|448547270|FG002|Weeks 13 - 24|Non-compliance|1|||
124943770|NCT00109031|449421961|FG000|Overall Study|Adverse Event|0|||
124943771|NCT00109031|449421962|FG001|Overall Study|Adverse Event|0|||
124943772|NCT00109031|449421963|FG002|Overall Study|Adverse Event|1|||
124943773|NCT00109031|449421964|FG003|Overall Study|Adverse Event|0|||
124705592|NCT00619866|448547271|FG003|Weeks 13 - 24|Non-compliance|0|||
124705593|NCT00619866|448547272|FG004|Weeks 13 - 24|Non-compliance|0|||
124705594|NCT00619866|448547268|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
124705595|NCT00619866|448547269|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
124705596|NCT00619866|448547270|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
124705597|NCT00619866|448547271|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
124705598|NCT00619866|448547272|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
124705599|NCT01968980|448547276|FG000|Overall Study|Death|0|||
124705600|NCT01968980|448547277|FG001|Overall Study|Death|1|||
124705601|NCT01968980|448547276|FG000|Overall Study|Adverse Event|1|||
124705602|NCT01968980|448547277|FG001|Overall Study|Adverse Event|3|||
124705603|NCT01968980|448547276|FG000|Overall Study|Does not meet entry criteria|1|||
124705604|NCT01968980|448547277|FG001|Overall Study|Does not meet entry criteria|3|||
124705605|NCT01968980|448547276|FG000|Overall Study|Withdrawal by Subject|13|||
124705606|NCT01968980|448547277|FG001|Overall Study|Withdrawal by Subject|5|||
124705607|NCT01968980|448547276|FG000|Overall Study|Other unspecified|1|||
124705608|NCT01968980|448547277|FG001|Overall Study|Other unspecified|2|||
124705609|NCT02589938|448547281|FG000|Overall Study|Withdrawal by Subject|11|||
124705610|NCT02589938|448547282|FG001|Overall Study|Withdrawal by Subject|5|||
124547870|NCT03917654|447960344|FG001|Year 2|Subject moved away from site|0|||
124547871|NCT03917654|447960345|FG002|Year 2|Subject moved away from site|0|||
124547872|NCT03917654|447960346|FG003|Year 2|Subject moved away from site|0|||
124547873|NCT03917654|447960347|FG004|Year 2|Subject moved away from site|1|||
124547874|NCT03917654|447960348|FG005|Year 2|Subject moved away from site|0|||
124547875|NCT03917654|447960349|FG006|Year 2|Subject moved away from site|2|||
124547876|NCT03917654|447960350|FG007|Year 2|Subject moved away from site|3|||
124547877|NCT03917654|447960351|FG008|Year 2|Subject moved away from site|0|||
124547878|NCT03917654|447960352|FG009|Year 2|Subject moved away from site|2|||
124547879|NCT03917654|447960353|FG010|Year 2|Subject moved away from site|0|||
124547880|NCT03917654|447960354|FG011|Year 2|Subject moved away from site|1|||
124547881|NCT03917654|447960343|FG000|Year 2|Year 2 Screening failure|0|||
124547882|NCT03917654|447960344|FG001|Year 2|Year 2 Screening failure|1|||
124705611|NCT02589938|448547283|FG002|Overall Study|Withdrawal by Subject|6|||
124705612|NCT02589938|448547281|FG000|Overall Study|Lost to Follow-up|3|||
124943774|NCT00109031|449421961|FG000|Overall Study|Withdrawal by Subject|0|||
124943775|NCT00109031|449421962|FG001|Overall Study|Withdrawal by Subject|1|||
124943776|NCT00109031|449421963|FG002|Overall Study|Withdrawal by Subject|0|||
124943777|NCT00109031|449421964|FG003|Overall Study|Withdrawal by Subject|0|||
124943778|NCT00109031|449421961|FG000|Overall Study|Physician Decision|0|||
124943779|NCT00109031|449421962|FG001|Overall Study|Physician Decision|1|||
124943780|NCT00109031|449421963|FG002|Overall Study|Physician Decision|0|||
124943781|NCT00109031|449421964|FG003|Overall Study|Physician Decision|0|||
124943782|NCT00109031|449421961|FG000|Overall Study|Protocol Violation|0|||
124943783|NCT00109031|449421962|FG001|Overall Study|Protocol Violation|0|||
124547883|NCT03917654|447960345|FG002|Year 2|Year 2 Screening failure|0|||
124547884|NCT03917654|447960346|FG003|Year 2|Year 2 Screening failure|0|||
124547885|NCT03917654|447960347|FG004|Year 2|Year 2 Screening failure|2|||
124705613|NCT02589938|448547282|FG001|Overall Study|Lost to Follow-up|3|||
124943784|NCT00109031|449421963|FG002|Overall Study|Protocol Violation|1|||
124943785|NCT00109031|449421964|FG003|Overall Study|Protocol Violation|0|||
124943786|NCT01822756|449421965|FG000|Overall Study|Adverse Event|0|||
124547886|NCT03917654|447960348|FG005|Year 2|Year 2 Screening failure|0|||
124547887|NCT03917654|447960349|FG006|Year 2|Year 2 Screening failure|4|||
124547888|NCT03917654|447960350|FG007|Year 2|Year 2 Screening failure|3|||
124705614|NCT02589938|448547283|FG002|Overall Study|Lost to Follow-up|3|||
124705615|NCT02589938|448547281|FG000|Overall Study|Death|1|||
124705616|NCT02589938|448547282|FG001|Overall Study|Death|0|||
124705617|NCT02589938|448547283|FG002|Overall Study|Death|1|||
124943787|NCT01822756|449421966|FG001|Overall Study|Adverse Event|0|||
124547889|NCT03917654|447960351|FG008|Year 2|Year 2 Screening failure|10|||
124547890|NCT03917654|447960352|FG009|Year 2|Year 2 Screening failure|2|||
124705618|NCT02589938|448547281|FG000|Overall Study|Protocol Violation|6|||
124705619|NCT02589938|448547282|FG001|Overall Study|Protocol Violation|2|||
124705620|NCT02589938|448547283|FG002|Overall Study|Protocol Violation|3|||
124943788|NCT01822756|449421967|FG002|Overall Study|Adverse Event|0|||
124943789|NCT01822756|449421968|FG003|Overall Study|Adverse Event|2|||
124943790|NCT01822756|449421969|FG004|Overall Study|Adverse Event|0|||
124943791|NCT01822756|449421965|FG000|Overall Study|Disease progression|11|||
124943792|NCT01822756|449421966|FG001|Overall Study|Disease progression|1|||
124943793|NCT01822756|449421967|FG002|Overall Study|Disease progression|7|||
124943794|NCT01822756|449421968|FG003|Overall Study|Disease progression|2|||
124943795|NCT01822756|449421969|FG004|Overall Study|Disease progression|6|||
124943796|NCT01822756|449421965|FG000|Overall Study|Death|2|||
124943797|NCT01822756|449421966|FG001|Overall Study|Death|2|||
124943798|NCT01822756|449421967|FG002|Overall Study|Death|1|||
124943799|NCT01822756|449421968|FG003|Overall Study|Death|0|||
124943800|NCT01822756|449421969|FG004|Overall Study|Death|0|||
124943801|NCT01822756|449421965|FG000|Overall Study|Lost to Follow-up|1|||
124943802|NCT01822756|449421966|FG001|Overall Study|Lost to Follow-up|0|||
124943803|NCT01822756|449421967|FG002|Overall Study|Lost to Follow-up|1|||
124943804|NCT01822756|449421968|FG003|Overall Study|Lost to Follow-up|0|||
124943805|NCT01822756|449421969|FG004|Overall Study|Lost to Follow-up|1|||
124943806|NCT01822756|449421965|FG000|Overall Study|Physician Decision|0|||
124943807|NCT01822756|449421966|FG001|Overall Study|Physician Decision|1|||
124943808|NCT01822756|449421967|FG002|Overall Study|Physician Decision|0|||
124943809|NCT01822756|449421968|FG003|Overall Study|Physician Decision|0|||
124943810|NCT01822756|449421969|FG004|Overall Study|Physician Decision|0|||
124943811|NCT01822756|449421965|FG000|Overall Study|disease progression & patient preference|2|||
124458344|NCT00708500|447638201|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
124458345|NCT00708500|447638199|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
124458346|NCT00708500|447638200|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
124458347|NCT00708500|447638201|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
124458348|NCT00708500|447638199|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
124458349|NCT00708500|447638200|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
124458350|NCT00708500|447638201|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
124458351|NCT00708500|447638199|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
124458352|NCT00708500|447638200|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
124458353|NCT00708500|447638201|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
124458354|NCT00708500|447638199|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
124458355|NCT00708500|447638200|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
124458356|NCT00708500|447638201|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
124458357|NCT00708500|447638199|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
124458358|NCT00708500|447638200|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
124458359|NCT00708500|447638201|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
124458360|NCT00708500|447638199|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
124458361|NCT00708500|447638200|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
124458362|NCT00708500|447638201|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
124458363|NCT00708500|447638199|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
124458364|NCT00708500|447638200|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
124458365|NCT00708500|447638201|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
124458366|NCT00708500|447638199|FG000|FOLLOWUP|Adverse Event|0|||
124458367|NCT00708500|447638200|FG001|FOLLOWUP|Adverse Event|1|||
124458368|NCT00708500|447638201|FG002|FOLLOWUP|Adverse Event|0|||
124458369|NCT00708500|447638199|FG000|FOLLOWUP|Lost to Follow-up|1|||
124458370|NCT00708500|447638200|FG001|FOLLOWUP|Lost to Follow-up|6|||
124458371|NCT00708500|447638201|FG002|FOLLOWUP|Lost to Follow-up|4|||
124458372|NCT00708500|447638199|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
124458373|NCT00708500|447638200|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
124458374|NCT00708500|447638201|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
124458375|NCT00708500|447638199|FG000|FOLLOWUP|Subject withdrew consent|31|||
124458376|NCT00708500|447638200|FG001|FOLLOWUP|Subject withdrew consent|4|||
124458377|NCT00708500|447638201|FG002|FOLLOWUP|Subject withdrew consent|5|||
124458378|NCT00708500|447638199|FG000|FOLLOWUP|Non-compliance with protocol|5|||
124458379|NCT00708500|447638200|FG001|FOLLOWUP|Non-compliance with protocol|0|||
124458380|NCT00708500|447638201|FG002|FOLLOWUP|Non-compliance with protocol|1|||
124458381|NCT00618410|447638206|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
124458382|NCT00618410|447638207|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
124458383|NCT00705783|447638208|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
124458384|NCT00705783|447638209|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
124458385|NCT00705783|447638210|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
124458386|NCT00705783|447638208|FG000|Conversion Phase|Lost to Follow-up|13|||
124458387|NCT00705783|447638209|FG001|Conversion Phase|Lost to Follow-up|0|||
124458388|NCT00705783|447638210|FG002|Conversion Phase|Lost to Follow-up|0|||
124458389|NCT00705783|447638208|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
124458390|NCT00705783|447638209|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
124943812|NCT01822756|449421966|FG001|Overall Study|disease progression & patient preference|0|||
124943813|NCT01822756|449421967|FG002|Overall Study|disease progression & patient preference|1|||
124943814|NCT01822756|449421968|FG003|Overall Study|disease progression & patient preference|0|||
124943815|NCT01822756|449421969|FG004|Overall Study|disease progression & patient preference|0|||
124705621|NCT02589938|448547281|FG000|Overall Study|Physician Decision|1|||
124705622|NCT02589938|448547282|FG001|Overall Study|Physician Decision|0|||
124705623|NCT02589938|448547283|FG002|Overall Study|Physician Decision|0|||
124705624|NCT02589938|448547281|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
124705625|NCT02589938|448547282|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
124705626|NCT02589938|448547283|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
124705627|NCT02521285|448547284|FG000|Overall Study|Lost to Follow-up|1|||
124705628|NCT02521285|448547285|FG001|Overall Study|Lost to Follow-up|1|||
124705629|NCT02521285|448547284|FG000|Overall Study|Withdrawal by Subject|1|||
124705630|NCT02521285|448547285|FG001|Overall Study|Withdrawal by Subject|1|||
124705631|NCT02521285|448547284|FG000|Overall Study|Adverse Event|0|||
124705632|NCT02521285|448547285|FG001|Overall Study|Adverse Event|1|||
124705633|NCT01849276|448547286|FG000|Followed for Survival for 5 Years|Death|1|||
124705634|NCT01849276|448547286|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
124705635|NCT01722669|448547289|FG000|Overall Study|Withdrawal by Subject|0|||
124705636|NCT01722669|448547290|FG001|Overall Study|Withdrawal by Subject|0|||
124705637|NCT01722669|448547291|FG002|Overall Study|Withdrawal by Subject|0|||
124705638|NCT01722669|448547292|FG003|Overall Study|Withdrawal by Subject|0|||
124705639|NCT01722669|448547293|FG004|Overall Study|Withdrawal by Subject|0|||
124705640|NCT01722669|448547294|FG005|Overall Study|Withdrawal by Subject|2|||
124705641|NCT03559556|448547296|FG000|Overall Study|Withdrawal by Subject|1|||
124705642|NCT03012880|448547303|FG000|Overall Study|Withdrawal by Subject|1|||
124705643|NCT03012880|448547304|FG001|Overall Study|Withdrawal by Subject|0|||
124705644|NCT03012880|448547303|FG000|Overall Study|Ineligible|1|||
124705645|NCT03012880|448547304|FG001|Overall Study|Ineligible|0|||
124705646|NCT01587196|448547305|FG000|Overall Study|Lost to Follow-up|50|||
124705647|NCT01587196|448547305|FG000|Overall Study|Withdrawal by Subject|4|||
124705648|NCT02769481|448547306|FG000|Overall Study|Protocol Violation|1|||
124705649|NCT02769481|448547307|FG001|Overall Study|Protocol Violation|0|||
124705650|NCT02769481|448547306|FG000|Overall Study|Adverse Event|3|||
124705651|NCT02769481|448547307|FG001|Overall Study|Adverse Event|6|||
124705652|NCT02769481|448547306|FG000|Overall Study|Entry Criteria Not Met|1|||
124705653|NCT02769481|448547307|FG001|Overall Study|Entry Criteria Not Met|2|||
124705654|NCT02769481|448547306|FG000|Overall Study|Withdrawal by Subject|14|||
124705655|NCT02769481|448547307|FG001|Overall Study|Withdrawal by Subject|16|||
124705656|NCT02769481|448547306|FG000|Overall Study|Lost to Follow-up|9|||
124705657|NCT02769481|448547307|FG001|Overall Study|Lost to Follow-up|9|||
124705658|NCT02769481|448547306|FG000|Overall Study|Physician Decision|0|||
124705659|NCT02769481|448547307|FG001|Overall Study|Physician Decision|1|||
124705660|NCT02769481|448547306|FG000|Overall Study|Terminated by Sponsor|1|||
124705661|NCT02769481|448547307|FG001|Overall Study|Terminated by Sponsor|0|||
124705662|NCT02769481|448547306|FG000|Overall Study|Death|0|||
124705663|NCT02769481|448547307|FG001|Overall Study|Death|1|||
124705664|NCT02769481|448547306|FG000|Overall Study|Undefined|4|||
124705665|NCT02769481|448547307|FG001|Overall Study|Undefined|1|||
124705666|NCT03510715|448547308|FG000|Overall Study|Adverse Event|1|||
124705667|NCT03510715|448547309|FG001|Overall Study|Adverse Event|0|||
124943816|NCT01328496|449421975|FG000|Overall Study|Significant Change in Health Status|1|||
124943817|NCT01328496|449421976|FG001|Overall Study|Significant Change in Health Status|0|||
124943818|NCT00853593|449421983|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
124943819|NCT00853593|449421983|FG000|Overall Study|Model 4396 lead not attempted|29|||
124943820|NCT00853593|449421983|FG000|Overall Study|Implant not attempted|4|||
124943821|NCT00600353|449421986|FG000|Overall Study|history of malignancy within 5 years|1|||
124943822|NCT00600353|449421987|FG001|Overall Study|history of malignancy within 5 years|0|||
124943823|NCT00600353|449421986|FG000|Overall Study|History of prepartive regimen|0|||
124943824|NCT00600353|449421987|FG001|Overall Study|History of prepartive regimen|1|||
124943825|NCT05966155|449421988|FG000|Overall Study|Death|1|||
124943826|NCT05966155|449421989|FG001|Overall Study|Death|2|||
124943827|NCT05966155|449421988|FG000|Overall Study|Lost to Follow-up|63|||
124943828|NCT05966155|449421989|FG001|Overall Study|Lost to Follow-up|67|||
124943829|NCT05966155|449421988|FG000|Overall Study|Protocol Violation|1|||
124943830|NCT05966155|449421989|FG001|Overall Study|Protocol Violation|0|||
124705668|NCT00643279|448547314|FG000|Overall Study|Death|13|||
124705669|NCT00643279|448547315|FG001|Overall Study|Death|11|||
124943831|NCT05966155|449421988|FG000|Overall Study|Withdrawal by Subject|8|||
124705670|NCT00643279|448547314|FG000|Overall Study|Withdrawal by Subject|3|||
124705671|NCT00643279|448547315|FG001|Overall Study|Withdrawal by Subject|0|||
124705672|NCT00643279|448547314|FG000|Overall Study|Lost to Follow-up|0|||
124705673|NCT00643279|448547315|FG001|Overall Study|Lost to Follow-up|1|||
124705674|NCT00643279|448547314|FG000|Overall Study|Physician Decision|0|||
124705675|NCT00643279|448547315|FG001|Overall Study|Physician Decision|1|||
124705676|NCT03612570|448547324|FG000|Overall Study|Lost to Follow-up|1|||
124705677|NCT03557502|448547325|FG000|Protocol 2|Withdrawal by Subject|1|||
124943832|NCT05966155|449421989|FG001|Overall Study|Withdrawal by Subject|9|||
124943833|NCT05966155|449421988|FG000|Overall Study|Enrolled Erroneously|0|||
124547891|NCT03917654|447960353|FG010|Year 2|Year 2 Screening failure|1|||
124547892|NCT03917654|447960354|FG011|Year 2|Year 2 Screening failure|1|||
124547893|NCT03917654|447960343|FG000|Year 2|Death|0|||
124547894|NCT03917654|447960344|FG001|Year 2|Death|0|||
124547895|NCT03917654|447960345|FG002|Year 2|Death|0|||
124547896|NCT03917654|447960346|FG003|Year 2|Death|0|||
124547897|NCT03917654|447960347|FG004|Year 2|Death|0|||
124547898|NCT03917654|447960348|FG005|Year 2|Death|1|||
124547899|NCT03917654|447960349|FG006|Year 2|Death|0|||
124547900|NCT03917654|447960350|FG007|Year 2|Death|0|||
124547901|NCT03917654|447960351|FG008|Year 2|Death|1|||
124547902|NCT03917654|447960352|FG009|Year 2|Death|1|||
124547903|NCT03917654|447960353|FG010|Year 2|Death|0|||
124547904|NCT03917654|447960354|FG011|Year 2|Death|0|||
124547905|NCT03917654|447960343|FG000|Year 2|Withdrawal by Subject|0|||
124547906|NCT03917654|447960344|FG001|Year 2|Withdrawal by Subject|0|||
124547907|NCT03917654|447960345|FG002|Year 2|Withdrawal by Subject|0|||
124547908|NCT03917654|447960346|FG003|Year 2|Withdrawal by Subject|0|||
124547909|NCT03917654|447960347|FG004|Year 2|Withdrawal by Subject|0|||
124547910|NCT03917654|447960348|FG005|Year 2|Withdrawal by Subject|0|||
124547911|NCT03917654|447960349|FG006|Year 2|Withdrawal by Subject|3|||
124547912|NCT03917654|447960350|FG007|Year 2|Withdrawal by Subject|0|||
124547913|NCT03917654|447960351|FG008|Year 2|Withdrawal by Subject|2|||
124547914|NCT03917654|447960352|FG009|Year 2|Withdrawal by Subject|5|||
124547915|NCT03917654|447960353|FG010|Year 2|Withdrawal by Subject|0|||
124547916|NCT03917654|447960354|FG011|Year 2|Withdrawal by Subject|0|||
124547917|NCT03917654|447960343|FG000|Year 2|Spouse/family member request|0|||
124547918|NCT03917654|447960344|FG001|Year 2|Spouse/family member request|0|||
124547919|NCT03917654|447960345|FG002|Year 2|Spouse/family member request|0|||
124547920|NCT03917654|447960346|FG003|Year 2|Spouse/family member request|0|||
124547921|NCT03917654|447960347|FG004|Year 2|Spouse/family member request|0|||
124547922|NCT03917654|447960348|FG005|Year 2|Spouse/family member request|0|||
124547923|NCT03917654|447960349|FG006|Year 2|Spouse/family member request|1|||
124547924|NCT03917654|447960350|FG007|Year 2|Spouse/family member request|0|||
124547925|NCT03917654|447960351|FG008|Year 2|Spouse/family member request|0|||
124547926|NCT03917654|447960352|FG009|Year 2|Spouse/family member request|0|||
124547927|NCT03917654|447960353|FG010|Year 2|Spouse/family member request|0|||
124547928|NCT03917654|447960354|FG011|Year 2|Spouse/family member request|0|||
124547929|NCT03917654|447960343|FG000|Year 2|Lost to Follow-up|0|||
124547930|NCT03917654|447960344|FG001|Year 2|Lost to Follow-up|0|||
124705678|NCT03557502|448547326|FG001|Protocol 2|Withdrawal by Subject|1|||
124705679|NCT03557502|448547325|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
124705680|NCT03557502|448547326|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
124705681|NCT02333799|448548460|FG000|Treatment Period|Withdrawal by Subject|1|||
124943834|NCT05966155|449421989|FG001|Overall Study|Enrolled Erroneously|1|||
124943835|NCT05966155|449421988|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
124943836|NCT05966155|449421989|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
124943837|NCT00553332|449421990|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
124943838|NCT02235298|449421992|FG000|Overall Study|Lost to Follow-up|6|||
124943839|NCT02235298|449421993|FG001|Overall Study|Lost to Follow-up|5|||
124943840|NCT02235298|449421992|FG000|Overall Study|Adverse Event|2|||
124943841|NCT02235298|449421993|FG001|Overall Study|Adverse Event|2|||
124943842|NCT02235298|449421992|FG000|Overall Study|Withdrawal by Subject|0|||
124943843|NCT02235298|449421993|FG001|Overall Study|Withdrawal by Subject|1|||
124943844|NCT02309294|449421996|FG000|Overall Study|Withdrawal by Subject|2|||
124943845|NCT03520036|449421997|FG000|Overall Study|Adverse Event|1|||
124943846|NCT03520036|449421998|FG001|Overall Study|Adverse Event|2|||
124943847|NCT03520036|449421999|FG002|Overall Study|Adverse Event|0|||
124943848|NCT03520036|449421997|FG000|Overall Study|Protocol Violation|1|||
124943849|NCT03520036|449421998|FG001|Overall Study|Protocol Violation|0|||
124943850|NCT03520036|449421999|FG002|Overall Study|Protocol Violation|0|||
124943851|NCT03520036|449421997|FG000|Overall Study|Withdrawal by Subject|0|||
124943852|NCT03520036|449421998|FG001|Overall Study|Withdrawal by Subject|1|||
124943853|NCT03520036|449421999|FG002|Overall Study|Withdrawal by Subject|4|||
124943854|NCT03520036|449421997|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
124943855|NCT03520036|449421998|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
124943856|NCT03520036|449421999|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
124943857|NCT05426109|449422004|FG000|Overall Study|Withdrawal by Subject|0|||
124547931|NCT03917654|447960345|FG002|Year 2|Lost to Follow-up|0|||
124547932|NCT03917654|447960346|FG003|Year 2|Lost to Follow-up|0|||
124547933|NCT03917654|447960347|FG004|Year 2|Lost to Follow-up|0|||
124705682|NCT02333799|448548460|FG000|Treatment Period|Death|6|||
124943858|NCT05426109|449422005|FG001|Overall Study|Withdrawal by Subject|1|||
124547934|NCT03917654|447960348|FG005|Year 2|Lost to Follow-up|0|||
124547935|NCT03917654|447960349|FG006|Year 2|Lost to Follow-up|1|||
124547936|NCT03917654|447960350|FG007|Year 2|Lost to Follow-up|0|||
124547937|NCT03917654|447960351|FG008|Year 2|Lost to Follow-up|1|||
124547938|NCT03917654|447960352|FG009|Year 2|Lost to Follow-up|0|||
124547939|NCT03917654|447960353|FG010|Year 2|Lost to Follow-up|0|||
124547940|NCT03917654|447960354|FG011|Year 2|Lost to Follow-up|1|||
124943859|NCT03102034|449422006|FG000|Overall Study|Withdrawal by Subject|1|||
124943860|NCT03102034|449422007|FG001|Overall Study|Withdrawal by Subject|0|||
124943861|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
124943862|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
124943863|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
124943864|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
124943865|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
124943866|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
124943867|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
124943868|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
124943869|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
124943870|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
124705683|NCT02333799|448548460|FG000|6 Month Follow Up Period|Physician Decision|1|||
124705684|NCT02333799|448548460|FG000|6 Month Follow Up Period|Death|1|||
124705685|NCT02333799|448548460|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
124705686|NCT02333799|448548460|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
124765264|NCT02587520|448767369|FG007|Overall Study|Withdrawal by Subject|0|||
124765265|NCT02587520|448767370|FG008|Overall Study|Withdrawal by Subject|0|||
124765266|NCT02587520|448767371|FG009|Overall Study|Withdrawal by Subject|0|||
124765267|NCT02587520|448767372|FG010|Overall Study|Withdrawal by Subject|0|||
124705687|NCT01657370|448548464|FG000|Overall Study|Withdrawal by Subject|0|||
124705688|NCT01657370|448548465|FG001|Overall Study|Withdrawal by Subject|0|||
124705689|NCT01657370|448548466|FG002|Overall Study|Withdrawal by Subject|1|||
124705690|NCT01657370|448548467|FG003|Overall Study|Withdrawal by Subject|0|||
124705691|NCT01657370|448548468|FG004|Overall Study|Withdrawal by Subject|0|||
124705692|NCT01657370|448548469|FG005|Overall Study|Withdrawal by Subject|1|||
124705693|NCT01657370|448548464|FG000|Overall Study|Physician Decision|2|||
124705694|NCT01657370|448548465|FG001|Overall Study|Physician Decision|3|||
124705695|NCT01657370|448548466|FG002|Overall Study|Physician Decision|1|||
124705696|NCT01657370|448548467|FG003|Overall Study|Physician Decision|2|||
124705697|NCT01657370|448548468|FG004|Overall Study|Physician Decision|5|||
124705698|NCT01657370|448548469|FG005|Overall Study|Physician Decision|0|||
124705699|NCT01657370|448548464|FG000|Overall Study|Lack of Qualifying Event|1|||
124705700|NCT01657370|448548465|FG001|Overall Study|Lack of Qualifying Event|0|||
124705701|NCT01657370|448548466|FG002|Overall Study|Lack of Qualifying Event|3|||
124705702|NCT01657370|448548467|FG003|Overall Study|Lack of Qualifying Event|2|||
124705703|NCT01657370|448548468|FG004|Overall Study|Lack of Qualifying Event|1|||
124705704|NCT01657370|448548469|FG005|Overall Study|Lack of Qualifying Event|2|||
124705705|NCT01657370|448548464|FG000|Overall Study|Adverse Event|0|||
124705706|NCT01657370|448548465|FG001|Overall Study|Adverse Event|0|||
124705707|NCT01657370|448548466|FG002|Overall Study|Adverse Event|0|||
124705708|NCT01657370|448548467|FG003|Overall Study|Adverse Event|0|||
124705709|NCT01657370|448548468|FG004|Overall Study|Adverse Event|1|||
124705710|NCT01657370|448548469|FG005|Overall Study|Adverse Event|0|||
124705711|NCT01657370|448548464|FG000|Overall Study|Protocol Violation|1|||
124705712|NCT01657370|448548465|FG001|Overall Study|Protocol Violation|1|||
124705713|NCT01657370|448548466|FG002|Overall Study|Protocol Violation|1|||
124705714|NCT01657370|448548467|FG003|Overall Study|Protocol Violation|1|||
124705715|NCT01657370|448548468|FG004|Overall Study|Protocol Violation|0|||
124705716|NCT01657370|448548469|FG005|Overall Study|Protocol Violation|0|||
124705717|NCT01657370|448548464|FG000|Overall Study|Lost to Follow-up|2|||
124705718|NCT01657370|448548465|FG001|Overall Study|Lost to Follow-up|0|||
124705719|NCT01657370|448548466|FG002|Overall Study|Lost to Follow-up|1|||
124705720|NCT01657370|448548467|FG003|Overall Study|Lost to Follow-up|0|||
124705721|NCT01657370|448548468|FG004|Overall Study|Lost to Follow-up|0|||
124705722|NCT01657370|448548469|FG005|Overall Study|Lost to Follow-up|1|||
124705723|NCT03021486|448548470|FG000|Overall Study|Withdrawal by Subject|1|||
124705724|NCT03021486|448548471|FG001|Overall Study|Withdrawal by Subject|1|||
124705725|NCT03021486|448548472|FG002|Overall Study|Withdrawal by Subject|3|||
124705726|NCT03021486|448548470|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
124705727|NCT03021486|448548471|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
124705728|NCT03021486|448548472|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
124705729|NCT04795531|448548473|FG000|Overall Study|Withdrawal by Subject|4|||
124705730|NCT04795531|448548474|FG001|Overall Study|Withdrawal by Subject|4|||
124705731|NCT04795531|448548473|FG000|Overall Study|Lost to Follow-up|0|||
124705732|NCT04795531|448548474|FG001|Overall Study|Lost to Follow-up|1|||
124705733|NCT04795531|448548473|FG000|Overall Study|Physician Decision|0|||
124705734|NCT04795531|448548474|FG001|Overall Study|Physician Decision|2|||
124705735|NCT04795531|448548473|FG000|Overall Study|Death|2|||
124705736|NCT04795531|448548474|FG001|Overall Study|Death|1|||
124765268|NCT02587520|448767373|FG011|Overall Study|Withdrawal by Subject|0|||
124765269|NCT02587520|448767374|FG012|Overall Study|Withdrawal by Subject|0|||
124765270|NCT02587520|448767375|FG013|Overall Study|Withdrawal by Subject|1|||
124765271|NCT02587520|448767376|FG014|Overall Study|Withdrawal by Subject|0|||
124765272|NCT02587520|448767377|FG015|Overall Study|Withdrawal by Subject|0|||
124765273|NCT02587520|448767378|FG016|Overall Study|Withdrawal by Subject|0|||
124943871|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
124943872|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
124943873|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
124705737|NCT04887831|448548475|FG000|Overall Study|Death|26|||
124705738|NCT04887831|448548476|FG001|Overall Study|Death|26|||
124705739|NCT04887831|448548475|FG000|Overall Study|Lost to Follow-up|0|||
124705740|NCT04887831|448548476|FG001|Overall Study|Lost to Follow-up|1|||
124705741|NCT04887831|448548475|FG000|Overall Study|Withdrawal by Subject|2|||
124705742|NCT04887831|448548476|FG001|Overall Study|Withdrawal by Subject|1|||
124765274|NCT02587520|448767379|FG017|Overall Study|Withdrawal by Subject|0|||
124705743|NCT04887831|448548475|FG000|Overall Study|Study Terminated by Sponsor|18|||
124705744|NCT04887831|448548476|FG001|Overall Study|Study Terminated by Sponsor|17|||
124547941|NCT03917654|447960343|FG000|Year 2|Adverse Event|0|||
124547942|NCT03917654|447960344|FG001|Year 2|Adverse Event|0|||
124547943|NCT03917654|447960345|FG002|Year 2|Adverse Event|0|||
124547944|NCT03917654|447960346|FG003|Year 2|Adverse Event|0|||
124547945|NCT03917654|447960347|FG004|Year 2|Adverse Event|0|||
124547946|NCT03917654|447960348|FG005|Year 2|Adverse Event|0|||
124547947|NCT03917654|447960349|FG006|Year 2|Adverse Event|0|||
124547948|NCT03917654|447960350|FG007|Year 2|Adverse Event|0|||
124547949|NCT03917654|447960351|FG008|Year 2|Adverse Event|0|||
124547950|NCT03917654|447960352|FG009|Year 2|Adverse Event|1|||
124547951|NCT03917654|447960353|FG010|Year 2|Adverse Event|0|||
124547952|NCT03917654|447960354|FG011|Year 2|Adverse Event|0|||
124705745|NCT04887831|448548475|FG000|Overall Study|Other|1|||
124705746|NCT04887831|448548476|FG001|Overall Study|Other|0|||
124705747|NCT04507204|448548479|FG000|Overall Study|Adverse Event|8|||
124705748|NCT04507204|448548480|FG001|Overall Study|Adverse Event|13|||
124705749|NCT04507204|448548479|FG000|Overall Study|Death|0|||
124705750|NCT04507204|448548480|FG001|Overall Study|Death|1|||
124705751|NCT04507204|448548479|FG000|Overall Study|Lost to Follow-up|15|||
124705752|NCT04507204|448548480|FG001|Overall Study|Lost to Follow-up|14|||
124705753|NCT04507204|448548479|FG000|Overall Study|Poor Compliance with Protocol|2|||
124705754|NCT04507204|448548480|FG001|Overall Study|Poor Compliance with Protocol|4|||
124705755|NCT04507204|448548479|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
124705756|NCT04507204|448548480|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
124705757|NCT04507204|448548479|FG000|Overall Study|Withdrawal of Patient Consent|21|||
124705758|NCT04507204|448548480|FG001|Overall Study|Withdrawal of Patient Consent|13|||
124705759|NCT03580044|448548481|FG000|Overall Study|Death|2|||
124705760|NCT03580044|448548482|FG001|Overall Study|Death|1|||
124705761|NCT03580044|448548481|FG000|Overall Study|Withdrawal by Subject|1|||
124705762|NCT03580044|448548482|FG001|Overall Study|Withdrawal by Subject|1|||
124705763|NCT02095106|448548485|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
124705764|NCT02095106|448548486|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
124547953|NCT00905437|447960356|FG000|Overall Study|Adverse Event|3|||
124547954|NCT00905437|447960357|FG001|Overall Study|Adverse Event|2|||
124547955|NCT00905437|447960356|FG000|Overall Study|Lost to Follow-up|0|||
124943874|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
124943875|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
124943876|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
124943877|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
124943878|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
124943879|NCT02222493|449422008|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
124943880|NCT02222493|449422009|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
124943881|NCT02222493|449422008|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
124943882|NCT02222493|449422009|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
124943883|NCT02222493|449422008|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
124705765|NCT05134649|448548489|FG000|Overall Study|Lost to Follow-up|12|||
124705766|NCT05134649|448548489|FG000|Overall Study|Withdrawal by Subject|14|||
124943884|NCT02222493|449422009|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
124943885|NCT02222493|449422008|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
124943886|NCT02222493|449422009|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
124943887|NCT02222493|449422008|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
124943888|NCT02222493|449422009|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
124943889|NCT02222493|449422008|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
124943890|NCT02222493|449422009|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
124943891|NCT02222493|449422008|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
124458391|NCT00705783|447638210|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
124458392|NCT00705783|447638208|FG000|Conversion Phase|Withdrawn by Investigator|4|||
124458393|NCT00705783|447638209|FG001|Conversion Phase|Withdrawn by Investigator|0|||
124458394|NCT00705783|447638210|FG002|Conversion Phase|Withdrawn by Investigator|0|||
124458395|NCT00705783|447638208|FG000|Conversion Phase|Withdrew Consent|24|||
124458396|NCT00705783|447638209|FG001|Conversion Phase|Withdrew Consent|0|||
124458397|NCT00705783|447638210|FG002|Conversion Phase|Withdrew Consent|0|||
124458398|NCT00705783|447638208|FG000|Conversion Phase|Protocol Deviation|2|||
124458399|NCT00705783|447638209|FG001|Conversion Phase|Protocol Deviation|0|||
124458400|NCT00705783|447638210|FG002|Conversion Phase|Protocol Deviation|0|||
124943892|NCT02222493|449422009|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
124943893|NCT02222493|449422008|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
124943894|NCT02222493|449422009|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
124943895|NCT02222493|449422008|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
124943896|NCT02222493|449422009|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
124943897|NCT02222493|449422008|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
124943898|NCT02222493|449422009|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
124943899|NCT02222493|449422008|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
124943900|NCT02222493|449422009|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
124943901|NCT02222493|449422008|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
124943902|NCT02222493|449422009|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
124943903|NCT02222493|449422008|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
124943904|NCT02222493|449422009|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
124943905|NCT03611075|449422012|FG000|Overall Study|Physician Decision|0|||
124458401|NCT00705783|447638208|FG000|Conversion Phase|Adverse Event|11|||
124458402|NCT00705783|447638209|FG001|Conversion Phase|Adverse Event|0|||
124458403|NCT00705783|447638210|FG002|Conversion Phase|Adverse Event|0|||
124458404|NCT00705783|447638208|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
124458405|NCT00705783|447638209|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
124458406|NCT00705783|447638210|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
124458407|NCT00705783|447638208|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
124458408|NCT00705783|447638209|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
124458409|NCT00705783|447638210|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
124458410|NCT00705783|447638208|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
124705767|NCT05134649|448548489|FG000|Overall Study|Pregnancy|1|||
124705768|NCT05134649|448548489|FG000|Overall Study|Other, not specified|3|||
124943906|NCT03611075|449422013|FG001|Overall Study|Physician Decision|1|||
124943907|NCT03611075|449422014|FG002|Overall Study|Physician Decision|1|||
124943908|NCT03611075|449422015|FG003|Overall Study|Physician Decision|0|||
124943909|NCT03611075|449422016|FG004|Overall Study|Physician Decision|0|||
124943910|NCT03611075|449422017|FG005|Overall Study|Physician Decision|0|||
124943911|NCT03611075|449422018|FG006|Overall Study|Physician Decision|0|||
124943912|NCT03611075|449422019|FG007|Overall Study|Physician Decision|0|||
124943913|NCT03611075|449422020|FG008|Overall Study|Physician Decision|0|||
124943914|NCT03611075|449422012|FG000|Overall Study|Lost to Follow-up|1|||
124943915|NCT03611075|449422013|FG001|Overall Study|Lost to Follow-up|0|||
124943916|NCT03611075|449422014|FG002|Overall Study|Lost to Follow-up|0|||
124458411|NCT00705783|447638209|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
124458412|NCT00705783|447638210|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
124943917|NCT03611075|449422015|FG003|Overall Study|Lost to Follow-up|2|||
124943918|NCT03611075|449422016|FG004|Overall Study|Lost to Follow-up|0|||
124943919|NCT03611075|449422017|FG005|Overall Study|Lost to Follow-up|0|||
124943920|NCT03611075|449422018|FG006|Overall Study|Lost to Follow-up|0|||
124943921|NCT03611075|449422019|FG007|Overall Study|Lost to Follow-up|0|||
124943922|NCT03611075|449422020|FG008|Overall Study|Lost to Follow-up|0|||
124943923|NCT03611075|449422012|FG000|Overall Study|Withdrawal by Subject|0|||
124943924|NCT03611075|449422013|FG001|Overall Study|Withdrawal by Subject|1|||
124943925|NCT03611075|449422014|FG002|Overall Study|Withdrawal by Subject|1|||
124943926|NCT03611075|449422015|FG003|Overall Study|Withdrawal by Subject|1|||
124943927|NCT03611075|449422016|FG004|Overall Study|Withdrawal by Subject|0|||
124943928|NCT03611075|449422017|FG005|Overall Study|Withdrawal by Subject|0|||
124943929|NCT03611075|449422018|FG006|Overall Study|Withdrawal by Subject|1|||
124943930|NCT03611075|449422019|FG007|Overall Study|Withdrawal by Subject|0|||
124943931|NCT03611075|449422020|FG008|Overall Study|Withdrawal by Subject|0|||
124943932|NCT03611075|449422012|FG000|Overall Study|Reason unknown|0|||
124943933|NCT03611075|449422013|FG001|Overall Study|Reason unknown|0|||
124943934|NCT03611075|449422014|FG002|Overall Study|Reason unknown|0|||
124943935|NCT03611075|449422015|FG003|Overall Study|Reason unknown|1|||
124943936|NCT03611075|449422016|FG004|Overall Study|Reason unknown|0|||
124943937|NCT03611075|449422017|FG005|Overall Study|Reason unknown|0|||
124943938|NCT03611075|449422018|FG006|Overall Study|Reason unknown|1|||
124943939|NCT03611075|449422019|FG007|Overall Study|Reason unknown|0|||
124943940|NCT03611075|449422020|FG008|Overall Study|Reason unknown|0|||
124943941|NCT00676091|449422021|FG000|Infant Series|Parent or legal guardian request|10|||
124943942|NCT00676091|449422022|FG001|Infant Series|Parent or legal guardian request|8|||
124943943|NCT00676091|449422021|FG000|Infant Series|Protocol Violation|6|||
124943944|NCT00676091|449422022|FG001|Infant Series|Protocol Violation|3|||
124943945|NCT00676091|449422021|FG000|Infant Series|Adverse Event|2|||
124705769|NCT01559935|448548490|FG000|Car Phase|Toxicity|4|||
124705770|NCT01559935|448548490|FG000|Car Phase|Death|1|||
124705771|NCT01559935|448548490|FG000|Car Phase|Lack of Efficacy|2|||
124705772|NCT01559935|448548490|FG000|Car Phase|Lost to Follow-up|1|||
124705773|NCT01559935|448548490|FG000|Car Phase|Physician Decision|1|||
124705774|NCT01559935|448548490|FG000|Car Phase|Withdrawal by Subject|2|||
124705775|NCT01559935|448548490|FG000|Car Phase|Per protocol|1|||
124705776|NCT01559935|448548490|FG000|Car Phase|Insurance|1|||
124705777|NCT01559935|448548490|FG000|Car Phase|non-compliance|1|||
124765275|NCT02587520|448767362|FG000|Overall Study|Lost to Follow-up|0|||
124943946|NCT00676091|449422022|FG001|Infant Series|Adverse Event|3|||
124943947|NCT00676091|449422021|FG000|Infant Series|Failed to return|1|||
124943948|NCT00676091|449422022|FG001|Infant Series|Failed to return|3|||
124943949|NCT00676091|449422021|FG000|Infant Series|Lost to Follow-up|1|||
124943950|NCT00676091|449422022|FG001|Infant Series|Lost to Follow-up|0|||
124943951|NCT00676091|449422021|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
124943952|NCT00676091|449422022|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
124943953|NCT00676091|449422021|FG000|After Infant Series|Adverse Event|0|||
124943954|NCT00676091|449422022|FG001|After Infant Series|Adverse Event|1|||
124943955|NCT00676091|449422021|FG000|After Infant Series|Protocol Violation|0|||
124943956|NCT00676091|449422022|FG001|After Infant Series|Protocol Violation|1|||
124943957|NCT00676091|449422021|FG000|After Infant Series|Failed to return|1|||
124943958|NCT00676091|449422022|FG001|After Infant Series|Failed to return|1|||
124943959|NCT00676091|449422021|FG000|Toddler Dose|Failed to return|2|||
124943960|NCT00676091|449422022|FG001|Toddler Dose|Failed to return|0|||
124943961|NCT00676091|449422021|FG000|Toddler Dose|Parent or legal guardian request|1|||
124943962|NCT00676091|449422022|FG001|Toddler Dose|Parent or legal guardian request|0|||
124943963|NCT01701401|449422026|FG000|Overall Study|Randomized But Not Treated|3|||
124943964|NCT01701401|449422027|FG001|Overall Study|Randomized But Not Treated|1|||
124943965|NCT01701401|449422028|FG002|Overall Study|Randomized But Not Treated|0|||
124943966|NCT01701401|449422029|FG003|Overall Study|Randomized But Not Treated|1|||
124943967|NCT01701401|449422026|FG000|Overall Study|Lost to Follow-up|5|||
124943968|NCT01701401|449422027|FG001|Overall Study|Lost to Follow-up|5|||
124943969|NCT01701401|449422028|FG002|Overall Study|Lost to Follow-up|1|||
124943970|NCT01701401|449422029|FG003|Overall Study|Lost to Follow-up|3|||
124943971|NCT01701401|449422026|FG000|Overall Study|Withdrew Consent|0|||
124943972|NCT01701401|449422027|FG001|Overall Study|Withdrew Consent|3|||
124943973|NCT01701401|449422028|FG002|Overall Study|Withdrew Consent|1|||
124943974|NCT01701401|449422029|FG003|Overall Study|Withdrew Consent|2|||
124547956|NCT00905437|447960357|FG001|Overall Study|Lost to Follow-up|1|||
124943975|NCT01701401|449422026|FG000|Overall Study|Lack of Efficacy|1|||
124705778|NCT01559935|448548490|FG000|BiRD Phase|Toxicity|1|||
124943976|NCT01701401|449422027|FG001|Overall Study|Lack of Efficacy|0|||
124943977|NCT01701401|449422028|FG002|Overall Study|Lack of Efficacy|2|||
124943978|NCT01701401|449422029|FG003|Overall Study|Lack of Efficacy|0|||
124943979|NCT01701401|449422026|FG000|Overall Study|Adverse Event|1|||
124943980|NCT01701401|449422027|FG001|Overall Study|Adverse Event|0|||
124943981|NCT01701401|449422028|FG002|Overall Study|Adverse Event|0|||
124705779|NCT01559935|448548490|FG000|BiRD Phase|Lack of Efficacy|1|||
124705780|NCT01559935|448548490|FG000|BiRD Phase|Withdrawal by Subject|2|||
124943982|NCT01701401|449422029|FG003|Overall Study|Adverse Event|0|||
124943983|NCT01701401|449422026|FG000|Overall Study|Protocol Violation|0|||
124943984|NCT01701401|449422027|FG001|Overall Study|Protocol Violation|0|||
124943985|NCT01701401|449422028|FG002|Overall Study|Protocol Violation|1|||
124943986|NCT01701401|449422029|FG003|Overall Study|Protocol Violation|0|||
124943987|NCT00933270|449422030|FG000|Overall Study|Withdrawal by Subject|26|||
124943988|NCT00933270|449422030|FG000|Overall Study|Insufficient Follow-up|10|||
124943989|NCT00933270|449422030|FG000|Overall Study|Lost to Follow-up|14|||
124943990|NCT00933270|449422030|FG000|Overall Study|Adverse Event|1|||
124943991|NCT00933270|449422030|FG000|Overall Study|Missed Visit|2|||
124943992|NCT00933270|449422030|FG000|Overall Study|Death|24|||
124943993|NCT00933270|449422030|FG000|Overall Study|Moved or would not return|10|||
124943994|NCT01000805|449422031|FG000|Overall Study|Adverse Event|21|||
124943995|NCT01000805|449422032|FG001|Overall Study|Adverse Event|9|||
124943996|NCT01000805|449422031|FG000|Overall Study|Lack of Efficacy|5|||
124943997|NCT01000805|449422032|FG001|Overall Study|Lack of Efficacy|16|||
124943998|NCT01000805|449422031|FG000|Overall Study|Lost to Follow-up|16|||
124943999|NCT01000805|449422032|FG001|Overall Study|Lost to Follow-up|21|||
124944000|NCT01000805|449422031|FG000|Overall Study|Physician Decision|0|||
124944001|NCT01000805|449422032|FG001|Overall Study|Physician Decision|1|||
124944002|NCT01000805|449422031|FG000|Overall Study|Protocol Violation|12|||
124944003|NCT01000805|449422032|FG001|Overall Study|Protocol Violation|8|||
124944004|NCT01000805|449422031|FG000|Overall Study|Withdrawal by Subject|16|||
124944005|NCT01000805|449422032|FG001|Overall Study|Withdrawal by Subject|6|||
124944006|NCT01000805|449422031|FG000|Overall Study|Sponsor Decision|0|||
124944007|NCT01000805|449422032|FG001|Overall Study|Sponsor Decision|1|||
124944008|NCT00989196|449422033|FG000|Treatment Period|Lost to Follow-up|1|||
124944009|NCT00989196|449422034|FG001|Treatment Period|Lost to Follow-up|0|||
124944010|NCT02409680|449422035|FG000|Overall Study|Lost to Follow-up|15|||
124944011|NCT02409680|449422036|FG001|Overall Study|Lost to Follow-up|30|||
124944012|NCT03343704|449422040|FG000|Overall Study|Refused to complete follow up|0|||
124944013|NCT03343704|449422041|FG001|Overall Study|Refused to complete follow up|1|||
124944014|NCT03343704|449422040|FG000|Overall Study|Death|0|||
124944015|NCT03343704|449422041|FG001|Overall Study|Death|1|||
124944016|NCT03343704|449422040|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
124944017|NCT03343704|449422041|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
124944018|NCT03789656|449422046|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
124944019|NCT03789656|449422047|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
124944020|NCT03789656|449422048|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
124944021|NCT03789656|449422049|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
124944022|NCT03789656|449422050|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
124944023|NCT03789656|449422046|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
124944024|NCT03789656|449422047|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
124944025|NCT03789656|449422048|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
124944026|NCT03789656|449422049|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
124944027|NCT03789656|449422050|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
124944028|NCT03789656|449422046|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
124944029|NCT03789656|449422047|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
124944030|NCT03789656|449422048|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
124944031|NCT03789656|449422049|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
124944032|NCT03789656|449422050|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
124944033|NCT03789656|449422046|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
124944034|NCT03789656|449422047|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
124944035|NCT03789656|449422048|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
124944036|NCT03789656|449422049|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
124944037|NCT03789656|449422050|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
124944038|NCT02434328|449422058|FG000|Overall Study|Adverse Event|9|||
124944039|NCT02434328|449422059|FG001|Overall Study|Adverse Event|4|||
124944040|NCT02434328|449422058|FG000|Overall Study|Lack of Efficacy|0|||
124944041|NCT02434328|449422059|FG001|Overall Study|Lack of Efficacy|2|||
124944042|NCT02434328|449422058|FG000|Overall Study|Physician Decision|0|||
124458413|NCT00705783|447638208|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
124458414|NCT00705783|447638209|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
124458415|NCT00705783|447638210|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
124458416|NCT00705783|447638208|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
124458417|NCT00705783|447638209|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
124458418|NCT00705783|447638210|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
124765276|NCT02587520|448767363|FG001|Overall Study|Lost to Follow-up|2|||
124944043|NCT02434328|449422059|FG001|Overall Study|Physician Decision|1|||
124944044|NCT02434328|449422058|FG000|Overall Study|Withdrawal by Subject|12|||
124944045|NCT02434328|449422059|FG001|Overall Study|Withdrawal by Subject|21|||
124765277|NCT02587520|448767364|FG002|Overall Study|Lost to Follow-up|0|||
124944046|NCT02434328|449422058|FG000|Overall Study|Death|4|||
124944047|NCT02434328|449422059|FG001|Overall Study|Death|7|||
124944048|NCT02434328|449422058|FG000|Overall Study|Lost to Follow-up|1|||
124944049|NCT02434328|449422059|FG001|Overall Study|Lost to Follow-up|6|||
124944050|NCT02434328|449422058|FG000|Overall Study|Other|4|||
124944051|NCT02434328|449422059|FG001|Overall Study|Other|1|||
124944052|NCT00302211|449422066|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
124944053|NCT00302211|449422067|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
124944054|NCT00302211|449422068|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
124547957|NCT00905437|447960356|FG000|Overall Study|Withdrawal by Subject|0|||
124547958|NCT00905437|447960357|FG001|Overall Study|Withdrawal by Subject|1|||
124547959|NCT00905437|447960356|FG000|Overall Study|Other|5|||
124547960|NCT00905437|447960357|FG001|Overall Study|Other|6|||
124547961|NCT03128931|447960360|FG000|Overall Study|Physician Decision|1|||
124547962|NCT03128931|447960360|FG000|Overall Study|Equipment Issues|3|||
124944055|NCT00302211|449422069|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
124944056|NCT00302211|449422070|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
124944057|NCT00302211|449422066|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
124944058|NCT00302211|449422067|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
124944059|NCT00302211|449422068|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
124547963|NCT03252015|447960361|FG000|Overall Study|Withdrawal by Subject|0|||
124547964|NCT03252015|447960362|FG001|Overall Study|Withdrawal by Subject|1|||
124547965|NCT03252015|447960363|FG002|Overall Study|Withdrawal by Subject|1|||
124547966|NCT03252015|447960364|FG003|Overall Study|Withdrawal by Subject|0|||
124944060|NCT00302211|449422069|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
124944061|NCT00302211|449422070|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
124944062|NCT00302211|449422066|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
124944063|NCT00302211|449422067|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
124547967|NCT03252015|447960361|FG000|Overall Study|Adverse Event|1|||
124944064|NCT00302211|449422068|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
124944065|NCT00302211|449422069|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
124944066|NCT00302211|449422070|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
124944067|NCT00302211|449422066|FG000|Double Blind Period (New Patients)|Disease progression|0|||
124944068|NCT00302211|449422067|FG001|Double Blind Period (New Patients)|Disease progression|1|||
124944069|NCT00302211|449422068|FG002|Double Blind Period (New Patients)|Disease progression|1|||
124944070|NCT00302211|449422069|FG003|Double Blind Period (New Patients)|Disease progression|0|||
124944071|NCT00302211|449422070|FG004|Double Blind Period (New Patients)|Disease progression|0|||
124944072|NCT00302211|449422066|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
124944073|NCT00302211|449422067|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
124547968|NCT03252015|447960362|FG001|Overall Study|Adverse Event|0|||
124944074|NCT00302211|449422068|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
124944075|NCT00302211|449422069|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
124944076|NCT00302211|449422070|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
124944077|NCT00302211|449422066|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
124944078|NCT00302211|449422067|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
124944079|NCT00302211|449422068|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
124944080|NCT00302211|449422069|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
124944081|NCT00302211|449422070|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
124944082|NCT00302211|449422066|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
124944083|NCT00302211|449422067|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
124944084|NCT00302211|449422068|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
124944085|NCT00302211|449422069|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
124944086|NCT00302211|449422070|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
124944087|NCT00302211|449422066|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
124944088|NCT00302211|449422067|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
124944089|NCT00302211|449422068|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
124944090|NCT00302211|449422069|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
124944091|NCT00302211|449422070|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
124944092|NCT00302211|449422066|FG000|Open Label-Patients From Double-Blind|Death|0|||
124944093|NCT00302211|449422067|FG001|Open Label-Patients From Double-Blind|Death|0|||
124944094|NCT00302211|449422068|FG002|Open Label-Patients From Double-Blind|Death|0|||
124944095|NCT00302211|449422069|FG003|Open Label-Patients From Double-Blind|Death|1|||
124944096|NCT00302211|449422070|FG004|Open Label-Patients From Double-Blind|Death|1|||
124944097|NCT00302211|449422066|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
124944098|NCT00302211|449422067|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
124944099|NCT00302211|449422068|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
124944100|NCT00302211|449422069|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
124944101|NCT00302211|449422070|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
124944102|NCT00302211|449422066|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
124944103|NCT00302211|449422067|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
124944104|NCT00302211|449422068|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
124944105|NCT00302211|449422069|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
124944106|NCT00302211|449422070|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
124944107|NCT00302211|449422066|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
124944108|NCT00302211|449422067|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
124944109|NCT00302211|449422068|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
124944110|NCT00302211|449422069|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
124944111|NCT00302211|449422070|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
124944112|NCT02294461|449422071|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
124944113|NCT02294461|449422072|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
124944114|NCT02294461|449422073|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
124944115|NCT02294461|449422071|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
124944116|NCT02294461|449422072|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
124944117|NCT02294461|449422073|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
124944118|NCT02294461|449422071|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
124944119|NCT02294461|449422072|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
124944120|NCT02294461|449422073|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
124944121|NCT02294461|449422071|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
124944122|NCT02294461|449422072|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
124944123|NCT02294461|449422073|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
124944124|NCT02294461|449422071|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
124944125|NCT02294461|449422072|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
124944126|NCT02294461|449422073|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
124944127|NCT02294461|449422071|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
124944128|NCT02294461|449422072|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
124944129|NCT02294461|449422073|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
124944130|NCT02294461|449422071|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
124944131|NCT02294461|449422072|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
124944132|NCT02294461|449422073|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
124944133|NCT02294461|449422071|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
124944134|NCT02294461|449422072|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
124944135|NCT02294461|449422073|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
124944136|NCT02294461|449422071|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
124944137|NCT02294461|449422072|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
124944138|NCT02294461|449422073|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
124944139|NCT02294461|449422071|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
124944140|NCT02294461|449422072|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
124944141|NCT02294461|449422073|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
124944142|NCT02294461|449422071|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
124705781|NCT01559935|448548490|FG000|Maintenance Phase|Remains on study|28|||
124765278|NCT02587520|448767365|FG003|Overall Study|Lost to Follow-up|2|||
124765279|NCT02587520|448767366|FG004|Overall Study|Lost to Follow-up|0|||
124765280|NCT02587520|448767367|FG005|Overall Study|Lost to Follow-up|1|||
124765281|NCT02587520|448767368|FG006|Overall Study|Lost to Follow-up|1|||
124765282|NCT02587520|448767369|FG007|Overall Study|Lost to Follow-up|1|||
124765283|NCT02587520|448767370|FG008|Overall Study|Lost to Follow-up|0|||
124765284|NCT02587520|448767371|FG009|Overall Study|Lost to Follow-up|2|||
124765285|NCT02587520|448767372|FG010|Overall Study|Lost to Follow-up|2|||
124765286|NCT02587520|448767373|FG011|Overall Study|Lost to Follow-up|1|||
124765287|NCT02587520|448767374|FG012|Overall Study|Lost to Follow-up|0|||
124765288|NCT02587520|448767375|FG013|Overall Study|Lost to Follow-up|0|||
124944143|NCT02294461|449422072|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
124705782|NCT01559935|448548490|FG000|Maintenance Phase|Toxicity|1|||
124705783|NCT01559935|448548490|FG000|Maintenance Phase|Lack of Efficacy|18|||
124705784|NCT01559935|448548490|FG000|Maintenance Phase|Withdrawal by Subject|5|||
124705785|NCT01559935|448548490|FG000|Maintenance Phase|Non-compliance|2|||
124705786|NCT02958865|448548491|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
124705787|NCT02958865|448548492|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
124705788|NCT02958865|448548493|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
124705789|NCT02958865|448548494|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
124705790|NCT02958865|448548495|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
124705791|NCT02958865|448548496|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
124705792|NCT02958865|448548497|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
124705793|NCT02958865|448548498|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
124705794|NCT02958865|448548499|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
124705795|NCT02958865|448548500|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
124705796|NCT02958865|448548501|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
124705797|NCT02958865|448548502|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
124705798|NCT02958865|448548503|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
124705799|NCT02958865|448548504|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
124705800|NCT02958865|448548505|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
124705801|NCT02958865|448548506|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
124705802|NCT02958865|448548491|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
124705803|NCT02958865|448548492|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
124705804|NCT02958865|448548493|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
124705805|NCT02958865|448548494|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
124705806|NCT02958865|448548495|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
124705807|NCT02958865|448548496|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
124705808|NCT02958865|448548497|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
124705809|NCT02958865|448548498|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
124705810|NCT02958865|448548499|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
124705811|NCT02958865|448548500|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
124705812|NCT02958865|448548501|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
124705813|NCT02958865|448548502|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
124705814|NCT02958865|448548503|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
124705815|NCT02958865|448548504|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
124705816|NCT02958865|448548505|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
124705817|NCT02958865|448548506|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
124705818|NCT02958865|448548491|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
124705819|NCT02958865|448548492|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
124944144|NCT02294461|449422073|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
124944145|NCT02294461|449422071|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
124944146|NCT02294461|449422072|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
124944147|NCT02294461|449422073|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
124944148|NCT02294461|449422071|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
124765289|NCT02587520|448767376|FG014|Overall Study|Lost to Follow-up|0|||
124705820|NCT02958865|448548493|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
124705821|NCT02958865|448548494|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
124705822|NCT02958865|448548495|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
124705823|NCT02958865|448548496|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
124705824|NCT02958865|448548497|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
124705825|NCT02958865|448548498|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
124705826|NCT02958865|448548499|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
124765290|NCT02587520|448767377|FG015|Overall Study|Lost to Follow-up|0|||
124765291|NCT02587520|448767378|FG016|Overall Study|Lost to Follow-up|0|||
124765292|NCT02587520|448767379|FG017|Overall Study|Lost to Follow-up|0|||
124765293|NCT01751061|448767380|FG000|Overall Study|Death|1|||
124944149|NCT02294461|449422072|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
124705827|NCT02958865|448548500|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
124705828|NCT02958865|448548501|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
124705829|NCT02958865|448548502|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
124705830|NCT02958865|448548503|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
124944150|NCT02294461|449422073|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
124944151|NCT02294461|449422071|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
124944152|NCT02294461|449422072|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
124944153|NCT02294461|449422073|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
124944154|NCT05432986|449422074|FG000|Overall Study|Withdrawal by Subject|2|||
124944155|NCT05432986|449422074|FG000|Overall Study|incomplete measurement|7|||
124944156|NCT03009344|449423147|FG000|Overall Study|Lack of Efficacy|5|||
124944157|NCT03009344|449423147|FG000|Overall Study|Withdrawal by Subject|1|||
124944158|NCT03009344|449423147|FG000|Overall Study|Adverse Event|1|||
124944159|NCT00378898|449423148|FG000|Overall Study|Withdrawal by Subject|10|||
124944160|NCT00378898|449423149|FG001|Overall Study|Withdrawal by Subject|5|||
124944161|NCT00378898|449423148|FG000|Overall Study|Protocol Violation|1|||
124944162|NCT00378898|449423149|FG001|Overall Study|Protocol Violation|1|||
124944163|NCT02534233|449423152|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
124944164|NCT00551421|449423153|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
124944165|NCT03136159|449423155|FG000|Overall Study|chorioamnionitis|2|||
124944166|NCT03136159|449423156|FG001|Overall Study|chorioamnionitis|0|||
124944167|NCT03136159|449423155|FG000|Overall Study|vertical skin incision|1|||
124944168|NCT03136159|449423156|FG001|Overall Study|vertical skin incision|0|||
124944169|NCT03136159|449423155|FG000|Overall Study|additional dressing|1|||
124944170|NCT03136159|449423156|FG001|Overall Study|additional dressing|0|||
124944171|NCT03136159|449423155|FG000|Overall Study|never got dressing placed|1|||
124944172|NCT03136159|449423156|FG001|Overall Study|never got dressing placed|0|||
124944173|NCT01732757|449423158|FG000|Overall Study|Lost to Follow-up|1|||
124944174|NCT01732757|449423159|FG001|Overall Study|Lost to Follow-up|0|||
124944175|NCT01732757|449423160|FG002|Overall Study|Lost to Follow-up|0|||
124944176|NCT00089609|449423166|FG000|Overall Study|Withdrawal by Subject|3|||
124944177|NCT00089609|449423167|FG001|Overall Study|Withdrawal by Subject|1|||
124944178|NCT03116464|449423168|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
124944179|NCT00597376|449423169|FG000|Overall Study|Withdrawal by Subject|4|||
124944180|NCT00597376|449423170|FG001|Overall Study|Withdrawal by Subject|3|||
124944181|NCT00597376|449423169|FG000|Overall Study|Adverse Event|4|||
124944182|NCT00597376|449423170|FG001|Overall Study|Adverse Event|1|||
124944183|NCT04693637|449423175|FG000|Overall Study|Death|4|||
124944184|NCT04693637|449423175|FG000|Overall Study|Withdrawal by Subject|3|||
124944185|NCT04693637|449423175|FG000|Overall Study|Physician Decision|2|||
124944186|NCT04693637|449423175|FG000|Overall Study|Lost to Follow-up|1|||
124944187|NCT04237792|449423176|FG000|Treatment (Day 1)|Adverse Event|1|||
124944188|NCT04237792|449423177|FG001|Treatment (Day 1)|Adverse Event|0|||
124944189|NCT04237792|449423178|FG002|Treatment (Day 1)|Adverse Event|0|||
124944190|NCT04237792|449423179|FG003|Treatment (Day 1)|Adverse Event|0|||
124705831|NCT02958865|448548504|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
124705832|NCT02958865|448548505|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
124705833|NCT02958865|448548506|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
124705834|NCT02958865|448548491|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
124705835|NCT02958865|448548492|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124705836|NCT02958865|448548493|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
124705837|NCT02958865|448548494|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
124705838|NCT02958865|448548495|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
124705839|NCT02958865|448548496|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
124705840|NCT02958865|448548497|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
124705841|NCT02958865|448548498|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124705842|NCT02958865|448548499|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124705843|NCT02958865|448548500|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124705844|NCT02958865|448548501|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124705845|NCT02958865|448548502|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124705846|NCT02958865|448548503|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124705847|NCT02958865|448548504|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124765294|NCT01751061|448767381|FG001|Overall Study|Death|0|||
124765295|NCT01751061|448767380|FG000|Overall Study|patient death|5|||
124944191|NCT04237792|449423180|FG004|Treatment (Day 1)|Adverse Event|1|||
124944192|NCT04237792|449423181|FG005|Treatment (Day 1)|Adverse Event|1|||
124944193|NCT04237792|449423176|FG000|Treatment (Day 1)|Other|0|||
124944194|NCT04237792|449423177|FG001|Treatment (Day 1)|Other|0|||
124944195|NCT04237792|449423178|FG002|Treatment (Day 1)|Other|1|||
124944196|NCT04237792|449423179|FG003|Treatment (Day 1)|Other|0|||
124944197|NCT04237792|449423180|FG004|Treatment (Day 1)|Other|0|||
124944198|NCT04237792|449423181|FG005|Treatment (Day 1)|Other|1|||
124944199|NCT04237792|449423176|FG000|Treatment (Day 1)|Not treated|1|||
124944200|NCT04237792|449423177|FG001|Treatment (Day 1)|Not treated|1|||
124944201|NCT04237792|449423178|FG002|Treatment (Day 1)|Not treated|2|||
124944202|NCT04237792|449423179|FG003|Treatment (Day 1)|Not treated|1|||
124944203|NCT04237792|449423180|FG004|Treatment (Day 1)|Not treated|0|||
124944204|NCT04237792|449423181|FG005|Treatment (Day 1)|Not treated|1|||
124944205|NCT03205566|449423184|FG000|Phase 1|Protocol Violation|1|||
124944206|NCT03205566|449423185|FG001|Phase 1|Protocol Violation|1|||
124944207|NCT02022670|449423186|FG000|Overall Study|Adverse Event|1|||
124944208|NCT02022670|449423187|FG001|Overall Study|Adverse Event|0|||
124944209|NCT02022670|449423188|FG002|Overall Study|Adverse Event|1|||
124944210|NCT02113449|449423189|FG000|Overall Study|Adverse Event|4|||
124944211|NCT01957163|449423192|FG000|Overall Study|Adverse Event|5|||
124944212|NCT01957163|449423193|FG001|Overall Study|Adverse Event|2|||
124944213|NCT01957163|449423194|FG002|Overall Study|Adverse Event|4|||
124944214|NCT01957163|449423192|FG000|Overall Study|Lack of Efficacy|5|||
124944215|NCT01957163|449423193|FG001|Overall Study|Lack of Efficacy|4|||
124944216|NCT01957163|449423194|FG002|Overall Study|Lack of Efficacy|9|||
124944217|NCT01957163|449423192|FG000|Overall Study|Protocol Violation|1|||
124944218|NCT01957163|449423193|FG001|Overall Study|Protocol Violation|2|||
124944219|NCT01957163|449423194|FG002|Overall Study|Protocol Violation|0|||
124944220|NCT01957163|449423192|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
124944221|NCT01957163|449423193|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
124944222|NCT01957163|449423194|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
124944223|NCT01957163|449423192|FG000|Overall Study|Lost to Follow-up|0|||
124944224|NCT01957163|449423193|FG001|Overall Study|Lost to Follow-up|1|||
124944225|NCT01957163|449423194|FG002|Overall Study|Lost to Follow-up|0|||
124944226|NCT01957163|449423192|FG000|Overall Study|Withdrawal by Subject|4|||
124944227|NCT01957163|449423193|FG001|Overall Study|Withdrawal by Subject|2|||
124944228|NCT01957163|449423194|FG002|Overall Study|Withdrawal by Subject|4|||
124705848|NCT02958865|448548505|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124944229|NCT03697603|449423195|FG000|Overall Study|Adverse Event|3|||
124944230|NCT03697603|449423196|FG001|Overall Study|Adverse Event|18|||
124944231|NCT03697603|449423197|FG002|Overall Study|Adverse Event|3|||
124944232|NCT03697603|449423195|FG000|Overall Study|Physician Decision|1|||
124944233|NCT03697603|449423196|FG001|Overall Study|Physician Decision|0|||
124944234|NCT03697603|449423197|FG002|Overall Study|Physician Decision|2|||
124944235|NCT03697603|449423195|FG000|Overall Study|Protocol Violation|3|||
124944236|NCT03697603|449423196|FG001|Overall Study|Protocol Violation|8|||
124944237|NCT03697603|449423197|FG002|Overall Study|Protocol Violation|5|||
124944238|NCT03697603|449423195|FG000|Overall Study|Withdrawal by Subject|5|||
124944239|NCT03697603|449423196|FG001|Overall Study|Withdrawal by Subject|1|||
124944240|NCT03697603|449423197|FG002|Overall Study|Withdrawal by Subject|1|||
124944241|NCT03697603|449423195|FG000|Overall Study|Protocol Violation|0|||
124944242|NCT03697603|449423196|FG001|Overall Study|Protocol Violation|0|||
124944243|NCT03697603|449423197|FG002|Overall Study|Protocol Violation|1|||
124944244|NCT02686658|449423198|FG000|Overall Study|Adverse Event|0|||
124944245|NCT02686658|449423199|FG001|Overall Study|Adverse Event|0|||
124944246|NCT02686658|449423200|FG002|Overall Study|Adverse Event|1|||
124944247|NCT02686658|449423201|FG003|Overall Study|Adverse Event|1|||
124547969|NCT03252015|447960363|FG002|Overall Study|Adverse Event|0|||
124547970|NCT03252015|447960364|FG003|Overall Study|Adverse Event|1|||
124547971|NCT01329562|447960365|FG000|Overall Study|Protocol Violation|5|||
124547972|NCT01329562|447960366|FG001|Overall Study|Protocol Violation|3|||
124547973|NCT01329562|447960365|FG000|Overall Study|Lost to Follow-up|1|||
124547974|NCT01329562|447960366|FG001|Overall Study|Lost to Follow-up|1|||
124547975|NCT01329562|447960365|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
124547976|NCT01329562|447960366|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
124547977|NCT01329562|447960365|FG000|Overall Study|Physician Decision|0|||
124547978|NCT01329562|447960366|FG001|Overall Study|Physician Decision|1|||
124547979|NCT00061568|447960369|FG000|Overall Study|Lost to Follow-up|12|||
124547980|NCT00061568|447960370|FG001|Overall Study|Lost to Follow-up|0|||
124547981|NCT00061568|447960369|FG000|Overall Study|Death|6|||
124944248|NCT02686658|449423202|FG004|Overall Study|Adverse Event|2|||
124944249|NCT02686658|449423203|FG005|Overall Study|Adverse Event|1|||
124944250|NCT02686658|449423198|FG000|Overall Study|Investigator decision|0|||
124944251|NCT02686658|449423199|FG001|Overall Study|Investigator decision|0|||
124944252|NCT02686658|449423200|FG002|Overall Study|Investigator decision|0|||
124944253|NCT02686658|449423201|FG003|Overall Study|Investigator decision|1|||
124944254|NCT02686658|449423202|FG004|Overall Study|Investigator decision|2|||
124944255|NCT02686658|449423203|FG005|Overall Study|Investigator decision|1|||
124944256|NCT02686658|449423198|FG000|Overall Study|Sponsor decision|1|||
124944257|NCT02686658|449423199|FG001|Overall Study|Sponsor decision|2|||
124944258|NCT02686658|449423200|FG002|Overall Study|Sponsor decision|1|||
124944259|NCT02686658|449423201|FG003|Overall Study|Sponsor decision|5|||
124944260|NCT02686658|449423202|FG004|Overall Study|Sponsor decision|13|||
124944261|NCT02686658|449423203|FG005|Overall Study|Sponsor decision|2|||
124944262|NCT02686658|449423198|FG000|Overall Study|Lost to Follow-up|0|||
124944263|NCT02686658|449423199|FG001|Overall Study|Lost to Follow-up|0|||
124944264|NCT02686658|449423200|FG002|Overall Study|Lost to Follow-up|2|||
124944265|NCT02686658|449423201|FG003|Overall Study|Lost to Follow-up|0|||
124944266|NCT02686658|449423202|FG004|Overall Study|Lost to Follow-up|0|||
124944267|NCT02686658|449423203|FG005|Overall Study|Lost to Follow-up|1|||
124944268|NCT02686658|449423198|FG000|Overall Study|Death|1|||
124944269|NCT02686658|449423199|FG001|Overall Study|Death|0|||
124944270|NCT02686658|449423200|FG002|Overall Study|Death|0|||
124944271|NCT02686658|449423201|FG003|Overall Study|Death|1|||
124944272|NCT02686658|449423202|FG004|Overall Study|Death|1|||
124944273|NCT02686658|449423203|FG005|Overall Study|Death|1|||
124944274|NCT02686658|449423198|FG000|Overall Study|Withdrawal by Subject|2|||
124944275|NCT02686658|449423199|FG001|Overall Study|Withdrawal by Subject|5|||
124944276|NCT02686658|449423200|FG002|Overall Study|Withdrawal by Subject|4|||
124944277|NCT02686658|449423201|FG003|Overall Study|Withdrawal by Subject|4|||
124944278|NCT02686658|449423202|FG004|Overall Study|Withdrawal by Subject|17|||
124944279|NCT02686658|449423203|FG005|Overall Study|Withdrawal by Subject|8|||
124944280|NCT02686658|449423198|FG000|Overall Study|Placed in hospice care|0|||
124944281|NCT02686658|449423199|FG001|Overall Study|Placed in hospice care|0|||
124944282|NCT02686658|449423200|FG002|Overall Study|Placed in hospice care|1|||
124944283|NCT02686658|449423201|FG003|Overall Study|Placed in hospice care|0|||
124944284|NCT02686658|449423202|FG004|Overall Study|Placed in hospice care|0|||
124547982|NCT00061568|447960370|FG001|Overall Study|Death|0|||
124944285|NCT02686658|449423203|FG005|Overall Study|Placed in hospice care|0|||
124944286|NCT02686658|449423198|FG000|Overall Study|Participant non-compliance|0|||
124944287|NCT02686658|449423199|FG001|Overall Study|Participant non-compliance|0|||
124944288|NCT02686658|449423200|FG002|Overall Study|Participant non-compliance|0|||
124944289|NCT02686658|449423201|FG003|Overall Study|Participant non-compliance|0|||
124944290|NCT02686658|449423202|FG004|Overall Study|Participant non-compliance|0|||
124944291|NCT02686658|449423203|FG005|Overall Study|Participant non-compliance|1|||
124944292|NCT02686658|449423198|FG000|Overall Study|Concern over coronavirus disease care|0|||
124944293|NCT02686658|449423199|FG001|Overall Study|Concern over coronavirus disease care|0|||
124944294|NCT02686658|449423200|FG002|Overall Study|Concern over coronavirus disease care|0|||
124944295|NCT02686658|449423201|FG003|Overall Study|Concern over coronavirus disease care|0|||
124547983|NCT00061568|447960369|FG000|Overall Study|Withdrawal by Subject|1|||
124547984|NCT00061568|447960370|FG001|Overall Study|Withdrawal by Subject|0|||
124944296|NCT02686658|449423202|FG004|Overall Study|Concern over coronavirus disease care|2|||
124944297|NCT02686658|449423203|FG005|Overall Study|Concern over coronavirus disease care|1|||
124944298|NCT00467272|449423204|FG000|Overall Study|Pneumonia|2|||
124944299|NCT00467272|449423204|FG000|Overall Study|Thrombophlebitis|1|||
124944300|NCT00570505|449423205|FG000|Overall Study|Adverse Event|7|||
124944301|NCT00570505|449423205|FG000|Overall Study|Withdrawal by Subject|7|||
124944302|NCT00570505|449423205|FG000|Overall Study|Lost to Follow-up|23|||
124944303|NCT00570505|449423205|FG000|Overall Study|Other loss to follow-up|4|||
124944304|NCT00614614|449423208|FG000|Primary Vaccination Phase|Adverse Event|6|||
124944305|NCT00614614|449423209|FG001|Primary Vaccination Phase|Adverse Event|0|||
124944306|NCT00614614|449423210|FG002|Primary Vaccination Phase|Adverse Event|0|||
124944307|NCT00614614|449423211|FG003|Primary Vaccination Phase|Adverse Event|0|||
124944308|NCT00614614|449423212|FG004|Primary Vaccination Phase|Adverse Event|0|||
124944309|NCT00614614|449423208|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
124944310|NCT00614614|449423209|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
124944311|NCT00614614|449423210|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
124944312|NCT00614614|449423211|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
124944313|NCT00614614|449423212|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
124944314|NCT00614614|449423208|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
124944315|NCT00614614|449423209|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
124944316|NCT00614614|449423210|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
124944317|NCT00614614|449423211|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
124944318|NCT00614614|449423212|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
124944319|NCT00614614|449423208|FG000|Primary Vaccination Phase|Protocol Violation|9|||
124944320|NCT00614614|449423209|FG001|Primary Vaccination Phase|Protocol Violation|3|||
124458419|NCT00705783|447638208|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
124458420|NCT00705783|447638209|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
124458421|NCT00705783|447638210|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
124458422|NCT00705783|447638208|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
124458423|NCT00705783|447638209|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
124458424|NCT00705783|447638210|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
124458425|NCT00705783|447638208|FG000|Oral Stabilization Phase|Adverse Event|14|||
124458426|NCT00705783|447638209|FG001|Oral Stabilization Phase|Adverse Event|0|||
124458427|NCT00705783|447638210|FG002|Oral Stabilization Phase|Adverse Event|0|||
124458428|NCT00705783|447638208|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
124458429|NCT00705783|447638209|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
124458430|NCT00705783|447638210|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
124458431|NCT00705783|447638208|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
124458432|NCT00705783|447638209|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
124458433|NCT00705783|447638210|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
124458434|NCT00705783|447638208|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
124458435|NCT00705783|447638209|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
124458436|NCT00705783|447638210|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
124458437|NCT00705783|447638208|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
124458438|NCT00705783|447638209|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
124458439|NCT00705783|447638210|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
124458440|NCT00705783|447638208|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
124458441|NCT00705783|447638209|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
124458442|NCT00705783|447638210|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
124458443|NCT00705783|447638208|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
124458444|NCT00705783|447638209|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
124458445|NCT00705783|447638210|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
124458446|NCT00705783|447638208|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
124547985|NCT01071278|447960374|FG000|Overall Study|Premature Discontinuation|254|||
124705849|NCT02958865|448548506|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124712017|NCT00800735|448570712|FG000|Overall Study|Insufficient Therapeutic Response|2|||
124458447|NCT00705783|447638209|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
124944321|NCT00614614|449423210|FG002|Primary Vaccination Phase|Protocol Violation|0|||
124944322|NCT00614614|449423211|FG003|Primary Vaccination Phase|Protocol Violation|0|||
124944323|NCT00614614|449423212|FG004|Primary Vaccination Phase|Protocol Violation|0|||
124944324|NCT00614614|449423208|FG000|Primary Vaccination Phase|Other|4|||
124944325|NCT00614614|449423209|FG001|Primary Vaccination Phase|Other|0|||
124944326|NCT00614614|449423210|FG002|Primary Vaccination Phase|Other|0|||
124705850|NCT02958865|448548491|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
124705851|NCT02958865|448548492|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
124705852|NCT02958865|448548493|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
124458448|NCT00705783|447638210|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
124458449|NCT00705783|447638208|FG000|Depot Stabilization Phase|Adverse Event|17|||
124458450|NCT00705783|447638209|FG001|Depot Stabilization Phase|Adverse Event|0|||
124458451|NCT00705783|447638210|FG002|Depot Stabilization Phase|Adverse Event|0|||
124458452|NCT00705783|447638208|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
124458453|NCT00705783|447638209|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
124944327|NCT00614614|449423211|FG003|Primary Vaccination Phase|Other|0|||
124944328|NCT00614614|449423212|FG004|Primary Vaccination Phase|Other|0|||
124944329|NCT00614614|449423208|FG000|Booster Vaccination Phase|Adverse Event|0|||
124944330|NCT00614614|449423209|FG001|Booster Vaccination Phase|Adverse Event|0|||
124944331|NCT00614614|449423210|FG002|Booster Vaccination Phase|Adverse Event|1|||
124944332|NCT00614614|449423211|FG003|Booster Vaccination Phase|Adverse Event|1|||
124944333|NCT00614614|449423212|FG004|Booster Vaccination Phase|Adverse Event|0|||
124944334|NCT00614614|449423208|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
124944335|NCT00614614|449423209|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
124944336|NCT00614614|449423210|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
124944337|NCT00614614|449423211|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
124944338|NCT00614614|449423212|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
124944339|NCT00614614|449423208|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
124944340|NCT00614614|449423209|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
124944341|NCT00614614|449423210|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
124944342|NCT00614614|449423211|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
124944343|NCT00614614|449423212|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
124944344|NCT00614614|449423208|FG000|Booster Vaccination Phase|Protocol Violation|0|||
124944345|NCT00614614|449423209|FG001|Booster Vaccination Phase|Protocol Violation|0|||
124944346|NCT00614614|449423210|FG002|Booster Vaccination Phase|Protocol Violation|2|||
124944347|NCT00614614|449423211|FG003|Booster Vaccination Phase|Protocol Violation|3|||
124944348|NCT00614614|449423212|FG004|Booster Vaccination Phase|Protocol Violation|0|||
124944349|NCT00614614|449423208|FG000|Booster Vaccination Phase|Other|0|||
124944350|NCT00614614|449423209|FG001|Booster Vaccination Phase|Other|1|||
124944351|NCT00614614|449423210|FG002|Booster Vaccination Phase|Other|3|||
124944352|NCT00614614|449423211|FG003|Booster Vaccination Phase|Other|2|||
124944353|NCT00614614|449423212|FG004|Booster Vaccination Phase|Other|1|||
124944354|NCT05212285|449423213|FG000|Overall Study|Lack of Efficacy|12|||
124944355|NCT05212285|449423214|FG001|Overall Study|Lack of Efficacy|8|||
124944356|NCT05212285|449423213|FG000|Overall Study|Withdrawal by Subject|8|||
124944357|NCT05212285|449423214|FG001|Overall Study|Withdrawal by Subject|1|||
124944358|NCT05212285|449423213|FG000|Overall Study|Lost to Follow-up|13|||
124944359|NCT05212285|449423214|FG001|Overall Study|Lost to Follow-up|1|||
124944360|NCT05212285|449423213|FG000|Overall Study|miss data|21|||
124944361|NCT05212285|449423214|FG001|Overall Study|miss data|2|||
124944362|NCT03924869|449423218|FG000|Overall Study|Death|66|||
124944363|NCT03924869|449423219|FG001|Overall Study|Death|53|||
124944364|NCT03924869|449423218|FG000|Overall Study|Lost to Follow-up|2|||
124944365|NCT03924869|449423219|FG001|Overall Study|Lost to Follow-up|0|||
124944366|NCT03924869|449423218|FG000|Overall Study|Physician Decision|0|||
124944367|NCT03924869|449423219|FG001|Overall Study|Physician Decision|3|||
124944368|NCT03924869|449423218|FG000|Overall Study|Withdrawal by Subject|5|||
124944369|NCT03924869|449423219|FG001|Overall Study|Withdrawal by Subject|1|||
124944370|NCT03924869|449423218|FG000|Overall Study|Participants Ongoing|154|||
124944371|NCT03924869|449423219|FG001|Overall Study|Participants Ongoing|164|||
124458454|NCT00705783|447638210|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
124458455|NCT00705783|447638208|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
124458456|NCT00705783|447638209|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
124458457|NCT00705783|447638210|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
124458458|NCT00705783|447638208|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
124458459|NCT00705783|447638209|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
124458460|NCT00705783|447638210|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
124458461|NCT00705783|447638208|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
124458462|NCT00705783|447638209|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
124458463|NCT00705783|447638210|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
124458464|NCT00705783|447638208|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
124458465|NCT00705783|447638209|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
124458466|NCT00705783|447638210|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
124458467|NCT00705783|447638208|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
124458468|NCT00705783|447638209|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
124458469|NCT00705783|447638210|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
124458470|NCT00705783|447638208|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
124458471|NCT00705783|447638209|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
124458472|NCT00705783|447638210|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
124458473|NCT00705783|447638208|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
124944372|NCT02542943|449423220|FG000|Overall Study|Lost to Follow-up|1|||
124944373|NCT02542943|449423221|FG001|Overall Study|Lost to Follow-up|0|||
124944374|NCT02542943|449423222|FG002|Overall Study|Lost to Follow-up|0|||
124944375|NCT02542943|449423220|FG000|Overall Study|Withdrawal by Subject|0|||
124944376|NCT02542943|449423221|FG001|Overall Study|Withdrawal by Subject|1|||
124944377|NCT02542943|449423222|FG002|Overall Study|Withdrawal by Subject|0|||
124944378|NCT03476798|449423228|FG000|Overall Study|Death|1|||
124944379|NCT03476798|449423228|FG000|Overall Study|Withdrawal by Subject|2|||
124944380|NCT03476798|449423228|FG000|Overall Study|Protocol Violation|2|||
124547986|NCT01071278|447960374|FG000|Overall Study|Completion Status Unknown|459|||
124547987|NCT00903409|447960375|FG000|Overall Study|Adverse Event|11|||
124547988|NCT00903409|447960376|FG001|Overall Study|Adverse Event|9|||
124547989|NCT00903409|447960375|FG000|Overall Study|Non-compliance with Protocol|1|||
124547990|NCT00903409|447960376|FG001|Overall Study|Non-compliance with Protocol|1|||
124547991|NCT00903409|447960375|FG000|Overall Study|Laboratory Abnormality|2|||
124944381|NCT05824559|449423229|FG000|Overall Study|Adverse Event|2|||
124944382|NCT05824559|449423229|FG000|Overall Study|Physician Decision|2|||
124944383|NCT05824559|449423229|FG000|Overall Study|Progressive Disease|16|||
124944384|NCT05824559|449423229|FG000|Overall Study|Study Terminated by Sponsor|1|||
124944385|NCT05824559|449423229|FG000|Overall Study|Withdrawal by Subject|2|||
124944386|NCT04602728|449423239|FG000|Overall Study|Lost to Follow-up|4|||
124944387|NCT04602728|449423240|FG001|Overall Study|Lost to Follow-up|4|||
124944388|NCT05865392|449423241|FG000|Overall Study|Withdrawal by Subject|4|||
124944389|NCT05865392|449423242|FG001|Overall Study|Withdrawal by Subject|0|||
124944390|NCT05865392|449423241|FG000|Overall Study|Didn't meet inclusion criteria|4|||
124944391|NCT05865392|449423242|FG001|Overall Study|Didn't meet inclusion criteria|0|||
124944392|NCT05366751|449423245|FG000|Overall Study|Adverse Event|25|||
124944393|NCT05366751|449423245|FG000|Overall Study|Physician Decision|3|||
124944394|NCT05366751|449423245|FG000|Overall Study|Lost to Follow-up|2|||
124944395|NCT05366751|449423245|FG000|Overall Study|Withdrawal by Subject|14|||
124944396|NCT05366751|449423245|FG000|Overall Study|Study Terminated by Sponsor|50|||
124944397|NCT05366751|449423245|FG000|Overall Study|Site Terminated by Sponsor|3|||
124944398|NCT04937504|449423246|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
124944399|NCT04937504|449423247|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
124944400|NCT04937504|449423246|FG000|9 Months Assessment|Lost to Follow-up|3|||
124944401|NCT04937504|449423247|FG001|9 Months Assessment|Lost to Follow-up|2|||
124944402|NCT04118894|449423248|FG000|Overall Study|Lost to Follow-up|21|||
124944403|NCT04118894|449423248|FG000|Overall Study|Withdrawal by Subject|10|||
124944404|NCT04118894|449423248|FG000|Overall Study|Adverse Event|4|||
124944405|NCT02634307|449424270|FG000|Overall Study|Adverse Event|50|||
124944406|NCT02634307|449424271|FG001|Overall Study|Adverse Event|24|||
124944407|NCT02634307|449424272|FG002|Overall Study|Adverse Event|14|||
124944408|NCT02634307|449424270|FG000|Overall Study|Lost to Follow-up|21|||
124944409|NCT02634307|449424271|FG001|Overall Study|Lost to Follow-up|5|||
124944410|NCT02634307|449424272|FG002|Overall Study|Lost to Follow-up|6|||
124944411|NCT02634307|449424270|FG000|Overall Study|Pregnancy|5|||
124944412|NCT02634307|449424271|FG001|Overall Study|Pregnancy|1|||
124944413|NCT02634307|449424272|FG002|Overall Study|Pregnancy|3|||
124944414|NCT02634307|449424270|FG000|Overall Study|Withdrawal by Subject|38|||
124944415|NCT02634307|449424271|FG001|Overall Study|Withdrawal by Subject|24|||
124944416|NCT02634307|449424272|FG002|Overall Study|Withdrawal by Subject|18|||
124944417|NCT02634307|449424270|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124944418|NCT02634307|449424271|FG001|Overall Study|Non-Compliance with Study Drug|2|||
124944419|NCT02634307|449424272|FG002|Overall Study|Non-Compliance with Study Drug|2|||
124944420|NCT02634307|449424270|FG000|Overall Study|Lack of Efficacy|1|||
124944421|NCT02634307|449424271|FG001|Overall Study|Lack of Efficacy|5|||
124944422|NCT02634307|449424272|FG002|Overall Study|Lack of Efficacy|3|||
124944423|NCT02634307|449424270|FG000|Overall Study|Physician Decision|7|||
124944424|NCT02634307|449424271|FG001|Overall Study|Physician Decision|5|||
124944425|NCT02634307|449424272|FG002|Overall Study|Physician Decision|5|||
124944426|NCT02634307|449424270|FG000|Overall Study|Reason not Specified|3|||
124944427|NCT02634307|449424271|FG001|Overall Study|Reason not Specified|5|||
124705853|NCT02958865|448548494|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
124705854|NCT02958865|448548495|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
124705855|NCT02958865|448548496|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
124705856|NCT02958865|448548497|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
124705857|NCT02958865|448548498|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
124944428|NCT02634307|449424272|FG002|Overall Study|Reason not Specified|10|||
124944429|NCT02698475|449424273|FG000|Main Study Period|Lack of Efficacy|1|||
124944430|NCT02698475|449424273|FG000|Main Study Period|Protocol Violation|2|||
124944431|NCT02698475|449424273|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
124944432|NCT02698475|449424273|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
124944433|NCT02698475|449424273|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
124944434|NCT02698475|449424273|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
124944435|NCT02698475|449424273|FG000|Long-Term Extension Period|Other|1|||
124944436|NCT02132949|449424274|FG000|Overall Study|Death|7|||
124944437|NCT02132949|449424275|FG001|Overall Study|Death|13|||
124944438|NCT02132949|449424274|FG000|Overall Study|Lost to Follow-up|14|||
124944439|NCT02132949|449424275|FG001|Overall Study|Lost to Follow-up|4|||
124944440|NCT02132949|449424274|FG000|Overall Study|Withdrawal by Subject|6|||
124944441|NCT02132949|449424275|FG001|Overall Study|Withdrawal by Subject|5|||
124944442|NCT02132949|449424274|FG000|Overall Study|Noncompliance|5|||
124944443|NCT02132949|449424275|FG001|Overall Study|Noncompliance|1|||
124944444|NCT02132949|449424274|FG000|Overall Study|Physician Decision|3|||
124944445|NCT02132949|449424275|FG001|Overall Study|Physician Decision|1|||
124944446|NCT02132949|449424274|FG000|Overall Study|Disease Progression|3|||
124944447|NCT02132949|449424275|FG001|Overall Study|Disease Progression|0|||
124944448|NCT02132949|449424274|FG000|Overall Study|Adverse Event|2|||
124944449|NCT02132949|449424275|FG001|Overall Study|Adverse Event|1|||
124944450|NCT02132949|449424274|FG000|Overall Study|Withdrew Prior to Treatment|1|||
124944451|NCT02132949|449424275|FG001|Overall Study|Withdrew Prior to Treatment|2|||
124944452|NCT02132949|449424274|FG000|Overall Study|Reason Unspecified|0|||
124944453|NCT02132949|449424275|FG001|Overall Study|Reason Unspecified|1|||
124944454|NCT01823224|449424276|FG000|Overall Study|Lost to Follow-up|5|||
124944455|NCT01823224|449424277|FG001|Overall Study|Lost to Follow-up|6|||
124944456|NCT01823224|449424276|FG000|Overall Study|didn't qualify|1|||
124944457|NCT01823224|449424277|FG001|Overall Study|didn't qualify|2|||
124944458|NCT01823224|449424276|FG000|Overall Study|pharmacy error|0|||
124944459|NCT01823224|449424277|FG001|Overall Study|pharmacy error|1|||
124944460|NCT01823224|449424276|FG000|Overall Study|missed med dose|0|||
124944461|NCT01823224|449424277|FG001|Overall Study|missed med dose|1|||
124944462|NCT01823224|449424276|FG000|Overall Study|Withdrawal by Subject|0|||
124944463|NCT01823224|449424277|FG001|Overall Study|Withdrawal by Subject|1|||
124944464|NCT00745875|449424283|FG000|Overall Study|Continuing study treatment|4|||
124944465|NCT00745875|449424284|FG001|Overall Study|Continuing study treatment|4|||
124944466|NCT01532648|449424285|FG000|Overall Study|Lost to Follow-up|3|||
124944467|NCT01532648|449424286|FG001|Overall Study|Lost to Follow-up|4|||
124944468|NCT01532648|449424285|FG000|Overall Study|Lack of Efficacy|4|||
124944469|NCT01532648|449424286|FG001|Overall Study|Lack of Efficacy|1|||
124944470|NCT01532648|449424285|FG000|Overall Study|Protocol Violation|1|||
124944471|NCT01532648|449424286|FG001|Overall Study|Protocol Violation|1|||
124944472|NCT01532648|449424285|FG000|Overall Study|Adverse Event|12|||
124944473|NCT01532648|449424286|FG001|Overall Study|Adverse Event|9|||
124944474|NCT01532648|449424285|FG000|Overall Study|Withdrawal by Subject|16|||
124944475|NCT01532648|449424286|FG001|Overall Study|Withdrawal by Subject|2|||
124944476|NCT02310581|449424287|FG000|Overall Study|Adverse Event|1|||
124944477|NCT02310581|449424288|FG001|Overall Study|Adverse Event|1|||
124944478|NCT02310581|449424289|FG002|Overall Study|Adverse Event|1|||
124944479|NCT02310581|449424290|FG003|Overall Study|Adverse Event|0|||
124944480|NCT02310581|449424287|FG000|Overall Study|Withdrawal by Subject|2|||
124944481|NCT02310581|449424288|FG001|Overall Study|Withdrawal by Subject|1|||
124944482|NCT02310581|449424289|FG002|Overall Study|Withdrawal by Subject|0|||
124944483|NCT02310581|449424290|FG003|Overall Study|Withdrawal by Subject|1|||
124944484|NCT01737021|449424291|FG000|Overall Study|Lost to Follow-up|5|||
124944485|NCT01737021|449424292|FG001|Overall Study|Lost to Follow-up|3|||
124944486|NCT04652869|449424293|FG000|Overall Study|Withdrawal by Subject|0|||
124944487|NCT04652869|449424294|FG001|Overall Study|Withdrawal by Subject|2|||
124944488|NCT04652869|449424295|FG002|Overall Study|Withdrawal by Subject|0|||
124944489|NCT04658784|449424300|FG000|6-month Follow-up|Lost to Follow-up|2|||
124944490|NCT04658784|449424301|FG001|6-month Follow-up|Lost to Follow-up|5|||
124944491|NCT02095145|449424303|FG000|Overall Study|Withdrawal by Subject|1|||
124944492|NCT02095145|449424304|FG001|Overall Study|Withdrawal by Subject|0|||
124944493|NCT02630186|449424305|FG000|Overall Study|Withdrawal by Subject|1|||
124944494|NCT01034306|449424314|FG000|Overall Study|Adverse Event|1|||
124944495|NCT01034306|449424315|FG001|Overall Study|Adverse Event|0|||
124944496|NCT01034306|449424314|FG000|Overall Study|Lost to Follow-up|0|||
124944497|NCT01034306|449424315|FG001|Overall Study|Lost to Follow-up|1|||
124944498|NCT01034306|449424314|FG000|Overall Study|Withdrawal by Subject|2|||
124944499|NCT01034306|449424315|FG001|Overall Study|Withdrawal by Subject|2|||
124944500|NCT01034306|449424314|FG000|Overall Study|hospitalized and decided to stop|1|||
124944501|NCT01034306|449424315|FG001|Overall Study|hospitalized and decided to stop|0|||
124944502|NCT01034306|449424314|FG000|Overall Study|Noncomplience|1|||
124944503|NCT01034306|449424315|FG001|Overall Study|Noncomplience|0|||
124944504|NCT00836498|449424316|FG000|Overall Study|Adverse Event|1|||
124944505|NCT00836498|449424317|FG001|Overall Study|Adverse Event|0|||
124944506|NCT00836498|449424316|FG000|Overall Study|Lost to Follow-up|1|||
124944507|NCT00836498|449424317|FG001|Overall Study|Lost to Follow-up|0|||
124944508|NCT00836498|449424316|FG000|Overall Study|Withdrawal by Subject|2|||
124944509|NCT00836498|449424317|FG001|Overall Study|Withdrawal by Subject|1|||
124944510|NCT01619059|449424318|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
124944511|NCT01619059|449424319|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
124944512|NCT01619059|449424318|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
124944513|NCT01619059|449424319|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
124944514|NCT01619059|449424318|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
124944515|NCT01619059|449424319|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
124944516|NCT01619059|449424318|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
124944517|NCT01619059|449424319|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
124944518|NCT01619059|449424318|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
124944519|NCT01619059|449424319|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
124944520|NCT01619059|449424318|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
124944521|NCT01619059|449424319|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
124944522|NCT01619059|449424318|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
124944523|NCT01619059|449424319|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
124944524|NCT01619059|449424318|FG000|Long-Term (LT) Treatment Period|Death|1|||
124944525|NCT01619059|449424319|FG001|Long-Term (LT) Treatment Period|Death|0|||
124944526|NCT01619059|449424318|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
124944527|NCT01619059|449424319|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
124944528|NCT01619059|449424318|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
124944529|NCT01619059|449424319|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
124944530|NCT03418545|449424320|FG000|Overall Study|Withdrawal by Participant|2|||
124944531|NCT03418545|449424321|FG001|Overall Study|Withdrawal by Participant|4|||
124944532|NCT03418545|449424320|FG000|Overall Study|Lost to Follow-up|3|||
124944533|NCT03418545|449424321|FG001|Overall Study|Lost to Follow-up|5|||
124944534|NCT03418545|449424320|FG000|Overall Study|Reason Not Specified|0|||
124944535|NCT03418545|449424321|FG001|Overall Study|Reason Not Specified|1|||
124944536|NCT03418545|449424320|FG000|Overall Study|Missing Completion Status|0|||
124944537|NCT03418545|449424321|FG001|Overall Study|Missing Completion Status|1|||
124944538|NCT02384382|449424329|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
124944539|NCT02384382|449424329|FG000|Overall Study|Death|1|||
124944540|NCT02384382|449424329|FG000|Overall Study|Adverse Event|1|||
124944541|NCT02384382|449424329|FG000|Overall Study|Disease progression|16|||
124944542|NCT01074242|449424338|FG000|Overall Study|Case report before date of contract|40|||
124944543|NCT01074242|449424338|FG000|Overall Study|Lost to Follow-up|1|||
124944544|NCT01074242|449424338|FG000|Overall Study|Case report unclear|6|||
124944545|NCT01074242|449424338|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
124944546|NCT01074242|449424338|FG000|Overall Study|Duplicate Case Report Form|5|||
124944547|NCT03567616|449424339|FG000|Overall Study|Disease progression|4|||
124944548|NCT03567616|449424339|FG000|Overall Study|Withdrawal by Subject|1|||
124944549|NCT03567616|449424339|FG000|Overall Study|Physician Decision|1|||
124944550|NCT03567616|449424339|FG000|Overall Study|Death|1|||
124944551|NCT03567616|449424339|FG000|Overall Study|Adverse Event|1|||
124944552|NCT04447027|449424354|FG000|Dose Escalation|Withdrawal by Subject|1|||
124944553|NCT04447027|449424355|FG001|Dose Escalation|Withdrawal by Subject|4|||
124944554|NCT04447027|449424356|FG002|Dose Escalation|Withdrawal by Subject|3|||
124944555|NCT04447027|449424357|FG003|Dose Escalation|Withdrawal by Subject|3|||
124944556|NCT04447027|449424358|FG004|Dose Escalation|Withdrawal by Subject|1|||
124944557|NCT04447027|449424359|FG005|Dose Escalation|Withdrawal by Subject|0|||
124944558|NCT04447027|449424360|FG006|Dose Escalation|Withdrawal by Subject|0|||
124944559|NCT04447027|449424361|FG007|Dose Escalation|Withdrawal by Subject|0|||
124765296|NCT01751061|448767381|FG001|Overall Study|patient death|0|||
124944560|NCT04447027|449424362|FG008|Dose Escalation|Withdrawal by Subject|0|||
124944561|NCT04447027|449424354|FG000|Dose Escalation|Refused further treatment|0|||
124944562|NCT04447027|449424355|FG001|Dose Escalation|Refused further treatment|1|||
124944563|NCT04447027|449424356|FG002|Dose Escalation|Refused further treatment|1|||
124944564|NCT04447027|449424357|FG003|Dose Escalation|Refused further treatment|0|||
124944565|NCT04447027|449424358|FG004|Dose Escalation|Refused further treatment|0|||
124944566|NCT04447027|449424359|FG005|Dose Escalation|Refused further treatment|0|||
124944567|NCT04447027|449424360|FG006|Dose Escalation|Refused further treatment|0|||
124944568|NCT04447027|449424361|FG007|Dose Escalation|Refused further treatment|0|||
124944569|NCT04447027|449424362|FG008|Dose Escalation|Refused further treatment|0|||
124944570|NCT04447027|449424354|FG000|Dose Expansion|Withdrawal by Subject|0|||
124944571|NCT04447027|449424355|FG001|Dose Expansion|Withdrawal by Subject|0|||
124944572|NCT04447027|449424356|FG002|Dose Expansion|Withdrawal by Subject|0|||
124944573|NCT04447027|449424357|FG003|Dose Expansion|Withdrawal by Subject|0|||
124944574|NCT04447027|449424358|FG004|Dose Expansion|Withdrawal by Subject|0|||
124944575|NCT04447027|449424359|FG005|Dose Expansion|Withdrawal by Subject|2|||
124944576|NCT04447027|449424360|FG006|Dose Expansion|Withdrawal by Subject|0|||
124944577|NCT04447027|449424361|FG007|Dose Expansion|Withdrawal by Subject|2|||
124944578|NCT04447027|449424362|FG008|Dose Expansion|Withdrawal by Subject|0|||
124944579|NCT02831049|449424363|FG000|Overall Study|Lost to Follow-up|0|||
124944580|NCT02831049|449424364|FG001|Overall Study|Lost to Follow-up|0|||
124944581|NCT02831049|449424365|FG002|Overall Study|Lost to Follow-up|1|||
124944582|NCT02831049|449424363|FG000|Overall Study|Withdrawal by Subject|0|||
124944583|NCT02831049|449424364|FG001|Overall Study|Withdrawal by Subject|1|||
124944584|NCT02831049|449424365|FG002|Overall Study|Withdrawal by Subject|1|||
124944585|NCT02831049|449424363|FG000|Overall Study|Pandemic shutdown|1|||
124944586|NCT02831049|449424364|FG001|Overall Study|Pandemic shutdown|0|||
124944587|NCT02831049|449424365|FG002|Overall Study|Pandemic shutdown|0|||
124944588|NCT04224272|449424366|FG000|Part 1 - Dose Finding|Death|4|||
124944589|NCT04224272|449424366|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
124944590|NCT04224272|449424366|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
124944591|NCT04224272|449424366|FG000|Part 2 - Dose Expansion|Death|10|||
124944592|NCT04224272|449424366|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
124944593|NCT02609048|449424367|FG000|Overall Study|Adverse Event|3|||
124944594|NCT02609048|449424368|FG001|Overall Study|Adverse Event|0|||
124944595|NCT02609048|449424369|FG002|Overall Study|Adverse Event|0|||
124944596|NCT02609048|449424367|FG000|Overall Study|Randomized but never treated|1|||
124944597|NCT02609048|449424368|FG001|Overall Study|Randomized but never treated|1|||
124944598|NCT02609048|449424369|FG002|Overall Study|Randomized but never treated|1|||
124944599|NCT02609048|449424367|FG000|Overall Study|Withdrawal of informed consent|1|||
124944600|NCT02609048|449424368|FG001|Overall Study|Withdrawal of informed consent|0|||
124944601|NCT02609048|449424369|FG002|Overall Study|Withdrawal of informed consent|0|||
124944602|NCT02609048|449424367|FG000|Overall Study|Reason not specified|6|||
124944603|NCT02609048|449424368|FG001|Overall Study|Reason not specified|9|||
124944604|NCT02609048|449424369|FG002|Overall Study|Reason not specified|9|||
124944605|NCT02485925|449424370|FG000|Overall Study|Withdrawal by Subject|3|||
124944606|NCT02485925|449424370|FG000|Overall Study|Death|1|||
124944607|NCT02485925|449424370|FG000|Overall Study|Lost to Follow-up|11|||
124944608|NCT05995977|449424371|FG000|Overall Study|Withdrawal by Subject|1|||
124944609|NCT05995977|449424372|FG001|Overall Study|Withdrawal by Subject|4|||
124944610|NCT05995977|449424371|FG000|Overall Study|Lost to Follow-up|2|||
124944611|NCT05995977|449424372|FG001|Overall Study|Lost to Follow-up|0|||
124944612|NCT04181788|449424373|FG000|TREATMENT|Adverse Event|0|||
124944613|NCT04181788|449424374|FG001|TREATMENT|Adverse Event|2|||
124944614|NCT04181788|449424375|FG002|TREATMENT|Adverse Event|1|||
124944615|NCT04181788|449424376|FG003|TREATMENT|Adverse Event|0|||
124944616|NCT04181788|449424377|FG004|TREATMENT|Adverse Event|1|||
124944617|NCT04181788|449424378|FG005|TREATMENT|Adverse Event|3|||
124944618|NCT04181788|449424373|FG000|TREATMENT|Death|0|||
124944619|NCT04181788|449424374|FG001|TREATMENT|Death|0|||
124944620|NCT04181788|449424375|FG002|TREATMENT|Death|0|||
124944621|NCT04181788|449424376|FG003|TREATMENT|Death|0|||
124944622|NCT04181788|449424377|FG004|TREATMENT|Death|8|||
124944623|NCT04181788|449424378|FG005|TREATMENT|Death|8|||
124944624|NCT04181788|449424373|FG000|TREATMENT|Physician Decision|0|||
124944625|NCT04181788|449424374|FG001|TREATMENT|Physician Decision|0|||
124944626|NCT04181788|449424375|FG002|TREATMENT|Physician Decision|0|||
124944627|NCT04181788|449424376|FG003|TREATMENT|Physician Decision|0|||
124944628|NCT04181788|449424377|FG004|TREATMENT|Physician Decision|0|||
124944629|NCT04181788|449424378|FG005|TREATMENT|Physician Decision|1|||
124944630|NCT04181788|449424373|FG000|TREATMENT|Progressive disease|3|||
124944631|NCT04181788|449424374|FG001|TREATMENT|Progressive disease|3|||
124944632|NCT04181788|449424375|FG002|TREATMENT|Progressive disease|5|||
124944633|NCT04181788|449424376|FG003|TREATMENT|Progressive disease|7|||
124944634|NCT04181788|449424377|FG004|TREATMENT|Progressive disease|20|||
124944635|NCT04181788|449424378|FG005|TREATMENT|Progressive disease|38|||
124944636|NCT04181788|449424373|FG000|TREATMENT|Global deterioration of health status|0|||
124944637|NCT04181788|449424374|FG001|TREATMENT|Global deterioration of health status|2|||
124944638|NCT04181788|449424375|FG002|TREATMENT|Global deterioration of health status|0|||
124944639|NCT04181788|449424376|FG003|TREATMENT|Global deterioration of health status|0|||
124944640|NCT04181788|449424377|FG004|TREATMENT|Global deterioration of health status|2|||
124944641|NCT04181788|449424378|FG005|TREATMENT|Global deterioration of health status|8|||
124944642|NCT04181788|449424373|FG000|TREATMENT|Withdrawal by Subject|1|||
124944643|NCT04181788|449424374|FG001|TREATMENT|Withdrawal by Subject|2|||
124944644|NCT04181788|449424375|FG002|TREATMENT|Withdrawal by Subject|0|||
124944645|NCT04181788|449424376|FG003|TREATMENT|Withdrawal by Subject|0|||
124944646|NCT04181788|449424377|FG004|TREATMENT|Withdrawal by Subject|3|||
124944647|NCT04181788|449424378|FG005|TREATMENT|Withdrawal by Subject|5|||
124547992|NCT00903409|447960376|FG001|Overall Study|Laboratory Abnormality|0|||
124547993|NCT00903409|447960375|FG000|Overall Study|Withdrawal by Subject|8|||
124547994|NCT00903409|447960376|FG001|Overall Study|Withdrawal by Subject|8|||
124547995|NCT00903409|447960375|FG000|Overall Study|Other|2|||
124547996|NCT00903409|447960376|FG001|Overall Study|Other|3|||
124547997|NCT00903409|447960375|FG000|Overall Study|Lost to Follow-up|2|||
124547998|NCT00903409|447960376|FG001|Overall Study|Lost to Follow-up|6|||
124547999|NCT00797316|447960377|FG000|Overall Study|Administrative problems|1|||
124705858|NCT02958865|448548499|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
124705859|NCT02958865|448548500|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
124705860|NCT02958865|448548501|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
124705861|NCT02958865|448548502|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
124705862|NCT02958865|448548503|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
124705863|NCT02958865|448548504|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
124705864|NCT02958865|448548505|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
124705865|NCT02958865|448548506|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
124705866|NCT02958865|448548491|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
124705867|NCT02958865|448548492|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
124705868|NCT02958865|448548493|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
124705869|NCT02958865|448548494|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
124944648|NCT04181788|449424373|FG000|TREATMENT|Other unspecified|0|||
124944649|NCT04181788|449424374|FG001|TREATMENT|Other unspecified|0|||
124944650|NCT04181788|449424375|FG002|TREATMENT|Other unspecified|0|||
124944651|NCT04181788|449424376|FG003|TREATMENT|Other unspecified|0|||
124944652|NCT04181788|449424377|FG004|TREATMENT|Other unspecified|0|||
124944653|NCT04181788|449424378|FG005|TREATMENT|Other unspecified|2|||
124944654|NCT04181788|449424373|FG000|TREATMENT|Ongoing|0|||
124944655|NCT04181788|449424374|FG001|TREATMENT|Ongoing|3|||
124944656|NCT04181788|449424375|FG002|TREATMENT|Ongoing|0|||
124944657|NCT04181788|449424376|FG003|TREATMENT|Ongoing|5|||
124944658|NCT04181788|449424377|FG004|TREATMENT|Ongoing|7|||
124944659|NCT04181788|449424378|FG005|TREATMENT|Ongoing|15|||
124944660|NCT04181788|449424373|FG000|FOLLOW-UP|Death|0|||
124944661|NCT04181788|449424374|FG001|FOLLOW-UP|Death|0|||
124944662|NCT04181788|449424375|FG002|FOLLOW-UP|Death|1|||
124944663|NCT04181788|449424376|FG003|FOLLOW-UP|Death|2|||
124944664|NCT04181788|449424377|FG004|FOLLOW-UP|Death|8|||
124944665|NCT04181788|449424378|FG005|FOLLOW-UP|Death|20|||
124944666|NCT04181788|449424373|FG000|FOLLOW-UP|Lost to Follow-up|0|||
124944667|NCT04181788|449424374|FG001|FOLLOW-UP|Lost to Follow-up|0|||
124944668|NCT04181788|449424375|FG002|FOLLOW-UP|Lost to Follow-up|0|||
124944669|NCT04181788|449424376|FG003|FOLLOW-UP|Lost to Follow-up|0|||
124944670|NCT04181788|449424377|FG004|FOLLOW-UP|Lost to Follow-up|0|||
124944671|NCT04181788|449424378|FG005|FOLLOW-UP|Lost to Follow-up|2|||
124944672|NCT04181788|449424373|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
124944673|NCT04181788|449424374|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
124944674|NCT04181788|449424375|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
124944675|NCT04181788|449424376|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
124944676|NCT04181788|449424377|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
124944677|NCT04181788|449424378|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
124944678|NCT04181788|449424373|FG000|FOLLOW-UP|Other unspecified|0|||
124944679|NCT04181788|449424374|FG001|FOLLOW-UP|Other unspecified|1|||
124944680|NCT04181788|449424375|FG002|FOLLOW-UP|Other unspecified|0|||
124944681|NCT04181788|449424376|FG003|FOLLOW-UP|Other unspecified|0|||
124944682|NCT04181788|449424377|FG004|FOLLOW-UP|Other unspecified|0|||
124944683|NCT04181788|449424378|FG005|FOLLOW-UP|Other unspecified|3|||
124944684|NCT04181788|449424373|FG000|FOLLOW-UP|Ongoing|0|||
124944685|NCT04181788|449424374|FG001|FOLLOW-UP|Ongoing|0|||
124944686|NCT04181788|449424375|FG002|FOLLOW-UP|Ongoing|1|||
124944687|NCT04181788|449424376|FG003|FOLLOW-UP|Ongoing|3|||
124944688|NCT04181788|449424377|FG004|FOLLOW-UP|Ongoing|2|||
124944689|NCT04181788|449424378|FG005|FOLLOW-UP|Ongoing|2|||
124944690|NCT04535414|449424379|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
124944691|NCT04535414|449424380|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
124944692|NCT04535414|449424379|FG000|Overall Study|Cancelled appointment|1|||
124548000|NCT00797316|447960378|FG001|Overall Study|Administrative problems|0|||
124548001|NCT00797316|447960377|FG000|Overall Study|Adverse Event|5|||
124548002|NCT00797316|447960378|FG001|Overall Study|Adverse Event|3|||
124548003|NCT00797316|447960377|FG000|Overall Study|Lost to Follow-up|4|||
124548004|NCT00797316|447960378|FG001|Overall Study|Lost to Follow-up|8|||
124548005|NCT00797316|447960377|FG000|Overall Study|Protocol Deviation|1|||
124548006|NCT00797316|447960378|FG001|Overall Study|Protocol Deviation|2|||
124548007|NCT00797316|447960377|FG000|Overall Study|Patient withdrew consent|12|||
124548008|NCT00797316|447960378|FG001|Overall Study|Patient withdrew consent|6|||
124548009|NCT00797316|447960377|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124548010|NCT00797316|447960378|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
124548011|NCT03239340|447960381|FG000|Overall Study|Other|26|||
124548012|NCT03239340|447960381|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
124548013|NCT03239340|447960381|FG000|Overall Study|Death|40|||
124548014|NCT03239340|447960381|FG000|Overall Study|Lost to Follow-up|2|||
124548015|NCT03239340|447960381|FG000|Overall Study|Physician Decision|16|||
124548016|NCT03239340|447960381|FG000|Overall Study|Withdrawal by Subject|27|||
124548017|NCT04066894|447960385|FG000|Overall Study|Lack of Efficacy|1|||
124548018|NCT04066894|447960385|FG000|Overall Study|Screen Failure|1|||
124548019|NCT03494816|447960386|FG000|Overall Study|Protocol Violation|2|||
124548020|NCT03494816|447960386|FG000|Overall Study|Physician Decision|2|||
124548021|NCT03494816|447960386|FG000|Overall Study|Did not start trial treatment|1|||
124548022|NCT03494816|447960386|FG000|Overall Study|Adverse Event|1|||
124548023|NCT00314262|447960387|FG000|Overall Study|Adverse Event|2|||
124548024|NCT00314262|447960387|FG000|Overall Study|Withdrawal by Subject|2|||
124548025|NCT00314262|447960387|FG000|Overall Study|Physician Decision|1|||
124548026|NCT01126359|447960388|FG000|First Intervention (20-minutes)|Physician Decision|0|||
124548027|NCT01126359|447960389|FG001|First Intervention (20-minutes)|Physician Decision|1|||
124548028|NCT00902486|447960390|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
124548029|NCT00902486|447960391|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
124548030|NCT00902486|447960392|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
124548031|NCT00902486|447960393|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
124548032|NCT00902486|447960394|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
124548033|NCT00902486|447960395|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
124548034|NCT00902486|447960390|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
124548035|NCT00902486|447960391|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
124944693|NCT04535414|449424380|FG001|Overall Study|Cancelled appointment|0|||
124944694|NCT04535414|449424379|FG000|Overall Study|cancelled - food in stomach|2|||
124944695|NCT04535414|449424380|FG001|Overall Study|cancelled - food in stomach|0|||
124944696|NCT04535414|449424379|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
124944697|NCT04535414|449424380|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
124944698|NCT04535414|449424379|FG000|Overall Study|Withdrawal by Subject|0|||
124944699|NCT04535414|449424380|FG001|Overall Study|Withdrawal by Subject|1|||
124944700|NCT03662659|449424381|FG000|Pre-treatment|Participant no longer met study criteria|1|||
124944701|NCT03662659|449424382|FG001|Pre-treatment|Participant no longer met study criteria|1|||
124944702|NCT03662659|449424381|FG000|Pre-treatment|Other reasons|1|||
124944703|NCT03662659|449424382|FG001|Pre-treatment|Other reasons|0|||
124944704|NCT03662659|449424381|FG000|Treatment|Completed Treatment|0|||
124944705|NCT03662659|449424382|FG001|Treatment|Completed Treatment|2|||
124944706|NCT03662659|449424381|FG000|Treatment|Disease Progression|85|||
124944707|NCT03662659|449424382|FG001|Treatment|Disease Progression|97|||
124944708|NCT03662659|449424381|FG000|Treatment|Study Drug Toxicity|19|||
124944709|NCT03662659|449424382|FG001|Treatment|Study Drug Toxicity|9|||
124944710|NCT03662659|449424381|FG000|Treatment|Death|11|||
124944711|NCT03662659|449424382|FG001|Treatment|Death|9|||
124458474|NCT00705783|447638209|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
124458475|NCT00705783|447638210|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
124458476|NCT00705783|447638208|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
124458477|NCT00705783|447638209|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
124458478|NCT00705783|447638210|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
124458479|NCT00705783|447638208|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
124458480|NCT00705783|447638209|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
124458481|NCT00705783|447638210|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
124458482|NCT00705783|447638208|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
124765297|NCT01751061|448767380|FG000|Overall Study|Lost to Follow-up|40|||
124705870|NCT02958865|448548495|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
124705871|NCT02958865|448548496|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
124705872|NCT02958865|448548497|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
124705873|NCT02958865|448548498|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
124705874|NCT02958865|448548499|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
124944712|NCT03662659|449424381|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
124944713|NCT03662659|449424382|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
124944714|NCT03662659|449424381|FG000|Treatment|Withdrawal by Subject|1|||
124944715|NCT03662659|449424382|FG001|Treatment|Withdrawal by Subject|1|||
124944716|NCT03662659|449424381|FG000|Treatment|Poor/Non-compliance|1|||
124944717|NCT03662659|449424382|FG001|Treatment|Poor/Non-compliance|0|||
124944718|NCT03662659|449424381|FG000|Treatment|Participant no longer meets study criteria|1|||
124944719|NCT03662659|449424382|FG001|Treatment|Participant no longer meets study criteria|0|||
124944720|NCT03662659|449424381|FG000|Treatment|Other reasons|10|||
124944721|NCT03662659|449424382|FG001|Treatment|Other reasons|8|||
124944722|NCT03662659|449424381|FG000|Treatment|Administrative reasons by sponsor|1|||
124944723|NCT03662659|449424382|FG001|Treatment|Administrative reasons by sponsor|0|||
124944724|NCT03662659|449424381|FG000|Treatment|maximum clinical benefit|0|||
124944725|NCT03662659|449424382|FG001|Treatment|maximum clinical benefit|2|||
124944726|NCT02556918|449426444|FG000|Overall Study|Protocol Violation|5|||
124944727|NCT02556918|449426445|FG001|Overall Study|Protocol Violation|6|||
124944728|NCT02556918|449426444|FG000|Overall Study|Withdrawal by Subject|4|||
124944729|NCT02556918|449426445|FG001|Overall Study|Withdrawal by Subject|4|||
124944730|NCT02148705|449426461|FG000|Overall Study|Death|2|||
124944731|NCT02148705|449426462|FG001|Overall Study|Death|0|||
124944732|NCT02148705|449426463|FG002|Overall Study|Death|0|||
124944733|NCT02148705|449426461|FG000|Overall Study|Lost to Follow-up|13|||
124944734|NCT02148705|449426462|FG001|Overall Study|Lost to Follow-up|4|||
124944735|NCT02148705|449426463|FG002|Overall Study|Lost to Follow-up|10|||
124944736|NCT02148705|449426461|FG000|Overall Study|Withdrawal by Subject|3|||
124944737|NCT02148705|449426462|FG001|Overall Study|Withdrawal by Subject|0|||
124944738|NCT02148705|449426463|FG002|Overall Study|Withdrawal by Subject|2|||
124944739|NCT02148705|449426461|FG000|Overall Study|Not Treated|0|||
124944740|NCT02148705|449426462|FG001|Overall Study|Not Treated|1|||
124944741|NCT02148705|449426463|FG002|Overall Study|Not Treated|5|||
124944742|NCT01583166|449426464|FG000|Overall Study|Withdrawal by Subject|4|||
124944743|NCT01583166|449426465|FG001|Overall Study|Withdrawal by Subject|6|||
124944744|NCT01833455|449426466|FG000|Overall Study|Withdrawal by Subject|1|||
124944745|NCT01833455|449426467|FG001|Overall Study|Withdrawal by Subject|0|||
124944746|NCT00887224|449426468|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
124944747|NCT00887224|449426469|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
124944748|NCT00887224|449426470|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
124944749|NCT00887224|449426468|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
124944750|NCT00887224|449426469|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
124944751|NCT00887224|449426470|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
124944752|NCT00887224|449426468|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
124944753|NCT00887224|449426469|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
124944754|NCT00887224|449426470|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
124944755|NCT00887224|449426468|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
124944756|NCT00887224|449426469|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
124944757|NCT00887224|449426470|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
124944758|NCT00887224|449426468|FG000|Open-label Response (OLR) Phase|Other|1|||
124944759|NCT00887224|449426469|FG001|Open-label Response (OLR) Phase|Other|0|||
124944760|NCT00887224|449426470|FG002|Open-label Response (OLR) Phase|Other|0|||
124944761|NCT00887224|449426468|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
124944762|NCT00887224|449426469|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
124944763|NCT00887224|449426470|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
124944764|NCT00887224|449426468|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
124944765|NCT00887224|449426469|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
124944766|NCT00887224|449426470|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
124944767|NCT00887224|449426468|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
124944768|NCT00887224|449426469|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
124944769|NCT00887224|449426470|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
124944770|NCT00887224|449426468|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
124944771|NCT00887224|449426469|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
124944772|NCT00887224|449426470|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
124944773|NCT00887224|449426468|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
124944774|NCT00887224|449426469|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
124944775|NCT00887224|449426470|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
124944776|NCT00887224|449426468|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
124705875|NCT02958865|448548500|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
124944777|NCT00887224|449426469|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
124944778|NCT00887224|449426470|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
124944779|NCT00887224|449426468|FG000|Open-label Stability (OLS) Phase|Other|1|||
124944780|NCT00887224|449426469|FG001|Open-label Stability (OLS) Phase|Other|0|||
124944781|NCT00887224|449426470|FG002|Open-label Stability (OLS) Phase|Other|0|||
124944782|NCT00887224|449426468|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
124944783|NCT00887224|449426469|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
124944784|NCT00887224|449426470|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
124944785|NCT00887224|449426468|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
124944786|NCT00887224|449426469|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
124944787|NCT00887224|449426470|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
124944788|NCT00887224|449426468|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
124548036|NCT00902486|447960392|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
124548037|NCT00902486|447960393|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
124548038|NCT00902486|447960394|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
124548039|NCT00902486|447960395|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
124944789|NCT00887224|449426469|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
124944790|NCT00887224|449426470|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
124944791|NCT00887224|449426468|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
124944792|NCT00887224|449426469|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
124944793|NCT00887224|449426470|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
124944794|NCT00887224|449426468|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
124944795|NCT00887224|449426469|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
124944796|NCT00887224|449426470|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
124944797|NCT00887224|449426468|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
124944798|NCT00887224|449426469|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
124944799|NCT00887224|449426470|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
124944800|NCT00887224|449426468|FG000|OL Taper Phase / OL Follow Up|Other|30|||
124944801|NCT00887224|449426469|FG001|OL Taper Phase / OL Follow Up|Other|0|||
124944802|NCT00887224|449426470|FG002|OL Taper Phase / OL Follow Up|Other|0|||
124944803|NCT00887224|449426468|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
124944804|NCT00887224|449426469|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
124944805|NCT00887224|449426470|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
124944806|NCT00887224|449426468|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
124944807|NCT00887224|449426469|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
124944808|NCT00887224|449426470|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
124548040|NCT00902486|447960390|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
124944809|NCT00887224|449426468|FG000|Double-blind (DB) Phase|Adverse Event|0|||
124944810|NCT00887224|449426469|FG001|Double-blind (DB) Phase|Adverse Event|7|||
124944811|NCT00887224|449426470|FG002|Double-blind (DB) Phase|Adverse Event|2|||
124944812|NCT00887224|449426468|FG000|Double-blind (DB) Phase|Failed to return|0|||
124944813|NCT00887224|449426469|FG001|Double-blind (DB) Phase|Failed to return|2|||
124705876|NCT02958865|448548501|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
124705877|NCT02958865|448548502|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
124705878|NCT02958865|448548503|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
124705879|NCT02958865|448548504|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
124705880|NCT02958865|448548505|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
124705881|NCT02958865|448548506|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
124705882|NCT02958865|448548491|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
124705883|NCT02958865|448548492|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
124705884|NCT02958865|448548493|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
124705885|NCT02958865|448548494|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124705886|NCT02958865|448548495|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124705887|NCT02958865|448548496|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124705888|NCT02958865|448548497|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124705889|NCT02958865|448548498|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124705890|NCT02958865|448548499|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124705891|NCT02958865|448548500|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124705892|NCT02958865|448548501|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124705893|NCT02958865|448548502|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124705894|NCT02958865|448548503|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124705895|NCT02958865|448548504|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124705896|NCT02958865|448548505|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124705897|NCT02958865|448548506|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124705898|NCT02958865|448548491|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
124705899|NCT02958865|448548492|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
124705900|NCT02958865|448548493|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
124705901|NCT02958865|448548494|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
124705902|NCT02958865|448548495|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
124705903|NCT02958865|448548496|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
124705904|NCT02958865|448548497|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
124705905|NCT02958865|448548498|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
124705906|NCT02958865|448548499|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
124705907|NCT02958865|448548500|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
124944814|NCT00887224|449426470|FG002|Double-blind (DB) Phase|Failed to return|2|||
124944815|NCT00887224|449426468|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
124944816|NCT00887224|449426469|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
124944817|NCT00887224|449426470|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
124944818|NCT00887224|449426468|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
124944819|NCT00887224|449426469|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
124944820|NCT00887224|449426470|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
124944821|NCT00887224|449426468|FG000|Double-blind (DB) Phase|Other|0|||
124944822|NCT00887224|449426469|FG001|Double-blind (DB) Phase|Other|2|||
124944823|NCT00887224|449426470|FG002|Double-blind (DB) Phase|Other|0|||
124944824|NCT00887224|449426468|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
124944825|NCT00887224|449426469|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
124944826|NCT00887224|449426470|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
124944827|NCT00887224|449426468|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
124944828|NCT00887224|449426469|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
124944829|NCT00887224|449426470|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
124944830|NCT00887224|449426468|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
124944831|NCT00887224|449426469|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
124944832|NCT00887224|449426470|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
124944833|NCT00887224|449426468|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
124944834|NCT00887224|449426469|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
124944835|NCT00887224|449426470|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
124944836|NCT00887224|449426468|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
124944837|NCT00887224|449426469|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
124944838|NCT00887224|449426470|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
124458483|NCT00705783|447638209|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
124944839|NCT00887224|449426468|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
124944840|NCT00887224|449426469|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
124944841|NCT00887224|449426470|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
124944842|NCT00887224|449426468|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
124705908|NCT02958865|448548501|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
124705909|NCT02958865|448548502|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
124705910|NCT02958865|448548503|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
124705911|NCT02958865|448548504|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
124705912|NCT02958865|448548505|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
124705913|NCT02958865|448548506|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
124944843|NCT00887224|449426469|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
124944844|NCT00887224|449426470|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
124944845|NCT00887224|449426468|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
124944846|NCT00887224|449426469|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
124944847|NCT00887224|449426470|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
124944848|NCT00887224|449426468|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
124944849|NCT00887224|449426469|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
124944850|NCT00887224|449426470|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
124944851|NCT03883828|449426471|FG000|Overall Study|Did not start radiotherapy|1|||
124944852|NCT03883828|449426472|FG001|Overall Study|Did not start radiotherapy|2|||
124944853|NCT01256359|449426473|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
124944854|NCT01256359|449426474|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
124944855|NCT01256359|449426473|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
124944856|NCT01256359|449426474|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
124944857|NCT02000752|449426477|FG000|Overall Study|Dystocic delivery|19|||
124944858|NCT02000752|449426478|FG001|Overall Study|Dystocic delivery|8|||
124944859|NCT02000752|449426477|FG000|Overall Study|Shift Changes|12|||
124944860|NCT02000752|449426478|FG001|Overall Study|Shift Changes|5|||
124944861|NCT04938453|449426482|FG000|Washout Period 1|Adverse Event|1|||
124944862|NCT04938453|449426483|FG001|Washout Period 1|Adverse Event|0|||
124944863|NCT04938453|449426482|FG000|Washout Period 1|Physician Decision|0|||
124944864|NCT04938453|449426483|FG001|Washout Period 1|Physician Decision|1|||
124944865|NCT00273052|449426484|FG000|Overall Study|Withdrawal by Subject|16|||
124944866|NCT00273052|449426485|FG001|Overall Study|Withdrawal by Subject|19|||
124944867|NCT00273052|449426484|FG000|Overall Study|Adverse Event|21|||
124944868|NCT00273052|449426485|FG001|Overall Study|Adverse Event|19|||
124944869|NCT00273052|449426484|FG000|Overall Study|Protocol Violation|14|||
124944870|NCT00273052|449426485|FG001|Overall Study|Protocol Violation|18|||
124944871|NCT00273052|449426484|FG000|Overall Study|Lost to Follow-up|7|||
124944872|NCT00273052|449426485|FG001|Overall Study|Lost to Follow-up|25|||
124944873|NCT00273052|449426484|FG000|Overall Study|Lack of Efficacy|6|||
124944874|NCT00273052|449426485|FG001|Overall Study|Lack of Efficacy|4|||
124944875|NCT00273052|449426484|FG000|Overall Study|Non-Compliance|3|||
124944876|NCT00273052|449426485|FG001|Overall Study|Non-Compliance|1|||
124944877|NCT00273052|449426484|FG000|Overall Study|Other|2|||
124944878|NCT00273052|449426485|FG001|Overall Study|Other|0|||
124944879|NCT00273052|449426484|FG000|Overall Study|Worsening serum lipid levels|0|||
124944880|NCT00273052|449426485|FG001|Overall Study|Worsening serum lipid levels|2|||
124944881|NCT00454194|449426487|FG000|Overall Study|Adverse Event|7|||
124944882|NCT00454194|449426488|FG001|Overall Study|Adverse Event|2|||
124944883|NCT00454194|449426487|FG000|Overall Study|Withdrawal by Subject|12|||
124944884|NCT00454194|449426488|FG001|Overall Study|Withdrawal by Subject|8|||
124944885|NCT00454194|449426487|FG000|Overall Study|Other Medical Problems|1|||
124944886|NCT00454194|449426488|FG001|Overall Study|Other Medical Problems|2|||
124944887|NCT00454194|449426487|FG000|Overall Study|Other Unspecified Reason|2|||
124944888|NCT00454194|449426488|FG001|Overall Study|Other Unspecified Reason|2|||
124944889|NCT02827201|449426489|FG000|Overall Study|Death|1|||
124944890|NCT02827201|449426490|FG001|Overall Study|Death|2|||
124944891|NCT02827201|449426489|FG000|Overall Study|Patients not treated|1|||
124944892|NCT02827201|449426490|FG001|Overall Study|Patients not treated|1|||
124944893|NCT03345979|449426491|FG000|Overall Study|Withdrawal by Subject|20|||
124944894|NCT03345979|449426492|FG001|Overall Study|Withdrawal by Subject|31|||
124944895|NCT03345979|449426491|FG000|Overall Study|Adverse Event|10|||
124944896|NCT03345979|449426492|FG001|Overall Study|Adverse Event|11|||
124944897|NCT03345979|449426491|FG000|Overall Study|Lost to Follow-up|8|||
124944898|NCT03345979|449426492|FG001|Overall Study|Lost to Follow-up|9|||
124944899|NCT03345979|449426491|FG000|Overall Study|Lack of Efficacy|4|||
124944900|NCT03345979|449426492|FG001|Overall Study|Lack of Efficacy|2|||
124944901|NCT03345979|449426491|FG000|Overall Study|Protocol Violation|1|||
124944902|NCT03345979|449426492|FG001|Overall Study|Protocol Violation|3|||
124944903|NCT03345979|449426491|FG000|Overall Study|Physician Decision|0|||
124944904|NCT03345979|449426492|FG001|Overall Study|Physician Decision|2|||
124944905|NCT00999596|449426493|FG000|Overall Study|Statistical population not required|101|||
124944906|NCT00439218|449426496|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
124944907|NCT03176407|449426497|FG000|Overall Study|Protocol Violation|1|||
124944908|NCT03176407|449426497|FG000|Overall Study|human failure|1|||
124458484|NCT00705783|447638210|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
124944909|NCT03176407|449426497|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
124944910|NCT00670488|449426498|FG000|Overall Study|Adverse Event|0|||
124944911|NCT00670488|449426499|FG001|Overall Study|Adverse Event|7|||
124944912|NCT00670488|449426500|FG002|Overall Study|Adverse Event|0|||
124458485|NCT03029143|447638216|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
124944913|NCT00670488|449426501|FG003|Overall Study|Adverse Event|3|||
124944914|NCT00670488|449426502|FG004|Overall Study|Adverse Event|1|||
124944915|NCT00670488|449426503|FG005|Overall Study|Adverse Event|1|||
124458486|NCT03029143|447638217|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
124944916|NCT00670488|449426504|FG006|Overall Study|Adverse Event|5|||
124944917|NCT00670488|449426505|FG007|Overall Study|Adverse Event|1|||
124944918|NCT00670488|449426506|FG008|Overall Study|Adverse Event|0|||
124944919|NCT00670488|449426507|FG009|Overall Study|Adverse Event|1|||
124944920|NCT00670488|449426498|FG000|Overall Study|Physician Decision|1|||
124944921|NCT00670488|449426499|FG001|Overall Study|Physician Decision|9|||
124944922|NCT00670488|449426500|FG002|Overall Study|Physician Decision|0|||
124944923|NCT00670488|449426501|FG003|Overall Study|Physician Decision|1|||
124944924|NCT00670488|449426502|FG004|Overall Study|Physician Decision|0|||
124944925|NCT00670488|449426503|FG005|Overall Study|Physician Decision|0|||
124944926|NCT00670488|449426504|FG006|Overall Study|Physician Decision|0|||
124944927|NCT00670488|449426505|FG007|Overall Study|Physician Decision|0|||
124944928|NCT00670488|449426506|FG008|Overall Study|Physician Decision|0|||
124944929|NCT00670488|449426507|FG009|Overall Study|Physician Decision|0|||
124944930|NCT00670488|449426498|FG000|Overall Study|Progressive Disease|2|||
124944931|NCT00670488|449426499|FG001|Overall Study|Progressive Disease|41|||
124944932|NCT00670488|449426500|FG002|Overall Study|Progressive Disease|3|||
124944933|NCT00670488|449426501|FG003|Overall Study|Progressive Disease|2|||
124944934|NCT00670488|449426502|FG004|Overall Study|Progressive Disease|2|||
124944935|NCT00670488|449426503|FG005|Overall Study|Progressive Disease|4|||
124944936|NCT00670488|449426504|FG006|Overall Study|Progressive Disease|11|||
124944937|NCT00670488|449426505|FG007|Overall Study|Progressive Disease|2|||
124944938|NCT00670488|449426506|FG008|Overall Study|Progressive Disease|2|||
124944939|NCT00670488|449426507|FG009|Overall Study|Progressive Disease|1|||
124944940|NCT00670488|449426498|FG000|Overall Study|Withdrawal by Subject|0|||
124944941|NCT00670488|449426499|FG001|Overall Study|Withdrawal by Subject|1|||
124944942|NCT00670488|449426500|FG002|Overall Study|Withdrawal by Subject|0|||
124944943|NCT00670488|449426501|FG003|Overall Study|Withdrawal by Subject|1|||
124944944|NCT00670488|449426502|FG004|Overall Study|Withdrawal by Subject|0|||
124944945|NCT00670488|449426503|FG005|Overall Study|Withdrawal by Subject|0|||
124944946|NCT00670488|449426504|FG006|Overall Study|Withdrawal by Subject|1|||
124944947|NCT00670488|449426505|FG007|Overall Study|Withdrawal by Subject|0|||
124944948|NCT00670488|449426506|FG008|Overall Study|Withdrawal by Subject|1|||
124944949|NCT00670488|449426507|FG009|Overall Study|Withdrawal by Subject|0|||
124944950|NCT01124045|449426510|FG000|Overall Study|Lost to Follow-up|0|||
124944951|NCT01124045|449426511|FG001|Overall Study|Lost to Follow-up|1|||
124944952|NCT01124045|449426510|FG000|Overall Study|Physician Decision|0|||
124944953|NCT01124045|449426511|FG001|Overall Study|Physician Decision|2|||
124944954|NCT03298087|449426512|FG000|Overall Study|Withdrawal by Subject|4|||
124944955|NCT05553366|449426515|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
124944956|NCT05553366|449426516|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
124944957|NCT05553366|449426517|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
124944958|NCT05553366|449426515|FG000|Overall Study|Lost to Follow-up|3|||
124944959|NCT05553366|449426516|FG001|Overall Study|Lost to Follow-up|3|||
124944960|NCT05553366|449426517|FG002|Overall Study|Lost to Follow-up|3|||
124944961|NCT05553366|449426515|FG000|Overall Study|Other non-compliance|1|||
124944962|NCT05553366|449426516|FG001|Overall Study|Other non-compliance|1|||
124944963|NCT05553366|449426517|FG002|Overall Study|Other non-compliance|0|||
124944964|NCT05553366|449426515|FG000|Overall Study|Randomized but not dosed|0|||
124944965|NCT05553366|449426516|FG001|Overall Study|Randomized but not dosed|0|||
124944966|NCT05553366|449426517|FG002|Overall Study|Randomized but not dosed|2|||
124944967|NCT02022657|449426518|FG000|Overall Study|Withdrawal by Subject|2|||
124944968|NCT02022657|449426519|FG001|Overall Study|Withdrawal by Subject|0|||
124944969|NCT02022657|449426520|FG002|Overall Study|Withdrawal by Subject|1|||
124944970|NCT02022657|449426521|FG003|Overall Study|Withdrawal by Subject|0|||
124944971|NCT02022657|449426522|FG004|Overall Study|Withdrawal by Subject|0|||
124944972|NCT02022657|449426523|FG005|Overall Study|Withdrawal by Subject|0|||
124705914|NCT02958865|448548491|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124765298|NCT01751061|448767381|FG001|Overall Study|Lost to Follow-up|25|||
124944973|NCT02022657|449426518|FG000|Overall Study|Physician Decision|0|||
124944974|NCT02022657|449426519|FG001|Overall Study|Physician Decision|0|||
124944975|NCT02022657|449426520|FG002|Overall Study|Physician Decision|0|||
124944976|NCT02022657|449426521|FG003|Overall Study|Physician Decision|0|||
124944977|NCT02022657|449426522|FG004|Overall Study|Physician Decision|0|||
124944978|NCT02022657|449426523|FG005|Overall Study|Physician Decision|1|||
124944979|NCT01530334|449426524|FG000|Overall Study|Adverse Event|3|||
124944980|NCT01530334|449426524|FG000|Overall Study|unknown reason|1|||
124944981|NCT01530334|449426524|FG000|Overall Study|Progressive disease|47|||
124944982|NCT01485887|449426526|FG000|Overall Study|Withdrawal by Subject|2|||
124944983|NCT01485887|449426526|FG000|Overall Study|Adverse Event|8|||
124944984|NCT01485887|449426526|FG000|Overall Study|Deterioration of primary disease|1|||
124944985|NCT01485887|449426526|FG000|Overall Study|Primary disease markedly improved|1|||
124944986|NCT00659373|449426531|FG000|Overall Study|Withdrawal by Subject|3|||
124944987|NCT00659373|449426532|FG001|Overall Study|Withdrawal by Subject|5|||
124944988|NCT00659373|449426531|FG000|Overall Study|Assessment Missed|2|||
124944989|NCT00659373|449426532|FG001|Overall Study|Assessment Missed|2|||
124944990|NCT02382640|449426533|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
124944991|NCT02382640|449426534|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
124944992|NCT02382640|449426535|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
124944993|NCT02382640|449426536|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
124944994|NCT03162614|449426539|FG000|Overall Study|Lost to Follow-up|2|||
124944995|NCT03162614|449426540|FG001|Overall Study|Lost to Follow-up|1|||
124944996|NCT03162614|449426541|FG002|Overall Study|Lost to Follow-up|1|||
124944997|NCT03162614|449426542|FG003|Overall Study|Lost to Follow-up|1|||
124944998|NCT03162614|449426543|FG004|Overall Study|Lost to Follow-up|2|||
124944999|NCT03162614|449426544|FG005|Overall Study|Lost to Follow-up|0|||
124945000|NCT03162614|449426539|FG000|Overall Study|Protocol Violation|0|||
124945001|NCT03162614|449426540|FG001|Overall Study|Protocol Violation|1|||
124945002|NCT03162614|449426541|FG002|Overall Study|Protocol Violation|0|||
124945003|NCT03162614|449426542|FG003|Overall Study|Protocol Violation|1|||
124945004|NCT03162614|449426543|FG004|Overall Study|Protocol Violation|0|||
124945005|NCT03162614|449426544|FG005|Overall Study|Protocol Violation|0|||
124945006|NCT03162614|449426539|FG000|Overall Study|Withdrawal by Subject|2|||
124945007|NCT03162614|449426540|FG001|Overall Study|Withdrawal by Subject|1|||
124945008|NCT03162614|449426541|FG002|Overall Study|Withdrawal by Subject|1|||
124945009|NCT03162614|449426542|FG003|Overall Study|Withdrawal by Subject|1|||
124945010|NCT03162614|449426543|FG004|Overall Study|Withdrawal by Subject|0|||
124945011|NCT03162614|449426544|FG005|Overall Study|Withdrawal by Subject|0|||
124945012|NCT03162614|449426539|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
124945013|NCT03162614|449426540|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
124705915|NCT02958865|448548492|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124945014|NCT03162614|449426541|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
124945015|NCT03162614|449426542|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
124945016|NCT03162614|449426543|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
124945017|NCT03162614|449426544|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
124945018|NCT00380250|449426545|FG000|Overall Study|Withdrawal by Subject|39|||
124945019|NCT00380250|449426546|FG001|Overall Study|Withdrawal by Subject|28|||
124945020|NCT00380250|449426545|FG000|Overall Study|Adverse Event|20|||
124945021|NCT00380250|449426546|FG001|Overall Study|Adverse Event|9|||
124945022|NCT00380250|449426545|FG000|Overall Study|Lack of Efficacy|10|||
124945023|NCT00380250|449426546|FG001|Overall Study|Lack of Efficacy|8|||
124945024|NCT00380250|449426545|FG000|Overall Study|Protocol Violation|15|||
124945025|NCT00380250|449426546|FG001|Overall Study|Protocol Violation|5|||
124945026|NCT00380250|449426545|FG000|Overall Study|Lost to Follow-up|14|||
124945027|NCT00380250|449426546|FG001|Overall Study|Lost to Follow-up|5|||
124945028|NCT00380250|449426545|FG000|Overall Study|Physician Decision|1|||
124945029|NCT00380250|449426546|FG001|Overall Study|Physician Decision|0|||
124945030|NCT02630966|449426547|FG000|Overall Study|Adverse Event|1|||
124945031|NCT02630966|449426548|FG001|Overall Study|Adverse Event|3|||
124945032|NCT02630966|449426547|FG000|Overall Study|Significant Protocol Deviation|0|||
124945033|NCT02630966|449426548|FG001|Overall Study|Significant Protocol Deviation|2|||
124945034|NCT02630966|449426547|FG000|Overall Study|Voluntary Withdrawal|1|||
124945035|NCT02630966|449426548|FG001|Overall Study|Voluntary Withdrawal|1|||
124945036|NCT02630966|449426547|FG000|Overall Study|Lack of Efficacy|0|||
124945037|NCT02630966|449426548|FG001|Overall Study|Lack of Efficacy|2|||
124945038|NCT00641537|449426549|FG000|96-week Period|Adverse Event|0|||
124945039|NCT00641537|449426550|FG001|96-week Period|Adverse Event|1|||
124945040|NCT00641537|449426551|FG002|96-week Period|Adverse Event|3|||
124945041|NCT00641537|449426552|FG003|96-week Period|Adverse Event|0|||
124945042|NCT00641537|449426553|FG004|96-week Period|Adverse Event|2|||
124945043|NCT00641537|449426554|FG005|96-week Period|Adverse Event|0|||
124945044|NCT00641537|449426555|FG006|96-week Period|Adverse Event|0|||
124945045|NCT00641537|449426556|FG007|96-week Period|Adverse Event|0|||
124945046|NCT00641537|449426549|FG000|96-week Period|Lost to Follow-up|3|||
124945047|NCT00641537|449426550|FG001|96-week Period|Lost to Follow-up|1|||
124945048|NCT00641537|449426551|FG002|96-week Period|Lost to Follow-up|2|||
124945049|NCT00641537|449426552|FG003|96-week Period|Lost to Follow-up|2|||
124945050|NCT00641537|449426553|FG004|96-week Period|Lost to Follow-up|4|||
124945051|NCT00641537|449426554|FG005|96-week Period|Lost to Follow-up|0|||
124945052|NCT00641537|449426555|FG006|96-week Period|Lost to Follow-up|1|||
124945053|NCT00641537|449426556|FG007|96-week Period|Lost to Follow-up|0|||
124945054|NCT00641537|449426549|FG000|96-week Period|Protocol Violation|0|||
124945055|NCT00641537|449426550|FG001|96-week Period|Protocol Violation|1|||
124945056|NCT00641537|449426551|FG002|96-week Period|Protocol Violation|0|||
124945057|NCT00641537|449426552|FG003|96-week Period|Protocol Violation|1|||
124945058|NCT00641537|449426553|FG004|96-week Period|Protocol Violation|0|||
124945059|NCT00641537|449426554|FG005|96-week Period|Protocol Violation|1|||
124945060|NCT00641537|449426555|FG006|96-week Period|Protocol Violation|0|||
124945061|NCT00641537|449426556|FG007|96-week Period|Protocol Violation|0|||
124945062|NCT00641537|449426549|FG000|96-week Period|Death|2|||
124945063|NCT00641537|449426550|FG001|96-week Period|Death|0|||
124945064|NCT00641537|449426551|FG002|96-week Period|Death|1|||
124945065|NCT00641537|449426552|FG003|96-week Period|Death|0|||
124945066|NCT00641537|449426553|FG004|96-week Period|Death|0|||
124945067|NCT00641537|449426554|FG005|96-week Period|Death|0|||
124705916|NCT02958865|448548493|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124945068|NCT00641537|449426555|FG006|96-week Period|Death|0|||
124945069|NCT00641537|449426556|FG007|96-week Period|Death|0|||
124945070|NCT00641537|449426549|FG000|96-week Period|Other|4|||
124945071|NCT00641537|449426550|FG001|96-week Period|Other|7|||
124705917|NCT02958865|448548494|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124945072|NCT00641537|449426551|FG002|96-week Period|Other|14|||
124945073|NCT00641537|449426552|FG003|96-week Period|Other|9|||
124945074|NCT00641537|449426553|FG004|96-week Period|Other|11|||
124945075|NCT00641537|449426554|FG005|96-week Period|Other|6|||
124945076|NCT00641537|449426555|FG006|96-week Period|Other|4|||
124945077|NCT00641537|449426556|FG007|96-week Period|Other|6|||
124945078|NCT00641537|449426549|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
124945079|NCT00641537|449426550|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
124945080|NCT00641537|449426551|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
124945081|NCT00641537|449426552|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
124945082|NCT00641537|449426553|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
124945083|NCT00641537|449426554|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
124945084|NCT00641537|449426555|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
124945085|NCT00641537|449426556|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
124945086|NCT00641537|449426549|FG000|24-Week Supplemental Follow-up Period|Other|0|||
124945087|NCT00641537|449426550|FG001|24-Week Supplemental Follow-up Period|Other|2|||
124945088|NCT00641537|449426551|FG002|24-Week Supplemental Follow-up Period|Other|2|||
124945089|NCT00641537|449426552|FG003|24-Week Supplemental Follow-up Period|Other|1|||
124945090|NCT00641537|449426553|FG004|24-Week Supplemental Follow-up Period|Other|3|||
124945091|NCT00641537|449426554|FG005|24-Week Supplemental Follow-up Period|Other|0|||
124945092|NCT00641537|449426555|FG006|24-Week Supplemental Follow-up Period|Other|1|||
124945093|NCT00641537|449426556|FG007|24-Week Supplemental Follow-up Period|Other|1|||
124945094|NCT01801007|449426557|FG000|Overall Study|Adverse Event|2|||
124945095|NCT01801007|449426557|FG000|Overall Study|Lost to Follow-up|4|||
124945096|NCT01801007|449426557|FG000|Overall Study|Withdrawal by Subject|5|||
124945097|NCT00665392|449426558|FG000|Overall Study|not treated|1|||
124945098|NCT00243867|449426559|FG000|Overall Study|Adverse Event|24|||
124945099|NCT00243867|449426560|FG001|Overall Study|Adverse Event|34|||
124945100|NCT00243867|449426559|FG000|Overall Study|Lack of Efficacy|115|||
124945101|NCT00243867|449426560|FG001|Overall Study|Lack of Efficacy|78|||
124945102|NCT00243867|449426559|FG000|Overall Study|Withdrawal by Subject|11|||
124945103|NCT00243867|449426560|FG001|Overall Study|Withdrawal by Subject|23|||
124945104|NCT00243867|449426559|FG000|Overall Study|Lost to Follow-up|2|||
124945105|NCT00243867|449426560|FG001|Overall Study|Lost to Follow-up|1|||
124945106|NCT00243867|449426559|FG000|Overall Study|Physician Decision|2|||
124945107|NCT00243867|449426560|FG001|Overall Study|Physician Decision|7|||
124945108|NCT00243867|449426559|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
124945109|NCT00243867|449426560|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
124945110|NCT01321073|449426565|FG000|Overall Study|Did not attempt implant|4|||
124945111|NCT01321073|449426565|FG000|Overall Study|Death|3|||
124945112|NCT01638000|449426572|FG000|Overall Study|Randomized but Never Received Drug|7|||
124945113|NCT01638000|449426573|FG001|Overall Study|Randomized but Never Received Drug|10|||
124945114|NCT01638000|449426572|FG000|Overall Study|Adverse Event|14|||
124945115|NCT01638000|449426573|FG001|Overall Study|Adverse Event|16|||
124945116|NCT01638000|449426572|FG000|Overall Study|Lack of Efficacy|5|||
124945117|NCT01638000|449426573|FG001|Overall Study|Lack of Efficacy|6|||
124945118|NCT01638000|449426572|FG000|Overall Study|Protocol Violation|11|||
124945119|NCT01638000|449426573|FG001|Overall Study|Protocol Violation|13|||
124945120|NCT01638000|449426572|FG000|Overall Study|Withdrawal by Subject|21|||
124945121|NCT01638000|449426573|FG001|Overall Study|Withdrawal by Subject|24|||
124945122|NCT01638000|449426572|FG000|Overall Study|Miscellaneous|2|||
124945123|NCT01638000|449426573|FG001|Overall Study|Miscellaneous|2|||
124945124|NCT05352230|449426574|FG000|First Intervention (3 Months)|study terminated|2|||
124945125|NCT05352230|449426575|FG001|First Intervention (3 Months)|study terminated|2|||
124945126|NCT01683409|449426576|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
124945127|NCT01683409|449426577|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
124945128|NCT01683409|449426578|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
124945129|NCT01683409|449426579|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
124945130|NCT01683409|449426580|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
124945131|NCT01683409|449426576|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
124945132|NCT01683409|449426577|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
124945133|NCT01683409|449426578|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
124945134|NCT01683409|449426579|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
124945135|NCT01683409|449426580|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
124945136|NCT01683409|449426576|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
124945137|NCT01683409|449426577|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
124945138|NCT01683409|449426578|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
124945139|NCT01683409|449426579|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
124945140|NCT01683409|449426580|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
124945141|NCT01683409|449426576|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
124945142|NCT01683409|449426577|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
124945143|NCT01683409|449426578|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
124945144|NCT01683409|449426579|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
124945145|NCT01683409|449426580|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
124945146|NCT01683409|449426576|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
124945147|NCT01683409|449426577|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
124945148|NCT01683409|449426578|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
124945149|NCT01683409|449426579|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
124945150|NCT01683409|449426580|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
124945151|NCT01683409|449426576|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
124945152|NCT01683409|449426577|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
124945153|NCT01683409|449426578|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
124945154|NCT01683409|449426579|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
124945155|NCT01683409|449426580|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
124945156|NCT01683409|449426576|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
124945157|NCT01683409|449426577|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
124945158|NCT01683409|449426578|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
124705918|NCT02958865|448548495|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
124705919|NCT02958865|448548496|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124705920|NCT02958865|448548497|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124705921|NCT02958865|448548498|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124705922|NCT02958865|448548499|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124705923|NCT02958865|448548500|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124705924|NCT02958865|448548501|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124945159|NCT01683409|449426579|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
124945160|NCT01683409|449426580|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
124945161|NCT01683409|449426576|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
124945162|NCT01683409|449426577|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
124945163|NCT01683409|449426578|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
124945164|NCT01683409|449426579|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
124945165|NCT01683409|449426580|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
124458487|NCT03029143|447638218|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
124458488|NCT03029143|447638216|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
124458489|NCT03029143|447638217|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
124458490|NCT03029143|447638218|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
124458491|NCT03029143|447638216|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
124458492|NCT03029143|447638217|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
124458493|NCT03029143|447638218|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
124458494|NCT03029143|447638216|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
124458495|NCT03029143|447638217|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
124458496|NCT03029143|447638218|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
124458497|NCT03029143|447638216|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
124458498|NCT03029143|447638217|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
124458499|NCT03029143|447638218|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
124458500|NCT03029143|447638216|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
124458501|NCT03029143|447638217|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
124458502|NCT03029143|447638218|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
124458503|NCT03029143|447638216|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
124458504|NCT03029143|447638217|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
124458505|NCT03029143|447638218|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
124458506|NCT03029143|447638216|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124458507|NCT03029143|447638217|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
124458508|NCT03029143|447638218|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
124458509|NCT03029143|447638216|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
124458510|NCT03029143|447638217|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
124458511|NCT03029143|447638218|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
124458512|NCT03029143|447638216|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
124458513|NCT03029143|447638217|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
124458514|NCT03029143|447638218|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
124458515|NCT03029143|447638216|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
124458516|NCT03029143|447638217|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
124458517|NCT03029143|447638218|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
124458518|NCT00974675|447638221|FG000|Overall Study|Adverse Event|2|||
124458519|NCT00974675|447638222|FG001|Overall Study|Adverse Event|1|||
124458520|NCT00974675|447638223|FG002|Overall Study|Adverse Event|1|||
124458521|NCT00974675|447638224|FG003|Overall Study|Adverse Event|1|||
124458522|NCT00974675|447638221|FG000|Overall Study|Physician Decision|0|||
124458523|NCT00974675|447638222|FG001|Overall Study|Physician Decision|0|||
124458524|NCT00974675|447638223|FG002|Overall Study|Physician Decision|1|||
124458525|NCT00974675|447638224|FG003|Overall Study|Physician Decision|0|||
124458526|NCT00974675|447638221|FG000|Overall Study|Participant on holiday; unable to attend|0|||
124458527|NCT00974675|447638222|FG001|Overall Study|Participant on holiday; unable to attend|0|||
124458528|NCT00974675|447638223|FG002|Overall Study|Participant on holiday; unable to attend|0|||
124458529|NCT00974675|447638224|FG003|Overall Study|Participant on holiday; unable to attend|1|||
124458530|NCT02121262|447638225|FG000|Overall Study|Adverse Event|6|||
124458531|NCT02121262|447638226|FG001|Overall Study|Adverse Event|3|||
124458532|NCT02121262|447638225|FG000|Overall Study|Lack of Efficacy|3|||
124458533|NCT02121262|447638226|FG001|Overall Study|Lack of Efficacy|0|||
124458534|NCT02121262|447638225|FG000|Overall Study|Personal Reasons|19|||
124458535|NCT02121262|447638226|FG001|Overall Study|Personal Reasons|5|||
124458536|NCT02121262|447638225|FG000|Overall Study|Protocol Violation|1|||
124458537|NCT02121262|447638226|FG001|Overall Study|Protocol Violation|1|||
124458538|NCT02121262|447638225|FG000|Overall Study|Participant Dropped-out|0|||
124458539|NCT02121262|447638226|FG001|Overall Study|Participant Dropped-out|1|||
124458540|NCT02121262|447638225|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
124458541|NCT02121262|447638226|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
124458542|NCT02121262|447638225|FG000|Overall Study|Consent Withdrawn|1|||
124945166|NCT01683409|449426576|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
124945167|NCT01683409|449426577|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
124945168|NCT01683409|449426578|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
124945169|NCT01683409|449426579|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
124945170|NCT01683409|449426580|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
124945171|NCT01683409|449426576|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
124945172|NCT01683409|449426577|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
124945173|NCT01683409|449426578|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
124945174|NCT01683409|449426579|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
124945175|NCT01683409|449426580|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
124945176|NCT01683409|449426576|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
124945177|NCT01683409|449426577|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
124945178|NCT01683409|449426578|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
124945179|NCT01683409|449426579|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
124945180|NCT01683409|449426580|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
124945181|NCT04218864|449426581|FG000|Overall Study|Lost to Follow-up|8|||
124945182|NCT04218864|449426582|FG001|Overall Study|Lost to Follow-up|4|||
124945183|NCT04218864|449426581|FG000|Overall Study|Withdrawal by Subject|1|||
124945184|NCT04218864|449426582|FG001|Overall Study|Withdrawal by Subject|3|||
124945185|NCT01227421|449426583|FG000|Overall Study|Lost to Follow-up|6|||
124945186|NCT01227421|449426584|FG001|Overall Study|Lost to Follow-up|7|||
124945187|NCT01227421|449426585|FG002|Overall Study|Lost to Follow-up|5|||
124458543|NCT02121262|447638226|FG001|Overall Study|Consent Withdrawn|0|||
124458544|NCT02025907|447638231|FG000|Overall Study|Lack of Efficacy|1|||
124458545|NCT02025907|447638232|FG001|Overall Study|Lack of Efficacy|0|||
124458546|NCT02025907|447638231|FG000|Overall Study|Withdrawal by Subject|15|||
124458547|NCT02025907|447638232|FG001|Overall Study|Withdrawal by Subject|8|||
124458548|NCT02025907|447638231|FG000|Overall Study|Protocol Violation|2|||
124458549|NCT02025907|447638232|FG001|Overall Study|Protocol Violation|0|||
124458550|NCT02025907|447638231|FG000|Overall Study|Physician Decision|2|||
124458551|NCT02025907|447638232|FG001|Overall Study|Physician Decision|0|||
124458552|NCT02025907|447638231|FG000|Overall Study|Lost to Follow-up|2|||
124458553|NCT02025907|447638232|FG001|Overall Study|Lost to Follow-up|2|||
124458554|NCT02025907|447638231|FG000|Overall Study|Adverse Event|3|||
124458555|NCT02025907|447638232|FG001|Overall Study|Adverse Event|1|||
124458556|NCT02025907|447638231|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
124458557|NCT02025907|447638232|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
124458558|NCT03681119|447638233|FG000|Overall Study|No specific reason|4|||
124945188|NCT01227421|449426583|FG000|Overall Study|Adverse Event|2|||
124945189|NCT01227421|449426584|FG001|Overall Study|Adverse Event|7|||
124945190|NCT01227421|449426585|FG002|Overall Study|Adverse Event|2|||
124945191|NCT01227421|449426583|FG000|Overall Study|Withdrawal by Subject|1|||
124945192|NCT01227421|449426584|FG001|Overall Study|Withdrawal by Subject|2|||
124945193|NCT01227421|449426585|FG002|Overall Study|Withdrawal by Subject|1|||
124945194|NCT01227421|449426583|FG000|Overall Study|Protocol Violation|1|||
124945195|NCT01227421|449426584|FG001|Overall Study|Protocol Violation|1|||
124945196|NCT01227421|449426585|FG002|Overall Study|Protocol Violation|2|||
124945197|NCT01227421|449426583|FG000|Overall Study|Randomized in error|1|||
124945198|NCT01227421|449426584|FG001|Overall Study|Randomized in error|1|||
124945199|NCT01227421|449426585|FG002|Overall Study|Randomized in error|0|||
124945200|NCT02499328|449426586|FG000|Overall Study|Withdrawal by Subject|1|||
124945201|NCT02499328|449426587|FG001|Overall Study|Withdrawal by Subject|1|||
124945202|NCT02499328|449426588|FG002|Overall Study|Withdrawal by Subject|5|||
124945203|NCT02499328|449426589|FG003|Overall Study|Withdrawal by Subject|3|||
124945204|NCT02499328|449426590|FG004|Overall Study|Withdrawal by Subject|5|||
124945205|NCT02499328|449426591|FG005|Overall Study|Withdrawal by Subject|0|||
124945206|NCT02499328|449426592|FG006|Overall Study|Withdrawal by Subject|0|||
124945207|NCT02499328|449426593|FG007|Overall Study|Withdrawal by Subject|0|||
124945208|NCT02499328|449426594|FG008|Overall Study|Withdrawal by Subject|2|||
124945209|NCT02499328|449426595|FG009|Overall Study|Withdrawal by Subject|2|||
124945210|NCT02499328|449426596|FG010|Overall Study|Withdrawal by Subject|0|||
124945211|NCT02499328|449426597|FG011|Overall Study|Withdrawal by Subject|3|||
124945212|NCT02499328|449426598|FG012|Overall Study|Withdrawal by Subject|7|||
124945213|NCT02499328|449426599|FG013|Overall Study|Withdrawal by Subject|3|||
124945214|NCT02499328|449426600|FG014|Overall Study|Withdrawal by Subject|1|||
124945215|NCT02499328|449426601|FG015|Overall Study|Withdrawal by Subject|0|||
124945216|NCT02499328|449426602|FG016|Overall Study|Withdrawal by Subject|0|||
124945217|NCT02499328|449426603|FG017|Overall Study|Withdrawal by Subject|3|||
124458559|NCT03681119|447638234|FG001|Overall Study|No specific reason|0|||
124458560|NCT03681119|447638233|FG000|Overall Study|Sickness|2|||
124945218|NCT02499328|449426604|FG018|Overall Study|Withdrawal by Subject|0|||
124945219|NCT02499328|449426586|FG000|Overall Study|Lost to Follow-up|0|||
124945220|NCT02499328|449426587|FG001|Overall Study|Lost to Follow-up|1|||
124458561|NCT03681119|447638234|FG001|Overall Study|Sickness|0|||
124458562|NCT00879645|447638237|FG000|Overall Study|Adverse Event|1|||
124458563|NCT00879645|447638238|FG001|Overall Study|Adverse Event|0|||
124548041|NCT00902486|447960391|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
124548042|NCT00902486|447960392|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
124548043|NCT00902486|447960393|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
124548044|NCT00902486|447960394|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
124705925|NCT02958865|448548502|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124705926|NCT02958865|448548503|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124705927|NCT02958865|448548504|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124945221|NCT02499328|449426588|FG002|Overall Study|Lost to Follow-up|1|||
124548045|NCT00902486|447960395|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
124548046|NCT00902486|447960390|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
124548047|NCT00902486|447960391|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
124548048|NCT00902486|447960392|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
124548049|NCT00902486|447960393|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
124548050|NCT00902486|447960394|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
124548051|NCT00902486|447960395|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
124548052|NCT00902486|447960390|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
124548053|NCT00902486|447960391|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
124548054|NCT00902486|447960392|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
124548055|NCT00902486|447960393|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
124548056|NCT00902486|447960394|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
124548057|NCT00902486|447960395|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
124548058|NCT00902486|447960390|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
124548059|NCT00902486|447960391|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
124548060|NCT00902486|447960392|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
124548061|NCT00902486|447960393|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
124548062|NCT00902486|447960394|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
124548063|NCT00902486|447960395|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
124548064|NCT00902486|447960390|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
124548065|NCT00902486|447960391|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
124548066|NCT00902486|447960392|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
124548067|NCT00902486|447960393|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
124548068|NCT00902486|447960394|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
124705928|NCT02958865|448548505|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124705929|NCT02958865|448548506|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124705930|NCT02958865|448548491|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
124705931|NCT02958865|448548492|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
124705932|NCT02958865|448548493|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
124945222|NCT02499328|449426589|FG003|Overall Study|Lost to Follow-up|2|||
124945223|NCT02499328|449426590|FG004|Overall Study|Lost to Follow-up|0|||
124945224|NCT02499328|449426591|FG005|Overall Study|Lost to Follow-up|0|||
124945225|NCT02499328|449426592|FG006|Overall Study|Lost to Follow-up|0|||
124945226|NCT02499328|449426593|FG007|Overall Study|Lost to Follow-up|2|||
124945227|NCT02499328|449426594|FG008|Overall Study|Lost to Follow-up|3|||
124945228|NCT02499328|449426595|FG009|Overall Study|Lost to Follow-up|0|||
124945229|NCT02499328|449426596|FG010|Overall Study|Lost to Follow-up|0|||
124945230|NCT02499328|449426597|FG011|Overall Study|Lost to Follow-up|0|||
124945231|NCT02499328|449426598|FG012|Overall Study|Lost to Follow-up|0|||
124945232|NCT02499328|449426599|FG013|Overall Study|Lost to Follow-up|0|||
124945233|NCT02499328|449426600|FG014|Overall Study|Lost to Follow-up|0|||
124945234|NCT02499328|449426601|FG015|Overall Study|Lost to Follow-up|0|||
124945235|NCT02499328|449426602|FG016|Overall Study|Lost to Follow-up|0|||
124945236|NCT02499328|449426603|FG017|Overall Study|Lost to Follow-up|0|||
124945237|NCT02499328|449426604|FG018|Overall Study|Lost to Follow-up|1|||
124945238|NCT02499328|449426586|FG000|Overall Study|Death|0|||
124705933|NCT02958865|448548494|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
124705934|NCT02958865|448548495|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
124705935|NCT02958865|448548496|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
124945239|NCT02499328|449426587|FG001|Overall Study|Death|3|||
124945240|NCT02499328|449426588|FG002|Overall Study|Death|3|||
124945241|NCT02499328|449426589|FG003|Overall Study|Death|2|||
124945242|NCT02499328|449426590|FG004|Overall Study|Death|4|||
124945243|NCT02499328|449426591|FG005|Overall Study|Death|7|||
124945244|NCT02499328|449426592|FG006|Overall Study|Death|3|||
124945245|NCT02499328|449426593|FG007|Overall Study|Death|0|||
124945246|NCT02499328|449426594|FG008|Overall Study|Death|2|||
124945247|NCT02499328|449426595|FG009|Overall Study|Death|6|||
124945248|NCT02499328|449426596|FG010|Overall Study|Death|6|||
124945249|NCT02499328|449426597|FG011|Overall Study|Death|20|||
124945250|NCT02499328|449426598|FG012|Overall Study|Death|9|||
124945251|NCT02499328|449426599|FG013|Overall Study|Death|7|||
124945252|NCT02499328|449426600|FG014|Overall Study|Death|3|||
124945253|NCT02499328|449426601|FG015|Overall Study|Death|1|||
124945254|NCT02499328|449426602|FG016|Overall Study|Death|1|||
124945255|NCT02499328|449426603|FG017|Overall Study|Death|16|||
124945256|NCT02499328|449426604|FG018|Overall Study|Death|5|||
124945257|NCT02499328|449426586|FG000|Overall Study|"Other"|2|||
124945258|NCT02499328|449426587|FG001|Overall Study|"Other"|2|||
124945259|NCT02499328|449426588|FG002|Overall Study|"Other"|1|||
124945260|NCT02499328|449426589|FG003|Overall Study|"Other"|3|||
124945261|NCT02499328|449426590|FG004|Overall Study|"Other"|6|||
124548069|NCT00902486|447960395|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
124548070|NCT00902486|447960390|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
124548071|NCT00902486|447960391|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
124548072|NCT00902486|447960392|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
124548073|NCT00902486|447960393|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
124548074|NCT00902486|447960394|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
124548075|NCT00902486|447960395|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
124548076|NCT00902486|447960390|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
124548077|NCT00902486|447960391|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
124548078|NCT00902486|447960392|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
124548079|NCT00902486|447960393|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
124548080|NCT00902486|447960394|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
124548081|NCT00902486|447960395|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
124548082|NCT00902486|447960390|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
124548083|NCT00902486|447960391|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
124548084|NCT00902486|447960392|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
124548085|NCT00902486|447960393|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
124548086|NCT00902486|447960394|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
124548087|NCT00902486|447960395|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
124548088|NCT00902486|447960390|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
124548089|NCT00902486|447960391|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
124548090|NCT00902486|447960392|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
124548091|NCT00902486|447960393|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
124548092|NCT00902486|447960394|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
124548093|NCT00902486|447960395|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
124548094|NCT02332655|447960396|FG000|Overall Study|Lack of Efficacy|1|||
124548095|NCT03505606|447962463|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
124548096|NCT03505606|447962464|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
124548097|NCT03505606|447962465|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
124548098|NCT03505606|447962463|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
124548099|NCT03505606|447962464|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
124705936|NCT02958865|448548497|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
124705937|NCT02958865|448548498|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
124705938|NCT02958865|448548499|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
124705939|NCT02958865|448548500|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
124705940|NCT02958865|448548501|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
124705941|NCT02958865|448548502|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
124705942|NCT02958865|448548503|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
124705943|NCT02958865|448548504|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
124705944|NCT02958865|448548505|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
124705945|NCT02958865|448548506|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
124705946|NCT02958865|448548491|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
124705947|NCT02958865|448548492|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
124705948|NCT02958865|448548493|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
124945262|NCT02499328|449426591|FG005|Overall Study|"Other"|2|||
124945263|NCT02499328|449426592|FG006|Overall Study|"Other"|3|||
124945264|NCT02499328|449426593|FG007|Overall Study|"Other"|4|||
124945265|NCT02499328|449426594|FG008|Overall Study|"Other"|6|||
124945266|NCT02499328|449426595|FG009|Overall Study|"Other"|16|||
124945267|NCT02499328|449426596|FG010|Overall Study|"Other"|13|||
124945268|NCT02499328|449426597|FG011|Overall Study|"Other"|31|||
124945269|NCT02499328|449426598|FG012|Overall Study|"Other"|8|||
124945270|NCT02499328|449426599|FG013|Overall Study|"Other"|7|||
124945271|NCT02499328|449426600|FG014|Overall Study|"Other"|6|||
124945272|NCT02499328|449426601|FG015|Overall Study|"Other"|0|||
124945273|NCT02499328|449426602|FG016|Overall Study|"Other"|0|||
124945274|NCT02499328|449426603|FG017|Overall Study|"Other"|34|||
124945275|NCT02499328|449426604|FG018|Overall Study|"Other"|43|||
124945276|NCT02499328|449426586|FG000|Overall Study|Disease Progression|0|||
124945277|NCT02499328|449426587|FG001|Overall Study|Disease Progression|0|||
124945278|NCT02499328|449426588|FG002|Overall Study|Disease Progression|0|||
124945279|NCT02499328|449426589|FG003|Overall Study|Disease Progression|0|||
124945280|NCT02499328|449426590|FG004|Overall Study|Disease Progression|0|||
124945281|NCT02499328|449426591|FG005|Overall Study|Disease Progression|0|||
124945282|NCT02499328|449426592|FG006|Overall Study|Disease Progression|1|||
124945283|NCT02499328|449426593|FG007|Overall Study|Disease Progression|0|||
124945284|NCT02499328|449426594|FG008|Overall Study|Disease Progression|1|||
124945285|NCT02499328|449426595|FG009|Overall Study|Disease Progression|0|||
124945286|NCT02499328|449426596|FG010|Overall Study|Disease Progression|1|||
124945287|NCT02499328|449426597|FG011|Overall Study|Disease Progression|0|||
124945288|NCT02499328|449426598|FG012|Overall Study|Disease Progression|0|||
124945289|NCT02499328|449426599|FG013|Overall Study|Disease Progression|0|||
124945290|NCT02499328|449426600|FG014|Overall Study|Disease Progression|0|||
124945291|NCT02499328|449426601|FG015|Overall Study|Disease Progression|0|||
124945292|NCT02499328|449426602|FG016|Overall Study|Disease Progression|0|||
124945293|NCT02499328|449426603|FG017|Overall Study|Disease Progression|2|||
124945294|NCT02499328|449426604|FG018|Overall Study|Disease Progression|0|||
124945295|NCT02499328|449426586|FG000|Overall Study|Adverse Event|1|||
124945296|NCT02499328|449426587|FG001|Overall Study|Adverse Event|0|||
124945297|NCT02499328|449426588|FG002|Overall Study|Adverse Event|0|||
124945298|NCT02499328|449426589|FG003|Overall Study|Adverse Event|1|||
124945299|NCT02499328|449426590|FG004|Overall Study|Adverse Event|0|||
124945300|NCT02499328|449426591|FG005|Overall Study|Adverse Event|0|||
124705949|NCT02958865|448548494|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
124705950|NCT02958865|448548495|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
124705951|NCT02958865|448548496|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
124945301|NCT02499328|449426592|FG006|Overall Study|Adverse Event|0|||
124945302|NCT02499328|449426593|FG007|Overall Study|Adverse Event|0|||
124945303|NCT02499328|449426594|FG008|Overall Study|Adverse Event|0|||
124945304|NCT02499328|449426595|FG009|Overall Study|Adverse Event|0|||
124945305|NCT02499328|449426596|FG010|Overall Study|Adverse Event|0|||
124945306|NCT02499328|449426597|FG011|Overall Study|Adverse Event|0|||
124945307|NCT02499328|449426598|FG012|Overall Study|Adverse Event|1|||
124548100|NCT03505606|447962465|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
124945308|NCT02499328|449426599|FG013|Overall Study|Adverse Event|0|||
124945309|NCT02499328|449426600|FG014|Overall Study|Adverse Event|0|||
124945310|NCT02499328|449426601|FG015|Overall Study|Adverse Event|0|||
124945311|NCT02499328|449426602|FG016|Overall Study|Adverse Event|0|||
124945312|NCT02499328|449426603|FG017|Overall Study|Adverse Event|0|||
124458564|NCT00879645|447638239|FG002|Overall Study|Adverse Event|0|||
124458565|NCT00879645|447638240|FG003|Overall Study|Adverse Event|0|||
124458566|NCT03631732|447638241|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
124458567|NCT03631732|447638242|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
124458568|NCT03631732|447638241|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
124458569|NCT03631732|447638242|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
124458570|NCT03631732|447638241|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
124458571|NCT03631732|447638242|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
124458572|NCT03631732|447638241|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
124458573|NCT03631732|447638242|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
124458574|NCT03631732|447638241|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
124458575|NCT03631732|447638242|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
124458576|NCT03631732|447638241|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
124458577|NCT03631732|447638242|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
124458578|NCT03631732|447638241|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
124458579|NCT03631732|447638242|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
124458580|NCT03631732|447638241|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
124458581|NCT03631732|447638242|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
124458582|NCT03631732|447638241|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
124458583|NCT03631732|447638242|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
124458584|NCT03631732|447638241|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
124458585|NCT03631732|447638242|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
124945313|NCT02499328|449426604|FG018|Overall Study|Adverse Event|0|||
124945314|NCT00145470|449426605|FG000|Overall Study|Adverse Event|19|||
124945315|NCT00145470|449426606|FG001|Overall Study|Adverse Event|25|||
124945316|NCT00145470|449426605|FG000|Overall Study|Lack of Efficacy|27|||
124945317|NCT00145470|449426606|FG001|Overall Study|Lack of Efficacy|13|||
124945318|NCT00145470|449426605|FG000|Overall Study|Withdrawal by Subject|36|||
124945319|NCT00145470|449426606|FG001|Overall Study|Withdrawal by Subject|34|||
124945320|NCT00145470|449426605|FG000|Overall Study|Lost to Follow-up|21|||
124945321|NCT00145470|449426606|FG001|Overall Study|Lost to Follow-up|17|||
124945322|NCT00145470|449426605|FG000|Overall Study|Reason Not Reported|9|||
124945323|NCT00145470|449426606|FG001|Overall Study|Reason Not Reported|9|||
124945324|NCT06269003|449426608|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
124945325|NCT06269003|449426609|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
124945326|NCT06269003|449426610|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
124945327|NCT06269003|449426611|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
124945328|NCT04186247|449426612|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
124945329|NCT04186247|449426613|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
124945330|NCT04186247|449426614|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
124945331|NCT04186247|449426615|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
124945332|NCT04186247|449426616|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
124945333|NCT04323800|449428194|FG000|Overall Study|Withdrawal by Subject|4|||
124945334|NCT04323800|449428195|FG001|Overall Study|Withdrawal by Subject|4|||
124945335|NCT04323800|449428194|FG000|Overall Study|Incomplete transfusion|1|||
124945336|NCT04323800|449428195|FG001|Overall Study|Incomplete transfusion|0|||
124945337|NCT04323800|449428194|FG000|Overall Study|Other|0|||
124945338|NCT04323800|449428195|FG001|Overall Study|Other|1|||
124945339|NCT04323800|449428194|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
124945340|NCT04323800|449428195|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
124945341|NCT00489554|449428196|FG000|Overall Study|Adverse Event|2|||
124945342|NCT00489554|449428196|FG000|Overall Study|Withdrawal by Subject|1|||
124945343|NCT00489554|449428196|FG000|Overall Study|Lost to Follow-up|1|||
124945344|NCT06571695|449428197|FG000|Overall Study|Lost to Follow-up|1|||
124945345|NCT06571695|449428198|FG001|Overall Study|Lost to Follow-up|6|||
124945346|NCT01380145|449428199|FG000|Overall Study|Progressive disease|4|||
124945347|NCT02038049|449428204|FG000|Overall Study|Lost to Follow-up|1|||
124945348|NCT02038049|449428205|FG001|Overall Study|Lost to Follow-up|0|||
124945349|NCT01808534|449428206|FG000|Overall Study|Disease progression|3|||
124945350|NCT01808534|449428206|FG000|Overall Study|Physician Decision|1|||
124945351|NCT02660086|449428207|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
124945352|NCT02660086|449428208|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
124945353|NCT02660086|449428207|FG000|Overall Study- 12-month|Left full-time employment|12|||
124945354|NCT02660086|449428208|FG001|Overall Study- 12-month|Left full-time employment|20|||
124458586|NCT04288154|447638243|FG000|Overall Study|Withdrawal by Subject|9|||
124458587|NCT04288154|447638244|FG001|Overall Study|Withdrawal by Subject|9|||
124945355|NCT02660086|449428207|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
124945356|NCT02660086|449428208|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
124945357|NCT02660086|449428207|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
124945358|NCT02660086|449428208|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
124945359|NCT02660086|449428207|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
124945360|NCT02660086|449428208|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
124945361|NCT02660086|449428207|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
124945362|NCT02660086|449428208|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
124945363|NCT00667017|449428211|FG000|Overall Study|Withdrawal by Subject|1|||
124945364|NCT01673594|449428219|FG000|Overall Study|Adverse Event|3|||
124945365|NCT01673594|449428220|FG001|Overall Study|Adverse Event|1|||
124945366|NCT01673594|449428219|FG000|Overall Study|Lost to Follow-up|1|||
124945367|NCT01673594|449428220|FG001|Overall Study|Lost to Follow-up|0|||
124945368|NCT01673594|449428219|FG000|Overall Study|Physician Decision|2|||
124945369|NCT01673594|449428220|FG001|Overall Study|Physician Decision|4|||
124945370|NCT01673594|449428219|FG000|Overall Study|Withdrawal by Subject|0|||
124945371|NCT01673594|449428220|FG001|Overall Study|Withdrawal by Subject|1|||
124945372|NCT02605174|449428226|FG000|Overall Study|Adverse Event|0|||
124945373|NCT02605174|449428227|FG001|Overall Study|Adverse Event|0|||
124945374|NCT02605174|449428228|FG002|Overall Study|Adverse Event|1|||
124945375|NCT02605174|449428229|FG003|Overall Study|Adverse Event|0|||
124945376|NCT02605174|449428230|FG004|Overall Study|Adverse Event|4|||
124945377|NCT02605174|449428231|FG005|Overall Study|Adverse Event|0|||
124945378|NCT02605174|449428232|FG006|Overall Study|Adverse Event|0|||
124945379|NCT02605174|449428226|FG000|Overall Study|Lost to Follow-up|20|||
124945380|NCT02605174|449428227|FG001|Overall Study|Lost to Follow-up|7|||
124945381|NCT02605174|449428228|FG002|Overall Study|Lost to Follow-up|27|||
124945382|NCT02605174|449428229|FG003|Overall Study|Lost to Follow-up|10|||
124945383|NCT02605174|449428230|FG004|Overall Study|Lost to Follow-up|20|||
124945384|NCT02605174|449428231|FG005|Overall Study|Lost to Follow-up|10|||
124458588|NCT01624662|447638245|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
124458589|NCT01624662|447638246|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
124458590|NCT01624662|447638247|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
124458591|NCT01624662|447638248|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
124458592|NCT01624662|447638245|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
124458593|NCT01624662|447638246|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
124458594|NCT01624662|447638247|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
124458595|NCT01624662|447638248|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
124458596|NCT01624662|447638245|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
124458597|NCT01624662|447638246|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
124458598|NCT01624662|447638247|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
124458599|NCT01624662|447638248|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
124458600|NCT01624662|447638245|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
124458601|NCT01624662|447638246|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
124458602|NCT01624662|447638247|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
124945385|NCT02605174|449428232|FG006|Overall Study|Lost to Follow-up|29|||
124945386|NCT02605174|449428226|FG000|Overall Study|Protocol Violation|10|||
124945387|NCT02605174|449428227|FG001|Overall Study|Protocol Violation|4|||
124945388|NCT02605174|449428228|FG002|Overall Study|Protocol Violation|14|||
124945389|NCT02605174|449428229|FG003|Overall Study|Protocol Violation|6|||
124945390|NCT02605174|449428230|FG004|Overall Study|Protocol Violation|7|||
124458603|NCT01624662|447638248|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
124458604|NCT01624662|447638245|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
124458605|NCT01624662|447638246|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
124458606|NCT01624662|447638247|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
124458607|NCT01624662|447638248|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
124458608|NCT01624662|447638245|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
124945391|NCT02605174|449428231|FG005|Overall Study|Protocol Violation|7|||
124945392|NCT02605174|449428232|FG006|Overall Study|Protocol Violation|12|||
124945393|NCT02605174|449428226|FG000|Overall Study|Pregnancy|1|||
124945394|NCT02605174|449428227|FG001|Overall Study|Pregnancy|0|||
124945395|NCT02605174|449428228|FG002|Overall Study|Pregnancy|0|||
124945396|NCT02605174|449428229|FG003|Overall Study|Pregnancy|2|||
124945397|NCT02605174|449428230|FG004|Overall Study|Pregnancy|0|||
124945398|NCT02605174|449428231|FG005|Overall Study|Pregnancy|0|||
124945399|NCT02605174|449428232|FG006|Overall Study|Pregnancy|0|||
124945400|NCT02605174|449428226|FG000|Overall Study|Withdrawal by Subject|9|||
124945401|NCT02605174|449428227|FG001|Overall Study|Withdrawal by Subject|6|||
124945402|NCT02605174|449428228|FG002|Overall Study|Withdrawal by Subject|14|||
124945403|NCT02605174|449428229|FG003|Overall Study|Withdrawal by Subject|11|||
124945404|NCT02605174|449428230|FG004|Overall Study|Withdrawal by Subject|6|||
124945405|NCT02605174|449428231|FG005|Overall Study|Withdrawal by Subject|4|||
124945406|NCT02605174|449428232|FG006|Overall Study|Withdrawal by Subject|15|||
124945407|NCT02605174|449428226|FG000|Overall Study|Physician Decision|2|||
124945408|NCT02605174|449428227|FG001|Overall Study|Physician Decision|0|||
124945409|NCT02605174|449428228|FG002|Overall Study|Physician Decision|0|||
124945410|NCT02605174|449428229|FG003|Overall Study|Physician Decision|0|||
124945411|NCT02605174|449428230|FG004|Overall Study|Physician Decision|0|||
124945412|NCT02605174|449428231|FG005|Overall Study|Physician Decision|0|||
124945413|NCT02605174|449428232|FG006|Overall Study|Physician Decision|3|||
124945414|NCT02605174|449428226|FG000|Overall Study|Randomization Failure|22|||
124945415|NCT02605174|449428227|FG001|Overall Study|Randomization Failure|6|||
124945416|NCT02605174|449428228|FG002|Overall Study|Randomization Failure|20|||
124945417|NCT02605174|449428229|FG003|Overall Study|Randomization Failure|7|||
124945418|NCT02605174|449428230|FG004|Overall Study|Randomization Failure|16|||
124945419|NCT02605174|449428231|FG005|Overall Study|Randomization Failure|11|||
124945420|NCT02605174|449428232|FG006|Overall Study|Randomization Failure|30|||
124945421|NCT03737110|449428234|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
124945422|NCT03737110|449428235|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
124945423|NCT03737110|449428236|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
124945424|NCT03737110|449428237|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
124945425|NCT03737110|449428238|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
124945426|NCT03737110|449428239|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
124945427|NCT03737110|449428234|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
124945428|NCT03737110|449428235|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
124945429|NCT03737110|449428236|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
124945430|NCT03737110|449428237|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
124945431|NCT03737110|449428238|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
124945432|NCT03737110|449428239|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
124945433|NCT03737110|449428234|FG000|Run-in (RI) Period|Adverse Event|4|||
124945434|NCT03737110|449428235|FG001|Run-in (RI) Period|Adverse Event|0|||
124945435|NCT03737110|449428236|FG002|Run-in (RI) Period|Adverse Event|0|||
124945436|NCT03737110|449428237|FG003|Run-in (RI) Period|Adverse Event|0|||
124945437|NCT03737110|449428238|FG004|Run-in (RI) Period|Adverse Event|0|||
124945438|NCT03737110|449428239|FG005|Run-in (RI) Period|Adverse Event|0|||
124945439|NCT03737110|449428234|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
124945440|NCT03737110|449428235|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
124945441|NCT03737110|449428236|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
124945442|NCT03737110|449428237|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
124945443|NCT03737110|449428238|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
124945444|NCT03737110|449428239|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
124945445|NCT03737110|449428234|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
124945446|NCT03737110|449428235|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
124945447|NCT03737110|449428236|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
124945448|NCT03737110|449428237|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
124945449|NCT03737110|449428238|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
124945450|NCT03737110|449428239|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
124945451|NCT03737110|449428234|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
124945452|NCT03737110|449428235|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
124945453|NCT03737110|449428236|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
124945454|NCT03737110|449428237|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
124945455|NCT03737110|449428238|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
124945456|NCT03737110|449428239|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
124945457|NCT03737110|449428234|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
124945458|NCT03737110|449428235|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
124945459|NCT03737110|449428236|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
124945460|NCT03737110|449428237|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
124945461|NCT03737110|449428238|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
124945462|NCT03737110|449428239|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
124945463|NCT03737110|449428234|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
124945464|NCT03737110|449428235|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
124945465|NCT03737110|449428236|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
124945466|NCT03737110|449428237|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
124945467|NCT03737110|449428238|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
124945468|NCT03737110|449428239|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
124945469|NCT02575365|449428244|FG000|Overall Study|Lost to Follow-up|4|||
124945470|NCT03392194|449428245|FG000|Overall Study|Withdrawal by Subject|1|||
124945471|NCT03392194|449428246|FG001|Overall Study|Withdrawal by Subject|2|||
124945472|NCT03392194|449428245|FG000|Overall Study|Conflicts with personal schedule|1|||
124945473|NCT03392194|449428246|FG001|Overall Study|Conflicts with personal schedule|0|||
124945474|NCT03865732|449428247|FG000|Overall Study|Adverse Event|0|||
124945475|NCT03865732|449428248|FG001|Overall Study|Adverse Event|1|||
124945476|NCT01951703|449428262|FG000|First Intervention|Withdrawal by Subject|1|||
124945477|NCT01951703|449428263|FG001|First Intervention|Withdrawal by Subject|0|||
124945478|NCT01951703|449428262|FG000|First Intervention|Subject was not compliant|1|||
124945479|NCT01951703|449428263|FG001|First Intervention|Subject was not compliant|1|||
124945480|NCT01951703|449428262|FG000|First Intervention|Physician Decision|1|||
124945481|NCT01951703|449428263|FG001|First Intervention|Physician Decision|0|||
124945482|NCT01951703|449428262|FG000|Second Intervention|Protocol Violation|0|||
124945483|NCT01951703|449428263|FG001|Second Intervention|Protocol Violation|1|||
124945484|NCT01951703|449428262|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
124945485|NCT01951703|449428263|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
124945486|NCT01009645|449428264|FG000|Overall Study|Lost to Follow-up|2|||
124945487|NCT01009645|449428265|FG001|Overall Study|Lost to Follow-up|8|||
124945488|NCT01009645|449428266|FG002|Overall Study|Lost to Follow-up|4|||
124945489|NCT01009645|449428267|FG003|Overall Study|Lost to Follow-up|5|||
124945490|NCT00620854|449428268|FG000|Washout 1|Withdrawal by Subject|0|||
124945491|NCT00620854|449428269|FG001|Washout 1|Withdrawal by Subject|0|||
124945492|NCT00620854|449428270|FG002|Washout 1|Withdrawal by Subject|1|||
124945493|NCT00620854|449428271|FG003|Washout 1|Withdrawal by Subject|1|||
124945494|NCT00620854|449428272|FG004|Washout 1|Withdrawal by Subject|0|||
124945495|NCT00620854|449428273|FG005|Washout 1|Withdrawal by Subject|0|||
124945496|NCT05124210|449428275|FG000|Overall Study|Lost to Follow-up|1|||
124945497|NCT05124210|449428276|FG001|Overall Study|Lost to Follow-up|0|||
124945498|NCT05124210|449428275|FG000|Overall Study|Withdrawal by Subject|1|||
124945499|NCT05124210|449428276|FG001|Overall Study|Withdrawal by Subject|0|||
124945500|NCT01428583|449428278|FG000|Overall Study|Adverse Event|75|||
124945501|NCT01428583|449428278|FG000|Overall Study|Withdrawal by Subject|51|||
124945502|NCT01428583|449428278|FG000|Overall Study|Lack of Efficacy|37|||
124945503|NCT01428583|449428278|FG000|Overall Study|Lost to Follow-up|17|||
124945504|NCT01428583|449428278|FG000|Overall Study|Death|1|||
124945505|NCT01428583|449428278|FG000|Overall Study|Pregnancy|1|||
124945506|NCT01428583|449428278|FG000|Overall Study|Protocol Violation|1|||
124945507|NCT01428583|449428278|FG000|Overall Study|Physician Decision|12|||
124945508|NCT01428583|449428278|FG000|Overall Study|Non-compliant|25|||
124945509|NCT01428583|449428278|FG000|Overall Study|Confirmed positive urine drug test|8|||
124945510|NCT01428583|449428278|FG000|Overall Study|Sponsor's request|3|||
124945511|NCT01428583|449428278|FG000|Overall Study|Other|6|||
124945512|NCT00768755|449428281|FG000|Phase 1|Death|6|||
124945513|NCT00768755|449428282|FG001|Phase 1|Death|0|||
124945514|NCT00768755|449428283|FG002|Phase 1|Death|0|||
124945515|NCT00768755|449428284|FG003|Phase 1|Death|0|||
124945516|NCT00768755|449428281|FG000|Phase 1|Other|4|||
124945517|NCT00768755|449428282|FG001|Phase 1|Other|0|||
124945518|NCT00768755|449428283|FG002|Phase 1|Other|0|||
124945519|NCT00768755|449428284|FG003|Phase 1|Other|0|||
124945520|NCT00768755|449428281|FG000|Phase 2|Death|0|||
124945521|NCT00768755|449428282|FG001|Phase 2|Death|37|||
124945522|NCT00768755|449428283|FG002|Phase 2|Death|48|||
124945523|NCT00768755|449428284|FG003|Phase 2|Death|31|||
124945524|NCT00768755|449428281|FG000|Phase 2|Protocol Violation|0|||
124945525|NCT00768755|449428282|FG001|Phase 2|Protocol Violation|2|||
124945526|NCT00768755|449428283|FG002|Phase 2|Protocol Violation|0|||
124945527|NCT00768755|449428284|FG003|Phase 2|Protocol Violation|1|||
124945528|NCT00768755|449428281|FG000|Phase 2|Lost to Follow-up|0|||
124945529|NCT00768755|449428282|FG001|Phase 2|Lost to Follow-up|1|||
124945530|NCT00768755|449428283|FG002|Phase 2|Lost to Follow-up|1|||
124945531|NCT00768755|449428284|FG003|Phase 2|Lost to Follow-up|4|||
124945532|NCT00768755|449428281|FG000|Phase 2|Withdrawal by Subject|0|||
124945533|NCT00768755|449428282|FG001|Phase 2|Withdrawal by Subject|1|||
124945534|NCT00768755|449428283|FG002|Phase 2|Withdrawal by Subject|0|||
124945535|NCT00768755|449428284|FG003|Phase 2|Withdrawal by Subject|1|||
124945536|NCT00768755|449428281|FG000|Phase 2|Other|0|||
124945537|NCT00768755|449428282|FG001|Phase 2|Other|1|||
124945538|NCT00768755|449428283|FG002|Phase 2|Other|2|||
124945539|NCT00768755|449428284|FG003|Phase 2|Other|4|||
124945540|NCT00768755|449428281|FG000|Phase 2|Study Terminated by Sponsor|0|||
124945541|NCT00768755|449428282|FG001|Phase 2|Study Terminated by Sponsor|13|||
124945542|NCT00768755|449428283|FG002|Phase 2|Study Terminated by Sponsor|7|||
124945543|NCT00768755|449428284|FG003|Phase 2|Study Terminated by Sponsor|14|||
124945544|NCT00768755|449428281|FG000|Phase 2|Randomized but not treated|0|||
124945545|NCT00768755|449428282|FG001|Phase 2|Randomized but not treated|0|||
124945546|NCT00768755|449428283|FG002|Phase 2|Randomized but not treated|0|||
124945547|NCT00768755|449428284|FG003|Phase 2|Randomized but not treated|2|||
124945548|NCT03184987|449428288|FG000|Overall Study|Withdrawal by Subject|0|||
124945549|NCT03184987|449428289|FG001|Overall Study|Withdrawal by Subject|1|||
124945550|NCT03184987|449428290|FG002|Overall Study|Withdrawal by Subject|2|||
124945551|NCT03184987|449428288|FG000|Overall Study|Physician Decision|0|||
124945552|NCT03184987|449428289|FG001|Overall Study|Physician Decision|0|||
124945553|NCT03184987|449428290|FG002|Overall Study|Physician Decision|1|||
124945554|NCT03184987|449428288|FG000|Overall Study|Adverse Event|1|||
124945555|NCT03184987|449428289|FG001|Overall Study|Adverse Event|0|||
124945556|NCT03184987|449428290|FG002|Overall Study|Adverse Event|1|||
124945557|NCT01220999|449428291|FG000|Overall Study|Progressive disease|0|||
124945558|NCT01220999|449428292|FG001|Overall Study|Progressive disease|0|||
124945559|NCT01220999|449428293|FG002|Overall Study|Progressive disease|1|||
124945560|NCT01220999|449428294|FG003|Overall Study|Progressive disease|0|||
124945561|NCT01220999|449428295|FG004|Overall Study|Progressive disease|0|||
124945562|NCT01560429|449428296|FG000|Overall Study|Protocol Violation|3|||
124945563|NCT01560429|449428297|FG001|Overall Study|Protocol Violation|6|||
124945564|NCT03026166|449428306|FG000|Overall Study|Death|22|||
124945565|NCT03026166|449428307|FG001|Overall Study|Death|7|||
124945566|NCT03026166|449428306|FG000|Overall Study|Physician Decision|2|||
124945567|NCT03026166|449428307|FG001|Overall Study|Physician Decision|0|||
124945568|NCT03026166|449428306|FG000|Overall Study|Withdrawal by Subject|1|||
124945569|NCT03026166|449428307|FG001|Overall Study|Withdrawal by Subject|2|||
124945570|NCT03026166|449428306|FG000|Overall Study|Lost to Follow-up|1|||
124945571|NCT03026166|449428307|FG001|Overall Study|Lost to Follow-up|0|||
124945572|NCT03026166|449428306|FG000|Overall Study|Study Terminated by Sponsor|3|||
124548101|NCT03505606|447962463|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
124548102|NCT03505606|447962464|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
124945573|NCT03026166|449428307|FG001|Overall Study|Study Terminated by Sponsor|3|||
124945574|NCT03026166|449428306|FG000|Overall Study|Other|1|||
124945575|NCT03026166|449428307|FG001|Overall Study|Other|0|||
124945576|NCT03035942|449428308|FG000|Overall Study|Adverse Event|8|||
124945577|NCT03035942|449428309|FG001|Overall Study|Adverse Event|4|||
124945578|NCT03035942|449428310|FG002|Overall Study|Adverse Event|5|||
124945579|NCT05270460|449428311|FG000|Overall Study|Adverse Event|0|||
124945580|NCT05270460|449428312|FG001|Overall Study|Adverse Event|1|||
124945581|NCT05270460|449428313|FG002|Overall Study|Adverse Event|0|||
124945582|NCT05270460|449428311|FG000|Overall Study|Early Termination|0|||
124945583|NCT05270460|449428312|FG001|Overall Study|Early Termination|1|||
124945584|NCT05270460|449428313|FG002|Overall Study|Early Termination|0|||
124945585|NCT02091752|449428314|FG000|Overall Study|Study terminated by Sponsor|2|||
124945586|NCT02091752|449428314|FG000|Overall Study|Adverse Event|1|||
124945587|NCT01989104|449428315|FG000|Overall Study|Withdrawal by Subject|3|||
124945588|NCT01989104|449428316|FG001|Overall Study|Withdrawal by Subject|0|||
124945589|NCT01989104|449428317|FG002|Overall Study|Withdrawal by Subject|0|||
124945590|NCT01989104|449428318|FG003|Overall Study|Withdrawal by Subject|0|||
124945591|NCT01989104|449428319|FG004|Overall Study|Withdrawal by Subject|0|||
124548103|NCT03505606|447962465|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
124945592|NCT04029090|449428321|FG000|Overall Study|Protocol Violation|1|||
124945593|NCT04029090|449428322|FG001|Overall Study|Protocol Violation|0|||
124945594|NCT04029090|449428323|FG002|Overall Study|Protocol Violation|0|||
124945595|NCT04029090|449428321|FG000|Overall Study|Withdrawal by Subject|0|||
124945596|NCT04029090|449428322|FG001|Overall Study|Withdrawal by Subject|1|||
124945597|NCT04029090|449428323|FG002|Overall Study|Withdrawal by Subject|0|||
124945598|NCT01065779|449428327|FG000|Overall Study|Duplicate Investigation|1|||
124945599|NCT01065779|449428327|FG000|Overall Study|Investigation Before Contract Date|37|||
124945600|NCT01065779|449428327|FG000|Overall Study|Non-enrollment Period Administration|10|||
124945601|NCT01065779|449428327|FG000|Overall Study|Not Administered With Study Drug|17|||
124945602|NCT01065779|449428327|FG000|Overall Study|Failed to Follow-up|10|||
124945603|NCT01065779|449428327|FG000|Overall Study|Inclusion Criteria Violation|7|||
124945604|NCT02157948|449428328|FG000|Overall Study|Withdrawal by Subject|4|||
124945605|NCT02157948|449428329|FG001|Overall Study|Withdrawal by Subject|5|||
124945606|NCT02157948|449428328|FG000|Overall Study|Lost to Follow-up|3|||
124945607|NCT02157948|449428329|FG001|Overall Study|Lost to Follow-up|2|||
124945608|NCT02157948|449428328|FG000|Overall Study|Protocol Specified Criteria|2|||
124945609|NCT02157948|449428329|FG001|Overall Study|Protocol Specified Criteria|1|||
124945610|NCT02157948|449428328|FG000|Overall Study|Decision by Sponsor|0|||
124945611|NCT02157948|449428329|FG001|Overall Study|Decision by Sponsor|1|||
124945612|NCT01604824|449428330|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
124945613|NCT01604824|449428331|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
124945614|NCT01604824|449428332|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
124945615|NCT01604824|449428333|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
124945616|NCT01604824|449428334|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
124945617|NCT01604824|449428335|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
124945618|NCT01604824|449428330|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
124945619|NCT01604824|449428331|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
124945620|NCT01604824|449428332|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
124945621|NCT01604824|449428333|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
124945622|NCT01604824|449428334|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
124945623|NCT01604824|449428335|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
124945624|NCT03775213|449428342|FG000|Overall Study|Withdrawal by Subject|51|||
124945625|NCT03775213|449428343|FG001|Overall Study|Withdrawal by Subject|53|||
124548104|NCT03505606|447962463|FG000|Overall Study|Poor compliance with refractive correction|0|||
124548105|NCT03505606|447962464|FG001|Overall Study|Poor compliance with refractive correction|0|||
124548106|NCT03505606|447962465|FG002|Overall Study|Poor compliance with refractive correction|1|||
124548107|NCT03505606|447962463|FG000|Overall Study|Insufficient anisometropia|0|||
124548108|NCT03505606|447962464|FG001|Overall Study|Insufficient anisometropia|0|||
124548109|NCT03505606|447962465|FG002|Overall Study|Insufficient anisometropia|2|||
124548110|NCT03505606|447962463|FG000|Overall Study|Ectopia Lentis|0|||
124548111|NCT03505606|447962464|FG001|Overall Study|Ectopia Lentis|0|||
124548112|NCT03505606|447962465|FG002|Overall Study|Ectopia Lentis|1|||
124548113|NCT03505606|447962463|FG000|Overall Study|alternation of amblyopic eye|0|||
124548114|NCT03505606|447962464|FG001|Overall Study|alternation of amblyopic eye|1|||
124548115|NCT03505606|447962465|FG002|Overall Study|alternation of amblyopic eye|0|||
124548116|NCT01808508|447962491|FG000|Overall Study|Lost to Follow-up|1|||
124945626|NCT03775213|449428342|FG000|Overall Study|Incomplete Survey|7|||
124945627|NCT03775213|449428343|FG001|Overall Study|Incomplete Survey|7|||
124945628|NCT04821271|449428344|FG000|Period 1|Withdrawal by Subject|2|||
124945629|NCT04821271|449428345|FG001|Period 1|Withdrawal by Subject|0|||
124945630|NCT01567852|449429172|FG000|Overall Study|Withdrawal by Subject|3|||
124945631|NCT01567852|449429173|FG001|Overall Study|Withdrawal by Subject|6|||
124548117|NCT01808508|447962492|FG001|Overall Study|Lost to Follow-up|0|||
124548118|NCT01808508|447962493|FG002|Overall Study|Lost to Follow-up|0|||
124548119|NCT01017731|447962494|FG000|Overall Study|Lost to Follow-up|2|||
124548120|NCT01017731|447962494|FG000|Overall Study|Withdrawal by Subject|3|||
124945632|NCT01567852|449429172|FG000|Overall Study|ECT discontinued|1|||
124945633|NCT01567852|449429173|FG001|Overall Study|ECT discontinued|1|||
124945634|NCT04809623|449429174|FG000|Overall Study|Study Terminated by Sponsor|1|||
124945635|NCT04809623|449429175|FG001|Overall Study|Study Terminated by Sponsor|0|||
124945636|NCT02202317|449429176|FG000|Overall Study|Lost to Follow-up|1|||
124945637|NCT01450007|449429182|FG000|Overall Study|Late exclusion before treatment|2|||
124945638|NCT01450007|449429183|FG001|Overall Study|Late exclusion before treatment|3|||
124945639|NCT01450007|449429184|FG002|Overall Study|Late exclusion before treatment|2|||
124945640|NCT01450007|449429182|FG000|Overall Study|Protocol Violation|0|||
124945641|NCT01450007|449429183|FG001|Overall Study|Protocol Violation|1|||
124945642|NCT01450007|449429184|FG002|Overall Study|Protocol Violation|1|||
124945643|NCT01450007|449429182|FG000|Overall Study|Adverse Event|0|||
124945644|NCT01450007|449429183|FG001|Overall Study|Adverse Event|1|||
124945645|NCT01450007|449429184|FG002|Overall Study|Adverse Event|0|||
124945646|NCT01852045|449429191|FG000|Overall Study|Adverse Event|1|||
124945647|NCT01852045|449429192|FG001|Overall Study|Adverse Event|0|||
124945648|NCT01852045|449429193|FG002|Overall Study|Adverse Event|0|||
124945649|NCT01852045|449429191|FG000|Overall Study|Lack of Efficacy|3|||
124945650|NCT01852045|449429192|FG001|Overall Study|Lack of Efficacy|0|||
124945651|NCT01852045|449429193|FG002|Overall Study|Lack of Efficacy|0|||
124945652|NCT01852045|449429191|FG000|Overall Study|Lost to Follow-up|0|||
124945653|NCT01852045|449429192|FG001|Overall Study|Lost to Follow-up|1|||
124945654|NCT01852045|449429193|FG002|Overall Study|Lost to Follow-up|1|||
124945655|NCT01852045|449429191|FG000|Overall Study|Withdrawal by Subject|1|||
124945656|NCT01852045|449429192|FG001|Overall Study|Withdrawal by Subject|0|||
124945657|NCT01852045|449429193|FG002|Overall Study|Withdrawal by Subject|1|||
124945658|NCT01852045|449429191|FG000|Overall Study|Other Miscellaneous Reasons|1|||
124945659|NCT01852045|449429192|FG001|Overall Study|Other Miscellaneous Reasons|3|||
124945660|NCT01852045|449429193|FG002|Overall Study|Other Miscellaneous Reasons|2|||
124945661|NCT00487240|449429196|FG000|Overall Study|Withdrawal by Subject|12|||
124945662|NCT00487240|449429197|FG001|Overall Study|Withdrawal by Subject|6|||
124945663|NCT00487240|449429196|FG000|Overall Study|Lost to Follow-up|7|||
124945664|NCT00487240|449429197|FG001|Overall Study|Lost to Follow-up|6|||
124945665|NCT00487240|449429196|FG000|Overall Study|Adverse Event|0|||
124945666|NCT00487240|449429197|FG001|Overall Study|Adverse Event|4|||
124945667|NCT00487240|449429196|FG000|Overall Study|Protocol Violation|5|||
124945668|NCT00487240|449429197|FG001|Overall Study|Protocol Violation|5|||
124945669|NCT00487240|449429196|FG000|Overall Study|Entry Criteria Not Met|3|||
124945670|NCT00487240|449429197|FG001|Overall Study|Entry Criteria Not Met|4|||
124945671|NCT00487240|449429196|FG000|Overall Study|Sponsor Decision|2|||
124945672|NCT00487240|449429197|FG001|Overall Study|Sponsor Decision|1|||
124945673|NCT00487240|449429196|FG000|Overall Study|Physician Decision|2|||
124945674|NCT00487240|449429197|FG001|Overall Study|Physician Decision|0|||
124945675|NCT01698918|449429198|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
124945676|NCT01698918|449429198|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
124945677|NCT01698918|449429198|FG000|First Line Treatment (Core+Extension)|Death|2|||
124945678|NCT01698918|449429198|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
124945679|NCT01698918|449429198|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
124945680|NCT01698918|449429198|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
124945681|NCT01698918|449429198|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
124945682|NCT01698918|449429198|FG000|Second Line Treatment (Core+Extension)|Death|1|||
124945683|NCT01698918|449429198|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
124945684|NCT01698918|449429198|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
124945685|NCT01019135|449429199|FG000|Overall Study|Did not receive allocated intervention|12|||
124945686|NCT01019135|449429200|FG001|Overall Study|Did not receive allocated intervention|6|||
124945687|NCT01019135|449429201|FG002|Overall Study|Did not receive allocated intervention|25|||
124945688|NCT01019135|449429199|FG000|Overall Study|Did not attend CR|8|||
124945689|NCT01019135|449429200|FG001|Overall Study|Did not attend CR|13|||
124945690|NCT01019135|449429201|FG002|Overall Study|Did not attend CR|6|||
124945691|NCT02095678|449429204|FG000|Overall Study|Withdrawal by Subject|0|||
124945692|NCT02095678|449429205|FG001|Overall Study|Withdrawal by Subject|1|||
124945693|NCT02095678|449429204|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
124945694|NCT02095678|449429205|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
124945695|NCT02095678|449429204|FG000|Overall Study|lesion impacted by previous treatment|1|||
124945696|NCT02095678|449429205|FG001|Overall Study|lesion impacted by previous treatment|1|||
124945697|NCT02095678|449429204|FG000|Overall Study|No Confirmed Diagnosis|0|||
124945698|NCT02095678|449429205|FG001|Overall Study|No Confirmed Diagnosis|3|||
124945699|NCT02095678|449429204|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
124945700|NCT02095678|449429205|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
124945701|NCT02095678|449429204|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
124945702|NCT02095678|449429205|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
124945703|NCT02203799|449429206|FG000|Overall Study|Withdrawal by Subject|3|||
124945704|NCT00681109|449429207|FG000|Overall Study|Lost to Follow-up|2|||
124945705|NCT00681109|449429208|FG001|Overall Study|Lost to Follow-up|6|||
124945706|NCT00681109|449429209|FG002|Overall Study|Lost to Follow-up|0|||
124945707|NCT04660799|449429210|FG000|Overall Study|Progressive Disease|1|||
124945708|NCT04660799|449429211|FG001|Overall Study|Progressive Disease|1|||
124945709|NCT04660799|449429210|FG000|Overall Study|Death|2|||
124945710|NCT04660799|449429211|FG001|Overall Study|Death|1|||
124945711|NCT04660799|449429210|FG000|Overall Study|Adverse Event|2|||
124945712|NCT04660799|449429211|FG001|Overall Study|Adverse Event|1|||
124945713|NCT04660799|449429210|FG000|Overall Study|Withdrawal by Subject|2|||
124945714|NCT04660799|449429211|FG001|Overall Study|Withdrawal by Subject|5|||
124945715|NCT02106884|449429216|FG000|Overall Study|Change of diagnosis/exclusion|0|||
124945716|NCT02106884|449429217|FG001|Overall Study|Change of diagnosis/exclusion|1|||
124945717|NCT02037568|449429220|FG000|Overall Study|Withdrawal by Subject|17|||
124945718|NCT02037568|449429221|FG001|Overall Study|Withdrawal by Subject|24|||
124945719|NCT02037568|449429220|FG000|Overall Study|Lost to Follow-up|16|||
124945720|NCT02037568|449429221|FG001|Overall Study|Lost to Follow-up|13|||
124945721|NCT02037568|449429220|FG000|Overall Study|Screen Failure|3|||
124945722|NCT02037568|449429221|FG001|Overall Study|Screen Failure|1|||
124945723|NCT02037568|449429220|FG000|Overall Study|Patient did not receive transplant|0|||
124945724|NCT02037568|449429221|FG001|Overall Study|Patient did not receive transplant|1|||
124945725|NCT03861234|449429222|FG000|Overall Study|Not treated|0|||
124945726|NCT03861234|449429223|FG001|Overall Study|Not treated|0|||
124945727|NCT03861234|449429224|FG002|Overall Study|Not treated|0|||
124945728|NCT03861234|449429225|FG003|Overall Study|Not treated|0|||
124945729|NCT03861234|449429226|FG004|Overall Study|Not treated|0|||
124945730|NCT03861234|449429227|FG005|Overall Study|Not treated|1|||
124945731|NCT03861234|449429228|FG006|Overall Study|Not treated|0|||
124945732|NCT03861234|449429229|FG007|Overall Study|Not treated|0|||
124945733|NCT03861234|449429222|FG000|Overall Study|Adverse Event|0|||
124945734|NCT03861234|449429223|FG001|Overall Study|Adverse Event|0|||
124945735|NCT03861234|449429224|FG002|Overall Study|Adverse Event|0|||
124945736|NCT03861234|449429225|FG003|Overall Study|Adverse Event|0|||
124458609|NCT01624662|447638246|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
124945737|NCT03861234|449429226|FG004|Overall Study|Adverse Event|0|||
124945738|NCT03861234|449429227|FG005|Overall Study|Adverse Event|1|||
124945739|NCT03861234|449429228|FG006|Overall Study|Adverse Event|0|||
124945740|NCT03861234|449429229|FG007|Overall Study|Adverse Event|0|||
124945741|NCT03861234|449429222|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
124945742|NCT03861234|449429223|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
124945743|NCT03861234|449429224|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
124945744|NCT03861234|449429225|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
124945745|NCT03861234|449429226|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
124945746|NCT03861234|449429227|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
124945747|NCT03861234|449429228|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
124945748|NCT03861234|449429229|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
124945749|NCT03861234|449429222|FG000|Overall Study|As per sponsor decision|0|||
124945750|NCT03861234|449429223|FG001|Overall Study|As per sponsor decision|0|||
124945751|NCT03861234|449429224|FG002|Overall Study|As per sponsor decision|0|||
124945752|NCT03861234|449429225|FG003|Overall Study|As per sponsor decision|0|||
124945753|NCT03861234|449429226|FG004|Overall Study|As per sponsor decision|0|||
124945754|NCT03861234|449429227|FG005|Overall Study|As per sponsor decision|0|||
124945755|NCT03861234|449429228|FG006|Overall Study|As per sponsor decision|1|||
124945756|NCT03861234|449429229|FG007|Overall Study|As per sponsor decision|0|||
124945757|NCT03861234|449429222|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
124945758|NCT03861234|449429223|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
124945759|NCT03861234|449429224|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
124945760|NCT03861234|449429225|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
124945761|NCT03861234|449429226|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
124945762|NCT03861234|449429227|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
124945763|NCT03861234|449429228|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
124458610|NCT01624662|447638247|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
124458611|NCT01624662|447638248|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
124458612|NCT01624662|447638245|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
124458613|NCT01624662|447638246|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
124458614|NCT01624662|447638247|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
124458615|NCT01624662|447638248|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
124458616|NCT00102960|447638256|FG000|Overall Study|Death|23|||
124458617|NCT00102960|447638257|FG001|Overall Study|Death|11|||
124458618|NCT00102960|447638258|FG002|Overall Study|Death|11|||
124458619|NCT00102960|447638256|FG000|Overall Study|Lost to Follow-up|6|||
124458620|NCT00102960|447638257|FG001|Overall Study|Lost to Follow-up|12|||
124458621|NCT00102960|447638258|FG002|Overall Study|Lost to Follow-up|16|||
124458622|NCT00102960|447638256|FG000|Overall Study|Withdrawal by Subject|1|||
124458623|NCT00102960|447638257|FG001|Overall Study|Withdrawal by Subject|0|||
124458624|NCT00102960|447638258|FG002|Overall Study|Withdrawal by Subject|1|||
124458625|NCT01849874|447640406|FG000|Overall Study|Death|89|||
124705952|NCT02958865|448548497|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
124945764|NCT03861234|449429229|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
124945765|NCT00621842|449429230|FG000|Overall Study|Adverse Event|6|||
124945766|NCT00621842|449429230|FG000|Overall Study|Withdrawal by Subject|7|||
124945767|NCT00621842|449429230|FG000|Overall Study|Protocol Violation|4|||
124945768|NCT00621842|449429230|FG000|Overall Study|Lack of Efficacy|2|||
124945769|NCT02066636|449429231|FG000|Overall Study|Disease progression|51|||
124945770|NCT02066636|449429232|FG001|Overall Study|Disease progression|60|||
124945771|NCT02066636|449429233|FG002|Overall Study|Disease progression|700|||
124945772|NCT02066636|449429231|FG000|Overall Study|Study drug toxicity|13|||
124945773|NCT02066636|449429232|FG001|Overall Study|Study drug toxicity|2|||
124458626|NCT01849874|447640407|FG001|Overall Study|Death|42|||
124458627|NCT01849874|447640406|FG000|Overall Study|Withdrawal by Subject|17|||
124945774|NCT02066636|449429233|FG002|Overall Study|Study drug toxicity|58|||
124945775|NCT02066636|449429231|FG000|Overall Study|Death|4|||
124945776|NCT02066636|449429232|FG001|Overall Study|Death|2|||
124705953|NCT02958865|448548498|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
124705954|NCT02958865|448548499|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
124705955|NCT02958865|448548500|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
124705956|NCT02958865|448548501|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
124945777|NCT02066636|449429233|FG002|Overall Study|Death|158|||
124945778|NCT02066636|449429231|FG000|Overall Study|Adverse event unrelated to study drug|6|||
124945779|NCT02066636|449429232|FG001|Overall Study|Adverse event unrelated to study drug|4|||
124945780|NCT02066636|449429233|FG002|Overall Study|Adverse event unrelated to study drug|45|||
124945781|NCT02066636|449429231|FG000|Overall Study|Participant request to discontinue treatment|12|||
124945782|NCT02066636|449429232|FG001|Overall Study|Participant request to discontinue treatment|12|||
124945783|NCT02066636|449429233|FG002|Overall Study|Participant request to discontinue treatment|70|||
124945784|NCT02066636|449429231|FG000|Overall Study|Participant withdrew consent|10|||
124945785|NCT02066636|449429232|FG001|Overall Study|Participant withdrew consent|18|||
124945786|NCT02066636|449429233|FG002|Overall Study|Participant withdrew consent|61|||
124945787|NCT02066636|449429231|FG000|Overall Study|Lost to Follow-up|0|||
124945788|NCT02066636|449429232|FG001|Overall Study|Lost to Follow-up|2|||
124945789|NCT02066636|449429233|FG002|Overall Study|Lost to Follow-up|2|||
124945790|NCT02066636|449429231|FG000|Overall Study|Maximum clinical benefit|2|||
124945791|NCT02066636|449429232|FG001|Overall Study|Maximum clinical benefit|2|||
124945792|NCT02066636|449429233|FG002|Overall Study|Maximum clinical benefit|3|||
124945793|NCT02066636|449429231|FG000|Overall Study|Poor/non-compliance|2|||
124945794|NCT02066636|449429232|FG001|Overall Study|Poor/non-compliance|1|||
124945795|NCT02066636|449429233|FG002|Overall Study|Poor/non-compliance|1|||
124945796|NCT02066636|449429231|FG000|Overall Study|Participant no loner meets study criteria|3|||
124945797|NCT02066636|449429232|FG001|Overall Study|Participant no loner meets study criteria|2|||
124945798|NCT02066636|449429233|FG002|Overall Study|Participant no loner meets study criteria|28|||
124945799|NCT02066636|449429231|FG000|Overall Study|Administrative reasons by sponsor|8|||
124945800|NCT02066636|449429232|FG001|Overall Study|Administrative reasons by sponsor|5|||
124945801|NCT02066636|449429233|FG002|Overall Study|Administrative reasons by sponsor|0|||
124945802|NCT02066636|449429231|FG000|Overall Study|Other reasons|16|||
124945803|NCT02066636|449429232|FG001|Overall Study|Other reasons|15|||
124945804|NCT02066636|449429233|FG002|Overall Study|Other reasons|50|||
124945805|NCT00391170|449429240|FG000|Overall Study|Withdrawal by Subject|1|||
124945806|NCT00391170|449429241|FG001|Overall Study|Withdrawal by Subject|0|||
124705957|NCT02958865|448548502|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
124945807|NCT00391170|449429240|FG000|Overall Study|Adverse Event|3|||
124548121|NCT01017731|447962494|FG000|Overall Study|Physician Decision|2|||
124945808|NCT00391170|449429241|FG001|Overall Study|Adverse Event|2|||
124945809|NCT00391170|449429240|FG000|Overall Study|Physician Decision|2|||
124705958|NCT02958865|448548503|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
124705959|NCT02958865|448548504|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
124705960|NCT02958865|448548505|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
124705961|NCT02958865|448548506|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
124705962|NCT02958865|448548491|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
124705963|NCT02958865|448548492|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
124705964|NCT02958865|448548493|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
124705965|NCT02958865|448548494|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
124705966|NCT02958865|448548495|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
124705967|NCT02958865|448548496|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
124705968|NCT02958865|448548497|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
124705969|NCT02958865|448548498|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
124705970|NCT02958865|448548499|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
124705971|NCT02958865|448548500|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
124705972|NCT02958865|448548501|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
124705973|NCT02958865|448548502|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
124705974|NCT02958865|448548503|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
124705975|NCT02958865|448548504|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
124705976|NCT02958865|448548505|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
124705977|NCT02958865|448548506|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
124705978|NCT02958865|448548491|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
124705979|NCT02958865|448548492|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
124705980|NCT02958865|448548493|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
124705981|NCT02958865|448548494|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
124705982|NCT02958865|448548495|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
124705983|NCT02958865|448548496|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
124705984|NCT02958865|448548497|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
124705985|NCT02958865|448548498|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
124705986|NCT02958865|448548499|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
124705987|NCT02958865|448548500|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
124705988|NCT02958865|448548501|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
124705989|NCT02958865|448548502|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
124705990|NCT02958865|448548503|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
124705991|NCT02958865|448548504|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
124705992|NCT02958865|448548505|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
124705993|NCT02958865|448548506|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
124705994|NCT02958865|448548491|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
124705995|NCT02958865|448548492|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
124705996|NCT02958865|448548493|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
124705997|NCT02958865|448548494|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
124705998|NCT02958865|448548495|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
124705999|NCT02958865|448548496|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
124706000|NCT02958865|448548497|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
124706001|NCT02958865|448548498|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
124706002|NCT02958865|448548499|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
124706003|NCT02958865|448548500|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
124706004|NCT02958865|448548501|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
124706005|NCT02958865|448548502|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
124706006|NCT02958865|448548503|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
124706007|NCT02958865|448548504|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
124706008|NCT02958865|448548505|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
124706009|NCT02958865|448548506|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
124706010|NCT02958865|448548491|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
124945810|NCT00391170|449429241|FG001|Overall Study|Physician Decision|2|||
124945811|NCT01218594|449429245|FG000|Overall Study|Death|1|||
124945812|NCT01218594|449429245|FG000|Overall Study|Withdrawal by Subject|3|||
124945813|NCT01218594|449429245|FG000|Overall Study|Adverse Event|2|||
124945814|NCT01218594|449429245|FG000|Overall Study|Physician Decision|6|||
124945815|NCT00452114|449429246|FG000|Overall Study|Physician Decision|3|||
124945816|NCT00452114|449429247|FG001|Overall Study|Physician Decision|3|||
124706011|NCT02958865|448548492|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
124706012|NCT02958865|448548493|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
124706013|NCT02958865|448548494|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
124706014|NCT02958865|448548495|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
124706015|NCT02958865|448548496|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
124706016|NCT02958865|448548497|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
124706017|NCT02958865|448548498|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
124706018|NCT02958865|448548499|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
124945817|NCT00949117|449430904|FG000|Overall Study|Lack of Efficacy|2|||
124945818|NCT00949117|449430905|FG001|Overall Study|Lack of Efficacy|3|||
124706019|NCT02958865|448548500|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
124706020|NCT02958865|448548501|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
124706021|NCT02958865|448548502|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
124706022|NCT02958865|448548503|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
124706023|NCT02958865|448548504|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
124706024|NCT02958865|448548505|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
124706025|NCT02958865|448548506|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
124706026|NCT02958865|448548491|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
124706027|NCT02958865|448548492|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
124706028|NCT02958865|448548493|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
124706029|NCT02958865|448548494|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
124706030|NCT02958865|448548495|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
124706031|NCT02958865|448548496|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
124706032|NCT02958865|448548497|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
124706033|NCT02958865|448548498|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
124706034|NCT02958865|448548499|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
124706035|NCT02958865|448548500|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
124706036|NCT02958865|448548501|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
124706037|NCT02958865|448548502|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
124945819|NCT00949117|449430904|FG000|Overall Study|Protocol Violation|1|||
124945820|NCT00949117|449430905|FG001|Overall Study|Protocol Violation|1|||
124945821|NCT00949117|449430904|FG000|Overall Study|Adverse Event|0|||
124945822|NCT00949117|449430905|FG001|Overall Study|Adverse Event|1|||
124945823|NCT01214200|449430906|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
124945824|NCT01214200|449430906|FG000|Overall Study|Withdrawal by Subject|2|||
124945825|NCT01719172|449430907|FG000|Overall Study|Lost to Follow-up|1|||
124945826|NCT01719172|449430907|FG000|Overall Study|Death|1|||
124945827|NCT04250636|449430910|FG000|Overall Study|Lost to Follow-up|2|||
124945828|NCT03041090|449430911|FG000|Overall Study|technical error|0|||
124945829|NCT03041090|449430912|FG001|Overall Study|technical error|3|||
124945830|NCT01353274|449430913|FG000|Overall Study|No case report form (CRF) collected|28|||
124945831|NCT01409837|449430914|FG000|Overall Study|Withdrawal by Subject|2|||
124945832|NCT01409837|449430915|FG001|Overall Study|Withdrawal by Subject|1|||
124945833|NCT01409837|449430914|FG000|Overall Study|Lost to Follow-up|1|||
124945834|NCT01409837|449430915|FG001|Overall Study|Lost to Follow-up|0|||
124945835|NCT01409837|449430914|FG000|Overall Study|Physician Decision|0|||
124945836|NCT01409837|449430915|FG001|Overall Study|Physician Decision|1|||
124945837|NCT03960645|449430916|FG000|Overall Study|Protocol Violation|1|||
124945838|NCT03960645|449430917|FG001|Overall Study|Protocol Violation|0|||
124945839|NCT03292406|449430918|FG000|Overall Study|Progressive Disease|6|||
124945840|NCT03292406|449430919|FG001|Overall Study|Progressive Disease|3|||
124945841|NCT03292406|449430920|FG002|Overall Study|Progressive Disease|4|||
124945842|NCT03292406|449430918|FG000|Overall Study|Adverse Event|7|||
124945843|NCT03292406|449430919|FG001|Overall Study|Adverse Event|1|||
124945844|NCT03292406|449430920|FG002|Overall Study|Adverse Event|4|||
124945845|NCT03292406|449430918|FG000|Overall Study|Withdrawal by Subject|0|||
124945846|NCT03292406|449430919|FG001|Overall Study|Withdrawal by Subject|7|||
124945847|NCT03292406|449430920|FG002|Overall Study|Withdrawal by Subject|2|||
124945848|NCT03292406|449430918|FG000|Overall Study|Protocol Violation|0|||
124945849|NCT03292406|449430919|FG001|Overall Study|Protocol Violation|1|||
124945850|NCT03292406|449430920|FG002|Overall Study|Protocol Violation|1|||
124945851|NCT03292406|449430918|FG000|Overall Study|Other|0|||
124945852|NCT03292406|449430919|FG001|Overall Study|Other|1|||
124945853|NCT03292406|449430920|FG002|Overall Study|Other|2|||
124945854|NCT00403494|449430921|FG000|Overall Study|Adverse Event|10|||
124945855|NCT00403494|449430922|FG001|Overall Study|Adverse Event|8|||
124945856|NCT00403494|449430921|FG000|Overall Study|Withdrew Consent|3|||
124945857|NCT00403494|449430922|FG001|Overall Study|Withdrew Consent|2|||
124458628|NCT01849874|447640407|FG001|Overall Study|Withdrawal by Subject|16|||
124706038|NCT02958865|448548503|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
124706039|NCT02958865|448548504|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
124945858|NCT00403494|449430921|FG000|Overall Study|Inappropriately enrolled|0|||
124945859|NCT00403494|449430922|FG001|Overall Study|Inappropriately enrolled|1|||
124945860|NCT00403494|449430921|FG000|Overall Study|Lost to Follow-up|0|||
124945861|NCT00403494|449430922|FG001|Overall Study|Lost to Follow-up|2|||
124945862|NCT00403494|449430921|FG000|Overall Study|Protocol noncompliance|0|||
124945863|NCT00403494|449430922|FG001|Overall Study|Protocol noncompliance|1|||
124945864|NCT00403494|449430921|FG000|Overall Study|Death|1|||
124945865|NCT00403494|449430922|FG001|Overall Study|Death|0|||
124945866|NCT00403494|449430921|FG000|Overall Study|Sponsor Request|1|||
124945867|NCT00403494|449430922|FG001|Overall Study|Sponsor Request|0|||
124945868|NCT03851094|449430924|FG000|Overall Study|Withdrawal by Subject|0|||
124945869|NCT03851094|449430925|FG001|Overall Study|Withdrawal by Subject|1|||
124458629|NCT01849874|447640406|FG000|Overall Study|Lost to Follow-up|3|||
124706040|NCT02958865|448548505|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
124945870|NCT03851094|449430924|FG000|Overall Study|Participant lost device|0|||
124945871|NCT03851094|449430925|FG001|Overall Study|Participant lost device|1|||
124945872|NCT03851094|449430924|FG000|Overall Study|Participant returned device|0|||
124945873|NCT03851094|449430925|FG001|Overall Study|Participant returned device|2|||
124945874|NCT01536704|449430926|FG000|Washout Period 1|Withdrawal by Subject|1|||
124945875|NCT01536704|449430927|FG001|Washout Period 1|Withdrawal by Subject|2|||
124945876|NCT01536704|449430928|FG002|Washout Period 1|Withdrawal by Subject|0|||
124945877|NCT01536704|449430929|FG003|Washout Period 1|Withdrawal by Subject|0|||
124945878|NCT01536704|449430926|FG000|Washout Period 2|Adverse Event|1|||
124945879|NCT01536704|449430927|FG001|Washout Period 2|Adverse Event|0|||
124945880|NCT01536704|449430928|FG002|Washout Period 2|Adverse Event|0|||
124945881|NCT01536704|449430929|FG003|Washout Period 2|Adverse Event|0|||
124945882|NCT01536704|449430926|FG000|Washout Period 2|Withdrawal by Subject|0|||
124945883|NCT01536704|449430927|FG001|Washout Period 2|Withdrawal by Subject|0|||
124945884|NCT01536704|449430928|FG002|Washout Period 2|Withdrawal by Subject|0|||
124945885|NCT01536704|449430929|FG003|Washout Period 2|Withdrawal by Subject|1|||
124945886|NCT01536704|449430926|FG000|Period 3|Adverse Event|0|||
124945887|NCT01536704|449430927|FG001|Period 3|Adverse Event|0|||
124945888|NCT01536704|449430928|FG002|Period 3|Adverse Event|0|||
124945889|NCT01536704|449430929|FG003|Period 3|Adverse Event|1|||
124945890|NCT01536704|449430926|FG000|Washout Period 3|Adverse Event|0|||
124945891|NCT01536704|449430927|FG001|Washout Period 3|Adverse Event|0|||
124945892|NCT01536704|449430928|FG002|Washout Period 3|Adverse Event|1|||
124945893|NCT01536704|449430929|FG003|Washout Period 3|Adverse Event|0|||
124945894|NCT00047385|449430930|FG000|Overall Study|Death before any screening|2|||
124945895|NCT00047385|449430931|FG001|Overall Study|Death before any screening|5|||
124945896|NCT00047385|449430930|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
124945897|NCT00047385|449430931|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
124945898|NCT00047385|449430930|FG000|Overall Study|Eligible for screening but had no screen|260|||
124945899|NCT00047385|449430931|FG001|Overall Study|Eligible for screening but had no screen|492|||
124945900|NCT03490032|449430932|FG000|Overall Study|family issue (child custody)|1|||
124945901|NCT03490032|449430933|FG001|Overall Study|family issue (child custody)|0|||
124945902|NCT03490032|449430934|FG002|Overall Study|family issue (child custody)|0|||
124945903|NCT00310037|449430937|FG000|Overall Study|Adverse Event|7|||
124945904|NCT00310037|449430938|FG001|Overall Study|Adverse Event|14|||
124945905|NCT00310037|449430937|FG000|Overall Study|Withdrawal by Subject|4|||
124945906|NCT00310037|449430938|FG001|Overall Study|Withdrawal by Subject|3|||
124945907|NCT00310037|449430937|FG000|Overall Study|Progression|6|||
124945908|NCT00310037|449430938|FG001|Overall Study|Progression|0|||
124945909|NCT00310037|449430937|FG000|Overall Study|Non-protocol treatment|1|||
124945910|NCT00310037|449430938|FG001|Overall Study|Non-protocol treatment|0|||
124945911|NCT02128269|449430943|FG000|Treatment Period|Adverse Event|1|||
124945912|NCT02128269|449430943|FG000|Treatment Period|Physician Decision|1|||
124458630|NCT01849874|447640407|FG001|Overall Study|Lost to Follow-up|2|||
124945913|NCT00878189|449430944|FG000|Overall Study|Death|0|||
124945914|NCT00878189|449430945|FG001|Overall Study|Death|1|||
124945915|NCT00878189|449430946|FG002|Overall Study|Death|0|||
124945916|NCT00878189|449430947|FG003|Overall Study|Death|1|||
124945917|NCT00878189|449430948|FG004|Overall Study|Death|0|||
124945918|NCT00878189|449430949|FG005|Overall Study|Death|0|||
124945919|NCT00878189|449430950|FG006|Overall Study|Death|0|||
124945920|NCT00878189|449430951|FG007|Overall Study|Death|0|||
124945921|NCT00878189|449430952|FG008|Overall Study|Death|1|||
124945922|NCT00878189|449430944|FG000|Overall Study|Participant Refused to Follow-up|0|||
124945923|NCT00878189|449430945|FG001|Overall Study|Participant Refused to Follow-up|0|||
124945924|NCT00878189|449430946|FG002|Overall Study|Participant Refused to Follow-up|0|||
124945925|NCT00878189|449430947|FG003|Overall Study|Participant Refused to Follow-up|0|||
124945926|NCT00878189|449430948|FG004|Overall Study|Participant Refused to Follow-up|0|||
124945927|NCT00878189|449430949|FG005|Overall Study|Participant Refused to Follow-up|4|||
124945928|NCT00878189|449430950|FG006|Overall Study|Participant Refused to Follow-up|0|||
124945929|NCT00878189|449430951|FG007|Overall Study|Participant Refused to Follow-up|0|||
124945930|NCT00878189|449430952|FG008|Overall Study|Participant Refused to Follow-up|0|||
124945931|NCT00878189|449430944|FG000|Overall Study|Other|3|||
124945932|NCT00878189|449430945|FG001|Overall Study|Other|2|||
124945933|NCT00878189|449430946|FG002|Overall Study|Other|4|||
124945934|NCT00878189|449430947|FG003|Overall Study|Other|7|||
124945935|NCT00878189|449430948|FG004|Overall Study|Other|4|||
124945936|NCT00878189|449430949|FG005|Overall Study|Other|18|||
124945937|NCT00878189|449430950|FG006|Overall Study|Other|15|||
124945938|NCT00878189|449430951|FG007|Overall Study|Other|3|||
124706041|NCT02958865|448548506|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
124945939|NCT00878189|449430952|FG008|Overall Study|Other|4|||
124945940|NCT00878189|449430944|FG000|Overall Study|Lost to Follow-up|0|||
124945941|NCT00878189|449430945|FG001|Overall Study|Lost to Follow-up|0|||
124945942|NCT00878189|449430946|FG002|Overall Study|Lost to Follow-up|0|||
124945943|NCT00878189|449430947|FG003|Overall Study|Lost to Follow-up|0|||
124945944|NCT00878189|449430948|FG004|Overall Study|Lost to Follow-up|0|||
124458631|NCT01849874|447640406|FG000|Overall Study|Study Termination By Sponsor|93|||
124458632|NCT01849874|447640407|FG001|Overall Study|Study Termination By Sponsor|48|||
124458633|NCT01849874|447640406|FG000|Overall Study|Completed as per protocol amendment 6|3|||
124458634|NCT01849874|447640407|FG001|Overall Study|Completed as per protocol amendment 6|0|||
124458635|NCT01849874|447640406|FG000|Overall Study|Physician Decision|7|||
124945945|NCT00878189|449430949|FG005|Overall Study|Lost to Follow-up|1|||
124945946|NCT00878189|449430950|FG006|Overall Study|Lost to Follow-up|1|||
124945947|NCT00878189|449430951|FG007|Overall Study|Lost to Follow-up|0|||
124458636|NCT01849874|447640407|FG001|Overall Study|Physician Decision|1|||
124458637|NCT01849874|447640406|FG000|Overall Study|Other|16|||
124458638|NCT01849874|447640407|FG001|Overall Study|Other|4|||
124706042|NCT02958865|448548491|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
124706043|NCT02958865|448548492|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
124706044|NCT02958865|448548493|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
124706045|NCT02958865|448548494|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
124706046|NCT02958865|448548495|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
124706047|NCT02958865|448548496|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
124706048|NCT02958865|448548497|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
124706049|NCT02958865|448548498|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
124945948|NCT00878189|449430952|FG008|Overall Study|Lost to Follow-up|0|||
124945949|NCT00878189|449430944|FG000|Overall Study|Objection Progression or Relapse|0|||
124945950|NCT00878189|449430945|FG001|Overall Study|Objection Progression or Relapse|0|||
124945951|NCT00878189|449430946|FG002|Overall Study|Objection Progression or Relapse|0|||
124945952|NCT00878189|449430947|FG003|Overall Study|Objection Progression or Relapse|0|||
124945953|NCT00878189|449430948|FG004|Overall Study|Objection Progression or Relapse|0|||
124945954|NCT00878189|449430949|FG005|Overall Study|Objection Progression or Relapse|0|||
124945955|NCT00878189|449430950|FG006|Overall Study|Objection Progression or Relapse|0|||
124945956|NCT00878189|449430951|FG007|Overall Study|Objection Progression or Relapse|0|||
124945957|NCT00878189|449430952|FG008|Overall Study|Objection Progression or Relapse|3|||
124945958|NCT02007070|449430953|FG000|Overall Study|Adverse Event|4|||
124945959|NCT02007070|449430953|FG000|Overall Study|Clinical Progression|4|||
124945960|NCT02007070|449430953|FG000|Overall Study|Death|1|||
124945961|NCT02007070|449430953|FG000|Overall Study|Protocol Violation|2|||
124945962|NCT02007070|449430953|FG000|Overall Study|Physician Decision|1|||
124945963|NCT02007070|449430953|FG000|Overall Study|Progressive Disease|21|||
124945964|NCT00703092|449430954|FG000|Overall Study|Withdrawal by Subject|2|||
124945965|NCT02708498|449430955|FG000|Overall Study|Death|20|||
124945966|NCT02708498|449430956|FG001|Overall Study|Death|19|||
124945967|NCT02708498|449430957|FG002|Overall Study|Death|0|||
124945968|NCT02708498|449430958|FG003|Overall Study|Death|0|||
124945969|NCT02708498|449430959|FG004|Overall Study|Death|1|||
124945970|NCT02708498|449430960|FG005|Overall Study|Death|0|||
124945971|NCT02708498|449430961|FG006|Overall Study|Death|0|||
124945972|NCT02708498|449430962|FG007|Overall Study|Death|0|||
124945973|NCT02708498|449430955|FG000|Overall Study|Unknown reason, missing data|0|||
124945974|NCT02708498|449430956|FG001|Overall Study|Unknown reason, missing data|0|||
124945975|NCT02708498|449430957|FG002|Overall Study|Unknown reason, missing data|62|||
124945976|NCT02708498|449430958|FG003|Overall Study|Unknown reason, missing data|51|||
124945977|NCT02708498|449430959|FG004|Overall Study|Unknown reason, missing data|195|||
124945978|NCT02708498|449430960|FG005|Overall Study|Unknown reason, missing data|132|||
124945979|NCT02708498|449430961|FG006|Overall Study|Unknown reason, missing data|0|||
124945980|NCT02708498|449430962|FG007|Overall Study|Unknown reason, missing data|0|||
124945981|NCT01021748|449430964|FG000|Overall Study|Adverse Event|2|||
124945982|NCT01021748|449430965|FG001|Overall Study|Adverse Event|1|||
124945983|NCT01021748|449430966|FG002|Overall Study|Adverse Event|2|||
124945984|NCT01021748|449430967|FG003|Overall Study|Adverse Event|0|||
124945985|NCT01021748|449430968|FG004|Overall Study|Adverse Event|2|||
124945986|NCT01021748|449430969|FG005|Overall Study|Adverse Event|0|||
124945987|NCT01021748|449430970|FG006|Overall Study|Adverse Event|1|||
124945988|NCT01021748|449430971|FG007|Overall Study|Adverse Event|0|||
124945989|NCT01021748|449430972|FG008|Overall Study|Adverse Event|7|||
124945990|NCT01021748|449430964|FG000|Overall Study|Physician Decision|1|||
124945991|NCT01021748|449430965|FG001|Overall Study|Physician Decision|0|||
124945992|NCT01021748|449430966|FG002|Overall Study|Physician Decision|1|||
124945993|NCT01021748|449430967|FG003|Overall Study|Physician Decision|1|||
124945994|NCT01021748|449430968|FG004|Overall Study|Physician Decision|0|||
124945995|NCT01021748|449430969|FG005|Overall Study|Physician Decision|0|||
124458639|NCT02104583|447640408|FG000|Overall Study|New ICD or CRT-D implanted|2|||
124458640|NCT02104583|447640409|FG001|Overall Study|New ICD or CRT-D implanted|0|||
124458641|NCT02104583|447640410|FG002|Overall Study|New ICD or CRT-D implanted|1|||
124945996|NCT01021748|449430970|FG006|Overall Study|Physician Decision|1|||
124945997|NCT01021748|449430971|FG007|Overall Study|Physician Decision|1|||
124945998|NCT01021748|449430972|FG008|Overall Study|Physician Decision|2|||
124945999|NCT01021748|449430964|FG000|Overall Study|Progressive Disease|3|||
124946000|NCT01021748|449430965|FG001|Overall Study|Progressive Disease|3|||
124946001|NCT01021748|449430966|FG002|Overall Study|Progressive Disease|4|||
124946002|NCT01021748|449430967|FG003|Overall Study|Progressive Disease|6|||
124458642|NCT02104583|447640411|FG003|Overall Study|New ICD or CRT-D implanted|0|||
124458643|NCT02104583|447640412|FG004|Overall Study|New ICD or CRT-D implanted|0|||
124946003|NCT01021748|449430968|FG004|Overall Study|Progressive Disease|7|||
124946004|NCT01021748|449430969|FG005|Overall Study|Progressive Disease|3|||
124946005|NCT01021748|449430970|FG006|Overall Study|Progressive Disease|0|||
124946006|NCT01021748|449430971|FG007|Overall Study|Progressive Disease|5|||
124946007|NCT01021748|449430972|FG008|Overall Study|Progressive Disease|6|||
124946008|NCT01021748|449430964|FG000|Overall Study|Withdrawal by Subject|0|||
124946009|NCT01021748|449430965|FG001|Overall Study|Withdrawal by Subject|0|||
124946010|NCT01021748|449430966|FG002|Overall Study|Withdrawal by Subject|0|||
124946011|NCT01021748|449430967|FG003|Overall Study|Withdrawal by Subject|0|||
124946012|NCT01021748|449430968|FG004|Overall Study|Withdrawal by Subject|0|||
124946013|NCT01021748|449430969|FG005|Overall Study|Withdrawal by Subject|0|||
124946014|NCT01021748|449430970|FG006|Overall Study|Withdrawal by Subject|1|||
124946015|NCT01021748|449430971|FG007|Overall Study|Withdrawal by Subject|0|||
124946016|NCT01021748|449430972|FG008|Overall Study|Withdrawal by Subject|1|||
124946017|NCT01021748|449430964|FG000|Overall Study|Not Treated|0|||
124946018|NCT01021748|449430965|FG001|Overall Study|Not Treated|1|||
124946019|NCT01021748|449430966|FG002|Overall Study|Not Treated|0|||
124946020|NCT01021748|449430967|FG003|Overall Study|Not Treated|0|||
124946021|NCT01021748|449430968|FG004|Overall Study|Not Treated|0|||
124946022|NCT01021748|449430969|FG005|Overall Study|Not Treated|0|||
124946023|NCT01021748|449430970|FG006|Overall Study|Not Treated|0|||
124946024|NCT01021748|449430971|FG007|Overall Study|Not Treated|0|||
124946025|NCT01021748|449430972|FG008|Overall Study|Not Treated|0|||
124946026|NCT03316170|449430979|FG000|Overall Study|Death|1|||
124946027|NCT03316170|449430980|FG001|Overall Study|Death|0|||
124946028|NCT03316170|449430979|FG000|Overall Study|Lost to Follow-up|6|||
124946029|NCT03316170|449430980|FG001|Overall Study|Lost to Follow-up|7|||
124946030|NCT03052517|449430981|FG000|Overall Study|Study Terminated By Sponsor|928|||
124946031|NCT03052517|449430982|FG001|Overall Study|Study Terminated By Sponsor|938|||
124946032|NCT03052517|449430983|FG002|Overall Study|Study Terminated By Sponsor|296|||
124946033|NCT03052517|449430981|FG000|Overall Study|Subject/Guardian Decision|50|||
124946034|NCT03052517|449430982|FG001|Overall Study|Subject/Guardian Decision|45|||
124946035|NCT03052517|449430983|FG002|Overall Study|Subject/Guardian Decision|22|||
124946036|NCT03052517|449430981|FG000|Overall Study|Lack of Efficacy|23|||
124946037|NCT03052517|449430982|FG001|Overall Study|Lack of Efficacy|14|||
124946038|NCT03052517|449430983|FG002|Overall Study|Lack of Efficacy|7|||
124946039|NCT03052517|449430981|FG000|Overall Study|Adverse Event|6|||
124946040|NCT03052517|449430982|FG001|Overall Study|Adverse Event|5|||
124946041|NCT03052517|449430983|FG002|Overall Study|Adverse Event|0|||
124946042|NCT03052517|449430981|FG000|Overall Study|Physician Decision|4|||
124946043|NCT03052517|449430982|FG001|Overall Study|Physician Decision|5|||
124946044|NCT03052517|449430983|FG002|Overall Study|Physician Decision|1|||
124946045|NCT03052517|449430981|FG000|Overall Study|Death|3|||
124946046|NCT03052517|449430982|FG001|Overall Study|Death|0|||
124946047|NCT03052517|449430983|FG002|Overall Study|Death|1|||
124946048|NCT03052517|449430981|FG000|Overall Study|Lost to Follow-up|2|||
124946049|NCT03052517|449430982|FG001|Overall Study|Lost to Follow-up|4|||
124946050|NCT03052517|449430983|FG002|Overall Study|Lost to Follow-up|0|||
124946051|NCT03052517|449430981|FG000|Overall Study|Pregnancy|1|||
124946052|NCT03052517|449430982|FG001|Overall Study|Pregnancy|0|||
124946053|NCT03052517|449430983|FG002|Overall Study|Pregnancy|1|||
124946054|NCT03052517|449430981|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
124946055|NCT03052517|449430982|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
124946056|NCT03052517|449430983|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
124946057|NCT03052517|449430981|FG000|Overall Study|Technical Problems|0|||
124946058|NCT03052517|449430982|FG001|Overall Study|Technical Problems|1|||
124946059|NCT03052517|449430983|FG002|Overall Study|Technical Problems|0|||
124946060|NCT01640288|449430984|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
124946061|NCT01640288|449430985|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
124946062|NCT01640288|449430984|FG000|Overall Study|Screen Failure|20|||
124458644|NCT02104583|447640408|FG000|Overall Study|Death|2|||
124458645|NCT02104583|447640409|FG001|Overall Study|Death|1|||
124458646|NCT02104583|447640410|FG002|Overall Study|Death|3|||
124458647|NCT02104583|447640411|FG003|Overall Study|Death|3|||
124458648|NCT02104583|447640412|FG004|Overall Study|Death|5|||
124458649|NCT02104583|447640408|FG000|Overall Study|Subject required cardiac ablation|6|||
124458650|NCT02104583|447640409|FG001|Overall Study|Subject required cardiac ablation|4|||
124946063|NCT01640288|449430985|FG001|Overall Study|Screen Failure|18|||
124946064|NCT01640288|449430984|FG000|Overall Study|Withdrawn by PI|5|||
124946065|NCT01640288|449430985|FG001|Overall Study|Withdrawn by PI|0|||
124946066|NCT01640288|449430984|FG000|Overall Study|Withdrawal by Subject|1|||
124946067|NCT01640288|449430985|FG001|Overall Study|Withdrawal by Subject|0|||
124946068|NCT04803734|449430986|FG000|Overall Study|Withdrawal by Subject|0|||
124946069|NCT04803734|449430987|FG001|Overall Study|Withdrawal by Subject|1|||
124946070|NCT04803734|449430986|FG000|Overall Study|Protocol Violation|0|||
124946071|NCT04803734|449430987|FG001|Overall Study|Protocol Violation|1|||
124458651|NCT02104583|447640410|FG002|Overall Study|Subject required cardiac ablation|4|||
124946072|NCT00195819|449430995|FG000|Double-Blind|Withdrawal by Subject|1|||
124946073|NCT00195819|449430996|FG001|Double-Blind|Withdrawal by Subject|0|||
124946074|NCT00195819|449430995|FG000|Double-Blind|Moved|1|||
124946075|NCT00195819|449430996|FG001|Double-Blind|Moved|0|||
124946076|NCT00195819|449430995|FG000|Open-label|Adverse Event|0|||
124946077|NCT00195819|449430996|FG001|Open-label|Adverse Event|9|||
124946078|NCT00195819|449430995|FG000|Open-label|Lack of Efficacy|0|||
124946079|NCT00195819|449430996|FG001|Open-label|Lack of Efficacy|2|||
124946080|NCT00195819|449430995|FG000|Open-label|Pregnancy|0|||
124946081|NCT00195819|449430996|FG001|Open-label|Pregnancy|1|||
124946082|NCT00195819|449430995|FG000|Open-label|Protocol Violation|0|||
124946083|NCT00195819|449430996|FG001|Open-label|Protocol Violation|2|||
124946084|NCT00195819|449430995|FG000|Open-label|Moved|0|||
124946085|NCT00195819|449430996|FG001|Open-label|Moved|1|||
124946086|NCT00195819|449430995|FG000|Open-label|Withdrawal by Subject|0|||
124946087|NCT00195819|449430996|FG001|Open-label|Withdrawal by Subject|5|||
124946088|NCT01629589|449430999|FG000|Overall Study|Protocol Violation|4|||
124946089|NCT01629589|449431000|FG001|Overall Study|Protocol Violation|2|||
124946090|NCT01629589|449430999|FG000|Overall Study|Lost to Follow-up|2|||
124946091|NCT01629589|449431000|FG001|Overall Study|Lost to Follow-up|1|||
124946092|NCT01629589|449430999|FG000|Overall Study|Withdrawal by Subject|2|||
124946093|NCT01629589|449431000|FG001|Overall Study|Withdrawal by Subject|3|||
124946094|NCT01629589|449430999|FG000|Overall Study|Did not receive study vaccine|0|||
124946095|NCT01629589|449431000|FG001|Overall Study|Did not receive study vaccine|1|||
124946096|NCT03781375|449431001|FG000|Double-blind Phase|Adverse Event|0|||
124946097|NCT03781375|449431002|FG001|Double-blind Phase|Adverse Event|1|||
124946098|NCT03781375|449431001|FG000|Double-blind Phase|Lack of Response|6|||
124946099|NCT03781375|449431002|FG001|Double-blind Phase|Lack of Response|2|||
124946100|NCT03781375|449431001|FG000|Double-blind Phase|Other|1|||
124946101|NCT03781375|449431002|FG001|Double-blind Phase|Other|3|||
124946102|NCT03781375|449431001|FG000|Open-label Phase|Protocol Issues|0|||
124946103|NCT03781375|449431002|FG001|Open-label Phase|Protocol Issues|1|||
124946104|NCT03781375|449431001|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
124946105|NCT03781375|449431002|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
124946106|NCT03781375|449431001|FG000|Open-label Phase|Other|2|||
124946107|NCT03781375|449431002|FG001|Open-label Phase|Other|2|||
124946108|NCT01303510|449431005|FG000|Overall Study|Lost to Follow-up|1|||
124946109|NCT01303510|449431006|FG001|Overall Study|Lost to Follow-up|0|||
124946110|NCT02404441|449431007|FG000|Phase 1 Part|Adverse Event|1|||
124946111|NCT02404441|449431008|FG001|Phase 1 Part|Adverse Event|0|||
124946112|NCT02404441|449431009|FG002|Phase 1 Part|Adverse Event|0|||
124946113|NCT02404441|449431010|FG003|Phase 1 Part|Adverse Event|0|||
124946114|NCT02404441|449431011|FG004|Phase 1 Part|Adverse Event|0|||
124946115|NCT02404441|449431012|FG005|Phase 1 Part|Adverse Event|0|||
124946116|NCT02404441|449431013|FG006|Phase 1 Part|Adverse Event|0|||
124946117|NCT02404441|449431014|FG007|Phase 1 Part|Adverse Event|0|||
124946118|NCT02404441|449431015|FG008|Phase 1 Part|Adverse Event|0|||
124946119|NCT02404441|449431016|FG009|Phase 1 Part|Adverse Event|0|||
124946120|NCT02404441|449431007|FG000|Phase 1 Part|Physician Decision|0|||
124946121|NCT02404441|449431008|FG001|Phase 1 Part|Physician Decision|1|||
124946122|NCT02404441|449431009|FG002|Phase 1 Part|Physician Decision|0|||
124946123|NCT02404441|449431010|FG003|Phase 1 Part|Physician Decision|0|||
124946124|NCT02404441|449431011|FG004|Phase 1 Part|Physician Decision|0|||
124946125|NCT02404441|449431012|FG005|Phase 1 Part|Physician Decision|0|||
124946126|NCT02404441|449431013|FG006|Phase 1 Part|Physician Decision|0|||
124946127|NCT02404441|449431014|FG007|Phase 1 Part|Physician Decision|0|||
124946128|NCT02404441|449431015|FG008|Phase 1 Part|Physician Decision|0|||
124946129|NCT02404441|449431016|FG009|Phase 1 Part|Physician Decision|0|||
124946130|NCT02404441|449431007|FG000|Phase 1 Part|Progressive Disease|14|||
124946131|NCT02404441|449431008|FG001|Phase 1 Part|Progressive Disease|11|||
124946132|NCT02404441|449431009|FG002|Phase 1 Part|Progressive Disease|7|||
124946133|NCT02404441|449431010|FG003|Phase 1 Part|Progressive Disease|6|||
124946134|NCT02404441|449431011|FG004|Phase 1 Part|Progressive Disease|9|||
124946135|NCT02404441|449431012|FG005|Phase 1 Part|Progressive Disease|0|||
124946136|NCT02404441|449431013|FG006|Phase 1 Part|Progressive Disease|0|||
124765299|NCT01751061|448767380|FG000|Overall Study|patient regained decisional capacity|4|||
124765300|NCT01751061|448767381|FG001|Overall Study|patient regained decisional capacity|8|||
124765301|NCT01751061|448767380|FG000|Overall Study|Withdrawal by Subject|4|||
124765302|NCT01751061|448767381|FG001|Overall Study|Withdrawal by Subject|1|||
124946137|NCT02404441|449431014|FG007|Phase 1 Part|Progressive Disease|0|||
124946138|NCT02404441|449431015|FG008|Phase 1 Part|Progressive Disease|0|||
124946139|NCT02404441|449431016|FG009|Phase 1 Part|Progressive Disease|0|||
124946140|NCT02404441|449431007|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
124946141|NCT02404441|449431008|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
124946142|NCT02404441|449431009|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
124946143|NCT02404441|449431010|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
124765303|NCT01751061|448767380|FG000|Overall Study|Physician Decision|2|||
124765304|NCT01751061|448767381|FG001|Overall Study|Physician Decision|0|||
124946144|NCT02404441|449431011|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
124946145|NCT02404441|449431012|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
124946146|NCT02404441|449431013|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
124946147|NCT02404441|449431014|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
124946148|NCT02404441|449431015|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
124946149|NCT02404441|449431016|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
124946150|NCT02404441|449431007|FG000|Phase 1 Part|Death|1|||
124946151|NCT02404441|449431008|FG001|Phase 1 Part|Death|1|||
124946152|NCT02404441|449431009|FG002|Phase 1 Part|Death|1|||
124946153|NCT02404441|449431010|FG003|Phase 1 Part|Death|0|||
124946154|NCT02404441|449431011|FG004|Phase 1 Part|Death|1|||
124946155|NCT02404441|449431012|FG005|Phase 1 Part|Death|0|||
124946156|NCT02404441|449431013|FG006|Phase 1 Part|Death|0|||
124946157|NCT02404441|449431014|FG007|Phase 1 Part|Death|0|||
124946158|NCT02404441|449431015|FG008|Phase 1 Part|Death|0|||
124946159|NCT02404441|449431016|FG009|Phase 1 Part|Death|0|||
124946160|NCT02404441|449431007|FG000|Phase 2 Part|Adverse Event|0|||
124946161|NCT02404441|449431008|FG001|Phase 2 Part|Adverse Event|0|||
124946162|NCT02404441|449431009|FG002|Phase 2 Part|Adverse Event|0|||
124946163|NCT02404441|449431010|FG003|Phase 2 Part|Adverse Event|0|||
124946164|NCT02404441|449431011|FG004|Phase 2 Part|Adverse Event|0|||
124946165|NCT02404441|449431012|FG005|Phase 2 Part|Adverse Event|2|||
124946166|NCT02404441|449431013|FG006|Phase 2 Part|Adverse Event|3|||
124946167|NCT02404441|449431014|FG007|Phase 2 Part|Adverse Event|3|||
124946168|NCT02404441|449431015|FG008|Phase 2 Part|Adverse Event|6|||
124946169|NCT02404441|449431016|FG009|Phase 2 Part|Adverse Event|1|||
124946170|NCT02404441|449431007|FG000|Phase 2 Part|Physician Decision|0|||
124946171|NCT02404441|449431008|FG001|Phase 2 Part|Physician Decision|0|||
124946172|NCT02404441|449431009|FG002|Phase 2 Part|Physician Decision|0|||
124946173|NCT02404441|449431010|FG003|Phase 2 Part|Physician Decision|0|||
124946174|NCT02404441|449431011|FG004|Phase 2 Part|Physician Decision|0|||
124946175|NCT02404441|449431012|FG005|Phase 2 Part|Physician Decision|7|||
124946176|NCT02404441|449431013|FG006|Phase 2 Part|Physician Decision|9|||
124946177|NCT02404441|449431014|FG007|Phase 2 Part|Physician Decision|2|||
124946178|NCT02404441|449431015|FG008|Phase 2 Part|Physician Decision|1|||
124946179|NCT02404441|449431016|FG009|Phase 2 Part|Physician Decision|3|||
124946180|NCT02404441|449431007|FG000|Phase 2 Part|Progressive disease|0|||
124946181|NCT02404441|449431008|FG001|Phase 2 Part|Progressive disease|0|||
124946182|NCT02404441|449431009|FG002|Phase 2 Part|Progressive disease|0|||
124946183|NCT02404441|449431010|FG003|Phase 2 Part|Progressive disease|0|||
124946184|NCT02404441|449431011|FG004|Phase 2 Part|Progressive disease|0|||
124946185|NCT02404441|449431012|FG005|Phase 2 Part|Progressive disease|43|||
124946186|NCT02404441|449431013|FG006|Phase 2 Part|Progressive disease|32|||
124946187|NCT02404441|449431014|FG007|Phase 2 Part|Progressive disease|31|||
124946188|NCT02404441|449431015|FG008|Phase 2 Part|Progressive disease|39|||
124946189|NCT02404441|449431016|FG009|Phase 2 Part|Progressive disease|27|||
124946190|NCT02404441|449431007|FG000|Phase 2 Part|Subject/guardian decision|0|||
124946191|NCT02404441|449431008|FG001|Phase 2 Part|Subject/guardian decision|0|||
124946192|NCT02404441|449431009|FG002|Phase 2 Part|Subject/guardian decision|0|||
124946193|NCT02404441|449431010|FG003|Phase 2 Part|Subject/guardian decision|0|||
124946194|NCT02404441|449431011|FG004|Phase 2 Part|Subject/guardian decision|0|||
124946195|NCT02404441|449431012|FG005|Phase 2 Part|Subject/guardian decision|3|||
124946196|NCT02404441|449431013|FG006|Phase 2 Part|Subject/guardian decision|9|||
124946197|NCT02404441|449431014|FG007|Phase 2 Part|Subject/guardian decision|0|||
124946198|NCT02404441|449431015|FG008|Phase 2 Part|Subject/guardian decision|3|||
124946199|NCT02404441|449431016|FG009|Phase 2 Part|Subject/guardian decision|2|||
124946200|NCT02404441|449431007|FG000|Phase 2 Part|Death|0|||
124946201|NCT02404441|449431008|FG001|Phase 2 Part|Death|0|||
124946202|NCT02404441|449431009|FG002|Phase 2 Part|Death|0|||
124946203|NCT02404441|449431010|FG003|Phase 2 Part|Death|0|||
124946204|NCT02404441|449431011|FG004|Phase 2 Part|Death|0|||
124946205|NCT02404441|449431012|FG005|Phase 2 Part|Death|4|||
124946206|NCT02404441|449431013|FG006|Phase 2 Part|Death|8|||
124946207|NCT02404441|449431014|FG007|Phase 2 Part|Death|4|||
124946208|NCT02404441|449431015|FG008|Phase 2 Part|Death|10|||
124946209|NCT02404441|449431016|FG009|Phase 2 Part|Death|9|||
124946210|NCT00822900|449431017|FG000|Overall Study|Withdrawal by Subject|14|||
124946211|NCT00822900|449431018|FG001|Overall Study|Withdrawal by Subject|14|||
124946212|NCT00822900|449431017|FG000|Overall Study|Lost to Follow-up|9|||
124946213|NCT00822900|449431018|FG001|Overall Study|Lost to Follow-up|9|||
124946214|NCT00822900|449431017|FG000|Overall Study|Death|83|||
124946215|NCT00822900|449431018|FG001|Overall Study|Death|69|||
124946216|NCT00822900|449431017|FG000|Overall Study|Became a ward of the state|2|||
124946217|NCT00822900|449431018|FG001|Overall Study|Became a ward of the state|1|||
124946218|NCT04679675|449431019|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
124946219|NCT04679675|449431020|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
124946220|NCT04679675|449431021|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
124946221|NCT04679675|449431022|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
124946222|NCT04679675|449431019|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
124946223|NCT04679675|449431020|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
124946224|NCT04679675|449431021|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
124946225|NCT04679675|449431022|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
124946226|NCT02234141|449431023|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
124946227|NCT02234141|449431024|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
124946228|NCT02234141|449431025|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
124946229|NCT02234141|449431026|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
124946230|NCT02234141|449431027|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
124946231|NCT02234141|449431028|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
124946232|NCT02234141|449431029|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
124946233|NCT02234141|449431023|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
124946234|NCT02234141|449431024|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
124946235|NCT02234141|449431025|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
124946236|NCT02234141|449431026|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
124946237|NCT02234141|449431027|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
124946238|NCT02234141|449431028|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
124946239|NCT02234141|449431029|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
124946240|NCT02234141|449431023|FG000|Treatment Period (24 Weeks)|Death|1|||
124946241|NCT02234141|449431024|FG001|Treatment Period (24 Weeks)|Death|2|||
124946242|NCT02234141|449431025|FG002|Treatment Period (24 Weeks)|Death|0|||
124946243|NCT02234141|449431026|FG003|Treatment Period (24 Weeks)|Death|1|||
124946244|NCT02234141|449431027|FG004|Treatment Period (24 Weeks)|Death|0|||
124946245|NCT02234141|449431028|FG005|Treatment Period (24 Weeks)|Death|0|||
124946246|NCT02234141|449431029|FG006|Treatment Period (24 Weeks)|Death|0|||
124946247|NCT02234141|449431023|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
124946248|NCT02234141|449431024|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
124946249|NCT02234141|449431025|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
124946250|NCT02234141|449431026|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
124946251|NCT02234141|449431027|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
124946252|NCT02234141|449431028|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
124946253|NCT02234141|449431029|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
124946254|NCT02234141|449431023|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
124946255|NCT02234141|449431024|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
124946256|NCT02234141|449431025|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
124946257|NCT02234141|449431026|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
124946258|NCT02234141|449431027|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
124946259|NCT02234141|449431028|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
124946260|NCT02234141|449431029|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
124946261|NCT02234141|449431023|FG000|Long-Term Treatment Period|Death|0|||
124946262|NCT02234141|449431024|FG001|Long-Term Treatment Period|Death|0|||
124946263|NCT02234141|449431025|FG002|Long-Term Treatment Period|Death|0|||
124946264|NCT02234141|449431026|FG003|Long-Term Treatment Period|Death|0|||
124946265|NCT02234141|449431027|FG004|Long-Term Treatment Period|Death|0|||
124946266|NCT02234141|449431028|FG005|Long-Term Treatment Period|Death|1|||
124946267|NCT02234141|449431029|FG006|Long-Term Treatment Period|Death|0|||
124946268|NCT02234141|449431023|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
124946269|NCT02234141|449431024|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
124946270|NCT02234141|449431025|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
124946271|NCT02234141|449431026|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
124946272|NCT02234141|449431027|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
124946273|NCT02234141|449431028|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
124946274|NCT02234141|449431029|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
124946275|NCT02234141|449431023|FG000|Long-Term Treatment Period|Adverse Event|4|||
124946276|NCT02234141|449431024|FG001|Long-Term Treatment Period|Adverse Event|0|||
124946277|NCT02234141|449431025|FG002|Long-Term Treatment Period|Adverse Event|5|||
124946278|NCT02234141|449431026|FG003|Long-Term Treatment Period|Adverse Event|0|||
124946279|NCT02234141|449431027|FG004|Long-Term Treatment Period|Adverse Event|1|||
124946280|NCT02234141|449431028|FG005|Long-Term Treatment Period|Adverse Event|1|||
124946281|NCT02234141|449431029|FG006|Long-Term Treatment Period|Adverse Event|1|||
124946282|NCT02234141|449431023|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
124946283|NCT02234141|449431024|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
124946284|NCT02234141|449431025|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
124946285|NCT02234141|449431026|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
124946286|NCT02234141|449431027|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
124946287|NCT02234141|449431028|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
124946288|NCT02234141|449431029|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
124946289|NCT02234141|449431023|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
124458652|NCT02104583|447640411|FG003|Overall Study|Subject required cardiac ablation|5|||
124946290|NCT02234141|449431024|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
124946291|NCT02234141|449431025|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
124946292|NCT02234141|449431026|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
124946293|NCT02234141|449431027|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
124458653|NCT02104583|447640412|FG004|Overall Study|Subject required cardiac ablation|4|||
124946294|NCT02234141|449431028|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
124946295|NCT02234141|449431029|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
124946296|NCT00701415|449431030|FG000|Overall Study|Adverse Event|0|||
124946297|NCT00701415|449431031|FG001|Overall Study|Adverse Event|1|||
124946298|NCT00701415|449431030|FG000|Overall Study|Social/family issues and needle phobia|1|||
124946299|NCT00701415|449431031|FG001|Overall Study|Social/family issues and needle phobia|0|||
124946300|NCT02161458|449431032|FG000|Overall Study|Withdrawal by Subject|0|||
124946301|NCT02161458|449431033|FG001|Overall Study|Withdrawal by Subject|4|||
124946302|NCT02161458|449431034|FG002|Overall Study|Withdrawal by Subject|4|||
124946303|NCT02161458|449431035|FG003|Overall Study|Withdrawal by Subject|0|||
124946304|NCT02161458|449431032|FG000|Overall Study|Lost to Follow-up|0|||
124946305|NCT02161458|449431033|FG001|Overall Study|Lost to Follow-up|2|||
124946306|NCT02161458|449431034|FG002|Overall Study|Lost to Follow-up|1|||
124946307|NCT02161458|449431035|FG003|Overall Study|Lost to Follow-up|0|||
124946308|NCT03042767|449431036|FG000|Overall Study|Lost to Follow-up|1|||
124946309|NCT03042767|449431037|FG001|Overall Study|Lost to Follow-up|2|||
124946310|NCT00705159|449431039|FG000|Overall Study|Withdrawal by Subject|0|||
124946311|NCT00705159|449431040|FG001|Overall Study|Withdrawal by Subject|1|||
124946312|NCT00705159|449431041|FG002|Overall Study|Withdrawal by Subject|1|||
124946313|NCT00705159|449431042|FG003|Overall Study|Withdrawal by Subject|1|||
124946314|NCT00705159|449431039|FG000|Overall Study|Protocol Violation|0|||
124946315|NCT00705159|449431040|FG001|Overall Study|Protocol Violation|1|||
124946316|NCT00705159|449431041|FG002|Overall Study|Protocol Violation|0|||
124946317|NCT00705159|449431042|FG003|Overall Study|Protocol Violation|0|||
124946318|NCT00705159|449431039|FG000|Overall Study|Adverse Event|0|||
124946319|NCT00705159|449431040|FG001|Overall Study|Adverse Event|0|||
124946320|NCT00705159|449431041|FG002|Overall Study|Adverse Event|1|||
124946321|NCT00705159|449431042|FG003|Overall Study|Adverse Event|0|||
124946322|NCT00705159|449431039|FG000|Overall Study|Lost to Follow-up|0|||
124946323|NCT00705159|449431040|FG001|Overall Study|Lost to Follow-up|0|||
124946324|NCT00705159|449431041|FG002|Overall Study|Lost to Follow-up|3|||
124946325|NCT00705159|449431042|FG003|Overall Study|Lost to Follow-up|2|||
124946326|NCT00705159|449431039|FG000|Overall Study|Screen Failure|0|||
124946327|NCT00705159|449431040|FG001|Overall Study|Screen Failure|0|||
124946328|NCT00705159|449431041|FG002|Overall Study|Screen Failure|0|||
124946329|NCT00705159|449431042|FG003|Overall Study|Screen Failure|1|||
124946330|NCT00526994|449431043|FG000|Overall Study|Lost to Follow-up|98|||
124946331|NCT00526994|449431044|FG001|Overall Study|Lost to Follow-up|108|||
124946332|NCT00526994|449431045|FG002|Overall Study|Lost to Follow-up|96|||
124946333|NCT00526994|449431043|FG000|Overall Study|Death|4|||
124946334|NCT00526994|449431044|FG001|Overall Study|Death|3|||
124946335|NCT00526994|449431045|FG002|Overall Study|Death|3|||
124946336|NCT00526994|449431043|FG000|Overall Study|Withdrawal by Subject|2|||
124946337|NCT00526994|449431044|FG001|Overall Study|Withdrawal by Subject|7|||
124946338|NCT00526994|449431045|FG002|Overall Study|Withdrawal by Subject|5|||
124946339|NCT00526994|449431043|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
124946340|NCT00526994|449431044|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
124946341|NCT00526994|449431045|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
124946342|NCT02833948|449431051|FG000|Overall Study|Death|2|||
124946343|NCT02833948|449431052|FG001|Overall Study|Death|3|||
124946344|NCT02833948|449431051|FG000|Overall Study|were not scanned|8|||
124946345|NCT02833948|449431052|FG001|Overall Study|were not scanned|13|||
124946346|NCT02833948|449431051|FG000|Overall Study|scans could not be evaluated|5|||
124946347|NCT02833948|449431052|FG001|Overall Study|scans could not be evaluated|2|||
124946348|NCT02644122|449431053|FG000|Overall Study|Withdrawal by Subject|1|||
124946349|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
124946350|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
124946351|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
124946352|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
124946353|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
124946354|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
124946355|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
124946356|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
124946357|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
124946358|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
124946359|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
124946360|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
124946361|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
124946362|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
124946363|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
124946364|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
124946365|NCT03182244|449431054|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
124946366|NCT03182244|449431055|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
124946367|NCT03182244|449431054|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
124946368|NCT03182244|449431055|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
124946369|NCT03182244|449431054|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
124946370|NCT03182244|449431055|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
124458654|NCT02104583|447640408|FG000|Overall Study|Subject required prohibited medication|0|||
124458655|NCT02104583|447640409|FG001|Overall Study|Subject required prohibited medication|1|||
124548122|NCT01017731|447962494|FG000|Overall Study|Adverse Event|1|||
124548123|NCT05378269|447962495|FG000|Overall Study|Protocol Violation|1|||
124548124|NCT05378269|447962496|FG001|Overall Study|Protocol Violation|0|||
124548125|NCT05378269|447962497|FG002|Overall Study|Protocol Violation|2|||
124548126|NCT05378269|447962498|FG003|Overall Study|Protocol Violation|0|||
124548127|NCT05378269|447962499|FG004|Overall Study|Protocol Violation|0|||
124548128|NCT00359073|447962500|FG000|Overall Study|Withdrawal by Subject|1|||
124548129|NCT00359073|447962501|FG001|Overall Study|Withdrawal by Subject|1|||
124548130|NCT00359073|447962500|FG000|Overall Study|Eligibility criteria no longer met|3|||
124548131|NCT00359073|447962501|FG001|Overall Study|Eligibility criteria no longer met|0|||
124548132|NCT00359073|447962500|FG000|Overall Study|developed RV16 antibody|0|||
124548133|NCT00359073|447962501|FG001|Overall Study|developed RV16 antibody|1|||
124548134|NCT03387423|447962504|FG000|Overall Study|Lost to Follow-up|16|||
124548135|NCT03387423|447962505|FG001|Overall Study|Lost to Follow-up|12|||
124548136|NCT03387423|447962506|FG002|Overall Study|Lost to Follow-up|1|||
124548137|NCT03387423|447962507|FG003|Overall Study|Lost to Follow-up|0|||
124548138|NCT03387423|447962504|FG000|Overall Study|Other|0|||
124548139|NCT03387423|447962505|FG001|Overall Study|Other|3|||
124548140|NCT03387423|447962506|FG002|Overall Study|Other|0|||
124548141|NCT03387423|447962507|FG003|Overall Study|Other|0|||
124548142|NCT03387423|447962504|FG000|Overall Study|Administrative Reason|166|||
124548143|NCT03387423|447962505|FG001|Overall Study|Administrative Reason|89|||
124548144|NCT03387423|447962506|FG002|Overall Study|Administrative Reason|17|||
124548145|NCT03387423|447962507|FG003|Overall Study|Administrative Reason|19|||
124548146|NCT03387423|447962504|FG000|Overall Study|Revocation Consent|76|||
124548147|NCT03387423|447962505|FG001|Overall Study|Revocation Consent|32|||
124946371|NCT03182244|449431054|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
124946372|NCT03182244|449431055|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
124946373|NCT03182244|449431054|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
124946374|NCT03182244|449431055|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
124946375|NCT02852824|449431058|FG000|Overall Study|Withdrawal by Subject|1|||
124946376|NCT02852824|449431059|FG001|Overall Study|Withdrawal by Subject|0|||
124946377|NCT02852824|449431060|FG002|Overall Study|Withdrawal by Subject|0|||
124706050|NCT02958865|448548499|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
124706051|NCT02958865|448548500|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
124706052|NCT02958865|448548501|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
124765305|NCT01194830|448767383|FG000|Overall Study|Adverse Event|3|||
124548148|NCT03387423|447962506|FG002|Overall Study|Revocation Consent|3|||
124548149|NCT03387423|447962507|FG003|Overall Study|Revocation Consent|5|||
124548150|NCT01371006|447962508|FG000|Overall Study|Adverse Event|1|||
124706053|NCT02958865|448548502|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
124706054|NCT02958865|448548503|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
124706055|NCT02958865|448548504|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
124706056|NCT02958865|448548505|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
124706057|NCT02958865|448548506|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
124706058|NCT01038323|448548520|FG000|Overall Study|Withdrawal by Subject|3|||
124706059|NCT01038323|448548521|FG001|Overall Study|Withdrawal by Subject|2|||
124706060|NCT01038323|448548522|FG002|Overall Study|Withdrawal by Subject|4|||
124706061|NCT01143402|448548523|FG000|Overall Study|Rapid clinical decline|1|||
124706062|NCT01143402|448548524|FG001|Overall Study|Rapid clinical decline|1|||
124706063|NCT01143402|448548525|FG002|Overall Study|Rapid clinical decline|0|||
124706064|NCT01143402|448548523|FG000|Overall Study|Not Treated|0|||
124706065|NCT01143402|448548524|FG001|Overall Study|Not Treated|0|||
124706066|NCT01143402|448548525|FG002|Overall Study|Not Treated|1|||
124706067|NCT04462471|448548526|FG000|Overall Study|Adverse Event|0|||
124706068|NCT04462471|448548527|FG001|Overall Study|Adverse Event|1|||
124706069|NCT04462471|448548528|FG002|Overall Study|Adverse Event|0|||
124706070|NCT04462471|448548529|FG003|Overall Study|Adverse Event|0|||
124706071|NCT04462471|448548526|FG000|Overall Study|Disease progression|1|||
124706072|NCT04462471|448548527|FG001|Overall Study|Disease progression|0|||
124706073|NCT04462471|448548528|FG002|Overall Study|Disease progression|0|||
124706074|NCT04462471|448548529|FG003|Overall Study|Disease progression|0|||
124706075|NCT02526290|448548531|FG000|Overall Study|Adverse Event|3|||
124706076|NCT02526290|448548531|FG000|Overall Study|Withdrawal by Subject|4|||
124706077|NCT02526290|448548531|FG000|Overall Study|Physician Decision|1|||
124706078|NCT01380080|448548540|FG000|Overall Study|Death|36|||
124706079|NCT01380080|448548541|FG001|Overall Study|Death|44|||
124706080|NCT01380080|448548540|FG000|Overall Study|Site is closing|28|||
124706081|NCT01380080|448548541|FG001|Overall Study|Site is closing|31|||
124706082|NCT01380080|448548540|FG000|Overall Study|Not able to get to clinic|7|||
124706083|NCT01380080|448548541|FG001|Overall Study|Not able to get to clinic|1|||
124706084|NCT01380080|448548540|FG000|Overall Study|Not willing to adhere to requirements|6|||
124706085|NCT01380080|448548541|FG001|Overall Study|Not willing to adhere to requirements|2|||
124706086|NCT01380080|448548540|FG000|Overall Study|Withdrawal by Subject|5|||
124706087|NCT01380080|448548541|FG001|Overall Study|Withdrawal by Subject|2|||
124706088|NCT01380080|448548540|FG000|Overall Study|Lost to Follow-up|3|||
124706089|NCT01380080|448548541|FG001|Overall Study|Lost to Follow-up|3|||
124706090|NCT00210132|448548546|FG000|Overall Study|Protocol Violation|1|||
124706091|NCT00210132|448548547|FG001|Overall Study|Protocol Violation|4|||
124706092|NCT00432965|448548548|FG000|Overall Study|Lost to Follow-up|22|||
124706093|NCT00432965|448548549|FG001|Overall Study|Lost to Follow-up|19|||
124706094|NCT00432965|448548548|FG000|Overall Study|Withdrawal by Subject|13|||
124706095|NCT00432965|448548549|FG001|Overall Study|Withdrawal by Subject|13|||
124706096|NCT00432965|448548548|FG000|Overall Study|Physician Decision|14|||
124706097|NCT00432965|448548549|FG001|Overall Study|Physician Decision|13|||
124706098|NCT00432965|448548548|FG000|Overall Study|Lack of Efficacy|8|||
124946378|NCT02852824|449431061|FG003|Overall Study|Withdrawal by Subject|0|||
124946379|NCT02852824|449431062|FG004|Overall Study|Withdrawal by Subject|0|||
124548151|NCT01371006|447962509|FG001|Overall Study|Adverse Event|0|||
124548152|NCT03926728|447962510|FG000|Overall Study|Withdrawal by Subject|0|||
124706099|NCT00432965|448548549|FG001|Overall Study|Lack of Efficacy|13|||
124706100|NCT00432965|448548548|FG000|Overall Study|Non-compliance|7|||
124706101|NCT00432965|448548549|FG001|Overall Study|Non-compliance|0|||
124706102|NCT00432965|448548548|FG000|Overall Study|Adverse Event|22|||
124706103|NCT00432965|448548549|FG001|Overall Study|Adverse Event|19|||
124706104|NCT00432965|448548548|FG000|Overall Study|Death|3|||
124706105|NCT00432965|448548549|FG001|Overall Study|Death|4|||
124706106|NCT00432965|448548548|FG000|Overall Study|Exclusionary Methods|1|||
124946380|NCT02852824|449431063|FG005|Overall Study|Withdrawal by Subject|0|||
124946381|NCT02852824|449431064|FG006|Overall Study|Withdrawal by Subject|0|||
124946382|NCT02852824|449431058|FG000|Overall Study|Adverse Event|0|||
124946383|NCT02852824|449431059|FG001|Overall Study|Adverse Event|0|||
124946384|NCT02852824|449431060|FG002|Overall Study|Adverse Event|0|||
124946385|NCT02852824|449431061|FG003|Overall Study|Adverse Event|0|||
124946386|NCT02852824|449431062|FG004|Overall Study|Adverse Event|2|||
124946387|NCT02852824|449431063|FG005|Overall Study|Adverse Event|0|||
124946388|NCT02852824|449431064|FG006|Overall Study|Adverse Event|0|||
124946389|NCT00680771|449431065|FG000|Overall Study|Withdrawal by Subject|1|||
124706107|NCT00432965|448548549|FG001|Overall Study|Exclusionary Methods|2|||
124706108|NCT00432965|448548548|FG000|Overall Study|Incomplete Data|4|||
124946390|NCT00680771|449431066|FG001|Overall Study|Withdrawal by Subject|0|||
124946391|NCT00680771|449431065|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
124946392|NCT00680771|449431066|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
124946393|NCT00680771|449431065|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
124946394|NCT00680771|449431066|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
124946395|NCT04076059|449431072|FG000|Double Blind Phase|Progressive disease|22|||
124946396|NCT04076059|449431073|FG001|Double Blind Phase|Progressive disease|26|||
124946397|NCT04076059|449431074|FG002|Double Blind Phase|Progressive disease|0|||
124946398|NCT04076059|449431072|FG000|Double Blind Phase|Withdrawal by Subject|4|||
124946399|NCT04076059|449431073|FG001|Double Blind Phase|Withdrawal by Subject|11|||
124946400|NCT04076059|449431074|FG002|Double Blind Phase|Withdrawal by Subject|0|||
124946401|NCT04076059|449431072|FG000|Double Blind Phase|Death|1|||
124946402|NCT04076059|449431073|FG001|Double Blind Phase|Death|1|||
124946403|NCT04076059|449431074|FG002|Double Blind Phase|Death|0|||
124946404|NCT04076059|449431072|FG000|Double Blind Phase|Lost to Follow-up|1|||
124946405|NCT04076059|449431073|FG001|Double Blind Phase|Lost to Follow-up|0|||
124946406|NCT04076059|449431074|FG002|Double Blind Phase|Lost to Follow-up|0|||
124946407|NCT04076059|449431072|FG000|Double Blind Phase|Adverse Event|5|||
124946408|NCT04076059|449431073|FG001|Double Blind Phase|Adverse Event|1|||
124946409|NCT04076059|449431074|FG002|Double Blind Phase|Adverse Event|0|||
124946410|NCT04076059|449431072|FG000|Double Blind Phase|Ongoing Participants|82|||
124458656|NCT02104583|447640410|FG002|Overall Study|Subject required prohibited medication|1|||
124458657|NCT02104583|447640411|FG003|Overall Study|Subject required prohibited medication|0|||
124458658|NCT02104583|447640412|FG004|Overall Study|Subject required prohibited medication|1|||
124946411|NCT04076059|449431073|FG001|Double Blind Phase|Ongoing Participants|18|||
124946412|NCT04076059|449431074|FG002|Double Blind Phase|Ongoing Participants|0|||
124946413|NCT04076059|449431072|FG000|Double Blind Phase|Miscellaneous|3|||
124458659|NCT02104583|447640408|FG000|Overall Study|Withdrew Consent|3|||
124458660|NCT02104583|447640409|FG001|Overall Study|Withdrew Consent|2|||
124458661|NCT02104583|447640410|FG002|Overall Study|Withdrew Consent|0|||
124458662|NCT02104583|447640411|FG003|Overall Study|Withdrew Consent|2|||
124458663|NCT02104583|447640412|FG004|Overall Study|Withdrew Consent|1|||
124458664|NCT02104583|447640408|FG000|Overall Study|Investigator's Discretion|1|||
124458665|NCT02104583|447640409|FG001|Overall Study|Investigator's Discretion|0|||
124458666|NCT02104583|447640410|FG002|Overall Study|Investigator's Discretion|0|||
124458667|NCT02104583|447640411|FG003|Overall Study|Investigator's Discretion|0|||
124458668|NCT02104583|447640412|FG004|Overall Study|Investigator's Discretion|0|||
124458669|NCT02104583|447640408|FG000|Overall Study|Protocol Violation|0|||
124458670|NCT02104583|447640409|FG001|Overall Study|Protocol Violation|0|||
124458671|NCT02104583|447640410|FG002|Overall Study|Protocol Violation|1|||
124458672|NCT02104583|447640411|FG003|Overall Study|Protocol Violation|0|||
124458673|NCT02104583|447640412|FG004|Overall Study|Protocol Violation|0|||
124458674|NCT02104583|447640408|FG000|Overall Study|Adverse Event|3|||
124458675|NCT02104583|447640409|FG001|Overall Study|Adverse Event|3|||
124458676|NCT02104583|447640410|FG002|Overall Study|Adverse Event|6|||
124458677|NCT02104583|447640411|FG003|Overall Study|Adverse Event|6|||
124946414|NCT04076059|449431073|FG001|Double Blind Phase|Miscellaneous|1|||
124946415|NCT04076059|449431074|FG002|Double Blind Phase|Miscellaneous|0|||
124946416|NCT04076059|449431072|FG000|Double Blind Phase|Protocol Deviation|1|||
124458678|NCT02104583|447640412|FG004|Overall Study|Adverse Event|1|||
124946417|NCT04076059|449431073|FG001|Double Blind Phase|Protocol Deviation|1|||
124946418|NCT04076059|449431074|FG002|Double Blind Phase|Protocol Deviation|0|||
124946419|NCT04076059|449431072|FG000|Double Blind Phase|Did not take study drug|1|||
124946420|NCT04076059|449431073|FG001|Double Blind Phase|Did not take study drug|1|||
124946421|NCT04076059|449431074|FG002|Double Blind Phase|Did not take study drug|0|||
124946422|NCT04076059|449431072|FG000|Open Label Phase|Progressive disease|0|||
124946423|NCT04076059|449431073|FG001|Open Label Phase|Progressive disease|0|||
124946424|NCT04076059|449431074|FG002|Open Label Phase|Progressive disease|7|||
124946425|NCT04076059|449431072|FG000|Open Label Phase|Withdrawal by Subject|0|||
124946426|NCT04076059|449431073|FG001|Open Label Phase|Withdrawal by Subject|0|||
124946427|NCT04076059|449431074|FG002|Open Label Phase|Withdrawal by Subject|3|||
124946428|NCT04076059|449431072|FG000|Open Label Phase|Death|0|||
124946429|NCT04076059|449431073|FG001|Open Label Phase|Death|0|||
124946430|NCT04076059|449431074|FG002|Open Label Phase|Death|2|||
124946431|NCT04076059|449431072|FG000|Open Label Phase|Ongoing Participants|0|||
124946432|NCT04076059|449431073|FG001|Open Label Phase|Ongoing Participants|0|||
124946433|NCT04076059|449431074|FG002|Open Label Phase|Ongoing Participants|11|||
124946434|NCT02521493|449431075|FG000|Overall Study|Death|3|||
124946435|NCT02521493|449431076|FG001|Overall Study|Death|4|||
124946436|NCT02521493|449431077|FG002|Overall Study|Death|1|||
124946437|NCT02521493|449431075|FG000|Overall Study|Physician Decision|19|||
124946438|NCT02521493|449431076|FG001|Overall Study|Physician Decision|1|||
124946439|NCT02521493|449431077|FG002|Overall Study|Physician Decision|2|||
124946440|NCT02521493|449431075|FG000|Overall Study|Withdrawal by Subject|3|||
124946441|NCT02521493|449431076|FG001|Overall Study|Withdrawal by Subject|0|||
124946442|NCT02521493|449431077|FG002|Overall Study|Withdrawal by Subject|0|||
124946443|NCT02521493|449431075|FG000|Overall Study|Ineligible|0|||
124458679|NCT02104583|447640408|FG000|Overall Study|Lost to Follow-up|1|||
124458680|NCT02104583|447640409|FG001|Overall Study|Lost to Follow-up|0|||
124458681|NCT02104583|447640410|FG002|Overall Study|Lost to Follow-up|0|||
124458682|NCT02104583|447640411|FG003|Overall Study|Lost to Follow-up|0|||
124458683|NCT02104583|447640412|FG004|Overall Study|Lost to Follow-up|0|||
124458684|NCT02104583|447640408|FG000|Overall Study|Randomized but Never Treated|0|||
124458685|NCT02104583|447640409|FG001|Overall Study|Randomized but Never Treated|0|||
124458686|NCT02104583|447640410|FG002|Overall Study|Randomized but Never Treated|0|||
124458687|NCT02104583|447640411|FG003|Overall Study|Randomized but Never Treated|1|||
124458688|NCT02104583|447640412|FG004|Overall Study|Randomized but Never Treated|0|||
124458689|NCT02347098|447640413|FG000|Overall Study|Death|1|||
124458690|NCT02347098|447640414|FG001|Overall Study|Death|0|||
124458691|NCT02347098|447640413|FG000|Overall Study|Withdrawal by Subject|1|||
124458692|NCT02347098|447640414|FG001|Overall Study|Withdrawal by Subject|0|||
124458693|NCT02347098|447640413|FG000|Overall Study|Lost to Follow-up|2|||
124458694|NCT02347098|447640414|FG001|Overall Study|Lost to Follow-up|2|||
124458695|NCT02347098|447640413|FG000|Overall Study|Refuse Follow-up Visit|1|||
124946444|NCT02521493|449431076|FG001|Overall Study|Ineligible|1|||
124946445|NCT02521493|449431077|FG002|Overall Study|Ineligible|0|||
124946446|NCT02521493|449431075|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
124458696|NCT02347098|447640414|FG001|Overall Study|Refuse Follow-up Visit|5|||
124458697|NCT02347098|447640413|FG000|Overall Study|no visit due to illness|2|||
124458698|NCT02347098|447640414|FG001|Overall Study|no visit due to illness|1|||
124458699|NCT02187172|447640415|FG000|Overall Study|Lost to Follow-up|1|||
124458700|NCT02187172|447640416|FG001|Overall Study|Lost to Follow-up|2|||
124458701|NCT02187172|447640415|FG000|Overall Study|Lack of Efficacy|1|||
124458702|NCT02187172|447640416|FG001|Overall Study|Lack of Efficacy|2|||
124458703|NCT02187172|447640415|FG000|Overall Study|Adverse Event|0|||
124458704|NCT02187172|447640416|FG001|Overall Study|Adverse Event|1|||
124458705|NCT02187172|447640415|FG000|Overall Study|Physician Decision|1|||
124458706|NCT02187172|447640416|FG001|Overall Study|Physician Decision|1|||
124458707|NCT02830880|447640420|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
124458708|NCT02830880|447640420|FG000|Overall Study|Death|1|||
124458709|NCT02830880|447640420|FG000|Overall Study|Physician Decision|1|||
124458710|NCT02646982|447640425|FG000|Overall Study|Adverse Event|1|||
124458711|NCT02646982|447640426|FG001|Overall Study|Adverse Event|1|||
124946447|NCT02521493|449431076|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
124946448|NCT02521493|449431077|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
124458712|NCT02646982|447640425|FG000|Overall Study|Withdrawal by Subject|2|||
124548153|NCT03926728|447962511|FG001|Overall Study|Withdrawal by Subject|1|||
124946449|NCT02521493|449431075|FG000|Overall Study|No MRD result|0|||
124946450|NCT02521493|449431076|FG001|Overall Study|No MRD result|0|||
124946451|NCT02521493|449431077|FG002|Overall Study|No MRD result|4|||
124946452|NCT04748341|449431078|FG000|Overall Study|Lost to Follow-up|1|||
124458713|NCT02646982|447640426|FG001|Overall Study|Withdrawal by Subject|1|||
124458714|NCT03551509|447640431|FG000|Overall Study|Lost to Follow-up|0|||
124458715|NCT03551509|447640432|FG001|Overall Study|Lost to Follow-up|1|||
124458716|NCT03551509|447640433|FG002|Overall Study|Lost to Follow-up|0|||
124458717|NCT01040351|447640434|FG000|Overall Study|poor ovarian response|1|||
124946453|NCT04748341|449431079|FG001|Overall Study|Lost to Follow-up|1|||
124946454|NCT03769090|449432681|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
124946455|NCT03769090|449432682|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
124946456|NCT03769090|449432683|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
124946457|NCT03769090|449432681|FG000|Overall Study|Withdrawal by Subject|52|||
124946458|NCT03769090|449432682|FG001|Overall Study|Withdrawal by Subject|62|||
124946459|NCT03769090|449432683|FG002|Overall Study|Withdrawal by Subject|74|||
124946460|NCT03769090|449432681|FG000|Overall Study|Death|4|||
124946461|NCT03769090|449432682|FG001|Overall Study|Death|2|||
124946462|NCT03769090|449432683|FG002|Overall Study|Death|2|||
124458718|NCT01040351|447640435|FG001|Overall Study|poor ovarian response|2|||
124458719|NCT01230307|447640436|FG000|Overall Study|LVAD Placement|0|||
124458720|NCT01230307|447640437|FG001|Overall Study|LVAD Placement|2|||
124458721|NCT00530894|447640442|FG000|Overall Study|Death|84|||
124458722|NCT00530894|447640443|FG001|Overall Study|Death|89|||
124458723|NCT00530894|447640444|FG002|Overall Study|Death|55|||
124458724|NCT00530894|447640445|FG003|Overall Study|Death|89|||
124946463|NCT03769090|449432681|FG000|Overall Study|Adverse Event|7|||
124946464|NCT03769090|449432682|FG001|Overall Study|Adverse Event|7|||
124946465|NCT03769090|449432683|FG002|Overall Study|Adverse Event|8|||
124946466|NCT03769090|449432681|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
124946467|NCT03769090|449432682|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
124946468|NCT03769090|449432683|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
124946469|NCT03769090|449432681|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
124946470|NCT03769090|449432682|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
124946471|NCT03769090|449432683|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
124946472|NCT03769090|449432681|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
124946473|NCT03769090|449432682|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
124946474|NCT03769090|449432683|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
124946475|NCT03769090|449432681|FG000|Overall Study|Protocol Violation|5|||
124946476|NCT03769090|449432682|FG001|Overall Study|Protocol Violation|6|||
124946477|NCT03769090|449432683|FG002|Overall Study|Protocol Violation|8|||
124946478|NCT03769090|449432681|FG000|Overall Study|Pregnancy|1|||
124946479|NCT03769090|449432682|FG001|Overall Study|Pregnancy|0|||
124946480|NCT03769090|449432683|FG002|Overall Study|Pregnancy|3|||
124946481|NCT03769090|449432681|FG000|Overall Study|Lost to Follow-up|19|||
124946482|NCT03769090|449432682|FG001|Overall Study|Lost to Follow-up|25|||
124946483|NCT03769090|449432683|FG002|Overall Study|Lost to Follow-up|21|||
124946484|NCT03769090|449432681|FG000|Overall Study|Condition under investigation worsened|2|||
124946485|NCT03769090|449432682|FG001|Overall Study|Condition under investigation worsened|0|||
124458725|NCT00530894|447640442|FG000|Overall Study|Lost to Follow-up|1|||
124458726|NCT00530894|447640443|FG001|Overall Study|Lost to Follow-up|3|||
124946486|NCT03769090|449432683|FG002|Overall Study|Condition under investigation worsened|1|||
124946487|NCT03769090|449432681|FG000|Overall Study|Lack of Efficacy|1|||
124946488|NCT03769090|449432682|FG001|Overall Study|Lack of Efficacy|2|||
124946489|NCT03769090|449432683|FG002|Overall Study|Lack of Efficacy|2|||
124946490|NCT03769090|449432681|FG000|Overall Study|Other reasons|8|||
124946491|NCT03769090|449432682|FG001|Overall Study|Other reasons|12|||
124946492|NCT03769090|449432683|FG002|Overall Study|Other reasons|15|||
124946493|NCT00799409|449432684|FG000|Overall Study|Withdrawal by Subject|1|||
124946494|NCT00799409|449432685|FG001|Overall Study|Withdrawal by Subject|0|||
124946495|NCT00799409|449432686|FG002|Overall Study|Withdrawal by Subject|0|||
124946496|NCT00799409|449432684|FG000|Overall Study|Lost to Follow-up|1|||
124946497|NCT00799409|449432685|FG001|Overall Study|Lost to Follow-up|0|||
124946498|NCT00799409|449432686|FG002|Overall Study|Lost to Follow-up|0|||
124946499|NCT00799409|449432684|FG000|Overall Study|Optimal Dose Not Achieved|2|||
124946500|NCT00799409|449432685|FG001|Overall Study|Optimal Dose Not Achieved|0|||
124946501|NCT00799409|449432686|FG002|Overall Study|Optimal Dose Not Achieved|0|||
124946502|NCT00799409|449432684|FG000|Overall Study|Failure to follow study protocol)|1|||
124946503|NCT00799409|449432685|FG001|Overall Study|Failure to follow study protocol)|0|||
124946504|NCT00799409|449432686|FG002|Overall Study|Failure to follow study protocol)|0|||
124946505|NCT00799409|449432684|FG000|Overall Study|Did not attend lab school day 1|1|||
124946506|NCT00799409|449432685|FG001|Overall Study|Did not attend lab school day 1|0|||
124946507|NCT00799409|449432686|FG002|Overall Study|Did not attend lab school day 1|0|||
124946508|NCT00799409|449432684|FG000|Overall Study|medication compliance|1|||
124946509|NCT00799409|449432685|FG001|Overall Study|medication compliance|0|||
124946510|NCT00799409|449432686|FG002|Overall Study|medication compliance|0|||
124946511|NCT03964974|449432687|FG000|Overall Study|Lost to Follow-up|3|||
124946512|NCT03964974|449432688|FG001|Overall Study|Lost to Follow-up|2|||
124946513|NCT03964974|449432687|FG000|Overall Study|Withdrawal by Subject|0|||
124946514|NCT03964974|449432688|FG001|Overall Study|Withdrawal by Subject|3|||
124946515|NCT01779050|449432691|FG000|Overall Study|Withdrawal by Subject|1|||
124946516|NCT01779050|449432692|FG001|Overall Study|Withdrawal by Subject|0|||
124946517|NCT00022672|449432695|FG000|Main Phase: 24 Months|Adverse Event|6|||
124946518|NCT00022672|449432696|FG001|Main Phase: 24 Months|Adverse Event|0|||
124946519|NCT00022672|449432695|FG000|Main Phase: 24 Months|Death|0|||
124946520|NCT00022672|449432696|FG001|Main Phase: 24 Months|Death|3|||
124946521|NCT00022672|449432695|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
124946522|NCT00022672|449432696|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
124946523|NCT00022672|449432695|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
124946524|NCT00022672|449432696|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
124946525|NCT00022672|449432695|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
124946526|NCT00022672|449432696|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
124946527|NCT00022672|449432695|FG000|Main Phase: 24 Months|Refused Treatment|3|||
124946528|NCT00022672|449432696|FG001|Main Phase: 24 Months|Refused Treatment|4|||
124946529|NCT00022672|449432695|FG000|Main Phase: 24 Months|Failure to Return|1|||
124946530|NCT00022672|449432696|FG001|Main Phase: 24 Months|Failure to Return|1|||
124946531|NCT00022672|449432695|FG000|Main Phase: 24 Months|Other|1|||
124946532|NCT00022672|449432696|FG001|Main Phase: 24 Months|Other|0|||
124946533|NCT00022672|449432695|FG000|Extension Phase|Adverse Event|1|||
124946534|NCT00022672|449432696|FG001|Extension Phase|Adverse Event|3|||
124946535|NCT00022672|449432695|FG000|Extension Phase|Death|0|||
124946536|NCT00022672|449432696|FG001|Extension Phase|Death|1|||
124946537|NCT00022672|449432695|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
124946538|NCT00022672|449432696|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
124946539|NCT00022672|449432695|FG000|Extension Phase|Refused Treatment|0|||
124946540|NCT00022672|449432696|FG001|Extension Phase|Refused Treatment|2|||
124946541|NCT00022672|449432695|FG000|Extension Phase|Other|1|||
124946542|NCT00022672|449432696|FG001|Extension Phase|Other|1|||
124946543|NCT01332266|449432697|FG000|Phase 1b|Death|3|||
124946544|NCT01332266|449432698|FG001|Phase 1b|Death|3|||
124946545|NCT01332266|449432699|FG002|Phase 1b|Death|2|||
124946546|NCT01332266|449432700|FG003|Phase 1b|Death|0|||
124946547|NCT01332266|449432701|FG004|Phase 1b|Death|0|||
124946548|NCT01332266|449432697|FG000|Phase 1b|Lost to Follow-up|0|||
124946549|NCT01332266|449432698|FG001|Phase 1b|Lost to Follow-up|1|||
124946550|NCT01332266|449432699|FG002|Phase 1b|Lost to Follow-up|0|||
124946551|NCT01332266|449432700|FG003|Phase 1b|Lost to Follow-up|0|||
124946552|NCT01332266|449432701|FG004|Phase 1b|Lost to Follow-up|0|||
124946553|NCT01332266|449432697|FG000|Phase 1b|Withdrawal by Subject|1|||
124946554|NCT01332266|449432698|FG001|Phase 1b|Withdrawal by Subject|1|||
124946555|NCT01332266|449432699|FG002|Phase 1b|Withdrawal by Subject|1|||
124946556|NCT01332266|449432700|FG003|Phase 1b|Withdrawal by Subject|0|||
124946557|NCT01332266|449432701|FG004|Phase 1b|Withdrawal by Subject|0|||
124946558|NCT01332266|449432697|FG000|Phase 2|Death|0|||
124946559|NCT01332266|449432698|FG001|Phase 2|Death|0|||
124946560|NCT01332266|449432699|FG002|Phase 2|Death|0|||
124946561|NCT01332266|449432700|FG003|Phase 2|Death|33|||
124946562|NCT01332266|449432701|FG004|Phase 2|Death|36|||
124706109|NCT00432965|448548549|FG001|Overall Study|Incomplete Data|3|||
124706110|NCT03636022|448548554|FG000|Overall Study|Withdrawal by Subject|1|||
124706111|NCT03636022|448548555|FG001|Overall Study|Withdrawal by Subject|3|||
124706112|NCT04532749|448548556|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
124706113|NCT04532749|448548557|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
124706114|NCT04532749|448548556|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
124706115|NCT04532749|448548557|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
124706116|NCT04532749|448548556|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
124706117|NCT04532749|448548557|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
124706118|NCT04532749|448548556|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
124706119|NCT04532749|448548557|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
124706120|NCT04532749|448548556|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
124706121|NCT04532749|448548557|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
124706122|NCT04532749|448548556|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
124706123|NCT04532749|448548557|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
124706124|NCT04532749|448548556|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
124706125|NCT04532749|448548557|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
124706126|NCT04532749|448548556|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
124706127|NCT04532749|448548557|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
124706128|NCT04532749|448548556|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
124706129|NCT04532749|448548557|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
124706130|NCT04532749|448548556|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
124706131|NCT04532749|448548557|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
124706132|NCT00642759|448548558|FG000|Overall Study|Protocol Violation|1|||
124706133|NCT01346176|448548561|FG000|Recruited|Protocol Violation|1|||
124706134|NCT01346176|448548562|FG001|Recruited|Protocol Violation|0|||
124706135|NCT01346176|448548563|FG002|Recruited|Protocol Violation|0|||
124706136|NCT01346176|448548561|FG000|Completed Advance Directive|Death|3|||
124706137|NCT01346176|448548562|FG001|Completed Advance Directive|Death|2|||
124706138|NCT01346176|448548563|FG002|Completed Advance Directive|Death|2|||
124706139|NCT01346176|448548561|FG000|Completed Advance Directive|Became Ineligible|3|||
124706140|NCT01346176|448548562|FG001|Completed Advance Directive|Became Ineligible|0|||
124706141|NCT01346176|448548563|FG002|Completed Advance Directive|Became Ineligible|1|||
124706142|NCT01346176|448548561|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
124706143|NCT01346176|448548562|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
124706144|NCT01346176|448548563|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
124706145|NCT01346176|448548561|FG000|Completed Satisfaction Survey|Death|3|||
124706146|NCT01346176|448548562|FG001|Completed Satisfaction Survey|Death|0|||
124706147|NCT01346176|448548563|FG002|Completed Satisfaction Survey|Death|2|||
124706148|NCT01346176|448548561|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
124706149|NCT01346176|448548562|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
124946563|NCT01332266|449432697|FG000|Phase 2|Lost to Follow-up|0|||
124946564|NCT01332266|449432698|FG001|Phase 2|Lost to Follow-up|0|||
124946565|NCT01332266|449432699|FG002|Phase 2|Lost to Follow-up|0|||
124946566|NCT01332266|449432700|FG003|Phase 2|Lost to Follow-up|2|||
124946567|NCT01332266|449432701|FG004|Phase 2|Lost to Follow-up|0|||
124946568|NCT01332266|449432697|FG000|Phase 2|Physician Decision|0|||
124946569|NCT01332266|449432698|FG001|Phase 2|Physician Decision|0|||
124946570|NCT01332266|449432699|FG002|Phase 2|Physician Decision|0|||
124946571|NCT01332266|449432700|FG003|Phase 2|Physician Decision|3|||
124946572|NCT01332266|449432701|FG004|Phase 2|Physician Decision|1|||
124946573|NCT01332266|449432697|FG000|Phase 2|Symptomatic deterioration|0|||
124946574|NCT01332266|449432698|FG001|Phase 2|Symptomatic deterioration|0|||
124946575|NCT01332266|449432699|FG002|Phase 2|Symptomatic deterioration|0|||
124458727|NCT00530894|447640444|FG002|Overall Study|Lost to Follow-up|0|||
124458728|NCT00530894|447640445|FG003|Overall Study|Lost to Follow-up|0|||
124458729|NCT00530894|447640442|FG000|Overall Study|Withdrawal by Subject|1|||
124458730|NCT00530894|447640443|FG001|Overall Study|Withdrawal by Subject|23|||
124458731|NCT00530894|447640444|FG002|Overall Study|Withdrawal by Subject|0|||
124458732|NCT00530894|447640445|FG003|Overall Study|Withdrawal by Subject|5|||
124458733|NCT00530894|447640442|FG000|Overall Study|Alive and censored prior to 1 year|2|||
124706150|NCT01346176|448548563|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
124706151|NCT02255435|448549880|FG000|Overall Study|Patient's Limited Time Availability|0|||
124706152|NCT02255435|448549881|FG001|Overall Study|Patient's Limited Time Availability|0|||
124946576|NCT01332266|449432700|FG003|Phase 2|Symptomatic deterioration|0|||
124946577|NCT01332266|449432701|FG004|Phase 2|Symptomatic deterioration|1|||
124946578|NCT01332266|449432697|FG000|Phase 2|Progression Disease|0|||
124946579|NCT01332266|449432698|FG001|Phase 2|Progression Disease|0|||
124946580|NCT01332266|449432699|FG002|Phase 2|Progression Disease|0|||
124946581|NCT01332266|449432700|FG003|Phase 2|Progression Disease|2|||
124765306|NCT01194830|448767384|FG001|Overall Study|Adverse Event|2|||
124946582|NCT01332266|449432701|FG004|Phase 2|Progression Disease|1|||
124946583|NCT01332266|449432697|FG000|Phase 2|Withdrawal by Subject|0|||
124946584|NCT01332266|449432698|FG001|Phase 2|Withdrawal by Subject|0|||
124458734|NCT00530894|447640443|FG001|Overall Study|Alive and censored prior to 1 year|0|||
124458735|NCT00530894|447640444|FG002|Overall Study|Alive and censored prior to 1 year|0|||
124458736|NCT00530894|447640445|FG003|Overall Study|Alive and censored prior to 1 year|0|||
124458737|NCT02256540|447640446|FG000|Overall Study|Withdrawal by Subject|0|||
124458738|NCT02256540|447640447|FG001|Overall Study|Withdrawal by Subject|1|||
124458739|NCT02256540|447640448|FG002|Overall Study|Withdrawal by Subject|1|||
124458740|NCT02256540|447640446|FG000|Overall Study|Back pain preventing exercise|0|||
124458741|NCT02256540|447640447|FG001|Overall Study|Back pain preventing exercise|0|||
124458742|NCT02256540|447640448|FG002|Overall Study|Back pain preventing exercise|1|||
124458743|NCT03923426|447640456|FG000|Overall Study|Other|19|||
124458744|NCT03923426|447640456|FG000|Overall Study|Lost to Follow-up|16|||
124458745|NCT03923426|447640456|FG000|Overall Study|Death|107|||
124458746|NCT03923426|447640456|FG000|Overall Study|Incomplete response to question|13|||
124458747|NCT00769002|447640457|FG000|Overall Study|Study was not completed, no data|9|||
124458748|NCT00769002|447640458|FG001|Overall Study|Study was not completed, no data|9|||
124458749|NCT01918007|447640459|FG000|Overall Study|Baseline oximetry not acceptable|11|||
124458750|NCT01918007|447640460|FG001|Overall Study|Baseline oximetry not acceptable|7|||
124458751|NCT01918007|447640459|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
124458752|NCT01918007|447640460|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
124458753|NCT01918007|447640459|FG000|Overall Study|Lost to Follow-up|4|||
124458754|NCT01918007|447640460|FG001|Overall Study|Lost to Follow-up|7|||
124458755|NCT01732796|447640467|FG000|Overall Study|Adverse Event|16|||
124458756|NCT01732796|447640468|FG001|Overall Study|Adverse Event|16|||
124946585|NCT01332266|449432699|FG002|Phase 2|Withdrawal by Subject|0|||
124946586|NCT01332266|449432700|FG003|Phase 2|Withdrawal by Subject|2|||
124946587|NCT01332266|449432701|FG004|Phase 2|Withdrawal by Subject|2|||
124946588|NCT02392507|449432704|FG000|Induction Regimen|Death|3|||
124458757|NCT01732796|447640469|FG002|Overall Study|Adverse Event|4|||
124458758|NCT01732796|447640467|FG000|Overall Study|Lack of Efficacy|21|||
124458759|NCT01732796|447640468|FG001|Overall Study|Lack of Efficacy|18|||
124458760|NCT01732796|447640469|FG002|Overall Study|Lack of Efficacy|5|||
124458761|NCT01732796|447640467|FG000|Overall Study|Lost to Follow-up|2|||
124458762|NCT01732796|447640468|FG001|Overall Study|Lost to Follow-up|0|||
124458763|NCT01732796|447640469|FG002|Overall Study|Lost to Follow-up|0|||
124458764|NCT01732796|447640467|FG000|Overall Study|Withdrawal by Subject|6|||
124458765|NCT01732796|447640468|FG001|Overall Study|Withdrawal by Subject|8|||
124458766|NCT01732796|447640469|FG002|Overall Study|Withdrawal by Subject|2|||
124458767|NCT01732796|447640467|FG000|Overall Study|Other reason not defined above|1|||
124458768|NCT01732796|447640468|FG001|Overall Study|Other reason not defined above|0|||
124458769|NCT01732796|447640469|FG002|Overall Study|Other reason not defined above|2|||
124458770|NCT03972969|447640471|FG000|3-month Follow-up|Death|1|||
124458771|NCT03972969|447640472|FG001|3-month Follow-up|Death|1|||
124458772|NCT03972969|447640473|FG002|3-month Follow-up|Death|0|||
124458773|NCT03972969|447640471|FG000|6-month Follow-up|Death|1|||
124458774|NCT03972969|447640472|FG001|6-month Follow-up|Death|1|||
124458775|NCT03972969|447640473|FG002|6-month Follow-up|Death|1|||
124458776|NCT03972969|447640471|FG000|6-month Follow-up|Lost to Follow-up|2|||
124458777|NCT03972969|447640472|FG001|6-month Follow-up|Lost to Follow-up|2|||
124458778|NCT03972969|447640473|FG002|6-month Follow-up|Lost to Follow-up|2|||
124458779|NCT02182687|447640484|FG000|Overall Study|Withdrawal by Subject|4|||
124458780|NCT02182687|447640485|FG001|Overall Study|Withdrawal by Subject|0|||
124458781|NCT02182687|447640484|FG000|Overall Study|Adverse Event|1|||
124458782|NCT02182687|447640485|FG001|Overall Study|Adverse Event|0|||
124458783|NCT02182687|447640484|FG000|Overall Study|Lost to Follow-up|0|||
124458784|NCT02182687|447640485|FG001|Overall Study|Lost to Follow-up|1|||
124458785|NCT02829138|447640488|FG000|Overall Study|Withdrawal by Subject|1|||
124458786|NCT02829138|447640489|FG001|Overall Study|Withdrawal by Subject|0|||
124458787|NCT01394627|447640491|FG000|First Intervention (1 Day)|poor intravenous access|0|||
124458788|NCT01394627|447640492|FG001|First Intervention (1 Day)|poor intravenous access|1|||
124458789|NCT01394627|447640491|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
124458790|NCT01394627|447640492|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
124458791|NCT01765920|447640493|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
124458792|NCT01765920|447640494|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
124458793|NCT01765920|447640493|FG000|Overall Study|Patient code disclosure|0|||
124458794|NCT01765920|447640494|FG001|Overall Study|Patient code disclosure|1|||
124458795|NCT01081249|447640495|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
124458796|NCT01081249|447640496|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
124458797|NCT02411539|447640497|FG000|Overall Study|Lost to Follow-up|2|||
124458798|NCT02411539|447640498|FG001|Overall Study|Lost to Follow-up|0|||
124458799|NCT02411539|447640497|FG000|Overall Study|Confounding medical condition|0|||
124458800|NCT02411539|447640498|FG001|Overall Study|Confounding medical condition|1|||
124458801|NCT00282334|447640499|FG000|Overall Study|Withdrawal by Subject|8|||
124458802|NCT00282334|447640500|FG001|Overall Study|Withdrawal by Subject|5|||
124458803|NCT01347554|447640502|FG000|Overall Study|Lack of Efficacy|7|||
124458804|NCT01347554|447640503|FG001|Overall Study|Lack of Efficacy|11|||
124458805|NCT01439204|447640504|FG000|Overall Study|Withdrawal by Subject|0|||
124458806|NCT01439204|447640505|FG001|Overall Study|Withdrawal by Subject|1|||
124458807|NCT01439204|447640504|FG000|Overall Study|Lost to Follow-up|0|||
124458808|NCT01439204|447640505|FG001|Overall Study|Lost to Follow-up|2|||
124458809|NCT01439204|447640504|FG000|Overall Study|No longer meets study criteria|1|||
124946589|NCT02392507|449432704|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
124946590|NCT02392507|449432704|FG000|Induction Regimen|Physician Decision|1|||
124946591|NCT02392507|449432704|FG000|Induction Regimen|Withdrawal by Subject|2|||
124458810|NCT01439204|447640505|FG001|Overall Study|No longer meets study criteria|0|||
124706153|NCT02255435|448549882|FG002|Overall Study|Patient's Limited Time Availability|0|||
124946592|NCT02392507|449432704|FG000|Maintenance Regimen|Death|1|||
124458811|NCT01439204|447640504|FG000|Overall Study|poor/non-compliance|3|||
124458812|NCT01439204|447640505|FG001|Overall Study|poor/non-compliance|0|||
124458813|NCT03917823|447640509|FG000|Overall Study|Lost to Follow-up|1|||
124458814|NCT03917823|447640510|FG001|Overall Study|Lost to Follow-up|1|||
124458815|NCT03917823|447640509|FG000|Overall Study|Withdrawal by Subject|0|||
124458816|NCT03917823|447640510|FG001|Overall Study|Withdrawal by Subject|1|||
124458817|NCT03775421|447640511|FG000|Overall Study|Lost to Follow-up|2|||
124458818|NCT03775421|447640511|FG000|Overall Study|Withdrawal by Subject|10|||
124706154|NCT02255435|448549883|FG003|Overall Study|Patient's Limited Time Availability|0|||
124458819|NCT03775421|447640511|FG000|Overall Study|Physician Decision|3|||
124946593|NCT02392507|449432704|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
124946594|NCT02224755|449432705|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
124458820|NCT03775421|447640511|FG000|Overall Study|Death|1|||
124946595|NCT02224755|449432706|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
124946596|NCT02224755|449432705|FG000|Two Year Follow up Post-implant|Death|103|||
124946597|NCT02224755|449432706|FG001|Two Year Follow up Post-implant|Death|98|||
124946598|NCT02224755|449432705|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
124946599|NCT02224755|449432706|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
124946600|NCT02224755|449432705|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
124946601|NCT02224755|449432706|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
124946602|NCT02224755|449432705|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
124946603|NCT02224755|449432706|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
124946604|NCT01829711|449432707|FG000|Overall Study|Lost to Follow-up|2|||
124946605|NCT01829711|449432707|FG000|Overall Study|Withdrawal by Subject|3|||
124946606|NCT01829711|449432707|FG000|Overall Study|Death|4|||
124946607|NCT01829711|449432707|FG000|Overall Study|Started new therapies|17|||
124946608|NCT01829711|449432707|FG000|Overall Study|Adverse Event|3|||
124946609|NCT01829711|449432707|FG000|Overall Study|Due to progression of disease|13|||
124946610|NCT01829711|449432707|FG000|Overall Study|Due to lack of response|1|||
124946611|NCT01480258|449432710|FG000|Infant Series|Protocol Violation|2|||
124946612|NCT01480258|449432711|FG001|Infant Series|Protocol Violation|0|||
124458821|NCT03775421|447640511|FG000|Overall Study|Study Terminated by Sponsor|94|||
124946613|NCT01480258|449432710|FG000|Infant Series|Physician Decision|0|||
124458822|NCT00135668|447640512|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
124458823|NCT00135668|447640513|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
124458824|NCT00135668|447640514|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
124458825|NCT00135668|447640515|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
124458826|NCT00455013|447640525|FG000|Short Term Period|Adverse Event|2|||
124458827|NCT00455013|447640526|FG001|Short Term Period|Adverse Event|5|||
124946614|NCT01480258|449432711|FG001|Infant Series|Physician Decision|1|||
124946615|NCT01480258|449432710|FG000|Infant Series|Not Vaccinated|3|||
124946616|NCT01480258|449432711|FG001|Infant Series|Not Vaccinated|0|||
124946617|NCT01480258|449432710|FG000|Infant Series|Adverse Event|1|||
124946618|NCT01480258|449432711|FG001|Infant Series|Adverse Event|1|||
124946619|NCT01480258|449432710|FG000|Infant Series|Withdrawal by Subject|1|||
124946620|NCT01480258|449432711|FG001|Infant Series|Withdrawal by Subject|6|||
124946621|NCT01480258|449432710|FG000|Interim Period|Lost to Follow-up|0|||
124946622|NCT01480258|449432711|FG001|Interim Period|Lost to Follow-up|2|||
124946623|NCT01480258|449432710|FG000|Interim Period|Physician Decision|1|||
124946624|NCT01480258|449432711|FG001|Interim Period|Physician Decision|0|||
124946625|NCT01480258|449432710|FG000|Interim Period|Protocol Violation|0|||
124946626|NCT01480258|449432711|FG001|Interim Period|Protocol Violation|1|||
124946627|NCT01480258|449432710|FG000|Interim Period|Withdrawal by Subject|9|||
124946628|NCT01480258|449432711|FG001|Interim Period|Withdrawal by Subject|6|||
124946629|NCT02169414|449432712|FG000|Overall Study|Withdrawal by Subject|1|||
124946630|NCT02169414|449432713|FG001|Overall Study|Withdrawal by Subject|0|||
124946631|NCT02169414|449432714|FG002|Overall Study|Withdrawal by Subject|0|||
124946632|NCT02169414|449432715|FG003|Overall Study|Withdrawal by Subject|0|||
124946633|NCT02169414|449432712|FG000|Overall Study|Adverse Event|0|||
124946634|NCT02169414|449432713|FG001|Overall Study|Adverse Event|1|||
124946635|NCT02169414|449432714|FG002|Overall Study|Adverse Event|0|||
124946636|NCT02169414|449432715|FG003|Overall Study|Adverse Event|0|||
124946637|NCT03374254|449432716|FG000|Overall Study|Death|5|||
124946638|NCT03374254|449432717|FG001|Overall Study|Death|16|||
124946639|NCT03374254|449432718|FG002|Overall Study|Death|13|||
124946640|NCT03374254|449432719|FG003|Overall Study|Death|11|||
124946641|NCT03374254|449432720|FG004|Overall Study|Death|9|||
124946642|NCT03374254|449432721|FG005|Overall Study|Death|12|||
124946643|NCT03374254|449432722|FG006|Overall Study|Death|11|||
124946644|NCT03374254|449432723|FG007|Overall Study|Death|6|||
124946645|NCT03374254|449432724|FG008|Overall Study|Death|7|||
124946646|NCT03374254|449432716|FG000|Overall Study|Lost to Follow-up|0|||
124946647|NCT03374254|449432717|FG001|Overall Study|Lost to Follow-up|0|||
124946648|NCT03374254|449432718|FG002|Overall Study|Lost to Follow-up|0|||
124946649|NCT03374254|449432719|FG003|Overall Study|Lost to Follow-up|0|||
124458828|NCT00455013|447640527|FG002|Short Term Period|Adverse Event|0|||
124458829|NCT00455013|447640525|FG000|Short Term Period|Withdrawal by Subject|0|||
124765307|NCT01194830|448767383|FG000|Overall Study|Protocol Violation|5|||
124946650|NCT03374254|449432720|FG004|Overall Study|Lost to Follow-up|0|||
124946651|NCT03374254|449432721|FG005|Overall Study|Lost to Follow-up|0|||
124946652|NCT03374254|449432722|FG006|Overall Study|Lost to Follow-up|2|||
124946653|NCT03374254|449432723|FG007|Overall Study|Lost to Follow-up|0|||
124946654|NCT03374254|449432724|FG008|Overall Study|Lost to Follow-up|0|||
124946655|NCT03374254|449432716|FG000|Overall Study|Sponsor Decision|1|||
124946656|NCT03374254|449432717|FG001|Overall Study|Sponsor Decision|0|||
124946657|NCT03374254|449432718|FG002|Overall Study|Sponsor Decision|2|||
124946658|NCT03374254|449432719|FG003|Overall Study|Sponsor Decision|3|||
124946659|NCT03374254|449432720|FG004|Overall Study|Sponsor Decision|2|||
124946660|NCT03374254|449432721|FG005|Overall Study|Sponsor Decision|3|||
124946661|NCT03374254|449432722|FG006|Overall Study|Sponsor Decision|3|||
124706155|NCT02255435|448549884|FG004|Overall Study|Patient's Limited Time Availability|0|||
124706156|NCT02255435|448549885|FG005|Overall Study|Patient's Limited Time Availability|0|||
124706157|NCT02255435|448549886|FG006|Overall Study|Patient's Limited Time Availability|0|||
124706158|NCT02255435|448549887|FG007|Overall Study|Patient's Limited Time Availability|1|||
124706159|NCT02255435|448549888|FG008|Overall Study|Patient's Limited Time Availability|0|||
124706160|NCT02255435|448549889|FG009|Overall Study|Patient's Limited Time Availability|0|||
124706161|NCT02255435|448549880|FG000|Overall Study|Withdrawal by Subject|0|||
124706162|NCT02255435|448549881|FG001|Overall Study|Withdrawal by Subject|0|||
124706163|NCT02255435|448549882|FG002|Overall Study|Withdrawal by Subject|0|||
124706164|NCT02255435|448549883|FG003|Overall Study|Withdrawal by Subject|0|||
124706165|NCT02255435|448549884|FG004|Overall Study|Withdrawal by Subject|0|||
124706166|NCT02255435|448549885|FG005|Overall Study|Withdrawal by Subject|0|||
124706167|NCT02255435|448549886|FG006|Overall Study|Withdrawal by Subject|0|||
124706168|NCT02255435|448549887|FG007|Overall Study|Withdrawal by Subject|0|||
124706169|NCT02255435|448549888|FG008|Overall Study|Withdrawal by Subject|1|||
124706170|NCT02255435|448549889|FG009|Overall Study|Withdrawal by Subject|4|||
124706171|NCT02255435|448549880|FG000|Overall Study|Administrative reasons|0|||
124706172|NCT02255435|448549881|FG001|Overall Study|Administrative reasons|0|||
124706173|NCT02255435|448549882|FG002|Overall Study|Administrative reasons|0|||
124706174|NCT02255435|448549883|FG003|Overall Study|Administrative reasons|0|||
124706175|NCT02255435|448549884|FG004|Overall Study|Administrative reasons|0|||
124706176|NCT02255435|448549885|FG005|Overall Study|Administrative reasons|0|||
124706177|NCT02255435|448549886|FG006|Overall Study|Administrative reasons|0|||
124706178|NCT02255435|448549887|FG007|Overall Study|Administrative reasons|0|||
124706179|NCT02255435|448549888|FG008|Overall Study|Administrative reasons|0|||
124706180|NCT02255435|448549889|FG009|Overall Study|Administrative reasons|2|||
124706181|NCT00442702|448549891|FG000|Titration Period|Adverse Event|2|||
124706182|NCT00442702|448549892|FG001|Titration Period|Adverse Event|0|||
124706183|NCT00442702|448549891|FG000|Titration Period|Death|3|||
124548154|NCT03926728|447962512|FG002|Overall Study|Withdrawal by Subject|1|||
124548155|NCT03926728|447962513|FG003|Overall Study|Withdrawal by Subject|0|||
124548156|NCT03926728|447962514|FG004|Overall Study|Withdrawal by Subject|0|||
124548157|NCT03926728|447962515|FG005|Overall Study|Withdrawal by Subject|1|||
124548158|NCT03926728|447962516|FG006|Overall Study|Withdrawal by Subject|1|||
124548159|NCT03926728|447962517|FG007|Overall Study|Withdrawal by Subject|0|||
124548160|NCT03926728|447962518|FG008|Overall Study|Withdrawal by Subject|0|||
124548161|NCT03926728|447962519|FG009|Overall Study|Withdrawal by Subject|1|||
124548162|NCT03926728|447962520|FG010|Overall Study|Withdrawal by Subject|0|||
124548163|NCT03926728|447962521|FG011|Overall Study|Withdrawal by Subject|0|||
124548164|NCT01956123|447962524|FG000|COS Cycle 2|Protocol Violation|8|||
124548165|NCT01956123|447962525|FG001|COS Cycle 2|Protocol Violation|3|||
124548166|NCT01956123|447962526|FG002|COS Cycle 2|Protocol Violation|0|||
124548167|NCT01956123|447962527|FG003|COS Cycle 2|Protocol Violation|0|||
124548168|NCT01956123|447962524|FG000|COS Cycle 2|Adverse Event|3|||
124548169|NCT01956123|447962525|FG001|COS Cycle 2|Adverse Event|4|||
124548170|NCT01956123|447962526|FG002|COS Cycle 2|Adverse Event|0|||
124706184|NCT00442702|448549892|FG001|Titration Period|Death|2|||
124706185|NCT00442702|448549891|FG000|Titration Period|Insufficient Therapeutic Response|1|||
124706186|NCT00442702|448549892|FG001|Titration Period|Insufficient Therapeutic Response|0|||
124706187|NCT00442702|448549891|FG000|Titration Period|Refused Treatment|4|||
124706188|NCT00442702|448549892|FG001|Titration Period|Refused Treatment|1|||
124706189|NCT00442702|448549891|FG000|Titration Period|Failure to return|1|||
124706190|NCT00442702|448549892|FG001|Titration Period|Failure to return|0|||
124706191|NCT00442702|448549891|FG000|Titration Period|Hospitalized in another hospital|1|||
124706192|NCT00442702|448549892|FG001|Titration Period|Hospitalized in another hospital|0|||
124706193|NCT00442702|448549891|FG000|Evaluation Period|Adverse Event|1|||
124706194|NCT00442702|448549892|FG001|Evaluation Period|Adverse Event|0|||
124706195|NCT00442702|448549891|FG000|Evaluation Period|Death|1|||
124706196|NCT00442702|448549892|FG001|Evaluation Period|Death|1|||
124706197|NCT00442702|448549891|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
124706198|NCT00442702|448549892|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
124706199|NCT00442702|448549891|FG000|Evaluation Period|Refused treatment|1|||
124706200|NCT00442702|448549892|FG001|Evaluation Period|Refused treatment|1|||
124548171|NCT01956123|447962527|FG003|COS Cycle 2|Adverse Event|0|||
124548172|NCT01956123|447962524|FG000|COS Cycle 2|Personal Reasons|2|||
124548173|NCT01956123|447962525|FG001|COS Cycle 2|Personal Reasons|0|||
124548174|NCT01956123|447962526|FG002|COS Cycle 2|Personal Reasons|0|||
124548175|NCT01956123|447962527|FG003|COS Cycle 2|Personal Reasons|0|||
124706201|NCT00442702|448549891|FG000|Evaluation Period|Renal transplant|0|||
124946662|NCT03374254|449432723|FG007|Overall Study|Sponsor Decision|3|||
124946663|NCT03374254|449432724|FG008|Overall Study|Sponsor Decision|4|||
124946664|NCT03374254|449432716|FG000|Overall Study|Withdrawal by Subject|0|||
124946665|NCT03374254|449432717|FG001|Overall Study|Withdrawal by Subject|0|||
124946666|NCT03374254|449432718|FG002|Overall Study|Withdrawal by Subject|0|||
124946667|NCT03374254|449432719|FG003|Overall Study|Withdrawal by Subject|2|||
124946668|NCT03374254|449432720|FG004|Overall Study|Withdrawal by Subject|0|||
124946669|NCT03374254|449432721|FG005|Overall Study|Withdrawal by Subject|1|||
124946670|NCT03374254|449432722|FG006|Overall Study|Withdrawal by Subject|0|||
124946671|NCT03374254|449432723|FG007|Overall Study|Withdrawal by Subject|0|||
124946672|NCT03374254|449432724|FG008|Overall Study|Withdrawal by Subject|0|||
124946673|NCT02309515|449432725|FG000|Overall Study|Withdrawal by Subject|0|||
124946674|NCT02309515|449432726|FG001|Overall Study|Withdrawal by Subject|1|||
124946675|NCT00624377|449432730|FG000|Overall Study|Lost to Follow-up|355|||
124946676|NCT00624377|449432730|FG000|Overall Study|Withdrawal by Subject|100|||
124946677|NCT00624377|449432730|FG000|Overall Study|Adverse Event|14|||
124946678|NCT00624377|449432730|FG000|Overall Study|Other|91|||
124946679|NCT00624377|449432730|FG000|Overall Study|Non-evaluable population|84|||
124706202|NCT00442702|448549892|FG001|Evaluation Period|Renal transplant|1|||
124946680|NCT05260437|449432731|FG000|Overall Study|Lost to Follow-up|5|||
124946681|NCT05260437|449432732|FG001|Overall Study|Lost to Follow-up|2|||
124946682|NCT05260437|449432733|FG002|Overall Study|Lost to Follow-up|1|||
124946683|NCT05260437|449432734|FG003|Overall Study|Lost to Follow-up|2|||
124946684|NCT05260437|449432735|FG004|Overall Study|Lost to Follow-up|2|||
124946685|NCT05260437|449432731|FG000|Overall Study|Withdrawal by Subject|3|||
124946686|NCT05260437|449432732|FG001|Overall Study|Withdrawal by Subject|0|||
124946687|NCT05260437|449432733|FG002|Overall Study|Withdrawal by Subject|4|||
124946688|NCT05260437|449432734|FG003|Overall Study|Withdrawal by Subject|5|||
124946689|NCT05260437|449432735|FG004|Overall Study|Withdrawal by Subject|0|||
124946690|NCT05260437|449432731|FG000|Overall Study|Vaccine Not Administered|0|||
124946691|NCT05260437|449432732|FG001|Overall Study|Vaccine Not Administered|1|||
124946692|NCT05260437|449432733|FG002|Overall Study|Vaccine Not Administered|0|||
124946693|NCT05260437|449432734|FG003|Overall Study|Vaccine Not Administered|0|||
124946694|NCT05260437|449432735|FG004|Overall Study|Vaccine Not Administered|0|||
124946695|NCT00910962|449432736|FG000|Overall Study|Adverse Event|5|||
124946696|NCT00910962|449432737|FG001|Overall Study|Adverse Event|20|||
124946697|NCT00910962|449432738|FG002|Overall Study|Adverse Event|17|||
124946698|NCT00910962|449432736|FG000|Overall Study|Protocol Violation|1|||
124946699|NCT00910962|449432737|FG001|Overall Study|Protocol Violation|3|||
124946700|NCT00910962|449432738|FG002|Overall Study|Protocol Violation|3|||
124946701|NCT00910962|449432736|FG000|Overall Study|Lost to Follow-up|0|||
124946702|NCT00910962|449432737|FG001|Overall Study|Lost to Follow-up|3|||
124946703|NCT00910962|449432738|FG002|Overall Study|Lost to Follow-up|1|||
124946704|NCT00910962|449432736|FG000|Overall Study|Physician Decision|0|||
124946705|NCT00910962|449432737|FG001|Overall Study|Physician Decision|6|||
124946706|NCT00910962|449432738|FG002|Overall Study|Physician Decision|6|||
124946707|NCT00910962|449432736|FG000|Overall Study|Withdrawal by Subject|25|||
124946708|NCT00910962|449432737|FG001|Overall Study|Withdrawal by Subject|32|||
124946709|NCT00910962|449432738|FG002|Overall Study|Withdrawal by Subject|32|||
124946710|NCT00910962|449432736|FG000|Overall Study|Reached defined stopping criteria|12|||
124946711|NCT00910962|449432737|FG001|Overall Study|Reached defined stopping criteria|14|||
124946712|NCT00910962|449432738|FG002|Overall Study|Reached defined stopping criteria|17|||
124946713|NCT00923078|449432739|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
124946714|NCT00923078|449432740|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
124946715|NCT00923078|449432741|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
124946716|NCT00923078|449432739|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
124946717|NCT00923078|449432740|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
124946718|NCT00923078|449432741|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
124946719|NCT01858688|449432742|FG000|Overall Study|Withdrawal by Subject|8|||
124946720|NCT01858688|449432742|FG000|Overall Study|Participant began another therapy|3|||
124946721|NCT01858688|449432742|FG000|Overall Study|Physician Decision|2|||
124946722|NCT01858688|449432742|FG000|Overall Study|Progressive Disease|2|||
124946723|NCT01858688|449432742|FG000|Overall Study|Reason not reproted|5|||
124946724|NCT01999335|449432743|FG000|Overall Study|Discontinued before receiving treatment|0|||
124946725|NCT01999335|449432744|FG001|Overall Study|Discontinued before receiving treatment|0|||
124946726|NCT01999335|449432745|FG002|Overall Study|Discontinued before receiving treatment|0|||
124946727|NCT01999335|449432746|FG003|Overall Study|Discontinued before receiving treatment|0|||
124946728|NCT01999335|449432747|FG004|Overall Study|Discontinued before receiving treatment|2|||
124946729|NCT00787176|449432748|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
124946730|NCT00787176|449432749|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
124946731|NCT00787176|449432750|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
124946732|NCT00787176|449432751|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
124946733|NCT02449902|449432756|FG000|Overall Study|Adverse Event|0|||
124946734|NCT02449902|449432757|FG001|Overall Study|Adverse Event|1|||
124548176|NCT01956123|447962524|FG000|COS Cycle 2|Withdrawal by Subject|1|||
124548177|NCT01956123|447962525|FG001|COS Cycle 2|Withdrawal by Subject|0|||
124548178|NCT01956123|447962526|FG002|COS Cycle 2|Withdrawal by Subject|0|||
124548179|NCT01956123|447962527|FG003|COS Cycle 2|Withdrawal by Subject|0|||
124548180|NCT01956123|447962524|FG000|COS Cycle 3|Protocol Violation|0|||
124548181|NCT01956123|447962525|FG001|COS Cycle 3|Protocol Violation|0|||
124548182|NCT01956123|447962526|FG002|COS Cycle 3|Protocol Violation|2|||
124946735|NCT02449902|449432756|FG000|Overall Study|Withdrawal by Subject|0|||
124946736|NCT02449902|449432757|FG001|Overall Study|Withdrawal by Subject|1|||
124946737|NCT02362789|449432758|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
124946738|NCT02362789|449432759|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
124946739|NCT02362789|449432760|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
124946740|NCT02362789|449432758|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
124946741|NCT02362789|449432759|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
124946742|NCT02362789|449432760|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
124946743|NCT02362789|449432758|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
124946744|NCT02362789|449432759|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
124946745|NCT02362789|449432760|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
124946746|NCT02362789|449432758|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
124946747|NCT02362789|449432759|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
124946748|NCT02362789|449432760|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
124946749|NCT02362789|449432758|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
124946750|NCT02362789|449432759|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
124946751|NCT02362789|449432760|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
124946752|NCT03326856|449432761|FG000|Overall Study|Lost to Follow-up|1|||
124946753|NCT03326856|449432762|FG001|Overall Study|Lost to Follow-up|1|||
124946754|NCT03326856|449432763|FG002|Overall Study|Lost to Follow-up|0|||
124946755|NCT03326856|449432764|FG003|Overall Study|Lost to Follow-up|0|||
124946756|NCT03326856|449432765|FG004|Overall Study|Lost to Follow-up|0|||
124946757|NCT03692871|449432766|FG000|Overall Study|Death|1|||
124946758|NCT03692871|449432767|FG001|Overall Study|Death|1|||
124946759|NCT03692871|449432766|FG000|Overall Study|Lost to Follow-up|24|||
124946760|NCT03692871|449432767|FG001|Overall Study|Lost to Follow-up|9|||
124946761|NCT03692871|449432766|FG000|Overall Study|Physician Decision|22|||
124946762|NCT03692871|449432767|FG001|Overall Study|Physician Decision|7|||
124946763|NCT03692871|449432766|FG000|Overall Study|Protocol Deviation|1|||
124946764|NCT03692871|449432767|FG001|Overall Study|Protocol Deviation|0|||
124946765|NCT03692871|449432766|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
124946766|NCT03692871|449432767|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
124946767|NCT01316913|449432770|FG000|Overall Study|Adverse Event|17|||
124946768|NCT01316913|449432771|FG001|Overall Study|Adverse Event|20|||
124946769|NCT01316913|449432772|FG002|Overall Study|Adverse Event|15|||
124946770|NCT01316913|449432773|FG003|Overall Study|Adverse Event|11|||
124946771|NCT01316913|449432770|FG000|Overall Study|Lack of Efficacy|22|||
124946772|NCT01316913|449432771|FG001|Overall Study|Lack of Efficacy|12|||
124946773|NCT01316913|449432772|FG002|Overall Study|Lack of Efficacy|9|||
124946774|NCT01316913|449432773|FG003|Overall Study|Lack of Efficacy|13|||
124946775|NCT01316913|449432770|FG000|Overall Study|Protocol Violation|1|||
124946776|NCT01316913|449432771|FG001|Overall Study|Protocol Violation|4|||
124946777|NCT01316913|449432772|FG002|Overall Study|Protocol Violation|4|||
124946778|NCT01316913|449432773|FG003|Overall Study|Protocol Violation|1|||
124946779|NCT01316913|449432770|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
124946780|NCT01316913|449432771|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
124946781|NCT01316913|449432772|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
124946782|NCT01316913|449432773|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
124946783|NCT01316913|449432770|FG000|Overall Study|Lost to Follow-up|0|||
124946784|NCT01316913|449432771|FG001|Overall Study|Lost to Follow-up|1|||
124946785|NCT01316913|449432772|FG002|Overall Study|Lost to Follow-up|0|||
124946786|NCT01316913|449432773|FG003|Overall Study|Lost to Follow-up|2|||
124706203|NCT00442702|448549891|FG000|Evaluation Period|Failure to return|1|||
124946787|NCT01316913|449432770|FG000|Overall Study|Withdrawal by Subject|10|||
124946788|NCT01316913|449432771|FG001|Overall Study|Withdrawal by Subject|9|||
124946789|NCT01316913|449432772|FG002|Overall Study|Withdrawal by Subject|10|||
124946790|NCT01316913|449432773|FG003|Overall Study|Withdrawal by Subject|6|||
124946791|NCT02691702|449432774|FG000|Overall Study|Adverse Event|1|||
124946792|NCT02691702|449432775|FG001|Overall Study|Adverse Event|0|||
124946793|NCT02691702|449432776|FG002|Overall Study|Adverse Event|0|||
124946794|NCT02691702|449432777|FG003|Overall Study|Adverse Event|0|||
124946795|NCT02691702|449432778|FG004|Overall Study|Adverse Event|0|||
124946796|NCT02691702|449432779|FG005|Overall Study|Adverse Event|0|||
124548183|NCT01956123|447962527|FG003|COS Cycle 3|Protocol Violation|1|||
124548184|NCT01956123|447962524|FG000|COS Cycle 3|Adverse Event|0|||
124946797|NCT02691702|449432780|FG006|Overall Study|Adverse Event|0|||
124946798|NCT02691702|449432781|FG007|Overall Study|Adverse Event|0|||
124946799|NCT02691702|449432782|FG008|Overall Study|Adverse Event|1|||
124946800|NCT02691702|449432783|FG009|Overall Study|Adverse Event|0|||
124946801|NCT02691702|449432784|FG010|Overall Study|Adverse Event|1|||
124946802|NCT02691702|449432774|FG000|Overall Study|Lost to Follow-up|0|||
124946803|NCT02691702|449432775|FG001|Overall Study|Lost to Follow-up|0|||
124946804|NCT02691702|449432776|FG002|Overall Study|Lost to Follow-up|1|||
124946805|NCT02691702|449432777|FG003|Overall Study|Lost to Follow-up|0|||
124946806|NCT02691702|449432778|FG004|Overall Study|Lost to Follow-up|0|||
124946807|NCT02691702|449432779|FG005|Overall Study|Lost to Follow-up|2|||
124946808|NCT02691702|449432780|FG006|Overall Study|Lost to Follow-up|0|||
124946809|NCT02691702|449432781|FG007|Overall Study|Lost to Follow-up|0|||
124946810|NCT02691702|449432782|FG008|Overall Study|Lost to Follow-up|0|||
124946811|NCT02691702|449432783|FG009|Overall Study|Lost to Follow-up|0|||
124946812|NCT02691702|449432784|FG010|Overall Study|Lost to Follow-up|1|||
124946813|NCT02691702|449432774|FG000|Overall Study|Withdrawal by Subject|1|||
124946814|NCT02691702|449432775|FG001|Overall Study|Withdrawal by Subject|1|||
124946815|NCT02691702|449432776|FG002|Overall Study|Withdrawal by Subject|0|||
124946816|NCT02691702|449432777|FG003|Overall Study|Withdrawal by Subject|0|||
124946817|NCT02691702|449432778|FG004|Overall Study|Withdrawal by Subject|0|||
124946818|NCT02691702|449432779|FG005|Overall Study|Withdrawal by Subject|1|||
124946819|NCT02691702|449432780|FG006|Overall Study|Withdrawal by Subject|2|||
124946820|NCT02691702|449432781|FG007|Overall Study|Withdrawal by Subject|0|||
124946821|NCT02691702|449432782|FG008|Overall Study|Withdrawal by Subject|0|||
124946822|NCT02691702|449432783|FG009|Overall Study|Withdrawal by Subject|0|||
124946823|NCT02691702|449432784|FG010|Overall Study|Withdrawal by Subject|0|||
124946824|NCT02691702|449432774|FG000|Overall Study|Other|0|||
124946825|NCT02691702|449432775|FG001|Overall Study|Other|0|||
124946826|NCT02691702|449432776|FG002|Overall Study|Other|0|||
124946827|NCT02691702|449432777|FG003|Overall Study|Other|0|||
124946828|NCT02691702|449432778|FG004|Overall Study|Other|0|||
124946829|NCT02691702|449432779|FG005|Overall Study|Other|0|||
124946830|NCT02691702|449432780|FG006|Overall Study|Other|1|||
124946831|NCT02691702|449432781|FG007|Overall Study|Other|0|||
124946832|NCT02691702|449432782|FG008|Overall Study|Other|1|||
124946833|NCT02691702|449432783|FG009|Overall Study|Other|0|||
124458830|NCT00455013|447640526|FG001|Short Term Period|Withdrawal by Subject|0|||
124458831|NCT00455013|447640527|FG002|Short Term Period|Withdrawal by Subject|1|||
124458832|NCT00455013|447640525|FG000|Short Term Period|Lack of Efficacy|4|||
124458833|NCT00455013|447640526|FG001|Short Term Period|Lack of Efficacy|0|||
124458834|NCT00455013|447640527|FG002|Short Term Period|Lack of Efficacy|0|||
124458835|NCT00455013|447640525|FG000|Short Term Period|Other|0|||
124946834|NCT02691702|449432784|FG010|Overall Study|Other|0|||
124946835|NCT02691702|449432774|FG000|Overall Study|Protocol Violation|0|||
124946836|NCT02691702|449432775|FG001|Overall Study|Protocol Violation|0|||
124946837|NCT02691702|449432776|FG002|Overall Study|Protocol Violation|0|||
124946838|NCT02691702|449432777|FG003|Overall Study|Protocol Violation|0|||
124946839|NCT02691702|449432778|FG004|Overall Study|Protocol Violation|0|||
124946840|NCT02691702|449432779|FG005|Overall Study|Protocol Violation|0|||
124946841|NCT02691702|449432780|FG006|Overall Study|Protocol Violation|0|||
124946842|NCT02691702|449432781|FG007|Overall Study|Protocol Violation|0|||
124946843|NCT02691702|449432782|FG008|Overall Study|Protocol Violation|0|||
124946844|NCT02691702|449432783|FG009|Overall Study|Protocol Violation|2|||
124946845|NCT02691702|449432784|FG010|Overall Study|Protocol Violation|0|||
124946846|NCT05169684|449432785|FG000|Overall Study|Adverse Event|1|||
124946847|NCT05169684|449432786|FG001|Overall Study|Adverse Event|3|||
124946848|NCT05169684|449432785|FG000|Overall Study|Physician Decision|0|||
124946849|NCT05169684|449432786|FG001|Overall Study|Physician Decision|1|||
124946850|NCT05169684|449432785|FG000|Overall Study|Progressive Disease|1|||
124946851|NCT05169684|449432786|FG001|Overall Study|Progressive Disease|1|||
124946852|NCT05169684|449432785|FG000|Overall Study|Participant request to discontinue treatment|0|||
124946853|NCT05169684|449432786|FG001|Overall Study|Participant request to discontinue treatment|1|||
124946854|NCT05169684|449432785|FG000|Overall Study|Other Reason|0|||
124458836|NCT00455013|447640526|FG001|Short Term Period|Other|0|||
124458837|NCT00455013|447640527|FG002|Short Term Period|Other|1|||
124458838|NCT00455013|447640525|FG000|Long Term Extension (LTE)|Adverse Event|0|||
124946855|NCT05169684|449432786|FG001|Overall Study|Other Reason|1|||
124946856|NCT01668719|449432787|FG000|Phase I|On treatment|1|||
124946857|NCT01668719|449432788|FG001|Phase I|On treatment|0|||
124946858|NCT01668719|449432789|FG002|Phase I|On treatment|0|||
124946859|NCT01668719|449432787|FG000|Phase I|Adverse Event|2|||
124946860|NCT01668719|449432788|FG001|Phase I|Adverse Event|0|||
124946861|NCT01668719|449432789|FG002|Phase I|Adverse Event|0|||
124946862|NCT01668719|449432787|FG000|Phase I|Progression/relapse|1|||
124946863|NCT01668719|449432788|FG001|Phase I|Progression/relapse|0|||
124946864|NCT01668719|449432789|FG002|Phase I|Progression/relapse|0|||
124548185|NCT01956123|447962525|FG001|COS Cycle 3|Adverse Event|0|||
124946865|NCT01668719|449432787|FG000|Phase I|not protocol specified|2|||
124946866|NCT01668719|449432788|FG001|Phase I|not protocol specified|0|||
124946867|NCT01668719|449432789|FG002|Phase I|not protocol specified|0|||
124946868|NCT01668719|449432787|FG000|Phase II|On treatment|0|||
124946869|NCT01668719|449432788|FG001|Phase II|On treatment|4|||
124946870|NCT01668719|449432789|FG002|Phase II|On treatment|3|||
124458839|NCT00455013|447640526|FG001|Long Term Extension (LTE)|Adverse Event|1|||
124458840|NCT00455013|447640527|FG002|Long Term Extension (LTE)|Adverse Event|1|||
124458841|NCT00455013|447640525|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
124458842|NCT00455013|447640526|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
124458843|NCT00455013|447640527|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
124458844|NCT00455013|447640525|FG000|Long Term Extension (LTE)|Death|1|||
124458845|NCT00455013|447640526|FG001|Long Term Extension (LTE)|Death|1|||
124706204|NCT00442702|448549892|FG001|Evaluation Period|Failure to return|0|||
124706205|NCT00442702|448549891|FG000|Evaluation Period|Site closure|0|||
124706206|NCT00442702|448549892|FG001|Evaluation Period|Site closure|1|||
124706207|NCT01664624|448549893|FG000|Overall Study|Adverse Event|0|||
124706208|NCT01664624|448549894|FG001|Overall Study|Adverse Event|1|||
124706209|NCT01664624|448549895|FG002|Overall Study|Adverse Event|0|||
124458846|NCT00455013|447640527|FG002|Long Term Extension (LTE)|Death|0|||
124458847|NCT00455013|447640525|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
124458848|NCT00455013|447640526|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
124458849|NCT00455013|447640527|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
124458850|NCT00455013|447640525|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
124458851|NCT00455013|447640526|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
124458852|NCT00455013|447640527|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
124458853|NCT00455013|447640525|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
124458854|NCT00455013|447640526|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
124458855|NCT00455013|447640527|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
124458856|NCT00455013|447640525|FG000|Long Term Extension (LTE)|non-specified|0|||
124458857|NCT00455013|447640526|FG001|Long Term Extension (LTE)|non-specified|0|||
124458858|NCT00455013|447640527|FG002|Long Term Extension (LTE)|non-specified|1|||
124458859|NCT02739620|447640530|FG000|Overall Study|Lost to Follow-up|3|||
124458860|NCT02739620|447640531|FG001|Overall Study|Lost to Follow-up|1|||
124458861|NCT02739620|447640530|FG000|Overall Study|Adverse Event|0|||
124458862|NCT02739620|447640531|FG001|Overall Study|Adverse Event|1|||
124458863|NCT02873936|447640532|FG000|Overall Study|Withdrew Consent|4|||
124458864|NCT02873936|447640533|FG001|Overall Study|Withdrew Consent|11|||
124458865|NCT02873936|447640534|FG002|Overall Study|Withdrew Consent|20|||
124458866|NCT02873936|447640532|FG000|Overall Study|Investigator's Discretion|3|||
124458867|NCT02873936|447640533|FG001|Overall Study|Investigator's Discretion|5|||
124458868|NCT02873936|447640534|FG002|Overall Study|Investigator's Discretion|4|||
124458869|NCT02873936|447640532|FG000|Overall Study|Adverse Event|3|||
124458870|NCT02873936|447640533|FG001|Overall Study|Adverse Event|5|||
124458871|NCT02873936|447640534|FG002|Overall Study|Adverse Event|3|||
124706210|NCT01664624|448549896|FG003|Overall Study|Adverse Event|0|||
124706211|NCT01500317|448549899|FG000|Overall Study|Withdrawal by Subject|3|||
124946871|NCT01668719|449432787|FG000|Phase II|Adverse Event|0|||
124946872|NCT01668719|449432788|FG001|Phase II|Adverse Event|18|||
124946873|NCT01668719|449432789|FG002|Phase II|Adverse Event|18|||
124946874|NCT01668719|449432787|FG000|Phase II|Refusal unrelated to adverse event|0|||
124946875|NCT01668719|449432788|FG001|Phase II|Refusal unrelated to adverse event|4|||
124946876|NCT01668719|449432789|FG002|Phase II|Refusal unrelated to adverse event|1|||
124946877|NCT01668719|449432787|FG000|Phase II|Progression/relapse|0|||
124946878|NCT01668719|449432788|FG001|Phase II|Progression/relapse|13|||
124946879|NCT01668719|449432789|FG002|Phase II|Progression/relapse|17|||
124946880|NCT01668719|449432787|FG000|Phase II|Death|0|||
124946881|NCT01668719|449432788|FG001|Phase II|Death|0|||
124946882|NCT01668719|449432789|FG002|Phase II|Death|2|||
124946883|NCT01668719|449432787|FG000|Phase II|not protocol specified|0|||
124946884|NCT01668719|449432788|FG001|Phase II|not protocol specified|13|||
124946885|NCT01668719|449432789|FG002|Phase II|not protocol specified|7|||
124946886|NCT03539055|449432790|FG000|Overall Study|Death|4|||
124946887|NCT03539055|449432790|FG000|Overall Study|Lost to Follow-up|1|||
124946888|NCT03539055|449432790|FG000|Overall Study|Withdrawal by Subject|2|||
124946889|NCT03539055|449432790|FG000|Overall Study|Screen Fail|7|||
124946890|NCT03539055|449432790|FG000|Overall Study|Drug Intolerance|2|||
124946891|NCT02060487|449432791|FG000|Overall Study|Other|1|||
124946892|NCT02060487|449432792|FG001|Overall Study|Other|2|||
124946893|NCT02060487|449432793|FG002|Overall Study|Other|1|||
124946894|NCT02060487|449432791|FG000|Overall Study|Lack of Efficacy|0|||
124946895|NCT02060487|449432792|FG001|Overall Study|Lack of Efficacy|1|||
124946896|NCT02060487|449432793|FG002|Overall Study|Lack of Efficacy|0|||
124946897|NCT02060487|449432791|FG000|Overall Study|Withdrawal by Subject|3|||
124946898|NCT02060487|449432792|FG001|Overall Study|Withdrawal by Subject|10|||
124946899|NCT02060487|449432793|FG002|Overall Study|Withdrawal by Subject|4|||
124946900|NCT02060487|449432791|FG000|Overall Study|Study Terminated By Sponsor|87|||
124946901|NCT02060487|449432792|FG001|Overall Study|Study Terminated By Sponsor|89|||
124946902|NCT02060487|449432793|FG002|Overall Study|Study Terminated By Sponsor|100|||
124946903|NCT02060487|449432791|FG000|Overall Study|Randomized in error|1|||
124946904|NCT02060487|449432792|FG001|Overall Study|Randomized in error|0|||
124946905|NCT02060487|449432793|FG002|Overall Study|Randomized in error|0|||
124946906|NCT02060487|449432791|FG000|Overall Study|Protocol Violation|0|||
124946907|NCT02060487|449432792|FG001|Overall Study|Protocol Violation|1|||
124946908|NCT02060487|449432793|FG002|Overall Study|Protocol Violation|1|||
124946909|NCT02060487|449432791|FG000|Overall Study|Lost to Follow-up|3|||
124946910|NCT02060487|449432792|FG001|Overall Study|Lost to Follow-up|0|||
124946911|NCT02060487|449432793|FG002|Overall Study|Lost to Follow-up|2|||
124946912|NCT02060487|449432791|FG000|Overall Study|Death|34|||
124946913|NCT02060487|449432792|FG001|Overall Study|Death|25|||
124946914|NCT02060487|449432793|FG002|Overall Study|Death|19|||
124946915|NCT02060487|449432791|FG000|Overall Study|Adverse Event|0|||
124946916|NCT02060487|449432792|FG001|Overall Study|Adverse Event|0|||
124946917|NCT02060487|449432793|FG002|Overall Study|Adverse Event|1|||
124946918|NCT05484661|449432794|FG000|Overall Study|Withdrawal by Subject|1|||
124946919|NCT05484661|449432795|FG001|Overall Study|Withdrawal by Subject|0|||
124946920|NCT01856569|449432796|FG000|Overall Study|Other|1|||
124946921|NCT01856569|449432796|FG000|Overall Study|Changed Site/Structure|1|||
124946922|NCT01856569|449432796|FG000|Overall Study|Lost to Follow-up|3|||
124946923|NCT01856569|449432796|FG000|Overall Study|Did not met inclusion criteria|8|||
124946924|NCT01860079|449432797|FG000|Overall Study|Physician Decision|14|||
124946925|NCT01860079|449432798|FG001|Overall Study|Physician Decision|22|||
124946926|NCT02950961|449432806|FG000|Overall Study|Study had to stop due to COVID.|7|||
124946927|NCT02241785|449432807|FG000|Overall Study|Sponsor Termination|43|||
124946928|NCT02241785|449432807|FG000|Overall Study|Withdrawal by Subject|1|||
124946929|NCT02241785|449432807|FG000|Overall Study|Lost to Follow-up|2|||
124946930|NCT02241785|449432807|FG000|Overall Study|Adverse Event|1|||
124946931|NCT03055988|449432810|FG000|Period 1|Adverse Event|0|||
124946932|NCT03055988|449432811|FG001|Period 1|Adverse Event|1|||
124946933|NCT03055988|449432810|FG000|Period 1|Lost to Follow-up|1|||
124946934|NCT03055988|449432811|FG001|Period 1|Lost to Follow-up|0|||
124946935|NCT03055988|449432810|FG000|Period 1|Withdrawal by Subject|0|||
124946936|NCT03055988|449432811|FG001|Period 1|Withdrawal by Subject|4|||
124946937|NCT03055988|449432810|FG000|Period 2|Adverse Event|0|||
124946938|NCT03055988|449432811|FG001|Period 2|Adverse Event|1|||
124946939|NCT03055988|449432810|FG000|Period 2|Other than listed|1|||
124548186|NCT01956123|447962526|FG002|COS Cycle 3|Adverse Event|3|||
124548187|NCT01956123|447962527|FG003|COS Cycle 3|Adverse Event|0|||
124548188|NCT01956123|447962524|FG000|COS Cycle 3|Personal Reasons|0|||
124548189|NCT01956123|447962525|FG001|COS Cycle 3|Personal Reasons|0|||
124548190|NCT01956123|447962526|FG002|COS Cycle 3|Personal Reasons|1|||
124548191|NCT01956123|447962527|FG003|COS Cycle 3|Personal Reasons|0|||
124548192|NCT01956123|447962524|FG000|COS Cycle 3|Withdrawal by Subject|0|||
124548193|NCT01956123|447962525|FG001|COS Cycle 3|Withdrawal by Subject|0|||
124548194|NCT01956123|447962526|FG002|COS Cycle 3|Withdrawal by Subject|0|||
124548195|NCT01956123|447962527|FG003|COS Cycle 3|Withdrawal by Subject|1|||
124548196|NCT00398632|447962528|FG000|Overall Study|Withdrawal by Subject|1|||
124548197|NCT00398632|447962528|FG000|Overall Study|Lack of Efficacy|1|||
124548198|NCT02118896|447962529|FG000|Overall Study|Death|4|||
124548199|NCT02118896|447962530|FG001|Overall Study|Death|0|||
124548200|NCT02118896|447962531|FG002|Overall Study|Death|4|||
124548201|NCT02118896|447962532|FG003|Overall Study|Death|6|||
124548202|NCT02118896|447962533|FG004|Overall Study|Death|3|||
124548203|NCT02118896|447962534|FG005|Overall Study|Death|1|||
124548204|NCT02118896|447962535|FG006|Overall Study|Death|0|||
124548205|NCT02118896|447962536|FG007|Overall Study|Death|0|||
124548206|NCT02118896|447962537|FG008|Overall Study|Death|0|||
124548207|NCT02118896|447962538|FG009|Overall Study|Death|0|||
124548208|NCT02118896|447962529|FG000|Overall Study|Adverse Event|5|||
124548209|NCT02118896|447962530|FG001|Overall Study|Adverse Event|4|||
124548210|NCT02118896|447962531|FG002|Overall Study|Adverse Event|4|||
124548211|NCT02118896|447962532|FG003|Overall Study|Adverse Event|5|||
124548212|NCT02118896|447962533|FG004|Overall Study|Adverse Event|5|||
124548213|NCT02118896|447962534|FG005|Overall Study|Adverse Event|9|||
124548214|NCT02118896|447962535|FG006|Overall Study|Adverse Event|1|||
124548215|NCT02118896|447962536|FG007|Overall Study|Adverse Event|1|||
124548216|NCT02118896|447962537|FG008|Overall Study|Adverse Event|4|||
124548217|NCT02118896|447962538|FG009|Overall Study|Adverse Event|0|||
124548218|NCT02118896|447962529|FG000|Overall Study|Consent withdrawn|2|||
124548219|NCT02118896|447962530|FG001|Overall Study|Consent withdrawn|0|||
124548220|NCT02118896|447962531|FG002|Overall Study|Consent withdrawn|3|||
124548221|NCT02118896|447962532|FG003|Overall Study|Consent withdrawn|4|||
124548222|NCT02118896|447962533|FG004|Overall Study|Consent withdrawn|1|||
124548223|NCT02118896|447962534|FG005|Overall Study|Consent withdrawn|4|||
124548224|NCT02118896|447962535|FG006|Overall Study|Consent withdrawn|0|||
124548225|NCT02118896|447962536|FG007|Overall Study|Consent withdrawn|0|||
124548226|NCT02118896|447962537|FG008|Overall Study|Consent withdrawn|0|||
124548227|NCT02118896|447962538|FG009|Overall Study|Consent withdrawn|0|||
124548228|NCT02118896|447962529|FG000|Overall Study|Non-compliance|2|||
124548229|NCT02118896|447962530|FG001|Overall Study|Non-compliance|1|||
124548230|NCT02118896|447962531|FG002|Overall Study|Non-compliance|1|||
124946940|NCT03055988|449432811|FG001|Period 2|Other than listed|1|||
124946941|NCT00845520|449432812|FG000|Overall Study|Death|1|||
124946942|NCT00845520|449432813|FG001|Overall Study|Death|2|||
124946943|NCT00845520|449432814|FG002|Overall Study|Death|0|||
124946944|NCT00845520|449432812|FG000|Overall Study|Lost to Follow-up|1|||
124946945|NCT00845520|449432813|FG001|Overall Study|Lost to Follow-up|0|||
124946946|NCT00845520|449432814|FG002|Overall Study|Lost to Follow-up|0|||
124946947|NCT00845520|449432812|FG000|Overall Study|Adverse Event|0|||
124946948|NCT00845520|449432813|FG001|Overall Study|Adverse Event|0|||
124946949|NCT00845520|449432814|FG002|Overall Study|Adverse Event|1|||
124946950|NCT01736475|449432815|FG000|Overall Study|Adverse Event|4|||
124548231|NCT02118896|447962532|FG003|Overall Study|Non-compliance|5|||
124706212|NCT01500317|448549900|FG001|Overall Study|Withdrawal by Subject|2|||
124946951|NCT01736475|449432816|FG001|Overall Study|Adverse Event|0|||
124548232|NCT02118896|447962533|FG004|Overall Study|Non-compliance|0|||
124548233|NCT02118896|447962534|FG005|Overall Study|Non-compliance|1|||
124548234|NCT02118896|447962535|FG006|Overall Study|Non-compliance|0|||
124548235|NCT02118896|447962536|FG007|Overall Study|Non-compliance|1|||
124548236|NCT02118896|447962537|FG008|Overall Study|Non-compliance|0|||
124548237|NCT02118896|447962538|FG009|Overall Study|Non-compliance|0|||
124548238|NCT02118896|447962529|FG000|Overall Study|Pregnancy|1|||
124548239|NCT02118896|447962530|FG001|Overall Study|Pregnancy|1|||
124548240|NCT02118896|447962531|FG002|Overall Study|Pregnancy|0|||
124946952|NCT01736475|449432815|FG000|Overall Study|Withdrawal by Subject|2|||
124946953|NCT01736475|449432816|FG001|Overall Study|Withdrawal by Subject|0|||
124946954|NCT01736475|449432815|FG000|Overall Study|Protocol Violation|4|||
124946955|NCT01736475|449432816|FG001|Overall Study|Protocol Violation|0|||
124946956|NCT01736475|449432815|FG000|Overall Study|Other - Screen failure|1|||
124946957|NCT01736475|449432816|FG001|Overall Study|Other - Screen failure|0|||
124946958|NCT01736475|449432815|FG000|Overall Study|Other - Surgical procedure|1|||
124946959|NCT01736475|449432816|FG001|Overall Study|Other - Surgical procedure|0|||
124946960|NCT02807857|449432817|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
124946961|NCT02807857|449432817|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
124946962|NCT02807857|449432817|FG000|Follow-Up Set|Withdrawal by Subject|8|||
124946963|NCT02807857|449432817|FG000|Follow-Up Set|Lost to Follow-up|7|||
124946964|NCT02807857|449432817|FG000|Follow-Up Set|Physician Decision|6|||
124946965|NCT02807857|449432817|FG000|Follow-Up Set|Adverse Event|3|||
124946966|NCT02807857|449432817|FG000|Follow-Up Set|Death|27|||
124946967|NCT02807857|449432817|FG000|Follow-Up Set|Relocation|2|||
124946968|NCT03905642|449432821|FG000|Overall Study|Withdrawal by Subject|3|||
124946969|NCT03905642|449432821|FG000|Overall Study|Pregnancy|1|||
124946970|NCT03905642|449432821|FG000|Overall Study|Adverse Event|1|||
124946971|NCT03905642|449432821|FG000|Overall Study|Lack of Efficacy|1|||
124946972|NCT03905642|449432821|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
124946973|NCT00443820|449434251|FG000|Overall Study|Adverse Event|1|||
124946974|NCT00443820|449434252|FG001|Overall Study|Adverse Event|1|||
124946975|NCT00443820|449434253|FG002|Overall Study|Adverse Event|0|||
124946976|NCT00443820|449434254|FG003|Overall Study|Adverse Event|0|||
124946977|NCT00443820|449434251|FG000|Overall Study|Lack of Efficacy|3|||
124946978|NCT00443820|449434252|FG001|Overall Study|Lack of Efficacy|2|||
124946979|NCT00443820|449434253|FG002|Overall Study|Lack of Efficacy|1|||
124946980|NCT00443820|449434254|FG003|Overall Study|Lack of Efficacy|1|||
124946981|NCT00443820|449434251|FG000|Overall Study|Protocol Violation|2|||
124946982|NCT00443820|449434252|FG001|Overall Study|Protocol Violation|1|||
124946983|NCT00443820|449434253|FG002|Overall Study|Protocol Violation|2|||
124946984|NCT00443820|449434254|FG003|Overall Study|Protocol Violation|1|||
124946985|NCT00443820|449434251|FG000|Overall Study|Withdrawal by Subject|6|||
124946986|NCT00443820|449434252|FG001|Overall Study|Withdrawal by Subject|7|||
124946987|NCT00443820|449434253|FG002|Overall Study|Withdrawal by Subject|8|||
124946988|NCT00443820|449434254|FG003|Overall Study|Withdrawal by Subject|9|||
124946989|NCT00443820|449434251|FG000|Overall Study|Lost to Follow-up|9|||
124946990|NCT00443820|449434252|FG001|Overall Study|Lost to Follow-up|8|||
124946991|NCT00443820|449434253|FG002|Overall Study|Lost to Follow-up|6|||
124946992|NCT00443820|449434254|FG003|Overall Study|Lost to Follow-up|5|||
124946993|NCT00443820|449434251|FG000|Overall Study|Administrative problems|0|||
124946994|NCT00443820|449434252|FG001|Overall Study|Administrative problems|0|||
124946995|NCT00443820|449434253|FG002|Overall Study|Administrative problems|0|||
124946996|NCT00443820|449434254|FG003|Overall Study|Administrative problems|1|||
124946997|NCT00443820|449434251|FG000|Overall Study|Death|0|||
124946998|NCT00443820|449434252|FG001|Overall Study|Death|0|||
124946999|NCT00443820|449434253|FG002|Overall Study|Death|1|||
124947000|NCT00443820|449434254|FG003|Overall Study|Death|0|||
124947001|NCT04633200|449434255|FG000|Overall Study|Lost to Follow-up|3|||
124706213|NCT01500317|448549901|FG002|Overall Study|Withdrawal by Subject|0|||
124947002|NCT04633200|449434256|FG001|Overall Study|Lost to Follow-up|5|||
124947003|NCT02713594|449434257|FG000|Overall Study|Withdrawal by Subject|32|||
124947004|NCT02713594|449434258|FG001|Overall Study|Withdrawal by Subject|22|||
124947005|NCT02713594|449434257|FG000|Overall Study|Lost to Follow-up|358|||
124947006|NCT02713594|449434258|FG001|Overall Study|Lost to Follow-up|374|||
124947007|NCT00670449|449434259|FG000|Overall Study|Adverse Event|6|||
124947008|NCT00670449|449434260|FG001|Overall Study|Adverse Event|2|||
124947009|NCT00670449|449434261|FG002|Overall Study|Adverse Event|8|||
124947010|NCT00670449|449434262|FG003|Overall Study|Adverse Event|5|||
124947011|NCT00670449|449434259|FG000|Overall Study|Protocol Deviation|1|||
124947012|NCT00670449|449434260|FG001|Overall Study|Protocol Deviation|2|||
124947013|NCT00670449|449434261|FG002|Overall Study|Protocol Deviation|0|||
124947014|NCT00670449|449434262|FG003|Overall Study|Protocol Deviation|1|||
124947015|NCT00670449|449434259|FG000|Overall Study|Administrative Problems|0|||
124947016|NCT00670449|449434260|FG001|Overall Study|Administrative Problems|2|||
124947017|NCT00670449|449434261|FG002|Overall Study|Administrative Problems|0|||
124947018|NCT00670449|449434262|FG003|Overall Study|Administrative Problems|1|||
124947019|NCT00670449|449434259|FG000|Overall Study|Subject Withdrew Consent|0|||
124947020|NCT00670449|449434260|FG001|Overall Study|Subject Withdrew Consent|2|||
124947021|NCT00670449|449434261|FG002|Overall Study|Subject Withdrew Consent|0|||
124947022|NCT00670449|449434262|FG003|Overall Study|Subject Withdrew Consent|1|||
124947023|NCT00670449|449434259|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
124947024|NCT00670449|449434260|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124947025|NCT00670449|449434261|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
124947026|NCT00670449|449434262|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124947027|NCT00670449|449434259|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
124947028|NCT00670449|449434260|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
124947029|NCT00670449|449434261|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
124947030|NCT00670449|449434262|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
124947031|NCT02771366|449434263|FG000|Period 1|Withdrawal by Subject|0|||
124947032|NCT02771366|449434264|FG001|Period 1|Withdrawal by Subject|2|||
124947033|NCT02771366|449434263|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
124947034|NCT02771366|449434264|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
124947035|NCT00671853|449434265|FG000|Overall Study|Lack of Efficacy|3|||
124947036|NCT00671853|449434266|FG001|Overall Study|Lack of Efficacy|7|||
124947037|NCT00671853|449434265|FG000|Overall Study|Adverse Event|7|||
124947038|NCT00671853|449434266|FG001|Overall Study|Adverse Event|1|||
124947039|NCT00671853|449434265|FG000|Overall Study|Withdrawal by Subject|1|||
124947040|NCT00671853|449434266|FG001|Overall Study|Withdrawal by Subject|5|||
124458872|NCT02873936|447640532|FG000|Overall Study|Protocol Violation|0|||
124458873|NCT02873936|447640533|FG001|Overall Study|Protocol Violation|1|||
124458874|NCT02873936|447640534|FG002|Overall Study|Protocol Violation|3|||
124458875|NCT02873936|447640532|FG000|Overall Study|Lost to Follow-up|1|||
124458876|NCT02873936|447640533|FG001|Overall Study|Lost to Follow-up|1|||
124458877|NCT02873936|447640534|FG002|Overall Study|Lost to Follow-up|1|||
124458878|NCT02873936|447640532|FG000|Overall Study|Non-compliance With Study Drug|1|||
124458879|NCT02873936|447640533|FG001|Overall Study|Non-compliance With Study Drug|0|||
124458880|NCT02873936|447640534|FG002|Overall Study|Non-compliance With Study Drug|1|||
124458881|NCT02873936|447640532|FG000|Overall Study|Randomized but not Dosed|1|||
124458882|NCT02873936|447640533|FG001|Overall Study|Randomized but not Dosed|0|||
124458883|NCT02873936|447640534|FG002|Overall Study|Randomized but not Dosed|0|||
124458884|NCT05513625|447640535|FG000|Overall Study|Withdrawal by Subject|1|||
124458885|NCT00754793|447640536|FG000|Overall Study|voluntary withdrawn from study|0|||
124458886|NCT00754793|447640537|FG001|Overall Study|voluntary withdrawn from study|1|||
124458887|NCT01225731|447640539|FG000|Part 1|Did not meet eligibility criteria|1|||
124458888|NCT01225731|447640540|FG001|Part 1|Did not meet eligibility criteria|0|||
124458889|NCT01225731|447640541|FG002|Part 1|Did not meet eligibility criteria|0|||
124458890|NCT01225731|447640542|FG003|Part 1|Did not meet eligibility criteria|0|||
124458891|NCT01225731|447640543|FG004|Part 1|Did not meet eligibility criteria|1|||
124458892|NCT01225731|447640544|FG005|Part 1|Did not meet eligibility criteria|0|||
124458893|NCT01225731|447640545|FG006|Part 1|Did not meet eligibility criteria|0|||
124947041|NCT00671853|449434265|FG000|Overall Study|Lost to Follow-up|8|||
124947042|NCT00671853|449434266|FG001|Overall Study|Lost to Follow-up|8|||
124947043|NCT00671853|449434265|FG000|Overall Study|Physician Decision|0|||
124947044|NCT00671853|449434266|FG001|Overall Study|Physician Decision|2|||
124947045|NCT00671853|449434265|FG000|Overall Study|Non-adherence with study procedures|1|||
124947046|NCT00671853|449434266|FG001|Overall Study|Non-adherence with study procedures|4|||
124947047|NCT00587171|449434268|FG000|Overall Study|Lost to Follow-up|1|||
124947048|NCT00587171|449434269|FG001|Overall Study|Lost to Follow-up|1|||
124947049|NCT01848483|449434270|FG000|Overall Study|Death|2|||
124947050|NCT01848483|449434271|FG001|Overall Study|Death|1|||
124947051|NCT01848483|449434270|FG000|Overall Study|Lost to Follow-up|6|||
124947052|NCT01848483|449434271|FG001|Overall Study|Lost to Follow-up|8|||
124947053|NCT01848483|449434270|FG000|Overall Study|Withdrawal by Subject|1|||
124947054|NCT01848483|449434271|FG001|Overall Study|Withdrawal by Subject|0|||
124947055|NCT01848483|449434270|FG000|Overall Study|Incarceration|2|||
124947056|NCT01848483|449434271|FG001|Overall Study|Incarceration|2|||
124947057|NCT01148017|449434272|FG000|Overall Study|Withdrawal by Subject|31|||
124947058|NCT01148017|449434273|FG001|Overall Study|Withdrawal by Subject|14|||
124947059|NCT01148017|449434274|FG002|Overall Study|Withdrawal by Subject|0|||
124947060|NCT01148017|449434275|FG003|Overall Study|Withdrawal by Subject|0|||
124947061|NCT01148017|449434272|FG000|Overall Study|Lost to Follow-up|23|||
124947062|NCT01148017|449434273|FG001|Overall Study|Lost to Follow-up|10|||
124947063|NCT01148017|449434274|FG002|Overall Study|Lost to Follow-up|0|||
124947064|NCT01148017|449434275|FG003|Overall Study|Lost to Follow-up|0|||
124947065|NCT01148017|449434272|FG000|Overall Study|Inappropriate enrollment|1|||
124947066|NCT01148017|449434273|FG001|Overall Study|Inappropriate enrollment|0|||
124947067|NCT01148017|449434274|FG002|Overall Study|Inappropriate enrollment|0|||
124947068|NCT01148017|449434275|FG003|Overall Study|Inappropriate enrollment|0|||
124947069|NCT01148017|449434272|FG000|Overall Study|Administrative reason|22|||
124947070|NCT01148017|449434273|FG001|Overall Study|Administrative reason|9|||
124947071|NCT01148017|449434274|FG002|Overall Study|Administrative reason|0|||
124947072|NCT01148017|449434275|FG003|Overall Study|Administrative reason|0|||
124947073|NCT01148017|449434272|FG000|Overall Study|Unable to classify|3|||
124947074|NCT01148017|449434273|FG001|Overall Study|Unable to classify|1|||
124947075|NCT01148017|449434274|FG002|Overall Study|Unable to classify|0|||
124947076|NCT01148017|449434275|FG003|Overall Study|Unable to classify|0|||
124458894|NCT01225731|447640546|FG007|Part 1|Did not meet eligibility criteria|0|||
124458895|NCT01225731|447640547|FG008|Part 1|Did not meet eligibility criteria|0|||
124458896|NCT01225731|447640548|FG009|Part 1|Did not meet eligibility criteria|0|||
124458897|NCT01225731|447640549|FG010|Part 1|Did not meet eligibility criteria|0|||
124458898|NCT01225731|447640550|FG011|Part 1|Did not meet eligibility criteria|0|||
124458899|NCT01225731|447640551|FG012|Part 1|Did not meet eligibility criteria|0|||
124458900|NCT01225731|447640539|FG000|Part 1|Adverse Event|1|||
124458901|NCT01225731|447640540|FG001|Part 1|Adverse Event|2|||
124947077|NCT03928743|449434276|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
124969598|NCT03520075|449517416|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124947078|NCT03928743|449434277|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
124947079|NCT03928743|449434278|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
124947080|NCT03928743|449434276|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
124947081|NCT03928743|449434277|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
124947082|NCT03928743|449434278|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
124548241|NCT02118896|447962532|FG003|Overall Study|Pregnancy|0|||
124548242|NCT02118896|447962533|FG004|Overall Study|Pregnancy|1|||
124548243|NCT02118896|447962534|FG005|Overall Study|Pregnancy|3|||
124548244|NCT02118896|447962535|FG006|Overall Study|Pregnancy|1|||
124548245|NCT02118896|447962536|FG007|Overall Study|Pregnancy|0|||
124548246|NCT02118896|447962537|FG008|Overall Study|Pregnancy|0|||
124548247|NCT02118896|447962538|FG009|Overall Study|Pregnancy|0|||
124548248|NCT02118896|447962529|FG000|Overall Study|Lost to Follow-up|1|||
124548249|NCT02118896|447962530|FG001|Overall Study|Lost to Follow-up|2|||
124548250|NCT02118896|447962531|FG002|Overall Study|Lost to Follow-up|1|||
124548251|NCT02118896|447962532|FG003|Overall Study|Lost to Follow-up|0|||
124548252|NCT02118896|447962533|FG004|Overall Study|Lost to Follow-up|2|||
124548253|NCT02118896|447962534|FG005|Overall Study|Lost to Follow-up|1|||
124548254|NCT02118896|447962535|FG006|Overall Study|Lost to Follow-up|0|||
124548255|NCT02118896|447962536|FG007|Overall Study|Lost to Follow-up|0|||
124548256|NCT02118896|447962537|FG008|Overall Study|Lost to Follow-up|0|||
124548257|NCT02118896|447962538|FG009|Overall Study|Lost to Follow-up|0|||
124548258|NCT02118896|447962529|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
124548259|NCT02118896|447962530|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
124947083|NCT03928743|449434276|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
124947084|NCT03928743|449434277|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
124548260|NCT02118896|447962531|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
124548261|NCT02118896|447962532|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
124548262|NCT02118896|447962533|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
124548263|NCT02118896|447962534|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
124548264|NCT02118896|447962535|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
124548265|NCT02118896|447962536|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
124548266|NCT02118896|447962537|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
124548267|NCT02118896|447962538|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
124548268|NCT02118896|447962529|FG000|Overall Study|Prohibited medication|0|||
124548269|NCT02118896|447962530|FG001|Overall Study|Prohibited medication|0|||
124548270|NCT02118896|447962531|FG002|Overall Study|Prohibited medication|0|||
124548271|NCT02118896|447962532|FG003|Overall Study|Prohibited medication|0|||
124548272|NCT02118896|447962533|FG004|Overall Study|Prohibited medication|1|||
124548273|NCT02118896|447962534|FG005|Overall Study|Prohibited medication|3|||
124548274|NCT02118896|447962535|FG006|Overall Study|Prohibited medication|0|||
124548275|NCT02118896|447962536|FG007|Overall Study|Prohibited medication|0|||
124548276|NCT02118896|447962537|FG008|Overall Study|Prohibited medication|0|||
124548277|NCT02118896|447962538|FG009|Overall Study|Prohibited medication|0|||
124548278|NCT02118896|447962529|FG000|Overall Study|Miscellaneous|1|||
124548279|NCT02118896|447962530|FG001|Overall Study|Miscellaneous|2|||
124548280|NCT02118896|447962531|FG002|Overall Study|Miscellaneous|0|||
124548281|NCT02118896|447962532|FG003|Overall Study|Miscellaneous|2|||
124548282|NCT02118896|447962533|FG004|Overall Study|Miscellaneous|0|||
124548283|NCT02118896|447962534|FG005|Overall Study|Miscellaneous|4|||
124548284|NCT02118896|447962535|FG006|Overall Study|Miscellaneous|0|||
124548285|NCT02118896|447962536|FG007|Overall Study|Miscellaneous|0|||
124548286|NCT02118896|447962537|FG008|Overall Study|Miscellaneous|0|||
124548287|NCT02118896|447962538|FG009|Overall Study|Miscellaneous|0|||
124548288|NCT02050373|447962542|FG000|Overall Study|Adverse Event|4|||
124548289|NCT02050373|447962543|FG001|Overall Study|Adverse Event|7|||
124548290|NCT02050373|447962542|FG000|Overall Study|Death|3|||
124548291|NCT02050373|447962543|FG001|Overall Study|Death|3|||
124548292|NCT00572910|447962546|FG000|Overall Study|Adverse Event|1|||
124548293|NCT00572910|447962547|FG001|Overall Study|Adverse Event|2|||
124548294|NCT00572910|447962548|FG002|Overall Study|Adverse Event|0|||
124947085|NCT03928743|449434278|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
124947086|NCT03928743|449434276|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
124947087|NCT03928743|449434277|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
124947088|NCT03928743|449434278|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
124548295|NCT00572910|447962549|FG003|Overall Study|Adverse Event|2|||
124548296|NCT00572910|447962550|FG004|Overall Study|Adverse Event|0|||
124548297|NCT00572910|447962551|FG005|Overall Study|Adverse Event|0|||
124548298|NCT00572910|447962552|FG006|Overall Study|Adverse Event|4|||
124548299|NCT00572910|447962553|FG007|Overall Study|Adverse Event|2|||
124548300|NCT00572910|447962554|FG008|Overall Study|Adverse Event|1|||
124548301|NCT00572910|447962555|FG009|Overall Study|Adverse Event|3|||
124548302|NCT00572910|447962556|FG010|Overall Study|Adverse Event|2|||
124548303|NCT00572910|447962546|FG000|Overall Study|Lost to Follow-up|0|||
124548304|NCT00572910|447962547|FG001|Overall Study|Lost to Follow-up|1|||
124548305|NCT00572910|447962548|FG002|Overall Study|Lost to Follow-up|1|||
124947089|NCT03928743|449434276|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
124947090|NCT03928743|449434277|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
124947091|NCT03928743|449434278|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
124947092|NCT03928743|449434276|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
124947093|NCT03928743|449434277|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
124947094|NCT03928743|449434278|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
124947095|NCT03928743|449434276|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
124947096|NCT03928743|449434277|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
124947097|NCT03928743|449434278|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
124947098|NCT03928743|449434276|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
124947099|NCT03928743|449434277|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
124947100|NCT03928743|449434278|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
124947101|NCT03928743|449434276|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
124947102|NCT03928743|449434277|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
124947103|NCT03928743|449434278|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
124947104|NCT03928743|449434276|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
124947105|NCT03928743|449434277|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
124947106|NCT03928743|449434278|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
124947107|NCT03928743|449434276|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
124947108|NCT03928743|449434277|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
124947109|NCT03928743|449434278|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
124947110|NCT01128959|449434279|FG000|Lead in Period|Adverse Event|3|||
124947111|NCT01128959|449434279|FG000|Treatment Period|Adverse Event|3|||
124947112|NCT01128959|449434279|FG000|Treatment Period|Withdrawal by Subject|1|||
124947113|NCT02338999|449434280|FG000|First Intervention|Withdrawal by Subject|3|||
124947114|NCT02338999|449434281|FG001|First Intervention|Withdrawal by Subject|1|||
124947115|NCT02338999|449434280|FG000|Washout Period|Withdrawal by Subject|0|||
124947116|NCT02338999|449434281|FG001|Washout Period|Withdrawal by Subject|2|||
124947117|NCT02338999|449434280|FG000|Second Intervention|Withdrawal by Subject|0|||
124947118|NCT02338999|449434281|FG001|Second Intervention|Withdrawal by Subject|2|||
124947119|NCT02958553|449434282|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
124947120|NCT02958553|449434282|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
124947121|NCT00308308|449434283|FG000|Overall Study|Adverse Event|17|||
124947122|NCT00308308|449434284|FG001|Overall Study|Adverse Event|2|||
124947123|NCT00308308|449434283|FG000|Overall Study|Lost to Follow-up|5|||
124947124|NCT00308308|449434284|FG001|Overall Study|Lost to Follow-up|5|||
124947125|NCT00308308|449434283|FG000|Overall Study|Physician Decision|15|||
124947126|NCT00308308|449434284|FG001|Overall Study|Physician Decision|7|||
124947127|NCT00308308|449434283|FG000|Overall Study|Protocol Violation|3|||
124947128|NCT00308308|449434284|FG001|Overall Study|Protocol Violation|14|||
124947129|NCT00308308|449434283|FG000|Overall Study|Withdrawal by Subject|47|||
124947130|NCT00308308|449434284|FG001|Overall Study|Withdrawal by Subject|19|||
124458902|NCT01225731|447640541|FG002|Part 1|Adverse Event|1|||
124458903|NCT01225731|447640542|FG003|Part 1|Adverse Event|1|||
124458904|NCT01225731|447640543|FG004|Part 1|Adverse Event|1|||
124458905|NCT01225731|447640544|FG005|Part 1|Adverse Event|0|||
124458906|NCT01225731|447640545|FG006|Part 1|Adverse Event|0|||
124458907|NCT01225731|447640546|FG007|Part 1|Adverse Event|0|||
124458908|NCT01225731|447640547|FG008|Part 1|Adverse Event|0|||
124458909|NCT01225731|447640548|FG009|Part 1|Adverse Event|0|||
124458910|NCT01225731|447640549|FG010|Part 1|Adverse Event|0|||
124458911|NCT01225731|447640550|FG011|Part 1|Adverse Event|0|||
124458912|NCT01225731|447640551|FG012|Part 1|Adverse Event|0|||
124458913|NCT01225731|447640539|FG000|Part 1|Withdrawal by Subject|0|||
124458914|NCT01225731|447640540|FG001|Part 1|Withdrawal by Subject|3|||
124458915|NCT01225731|447640541|FG002|Part 1|Withdrawal by Subject|0|||
124458916|NCT01225731|447640542|FG003|Part 1|Withdrawal by Subject|0|||
124458917|NCT01225731|447640543|FG004|Part 1|Withdrawal by Subject|4|||
124458918|NCT01225731|447640544|FG005|Part 1|Withdrawal by Subject|0|||
124458919|NCT01225731|447640545|FG006|Part 1|Withdrawal by Subject|0|||
124458920|NCT01225731|447640546|FG007|Part 1|Withdrawal by Subject|0|||
124458921|NCT01225731|447640547|FG008|Part 1|Withdrawal by Subject|0|||
124947131|NCT00308308|449434283|FG000|Overall Study|Various|7|||
124947132|NCT00308308|449434284|FG001|Overall Study|Various|5|||
124947133|NCT00308308|449434283|FG000|Overall Study|Randomized but not dosed|8|||
124947134|NCT00308308|449434284|FG001|Overall Study|Randomized but not dosed|16|||
124947135|NCT00308308|449434283|FG000|Overall Study|Other|1|||
124947136|NCT00308308|449434284|FG001|Overall Study|Other|0|||
124947137|NCT01686152|449434285|FG000|Overall Study|Withdrawal by Subject|11|||
124947138|NCT01686152|449434286|FG001|Overall Study|Withdrawal by Subject|11|||
124947139|NCT01686152|449434287|FG002|Overall Study|Withdrawal by Subject|3|||
124458922|NCT01225731|447640548|FG009|Part 1|Withdrawal by Subject|0|||
124458923|NCT01225731|447640549|FG010|Part 1|Withdrawal by Subject|0|||
124458924|NCT01225731|447640550|FG011|Part 1|Withdrawal by Subject|0|||
124458925|NCT01225731|447640551|FG012|Part 1|Withdrawal by Subject|0|||
124706214|NCT00335829|448549902|FG000|Overall Study|Withdrawal by Subject|1|||
124706215|NCT00335829|448549902|FG000|Overall Study|Lost to Follow-up|1|||
124706216|NCT00335829|448549902|FG000|Overall Study|Adverse Event|1|||
124706217|NCT04067011|448549904|FG000|Overall Study|Not Treated|8|||
124706218|NCT04067011|448549905|FG001|Overall Study|Not Treated|7|||
124706219|NCT04067011|448549906|FG002|Overall Study|Not Treated|5|||
124706220|NCT04067011|448549904|FG000|Overall Study|Adverse Event|2|||
124706221|NCT04067011|448549905|FG001|Overall Study|Adverse Event|1|||
124706222|NCT04067011|448549906|FG002|Overall Study|Adverse Event|0|||
124706223|NCT04067011|448549904|FG000|Overall Study|Withdrawal by Subject|6|||
124706224|NCT04067011|448549905|FG001|Overall Study|Withdrawal by Subject|2|||
124706225|NCT04067011|448549906|FG002|Overall Study|Withdrawal by Subject|1|||
124706226|NCT04067011|448549904|FG000|Overall Study|Lost to Follow-up|0|||
124706227|NCT04067011|448549905|FG001|Overall Study|Lost to Follow-up|0|||
124706228|NCT04067011|448549906|FG002|Overall Study|Lost to Follow-up|1|||
124706229|NCT04067011|448549904|FG000|Overall Study|Physician Decision|1|||
124706230|NCT04067011|448549905|FG001|Overall Study|Physician Decision|1|||
124706231|NCT04067011|448549906|FG002|Overall Study|Physician Decision|0|||
124548306|NCT00572910|447962549|FG003|Overall Study|Lost to Follow-up|2|||
124548307|NCT00572910|447962550|FG004|Overall Study|Lost to Follow-up|1|||
124548308|NCT00572910|447962551|FG005|Overall Study|Lost to Follow-up|0|||
124548309|NCT00572910|447962552|FG006|Overall Study|Lost to Follow-up|0|||
124548310|NCT00572910|447962553|FG007|Overall Study|Lost to Follow-up|0|||
124548311|NCT00572910|447962554|FG008|Overall Study|Lost to Follow-up|0|||
124548312|NCT00572910|447962555|FG009|Overall Study|Lost to Follow-up|1|||
124548313|NCT00572910|447962556|FG010|Overall Study|Lost to Follow-up|0|||
124548314|NCT00572910|447962546|FG000|Overall Study|Withdrawal by Subject|3|||
124548315|NCT00572910|447962547|FG001|Overall Study|Withdrawal by Subject|0|||
124548316|NCT00572910|447962548|FG002|Overall Study|Withdrawal by Subject|1|||
124548317|NCT00572910|447962549|FG003|Overall Study|Withdrawal by Subject|0|||
124548318|NCT00572910|447962550|FG004|Overall Study|Withdrawal by Subject|1|||
124548319|NCT00572910|447962551|FG005|Overall Study|Withdrawal by Subject|3|||
124548320|NCT00572910|447962552|FG006|Overall Study|Withdrawal by Subject|0|||
124548321|NCT00572910|447962553|FG007|Overall Study|Withdrawal by Subject|2|||
124548322|NCT00572910|447962554|FG008|Overall Study|Withdrawal by Subject|2|||
124548323|NCT00572910|447962555|FG009|Overall Study|Withdrawal by Subject|2|||
124548324|NCT00572910|447962556|FG010|Overall Study|Withdrawal by Subject|1|||
124548325|NCT00592007|447962561|FG000|Overall Study|Withdrawal by Subject|1|||
124706232|NCT04067011|448549904|FG000|Overall Study|Other Reasons|2|||
124706233|NCT04067011|448549905|FG001|Overall Study|Other Reasons|0|||
124706234|NCT04067011|448549906|FG002|Overall Study|Other Reasons|1|||
124706235|NCT04067011|448549904|FG000|Overall Study|Missing|0|||
124706236|NCT04067011|448549905|FG001|Overall Study|Missing|2|||
124706237|NCT04067011|448549906|FG002|Overall Study|Missing|0|||
124706238|NCT03746015|448549907|FG000|Overall Study|Withdrawal of Consent|1|||
124706239|NCT03746015|448549908|FG001|Overall Study|Withdrawal of Consent|0|||
124947140|NCT01686152|449434285|FG000|Overall Study|Drug Code Unblinded|0|||
124458926|NCT01225731|447640539|FG000|Part 1|Protocol Violation|0|||
124458927|NCT01225731|447640540|FG001|Part 1|Protocol Violation|0|||
124458928|NCT01225731|447640541|FG002|Part 1|Protocol Violation|0|||
124458929|NCT01225731|447640542|FG003|Part 1|Protocol Violation|1|||
124458930|NCT01225731|447640543|FG004|Part 1|Protocol Violation|0|||
124458931|NCT01225731|447640544|FG005|Part 1|Protocol Violation|0|||
124458932|NCT01225731|447640545|FG006|Part 1|Protocol Violation|0|||
124458933|NCT01225731|447640546|FG007|Part 1|Protocol Violation|0|||
124458934|NCT01225731|447640547|FG008|Part 1|Protocol Violation|0|||
124458935|NCT01225731|447640548|FG009|Part 1|Protocol Violation|0|||
124458936|NCT01225731|447640549|FG010|Part 1|Protocol Violation|0|||
124458937|NCT01225731|447640550|FG011|Part 1|Protocol Violation|0|||
124458938|NCT01225731|447640551|FG012|Part 1|Protocol Violation|0|||
124458939|NCT01225731|447640539|FG000|Part 2|Protocol Violation|0|||
124458940|NCT01225731|447640540|FG001|Part 2|Protocol Violation|0|||
124458941|NCT01225731|447640541|FG002|Part 2|Protocol Violation|0|||
124458942|NCT01225731|447640542|FG003|Part 2|Protocol Violation|0|||
124458943|NCT01225731|447640543|FG004|Part 2|Protocol Violation|0|||
124458944|NCT01225731|447640544|FG005|Part 2|Protocol Violation|1|||
124458945|NCT01225731|447640545|FG006|Part 2|Protocol Violation|0|||
124458946|NCT01225731|447640546|FG007|Part 2|Protocol Violation|0|||
124458947|NCT01225731|447640547|FG008|Part 2|Protocol Violation|1|||
124458948|NCT01225731|447640548|FG009|Part 2|Protocol Violation|0|||
124458949|NCT01225731|447640549|FG010|Part 2|Protocol Violation|0|||
124458950|NCT01225731|447640550|FG011|Part 2|Protocol Violation|0|||
124458951|NCT01225731|447640551|FG012|Part 2|Protocol Violation|0|||
124458952|NCT01225731|447640539|FG000|Part 2|Adverse Event|0|||
124458953|NCT01225731|447640540|FG001|Part 2|Adverse Event|0|||
124458954|NCT01225731|447640541|FG002|Part 2|Adverse Event|0|||
124458955|NCT01225731|447640542|FG003|Part 2|Adverse Event|0|||
124458956|NCT01225731|447640543|FG004|Part 2|Adverse Event|0|||
124458957|NCT01225731|447640544|FG005|Part 2|Adverse Event|0|||
124458958|NCT01225731|447640545|FG006|Part 2|Adverse Event|4|||
124458959|NCT01225731|447640546|FG007|Part 2|Adverse Event|4|||
124458960|NCT01225731|447640547|FG008|Part 2|Adverse Event|2|||
124947141|NCT01686152|449434286|FG001|Overall Study|Drug Code Unblinded|1|||
124947142|NCT01686152|449434287|FG002|Overall Study|Drug Code Unblinded|0|||
124947143|NCT01686152|449434285|FG000|Overall Study|Protocol Violation|6|||
124947144|NCT01686152|449434286|FG001|Overall Study|Protocol Violation|1|||
124947145|NCT01686152|449434287|FG002|Overall Study|Protocol Violation|0|||
124947146|NCT01686152|449434285|FG000|Overall Study|Adverse Event|12|||
124947147|NCT01686152|449434286|FG001|Overall Study|Adverse Event|11|||
124947148|NCT01686152|449434287|FG002|Overall Study|Adverse Event|0|||
124947149|NCT01686152|449434285|FG000|Overall Study|Lack of Efficacy|0|||
124458961|NCT01225731|447640548|FG009|Part 2|Adverse Event|0|||
124458962|NCT01225731|447640549|FG010|Part 2|Adverse Event|0|||
124458963|NCT01225731|447640550|FG011|Part 2|Adverse Event|0|||
124458964|NCT01225731|447640551|FG012|Part 2|Adverse Event|0|||
124458965|NCT01225731|447640539|FG000|Part 2|Lack of Efficacy|0|||
124458966|NCT01225731|447640540|FG001|Part 2|Lack of Efficacy|0|||
124458967|NCT01225731|447640541|FG002|Part 2|Lack of Efficacy|0|||
124458968|NCT01225731|447640542|FG003|Part 2|Lack of Efficacy|0|||
124458969|NCT01225731|447640543|FG004|Part 2|Lack of Efficacy|0|||
124458970|NCT01225731|447640544|FG005|Part 2|Lack of Efficacy|1|||
124458971|NCT01225731|447640545|FG006|Part 2|Lack of Efficacy|0|||
124458972|NCT01225731|447640546|FG007|Part 2|Lack of Efficacy|12|||
124458973|NCT01225731|447640547|FG008|Part 2|Lack of Efficacy|3|||
124458974|NCT01225731|447640548|FG009|Part 2|Lack of Efficacy|0|||
124458975|NCT01225731|447640549|FG010|Part 2|Lack of Efficacy|0|||
124458976|NCT01225731|447640550|FG011|Part 2|Lack of Efficacy|0|||
124947150|NCT01686152|449434286|FG001|Overall Study|Lack of Efficacy|0|||
124947151|NCT01686152|449434287|FG002|Overall Study|Lack of Efficacy|1|||
124947152|NCT01686152|449434285|FG000|Overall Study|IP Non-compliance|5|||
124947153|NCT01686152|449434286|FG001|Overall Study|IP Non-compliance|5|||
124947154|NCT01686152|449434287|FG002|Overall Study|IP Non-compliance|0|||
124947155|NCT01686152|449434285|FG000|Overall Study|Lost to Follow-up|7|||
124947156|NCT01686152|449434286|FG001|Overall Study|Lost to Follow-up|6|||
124947157|NCT01686152|449434287|FG002|Overall Study|Lost to Follow-up|5|||
124947158|NCT01802333|449434288|FG000|Overall Study|Ineligible|2|||
124947159|NCT01802333|449434289|FG001|Overall Study|Ineligible|6|||
124947160|NCT01802333|449434290|FG002|Overall Study|Ineligible|8|||
124947161|NCT01802333|449434288|FG000|Overall Study|Adverse Event|1|||
124947162|NCT01802333|449434289|FG001|Overall Study|Adverse Event|8|||
124947163|NCT01802333|449434290|FG002|Overall Study|Adverse Event|8|||
124947164|NCT01802333|449434288|FG000|Overall Study|Withdrawal by Subject|6|||
124947165|NCT01802333|449434289|FG001|Overall Study|Withdrawal by Subject|6|||
124947166|NCT01802333|449434290|FG002|Overall Study|Withdrawal by Subject|5|||
124947167|NCT01802333|449434288|FG000|Overall Study|Progression/relapse|1|||
124458977|NCT01225731|447640551|FG012|Part 2|Lack of Efficacy|0|||
124458978|NCT01225731|447640539|FG000|Part 2|Pregnancy|0|||
124458979|NCT01225731|447640540|FG001|Part 2|Pregnancy|0|||
124458980|NCT01225731|447640541|FG002|Part 2|Pregnancy|0|||
124458981|NCT01225731|447640542|FG003|Part 2|Pregnancy|0|||
124458982|NCT01225731|447640543|FG004|Part 2|Pregnancy|0|||
124458983|NCT01225731|447640544|FG005|Part 2|Pregnancy|0|||
124458984|NCT01225731|447640545|FG006|Part 2|Pregnancy|1|||
124458985|NCT01225731|447640546|FG007|Part 2|Pregnancy|0|||
124458986|NCT01225731|447640547|FG008|Part 2|Pregnancy|1|||
124458987|NCT01225731|447640548|FG009|Part 2|Pregnancy|0|||
124458988|NCT01225731|447640549|FG010|Part 2|Pregnancy|0|||
124458989|NCT01225731|447640550|FG011|Part 2|Pregnancy|0|||
124458990|NCT01225731|447640551|FG012|Part 2|Pregnancy|0|||
124458991|NCT01225731|447640539|FG000|Part 2|Lost to Follow-up|0|||
124458992|NCT01225731|447640540|FG001|Part 2|Lost to Follow-up|0|||
124458993|NCT01225731|447640541|FG002|Part 2|Lost to Follow-up|0|||
124765308|NCT01194830|448767384|FG001|Overall Study|Protocol Violation|4|||
124765309|NCT01194830|448767383|FG000|Overall Study|Lost to Follow-up|9|||
124765310|NCT01194830|448767384|FG001|Overall Study|Lost to Follow-up|7|||
124947168|NCT01802333|449434289|FG001|Overall Study|Progression/relapse|3|||
124947169|NCT01802333|449434290|FG002|Overall Study|Progression/relapse|0|||
124947170|NCT01802333|449434288|FG000|Overall Study|Death|7|||
124458994|NCT01225731|447640542|FG003|Part 2|Lost to Follow-up|0|||
124458995|NCT01225731|447640543|FG004|Part 2|Lost to Follow-up|0|||
124458996|NCT01225731|447640544|FG005|Part 2|Lost to Follow-up|0|||
124458997|NCT01225731|447640545|FG006|Part 2|Lost to Follow-up|0|||
124458998|NCT01225731|447640546|FG007|Part 2|Lost to Follow-up|3|||
124458999|NCT01225731|447640547|FG008|Part 2|Lost to Follow-up|1|||
124765311|NCT01194830|448767383|FG000|Overall Study|Withdrawal by Subject|2|||
124947171|NCT01802333|449434289|FG001|Overall Study|Death|14|||
124947172|NCT01802333|449434290|FG002|Overall Study|Death|13|||
124706240|NCT03746015|448549909|FG002|Overall Study|Withdrawal of Consent|0|||
124706241|NCT05209386|448549910|FG000|Overall Study|Withdrawal by Subject|8|||
124706242|NCT05209386|448549910|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
124706243|NCT05200845|448549911|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
124706244|NCT05200845|448549912|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
124706245|NCT05200845|448549913|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
124706246|NCT05200845|448549914|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
124947173|NCT01802333|449434288|FG000|Overall Study|Other - not protocol specified|32|||
124947174|NCT01802333|449434289|FG001|Overall Study|Other - not protocol specified|22|||
124947175|NCT01802333|449434290|FG002|Overall Study|Other - not protocol specified|24|||
124947176|NCT01802333|449434288|FG000|Overall Study|Did not start treatment|0|||
124947177|NCT01802333|449434289|FG001|Overall Study|Did not start treatment|2|||
124947178|NCT01802333|449434290|FG002|Overall Study|Did not start treatment|5|||
124706247|NCT05200845|448549911|FG000|Overall Study|Withdrawal by Subject|0|||
124706248|NCT05200845|448549912|FG001|Overall Study|Withdrawal by Subject|1|||
124706249|NCT05200845|448549913|FG002|Overall Study|Withdrawal by Subject|1|||
124706250|NCT05200845|448549914|FG003|Overall Study|Withdrawal by Subject|0|||
124706251|NCT02303262|448549915|FG000|Overall Study|Withdrawal by Subject|2|||
124706252|NCT01121757|448549916|FG000|First Drug|Death|1|||
124706253|NCT01121757|448549917|FG001|First Drug|Death|0|||
124706254|NCT01121757|448549916|FG000|First Drug|Disease Progression|0|||
124706255|NCT01121757|448549917|FG001|First Drug|Disease Progression|2|||
124706256|NCT01121757|448549916|FG000|Combination|Physician Decision|0|||
124706257|NCT01121757|448549917|FG001|Combination|Physician Decision|1|||
124706258|NCT01121757|448549916|FG000|Combination|Disease Progression|2|||
124947179|NCT01947491|449434292|FG000|Overall Study|Lost to Follow-up|5|||
124947180|NCT01947491|449434293|FG001|Overall Study|Lost to Follow-up|3|||
124947181|NCT01947491|449434294|FG002|Overall Study|Lost to Follow-up|1|||
124947182|NCT01947491|449434295|FG003|Overall Study|Lost to Follow-up|2|||
124947183|NCT01947491|449434292|FG000|Overall Study|Lack of Efficacy|1|||
124947184|NCT01947491|449434293|FG001|Overall Study|Lack of Efficacy|0|||
124947185|NCT01947491|449434294|FG002|Overall Study|Lack of Efficacy|0|||
124947186|NCT01947491|449434295|FG003|Overall Study|Lack of Efficacy|1|||
124947187|NCT01947491|449434292|FG000|Overall Study|Protocol Violation|1|||
124459000|NCT01225731|447640548|FG009|Part 2|Lost to Follow-up|0|||
124459001|NCT01225731|447640549|FG010|Part 2|Lost to Follow-up|0|||
124459002|NCT01225731|447640550|FG011|Part 2|Lost to Follow-up|0|||
124459003|NCT01225731|447640551|FG012|Part 2|Lost to Follow-up|0|||
124459004|NCT01225731|447640539|FG000|Part 2|Physician Decision|0|||
124459005|NCT01225731|447640540|FG001|Part 2|Physician Decision|0|||
124459006|NCT01225731|447640541|FG002|Part 2|Physician Decision|0|||
124459007|NCT01225731|447640542|FG003|Part 2|Physician Decision|0|||
124459008|NCT01225731|447640543|FG004|Part 2|Physician Decision|0|||
124459009|NCT01225731|447640544|FG005|Part 2|Physician Decision|0|||
124459010|NCT01225731|447640545|FG006|Part 2|Physician Decision|0|||
124459011|NCT01225731|447640546|FG007|Part 2|Physician Decision|2|||
124706259|NCT01121757|448549917|FG001|Combination|Disease Progression|0|||
124706260|NCT04251533|448549918|FG000|Overall Study|Progressive disease|33|||
124706261|NCT04251533|448549919|FG001|Overall Study|Progressive disease|29|||
124947188|NCT01947491|449434293|FG001|Overall Study|Protocol Violation|0|||
124947189|NCT01947491|449434294|FG002|Overall Study|Protocol Violation|0|||
124947190|NCT01947491|449434295|FG003|Overall Study|Protocol Violation|0|||
124947191|NCT01947491|449434292|FG000|Overall Study|Withdrawal by Subject|1|||
124947192|NCT01947491|449434293|FG001|Overall Study|Withdrawal by Subject|1|||
124947193|NCT01947491|449434294|FG002|Overall Study|Withdrawal by Subject|1|||
124947194|NCT01947491|449434295|FG003|Overall Study|Withdrawal by Subject|0|||
124947195|NCT01947491|449434292|FG000|Overall Study|Worsening of condition|0|||
124706262|NCT04251533|448549920|FG002|Overall Study|Progressive disease|22|||
124706263|NCT04251533|448549918|FG000|Overall Study|Death|5|||
124706264|NCT04251533|448549919|FG001|Overall Study|Death|1|||
124706265|NCT04251533|448549920|FG002|Overall Study|Death|3|||
124706266|NCT04251533|448549918|FG000|Overall Study|Physician Decision|3|||
124947196|NCT01947491|449434293|FG001|Overall Study|Worsening of condition|1|||
124947197|NCT01947491|449434294|FG002|Overall Study|Worsening of condition|0|||
124947198|NCT01947491|449434295|FG003|Overall Study|Worsening of condition|0|||
124947199|NCT01947491|449434292|FG000|Overall Study|Adverse Event|0|||
124947200|NCT01947491|449434293|FG001|Overall Study|Adverse Event|1|||
124947201|NCT01947491|449434294|FG002|Overall Study|Adverse Event|0|||
124459012|NCT01225731|447640547|FG008|Part 2|Physician Decision|2|||
124947202|NCT01947491|449434295|FG003|Overall Study|Adverse Event|2|||
124947203|NCT02067663|449434296|FG000|Overall Study|Lost to Follow-up|13|||
124459013|NCT01225731|447640548|FG009|Part 2|Physician Decision|0|||
124947204|NCT02067663|449434297|FG001|Overall Study|Lost to Follow-up|14|||
124947205|NCT00704340|449434298|FG000|Overall Study|Lost to Follow-up|2|||
124947206|NCT00704340|449434299|FG001|Overall Study|Lost to Follow-up|1|||
124459014|NCT01225731|447640549|FG010|Part 2|Physician Decision|0|||
124459015|NCT01225731|447640550|FG011|Part 2|Physician Decision|0|||
124706267|NCT04251533|448549919|FG001|Overall Study|Physician Decision|2|||
124947207|NCT00704340|449434298|FG000|Overall Study|Death|0|||
124947208|NCT00704340|449434299|FG001|Overall Study|Death|1|||
124947209|NCT03137784|449434300|FG000|Overall Study|Adverse Event|1|||
124947210|NCT03137784|449434301|FG001|Overall Study|Adverse Event|1|||
124947211|NCT03137784|449434302|FG002|Overall Study|Adverse Event|0|||
124947212|NCT03137784|449434303|FG003|Overall Study|Adverse Event|0|||
124947213|NCT03137784|449434304|FG004|Overall Study|Adverse Event|0|||
124947214|NCT03137784|449434305|FG005|Overall Study|Adverse Event|0|||
124947215|NCT03137784|449434300|FG000|Overall Study|Subject/guardian decision|1|||
124947216|NCT03137784|449434301|FG001|Overall Study|Subject/guardian decision|0|||
124947217|NCT03137784|449434302|FG002|Overall Study|Subject/guardian decision|0|||
124947218|NCT03137784|449434303|FG003|Overall Study|Subject/guardian decision|0|||
124947219|NCT03137784|449434304|FG004|Overall Study|Subject/guardian decision|0|||
124947220|NCT03137784|449434305|FG005|Overall Study|Subject/guardian decision|0|||
124947221|NCT03137784|449434300|FG000|Overall Study|Non-compliance with study treatment|0|||
124947222|NCT03137784|449434301|FG001|Overall Study|Non-compliance with study treatment|0|||
124947223|NCT03137784|449434302|FG002|Overall Study|Non-compliance with study treatment|0|||
124947224|NCT03137784|449434303|FG003|Overall Study|Non-compliance with study treatment|0|||
124947225|NCT03137784|449434304|FG004|Overall Study|Non-compliance with study treatment|1|||
124947226|NCT03137784|449434305|FG005|Overall Study|Non-compliance with study treatment|0|||
124947227|NCT02736188|449434306|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
124947228|NCT02736188|449434306|FG000|Overall Study|Adverse Event|1|||
124947229|NCT02736188|449434306|FG000|Overall Study|Withdrawal by Subject|1|||
124947230|NCT02736188|449434306|FG000|Overall Study|Other|6|||
124947231|NCT04070105|449434307|FG000|Overall Study|Lost to Follow-up|0|||
124947232|NCT04070105|449434308|FG001|Overall Study|Lost to Follow-up|0|||
124947233|NCT04070105|449434309|FG002|Overall Study|Lost to Follow-up|0|||
124947234|NCT04070105|449434310|FG003|Overall Study|Lost to Follow-up|0|||
124947235|NCT04070105|449434311|FG004|Overall Study|Lost to Follow-up|0|||
124947236|NCT04070105|449434312|FG005|Overall Study|Lost to Follow-up|1|||
124947237|NCT03547154|449434326|FG000|Overall Study|Disease Progression/Recurrence|6|||
124947238|NCT03547154|449434327|FG001|Overall Study|Disease Progression/Recurrence|14|||
124947239|NCT03547154|449434326|FG000|Overall Study|Adverse Event|26|||
124947240|NCT03547154|449434327|FG001|Overall Study|Adverse Event|31|||
124947241|NCT03547154|449434326|FG000|Overall Study|Protocol Violation|6|||
124947242|NCT03547154|449434327|FG001|Overall Study|Protocol Violation|1|||
124947243|NCT03547154|449434326|FG000|Overall Study|Physician Decision|4|||
124947244|NCT03547154|449434327|FG001|Overall Study|Physician Decision|3|||
124947245|NCT03547154|449434326|FG000|Overall Study|Insufficient Therapeutic Response|13|||
124947246|NCT03547154|449434327|FG001|Overall Study|Insufficient Therapeutic Response|10|||
124947247|NCT03547154|449434326|FG000|Overall Study|Withdrawal by Subject|10|||
124947248|NCT03547154|449434327|FG001|Overall Study|Withdrawal by Subject|6|||
124947249|NCT03547154|449434326|FG000|Overall Study|Not Selected|0|||
124706268|NCT04251533|448549920|FG002|Overall Study|Physician Decision|4|||
124947250|NCT03547154|449434327|FG001|Overall Study|Not Selected|1|||
124947251|NCT03547154|449434326|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
124947252|NCT03547154|449434327|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
124947253|NCT00895245|449434328|FG000|Overall Study|Lack of Efficacy|6|||
124947254|NCT02706483|449434329|FG000|Overall Study|Adverse Event|97|||
124947255|NCT02706483|449434329|FG000|Overall Study|Death|1|||
124947256|NCT02706483|449434329|FG000|Overall Study|Lack of Efficacy|39|||
124947257|NCT02706483|449434329|FG000|Overall Study|Lost to Follow-up|101|||
124947258|NCT02706483|449434329|FG000|Overall Study|Non-compliance with study drug|15|||
124947259|NCT02706483|449434329|FG000|Overall Study|Physician Decision|6|||
124947260|NCT02706483|449434329|FG000|Overall Study|Pregnancy|6|||
124947261|NCT02706483|449434329|FG000|Overall Study|Protocol Violation|18|||
124947262|NCT02706483|449434329|FG000|Overall Study|Withdrawal by Subject|136|||
124947263|NCT02706483|449434329|FG000|Overall Study|Non-compliance with visits|6|||
124947264|NCT02706483|449434329|FG000|Overall Study|Site closure|4|||
124947265|NCT02706483|449434329|FG000|Overall Study|Subject moved|1|||
124947266|NCT01972776|449434330|FG000|Part 1|Withdrawal by Subject|0|||
124947267|NCT01972776|449434331|FG001|Part 1|Withdrawal by Subject|0|||
124947268|NCT01972776|449434332|FG002|Part 1|Withdrawal by Subject|1|||
124947269|NCT01972776|449434333|FG003|Part 1|Withdrawal by Subject|0|||
124947270|NCT01972776|449434334|FG004|Part 1|Withdrawal by Subject|0|||
124947271|NCT01972776|449434335|FG005|Part 1|Withdrawal by Subject|0|||
124947272|NCT01972776|449434330|FG000|Part 1|Adverse Event|0|||
124947273|NCT01972776|449434331|FG001|Part 1|Adverse Event|0|||
124947274|NCT01972776|449434332|FG002|Part 1|Adverse Event|1|||
124947275|NCT01972776|449434333|FG003|Part 1|Adverse Event|1|||
124947276|NCT01972776|449434334|FG004|Part 1|Adverse Event|0|||
124947277|NCT01972776|449434335|FG005|Part 1|Adverse Event|0|||
124947278|NCT01972776|449434330|FG000|Part 2|Adverse Event|0|||
124947279|NCT01972776|449434331|FG001|Part 2|Adverse Event|0|||
124947280|NCT01972776|449434332|FG002|Part 2|Adverse Event|0|||
124947281|NCT01972776|449434333|FG003|Part 2|Adverse Event|0|||
124947282|NCT01972776|449434334|FG004|Part 2|Adverse Event|3|||
124947283|NCT01972776|449434335|FG005|Part 2|Adverse Event|0|||
124947284|NCT01972776|449434330|FG000|Part 2|Administrative problems|0|||
124947285|NCT01972776|449434331|FG001|Part 2|Administrative problems|0|||
124947286|NCT01972776|449434332|FG002|Part 2|Administrative problems|0|||
124947287|NCT01972776|449434333|FG003|Part 2|Administrative problems|0|||
124459016|NCT01225731|447640551|FG012|Part 2|Physician Decision|0|||
124459017|NCT01225731|447640539|FG000|Part 2|Withdrawal by Subject|0|||
124459018|NCT01225731|447640540|FG001|Part 2|Withdrawal by Subject|0|||
124459019|NCT01225731|447640541|FG002|Part 2|Withdrawal by Subject|0|||
124459020|NCT01225731|447640542|FG003|Part 2|Withdrawal by Subject|0|||
124459021|NCT01225731|447640543|FG004|Part 2|Withdrawal by Subject|0|||
124459022|NCT01225731|447640544|FG005|Part 2|Withdrawal by Subject|1|||
124459023|NCT01225731|447640545|FG006|Part 2|Withdrawal by Subject|3|||
124459024|NCT01225731|447640546|FG007|Part 2|Withdrawal by Subject|4|||
124459025|NCT01225731|447640547|FG008|Part 2|Withdrawal by Subject|1|||
124459026|NCT01225731|447640548|FG009|Part 2|Withdrawal by Subject|0|||
124459027|NCT01225731|447640549|FG010|Part 2|Withdrawal by Subject|0|||
124459028|NCT01225731|447640550|FG011|Part 2|Withdrawal by Subject|0|||
124459029|NCT01225731|447640551|FG012|Part 2|Withdrawal by Subject|0|||
124459030|NCT01225731|447640539|FG000|Part 3|Adverse Event|0|||
124459031|NCT01225731|447640540|FG001|Part 3|Adverse Event|0|||
124459032|NCT01225731|447640541|FG002|Part 3|Adverse Event|0|||
124459033|NCT01225731|447640542|FG003|Part 3|Adverse Event|0|||
124548326|NCT00592007|447962561|FG000|Overall Study|patient ineligible (out of lab range)|1|||
124947288|NCT01972776|449434334|FG004|Part 2|Administrative problems|10|||
124947289|NCT01972776|449434335|FG005|Part 2|Administrative problems|7|||
124947290|NCT01543204|449434336|FG000|Overall Study|Non-compliance|1|||
124947291|NCT01543204|449434336|FG000|Overall Study|Adverse Event|1|||
124947292|NCT01543204|449434336|FG000|Overall Study|Withdrawal by Subject|4|||
124947293|NCT01543204|449434336|FG000|Overall Study|Requirement for Alternative Therapy|1|||
124947294|NCT01543204|449434336|FG000|Overall Study|Lost to Follow-up|1|||
124947295|NCT03938272|449434344|FG000|Overall Study|Withdrawal by Subject|1|||
124947296|NCT03938272|449434345|FG001|Overall Study|Withdrawal by Subject|0|||
124947297|NCT03938272|449434344|FG000|Overall Study|Physician Decision|0|||
124947298|NCT03938272|449434345|FG001|Overall Study|Physician Decision|2|||
124947299|NCT03938272|449434344|FG000|Overall Study|Study termination by sponsor|10|||
124947300|NCT03938272|449434345|FG001|Overall Study|Study termination by sponsor|8|||
124947301|NCT00068107|449434348|FG000|Overall Study|end-stage renal disease|6|||
124947302|NCT00068107|449434348|FG000|Overall Study|Death|2|||
124947303|NCT00068107|449434348|FG000|Overall Study|Withdrawal by Subject|1|||
124947304|NCT03288506|449434349|FG000|Overall Study|Withdrawal by Subject|52|||
124947305|NCT01419184|449434352|FG000|Overall Study|Site data not available|3|||
124947306|NCT01419184|449434353|FG001|Overall Study|Site data not available|2|||
124947307|NCT01419184|449434352|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
124947308|NCT01419184|449434353|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
124459034|NCT01225731|447640543|FG004|Part 3|Adverse Event|0|||
124459035|NCT01225731|447640544|FG005|Part 3|Adverse Event|0|||
124459036|NCT01225731|447640545|FG006|Part 3|Adverse Event|0|||
124947309|NCT01419184|449434352|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
124459037|NCT01225731|447640546|FG007|Part 3|Adverse Event|0|||
124947310|NCT01419184|449434353|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
124459038|NCT01225731|447640547|FG008|Part 3|Adverse Event|0|||
124459039|NCT01225731|447640548|FG009|Part 3|Adverse Event|0|||
124947311|NCT01419184|449434352|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
124947312|NCT01419184|449434353|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
124706269|NCT04251533|448549918|FG000|Overall Study|Participant decision|1|||
124947313|NCT01419184|449434352|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
124947314|NCT01419184|449434353|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
124947315|NCT01419184|449434352|FG000|Overall Study|Participant randomized, not treated|1|||
124947316|NCT01419184|449434353|FG001|Overall Study|Participant randomized, not treated|0|||
124947317|NCT00875706|449434354|FG000|Overall Study|Withdrawal by Subject|1|||
124947318|NCT00875706|449434355|FG001|Overall Study|Withdrawal by Subject|0|||
124947319|NCT00875706|449434356|FG002|Overall Study|Withdrawal by Subject|0|||
124947320|NCT00786188|449434357|FG000|Overall Study|Adverse Event|3|||
124947321|NCT00786188|449434358|FG001|Overall Study|Adverse Event|1|||
124947322|NCT00786188|449434357|FG000|Overall Study|Withdrawal by Subject|2|||
124947323|NCT00786188|449434358|FG001|Overall Study|Withdrawal by Subject|0|||
124947324|NCT02279732|449434360|FG000|Overall Study|Death|23|||
124947325|NCT02279732|449434361|FG001|Overall Study|Death|20|||
124947326|NCT02279732|449434360|FG000|Overall Study|Disease Progression|13|||
124947327|NCT02279732|449434361|FG001|Overall Study|Disease Progression|3|||
124947328|NCT02279732|449434360|FG000|Overall Study|Withdrawal by Subject|2|||
124947329|NCT02279732|449434361|FG001|Overall Study|Withdrawal by Subject|7|||
124947330|NCT02279732|449434360|FG000|Overall Study|Adverse Event|1|||
124947331|NCT02279732|449434361|FG001|Overall Study|Adverse Event|2|||
124947332|NCT02279732|449434360|FG000|Overall Study|Administrative Reason By Sponsor|0|||
124947333|NCT02279732|449434361|FG001|Overall Study|Administrative Reason By Sponsor|2|||
124947334|NCT02279732|449434360|FG000|Overall Study|Study Drug Toxicity|2|||
124947335|NCT02279732|449434361|FG001|Overall Study|Study Drug Toxicity|0|||
124947336|NCT02279732|449434360|FG000|Overall Study|Lost to Follow-up|0|||
124947337|NCT02279732|449434361|FG001|Overall Study|Lost to Follow-up|1|||
124947338|NCT02279732|449434360|FG000|Overall Study|Maximum Clinical Benefit|1|||
124947339|NCT02279732|449434361|FG001|Overall Study|Maximum Clinical Benefit|0|||
124947340|NCT02279732|449434360|FG000|Overall Study|Subject Requested to Discontinue|0|||
124947341|NCT02279732|449434361|FG001|Overall Study|Subject Requested to Discontinue|1|||
124947342|NCT02279732|449434360|FG000|Overall Study|Other|53|||
124947343|NCT02279732|449434361|FG001|Overall Study|Other|67|||
124947344|NCT02279732|449434360|FG000|Overall Study|Other|3|||
124947345|NCT02279732|449434361|FG001|Overall Study|Other|3|||
124947346|NCT02970318|449434362|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
124947347|NCT02970318|449434363|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
124947348|NCT02970318|449434364|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
124947349|NCT02970318|449434365|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
124947350|NCT02970318|449434362|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
124947351|NCT02970318|449434363|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
124947352|NCT02970318|449434364|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
124947353|NCT02970318|449434365|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
124947354|NCT02970318|449434362|FG000|Overall for Arm A & Main for Arm B|Death|41|||
124947355|NCT02970318|449434363|FG001|Overall for Arm A & Main for Arm B|Death|33|||
124947356|NCT02970318|449434364|FG002|Overall for Arm A & Main for Arm B|Death|0|||
124947357|NCT02970318|449434365|FG003|Overall for Arm A & Main for Arm B|Death|0|||
124947358|NCT02970318|449434362|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
124947359|NCT02970318|449434363|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
124947360|NCT02970318|449434364|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
124947361|NCT02970318|449434365|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
124947362|NCT02970318|449434362|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
124947363|NCT02970318|449434363|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
124947364|NCT02970318|449434364|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
124947365|NCT02970318|449434365|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
124947366|NCT02970318|449434362|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
124947367|NCT02970318|449434363|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
124947368|NCT02970318|449434364|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
124947369|NCT02970318|449434365|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
124947370|NCT02970318|449434362|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
124947371|NCT02970318|449434363|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
124947372|NCT02970318|449434364|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
124706270|NCT04251533|448549919|FG001|Overall Study|Participant decision|3|||
124947373|NCT02970318|449434365|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
124947374|NCT00824408|449434366|FG000|Run-in Phase|Progressive disease|4|||
124947375|NCT00824408|449434367|FG001|Run-in Phase|Progressive disease|4|||
124947376|NCT00824408|449434368|FG002|Run-in Phase|Progressive disease|0|||
124706271|NCT04251533|448549920|FG002|Overall Study|Participant decision|1|||
124947377|NCT00824408|449434369|FG003|Run-in Phase|Progressive disease|0|||
124947378|NCT00824408|449434370|FG004|Run-in Phase|Progressive disease|0|||
124947379|NCT00824408|449434366|FG000|Run-in Phase|Adverse Event|1|||
124947380|NCT00824408|449434367|FG001|Run-in Phase|Adverse Event|1|||
124706272|NCT04251533|448549918|FG000|Overall Study|Adverse Event|2|||
124548327|NCT01569074|447962565|FG000|Overall Study|Study stopped|6|||
124548328|NCT01569074|447962566|FG001|Overall Study|Study stopped|6|||
124548329|NCT01569074|447962567|FG002|Overall Study|Study stopped|8|||
124548330|NCT01569074|447962568|FG003|Overall Study|Study stopped|7|||
124548331|NCT01569074|447962569|FG004|Overall Study|Study stopped|7|||
124548332|NCT01569074|447962565|FG000|Overall Study|Study-specific discontinuation criteria|0|||
124548333|NCT01569074|447962566|FG001|Overall Study|Study-specific discontinuation criteria|1|||
124548334|NCT01569074|447962567|FG002|Overall Study|Study-specific discontinuation criteria|0|||
124706273|NCT04251533|448549919|FG001|Overall Study|Adverse Event|1|||
124706274|NCT04251533|448549920|FG002|Overall Study|Adverse Event|1|||
124548335|NCT01569074|447962568|FG003|Overall Study|Study-specific discontinuation criteria|0|||
124548336|NCT01569074|447962569|FG004|Overall Study|Study-specific discontinuation criteria|0|||
124706275|NCT05901636|448549921|FG000|Overall Study|Lost to Follow-up|0|||
124706276|NCT05901636|448549922|FG001|Overall Study|Lost to Follow-up|1|||
124706277|NCT05901636|448549923|FG002|Overall Study|Lost to Follow-up|0|||
124706278|NCT05901636|448549924|FG003|Overall Study|Lost to Follow-up|1|||
124706279|NCT05901636|448549925|FG004|Overall Study|Lost to Follow-up|1|||
124706280|NCT05901636|448549926|FG005|Overall Study|Lost to Follow-up|3|||
124706281|NCT05901636|448549927|FG006|Overall Study|Lost to Follow-up|1|||
124706282|NCT05901636|448549921|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
124706283|NCT05901636|448549922|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
124706284|NCT05901636|448549923|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
124706285|NCT05901636|448549924|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
124706286|NCT05901636|448549925|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
124706287|NCT05901636|448549926|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
124706288|NCT05901636|448549927|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
124706289|NCT05901636|448549921|FG000|Overall Study|Withdrawal by Subject|1|||
124947381|NCT00824408|449434368|FG002|Run-in Phase|Adverse Event|0|||
124947382|NCT00824408|449434369|FG003|Run-in Phase|Adverse Event|0|||
124947383|NCT00824408|449434370|FG004|Run-in Phase|Adverse Event|0|||
124947384|NCT00824408|449434366|FG000|Run-in Phase|Refused to continue medication|1|||
124947385|NCT00824408|449434367|FG001|Run-in Phase|Refused to continue medication|0|||
124947386|NCT00824408|449434368|FG002|Run-in Phase|Refused to continue medication|0|||
124947387|NCT00824408|449434369|FG003|Run-in Phase|Refused to continue medication|0|||
124947388|NCT00824408|449434370|FG004|Run-in Phase|Refused to continue medication|0|||
124947389|NCT00824408|449434366|FG000|Run-in Phase|Other reason not defined above|0|||
124947390|NCT00824408|449434367|FG001|Run-in Phase|Other reason not defined above|1|||
124947391|NCT00824408|449434368|FG002|Run-in Phase|Other reason not defined above|0|||
124947392|NCT00824408|449434369|FG003|Run-in Phase|Other reason not defined above|0|||
124947393|NCT00824408|449434370|FG004|Run-in Phase|Other reason not defined above|0|||
124947394|NCT00824408|449434366|FG000|Randomized Phase|Not treated|0|||
124947395|NCT00824408|449434367|FG001|Randomized Phase|Not treated|0|||
124947396|NCT00824408|449434368|FG002|Randomized Phase|Not treated|1|||
124947397|NCT00824408|449434369|FG003|Randomized Phase|Not treated|1|||
124947398|NCT00824408|449434370|FG004|Randomized Phase|Not treated|1|||
124947399|NCT00824408|449434366|FG000|Randomized Phase|Progressive disease|0|||
124947400|NCT00824408|449434367|FG001|Randomized Phase|Progressive disease|0|||
124947401|NCT00824408|449434368|FG002|Randomized Phase|Progressive disease|25|||
124947402|NCT00824408|449434369|FG003|Randomized Phase|Progressive disease|36|||
124947403|NCT00824408|449434370|FG004|Randomized Phase|Progressive disease|34|||
124947404|NCT00824408|449434366|FG000|Randomized Phase|Adverse Event|0|||
124947405|NCT00824408|449434367|FG001|Randomized Phase|Adverse Event|0|||
124947406|NCT00824408|449434368|FG002|Randomized Phase|Adverse Event|4|||
124947407|NCT00824408|449434369|FG003|Randomized Phase|Adverse Event|5|||
124947408|NCT00824408|449434370|FG004|Randomized Phase|Adverse Event|5|||
124947409|NCT00824408|449434366|FG000|Randomized Phase|Refused to continue medication|0|||
124947410|NCT00824408|449434367|FG001|Randomized Phase|Refused to continue medication|0|||
124947411|NCT00824408|449434368|FG002|Randomized Phase|Refused to continue medication|2|||
124947412|NCT00824408|449434369|FG003|Randomized Phase|Refused to continue medication|2|||
124706290|NCT05901636|448549922|FG001|Overall Study|Withdrawal by Subject|1|||
124706291|NCT05901636|448549923|FG002|Overall Study|Withdrawal by Subject|0|||
124706292|NCT05901636|448549924|FG003|Overall Study|Withdrawal by Subject|0|||
124706293|NCT05901636|448549925|FG004|Overall Study|Withdrawal by Subject|1|||
124947413|NCT00824408|449434370|FG004|Randomized Phase|Refused to continue medication|2|||
124947414|NCT00824408|449434366|FG000|Randomized Phase|Other reason not defined above|0|||
124947415|NCT00824408|449434367|FG001|Randomized Phase|Other reason not defined above|0|||
124548337|NCT01569074|447962565|FG000|Overall Study|Severe non-compliance to protocol|0|||
124548338|NCT01569074|447962566|FG001|Overall Study|Severe non-compliance to protocol|0|||
124548339|NCT01569074|447962567|FG002|Overall Study|Severe non-compliance to protocol|1|||
124706294|NCT05901636|448549926|FG005|Overall Study|Withdrawal by Subject|1|||
124706295|NCT05901636|448549927|FG006|Overall Study|Withdrawal by Subject|0|||
124706296|NCT05901636|448549921|FG000|Overall Study|Other|0|||
124706297|NCT05901636|448549922|FG001|Overall Study|Other|0|||
124706298|NCT05901636|448549923|FG002|Overall Study|Other|1|||
124706299|NCT05901636|448549924|FG003|Overall Study|Other|1|||
124706300|NCT05901636|448549925|FG004|Overall Study|Other|0|||
124706301|NCT05901636|448549926|FG005|Overall Study|Other|0|||
124706302|NCT05901636|448549927|FG006|Overall Study|Other|0|||
124706303|NCT04583618|448549928|FG000|Overall Study|Adverse Event|0|||
124706304|NCT04583618|448549929|FG001|Overall Study|Adverse Event|0|||
124947416|NCT00824408|449434368|FG002|Randomized Phase|Other reason not defined above|4|||
124947417|NCT00824408|449434369|FG003|Randomized Phase|Other reason not defined above|2|||
124947418|NCT00824408|449434370|FG004|Randomized Phase|Other reason not defined above|4|||
124947419|NCT01880736|449434371|FG000|Overall Study|Adverse Event|0|||
124947420|NCT01880736|449434372|FG001|Overall Study|Adverse Event|0|||
124947421|NCT01880736|449434373|FG002|Overall Study|Adverse Event|0|||
124947422|NCT01880736|449434374|FG003|Overall Study|Adverse Event|1|||
124947423|NCT01880736|449434371|FG000|Overall Study|Withdrawal Criteria|1|||
124947424|NCT01880736|449434372|FG001|Overall Study|Withdrawal Criteria|2|||
124947425|NCT01880736|449434373|FG002|Overall Study|Withdrawal Criteria|1|||
124947426|NCT01880736|449434374|FG003|Overall Study|Withdrawal Criteria|5|||
124947427|NCT00266656|449434378|FG000|Overall Study|Death|1|||
124947428|NCT00266656|449434379|FG001|Overall Study|Death|0|||
124947429|NCT00266656|449434378|FG000|Overall Study|Lost to Follow-up|4|||
124947430|NCT00266656|449434379|FG001|Overall Study|Lost to Follow-up|1|||
124947431|NCT00266656|449434378|FG000|Overall Study|Withdrawal by Subject|4|||
124947432|NCT00266656|449434379|FG001|Overall Study|Withdrawal by Subject|2|||
124947433|NCT00266656|449434378|FG000|Overall Study|Did Not Reach Final Height|4|||
124947434|NCT00266656|449434379|FG001|Overall Study|Did Not Reach Final Height|8|||
124947435|NCT00266656|449434378|FG000|Overall Study|Parent/Caregiver Decision|1|||
124947436|NCT00266656|449434379|FG001|Overall Study|Parent/Caregiver Decision|2|||
124947437|NCT02915783|449434380|FG000|Overall Study|Death|21|||
124947438|NCT02915783|449434380|FG000|Overall Study|Lost to Follow-up|1|||
124947439|NCT02915783|449434380|FG000|Overall Study|Withdrawal by Subject|2|||
124947440|NCT02203032|449434381|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
124947441|NCT02203032|449434382|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
124947442|NCT02203032|449434383|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
124947443|NCT02203032|449434384|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
124947444|NCT02203032|449434381|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
124947445|NCT02203032|449434382|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
124947446|NCT02203032|449434383|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
124947447|NCT02203032|449434384|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
124947448|NCT02203032|449434381|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
124947449|NCT02203032|449434382|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
124947450|NCT02203032|449434383|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
124947451|NCT02203032|449434384|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
124947452|NCT02203032|449434381|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
124947453|NCT02203032|449434382|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
124947454|NCT02203032|449434383|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
124947455|NCT02203032|449434384|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
124947456|NCT02203032|449434381|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
124947457|NCT02203032|449434382|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
124947458|NCT02203032|449434383|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
124947459|NCT02203032|449434384|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
124947460|NCT02203032|449434381|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
124947461|NCT02203032|449434382|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
124947462|NCT02203032|449434383|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
124947463|NCT02203032|449434384|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
124947464|NCT02203032|449434381|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
124947465|NCT02203032|449434382|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
124947466|NCT02203032|449434383|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
124947467|NCT02203032|449434384|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
124947468|NCT02203032|449434381|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
124947469|NCT02203032|449434382|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
124947470|NCT02203032|449434383|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
124947471|NCT02203032|449434384|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
124706305|NCT04583618|448549930|FG002|Overall Study|Adverse Event|1|||
124947472|NCT02203032|449434381|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
124947473|NCT02203032|449434382|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
124947474|NCT02203032|449434383|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
124947475|NCT02203032|449434384|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
124947476|NCT02203032|449434381|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
124947477|NCT02203032|449434382|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
124706306|NCT04583618|448549931|FG003|Overall Study|Adverse Event|0|||
124706307|NCT04583618|448549932|FG004|Overall Study|Adverse Event|0|||
124947478|NCT02203032|449434383|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
124947479|NCT02203032|449434384|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
124947480|NCT02203032|449434381|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
124947481|NCT02203032|449434382|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
124947482|NCT02203032|449434383|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
124548340|NCT01569074|447962568|FG003|Overall Study|Severe non-compliance to protocol|0|||
124548341|NCT01569074|447962569|FG004|Overall Study|Severe non-compliance to protocol|0|||
124548342|NCT01569074|447962565|FG000|Overall Study|eg change in circumstances|0|||
124548343|NCT01569074|447962566|FG001|Overall Study|eg change in circumstances|2|||
124548344|NCT01569074|447962567|FG002|Overall Study|eg change in circumstances|0|||
124548345|NCT01569074|447962568|FG003|Overall Study|eg change in circumstances|1|||
124548346|NCT01569074|447962569|FG004|Overall Study|eg change in circumstances|1|||
124548347|NCT01569074|447962565|FG000|Overall Study|Adverse Event|1|||
124548348|NCT01569074|447962566|FG001|Overall Study|Adverse Event|0|||
124548349|NCT01569074|447962567|FG002|Overall Study|Adverse Event|3|||
124947483|NCT02203032|449434384|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
124947484|NCT02203032|449434381|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
124548350|NCT01569074|447962568|FG003|Overall Study|Adverse Event|0|||
124947485|NCT02203032|449434382|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
124947486|NCT02203032|449434383|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
124947487|NCT02203032|449434384|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
124947488|NCT01915914|449434385|FG000|Acute Phase|Withdrawal by Subject|4|||
124947489|NCT01915914|449434386|FG001|Acute Phase|Withdrawal by Subject|0|||
124947490|NCT01915914|449434387|FG002|Acute Phase|Withdrawal by Subject|0|||
124947491|NCT01915914|449434388|FG003|Acute Phase|Withdrawal by Subject|0|||
124947492|NCT01915914|449434385|FG000|Acute Phase|Lost to Follow-up|4|||
124947493|NCT01915914|449434386|FG001|Acute Phase|Lost to Follow-up|0|||
124947494|NCT01915914|449434387|FG002|Acute Phase|Lost to Follow-up|0|||
124947495|NCT01915914|449434388|FG003|Acute Phase|Lost to Follow-up|0|||
124947496|NCT01915914|449434385|FG000|Acute Phase|Physician Decision|1|||
124947497|NCT01915914|449434386|FG001|Acute Phase|Physician Decision|0|||
124947498|NCT01915914|449434387|FG002|Acute Phase|Physician Decision|0|||
124947499|NCT01915914|449434388|FG003|Acute Phase|Physician Decision|0|||
124947500|NCT01915914|449434385|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
124947501|NCT01915914|449434386|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
124947502|NCT01915914|449434387|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
124947503|NCT01915914|449434388|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
124947504|NCT01915914|449434385|FG000|Acute Phase|"Not Achieved treatment success"|1|||
124548351|NCT01569074|447962569|FG004|Overall Study|Adverse Event|0|||
124548352|NCT01803464|447962570|FG000|Overall Study|Incomplete data|0|||
124548353|NCT01803464|447962571|FG001|Overall Study|Incomplete data|0|||
124548354|NCT01803464|447962572|FG002|Overall Study|Incomplete data|4|||
124706308|NCT04583618|448549928|FG000|Overall Study|Protocol deviation|1|||
124706309|NCT04583618|448549929|FG001|Overall Study|Protocol deviation|1|||
124706310|NCT04583618|448549930|FG002|Overall Study|Protocol deviation|1|||
124947505|NCT01915914|449434386|FG001|Acute Phase|"Not Achieved treatment success"|0|||
124947506|NCT01915914|449434387|FG002|Acute Phase|"Not Achieved treatment success"|0|||
124947507|NCT01915914|449434388|FG003|Acute Phase|"Not Achieved treatment success"|0|||
124947508|NCT01915914|449434385|FG000|Acute Phase|Missing|1|||
124947509|NCT01915914|449434386|FG001|Acute Phase|Missing|0|||
124947510|NCT01915914|449434387|FG002|Acute Phase|Missing|0|||
124947511|NCT01915914|449434388|FG003|Acute Phase|Missing|0|||
124947512|NCT01915914|449434385|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124947513|NCT01915914|449434386|FG001|Maintenance Phase|Withdrawal by Subject|1|||
124947514|NCT01915914|449434387|FG002|Maintenance Phase|Withdrawal by Subject|1|||
124947515|NCT01915914|449434388|FG003|Maintenance Phase|Withdrawal by Subject|0|||
124947516|NCT01915914|449434385|FG000|Maintenance Phase|Lost to Follow-up|0|||
124947517|NCT01915914|449434386|FG001|Maintenance Phase|Lost to Follow-up|4|||
124548355|NCT01803464|447962573|FG003|Overall Study|Incomplete data|0|||
124548356|NCT01803464|447962570|FG000|Overall Study|Withdrawal by Subject|1|||
124706311|NCT04583618|448549931|FG003|Overall Study|Protocol deviation|0|||
124548357|NCT01803464|447962571|FG001|Overall Study|Withdrawal by Subject|0|||
124548358|NCT01803464|447962572|FG002|Overall Study|Withdrawal by Subject|0|||
124548359|NCT01803464|447962573|FG003|Overall Study|Withdrawal by Subject|0|||
124947518|NCT01915914|449434387|FG002|Maintenance Phase|Lost to Follow-up|1|||
124947519|NCT01915914|449434388|FG003|Maintenance Phase|Lost to Follow-up|0|||
124947520|NCT01915914|449434385|FG000|Maintenance Phase|Missing|0|||
124947521|NCT01915914|449434386|FG001|Maintenance Phase|Missing|1|||
124947522|NCT01915914|449434387|FG002|Maintenance Phase|Missing|0|||
124947523|NCT01915914|449434388|FG003|Maintenance Phase|Missing|0|||
124947524|NCT01915914|449434385|FG000|Follow-up Phase|Withdrawal by Subject|0|||
124947525|NCT01915914|449434386|FG001|Follow-up Phase|Withdrawal by Subject|0|||
124947526|NCT01915914|449434387|FG002|Follow-up Phase|Withdrawal by Subject|0|||
124947527|NCT01915914|449434388|FG003|Follow-up Phase|Withdrawal by Subject|1|||
124548360|NCT02860039|447962579|FG000|Overall Study|Death|4|||
124548361|NCT02860039|447962580|FG001|Overall Study|Death|0|||
124548362|NCT02860039|447962579|FG000|Overall Study|Lost to Follow-up|2|||
124947528|NCT01915914|449434385|FG000|Follow-up Phase|Physician Decision|0|||
124947529|NCT01915914|449434386|FG001|Follow-up Phase|Physician Decision|0|||
124947530|NCT01915914|449434387|FG002|Follow-up Phase|Physician Decision|0|||
124947531|NCT01915914|449434388|FG003|Follow-up Phase|Physician Decision|1|||
124947532|NCT00116649|449434389|FG000|Overall Study|Adverse Event|20|||
124947533|NCT00116649|449434389|FG000|Overall Study|Lack of Efficacy|1|||
124947534|NCT00116649|449434389|FG000|Overall Study|Lost to Follow-up|32|||
124947535|NCT00116649|449434389|FG000|Overall Study|Withdrawal by Subject|68|||
124947536|NCT00116649|449434389|FG000|Overall Study|Local Skin Reaction|9|||
124947537|NCT00116649|449434389|FG000|Overall Study|Various Reasons|18|||
124947538|NCT00116649|449434389|FG000|Overall Study|Protocol Specified|7|||
124947539|NCT02114515|449434390|FG000|Overall Study|Lost to Follow-up|52|||
124947540|NCT02114515|449434391|FG001|Overall Study|Lost to Follow-up|55|||
124947541|NCT02114515|449434390|FG000|Overall Study|Death|12|||
124947542|NCT02114515|449434391|FG001|Overall Study|Death|12|||
124947543|NCT02114515|449434390|FG000|Overall Study|Withdrawal by Subject|4|||
124947544|NCT02114515|449434391|FG001|Overall Study|Withdrawal by Subject|22|||
124947545|NCT02114515|449434390|FG000|Overall Study|Other|65|||
124947546|NCT02114515|449434391|FG001|Overall Study|Other|61|||
124947547|NCT02659540|449434394|FG000|Overall Study|Adverse Event|3|||
124947548|NCT02659540|449434395|FG001|Overall Study|Adverse Event|2|||
124947549|NCT02659540|449434394|FG000|Overall Study|Death|1|||
124947550|NCT02659540|449434395|FG001|Overall Study|Death|0|||
124947551|NCT02659540|449434394|FG000|Overall Study|Progressive disease|2|||
124947552|NCT02659540|449434395|FG001|Overall Study|Progressive disease|6|||
124947553|NCT01075152|449434398|FG000|Overall Study|Withdrawal by Subject|1|||
124947554|NCT01075152|449434399|FG001|Overall Study|Withdrawal by Subject|0|||
124947555|NCT04820491|449434400|FG000|Overall Study|Withdrawal by Subject|1|||
124947556|NCT04820491|449434401|FG001|Overall Study|Withdrawal by Subject|0|||
124947557|NCT02334215|449434402|FG000|Overall Study|Death|1|||
124947558|NCT02334215|449434403|FG001|Overall Study|Death|1|||
124947559|NCT02334215|449434404|FG002|Overall Study|Death|0|||
124947560|NCT02334215|449434402|FG000|Overall Study|Lost to Follow-up|1|||
124947561|NCT02334215|449434403|FG001|Overall Study|Lost to Follow-up|0|||
124947562|NCT02334215|449434404|FG002|Overall Study|Lost to Follow-up|4|||
124947563|NCT02334215|449434402|FG000|Overall Study|Withdrawal by Subject|2|||
124947564|NCT02334215|449434403|FG001|Overall Study|Withdrawal by Subject|2|||
124947565|NCT02334215|449434404|FG002|Overall Study|Withdrawal by Subject|1|||
124947566|NCT02334215|449434402|FG000|Overall Study|Not released from incarceration on time|3|||
124947567|NCT02334215|449434403|FG001|Overall Study|Not released from incarceration on time|3|||
124947568|NCT02334215|449434404|FG002|Overall Study|Not released from incarceration on time|3|||
124947569|NCT02334215|449434402|FG000|Overall Study|Incarcerated|0|||
124947570|NCT02334215|449434403|FG001|Overall Study|Incarcerated|0|||
124947571|NCT02334215|449434404|FG002|Overall Study|Incarcerated|7|||
124947572|NCT03976323|449434407|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
124947573|NCT03976323|449434408|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
124947574|NCT03976323|449434409|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
124947575|NCT03976323|449434407|FG000|Induction Phase|Death|80|||
124947576|NCT03976323|449434408|FG001|Induction Phase|Death|0|||
124947577|NCT03976323|449434409|FG002|Induction Phase|Death|0|||
124947578|NCT03976323|449434407|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
124947579|NCT03976323|449434408|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
124947580|NCT03976323|449434409|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
124947581|NCT03976323|449434407|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124947582|NCT03976323|449434408|FG001|Maintenance Phase|Withdrawal by Subject|9|||
124947583|NCT03976323|449434409|FG002|Maintenance Phase|Withdrawal by Subject|3|||
124947584|NCT03976323|449434407|FG000|Maintenance Phase|Physician Decision|0|||
124947585|NCT03976323|449434408|FG001|Maintenance Phase|Physician Decision|0|||
124947586|NCT03976323|449434409|FG002|Maintenance Phase|Physician Decision|1|||
124947587|NCT03976323|449434407|FG000|Maintenance Phase|Death|0|||
124947588|NCT03976323|449434408|FG001|Maintenance Phase|Death|228|||
124947589|NCT03976323|449434409|FG002|Maintenance Phase|Death|234|||
124947590|NCT00535626|449436407|FG000|Overall Study|Death|15|||
124947591|NCT00535626|449436407|FG000|Overall Study|Lost to Follow-up|29|||
124947592|NCT00535626|449436407|FG000|Overall Study|Withdrawal by Subject|20|||
124947593|NCT00535626|449436407|FG000|Overall Study|Removal/revision of study component|8|||
124947594|NCT00535626|449436407|FG000|Overall Study|Subject terminated|31|||
124947595|NCT00535626|449436407|FG000|Overall Study|Unable to return|2|||
124947596|NCT02710669|449436408|FG000|Overall Study|Physician Decision|2|||
124947597|NCT02710669|449436409|FG001|Overall Study|Physician Decision|1|||
124947598|NCT02710669|449436410|FG002|Overall Study|Physician Decision|0|||
124947599|NCT02710669|449436408|FG000|Overall Study|Institutional delays (including COVID)|2|||
124947600|NCT02710669|449436409|FG001|Overall Study|Institutional delays (including COVID)|2|||
124947601|NCT02710669|449436410|FG002|Overall Study|Institutional delays (including COVID)|0|||
124947602|NCT02710669|449436408|FG000|Overall Study|arrived in afib/aflutter|10|||
124947603|NCT02710669|449436409|FG001|Overall Study|arrived in afib/aflutter|8|||
124947604|NCT02710669|449436410|FG002|Overall Study|arrived in afib/aflutter|2|||
124947605|NCT02014402|449436416|FG000|Overall Study|Adverse Event|1|||
124947606|NCT02014402|449436417|FG001|Overall Study|Adverse Event|0|||
124947607|NCT02014402|449436418|FG002|Overall Study|Adverse Event|0|||
124947608|NCT02014402|449436419|FG003|Overall Study|Adverse Event|0|||
124947609|NCT02014402|449436416|FG000|Overall Study|Withdrawal by Subject|1|||
124947610|NCT02014402|449436417|FG001|Overall Study|Withdrawal by Subject|2|||
124947611|NCT02014402|449436418|FG002|Overall Study|Withdrawal by Subject|2|||
124947612|NCT02014402|449436419|FG003|Overall Study|Withdrawal by Subject|1|||
124947613|NCT02014402|449436416|FG000|Overall Study|Subject did not have transportation|0|||
124947614|NCT02014402|449436417|FG001|Overall Study|Subject did not have transportation|1|||
124947615|NCT02014402|449436418|FG002|Overall Study|Subject did not have transportation|0|||
124947616|NCT02014402|449436419|FG003|Overall Study|Subject did not have transportation|0|||
124947617|NCT02014402|449436416|FG000|Overall Study|Lost to Follow-up|0|||
124947618|NCT02014402|449436417|FG001|Overall Study|Lost to Follow-up|0|||
124947619|NCT02014402|449436418|FG002|Overall Study|Lost to Follow-up|1|||
124947620|NCT02014402|449436419|FG003|Overall Study|Lost to Follow-up|2|||
124947621|NCT01190124|449436421|FG000|Overall Study|Death|3|||
124947622|NCT01190124|449436422|FG001|Overall Study|Death|0|||
124947623|NCT01190124|449436423|FG002|Overall Study|Death|0|||
124947624|NCT01190124|449436421|FG000|Overall Study|Therapeutic Failure|12|||
124947625|NCT01190124|449436422|FG001|Overall Study|Therapeutic Failure|0|||
124947626|NCT01190124|449436423|FG002|Overall Study|Therapeutic Failure|1|||
124947627|NCT01190124|449436421|FG000|Overall Study|Lost to Follow-up|2|||
124947628|NCT01190124|449436422|FG001|Overall Study|Lost to Follow-up|0|||
124947629|NCT01190124|449436423|FG002|Overall Study|Lost to Follow-up|0|||
124947630|NCT03493282|449436424|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
124947631|NCT03493282|449436425|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
124947632|NCT03493282|449436426|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
124947633|NCT03493282|449436424|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
124947634|NCT03493282|449436425|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
124947635|NCT03493282|449436426|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
124947636|NCT00070707|449436427|FG000|Overall Study|Adverse Event|1|||
124947637|NCT00070707|449436428|FG001|Overall Study|Adverse Event|2|||
124947638|NCT00070707|449436427|FG000|Overall Study|Lack of Efficacy|4|||
124947639|NCT00070707|449436428|FG001|Overall Study|Lack of Efficacy|1|||
124947640|NCT00070707|449436427|FG000|Overall Study|Protocol Violation|8|||
124947641|NCT00070707|449436428|FG001|Overall Study|Protocol Violation|4|||
124947642|NCT00070707|449436427|FG000|Overall Study|Unrelated to Study Medication|1|||
124947643|NCT00070707|449436428|FG001|Overall Study|Unrelated to Study Medication|0|||
124947644|NCT01523392|449436429|FG000|Treatment Period 1|Withdrawal by Subject|2|||
124947645|NCT01523392|449436430|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124947646|NCT01523392|449436429|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
124947647|NCT01523392|449436430|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
124947648|NCT01523392|449436429|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
124947649|NCT01523392|449436430|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
124947650|NCT02002689|449436432|FG000|Overall Study|Disease Progression|7|||
124947651|NCT02002689|449436432|FG000|Overall Study|Adverse Event|3|||
124947652|NCT01377844|449436433|FG000|Overall Study|Withdrawal by Subject|25|||
124947653|NCT01377844|449436434|FG001|Overall Study|Withdrawal by Subject|28|||
124947654|NCT01377844|449436433|FG000|Overall Study|Protocol Violation|2|||
124947655|NCT01377844|449436434|FG001|Overall Study|Protocol Violation|3|||
124947656|NCT01377844|449436433|FG000|Overall Study|Adverse Event|3|||
124947657|NCT01377844|449436434|FG001|Overall Study|Adverse Event|0|||
124947658|NCT01377844|449436433|FG000|Overall Study|Physician Decision|6|||
124947659|NCT01377844|449436434|FG001|Overall Study|Physician Decision|3|||
124947660|NCT01377844|449436433|FG000|Overall Study|Study terminated by Sponsor|0|||
124947661|NCT01377844|449436434|FG001|Overall Study|Study terminated by Sponsor|1|||
124947662|NCT02236611|449436436|FG000|Overall Study|Adverse Event|10|||
124947663|NCT02236611|449436437|FG001|Overall Study|Adverse Event|16|||
124947664|NCT02236611|449436436|FG000|Overall Study|Lack of Efficacy|4|||
124947665|NCT02236611|449436437|FG001|Overall Study|Lack of Efficacy|7|||
124947666|NCT02236611|449436436|FG000|Overall Study|Lost to Follow-up|0|||
124947667|NCT02236611|449436437|FG001|Overall Study|Lost to Follow-up|2|||
124947668|NCT02236611|449436436|FG000|Overall Study|Protocol deviation|3|||
124947669|NCT02236611|449436437|FG001|Overall Study|Protocol deviation|5|||
124947670|NCT02236611|449436436|FG000|Overall Study|Withdrew consent|9|||
124947671|NCT02236611|449436437|FG001|Overall Study|Withdrew consent|4|||
124947672|NCT03403036|449436441|FG000|Overall Study|Lack of Efficacy|5|||
124947673|NCT02701296|449436444|FG000|Overall Study|Incomplete Data|0|||
124947674|NCT02701296|449436445|FG001|Overall Study|Incomplete Data|2|||
124947675|NCT00240994|449436446|FG000|Overall Study|Lost to Follow-up|1|||
124947676|NCT00240994|449436446|FG000|Overall Study|Protocol Violation|1|||
124947677|NCT00240994|449436446|FG000|Overall Study|Graft failure|1|||
124947678|NCT01437540|449436447|FG000|Overall Study|Not listed below|7|||
124947679|NCT01437540|449436448|FG001|Overall Study|Not listed below|6|||
124706312|NCT04583618|448549932|FG004|Overall Study|Protocol deviation|0|||
124947680|NCT01437540|449436447|FG000|Overall Study|COPD exacerbation|13|||
124947681|NCT01437540|449436448|FG001|Overall Study|COPD exacerbation|3|||
124947682|NCT01437540|449436447|FG000|Overall Study|Lost to Follow-up|3|||
124947683|NCT01437540|449436448|FG001|Overall Study|Lost to Follow-up|5|||
124947684|NCT01437540|449436447|FG000|Overall Study|Lack of Efficacy|23|||
124947685|NCT01437540|449436448|FG001|Overall Study|Lack of Efficacy|11|||
124947686|NCT01437540|449436447|FG000|Overall Study|Protocol Violation|24|||
124947687|NCT01437540|449436448|FG001|Overall Study|Protocol Violation|12|||
124947688|NCT01437540|449436447|FG000|Overall Study|Adverse Event|26|||
124947689|NCT01437540|449436448|FG001|Overall Study|Adverse Event|13|||
124947690|NCT01437540|449436447|FG000|Overall Study|Withdrawal by Subject|31|||
124947691|NCT01437540|449436448|FG001|Overall Study|Withdrawal by Subject|15|||
124947692|NCT03142932|449436449|FG000|Overall Study|Lost to Follow-up|2|||
124947693|NCT03142932|449436450|FG001|Overall Study|Lost to Follow-up|11|||
124947694|NCT00749944|449436455|FG000|Overall Study|Lost to Follow-up|2|||
124947695|NCT00749944|449436456|FG001|Overall Study|Lost to Follow-up|1|||
124947696|NCT00749944|449436455|FG000|Overall Study|Other|1|||
124947697|NCT00749944|449436456|FG001|Overall Study|Other|0|||
124947698|NCT00749944|449436455|FG000|Overall Study|Withdrawal by Subject|2|||
124947699|NCT00749944|449436456|FG001|Overall Study|Withdrawal by Subject|0|||
124947700|NCT02547974|449436457|FG000|Overall Study|Withdrawal by Subject|1|||
124947701|NCT02547974|449436458|FG001|Overall Study|Withdrawal by Subject|0|||
124947702|NCT02547974|449436459|FG002|Overall Study|Withdrawal by Subject|0|||
124947703|NCT02547974|449436460|FG003|Overall Study|Withdrawal by Subject|0|||
124947704|NCT01393600|449436464|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
124947705|NCT01393600|449436465|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
124947706|NCT01393600|449436466|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
124947707|NCT01393600|449436467|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
124947708|NCT01393600|449436464|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
124947709|NCT01393600|449436465|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
124947710|NCT01393600|449436466|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
124947711|NCT01393600|449436467|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
124947712|NCT01393600|449436464|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
124947713|NCT01393600|449436465|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
124947714|NCT01393600|449436466|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
124947715|NCT01393600|449436467|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
124947716|NCT01393600|449436464|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
124947717|NCT01393600|449436465|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
124947718|NCT01393600|449436466|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
124947719|NCT01393600|449436467|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
124947720|NCT01393600|449436464|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
124947721|NCT01393600|449436465|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
124947722|NCT01393600|449436466|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
124947723|NCT01393600|449436467|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
124947724|NCT01393600|449436464|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
124947725|NCT01393600|449436465|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
124947726|NCT01393600|449436466|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
124459040|NCT01225731|447640549|FG010|Part 3|Adverse Event|1|||
124459041|NCT01225731|447640550|FG011|Part 3|Adverse Event|1|||
124459042|NCT01225731|447640551|FG012|Part 3|Adverse Event|0|||
124459043|NCT01225731|447640539|FG000|Part 3|Lost to Follow-up|0|||
124459044|NCT01225731|447640540|FG001|Part 3|Lost to Follow-up|0|||
124459045|NCT01225731|447640541|FG002|Part 3|Lost to Follow-up|0|||
124459046|NCT01225731|447640542|FG003|Part 3|Lost to Follow-up|0|||
124459047|NCT01225731|447640543|FG004|Part 3|Lost to Follow-up|0|||
124459048|NCT01225731|447640544|FG005|Part 3|Lost to Follow-up|0|||
124459049|NCT01225731|447640545|FG006|Part 3|Lost to Follow-up|0|||
124459050|NCT01225731|447640546|FG007|Part 3|Lost to Follow-up|0|||
124459051|NCT01225731|447640547|FG008|Part 3|Lost to Follow-up|0|||
124459052|NCT01225731|447640548|FG009|Part 3|Lost to Follow-up|0|||
124459053|NCT01225731|447640549|FG010|Part 3|Lost to Follow-up|1|||
124459054|NCT01225731|447640550|FG011|Part 3|Lost to Follow-up|2|||
124459055|NCT01225731|447640551|FG012|Part 3|Lost to Follow-up|1|||
124548363|NCT02860039|447962580|FG001|Overall Study|Lost to Follow-up|2|||
124947727|NCT01393600|449436467|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
124947728|NCT01393600|449436464|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
124947729|NCT01393600|449436465|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
124947730|NCT01393600|449436466|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
124947731|NCT01393600|449436467|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
124947732|NCT00603798|449436468|FG000|Overall Study|Adverse Event|4|||
124459056|NCT01225731|447640539|FG000|Part 3|Physician Decision|0|||
124459057|NCT01225731|447640540|FG001|Part 3|Physician Decision|0|||
124459058|NCT01225731|447640541|FG002|Part 3|Physician Decision|0|||
124459059|NCT01225731|447640542|FG003|Part 3|Physician Decision|0|||
124548364|NCT02860039|447962579|FG000|Overall Study|Protocol Violation|3|||
124947733|NCT00603798|449436469|FG001|Overall Study|Adverse Event|2|||
124947734|NCT00603798|449436470|FG002|Overall Study|Adverse Event|1|||
124947735|NCT00603798|449436468|FG000|Overall Study|Withdrawal by Subject|4|||
124947736|NCT00603798|449436469|FG001|Overall Study|Withdrawal by Subject|3|||
124947737|NCT00603798|449436470|FG002|Overall Study|Withdrawal by Subject|4|||
124947738|NCT00603798|449436468|FG000|Overall Study|Lost to Follow-up|1|||
124947739|NCT00603798|449436469|FG001|Overall Study|Lost to Follow-up|0|||
124947740|NCT00603798|449436470|FG002|Overall Study|Lost to Follow-up|1|||
124947741|NCT00603798|449436468|FG000|Overall Study|Non-compliance with study procedures|0|||
124947742|NCT00603798|449436469|FG001|Overall Study|Non-compliance with study procedures|1|||
124947743|NCT00603798|449436470|FG002|Overall Study|Non-compliance with study procedures|0|||
124947744|NCT00603798|449436468|FG000|Overall Study|Not due to AE|1|||
124947745|NCT00603798|449436469|FG001|Overall Study|Not due to AE|1|||
124947746|NCT00603798|449436470|FG002|Overall Study|Not due to AE|4|||
124947747|NCT04766996|449436471|FG000|Overall Study|Withdrawal by Subject|1|||
124947748|NCT04766996|449436472|FG001|Overall Study|Withdrawal by Subject|0|||
124947749|NCT04766996|449436473|FG002|Overall Study|Withdrawal by Subject|13|||
124947750|NCT02988713|449436476|FG000|Overall Study|Withdrawal by Subject|1|||
124947751|NCT02988713|449436476|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
124947752|NCT04248868|449436482|FG000|Overall Study|Death|1|||
124947753|NCT04248868|449436482|FG000|Overall Study|Lost to Follow-up|3|||
124947754|NCT04248868|449436482|FG000|Overall Study|Protocol Violation|2|||
124947755|NCT03131713|449436483|FG000|Overall Study|Lost to Follow-up|5|||
124947756|NCT03131713|449436484|FG001|Overall Study|Lost to Follow-up|0|||
124947757|NCT02208843|449436485|FG000|Overall Study|Clinical symptoms of progression|2|||
124947758|NCT02208843|449436485|FG000|Overall Study|Progression disease according to RECIST|24|||
124947759|NCT02208843|449436485|FG000|Overall Study|Adverse Event|12|||
124947760|NCT02208843|449436485|FG000|Overall Study|Protocol Violation|1|||
124947761|NCT02208843|449436485|FG000|Overall Study|Withdrawal by Subject|1|||
124947762|NCT02208843|449436485|FG000|Overall Study|Switched to commercial afatinib|20|||
124947763|NCT01976507|449436486|FG000|Overall Study|Adverse Event|6|||
124947764|NCT01976507|449436486|FG000|Overall Study|ablation not done, drug not given|1|||
124947765|NCT01794299|449436496|FG000|Overall Study|ATIR manufacturing not possible|1|||
124947766|NCT01794299|449436496|FG000|Overall Study|Death|14|||
124947767|NCT01794299|449436496|FG000|Overall Study|Graft failure|1|||
124947768|NCT01794299|449436496|FG000|Overall Study|ATIR batch rejected|2|||
124947769|NCT01794299|449436496|FG000|Overall Study|Relapse|2|||
124947770|NCT01794299|449436496|FG000|Overall Study|Discontinued from active follow-up|1|||
124947771|NCT01794299|449436496|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
124947772|NCT01029704|449436497|FG000|Overall Study|Adverse Event|0|||
124947773|NCT01029704|449436498|FG001|Overall Study|Adverse Event|0|||
124947774|NCT01029704|449436499|FG002|Overall Study|Adverse Event|0|||
124947775|NCT01029704|449436500|FG003|Overall Study|Adverse Event|0|||
124947776|NCT01029704|449436501|FG004|Overall Study|Adverse Event|0|||
124947777|NCT01029704|449436502|FG005|Overall Study|Adverse Event|0|||
124947778|NCT01029704|449436503|FG006|Overall Study|Adverse Event|1|||
124947779|NCT01029704|449436504|FG007|Overall Study|Adverse Event|1|||
124947780|NCT01029704|449436505|FG008|Overall Study|Adverse Event|0|||
124947781|NCT01029704|449436497|FG000|Overall Study|Withdrawal by Subject|0|||
124947782|NCT01029704|449436498|FG001|Overall Study|Withdrawal by Subject|0|||
124947783|NCT01029704|449436499|FG002|Overall Study|Withdrawal by Subject|0|||
124947784|NCT01029704|449436500|FG003|Overall Study|Withdrawal by Subject|0|||
124947785|NCT01029704|449436501|FG004|Overall Study|Withdrawal by Subject|2|||
124947786|NCT01029704|449436502|FG005|Overall Study|Withdrawal by Subject|1|||
124947787|NCT01029704|449436503|FG006|Overall Study|Withdrawal by Subject|1|||
124947788|NCT01029704|449436504|FG007|Overall Study|Withdrawal by Subject|1|||
124947789|NCT01029704|449436505|FG008|Overall Study|Withdrawal by Subject|0|||
124947790|NCT01029704|449436497|FG000|Overall Study|Lost to Follow-up|0|||
124947791|NCT01029704|449436498|FG001|Overall Study|Lost to Follow-up|0|||
124947792|NCT01029704|449436499|FG002|Overall Study|Lost to Follow-up|0|||
124947793|NCT01029704|449436500|FG003|Overall Study|Lost to Follow-up|0|||
124947794|NCT01029704|449436501|FG004|Overall Study|Lost to Follow-up|0|||
124947795|NCT01029704|449436502|FG005|Overall Study|Lost to Follow-up|0|||
124947796|NCT01029704|449436503|FG006|Overall Study|Lost to Follow-up|1|||
124947797|NCT01029704|449436504|FG007|Overall Study|Lost to Follow-up|1|||
124459060|NCT01225731|447640543|FG004|Part 3|Physician Decision|0|||
124947798|NCT01029704|449436505|FG008|Overall Study|Lost to Follow-up|1|||
124947799|NCT01029704|449436497|FG000|Overall Study|Lack of Efficacy|0|||
124947800|NCT01029704|449436498|FG001|Overall Study|Lack of Efficacy|0|||
124947801|NCT01029704|449436499|FG002|Overall Study|Lack of Efficacy|0|||
124947802|NCT01029704|449436500|FG003|Overall Study|Lack of Efficacy|0|||
124947803|NCT01029704|449436501|FG004|Overall Study|Lack of Efficacy|2|||
124947804|NCT01029704|449436502|FG005|Overall Study|Lack of Efficacy|3|||
124947805|NCT01029704|449436503|FG006|Overall Study|Lack of Efficacy|1|||
124947806|NCT01029704|449436504|FG007|Overall Study|Lack of Efficacy|2|||
124947807|NCT01029704|449436505|FG008|Overall Study|Lack of Efficacy|0|||
124947808|NCT01029704|449436497|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
124947809|NCT01029704|449436498|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
124947810|NCT01029704|449436499|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
124947811|NCT01029704|449436500|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
124947812|NCT01029704|449436501|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
124947813|NCT01029704|449436502|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
124947814|NCT01029704|449436503|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
124947815|NCT01029704|449436504|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
124947816|NCT01029704|449436505|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
124947817|NCT00089791|449436509|FG000|Overall Study|Physician Decision|6|||
124947818|NCT00089791|449436510|FG001|Overall Study|Physician Decision|3|||
124947819|NCT00089791|449436509|FG000|Overall Study|Adverse Event|81|||
124947820|NCT00089791|449436510|FG001|Overall Study|Adverse Event|93|||
124947821|NCT00089791|449436509|FG000|Overall Study|Withdrawal by Subject|403|||
124947822|NCT00089791|449436510|FG001|Overall Study|Withdrawal by Subject|344|||
124947823|NCT00089791|449436509|FG000|Overall Study|Death|78|||
124947824|NCT00089791|449436510|FG001|Overall Study|Death|62|||
124947825|NCT00089791|449436509|FG000|Overall Study|Disease progression|7|||
124947826|NCT00089791|449436510|FG001|Overall Study|Disease progression|3|||
124947827|NCT00089791|449436509|FG000|Overall Study|Ineligibility determined|12|||
124947828|NCT00089791|449436510|FG001|Overall Study|Ineligibility determined|9|||
124947829|NCT00089791|449436509|FG000|Overall Study|Lost to Follow-up|57|||
124947830|NCT00089791|449436510|FG001|Overall Study|Lost to Follow-up|57|||
124947831|NCT00089791|449436509|FG000|Overall Study|Noncompliance|17|||
124947832|NCT00089791|449436510|FG001|Overall Study|Noncompliance|13|||
124947833|NCT00089791|449436509|FG000|Overall Study|Other|20|||
124947834|NCT00089791|449436510|FG001|Overall Study|Other|32|||
124947835|NCT00089791|449436509|FG000|Overall Study|Protocol deviation|12|||
124947836|NCT00089791|449436510|FG001|Overall Study|Protocol deviation|10|||
124947837|NCT00089791|449436509|FG000|Overall Study|Requirement for alternative therapy|7|||
124947838|NCT00089791|449436510|FG001|Overall Study|Requirement for alternative therapy|4|||
124947839|NCT00148122|449436511|FG000|Overall Study|Withdrawal by Subject|2|||
124947840|NCT05376397|449436514|FG000|Overall Study|Lost to Follow-up|1|||
124947841|NCT01137682|449436515|FG000|Overall Study|Adverse Event-CORE|2|||
124947842|NCT01137682|449436516|FG001|Overall Study|Adverse Event-CORE|4|||
124947843|NCT01137682|449436517|FG002|Overall Study|Adverse Event-CORE|0|||
124947844|NCT01137682|449436515|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
124947845|NCT01137682|449436516|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
124947846|NCT01137682|449436517|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
124947847|NCT01137682|449436515|FG000|Overall Study|Administrative problems-CORE|2|||
124947848|NCT01137682|449436516|FG001|Overall Study|Administrative problems-CORE|1|||
124947849|NCT01137682|449436517|FG002|Overall Study|Administrative problems-CORE|0|||
124947850|NCT01137682|449436515|FG000|Overall Study|Protocol Violation-CORE|0|||
124947851|NCT01137682|449436516|FG001|Overall Study|Protocol Violation-CORE|1|||
124947852|NCT01137682|449436517|FG002|Overall Study|Protocol Violation-CORE|1|||
124947853|NCT01137682|449436515|FG000|Overall Study|Adverse Event-Extension|4|||
124947854|NCT01137682|449436516|FG001|Overall Study|Adverse Event-Extension|8|||
124947855|NCT01137682|449436517|FG002|Overall Study|Adverse Event-Extension|7|||
124947856|NCT01137682|449436515|FG000|Overall Study|Lack of Efficacy-Extension|15|||
124947857|NCT01137682|449436516|FG001|Overall Study|Lack of Efficacy-Extension|9|||
124947858|NCT01137682|449436517|FG002|Overall Study|Lack of Efficacy-Extension|13|||
124947859|NCT01137682|449436515|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
124947860|NCT01137682|449436516|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
124947861|NCT01137682|449436517|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
124947862|NCT01137682|449436515|FG000|Overall Study|Lost to Follow Up-Extension|0|||
124947863|NCT01137682|449436516|FG001|Overall Study|Lost to Follow Up-Extension|1|||
124947864|NCT01137682|449436517|FG002|Overall Study|Lost to Follow Up-Extension|0|||
124947865|NCT01137682|449436515|FG000|Overall Study|Administrative problems-Extension|0|||
124548365|NCT02860039|447962580|FG001|Overall Study|Protocol Violation|1|||
124947866|NCT01137682|449436516|FG001|Overall Study|Administrative problems-Extension|2|||
124947867|NCT01137682|449436517|FG002|Overall Study|Administrative problems-Extension|0|||
124947868|NCT01137682|449436515|FG000|Overall Study|Death-Extension|2|||
124947869|NCT01137682|449436516|FG001|Overall Study|Death-Extension|0|||
124947870|NCT01137682|449436517|FG002|Overall Study|Death-Extension|0|||
124947871|NCT01137682|449436515|FG000|Overall Study|Protocol Violation-Extension|2|||
124947872|NCT01137682|449436516|FG001|Overall Study|Protocol Violation-Extension|1|||
124947873|NCT01137682|449436517|FG002|Overall Study|Protocol Violation-Extension|0|||
124947874|NCT01137682|449436515|FG000|Overall Study|Did not enter extension|2|||
124947875|NCT01137682|449436516|FG001|Overall Study|Did not enter extension|3|||
124947876|NCT01137682|449436517|FG002|Overall Study|Did not enter extension|2|||
124947877|NCT01137682|449436515|FG000|Overall Study|Did not receive treatment in extension|0|||
124947878|NCT01137682|449436516|FG001|Overall Study|Did not receive treatment in extension|0|||
124947879|NCT01137682|449436517|FG002|Overall Study|Did not receive treatment in extension|1|||
124947880|NCT01365546|449436518|FG000|Overall Study|Withdrawal by Subject|1|||
124947881|NCT01365546|449436518|FG000|Overall Study|Screen failure|9|||
124947882|NCT01365546|449436518|FG000|Overall Study|Study termination|1|||
124947883|NCT00721734|449436519|FG000|Overall Study|Progressive Disease|3|||
124947884|NCT00721734|449436520|FG001|Overall Study|Progressive Disease|10|||
124947885|NCT00721734|449436521|FG002|Overall Study|Progressive Disease|4|||
124947886|NCT00721734|449436522|FG003|Overall Study|Progressive Disease|5|||
124947887|NCT00721734|449436523|FG004|Overall Study|Progressive Disease|2|||
124947888|NCT00721734|449436519|FG000|Overall Study|Adverse Event|3|||
124947889|NCT00721734|449436520|FG001|Overall Study|Adverse Event|1|||
124947890|NCT00721734|449436521|FG002|Overall Study|Adverse Event|4|||
124947891|NCT00721734|449436522|FG003|Overall Study|Adverse Event|0|||
124947892|NCT00721734|449436523|FG004|Overall Study|Adverse Event|3|||
124947893|NCT00721734|449436519|FG000|Overall Study|Withdrawal by Subject|2|||
124947894|NCT00721734|449436520|FG001|Overall Study|Withdrawal by Subject|1|||
124947895|NCT00721734|449436521|FG002|Overall Study|Withdrawal by Subject|0|||
124947896|NCT00721734|449436522|FG003|Overall Study|Withdrawal by Subject|0|||
124947897|NCT00721734|449436523|FG004|Overall Study|Withdrawal by Subject|1|||
124947898|NCT00721734|449436519|FG000|Overall Study|Other|0|||
124947899|NCT00721734|449436520|FG001|Overall Study|Other|0|||
124947900|NCT00721734|449436521|FG002|Overall Study|Other|0|||
124947901|NCT00721734|449436522|FG003|Overall Study|Other|1|||
124947902|NCT00721734|449436523|FG004|Overall Study|Other|0|||
124947903|NCT00472082|449436524|FG000|Overall Study|Study prematurely terminated|5|||
124947904|NCT04617847|449436525|FG000|Overall Study|Withdrawal by Subject|1|||
124947905|NCT04617847|449436526|FG001|Overall Study|Withdrawal by Subject|0|||
124947906|NCT04617847|449436525|FG000|Overall Study|Adverse Event|0|||
124947907|NCT04617847|449436526|FG001|Overall Study|Adverse Event|2|||
124947908|NCT04617847|449436525|FG000|Overall Study|Death|0|||
124947909|NCT04617847|449436526|FG001|Overall Study|Death|1|||
124947910|NCT04617847|449436525|FG000|Overall Study|Termination of Study by Sponsor|2|||
124947911|NCT04617847|449436526|FG001|Overall Study|Termination of Study by Sponsor|21|||
124947912|NCT01989689|449436527|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
124947913|NCT01989689|449436528|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
124947914|NCT01989689|449436527|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
124947915|NCT01989689|449436528|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
124947916|NCT00761267|449436529|FG000|Overall Study|Death|1|||
124947917|NCT00761267|449436530|FG001|Overall Study|Death|2|||
124947918|NCT00761267|449436531|FG002|Overall Study|Death|5|||
124947919|NCT00761267|449436529|FG000|Overall Study|Lost to Follow-up|0|||
124947920|NCT00761267|449436530|FG001|Overall Study|Lost to Follow-up|0|||
124947921|NCT00761267|449436531|FG002|Overall Study|Lost to Follow-up|1|||
124947922|NCT00761267|449436529|FG000|Overall Study|Randomized but not treated|1|||
124459061|NCT01225731|447640544|FG005|Part 3|Physician Decision|0|||
124947923|NCT00761267|449436530|FG001|Overall Study|Randomized but not treated|1|||
124947924|NCT00761267|449436531|FG002|Overall Study|Randomized but not treated|0|||
124947925|NCT00761267|449436529|FG000|Overall Study|Withdrawal by Subject|0|||
124947926|NCT00761267|449436530|FG001|Overall Study|Withdrawal by Subject|1|||
124947927|NCT00761267|449436531|FG002|Overall Study|Withdrawal by Subject|0|||
124947928|NCT04492475|449436532|FG000|Overall Study|Enrolled but not treated|8|||
124947929|NCT04492475|449436533|FG001|Overall Study|Enrolled but not treated|8|||
124947930|NCT04492475|449436532|FG000|Overall Study|Withdrawal by Subject|4|||
124459062|NCT01225731|447640545|FG006|Part 3|Physician Decision|0|||
124947931|NCT04492475|449436533|FG001|Overall Study|Withdrawal by Subject|0|||
124947932|NCT04492475|449436532|FG000|Overall Study|Became ineligible after enrollment|2|||
124947933|NCT04492475|449436533|FG001|Overall Study|Became ineligible after enrollment|0|||
124947934|NCT03989232|449436534|FG000|Overall Study|Lost to Follow-up|3|||
124947935|NCT03989232|449436535|FG001|Overall Study|Lost to Follow-up|10|||
124947936|NCT03989232|449436534|FG000|Overall Study|Withdrawal by Subject|6|||
124947937|NCT03989232|449436535|FG001|Overall Study|Withdrawal by Subject|6|||
124947938|NCT03989232|449436534|FG000|Overall Study|Death|1|||
124947939|NCT03989232|449436535|FG001|Overall Study|Death|2|||
124947940|NCT01323790|449436545|FG000|Overall Study|Other|3|||
124947941|NCT01323790|449436546|FG001|Overall Study|Other|2|||
124947942|NCT01323790|449436547|FG002|Overall Study|Other|1|||
124947943|NCT01323790|449436545|FG000|Overall Study|Lost to Follow-up|11|||
124947944|NCT01323790|449436546|FG001|Overall Study|Lost to Follow-up|9|||
124947945|NCT01323790|449436547|FG002|Overall Study|Lost to Follow-up|9|||
124947946|NCT01323790|449436545|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
124947947|NCT01323790|449436546|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
124459063|NCT01225731|447640546|FG007|Part 3|Physician Decision|0|||
124706313|NCT04583618|448549928|FG000|Overall Study|Withdrawal by Subject|2|||
124706314|NCT04583618|448549929|FG001|Overall Study|Withdrawal by Subject|1|||
124947948|NCT01323790|449436547|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
124947949|NCT01323790|449436545|FG000|Overall Study|Lack of Efficacy|3|||
124947950|NCT01323790|449436546|FG001|Overall Study|Lack of Efficacy|0|||
124947951|NCT01323790|449436547|FG002|Overall Study|Lack of Efficacy|3|||
124947952|NCT01323790|449436545|FG000|Overall Study|Adverse Event|11|||
124947953|NCT01323790|449436546|FG001|Overall Study|Adverse Event|24|||
124947954|NCT01323790|449436547|FG002|Overall Study|Adverse Event|12|||
124947955|NCT01323790|449436545|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
124947956|NCT01323790|449436546|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
124947957|NCT01323790|449436547|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
124947958|NCT01323790|449436545|FG000|Overall Study|Withdrawal by Subject|23|||
124947959|NCT01323790|449436546|FG001|Overall Study|Withdrawal by Subject|20|||
124947960|NCT01323790|449436547|FG002|Overall Study|Withdrawal by Subject|13|||
124947961|NCT01323790|449436545|FG000|Overall Study|Did Not Receive Treatment|2|||
124947962|NCT01323790|449436546|FG001|Overall Study|Did Not Receive Treatment|0|||
124947963|NCT01323790|449436547|FG002|Overall Study|Did Not Receive Treatment|1|||
124947964|NCT01323790|449436545|FG000|Overall Study|Severe non-compliance with protocol|2|||
124947965|NCT01323790|449436546|FG001|Overall Study|Severe non-compliance with protocol|2|||
124947966|NCT01323790|449436547|FG002|Overall Study|Severe non-compliance with protocol|2|||
124947967|NCT01263496|449436548|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
124947968|NCT01263496|449436549|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
124947969|NCT01263496|449436550|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
124947970|NCT01263496|449436551|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
124947971|NCT01263496|449436552|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
124947972|NCT01263496|449436553|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
124947973|NCT01263496|449436554|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
124947974|NCT01263496|449436555|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
124947975|NCT01263496|449436556|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
124947976|NCT01263496|449436548|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124947977|NCT01263496|449436549|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124947978|NCT01263496|449436550|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124947979|NCT01263496|449436551|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
124947980|NCT01263496|449436552|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
124947981|NCT01263496|449436553|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124947982|NCT01263496|449436554|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124947983|NCT01263496|449436555|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124947984|NCT01263496|449436556|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124947985|NCT01263496|449436548|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
124947986|NCT01263496|449436549|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
124947987|NCT01263496|449436550|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
124947988|NCT01263496|449436551|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
124947989|NCT01263496|449436552|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
124947990|NCT01263496|449436553|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
124947991|NCT01263496|449436554|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
124947992|NCT01263496|449436555|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
124947993|NCT01263496|449436556|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
124947994|NCT01263496|449436548|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124947995|NCT01263496|449436549|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
124947996|NCT01263496|449436550|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124947997|NCT01263496|449436551|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124947998|NCT01263496|449436552|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124947999|NCT01263496|449436553|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124948000|NCT01263496|449436554|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124948001|NCT01263496|449436555|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124948002|NCT01263496|449436556|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124948003|NCT01263496|449436548|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
124948004|NCT01263496|449436549|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
124948005|NCT01263496|449436550|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
124948006|NCT01263496|449436551|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
124948007|NCT01263496|449436552|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
124548366|NCT02860039|447962579|FG000|Overall Study|Withdrawal by Subject|1|||
124948008|NCT01263496|449436553|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
124948009|NCT01263496|449436554|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
124706315|NCT04583618|448549930|FG002|Overall Study|Withdrawal by Subject|3|||
124948010|NCT01263496|449436555|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
124948011|NCT01263496|449436556|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
124948012|NCT01263496|449436548|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
124948013|NCT01263496|449436549|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
124948014|NCT01263496|449436550|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
124948015|NCT01263496|449436551|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
124948016|NCT01263496|449436552|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
124948017|NCT01263496|449436553|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
124948018|NCT01263496|449436554|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
124948019|NCT01263496|449436555|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
124948020|NCT01263496|449436556|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
124948021|NCT01263496|449436548|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124948022|NCT01263496|449436549|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124948023|NCT01263496|449436550|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124948024|NCT01263496|449436551|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124948025|NCT01263496|449436552|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124948026|NCT01263496|449436553|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124948027|NCT01263496|449436554|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124948028|NCT01263496|449436555|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
124948029|NCT01263496|449436556|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
124948030|NCT02432274|449436557|FG000|Overall Study|Death|2|||
124948031|NCT02432274|449436558|FG001|Overall Study|Death|6|||
124948032|NCT02432274|449436559|FG002|Overall Study|Death|7|||
124948033|NCT02432274|449436560|FG003|Overall Study|Death|0|||
124948034|NCT02432274|449436561|FG004|Overall Study|Death|27|||
124948035|NCT02432274|449436562|FG005|Overall Study|Death|7|||
124948036|NCT02432274|449436563|FG006|Overall Study|Death|9|||
124948037|NCT02432274|449436564|FG007|Overall Study|Death|14|||
124948038|NCT02432274|449436557|FG000|Overall Study|Withdrawal of Consent|0|||
124948039|NCT02432274|449436558|FG001|Overall Study|Withdrawal of Consent|0|||
124948040|NCT02432274|449436559|FG002|Overall Study|Withdrawal of Consent|0|||
124948041|NCT02432274|449436560|FG003|Overall Study|Withdrawal of Consent|0|||
124948042|NCT02432274|449436561|FG004|Overall Study|Withdrawal of Consent|2|||
124948043|NCT02432274|449436562|FG005|Overall Study|Withdrawal of Consent|0|||
124948044|NCT02432274|449436563|FG006|Overall Study|Withdrawal of Consent|1|||
124948045|NCT02432274|449436564|FG007|Overall Study|Withdrawal of Consent|2|||
124948046|NCT00513071|449436567|FG000|Overall Study|Adverse Event|1|||
124948047|NCT00513071|449436567|FG000|Overall Study|Withdrawal by Subject|1|||
124948048|NCT00513071|449436567|FG000|Overall Study|Physician Decision|3|||
124948049|NCT00667732|449436570|FG000|Run -In (8 Weeks)|Adverse Event|4|||
124948050|NCT00667732|449436571|FG001|Run -In (8 Weeks)|Adverse Event|0|||
124948051|NCT00667732|449436572|FG002|Run -In (8 Weeks)|Adverse Event|0|||
124948052|NCT00667732|449436570|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
124948053|NCT00667732|449436571|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
124948054|NCT00667732|449436572|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
124948055|NCT00667732|449436570|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
124948056|NCT00667732|449436571|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
124948057|NCT00667732|449436572|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
124948058|NCT01240590|449436573|FG000|Phase I|Refused further treatment|0|||
124948059|NCT01240590|449436574|FG001|Phase I|Refused further treatment|0|||
124948060|NCT01240590|449436575|FG002|Phase I|Refused further treatment|3|||
124948061|NCT01240590|449436576|FG003|Phase I|Refused further treatment|0|||
124948062|NCT01240590|449436577|FG004|Phase I|Refused further treatment|0|||
124948063|NCT01240590|449436573|FG000|Phase II|Refused further treatment|0|||
124948064|NCT01240590|449436574|FG001|Phase II|Refused further treatment|0|||
124948065|NCT01240590|449436575|FG002|Phase II|Refused further treatment|0|||
124948066|NCT01240590|449436576|FG003|Phase II|Refused further treatment|2|||
124948067|NCT01240590|449436577|FG004|Phase II|Refused further treatment|1|||
124948068|NCT03890484|449436578|FG000|Overall Study|Lost to Follow-up|1|||
124948069|NCT03890484|449436579|FG001|Overall Study|Lost to Follow-up|1|||
124948070|NCT02106325|449436580|FG000|Phase 1|Lost to Follow-up|2|||
124948071|NCT02106325|449436581|FG001|Phase 1|Lost to Follow-up|2|||
124459064|NCT01225731|447640547|FG008|Part 3|Physician Decision|0|||
124459065|NCT01225731|447640548|FG009|Part 3|Physician Decision|0|||
124459066|NCT01225731|447640549|FG010|Part 3|Physician Decision|0|||
124459067|NCT01225731|447640550|FG011|Part 3|Physician Decision|1|||
124459068|NCT01225731|447640551|FG012|Part 3|Physician Decision|2|||
124459069|NCT01225731|447640539|FG000|Part 3|Withdrawal by Subject|0|||
124948072|NCT02106325|449436580|FG000|Phase 2|Lost to Follow-up|2|||
124948073|NCT02106325|449436581|FG001|Phase 2|Lost to Follow-up|3|||
124948074|NCT02106325|449436580|FG000|Phase 3|Lost to Follow-up|2|||
124948075|NCT02106325|449436581|FG001|Phase 3|Lost to Follow-up|1|||
124948076|NCT00824850|449436582|FG000|Overall Study|Withdrawal by Subject|0|||
124948077|NCT00824850|449436583|FG001|Overall Study|Withdrawal by Subject|1|||
124459070|NCT01225731|447640540|FG001|Part 3|Withdrawal by Subject|0|||
124948078|NCT01185340|449438087|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
124948079|NCT01185340|449438088|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124948080|NCT01185340|449438089|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124948081|NCT01185340|449438090|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124948082|NCT01185340|449438087|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
124948083|NCT01185340|449438088|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124948084|NCT01185340|449438089|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124948085|NCT01185340|449438090|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124948086|NCT01185340|449438087|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
124948087|NCT01185340|449438088|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124948088|NCT01185340|449438089|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124948089|NCT01185340|449438090|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124948090|NCT01185340|449438087|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
124948091|NCT01185340|449438088|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124948092|NCT01185340|449438089|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124948093|NCT01185340|449438090|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124948094|NCT01185340|449438087|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
124948095|NCT01185340|449438088|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124948096|NCT01185340|449438089|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124948097|NCT01185340|449438090|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124948098|NCT01185340|449438087|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
124948099|NCT01185340|449438088|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124948100|NCT01185340|449438089|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124948101|NCT01185340|449438090|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124948102|NCT01185340|449438087|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
124948103|NCT01185340|449438088|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124948104|NCT01185340|449438089|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124948105|NCT01185340|449438090|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124948106|NCT01185340|449438087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
124948107|NCT01185340|449438088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
124948108|NCT01185340|449438089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
124948109|NCT01185340|449438090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
124948110|NCT01185340|449438087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
124948111|NCT01185340|449438088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
124948112|NCT01185340|449438089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
124948113|NCT01185340|449438090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
124948114|NCT01185340|449438087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
124948115|NCT01185340|449438088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
124948116|NCT01185340|449438089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
124948117|NCT01185340|449438090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
124948118|NCT01185340|449438087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
124948119|NCT01185340|449438088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
124948120|NCT01185340|449438089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
124948121|NCT01185340|449438090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
124948122|NCT01185340|449438087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
124948123|NCT01185340|449438088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
124948124|NCT01185340|449438089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
124948125|NCT01185340|449438090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
124948126|NCT01185340|449438087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
124948127|NCT01185340|449438088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
124948128|NCT01185340|449438089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
124948129|NCT01185340|449438090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
124948130|NCT01185340|449438087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
124948131|NCT01185340|449438088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
124948132|NCT01185340|449438089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
124948133|NCT01185340|449438090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
124948134|NCT00087516|449438091|FG000|Overall Study|Adverse Event|10|||
124948135|NCT00087516|449438092|FG001|Overall Study|Adverse Event|10|||
124948136|NCT00087516|449438093|FG002|Overall Study|Adverse Event|3|||
124948137|NCT00087516|449438094|FG003|Overall Study|Adverse Event|6|||
124948138|NCT00087516|449438091|FG000|Overall Study|Lack of Efficacy|82|||
124948139|NCT00087516|449438092|FG001|Overall Study|Lack of Efficacy|80|||
124948140|NCT00087516|449438093|FG002|Overall Study|Lack of Efficacy|39|||
124948141|NCT00087516|449438094|FG003|Overall Study|Lack of Efficacy|29|||
124948142|NCT00087516|449438091|FG000|Overall Study|Lost to Follow-up|8|||
124948143|NCT00087516|449438092|FG001|Overall Study|Lost to Follow-up|6|||
124948144|NCT00087516|449438093|FG002|Overall Study|Lost to Follow-up|5|||
124948145|NCT00087516|449438094|FG003|Overall Study|Lost to Follow-up|5|||
124948146|NCT00087516|449438091|FG000|Overall Study|Protocol Violation|4|||
124948147|NCT00087516|449438092|FG001|Overall Study|Protocol Violation|8|||
124948148|NCT00087516|449438093|FG002|Overall Study|Protocol Violation|3|||
124948149|NCT00087516|449438094|FG003|Overall Study|Protocol Violation|6|||
124948150|NCT00087516|449438091|FG000|Overall Study|Withdrawal by Subject|16|||
124948151|NCT00087516|449438092|FG001|Overall Study|Withdrawal by Subject|27|||
124948152|NCT00087516|449438093|FG002|Overall Study|Withdrawal by Subject|11|||
124948153|NCT00087516|449438094|FG003|Overall Study|Withdrawal by Subject|12|||
124948154|NCT00087516|449438091|FG000|Overall Study|Site terminated|0|||
124948155|NCT00087516|449438092|FG001|Overall Study|Site terminated|2|||
124948156|NCT00087516|449438093|FG002|Overall Study|Site terminated|1|||
124948157|NCT00087516|449438094|FG003|Overall Study|Site terminated|0|||
124948158|NCT00087516|449438091|FG000|Overall Study|Protocol specified discontinuation|35|||
124948159|NCT00087516|449438092|FG001|Overall Study|Protocol specified discontinuation|33|||
124948160|NCT00087516|449438093|FG002|Overall Study|Protocol specified discontinuation|33|||
124948161|NCT00087516|449438094|FG003|Overall Study|Protocol specified discontinuation|26|||
124948162|NCT00087516|449438091|FG000|Overall Study|Patient moved|3|||
124948163|NCT00087516|449438092|FG001|Overall Study|Patient moved|2|||
124948164|NCT00087516|449438093|FG002|Overall Study|Patient moved|1|||
124948165|NCT00087516|449438094|FG003|Overall Study|Patient moved|0|||
124948166|NCT00087516|449438091|FG000|Overall Study|Patient was non-compliant|3|||
124948167|NCT00087516|449438092|FG001|Overall Study|Patient was non-compliant|1|||
124948168|NCT00087516|449438093|FG002|Overall Study|Patient was non-compliant|0|||
124948169|NCT00087516|449438094|FG003|Overall Study|Patient was non-compliant|0|||
124948170|NCT00087516|449438091|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
124948171|NCT00087516|449438092|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
124948172|NCT00087516|449438093|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
124948173|NCT00087516|449438094|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
124948174|NCT00087516|449438091|FG000|Overall Study|Other|0|||
124948175|NCT00087516|449438092|FG001|Overall Study|Other|0|||
124948176|NCT00087516|449438093|FG002|Overall Study|Other|1|||
124948177|NCT00087516|449438094|FG003|Overall Study|Other|0|||
124948178|NCT02065895|449438095|FG000|Overall Study|Protocol Violation|1|||
124948179|NCT02065895|449438096|FG001|Overall Study|Protocol Violation|0|||
124948180|NCT02065895|449438097|FG002|Overall Study|Protocol Violation|0|||
124948181|NCT02065895|449438098|FG003|Overall Study|Protocol Violation|1|||
124948182|NCT02065895|449438099|FG004|Overall Study|Protocol Violation|0|||
124948183|NCT02065895|449438100|FG005|Overall Study|Protocol Violation|0|||
124948184|NCT02065895|449438095|FG000|Overall Study|Scheduling conflicts|0|||
124948185|NCT02065895|449438096|FG001|Overall Study|Scheduling conflicts|1|||
124948186|NCT02065895|449438097|FG002|Overall Study|Scheduling conflicts|0|||
124948187|NCT02065895|449438098|FG003|Overall Study|Scheduling conflicts|0|||
124948188|NCT02065895|449438099|FG004|Overall Study|Scheduling conflicts|0|||
124948189|NCT02065895|449438100|FG005|Overall Study|Scheduling conflicts|0|||
124948190|NCT00569166|449438105|FG000|Overall Study|Withdrawal by Subject|7|||
124948191|NCT00569166|449438106|FG001|Overall Study|Withdrawal by Subject|5|||
124948192|NCT00569166|449438107|FG002|Overall Study|Withdrawal by Subject|3|||
124948193|NCT00569166|449438105|FG000|Overall Study|Lost to Follow-up|2|||
124948194|NCT00569166|449438106|FG001|Overall Study|Lost to Follow-up|1|||
124948195|NCT00569166|449438107|FG002|Overall Study|Lost to Follow-up|1|||
124948196|NCT05005247|449438108|FG000|Overall Study|Withdrawal by Subject|0|||
124948197|NCT05005247|449438109|FG001|Overall Study|Withdrawal by Subject|1|||
124948198|NCT05005247|449438110|FG002|Overall Study|Withdrawal by Subject|0|||
124459071|NCT01225731|447640541|FG002|Part 3|Withdrawal by Subject|0|||
124459072|NCT01225731|447640542|FG003|Part 3|Withdrawal by Subject|0|||
124459073|NCT01225731|447640543|FG004|Part 3|Withdrawal by Subject|0|||
124459074|NCT01225731|447640544|FG005|Part 3|Withdrawal by Subject|0|||
124459075|NCT01225731|447640545|FG006|Part 3|Withdrawal by Subject|0|||
124459076|NCT01225731|447640546|FG007|Part 3|Withdrawal by Subject|0|||
124459077|NCT01225731|447640547|FG008|Part 3|Withdrawal by Subject|0|||
124459078|NCT01225731|447640548|FG009|Part 3|Withdrawal by Subject|0|||
124459079|NCT01225731|447640549|FG010|Part 3|Withdrawal by Subject|4|||
124459080|NCT01225731|447640550|FG011|Part 3|Withdrawal by Subject|6|||
124948199|NCT00484198|449438111|FG000|Overall Study|Participant Withdrew Consent|12|||
124948200|NCT00484198|449438112|FG001|Overall Study|Participant Withdrew Consent|21|||
124948201|NCT00484198|449438113|FG002|Overall Study|Participant Withdrew Consent|47|||
124948202|NCT00484198|449438114|FG003|Overall Study|Participant Withdrew Consent|59|||
124948203|NCT00484198|449438111|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
124948204|NCT00484198|449438112|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
124948205|NCT00484198|449438113|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
124948206|NCT00484198|449438114|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
124948207|NCT00484198|449438111|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
124948208|NCT00484198|449438112|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
124948209|NCT00484198|449438113|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
124459081|NCT01225731|447640551|FG012|Part 3|Withdrawal by Subject|4|||
124459082|NCT00917150|447640556|FG000|Overall Study|Adverse Event|12|||
124459083|NCT00917150|447640557|FG001|Overall Study|Adverse Event|7|||
124459084|NCT00917150|447640558|FG002|Overall Study|Adverse Event|12|||
124459085|NCT00917150|447640559|FG003|Overall Study|Adverse Event|11|||
124459086|NCT00917150|447640556|FG000|Overall Study|Death|1|||
124459087|NCT00917150|447640557|FG001|Overall Study|Death|4|||
124459088|NCT00917150|447640558|FG002|Overall Study|Death|3|||
124459089|NCT00917150|447640559|FG003|Overall Study|Death|2|||
124459090|NCT00917150|447640556|FG000|Overall Study|Lost to Follow-up|1|||
124459091|NCT00917150|447640557|FG001|Overall Study|Lost to Follow-up|0|||
124459092|NCT00917150|447640558|FG002|Overall Study|Lost to Follow-up|4|||
124459093|NCT00917150|447640559|FG003|Overall Study|Lost to Follow-up|2|||
124459094|NCT00917150|447640556|FG000|Overall Study|Physician Decision|0|||
124459095|NCT00917150|447640557|FG001|Overall Study|Physician Decision|2|||
124459096|NCT00917150|447640558|FG002|Overall Study|Physician Decision|0|||
124459097|NCT00917150|447640559|FG003|Overall Study|Physician Decision|1|||
124459098|NCT00917150|447640556|FG000|Overall Study|Protocol Violation|5|||
124459099|NCT00917150|447640557|FG001|Overall Study|Protocol Violation|5|||
124459100|NCT00917150|447640558|FG002|Overall Study|Protocol Violation|3|||
124459101|NCT00917150|447640559|FG003|Overall Study|Protocol Violation|5|||
124548367|NCT02860039|447962580|FG001|Overall Study|Withdrawal by Subject|0|||
124548368|NCT02860039|447962579|FG000|Overall Study|Not otherwise eligible|1|||
124548369|NCT02860039|447962580|FG001|Overall Study|Not otherwise eligible|1|||
124948210|NCT00484198|449438114|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
124948211|NCT00484198|449438111|FG000|Overall Study|Adverse Event|3|||
124948212|NCT00484198|449438112|FG001|Overall Study|Adverse Event|11|||
124948213|NCT00484198|449438113|FG002|Overall Study|Adverse Event|32|||
124948214|NCT00484198|449438114|FG003|Overall Study|Adverse Event|31|||
124948215|NCT00484198|449438111|FG000|Overall Study|Protocol Violation|0|||
124948216|NCT00484198|449438112|FG001|Overall Study|Protocol Violation|5|||
124948217|NCT00484198|449438113|FG002|Overall Study|Protocol Violation|6|||
124948218|NCT00484198|449438114|FG003|Overall Study|Protocol Violation|8|||
124948219|NCT00484198|449438111|FG000|Overall Study|Other|7|||
124948220|NCT00484198|449438112|FG001|Overall Study|Other|10|||
124948221|NCT00484198|449438113|FG002|Overall Study|Other|31|||
124948222|NCT00484198|449438114|FG003|Overall Study|Other|28|||
124948223|NCT00486954|449438116|FG000|Pilot Part|Adverse Event|4|||
124948224|NCT00486954|449438117|FG001|Pilot Part|Adverse Event|0|||
124948225|NCT00486954|449438118|FG002|Pilot Part|Adverse Event|5|||
124948226|NCT00486954|449438119|FG003|Pilot Part|Adverse Event|0|||
124948227|NCT00486954|449438120|FG004|Pilot Part|Adverse Event|0|||
124948228|NCT00486954|449438116|FG000|Pilot Part|Disease Progression|2|||
124948229|NCT00486954|449438117|FG001|Pilot Part|Disease Progression|0|||
124948230|NCT00486954|449438118|FG002|Pilot Part|Disease Progression|1|||
124948231|NCT00486954|449438119|FG003|Pilot Part|Disease Progression|0|||
124948232|NCT00486954|449438120|FG004|Pilot Part|Disease Progression|0|||
124948233|NCT00486954|449438116|FG000|Randomized Part|Lost to Follow-up|0|||
124459102|NCT00917150|447640556|FG000|Overall Study|Withdrawal by Subject|15|||
124459103|NCT00917150|447640557|FG001|Overall Study|Withdrawal by Subject|16|||
124459104|NCT00917150|447640558|FG002|Overall Study|Withdrawal by Subject|18|||
124948234|NCT00486954|449438117|FG001|Randomized Part|Lost to Follow-up|0|||
124948235|NCT00486954|449438118|FG002|Randomized Part|Lost to Follow-up|0|||
124948236|NCT00486954|449438119|FG003|Randomized Part|Lost to Follow-up|0|||
124459105|NCT00917150|447640559|FG003|Overall Study|Withdrawal by Subject|11|||
124548370|NCT01360021|447962581|FG000|Overall Study|Eligibility criteria + other|2|||
124948237|NCT00486954|449438120|FG004|Randomized Part|Lost to Follow-up|1|||
124706316|NCT04583618|448549931|FG003|Overall Study|Withdrawal by Subject|1|||
124706317|NCT04583618|448549932|FG004|Overall Study|Withdrawal by Subject|1|||
124706318|NCT04583618|448549928|FG000|Overall Study|Lost to Follow-up|0|||
124706319|NCT04583618|448549929|FG001|Overall Study|Lost to Follow-up|1|||
124706320|NCT04583618|448549930|FG002|Overall Study|Lost to Follow-up|3|||
124706321|NCT04583618|448549931|FG003|Overall Study|Lost to Follow-up|1|||
124706322|NCT04583618|448549932|FG004|Overall Study|Lost to Follow-up|1|||
124706323|NCT02711202|448549933|FG000|Overall Study|Adverse Event|3|||
124706324|NCT02711202|448549934|FG001|Overall Study|Adverse Event|0|||
124706325|NCT02711202|448549933|FG000|Overall Study|graft loss|1|||
124706326|NCT02711202|448549934|FG001|Overall Study|graft loss|0|||
124706327|NCT03189719|448549938|FG000|Overall Study|Death|325|||
124706328|NCT03189719|448549939|FG001|Overall Study|Death|361|||
124706329|NCT03189719|448549938|FG000|Overall Study|Physician Decision|1|||
124706330|NCT03189719|448549939|FG001|Overall Study|Physician Decision|0|||
124706331|NCT03189719|448549938|FG000|Overall Study|Sponsor Decision|40|||
124706332|NCT03189719|448549939|FG001|Overall Study|Sponsor Decision|12|||
124706333|NCT03189719|448549938|FG000|Overall Study|Withdrawal by Subject|7|||
124706334|NCT03189719|448549939|FG001|Overall Study|Withdrawal by Subject|3|||
124706335|NCT03448393|448549940|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
124948238|NCT00486954|449438116|FG000|Randomized Part|Withdrawal by Subject|0|||
124948239|NCT00486954|449438117|FG001|Randomized Part|Withdrawal by Subject|0|||
124706336|NCT03448393|448549941|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
124948240|NCT00486954|449438118|FG002|Randomized Part|Withdrawal by Subject|0|||
124948241|NCT00486954|449438119|FG003|Randomized Part|Withdrawal by Subject|1|||
124948242|NCT00486954|449438120|FG004|Randomized Part|Withdrawal by Subject|0|||
124948243|NCT00486954|449438116|FG000|Randomized Part|Sponsor Terminated Study|0|||
124948244|NCT00486954|449438117|FG001|Randomized Part|Sponsor Terminated Study|0|||
124948245|NCT00486954|449438118|FG002|Randomized Part|Sponsor Terminated Study|0|||
124948246|NCT00486954|449438119|FG003|Randomized Part|Sponsor Terminated Study|19|||
124948247|NCT00486954|449438120|FG004|Randomized Part|Sponsor Terminated Study|13|||
124948248|NCT00929526|449438121|FG000|Overall Study|Withdrawal by Subject|1|||
124948249|NCT00929526|449438122|FG001|Overall Study|Withdrawal by Subject|11|||
124948250|NCT00929526|449438121|FG000|Overall Study|Lost to Follow-up|8|||
124948251|NCT00929526|449438122|FG001|Overall Study|Lost to Follow-up|12|||
124706337|NCT03448393|448549942|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
124948252|NCT00929526|449438121|FG000|Overall Study|Other|8|||
124948253|NCT00929526|449438122|FG001|Overall Study|Other|6|||
124948254|NCT01836523|449438123|FG000|Overall Study|Adverse Event|15|||
124948255|NCT01836523|449438124|FG001|Overall Study|Adverse Event|41|||
124948256|NCT01836523|449438125|FG002|Overall Study|Adverse Event|49|||
124948257|NCT01836523|449438126|FG003|Overall Study|Adverse Event|14|||
124948258|NCT01836523|449438123|FG000|Overall Study|Protocol Violation|6|||
124948259|NCT01836523|449438124|FG001|Overall Study|Protocol Violation|3|||
124948260|NCT01836523|449438125|FG002|Overall Study|Protocol Violation|2|||
124948261|NCT01836523|449438126|FG003|Overall Study|Protocol Violation|4|||
124948262|NCT01836523|449438123|FG000|Overall Study|Met Withdrawal Criteria|13|||
124948263|NCT01836523|449438124|FG001|Overall Study|Met Withdrawal Criteria|13|||
124948264|NCT01836523|449438125|FG002|Overall Study|Met Withdrawal Criteria|21|||
124948265|NCT01836523|449438126|FG003|Overall Study|Met Withdrawal Criteria|27|||
124706338|NCT03448393|448549943|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
124706339|NCT03448393|448549944|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
124706340|NCT03448393|448549945|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
124706341|NCT03448393|448549946|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
124706342|NCT03448393|448549947|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
124706343|NCT03448393|448549948|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
124706344|NCT03448393|448549940|FG000|Dose Expansion|Not treated - screen failure|0|||
124706345|NCT03448393|448549941|FG001|Dose Expansion|Not treated - screen failure|0|||
124706346|NCT03448393|448549942|FG002|Dose Expansion|Not treated - screen failure|0|||
124706347|NCT03448393|448549943|FG003|Dose Expansion|Not treated - screen failure|0|||
124706348|NCT03448393|448549944|FG004|Dose Expansion|Not treated - screen failure|0|||
124706349|NCT03448393|448549945|FG005|Dose Expansion|Not treated - screen failure|0|||
124706350|NCT03448393|448549946|FG006|Dose Expansion|Not treated - screen failure|0|||
124706351|NCT03448393|448549947|FG007|Dose Expansion|Not treated - screen failure|0|||
124706352|NCT03448393|448549948|FG008|Dose Expansion|Not treated - screen failure|7|||
124706353|NCT03330847|448549949|FG000|Overall Study|Patients ongoing study|62|||
124706354|NCT03330847|448549950|FG001|Overall Study|Patients ongoing study|65|||
124706355|NCT03330847|448549951|FG002|Overall Study|Patients ongoing study|15|||
124706356|NCT01355627|448549952|FG000|Overall Study|Request By the Patient to Discontinue|5|||
124706357|NCT01355627|448549953|FG001|Overall Study|Request By the Patient to Discontinue|7|||
124706358|NCT01355627|448549952|FG000|Overall Study|Lost to Follow-up|8|||
124706359|NCT01355627|448549953|FG001|Overall Study|Lost to Follow-up|7|||
124706360|NCT01355627|448549952|FG000|Overall Study|Fatal Adverse Event|19|||
124948266|NCT01836523|449438123|FG000|Overall Study|Unclassified|17|||
124548371|NCT01360021|447962582|FG001|Overall Study|Eligibility criteria + other|1|||
124548372|NCT01360021|447962583|FG002|Overall Study|Eligibility criteria + other|1|||
124706361|NCT01355627|448549953|FG001|Overall Study|Fatal Adverse Event|23|||
124948267|NCT01836523|449438124|FG001|Overall Study|Unclassified|28|||
124948268|NCT01836523|449438125|FG002|Overall Study|Unclassified|19|||
124948269|NCT01836523|449438126|FG003|Overall Study|Unclassified|29|||
124948270|NCT00813709|449438129|FG000|Double Blind Period|Adverse Event|4|||
124948271|NCT00813709|449438130|FG001|Double Blind Period|Adverse Event|1|||
124948272|NCT00813709|449438131|FG002|Double Blind Period|Adverse Event|4|||
124948273|NCT00813709|449438132|FG003|Double Blind Period|Adverse Event|0|||
124948274|NCT00813709|449438133|FG004|Double Blind Period|Adverse Event|0|||
124948275|NCT00813709|449438134|FG005|Double Blind Period|Adverse Event|0|||
124948276|NCT00813709|449438129|FG000|Double Blind Period|Lost to Follow-up|3|||
124948277|NCT00813709|449438130|FG001|Double Blind Period|Lost to Follow-up|2|||
124948278|NCT00813709|449438131|FG002|Double Blind Period|Lost to Follow-up|2|||
124948279|NCT00813709|449438132|FG003|Double Blind Period|Lost to Follow-up|0|||
124948280|NCT00813709|449438133|FG004|Double Blind Period|Lost to Follow-up|0|||
124948281|NCT00813709|449438134|FG005|Double Blind Period|Lost to Follow-up|0|||
124948282|NCT00813709|449438129|FG000|Double Blind Period|Switched to open label phase|9|||
124948283|NCT00813709|449438130|FG001|Double Blind Period|Switched to open label phase|26|||
124948284|NCT00813709|449438131|FG002|Double Blind Period|Switched to open label phase|18|||
124948285|NCT00813709|449438132|FG003|Double Blind Period|Switched to open label phase|0|||
124948286|NCT00813709|449438133|FG004|Double Blind Period|Switched to open label phase|0|||
124948287|NCT00813709|449438134|FG005|Double Blind Period|Switched to open label phase|0|||
124948288|NCT00813709|449438129|FG000|Double Blind Period|Randomized but not treated|1|||
124948289|NCT00813709|449438130|FG001|Double Blind Period|Randomized but not treated|3|||
124948290|NCT00813709|449438131|FG002|Double Blind Period|Randomized but not treated|1|||
124948291|NCT00813709|449438132|FG003|Double Blind Period|Randomized but not treated|0|||
124948292|NCT00813709|449438133|FG004|Double Blind Period|Randomized but not treated|0|||
124948293|NCT00813709|449438134|FG005|Double Blind Period|Randomized but not treated|0|||
124948294|NCT00813709|449438129|FG000|Double Blind Period|Other|14|||
124948295|NCT00813709|449438130|FG001|Double Blind Period|Other|9|||
124948296|NCT00813709|449438131|FG002|Double Blind Period|Other|6|||
124948297|NCT00813709|449438132|FG003|Double Blind Period|Other|0|||
124948298|NCT00813709|449438133|FG004|Double Blind Period|Other|0|||
124948299|NCT00813709|449438134|FG005|Double Blind Period|Other|0|||
124948300|NCT00813709|449438129|FG000|Open Label Period|Adverse Event|0|||
124948301|NCT00813709|449438130|FG001|Open Label Period|Adverse Event|0|||
124948302|NCT00813709|449438131|FG002|Open Label Period|Adverse Event|0|||
124948303|NCT00813709|449438132|FG003|Open Label Period|Adverse Event|5|||
124948304|NCT00813709|449438133|FG004|Open Label Period|Adverse Event|4|||
124948305|NCT00813709|449438134|FG005|Open Label Period|Adverse Event|3|||
124948306|NCT00813709|449438129|FG000|Open Label Period|Lack of Efficacy|0|||
124948307|NCT00813709|449438130|FG001|Open Label Period|Lack of Efficacy|0|||
124459106|NCT00917150|447640556|FG000|Overall Study|Other than specified|3|||
124459107|NCT00917150|447640557|FG001|Overall Study|Other than specified|3|||
124459108|NCT00917150|447640558|FG002|Overall Study|Other than specified|2|||
124459109|NCT00917150|447640559|FG003|Overall Study|Other than specified|2|||
124459110|NCT03891264|447640560|FG000|Overall Study|Adverse Event|1|||
124459111|NCT03891264|447640560|FG000|Overall Study|Withdrawal by Subject|2|||
124459112|NCT03891264|447640560|FG000|Overall Study|Physician Decision|2|||
124459113|NCT01692275|447640561|FG000|Overall Study|Lost to Follow-up|57|||
124459114|NCT01692275|447640562|FG001|Overall Study|Lost to Follow-up|48|||
124548373|NCT01360021|447962581|FG000|Overall Study|Protocol Violation|0|||
124548374|NCT01360021|447962582|FG001|Overall Study|Protocol Violation|0|||
124948308|NCT00813709|449438131|FG002|Open Label Period|Lack of Efficacy|0|||
124948309|NCT00813709|449438132|FG003|Open Label Period|Lack of Efficacy|3|||
124948310|NCT00813709|449438133|FG004|Open Label Period|Lack of Efficacy|1|||
124948311|NCT00813709|449438134|FG005|Open Label Period|Lack of Efficacy|1|||
124948312|NCT00813709|449438129|FG000|Open Label Period|Randomized but not treated|0|||
124948313|NCT00813709|449438130|FG001|Open Label Period|Randomized but not treated|0|||
124948314|NCT00813709|449438131|FG002|Open Label Period|Randomized but not treated|0|||
124948315|NCT00813709|449438132|FG003|Open Label Period|Randomized but not treated|1|||
124948316|NCT00813709|449438133|FG004|Open Label Period|Randomized but not treated|0|||
124948317|NCT00813709|449438134|FG005|Open Label Period|Randomized but not treated|1|||
124948318|NCT00813709|449438129|FG000|Open Label Period|Other|0|||
124948319|NCT00813709|449438130|FG001|Open Label Period|Other|0|||
124948320|NCT00813709|449438131|FG002|Open Label Period|Other|0|||
124948321|NCT00813709|449438132|FG003|Open Label Period|Other|11|||
124948322|NCT00813709|449438133|FG004|Open Label Period|Other|5|||
124948323|NCT00813709|449438134|FG005|Open Label Period|Other|6|||
124948324|NCT02753075|449438135|FG000|Overall Study|Adverse Event|2|||
124948325|NCT02753075|449438136|FG001|Overall Study|Adverse Event|1|||
124948326|NCT02753075|449438137|FG002|Overall Study|Adverse Event|0|||
124948327|NCT02753075|449438135|FG000|Overall Study|Lost to Follow-up|2|||
124548375|NCT01360021|447962583|FG002|Overall Study|Protocol Violation|1|||
124548376|NCT01360021|447962581|FG000|Overall Study|Withdrawal by Subject|4|||
124548377|NCT01360021|447962582|FG001|Overall Study|Withdrawal by Subject|0|||
124548378|NCT01360021|447962583|FG002|Overall Study|Withdrawal by Subject|2|||
124548379|NCT01360021|447962581|FG000|Overall Study|Adverse Event|2|||
124548380|NCT01360021|447962582|FG001|Overall Study|Adverse Event|3|||
124548381|NCT01360021|447962583|FG002|Overall Study|Adverse Event|3|||
124548382|NCT01257737|447962585|FG000|Overall Study|Lost to Follow-up|1|||
124548383|NCT01257737|447962586|FG001|Overall Study|Lost to Follow-up|2|||
124548384|NCT01257737|447962585|FG000|Overall Study|Liver transplant|1|||
124548385|NCT01257737|447962586|FG001|Overall Study|Liver transplant|0|||
124548386|NCT01257737|447962585|FG000|Overall Study|Relocation out of the country|0|||
124548387|NCT01257737|447962586|FG001|Overall Study|Relocation out of the country|1|||
124548388|NCT01257737|447962585|FG000|Overall Study|Withdrew from study|0|||
124548389|NCT01257737|447962586|FG001|Overall Study|Withdrew from study|1|||
124548390|NCT03170271|447962590|FG000|Overall Study|Adverse Event|7|||
124548391|NCT03170271|447962591|FG001|Overall Study|Adverse Event|2|||
124548392|NCT03170271|447962590|FG000|Overall Study|Lost to Follow-up|0|||
124548393|NCT03170271|447962591|FG001|Overall Study|Lost to Follow-up|1|||
124548394|NCT03170271|447962590|FG000|Overall Study|Physician Decision|1|||
124548395|NCT03170271|447962591|FG001|Overall Study|Physician Decision|0|||
124548396|NCT03170271|447962590|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
124548397|NCT03170271|447962591|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
124548398|NCT03170271|447962590|FG000|Overall Study|Withdrawal by Subject|17|||
124548399|NCT03170271|447962591|FG001|Overall Study|Withdrawal by Subject|5|||
124548400|NCT03170271|447962590|FG000|Overall Study|Other|2|||
124948328|NCT02753075|449438136|FG001|Overall Study|Lost to Follow-up|0|||
124948329|NCT02753075|449438137|FG002|Overall Study|Lost to Follow-up|0|||
124948330|NCT02753075|449438135|FG000|Overall Study|Withdrawal of Consent|1|||
124548401|NCT03170271|447962591|FG001|Overall Study|Other|2|||
124548402|NCT03170271|447962590|FG000|Overall Study|Randomized in error|4|||
124548403|NCT03170271|447962591|FG001|Overall Study|Randomized in error|0|||
124548404|NCT04935931|447962594|FG000|Overall Study|Withdrawal by Subject|1|||
124948331|NCT02753075|449438136|FG001|Overall Study|Withdrawal of Consent|1|||
124948332|NCT02753075|449438137|FG002|Overall Study|Withdrawal of Consent|3|||
124948333|NCT02753075|449438135|FG000|Overall Study|Physician Decision|3|||
124948334|NCT02753075|449438136|FG001|Overall Study|Physician Decision|1|||
124948335|NCT02753075|449438137|FG002|Overall Study|Physician Decision|0|||
124948336|NCT02245620|449438138|FG000|Overall Study|Physician Decision|1|||
124948337|NCT02245620|449438139|FG001|Overall Study|Physician Decision|1|||
124948338|NCT01102426|449438140|FG000|Overall Study|Randomized but not treated|4|||
124948339|NCT01102426|449438141|FG001|Overall Study|Randomized but not treated|1|||
124948340|NCT01102426|449438140|FG000|Overall Study|Adverse Events (treatment-related)|15|||
124948341|NCT01102426|449438141|FG001|Overall Study|Adverse Events (treatment-related)|8|||
124948342|NCT01102426|449438140|FG000|Overall Study|Physician Decision|9|||
124948343|NCT01102426|449438141|FG001|Overall Study|Physician Decision|6|||
124948344|NCT01102426|449438140|FG000|Overall Study|Progressive Disease|85|||
124948345|NCT01102426|449438141|FG001|Overall Study|Progressive Disease|44|||
124948346|NCT01102426|449438140|FG000|Overall Study|Adverse Events (unrelated to|9|||
124948347|NCT01102426|449438141|FG001|Overall Study|Adverse Events (unrelated to|1|||
124948348|NCT01102426|449438140|FG000|Overall Study|Patient Refusal|24|||
124948349|NCT01102426|449438141|FG001|Overall Study|Patient Refusal|12|||
124948350|NCT01102426|449438140|FG000|Overall Study|Death (due to adverse events|0|||
124948351|NCT01102426|449438141|FG001|Overall Study|Death (due to adverse events|1|||
124948352|NCT01102426|449438140|FG000|Overall Study|Death (non-related to the study|19|||
124948353|NCT01102426|449438141|FG001|Overall Study|Death (non-related to the study|8|||
124948354|NCT00889863|449438142|FG000|Part I: Open Label|Death|1|||
124948355|NCT00889863|449438143|FG001|Part I: Open Label|Death|0|||
124948356|NCT00889863|449438142|FG000|Part I: Open Label|Adverse Event|4|||
124948357|NCT00889863|449438143|FG001|Part I: Open Label|Adverse Event|0|||
124948358|NCT00889863|449438142|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
124948359|NCT00889863|449438143|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
124548405|NCT05168657|447962595|FG000|Overall Study|Adverse Event|0|||
124548406|NCT05168657|447962596|FG001|Overall Study|Adverse Event|0|||
124548407|NCT05168657|447962597|FG002|Overall Study|Adverse Event|1|||
124548408|NCT05168657|447962598|FG003|Overall Study|Adverse Event|0|||
124548409|NCT05168657|447962599|FG004|Overall Study|Adverse Event|0|||
124948360|NCT00889863|449438142|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
124948361|NCT00889863|449438143|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
124948362|NCT00889863|449438142|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
124548410|NCT05168657|447962600|FG005|Overall Study|Adverse Event|0|||
124948363|NCT00889863|449438143|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
124548411|NCT05168657|447962601|FG006|Overall Study|Adverse Event|0|||
124548412|NCT05168657|447962602|FG007|Overall Study|Adverse Event|0|||
124548413|NCT00424632|447962605|FG000|Overall Study|Death|0|||
124548414|NCT00424632|447962606|FG001|Overall Study|Death|0|||
124548415|NCT00424632|447962607|FG002|Overall Study|Death|0|||
124548416|NCT00424632|447962608|FG003|Overall Study|Death|0|||
124548417|NCT00424632|447962609|FG004|Overall Study|Death|0|||
124548418|NCT00424632|447962610|FG005|Overall Study|Death|2|||
124548419|NCT00424632|447962611|FG006|Overall Study|Death|0|||
124548420|NCT00424632|447962612|FG007|Overall Study|Death|0|||
124548421|NCT00424632|447962613|FG008|Overall Study|Death|0|||
124548422|NCT00424632|447962614|FG009|Overall Study|Death|0|||
124548423|NCT00424632|447962605|FG000|Overall Study|Adverse Event|0|||
124548424|NCT00424632|447962606|FG001|Overall Study|Adverse Event|0|||
124706362|NCT01355627|448549952|FG000|Overall Study|Other|1|||
124706363|NCT01355627|448549953|FG001|Overall Study|Other|1|||
124706364|NCT02293551|448549956|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
124706365|NCT02293551|448549957|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
124706366|NCT02293551|448549958|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
124548425|NCT00424632|447962607|FG002|Overall Study|Adverse Event|0|||
124548426|NCT00424632|447962608|FG003|Overall Study|Adverse Event|0|||
124706367|NCT02293551|448549959|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
124548427|NCT00424632|447962609|FG004|Overall Study|Adverse Event|0|||
124948364|NCT00889863|449438142|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
124948365|NCT00889863|449438143|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
124948366|NCT00889863|449438142|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
124948367|NCT00889863|449438143|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
124948368|NCT04361617|449438144|FG000|Overall Study|Withdrawal by Subject|0|||
124948369|NCT04361617|449438145|FG001|Overall Study|Withdrawal by Subject|1|||
124948370|NCT00930644|449438146|FG000|Overall Study|Withdrawal by Subject|4|||
124948371|NCT00930644|449438146|FG000|Overall Study|Physician Decision|2|||
124948372|NCT00930644|449438146|FG000|Overall Study|Death|1|||
124948373|NCT00930644|449438146|FG000|Overall Study|Adverse Event|16|||
124948374|NCT01918033|449438148|FG000|Overall Study|Adverse Event|1|||
124948375|NCT01918033|449438149|FG001|Overall Study|Adverse Event|0|||
124948376|NCT01918033|449438150|FG002|Overall Study|Adverse Event|2|||
124948377|NCT01918033|449438148|FG000|Overall Study|Lost to Follow-up|0|||
124948378|NCT01918033|449438149|FG001|Overall Study|Lost to Follow-up|1|||
124948379|NCT01918033|449438150|FG002|Overall Study|Lost to Follow-up|0|||
124948380|NCT01918033|449438148|FG000|Overall Study|Protocol Violation|2|||
124948381|NCT01918033|449438149|FG001|Overall Study|Protocol Violation|0|||
124948382|NCT01918033|449438150|FG002|Overall Study|Protocol Violation|1|||
124948383|NCT01918033|449438148|FG000|Overall Study|Withdrawal by Subject|2|||
124948384|NCT01918033|449438149|FG001|Overall Study|Withdrawal by Subject|1|||
124948385|NCT01918033|449438150|FG002|Overall Study|Withdrawal by Subject|0|||
124948386|NCT03259568|449438158|FG000|Overall Study|Participant performance was low|3|||
124948387|NCT03136861|449438159|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
124948388|NCT03136861|449438160|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
124948389|NCT03136861|449438161|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
124948390|NCT03136861|449438162|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
124948391|NCT03136861|449438163|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
124948392|NCT03136861|449438164|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
124948393|NCT03136861|449438165|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
124948394|NCT03136861|449438159|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
124948395|NCT03136861|449438160|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
124948396|NCT03136861|449438161|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
124948397|NCT03136861|449438162|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
124948398|NCT03136861|449438163|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
124948399|NCT03136861|449438164|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
124948400|NCT03136861|449438165|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
124948401|NCT03136861|449438159|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
124948402|NCT03136861|449438160|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
124948403|NCT03136861|449438161|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
124948404|NCT03136861|449438162|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
124948405|NCT03136861|449438163|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
124948406|NCT03136861|449438164|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
124948407|NCT03136861|449438165|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
124948408|NCT03136861|449438159|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
124948409|NCT03136861|449438160|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
124948410|NCT03136861|449438161|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
124948411|NCT03136861|449438162|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
124948412|NCT03136861|449438163|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
124948413|NCT03136861|449438164|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
124948414|NCT03136861|449438165|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
124948415|NCT03136861|449438159|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
124948416|NCT03136861|449438160|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
124948417|NCT03136861|449438161|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
124948418|NCT03136861|449438162|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
124948419|NCT03136861|449438163|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
124948420|NCT03136861|449438164|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
124948421|NCT03136861|449438165|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
124948422|NCT03136861|449438159|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
124948423|NCT03136861|449438160|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
124948424|NCT03136861|449438161|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
124948425|NCT03136861|449438162|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
124948426|NCT03136861|449438163|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
124948427|NCT03136861|449438164|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
124948428|NCT03136861|449438165|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
124948429|NCT03136861|449438159|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
124948430|NCT03136861|449438160|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
124948431|NCT03136861|449438161|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
124948432|NCT03136861|449438162|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
124948433|NCT03136861|449438163|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
124948434|NCT03136861|449438164|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
124948435|NCT03136861|449438165|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
124948436|NCT03136861|449438159|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
124948437|NCT03136861|449438160|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
124948438|NCT03136861|449438161|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
124948439|NCT03136861|449438162|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
124948440|NCT03136861|449438163|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
124948441|NCT03136861|449438164|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
124948442|NCT03136861|449438165|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
124948443|NCT03200574|449438181|FG000|Overall Study|Death|4|||
124948444|NCT03200574|449438181|FG000|Overall Study|Withdrawal by Subject|8|||
124948445|NCT03200574|449438181|FG000|Overall Study|Long-Term need for anticoagulation|1|||
124948446|NCT03200574|449438181|FG000|Overall Study|Relocation|2|||
124948447|NCT03200574|449438181|FG000|Overall Study|Lost to Follow-up|2|||
124948448|NCT04183491|449438182|FG000|Overall Study|Withdrawal by Subject|0|||
124948449|NCT04183491|449438183|FG001|Overall Study|Withdrawal by Subject|0|||
124948450|NCT04183491|449438184|FG002|Overall Study|Withdrawal by Subject|1|||
124948451|NCT04183491|449438185|FG003|Overall Study|Withdrawal by Subject|0|||
124948452|NCT04183491|449438186|FG004|Overall Study|Withdrawal by Subject|0|||
124948453|NCT04183491|449438187|FG005|Overall Study|Withdrawal by Subject|1|||
124948454|NCT04183491|449438188|FG006|Overall Study|Withdrawal by Subject|0|||
124948455|NCT01262456|449438189|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
124948456|NCT01262456|449438190|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
124948457|NCT01262456|449438191|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
124948458|NCT01262456|449438189|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
124948459|NCT01262456|449438190|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
124948460|NCT01262456|449438191|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
124948461|NCT01262456|449438189|FG000|3-Month Double-Blind Period|Adverse Event|6|||
124948462|NCT01262456|449438190|FG001|3-Month Double-Blind Period|Adverse Event|4|||
124948463|NCT01262456|449438191|FG002|3-Month Double-Blind Period|Adverse Event|8|||
124948464|NCT01262456|449438189|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
124948465|NCT01262456|449438190|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
124948466|NCT01262456|449438191|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
124948467|NCT01262456|449438189|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
124948468|NCT01262456|449438190|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
124548428|NCT00424632|447962610|FG005|Overall Study|Adverse Event|0|||
124548429|NCT00424632|447962611|FG006|Overall Study|Adverse Event|0|||
124548430|NCT00424632|447962612|FG007|Overall Study|Adverse Event|0|||
124548431|NCT00424632|447962613|FG008|Overall Study|Adverse Event|3|||
124548432|NCT00424632|447962614|FG009|Overall Study|Adverse Event|2|||
124548433|NCT00424632|447962605|FG000|Overall Study|Global deterioration of health status|0|||
124548434|NCT00424632|447962606|FG001|Overall Study|Global deterioration of health status|0|||
124548435|NCT00424632|447962607|FG002|Overall Study|Global deterioration of health status|0|||
124548436|NCT00424632|447962608|FG003|Overall Study|Global deterioration of health status|1|||
124548437|NCT00424632|447962609|FG004|Overall Study|Global deterioration of health status|1|||
124548438|NCT00424632|447962610|FG005|Overall Study|Global deterioration of health status|0|||
124548439|NCT00424632|447962611|FG006|Overall Study|Global deterioration of health status|0|||
124548440|NCT00424632|447962612|FG007|Overall Study|Global deterioration of health status|0|||
124548441|NCT00424632|447962613|FG008|Overall Study|Global deterioration of health status|0|||
124548442|NCT00424632|447962614|FG009|Overall Study|Global deterioration of health status|0|||
124548443|NCT00424632|447962605|FG000|Overall Study|Objective progression or relapse|1|||
124948469|NCT01262456|449438191|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
124948470|NCT01262456|449438189|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
124948471|NCT01262456|449438190|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
124948472|NCT01262456|449438191|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
124948473|NCT01262456|449438189|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
124948474|NCT01262456|449438190|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
124948475|NCT01262456|449438191|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
124948476|NCT01262456|449438189|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
124948477|NCT01262456|449438190|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
124948478|NCT01262456|449438191|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
124948479|NCT01262456|449438189|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
124948480|NCT01262456|449438190|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
124948481|NCT01262456|449438191|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
124948482|NCT02538094|449438192|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
124948483|NCT02538094|449438193|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
124948484|NCT02538094|449438192|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
124948485|NCT02538094|449438193|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
124948486|NCT03652610|449438199|FG000|Overall Study|Lost to Follow-up|1|||
124948487|NCT03652610|449438200|FG001|Overall Study|Lost to Follow-up|0|||
124948488|NCT03652610|449438199|FG000|Overall Study|Withdrawal by Subject|3|||
124948489|NCT03652610|449438200|FG001|Overall Study|Withdrawal by Subject|5|||
124948490|NCT00326183|449438201|FG000|Overall Study|Lost to Follow-up|104|||
124948491|NCT00326183|449438202|FG001|Overall Study|Lost to Follow-up|56|||
124948492|NCT00326183|449438201|FG000|Overall Study|Protocol Violation|6|||
124948493|NCT00326183|449438202|FG001|Overall Study|Protocol Violation|3|||
124948494|NCT00326183|449438201|FG000|Overall Study|Withdrawal by Subject|35|||
124948495|NCT00326183|449438202|FG001|Overall Study|Withdrawal by Subject|7|||
124948496|NCT00326183|449438201|FG000|Overall Study|Subject Moved|7|||
124948497|NCT00326183|449438202|FG001|Overall Study|Subject Moved|4|||
124948498|NCT00326183|449438201|FG000|Overall Study|Other|47|||
124948499|NCT00326183|449438202|FG001|Overall Study|Other|13|||
124948500|NCT00326183|449438201|FG000|Overall Study|Adverse Event|1|||
124948501|NCT00326183|449438202|FG001|Overall Study|Adverse Event|0|||
124948502|NCT01528605|449438211|FG000|Overall Study|Lost to Follow-up|1|||
124948503|NCT01528605|449438212|FG001|Overall Study|Lost to Follow-up|0|||
124948504|NCT01528605|449438213|FG002|Overall Study|Lost to Follow-up|1|||
124948505|NCT01528605|449438214|FG003|Overall Study|Lost to Follow-up|1|||
124948506|NCT01528605|449438215|FG004|Overall Study|Lost to Follow-up|0|||
124948507|NCT01528605|449438216|FG005|Overall Study|Lost to Follow-up|0|||
124948508|NCT01528605|449438211|FG000|Overall Study|Death|1|||
124948509|NCT01528605|449438212|FG001|Overall Study|Death|0|||
124948510|NCT01528605|449438213|FG002|Overall Study|Death|0|||
124948511|NCT01528605|449438214|FG003|Overall Study|Death|0|||
124948512|NCT01528605|449438215|FG004|Overall Study|Death|0|||
124948513|NCT01528605|449438216|FG005|Overall Study|Death|0|||
124948514|NCT01156675|449438217|FG000|Overall Study|Death|5|||
124948515|NCT01156675|449438218|FG001|Overall Study|Death|3|||
124948516|NCT01156675|449438219|FG002|Overall Study|Death|0|||
124948517|NCT01156675|449438217|FG000|Overall Study|No data|29|||
124548444|NCT00424632|447962606|FG001|Overall Study|Objective progression or relapse|1|||
124948518|NCT01156675|449438218|FG001|Overall Study|No data|22|||
124948519|NCT01156675|449438219|FG002|Overall Study|No data|2|||
124548445|NCT00424632|447962607|FG002|Overall Study|Objective progression or relapse|1|||
124706368|NCT02293551|448549960|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
124706369|NCT02293551|448549961|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
124706370|NCT02293551|448549956|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
124948520|NCT02326220|449438220|FG000|Double-blind Treatment Period|Adverse Event|1|||
124948521|NCT02326220|449438221|FG001|Double-blind Treatment Period|Adverse Event|2|||
124948522|NCT02326220|449438222|FG002|Double-blind Treatment Period|Adverse Event|0|||
124548446|NCT00424632|447962608|FG003|Overall Study|Objective progression or relapse|2|||
124548447|NCT00424632|447962609|FG004|Overall Study|Objective progression or relapse|2|||
124548448|NCT00424632|447962610|FG005|Overall Study|Objective progression or relapse|13|||
124548449|NCT00424632|447962611|FG006|Overall Study|Objective progression or relapse|7|||
124548450|NCT00424632|447962612|FG007|Overall Study|Objective progression or relapse|3|||
124548451|NCT00424632|447962613|FG008|Overall Study|Objective progression or relapse|12|||
124548452|NCT00424632|447962614|FG009|Overall Study|Objective progression or relapse|4|||
124548453|NCT00424632|447962605|FG000|Overall Study|Other|0|||
124548454|NCT00424632|447962606|FG001|Overall Study|Other|0|||
124548455|NCT00424632|447962607|FG002|Overall Study|Other|0|||
124548456|NCT00424632|447962608|FG003|Overall Study|Other|1|||
124548457|NCT00424632|447962609|FG004|Overall Study|Other|0|||
124548458|NCT00424632|447962610|FG005|Overall Study|Other|0|||
124548459|NCT00424632|447962611|FG006|Overall Study|Other|0|||
124548460|NCT00424632|447962612|FG007|Overall Study|Other|0|||
124548461|NCT00424632|447962613|FG008|Overall Study|Other|1|||
124948523|NCT02326220|449438220|FG000|Double-blind Treatment Period|Protocol Violation|0|||
124948524|NCT02326220|449438221|FG001|Double-blind Treatment Period|Protocol Violation|1|||
124948525|NCT02326220|449438222|FG002|Double-blind Treatment Period|Protocol Violation|0|||
124948526|NCT02326220|449438220|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
124948527|NCT02326220|449438221|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
124948528|NCT02326220|449438222|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
124948529|NCT02326220|449438220|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
124948530|NCT02326220|449438221|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
124948531|NCT02326220|449438222|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
124948532|NCT02326220|449438220|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
124948533|NCT02326220|449438221|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
124948534|NCT02326220|449438222|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
124948535|NCT02699099|449438223|FG000|Overall Study|Adverse Event|1|||
124948536|NCT02699099|449438224|FG001|Overall Study|Adverse Event|0|||
124948537|NCT02699099|449438225|FG002|Overall Study|Adverse Event|2|||
124948538|NCT02699099|449438223|FG000|Overall Study|Lost to Follow-up|0|||
124948539|NCT02699099|449438224|FG001|Overall Study|Lost to Follow-up|1|||
124948540|NCT02699099|449438225|FG002|Overall Study|Lost to Follow-up|0|||
124948541|NCT02699099|449438223|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
124948542|NCT02699099|449438224|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
124948543|NCT02699099|449438225|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
124948544|NCT05184062|449438227|FG000|Overall Study|Lost to Follow-up|5|||
124948545|NCT05184062|449438228|FG001|Overall Study|Lost to Follow-up|1|||
124948546|NCT05184062|449438227|FG000|Overall Study|Withdrawal by Subject|1|||
124948547|NCT05184062|449438228|FG001|Overall Study|Withdrawal by Subject|0|||
124948548|NCT03659136|449438233|FG000|Overall Study|Not treated|2|||
124948549|NCT03659136|449438234|FG001|Overall Study|Not treated|0|||
124948550|NCT03659136|449438233|FG000|Overall Study|Covid-19 related|1|||
124948551|NCT03659136|449438234|FG001|Overall Study|Covid-19 related|1|||
124948552|NCT03659136|449438233|FG000|Overall Study|Withdrawal by Subject|1|||
124948553|NCT03659136|449438234|FG001|Overall Study|Withdrawal by Subject|6|||
124948554|NCT03659136|449438233|FG000|Overall Study|Adverse Event|4|||
124948555|NCT03659136|449438234|FG001|Overall Study|Adverse Event|6|||
124948556|NCT03659136|449438233|FG000|Overall Study|Progressive disease|37|||
124948557|NCT03659136|449438234|FG001|Overall Study|Progressive disease|31|||
124948558|NCT03659136|449438233|FG000|Overall Study|Study closure|2|||
124948559|NCT03659136|449438234|FG001|Overall Study|Study closure|2|||
124948560|NCT03659136|449438233|FG000|Overall Study|Sponsor decision/recommendation|3|||
124948561|NCT03659136|449438234|FG001|Overall Study|Sponsor decision/recommendation|2|||
124948562|NCT03659136|449438233|FG000|Overall Study|Switched to other drug/therapy|2|||
124548462|NCT00424632|447962614|FG009|Overall Study|Other|0|||
124548463|NCT01984229|447962615|FG000|Safety Follow-up Period|Adverse Event|1|||
124948563|NCT03659136|449438234|FG001|Overall Study|Switched to other drug/therapy|2|||
124948564|NCT03659136|449438233|FG000|Overall Study|Lack of clinical benefit|0|||
124948565|NCT03659136|449438234|FG001|Overall Study|Lack of clinical benefit|1|||
124948566|NCT02830893|449439983|FG000|Overall Study|Relocation to out of the country|1|||
124948567|NCT02830893|449439984|FG001|Overall Study|Relocation to out of the country|0|||
124948568|NCT02830893|449439983|FG000|Overall Study|Lost to Follow-up|0|||
124548464|NCT01984229|447962616|FG001|Safety Follow-up Period|Adverse Event|1|||
124548465|NCT01984229|447962615|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
124548466|NCT01984229|447962616|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
124548467|NCT02325739|447962619|FG000|Phase I Part|Adverse Event|1|||
124948569|NCT02830893|449439984|FG001|Overall Study|Lost to Follow-up|2|||
124948570|NCT02830893|449439983|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
124948571|NCT02830893|449439984|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
124548468|NCT02325739|447962620|FG001|Phase I Part|Adverse Event|0|||
124948572|NCT01277302|449439985|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
124948573|NCT01277302|449439986|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
124706371|NCT02293551|448549957|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
124706372|NCT02293551|448549958|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
124706373|NCT02293551|448549959|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
124706374|NCT02293551|448549960|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
124706375|NCT02293551|448549961|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
124706376|NCT02293551|448549956|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
124706377|NCT02293551|448549957|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
124706378|NCT02293551|448549958|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
124706379|NCT02293551|448549959|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
124706380|NCT02293551|448549960|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
124706381|NCT02293551|448549961|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
124706382|NCT04756531|448549967|FG000|Overall Study|Adverse Event|0|||
124706383|NCT04756531|448549968|FG001|Overall Study|Adverse Event|0|||
124706384|NCT04756531|448549969|FG002|Overall Study|Adverse Event|0|||
124706385|NCT04756531|448549970|FG003|Overall Study|Adverse Event|0|||
124706386|NCT04756531|448549971|FG004|Overall Study|Adverse Event|1|||
124706387|NCT04756531|448549972|FG005|Overall Study|Adverse Event|0|||
124706388|NCT04756531|448549973|FG006|Overall Study|Adverse Event|0|||
124706389|NCT04756531|448549974|FG007|Overall Study|Adverse Event|0|||
124706390|NCT04756531|448549975|FG008|Overall Study|Adverse Event|0|||
124706391|NCT04756531|448549976|FG009|Overall Study|Adverse Event|0|||
124706392|NCT04756531|448549977|FG010|Overall Study|Adverse Event|0|||
124706393|NCT04756531|448549978|FG011|Overall Study|Adverse Event|0|||
124706394|NCT04756531|448549979|FG012|Overall Study|Adverse Event|0|||
124706395|NCT04756531|448549980|FG013|Overall Study|Adverse Event|0|||
124706396|NCT04756531|448549981|FG014|Overall Study|Adverse Event|0|||
124706397|NCT04756531|448549982|FG015|Overall Study|Adverse Event|0|||
124706398|NCT04756531|448549983|FG016|Overall Study|Adverse Event|0|||
124706399|NCT04756531|448549984|FG017|Overall Study|Adverse Event|0|||
124706400|NCT04756531|448549967|FG000|Overall Study|Withdrawal by Subject|0|||
124706401|NCT04756531|448549968|FG001|Overall Study|Withdrawal by Subject|0|||
124706402|NCT04756531|448549969|FG002|Overall Study|Withdrawal by Subject|0|||
124706403|NCT04756531|448549970|FG003|Overall Study|Withdrawal by Subject|0|||
124706404|NCT04756531|448549971|FG004|Overall Study|Withdrawal by Subject|0|||
124706405|NCT04756531|448549972|FG005|Overall Study|Withdrawal by Subject|0|||
124706406|NCT04756531|448549973|FG006|Overall Study|Withdrawal by Subject|1|||
124706407|NCT04756531|448549974|FG007|Overall Study|Withdrawal by Subject|0|||
124706408|NCT04756531|448549975|FG008|Overall Study|Withdrawal by Subject|0|||
124706409|NCT04756531|448549976|FG009|Overall Study|Withdrawal by Subject|0|||
124706410|NCT04756531|448549977|FG010|Overall Study|Withdrawal by Subject|0|||
124706411|NCT04756531|448549978|FG011|Overall Study|Withdrawal by Subject|0|||
124706412|NCT04756531|448549979|FG012|Overall Study|Withdrawal by Subject|0|||
124948574|NCT01277302|449439987|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
124948575|NCT01277302|449439985|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
124948576|NCT01277302|449439986|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
124948577|NCT01277302|449439987|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
124948578|NCT01277302|449439985|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
124948579|NCT01277302|449439986|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
124948580|NCT01277302|449439987|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
124948581|NCT01277302|449439985|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
124948582|NCT01277302|449439986|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
124948583|NCT01277302|449439987|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
124948584|NCT01277302|449439985|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
124948585|NCT01277302|449439986|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
124948586|NCT01277302|449439987|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
124948587|NCT01277302|449439985|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
124948588|NCT01277302|449439986|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
124948589|NCT01277302|449439987|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
124948590|NCT01277302|449439985|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
124948591|NCT01277302|449439986|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
124948592|NCT01277302|449439987|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
124948593|NCT01277302|449439985|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
124948594|NCT01277302|449439986|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
124948595|NCT01277302|449439987|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
124948596|NCT01277302|449439985|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
124548469|NCT02325739|447962621|FG002|Phase I Part|Adverse Event|1|||
124706413|NCT04756531|448549980|FG013|Overall Study|Withdrawal by Subject|0|||
124706414|NCT04756531|448549981|FG014|Overall Study|Withdrawal by Subject|0|||
124706415|NCT04756531|448549982|FG015|Overall Study|Withdrawal by Subject|0|||
124706416|NCT04756531|448549983|FG016|Overall Study|Withdrawal by Subject|0|||
124706417|NCT04756531|448549984|FG017|Overall Study|Withdrawal by Subject|0|||
124948597|NCT01277302|449439986|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
124948598|NCT01277302|449439987|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
124948599|NCT00731692|449439988|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
124948600|NCT00731692|449439989|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
124948601|NCT00731692|449439990|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
124948602|NCT00731692|449439988|FG000|Core Study (36 Months)|Physician Decision|1|||
124948603|NCT00731692|449439989|FG001|Core Study (36 Months)|Physician Decision|0|||
124948604|NCT00731692|449439990|FG002|Core Study (36 Months)|Physician Decision|2|||
124948605|NCT00731692|449439988|FG000|Core Study (36 Months)|Death|2|||
124948606|NCT00731692|449439989|FG001|Core Study (36 Months)|Death|1|||
124948607|NCT00731692|449439990|FG002|Core Study (36 Months)|Death|2|||
124948608|NCT00731692|449439988|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
124948609|NCT00731692|449439989|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
124948610|NCT00731692|449439990|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
124948611|NCT00731692|449439988|FG000|Core Study (36 Months)|Administrative|2|||
124948612|NCT00731692|449439989|FG001|Core Study (36 Months)|Administrative|2|||
124948613|NCT00731692|449439990|FG002|Core Study (36 Months)|Administrative|6|||
124948614|NCT00731692|449439988|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
124948615|NCT00731692|449439989|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
124948616|NCT00731692|449439990|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
124948617|NCT00731692|449439988|FG000|Core Study (36 Months)|Protocol Violation|4|||
124948618|NCT00731692|449439989|FG001|Core Study (36 Months)|Protocol Violation|5|||
124948619|NCT00731692|449439990|FG002|Core Study (36 Months)|Protocol Violation|8|||
124948620|NCT00731692|449439988|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
124948621|NCT00731692|449439989|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
124948622|NCT00731692|449439990|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
124948623|NCT00731692|449439988|FG000|Core Study (36 Months)|Adverse Event|25|||
124948624|NCT00731692|449439989|FG001|Core Study (36 Months)|Adverse Event|28|||
124948625|NCT00731692|449439990|FG002|Core Study (36 Months)|Adverse Event|29|||
124948626|NCT00731692|449439988|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
124948627|NCT00731692|449439989|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
124948628|NCT00731692|449439990|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
124948629|NCT00731692|449439988|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
124948630|NCT00731692|449439989|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
124948631|NCT00731692|449439990|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
124948632|NCT00731692|449439988|FG000|Extension Phase|Abnormal test procedure|0|||
124948633|NCT00731692|449439989|FG001|Extension Phase|Abnormal test procedure|0|||
124948634|NCT00731692|449439990|FG002|Extension Phase|Abnormal test procedure|1|||
124948635|NCT00731692|449439988|FG000|Extension Phase|Abnormal lab values|0|||
124948636|NCT00731692|449439989|FG001|Extension Phase|Abnormal lab values|0|||
124948637|NCT00731692|449439990|FG002|Extension Phase|Abnormal lab values|1|||
124948638|NCT00731692|449439988|FG000|Extension Phase|Lost to Follow-up|0|||
124948639|NCT00731692|449439989|FG001|Extension Phase|Lost to Follow-up|1|||
124948640|NCT00731692|449439990|FG002|Extension Phase|Lost to Follow-up|4|||
124948641|NCT00731692|449439988|FG000|Extension Phase|Withdrawal by Subject|4|||
124948642|NCT00731692|449439989|FG001|Extension Phase|Withdrawal by Subject|5|||
124948643|NCT00731692|449439990|FG002|Extension Phase|Withdrawal by Subject|3|||
124948644|NCT00731692|449439988|FG000|Extension Phase|Adverse Event|1|||
124948645|NCT00731692|449439989|FG001|Extension Phase|Adverse Event|1|||
124948646|NCT00731692|449439990|FG002|Extension Phase|Adverse Event|15|||
124948647|NCT03332589|449439991|FG000|Overall Study|Lack of Efficacy|2|||
124948648|NCT03332589|449439992|FG001|Overall Study|Lack of Efficacy|0|||
124948649|NCT03332589|449439993|FG002|Overall Study|Lack of Efficacy|0|||
124948650|NCT03332589|449439991|FG000|Overall Study|Adverse Event|1|||
124948651|NCT03332589|449439992|FG001|Overall Study|Adverse Event|0|||
124948652|NCT03332589|449439993|FG002|Overall Study|Adverse Event|0|||
124948653|NCT03332589|449439991|FG000|Overall Study|Death|1|||
124948654|NCT03332589|449439992|FG001|Overall Study|Death|0|||
124706418|NCT05643495|448549985|FG000|Overall Study|Adverse Event|0|||
124706419|NCT05643495|448549986|FG001|Overall Study|Adverse Event|1|||
124948655|NCT03332589|449439993|FG002|Overall Study|Death|0|||
124948656|NCT00108355|449439997|FG000|Overall Study|Peritonitis at index paracentesis|1|||
124948657|NCT00108355|449439998|FG001|Overall Study|Peritonitis at index paracentesis|1|||
124948658|NCT00108355|449439997|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
124948659|NCT00108355|449439998|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
124948660|NCT00647699|449439999|FG000|Overall Study|Lost to Follow-up|5|||
124548470|NCT02325739|447962622|FG003|Phase I Part|Adverse Event|2|||
124706420|NCT05643495|448549985|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
124948661|NCT00647699|449440000|FG001|Overall Study|Lost to Follow-up|4|||
124948662|NCT00647699|449439999|FG000|Overall Study|Withdrawal by Subject|3|||
124948663|NCT00647699|449440000|FG001|Overall Study|Withdrawal by Subject|8|||
124948664|NCT00413283|449440001|FG000|Overall Study|Withdrawal by Subject|1|||
124948665|NCT00413283|449440002|FG001|Overall Study|Withdrawal by Subject|0|||
124948666|NCT00413283|449440003|FG002|Overall Study|Withdrawal by Subject|0|||
124948667|NCT00413283|449440004|FG003|Overall Study|Withdrawal by Subject|1|||
124948668|NCT00413283|449440001|FG000|Overall Study|Death|0|||
124948669|NCT00413283|449440002|FG001|Overall Study|Death|0|||
124948670|NCT00413283|449440003|FG002|Overall Study|Death|1|||
124948671|NCT00413283|449440004|FG003|Overall Study|Death|1|||
124948672|NCT00413283|449440001|FG000|Overall Study|Adverse Event|0|||
124948673|NCT00413283|449440002|FG001|Overall Study|Adverse Event|0|||
124948674|NCT00413283|449440003|FG002|Overall Study|Adverse Event|0|||
124948675|NCT00413283|449440004|FG003|Overall Study|Adverse Event|1|||
124948676|NCT00413283|449440001|FG000|Overall Study|Ineligibility determined|0|||
124948677|NCT00413283|449440002|FG001|Overall Study|Ineligibility determined|0|||
124948678|NCT00413283|449440003|FG002|Overall Study|Ineligibility determined|0|||
124948679|NCT00413283|449440004|FG003|Overall Study|Ineligibility determined|1|||
124948680|NCT00413283|449440001|FG000|Overall Study|Protocol deviation|0|||
124948681|NCT00413283|449440002|FG001|Overall Study|Protocol deviation|1|||
124948682|NCT00413283|449440003|FG002|Overall Study|Protocol deviation|0|||
124948683|NCT00413283|449440004|FG003|Overall Study|Protocol deviation|0|||
124948684|NCT00413283|449440001|FG000|Overall Study|Requirement for alternative therapy|0|||
124948685|NCT00413283|449440002|FG001|Overall Study|Requirement for alternative therapy|2|||
124948686|NCT00413283|449440003|FG002|Overall Study|Requirement for alternative therapy|0|||
124948687|NCT00413283|449440004|FG003|Overall Study|Requirement for alternative therapy|0|||
124948688|NCT00413283|449440001|FG000|Overall Study|Other|0|||
124948689|NCT00413283|449440002|FG001|Overall Study|Other|0|||
124948690|NCT00413283|449440003|FG002|Overall Study|Other|1|||
124948691|NCT00413283|449440004|FG003|Overall Study|Other|0|||
124948692|NCT02354417|449440005|FG000|Overall Study|Physician Decision|1|||
124948693|NCT00246129|449440006|FG000|Overall Study|Lost to Follow-up|1|||
124948694|NCT00246129|449440007|FG001|Overall Study|Lost to Follow-up|0|||
124948695|NCT00246129|449440006|FG000|Overall Study|Death|2|||
124948696|NCT00246129|449440007|FG001|Overall Study|Death|1|||
124948697|NCT00246129|449440006|FG000|Overall Study|suffered primary non-function|1|||
124948698|NCT00246129|449440007|FG001|Overall Study|suffered primary non-function|0|||
124948699|NCT00246129|449440006|FG000|Overall Study|grafts failed|3|||
124948700|NCT00246129|449440007|FG001|Overall Study|grafts failed|1|||
124948701|NCT03469258|449440008|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
124948702|NCT03340961|449440012|FG000|Overall Study|Adverse Event|1|||
124948703|NCT03340961|449440013|FG001|Overall Study|Adverse Event|3|||
124948704|NCT03340961|449440014|FG002|Overall Study|Adverse Event|2|||
124948705|NCT03340961|449440015|FG003|Overall Study|Adverse Event|4|||
124948706|NCT03340961|449440012|FG000|Overall Study|Lost to Follow-up|0|||
124948707|NCT03340961|449440013|FG001|Overall Study|Lost to Follow-up|1|||
124948708|NCT03340961|449440014|FG002|Overall Study|Lost to Follow-up|0|||
124948709|NCT03340961|449440015|FG003|Overall Study|Lost to Follow-up|1|||
124948710|NCT03340961|449440012|FG000|Overall Study|Withdrawal by Subject|3|||
124948711|NCT03340961|449440013|FG001|Overall Study|Withdrawal by Subject|2|||
124948712|NCT03340961|449440014|FG002|Overall Study|Withdrawal by Subject|4|||
124948713|NCT03340961|449440015|FG003|Overall Study|Withdrawal by Subject|7|||
124948714|NCT03340961|449440012|FG000|Overall Study|Use of prohibited treatment|0|||
124948715|NCT03340961|449440013|FG001|Overall Study|Use of prohibited treatment|3|||
124948716|NCT03340961|449440014|FG002|Overall Study|Use of prohibited treatment|2|||
124948717|NCT03340961|449440015|FG003|Overall Study|Use of prohibited treatment|4|||
124948718|NCT03340961|449440012|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
124948719|NCT03340961|449440013|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
124948720|NCT03340961|449440014|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
124948721|NCT03340961|449440015|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
124948722|NCT03340961|449440012|FG000|Overall Study|Subject developed an exclusion criterion|0|||
124948723|NCT03340961|449440013|FG001|Overall Study|Subject developed an exclusion criterion|1|||
124948724|NCT03340961|449440014|FG002|Overall Study|Subject developed an exclusion criterion|0|||
124948725|NCT03340961|449440015|FG003|Overall Study|Subject developed an exclusion criterion|0|||
124948726|NCT03340961|449440012|FG000|Overall Study|Protocol Violation|1|||
124948727|NCT03340961|449440013|FG001|Overall Study|Protocol Violation|0|||
124948728|NCT03340961|449440014|FG002|Overall Study|Protocol Violation|1|||
124948729|NCT03340961|449440015|FG003|Overall Study|Protocol Violation|0|||
124948730|NCT03340961|449440012|FG000|Overall Study|Adverse Event|1|||
124548471|NCT02325739|447962623|FG004|Phase I Part|Adverse Event|3|||
124948731|NCT03340961|449440013|FG001|Overall Study|Adverse Event|1|||
124948732|NCT03340961|449440014|FG002|Overall Study|Adverse Event|0|||
124948733|NCT03340961|449440015|FG003|Overall Study|Adverse Event|0|||
124948734|NCT03340961|449440012|FG000|Overall Study|Lack of Efficacy|0|||
124948735|NCT03340961|449440013|FG001|Overall Study|Lack of Efficacy|0|||
124948736|NCT03340961|449440014|FG002|Overall Study|Lack of Efficacy|0|||
124948737|NCT03340961|449440015|FG003|Overall Study|Lack of Efficacy|1|||
124948738|NCT01853384|449440016|FG000|Randomized|Adverse Event|5|||
124948739|NCT01853384|449440017|FG001|Randomized|Adverse Event|3|||
124948740|NCT01853384|449440016|FG000|Randomized|Death|1|||
124948741|NCT01853384|449440017|FG001|Randomized|Death|2|||
124948742|NCT01853384|449440016|FG000|Randomized|Lost to Follow-up|1|||
124948743|NCT01853384|449440017|FG001|Randomized|Lost to Follow-up|1|||
124948744|NCT01853384|449440016|FG000|Randomized|Withdrawal by Subject|5|||
124948745|NCT01853384|449440017|FG001|Randomized|Withdrawal by Subject|3|||
124948746|NCT01853384|449440016|FG000|Randomized|Sponsor Decision|47|||
124948747|NCT01853384|449440017|FG001|Randomized|Sponsor Decision|34|||
124948748|NCT01853384|449440016|FG000|Randomized|Other|3|||
124948749|NCT01853384|449440017|FG001|Randomized|Other|3|||
124948750|NCT01853384|449440016|FG000|Completed Follow up Visit 1|Early Termination|13|||
124948751|NCT01853384|449440017|FG001|Completed Follow up Visit 1|Early Termination|9|||
124948752|NCT01853384|449440016|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
124948753|NCT01853384|449440017|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
124948754|NCT01853384|449440016|FG000|Completed Follow up Visit 2|Adverse Event|1|||
124948755|NCT01853384|449440017|FG001|Completed Follow up Visit 2|Adverse Event|0|||
124948756|NCT01853384|449440016|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
124948757|NCT01853384|449440017|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
124948758|NCT01853384|449440016|FG000|Completed Follow up Visit 2|Death|1|||
124948759|NCT01853384|449440017|FG001|Completed Follow up Visit 2|Death|0|||
124948760|NCT01853384|449440016|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
124948761|NCT01853384|449440017|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
124948762|NCT04311983|449440018|FG000|Overall Study|Lost to Follow-up|421|||
124948763|NCT04311983|449440019|FG001|Overall Study|Lost to Follow-up|456|||
124948764|NCT04311983|449440018|FG000|Overall Study|Incomplete survey|7|||
124948765|NCT04311983|449440019|FG001|Overall Study|Incomplete survey|9|||
124948766|NCT04311983|449440018|FG000|Overall Study|Death|1|||
124948767|NCT04311983|449440019|FG001|Overall Study|Death|0|||
124948768|NCT01205126|449440023|FG000|Titration Phase|Adverse Event|5|||
124948769|NCT01205126|449440024|FG001|Titration Phase|Adverse Event|3|||
124948770|NCT01205126|449440023|FG000|Titration Phase|Withdrawal by Subject|5|||
124948771|NCT01205126|449440024|FG001|Titration Phase|Withdrawal by Subject|5|||
124948772|NCT01205126|449440023|FG000|Titration Phase|Lost to Follow-up|2|||
124948773|NCT01205126|449440024|FG001|Titration Phase|Lost to Follow-up|2|||
124948774|NCT01205126|449440023|FG000|Titration Phase|No stable titration dose|1|||
124948775|NCT01205126|449440024|FG001|Titration Phase|No stable titration dose|0|||
124948776|NCT01205126|449440023|FG000|Titration Phase|More than maximum dosage required|2|||
124948777|NCT01205126|449440024|FG001|Titration Phase|More than maximum dosage required|3|||
124948778|NCT01205126|449440023|FG000|Titration Phase|Other|8|||
124948779|NCT01205126|449440024|FG001|Titration Phase|Other|6|||
124948780|NCT01205126|449440023|FG000|Between Titration & Maintenance Phase|Other|0|||
124948781|NCT01205126|449440024|FG001|Between Titration & Maintenance Phase|Other|4|||
124948782|NCT01205126|449440023|FG000|Maintenance Phase|Adverse Event|3|||
124948783|NCT01205126|449440024|FG001|Maintenance Phase|Adverse Event|7|||
124948784|NCT01205126|449440023|FG000|Maintenance Phase|Death|4|||
124948785|NCT01205126|449440024|FG001|Maintenance Phase|Death|4|||
124948786|NCT01205126|449440023|FG000|Maintenance Phase|More than the maximum dosage required|5|||
124948787|NCT01205126|449440024|FG001|Maintenance Phase|More than the maximum dosage required|5|||
124948788|NCT01205126|449440023|FG000|Maintenance Phase|Prohibited drugs used|1|||
124948789|NCT01205126|449440024|FG001|Maintenance Phase|Prohibited drugs used|0|||
124948790|NCT01205126|449440023|FG000|Maintenance Phase|Other|11|||
124948791|NCT01205126|449440024|FG001|Maintenance Phase|Other|8|||
124948792|NCT01205126|449440023|FG000|Maintenance Phase|Lost to Follow-up|5|||
124948793|NCT01205126|449440024|FG001|Maintenance Phase|Lost to Follow-up|5|||
124948794|NCT01205126|449440023|FG000|Maintenance Phase|Withdrawal by Subject|8|||
124948795|NCT01205126|449440024|FG001|Maintenance Phase|Withdrawal by Subject|11|||
124948796|NCT00638456|449440027|FG000|Overall Study|Withdrawal by Subject|6|||
124948797|NCT00638456|449440028|FG001|Overall Study|Withdrawal by Subject|2|||
124948798|NCT03236779|449440029|FG000|Overall Study|Lost to Follow-up|13|||
124948799|NCT03236779|449440030|FG001|Overall Study|Lost to Follow-up|21|||
124948800|NCT00687297|449440032|FG000|Randomization|Withdrawal by Subject|2|||
124948801|NCT00687297|449440033|FG001|Randomization|Withdrawal by Subject|0|||
124548472|NCT02325739|447962624|FG005|Phase I Part|Adverse Event|1|||
124948802|NCT00687297|449440032|FG000|Randomization|Withdrew before treatment, ineligible|1|||
124948803|NCT00687297|449440033|FG001|Randomization|Withdrew before treatment, ineligible|1|||
124948804|NCT00687297|449440032|FG000|Induction|Withdrawal by Subject|4|||
124948805|NCT00687297|449440033|FG001|Induction|Withdrawal by Subject|4|||
124948806|NCT00687297|449440032|FG000|Induction|Adverse Event|16|||
124948807|NCT00687297|449440033|FG001|Induction|Adverse Event|15|||
124948808|NCT00687297|449440032|FG000|Induction|Death|7|||
124948809|NCT00687297|449440033|FG001|Induction|Death|11|||
124948810|NCT00687297|449440032|FG000|Induction|Lack of Efficacy|17|||
124948811|NCT00687297|449440033|FG001|Induction|Lack of Efficacy|21|||
124948812|NCT00687297|449440032|FG000|Induction|Ineligible|0|||
124948813|NCT00687297|449440033|FG001|Induction|Ineligible|1|||
124948814|NCT00687297|449440032|FG000|Induction|Patient Noncompliance|1|||
124948815|NCT00687297|449440033|FG001|Induction|Patient Noncompliance|0|||
124948816|NCT00687297|449440032|FG000|Induction|Physician Decision|0|||
124948817|NCT00687297|449440033|FG001|Induction|Physician Decision|2|||
124948818|NCT00687297|449440032|FG000|Induction|Other|0|||
124948819|NCT00687297|449440033|FG001|Induction|Other|1|||
124948820|NCT03006393|449440034|FG000|Overall Study|Withdrawal by Subject|1|||
124948821|NCT03006393|449440035|FG001|Overall Study|Withdrawal by Subject|1|||
124948822|NCT03006393|449440034|FG000|Overall Study|Pregnancy|0|||
124948823|NCT03006393|449440035|FG001|Overall Study|Pregnancy|1|||
124948824|NCT03006393|449440034|FG000|Overall Study|Lost to Follow-up|0|||
124948825|NCT03006393|449440035|FG001|Overall Study|Lost to Follow-up|1|||
124948826|NCT01584648|449440036|FG000|Overall Study|Death|136|||
124948827|NCT01584648|449440037|FG001|Overall Study|Death|146|||
124948828|NCT01584648|449440036|FG000|Overall Study|Lost to Follow-up|9|||
124948829|NCT01584648|449440037|FG001|Overall Study|Lost to Follow-up|9|||
124948830|NCT01584648|449440036|FG000|Overall Study|Investigator discretion|3|||
124948831|NCT01584648|449440037|FG001|Overall Study|Investigator discretion|2|||
124948832|NCT01584648|449440036|FG000|Overall Study|Withdrew consent|13|||
124948833|NCT01584648|449440037|FG001|Overall Study|Withdrew consent|4|||
124948834|NCT01584648|449440036|FG000|Overall Study|Study closed/terminated|50|||
124948835|NCT01584648|449440037|FG001|Overall Study|Study closed/terminated|23|||
124948836|NCT01584648|449440036|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
124948837|NCT01584648|449440037|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
124948838|NCT01328756|449440038|FG000|Overall Study|Protocol Violation|4|||
124948839|NCT01328756|449440038|FG000|Overall Study|Adverse Event|39|||
124948840|NCT01328756|449440038|FG000|Overall Study|Lack of Efficacy|5|||
124948841|NCT01328756|449440038|FG000|Overall Study|Withdrawal by Subject|41|||
124948842|NCT01328756|449440038|FG000|Overall Study|Lost to Follow-up|5|||
124948843|NCT01328756|449440038|FG000|Overall Study|Other|29|||
124948844|NCT00244751|449440043|FG000|Overall Study|Adverse Event|7|||
124948845|NCT00244751|449440044|FG001|Overall Study|Adverse Event|7|||
124948846|NCT00244751|449440045|FG002|Overall Study|Adverse Event|5|||
124948847|NCT00244751|449440043|FG000|Overall Study|Lost to Follow-up|0|||
124948848|NCT00244751|449440044|FG001|Overall Study|Lost to Follow-up|1|||
124948849|NCT00244751|449440045|FG002|Overall Study|Lost to Follow-up|0|||
124948850|NCT00244751|449440043|FG000|Overall Study|Protocol Violation|1|||
124948851|NCT00244751|449440044|FG001|Overall Study|Protocol Violation|0|||
124948852|NCT00244751|449440045|FG002|Overall Study|Protocol Violation|1|||
124948853|NCT00244751|449440043|FG000|Overall Study|Withdrawal by Subject|7|||
124948854|NCT00244751|449440044|FG001|Overall Study|Withdrawal by Subject|5|||
124948855|NCT00244751|449440045|FG002|Overall Study|Withdrawal by Subject|3|||
124948856|NCT00244751|449440043|FG000|Overall Study|Elevated liver enzymes|1|||
124948857|NCT00244751|449440044|FG001|Overall Study|Elevated liver enzymes|0|||
124948858|NCT00244751|449440045|FG002|Overall Study|Elevated liver enzymes|0|||
124948859|NCT00244751|449440043|FG000|Overall Study|Lack of compliance with protocol|0|||
124948860|NCT00244751|449440044|FG001|Overall Study|Lack of compliance with protocol|1|||
124948861|NCT00244751|449440045|FG002|Overall Study|Lack of compliance with protocol|0|||
124948862|NCT00244751|449440043|FG000|Overall Study|Safety reasons|0|||
124459115|NCT01692275|447640561|FG000|Overall Study|Withdrawal by Subject|9|||
124459116|NCT01692275|447640562|FG001|Overall Study|Withdrawal by Subject|11|||
124459117|NCT03099187|447640563|FG000|Double-blind Treatment|Adverse Event|19|||
124459118|NCT03099187|447640564|FG001|Double-blind Treatment|Adverse Event|1|||
124459119|NCT03099187|447640565|FG002|Double-blind Treatment|Adverse Event|0|||
124459120|NCT03099187|447640566|FG003|Double-blind Treatment|Adverse Event|0|||
124459121|NCT03099187|447640563|FG000|Double-blind Treatment|Death|1|||
124459122|NCT03099187|447640564|FG001|Double-blind Treatment|Death|3|||
124459123|NCT03099187|447640565|FG002|Double-blind Treatment|Death|0|||
124459124|NCT03099187|447640566|FG003|Double-blind Treatment|Death|0|||
124948863|NCT00244751|449440044|FG001|Overall Study|Safety reasons|1|||
124459125|NCT03099187|447640563|FG000|Double-blind Treatment|Lack of Efficacy|1|||
124548473|NCT02325739|447962625|FG006|Phase I Part|Adverse Event|0|||
124948864|NCT00244751|449440045|FG002|Overall Study|Safety reasons|0|||
124948865|NCT00244751|449440043|FG000|Overall Study|Participant randomized by mistake|0|||
124948866|NCT00244751|449440044|FG001|Overall Study|Participant randomized by mistake|0|||
124948867|NCT00244751|449440045|FG002|Overall Study|Participant randomized by mistake|1|||
124948868|NCT02206607|449440046|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
124948869|NCT02206607|449440047|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
124948870|NCT02206607|449440048|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
124948871|NCT02206607|449440049|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
124948872|NCT02206607|449440050|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
124948873|NCT02206607|449440046|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
124459126|NCT03099187|447640564|FG001|Double-blind Treatment|Lack of Efficacy|0|||
124459127|NCT03099187|447640565|FG002|Double-blind Treatment|Lack of Efficacy|0|||
124548474|NCT02325739|447962626|FG007|Phase I Part|Adverse Event|2|||
124548475|NCT02325739|447962627|FG008|Phase I Part|Adverse Event|0|||
124548476|NCT02325739|447962628|FG009|Phase I Part|Adverse Event|0|||
124548477|NCT02325739|447962629|FG010|Phase I Part|Adverse Event|0|||
124548478|NCT02325739|447962619|FG000|Phase I Part|Progressive disease|9|||
124548479|NCT02325739|447962620|FG001|Phase I Part|Progressive disease|6|||
124548480|NCT02325739|447962621|FG002|Phase I Part|Progressive disease|3|||
124548481|NCT02325739|447962622|FG003|Phase I Part|Progressive disease|23|||
124548482|NCT02325739|447962623|FG004|Phase I Part|Progressive disease|14|||
124548483|NCT02325739|447962624|FG005|Phase I Part|Progressive disease|6|||
124548484|NCT02325739|447962625|FG006|Phase I Part|Progressive disease|6|||
124548485|NCT02325739|447962626|FG007|Phase I Part|Progressive disease|3|||
124548486|NCT02325739|447962627|FG008|Phase I Part|Progressive disease|0|||
124548487|NCT02325739|447962628|FG009|Phase I Part|Progressive disease|0|||
124548488|NCT02325739|447962629|FG010|Phase I Part|Progressive disease|0|||
124548489|NCT02325739|447962619|FG000|Phase I Part|Subject/guardian decision|1|||
124548490|NCT02325739|447962620|FG001|Phase I Part|Subject/guardian decision|0|||
124548491|NCT02325739|447962621|FG002|Phase I Part|Subject/guardian decision|1|||
124548492|NCT02325739|447962622|FG003|Phase I Part|Subject/guardian decision|1|||
124548493|NCT02325739|447962623|FG004|Phase I Part|Subject/guardian decision|0|||
124548494|NCT02325739|447962624|FG005|Phase I Part|Subject/guardian decision|0|||
124548495|NCT02325739|447962625|FG006|Phase I Part|Subject/guardian decision|0|||
124548496|NCT02325739|447962626|FG007|Phase I Part|Subject/guardian decision|1|||
124548497|NCT02325739|447962627|FG008|Phase I Part|Subject/guardian decision|0|||
124548498|NCT02325739|447962628|FG009|Phase I Part|Subject/guardian decision|0|||
124548499|NCT02325739|447962629|FG010|Phase I Part|Subject/guardian decision|0|||
124548500|NCT02325739|447962619|FG000|Phase I Part|Death|0|||
124548501|NCT02325739|447962620|FG001|Phase I Part|Death|0|||
124548502|NCT02325739|447962621|FG002|Phase I Part|Death|0|||
124548503|NCT02325739|447962622|FG003|Phase I Part|Death|0|||
124548504|NCT02325739|447962623|FG004|Phase I Part|Death|2|||
124548505|NCT02325739|447962624|FG005|Phase I Part|Death|0|||
124548506|NCT02325739|447962625|FG006|Phase I Part|Death|0|||
124548507|NCT02325739|447962626|FG007|Phase I Part|Death|0|||
124548508|NCT02325739|447962627|FG008|Phase I Part|Death|0|||
124548509|NCT02325739|447962628|FG009|Phase I Part|Death|0|||
124548510|NCT02325739|447962629|FG010|Phase I Part|Death|0|||
124548511|NCT02325739|447962619|FG000|Phase II Part|Adverse Event|0|||
124548512|NCT02325739|447962620|FG001|Phase II Part|Adverse Event|0|||
124548513|NCT02325739|447962621|FG002|Phase II Part|Adverse Event|0|||
124548514|NCT02325739|447962622|FG003|Phase II Part|Adverse Event|0|||
124548515|NCT02325739|447962623|FG004|Phase II Part|Adverse Event|0|||
124548516|NCT02325739|447962624|FG005|Phase II Part|Adverse Event|0|||
124548517|NCT02325739|447962625|FG006|Phase II Part|Adverse Event|0|||
124548518|NCT02325739|447962626|FG007|Phase II Part|Adverse Event|0|||
124548519|NCT02325739|447962627|FG008|Phase II Part|Adverse Event|4|||
124548520|NCT02325739|447962628|FG009|Phase II Part|Adverse Event|5|||
124548521|NCT02325739|447962629|FG010|Phase II Part|Adverse Event|1|||
124548522|NCT02325739|447962619|FG000|Phase II Part|Physician Decision|0|||
124948874|NCT02206607|449440047|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
124948875|NCT02206607|449440048|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
124948876|NCT02206607|449440049|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
124948877|NCT02206607|449440050|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
124948878|NCT00879710|449440051|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
124948879|NCT00879710|449440052|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
124948880|NCT00879710|449440053|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
124948881|NCT00879710|449440054|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
124948882|NCT00879710|449440051|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
124948883|NCT00879710|449440052|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
124948884|NCT00879710|449440053|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
124948885|NCT00879710|449440054|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
124948886|NCT04085614|449440055|FG000|Overall Study|Protocol Violation|9|||
124948887|NCT04085614|449440056|FG001|Overall Study|Protocol Violation|6|||
124948888|NCT02399449|449440057|FG000|Overall Study|Withdrawal by Subject|3|||
124948889|NCT02399449|449440058|FG001|Overall Study|Withdrawal by Subject|9|||
124948890|NCT02399449|449440057|FG000|Overall Study|Physician Decision|0|||
124948891|NCT02399449|449440058|FG001|Overall Study|Physician Decision|1|||
124948892|NCT02516202|449440059|FG000|Overall Study|Withdrawal by Subject|1|||
124948893|NCT02516202|449440060|FG001|Overall Study|Withdrawal by Subject|0|||
124948894|NCT02516202|449440061|FG002|Overall Study|Withdrawal by Subject|1|||
124948895|NCT02516202|449440059|FG000|Overall Study|Lost to Follow-up|1|||
124948896|NCT02516202|449440060|FG001|Overall Study|Lost to Follow-up|1|||
124548523|NCT02325739|447962620|FG001|Phase II Part|Physician Decision|0|||
124548524|NCT02325739|447962621|FG002|Phase II Part|Physician Decision|0|||
124548525|NCT02325739|447962622|FG003|Phase II Part|Physician Decision|0|||
124548526|NCT02325739|447962623|FG004|Phase II Part|Physician Decision|0|||
124548527|NCT02325739|447962624|FG005|Phase II Part|Physician Decision|0|||
124548528|NCT02325739|447962625|FG006|Phase II Part|Physician Decision|0|||
124548529|NCT02325739|447962626|FG007|Phase II Part|Physician Decision|0|||
124548530|NCT02325739|447962627|FG008|Phase II Part|Physician Decision|0|||
124706421|NCT05643495|448549986|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
124948897|NCT02516202|449440061|FG002|Overall Study|Lost to Follow-up|1|||
124948898|NCT02516202|449440059|FG000|Overall Study|Stopped Follow-up|0|||
124948899|NCT02516202|449440060|FG001|Overall Study|Stopped Follow-up|0|||
124948900|NCT02516202|449440061|FG002|Overall Study|Stopped Follow-up|1|||
124948901|NCT00337610|449440062|FG000|Overall Study|Adverse Event|2|||
124948902|NCT00337610|449440063|FG001|Overall Study|Adverse Event|2|||
124948903|NCT00337610|449440062|FG000|Overall Study|Death|0|||
124948904|NCT00337610|449440063|FG001|Overall Study|Death|1|||
124948905|NCT00337610|449440062|FG000|Overall Study|Lack of Efficacy|6|||
124948906|NCT00337610|449440063|FG001|Overall Study|Lack of Efficacy|3|||
124948907|NCT00337610|449440062|FG000|Overall Study|Lost to Follow-up|3|||
124948908|NCT00337610|449440063|FG001|Overall Study|Lost to Follow-up|3|||
124948909|NCT00337610|449440062|FG000|Overall Study|Withdrawal by Subject|6|||
124948910|NCT00337610|449440063|FG001|Overall Study|Withdrawal by Subject|5|||
124948911|NCT03541369|449440064|FG000|Overall Study|Death|0|||
124948912|NCT03541369|449440065|FG001|Overall Study|Death|0|||
124948913|NCT03541369|449440066|FG002|Overall Study|Death|0|||
124948914|NCT03541369|449440067|FG003|Overall Study|Death|0|||
124948915|NCT03541369|449440068|FG004|Overall Study|Death|1|||
124948916|NCT03541369|449440069|FG005|Overall Study|Death|1|||
124948917|NCT03541369|449440070|FG006|Overall Study|Death|0|||
124948918|NCT03541369|449440071|FG007|Overall Study|Death|2|||
124948919|NCT03541369|449440072|FG008|Overall Study|Death|1|||
124948920|NCT03541369|449440073|FG009|Overall Study|Death|2|||
124948921|NCT03541369|449440074|FG010|Overall Study|Death|1|||
124948922|NCT03541369|449440075|FG011|Overall Study|Death|0|||
124948923|NCT03541369|449440076|FG012|Overall Study|Death|2|||
124948924|NCT03541369|449440077|FG013|Overall Study|Death|1|||
124948925|NCT03541369|449440078|FG014|Overall Study|Death|1|||
124948926|NCT03541369|449440079|FG015|Overall Study|Death|1|||
124948927|NCT03541369|449440080|FG016|Overall Study|Death|0|||
124948928|NCT03541369|449440081|FG017|Overall Study|Death|1|||
124948929|NCT03541369|449440064|FG000|Overall Study|Decision by sponsor|0|||
124948930|NCT03541369|449440065|FG001|Overall Study|Decision by sponsor|0|||
124948931|NCT03541369|449440066|FG002|Overall Study|Decision by sponsor|0|||
124948932|NCT03541369|449440067|FG003|Overall Study|Decision by sponsor|1|||
124948933|NCT03541369|449440068|FG004|Overall Study|Decision by sponsor|0|||
124948934|NCT03541369|449440069|FG005|Overall Study|Decision by sponsor|2|||
124948935|NCT03541369|449440070|FG006|Overall Study|Decision by sponsor|0|||
124948936|NCT03541369|449440071|FG007|Overall Study|Decision by sponsor|1|||
124948937|NCT03541369|449440072|FG008|Overall Study|Decision by sponsor|2|||
124948938|NCT03541369|449440073|FG009|Overall Study|Decision by sponsor|0|||
124948939|NCT03541369|449440074|FG010|Overall Study|Decision by sponsor|0|||
124948940|NCT03541369|449440075|FG011|Overall Study|Decision by sponsor|0|||
124948941|NCT03541369|449440076|FG012|Overall Study|Decision by sponsor|2|||
124948942|NCT03541369|449440077|FG013|Overall Study|Decision by sponsor|2|||
124948943|NCT03541369|449440078|FG014|Overall Study|Decision by sponsor|0|||
124948944|NCT03541369|449440079|FG015|Overall Study|Decision by sponsor|1|||
124948945|NCT03541369|449440080|FG016|Overall Study|Decision by sponsor|1|||
124948946|NCT03541369|449440081|FG017|Overall Study|Decision by sponsor|1|||
124948947|NCT03541369|449440064|FG000|Overall Study|Withdrawal by Subject|0|||
124948948|NCT03541369|449440065|FG001|Overall Study|Withdrawal by Subject|0|||
124948949|NCT03541369|449440066|FG002|Overall Study|Withdrawal by Subject|0|||
124948950|NCT03541369|449440067|FG003|Overall Study|Withdrawal by Subject|0|||
124948951|NCT03541369|449440068|FG004|Overall Study|Withdrawal by Subject|0|||
124948952|NCT03541369|449440069|FG005|Overall Study|Withdrawal by Subject|0|||
124948953|NCT03541369|449440070|FG006|Overall Study|Withdrawal by Subject|1|||
124948954|NCT03541369|449440071|FG007|Overall Study|Withdrawal by Subject|0|||
124948955|NCT03541369|449440072|FG008|Overall Study|Withdrawal by Subject|0|||
124948956|NCT03541369|449440073|FG009|Overall Study|Withdrawal by Subject|0|||
124948957|NCT03541369|449440074|FG010|Overall Study|Withdrawal by Subject|0|||
124948958|NCT03541369|449440075|FG011|Overall Study|Withdrawal by Subject|1|||
124948959|NCT03541369|449440076|FG012|Overall Study|Withdrawal by Subject|0|||
124948960|NCT03541369|449440077|FG013|Overall Study|Withdrawal by Subject|0|||
124948961|NCT03541369|449440078|FG014|Overall Study|Withdrawal by Subject|3|||
124948962|NCT03541369|449440079|FG015|Overall Study|Withdrawal by Subject|0|||
124948963|NCT03541369|449440080|FG016|Overall Study|Withdrawal by Subject|4|||
124706422|NCT02257528|448549987|FG000|Overall Study|Never received study treatment|1|||
124948964|NCT03541369|449440081|FG017|Overall Study|Withdrawal by Subject|2|||
124948965|NCT03541369|449440064|FG000|Overall Study|Lost to Follow-up|0|||
124948966|NCT03541369|449440065|FG001|Overall Study|Lost to Follow-up|0|||
124948967|NCT03541369|449440066|FG002|Overall Study|Lost to Follow-up|0|||
124948968|NCT03541369|449440067|FG003|Overall Study|Lost to Follow-up|0|||
124948969|NCT03541369|449440068|FG004|Overall Study|Lost to Follow-up|1|||
124948970|NCT03541369|449440069|FG005|Overall Study|Lost to Follow-up|0|||
124948971|NCT03541369|449440070|FG006|Overall Study|Lost to Follow-up|0|||
124948972|NCT03541369|449440071|FG007|Overall Study|Lost to Follow-up|0|||
124948973|NCT03541369|449440072|FG008|Overall Study|Lost to Follow-up|1|||
124948974|NCT03541369|449440073|FG009|Overall Study|Lost to Follow-up|0|||
124948975|NCT03541369|449440074|FG010|Overall Study|Lost to Follow-up|0|||
124548531|NCT02325739|447962628|FG009|Phase II Part|Physician Decision|1|||
124548532|NCT02325739|447962629|FG010|Phase II Part|Physician Decision|0|||
124548533|NCT02325739|447962619|FG000|Phase II Part|Progressive disease|0|||
124548534|NCT02325739|447962620|FG001|Phase II Part|Progressive disease|0|||
124548535|NCT02325739|447962621|FG002|Phase II Part|Progressive disease|0|||
124548536|NCT02325739|447962622|FG003|Phase II Part|Progressive disease|0|||
124548537|NCT02325739|447962623|FG004|Phase II Part|Progressive disease|0|||
124548538|NCT02325739|447962624|FG005|Phase II Part|Progressive disease|0|||
124548539|NCT02325739|447962625|FG006|Phase II Part|Progressive disease|0|||
124548540|NCT02325739|447962626|FG007|Phase II Part|Progressive disease|0|||
124548541|NCT02325739|447962627|FG008|Phase II Part|Progressive disease|22|||
124548542|NCT02325739|447962628|FG009|Phase II Part|Progressive disease|29|||
124548543|NCT02325739|447962629|FG010|Phase II Part|Progressive disease|18|||
124548544|NCT02325739|447962619|FG000|Phase II Part|Subject/guardian decision|0|||
124948976|NCT03541369|449440075|FG011|Overall Study|Lost to Follow-up|0|||
124948977|NCT03541369|449440076|FG012|Overall Study|Lost to Follow-up|1|||
124948978|NCT03541369|449440077|FG013|Overall Study|Lost to Follow-up|0|||
124948979|NCT03541369|449440078|FG014|Overall Study|Lost to Follow-up|0|||
124948980|NCT03541369|449440079|FG015|Overall Study|Lost to Follow-up|0|||
124948981|NCT03541369|449440080|FG016|Overall Study|Lost to Follow-up|0|||
124948982|NCT03541369|449440081|FG017|Overall Study|Lost to Follow-up|0|||
124948983|NCT03205488|449440084|FG000|Overall Study|Adverse Event|1|||
124948984|NCT03205488|449440085|FG001|Overall Study|Adverse Event|2|||
124948985|NCT03205488|449440086|FG002|Overall Study|Adverse Event|4|||
124948986|NCT03205488|449440084|FG000|Overall Study|Protocol Violation|0|||
124948987|NCT03205488|449440085|FG001|Overall Study|Protocol Violation|0|||
124948988|NCT03205488|449440086|FG002|Overall Study|Protocol Violation|1|||
124948989|NCT04867382|449440087|FG000|Overall Study|Did not complete the survey|2|||
124948990|NCT04867382|449440088|FG001|Overall Study|Did not complete the survey|1|||
124948991|NCT05445557|449440096|FG000|Double Blind Part|Lost to Follow-up|1|||
124948992|NCT02008916|449440097|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
124548545|NCT02325739|447962620|FG001|Phase II Part|Subject/guardian decision|0|||
124548546|NCT02325739|447962621|FG002|Phase II Part|Subject/guardian decision|0|||
124548547|NCT02325739|447962622|FG003|Phase II Part|Subject/guardian decision|0|||
124706423|NCT06272383|448549988|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
124706424|NCT06272383|448549989|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
124706425|NCT04569084|448549994|FG000|Overall Study|Adverse Event|10|||
124706426|NCT04569084|448549995|FG001|Overall Study|Adverse Event|14|||
124706427|NCT04569084|448549994|FG000|Overall Study|Death|2|||
124706428|NCT04569084|448549995|FG001|Overall Study|Death|3|||
124706429|NCT04569084|448549994|FG000|Overall Study|Lost to Follow-up|1|||
124706430|NCT04569084|448549995|FG001|Overall Study|Lost to Follow-up|1|||
124706431|NCT04569084|448549994|FG000|Overall Study|Physician Decision|3|||
124706432|NCT04569084|448549995|FG001|Overall Study|Physician Decision|3|||
124706433|NCT04569084|448549994|FG000|Overall Study|Protocol Violation|2|||
124706434|NCT04569084|448549995|FG001|Overall Study|Protocol Violation|1|||
124706435|NCT04569084|448549994|FG000|Overall Study|Withdrawal by Subject|20|||
124706436|NCT04569084|448549995|FG001|Overall Study|Withdrawal by Subject|21|||
124706437|NCT04569084|448549994|FG000|Overall Study|Study terminated by sponsor|26|||
124706438|NCT04569084|448549995|FG001|Overall Study|Study terminated by sponsor|23|||
124706439|NCT04569084|448549994|FG000|Overall Study|Other|3|||
124706440|NCT04569084|448549995|FG001|Overall Study|Other|5|||
124706441|NCT01994876|448549996|FG000|Test Period 1|Withdrawal by Subject|0|||
124706442|NCT01994876|448549997|FG001|Test Period 1|Withdrawal by Subject|1|||
124706443|NCT01994876|448549996|FG000|Test Period 1|Adverse Event|0|||
124706444|NCT01994876|448549997|FG001|Test Period 1|Adverse Event|1|||
124706445|NCT01994876|448549996|FG000|Test Period 2|Adverse Event|1|||
124706446|NCT01994876|448549997|FG001|Test Period 2|Adverse Event|0|||
124706447|NCT01994876|448549996|FG000|Test Period 2|Protocol Violation|0|||
124706448|NCT01994876|448549997|FG001|Test Period 2|Protocol Violation|1|||
124706449|NCT01400412|448549998|FG000|Overall Study|Lost to Follow-up|4|||
124706450|NCT01400412|448549999|FG001|Overall Study|Lost to Follow-up|7|||
124706451|NCT01400412|448549998|FG000|Overall Study|Withdrawal by Subject|3|||
124706452|NCT01400412|448549999|FG001|Overall Study|Withdrawal by Subject|4|||
124706453|NCT01400412|448549998|FG000|Overall Study|Unable to complete|3|||
124706454|NCT01400412|448549999|FG001|Overall Study|Unable to complete|3|||
124706455|NCT01400412|448549998|FG000|Overall Study|Never started study treatment|0|||
124706456|NCT01400412|448549999|FG001|Overall Study|Never started study treatment|3|||
124706457|NCT04043286|448551643|FG000|Overall Study|Withdrawal by Subject|2|||
124706458|NCT04043286|448551644|FG001|Overall Study|Withdrawal by Subject|2|||
124706459|NCT01323192|448551645|FG000|Overall Study|Adverse Event|6|||
124706460|NCT01323192|448551646|FG001|Overall Study|Adverse Event|1|||
124948993|NCT02008916|449440098|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
124548548|NCT02325739|447962623|FG004|Phase II Part|Subject/guardian decision|0|||
124548549|NCT02325739|447962624|FG005|Phase II Part|Subject/guardian decision|0|||
124548550|NCT02325739|447962625|FG006|Phase II Part|Subject/guardian decision|0|||
124548551|NCT02325739|447962626|FG007|Phase II Part|Subject/guardian decision|0|||
124548552|NCT02325739|447962627|FG008|Phase II Part|Subject/guardian decision|4|||
124548553|NCT02325739|447962628|FG009|Phase II Part|Subject/guardian decision|1|||
124548554|NCT02325739|447962629|FG010|Phase II Part|Subject/guardian decision|1|||
124548555|NCT03186794|447962630|FG000|Overall Study|Physician Decision|2|||
124548556|NCT03186794|447962630|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
124548557|NCT02380248|447962632|FG000|Overall Study|Lost to Follow-up|11|||
124706461|NCT01323192|448551645|FG000|Overall Study|Withdrawal by Subject|3|||
124765312|NCT01194830|448767384|FG001|Overall Study|Withdrawal by Subject|1|||
124948994|NCT02008916|449440099|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
124948995|NCT02008916|449440097|FG000|Week 16 - 156|Adverse Event|4|||
124948996|NCT02008916|449440098|FG001|Week 16 - 156|Adverse Event|2|||
124948997|NCT02008916|449440099|FG002|Week 16 - 156|Adverse Event|3|||
124948998|NCT02008916|449440097|FG000|Week 16 - 156|Withdrawal by Subject|7|||
124948999|NCT02008916|449440098|FG001|Week 16 - 156|Withdrawal by Subject|3|||
124949000|NCT02008916|449440099|FG002|Week 16 - 156|Withdrawal by Subject|5|||
124949001|NCT02008916|449440097|FG000|Week 16 - 156|No longer requires treatment|0|||
124949002|NCT02008916|449440098|FG001|Week 16 - 156|No longer requires treatment|1|||
124949003|NCT02008916|449440099|FG002|Week 16 - 156|No longer requires treatment|0|||
124949004|NCT02008916|449440097|FG000|Week 16 - 156|Lost to Follow-up|5|||
124949005|NCT02008916|449440098|FG001|Week 16 - 156|Lost to Follow-up|0|||
124949006|NCT02008916|449440099|FG002|Week 16 - 156|Lost to Follow-up|0|||
124949007|NCT02008916|449440097|FG000|Week 16 - 156|Lack of Efficacy|3|||
124949008|NCT02008916|449440098|FG001|Week 16 - 156|Lack of Efficacy|5|||
124949009|NCT02008916|449440099|FG002|Week 16 - 156|Lack of Efficacy|2|||
124949010|NCT02008916|449440097|FG000|Week 16 - 156|Pregnancy|0|||
124949011|NCT02008916|449440098|FG001|Week 16 - 156|Pregnancy|1|||
124949012|NCT02008916|449440099|FG002|Week 16 - 156|Pregnancy|0|||
124949013|NCT02008916|449440097|FG000|Week 16 - 156|Physician Decision|0|||
124949014|NCT02008916|449440098|FG001|Week 16 - 156|Physician Decision|1|||
124949015|NCT02008916|449440099|FG002|Week 16 - 156|Physician Decision|0|||
124949016|NCT03803475|449440100|FG000|Overall Study|Physician Decision|1|||
124949017|NCT00392197|449440103|FG000|Overall Study|Adverse Event|4|||
124949018|NCT00392197|449440104|FG001|Overall Study|Adverse Event|12|||
124949019|NCT00392197|449440103|FG000|Overall Study|Lack of Efficacy|3|||
124949020|NCT00392197|449440104|FG001|Overall Study|Lack of Efficacy|4|||
124949021|NCT00392197|449440103|FG000|Overall Study|Lost to Follow-up|0|||
124949022|NCT00392197|449440104|FG001|Overall Study|Lost to Follow-up|1|||
124949023|NCT00392197|449440103|FG000|Overall Study|Physician Decision|3|||
124949024|NCT00392197|449440104|FG001|Overall Study|Physician Decision|2|||
124949025|NCT00392197|449440103|FG000|Overall Study|Protocol Violation|7|||
124949026|NCT00392197|449440104|FG001|Overall Study|Protocol Violation|5|||
124949027|NCT00392197|449440103|FG000|Overall Study|Withdrawal by Subject|4|||
124949028|NCT00392197|449440104|FG001|Overall Study|Withdrawal by Subject|6|||
124949029|NCT00428714|449440106|FG000|Overall Study|Progressive Disease|28|||
124949030|NCT00428714|449440107|FG001|Overall Study|Progressive Disease|36|||
124459128|NCT03099187|447640566|FG003|Double-blind Treatment|Lack of Efficacy|0|||
124459129|NCT03099187|447640563|FG000|Double-blind Treatment|Physician Decision|2|||
124459130|NCT03099187|447640564|FG001|Double-blind Treatment|Physician Decision|1|||
124459131|NCT03099187|447640565|FG002|Double-blind Treatment|Physician Decision|0|||
124459132|NCT03099187|447640566|FG003|Double-blind Treatment|Physician Decision|0|||
124459133|NCT03099187|447640563|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
124459134|NCT03099187|447640564|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
124459135|NCT03099187|447640565|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
124459136|NCT03099187|447640566|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
124706462|NCT01323192|448551646|FG001|Overall Study|Withdrawal by Subject|1|||
124706463|NCT01323192|448551645|FG000|Overall Study|Noncompliance with study medication|0|||
124706464|NCT01323192|448551646|FG001|Overall Study|Noncompliance with study medication|3|||
124706465|NCT01323192|448551645|FG000|Overall Study|Nonmedical reasons|0|||
124706466|NCT01323192|448551646|FG001|Overall Study|Nonmedical reasons|1|||
124706467|NCT02296476|448551647|FG000|Overall Study|Disease Progression|6|||
124706468|NCT02296476|448551648|FG001|Overall Study|Disease Progression|4|||
124706469|NCT02296476|448551649|FG002|Overall Study|Disease Progression|2|||
124706470|NCT03122184|448551656|FG000|Overall Study|Lost to Follow-up|4|||
124706471|NCT03122184|448551657|FG001|Overall Study|Lost to Follow-up|6|||
124706472|NCT03122184|448551656|FG000|Overall Study|Withdrawal by Subject|3|||
124706473|NCT03122184|448551657|FG001|Overall Study|Withdrawal by Subject|0|||
124765313|NCT01194830|448767383|FG000|Overall Study|Lack of Efficacy|1|||
124765314|NCT01194830|448767384|FG001|Overall Study|Lack of Efficacy|1|||
124949031|NCT00428714|449440106|FG000|Overall Study|Withdrawal by Subject|0|||
124949032|NCT00428714|449440107|FG001|Overall Study|Withdrawal by Subject|3|||
124949033|NCT00428714|449440106|FG000|Overall Study|Adverse Event|0|||
124949034|NCT00428714|449440107|FG001|Overall Study|Adverse Event|2|||
124949035|NCT00428714|449440106|FG000|Overall Study|Physician Decision|1|||
124949036|NCT00428714|449440107|FG001|Overall Study|Physician Decision|1|||
124459137|NCT03099187|447640563|FG000|Double-blind Treatment|Lung transplantation|0|||
124765315|NCT01194830|448767383|FG000|Overall Study|Non-compliance issues|4|||
124706474|NCT03122184|448551656|FG000|Overall Study|Terminated due to cognitive problem|1|||
124949037|NCT00428714|449440106|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
124949038|NCT00428714|449440107|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
124949039|NCT00428714|449440106|FG000|Overall Study|Death due to other then PD|1|||
124949040|NCT00428714|449440107|FG001|Overall Study|Death due to other then PD|0|||
124949041|NCT01681511|449440108|FG000|Overall Study|No Treatment Received|1|||
124949042|NCT01681511|449440109|FG001|Overall Study|No Treatment Received|3|||
124949043|NCT01681511|449440108|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
124765316|NCT01194830|448767384|FG001|Overall Study|Non-compliance issues|4|||
124765317|NCT01194830|448767383|FG000|Overall Study|Other Reason|12|||
124765318|NCT01194830|448767384|FG001|Overall Study|Other Reason|8|||
124765319|NCT01815918|448767387|FG000|Overall Study|Patient samples not analyzable|3|||
124765320|NCT01815918|448767388|FG001|Overall Study|Patient samples not analyzable|4|||
124765321|NCT01815918|448767387|FG000|Overall Study|Lack of Efficacy|15|||
124765322|NCT01815918|448767388|FG001|Overall Study|Lack of Efficacy|15|||
124765323|NCT02814916|448767391|FG000|Overall Study|Withdrawal of consent|0|||
124765324|NCT02814916|448767392|FG001|Overall Study|Withdrawal of consent|2|||
124765325|NCT02814916|448767393|FG002|Overall Study|Withdrawal of consent|0|||
124765326|NCT02814916|448767391|FG000|Overall Study|Lost to Follow-up|0|||
124765327|NCT02814916|448767392|FG001|Overall Study|Lost to Follow-up|1|||
124765328|NCT02814916|448767393|FG002|Overall Study|Lost to Follow-up|0|||
124765329|NCT02814916|448767391|FG000|Overall Study|Other, not specified|0|||
124765330|NCT02814916|448767392|FG001|Overall Study|Other, not specified|1|||
124765331|NCT02814916|448767393|FG002|Overall Study|Other, not specified|0|||
124765332|NCT04739982|448767404|FG000|Overall Study|Lost to Follow-up|176|||
124765333|NCT04739982|448767405|FG001|Overall Study|Lost to Follow-up|65|||
124765334|NCT04739982|448767404|FG000|Overall Study|Withdrawal by Subject|19|||
124765335|NCT04739982|448767405|FG001|Overall Study|Withdrawal by Subject|0|||
124765336|NCT04739982|448767404|FG000|Overall Study|Protocol Violation|0|||
124765337|NCT04739982|448767405|FG001|Overall Study|Protocol Violation|5|||
124765338|NCT00702702|448767406|FG000|Overall Study|Study prematurely terminated|56|||
124765339|NCT02240485|448767407|FG000|3 Months Post-admission|Lost to Follow-up|1|||
124765340|NCT02240485|448767408|FG001|3 Months Post-admission|Lost to Follow-up|5|||
124765341|NCT02240485|448767407|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
124765342|NCT02240485|448767408|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
124765343|NCT02240485|448767407|FG000|9 Months Post-admission|Lost to Follow-up|3|||
124765344|NCT02240485|448767408|FG001|9 Months Post-admission|Lost to Follow-up|1|||
124765345|NCT02240485|448767407|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
124765346|NCT02240485|448767408|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
124765347|NCT02240485|448767407|FG000|18 Months Post-admission|Lost to Follow-up|1|||
124765348|NCT02240485|448767408|FG001|18 Months Post-admission|Lost to Follow-up|1|||
124765349|NCT02240485|448767407|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
124765350|NCT02240485|448767408|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
124765351|NCT00953667|448767409|FG000|Overall Study|Lost to Follow-up|11|||
124765352|NCT00953667|448767409|FG000|Overall Study|Physician Decision|35|||
124765353|NCT00953667|448767409|FG000|Overall Study|Withdrawal by Subject|63|||
124765354|NCT00953667|448767409|FG000|Overall Study|Adverse Event|10|||
124765355|NCT00953667|448767409|FG000|Overall Study|poor venous access,unable to draw blood|4|||
124765356|NCT04819945|448767410|FG000|Overall Study|Lost to Follow-up|1|||
124765357|NCT00475670|448767411|FG000|Overall Study|Death|0|||
124765358|NCT00475670|448767412|FG001|Overall Study|Death|1|||
124765359|NCT00475670|448767411|FG000|Overall Study|Lack of Efficacy|3|||
124765360|NCT00475670|448767412|FG001|Overall Study|Lack of Efficacy|34|||
124765361|NCT00475670|448767411|FG000|Overall Study|Refused treatment|0|||
124765362|NCT00475670|448767412|FG001|Overall Study|Refused treatment|2|||
124706475|NCT03122184|448551657|FG001|Overall Study|Terminated due to cognitive problem|0|||
124706476|NCT02835690|448551658|FG000|Overall Study|Death|12|||
124706477|NCT02835690|448551659|FG001|Overall Study|Death|11|||
124706478|NCT02835690|448551660|FG002|Overall Study|Death|13|||
124706479|NCT02835690|448551658|FG000|Overall Study|Transferred to Extension Study|2|||
124706480|NCT02835690|448551659|FG001|Overall Study|Transferred to Extension Study|2|||
124706481|NCT02835690|448551660|FG002|Overall Study|Transferred to Extension Study|1|||
124949044|NCT01681511|449440109|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
124459138|NCT03099187|447640564|FG001|Double-blind Treatment|Lung transplantation|1|||
124765363|NCT00475670|448767411|FG000|Overall Study|Failure to Return|0|||
124765364|NCT00475670|448767412|FG001|Overall Study|Failure to Return|1|||
124765365|NCT00475670|448767411|FG000|Overall Study|Other|0|||
124765366|NCT00475670|448767412|FG001|Overall Study|Other|3|||
124765367|NCT04949191|448767413|FG000|Overall Study|Non-compliance with Study Drug|1|||
124459139|NCT03099187|447640565|FG002|Double-blind Treatment|Lung transplantation|0|||
124765368|NCT04949191|448767414|FG001|Overall Study|Non-compliance with Study Drug|0|||
124765369|NCT04949191|448767415|FG002|Overall Study|Non-compliance with Study Drug|0|||
124765370|NCT04949191|448767416|FG003|Overall Study|Non-compliance with Study Drug|0|||
124765371|NCT04949191|448767413|FG000|Overall Study|Progressive Disease|0|||
124459140|NCT03099187|447640566|FG003|Double-blind Treatment|Lung transplantation|0|||
124949045|NCT01681511|449440108|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
124949046|NCT01681511|449440109|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
124949047|NCT01681511|449440108|FG000|Overall Study|No Daily Urine Sample Collected|0|||
124949048|NCT01681511|449440109|FG001|Overall Study|No Daily Urine Sample Collected|1|||
124949049|NCT01681511|449440108|FG000|Overall Study|No post-catheter sample collected|11|||
124949050|NCT01681511|449440109|FG001|Overall Study|No post-catheter sample collected|4|||
124949051|NCT00090519|449440123|FG000|Overall Study|Adverse Event|5|||
124949052|NCT00090519|449440124|FG001|Overall Study|Adverse Event|4|||
124949053|NCT00090519|449440123|FG000|Overall Study|Death|9|||
124949054|NCT00090519|449440124|FG001|Overall Study|Death|9|||
124949055|NCT00090519|449440123|FG000|Overall Study|Lost to Follow-up|26|||
124548558|NCT02380248|447962632|FG000|Overall Study|Withdrawal by Subject|3|||
124548559|NCT03728257|447962633|FG000|Overall Study|Death|3|||
124548560|NCT03728257|447962634|FG001|Overall Study|Death|0|||
124548561|NCT00621309|447962636|FG000|Overall Study|Withdrawal by Subject|2|||
124548562|NCT00621309|447962637|FG001|Overall Study|Withdrawal by Subject|0|||
124548563|NCT00621309|447962638|FG002|Overall Study|Withdrawal by Subject|1|||
124548564|NCT00621309|447962639|FG003|Overall Study|Withdrawal by Subject|1|||
124548565|NCT00621309|447962640|FG004|Overall Study|Withdrawal by Subject|1|||
124548566|NCT00621309|447962641|FG005|Overall Study|Withdrawal by Subject|1|||
124548567|NCT01306968|447962644|FG000|Overall Study|Lost to Follow-up|1|||
124548568|NCT01306968|447962645|FG001|Overall Study|Lost to Follow-up|1|||
124548569|NCT01306968|447962646|FG002|Overall Study|Lost to Follow-up|0|||
124548570|NCT01306968|447962647|FG003|Overall Study|Lost to Follow-up|0|||
124548571|NCT01306968|447962644|FG000|Overall Study|Physician Decision|0|||
124548572|NCT01306968|447962645|FG001|Overall Study|Physician Decision|1|||
124548573|NCT01306968|447962646|FG002|Overall Study|Physician Decision|0|||
124548574|NCT01306968|447962647|FG003|Overall Study|Physician Decision|0|||
124548575|NCT01306968|447962644|FG000|Overall Study|Relocated and left active duty|0|||
124548576|NCT01306968|447962645|FG001|Overall Study|Relocated and left active duty|1|||
124548577|NCT01306968|447962646|FG002|Overall Study|Relocated and left active duty|1|||
124548578|NCT01306968|447962647|FG003|Overall Study|Relocated and left active duty|1|||
124548579|NCT01306968|447962644|FG000|Overall Study|Withdrew - time commitment|0|||
124548580|NCT01306968|447962645|FG001|Overall Study|Withdrew - time commitment|0|||
124548581|NCT01306968|447962646|FG002|Overall Study|Withdrew - time commitment|0|||
124548582|NCT01306968|447962647|FG003|Overall Study|Withdrew - time commitment|2|||
124548583|NCT01306968|447962644|FG000|Overall Study|Withdrew over privacy concerns|0|||
124548584|NCT01306968|447962645|FG001|Overall Study|Withdrew over privacy concerns|0|||
124548585|NCT01306968|447962646|FG002|Overall Study|Withdrew over privacy concerns|0|||
124548586|NCT01306968|447962647|FG003|Overall Study|Withdrew over privacy concerns|1|||
124548587|NCT04993339|447962648|FG000|Overall Study|Lost to Follow-up|0|||
124548588|NCT04993339|447962649|FG001|Overall Study|Lost to Follow-up|1|||
124548589|NCT04993339|447962648|FG000|Overall Study|no MRI scan|3|||
124548590|NCT04993339|447962649|FG001|Overall Study|no MRI scan|1|||
124548591|NCT03868059|447962655|FG000|Overall Study|Adverse Event|3|||
124548592|NCT03868059|447962655|FG000|Overall Study|Lost to Follow-up|3|||
124548593|NCT03868059|447962655|FG000|Overall Study|Withdrawal by Subject|6|||
124548594|NCT02949219|447962656|FG000|Overall Study|Withdrawal by Subject|1|||
124548595|NCT02044094|447962673|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
124706482|NCT02835690|448551658|FG000|Overall Study|Did Not Continue on Extension Study|0|||
124706483|NCT02835690|448551659|FG001|Overall Study|Did Not Continue on Extension Study|0|||
124706484|NCT02835690|448551660|FG002|Overall Study|Did Not Continue on Extension Study|1|||
124706485|NCT02835690|448551658|FG000|Overall Study|Not Treated|0|||
124706486|NCT02835690|448551659|FG001|Overall Study|Not Treated|2|||
124706487|NCT02835690|448551660|FG002|Overall Study|Not Treated|0|||
124706488|NCT03674281|448551661|FG000|Overall Study|screen failure|2|||
124706489|NCT03674281|448551662|FG001|Overall Study|screen failure|0|||
124706490|NCT03674281|448551663|FG002|Overall Study|screen failure|0|||
124706491|NCT03674281|448551661|FG000|Overall Study|Withdrawal by Subject|1|||
124706492|NCT03674281|448551662|FG001|Overall Study|Withdrawal by Subject|3|||
124706493|NCT03674281|448551663|FG002|Overall Study|Withdrawal by Subject|3|||
124706494|NCT00710593|448551664|FG000|Overall Study|Incarceration|1|||
124706495|NCT00710593|448551665|FG001|Overall Study|Incarceration|0|||
124706496|NCT00710593|448551664|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
124706497|NCT00710593|448551665|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
124706498|NCT00710593|448551664|FG000|Overall Study|Lost to Follow-up|3|||
124706499|NCT00710593|448551665|FG001|Overall Study|Lost to Follow-up|1|||
124706500|NCT00710593|448551664|FG000|Overall Study|Moved out of area|1|||
124706501|NCT00710593|448551665|FG001|Overall Study|Moved out of area|0|||
124706502|NCT00710593|448551664|FG000|Overall Study|Failure to adhere or complete study eval|1|||
124706503|NCT00710593|448551665|FG001|Overall Study|Failure to adhere or complete study eval|1|||
124706504|NCT00710593|448551664|FG000|Overall Study|Protocol Violation|1|||
124706505|NCT00710593|448551665|FG001|Overall Study|Protocol Violation|1|||
124706506|NCT00710593|448551664|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
124706507|NCT00710593|448551665|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
124706508|NCT04490278|448551666|FG000|Overall Study|Lost to Follow-up|6|||
124548596|NCT02044094|447962673|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
124548597|NCT02044094|447962673|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
124548598|NCT02044094|447962673|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
124548599|NCT02044094|447962673|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
124949056|NCT00090519|449440124|FG001|Overall Study|Lost to Follow-up|29|||
124949057|NCT00090519|449440123|FG000|Overall Study|Withdrawal by Subject|28|||
124949058|NCT00090519|449440124|FG001|Overall Study|Withdrawal by Subject|29|||
124949059|NCT00090519|449440123|FG000|Overall Study|Physician Decision|2|||
124949060|NCT00090519|449440124|FG001|Overall Study|Physician Decision|3|||
124949061|NCT00090519|449440123|FG000|Overall Study|Sponsor Decision|3|||
124949062|NCT00090519|449440124|FG001|Overall Study|Sponsor Decision|1|||
124949063|NCT02161146|449440125|FG000|Overall Study|Adverse Event|1|||
124949064|NCT02161146|449440126|FG001|Overall Study|Adverse Event|1|||
124949065|NCT02161146|449440127|FG002|Overall Study|Adverse Event|0|||
124949066|NCT02161146|449440128|FG003|Overall Study|Adverse Event|1|||
124949067|NCT02161146|449440129|FG004|Overall Study|Adverse Event|0|||
124949068|NCT02161146|449440125|FG000|Overall Study|Lost to Follow-up|0|||
124949069|NCT02161146|449440126|FG001|Overall Study|Lost to Follow-up|1|||
124949070|NCT02161146|449440127|FG002|Overall Study|Lost to Follow-up|0|||
124949071|NCT02161146|449440128|FG003|Overall Study|Lost to Follow-up|0|||
124949072|NCT02161146|449440129|FG004|Overall Study|Lost to Follow-up|0|||
124949073|NCT02161146|449440125|FG000|Overall Study|Personal Reasons|0|||
124949074|NCT02161146|449440126|FG001|Overall Study|Personal Reasons|1|||
124949075|NCT02161146|449440127|FG002|Overall Study|Personal Reasons|0|||
124949076|NCT02161146|449440128|FG003|Overall Study|Personal Reasons|2|||
124949077|NCT02161146|449440129|FG004|Overall Study|Personal Reasons|1|||
124949078|NCT02161146|449440125|FG000|Overall Study|Other Miscellaneous Reasons|0|||
124949079|NCT02161146|449440126|FG001|Overall Study|Other Miscellaneous Reasons|1|||
124949080|NCT02161146|449440127|FG002|Overall Study|Other Miscellaneous Reasons|0|||
124949081|NCT02161146|449440128|FG003|Overall Study|Other Miscellaneous Reasons|0|||
124949082|NCT02161146|449440129|FG004|Overall Study|Other Miscellaneous Reasons|0|||
124949083|NCT02613403|449440132|FG000|Overall Study|Lost to Follow-up|0|||
124949084|NCT02613403|449440133|FG001|Overall Study|Lost to Follow-up|1|||
124949085|NCT02613403|449440134|FG002|Overall Study|Lost to Follow-up|0|||
124949086|NCT02613403|449440135|FG003|Overall Study|Lost to Follow-up|0|||
124949087|NCT02613403|449440136|FG004|Overall Study|Lost to Follow-up|0|||
124949088|NCT02613403|449440132|FG000|Overall Study|Withdrawal by Subject|2|||
124949089|NCT02613403|449440133|FG001|Overall Study|Withdrawal by Subject|0|||
124949090|NCT02613403|449440134|FG002|Overall Study|Withdrawal by Subject|0|||
124949091|NCT02613403|449440135|FG003|Overall Study|Withdrawal by Subject|0|||
124949092|NCT02613403|449440136|FG004|Overall Study|Withdrawal by Subject|0|||
124949093|NCT02189759|449440137|FG000|Overall Study|Lost to Follow-up|0|||
124949094|NCT02189759|449440138|FG001|Overall Study|Lost to Follow-up|0|||
124949095|NCT02189759|449440139|FG002|Overall Study|Lost to Follow-up|2|||
124949096|NCT02189759|449440140|FG003|Overall Study|Lost to Follow-up|5|||
124949097|NCT00800176|449440143|FG000|Overall Study|Adverse Event|2|||
124949098|NCT00800176|449440144|FG001|Overall Study|Adverse Event|1|||
124949099|NCT00800176|449440145|FG002|Overall Study|Adverse Event|0|||
124949100|NCT00800176|449440146|FG003|Overall Study|Adverse Event|2|||
124949101|NCT00800176|449440147|FG004|Overall Study|Adverse Event|1|||
124949102|NCT00800176|449440148|FG005|Overall Study|Adverse Event|1|||
124949103|NCT00800176|449440143|FG000|Overall Study|Refused treatment|3|||
124949104|NCT00800176|449440144|FG001|Overall Study|Refused treatment|2|||
124949105|NCT00800176|449440145|FG002|Overall Study|Refused treatment|0|||
124949106|NCT00800176|449440146|FG003|Overall Study|Refused treatment|0|||
124949107|NCT00800176|449440147|FG004|Overall Study|Refused treatment|1|||
124949108|NCT00800176|449440148|FG005|Overall Study|Refused treatment|4|||
124949109|NCT00800176|449440143|FG000|Overall Study|Failure to return|3|||
124949110|NCT00800176|449440144|FG001|Overall Study|Failure to return|3|||
124548600|NCT02044094|447962673|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
124548601|NCT02044094|447962673|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
124548602|NCT02044094|447962673|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
124949111|NCT00800176|449440145|FG002|Overall Study|Failure to return|0|||
124949112|NCT00800176|449440146|FG003|Overall Study|Failure to return|2|||
124949113|NCT00800176|449440147|FG004|Overall Study|Failure to return|0|||
124949114|NCT00800176|449440148|FG005|Overall Study|Failure to return|0|||
124949115|NCT00800176|449440143|FG000|Overall Study|Other|1|||
124949116|NCT00800176|449440144|FG001|Overall Study|Other|0|||
124949117|NCT00800176|449440145|FG002|Overall Study|Other|0|||
124949118|NCT00800176|449440146|FG003|Overall Study|Other|0|||
124949119|NCT00800176|449440147|FG004|Overall Study|Other|2|||
124949120|NCT00800176|449440148|FG005|Overall Study|Other|0|||
124949121|NCT02548585|449440151|FG000|Overall Study|Withdrawal by Subject|0|||
124949122|NCT02548585|449440152|FG001|Overall Study|Withdrawal by Subject|0|||
124949123|NCT02548585|449440153|FG002|Overall Study|Withdrawal by Subject|0|||
124949124|NCT02548585|449440154|FG003|Overall Study|Withdrawal by Subject|0|||
124949125|NCT02548585|449440155|FG004|Overall Study|Withdrawal by Subject|0|||
124949126|NCT02548585|449440156|FG005|Overall Study|Withdrawal by Subject|1|||
124949127|NCT02548585|449440157|FG006|Overall Study|Withdrawal by Subject|0|||
124949128|NCT02548585|449440151|FG000|Overall Study|Lost to Follow-up|1|||
124949129|NCT02548585|449440152|FG001|Overall Study|Lost to Follow-up|0|||
124949130|NCT02548585|449440153|FG002|Overall Study|Lost to Follow-up|0|||
124949131|NCT02548585|449440154|FG003|Overall Study|Lost to Follow-up|0|||
124949132|NCT02548585|449440155|FG004|Overall Study|Lost to Follow-up|0|||
124949133|NCT02548585|449440156|FG005|Overall Study|Lost to Follow-up|0|||
124949134|NCT02548585|449440157|FG006|Overall Study|Lost to Follow-up|0|||
124949135|NCT02548585|449440151|FG000|Overall Study|Other|1|||
124949136|NCT02548585|449440152|FG001|Overall Study|Other|0|||
124949137|NCT02548585|449440153|FG002|Overall Study|Other|0|||
124949138|NCT02548585|449440154|FG003|Overall Study|Other|2|||
124949139|NCT02548585|449440155|FG004|Overall Study|Other|3|||
124949140|NCT02548585|449440156|FG005|Overall Study|Other|0|||
124949141|NCT02548585|449440157|FG006|Overall Study|Other|1|||
124949142|NCT02548585|449440151|FG000|Overall Study|Randomized but not treated|0|||
124949143|NCT02548585|449440152|FG001|Overall Study|Randomized but not treated|0|||
124949144|NCT02548585|449440153|FG002|Overall Study|Randomized but not treated|0|||
124949145|NCT02548585|449440154|FG003|Overall Study|Randomized but not treated|0|||
124949146|NCT02548585|449440155|FG004|Overall Study|Randomized but not treated|0|||
124949147|NCT02548585|449440156|FG005|Overall Study|Randomized but not treated|1|||
124949148|NCT02548585|449440157|FG006|Overall Study|Randomized but not treated|0|||
124949149|NCT03242863|449440161|FG000|Study Week 1|Withdrawal by Subject|0|||
124949150|NCT03242863|449440162|FG001|Study Week 1|Withdrawal by Subject|1|||
124949151|NCT03242863|449440163|FG002|Study Week 1|Withdrawal by Subject|0|||
124949152|NCT03242863|449440164|FG003|Study Week 1|Withdrawal by Subject|0|||
124459141|NCT03099187|447640563|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
124459142|NCT03099187|447640564|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
124459143|NCT03099187|447640565|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
124706509|NCT02829996|448551669|FG000|Overall Study|Withdrawal by Subject|1|||
124949153|NCT03242863|449440165|FG004|Study Week 1|Withdrawal by Subject|3|||
124949154|NCT03242863|449440166|FG005|Study Week 1|Withdrawal by Subject|0|||
124949155|NCT01079949|449440170|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
124949156|NCT01079949|449440171|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
124949157|NCT01079949|449440170|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
124949158|NCT01079949|449440171|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
124949159|NCT01079949|449440170|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
124949160|NCT01079949|449440171|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
124949161|NCT01079949|449440170|FG000|Overall Study|Randomized but not treated|1|||
124949162|NCT01079949|449440171|FG001|Overall Study|Randomized but not treated|0|||
124949163|NCT02144285|449440172|FG000|Overall Study|Withdrawal by Subject|0|||
124949164|NCT02144285|449440173|FG001|Overall Study|Withdrawal by Subject|0|||
124949165|NCT02144285|449440174|FG002|Overall Study|Withdrawal by Subject|0|||
124949166|NCT02144285|449440175|FG003|Overall Study|Withdrawal by Subject|0|||
124949167|NCT02144285|449440176|FG004|Overall Study|Withdrawal by Subject|1|||
124949168|NCT02144285|449440177|FG005|Overall Study|Withdrawal by Subject|0|||
124949169|NCT02144285|449440178|FG006|Overall Study|Withdrawal by Subject|0|||
124949170|NCT02144285|449440179|FG007|Overall Study|Withdrawal by Subject|0|||
124949171|NCT02144285|449440180|FG008|Overall Study|Withdrawal by Subject|0|||
124949172|NCT02144285|449440181|FG009|Overall Study|Withdrawal by Subject|0|||
124949173|NCT01529632|449440182|FG000|Overall Study|Administrative problem|2|||
124949174|NCT01529632|449440183|FG001|Overall Study|Administrative problem|1|||
124949175|NCT01529632|449440182|FG000|Overall Study|Protocol Violation|0|||
124949176|NCT01529632|449440183|FG001|Overall Study|Protocol Violation|1|||
124949177|NCT01529632|449440182|FG000|Overall Study|Adverse Event|1|||
124949178|NCT01529632|449440183|FG001|Overall Study|Adverse Event|1|||
124949179|NCT01276509|449441778|FG000|Overall Study|Adverse Event|9|||
124949180|NCT01276509|449441779|FG001|Overall Study|Adverse Event|8|||
124949181|NCT01276509|449441780|FG002|Overall Study|Adverse Event|4|||
124949182|NCT01276509|449441781|FG003|Overall Study|Adverse Event|3|||
124949183|NCT01276509|449441778|FG000|Overall Study|Lack of Efficacy|2|||
124459144|NCT03099187|447640566|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
124949184|NCT01276509|449441779|FG001|Overall Study|Lack of Efficacy|1|||
124949185|NCT01276509|449441780|FG002|Overall Study|Lack of Efficacy|1|||
124949186|NCT01276509|449441781|FG003|Overall Study|Lack of Efficacy|2|||
124949187|NCT01276509|449441778|FG000|Overall Study|Pregnancy|1|||
124949188|NCT01276509|449441779|FG001|Overall Study|Pregnancy|0|||
124949189|NCT01276509|449441780|FG002|Overall Study|Pregnancy|0|||
124949190|NCT01276509|449441781|FG003|Overall Study|Pregnancy|0|||
124949191|NCT01276509|449441778|FG000|Overall Study|Withdrawal by Subject|1|||
124949192|NCT01276509|449441779|FG001|Overall Study|Withdrawal by Subject|2|||
124949193|NCT01276509|449441780|FG002|Overall Study|Withdrawal by Subject|0|||
124949194|NCT01276509|449441781|FG003|Overall Study|Withdrawal by Subject|0|||
124548603|NCT03353415|447962676|FG000|Masked CGM Wear|Lost to Follow-up|2|||
124949195|NCT01276509|449441778|FG000|Overall Study|Other|0|||
124949196|NCT01276509|449441779|FG001|Overall Study|Other|1|||
124949197|NCT01276509|449441780|FG002|Overall Study|Other|0|||
124949198|NCT01276509|449441781|FG003|Overall Study|Other|0|||
124949199|NCT02196259|449441787|FG000|Overall Study|Researcher choice|0|||
124949200|NCT02196259|449441788|FG001|Overall Study|Researcher choice|0|||
124949201|NCT02196259|449441789|FG002|Overall Study|Researcher choice|1|||
124949202|NCT02196259|449441787|FG000|Overall Study|Partial data analysis|0|||
124706510|NCT02829996|448551670|FG001|Overall Study|Withdrawal by Subject|0|||
124706511|NCT02829996|448551671|FG002|Overall Study|Withdrawal by Subject|0|||
124706512|NCT02829996|448551672|FG003|Overall Study|Withdrawal by Subject|0|||
124706513|NCT02829996|448551673|FG004|Overall Study|Withdrawal by Subject|0|||
124706514|NCT01441960|448551674|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
124949203|NCT02196259|449441788|FG001|Overall Study|Partial data analysis|3|||
124949204|NCT02196259|449441789|FG002|Overall Study|Partial data analysis|0|||
124949205|NCT01668355|449441790|FG000|Overall Study|Death|3|||
124949206|NCT01668355|449441791|FG001|Overall Study|Death|1|||
124706515|NCT01441960|448551675|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
124949207|NCT01668355|449441790|FG000|Overall Study|Withdrawal by Subject|6|||
124949208|NCT01668355|449441791|FG001|Overall Study|Withdrawal by Subject|1|||
124949209|NCT00215943|449441792|FG000|Overall Study|Disease Progression|3|||
124949210|NCT00215943|449441793|FG001|Overall Study|Disease Progression|5|||
124459145|NCT03099187|447640563|FG000|Double-blind Treatment|Disease progression|0|||
124459146|NCT03099187|447640564|FG001|Double-blind Treatment|Disease progression|1|||
124459147|NCT03099187|447640565|FG002|Double-blind Treatment|Disease progression|0|||
124459148|NCT03099187|447640566|FG003|Double-blind Treatment|Disease progression|0|||
124459149|NCT03099187|447640563|FG000|Double-blind Treatment|Randomization error|0|||
124459150|NCT03099187|447640564|FG001|Double-blind Treatment|Randomization error|2|||
124459151|NCT03099187|447640565|FG002|Double-blind Treatment|Randomization error|0|||
124459152|NCT03099187|447640566|FG003|Double-blind Treatment|Randomization error|0|||
124459153|NCT03099187|447640563|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
124459154|NCT03099187|447640564|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
124459155|NCT03099187|447640565|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
124459156|NCT03099187|447640566|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
124459157|NCT03099187|447640563|FG000|12-month Safety Follow-up|Adverse Event|0|||
124459158|NCT03099187|447640564|FG001|12-month Safety Follow-up|Adverse Event|0|||
124459159|NCT03099187|447640565|FG002|12-month Safety Follow-up|Adverse Event|5|||
124459160|NCT03099187|447640566|FG003|12-month Safety Follow-up|Adverse Event|12|||
124459161|NCT03099187|447640563|FG000|12-month Safety Follow-up|Death|0|||
124459162|NCT03099187|447640564|FG001|12-month Safety Follow-up|Death|0|||
124459163|NCT03099187|447640565|FG002|12-month Safety Follow-up|Death|7|||
124459164|NCT03099187|447640566|FG003|12-month Safety Follow-up|Death|9|||
124459165|NCT03099187|447640563|FG000|12-month Safety Follow-up|Lung transplantation|0|||
124459166|NCT03099187|447640564|FG001|12-month Safety Follow-up|Lung transplantation|0|||
124459167|NCT03099187|447640565|FG002|12-month Safety Follow-up|Lung transplantation|2|||
124459168|NCT03099187|447640566|FG003|12-month Safety Follow-up|Lung transplantation|1|||
124459169|NCT03099187|447640563|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
124459170|NCT03099187|447640564|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
124459171|NCT03099187|447640565|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
124459172|NCT03099187|447640566|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
124459173|NCT03099187|447640563|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
124459174|NCT03099187|447640564|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
124459175|NCT03099187|447640565|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
124459176|NCT03099187|447640566|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
124459177|NCT03099187|447640563|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
124459178|NCT03099187|447640564|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
124459179|NCT03099187|447640565|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
124459180|NCT03099187|447640566|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
124459181|NCT03099187|447640563|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
124459182|NCT03099187|447640564|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
124459183|NCT03099187|447640565|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
124459184|NCT03099187|447640566|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
124459185|NCT01100437|447640567|FG000|Titration/Stabilization|Adverse Event|0|||
124459186|NCT01100437|447640568|FG001|Titration/Stabilization|Adverse Event|0|||
124459187|NCT01100437|447640569|FG002|Titration/Stabilization|Adverse Event|4|||
124459188|NCT01100437|447640567|FG000|Titration/Stabilization|Non-compliance|0|||
124459189|NCT01100437|447640568|FG001|Titration/Stabilization|Non-compliance|0|||
124459190|NCT01100437|447640569|FG002|Titration/Stabilization|Non-compliance|1|||
124459191|NCT01100437|447640567|FG000|Titration/Stabilization|Sponsor canceled study|0|||
124459192|NCT01100437|447640568|FG001|Titration/Stabilization|Sponsor canceled study|0|||
124459193|NCT01100437|447640569|FG002|Titration/Stabilization|Sponsor canceled study|1|||
124459194|NCT01100437|447640567|FG000|Maintenance|Withdrawal by Subject|0|||
124459195|NCT01100437|447640568|FG001|Maintenance|Withdrawal by Subject|0|||
124459196|NCT01100437|447640569|FG002|Maintenance|Withdrawal by Subject|1|||
124459197|NCT01100437|447640567|FG000|Maintenance|Sponsor termination of study|0|||
124459198|NCT01100437|447640568|FG001|Maintenance|Sponsor termination of study|0|||
124459199|NCT01100437|447640569|FG002|Maintenance|Sponsor termination of study|1|||
124459200|NCT03077685|447640572|FG000|Overall Study|Lost to Follow-up|0|||
124459201|NCT03077685|447640573|FG001|Overall Study|Lost to Follow-up|0|||
124459202|NCT03077685|447640574|FG002|Overall Study|Lost to Follow-up|0|||
124706516|NCT01441960|448551674|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
124706517|NCT01441960|448551675|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
124706518|NCT01441960|448551674|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
124706519|NCT01441960|448551675|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
124706520|NCT02986074|448551677|FG000|First Trial Period|Adverse Event|1|||
124706521|NCT02986074|448551678|FG001|First Trial Period|Adverse Event|0|||
124706522|NCT02986074|448551679|FG002|First Trial Period|Adverse Event|0|||
124949211|NCT00215943|449441792|FG000|Overall Study|Alternate therapy|0|||
124949212|NCT00215943|449441793|FG001|Overall Study|Alternate therapy|1|||
124949213|NCT00215943|449441792|FG000|Overall Study|Adverse Event|3|||
124949214|NCT00215943|449441793|FG001|Overall Study|Adverse Event|6|||
124949215|NCT00215943|449441792|FG000|Overall Study|Other disease|0|||
124949216|NCT00215943|449441793|FG001|Overall Study|Other disease|1|||
124949217|NCT00215943|449441792|FG000|Overall Study|Other complications|3|||
124949218|NCT00215943|449441793|FG001|Overall Study|Other complications|1|||
124949219|NCT00403845|449441800|FG000|Treatment Period 1|Subject withdrew consent|1|||
124949220|NCT00403845|449441801|FG001|Treatment Period 1|Subject withdrew consent|0|||
124949221|NCT00403845|449441802|FG002|Treatment Period 1|Subject withdrew consent|0|||
124765372|NCT04949191|448767414|FG001|Overall Study|Progressive Disease|1|||
124765373|NCT04949191|448767415|FG002|Overall Study|Progressive Disease|0|||
124949222|NCT00403845|449441803|FG003|Treatment Period 1|Subject withdrew consent|0|||
124949223|NCT00403845|449441800|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
124949224|NCT00403845|449441801|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
124949225|NCT00403845|449441802|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
124949226|NCT00403845|449441803|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
124949227|NCT00403845|449441800|FG000|Treatment Period 2|Subject withdrew consent|1|||
124765374|NCT04949191|448767416|FG003|Overall Study|Progressive Disease|0|||
124949228|NCT00403845|449441801|FG001|Treatment Period 2|Subject withdrew consent|0|||
124949229|NCT00403845|449441802|FG002|Treatment Period 2|Subject withdrew consent|0|||
124949230|NCT00403845|449441803|FG003|Treatment Period 2|Subject withdrew consent|0|||
124949231|NCT00403845|449441800|FG000|Treatment Period 3|Subject withdrew consent|0|||
124949232|NCT00403845|449441801|FG001|Treatment Period 3|Subject withdrew consent|0|||
124949233|NCT00403845|449441802|FG002|Treatment Period 3|Subject withdrew consent|0|||
124949234|NCT00403845|449441803|FG003|Treatment Period 3|Subject withdrew consent|1|||
124949235|NCT00403845|449441800|FG000|Treatment Period 3|Adverse Event|0|||
124949236|NCT00403845|449441801|FG001|Treatment Period 3|Adverse Event|0|||
124949237|NCT00403845|449441802|FG002|Treatment Period 3|Adverse Event|0|||
124765375|NCT04949191|448767413|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
124765376|NCT04949191|448767414|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
124765377|NCT04949191|448767415|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
124765378|NCT04949191|448767416|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
124765379|NCT04949191|448767413|FG000|Overall Study|Sponsor Terminated Study|0|||
124765380|NCT04949191|448767414|FG001|Overall Study|Sponsor Terminated Study|0|||
124765381|NCT04949191|448767415|FG002|Overall Study|Sponsor Terminated Study|1|||
124765382|NCT04949191|448767416|FG003|Overall Study|Sponsor Terminated Study|1|||
124765383|NCT02913482|448767417|FG000|Overall Study|Death|0|||
124765384|NCT02913482|448767418|FG001|Overall Study|Death|2|||
124765385|NCT02913482|448767419|FG002|Overall Study|Death|2|||
124765386|NCT02913482|448767417|FG000|Overall Study|Progressive Disease|1|||
124765387|NCT02913482|448767418|FG001|Overall Study|Progressive Disease|1|||
124765388|NCT02913482|448767419|FG002|Overall Study|Progressive Disease|1|||
124765389|NCT02913482|448767417|FG000|Overall Study|Reason not specified|0|||
124765390|NCT02913482|448767418|FG001|Overall Study|Reason not specified|0|||
124765391|NCT02913482|448767419|FG002|Overall Study|Reason not specified|1|||
124765392|NCT02913482|448767417|FG000|Overall Study|Withdrawal by Subject|0|||
124765393|NCT02913482|448767418|FG001|Overall Study|Withdrawal by Subject|1|||
124765394|NCT02913482|448767419|FG002|Overall Study|Withdrawal by Subject|1|||
124765395|NCT00918385|448767422|FG000|Monotherapy|Adverse Event|1|||
124765396|NCT00918385|448767423|FG001|Monotherapy|Adverse Event|6|||
124765397|NCT00918385|448767422|FG000|Monotherapy|Complicating illness|1|||
124949238|NCT00403845|449441803|FG003|Treatment Period 3|Adverse Event|1|||
124765398|NCT00918385|448767423|FG001|Monotherapy|Complicating illness|0|||
124765399|NCT00918385|448767422|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
124949239|NCT00805792|449441804|FG000|Overall Study|Death|3|||
124949240|NCT00805792|449441804|FG000|Overall Study|Lost to Follow-up|2|||
124949241|NCT02152384|449441805|FG000|Period 1|Withdrawal by Subject|0|||
124949242|NCT02152384|449441806|FG001|Period 1|Withdrawal by Subject|1|||
124765400|NCT00918385|448767423|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
124949243|NCT02152384|449441805|FG000|Period 1|Adverse Event|1|||
124949244|NCT02152384|449441806|FG001|Period 1|Adverse Event|1|||
124949245|NCT01393964|449441811|FG000|Overall Study|Disease Progression|4|||
124949246|NCT01393964|449441812|FG001|Overall Study|Disease Progression|3|||
124949247|NCT01393964|449441813|FG002|Overall Study|Disease Progression|5|||
124765401|NCT00918385|448767422|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
124765402|NCT00918385|448767423|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
124765403|NCT00918385|448767422|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
124765404|NCT00918385|448767423|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
124765405|NCT00918385|448767422|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
124765406|NCT00918385|448767423|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
124765407|NCT00317473|448767425|FG000|Overall Study|Withdrawal by Subject|2|||
124765408|NCT00317473|448767426|FG001|Overall Study|Withdrawal by Subject|1|||
124765409|NCT00317473|448767427|FG002|Overall Study|Withdrawal by Subject|2|||
124765410|NCT00317473|448767428|FG003|Overall Study|Withdrawal by Subject|1|||
124765411|NCT00317473|448767429|FG004|Overall Study|Withdrawal by Subject|3|||
124765412|NCT00317473|448767430|FG005|Overall Study|Withdrawal by Subject|1|||
124765413|NCT00317473|448767425|FG000|Overall Study|Relocation|1|||
124765414|NCT00317473|448767426|FG001|Overall Study|Relocation|0|||
124765415|NCT00317473|448767427|FG002|Overall Study|Relocation|1|||
124765416|NCT00317473|448767428|FG003|Overall Study|Relocation|1|||
124765417|NCT00317473|448767429|FG004|Overall Study|Relocation|5|||
124765418|NCT00317473|448767430|FG005|Overall Study|Relocation|2|||
124765419|NCT00317473|448767425|FG000|Overall Study|Death|1|||
124765420|NCT00317473|448767426|FG001|Overall Study|Death|0|||
124765421|NCT00317473|448767427|FG002|Overall Study|Death|0|||
124765422|NCT00317473|448767428|FG003|Overall Study|Death|0|||
124765423|NCT00317473|448767429|FG004|Overall Study|Death|0|||
124765424|NCT00317473|448767430|FG005|Overall Study|Death|0|||
124765425|NCT00317473|448767425|FG000|Overall Study|Other|0|||
124765426|NCT00317473|448767426|FG001|Overall Study|Other|2|||
124765427|NCT00317473|448767427|FG002|Overall Study|Other|0|||
124765428|NCT00317473|448767428|FG003|Overall Study|Other|0|||
124765429|NCT00317473|448767429|FG004|Overall Study|Other|0|||
124765430|NCT00317473|448767430|FG005|Overall Study|Other|0|||
124765431|NCT01323582|448767434|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
124765432|NCT01323582|448767435|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
124765433|NCT01323582|448767434|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
124765434|NCT01323582|448767435|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
124765435|NCT01323582|448767434|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
124765436|NCT01323582|448767435|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
124765437|NCT03416868|448767436|FG000|Overall Study|Withdrawal by Subject|2|||
124765438|NCT03416868|448767436|FG000|Overall Study|Lost to Follow-up|1|||
124765439|NCT00083889|448767437|FG000|Overall Study|Adverse Event|76|||
124765440|NCT00083889|448767438|FG001|Overall Study|Adverse Event|86|||
124765441|NCT00083889|448767437|FG000|Overall Study|Protocol Violation|2|||
124765442|NCT00083889|448767438|FG001|Overall Study|Protocol Violation|2|||
124765443|NCT00083889|448767437|FG000|Overall Study|Withdrawal by Subject|22|||
124765444|NCT00083889|448767438|FG001|Overall Study|Withdrawal by Subject|24|||
124765445|NCT00083889|448767437|FG000|Overall Study|Lack of Efficacy|240|||
124765446|NCT00083889|448767438|FG001|Overall Study|Lack of Efficacy|219|||
124765447|NCT00083889|448767437|FG000|Overall Study|Decision of sponsor|32|||
124765448|NCT00083889|448767438|FG001|Overall Study|Decision of sponsor|4|||
124765449|NCT00083889|448767437|FG000|Overall Study|Randomized: did not take study drug|0|||
124765450|NCT00083889|448767438|FG001|Overall Study|Randomized: did not take study drug|15|||
124765451|NCT00083889|448767437|FG000|Overall Study|Completed on marketed sunitinub|3|||
124765452|NCT00083889|448767438|FG001|Overall Study|Completed on marketed sunitinub|0|||
124765453|NCT00083889|448767437|FG000|Overall Study|Crossover to SU011248|0|||
124765454|NCT00083889|448767438|FG001|Overall Study|Crossover to SU011248|25|||
124765455|NCT00388349|448767439|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
124765456|NCT00388349|448767440|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
124765457|NCT00112736|448767441|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
124765458|NCT00112736|448767442|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
124459203|NCT03077685|447640575|FG003|Overall Study|Lost to Follow-up|0|||
124459204|NCT03077685|447640576|FG004|Overall Study|Lost to Follow-up|1|||
124459205|NCT03077685|447640572|FG000|Overall Study|Death|0|||
124459206|NCT03077685|447640573|FG001|Overall Study|Death|0|||
124765459|NCT05435339|448767443|FG000|Overall Study|Death|1|||
124459207|NCT03077685|447640574|FG002|Overall Study|Death|1|||
124459208|NCT03077685|447640575|FG003|Overall Study|Death|1|||
124765460|NCT05435339|448767444|FG001|Overall Study|Death|0|||
124765461|NCT05435339|448767445|FG002|Overall Study|Death|3|||
124765462|NCT05435339|448767446|FG003|Overall Study|Death|1|||
124765463|NCT05435339|448767447|FG004|Overall Study|Death|3|||
124949248|NCT01393964|449441811|FG000|Overall Study|Study drug toxicity|1|||
124949249|NCT01393964|449441812|FG001|Overall Study|Study drug toxicity|0|||
124765464|NCT05435339|448767448|FG005|Overall Study|Death|2|||
124765465|NCT05435339|448767449|FG006|Overall Study|Death|4|||
124765466|NCT05435339|448767450|FG007|Overall Study|Death|6|||
124765467|NCT05435339|448767443|FG000|Overall Study|Sponsor Decision|0|||
124949250|NCT01393964|449441813|FG002|Overall Study|Study drug toxicity|0|||
124765468|NCT05435339|448767444|FG001|Overall Study|Sponsor Decision|1|||
124765469|NCT05435339|448767445|FG002|Overall Study|Sponsor Decision|0|||
124765470|NCT05435339|448767446|FG003|Overall Study|Sponsor Decision|0|||
124765471|NCT05435339|448767447|FG004|Overall Study|Sponsor Decision|2|||
124765472|NCT05435339|448767448|FG005|Overall Study|Sponsor Decision|1|||
124459209|NCT03077685|447640576|FG004|Overall Study|Death|3|||
124459210|NCT03077685|447640572|FG000|Overall Study|Withdrawal by Subject|0|||
124765473|NCT05435339|448767449|FG006|Overall Study|Sponsor Decision|2|||
124765474|NCT05435339|448767450|FG007|Overall Study|Sponsor Decision|2|||
124765475|NCT05435339|448767443|FG000|Overall Study|Withdrawal by Subject|0|||
124949251|NCT01393964|449441811|FG000|Overall Study|Withdrawal by Subject|0|||
124949252|NCT01393964|449441812|FG001|Overall Study|Withdrawal by Subject|0|||
124949253|NCT01393964|449441813|FG002|Overall Study|Withdrawal by Subject|1|||
124949254|NCT01393964|449441811|FG000|Overall Study|Adverse event unrelated to study drug|0|||
124949255|NCT01393964|449441812|FG001|Overall Study|Adverse event unrelated to study drug|3|||
124949256|NCT01393964|449441813|FG002|Overall Study|Adverse event unrelated to study drug|0|||
124949257|NCT01393964|449441811|FG000|Overall Study|Subject request stop study treatment|0|||
124459211|NCT03077685|447640573|FG001|Overall Study|Withdrawal by Subject|0|||
124459212|NCT03077685|447640574|FG002|Overall Study|Withdrawal by Subject|0|||
124459213|NCT03077685|447640575|FG003|Overall Study|Withdrawal by Subject|2|||
124765476|NCT05435339|448767444|FG001|Overall Study|Withdrawal by Subject|0|||
124765477|NCT05435339|448767445|FG002|Overall Study|Withdrawal by Subject|0|||
124765478|NCT05435339|448767446|FG003|Overall Study|Withdrawal by Subject|0|||
124765479|NCT05435339|448767447|FG004|Overall Study|Withdrawal by Subject|1|||
124765480|NCT05435339|448767448|FG005|Overall Study|Withdrawal by Subject|0|||
124765481|NCT05435339|448767449|FG006|Overall Study|Withdrawal by Subject|1|||
124765482|NCT05435339|448767450|FG007|Overall Study|Withdrawal by Subject|1|||
124765483|NCT00537394|448767453|FG000|First Year of Follow-up|Death|7|||
124765484|NCT00537394|448767454|FG001|First Year of Follow-up|Death|0|||
124765485|NCT00537394|448767455|FG002|First Year of Follow-up|Death|0|||
124765486|NCT00537394|448767453|FG000|First Year of Follow-up|Severe debilitation|1|||
124765487|NCT00537394|448767454|FG001|First Year of Follow-up|Severe debilitation|0|||
124765488|NCT00537394|448767455|FG002|First Year of Follow-up|Severe debilitation|1|||
124765489|NCT00537394|448767453|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
124765490|NCT00537394|448767454|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
124765491|NCT00537394|448767455|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
124765492|NCT00537394|448767453|FG000|First Year of Follow-up|Lost to Follow-up|1|||
124765493|NCT00537394|448767454|FG001|First Year of Follow-up|Lost to Follow-up|5|||
124765494|NCT00537394|448767455|FG002|First Year of Follow-up|Lost to Follow-up|1|||
124765495|NCT00537394|448767453|FG000|2nd Year of Follow-up|Death|4|||
124765496|NCT00537394|448767454|FG001|2nd Year of Follow-up|Death|1|||
124765497|NCT00537394|448767455|FG002|2nd Year of Follow-up|Death|2|||
124765498|NCT00537394|448767453|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
124765499|NCT00537394|448767454|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
124765500|NCT00537394|448767455|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
124765501|NCT00537394|448767453|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
124765502|NCT00537394|448767454|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
124765503|NCT00537394|448767455|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
124765504|NCT00537394|448767453|FG000|2nd Year of Follow-up|Clinic site closure|1|||
124765505|NCT00537394|448767454|FG001|2nd Year of Follow-up|Clinic site closure|0|||
124765506|NCT00537394|448767455|FG002|2nd Year of Follow-up|Clinic site closure|0|||
124765507|NCT03473236|448767459|FG000|Overall Study|Withdrawal by Subject|0|||
124765508|NCT03473236|448767460|FG001|Overall Study|Withdrawal by Subject|0|||
124765509|NCT03473236|448767461|FG002|Overall Study|Withdrawal by Subject|0|||
124765510|NCT03473236|448767462|FG003|Overall Study|Withdrawal by Subject|0|||
124765511|NCT03473236|448767463|FG004|Overall Study|Withdrawal by Subject|0|||
124765512|NCT03473236|448767464|FG005|Overall Study|Withdrawal by Subject|1|||
124765513|NCT03473236|448767465|FG006|Overall Study|Withdrawal by Subject|0|||
124459214|NCT03077685|447640576|FG004|Overall Study|Withdrawal by Subject|1|||
124459215|NCT03077685|447640572|FG000|Overall Study|Physician Decision|0|||
124459216|NCT03077685|447640573|FG001|Overall Study|Physician Decision|0|||
124459217|NCT03077685|447640574|FG002|Overall Study|Physician Decision|1|||
124459218|NCT03077685|447640575|FG003|Overall Study|Physician Decision|0|||
124459219|NCT03077685|447640576|FG004|Overall Study|Physician Decision|3|||
124765514|NCT03473236|448767466|FG007|Overall Study|Withdrawal by Subject|0|||
124765515|NCT03473236|448767467|FG008|Overall Study|Withdrawal by Subject|1|||
124548604|NCT03353415|447962676|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
124765516|NCT03473236|448767468|FG009|Overall Study|Withdrawal by Subject|0|||
124765517|NCT00685165|448767469|FG000|Washout Period of 14 Days|Adverse Event|1|||
124459220|NCT03077685|447640572|FG000|Overall Study|Disease Progression|1|||
124459221|NCT03077685|447640573|FG001|Overall Study|Disease Progression|0|||
124765518|NCT00685165|448767470|FG001|Washout Period of 14 Days|Adverse Event|0|||
124765519|NCT05135871|448767471|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
124765520|NCT05135871|448767472|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
124765521|NCT05135871|448767473|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
124765522|NCT05135871|448767474|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
124765523|NCT04886154|448767480|FG000|Overall Study|Adverse Event|0|||
124765524|NCT04886154|448767481|FG001|Overall Study|Adverse Event|0|||
124765525|NCT04886154|448767482|FG002|Overall Study|Adverse Event|0|||
124765526|NCT04886154|448767483|FG003|Overall Study|Adverse Event|0|||
124765527|NCT04886154|448767484|FG004|Overall Study|Adverse Event|1|||
124765528|NCT04886154|448767485|FG005|Overall Study|Adverse Event|0|||
124765529|NCT04886154|448767486|FG006|Overall Study|Adverse Event|0|||
124765530|NCT04886154|448767487|FG007|Overall Study|Adverse Event|1|||
124765531|NCT04886154|448767488|FG008|Overall Study|Adverse Event|1|||
124765532|NCT04886154|448767489|FG009|Overall Study|Adverse Event|0|||
124765533|NCT04886154|448767490|FG010|Overall Study|Adverse Event|0|||
124765534|NCT04886154|448767491|FG011|Overall Study|Adverse Event|1|||
124765535|NCT04886154|448767492|FG012|Overall Study|Adverse Event|0|||
124765536|NCT04886154|448767493|FG013|Overall Study|Adverse Event|0|||
124765537|NCT04886154|448767494|FG014|Overall Study|Adverse Event|3|||
124765538|NCT04886154|448767480|FG000|Overall Study|Lost to Follow-up|1|||
124765539|NCT04886154|448767481|FG001|Overall Study|Lost to Follow-up|0|||
124765540|NCT04886154|448767482|FG002|Overall Study|Lost to Follow-up|2|||
124765541|NCT04886154|448767483|FG003|Overall Study|Lost to Follow-up|0|||
124765542|NCT04886154|448767484|FG004|Overall Study|Lost to Follow-up|17|||
124765543|NCT04886154|448767485|FG005|Overall Study|Lost to Follow-up|7|||
124765544|NCT04886154|448767486|FG006|Overall Study|Lost to Follow-up|8|||
124765545|NCT04886154|448767487|FG007|Overall Study|Lost to Follow-up|7|||
124765546|NCT04886154|448767488|FG008|Overall Study|Lost to Follow-up|8|||
124765547|NCT04886154|448767489|FG009|Overall Study|Lost to Follow-up|0|||
124765548|NCT04886154|448767490|FG010|Overall Study|Lost to Follow-up|2|||
124765549|NCT04886154|448767491|FG011|Overall Study|Lost to Follow-up|0|||
124765550|NCT04886154|448767492|FG012|Overall Study|Lost to Follow-up|0|||
124765551|NCT04886154|448767493|FG013|Overall Study|Lost to Follow-up|0|||
124765552|NCT04886154|448767494|FG014|Overall Study|Lost to Follow-up|0|||
124765553|NCT04886154|448767480|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
124765554|NCT04886154|448767481|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
124765555|NCT04886154|448767482|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
124765556|NCT04886154|448767483|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
124765557|NCT04886154|448767484|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
124765558|NCT04886154|448767485|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
124765559|NCT04886154|448767486|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
124765560|NCT04886154|448767487|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
124765561|NCT04886154|448767488|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
124765562|NCT04886154|448767489|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
124765563|NCT04886154|448767490|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
124765564|NCT04886154|448767491|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
124765565|NCT04886154|448767492|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
124765566|NCT04886154|448767493|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
124765567|NCT04886154|448767494|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
124765568|NCT04886154|448767480|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124765569|NCT04886154|448767481|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124765570|NCT04886154|448767482|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124459222|NCT03077685|447640574|FG002|Overall Study|Disease Progression|0|||
124459223|NCT03077685|447640575|FG003|Overall Study|Disease Progression|2|||
124459224|NCT03077685|447640576|FG004|Overall Study|Disease Progression|1|||
124459225|NCT03077685|447640572|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
124459226|NCT03077685|447640573|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
124459227|NCT03077685|447640574|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
124459228|NCT03077685|447640575|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
124459229|NCT03077685|447640576|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
124459230|NCT03077685|447640572|FG000|Overall Study|Subject entered hospice care|0|||
124459231|NCT03077685|447640573|FG001|Overall Study|Subject entered hospice care|0|||
124459232|NCT03077685|447640574|FG002|Overall Study|Subject entered hospice care|0|||
124459233|NCT03077685|447640575|FG003|Overall Study|Subject entered hospice care|0|||
124459234|NCT03077685|447640576|FG004|Overall Study|Subject entered hospice care|1|||
124459235|NCT01246583|447640578|FG000|Overall Study|Lost to Follow-up|0|||
124459236|NCT01246583|447640579|FG001|Overall Study|Lost to Follow-up|0|||
124459237|NCT01246583|447640580|FG002|Overall Study|Lost to Follow-up|0|||
124459238|NCT01246583|447640581|FG003|Overall Study|Lost to Follow-up|1|||
124765571|NCT04886154|448767483|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124765572|NCT04886154|448767484|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124765573|NCT04886154|448767485|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124459239|NCT01246583|447640578|FG000|Overall Study|Protocol Violation|0|||
124548605|NCT02392377|447962677|FG000|Overall Study|Withdrawal by Subject|0|||
124765574|NCT04886154|448767486|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
124765575|NCT04886154|448767487|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124765576|NCT04886154|448767488|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124548606|NCT02392377|447962678|FG001|Overall Study|Withdrawal by Subject|1|||
124706523|NCT02986074|448551680|FG003|First Trial Period|Adverse Event|0|||
124706524|NCT02986074|448551677|FG000|Follow up Period|system explant|0|||
124706525|NCT02986074|448551678|FG001|Follow up Period|system explant|0|||
124706526|NCT02986074|448551679|FG002|Follow up Period|system explant|1|||
124706527|NCT02986074|448551680|FG003|Follow up Period|system explant|2|||
124706528|NCT02986074|448551677|FG000|Follow up Period|Physician Decision|0|||
124706529|NCT02986074|448551678|FG001|Follow up Period|Physician Decision|0|||
124706530|NCT02986074|448551679|FG002|Follow up Period|Physician Decision|0|||
124706531|NCT02986074|448551680|FG003|Follow up Period|Physician Decision|1|||
124706532|NCT00069641|448551685|FG000|Overall Study|Death|1|||
124706533|NCT00069641|448551686|FG001|Overall Study|Death|0|||
124706534|NCT00069641|448551687|FG002|Overall Study|Death|1|||
124706535|NCT03186638|448551688|FG000|Overall Study|Withdrawal by Subject|4|||
124706536|NCT03186638|448551689|FG001|Overall Study|Withdrawal by Subject|4|||
124765577|NCT04886154|448767489|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124765578|NCT04886154|448767490|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124765579|NCT04886154|448767491|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124765580|NCT04886154|448767492|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124765581|NCT04886154|448767493|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124765582|NCT04886154|448767494|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124765583|NCT04886154|448767480|FG000|Overall Study|Other, Not Specified|0|||
124765584|NCT04886154|448767481|FG001|Overall Study|Other, Not Specified|0|||
124765585|NCT04886154|448767482|FG002|Overall Study|Other, Not Specified|0|||
124765586|NCT04886154|448767483|FG003|Overall Study|Other, Not Specified|0|||
124765587|NCT04886154|448767484|FG004|Overall Study|Other, Not Specified|11|||
124765588|NCT04886154|448767485|FG005|Overall Study|Other, Not Specified|8|||
124765589|NCT04886154|448767486|FG006|Overall Study|Other, Not Specified|9|||
124765590|NCT04886154|448767487|FG007|Overall Study|Other, Not Specified|10|||
124765591|NCT04886154|448767488|FG008|Overall Study|Other, Not Specified|6|||
124765592|NCT04886154|448767489|FG009|Overall Study|Other, Not Specified|1|||
124765593|NCT04886154|448767490|FG010|Overall Study|Other, Not Specified|1|||
124765594|NCT04886154|448767491|FG011|Overall Study|Other, Not Specified|2|||
124765595|NCT04886154|448767492|FG012|Overall Study|Other, Not Specified|1|||
124765596|NCT04886154|448767493|FG013|Overall Study|Other, Not Specified|2|||
124765597|NCT04886154|448767494|FG014|Overall Study|Other, Not Specified|3|||
124765598|NCT01400698|448767496|FG000|Overall Study|Lost to Follow-up|2|||
124765599|NCT01400698|448767497|FG001|Overall Study|Lost to Follow-up|5|||
124765600|NCT01400698|448767498|FG002|Overall Study|Lost to Follow-up|2|||
124765601|NCT01400698|448767499|FG003|Overall Study|Lost to Follow-up|1|||
124765602|NCT01400698|448767500|FG004|Overall Study|Lost to Follow-up|4|||
124765603|NCT01400698|448767501|FG005|Overall Study|Lost to Follow-up|3|||
124765604|NCT01400698|448767496|FG000|Overall Study|Withdrawal by Subject|8|||
124765605|NCT01400698|448767497|FG001|Overall Study|Withdrawal by Subject|2|||
124765606|NCT01400698|448767498|FG002|Overall Study|Withdrawal by Subject|0|||
124765607|NCT01400698|448767499|FG003|Overall Study|Withdrawal by Subject|4|||
124765608|NCT01400698|448767500|FG004|Overall Study|Withdrawal by Subject|1|||
124765609|NCT01400698|448767501|FG005|Overall Study|Withdrawal by Subject|3|||
124765610|NCT01400698|448767496|FG000|Overall Study|Protocol Violation|0|||
124765611|NCT01400698|448767497|FG001|Overall Study|Protocol Violation|1|||
124765612|NCT01400698|448767498|FG002|Overall Study|Protocol Violation|0|||
124765613|NCT01400698|448767499|FG003|Overall Study|Protocol Violation|0|||
124765614|NCT01400698|448767500|FG004|Overall Study|Protocol Violation|1|||
124765615|NCT01400698|448767501|FG005|Overall Study|Protocol Violation|0|||
124765616|NCT01400698|448767496|FG000|Overall Study|Non-compliance|0|||
124765617|NCT01400698|448767497|FG001|Overall Study|Non-compliance|1|||
124765618|NCT01400698|448767498|FG002|Overall Study|Non-compliance|0|||
124765619|NCT01400698|448767499|FG003|Overall Study|Non-compliance|1|||
124459240|NCT01246583|447640579|FG001|Overall Study|Protocol Violation|0|||
124765620|NCT01400698|448767500|FG004|Overall Study|Non-compliance|0|||
124765621|NCT01400698|448767501|FG005|Overall Study|Non-compliance|0|||
124765622|NCT01400698|448767496|FG000|Overall Study|Adverse Event|1|||
124765623|NCT01400698|448767497|FG001|Overall Study|Adverse Event|0|||
124765624|NCT01400698|448767498|FG002|Overall Study|Adverse Event|0|||
124765625|NCT01400698|448767499|FG003|Overall Study|Adverse Event|0|||
124765626|NCT01400698|448767500|FG004|Overall Study|Adverse Event|0|||
124765627|NCT01400698|448767501|FG005|Overall Study|Adverse Event|0|||
124765628|NCT01400698|448767496|FG000|Overall Study|Other|4|||
124765629|NCT01400698|448767497|FG001|Overall Study|Other|2|||
124765630|NCT01400698|448767498|FG002|Overall Study|Other|0|||
124765631|NCT01400698|448767499|FG003|Overall Study|Other|2|||
124765632|NCT01400698|448767500|FG004|Overall Study|Other|1|||
124765633|NCT01400698|448767501|FG005|Overall Study|Other|0|||
124765634|NCT00948064|448769216|FG000|Phase I|No treatment received|1|||
124765635|NCT00948064|448769217|FG001|Phase I|No treatment received|0|||
124765636|NCT00948064|448769218|FG002|Phase I|No treatment received|0|||
124765637|NCT00948064|448769216|FG000|Phase II|Physician Decision|0|||
124765638|NCT00948064|448769217|FG001|Phase II|Physician Decision|0|||
124765639|NCT00948064|448769218|FG002|Phase II|Physician Decision|1|||
124765640|NCT00948064|448769216|FG000|Phase II|Withdrawal by Subject|0|||
124765641|NCT00948064|448769217|FG001|Phase II|Withdrawal by Subject|1|||
124765642|NCT00948064|448769218|FG002|Phase II|Withdrawal by Subject|0|||
124765643|NCT00179621|448769220|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
124765644|NCT00179621|448769221|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
124765645|NCT00179621|448769222|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
124765646|NCT00179621|448769223|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
124765647|NCT00179621|448769220|FG000|Double-Blind Period|Adverse Event|2|||
124765648|NCT00179621|448769221|FG001|Double-Blind Period|Adverse Event|7|||
124765649|NCT00179621|448769222|FG002|Double-Blind Period|Adverse Event|4|||
124765650|NCT00179621|448769223|FG003|Double-Blind Period|Adverse Event|0|||
124765651|NCT00179621|448769220|FG000|Double-Blind Period|Withdrawal by Subject|2|||
124949258|NCT01393964|449441812|FG001|Overall Study|Subject request stop study treatment|1|||
124765652|NCT00179621|448769221|FG001|Double-Blind Period|Withdrawal by Subject|1|||
124765653|NCT00179621|448769222|FG002|Double-Blind Period|Withdrawal by Subject|3|||
124765654|NCT00179621|448769223|FG003|Double-Blind Period|Withdrawal by Subject|0|||
124765655|NCT00179621|448769220|FG000|Double-Blind Period|Death|0|||
124765656|NCT00179621|448769221|FG001|Double-Blind Period|Death|1|||
124765657|NCT00179621|448769222|FG002|Double-Blind Period|Death|2|||
124765658|NCT00179621|448769223|FG003|Double-Blind Period|Death|0|||
124765659|NCT00179621|448769220|FG000|Double-Blind Period|Protocol Violation|1|||
124765660|NCT00179621|448769221|FG001|Double-Blind Period|Protocol Violation|0|||
124765661|NCT00179621|448769222|FG002|Double-Blind Period|Protocol Violation|0|||
124765662|NCT00179621|448769223|FG003|Double-Blind Period|Protocol Violation|0|||
124765663|NCT00179621|448769220|FG000|Double-Blind Period|Other|0|||
124765664|NCT00179621|448769221|FG001|Double-Blind Period|Other|2|||
124765665|NCT00179621|448769222|FG002|Double-Blind Period|Other|2|||
124765666|NCT00179621|448769223|FG003|Double-Blind Period|Other|0|||
124765667|NCT00179621|448769220|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
124765668|NCT00179621|448769221|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
124765669|NCT00179621|448769222|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
124765670|NCT00179621|448769223|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
124459241|NCT01246583|447640580|FG002|Overall Study|Protocol Violation|1|||
124459242|NCT01246583|447640581|FG003|Overall Study|Protocol Violation|0|||
124459243|NCT01246583|447640578|FG000|Overall Study|Withdrawal by Subject|1|||
124459244|NCT01246583|447640579|FG001|Overall Study|Withdrawal by Subject|0|||
124459245|NCT01246583|447640580|FG002|Overall Study|Withdrawal by Subject|0|||
124459246|NCT01246583|447640581|FG003|Overall Study|Withdrawal by Subject|0|||
124459247|NCT01806779|447640585|FG000|Overall Study|Physician Decision|2|||
124459248|NCT01806779|447640586|FG001|Overall Study|Physician Decision|0|||
124459249|NCT01806779|447640587|FG002|Overall Study|Physician Decision|1|||
124459250|NCT01806779|447640585|FG000|Overall Study|Lack of Efficacy|1|||
124765671|NCT00179621|448769220|FG000|Open-Label Period|Adverse Event|0|||
124765672|NCT00179621|448769221|FG001|Open-Label Period|Adverse Event|6|||
124765673|NCT00179621|448769222|FG002|Open-Label Period|Adverse Event|5|||
124459251|NCT01806779|447640586|FG001|Overall Study|Lack of Efficacy|1|||
124765674|NCT00179621|448769223|FG003|Open-Label Period|Adverse Event|6|||
124765675|NCT00179621|448769220|FG000|Open-Label Period|Withdrawal by Subject|0|||
124459252|NCT01806779|447640587|FG002|Overall Study|Lack of Efficacy|0|||
124459253|NCT01806779|447640585|FG000|Overall Study|Lost to Follow-up|19|||
124765676|NCT00179621|448769221|FG001|Open-Label Period|Withdrawal by Subject|2|||
124765677|NCT00179621|448769222|FG002|Open-Label Period|Withdrawal by Subject|2|||
124765678|NCT00179621|448769223|FG003|Open-Label Period|Withdrawal by Subject|2|||
124765679|NCT00179621|448769220|FG000|Open-Label Period|Death|0|||
124459254|NCT01806779|447640586|FG001|Overall Study|Lost to Follow-up|20|||
124459255|NCT01806779|447640587|FG002|Overall Study|Lost to Follow-up|0|||
124765680|NCT00179621|448769221|FG001|Open-Label Period|Death|0|||
124765681|NCT00179621|448769222|FG002|Open-Label Period|Death|1|||
124765682|NCT00179621|448769223|FG003|Open-Label Period|Death|2|||
124765683|NCT00179621|448769220|FG000|Open-Label Period|Other|0|||
124765684|NCT00179621|448769221|FG001|Open-Label Period|Other|1|||
124765685|NCT00179621|448769222|FG002|Open-Label Period|Other|1|||
124765686|NCT00179621|448769223|FG003|Open-Label Period|Other|2|||
124765687|NCT02973100|448769225|FG000|Overall Study|Adverse Event|1|||
124765688|NCT02973100|448769226|FG001|Overall Study|Adverse Event|2|||
124765689|NCT02973100|448769227|FG002|Overall Study|Adverse Event|1|||
124765690|NCT02973100|448769228|FG003|Overall Study|Adverse Event|2|||
124765691|NCT02973100|448769225|FG000|Overall Study|Lost to Follow-up|3|||
124459256|NCT01806779|447640585|FG000|Overall Study|Withdrawal by Subject|20|||
124459257|NCT01806779|447640586|FG001|Overall Study|Withdrawal by Subject|23|||
124459258|NCT01806779|447640587|FG002|Overall Study|Withdrawal by Subject|22|||
124459259|NCT04218201|447642254|FG000|Overall Study|Death|0|||
124459260|NCT04218201|447642255|FG001|Overall Study|Death|0|||
124459261|NCT04218201|447642256|FG002|Overall Study|Death|2|||
124459262|NCT04218201|447642257|FG003|Overall Study|Death|0|||
124459263|NCT04218201|447642254|FG000|Overall Study|Unable to contact participant|4|||
124459264|NCT04218201|447642255|FG001|Overall Study|Unable to contact participant|0|||
124459265|NCT04218201|447642256|FG002|Overall Study|Unable to contact participant|3|||
124459266|NCT04218201|447642257|FG003|Overall Study|Unable to contact participant|0|||
124459267|NCT04218201|447642254|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
124459268|NCT04218201|447642255|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
124459269|NCT04218201|447642256|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
124459270|NCT04218201|447642257|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
124459271|NCT04218201|447642254|FG000|Overall Study|Withdrawal by Subject|2|||
124459272|NCT04218201|447642255|FG001|Overall Study|Withdrawal by Subject|0|||
124459273|NCT04218201|447642256|FG002|Overall Study|Withdrawal by Subject|0|||
124459274|NCT04218201|447642257|FG003|Overall Study|Withdrawal by Subject|0|||
124459275|NCT04218201|447642254|FG000|Overall Study|PCP plans to leave practice|0|||
124459276|NCT04218201|447642255|FG001|Overall Study|PCP plans to leave practice|8|||
124459277|NCT04218201|447642256|FG002|Overall Study|PCP plans to leave practice|0|||
124459278|NCT04218201|447642257|FG003|Overall Study|PCP plans to leave practice|5|||
124459279|NCT04218201|447642254|FG000|Overall Study|Reduced panel|0|||
124459280|NCT04218201|447642255|FG001|Overall Study|Reduced panel|0|||
124459281|NCT04218201|447642256|FG002|Overall Study|Reduced panel|0|||
124459282|NCT04218201|447642257|FG003|Overall Study|Reduced panel|1|||
124459283|NCT04218201|447642254|FG000|Overall Study|No longer interested in participating|0|||
124459284|NCT04218201|447642255|FG001|Overall Study|No longer interested in participating|1|||
124459285|NCT04218201|447642256|FG002|Overall Study|No longer interested in participating|0|||
124459286|NCT04218201|447642257|FG003|Overall Study|No longer interested in participating|0|||
124459287|NCT03723707|447642265|FG000|Overall Study|Death|32|||
124459288|NCT03723707|447642266|FG001|Overall Study|Death|32|||
124459289|NCT03723707|447642265|FG000|Overall Study|Admitted to long term care|12|||
124459290|NCT03723707|447642266|FG001|Overall Study|Admitted to long term care|12|||
124459291|NCT03723707|447642265|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
124459292|NCT03723707|447642266|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
124459293|NCT03723707|447642265|FG000|Overall Study|Lost to Follow-up|40|||
124459294|NCT03723707|447642266|FG001|Overall Study|Lost to Follow-up|22|||
124459295|NCT03723707|447642265|FG000|Overall Study|Discontinued after study closure|24|||
124459296|NCT03723707|447642266|FG001|Overall Study|Discontinued after study closure|12|||
124459297|NCT05121480|447642267|FG000|Overall Study|Lack of Efficacy|2|||
124459298|NCT05121480|447642268|FG001|Overall Study|Lack of Efficacy|2|||
124459299|NCT05121480|447642269|FG002|Overall Study|Lack of Efficacy|1|||
124459300|NCT05121480|447642270|FG003|Overall Study|Lack of Efficacy|4|||
124459301|NCT05121480|447642271|FG004|Overall Study|Lack of Efficacy|0|||
124765692|NCT02973100|448769226|FG001|Overall Study|Lost to Follow-up|1|||
124765693|NCT02973100|448769227|FG002|Overall Study|Lost to Follow-up|1|||
124459302|NCT05121480|447642272|FG005|Overall Study|Lack of Efficacy|1|||
124459303|NCT05121480|447642273|FG006|Overall Study|Lack of Efficacy|0|||
124459304|NCT05121480|447642274|FG007|Overall Study|Lack of Efficacy|2|||
124765694|NCT02973100|448769228|FG003|Overall Study|Lost to Follow-up|0|||
124765695|NCT02973100|448769225|FG000|Overall Study|Withdrawal by Subject|3|||
124765696|NCT02973100|448769226|FG001|Overall Study|Withdrawal by Subject|5|||
124765697|NCT02973100|448769227|FG002|Overall Study|Withdrawal by Subject|1|||
124459305|NCT05121480|447642267|FG000|Overall Study|Treatment Failure|0|||
124459306|NCT05121480|447642268|FG001|Overall Study|Treatment Failure|2|||
124459307|NCT05121480|447642269|FG002|Overall Study|Treatment Failure|0|||
124459308|NCT05121480|447642270|FG003|Overall Study|Treatment Failure|1|||
124459309|NCT05121480|447642271|FG004|Overall Study|Treatment Failure|0|||
124459310|NCT05121480|447642272|FG005|Overall Study|Treatment Failure|0|||
124459311|NCT05121480|447642273|FG006|Overall Study|Treatment Failure|0|||
124459312|NCT05121480|447642274|FG007|Overall Study|Treatment Failure|0|||
124459313|NCT05121480|447642267|FG000|Overall Study|Adverse Event|0|||
124459314|NCT05121480|447642268|FG001|Overall Study|Adverse Event|1|||
124459315|NCT05121480|447642269|FG002|Overall Study|Adverse Event|0|||
124765698|NCT02973100|448769228|FG003|Overall Study|Withdrawal by Subject|4|||
124459316|NCT05121480|447642270|FG003|Overall Study|Adverse Event|5|||
124459317|NCT05121480|447642271|FG004|Overall Study|Adverse Event|3|||
124459318|NCT05121480|447642272|FG005|Overall Study|Adverse Event|2|||
124459319|NCT05121480|447642273|FG006|Overall Study|Adverse Event|0|||
124459320|NCT05121480|447642274|FG007|Overall Study|Adverse Event|4|||
124459321|NCT05121480|447642267|FG000|Overall Study|Withdrawal by Subject|4|||
124459322|NCT05121480|447642268|FG001|Overall Study|Withdrawal by Subject|9|||
124459323|NCT05121480|447642269|FG002|Overall Study|Withdrawal by Subject|1|||
124459324|NCT05121480|447642270|FG003|Overall Study|Withdrawal by Subject|8|||
124459325|NCT05121480|447642271|FG004|Overall Study|Withdrawal by Subject|0|||
124459326|NCT05121480|447642272|FG005|Overall Study|Withdrawal by Subject|9|||
124459327|NCT05121480|447642273|FG006|Overall Study|Withdrawal by Subject|0|||
124459328|NCT05121480|447642274|FG007|Overall Study|Withdrawal by Subject|4|||
124459329|NCT05121480|447642267|FG000|Overall Study|Non-compliance with the protocol|0|||
124459330|NCT05121480|447642268|FG001|Overall Study|Non-compliance with the protocol|0|||
124459331|NCT05121480|447642269|FG002|Overall Study|Non-compliance with the protocol|0|||
124459332|NCT05121480|447642270|FG003|Overall Study|Non-compliance with the protocol|0|||
124459333|NCT05121480|447642271|FG004|Overall Study|Non-compliance with the protocol|1|||
124459334|NCT05121480|447642272|FG005|Overall Study|Non-compliance with the protocol|6|||
124459335|NCT05121480|447642273|FG006|Overall Study|Non-compliance with the protocol|0|||
124459336|NCT05121480|447642274|FG007|Overall Study|Non-compliance with the protocol|1|||
124459337|NCT05121480|447642267|FG000|Overall Study|Lost to Follow-up|0|||
124459338|NCT05121480|447642268|FG001|Overall Study|Lost to Follow-up|4|||
124548607|NCT01298661|447962681|FG000|Overall Study|Withdrawal by Subject|2|||
124548608|NCT01298661|447962682|FG001|Overall Study|Withdrawal by Subject|0|||
124706537|NCT03186638|448551688|FG000|Overall Study|Withdrawn due to medical problem|3|||
124706538|NCT03186638|448551689|FG001|Overall Study|Withdrawn due to medical problem|2|||
124706539|NCT03186638|448551688|FG000|Overall Study|Lost to Follow-up|1|||
124706540|NCT03186638|448551689|FG001|Overall Study|Lost to Follow-up|0|||
124706541|NCT01263119|448551690|FG000|Period 1|Protocol Violation|2|||
124706542|NCT01263119|448551690|FG000|Period 2|Adverse Event|2|||
124706543|NCT04573972|448551693|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
124706544|NCT04573972|448551694|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
124706545|NCT05067335|448551695|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
124706546|NCT05067335|448551696|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
124706547|NCT05067335|448551697|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
124706548|NCT05067335|448551698|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
124706549|NCT05067335|448551695|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
124706550|NCT05067335|448551696|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
124706551|NCT05067335|448551697|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
124706552|NCT05067335|448551698|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
124706553|NCT05067335|448551695|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
124706554|NCT05067335|448551696|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
124706555|NCT05067335|448551697|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
124706556|NCT05067335|448551698|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
124706557|NCT05067335|448551695|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
124706558|NCT05067335|448551696|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
124706559|NCT05067335|448551697|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
124706560|NCT05067335|448551698|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
124706561|NCT05067335|448551695|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
124706562|NCT05067335|448551696|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
124706563|NCT05067335|448551697|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
124706564|NCT05067335|448551698|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
124706565|NCT05067335|448551695|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
124706566|NCT05067335|448551696|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
124706567|NCT05067335|448551697|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
124706568|NCT05067335|448551698|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
124706569|NCT05067335|448551695|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
124706570|NCT05067335|448551696|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
124706571|NCT05067335|448551697|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
124706572|NCT05067335|448551698|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
124706573|NCT05067335|448551695|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
124706574|NCT05067335|448551696|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
124765699|NCT02973100|448769225|FG000|Overall Study|Notification of change in address|0|||
124459339|NCT05121480|447642269|FG002|Overall Study|Lost to Follow-up|1|||
124459340|NCT05121480|447642270|FG003|Overall Study|Lost to Follow-up|3|||
124459341|NCT05121480|447642271|FG004|Overall Study|Lost to Follow-up|1|||
124459342|NCT05121480|447642272|FG005|Overall Study|Lost to Follow-up|1|||
124459343|NCT05121480|447642273|FG006|Overall Study|Lost to Follow-up|1|||
124459344|NCT05121480|447642274|FG007|Overall Study|Lost to Follow-up|4|||
124459345|NCT05121480|447642267|FG000|Overall Study|Physician Decision|0|||
124459346|NCT05121480|447642268|FG001|Overall Study|Physician Decision|0|||
124459347|NCT05121480|447642269|FG002|Overall Study|Physician Decision|0|||
124459348|NCT05121480|447642270|FG003|Overall Study|Physician Decision|0|||
124459349|NCT05121480|447642271|FG004|Overall Study|Physician Decision|0|||
124459350|NCT05121480|447642272|FG005|Overall Study|Physician Decision|1|||
124459351|NCT05121480|447642273|FG006|Overall Study|Physician Decision|0|||
124459352|NCT05121480|447642274|FG007|Overall Study|Physician Decision|1|||
124459353|NCT05121480|447642267|FG000|Overall Study|Other Reason|0|||
124459354|NCT05121480|447642268|FG001|Overall Study|Other Reason|0|||
124459355|NCT05121480|447642269|FG002|Overall Study|Other Reason|0|||
124459356|NCT05121480|447642270|FG003|Overall Study|Other Reason|0|||
124459357|NCT05121480|447642271|FG004|Overall Study|Other Reason|0|||
124459358|NCT05121480|447642272|FG005|Overall Study|Other Reason|1|||
124459359|NCT05121480|447642273|FG006|Overall Study|Other Reason|1|||
124459360|NCT05121480|447642274|FG007|Overall Study|Other Reason|1|||
124459361|NCT01135498|447642279|FG000|Overall Study|Adverse Event|20|||
124459362|NCT01135498|447642279|FG000|Overall Study|Progressive disease|38|||
124459363|NCT01135498|447642279|FG000|Overall Study|Investigator judgement|25|||
124459364|NCT01135498|447642279|FG000|Overall Study|Withdrawal by Subject|4|||
124459365|NCT01135498|447642279|FG000|Overall Study|Death|1|||
124459366|NCT01135498|447642279|FG000|Overall Study|Ongoing at time of analysis|2|||
124459367|NCT00713700|447642281|FG000|Overall Study|Lost to Follow-up|3|||
124706575|NCT05067335|448551697|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
124706576|NCT05067335|448551698|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
124706577|NCT05067335|448551695|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
124706578|NCT05067335|448551696|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
124706579|NCT05067335|448551697|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
124706580|NCT05067335|448551698|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
124706581|NCT05067335|448551695|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
124706582|NCT05067335|448551696|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
124706583|NCT05067335|448551697|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
124706584|NCT05067335|448551698|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
124706585|NCT01645176|448551699|FG000|Overall Study|Lack of Efficacy|4|||
124706586|NCT01645176|448551699|FG000|Overall Study|did not complete final MRI|1|||
124706587|NCT00560417|448551700|FG000|Overall Study|Adverse Event|3|||
124706588|NCT00560417|448551701|FG001|Overall Study|Adverse Event|2|||
124706589|NCT00560417|448551700|FG000|Overall Study|Entry Criteria Not Met|1|||
124706590|NCT00560417|448551701|FG001|Overall Study|Entry Criteria Not Met|0|||
124706591|NCT00560417|448551700|FG000|Overall Study|Lost to Follow-up|0|||
124706592|NCT00560417|448551701|FG001|Overall Study|Lost to Follow-up|1|||
124706593|NCT00560417|448551700|FG000|Overall Study|Physician Decision|2|||
124706594|NCT00560417|448551701|FG001|Overall Study|Physician Decision|6|||
124706595|NCT00560417|448551700|FG000|Overall Study|Protocol Violation|6|||
124706596|NCT00560417|448551701|FG001|Overall Study|Protocol Violation|5|||
124706597|NCT00560417|448551700|FG000|Overall Study|Sponsor Decision|2|||
124706598|NCT00560417|448551701|FG001|Overall Study|Sponsor Decision|0|||
124706599|NCT00560417|448551700|FG000|Overall Study|Withdrawal by Subject|3|||
124706600|NCT00560417|448551701|FG001|Overall Study|Withdrawal by Subject|3|||
124706601|NCT00261833|448551702|FG000|Overall Study|Death|1|||
124706602|NCT00261833|448551703|FG001|Overall Study|Death|3|||
124706603|NCT00261833|448551702|FG000|Overall Study|Adverse Event|1|||
124706604|NCT00261833|448551703|FG001|Overall Study|Adverse Event|4|||
124706605|NCT00261833|448551702|FG000|Overall Study|Withdrawal by Subject|5|||
124706606|NCT00261833|448551703|FG001|Overall Study|Withdrawal by Subject|7|||
124706607|NCT00261833|448551702|FG000|Overall Study|Protocol Violation|0|||
124706608|NCT00261833|448551703|FG001|Overall Study|Protocol Violation|1|||
124706609|NCT00261833|448551702|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
124706610|NCT00261833|448551703|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
124706611|NCT00261833|448551702|FG000|Overall Study|Lung transplantation|1|||
124706612|NCT00261833|448551703|FG001|Overall Study|Lung transplantation|1|||
124706613|NCT00261833|448551702|FG000|Overall Study|Missing reason|1|||
124706614|NCT00261833|448551703|FG001|Overall Study|Missing reason|0|||
124459368|NCT00713700|447642281|FG000|Overall Study|Withdrawal by Subject|1|||
124459369|NCT00847912|447642289|FG000|Overall Study|Protocol Violation|6|||
124459370|NCT00847912|447642290|FG001|Overall Study|Protocol Violation|7|||
124459371|NCT00847912|447642289|FG000|Overall Study|Withdrawal by Subject|3|||
124459372|NCT00847912|447642290|FG001|Overall Study|Withdrawal by Subject|6|||
124459373|NCT00838331|447642292|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
124459374|NCT01074190|447642293|FG000|Overall Study|Emergency Cesarean Delivery|1|||
124459375|NCT01074190|447642294|FG001|Overall Study|Emergency Cesarean Delivery|2|||
124459376|NCT01074190|447642295|FG002|Overall Study|Emergency Cesarean Delivery|1|||
124459377|NCT01074190|447642293|FG000|Overall Study|Protocol Violation|2|||
124459378|NCT01074190|447642294|FG001|Overall Study|Protocol Violation|1|||
124459379|NCT01074190|447642295|FG002|Overall Study|Protocol Violation|0|||
124459380|NCT01074190|447642293|FG000|Overall Study|Delivered in under 90 minutes|0|||
124459381|NCT01074190|447642294|FG001|Overall Study|Delivered in under 90 minutes|2|||
124459382|NCT01074190|447642295|FG002|Overall Study|Delivered in under 90 minutes|1|||
124459383|NCT01074190|447642293|FG000|Overall Study|Subject withdrew consent|1|||
124459384|NCT01074190|447642294|FG001|Overall Study|Subject withdrew consent|1|||
124459385|NCT01074190|447642295|FG002|Overall Study|Subject withdrew consent|1|||
124548609|NCT01298661|447962683|FG002|Overall Study|Withdrawal by Subject|2|||
124548610|NCT03515837|447965283|FG000|Overall Study|Death|219|||
124548611|NCT03515837|447965284|FG001|Overall Study|Death|227|||
124548612|NCT03515837|447965283|FG000|Overall Study|Lost to Follow-up|0|||
124765700|NCT02973100|448769226|FG001|Overall Study|Notification of change in address|0|||
124765701|NCT02973100|448769227|FG002|Overall Study|Notification of change in address|0|||
124459386|NCT00264875|447642296|FG000|Overall Study|Adverse Event|6|||
124459387|NCT00264875|447642296|FG000|Overall Study|Lost to Follow-up|6|||
124459388|NCT00264875|447642296|FG000|Overall Study|Protocol Violation|11|||
124459389|NCT00264875|447642296|FG000|Overall Study|Withdrawal by Subject|7|||
124459390|NCT00732303|447642303|FG000|Overall Study|Study Terminated|2|||
124459391|NCT01500278|447642304|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
124459392|NCT01500278|447642305|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
124459393|NCT01500278|447642304|FG000|Week 0 - Week 12|Protocol Violation|10|||
124459394|NCT01500278|447642305|FG001|Week 0 - Week 12|Protocol Violation|16|||
124459395|NCT01500278|447642304|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
124459396|NCT01500278|447642305|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
124459397|NCT01500278|447642304|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
124459398|NCT01500278|447642305|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
124459399|NCT01500278|447642304|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
124459400|NCT01500278|447642305|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
124459401|NCT01500278|447642304|FG000|Week 0 - Week 12|Patient decision|1|||
124459402|NCT01500278|447642305|FG001|Week 0 - Week 12|Patient decision|0|||
124459403|NCT01500278|447642304|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
124459404|NCT01500278|447642305|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
124459405|NCT01500278|447642304|FG000|Week 0 - Week 12|Investigator decision|1|||
124459406|NCT01500278|447642305|FG001|Week 0 - Week 12|Investigator decision|0|||
124459407|NCT01500278|447642304|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
124459408|NCT01500278|447642305|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
124459409|NCT01500278|447642304|FG000|Week 0 - Week 12|Sponsor decision|1|||
124459410|NCT01500278|447642305|FG001|Week 0 - Week 12|Sponsor decision|0|||
124459411|NCT01500278|447642304|FG000|Week 0 - Week 12|Personal reason|0|||
124459412|NCT01500278|447642305|FG001|Week 0 - Week 12|Personal reason|1|||
124459413|NCT01500278|447642304|FG000|Week 0 - Week 12|Other serious disease|0|||
124459414|NCT01500278|447642305|FG001|Week 0 - Week 12|Other serious disease|1|||
124459415|NCT01500278|447642304|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
124459416|NCT01500278|447642305|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
124459417|NCT01500278|447642304|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
124459418|NCT01500278|447642305|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
124459419|NCT01500278|447642304|FG000|Week 13 - Week 104|Protocol Violation|6|||
124459420|NCT01500278|447642305|FG001|Week 13 - Week 104|Protocol Violation|6|||
124459421|NCT01500278|447642304|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
124548613|NCT03515837|447965284|FG001|Overall Study|Lost to Follow-up|1|||
124548614|NCT03515837|447965283|FG000|Overall Study|Withdrawal by Subject|0|||
124765702|NCT02973100|448769228|FG003|Overall Study|Notification of change in address|1|||
124765703|NCT02973100|448769225|FG000|Overall Study|Failed to attend Safety followup period|0|||
124765704|NCT02973100|448769226|FG001|Overall Study|Failed to attend Safety followup period|0|||
124765705|NCT02973100|448769227|FG002|Overall Study|Failed to attend Safety followup period|1|||
124765706|NCT02973100|448769228|FG003|Overall Study|Failed to attend Safety followup period|0|||
124765707|NCT04516746|448769239|FG000|Overall Study|Randomized but not Treated|51|||
124765708|NCT04516746|448769240|FG001|Overall Study|Randomized but not Treated|19|||
124765709|NCT04516746|448769239|FG000|Overall Study|Adverse Event|0|||
124765710|NCT04516746|448769240|FG001|Overall Study|Adverse Event|1|||
124765711|NCT04516746|448769239|FG000|Overall Study|Death|62|||
124765712|NCT04516746|448769240|FG001|Overall Study|Death|32|||
124765713|NCT04516746|448769239|FG000|Overall Study|Lost to Follow-up|3431|||
124765714|NCT04516746|448769240|FG001|Overall Study|Lost to Follow-up|1831|||
124459422|NCT01500278|447642305|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
124949259|NCT01393964|449441813|FG002|Overall Study|Subject request stop study treatment|0|||
124459423|NCT01500278|447642304|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
124459424|NCT01500278|447642305|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
124459425|NCT01500278|447642304|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
124459426|NCT01500278|447642305|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
124459427|NCT01500278|447642304|FG000|Week 13 - Week 104|Non/bad compliance|7|||
124459428|NCT01500278|447642305|FG001|Week 13 - Week 104|Non/bad compliance|5|||
124706615|NCT00261833|448551702|FG000|Overall Study|Not interested in being participant|0|||
124706616|NCT00261833|448551703|FG001|Overall Study|Not interested in being participant|1|||
124706617|NCT00622726|448551704|FG000|March, 2008 to August, 2010|Death|5|||
124706618|NCT00622726|448551705|FG001|March, 2008 to August, 2010|Death|2|||
124706619|NCT00622726|448551704|FG000|August, 2010 to April, 2013|Death|1|||
124706620|NCT00622726|448551705|FG001|August, 2010 to April, 2013|Death|5|||
124706621|NCT01948427|448551706|FG000|Overall Study|Serious Adverse Event|3|||
124706622|NCT01948427|448551707|FG001|Overall Study|Serious Adverse Event|0|||
124706623|NCT01948427|448551708|FG002|Overall Study|Serious Adverse Event|0|||
124706624|NCT01948427|448551709|FG003|Overall Study|Serious Adverse Event|0|||
124706625|NCT01948427|448551710|FG004|Overall Study|Serious Adverse Event|1|||
124706626|NCT01948427|448551706|FG000|Overall Study|Investigator Request|0|||
124706627|NCT01948427|448551707|FG001|Overall Study|Investigator Request|8|||
124706628|NCT01948427|448551708|FG002|Overall Study|Investigator Request|0|||
124706629|NCT01948427|448551709|FG003|Overall Study|Investigator Request|0|||
124706630|NCT01948427|448551710|FG004|Overall Study|Investigator Request|6|||
124706631|NCT01948427|448551706|FG000|Overall Study|Lost to Follow-up|1|||
124706632|NCT01948427|448551707|FG001|Overall Study|Lost to Follow-up|0|||
124706633|NCT01948427|448551708|FG002|Overall Study|Lost to Follow-up|0|||
124706634|NCT01948427|448551709|FG003|Overall Study|Lost to Follow-up|0|||
124706635|NCT01948427|448551710|FG004|Overall Study|Lost to Follow-up|4|||
124706636|NCT01948427|448551706|FG000|Overall Study|Withdrawal by Subject|2|||
124706637|NCT01948427|448551707|FG001|Overall Study|Withdrawal by Subject|0|||
124706638|NCT01948427|448551708|FG002|Overall Study|Withdrawal by Subject|0|||
124706639|NCT01948427|448551709|FG003|Overall Study|Withdrawal by Subject|0|||
124706640|NCT01948427|448551710|FG004|Overall Study|Withdrawal by Subject|1|||
124706641|NCT01948427|448551706|FG000|Overall Study|Other, Not Specified|1|||
124706642|NCT01948427|448551707|FG001|Overall Study|Other, Not Specified|9|||
124706643|NCT01948427|448551708|FG002|Overall Study|Other, Not Specified|0|||
124706644|NCT01948427|448551709|FG003|Overall Study|Other, Not Specified|0|||
124706645|NCT01948427|448551710|FG004|Overall Study|Other, Not Specified|2|||
124706646|NCT00402987|448551711|FG000|Overall Study|Lack of Efficacy|0|||
124706647|NCT00402987|448551712|FG001|Overall Study|Lack of Efficacy|0|||
124706648|NCT00402987|448551713|FG002|Overall Study|Lack of Efficacy|1|||
124706649|NCT00402987|448551714|FG003|Overall Study|Lack of Efficacy|0|||
124706650|NCT02006927|448551722|FG000|Overall Study|Adverse Event|2|||
124706651|NCT02006927|448551722|FG000|Overall Study|Withdrawal by Subject|1|||
124706652|NCT02735200|448551725|FG000|Overall Study|Lost to Follow-up|0|||
124706653|NCT02735200|448551726|FG001|Overall Study|Lost to Follow-up|5|||
124706654|NCT02735200|448551725|FG000|Overall Study|Withdrawal by Subject|8|||
124706655|NCT02735200|448551726|FG001|Overall Study|Withdrawal by Subject|0|||
124765715|NCT04516746|448769239|FG000|Overall Study|Withdrawal by Subject|1946|||
124765716|NCT04516746|448769240|FG001|Overall Study|Withdrawal by Subject|1696|||
124765717|NCT04516746|448769239|FG000|Overall Study|Physician Decision|10|||
124765718|NCT04516746|448769240|FG001|Overall Study|Physician Decision|8|||
124765719|NCT04516746|448769239|FG000|Overall Study|Other|35|||
124765720|NCT04516746|448769240|FG001|Overall Study|Other|16|||
124765721|NCT03115359|448769243|FG000|Overall Study|Withdrawal by Subject|29|||
124765722|NCT03115359|448769244|FG001|Overall Study|Withdrawal by Subject|39|||
124765723|NCT03115359|448769243|FG000|Overall Study|Scheduling conflict|25|||
124765724|NCT03115359|448769244|FG001|Overall Study|Scheduling conflict|23|||
124765725|NCT03115359|448769243|FG000|Overall Study|Personal reasons including health|12|||
124765726|NCT03115359|448769244|FG001|Overall Study|Personal reasons including health|9|||
124765727|NCT03115359|448769243|FG000|Overall Study|Transportation barriers|3|||
124765728|NCT03115359|448769244|FG001|Overall Study|Transportation barriers|0|||
124765729|NCT03115359|448769243|FG000|Overall Study|No longer interested|5|||
124765730|NCT03115359|448769244|FG001|Overall Study|No longer interested|4|||
124765731|NCT03115359|448769243|FG000|Overall Study|No reason provided|45|||
124765732|NCT03115359|448769244|FG001|Overall Study|No reason provided|47|||
124765733|NCT05543265|448769250|FG000|Overall Study|Lost to Follow-up|3|||
124765734|NCT05543265|448769251|FG001|Overall Study|Lost to Follow-up|3|||
124706656|NCT00673920|448551727|FG000|Baseline up to Week 48|Withdrew consent|1|||
124706657|NCT00673920|448551728|FG001|Baseline up to Week 48|Withdrew consent|0|||
124706658|NCT00673920|448551729|FG002|Baseline up to Week 48|Withdrew consent|2|||
124706659|NCT00673920|448551730|FG003|Baseline up to Week 48|Withdrew consent|0|||
124765735|NCT05543265|448769250|FG000|Overall Study|Withdrawal by Subject|0|||
124765736|NCT05543265|448769251|FG001|Overall Study|Withdrawal by Subject|1|||
124765737|NCT05316597|448769252|FG000|First Session|Withdrawal by Subject|0|||
124548615|NCT03515837|447965284|FG001|Overall Study|Withdrawal by Subject|4|||
124706660|NCT00673920|448551731|FG004|Baseline up to Week 48|Withdrew consent|0|||
124706661|NCT00673920|448551732|FG005|Baseline up to Week 48|Withdrew consent|0|||
124706662|NCT00673920|448551733|FG006|Baseline up to Week 48|Withdrew consent|0|||
124706663|NCT00673920|448551734|FG007|Baseline up to Week 48|Withdrew consent|0|||
124706664|NCT00673920|448551727|FG000|Baseline up to Week 48|Refused treatment|1|||
124706665|NCT00673920|448551728|FG001|Baseline up to Week 48|Refused treatment|0|||
124765738|NCT05316597|448769253|FG001|First Session|Withdrawal by Subject|1|||
124765739|NCT05316597|448769252|FG000|Washout Period|Lost to Follow-up|1|||
124765740|NCT05316597|448769253|FG001|Washout Period|Lost to Follow-up|2|||
124765741|NCT05316597|448769252|FG000|Washout Period|Physician Decision|1|||
124765742|NCT05316597|448769253|FG001|Washout Period|Physician Decision|1|||
124765743|NCT05316597|448769252|FG000|Washout Period|Excluded before second session|1|||
124765744|NCT05316597|448769253|FG001|Washout Period|Excluded before second session|1|||
124765745|NCT05316597|448769252|FG000|Washout Period|Withdrawal by Subject|0|||
124765746|NCT05316597|448769253|FG001|Washout Period|Withdrawal by Subject|4|||
124765747|NCT05526716|448769254|FG000|Overall Study|Death|1|||
124765748|NCT05526716|448769255|FG001|Overall Study|Death|2|||
124765749|NCT05526716|448769254|FG000|Overall Study|Lost to Follow-up|17|||
124765750|NCT05526716|448769255|FG001|Overall Study|Lost to Follow-up|15|||
124765751|NCT05526716|448769254|FG000|Overall Study|Physician Decision|0|||
124765752|NCT05526716|448769255|FG001|Overall Study|Physician Decision|1|||
124765753|NCT05526716|448769254|FG000|Overall Study|Randomized by mistake without study treatment|0|||
124765754|NCT05526716|448769255|FG001|Overall Study|Randomized by mistake without study treatment|1|||
124765755|NCT05526716|448769254|FG000|Overall Study|Withdrawal by Subject|12|||
124765756|NCT05526716|448769255|FG001|Overall Study|Withdrawal by Subject|12|||
124765757|NCT05526716|448769254|FG000|Overall Study|Not reported|0|||
124765758|NCT05526716|448769255|FG001|Overall Study|Not reported|2|||
124765759|NCT04750824|448769256|FG000|Overall Study|Toxicity/intolerability|3|||
124765760|NCT04750824|448769257|FG001|Overall Study|Toxicity/intolerability|1|||
124765761|NCT04750824|448769256|FG000|Overall Study|Death|1|||
124765762|NCT04750824|448769257|FG001|Overall Study|Death|3|||
124765763|NCT04750824|448769256|FG000|Overall Study|Scheduled duration of therapy complete|1|||
124765764|NCT04750824|448769257|FG001|Overall Study|Scheduled duration of therapy complete|9|||
124765765|NCT04750824|448769256|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
124765766|NCT04750824|448769257|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
124765767|NCT03547518|448769265|FG000|Overall Study|Lost to Follow-up|2|||
124765768|NCT03547518|448769266|FG001|Overall Study|Lost to Follow-up|0|||
124765769|NCT02384551|448769268|FG000|Overall Study|Lost to Follow-up|13|||
124765770|NCT02384551|448769269|FG001|Overall Study|Lost to Follow-up|14|||
124765771|NCT02384551|448769270|FG002|Overall Study|Lost to Follow-up|14|||
124765772|NCT02384551|448769271|FG003|Overall Study|Lost to Follow-up|14|||
124706666|NCT00673920|448551729|FG002|Baseline up to Week 48|Refused treatment|0|||
124706667|NCT00673920|448551730|FG003|Baseline up to Week 48|Refused treatment|0|||
124706668|NCT00673920|448551731|FG004|Baseline up to Week 48|Refused treatment|0|||
124706669|NCT00673920|448551732|FG005|Baseline up to Week 48|Refused treatment|0|||
124706670|NCT00673920|448551733|FG006|Baseline up to Week 48|Refused treatment|0|||
124706671|NCT00673920|448551734|FG007|Baseline up to Week 48|Refused treatment|0|||
124706672|NCT00673920|448551727|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
124706673|NCT00673920|448551728|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
124706674|NCT00673920|448551729|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
124706675|NCT00673920|448551730|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
124706676|NCT00673920|448551731|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
124765773|NCT04742556|448769272|FG000|Overall Study|Withdrawal by Subject|0|||
124765774|NCT04742556|448769273|FG001|Overall Study|Withdrawal by Subject|1|||
124765775|NCT04742556|448769274|FG002|Overall Study|Withdrawal by Subject|0|||
124765776|NCT04742556|448769272|FG000|Overall Study|Adverse Event|0|||
124765777|NCT04742556|448769273|FG001|Overall Study|Adverse Event|0|||
124765778|NCT04742556|448769274|FG002|Overall Study|Adverse Event|2|||
124765779|NCT04742556|448769272|FG000|Overall Study|Clinical disease progression|0|||
124706677|NCT00673920|448551732|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
124706678|NCT00673920|448551733|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
124706679|NCT00673920|448551734|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
124706680|NCT00673920|448551727|FG000|Baseline up to Week 48|Protocol Violation|0|||
124706681|NCT00673920|448551728|FG001|Baseline up to Week 48|Protocol Violation|0|||
124706682|NCT00673920|448551729|FG002|Baseline up to Week 48|Protocol Violation|1|||
124706683|NCT00673920|448551730|FG003|Baseline up to Week 48|Protocol Violation|0|||
124706684|NCT00673920|448551731|FG004|Baseline up to Week 48|Protocol Violation|0|||
124706685|NCT00673920|448551732|FG005|Baseline up to Week 48|Protocol Violation|0|||
124706686|NCT00673920|448551733|FG006|Baseline up to Week 48|Protocol Violation|0|||
124706687|NCT00673920|448551734|FG007|Baseline up to Week 48|Protocol Violation|0|||
124706688|NCT00673920|448551727|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
124706689|NCT00673920|448551728|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
124706690|NCT00673920|448551729|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
124706691|NCT00673920|448551730|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
124706692|NCT00673920|448551731|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
124706693|NCT00673920|448551732|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
124706694|NCT00673920|448551733|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
124706695|NCT00673920|448551734|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
124706696|NCT00673920|448551727|FG000|Baseline up to Week 48|Administrative/Other|0|||
124706697|NCT00673920|448551728|FG001|Baseline up to Week 48|Administrative/Other|1|||
124706698|NCT00673920|448551729|FG002|Baseline up to Week 48|Administrative/Other|2|||
124706699|NCT00673920|448551730|FG003|Baseline up to Week 48|Administrative/Other|0|||
124706700|NCT00673920|448551731|FG004|Baseline up to Week 48|Administrative/Other|0|||
124706701|NCT00673920|448551732|FG005|Baseline up to Week 48|Administrative/Other|0|||
124706702|NCT00673920|448551733|FG006|Baseline up to Week 48|Administrative/Other|0|||
124706703|NCT00673920|448551734|FG007|Baseline up to Week 48|Administrative/Other|0|||
124706704|NCT00673920|448551727|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
124706705|NCT00673920|448551728|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
124706706|NCT00673920|448551729|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
124706707|NCT00673920|448551730|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
124706708|NCT00673920|448551731|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
124706709|NCT00673920|448551732|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
124706710|NCT00673920|448551733|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
124706711|NCT00673920|448551734|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
124706712|NCT00673920|448551727|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
124706713|NCT00673920|448551728|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
124706714|NCT00673920|448551729|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
124706715|NCT00673920|448551730|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
124706716|NCT00673920|448551731|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
124706717|NCT00673920|448551732|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
124706718|NCT00673920|448551733|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
124706719|NCT00673920|448551734|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
124706720|NCT00673920|448551727|FG000|Week 24 to Week 48|Failure to return|0|||
124706721|NCT00673920|448551728|FG001|Week 24 to Week 48|Failure to return|0|||
124706722|NCT00673920|448551729|FG002|Week 24 to Week 48|Failure to return|0|||
124706723|NCT00673920|448551730|FG003|Week 24 to Week 48|Failure to return|0|||
124706724|NCT00673920|448551731|FG004|Week 24 to Week 48|Failure to return|0|||
124706725|NCT00673920|448551732|FG005|Week 24 to Week 48|Failure to return|1|||
124706726|NCT00673920|448551733|FG006|Week 24 to Week 48|Failure to return|0|||
124706727|NCT00673920|448551734|FG007|Week 24 to Week 48|Failure to return|0|||
124706728|NCT00673920|448551727|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
124706729|NCT00673920|448551728|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
124706730|NCT00673920|448551729|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
124706731|NCT00673920|448551730|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
124706732|NCT00673920|448551731|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
124706733|NCT00673920|448551732|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
124706734|NCT00673920|448551733|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
124706735|NCT00673920|448551734|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
124706736|NCT00673920|448551727|FG000|Week 24 to Week 48|Death|0|||
124706737|NCT00673920|448551728|FG001|Week 24 to Week 48|Death|0|||
124706738|NCT00673920|448551729|FG002|Week 24 to Week 48|Death|0|||
124706739|NCT00673920|448551730|FG003|Week 24 to Week 48|Death|0|||
124706740|NCT00673920|448551731|FG004|Week 24 to Week 48|Death|0|||
124706741|NCT00673920|448551732|FG005|Week 24 to Week 48|Death|1|||
124706742|NCT00673920|448551733|FG006|Week 24 to Week 48|Death|0|||
124706743|NCT00673920|448551734|FG007|Week 24 to Week 48|Death|0|||
124706744|NCT00673920|448551727|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
124706745|NCT00673920|448551728|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
124706746|NCT00673920|448551729|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
124706747|NCT00673920|448551730|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
124706748|NCT00673920|448551731|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
124706749|NCT00673920|448551732|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
124706750|NCT00673920|448551733|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
124706751|NCT00673920|448551734|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
124706752|NCT01164007|448551737|FG000|Overall Study|Adverse Event|5|||
124706753|NCT01164007|448551737|FG000|Overall Study|Progression of Disease|30|||
124706754|NCT01164007|448551737|FG000|Overall Study|Protocol Violation|1|||
124706755|NCT01164007|448551737|FG000|Overall Study|Withdrawal by Subject|1|||
124706756|NCT01164007|448551737|FG000|Overall Study|Medical Decision|3|||
124706757|NCT04165824|448551738|FG000|Overall Study|Adverse Event|23|||
124706758|NCT04165824|448551738|FG000|Overall Study|Physician Decision|1|||
124706759|NCT04165824|448551738|FG000|Overall Study|Withdrawal by Subject|17|||
124706760|NCT04165824|448551738|FG000|Overall Study|Other|5|||
124706761|NCT04138056|448551739|FG000|Primary Study|Lost to Follow-up|3|||
124706762|NCT04138056|448551740|FG001|Primary Study|Lost to Follow-up|4|||
124706763|NCT04138056|448551741|FG002|Primary Study|Lost to Follow-up|1|||
124706764|NCT04138056|448551742|FG003|Primary Study|Lost to Follow-up|1|||
124706765|NCT04138056|448551743|FG004|Primary Study|Lost to Follow-up|4|||
124706766|NCT04138056|448551739|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
124706767|NCT04138056|448551740|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
124706768|NCT04138056|448551741|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
124706769|NCT04138056|448551742|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
124706770|NCT04138056|448551743|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
124706771|NCT04138056|448551739|FG000|Extension Study|Lost to Follow-up|1|||
124706772|NCT04138056|448551740|FG001|Extension Study|Lost to Follow-up|2|||
124706773|NCT04138056|448551741|FG002|Extension Study|Lost to Follow-up|1|||
124706774|NCT04138056|448551742|FG003|Extension Study|Lost to Follow-up|0|||
124706775|NCT04138056|448551743|FG004|Extension Study|Lost to Follow-up|1|||
124706776|NCT01215851|448551744|FG000|Treatment Period|Adverse Event|1|||
124706777|NCT01215851|448551745|FG001|Treatment Period|Adverse Event|1|||
124706778|NCT01215851|448551746|FG002|Treatment Period|Adverse Event|1|||
124706779|NCT01215851|448551747|FG003|Treatment Period|Adverse Event|3|||
124706780|NCT01215851|448551748|FG004|Treatment Period|Adverse Event|0|||
124706781|NCT01215851|448551749|FG005|Treatment Period|Adverse Event|1|||
124706782|NCT01215851|448551744|FG000|Follow up Period|Lost to Follow-up|0|||
124706783|NCT01215851|448551745|FG001|Follow up Period|Lost to Follow-up|0|||
124706784|NCT01215851|448551746|FG002|Follow up Period|Lost to Follow-up|0|||
124706785|NCT01215851|448551747|FG003|Follow up Period|Lost to Follow-up|0|||
124706786|NCT01215851|448551748|FG004|Follow up Period|Lost to Follow-up|0|||
124706787|NCT01215851|448551749|FG005|Follow up Period|Lost to Follow-up|1|||
124706788|NCT00862940|448551753|FG000|Overall Study|Adverse Event|15|||
124706789|NCT00862940|448551754|FG001|Overall Study|Adverse Event|12|||
124706790|NCT00862940|448551753|FG000|Overall Study|Lack of Efficacy|1|||
124706791|NCT00862940|448551754|FG001|Overall Study|Lack of Efficacy|3|||
124949260|NCT01393964|449441811|FG000|Overall Study|Subject decided to move to transplant|1|||
124706792|NCT00862940|448551753|FG000|Overall Study|Protocol Violation|2|||
124706793|NCT00862940|448551754|FG001|Overall Study|Protocol Violation|5|||
124706794|NCT00862940|448551753|FG000|Overall Study|Withdrawal by Subject|4|||
124706795|NCT00862940|448551754|FG001|Overall Study|Withdrawal by Subject|6|||
124706796|NCT00862940|448551753|FG000|Overall Study|Non-compliance|4|||
124706797|NCT00862940|448551754|FG001|Overall Study|Non-compliance|0|||
124706798|NCT00862940|448551753|FG000|Overall Study|Lost to Follow-up|0|||
124706799|NCT00862940|448551754|FG001|Overall Study|Lost to Follow-up|1|||
124706800|NCT00862940|448551753|FG000|Overall Study|Administrative or other reason(s)|4|||
124706801|NCT00862940|448551754|FG001|Overall Study|Administrative or other reason(s)|3|||
124706802|NCT05552859|448551755|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
124706803|NCT05552859|448551756|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
124706804|NCT03423979|448551765|FG000|Overall Study|Death|1|||
124706805|NCT05239221|448551766|FG000|Overall Study|Adverse Event|0|||
124706806|NCT05239221|448551767|FG001|Overall Study|Adverse Event|0|||
124459429|NCT01500278|447642304|FG000|Week 13 - Week 104|Recurrent infections|1|||
124459430|NCT01500278|447642305|FG001|Week 13 - Week 104|Recurrent infections|0|||
124459431|NCT01500278|447642304|FG000|Week 13 - Week 104|False positive test|1|||
124459432|NCT01500278|447642305|FG001|Week 13 - Week 104|False positive test|2|||
124459433|NCT01500278|447642304|FG000|Week 13 - Week 104|Sponsor request|4|||
124459434|NCT01500278|447642305|FG001|Week 13 - Week 104|Sponsor request|0|||
124459435|NCT01500278|447642304|FG000|Week 13 - Week 104|Withdrawn in error|1|||
124459436|NCT01500278|447642305|FG001|Week 13 - Week 104|Withdrawn in error|0|||
124459437|NCT01500278|447642304|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
124459438|NCT01500278|447642305|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
124459439|NCT01500278|447642304|FG000|Week 13 - Week 104|Protocol deviation|1|||
124459440|NCT01500278|447642305|FG001|Week 13 - Week 104|Protocol deviation|0|||
124459441|NCT01500278|447642304|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
124459442|NCT01500278|447642305|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
124459443|NCT01500278|447642304|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
124459444|NCT01500278|447642305|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
124459445|NCT01500278|447642304|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
124459446|NCT01500278|447642305|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
124459447|NCT01500278|447642304|FG000|Week 13 - Week 104|Relocation|0|||
124459448|NCT01500278|447642305|FG001|Week 13 - Week 104|Relocation|1|||
124459449|NCT01500278|447642304|FG000|Week 13 - Week 104|Sponsor decision|0|||
124459450|NCT01500278|447642305|FG001|Week 13 - Week 104|Sponsor decision|2|||
124459451|NCT01500278|447642304|FG000|Week 13 - Week 104|Medical monitor decision|0|||
124459452|NCT01500278|447642305|FG001|Week 13 - Week 104|Medical monitor decision|2|||
124459453|NCT01500278|447642304|FG000|Week 13 - Week 104|Personal reason|0|||
124459454|NCT01500278|447642305|FG001|Week 13 - Week 104|Personal reason|1|||
124459455|NCT01500278|447642304|FG000|Week 13 - Week 104|Not completed|0|||
124459456|NCT01500278|447642305|FG001|Week 13 - Week 104|Not completed|1|||
124459457|NCT01500278|447642304|FG000|Week 13 - Week 104|Death|2|||
124459458|NCT01500278|447642305|FG001|Week 13 - Week 104|Death|4|||
124459459|NCT01500278|447642304|FG000|Week 13 - Week 104|Adverse Event|54|||
124459460|NCT01500278|447642305|FG001|Week 13 - Week 104|Adverse Event|54|||
124459461|NCT01709435|447642306|FG000|Overall Study|Adverse Event|1|||
124459462|NCT01709435|447642307|FG001|Overall Study|Adverse Event|1|||
124459463|NCT01709435|447642308|FG002|Overall Study|Adverse Event|1|||
124459464|NCT01709435|447642309|FG003|Overall Study|Adverse Event|0|||
124459465|NCT01709435|447642310|FG004|Overall Study|Adverse Event|0|||
124459466|NCT01709435|447642311|FG005|Overall Study|Adverse Event|1|||
124459467|NCT01709435|447642306|FG000|Overall Study|Lack of Efficacy|5|||
124459468|NCT01709435|447642307|FG001|Overall Study|Lack of Efficacy|7|||
124459469|NCT01709435|447642308|FG002|Overall Study|Lack of Efficacy|2|||
124459470|NCT01709435|447642309|FG003|Overall Study|Lack of Efficacy|2|||
124459471|NCT01709435|447642310|FG004|Overall Study|Lack of Efficacy|6|||
124459472|NCT01709435|447642311|FG005|Overall Study|Lack of Efficacy|3|||
124459473|NCT01709435|447642306|FG000|Overall Study|Physician Decision|0|||
124459474|NCT01709435|447642307|FG001|Overall Study|Physician Decision|1|||
124459475|NCT01709435|447642308|FG002|Overall Study|Physician Decision|0|||
124706807|NCT05239221|448551768|FG002|Overall Study|Adverse Event|0|||
124706808|NCT05239221|448551769|FG003|Overall Study|Adverse Event|0|||
124706809|NCT05239221|448551770|FG004|Overall Study|Adverse Event|0|||
124706810|NCT05239221|448551771|FG005|Overall Study|Adverse Event|0|||
124706811|NCT05239221|448551772|FG006|Overall Study|Adverse Event|1|||
124706812|NCT05239221|448551773|FG007|Overall Study|Adverse Event|0|||
124706813|NCT05239221|448551774|FG008|Overall Study|Adverse Event|0|||
124706814|NCT05239221|448551775|FG009|Overall Study|Adverse Event|0|||
124706815|NCT05239221|448551776|FG010|Overall Study|Adverse Event|1|||
124706816|NCT05239221|448551777|FG011|Overall Study|Adverse Event|1|||
124706817|NCT05239221|448551778|FG012|Overall Study|Adverse Event|0|||
124706818|NCT05239221|448551779|FG013|Overall Study|Adverse Event|0|||
124706819|NCT05239221|448551780|FG014|Overall Study|Adverse Event|0|||
124706820|NCT05239221|448551781|FG015|Overall Study|Adverse Event|0|||
124706821|NCT05239221|448551766|FG000|Overall Study|Withdrawal by Subject|0|||
124706822|NCT05239221|448551767|FG001|Overall Study|Withdrawal by Subject|0|||
124706823|NCT05239221|448551768|FG002|Overall Study|Withdrawal by Subject|0|||
124459476|NCT01709435|447642309|FG003|Overall Study|Physician Decision|1|||
124459477|NCT01709435|447642310|FG004|Overall Study|Physician Decision|2|||
124459478|NCT01709435|447642311|FG005|Overall Study|Physician Decision|0|||
124459479|NCT01709435|447642306|FG000|Overall Study|Withdrawal by Subject|0|||
124459480|NCT01709435|447642307|FG001|Overall Study|Withdrawal by Subject|0|||
124706824|NCT05239221|448551769|FG003|Overall Study|Withdrawal by Subject|0|||
124706825|NCT05239221|448551770|FG004|Overall Study|Withdrawal by Subject|0|||
124706826|NCT05239221|448551771|FG005|Overall Study|Withdrawal by Subject|0|||
124706827|NCT05239221|448551772|FG006|Overall Study|Withdrawal by Subject|0|||
124765780|NCT04742556|448769273|FG001|Overall Study|Clinical disease progression|1|||
124765781|NCT04742556|448769274|FG002|Overall Study|Clinical disease progression|2|||
124765782|NCT04742556|448769272|FG000|Overall Study|Objective disease progression|3|||
124765783|NCT04742556|448769273|FG001|Overall Study|Objective disease progression|2|||
124765784|NCT04742556|448769274|FG002|Overall Study|Objective disease progression|4|||
124765785|NCT03035032|448769275|FG000|Overall Study|Adverse Event|2|||
124765786|NCT03035032|448769275|FG000|Overall Study|Death|9|||
124765787|NCT03035032|448769275|FG000|Overall Study|Lost to Follow-up|1|||
124765788|NCT03035032|448769275|FG000|Overall Study|Progressive Disease|22|||
124765789|NCT03035032|448769275|FG000|Overall Study|Protocol Violation|2|||
124765790|NCT03035032|448769275|FG000|Overall Study|Withdrawal by Subject|2|||
124765791|NCT03035032|448769275|FG000|Overall Study|Physician Decision|5|||
124765792|NCT02201524|448769276|FG000|Overall Study|Adverse Event|0|||
124765793|NCT02201524|448769277|FG001|Overall Study|Adverse Event|2|||
124765794|NCT02201524|448769278|FG002|Overall Study|Adverse Event|1|||
124765795|NCT02201524|448769279|FG003|Overall Study|Adverse Event|0|||
124765796|NCT02201524|448769276|FG000|Overall Study|Insufficient clinical response|1|||
124765797|NCT02201524|448769277|FG001|Overall Study|Insufficient clinical response|0|||
124765798|NCT02201524|448769278|FG002|Overall Study|Insufficient clinical response|0|||
124765799|NCT02201524|448769279|FG003|Overall Study|Insufficient clinical response|0|||
124765800|NCT02201524|448769276|FG000|Overall Study|Lost to Follow-up|0|||
124765801|NCT02201524|448769277|FG001|Overall Study|Lost to Follow-up|0|||
124765802|NCT02201524|448769278|FG002|Overall Study|Lost to Follow-up|2|||
124765803|NCT02201524|448769279|FG003|Overall Study|Lost to Follow-up|0|||
124765804|NCT02201524|448769276|FG000|Overall Study|No longer meets eligibility criteria|0|||
124765805|NCT02201524|448769277|FG001|Overall Study|No longer meets eligibility criteria|0|||
124765806|NCT02201524|448769278|FG002|Overall Study|No longer meets eligibility criteria|0|||
124765807|NCT02201524|448769279|FG003|Overall Study|No longer meets eligibility criteria|2|||
124765808|NCT02201524|448769276|FG000|Overall Study|Protocol Violation|0|||
124765809|NCT02201524|448769277|FG001|Overall Study|Protocol Violation|0|||
124765810|NCT02201524|448769278|FG002|Overall Study|Protocol Violation|0|||
124765811|NCT02201524|448769279|FG003|Overall Study|Protocol Violation|1|||
124765812|NCT02201524|448769276|FG000|Overall Study|Withdrawal by Subject|0|||
124765813|NCT02201524|448769277|FG001|Overall Study|Withdrawal by Subject|0|||
124765814|NCT02201524|448769278|FG002|Overall Study|Withdrawal by Subject|1|||
124765815|NCT02201524|448769279|FG003|Overall Study|Withdrawal by Subject|1|||
124765816|NCT02201524|448769276|FG000|Overall Study|Other|1|||
124765817|NCT02201524|448769277|FG001|Overall Study|Other|1|||
124765818|NCT02201524|448769278|FG002|Overall Study|Other|0|||
124459481|NCT01709435|447642308|FG002|Overall Study|Withdrawal by Subject|3|||
124459482|NCT01709435|447642309|FG003|Overall Study|Withdrawal by Subject|0|||
124459483|NCT01709435|447642310|FG004|Overall Study|Withdrawal by Subject|2|||
124765819|NCT02201524|448769279|FG003|Overall Study|Other|0|||
124765820|NCT02914639|448769281|FG000|Overall Study|Withdrawal by Subject|0|||
124765821|NCT02914639|448769282|FG001|Overall Study|Withdrawal by Subject|2|||
124765822|NCT01018030|448769284|FG000|Overall Study|Adverse Event|10|||
124765823|NCT01018030|448769285|FG001|Overall Study|Adverse Event|5|||
124765824|NCT01018030|448769286|FG002|Overall Study|Adverse Event|5|||
124765825|NCT01018030|448769284|FG000|Overall Study|Withdrawal by Subject|2|||
124765826|NCT01018030|448769285|FG001|Overall Study|Withdrawal by Subject|2|||
124949261|NCT01393964|449441812|FG001|Overall Study|Subject decided to move to transplant|0|||
124949262|NCT01393964|449441813|FG002|Overall Study|Subject decided to move to transplant|0|||
124949263|NCT01393964|449441811|FG000|Overall Study|Subject switched to commercial supply|1|||
124949264|NCT01393964|449441812|FG001|Overall Study|Subject switched to commercial supply|0|||
124949265|NCT01393964|449441813|FG002|Overall Study|Subject switched to commercial supply|2|||
124949266|NCT01393964|449441811|FG000|Overall Study|Subject plateaued in terms of effect|1|||
124949267|NCT01393964|449441812|FG001|Overall Study|Subject plateaued in terms of effect|0|||
124949268|NCT01393964|449441813|FG002|Overall Study|Subject plateaued in terms of effect|0|||
124949269|NCT01393964|449441811|FG000|Overall Study|Investigator removed subject from study|0|||
124949270|NCT01393964|449441812|FG001|Overall Study|Investigator removed subject from study|1|||
124949271|NCT01393964|449441813|FG002|Overall Study|Investigator removed subject from study|0|||
124949272|NCT01393964|449441811|FG000|Overall Study|Subject converted to roll-over study|0|||
124949273|NCT01393964|449441812|FG001|Overall Study|Subject converted to roll-over study|1|||
124949274|NCT01393964|449441813|FG002|Overall Study|Subject converted to roll-over study|0|||
124949275|NCT01393964|449441811|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
124949276|NCT01393964|449441812|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
124949277|NCT01393964|449441813|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
124949278|NCT03265132|449441820|FG000|Overall Study|Adverse Event|0|||
124949279|NCT03265132|449441821|FG001|Overall Study|Adverse Event|1|||
124949280|NCT03265132|449441820|FG000|Overall Study|Lack of Efficacy|0|||
124949281|NCT03265132|449441821|FG001|Overall Study|Lack of Efficacy|2|||
124949282|NCT03265132|449441820|FG000|Overall Study|Progressive disease|0|||
124949283|NCT03265132|449441821|FG001|Overall Study|Progressive disease|2|||
124949284|NCT03265132|449441820|FG000|Overall Study|Withdrawal by Subject|0|||
124765827|NCT01018030|448769286|FG002|Overall Study|Withdrawal by Subject|4|||
124765828|NCT01018030|448769284|FG000|Overall Study|Lost to Follow-up|2|||
124765829|NCT01018030|448769285|FG001|Overall Study|Lost to Follow-up|0|||
124765830|NCT01018030|448769286|FG002|Overall Study|Lost to Follow-up|3|||
124765831|NCT01018030|448769284|FG000|Overall Study|Protocol Violation|2|||
124765832|NCT01018030|448769285|FG001|Overall Study|Protocol Violation|1|||
124765833|NCT01018030|448769286|FG002|Overall Study|Protocol Violation|0|||
124765834|NCT01018030|448769284|FG000|Overall Study|Physician Decision|1|||
124765835|NCT01018030|448769285|FG001|Overall Study|Physician Decision|0|||
124765836|NCT01018030|448769286|FG002|Overall Study|Physician Decision|1|||
124765837|NCT01018030|448769284|FG000|Overall Study|Lack of Efficacy|1|||
124949285|NCT03265132|449441821|FG001|Overall Study|Withdrawal by Subject|1|||
124949286|NCT00088166|449441822|FG000|Overall Study|Adverse Event|11|||
124949287|NCT00088166|449441823|FG001|Overall Study|Adverse Event|9|||
124949288|NCT00088166|449441822|FG000|Overall Study|Death|3|||
124949289|NCT00088166|449441823|FG001|Overall Study|Death|1|||
124949290|NCT00088166|449441822|FG000|Overall Study|Lost to Follow-up|0|||
124949291|NCT00088166|449441823|FG001|Overall Study|Lost to Follow-up|1|||
124949292|NCT00088166|449441822|FG000|Overall Study|Physician Decision|4|||
124949293|NCT00088166|449441823|FG001|Overall Study|Physician Decision|1|||
124949294|NCT00088166|449441822|FG000|Overall Study|Protocol Violation|1|||
124949295|NCT00088166|449441823|FG001|Overall Study|Protocol Violation|5|||
124949296|NCT00088166|449441822|FG000|Overall Study|Patient deterioration|29|||
124949297|NCT00088166|449441823|FG001|Overall Study|Patient deterioration|39|||
124949298|NCT00088166|449441822|FG000|Overall Study|Withdrawal by Subject|5|||
124949299|NCT00088166|449441823|FG001|Overall Study|Withdrawal by Subject|5|||
124949300|NCT02671266|449441824|FG000|Overall Study|Withdrawal by Subject|1|||
124949301|NCT02671266|449441825|FG001|Overall Study|Withdrawal by Subject|1|||
124949302|NCT00666705|449441826|FG000|Overall Study|Withdrawal by Subject|1|||
124949303|NCT01109979|449441827|FG000|Overall Study|Physician Decision|2|||
124949304|NCT01109979|449441828|FG001|Overall Study|Physician Decision|0|||
124949305|NCT01109979|449441827|FG000|Overall Study|Withdrawal by Subject|0|||
124949306|NCT01109979|449441828|FG001|Overall Study|Withdrawal by Subject|1|||
124949307|NCT01228734|449441829|FG000|Overall Study|Randomized, but not treated|0|||
124949308|NCT01228734|449441830|FG001|Overall Study|Randomized, but not treated|4|||
124949309|NCT03128099|449441834|FG000|Overall Study|High dose task was too long|0|||
124949310|NCT03128099|449441835|FG001|Overall Study|High dose task was too long|4|||
124949311|NCT03128099|449441836|FG002|Overall Study|High dose task was too long|0|||
124949312|NCT03128099|449441834|FG000|Overall Study|Participant got a full time job.|1|||
124949313|NCT03128099|449441835|FG001|Overall Study|Participant got a full time job.|0|||
124949314|NCT03128099|449441836|FG002|Overall Study|Participant got a full time job.|0|||
124949315|NCT03128099|449441834|FG000|Overall Study|Became homeless and lost contact|1|||
124949316|NCT03128099|449441835|FG001|Overall Study|Became homeless and lost contact|0|||
124949317|NCT03128099|449441836|FG002|Overall Study|Became homeless and lost contact|0|||
124949318|NCT03128099|449441834|FG000|Overall Study|Did not complete all the assessments|0|||
124949319|NCT03128099|449441835|FG001|Overall Study|Did not complete all the assessments|0|||
124949320|NCT03128099|449441836|FG002|Overall Study|Did not complete all the assessments|1|||
124949321|NCT03456856|449441837|FG000|Overall Study|Lost to Follow-up|2|||
124949322|NCT03456856|449441837|FG000|Overall Study|Withdrawal by Subject|1|||
124949323|NCT02542696|449441842|FG000|Overall Study|Adverse Event|167|||
124949324|NCT02542696|449441842|FG000|Overall Study|Lack of Efficacy|26|||
124949325|NCT02542696|449441842|FG000|Overall Study|Lost to Follow-up|6|||
124949326|NCT02542696|449441842|FG000|Overall Study|Withdrawal by Subject|104|||
124949327|NCT02542696|449441842|FG000|Overall Study|Protocol Violation|5|||
124949328|NCT02542696|449441842|FG000|Overall Study|Death|8|||
124949329|NCT02542696|449441842|FG000|Overall Study|DECREASED OFF TIME|1|||
124765838|NCT01018030|448769285|FG001|Overall Study|Lack of Efficacy|0|||
124765839|NCT01018030|448769286|FG002|Overall Study|Lack of Efficacy|0|||
124765840|NCT01018030|448769284|FG000|Overall Study|Did Not Receive Study Drug|1|||
124765841|NCT01018030|448769285|FG001|Overall Study|Did Not Receive Study Drug|3|||
124765842|NCT01018030|448769286|FG002|Overall Study|Did Not Receive Study Drug|0|||
124765843|NCT03617172|448769289|FG000|Overall Study|Lost to Follow-up|1|||
124765844|NCT03617172|448769290|FG001|Overall Study|Lost to Follow-up|0|||
124765845|NCT01089504|448769291|FG000|Overall Study|Lost to Follow-up|1|||
124765846|NCT01089504|448769292|FG001|Overall Study|Lost to Follow-up|1|||
124765847|NCT01089504|448769291|FG000|Overall Study|Withdrawal by Subject|2|||
124765848|NCT01089504|448769292|FG001|Overall Study|Withdrawal by Subject|0|||
124765849|NCT01924845|448769293|FG000|Overall Study|Adverse Event|3|||
124765850|NCT01924845|448769293|FG000|Overall Study|Withdrawal by Subject|2|||
124765851|NCT01924845|448769293|FG000|Overall Study|Protocol Violation|1|||
124949330|NCT02542696|449441842|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
124765852|NCT00062439|448769294|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
124765853|NCT00062439|448769294|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
124765854|NCT00062439|448769294|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
124765855|NCT00062439|448769294|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
124949331|NCT02542696|449441842|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
124949332|NCT02542696|449441842|FG000|Overall Study|MEDICAL HISTORY|1|||
124949333|NCT02542696|449441842|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
124949334|NCT02542696|449441842|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
124949335|NCT02542696|449441842|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
124949336|NCT02542696|449441842|FG000|Overall Study|SPONSOR DECISION|3|||
124949337|NCT02542696|449441842|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
124459484|NCT01709435|447642311|FG005|Overall Study|Withdrawal by Subject|2|||
124459485|NCT00053417|447642312|FG000|Overall Study|Adverse Event|1|||
124459486|NCT00053417|447642313|FG001|Overall Study|Adverse Event|0|||
124459487|NCT00053417|447642314|FG002|Overall Study|Adverse Event|1|||
124459488|NCT00053417|447642315|FG003|Overall Study|Adverse Event|5|||
124459489|NCT00053417|447642312|FG000|Overall Study|Non-Compliance|0|||
124459490|NCT00053417|447642313|FG001|Overall Study|Non-Compliance|0|||
124459491|NCT00053417|447642314|FG002|Overall Study|Non-Compliance|0|||
124459492|NCT00053417|447642315|FG003|Overall Study|Non-Compliance|1|||
124459493|NCT00053417|447642312|FG000|Overall Study|Withdrawal by Subject|0|||
124459494|NCT00053417|447642313|FG001|Overall Study|Withdrawal by Subject|1|||
124459495|NCT00053417|447642314|FG002|Overall Study|Withdrawal by Subject|0|||
124459496|NCT00053417|447642315|FG003|Overall Study|Withdrawal by Subject|0|||
124459497|NCT00053417|447642312|FG000|Overall Study|Lost to Follow-up|1|||
124706828|NCT05239221|448551773|FG007|Overall Study|Withdrawal by Subject|0|||
124706829|NCT05239221|448551774|FG008|Overall Study|Withdrawal by Subject|0|||
124706830|NCT05239221|448551775|FG009|Overall Study|Withdrawal by Subject|0|||
124706831|NCT05239221|448551776|FG010|Overall Study|Withdrawal by Subject|1|||
124706832|NCT05239221|448551777|FG011|Overall Study|Withdrawal by Subject|0|||
124706833|NCT05239221|448551778|FG012|Overall Study|Withdrawal by Subject|0|||
124706834|NCT05239221|448551779|FG013|Overall Study|Withdrawal by Subject|0|||
124706835|NCT05239221|448551780|FG014|Overall Study|Withdrawal by Subject|0|||
124706836|NCT05239221|448551781|FG015|Overall Study|Withdrawal by Subject|1|||
124706837|NCT02581930|448551782|FG000|Overall Study|Withdrawal by Subject|1|||
124706838|NCT02581930|448551782|FG000|Overall Study|patient declined further treatment|1|||
124706839|NCT03386773|448552832|FG000|Overall Study|Lost to Follow-up|24|||
124706840|NCT03386773|448552833|FG001|Overall Study|Lost to Follow-up|33|||
124706841|NCT03386773|448552832|FG000|Overall Study|Withdrawal by Subject|3|||
124706842|NCT03386773|448552833|FG001|Overall Study|Withdrawal by Subject|2|||
124706843|NCT03983421|448552834|FG000|Overall Study|Lost to Follow-up|1|||
124706844|NCT03639610|448552835|FG000|Overall Study|Adverse Event|7|||
124706845|NCT03639610|448552836|FG001|Overall Study|Adverse Event|1|||
124706846|NCT03639610|448552837|FG002|Overall Study|Adverse Event|0|||
124706847|NCT03639610|448552835|FG000|Overall Study|Physician Decision|3|||
124706848|NCT03639610|448552836|FG001|Overall Study|Physician Decision|1|||
124706849|NCT03639610|448552837|FG002|Overall Study|Physician Decision|0|||
124706850|NCT03639610|448552835|FG000|Overall Study|Disease progression|8|||
124706851|NCT03639610|448552836|FG001|Overall Study|Disease progression|5|||
124706852|NCT03639610|448552837|FG002|Overall Study|Disease progression|3|||
124706853|NCT03639610|448552835|FG000|Overall Study|Study terminated by sponsor|2|||
124706854|NCT03639610|448552836|FG001|Overall Study|Study terminated by sponsor|1|||
124706855|NCT03639610|448552837|FG002|Overall Study|Study terminated by sponsor|1|||
124706856|NCT03639610|448552835|FG000|Overall Study|Patient request to stop treatment|1|||
124706857|NCT03639610|448552836|FG001|Overall Study|Patient request to stop treatment|2|||
124706858|NCT03639610|448552837|FG002|Overall Study|Patient request to stop treatment|0|||
124706859|NCT02410772|448552840|FG000|Overall Study|Death|3|||
124706860|NCT02410772|448552841|FG001|Overall Study|Death|4|||
124706861|NCT02410772|448552842|FG002|Overall Study|Death|8|||
124706862|NCT02410772|448552840|FG000|Overall Study|Lost to Follow-up|31|||
124706863|NCT02410772|448552841|FG001|Overall Study|Lost to Follow-up|23|||
124706864|NCT02410772|448552842|FG002|Overall Study|Lost to Follow-up|22|||
124706865|NCT02410772|448552840|FG000|Overall Study|Pregnancy|8|||
124706866|NCT02410772|448552841|FG001|Overall Study|Pregnancy|4|||
124706867|NCT02410772|448552842|FG002|Overall Study|Pregnancy|5|||
124706868|NCT02410772|448552840|FG000|Overall Study|Protocol Violation|8|||
124706869|NCT02410772|448552841|FG001|Overall Study|Protocol Violation|8|||
124706870|NCT02410772|448552842|FG002|Overall Study|Protocol Violation|4|||
124706871|NCT02410772|448552840|FG000|Overall Study|Baseline Drug Resistance|49|||
124706872|NCT02410772|448552841|FG001|Overall Study|Baseline Drug Resistance|40|||
124706873|NCT02410772|448552842|FG002|Overall Study|Baseline Drug Resistance|51|||
124706874|NCT02410772|448552840|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
124706875|NCT02410772|448552841|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
124459498|NCT00053417|447642313|FG001|Overall Study|Lost to Follow-up|1|||
124459499|NCT00053417|447642314|FG002|Overall Study|Lost to Follow-up|0|||
124459500|NCT00053417|447642315|FG003|Overall Study|Lost to Follow-up|0|||
124548616|NCT03515837|447965283|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
124706876|NCT02410772|448552842|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
124706877|NCT02410772|448552840|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
124706878|NCT02410772|448552841|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
124706879|NCT02410772|448552842|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
124706880|NCT01517984|448552843|FG000|Overall Study|Lost to Follow-up|0|||
124706881|NCT01517984|448552844|FG001|Overall Study|Lost to Follow-up|1|||
124949338|NCT02542696|449441842|FG000|Overall Study|SUBJECT DECISION|2|||
124949339|NCT02410278|449441843|FG000|Run-in Period|Adverse Event|5|||
124949340|NCT02410278|449441844|FG001|Run-in Period|Adverse Event|0|||
124949341|NCT02410278|449441845|FG002|Run-in Period|Adverse Event|0|||
124949342|NCT02410278|449441843|FG000|Run-in Period|GSRS Threshold Not Met|30|||
124949343|NCT02410278|449441844|FG001|Run-in Period|GSRS Threshold Not Met|0|||
124949344|NCT02410278|449441845|FG002|Run-in Period|GSRS Threshold Not Met|0|||
124949345|NCT02410278|449441843|FG000|Run-in Period|Lost to Follow-up|1|||
124949346|NCT02410278|449441844|FG001|Run-in Period|Lost to Follow-up|0|||
124949347|NCT02410278|449441845|FG002|Run-in Period|Lost to Follow-up|0|||
124949348|NCT02410278|449441843|FG000|Run-in Period|Withdrawal by Subject|1|||
124949349|NCT02410278|449441844|FG001|Run-in Period|Withdrawal by Subject|0|||
124949350|NCT02410278|449441845|FG002|Run-in Period|Withdrawal by Subject|0|||
124706882|NCT01517984|448552845|FG002|Overall Study|Lost to Follow-up|0|||
124706883|NCT01517984|448552846|FG003|Overall Study|Lost to Follow-up|0|||
124706884|NCT01517984|448552843|FG000|Overall Study|Withdrawal by Subject|1|||
124706885|NCT01517984|448552844|FG001|Overall Study|Withdrawal by Subject|8|||
124706886|NCT01517984|448552845|FG002|Overall Study|Withdrawal by Subject|4|||
124706887|NCT01517984|448552846|FG003|Overall Study|Withdrawal by Subject|1|||
124706888|NCT01517984|448552843|FG000|Overall Study|Screen Failure|4|||
124706889|NCT01517984|448552844|FG001|Overall Study|Screen Failure|0|||
124706890|NCT01517984|448552845|FG002|Overall Study|Screen Failure|0|||
124706891|NCT01517984|448552846|FG003|Overall Study|Screen Failure|0|||
124706892|NCT01517984|448552843|FG000|Overall Study|Ineligible for randomization|0|||
124706893|NCT01517984|448552844|FG001|Overall Study|Ineligible for randomization|14|||
124706894|NCT01517984|448552845|FG002|Overall Study|Ineligible for randomization|0|||
124706895|NCT01517984|448552846|FG003|Overall Study|Ineligible for randomization|0|||
124706896|NCT02234362|448552847|FG000|Overall Study|Not eligible after first screening visit|17|||
124706897|NCT02234362|448552847|FG000|Overall Study|Lost to Follow-up|6|||
124706898|NCT02234362|448552847|FG000|Overall Study|Withdrawal by Subject|3|||
124706899|NCT02164864|448552848|FG000|Overall Study|Trial disease worsening|7|||
124706900|NCT02164864|448552849|FG001|Overall Study|Trial disease worsening|5|||
124706901|NCT02164864|448552850|FG002|Overall Study|Trial disease worsening|1|||
124706902|NCT02164864|448552848|FG000|Overall Study|Other pre-existing disease worsening|6|||
124706903|NCT02164864|448552849|FG001|Overall Study|Other pre-existing disease worsening|4|||
124706904|NCT02164864|448552850|FG002|Overall Study|Other pre-existing disease worsening|9|||
124706905|NCT02164864|448552848|FG000|Overall Study|Other Adverse Event (AE)|52|||
124706906|NCT02164864|448552849|FG001|Overall Study|Other Adverse Event (AE)|32|||
124706907|NCT02164864|448552850|FG002|Overall Study|Other Adverse Event (AE)|49|||
124706908|NCT02164864|448552848|FG000|Overall Study|Protocol Violation|2|||
124706909|NCT02164864|448552849|FG001|Overall Study|Protocol Violation|4|||
124706910|NCT02164864|448552850|FG002|Overall Study|Protocol Violation|1|||
124949351|NCT02410278|449441843|FG000|Run-in Period|Pregnancy|1|||
124765856|NCT00062439|448769294|FG000|Post Chemoradiation Assessment|Death|1|||
124765857|NCT00062439|448769294|FG000|Post Chemoradiation Assessment|Disease progression|2|||
124765858|NCT00062439|448769294|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
124765859|NCT00062439|448769294|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
124765860|NCT00062439|448769294|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
124765861|NCT00062439|448769294|FG000|Surgery|Physician Decision|4|||
124765862|NCT00062439|448769294|FG000|Surgery|Death|1|||
124949352|NCT02410278|449441844|FG001|Run-in Period|Pregnancy|0|||
124949353|NCT02410278|449441845|FG002|Run-in Period|Pregnancy|0|||
124949354|NCT02410278|449441843|FG000|Study Treatment Period|Adverse Event|0|||
124949355|NCT02410278|449441844|FG001|Study Treatment Period|Adverse Event|6|||
124949356|NCT02410278|449441845|FG002|Study Treatment Period|Adverse Event|3|||
124949357|NCT02410278|449441843|FG000|Study Treatment Period|Physician Decision|0|||
124949358|NCT02410278|449441844|FG001|Study Treatment Period|Physician Decision|0|||
124949359|NCT02410278|449441845|FG002|Study Treatment Period|Physician Decision|1|||
124949360|NCT02410278|449441843|FG000|Study Treatment Period|Withdrawal by Subject|0|||
124949361|NCT02410278|449441844|FG001|Study Treatment Period|Withdrawal by Subject|1|||
124949362|NCT02410278|449441845|FG002|Study Treatment Period|Withdrawal by Subject|0|||
124949363|NCT02410278|449441843|FG000|Study Treatment Period|Other|0|||
124949364|NCT02410278|449441844|FG001|Study Treatment Period|Other|3|||
124706911|NCT02164864|448552848|FG000|Overall Study|Lost to Follow-up|4|||
124706912|NCT02164864|448552849|FG001|Overall Study|Lost to Follow-up|3|||
124706913|NCT02164864|448552850|FG002|Overall Study|Lost to Follow-up|2|||
124706914|NCT02164864|448552848|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
124706915|NCT02164864|448552849|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
124706916|NCT02164864|448552850|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
124706917|NCT02164864|448552848|FG000|Overall Study|Other than stated|3|||
124706918|NCT02164864|448552849|FG001|Overall Study|Other than stated|4|||
124706919|NCT02164864|448552850|FG002|Overall Study|Other than stated|14|||
124706920|NCT02569853|448552853|FG000|Overall Study|Adverse Event|2|||
124949365|NCT02410278|449441845|FG002|Study Treatment Period|Other|0|||
124949366|NCT02410278|449441843|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
124949367|NCT02410278|449441844|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
124949368|NCT02410278|449441845|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
124949369|NCT03695185|449441847|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
124949370|NCT03695185|449441847|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
124949371|NCT03695185|449441847|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
124949372|NCT03695185|449441847|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
124949373|NCT03695185|449441847|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
124765863|NCT00062439|448769294|FG000|Surgery|Adverse Event|2|||
124765864|NCT00062439|448769294|FG000|Consolidation Chemotherapy|Adverse Event|2|||
124765865|NCT00001832|448769298|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
124765866|NCT00001832|448769299|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
124765867|NCT00001832|448769300|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
124765868|NCT00001832|448769301|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
124765869|NCT00001832|448769302|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
124765870|NCT00001832|448769303|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
124765871|NCT00001832|448769304|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
124765872|NCT00001832|448769305|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
124765873|NCT00001832|448769306|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
124765874|NCT00001832|448769307|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
124765875|NCT00001832|448769308|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
124765876|NCT00001832|448769309|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
124765877|NCT00001832|448769310|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
124765878|NCT00001832|448769311|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
124765879|NCT00001832|448769312|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
124765880|NCT00001832|448769298|FG000|Treatment Period|Death during treatment|0|||
124765881|NCT00001832|448769299|FG001|Treatment Period|Death during treatment|0|||
124765882|NCT00001832|448769300|FG002|Treatment Period|Death during treatment|0|||
124765883|NCT00001832|448769301|FG003|Treatment Period|Death during treatment|0|||
124765884|NCT00001832|448769302|FG004|Treatment Period|Death during treatment|0|||
124765885|NCT00001832|448769303|FG005|Treatment Period|Death during treatment|1|||
124765886|NCT00001832|448769304|FG006|Treatment Period|Death during treatment|0|||
124765887|NCT00001832|448769305|FG007|Treatment Period|Death during treatment|0|||
124765888|NCT00001832|448769306|FG008|Treatment Period|Death during treatment|0|||
124765889|NCT00001832|448769307|FG009|Treatment Period|Death during treatment|0|||
124949374|NCT03695185|449441847|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
124949375|NCT02137785|449441850|FG000|Overall Study|Lost to Follow-up|1|||
124949376|NCT02137785|449441851|FG001|Overall Study|Lost to Follow-up|0|||
124949377|NCT02137785|449441850|FG000|Overall Study|Withdrawal by Subject|1|||
124765890|NCT00001832|448769308|FG010|Treatment Period|Death during treatment|0|||
124765891|NCT00001832|448769309|FG011|Treatment Period|Death during treatment|0|||
124765892|NCT00001832|448769310|FG012|Treatment Period|Death during treatment|0|||
124765893|NCT00001832|448769311|FG013|Treatment Period|Death during treatment|0|||
124765894|NCT00001832|448769312|FG014|Treatment Period|Death during treatment|0|||
124765895|NCT00001832|448769298|FG000|Treatment Period|Not treated|0|||
124949378|NCT02137785|449441851|FG001|Overall Study|Withdrawal by Subject|4|||
124949379|NCT02137785|449441850|FG000|Overall Study|subject moved out of state|1|||
124949380|NCT02137785|449441851|FG001|Overall Study|subject moved out of state|0|||
124949381|NCT02584257|449441852|FG000|Period 1|Withdrawal by Subject|0|||
124949382|NCT02584257|449441853|FG001|Period 1|Withdrawal by Subject|0|||
124949383|NCT02584257|449441854|FG002|Period 1|Withdrawal by Subject|0|||
124949384|NCT02584257|449441855|FG003|Period 1|Withdrawal by Subject|0|||
124949385|NCT02584257|449441856|FG004|Period 1|Withdrawal by Subject|0|||
124949386|NCT02584257|449441857|FG005|Period 1|Withdrawal by Subject|0|||
124949387|NCT02584257|449441858|FG006|Period 1|Withdrawal by Subject|1|||
124949388|NCT02584257|449441859|FG007|Period 1|Withdrawal by Subject|0|||
124949389|NCT02584257|449441860|FG008|Period 1|Withdrawal by Subject|0|||
124949390|NCT02584257|449441852|FG000|Period 2|Physician Decision|1|||
124949391|NCT02584257|449441853|FG001|Period 2|Physician Decision|0|||
124949392|NCT02584257|449441854|FG002|Period 2|Physician Decision|0|||
124949393|NCT02584257|449441855|FG003|Period 2|Physician Decision|0|||
124949394|NCT02584257|449441856|FG004|Period 2|Physician Decision|0|||
124548617|NCT03515837|447965284|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
124548618|NCT01964898|447965285|FG000|Overall Study|ineligible post-randomization|1|||
124548619|NCT01964898|447965286|FG001|Overall Study|ineligible post-randomization|1|||
124765896|NCT00001832|448769299|FG001|Treatment Period|Not treated|0|||
124765897|NCT00001832|448769300|FG002|Treatment Period|Not treated|0|||
124765898|NCT00001832|448769301|FG003|Treatment Period|Not treated|0|||
124765899|NCT00001832|448769302|FG004|Treatment Period|Not treated|0|||
124765900|NCT00001832|448769303|FG005|Treatment Period|Not treated|0|||
124765901|NCT00001832|448769304|FG006|Treatment Period|Not treated|0|||
124765902|NCT00001832|448769305|FG007|Treatment Period|Not treated|1|||
124765903|NCT00001832|448769306|FG008|Treatment Period|Not treated|0|||
124949395|NCT02584257|449441857|FG005|Period 2|Physician Decision|0|||
124949396|NCT02584257|449441858|FG006|Period 2|Physician Decision|0|||
124949397|NCT02584257|449441859|FG007|Period 2|Physician Decision|0|||
124949398|NCT02584257|449441860|FG008|Period 2|Physician Decision|0|||
124949399|NCT02584257|449441852|FG000|Period 2|Adverse Event|0|||
124949400|NCT02584257|449441853|FG001|Period 2|Adverse Event|1|||
124949401|NCT02584257|449441854|FG002|Period 2|Adverse Event|0|||
124949402|NCT02584257|449441855|FG003|Period 2|Adverse Event|0|||
124548620|NCT01964898|447965285|FG000|Overall Study|did not receive the allocated interventi|2|||
124548621|NCT01964898|447965286|FG001|Overall Study|did not receive the allocated interventi|1|||
124548622|NCT01964898|447965285|FG000|Overall Study|Lost to Follow-up|3|||
124548623|NCT01964898|447965286|FG001|Overall Study|Lost to Follow-up|5|||
124548624|NCT01964898|447965285|FG000|Overall Study|Withdrawal by Subject|1|||
124548625|NCT01964898|447965286|FG001|Overall Study|Withdrawal by Subject|0|||
124548626|NCT02325401|447965287|FG000|Overall Study|Withdrawal by Subject|0|||
124548627|NCT02325401|447965288|FG001|Overall Study|Withdrawal by Subject|1|||
124548628|NCT02325401|447965289|FG002|Overall Study|Withdrawal by Subject|1|||
124548629|NCT03526679|447965290|FG000|Overall Study|still under treatment|2|||
124548630|NCT02545868|447965291|FG000|Overall Study|Lack of Efficacy|1|||
124548631|NCT02545868|447965292|FG001|Overall Study|Lack of Efficacy|1|||
124548632|NCT02545868|447965293|FG002|Overall Study|Lack of Efficacy|0|||
124548633|NCT02545868|447965291|FG000|Overall Study|Lost to Follow-up|1|||
124548634|NCT02545868|447965292|FG001|Overall Study|Lost to Follow-up|5|||
124548635|NCT02545868|447965293|FG002|Overall Study|Lost to Follow-up|1|||
124548636|NCT02545868|447965291|FG000|Overall Study|Non-compliance|1|||
124548637|NCT02545868|447965292|FG001|Overall Study|Non-compliance|1|||
124548638|NCT02545868|447965293|FG002|Overall Study|Non-compliance|1|||
124548639|NCT02545868|447965291|FG000|Overall Study|Treatment change|21|||
124548640|NCT02545868|447965292|FG001|Overall Study|Treatment change|19|||
124548641|NCT02545868|447965293|FG002|Overall Study|Treatment change|22|||
124548642|NCT02545868|447965291|FG000|Overall Study|Physician Decision|1|||
124548643|NCT02545868|447965292|FG001|Overall Study|Physician Decision|1|||
124548644|NCT02545868|447965293|FG002|Overall Study|Physician Decision|1|||
124548645|NCT02545868|447965291|FG000|Overall Study|Withdrawal by Subject|6|||
124548646|NCT02545868|447965292|FG001|Overall Study|Withdrawal by Subject|7|||
124548647|NCT02545868|447965293|FG002|Overall Study|Withdrawal by Subject|9|||
124548648|NCT04465916|447965298|FG000|Overall Study|Withdrawal by Subject|0|||
124548649|NCT04465916|447965299|FG001|Overall Study|Withdrawal by Subject|1|||
124548650|NCT00468312|447965301|FG000|Overall Study|Adverse Event|2|||
124548651|NCT00468312|447965302|FG001|Overall Study|Adverse Event|1|||
124548652|NCT00468312|447965301|FG000|Overall Study|Lack of Efficacy|0|||
124548653|NCT00468312|447965302|FG001|Overall Study|Lack of Efficacy|1|||
124548654|NCT00468312|447965301|FG000|Overall Study|Withdrawal by Subject|0|||
124548655|NCT00468312|447965302|FG001|Overall Study|Withdrawal by Subject|1|||
124548656|NCT00468312|447965301|FG000|Overall Study|Protocol Violation|2|||
124548657|NCT00468312|447965302|FG001|Overall Study|Protocol Violation|1|||
124548658|NCT00468312|447965301|FG000|Overall Study|Did not meet protocol eligibility|0|||
124548659|NCT00468312|447965302|FG001|Overall Study|Did not meet protocol eligibility|1|||
124548660|NCT01052038|447965303|FG000|Overall Study|Lost to Follow-up|2|||
124548661|NCT01052038|447965304|FG001|Overall Study|Lost to Follow-up|3|||
124548662|NCT01052038|447965305|FG002|Overall Study|Lost to Follow-up|1|||
124548663|NCT01052038|447965303|FG000|Overall Study|Protocol Violation|2|||
124548664|NCT01052038|447965304|FG001|Overall Study|Protocol Violation|3|||
124706921|NCT02569853|448552854|FG001|Overall Study|Adverse Event|0|||
124706922|NCT02569853|448552853|FG000|Overall Study|Withdrawal by Subject|3|||
124706923|NCT02569853|448552854|FG001|Overall Study|Withdrawal by Subject|2|||
124706924|NCT02569853|448552853|FG000|Overall Study|Lost to Follow-up|3|||
124706925|NCT02569853|448552854|FG001|Overall Study|Lost to Follow-up|3|||
124706926|NCT02569853|448552853|FG000|Overall Study|Protocol Violation|1|||
124706927|NCT02569853|448552854|FG001|Overall Study|Protocol Violation|1|||
124706928|NCT02569853|448552853|FG000|Overall Study|Did not experience migraine attack|10|||
124706929|NCT02569853|448552854|FG001|Overall Study|Did not experience migraine attack|7|||
124706930|NCT02569853|448552853|FG000|Overall Study|Physician Decision|1|||
124706931|NCT02569853|448552854|FG001|Overall Study|Physician Decision|1|||
124706932|NCT02434081|448552857|FG000|Overall Study|Death (never started treatment)|2|||
124706933|NCT02434081|448552857|FG000|Overall Study|Death|2|||
124706934|NCT02434081|448552857|FG000|Overall Study|Progression|20|||
124706935|NCT02434081|448552857|FG000|Overall Study|Adverse Event|20|||
124706936|NCT02434081|448552857|FG000|Overall Study|Physician Decision|2|||
124706937|NCT02434081|448552857|FG000|Overall Study|Withdrawal by Subject|1|||
124706938|NCT02434081|448552857|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
124706939|NCT01668004|448552858|FG000|Overall Study|Adverse Event|7|||
124706940|NCT01668004|448552858|FG000|Overall Study|Withdrawal by Subject|2|||
124706941|NCT01668004|448552858|FG000|Overall Study|Lost to Follow-up|5|||
124706942|NCT01668004|448552858|FG000|Overall Study|Lack of Efficacy|9|||
124706943|NCT01668004|448552858|FG000|Overall Study|Non-compliance with treatment|2|||
124706944|NCT00419744|448552859|FG000|Overall Study|Adverse Event|39|||
124706945|NCT00419744|448552860|FG001|Overall Study|Adverse Event|40|||
124706946|NCT00419744|448552861|FG002|Overall Study|Adverse Event|50|||
124706947|NCT00419744|448552859|FG000|Overall Study|Withdrawal by Subject|45|||
124706948|NCT00419744|448552860|FG001|Overall Study|Withdrawal by Subject|49|||
124949403|NCT02584257|449441856|FG004|Period 2|Adverse Event|0|||
124548665|NCT01052038|447965305|FG002|Overall Study|Protocol Violation|3|||
124548666|NCT03976076|447965306|FG000|Overall Study|Withdrawal by Subject|2|||
124706949|NCT00419744|448552861|FG002|Overall Study|Withdrawal by Subject|52|||
124706950|NCT00419744|448552859|FG000|Overall Study|Lost to Follow-up|8|||
124706951|NCT00419744|448552860|FG001|Overall Study|Lost to Follow-up|10|||
124765904|NCT00001832|448769307|FG009|Treatment Period|Not treated|0|||
124765905|NCT00001832|448769308|FG010|Treatment Period|Not treated|0|||
124765906|NCT00001832|448769309|FG011|Treatment Period|Not treated|0|||
124765907|NCT00001832|448769310|FG012|Treatment Period|Not treated|0|||
124765908|NCT00001832|448769311|FG013|Treatment Period|Not treated|0|||
124765909|NCT00001832|448769312|FG014|Treatment Period|Not treated|0|||
124765910|NCT01546857|448769314|FG000|Overall Study|Withdrawal by Subject|2|||
124765911|NCT01546857|448769315|FG001|Overall Study|Withdrawal by Subject|3|||
124765912|NCT01469221|448769316|FG000|Double Blind Phase|Protocol Violation|1|||
124765913|NCT01469221|448769317|FG001|Double Blind Phase|Protocol Violation|0|||
124765914|NCT01469221|448769318|FG002|Double Blind Phase|Protocol Violation|0|||
124765915|NCT01469221|448769316|FG000|Double Blind Phase|Physician Decision|1|||
124765916|NCT01469221|448769317|FG001|Double Blind Phase|Physician Decision|1|||
124949404|NCT02584257|449441857|FG005|Period 2|Adverse Event|0|||
124949405|NCT02584257|449441858|FG006|Period 2|Adverse Event|0|||
124949406|NCT02584257|449441859|FG007|Period 2|Adverse Event|0|||
124949407|NCT02584257|449441860|FG008|Period 2|Adverse Event|0|||
124949408|NCT01670877|449441861|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
124949409|NCT01670877|449441862|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
124548667|NCT01325701|447965307|FG000|Overall Study|Adverse Event|12|||
124706952|NCT00419744|448552861|FG002|Overall Study|Lost to Follow-up|6|||
124706953|NCT00419744|448552859|FG000|Overall Study|Protocol Violation|4|||
124706954|NCT00419744|448552860|FG001|Overall Study|Protocol Violation|7|||
124706955|NCT00419744|448552861|FG002|Overall Study|Protocol Violation|8|||
124706956|NCT00419744|448552859|FG000|Overall Study|Randomized in error|9|||
124706957|NCT00419744|448552860|FG001|Overall Study|Randomized in error|6|||
124706958|NCT00419744|448552861|FG002|Overall Study|Randomized in error|7|||
124706959|NCT00419744|448552859|FG000|Overall Study|Moving out of state|2|||
124706960|NCT00419744|448552860|FG001|Overall Study|Moving out of state|0|||
124706961|NCT00419744|448552861|FG002|Overall Study|Moving out of state|1|||
124706962|NCT00419744|448552859|FG000|Overall Study|Physician Decision|10|||
124706963|NCT00419744|448552860|FG001|Overall Study|Physician Decision|5|||
124706964|NCT00419744|448552861|FG002|Overall Study|Physician Decision|6|||
124706965|NCT00419744|448552859|FG000|Overall Study|Spirometry mouthpiece issues|0|||
124706966|NCT00419744|448552860|FG001|Overall Study|Spirometry mouthpiece issues|1|||
124706967|NCT00419744|448552861|FG002|Overall Study|Spirometry mouthpiece issues|2|||
124706968|NCT00419744|448552859|FG000|Overall Study|Incorrect medication kit dispensed|0|||
124706969|NCT00419744|448552860|FG001|Overall Study|Incorrect medication kit dispensed|0|||
124706970|NCT00419744|448552861|FG002|Overall Study|Incorrect medication kit dispensed|1|||
124706971|NCT02448381|448552866|FG000|Overall Study|Adverse Event|2|||
124706972|NCT02448381|448552867|FG001|Overall Study|Adverse Event|0|||
124706973|NCT02448381|448552866|FG000|Overall Study|Lost to Follow-up|16|||
124706974|NCT02448381|448552867|FG001|Overall Study|Lost to Follow-up|9|||
124706975|NCT02448381|448552866|FG000|Overall Study|Physician Decision|1|||
124706976|NCT02448381|448552867|FG001|Overall Study|Physician Decision|1|||
124706977|NCT02448381|448552866|FG000|Overall Study|Pregnancy|1|||
124706978|NCT02448381|448552867|FG001|Overall Study|Pregnancy|0|||
124706979|NCT02448381|448552866|FG000|Overall Study|Withdrawal by Subject|13|||
124706980|NCT02448381|448552867|FG001|Overall Study|Withdrawal by Subject|9|||
124706981|NCT02448381|448552866|FG000|Overall Study|Noncompliance with Study Procedures|2|||
124706982|NCT02448381|448552867|FG001|Overall Study|Noncompliance with Study Procedures|0|||
124706983|NCT04856527|448552868|FG000|Overall Study|Unable to complete experimental task|2|||
124706984|NCT04856527|448552869|FG001|Overall Study|Unable to complete experimental task|0|||
124706985|NCT01816295|448552870|FG000|Double Blind Phase|Adverse Event|11|||
124706986|NCT01816295|448552871|FG001|Double Blind Phase|Adverse Event|8|||
124706987|NCT01816295|448552870|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
124706988|NCT01816295|448552871|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
124706989|NCT01816295|448552870|FG000|Double Blind Phase|Lost to Follow-up|3|||
124706990|NCT01816295|448552871|FG001|Double Blind Phase|Lost to Follow-up|5|||
124706991|NCT01816295|448552870|FG000|Double Blind Phase|Physician Decision|2|||
124706992|NCT01816295|448552871|FG001|Double Blind Phase|Physician Decision|2|||
124706993|NCT01816295|448552870|FG000|Double Blind Phase|Protocol Violation|17|||
124706994|NCT01816295|448552871|FG001|Double Blind Phase|Protocol Violation|11|||
124706995|NCT01816295|448552870|FG000|Double Blind Phase|Sponsor Decision|8|||
124706996|NCT01816295|448552871|FG001|Double Blind Phase|Sponsor Decision|8|||
124706997|NCT01816295|448552870|FG000|Double Blind Phase|Withdrawal by Subject|22|||
124706998|NCT01816295|448552871|FG001|Double Blind Phase|Withdrawal by Subject|20|||
124706999|NCT01816295|448552870|FG000|OLE Phase|Adverse Event|17|||
124765917|NCT01469221|448769318|FG002|Double Blind Phase|Physician Decision|0|||
124765918|NCT01469221|448769316|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
124949410|NCT01670877|449441863|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
124707000|NCT01816295|448552871|FG001|OLE Phase|Adverse Event|15|||
124707001|NCT01816295|448552870|FG000|OLE Phase|Death|1|||
124707002|NCT01816295|448552871|FG001|OLE Phase|Death|0|||
124707003|NCT01816295|448552870|FG000|OLE Phase|Entry Criteria Not Met|3|||
124707004|NCT01816295|448552871|FG001|OLE Phase|Entry Criteria Not Met|5|||
124765919|NCT01469221|448769317|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
124765920|NCT01469221|448769318|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
124765921|NCT01149096|448769326|FG000|Overall Study|Lost to Follow-up|0|||
124949411|NCT01670877|449441864|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
124949412|NCT01670877|449441865|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
124765922|NCT01149096|448769327|FG001|Overall Study|Lost to Follow-up|1|||
124765923|NCT02004236|448769328|FG000|Overall Study|Lack of Efficacy|0|||
124949413|NCT01670877|449441866|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
124949414|NCT01670877|449441861|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
124949415|NCT01670877|449441862|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
124949416|NCT01670877|449441863|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
124949417|NCT01670877|449441864|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
124949418|NCT01670877|449441865|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
124765924|NCT02004236|448769329|FG001|Overall Study|Lack of Efficacy|0|||
124765925|NCT02004236|448769330|FG002|Overall Study|Lack of Efficacy|16|||
124765926|NCT00918281|448769333|FG000|Overall Study|Physician Decision|29|||
124765927|NCT00168844|448769334|FG000|Overall Study|Adverse Event|31|||
124765928|NCT00168844|448769335|FG001|Overall Study|Adverse Event|32|||
124765929|NCT00168844|448769336|FG002|Overall Study|Adverse Event|48|||
124765930|NCT00168844|448769334|FG000|Overall Study|Lost to Follow-up|4|||
124765931|NCT00168844|448769335|FG001|Overall Study|Lost to Follow-up|5|||
124765932|NCT00168844|448769336|FG002|Overall Study|Lost to Follow-up|11|||
124765933|NCT00168844|448769334|FG000|Overall Study|Withdrawal by Subject|12|||
124765934|NCT00168844|448769335|FG001|Overall Study|Withdrawal by Subject|9|||
124949419|NCT01670877|449441866|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
124949420|NCT01670877|449441861|FG000|Part I and Part 2|Grade 2 vomiting|0|||
124765935|NCT00168844|448769336|FG002|Overall Study|Withdrawal by Subject|19|||
124765936|NCT00168844|448769334|FG000|Overall Study|Protocol Violation|2|||
124765937|NCT00168844|448769335|FG001|Overall Study|Protocol Violation|2|||
124765938|NCT00168844|448769336|FG002|Overall Study|Protocol Violation|4|||
124765939|NCT00168844|448769334|FG000|Overall Study|Other|6|||
124765940|NCT00168844|448769335|FG001|Overall Study|Other|7|||
124765941|NCT00168844|448769336|FG002|Overall Study|Other|9|||
124765942|NCT00849940|448769345|FG000|Overall Study|Physician Decision|4|||
124765943|NCT00601835|448769346|FG000|Overall Study|Withdrawal by Subject|9|||
124765944|NCT00601835|448769347|FG001|Overall Study|Withdrawal by Subject|6|||
124765945|NCT00601835|448769346|FG000|Overall Study|Physician Decision|1|||
124765946|NCT00601835|448769347|FG001|Overall Study|Physician Decision|0|||
124765947|NCT00601835|448769346|FG000|Overall Study|Lost to Follow-up|37|||
124765948|NCT00601835|448769347|FG001|Overall Study|Lost to Follow-up|5|||
124765949|NCT00601835|448769346|FG000|Overall Study|Adverse Event|1|||
124949421|NCT01670877|449441862|FG001|Part I and Part 2|Grade 2 vomiting|0|||
124949422|NCT01670877|449441863|FG002|Part I and Part 2|Grade 2 vomiting|0|||
124949423|NCT01670877|449441864|FG003|Part I and Part 2|Grade 2 vomiting|1|||
124949424|NCT01670877|449441865|FG004|Part I and Part 2|Grade 2 vomiting|0|||
124949425|NCT01670877|449441866|FG005|Part I and Part 2|Grade 2 vomiting|0|||
124949426|NCT01670877|449441861|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
124949427|NCT01670877|449441862|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
124949428|NCT01670877|449441863|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
124949429|NCT01670877|449441864|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
124949430|NCT01670877|449441865|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
124949431|NCT01670877|449441866|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
124949432|NCT01670877|449441861|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
124949433|NCT01670877|449441862|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
124949434|NCT01670877|449441863|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
124949435|NCT01670877|449441864|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
124949436|NCT01670877|449441865|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
124949437|NCT01670877|449441866|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
124949438|NCT03390166|449441867|FG000|Overall Study|Death|0|||
124548668|NCT01325701|447965308|FG001|Overall Study|Adverse Event|0|||
124548669|NCT01325701|447965307|FG000|Overall Study|Protocol Violation|1|||
124949439|NCT03390166|449441868|FG001|Overall Study|Death|1|||
124949440|NCT03390166|449441867|FG000|Overall Study|Lost to Follow-up|6|||
124949441|NCT03390166|449441868|FG001|Overall Study|Lost to Follow-up|4|||
124949442|NCT03390166|449441867|FG000|Overall Study|Physician Decision|2|||
124949443|NCT03390166|449441868|FG001|Overall Study|Physician Decision|1|||
124765950|NCT00601835|448769347|FG001|Overall Study|Adverse Event|1|||
124765951|NCT00601835|448769346|FG000|Overall Study|Relocate|12|||
124765952|NCT00601835|448769347|FG001|Overall Study|Relocate|2|||
124949444|NCT03390166|449441867|FG000|Overall Study|Move from study area|3|||
124949445|NCT03390166|449441868|FG001|Overall Study|Move from study area|2|||
124949446|NCT03390166|449441867|FG000|Overall Study|To militarycamp for conscript|1|||
124949447|NCT03390166|449441868|FG001|Overall Study|To militarycamp for conscript|0|||
124949448|NCT03390166|449441867|FG000|Overall Study|To drug therapy course|0|||
124548670|NCT01325701|447965308|FG001|Overall Study|Protocol Violation|0|||
124707005|NCT01816295|448552870|FG000|OLE Phase|Lost to Follow-up|5|||
124707006|NCT01816295|448552871|FG001|OLE Phase|Lost to Follow-up|5|||
124707007|NCT01816295|448552870|FG000|OLE Phase|Physician Decision|3|||
124949449|NCT03390166|449441868|FG001|Overall Study|To drug therapy course|1|||
124949450|NCT03390166|449441867|FG000|Overall Study|Move to work oversea|0|||
124949451|NCT03390166|449441868|FG001|Overall Study|Move to work oversea|1|||
124949452|NCT03693989|449441871|FG000|Overall Study|Protocol Violation|3|||
124949453|NCT03693989|449441872|FG001|Overall Study|Protocol Violation|4|||
124949454|NCT00113529|449441873|FG000|Overall Study|Adverse Event|4|||
124949455|NCT00113529|449441873|FG000|Overall Study|Lack of Efficacy|20|||
124949456|NCT00113529|449441873|FG000|Overall Study|Decision of sponsor|6|||
124949457|NCT00113529|449441873|FG000|Overall Study|Withdrawal by Subject|4|||
124949458|NCT02825550|449441875|FG000|Overall Study|Physician Decision|1|||
124949459|NCT00042939|449441876|FG000|Overall Study|Adverse Event|6|||
124949460|NCT00042939|449441877|FG001|Overall Study|Adverse Event|7|||
124949461|NCT00042939|449441876|FG000|Overall Study|Death|3|||
124949462|NCT00042939|449441877|FG001|Overall Study|Death|2|||
124949463|NCT00042939|449441876|FG000|Overall Study|Withdrawal by Subject|3|||
124949464|NCT00042939|449441877|FG001|Overall Study|Withdrawal by Subject|4|||
124949465|NCT00042939|449441876|FG000|Overall Study|Other disease|1|||
124949466|NCT00042939|449441877|FG001|Overall Study|Other disease|0|||
124949467|NCT00042939|449441876|FG000|Overall Study|Ineligible|2|||
124949468|NCT00042939|449441877|FG001|Overall Study|Ineligible|2|||
124949469|NCT00042939|449441876|FG000|Overall Study|Deterioration of health|3|||
124949470|NCT00042939|449441877|FG001|Overall Study|Deterioration of health|4|||
124949471|NCT00042939|449441876|FG000|Overall Study|QOL diminished|1|||
124949472|NCT00042939|449441877|FG001|Overall Study|QOL diminished|0|||
124949473|NCT00042939|449441876|FG000|Overall Study|Rising ca 19-9|1|||
124949474|NCT00042939|449441877|FG001|Overall Study|Rising ca 19-9|0|||
124949475|NCT00042939|449441876|FG000|Overall Study|Patient non-compliance|1|||
124949476|NCT00042939|449441877|FG001|Overall Study|Patient non-compliance|0|||
124949477|NCT00042939|449441876|FG000|Overall Study|Still on treatment|1|||
124949478|NCT00042939|449441877|FG001|Overall Study|Still on treatment|0|||
124949479|NCT00042939|449441876|FG000|Overall Study|Treatment break > 4 weeks|0|||
124949480|NCT00042939|449441877|FG001|Overall Study|Treatment break > 4 weeks|1|||
124949481|NCT00042939|449441876|FG000|Overall Study|Did not start treatment|2|||
124949482|NCT00042939|449441877|FG001|Overall Study|Did not start treatment|1|||
124949483|NCT00795639|449441878|FG000|Overall Study|Death|1|||
124459501|NCT01297270|447642319|FG000|Overall Study|Adverse Event|19|||
124459502|NCT01297270|447642320|FG001|Overall Study|Adverse Event|32|||
124459503|NCT01297270|447642321|FG002|Overall Study|Adverse Event|5|||
124459504|NCT01297270|447642319|FG000|Overall Study|Lack of Efficacy|15|||
124459505|NCT01297270|447642320|FG001|Overall Study|Lack of Efficacy|17|||
124459506|NCT01297270|447642321|FG002|Overall Study|Lack of Efficacy|15|||
124459507|NCT01297270|447642319|FG000|Overall Study|Lost to Follow-up|1|||
124459508|NCT01297270|447642320|FG001|Overall Study|Lost to Follow-up|2|||
124459509|NCT01297270|447642321|FG002|Overall Study|Lost to Follow-up|1|||
124459510|NCT01297270|447642319|FG000|Overall Study|Protocol Violation|0|||
124459511|NCT01297270|447642320|FG001|Overall Study|Protocol Violation|2|||
124459512|NCT01297270|447642321|FG002|Overall Study|Protocol Violation|0|||
124459513|NCT01297270|447642319|FG000|Overall Study|Withdrawal by Subject|7|||
124459514|NCT01297270|447642320|FG001|Overall Study|Withdrawal by Subject|15|||
124459515|NCT01297270|447642321|FG002|Overall Study|Withdrawal by Subject|7|||
124459516|NCT01297270|447642319|FG000|Overall Study|Other reason not defined above|3|||
124459517|NCT01297270|447642320|FG001|Overall Study|Other reason not defined above|3|||
124459518|NCT01297270|447642321|FG002|Overall Study|Other reason not defined above|1|||
124459519|NCT01297270|447642319|FG000|Overall Study|Not treated|0|||
124459520|NCT01297270|447642320|FG001|Overall Study|Not treated|1|||
124459521|NCT01297270|447642321|FG002|Overall Study|Not treated|0|||
124459522|NCT02863809|447642322|FG000|Overall Study|Adverse Event|8|||
124707008|NCT01816295|448552871|FG001|OLE Phase|Physician Decision|1|||
124949484|NCT00795639|449441879|FG001|Overall Study|Death|6|||
124949485|NCT00795639|449441878|FG000|Overall Study|Withdrawal by Subject|1|||
124949486|NCT00795639|449441879|FG001|Overall Study|Withdrawal by Subject|3|||
124949487|NCT00795639|449441878|FG000|Overall Study|Pregnancy|1|||
124459523|NCT02863809|447642323|FG001|Overall Study|Adverse Event|8|||
124459524|NCT02863809|447642322|FG000|Overall Study|Withdrawal by Subject|0|||
124459525|NCT02863809|447642323|FG001|Overall Study|Withdrawal by Subject|1|||
124459526|NCT02863809|447642322|FG000|Overall Study|Lost to Follow-up|1|||
124949488|NCT00795639|449441879|FG001|Overall Study|Pregnancy|0|||
124949489|NCT00795639|449441878|FG000|Overall Study|Adverse Event|5|||
124949490|NCT00795639|449441879|FG001|Overall Study|Adverse Event|2|||
124949491|NCT00795639|449441878|FG000|Overall Study|Other|0|||
124707009|NCT01816295|448552870|FG000|OLE Phase|Protocol Violation|4|||
124949492|NCT00795639|449441879|FG001|Overall Study|Other|2|||
124949493|NCT00795639|449441878|FG000|Overall Study|Terminated by sponsor|13|||
124949494|NCT00795639|449441879|FG001|Overall Study|Terminated by sponsor|12|||
124949495|NCT00795639|449441878|FG000|Overall Study|Randomized and not treated|0|||
124949496|NCT00795639|449441879|FG001|Overall Study|Randomized and not treated|1|||
124949497|NCT02525744|449441880|FG000|Period 1|Physician Decision|0|||
124548671|NCT01325701|447965307|FG000|Overall Study|Physician Decision|2|||
124548672|NCT01325701|447965308|FG001|Overall Study|Physician Decision|2|||
124548673|NCT01325701|447965307|FG000|Overall Study|Withdrawal by Subject|2|||
124949498|NCT02525744|449441881|FG001|Period 1|Physician Decision|0|||
124949499|NCT02525744|449441882|FG002|Period 1|Physician Decision|1|||
124949500|NCT02525744|449441883|FG003|Period 1|Physician Decision|0|||
124949501|NCT02525744|449441880|FG000|Period 3|Adverse Event|0|||
124949502|NCT02525744|449441881|FG001|Period 3|Adverse Event|1|||
124949503|NCT02525744|449441882|FG002|Period 3|Adverse Event|0|||
124949504|NCT02525744|449441883|FG003|Period 3|Adverse Event|0|||
124949505|NCT02525744|449441880|FG000|Period 4|Withdrawal by Subject|1|||
124949506|NCT02525744|449441881|FG001|Period 4|Withdrawal by Subject|0|||
124949507|NCT02525744|449441882|FG002|Period 4|Withdrawal by Subject|0|||
124949508|NCT02525744|449441883|FG003|Period 4|Withdrawal by Subject|0|||
124949509|NCT02525744|449441880|FG000|Period 5|Physician Decision|1|||
124949510|NCT02525744|449441881|FG001|Period 5|Physician Decision|0|||
124949511|NCT02525744|449441882|FG002|Period 5|Physician Decision|0|||
124949512|NCT02525744|449441883|FG003|Period 5|Physician Decision|0|||
124949513|NCT01138657|449441886|FG000|Overall Study|Adverse Event|3|||
124949514|NCT01138657|449441887|FG001|Overall Study|Adverse Event|10|||
124949515|NCT01138657|449441886|FG000|Overall Study|Lack of Efficacy|2|||
124949516|NCT01138657|449441887|FG001|Overall Study|Lack of Efficacy|1|||
124949517|NCT01138657|449441886|FG000|Overall Study|Lost to Follow-up|0|||
124949518|NCT01138657|449441887|FG001|Overall Study|Lost to Follow-up|3|||
124949519|NCT01138657|449441886|FG000|Overall Study|Miscellaneous Reasons|3|||
124949520|NCT01138657|449441887|FG001|Overall Study|Miscellaneous Reasons|4|||
124949521|NCT03150589|449441888|FG000|Overall Study|Withdrawal by Subject|16|||
124949522|NCT03150589|449441889|FG001|Overall Study|Withdrawal by Subject|9|||
124949523|NCT03150589|449441888|FG000|Overall Study|Adverse Event|7|||
124949524|NCT03150589|449441889|FG001|Overall Study|Adverse Event|6|||
124949525|NCT03150589|449441888|FG000|Overall Study|Protocol Violation|4|||
124949526|NCT03150589|449441889|FG001|Overall Study|Protocol Violation|3|||
124949527|NCT03150589|449441888|FG000|Overall Study|Lost to Follow-up|3|||
124949528|NCT03150589|449441889|FG001|Overall Study|Lost to Follow-up|3|||
124949529|NCT03150589|449441888|FG000|Overall Study|Death|2|||
124949530|NCT03150589|449441889|FG001|Overall Study|Death|3|||
124949531|NCT03150589|449441888|FG000|Overall Study|IP non-compliance and other reasons|12|||
124949532|NCT03150589|449441889|FG001|Overall Study|IP non-compliance and other reasons|3|||
124949533|NCT01000649|449441892|FG000|Overall Study|Adverse Event|5|||
124949534|NCT01000649|449441893|FG001|Overall Study|Adverse Event|1|||
124949535|NCT01000649|449441894|FG002|Overall Study|Adverse Event|2|||
124949536|NCT01000649|449441895|FG003|Overall Study|Adverse Event|4|||
124949537|NCT01000649|449441892|FG000|Overall Study|Lost to Follow-up|0|||
124949538|NCT01000649|449441893|FG001|Overall Study|Lost to Follow-up|2|||
124949539|NCT01000649|449441894|FG002|Overall Study|Lost to Follow-up|0|||
124949540|NCT01000649|449441895|FG003|Overall Study|Lost to Follow-up|2|||
124949541|NCT00346398|449441896|FG000|Overall Study|Lost to Follow-up|3|||
124949542|NCT00346398|449441897|FG001|Overall Study|Lost to Follow-up|0|||
124949543|NCT00346398|449441896|FG000|Overall Study|Withdrawal by Subject|0|||
124949544|NCT00346398|449441897|FG001|Overall Study|Withdrawal by Subject|2|||
124949545|NCT03979040|449441898|FG000|Overall Study|Withdrawal by Subject|24|||
124949546|NCT03979040|449441899|FG001|Overall Study|Withdrawal by Subject|32|||
124949547|NCT03979040|449441898|FG000|Overall Study|randomized but never started treatment|32|||
124949548|NCT03979040|449441899|FG001|Overall Study|randomized but never started treatment|39|||
124949549|NCT03979040|449441898|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
124949550|NCT03979040|449441899|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
124949551|NCT02607956|449441900|FG000|Double-Blinded Phase|Withdrew Consent|17|||
124548674|NCT01325701|447965308|FG001|Overall Study|Withdrawal by Subject|1|||
124548675|NCT01325701|447965307|FG000|Overall Study|Rollerover Extension Study|4|||
124548676|NCT01325701|447965308|FG001|Overall Study|Rollerover Extension Study|0|||
124765953|NCT01927497|448769348|FG000|Overall Study|Death|0|||
124765954|NCT01927497|448769349|FG001|Overall Study|Death|1|||
124548677|NCT01643928|447965315|FG000|Overall Study|Lost to Follow-up|1|||
124949552|NCT02607956|449441901|FG001|Double-Blinded Phase|Withdrew Consent|19|||
124949553|NCT02607956|449441902|FG002|Double-Blinded Phase|Withdrew Consent|0|||
124949554|NCT02607956|449441903|FG003|Double-Blinded Phase|Withdrew Consent|0|||
124548678|NCT01643928|447965316|FG001|Overall Study|Lost to Follow-up|0|||
124548679|NCT01643928|447965317|FG002|Overall Study|Lost to Follow-up|2|||
124548680|NCT01643928|447965318|FG003|Overall Study|Lost to Follow-up|0|||
124949555|NCT02607956|449441900|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
124949556|NCT02607956|449441901|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
124949557|NCT02607956|449441902|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
124949558|NCT02607956|449441903|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
124949559|NCT02607956|449441900|FG000|Double-Blinded Phase|Randomized but never treated|7|||
124949560|NCT02607956|449441901|FG001|Double-Blinded Phase|Randomized but never treated|5|||
124949561|NCT02607956|449441902|FG002|Double-Blinded Phase|Randomized but never treated|0|||
124949562|NCT02607956|449441903|FG003|Double-Blinded Phase|Randomized but never treated|0|||
124949563|NCT02607956|449441900|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
124949564|NCT02607956|449441901|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
124949565|NCT02607956|449441902|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
124949566|NCT02607956|449441903|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
124949567|NCT02607956|449441900|FG000|Double-Blinded Phase|Death|4|||
124765955|NCT01927497|448769348|FG000|Overall Study|Protocol Violation|2|||
124765956|NCT01927497|448769349|FG001|Overall Study|Protocol Violation|0|||
124765957|NCT03914417|448769350|FG000|Overall Study|Withdrawal by Subject|2|||
124765958|NCT03361137|448769351|FG000|Overall Study|Reason not specified|1|||
124765959|NCT03361137|448769352|FG001|Overall Study|Reason not specified|0|||
124765960|NCT03361137|448769353|FG002|Overall Study|Reason not specified|0|||
124765961|NCT03361137|448769354|FG003|Overall Study|Reason not specified|0|||
124765962|NCT03361137|448769355|FG004|Overall Study|Reason not specified|0|||
124765963|NCT03009058|448769356|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
124765964|NCT01486966|448769359|FG000|Overall Study|Adverse Event|0|||
124765965|NCT01486966|448769360|FG001|Overall Study|Adverse Event|1|||
124765966|NCT01486966|448769359|FG000|Overall Study|Withdrawal by Subject|0|||
124765967|NCT01486966|448769360|FG001|Overall Study|Withdrawal by Subject|1|||
124765968|NCT00506350|448769361|FG000|Overall Study|Serious Adverse Event|1|||
124765969|NCT00506350|448769362|FG001|Overall Study|Serious Adverse Event|0|||
124765970|NCT00506350|448769363|FG002|Overall Study|Serious Adverse Event|0|||
124765971|NCT00506350|448769364|FG003|Overall Study|Serious Adverse Event|0|||
124765972|NCT00506350|448769365|FG004|Overall Study|Serious Adverse Event|0|||
124765973|NCT00506350|448769366|FG005|Overall Study|Serious Adverse Event|0|||
124765974|NCT00506350|448769367|FG006|Overall Study|Serious Adverse Event|0|||
124765975|NCT00506350|448769368|FG007|Overall Study|Serious Adverse Event|0|||
124765976|NCT00506350|448769369|FG008|Overall Study|Serious Adverse Event|0|||
124765977|NCT00506350|448769361|FG000|Overall Study|Adverse Event|0|||
124765978|NCT00506350|448769362|FG001|Overall Study|Adverse Event|0|||
124765979|NCT00506350|448769363|FG002|Overall Study|Adverse Event|0|||
124765980|NCT00506350|448769364|FG003|Overall Study|Adverse Event|0|||
124765981|NCT00506350|448769365|FG004|Overall Study|Adverse Event|0|||
124765982|NCT00506350|448769366|FG005|Overall Study|Adverse Event|0|||
124765983|NCT00506350|448769367|FG006|Overall Study|Adverse Event|0|||
124765984|NCT00506350|448769368|FG007|Overall Study|Adverse Event|1|||
124765985|NCT00506350|448769369|FG008|Overall Study|Adverse Event|1|||
124765986|NCT00506350|448769361|FG000|Overall Study|Protocol Violation|0|||
124765987|NCT00506350|448769362|FG001|Overall Study|Protocol Violation|0|||
124765988|NCT00506350|448769363|FG002|Overall Study|Protocol Violation|1|||
124765989|NCT00506350|448769364|FG003|Overall Study|Protocol Violation|0|||
124765990|NCT00506350|448769365|FG004|Overall Study|Protocol Violation|0|||
124765991|NCT00506350|448769366|FG005|Overall Study|Protocol Violation|0|||
124765992|NCT00506350|448769367|FG006|Overall Study|Protocol Violation|1|||
124765993|NCT00506350|448769368|FG007|Overall Study|Protocol Violation|0|||
124765994|NCT00506350|448769369|FG008|Overall Study|Protocol Violation|0|||
124765995|NCT00506350|448769361|FG000|Overall Study|Withdrawal by Subject|0|||
124765996|NCT00506350|448769362|FG001|Overall Study|Withdrawal by Subject|1|||
124765997|NCT00506350|448769363|FG002|Overall Study|Withdrawal by Subject|1|||
124765998|NCT00506350|448769364|FG003|Overall Study|Withdrawal by Subject|1|||
124765999|NCT00506350|448769365|FG004|Overall Study|Withdrawal by Subject|4|||
124766000|NCT00506350|448769366|FG005|Overall Study|Withdrawal by Subject|1|||
124548681|NCT01643928|447965319|FG004|Overall Study|Lost to Follow-up|0|||
124766001|NCT00506350|448769367|FG006|Overall Study|Withdrawal by Subject|1|||
124766002|NCT00506350|448769368|FG007|Overall Study|Withdrawal by Subject|2|||
124766003|NCT00506350|448769369|FG008|Overall Study|Withdrawal by Subject|0|||
124766004|NCT00506350|448769361|FG000|Overall Study|Lost to Follow-up|1|||
124766005|NCT00506350|448769362|FG001|Overall Study|Lost to Follow-up|1|||
124766006|NCT00506350|448769363|FG002|Overall Study|Lost to Follow-up|1|||
124766007|NCT00506350|448769364|FG003|Overall Study|Lost to Follow-up|1|||
124766008|NCT00506350|448769365|FG004|Overall Study|Lost to Follow-up|2|||
124766009|NCT00506350|448769366|FG005|Overall Study|Lost to Follow-up|1|||
124766010|NCT00506350|448769367|FG006|Overall Study|Lost to Follow-up|0|||
124949568|NCT02607956|449441901|FG001|Double-Blinded Phase|Death|4|||
124949569|NCT02607956|449441902|FG002|Double-Blinded Phase|Death|0|||
124949570|NCT02607956|449441903|FG003|Double-Blinded Phase|Death|0|||
124949571|NCT02607956|449441900|FG000|Double-Blinded Phase|Adverse Event|4|||
124949572|NCT02607956|449441901|FG001|Double-Blinded Phase|Adverse Event|3|||
124949573|NCT02607956|449441902|FG002|Double-Blinded Phase|Adverse Event|0|||
124949574|NCT02607956|449441903|FG003|Double-Blinded Phase|Adverse Event|0|||
124949575|NCT02607956|449441900|FG000|Double-Blinded Phase|Protocol Violation|3|||
124949576|NCT02607956|449441901|FG001|Double-Blinded Phase|Protocol Violation|1|||
124949577|NCT02607956|449441902|FG002|Double-Blinded Phase|Protocol Violation|0|||
124949578|NCT02607956|449441903|FG003|Double-Blinded Phase|Protocol Violation|0|||
124949579|NCT02607956|449441900|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
124949580|NCT02607956|449441901|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
124949581|NCT02607956|449441902|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
124949582|NCT02607956|449441903|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
124766011|NCT00506350|448769368|FG007|Overall Study|Lost to Follow-up|0|||
124766012|NCT00506350|448769369|FG008|Overall Study|Lost to Follow-up|2|||
124766013|NCT00506350|448769361|FG000|Overall Study|Medical Reason|0|||
124766014|NCT00506350|448769362|FG001|Overall Study|Medical Reason|0|||
124766015|NCT00506350|448769363|FG002|Overall Study|Medical Reason|0|||
124766016|NCT00506350|448769364|FG003|Overall Study|Medical Reason|0|||
124766017|NCT00506350|448769365|FG004|Overall Study|Medical Reason|1|||
124766018|NCT00506350|448769366|FG005|Overall Study|Medical Reason|0|||
124766019|NCT00506350|448769367|FG006|Overall Study|Medical Reason|0|||
124766020|NCT00506350|448769368|FG007|Overall Study|Medical Reason|0|||
124766021|NCT00506350|448769369|FG008|Overall Study|Medical Reason|0|||
124766022|NCT00506350|448769361|FG000|Overall Study|Other|1|||
124766023|NCT00506350|448769362|FG001|Overall Study|Other|1|||
124766024|NCT00506350|448769363|FG002|Overall Study|Other|3|||
124766025|NCT00506350|448769364|FG003|Overall Study|Other|0|||
124766026|NCT00506350|448769365|FG004|Overall Study|Other|3|||
124766027|NCT00506350|448769366|FG005|Overall Study|Other|0|||
124766028|NCT00506350|448769367|FG006|Overall Study|Other|0|||
124766029|NCT00506350|448769368|FG007|Overall Study|Other|2|||
124766030|NCT00506350|448769369|FG008|Overall Study|Other|2|||
124766031|NCT01691794|448769370|FG000|Overall Study|Poor/Non-Compliance|1|||
124766032|NCT01691794|448769371|FG001|Overall Study|Poor/Non-Compliance|4|||
124766033|NCT01691794|448769372|FG002|Overall Study|Poor/Non-Compliance|1|||
124766034|NCT01691794|448769370|FG000|Overall Study|Death|0|||
124766035|NCT01691794|448769371|FG001|Overall Study|Death|0|||
124766036|NCT01691794|448769372|FG002|Overall Study|Death|1|||
124766037|NCT01691794|448769370|FG000|Overall Study|Lack of Efficacy|0|||
124766038|NCT01691794|448769371|FG001|Overall Study|Lack of Efficacy|7|||
124766039|NCT01691794|448769372|FG002|Overall Study|Lack of Efficacy|1|||
124766040|NCT01691794|448769370|FG000|Overall Study|Participant request to discontinue|0|||
124766041|NCT01691794|448769371|FG001|Overall Study|Participant request to discontinue|1|||
124766042|NCT01691794|448769372|FG002|Overall Study|Participant request to discontinue|0|||
124766043|NCT01691794|448769370|FG000|Overall Study|Adverse Event|0|||
124766044|NCT01691794|448769371|FG001|Overall Study|Adverse Event|1|||
124766045|NCT01691794|448769372|FG002|Overall Study|Adverse Event|1|||
124766046|NCT01691794|448769370|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
124766047|NCT01691794|448769371|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
124766048|NCT01691794|448769372|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
124766049|NCT01691794|448769370|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
124459527|NCT02863809|447642323|FG001|Overall Study|Lost to Follow-up|1|||
124459528|NCT02863809|447642322|FG000|Overall Study|Death|1|||
124459529|NCT02863809|447642323|FG001|Overall Study|Death|0|||
124459530|NCT02830776|447642324|FG000|Overall Study|Lost to Follow-up|1|||
124459531|NCT00607386|447642325|FG000|Overall Study|Physician Decision|1|||
124459532|NCT00440947|447642326|FG000|36-Week Induction Phase|Adverse Event|16|||
124459533|NCT00440947|447642327|FG001|36-Week Induction Phase|Adverse Event|0|||
124459534|NCT00440947|447642328|FG002|36-Week Induction Phase|Adverse Event|0|||
124459535|NCT00440947|447642329|FG003|36-Week Induction Phase|Adverse Event|0|||
124459536|NCT00440947|447642330|FG004|36-Week Induction Phase|Adverse Event|0|||
124459537|NCT00440947|447642326|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
124459538|NCT00440947|447642327|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
124459539|NCT00440947|447642328|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
124459540|NCT00440947|447642329|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
124459541|NCT00440947|447642330|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
124459542|NCT00440947|447642326|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
124459543|NCT00440947|447642327|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
124459544|NCT00440947|447642328|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
124459545|NCT00440947|447642329|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
124459546|NCT00440947|447642330|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
124459547|NCT00440947|447642326|FG000|36-Week Induction Phase|Non-compliance|10|||
124459548|NCT00440947|447642327|FG001|36-Week Induction Phase|Non-compliance|0|||
124459549|NCT00440947|447642328|FG002|36-Week Induction Phase|Non-compliance|0|||
124459550|NCT00440947|447642329|FG003|36-Week Induction Phase|Non-compliance|0|||
124459551|NCT00440947|447642330|FG004|36-Week Induction Phase|Non-compliance|0|||
124459552|NCT00440947|447642326|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
124459553|NCT00440947|447642327|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
124766050|NCT01691794|448769371|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
124766051|NCT01691794|448769372|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
124766052|NCT04972786|448769373|FG000|First Intervention (1 Day)|Adverse Event|1|||
124766053|NCT04972786|448769374|FG001|First Intervention (1 Day)|Adverse Event|0|||
124766054|NCT00844844|448769375|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
124766055|NCT00844844|448769375|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
124766056|NCT00844844|448769375|FG000|Extension Treatment Period|Adverse Event|2|||
124766057|NCT00844844|448769375|FG000|Post Treatment Period|Withdrawal by Subject|1|||
124459554|NCT00440947|447642328|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
124766058|NCT05472090|448769378|FG000|Overall Study|Adverse Event|2|||
124707010|NCT01816295|448552871|FG001|OLE Phase|Protocol Violation|4|||
124707011|NCT01816295|448552870|FG000|OLE Phase|Sponsor Decision|7|||
124707012|NCT01816295|448552871|FG001|OLE Phase|Sponsor Decision|9|||
124707013|NCT01816295|448552870|FG000|OLE Phase|Withdrawal by Subject|10|||
124707014|NCT01816295|448552871|FG001|OLE Phase|Withdrawal by Subject|10|||
124707015|NCT01816295|448552870|FG000|OLE Phase|Lack of Efficacy|3|||
124707016|NCT01816295|448552871|FG001|OLE Phase|Lack of Efficacy|7|||
124707017|NCT01823289|448552872|FG000|Overall Study|Lost to Follow-up|5|||
124707018|NCT01823289|448552872|FG000|Overall Study|Adverse Event|5|||
124766059|NCT05472090|448769379|FG001|Overall Study|Adverse Event|3|||
124766060|NCT05472090|448769378|FG000|Overall Study|Lack of Efficacy|1|||
124766061|NCT05472090|448769379|FG001|Overall Study|Lack of Efficacy|0|||
124766062|NCT05472090|448769378|FG000|Overall Study|Physician Decision|1|||
124766063|NCT05472090|448769379|FG001|Overall Study|Physician Decision|0|||
124766064|NCT05472090|448769378|FG000|Overall Study|Withdrawal by Subject|2|||
124766065|NCT05472090|448769379|FG001|Overall Study|Withdrawal by Subject|0|||
124766066|NCT05472090|448769378|FG000|Overall Study|Lost to Follow-up|0|||
124766067|NCT05472090|448769379|FG001|Overall Study|Lost to Follow-up|3|||
124766068|NCT01350999|448769381|FG000|Overall Study|Adverse Event|4|||
124766069|NCT01350999|448769382|FG001|Overall Study|Adverse Event|9|||
124766070|NCT01350999|448769383|FG002|Overall Study|Adverse Event|10|||
124766071|NCT01350999|448769381|FG000|Overall Study|Voluntary withdrawal|3|||
124766072|NCT01350999|448769382|FG001|Overall Study|Voluntary withdrawal|4|||
124766073|NCT01350999|448769383|FG002|Overall Study|Voluntary withdrawal|6|||
124766074|NCT01350999|448769381|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
124766075|NCT01350999|448769382|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
124766076|NCT01350999|448769383|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
124766077|NCT02891174|448771583|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
124766078|NCT02891174|448771584|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
124766079|NCT02891174|448771583|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
124766080|NCT02891174|448771584|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
124766081|NCT02891174|448771583|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
124766082|NCT02891174|448771584|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
124766083|NCT02891174|448771583|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
124766084|NCT02891174|448771584|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
124766085|NCT02891174|448771583|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
124766086|NCT02891174|448771584|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
124766087|NCT02891174|448771583|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
124766088|NCT02891174|448771584|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
124766089|NCT02891174|448771583|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
124766090|NCT02891174|448771584|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
124766091|NCT04124939|448771585|FG000|Overall Study|Lost to Follow-up|1|||
124766092|NCT04124939|448771586|FG001|Overall Study|Lost to Follow-up|3|||
124766093|NCT04235140|448771587|FG000|Overall Study|Adverse Event|2|||
124766094|NCT04235140|448771587|FG000|Overall Study|Lost to Follow-up|1|||
124766095|NCT04235140|448771587|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
124766096|NCT04235140|448771587|FG000|Overall Study|Commercial drug is available for participants|7|||
124766097|NCT02177695|448771589|FG000|ITT Analysis|Ineligible|5|||
124766098|NCT02177695|448771590|FG001|ITT Analysis|Ineligible|5|||
124766099|NCT02177695|448771589|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
124766100|NCT02177695|448771590|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
124766101|NCT02177695|448771589|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
124766102|NCT02177695|448771590|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
124766103|NCT02177695|448771589|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
124766104|NCT02177695|448771590|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
124766105|NCT00419393|448771591|FG000|Overall Study|Adverse Event|5|||
124766106|NCT00419393|448771591|FG000|Overall Study|Protocol Violation|5|||
124766107|NCT00419393|448771591|FG000|Overall Study|Withdrawal by Subject|7|||
124766108|NCT00419393|448771591|FG000|Overall Study|Other: Sponsor request|3|||
124949583|NCT02607956|449441900|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
124949584|NCT02607956|449441901|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
124949585|NCT02607956|449441902|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
124949586|NCT02607956|449441903|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
124949587|NCT02607956|449441900|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
124949588|NCT02607956|449441901|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
124949589|NCT02607956|449441902|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
124949590|NCT02607956|449441903|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
124766109|NCT00419393|448771591|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
124949591|NCT02607956|449441900|FG000|Open-Label Extension Phase|Death|0|||
124707019|NCT01823289|448552872|FG000|Overall Study|Lack of Efficacy|1|||
124707020|NCT01823289|448552872|FG000|Overall Study|Physician Decision|9|||
124707021|NCT01823289|448552872|FG000|Overall Study|Administered contraindicated medicine|1|||
124949592|NCT02607956|449441901|FG001|Open-Label Extension Phase|Death|0|||
124949593|NCT02607956|449441902|FG002|Open-Label Extension Phase|Death|1|||
124949594|NCT02607956|449441903|FG003|Open-Label Extension Phase|Death|3|||
124949595|NCT02607956|449441900|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
124949596|NCT02607956|449441901|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
124949597|NCT02607956|449441902|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
124949598|NCT02607956|449441903|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
124949599|NCT02607956|449441900|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
124949600|NCT02607956|449441901|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
124949601|NCT02607956|449441902|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
124949602|NCT02607956|449441903|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
124949603|NCT02607956|449441900|FG000|Open-Label Extension Phase|Protocol Violation|0|||
124949604|NCT02607956|449441901|FG001|Open-Label Extension Phase|Protocol Violation|0|||
124949605|NCT02607956|449441902|FG002|Open-Label Extension Phase|Protocol Violation|0|||
124949606|NCT02607956|449441903|FG003|Open-Label Extension Phase|Protocol Violation|2|||
124949607|NCT02607956|449441900|FG000|Open-Label Extension Phase|Pregnancy|0|||
124949608|NCT02607956|449441901|FG001|Open-Label Extension Phase|Pregnancy|0|||
124949609|NCT02607956|449441902|FG002|Open-Label Extension Phase|Pregnancy|0|||
124949610|NCT02607956|449441903|FG003|Open-Label Extension Phase|Pregnancy|1|||
124949611|NCT01005914|449441904|FG000|Overall Study|Adverse Event|4|||
124949612|NCT01005914|449441904|FG000|Overall Study|Death|4|||
124949613|NCT01005914|449441904|FG000|Overall Study|Lack of Efficacy|1|||
124949614|NCT01005914|449441904|FG000|Overall Study|Withdrawal by Subject|1|||
124949615|NCT04108858|449441905|FG000|Overall Study|Adverse Event|1|||
124949616|NCT01240785|449441907|FG000|Overall Study|Lost to Follow-up|1|||
124949617|NCT01240785|449441908|FG001|Overall Study|Lost to Follow-up|0|||
124949618|NCT01240785|449441907|FG000|Overall Study|Protocol Violation|0|||
124949619|NCT01240785|449441908|FG001|Overall Study|Protocol Violation|3|||
124949620|NCT00696241|449441909|FG000|Overall Study|Adverse Event|11|||
124949621|NCT00696241|449441910|FG001|Overall Study|Adverse Event|3|||
124949622|NCT00696241|449441911|FG002|Overall Study|Adverse Event|6|||
124949623|NCT00696241|449441912|FG003|Overall Study|Adverse Event|4|||
124949624|NCT00696241|449441913|FG004|Overall Study|Adverse Event|5|||
124707022|NCT01823289|448552872|FG000|Overall Study|Transaminase increased more than 3 times|1|||
124707023|NCT01823289|448552872|FG000|Overall Study|Drug affected efficacy and safety|1|||
124707024|NCT01823289|448552872|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
124707025|NCT01656161|448552880|FG000|Overall Study|Death|3|||
124707026|NCT01656161|448552880|FG000|Overall Study|Adverse Event|2|||
124707027|NCT01656161|448552880|FG000|Overall Study|Protocol Violation|1|||
124707028|NCT01656161|448552880|FG000|Overall Study|Withdrawal by Subject|1|||
124707029|NCT03510273|448552881|FG000|Overall Study|Withdrawal by Subject|2|||
124707030|NCT03510273|448552881|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
124707031|NCT03510273|448552881|FG000|Overall Study|Moved away from study area|4|||
124707032|NCT01276106|448552882|FG000|Overall Study|Adverse Event|3|||
124707033|NCT01276106|448552883|FG001|Overall Study|Adverse Event|3|||
124707034|NCT01276106|448552884|FG002|Overall Study|Adverse Event|11|||
124707035|NCT01276106|448552885|FG003|Overall Study|Adverse Event|3|||
124707036|NCT01276106|448552882|FG000|Overall Study|Withdrawal by Subject|6|||
124707037|NCT01276106|448552883|FG001|Overall Study|Withdrawal by Subject|3|||
124707038|NCT01276106|448552884|FG002|Overall Study|Withdrawal by Subject|1|||
124707039|NCT01276106|448552885|FG003|Overall Study|Withdrawal by Subject|6|||
124707040|NCT01276106|448552882|FG000|Overall Study|Lack of Efficacy|0|||
124707041|NCT01276106|448552883|FG001|Overall Study|Lack of Efficacy|1|||
124707042|NCT01276106|448552884|FG002|Overall Study|Lack of Efficacy|0|||
124707043|NCT01276106|448552885|FG003|Overall Study|Lack of Efficacy|1|||
124707044|NCT01276106|448552882|FG000|Overall Study|Lost to Follow-up|2|||
124707045|NCT01276106|448552883|FG001|Overall Study|Lost to Follow-up|1|||
124707046|NCT01276106|448552884|FG002|Overall Study|Lost to Follow-up|1|||
124707047|NCT01276106|448552885|FG003|Overall Study|Lost to Follow-up|0|||
124949625|NCT00696241|449441909|FG000|Overall Study|Protocol Violation|1|||
124949626|NCT00696241|449441910|FG001|Overall Study|Protocol Violation|1|||
124949627|NCT00696241|449441911|FG002|Overall Study|Protocol Violation|2|||
124949628|NCT00696241|449441912|FG003|Overall Study|Protocol Violation|0|||
124707048|NCT01276106|448552882|FG000|Overall Study|Physician Decision|0|||
124707049|NCT01276106|448552883|FG001|Overall Study|Physician Decision|0|||
124707050|NCT01276106|448552884|FG002|Overall Study|Physician Decision|1|||
124707051|NCT01276106|448552885|FG003|Overall Study|Physician Decision|1|||
124707052|NCT01276106|448552882|FG000|Overall Study|Protocol Violation|1|||
124766110|NCT00419393|448771591|FG000|Overall Study|Other: Site closure|1|||
124766111|NCT00419393|448771591|FG000|Overall Study|Other: Other health problems|1|||
124766112|NCT00419393|448771591|FG000|Overall Study|Other: Investigator decision|1|||
124766113|NCT00979901|448771592|FG000|Overall Study|Adverse Event|1|||
124766114|NCT00979901|448771593|FG001|Overall Study|Adverse Event|3|||
124766115|NCT00979901|448771594|FG002|Overall Study|Adverse Event|9|||
124766116|NCT00979901|448771595|FG003|Overall Study|Adverse Event|2|||
124766117|NCT00979901|448771592|FG000|Overall Study|Lack of Efficacy|8|||
124766118|NCT00979901|448771593|FG001|Overall Study|Lack of Efficacy|4|||
124766119|NCT00979901|448771594|FG002|Overall Study|Lack of Efficacy|9|||
124766120|NCT00979901|448771595|FG003|Overall Study|Lack of Efficacy|0|||
124766121|NCT00979901|448771592|FG000|Overall Study|Lost to Follow-up|1|||
124766122|NCT00979901|448771593|FG001|Overall Study|Lost to Follow-up|1|||
124766123|NCT00979901|448771594|FG002|Overall Study|Lost to Follow-up|2|||
124766124|NCT00979901|448771595|FG003|Overall Study|Lost to Follow-up|0|||
124766125|NCT00979901|448771592|FG000|Overall Study|Protocol Violation|2|||
124766126|NCT00979901|448771593|FG001|Overall Study|Protocol Violation|2|||
124766127|NCT00979901|448771594|FG002|Overall Study|Protocol Violation|7|||
124766128|NCT00979901|448771595|FG003|Overall Study|Protocol Violation|1|||
124766129|NCT00979901|448771592|FG000|Overall Study|Withdrawal by Subject|2|||
124766130|NCT00979901|448771593|FG001|Overall Study|Withdrawal by Subject|1|||
124766131|NCT00979901|448771594|FG002|Overall Study|Withdrawal by Subject|1|||
124766132|NCT00979901|448771595|FG003|Overall Study|Withdrawal by Subject|1|||
124766133|NCT00979901|448771592|FG000|Overall Study|Noncompliance|1|||
124949629|NCT00696241|449441913|FG004|Overall Study|Protocol Violation|3|||
124949630|NCT00696241|449441909|FG000|Overall Study|Lost to Follow-up|1|||
124949631|NCT00696241|449441910|FG001|Overall Study|Lost to Follow-up|4|||
124949632|NCT00696241|449441911|FG002|Overall Study|Lost to Follow-up|1|||
124949633|NCT00696241|449441912|FG003|Overall Study|Lost to Follow-up|2|||
124949634|NCT00696241|449441913|FG004|Overall Study|Lost to Follow-up|0|||
124949635|NCT00696241|449441909|FG000|Overall Study|Withdrawal by Subject|4|||
124949636|NCT00696241|449441910|FG001|Overall Study|Withdrawal by Subject|8|||
124949637|NCT00696241|449441911|FG002|Overall Study|Withdrawal by Subject|6|||
124949638|NCT00696241|449441912|FG003|Overall Study|Withdrawal by Subject|1|||
124949639|NCT00696241|449441913|FG004|Overall Study|Withdrawal by Subject|0|||
124949640|NCT00696241|449441909|FG000|Overall Study|Lack of Efficacy|1|||
124949641|NCT00696241|449441910|FG001|Overall Study|Lack of Efficacy|5|||
124949642|NCT00696241|449441911|FG002|Overall Study|Lack of Efficacy|4|||
124766134|NCT00979901|448771593|FG001|Overall Study|Noncompliance|0|||
124766135|NCT00979901|448771594|FG002|Overall Study|Noncompliance|0|||
124766136|NCT00979901|448771595|FG003|Overall Study|Noncompliance|0|||
124766137|NCT00979901|448771592|FG000|Overall Study|out-of-state|1|||
124766138|NCT00979901|448771593|FG001|Overall Study|out-of-state|0|||
124766139|NCT00979901|448771594|FG002|Overall Study|out-of-state|0|||
124766140|NCT00979901|448771595|FG003|Overall Study|out-of-state|0|||
124766141|NCT00979901|448771592|FG000|Overall Study|vacation|1|||
124766142|NCT00979901|448771593|FG001|Overall Study|vacation|0|||
124766143|NCT00979901|448771594|FG002|Overall Study|vacation|0|||
124766144|NCT00979901|448771595|FG003|Overall Study|vacation|0|||
124766145|NCT00979901|448771592|FG000|Overall Study|elevated lab values pre-randomization|1|||
124766146|NCT00979901|448771593|FG001|Overall Study|elevated lab values pre-randomization|0|||
124766147|NCT00979901|448771594|FG002|Overall Study|elevated lab values pre-randomization|0|||
124766148|NCT00979901|448771595|FG003|Overall Study|elevated lab values pre-randomization|0|||
124766149|NCT00979901|448771592|FG000|Overall Study|Discontinued in Error|0|||
124766150|NCT00979901|448771593|FG001|Overall Study|Discontinued in Error|1|||
124766151|NCT00979901|448771594|FG002|Overall Study|Discontinued in Error|0|||
124766152|NCT00979901|448771595|FG003|Overall Study|Discontinued in Error|0|||
124949643|NCT00696241|449441912|FG003|Overall Study|Lack of Efficacy|5|||
124949644|NCT00696241|449441913|FG004|Overall Study|Lack of Efficacy|3|||
124949645|NCT00696241|449441909|FG000|Overall Study|Other|6|||
124949646|NCT00696241|449441910|FG001|Overall Study|Other|1|||
124949647|NCT00696241|449441911|FG002|Overall Study|Other|5|||
124459555|NCT00440947|447642329|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
124459556|NCT00440947|447642330|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
124459557|NCT00440947|447642326|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
124459558|NCT00440947|447642327|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
124766153|NCT00979901|448771592|FG000|Overall Study|Left Country|0|||
124766154|NCT00979901|448771593|FG001|Overall Study|Left Country|0|||
124766155|NCT00979901|448771594|FG002|Overall Study|Left Country|1|||
124766156|NCT00979901|448771595|FG003|Overall Study|Left Country|0|||
124766157|NCT00979901|448771592|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
124766158|NCT00979901|448771593|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
124949648|NCT00696241|449441912|FG003|Overall Study|Other|2|||
124949649|NCT00696241|449441913|FG004|Overall Study|Other|1|||
124459559|NCT00440947|447642328|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
124766159|NCT00979901|448771594|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
124949650|NCT03347396|449441916|FG000|Part A (26 Weeks)|Adverse Event|1|||
124949651|NCT03347396|449441917|FG001|Part A (26 Weeks)|Adverse Event|0|||
124766160|NCT00979901|448771595|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
124766161|NCT01317472|448771597|FG000|Overall Study|Withdrawal by Subject|1|||
124766162|NCT01317472|448771598|FG001|Overall Study|Withdrawal by Subject|0|||
124766163|NCT01317472|448771597|FG000|Overall Study|Unrelated hospitalization|1|||
124766164|NCT01317472|448771598|FG001|Overall Study|Unrelated hospitalization|0|||
124766173|NCT02182895|448771609|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
124766174|NCT02182895|448771610|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
124766175|NCT00836589|448771617|FG000|Overall Study|Lost to Follow-up|246|||
124766176|NCT00836589|448771617|FG000|Overall Study|Death|429|||
124766177|NCT00836589|448771617|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
124766178|NCT02399215|448771639|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
124766179|NCT02399215|448771639|FG000|Overall Study|Withdrawal by Subject|1|||
124766180|NCT00772538|448771640|FG000|Overall Study|Adverse Event|6|||
124766181|NCT00772538|448771641|FG001|Overall Study|Adverse Event|6|||
124766182|NCT00772538|448771640|FG000|Overall Study|Protocol Violation|3|||
124766183|NCT00772538|448771641|FG001|Overall Study|Protocol Violation|3|||
124766184|NCT00772538|448771640|FG000|Overall Study|Lost to Follow-up|1|||
124766185|NCT00772538|448771641|FG001|Overall Study|Lost to Follow-up|1|||
124707053|NCT01276106|448552883|FG001|Overall Study|Protocol Violation|1|||
124707054|NCT01276106|448552884|FG002|Overall Study|Protocol Violation|0|||
124707055|NCT01276106|448552885|FG003|Overall Study|Protocol Violation|2|||
124707056|NCT01276106|448552882|FG000|Overall Study|Insufficient therapeutic effects|0|||
124707057|NCT01276106|448552883|FG001|Overall Study|Insufficient therapeutic effects|0|||
124707058|NCT01276106|448552884|FG002|Overall Study|Insufficient therapeutic effects|2|||
124707059|NCT01276106|448552885|FG003|Overall Study|Insufficient therapeutic effects|0|||
124707060|NCT04079738|448552888|FG000|Study Treatment|Death|1|||
124707061|NCT04079738|448552889|FG001|Study Treatment|Death|0|||
124707062|NCT04079738|448552890|FG002|Study Treatment|Death|0|||
124707063|NCT04079738|448552891|FG003|Study Treatment|Death|0|||
124707064|NCT04079738|448552888|FG000|Study Treatment|Adverse Event|2|||
124766186|NCT00772538|448771640|FG000|Overall Study|Withdrawal by Subject|3|||
124766187|NCT00772538|448771641|FG001|Overall Study|Withdrawal by Subject|8|||
124766188|NCT00772538|448771640|FG000|Overall Study|Lack of Efficacy|0|||
124766189|NCT00772538|448771641|FG001|Overall Study|Lack of Efficacy|1|||
124766190|NCT00772538|448771640|FG000|Overall Study|Other|7|||
124766191|NCT00772538|448771641|FG001|Overall Study|Other|7|||
124766192|NCT00189540|448771642|FG000|Overall Study|Withdrawal by Subject|3|||
124766193|NCT00189540|448771643|FG001|Overall Study|Withdrawal by Subject|0|||
124766194|NCT00189540|448771642|FG000|Overall Study|Death|4|||
124949652|NCT03347396|449441916|FG000|Part A (26 Weeks)|Death|0|||
124949653|NCT03347396|449441917|FG001|Part A (26 Weeks)|Death|1|||
124949654|NCT03347396|449441916|FG000|Part B (149 Weeks)|Adverse Event|1|||
124949655|NCT03347396|449441917|FG001|Part B (149 Weeks)|Adverse Event|1|||
124949656|NCT03347396|449441916|FG000|Part B (149 Weeks)|Death|1|||
124949657|NCT03347396|449441917|FG001|Part B (149 Weeks)|Death|0|||
124949658|NCT03060525|449441918|FG000|Overall Study|moved out of state|1|||
124949659|NCT03060525|449441919|FG001|Overall Study|moved out of state|1|||
124949660|NCT03060525|449441920|FG002|Overall Study|moved out of state|1|||
124949661|NCT03060525|449441921|FG003|Overall Study|moved out of state|1|||
124949662|NCT03060525|449441918|FG000|Overall Study|unable to meet time commitment required of study|2|||
124949663|NCT03060525|449441919|FG001|Overall Study|unable to meet time commitment required of study|3|||
124949664|NCT03060525|449441920|FG002|Overall Study|unable to meet time commitment required of study|3|||
124949665|NCT03060525|449441921|FG003|Overall Study|unable to meet time commitment required of study|1|||
124949666|NCT03060525|449441918|FG000|Overall Study|no longer interested in doing intervention|0|||
124949667|NCT03060525|449441919|FG001|Overall Study|no longer interested in doing intervention|0|||
124707065|NCT04079738|448552889|FG001|Study Treatment|Adverse Event|0|||
124707066|NCT04079738|448552890|FG002|Study Treatment|Adverse Event|0|||
124707067|NCT04079738|448552891|FG003|Study Treatment|Adverse Event|0|||
124459560|NCT00440947|447642329|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
124459561|NCT00440947|447642330|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
124459562|NCT00440947|447642326|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
124459563|NCT00440947|447642327|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
124459564|NCT00440947|447642328|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
124459565|NCT00440947|447642329|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
124766195|NCT00189540|448771643|FG001|Overall Study|Death|1|||
124766196|NCT01903356|448771644|FG000|Overall Study|Lost to Follow-up|7|||
124459566|NCT00440947|447642330|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
124459567|NCT00440947|447642326|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
124459568|NCT00440947|447642327|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
124459569|NCT00440947|447642328|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
124459570|NCT00440947|447642329|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
124459571|NCT00440947|447642330|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
124766197|NCT01903356|448771644|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
124766198|NCT01903356|448771644|FG000|Overall Study|Violated the dosage and administration|3|||
124766199|NCT00713609|448771645|FG000|Overall Study|Adverse Event|2|||
124766200|NCT00713609|448771646|FG001|Overall Study|Adverse Event|0|||
124766201|NCT00713609|448771647|FG002|Overall Study|Adverse Event|2|||
124949668|NCT03060525|449441920|FG002|Overall Study|no longer interested in doing intervention|0|||
124949669|NCT03060525|449441921|FG003|Overall Study|no longer interested in doing intervention|1|||
124766202|NCT00713609|448771648|FG003|Overall Study|Adverse Event|2|||
124766203|NCT00713609|448771649|FG004|Overall Study|Adverse Event|3|||
124766204|NCT00713609|448771650|FG005|Overall Study|Adverse Event|1|||
124459572|NCT00440947|447642326|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
124459573|NCT00440947|447642327|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
124459574|NCT00440947|447642328|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
124459575|NCT00440947|447642329|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
124459576|NCT00440947|447642330|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
124459577|NCT00440947|447642326|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
124766205|NCT00713609|448771645|FG000|Overall Study|Lost to Follow-up|5|||
124766206|NCT00713609|448771646|FG001|Overall Study|Lost to Follow-up|7|||
124766207|NCT00713609|448771647|FG002|Overall Study|Lost to Follow-up|5|||
124949670|NCT00747149|449443476|FG000|Overall Study|Adverse Event|0|||
124949671|NCT00747149|449443477|FG001|Overall Study|Adverse Event|15|||
124459578|NCT00440947|447642327|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
124459579|NCT00440947|447642328|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
124459580|NCT00440947|447642329|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
124548682|NCT01643928|447965315|FG000|Overall Study|Withdrawal by Subject|2|||
124548683|NCT01643928|447965316|FG001|Overall Study|Withdrawal by Subject|0|||
124949672|NCT00747149|449443476|FG000|Overall Study|Lost to Follow-up|0|||
124949673|NCT00747149|449443477|FG001|Overall Study|Lost to Follow-up|10|||
124949674|NCT00747149|449443476|FG000|Overall Study|Withdrawal by Subject|0|||
124949675|NCT00747149|449443477|FG001|Overall Study|Withdrawal by Subject|6|||
124949676|NCT00747149|449443476|FG000|Overall Study|Did not receive treatment|0|||
124949677|NCT00747149|449443477|FG001|Overall Study|Did not receive treatment|1|||
124949678|NCT00747149|449443476|FG000|Overall Study|Incorrect enrollment|0|||
124949679|NCT00747149|449443477|FG001|Overall Study|Incorrect enrollment|6|||
124949680|NCT00747149|449443476|FG000|Overall Study|Severe non-compliance to protocol|0|||
124949681|NCT00747149|449443477|FG001|Overall Study|Severe non-compliance to protocol|1|||
124949682|NCT00747149|449443476|FG000|Overall Study|Not reported|1|||
124949683|NCT00747149|449443477|FG001|Overall Study|Not reported|4|||
124949684|NCT05522777|449443478|FG000|Overall Study|Lack of Efficacy|1|||
124949685|NCT05522777|449443478|FG000|Overall Study|Withdrawal by Subject|1|||
124949686|NCT05006703|449443479|FG000|Overall Study|Withdrawal by Subject|1|||
124949687|NCT05006703|449443480|FG001|Overall Study|Withdrawal by Subject|0|||
124949688|NCT05006703|449443479|FG000|Overall Study|Lost to Follow-up|13|||
124949689|NCT05006703|449443480|FG001|Overall Study|Lost to Follow-up|5|||
124949690|NCT01381549|449443481|FG000|Overall Study|Ineligible: No organisms isolated|0|||
124949691|NCT01381549|449443482|FG001|Overall Study|Ineligible: No organisms isolated|0|||
124949692|NCT01381549|449443483|FG002|Overall Study|Ineligible: No organisms isolated|1|||
124949693|NCT01416285|449443484|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
124548684|NCT01643928|447965317|FG002|Overall Study|Withdrawal by Subject|0|||
124548685|NCT01643928|447965318|FG003|Overall Study|Withdrawal by Subject|1|||
124766208|NCT00713609|448771648|FG003|Overall Study|Lost to Follow-up|5|||
124766209|NCT00713609|448771649|FG004|Overall Study|Lost to Follow-up|7|||
124766210|NCT00713609|448771650|FG005|Overall Study|Lost to Follow-up|0|||
124766211|NCT00713609|448771645|FG000|Overall Study|Lack of Efficacy|1|||
124949694|NCT01416285|449443485|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
124949695|NCT00578344|449443486|FG000|Overall Study|Insurance problems|1|||
124949696|NCT00578344|449443486|FG000|Overall Study|Graft failure|1|||
124949697|NCT02935673|449443487|FG000|Overall Study|Adverse Event|0|||
124707068|NCT04079738|448552888|FG000|Study Treatment|withdrawal before treatment|1|||
124707069|NCT04079738|448552889|FG001|Study Treatment|withdrawal before treatment|0|||
124707070|NCT04079738|448552890|FG002|Study Treatment|withdrawal before treatment|0|||
124707071|NCT04079738|448552891|FG003|Study Treatment|withdrawal before treatment|0|||
124707072|NCT04079738|448552888|FG000|Study Treatment|symptomatic deterioration|2|||
124707073|NCT04079738|448552889|FG001|Study Treatment|symptomatic deterioration|0|||
124707074|NCT04079738|448552890|FG002|Study Treatment|symptomatic deterioration|0|||
124707075|NCT04079738|448552891|FG003|Study Treatment|symptomatic deterioration|0|||
124707076|NCT04079738|448552888|FG000|Study Treatment|Disease Progression|1|||
124707077|NCT04079738|448552889|FG001|Study Treatment|Disease Progression|0|||
124766212|NCT00713609|448771646|FG001|Overall Study|Lack of Efficacy|3|||
124766213|NCT00713609|448771647|FG002|Overall Study|Lack of Efficacy|0|||
124766214|NCT00713609|448771648|FG003|Overall Study|Lack of Efficacy|0|||
124766215|NCT00713609|448771649|FG004|Overall Study|Lack of Efficacy|1|||
124766216|NCT00713609|448771650|FG005|Overall Study|Lack of Efficacy|0|||
124766217|NCT00713609|448771645|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
124766218|NCT00713609|448771646|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
124766219|NCT00713609|448771647|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
124766220|NCT00713609|448771648|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
124766221|NCT00713609|448771649|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
124766222|NCT00713609|448771650|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
124766223|NCT00713609|448771645|FG000|Overall Study|Withdrawal by Subject|6|||
124766224|NCT00713609|448771646|FG001|Overall Study|Withdrawal by Subject|1|||
124949698|NCT02935673|449443488|FG001|Overall Study|Adverse Event|1|||
124949699|NCT02935673|449443489|FG002|Overall Study|Adverse Event|0|||
124949700|NCT02935673|449443487|FG000|Overall Study|Withdrawal by Subject|1|||
124949701|NCT02935673|449443488|FG001|Overall Study|Withdrawal by Subject|2|||
124949702|NCT02935673|449443489|FG002|Overall Study|Withdrawal by Subject|0|||
124459581|NCT00440947|447642330|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
124459582|NCT00440947|447642326|FG000|36-Week Induction Phase|Incarceration|3|||
124459583|NCT00440947|447642327|FG001|36-Week Induction Phase|Incarceration|0|||
124459584|NCT00440947|447642328|FG002|36-Week Induction Phase|Incarceration|0|||
124459585|NCT00440947|447642329|FG003|36-Week Induction Phase|Incarceration|0|||
124459586|NCT00440947|447642330|FG004|36-Week Induction Phase|Incarceration|0|||
124459587|NCT00440947|447642326|FG000|36-Week Induction Phase|Pregnancy|1|||
124459588|NCT00440947|447642327|FG001|36-Week Induction Phase|Pregnancy|0|||
124459589|NCT00440947|447642328|FG002|36-Week Induction Phase|Pregnancy|0|||
124459590|NCT00440947|447642329|FG003|36-Week Induction Phase|Pregnancy|0|||
124459591|NCT00440947|447642330|FG004|36-Week Induction Phase|Pregnancy|0|||
124459592|NCT00440947|447642326|FG000|48-Week Randomization Phase|Adverse Event|0|||
124459593|NCT00440947|447642327|FG001|48-Week Randomization Phase|Adverse Event|2|||
124459594|NCT00440947|447642328|FG002|48-Week Randomization Phase|Adverse Event|5|||
124459595|NCT00440947|447642329|FG003|48-Week Randomization Phase|Adverse Event|0|||
124459596|NCT00440947|447642330|FG004|48-Week Randomization Phase|Adverse Event|0|||
124459597|NCT00440947|447642326|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
124459598|NCT00440947|447642327|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
124459599|NCT00440947|447642328|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
124459600|NCT00440947|447642329|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
124459601|NCT00440947|447642330|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
124459602|NCT00440947|447642326|FG000|48-Week Randomization Phase|Non-compliance|0|||
124459603|NCT00440947|447642327|FG001|48-Week Randomization Phase|Non-compliance|3|||
124459604|NCT00440947|447642328|FG002|48-Week Randomization Phase|Non-compliance|4|||
124459605|NCT00440947|447642329|FG003|48-Week Randomization Phase|Non-compliance|0|||
124459606|NCT00440947|447642330|FG004|48-Week Randomization Phase|Non-compliance|0|||
124707078|NCT04079738|448552890|FG002|Study Treatment|Disease Progression|0|||
124766225|NCT00713609|448771647|FG002|Overall Study|Withdrawal by Subject|5|||
124949703|NCT04328467|449443490|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
124949704|NCT04328467|449443491|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
124949705|NCT04328467|449443492|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
124949706|NCT00990184|449443493|FG000|Overall Study|Physician Decision|1|||
124949707|NCT01090739|449443496|FG000|Enrollment|Withdrawal by Subject|24|||
124949708|NCT01090739|449443496|FG000|Enrollment|Protocol Violation|14|||
124949709|NCT01090739|449443496|FG000|Enrollment|Lost to Follow-up|5|||
124949710|NCT01090739|449443496|FG000|Enrollment|Physician Decision|5|||
124949711|NCT01090739|449443496|FG000|Enrollment|Sponsor termination of site|4|||
124949712|NCT01090739|449443496|FG000|Enrollment|Study implant limit reached|2|||
124459607|NCT00440947|447642326|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
124766226|NCT00713609|448771648|FG003|Overall Study|Withdrawal by Subject|1|||
124766227|NCT00713609|448771649|FG004|Overall Study|Withdrawal by Subject|5|||
124766228|NCT00713609|448771650|FG005|Overall Study|Withdrawal by Subject|7|||
124949713|NCT01090739|449443496|FG000|Enrollment|Adverse Event|1|||
124949714|NCT01090739|449443496|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
124459608|NCT00440947|447642327|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
124459609|NCT00440947|447642328|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
124459610|NCT00440947|447642329|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
124459611|NCT00440947|447642330|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
124459612|NCT00440947|447642326|FG000|48-Week Randomization Phase|Protocol Violation|0|||
124459613|NCT00440947|447642327|FG001|48-Week Randomization Phase|Protocol Violation|0|||
124459614|NCT00440947|447642328|FG002|48-Week Randomization Phase|Protocol Violation|1|||
124459615|NCT00440947|447642329|FG003|48-Week Randomization Phase|Protocol Violation|0|||
124459616|NCT00440947|447642330|FG004|48-Week Randomization Phase|Protocol Violation|0|||
124459617|NCT00440947|447642326|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
124459618|NCT00440947|447642327|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
124459619|NCT00440947|447642328|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
124459620|NCT00440947|447642329|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
124459621|NCT00440947|447642330|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
124548686|NCT01643928|447965319|FG004|Overall Study|Withdrawal by Subject|0|||
124707079|NCT04079738|448552891|FG003|Study Treatment|Disease Progression|0|||
124707080|NCT04079738|448552888|FG000|Study Treatment|withdrawal after treatment|1|||
124459622|NCT00440947|447642326|FG000|48-Week Randomization Phase|Pregnancy|0|||
124548687|NCT01643928|447965315|FG000|Overall Study|Pregnancy|0|||
124707081|NCT04079738|448552889|FG001|Study Treatment|withdrawal after treatment|0|||
124707082|NCT04079738|448552890|FG002|Study Treatment|withdrawal after treatment|0|||
124707083|NCT04079738|448552891|FG003|Study Treatment|withdrawal after treatment|0|||
124707084|NCT04079738|448552888|FG000|Follow up|Withdrawal by Subject|3|||
124707085|NCT04079738|448552889|FG001|Follow up|Withdrawal by Subject|0|||
124707086|NCT04079738|448552890|FG002|Follow up|Withdrawal by Subject|0|||
124707087|NCT04079738|448552891|FG003|Follow up|Withdrawal by Subject|0|||
124707088|NCT04079738|448552888|FG000|Follow up|Death|5|||
124707089|NCT04079738|448552889|FG001|Follow up|Death|0|||
124707090|NCT04079738|448552890|FG002|Follow up|Death|0|||
124707091|NCT04079738|448552891|FG003|Follow up|Death|0|||
124707092|NCT00867035|448552894|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
124707093|NCT00867035|448552895|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
124707094|NCT00867035|448552894|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
124707095|NCT00867035|448552895|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
124459623|NCT00440947|447642327|FG001|48-Week Randomization Phase|Pregnancy|0|||
124459624|NCT00440947|447642328|FG002|48-Week Randomization Phase|Pregnancy|1|||
124459625|NCT00440947|447642329|FG003|48-Week Randomization Phase|Pregnancy|0|||
124459626|NCT00440947|447642330|FG004|48-Week Randomization Phase|Pregnancy|0|||
124459627|NCT00440947|447642326|FG000|48-Week Randomization Phase|Incarceration|0|||
124459628|NCT00440947|447642327|FG001|48-Week Randomization Phase|Incarceration|3|||
124459629|NCT00440947|447642328|FG002|48-Week Randomization Phase|Incarceration|0|||
124459630|NCT00440947|447642329|FG003|48-Week Randomization Phase|Incarceration|0|||
124459631|NCT00440947|447642330|FG004|48-Week Randomization Phase|Incarceration|0|||
124459632|NCT00440947|447642326|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
124459633|NCT00440947|447642327|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
124459634|NCT00440947|447642328|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
124459635|NCT00440947|447642329|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
124459636|NCT00440947|447642330|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
124459637|NCT00440947|447642326|FG000|48-Week Randomization Phase|Physician Decision|0|||
124459638|NCT00440947|447642327|FG001|48-Week Randomization Phase|Physician Decision|2|||
124459639|NCT00440947|447642328|FG002|48-Week Randomization Phase|Physician Decision|0|||
124459640|NCT00440947|447642329|FG003|48-Week Randomization Phase|Physician Decision|0|||
124459641|NCT00440947|447642330|FG004|48-Week Randomization Phase|Physician Decision|0|||
124459642|NCT00440947|447642326|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
124459643|NCT00440947|447642327|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
124707096|NCT00404248|448552896|FG000|Overall Study|pts declining status|0|||
124707097|NCT00404248|448552897|FG001|Overall Study|pts declining status|1|||
124707098|NCT00404248|448552898|FG002|Overall Study|pts declining status|0|||
124459644|NCT00440947|447642328|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
124459645|NCT00440947|447642329|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
124459646|NCT00440947|447642330|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
124459647|NCT00440947|447642326|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
124707099|NCT00404248|448552899|FG003|Overall Study|pts declining status|0|||
124707100|NCT00404248|448552900|FG004|Overall Study|pts declining status|0|||
124707101|NCT00404248|448552901|FG005|Overall Study|pts declining status|0|||
124707102|NCT00404248|448552902|FG006|Overall Study|pts declining status|0|||
124707103|NCT00404248|448552903|FG007|Overall Study|pts declining status|0|||
124707104|NCT00404248|448552904|FG008|Overall Study|pts declining status|0|||
124707105|NCT00789555|448552905|FG000|Overall Study|Protocol Amendment|78|||
124707106|NCT00789555|448552906|FG001|Overall Study|Protocol Amendment|76|||
124707107|NCT00789555|448552907|FG002|Overall Study|Protocol Amendment|80|||
124707108|NCT00789555|448552905|FG000|Overall Study|Adverse Event|17|||
124707109|NCT00789555|448552906|FG001|Overall Study|Adverse Event|7|||
124707110|NCT00789555|448552907|FG002|Overall Study|Adverse Event|10|||
124707111|NCT00789555|448552905|FG000|Overall Study|Lost to Follow-up|9|||
124707112|NCT00789555|448552906|FG001|Overall Study|Lost to Follow-up|10|||
124707113|NCT00789555|448552907|FG002|Overall Study|Lost to Follow-up|18|||
124707114|NCT00789555|448552905|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
124707115|NCT00789555|448552906|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
124707116|NCT00789555|448552907|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
124707117|NCT00789555|448552905|FG000|Overall Study|Treatment failure|11|||
124707118|NCT00789555|448552906|FG001|Overall Study|Treatment failure|8|||
124707119|NCT00789555|448552907|FG002|Overall Study|Treatment failure|12|||
124707120|NCT00789555|448552905|FG000|Overall Study|Protocol Violation|6|||
124707121|NCT00789555|448552906|FG001|Overall Study|Protocol Violation|9|||
124707122|NCT00789555|448552907|FG002|Overall Study|Protocol Violation|13|||
124707123|NCT04646005|448552908|FG000|Overall Study|Adverse Event|1|||
124707124|NCT04646005|448552908|FG000|Overall Study|Progressive Disease|71|||
124707125|NCT04646005|448552908|FG000|Overall Study|Death|20|||
124459648|NCT00440947|447642327|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
124548688|NCT01643928|447965316|FG001|Overall Study|Pregnancy|0|||
124548689|NCT01643928|447965317|FG002|Overall Study|Pregnancy|0|||
124707126|NCT04646005|448552908|FG000|Overall Study|Withdrawal by Subject|12|||
124707127|NCT04646005|448552908|FG000|Overall Study|Sponsor Request|9|||
124707128|NCT04398706|448552909|FG000|Overall Study|Adverse Event|0|||
124707129|NCT04398706|448552910|FG001|Overall Study|Adverse Event|0|||
124707130|NCT04398706|448552911|FG002|Overall Study|Adverse Event|0|||
124707131|NCT04398706|448552912|FG003|Overall Study|Adverse Event|0|||
124707132|NCT04398706|448552913|FG004|Overall Study|Adverse Event|0|||
124707133|NCT04398706|448552914|FG005|Overall Study|Adverse Event|1|||
124707134|NCT04398706|448552915|FG006|Overall Study|Adverse Event|1|||
124707135|NCT04398706|448552916|FG007|Overall Study|Adverse Event|0|||
124707136|NCT04398706|448552909|FG000|Overall Study|Lost to Follow-up|0|||
124707137|NCT04398706|448552910|FG001|Overall Study|Lost to Follow-up|1|||
124707138|NCT04398706|448552911|FG002|Overall Study|Lost to Follow-up|2|||
124707139|NCT04398706|448552912|FG003|Overall Study|Lost to Follow-up|1|||
124707140|NCT04398706|448552913|FG004|Overall Study|Lost to Follow-up|6|||
124707141|NCT04398706|448552914|FG005|Overall Study|Lost to Follow-up|3|||
124707142|NCT04398706|448552915|FG006|Overall Study|Lost to Follow-up|8|||
124766229|NCT00713609|448771645|FG000|Overall Study|Protocol Violation|6|||
124766230|NCT00713609|448771646|FG001|Overall Study|Protocol Violation|3|||
124766231|NCT00713609|448771647|FG002|Overall Study|Protocol Violation|1|||
124766232|NCT00713609|448771648|FG003|Overall Study|Protocol Violation|1|||
124766233|NCT00713609|448771649|FG004|Overall Study|Protocol Violation|2|||
124766234|NCT00713609|448771650|FG005|Overall Study|Protocol Violation|0|||
124766235|NCT04529083|448771651|FG000|Overall Study|Withdrawal by Subject|3|||
124766236|NCT03305666|448771652|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
124766237|NCT03305666|448771653|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
124766238|NCT04196686|448771655|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
124766239|NCT04196686|448771656|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
124766240|NCT02587221|448771660|FG000|Overall Study|Adverse Event|3|||
124766241|NCT02587221|448771661|FG001|Overall Study|Adverse Event|3|||
124766242|NCT02587221|448771660|FG000|Overall Study|Death|33|||
124766243|NCT02587221|448771661|FG001|Overall Study|Death|34|||
124766244|NCT02587221|448771660|FG000|Overall Study|Withdrawal by Subject|66|||
124766245|NCT02587221|448771661|FG001|Overall Study|Withdrawal by Subject|61|||
124766246|NCT02587221|448771660|FG000|Overall Study|Lost to Follow-up|21|||
124766247|NCT02587221|448771661|FG001|Overall Study|Lost to Follow-up|19|||
124949715|NCT01090739|449443496|FG000|12 Month Follow-up|Lost to Follow-up|1|||
124949716|NCT01090739|449443496|FG000|12 Month Follow-up|Physician Decision|1|||
124949717|NCT01090739|449443496|FG000|12 Month Follow-up|Death|1|||
124949718|NCT01090739|449443496|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
124949719|NCT01090739|449443496|FG000|24 Month Follow-up|Lost to Follow-up|1|||
124949720|NCT01090739|449443496|FG000|24 Month Follow-up|Death|1|||
124949721|NCT01090739|449443496|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
124949722|NCT01090739|449443496|FG000|36 Month Follow-up|Visit still pending|17|||
124949723|NCT00441168|449443497|FG000|Treatment Period|Death|3|||
124949724|NCT00441168|449443498|FG001|Treatment Period|Death|0|||
124949725|NCT00441168|449443497|FG000|Treatment Period|Adverse Event|1|||
124949726|NCT00441168|449443498|FG001|Treatment Period|Adverse Event|2|||
124949727|NCT00441168|449443497|FG000|Treatment Period|Progressive Disease|0|||
124949728|NCT00441168|449443498|FG001|Treatment Period|Progressive Disease|2|||
124949729|NCT00441168|449443497|FG000|Treatment Period|Protocol Violation|0|||
124949730|NCT00441168|449443498|FG001|Treatment Period|Protocol Violation|1|||
124707143|NCT04398706|448552916|FG007|Overall Study|Lost to Follow-up|2|||
124766248|NCT02587221|448771660|FG000|Overall Study|Protocol Violation|6|||
124766249|NCT02587221|448771661|FG001|Overall Study|Protocol Violation|5|||
124766250|NCT02587221|448771660|FG000|Overall Study|Other Reason or Unspecified|2|||
124766251|NCT02587221|448771661|FG001|Overall Study|Other Reason or Unspecified|1|||
124766252|NCT02546609|448771662|FG000|Overall Study|Withdrawal by Subject|0|||
124766253|NCT02546609|448771663|FG001|Overall Study|Withdrawal by Subject|1|||
124766254|NCT02546609|448771664|FG002|Overall Study|Withdrawal by Subject|2|||
124707144|NCT04398706|448552909|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124707145|NCT04398706|448552910|FG001|Overall Study|Withdrawal by parent/guardian|2|||
124707146|NCT04398706|448552911|FG002|Overall Study|Withdrawal by parent/guardian|1|||
124707147|NCT04398706|448552912|FG003|Overall Study|Withdrawal by parent/guardian|2|||
124707148|NCT04398706|448552913|FG004|Overall Study|Withdrawal by parent/guardian|19|||
124707149|NCT04398706|448552914|FG005|Overall Study|Withdrawal by parent/guardian|23|||
124766255|NCT02546609|448771662|FG000|Overall Study|Adverse Event|0|||
124766256|NCT02546609|448771663|FG001|Overall Study|Adverse Event|6|||
124766257|NCT02546609|448771664|FG002|Overall Study|Adverse Event|1|||
124766258|NCT02546609|448771662|FG000|Overall Study|Protocol Violation|0|||
124766259|NCT02546609|448771663|FG001|Overall Study|Protocol Violation|1|||
124949731|NCT00441168|449443497|FG000|Treatment Period|Lost to Follow-up|0|||
124949732|NCT00441168|449443498|FG001|Treatment Period|Lost to Follow-up|1|||
124949733|NCT00441168|449443497|FG000|Treatment Period|Withdrawal by Subject|3|||
124766260|NCT02546609|448771664|FG002|Overall Study|Protocol Violation|1|||
124766261|NCT02546609|448771662|FG000|Overall Study|Lost to Follow-up|2|||
124766262|NCT02546609|448771663|FG001|Overall Study|Lost to Follow-up|3|||
124766263|NCT02546609|448771664|FG002|Overall Study|Lost to Follow-up|1|||
124766264|NCT02546609|448771662|FG000|Overall Study|travel or work schedule restriction|0|||
124949734|NCT00441168|449443498|FG001|Treatment Period|Withdrawal by Subject|0|||
124459649|NCT00440947|447642328|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
124459650|NCT00440947|447642329|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
124459651|NCT00440947|447642330|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
124459652|NCT00440947|447642326|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
124459653|NCT00440947|447642327|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
124459654|NCT00440947|447642328|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
124459655|NCT00440947|447642329|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
124459656|NCT00440947|447642330|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
124459657|NCT00440947|447642326|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
124459658|NCT00440947|447642327|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
124459659|NCT00440947|447642328|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
124459660|NCT00440947|447642329|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
124766265|NCT02546609|448771663|FG001|Overall Study|travel or work schedule restriction|0|||
124766266|NCT02546609|448771664|FG002|Overall Study|travel or work schedule restriction|2|||
124766267|NCT00914849|448771665|FG000|Overall Study|Withdrawal by Subject|1|||
124766268|NCT00914849|448771666|FG001|Overall Study|Withdrawal by Subject|0|||
124766269|NCT00914849|448771665|FG000|Overall Study|Not eligible|0|||
124766270|NCT00914849|448771666|FG001|Overall Study|Not eligible|1|||
124766271|NCT01001221|448771667|FG000|Overall Study|Adverse Event|1|||
124766272|NCT01001221|448771668|FG001|Overall Study|Adverse Event|2|||
124766273|NCT01001221|448771669|FG002|Overall Study|Adverse Event|0|||
124766274|NCT01001221|448771670|FG003|Overall Study|Adverse Event|2|||
124766275|NCT01001221|448771671|FG004|Overall Study|Adverse Event|0|||
124766276|NCT01001221|448771667|FG000|Overall Study|Disease progression|3|||
124766277|NCT01001221|448771668|FG001|Overall Study|Disease progression|2|||
124766278|NCT01001221|448771669|FG002|Overall Study|Disease progression|2|||
124766279|NCT01001221|448771670|FG003|Overall Study|Disease progression|4|||
124766280|NCT01001221|448771671|FG004|Overall Study|Disease progression|0|||
124766281|NCT01001221|448771667|FG000|Overall Study|Other|1|||
124766282|NCT01001221|448771668|FG001|Overall Study|Other|1|||
124949735|NCT00441168|449443497|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
124459661|NCT00440947|447642330|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
124766283|NCT01001221|448771669|FG002|Overall Study|Other|0|||
124766284|NCT01001221|448771670|FG003|Overall Study|Other|0|||
124766285|NCT01001221|448771671|FG004|Overall Study|Other|0|||
124459662|NCT00440947|447642326|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
124459663|NCT00440947|447642327|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
124459664|NCT00440947|447642328|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
124459665|NCT00440947|447642329|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
124459666|NCT00440947|447642330|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
124459667|NCT00440947|447642326|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
124459668|NCT00440947|447642327|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
124459669|NCT00440947|447642328|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
124459670|NCT00440947|447642329|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
124459671|NCT00440947|447642330|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
124459672|NCT00440947|447642326|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
124459673|NCT00440947|447642327|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
124459674|NCT00440947|447642328|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
124459675|NCT00440947|447642329|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
124548690|NCT01643928|447965318|FG003|Overall Study|Pregnancy|1|||
124548691|NCT01643928|447965319|FG004|Overall Study|Pregnancy|0|||
124766286|NCT01001221|448771667|FG000|Overall Study|Not treated; protocol exclusion|0|||
124766287|NCT01001221|448771668|FG001|Overall Study|Not treated; protocol exclusion|0|||
124766288|NCT01001221|448771669|FG002|Overall Study|Not treated; protocol exclusion|1|||
124766289|NCT01001221|448771670|FG003|Overall Study|Not treated; protocol exclusion|0|||
124766290|NCT01001221|448771671|FG004|Overall Study|Not treated; protocol exclusion|0|||
124766291|NCT05106959|448771672|FG000|Overall Study|Lost to Follow-up|1|||
124766292|NCT01292486|448771673|FG000|Overall Study|Protocol Violation|2|||
124766293|NCT01292486|448771673|FG000|Overall Study|Did not meet screening criteria|2|||
124766294|NCT01292486|448771673|FG000|Overall Study|Adverse Event|1|||
124766295|NCT01292486|448771673|FG000|Overall Study|Physician Decision|1|||
124766296|NCT04602390|448771678|FG000|Overall Study|Withdrawal by Subject|0|||
124766297|NCT04602390|448771679|FG001|Overall Study|Withdrawal by Subject|0|||
124766298|NCT04602390|448771680|FG002|Overall Study|Withdrawal by Subject|0|||
124766299|NCT04602390|448771681|FG003|Overall Study|Withdrawal by Subject|0|||
124766300|NCT04602390|448771682|FG004|Overall Study|Withdrawal by Subject|1|||
124766301|NCT04602390|448771683|FG005|Overall Study|Withdrawal by Subject|0|||
124766302|NCT04602390|448771678|FG000|Overall Study|Adverse Event|0|||
124766303|NCT04602390|448771679|FG001|Overall Study|Adverse Event|0|||
124766304|NCT04602390|448771680|FG002|Overall Study|Adverse Event|0|||
124949736|NCT00441168|449443498|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
124949737|NCT00441168|449443497|FG000|Treatment Period|refractory disease|1|||
124707150|NCT04398706|448552915|FG006|Overall Study|Withdrawal by parent/guardian|13|||
124707151|NCT04398706|448552916|FG007|Overall Study|Withdrawal by parent/guardian|11|||
124707152|NCT04398706|448552909|FG000|Overall Study|Protocol deviation|0|||
124707153|NCT04398706|448552910|FG001|Overall Study|Protocol deviation|1|||
124707154|NCT04398706|448552911|FG002|Overall Study|Protocol deviation|0|||
124707155|NCT04398706|448552912|FG003|Overall Study|Protocol deviation|0|||
124707156|NCT04398706|448552913|FG004|Overall Study|Protocol deviation|6|||
124707157|NCT04398706|448552914|FG005|Overall Study|Protocol deviation|4|||
124707158|NCT04398706|448552915|FG006|Overall Study|Protocol deviation|6|||
124707159|NCT04398706|448552916|FG007|Overall Study|Protocol deviation|3|||
124707160|NCT02611037|448552917|FG000|Overall Study|Withdrawal prior to treatment|2|||
124707161|NCT02611037|448552918|FG001|Overall Study|Withdrawal prior to treatment|0|||
124707162|NCT04577404|448552919|FG000|Overall Study|Adverse Event|31|||
124707163|NCT04577404|448552919|FG000|Overall Study|Death|1|||
124707164|NCT04577404|448552919|FG000|Overall Study|Lack of Efficacy|3|||
124707165|NCT04577404|448552919|FG000|Overall Study|Physician Decision|7|||
124707166|NCT04577404|448552919|FG000|Overall Study|Withdrawal by Subject|21|||
124707167|NCT04577404|448552919|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
124707168|NCT04237584|448552926|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
124707169|NCT04237584|448552927|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
124707170|NCT04237584|448552928|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
124707171|NCT04237584|448552929|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
124707172|NCT04237584|448552926|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
124707173|NCT04237584|448552927|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
124707174|NCT04237584|448552928|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
124707175|NCT04237584|448552929|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
124707176|NCT04237584|448552926|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
124707177|NCT04237584|448552927|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
124707178|NCT04237584|448552928|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
124707179|NCT04237584|448552929|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
124707180|NCT04237584|448552926|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
124707181|NCT04237584|448552927|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
124707182|NCT04237584|448552928|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
124707183|NCT04237584|448552929|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
124707184|NCT04237584|448552926|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
124707185|NCT04237584|448552927|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
124707186|NCT04237584|448552928|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
124707187|NCT04237584|448552929|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
124707188|NCT03586973|448552930|FG000|Overall Study|Death|15|||
124707189|NCT03586973|448552931|FG001|Overall Study|Death|8|||
124707190|NCT03586973|448552930|FG000|Overall Study|Site Terminated by Sponsor|3|||
124707191|NCT03586973|448552931|FG001|Overall Study|Site Terminated by Sponsor|6|||
124707192|NCT03586973|448552930|FG000|Overall Study|Withdrawal by Subject|1|||
124707193|NCT03586973|448552931|FG001|Overall Study|Withdrawal by Subject|0|||
124707194|NCT03586973|448552930|FG000|Overall Study|Lost to Follow-up|1|||
124707195|NCT03586973|448552931|FG001|Overall Study|Lost to Follow-up|0|||
124707196|NCT02661672|448552935|FG000|Overall Study|Lost to Follow-up|1|||
124707197|NCT02661672|448552935|FG000|Overall Study|Death|4|||
124707198|NCT04696146|448554553|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
124707199|NCT04696146|448554554|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
124707200|NCT04696146|448554553|FG000|Overall Study|Off hours issue with product|1|||
124707201|NCT04696146|448554554|FG001|Overall Study|Off hours issue with product|0|||
124707202|NCT01334918|448554559|FG000|Overall Study|Did not receive study drug|6|||
124707203|NCT01334918|448554560|FG001|Overall Study|Did not receive study drug|0|||
124707204|NCT01334918|448554559|FG000|Overall Study|Adverse Event|2|||
124707205|NCT01334918|448554560|FG001|Overall Study|Adverse Event|0|||
124707206|NCT01334918|448554559|FG000|Overall Study|Withdrawal by Subject|0|||
124707207|NCT01334918|448554560|FG001|Overall Study|Withdrawal by Subject|1|||
124707208|NCT00529633|448554561|FG000|Overall Study|Withdrawal by Subject|1|||
124707209|NCT00529633|448554562|FG001|Overall Study|Withdrawal by Subject|1|||
124707210|NCT01576783|448554563|FG000|Overall Study|Change in Medical Care|1|||
124707211|NCT01576783|448554564|FG001|Overall Study|Change in Medical Care|0|||
124707212|NCT01576783|448554563|FG000|Overall Study|Lost to Follow-up|14|||
124707213|NCT01576783|448554564|FG001|Overall Study|Lost to Follow-up|16|||
124707214|NCT01576783|448554563|FG000|Overall Study|Withdrawal by Subject|5|||
124707215|NCT01576783|448554564|FG001|Overall Study|Withdrawal by Subject|1|||
124707216|NCT01897493|448554566|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
124766305|NCT04602390|448771681|FG003|Overall Study|Adverse Event|0|||
124766306|NCT04602390|448771682|FG004|Overall Study|Adverse Event|0|||
124766307|NCT04602390|448771683|FG005|Overall Study|Adverse Event|1|||
124766308|NCT00265564|448771684|FG000|Overall Study|Lost to Follow-up|5|||
124766309|NCT00265564|448771685|FG001|Overall Study|Lost to Follow-up|7|||
124766310|NCT00265564|448771684|FG000|Overall Study|met exclusion criteria|5|||
124766311|NCT00265564|448771685|FG001|Overall Study|met exclusion criteria|2|||
124766312|NCT01553084|448771686|FG000|Overall Study|Withdrawal by Subject|15|||
124766313|NCT01553084|448771687|FG001|Overall Study|Withdrawal by Subject|13|||
124766314|NCT01553084|448771688|FG002|Overall Study|Withdrawal by Subject|35|||
124766315|NCT03988400|448771689|FG000|Overall Study|Adverse Event|1|||
124766316|NCT03988400|448771690|FG001|Overall Study|Adverse Event|0|||
124766317|NCT03988400|448771689|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
124949738|NCT00441168|449443498|FG001|Treatment Period|refractory disease|0|||
124949739|NCT00441168|449443497|FG000|Follow-up Period|Death|3|||
124949740|NCT00441168|449443498|FG001|Follow-up Period|Death|0|||
124949741|NCT00441168|449443497|FG000|Follow-up Period|Lost to Follow-up|5|||
124949742|NCT00441168|449443498|FG001|Follow-up Period|Lost to Follow-up|6|||
124949743|NCT00441168|449443497|FG000|Follow-up Period|Withdrawal by Subject|3|||
124949744|NCT00441168|449443498|FG001|Follow-up Period|Withdrawal by Subject|0|||
124949745|NCT00441168|449443497|FG000|Follow-up Period|Other|1|||
124949746|NCT00441168|449443498|FG001|Follow-up Period|Other|3|||
124949747|NCT03909100|449443499|FG000|Overall Study|Protocol Deviation|2|||
124949748|NCT03909100|449443499|FG000|Overall Study|Technical Problems|4|||
124949749|NCT03909100|449443499|FG000|Overall Study|Withdrawal by Subject|4|||
124949750|NCT03909100|449443499|FG000|Overall Study|Lost to Follow-up|1|||
124949751|NCT03909100|449443499|FG000|Overall Study|Reason not Specified|4|||
124949752|NCT00807599|449443500|FG000|Overall Study|Not treated on protocol study|0|||
124949753|NCT00807599|449443501|FG001|Overall Study|Not treated on protocol study|0|||
124949754|NCT00807599|449443502|FG002|Overall Study|Not treated on protocol study|2|||
124949755|NCT00807599|449443500|FG000|Overall Study|Adverse Event|0|||
124949756|NCT00807599|449443501|FG001|Overall Study|Adverse Event|0|||
124949757|NCT00807599|449443502|FG002|Overall Study|Adverse Event|5|||
124949758|NCT00807599|449443500|FG000|Overall Study|Inadequate response to induction|0|||
124949759|NCT00807599|449443501|FG001|Overall Study|Inadequate response to induction|0|||
124949760|NCT00807599|449443502|FG002|Overall Study|Inadequate response to induction|9|||
124949761|NCT00807599|449443500|FG000|Overall Study|Withdrawal by Subject|0|||
124766318|NCT03988400|448771690|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
124766319|NCT03988400|448771689|FG000|Overall Study|Lost to Follow-up|0|||
124766320|NCT03988400|448771690|FG001|Overall Study|Lost to Follow-up|1|||
124766321|NCT04201431|448771691|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
124766322|NCT04201431|448771692|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
124766323|NCT04201431|448771693|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
124766324|NCT01176032|448771694|FG000|Overall Study|Adverse Event|1|||
124766325|NCT01176032|448771695|FG001|Overall Study|Adverse Event|0|||
124766326|NCT01176032|448771694|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124766327|NCT01176032|448771695|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124766328|NCT01176032|448771694|FG000|Overall Study|Protocol Violation|1|||
124766329|NCT01176032|448771695|FG001|Overall Study|Protocol Violation|0|||
124766330|NCT01176032|448771694|FG000|Overall Study|Informed consent withdrawn|3|||
124459676|NCT00440947|447642330|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
124459677|NCT00440947|447642326|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
124766331|NCT01176032|448771695|FG001|Overall Study|Informed consent withdrawn|0|||
124949762|NCT00807599|449443501|FG001|Overall Study|Withdrawal by Subject|0|||
124949763|NCT00807599|449443502|FG002|Overall Study|Withdrawal by Subject|1|||
124949764|NCT00529529|449443503|FG000|Overall Study|Adverse Event|12|||
124949765|NCT00529529|449443504|FG001|Overall Study|Adverse Event|17|||
124949766|NCT00529529|449443505|FG002|Overall Study|Adverse Event|8|||
124949767|NCT00529529|449443503|FG000|Overall Study|Subject withdrew consent|12|||
124766332|NCT01176032|448771694|FG000|Overall Study|Other|1|||
124766333|NCT01176032|448771695|FG001|Overall Study|Other|0|||
124766334|NCT01791244|448771698|FG000|Overall Study|Adverse Event|5|||
124766335|NCT01791244|448771699|FG001|Overall Study|Adverse Event|7|||
124766336|NCT01791244|448771698|FG000|Overall Study|Insufficient clinical response|10|||
124766337|NCT01791244|448771699|FG001|Overall Study|Insufficient clinical response|10|||
124766338|NCT01791244|448771698|FG000|Overall Study|Laboratory Abnormality|0|||
124766339|NCT01791244|448771699|FG001|Overall Study|Laboratory Abnormality|1|||
124766340|NCT04079296|448771700|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
124766341|NCT04079296|448771701|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
124766342|NCT04079296|448771702|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
124766343|NCT04079296|448771703|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
124766344|NCT04079296|448771704|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
124766345|NCT04079296|448771700|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
124766346|NCT04079296|448771701|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
124766347|NCT04079296|448771702|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
124766348|NCT04079296|448771703|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
124766349|NCT04079296|448771704|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
124766350|NCT04079296|448771700|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
124766351|NCT04079296|448771701|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
124766352|NCT04079296|448771702|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
124766353|NCT04079296|448771703|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
124766354|NCT04079296|448771704|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
124766355|NCT04079296|448771700|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
124766356|NCT04079296|448771701|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
124766357|NCT04079296|448771702|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
124766358|NCT04079296|448771703|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
124766359|NCT04079296|448771704|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
124949768|NCT00529529|449443504|FG001|Overall Study|Subject withdrew consent|9|||
124949769|NCT00529529|449443505|FG002|Overall Study|Subject withdrew consent|12|||
124949770|NCT00529529|449443503|FG000|Overall Study|Protocol deviation|8|||
124949771|NCT00529529|449443504|FG001|Overall Study|Protocol deviation|12|||
124949772|NCT00529529|449443505|FG002|Overall Study|Protocol deviation|5|||
124949773|NCT00529529|449443503|FG000|Overall Study|Lost to Follow-up|5|||
124949774|NCT00529529|449443504|FG001|Overall Study|Lost to Follow-up|3|||
124949775|NCT00529529|449443505|FG002|Overall Study|Lost to Follow-up|1|||
124949776|NCT00529529|449443503|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124949777|NCT00529529|449443504|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124949778|NCT00529529|449443505|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
124949779|NCT00529529|449443503|FG000|Overall Study|Death|2|||
124949780|NCT00529529|449443504|FG001|Overall Study|Death|0|||
124949781|NCT00529529|449443505|FG002|Overall Study|Death|0|||
124949782|NCT00529529|449443503|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124949783|NCT00529529|449443504|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124949784|NCT00529529|449443505|FG002|Overall Study|Abnormal test procedure result(s)|0|||
124949785|NCT00529529|449443503|FG000|Overall Study|Administrative problems|1|||
124949786|NCT00529529|449443504|FG001|Overall Study|Administrative problems|0|||
124949787|NCT00529529|449443505|FG002|Overall Study|Administrative problems|3|||
124949788|NCT01020435|449443506|FG000|Overall Study|Lost to Follow-up|0|||
124949789|NCT01020435|449443507|FG001|Overall Study|Lost to Follow-up|1|||
124949790|NCT00103857|449443508|FG000|54-Week Base Study|Adverse Event|12|||
124949791|NCT00103857|449443509|FG001|54-Week Base Study|Adverse Event|9|||
124949792|NCT00103857|449443510|FG002|54-Week Base Study|Adverse Event|11|||
124949793|NCT00103857|449443511|FG003|54-Week Base Study|Adverse Event|6|||
124949794|NCT00103857|449443512|FG004|54-Week Base Study|Adverse Event|5|||
124949795|NCT00103857|449443513|FG005|54-Week Base Study|Adverse Event|11|||
124949796|NCT00103857|449443514|FG006|54-Week Base Study|Adverse Event|3|||
124949797|NCT00103857|449443508|FG000|54-Week Base Study|Death|0|||
124949798|NCT00103857|449443509|FG001|54-Week Base Study|Death|0|||
124949799|NCT00103857|449443510|FG002|54-Week Base Study|Death|0|||
124949800|NCT00103857|449443511|FG003|54-Week Base Study|Death|0|||
124949801|NCT00103857|449443512|FG004|54-Week Base Study|Death|1|||
124949802|NCT00103857|449443513|FG005|54-Week Base Study|Death|1|||
124459678|NCT00440947|447642327|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
124459679|NCT00440947|447642328|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
124459680|NCT00440947|447642329|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
124766360|NCT04079296|448771700|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
124949803|NCT00103857|449443514|FG006|54-Week Base Study|Death|0|||
124949804|NCT00103857|449443508|FG000|54-Week Base Study|Lack of Efficacy|11|||
124949805|NCT00103857|449443509|FG001|54-Week Base Study|Lack of Efficacy|14|||
124949806|NCT00103857|449443510|FG002|54-Week Base Study|Lack of Efficacy|8|||
124949807|NCT00103857|449443511|FG003|54-Week Base Study|Lack of Efficacy|4|||
124949808|NCT00103857|449443512|FG004|54-Week Base Study|Lack of Efficacy|3|||
124949809|NCT00103857|449443513|FG005|54-Week Base Study|Lack of Efficacy|14|||
124949810|NCT00103857|449443514|FG006|54-Week Base Study|Lack of Efficacy|19|||
124949811|NCT00103857|449443508|FG000|54-Week Base Study|Lost to Follow-up|5|||
124949812|NCT00103857|449443509|FG001|54-Week Base Study|Lost to Follow-up|4|||
124949813|NCT00103857|449443510|FG002|54-Week Base Study|Lost to Follow-up|7|||
124949814|NCT00103857|449443511|FG003|54-Week Base Study|Lost to Follow-up|5|||
124949815|NCT00103857|449443512|FG004|54-Week Base Study|Lost to Follow-up|10|||
124949816|NCT00103857|449443513|FG005|54-Week Base Study|Lost to Follow-up|9|||
124949817|NCT00103857|449443514|FG006|54-Week Base Study|Lost to Follow-up|3|||
124949818|NCT00103857|449443508|FG000|54-Week Base Study|Physician Decision|1|||
124949819|NCT00103857|449443509|FG001|54-Week Base Study|Physician Decision|1|||
124949820|NCT00103857|449443510|FG002|54-Week Base Study|Physician Decision|0|||
124949821|NCT00103857|449443511|FG003|54-Week Base Study|Physician Decision|0|||
124949822|NCT00103857|449443512|FG004|54-Week Base Study|Physician Decision|1|||
124949823|NCT00103857|449443513|FG005|54-Week Base Study|Physician Decision|0|||
124949824|NCT00103857|449443514|FG006|54-Week Base Study|Physician Decision|0|||
124949825|NCT00103857|449443508|FG000|54-Week Base Study|Pregnancy|1|||
124949826|NCT00103857|449443509|FG001|54-Week Base Study|Pregnancy|0|||
124949827|NCT00103857|449443510|FG002|54-Week Base Study|Pregnancy|0|||
124949828|NCT00103857|449443511|FG003|54-Week Base Study|Pregnancy|0|||
124949829|NCT00103857|449443512|FG004|54-Week Base Study|Pregnancy|1|||
124949830|NCT00103857|449443513|FG005|54-Week Base Study|Pregnancy|0|||
124548692|NCT01643928|447965315|FG000|Overall Study|Other|5|||
124548693|NCT01643928|447965316|FG001|Overall Study|Other|1|||
124548694|NCT01643928|447965317|FG002|Overall Study|Other|1|||
124548695|NCT01643928|447965318|FG003|Overall Study|Other|0|||
124548696|NCT01643928|447965319|FG004|Overall Study|Other|0|||
124548697|NCT01643928|447965315|FG000|Overall Study|Adverse Event|2|||
124548698|NCT01643928|447965316|FG001|Overall Study|Adverse Event|1|||
124548699|NCT01643928|447965317|FG002|Overall Study|Adverse Event|0|||
124548700|NCT01643928|447965318|FG003|Overall Study|Adverse Event|1|||
124949831|NCT00103857|449443514|FG006|54-Week Base Study|Pregnancy|1|||
124949832|NCT00103857|449443508|FG000|54-Week Base Study|Protocol Violation|6|||
124548701|NCT01643928|447965319|FG004|Overall Study|Adverse Event|2|||
124548702|NCT03692078|447965320|FG000|Overall Study|Adverse Event|0|||
124548703|NCT03692078|447965321|FG001|Overall Study|Adverse Event|0|||
124707217|NCT05489328|448554567|FG000|Overall Study|Lost to Follow-up|0|||
124707218|NCT05489328|448554568|FG001|Overall Study|Lost to Follow-up|0|||
124707219|NCT05489328|448554569|FG002|Overall Study|Lost to Follow-up|1|||
124707220|NCT05489328|448554570|FG003|Overall Study|Lost to Follow-up|0|||
124707221|NCT05489328|448554571|FG004|Overall Study|Lost to Follow-up|2|||
124707222|NCT05489328|448554572|FG005|Overall Study|Lost to Follow-up|0|||
124707223|NCT05489328|448554573|FG006|Overall Study|Lost to Follow-up|0|||
124707224|NCT05489328|448554574|FG007|Overall Study|Lost to Follow-up|1|||
124707225|NCT05489328|448554575|FG008|Overall Study|Lost to Follow-up|0|||
124707226|NCT05489328|448554567|FG000|Overall Study|Withdrawal by Subject|0|||
124707227|NCT05489328|448554568|FG001|Overall Study|Withdrawal by Subject|0|||
124707228|NCT05489328|448554569|FG002|Overall Study|Withdrawal by Subject|0|||
124707229|NCT05489328|448554570|FG003|Overall Study|Withdrawal by Subject|0|||
124707230|NCT05489328|448554571|FG004|Overall Study|Withdrawal by Subject|0|||
124707231|NCT05489328|448554572|FG005|Overall Study|Withdrawal by Subject|0|||
124707232|NCT05489328|448554573|FG006|Overall Study|Withdrawal by Subject|1|||
124707233|NCT05489328|448554574|FG007|Overall Study|Withdrawal by Subject|1|||
124707234|NCT05489328|448554575|FG008|Overall Study|Withdrawal by Subject|0|||
124707235|NCT05489328|448554567|FG000|Overall Study|Other|0|||
124707236|NCT05489328|448554568|FG001|Overall Study|Other|0|||
124707237|NCT05489328|448554569|FG002|Overall Study|Other|0|||
124707238|NCT05489328|448554570|FG003|Overall Study|Other|0|||
124707239|NCT05489328|448554571|FG004|Overall Study|Other|0|||
124707240|NCT05489328|448554572|FG005|Overall Study|Other|0|||
124707241|NCT05489328|448554573|FG006|Overall Study|Other|0|||
124707242|NCT05489328|448554574|FG007|Overall Study|Other|1|||
124707243|NCT05489328|448554575|FG008|Overall Study|Other|1|||
124707244|NCT01083602|448554576|FG000|Overall Study|Adverse Event|11|||
124707245|NCT01083602|448554576|FG000|Overall Study|New Cancer Therapy|2|||
124707246|NCT01083602|448554576|FG000|Overall Study|Death|1|||
124707247|NCT01083602|448554576|FG000|Overall Study|Withdrawal by Subject|5|||
124707248|NCT01083602|448554576|FG000|Overall Study|Lack of Efficacy|36|||
124707249|NCT03698279|448554577|FG000|Overall Study|Withdrawal by parent/guardian|1|||
124707250|NCT03698279|448554578|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124707251|NCT03698279|448554579|FG002|Overall Study|Withdrawal by parent/guardian|1|||
124707252|NCT03698279|448554580|FG003|Overall Study|Withdrawal by parent/guardian|1|||
124707253|NCT03698279|448554581|FG004|Overall Study|Withdrawal by parent/guardian|0|||
124707254|NCT03698279|448554582|FG005|Overall Study|Withdrawal by parent/guardian|0|||
124707255|NCT03698279|448554577|FG000|Overall Study|Protocol deviation|1|||
124949833|NCT00103857|449443509|FG001|54-Week Base Study|Protocol Violation|4|||
124949834|NCT00103857|449443510|FG002|54-Week Base Study|Protocol Violation|2|||
124949835|NCT00103857|449443511|FG003|54-Week Base Study|Protocol Violation|4|||
124949836|NCT00103857|449443512|FG004|54-Week Base Study|Protocol Violation|0|||
124949837|NCT00103857|449443513|FG005|54-Week Base Study|Protocol Violation|3|||
124548704|NCT03692078|447965322|FG002|Overall Study|Adverse Event|0|||
124707256|NCT03698279|448554578|FG001|Overall Study|Protocol deviation|0|||
124707257|NCT03698279|448554579|FG002|Overall Study|Protocol deviation|1|||
124949838|NCT00103857|449443514|FG006|54-Week Base Study|Protocol Violation|3|||
124949839|NCT00103857|449443508|FG000|54-Week Base Study|Withdrawal by Subject|17|||
124949840|NCT00103857|449443509|FG001|54-Week Base Study|Withdrawal by Subject|16|||
124949841|NCT00103857|449443510|FG002|54-Week Base Study|Withdrawal by Subject|16|||
124949842|NCT00103857|449443511|FG003|54-Week Base Study|Withdrawal by Subject|15|||
124949843|NCT00103857|449443512|FG004|54-Week Base Study|Withdrawal by Subject|10|||
124949844|NCT00103857|449443513|FG005|54-Week Base Study|Withdrawal by Subject|15|||
124949845|NCT00103857|449443514|FG006|54-Week Base Study|Withdrawal by Subject|4|||
124459681|NCT00440947|447642330|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
124459682|NCT00440947|447642326|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
124459683|NCT00440947|447642327|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
124459684|NCT00440947|447642328|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
124459685|NCT00440947|447642329|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
124459686|NCT00440947|447642330|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
124459687|NCT00440947|447642326|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
124459688|NCT00440947|447642327|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
124459689|NCT00440947|447642328|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
124459690|NCT00440947|447642329|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
124459691|NCT00440947|447642330|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
124459692|NCT00440947|447642326|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
124459693|NCT00440947|447642327|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
124459694|NCT00440947|447642328|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
124459695|NCT00440947|447642329|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
124459696|NCT00440947|447642330|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
124548705|NCT03692078|447965323|FG003|Overall Study|Adverse Event|0|||
124707258|NCT03698279|448554580|FG003|Overall Study|Protocol deviation|0|||
124707259|NCT03698279|448554581|FG004|Overall Study|Protocol deviation|0|||
124707260|NCT03698279|448554582|FG005|Overall Study|Protocol deviation|0|||
124707261|NCT03698279|448554577|FG000|Overall Study|Withdrawal by Subject|0|||
124707262|NCT03698279|448554578|FG001|Overall Study|Withdrawal by Subject|0|||
124707263|NCT03698279|448554579|FG002|Overall Study|Withdrawal by Subject|1|||
124707264|NCT03698279|448554580|FG003|Overall Study|Withdrawal by Subject|0|||
124707265|NCT03698279|448554581|FG004|Overall Study|Withdrawal by Subject|0|||
124707266|NCT03698279|448554582|FG005|Overall Study|Withdrawal by Subject|0|||
124707267|NCT03698279|448554577|FG000|Overall Study|Lost to Follow-up|3|||
124707268|NCT03698279|448554578|FG001|Overall Study|Lost to Follow-up|1|||
124707269|NCT03698279|448554579|FG002|Overall Study|Lost to Follow-up|4|||
124707270|NCT03698279|448554580|FG003|Overall Study|Lost to Follow-up|5|||
124707271|NCT03698279|448554581|FG004|Overall Study|Lost to Follow-up|0|||
124707272|NCT03698279|448554582|FG005|Overall Study|Lost to Follow-up|0|||
124707273|NCT01276704|448554585|FG000|Overall Study|Lost to Follow-up|2|||
124707274|NCT01276704|448554586|FG001|Overall Study|Lost to Follow-up|3|||
124707275|NCT01276704|448554585|FG000|Overall Study|Non-compliant|2|||
124707276|NCT01276704|448554586|FG001|Overall Study|Non-compliant|2|||
124707277|NCT01276704|448554585|FG000|Overall Study|Withdrawal by Subject|7|||
124707278|NCT01276704|448554586|FG001|Overall Study|Withdrawal by Subject|1|||
124707279|NCT01276704|448554585|FG000|Overall Study|Physician Decision|3|||
124707280|NCT01276704|448554586|FG001|Overall Study|Physician Decision|5|||
124707281|NCT02276040|448554587|FG000|Overall Study|Physician Decision|15|||
124707282|NCT02239926|448554588|FG000|Overall Study|Withdrawal by Subject|0|||
124707283|NCT02239926|448554589|FG001|Overall Study|Withdrawal by Subject|1|||
124707284|NCT02704208|448554590|FG000|Overall Study|Lost to Follow-up|42|||
124707285|NCT02704208|448554591|FG001|Overall Study|Lost to Follow-up|37|||
124707286|NCT03801525|448554592|FG000|Overall Study|Adverse Event|17|||
124707287|NCT03801525|448554593|FG001|Overall Study|Adverse Event|1|||
124707288|NCT03801525|448554594|FG002|Overall Study|Adverse Event|0|||
124707289|NCT03801525|448554592|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
124707290|NCT03801525|448554593|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
124707291|NCT03801525|448554594|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
124707292|NCT03801525|448554592|FG000|Overall Study|Death|29|||
124707293|NCT03801525|448554593|FG001|Overall Study|Death|1|||
124707294|NCT03801525|448554594|FG002|Overall Study|Death|4|||
124707295|NCT03801525|448554592|FG000|Overall Study|Disease Progression|6|||
124707296|NCT03801525|448554593|FG001|Overall Study|Disease Progression|0|||
124707297|NCT03801525|448554594|FG002|Overall Study|Disease Progression|1|||
124707298|NCT03801525|448554592|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
124707299|NCT03801525|448554593|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
124707300|NCT03801525|448554594|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
124949846|NCT00103857|449443508|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
124707301|NCT03801525|448554592|FG000|Overall Study|Investigator Decision|18|||
124949847|NCT00103857|449443509|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
124949848|NCT00103857|449443510|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
124949849|NCT00103857|449443511|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
124949850|NCT00103857|449443512|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
124949851|NCT00103857|449443513|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
124949852|NCT00103857|449443514|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
124949853|NCT00103857|449443508|FG000|54-Week Base Study|patient moved|0|||
124949854|NCT00103857|449443509|FG001|54-Week Base Study|patient moved|1|||
124949855|NCT00103857|449443510|FG002|54-Week Base Study|patient moved|1|||
124459697|NCT00440947|447642326|FG000|Optional 60-Week Extension Phase|Other|0|||
124459698|NCT00440947|447642327|FG001|Optional 60-Week Extension Phase|Other|0|||
124459699|NCT00440947|447642328|FG002|Optional 60-Week Extension Phase|Other|0|||
124459700|NCT00440947|447642329|FG003|Optional 60-Week Extension Phase|Other|1|||
124459701|NCT00440947|447642330|FG004|Optional 60-Week Extension Phase|Other|0|||
124459702|NCT00440947|447642326|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
124459703|NCT00440947|447642327|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
124459704|NCT00440947|447642328|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
124459705|NCT00440947|447642329|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
124459706|NCT00440947|447642330|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
124459707|NCT00440947|447642326|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
124459708|NCT00440947|447642327|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
124459709|NCT00440947|447642328|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
124459710|NCT00440947|447642329|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
124459711|NCT00440947|447642330|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
124459712|NCT01265797|447642334|FG000|Run-in Month|Withdrawal by Subject|0|||
124707302|NCT03801525|448554593|FG001|Overall Study|Investigator Decision|1|||
124707303|NCT03801525|448554594|FG002|Overall Study|Investigator Decision|0|||
124707304|NCT03801525|448554592|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
124707305|NCT03801525|448554593|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
124707306|NCT03801525|448554594|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
124707307|NCT03801525|448554592|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
124707308|NCT03801525|448554593|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
124707309|NCT03801525|448554594|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
124707310|NCT03801525|448554592|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
124707311|NCT03801525|448554593|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
124707312|NCT03801525|448554594|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
124707313|NCT03801525|448554592|FG000|Overall Study|Withdrawal of Subject Consent|38|||
124707314|NCT03801525|448554593|FG001|Overall Study|Withdrawal of Subject Consent|2|||
124707315|NCT03801525|448554594|FG002|Overall Study|Withdrawal of Subject Consent|1|||
124707316|NCT03801525|448554592|FG000|Overall Study|Reason not Specified|4|||
124707317|NCT03801525|448554593|FG001|Overall Study|Reason not Specified|0|||
124707318|NCT03801525|448554594|FG002|Overall Study|Reason not Specified|4|||
124707319|NCT04388826|448554598|FG000|Overall Study|Lost to Follow-up|3|||
124707320|NCT04388826|448554599|FG001|Overall Study|Lost to Follow-up|2|||
124707321|NCT04388826|448554598|FG000|Overall Study|Adverse Event|1|||
124707322|NCT04388826|448554599|FG001|Overall Study|Adverse Event|0|||
124707323|NCT00329420|448554600|FG000|Re-induction Phase|Lack of Efficacy|0|||
124707324|NCT00329420|448554601|FG001|Re-induction Phase|Lack of Efficacy|1|||
124707325|NCT00329420|448554602|FG002|Re-induction Phase|Lack of Efficacy|0|||
124707326|NCT00329420|448554600|FG000|Re-induction Phase|Withdrawal of Consent|0|||
124707327|NCT00329420|448554601|FG001|Re-induction Phase|Withdrawal of Consent|0|||
124707328|NCT00329420|448554602|FG002|Re-induction Phase|Withdrawal of Consent|1|||
124707329|NCT00329420|448554600|FG000|Re-induction Phase|Did not respond to re-induction|6|||
124707330|NCT00329420|448554601|FG001|Re-induction Phase|Did not respond to re-induction|5|||
124707331|NCT00329420|448554602|FG002|Re-induction Phase|Did not respond to re-induction|7|||
124707332|NCT00329420|448554600|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
124707333|NCT00329420|448554601|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
124707334|NCT00329420|448554602|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
124707335|NCT00329420|448554600|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
124707336|NCT00329420|448554601|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
124707337|NCT00329420|448554602|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
124707338|NCT00329420|448554600|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
124707339|NCT00329420|448554601|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
124707340|NCT00329420|448554602|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
124707341|NCT02862574|448554603|FG000|Double-Blind Treatment Period|Adverse Event|0|||
124707342|NCT02862574|448554604|FG001|Double-Blind Treatment Period|Adverse Event|1|||
124949856|NCT00103857|449443511|FG003|54-Week Base Study|patient moved|2|||
124459713|NCT01265797|447642335|FG001|Run-in Month|Withdrawal by Subject|4|||
124459714|NCT01265797|447642334|FG000|Run-in Month|1st seizure during run-in month|0|||
124459715|NCT01265797|447642335|FG001|Run-in Month|1st seizure during run-in month|1|||
124949857|NCT00103857|449443512|FG004|54-Week Base Study|patient moved|3|||
124949858|NCT00103857|449443513|FG005|54-Week Base Study|patient moved|1|||
124949859|NCT00103857|449443514|FG006|54-Week Base Study|patient moved|0|||
124949860|NCT00103857|449443508|FG000|54-Week Base Study|non-compliance with study procedures|1|||
124949861|NCT00103857|449443509|FG001|54-Week Base Study|non-compliance with study procedures|2|||
124949862|NCT00103857|449443510|FG002|54-Week Base Study|non-compliance with study procedures|0|||
124949863|NCT00103857|449443511|FG003|54-Week Base Study|non-compliance with study procedures|0|||
124949864|NCT00103857|449443512|FG004|54-Week Base Study|non-compliance with study procedures|0|||
124949865|NCT00103857|449443513|FG005|54-Week Base Study|non-compliance with study procedures|2|||
124949866|NCT00103857|449443514|FG006|54-Week Base Study|non-compliance with study procedures|0|||
124949867|NCT00103857|449443508|FG000|54-Week Base Study|patient incarcerated|0|||
124949868|NCT00103857|449443509|FG001|54-Week Base Study|patient incarcerated|0|||
124949869|NCT00103857|449443510|FG002|54-Week Base Study|patient incarcerated|0|||
124949870|NCT00103857|449443511|FG003|54-Week Base Study|patient incarcerated|0|||
124949871|NCT00103857|449443512|FG004|54-Week Base Study|patient incarcerated|1|||
124949872|NCT00103857|449443513|FG005|54-Week Base Study|patient incarcerated|1|||
124949873|NCT00103857|449443514|FG006|54-Week Base Study|patient incarcerated|0|||
124949874|NCT00103857|449443508|FG000|54-Week Base Study|laboratory reporting error|0|||
124949875|NCT00103857|449443509|FG001|54-Week Base Study|laboratory reporting error|0|||
124949876|NCT00103857|449443510|FG002|54-Week Base Study|laboratory reporting error|0|||
124949877|NCT00103857|449443511|FG003|54-Week Base Study|laboratory reporting error|0|||
124949878|NCT00103857|449443512|FG004|54-Week Base Study|laboratory reporting error|1|||
124949879|NCT00103857|449443513|FG005|54-Week Base Study|laboratory reporting error|0|||
124949880|NCT00103857|449443514|FG006|54-Week Base Study|laboratory reporting error|0|||
124949881|NCT00103857|449443508|FG000|54-Week Base Study|site error|0|||
124949882|NCT00103857|449443509|FG001|54-Week Base Study|site error|0|||
124949883|NCT00103857|449443510|FG002|54-Week Base Study|site error|0|||
124949884|NCT00103857|449443511|FG003|54-Week Base Study|site error|0|||
124949885|NCT00103857|449443512|FG004|54-Week Base Study|site error|0|||
124949886|NCT00103857|449443513|FG005|54-Week Base Study|site error|1|||
124949887|NCT00103857|449443514|FG006|54-Week Base Study|site error|0|||
124949888|NCT00103857|449443508|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
124949889|NCT00103857|449443509|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
124949890|NCT00103857|449443510|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
124949891|NCT00103857|449443511|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
124949892|NCT00103857|449443512|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
124949893|NCT00103857|449443513|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
124949894|NCT00103857|449443514|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
124949895|NCT00103857|449443508|FG000|50-Week Extension Study|Adverse Event|2|||
124949896|NCT00103857|449443509|FG001|50-Week Extension Study|Adverse Event|3|||
124949897|NCT00103857|449443510|FG002|50-Week Extension Study|Adverse Event|2|||
124949898|NCT00103857|449443511|FG003|50-Week Extension Study|Adverse Event|0|||
124949899|NCT00103857|449443512|FG004|50-Week Extension Study|Adverse Event|1|||
124949900|NCT00103857|449443513|FG005|50-Week Extension Study|Adverse Event|1|||
124949901|NCT00103857|449443514|FG006|50-Week Extension Study|Adverse Event|0|||
124949902|NCT00103857|449443508|FG000|50-Week Extension Study|Death|0|||
124949903|NCT00103857|449443509|FG001|50-Week Extension Study|Death|0|||
124949904|NCT00103857|449443510|FG002|50-Week Extension Study|Death|0|||
124949905|NCT00103857|449443511|FG003|50-Week Extension Study|Death|1|||
124949906|NCT00103857|449443512|FG004|50-Week Extension Study|Death|0|||
124459716|NCT01265797|447642334|FG000|Blinded Month|Lack of Efficacy|5|||
124459717|NCT01265797|447642335|FG001|Blinded Month|Lack of Efficacy|0|||
124459718|NCT01265797|447642334|FG000|Blinded Month|Lost to Follow-up|1|||
124949907|NCT00103857|449443513|FG005|50-Week Extension Study|Death|1|||
124949908|NCT00103857|449443514|FG006|50-Week Extension Study|Death|0|||
124949909|NCT00103857|449443508|FG000|50-Week Extension Study|Lack of Efficacy|26|||
124949910|NCT00103857|449443509|FG001|50-Week Extension Study|Lack of Efficacy|15|||
124949911|NCT00103857|449443510|FG002|50-Week Extension Study|Lack of Efficacy|13|||
124949912|NCT00103857|449443511|FG003|50-Week Extension Study|Lack of Efficacy|16|||
124949913|NCT00103857|449443512|FG004|50-Week Extension Study|Lack of Efficacy|8|||
124949914|NCT00103857|449443513|FG005|50-Week Extension Study|Lack of Efficacy|8|||
124949915|NCT00103857|449443514|FG006|50-Week Extension Study|Lack of Efficacy|0|||
124949916|NCT00103857|449443508|FG000|50-Week Extension Study|Lost to Follow-up|4|||
124949917|NCT00103857|449443509|FG001|50-Week Extension Study|Lost to Follow-up|0|||
124949918|NCT00103857|449443510|FG002|50-Week Extension Study|Lost to Follow-up|1|||
124949919|NCT00103857|449443511|FG003|50-Week Extension Study|Lost to Follow-up|4|||
124949920|NCT00103857|449443512|FG004|50-Week Extension Study|Lost to Follow-up|3|||
124949921|NCT00103857|449443513|FG005|50-Week Extension Study|Lost to Follow-up|3|||
124949922|NCT00103857|449443514|FG006|50-Week Extension Study|Lost to Follow-up|0|||
124949923|NCT00103857|449443508|FG000|50-Week Extension Study|Physician Decision|0|||
124949924|NCT00103857|449443509|FG001|50-Week Extension Study|Physician Decision|1|||
124949925|NCT00103857|449443510|FG002|50-Week Extension Study|Physician Decision|1|||
124949926|NCT00103857|449443511|FG003|50-Week Extension Study|Physician Decision|0|||
124949927|NCT00103857|449443512|FG004|50-Week Extension Study|Physician Decision|0|||
124949928|NCT00103857|449443513|FG005|50-Week Extension Study|Physician Decision|0|||
124949929|NCT00103857|449443514|FG006|50-Week Extension Study|Physician Decision|0|||
124949930|NCT00103857|449443508|FG000|50-Week Extension Study|Pregnancy|0|||
124949931|NCT00103857|449443509|FG001|50-Week Extension Study|Pregnancy|0|||
124949932|NCT00103857|449443510|FG002|50-Week Extension Study|Pregnancy|1|||
124949933|NCT00103857|449443511|FG003|50-Week Extension Study|Pregnancy|0|||
124949934|NCT00103857|449443512|FG004|50-Week Extension Study|Pregnancy|1|||
124949935|NCT00103857|449443513|FG005|50-Week Extension Study|Pregnancy|0|||
124949936|NCT00103857|449443514|FG006|50-Week Extension Study|Pregnancy|0|||
124949937|NCT00103857|449443508|FG000|50-Week Extension Study|Protocol Violation|1|||
124949938|NCT00103857|449443509|FG001|50-Week Extension Study|Protocol Violation|1|||
124949939|NCT00103857|449443510|FG002|50-Week Extension Study|Protocol Violation|1|||
124949940|NCT00103857|449443511|FG003|50-Week Extension Study|Protocol Violation|2|||
124949941|NCT00103857|449443512|FG004|50-Week Extension Study|Protocol Violation|0|||
124949942|NCT00103857|449443513|FG005|50-Week Extension Study|Protocol Violation|1|||
124949943|NCT00103857|449443514|FG006|50-Week Extension Study|Protocol Violation|0|||
124949944|NCT00103857|449443508|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
124949945|NCT00103857|449443509|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
124949946|NCT00103857|449443510|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
124949947|NCT00103857|449443511|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
124949948|NCT00103857|449443512|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
124949949|NCT00103857|449443513|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
124949950|NCT00103857|449443514|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
124949951|NCT00103857|449443508|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
124949952|NCT00103857|449443509|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
124949953|NCT00103857|449443510|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
124949954|NCT00103857|449443511|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
124949955|NCT00103857|449443512|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
124949956|NCT00103857|449443513|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
124949957|NCT00103857|449443514|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
124949958|NCT00103857|449443508|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
124949959|NCT00103857|449443509|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
124949960|NCT00103857|449443510|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
124949961|NCT00103857|449443511|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
124949962|NCT00103857|449443512|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
124949963|NCT00103857|449443513|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
124949964|NCT00103857|449443514|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
124949965|NCT00103857|449443508|FG000|50-Week Extension Study|patient moved|0|||
124949966|NCT00103857|449443509|FG001|50-Week Extension Study|patient moved|0|||
124949967|NCT00103857|449443510|FG002|50-Week Extension Study|patient moved|1|||
124949968|NCT00103857|449443511|FG003|50-Week Extension Study|patient moved|2|||
124949969|NCT00103857|449443512|FG004|50-Week Extension Study|patient moved|0|||
124949970|NCT00103857|449443513|FG005|50-Week Extension Study|patient moved|0|||
124459719|NCT01265797|447642335|FG001|Blinded Month|Lost to Follow-up|0|||
124459720|NCT01265797|447642334|FG000|Blinded Month|Protocol Violation|2|||
124459721|NCT01265797|447642335|FG001|Blinded Month|Protocol Violation|1|||
124459722|NCT01265797|447642334|FG000|Blinded Month|Adverse Event|2|||
124459723|NCT01265797|447642335|FG001|Blinded Month|Adverse Event|0|||
124949971|NCT00103857|449443514|FG006|50-Week Extension Study|patient moved|0|||
124459724|NCT01265797|447642334|FG000|Blinded Month|Diary data incomplete|0|||
124459725|NCT01265797|447642335|FG001|Blinded Month|Diary data incomplete|1|||
124766361|NCT04079296|448771701|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
124949972|NCT00103857|449443508|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
124949973|NCT00103857|449443509|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
124949974|NCT00103857|449443510|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
124949975|NCT00103857|449443511|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
124949976|NCT00103857|449443512|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
124949977|NCT00103857|449443513|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
124949978|NCT00103857|449443514|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
124949979|NCT00103857|449443508|FG000|50-Week Extension Study|reason unspecified|0|||
124949980|NCT00103857|449443509|FG001|50-Week Extension Study|reason unspecified|0|||
124949981|NCT00103857|449443510|FG002|50-Week Extension Study|reason unspecified|0|||
124949982|NCT00103857|449443511|FG003|50-Week Extension Study|reason unspecified|0|||
124949983|NCT00103857|449443512|FG004|50-Week Extension Study|reason unspecified|1|||
124949984|NCT00103857|449443513|FG005|50-Week Extension Study|reason unspecified|0|||
124949985|NCT00103857|449443514|FG006|50-Week Extension Study|reason unspecified|0|||
124949986|NCT02132195|449443517|FG000|Initial Assignment|Relapsed|14|||
124949987|NCT02132195|449443518|FG001|Initial Assignment|Relapsed|0|||
124949988|NCT02132195|449443519|FG002|Initial Assignment|Relapsed|0|||
124949989|NCT02132195|449443517|FG000|Rescue Therapy|Relapsed|0|||
124949990|NCT02132195|449443518|FG001|Rescue Therapy|Relapsed|0|||
124949991|NCT02132195|449443519|FG002|Rescue Therapy|Relapsed|7|||
124949992|NCT02132195|449443517|FG000|Rescue Therapy|Physician Decision|0|||
124949993|NCT02132195|449443518|FG001|Rescue Therapy|Physician Decision|0|||
124949994|NCT02132195|449443519|FG002|Rescue Therapy|Physician Decision|1|||
124949995|NCT02132195|449443517|FG000|Rescue Therapy|Withdrawal by Subject|0|||
124949996|NCT02132195|449443518|FG001|Rescue Therapy|Withdrawal by Subject|0|||
124949997|NCT02132195|449443519|FG002|Rescue Therapy|Withdrawal by Subject|1|||
124949998|NCT02132195|449443517|FG000|Rescue Therapy|Adverse Event|0|||
124949999|NCT02132195|449443518|FG001|Rescue Therapy|Adverse Event|0|||
124950000|NCT02132195|449443519|FG002|Rescue Therapy|Adverse Event|2|||
124950001|NCT03065400|449443522|FG000|Overall Study|Adverse Event|1|||
124950002|NCT03065400|449443522|FG000|Overall Study|Physician Decision|3|||
124950003|NCT03065400|449443522|FG000|Overall Study|Withdrawal by Subject|1|||
124950004|NCT03065400|449443522|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
124950005|NCT02102724|449443523|FG000|Overall Study|Lost to Follow-up|1|||
124950006|NCT02102724|449443524|FG001|Overall Study|Lost to Follow-up|0|||
124950007|NCT02102724|449443523|FG000|Overall Study|surgery for brain aneurysm|1|||
124950008|NCT02102724|449443524|FG001|Overall Study|surgery for brain aneurysm|1|||
124950009|NCT03072862|449443525|FG000|Overall Study|Withdrawal by Subject|4|||
124950010|NCT03072862|449443525|FG000|Overall Study|Lost to Follow-up|6|||
124950011|NCT03072862|449443525|FG000|Overall Study|Protocol Violation|4|||
124950012|NCT03072862|449443525|FG000|Overall Study|Physician Decision|2|||
124950013|NCT03072862|449443525|FG000|Overall Study|Death|1|||
124950014|NCT03072862|449443525|FG000|Overall Study|Adverse Event|1|||
124950015|NCT02203513|449443526|FG000|Overall Study|Refused further treatment|2|||
124950016|NCT02203513|449443527|FG001|Overall Study|Refused further treatment|0|||
124950017|NCT02203513|449443528|FG002|Overall Study|Refused further treatment|1|||
124950018|NCT02203513|449443529|FG003|Overall Study|Refused further treatment|0|||
124950019|NCT02203513|449443530|FG004|Overall Study|Refused further treatment|0|||
124950020|NCT02203513|449443526|FG000|Overall Study|Switched to alternative treatment|3|||
124950021|NCT02203513|449443527|FG001|Overall Study|Switched to alternative treatment|4|||
124950022|NCT02203513|449443528|FG002|Overall Study|Switched to alternative treatment|0|||
124950023|NCT02203513|449443529|FG003|Overall Study|Switched to alternative treatment|0|||
124950024|NCT02203513|449443530|FG004|Overall Study|Switched to alternative treatment|4|||
124950025|NCT02203513|449443526|FG000|Overall Study|Did not receive investigational product (IP)|0|||
124950026|NCT02203513|449443527|FG001|Overall Study|Did not receive investigational product (IP)|1|||
124950027|NCT02203513|449443528|FG002|Overall Study|Did not receive investigational product (IP)|0|||
124950028|NCT02203513|449443529|FG003|Overall Study|Did not receive investigational product (IP)|0|||
124950029|NCT02203513|449443530|FG004|Overall Study|Did not receive investigational product (IP)|0|||
124950030|NCT02203513|449443526|FG000|Overall Study|Death (unrelated to study therapy)|1|||
124950031|NCT02203513|449443527|FG001|Overall Study|Death (unrelated to study therapy)|3|||
124950032|NCT02203513|449443528|FG002|Overall Study|Death (unrelated to study therapy)|1|||
124950033|NCT02203513|449443529|FG003|Overall Study|Death (unrelated to study therapy)|0|||
124950034|NCT02203513|449443530|FG004|Overall Study|Death (unrelated to study therapy)|2|||
124950035|NCT02203513|449443526|FG000|Overall Study|Lost to Follow-up|0|||
124950036|NCT02203513|449443527|FG001|Overall Study|Lost to Follow-up|0|||
124950037|NCT02203513|449443528|FG002|Overall Study|Lost to Follow-up|1|||
124950038|NCT02203513|449443529|FG003|Overall Study|Lost to Follow-up|1|||
124950039|NCT02203513|449443530|FG004|Overall Study|Lost to Follow-up|0|||
124950040|NCT02513667|449443531|FG000|Overall Study|Withdrawal by Subject|0|||
124950041|NCT02513667|449443532|FG001|Overall Study|Withdrawal by Subject|1|||
124950042|NCT01964547|449443543|FG000|Overall Study|Adverse Event|8|||
124548706|NCT03692078|447965324|FG004|Overall Study|Adverse Event|0|||
124548707|NCT03692078|447965325|FG005|Overall Study|Adverse Event|1|||
124548708|NCT03692078|447965326|FG006|Overall Study|Adverse Event|0|||
124950043|NCT01964547|449443544|FG001|Overall Study|Adverse Event|2|||
124950044|NCT01964547|449443543|FG000|Overall Study|Withdrawal by Subject|4|||
124950045|NCT01964547|449443544|FG001|Overall Study|Withdrawal by Subject|7|||
124950046|NCT01964547|449443543|FG000|Overall Study|Lost to Follow-up|0|||
124950047|NCT01964547|449443544|FG001|Overall Study|Lost to Follow-up|1|||
124950048|NCT01964547|449443543|FG000|Overall Study|Withdrawal by Investigator|0|||
124950049|NCT01964547|449443544|FG001|Overall Study|Withdrawal by Investigator|1|||
124950050|NCT00912964|449443545|FG000|Overall Study|Eligibility criterion not met|1|||
124950051|NCT00912964|449443546|FG001|Overall Study|Eligibility criterion not met|1|||
124950052|NCT00912964|449443547|FG002|Overall Study|Eligibility criterion not met|0|||
124950053|NCT00912964|449443545|FG000|Overall Study|Adverse Event|15|||
124950054|NCT00912964|449443546|FG001|Overall Study|Adverse Event|18|||
124950055|NCT00912964|449443547|FG002|Overall Study|Adverse Event|12|||
124950056|NCT00912964|449443545|FG000|Overall Study|Lack of Efficacy|11|||
124950057|NCT00912964|449443546|FG001|Overall Study|Lack of Efficacy|4|||
124950058|NCT00912964|449443547|FG002|Overall Study|Lack of Efficacy|3|||
124950059|NCT00912964|449443545|FG000|Overall Study|Withdrawal by Subject|20|||
124950060|NCT00912964|449443546|FG001|Overall Study|Withdrawal by Subject|12|||
124950061|NCT00912964|449443547|FG002|Overall Study|Withdrawal by Subject|18|||
124950062|NCT00912964|449443545|FG000|Overall Study|Lost to Follow-up|4|||
124950063|NCT00912964|449443546|FG001|Overall Study|Lost to Follow-up|3|||
124950064|NCT00912964|449443547|FG002|Overall Study|Lost to Follow-up|3|||
124950065|NCT00912964|449443545|FG000|Overall Study|Protocol Violation|5|||
124950066|NCT00912964|449443546|FG001|Overall Study|Protocol Violation|3|||
124950067|NCT00912964|449443547|FG002|Overall Study|Protocol Violation|8|||
124950068|NCT00912964|449443545|FG000|Overall Study|Taking exclusionary medications|7|||
124950069|NCT00912964|449443546|FG001|Overall Study|Taking exclusionary medications|4|||
124950070|NCT00912964|449443547|FG002|Overall Study|Taking exclusionary medications|8|||
124950071|NCT00912964|449443545|FG000|Overall Study|Medical History|1|||
124950072|NCT00912964|449443546|FG001|Overall Study|Medical History|0|||
124950073|NCT00912964|449443547|FG002|Overall Study|Medical History|0|||
124950074|NCT00912964|449443545|FG000|Overall Study|Non-compliance with study procedures|2|||
124950075|NCT00912964|449443546|FG001|Overall Study|Non-compliance with study procedures|0|||
124950076|NCT00912964|449443547|FG002|Overall Study|Non-compliance with study procedures|0|||
124950077|NCT00912964|449443545|FG000|Overall Study|Violation of exclusion criterion|0|||
124950078|NCT00912964|449443546|FG001|Overall Study|Violation of exclusion criterion|0|||
124950079|NCT00912964|449443547|FG002|Overall Study|Violation of exclusion criterion|2|||
124950080|NCT00912964|449443545|FG000|Overall Study|Randomized but never received study drug|0|||
124950081|NCT00912964|449443546|FG001|Overall Study|Randomized but never received study drug|1|||
124950082|NCT00912964|449443547|FG002|Overall Study|Randomized but never received study drug|0|||
124950083|NCT02978716|449443548|FG000|Overall Study|Death|25|||
124950084|NCT02978716|449443549|FG001|Overall Study|Death|13|||
124548709|NCT03692078|447965320|FG000|Overall Study|Enrollment Closed|5|||
124548710|NCT03692078|447965321|FG001|Overall Study|Enrollment Closed|0|||
124548711|NCT03692078|447965322|FG002|Overall Study|Enrollment Closed|0|||
124548712|NCT03692078|447965323|FG003|Overall Study|Enrollment Closed|0|||
124548713|NCT03692078|447965324|FG004|Overall Study|Enrollment Closed|0|||
124548714|NCT03692078|447965325|FG005|Overall Study|Enrollment Closed|0|||
124548715|NCT03692078|447965326|FG006|Overall Study|Enrollment Closed|0|||
124548716|NCT03692078|447965320|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
124548717|NCT03692078|447965321|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
124548718|NCT03692078|447965322|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
124548719|NCT03692078|447965323|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
124950085|NCT02978716|449443550|FG002|Overall Study|Death|20|||
124548720|NCT03692078|447965324|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
124950086|NCT02978716|449443548|FG000|Overall Study|Lost to Follow-up|0|||
124950087|NCT02978716|449443549|FG001|Overall Study|Lost to Follow-up|0|||
124950088|NCT02978716|449443550|FG002|Overall Study|Lost to Follow-up|1|||
124950089|NCT02978716|449443548|FG000|Overall Study|Withdrawal by Subject|6|||
124950090|NCT02978716|449443549|FG001|Overall Study|Withdrawal by Subject|4|||
124950091|NCT02978716|449443550|FG002|Overall Study|Withdrawal by Subject|5|||
124950092|NCT02978716|449443548|FG000|Overall Study|Sponsor terminated|2|||
124950093|NCT02978716|449443549|FG001|Overall Study|Sponsor terminated|13|||
124950094|NCT02978716|449443550|FG002|Overall Study|Sponsor terminated|9|||
124950095|NCT02978716|449443548|FG000|Overall Study|Other|1|||
124950096|NCT02978716|449443549|FG001|Overall Study|Other|3|||
124707343|NCT02862574|448554605|FG002|Double-Blind Treatment Period|Adverse Event|0|||
124459726|NCT01265797|447642334|FG000|Open Label Month|Lost to Follow-up|0|||
124459727|NCT01265797|447642335|FG001|Open Label Month|Lost to Follow-up|1|||
124459728|NCT02813694|447642336|FG000|Overall Study|Physician Decision|0|||
124459729|NCT02813694|447642337|FG001|Overall Study|Physician Decision|1|||
124459730|NCT02813694|447642336|FG000|Overall Study|Withdrawal by Subject|10|||
124459731|NCT02813694|447642337|FG001|Overall Study|Withdrawal by Subject|9|||
124459732|NCT02813694|447642336|FG000|Overall Study|Lost to Follow-up|1|||
124459733|NCT02813694|447642337|FG001|Overall Study|Lost to Follow-up|1|||
124459734|NCT02813694|447642336|FG000|Overall Study|Death|3|||
124459735|NCT02813694|447642337|FG001|Overall Study|Death|3|||
124459736|NCT02813694|447642336|FG000|Overall Study|Randomized- did not receive study drug|2|||
124459737|NCT02813694|447642337|FG001|Overall Study|Randomized- did not receive study drug|0|||
124459738|NCT02813694|447642336|FG000|Overall Study|Patient hospitalized|1|||
124459739|NCT02813694|447642337|FG001|Overall Study|Patient hospitalized|0|||
124459740|NCT04041284|447642339|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
124459741|NCT04041284|447642340|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
124459742|NCT04041284|447642339|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
124459743|NCT04041284|447642340|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
124459744|NCT04041284|447642339|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
124459745|NCT04041284|447642340|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
124459746|NCT04041284|447642339|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
124459747|NCT04041284|447642340|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
124459748|NCT04041284|447642339|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
124459749|NCT04041284|447642340|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
124459750|NCT04041284|447642339|FG000|DB Phase (12 Weeks)|Other than specified|1|||
124459751|NCT04041284|447642340|FG001|DB Phase (12 Weeks)|Other than specified|0|||
124459752|NCT04041284|447642339|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
124459753|NCT04041284|447642340|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
124459754|NCT04041284|447642339|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
124459755|NCT04041284|447642340|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
124459756|NCT04041284|447642339|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
124459757|NCT04041284|447642340|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
124459758|NCT04041284|447642339|FG000|OL Phase (12 Weeks)|Other than specified|6|||
124459759|NCT04041284|447642340|FG001|OL Phase (12 Weeks)|Other than specified|2|||
124459760|NCT02980224|447642341|FG000|Overall Study|Adverse Event|4|||
124459761|NCT02980224|447642342|FG001|Overall Study|Adverse Event|1|||
124707344|NCT02862574|448554603|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
124950097|NCT02978716|449443550|FG002|Overall Study|Other|0|||
124950098|NCT00960206|449443551|FG000|Overall Study|Death|7|||
124950099|NCT00960206|449443552|FG001|Overall Study|Death|4|||
124950100|NCT00960206|449443553|FG002|Overall Study|Death|1|||
124950101|NCT00960206|449443551|FG000|Overall Study|Unwilling/Unable to return|1|||
124950102|NCT00960206|449443552|FG001|Overall Study|Unwilling/Unable to return|2|||
124950103|NCT00960206|449443553|FG002|Overall Study|Unwilling/Unable to return|0|||
124950104|NCT00960206|449443551|FG000|Overall Study|Lost to Follow-up|8|||
124950105|NCT00960206|449443552|FG001|Overall Study|Lost to Follow-up|14|||
124950106|NCT00960206|449443553|FG002|Overall Study|Lost to Follow-up|8|||
124950107|NCT00960206|449443551|FG000|Overall Study|Withdrawal by Subject|2|||
124950108|NCT00960206|449443552|FG001|Overall Study|Withdrawal by Subject|4|||
124950109|NCT00960206|449443553|FG002|Overall Study|Withdrawal by Subject|0|||
124950110|NCT00960206|449443551|FG000|Overall Study|Revision of study component|2|||
124950111|NCT00960206|449443552|FG001|Overall Study|Revision of study component|2|||
124950112|NCT00960206|449443553|FG002|Overall Study|Revision of study component|2|||
124950113|NCT00960206|449443551|FG000|Overall Study|Missing 10 year data|20|||
124950114|NCT00960206|449443552|FG001|Overall Study|Missing 10 year data|1|||
124950115|NCT00960206|449443553|FG002|Overall Study|Missing 10 year data|1|||
124950116|NCT02470806|449443554|FG000|Overall Study|Lost to Follow-up|1|||
124950117|NCT02470806|449443555|FG001|Overall Study|Lost to Follow-up|1|||
124950118|NCT02470806|449443554|FG000|Overall Study|Adverse Event|5|||
124950119|NCT02470806|449443555|FG001|Overall Study|Adverse Event|2|||
124950120|NCT02470806|449443554|FG000|Overall Study|Protocol Violation|4|||
124950121|NCT02470806|449443555|FG001|Overall Study|Protocol Violation|11|||
124950122|NCT02470806|449443554|FG000|Overall Study|Physician Decision|0|||
124950123|NCT02470806|449443555|FG001|Overall Study|Physician Decision|3|||
124950124|NCT02470806|449443554|FG000|Overall Study|Withdrawal by Subject|3|||
124950125|NCT02470806|449443555|FG001|Overall Study|Withdrawal by Subject|10|||
124950126|NCT02470806|449443554|FG000|Overall Study|Lack of Efficacy|5|||
124950127|NCT02470806|449443555|FG001|Overall Study|Lack of Efficacy|15|||
124950128|NCT01147471|449443556|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
124950129|NCT01147471|449443557|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
124950130|NCT01147471|449443556|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
124950131|NCT01147471|449443557|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
124950132|NCT01147471|449443556|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
124950133|NCT01147471|449443557|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
124950134|NCT01147471|449443556|FG000|3 Month Follow Up|Lost to Follow-up|1|||
124950135|NCT01147471|449443557|FG001|3 Month Follow Up|Lost to Follow-up|1|||
124950136|NCT01147471|449443556|FG000|3 Month Follow Up|Physician Decision|0|||
124950137|NCT01147471|449443557|FG001|3 Month Follow Up|Physician Decision|1|||
124950138|NCT01147471|449443556|FG000|6 Month Follow Up|Lost to Follow-up|4|||
124950139|NCT01147471|449443557|FG001|6 Month Follow Up|Lost to Follow-up|2|||
124950140|NCT01294644|449443565|FG000|Overall Study|Adverse Event|2|||
124950141|NCT01294644|449443566|FG001|Overall Study|Adverse Event|0|||
124950142|NCT01294644|449443567|FG002|Overall Study|Adverse Event|1|||
124950143|NCT01294644|449443565|FG000|Overall Study|Withdrawal by Subject|3|||
124950144|NCT01294644|449443566|FG001|Overall Study|Withdrawal by Subject|7|||
124950145|NCT01294644|449443567|FG002|Overall Study|Withdrawal by Subject|4|||
124950146|NCT01294644|449443565|FG000|Overall Study|Lost to Follow-up|3|||
124950147|NCT01294644|449443566|FG001|Overall Study|Lost to Follow-up|2|||
124950148|NCT01294644|449443567|FG002|Overall Study|Lost to Follow-up|5|||
124950149|NCT01294644|449443565|FG000|Overall Study|Miscellaneous Reason|2|||
124950150|NCT01294644|449443566|FG001|Overall Study|Miscellaneous Reason|1|||
124950151|NCT01294644|449443567|FG002|Overall Study|Miscellaneous Reason|4|||
124950152|NCT03075878|449443568|FG000|Overall Study|Physician Decision|1|||
124950153|NCT02188459|449443569|FG000|Overall Study|Lost to Follow-up|3|||
124950154|NCT02188459|449443570|FG001|Overall Study|Lost to Follow-up|4|||
124950155|NCT02188459|449443569|FG000|Overall Study|Early Termination|0|||
124950156|NCT02188459|449443570|FG001|Overall Study|Early Termination|3|||
124950157|NCT01986348|449443571|FG000|Overall Study|Death|8|||
124950158|NCT01986348|449443572|FG001|Overall Study|Death|22|||
124950159|NCT01986348|449443573|FG002|Overall Study|Death|10|||
124950160|NCT01986348|449443574|FG003|Overall Study|Death|21|||
124548721|NCT03692078|447965325|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
124950161|NCT01986348|449443571|FG000|Overall Study|Lost to Follow-up|0|||
124950162|NCT01986348|449443572|FG001|Overall Study|Lost to Follow-up|0|||
124950163|NCT01986348|449443573|FG002|Overall Study|Lost to Follow-up|0|||
124950164|NCT01986348|449443574|FG003|Overall Study|Lost to Follow-up|2|||
124950165|NCT01986348|449443571|FG000|Overall Study|Physician Decision|0|||
124950166|NCT01986348|449443572|FG001|Overall Study|Physician Decision|0|||
124950167|NCT01986348|449443573|FG002|Overall Study|Physician Decision|0|||
124950168|NCT01986348|449443574|FG003|Overall Study|Physician Decision|1|||
124950169|NCT01986348|449443571|FG000|Overall Study|Progressive Disease|0|||
124950170|NCT01986348|449443572|FG001|Overall Study|Progressive Disease|0|||
124950171|NCT01986348|449443573|FG002|Overall Study|Progressive Disease|2|||
124950172|NCT01986348|449443574|FG003|Overall Study|Progressive Disease|0|||
124950173|NCT01986348|449443571|FG000|Overall Study|Withdrawal by Participant|0|||
124950174|NCT01986348|449443572|FG001|Overall Study|Withdrawal by Participant|1|||
124950175|NCT01986348|449443573|FG002|Overall Study|Withdrawal by Participant|2|||
124950176|NCT01986348|449443574|FG003|Overall Study|Withdrawal by Participant|1|||
124950177|NCT01986348|449443571|FG000|Overall Study|Study Terminated by Sponsor|0|||
124950178|NCT01986348|449443572|FG001|Overall Study|Study Terminated by Sponsor|0|||
124950179|NCT01986348|449443573|FG002|Overall Study|Study Terminated by Sponsor|0|||
124950180|NCT01986348|449443574|FG003|Overall Study|Study Terminated by Sponsor|3|||
124950181|NCT01986348|449443571|FG000|Overall Study|Other-unspecified|0|||
124950182|NCT01986348|449443572|FG001|Overall Study|Other-unspecified|1|||
124950183|NCT01986348|449443573|FG002|Overall Study|Other-unspecified|0|||
124950184|NCT01986348|449443574|FG003|Overall Study|Other-unspecified|2|||
124950185|NCT02935894|449443579|FG000|Overall Study|Subject dismissed|1|||
124950186|NCT00853957|449443580|FG000|Overall Study|Adverse Event|9|||
124950187|NCT00853957|449443581|FG001|Overall Study|Adverse Event|3|||
124950188|NCT00853957|449443580|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124950189|NCT00853957|449443581|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124950190|NCT00853957|449443580|FG000|Overall Study|Subject withdrew consent|4|||
124950191|NCT00853957|449443581|FG001|Overall Study|Subject withdrew consent|5|||
124950192|NCT00853957|449443580|FG000|Overall Study|Lost to Follow-up|1|||
124950193|NCT00853957|449443581|FG001|Overall Study|Lost to Follow-up|6|||
124950194|NCT00853957|449443580|FG000|Overall Study|Protocol deviation|0|||
124950195|NCT00853957|449443581|FG001|Overall Study|Protocol deviation|3|||
124950196|NCT02158806|449443582|FG000|Overall Study|Death|2|||
124950197|NCT02158806|449443583|FG001|Overall Study|Death|0|||
124950198|NCT02158806|449443582|FG000|Overall Study|Withdrawal by Subject|2|||
124950199|NCT02158806|449443583|FG001|Overall Study|Withdrawal by Subject|0|||
124950200|NCT02158806|449443582|FG000|Overall Study|Lost to Follow-up|0|||
124950201|NCT02158806|449443583|FG001|Overall Study|Lost to Follow-up|3|||
124950202|NCT02158806|449443582|FG000|Overall Study|Moved out of area|0|||
124950203|NCT02158806|449443583|FG001|Overall Study|Moved out of area|1|||
124950204|NCT02158806|449443582|FG000|Overall Study|Transferred to palliative care|0|||
124950205|NCT02158806|449443583|FG001|Overall Study|Transferred to palliative care|1|||
124950206|NCT01898299|449443587|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
124950207|NCT01898299|449443588|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
124950208|NCT04895085|449443589|FG000|Overall Study|Death|1|||
124950209|NCT04895085|449443589|FG000|Overall Study|Withdrawal by Subject|1|||
124950210|NCT04895085|449443589|FG000|Overall Study|No longer eligible: Moved from area|1|||
124950211|NCT04919499|449443590|FG000|Overall Study|Adverse Event|0|||
124950212|NCT04919499|449443591|FG001|Overall Study|Adverse Event|0|||
124950213|NCT04919499|449443592|FG002|Overall Study|Adverse Event|0|||
124950214|NCT04919499|449443593|FG003|Overall Study|Adverse Event|0|||
124950215|NCT04919499|449443594|FG004|Overall Study|Adverse Event|2|||
124950216|NCT04919499|449443590|FG000|Overall Study|Not treated|0|||
124950217|NCT04919499|449443591|FG001|Overall Study|Not treated|0|||
124950218|NCT04919499|449443592|FG002|Overall Study|Not treated|0|||
124950219|NCT04919499|449443593|FG003|Overall Study|Not treated|1|||
124950220|NCT04919499|449443594|FG004|Overall Study|Not treated|0|||
124950221|NCT04520256|449443598|FG000|Overall Study|Lost to Follow-up|6|||
124950222|NCT04520256|449443599|FG001|Overall Study|Lost to Follow-up|4|||
124950223|NCT04520256|449443600|FG002|Overall Study|Lost to Follow-up|2|||
124950224|NCT04520256|449443601|FG003|Overall Study|Lost to Follow-up|3|||
124950225|NCT04520256|449443602|FG004|Overall Study|Lost to Follow-up|6|||
124950226|NCT04520256|449443603|FG005|Overall Study|Lost to Follow-up|6|||
124950227|NCT04520256|449443604|FG006|Overall Study|Lost to Follow-up|4|||
124950228|NCT04520256|449443605|FG007|Overall Study|Lost to Follow-up|6|||
124950229|NCT04520256|449443606|FG008|Overall Study|Lost to Follow-up|1|||
124950230|NCT04520256|449443607|FG009|Overall Study|Lost to Follow-up|3|||
124950231|NCT04520256|449443608|FG010|Overall Study|Lost to Follow-up|3|||
124548722|NCT03692078|447965326|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
124950232|NCT04520256|449443609|FG011|Overall Study|Lost to Follow-up|2|||
124950233|NCT04520256|449443610|FG012|Overall Study|Lost to Follow-up|5|||
124950234|NCT04520256|449443611|FG013|Overall Study|Lost to Follow-up|3|||
124950235|NCT04520256|449443612|FG014|Overall Study|Lost to Follow-up|3|||
124950236|NCT04520256|449443613|FG015|Overall Study|Lost to Follow-up|6|||
124950237|NCT04520256|449443614|FG016|Overall Study|Lost to Follow-up|6|||
124950238|NCT04520256|449443615|FG017|Overall Study|Lost to Follow-up|4|||
124950239|NCT04520256|449443616|FG018|Overall Study|Lost to Follow-up|3|||
124950240|NCT04520256|449443617|FG019|Overall Study|Lost to Follow-up|3|||
124950241|NCT04520256|449443618|FG020|Overall Study|Lost to Follow-up|7|||
124950242|NCT04520256|449443619|FG021|Overall Study|Lost to Follow-up|3|||
124950243|NCT04520256|449443620|FG022|Overall Study|Lost to Follow-up|3|||
124950244|NCT04520256|449443621|FG023|Overall Study|Lost to Follow-up|8|||
124950245|NCT04520256|449443622|FG024|Overall Study|Lost to Follow-up|5|||
124950246|NCT04520256|449443623|FG025|Overall Study|Lost to Follow-up|4|||
124950247|NCT04520256|449443624|FG026|Overall Study|Lost to Follow-up|3|||
124950248|NCT04520256|449443625|FG027|Overall Study|Lost to Follow-up|4|||
124950249|NCT04520256|449443626|FG028|Overall Study|Lost to Follow-up|3|||
124950250|NCT04520256|449443627|FG029|Overall Study|Lost to Follow-up|4|||
124950251|NCT04520256|449443628|FG030|Overall Study|Lost to Follow-up|4|||
124950252|NCT04520256|449443629|FG031|Overall Study|Lost to Follow-up|4|||
124950253|NCT03786471|449443630|FG000|Overall Study|Death|254|||
124950254|NCT03786471|449443631|FG001|Overall Study|Death|223|||
124950255|NCT03786471|449443632|FG002|Overall Study|Death|37|||
124950256|NCT03786471|449443630|FG000|Overall Study|Lost to Follow-up|63|||
124950257|NCT03786471|449443631|FG001|Overall Study|Lost to Follow-up|50|||
124950258|NCT03786471|449443632|FG002|Overall Study|Lost to Follow-up|15|||
124950259|NCT03786471|449443630|FG000|Overall Study|Withdrawal by Subject|99|||
124950260|NCT03786471|449443631|FG001|Overall Study|Withdrawal by Subject|81|||
124950261|NCT03786471|449443632|FG002|Overall Study|Withdrawal by Subject|11|||
124969599|NCT03520075|449517417|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969600|NCT03520075|449517418|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969601|NCT03520075|449517419|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969602|NCT03520075|449517420|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969603|NCT03520075|449517421|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969604|NCT03520075|449517422|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969605|NCT03520075|449517423|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
124969606|NCT03520075|449517424|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
124969607|NCT03520075|449517425|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969608|NCT03520075|449517426|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
124969609|NCT03520075|449517427|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
124969610|NCT03520075|449517409|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969611|NCT03520075|449517410|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969612|NCT03520075|449517411|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969613|NCT03520075|449517412|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969614|NCT03520075|449517413|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969615|NCT03520075|449517414|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969616|NCT03520075|449517415|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969617|NCT03520075|449517416|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969618|NCT03520075|449517417|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969619|NCT03520075|449517418|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969620|NCT03520075|449517419|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969621|NCT03520075|449517420|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969622|NCT03520075|449517421|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969623|NCT03520075|449517422|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
124969624|NCT03520075|449517423|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969625|NCT03520075|449517424|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969626|NCT03520075|449517425|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
124969627|NCT03520075|449517426|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
124969628|NCT03520075|449517427|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
124969629|NCT05382039|449517428|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
124969630|NCT05382039|449517429|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
124969631|NCT05382039|449517430|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
124969632|NCT05382039|449517428|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
124969633|NCT05382039|449517429|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
124969634|NCT05382039|449517430|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
124969635|NCT05382039|449517428|FG000|Overall Study|waiting for confirmation|0|||
124969636|NCT05382039|449517429|FG001|Overall Study|waiting for confirmation|0|||
124969637|NCT05382039|449517430|FG002|Overall Study|waiting for confirmation|1|||
124969638|NCT01432626|449517431|FG000|Overall Study|LV function recovered|2|||
124969639|NCT01432626|449517431|FG000|Overall Study|Withdrawal by Subject|2|||
124969640|NCT01432626|449517431|FG000|Overall Study|Only 1 image competed|2|||
124969641|NCT01432626|449517431|FG000|Overall Study|Imaging agent not available|1|||
124459762|NCT02980224|447642341|FG000|Overall Study|Withdrawal by Subject|0|||
124459763|NCT02980224|447642342|FG001|Overall Study|Withdrawal by Subject|2|||
124459764|NCT00606320|447642343|FG000|Overall Study|Adverse Event|3|||
124459765|NCT00606320|447642343|FG000|Overall Study|Lack of Efficacy|5|||
124459766|NCT00606320|447642343|FG000|Overall Study|Physician Decision|7|||
124459767|NCT00606320|447642343|FG000|Overall Study|Protocol Violation|8|||
124459768|NCT00606320|447642343|FG000|Overall Study|Withdrawal by Subject|10|||
124459769|NCT00606320|447642343|FG000|Overall Study|Progression to depressive phase|4|||
124459770|NCT00563186|447642344|FG000|Overall Study|LOS<48 hours|97|||
124459771|NCT00563186|447642345|FG001|Overall Study|LOS<48 hours|74|||
124459772|NCT00563186|447642344|FG000|Overall Study|Incomplete data|1|||
124459773|NCT00563186|447642345|FG001|Overall Study|Incomplete data|1|||
124459774|NCT04839380|447642346|FG000|Overall Study|Withdrawal by Subject|2|||
124459775|NCT04839380|447642346|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
124459776|NCT01087905|447642347|FG000|Overall Study|Lost to Follow-up|24|||
124548723|NCT03692078|447965320|FG000|Overall Study|Withdrawal by Subject|0|||
124548724|NCT03692078|447965321|FG001|Overall Study|Withdrawal by Subject|2|||
124950262|NCT04369664|449445336|FG000|Overall Study|Physician Decision|1|||
124950263|NCT04369664|449445337|FG001|Overall Study|Physician Decision|0|||
124950264|NCT03840200|449445338|FG000|Overall Study|Death|6|||
124950265|NCT03840200|449445339|FG001|Overall Study|Death|3|||
124950266|NCT03840200|449445340|FG002|Overall Study|Death|6|||
124950267|NCT03840200|449445341|FG003|Overall Study|Death|10|||
124950268|NCT03840200|449445338|FG000|Overall Study|Reason Not Specified|2|||
124950269|NCT03840200|449445339|FG001|Overall Study|Reason Not Specified|2|||
124950270|NCT03840200|449445340|FG002|Overall Study|Reason Not Specified|1|||
124950271|NCT03840200|449445341|FG003|Overall Study|Reason Not Specified|15|||
124950272|NCT03840200|449445338|FG000|Overall Study|Physician Decision|0|||
124950273|NCT03840200|449445339|FG001|Overall Study|Physician Decision|0|||
124950274|NCT03840200|449445340|FG002|Overall Study|Physician Decision|0|||
124950275|NCT03840200|449445341|FG003|Overall Study|Physician Decision|2|||
124950276|NCT03840200|449445338|FG000|Overall Study|Progressive Disease|0|||
124950277|NCT03840200|449445339|FG001|Overall Study|Progressive Disease|0|||
124950278|NCT03840200|449445340|FG002|Overall Study|Progressive Disease|0|||
124950279|NCT03840200|449445341|FG003|Overall Study|Progressive Disease|1|||
124950280|NCT03840200|449445338|FG000|Overall Study|Withdrawal by Subject|0|||
124950281|NCT03840200|449445339|FG001|Overall Study|Withdrawal by Subject|1|||
124950282|NCT03840200|449445340|FG002|Overall Study|Withdrawal by Subject|0|||
124950283|NCT03840200|449445341|FG003|Overall Study|Withdrawal by Subject|2|||
124950284|NCT05487300|449445346|FG000|Overall Study|Withdrawal by Subject|1|||
124950285|NCT05487300|449445347|FG001|Overall Study|Withdrawal by Subject|0|||
124950286|NCT02880293|449445350|FG000|Overall Study|Inevaluable|5|||
124950287|NCT00264576|449445351|FG000|Overall Study|Lost to Follow-up|1|||
124950288|NCT00264576|449445352|FG001|Overall Study|Lost to Follow-up|1|||
124950289|NCT03976102|449445357|FG000|Overall Study|Withdrawal by Subject|4|||
124950290|NCT03976102|449445358|FG001|Overall Study|Withdrawal by Subject|4|||
124950291|NCT03976102|449445357|FG000|Overall Study|Adverse Event|2|||
124950292|NCT03976102|449445358|FG001|Overall Study|Adverse Event|4|||
124950293|NCT03976102|449445357|FG000|Overall Study|Not related to Covid-19|9|||
124950294|NCT03976102|449445358|FG001|Overall Study|Not related to Covid-19|13|||
124950295|NCT03976102|449445357|FG000|Overall Study|Lost to Follow-up|0|||
124950296|NCT03976102|449445358|FG001|Overall Study|Lost to Follow-up|2|||
124950297|NCT03976102|449445357|FG000|Overall Study|Death|3|||
124950298|NCT03976102|449445358|FG001|Overall Study|Death|2|||
124950299|NCT03976102|449445357|FG000|Overall Study|Physician Decision|1|||
124950300|NCT03976102|449445358|FG001|Overall Study|Physician Decision|1|||
124950301|NCT00092456|449445364|FG000|Overall Study|Adverse Event|0|||
124950302|NCT00092456|449445365|FG001|Overall Study|Adverse Event|0|||
124950303|NCT00092456|449445366|FG002|Overall Study|Adverse Event|1|||
124459777|NCT01087905|447642348|FG001|Overall Study|Lost to Follow-up|28|||
124459778|NCT01087905|447642349|FG002|Overall Study|Lost to Follow-up|18|||
124459779|NCT01087905|447642350|FG003|Overall Study|Lost to Follow-up|31|||
124459780|NCT01087905|447642351|FG004|Overall Study|Lost to Follow-up|27|||
124459781|NCT01087905|447642352|FG005|Overall Study|Lost to Follow-up|25|||
124459782|NCT01087905|447642353|FG006|Overall Study|Lost to Follow-up|20|||
124459783|NCT01087905|447642354|FG007|Overall Study|Lost to Follow-up|24|||
124459784|NCT01087905|447642347|FG000|Overall Study|Withdrawal by Subject|5|||
124459785|NCT01087905|447642348|FG001|Overall Study|Withdrawal by Subject|4|||
124459786|NCT01087905|447642349|FG002|Overall Study|Withdrawal by Subject|4|||
124459787|NCT01087905|447642350|FG003|Overall Study|Withdrawal by Subject|5|||
124459788|NCT01087905|447642351|FG004|Overall Study|Withdrawal by Subject|4|||
124459789|NCT01087905|447642352|FG005|Overall Study|Withdrawal by Subject|3|||
124459790|NCT01087905|447642353|FG006|Overall Study|Withdrawal by Subject|3|||
124459791|NCT01087905|447642354|FG007|Overall Study|Withdrawal by Subject|5|||
124459792|NCT00886600|447642355|FG000|Double-blind Monotherapy|Adverse Event|1|||
124459793|NCT00886600|447642356|FG001|Double-blind Monotherapy|Adverse Event|1|||
124459794|NCT00886600|447642357|FG002|Double-blind Monotherapy|Adverse Event|1|||
124459795|NCT00886600|447642358|FG003|Double-blind Monotherapy|Adverse Event|1|||
124459796|NCT00886600|447642355|FG000|Double-blind Monotherapy|Protocol Violation|0|||
124950304|NCT00092456|449445367|FG003|Overall Study|Adverse Event|1|||
124459797|NCT00886600|447642356|FG001|Double-blind Monotherapy|Protocol Violation|0|||
124950305|NCT00092456|449445364|FG000|Overall Study|Lost to Follow-up|2|||
124950306|NCT00092456|449445365|FG001|Overall Study|Lost to Follow-up|2|||
124950307|NCT00092456|449445366|FG002|Overall Study|Lost to Follow-up|1|||
124950308|NCT00092456|449445367|FG003|Overall Study|Lost to Follow-up|2|||
124950309|NCT00092456|449445364|FG000|Overall Study|Protocol Violation|5|||
124459798|NCT00886600|447642357|FG002|Double-blind Monotherapy|Protocol Violation|0|||
124459799|NCT00886600|447642358|FG003|Double-blind Monotherapy|Protocol Violation|1|||
124459800|NCT00886600|447642355|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
124459801|NCT00886600|447642356|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
124950310|NCT00092456|449445365|FG001|Overall Study|Protocol Violation|7|||
124950311|NCT00092456|449445366|FG002|Overall Study|Protocol Violation|8|||
124950312|NCT00092456|449445367|FG003|Overall Study|Protocol Violation|6|||
124950313|NCT00092456|449445364|FG000|Overall Study|Withdrawal by Subject|13|||
124950314|NCT00092456|449445365|FG001|Overall Study|Withdrawal by Subject|5|||
124950315|NCT00092456|449445366|FG002|Overall Study|Withdrawal by Subject|16|||
124950316|NCT00092456|449445367|FG003|Overall Study|Withdrawal by Subject|6|||
124950317|NCT00092456|449445364|FG000|Overall Study|Moved|1|||
124950318|NCT00092456|449445365|FG001|Overall Study|Moved|1|||
124950319|NCT00092456|449445366|FG002|Overall Study|Moved|0|||
124950320|NCT00092456|449445367|FG003|Overall Study|Moved|1|||
124950321|NCT00092456|449445364|FG000|Overall Study|Other|4|||
124950322|NCT00092456|449445365|FG001|Overall Study|Other|2|||
124950323|NCT00092456|449445366|FG002|Overall Study|Other|3|||
124950324|NCT00092456|449445367|FG003|Overall Study|Other|0|||
124950325|NCT04783389|449445368|FG000|Overall Study|Withdrawal by Subject|2|||
124950326|NCT04783389|449445369|FG001|Overall Study|Withdrawal by Subject|0|||
124950327|NCT04783389|449445370|FG002|Overall Study|Withdrawal by Subject|0|||
124950328|NCT04783389|449445368|FG000|Overall Study|Termination of Study by Sponsor|10|||
124950329|NCT04783389|449445369|FG001|Overall Study|Termination of Study by Sponsor|12|||
124950330|NCT04783389|449445370|FG002|Overall Study|Termination of Study by Sponsor|14|||
124950331|NCT00451906|449445371|FG000|Overall Study|Adverse Event|515|||
124950332|NCT00451906|449445371|FG000|Overall Study|Lost to Follow-up|31|||
124950333|NCT00451906|449445371|FG000|Overall Study|Withdrawal by Subject|111|||
124950334|NCT00451906|449445371|FG000|Overall Study|Protocol Violation|21|||
124950335|NCT00451906|449445371|FG000|Overall Study|Progressive disease|1328|||
124950336|NCT00451906|449445371|FG000|Overall Study|Termination of the study|108|||
124950337|NCT00451906|449445371|FG000|Overall Study|Other Reasons|121|||
124950338|NCT00451906|449445371|FG000|Overall Study|Did not complete final visit|4|||
124950339|NCT02121808|449445373|FG000|Overall Study|Technical problem|3|||
124950340|NCT04820023|449445378|FG000|Overall Study|Death|0|||
124950341|NCT04820023|449445379|FG001|Overall Study|Death|0|||
124950342|NCT04820023|449445380|FG002|Overall Study|Death|0|||
124950343|NCT04820023|449445381|FG003|Overall Study|Death|0|||
124950344|NCT04820023|449445382|FG004|Overall Study|Death|0|||
124950345|NCT04820023|449445383|FG005|Overall Study|Death|0|||
124950346|NCT04820023|449445384|FG006|Overall Study|Death|1|||
124950347|NCT04820023|449445385|FG007|Overall Study|Death|0|||
124950348|NCT04820023|449445386|FG008|Overall Study|Death|1|||
124950349|NCT04820023|449445378|FG000|Overall Study|Withdrawal by Subject|1|||
124950350|NCT04820023|449445379|FG001|Overall Study|Withdrawal by Subject|2|||
124950351|NCT04820023|449445380|FG002|Overall Study|Withdrawal by Subject|2|||
124950352|NCT04820023|449445381|FG003|Overall Study|Withdrawal by Subject|1|||
124950353|NCT04820023|449445382|FG004|Overall Study|Withdrawal by Subject|4|||
124950354|NCT04820023|449445383|FG005|Overall Study|Withdrawal by Subject|3|||
124950355|NCT04820023|449445384|FG006|Overall Study|Withdrawal by Subject|3|||
124950356|NCT04820023|449445385|FG007|Overall Study|Withdrawal by Subject|6|||
124950357|NCT04820023|449445386|FG008|Overall Study|Withdrawal by Subject|5|||
124950358|NCT04820023|449445378|FG000|Overall Study|Progressive Disease|3|||
124950359|NCT04820023|449445379|FG001|Overall Study|Progressive Disease|0|||
124950360|NCT04820023|449445380|FG002|Overall Study|Progressive Disease|2|||
124950361|NCT04820023|449445381|FG003|Overall Study|Progressive Disease|2|||
124950362|NCT04820023|449445382|FG004|Overall Study|Progressive Disease|2|||
124950363|NCT04820023|449445383|FG005|Overall Study|Progressive Disease|0|||
124950364|NCT04820023|449445384|FG006|Overall Study|Progressive Disease|1|||
124950365|NCT04820023|449445385|FG007|Overall Study|Progressive Disease|1|||
124950366|NCT04820023|449445386|FG008|Overall Study|Progressive Disease|0|||
124950367|NCT04820023|449445378|FG000|Overall Study|New anti-cancer therapy|0|||
124950368|NCT04820023|449445379|FG001|Overall Study|New anti-cancer therapy|0|||
124950369|NCT04820023|449445380|FG002|Overall Study|New anti-cancer therapy|0|||
124950370|NCT04820023|449445381|FG003|Overall Study|New anti-cancer therapy|0|||
124950371|NCT04820023|449445382|FG004|Overall Study|New anti-cancer therapy|2|||
124950372|NCT04820023|449445383|FG005|Overall Study|New anti-cancer therapy|0|||
124950373|NCT04820023|449445384|FG006|Overall Study|New anti-cancer therapy|0|||
124950374|NCT04820023|449445385|FG007|Overall Study|New anti-cancer therapy|0|||
124950375|NCT04820023|449445386|FG008|Overall Study|New anti-cancer therapy|0|||
124950376|NCT04820023|449445378|FG000|Overall Study|Other|0|||
124950377|NCT04820023|449445379|FG001|Overall Study|Other|1|||
124950378|NCT04820023|449445380|FG002|Overall Study|Other|0|||
124950379|NCT04820023|449445381|FG003|Overall Study|Other|0|||
124950380|NCT04820023|449445382|FG004|Overall Study|Other|0|||
124950381|NCT04820023|449445383|FG005|Overall Study|Other|0|||
124950382|NCT04820023|449445384|FG006|Overall Study|Other|0|||
124950383|NCT04820023|449445385|FG007|Overall Study|Other|2|||
124950384|NCT04820023|449445386|FG008|Overall Study|Other|0|||
124950385|NCT05066230|449445387|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
124950386|NCT05066230|449445388|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
124950387|NCT05066230|449445387|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
124950388|NCT05066230|449445388|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
124548725|NCT03692078|447965322|FG002|Overall Study|Withdrawal by Subject|0|||
124707345|NCT02862574|448554604|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
124707346|NCT02862574|448554605|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
124707347|NCT02862574|448554603|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
124707348|NCT02862574|448554604|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
124950389|NCT05066230|449445387|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
124950390|NCT05066230|449445388|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
124950391|NCT05066230|449445387|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
124950392|NCT05066230|449445388|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
124950393|NCT05066230|449445387|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
124950394|NCT05066230|449445388|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
124950395|NCT05066230|449445387|FG000|After Week 48|Adverse Event|1|||
124950396|NCT05066230|449445388|FG001|After Week 48|Adverse Event|0|||
124950397|NCT05066230|449445387|FG000|After Week 48|Non-compliance with study schedule|1|||
124950398|NCT05066230|449445388|FG001|After Week 48|Non-compliance with study schedule|0|||
124950399|NCT05066230|449445387|FG000|After Week 48|Withdrawal by Subject|0|||
124950400|NCT05066230|449445388|FG001|After Week 48|Withdrawal by Subject|1|||
124950401|NCT05066230|449445387|FG000|After Week 48|Lost to Follow-up|3|||
124950402|NCT05066230|449445388|FG001|After Week 48|Lost to Follow-up|3|||
124950403|NCT05066230|449445387|FG000|After Week 48|Sponsor Request|115|||
124950404|NCT05066230|449445388|FG001|After Week 48|Sponsor Request|111|||
124950405|NCT02164578|449445389|FG000|Treatment Period|Withdrawal by Subject|3|||
124950406|NCT02164578|449445390|FG001|Treatment Period|Withdrawal by Subject|3|||
124950407|NCT02164578|449445389|FG000|Treatment Period|Adverse Event|13|||
124950408|NCT02164578|449445390|FG001|Treatment Period|Adverse Event|6|||
124950409|NCT02164578|449445389|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
124950410|NCT02164578|449445390|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
124950411|NCT02164578|449445389|FG000|Treatment Period|Protocol Violation|0|||
124950412|NCT02164578|449445390|FG001|Treatment Period|Protocol Violation|2|||
124459802|NCT00886600|447642357|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
124459803|NCT00886600|447642358|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
124459804|NCT00886600|447642355|FG000|Combination Therapy Period|Adverse Event|0|||
124459805|NCT00886600|447642356|FG001|Combination Therapy Period|Adverse Event|0|||
124459806|NCT00886600|447642357|FG002|Combination Therapy Period|Adverse Event|1|||
124459807|NCT00886600|447642358|FG003|Combination Therapy Period|Adverse Event|0|||
124459808|NCT00886600|447642355|FG000|Combination Therapy Period|Protocol Violation|0|||
124459809|NCT00886600|447642356|FG001|Combination Therapy Period|Protocol Violation|0|||
124459810|NCT00886600|447642357|FG002|Combination Therapy Period|Protocol Violation|1|||
124459811|NCT00886600|447642358|FG003|Combination Therapy Period|Protocol Violation|0|||
124459812|NCT02937818|447642361|FG000|Overall Study|Participants decision|2|||
124459813|NCT02937818|447642362|FG001|Overall Study|Participants decision|1|||
124459814|NCT02937818|447642363|FG002|Overall Study|Participants decision|1|||
124459815|NCT02937818|447642364|FG003|Overall Study|Participants decision|1|||
124459816|NCT02937818|447642361|FG000|Overall Study|Adverse Event|2|||
124459817|NCT02937818|447642362|FG001|Overall Study|Adverse Event|4|||
124459818|NCT02937818|447642363|FG002|Overall Study|Adverse Event|1|||
124459819|NCT02937818|447642364|FG003|Overall Study|Adverse Event|1|||
124459820|NCT02937818|447642361|FG000|Overall Study|Disease progression|17|||
124459821|NCT02937818|447642362|FG001|Overall Study|Disease progression|15|||
124459822|NCT02937818|447642363|FG002|Overall Study|Disease progression|7|||
124459823|NCT02937818|447642364|FG003|Overall Study|Disease progression|19|||
124459824|NCT02937818|447642361|FG000|Overall Study|Condition under investigation worsened|0|||
124459825|NCT02937818|447642362|FG001|Overall Study|Condition under investigation worsened|0|||
124459826|NCT02937818|447642363|FG002|Overall Study|Condition under investigation worsened|1|||
124459827|NCT02937818|447642364|FG003|Overall Study|Condition under investigation worsened|0|||
124459828|NCT00205855|447642365|FG000|Overall Study|Only received temporary implants|16|||
124459829|NCT00205855|447642365|FG000|Overall Study|Withdrawal by Subject|5|||
124459830|NCT00361270|447642367|FG000|Overall Study|Death|0|||
124459831|NCT00361270|447642368|FG001|Overall Study|Death|0|||
124459832|NCT00361270|447642369|FG002|Overall Study|Death|0|||
124459833|NCT00361270|447642370|FG003|Overall Study|Death|2|||
124459834|NCT00361270|447642367|FG000|Overall Study|Lost to Follow-up|4|||
124459835|NCT00361270|447642368|FG001|Overall Study|Lost to Follow-up|1|||
124459836|NCT00361270|447642369|FG002|Overall Study|Lost to Follow-up|0|||
124459837|NCT00361270|447642370|FG003|Overall Study|Lost to Follow-up|0|||
124459838|NCT00361270|447642367|FG000|Overall Study|Physician Decision|0|||
124459839|NCT00361270|447642368|FG001|Overall Study|Physician Decision|0|||
124459840|NCT00361270|447642369|FG002|Overall Study|Physician Decision|1|||
124459841|NCT00361270|447642370|FG003|Overall Study|Physician Decision|0|||
124459842|NCT00361270|447642367|FG000|Overall Study|Protocol Violation|9|||
124459843|NCT00361270|447642368|FG001|Overall Study|Protocol Violation|4|||
124459844|NCT00361270|447642369|FG002|Overall Study|Protocol Violation|5|||
124459845|NCT00361270|447642370|FG003|Overall Study|Protocol Violation|4|||
124950413|NCT02164578|449445389|FG000|Extension Period|Withdrawal by Subject|2|||
124950414|NCT02164578|449445390|FG001|Extension Period|Withdrawal by Subject|0|||
124766362|NCT04079296|448771702|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
124950415|NCT02164578|449445389|FG000|Extension Period|Adverse Event|4|||
124950416|NCT02164578|449445390|FG001|Extension Period|Adverse Event|0|||
124950417|NCT02164578|449445389|FG000|Extension Period|Expiry of study medication|1|||
124950418|NCT02164578|449445390|FG001|Extension Period|Expiry of study medication|0|||
124950419|NCT02164578|449445389|FG000|Extension Period|Protocol Violation|0|||
124950420|NCT02164578|449445390|FG001|Extension Period|Protocol Violation|1|||
124950421|NCT02507297|449445391|FG000|Overall Study|Withdrawal by Subject|1|||
124950422|NCT02507297|449445392|FG001|Overall Study|Withdrawal by Subject|0|||
124950423|NCT02507297|449445391|FG000|Overall Study|Lost to Follow-up|0|||
124950424|NCT02507297|449445392|FG001|Overall Study|Lost to Follow-up|1|||
124950425|NCT01018992|449445393|FG000|Overall Study|Adverse Event|8|||
124950426|NCT01018992|449445394|FG001|Overall Study|Adverse Event|3|||
124950427|NCT01018992|449445393|FG000|Overall Study|Withdrawal by Subject|3|||
124950428|NCT01018992|449445394|FG001|Overall Study|Withdrawal by Subject|8|||
124950429|NCT01018992|449445393|FG000|Overall Study|Protocol Violation|0|||
124950430|NCT01018992|449445394|FG001|Overall Study|Protocol Violation|4|||
124950431|NCT01018992|449445393|FG000|Overall Study|Lost to Follow-up|5|||
124950432|NCT01018992|449445394|FG001|Overall Study|Lost to Follow-up|1|||
124950433|NCT03029585|449445395|FG000|Overall Study|Death|1|||
124950434|NCT03029585|449445396|FG001|Overall Study|Death|1|||
124950435|NCT03029585|449445395|FG000|Overall Study|Withdrawal by Subject|1|||
124950436|NCT03029585|449445396|FG001|Overall Study|Withdrawal by Subject|0|||
124950437|NCT02092285|449445397|FG000|Induction Phase|Adverse Event|7|||
124950438|NCT02092285|449445397|FG000|Induction Phase|Physician Decision|4|||
124950439|NCT02092285|449445397|FG000|Induction Phase|Pregnancy|1|||
124950440|NCT02092285|449445397|FG000|Induction Phase|Relapse/Recurrence|7|||
124950441|NCT02092285|449445397|FG000|Induction Phase|Withdrawal by Subject|2|||
124950442|NCT02092285|449445397|FG000|Induction Phase|Lack of Efficacy|14|||
124950443|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
124950444|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
124950445|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
124950446|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
124950447|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
124950448|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
124950449|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
124950450|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
124950451|NCT02092285|449445397|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
124950452|NCT01825785|449445398|FG000|Overall Study|Adverse Event|0|||
124950453|NCT01825785|449445399|FG001|Overall Study|Adverse Event|0|||
124950454|NCT01825785|449445400|FG002|Overall Study|Adverse Event|0|||
124950455|NCT01825785|449445401|FG003|Overall Study|Adverse Event|0|||
124950456|NCT01825785|449445402|FG004|Overall Study|Adverse Event|1|||
124766363|NCT04079296|448771703|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
124950457|NCT01825785|449445403|FG005|Overall Study|Adverse Event|0|||
124950458|NCT01825785|449445404|FG006|Overall Study|Adverse Event|0|||
124950459|NCT01825785|449445398|FG000|Overall Study|Withdrawal by Subject|0|||
124950460|NCT01825785|449445399|FG001|Overall Study|Withdrawal by Subject|0|||
124950461|NCT01825785|449445400|FG002|Overall Study|Withdrawal by Subject|0|||
124950462|NCT01825785|449445401|FG003|Overall Study|Withdrawal by Subject|0|||
124950463|NCT01825785|449445402|FG004|Overall Study|Withdrawal by Subject|1|||
124950464|NCT01825785|449445403|FG005|Overall Study|Withdrawal by Subject|1|||
124950465|NCT01825785|449445404|FG006|Overall Study|Withdrawal by Subject|0|||
124950466|NCT01304940|449445406|FG000|Overall Study|not meet symptom severity requirement|3|||
124950467|NCT01304940|449445407|FG001|Overall Study|not meet symptom severity requirement|0|||
124950468|NCT00278395|449445408|FG000|Overall Study|Adverse Event|2|||
124950469|NCT00278395|449445408|FG000|Overall Study|Nonevaluable|1|||
124950470|NCT03740737|449445411|FG000|Overall Study|Protocol deviation|13|||
124548726|NCT03692078|447965323|FG003|Overall Study|Withdrawal by Subject|1|||
124548727|NCT03692078|447965324|FG004|Overall Study|Withdrawal by Subject|5|||
124950471|NCT03740737|449445412|FG001|Overall Study|Protocol deviation|0|||
124950472|NCT03740737|449445411|FG000|Overall Study|Adverse Event|2|||
124950473|NCT03740737|449445412|FG001|Overall Study|Adverse Event|0|||
124950474|NCT03740737|449445411|FG000|Overall Study|Lost to Follow-up|1|||
124950475|NCT03740737|449445412|FG001|Overall Study|Lost to Follow-up|0|||
124950476|NCT03740737|449445411|FG000|Overall Study|Randomization failure|1|||
124548728|NCT03692078|447965325|FG005|Overall Study|Withdrawal by Subject|3|||
124548729|NCT03692078|447965326|FG006|Overall Study|Withdrawal by Subject|3|||
124548730|NCT01005680|447965327|FG000|Overall Study|Lost to Follow-up|4|||
124548731|NCT01005680|447965328|FG001|Overall Study|Lost to Follow-up|6|||
124548732|NCT01005680|447965327|FG000|Overall Study|Withdrawal by Subject|1|||
124548733|NCT01005680|447965328|FG001|Overall Study|Withdrawal by Subject|4|||
124548734|NCT01005680|447965327|FG000|Overall Study|Physician Decision|1|||
124548735|NCT01005680|447965328|FG001|Overall Study|Physician Decision|1|||
124548736|NCT03576131|447965329|FG000|Overall Study|Investigator decision|0|||
124548737|NCT03576131|447965330|FG001|Overall Study|Investigator decision|0|||
124548738|NCT03576131|447965331|FG002|Overall Study|Investigator decision|0|||
124548739|NCT03576131|447965332|FG003|Overall Study|Investigator decision|1|||
124548740|NCT03576131|447965333|FG004|Overall Study|Investigator decision|0|||
124548741|NCT03576131|447965334|FG005|Overall Study|Investigator decision|1|||
124548742|NCT03576131|447965335|FG006|Overall Study|Investigator decision|0|||
124548743|NCT03576131|447965336|FG007|Overall Study|Investigator decision|0|||
124548744|NCT03576131|447965329|FG000|Overall Study|Withdrawal by Subject|1|||
124548745|NCT03576131|447965330|FG001|Overall Study|Withdrawal by Subject|1|||
124548746|NCT03576131|447965331|FG002|Overall Study|Withdrawal by Subject|0|||
124548747|NCT03576131|447965332|FG003|Overall Study|Withdrawal by Subject|1|||
124548748|NCT03576131|447965333|FG004|Overall Study|Withdrawal by Subject|2|||
124548749|NCT03576131|447965334|FG005|Overall Study|Withdrawal by Subject|3|||
124548750|NCT03576131|447965335|FG006|Overall Study|Withdrawal by Subject|1|||
124548751|NCT03576131|447965336|FG007|Overall Study|Withdrawal by Subject|0|||
124548752|NCT03576131|447965329|FG000|Overall Study|Death|3|||
124548753|NCT03576131|447965330|FG001|Overall Study|Death|3|||
124548754|NCT03576131|447965331|FG002|Overall Study|Death|1|||
124548755|NCT03576131|447965332|FG003|Overall Study|Death|5|||
124548756|NCT03576131|447965333|FG004|Overall Study|Death|4|||
124950477|NCT03740737|449445412|FG001|Overall Study|Randomization failure|0|||
124950478|NCT03740737|449445411|FG000|Overall Study|Participant withdrew consent|1|||
124950479|NCT03740737|449445412|FG001|Overall Study|Participant withdrew consent|0|||
124950480|NCT03740737|449445411|FG000|Overall Study|Participant withdrew from trial|2|||
124950481|NCT03740737|449445412|FG001|Overall Study|Participant withdrew from trial|1|||
124950482|NCT01286311|449445414|FG000|Overall Study|Physician did not want outreach sent|14|||
124950483|NCT01286311|449445415|FG001|Overall Study|Physician did not want outreach sent|0|||
124950484|NCT02981953|449445421|FG000|Overall Study|Death|9|||
124950485|NCT02981953|449445421|FG000|Overall Study|Withdrawal by Subject|1|||
124950486|NCT02981953|449445421|FG000|Overall Study|Withdrawal to non-compliance|1|||
124950487|NCT02889900|449445422|FG000|Overall Study|Adverse Event|11|||
124950488|NCT02889900|449445422|FG000|Overall Study|Condition under investigation worsened|32|||
124950489|NCT02889900|449445422|FG000|Overall Study|Other|5|||
124950490|NCT02889900|449445422|FG000|Overall Study|Withdrawal by Subject|7|||
124950491|NCT02889900|449445422|FG000|Overall Study|Not treated|2|||
124950492|NCT03146845|449445424|FG000|Overall Study|Reference ulcer healed|1|||
124950493|NCT03146845|449445425|FG001|Overall Study|Reference ulcer healed|0|||
124950494|NCT03146845|449445424|FG000|Overall Study|Physician Decision|1|||
124950495|NCT03146845|449445425|FG001|Overall Study|Physician Decision|0|||
124950496|NCT03146845|449445424|FG000|Overall Study|Adverse Event|1|||
124950497|NCT03146845|449445425|FG001|Overall Study|Adverse Event|0|||
124950498|NCT03146845|449445424|FG000|Overall Study|Withdrawal by Subject|2|||
124950499|NCT03146845|449445425|FG001|Overall Study|Withdrawal by Subject|0|||
124950500|NCT03146845|449445424|FG000|Overall Study|Noncompliance|0|||
124950501|NCT03146845|449445425|FG001|Overall Study|Noncompliance|1|||
124950502|NCT03146845|449445424|FG000|Overall Study|Protocol Violation|0|||
124950503|NCT03146845|449445425|FG001|Overall Study|Protocol Violation|2|||
124950504|NCT03146845|449445424|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
124950505|NCT03146845|449445425|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
124950506|NCT01535261|449445432|FG000|Overall Study|Physician Decision|8|||
124950507|NCT01535261|449445432|FG000|Overall Study|Protocol Violation|3|||
124950508|NCT01535261|449445432|FG000|Overall Study|Death|5|||
124548757|NCT03576131|447965334|FG005|Overall Study|Death|1|||
124707349|NCT02862574|448554605|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
124707350|NCT02724839|448554610|FG000|Overall Study|Withdrawal by Subject|1|||
124548758|NCT03576131|447965335|FG006|Overall Study|Death|0|||
124548759|NCT03576131|447965336|FG007|Overall Study|Death|1|||
124548760|NCT03576131|447965329|FG000|Overall Study|New anti-cancer treatment|5|||
124548761|NCT03576131|447965330|FG001|Overall Study|New anti-cancer treatment|1|||
124548762|NCT03576131|447965331|FG002|Overall Study|New anti-cancer treatment|2|||
124548763|NCT03576131|447965332|FG003|Overall Study|New anti-cancer treatment|3|||
124950509|NCT01535261|449445432|FG000|Overall Study|Lost to Follow-up|8|||
124950510|NCT01535261|449445432|FG000|Overall Study|Withdrawal by Subject|14|||
124950511|NCT01535261|449445432|FG000|Overall Study|Adverse Event|12|||
124950512|NCT01757288|449445436|FG000|Overall Study|Consent withdrawal|0|||
124950513|NCT01757288|449445437|FG001|Overall Study|Consent withdrawal|4|||
124548764|NCT03576131|447965333|FG004|Overall Study|New anti-cancer treatment|0|||
124548765|NCT03576131|447965334|FG005|Overall Study|New anti-cancer treatment|0|||
124548766|NCT03576131|447965335|FG006|Overall Study|New anti-cancer treatment|0|||
124548767|NCT03576131|447965336|FG007|Overall Study|New anti-cancer treatment|0|||
124548768|NCT03576131|447965329|FG000|Overall Study|Unspecified reason|0|||
124548769|NCT03576131|447965330|FG001|Overall Study|Unspecified reason|0|||
124548770|NCT03576131|447965331|FG002|Overall Study|Unspecified reason|1|||
124548771|NCT03576131|447965332|FG003|Overall Study|Unspecified reason|1|||
124548772|NCT03576131|447965333|FG004|Overall Study|Unspecified reason|1|||
124950514|NCT01757288|449445438|FG002|Overall Study|Consent withdrawal|4|||
124950515|NCT01757288|449445436|FG000|Overall Study|Patient off study, IRB hold.|0|||
124950516|NCT01757288|449445437|FG001|Overall Study|Patient off study, IRB hold.|0|||
124950517|NCT01757288|449445438|FG002|Overall Study|Patient off study, IRB hold.|1|||
124950518|NCT01757288|449445436|FG000|Overall Study|Patient death prior to starting treatment|0|||
124950519|NCT01757288|449445437|FG001|Overall Study|Patient death prior to starting treatment|0|||
124950520|NCT01757288|449445438|FG002|Overall Study|Patient death prior to starting treatment|1|||
124950521|NCT01757288|449445436|FG000|Overall Study|Wrong medication administered|0|||
124950522|NCT01757288|449445437|FG001|Overall Study|Wrong medication administered|1|||
124950523|NCT01757288|449445438|FG002|Overall Study|Wrong medication administered|0|||
124950524|NCT01757288|449445436|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
124950525|NCT01757288|449445437|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
124950526|NCT01757288|449445438|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
124950527|NCT01757288|449445436|FG000|Overall Study|Not meeting protocol constraints|0|||
124950528|NCT01757288|449445437|FG001|Overall Study|Not meeting protocol constraints|1|||
124950529|NCT01757288|449445438|FG002|Overall Study|Not meeting protocol constraints|1|||
124950530|NCT01757288|449445436|FG000|Overall Study|Multiple missed appointments|0|||
124950531|NCT01757288|449445437|FG001|Overall Study|Multiple missed appointments|1|||
124950532|NCT01757288|449445438|FG002|Overall Study|Multiple missed appointments|0|||
124950533|NCT01757288|449445436|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
124950534|NCT01757288|449445437|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
124950535|NCT01757288|449445438|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
124950536|NCT01757288|449445436|FG000|Overall Study|>2 weeks treatment break|0|||
124950537|NCT01757288|449445437|FG001|Overall Study|>2 weeks treatment break|0|||
124950538|NCT01757288|449445438|FG002|Overall Study|>2 weeks treatment break|1|||
124950539|NCT03349476|449445444|FG000|Overall Study|Physician Decision|3|||
124950540|NCT04421456|449445451|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
124950541|NCT04421456|449445452|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
124950542|NCT04421456|449445453|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
124950543|NCT04421456|449445451|FG000|Randomized Treatment Period|Adverse Event|0|||
124950544|NCT04421456|449445452|FG001|Randomized Treatment Period|Adverse Event|1|||
124548773|NCT03576131|447965334|FG005|Overall Study|Unspecified reason|1|||
124548774|NCT03576131|447965335|FG006|Overall Study|Unspecified reason|0|||
124548775|NCT03576131|447965336|FG007|Overall Study|Unspecified reason|0|||
124707351|NCT02724839|448554611|FG001|Overall Study|Withdrawal by Subject|1|||
124707352|NCT02724839|448554612|FG002|Overall Study|Withdrawal by Subject|0|||
124707353|NCT02724839|448554610|FG000|Overall Study|Lost to Follow-up|0|||
124707354|NCT02724839|448554611|FG001|Overall Study|Lost to Follow-up|3|||
124707355|NCT02724839|448554612|FG002|Overall Study|Lost to Follow-up|2|||
124707356|NCT02724839|448554610|FG000|Overall Study|Physician Decision|0|||
124707357|NCT02724839|448554611|FG001|Overall Study|Physician Decision|0|||
124707358|NCT02724839|448554612|FG002|Overall Study|Physician Decision|3|||
124707359|NCT05878067|448554613|FG000|Overall Study|Lost to Follow-up|2|||
124707360|NCT00949533|448554614|FG000|Overall Study|Lost to Follow-up|0|||
124707361|NCT00949533|448554615|FG001|Overall Study|Lost to Follow-up|1|||
124707362|NCT00320606|448554623|FG000|Overall Study|Adverse Event|1|||
124707363|NCT00320606|448554623|FG000|Overall Study|Protocol Violation|1|||
124707364|NCT00320606|448554623|FG000|Overall Study|Withdrawal by Subject|1|||
124950545|NCT04421456|449445453|FG002|Randomized Treatment Period|Adverse Event|0|||
124950546|NCT04421456|449445451|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
124950547|NCT04421456|449445452|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
124950548|NCT04421456|449445453|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
124950549|NCT04421456|449445451|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
124950550|NCT04421456|449445452|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
124950551|NCT04421456|449445453|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
124707365|NCT03984825|448554624|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
124707366|NCT03984825|448554624|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
124707367|NCT03984825|448554624|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
124707368|NCT00399035|448554627|FG000|Overall Study|Death|289|||
124950552|NCT04421456|449445451|FG000|Randomized Treatment Period|Participant non-compliance|1|||
124950553|NCT04421456|449445452|FG001|Randomized Treatment Period|Participant non-compliance|1|||
124548776|NCT03576131|447965329|FG000|Overall Study|Subject non-compliance|0|||
124707369|NCT00399035|448554628|FG001|Overall Study|Death|141|||
124707370|NCT00399035|448554629|FG002|Overall Study|Death|234|||
124950554|NCT04421456|449445453|FG002|Randomized Treatment Period|Participant non-compliance|2|||
124950555|NCT04421456|449445451|FG000|Randomized Treatment Period|Other|0|||
124950556|NCT04421456|449445452|FG001|Randomized Treatment Period|Other|1|||
124950557|NCT04421456|449445453|FG002|Randomized Treatment Period|Other|3|||
124950558|NCT00274287|449445454|FG000|Overall Study|Withdrawal by Subject|1|||
124950559|NCT00274287|449445454|FG000|Overall Study|subject non-compliance|1|||
124950560|NCT01777932|449445457|FG000|Overall Study|Disease progression|136|||
124950561|NCT01777932|449445457|FG000|Overall Study|Death|3|||
124950562|NCT01777932|449445457|FG000|Overall Study|Adverse Event|34|||
124950563|NCT01777932|449445457|FG000|Overall Study|Lost to Follow-up|3|||
124950564|NCT01777932|449445457|FG000|Overall Study|Investigator decision|10|||
124950565|NCT01777932|449445457|FG000|Overall Study|Reimbursement limit|9|||
124950566|NCT01777932|449445457|FG000|Overall Study|Patient refused further treatment|10|||
124950567|NCT03031782|449445465|FG000|Treatment Period 1|Lack of Efficacy|3|||
124950568|NCT03031782|449445466|FG001|Treatment Period 1|Lack of Efficacy|0|||
124950569|NCT03031782|449445467|FG002|Treatment Period 1|Lack of Efficacy|0|||
124950570|NCT03031782|449445468|FG003|Treatment Period 1|Lack of Efficacy|0|||
124950571|NCT03031782|449445469|FG004|Treatment Period 1|Lack of Efficacy|0|||
124950572|NCT03031782|449445465|FG000|Treatment Period 2|Physician Decision|0|||
124950573|NCT03031782|449445466|FG001|Treatment Period 2|Physician Decision|1|||
124950574|NCT03031782|449445467|FG002|Treatment Period 2|Physician Decision|0|||
124950575|NCT03031782|449445468|FG003|Treatment Period 2|Physician Decision|0|||
124950576|NCT03031782|449445469|FG004|Treatment Period 2|Physician Decision|3|||
124950577|NCT03031782|449445465|FG000|Treatment Period 2|Lack of Efficacy|0|||
124950578|NCT03031782|449445466|FG001|Treatment Period 2|Lack of Efficacy|1|||
124950579|NCT03031782|449445467|FG002|Treatment Period 2|Lack of Efficacy|0|||
124950580|NCT03031782|449445468|FG003|Treatment Period 2|Lack of Efficacy|0|||
124950581|NCT03031782|449445469|FG004|Treatment Period 2|Lack of Efficacy|1|||
124950582|NCT03031782|449445465|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124950583|NCT03031782|449445466|FG001|Treatment Period 2|Withdrawal by Subject|3|||
124950584|NCT03031782|449445467|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124950585|NCT03031782|449445468|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124950586|NCT03031782|449445469|FG004|Treatment Period 2|Withdrawal by Subject|1|||
124950587|NCT03031782|449445465|FG000|Treatment Period 2|Adverse Event|0|||
124950588|NCT03031782|449445466|FG001|Treatment Period 2|Adverse Event|1|||
124707371|NCT00399035|448554627|FG000|Overall Study|Lost to Follow-up|2|||
124950589|NCT03031782|449445467|FG002|Treatment Period 2|Adverse Event|2|||
124950590|NCT03031782|449445468|FG003|Treatment Period 2|Adverse Event|0|||
124950591|NCT03031782|449445469|FG004|Treatment Period 2|Adverse Event|0|||
124950592|NCT03031782|449445465|FG000|Treatment Period 3|Withdrawal by Subject|0|||
124950593|NCT03031782|449445466|FG001|Treatment Period 3|Withdrawal by Subject|0|||
124950594|NCT03031782|449445467|FG002|Treatment Period 3|Withdrawal by Subject|0|||
124950595|NCT03031782|449445468|FG003|Treatment Period 3|Withdrawal by Subject|1|||
124950596|NCT03031782|449445469|FG004|Treatment Period 3|Withdrawal by Subject|0|||
124950597|NCT01930188|449445470|FG000|Overall Study|unclassified|4|||
124950598|NCT01930188|449445471|FG001|Overall Study|unclassified|5|||
124950599|NCT01930188|449445472|FG002|Overall Study|unclassified|3|||
124950600|NCT01930188|449445470|FG000|Overall Study|Missing follow-up information|2|||
124950601|NCT01930188|449445471|FG001|Overall Study|Missing follow-up information|2|||
124950602|NCT01930188|449445472|FG002|Overall Study|Missing follow-up information|3|||
124950603|NCT01930188|449445470|FG000|Overall Study|Lost to Follow-up|5|||
124950604|NCT01930188|449445471|FG001|Overall Study|Lost to Follow-up|2|||
124950605|NCT01930188|449445472|FG002|Overall Study|Lost to Follow-up|2|||
124950606|NCT01930188|449445470|FG000|Overall Study|Death|2|||
124950607|NCT01930188|449445471|FG001|Overall Study|Death|1|||
124950608|NCT01930188|449445472|FG002|Overall Study|Death|3|||
124950609|NCT01930188|449445470|FG000|Overall Study|Withdrawal by Subject|9|||
124950610|NCT01930188|449445471|FG001|Overall Study|Withdrawal by Subject|11|||
124950611|NCT01930188|449445472|FG002|Overall Study|Withdrawal by Subject|8|||
124950612|NCT02514824|449445473|FG000|Overall Study|Withdrawal by Subject|1|||
124950613|NCT02514824|449445474|FG001|Overall Study|Withdrawal by Subject|0|||
124950614|NCT02514824|449445475|FG002|Overall Study|Withdrawal by Subject|0|||
124950615|NCT02514824|449445476|FG003|Overall Study|Withdrawal by Subject|0|||
124950616|NCT02514824|449445473|FG000|Overall Study|Dose-Limiting Toxicity|0|||
124950617|NCT02514824|449445474|FG001|Overall Study|Dose-Limiting Toxicity|1|||
124950618|NCT02514824|449445475|FG002|Overall Study|Dose-Limiting Toxicity|0|||
124950619|NCT02514824|449445476|FG003|Overall Study|Dose-Limiting Toxicity|0|||
124950620|NCT02170207|449445479|FG000|Overall Study|Case report forms unavailable|5|||
124950621|NCT00886834|449445480|FG000|Overall Study|Protocol Violation|0|||
124950622|NCT00886834|449445481|FG001|Overall Study|Protocol Violation|3|||
124950623|NCT03122860|449445482|FG000|Overall Study|Discontinued Before Treatment|1|||
124950624|NCT03122860|449445483|FG001|Overall Study|Discontinued Before Treatment|1|||
124950625|NCT03122860|449445484|FG002|Overall Study|Discontinued Before Treatment|2|||
124950626|NCT03122860|449445485|FG003|Overall Study|Discontinued Before Treatment|0|||
124950627|NCT03122860|449445486|FG004|Overall Study|Discontinued Before Treatment|1|||
124950628|NCT03122860|449445487|FG005|Overall Study|Discontinued Before Treatment|0|||
124950629|NCT03122860|449445482|FG000|Overall Study|Adverse Event|1|||
124950630|NCT03122860|449445483|FG001|Overall Study|Adverse Event|0|||
124950631|NCT03122860|449445484|FG002|Overall Study|Adverse Event|1|||
124950632|NCT03122860|449445485|FG003|Overall Study|Adverse Event|1|||
124950633|NCT03122860|449445486|FG004|Overall Study|Adverse Event|0|||
124950634|NCT03122860|449445487|FG005|Overall Study|Adverse Event|0|||
124950635|NCT03122860|449445482|FG000|Overall Study|Lost to Follow-up|5|||
124950636|NCT03122860|449445483|FG001|Overall Study|Lost to Follow-up|2|||
124950637|NCT03122860|449445484|FG002|Overall Study|Lost to Follow-up|3|||
124950638|NCT03122860|449445485|FG003|Overall Study|Lost to Follow-up|3|||
124950639|NCT03122860|449445486|FG004|Overall Study|Lost to Follow-up|5|||
124950640|NCT03122860|449445487|FG005|Overall Study|Lost to Follow-up|4|||
124950641|NCT03122860|449445482|FG000|Overall Study|Subject Non-Compliance|0|||
124950642|NCT03122860|449445483|FG001|Overall Study|Subject Non-Compliance|0|||
124950643|NCT03122860|449445484|FG002|Overall Study|Subject Non-Compliance|1|||
124459846|NCT00361270|447642367|FG000|Overall Study|Withdrawal by Subject|6|||
124459847|NCT00361270|447642368|FG001|Overall Study|Withdrawal by Subject|6|||
124459848|NCT00361270|447642369|FG002|Overall Study|Withdrawal by Subject|3|||
124459849|NCT00361270|447642370|FG003|Overall Study|Withdrawal by Subject|7|||
124459850|NCT00361270|447642367|FG000|Overall Study|Afraid of Hypnosis|1|||
124459851|NCT00361270|447642368|FG001|Overall Study|Afraid of Hypnosis|2|||
124459852|NCT00361270|447642369|FG002|Overall Study|Afraid of Hypnosis|0|||
124459853|NCT00361270|447642370|FG003|Overall Study|Afraid of Hypnosis|0|||
124459854|NCT00361270|447642367|FG000|Overall Study|Problems with Transportation|4|||
124766364|NCT04079296|448771704|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
124766365|NCT04079296|448771700|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
124766366|NCT04079296|448771701|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
124950644|NCT03122860|449445485|FG003|Overall Study|Subject Non-Compliance|0|||
124950645|NCT03122860|449445486|FG004|Overall Study|Subject Non-Compliance|0|||
124950646|NCT03122860|449445487|FG005|Overall Study|Subject Non-Compliance|0|||
124950647|NCT03122860|449445482|FG000|Overall Study|Withdrawal by Subject|3|||
124950648|NCT03122860|449445483|FG001|Overall Study|Withdrawal by Subject|2|||
124950649|NCT03122860|449445484|FG002|Overall Study|Withdrawal by Subject|5|||
124950650|NCT03122860|449445485|FG003|Overall Study|Withdrawal by Subject|7|||
124950651|NCT03122860|449445486|FG004|Overall Study|Withdrawal by Subject|9|||
124950652|NCT03122860|449445487|FG005|Overall Study|Withdrawal by Subject|8|||
124950653|NCT03875729|449445488|FG000|Overall Study|Adverse Event|0|||
124950654|NCT03875729|449445489|FG001|Overall Study|Adverse Event|5|||
124950655|NCT03875729|449445488|FG000|Overall Study|Withdrawal by Subject|8|||
124950656|NCT03875729|449445489|FG001|Overall Study|Withdrawal by Subject|11|||
124950657|NCT03875729|449445488|FG000|Overall Study|Pregnancy|0|||
124950658|NCT03875729|449445489|FG001|Overall Study|Pregnancy|1|||
124950659|NCT03875729|449445488|FG000|Overall Study|Lost to Follow-up|0|||
124950660|NCT03875729|449445489|FG001|Overall Study|Lost to Follow-up|5|||
124950661|NCT03875729|449445488|FG000|Overall Study|Personal reasons|2|||
124950662|NCT03875729|449445489|FG001|Overall Study|Personal reasons|0|||
124950663|NCT02764320|449445490|FG000|Overall Study|Withdrawal by Subject|35|||
124950664|NCT02764320|449445491|FG001|Overall Study|Withdrawal by Subject|38|||
124950665|NCT02764320|449445490|FG000|Overall Study|Protocol Violation|11|||
124950666|NCT02764320|449445491|FG001|Overall Study|Protocol Violation|6|||
124950667|NCT02764320|449445490|FG000|Overall Study|Adverse Event|2|||
124950668|NCT02764320|449445491|FG001|Overall Study|Adverse Event|0|||
124950669|NCT02764320|449445490|FG000|Overall Study|Health Issues unable to continue|2|||
124707372|NCT00399035|448554628|FG001|Overall Study|Lost to Follow-up|1|||
124707373|NCT00399035|448554629|FG002|Overall Study|Lost to Follow-up|5|||
124950670|NCT02764320|449445491|FG001|Overall Study|Health Issues unable to continue|0|||
124950671|NCT02764320|449445490|FG000|Overall Study|Did not meet inclusion criteria|1|||
124950672|NCT02764320|449445491|FG001|Overall Study|Did not meet inclusion criteria|0|||
124950673|NCT02764320|449445490|FG000|Overall Study|Subject moved|0|||
124950674|NCT02764320|449445491|FG001|Overall Study|Subject moved|2|||
124950675|NCT02764320|449445490|FG000|Overall Study|Overused medication unavailable|0|||
124950676|NCT02764320|449445491|FG001|Overall Study|Overused medication unavailable|1|||
124950677|NCT02764320|449445490|FG000|Overall Study|Seeking care outside site|0|||
124950678|NCT02764320|449445491|FG001|Overall Study|Seeking care outside site|1|||
124950679|NCT02764320|449445490|FG000|Overall Study|Technology barriers|0|||
124950680|NCT02764320|449445491|FG001|Overall Study|Technology barriers|1|||
124950681|NCT01405508|449445494|FG000|Overall Study|AE, non-serious non-fatal|1|||
124950682|NCT01405508|449445495|FG001|Overall Study|AE, non-serious non-fatal|1|||
124950683|NCT01405508|449445496|FG002|Overall Study|AE, non-serious non-fatal|0|||
124950684|NCT01405508|449445497|FG003|Overall Study|AE, non-serious non-fatal|0|||
124950685|NCT00476957|449445502|FG000|Overall Study|Lost to Follow-up|176|||
124950686|NCT00476957|449445503|FG001|Overall Study|Lost to Follow-up|193|||
124950687|NCT02159352|449445504|FG000|Overall Study|Adverse Event|3|||
124950688|NCT02159352|449445505|FG001|Overall Study|Adverse Event|1|||
124950689|NCT02159352|449445504|FG000|Overall Study|Withdrawal by Subject|0|||
124950690|NCT02159352|449445505|FG001|Overall Study|Withdrawal by Subject|1|||
124950691|NCT04620733|449447343|FG000|Overall Study|Adverse Event|4|||
124950692|NCT04620733|449447344|FG001|Overall Study|Adverse Event|3|||
124950693|NCT04620733|449447343|FG000|Overall Study|Withdrawal by Subject|2|||
124950694|NCT04620733|449447344|FG001|Overall Study|Withdrawal by Subject|5|||
124950695|NCT04620733|449447343|FG000|Overall Study|Lost to Follow-up|1|||
124950696|NCT04620733|449447344|FG001|Overall Study|Lost to Follow-up|1|||
124950697|NCT04620733|449447343|FG000|Overall Study|Protocol Deviation|1|||
124950698|NCT04620733|449447344|FG001|Overall Study|Protocol Deviation|1|||
124950699|NCT04620733|449447343|FG000|Overall Study|Reason Not Specified|0|||
124950700|NCT04620733|449447344|FG001|Overall Study|Reason Not Specified|1|||
124950701|NCT02659059|449447351|FG000|Overall Study|Other reasons|6|||
124950702|NCT02659059|449447352|FG001|Overall Study|Other reasons|1|||
124950703|NCT02659059|449447351|FG000|Overall Study|Disease Progression|143|||
124950704|NCT02659059|449447352|FG001|Overall Study|Disease Progression|16|||
124950705|NCT02659059|449447351|FG000|Overall Study|Study Drug toxicity|56|||
124459855|NCT00361270|447642368|FG001|Overall Study|Problems with Transportation|0|||
124459856|NCT00361270|447642369|FG002|Overall Study|Problems with Transportation|0|||
124459857|NCT00361270|447642370|FG003|Overall Study|Problems with Transportation|0|||
124459858|NCT00361270|447642367|FG000|Overall Study|Adverse Event|0|||
124459859|NCT00361270|447642368|FG001|Overall Study|Adverse Event|1|||
124459860|NCT00361270|447642369|FG002|Overall Study|Adverse Event|1|||
124459861|NCT00361270|447642370|FG003|Overall Study|Adverse Event|0|||
124459862|NCT00677014|447642371|FG000|Overall Study|Lost to Follow-up|20|||
124459863|NCT00677014|447642372|FG001|Overall Study|Lost to Follow-up|12|||
124459864|NCT00677014|447642373|FG002|Overall Study|Lost to Follow-up|24|||
124459865|NCT00677014|447642371|FG000|Overall Study|Death|6|||
124459866|NCT00677014|447642372|FG001|Overall Study|Death|15|||
124459867|NCT00677014|447642373|FG002|Overall Study|Death|7|||
124548777|NCT03576131|447965330|FG001|Overall Study|Subject non-compliance|0|||
124707374|NCT00399035|448554627|FG000|Overall Study|Withdrawal by Subject|19|||
124707375|NCT00399035|448554628|FG001|Overall Study|Withdrawal by Subject|15|||
124950706|NCT02659059|449447352|FG001|Overall Study|Study Drug toxicity|9|||
124950707|NCT02659059|449447351|FG000|Overall Study|Death|3|||
124950708|NCT02659059|449447352|FG001|Overall Study|Death|1|||
124950709|NCT02659059|449447351|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
124950710|NCT02659059|449447352|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
124459868|NCT00677014|447642371|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
124548778|NCT03576131|447965331|FG002|Overall Study|Subject non-compliance|0|||
124707376|NCT00399035|448554629|FG002|Overall Study|Withdrawal by Subject|12|||
124950711|NCT02659059|449447351|FG000|Overall Study|Participant request to discontinue study treatment|5|||
124950712|NCT02659059|449447352|FG001|Overall Study|Participant request to discontinue study treatment|0|||
124950713|NCT02659059|449447351|FG000|Overall Study|Participant withdrew consent|6|||
124950714|NCT02659059|449447352|FG001|Overall Study|Participant withdrew consent|1|||
124548779|NCT03576131|447965332|FG003|Overall Study|Subject non-compliance|0|||
124548780|NCT03576131|447965333|FG004|Overall Study|Subject non-compliance|0|||
124548781|NCT03576131|447965334|FG005|Overall Study|Subject non-compliance|1|||
124548782|NCT03576131|447965335|FG006|Overall Study|Subject non-compliance|0|||
124548783|NCT03576131|447965336|FG007|Overall Study|Subject non-compliance|0|||
124548784|NCT03069365|447965353|FG000|Overall Study|Adverse Event|1|||
124548785|NCT01965431|447965354|FG000|Overall Study|Adverse Event|0|||
124548786|NCT01965431|447965355|FG001|Overall Study|Adverse Event|1|||
124548787|NCT01965431|447965356|FG002|Overall Study|Adverse Event|0|||
124950715|NCT03072238|449447355|FG000|Overall Study|Withdrawal by Subject|44|||
124950716|NCT03072238|449447356|FG001|Overall Study|Withdrawal by Subject|64|||
124950717|NCT03072238|449447355|FG000|Overall Study|Lost to Follow-up|14|||
124950718|NCT03072238|449447356|FG001|Overall Study|Lost to Follow-up|5|||
124950719|NCT03072238|449447355|FG000|Overall Study|Physician Decision|4|||
124950720|NCT03072238|449447356|FG001|Overall Study|Physician Decision|6|||
124950721|NCT03072238|449447355|FG000|Overall Study|Death|351|||
124950722|NCT03072238|449447356|FG001|Overall Study|Death|318|||
124950723|NCT03072238|449447355|FG000|Overall Study|Progressive Disease|3|||
124950724|NCT03072238|449447356|FG001|Overall Study|Progressive Disease|4|||
124950725|NCT03072238|449447355|FG000|Overall Study|Reason Not Specified|138|||
124950726|NCT03072238|449447356|FG001|Overall Study|Reason Not Specified|150|||
124950727|NCT03924193|449447362|FG000|Overall Study|Adverse Event|10|||
124950728|NCT03924193|449447363|FG001|Overall Study|Adverse Event|0|||
124950729|NCT03924193|449447364|FG002|Overall Study|Adverse Event|10|||
124950730|NCT03924193|449447362|FG000|Overall Study|Withdrawal by Subject|5|||
124950731|NCT03924193|449447363|FG001|Overall Study|Withdrawal by Subject|10|||
124950732|NCT03924193|449447364|FG002|Overall Study|Withdrawal by Subject|2|||
124950733|NCT02489799|449447365|FG000|Overall Study|Lost to Follow-up|4|||
124950734|NCT02489799|449447366|FG001|Overall Study|Lost to Follow-up|1|||
124950735|NCT02489799|449447365|FG000|Overall Study|Failure to Maintain Eligibility|4|||
124950736|NCT02489799|449447366|FG001|Overall Study|Failure to Maintain Eligibility|6|||
124950737|NCT02489799|449447365|FG000|Overall Study|Withdrawal by Subject|1|||
124950738|NCT02489799|449447366|FG001|Overall Study|Withdrawal by Subject|1|||
124950739|NCT02489799|449447365|FG000|Overall Study|Death|0|||
124950740|NCT02489799|449447366|FG001|Overall Study|Death|1|||
124950741|NCT04909593|449447367|FG000|Overall Study|Withdrawal by Subject|1|||
124950742|NCT01241448|449447368|FG000|Overall Study|Adverse Event|1|||
124950743|NCT01241448|449447369|FG001|Overall Study|Adverse Event|0|||
124950744|NCT01241448|449447370|FG002|Overall Study|Adverse Event|2|||
124950745|NCT01241448|449447371|FG003|Overall Study|Adverse Event|2|||
124950746|NCT01241448|449447368|FG000|Overall Study|Lost to Follow-up|2|||
124950747|NCT01241448|449447369|FG001|Overall Study|Lost to Follow-up|1|||
124950748|NCT01241448|449447370|FG002|Overall Study|Lost to Follow-up|1|||
124950749|NCT01241448|449447371|FG003|Overall Study|Lost to Follow-up|1|||
124950750|NCT01241448|449447368|FG000|Overall Study|Physician Decision|0|||
124950751|NCT01241448|449447369|FG001|Overall Study|Physician Decision|2|||
124950752|NCT01241448|449447370|FG002|Overall Study|Physician Decision|0|||
124950753|NCT01241448|449447371|FG003|Overall Study|Physician Decision|0|||
124950754|NCT01241448|449447368|FG000|Overall Study|Protocol Violation|10|||
124950755|NCT01241448|449447369|FG001|Overall Study|Protocol Violation|5|||
124950756|NCT01241448|449447370|FG002|Overall Study|Protocol Violation|3|||
124950757|NCT01241448|449447371|FG003|Overall Study|Protocol Violation|6|||
124548788|NCT01965431|447965357|FG003|Overall Study|Adverse Event|0|||
124548789|NCT01965431|447965358|FG004|Overall Study|Adverse Event|0|||
124548790|NCT01965431|447965359|FG005|Overall Study|Adverse Event|0|||
124548791|NCT01965431|447965354|FG000|Overall Study|Other than stated above|6|||
124766367|NCT04079296|448771702|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
124766368|NCT04079296|448771703|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
124766369|NCT04079296|448771704|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
124950758|NCT01241448|449447368|FG000|Overall Study|Sponsor Decision|17|||
124950759|NCT01241448|449447369|FG001|Overall Study|Sponsor Decision|14|||
124950760|NCT01241448|449447370|FG002|Overall Study|Sponsor Decision|12|||
124950761|NCT01241448|449447371|FG003|Overall Study|Sponsor Decision|6|||
124950762|NCT01241448|449447368|FG000|Overall Study|Withdrawal by Subject|4|||
124950763|NCT01241448|449447369|FG001|Overall Study|Withdrawal by Subject|5|||
124950764|NCT01241448|449447370|FG002|Overall Study|Withdrawal by Subject|3|||
124950765|NCT01241448|449447371|FG003|Overall Study|Withdrawal by Subject|6|||
124950766|NCT01241448|449447368|FG000|Overall Study|Excluded due to data integrity issues|3|||
124950767|NCT01241448|449447369|FG001|Overall Study|Excluded due to data integrity issues|2|||
124950768|NCT01241448|449447370|FG002|Overall Study|Excluded due to data integrity issues|2|||
124950769|NCT01241448|449447371|FG003|Overall Study|Excluded due to data integrity issues|2|||
124950770|NCT02165202|449447375|FG000|Oral Phase|Refused further participation|5|||
124950771|NCT02165202|449447376|FG001|Oral Phase|Refused further participation|1|||
124950772|NCT02165202|449447375|FG000|Oral Phase|Study product Related Toxicity|1|||
124950773|NCT02165202|449447376|FG001|Oral Phase|Study product Related Toxicity|0|||
124950774|NCT02165202|449447375|FG000|Oral Phase|Unable to contact Participant|1|||
124950775|NCT02165202|449447376|FG001|Oral Phase|Unable to contact Participant|1|||
124707377|NCT00399035|448554627|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
124707378|NCT00399035|448554628|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
124707379|NCT00399035|448554629|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
124707380|NCT00399035|448554627|FG000|Overall Study|Severe non-compliance with protocol|2|||
124950776|NCT02165202|449447375|FG000|Oral Phase|Clinical reasons|1|||
124950777|NCT02165202|449447376|FG001|Oral Phase|Clinical reasons|0|||
124950778|NCT02165202|449447375|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
124950779|NCT02165202|449447376|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
124950780|NCT02165202|449447375|FG000|Oral Phase|CMC advised termination|1|||
124950781|NCT02165202|449447376|FG001|Oral Phase|CMC advised termination|0|||
124950782|NCT02165202|449447375|FG000|Oral Phase|Relocated, no follow-up planned|1|||
124950783|NCT02165202|449447376|FG001|Oral Phase|Relocated, no follow-up planned|0|||
124950784|NCT02165202|449447375|FG000|Oral Phase|Abnormal EKG|0|||
124950785|NCT02165202|449447376|FG001|Oral Phase|Abnormal EKG|1|||
124950786|NCT02165202|449447375|FG000|Injection Phase|Abnormal Lab Value|5|||
124950787|NCT02165202|449447376|FG001|Injection Phase|Abnormal Lab Value|1|||
124459869|NCT00677014|447642372|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
124459870|NCT00677014|447642373|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
124459871|NCT01033825|447642374|FG000|Overall Study|Withdrawal by Subject|2|||
124459872|NCT01033825|447642375|FG001|Overall Study|Withdrawal by Subject|3|||
124459873|NCT01033825|447642376|FG002|Overall Study|Withdrawal by Subject|2|||
124459874|NCT01033825|447642377|FG003|Overall Study|Withdrawal by Subject|1|||
124459875|NCT01033825|447642378|FG004|Overall Study|Withdrawal by Subject|1|||
124459876|NCT01033825|447642379|FG005|Overall Study|Withdrawal by Subject|0|||
124459877|NCT01033825|447642380|FG006|Overall Study|Withdrawal by Subject|0|||
124459878|NCT01033825|447642374|FG000|Overall Study|Adverse Event|0|||
124459879|NCT01033825|447642375|FG001|Overall Study|Adverse Event|0|||
124459880|NCT01033825|447642376|FG002|Overall Study|Adverse Event|0|||
124459881|NCT01033825|447642377|FG003|Overall Study|Adverse Event|1|||
124459882|NCT01033825|447642378|FG004|Overall Study|Adverse Event|0|||
124459883|NCT01033825|447642379|FG005|Overall Study|Adverse Event|0|||
124459884|NCT01033825|447642380|FG006|Overall Study|Adverse Event|0|||
124459885|NCT01033825|447642374|FG000|Overall Study|Protocol Violation|1|||
124459886|NCT01033825|447642375|FG001|Overall Study|Protocol Violation|0|||
124459887|NCT01033825|447642376|FG002|Overall Study|Protocol Violation|0|||
124459888|NCT01033825|447642377|FG003|Overall Study|Protocol Violation|0|||
124459889|NCT01033825|447642378|FG004|Overall Study|Protocol Violation|0|||
124459890|NCT01033825|447642379|FG005|Overall Study|Protocol Violation|0|||
124459891|NCT01033825|447642380|FG006|Overall Study|Protocol Violation|0|||
124459892|NCT01033825|447642374|FG000|Overall Study|Other|0|||
124459893|NCT01033825|447642375|FG001|Overall Study|Other|0|||
124459894|NCT01033825|447642376|FG002|Overall Study|Other|0|||
124459895|NCT01033825|447642377|FG003|Overall Study|Other|0|||
124459896|NCT01033825|447642378|FG004|Overall Study|Other|1|||
124459897|NCT01033825|447642379|FG005|Overall Study|Other|0|||
124459898|NCT01033825|447642380|FG006|Overall Study|Other|0|||
124459899|NCT00081159|447642381|FG000|Overall Study|Withdrawal by Subject|0|||
124459900|NCT00081159|447642382|FG001|Overall Study|Withdrawal by Subject|3|||
124459901|NCT00081159|447642381|FG000|Overall Study|Myelosuppression prior to treatment|0|||
124459902|NCT00081159|447642382|FG001|Overall Study|Myelosuppression prior to treatment|1|||
124459903|NCT00081159|447642381|FG000|Overall Study|Lost to Follow-up|2|||
124459904|NCT00081159|447642382|FG001|Overall Study|Lost to Follow-up|1|||
124459905|NCT01553136|447642388|FG000|Overall Study|Adverse Event|3|||
124459906|NCT01553136|447642389|FG001|Overall Study|Adverse Event|2|||
124459907|NCT01553136|447642388|FG000|Overall Study|Withdrawal by Subject|2|||
124459908|NCT01553136|447642389|FG001|Overall Study|Withdrawal by Subject|3|||
124459909|NCT01553136|447642388|FG000|Overall Study|Lost to Follow-up|4|||
124459910|NCT01553136|447642389|FG001|Overall Study|Lost to Follow-up|10|||
124459911|NCT01553136|447642388|FG000|Overall Study|Physician Decision|2|||
124459912|NCT01553136|447642389|FG001|Overall Study|Physician Decision|3|||
124459913|NCT01553136|447642388|FG000|Overall Study|Scheduling Difficulties|5|||
124459914|NCT01553136|447642389|FG001|Overall Study|Scheduling Difficulties|4|||
124459915|NCT00894556|447642392|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
124459916|NCT00894556|447642393|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
124459917|NCT00894556|447642394|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
124459918|NCT00894556|447642395|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
124707381|NCT00399035|448554628|FG001|Overall Study|Severe non-compliance with protocol|1|||
124459919|NCT00894556|447642392|FG000|Treatment Phase|Lost to Follow-up|2|||
124459920|NCT00894556|447642393|FG001|Treatment Phase|Lost to Follow-up|3|||
124707382|NCT00399035|448554629|FG002|Overall Study|Severe non-compliance with protocol|0|||
124707383|NCT02921256|448554636|FG000|Arm 1a v. Arm II|Adverse Event|6|||
124459921|NCT00894556|447642394|FG002|Treatment Phase|Lost to Follow-up|1|||
124459922|NCT00894556|447642395|FG003|Treatment Phase|Lost to Follow-up|0|||
124707384|NCT02921256|448554637|FG001|Arm 1a v. Arm II|Adverse Event|15|||
124950788|NCT02165202|449447375|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
124950789|NCT02165202|449447376|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
124950790|NCT02165202|449447375|FG000|Injection Phase|Unable to attend within Visit Window|1|||
124950791|NCT02165202|449447376|FG001|Injection Phase|Unable to attend within Visit Window|0|||
124950792|NCT02165202|449447375|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
124950793|NCT02165202|449447376|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
124950794|NCT02165202|449447375|FG000|Injection Phase|End of Study|2|||
124950795|NCT02165202|449447376|FG001|Injection Phase|End of Study|1|||
124950796|NCT02165202|449447375|FG000|Injection Phase|Study Product related Toxicity|1|||
124950797|NCT02165202|449447376|FG001|Injection Phase|Study Product related Toxicity|0|||
124950798|NCT02165202|449447375|FG000|Injection Phase|No longer interested|0|||
124950799|NCT02165202|449447376|FG001|Injection Phase|No longer interested|1|||
124950800|NCT02165202|449447375|FG000|Injection Phase|Participant unwilling to comply|1|||
124950801|NCT02165202|449447376|FG001|Injection Phase|Participant unwilling to comply|0|||
124950802|NCT01655498|449447392|FG000|Overall Study|Unrelated health issue|2|||
124950803|NCT01655498|449447392|FG000|Overall Study|Protocol Violation|2|||
124950804|NCT01655498|449447392|FG000|Overall Study|Withdrawal by Subject|1|||
124950805|NCT02291861|449447399|FG000|Overall Study|Adverse Event|2|||
124950806|NCT02291861|449447400|FG001|Overall Study|Adverse Event|4|||
124950807|NCT02291861|449447401|FG002|Overall Study|Adverse Event|1|||
124950808|NCT02291861|449447402|FG003|Overall Study|Adverse Event|2|||
124950809|NCT02291861|449447399|FG000|Overall Study|Death|0|||
124950810|NCT02291861|449447400|FG001|Overall Study|Death|0|||
124950811|NCT02291861|449447401|FG002|Overall Study|Death|1|||
124950812|NCT02291861|449447402|FG003|Overall Study|Death|1|||
124950813|NCT02291861|449447399|FG000|Overall Study|Protocol Violation|1|||
124950814|NCT02291861|449447400|FG001|Overall Study|Protocol Violation|0|||
124950815|NCT02291861|449447401|FG002|Overall Study|Protocol Violation|0|||
124459923|NCT00894556|447642392|FG000|Treatment Phase|Lack of Qualifying Event|2|||
124459924|NCT00894556|447642393|FG001|Treatment Phase|Lack of Qualifying Event|1|||
124459925|NCT00894556|447642394|FG002|Treatment Phase|Lack of Qualifying Event|0|||
124459926|NCT00894556|447642395|FG003|Treatment Phase|Lack of Qualifying Event|0|||
124459927|NCT01439555|447642396|FG000|Overall Study|Protocol Violation|1|||
124459928|NCT03921424|447642402|FG000|Overall Study|Lost to Follow-up|0|||
124459929|NCT03921424|447642403|FG001|Overall Study|Lost to Follow-up|1|||
124459930|NCT03921424|447642402|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
124459931|NCT03921424|447642403|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
124459932|NCT02581202|447642414|FG000|Overall Study|Lack of Efficacy|2|||
124459933|NCT02581202|447642414|FG000|Overall Study|Withdrawal by Subject|4|||
124459934|NCT02581202|447642414|FG000|Overall Study|Lost to Follow-up|5|||
124459935|NCT02581202|447642414|FG000|Overall Study|Pregnancy|3|||
124459936|NCT02595450|447642419|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
124459937|NCT02595450|447642419|FG000|Overall Study|Enrolled, but not treated|8|||
124459938|NCT04294901|447642421|FG000|Overall Study|Death|86|||
124459939|NCT04294901|447642422|FG001|Overall Study|Death|110|||
124459940|NCT04294901|447642421|FG000|Overall Study|Provider did not have historical control patients|581|||
124459941|NCT04294901|447642422|FG001|Overall Study|Provider did not have historical control patients|0|||
124459942|NCT04294901|447642421|FG000|Overall Study|Provider did not have intervention patients|0|||
124459943|NCT04294901|447642422|FG001|Overall Study|Provider did not have intervention patients|98|||
124459944|NCT01934556|447642423|FG000|Overall Study|Withdrawal by Subject|0|||
124548792|NCT01965431|447965355|FG001|Overall Study|Other than stated above|5|||
124548793|NCT01965431|447965356|FG002|Overall Study|Other than stated above|6|||
124548794|NCT01965431|447965357|FG003|Overall Study|Other than stated above|6|||
124950816|NCT02291861|449447402|FG003|Overall Study|Protocol Violation|1|||
124950817|NCT02291861|449447399|FG000|Overall Study|Withdrawal by Subject|1|||
124950818|NCT02291861|449447400|FG001|Overall Study|Withdrawal by Subject|2|||
124950819|NCT02291861|449447401|FG002|Overall Study|Withdrawal by Subject|1|||
124950820|NCT02291861|449447402|FG003|Overall Study|Withdrawal by Subject|4|||
124950821|NCT02291861|449447399|FG000|Overall Study|Noncompliance|1|||
124950822|NCT02291861|449447400|FG001|Overall Study|Noncompliance|1|||
124950823|NCT02291861|449447401|FG002|Overall Study|Noncompliance|2|||
124950824|NCT02291861|449447402|FG003|Overall Study|Noncompliance|1|||
124950825|NCT02291861|449447399|FG000|Overall Study|Lost to Follow-up|2|||
124950826|NCT02291861|449447400|FG001|Overall Study|Lost to Follow-up|1|||
124950827|NCT02291861|449447401|FG002|Overall Study|Lost to Follow-up|4|||
124950828|NCT02291861|449447402|FG003|Overall Study|Lost to Follow-up|0|||
124950829|NCT02291861|449447399|FG000|Overall Study|Other|0|||
124950830|NCT02291861|449447400|FG001|Overall Study|Other|0|||
124950831|NCT02291861|449447401|FG002|Overall Study|Other|0|||
124950832|NCT02291861|449447402|FG003|Overall Study|Other|1|||
124950833|NCT00963924|449447403|FG000|Overall Study|Adverse Event|1|||
124950834|NCT00963924|449447404|FG001|Overall Study|Adverse Event|0|||
124950835|NCT00963924|449447403|FG000|Overall Study|Withdrawal by Subject|0|||
124950836|NCT00963924|449447404|FG001|Overall Study|Withdrawal by Subject|1|||
124950837|NCT00963924|449447403|FG000|Overall Study|Changed antipsychotic|0|||
124950838|NCT00963924|449447404|FG001|Overall Study|Changed antipsychotic|1|||
124950839|NCT00963924|449447403|FG000|Overall Study|Lost to Follow-up|0|||
124950840|NCT00963924|449447404|FG001|Overall Study|Lost to Follow-up|1|||
124950841|NCT00237809|449447405|FG000|Overall Study|Lost to Follow-up|11|||
124950842|NCT00237809|449447406|FG001|Overall Study|Lost to Follow-up|10|||
124950843|NCT00237809|449447407|FG002|Overall Study|Lost to Follow-up|9|||
124950844|NCT00237809|449447408|FG003|Overall Study|Lost to Follow-up|9|||
124950845|NCT00871715|449447413|FG000|Overall Study|Withdrawal by Subject|6|||
124950846|NCT00871715|449447414|FG001|Overall Study|Withdrawal by Subject|10|||
124950847|NCT00871715|449447415|FG002|Overall Study|Withdrawal by Subject|15|||
124950848|NCT00871715|449447413|FG000|Overall Study|Physician Decision|6|||
124950849|NCT00871715|449447414|FG001|Overall Study|Physician Decision|0|||
124950850|NCT00871715|449447415|FG002|Overall Study|Physician Decision|2|||
124950851|NCT00871715|449447413|FG000|Overall Study|Lost to Follow-up|3|||
124950852|NCT00871715|449447414|FG001|Overall Study|Lost to Follow-up|6|||
124950853|NCT00871715|449447415|FG002|Overall Study|Lost to Follow-up|9|||
124950854|NCT03015220|449447416|FG000|Overall Study|Withdrawal by Subject|3|||
124950855|NCT03015220|449447417|FG001|Overall Study|Withdrawal by Subject|2|||
124950856|NCT03015220|449447418|FG002|Overall Study|Withdrawal by Subject|2|||
124950857|NCT03015220|449447419|FG003|Overall Study|Withdrawal by Subject|2|||
124950858|NCT03015220|449447416|FG000|Overall Study|Lost to Follow-up|0|||
124950859|NCT03015220|449447417|FG001|Overall Study|Lost to Follow-up|0|||
124950860|NCT03015220|449447418|FG002|Overall Study|Lost to Follow-up|1|||
124950861|NCT03015220|449447419|FG003|Overall Study|Lost to Follow-up|0|||
124950862|NCT01670526|449447421|FG000|Overall Study|Withdrawal by Subject|3|||
124950863|NCT01670526|449447422|FG001|Overall Study|Withdrawal by Subject|1|||
124950864|NCT01670526|449447421|FG000|Overall Study|Lost to Follow-up|9|||
124950865|NCT01670526|449447422|FG001|Overall Study|Lost to Follow-up|5|||
124950866|NCT02291549|449447423|FG000|Overall Study|Lost to Follow-up|1|||
124950867|NCT02291549|449447424|FG001|Overall Study|Lost to Follow-up|0|||
124950868|NCT02291549|449447423|FG000|Overall Study|Withdrawal by Subject|0|||
124950869|NCT02291549|449447424|FG001|Overall Study|Withdrawal by Subject|1|||
124950870|NCT01970527|449447426|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
124950871|NCT01970527|449447427|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
124950872|NCT01970527|449447426|FG000|Treatment|Disease progression|0|||
124950873|NCT01970527|449447427|FG001|Treatment|Disease progression|1|||
124950874|NCT01970527|449447426|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
124950875|NCT01970527|449447427|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
124950876|NCT01970527|449447426|FG000|Treatment|Death|0|||
124950877|NCT01970527|449447427|FG001|Treatment|Death|1|||
124950878|NCT01970527|449447426|FG000|Follow-up Clinic Visit|Disease progression|1|||
124950879|NCT01970527|449447427|FG001|Follow-up Clinic Visit|Disease progression|1|||
124950880|NCT01970527|449447426|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
124950881|NCT01970527|449447427|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
124950882|NCT01970527|449447426|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
124950883|NCT01970527|449447427|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
124950884|NCT01115309|449447428|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
124766370|NCT04079296|448771700|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
124950885|NCT01115309|449447428|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
124950886|NCT01115309|449447428|FG000|Long-term Follow-up|Lost to Follow-up|6|||
124950887|NCT04447287|449447429|FG000|Period 1: Run-in Period|Adverse Event|3|||
124950888|NCT04447287|449447430|FG001|Period 1: Run-in Period|Adverse Event|0|||
124950889|NCT04447287|449447431|FG002|Period 1: Run-in Period|Adverse Event|0|||
124950890|NCT04447287|449447429|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
124950891|NCT04447287|449447430|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
124950892|NCT04447287|449447431|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
124950893|NCT04447287|449447429|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
124950894|NCT04447287|449447430|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
124950895|NCT04447287|449447431|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
124766371|NCT04079296|448771701|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
124950896|NCT05700851|449447432|FG000|Overall Study|Received a kidney transplant|1|||
124950897|NCT05700851|449447432|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
124950898|NCT05700851|449447432|FG000|Overall Study|Withdrawal by Subject|1|||
124950899|NCT02147093|449447435|FG000|Period 1|Lost to Follow-up|0|||
124950900|NCT02147093|449447436|FG001|Period 1|Lost to Follow-up|1|||
124950901|NCT02147093|449447435|FG000|Period 2|Protocol Violation|2|||
124950902|NCT02147093|449447436|FG001|Period 2|Protocol Violation|0|||
124950903|NCT03246724|449447437|FG000|Overall Study|Withdrawal by Subject|5|||
124950904|NCT03246724|449447438|FG001|Overall Study|Withdrawal by Subject|2|||
124950905|NCT03246724|449447439|FG002|Overall Study|Withdrawal by Subject|4|||
124950906|NCT03246724|449447440|FG003|Overall Study|Withdrawal by Subject|2|||
124950907|NCT03246724|449447437|FG000|Overall Study|Ineligible on day of surgery|7|||
124950908|NCT03246724|449447438|FG001|Overall Study|Ineligible on day of surgery|2|||
124950909|NCT03246724|449447439|FG002|Overall Study|Ineligible on day of surgery|0|||
124950910|NCT03246724|449447440|FG003|Overall Study|Ineligible on day of surgery|3|||
124950911|NCT03246724|449447437|FG000|Overall Study|Study completed before surgical date|2|||
124950912|NCT03246724|449447438|FG001|Overall Study|Study completed before surgical date|1|||
124950913|NCT03246724|449447439|FG002|Overall Study|Study completed before surgical date|8|||
124950914|NCT03246724|449447440|FG003|Overall Study|Study completed before surgical date|1|||
124950915|NCT03246724|449447437|FG000|Overall Study|Transferred to other arm|0|||
124950916|NCT03246724|449447438|FG001|Overall Study|Transferred to other arm|0|||
124950917|NCT03246724|449447439|FG002|Overall Study|Transferred to other arm|1|||
124950918|NCT03246724|449447440|FG003|Overall Study|Transferred to other arm|0|||
124950919|NCT03246724|449447437|FG000|Overall Study|Unable to obtain medication timely|0|||
124950920|NCT03246724|449447438|FG001|Overall Study|Unable to obtain medication timely|2|||
124950921|NCT03246724|449447439|FG002|Overall Study|Unable to obtain medication timely|2|||
124950922|NCT03246724|449447440|FG003|Overall Study|Unable to obtain medication timely|1|||
124950923|NCT03246724|449447437|FG000|Overall Study|Re-consented to participate|0|||
124950924|NCT03246724|449447438|FG001|Overall Study|Re-consented to participate|0|||
124950925|NCT03246724|449447439|FG002|Overall Study|Re-consented to participate|0|||
124950926|NCT03246724|449447440|FG003|Overall Study|Re-consented to participate|1|||
124950927|NCT00655824|449447441|FG000|Overall Study|Adverse Event|3|||
124950928|NCT00655824|449447441|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
124707385|NCT02921256|448554638|FG002|Arm 1a v. Arm II|Adverse Event|0|||
124707386|NCT02921256|448554636|FG000|Arm 1a v. Arm II|Death|0|||
124707387|NCT02921256|448554637|FG001|Arm 1a v. Arm II|Death|2|||
124707388|NCT02921256|448554638|FG002|Arm 1a v. Arm II|Death|0|||
124707389|NCT02921256|448554636|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
124707390|NCT02921256|448554637|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
124707391|NCT02921256|448554638|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
124707392|NCT02921256|448554636|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
124707393|NCT02921256|448554637|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
124707394|NCT02921256|448554638|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
124707395|NCT02921256|448554636|FG000|Arm 1a v. Arm II|Physician Decision|1|||
124707396|NCT02921256|448554637|FG001|Arm 1a v. Arm II|Physician Decision|1|||
124707397|NCT02921256|448554638|FG002|Arm 1a v. Arm II|Physician Decision|0|||
124707398|NCT02921256|448554636|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
124707399|NCT02921256|448554637|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
124707400|NCT02921256|448554638|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
124707401|NCT02921256|448554636|FG000|Arm Ib v Arm III|Adverse Event|9|||
124707402|NCT02921256|448554637|FG001|Arm Ib v Arm III|Adverse Event|0|||
124707403|NCT02921256|448554638|FG002|Arm Ib v Arm III|Adverse Event|4|||
124707404|NCT02921256|448554636|FG000|Arm Ib v Arm III|Death|1|||
124707405|NCT02921256|448554637|FG001|Arm Ib v Arm III|Death|0|||
124707406|NCT02921256|448554638|FG002|Arm Ib v Arm III|Death|1|||
124707407|NCT02921256|448554636|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
124950929|NCT00655824|449447441|FG000|Overall Study|Protocol Violation|1|||
124950930|NCT00655824|449447441|FG000|Overall Study|Withdrawal by Subject|4|||
124459945|NCT01934556|447642424|FG001|Overall Study|Withdrawal by Subject|1|||
124459946|NCT01934556|447642425|FG002|Overall Study|Withdrawal by Subject|1|||
124459947|NCT01934556|447642423|FG000|Overall Study|Lost to Follow-up|4|||
124459948|NCT01934556|447642424|FG001|Overall Study|Lost to Follow-up|10|||
124459949|NCT01934556|447642425|FG002|Overall Study|Lost to Follow-up|7|||
124459950|NCT01934556|447642423|FG000|Overall Study|Death|1|||
124459951|NCT01934556|447642424|FG001|Overall Study|Death|5|||
124459952|NCT01934556|447642425|FG002|Overall Study|Death|2|||
124707408|NCT02921256|448554637|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
124707409|NCT02921256|448554638|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
124707410|NCT02921256|448554636|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
124707411|NCT02921256|448554637|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
124707412|NCT02921256|448554638|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
124707413|NCT02921256|448554636|FG000|Arm Ib v Arm III|Physician Decision|4|||
124707414|NCT02921256|448554637|FG001|Arm Ib v Arm III|Physician Decision|0|||
124707415|NCT02921256|448554638|FG002|Arm Ib v Arm III|Physician Decision|1|||
124950931|NCT00655824|449447441|FG000|Overall Study|Deterioration of Trial Disease|2|||
124950932|NCT00589628|449447442|FG000|Overall Study|Lost to Follow-up|0|||
124950933|NCT00589628|449447443|FG001|Overall Study|Lost to Follow-up|1|||
124950934|NCT03032198|449447451|FG000|Overall Study|Screen Fail|1|||
124950935|NCT01307800|449447453|FG000|Overall Study|Adverse Event|9|||
124950936|NCT01307800|449447454|FG001|Overall Study|Adverse Event|8|||
124950937|NCT01307800|449447455|FG002|Overall Study|Adverse Event|10|||
124950938|NCT01307800|449447456|FG003|Overall Study|Adverse Event|14|||
124950939|NCT01307800|449447453|FG000|Overall Study|Entry Criteria Not Met|0|||
124950940|NCT01307800|449447454|FG001|Overall Study|Entry Criteria Not Met|0|||
124950941|NCT01307800|449447455|FG002|Overall Study|Entry Criteria Not Met|0|||
124950942|NCT01307800|449447456|FG003|Overall Study|Entry Criteria Not Met|2|||
124950943|NCT01307800|449447453|FG000|Overall Study|Lost to Follow-up|5|||
124950944|NCT01307800|449447454|FG001|Overall Study|Lost to Follow-up|6|||
124950945|NCT01307800|449447455|FG002|Overall Study|Lost to Follow-up|2|||
124950946|NCT01307800|449447456|FG003|Overall Study|Lost to Follow-up|8|||
124950947|NCT01307800|449447453|FG000|Overall Study|Perceived Lack of Efficacy|24|||
124950948|NCT01307800|449447454|FG001|Overall Study|Perceived Lack of Efficacy|23|||
124950949|NCT01307800|449447455|FG002|Overall Study|Perceived Lack of Efficacy|20|||
124950950|NCT01307800|449447456|FG003|Overall Study|Perceived Lack of Efficacy|33|||
124950951|NCT01307800|449447453|FG000|Overall Study|Protocol Violation|0|||
124950952|NCT01307800|449447454|FG001|Overall Study|Protocol Violation|3|||
124950953|NCT01307800|449447455|FG002|Overall Study|Protocol Violation|4|||
124950954|NCT01307800|449447456|FG003|Overall Study|Protocol Violation|5|||
124950955|NCT01307800|449447453|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
124950956|NCT01307800|449447454|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
124950957|NCT01307800|449447455|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
124950958|NCT01307800|449447456|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
124950959|NCT01307800|449447453|FG000|Overall Study|Sponsor Decision|6|||
124950960|NCT01307800|449447454|FG001|Overall Study|Sponsor Decision|9|||
124950961|NCT01307800|449447455|FG002|Overall Study|Sponsor Decision|12|||
124950962|NCT01307800|449447456|FG003|Overall Study|Sponsor Decision|28|||
124950963|NCT01307800|449447453|FG000|Overall Study|Withdrawal by Subject|10|||
124950964|NCT01307800|449447454|FG001|Overall Study|Withdrawal by Subject|11|||
124950965|NCT01307800|449447455|FG002|Overall Study|Withdrawal by Subject|8|||
124950966|NCT01307800|449447456|FG003|Overall Study|Withdrawal by Subject|15|||
124950967|NCT01307800|449447453|FG000|Overall Study|Participant Moved|0|||
124950968|NCT01307800|449447454|FG001|Overall Study|Participant Moved|2|||
124950969|NCT01307800|449447455|FG002|Overall Study|Participant Moved|1|||
124950970|NCT01307800|449447456|FG003|Overall Study|Participant Moved|3|||
124950971|NCT02892019|449447457|FG000|Overall Study|randomized but not treated|0|||
124950972|NCT02892019|449447458|FG001|Overall Study|randomized but not treated|1|||
124950973|NCT02892019|449447457|FG000|Overall Study|Withdrawal by Subject|0|||
124950974|NCT02892019|449447458|FG001|Overall Study|Withdrawal by Subject|1|||
124950975|NCT02892019|449447457|FG000|Overall Study|Adverse Event|1|||
124950976|NCT02892019|449447458|FG001|Overall Study|Adverse Event|1|||
124950977|NCT00689351|449447459|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
124950978|NCT00689351|449447460|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
124950979|NCT00689351|449447459|FG000|Infant Series of Dosing|Adverse Event|1|||
124950980|NCT00689351|449447460|FG001|Infant Series of Dosing|Adverse Event|0|||
124950981|NCT00689351|449447459|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
124950982|NCT00689351|449447460|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
124950983|NCT00689351|449447459|FG000|After Infant Series|Parent/legal guardian request|1|||
124950984|NCT00689351|449447460|FG001|After Infant Series|Parent/legal guardian request|0|||
124950985|NCT01766206|449447461|FG000|Overall Study|Withdrawal by Subject|22|||
124950986|NCT01766206|449447461|FG000|Overall Study|Lost to Follow-up|10|||
124950987|NCT01766206|449447461|FG000|Overall Study|Inappropriate enrollment|18|||
124950988|NCT01766206|449447461|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
124950989|NCT01662505|449447462|FG000|Overall Study|Progressive disease|6|||
124950990|NCT01662505|449447463|FG001|Overall Study|Progressive disease|1|||
124950991|NCT01662505|449447464|FG002|Overall Study|Progressive disease|5|||
124950992|NCT01662505|449447462|FG000|Overall Study|Refused cont. medication|0|||
124950993|NCT01662505|449447463|FG001|Overall Study|Refused cont. medication|0|||
124950994|NCT01662505|449447464|FG002|Overall Study|Refused cont. medication|1|||
124950995|NCT01662505|449447462|FG000|Overall Study|Not specified above|1|||
124950996|NCT01662505|449447463|FG001|Overall Study|Not specified above|3|||
124950997|NCT01662505|449447464|FG002|Overall Study|Not specified above|2|||
124766372|NCT04079296|448771702|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
124950998|NCT01313663|449447465|FG000|Overall Study|Study Closed/Terminated|2|||
124950999|NCT01313663|449447466|FG001|Overall Study|Study Closed/Terminated|4|||
124951000|NCT01313663|449447465|FG000|Overall Study|Lost to Follow-up|0|||
124951001|NCT01313663|449447466|FG001|Overall Study|Lost to Follow-up|1|||
124951002|NCT01313663|449447465|FG000|Overall Study|Physician Decision|0|||
124951003|NCT01313663|449447466|FG001|Overall Study|Physician Decision|2|||
124951004|NCT01313663|449447465|FG000|Overall Study|Withdrawal by Subject|2|||
124951005|NCT01313663|449447466|FG001|Overall Study|Withdrawal by Subject|1|||
124951006|NCT02255474|449447467|FG000|Overall Study|Lost to Follow-up|1|||
124951007|NCT02255474|449447468|FG001|Overall Study|Lost to Follow-up|1|||
124951008|NCT02255474|449447469|FG002|Overall Study|Lost to Follow-up|3|||
124951009|NCT02255474|449447467|FG000|Overall Study|Withdrawal by Subject|1|||
124951010|NCT02255474|449447468|FG001|Overall Study|Withdrawal by Subject|1|||
124951011|NCT02255474|449447469|FG002|Overall Study|Withdrawal by Subject|0|||
124951012|NCT01229176|449447473|FG000|Overall Study|Withdrawal by Subject|0|||
124951013|NCT01229176|449447474|FG001|Overall Study|Withdrawal by Subject|0|||
124951014|NCT01229176|449447475|FG002|Overall Study|Withdrawal by Subject|0|||
124951015|NCT01229176|449447476|FG003|Overall Study|Withdrawal by Subject|1|||
124951016|NCT01229176|449447477|FG004|Overall Study|Withdrawal by Subject|1|||
124951017|NCT01229176|449447478|FG005|Overall Study|Withdrawal by Subject|1|||
124951018|NCT01229176|449447479|FG006|Overall Study|Withdrawal by Subject|0|||
124951019|NCT01229176|449447480|FG007|Overall Study|Withdrawal by Subject|1|||
124951020|NCT01229176|449447473|FG000|Overall Study|Lost to Follow-up|0|||
124951021|NCT01229176|449447474|FG001|Overall Study|Lost to Follow-up|3|||
124951022|NCT01229176|449447475|FG002|Overall Study|Lost to Follow-up|0|||
124951023|NCT01229176|449447476|FG003|Overall Study|Lost to Follow-up|0|||
124951024|NCT01229176|449447477|FG004|Overall Study|Lost to Follow-up|1|||
124951025|NCT01229176|449447478|FG005|Overall Study|Lost to Follow-up|1|||
124951026|NCT01229176|449447479|FG006|Overall Study|Lost to Follow-up|0|||
124951027|NCT01229176|449447480|FG007|Overall Study|Lost to Follow-up|2|||
124951028|NCT02367794|449447488|FG000|Overall Study|Death|252|||
124951029|NCT02367794|449447489|FG001|Overall Study|Death|245|||
124951030|NCT02367794|449447490|FG002|Overall Study|Death|243|||
124951031|NCT02367794|449447488|FG000|Overall Study|Lost to Follow-up|1|||
124951032|NCT02367794|449447489|FG001|Overall Study|Lost to Follow-up|2|||
124951033|NCT02367794|449447490|FG002|Overall Study|Lost to Follow-up|2|||
124951034|NCT02367794|449447488|FG000|Overall Study|Physician Decision|0|||
124951035|NCT02367794|449447489|FG001|Overall Study|Physician Decision|5|||
124951036|NCT02367794|449447490|FG002|Overall Study|Physician Decision|3|||
124951037|NCT02367794|449447488|FG000|Overall Study|Protocol Violation|1|||
124951038|NCT02367794|449447489|FG001|Overall Study|Protocol Violation|0|||
124951039|NCT02367794|449447490|FG002|Overall Study|Protocol Violation|1|||
124951040|NCT02367794|449447488|FG000|Overall Study|Withdrawal by Subject|25|||
124951041|NCT02367794|449447489|FG001|Overall Study|Withdrawal by Subject|12|||
124951042|NCT02367794|449447490|FG002|Overall Study|Withdrawal by Subject|20|||
124951043|NCT02367794|449447488|FG000|Overall Study|Brain metastasis|1|||
124951044|NCT02367794|449447489|FG001|Overall Study|Brain metastasis|0|||
124951045|NCT02367794|449447490|FG002|Overall Study|Brain metastasis|0|||
124951046|NCT02367794|449447488|FG000|Overall Study|Randomized in error|0|||
124951047|NCT02367794|449447489|FG001|Overall Study|Randomized in error|0|||
124951048|NCT02367794|449447490|FG002|Overall Study|Randomized in error|1|||
124951049|NCT02367794|449447488|FG000|Overall Study|Patient unable to receive carboplatin|0|||
124951050|NCT02367794|449447489|FG001|Overall Study|Patient unable to receive carboplatin|0|||
124951051|NCT02367794|449447490|FG002|Overall Study|Patient unable to receive carboplatin|1|||
124951052|NCT02367794|449447488|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
124951053|NCT02367794|449447489|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
124951054|NCT02367794|449447490|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
124951055|NCT02367794|449447488|FG000|Overall Study|Adverse Event|0|||
124951056|NCT02367794|449447489|FG001|Overall Study|Adverse Event|0|||
124951057|NCT02367794|449447490|FG002|Overall Study|Adverse Event|2|||
124951058|NCT02367794|449447488|FG000|Overall Study|Study Terminated By Sponsor|0|||
124951059|NCT02367794|449447489|FG001|Overall Study|Study Terminated By Sponsor|1|||
124951060|NCT02367794|449447490|FG002|Overall Study|Study Terminated By Sponsor|1|||
124951061|NCT02367794|449447488|FG000|Overall Study|Moved to Roll-Over Study|0|||
124548795|NCT01965431|447965358|FG004|Overall Study|Other than stated above|6|||
124548796|NCT01965431|447965359|FG005|Overall Study|Other than stated above|6|||
124548797|NCT04635631|447965360|FG000|Overall Study|Adverse Event|1|||
124548798|NCT04635631|447965360|FG000|Overall Study|Progressive disease|13|||
124548799|NCT04635631|447965360|FG000|Overall Study|Withdrawal by Subject|1|||
124548800|NCT03901339|447965361|FG000|Overall Study|Death|220|||
124951062|NCT02367794|449447489|FG001|Overall Study|Moved to Roll-Over Study|15|||
124548801|NCT03901339|447965362|FG001|Overall Study|Death|192|||
124548802|NCT03901339|447965361|FG000|Overall Study|Informed consent withdrawn|13|||
124951063|NCT02367794|449447490|FG002|Overall Study|Moved to Roll-Over Study|13|||
124951064|NCT02367794|449447488|FG000|Overall Study|Sponsor Request|60|||
124951065|NCT02367794|449447489|FG001|Overall Study|Sponsor Request|57|||
124548803|NCT03901339|447965362|FG001|Overall Study|Informed consent withdrawn|40|||
124951066|NCT02367794|449447490|FG002|Overall Study|Sponsor Request|45|||
124951067|NCT02367794|449447488|FG000|Overall Study|Moved into PTAP Study|0|||
124951068|NCT02367794|449447489|FG001|Overall Study|Moved into PTAP Study|2|||
124951069|NCT02367794|449447490|FG002|Overall Study|Moved into PTAP Study|3|||
124951070|NCT02367794|449447488|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
124951071|NCT02367794|449447489|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
124951072|NCT02367794|449447490|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
124951073|NCT02367794|449447488|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
124951074|NCT02367794|449447489|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
124951075|NCT02367794|449447490|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
124951076|NCT02367794|449447488|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
124951077|NCT02367794|449447489|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
124951078|NCT02367794|449447490|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
124951079|NCT02367794|449447488|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
124951080|NCT02367794|449447489|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
124707416|NCT02921256|448554636|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
124707417|NCT02921256|448554637|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
124707418|NCT02921256|448554638|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
124707419|NCT02943473|448554639|FG000|Overall Study|enrolled but not dosed|1|||
124707420|NCT02943473|448554639|FG000|Overall Study|screen failure|1|||
124707421|NCT02943473|448554639|FG000|Overall Study|Physician Decision|4|||
124707422|NCT04211363|448554642|FG000|Overall Study|Adverse Event|5|||
124707423|NCT04211363|448554643|FG001|Overall Study|Adverse Event|2|||
124707424|NCT04211363|448554642|FG000|Overall Study|Physician Decision|0|||
124707425|NCT04211363|448554643|FG001|Overall Study|Physician Decision|1|||
124707426|NCT04211363|448554642|FG000|Overall Study|Protocol Violation|1|||
124707427|NCT04211363|448554643|FG001|Overall Study|Protocol Violation|0|||
124707428|NCT04211363|448554642|FG000|Overall Study|Pregnancy|1|||
124707429|NCT04211363|448554643|FG001|Overall Study|Pregnancy|0|||
124707430|NCT04211363|448554642|FG000|Overall Study|Lost to Follow-up|12|||
124707431|NCT04211363|448554643|FG001|Overall Study|Lost to Follow-up|4|||
124707432|NCT04211363|448554642|FG000|Overall Study|Withdrawal by Subject|11|||
124707433|NCT04211363|448554643|FG001|Overall Study|Withdrawal by Subject|11|||
124707434|NCT04211363|448554642|FG000|Overall Study|Other|1|||
124707435|NCT04211363|448554643|FG001|Overall Study|Other|2|||
124459953|NCT05038020|447642427|FG000|Overall Study|Early Termination|3|||
124459954|NCT05038020|447642428|FG001|Overall Study|Early Termination|0|||
124459955|NCT02831673|447644008|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
124459956|NCT02831673|447644009|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
124459957|NCT02831673|447644010|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
124459958|NCT02831673|447644011|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
124459959|NCT02831673|447644012|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
124459960|NCT02831673|447644008|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
124459961|NCT02831673|447644009|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
124459962|NCT02831673|447644010|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
124459963|NCT02831673|447644011|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
124459964|NCT02831673|447644012|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
124459965|NCT02831673|447644008|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
124459966|NCT02831673|447644009|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
124459967|NCT02831673|447644010|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
124707436|NCT03097289|448554644|FG000|Overall Study|Adverse Event|1|||
124707437|NCT03097289|448554644|FG000|Overall Study|Equipment failure|2|||
124707438|NCT03097289|448554644|FG000|Overall Study|Collected platelet product unusable|3|||
124707439|NCT01736917|448554645|FG000|Overall Study|Adverse Event|1|||
124951081|NCT02367794|449447490|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
124951082|NCT00882050|449447491|FG000|Overall Study|Physician Decision|1|||
124951083|NCT00882050|449447492|FG001|Overall Study|Physician Decision|0|||
124951084|NCT00882050|449447493|FG002|Overall Study|Physician Decision|0|||
124951085|NCT02010684|449447494|FG000|Overall Study|Lost to Follow-up|8|||
124459968|NCT02831673|447644011|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
124459969|NCT02831673|447644012|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
124459970|NCT02831673|447644008|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
124459971|NCT02831673|447644009|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
124459972|NCT02831673|447644010|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
124459973|NCT02831673|447644011|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
124459974|NCT02831673|447644012|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
124459975|NCT02831673|447644008|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
124459976|NCT02831673|447644009|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
124459977|NCT02831673|447644010|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
124548804|NCT03901339|447965361|FG000|Overall Study|Sponsor request|30|||
124459978|NCT02831673|447644011|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
124707440|NCT01736917|448554645|FG000|Overall Study|Protocol Violation|10|||
124707441|NCT01911260|448554646|FG000|Supplementation Period|transference or evasion of school|7|||
124707442|NCT01911260|448554647|FG001|Supplementation Period|transference or evasion of school|9|||
124707443|NCT01911260|448554648|FG002|Supplementation Period|transference or evasion of school|7|||
124707444|NCT01911260|448554649|FG003|Supplementation Period|transference or evasion of school|6|||
124707445|NCT01911260|448554646|FG000|Supplementation Period|Adverse Event|2|||
124707446|NCT01911260|448554647|FG001|Supplementation Period|Adverse Event|0|||
124707447|NCT01911260|448554648|FG002|Supplementation Period|Adverse Event|1|||
124951086|NCT02010684|449447495|FG001|Overall Study|Lost to Follow-up|18|||
124951087|NCT02010684|449447494|FG000|Overall Study|Withdrawal by Subject|4|||
124951088|NCT02010684|449447495|FG001|Overall Study|Withdrawal by Subject|5|||
124951089|NCT02612285|449447496|FG000|Overall Study|Withdrawal by Subject|1|||
124951090|NCT00805441|449447497|FG000|Overall Study|Adverse Event|5|||
124951091|NCT00805441|449447498|FG001|Overall Study|Adverse Event|2|||
124951092|NCT00805441|449447497|FG000|Overall Study|Lack of Efficacy|0|||
124951093|NCT00805441|449447498|FG001|Overall Study|Lack of Efficacy|2|||
124951094|NCT00805441|449447497|FG000|Overall Study|Protocol Violation|4|||
124951095|NCT00805441|449447498|FG001|Overall Study|Protocol Violation|8|||
124951096|NCT00805441|449447497|FG000|Overall Study|Lost to Follow-up|10|||
124951097|NCT00805441|449447498|FG001|Overall Study|Lost to Follow-up|13|||
124951098|NCT00805441|449447497|FG000|Overall Study|Withdrawal by Subject|15|||
124951099|NCT00805441|449447498|FG001|Overall Study|Withdrawal by Subject|9|||
124951100|NCT00805441|449447497|FG000|Overall Study|Physician Decision|0|||
124951101|NCT00805441|449447498|FG001|Overall Study|Physician Decision|1|||
124951102|NCT00805441|449447497|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
124951103|NCT00805441|449447498|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
124951104|NCT01884571|449447503|FG000|Overall Study|Adverse Event|1|||
124951105|NCT01884571|449447503|FG000|Overall Study|Death|2|||
124951106|NCT01884571|449447503|FG000|Overall Study|Withdrawal by Subject|2|||
124951107|NCT01884571|449447503|FG000|Overall Study|Disease progression|3|||
124951108|NCT00091572|449447504|FG000|Overall Study|Lost to Follow-up|1|||
124951109|NCT00091572|449447505|FG001|Overall Study|Lost to Follow-up|1|||
124951110|NCT00091572|449447504|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
124951111|NCT00091572|449447505|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
124951112|NCT00091572|449447504|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
124951113|NCT00091572|449447505|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
124951114|NCT00091572|449447504|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
124951115|NCT00091572|449447505|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
124951116|NCT00091572|449447504|FG000|Overall Study|Other Reason|6|||
124951117|NCT00091572|449447505|FG001|Overall Study|Other Reason|13|||
124951118|NCT00091572|449447504|FG000|Overall Study|Ongoing (still on treatment)|8|||
124951119|NCT00091572|449447505|FG001|Overall Study|Ongoing (still on treatment)|12|||
124951120|NCT00091572|449447504|FG000|Overall Study|Major Protocol Violation|2|||
124951121|NCT00091572|449447505|FG001|Overall Study|Major Protocol Violation|0|||
124951122|NCT00091572|449447504|FG000|Overall Study|Toxicity (Related AE)|53|||
124951123|NCT00091572|449447505|FG001|Overall Study|Toxicity (Related AE)|9|||
124951124|NCT02942771|449447507|FG000|Overall Study|Adverse Event|1|||
124951125|NCT02942771|449447508|FG001|Overall Study|Adverse Event|0|||
124951126|NCT02942771|449447509|FG002|Overall Study|Adverse Event|0|||
124951127|NCT02942771|449447510|FG003|Overall Study|Adverse Event|0|||
124951128|NCT02942771|449447511|FG004|Overall Study|Adverse Event|2|||
124951129|NCT02942771|449447507|FG000|Overall Study|Lost to Follow-up|1|||
124951130|NCT02942771|449447508|FG001|Overall Study|Lost to Follow-up|0|||
124951131|NCT02942771|449447509|FG002|Overall Study|Lost to Follow-up|0|||
124951132|NCT02942771|449447510|FG003|Overall Study|Lost to Follow-up|0|||
124951133|NCT02942771|449447511|FG004|Overall Study|Lost to Follow-up|0|||
124951134|NCT02942771|449447507|FG000|Overall Study|Withdrawal by Subject|1|||
124951135|NCT02942771|449447508|FG001|Overall Study|Withdrawal by Subject|0|||
124951136|NCT02942771|449447509|FG002|Overall Study|Withdrawal by Subject|0|||
124951137|NCT02942771|449447510|FG003|Overall Study|Withdrawal by Subject|0|||
124951138|NCT02942771|449447511|FG004|Overall Study|Withdrawal by Subject|2|||
124951139|NCT02340806|449447515|FG000|Overall Study|Protocol Violation|2|||
124951140|NCT02340806|449447516|FG001|Overall Study|Protocol Violation|0|||
124951141|NCT02340806|449447515|FG000|Overall Study|epidural catheter replaced|2|||
124951142|NCT02340806|449447516|FG001|Overall Study|epidural catheter replaced|1|||
124951143|NCT02340806|449447515|FG000|Overall Study|history of chronic pain medication|1|||
124951144|NCT02340806|449447516|FG001|Overall Study|history of chronic pain medication|0|||
124951145|NCT02340806|449447515|FG000|Overall Study|re-dose < 90 min of CSE|1|||
124707448|NCT01911260|448554649|FG003|Supplementation Period|Adverse Event|0|||
124951146|NCT02340806|449447516|FG001|Overall Study|re-dose < 90 min of CSE|3|||
124951147|NCT01186809|449447517|FG000|Overall Study|Death|30|||
124951148|NCT00452452|449447518|FG000|Overall Study|Protocol Violation|0|||
124951149|NCT00452452|449447519|FG001|Overall Study|Protocol Violation|0|||
124951150|NCT00452452|449447520|FG002|Overall Study|Protocol Violation|1|||
124951151|NCT00452452|449447518|FG000|Overall Study|Withdrawal by Subject|1|||
124951152|NCT00452452|449447519|FG001|Overall Study|Withdrawal by Subject|0|||
124951153|NCT00452452|449447520|FG002|Overall Study|Withdrawal by Subject|0|||
124951154|NCT00452452|449447518|FG000|Overall Study|Lost to Follow-up|1|||
124951155|NCT00452452|449447519|FG001|Overall Study|Lost to Follow-up|0|||
124951156|NCT00452452|449447520|FG002|Overall Study|Lost to Follow-up|0|||
124951157|NCT01159600|449447526|FG000|Overall Study|Not treated|0|||
124951158|NCT01159600|449447527|FG001|Overall Study|Not treated|0|||
124951159|NCT01159600|449447528|FG002|Overall Study|Not treated|1|||
124951160|NCT01159600|449447529|FG003|Overall Study|Not treated|0|||
124951161|NCT01159600|449447530|FG004|Overall Study|Not treated|0|||
124951162|NCT01159600|449447531|FG005|Overall Study|Not treated|1|||
124951163|NCT01159600|449447532|FG006|Overall Study|Not treated|2|||
124951164|NCT01159600|449447533|FG007|Overall Study|Not treated|2|||
124951165|NCT01159600|449447526|FG000|Overall Study|Adverse Event|7|||
124951166|NCT01159600|449447527|FG001|Overall Study|Adverse Event|2|||
124951167|NCT01159600|449447528|FG002|Overall Study|Adverse Event|5|||
124951168|NCT01159600|449447529|FG003|Overall Study|Adverse Event|1|||
124951169|NCT01159600|449447530|FG004|Overall Study|Adverse Event|8|||
124951170|NCT01159600|449447531|FG005|Overall Study|Adverse Event|6|||
124951171|NCT01159600|449447532|FG006|Overall Study|Adverse Event|7|||
124951172|NCT01159600|449447533|FG007|Overall Study|Adverse Event|5|||
124951173|NCT01159600|449447526|FG000|Overall Study|Lack of Efficacy|0|||
124951174|NCT01159600|449447527|FG001|Overall Study|Lack of Efficacy|0|||
124951175|NCT01159600|449447528|FG002|Overall Study|Lack of Efficacy|0|||
124951176|NCT01159600|449447529|FG003|Overall Study|Lack of Efficacy|0|||
124951177|NCT01159600|449447530|FG004|Overall Study|Lack of Efficacy|2|||
124951178|NCT01159600|449447531|FG005|Overall Study|Lack of Efficacy|0|||
124951179|NCT01159600|449447532|FG006|Overall Study|Lack of Efficacy|0|||
124951180|NCT01159600|449447533|FG007|Overall Study|Lack of Efficacy|1|||
124951181|NCT01159600|449447526|FG000|Overall Study|Non compliant with protocol|2|||
124951182|NCT01159600|449447527|FG001|Overall Study|Non compliant with protocol|1|||
124951183|NCT01159600|449447528|FG002|Overall Study|Non compliant with protocol|0|||
124951184|NCT01159600|449447529|FG003|Overall Study|Non compliant with protocol|0|||
124951185|NCT01159600|449447530|FG004|Overall Study|Non compliant with protocol|2|||
124951186|NCT01159600|449447531|FG005|Overall Study|Non compliant with protocol|0|||
124951187|NCT01159600|449447532|FG006|Overall Study|Non compliant with protocol|2|||
124951188|NCT01159600|449447533|FG007|Overall Study|Non compliant with protocol|0|||
124951189|NCT01159600|449447526|FG000|Overall Study|Lost to Follow-up|2|||
124951190|NCT01159600|449447527|FG001|Overall Study|Lost to Follow-up|3|||
124951191|NCT01159600|449447528|FG002|Overall Study|Lost to Follow-up|4|||
124951192|NCT01159600|449447529|FG003|Overall Study|Lost to Follow-up|3|||
124951193|NCT01159600|449447530|FG004|Overall Study|Lost to Follow-up|3|||
124951194|NCT01159600|449447531|FG005|Overall Study|Lost to Follow-up|0|||
124951195|NCT01159600|449447532|FG006|Overall Study|Lost to Follow-up|3|||
124951196|NCT01159600|449447533|FG007|Overall Study|Lost to Follow-up|2|||
124951197|NCT01159600|449447526|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
124951198|NCT01159600|449447527|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
124951199|NCT01159600|449447528|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
124951200|NCT01159600|449447529|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
124951201|NCT01159600|449447530|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
124951202|NCT01159600|449447531|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
124951203|NCT01159600|449447532|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
124951204|NCT01159600|449447533|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
124951205|NCT01159600|449447526|FG000|Overall Study|Other reason not defined above|3|||
124951206|NCT01159600|449447527|FG001|Overall Study|Other reason not defined above|0|||
124951207|NCT01159600|449447528|FG002|Overall Study|Other reason not defined above|4|||
124951208|NCT01159600|449447529|FG003|Overall Study|Other reason not defined above|2|||
124951209|NCT01159600|449447530|FG004|Overall Study|Other reason not defined above|5|||
124951210|NCT01159600|449447531|FG005|Overall Study|Other reason not defined above|7|||
124951211|NCT01159600|449447532|FG006|Overall Study|Other reason not defined above|3|||
124951212|NCT01159600|449447533|FG007|Overall Study|Other reason not defined above|3|||
124951213|NCT04433091|449447534|FG000|Overall Study|Lost to Follow-up|1|||
124951214|NCT04433091|449447535|FG001|Overall Study|Lost to Follow-up|0|||
124951215|NCT04433091|449447534|FG000|Overall Study|Withdrawn .|2|||
124951216|NCT04433091|449447535|FG001|Overall Study|Withdrawn .|4|||
124951217|NCT04097535|449447536|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
124951218|NCT03070301|449447537|FG000|Overall Study|Progression of disease|16|||
124951219|NCT03070301|449447537|FG000|Overall Study|Physician Decision|3|||
124951220|NCT03070301|449447537|FG000|Overall Study|Withdrawal by Subject|1|||
124951221|NCT01975701|449449421|FG000|Overall Study|Lost to Follow-up|1|||
124951222|NCT01975701|449449421|FG000|Overall Study|Death|23|||
124951223|NCT01975701|449449421|FG000|Overall Study|Physician Decision|1|||
124951224|NCT01072149|449449424|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951225|NCT01072149|449449425|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951226|NCT01072149|449449426|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
124951227|NCT01072149|449449427|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951228|NCT01072149|449449428|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951229|NCT01072149|449449429|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951230|NCT01072149|449449430|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951231|NCT01072149|449449431|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951232|NCT01072149|449449432|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951233|NCT01072149|449449433|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951234|NCT01072149|449449434|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951235|NCT01072149|449449435|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951236|NCT01072149|449449436|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951237|NCT01072149|449449437|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951238|NCT01072149|449449438|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951239|NCT01072149|449449439|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951240|NCT01072149|449449440|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951241|NCT01072149|449449441|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
124951242|NCT01072149|449449424|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951243|NCT01072149|449449425|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951244|NCT01072149|449449426|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951245|NCT01072149|449449427|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951246|NCT01072149|449449428|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951247|NCT01072149|449449429|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951248|NCT01072149|449449430|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951249|NCT01072149|449449431|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951250|NCT01072149|449449432|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951251|NCT01072149|449449433|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951252|NCT01072149|449449434|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951253|NCT01072149|449449435|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951254|NCT01072149|449449436|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951255|NCT01072149|449449437|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951256|NCT01072149|449449438|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951257|NCT01072149|449449439|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951258|NCT01072149|449449440|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
124951259|NCT01072149|449449441|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
124951260|NCT01072149|449449424|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951261|NCT01072149|449449425|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951262|NCT01072149|449449426|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951263|NCT01072149|449449427|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951264|NCT01072149|449449428|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951265|NCT01072149|449449429|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951266|NCT01072149|449449430|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951267|NCT01072149|449449431|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951268|NCT01072149|449449432|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951269|NCT01072149|449449433|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951270|NCT01072149|449449434|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
124951271|NCT01072149|449449435|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951272|NCT01072149|449449436|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951273|NCT01072149|449449437|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951274|NCT01072149|449449438|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951275|NCT01072149|449449439|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951276|NCT01072149|449449440|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951277|NCT01072149|449449441|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
124951278|NCT01072149|449449424|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951279|NCT01072149|449449425|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
124951280|NCT01072149|449449426|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951281|NCT01072149|449449427|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951282|NCT01072149|449449428|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951283|NCT01072149|449449429|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951284|NCT01072149|449449430|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951285|NCT01072149|449449431|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951286|NCT01072149|449449432|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951287|NCT01072149|449449433|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951288|NCT01072149|449449434|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951289|NCT01072149|449449435|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951290|NCT01072149|449449436|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124766373|NCT04079296|448771703|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
124766374|NCT04079296|448771704|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
124766375|NCT04079296|448771700|FG000|Dose Expansion Phase (168 Days)|Death|0|||
124766376|NCT04079296|448771701|FG001|Dose Expansion Phase (168 Days)|Death|0|||
124951291|NCT01072149|449449437|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951292|NCT01072149|449449438|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951293|NCT01072149|449449439|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124766377|NCT04079296|448771702|FG002|Dose Expansion Phase (168 Days)|Death|0|||
124951294|NCT01072149|449449440|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124766378|NCT04079296|448771703|FG003|Dose Expansion Phase (168 Days)|Death|1|||
124766379|NCT04079296|448771704|FG004|Dose Expansion Phase (168 Days)|Death|0|||
124766380|NCT01346358|448771717|FG000|Overall Study|Withdrawal by Subject|1|||
124766381|NCT01346358|448771718|FG001|Overall Study|Withdrawal by Subject|0|||
124766382|NCT01346358|448771719|FG002|Overall Study|Withdrawal by Subject|1|||
124766383|NCT01346358|448771720|FG003|Overall Study|Withdrawal by Subject|1|||
124766384|NCT01346358|448771721|FG004|Overall Study|Withdrawal by Subject|0|||
124766385|NCT01346358|448771722|FG005|Overall Study|Withdrawal by Subject|2|||
124766386|NCT01346358|448771723|FG006|Overall Study|Withdrawal by Subject|1|||
124766387|NCT01346358|448771724|FG007|Overall Study|Withdrawal by Subject|1|||
124766388|NCT01346358|448771725|FG008|Overall Study|Withdrawal by Subject|1|||
124766389|NCT01346358|448771717|FG000|Overall Study|Adverse Event|1|||
124766390|NCT01346358|448771718|FG001|Overall Study|Adverse Event|0|||
124766391|NCT01346358|448771719|FG002|Overall Study|Adverse Event|0|||
124766392|NCT01346358|448771720|FG003|Overall Study|Adverse Event|0|||
124766393|NCT01346358|448771721|FG004|Overall Study|Adverse Event|1|||
124766394|NCT01346358|448771722|FG005|Overall Study|Adverse Event|0|||
124766395|NCT01346358|448771723|FG006|Overall Study|Adverse Event|0|||
124766396|NCT01346358|448771724|FG007|Overall Study|Adverse Event|0|||
124766397|NCT01346358|448771725|FG008|Overall Study|Adverse Event|1|||
124766398|NCT01346358|448771717|FG000|Overall Study|Non-Compliance|0|||
124951295|NCT01072149|449449441|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
124951296|NCT01072149|449449424|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951297|NCT01072149|449449425|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951298|NCT01072149|449449426|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
124951299|NCT01072149|449449427|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951300|NCT01072149|449449428|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951301|NCT01072149|449449429|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951302|NCT01072149|449449430|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951303|NCT01072149|449449431|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951304|NCT01072149|449449432|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951305|NCT01072149|449449433|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951306|NCT01072149|449449434|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951307|NCT01072149|449449435|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951308|NCT01072149|449449436|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951309|NCT01072149|449449437|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951310|NCT01072149|449449438|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951311|NCT01072149|449449439|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951312|NCT01072149|449449440|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951313|NCT01072149|449449441|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
124951314|NCT01072149|449449424|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951315|NCT01072149|449449425|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951316|NCT01072149|449449426|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951317|NCT01072149|449449427|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951318|NCT01072149|449449428|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951319|NCT01072149|449449429|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951320|NCT01072149|449449430|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951321|NCT01072149|449449431|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
124951322|NCT01072149|449449432|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951323|NCT01072149|449449433|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951324|NCT01072149|449449434|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951325|NCT01072149|449449435|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951326|NCT01072149|449449436|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951327|NCT01072149|449449437|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951328|NCT01072149|449449438|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951329|NCT01072149|449449439|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951330|NCT01072149|449449440|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951331|NCT01072149|449449441|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
124951332|NCT01072149|449449424|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
124951333|NCT01072149|449449425|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
124951334|NCT01072149|449449426|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
124951335|NCT01072149|449449427|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
124459979|NCT02831673|447644012|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
124459980|NCT02831673|447644008|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
124766399|NCT01346358|448771718|FG001|Overall Study|Non-Compliance|0|||
124459981|NCT02831673|447644009|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
124766400|NCT01346358|448771719|FG002|Overall Study|Non-Compliance|0|||
124766401|NCT01346358|448771720|FG003|Overall Study|Non-Compliance|0|||
124766402|NCT01346358|448771721|FG004|Overall Study|Non-Compliance|0|||
124766403|NCT01346358|448771722|FG005|Overall Study|Non-Compliance|0|||
124951336|NCT01072149|449449428|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
124951337|NCT01072149|449449429|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
124951338|NCT01072149|449449430|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
124951339|NCT01072149|449449431|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
124951340|NCT01072149|449449432|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
124951341|NCT01072149|449449433|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
124951342|NCT01072149|449449434|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
124951343|NCT01072149|449449435|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
124951344|NCT01072149|449449436|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
124951345|NCT01072149|449449437|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
124951346|NCT01072149|449449438|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
124951347|NCT01072149|449449439|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
124951348|NCT01072149|449449440|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
124951349|NCT01072149|449449441|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
124951350|NCT01072149|449449424|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951351|NCT01072149|449449425|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951352|NCT01072149|449449426|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951353|NCT01072149|449449427|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951354|NCT01072149|449449428|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951355|NCT01072149|449449429|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951356|NCT01072149|449449430|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951357|NCT01072149|449449431|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951358|NCT01072149|449449432|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951359|NCT01072149|449449433|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951360|NCT01072149|449449434|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951361|NCT01072149|449449435|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951362|NCT01072149|449449436|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951363|NCT01072149|449449437|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951364|NCT01072149|449449438|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951365|NCT01072149|449449439|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
124951366|NCT01072149|449449440|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951367|NCT01072149|449449441|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
124951368|NCT01072149|449449424|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
124951369|NCT01072149|449449425|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
124951370|NCT01072149|449449426|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
124951371|NCT01072149|449449427|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
124951372|NCT01072149|449449428|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
124951373|NCT01072149|449449429|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
124951374|NCT01072149|449449430|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
124951375|NCT01072149|449449431|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
124951376|NCT01072149|449449432|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
124951377|NCT01072149|449449433|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
124951378|NCT01072149|449449434|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
124951379|NCT01072149|449449435|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
124951380|NCT01072149|449449436|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
124951381|NCT01072149|449449437|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
124951382|NCT01072149|449449438|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
124951383|NCT01072149|449449439|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
124951384|NCT01072149|449449440|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
124951385|NCT01072149|449449441|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
124951386|NCT01072149|449449424|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951387|NCT01072149|449449425|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951388|NCT01072149|449449426|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951389|NCT01072149|449449427|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951390|NCT01072149|449449428|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951391|NCT01072149|449449429|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951392|NCT01072149|449449430|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951393|NCT01072149|449449431|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951394|NCT01072149|449449432|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951395|NCT01072149|449449433|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951396|NCT01072149|449449434|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124548805|NCT03901339|447965362|FG001|Overall Study|Sponsor request|23|||
124548806|NCT03901339|447965361|FG000|Overall Study|Reason not specified|5|||
124548807|NCT03901339|447965362|FG001|Overall Study|Reason not specified|7|||
124548808|NCT03901339|447965361|FG000|Overall Study|Lost to Follow-up|4|||
124548809|NCT03901339|447965362|FG001|Overall Study|Lost to Follow-up|7|||
124548810|NCT03901339|447965361|FG000|Overall Study|Covid19|0|||
124548811|NCT03901339|447965362|FG001|Overall Study|Covid19|2|||
124548812|NCT02886494|447965364|FG000|Overall Study|Adverse Event|1|||
124548813|NCT02886494|447965365|FG001|Overall Study|Adverse Event|0|||
124548814|NCT02886494|447965364|FG000|Overall Study|Withdrawal by Subject|12|||
124548815|NCT02886494|447965365|FG001|Overall Study|Withdrawal by Subject|3|||
124951397|NCT01072149|449449435|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951398|NCT01072149|449449436|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
124951399|NCT01072149|449449437|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951400|NCT01072149|449449438|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951401|NCT01072149|449449439|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951402|NCT01072149|449449440|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951403|NCT01072149|449449441|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
124951404|NCT01072149|449449424|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951405|NCT01072149|449449425|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951406|NCT01072149|449449426|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
124951407|NCT01072149|449449427|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951408|NCT01072149|449449428|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951409|NCT01072149|449449429|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951410|NCT01072149|449449430|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951411|NCT01072149|449449431|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951412|NCT01072149|449449432|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951413|NCT01072149|449449433|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951414|NCT01072149|449449434|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951415|NCT01072149|449449435|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951416|NCT01072149|449449436|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951417|NCT01072149|449449437|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
124951418|NCT01072149|449449438|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951419|NCT01072149|449449439|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951420|NCT01072149|449449440|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951421|NCT01072149|449449441|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
124951422|NCT02784834|449449442|FG000|Overall Study|Lack of Efficacy|1|||
124459982|NCT02831673|447644010|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
124707449|NCT01911260|448554646|FG000|Supplementation Period|refused to receive supplement|1|||
124707450|NCT01911260|448554647|FG001|Supplementation Period|refused to receive supplement|0|||
124707451|NCT01911260|448554648|FG002|Supplementation Period|refused to receive supplement|1|||
124707452|NCT01911260|448554649|FG003|Supplementation Period|refused to receive supplement|0|||
124707453|NCT01911260|448554646|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
124707454|NCT01911260|448554647|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
124707455|NCT01911260|448554648|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
124951423|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
124951424|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
124951425|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
124459983|NCT02831673|447644011|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
124459984|NCT02831673|447644012|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
124459985|NCT02831673|447644008|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
124459986|NCT02831673|447644009|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
124459987|NCT02831673|447644010|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
124459988|NCT02831673|447644011|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
124459989|NCT02831673|447644012|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
124459990|NCT02831673|447644008|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
124459991|NCT02831673|447644009|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
124459992|NCT02831673|447644010|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
124459993|NCT02831673|447644011|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
124459994|NCT02831673|447644012|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
124459995|NCT02831673|447644008|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
124459996|NCT02831673|447644009|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
124707456|NCT01911260|448554649|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
124951426|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
124951427|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Adverse Event|7|||
124951428|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Adverse Event|8|||
124951429|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Adverse Event|8|||
124951430|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Adverse Event|9|||
124951431|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
124951432|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
124951433|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
124951434|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
124951435|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
124951436|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
124951437|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
124951438|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
124951439|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Pregnancy|0|||
124951440|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Pregnancy|2|||
124951441|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Pregnancy|2|||
124951442|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Pregnancy|0|||
124951443|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Non-compliance|1|||
124951444|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Non-compliance|0|||
124951445|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Non-compliance|0|||
124459997|NCT02831673|447644010|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
124951446|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Non-compliance|3|||
124951447|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Other|3|||
124459998|NCT02831673|447644011|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
124459999|NCT02831673|447644012|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
124460000|NCT02831673|447644008|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
124460001|NCT02831673|447644009|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
124460002|NCT02831673|447644010|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
124460003|NCT02831673|447644011|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
124460004|NCT02831673|447644012|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
124460005|NCT02831673|447644008|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
124460006|NCT02831673|447644009|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
124460007|NCT02831673|447644010|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
124460008|NCT02831673|447644011|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
124460009|NCT02831673|447644012|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
124460010|NCT02831673|447644008|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
124460011|NCT02831673|447644009|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
124460012|NCT02831673|447644010|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
124460013|NCT02831673|447644011|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
124460014|NCT02831673|447644012|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
124460015|NCT02831673|447644008|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
124460016|NCT02831673|447644009|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
124460017|NCT02831673|447644010|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
124460018|NCT02831673|447644011|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
124460019|NCT02831673|447644012|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
124460020|NCT02831673|447644008|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
124460021|NCT02831673|447644009|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
124460022|NCT02831673|447644010|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
124460023|NCT02831673|447644011|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
124460024|NCT02831673|447644012|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
124460025|NCT02831673|447644008|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
124460026|NCT02831673|447644009|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
124460027|NCT02831673|447644010|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
124460028|NCT02831673|447644011|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
124460029|NCT02831673|447644012|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
124460030|NCT02831673|447644008|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
124460031|NCT02831673|447644009|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
124460032|NCT02831673|447644010|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
124460033|NCT02831673|447644011|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
124951448|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Other|0|||
124951449|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Other|3|||
124951450|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Other|2|||
124951451|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
124951452|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
124951453|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
124951454|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
124548816|NCT02886494|447965364|FG000|Overall Study|Protocol Violation|4|||
124548817|NCT02886494|447965365|FG001|Overall Study|Protocol Violation|1|||
124548818|NCT00457418|447965366|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
124548819|NCT00457418|447965366|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
124548820|NCT00457418|447965366|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
124548821|NCT00457418|447965366|FG000|Post PK Maintenance|Adverse Event|10|||
124548822|NCT00457418|447965366|FG000|Post PK Maintenance|Progression of Disease|6|||
124548823|NCT00457418|447965366|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
124548824|NCT00457418|447965366|FG000|Post PK Maintenance|Lost to Follow-up|1|||
124548825|NCT01785472|447965367|FG000|Overall Study|Adverse Event|5|||
124548826|NCT01785472|447965368|FG001|Overall Study|Adverse Event|4|||
124548827|NCT01785472|447965369|FG002|Overall Study|Adverse Event|6|||
124460034|NCT02831673|447644012|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
124460035|NCT02831673|447644008|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
124460036|NCT02831673|447644009|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
124460037|NCT02831673|447644010|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
124460038|NCT02831673|447644011|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
124460039|NCT02831673|447644012|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
124460040|NCT02831673|447644008|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
124460041|NCT02831673|447644009|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
124460042|NCT02831673|447644010|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
124460043|NCT02831673|447644011|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
124548828|NCT01785472|447965367|FG000|Overall Study|Lack of Efficacy|2|||
124548829|NCT01785472|447965368|FG001|Overall Study|Lack of Efficacy|0|||
124548830|NCT01785472|447965369|FG002|Overall Study|Lack of Efficacy|1|||
124548831|NCT01785472|447965367|FG000|Overall Study|Lost to Follow-up|1|||
124766404|NCT01346358|448771723|FG006|Overall Study|Non-Compliance|0|||
124548832|NCT01785472|447965368|FG001|Overall Study|Lost to Follow-up|2|||
124548833|NCT01785472|447965369|FG002|Overall Study|Lost to Follow-up|0|||
124548834|NCT01785472|447965367|FG000|Overall Study|Physician Decision|1|||
124548835|NCT01785472|447965368|FG001|Overall Study|Physician Decision|1|||
124548836|NCT01785472|447965369|FG002|Overall Study|Physician Decision|1|||
124548837|NCT01785472|447965367|FG000|Overall Study|Protocol deviation|0|||
124548838|NCT01785472|447965368|FG001|Overall Study|Protocol deviation|2|||
124548839|NCT01785472|447965369|FG002|Overall Study|Protocol deviation|2|||
124548840|NCT01785472|447965367|FG000|Overall Study|Subject/guardian decision|15|||
124548841|NCT01785472|447965368|FG001|Overall Study|Subject/guardian decision|10|||
124548842|NCT01785472|447965369|FG002|Overall Study|Subject/guardian decision|11|||
124548843|NCT01785472|447965367|FG000|Overall Study|Technical problems|0|||
124548844|NCT01785472|447965368|FG001|Overall Study|Technical problems|0|||
124548845|NCT01785472|447965369|FG002|Overall Study|Technical problems|1|||
124548846|NCT00595127|447965370|FG000|Overall Study|Death|6|||
124548847|NCT00595127|447965370|FG000|Overall Study|Relapsed|3|||
124548848|NCT00595127|447965370|FG000|Overall Study|joined another trial|1|||
124548849|NCT02086968|447965372|FG000|Overall Study|Adverse Event|1|||
124548850|NCT02086968|447965373|FG001|Overall Study|Adverse Event|5|||
124548851|NCT02086968|447965372|FG000|Overall Study|Lost to Follow-up|2|||
124548852|NCT02086968|447965373|FG001|Overall Study|Lost to Follow-up|3|||
124548853|NCT02086968|447965372|FG000|Overall Study|Study drug received outside protocol|0|||
124548854|NCT02086968|447965373|FG001|Overall Study|Study drug received outside protocol|1|||
124548855|NCT02086968|447965372|FG000|Overall Study|Physician Decision|4|||
124548856|NCT02086968|447965373|FG001|Overall Study|Physician Decision|0|||
124548857|NCT02086968|447965372|FG000|Overall Study|Withdrawal by Subject|1|||
124548858|NCT02086968|447965373|FG001|Overall Study|Withdrawal by Subject|4|||
124548859|NCT03099161|447965374|FG000|Overall Study|Adverse Event|0|||
124548860|NCT03099161|447965375|FG001|Overall Study|Adverse Event|0|||
124951455|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
124951456|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
124951457|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
124951458|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
124951459|NCT02143713|449449443|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
124951460|NCT02143713|449449444|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
124951461|NCT02143713|449449445|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
124951462|NCT02143713|449449446|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
124951463|NCT02143713|449449443|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
124951464|NCT02143713|449449444|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
124951465|NCT02143713|449449445|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
124951466|NCT02143713|449449446|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
124951467|NCT02143713|449449443|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
124951468|NCT02143713|449449444|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
124951469|NCT02143713|449449445|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
124951470|NCT02143713|449449446|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
124951471|NCT02143713|449449443|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
124951472|NCT02143713|449449444|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
124951473|NCT02143713|449449445|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
124951474|NCT02143713|449449446|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
124951475|NCT02143713|449449443|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
124951476|NCT02143713|449449444|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
124951477|NCT02143713|449449445|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
124951478|NCT02143713|449449446|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
124951479|NCT02143713|449449443|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
124951480|NCT02143713|449449444|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
124951481|NCT02143713|449449445|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
124951482|NCT02143713|449449446|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
124951483|NCT02143713|449449443|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
124951484|NCT02143713|449449444|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
124951485|NCT02143713|449449445|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
124951486|NCT02143713|449449446|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
124951487|NCT01768572|449449449|FG000|Overall Study|Adverse Event|7|||
124951488|NCT01768572|449449450|FG001|Overall Study|Adverse Event|8|||
124951489|NCT01768572|449449451|FG002|Overall Study|Adverse Event|4|||
124548861|NCT03099161|447965376|FG002|Overall Study|Adverse Event|2|||
124548862|NCT03099161|447965374|FG000|Overall Study|Physician Decision|2|||
124548863|NCT03099161|447965375|FG001|Overall Study|Physician Decision|0|||
124548864|NCT03099161|447965376|FG002|Overall Study|Physician Decision|0|||
124548865|NCT03099161|447965374|FG000|Overall Study|Progressive Disease|1|||
124548866|NCT03099161|447965375|FG001|Overall Study|Progressive Disease|4|||
124548867|NCT03099161|447965376|FG002|Overall Study|Progressive Disease|1|||
124548868|NCT02723786|447965377|FG000|Overall Study|Lost to Follow-up|1|||
124951490|NCT01768572|449449449|FG000|Overall Study|Lack of Efficacy|1|||
124951491|NCT01768572|449449450|FG001|Overall Study|Lack of Efficacy|3|||
124951492|NCT01768572|449449451|FG002|Overall Study|Lack of Efficacy|1|||
124951493|NCT01768572|449449449|FG000|Overall Study|Other, Not due to an adverse event|1|||
124951494|NCT01768572|449449450|FG001|Overall Study|Other, Not due to an adverse event|1|||
124951495|NCT01768572|449449451|FG002|Overall Study|Other, Not due to an adverse event|1|||
124951496|NCT00080119|449449452|FG000|Overall Study|Discontinued because of study closure|0|||
124951497|NCT00080119|449449453|FG001|Overall Study|Discontinued because of study closure|0|||
124951498|NCT00080119|449449454|FG002|Overall Study|Discontinued because of study closure|130|||
124951499|NCT00080119|449449455|FG003|Overall Study|Discontinued because of study closure|141|||
124951500|NCT00080119|449449452|FG000|Overall Study|Unable to get to clinic|24|||
124951501|NCT00080119|449449453|FG001|Overall Study|Unable to get to clinic|24|||
124951502|NCT00080119|449449454|FG002|Overall Study|Unable to get to clinic|7|||
124951503|NCT00080119|449449455|FG003|Overall Study|Unable to get to clinic|1|||
124951504|NCT00080119|449449452|FG000|Overall Study|Consent withdrawn|13|||
124951505|NCT00080119|449449453|FG001|Overall Study|Consent withdrawn|17|||
124951506|NCT00080119|449449454|FG002|Overall Study|Consent withdrawn|4|||
124951507|NCT00080119|449449455|FG003|Overall Study|Consent withdrawn|6|||
124951508|NCT00080119|449449452|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
124951509|NCT00080119|449449453|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
124951510|NCT00080119|449449454|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
124951511|NCT00080119|449449455|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
124951512|NCT00080119|449449452|FG000|Overall Study|Lost to Follow-up|16|||
124951513|NCT00080119|449449453|FG001|Overall Study|Lost to Follow-up|19|||
124951514|NCT00080119|449449454|FG002|Overall Study|Lost to Follow-up|19|||
124951515|NCT00080119|449449455|FG003|Overall Study|Lost to Follow-up|14|||
124951516|NCT01919489|449449457|FG000|Overall Study|Rejected the need of injections|4|||
124951517|NCT01919489|449449458|FG001|Overall Study|Rejected the need of injections|7|||
124951518|NCT01919489|449449457|FG000|Overall Study|Adverse Event|10|||
124951519|NCT01919489|449449458|FG001|Overall Study|Adverse Event|0|||
124951520|NCT01919489|449449457|FG000|Overall Study|Hospital readmission|2|||
124951521|NCT01919489|449449458|FG001|Overall Study|Hospital readmission|9|||
124951522|NCT01919489|449449457|FG000|Overall Study|Death|2|||
124951523|NCT01919489|449449458|FG001|Overall Study|Death|1|||
124766405|NCT01346358|448771724|FG007|Overall Study|Non-Compliance|2|||
124766406|NCT01346358|448771725|FG008|Overall Study|Non-Compliance|0|||
124951524|NCT01919489|449449457|FG000|Overall Study|Lost to Follow-up|38|||
124951525|NCT01919489|449449458|FG001|Overall Study|Lost to Follow-up|27|||
124951526|NCT01322386|449449459|FG000|Overall Study|Protocol Violation|0|||
124951527|NCT01322386|449449460|FG001|Overall Study|Protocol Violation|1|||
124951528|NCT01322386|449449459|FG000|Overall Study|Physician Decision|0|||
124951529|NCT01322386|449449460|FG001|Overall Study|Physician Decision|1|||
124951530|NCT00871494|449449463|FG000|Overall Study|Protocol Violation|5|||
124951531|NCT00871494|449449463|FG000|Overall Study|Lack of Efficacy|4|||
124951532|NCT00871494|449449463|FG000|Overall Study|Adverse Event|4|||
124951533|NCT00871494|449449463|FG000|Overall Study|Lost to Follow-up|1|||
124951534|NCT03761849|449449464|FG000|Overall Study|transferred to OpenLabelExtension|35|||
124951535|NCT03761849|449449465|FG001|Overall Study|transferred to OpenLabelExtension|34|||
124951536|NCT03761849|449449466|FG002|Overall Study|transferred to OpenLabelExtension|36|||
124951537|NCT03761849|449449467|FG003|Overall Study|transferred to OpenLabelExtension|0|||
124951538|NCT03761849|449449468|FG004|Overall Study|transferred to OpenLabelExtension|0|||
124951539|NCT03761849|449449469|FG005|Overall Study|transferred to OpenLabelExtension|0|||
124951540|NCT03761849|449449464|FG000|Overall Study|Adverse Event|1|||
124951541|NCT03761849|449449465|FG001|Overall Study|Adverse Event|0|||
124951542|NCT03761849|449449466|FG002|Overall Study|Adverse Event|0|||
124766407|NCT01346358|448771717|FG000|Overall Study|Physician Decision|0|||
124951543|NCT03761849|449449467|FG003|Overall Study|Adverse Event|0|||
124951544|NCT03761849|449449468|FG004|Overall Study|Adverse Event|2|||
124951545|NCT03761849|449449469|FG005|Overall Study|Adverse Event|3|||
124951546|NCT03761849|449449464|FG000|Overall Study|Withdrawal by Subject|0|||
124951547|NCT03761849|449449465|FG001|Overall Study|Withdrawal by Subject|0|||
124951548|NCT03761849|449449466|FG002|Overall Study|Withdrawal by Subject|0|||
124951549|NCT03761849|449449467|FG003|Overall Study|Withdrawal by Subject|41|||
124951550|NCT03761849|449449468|FG004|Overall Study|Withdrawal by Subject|43|||
124951551|NCT03761849|449449469|FG005|Overall Study|Withdrawal by Subject|35|||
124951552|NCT03761849|449449464|FG000|Overall Study|Lost to Follow-up|0|||
124951553|NCT03761849|449449465|FG001|Overall Study|Lost to Follow-up|1|||
124951554|NCT03761849|449449466|FG002|Overall Study|Lost to Follow-up|0|||
124951555|NCT03761849|449449467|FG003|Overall Study|Lost to Follow-up|2|||
124951556|NCT03761849|449449468|FG004|Overall Study|Lost to Follow-up|4|||
124951557|NCT03761849|449449469|FG005|Overall Study|Lost to Follow-up|5|||
124951558|NCT03761849|449449464|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
124951559|NCT03761849|449449465|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
124951560|NCT03761849|449449466|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
124951561|NCT03761849|449449467|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
124951562|NCT03761849|449449468|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
124951563|NCT03761849|449449469|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
124951564|NCT03761849|449449464|FG000|Overall Study|Physician Decision|0|||
124951565|NCT03761849|449449465|FG001|Overall Study|Physician Decision|0|||
124951566|NCT03761849|449449466|FG002|Overall Study|Physician Decision|0|||
124951567|NCT03761849|449449467|FG003|Overall Study|Physician Decision|1|||
124951568|NCT03761849|449449468|FG004|Overall Study|Physician Decision|4|||
124951569|NCT03761849|449449469|FG005|Overall Study|Physician Decision|4|||
124951570|NCT03761849|449449464|FG000|Overall Study|Death|0|||
124951571|NCT03761849|449449465|FG001|Overall Study|Death|0|||
124951572|NCT03761849|449449466|FG002|Overall Study|Death|0|||
124951573|NCT03761849|449449467|FG003|Overall Study|Death|1|||
124951574|NCT03761849|449449468|FG004|Overall Study|Death|1|||
124951575|NCT03761849|449449469|FG005|Overall Study|Death|3|||
124951576|NCT03761849|449449464|FG000|Overall Study|Protocol Violation|0|||
124951577|NCT03761849|449449465|FG001|Overall Study|Protocol Violation|0|||
124951578|NCT03761849|449449466|FG002|Overall Study|Protocol Violation|0|||
124951579|NCT03761849|449449467|FG003|Overall Study|Protocol Violation|2|||
124951580|NCT03761849|449449468|FG004|Overall Study|Protocol Violation|2|||
124951581|NCT03761849|449449469|FG005|Overall Study|Protocol Violation|1|||
124951582|NCT03761849|449449464|FG000|Overall Study|Participant could not come to site|0|||
124951583|NCT03761849|449449465|FG001|Overall Study|Participant could not come to site|0|||
124951584|NCT03761849|449449466|FG002|Overall Study|Participant could not come to site|0|||
124951585|NCT03761849|449449467|FG003|Overall Study|Participant could not come to site|0|||
124951586|NCT03761849|449449468|FG004|Overall Study|Participant could not come to site|1|||
124951587|NCT03761849|449449469|FG005|Overall Study|Participant could not come to site|0|||
124951588|NCT03761849|449449464|FG000|Overall Study|SF- safety Finding|0|||
124951589|NCT03761849|449449465|FG001|Overall Study|SF- safety Finding|0|||
124951590|NCT03761849|449449466|FG002|Overall Study|SF- safety Finding|0|||
124951591|NCT03761849|449449467|FG003|Overall Study|SF- safety Finding|0|||
124951592|NCT03761849|449449468|FG004|Overall Study|SF- safety Finding|0|||
124951593|NCT03761849|449449469|FG005|Overall Study|SF- safety Finding|1|||
124951594|NCT03761849|449449464|FG000|Overall Study|Patient did not attend visit|0|||
124951595|NCT03761849|449449465|FG001|Overall Study|Patient did not attend visit|0|||
124460044|NCT02831673|447644012|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
124460045|NCT02831673|447644008|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
124460046|NCT02831673|447644009|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
124460047|NCT02831673|447644010|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
124460048|NCT02831673|447644011|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
124460049|NCT02831673|447644012|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
124460050|NCT02831673|447644008|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
124460051|NCT02831673|447644009|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
124460052|NCT02831673|447644010|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
124460053|NCT02831673|447644011|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
124460054|NCT02831673|447644012|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
124460055|NCT02356562|447644014|FG000|Overall Study|Withdrawal by Subject|0|||
124460056|NCT02356562|447644015|FG001|Overall Study|Withdrawal by Subject|1|||
124460057|NCT02356562|447644014|FG000|Overall Study|Re-entered treatment in a previous study|1|||
124460058|NCT02356562|447644015|FG001|Overall Study|Re-entered treatment in a previous study|0|||
124460059|NCT02356562|447644014|FG000|Overall Study|site closure|1|||
124460060|NCT02356562|447644015|FG001|Overall Study|site closure|0|||
124460061|NCT01351389|447644024|FG000|Overall Study|Withdrawal by Subject|7|||
124460062|NCT01351389|447644025|FG001|Overall Study|Withdrawal by Subject|0|||
124460063|NCT01351389|447644024|FG000|Overall Study|did not complete intervention|23|||
124460064|NCT01351389|447644025|FG001|Overall Study|did not complete intervention|15|||
124460065|NCT03719690|447644026|FG000|Overall Study|Withdrawal by Subject|5|||
124460066|NCT03719690|447644027|FG001|Overall Study|Withdrawal by Subject|10|||
124460067|NCT03719690|447644026|FG000|Overall Study|Death|40|||
124460068|NCT03719690|447644027|FG001|Overall Study|Death|149|||
124460069|NCT03719690|447644026|FG000|Overall Study|Miscellaneous|12|||
124951596|NCT03761849|449449466|FG002|Overall Study|Patient did not attend visit|0|||
124460070|NCT03719690|447644027|FG001|Overall Study|Miscellaneous|56|||
124460071|NCT03719690|447644026|FG000|Overall Study|Lost to Follow-up|2|||
124460072|NCT03719690|447644027|FG001|Overall Study|Lost to Follow-up|18|||
124460073|NCT03719690|447644026|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
124951597|NCT03761849|449449467|FG003|Overall Study|Patient did not attend visit|0|||
124951598|NCT03761849|449449468|FG004|Overall Study|Patient did not attend visit|0|||
124951599|NCT03761849|449449469|FG005|Overall Study|Patient did not attend visit|1|||
124548869|NCT03123120|447965378|FG000|Overall Study|Lost to Follow-up|0|||
124951600|NCT03344458|449449473|FG000|Overall Study|Physician Decision|1|||
124951601|NCT03344458|449449473|FG000|Overall Study|Withdrawal by Subject|16|||
124951602|NCT03344458|449449473|FG000|Overall Study|Other reasons|10|||
124707457|NCT01911260|448554646|FG000|Follow-up Period|transference or evasion of school|13|||
124707458|NCT01911260|448554647|FG001|Follow-up Period|transference or evasion of school|20|||
124707459|NCT01911260|448554648|FG002|Follow-up Period|transference or evasion of school|15|||
124707460|NCT01911260|448554649|FG003|Follow-up Period|transference or evasion of school|12|||
124951603|NCT03344458|449449473|FG000|Overall Study|Lost to Follow-up|9|||
124951604|NCT03344458|449449473|FG000|Overall Study|Protocol Violation|3|||
124951605|NCT03840993|449449474|FG000|Overall Study|Adverse Event|1|||
124951606|NCT03840993|449449475|FG001|Overall Study|Adverse Event|0|||
124951607|NCT03840993|449449474|FG000|Overall Study|Lost to Follow-up|4|||
124951608|NCT03840993|449449475|FG001|Overall Study|Lost to Follow-up|0|||
124951609|NCT03840993|449449474|FG000|Overall Study|Physician Decision|0|||
124951610|NCT03840993|449449475|FG001|Overall Study|Physician Decision|1|||
124951611|NCT03840993|449449474|FG000|Overall Study|Pregnancy|0|||
124951612|NCT03840993|449449475|FG001|Overall Study|Pregnancy|1|||
124951613|NCT03840993|449449474|FG000|Overall Study|Withdrawal by Subject|1|||
124951614|NCT03840993|449449475|FG001|Overall Study|Withdrawal by Subject|3|||
124951615|NCT03840993|449449474|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
124951616|NCT03840993|449449475|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
124951617|NCT00988429|449449476|FG000|Overall Study|Adverse Event|9|||
124951618|NCT00988429|449449477|FG001|Overall Study|Adverse Event|21|||
124951619|NCT00988429|449449478|FG002|Overall Study|Adverse Event|45|||
124951620|NCT00988429|449449476|FG000|Overall Study|Lack of Efficacy|0|||
124951621|NCT00988429|449449477|FG001|Overall Study|Lack of Efficacy|0|||
124951622|NCT00988429|449449478|FG002|Overall Study|Lack of Efficacy|1|||
124951623|NCT00988429|449449476|FG000|Overall Study|Non-Compliance with Study Drug|5|||
124951624|NCT00988429|449449477|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124951625|NCT00988429|449449478|FG002|Overall Study|Non-Compliance with Study Drug|3|||
124951626|NCT00988429|449449476|FG000|Overall Study|Physician Decision|1|||
124951627|NCT00988429|449449477|FG001|Overall Study|Physician Decision|0|||
124951628|NCT00988429|449449478|FG002|Overall Study|Physician Decision|3|||
124951629|NCT00988429|449449476|FG000|Overall Study|Pregnancy|2|||
124951630|NCT00988429|449449477|FG001|Overall Study|Pregnancy|1|||
124707461|NCT00654732|448554650|FG000|Overall Study|Adverse Event|4|||
124707462|NCT00654732|448554651|FG001|Overall Study|Adverse Event|6|||
124951631|NCT00988429|449449478|FG002|Overall Study|Pregnancy|0|||
124951632|NCT00988429|449449476|FG000|Overall Study|Protocol Violation|4|||
124951633|NCT00988429|449449477|FG001|Overall Study|Protocol Violation|3|||
124951634|NCT00988429|449449478|FG002|Overall Study|Protocol Violation|3|||
124951635|NCT00988429|449449476|FG000|Overall Study|Withdrawal by Subject|7|||
124707463|NCT01734902|448554656|FG000|Overall Study|Other than listed|0|||
124707464|NCT01734902|448554657|FG001|Overall Study|Other than listed|2|||
124951636|NCT00988429|449449477|FG001|Overall Study|Withdrawal by Subject|7|||
124951637|NCT00988429|449449478|FG002|Overall Study|Withdrawal by Subject|12|||
124951638|NCT00988429|449449476|FG000|Overall Study|Administrative Reasons|1|||
124460074|NCT03719690|447644027|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
124460075|NCT04091087|447644028|FG000|Overall Study|Not treated|1|||
124460076|NCT04091087|447644029|FG001|Overall Study|Not treated|0|||
124460077|NCT04091087|447644028|FG000|Overall Study|Adverse Event|4|||
124460078|NCT04091087|447644029|FG001|Overall Study|Adverse Event|4|||
124460079|NCT04091087|447644028|FG000|Overall Study|Protocol Violation|0|||
124460080|NCT04091087|447644029|FG001|Overall Study|Protocol Violation|1|||
124460081|NCT04091087|447644028|FG000|Overall Study|Withdrawal by Subject|5|||
124460082|NCT04091087|447644029|FG001|Overall Study|Withdrawal by Subject|2|||
124707465|NCT01959932|448554658|FG000|Overall Study|Withdrawal by Subject|1|||
124707466|NCT01959932|448554659|FG001|Overall Study|Withdrawal by Subject|0|||
124951639|NCT00988429|449449477|FG001|Overall Study|Administrative Reasons|2|||
124951640|NCT00988429|449449478|FG002|Overall Study|Administrative Reasons|1|||
124951641|NCT00988429|449449476|FG000|Overall Study|other reasons|8|||
124951642|NCT00988429|449449477|FG001|Overall Study|other reasons|8|||
124951643|NCT00988429|449449478|FG002|Overall Study|other reasons|1|||
124951644|NCT01074229|449449479|FG000|Overall Study|Lost to Follow-up|1|||
124951645|NCT01074229|449449480|FG001|Overall Study|Lost to Follow-up|0|||
124951646|NCT01074229|449449481|FG002|Overall Study|Lost to Follow-up|0|||
124951647|NCT01074229|449449479|FG000|Overall Study|Change to open surgical procedure|1|||
124951648|NCT01074229|449449480|FG001|Overall Study|Change to open surgical procedure|3|||
124951649|NCT01074229|449449481|FG002|Overall Study|Change to open surgical procedure|4|||
124951650|NCT02823574|449449487|FG000|Randomization|Disease Progression|0|||
124951651|NCT02823574|449449488|FG001|Randomization|Disease Progression|0|||
124951652|NCT02823574|449449489|FG002|Randomization|Disease Progression|1|||
124951653|NCT02823574|449449490|FG003|Randomization|Disease Progression|0|||
124951654|NCT02823574|449449487|FG000|Randomization|AE unrelated to Study Drug|1|||
124951655|NCT02823574|449449488|FG001|Randomization|AE unrelated to Study Drug|0|||
124951656|NCT02823574|449449489|FG002|Randomization|AE unrelated to Study Drug|0|||
124951657|NCT02823574|449449490|FG003|Randomization|AE unrelated to Study Drug|0|||
124951658|NCT02823574|449449487|FG000|Treatment Period|Poor/Non Compliance|1|||
124951659|NCT02823574|449449488|FG001|Treatment Period|Poor/Non Compliance|0|||
124951660|NCT02823574|449449489|FG002|Treatment Period|Poor/Non Compliance|0|||
124951661|NCT02823574|449449490|FG003|Treatment Period|Poor/Non Compliance|1|||
124951662|NCT02823574|449449487|FG000|Treatment Period|Maximum Clinical Benefit|8|||
124951663|NCT02823574|449449488|FG001|Treatment Period|Maximum Clinical Benefit|4|||
124951664|NCT02823574|449449489|FG002|Treatment Period|Maximum Clinical Benefit|7|||
124951665|NCT02823574|449449490|FG003|Treatment Period|Maximum Clinical Benefit|1|||
124951666|NCT02823574|449449487|FG000|Treatment Period|Lost to Follow-up|1|||
124951667|NCT02823574|449449488|FG001|Treatment Period|Lost to Follow-up|1|||
124951668|NCT02823574|449449489|FG002|Treatment Period|Lost to Follow-up|0|||
124951669|NCT02823574|449449490|FG003|Treatment Period|Lost to Follow-up|0|||
124951670|NCT02823574|449449487|FG000|Treatment Period|Participant withdrew consent|4|||
124951671|NCT02823574|449449488|FG001|Treatment Period|Participant withdrew consent|0|||
124951672|NCT02823574|449449489|FG002|Treatment Period|Participant withdrew consent|0|||
124951673|NCT02823574|449449490|FG003|Treatment Period|Participant withdrew consent|1|||
124951674|NCT02823574|449449487|FG000|Treatment Period|Participant request to discontinue|5|||
124951675|NCT02823574|449449488|FG001|Treatment Period|Participant request to discontinue|0|||
124951676|NCT02823574|449449489|FG002|Treatment Period|Participant request to discontinue|3|||
124951677|NCT02823574|449449490|FG003|Treatment Period|Participant request to discontinue|2|||
124951678|NCT02823574|449449487|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
124951679|NCT02823574|449449488|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
124951680|NCT02823574|449449489|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
124951681|NCT02823574|449449490|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
124951682|NCT02823574|449449487|FG000|Treatment Period|Study Drug Toxicity|11|||
124951683|NCT02823574|449449488|FG001|Treatment Period|Study Drug Toxicity|2|||
124951684|NCT02823574|449449489|FG002|Treatment Period|Study Drug Toxicity|14|||
124951685|NCT02823574|449449490|FG003|Treatment Period|Study Drug Toxicity|4|||
124951686|NCT02823574|449449487|FG000|Treatment Period|Disease Progression|113|||
124951687|NCT02823574|449449488|FG001|Treatment Period|Disease Progression|64|||
124951688|NCT02823574|449449489|FG002|Treatment Period|Disease Progression|82|||
124951689|NCT02823574|449449490|FG003|Treatment Period|Disease Progression|43|||
124951690|NCT02823574|449449487|FG000|Treatment Period|Other reasons|5|||
124951691|NCT02823574|449449488|FG001|Treatment Period|Other reasons|9|||
124548870|NCT03123120|447965379|FG001|Overall Study|Lost to Follow-up|1|||
124951692|NCT02823574|449449489|FG002|Treatment Period|Other reasons|3|||
124951693|NCT02823574|449449490|FG003|Treatment Period|Other reasons|6|||
124951694|NCT02823574|449449487|FG000|Treatment Period|Participant no longer meets study criteria|0|||
124460083|NCT01577186|447644031|FG000|Overall Study|Adverse Event|23|||
124951695|NCT02823574|449449488|FG001|Treatment Period|Participant no longer meets study criteria|0|||
124951696|NCT02823574|449449489|FG002|Treatment Period|Participant no longer meets study criteria|1|||
124951697|NCT02823574|449449490|FG003|Treatment Period|Participant no longer meets study criteria|0|||
124951698|NCT02823574|449449487|FG000|Treatment Period|Death|0|||
124460084|NCT01577186|447644031|FG000|Overall Study|Death|1|||
124460085|NCT01577186|447644031|FG000|Overall Study|Lost to Follow-up|28|||
124460086|NCT01577186|447644031|FG000|Overall Study|Withdrawal by Subject|35|||
124460087|NCT01577186|447644031|FG000|Overall Study|Insufficient Response|18|||
124951699|NCT02823574|449449488|FG001|Treatment Period|Death|0|||
124951700|NCT02823574|449449489|FG002|Treatment Period|Death|3|||
124951701|NCT02823574|449449490|FG003|Treatment Period|Death|1|||
124951702|NCT00590759|449449491|FG000|Overall Study|Death|52|||
124951703|NCT00590759|449449491|FG000|Overall Study|Lost to Follow-up|28|||
124951704|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
124951705|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
124951706|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
124951707|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
124951708|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Death|0|||
124951709|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Death|0|||
124951710|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Death|1|||
124951711|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Death|0|||
124951712|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
124951713|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
124951714|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
124951715|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
124951716|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
124951717|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
124951718|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
124951719|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
124951720|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
124951721|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
124951722|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
124951723|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
124951724|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
124951725|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
124951726|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
124951727|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
124951728|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
124951729|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
124951730|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
124951731|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
124951732|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Other|2|||
124951733|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Other|0|||
124951734|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Other|0|||
124951735|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Other|0|||
124951736|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
124951737|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
124951738|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
124460088|NCT01577186|447644031|FG000|Overall Study|Ineligible to Continue|15|||
124460089|NCT01577186|447644031|FG000|Overall Study|Non-Compliant|8|||
124460090|NCT01577186|447644031|FG000|Overall Study|Other|2|||
124460091|NCT00631020|447644035|FG000|Overall Study|Lost to Follow-up|7|||
124460092|NCT00631020|447644035|FG000|Overall Study|Incarcerated|1|||
124460093|NCT03221751|447644036|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
124460094|NCT03221751|447644037|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
124460095|NCT03571646|447644038|FG000|Overall Study|Adverse Event|1|||
124460096|NCT03571646|447644039|FG001|Overall Study|Adverse Event|0|||
124460097|NCT03571646|447644038|FG000|Overall Study|Withdrawal by Subject|1|||
124460098|NCT03571646|447644039|FG001|Overall Study|Withdrawal by Subject|1|||
124460099|NCT01604265|447644042|FG000|Overall Study|Adverse Event|1|||
124460100|NCT01604265|447644043|FG001|Overall Study|Adverse Event|0|||
124460101|NCT01604265|447644042|FG000|Overall Study|Withdrawal by Subject|1|||
124460102|NCT01604265|447644043|FG001|Overall Study|Withdrawal by Subject|0|||
124951739|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
124951740|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
124951741|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
124951742|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
124951743|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
124951744|NCT03845517|449449498|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
124951745|NCT03845517|449449499|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
124951746|NCT03845517|449449500|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
124951747|NCT03845517|449449501|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
124460103|NCT02706873|447644044|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
124460104|NCT02706873|447644045|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
124460105|NCT02706873|447644046|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
124460106|NCT02706873|447644047|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
124460107|NCT02706873|447644044|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
124460108|NCT02706873|447644045|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
124951748|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
124951749|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
124951750|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
124951751|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
124951752|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Death|0|||
124951753|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Death|0|||
124951754|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Death|1|||
124951755|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Death|1|||
124951756|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
124951757|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
124951758|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
124951759|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
124548871|NCT03123120|447965378|FG000|Overall Study|Withdrawal by Subject|0|||
124548872|NCT03123120|447965379|FG001|Overall Study|Withdrawal by Subject|1|||
124548873|NCT00203892|447965380|FG000|Overall Study|Physician Decision|1|||
124548874|NCT00203892|447965381|FG001|Overall Study|Physician Decision|2|||
124548875|NCT00203892|447965382|FG002|Overall Study|Physician Decision|0|||
124548876|NCT00203892|447965380|FG000|Overall Study|Death|1|||
124548877|NCT00203892|447965381|FG001|Overall Study|Death|0|||
124548878|NCT00203892|447965382|FG002|Overall Study|Death|0|||
124548879|NCT00806416|447965383|FG000|Period 1 - Part I|Adverse Event|0|||
124548880|NCT00806416|447965384|FG001|Period 1 - Part I|Adverse Event|1|||
124548881|NCT00806416|447965385|FG002|Period 1 - Part I|Adverse Event|0|||
124951760|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
124951761|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
124951762|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
124951763|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
124951764|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
124951765|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
124951766|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
124951767|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
124951768|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Other|1|||
124951769|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Other|0|||
124951770|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Other|1|||
124951771|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Other|0|||
124951772|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
124951773|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
124951774|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
124951775|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
124548882|NCT00806416|447965386|FG003|Period 1 - Part I|Adverse Event|0|||
124548883|NCT00806416|447965383|FG000|Period 1 - Part I|Lost to Follow-up|0|||
124548884|NCT00806416|447965384|FG001|Period 1 - Part I|Lost to Follow-up|2|||
124548885|NCT00806416|447965385|FG002|Period 1 - Part I|Lost to Follow-up|0|||
124548886|NCT00806416|447965386|FG003|Period 1 - Part I|Lost to Follow-up|0|||
124548887|NCT00806416|447965383|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
124548888|NCT00806416|447965384|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
124548889|NCT00806416|447965385|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
124548890|NCT00806416|447965386|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
124548891|NCT00806416|447965383|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
124548892|NCT00806416|447965384|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
124548893|NCT00806416|447965385|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
124548894|NCT00806416|447965386|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
124548895|NCT03359473|447965398|FG000|Overall Study|Adverse Event|0|||
124548896|NCT03359473|447965399|FG001|Overall Study|Adverse Event|2|||
124707467|NCT01959932|448554660|FG002|Overall Study|Withdrawal by Subject|0|||
124707468|NCT00060944|448554663|FG000|Overall Study|Adverse Event|12|||
124707469|NCT00060944|448554664|FG001|Overall Study|Adverse Event|10|||
124707470|NCT00060944|448554663|FG000|Overall Study|Death|2|||
124707471|NCT00060944|448554664|FG001|Overall Study|Death|3|||
124707472|NCT00060944|448554663|FG000|Overall Study|Withdrawal by Subject|18|||
124707473|NCT00060944|448554664|FG001|Overall Study|Withdrawal by Subject|5|||
124707474|NCT00060944|448554663|FG000|Overall Study|Disease Progression|93|||
124707475|NCT00060944|448554664|FG001|Overall Study|Disease Progression|94|||
124951776|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
124951777|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
124951778|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
124548897|NCT03359473|447965400|FG002|Overall Study|Adverse Event|5|||
124548898|NCT03359473|447965401|FG003|Overall Study|Adverse Event|3|||
124548899|NCT03359473|447965398|FG000|Overall Study|Lost to Follow-up|0|||
124548900|NCT03359473|447965399|FG001|Overall Study|Lost to Follow-up|1|||
124707476|NCT00060944|448554663|FG000|Overall Study|Lost to Follow-up|1|||
124951779|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
124951780|NCT03845517|449449498|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
124707477|NCT00060944|448554664|FG001|Overall Study|Lost to Follow-up|0|||
124707478|NCT00060944|448554663|FG000|Overall Study|Subject Ineligible To Continue|2|||
124951781|NCT03845517|449449499|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
124707479|NCT00060944|448554664|FG001|Overall Study|Subject Ineligible To Continue|1|||
124707480|NCT00060944|448554663|FG000|Overall Study|Treatment Switch|0|||
124707481|NCT00060944|448554664|FG001|Overall Study|Treatment Switch|13|||
124951782|NCT03845517|449449500|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
124951783|NCT03845517|449449501|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
124951784|NCT01494467|449449502|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
124951785|NCT01494467|449449503|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
124951786|NCT01494467|449449502|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
124951787|NCT01494467|449449503|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
124951788|NCT01494467|449449502|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
124951789|NCT01494467|449449503|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
124951790|NCT01494467|449449502|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
124951791|NCT01494467|449449503|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
124951792|NCT01494467|449449502|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
124951793|NCT01494467|449449503|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
124951794|NCT01494467|449449502|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
124951795|NCT01494467|449449503|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
124951796|NCT01494467|449449502|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
124951797|NCT01494467|449449503|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
124951798|NCT01494467|449449502|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
124951799|NCT01494467|449449503|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
124951800|NCT01494467|449449502|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
124951801|NCT01494467|449449503|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
124951802|NCT01494467|449449502|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
124951803|NCT01494467|449449503|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
124951804|NCT01494467|449449502|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
124951805|NCT01494467|449449503|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
124951806|NCT01494467|449449502|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
124951807|NCT01494467|449449503|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
124951808|NCT01494467|449449502|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
124951809|NCT01494467|449449503|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
124951810|NCT01494467|449449502|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
124951811|NCT01494467|449449503|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
124951812|NCT00417885|449449504|FG000|Overall Study|Adverse Event|1|||
124951813|NCT00417885|449449504|FG000|Overall Study|Objective Progression or Relapse|3|||
124951814|NCT00417885|449449504|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
124951815|NCT01190436|449449505|FG000|Overall Study|Lost to Follow-up|35|||
124951816|NCT01190436|449449505|FG000|Overall Study|Other|4|||
124951817|NCT02721147|449449506|FG000|Overall Study|Lost to Follow-up|2|||
124951818|NCT02721147|449449507|FG001|Overall Study|Lost to Follow-up|0|||
124951819|NCT02721147|449449508|FG002|Overall Study|Lost to Follow-up|0|||
124951820|NCT01722097|449449509|FG000|Overall Study|Patient sheets not returned|6|||
124951821|NCT01722097|449449510|FG001|Overall Study|Patient sheets not returned|5|||
124951822|NCT02009332|449449513|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
124951823|NCT02009332|449449514|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
124951824|NCT02009332|449449515|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
124460109|NCT02706873|447644046|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
124460110|NCT02706873|447644047|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
124460111|NCT02706873|447644044|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
124460112|NCT02706873|447644045|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
124460113|NCT02706873|447644046|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
124460114|NCT02706873|447644047|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
124460115|NCT02706873|447644044|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
124460116|NCT02706873|447644045|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
124460117|NCT02706873|447644046|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
124460118|NCT02706873|447644047|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
124460119|NCT02706873|447644044|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
124460120|NCT02706873|447644045|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
124460121|NCT02706873|447644046|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
124460122|NCT02706873|447644047|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
124460123|NCT02706873|447644044|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
124951825|NCT02009332|449449516|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
124951826|NCT02009332|449449517|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
124951827|NCT02009332|449449518|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
124951828|NCT02009332|449449513|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
124460124|NCT02706873|447644045|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
124460125|NCT02706873|447644046|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
124460126|NCT02706873|447644047|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
124460127|NCT02706873|447644044|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
124707482|NCT00060944|448554663|FG000|Overall Study|Other|2|||
124548901|NCT03359473|447965400|FG002|Overall Study|Lost to Follow-up|0|||
124548902|NCT03359473|447965401|FG003|Overall Study|Lost to Follow-up|0|||
124548903|NCT03359473|447965398|FG000|Overall Study|Physician Decision|0|||
124548904|NCT03359473|447965399|FG001|Overall Study|Physician Decision|1|||
124548905|NCT03359473|447965400|FG002|Overall Study|Physician Decision|0|||
124548906|NCT03359473|447965401|FG003|Overall Study|Physician Decision|1|||
124548907|NCT03359473|447965398|FG000|Overall Study|Withdrawal by Subject|1|||
124766408|NCT01346358|448771718|FG001|Overall Study|Physician Decision|1|||
124548908|NCT03359473|447965399|FG001|Overall Study|Withdrawal by Subject|2|||
124548909|NCT03359473|447965400|FG002|Overall Study|Withdrawal by Subject|1|||
124460128|NCT02706873|447644045|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
124460129|NCT02706873|447644046|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
124460130|NCT02706873|447644047|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
124460131|NCT02706873|447644044|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
124460132|NCT02706873|447644045|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
124460133|NCT02706873|447644046|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
124460134|NCT02706873|447644047|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
124460135|NCT02706873|447644044|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
124951829|NCT02009332|449449514|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
124951830|NCT02009332|449449515|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
124951831|NCT02009332|449449516|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
124951832|NCT02009332|449449517|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
124951833|NCT02009332|449449518|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
124951834|NCT02009332|449449513|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
124951835|NCT02009332|449449514|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
124951836|NCT02009332|449449515|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
124951837|NCT02009332|449449516|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
124951838|NCT02009332|449449517|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
124951839|NCT02009332|449449518|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
124951840|NCT01912599|449449519|FG000|Overall Study|Withdrawal by Subject|0|||
124951841|NCT01912599|449449520|FG001|Overall Study|Withdrawal by Subject|1|||
124951842|NCT04739306|449449521|FG000|Main Study Period|Adverse Event|6|||
124951843|NCT04739306|449449522|FG001|Main Study Period|Adverse Event|7|||
124951844|NCT04739306|449449521|FG000|Main Study Period|Lost to Follow-up|4|||
124951845|NCT04739306|449449522|FG001|Main Study Period|Lost to Follow-up|6|||
124951846|NCT04739306|449449521|FG000|Main Study Period|Physician Decision|1|||
124951847|NCT04739306|449449522|FG001|Main Study Period|Physician Decision|1|||
124951848|NCT04739306|449449521|FG000|Main Study Period|Withdrawal by Subject|8|||
124951849|NCT04739306|449449522|FG001|Main Study Period|Withdrawal by Subject|6|||
124951850|NCT04739306|449449521|FG000|Main Study Period|Protocol Violation|0|||
124951851|NCT04739306|449449522|FG001|Main Study Period|Protocol Violation|1|||
124951852|NCT04739306|449449521|FG000|Main Study Period|War in Ukraine|1|||
124460136|NCT02706873|447644045|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
124460137|NCT02706873|447644046|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
124460138|NCT02706873|447644047|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
124460139|NCT02706873|447644044|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
124460140|NCT02706873|447644045|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
124460141|NCT02706873|447644046|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
124460142|NCT02706873|447644047|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
124460143|NCT02706873|447644044|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
124460144|NCT02706873|447644045|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
124460145|NCT02706873|447644046|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
124460146|NCT02706873|447644047|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
124460147|NCT02706873|447644044|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
124460148|NCT02706873|447644045|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
124460149|NCT02706873|447644046|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
124460150|NCT02706873|447644047|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
124460151|NCT02706873|447644044|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
124460152|NCT02706873|447644045|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
124460153|NCT02706873|447644046|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
124460154|NCT02706873|447644047|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
124460155|NCT00586495|447644053|FG000|Treatment Period|Adverse Event|11|||
124460156|NCT00586495|447644053|FG000|Treatment Period|Death|1|||
124460157|NCT00586495|447644053|FG000|Treatment Period|Protocol Violation|1|||
124460158|NCT00586495|447644053|FG000|Treatment Period|Withdrawal by Subject|1|||
124460159|NCT00586495|447644053|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
124460160|NCT00586495|447644053|FG000|Treatment Period|Switch to commercial drug|10|||
124951853|NCT04739306|449449522|FG001|Main Study Period|War in Ukraine|1|||
124951854|NCT03386344|449449523|FG000|Overall Study|Adverse Event|6|||
124951855|NCT03386344|449449524|FG001|Overall Study|Adverse Event|3|||
124951856|NCT03386344|449449525|FG002|Overall Study|Adverse Event|1|||
124951857|NCT03386344|449449523|FG000|Overall Study|Poor Compliance to Protocol|0|||
124951858|NCT03386344|449449524|FG001|Overall Study|Poor Compliance to Protocol|1|||
124951859|NCT03386344|449449525|FG002|Overall Study|Poor Compliance to Protocol|0|||
124951860|NCT03386344|449449523|FG000|Overall Study|Study Terminated by Sponsor|101|||
124951861|NCT03386344|449449524|FG001|Overall Study|Study Terminated by Sponsor|102|||
124951862|NCT03386344|449449525|FG002|Overall Study|Study Terminated by Sponsor|106|||
124951863|NCT03386344|449449523|FG000|Overall Study|Lost to Follow-up|3|||
124951864|NCT03386344|449449524|FG001|Overall Study|Lost to Follow-up|2|||
124951865|NCT03386344|449449525|FG002|Overall Study|Lost to Follow-up|1|||
124951866|NCT03386344|449449523|FG000|Overall Study|At the Participant's own Request|7|||
124951867|NCT03386344|449449524|FG001|Overall Study|At the Participant's own Request|7|||
124460161|NCT00586495|447644053|FG000|Follow-up|Death|40|||
124460162|NCT00586495|447644053|FG000|Follow-up|Lost to Follow-up|1|||
124460163|NCT00586495|447644053|FG000|Follow-up|Withdrawal by Subject|4|||
124460164|NCT00586495|447644053|FG000|Follow-up|Protocol driven decision point|37|||
124766409|NCT01346358|448771719|FG002|Overall Study|Physician Decision|0|||
124460165|NCT00586495|447644053|FG000|Follow-up|Switch to commercial drug|10|||
124460166|NCT03882970|447644054|FG000|Overall Study|Adverse Event|5|||
124548910|NCT03359473|447965401|FG003|Overall Study|Withdrawal by Subject|0|||
124548911|NCT03359473|447965398|FG000|Overall Study|Protocol-defined stopping criteria|1|||
124548912|NCT03359473|447965399|FG001|Overall Study|Protocol-defined stopping criteria|0|||
124548913|NCT03359473|447965400|FG002|Overall Study|Protocol-defined stopping criteria|0|||
124548914|NCT03359473|447965401|FG003|Overall Study|Protocol-defined stopping criteria|1|||
124951868|NCT03386344|449449525|FG002|Overall Study|At the Participant's own Request|8|||
124951869|NCT03386344|449449523|FG000|Overall Study|Reason not Specified|0|||
124951870|NCT03386344|449449524|FG001|Overall Study|Reason not Specified|1|||
124951871|NCT03386344|449449525|FG002|Overall Study|Reason not Specified|0|||
124951872|NCT03481725|449449526|FG000|Overall Study|Withdrawal by Subject|1|||
124951873|NCT03481725|449449527|FG001|Overall Study|Withdrawal by Subject|0|||
124951874|NCT02991118|449449530|FG000|Overall Study|Death|3|||
124951875|NCT02991118|449449531|FG001|Overall Study|Death|8|||
124951876|NCT02991118|449449530|FG000|Overall Study|Protocol Violation|0|||
124951877|NCT02991118|449449531|FG001|Overall Study|Protocol Violation|3|||
124951878|NCT02991118|449449530|FG000|Overall Study|Physician Decision|0|||
124951879|NCT02991118|449449531|FG001|Overall Study|Physician Decision|1|||
124951880|NCT02991118|449449530|FG000|Overall Study|Moved out of the country|0|||
124951881|NCT02991118|449449531|FG001|Overall Study|Moved out of the country|1|||
124951882|NCT02991118|449449530|FG000|Overall Study|Adverse Event|2|||
124951883|NCT02991118|449449531|FG001|Overall Study|Adverse Event|2|||
124951884|NCT02991118|449449530|FG000|Overall Study|Withdrawal by Subject|1|||
124951885|NCT02991118|449449531|FG001|Overall Study|Withdrawal by Subject|7|||
124951886|NCT02991118|449449530|FG000|Overall Study|Could not attend study visits|0|||
124951887|NCT02991118|449449531|FG001|Overall Study|Could not attend study visits|1|||
124951888|NCT02991118|449449530|FG000|Overall Study|Lost to Follow-up|1|||
124951889|NCT02991118|449449531|FG001|Overall Study|Lost to Follow-up|9|||
124951890|NCT00595959|449449532|FG000|Overall Study|Withdrawal by Subject|1|||
124951891|NCT00595959|449449532|FG000|Overall Study|Lost to Follow-up|1|||
124951892|NCT02077374|449449536|FG000|Overall Study|Withdrawal by Subject|0|||
124951893|NCT02077374|449449537|FG001|Overall Study|Withdrawal by Subject|1|||
124951894|NCT02077374|449449536|FG000|Overall Study|Protocol Violation|0|||
124951895|NCT02077374|449449537|FG001|Overall Study|Protocol Violation|1|||
124951896|NCT00446095|449449538|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
124951897|NCT00446095|449449539|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
124951898|NCT00446095|449449540|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
124951899|NCT00446095|449449541|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
124951900|NCT00446095|449449542|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
124951901|NCT00446095|449449538|FG000|Phase II (8 Weeks)|Adverse Event|0|||
124951902|NCT00446095|449449539|FG001|Phase II (8 Weeks)|Adverse Event|1|||
124951903|NCT00446095|449449540|FG002|Phase II (8 Weeks)|Adverse Event|1|||
124951904|NCT00446095|449449541|FG003|Phase II (8 Weeks)|Adverse Event|0|||
124460167|NCT03882970|447644055|FG001|Overall Study|Adverse Event|7|||
124460168|NCT03882970|447644056|FG002|Overall Study|Adverse Event|3|||
124460169|NCT03882970|447644057|FG003|Overall Study|Adverse Event|1|||
124460170|NCT03882970|447644054|FG000|Overall Study|Death|1|||
124460171|NCT03882970|447644055|FG001|Overall Study|Death|2|||
124460172|NCT03882970|447644056|FG002|Overall Study|Death|1|||
124460173|NCT03882970|447644057|FG003|Overall Study|Death|1|||
124460174|NCT03882970|447644054|FG000|Overall Study|Lost to Follow-up|8|||
124460175|NCT03882970|447644055|FG001|Overall Study|Lost to Follow-up|9|||
124460176|NCT03882970|447644056|FG002|Overall Study|Lost to Follow-up|5|||
124460177|NCT03882970|447644057|FG003|Overall Study|Lost to Follow-up|5|||
124460178|NCT03882970|447644054|FG000|Overall Study|Physician Decision|0|||
124460179|NCT03882970|447644055|FG001|Overall Study|Physician Decision|2|||
124460180|NCT03882970|447644056|FG002|Overall Study|Physician Decision|2|||
124460181|NCT03882970|447644057|FG003|Overall Study|Physician Decision|2|||
124460182|NCT03882970|447644054|FG000|Overall Study|Protocol Violation|2|||
124460183|NCT03882970|447644055|FG001|Overall Study|Protocol Violation|0|||
124460184|NCT03882970|447644056|FG002|Overall Study|Protocol Violation|0|||
124460185|NCT03882970|447644057|FG003|Overall Study|Protocol Violation|0|||
124460186|NCT03882970|447644054|FG000|Overall Study|Withdrawal by Subject|8|||
124460187|NCT03882970|447644055|FG001|Overall Study|Withdrawal by Subject|17|||
124460188|NCT03882970|447644056|FG002|Overall Study|Withdrawal by Subject|7|||
124460189|NCT03882970|447644057|FG003|Overall Study|Withdrawal by Subject|22|||
124548915|NCT05302414|447965402|FG000|Pretest to Posttest|Lost to Follow-up|12|||
124548916|NCT05302414|447965403|FG001|Pretest to Posttest|Lost to Follow-up|8|||
124951905|NCT00446095|449449542|FG004|Phase II (8 Weeks)|Adverse Event|0|||
124951906|NCT00446095|449449538|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
124951907|NCT00446095|449449539|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
124951908|NCT00446095|449449540|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
124951909|NCT00446095|449449541|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
124951910|NCT00446095|449449542|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
124548917|NCT05302414|447965404|FG002|Pretest to Posttest|Lost to Follow-up|8|||
124548918|NCT05302414|447965402|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
124951911|NCT00446095|449449538|FG000|Phase II (8 Weeks)|Physician Decision|1|||
124460190|NCT03882970|447644054|FG000|Overall Study|Personal Reason|2|||
124460191|NCT03882970|447644055|FG001|Overall Study|Personal Reason|3|||
124707483|NCT00060944|448554664|FG001|Overall Study|Other|4|||
124951912|NCT00446095|449449539|FG001|Phase II (8 Weeks)|Physician Decision|0|||
124951913|NCT00446095|449449540|FG002|Phase II (8 Weeks)|Physician Decision|0|||
124951914|NCT00446095|449449541|FG003|Phase II (8 Weeks)|Physician Decision|0|||
124951915|NCT00446095|449449542|FG004|Phase II (8 Weeks)|Physician Decision|0|||
124951916|NCT00446095|449449538|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
124951917|NCT00446095|449449539|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
124951918|NCT00446095|449449540|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
124951919|NCT00446095|449449541|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
124951920|NCT00446095|449449542|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
124951921|NCT00446095|449449538|FG000|Phase II (8 Weeks)|Ongoing|0|||
124951922|NCT00446095|449449539|FG001|Phase II (8 Weeks)|Ongoing|0|||
124951923|NCT00446095|449449540|FG002|Phase II (8 Weeks)|Ongoing|1|||
124951924|NCT00446095|449449541|FG003|Phase II (8 Weeks)|Ongoing|0|||
124951925|NCT00446095|449449542|FG004|Phase II (8 Weeks)|Ongoing|0|||
124951926|NCT00446095|449449538|FG000|Phase I (28 Days)|Adverse Event|0|||
124951927|NCT00446095|449449539|FG001|Phase I (28 Days)|Adverse Event|0|||
124951928|NCT00446095|449449540|FG002|Phase I (28 Days)|Adverse Event|0|||
124951929|NCT00446095|449449541|FG003|Phase I (28 Days)|Adverse Event|1|||
124951930|NCT00446095|449449542|FG004|Phase I (28 Days)|Adverse Event|0|||
124951931|NCT00446095|449449538|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
124951932|NCT00446095|449449539|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
124951933|NCT00446095|449449540|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
124951934|NCT00446095|449449541|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
124951935|NCT00446095|449449542|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
124951936|NCT00409747|449449543|FG000|Overall Study|Withdrawal by Subject|1|||
124951937|NCT01916109|449449546|FG000|Overall Study|Withdrawal by Subject|1|||
124951938|NCT00636168|449449549|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
124951939|NCT00636168|449449550|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
124951940|NCT00636168|449449549|FG000|Randomized to Study Drug|Adverse Event|1|||
124951941|NCT00636168|449449550|FG001|Randomized to Study Drug|Adverse Event|0|||
124951942|NCT00636168|449449549|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
124951943|NCT00636168|449449550|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
124951944|NCT00636168|449449549|FG000|Treated With Study Drug|Recurrence of disease|135|||
124951945|NCT00636168|449449550|FG001|Treated With Study Drug|Recurrence of disease|282|||
124951946|NCT00636168|449449549|FG000|Treated With Study Drug|Adverse Event|250|||
124951947|NCT00636168|449449550|FG001|Treated With Study Drug|Adverse Event|22|||
124951948|NCT00636168|449449549|FG000|Treated With Study Drug|Participant withdrew consent|16|||
124951949|NCT00636168|449449550|FG001|Treated With Study Drug|Participant withdrew consent|21|||
124951950|NCT00636168|449449549|FG000|Treated With Study Drug|Poor/non-compliance|1|||
124951951|NCT00636168|449449550|FG001|Treated With Study Drug|Poor/non-compliance|3|||
124951952|NCT00636168|449449549|FG000|Treated With Study Drug|Death|3|||
124951953|NCT00636168|449449550|FG001|Treated With Study Drug|Death|0|||
124951954|NCT00636168|449449549|FG000|Treated With Study Drug|Pregnancy|1|||
124951955|NCT00636168|449449550|FG001|Treated With Study Drug|Pregnancy|0|||
124951956|NCT00636168|449449549|FG000|Treated With Study Drug|No longer meets study criteria|1|||
124951957|NCT00636168|449449550|FG001|Treated With Study Drug|No longer meets study criteria|0|||
124951958|NCT00636168|449449549|FG000|Treated With Study Drug|Other reason|1|||
124951959|NCT00636168|449449550|FG001|Treated With Study Drug|Other reason|3|||
124951960|NCT00636168|449449549|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
124951961|NCT00636168|449449550|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
124951962|NCT00636168|449449549|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
124951963|NCT00636168|449449550|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
124951964|NCT00636168|449449549|FG000|Long Term Follow-Up|Death|8|||
124951965|NCT00636168|449449550|FG001|Long Term Follow-Up|Death|9|||
124951966|NCT02707952|449449553|FG000|Overall Study|Adverse Event|1|||
124951967|NCT02707952|449449554|FG001|Overall Study|Adverse Event|0|||
124951968|NCT02707952|449449555|FG002|Overall Study|Adverse Event|0|||
124951969|NCT02707952|449449556|FG003|Overall Study|Adverse Event|0|||
124951970|NCT02707952|449449553|FG000|Overall Study|Lost to Follow-up|1|||
124951971|NCT02707952|449449554|FG001|Overall Study|Lost to Follow-up|0|||
124951972|NCT02707952|449449555|FG002|Overall Study|Lost to Follow-up|0|||
124951973|NCT02707952|449449556|FG003|Overall Study|Lost to Follow-up|0|||
124951974|NCT02707952|449449553|FG000|Overall Study|Withdrawal by Subject|0|||
124951975|NCT02707952|449449554|FG001|Overall Study|Withdrawal by Subject|1|||
124951976|NCT02707952|449449555|FG002|Overall Study|Withdrawal by Subject|2|||
124951977|NCT02707952|449449556|FG003|Overall Study|Withdrawal by Subject|0|||
124951978|NCT02006641|449449557|FG000|Overall Study|Withdrawal before treatment|2|||
124951979|NCT02006641|449449558|FG001|Overall Study|Withdrawal before treatment|5|||
124951980|NCT02006641|449449559|FG002|Overall Study|Withdrawal before treatment|3|||
124951981|NCT02006641|449449557|FG000|Overall Study|Adverse Event|15|||
124951982|NCT02006641|449449558|FG001|Overall Study|Adverse Event|11|||
124951983|NCT02006641|449449559|FG002|Overall Study|Adverse Event|15|||
124951984|NCT02006641|449449557|FG000|Overall Study|Protocol Violation|0|||
124951985|NCT02006641|449449558|FG001|Overall Study|Protocol Violation|2|||
124951986|NCT02006641|449449559|FG002|Overall Study|Protocol Violation|2|||
124707484|NCT00060944|448554663|FG000|Overall Study|randomized but not treated|6|||
124707485|NCT00060944|448554664|FG001|Overall Study|randomized but not treated|4|||
124707486|NCT00776230|448554668|FG000|Overall Study|Lost to Follow-up|2|||
124951987|NCT02006641|449449557|FG000|Overall Study|Lost to Follow-up|0|||
124951988|NCT02006641|449449558|FG001|Overall Study|Lost to Follow-up|1|||
124951989|NCT02006641|449449559|FG002|Overall Study|Lost to Follow-up|0|||
124951990|NCT02006641|449449557|FG000|Overall Study|Withdrawal by Subject|7|||
124951991|NCT02006641|449449558|FG001|Overall Study|Withdrawal by Subject|12|||
124951992|NCT02006641|449449559|FG002|Overall Study|Withdrawal by Subject|11|||
124951993|NCT02006641|449449557|FG000|Overall Study|Other reason: patient didn't show up|1|||
124951994|NCT02006641|449449558|FG001|Overall Study|Other reason: patient didn't show up|0|||
124951995|NCT02006641|449449559|FG002|Overall Study|Other reason: patient didn't show up|0|||
124951996|NCT02006641|449449557|FG000|Overall Study|Other reason:patient didn't want to come|0|||
124951997|NCT02006641|449449558|FG001|Overall Study|Other reason:patient didn't want to come|0|||
124951998|NCT02006641|449449559|FG002|Overall Study|Other reason:patient didn't want to come|1|||
124951999|NCT02006641|449449557|FG000|Overall Study|Other reason: patient has moved|1|||
124952000|NCT02006641|449449558|FG001|Overall Study|Other reason: patient has moved|0|||
124952001|NCT02006641|449449559|FG002|Overall Study|Other reason: patient has moved|1|||
124952002|NCT02006641|449449557|FG000|Overall Study|Other reason: caregiver in hospital|0|||
124952003|NCT02006641|449449558|FG001|Overall Study|Other reason: caregiver in hospital|1|||
124952004|NCT02006641|449449559|FG002|Overall Study|Other reason: caregiver in hospital|0|||
124952005|NCT02006641|449449557|FG000|Overall Study|Other reason: patient's wife has died|0|||
124952006|NCT02006641|449449558|FG001|Overall Study|Other reason: patient's wife has died|0|||
124952007|NCT02006641|449449559|FG002|Overall Study|Other reason: patient's wife has died|1|||
124460192|NCT03882970|447644056|FG002|Overall Study|Personal Reason|1|||
124952008|NCT02006641|449449557|FG000|Overall Study|Other reason: hospitalisation|0|||
124952009|NCT02006641|449449558|FG001|Overall Study|Other reason: hospitalisation|1|||
124952010|NCT02006641|449449559|FG002|Overall Study|Other reason: hospitalisation|0|||
124952011|NCT02006641|449449557|FG000|Overall Study|Other reason: caregiver impossibility|0|||
124460193|NCT03882970|447644057|FG003|Overall Study|Personal Reason|3|||
124952012|NCT02006641|449449558|FG001|Overall Study|Other reason: caregiver impossibility|0|||
124952013|NCT02006641|449449559|FG002|Overall Study|Other reason: caregiver impossibility|1|||
124952014|NCT02006641|449449557|FG000|Overall Study|Other reason: protocol non-compliance|0|||
124952015|NCT02006641|449449558|FG001|Overall Study|Other reason: protocol non-compliance|0|||
124952016|NCT02006641|449449559|FG002|Overall Study|Other reason: protocol non-compliance|1|||
124952017|NCT01287832|449449560|FG000|Overall Study|Adverse Event|1|||
124952018|NCT01287832|449449561|FG001|Overall Study|Adverse Event|0|||
124952019|NCT01287832|449449560|FG000|Overall Study|Death|0|||
124952020|NCT01287832|449449561|FG001|Overall Study|Death|1|||
124952021|NCT04749797|449449563|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
124952022|NCT04749797|449449564|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
124460194|NCT02716987|447644071|FG000|Overall Study|Ligand synthesis failure|0|||
124460195|NCT02716987|447644072|FG001|Overall Study|Ligand synthesis failure|0|||
124460196|NCT02716987|447644073|FG002|Overall Study|Ligand synthesis failure|1|||
124460197|NCT02716987|447644074|FG003|Overall Study|Ligand synthesis failure|0|||
124460198|NCT02716987|447644075|FG004|Overall Study|Ligand synthesis failure|0|||
124460199|NCT02716987|447644076|FG005|Overall Study|Ligand synthesis failure|0|||
124460200|NCT02716987|447644071|FG000|Overall Study|Withdrawal by Subject|0|||
124460201|NCT02716987|447644072|FG001|Overall Study|Withdrawal by Subject|0|||
124460202|NCT02716987|447644073|FG002|Overall Study|Withdrawal by Subject|0|||
124460203|NCT02716987|447644074|FG003|Overall Study|Withdrawal by Subject|0|||
124460204|NCT02716987|447644075|FG004|Overall Study|Withdrawal by Subject|1|||
124460205|NCT02716987|447644076|FG005|Overall Study|Withdrawal by Subject|1|||
124460206|NCT03223428|447644080|FG000|Overall Study|No longer taking Xermelo|27|||
124460207|NCT03223428|447644080|FG000|Overall Study|Declined Consent|1|||
124460208|NCT03223428|447644080|FG000|Overall Study|Non-responders|56|||
124460209|NCT03223428|447644080|FG000|Overall Study|Withdrawal by Subject|14|||
124548919|NCT05302414|447965403|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
124952023|NCT04749797|449449565|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
124952024|NCT00632736|449449566|FG000|Overall Study|Adverse Event|104|||
124460210|NCT01834274|447644081|FG000|Overall Study|Study Termination|41|||
124460211|NCT01834274|447644082|FG001|Overall Study|Study Termination|38|||
124460212|NCT01834274|447644081|FG000|Overall Study|Withdrawal by Subject|1|||
124548920|NCT05302414|447965404|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
124460213|NCT01834274|447644082|FG001|Overall Study|Withdrawal by Subject|1|||
124460214|NCT01834274|447644081|FG000|Overall Study|Lost to Follow-up|3|||
124460215|NCT01834274|447644082|FG001|Overall Study|Lost to Follow-up|1|||
124707487|NCT00776230|448554669|FG001|Overall Study|Lost to Follow-up|1|||
124707488|NCT00776230|448554670|FG002|Overall Study|Lost to Follow-up|5|||
124952025|NCT00632736|449449566|FG000|Overall Study|Lost to Follow-up|15|||
124460216|NCT01834274|447644081|FG000|Overall Study|Other|2|||
124460217|NCT01834274|447644082|FG001|Overall Study|Other|1|||
124952026|NCT00632736|449449566|FG000|Overall Study|Protocol Violation|14|||
124952027|NCT00632736|449449566|FG000|Overall Study|Withdrawal by Subject|99|||
124952028|NCT00632736|449449566|FG000|Overall Study|Lack of Efficacy|5|||
124952029|NCT00632736|449449566|FG000|Overall Study|Sponsor terminated study|5|||
124952030|NCT00632736|449449566|FG000|Overall Study|Non-compliance|10|||
124952031|NCT00632736|449449566|FG000|Overall Study|Other|16|||
124952032|NCT01441596|449449567|FG000|Overall Study|Other reason not defined below|0|||
124952033|NCT01441596|449449568|FG001|Overall Study|Other reason not defined below|2|||
124952034|NCT01441596|449449569|FG002|Overall Study|Other reason not defined below|1|||
124952035|NCT01441596|449449567|FG000|Overall Study|Withdrawal by Subject|4|||
124952036|NCT01441596|449449568|FG001|Overall Study|Withdrawal by Subject|0|||
124952037|NCT01441596|449449569|FG002|Overall Study|Withdrawal by Subject|2|||
124952038|NCT01441596|449449567|FG000|Overall Study|Not treated|0|||
124952039|NCT01441596|449449568|FG001|Overall Study|Not treated|1|||
124952040|NCT01441596|449449569|FG002|Overall Study|Not treated|1|||
124952041|NCT01794689|449449570|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
124952042|NCT01794689|449449571|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
124952043|NCT01794689|449449572|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
124952044|NCT01794689|449449573|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
124952045|NCT01794689|449449570|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
124952046|NCT01794689|449449571|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
124952047|NCT01794689|449449572|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
124952048|NCT01794689|449449573|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
124952049|NCT01794689|449449570|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
124952050|NCT01794689|449449571|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
124952051|NCT01794689|449449572|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
124952052|NCT01794689|449449573|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
124952053|NCT01794689|449449570|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
124952054|NCT01794689|449449571|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
124952055|NCT01794689|449449572|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
124952056|NCT01794689|449449573|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
124952057|NCT01697956|449449574|FG000|Overall Study|Protocol Violation|1|||
124952058|NCT01697956|449449575|FG001|Overall Study|Protocol Violation|1|||
124952059|NCT00736502|449449586|FG000|Overall Study|Adverse Event|22|||
124952060|NCT00736502|449449586|FG000|Overall Study|Lack of Efficacy|16|||
124952061|NCT00736502|449449586|FG000|Overall Study|Lost to Follow-up|27|||
124952062|NCT00866619|449449587|FG000|Overall Study|Adverse Event|112|||
124952063|NCT00866619|449449588|FG001|Overall Study|Adverse Event|106|||
124952064|NCT00866619|449449589|FG002|Overall Study|Adverse Event|47|||
124952065|NCT00866619|449449590|FG003|Overall Study|Adverse Event|44|||
124952066|NCT00866619|449449587|FG000|Overall Study|Protocol Violation|2|||
124952067|NCT00866619|449449588|FG001|Overall Study|Protocol Violation|39|||
124952068|NCT00866619|449449589|FG002|Overall Study|Protocol Violation|2|||
124952069|NCT00866619|449449590|FG003|Overall Study|Protocol Violation|17|||
124952070|NCT00866619|449449587|FG000|Overall Study|Withdrawal by Subject|587|||
124952071|NCT00866619|449449588|FG001|Overall Study|Withdrawal by Subject|295|||
124952072|NCT00866619|449449589|FG002|Overall Study|Withdrawal by Subject|272|||
124952073|NCT00866619|449449590|FG003|Overall Study|Withdrawal by Subject|144|||
124952074|NCT00866619|449449587|FG000|Overall Study|Lost to Follow-up|1145|||
124952075|NCT00866619|449449588|FG001|Overall Study|Lost to Follow-up|830|||
124952076|NCT00866619|449449589|FG002|Overall Study|Lost to Follow-up|568|||
124952077|NCT00866619|449449590|FG003|Overall Study|Lost to Follow-up|425|||
124952078|NCT00645411|449449591|FG000|Overall Study|Adverse Event|0|||
124952079|NCT00645411|449449592|FG001|Overall Study|Adverse Event|0|||
124952080|NCT00645411|449449593|FG002|Overall Study|Adverse Event|0|||
124952081|NCT00645411|449449594|FG003|Overall Study|Adverse Event|2|||
124952082|NCT00645411|449449591|FG000|Overall Study|Withdrawal by Subject|2|||
124952083|NCT00645411|449449592|FG001|Overall Study|Withdrawal by Subject|1|||
124952084|NCT00645411|449449593|FG002|Overall Study|Withdrawal by Subject|19|||
124952085|NCT00645411|449449594|FG003|Overall Study|Withdrawal by Subject|21|||
124952086|NCT00645411|449449591|FG000|Overall Study|Lost to Follow-up|10|||
124952087|NCT00645411|449449592|FG001|Overall Study|Lost to Follow-up|5|||
124952088|NCT00645411|449449593|FG002|Overall Study|Lost to Follow-up|124|||
124952089|NCT00645411|449449594|FG003|Overall Study|Lost to Follow-up|75|||
124952090|NCT00645411|449449591|FG000|Overall Study|Protocol Violation|1|||
124952091|NCT00645411|449449592|FG001|Overall Study|Protocol Violation|0|||
124952092|NCT00645411|449449593|FG002|Overall Study|Protocol Violation|1|||
124952093|NCT00645411|449449594|FG003|Overall Study|Protocol Violation|0|||
124952094|NCT00645411|449449591|FG000|Overall Study|Inappropriate enrollment|0|||
124952095|NCT00645411|449449592|FG001|Overall Study|Inappropriate enrollment|0|||
124952096|NCT00645411|449449593|FG002|Overall Study|Inappropriate enrollment|4|||
124952097|NCT00645411|449449594|FG003|Overall Study|Inappropriate enrollment|1|||
124952098|NCT00645411|449449591|FG000|Overall Study|Unable to classify|0|||
124952099|NCT00645411|449449592|FG001|Overall Study|Unable to classify|0|||
124952100|NCT00645411|449449593|FG002|Overall Study|Unable to classify|3|||
124952101|NCT00645411|449449594|FG003|Overall Study|Unable to classify|4|||
124952102|NCT03987074|449449595|FG000|Overall Study|Withdrew Consent|1|||
124952103|NCT03987074|449449596|FG001|Overall Study|Withdrew Consent|1|||
124952104|NCT03987074|449449597|FG002|Overall Study|Withdrew Consent|0|||
124952105|NCT03987074|449449598|FG003|Overall Study|Withdrew Consent|2|||
124952106|NCT03987074|449449599|FG004|Overall Study|Withdrew Consent|1|||
124952107|NCT03987074|449449595|FG000|Overall Study|Adverse Event|2|||
124952108|NCT03987074|449449596|FG001|Overall Study|Adverse Event|1|||
124952109|NCT03987074|449449597|FG002|Overall Study|Adverse Event|0|||
124952110|NCT03987074|449449598|FG003|Overall Study|Adverse Event|0|||
124952111|NCT03987074|449449599|FG004|Overall Study|Adverse Event|1|||
124952112|NCT03987074|449449595|FG000|Overall Study|Lost to Follow-up|0|||
124952113|NCT03987074|449449596|FG001|Overall Study|Lost to Follow-up|0|||
124952114|NCT03987074|449449597|FG002|Overall Study|Lost to Follow-up|1|||
124952115|NCT03987074|449449598|FG003|Overall Study|Lost to Follow-up|1|||
124952116|NCT03987074|449449599|FG004|Overall Study|Lost to Follow-up|0|||
124952117|NCT03987074|449449595|FG000|Overall Study|Investigator's Discretion|0|||
124952118|NCT03987074|449449596|FG001|Overall Study|Investigator's Discretion|0|||
124952119|NCT03987074|449449597|FG002|Overall Study|Investigator's Discretion|0|||
124952120|NCT03987074|449449598|FG003|Overall Study|Investigator's Discretion|1|||
124952121|NCT03987074|449449599|FG004|Overall Study|Investigator's Discretion|0|||
124952122|NCT03100370|449449600|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124952123|NCT03100370|449449601|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124952124|NCT03100370|449449602|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124952125|NCT03100370|449449603|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
124952126|NCT03100370|449449604|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124952127|NCT03100370|449449605|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124952128|NCT01562275|449450878|FG000|Stage 1|Adverse Event|0|||
124952129|NCT01562275|449450879|FG001|Stage 1|Adverse Event|0|||
124952130|NCT01562275|449450880|FG002|Stage 1|Adverse Event|0|||
124952131|NCT01562275|449450881|FG003|Stage 1|Adverse Event|1|||
124952132|NCT01562275|449450882|FG004|Stage 1|Adverse Event|1|||
124952133|NCT01562275|449450883|FG005|Stage 1|Adverse Event|0|||
124952134|NCT01562275|449450884|FG006|Stage 1|Adverse Event|0|||
124952135|NCT01562275|449450885|FG007|Stage 1|Adverse Event|0|||
124952136|NCT01562275|449450886|FG008|Stage 1|Adverse Event|0|||
124952137|NCT01562275|449450887|FG009|Stage 1|Adverse Event|1|||
124952138|NCT01562275|449450888|FG010|Stage 1|Adverse Event|0|||
124952139|NCT01562275|449450889|FG011|Stage 1|Adverse Event|0|||
124952140|NCT01562275|449450890|FG012|Stage 1|Adverse Event|0|||
124952141|NCT01562275|449450878|FG000|Stage 1|Death|1|||
124952142|NCT01562275|449450879|FG001|Stage 1|Death|0|||
124952143|NCT01562275|449450880|FG002|Stage 1|Death|0|||
124952144|NCT01562275|449450881|FG003|Stage 1|Death|0|||
124952145|NCT01562275|449450882|FG004|Stage 1|Death|0|||
124707489|NCT00776230|448554668|FG000|Overall Study|Not vaccinated at Day 0|1|||
124707490|NCT00776230|448554669|FG001|Overall Study|Not vaccinated at Day 0|0|||
124707491|NCT00776230|448554670|FG002|Overall Study|Not vaccinated at Day 0|0|||
124707492|NCT00776230|448554668|FG000|Overall Study|Withdrawal by Subject|0|||
124952146|NCT01562275|449450883|FG005|Stage 1|Death|0|||
124952147|NCT01562275|449450884|FG006|Stage 1|Death|0|||
124952148|NCT01562275|449450885|FG007|Stage 1|Death|0|||
124952149|NCT01562275|449450886|FG008|Stage 1|Death|0|||
124952150|NCT01562275|449450887|FG009|Stage 1|Death|0|||
124952151|NCT01562275|449450888|FG010|Stage 1|Death|0|||
124952152|NCT01562275|449450889|FG011|Stage 1|Death|0|||
124952153|NCT01562275|449450890|FG012|Stage 1|Death|0|||
124952154|NCT01562275|449450878|FG000|Stage 1|Non Compliance|0|||
124952155|NCT01562275|449450879|FG001|Stage 1|Non Compliance|0|||
124952156|NCT01562275|449450880|FG002|Stage 1|Non Compliance|1|||
124952157|NCT01562275|449450881|FG003|Stage 1|Non Compliance|0|||
124952158|NCT01562275|449450882|FG004|Stage 1|Non Compliance|0|||
124952159|NCT01562275|449450883|FG005|Stage 1|Non Compliance|0|||
124952160|NCT01562275|449450884|FG006|Stage 1|Non Compliance|0|||
124952161|NCT01562275|449450885|FG007|Stage 1|Non Compliance|0|||
124952162|NCT01562275|449450886|FG008|Stage 1|Non Compliance|0|||
124952163|NCT01562275|449450887|FG009|Stage 1|Non Compliance|0|||
124952164|NCT01562275|449450888|FG010|Stage 1|Non Compliance|0|||
124952165|NCT01562275|449450889|FG011|Stage 1|Non Compliance|0|||
124952166|NCT01562275|449450890|FG012|Stage 1|Non Compliance|0|||
124952167|NCT01562275|449450878|FG000|Stage 1|Physician Decision|0|||
124952168|NCT01562275|449450879|FG001|Stage 1|Physician Decision|0|||
124952169|NCT01562275|449450880|FG002|Stage 1|Physician Decision|0|||
124952170|NCT01562275|449450881|FG003|Stage 1|Physician Decision|0|||
124952171|NCT01562275|449450882|FG004|Stage 1|Physician Decision|1|||
124952172|NCT01562275|449450883|FG005|Stage 1|Physician Decision|0|||
124952173|NCT01562275|449450884|FG006|Stage 1|Physician Decision|1|||
124952174|NCT01562275|449450885|FG007|Stage 1|Physician Decision|0|||
124952175|NCT01562275|449450886|FG008|Stage 1|Physician Decision|1|||
124952176|NCT01562275|449450887|FG009|Stage 1|Physician Decision|0|||
124952177|NCT01562275|449450888|FG010|Stage 1|Physician Decision|0|||
124952178|NCT01562275|449450889|FG011|Stage 1|Physician Decision|0|||
124952179|NCT01562275|449450890|FG012|Stage 1|Physician Decision|0|||
124952180|NCT01562275|449450878|FG000|Stage 1|Progression of Disease|2|||
124952181|NCT01562275|449450879|FG001|Stage 1|Progression of Disease|6|||
124952182|NCT01562275|449450880|FG002|Stage 1|Progression of Disease|2|||
124952183|NCT01562275|449450881|FG003|Stage 1|Progression of Disease|1|||
124952184|NCT01562275|449450882|FG004|Stage 1|Progression of Disease|2|||
124952185|NCT01562275|449450883|FG005|Stage 1|Progression of Disease|4|||
124952186|NCT01562275|449450884|FG006|Stage 1|Progression of Disease|1|||
124952187|NCT01562275|449450885|FG007|Stage 1|Progression of Disease|7|||
124952188|NCT01562275|449450886|FG008|Stage 1|Progression of Disease|2|||
124952189|NCT01562275|449450887|FG009|Stage 1|Progression of Disease|5|||
124952190|NCT01562275|449450888|FG010|Stage 1|Progression of Disease|3|||
124952191|NCT01562275|449450889|FG011|Stage 1|Progression of Disease|0|||
124952192|NCT01562275|449450890|FG012|Stage 1|Progression of Disease|0|||
124952193|NCT01562275|449450878|FG000|Stage 1|Withdrawal by Subject|0|||
124952194|NCT01562275|449450879|FG001|Stage 1|Withdrawal by Subject|1|||
124952195|NCT01562275|449450880|FG002|Stage 1|Withdrawal by Subject|0|||
124952196|NCT01562275|449450881|FG003|Stage 1|Withdrawal by Subject|2|||
124952197|NCT01562275|449450882|FG004|Stage 1|Withdrawal by Subject|0|||
124952198|NCT01562275|449450883|FG005|Stage 1|Withdrawal by Subject|0|||
124952199|NCT01562275|449450884|FG006|Stage 1|Withdrawal by Subject|1|||
124952200|NCT01562275|449450885|FG007|Stage 1|Withdrawal by Subject|0|||
124952201|NCT01562275|449450886|FG008|Stage 1|Withdrawal by Subject|0|||
124952202|NCT01562275|449450887|FG009|Stage 1|Withdrawal by Subject|1|||
124952203|NCT01562275|449450888|FG010|Stage 1|Withdrawal by Subject|0|||
124952204|NCT01562275|449450889|FG011|Stage 1|Withdrawal by Subject|0|||
124952205|NCT01562275|449450890|FG012|Stage 1|Withdrawal by Subject|0|||
124952206|NCT01562275|449450878|FG000|Stage 2|Death|0|||
124952207|NCT01562275|449450879|FG001|Stage 2|Death|0|||
124952208|NCT01562275|449450880|FG002|Stage 2|Death|0|||
124952209|NCT01562275|449450881|FG003|Stage 2|Death|0|||
124952210|NCT01562275|449450882|FG004|Stage 2|Death|0|||
124952211|NCT01562275|449450883|FG005|Stage 2|Death|0|||
124952212|NCT01562275|449450884|FG006|Stage 2|Death|0|||
124952213|NCT01562275|449450885|FG007|Stage 2|Death|0|||
124952214|NCT01562275|449450886|FG008|Stage 2|Death|0|||
124952215|NCT01562275|449450887|FG009|Stage 2|Death|0|||
124952216|NCT01562275|449450888|FG010|Stage 2|Death|0|||
124952217|NCT01562275|449450889|FG011|Stage 2|Death|2|||
124952218|NCT01562275|449450890|FG012|Stage 2|Death|1|||
124952219|NCT01562275|449450878|FG000|Stage 2|Progression of Disease|0|||
124952220|NCT01562275|449450879|FG001|Stage 2|Progression of Disease|0|||
124952221|NCT01562275|449450880|FG002|Stage 2|Progression of Disease|0|||
124952222|NCT01562275|449450881|FG003|Stage 2|Progression of Disease|0|||
124952223|NCT01562275|449450882|FG004|Stage 2|Progression of Disease|0|||
124952224|NCT01562275|449450883|FG005|Stage 2|Progression of Disease|0|||
124952225|NCT01562275|449450884|FG006|Stage 2|Progression of Disease|0|||
124952226|NCT01562275|449450885|FG007|Stage 2|Progression of Disease|0|||
124952227|NCT01562275|449450886|FG008|Stage 2|Progression of Disease|0|||
124952228|NCT01562275|449450887|FG009|Stage 2|Progression of Disease|0|||
124952229|NCT01562275|449450888|FG010|Stage 2|Progression of Disease|0|||
124952230|NCT01562275|449450889|FG011|Stage 2|Progression of Disease|12|||
124952231|NCT01562275|449450890|FG012|Stage 2|Progression of Disease|4|||
124952232|NCT01863368|449450891|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
124952233|NCT01863368|449450892|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
124952234|NCT01863368|449450891|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
124952235|NCT01863368|449450892|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
124952236|NCT01863368|449450891|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
124952237|NCT01863368|449450892|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
124548921|NCT01610284|447965405|FG000|Randomization Phase|Adverse Event|1|||
124952238|NCT01863368|449450891|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
124952239|NCT01863368|449450892|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
124952240|NCT01863368|449450891|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
124952241|NCT01863368|449450892|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
124952242|NCT01863368|449450891|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
124952243|NCT01863368|449450892|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
124952244|NCT01020487|449450894|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
124952245|NCT01020487|449450895|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
124548922|NCT01610284|447965406|FG001|Randomization Phase|Adverse Event|0|||
124548923|NCT01610284|447965405|FG000|Randomization Phase|Physician Decision|1|||
124548924|NCT01610284|447965406|FG001|Randomization Phase|Physician Decision|1|||
124548925|NCT01610284|447965405|FG000|Randomization Phase|Death|0|||
124548926|NCT01610284|447965406|FG001|Randomization Phase|Death|1|||
124548927|NCT01610284|447965405|FG000|Treatment Phase|Adverse Event|80|||
124548928|NCT01610284|447965406|FG001|Treatment Phase|Adverse Event|12|||
124548929|NCT01610284|447965405|FG000|Treatment Phase|Lost to Follow-up|1|||
124548930|NCT01610284|447965406|FG001|Treatment Phase|Lost to Follow-up|0|||
124548931|NCT01610284|447965405|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
124548932|NCT01610284|447965406|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
124707493|NCT00776230|448554669|FG001|Overall Study|Withdrawal by Subject|1|||
124707494|NCT00776230|448554670|FG002|Overall Study|Withdrawal by Subject|0|||
124707495|NCT00776230|448554668|FG000|Overall Study|Subject missed Visit 4|0|||
124707496|NCT00776230|448554669|FG001|Overall Study|Subject missed Visit 4|1|||
124707497|NCT00776230|448554670|FG002|Overall Study|Subject missed Visit 4|0|||
124707498|NCT01242514|448554672|FG000|Overall Study|e.g., project closure|1042|||
124707499|NCT01242514|448554673|FG001|Overall Study|e.g., project closure|305|||
124707500|NCT01242514|448554674|FG002|Overall Study|e.g., project closure|171|||
124707501|NCT01242514|448554672|FG000|Overall Study|Subject decision|33|||
124707502|NCT01242514|448554673|FG001|Overall Study|Subject decision|8|||
124707503|NCT01242514|448554674|FG002|Overall Study|Subject decision|2|||
124707504|NCT01242514|448554672|FG000|Overall Study|Severe non-compliance to protocol|5|||
124707505|NCT01242514|448554673|FG001|Overall Study|Severe non-compliance to protocol|2|||
124707506|NCT01242514|448554674|FG002|Overall Study|Severe non-compliance to protocol|1|||
124707507|NCT01242514|448554672|FG000|Overall Study|Lack of therapeutic response|99|||
124707508|NCT01242514|448554673|FG001|Overall Study|Lack of therapeutic response|16|||
124707509|NCT01242514|448554674|FG002|Overall Study|Lack of therapeutic response|10|||
124707510|NCT01242514|448554672|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
124707511|NCT01242514|448554673|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
124707512|NCT01242514|448554674|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
124707513|NCT01242514|448554672|FG000|Overall Study|Lost to Follow-up|14|||
124707514|NCT01242514|448554673|FG001|Overall Study|Lost to Follow-up|5|||
124707515|NCT01242514|448554674|FG002|Overall Study|Lost to Follow-up|4|||
124707516|NCT01242514|448554672|FG000|Overall Study|Adverse Event|129|||
124707517|NCT01242514|448554673|FG001|Overall Study|Adverse Event|18|||
124707518|NCT01242514|448554674|FG002|Overall Study|Adverse Event|19|||
124952246|NCT01020487|449450896|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
124952247|NCT01020487|449450894|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
124952248|NCT01020487|449450895|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
124952249|NCT01020487|449450896|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
124952250|NCT01020487|449450894|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
124952251|NCT01020487|449450895|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
124952252|NCT01020487|449450896|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
124952253|NCT01020487|449450894|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
124952254|NCT01020487|449450895|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
124952255|NCT01020487|449450896|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
124952256|NCT01020487|449450894|FG000|Part 2 Open-label Period|Adverse Event|0|||
124952257|NCT01020487|449450895|FG001|Part 2 Open-label Period|Adverse Event|4|||
124952258|NCT01020487|449450896|FG002|Part 2 Open-label Period|Adverse Event|1|||
124952259|NCT04049578|449450897|FG000|Overall Study|Physician Decision|1|||
124952260|NCT02400749|449450900|FG000|Week 0 -16|Withdrawal by Subject|5|||
124952261|NCT02400749|449450901|FG001|Week 0 -16|Withdrawal by Subject|5|||
124952262|NCT02400749|449450900|FG000|Week 0 -16|Adverse Event|3|||
124952263|NCT02400749|449450901|FG001|Week 0 -16|Adverse Event|1|||
124952264|NCT02400749|449450900|FG000|Week 0 -16|Lost to Follow-up|2|||
124707519|NCT03110562|448554690|FG000|Initial Treatment Period|Disease Progression|1|||
124707520|NCT03110562|448554691|FG001|Initial Treatment Period|Disease Progression|1|||
124952265|NCT02400749|449450901|FG001|Week 0 -16|Lost to Follow-up|0|||
124952266|NCT02400749|449450900|FG000|Week 0 -16|Protocol Violation|1|||
124952267|NCT02400749|449450901|FG001|Week 0 -16|Protocol Violation|0|||
124952268|NCT02400749|449450900|FG000|Week 17 - 32|Withdrawal by Subject|3|||
124952269|NCT02400749|449450901|FG001|Week 17 - 32|Withdrawal by Subject|2|||
124952270|NCT02400749|449450900|FG000|Week 17 - 32|Adverse Event|2|||
124952271|NCT02400749|449450901|FG001|Week 17 - 32|Adverse Event|1|||
124952272|NCT04425252|449450904|FG000|Overall Study|Withdrawal by Subject|2|||
124952273|NCT04425252|449450905|FG001|Overall Study|Withdrawal by Subject|1|||
124548933|NCT01610284|447965405|FG000|Treatment Phase|Physician Decision|27|||
124548934|NCT01610284|447965406|FG001|Treatment Phase|Physician Decision|24|||
124548935|NCT01610284|447965405|FG000|Treatment Phase|Progressive Disease|377|||
124548936|NCT01610284|447965406|FG001|Treatment Phase|Progressive Disease|486|||
124548937|NCT01610284|447965405|FG000|Treatment Phase|Protocol Deviation|2|||
124707521|NCT03110562|448554692|FG002|Initial Treatment Period|Disease Progression|0|||
124707522|NCT03110562|448554693|FG003|Initial Treatment Period|Disease Progression|0|||
124707523|NCT03110562|448554690|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
124952274|NCT04425252|449450904|FG000|Overall Study|Lost to Follow-up|1|||
124952275|NCT04425252|449450905|FG001|Overall Study|Lost to Follow-up|0|||
124952276|NCT04425252|449450904|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
124952277|NCT04425252|449450905|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
124952278|NCT00307489|449450906|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
124952279|NCT00307489|449450907|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
124952280|NCT00307489|449450906|FG000|Baseline Through Week 48|Physician Decision|1|||
124952281|NCT00307489|449450907|FG001|Baseline Through Week 48|Physician Decision|0|||
124952282|NCT00307489|449450906|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
124952283|NCT00307489|449450907|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
124952284|NCT00307489|449450906|FG000|Week 48 Through Week 168|Adverse Event|1|||
124952285|NCT00307489|449450907|FG001|Week 48 Through Week 168|Adverse Event|0|||
124952286|NCT00307489|449450906|FG000|Week 48 Through Week 168|Physician Decision|1|||
124952287|NCT00307489|449450907|FG001|Week 48 Through Week 168|Physician Decision|0|||
124952288|NCT00307489|449450906|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
124952289|NCT00307489|449450907|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
124952290|NCT00307489|449450906|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
124952291|NCT00307489|449450907|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
124952292|NCT00307489|449450906|FG000|Week 48 Through Week 168|Death|0|||
124952293|NCT00307489|449450907|FG001|Week 48 Through Week 168|Death|1|||
124952294|NCT00307489|449450906|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
124952295|NCT00307489|449450907|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
124952296|NCT00307489|449450906|FG000|Week 48 Through Week 168|Seroconversion|1|||
124952297|NCT00307489|449450907|FG001|Week 48 Through Week 168|Seroconversion|0|||
124952298|NCT02446015|449450909|FG000|Overall Study|Adverse Event|0|||
124952299|NCT02446015|449450910|FG001|Overall Study|Adverse Event|1|||
124952300|NCT02446015|449450909|FG000|Overall Study|Withdrawal by Subject|1|||
124952301|NCT02446015|449450910|FG001|Overall Study|Withdrawal by Subject|0|||
124952302|NCT02964234|449450912|FG000|Overall Study|Lost to Follow-up|22|||
124952303|NCT02964234|449450913|FG001|Overall Study|Lost to Follow-up|13|||
124952304|NCT02163499|449450914|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
124952305|NCT02163499|449450914|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
124952306|NCT02163499|449450914|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
124952307|NCT02163499|449450914|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
124952308|NCT02163499|449450914|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
124952309|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
124952310|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
124952311|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
124952312|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
124952313|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
124952314|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
124952315|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
124952316|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
124952317|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
124952318|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Death|8|||
124952319|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
124952320|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
124952321|NCT02163499|449450914|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
124952322|NCT00857311|449450915|FG000|Overall Study|Lost to Follow-up|1|||
124952323|NCT00857311|449450916|FG001|Overall Study|Lost to Follow-up|0|||
124952324|NCT00857311|449450917|FG002|Overall Study|Lost to Follow-up|0|||
124952325|NCT00857311|449450918|FG003|Overall Study|Lost to Follow-up|0|||
124952326|NCT00828139|449450923|FG000|Overall Study|Adverse Event|8|||
124952327|NCT00828139|449450924|FG001|Overall Study|Adverse Event|1|||
124952328|NCT00828139|449450925|FG002|Overall Study|Adverse Event|10|||
124952329|NCT00828139|449450926|FG003|Overall Study|Adverse Event|5|||
124952330|NCT00828139|449450923|FG000|Overall Study|Death|2|||
124952331|NCT00828139|449450924|FG001|Overall Study|Death|1|||
124952332|NCT00828139|449450925|FG002|Overall Study|Death|0|||
124952333|NCT00828139|449450926|FG003|Overall Study|Death|2|||
124707524|NCT03110562|448554691|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
124707525|NCT03110562|448554692|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
124707526|NCT03110562|448554693|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
124707527|NCT03110562|448554690|FG000|Initial Treatment Period|Adverse Event|1|||
124952334|NCT00828139|449450923|FG000|Overall Study|Refusal unrelated to toxicity|3|||
124707528|NCT03110562|448554691|FG001|Initial Treatment Period|Adverse Event|0|||
124707529|NCT03110562|448554692|FG002|Initial Treatment Period|Adverse Event|0|||
124952335|NCT00828139|449450924|FG001|Overall Study|Refusal unrelated to toxicity|4|||
124952336|NCT00828139|449450925|FG002|Overall Study|Refusal unrelated to toxicity|5|||
124952337|NCT00828139|449450926|FG003|Overall Study|Refusal unrelated to toxicity|3|||
124952338|NCT00828139|449450923|FG000|Overall Study|Disease Progression|24|||
124952339|NCT00828139|449450924|FG001|Overall Study|Disease Progression|33|||
124952340|NCT00828139|449450925|FG002|Overall Study|Disease Progression|35|||
124548938|NCT01610284|447965406|FG001|Treatment Phase|Protocol Deviation|3|||
124548939|NCT01610284|447965405|FG000|Treatment Phase|Study terminated by Sponsor|18|||
124548940|NCT01610284|447965406|FG001|Treatment Phase|Study terminated by Sponsor|15|||
124548941|NCT01610284|447965405|FG000|Treatment Phase|Subject/Guardian Decision|55|||
124548942|NCT01610284|447965406|FG001|Treatment Phase|Subject/Guardian Decision|23|||
124548943|NCT01610284|447965405|FG000|Treatment Phase|Death|6|||
124548944|NCT01610284|447965406|FG001|Treatment Phase|Death|5|||
124548945|NCT01610284|447965405|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
124548946|NCT01610284|447965406|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
124548947|NCT01610284|447965405|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
124548948|NCT01610284|447965406|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
124548949|NCT01610284|447965405|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
124548950|NCT01610284|447965406|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
124548951|NCT01610284|447965405|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
124548952|NCT01610284|447965406|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
124548953|NCT01610284|447965405|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
124548954|NCT01610284|447965406|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
124548955|NCT01610284|447965405|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
124548956|NCT01610284|447965406|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
124548957|NCT01102972|447965409|FG000|Overall Study|Adverse Event|8|||
124548958|NCT01102972|447965410|FG001|Overall Study|Adverse Event|2|||
124548959|NCT01102972|447965409|FG000|Overall Study|Lack of Efficacy|2|||
124952341|NCT00828139|449450926|FG003|Overall Study|Disease Progression|39|||
124952342|NCT00828139|449450923|FG000|Overall Study|Other|4|||
124952343|NCT00828139|449450924|FG001|Overall Study|Other|2|||
124952344|NCT00828139|449450925|FG002|Overall Study|Other|5|||
124952345|NCT00828139|449450926|FG003|Overall Study|Other|2|||
124952346|NCT01714947|449450927|FG000|Part B|Progressive Disease|3|||
124952347|NCT01922102|449450928|FG000|Overall Study|Withdrawal by Subject|7|||
124952348|NCT01922102|449450929|FG001|Overall Study|Withdrawal by Subject|3|||
124952349|NCT01922102|449450930|FG002|Overall Study|Withdrawal by Subject|7|||
124952350|NCT01922102|449450928|FG000|Overall Study|Physician Decision|0|||
124952351|NCT01922102|449450929|FG001|Overall Study|Physician Decision|2|||
124952352|NCT01922102|449450930|FG002|Overall Study|Physician Decision|1|||
124952353|NCT01922102|449450928|FG000|Overall Study|Adverse Event|1|||
124952354|NCT01922102|449450929|FG001|Overall Study|Adverse Event|2|||
124952355|NCT01922102|449450930|FG002|Overall Study|Adverse Event|0|||
124952356|NCT01922102|449450928|FG000|Overall Study|Lost to Follow-up|1|||
124952357|NCT01922102|449450929|FG001|Overall Study|Lost to Follow-up|0|||
124952358|NCT01922102|449450930|FG002|Overall Study|Lost to Follow-up|0|||
124952359|NCT01922102|449450928|FG000|Overall Study|Administrative problems|0|||
124952360|NCT01922102|449450929|FG001|Overall Study|Administrative problems|2|||
124952361|NCT01922102|449450930|FG002|Overall Study|Administrative problems|0|||
124952362|NCT01123356|449450934|FG000|Overall Study|Adverse Event|2|||
124952363|NCT01123356|449450934|FG000|Overall Study|Lack of Efficacy|4|||
124952364|NCT01123356|449450934|FG000|Overall Study|Withdrawal by Subject|1|||
124952365|NCT03262389|449450937|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
124952366|NCT03262389|449450937|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
124952367|NCT03262389|449450937|FG000|Overall Study|opted out of PET/MR|1|||
124952368|NCT01052272|449450938|FG000|Overall Study|Death|0|||
124952369|NCT01052272|449450939|FG001|Overall Study|Death|0|||
124952370|NCT01052272|449450940|FG002|Overall Study|Death|1|||
124952371|NCT01052272|449450941|FG003|Overall Study|Death|1|||
124952372|NCT01052272|449450938|FG000|Overall Study|Physician Decision|0|||
124952373|NCT01052272|449450939|FG001|Overall Study|Physician Decision|1|||
124952374|NCT01052272|449450940|FG002|Overall Study|Physician Decision|0|||
124952375|NCT01052272|449450941|FG003|Overall Study|Physician Decision|0|||
124952376|NCT01052272|449450938|FG000|Overall Study|patient refuses follow-up|5|||
124952377|NCT01052272|449450939|FG001|Overall Study|patient refuses follow-up|4|||
124548960|NCT01102972|447965410|FG001|Overall Study|Lack of Efficacy|1|||
124548961|NCT01102972|447965409|FG000|Overall Study|Protocol Violation|1|||
124952378|NCT01052272|449450940|FG002|Overall Study|patient refuses follow-up|2|||
124952379|NCT01052272|449450941|FG003|Overall Study|patient refuses follow-up|4|||
124952380|NCT01052272|449450938|FG000|Overall Study|Withdrawal by Subject|0|||
124952381|NCT01052272|449450939|FG001|Overall Study|Withdrawal by Subject|2|||
124952382|NCT01052272|449450940|FG002|Overall Study|Withdrawal by Subject|3|||
124952383|NCT01052272|449450941|FG003|Overall Study|Withdrawal by Subject|2|||
124952384|NCT01052272|449450938|FG000|Overall Study|placed in long-term care|0|||
124952385|NCT01052272|449450939|FG001|Overall Study|placed in long-term care|0|||
124952386|NCT01052272|449450940|FG002|Overall Study|placed in long-term care|1|||
124548962|NCT01102972|447965410|FG001|Overall Study|Protocol Violation|0|||
124548963|NCT01102972|447965409|FG000|Overall Study|Lost to Follow-up|10|||
124952387|NCT01052272|449450941|FG003|Overall Study|placed in long-term care|0|||
124952388|NCT01052272|449450938|FG000|Overall Study|decline in health|0|||
124952389|NCT01052272|449450939|FG001|Overall Study|decline in health|0|||
124952390|NCT01052272|449450940|FG002|Overall Study|decline in health|1|||
124460218|NCT02595723|447644091|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
124460219|NCT02595723|447644092|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
124460220|NCT02595723|447644093|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
124460221|NCT02595723|447644091|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
124460222|NCT02595723|447644092|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
124460223|NCT02595723|447644093|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
124460224|NCT00004259|447644094|FG000|Overall Study|Protocol Violation|1|||
124460225|NCT00004259|447644095|FG001|Overall Study|Protocol Violation|2|||
124460226|NCT00004259|447644096|FG002|Overall Study|Protocol Violation|0|||
124460227|NCT00004259|447644097|FG003|Overall Study|Protocol Violation|0|||
124460228|NCT00004259|447644094|FG000|Overall Study|Withdrawal by Subject|0|||
124460229|NCT00004259|447644095|FG001|Overall Study|Withdrawal by Subject|2|||
124460230|NCT00004259|447644096|FG002|Overall Study|Withdrawal by Subject|0|||
124460231|NCT00004259|447644097|FG003|Overall Study|Withdrawal by Subject|0|||
124460232|NCT00996944|447644098|FG000|Double-blind Treatment Period|Adverse Event|2|||
124460233|NCT00996944|447644099|FG001|Double-blind Treatment Period|Adverse Event|1|||
124460234|NCT00996944|447644098|FG000|Double-blind Treatment Period|Protocol Violation|1|||
124460235|NCT00996944|447644099|FG001|Double-blind Treatment Period|Protocol Violation|0|||
124460236|NCT00996944|447644098|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
124460237|NCT00996944|447644099|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
124460238|NCT00996944|447644098|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
124460239|NCT00996944|447644099|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
124460240|NCT00996944|447644098|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
124460241|NCT00996944|447644099|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
124460242|NCT00769184|447644100|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
124460243|NCT00769184|447644101|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
124460244|NCT00769184|447644100|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
124460245|NCT00769184|447644101|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
124460246|NCT00769184|447644100|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
124460247|NCT00769184|447644101|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
124460248|NCT01015768|447644103|FG000|Overall Study|Some subject data unuseable|4|||
124460249|NCT01015768|447644104|FG001|Overall Study|Some subject data unuseable|4|||
124460250|NCT02943564|447644105|FG000|Overall Study|Miscellaneous Reasons|0|||
124460251|NCT02943564|447644106|FG001|Overall Study|Miscellaneous Reasons|0|||
124460252|NCT02943564|447644107|FG002|Overall Study|Miscellaneous Reasons|3|||
124952391|NCT01052272|449450941|FG003|Overall Study|decline in health|0|||
124952392|NCT01077284|449450943|FG000|Overall Study|Adverse Event|2|||
124952393|NCT01077284|449450944|FG001|Overall Study|Adverse Event|0|||
124952394|NCT01077284|449450945|FG002|Overall Study|Adverse Event|1|||
124952395|NCT01077284|449450943|FG000|Overall Study|Lost to Follow-up|1|||
124952396|NCT01077284|449450944|FG001|Overall Study|Lost to Follow-up|2|||
124952397|NCT01077284|449450945|FG002|Overall Study|Lost to Follow-up|0|||
124952398|NCT01077284|449450943|FG000|Overall Study|Withdrawal by Subject|2|||
124952399|NCT01077284|449450944|FG001|Overall Study|Withdrawal by Subject|3|||
124952400|NCT01077284|449450945|FG002|Overall Study|Withdrawal by Subject|1|||
124952401|NCT01077284|449450943|FG000|Overall Study|Other|0|||
124952402|NCT01077284|449450944|FG001|Overall Study|Other|0|||
124952403|NCT01077284|449450945|FG002|Overall Study|Other|1|||
124952404|NCT01280721|449450946|FG000|Overall Study|Adverse Event|4|||
124952405|NCT01280721|449450946|FG000|Overall Study|Physician Decision|3|||
124952406|NCT01280721|449450946|FG000|Overall Study|Withdrawal by Subject|6|||
124952407|NCT01280721|449450946|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
124952408|NCT01280721|449450946|FG000|Overall Study|No tolerability for the lowest dose|2|||
124952409|NCT01180400|449450947|FG000|Overall Study|Withdrawal by Subject|5|||
124952410|NCT01180400|449450948|FG001|Overall Study|Withdrawal by Subject|6|||
124952411|NCT01180400|449450947|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124952412|NCT01180400|449450948|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
124952413|NCT01180400|449450947|FG000|Overall Study|Adverse Event|12|||
124952414|NCT01180400|449450948|FG001|Overall Study|Adverse Event|10|||
124952415|NCT01180400|449450947|FG000|Overall Study|Severe non-compliance to protocol|1|||
124952416|NCT01180400|449450948|FG001|Overall Study|Severe non-compliance to protocol|2|||
124952417|NCT01180400|449450947|FG000|Overall Study|Condition under investigation worsened|2|||
124460253|NCT02943564|447644105|FG000|Overall Study|Site terminated by sponsor|0|||
124460254|NCT02943564|447644106|FG001|Overall Study|Site terminated by sponsor|1|||
124952418|NCT01180400|449450948|FG001|Overall Study|Condition under investigation worsened|1|||
124952419|NCT01180400|449450947|FG000|Overall Study|Lack of Efficacy|2|||
124952420|NCT01180400|449450948|FG001|Overall Study|Lack of Efficacy|0|||
124952421|NCT01180400|449450947|FG000|Overall Study|Study-specific withdrawal criteria|1|||
124460255|NCT02943564|447644107|FG002|Overall Study|Site terminated by sponsor|0|||
124460256|NCT02943564|447644105|FG000|Overall Study|Non-compliance with study drug|0|||
124460257|NCT02943564|447644106|FG001|Overall Study|Non-compliance with study drug|1|||
124460258|NCT02943564|447644107|FG002|Overall Study|Non-compliance with study drug|0|||
124460259|NCT02943564|447644105|FG000|Overall Study|Pregnancy|0|||
124952422|NCT01180400|449450948|FG001|Overall Study|Study-specific withdrawal criteria|2|||
124952423|NCT01180400|449450947|FG000|Overall Study|Lost to Follow-up|2|||
124952424|NCT01180400|449450948|FG001|Overall Study|Lost to Follow-up|3|||
124952425|NCT01180400|449450947|FG000|Overall Study|Other|0|||
124952426|NCT01180400|449450948|FG001|Overall Study|Other|1|||
124952427|NCT00096278|449450950|FG000|Overall Study|No follow-up data|15|||
124952428|NCT00096278|449450951|FG001|Overall Study|No follow-up data|18|||
124952429|NCT00096278|449450950|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
124952430|NCT00096278|449450951|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
124952431|NCT00248794|449450952|FG000|Overall Study|Lost to Follow-up|6|||
124952432|NCT00248794|449450953|FG001|Overall Study|Lost to Follow-up|8|||
124952433|NCT00248794|449450954|FG002|Overall Study|Lost to Follow-up|3|||
124952434|NCT03449979|449450955|FG000|Overall Study|Technical difficulty|0|||
124952435|NCT03449979|449450956|FG001|Overall Study|Technical difficulty|0|||
124952436|NCT03449979|449450957|FG002|Overall Study|Technical difficulty|0|||
124952437|NCT03449979|449450958|FG003|Overall Study|Technical difficulty|1|||
124952438|NCT02632747|449450959|FG000|Wash-out Period|Adverse Event|1|||
124952439|NCT02632747|449450960|FG001|Wash-out Period|Adverse Event|0|||
124952440|NCT02069379|449450961|FG000|Baseline Measurements|Lost to Follow-up|1|||
124952441|NCT02069379|449450962|FG001|Baseline Measurements|Lost to Follow-up|0|||
124952442|NCT02069379|449450963|FG002|Baseline Measurements|Lost to Follow-up|0|||
124952443|NCT02069379|449450964|FG003|Baseline Measurements|Lost to Follow-up|0|||
124952444|NCT02069379|449450961|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
124952445|NCT02069379|449450962|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
124952446|NCT02069379|449450963|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
124952447|NCT02069379|449450964|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
124952448|NCT02069379|449450961|FG000|First Treatment Arm|Lost to Follow-up|0|||
124952449|NCT02069379|449450962|FG001|First Treatment Arm|Lost to Follow-up|1|||
124952450|NCT02069379|449450963|FG002|First Treatment Arm|Lost to Follow-up|1|||
124952451|NCT02069379|449450964|FG003|First Treatment Arm|Lost to Follow-up|0|||
124952452|NCT02069379|449450961|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
124952453|NCT02069379|449450962|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
124952454|NCT02069379|449450963|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
124952455|NCT02069379|449450964|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
124952456|NCT02069379|449450961|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
124952457|NCT02069379|449450962|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
124952458|NCT02069379|449450963|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
124952459|NCT02069379|449450964|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
124952460|NCT02069379|449450961|FG000|Second Treatment Arm|Lost to Follow-up|0|||
124952461|NCT02069379|449450962|FG001|Second Treatment Arm|Lost to Follow-up|0|||
124952462|NCT02069379|449450963|FG002|Second Treatment Arm|Lost to Follow-up|1|||
124952463|NCT02069379|449450964|FG003|Second Treatment Arm|Lost to Follow-up|0|||
124952464|NCT00700999|449450967|FG000|Overall Study|Lost to Follow-up|7|||
124460260|NCT02943564|447644106|FG001|Overall Study|Pregnancy|1|||
124460261|NCT02943564|447644107|FG002|Overall Study|Pregnancy|1|||
124460262|NCT02943564|447644105|FG000|Overall Study|Protocol Violation|2|||
124460263|NCT02943564|447644106|FG001|Overall Study|Protocol Violation|2|||
124460264|NCT02943564|447644107|FG002|Overall Study|Protocol Violation|2|||
124460265|NCT02943564|447644105|FG000|Overall Study|Lost to Follow-up|1|||
124460266|NCT02943564|447644106|FG001|Overall Study|Lost to Follow-up|0|||
124460267|NCT02943564|447644107|FG002|Overall Study|Lost to Follow-up|0|||
124460268|NCT02943564|447644105|FG000|Overall Study|Withdrawal by Subject|6|||
124460269|NCT02943564|447644106|FG001|Overall Study|Withdrawal by Subject|5|||
124460270|NCT02943564|447644107|FG002|Overall Study|Withdrawal by Subject|2|||
124460271|NCT02943564|447644105|FG000|Overall Study|Adverse Event|1|||
124460272|NCT02943564|447644106|FG001|Overall Study|Adverse Event|2|||
124460273|NCT02943564|447644107|FG002|Overall Study|Adverse Event|1|||
124460274|NCT02943564|447644105|FG000|Overall Study|Lack of Efficacy|0|||
124460275|NCT02943564|447644106|FG001|Overall Study|Lack of Efficacy|1|||
124460276|NCT02943564|447644107|FG002|Overall Study|Lack of Efficacy|0|||
124707530|NCT03110562|448554693|FG003|Initial Treatment Period|Adverse Event|0|||
124952465|NCT00700999|449450968|FG001|Overall Study|Lost to Follow-up|7|||
124707531|NCT03110562|448554690|FG000|Initial Treatment Period|Death|74|||
124952466|NCT00700999|449450967|FG000|Overall Study|Excluded - did not meet study criteria|0|||
124952467|NCT00700999|449450968|FG001|Overall Study|Excluded - did not meet study criteria|1|||
124460277|NCT01073267|447644110|FG000|Overall Study|Disease Progression|3|||
124460278|NCT00577642|447644111|FG000|Overall Study|Clinical Disease Progression|1|||
124460279|NCT01505634|447644116|FG000|Overall Study|Withdrawal by Subject|2|||
124460280|NCT01505634|447644117|FG001|Overall Study|Withdrawal by Subject|5|||
124707532|NCT03110562|448554691|FG001|Initial Treatment Period|Death|82|||
124952468|NCT00700999|449450967|FG000|Overall Study|Withdrawal by Subject|8|||
124952469|NCT00700999|449450968|FG001|Overall Study|Withdrawal by Subject|1|||
124952470|NCT03651271|449450969|FG000|Overall Study|Death|4|||
124952471|NCT03651271|449450970|FG001|Overall Study|Death|37|||
124952472|NCT03651271|449450971|FG002|Overall Study|Death|0|||
124952473|NCT03651271|449450972|FG003|Overall Study|Death|2|||
124952474|NCT03651271|449450973|FG004|Overall Study|Death|6|||
124952475|NCT03651271|449450969|FG000|Overall Study|Lost to Follow-up|1|||
124952476|NCT03651271|449450970|FG001|Overall Study|Lost to Follow-up|5|||
124952477|NCT03651271|449450971|FG002|Overall Study|Lost to Follow-up|0|||
124952478|NCT03651271|449450972|FG003|Overall Study|Lost to Follow-up|1|||
124952479|NCT03651271|449450973|FG004|Overall Study|Lost to Follow-up|0|||
124952480|NCT03651271|449450969|FG000|Overall Study|Physician Decision|0|||
124952481|NCT03651271|449450970|FG001|Overall Study|Physician Decision|2|||
124952482|NCT03651271|449450971|FG002|Overall Study|Physician Decision|0|||
124952483|NCT03651271|449450972|FG003|Overall Study|Physician Decision|0|||
124952484|NCT03651271|449450973|FG004|Overall Study|Physician Decision|0|||
124952485|NCT03651271|449450969|FG000|Overall Study|Withdrawal by Subject|1|||
124952486|NCT03651271|449450970|FG001|Overall Study|Withdrawal by Subject|15|||
124952487|NCT03651271|449450971|FG002|Overall Study|Withdrawal by Subject|0|||
124952488|NCT03651271|449450972|FG003|Overall Study|Withdrawal by Subject|0|||
124952489|NCT03651271|449450973|FG004|Overall Study|Withdrawal by Subject|1|||
124952490|NCT03651271|449450969|FG000|Overall Study|Patient medically unable to continue|0|||
124952491|NCT03651271|449450970|FG001|Overall Study|Patient medically unable to continue|0|||
124952492|NCT03651271|449450971|FG002|Overall Study|Patient medically unable to continue|0|||
124952493|NCT03651271|449450972|FG003|Overall Study|Patient medically unable to continue|1|||
124952494|NCT03651271|449450973|FG004|Overall Study|Patient medically unable to continue|0|||
124952495|NCT03444155|449450976|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
124952496|NCT03444155|449450977|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
124952497|NCT00821093|449450978|FG000|Overall Study|Adverse Event|20|||
124952498|NCT00821093|449450979|FG001|Overall Study|Adverse Event|12|||
124952499|NCT00821093|449450978|FG000|Overall Study|Withdrawal by Subject|9|||
124952500|NCT00821093|449450979|FG001|Overall Study|Withdrawal by Subject|13|||
124952501|NCT00821093|449450978|FG000|Overall Study|Lost to Follow-up|9|||
124952502|NCT00821093|449450979|FG001|Overall Study|Lost to Follow-up|3|||
124952503|NCT00821093|449450978|FG000|Overall Study|Protocol deviation|3|||
124952504|NCT00821093|449450979|FG001|Overall Study|Protocol deviation|6|||
124952505|NCT00821093|449450978|FG000|Overall Study|Abnormal laboratory value(s)|2|||
124952506|NCT00821093|449450979|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124952507|NCT00821093|449450978|FG000|Overall Study|Lack of Efficacy|2|||
124952508|NCT00821093|449450979|FG001|Overall Study|Lack of Efficacy|2|||
124952509|NCT00821093|449450978|FG000|Overall Study|Death|2|||
124952510|NCT00821093|449450979|FG001|Overall Study|Death|1|||
124952511|NCT00821093|449450978|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124952512|NCT00821093|449450979|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124460281|NCT01505634|447644118|FG002|Overall Study|Withdrawal by Subject|1|||
124460282|NCT01505634|447644116|FG000|Overall Study|Physician Decision|1|||
124460283|NCT01505634|447644117|FG001|Overall Study|Physician Decision|1|||
124460284|NCT01505634|447644118|FG002|Overall Study|Physician Decision|0|||
124460285|NCT01505634|447644116|FG000|Overall Study|Adverse Event|1|||
124460286|NCT01505634|447644117|FG001|Overall Study|Adverse Event|0|||
124460287|NCT01505634|447644118|FG002|Overall Study|Adverse Event|0|||
124460288|NCT01505634|447644116|FG000|Overall Study|Insufficient supply of drug at site|1|||
124460289|NCT01505634|447644117|FG001|Overall Study|Insufficient supply of drug at site|0|||
124460290|NCT01505634|447644118|FG002|Overall Study|Insufficient supply of drug at site|0|||
124460291|NCT01505634|447644116|FG000|Overall Study|Protocol Violation|2|||
124460292|NCT01505634|447644117|FG001|Overall Study|Protocol Violation|0|||
124460293|NCT01505634|447644118|FG002|Overall Study|Protocol Violation|0|||
124460294|NCT01505634|447644116|FG000|Overall Study|Lost to Follow-up|1|||
124460295|NCT01505634|447644117|FG001|Overall Study|Lost to Follow-up|4|||
124460296|NCT01505634|447644118|FG002|Overall Study|Lost to Follow-up|4|||
124460297|NCT01505634|447644116|FG000|Overall Study|Death|1|||
124460298|NCT01505634|447644117|FG001|Overall Study|Death|0|||
124460299|NCT01505634|447644118|FG002|Overall Study|Death|0|||
124460300|NCT01505634|447644116|FG000|Overall Study|In a conflict zone|0|||
124460301|NCT01505634|447644117|FG001|Overall Study|In a conflict zone|0|||
124460302|NCT01505634|447644118|FG002|Overall Study|In a conflict zone|1|||
124460303|NCT02054897|447644119|FG000|Overall Study|Withdrawal by Subject|2|||
124460304|NCT02054897|447644120|FG001|Overall Study|Withdrawal by Subject|0|||
124460305|NCT02054897|447644121|FG002|Overall Study|Withdrawal by Subject|2|||
124460306|NCT02054897|447644119|FG000|Overall Study|Missing follow-up information|3|||
124460307|NCT02054897|447644120|FG001|Overall Study|Missing follow-up information|5|||
124460308|NCT02054897|447644121|FG002|Overall Study|Missing follow-up information|3|||
124952513|NCT00821093|449450978|FG000|Overall Study|Administrative problems|1|||
124952514|NCT00821093|449450979|FG001|Overall Study|Administrative problems|2|||
124460309|NCT02054897|447644119|FG000|Overall Study|Lost to Follow-up|4|||
124460310|NCT02054897|447644120|FG001|Overall Study|Lost to Follow-up|2|||
124952515|NCT02877680|449450984|FG000|Overall Study|Lost to Follow-up|1|||
124952516|NCT02877680|449450985|FG001|Overall Study|Lost to Follow-up|1|||
124952517|NCT01133678|449450986|FG000|Overall Study|Death|1|||
124952518|NCT01133678|449450987|FG001|Overall Study|Death|1|||
124952519|NCT05104242|449450994|FG000|Overall Study|Withdrawal by Subject|1|||
124952520|NCT05104242|449450995|FG001|Overall Study|Withdrawal by Subject|5|||
124460311|NCT02054897|447644121|FG002|Overall Study|Lost to Follow-up|7|||
124460312|NCT02054897|447644119|FG000|Overall Study|Randomized but not exposed|1|||
124548964|NCT01102972|447965410|FG001|Overall Study|Lost to Follow-up|5|||
124548965|NCT01102972|447965409|FG000|Overall Study|Investigator Discretion|2|||
124548966|NCT01102972|447965410|FG001|Overall Study|Investigator Discretion|0|||
124548967|NCT01102972|447965409|FG000|Overall Study|Withdrawal by Subject|6|||
124548968|NCT01102972|447965410|FG001|Overall Study|Withdrawal by Subject|6|||
124548969|NCT01856257|447965414|FG000|Overall Study|Death|2|||
124548970|NCT01856257|447965415|FG001|Overall Study|Death|0|||
124548971|NCT01856257|447965416|FG002|Overall Study|Death|0|||
124548972|NCT01856257|447965417|FG003|Overall Study|Death|0|||
124548973|NCT01856257|447965414|FG000|Overall Study|Physician Decision|0|||
124548974|NCT01856257|447965415|FG001|Overall Study|Physician Decision|0|||
124548975|NCT01856257|447965416|FG002|Overall Study|Physician Decision|0|||
124548976|NCT01856257|447965417|FG003|Overall Study|Physician Decision|1|||
124548977|NCT01856257|447965414|FG000|Overall Study|Withdrawal by Subject|1|||
124707533|NCT03110562|448554692|FG002|Initial Treatment Period|Death|0|||
124707534|NCT03110562|448554693|FG003|Initial Treatment Period|Death|0|||
124707535|NCT03110562|448554690|FG000|Initial Treatment Period|Lost to Follow-up|13|||
124707536|NCT03110562|448554691|FG001|Initial Treatment Period|Lost to Follow-up|8|||
124707537|NCT03110562|448554692|FG002|Initial Treatment Period|Lost to Follow-up|0|||
124707538|NCT03110562|448554693|FG003|Initial Treatment Period|Lost to Follow-up|0|||
124707539|NCT03110562|448554690|FG000|Initial Treatment Period|Protocol Deviation|1|||
124707540|NCT03110562|448554691|FG001|Initial Treatment Period|Protocol Deviation|0|||
124707541|NCT03110562|448554692|FG002|Initial Treatment Period|Protocol Deviation|0|||
124707542|NCT03110562|448554693|FG003|Initial Treatment Period|Protocol Deviation|0|||
124548978|NCT01856257|447965415|FG001|Overall Study|Withdrawal by Subject|1|||
124548979|NCT01856257|447965416|FG002|Overall Study|Withdrawal by Subject|0|||
124548980|NCT01856257|447965417|FG003|Overall Study|Withdrawal by Subject|0|||
124707543|NCT03110562|448554690|FG000|Initial Treatment Period|Physician Decision|2|||
124707544|NCT03110562|448554691|FG001|Initial Treatment Period|Physician Decision|1|||
124707545|NCT03110562|448554692|FG002|Initial Treatment Period|Physician Decision|0|||
124707546|NCT03110562|448554693|FG003|Initial Treatment Period|Physician Decision|0|||
124707547|NCT03110562|448554690|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
124707548|NCT03110562|448554691|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
124707549|NCT03110562|448554692|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
124707550|NCT03110562|448554693|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
124707551|NCT03110562|448554690|FG000|Initial Treatment Period|Other|5|||
124707552|NCT03110562|448554691|FG001|Initial Treatment Period|Other|4|||
124707553|NCT03110562|448554692|FG002|Initial Treatment Period|Other|0|||
124707554|NCT03110562|448554693|FG003|Initial Treatment Period|Other|0|||
124952521|NCT05104242|449450994|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
124952522|NCT05104242|449450995|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
124952523|NCT01864200|449450996|FG000|Overall Study|Lost to Follow-up|1|||
124952524|NCT01864200|449450997|FG001|Overall Study|Lost to Follow-up|3|||
124952525|NCT01864200|449450996|FG000|Overall Study|Protocol Violation|1|||
124952526|NCT01864200|449450997|FG001|Overall Study|Protocol Violation|0|||
124952527|NCT00424476|449450999|FG000|Overall Study|Withdrawal by Subject|7|||
124952528|NCT00424476|449451000|FG001|Overall Study|Withdrawal by Subject|6|||
124952529|NCT00424476|449451001|FG002|Overall Study|Withdrawal by Subject|3|||
124952530|NCT00424476|449450999|FG000|Overall Study|Adverse Event|19|||
124952531|NCT00424476|449451000|FG001|Overall Study|Adverse Event|16|||
124952532|NCT00424476|449451001|FG002|Overall Study|Adverse Event|15|||
124952533|NCT00424476|449450999|FG000|Overall Study|Lack of Efficacy|16|||
124952534|NCT00424476|449451000|FG001|Overall Study|Lack of Efficacy|12|||
124952535|NCT00424476|449451001|FG002|Overall Study|Lack of Efficacy|12|||
124952536|NCT00424476|449450999|FG000|Overall Study|Lack of Compliance|1|||
124952537|NCT00424476|449451000|FG001|Overall Study|Lack of Compliance|1|||
124952538|NCT00424476|449451001|FG002|Overall Study|Lack of Compliance|1|||
124952539|NCT00424476|449450999|FG000|Overall Study|Lost to Follow-up|4|||
124952540|NCT00424476|449451000|FG001|Overall Study|Lost to Follow-up|6|||
124952541|NCT00424476|449451001|FG002|Overall Study|Lost to Follow-up|3|||
124952542|NCT00424476|449450999|FG000|Overall Study|Protocol Violation|7|||
124952543|NCT00424476|449451000|FG001|Overall Study|Protocol Violation|2|||
124952544|NCT00424476|449451001|FG002|Overall Study|Protocol Violation|3|||
124952545|NCT00424476|449450999|FG000|Overall Study|Physician Decision|3|||
124952546|NCT00424476|449451000|FG001|Overall Study|Physician Decision|2|||
124952547|NCT00424476|449451001|FG002|Overall Study|Physician Decision|3|||
124952548|NCT00424476|449450999|FG000|Overall Study|Other|4|||
124952549|NCT00424476|449451000|FG001|Overall Study|Other|3|||
124952550|NCT00424476|449451001|FG002|Overall Study|Other|9|||
124952551|NCT02574286|449451002|FG000|Overall Study|Adverse Event|3|||
124952552|NCT02574286|449451002|FG000|Overall Study|Withdrawal by Subject|2|||
124952553|NCT01280656|449451003|FG000|Overall Study|Adverse Event|1|||
124548981|NCT01856257|447965414|FG000|Overall Study|Donor complication|0|||
124548982|NCT01856257|447965415|FG001|Overall Study|Donor complication|0|||
124707555|NCT03110562|448554690|FG000|Initial Treatment Period|Randomized but never treated|0|||
124952554|NCT01280656|449451004|FG001|Overall Study|Adverse Event|14|||
124952555|NCT01280656|449451005|FG002|Overall Study|Adverse Event|13|||
124952556|NCT01280656|449451003|FG000|Overall Study|Lack of Efficacy|1|||
124952557|NCT01280656|449451004|FG001|Overall Study|Lack of Efficacy|22|||
124952558|NCT01280656|449451005|FG002|Overall Study|Lack of Efficacy|38|||
124952559|NCT01280656|449451003|FG000|Overall Study|Treatment shortening (RGT)|0|||
124952560|NCT01280656|449451004|FG001|Overall Study|Treatment shortening (RGT)|4|||
124952561|NCT01280656|449451005|FG002|Overall Study|Treatment shortening (RGT)|5|||
124952562|NCT01280656|449451003|FG000|Overall Study|Other|1|||
124952563|NCT01280656|449451004|FG001|Overall Study|Other|7|||
124952564|NCT01280656|449451005|FG002|Overall Study|Other|7|||
124952565|NCT02138838|449451006|FG000|Overall Study|Study Closure|7|||
124952566|NCT02138838|449451007|FG001|Overall Study|Study Closure|6|||
124952567|NCT02138838|449451006|FG000|Overall Study|Withdrawal by Subject|1|||
124952568|NCT02138838|449451007|FG001|Overall Study|Withdrawal by Subject|5|||
124952569|NCT02993926|449451010|FG000|Enantone Treatment Phase|Adverse Event|1|||
124952570|NCT02993926|449451011|FG001|Enantone Treatment Phase|Adverse Event|0|||
124952571|NCT02993926|449451012|FG002|Enantone Treatment Phase|Adverse Event|0|||
124952572|NCT02993926|449451010|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
124952573|NCT02993926|449451011|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
124952574|NCT02993926|449451012|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
124952575|NCT02993926|449451010|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
124952576|NCT02993926|449451011|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
124952577|NCT02993926|449451012|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
124952578|NCT02993926|449451010|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
124952579|NCT02993926|449451011|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
124952580|NCT02993926|449451012|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
124952581|NCT01084772|449451014|FG000|Baseline|Withdrawal by Subject|7|||
124952582|NCT01084772|449451015|FG001|Baseline|Withdrawal by Subject|6|||
124952583|NCT01084772|449451014|FG000|3 Months|Death|1|||
124952584|NCT01084772|449451015|FG001|3 Months|Death|0|||
124952585|NCT01084772|449451014|FG000|3 Months|Study Termination|2|||
124952586|NCT01084772|449451015|FG001|3 Months|Study Termination|2|||
124952587|NCT01084772|449451014|FG000|1 Year|Withdrawal by Subject|0|||
124952588|NCT01084772|449451015|FG001|1 Year|Withdrawal by Subject|1|||
124952589|NCT01084772|449451014|FG000|1 Year|Lost to Follow-up|3|||
124952590|NCT01084772|449451015|FG001|1 Year|Lost to Follow-up|0|||
124952591|NCT01084772|449451014|FG000|1 Year|Study Termination|0|||
124952592|NCT01084772|449451015|FG001|1 Year|Study Termination|7|||
124952593|NCT01084772|449451014|FG000|2 Years|Withdrawal by Subject|1|||
124952594|NCT01084772|449451015|FG001|2 Years|Withdrawal by Subject|0|||
124952595|NCT01084772|449451014|FG000|2 Years|Lost to Follow-up|5|||
124952596|NCT01084772|449451015|FG001|2 Years|Lost to Follow-up|2|||
124952597|NCT01084772|449451014|FG000|2 Years|Study Termination|3|||
124952598|NCT01084772|449451015|FG001|2 Years|Study Termination|2|||
124952599|NCT01867307|449451016|FG000|Overall Study|Protocol Violation|2|||
124952600|NCT01867307|449451017|FG001|Overall Study|Protocol Violation|0|||
124952601|NCT01867307|449451016|FG000|Overall Study|Other Adverse Event|1|||
124952602|NCT01867307|449451017|FG001|Overall Study|Other Adverse Event|3|||
124952603|NCT00518206|449451018|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
124952604|NCT00518206|449451019|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
124460313|NCT02054897|447644120|FG001|Overall Study|Randomized but not exposed|0|||
124460314|NCT02054897|447644121|FG002|Overall Study|Randomized but not exposed|0|||
124460315|NCT00794157|447644123|FG000|Overall Study|Adverse Event|4|||
124460316|NCT00794157|447644124|FG001|Overall Study|Adverse Event|1|||
124460317|NCT00794157|447644125|FG002|Overall Study|Adverse Event|8|||
124460318|NCT00794157|447644123|FG000|Overall Study|Subject withdrew consent|2|||
124460319|NCT00794157|447644124|FG001|Overall Study|Subject withdrew consent|0|||
124460320|NCT00794157|447644125|FG002|Overall Study|Subject withdrew consent|3|||
124460321|NCT00794157|447644123|FG000|Overall Study|Lost to Follow-up|2|||
124460322|NCT00794157|447644124|FG001|Overall Study|Lost to Follow-up|0|||
124460323|NCT00794157|447644125|FG002|Overall Study|Lost to Follow-up|1|||
124952605|NCT00518206|449451018|FG000|Overall Study|Withdrawal by Subject|2|||
124952606|NCT00518206|449451019|FG001|Overall Study|Withdrawal by Subject|0|||
124952607|NCT00518206|449451018|FG000|Overall Study|Drug Supply Issue|1|||
124952608|NCT00518206|449451019|FG001|Overall Study|Drug Supply Issue|0|||
124952609|NCT00518206|449451018|FG000|Overall Study|Reason Unknown|1|||
124952610|NCT00518206|449451019|FG001|Overall Study|Reason Unknown|0|||
124952611|NCT00518206|449451018|FG000|Overall Study|Completion Status Unknown|1|||
124460324|NCT00794157|447644123|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124460325|NCT00794157|447644124|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124952612|NCT00518206|449451019|FG001|Overall Study|Completion Status Unknown|0|||
124952613|NCT01199302|449451022|FG000|Overall Study|Adverse Event|1|||
124952614|NCT01199302|449451023|FG001|Overall Study|Adverse Event|1|||
124952615|NCT01199302|449451024|FG002|Overall Study|Adverse Event|2|||
124952616|NCT01199302|449451025|FG003|Overall Study|Adverse Event|0|||
124460326|NCT00794157|447644125|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
124952617|NCT01199302|449451022|FG000|Overall Study|Withdrawal by Subject|2|||
124952618|NCT01199302|449451023|FG001|Overall Study|Withdrawal by Subject|2|||
124952619|NCT01199302|449451024|FG002|Overall Study|Withdrawal by Subject|3|||
124952620|NCT01199302|449451025|FG003|Overall Study|Withdrawal by Subject|0|||
124952621|NCT01199302|449451022|FG000|Overall Study|Disease Progression|3|||
124952622|NCT01199302|449451023|FG001|Overall Study|Disease Progression|4|||
124952623|NCT01199302|449451024|FG002|Overall Study|Disease Progression|4|||
124952624|NCT01199302|449451025|FG003|Overall Study|Disease Progression|2|||
124952625|NCT01199302|449451022|FG000|Overall Study|Study Termination|13|||
124952626|NCT01199302|449451023|FG001|Overall Study|Study Termination|8|||
124952627|NCT01199302|449451024|FG002|Overall Study|Study Termination|11|||
124952628|NCT01199302|449451025|FG003|Overall Study|Study Termination|9|||
124952629|NCT01199302|449451022|FG000|Overall Study|Lost to Follow-up|0|||
124952630|NCT01199302|449451023|FG001|Overall Study|Lost to Follow-up|1|||
124952631|NCT01199302|449451024|FG002|Overall Study|Lost to Follow-up|0|||
124952632|NCT01199302|449451025|FG003|Overall Study|Lost to Follow-up|0|||
124952633|NCT01199302|449451022|FG000|Overall Study|Other|1|||
124952634|NCT01199302|449451023|FG001|Overall Study|Other|0|||
124952635|NCT01199302|449451024|FG002|Overall Study|Other|0|||
124952636|NCT01199302|449451025|FG003|Overall Study|Other|0|||
124952637|NCT03820024|449451028|FG000|Overall Study|Physician Decision|1|||
124952638|NCT03820024|449451029|FG001|Overall Study|Physician Decision|2|||
124952639|NCT01945593|449453109|FG000|Overall Study|Adverse Event|0|||
124952640|NCT01945593|449453110|FG001|Overall Study|Adverse Event|0|||
124952641|NCT01945593|449453111|FG002|Overall Study|Adverse Event|0|||
124952642|NCT01945593|449453112|FG003|Overall Study|Adverse Event|5|||
124952643|NCT01945593|449453109|FG000|Overall Study|Physician Decision|0|||
124952644|NCT01945593|449453110|FG001|Overall Study|Physician Decision|0|||
124952645|NCT01945593|449453111|FG002|Overall Study|Physician Decision|1|||
124952646|NCT01945593|449453112|FG003|Overall Study|Physician Decision|1|||
124952647|NCT01945593|449453109|FG000|Overall Study|Withdrawal by Subject|0|||
124952648|NCT01945593|449453110|FG001|Overall Study|Withdrawal by Subject|2|||
124952649|NCT01945593|449453111|FG002|Overall Study|Withdrawal by Subject|0|||
124952650|NCT01945593|449453112|FG003|Overall Study|Withdrawal by Subject|4|||
124952651|NCT01945593|449453109|FG000|Overall Study|Protocol Violation|0|||
124952652|NCT01945593|449453110|FG001|Overall Study|Protocol Violation|2|||
124952653|NCT01945593|449453111|FG002|Overall Study|Protocol Violation|1|||
124952654|NCT01945593|449453112|FG003|Overall Study|Protocol Violation|3|||
124952655|NCT01945593|449453109|FG000|Overall Study|Death|0|||
124952656|NCT01945593|449453110|FG001|Overall Study|Death|0|||
124952657|NCT01945593|449453111|FG002|Overall Study|Death|1|||
124952658|NCT01945593|449453112|FG003|Overall Study|Death|0|||
124952659|NCT01945593|449453109|FG000|Overall Study|Other: Terminated|0|||
124952660|NCT01945593|449453110|FG001|Overall Study|Other: Terminated|0|||
124952661|NCT01945593|449453111|FG002|Overall Study|Other: Terminated|0|||
124952662|NCT01945593|449453112|FG003|Overall Study|Other: Terminated|1|||
124952663|NCT01945593|449453109|FG000|Overall Study|Other: Surgical Procedure|0|||
124952664|NCT01945593|449453110|FG001|Overall Study|Other: Surgical Procedure|2|||
124952665|NCT01945593|449453111|FG002|Overall Study|Other: Surgical Procedure|0|||
124952666|NCT01945593|449453112|FG003|Overall Study|Other: Surgical Procedure|6|||
124952667|NCT01945593|449453109|FG000|Overall Study|Other: Screen Failure|0|||
124952668|NCT01945593|449453110|FG001|Overall Study|Other: Screen Failure|2|||
124952669|NCT01945593|449453111|FG002|Overall Study|Other: Screen Failure|0|||
124952670|NCT01945593|449453112|FG003|Overall Study|Other: Screen Failure|0|||
124952671|NCT01540474|449453115|FG000|Vaccination Period|Lost to Follow-up|0|||
124952672|NCT01540474|449453116|FG001|Vaccination Period|Lost to Follow-up|1|||
124952673|NCT01540474|449453117|FG002|Vaccination Period|Lost to Follow-up|0|||
124460327|NCT00794157|447644123|FG000|Overall Study|Administrative problems|1|||
124460328|NCT00794157|447644124|FG001|Overall Study|Administrative problems|7|||
124460329|NCT00794157|447644125|FG002|Overall Study|Administrative problems|4|||
124460330|NCT00794157|447644123|FG000|Overall Study|Abnormal test procedure result(s)|0|||
124460331|NCT00794157|447644124|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124460332|NCT00794157|447644125|FG002|Overall Study|Abnormal test procedure result(s)|0|||
124460333|NCT00794157|447644123|FG000|Overall Study|Protocol deviation|0|||
124952674|NCT01540474|449453118|FG003|Vaccination Period|Lost to Follow-up|0|||
124952675|NCT04454125|449453119|FG000|Overall Study|Lost to Follow-up|0|||
124952676|NCT04454125|449453120|FG001|Overall Study|Lost to Follow-up|1|||
124952677|NCT01587703|449453121|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
124952678|NCT01587703|449453122|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952679|NCT01587703|449453123|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952680|NCT01587703|449453124|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952681|NCT01587703|449453125|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952682|NCT01587703|449453126|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952683|NCT01587703|449453127|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952684|NCT01587703|449453128|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952685|NCT01587703|449453129|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952686|NCT01587703|449453130|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952687|NCT01587703|449453131|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952688|NCT01587703|449453132|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952689|NCT01587703|449453133|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952690|NCT01587703|449453134|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952691|NCT01587703|449453135|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952692|NCT01587703|449453136|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952693|NCT01587703|449453137|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952694|NCT01587703|449453138|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952695|NCT01587703|449453139|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
124952696|NCT01587703|449453121|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952697|NCT01587703|449453122|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952698|NCT01587703|449453123|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952699|NCT01587703|449453124|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952700|NCT01587703|449453125|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952701|NCT01587703|449453126|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
124952702|NCT01587703|449453127|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952703|NCT01587703|449453128|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
124952704|NCT01587703|449453129|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952705|NCT01587703|449453130|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952706|NCT01587703|449453131|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952707|NCT01587703|449453132|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952708|NCT01587703|449453133|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952709|NCT01587703|449453134|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952710|NCT01587703|449453135|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952711|NCT01587703|449453136|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952712|NCT01587703|449453137|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952713|NCT01587703|449453138|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952714|NCT01587703|449453139|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
124952715|NCT01587703|449453121|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952716|NCT01587703|449453122|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952717|NCT01587703|449453123|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952718|NCT01587703|449453124|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952719|NCT01587703|449453125|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952720|NCT01587703|449453126|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952721|NCT01587703|449453127|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
124952722|NCT01587703|449453128|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952723|NCT01587703|449453129|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952724|NCT01587703|449453130|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952725|NCT01587703|449453131|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952726|NCT01587703|449453132|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124460334|NCT00794157|447644124|FG001|Overall Study|Protocol deviation|1|||
124460335|NCT00794157|447644125|FG002|Overall Study|Protocol deviation|1|||
124460336|NCT00531752|447644126|FG000|First Double-blind Intervention Period|Adverse Event|2|||
124460337|NCT00531752|447644127|FG001|First Double-blind Intervention Period|Adverse Event|0|||
124460338|NCT00531752|447644128|FG002|First Double-blind Intervention Period|Adverse Event|1|||
124952727|NCT01587703|449453133|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124460339|NCT00531752|447644129|FG003|First Double-blind Intervention Period|Adverse Event|1|||
124460340|NCT00531752|447644126|FG000|First Double-blind Intervention Period|Other|1|||
124952728|NCT01587703|449453134|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952729|NCT01587703|449453135|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952730|NCT01587703|449453136|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952731|NCT01587703|449453137|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952732|NCT01587703|449453138|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952733|NCT01587703|449453139|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
124952734|NCT01587703|449453121|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
124952735|NCT01587703|449453122|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
124952736|NCT01587703|449453123|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
124952737|NCT01587703|449453124|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
124952738|NCT01587703|449453125|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
124952739|NCT01587703|449453126|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
124952740|NCT01587703|449453127|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
124952741|NCT01587703|449453128|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
124952742|NCT01587703|449453129|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952743|NCT01587703|449453130|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952744|NCT01587703|449453131|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952745|NCT01587703|449453132|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952746|NCT01587703|449453133|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952747|NCT01587703|449453134|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952748|NCT01587703|449453135|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952749|NCT01587703|449453136|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952750|NCT01587703|449453137|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952751|NCT01587703|449453138|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952752|NCT01587703|449453139|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
124952753|NCT01587703|449453121|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952754|NCT01587703|449453122|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952755|NCT01587703|449453123|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952756|NCT01587703|449453124|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952757|NCT01587703|449453125|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952758|NCT01587703|449453126|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952759|NCT01587703|449453127|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952760|NCT01587703|449453128|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952761|NCT01587703|449453129|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
124952762|NCT01587703|449453130|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
124952763|NCT01587703|449453131|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
124952764|NCT01587703|449453132|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952765|NCT01587703|449453133|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952766|NCT01587703|449453134|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952767|NCT01587703|449453135|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952768|NCT01587703|449453136|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952769|NCT01587703|449453137|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952770|NCT01587703|449453138|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952771|NCT01587703|449453139|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
124952772|NCT01587703|449453121|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952773|NCT01587703|449453122|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952774|NCT01587703|449453123|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952775|NCT01587703|449453124|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952776|NCT01587703|449453125|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952777|NCT01587703|449453126|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952778|NCT01587703|449453127|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952779|NCT01587703|449453128|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952780|NCT01587703|449453129|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
124952781|NCT01587703|449453130|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952782|NCT01587703|449453131|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
124952783|NCT01587703|449453132|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952784|NCT01587703|449453133|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124460341|NCT00531752|447644127|FG001|First Double-blind Intervention Period|Other|4|||
124460342|NCT00531752|447644128|FG002|First Double-blind Intervention Period|Other|4|||
124460343|NCT00531752|447644129|FG003|First Double-blind Intervention Period|Other|0|||
124707556|NCT03110562|448554691|FG001|Initial Treatment Period|Randomized but never treated|3|||
124952785|NCT01587703|449453134|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952786|NCT01587703|449453135|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952787|NCT01587703|449453136|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952788|NCT01587703|449453137|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952789|NCT01587703|449453138|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952790|NCT01587703|449453139|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
124952791|NCT01587703|449453121|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952792|NCT01587703|449453122|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952793|NCT01587703|449453123|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952794|NCT01587703|449453124|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952795|NCT01587703|449453125|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952796|NCT01587703|449453126|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952797|NCT01587703|449453127|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952798|NCT01587703|449453128|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952799|NCT01587703|449453129|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952800|NCT01587703|449453130|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
124952801|NCT01587703|449453131|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
124952802|NCT01587703|449453132|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952803|NCT01587703|449453133|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952804|NCT01587703|449453134|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952805|NCT01587703|449453135|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952806|NCT01587703|449453136|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952807|NCT01587703|449453137|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952808|NCT01587703|449453138|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952809|NCT01587703|449453139|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
124952810|NCT01587703|449453121|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952811|NCT01587703|449453122|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952812|NCT01587703|449453123|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952813|NCT01587703|449453124|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952814|NCT01587703|449453125|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952815|NCT01587703|449453126|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952816|NCT01587703|449453127|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952817|NCT01587703|449453128|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952818|NCT01587703|449453129|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
124952819|NCT01587703|449453130|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952820|NCT01587703|449453131|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952821|NCT01587703|449453132|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952822|NCT01587703|449453133|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952823|NCT01587703|449453134|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952824|NCT01587703|449453135|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952825|NCT01587703|449453136|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952826|NCT01587703|449453137|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952827|NCT01587703|449453138|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952828|NCT01587703|449453139|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
124952829|NCT01587703|449453121|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952830|NCT01587703|449453122|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952831|NCT01587703|449453123|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952832|NCT01587703|449453124|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952833|NCT01587703|449453125|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952834|NCT01587703|449453126|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952835|NCT01587703|449453127|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952836|NCT01587703|449453128|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952837|NCT01587703|449453129|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952838|NCT01587703|449453130|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952839|NCT01587703|449453131|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952840|NCT01587703|449453132|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952841|NCT01587703|449453133|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952842|NCT01587703|449453134|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124707557|NCT03110562|448554692|FG002|Initial Treatment Period|Randomized but never treated|0|||
124460344|NCT00531752|447644126|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
124460345|NCT00531752|447644127|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
124460346|NCT00531752|447644128|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
124460347|NCT00531752|447644129|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
124460348|NCT00531752|447644126|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
124460349|NCT00531752|447644127|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
124460350|NCT00531752|447644128|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
124460351|NCT00531752|447644129|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
124460352|NCT00531752|447644126|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
124460353|NCT00531752|447644127|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
124460354|NCT00531752|447644128|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
124460355|NCT00531752|447644129|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
124460356|NCT00531752|447644126|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
124460357|NCT00531752|447644127|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
124460358|NCT00531752|447644128|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
124460359|NCT00531752|447644129|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
124460360|NCT00531752|447644126|FG000|Second Double-blind Intervention Period|Other|1|||
124460361|NCT00531752|447644127|FG001|Second Double-blind Intervention Period|Other|1|||
124460362|NCT00531752|447644128|FG002|Second Double-blind Intervention Period|Other|0|||
124460363|NCT00531752|447644129|FG003|Second Double-blind Intervention Period|Other|0|||
124460364|NCT00531752|447644126|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
124460365|NCT00531752|447644127|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
124460366|NCT00531752|447644128|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
124460367|NCT00531752|447644129|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
124707558|NCT03110562|448554693|FG003|Initial Treatment Period|Randomized but never treated|0|||
124707559|NCT03110562|448554690|FG000|Crossover Period|Disease Progression|0|||
124707560|NCT03110562|448554691|FG001|Crossover Period|Disease Progression|0|||
124952843|NCT01587703|449453135|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952844|NCT01587703|449453136|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952845|NCT01587703|449453137|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952846|NCT01587703|449453138|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
124952847|NCT01587703|449453139|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
124952848|NCT01587703|449453121|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952849|NCT01587703|449453122|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952850|NCT01587703|449453123|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124707561|NCT03110562|448554692|FG002|Crossover Period|Disease Progression|1|||
124707562|NCT03110562|448554693|FG003|Crossover Period|Disease Progression|0|||
124707563|NCT03110562|448554690|FG000|Crossover Period|Withdrawal by Subject|0|||
124707564|NCT03110562|448554691|FG001|Crossover Period|Withdrawal by Subject|0|||
124952851|NCT01587703|449453124|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952852|NCT01587703|449453125|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952853|NCT01587703|449453126|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952854|NCT01587703|449453127|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952855|NCT01587703|449453128|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952856|NCT01587703|449453129|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952857|NCT01587703|449453130|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952858|NCT01587703|449453131|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952859|NCT01587703|449453132|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124707565|NCT03110562|448554692|FG002|Crossover Period|Withdrawal by Subject|8|||
124707566|NCT03110562|448554693|FG003|Crossover Period|Withdrawal by Subject|6|||
124707567|NCT03110562|448554690|FG000|Crossover Period|Death|0|||
124707568|NCT03110562|448554691|FG001|Crossover Period|Death|0|||
124952860|NCT01587703|449453133|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952861|NCT01587703|449453134|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952862|NCT01587703|449453135|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952863|NCT01587703|449453136|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952864|NCT01587703|449453137|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
124952865|NCT01587703|449453138|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
124952866|NCT01587703|449453139|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
124952867|NCT01587703|449453121|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952868|NCT01587703|449453122|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952869|NCT01587703|449453123|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952870|NCT01587703|449453124|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952871|NCT01587703|449453125|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952872|NCT01587703|449453126|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952873|NCT01587703|449453127|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952874|NCT01587703|449453128|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952875|NCT01587703|449453129|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952876|NCT01587703|449453130|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952877|NCT01587703|449453131|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952878|NCT01587703|449453132|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952879|NCT01587703|449453133|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952880|NCT01587703|449453134|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952881|NCT01587703|449453135|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952882|NCT01587703|449453136|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
124952883|NCT01587703|449453137|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952884|NCT01587703|449453138|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952885|NCT01587703|449453139|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
124952886|NCT01587703|449453121|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952887|NCT01587703|449453122|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952888|NCT01587703|449453123|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952889|NCT01587703|449453124|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952890|NCT01587703|449453125|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952891|NCT01587703|449453126|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952892|NCT01587703|449453127|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952893|NCT01587703|449453128|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952894|NCT01587703|449453129|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952895|NCT01587703|449453130|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952896|NCT01587703|449453131|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952897|NCT01587703|449453132|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
124952898|NCT01587703|449453133|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124707569|NCT03110562|448554692|FG002|Crossover Period|Death|37|||
124707570|NCT03110562|448554693|FG003|Crossover Period|Death|3|||
124707571|NCT03110562|448554690|FG000|Crossover Period|Lost to Follow-up|0|||
124707572|NCT03110562|448554691|FG001|Crossover Period|Lost to Follow-up|0|||
124707573|NCT03110562|448554692|FG002|Crossover Period|Lost to Follow-up|0|||
124707574|NCT03110562|448554693|FG003|Crossover Period|Lost to Follow-up|1|||
124707575|NCT03110562|448554690|FG000|Crossover Period|Other|0|||
124707576|NCT03110562|448554691|FG001|Crossover Period|Other|0|||
124707577|NCT03110562|448554692|FG002|Crossover Period|Other|1|||
124707578|NCT03110562|448554693|FG003|Crossover Period|Other|1|||
124707579|NCT03110562|448554690|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
124707580|NCT03110562|448554691|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
124707581|NCT03110562|448554692|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
124707582|NCT03110562|448554693|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
124707583|NCT02936323|448554694|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
124707584|NCT02936323|448554695|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
124707585|NCT02936323|448554696|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
124707586|NCT02936323|448554697|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
124707587|NCT02936323|448554698|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
124707588|NCT02936323|448554699|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
124952899|NCT01587703|449453134|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952900|NCT01587703|449453135|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
124952901|NCT01587703|449453136|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952902|NCT01587703|449453137|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952903|NCT01587703|449453138|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952904|NCT01587703|449453139|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
124952905|NCT01587703|449453121|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952906|NCT01587703|449453122|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952907|NCT01587703|449453123|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952908|NCT01587703|449453124|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952909|NCT01587703|449453125|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952910|NCT01587703|449453126|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952911|NCT01587703|449453127|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952912|NCT01587703|449453128|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952913|NCT01587703|449453129|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952914|NCT01587703|449453130|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952915|NCT01587703|449453131|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952916|NCT01587703|449453132|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
124952917|NCT01587703|449453133|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
124952918|NCT01587703|449453134|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
124952919|NCT01587703|449453135|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
124952920|NCT01587703|449453136|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
124952921|NCT01587703|449453137|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
124952922|NCT01587703|449453138|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952923|NCT01587703|449453139|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
124952924|NCT01587703|449453121|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952925|NCT01587703|449453122|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952926|NCT01587703|449453123|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952927|NCT01587703|449453124|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952928|NCT01587703|449453125|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952929|NCT01587703|449453126|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952930|NCT01587703|449453127|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952931|NCT01587703|449453128|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952932|NCT01587703|449453129|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952933|NCT01587703|449453130|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952934|NCT01587703|449453131|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952935|NCT01587703|449453132|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
124952936|NCT01587703|449453133|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
124952937|NCT01587703|449453134|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
124952938|NCT01587703|449453135|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
124952939|NCT01587703|449453136|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
124952940|NCT01587703|449453137|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
124952941|NCT01587703|449453138|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952942|NCT01587703|449453139|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
124952943|NCT01587703|449453121|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124707589|NCT02936323|448554700|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
124952944|NCT01587703|449453122|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952945|NCT01587703|449453123|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952946|NCT01587703|449453124|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952947|NCT01587703|449453125|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952948|NCT01587703|449453126|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124707590|NCT02936323|448554701|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
124952949|NCT01587703|449453127|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952950|NCT01587703|449453128|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952951|NCT01587703|449453129|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952952|NCT01587703|449453130|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952953|NCT01587703|449453131|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952954|NCT01587703|449453132|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
124952955|NCT01587703|449453133|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952956|NCT01587703|449453134|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952957|NCT01587703|449453135|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952958|NCT01587703|449453136|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952959|NCT01587703|449453137|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952960|NCT01587703|449453138|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952961|NCT01587703|449453139|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
124952962|NCT01799993|449453140|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
124707591|NCT02936323|448554702|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
124707592|NCT02936323|448554703|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
124952963|NCT01799993|449453141|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
124952964|NCT01799993|449453140|FG000|Overall Study|Death|61|||
124952965|NCT01799993|449453141|FG001|Overall Study|Death|45|||
124952966|NCT01799993|449453140|FG000|Overall Study|Withdrawal by Subject|23|||
124952967|NCT01799993|449453141|FG001|Overall Study|Withdrawal by Subject|24|||
124952968|NCT01799993|449453140|FG000|Overall Study|Lost to Follow-up|5|||
124952969|NCT01799993|449453141|FG001|Overall Study|Lost to Follow-up|8|||
124952970|NCT01799993|449453140|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
124952971|NCT01799993|449453141|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
124952972|NCT01799993|449453140|FG000|Overall Study|Protocol driven decision point|0|||
124952973|NCT01799993|449453141|FG001|Overall Study|Protocol driven decision point|3|||
124952974|NCT01799993|449453140|FG000|Overall Study|Protocol Violation|1|||
124952975|NCT01799993|449453141|FG001|Overall Study|Protocol Violation|1|||
124952976|NCT01799993|449453140|FG000|Overall Study|Deterioration of general conditions|2|||
124952977|NCT01799993|449453141|FG001|Overall Study|Deterioration of general conditions|0|||
124952978|NCT01799993|449453140|FG000|Overall Study|Screen failure|0|||
124952979|NCT01799993|449453141|FG001|Overall Study|Screen failure|1|||
124952980|NCT01799993|449453140|FG000|Overall Study|Adverse Event|1|||
124952981|NCT01799993|449453141|FG001|Overall Study|Adverse Event|0|||
124952982|NCT01799993|449453140|FG000|Overall Study|Lack of Efficacy|1|||
124952983|NCT01799993|449453141|FG001|Overall Study|Lack of Efficacy|0|||
124952984|NCT01799993|449453140|FG000|Overall Study|Recovery|0|||
124952985|NCT01799993|449453141|FG001|Overall Study|Recovery|1|||
124952986|NCT01799993|449453140|FG000|Overall Study|Logistical difficulties|1|||
124952987|NCT01799993|449453141|FG001|Overall Study|Logistical difficulties|0|||
124952988|NCT01799993|449453140|FG000|Overall Study|Protocol deviation|1|||
124707593|NCT02936323|448554694|FG000|Phase 1 Dose Escalation|Death|2|||
124707594|NCT02936323|448554695|FG001|Phase 1 Dose Escalation|Death|1|||
124707595|NCT02936323|448554696|FG002|Phase 1 Dose Escalation|Death|3|||
124707596|NCT02936323|448554697|FG003|Phase 1 Dose Escalation|Death|1|||
124707597|NCT02936323|448554698|FG004|Phase 1 Dose Escalation|Death|2|||
124707598|NCT02936323|448554699|FG005|Phase 1 Dose Escalation|Death|3|||
124707599|NCT02936323|448554700|FG006|Phase 1 Dose Escalation|Death|3|||
124707600|NCT02936323|448554701|FG007|Phase 1 Dose Escalation|Death|0|||
124707601|NCT02936323|448554702|FG008|Phase 1 Dose Escalation|Death|0|||
124707602|NCT02936323|448554703|FG009|Phase 1 Dose Escalation|Death|0|||
124707603|NCT02936323|448554694|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
124707604|NCT02936323|448554695|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
124707605|NCT02936323|448554696|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
124707606|NCT02936323|448554697|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
124952989|NCT01799993|449453141|FG001|Overall Study|Protocol deviation|0|||
124952990|NCT01799993|449453140|FG000|Overall Study|Non-compliance with medical device|1|||
124952991|NCT01799993|449453141|FG001|Overall Study|Non-compliance with medical device|0|||
124952992|NCT01799993|449453140|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124952993|NCT01799993|449453141|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124952994|NCT01799993|449453140|FG000|Overall Study|Other|1|||
124952995|NCT01799993|449453141|FG001|Overall Study|Other|0|||
124952996|NCT01799993|449453140|FG000|Overall Study|Subject didn't return for follow-up|0|||
124952997|NCT01799993|449453141|FG001|Overall Study|Subject didn't return for follow-up|1|||
124952998|NCT04271254|449453142|FG000|Overall Study|Withdrawal by Subject|3|||
124952999|NCT04410445|449453143|FG000|Overall Study|Lost to Follow-up|3|||
124953000|NCT04410445|449453144|FG001|Overall Study|Lost to Follow-up|9|||
124953001|NCT04410445|449453143|FG000|Overall Study|Withdrawal by Subject|27|||
124707607|NCT02936323|448554698|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
124707608|NCT02936323|448554699|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
124766410|NCT01346358|448771720|FG003|Overall Study|Physician Decision|0|||
124548983|NCT01856257|447965416|FG002|Overall Study|Donor complication|0|||
124548984|NCT01856257|447965417|FG003|Overall Study|Donor complication|1|||
124548985|NCT01125358|447965418|FG000|Overall Study|Adverse Event|3|||
124548986|NCT01125358|447965419|FG001|Overall Study|Adverse Event|0|||
124548987|NCT01125358|447965420|FG002|Overall Study|Adverse Event|0|||
124548988|NCT01125358|447965421|FG003|Overall Study|Adverse Event|2|||
124548989|NCT01125358|447965418|FG000|Overall Study|Perceived Lack of Efficacy|6|||
124548990|NCT01125358|447965419|FG001|Overall Study|Perceived Lack of Efficacy|3|||
124953002|NCT04410445|449453144|FG001|Overall Study|Withdrawal by Subject|15|||
124953003|NCT01320683|449453145|FG000|Overall Study|Positive antibody response|1|||
124953004|NCT00759681|449453146|FG000|Overall Study|Death|2|||
124953005|NCT00759681|449453147|FG001|Overall Study|Death|5|||
124953006|NCT00759681|449453146|FG000|Overall Study|Lost to Follow-up|8|||
124953007|NCT00759681|449453147|FG001|Overall Study|Lost to Follow-up|5|||
124953008|NCT00476151|449453148|FG000|Overall Study|Adverse Event|0|||
124953009|NCT00476151|449453149|FG001|Overall Study|Adverse Event|2|||
124953010|NCT00476151|449453148|FG000|Overall Study|Protocol Violation|1|||
124953011|NCT00476151|449453149|FG001|Overall Study|Protocol Violation|3|||
124953012|NCT00476151|449453148|FG000|Overall Study|Withdrawal by Subject|2|||
124953013|NCT00476151|449453149|FG001|Overall Study|Withdrawal by Subject|0|||
124953014|NCT00476151|449453148|FG000|Overall Study|Physician Decision|0|||
124953015|NCT00476151|449453149|FG001|Overall Study|Physician Decision|2|||
124953016|NCT02005484|449453157|FG000|Overall Study|Death|1|||
124953017|NCT02005484|449453157|FG000|Overall Study|Disease progression|1|||
124953018|NCT02005484|449453157|FG000|Overall Study|Changed to a Different Study|1|||
124953019|NCT02005484|449453157|FG000|Overall Study|Sponsor decision|1|||
124953020|NCT01129011|449453158|FG000|Overall Study|Adverse Event|20|||
124953021|NCT01129011|449453159|FG001|Overall Study|Adverse Event|30|||
124953022|NCT01129011|449453158|FG000|Overall Study|Withdrawal by Subject|24|||
124953023|NCT01129011|449453159|FG001|Overall Study|Withdrawal by Subject|8|||
124953024|NCT01129011|449453158|FG000|Overall Study|Lost to Follow-up|6|||
124953025|NCT01129011|449453159|FG001|Overall Study|Lost to Follow-up|7|||
124953026|NCT01129011|449453158|FG000|Overall Study|Duodenal Ulcer|2|||
124953027|NCT01129011|449453159|FG001|Overall Study|Duodenal Ulcer|8|||
124953028|NCT01129011|449453158|FG000|Overall Study|misc|7|||
124953029|NCT01129011|449453159|FG001|Overall Study|misc|4|||
124953030|NCT01767376|449453163|FG000|Overall Study|Lost to Follow-up|3|||
124953031|NCT01767376|449453164|FG001|Overall Study|Lost to Follow-up|2|||
124953032|NCT01767376|449453165|FG002|Overall Study|Lost to Follow-up|0|||
124548991|NCT01125358|447965420|FG002|Overall Study|Perceived Lack of Efficacy|7|||
124953033|NCT01767376|449453163|FG000|Overall Study|Withdrawal by Subject|1|||
124953034|NCT01767376|449453164|FG001|Overall Study|Withdrawal by Subject|1|||
124548992|NCT01125358|447965421|FG003|Overall Study|Perceived Lack of Efficacy|4|||
124953035|NCT01767376|449453165|FG002|Overall Study|Withdrawal by Subject|0|||
124460368|NCT00531752|447644126|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
124460369|NCT00531752|447644127|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
124460370|NCT00531752|447644128|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
124460371|NCT00531752|447644129|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
124460372|NCT00401375|447644131|FG000|Overall Study|Protocol Violation|2|||
124460373|NCT00401375|447644132|FG001|Overall Study|Protocol Violation|2|||
124460374|NCT00401375|447644133|FG002|Overall Study|Protocol Violation|1|||
124460375|NCT00401375|447644131|FG000|Overall Study|Adverse Event|6|||
124460376|NCT00401375|447644132|FG001|Overall Study|Adverse Event|11|||
124460377|NCT00401375|447644133|FG002|Overall Study|Adverse Event|10|||
124460378|NCT00401375|447644131|FG000|Overall Study|Withdrawal by Subject|9|||
124460379|NCT00401375|447644132|FG001|Overall Study|Withdrawal by Subject|7|||
124460380|NCT00401375|447644133|FG002|Overall Study|Withdrawal by Subject|7|||
124460381|NCT00401375|447644131|FG000|Overall Study|Lost to Follow-up|0|||
124460382|NCT00401375|447644132|FG001|Overall Study|Lost to Follow-up|1|||
124460383|NCT00401375|447644133|FG002|Overall Study|Lost to Follow-up|1|||
124460384|NCT00401375|447644131|FG000|Overall Study|Other than specified|2|||
124460385|NCT00401375|447644132|FG001|Overall Study|Other than specified|1|||
124953036|NCT01113541|449453166|FG000|Overall Study|Withdrawal by Subject|1|||
124953037|NCT01113541|449453166|FG000|Overall Study|Protocol Violation|1|||
124953038|NCT01113541|449453166|FG000|Overall Study|Study Terminated by Sponsor|7|||
124953039|NCT01113541|449453166|FG000|Overall Study|Adverse Event|4|||
124953040|NCT03745651|449453167|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
124953041|NCT03745651|449453168|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
124953042|NCT03745651|449453169|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
124953043|NCT03745651|449453170|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
124953044|NCT03745651|449453171|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
124953045|NCT03745651|449453172|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
124953046|NCT03745651|449453173|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
124953047|NCT03745651|449453167|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
124953048|NCT03745651|449453168|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
124953049|NCT03745651|449453169|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
124953050|NCT03745651|449453170|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124953051|NCT03745651|449453171|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124953052|NCT03745651|449453172|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124953053|NCT03745651|449453173|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124953054|NCT03745651|449453167|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
124953055|NCT03745651|449453168|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
124953056|NCT03745651|449453169|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
124953057|NCT03745651|449453170|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
124953058|NCT03745651|449453171|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
124953059|NCT03745651|449453172|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
124953060|NCT03745651|449453173|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
124953061|NCT03745651|449453167|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124953062|NCT03745651|449453168|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
124953063|NCT03745651|449453169|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124953064|NCT03745651|449453170|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124953065|NCT03745651|449453171|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124953066|NCT03745651|449453172|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124953067|NCT03745651|449453173|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124953068|NCT03745651|449453167|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
124953069|NCT03745651|449453168|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
124953070|NCT03745651|449453169|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
124953071|NCT03745651|449453170|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124953072|NCT03745651|449453171|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124953073|NCT03745651|449453172|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124953074|NCT03745651|449453173|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124460386|NCT00401375|447644133|FG002|Overall Study|Other than specified|3|||
124460387|NCT00401375|447644131|FG000|Overall Study|Randomized but not treated|3|||
124460388|NCT00401375|447644132|FG001|Overall Study|Randomized but not treated|3|||
124707609|NCT02936323|448554700|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
124707610|NCT02936323|448554701|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
124460389|NCT00401375|447644133|FG002|Overall Study|Randomized but not treated|3|||
124460390|NCT00950664|447644135|FG000|First Intervention|Lost to Follow-up|1|||
124460391|NCT00950664|447644136|FG001|First Intervention|Lost to Follow-up|3|||
124460392|NCT00950664|447644135|FG000|First Intervention|Withdrawal by Subject|2|||
124766411|NCT01346358|448771721|FG004|Overall Study|Physician Decision|0|||
124953075|NCT03745651|449453167|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
124953076|NCT03745651|449453168|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
124953077|NCT03745651|449453169|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
124953078|NCT03745651|449453170|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
124953079|NCT03745651|449453171|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
124953080|NCT03745651|449453172|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
124953081|NCT03745651|449453173|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
124953082|NCT03745651|449453167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
124953083|NCT03745651|449453168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
124953084|NCT03745651|449453169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
124953085|NCT03745651|449453170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
124953086|NCT03745651|449453171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
124953087|NCT03745651|449453172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
124953088|NCT03745651|449453173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
124953089|NCT03745651|449453167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124953090|NCT03745651|449453168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124953091|NCT03745651|449453169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124953092|NCT03745651|449453170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
124953093|NCT03745651|449453171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124953094|NCT03745651|449453172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
124953095|NCT03745651|449453173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
124953096|NCT03745651|449453167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
124953097|NCT03745651|449453168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
124953098|NCT03745651|449453169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
124953099|NCT03745651|449453170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
124953100|NCT03745651|449453171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
124953101|NCT03745651|449453172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
124953102|NCT03745651|449453173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
124953103|NCT03745651|449453167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
124953104|NCT03745651|449453168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
124953105|NCT03745651|449453169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
124953106|NCT03745651|449453170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
124953107|NCT03745651|449453171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
124953108|NCT03745651|449453172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
124953109|NCT03745651|449453173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
124953110|NCT03745651|449453167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
124953111|NCT03745651|449453168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
124953112|NCT03745651|449453169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
124953113|NCT03745651|449453170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
124953114|NCT03745651|449453171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
124953115|NCT03745651|449453172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
124953116|NCT03745651|449453173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
124953117|NCT03745651|449453167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124953118|NCT03745651|449453168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124953119|NCT03745651|449453169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124953120|NCT03745651|449453170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124953121|NCT03745651|449453171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124953122|NCT03745651|449453172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
124953123|NCT03745651|449453173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124953124|NCT03745651|449453167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
124953125|NCT03745651|449453168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
124953126|NCT03745651|449453169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
124953127|NCT03745651|449453170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
124953128|NCT03745651|449453171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
124953129|NCT03745651|449453172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
124953130|NCT03745651|449453173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
124953131|NCT03745651|449453167|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
124953132|NCT03745651|449453168|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
124953133|NCT03745651|449453169|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
124953134|NCT03745651|449453170|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
124953135|NCT03745651|449453171|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
124953136|NCT03745651|449453172|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
124953137|NCT03745651|449453173|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
124953138|NCT00946088|449453174|FG000|Overall Study|Withdrawal by Subject|0|||
124953139|NCT00946088|449453175|FG001|Overall Study|Withdrawal by Subject|1|||
124953140|NCT04883541|449453176|FG000|Overall Study|Not attending regular yoga class|16|||
124953141|NCT04883541|449453177|FG001|Overall Study|Not attending regular yoga class|0|||
124953142|NCT04883541|449453176|FG000|Overall Study|Not attending the pregnancy school|0|||
124953143|NCT04883541|449453177|FG001|Overall Study|Not attending the pregnancy school|9|||
124953144|NCT02309892|449453182|FG000|Overall Study|Physician Decision|1|||
124953145|NCT02309892|449453183|FG001|Overall Study|Physician Decision|0|||
124953146|NCT02309892|449453184|FG002|Overall Study|Physician Decision|0|||
124953147|NCT02309892|449453185|FG003|Overall Study|Physician Decision|0|||
124953148|NCT02309892|449453186|FG004|Overall Study|Physician Decision|0|||
124953149|NCT02309892|449453187|FG005|Overall Study|Physician Decision|0|||
124953150|NCT02309892|449453188|FG006|Overall Study|Physician Decision|0|||
124953151|NCT02309892|449453182|FG000|Overall Study|Adverse Event|1|||
124953152|NCT02309892|449453183|FG001|Overall Study|Adverse Event|0|||
124953153|NCT02309892|449453184|FG002|Overall Study|Adverse Event|1|||
124953154|NCT02309892|449453185|FG003|Overall Study|Adverse Event|0|||
124953155|NCT02309892|449453186|FG004|Overall Study|Adverse Event|0|||
124953156|NCT02309892|449453187|FG005|Overall Study|Adverse Event|0|||
124953157|NCT02309892|449453188|FG006|Overall Study|Adverse Event|0|||
124953158|NCT02309892|449453182|FG000|Overall Study|Progressive Disease|0|||
124953159|NCT02309892|449453183|FG001|Overall Study|Progressive Disease|1|||
124953160|NCT02309892|449453184|FG002|Overall Study|Progressive Disease|0|||
124953161|NCT02309892|449453185|FG003|Overall Study|Progressive Disease|0|||
124953162|NCT02309892|449453186|FG004|Overall Study|Progressive Disease|1|||
124953163|NCT02309892|449453187|FG005|Overall Study|Progressive Disease|0|||
124953164|NCT02309892|449453188|FG006|Overall Study|Progressive Disease|0|||
124953165|NCT02309892|449453182|FG000|Overall Study|Death|0|||
124953166|NCT02309892|449453183|FG001|Overall Study|Death|0|||
124953167|NCT02309892|449453184|FG002|Overall Study|Death|0|||
124953168|NCT02309892|449453185|FG003|Overall Study|Death|0|||
124953169|NCT02309892|449453186|FG004|Overall Study|Death|0|||
124953170|NCT02309892|449453187|FG005|Overall Study|Death|1|||
124953171|NCT02309892|449453188|FG006|Overall Study|Death|0|||
124953172|NCT01901302|449453189|FG000|Overall Study|Adverse Event|2|||
124953173|NCT01901302|449453190|FG001|Overall Study|Adverse Event|1|||
124953174|NCT01901302|449453189|FG000|Overall Study|Lack of Efficacy|0|||
124953175|NCT01901302|449453190|FG001|Overall Study|Lack of Efficacy|2|||
124953176|NCT01901302|449453189|FG000|Overall Study|Study Terminated by Sponsor|23|||
124953177|NCT01901302|449453190|FG001|Overall Study|Study Terminated by Sponsor|20|||
124953178|NCT01901302|449453189|FG000|Overall Study|Withdrawal by Subject|2|||
124953179|NCT01901302|449453190|FG001|Overall Study|Withdrawal by Subject|0|||
124953180|NCT01124916|449453191|FG000|Overall Study|Lost to Follow-up|3|||
124953181|NCT01124916|449453192|FG001|Overall Study|Lost to Follow-up|2|||
124953182|NCT01029925|449453198|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
124953183|NCT01029925|449453198|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
124953184|NCT01029925|449453198|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
124953185|NCT05265247|449453199|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
124953186|NCT05265247|449453200|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
124953187|NCT05265247|449453199|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
124953188|NCT05265247|449453200|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
124953189|NCT05265247|449453199|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
124953190|NCT05265247|449453200|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
124953191|NCT00134056|449453208|FG000|Randomization|Not eligible for assigned treatment|22|||
124953192|NCT00134056|449453209|FG001|Randomization|Not eligible for assigned treatment|20|||
124953193|NCT00134056|449453208|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
124953194|NCT00134056|449453209|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
124953195|NCT00134056|449453208|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
124953196|NCT00134056|449453209|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
124953197|NCT00134056|449453208|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
124953198|NCT00134056|449453209|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
124953199|NCT00134056|449453208|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
124953200|NCT00134056|449453209|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
124953201|NCT02555397|449453213|FG000|Overall Study|Withdrawal by Subject|1|||
124953202|NCT02555397|449453214|FG001|Overall Study|Withdrawal by Subject|0|||
124953203|NCT02555397|449453215|FG002|Overall Study|Withdrawal by Subject|0|||
124953204|NCT02555397|449453216|FG003|Overall Study|Withdrawal by Subject|0|||
124953205|NCT02555397|449453217|FG004|Overall Study|Withdrawal by Subject|0|||
124953206|NCT00537914|449453221|FG000|Overall Study|Death|1|||
124953207|NCT00537914|449453221|FG000|Overall Study|Adverse Event|7|||
124953208|NCT00537914|449453221|FG000|Overall Study|Treatment failure|10|||
124953209|NCT00537914|449453221|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
124953210|NCT00537914|449453221|FG000|Overall Study|Lost to Follow-up|19|||
124953211|NCT00537914|449453221|FG000|Overall Study|Withdrawal of informed consent|59|||
124953212|NCT02312258|449453222|FG000|Overall Study|Lost to Follow-up|8|||
124953213|NCT02312258|449453223|FG001|Overall Study|Lost to Follow-up|8|||
124953214|NCT02312258|449453222|FG000|Overall Study|Withdrawal by Patient|49|||
124953215|NCT02312258|449453223|FG001|Overall Study|Withdrawal by Patient|76|||
124953216|NCT02312258|449453222|FG000|Overall Study|Reason not Specified|107|||
124953217|NCT02312258|449453223|FG001|Overall Study|Reason not Specified|159|||
124953218|NCT02312258|449453222|FG000|Overall Study|Missing|2|||
124953219|NCT02312258|449453223|FG001|Overall Study|Missing|1|||
124953220|NCT02312258|449453222|FG000|Overall Study|Death|115|||
124953221|NCT02312258|449453223|FG001|Overall Study|Death|181|||
124953222|NCT01468597|449453225|FG000|Overall Study|Found ineligible|17|||
124548993|NCT01125358|447965418|FG000|Overall Study|Protocol Violation|1|||
124460393|NCT00950664|447644136|FG001|First Intervention|Withdrawal by Subject|2|||
124460394|NCT02821715|447644137|FG000|Overall Study|Protocol Violation|1|||
124460395|NCT02821715|447644138|FG001|Overall Study|Protocol Violation|0|||
124460396|NCT02821715|447644139|FG002|Overall Study|Protocol Violation|0|||
124460397|NCT02821715|447644140|FG003|Overall Study|Protocol Violation|0|||
124460398|NCT02821715|447644141|FG004|Overall Study|Protocol Violation|0|||
124460399|NCT02821715|447644142|FG005|Overall Study|Protocol Violation|0|||
124460400|NCT00640328|447644143|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
124460401|NCT00640328|447644144|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
124460402|NCT00640328|447644145|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
124460403|NCT00640328|447644146|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
124460404|NCT00640328|447644147|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
124460405|NCT00640328|447644148|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
124460406|NCT00640328|447644143|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
124460407|NCT00640328|447644144|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
124460408|NCT00640328|447644145|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
124707611|NCT02936323|448554702|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
124707612|NCT02936323|448554703|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
124707613|NCT02936323|448554694|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
124953223|NCT01468597|449453225|FG000|Overall Study|concomitant valves|12|||
124953224|NCT01468597|449453225|FG000|Overall Study|off-pump CABG|1|||
124953225|NCT01468597|449453225|FG000|Overall Study|no platelet function data|5|||
124953226|NCT02260154|449453226|FG000|Overall Study|Screening failure|2|||
124953227|NCT02561195|449453228|FG000|Vaccination 1 to 3|Adverse Event|4|||
124953228|NCT02561195|449453229|FG001|Vaccination 1 to 3|Adverse Event|5|||
124953229|NCT02561195|449453230|FG002|Vaccination 1 to 3|Adverse Event|0|||
124953230|NCT02561195|449453231|FG003|Vaccination 1 to 3|Adverse Event|3|||
124953231|NCT02561195|449453232|FG004|Vaccination 1 to 3|Adverse Event|4|||
124953232|NCT02561195|449453233|FG005|Vaccination 1 to 3|Adverse Event|0|||
124953233|NCT02561195|449453234|FG006|Vaccination 1 to 3|Adverse Event|0|||
124953234|NCT02561195|449453235|FG007|Vaccination 1 to 3|Adverse Event|0|||
124953235|NCT02561195|449453236|FG008|Vaccination 1 to 3|Adverse Event|0|||
124953236|NCT02561195|449453237|FG009|Vaccination 1 to 3|Adverse Event|0|||
124953237|NCT02561195|449453238|FG010|Vaccination 1 to 3|Adverse Event|0|||
124953238|NCT02561195|449453239|FG011|Vaccination 1 to 3|Adverse Event|0|||
124953239|NCT02561195|449453240|FG012|Vaccination 1 to 3|Adverse Event|0|||
124953240|NCT02561195|449453241|FG013|Vaccination 1 to 3|Adverse Event|0|||
124953241|NCT02561195|449453228|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
124953242|NCT02561195|449453229|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
124953243|NCT02561195|449453230|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
124953244|NCT02561195|449453231|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
124953245|NCT02561195|449453232|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
124953246|NCT02561195|449453233|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
124953247|NCT02561195|449453234|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
124953248|NCT02561195|449453235|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
124953249|NCT02561195|449453236|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
124953250|NCT02561195|449453237|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
124953251|NCT02561195|449453238|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
124953252|NCT02561195|449453239|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
124953253|NCT02561195|449453240|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
124953254|NCT02561195|449453241|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
124953255|NCT02561195|449453228|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953256|NCT02561195|449453229|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
124953257|NCT02561195|449453230|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953258|NCT02561195|449453231|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
124953259|NCT02561195|449453232|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
124953260|NCT02561195|449453233|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
124953261|NCT02561195|449453234|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953262|NCT02561195|449453235|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953263|NCT02561195|449453236|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953264|NCT02561195|449453237|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953265|NCT02561195|449453238|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953266|NCT02561195|449453239|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953267|NCT02561195|449453240|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953268|NCT02561195|449453241|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
124953269|NCT02561195|449453228|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
124953270|NCT02561195|449453229|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
124953271|NCT02561195|449453230|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
124953272|NCT02561195|449453231|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
124953273|NCT02561195|449453232|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
124953274|NCT02561195|449453233|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
124953275|NCT02561195|449453234|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
124953276|NCT02561195|449453235|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
124953277|NCT02561195|449453236|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
124953278|NCT02561195|449453237|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
124953279|NCT02561195|449453238|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
124953280|NCT02561195|449453239|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
124953281|NCT02561195|449453240|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
124953282|NCT02561195|449453241|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
124953283|NCT02561195|449453228|FG000|Vaccination 1 to 3|Other|7|||
124953284|NCT02561195|449453229|FG001|Vaccination 1 to 3|Other|3|||
124953285|NCT02561195|449453230|FG002|Vaccination 1 to 3|Other|1|||
124953286|NCT02561195|449453231|FG003|Vaccination 1 to 3|Other|7|||
124953287|NCT02561195|449453232|FG004|Vaccination 1 to 3|Other|5|||
124953288|NCT02561195|449453233|FG005|Vaccination 1 to 3|Other|1|||
124953289|NCT02561195|449453234|FG006|Vaccination 1 to 3|Other|0|||
124953290|NCT02561195|449453235|FG007|Vaccination 1 to 3|Other|0|||
124953291|NCT02561195|449453236|FG008|Vaccination 1 to 3|Other|0|||
124953292|NCT02561195|449453237|FG009|Vaccination 1 to 3|Other|0|||
124953293|NCT02561195|449453238|FG010|Vaccination 1 to 3|Other|0|||
124953294|NCT02561195|449453239|FG011|Vaccination 1 to 3|Other|0|||
124953295|NCT02561195|449453240|FG012|Vaccination 1 to 3|Other|0|||
124953296|NCT02561195|449453241|FG013|Vaccination 1 to 3|Other|0|||
124953297|NCT02561195|449453228|FG000|Vaccination 1 to 3|Protocol Violation|1|||
124953298|NCT02561195|449453229|FG001|Vaccination 1 to 3|Protocol Violation|0|||
124953299|NCT02561195|449453230|FG002|Vaccination 1 to 3|Protocol Violation|1|||
124953300|NCT02561195|449453231|FG003|Vaccination 1 to 3|Protocol Violation|2|||
124953301|NCT02561195|449453232|FG004|Vaccination 1 to 3|Protocol Violation|5|||
124953302|NCT02561195|449453233|FG005|Vaccination 1 to 3|Protocol Violation|2|||
124953303|NCT02561195|449453234|FG006|Vaccination 1 to 3|Protocol Violation|0|||
124953304|NCT02561195|449453235|FG007|Vaccination 1 to 3|Protocol Violation|0|||
124953305|NCT02561195|449453236|FG008|Vaccination 1 to 3|Protocol Violation|0|||
124953306|NCT02561195|449453237|FG009|Vaccination 1 to 3|Protocol Violation|0|||
124953307|NCT02561195|449453238|FG010|Vaccination 1 to 3|Protocol Violation|0|||
124953308|NCT02561195|449453239|FG011|Vaccination 1 to 3|Protocol Violation|0|||
124953309|NCT02561195|449453240|FG012|Vaccination 1 to 3|Protocol Violation|0|||
124953310|NCT02561195|449453241|FG013|Vaccination 1 to 3|Protocol Violation|0|||
124953311|NCT02561195|449453228|FG000|Vaccination 1 to 3|Death|2|||
124953312|NCT02561195|449453229|FG001|Vaccination 1 to 3|Death|1|||
124953313|NCT02561195|449453230|FG002|Vaccination 1 to 3|Death|0|||
124953314|NCT02561195|449453231|FG003|Vaccination 1 to 3|Death|2|||
124953315|NCT02561195|449453232|FG004|Vaccination 1 to 3|Death|0|||
124953316|NCT02561195|449453233|FG005|Vaccination 1 to 3|Death|0|||
124953317|NCT02561195|449453234|FG006|Vaccination 1 to 3|Death|0|||
124953318|NCT02561195|449453235|FG007|Vaccination 1 to 3|Death|0|||
124953319|NCT02561195|449453236|FG008|Vaccination 1 to 3|Death|0|||
124953320|NCT02561195|449453237|FG009|Vaccination 1 to 3|Death|0|||
124953321|NCT02561195|449453238|FG010|Vaccination 1 to 3|Death|0|||
124953322|NCT02561195|449453239|FG011|Vaccination 1 to 3|Death|0|||
124953323|NCT02561195|449453240|FG012|Vaccination 1 to 3|Death|0|||
124953324|NCT02561195|449453241|FG013|Vaccination 1 to 3|Death|0|||
124953325|NCT02561195|449453228|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
124953326|NCT02561195|449453229|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
124953327|NCT02561195|449453230|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
124953328|NCT02561195|449453231|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
124953329|NCT02561195|449453232|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
124953330|NCT02561195|449453233|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953331|NCT02561195|449453234|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953332|NCT02561195|449453235|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953333|NCT02561195|449453236|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953334|NCT02561195|449453237|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953335|NCT02561195|449453238|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953336|NCT02561195|449453239|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953337|NCT02561195|449453240|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953338|NCT02561195|449453241|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
124953339|NCT02561195|449453228|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
124953340|NCT02561195|449453229|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
124953341|NCT02561195|449453230|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
124953342|NCT02561195|449453231|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
124953343|NCT02561195|449453232|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
124953344|NCT02561195|449453233|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
124953345|NCT02561195|449453234|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
124953346|NCT02561195|449453235|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
124953347|NCT02561195|449453236|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
124953348|NCT02561195|449453237|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
124953349|NCT02561195|449453238|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
124953350|NCT02561195|449453239|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
124953351|NCT02561195|449453240|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
124953352|NCT02561195|449453241|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
124953353|NCT02561195|449453228|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953354|NCT02561195|449453229|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953355|NCT02561195|449453230|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953356|NCT02561195|449453231|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953357|NCT02561195|449453232|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953358|NCT02561195|449453233|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953359|NCT02561195|449453234|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953360|NCT02561195|449453235|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953361|NCT02561195|449453236|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
124953362|NCT02561195|449453237|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
124953363|NCT02561195|449453238|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
124953364|NCT02561195|449453239|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
124953365|NCT02561195|449453240|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
124953366|NCT02561195|449453241|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
124953367|NCT02561195|449453228|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953368|NCT02561195|449453229|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953369|NCT02561195|449453230|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953370|NCT02561195|449453231|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953371|NCT02561195|449453232|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953372|NCT02561195|449453233|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953373|NCT02561195|449453234|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953374|NCT02561195|449453235|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953375|NCT02561195|449453236|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953376|NCT02561195|449453237|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953377|NCT02561195|449453238|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953378|NCT02561195|449453239|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
124953379|NCT02561195|449453240|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
124548994|NCT01125358|447965419|FG001|Overall Study|Protocol Violation|0|||
124548995|NCT01125358|447965420|FG002|Overall Study|Protocol Violation|0|||
124953380|NCT02561195|449453241|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
124953381|NCT02561195|449453228|FG000|Extension Stage (Vaccination 4)|Death|0|||
124953382|NCT02561195|449453229|FG001|Extension Stage (Vaccination 4)|Death|0|||
124953383|NCT02561195|449453230|FG002|Extension Stage (Vaccination 4)|Death|0|||
124953384|NCT02561195|449453231|FG003|Extension Stage (Vaccination 4)|Death|0|||
124953385|NCT02561195|449453232|FG004|Extension Stage (Vaccination 4)|Death|0|||
124953386|NCT02561195|449453233|FG005|Extension Stage (Vaccination 4)|Death|0|||
124953387|NCT02561195|449453234|FG006|Extension Stage (Vaccination 4)|Death|0|||
124953388|NCT02561195|449453235|FG007|Extension Stage (Vaccination 4)|Death|0|||
124953389|NCT02561195|449453236|FG008|Extension Stage (Vaccination 4)|Death|0|||
124953390|NCT02561195|449453237|FG009|Extension Stage (Vaccination 4)|Death|1|||
124953391|NCT02561195|449453238|FG010|Extension Stage (Vaccination 4)|Death|0|||
124953392|NCT02561195|449453239|FG011|Extension Stage (Vaccination 4)|Death|0|||
124953393|NCT02561195|449453240|FG012|Extension Stage (Vaccination 4)|Death|0|||
124953394|NCT02561195|449453241|FG013|Extension Stage (Vaccination 4)|Death|0|||
124953395|NCT02561195|449453228|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
124953396|NCT02561195|449453229|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
124953397|NCT02561195|449453230|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
124953398|NCT02561195|449453231|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
124953399|NCT02561195|449453232|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
124953400|NCT02561195|449453233|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
124953401|NCT02561195|449453234|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
124953402|NCT02561195|449453235|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
124953403|NCT02561195|449453236|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
124953404|NCT02561195|449453237|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
124953405|NCT02561195|449453238|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
124953406|NCT02561195|449453239|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
124953407|NCT02561195|449453240|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
124953408|NCT02561195|449453241|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
124953409|NCT02561195|449453228|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953410|NCT02561195|449453229|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953411|NCT02561195|449453230|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953412|NCT02561195|449453231|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953413|NCT02561195|449453232|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953414|NCT02561195|449453233|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953415|NCT02561195|449453234|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953416|NCT02561195|449453235|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953417|NCT02561195|449453236|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124460409|NCT00640328|447644146|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
124460410|NCT00640328|447644147|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
124460411|NCT00640328|447644148|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
124460412|NCT00640328|447644143|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
124460413|NCT00640328|447644144|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
124460414|NCT00640328|447644145|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
124460415|NCT00640328|447644146|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
124460416|NCT00640328|447644147|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
124460417|NCT00640328|447644148|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
124460418|NCT00640328|447644143|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
124460419|NCT00640328|447644144|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
124460420|NCT00640328|447644145|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
124460421|NCT00640328|447644146|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
124460422|NCT00640328|447644147|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
124460423|NCT00640328|447644148|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
124460424|NCT02374099|447644149|FG000|Overall Study|Adverse Event|1|||
124460425|NCT02374099|447644150|FG001|Overall Study|Adverse Event|0|||
124460426|NCT02374099|447644149|FG000|Overall Study|Progressive Disease|35|||
124460427|NCT02374099|447644150|FG001|Overall Study|Progressive Disease|40|||
124460428|NCT02374099|447644149|FG000|Overall Study|Withdrawal by Subject|5|||
124460429|NCT02374099|447644150|FG001|Overall Study|Withdrawal by Subject|1|||
124460430|NCT02374099|447644149|FG000|Overall Study|Miscellaneous|2|||
124460431|NCT02374099|447644150|FG001|Overall Study|Miscellaneous|3|||
124460432|NCT02374099|447644149|FG000|Overall Study|Randomized, but not treated|2|||
124460433|NCT02374099|447644150|FG001|Overall Study|Randomized, but not treated|1|||
124460434|NCT02374099|447644149|FG000|Overall Study|Study Terminated by Sponsor|3|||
124460435|NCT02374099|447644150|FG001|Overall Study|Study Terminated by Sponsor|4|||
124460436|NCT01326546|447644151|FG000|Overall Study|Lost to Follow-up|8|||
124460437|NCT01326546|447644152|FG001|Overall Study|Lost to Follow-up|7|||
124460438|NCT01326546|447644151|FG000|Overall Study|Protocol Violation|3|||
124460439|NCT01326546|447644152|FG001|Overall Study|Protocol Violation|4|||
124460440|NCT01326546|447644151|FG000|Overall Study|Pregnancy|0|||
124460441|NCT01326546|447644152|FG001|Overall Study|Pregnancy|1|||
124460442|NCT01326546|447644151|FG000|Overall Study|Adverse Event|1|||
124460443|NCT01326546|447644152|FG001|Overall Study|Adverse Event|0|||
124460444|NCT01326546|447644151|FG000|Overall Study|Withdrawal by Subject|5|||
124460445|NCT01326546|447644152|FG001|Overall Study|Withdrawal by Subject|1|||
124460446|NCT03152019|447644153|FG000|Overall Study|Adverse Event|0|||
124460447|NCT03152019|447644154|FG001|Overall Study|Adverse Event|1|||
124460448|NCT04294719|447644155|FG000|Overall Study|Withdrawal by Subject|1|||
124460449|NCT01714687|447644156|FG000|Overall Study|Withdrawal by Subject|1|||
124460450|NCT01714687|447644157|FG001|Overall Study|Withdrawal by Subject|0|||
124460451|NCT01714687|447644156|FG000|Overall Study|Lost to Follow-up|2|||
124460452|NCT01714687|447644157|FG001|Overall Study|Lost to Follow-up|4|||
124460453|NCT01979536|447644158|FG000|Overall Study|Physician Decision|2|||
124460454|NCT01979536|447644159|FG001|Overall Study|Physician Decision|3|||
124460455|NCT01979536|447644158|FG000|Overall Study|Withdrawal by Subject|0|||
124460456|NCT01979536|447644159|FG001|Overall Study|Withdrawal by Subject|1|||
124460457|NCT01979536|447644158|FG000|Overall Study|Refusal|0|||
124460458|NCT01979536|447644159|FG001|Overall Study|Refusal|1|||
124460459|NCT01979536|447644158|FG000|Overall Study|Relapse|0|||
124460460|NCT01979536|447644159|FG001|Overall Study|Relapse|1|||
124460461|NCT01979536|447644158|FG000|Overall Study|Study terminated by Sponsor|0|||
124460462|NCT01979536|447644159|FG001|Overall Study|Study terminated by Sponsor|1|||
124460463|NCT01979536|447644158|FG000|Overall Study|Did not start treatment|0|||
124460464|NCT01979536|447644159|FG001|Overall Study|Did not start treatment|1|||
124460465|NCT03770260|447645923|FG000|Overall Study|Disease progression|0|||
124460466|NCT03770260|447645924|FG001|Overall Study|Disease progression|1|||
124460467|NCT03770260|447645925|FG002|Overall Study|Disease progression|0|||
124460468|NCT03770260|447645926|FG003|Overall Study|Disease progression|0|||
124460469|NCT04649255|447645929|FG000|Overall Study|Death|9|||
124953418|NCT02561195|449453237|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953419|NCT02561195|449453238|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
124953420|NCT02561195|449453239|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
124460470|NCT04649255|447645929|FG000|Overall Study|Withdrawal by Subject|1|||
124460471|NCT01652885|447645933|FG000|Overall Study|Adverse Event|1|||
124460472|NCT00075400|447645934|FG000|Overall Study|Ineligible: wrong primary|1|||
124460473|NCT00075400|447645934|FG000|Overall Study|Never treated|2|||
124460474|NCT00490568|447645935|FG000|Overall Study|Adverse Event|116|||
124460475|NCT00490568|447645935|FG000|Overall Study|Lost to Follow-up|13|||
124460476|NCT00490568|447645935|FG000|Overall Study|Protocol Violation|45|||
124460477|NCT00490568|447645935|FG000|Overall Study|Withdrawal by Subject|135|||
124460478|NCT00490568|447645935|FG000|Overall Study|Still in the study at termination|974|||
124460479|NCT00490568|447645935|FG000|Overall Study|Other|1|||
124460480|NCT00490568|447645935|FG000|Overall Study|Exclusion criteria met|1|||
124460481|NCT00490568|447645935|FG000|Overall Study|Caregiver related|20|||
124460482|NCT00490568|447645935|FG000|Overall Study|Abnormal ECG|25|||
124460483|NCT00490568|447645935|FG000|Overall Study|Participant refused follow-up|9|||
124460484|NCT00490568|447645935|FG000|Overall Study|Legal representative withdrew consent|1|||
124460485|NCT00490568|447645935|FG000|Overall Study|Disease progression|4|||
124460486|NCT00490568|447645935|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
124460487|NCT00490568|447645935|FG000|Overall Study|Investigator decision|3|||
124460488|NCT00490568|447645935|FG000|Overall Study|Non-Compliance|7|||
124460489|NCT00490568|447645935|FG000|Overall Study|Efficacy related|3|||
124460490|NCT00490568|447645935|FG000|Overall Study|Participant died|1|||
124460491|NCT00490568|447645935|FG000|Overall Study|Participant withdrawal due to surgery|1|||
124460492|NCT01395394|447645936|FG000|Baseline Study Visit|Protocol Violation|1|||
124460493|NCT01395394|447645937|FG001|Baseline Study Visit|Protocol Violation|0|||
124460494|NCT01395394|447645938|FG002|Baseline Study Visit|Protocol Violation|0|||
124460495|NCT03451773|447645941|FG000|Overall Study|Death on study|1|||
124460496|NCT03451773|447645942|FG001|Overall Study|Death on study|5|||
124460497|NCT03451773|447645941|FG000|Overall Study|Death during follow-up period|0|||
124460498|NCT03451773|447645942|FG001|Overall Study|Death during follow-up period|1|||
124460499|NCT01964352|447645943|FG000|Overall Study|Adverse Event|13|||
124460500|NCT01964352|447645944|FG001|Overall Study|Adverse Event|3|||
124460501|NCT01964352|447645945|FG002|Overall Study|Adverse Event|4|||
124460502|NCT01964352|447645946|FG003|Overall Study|Adverse Event|3|||
124460503|NCT01964352|447645943|FG000|Overall Study|Lack of Efficacy|6|||
124460504|NCT01964352|447645944|FG001|Overall Study|Lack of Efficacy|0|||
124460505|NCT01964352|447645945|FG002|Overall Study|Lack of Efficacy|0|||
124460506|NCT01964352|447645946|FG003|Overall Study|Lack of Efficacy|0|||
124460507|NCT01964352|447645943|FG000|Overall Study|Protocol Violation|2|||
124460508|NCT01964352|447645944|FG001|Overall Study|Protocol Violation|4|||
124460509|NCT01964352|447645945|FG002|Overall Study|Protocol Violation|0|||
124460510|NCT01964352|447645946|FG003|Overall Study|Protocol Violation|2|||
124460511|NCT01964352|447645943|FG000|Overall Study|Lost to Follow-up|1|||
124460512|NCT01964352|447645944|FG001|Overall Study|Lost to Follow-up|0|||
124460513|NCT01964352|447645945|FG002|Overall Study|Lost to Follow-up|0|||
124460514|NCT01964352|447645946|FG003|Overall Study|Lost to Follow-up|1|||
124460515|NCT01964352|447645943|FG000|Overall Study|Withdrawal by Subject|4|||
124460516|NCT01964352|447645944|FG001|Overall Study|Withdrawal by Subject|2|||
124460517|NCT01964352|447645945|FG002|Overall Study|Withdrawal by Subject|1|||
124460518|NCT01964352|447645946|FG003|Overall Study|Withdrawal by Subject|0|||
124460519|NCT01964352|447645943|FG000|Overall Study|Other than stated above|0|||
124460520|NCT01964352|447645944|FG001|Overall Study|Other than stated above|2|||
124460521|NCT01964352|447645945|FG002|Overall Study|Other than stated above|1|||
124460522|NCT01964352|447645946|FG003|Overall Study|Other than stated above|2|||
124460523|NCT03468855|447645947|FG000|Overall Study|Adverse Event|2|||
124460524|NCT03468855|447645947|FG000|Overall Study|Lost to Follow-up|5|||
124460525|NCT03468855|447645947|FG000|Overall Study|Withdrawal by Subject|3|||
124460526|NCT03468855|447645947|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
124460527|NCT01908101|447645948|FG000|Overall Study|Physician Decision|1|||
124460528|NCT01908101|447645948|FG000|Overall Study|Withdrawal by Subject|1|||
124460529|NCT01908101|447645948|FG000|Overall Study|Incorrect Diagnosis|2|||
124460530|NCT01908101|447645948|FG000|Overall Study|Incorrect Starting Dose|1|||
124460531|NCT01908101|447645948|FG000|Overall Study|Did not complete the first cycle|4|||
124460532|NCT00412750|447645952|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124460533|NCT00412750|447645953|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124460534|NCT00412750|447645954|FG002|Overall Study|Abnormal laboratory value(s)|0|||
124460535|NCT00412750|447645952|FG000|Overall Study|Administrative problems|21|||
124460536|NCT00412750|447645953|FG001|Overall Study|Administrative problems|17|||
124460537|NCT00412750|447645954|FG002|Overall Study|Administrative problems|14|||
124460538|NCT00412750|447645952|FG000|Overall Study|Adverse Event|8|||
124460539|NCT00412750|447645953|FG001|Overall Study|Adverse Event|3|||
124460540|NCT00412750|447645954|FG002|Overall Study|Adverse Event|3|||
124460541|NCT00412750|447645952|FG000|Overall Study|Lost to Follow-up|1|||
124460542|NCT00412750|447645953|FG001|Overall Study|Lost to Follow-up|0|||
124707614|NCT02936323|448554695|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
124707615|NCT02936323|448554696|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
124460543|NCT00412750|447645954|FG002|Overall Study|Lost to Follow-up|1|||
124460544|NCT00412750|447645952|FG000|Overall Study|Withdrawal by Subject|0|||
124460545|NCT00412750|447645953|FG001|Overall Study|Withdrawal by Subject|1|||
124460546|NCT00412750|447645954|FG002|Overall Study|Withdrawal by Subject|2|||
124707616|NCT02936323|448554697|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
124460547|NCT00412750|447645952|FG000|Overall Study|Lack of Efficacy|0|||
124460548|NCT00412750|447645953|FG001|Overall Study|Lack of Efficacy|0|||
124460549|NCT00412750|447645954|FG002|Overall Study|Lack of Efficacy|3|||
124460550|NCT00477165|447645955|FG000|Overall Study|Adverse Event|7|||
124460551|NCT00477165|447645956|FG001|Overall Study|Adverse Event|2|||
124707617|NCT02936323|448554698|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
124707618|NCT02936323|448554699|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
124707619|NCT02936323|448554700|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
124707620|NCT02936323|448554701|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
124707621|NCT02936323|448554702|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
124707622|NCT02936323|448554703|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
124707623|NCT02936323|448554694|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
124707624|NCT02936323|448554695|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
124707625|NCT02936323|448554696|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
124707626|NCT02936323|448554697|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
124707627|NCT02936323|448554698|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
124953421|NCT02561195|449453240|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
124953422|NCT02561195|449453241|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
124953423|NCT02561195|449453228|FG000|Extension Stage (Vaccination 4)|Other|0|||
124953424|NCT02561195|449453229|FG001|Extension Stage (Vaccination 4)|Other|0|||
124953425|NCT02561195|449453230|FG002|Extension Stage (Vaccination 4)|Other|0|||
124953426|NCT02561195|449453231|FG003|Extension Stage (Vaccination 4)|Other|0|||
124953427|NCT02561195|449453232|FG004|Extension Stage (Vaccination 4)|Other|0|||
124953428|NCT02561195|449453233|FG005|Extension Stage (Vaccination 4)|Other|0|||
124953429|NCT02561195|449453234|FG006|Extension Stage (Vaccination 4)|Other|0|||
124953430|NCT02561195|449453235|FG007|Extension Stage (Vaccination 4)|Other|0|||
124953431|NCT02561195|449453236|FG008|Extension Stage (Vaccination 4)|Other|0|||
124953432|NCT02561195|449453237|FG009|Extension Stage (Vaccination 4)|Other|0|||
124953433|NCT02561195|449453238|FG010|Extension Stage (Vaccination 4)|Other|2|||
124953434|NCT02561195|449453239|FG011|Extension Stage (Vaccination 4)|Other|2|||
124953435|NCT02561195|449453240|FG012|Extension Stage (Vaccination 4)|Other|1|||
124953436|NCT02561195|449453241|FG013|Extension Stage (Vaccination 4)|Other|0|||
124953437|NCT02561195|449453228|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953438|NCT02561195|449453229|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953439|NCT02561195|449453230|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953440|NCT02561195|449453231|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953441|NCT02561195|449453232|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953442|NCT02561195|449453233|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953443|NCT02561195|449453234|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
124953444|NCT02561195|449453235|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953445|NCT02561195|449453236|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953446|NCT02561195|449453237|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953447|NCT02561195|449453238|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
124953448|NCT02561195|449453239|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
124953449|NCT02561195|449453240|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
124953450|NCT02561195|449453241|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
124953451|NCT03905512|449453242|FG000|Overall Study|Withdrawal by Subject|9|||
124953452|NCT03905512|449453243|FG001|Overall Study|Withdrawal by Subject|8|||
124953453|NCT03905512|449453242|FG000|Overall Study|Adverse Event|1|||
124953454|NCT03905512|449453243|FG001|Overall Study|Adverse Event|2|||
124953455|NCT03905512|449453242|FG000|Overall Study|Lost to Follow-up|4|||
124953456|NCT03905512|449453243|FG001|Overall Study|Lost to Follow-up|3|||
124953457|NCT03905512|449453242|FG000|Overall Study|Other than Specified|7|||
124953458|NCT03905512|449453243|FG001|Overall Study|Other than Specified|4|||
124953459|NCT03560206|449453246|FG000|Overall Study|Lost to Follow-up|19|||
124953460|NCT03560206|449453247|FG001|Overall Study|Lost to Follow-up|11|||
124953461|NCT03560206|449453246|FG000|Overall Study|Withdrawal by Subject|2|||
124953462|NCT03560206|449453247|FG001|Overall Study|Withdrawal by Subject|4|||
124953463|NCT03560206|449453246|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
124953464|NCT03560206|449453247|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
124953465|NCT03560206|449453246|FG000|Overall Study|Busy schedule|14|||
124953466|NCT03560206|449453247|FG001|Overall Study|Busy schedule|2|||
124953467|NCT03560206|449453246|FG000|Overall Study|patients' new health condition such as cancer|10|||
124953468|NCT03560206|449453247|FG001|Overall Study|patients' new health condition such as cancer|1|||
124953469|NCT03138499|449453252|FG000|Overall Study|Lost to Follow-up|1|||
124953470|NCT03138499|449453253|FG001|Overall Study|Lost to Follow-up|0|||
124953471|NCT03138499|449453252|FG000|Overall Study|Participants withdrew consent|1|||
124953472|NCT03138499|449453253|FG001|Overall Study|Participants withdrew consent|0|||
124460552|NCT00105443|447645957|FG000|Double-Blind Treatment|Adverse Event|1|||
124707628|NCT02936323|448554699|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
124707629|NCT02936323|448554700|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
124707630|NCT02936323|448554701|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
124953473|NCT03138499|449453252|FG000|Overall Study|Participant discontinued study before treatment|0|||
124707631|NCT02936323|448554702|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
124460553|NCT00105443|447645958|FG001|Double-Blind Treatment|Adverse Event|0|||
124460554|NCT00105443|447645959|FG002|Double-Blind Treatment|Adverse Event|0|||
124953474|NCT03138499|449453253|FG001|Overall Study|Participant discontinued study before treatment|1|||
124953475|NCT03138499|449453252|FG000|Overall Study|Disease Progression|2|||
124953476|NCT03138499|449453253|FG001|Overall Study|Disease Progression|6|||
124953477|NCT03138499|449453252|FG000|Overall Study|Study drug toxicity|2|||
124953478|NCT03138499|449453253|FG001|Overall Study|Study drug toxicity|2|||
124953479|NCT03138499|449453252|FG000|Overall Study|Participant request to discontinue study treatment|1|||
124953480|NCT03138499|449453253|FG001|Overall Study|Participant request to discontinue study treatment|1|||
124953481|NCT03138499|449453252|FG000|Overall Study|Other reasons|2|||
124953482|NCT03138499|449453253|FG001|Overall Study|Other reasons|0|||
124953483|NCT01334606|449453254|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
124953484|NCT02674399|449453255|FG000|Overall Study|Lost to Follow-up|2|||
124953485|NCT02674399|449453256|FG001|Overall Study|Lost to Follow-up|0|||
124953486|NCT01661972|449453257|FG000|Overall Study|Adverse Event|1|||
124953487|NCT01661972|449453258|FG001|Overall Study|Adverse Event|2|||
124953488|NCT01661972|449453257|FG000|Overall Study|Death during Treatment period|1|||
124953489|NCT01661972|449453258|FG001|Overall Study|Death during Treatment period|1|||
124953490|NCT01661972|449453257|FG000|Overall Study|Withdrawal by Subject|0|||
124953491|NCT01661972|449453258|FG001|Overall Study|Withdrawal by Subject|1|||
124953492|NCT01634165|449453270|FG000|Period 2|Adverse Event|0|||
124953493|NCT01634165|449453271|FG001|Period 2|Adverse Event|1|||
124953494|NCT01634165|449453272|FG002|Period 2|Adverse Event|0|||
124953495|NCT01634165|449453273|FG003|Period 2|Adverse Event|0|||
124953496|NCT05379400|449454682|FG000|Overall Study|Lost to Follow-up|1|||
124953497|NCT05379400|449454683|FG001|Overall Study|Lost to Follow-up|1|||
124953498|NCT03978130|449454685|FG000|Overall Study|Lost to Follow-up|13|||
124953499|NCT03978130|449454686|FG001|Overall Study|Lost to Follow-up|14|||
124953500|NCT03978130|449454685|FG000|Overall Study|Withdrawal by Subject|12|||
124953501|NCT03978130|449454686|FG001|Overall Study|Withdrawal by Subject|2|||
124953502|NCT03978130|449454685|FG000|Overall Study|Adverse Event|2|||
124953503|NCT03978130|449454686|FG001|Overall Study|Adverse Event|1|||
124460555|NCT00105443|447645960|FG003|Double-Blind Treatment|Adverse Event|0|||
124460556|NCT00105443|447645957|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
124953504|NCT00515112|449454687|FG000|Overall Study|Death|0|||
124953505|NCT00515112|449454688|FG001|Overall Study|Death|1|||
124953506|NCT00515112|449454687|FG000|Overall Study|The study was terminated|3|||
124953507|NCT00515112|449454688|FG001|Overall Study|The study was terminated|2|||
124953508|NCT00304278|449454692|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
124953509|NCT00304278|449454692|FG000|Overall Study|PT had medical condition preventing TX|1|||
124953510|NCT00409006|449454693|FG000|Overall Study|Death|15|||
124953511|NCT00409006|449454694|FG001|Overall Study|Death|6|||
124953512|NCT00409006|449454693|FG000|Overall Study|Lost to Follow-up|1|||
124953513|NCT00409006|449454694|FG001|Overall Study|Lost to Follow-up|2|||
124953514|NCT00409006|449454693|FG000|Overall Study|Withdrawal by Subject|3|||
124953515|NCT00409006|449454694|FG001|Overall Study|Withdrawal by Subject|2|||
124953516|NCT00409006|449454693|FG000|Overall Study|Physician Decision|1|||
124953517|NCT00409006|449454694|FG001|Overall Study|Physician Decision|2|||
124953518|NCT00228813|449454695|FG000|Overall Study|Death|4|||
124460557|NCT00105443|447645958|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
124460558|NCT00105443|447645959|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
124460559|NCT00105443|447645960|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
124460560|NCT00105443|447645957|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
124460561|NCT00105443|447645958|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
124460562|NCT00105443|447645959|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
124460563|NCT00105443|447645960|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
124460564|NCT00105443|447645957|FG000|Double-Blind Treatment|Physician Decision|1|||
124460565|NCT00105443|447645958|FG001|Double-Blind Treatment|Physician Decision|0|||
124460566|NCT00105443|447645959|FG002|Double-Blind Treatment|Physician Decision|2|||
124460567|NCT00105443|447645960|FG003|Double-Blind Treatment|Physician Decision|0|||
124460568|NCT00105443|447645957|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
124460569|NCT00105443|447645958|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
124460570|NCT00105443|447645959|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
124460571|NCT00105443|447645960|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
124953519|NCT00507429|449454696|FG000|Treatment Phase|Disease Progression|12|||
124953520|NCT00507429|449454697|FG001|Treatment Phase|Disease Progression|5|||
124953521|NCT00507429|449454696|FG000|Treatment Phase|Adverse Event|12|||
124953522|NCT00507429|449454697|FG001|Treatment Phase|Adverse Event|5|||
124548996|NCT01125358|447965421|FG003|Overall Study|Protocol Violation|0|||
124953523|NCT00507429|449454696|FG000|Treatment Phase|Withdrawal by Subject|3|||
124953524|NCT00507429|449454697|FG001|Treatment Phase|Withdrawal by Subject|3|||
124953525|NCT00507429|449454696|FG000|Treatment Phase|Physician Decision|4|||
124953526|NCT00507429|449454697|FG001|Treatment Phase|Physician Decision|2|||
124953527|NCT00507429|449454696|FG000|Treatment Phase|Other|6|||
124953528|NCT00507429|449454697|FG001|Treatment Phase|Other|3|||
124953529|NCT00507429|449454696|FG000|Maintenance Phase|Progressive Disease|14|||
124953530|NCT00507429|449454697|FG001|Maintenance Phase|Progressive Disease|0|||
124953531|NCT04025762|449454699|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
124953532|NCT04025762|449454700|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
124953533|NCT00608959|449454703|FG000|Part 1|Did not meet eligibility criteria|1|||
124953534|NCT01005602|449454706|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
124953535|NCT01005602|449454707|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
124953536|NCT01248715|449454708|FG000|Overall Study|Not influenza positive|501|||
124953537|NCT01248715|449454709|FG001|Overall Study|Not influenza positive|510|||
124953538|NCT03409276|449454715|FG000|Overall Study|Withdrawal by Subject|0|||
124953539|NCT03409276|449454716|FG001|Overall Study|Withdrawal by Subject|0|||
124953540|NCT03409276|449454717|FG002|Overall Study|Withdrawal by Subject|0|||
124953541|NCT03409276|449454718|FG003|Overall Study|Withdrawal by Subject|0|||
124953542|NCT03409276|449454719|FG004|Overall Study|Withdrawal by Subject|1|||
124953543|NCT03409276|449454715|FG000|Overall Study|Lost to Follow-up|0|||
124953544|NCT03409276|449454716|FG001|Overall Study|Lost to Follow-up|0|||
124953545|NCT03409276|449454717|FG002|Overall Study|Lost to Follow-up|0|||
124953546|NCT03409276|449454718|FG003|Overall Study|Lost to Follow-up|2|||
124953547|NCT03409276|449454719|FG004|Overall Study|Lost to Follow-up|2|||
124953548|NCT03605745|449454720|FG000|Overall Study|Study was terminated for business reasons|47|||
124953549|NCT01279447|449454721|FG000|Overall Study|Lost to Follow-up|3|||
124953550|NCT01279447|449454722|FG001|Overall Study|Lost to Follow-up|1|||
124953551|NCT01215253|449454723|FG000|Overall Study|Withdrawal by Subject|57|||
124953552|NCT01215253|449454724|FG001|Overall Study|Withdrawal by Subject|35|||
124953553|NCT01215253|449454723|FG000|Overall Study|Physician Decision|9|||
124953554|NCT01215253|449454724|FG001|Overall Study|Physician Decision|12|||
124953555|NCT01215253|449454723|FG000|Overall Study|Lost to Follow-up|6|||
124953556|NCT01215253|449454724|FG001|Overall Study|Lost to Follow-up|4|||
124953557|NCT01215253|449454723|FG000|Overall Study|Other|14|||
124953558|NCT01215253|449454724|FG001|Overall Study|Other|12|||
124953559|NCT01131325|449454731|FG000|Overall Study|Adverse Event|1|||
124953560|NCT01131325|449454731|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
124953561|NCT03884478|449454732|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
124953562|NCT03884478|449454733|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
124953563|NCT03884478|449454734|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
124953564|NCT03884478|449454732|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
124953565|NCT03884478|449454733|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
124953566|NCT03884478|449454734|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
124953567|NCT03884478|449454732|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
124953568|NCT03884478|449454733|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
124953569|NCT03884478|449454734|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
124953570|NCT03884478|449454732|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
124953571|NCT03884478|449454733|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
124953572|NCT03884478|449454734|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
124953573|NCT02213094|449454737|FG000|Overall Study|Adverse Event|1|||
124953574|NCT02213094|449454738|FG001|Overall Study|Adverse Event|0|||
124953575|NCT01807234|449454739|FG000|Overall Study|Lost to Follow-up|2|||
124953576|NCT01807234|449454740|FG001|Overall Study|Lost to Follow-up|5|||
124953577|NCT01807234|449454741|FG002|Overall Study|Lost to Follow-up|1|||
124953578|NCT01807234|449454742|FG003|Overall Study|Lost to Follow-up|1|||
124953579|NCT01807234|449454743|FG004|Overall Study|Lost to Follow-up|1|||
124953580|NCT01807234|449454744|FG005|Overall Study|Lost to Follow-up|2|||
124953581|NCT01807234|449454739|FG000|Overall Study|Withdrawal by Subject|3|||
124953582|NCT01807234|449454740|FG001|Overall Study|Withdrawal by Subject|1|||
124953583|NCT01807234|449454741|FG002|Overall Study|Withdrawal by Subject|1|||
124953584|NCT01807234|449454742|FG003|Overall Study|Withdrawal by Subject|1|||
124953585|NCT01807234|449454743|FG004|Overall Study|Withdrawal by Subject|2|||
124953586|NCT01807234|449454744|FG005|Overall Study|Withdrawal by Subject|1|||
124953587|NCT01807234|449454739|FG000|Overall Study|Lack of Efficacy|0|||
124953588|NCT01807234|449454740|FG001|Overall Study|Lack of Efficacy|0|||
124953589|NCT01807234|449454741|FG002|Overall Study|Lack of Efficacy|0|||
124953590|NCT01807234|449454742|FG003|Overall Study|Lack of Efficacy|0|||
124953591|NCT01807234|449454743|FG004|Overall Study|Lack of Efficacy|1|||
124953592|NCT01807234|449454744|FG005|Overall Study|Lack of Efficacy|1|||
124953593|NCT00538629|449454745|FG000|Overall Study|At subject's request|1|||
124953594|NCT00538629|449454745|FG000|Overall Study|Adverse Event|2|||
124953595|NCT00538629|449454745|FG000|Overall Study|Lack of Efficacy|12|||
124953596|NCT00538629|449454745|FG000|Overall Study|Lost to Follow-up|6|||
124953597|NCT00538629|449454745|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
124953598|NCT00555620|449454747|FG000|Overall Study|Death|0|||
124953599|NCT00555620|449454748|FG001|Overall Study|Death|1|||
124953600|NCT00555620|449454749|FG002|Overall Study|Death|0|||
124953601|NCT00555620|449454750|FG003|Overall Study|Death|0|||
124953602|NCT00555620|449454751|FG004|Overall Study|Death|0|||
124953603|NCT00555620|449454752|FG005|Overall Study|Death|1|||
124953604|NCT00555620|449454747|FG000|Overall Study|Study terminated by sponsor|0|||
124953605|NCT00555620|449454748|FG001|Overall Study|Study terminated by sponsor|0|||
124953606|NCT00555620|449454749|FG002|Overall Study|Study terminated by sponsor|1|||
124707632|NCT02936323|448554703|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
124707633|NCT02936323|448554694|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
124707634|NCT02936323|448554695|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
124707635|NCT02936323|448554696|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
124707636|NCT02936323|448554697|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
124707637|NCT02936323|448554698|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
124707638|NCT02936323|448554699|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
124707639|NCT02936323|448554700|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
124707640|NCT02936323|448554701|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
124707641|NCT02936323|448554702|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
124707642|NCT02936323|448554703|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
124707643|NCT02936323|448554694|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
124707644|NCT02936323|448554695|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
124707645|NCT02936323|448554696|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
124707646|NCT02936323|448554697|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
124953607|NCT00555620|449454750|FG003|Overall Study|Study terminated by sponsor|0|||
124953608|NCT00555620|449454751|FG004|Overall Study|Study terminated by sponsor|0|||
124953609|NCT00555620|449454752|FG005|Overall Study|Study terminated by sponsor|0|||
124953610|NCT00555620|449454747|FG000|Overall Study|Adverse Event|0|||
124953611|NCT00555620|449454748|FG001|Overall Study|Adverse Event|0|||
124953612|NCT00555620|449454749|FG002|Overall Study|Adverse Event|1|||
124953613|NCT00555620|449454750|FG003|Overall Study|Adverse Event|5|||
124953614|NCT00555620|449454751|FG004|Overall Study|Adverse Event|0|||
124953615|NCT00555620|449454752|FG005|Overall Study|Adverse Event|1|||
124953616|NCT00555620|449454747|FG000|Overall Study|Objective progression or relapse|6|||
124953617|NCT00555620|449454748|FG001|Overall Study|Objective progression or relapse|5|||
124953618|NCT00555620|449454749|FG002|Overall Study|Objective progression or relapse|12|||
124953619|NCT00555620|449454750|FG003|Overall Study|Objective progression or relapse|17|||
124953620|NCT00555620|449454751|FG004|Overall Study|Objective progression or relapse|3|||
124953621|NCT00555620|449454752|FG005|Overall Study|Objective progression or relapse|16|||
124953622|NCT00555620|449454747|FG000|Overall Study|Participant refused treatment|0|||
124953623|NCT00555620|449454748|FG001|Overall Study|Participant refused treatment|1|||
124953624|NCT00555620|449454749|FG002|Overall Study|Participant refused treatment|1|||
124953625|NCT00555620|449454750|FG003|Overall Study|Participant refused treatment|0|||
124953626|NCT00555620|449454751|FG004|Overall Study|Participant refused treatment|0|||
124953627|NCT00555620|449454752|FG005|Overall Study|Participant refused treatment|1|||
124953628|NCT00555620|449454747|FG000|Overall Study|Other|0|||
124953629|NCT00555620|449454748|FG001|Overall Study|Other|0|||
124953630|NCT00555620|449454749|FG002|Overall Study|Other|0|||
124953631|NCT00555620|449454750|FG003|Overall Study|Other|1|||
124953632|NCT00555620|449454751|FG004|Overall Study|Other|0|||
124953633|NCT00555620|449454752|FG005|Overall Study|Other|3|||
124953634|NCT05203822|449454753|FG000|Overall Study|Adverse Event|1|||
124953635|NCT05203822|449454753|FG000|Overall Study|Withdrawal by Subject|1|||
124953636|NCT01345253|449454755|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
124953637|NCT01345253|449454756|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
124953638|NCT01345253|449454755|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
124953639|NCT01345253|449454756|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
124953640|NCT01345253|449454755|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
124953641|NCT01345253|449454756|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
124953642|NCT01345253|449454755|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
124953643|NCT01345253|449454756|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
124953644|NCT01345253|449454755|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
124953645|NCT01345253|449454756|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
124953646|NCT01345253|449454755|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
124953647|NCT01345253|449454756|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
124953648|NCT01345253|449454755|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
124953649|NCT01345253|449454756|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
124707647|NCT02936323|448554698|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
124707648|NCT02936323|448554699|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
124707649|NCT02936323|448554700|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
124707650|NCT02936323|448554701|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
124707651|NCT02936323|448554702|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
124953650|NCT01345253|449454755|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
124548997|NCT01125358|447965418|FG000|Overall Study|Sponsor Decision|0|||
124953651|NCT01345253|449454756|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
124953652|NCT01345253|449454755|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
124953653|NCT01345253|449454756|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
124953654|NCT01345253|449454755|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
124953655|NCT01345253|449454756|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
124707652|NCT02936323|448554703|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
124707653|NCT02936323|448554694|FG000|Phase 2a Dose Expansion|Death|0|||
124707654|NCT02936323|448554695|FG001|Phase 2a Dose Expansion|Death|0|||
124953656|NCT01345253|449454755|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
124953657|NCT01345253|449454756|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
124953658|NCT01345253|449454755|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
124953659|NCT01345253|449454756|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
124953660|NCT01345253|449454755|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
124953661|NCT01345253|449454756|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
124953662|NCT01345253|449454755|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
124953663|NCT01345253|449454756|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
124953664|NCT01345253|449454755|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
124953665|NCT01345253|449454756|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
124953666|NCT00648895|449454759|FG000|Overall Study|Lack of Efficacy|0|||
124953667|NCT00648895|449454760|FG001|Overall Study|Lack of Efficacy|1|||
124953668|NCT02865083|449454761|FG000|Overall Study|Early Termination|3|||
124953669|NCT02865083|449454762|FG001|Overall Study|Early Termination|1|||
124953670|NCT00841321|449454763|FG000|Overall Study|Lost to Follow-up|1|||
124953671|NCT00841321|449454764|FG001|Overall Study|Lost to Follow-up|1|||
124953672|NCT00841321|449454763|FG000|Overall Study|Adverse Event|0|||
124953673|NCT00841321|449454764|FG001|Overall Study|Adverse Event|2|||
124953674|NCT02379078|449454765|FG000|Overall Study|Lost to Follow-up|33|||
124953675|NCT02379078|449454766|FG001|Overall Study|Lost to Follow-up|30|||
124953676|NCT02379078|449454765|FG000|Overall Study|Withdrawal by Subject|6|||
124953677|NCT02379078|449454766|FG001|Overall Study|Withdrawal by Subject|5|||
124953678|NCT04908488|449454767|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
124953679|NCT04908488|449454768|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
124953680|NCT04908488|449454767|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
124953681|NCT04908488|449454768|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
124953682|NCT01894620|449454772|FG000|Overall Study|Withdrawal by Subject|0|||
124953683|NCT01894620|449454773|FG001|Overall Study|Withdrawal by Subject|1|||
124953684|NCT00657709|449454774|FG000|Overall Study|AE or Death|7|||
124953685|NCT00657709|449454775|FG001|Overall Study|AE or Death|7|||
124953686|NCT00657709|449454776|FG002|Overall Study|AE or Death|6|||
124953687|NCT00657709|449454777|FG003|Overall Study|AE or Death|7|||
124953688|NCT00657709|449454778|FG004|Overall Study|AE or Death|1|||
124953689|NCT00657709|449454774|FG000|Overall Study|Withdrawal by Subject|7|||
124953690|NCT00657709|449454775|FG001|Overall Study|Withdrawal by Subject|15|||
124953691|NCT00657709|449454776|FG002|Overall Study|Withdrawal by Subject|15|||
124953692|NCT00657709|449454777|FG003|Overall Study|Withdrawal by Subject|5|||
124953693|NCT00657709|449454778|FG004|Overall Study|Withdrawal by Subject|9|||
124953694|NCT00657709|449454774|FG000|Overall Study|Lost to Follow-up|9|||
124953695|NCT00657709|449454775|FG001|Overall Study|Lost to Follow-up|9|||
124953696|NCT00657709|449454776|FG002|Overall Study|Lost to Follow-up|7|||
124953697|NCT00657709|449454777|FG003|Overall Study|Lost to Follow-up|1|||
124953698|NCT00657709|449454778|FG004|Overall Study|Lost to Follow-up|21|||
124953699|NCT00657709|449454774|FG000|Overall Study|Protocol Violation|0|||
124953700|NCT00657709|449454775|FG001|Overall Study|Protocol Violation|2|||
124953701|NCT00657709|449454776|FG002|Overall Study|Protocol Violation|0|||
124953702|NCT00657709|449454777|FG003|Overall Study|Protocol Violation|1|||
124953703|NCT00657709|449454778|FG004|Overall Study|Protocol Violation|2|||
124953704|NCT00901459|449454779|FG000|Overall Study|Withdrawal by Subject|6|||
124953705|NCT04765046|449454780|FG000|Overall Study|Screen Failure|2|||
124953706|NCT04765046|449454780|FG000|Overall Study|Withdrawal by Subject|4|||
124953707|NCT04765046|449454780|FG000|Overall Study|Physician Decision|4|||
124953708|NCT04765046|449454780|FG000|Overall Study|Surgery Cancelled|8|||
124953709|NCT04930263|449454785|FG000|Overall Study|Withdrawal by Subject|3|||
124953710|NCT04930263|449454786|FG001|Overall Study|Withdrawal by Subject|5|||
124953711|NCT00850993|449454789|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
124953712|NCT00850993|449454790|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
124953713|NCT00850993|449454791|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
124707655|NCT02936323|448554696|FG002|Phase 2a Dose Expansion|Death|0|||
124707656|NCT02936323|448554697|FG003|Phase 2a Dose Expansion|Death|0|||
124707657|NCT02936323|448554698|FG004|Phase 2a Dose Expansion|Death|0|||
124707658|NCT02936323|448554699|FG005|Phase 2a Dose Expansion|Death|0|||
124707659|NCT02936323|448554700|FG006|Phase 2a Dose Expansion|Death|0|||
124707660|NCT02936323|448554701|FG007|Phase 2a Dose Expansion|Death|4|||
124953714|NCT00850993|449454792|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
124953715|NCT03839355|449454793|FG000|Overall Study|Withdrawal by Subject|1|||
124953716|NCT03839355|449454794|FG001|Overall Study|Withdrawal by Subject|0|||
124707661|NCT02936323|448554702|FG008|Phase 2a Dose Expansion|Death|8|||
124707662|NCT02936323|448554703|FG009|Phase 2a Dose Expansion|Death|10|||
124766412|NCT01346358|448771722|FG005|Overall Study|Physician Decision|0|||
124953717|NCT03547167|449454800|FG000|Overall Study|Withdrawal by Subject|34|||
124953718|NCT03547167|449454801|FG001|Overall Study|Withdrawal by Subject|12|||
124953719|NCT03547167|449454800|FG000|Overall Study|Screen Failure|0|||
124953720|NCT03547167|449454801|FG001|Overall Study|Screen Failure|1|||
124953721|NCT03547167|449454800|FG000|Overall Study|Lost to Follow-up|59|||
124953722|NCT03547167|449454801|FG001|Overall Study|Lost to Follow-up|15|||
124953723|NCT03547167|449454800|FG000|Overall Study|Death|4|||
124953724|NCT03547167|449454801|FG001|Overall Study|Death|2|||
124953725|NCT02009865|449454805|FG000|Overall Study|Adverse Event|0|||
124953726|NCT02009865|449454806|FG001|Overall Study|Adverse Event|2|||
124953727|NCT02009865|449454805|FG000|Overall Study|Protocol Violation|0|||
124953728|NCT02009865|449454806|FG001|Overall Study|Protocol Violation|2|||
124953729|NCT02009865|449454805|FG000|Overall Study|Withdrawal by Subject|1|||
124953730|NCT02009865|449454806|FG001|Overall Study|Withdrawal by Subject|1|||
124953731|NCT01760876|449454807|FG000|Overall Study|Non-cardiac death (head injury)|1|||
124953732|NCT01760876|449454807|FG000|Overall Study|Carcinoma of prostate|1|||
124953733|NCT01760876|449454807|FG000|Overall Study|Impaired renal function|1|||
124953734|NCT01760876|449454807|FG000|Overall Study|Major depression|1|||
124953735|NCT01760876|449454807|FG000|Overall Study|Very poor baseline OCT quality|2|||
124953736|NCT01517282|449454810|FG000|Overall Study|Consent withdrawn|0|||
124953737|NCT01517282|449454811|FG001|Overall Study|Consent withdrawn|1|||
124953738|NCT01517282|449454812|FG002|Overall Study|Consent withdrawn|1|||
124953739|NCT01517282|449454813|FG003|Overall Study|Consent withdrawn|1|||
124953740|NCT01517282|449454810|FG000|Overall Study|Physician Decision|1|||
124953741|NCT01517282|449454811|FG001|Overall Study|Physician Decision|0|||
124953742|NCT01517282|449454812|FG002|Overall Study|Physician Decision|0|||
124953743|NCT01517282|449454813|FG003|Overall Study|Physician Decision|0|||
124953744|NCT00525915|449454814|FG000|Overall Study|Non-Compliance|0|||
124953745|NCT00525915|449454815|FG001|Overall Study|Non-Compliance|1|||
124953746|NCT00525915|449454814|FG000|Overall Study|Disease Progression|5|||
124953747|NCT00525915|449454815|FG001|Overall Study|Disease Progression|6|||
124953748|NCT00525915|449454814|FG000|Overall Study|Withdrawal by Subject|1|||
124953749|NCT00525915|449454815|FG001|Overall Study|Withdrawal by Subject|0|||
124953750|NCT00525915|449454814|FG000|Overall Study|Refused Surgery|1|||
124953751|NCT00525915|449454815|FG001|Overall Study|Refused Surgery|2|||
124953752|NCT00525915|449454814|FG000|Overall Study|Unrelated illness|1|||
124953753|NCT00525915|449454815|FG001|Overall Study|Unrelated illness|0|||
124953754|NCT00760877|449456105|FG000|Overall Study|Protocol Violation|1|||
124953755|NCT00760877|449456106|FG001|Overall Study|Protocol Violation|0|||
124953756|NCT00760877|449456105|FG000|Overall Study|Non-compliance with protocol treatment|2|||
124953757|NCT00760877|449456106|FG001|Overall Study|Non-compliance with protocol treatment|1|||
124953758|NCT00760877|449456105|FG000|Overall Study|Pregnancy|1|||
124953759|NCT00760877|449456106|FG001|Overall Study|Pregnancy|4|||
124707663|NCT05788991|448554704|FG000|Overall Study|Not treated with study medication|1|||
124707664|NCT05788991|448554705|FG001|Overall Study|Not treated with study medication|3|||
124707665|NCT05788991|448554704|FG000|Overall Study|Withdrawal by Subject|1|||
124953760|NCT00760877|449456105|FG000|Overall Study|Death|2|||
124953761|NCT00760877|449456106|FG001|Overall Study|Death|1|||
124953762|NCT00760877|449456105|FG000|Overall Study|Withdrawal by Subject|7|||
124953763|NCT00760877|449456106|FG001|Overall Study|Withdrawal by Subject|3|||
124953764|NCT00760877|449456105|FG000|Overall Study|Adverse Event|19|||
124460572|NCT00105443|447645957|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
124460573|NCT00105443|447645958|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
124460574|NCT00105443|447645959|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
124460575|NCT00105443|447645960|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
124460576|NCT00105443|447645957|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
124460577|NCT00105443|447645958|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
124953765|NCT00760877|449456106|FG001|Overall Study|Adverse Event|12|||
124953766|NCT00760877|449456105|FG000|Overall Study|Participant diagnosed with AML|0|||
124953767|NCT00760877|449456106|FG001|Overall Study|Participant diagnosed with AML|1|||
124953768|NCT00760877|449456105|FG000|Overall Study|Participant not eligible to cross-over|0|||
124953769|NCT00760877|449456106|FG001|Overall Study|Participant not eligible to cross-over|1|||
124953770|NCT00760877|449456105|FG000|Overall Study|Physician Decision|1|||
124953771|NCT00760877|449456106|FG001|Overall Study|Physician Decision|2|||
124953772|NCT00760877|449456105|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
124953773|NCT00760877|449456106|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
124953774|NCT00760877|449456105|FG000|Overall Study|Treatment failure|1|||
124460578|NCT00105443|447645959|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
124460579|NCT00105443|447645960|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
124707666|NCT05788991|448554705|FG001|Overall Study|Withdrawal by Subject|0|||
124953775|NCT00760877|449456106|FG001|Overall Study|Treatment failure|0|||
124953776|NCT00711555|449456109|FG000|Overall Study|Adverse Event|3|||
124953777|NCT00946998|449456110|FG000|Overall Study|Exited prior to first outcome assessment|5|||
124953778|NCT00946998|449456111|FG001|Overall Study|Exited prior to first outcome assessment|3|||
124953779|NCT03020914|449456112|FG000|Overall Study|Surgery Cancelled|1|||
124953780|NCT03020914|449456113|FG001|Overall Study|Surgery Cancelled|0|||
124953781|NCT00668746|449456117|FG000|Overall Study|Lost to Follow-up|2|||
124953782|NCT00668746|449456118|FG001|Overall Study|Lost to Follow-up|1|||
124953783|NCT02109172|449456119|FG000|Overall Study|Withdrawal by Subject|1|||
124548998|NCT01125358|447965419|FG001|Overall Study|Sponsor Decision|0|||
124707667|NCT05788991|448554704|FG000|Overall Study|Lack of Efficacy|0|||
124707668|NCT05788991|448554705|FG001|Overall Study|Lack of Efficacy|1|||
124953784|NCT02109172|449456120|FG001|Overall Study|Withdrawal by Subject|0|||
124953785|NCT02109172|449456121|FG002|Overall Study|Withdrawal by Subject|0|||
124953786|NCT02109172|449456122|FG003|Overall Study|Withdrawal by Subject|1|||
124953787|NCT02109172|449456123|FG004|Overall Study|Withdrawal by Subject|0|||
124953788|NCT02109172|449456124|FG005|Overall Study|Withdrawal by Subject|0|||
124953789|NCT02109172|449456119|FG000|Overall Study|Adverse Event|0|||
124953790|NCT02109172|449456120|FG001|Overall Study|Adverse Event|0|||
124953791|NCT02109172|449456121|FG002|Overall Study|Adverse Event|1|||
124953792|NCT02109172|449456122|FG003|Overall Study|Adverse Event|0|||
124953793|NCT02109172|449456123|FG004|Overall Study|Adverse Event|0|||
124953794|NCT02109172|449456124|FG005|Overall Study|Adverse Event|1|||
124953795|NCT02109172|449456119|FG000|Overall Study|Death|0|||
124953796|NCT02109172|449456120|FG001|Overall Study|Death|0|||
124953797|NCT02109172|449456121|FG002|Overall Study|Death|0|||
124953798|NCT02109172|449456122|FG003|Overall Study|Death|0|||
124953799|NCT02109172|449456123|FG004|Overall Study|Death|1|||
124953800|NCT02109172|449456124|FG005|Overall Study|Death|0|||
124953801|NCT02011568|449456125|FG000|Overall Study|Withdrawal by Subject|8|||
124953802|NCT02011568|449456126|FG001|Overall Study|Withdrawal by Subject|10|||
124953803|NCT02011568|449456125|FG000|Overall Study|Physician Decision|1|||
124953804|NCT02011568|449456126|FG001|Overall Study|Physician Decision|3|||
124953805|NCT01816165|449456128|FG000|Overall Study|Adverse Event|1|||
124953806|NCT01816165|449456129|FG001|Overall Study|Adverse Event|0|||
124953807|NCT01816165|449456130|FG002|Overall Study|Adverse Event|0|||
124953808|NCT01816165|449456131|FG003|Overall Study|Adverse Event|0|||
124953809|NCT01322347|449456137|FG000|Overall Study|Adverse Event|7|||
124953810|NCT01322347|449456138|FG001|Overall Study|Adverse Event|2|||
124953811|NCT01322347|449456137|FG000|Overall Study|Death|5|||
124953812|NCT01322347|449456138|FG001|Overall Study|Death|3|||
124953813|NCT01322347|449456137|FG000|Overall Study|Physician Decision|2|||
124953814|NCT01322347|449456138|FG001|Overall Study|Physician Decision|1|||
124953815|NCT01322347|449456137|FG000|Overall Study|Protocol Violation|5|||
124953816|NCT01322347|449456138|FG001|Overall Study|Protocol Violation|2|||
124953817|NCT01322347|449456137|FG000|Overall Study|Withdrawal by Subject|1|||
124953818|NCT01322347|449456138|FG001|Overall Study|Withdrawal by Subject|4|||
124953819|NCT01322347|449456137|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
124953820|NCT01322347|449456138|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
124953821|NCT01322347|449456137|FG000|Overall Study|blood transfusion|5|||
124953822|NCT01322347|449456138|FG001|Overall Study|blood transfusion|5|||
124953823|NCT01322347|449456137|FG000|Overall Study|sponsor decision|1|||
124953824|NCT01322347|449456138|FG001|Overall Study|sponsor decision|3|||
124953825|NCT01322347|449456137|FG000|Overall Study|ineligible|6|||
124953826|NCT01322347|449456138|FG001|Overall Study|ineligible|3|||
124953827|NCT01322347|449456137|FG000|Overall Study|kidney transplant|3|||
124953828|NCT01322347|449456138|FG001|Overall Study|kidney transplant|1|||
124953829|NCT01322347|449456137|FG000|Overall Study|study drug withheld > 12 wks|0|||
124953830|NCT01322347|449456138|FG001|Overall Study|study drug withheld > 12 wks|1|||
124953831|NCT01322347|449456137|FG000|Overall Study|moved/changed dialysis|2|||
124953832|NCT01322347|449456138|FG001|Overall Study|moved/changed dialysis|4|||
124953833|NCT01369147|449456140|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
124953834|NCT01369147|449456141|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
124953835|NCT01369147|449456142|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
124953836|NCT00379210|449456146|FG000|Overall Study|Withdrawal by Subject|10|||
124953837|NCT00379210|449456147|FG001|Overall Study|Withdrawal by Subject|7|||
124953838|NCT01525875|449456148|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
124953839|NCT01525875|449456149|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
124953840|NCT01525875|449456148|FG000|Open-label Period|Lost to Follow-up|0|||
124953841|NCT01525875|449456149|FG001|Open-label Period|Lost to Follow-up|2|||
124953842|NCT01762345|449456150|FG000|Overall Study|Adverse Event|5|||
124953843|NCT01762345|449456150|FG000|Overall Study|Protocol Violation|2|||
124953844|NCT01358175|449456151|FG000|Overall Study|Death|1|||
124707669|NCT05788991|448554704|FG000|Overall Study|Protocol Violation|1|||
124953845|NCT01358175|449456152|FG001|Overall Study|Death|0|||
124953846|NCT01358175|449456153|FG002|Overall Study|Death|1|||
124460580|NCT00105443|447645957|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
124460581|NCT00105443|447645958|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
124460582|NCT00105443|447645959|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
124460583|NCT00105443|447645960|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
124460584|NCT00105443|447645957|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
124460585|NCT00105443|447645958|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
124460586|NCT00105443|447645959|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
124460587|NCT00105443|447645960|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
124460588|NCT00105443|447645957|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
124953847|NCT01358175|449456151|FG000|Overall Study|Withdrawal by Subject|9|||
124953848|NCT01358175|449456152|FG001|Overall Study|Withdrawal by Subject|5|||
124953849|NCT01358175|449456153|FG002|Overall Study|Withdrawal by Subject|10|||
124953850|NCT01358175|449456151|FG000|Overall Study|Technical issues|0|||
124953851|NCT01358175|449456152|FG001|Overall Study|Technical issues|1|||
124953852|NCT01358175|449456153|FG002|Overall Study|Technical issues|0|||
124953853|NCT01358175|449456151|FG000|Overall Study|Pregnancy|0|||
124953854|NCT01358175|449456152|FG001|Overall Study|Pregnancy|1|||
124953855|NCT01358175|449456153|FG002|Overall Study|Pregnancy|0|||
124953856|NCT01358175|449456151|FG000|Overall Study|Physician Decision|1|||
124953857|NCT01358175|449456152|FG001|Overall Study|Physician Decision|0|||
124953858|NCT01358175|449456153|FG002|Overall Study|Physician Decision|0|||
124953859|NCT01358175|449456151|FG000|Overall Study|Non Compliance with Study Treatment|0|||
124953860|NCT01358175|449456152|FG001|Overall Study|Non Compliance with Study Treatment|1|||
124953861|NCT01358175|449456153|FG002|Overall Study|Non Compliance with Study Treatment|1|||
124953862|NCT01358175|449456151|FG000|Overall Study|Lost to Follow-up|1|||
124953863|NCT01358175|449456152|FG001|Overall Study|Lost to Follow-up|1|||
124953864|NCT01358175|449456153|FG002|Overall Study|Lost to Follow-up|3|||
124953865|NCT01358175|449456151|FG000|Overall Study|Lack of Efficacy|3|||
124953866|NCT01358175|449456152|FG001|Overall Study|Lack of Efficacy|8|||
124953867|NCT01358175|449456153|FG002|Overall Study|Lack of Efficacy|6|||
124953868|NCT01358175|449456151|FG000|Overall Study|Adverse Event|6|||
124953869|NCT01358175|449456152|FG001|Overall Study|Adverse Event|11|||
124953870|NCT01358175|449456153|FG002|Overall Study|Adverse Event|11|||
124953871|NCT05072795|449456154|FG000|Overall Study|Lost to Follow-up|5|||
124953872|NCT01107912|449456157|FG000|Period 1|Adverse Event|0|||
124953873|NCT01107912|449456158|FG001|Period 1|Adverse Event|0|||
124953874|NCT01107912|449456159|FG002|Period 1|Adverse Event|0|||
124953875|NCT01107912|449456160|FG003|Period 1|Adverse Event|0|||
124953876|NCT01107912|449456161|FG004|Period 1|Adverse Event|2|||
124953877|NCT01107912|449456162|FG005|Period 1|Adverse Event|0|||
124953878|NCT01107912|449456157|FG000|Period 1|Physician Decision|0|||
124953879|NCT01107912|449456158|FG001|Period 1|Physician Decision|0|||
124460589|NCT00105443|447645958|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
124460590|NCT00105443|447645959|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
124953880|NCT01107912|449456159|FG002|Period 1|Physician Decision|0|||
124953881|NCT01107912|449456160|FG003|Period 1|Physician Decision|0|||
124953882|NCT01107912|449456161|FG004|Period 1|Physician Decision|1|||
124953883|NCT01107912|449456162|FG005|Period 1|Physician Decision|0|||
124953884|NCT01107912|449456157|FG000|Period 1|Withdrawal by Subject|1|||
124953885|NCT01107912|449456158|FG001|Period 1|Withdrawal by Subject|0|||
124707670|NCT05788991|448554705|FG001|Overall Study|Protocol Violation|2|||
124707671|NCT05270863|448554706|FG000|Visit 2 First Intervention|Randomization error|0|||
124707672|NCT05270863|448554707|FG001|Visit 2 First Intervention|Randomization error|0|||
124953886|NCT01107912|449456159|FG002|Period 1|Withdrawal by Subject|0|||
124953887|NCT01107912|449456160|FG003|Period 1|Withdrawal by Subject|0|||
124953888|NCT01107912|449456161|FG004|Period 1|Withdrawal by Subject|0|||
124953889|NCT01107912|449456162|FG005|Period 1|Withdrawal by Subject|0|||
124953890|NCT01107912|449456157|FG000|Period 2|Physician Decision|0|||
124953891|NCT01107912|449456158|FG001|Period 2|Physician Decision|0|||
124953892|NCT01107912|449456159|FG002|Period 2|Physician Decision|1|||
124953893|NCT01107912|449456160|FG003|Period 2|Physician Decision|0|||
124953894|NCT01107912|449456161|FG004|Period 2|Physician Decision|0|||
124953895|NCT01107912|449456162|FG005|Period 2|Physician Decision|0|||
124953896|NCT01107912|449456157|FG000|Period 3|Adverse Event|0|||
124953897|NCT01107912|449456158|FG001|Period 3|Adverse Event|1|||
124953898|NCT01107912|449456159|FG002|Period 3|Adverse Event|1|||
124953899|NCT01107912|449456160|FG003|Period 3|Adverse Event|0|||
124953900|NCT01107912|449456161|FG004|Period 3|Adverse Event|0|||
124953901|NCT01107912|449456162|FG005|Period 3|Adverse Event|0|||
124953902|NCT01107912|449456157|FG000|Period 3|Withdrawal by Subject|0|||
124953903|NCT01107912|449456158|FG001|Period 3|Withdrawal by Subject|0|||
124953904|NCT01107912|449456159|FG002|Period 3|Withdrawal by Subject|0|||
124953905|NCT01107912|449456160|FG003|Period 3|Withdrawal by Subject|1|||
124953906|NCT01107912|449456161|FG004|Period 3|Withdrawal by Subject|0|||
124953907|NCT01107912|449456162|FG005|Period 3|Withdrawal by Subject|0|||
124953908|NCT01601821|449456163|FG000|Overall Study|Death|2|||
124953909|NCT01601821|449456164|FG001|Overall Study|Death|5|||
124953910|NCT01601821|449456163|FG000|Overall Study|Protocol Violation|2|||
124953911|NCT01601821|449456164|FG001|Overall Study|Protocol Violation|2|||
124953912|NCT01601821|449456163|FG000|Overall Study|Lost to Follow-up|6|||
124953913|NCT01601821|449456164|FG001|Overall Study|Lost to Follow-up|14|||
124953914|NCT01601821|449456163|FG000|Overall Study|Withdrawal by Subject|1|||
124953915|NCT01601821|449456164|FG001|Overall Study|Withdrawal by Subject|0|||
124953916|NCT01601821|449456163|FG000|Overall Study|Graft Loss|6|||
124953917|NCT01601821|449456164|FG001|Overall Study|Graft Loss|6|||
124953918|NCT01601821|449456163|FG000|Overall Study|Study Events|7|||
124953919|NCT01601821|449456164|FG001|Overall Study|Study Events|1|||
124953920|NCT01601821|449456163|FG000|Overall Study|Other|5|||
124953921|NCT01601821|449456164|FG001|Overall Study|Other|1|||
124953922|NCT00442559|449456172|FG000|Overall Study|Lost to Follow-up|32|||
124953923|NCT00442559|449456173|FG001|Overall Study|Lost to Follow-up|34|||
124953924|NCT00442559|449456172|FG000|Overall Study|Protocol Violation|1|||
124953925|NCT00442559|449456173|FG001|Overall Study|Protocol Violation|1|||
124953926|NCT00442559|449456172|FG000|Overall Study|Withdrawal by Subject|1|||
124953927|NCT00442559|449456173|FG001|Overall Study|Withdrawal by Subject|0|||
124953928|NCT00753896|449456182|FG000|Overall Study|Adverse Event|4|||
124953929|NCT00753896|449456182|FG000|Overall Study|Death|1|||
124953930|NCT00753896|449456182|FG000|Overall Study|Lost to Follow-up|2|||
124953931|NCT00753896|449456182|FG000|Overall Study|Protocol Violation|1|||
124953932|NCT00753896|449456182|FG000|Overall Study|Withdrawal by Subject|4|||
124953933|NCT00753896|449456182|FG000|Overall Study|Entry Criteria Not Met|4|||
124953934|NCT02959866|449456183|FG000|Overall Study|Withdrawal by Subject|1|||
124953935|NCT00952523|449456184|FG000|Overall Study|Withdrawal by Subject|7|||
124953936|NCT00848198|449456185|FG000|Overall Study|Incomplete Case Report Forms|15|||
124953937|NCT03708744|449456186|FG000|Overall Study|Withdrawal by Subject|0|||
124953938|NCT03708744|449456187|FG001|Overall Study|Withdrawal by Subject|0|||
124953939|NCT03708744|449456188|FG002|Overall Study|Withdrawal by Subject|1|||
124953940|NCT03708744|449456189|FG003|Overall Study|Withdrawal by Subject|0|||
124953941|NCT03529942|449456190|FG000|Overall Study|Withdrawal by Subject|13|||
124953942|NCT03529942|449456190|FG000|Overall Study|Physician Decision|1|||
124953943|NCT03529942|449456190|FG000|Overall Study|Lost to Follow-up|7|||
124707673|NCT05270863|448554708|FG002|Visit 2 First Intervention|Randomization error|0|||
124707674|NCT05270863|448554709|FG003|Visit 2 First Intervention|Randomization error|1|||
124707675|NCT05270863|448554710|FG004|Visit 2 First Intervention|Randomization error|0|||
124707676|NCT05270863|448554711|FG005|Visit 2 First Intervention|Randomization error|0|||
124707677|NCT05270863|448554706|FG000|First Washout|Withdrawal by Subject|0|||
124766413|NCT01346358|448771723|FG006|Overall Study|Physician Decision|0|||
124953944|NCT03529942|449456190|FG000|Overall Study|Needle inserted but no drug administered|1|||
124953945|NCT03529942|449456190|FG000|Overall Study|Personal reasons|1|||
124953946|NCT01989156|449456191|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
124953947|NCT01989156|449456192|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
124953948|NCT01989156|449456193|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
124953949|NCT01989156|449456191|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
124953950|NCT01989156|449456192|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
124953951|NCT01989156|449456193|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
124953952|NCT01989156|449456191|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
124953953|NCT01989156|449456192|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
124460591|NCT00105443|447645960|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
124953954|NCT01989156|449456193|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
124953955|NCT01989156|449456191|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
124953956|NCT01989156|449456192|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
124953957|NCT01989156|449456193|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
124953958|NCT01989156|449456191|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
124953959|NCT01989156|449456192|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
124953960|NCT01989156|449456193|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
124953961|NCT01989156|449456191|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
124953962|NCT01989156|449456192|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
124953963|NCT01989156|449456193|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
124953964|NCT01989156|449456191|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
124953965|NCT01989156|449456192|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
124953966|NCT01989156|449456193|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
124953967|NCT01989156|449456191|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
124953968|NCT01989156|449456192|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
124953969|NCT01989156|449456193|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
124953970|NCT01721109|449456197|FG000|Overall Study|Lack of Efficacy|1|||
124953971|NCT01721109|449456197|FG000|Overall Study|Non- Compliance with Study Drug|3|||
124953972|NCT01721109|449456197|FG000|Overall Study|Withdrew Consent|1|||
124953973|NCT01721109|449456197|FG000|Overall Study|Lost to Follow-up|2|||
124953974|NCT04362176|449456198|FG000|Overall Study|Lost to Follow-up|5|||
124953975|NCT04362176|449456199|FG001|Overall Study|Lost to Follow-up|8|||
124953976|NCT04362176|449456198|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
124953977|NCT04362176|449456199|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
124953978|NCT00742560|449456200|FG000|Overall Study|Adverse Event|0|||
124953979|NCT00742560|449456201|FG001|Overall Study|Adverse Event|0|||
124953980|NCT00742560|449456202|FG002|Overall Study|Adverse Event|1|||
124953981|NCT00742560|449456203|FG003|Overall Study|Adverse Event|1|||
124953982|NCT00742560|449456204|FG004|Overall Study|Adverse Event|1|||
124953983|NCT00742560|449456200|FG000|Overall Study|Death|0|||
124953984|NCT00742560|449456201|FG001|Overall Study|Death|2|||
124953985|NCT00742560|449456202|FG002|Overall Study|Death|0|||
124953986|NCT00742560|449456203|FG003|Overall Study|Death|2|||
124953987|NCT00742560|449456204|FG004|Overall Study|Death|3|||
124953988|NCT00742560|449456200|FG000|Overall Study|Subject's Decision|1|||
124953989|NCT00742560|449456201|FG001|Overall Study|Subject's Decision|0|||
124953990|NCT00742560|449456202|FG002|Overall Study|Subject's Decision|2|||
124953991|NCT00742560|449456203|FG003|Overall Study|Subject's Decision|3|||
124953992|NCT00742560|449456204|FG004|Overall Study|Subject's Decision|3|||
124953993|NCT00742560|449456200|FG000|Overall Study|Investigator's Decision|0|||
124953994|NCT00742560|449456201|FG001|Overall Study|Investigator's Decision|0|||
124953995|NCT00742560|449456202|FG002|Overall Study|Investigator's Decision|4|||
124953996|NCT00742560|449456203|FG003|Overall Study|Investigator's Decision|1|||
124953997|NCT00742560|449456204|FG004|Overall Study|Investigator's Decision|0|||
124953998|NCT00742560|449456200|FG000|Overall Study|Disease Progression|1|||
124953999|NCT00742560|449456201|FG001|Overall Study|Disease Progression|0|||
124954000|NCT00742560|449456202|FG002|Overall Study|Disease Progression|5|||
124954001|NCT00742560|449456203|FG003|Overall Study|Disease Progression|17|||
124954002|NCT00742560|449456204|FG004|Overall Study|Disease Progression|16|||
124954003|NCT00742560|449456200|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
124954004|NCT00742560|449456201|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
124954005|NCT00742560|449456202|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
124954006|NCT00742560|449456203|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
124954007|NCT00742560|449456204|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
124954008|NCT00742560|449456200|FG000|Overall Study|Other|0|||
124954009|NCT00742560|449456201|FG001|Overall Study|Other|1|||
124954010|NCT00742560|449456202|FG002|Overall Study|Other|8|||
124954011|NCT00742560|449456203|FG003|Overall Study|Other|9|||
124954012|NCT00742560|449456204|FG004|Overall Study|Other|9|||
124954013|NCT00742560|449456200|FG000|Overall Study|MIssing|0|||
124954014|NCT00742560|449456201|FG001|Overall Study|MIssing|0|||
124954015|NCT00742560|449456202|FG002|Overall Study|MIssing|0|||
124954016|NCT00742560|449456203|FG003|Overall Study|MIssing|0|||
124954017|NCT00742560|449456204|FG004|Overall Study|MIssing|1|||
124460592|NCT00105443|447645957|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
124954018|NCT01426217|449456206|FG000|Overall Study|lost sample|8|||
124954019|NCT01426217|449456207|FG001|Overall Study|lost sample|14|||
124548999|NCT01125358|447965420|FG002|Overall Study|Sponsor Decision|1|||
124954020|NCT01536795|449456208|FG000|Overall Study|Lost to Follow-up|0|||
124954021|NCT01536795|449456209|FG001|Overall Study|Lost to Follow-up|2|||
124954022|NCT01536795|449456208|FG000|Overall Study|Lack of Efficacy|1|||
124954023|NCT01536795|449456209|FG001|Overall Study|Lack of Efficacy|0|||
124954024|NCT01812837|449456210|FG000|Overall Study|Lost to Follow-up|1|||
124954025|NCT01812837|449456211|FG001|Overall Study|Lost to Follow-up|1|||
124954026|NCT01812837|449456212|FG002|Overall Study|Lost to Follow-up|0|||
124549000|NCT01125358|447965421|FG003|Overall Study|Sponsor Decision|1|||
124549001|NCT01125358|447965418|FG000|Overall Study|Withdrawal by Subject|2|||
124766414|NCT01346358|448771724|FG007|Overall Study|Physician Decision|1|||
124954027|NCT01812837|449456210|FG000|Overall Study|Protocol Violation|1|||
124954028|NCT01812837|449456211|FG001|Overall Study|Protocol Violation|0|||
124954029|NCT01812837|449456212|FG002|Overall Study|Protocol Violation|0|||
124954030|NCT05008224|449456214|FG000|Overall Study|Death|3|||
124954031|NCT05008224|449456214|FG000|Overall Study|Lost to Follow-up|2|||
124954032|NCT05008224|449456214|FG000|Overall Study|Did Not Continue on Extension Study|39|||
124954033|NCT05008224|449456214|FG000|Overall Study|Transferred to Extension Study|100|||
124954034|NCT05008224|449456214|FG000|Overall Study|Withdrawal by Subject|2|||
124954035|NCT05234632|449456215|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
124954036|NCT05234632|449456216|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
124954037|NCT05234632|449456215|FG000|Overall Study|Withdrawal by Subject|2|||
124954038|NCT05234632|449456216|FG001|Overall Study|Withdrawal by Subject|0|||
124954039|NCT05234632|449456215|FG000|Overall Study|Adverse Event|0|||
124954040|NCT05234632|449456216|FG001|Overall Study|Adverse Event|4|||
124954041|NCT05234632|449456215|FG000|Overall Study|Physician Decision|1|||
124954042|NCT05234632|449456216|FG001|Overall Study|Physician Decision|1|||
124954043|NCT05234632|449456215|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
124954044|NCT05234632|449456216|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
124954045|NCT05234632|449456215|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
124954046|NCT05234632|449456216|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
124954047|NCT00658632|449456217|FG000|Overall Study|Adverse Event|13|||
124954048|NCT00658632|449456218|FG001|Overall Study|Adverse Event|11|||
124954049|NCT00658632|449456217|FG000|Overall Study|Lost to Follow-up|25|||
124954050|NCT00658632|449456218|FG001|Overall Study|Lost to Follow-up|23|||
124954051|NCT00658632|449456217|FG000|Overall Study|Withdrawal by Subject|10|||
124954052|NCT00658632|449456218|FG001|Overall Study|Withdrawal by Subject|7|||
124954053|NCT00658632|449456217|FG000|Overall Study|Lack of Efficacy|0|||
124954054|NCT00658632|449456218|FG001|Overall Study|Lack of Efficacy|1|||
124954055|NCT00658632|449456217|FG000|Overall Study|Withdrawal of consent|8|||
124954056|NCT00658632|449456218|FG001|Overall Study|Withdrawal of consent|14|||
124954057|NCT00658632|449456217|FG000|Overall Study|Pregnancy|1|||
124954058|NCT00658632|449456218|FG001|Overall Study|Pregnancy|1|||
124954059|NCT00658632|449456217|FG000|Overall Study|Other|7|||
124954060|NCT00658632|449456218|FG001|Overall Study|Other|8|||
124954061|NCT02991456|449456220|FG000|Overall Study|Adverse Event|2|||
124954062|NCT02991456|449456221|FG001|Overall Study|Adverse Event|0|||
124954063|NCT02991456|449456220|FG000|Overall Study|Lost to Follow-up|0|||
124954064|NCT02991456|449456221|FG001|Overall Study|Lost to Follow-up|2|||
124954065|NCT02991456|449456220|FG000|Overall Study|Withdrawal by Subject|1|||
124954066|NCT02991456|449456221|FG001|Overall Study|Withdrawal by Subject|0|||
124954067|NCT01699178|449456222|FG000|Overall Study|Adverse Event|1|||
124954068|NCT01699178|449456223|FG001|Overall Study|Adverse Event|5|||
124954069|NCT01699178|449456222|FG000|Overall Study|Lost to Follow-up|1|||
124954070|NCT01699178|449456223|FG001|Overall Study|Lost to Follow-up|6|||
124954071|NCT01699178|449456222|FG000|Overall Study|Non-compliance with Study Drug|3|||
124954072|NCT01699178|449456223|FG001|Overall Study|Non-compliance with Study Drug|1|||
124954073|NCT01699178|449456222|FG000|Overall Study|Physician Decision|1|||
124954074|NCT01699178|449456223|FG001|Overall Study|Physician Decision|0|||
124954075|NCT01699178|449456222|FG000|Overall Study|Withdrawal by Subject|4|||
124954076|NCT01699178|449456223|FG001|Overall Study|Withdrawal by Subject|12|||
124954077|NCT01699178|449456222|FG000|Overall Study|Hematocrit >54%|1|||
124954078|NCT01699178|449456223|FG001|Overall Study|Hematocrit >54%|1|||
124954079|NCT01699178|449456222|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
124954080|NCT01699178|449456223|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
124954081|NCT01699178|449456222|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
124954082|NCT01699178|449456223|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
124954083|NCT00738400|449456226|FG000|Overall Study|Adverse Event|3|||
124954084|NCT00738400|449456227|FG001|Overall Study|Adverse Event|1|||
124954085|NCT00738400|449456226|FG000|Overall Study|Withdrawal by Subject|0|||
124954086|NCT00738400|449456227|FG001|Overall Study|Withdrawal by Subject|1|||
124954087|NCT00738400|449456226|FG000|Overall Study|Lack of Efficacy|0|||
124954088|NCT00738400|449456227|FG001|Overall Study|Lack of Efficacy|1|||
124954089|NCT00738400|449456226|FG000|Overall Study|Lost to Follow-up|0|||
124954090|NCT00738400|449456227|FG001|Overall Study|Lost to Follow-up|3|||
124954091|NCT00738400|449456226|FG000|Overall Study|Protocol Violation|1|||
124954092|NCT00738400|449456227|FG001|Overall Study|Protocol Violation|0|||
124954093|NCT00738400|449456226|FG000|Overall Study|Non-compliant with study medication|0|||
124954094|NCT00738400|449456227|FG001|Overall Study|Non-compliant with study medication|1|||
124954095|NCT02312245|449456228|FG000|Overall Study|Death|0|||
124954096|NCT02312245|449456229|FG001|Overall Study|Death|0|||
124954097|NCT02312245|449456230|FG002|Overall Study|Death|0|||
124954098|NCT02312245|449456231|FG003|Overall Study|Death|1|||
124954099|NCT02312245|449456228|FG000|Overall Study|Withdrawal by Subject|1|||
124954100|NCT02312245|449456229|FG001|Overall Study|Withdrawal by Subject|1|||
124954101|NCT02312245|449456230|FG002|Overall Study|Withdrawal by Subject|0|||
124954102|NCT02312245|449456231|FG003|Overall Study|Withdrawal by Subject|2|||
124954103|NCT02312245|449456228|FG000|Overall Study|Alternative Therapy|1|||
124460593|NCT00105443|447645958|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
124460594|NCT00105443|447645959|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
124460595|NCT00105443|447645960|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
124460596|NCT00105443|447645957|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
124460597|NCT00105443|447645958|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
124460598|NCT00105443|447645959|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
124954104|NCT02312245|449456229|FG001|Overall Study|Alternative Therapy|0|||
124954105|NCT02312245|449456230|FG002|Overall Study|Alternative Therapy|0|||
124954106|NCT02312245|449456231|FG003|Overall Study|Alternative Therapy|0|||
124954107|NCT02312245|449456228|FG000|Overall Study|Progression|0|||
124954108|NCT02312245|449456229|FG001|Overall Study|Progression|0|||
124954109|NCT02312245|449456230|FG002|Overall Study|Progression|0|||
124954110|NCT02312245|449456231|FG003|Overall Study|Progression|5|||
124954111|NCT02312245|449456228|FG000|Overall Study|Patient went to hospice|0|||
124954112|NCT02312245|449456229|FG001|Overall Study|Patient went to hospice|0|||
124954113|NCT02312245|449456230|FG002|Overall Study|Patient went to hospice|0|||
124954114|NCT02312245|449456231|FG003|Overall Study|Patient went to hospice|1|||
124954115|NCT02312245|449456228|FG000|Overall Study|Ineligible|1|||
124954116|NCT02312245|449456229|FG001|Overall Study|Ineligible|0|||
124954117|NCT02312245|449456230|FG002|Overall Study|Ineligible|0|||
124954118|NCT02312245|449456231|FG003|Overall Study|Ineligible|0|||
124954119|NCT00508144|449456232|FG000|Overall Study|Not eligible|6|||
124954120|NCT00508144|449456232|FG000|Overall Study|Death|5|||
124954121|NCT03122548|449456237|FG000|Overall Study|Death|2|||
124954122|NCT03122548|449456237|FG000|Overall Study|Progression - subject went into hospice|1|||
124954123|NCT03122548|449456237|FG000|Overall Study|Study Terminated by Sponsor|2|||
124954124|NCT02332889|449456240|FG000|Overall Study|Physician Decision|1|||
124954125|NCT04448561|449456242|FG000|Overall Study|Noncompliance|1|||
124954126|NCT04448561|449456243|FG001|Overall Study|Noncompliance|0|||
124954127|NCT05356130|449457628|FG000|Overall Study|Withdrawal by Subject|0|||
124954128|NCT05356130|449457629|FG001|Overall Study|Withdrawal by Subject|0|||
124954129|NCT05356130|449457630|FG002|Overall Study|Withdrawal by Subject|3|||
124954130|NCT03141177|449457631|FG000|Overall Study|Death|62|||
124954131|NCT03141177|449457632|FG001|Overall Study|Death|13|||
124954132|NCT03141177|449457633|FG002|Overall Study|Death|84|||
124954133|NCT03141177|449457631|FG000|Overall Study|Participant withdrew consent|9|||
124954134|NCT03141177|449457632|FG001|Overall Study|Participant withdrew consent|2|||
124954135|NCT03141177|449457633|FG002|Overall Study|Participant withdrew consent|13|||
124954136|NCT03141177|449457631|FG000|Overall Study|Not reported|1|||
124954137|NCT03141177|449457632|FG001|Overall Study|Not reported|0|||
124954138|NCT03141177|449457633|FG002|Overall Study|Not reported|1|||
124954139|NCT03141177|449457631|FG000|Overall Study|Lost to Follow-up|2|||
124954140|NCT03141177|449457632|FG001|Overall Study|Lost to Follow-up|1|||
124954141|NCT03141177|449457633|FG002|Overall Study|Lost to Follow-up|1|||
124954142|NCT03141177|449457631|FG000|Overall Study|Other reasons|4|||
124954143|NCT03141177|449457632|FG001|Overall Study|Other reasons|0|||
124954144|NCT03141177|449457633|FG002|Overall Study|Other reasons|11|||
124954145|NCT03141177|449457631|FG000|Overall Study|Participants did not start treatment period|3|||
124954146|NCT03141177|449457632|FG001|Overall Study|Participants did not start treatment period|0|||
124954147|NCT03141177|449457633|FG002|Overall Study|Participants did not start treatment period|8|||
124954148|NCT03696342|449457642|FG000|Overall Study|Lost to Follow-up|1|||
124954149|NCT03696342|449457643|FG001|Overall Study|Lost to Follow-up|0|||
124954150|NCT05361304|449457646|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
124954151|NCT05361304|449457647|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
124954152|NCT05361304|449457646|FG000|Overall Study|COVID-19 Related|1|||
124954153|NCT05361304|449457647|FG001|Overall Study|COVID-19 Related|2|||
124954154|NCT05361304|449457646|FG000|Overall Study|Withdrawal by Subject|1|||
124954155|NCT05361304|449457647|FG001|Overall Study|Withdrawal by Subject|0|||
124954156|NCT02409732|449457648|FG000|Overall Study|Withdrawal by Subject|4|||
124954157|NCT02409732|449457648|FG000|Overall Study|Lost to Follow-up|2|||
124954158|NCT00376259|449457651|FG000|Overall Study|Sponsor request - study termination|21|||
124954159|NCT00376259|449457652|FG001|Overall Study|Sponsor request - study termination|21|||
124460599|NCT00105443|447645960|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
124460600|NCT00105443|447645957|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
124460601|NCT00105443|447645958|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
124460602|NCT00105443|447645959|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
124549002|NCT01125358|447965419|FG001|Overall Study|Withdrawal by Subject|1|||
124766415|NCT01346358|448771725|FG008|Overall Study|Physician Decision|1|||
124954160|NCT00376259|449457651|FG000|Overall Study|Patient request|1|||
124954161|NCT00376259|449457652|FG001|Overall Study|Patient request|0|||
124954162|NCT01877720|449457654|FG000|Overall Study|Adverse Event|1|||
124954163|NCT01877720|449457655|FG001|Overall Study|Adverse Event|0|||
124954164|NCT00447499|449457656|FG000|Overall Study|Adverse Event|1|||
124954165|NCT00447499|449457656|FG000|Overall Study|Patient Decision|4|||
124954166|NCT00447499|449457656|FG000|Overall Study|Sponsor Decision|1|||
124954167|NCT00447499|449457656|FG000|Overall Study|Physician Decision|1|||
124954168|NCT02068352|449457657|FG000|Overall Study|Lost to Follow-up|0|||
124954169|NCT02068352|449457658|FG001|Overall Study|Lost to Follow-up|2|||
124954170|NCT02068352|449457659|FG002|Overall Study|Lost to Follow-up|0|||
124954171|NCT02068352|449457657|FG000|Overall Study|Adverse Event|4|||
124954172|NCT02068352|449457658|FG001|Overall Study|Adverse Event|2|||
124954173|NCT02068352|449457659|FG002|Overall Study|Adverse Event|7|||
124954174|NCT02068352|449457657|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
124954175|NCT02068352|449457658|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
124954176|NCT02068352|449457659|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
124954177|NCT02068352|449457657|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
124954178|NCT02068352|449457658|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
124954179|NCT02068352|449457659|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
124954180|NCT02068352|449457657|FG000|Overall Study|Protocol Deviation|0|||
124954181|NCT02068352|449457658|FG001|Overall Study|Protocol Deviation|0|||
124954182|NCT02068352|449457659|FG002|Overall Study|Protocol Deviation|1|||
124954183|NCT03960437|449457661|FG000|Overall Study|Removed by PI|4|||
124954184|NCT03960437|449457661|FG000|Overall Study|Lost to Follow-up|2|||
124954185|NCT03960437|449457661|FG000|Overall Study|Withdrawal by Subject|1|||
124954186|NCT03960437|449457661|FG000|Overall Study|Death|2|||
124954187|NCT00473512|449457664|FG000|Period 1 (Phase 1)|Adverse Event|0|||
124954188|NCT00473512|449457665|FG001|Period 1 (Phase 1)|Adverse Event|0|||
124954189|NCT00473512|449457666|FG002|Period 1 (Phase 1)|Adverse Event|0|||
124954190|NCT00473512|449457667|FG003|Period 1 (Phase 1)|Adverse Event|5|||
124954191|NCT00473512|449457668|FG004|Period 1 (Phase 1)|Adverse Event|0|||
124954192|NCT00473512|449457664|FG000|Period 1 (Phase 1)|Death|0|||
124954193|NCT00473512|449457665|FG001|Period 1 (Phase 1)|Death|0|||
124954194|NCT00473512|449457666|FG002|Period 1 (Phase 1)|Death|0|||
124954195|NCT00473512|449457667|FG003|Period 1 (Phase 1)|Death|1|||
124954196|NCT00473512|449457668|FG004|Period 1 (Phase 1)|Death|0|||
124954197|NCT00473512|449457664|FG000|Period 1 (Phase 1)|Disease Progression|1|||
124954198|NCT00473512|449457665|FG001|Period 1 (Phase 1)|Disease Progression|1|||
124954199|NCT00473512|449457666|FG002|Period 1 (Phase 1)|Disease Progression|0|||
124954200|NCT00473512|449457667|FG003|Period 1 (Phase 1)|Disease Progression|10|||
124954201|NCT00473512|449457668|FG004|Period 1 (Phase 1)|Disease Progression|1|||
124954202|NCT00473512|449457664|FG000|Period 1 (Phase 1)|Other|0|||
124954203|NCT00473512|449457665|FG001|Period 1 (Phase 1)|Other|0|||
124954204|NCT00473512|449457666|FG002|Period 1 (Phase 1)|Other|0|||
124954205|NCT00473512|449457667|FG003|Period 1 (Phase 1)|Other|1|||
124954206|NCT00473512|449457668|FG004|Period 1 (Phase 1)|Other|0|||
124954207|NCT00473512|449457664|FG000|Period 2 (Phase 2)|Adverse Event|0|||
124954208|NCT00473512|449457665|FG001|Period 2 (Phase 2)|Adverse Event|0|||
124954209|NCT00473512|449457666|FG002|Period 2 (Phase 2)|Adverse Event|0|||
124954210|NCT00473512|449457667|FG003|Period 2 (Phase 2)|Adverse Event|1|||
124954211|NCT00473512|449457668|FG004|Period 2 (Phase 2)|Adverse Event|0|||
124954212|NCT00473512|449457664|FG000|Period 2 (Phase 2)|Death|0|||
124954213|NCT00473512|449457665|FG001|Period 2 (Phase 2)|Death|0|||
124954214|NCT00473512|449457666|FG002|Period 2 (Phase 2)|Death|0|||
124954215|NCT00473512|449457667|FG003|Period 2 (Phase 2)|Death|1|||
124954216|NCT00473512|449457668|FG004|Period 2 (Phase 2)|Death|1|||
124707678|NCT05270863|448554707|FG001|First Washout|Withdrawal by Subject|0|||
124707679|NCT05270863|448554708|FG002|First Washout|Withdrawal by Subject|0|||
124707680|NCT05270863|448554709|FG003|First Washout|Withdrawal by Subject|0|||
124707681|NCT05270863|448554710|FG004|First Washout|Withdrawal by Subject|1|||
124954217|NCT00473512|449457664|FG000|Period 2 (Phase 2)|Disease Progression|0|||
124954218|NCT00473512|449457665|FG001|Period 2 (Phase 2)|Disease Progression|2|||
124954219|NCT00473512|449457666|FG002|Period 2 (Phase 2)|Disease Progression|2|||
124954220|NCT00473512|449457667|FG003|Period 2 (Phase 2)|Disease Progression|17|||
124954221|NCT00473512|449457668|FG004|Period 2 (Phase 2)|Disease Progression|1|||
124954222|NCT00473512|449457664|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
124954223|NCT00473512|449457665|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
124954224|NCT00473512|449457666|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
124954225|NCT00473512|449457667|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
124954226|NCT00473512|449457668|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
124954227|NCT00473512|449457664|FG000|Period 2 (Phase 2)|Other|1|||
124954228|NCT00473512|449457665|FG001|Period 2 (Phase 2)|Other|0|||
124954229|NCT00473512|449457666|FG002|Period 2 (Phase 2)|Other|0|||
124954230|NCT00473512|449457667|FG003|Period 2 (Phase 2)|Other|3|||
124954231|NCT00473512|449457668|FG004|Period 2 (Phase 2)|Other|0|||
124954232|NCT00267956|449457669|FG000|Controlled Period|Adverse Event|4|||
124954233|NCT00267956|449457670|FG001|Controlled Period|Adverse Event|1|||
124954234|NCT00267956|449457671|FG002|Controlled Period|Adverse Event|0|||
124954235|NCT00267956|449457672|FG003|Controlled Period|Adverse Event|0|||
124954236|NCT00267956|449457669|FG000|Controlled Period|Lack of Efficacy|4|||
124954237|NCT00267956|449457670|FG001|Controlled Period|Lack of Efficacy|2|||
124954238|NCT00267956|449457671|FG002|Controlled Period|Lack of Efficacy|0|||
124954239|NCT00267956|449457672|FG003|Controlled Period|Lack of Efficacy|0|||
124954240|NCT00267956|449457669|FG000|Controlled Period|Lost to Follow-up|2|||
124954241|NCT00267956|449457670|FG001|Controlled Period|Lost to Follow-up|0|||
124954242|NCT00267956|449457671|FG002|Controlled Period|Lost to Follow-up|0|||
124954243|NCT00267956|449457672|FG003|Controlled Period|Lost to Follow-up|0|||
124954244|NCT00267956|449457669|FG000|Controlled Period|Withdrew consent|3|||
124954245|NCT00267956|449457670|FG001|Controlled Period|Withdrew consent|1|||
124954246|NCT00267956|449457671|FG002|Controlled Period|Withdrew consent|0|||
124954247|NCT00267956|449457672|FG003|Controlled Period|Withdrew consent|0|||
124954248|NCT00267956|449457669|FG000|After Controlled Period|Adverse Event|0|||
124954249|NCT00267956|449457670|FG001|After Controlled Period|Adverse Event|0|||
124954250|NCT00267956|449457671|FG002|After Controlled Period|Adverse Event|2|||
124954251|NCT00267956|449457672|FG003|After Controlled Period|Adverse Event|1|||
124954252|NCT00267956|449457669|FG000|After Controlled Period|Lack of Efficacy|0|||
124954253|NCT00267956|449457670|FG001|After Controlled Period|Lack of Efficacy|0|||
124954254|NCT00267956|449457671|FG002|After Controlled Period|Lack of Efficacy|1|||
124954255|NCT00267956|449457672|FG003|After Controlled Period|Lack of Efficacy|1|||
124954256|NCT00267956|449457669|FG000|After Controlled Period|Lost to Follow-up|0|||
124954257|NCT00267956|449457670|FG001|After Controlled Period|Lost to Follow-up|0|||
124954258|NCT00267956|449457671|FG002|After Controlled Period|Lost to Follow-up|1|||
124954259|NCT00267956|449457672|FG003|After Controlled Period|Lost to Follow-up|0|||
124954260|NCT00267956|449457669|FG000|After Controlled Period|Withdrew consent|0|||
124954261|NCT00267956|449457670|FG001|After Controlled Period|Withdrew consent|0|||
124954262|NCT00267956|449457671|FG002|After Controlled Period|Withdrew consent|1|||
124954263|NCT00267956|449457672|FG003|After Controlled Period|Withdrew consent|0|||
124954264|NCT01263223|449457673|FG000|Period 2|Withdrawal by Subject|0|||
124954265|NCT01263223|449457674|FG001|Period 2|Withdrawal by Subject|1|||
124954266|NCT01263223|449457673|FG000|7-day Follow-up|Withdrawal by Subject|0|||
124954267|NCT01263223|449457674|FG001|7-day Follow-up|Withdrawal by Subject|1|||
124954268|NCT01263223|449457673|FG000|7-day Follow-up|Lost to Follow-up|1|||
124954269|NCT01263223|449457674|FG001|7-day Follow-up|Lost to Follow-up|0|||
124954270|NCT02246647|449457675|FG000|Overall Study|Withdrawal by Subject|1|||
124954271|NCT02246647|449457676|FG001|Overall Study|Withdrawal by Subject|1|||
124954272|NCT01012999|449457678|FG000|Overall Study|Protocol Violation|1|||
124954273|NCT03557307|449457679|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
124954274|NCT03557307|449457679|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
124954275|NCT03557307|449457679|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
124954276|NCT03557307|449457679|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
124954277|NCT03557307|449457679|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
124954278|NCT03557307|449457679|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
124954279|NCT03557307|449457679|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
124954280|NCT03557307|449457679|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
124954281|NCT03557307|449457679|FG000|Period 2: Maintenance Phase|Death|3|||
124954282|NCT03557307|449457679|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
124954283|NCT03557307|449457679|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
124954284|NCT03557307|449457679|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
124954285|NCT03557307|449457679|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
124954286|NCT03557307|449457679|FG000|Period 2: Maintenance Phase|other|3|||
124954287|NCT04175834|449457680|FG000|Overall Study|Withdrawal by Subject|1|||
124954288|NCT04175834|449457681|FG001|Overall Study|Withdrawal by Subject|0|||
124954289|NCT03184519|449457682|FG000|Overall Study|Lost to Follow-up|6|||
124954290|NCT03184519|449457682|FG000|Overall Study|Physician Decision|21|||
124954291|NCT04239911|449457683|FG000|Overall Study|Lost to Follow-up|2|||
124954292|NCT04239911|449457684|FG001|Overall Study|Lost to Follow-up|1|||
124954293|NCT00584909|449457690|FG000|Overall Study|Adverse Event|4|||
124954294|NCT03345407|449457691|FG000|Overall Study|Withdrawal by Subject|11|||
124954295|NCT03345407|449457692|FG001|Overall Study|Withdrawal by Subject|1|||
124954296|NCT03345407|449457693|FG002|Overall Study|Withdrawal by Subject|5|||
124954297|NCT03345407|449457694|FG003|Overall Study|Withdrawal by Subject|6|||
124954298|NCT03345407|449457695|FG004|Overall Study|Withdrawal by Subject|3|||
124766416|NCT05058365|448771728|FG000|Overall Study|Migration|1|||
124766417|NCT05058365|448771729|FG001|Overall Study|Migration|1|||
124766418|NCT04038359|448771730|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
124766419|NCT04038359|448771731|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
124766420|NCT04038359|448771730|FG000|Overall Study|Death|8|||
124766421|NCT04038359|448771731|FG001|Overall Study|Death|7|||
124766422|NCT04038359|448771730|FG000|Overall Study|Lost to Follow-up|3|||
124766423|NCT04038359|448771731|FG001|Overall Study|Lost to Follow-up|0|||
124766424|NCT04038359|448771730|FG000|Overall Study|Participant Moved|1|||
124766425|NCT04038359|448771731|FG001|Overall Study|Participant Moved|0|||
124766426|NCT04038359|448771730|FG000|Overall Study|Withdrawal by Subject|4|||
124766427|NCT04038359|448771731|FG001|Overall Study|Withdrawal by Subject|3|||
124766428|NCT04038359|448771730|FG000|Overall Study|Physician Decision|3|||
124766429|NCT04038359|448771731|FG001|Overall Study|Physician Decision|2|||
124766430|NCT04038359|448771730|FG000|Overall Study|Adverse Event|0|||
124766431|NCT04038359|448771731|FG001|Overall Study|Adverse Event|2|||
124766432|NCT04038359|448771730|FG000|Overall Study|Progressive Disease|0|||
124766433|NCT04038359|448771731|FG001|Overall Study|Progressive Disease|1|||
124766434|NCT00703014|448771732|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
124766435|NCT00703014|448771733|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
124766436|NCT00703014|448771734|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
124766437|NCT00703014|448771735|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
124766438|NCT00703014|448771732|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
124954299|NCT03345407|449457696|FG005|Overall Study|Withdrawal by Subject|6|||
124954300|NCT03345407|449457697|FG006|Overall Study|Withdrawal by Subject|16|||
124954301|NCT03345407|449457691|FG000|Overall Study|Physician Decision|3|||
124954302|NCT03345407|449457692|FG001|Overall Study|Physician Decision|1|||
124954303|NCT03345407|449457693|FG002|Overall Study|Physician Decision|0|||
124954304|NCT03345407|449457694|FG003|Overall Study|Physician Decision|0|||
124954305|NCT03345407|449457695|FG004|Overall Study|Physician Decision|1|||
124954306|NCT03345407|449457696|FG005|Overall Study|Physician Decision|2|||
124954307|NCT03345407|449457697|FG006|Overall Study|Physician Decision|3|||
124954308|NCT03345407|449457691|FG000|Overall Study|Lost to Follow-up|2|||
124954309|NCT03345407|449457692|FG001|Overall Study|Lost to Follow-up|0|||
124954310|NCT03345407|449457693|FG002|Overall Study|Lost to Follow-up|1|||
124954311|NCT03345407|449457694|FG003|Overall Study|Lost to Follow-up|0|||
124954312|NCT03345407|449457695|FG004|Overall Study|Lost to Follow-up|1|||
124954313|NCT03345407|449457696|FG005|Overall Study|Lost to Follow-up|2|||
124954314|NCT03345407|449457697|FG006|Overall Study|Lost to Follow-up|3|||
124954315|NCT03345407|449457691|FG000|Overall Study|Protocol-defined stopping criteria|9|||
124954316|NCT03345407|449457692|FG001|Overall Study|Protocol-defined stopping criteria|0|||
124954317|NCT03345407|449457693|FG002|Overall Study|Protocol-defined stopping criteria|0|||
124954318|NCT03345407|449457694|FG003|Overall Study|Protocol-defined stopping criteria|0|||
124954319|NCT03345407|449457695|FG004|Overall Study|Protocol-defined stopping criteria|2|||
124954320|NCT03345407|449457696|FG005|Overall Study|Protocol-defined stopping criteria|1|||
124954321|NCT03345407|449457697|FG006|Overall Study|Protocol-defined stopping criteria|1|||
124954322|NCT03345407|449457691|FG000|Overall Study|Protocol Violation|2|||
124954323|NCT03345407|449457692|FG001|Overall Study|Protocol Violation|0|||
124954324|NCT03345407|449457693|FG002|Overall Study|Protocol Violation|0|||
124954325|NCT03345407|449457694|FG003|Overall Study|Protocol Violation|0|||
124954326|NCT03345407|449457695|FG004|Overall Study|Protocol Violation|1|||
124954327|NCT03345407|449457696|FG005|Overall Study|Protocol Violation|0|||
124954328|NCT03345407|449457697|FG006|Overall Study|Protocol Violation|3|||
124954329|NCT03345407|449457691|FG000|Overall Study|Lack of Efficacy|1|||
124954330|NCT03345407|449457692|FG001|Overall Study|Lack of Efficacy|1|||
124954331|NCT03345407|449457693|FG002|Overall Study|Lack of Efficacy|1|||
124954332|NCT03345407|449457694|FG003|Overall Study|Lack of Efficacy|1|||
124954333|NCT03345407|449457695|FG004|Overall Study|Lack of Efficacy|1|||
124954334|NCT03345407|449457696|FG005|Overall Study|Lack of Efficacy|0|||
124954335|NCT03345407|449457697|FG006|Overall Study|Lack of Efficacy|3|||
124954336|NCT03345407|449457691|FG000|Overall Study|Adverse Event|4|||
124954337|NCT03345407|449457692|FG001|Overall Study|Adverse Event|0|||
124954338|NCT03345407|449457693|FG002|Overall Study|Adverse Event|5|||
124954339|NCT03345407|449457694|FG003|Overall Study|Adverse Event|4|||
124954340|NCT03345407|449457695|FG004|Overall Study|Adverse Event|6|||
124954341|NCT03345407|449457696|FG005|Overall Study|Adverse Event|5|||
124954342|NCT03345407|449457697|FG006|Overall Study|Adverse Event|16|||
124954343|NCT02256553|449457700|FG000|Period I|Adverse Event|5|||
124954344|NCT02256553|449457700|FG000|Period I|Protocol Violation|1|||
124954345|NCT02256553|449457700|FG000|Period II|Adverse Event|1|||
124954346|NCT02256553|449457700|FG000|Period II|Subject Moved|1|||
124766439|NCT00703014|448771733|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
124766440|NCT00703014|448771734|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
124766441|NCT00703014|448771735|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
124954347|NCT02256553|449457700|FG000|Period III|Adverse Event|3|||
124954348|NCT02092909|449457701|FG000|Overall Study|Adverse Event|0|||
124954349|NCT02092909|449457702|FG001|Overall Study|Adverse Event|0|||
124954350|NCT02092909|449457703|FG002|Overall Study|Adverse Event|4|||
124954351|NCT02092909|449457704|FG003|Overall Study|Adverse Event|2|||
124954352|NCT02092909|449457701|FG000|Overall Study|Lack of Efficacy|0|||
124954353|NCT02092909|449457702|FG001|Overall Study|Lack of Efficacy|2|||
124954354|NCT02092909|449457703|FG002|Overall Study|Lack of Efficacy|1|||
124954355|NCT02092909|449457704|FG003|Overall Study|Lack of Efficacy|0|||
124954356|NCT02092909|449457701|FG000|Overall Study|Withdrawal by Subject|0|||
124954357|NCT02092909|449457702|FG001|Overall Study|Withdrawal by Subject|0|||
124954358|NCT02092909|449457703|FG002|Overall Study|Withdrawal by Subject|2|||
124954359|NCT02092909|449457704|FG003|Overall Study|Withdrawal by Subject|1|||
124954360|NCT02092909|449457701|FG000|Overall Study|Study terminated by Sponsor|0|||
124954361|NCT02092909|449457702|FG001|Overall Study|Study terminated by Sponsor|0|||
124954362|NCT02092909|449457703|FG002|Overall Study|Study terminated by Sponsor|0|||
124954363|NCT02092909|449457704|FG003|Overall Study|Study terminated by Sponsor|2|||
124954364|NCT02092909|449457701|FG000|Overall Study|Miscellaneous|1|||
124954365|NCT02092909|449457702|FG001|Overall Study|Miscellaneous|1|||
124954366|NCT02092909|449457703|FG002|Overall Study|Miscellaneous|2|||
124954367|NCT02092909|449457704|FG003|Overall Study|Miscellaneous|1|||
124954368|NCT03436797|449457705|FG000|Main Study|Withdrawal by Subject|2|||
124954369|NCT03436797|449457705|FG000|Main Study|Adverse Event|4|||
124954370|NCT03436797|449457705|FG000|Main Study|Lost to Follow-up|1|||
124954371|NCT03436797|449457705|FG000|Main Study|Death|1|||
124954372|NCT03436797|449457705|FG000|Main Study|Non-Specific|2|||
124954373|NCT03436797|449457705|FG000|Extended Dosing|Patient decision|1|||
124954374|NCT04626128|449457708|FG000|Overall Study|Withdrawal by Subject|0|||
124954375|NCT04626128|449457709|FG001|Overall Study|Withdrawal by Subject|1|||
124954376|NCT04626128|449457710|FG002|Overall Study|Withdrawal by Subject|0|||
124954377|NCT04626128|449457711|FG003|Overall Study|Withdrawal by Subject|0|||
124954378|NCT01182285|449457712|FG000|First Intervention Week 1-10|Disease progression|1|||
124954379|NCT01182285|449457713|FG001|First Intervention Week 1-10|Disease progression|0|||
124954380|NCT01182285|449457714|FG002|First Intervention Week 1-10|Disease progression|0|||
124954381|NCT01182285|449457712|FG000|First Intervention Week 1-10|Adverse Event|1|||
124954382|NCT01182285|449457713|FG001|First Intervention Week 1-10|Adverse Event|0|||
124954383|NCT01182285|449457714|FG002|First Intervention Week 1-10|Adverse Event|0|||
124954384|NCT01182285|449457712|FG000|First Intervention Week 1-10|Non-compliance|1|||
124954385|NCT01182285|449457713|FG001|First Intervention Week 1-10|Non-compliance|0|||
124954386|NCT01182285|449457714|FG002|First Intervention Week 1-10|Non-compliance|0|||
124954387|NCT01182285|449457712|FG000|Third Intervention Week 11-52|Disease Progression|0|||
124954388|NCT01182285|449457713|FG001|Third Intervention Week 11-52|Disease Progression|0|||
124954389|NCT01182285|449457714|FG002|Third Intervention Week 11-52|Disease Progression|6|||
124954390|NCT01182285|449457712|FG000|Third Intervention Week 11-52|Other|0|||
124954391|NCT01182285|449457713|FG001|Third Intervention Week 11-52|Other|0|||
124954392|NCT01182285|449457714|FG002|Third Intervention Week 11-52|Other|2|||
124954393|NCT01951105|449457717|FG000|Overall Study|Adverse Event|0|||
124954394|NCT01951105|449457718|FG001|Overall Study|Adverse Event|5|||
124954395|NCT01951105|449457719|FG002|Overall Study|Adverse Event|0|||
124954396|NCT01951105|449457717|FG000|Overall Study|Lost to Follow-up|0|||
124954397|NCT01951105|449457718|FG001|Overall Study|Lost to Follow-up|1|||
124954398|NCT01951105|449457719|FG002|Overall Study|Lost to Follow-up|0|||
124954399|NCT01951105|449457717|FG000|Overall Study|Protocol Violation|1|||
124954400|NCT01951105|449457718|FG001|Overall Study|Protocol Violation|1|||
124954401|NCT01951105|449457719|FG002|Overall Study|Protocol Violation|1|||
124954402|NCT01951105|449457717|FG000|Overall Study|Withdrawal by Subject|0|||
124954403|NCT01951105|449457718|FG001|Overall Study|Withdrawal by Subject|3|||
124954404|NCT01951105|449457719|FG002|Overall Study|Withdrawal by Subject|1|||
124954405|NCT03209492|449457720|FG000|Overall Study|Case Report Forms Uncollected|5|||
124954406|NCT02604199|449457723|FG000|Overall Study|Pregnancy|0|||
124954407|NCT02604199|449457724|FG001|Overall Study|Pregnancy|0|||
124954408|NCT02604199|449457725|FG002|Overall Study|Pregnancy|0|||
124954409|NCT02604199|449457726|FG003|Overall Study|Pregnancy|1|||
124954410|NCT02604199|449457723|FG000|Overall Study|Study terminated by sponsor|0|||
124954411|NCT02604199|449457724|FG001|Overall Study|Study terminated by sponsor|2|||
124954412|NCT02604199|449457725|FG002|Overall Study|Study terminated by sponsor|0|||
124954413|NCT02604199|449457726|FG003|Overall Study|Study terminated by sponsor|2|||
124954414|NCT02604199|449457723|FG000|Overall Study|Withdrawal by Subject|0|||
124954415|NCT02604199|449457724|FG001|Overall Study|Withdrawal by Subject|1|||
124954416|NCT02604199|449457725|FG002|Overall Study|Withdrawal by Subject|0|||
124954417|NCT02604199|449457726|FG003|Overall Study|Withdrawal by Subject|0|||
124954418|NCT02812706|449457727|FG000|Phase 1|Adverse Event|0|||
124954419|NCT02812706|449457728|FG001|Phase 1|Adverse Event|2|||
124954420|NCT02812706|449457729|FG002|Phase 1|Adverse Event|0|||
124954421|NCT02812706|449457727|FG000|Phase 1|Progressive disease|3|||
124954422|NCT02812706|449457728|FG001|Phase 1|Progressive disease|3|||
124954423|NCT02812706|449457729|FG002|Phase 1|Progressive disease|0|||
124954424|NCT02812706|449457727|FG000|Phase 2|Adverse Event|0|||
124460603|NCT00105443|447645960|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
124460604|NCT00105443|447645957|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
124460605|NCT00105443|447645958|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
124460606|NCT00105443|447645959|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
124460607|NCT00105443|447645960|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
124460608|NCT00105443|447645957|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
124460609|NCT00105443|447645958|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
124954425|NCT02812706|449457728|FG001|Phase 2|Adverse Event|0|||
124954426|NCT02812706|449457729|FG002|Phase 2|Adverse Event|2|||
124954427|NCT02812706|449457727|FG000|Phase 2|Progressive disease|0|||
124460610|NCT00105443|447645959|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
124460611|NCT00105443|447645960|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
124460612|NCT00105443|447645957|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
124460613|NCT00105443|447645958|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
124460614|NCT00105443|447645959|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
124460615|NCT00105443|447645960|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
124954428|NCT02812706|449457728|FG001|Phase 2|Progressive disease|0|||
124954429|NCT02812706|449457729|FG002|Phase 2|Progressive disease|22|||
124954430|NCT02812706|449457727|FG000|Phase 2|Other-Unspecified|0|||
124954431|NCT02812706|449457728|FG001|Phase 2|Other-Unspecified|0|||
124954432|NCT02812706|449457729|FG002|Phase 2|Other-Unspecified|4|||
124954433|NCT03166215|449457735|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
124954434|NCT03166215|449457736|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
124954435|NCT03166215|449457737|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
124954436|NCT03166215|449457735|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
124954437|NCT03166215|449457736|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
124954438|NCT03166215|449457737|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
124954439|NCT02632045|449457738|FG000|Overall Study|Withdrawal by Subject|1|||
124954440|NCT02632045|449457739|FG001|Overall Study|Withdrawal by Subject|2|||
124954441|NCT01613599|449457740|FG000|Overall Study|Death|9|||
124954442|NCT01613599|449457740|FG000|Overall Study|Lost to Follow-up|5|||
124954443|NCT01613599|449457740|FG000|Overall Study|Withdrawal by Subject|8|||
124954444|NCT01613599|449457740|FG000|Overall Study|Reason not specified|3|||
124954445|NCT01075815|449457742|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
124954446|NCT01075815|449457743|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
124954447|NCT01075815|449457742|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
124954448|NCT01075815|449457743|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
124954449|NCT01075815|449457742|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
124954450|NCT01075815|449457743|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
124954451|NCT00617708|449457744|FG000|Overall Study|Adverse Event|0|||
124954452|NCT00617708|449457745|FG001|Overall Study|Adverse Event|6|||
124954453|NCT00617708|449457746|FG002|Overall Study|Adverse Event|9|||
124954454|NCT00617708|449457744|FG000|Overall Study|Withdrawal by Subject|1|||
124954455|NCT00617708|449457745|FG001|Overall Study|Withdrawal by Subject|1|||
124954456|NCT00617708|449457746|FG002|Overall Study|Withdrawal by Subject|7|||
124954457|NCT00617708|449457744|FG000|Overall Study|Death|0|||
124954458|NCT00617708|449457745|FG001|Overall Study|Death|6|||
124954459|NCT00617708|449457746|FG002|Overall Study|Death|5|||
124954460|NCT00617708|449457744|FG000|Overall Study|Progression/Relapse|7|||
124954461|NCT00617708|449457745|FG001|Overall Study|Progression/Relapse|40|||
124954462|NCT00617708|449457746|FG002|Overall Study|Progression/Relapse|36|||
124954463|NCT00617708|449457744|FG000|Overall Study|Not protocol specified|1|||
124954464|NCT00617708|449457745|FG001|Overall Study|Not protocol specified|4|||
124460616|NCT00105443|447645957|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
124460617|NCT00105443|447645958|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
124460618|NCT00105443|447645959|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
124460619|NCT00105443|447645960|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
124460620|NCT00105443|447645957|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
124460621|NCT00105443|447645958|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
124460622|NCT00105443|447645959|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
124954465|NCT00617708|449457746|FG002|Overall Study|Not protocol specified|2|||
124954466|NCT00617708|449457744|FG000|Overall Study|Not eligible|1|||
124954467|NCT00617708|449457745|FG001|Overall Study|Not eligible|3|||
124954468|NCT00617708|449457746|FG002|Overall Study|Not eligible|5|||
124954469|NCT02058992|449457747|FG000|Overall Study|Lost to Follow-up|4|||
124954470|NCT02058992|449457747|FG000|Overall Study|Protocol Violation|92|||
124954471|NCT02058992|449457747|FG000|Overall Study|CRF Uncollected|20|||
124954472|NCT03503188|449457748|FG000|Overall Study|Non eligible in the sub study|0|||
124954473|NCT03503188|449457749|FG001|Overall Study|Non eligible in the sub study|1|||
124954474|NCT03747575|449457756|FG000|Overall Study|Withdrawal by Subject|6|||
124954475|NCT03747575|449457757|FG001|Overall Study|Withdrawal by Subject|3|||
124954476|NCT03747575|449457756|FG000|Overall Study|Lost to Follow-up|3|||
124954477|NCT03747575|449457757|FG001|Overall Study|Lost to Follow-up|3|||
124954478|NCT03747575|449457756|FG000|Overall Study|Adverse Event|0|||
124954479|NCT03747575|449457757|FG001|Overall Study|Adverse Event|1|||
124460623|NCT00105443|447645960|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
124954480|NCT00321555|449457758|FG000|Overall Study|Developed antibodies|1|||
124954481|NCT00321555|449457758|FG000|Overall Study|Switched to alternative treatment|3|||
124954482|NCT00321555|449457758|FG000|Overall Study|Physician Decision|1|||
124954483|NCT00321555|449457758|FG000|Overall Study|Disease progression on study|1|||
124954484|NCT02066389|449457763|FG000|Overall Study|Adverse Event|1|||
124954485|NCT02066389|449457764|FG001|Overall Study|Adverse Event|1|||
124954486|NCT02066389|449457765|FG002|Overall Study|Adverse Event|1|||
124954487|NCT02066389|449457766|FG003|Overall Study|Adverse Event|1|||
124954488|NCT02066389|449457767|FG004|Overall Study|Adverse Event|5|||
124954489|NCT02066389|449457768|FG005|Overall Study|Adverse Event|1|||
124954490|NCT02066389|449457763|FG000|Overall Study|Withdrawal by Subject|4|||
124954491|NCT02066389|449457764|FG001|Overall Study|Withdrawal by Subject|0|||
124954492|NCT02066389|449457765|FG002|Overall Study|Withdrawal by Subject|5|||
124954493|NCT02066389|449457766|FG003|Overall Study|Withdrawal by Subject|1|||
124954494|NCT02066389|449457767|FG004|Overall Study|Withdrawal by Subject|1|||
124954495|NCT02066389|449457768|FG005|Overall Study|Withdrawal by Subject|2|||
124954496|NCT02066389|449457763|FG000|Overall Study|Lost to Follow-up|0|||
124954497|NCT02066389|449457764|FG001|Overall Study|Lost to Follow-up|0|||
124954498|NCT02066389|449457765|FG002|Overall Study|Lost to Follow-up|0|||
124954499|NCT02066389|449457766|FG003|Overall Study|Lost to Follow-up|1|||
124954500|NCT02066389|449457767|FG004|Overall Study|Lost to Follow-up|1|||
124954501|NCT02066389|449457768|FG005|Overall Study|Lost to Follow-up|1|||
124954502|NCT02066389|449457763|FG000|Overall Study|Randomized in Error|0|||
124954503|NCT02066389|449457764|FG001|Overall Study|Randomized in Error|0|||
124954504|NCT02066389|449457765|FG002|Overall Study|Randomized in Error|0|||
124954505|NCT02066389|449457766|FG003|Overall Study|Randomized in Error|0|||
124954506|NCT02066389|449457767|FG004|Overall Study|Randomized in Error|0|||
124954507|NCT02066389|449457768|FG005|Overall Study|Randomized in Error|1|||
124954508|NCT01755598|449457771|FG000|Overall Study|Other|109|||
124954509|NCT01755598|449457772|FG001|Overall Study|Other|109|||
124954510|NCT01755598|449457771|FG000|Overall Study|Lost to Follow-up|32|||
124954511|NCT01755598|449457772|FG001|Overall Study|Lost to Follow-up|43|||
124954512|NCT01755598|449457771|FG000|Overall Study|Migrated/moved from study area|76|||
124954513|NCT01755598|449457772|FG001|Overall Study|Migrated/moved from study area|65|||
124954514|NCT01755598|449457771|FG000|Overall Study|Withdrawal by Subject|22|||
124954515|NCT01755598|449457772|FG001|Overall Study|Withdrawal by Subject|31|||
124954516|NCT01755598|449457771|FG000|Overall Study|Protocol Violation|7|||
124954517|NCT01755598|449457772|FG001|Overall Study|Protocol Violation|7|||
124954518|NCT01755598|449457771|FG000|Overall Study|Adverse Event|19|||
124954519|NCT01755598|449457772|FG001|Overall Study|Adverse Event|28|||
124954520|NCT02924051|449457775|FG000|Overall Study|Withdrawal by Subject|1|||
124954521|NCT02924051|449457776|FG001|Overall Study|Withdrawal by Subject|9|||
124954522|NCT03005106|449457779|FG000|Overall Study|Lost to Follow-up|16|||
124954523|NCT03005106|449457779|FG000|Overall Study|Adverse Event|1|||
124954524|NCT03005106|449457779|FG000|Overall Study|Physician Decision|1|||
124954525|NCT03005106|449457779|FG000|Overall Study|Death|2|||
124954526|NCT00321672|449457780|FG000|Overall Study|Withdrawal by Subject|5|||
124954527|NCT00321672|449457781|FG001|Overall Study|Withdrawal by Subject|1|||
124954528|NCT00321672|449457782|FG002|Overall Study|Withdrawal by Subject|2|||
124954529|NCT00321672|449457783|FG003|Overall Study|Withdrawal by Subject|0|||
124954530|NCT00321672|449457780|FG000|Overall Study|Noncompliance|1|||
124954531|NCT00321672|449457781|FG001|Overall Study|Noncompliance|2|||
124954532|NCT00321672|449457782|FG002|Overall Study|Noncompliance|1|||
124954533|NCT00321672|449457783|FG003|Overall Study|Noncompliance|0|||
124954534|NCT00321672|449457780|FG000|Overall Study|Adverse Event|1|||
124954535|NCT00321672|449457781|FG001|Overall Study|Adverse Event|1|||
124954536|NCT00321672|449457782|FG002|Overall Study|Adverse Event|0|||
124954537|NCT00321672|449457783|FG003|Overall Study|Adverse Event|0|||
124954538|NCT00321672|449457780|FG000|Overall Study|Lack of Efficacy|1|||
124954539|NCT00321672|449457781|FG001|Overall Study|Lack of Efficacy|1|||
124954540|NCT00321672|449457782|FG002|Overall Study|Lack of Efficacy|0|||
124954541|NCT00321672|449457783|FG003|Overall Study|Lack of Efficacy|0|||
124954542|NCT00321672|449457780|FG000|Overall Study|Lost to Follow-up|2|||
124954543|NCT00321672|449457781|FG001|Overall Study|Lost to Follow-up|0|||
124954544|NCT00321672|449457782|FG002|Overall Study|Lost to Follow-up|4|||
124954545|NCT00321672|449457783|FG003|Overall Study|Lost to Follow-up|2|||
124954546|NCT00321672|449457780|FG000|Overall Study|Death|1|||
124954547|NCT00321672|449457781|FG001|Overall Study|Death|0|||
124954548|NCT00321672|449457782|FG002|Overall Study|Death|0|||
124954549|NCT00321672|449457783|FG003|Overall Study|Death|0|||
124954550|NCT00321672|449457780|FG000|Overall Study|Too far to travel for visits|1|||
124954551|NCT00321672|449457781|FG001|Overall Study|Too far to travel for visits|0|||
124954552|NCT00321672|449457782|FG002|Overall Study|Too far to travel for visits|0|||
124954553|NCT00321672|449457783|FG003|Overall Study|Too far to travel for visits|0|||
124954554|NCT00321672|449457780|FG000|Overall Study|Incarcerated|0|||
124954555|NCT00321672|449457781|FG001|Overall Study|Incarcerated|0|||
124954556|NCT00321672|449457782|FG002|Overall Study|Incarcerated|2|||
124954557|NCT00321672|449457783|FG003|Overall Study|Incarcerated|0|||
124954558|NCT00321672|449457780|FG000|Overall Study|Moved out of state|0|||
124954559|NCT00321672|449457781|FG001|Overall Study|Moved out of state|1|||
124954560|NCT00321672|449457782|FG002|Overall Study|Moved out of state|1|||
124954561|NCT00321672|449457783|FG003|Overall Study|Moved out of state|0|||
124954562|NCT00321672|449457780|FG000|Overall Study|Protocol Violation|0|||
124954563|NCT00321672|449457781|FG001|Overall Study|Protocol Violation|0|||
124954564|NCT00321672|449457782|FG002|Overall Study|Protocol Violation|1|||
124954565|NCT00321672|449457783|FG003|Overall Study|Protocol Violation|0|||
124954566|NCT00321672|449457780|FG000|Overall Study|Diagnosis of testicular cancer|0|||
124954567|NCT00321672|449457781|FG001|Overall Study|Diagnosis of testicular cancer|1|||
124954568|NCT00321672|449457782|FG002|Overall Study|Diagnosis of testicular cancer|0|||
124954569|NCT00321672|449457783|FG003|Overall Study|Diagnosis of testicular cancer|0|||
124954570|NCT00321672|449457780|FG000|Overall Study|Extensive travel required for new job|0|||
124954571|NCT00321672|449457781|FG001|Overall Study|Extensive travel required for new job|1|||
124954572|NCT00321672|449457782|FG002|Overall Study|Extensive travel required for new job|0|||
124954573|NCT00321672|449457783|FG003|Overall Study|Extensive travel required for new job|0|||
124954574|NCT00512902|449457786|FG000|Overall Study|Adverse Event|7|||
124954575|NCT00512902|449457786|FG000|Overall Study|Lost to Follow-up|1|||
124954576|NCT01730118|449458978|FG000|Dose Escalation|Death on study|5|||
124954577|NCT01730118|449458979|FG001|Dose Escalation|Death on study|7|||
124954578|NCT01730118|449458980|FG002|Dose Escalation|Death on study|2|||
124954579|NCT01730118|449458981|FG003|Dose Escalation|Death on study|6|||
124954580|NCT01730118|449458982|FG004|Dose Escalation|Death on study|0|||
124954581|NCT01730118|449458983|FG005|Dose Escalation|Death on study|0|||
124954582|NCT01730118|449458984|FG006|Dose Escalation|Death on study|0|||
124954583|NCT01730118|449458978|FG000|Dose Escalation|Died before treatment|0|||
124954584|NCT01730118|449458979|FG001|Dose Escalation|Died before treatment|0|||
124954585|NCT01730118|449458980|FG002|Dose Escalation|Died before treatment|0|||
124954586|NCT01730118|449458981|FG003|Dose Escalation|Died before treatment|0|||
124954587|NCT01730118|449458982|FG004|Dose Escalation|Died before treatment|0|||
124954588|NCT01730118|449458983|FG005|Dose Escalation|Died before treatment|0|||
124954589|NCT01730118|449458984|FG006|Dose Escalation|Died before treatment|1|||
124954590|NCT01730118|449458978|FG000|Dose Escalation|Chose to start a different treatment|1|||
124954591|NCT01730118|449458979|FG001|Dose Escalation|Chose to start a different treatment|0|||
124954592|NCT01730118|449458980|FG002|Dose Escalation|Chose to start a different treatment|0|||
124954593|NCT01730118|449458981|FG003|Dose Escalation|Chose to start a different treatment|0|||
124954594|NCT01730118|449458982|FG004|Dose Escalation|Chose to start a different treatment|0|||
124954595|NCT01730118|449458983|FG005|Dose Escalation|Chose to start a different treatment|0|||
124954596|NCT01730118|449458984|FG006|Dose Escalation|Chose to start a different treatment|0|||
124954597|NCT01730118|449458978|FG000|Dose Escalation|Withdrawal by Subject|0|||
124954598|NCT01730118|449458979|FG001|Dose Escalation|Withdrawal by Subject|0|||
124954599|NCT01730118|449458980|FG002|Dose Escalation|Withdrawal by Subject|1|||
124954600|NCT01730118|449458981|FG003|Dose Escalation|Withdrawal by Subject|0|||
124954601|NCT01730118|449458982|FG004|Dose Escalation|Withdrawal by Subject|0|||
124954602|NCT01730118|449458983|FG005|Dose Escalation|Withdrawal by Subject|0|||
124954603|NCT01730118|449458984|FG006|Dose Escalation|Withdrawal by Subject|0|||
124954604|NCT01730118|449458978|FG000|Dose Escalation|Disease progression prior to treatment|0|||
124954605|NCT01730118|449458979|FG001|Dose Escalation|Disease progression prior to treatment|0|||
124954606|NCT01730118|449458980|FG002|Dose Escalation|Disease progression prior to treatment|0|||
124954607|NCT01730118|449458981|FG003|Dose Escalation|Disease progression prior to treatment|0|||
124954608|NCT01730118|449458982|FG004|Dose Escalation|Disease progression prior to treatment|0|||
124954609|NCT01730118|449458983|FG005|Dose Escalation|Disease progression prior to treatment|0|||
124954610|NCT01730118|449458984|FG006|Dose Escalation|Disease progression prior to treatment|1|||
124954611|NCT01730118|449458978|FG000|Dose Expansion|Death|0|||
124954612|NCT01730118|449458979|FG001|Dose Expansion|Death|0|||
124954613|NCT01730118|449458980|FG002|Dose Expansion|Death|0|||
124954614|NCT01730118|449458981|FG003|Dose Expansion|Death|0|||
124549003|NCT01125358|447965420|FG002|Overall Study|Withdrawal by Subject|1|||
124549004|NCT01125358|447965421|FG003|Overall Study|Withdrawal by Subject|1|||
124954615|NCT01730118|449458982|FG004|Dose Expansion|Death|1|||
124954616|NCT01730118|449458983|FG005|Dose Expansion|Death|0|||
124954617|NCT01730118|449458984|FG006|Dose Expansion|Death|0|||
124954618|NCT01730118|449458978|FG000|Dose Expansion|Other medical condition|0|||
124954619|NCT01730118|449458979|FG001|Dose Expansion|Other medical condition|0|||
124954620|NCT01730118|449458980|FG002|Dose Expansion|Other medical condition|0|||
124954621|NCT01730118|449458981|FG003|Dose Expansion|Other medical condition|0|||
124954622|NCT01730118|449458982|FG004|Dose Expansion|Other medical condition|1|||
124954623|NCT01730118|449458983|FG005|Dose Expansion|Other medical condition|0|||
124954624|NCT01730118|449458984|FG006|Dose Expansion|Other medical condition|0|||
124954625|NCT01730118|449458978|FG000|Dose Expansion|Withdrawal by Subject|0|||
124954626|NCT01730118|449458979|FG001|Dose Expansion|Withdrawal by Subject|0|||
124954627|NCT01730118|449458980|FG002|Dose Expansion|Withdrawal by Subject|0|||
124954628|NCT01730118|449458981|FG003|Dose Expansion|Withdrawal by Subject|0|||
124954629|NCT01730118|449458982|FG004|Dose Expansion|Withdrawal by Subject|1|||
124954630|NCT01730118|449458983|FG005|Dose Expansion|Withdrawal by Subject|0|||
124954631|NCT01730118|449458984|FG006|Dose Expansion|Withdrawal by Subject|0|||
124954632|NCT01730118|449458978|FG000|Dose Expansion|Disease progression|0|||
124954633|NCT01730118|449458979|FG001|Dose Expansion|Disease progression|0|||
124954634|NCT01730118|449458980|FG002|Dose Expansion|Disease progression|0|||
124954635|NCT01730118|449458981|FG003|Dose Expansion|Disease progression|0|||
124954636|NCT01730118|449458982|FG004|Dose Expansion|Disease progression|0|||
124954637|NCT01730118|449458983|FG005|Dose Expansion|Disease progression|1|||
124954638|NCT01730118|449458984|FG006|Dose Expansion|Disease progression|0|||
124954639|NCT01730118|449458978|FG000|Dose Expansion|Inability to return|0|||
124954640|NCT01730118|449458979|FG001|Dose Expansion|Inability to return|0|||
124954641|NCT01730118|449458980|FG002|Dose Expansion|Inability to return|0|||
124954642|NCT01730118|449458981|FG003|Dose Expansion|Inability to return|0|||
124954643|NCT01730118|449458982|FG004|Dose Expansion|Inability to return|0|||
124954644|NCT01730118|449458983|FG005|Dose Expansion|Inability to return|1|||
124954645|NCT01730118|449458984|FG006|Dose Expansion|Inability to return|0|||
124954646|NCT01730118|449458978|FG000|Dose Expansion|Physician Decision|0|||
124954647|NCT01730118|449458979|FG001|Dose Expansion|Physician Decision|0|||
124954648|NCT01730118|449458980|FG002|Dose Expansion|Physician Decision|0|||
124954649|NCT01730118|449458981|FG003|Dose Expansion|Physician Decision|0|||
124954650|NCT01730118|449458982|FG004|Dose Expansion|Physician Decision|0|||
124954651|NCT01730118|449458983|FG005|Dose Expansion|Physician Decision|1|||
124954652|NCT01730118|449458984|FG006|Dose Expansion|Physician Decision|0|||
124954653|NCT00489489|449458986|FG000|Overall Study|Not treated due to protocol violation|0|||
124954654|NCT00489489|449458987|FG001|Overall Study|Not treated due to protocol violation|1|||
124954655|NCT00489489|449458988|FG002|Overall Study|Not treated due to protocol violation|1|||
124954656|NCT00489489|449458986|FG000|Overall Study|Adverse Event|1|||
124954657|NCT00489489|449458987|FG001|Overall Study|Adverse Event|1|||
124954658|NCT00489489|449458988|FG002|Overall Study|Adverse Event|1|||
124954659|NCT00489489|449458986|FG000|Overall Study|Protocol Violation|1|||
124954660|NCT00489489|449458987|FG001|Overall Study|Protocol Violation|0|||
124954661|NCT00489489|449458988|FG002|Overall Study|Protocol Violation|1|||
124954662|NCT00489489|449458986|FG000|Overall Study|Progressive disease|0|||
124954663|NCT00489489|449458987|FG001|Overall Study|Progressive disease|1|||
124954664|NCT00489489|449458988|FG002|Overall Study|Progressive disease|0|||
124954665|NCT00489489|449458986|FG000|Overall Study|Participant did not wish to continue|1|||
124954666|NCT00489489|449458987|FG001|Overall Study|Participant did not wish to continue|1|||
124954667|NCT00489489|449458988|FG002|Overall Study|Participant did not wish to continue|0|||
124954668|NCT00489489|449458986|FG000|Overall Study|Other than above|0|||
124954669|NCT00489489|449458987|FG001|Overall Study|Other than above|1|||
124954670|NCT00489489|449458988|FG002|Overall Study|Other than above|0|||
124954671|NCT04851587|449458991|FG000|Overall Study|Lost to Follow-up|18|||
124954672|NCT02101554|449458995|FG000|Overall Study|Protocol Violation|0|||
124954673|NCT02101554|449458996|FG001|Overall Study|Protocol Violation|1|||
124954674|NCT02101554|449458997|FG002|Overall Study|Protocol Violation|0|||
124954675|NCT02101554|449458995|FG000|Overall Study|Insufficient Clinical Response|0|||
124954676|NCT02101554|449458996|FG001|Overall Study|Insufficient Clinical Response|2|||
124954677|NCT02101554|449458997|FG002|Overall Study|Insufficient Clinical Response|0|||
124954678|NCT02101554|449458995|FG000|Overall Study|Adverse Event|2|||
124954679|NCT02101554|449458996|FG001|Overall Study|Adverse Event|1|||
124954680|NCT02101554|449458997|FG002|Overall Study|Adverse Event|1|||
124954681|NCT02101554|449458995|FG000|Overall Study|Lost to Follow-up|0|||
124954682|NCT02101554|449458996|FG001|Overall Study|Lost to Follow-up|1|||
124954683|NCT02101554|449458997|FG002|Overall Study|Lost to Follow-up|0|||
124954684|NCT02101554|449458995|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
124954685|NCT02101554|449458996|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
124954686|NCT02101554|449458997|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
124954687|NCT01350102|449458998|FG000|Overall Study|Adverse Event|0|||
124954688|NCT01350102|449458999|FG001|Overall Study|Adverse Event|0|||
124954689|NCT01350102|449459000|FG002|Overall Study|Adverse Event|1|||
124954690|NCT01350102|449459001|FG003|Overall Study|Adverse Event|0|||
124954691|NCT02136797|449459004|FG000|Overall Study|Not Treated|8|||
124954692|NCT04523571|449459005|FG000|Received 2 Doses|Withdrawal by Subject|0|||
124954693|NCT04523571|449459006|FG001|Received 2 Doses|Withdrawal by Subject|0|||
124954694|NCT04523571|449459007|FG002|Received 2 Doses|Withdrawal by Subject|0|||
124549005|NCT01157065|447965422|FG000|Overall Study|Death|0|||
124549006|NCT01157065|447965423|FG001|Overall Study|Death|1|||
124954695|NCT04523571|449459008|FG003|Received 2 Doses|Withdrawal by Subject|1|||
124954696|NCT04523571|449459009|FG004|Received 2 Doses|Withdrawal by Subject|1|||
124954697|NCT04523571|449459010|FG005|Received 2 Doses|Withdrawal by Subject|0|||
124954698|NCT04523571|449459005|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
124954699|NCT04523571|449459006|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
124707682|NCT05270863|448554711|FG005|First Washout|Withdrawal by Subject|1|||
124707683|NCT05270863|448554706|FG000|First Washout|Lost to Follow-up|0|||
124707684|NCT05270863|448554707|FG001|First Washout|Lost to Follow-up|0|||
124954700|NCT04523571|449459007|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
124954701|NCT04523571|449459008|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
124954702|NCT04523571|449459009|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
124954703|NCT04523571|449459010|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
124954704|NCT04523571|449459005|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
124954705|NCT04523571|449459006|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
124954706|NCT04523571|449459007|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
124954707|NCT04523571|449459008|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
124954708|NCT04523571|449459009|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
124954709|NCT04523571|449459010|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
124954710|NCT04523571|449459005|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
124954711|NCT04523571|449459006|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
124954712|NCT04523571|449459007|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
124954713|NCT04523571|449459008|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
124954714|NCT04523571|449459009|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
124954715|NCT04523571|449459010|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
124954716|NCT03694210|449459012|FG000|Overall Study|Death|1|||
124954717|NCT03694210|449459012|FG000|Overall Study|Screen Failure|7|||
124954718|NCT03050372|449459013|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
124954719|NCT03050372|449459014|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
124954720|NCT03050372|449459013|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
124954721|NCT03050372|449459014|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
124954722|NCT04385849|449459015|FG000|Overall Study|Lost to Follow-up|1|||
124954723|NCT04385849|449459016|FG001|Overall Study|Lost to Follow-up|0|||
124954724|NCT01375777|449459017|FG000|Overall Study|Withdrawal by Subject|0|||
124954725|NCT01375777|449459018|FG001|Overall Study|Withdrawal by Subject|2|||
124954726|NCT01375777|449459019|FG002|Overall Study|Withdrawal by Subject|1|||
124954727|NCT01375777|449459020|FG003|Overall Study|Withdrawal by Subject|0|||
124954728|NCT01375777|449459021|FG004|Overall Study|Withdrawal by Subject|1|||
124954729|NCT01375777|449459022|FG005|Overall Study|Withdrawal by Subject|1|||
124954730|NCT01375777|449459023|FG006|Overall Study|Withdrawal by Subject|1|||
124954731|NCT01375777|449459024|FG007|Overall Study|Withdrawal by Subject|2|||
124954732|NCT01375777|449459025|FG008|Overall Study|Withdrawal by Subject|1|||
124954733|NCT01375777|449459017|FG000|Overall Study|Lost to Follow-up|1|||
124954734|NCT01375777|449459018|FG001|Overall Study|Lost to Follow-up|0|||
124954735|NCT01375777|449459019|FG002|Overall Study|Lost to Follow-up|0|||
124954736|NCT01375777|449459020|FG003|Overall Study|Lost to Follow-up|0|||
124954737|NCT01375777|449459021|FG004|Overall Study|Lost to Follow-up|0|||
124954738|NCT01375777|449459022|FG005|Overall Study|Lost to Follow-up|0|||
124954739|NCT01375777|449459023|FG006|Overall Study|Lost to Follow-up|1|||
124954740|NCT01375777|449459024|FG007|Overall Study|Lost to Follow-up|0|||
124954741|NCT01375777|449459025|FG008|Overall Study|Lost to Follow-up|0|||
124954742|NCT01375777|449459017|FG000|Overall Study|Other|1|||
124954743|NCT01375777|449459018|FG001|Overall Study|Other|1|||
124954744|NCT01375777|449459019|FG002|Overall Study|Other|0|||
124954745|NCT01375777|449459020|FG003|Overall Study|Other|0|||
124954746|NCT01375777|449459021|FG004|Overall Study|Other|0|||
124954747|NCT01375777|449459022|FG005|Overall Study|Other|0|||
124954748|NCT01375777|449459023|FG006|Overall Study|Other|0|||
124954749|NCT01375777|449459024|FG007|Overall Study|Other|0|||
124954750|NCT01375777|449459025|FG008|Overall Study|Other|1|||
124954751|NCT01838499|449459028|FG000|Overall Study|Protocol Violation|0|||
124954752|NCT01838499|449459029|FG001|Overall Study|Protocol Violation|1|||
124954753|NCT01838499|449459028|FG000|Overall Study|Lost to Follow-up|2|||
124954754|NCT01838499|449459029|FG001|Overall Study|Lost to Follow-up|4|||
124954755|NCT01838499|449459028|FG000|Overall Study|Lack of Efficacy|1|||
124954756|NCT01838499|449459029|FG001|Overall Study|Lack of Efficacy|2|||
124954757|NCT01838499|449459028|FG000|Overall Study|Adverse Event|2|||
124954758|NCT01838499|449459029|FG001|Overall Study|Adverse Event|1|||
124954759|NCT01838499|449459028|FG000|Overall Study|Withdrawal by Subject|19|||
124954760|NCT01838499|449459029|FG001|Overall Study|Withdrawal by Subject|9|||
124954761|NCT02368691|449459030|FG000|Overall Study|Death|13|||
124460624|NCT00105443|447645957|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
124954762|NCT02368691|449459030|FG000|Overall Study|Lack of Efficacy|15|||
124954763|NCT02368691|449459030|FG000|Overall Study|Physician Decision|4|||
124954764|NCT03314233|449459033|FG000|Overall Study|No longer eligible at time of delivery|1|||
124954765|NCT01114217|449459034|FG000|Overall Study|Adverse Event|5|||
124954766|NCT01114217|449459035|FG001|Overall Study|Adverse Event|3|||
124954767|NCT01114217|449459034|FG000|Overall Study|Lost to Follow-up|17|||
124954768|NCT01114217|449459035|FG001|Overall Study|Lost to Follow-up|33|||
124954769|NCT01114217|449459034|FG000|Overall Study|Withdrawal by Subject|21|||
124954770|NCT01114217|449459035|FG001|Overall Study|Withdrawal by Subject|28|||
124954771|NCT01114217|449459034|FG000|Overall Study|Other-Clerical Error|3|||
124954772|NCT01114217|449459035|FG001|Overall Study|Other-Clerical Error|0|||
124954773|NCT01114217|449459034|FG000|Overall Study|Other-Early termination|6|||
124954774|NCT01114217|449459035|FG001|Overall Study|Other-Early termination|10|||
124954775|NCT01114217|449459034|FG000|Overall Study|Other-Procedure|1|||
124954776|NCT01114217|449459035|FG001|Overall Study|Other-Procedure|1|||
124954777|NCT01114217|449459034|FG000|Overall Study|Other-Pregnancy|2|||
124954778|NCT01114217|449459035|FG001|Overall Study|Other-Pregnancy|4|||
124954779|NCT01114217|449459034|FG000|Overall Study|Other-Protocol Violation|1|||
124954780|NCT01114217|449459035|FG001|Overall Study|Other-Protocol Violation|3|||
124954781|NCT01114217|449459034|FG000|Overall Study|Other-Lack of Efficacy|1|||
124954782|NCT01114217|449459035|FG001|Overall Study|Other-Lack of Efficacy|0|||
124954783|NCT01114217|449459034|FG000|Overall Study|Other-Non Compliance|2|||
124954784|NCT01114217|449459035|FG001|Overall Study|Other-Non Compliance|0|||
124954785|NCT01114217|449459034|FG000|Overall Study|Other-Physician Decision|1|||
124954786|NCT01114217|449459035|FG001|Overall Study|Other-Physician Decision|1|||
124954787|NCT01114217|449459034|FG000|Overall Study|Other-Sponsor Decision|10|||
124954788|NCT01114217|449459035|FG001|Overall Study|Other-Sponsor Decision|12|||
124954789|NCT01114217|449459034|FG000|Overall Study|Other-Study Termination|0|||
124954790|NCT01114217|449459035|FG001|Overall Study|Other-Study Termination|1|||
124954791|NCT01114217|449459034|FG000|Overall Study|Other-Study Withdrawn|1|||
124954792|NCT01114217|449459035|FG001|Overall Study|Other-Study Withdrawn|1|||
124954793|NCT01114217|449459034|FG000|Overall Study|Other-Site Stopped Communicating|2|||
124954794|NCT01114217|449459035|FG001|Overall Study|Other-Site Stopped Communicating|0|||
124954795|NCT01114217|449459034|FG000|Overall Study|Other-Lost to Follow-up|1|||
124954796|NCT01114217|449459035|FG001|Overall Study|Other-Lost to Follow-up|0|||
124954797|NCT01114217|449459034|FG000|Overall Study|Other-Withdrawal by Subject|1|||
124954798|NCT01114217|449459035|FG001|Overall Study|Other-Withdrawal by Subject|1|||
124954799|NCT01183013|449459036|FG000|Overall Study|Adverse Event|6|||
124954800|NCT01183013|449459037|FG001|Overall Study|Adverse Event|8|||
124954801|NCT01183013|449459038|FG002|Overall Study|Adverse Event|5|||
124954802|NCT01183013|449459039|FG003|Overall Study|Adverse Event|5|||
124954803|NCT01183013|449459040|FG004|Overall Study|Adverse Event|10|||
124954804|NCT01183013|449459041|FG005|Overall Study|Adverse Event|10|||
124954805|NCT01183013|449459042|FG006|Overall Study|Adverse Event|6|||
124954806|NCT01183013|449459036|FG000|Overall Study|Lack of Efficacy|3|||
124954807|NCT01183013|449459037|FG001|Overall Study|Lack of Efficacy|2|||
124954808|NCT01183013|449459038|FG002|Overall Study|Lack of Efficacy|1|||
124954809|NCT01183013|449459039|FG003|Overall Study|Lack of Efficacy|2|||
124954810|NCT01183013|449459040|FG004|Overall Study|Lack of Efficacy|1|||
124954811|NCT01183013|449459041|FG005|Overall Study|Lack of Efficacy|2|||
124954812|NCT01183013|449459042|FG006|Overall Study|Lack of Efficacy|0|||
124954813|NCT01183013|449459036|FG000|Overall Study|Protocol Violation|5|||
124954814|NCT01183013|449459037|FG001|Overall Study|Protocol Violation|2|||
124954815|NCT01183013|449459038|FG002|Overall Study|Protocol Violation|4|||
124954816|NCT01183013|449459039|FG003|Overall Study|Protocol Violation|0|||
124954817|NCT01183013|449459040|FG004|Overall Study|Protocol Violation|4|||
124954818|NCT01183013|449459041|FG005|Overall Study|Protocol Violation|3|||
124954819|NCT01183013|449459042|FG006|Overall Study|Protocol Violation|3|||
124954820|NCT01183013|449459036|FG000|Overall Study|Lost to Follow-up|7|||
124954821|NCT01183013|449459037|FG001|Overall Study|Lost to Follow-up|3|||
124954822|NCT01183013|449459038|FG002|Overall Study|Lost to Follow-up|4|||
124954823|NCT01183013|449459039|FG003|Overall Study|Lost to Follow-up|3|||
124954824|NCT01183013|449459040|FG004|Overall Study|Lost to Follow-up|2|||
124954825|NCT01183013|449459041|FG005|Overall Study|Lost to Follow-up|6|||
124954826|NCT01183013|449459042|FG006|Overall Study|Lost to Follow-up|5|||
124954827|NCT01183013|449459036|FG000|Overall Study|Withdrawal by Subject|9|||
124954828|NCT01183013|449459037|FG001|Overall Study|Withdrawal by Subject|13|||
124954829|NCT01183013|449459038|FG002|Overall Study|Withdrawal by Subject|10|||
124954830|NCT01183013|449459039|FG003|Overall Study|Withdrawal by Subject|8|||
124954831|NCT01183013|449459040|FG004|Overall Study|Withdrawal by Subject|7|||
124954832|NCT01183013|449459041|FG005|Overall Study|Withdrawal by Subject|9|||
124954833|NCT01183013|449459042|FG006|Overall Study|Withdrawal by Subject|10|||
124954834|NCT01183013|449459036|FG000|Overall Study|Reasons other than stated above|15|||
124954835|NCT01183013|449459037|FG001|Overall Study|Reasons other than stated above|11|||
124954836|NCT01183013|449459038|FG002|Overall Study|Reasons other than stated above|17|||
124707685|NCT05270863|448554708|FG002|First Washout|Lost to Follow-up|0|||
124954837|NCT01183013|449459039|FG003|Overall Study|Reasons other than stated above|12|||
124954838|NCT01183013|449459040|FG004|Overall Study|Reasons other than stated above|12|||
124954839|NCT01183013|449459041|FG005|Overall Study|Reasons other than stated above|15|||
124954840|NCT01183013|449459042|FG006|Overall Study|Reasons other than stated above|13|||
124954841|NCT02722278|449459045|FG000|Overall Study|Withdrawal by Subject|5|||
124707686|NCT05270863|448554709|FG003|First Washout|Lost to Follow-up|0|||
124954842|NCT02722278|449459046|FG001|Overall Study|Withdrawal by Subject|3|||
124954843|NCT02722278|449459045|FG000|Overall Study|Adverse Event|4|||
124954844|NCT02722278|449459046|FG001|Overall Study|Adverse Event|1|||
124954845|NCT02722278|449459045|FG000|Overall Study|Lost to Follow-up|2|||
124954846|NCT02722278|449459046|FG001|Overall Study|Lost to Follow-up|0|||
124954847|NCT02722278|449459045|FG000|Overall Study|Protocol Violation|1|||
124954848|NCT02722278|449459046|FG001|Overall Study|Protocol Violation|0|||
124954849|NCT02722278|449459045|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
124954850|NCT02722278|449459046|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
124954851|NCT02722278|449459045|FG000|Overall Study|Subject declined after tx assignment|0|||
124954852|NCT02722278|449459046|FG001|Overall Study|Subject declined after tx assignment|1|||
124954853|NCT02722278|449459045|FG000|Overall Study|Site closure not study related|0|||
124954854|NCT02722278|449459046|FG001|Overall Study|Site closure not study related|1|||
124954855|NCT04175392|449459047|FG000|Overall Study|Withdrawal by Subject|3|||
124954856|NCT04175392|449459048|FG001|Overall Study|Withdrawal by Subject|2|||
124954857|NCT02727998|449459049|FG000|Overall Study|Lost to Follow-up|3|||
124954858|NCT02727998|449459050|FG001|Overall Study|Lost to Follow-up|3|||
124954859|NCT02727998|449459049|FG000|Overall Study|Withdrawal by Subject|0|||
124954860|NCT02727998|449459050|FG001|Overall Study|Withdrawal by Subject|1|||
124954861|NCT02105688|449459051|FG000|Part A: Double-Blind|Adverse Event|1|||
124954862|NCT02105688|449459052|FG001|Part A: Double-Blind|Adverse Event|0|||
124954863|NCT02105688|449459051|FG000|Part A: Double-Blind|Death|0|||
124954864|NCT02105688|449459052|FG001|Part A: Double-Blind|Death|1|||
124954865|NCT02105688|449459051|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
124954866|NCT02105688|449459052|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
124954867|NCT02105688|449459051|FG000|Part A: Double-Blind|Physician Decision|0|||
124954868|NCT02105688|449459052|FG001|Part A: Double-Blind|Physician Decision|1|||
124954869|NCT02105688|449459051|FG000|Part A: Double-Blind|Status Unknown|0|||
124954870|NCT02105688|449459052|FG001|Part A: Double-Blind|Status Unknown|2|||
124954871|NCT02105688|449459051|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
124954872|NCT02105688|449459052|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
124954873|NCT02105688|449459051|FG000|Part B: Observational Follow-up|Death|2|||
124954874|NCT02105688|449459052|FG001|Part B: Observational Follow-up|Death|1|||
124954875|NCT02105688|449459051|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
124954876|NCT02105688|449459052|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
124954877|NCT02105688|449459051|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
124954878|NCT02105688|449459052|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
124954879|NCT02105688|449459051|FG000|Part B: Observational Follow-up|Physician Decision|3|||
124954880|NCT02105688|449459052|FG001|Part B: Observational Follow-up|Physician Decision|1|||
124954881|NCT01757171|449459056|FG000|Overall Study|Adverse Event|5|||
124954882|NCT01757171|449459057|FG001|Overall Study|Adverse Event|1|||
124954883|NCT01757171|449459056|FG000|Overall Study|Disease Progression|1|||
124954884|NCT01757171|449459057|FG001|Overall Study|Disease Progression|0|||
124954885|NCT01757171|449459056|FG000|Overall Study|Hospitalization|1|||
124954886|NCT01757171|449459057|FG001|Overall Study|Hospitalization|0|||
124954887|NCT01757171|449459056|FG000|Overall Study|ECOG decline|1|||
124954888|NCT01757171|449459057|FG001|Overall Study|ECOG decline|0|||
124954889|NCT05878522|449459061|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954890|NCT05878522|449459062|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954891|NCT05878522|449459063|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954892|NCT05878522|449459064|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954893|NCT05878522|449459065|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954894|NCT05878522|449459066|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954895|NCT05878522|449459067|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954896|NCT05878522|449459068|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954897|NCT05878522|449459069|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
124954898|NCT05878522|449459070|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954899|NCT05878522|449459071|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954900|NCT05878522|449459072|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
124954901|NCT05878522|449459061|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
124954902|NCT05878522|449459062|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954903|NCT05878522|449459063|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954904|NCT05878522|449459064|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954905|NCT05878522|449459065|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954906|NCT05878522|449459066|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954907|NCT05878522|449459067|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954908|NCT05878522|449459068|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954909|NCT05878522|449459069|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954910|NCT05878522|449459070|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
124954911|NCT05878522|449459071|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954912|NCT05878522|449459072|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
124954913|NCT05878522|449459061|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954914|NCT05878522|449459062|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
124954915|NCT05878522|449459063|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954916|NCT05878522|449459064|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
124954917|NCT05878522|449459065|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954918|NCT05878522|449459066|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954919|NCT05878522|449459067|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954920|NCT05878522|449459068|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954921|NCT05878522|449459069|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954922|NCT05878522|449459070|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954923|NCT05878522|449459071|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954924|NCT05878522|449459072|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
124954925|NCT05878522|449459061|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954926|NCT05878522|449459062|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954927|NCT05878522|449459063|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954928|NCT05878522|449459064|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954929|NCT05878522|449459065|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
124954930|NCT05878522|449459066|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954931|NCT05878522|449459067|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954932|NCT05878522|449459068|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954933|NCT05878522|449459069|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954934|NCT05878522|449459070|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954935|NCT05878522|449459071|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954936|NCT05878522|449459072|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
124954937|NCT02252172|449459073|FG000|Overall Study|Lost to Follow-up|3|||
124954938|NCT02252172|449459074|FG001|Overall Study|Lost to Follow-up|1|||
124954939|NCT02252172|449459073|FG000|Overall Study|Ongoing|276|||
124954940|NCT02252172|449459074|FG001|Overall Study|Ongoing|298|||
124954941|NCT05740371|449459075|FG000|Overall Study|Death|1|||
124954942|NCT03019289|449459079|FG000|Overall Study|Adverse Event|1|||
124954943|NCT03019289|449459080|FG001|Overall Study|Adverse Event|0|||
124954944|NCT03019289|449459081|FG002|Overall Study|Adverse Event|0|||
124954945|NCT03019289|449459082|FG003|Overall Study|Adverse Event|0|||
124954946|NCT03019289|449459083|FG004|Overall Study|Adverse Event|0|||
124954947|NCT03019289|449459084|FG005|Overall Study|Adverse Event|0|||
124954948|NCT03019289|449459085|FG006|Overall Study|Adverse Event|0|||
124954949|NCT03019289|449459086|FG007|Overall Study|Adverse Event|0|||
124954950|NCT03019289|449459087|FG008|Overall Study|Adverse Event|1|||
124954951|NCT03019289|449459079|FG000|Overall Study|Other|1|||
124954952|NCT03019289|449459080|FG001|Overall Study|Other|0|||
124954953|NCT03019289|449459081|FG002|Overall Study|Other|0|||
124954954|NCT03019289|449459082|FG003|Overall Study|Other|0|||
124954955|NCT03019289|449459083|FG004|Overall Study|Other|0|||
124954956|NCT03019289|449459084|FG005|Overall Study|Other|0|||
124954957|NCT03019289|449459085|FG006|Overall Study|Other|0|||
124954958|NCT03019289|449459086|FG007|Overall Study|Other|0|||
124954959|NCT03019289|449459087|FG008|Overall Study|Other|0|||
124954960|NCT02389894|449459088|FG000|Overall Study|Death|4|||
124954961|NCT02389894|449459089|FG001|Overall Study|Death|5|||
124954962|NCT02389894|449459090|FG002|Overall Study|Death|3|||
124954963|NCT02389894|449459088|FG000|Overall Study|Withdrawal by Subject|2|||
124954964|NCT02389894|449459089|FG001|Overall Study|Withdrawal by Subject|4|||
124954965|NCT02389894|449459090|FG002|Overall Study|Withdrawal by Subject|5|||
124954966|NCT02389894|449459088|FG000|Overall Study|Lost to Follow-up|2|||
124954967|NCT02389894|449459089|FG001|Overall Study|Lost to Follow-up|1|||
124954968|NCT02389894|449459090|FG002|Overall Study|Lost to Follow-up|1|||
124954969|NCT00145496|449459093|FG000|Overall Study|Adverse Event|42|||
124954970|NCT00145496|449459094|FG001|Overall Study|Adverse Event|30|||
124954971|NCT00145496|449459093|FG000|Overall Study|Lack of Efficacy|12|||
124954972|NCT00145496|449459094|FG001|Overall Study|Lack of Efficacy|7|||
124954973|NCT00145496|449459093|FG000|Overall Study|Withdrawal by Subject|32|||
124954974|NCT00145496|449459094|FG001|Overall Study|Withdrawal by Subject|26|||
124954975|NCT00145496|449459093|FG000|Overall Study|Lost to Follow-up|12|||
124954976|NCT00145496|449459094|FG001|Overall Study|Lost to Follow-up|5|||
124954977|NCT00145496|449459093|FG000|Overall Study|Other|25|||
124954978|NCT00145496|449459094|FG001|Overall Study|Other|13|||
124954979|NCT01549951|449459098|FG000|Overall Study|Adverse Event|15|||
124954980|NCT01549951|449459098|FG000|Overall Study|Withdrawal by Subject|2|||
124954981|NCT01549951|449459098|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
124954982|NCT01549951|449459098|FG000|Overall Study|Progressive disease|29|||
124954983|NCT01549951|449459098|FG000|Overall Study|Symptomatic deterioration|1|||
124954984|NCT01549951|449459098|FG000|Overall Study|Other|2|||
124707687|NCT05270863|448554710|FG004|First Washout|Lost to Follow-up|0|||
124954985|NCT01123200|449459099|FG000|Overall Study|Withdrawal by Subject|1|||
124954986|NCT03689452|449459103|FG000|Overall Study|Lost to Follow-up|1|||
124954987|NCT03689452|449459104|FG001|Overall Study|Lost to Follow-up|1|||
124954988|NCT02676778|449459105|FG000|Overall Study|Disease Progression|7|||
124954989|NCT02676778|449459106|FG001|Overall Study|Disease Progression|3|||
124954990|NCT02676778|449459107|FG002|Overall Study|Disease Progression|1|||
124954991|NCT02676778|449459105|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
124954992|NCT02676778|449459106|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
124954993|NCT02676778|449459107|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
124954994|NCT02676778|449459105|FG000|Overall Study|Withdrawal by Subject|3|||
124954995|NCT02676778|449459106|FG001|Overall Study|Withdrawal by Subject|2|||
124954996|NCT02676778|449459107|FG002|Overall Study|Withdrawal by Subject|0|||
124954997|NCT02676778|449459105|FG000|Overall Study|Other|4|||
124954998|NCT02676778|449459106|FG001|Overall Study|Other|3|||
124954999|NCT02676778|449459107|FG002|Overall Study|Other|0|||
124955000|NCT02676778|449459105|FG000|Overall Study|Adverse Event|2|||
124955001|NCT02676778|449459106|FG001|Overall Study|Adverse Event|3|||
124955002|NCT02676778|449459107|FG002|Overall Study|Adverse Event|0|||
124955003|NCT00732498|449459108|FG000|Overall Study|Ineligible|1|||
124955004|NCT00732498|449459108|FG000|Overall Study|Adverse Event|2|||
124955005|NCT00732498|449459108|FG000|Overall Study|Physician Decision|3|||
124955006|NCT03394508|449459116|FG000|Overall Study|Protocol Violation|0|||
124955007|NCT03394508|449459117|FG001|Overall Study|Protocol Violation|3|||
124955008|NCT03394508|449459116|FG000|Overall Study|Lost to Follow-up|1|||
124955009|NCT03394508|449459117|FG001|Overall Study|Lost to Follow-up|0|||
124955010|NCT01288729|449459118|FG000|Overall Study|Withdrawal by Subject|1|||
124955011|NCT01288729|449459119|FG001|Overall Study|Withdrawal by Subject|0|||
124955012|NCT03214198|449459120|FG000|Overall Study|Case Report Forms Uncollected|18|||
124955013|NCT03214198|449459120|FG000|Overall Study|Protocol Deviation|18|||
124955014|NCT04295499|449459121|FG000|Overall Study|moving out of state|1|||
124955015|NCT04295499|449459122|FG001|Overall Study|moving out of state|0|||
124955016|NCT04295499|449459121|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
124955017|NCT04295499|449459122|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
124955018|NCT02135445|449459123|FG000|Overall Study|Lost to Follow-up|1|||
124955019|NCT02135445|449459124|FG001|Overall Study|Lost to Follow-up|0|||
124955020|NCT02135445|449459123|FG000|Overall Study|Withdrawal by Subject|1|||
124955021|NCT02135445|449459124|FG001|Overall Study|Withdrawal by Subject|0|||
124955022|NCT03451292|449460355|FG000|Overall Study|Death|44|||
124955023|NCT03451292|449460356|FG001|Overall Study|Death|59|||
124955024|NCT03451292|449460355|FG000|Overall Study|Withdrawal by Subject|18|||
124955025|NCT03451292|449460356|FG001|Overall Study|Withdrawal by Subject|13|||
124955026|NCT03451292|449460355|FG000|Overall Study|Transplantation|18|||
124955027|NCT03451292|449460356|FG001|Overall Study|Transplantation|12|||
124955028|NCT03451292|449460355|FG000|Overall Study|Lost to Follow-up|4|||
124955029|NCT03451292|449460356|FG001|Overall Study|Lost to Follow-up|12|||
124955030|NCT03451292|449460355|FG000|Overall Study|Physician Decision|4|||
124955031|NCT03451292|449460356|FG001|Overall Study|Physician Decision|3|||
124955032|NCT03451292|449460355|FG000|Overall Study|Adverse Event|3|||
124955033|NCT03451292|449460356|FG001|Overall Study|Adverse Event|3|||
124955034|NCT03451292|449460355|FG000|Overall Study|Non-compliance with Study Drug|2|||
124955035|NCT03451292|449460356|FG001|Overall Study|Non-compliance with Study Drug|0|||
124955036|NCT05878990|449460359|FG000|Overall Study|Lost to Follow-up|7|||
124955037|NCT05878990|449460359|FG000|Overall Study|Withdrawal by Subject|1|||
124955038|NCT02543294|449460362|FG000|Overall Study|Lost to Follow-up|3|||
124955039|NCT02543294|449460362|FG000|Overall Study|Physician Decision|2|||
124955040|NCT02543294|449460362|FG000|Overall Study|Withdrawal by Subject|7|||
124955041|NCT03672188|449460363|FG000|Overall Study|Withdrawal by Subject|0|||
124955042|NCT03672188|449460364|FG001|Overall Study|Withdrawal by Subject|0|||
124955043|NCT03672188|449460365|FG002|Overall Study|Withdrawal by Subject|0|||
124955044|NCT03672188|449460366|FG003|Overall Study|Withdrawal by Subject|3|||
124955045|NCT03672188|449460367|FG004|Overall Study|Withdrawal by Subject|0|||
124955046|NCT03672188|449460368|FG005|Overall Study|Withdrawal by Subject|0|||
124955047|NCT03672188|449460369|FG006|Overall Study|Withdrawal by Subject|0|||
124955048|NCT03672188|449460370|FG007|Overall Study|Withdrawal by Subject|0|||
124955049|NCT03672188|449460371|FG008|Overall Study|Withdrawal by Subject|0|||
124955050|NCT03672188|449460372|FG009|Overall Study|Withdrawal by Subject|0|||
124955051|NCT03672188|449460373|FG010|Overall Study|Withdrawal by Subject|0|||
124955052|NCT03672188|449460374|FG011|Overall Study|Withdrawal by Subject|0|||
124955053|NCT03672188|449460375|FG012|Overall Study|Withdrawal by Subject|0|||
124955054|NCT03672188|449460376|FG013|Overall Study|Withdrawal by Subject|0|||
124955055|NCT03672188|449460377|FG014|Overall Study|Withdrawal by Subject|0|||
124955056|NCT03672188|449460363|FG000|Overall Study|Death|0|||
124955057|NCT03672188|449460364|FG001|Overall Study|Death|0|||
124955058|NCT03672188|449460365|FG002|Overall Study|Death|0|||
124955059|NCT03672188|449460366|FG003|Overall Study|Death|0|||
124955060|NCT03672188|449460367|FG004|Overall Study|Death|0|||
124955061|NCT03672188|449460368|FG005|Overall Study|Death|0|||
124955062|NCT03672188|449460369|FG006|Overall Study|Death|0|||
124955063|NCT03672188|449460370|FG007|Overall Study|Death|0|||
124955064|NCT03672188|449460371|FG008|Overall Study|Death|0|||
124955065|NCT03672188|449460372|FG009|Overall Study|Death|0|||
124955066|NCT03672188|449460373|FG010|Overall Study|Death|0|||
124955067|NCT03672188|449460374|FG011|Overall Study|Death|0|||
124707688|NCT05270863|448554711|FG005|First Washout|Lost to Follow-up|1|||
124955068|NCT03672188|449460375|FG012|Overall Study|Death|1|||
124955069|NCT03672188|449460376|FG013|Overall Study|Death|0|||
124955070|NCT03672188|449460377|FG014|Overall Study|Death|0|||
124955071|NCT03672188|449460363|FG000|Overall Study|Lost to Follow-up|0|||
124955072|NCT03672188|449460364|FG001|Overall Study|Lost to Follow-up|0|||
124955073|NCT03672188|449460365|FG002|Overall Study|Lost to Follow-up|1|||
124955074|NCT03672188|449460366|FG003|Overall Study|Lost to Follow-up|0|||
124955075|NCT03672188|449460367|FG004|Overall Study|Lost to Follow-up|0|||
124955076|NCT03672188|449460368|FG005|Overall Study|Lost to Follow-up|0|||
124955077|NCT03672188|449460369|FG006|Overall Study|Lost to Follow-up|0|||
124955078|NCT03672188|449460370|FG007|Overall Study|Lost to Follow-up|0|||
124955079|NCT03672188|449460371|FG008|Overall Study|Lost to Follow-up|0|||
124955080|NCT03672188|449460372|FG009|Overall Study|Lost to Follow-up|0|||
124955081|NCT03672188|449460373|FG010|Overall Study|Lost to Follow-up|0|||
124955082|NCT03672188|449460374|FG011|Overall Study|Lost to Follow-up|0|||
124955083|NCT03672188|449460375|FG012|Overall Study|Lost to Follow-up|0|||
124955084|NCT03672188|449460376|FG013|Overall Study|Lost to Follow-up|0|||
124707689|NCT05270863|448554706|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
124707690|NCT05270863|448554707|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
124707691|NCT05270863|448554708|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
124707692|NCT05270863|448554709|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
124707693|NCT05270863|448554710|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
124707694|NCT05270863|448554711|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
124707695|NCT05270863|448554706|FG000|Second Washout|Withdrawal by Subject|1|||
124955085|NCT03672188|449460377|FG014|Overall Study|Lost to Follow-up|0|||
124955086|NCT00396409|449460383|FG000|Period 1 - 2007|Adverse Event|0|||
124955087|NCT00396409|449460384|FG001|Period 1 - 2007|Adverse Event|1|||
124955088|NCT00396409|449460383|FG000|Period 1 - 2007|Lack of Efficacy|0|||
124955089|NCT00396409|449460384|FG001|Period 1 - 2007|Lack of Efficacy|1|||
124955090|NCT00396409|449460383|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
124955091|NCT00396409|449460384|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
124955092|NCT00396409|449460383|FG000|Period 1 - 2007|Lost to Follow-up|2|||
124955093|NCT00396409|449460384|FG001|Period 1 - 2007|Lost to Follow-up|3|||
124955094|NCT00396409|449460383|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
124955095|NCT00396409|449460384|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
124955096|NCT00396409|449460383|FG000|Period 2 - 2008|Protocol Violation|1|||
124955097|NCT00396409|449460384|FG001|Period 2 - 2008|Protocol Violation|0|||
124955098|NCT00396409|449460383|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
124955099|NCT00396409|449460384|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
124955100|NCT00396409|449460383|FG000|Period 2 - 2008|Lost to Follow-up|3|||
124955101|NCT00396409|449460384|FG001|Period 2 - 2008|Lost to Follow-up|1|||
124955102|NCT04203199|449460387|FG000|First Intervention Period|Lost to Follow-up|0|||
124955103|NCT04203199|449460388|FG001|First Intervention Period|Lost to Follow-up|1|||
124955104|NCT04203199|449460387|FG000|Second Intervention Period|Medication change|1|||
124955105|NCT04203199|449460388|FG001|Second Intervention Period|Medication change|0|||
124955106|NCT03320941|449460389|FG000|Overall Study|subject/guardian decision|0|||
124955107|NCT03320941|449460390|FG001|Overall Study|subject/guardian decision|0|||
124955108|NCT03320941|449460391|FG002|Overall Study|subject/guardian decision|0|||
124955109|NCT03320941|449460392|FG003|Overall Study|subject/guardian decision|1|||
124955110|NCT03320941|449460393|FG004|Overall Study|subject/guardian decision|0|||
124955111|NCT03614923|449460394|FG000|Overall Study|Withdrawal by Subject|2|||
124955112|NCT03614923|449460395|FG001|Overall Study|Withdrawal by Subject|1|||
124955113|NCT03614923|449460396|FG002|Overall Study|Withdrawal by Subject|1|||
124955114|NCT03614923|449460394|FG000|Overall Study|Adverse Event|0|||
124955115|NCT03614923|449460395|FG001|Overall Study|Adverse Event|2|||
124955116|NCT03614923|449460396|FG002|Overall Study|Adverse Event|1|||
124955117|NCT03614923|449460394|FG000|Overall Study|Lost to Follow-up|1|||
124955118|NCT03614923|449460395|FG001|Overall Study|Lost to Follow-up|0|||
124707696|NCT05270863|448554707|FG001|Second Washout|Withdrawal by Subject|1|||
124955119|NCT03614923|449460396|FG002|Overall Study|Lost to Follow-up|1|||
124955120|NCT03614923|449460394|FG000|Overall Study|Lack of Efficacy|2|||
124955121|NCT03614923|449460395|FG001|Overall Study|Lack of Efficacy|0|||
124955122|NCT03614923|449460396|FG002|Overall Study|Lack of Efficacy|1|||
124955123|NCT03614923|449460394|FG000|Overall Study|Non-compliance|0|||
124955124|NCT03614923|449460395|FG001|Overall Study|Non-compliance|1|||
124955125|NCT03614923|449460396|FG002|Overall Study|Non-compliance|0|||
124955126|NCT03614923|449460394|FG000|Overall Study|Other|0|||
124955127|NCT03614923|449460395|FG001|Overall Study|Other|1|||
124955128|NCT03614923|449460396|FG002|Overall Study|Other|1|||
124955129|NCT01107353|449460397|FG000|Overall Study|Positive Drug Screen|1|||
124955130|NCT01107353|449460398|FG001|Overall Study|Positive Drug Screen|0|||
124955131|NCT01136733|449460399|FG000|Phase 1b|Adverse Event|0|||
124955132|NCT01136733|449460400|FG001|Phase 1b|Adverse Event|3|||
124955133|NCT01136733|449460401|FG002|Phase 1b|Adverse Event|1|||
124955134|NCT01136733|449460402|FG003|Phase 1b|Adverse Event|0|||
124955135|NCT01136733|449460403|FG004|Phase 1b|Adverse Event|0|||
124955136|NCT01136733|449460404|FG005|Phase 1b|Adverse Event|0|||
124955137|NCT01136733|449460405|FG006|Phase 1b|Adverse Event|0|||
124955138|NCT01136733|449460399|FG000|Phase 1b|Participant Choice|0|||
124955139|NCT01136733|449460400|FG001|Phase 1b|Participant Choice|0|||
124955140|NCT01136733|449460401|FG002|Phase 1b|Participant Choice|1|||
124955141|NCT01136733|449460402|FG003|Phase 1b|Participant Choice|0|||
124955142|NCT01136733|449460403|FG004|Phase 1b|Participant Choice|0|||
124955143|NCT01136733|449460404|FG005|Phase 1b|Participant Choice|0|||
124955144|NCT01136733|449460405|FG006|Phase 1b|Participant Choice|0|||
124955145|NCT01136733|449460399|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
124955146|NCT01136733|449460400|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
124955147|NCT01136733|449460401|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
124955148|NCT01136733|449460402|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
124955149|NCT01136733|449460403|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
124955150|NCT01136733|449460404|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
124955151|NCT01136733|449460405|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
124955152|NCT01136733|449460399|FG000|Phase 1b|Clinical Progression|1|||
124955153|NCT01136733|449460400|FG001|Phase 1b|Clinical Progression|1|||
124955154|NCT01136733|449460401|FG002|Phase 1b|Clinical Progression|0|||
124955155|NCT01136733|449460402|FG003|Phase 1b|Clinical Progression|0|||
124955156|NCT01136733|449460403|FG004|Phase 1b|Clinical Progression|0|||
124955157|NCT01136733|449460404|FG005|Phase 1b|Clinical Progression|0|||
124955158|NCT01136733|449460405|FG006|Phase 1b|Clinical Progression|0|||
124955159|NCT01136733|449460399|FG000|Phase 2|Disease Progression|0|||
124955160|NCT01136733|449460400|FG001|Phase 2|Disease Progression|0|||
124955161|NCT01136733|449460401|FG002|Phase 2|Disease Progression|0|||
124955162|NCT01136733|449460402|FG003|Phase 2|Disease Progression|0|||
124955163|NCT01136733|449460403|FG004|Phase 2|Disease Progression|30|||
124955164|NCT01136733|449460404|FG005|Phase 2|Disease Progression|32|||
124955165|NCT01136733|449460405|FG006|Phase 2|Disease Progression|38|||
124955166|NCT01136733|449460399|FG000|Phase 2|Adverse Event|0|||
124955167|NCT01136733|449460400|FG001|Phase 2|Adverse Event|0|||
124955168|NCT01136733|449460401|FG002|Phase 2|Adverse Event|0|||
124955169|NCT01136733|449460402|FG003|Phase 2|Adverse Event|0|||
124955170|NCT01136733|449460403|FG004|Phase 2|Adverse Event|11|||
124955171|NCT01136733|449460404|FG005|Phase 2|Adverse Event|13|||
124955172|NCT01136733|449460405|FG006|Phase 2|Adverse Event|5|||
124955173|NCT01136733|449460399|FG000|Phase 2|Participant Choice|0|||
124955174|NCT01136733|449460400|FG001|Phase 2|Participant Choice|0|||
124460625|NCT00105443|447645958|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
124460626|NCT00105443|447645959|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
124460627|NCT00105443|447645960|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
124955175|NCT01136733|449460401|FG002|Phase 2|Participant Choice|0|||
124460628|NCT02135692|447645961|FG000|Overall Study|Adverse Event|3|||
124955176|NCT01136733|449460402|FG003|Phase 2|Participant Choice|0|||
124955177|NCT01136733|449460403|FG004|Phase 2|Participant Choice|3|||
124955178|NCT01136733|449460404|FG005|Phase 2|Participant Choice|0|||
124955179|NCT01136733|449460405|FG006|Phase 2|Participant Choice|1|||
124955180|NCT01136733|449460399|FG000|Phase 2|Administrative-Withdrew Consent|0|||
124955181|NCT01136733|449460400|FG001|Phase 2|Administrative-Withdrew Consent|0|||
124955182|NCT01136733|449460401|FG002|Phase 2|Administrative-Withdrew Consent|0|||
124955183|NCT01136733|449460402|FG003|Phase 2|Administrative-Withdrew Consent|0|||
124955184|NCT01136733|449460403|FG004|Phase 2|Administrative-Withdrew Consent|1|||
124955185|NCT01136733|449460404|FG005|Phase 2|Administrative-Withdrew Consent|0|||
124955186|NCT01136733|449460405|FG006|Phase 2|Administrative-Withdrew Consent|0|||
124955187|NCT01136733|449460399|FG000|Phase 2|Other|0|||
124955188|NCT01136733|449460400|FG001|Phase 2|Other|0|||
124955189|NCT01136733|449460401|FG002|Phase 2|Other|0|||
124955190|NCT01136733|449460402|FG003|Phase 2|Other|0|||
124955191|NCT01136733|449460403|FG004|Phase 2|Other|6|||
124955192|NCT01136733|449460404|FG005|Phase 2|Other|7|||
124955193|NCT01136733|449460405|FG006|Phase 2|Other|6|||
124955194|NCT03360071|449460407|FG000|Overall Study|Lost to Follow-up|1|||
124955195|NCT03360071|449460408|FG001|Overall Study|Lost to Follow-up|0|||
124955196|NCT02504502|449460413|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
124955197|NCT02504502|449460414|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
124955198|NCT02504502|449460413|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
124955199|NCT02504502|449460414|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
124955200|NCT01014013|449460415|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
124955201|NCT01014013|449460416|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
124955202|NCT01014013|449460415|FG000|Overall Study|Clinical adverse experience|4|||
124955203|NCT01014013|449460416|FG001|Overall Study|Clinical adverse experience|2|||
124955204|NCT01014013|449460415|FG000|Overall Study|Laboratory adverse experience|1|||
124955205|NCT01014013|449460416|FG001|Overall Study|Laboratory adverse experience|1|||
124955206|NCT01014013|449460415|FG000|Overall Study|Protocol Violation|1|||
124955207|NCT01014013|449460416|FG001|Overall Study|Protocol Violation|3|||
124955208|NCT01014013|449460415|FG000|Overall Study|Withdrawal by Subject|7|||
124955209|NCT01014013|449460416|FG001|Overall Study|Withdrawal by Subject|4|||
124955210|NCT01014013|449460415|FG000|Overall Study|Clinical/microbiologic failure|1|||
124955211|NCT01014013|449460416|FG001|Overall Study|Clinical/microbiologic failure|2|||
124955212|NCT01014013|449460415|FG000|Overall Study|Pathogen culture = no growth|26|||
124955213|NCT01014013|449460416|FG001|Overall Study|Pathogen culture = no growth|34|||
124955214|NCT01014013|449460415|FG000|Overall Study|Negative urine culture|2|||
124955215|NCT01014013|449460416|FG001|Overall Study|Negative urine culture|0|||
124955216|NCT01014013|449460415|FG000|Overall Study|Pathogen resistant|7|||
124955217|NCT01014013|449460416|FG001|Overall Study|Pathogen resistant|4|||
124955218|NCT01014013|449460415|FG000|Overall Study|Physician Decision|0|||
124955219|NCT01014013|449460416|FG001|Overall Study|Physician Decision|1|||
124955220|NCT01014013|449460415|FG000|Overall Study|Another antibiotic therapy required|0|||
124955221|NCT01014013|449460416|FG001|Overall Study|Another antibiotic therapy required|1|||
124955222|NCT01014013|449460415|FG000|Overall Study|Appendectomy|1|||
124955223|NCT01014013|449460416|FG001|Overall Study|Appendectomy|0|||
124955224|NCT01014013|449460415|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
124955225|NCT01014013|449460416|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
124955226|NCT00316121|449460417|FG000|Overall Study|Death|1|||
124955227|NCT00316121|449460418|FG001|Overall Study|Death|0|||
124955228|NCT00316121|449460417|FG000|Overall Study|Lost to Follow-up|14|||
124955229|NCT00316121|449460418|FG001|Overall Study|Lost to Follow-up|8|||
124955230|NCT00316121|449460417|FG000|Overall Study|Withdrawal by Subject|2|||
124955231|NCT00316121|449460418|FG001|Overall Study|Withdrawal by Subject|0|||
124955232|NCT00316121|449460417|FG000|Overall Study|Reason is missing|1|||
124955233|NCT00316121|449460418|FG001|Overall Study|Reason is missing|0|||
124955234|NCT00316121|449460417|FG000|Overall Study|Subject relocated|1|||
124955235|NCT00316121|449460418|FG001|Overall Study|Subject relocated|1|||
124955236|NCT00316121|449460417|FG000|Overall Study|Subject refused to return|1|||
124955237|NCT00316121|449460418|FG001|Overall Study|Subject refused to return|0|||
124955238|NCT00316121|449460417|FG000|Overall Study|Subject no show for visit x 3|1|||
124707697|NCT05270863|448554708|FG002|Second Washout|Withdrawal by Subject|0|||
124955239|NCT00316121|449460418|FG001|Overall Study|Subject no show for visit x 3|0|||
124955240|NCT00316121|449460417|FG000|Overall Study|Subject did not have 24 month visit|1|||
124955241|NCT00316121|449460418|FG001|Overall Study|Subject did not have 24 month visit|0|||
124955242|NCT02305797|449460419|FG000|Overall Study|Adverse Event|11|||
124955243|NCT02305797|449460420|FG001|Overall Study|Adverse Event|2|||
124955244|NCT02305797|449460419|FG000|Overall Study|Withdrawal by Subject|9|||
124955245|NCT02305797|449460420|FG001|Overall Study|Withdrawal by Subject|10|||
124955246|NCT02305797|449460419|FG000|Overall Study|Lack of Efficacy|6|||
124955247|NCT02305797|449460420|FG001|Overall Study|Lack of Efficacy|0|||
124955248|NCT02305797|449460419|FG000|Overall Study|Lost to Follow-up|5|||
124955249|NCT02305797|449460420|FG001|Overall Study|Lost to Follow-up|11|||
124955250|NCT02305797|449460419|FG000|Overall Study|Pregnancy|0|||
124955251|NCT02305797|449460420|FG001|Overall Study|Pregnancy|2|||
124955252|NCT02305797|449460419|FG000|Overall Study|Noncompliance|14|||
124955253|NCT02305797|449460420|FG001|Overall Study|Noncompliance|12|||
124955254|NCT02305797|449460419|FG000|Overall Study|Reason not collected|0|||
124955255|NCT02305797|449460420|FG001|Overall Study|Reason not collected|1|||
124955256|NCT00460577|449460423|FG000|Overall Study|Protocol Violation|2|||
124955257|NCT00460577|449460424|FG001|Overall Study|Protocol Violation|6|||
124955258|NCT02213458|449460425|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
124955259|NCT02213458|449460426|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
124955260|NCT02213458|449460425|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
124955261|NCT02213458|449460426|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
124955262|NCT02213458|449460425|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
124955263|NCT02213458|449460426|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
124460629|NCT02135692|447645961|FG000|Overall Study|Lack of Efficacy|2|||
124955264|NCT02213458|449460425|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
124955265|NCT02213458|449460426|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
124955266|NCT02213458|449460425|FG000|Overall Study|Refused re-consent|6|||
124955267|NCT02213458|449460426|FG001|Overall Study|Refused re-consent|0|||
124955268|NCT02213458|449460425|FG000|Overall Study|Lost to Follow-up|2|||
124955269|NCT02213458|449460426|FG001|Overall Study|Lost to Follow-up|2|||
124955270|NCT02213458|449460425|FG000|Overall Study|Withdrawal by Subject|26|||
124955271|NCT02213458|449460426|FG001|Overall Study|Withdrawal by Subject|8|||
124955272|NCT00910871|449460427|FG000|Overall Study|Adverse Event|5|||
124955273|NCT00910871|449460427|FG000|Overall Study|Death|12|||
124707698|NCT05270863|448554709|FG003|Second Washout|Withdrawal by Subject|0|||
124707699|NCT05270863|448554710|FG004|Second Washout|Withdrawal by Subject|0|||
124707700|NCT05270863|448554711|FG005|Second Washout|Withdrawal by Subject|0|||
124955274|NCT00910871|449460427|FG000|Overall Study|Lost to Follow-up|8|||
124955275|NCT00910871|449460427|FG000|Overall Study|Protocol Violation|11|||
124955276|NCT00910871|449460427|FG000|Overall Study|Withdrawal by Subject|12|||
124955277|NCT00910871|449460427|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
124955278|NCT00910871|449460427|FG000|Overall Study|Undefined|1|||
124460630|NCT02135692|447645961|FG000|Overall Study|Protocol Violation|2|||
124707701|NCT05270863|448554706|FG000|Second Washout|Lost to Follow-up|0|||
124955279|NCT01878253|449460428|FG000|Overall Study|Death|1|||
124460631|NCT02135692|447645961|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
124460632|NCT02135692|447645961|FG000|Overall Study|Product commercially available|159|||
124955280|NCT01878253|449460428|FG000|Overall Study|SIdus System Removal|3|||
124955281|NCT01878253|449460428|FG000|Overall Study|Withdrawal by Subject|1|||
124955282|NCT01878253|449460428|FG000|Overall Study|Lost to Follow-up|2|||
124955283|NCT01878253|449460428|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
124955284|NCT04043806|449460429|FG000|Overall Study|Commercial drug is available for participants|13|||
124955285|NCT04043806|449460429|FG000|Overall Study|Physician Decision|2|||
124955286|NCT04043806|449460429|FG000|Overall Study|Other|12|||
124955287|NCT04043806|449460429|FG000|Overall Study|Adverse Event|2|||
124955288|NCT04043806|449460429|FG000|Overall Study|Lost to Follow-up|6|||
124955289|NCT04043806|449460429|FG000|Overall Study|Other non-compliance|2|||
124955290|NCT04043806|449460429|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
124955291|NCT04043806|449460429|FG000|Overall Study|Never Dosed|1|||
124955292|NCT01622088|449460430|FG000|Overall Study|Adverse Event|20|||
124955293|NCT01622088|449460430|FG000|Overall Study|Lost to Follow-up|1|||
124955294|NCT01622088|449460430|FG000|Overall Study|Withdrawal by Subject|20|||
124955295|NCT01622088|449460430|FG000|Overall Study|Investigator Decision|1|||
124955296|NCT01622088|449460430|FG000|Overall Study|Death|53|||
124955297|NCT01622088|449460430|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
124955298|NCT04799587|449460432|FG000|Overall Study|Withdrawal by Subject|0|||
124955299|NCT04799587|449460433|FG001|Overall Study|Withdrawal by Subject|1|||
124955300|NCT04598776|449460434|FG000|Overall Study|Protocol Violation|5|||
124955301|NCT04598776|449460434|FG000|Overall Study|Physician Decision|4|||
124955302|NCT06312566|449460441|FG000|Overall Study|Protocol Violation|0|||
124955303|NCT06312566|449460442|FG001|Overall Study|Protocol Violation|1|||
124955304|NCT04736472|449460443|FG000|Overall Study|Lost to Follow-up|1|||
124955305|NCT04736472|449460444|FG001|Overall Study|Lost to Follow-up|0|||
124955306|NCT04736472|449460445|FG002|Overall Study|Lost to Follow-up|0|||
124955307|NCT04736472|449460443|FG000|Overall Study|Withdrawal by Subject|2|||
124955308|NCT04736472|449460444|FG001|Overall Study|Withdrawal by Subject|0|||
124955309|NCT04736472|449460445|FG002|Overall Study|Withdrawal by Subject|0|||
124955310|NCT04736472|449460443|FG000|Overall Study|Protocol Violation|48|||
124955311|NCT04736472|449460444|FG001|Overall Study|Protocol Violation|0|||
124955312|NCT04736472|449460445|FG002|Overall Study|Protocol Violation|6|||
124955313|NCT02116582|449460446|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
124955314|NCT02116582|449460446|FG000|Overall Study|Adverse Event|22|||
124955315|NCT02116582|449460446|FG000|Overall Study|Death|9|||
124955316|NCT02116582|449460446|FG000|Overall Study|Progressive Disease|148|||
124955317|NCT02116582|449460446|FG000|Overall Study|Protocol Violation|3|||
124955318|NCT02116582|449460446|FG000|Overall Study|Withdrawal by Subject|8|||
124955319|NCT02116582|449460446|FG000|Overall Study|Other: Miscellaneous|11|||
124955320|NCT02116582|449460446|FG000|Overall Study|Lost to Follow-up|1|||
124955321|NCT02116582|449460446|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
124955322|NCT03861078|449460447|FG000|Overall Study|COVID-19 shut down|4|||
124955323|NCT03861078|449460447|FG000|Overall Study|Lost to Follow-up|1|||
124955324|NCT03861078|449460447|FG000|Overall Study|Protocol Violation|2|||
124955325|NCT03861078|449460447|FG000|Overall Study|lack of venous access|1|||
124955326|NCT02971683|449460448|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
124955327|NCT02971683|449460449|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
124955328|NCT02971683|449460448|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
124955329|NCT02971683|449460449|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
124955330|NCT02971683|449460448|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
124955331|NCT02971683|449460449|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
124955332|NCT02971683|449460448|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
124955333|NCT02971683|449460449|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
124955334|NCT02971683|449460448|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
124955335|NCT02971683|449460449|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
124955336|NCT02971683|449460448|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
124955337|NCT02971683|449460449|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
124955338|NCT02971683|449460448|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
124955339|NCT02971683|449460449|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
124955340|NCT02971683|449460448|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
124955341|NCT02971683|449460449|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
124955342|NCT02971683|449460448|FG000|Open-Label|Lost to Follow-up|1|||
124955343|NCT02971683|449460449|FG001|Open-Label|Lost to Follow-up|0|||
124955344|NCT02971683|449460448|FG000|Open-Label|Participants withdrew consent|0|||
124955345|NCT02971683|449460449|FG001|Open-Label|Participants withdrew consent|2|||
124955346|NCT02971683|449460448|FG000|Open-Label|Participant request to discontinue study treatment|1|||
124955347|NCT02971683|449460449|FG001|Open-Label|Participant request to discontinue study treatment|0|||
124955348|NCT02971683|449460448|FG000|Open-Label|Lack of Efficacy|2|||
124955349|NCT02971683|449460449|FG001|Open-Label|Lack of Efficacy|0|||
124955350|NCT02971683|449460448|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
124955351|NCT02971683|449460449|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
124955352|NCT02971683|449460448|FG000|Long-Term Open Label|Participant withdrew consent|1|||
124766442|NCT05121766|448771736|FG000|Overall Study|Covid reinfection|3|||
124549007|NCT01060007|447965424|FG000|Overall Study|Withdrawal by Subject|1|||
124549008|NCT01060007|447965424|FG000|Overall Study|Inevaluable for response at surgery|3|||
124549009|NCT00742859|447965429|FG000|Overall Study|Adverse Event|5|||
124549010|NCT00742859|447965430|FG001|Overall Study|Adverse Event|6|||
124549011|NCT00742859|447965431|FG002|Overall Study|Adverse Event|3|||
124766443|NCT05121766|448771737|FG001|Overall Study|Covid reinfection|0|||
124766444|NCT05121766|448771736|FG000|Overall Study|Withdrawal by Subject|3|||
124955353|NCT02971683|449460449|FG001|Long-Term Open Label|Participant withdrew consent|0|||
124955354|NCT02971683|449460448|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
124955355|NCT02971683|449460449|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
124955356|NCT02971683|449460448|FG000|Long-Term Open Label|Adverse Event|1|||
124955357|NCT02971683|449460449|FG001|Long-Term Open Label|Adverse Event|2|||
124955358|NCT02971683|449460448|FG000|Long-Term Open Label|Lack of Efficacy|1|||
124955359|NCT02971683|449460449|FG001|Long-Term Open Label|Lack of Efficacy|1|||
124955360|NCT02268526|449460452|FG000|Overall Study|Adverse Event|0|||
124955361|NCT02268526|449460453|FG001|Overall Study|Adverse Event|2|||
124955362|NCT02268526|449460454|FG002|Overall Study|Adverse Event|1|||
124955363|NCT02268526|449460452|FG000|Overall Study|Death|1|||
124955364|NCT02268526|449460453|FG001|Overall Study|Death|11|||
124955365|NCT02268526|449460454|FG002|Overall Study|Death|0|||
124955366|NCT02268526|449460452|FG000|Overall Study|protocol deviation|0|||
124955367|NCT02268526|449460453|FG001|Overall Study|protocol deviation|1|||
124955368|NCT02268526|449460454|FG002|Overall Study|protocol deviation|0|||
124955369|NCT02268526|449460452|FG000|Overall Study|Physician Decision|0|||
124955370|NCT02268526|449460453|FG001|Overall Study|Physician Decision|0|||
124955371|NCT02268526|449460454|FG002|Overall Study|Physician Decision|1|||
124955372|NCT02268526|449460452|FG000|Overall Study|Subject/guardian decision|0|||
124955373|NCT02268526|449460453|FG001|Overall Study|Subject/guardian decision|7|||
124955374|NCT02268526|449460454|FG002|Overall Study|Subject/guardian decision|3|||
124955375|NCT00596960|449460455|FG000|Overall Study|Death|1|||
124955376|NCT00596960|449460456|FG001|Overall Study|Death|2|||
124955377|NCT00596960|449460455|FG000|Overall Study|Lost to Follow-up|6|||
124955378|NCT00596960|449460456|FG001|Overall Study|Lost to Follow-up|5|||
124955379|NCT00596960|449460455|FG000|Overall Study|Withdrawal by Subject|1|||
124955380|NCT00596960|449460456|FG001|Overall Study|Withdrawal by Subject|0|||
124955381|NCT00596960|449460455|FG000|Overall Study|Incarcerated|2|||
124955382|NCT00596960|449460456|FG001|Overall Study|Incarcerated|0|||
124955383|NCT00596960|449460455|FG000|Overall Study|Physician Decision|1|||
124955384|NCT00596960|449460456|FG001|Overall Study|Physician Decision|0|||
124955385|NCT00596960|449460455|FG000|Overall Study|Protocol Violation|0|||
124955386|NCT00596960|449460456|FG001|Overall Study|Protocol Violation|1|||
124955387|NCT00596960|449460455|FG000|Overall Study|No alcohol use data|0|||
124955388|NCT00596960|449460456|FG001|Overall Study|No alcohol use data|1|||
124955389|NCT02130401|449460462|FG000|Overall Study|Poor enrollment|6|||
124955390|NCT00936065|449460463|FG000|Overall Study|Adverse Event|1|||
124955391|NCT00936065|449460464|FG001|Overall Study|Adverse Event|0|||
124955392|NCT00936065|449460465|FG002|Overall Study|Adverse Event|1|||
124955393|NCT00936065|449460463|FG000|Overall Study|Lack of Efficacy|1|||
124955394|NCT00936065|449460464|FG001|Overall Study|Lack of Efficacy|0|||
124955395|NCT00936065|449460465|FG002|Overall Study|Lack of Efficacy|1|||
124955396|NCT00936065|449460463|FG000|Overall Study|Lost to Follow-up|1|||
124955397|NCT00936065|449460464|FG001|Overall Study|Lost to Follow-up|0|||
124955398|NCT00936065|449460465|FG002|Overall Study|Lost to Follow-up|0|||
124955399|NCT00936065|449460463|FG000|Overall Study|Protocol Violation|1|||
124955400|NCT00936065|449460464|FG001|Overall Study|Protocol Violation|2|||
124955401|NCT00936065|449460465|FG002|Overall Study|Protocol Violation|1|||
124955402|NCT00936065|449460463|FG000|Overall Study|Withdrawal by Subject|0|||
124955403|NCT00936065|449460464|FG001|Overall Study|Withdrawal by Subject|2|||
124955404|NCT00936065|449460465|FG002|Overall Study|Withdrawal by Subject|4|||
124955405|NCT00070317|449460466|FG000|Overall Study|Inevaluable (Never Treated)|1|||
124955406|NCT00070317|449460466|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
124460633|NCT02135692|447645961|FG000|Overall Study|Study closed/terminated|153|||
124460634|NCT02135692|447645961|FG000|Overall Study|Lost to Follow-up|4|||
124460635|NCT02135692|447645961|FG000|Overall Study|Withdrawal by Subject|15|||
124460636|NCT04429061|447645964|FG000|Overall Study|Lost to Follow-up|62|||
124460637|NCT04429061|447645965|FG001|Overall Study|Lost to Follow-up|87|||
124460638|NCT04429061|447645964|FG000|Overall Study|Withdrawal by Subject|3|||
124955407|NCT00070317|449460466|FG000|Overall Study|Ineligible required test not done|1|||
124955408|NCT00070317|449460466|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
124955409|NCT00070317|449460466|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
124955410|NCT01429285|449460467|FG000|Overall Study|Protocol Violation|9|||
124955411|NCT01429285|449460468|FG001|Overall Study|Protocol Violation|4|||
124955412|NCT01429285|449460467|FG000|Overall Study|Missing Data|5|||
124955413|NCT01429285|449460468|FG001|Overall Study|Missing Data|3|||
124955414|NCT01429285|449460467|FG000|Overall Study|Erroneously Enrolled Twice|8|||
124955415|NCT01429285|449460468|FG001|Overall Study|Erroneously Enrolled Twice|2|||
124955416|NCT01885559|449460469|FG000|Overall Study|Lost to Follow-up|15|||
124955417|NCT01885559|449460470|FG001|Overall Study|Lost to Follow-up|16|||
124955418|NCT01885559|449460469|FG000|Overall Study|Less than full participation|9|||
124955419|NCT01885559|449460470|FG001|Overall Study|Less than full participation|19|||
124955420|NCT01885559|449460469|FG000|Overall Study|Protocol Violation|0|||
124955421|NCT01885559|449460470|FG001|Overall Study|Protocol Violation|1|||
124955422|NCT01052714|449460474|FG000|Overall Study|Adverse Event|6|||
124955423|NCT01052714|449460475|FG001|Overall Study|Adverse Event|3|||
124955424|NCT01052714|449460476|FG002|Overall Study|Adverse Event|0|||
124955425|NCT01052714|449460474|FG000|Overall Study|Death|1|||
124955426|NCT01052714|449460475|FG001|Overall Study|Death|2|||
124955427|NCT01052714|449460476|FG002|Overall Study|Death|0|||
124955428|NCT01052714|449460474|FG000|Overall Study|Lost to Follow-up|2|||
124955429|NCT01052714|449460475|FG001|Overall Study|Lost to Follow-up|3|||
124955430|NCT01052714|449460476|FG002|Overall Study|Lost to Follow-up|0|||
124955431|NCT01052714|449460474|FG000|Overall Study|Physician Decision|9|||
124955432|NCT01052714|449460475|FG001|Overall Study|Physician Decision|9|||
124955433|NCT01052714|449460476|FG002|Overall Study|Physician Decision|1|||
124955434|NCT01052714|449460474|FG000|Overall Study|Withdrawal by Subject|7|||
124955435|NCT01052714|449460475|FG001|Overall Study|Withdrawal by Subject|12|||
124955436|NCT01052714|449460476|FG002|Overall Study|Withdrawal by Subject|1|||
124955437|NCT00644332|449462255|FG000|Overall Study|Adverse Event|11|||
124955438|NCT00644332|449462255|FG000|Overall Study|Withdrawal by Subject|6|||
124955439|NCT00644332|449462255|FG000|Overall Study|Completion Status Unknown|2|||
124955440|NCT00644332|449462255|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
124955441|NCT00644332|449462255|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
124955442|NCT00627523|449462259|FG000|Overall Study|Lack of Efficacy|1|||
124955443|NCT00627523|449462260|FG001|Overall Study|Lack of Efficacy|0|||
124955444|NCT00627523|449462259|FG000|Overall Study|Withdrawal by Subject|0|||
124955445|NCT00627523|449462260|FG001|Overall Study|Withdrawal by Subject|2|||
124955446|NCT00627523|449462259|FG000|Overall Study|Other|1|||
124955447|NCT00627523|449462260|FG001|Overall Study|Other|0|||
124955448|NCT00355784|449462264|FG000|Overall Study|Withdrawal by Subject|0|||
124955449|NCT00355784|449462265|FG001|Overall Study|Withdrawal by Subject|0|||
124955450|NCT00355784|449462266|FG002|Overall Study|Withdrawal by Subject|2|||
124955451|NCT03602053|449462270|FG000|Overall Study|Withdrawal by Subject|7|||
124955452|NCT03602053|449462271|FG001|Overall Study|Withdrawal by Subject|9|||
124955453|NCT03602053|449462272|FG002|Overall Study|Withdrawal by Subject|7|||
124955454|NCT03602053|449462270|FG000|Overall Study|Lost to Follow-up|5|||
124955455|NCT03602053|449462271|FG001|Overall Study|Lost to Follow-up|6|||
124955456|NCT03602053|449462272|FG002|Overall Study|Lost to Follow-up|0|||
124955457|NCT03602053|449462270|FG000|Overall Study|Protocol Violation|3|||
124955458|NCT03602053|449462271|FG001|Overall Study|Protocol Violation|0|||
124955459|NCT03602053|449462272|FG002|Overall Study|Protocol Violation|4|||
124955460|NCT03602053|449462270|FG000|Overall Study|Physician Decision|1|||
124955461|NCT03602053|449462271|FG001|Overall Study|Physician Decision|0|||
124955462|NCT03602053|449462272|FG002|Overall Study|Physician Decision|0|||
124460639|NCT04429061|447645965|FG001|Overall Study|Withdrawal by Subject|4|||
124460640|NCT00879229|447645971|FG000|Overall Study|Study terminated by Sponsor|13|||
124460641|NCT00879229|447645972|FG001|Overall Study|Study terminated by Sponsor|12|||
124549012|NCT00742859|447965432|FG003|Overall Study|Adverse Event|1|||
124955463|NCT03602053|449462270|FG000|Overall Study|migration|2|||
124955464|NCT03602053|449462271|FG001|Overall Study|migration|3|||
124955465|NCT03602053|449462272|FG002|Overall Study|migration|0|||
124955466|NCT03602053|449462270|FG000|Overall Study|Other|1|||
124955467|NCT03602053|449462271|FG001|Overall Study|Other|0|||
124955468|NCT03602053|449462272|FG002|Overall Study|Other|0|||
124955469|NCT01038128|449462273|FG000|Overall Study|Lack of Efficacy|1|||
124955470|NCT01038128|449462273|FG000|Overall Study|Lost to Follow-up|1|||
124955471|NCT01038128|449462273|FG000|Overall Study|Withdrawal by Subject|2|||
124955472|NCT01193283|449462280|FG000|Overall Study|Death|1|||
124955473|NCT01838447|449462283|FG000|Overall Study|Change in surgical plan|1|||
124460642|NCT00879229|447645971|FG000|Overall Study|Death|4|||
124955474|NCT01838447|449462284|FG001|Overall Study|Change in surgical plan|2|||
124460643|NCT00879229|447645972|FG001|Overall Study|Death|2|||
124460644|NCT00879229|447645971|FG000|Overall Study|Adverse Event|2|||
124955475|NCT01838447|449462283|FG000|Overall Study|Withdrawal by Subject|1|||
124955476|NCT01838447|449462284|FG001|Overall Study|Withdrawal by Subject|1|||
124955477|NCT00168805|449462285|FG000|Overall Study|Adverse Event|7|||
124955478|NCT00168805|449462286|FG001|Overall Study|Adverse Event|11|||
124955479|NCT00168805|449462287|FG002|Overall Study|Adverse Event|16|||
124955480|NCT00168805|449462285|FG000|Overall Study|Protocol Violation|12|||
124955481|NCT00168805|449462286|FG001|Overall Study|Protocol Violation|11|||
124955482|NCT00168805|449462287|FG002|Overall Study|Protocol Violation|8|||
124955483|NCT00168805|449462285|FG000|Overall Study|Lost to Follow-up|12|||
124955484|NCT00168805|449462286|FG001|Overall Study|Lost to Follow-up|17|||
124955485|NCT00168805|449462287|FG002|Overall Study|Lost to Follow-up|11|||
124955486|NCT00168805|449462285|FG000|Overall Study|Withdrawal by Subject|16|||
124955487|NCT00168805|449462286|FG001|Overall Study|Withdrawal by Subject|18|||
124955488|NCT00168805|449462287|FG002|Overall Study|Withdrawal by Subject|21|||
124955489|NCT00168805|449462285|FG000|Overall Study|Other|24|||
124955490|NCT00168805|449462286|FG001|Overall Study|Other|21|||
124955491|NCT00168805|449462287|FG002|Overall Study|Other|22|||
124955492|NCT00168805|449462285|FG000|Treatment|Adverse Event|25|||
124955493|NCT00168805|449462286|FG001|Treatment|Adverse Event|26|||
124955494|NCT00168805|449462287|FG002|Treatment|Adverse Event|32|||
124955495|NCT00168805|449462285|FG000|Treatment|Protocol Violation|3|||
124955496|NCT00168805|449462286|FG001|Treatment|Protocol Violation|5|||
124955497|NCT00168805|449462287|FG002|Treatment|Protocol Violation|5|||
124955498|NCT00168805|449462285|FG000|Treatment|Withdrawal by Subject|3|||
124955499|NCT00168805|449462286|FG001|Treatment|Withdrawal by Subject|7|||
124955500|NCT00168805|449462287|FG002|Treatment|Withdrawal by Subject|8|||
124955501|NCT00168805|449462285|FG000|Treatment|Other|18|||
124955502|NCT00168805|449462286|FG001|Treatment|Other|18|||
124955503|NCT00168805|449462287|FG002|Treatment|Other|17|||
124955504|NCT00472199|449462310|FG000|Overall Study|Adverse Event|19|||
124955505|NCT00472199|449462311|FG001|Overall Study|Adverse Event|23|||
124955506|NCT00472199|449462310|FG000|Overall Study|Lack of Efficacy|4|||
124955507|NCT00472199|449462311|FG001|Overall Study|Lack of Efficacy|25|||
124955508|NCT00472199|449462310|FG000|Overall Study|Lost to Follow-up|2|||
124955509|NCT00472199|449462311|FG001|Overall Study|Lost to Follow-up|4|||
124955510|NCT00472199|449462310|FG000|Overall Study|Protocol Violation|3|||
124955511|NCT00472199|449462311|FG001|Overall Study|Protocol Violation|2|||
124955512|NCT00472199|449462310|FG000|Overall Study|Withdrawal by Subject|6|||
124955513|NCT00472199|449462311|FG001|Overall Study|Withdrawal by Subject|5|||
124955514|NCT00472199|449462310|FG000|Overall Study|personal reason|0|||
124955515|NCT00472199|449462311|FG001|Overall Study|personal reason|1|||
124955516|NCT00472199|449462310|FG000|Overall Study|patient was asymptomatic|1|||
124955517|NCT00472199|449462311|FG001|Overall Study|patient was asymptomatic|0|||
124955518|NCT02446912|449462313|FG000|Overall Study|Adverse Event|3|||
124955519|NCT02446912|449462314|FG001|Overall Study|Adverse Event|13|||
124955520|NCT02446912|449462315|FG002|Overall Study|Adverse Event|5|||
124955521|NCT02446912|449462313|FG000|Overall Study|Condition under investigation worsened|0|||
124955522|NCT02446912|449462314|FG001|Overall Study|Condition under investigation worsened|1|||
124955523|NCT02446912|449462315|FG002|Overall Study|Condition under investigation worsened|1|||
124955524|NCT02446912|449462313|FG000|Overall Study|Study-specific withdrawal criteria|1|||
124955525|NCT02446912|449462314|FG001|Overall Study|Study-specific withdrawal criteria|0|||
124955526|NCT02446912|449462315|FG002|Overall Study|Study-specific withdrawal criteria|0|||
124460645|NCT00879229|447645972|FG001|Overall Study|Adverse Event|0|||
124460646|NCT00879229|447645971|FG000|Overall Study|Withdrawal by Subject|1|||
124460647|NCT00879229|447645972|FG001|Overall Study|Withdrawal by Subject|0|||
124460648|NCT00879229|447645971|FG000|Overall Study|Clinical status did not improve|1|||
124460649|NCT00879229|447645972|FG001|Overall Study|Clinical status did not improve|0|||
124955527|NCT02446912|449462313|FG000|Overall Study|Lack of Efficacy|1|||
124955528|NCT02446912|449462314|FG001|Overall Study|Lack of Efficacy|4|||
124460650|NCT00879229|447645971|FG000|Overall Study|Other|1|||
124460651|NCT00879229|447645972|FG001|Overall Study|Other|0|||
124460652|NCT01097746|447645973|FG000|Overall Study|Adverse Event|4|||
124955529|NCT02446912|449462315|FG002|Overall Study|Lack of Efficacy|7|||
124955530|NCT02446912|449462313|FG000|Overall Study|Lost to Follow-up|0|||
124955531|NCT02446912|449462314|FG001|Overall Study|Lost to Follow-up|0|||
124955532|NCT02446912|449462315|FG002|Overall Study|Lost to Follow-up|2|||
124955533|NCT02446912|449462313|FG000|Overall Study|Severe non-compliance to protocol|1|||
124955534|NCT02446912|449462314|FG001|Overall Study|Severe non-compliance to protocol|0|||
124955535|NCT02446912|449462315|FG002|Overall Study|Severe non-compliance to protocol|1|||
124955536|NCT02446912|449462313|FG000|Overall Study|Withdrawal by Subject|10|||
124955537|NCT02446912|449462314|FG001|Overall Study|Withdrawal by Subject|15|||
124955538|NCT02446912|449462315|FG002|Overall Study|Withdrawal by Subject|15|||
124955539|NCT02446912|449462313|FG000|Overall Study|Miscellaneous|2|||
124955540|NCT02446912|449462314|FG001|Overall Study|Miscellaneous|2|||
124955541|NCT02446912|449462315|FG002|Overall Study|Miscellaneous|4|||
124955542|NCT01268488|449462316|FG000|Overall Study|Adverse Event|3|||
124460653|NCT01097746|447645973|FG000|Overall Study|taken off study before any treatment given|1|||
124460654|NCT00631371|447645980|FG000|Overall Study|Lost to Follow-up|24|||
124460655|NCT00631371|447645981|FG001|Overall Study|Lost to Follow-up|19|||
124460656|NCT00631371|447645980|FG000|Overall Study|Other reason|5|||
124460657|NCT00631371|447645981|FG001|Overall Study|Other reason|12|||
124460658|NCT00631371|447645980|FG000|Overall Study|subject request|38|||
124460659|NCT00631371|447645981|FG001|Overall Study|subject request|45|||
124460660|NCT00631371|447645980|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
124460661|NCT00631371|447645981|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
124460662|NCT00631371|447645980|FG000|Overall Study|Death|263|||
124460663|NCT00631371|447645981|FG001|Overall Study|Death|239|||
124460664|NCT00390546|447645982|FG000|Overall Study|Renal impairment|1|||
124460665|NCT00390546|447645983|FG001|Overall Study|Renal impairment|0|||
124460666|NCT00390546|447645982|FG000|Overall Study|Physician Decision|5|||
124460667|NCT00390546|447645983|FG001|Overall Study|Physician Decision|5|||
124460668|NCT00812214|447645992|FG000|Overall Study|Lost to Follow-up|3|||
124460669|NCT00812214|447645993|FG001|Overall Study|Lost to Follow-up|1|||
124460670|NCT02145741|447645995|FG000|Overall Study|Progressive disease|3|||
124460671|NCT02145741|447645996|FG001|Overall Study|Progressive disease|6|||
124460672|NCT02145741|447645997|FG002|Overall Study|Progressive disease|6|||
124460673|NCT02145741|447645995|FG000|Overall Study|quality issue with the administered drug|3|||
124955543|NCT01268488|449462316|FG000|Overall Study|Physician Decision|2|||
124955544|NCT00147745|449462319|FG000|Overall Study|Withdrawal by Subject|1|||
124955545|NCT00147745|449462320|FG001|Overall Study|Withdrawal by Subject|0|||
124955546|NCT00147745|449462321|FG002|Overall Study|Withdrawal by Subject|0|||
124955547|NCT05274906|449462325|FG000|Overall Study|Withdrawal by Subject|2|||
124955548|NCT05274906|449462326|FG001|Overall Study|Withdrawal by Subject|1|||
124955549|NCT03508830|449462327|FG000|Overall Study|Withdrawal by Subject|3|||
124955550|NCT03508830|449462328|FG001|Overall Study|Withdrawal by Subject|4|||
124955551|NCT03508830|449462327|FG000|Overall Study|Physician Decision|2|||
124955552|NCT03508830|449462328|FG001|Overall Study|Physician Decision|2|||
124955553|NCT02522299|449462329|FG000|Overall Study|Adverse Event|2|||
124955554|NCT02522299|449462330|FG001|Overall Study|Adverse Event|0|||
124955555|NCT02522299|449462329|FG000|Overall Study|Physician Decision|0|||
124955556|NCT02522299|449462330|FG001|Overall Study|Physician Decision|1|||
124955557|NCT02522299|449462329|FG000|Overall Study|Withdrawal by Subject|2|||
124955558|NCT02522299|449462330|FG001|Overall Study|Withdrawal by Subject|0|||
124955559|NCT04908800|449462333|FG000|Overall Study|Adverse Event|0|||
124955560|NCT04908800|449462334|FG001|Overall Study|Adverse Event|0|||
124955561|NCT04908800|449462335|FG002|Overall Study|Adverse Event|0|||
124955562|NCT04908800|449462336|FG003|Overall Study|Adverse Event|0|||
124955563|NCT04908800|449462337|FG004|Overall Study|Adverse Event|0|||
124955564|NCT04908800|449462338|FG005|Overall Study|Adverse Event|0|||
124955565|NCT04908800|449462339|FG006|Overall Study|Adverse Event|0|||
124955566|NCT04908800|449462340|FG007|Overall Study|Adverse Event|0|||
124955567|NCT04908800|449462341|FG008|Overall Study|Adverse Event|0|||
124955568|NCT04908800|449462342|FG009|Overall Study|Adverse Event|0|||
124955569|NCT04908800|449462343|FG010|Overall Study|Adverse Event|1|||
124955570|NCT04908800|449462344|FG011|Overall Study|Adverse Event|0|||
124955571|NCT04908800|449462345|FG012|Overall Study|Adverse Event|0|||
124955572|NCT02267746|449462346|FG000|Overall Study|Adverse Event|0|||
124955573|NCT02267746|449462347|FG001|Overall Study|Adverse Event|2|||
124955574|NCT02267746|449462348|FG002|Overall Study|Adverse Event|1|||
124955575|NCT02267746|449462346|FG000|Overall Study|Protocol Violation|8|||
124955576|NCT02267746|449462347|FG001|Overall Study|Protocol Violation|7|||
124460674|NCT02145741|447645996|FG001|Overall Study|quality issue with the administered drug|0|||
124460675|NCT02145741|447645997|FG002|Overall Study|quality issue with the administered drug|0|||
124460676|NCT01192022|447645998|FG000|Overall Study|Withdrawal of Consent|3|||
124460677|NCT01192022|447645999|FG001|Overall Study|Withdrawal of Consent|1|||
124955577|NCT02267746|449462348|FG002|Overall Study|Protocol Violation|3|||
124955578|NCT02267746|449462346|FG000|Overall Study|Lack of Efficacy|11|||
124955579|NCT02267746|449462347|FG001|Overall Study|Lack of Efficacy|11|||
124955580|NCT02267746|449462348|FG002|Overall Study|Lack of Efficacy|15|||
124955581|NCT02267746|449462346|FG000|Overall Study|Protocol Violation|1|||
124955582|NCT02267746|449462347|FG001|Overall Study|Protocol Violation|2|||
124955583|NCT02267746|449462348|FG002|Overall Study|Protocol Violation|1|||
124460678|NCT01192022|447646000|FG002|Overall Study|Withdrawal of Consent|0|||
124955584|NCT02267746|449462346|FG000|Overall Study|Miscellaneous|1|||
124955585|NCT02267746|449462347|FG001|Overall Study|Miscellaneous|0|||
124955586|NCT02267746|449462348|FG002|Overall Study|Miscellaneous|1|||
124955587|NCT00728884|449462353|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
124955588|NCT00728884|449462353|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
124955589|NCT00348283|449462354|FG000|Induction|Adverse Event|0|||
124955590|NCT00348283|449462355|FG001|Induction|Adverse Event|2|||
124460679|NCT01192022|447646001|FG003|Overall Study|Withdrawal of Consent|0|||
124460680|NCT01192022|447646002|FG004|Overall Study|Withdrawal of Consent|0|||
124460681|NCT01192022|447645998|FG000|Overall Study|Lost to Follow-up|4|||
124460682|NCT01192022|447645999|FG001|Overall Study|Lost to Follow-up|2|||
124460683|NCT01192022|447646000|FG002|Overall Study|Lost to Follow-up|1|||
124955591|NCT00348283|449462354|FG000|Induction|Protocol Violation|0|||
124955592|NCT00348283|449462355|FG001|Induction|Protocol Violation|4|||
124955593|NCT00348283|449462354|FG000|Double Blind|Adverse Event|2|||
124955594|NCT00348283|449462355|FG001|Double Blind|Adverse Event|5|||
124955595|NCT00348283|449462354|FG000|Double Blind|Withdrawal by Subject|1|||
124955596|NCT00348283|449462355|FG001|Double Blind|Withdrawal by Subject|1|||
124955597|NCT00348283|449462354|FG000|Double Blind|Protocol Violation|0|||
124955598|NCT00348283|449462355|FG001|Double Blind|Protocol Violation|1|||
124955599|NCT00348283|449462354|FG000|Double Blind|Lack of Efficacy|2|||
124955600|NCT00348283|449462355|FG001|Double Blind|Lack of Efficacy|2|||
124955601|NCT00348283|449462354|FG000|Double Blind|Pregnancy|0|||
124955602|NCT00348283|449462355|FG001|Double Blind|Pregnancy|1|||
124955603|NCT00348283|449462354|FG000|Open Label|Adverse Event|0|||
124955604|NCT00348283|449462355|FG001|Open Label|Adverse Event|8|||
124955605|NCT00348283|449462354|FG000|Open Label|Withdrawal by Subject|0|||
124955606|NCT00348283|449462355|FG001|Open Label|Withdrawal by Subject|4|||
124955607|NCT00348283|449462354|FG000|Open Label|Lost to Follow-up|0|||
124955608|NCT00348283|449462355|FG001|Open Label|Lost to Follow-up|1|||
124955609|NCT00348283|449462354|FG000|Open Label|Lack of Efficacy|0|||
124955610|NCT00348283|449462355|FG001|Open Label|Lack of Efficacy|13|||
124955611|NCT00348283|449462354|FG000|Open Label|Administrative reasons|0|||
124955612|NCT00348283|449462355|FG001|Open Label|Administrative reasons|5|||
124955613|NCT00348283|449462354|FG000|Open Label|Subject moved to the United States|0|||
124955614|NCT00348283|449462355|FG001|Open Label|Subject moved to the United States|1|||
124955615|NCT00348283|449462354|FG000|Open Label|Pregnancy|0|||
124955616|NCT00348283|449462355|FG001|Open Label|Pregnancy|1|||
124955617|NCT00348283|449462354|FG000|Open Label|Sponsor decision|0|||
124955618|NCT00348283|449462355|FG001|Open Label|Sponsor decision|1|||
124955619|NCT04372186|449462359|FG000|Overall Study|Death|24|||
124955620|NCT04372186|449462360|FG001|Overall Study|Death|11|||
124955621|NCT04372186|449462359|FG000|Overall Study|Transferred to a different facility for care|0|||
124955622|NCT04372186|449462360|FG001|Overall Study|Transferred to a different facility for care|2|||
124955623|NCT02374476|449462362|FG000|VT Induced Ablation|Screening Failures|36|||
124955624|NCT02374476|449462363|FG001|VT Induced Ablation|Screening Failures|0|||
124955625|NCT02374476|449462364|FG002|VT Induced Ablation|Screening Failures|0|||
124955626|NCT02374476|449462362|FG000|Arm Assignment|Withdrawal by Subject|0|||
124955627|NCT02374476|449462363|FG001|Arm Assignment|Withdrawal by Subject|0|||
124955628|NCT02374476|449462364|FG002|Arm Assignment|Withdrawal by Subject|1|||
124955629|NCT03305458|449462365|FG000|Overall Study|Withdrawal by Subject|50|||
124955630|NCT03305458|449462366|FG001|Overall Study|Withdrawal by Subject|46|||
124955631|NCT03305458|449462367|FG002|Overall Study|Withdrawal by Subject|93|||
124955632|NCT03305458|449462365|FG000|Overall Study|Lost to Follow-up|85|||
124955633|NCT03305458|449462366|FG001|Overall Study|Lost to Follow-up|85|||
124955634|NCT03305458|449462367|FG002|Overall Study|Lost to Follow-up|35|||
124955635|NCT05431543|449462368|FG000|Overall Study|Medical History|1|||
124955636|NCT05431543|449462369|FG001|Overall Study|Medical History|0|||
124955637|NCT05431543|449462370|FG002|Overall Study|Medical History|0|||
124955638|NCT00440037|449462371|FG000|Overall Study|Withdrawal by Subject|6|||
124955639|NCT00440037|449462371|FG000|Overall Study|Administrative decision|3|||
124955640|NCT00498797|449462372|FG000|Overall Study|Withdrawal by Subject|4|||
124955641|NCT00498797|449462373|FG001|Overall Study|Withdrawal by Subject|2|||
124955642|NCT00498797|449462372|FG000|Overall Study|Adverse Event|12|||
124955643|NCT00498797|449462373|FG001|Overall Study|Adverse Event|5|||
124955644|NCT00498797|449462372|FG000|Overall Study|Condition under investigation worsened|19|||
124955645|NCT00498797|449462373|FG001|Overall Study|Condition under investigation worsened|21|||
124955646|NCT00498797|449462372|FG000|Overall Study|Other|3|||
124955647|NCT00498797|449462373|FG001|Overall Study|Other|1|||
124955648|NCT00914732|449462374|FG000|Overall Study|Lost to Follow-up|6|||
124955649|NCT00914732|449462375|FG001|Overall Study|Lost to Follow-up|7|||
124955650|NCT00914732|449462376|FG002|Overall Study|Lost to Follow-up|9|||
124955651|NCT00914732|449462374|FG000|Overall Study|Withdrawal by Subject|3|||
124955652|NCT00914732|449462375|FG001|Overall Study|Withdrawal by Subject|0|||
124460684|NCT01192022|447646001|FG003|Overall Study|Lost to Follow-up|1|||
124955653|NCT00914732|449462376|FG002|Overall Study|Withdrawal by Subject|2|||
124460685|NCT01192022|447646002|FG004|Overall Study|Lost to Follow-up|0|||
124460686|NCT01192022|447645998|FG000|Overall Study|Adverse Event|1|||
124460687|NCT01192022|447645999|FG001|Overall Study|Adverse Event|0|||
124955654|NCT00914732|449462374|FG000|Overall Study|Adverse Event|1|||
124955655|NCT00914732|449462375|FG001|Overall Study|Adverse Event|0|||
124955656|NCT00914732|449462376|FG002|Overall Study|Adverse Event|0|||
124955657|NCT01855399|449462379|FG000|6 Month|Lost to Follow-up|12|||
124955658|NCT01855399|449462380|FG001|6 Month|Lost to Follow-up|9|||
124955659|NCT01855399|449462379|FG000|6 Month|Withdrawal by Subject|8|||
124955660|NCT01855399|449462380|FG001|6 Month|Withdrawal by Subject|6|||
124955661|NCT01855399|449462379|FG000|12 Month|Lost to Follow-up|7|||
124955662|NCT01855399|449462380|FG001|12 Month|Lost to Follow-up|11|||
124955663|NCT03953079|449462381|FG000|Core Study|Withdrawal by Subject|1|||
124955664|NCT03953079|449462382|FG001|Core Study|Withdrawal by Subject|2|||
124955665|NCT03953079|449462383|FG002|Core Study|Withdrawal by Subject|1|||
124955666|NCT03953079|449462381|FG000|Core Study|COVID-19|0|||
124955667|NCT03953079|449462382|FG001|Core Study|COVID-19|1|||
124955668|NCT03953079|449462383|FG002|Core Study|COVID-19|0|||
124955669|NCT03953079|449462381|FG000|Core Study|Difficulties leaving the house|0|||
124955670|NCT03953079|449462382|FG001|Core Study|Difficulties leaving the house|1|||
124955671|NCT03953079|449462383|FG002|Core Study|Difficulties leaving the house|0|||
124955672|NCT03953079|449462381|FG000|Extension Study|Withdrawal by Subject|1|||
124955673|NCT03953079|449462382|FG001|Extension Study|Withdrawal by Subject|0|||
124955674|NCT03953079|449462383|FG002|Extension Study|Withdrawal by Subject|0|||
124955675|NCT03953079|449462381|FG000|Extension Study|Received Rescue Treatment|5|||
124955676|NCT03953079|449462382|FG001|Extension Study|Received Rescue Treatment|6|||
124955677|NCT03953079|449462383|FG002|Extension Study|Received Rescue Treatment|5|||
124955678|NCT04394624|449462384|FG000|Overall Study|Adverse Event|6|||
124955679|NCT04394624|449462385|FG001|Overall Study|Adverse Event|0|||
124955680|NCT04394624|449462384|FG000|Overall Study|Progressive disease|24|||
124955681|NCT04394624|449462385|FG001|Overall Study|Progressive disease|0|||
124955682|NCT04394624|449462384|FG000|Overall Study|Not related to COVID-19|1|||
124955683|NCT04394624|449462385|FG001|Overall Study|Not related to COVID-19|0|||
124955684|NCT00448344|449462391|FG000|Overall Study|Lost to Follow-up|20|||
124955685|NCT00448344|449462392|FG001|Overall Study|Lost to Follow-up|22|||
124955686|NCT00448344|449462391|FG000|Overall Study|Withdrawal by Subject|6|||
124955687|NCT00448344|449462392|FG001|Overall Study|Withdrawal by Subject|8|||
124955688|NCT00448344|449462391|FG000|Overall Study|Death|3|||
124955689|NCT00448344|449462392|FG001|Overall Study|Death|4|||
124955690|NCT00448344|449462391|FG000|Overall Study|Physician Decision|1|||
124955691|NCT00448344|449462392|FG001|Overall Study|Physician Decision|2|||
124955692|NCT00141271|449462395|FG000|Overall Study|Adverse Event|31|||
124955693|NCT00141271|449462396|FG001|Overall Study|Adverse Event|19|||
124955694|NCT00141271|449462397|FG002|Overall Study|Adverse Event|17|||
124955695|NCT00141271|449462395|FG000|Overall Study|Laboratory Abnormality|2|||
124955696|NCT00141271|449462396|FG001|Overall Study|Laboratory Abnormality|1|||
124955697|NCT00141271|449462397|FG002|Overall Study|Laboratory Abnormality|1|||
124955698|NCT00141271|449462395|FG000|Overall Study|Lack of Efficacy|7|||
124955699|NCT00141271|449462396|FG001|Overall Study|Lack of Efficacy|7|||
124955700|NCT00141271|449462397|FG002|Overall Study|Lack of Efficacy|3|||
124955701|NCT00141271|449462395|FG000|Overall Study|Lost to Follow-up|15|||
124955702|NCT00141271|449462396|FG001|Overall Study|Lost to Follow-up|15|||
124955703|NCT00141271|449462397|FG002|Overall Study|Lost to Follow-up|21|||
124955704|NCT00141271|449462395|FG000|Overall Study|Withdrawal by Subject|14|||
124955705|NCT00141271|449462396|FG001|Overall Study|Withdrawal by Subject|9|||
124955706|NCT00141271|449462397|FG002|Overall Study|Withdrawal by Subject|10|||
124955707|NCT00141271|449462395|FG000|Overall Study|Other|11|||
124955708|NCT00141271|449462396|FG001|Overall Study|Other|12|||
124955709|NCT00141271|449462397|FG002|Overall Study|Other|5|||
124955710|NCT00990314|449462398|FG000|Overall Study|Death|2|||
124955711|NCT00990314|449462398|FG000|Overall Study|Adverse Event|2|||
124955712|NCT00990314|449462398|FG000|Overall Study|Withdrawal by Subject|3|||
124955713|NCT00990314|449462398|FG000|Overall Study|Non-Compliance|1|||
124955714|NCT00990314|449462398|FG000|Overall Study|Physician Decision|3|||
124955715|NCT00990314|449462398|FG000|Overall Study|Lack of Efficacy|1|||
124955716|NCT00267865|449462405|FG000|Induction Treatment|Died before completing.|2|||
124955717|NCT00267865|449462405|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
124955718|NCT03686176|449462406|FG000|Overall Study|Procedure cancelled|1|||
124955719|NCT03686176|449462407|FG001|Overall Study|Procedure cancelled|0|||
124955720|NCT03686176|449462408|FG002|Overall Study|Procedure cancelled|0|||
124955721|NCT03686176|449462406|FG000|Overall Study|VR Malfunction|1|||
124955722|NCT03686176|449462407|FG001|Overall Study|VR Malfunction|0|||
124955723|NCT03686176|449462408|FG002|Overall Study|VR Malfunction|0|||
124955724|NCT01636778|449462411|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
124955725|NCT01636778|449462412|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
124955726|NCT01636778|449462413|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
124955727|NCT01636778|449462411|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
124955728|NCT01636778|449462412|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
124955729|NCT01636778|449462413|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
124955730|NCT01636778|449462411|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
124955731|NCT01636778|449462412|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
124549013|NCT00742859|447965429|FG000|Overall Study|Death|1|||
124955732|NCT01636778|449462413|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
124955733|NCT01636778|449462411|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
124955734|NCT01636778|449462412|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
124955735|NCT01636778|449462413|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
124955736|NCT01636778|449462411|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
124955737|NCT01636778|449462412|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
124955738|NCT01636778|449462413|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
124955739|NCT01636778|449462411|FG000|Follow-up Period After Part 2|Other|0|||
124549014|NCT00742859|447965430|FG001|Overall Study|Death|0|||
124460688|NCT01192022|447646000|FG002|Overall Study|Adverse Event|0|||
124460689|NCT01192022|447646001|FG003|Overall Study|Adverse Event|0|||
124460690|NCT01192022|447646002|FG004|Overall Study|Adverse Event|0|||
124955740|NCT01636778|449462412|FG001|Follow-up Period After Part 2|Other|0|||
124955741|NCT01636778|449462413|FG002|Follow-up Period After Part 2|Other|1|||
124955742|NCT01636778|449462411|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
124955743|NCT01636778|449462412|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
124955744|NCT01636778|449462413|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
124955745|NCT01636778|449462411|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
124955746|NCT01636778|449462412|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
124955747|NCT01636778|449462413|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
124955748|NCT03530345|449462422|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
124955749|NCT03530345|449462423|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
124955750|NCT03530345|449462422|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
124955751|NCT03530345|449462423|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
124955752|NCT03530345|449462422|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
124955753|NCT03530345|449462423|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
124955754|NCT03530345|449462422|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
124955755|NCT03530345|449462423|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
124955756|NCT04853394|449462426|FG000|Follow-up Interviews|Lost to Follow-up|22|||
124955757|NCT04853394|449462427|FG001|Follow-up Interviews|Lost to Follow-up|15|||
124955758|NCT04212299|449462428|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
124955759|NCT00705614|449464218|FG000|Initial Intervention|Adverse Event|40|||
124955760|NCT00705614|449464219|FG001|Initial Intervention|Adverse Event|21|||
124955761|NCT00705614|449464218|FG000|Initial Intervention|Lost to Follow-up|310|||
124955762|NCT00705614|449464219|FG001|Initial Intervention|Lost to Follow-up|191|||
124955763|NCT00705614|449464218|FG000|Initial Intervention|Withdrawal by Subject|114|||
124955764|NCT00705614|449464219|FG001|Initial Intervention|Withdrawal by Subject|71|||
124955765|NCT00705614|449464218|FG000|Initial Intervention|Administrative Reason|51|||
124955766|NCT00705614|449464219|FG001|Initial Intervention|Administrative Reason|38|||
124955767|NCT00705614|449464218|FG000|Initial Intervention|Status completion unknown|3|||
124955768|NCT00705614|449464219|FG001|Initial Intervention|Status completion unknown|0|||
124955769|NCT00705614|449464218|FG000|Switch to Remicade|Adverse Event|0|||
124955770|NCT00705614|449464219|FG001|Switch to Remicade|Adverse Event|5|||
124955771|NCT00705614|449464218|FG000|Switch to Remicade|Lost to Follow-up|0|||
124955772|NCT00705614|449464219|FG001|Switch to Remicade|Lost to Follow-up|23|||
124955773|NCT00705614|449464218|FG000|Switch to Remicade|Withdrawal by Subject|0|||
124955774|NCT00705614|449464219|FG001|Switch to Remicade|Withdrawal by Subject|12|||
124955775|NCT00705614|449464218|FG000|Switch to Remicade|Administrative Reason|0|||
124955776|NCT00705614|449464219|FG001|Switch to Remicade|Administrative Reason|9|||
124955777|NCT00676195|449464222|FG000|Overall Study|Lost to Follow-up|1|||
124955778|NCT00676195|449464222|FG000|Overall Study|Adverse Event|1|||
124955779|NCT00676195|449464222|FG000|Overall Study|Physician Decision|1|||
124955780|NCT02878590|449464223|FG000|Overall Study|Withdrawal by Subject|2|||
124955781|NCT02661490|449464224|FG000|Overall Study|Lost to Follow-up|0|||
124955782|NCT02661490|449464225|FG001|Overall Study|Lost to Follow-up|1|||
124955783|NCT02661490|449464226|FG002|Overall Study|Lost to Follow-up|0|||
124955784|NCT02661490|449464227|FG003|Overall Study|Lost to Follow-up|0|||
124955785|NCT02661490|449464228|FG004|Overall Study|Lost to Follow-up|2|||
124955786|NCT02661490|449464224|FG000|Overall Study|Withdrawal by Subject|2|||
124955787|NCT02661490|449464225|FG001|Overall Study|Withdrawal by Subject|0|||
124955788|NCT02661490|449464226|FG002|Overall Study|Withdrawal by Subject|2|||
124955789|NCT02661490|449464227|FG003|Overall Study|Withdrawal by Subject|0|||
124955790|NCT02661490|449464228|FG004|Overall Study|Withdrawal by Subject|0|||
124955791|NCT02661490|449464224|FG000|Overall Study|Death|1|||
124955792|NCT02661490|449464225|FG001|Overall Study|Death|1|||
124955793|NCT02661490|449464226|FG002|Overall Study|Death|0|||
124955794|NCT02661490|449464227|FG003|Overall Study|Death|1|||
124955795|NCT02661490|449464228|FG004|Overall Study|Death|0|||
124955796|NCT02661490|449464224|FG000|Overall Study|Reason not Specified|0|||
124955797|NCT02661490|449464225|FG001|Overall Study|Reason not Specified|0|||
124955798|NCT02661490|449464226|FG002|Overall Study|Reason not Specified|0|||
124955799|NCT02661490|449464227|FG003|Overall Study|Reason not Specified|0|||
124460691|NCT01192022|447645998|FG000|Overall Study|Fatal Adverse Event|4|||
124460692|NCT01192022|447645999|FG001|Overall Study|Fatal Adverse Event|6|||
124460693|NCT01192022|447646000|FG002|Overall Study|Fatal Adverse Event|0|||
124460694|NCT01192022|447646001|FG003|Overall Study|Fatal Adverse Event|0|||
124460695|NCT01192022|447646002|FG004|Overall Study|Fatal Adverse Event|1|||
124460696|NCT01192022|447645998|FG000|Overall Study|Physician withdrew-patient hardship|1|||
124460697|NCT01192022|447645999|FG001|Overall Study|Physician withdrew-patient hardship|0|||
124460698|NCT01192022|447646000|FG002|Overall Study|Physician withdrew-patient hardship|0|||
124955800|NCT02661490|449464228|FG004|Overall Study|Reason not Specified|1|||
124955801|NCT02706834|449464229|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
124460699|NCT01192022|447646001|FG003|Overall Study|Physician withdrew-patient hardship|0|||
124460700|NCT01192022|447646002|FG004|Overall Study|Physician withdrew-patient hardship|0|||
124955802|NCT02706834|449464230|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
124955803|NCT02706834|449464231|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
124955804|NCT02706834|449464232|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
124955805|NCT02706834|449464233|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
124955806|NCT02706834|449464234|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
124955807|NCT02706834|449464235|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
124955808|NCT02706834|449464236|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
124955809|NCT02706834|449464237|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
124955810|NCT02706834|449464238|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
124955811|NCT02706834|449464239|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
124955812|NCT02706834|449464229|FG000|Overall Study|Lost to Follow-up|0|||
124955813|NCT02706834|449464230|FG001|Overall Study|Lost to Follow-up|0|||
124955814|NCT02706834|449464231|FG002|Overall Study|Lost to Follow-up|1|||
124955815|NCT02706834|449464232|FG003|Overall Study|Lost to Follow-up|0|||
124955816|NCT02706834|449464233|FG004|Overall Study|Lost to Follow-up|0|||
124955817|NCT02706834|449464234|FG005|Overall Study|Lost to Follow-up|0|||
124955818|NCT02706834|449464235|FG006|Overall Study|Lost to Follow-up|0|||
124955819|NCT02706834|449464236|FG007|Overall Study|Lost to Follow-up|0|||
124955820|NCT02706834|449464237|FG008|Overall Study|Lost to Follow-up|0|||
124955821|NCT02706834|449464238|FG009|Overall Study|Lost to Follow-up|0|||
124955822|NCT02706834|449464239|FG010|Overall Study|Lost to Follow-up|0|||
124955823|NCT02706834|449464229|FG000|Overall Study|Voluntary Withdrawal|1|||
124955824|NCT02706834|449464230|FG001|Overall Study|Voluntary Withdrawal|0|||
124955825|NCT02706834|449464231|FG002|Overall Study|Voluntary Withdrawal|0|||
124955826|NCT02706834|449464232|FG003|Overall Study|Voluntary Withdrawal|0|||
124955827|NCT02706834|449464233|FG004|Overall Study|Voluntary Withdrawal|0|||
124955828|NCT02706834|449464234|FG005|Overall Study|Voluntary Withdrawal|0|||
124955829|NCT02706834|449464235|FG006|Overall Study|Voluntary Withdrawal|0|||
124955830|NCT02706834|449464236|FG007|Overall Study|Voluntary Withdrawal|0|||
124955831|NCT02706834|449464237|FG008|Overall Study|Voluntary Withdrawal|0|||
124955832|NCT02706834|449464238|FG009|Overall Study|Voluntary Withdrawal|1|||
124955833|NCT02706834|449464239|FG010|Overall Study|Voluntary Withdrawal|0|||
124955834|NCT02706834|449464229|FG000|Overall Study|Other Reason Not Specified|1|||
124955835|NCT02706834|449464230|FG001|Overall Study|Other Reason Not Specified|0|||
124955836|NCT02706834|449464231|FG002|Overall Study|Other Reason Not Specified|0|||
124955837|NCT02706834|449464232|FG003|Overall Study|Other Reason Not Specified|0|||
124955838|NCT02706834|449464233|FG004|Overall Study|Other Reason Not Specified|1|||
124955839|NCT02706834|449464234|FG005|Overall Study|Other Reason Not Specified|0|||
124955840|NCT02706834|449464235|FG006|Overall Study|Other Reason Not Specified|0|||
124955841|NCT02706834|449464236|FG007|Overall Study|Other Reason Not Specified|0|||
124955842|NCT02706834|449464237|FG008|Overall Study|Other Reason Not Specified|0|||
124955843|NCT02706834|449464238|FG009|Overall Study|Other Reason Not Specified|0|||
124955844|NCT02706834|449464239|FG010|Overall Study|Other Reason Not Specified|0|||
124955845|NCT03034772|449464255|FG000|Overall Study|Adverse Event|0|||
124955846|NCT03034772|449464256|FG001|Overall Study|Adverse Event|1|||
124955847|NCT03034772|449464255|FG000|Overall Study|Withdrawal by Subject|0|||
124955848|NCT03034772|449464256|FG001|Overall Study|Withdrawal by Subject|1|||
124955849|NCT00116584|449464259|FG000|Overall Study|Withdrawal by Subject|1|||
124955850|NCT00116584|449464260|FG001|Overall Study|Withdrawal by Subject|0|||
124955851|NCT00116584|449464259|FG000|Overall Study|Protocol Violation|1|||
124460701|NCT01192022|447645998|FG000|Overall Study|Patient too sick from chemotherapy|0|||
124955852|NCT00116584|449464260|FG001|Overall Study|Protocol Violation|1|||
124955853|NCT01745380|449464261|FG000|Overall Study|Lost to Follow-up|1|||
124955854|NCT01745380|449464262|FG001|Overall Study|Lost to Follow-up|0|||
124955855|NCT01745380|449464261|FG000|Overall Study|Lack of Efficacy|0|||
124955856|NCT01745380|449464262|FG001|Overall Study|Lack of Efficacy|1|||
124955857|NCT01882088|449464263|FG000|Overall Study|Intolerance of esophageal manometry|1|||
124955858|NCT01882088|449464263|FG000|Overall Study|no possibility to place the catheter|1|||
124955859|NCT01882088|449464263|FG000|Overall Study|Protocol Violation|1|||
124955860|NCT01882088|449464263|FG000|Overall Study|inadequate pH-impedance tracings|2|||
124955861|NCT01797705|449464268|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
124955862|NCT01797705|449464268|FG000|Overall Study|Withdrawal by Subject|1|||
124955863|NCT01533181|449464271|FG000|Overall Study|Disease progression pre-active treatment|0|||
124955864|NCT01533181|449464272|FG001|Overall Study|Disease progression pre-active treatment|1|||
124955865|NCT01533181|449464271|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
124955866|NCT01533181|449464272|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
124955867|NCT01837719|449464273|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
124955868|NCT01837719|449464273|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
124955869|NCT01703988|449464274|FG000|Overall Study|Investigator Judgment|0|||
124955870|NCT01703988|449464275|FG001|Overall Study|Investigator Judgment|0|||
124955871|NCT01703988|449464276|FG002|Overall Study|Investigator Judgment|0|||
124955872|NCT01703988|449464277|FG003|Overall Study|Investigator Judgment|1|||
124955873|NCT02995733|449464278|FG000|Overall Study|Study site closed|9|||
124955874|NCT02995733|449464279|FG001|Overall Study|Study site closed|10|||
124955875|NCT02995733|449464278|FG000|Overall Study|Death|3|||
124955876|NCT02995733|449464279|FG001|Overall Study|Death|4|||
124955877|NCT02995733|449464278|FG000|Overall Study|Withdrawal by Subject|6|||
124955878|NCT02995733|449464279|FG001|Overall Study|Withdrawal by Subject|2|||
124955879|NCT02995733|449464278|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
124955880|NCT02995733|449464279|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
124955881|NCT02995733|449464278|FG000|Overall Study|Lost to Follow-up|48|||
124955882|NCT02995733|449464279|FG001|Overall Study|Lost to Follow-up|37|||
124955883|NCT02995733|449464278|FG000|Overall Study|Other|0|||
124955884|NCT02995733|449464279|FG001|Overall Study|Other|1|||
124955885|NCT03785210|449464285|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
124955886|NCT03785210|449464286|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
124955887|NCT04879823|449464287|FG000|Overall Study|Physician Decision|3|||
124955888|NCT04879823|449464288|FG001|Overall Study|Physician Decision|1|||
124955889|NCT04879823|449464287|FG000|Overall Study|Protocol Violation|2|||
124955890|NCT04879823|449464288|FG001|Overall Study|Protocol Violation|3|||
124955891|NCT04879823|449464287|FG000|Overall Study|Lost to Follow-up|43|||
124955892|NCT04879823|449464288|FG001|Overall Study|Lost to Follow-up|35|||
124955893|NCT04468633|449464291|FG000|Overall Study|Withdrawal by Subject|4|||
124955894|NCT04468633|449464292|FG001|Overall Study|Withdrawal by Subject|0|||
124955895|NCT00460434|449464295|FG000|Overall Study|Lost to Follow-up|3|||
124955896|NCT00460434|449464296|FG001|Overall Study|Lost to Follow-up|7|||
124955897|NCT02465866|449464297|FG000|Period 3|Withdrawal by Subject|0|||
124955898|NCT02465866|449464298|FG001|Period 3|Withdrawal by Subject|1|||
124955899|NCT02465866|449464299|FG002|Period 3|Withdrawal by Subject|0|||
124955900|NCT02465866|449464300|FG003|Period 3|Withdrawal by Subject|0|||
124955901|NCT00203502|449464301|FG000|Overall Study|Death|1|||
124955902|NCT01403805|449464302|FG000|Overall Study|Withdrawal by Subject|0|||
124955903|NCT01403805|449464303|FG001|Overall Study|Withdrawal by Subject|4|||
124955904|NCT01403805|449464302|FG000|Overall Study|Lost to Follow-up|0|||
124955905|NCT01403805|449464303|FG001|Overall Study|Lost to Follow-up|2|||
124955906|NCT01403805|449464302|FG000|Overall Study|Death|0|||
124955907|NCT01403805|449464303|FG001|Overall Study|Death|1|||
124955908|NCT01103141|449464306|FG000|Overall Study|Death|0|||
124955909|NCT01103141|449464307|FG001|Overall Study|Death|1|||
124955910|NCT01103141|449464306|FG000|Overall Study|Lost to Follow-up|2|||
124955911|NCT01103141|449464307|FG001|Overall Study|Lost to Follow-up|1|||
124955912|NCT01695993|449464308|FG000|Overall Study|Lost to Follow-up|2|||
124955913|NCT01695993|449464309|FG001|Overall Study|Lost to Follow-up|1|||
124955914|NCT01695993|449464310|FG002|Overall Study|Lost to Follow-up|3|||
124955915|NCT01695993|449464308|FG000|Overall Study|Withdrawal by Subject|2|||
124955916|NCT01695993|449464309|FG001|Overall Study|Withdrawal by Subject|2|||
124955917|NCT01695993|449464310|FG002|Overall Study|Withdrawal by Subject|2|||
124955918|NCT01695993|449464308|FG000|Overall Study|To ill to continue|1|||
124955919|NCT01695993|449464309|FG001|Overall Study|To ill to continue|2|||
124955920|NCT01695993|449464310|FG002|Overall Study|To ill to continue|0|||
124955921|NCT01695993|449464308|FG000|Overall Study|Changed Medical Facility|0|||
124549015|NCT00742859|447965431|FG002|Overall Study|Death|0|||
124549016|NCT00742859|447965432|FG003|Overall Study|Death|1|||
124955922|NCT01695993|449464309|FG001|Overall Study|Changed Medical Facility|0|||
124955923|NCT01695993|449464310|FG002|Overall Study|Changed Medical Facility|1|||
124955924|NCT04057937|449464311|FG000|Placebo-controlled Phase|Adverse Event|3|||
124955925|NCT04057937|449464312|FG001|Placebo-controlled Phase|Adverse Event|0|||
124955926|NCT04057937|449464311|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
124955927|NCT04057937|449464312|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
124955928|NCT04057937|449464311|FG000|Active-treatment Phase|Pregnancy|0|||
124955929|NCT04057937|449464312|FG001|Active-treatment Phase|Pregnancy|1|||
124955930|NCT04057937|449464311|FG000|Active-treatment Phase|Physician Decision|0|||
124955931|NCT04057937|449464312|FG001|Active-treatment Phase|Physician Decision|1|||
124955932|NCT00422162|449464322|FG000|Overall Study|Adverse Event|11|||
124955933|NCT00422162|449464323|FG001|Overall Study|Adverse Event|9|||
124955934|NCT00422162|449464322|FG000|Overall Study|Lack of Efficacy|4|||
124955935|NCT00422162|449464323|FG001|Overall Study|Lack of Efficacy|10|||
124955936|NCT00422162|449464322|FG000|Overall Study|Withdrawal by Subject|7|||
124955937|NCT00422162|449464323|FG001|Overall Study|Withdrawal by Subject|6|||
124955938|NCT00422162|449464322|FG000|Overall Study|Lost to Follow-up|1|||
124955939|NCT00422162|449464323|FG001|Overall Study|Lost to Follow-up|2|||
124955940|NCT00422162|449464322|FG000|Overall Study|Non-Compliant with Protocol|1|||
124955941|NCT00422162|449464323|FG001|Overall Study|Non-Compliant with Protocol|1|||
124955942|NCT00422162|449464322|FG000|Overall Study|Other|0|||
124955943|NCT00422162|449464323|FG001|Overall Study|Other|1|||
124955944|NCT00422162|449464322|FG000|Overall Study|Didn't Receive Treatment|0|||
124955945|NCT00422162|449464323|FG001|Overall Study|Didn't Receive Treatment|1|||
124955946|NCT01047306|449464327|FG000|Overall Study|Withdrawal by Subject|2|||
124955947|NCT01047306|449464328|FG001|Overall Study|Withdrawal by Subject|0|||
124955948|NCT01047306|449464327|FG000|Overall Study|Lost to Follow-up|1|||
124955949|NCT01047306|449464328|FG001|Overall Study|Lost to Follow-up|0|||
124955950|NCT00274846|449464331|FG000|Overall Study|Did not receive adequate NK cells|1|||
124955951|NCT01648699|449464334|FG000|Overall Study|Death|1|||
124955952|NCT01648699|449464334|FG000|Overall Study|Lost to Follow-up|2|||
124955953|NCT01648699|449464334|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
124955954|NCT02038803|449464335|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
124955955|NCT02038803|449464335|FG000|Overall Study|Lost to Follow-up|1|||
124955956|NCT02588027|449464336|FG000|Overall Study|Withdrawal by Subject|1|||
124955957|NCT02588027|449464337|FG001|Overall Study|Withdrawal by Subject|3|||
124955958|NCT02588027|449464336|FG000|Overall Study|Protocol Violation|4|||
124955959|NCT02588027|449464337|FG001|Overall Study|Protocol Violation|1|||
124955960|NCT03219216|449464338|FG000|Overall Study|Lost to Follow-up|0|||
124955961|NCT03219216|449464339|FG001|Overall Study|Lost to Follow-up|1|||
124707702|NCT05270863|448554707|FG001|Second Washout|Lost to Follow-up|0|||
124707703|NCT05270863|448554708|FG002|Second Washout|Lost to Follow-up|0|||
124707704|NCT05270863|448554709|FG003|Second Washout|Lost to Follow-up|1|||
124707705|NCT05270863|448554710|FG004|Second Washout|Lost to Follow-up|0|||
124955962|NCT02332824|449464340|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
124955963|NCT02332824|449464341|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
124955964|NCT02332824|449464342|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
124955965|NCT02332824|449464343|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
124955966|NCT02332824|449464344|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
124955967|NCT02332824|449464345|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
124955968|NCT02332824|449464340|FG000|Overall Study|Voluntary Withdrawal|1|||
124955969|NCT02332824|449464341|FG001|Overall Study|Voluntary Withdrawal|0|||
124955970|NCT02332824|449464342|FG002|Overall Study|Voluntary Withdrawal|0|||
124955971|NCT02332824|449464343|FG003|Overall Study|Voluntary Withdrawal|0|||
124955972|NCT02332824|449464344|FG004|Overall Study|Voluntary Withdrawal|0|||
124955973|NCT02332824|449464345|FG005|Overall Study|Voluntary Withdrawal|0|||
124955974|NCT02332824|449464340|FG000|Overall Study|Inconvenient schedule|1|||
124955975|NCT02332824|449464341|FG001|Overall Study|Inconvenient schedule|1|||
124955976|NCT02332824|449464342|FG002|Overall Study|Inconvenient schedule|0|||
124955977|NCT02332824|449464343|FG003|Overall Study|Inconvenient schedule|0|||
124955978|NCT02332824|449464344|FG004|Overall Study|Inconvenient schedule|0|||
124955979|NCT02332824|449464345|FG005|Overall Study|Inconvenient schedule|0|||
124955980|NCT02332824|449464340|FG000|Overall Study|Transfer|0|||
124955981|NCT02332824|449464341|FG001|Overall Study|Transfer|0|||
124955982|NCT02332824|449464342|FG002|Overall Study|Transfer|1|||
124955983|NCT02332824|449464343|FG003|Overall Study|Transfer|1|||
124955984|NCT02332824|449464344|FG004|Overall Study|Transfer|0|||
124955985|NCT02332824|449464345|FG005|Overall Study|Transfer|0|||
124955986|NCT03840148|449464346|FG000|Study Drug Disposition|Adverse Event|13|||
124955987|NCT03840148|449464347|FG001|Study Drug Disposition|Adverse Event|2|||
124955988|NCT03840148|449464346|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
124955989|NCT03840148|449464347|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
124955990|NCT03840148|449464346|FG000|Study Drug Disposition|Lack of Efficacy|3|||
124955991|NCT03840148|449464347|FG001|Study Drug Disposition|Lack of Efficacy|0|||
124955992|NCT03840148|449464346|FG000|Study Drug Disposition|Physician Decision|2|||
124955993|NCT03840148|449464347|FG001|Study Drug Disposition|Physician Decision|0|||
124955994|NCT03840148|449464346|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
124955995|NCT03840148|449464347|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
124955996|NCT03840148|449464346|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
124955997|NCT03840148|449464347|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
124955998|NCT03840148|449464346|FG000|Study Completion Disposition|Physician Decision|2|||
124955999|NCT03840148|449464347|FG001|Study Completion Disposition|Physician Decision|0|||
124956000|NCT03840148|449464346|FG000|Study Completion Disposition|Covid-19 related|2|||
124956001|NCT03840148|449464347|FG001|Study Completion Disposition|Covid-19 related|0|||
124956002|NCT03840148|449464346|FG000|Study Completion Disposition|Lost to Follow-up|1|||
124956003|NCT03840148|449464347|FG001|Study Completion Disposition|Lost to Follow-up|1|||
124956004|NCT03840148|449464346|FG000|Study Completion Disposition|Death|1|||
124956005|NCT03840148|449464347|FG001|Study Completion Disposition|Death|0|||
124956006|NCT03840148|449464346|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
124549017|NCT00742859|447965429|FG000|Overall Study|Physician Decision|1|||
124549018|NCT00742859|447965430|FG001|Overall Study|Physician Decision|2|||
124956007|NCT03840148|449464347|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
124956008|NCT03615404|449464348|FG000|Overall Study|Death|1|||
124956009|NCT03615404|449464348|FG000|Overall Study|vaccine did not pass quality assurance|1|||
124956010|NCT01774929|449464349|FG000|Overall Study|Adverse Event|3|||
124956011|NCT02577315|449464351|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
124956012|NCT02577315|449464352|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
124956013|NCT01945086|449464353|FG000|Overall Study|Withdrawal by Subject|1|||
124956014|NCT01945086|449464354|FG001|Overall Study|Withdrawal by Subject|0|||
124956015|NCT01945086|449464355|FG002|Overall Study|Withdrawal by Subject|1|||
124956016|NCT01945086|449464353|FG000|Overall Study|Adverse Event|0|||
124956017|NCT01945086|449464354|FG001|Overall Study|Adverse Event|0|||
124956018|NCT01945086|449464355|FG002|Overall Study|Adverse Event|1|||
124956019|NCT04413149|449466003|FG000|Overall Study|Death|10|||
124956020|NCT04413149|449466004|FG001|Overall Study|Death|5|||
124956021|NCT04413149|449466003|FG000|Overall Study|Lung transplantation|1|||
124956022|NCT04413149|449466004|FG001|Overall Study|Lung transplantation|0|||
124956023|NCT05335005|449466008|FG000|Overall Study|Lost to Follow-up|1|||
124956024|NCT04050722|449466009|FG000|Overall Study|Withdrawal by Subject|1|||
124956025|NCT04050722|449466010|FG001|Overall Study|Withdrawal by Subject|0|||
124956026|NCT00443755|449466014|FG000|Overall Study|Withdrawal by Subject|2|||
124956027|NCT00443755|449466015|FG001|Overall Study|Withdrawal by Subject|1|||
124956028|NCT00678899|449466016|FG000|Overall Study|Adverse Event|1|||
124956029|NCT02339506|449466028|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
124956030|NCT02339506|449466029|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
124956031|NCT02339506|449466028|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
124956032|NCT02339506|449466029|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
124956033|NCT01572493|449466030|FG000|Overall Study|Physician Decision|1|||
124956034|NCT01572493|449466031|FG001|Overall Study|Physician Decision|0|||
124956035|NCT01572493|449466032|FG002|Overall Study|Physician Decision|0|||
124956036|NCT01572493|449466033|FG003|Overall Study|Physician Decision|0|||
124956037|NCT01572493|449466034|FG004|Overall Study|Physician Decision|0|||
124956038|NCT01572493|449466035|FG005|Overall Study|Physician Decision|0|||
124956039|NCT01572493|449466036|FG006|Overall Study|Physician Decision|0|||
124956040|NCT01572493|449466037|FG007|Overall Study|Physician Decision|0|||
124956041|NCT01572493|449466038|FG008|Overall Study|Physician Decision|0|||
124956042|NCT01572493|449466030|FG000|Overall Study|Switched to alternative treatment|0|||
124956043|NCT01572493|449466031|FG001|Overall Study|Switched to alternative treatment|1|||
124956044|NCT01572493|449466032|FG002|Overall Study|Switched to alternative treatment|2|||
124956045|NCT01572493|449466033|FG003|Overall Study|Switched to alternative treatment|1|||
124956046|NCT01572493|449466034|FG004|Overall Study|Switched to alternative treatment|2|||
124956047|NCT01572493|449466035|FG005|Overall Study|Switched to alternative treatment|0|||
124956048|NCT01572493|449466036|FG006|Overall Study|Switched to alternative treatment|2|||
124956049|NCT01572493|449466037|FG007|Overall Study|Switched to alternative treatment|0|||
124956050|NCT01572493|449466038|FG008|Overall Study|Switched to alternative treatment|2|||
124956051|NCT01572493|449466030|FG000|Overall Study|Death|0|||
124956052|NCT01572493|449466031|FG001|Overall Study|Death|0|||
124956053|NCT01572493|449466032|FG002|Overall Study|Death|0|||
124956054|NCT01572493|449466033|FG003|Overall Study|Death|1|||
124956055|NCT01572493|449466034|FG004|Overall Study|Death|0|||
124956056|NCT01572493|449466035|FG005|Overall Study|Death|1|||
124956057|NCT01572493|449466036|FG006|Overall Study|Death|0|||
124956058|NCT01572493|449466037|FG007|Overall Study|Death|0|||
124956059|NCT01572493|449466038|FG008|Overall Study|Death|0|||
124956060|NCT01572493|449466030|FG000|Overall Study|Adverse Event|0|||
124549019|NCT00742859|447965431|FG002|Overall Study|Physician Decision|0|||
124956061|NCT01572493|449466031|FG001|Overall Study|Adverse Event|0|||
124956062|NCT01572493|449466032|FG002|Overall Study|Adverse Event|0|||
124956063|NCT01572493|449466033|FG003|Overall Study|Adverse Event|0|||
124956064|NCT01572493|449466034|FG004|Overall Study|Adverse Event|0|||
124956065|NCT01572493|449466035|FG005|Overall Study|Adverse Event|0|||
124956066|NCT01572493|449466036|FG006|Overall Study|Adverse Event|1|||
124956067|NCT01572493|449466037|FG007|Overall Study|Adverse Event|0|||
124956068|NCT01572493|449466038|FG008|Overall Study|Adverse Event|0|||
124956069|NCT00609245|449466039|FG000|Overall Study|Adverse Event|1|||
124956070|NCT01234675|449466040|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
124956071|NCT01234675|449466041|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
124956072|NCT01234675|449466040|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
124956073|NCT01234675|449466041|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
124956074|NCT00331799|449466042|FG000|Overall Study|Withdrawal by Subject|2|||
124956075|NCT00331799|449466042|FG000|Overall Study|Sedation|1|||
124956076|NCT02889809|449466043|FG000|Overall Study|Withdrawal by Subject|30|||
124956077|NCT02889809|449466044|FG001|Overall Study|Withdrawal by Subject|21|||
124956078|NCT02889809|449466043|FG000|Overall Study|Lost to Follow-up|1|||
124956079|NCT02889809|449466044|FG001|Overall Study|Lost to Follow-up|1|||
124956080|NCT02889809|449466043|FG000|Overall Study|Site Closed|12|||
124956081|NCT02889809|449466044|FG001|Overall Study|Site Closed|11|||
124956082|NCT01090076|449466047|FG000|Overall Study|Death|1|||
124956083|NCT01090076|449466048|FG001|Overall Study|Death|1|||
124956084|NCT01090076|449466047|FG000|Overall Study|Withdrawal by Subject|0|||
124956085|NCT01090076|449466048|FG001|Overall Study|Withdrawal by Subject|1|||
124956086|NCT01116440|449466053|FG000|Treatment|Withdrawal by Subject|2|||
124956087|NCT01116440|449466054|FG001|Treatment|Withdrawal by Subject|2|||
124956088|NCT01116440|449466053|FG000|Treatment|Lost to Follow-up|1|||
124956089|NCT01116440|449466054|FG001|Treatment|Lost to Follow-up|1|||
124956090|NCT01116440|449466053|FG000|Treatment|Protocol Violation|0|||
124956091|NCT01116440|449466054|FG001|Treatment|Protocol Violation|2|||
124956092|NCT01116440|449466053|FG000|Treatment|Lack of Efficacy|0|||
124956093|NCT01116440|449466054|FG001|Treatment|Lack of Efficacy|1|||
124956094|NCT01116440|449466053|FG000|Treatment|Adverse Event|0|||
124956095|NCT01116440|449466054|FG001|Treatment|Adverse Event|1|||
124956096|NCT01116440|449466053|FG000|Withdrawal|Withdrawal by Subject|0|||
124956097|NCT01116440|449466054|FG001|Withdrawal|Withdrawal by Subject|1|||
124956098|NCT01116440|449466053|FG000|Withdrawal|Lost to Follow-up|0|||
124956099|NCT01116440|449466054|FG001|Withdrawal|Lost to Follow-up|1|||
124956100|NCT01116440|449466053|FG000|Follow-up|Lost to Follow-up|0|||
124956101|NCT01116440|449466054|FG001|Follow-up|Lost to Follow-up|1|||
124956102|NCT01116440|449466053|FG000|Follow-up|Withdrawal by Subject|0|||
124956103|NCT01116440|449466054|FG001|Follow-up|Withdrawal by Subject|1|||
124956104|NCT01870999|449466057|FG000|Overall Study|Adverse Event|0|||
124956105|NCT01870999|449466058|FG001|Overall Study|Adverse Event|4|||
124956106|NCT01870999|449466059|FG002|Overall Study|Adverse Event|1|||
124956107|NCT01870999|449466057|FG000|Overall Study|Subject met withdrawal criteria|3|||
124956108|NCT01870999|449466058|FG001|Overall Study|Subject met withdrawal criteria|2|||
124956109|NCT01870999|449466059|FG002|Overall Study|Subject met withdrawal criteria|0|||
124956110|NCT01870999|449466057|FG000|Overall Study|Subject withdrawn by Investigator|1|||
124956111|NCT01870999|449466058|FG001|Overall Study|Subject withdrawn by Investigator|0|||
124956112|NCT01870999|449466059|FG002|Overall Study|Subject withdrawn by Investigator|0|||
124956113|NCT01870999|449466057|FG000|Overall Study|Withdrawal by Subject|0|||
124956114|NCT01870999|449466058|FG001|Overall Study|Withdrawal by Subject|2|||
124956115|NCT01870999|449466059|FG002|Overall Study|Withdrawal by Subject|5|||
124956116|NCT01870999|449466057|FG000|Overall Study|Protocol Violation|0|||
124956117|NCT01870999|449466058|FG001|Overall Study|Protocol Violation|0|||
124956118|NCT01870999|449466059|FG002|Overall Study|Protocol Violation|1|||
124956119|NCT01636258|449466060|FG000|Overall Study|Lost to Follow-up|1|||
124956120|NCT01636258|449466061|FG001|Overall Study|Lost to Follow-up|0|||
124956121|NCT02798861|449466064|FG000|Overall Study|Lost to Follow-up|22|||
124956122|NCT02798861|449466064|FG000|Overall Study|Withdrawal by Subject|1|||
124956123|NCT02186015|449466065|FG000|Overall Study|Physician Decision|1|||
124956124|NCT02186015|449466066|FG001|Overall Study|Physician Decision|0|||
124956125|NCT00907517|449466067|FG000|Overall Study|Progressive Disease|3|||
124956126|NCT00907517|449466068|FG001|Overall Study|Progressive Disease|3|||
124956127|NCT00907517|449466069|FG002|Overall Study|Progressive Disease|4|||
124956128|NCT00907517|449466070|FG003|Overall Study|Progressive Disease|4|||
124956129|NCT00907517|449466071|FG004|Overall Study|Progressive Disease|4|||
124956130|NCT00907517|449466067|FG000|Overall Study|Symptomatic Deterioration|0|||
124956131|NCT00907517|449466068|FG001|Overall Study|Symptomatic Deterioration|0|||
124956132|NCT00907517|449466069|FG002|Overall Study|Symptomatic Deterioration|0|||
124956133|NCT00907517|449466070|FG003|Overall Study|Symptomatic Deterioration|0|||
124956134|NCT00907517|449466071|FG004|Overall Study|Symptomatic Deterioration|1|||
124956135|NCT02660034|449466072|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
124956136|NCT02660034|449466073|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
124956137|NCT02660034|449466074|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
124956138|NCT02660034|449466075|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
124956139|NCT02660034|449466076|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
124956140|NCT02660034|449466077|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
124956141|NCT02660034|449466078|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
124956142|NCT02660034|449466079|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
124956143|NCT02660034|449466080|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
124956144|NCT02660034|449466081|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
124956145|NCT02660034|449466082|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
124956146|NCT02660034|449466083|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
124956147|NCT02660034|449466084|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
124956148|NCT02660034|449466085|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
124956149|NCT02660034|449466072|FG000|Overall Study|Progressive Disease (Clinical)|7|||
124956150|NCT02660034|449466073|FG001|Overall Study|Progressive Disease (Clinical)|8|||
124956151|NCT02660034|449466074|FG002|Overall Study|Progressive Disease (Clinical)|3|||
124956152|NCT02660034|449466075|FG003|Overall Study|Progressive Disease (Clinical)|9|||
124956153|NCT02660034|449466076|FG004|Overall Study|Progressive Disease (Clinical)|3|||
124956154|NCT02660034|449466077|FG005|Overall Study|Progressive Disease (Clinical)|0|||
124956155|NCT02660034|449466078|FG006|Overall Study|Progressive Disease (Clinical)|0|||
124956156|NCT02660034|449466079|FG007|Overall Study|Progressive Disease (Clinical)|0|||
124956157|NCT02660034|449466080|FG008|Overall Study|Progressive Disease (Clinical)|0|||
124956158|NCT02660034|449466081|FG009|Overall Study|Progressive Disease (Clinical)|0|||
124956159|NCT02660034|449466082|FG010|Overall Study|Progressive Disease (Clinical)|0|||
124956160|NCT02660034|449466083|FG011|Overall Study|Progressive Disease (Clinical)|0|||
124956161|NCT02660034|449466084|FG012|Overall Study|Progressive Disease (Clinical)|0|||
124956162|NCT02660034|449466085|FG013|Overall Study|Progressive Disease (Clinical)|0|||
124956163|NCT02660034|449466072|FG000|Overall Study|Lost to Follow-up|0|||
124956164|NCT02660034|449466073|FG001|Overall Study|Lost to Follow-up|0|||
124956165|NCT02660034|449466074|FG002|Overall Study|Lost to Follow-up|1|||
124956166|NCT02660034|449466075|FG003|Overall Study|Lost to Follow-up|1|||
124956167|NCT02660034|449466076|FG004|Overall Study|Lost to Follow-up|0|||
124956168|NCT02660034|449466077|FG005|Overall Study|Lost to Follow-up|0|||
124956169|NCT02660034|449466078|FG006|Overall Study|Lost to Follow-up|0|||
124956170|NCT02660034|449466079|FG007|Overall Study|Lost to Follow-up|0|||
124956171|NCT02660034|449466080|FG008|Overall Study|Lost to Follow-up|0|||
124956172|NCT02660034|449466081|FG009|Overall Study|Lost to Follow-up|1|||
124956173|NCT02660034|449466082|FG010|Overall Study|Lost to Follow-up|1|||
124956174|NCT02660034|449466083|FG011|Overall Study|Lost to Follow-up|1|||
124956175|NCT02660034|449466084|FG012|Overall Study|Lost to Follow-up|0|||
124956176|NCT02660034|449466085|FG013|Overall Study|Lost to Follow-up|0|||
124956177|NCT02660034|449466072|FG000|Overall Study|Participant moved into special access scheme|1|||
124956178|NCT02660034|449466073|FG001|Overall Study|Participant moved into special access scheme|2|||
124956179|NCT02660034|449466074|FG002|Overall Study|Participant moved into special access scheme|0|||
124956180|NCT02660034|449466075|FG003|Overall Study|Participant moved into special access scheme|0|||
124956181|NCT02660034|449466076|FG004|Overall Study|Participant moved into special access scheme|0|||
124956182|NCT02660034|449466077|FG005|Overall Study|Participant moved into special access scheme|0|||
124956183|NCT02660034|449466078|FG006|Overall Study|Participant moved into special access scheme|0|||
124956184|NCT02660034|449466079|FG007|Overall Study|Participant moved into special access scheme|0|||
124956185|NCT02660034|449466080|FG008|Overall Study|Participant moved into special access scheme|0|||
124956186|NCT02660034|449466081|FG009|Overall Study|Participant moved into special access scheme|0|||
124956187|NCT02660034|449466082|FG010|Overall Study|Participant moved into special access scheme|0|||
124956188|NCT02660034|449466083|FG011|Overall Study|Participant moved into special access scheme|0|||
124956189|NCT02660034|449466084|FG012|Overall Study|Participant moved into special access scheme|0|||
124956190|NCT02660034|449466085|FG013|Overall Study|Participant moved into special access scheme|0|||
124956191|NCT02660034|449466072|FG000|Overall Study|Adverse Event|1|||
124956192|NCT02660034|449466073|FG001|Overall Study|Adverse Event|0|||
124956193|NCT02660034|449466074|FG002|Overall Study|Adverse Event|0|||
124956194|NCT02660034|449466075|FG003|Overall Study|Adverse Event|0|||
124956195|NCT02660034|449466076|FG004|Overall Study|Adverse Event|0|||
124956196|NCT02660034|449466077|FG005|Overall Study|Adverse Event|0|||
124956197|NCT02660034|449466078|FG006|Overall Study|Adverse Event|0|||
124956198|NCT02660034|449466079|FG007|Overall Study|Adverse Event|0|||
124956199|NCT02660034|449466080|FG008|Overall Study|Adverse Event|0|||
124956200|NCT02660034|449466081|FG009|Overall Study|Adverse Event|0|||
124956201|NCT02660034|449466082|FG010|Overall Study|Adverse Event|0|||
124956202|NCT02660034|449466083|FG011|Overall Study|Adverse Event|0|||
124956203|NCT02660034|449466084|FG012|Overall Study|Adverse Event|0|||
124956204|NCT02660034|449466085|FG013|Overall Study|Adverse Event|0|||
124956205|NCT02660034|449466072|FG000|Overall Study|Sponsor Decision|0|||
124956206|NCT02660034|449466073|FG001|Overall Study|Sponsor Decision|1|||
124956207|NCT02660034|449466074|FG002|Overall Study|Sponsor Decision|2|||
124956208|NCT02660034|449466075|FG003|Overall Study|Sponsor Decision|2|||
124956209|NCT02660034|449466076|FG004|Overall Study|Sponsor Decision|3|||
124956210|NCT02660034|449466077|FG005|Overall Study|Sponsor Decision|0|||
124956211|NCT02660034|449466078|FG006|Overall Study|Sponsor Decision|0|||
124956212|NCT02660034|449466079|FG007|Overall Study|Sponsor Decision|0|||
124956213|NCT02660034|449466080|FG008|Overall Study|Sponsor Decision|0|||
124956214|NCT02660034|449466081|FG009|Overall Study|Sponsor Decision|0|||
124956215|NCT02660034|449466082|FG010|Overall Study|Sponsor Decision|0|||
124956216|NCT02660034|449466083|FG011|Overall Study|Sponsor Decision|0|||
124956217|NCT02660034|449466084|FG012|Overall Study|Sponsor Decision|0|||
124956218|NCT02660034|449466085|FG013|Overall Study|Sponsor Decision|1|||
124956219|NCT02660034|449466072|FG000|Overall Study|Withdrawal by Subject|0|||
124956220|NCT02660034|449466073|FG001|Overall Study|Withdrawal by Subject|0|||
124956221|NCT02660034|449466074|FG002|Overall Study|Withdrawal by Subject|0|||
124956222|NCT02660034|449466075|FG003|Overall Study|Withdrawal by Subject|0|||
124956223|NCT02660034|449466076|FG004|Overall Study|Withdrawal by Subject|0|||
124956224|NCT02660034|449466077|FG005|Overall Study|Withdrawal by Subject|0|||
124956225|NCT02660034|449466078|FG006|Overall Study|Withdrawal by Subject|1|||
124956226|NCT02660034|449466079|FG007|Overall Study|Withdrawal by Subject|1|||
124956227|NCT02660034|449466080|FG008|Overall Study|Withdrawal by Subject|1|||
124956228|NCT02660034|449466081|FG009|Overall Study|Withdrawal by Subject|0|||
124956229|NCT02660034|449466082|FG010|Overall Study|Withdrawal by Subject|0|||
124956230|NCT02660034|449466083|FG011|Overall Study|Withdrawal by Subject|1|||
124956231|NCT02660034|449466084|FG012|Overall Study|Withdrawal by Subject|2|||
124956232|NCT02660034|449466085|FG013|Overall Study|Withdrawal by Subject|0|||
124956233|NCT02660034|449466072|FG000|Overall Study|Death|0|||
124956234|NCT02660034|449466073|FG001|Overall Study|Death|0|||
124956235|NCT02660034|449466074|FG002|Overall Study|Death|0|||
124956236|NCT02660034|449466075|FG003|Overall Study|Death|0|||
124956237|NCT02660034|449466076|FG004|Overall Study|Death|0|||
124956238|NCT02660034|449466077|FG005|Overall Study|Death|13|||
124956239|NCT02660034|449466078|FG006|Overall Study|Death|14|||
124956240|NCT02660034|449466079|FG007|Overall Study|Death|10|||
124956241|NCT02660034|449466080|FG008|Overall Study|Death|9|||
124956242|NCT02660034|449466081|FG009|Overall Study|Death|21|||
124956243|NCT02660034|449466082|FG010|Overall Study|Death|17|||
124956244|NCT02660034|449466083|FG011|Overall Study|Death|15|||
124956245|NCT02660034|449466084|FG012|Overall Study|Death|18|||
124956246|NCT02660034|449466085|FG013|Overall Study|Death|7|||
124956247|NCT02660034|449466072|FG000|Overall Study|Physician Decision|0|||
124956248|NCT02660034|449466073|FG001|Overall Study|Physician Decision|0|||
124956249|NCT02660034|449466074|FG002|Overall Study|Physician Decision|0|||
124956250|NCT02660034|449466075|FG003|Overall Study|Physician Decision|0|||
124956251|NCT02660034|449466076|FG004|Overall Study|Physician Decision|0|||
124956252|NCT02660034|449466077|FG005|Overall Study|Physician Decision|0|||
124956253|NCT02660034|449466078|FG006|Overall Study|Physician Decision|0|||
124956254|NCT02660034|449466079|FG007|Overall Study|Physician Decision|0|||
124956255|NCT02660034|449466080|FG008|Overall Study|Physician Decision|0|||
124956256|NCT02660034|449466081|FG009|Overall Study|Physician Decision|0|||
124956257|NCT02660034|449466082|FG010|Overall Study|Physician Decision|0|||
124956258|NCT02660034|449466083|FG011|Overall Study|Physician Decision|0|||
124956259|NCT02660034|449466084|FG012|Overall Study|Physician Decision|0|||
124956260|NCT02660034|449466085|FG013|Overall Study|Physician Decision|1|||
124956261|NCT02660034|449466072|FG000|Overall Study|Participants transferred to LTE|0|||
124956262|NCT02660034|449466073|FG001|Overall Study|Participants transferred to LTE|0|||
124956263|NCT02660034|449466074|FG002|Overall Study|Participants transferred to LTE|0|||
124956264|NCT02660034|449466075|FG003|Overall Study|Participants transferred to LTE|0|||
124956265|NCT02660034|449466076|FG004|Overall Study|Participants transferred to LTE|0|||
124956266|NCT02660034|449466077|FG005|Overall Study|Participants transferred to LTE|10|||
124956267|NCT02660034|449466078|FG006|Overall Study|Participants transferred to LTE|8|||
124956268|NCT02660034|449466079|FG007|Overall Study|Participants transferred to LTE|8|||
124956269|NCT02660034|449466080|FG008|Overall Study|Participants transferred to LTE|10|||
124956270|NCT02660034|449466081|FG009|Overall Study|Participants transferred to LTE|1|||
124956271|NCT02660034|449466082|FG010|Overall Study|Participants transferred to LTE|2|||
124956272|NCT02660034|449466083|FG011|Overall Study|Participants transferred to LTE|4|||
124956273|NCT02660034|449466084|FG012|Overall Study|Participants transferred to LTE|1|||
124956274|NCT02660034|449466085|FG013|Overall Study|Participants transferred to LTE|1|||
124956275|NCT02030847|449466086|FG000|Overall Study|Death|10|||
124956276|NCT02030847|449466086|FG000|Overall Study|Disease Progression|15|||
124956277|NCT02030847|449466086|FG000|Overall Study|New Cancer Therapy|8|||
124956278|NCT02030847|449466086|FG000|Overall Study|Physician Decision|3|||
124956279|NCT02030847|449466086|FG000|Overall Study|Withdrawal by Subject|1|||
124956280|NCT06247488|449466089|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
124956281|NCT06247488|449466090|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
124956282|NCT06247488|449466091|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
124956283|NCT06247488|449466092|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
124956284|NCT06247488|449466093|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
124956285|NCT06247488|449466094|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
124956286|NCT06247488|449466089|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
124956287|NCT06247488|449466090|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
124956288|NCT06247488|449466091|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
124956289|NCT06247488|449466092|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
124956290|NCT06247488|449466093|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
124956291|NCT06247488|449466094|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
124956292|NCT06247488|449466089|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
124956293|NCT06247488|449466090|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
124956294|NCT06247488|449466091|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
124956295|NCT06247488|449466092|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
124956296|NCT06247488|449466093|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
124956297|NCT06247488|449466094|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
124956298|NCT06247488|449466089|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
124956299|NCT06247488|449466090|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
124956300|NCT06247488|449466091|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
124956301|NCT06247488|449466092|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
124956302|NCT06247488|449466093|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
124956303|NCT06247488|449466094|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
124956304|NCT06247488|449466089|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
124956305|NCT06247488|449466090|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
124956306|NCT06247488|449466091|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
124956307|NCT06247488|449466092|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
124956308|NCT06247488|449466093|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
124956309|NCT06247488|449466094|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
124956310|NCT06247488|449466089|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
124956311|NCT06247488|449466090|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
124956312|NCT06247488|449466091|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
124956313|NCT06247488|449466092|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
124460702|NCT01192022|447645999|FG001|Overall Study|Patient too sick from chemotherapy|1|||
124460703|NCT01192022|447646000|FG002|Overall Study|Patient too sick from chemotherapy|0|||
124460704|NCT01192022|447646001|FG003|Overall Study|Patient too sick from chemotherapy|0|||
124460705|NCT01192022|447646002|FG004|Overall Study|Patient too sick from chemotherapy|0|||
124460706|NCT01192022|447645998|FG000|Overall Study|Patient needed surgery|0|||
124460707|NCT01192022|447645999|FG001|Overall Study|Patient needed surgery|1|||
124460708|NCT01192022|447646000|FG002|Overall Study|Patient needed surgery|0|||
124460709|NCT01192022|447646001|FG003|Overall Study|Patient needed surgery|0|||
124460710|NCT01192022|447646002|FG004|Overall Study|Patient needed surgery|0|||
124460711|NCT01192022|447645998|FG000|Overall Study|Parents did not allow all follow up|0|||
124460712|NCT01192022|447645999|FG001|Overall Study|Parents did not allow all follow up|0|||
124460713|NCT01192022|447646000|FG002|Overall Study|Parents did not allow all follow up|0|||
124460714|NCT01192022|447646001|FG003|Overall Study|Parents did not allow all follow up|1|||
124549020|NCT00742859|447965432|FG003|Overall Study|Physician Decision|0|||
124549021|NCT00742859|447965429|FG000|Overall Study|Withdrawal by Subject|4|||
124549022|NCT00742859|447965430|FG001|Overall Study|Withdrawal by Subject|2|||
124549023|NCT00742859|447965431|FG002|Overall Study|Withdrawal by Subject|4|||
124549024|NCT00742859|447965432|FG003|Overall Study|Withdrawal by Subject|1|||
124549025|NCT00742859|447965429|FG000|Overall Study|Endpoint|0|||
124549026|NCT00742859|447965430|FG001|Overall Study|Endpoint|1|||
124549027|NCT00742859|447965431|FG002|Overall Study|Endpoint|1|||
124549028|NCT00742859|447965432|FG003|Overall Study|Endpoint|2|||
124549029|NCT00742859|447965429|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
124549030|NCT00742859|447965430|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
124549031|NCT00742859|447965431|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
124956314|NCT06247488|449466093|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
124549032|NCT00742859|447965432|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
124956315|NCT06247488|449466094|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
124956316|NCT06247488|449466089|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
124460715|NCT01192022|447646002|FG004|Overall Study|Parents did not allow all follow up|0|||
124549033|NCT00742859|447965429|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
124460716|NCT00129766|447646004|FG000|Overall Study|Death|3|||
124460717|NCT00129766|447646005|FG001|Overall Study|Death|8|||
124707706|NCT05270863|448554711|FG005|Second Washout|Lost to Follow-up|0|||
124707707|NCT04464473|448554712|FG000|Overall Study|New piercing could not be removed for scanning|0|||
124707708|NCT04464473|448554713|FG001|Overall Study|New piercing could not be removed for scanning|0|||
124707709|NCT04464473|448554714|FG002|Overall Study|New piercing could not be removed for scanning|0|||
124707710|NCT04464473|448554715|FG003|Overall Study|New piercing could not be removed for scanning|1|||
124707711|NCT04464473|448554716|FG004|Overall Study|New piercing could not be removed for scanning|0|||
124707712|NCT04464473|448554717|FG005|Overall Study|New piercing could not be removed for scanning|0|||
124707713|NCT04464473|448554712|FG000|Overall Study|Adverse Event|0|||
124956317|NCT06247488|449466090|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
124956318|NCT06247488|449466091|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
124956319|NCT06247488|449466092|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
124956320|NCT06247488|449466093|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
124460718|NCT00129766|447646004|FG000|Overall Study|Withdrawal of consent|31|||
124460719|NCT00129766|447646005|FG001|Overall Study|Withdrawal of consent|30|||
124460720|NCT00129766|447646004|FG000|Overall Study|Lost to Follow-up|26|||
124460721|NCT00129766|447646005|FG001|Overall Study|Lost to Follow-up|21|||
124956321|NCT06247488|449466094|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
124956322|NCT02720198|449466095|FG000|Overall Study|Withdrawal by Subject|0|||
124956323|NCT02720198|449466096|FG001|Overall Study|Withdrawal by Subject|1|||
124956324|NCT02023099|449466099|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
124956325|NCT02023099|449466100|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
124956326|NCT02023099|449466101|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
124956327|NCT02023099|449466099|FG000|Overall Study|Withdrawn Consent|3|||
124956328|NCT02023099|449466100|FG001|Overall Study|Withdrawn Consent|0|||
124956329|NCT02023099|449466101|FG002|Overall Study|Withdrawn Consent|1|||
124956330|NCT02023099|449466099|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
124956331|NCT02023099|449466100|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
124460722|NCT03865706|447646007|FG000|Overall Study|Death|0|||
124956332|NCT02023099|449466101|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
124956333|NCT02592434|449466102|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
124956334|NCT02592434|449466103|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
124956335|NCT02592434|449466104|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
124956336|NCT02592434|449466102|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
124956337|NCT02592434|449466103|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
124956338|NCT02592434|449466104|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
124956339|NCT02592434|449466102|FG000|Open-Label Phase (18 Weeks)|Other|3|||
124956340|NCT02592434|449466103|FG001|Open-Label Phase (18 Weeks)|Other|0|||
124956341|NCT02592434|449466104|FG002|Open-Label Phase (18 Weeks)|Other|0|||
124956342|NCT02592434|449466102|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
124956343|NCT02592434|449466103|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
124956344|NCT02592434|449466104|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
124956345|NCT02592434|449466102|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
124956346|NCT02592434|449466103|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
124460723|NCT03865706|447646008|FG001|Overall Study|Death|3|||
124460724|NCT03865706|447646009|FG002|Overall Study|Death|1|||
124460725|NCT01594853|447646010|FG000|Overall Study|Withdrawal by Subject|1|||
124707714|NCT04464473|448554713|FG001|Overall Study|Adverse Event|0|||
124956347|NCT02592434|449466104|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
124956348|NCT02592434|449466102|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
124956349|NCT02592434|449466103|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
124956350|NCT02592434|449466104|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
124956351|NCT02592434|449466102|FG000|Double Blind Phase (26 Weeks)|Other|0|||
124956352|NCT02592434|449466103|FG001|Double Blind Phase (26 Weeks)|Other|1|||
124956353|NCT02592434|449466104|FG002|Double Blind Phase (26 Weeks)|Other|0|||
124956354|NCT02592434|449466102|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
124956355|NCT02592434|449466103|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
124956356|NCT02592434|449466104|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
124460726|NCT01594853|447646011|FG001|Overall Study|Withdrawal by Subject|1|||
124707715|NCT04464473|448554714|FG002|Overall Study|Adverse Event|0|||
124707716|NCT04464473|448554715|FG003|Overall Study|Adverse Event|1|||
124707717|NCT04464473|448554716|FG004|Overall Study|Adverse Event|0|||
124707718|NCT04464473|448554717|FG005|Overall Study|Adverse Event|0|||
124707719|NCT04464473|448554712|FG000|Overall Study|Lost to Follow-up|0|||
124707720|NCT04464473|448554713|FG001|Overall Study|Lost to Follow-up|0|||
124707721|NCT04464473|448554714|FG002|Overall Study|Lost to Follow-up|0|||
124707722|NCT04464473|448554715|FG003|Overall Study|Lost to Follow-up|1|||
124707723|NCT04464473|448554716|FG004|Overall Study|Lost to Follow-up|0|||
124707724|NCT04464473|448554717|FG005|Overall Study|Lost to Follow-up|0|||
124956357|NCT02592434|449466102|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
124956358|NCT02592434|449466103|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
124460727|NCT01594853|447646010|FG000|Overall Study|Lost to Follow-up|1|||
124460728|NCT01594853|447646011|FG001|Overall Study|Lost to Follow-up|1|||
124549034|NCT00742859|447965430|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
124549035|NCT00742859|447965431|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
124549036|NCT00742859|447965432|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
124549037|NCT00742859|447965429|FG000|Overall Study|Sponsor request patient out of town|0|||
124549038|NCT00742859|447965430|FG001|Overall Study|Sponsor request patient out of town|0|||
124549039|NCT00742859|447965431|FG002|Overall Study|Sponsor request patient out of town|1|||
124549040|NCT00742859|447965432|FG003|Overall Study|Sponsor request patient out of town|1|||
124549041|NCT00742859|447965429|FG000|Overall Study|Site error|0|||
124549042|NCT00742859|447965430|FG001|Overall Study|Site error|0|||
124549043|NCT00742859|447965431|FG002|Overall Study|Site error|1|||
124549044|NCT00742859|447965432|FG003|Overall Study|Site error|1|||
124549045|NCT04527549|447965435|FG000|Overall Study|Withdrawal by Subject|1|||
124549046|NCT04527549|447965436|FG001|Overall Study|Withdrawal by Subject|1|||
124549047|NCT00962013|447965437|FG000|Overall Study|Did not have surgery|1|||
124549048|NCT00962013|447965437|FG000|Overall Study|Death|8|||
124549049|NCT00962013|447965437|FG000|Overall Study|Lost to Follow-up|12|||
124549050|NCT00962013|447965437|FG000|Overall Study|Unable/Unwilling to return|6|||
124549051|NCT00962013|447965437|FG000|Overall Study|Withdrawal by Subject|8|||
124549052|NCT00962013|447965437|FG000|Overall Study|Removal of study device|3|||
124549053|NCT00962013|447965437|FG000|Overall Study|Site Termination|24|||
124549054|NCT00962013|447965437|FG000|Overall Study|No 5 year evaluation|6|||
124549055|NCT00445458|447965450|FG000|Overall Study|Disease Progression|3|||
124549056|NCT00445458|447965451|FG001|Overall Study|Disease Progression|4|||
124549057|NCT00445458|447965452|FG002|Overall Study|Disease Progression|54|||
124549058|NCT00445458|447965453|FG003|Overall Study|Disease Progression|27|||
124549059|NCT00445458|447965450|FG000|Overall Study|Withdrawal by Subject|0|||
124549060|NCT00445458|447965451|FG001|Overall Study|Withdrawal by Subject|0|||
124549061|NCT00445458|447965452|FG002|Overall Study|Withdrawal by Subject|7|||
124549062|NCT00445458|447965453|FG003|Overall Study|Withdrawal by Subject|0|||
124549063|NCT00445458|447965450|FG000|Overall Study|Adverse Event|0|||
124549064|NCT00445458|447965451|FG001|Overall Study|Adverse Event|0|||
124956359|NCT02592434|449466104|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
124956360|NCT02592434|449466102|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
124956361|NCT02592434|449466103|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
124956362|NCT02592434|449466104|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
124956363|NCT01469819|449466105|FG000|Overall Study|Withdrawal by Subject|1|||
124956364|NCT01469819|449466105|FG000|Overall Study|Did not meet inclusionary criteria|2|||
124956365|NCT01469819|449466105|FG000|Overall Study|Could not swallow SmartPill|2|||
124956366|NCT01469819|449466105|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
124956367|NCT02029521|449466106|FG000|Overall Study|Protocol Violation|1|||
124956368|NCT02029521|449466107|FG001|Overall Study|Protocol Violation|0|||
124956369|NCT02029521|449466106|FG000|Overall Study|Withdrawal by Subject|1|||
124956370|NCT02029521|449466107|FG001|Overall Study|Withdrawal by Subject|1|||
124956371|NCT00428441|449466110|FG000|Overall Study|Lost to Follow-up|1|||
124956372|NCT00510783|449466115|FG000|Overall Study|Lost to Follow-up|29|||
124956373|NCT00510783|449466116|FG001|Overall Study|Lost to Follow-up|25|||
124956374|NCT00510783|449466115|FG000|Overall Study|Withdrawal by Subject|2|||
124956375|NCT00510783|449466116|FG001|Overall Study|Withdrawal by Subject|3|||
124956376|NCT00510783|449466115|FG000|Overall Study|Protocol Violation|0|||
124956377|NCT00510783|449466116|FG001|Overall Study|Protocol Violation|1|||
124956378|NCT02744898|449466117|FG000|Overall Study|Progressive Disease|2|||
124956379|NCT02744898|449466117|FG000|Overall Study|Physician Decision|1|||
124956380|NCT02744898|449466117|FG000|Overall Study|Toxicity|1|||
124956381|NCT01348763|449466120|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
124956382|NCT01348763|449466120|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
124956383|NCT01078571|449466121|FG000|Overall Study|Adverse Event|36|||
124956384|NCT01078571|449466121|FG000|Overall Study|Lack of effectiveness|36|||
124956385|NCT01078571|449466121|FG000|Overall Study|Reason not reported|21|||
124956386|NCT01078571|449466121|FG000|Overall Study|Withdrawal by Subject|12|||
124956387|NCT01078571|449466121|FG000|Overall Study|Lost to Follow-up|8|||
124956388|NCT01078571|449466121|FG000|Overall Study|Protocol Violation|2|||
124956389|NCT03647709|449466123|FG000|Overall Study|Lost to Follow-up|5|||
124956390|NCT03647709|449466123|FG000|Overall Study|Physician Decision|6|||
124956391|NCT03647709|449466123|FG000|Overall Study|Withdrawal by Subject|3|||
124549065|NCT00445458|447965452|FG002|Overall Study|Adverse Event|3|||
124549066|NCT00445458|447965453|FG003|Overall Study|Adverse Event|0|||
124956392|NCT03802513|449466125|FG000|Overall Study|Lost to Follow-up|1|||
124956393|NCT03045302|449466141|FG000|Overall Study|Pre-treatment adverse event|1|||
124956394|NCT05287178|449466142|FG000|Overall Study|Lost to Follow-up|2|||
124956395|NCT00603278|449466143|FG000|Overall Study|Lack of Efficacy|35|||
124956396|NCT00603278|449466144|FG001|Overall Study|Lack of Efficacy|10|||
124956397|NCT00603278|449466145|FG002|Overall Study|Lack of Efficacy|11|||
124956398|NCT00603278|449466146|FG003|Overall Study|Lack of Efficacy|8|||
124956399|NCT00603278|449466147|FG004|Overall Study|Lack of Efficacy|7|||
124956400|NCT00603278|449466148|FG005|Overall Study|Lack of Efficacy|14|||
124956401|NCT00603278|449466143|FG000|Overall Study|Adverse Event|0|||
124956402|NCT00603278|449466144|FG001|Overall Study|Adverse Event|3|||
124956403|NCT00603278|449466145|FG002|Overall Study|Adverse Event|1|||
124956404|NCT00603278|449466146|FG003|Overall Study|Adverse Event|0|||
124956405|NCT00603278|449466147|FG004|Overall Study|Adverse Event|2|||
124956406|NCT00603278|449466148|FG005|Overall Study|Adverse Event|1|||
124956407|NCT00603278|449466143|FG000|Overall Study|Withdrawal by Subject|2|||
124956408|NCT00603278|449466144|FG001|Overall Study|Withdrawal by Subject|3|||
124956409|NCT00603278|449466145|FG002|Overall Study|Withdrawal by Subject|1|||
124956410|NCT00603278|449466146|FG003|Overall Study|Withdrawal by Subject|2|||
124956411|NCT00603278|449466147|FG004|Overall Study|Withdrawal by Subject|1|||
124956412|NCT00603278|449466148|FG005|Overall Study|Withdrawal by Subject|2|||
124956413|NCT00603278|449466143|FG000|Overall Study|Protocol Violation|3|||
124956414|NCT00603278|449466144|FG001|Overall Study|Protocol Violation|0|||
124956415|NCT00603278|449466145|FG002|Overall Study|Protocol Violation|1|||
124956416|NCT00603278|449466146|FG003|Overall Study|Protocol Violation|1|||
124956417|NCT00603278|449466147|FG004|Overall Study|Protocol Violation|0|||
124956418|NCT00603278|449466148|FG005|Overall Study|Protocol Violation|1|||
124956419|NCT00603278|449466143|FG000|Overall Study|Physician Decision|0|||
124956420|NCT00603278|449466144|FG001|Overall Study|Physician Decision|1|||
124956421|NCT00603278|449466145|FG002|Overall Study|Physician Decision|0|||
124956422|NCT00603278|449466146|FG003|Overall Study|Physician Decision|0|||
124956423|NCT00603278|449466147|FG004|Overall Study|Physician Decision|2|||
124956424|NCT00603278|449466148|FG005|Overall Study|Physician Decision|1|||
124956425|NCT00603278|449466143|FG000|Overall Study|Lost to Follow-up|1|||
124956426|NCT00603278|449466144|FG001|Overall Study|Lost to Follow-up|0|||
124956427|NCT00603278|449466145|FG002|Overall Study|Lost to Follow-up|0|||
124956428|NCT00603278|449466146|FG003|Overall Study|Lost to Follow-up|0|||
124956429|NCT00603278|449466147|FG004|Overall Study|Lost to Follow-up|1|||
124956430|NCT00603278|449466148|FG005|Overall Study|Lost to Follow-up|0|||
124956431|NCT04374253|449466152|FG000|Overall Study|Adverse Event|0|||
124956432|NCT04374253|449466153|FG001|Overall Study|Adverse Event|26|||
124956433|NCT04374253|449466154|FG002|Overall Study|Adverse Event|2|||
124956434|NCT04374253|449466155|FG003|Overall Study|Adverse Event|12|||
124956435|NCT04374253|449466152|FG000|Overall Study|Study terminated by sponsor|13|||
124956436|NCT04374253|449466153|FG001|Overall Study|Study terminated by sponsor|593|||
124956437|NCT04374253|449466154|FG002|Overall Study|Study terminated by sponsor|21|||
124956438|NCT04374253|449466155|FG003|Overall Study|Study terminated by sponsor|567|||
124956439|NCT04374253|449466152|FG000|Overall Study|Withdrawal by Subject|0|||
124956440|NCT04374253|449466153|FG001|Overall Study|Withdrawal by Subject|55|||
124956441|NCT04374253|449466154|FG002|Overall Study|Withdrawal by Subject|3|||
124956442|NCT04374253|449466155|FG003|Overall Study|Withdrawal by Subject|40|||
124956443|NCT04374253|449466152|FG000|Overall Study|Physician Decision|1|||
124956444|NCT04374253|449466153|FG001|Overall Study|Physician Decision|10|||
124956445|NCT04374253|449466154|FG002|Overall Study|Physician Decision|1|||
124956446|NCT04374253|449466155|FG003|Overall Study|Physician Decision|10|||
124956447|NCT04374253|449466152|FG000|Overall Study|Protocol Violation|0|||
124956448|NCT04374253|449466153|FG001|Overall Study|Protocol Violation|0|||
124707725|NCT01585025|448555870|FG000|Overall Study|Withdrawal by Subject|0|||
124707726|NCT01585025|448555871|FG001|Overall Study|Withdrawal by Subject|3|||
124707727|NCT01585025|448555872|FG002|Overall Study|Withdrawal by Subject|4|||
124707728|NCT00805389|448555873|FG000|Overall Study|Adverse Event|0|||
124707729|NCT00805389|448555874|FG001|Overall Study|Adverse Event|0|||
124707730|NCT00805389|448555875|FG002|Overall Study|Adverse Event|1|||
124707731|NCT00805389|448555876|FG003|Overall Study|Adverse Event|2|||
124707732|NCT00805389|448555877|FG004|Overall Study|Adverse Event|0|||
124707733|NCT00805389|448555873|FG000|Overall Study|Lost to Follow-up|4|||
124956449|NCT04374253|449466154|FG002|Overall Study|Protocol Violation|0|||
124956450|NCT04374253|449466155|FG003|Overall Study|Protocol Violation|2|||
124956451|NCT04374253|449466152|FG000|Overall Study|Death|0|||
124956452|NCT04374253|449466153|FG001|Overall Study|Death|3|||
124956453|NCT04374253|449466154|FG002|Overall Study|Death|1|||
124956454|NCT04374253|449466155|FG003|Overall Study|Death|1|||
124956455|NCT04374253|449466152|FG000|Overall Study|Lack of Efficacy|0|||
124956456|NCT04374253|449466153|FG001|Overall Study|Lack of Efficacy|0|||
124956457|NCT04374253|449466154|FG002|Overall Study|Lack of Efficacy|0|||
124956458|NCT04374253|449466155|FG003|Overall Study|Lack of Efficacy|1|||
124956459|NCT04374253|449466152|FG000|Overall Study|Lost to Follow-up|1|||
124956460|NCT04374253|449466153|FG001|Overall Study|Lost to Follow-up|1|||
124956461|NCT04374253|449466154|FG002|Overall Study|Lost to Follow-up|0|||
124956462|NCT04374253|449466155|FG003|Overall Study|Lost to Follow-up|2|||
124956463|NCT04374253|449466152|FG000|Overall Study|Reason Not Specified|0|||
124956464|NCT04374253|449466153|FG001|Overall Study|Reason Not Specified|8|||
124956465|NCT04374253|449466154|FG002|Overall Study|Reason Not Specified|0|||
124956466|NCT04374253|449466155|FG003|Overall Study|Reason Not Specified|8|||
124956467|NCT01207453|449466156|FG000|First Intervention|Adverse Event|2|||
124956468|NCT01207453|449466157|FG001|First Intervention|Adverse Event|1|||
124956469|NCT01207453|449466156|FG000|Washout|Adverse Event|1|||
124956470|NCT01207453|449466157|FG001|Washout|Adverse Event|0|||
124956471|NCT01207453|449466156|FG000|Washout|Lost to Follow-up|1|||
124460729|NCT01594853|447646010|FG000|Overall Study|noncompliance with exercise|0|||
124460730|NCT01594853|447646011|FG001|Overall Study|noncompliance with exercise|1|||
124460731|NCT03709654|447646012|FG000|Overall Study|Lost to Follow-up|1|||
124956472|NCT01207453|449466157|FG001|Washout|Lost to Follow-up|0|||
124956473|NCT01207453|449466156|FG000|2nd Intervention|Adverse Event|1|||
124956474|NCT01207453|449466157|FG001|2nd Intervention|Adverse Event|2|||
124956475|NCT01207453|449466156|FG000|2nd Intervention|Lost to Follow-up|1|||
124956476|NCT01207453|449466157|FG001|2nd Intervention|Lost to Follow-up|0|||
124956477|NCT00990821|449466158|FG000|Overall Study|Withdrawal by Subject|0|||
124956478|NCT00990821|449466159|FG001|Overall Study|Withdrawal by Subject|2|||
124956479|NCT00990821|449466160|FG002|Overall Study|Withdrawal by Subject|0|||
124956480|NCT00990821|449466161|FG003|Overall Study|Withdrawal by Subject|0|||
124956481|NCT00990821|449466162|FG004|Overall Study|Withdrawal by Subject|3|||
124956482|NCT00990821|449466163|FG005|Overall Study|Withdrawal by Subject|3|||
124956483|NCT00990821|449466164|FG006|Overall Study|Withdrawal by Subject|1|||
124956484|NCT00990821|449466165|FG007|Overall Study|Withdrawal by Subject|0|||
124956485|NCT00990821|449466166|FG008|Overall Study|Withdrawal by Subject|0|||
124956486|NCT00990821|449466167|FG009|Overall Study|Withdrawal by Subject|1|||
124956487|NCT00990821|449466168|FG010|Overall Study|Withdrawal by Subject|3|||
124956488|NCT00990821|449466169|FG011|Overall Study|Withdrawal by Subject|5|||
124956489|NCT00990821|449466170|FG012|Overall Study|Withdrawal by Subject|2|||
124956490|NCT00990821|449466171|FG013|Overall Study|Withdrawal by Subject|1|||
124956491|NCT00308113|449466172|FG000|Overall Study|Protocol closure|0|||
124956492|NCT00308113|449466173|FG001|Overall Study|Protocol closure|0|||
124956493|NCT00308113|449466174|FG002|Overall Study|Protocol closure|0|||
124956494|NCT00308113|449466175|FG003|Overall Study|Protocol closure|1|||
124956495|NCT01123642|449467821|FG000|Overall Study|Lost to Follow-up|23|||
124956496|NCT01123642|449467821|FG000|Overall Study|Withdrawal by Subject|9|||
124956497|NCT01123642|449467821|FG000|Overall Study|ineligible at baseline assessment|36|||
124956498|NCT00925288|449467822|FG000|Overall Study|Lost to Follow-up|9|||
124956499|NCT00925288|449467823|FG001|Overall Study|Lost to Follow-up|7|||
124956500|NCT03322514|449467824|FG000|Overall Study|Withdrawal by Subject|1|||
124956501|NCT03322514|449467825|FG001|Overall Study|Withdrawal by Subject|1|||
124956502|NCT01184859|449467826|FG000|Period 1: Single Dose|Insufficient urine production|0|||
124956503|NCT01184859|449467827|FG001|Period 1: Single Dose|Insufficient urine production|1|||
124956504|NCT01184859|449467828|FG002|Period 1: Single Dose|Insufficient urine production|0|||
124956505|NCT01184859|449467829|FG003|Period 1: Single Dose|Insufficient urine production|0|||
124956506|NCT01184859|449467830|FG004|Period 1: Single Dose|Insufficient urine production|0|||
124460732|NCT03709654|447646013|FG001|Overall Study|Lost to Follow-up|1|||
124460733|NCT03709654|447646012|FG000|Overall Study|Withdrawal by Subject|1|||
124460734|NCT03709654|447646013|FG001|Overall Study|Withdrawal by Subject|1|||
124460735|NCT03709654|447646012|FG000|Overall Study|Adverse Event|1|||
124460736|NCT03709654|447646013|FG001|Overall Study|Adverse Event|0|||
124460737|NCT02631200|447646016|FG000|First Period|Death|1|||
124460738|NCT02631200|447646017|FG001|First Period|Death|2|||
124460739|NCT02631200|447646016|FG000|First Period|Patient ill-health|2|||
124460740|NCT02631200|447646017|FG001|First Period|Patient ill-health|4|||
124460741|NCT02631200|447646016|FG000|First Period|Withdrawal by Subject|4|||
124460742|NCT02631200|447646017|FG001|First Period|Withdrawal by Subject|1|||
124460743|NCT02631200|447646016|FG000|Deferred Period|Death|0|||
124460744|NCT02631200|447646017|FG001|Deferred Period|Death|1|||
124766445|NCT05121766|448771737|FG001|Overall Study|Withdrawal by Subject|1|||
124956507|NCT01184859|449467826|FG000|Period 1: Single Dose|Protocol Violation|0|||
124956508|NCT01184859|449467827|FG001|Period 1: Single Dose|Protocol Violation|1|||
124956509|NCT01184859|449467828|FG002|Period 1: Single Dose|Protocol Violation|0|||
124956510|NCT01184859|449467829|FG003|Period 1: Single Dose|Protocol Violation|0|||
124956511|NCT01184859|449467830|FG004|Period 1: Single Dose|Protocol Violation|0|||
124956512|NCT01184859|449467826|FG000|Period 1: Single Dose|Adverse Event|0|||
124956513|NCT01184859|449467827|FG001|Period 1: Single Dose|Adverse Event|0|||
124956514|NCT01184859|449467828|FG002|Period 1: Single Dose|Adverse Event|0|||
124460745|NCT02631200|447646016|FG000|Deferred Period|Received kidney transplant|0|||
124460746|NCT02631200|447646017|FG001|Deferred Period|Received kidney transplant|1|||
124460747|NCT02631200|447646016|FG000|Deferred Period|Withdrawal by Subject|0|||
124956515|NCT01184859|449467829|FG003|Period 1: Single Dose|Adverse Event|0|||
124956516|NCT01184859|449467830|FG004|Period 1: Single Dose|Adverse Event|1|||
124956517|NCT01184859|449467826|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
124956518|NCT01184859|449467827|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
124956519|NCT01184859|449467828|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
124956520|NCT01184859|449467829|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
124460748|NCT02631200|447646017|FG001|Deferred Period|Withdrawal by Subject|2|||
124460749|NCT02631200|447646016|FG000|Deferred Period|Lost to Follow-up|0|||
124460750|NCT02631200|447646017|FG001|Deferred Period|Lost to Follow-up|1|||
124460751|NCT01081912|447646019|FG000|Conversion/Titration|Adverse Event|47|||
124460752|NCT01081912|447646020|FG001|Conversion/Titration|Adverse Event|0|||
124460753|NCT01081912|447646021|FG002|Conversion/Titration|Adverse Event|0|||
124707734|NCT00805389|448555874|FG001|Overall Study|Lost to Follow-up|3|||
124707735|NCT00805389|448555875|FG002|Overall Study|Lost to Follow-up|6|||
124707736|NCT00805389|448555876|FG003|Overall Study|Lost to Follow-up|10|||
124707737|NCT00805389|448555877|FG004|Overall Study|Lost to Follow-up|9|||
124956521|NCT01184859|449467830|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
124956522|NCT01184859|449467826|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
124956523|NCT01184859|449467827|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
124956524|NCT01184859|449467828|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
124956525|NCT01184859|449467829|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
124956526|NCT01184859|449467830|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
124956527|NCT00961298|449467831|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
124956528|NCT00961298|449467831|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
124956529|NCT00961298|449467831|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
124956530|NCT01904019|449467833|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
124956531|NCT01904019|449467833|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
124956532|NCT01904019|449467833|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
124956533|NCT01904019|449467833|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
124956534|NCT01904019|449467833|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
124956535|NCT01904019|449467833|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
124956536|NCT01537120|449467834|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
124956537|NCT01537120|449467834|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
124956538|NCT01503515|449467839|FG000|Overall Study|Adverse Event|4|||
124956539|NCT01503515|449467840|FG001|Overall Study|Adverse Event|5|||
124956540|NCT01503515|449467839|FG000|Overall Study|Death|0|||
124956541|NCT01503515|449467840|FG001|Overall Study|Death|1|||
124956542|NCT01503515|449467839|FG000|Overall Study|Physician Decision|14|||
124956543|NCT01503515|449467840|FG001|Overall Study|Physician Decision|23|||
124956544|NCT01503515|449467839|FG000|Overall Study|Withdrawal by Subject|0|||
124956545|NCT01503515|449467840|FG001|Overall Study|Withdrawal by Subject|1|||
124956546|NCT01503515|449467839|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
124956547|NCT01503515|449467840|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
124956548|NCT01503515|449467839|FG000|Overall Study|Ineligible|1|||
124956549|NCT01503515|449467840|FG001|Overall Study|Ineligible|1|||
124956550|NCT03087851|449467842|FG000|Overall Study|Withdraw on medical grounds|0|||
124956551|NCT03087851|449467843|FG001|Overall Study|Withdraw on medical grounds|1|||
124956552|NCT03087851|449467844|FG002|Overall Study|Withdraw on medical grounds|2|||
124956553|NCT02123797|449467847|FG000|Baseline Intervention|Death|9|||
124956554|NCT02123797|449467848|FG001|Baseline Intervention|Death|16|||
124956555|NCT02123797|449467849|FG002|Baseline Intervention|Death|0|||
124956556|NCT02123797|449467850|FG003|Baseline Intervention|Death|0|||
124956557|NCT02123797|449467851|FG004|Baseline Intervention|Death|0|||
124956558|NCT02123797|449467847|FG000|Baseline Intervention|Withdrawal by Subject|2|||
124956559|NCT02123797|449467848|FG001|Baseline Intervention|Withdrawal by Subject|8|||
124956560|NCT02123797|449467849|FG002|Baseline Intervention|Withdrawal by Subject|0|||
124956561|NCT02123797|449467850|FG003|Baseline Intervention|Withdrawal by Subject|0|||
124956562|NCT02123797|449467851|FG004|Baseline Intervention|Withdrawal by Subject|0|||
124956563|NCT02123797|449467847|FG000|Baseline Intervention|Relocation|2|||
124956564|NCT02123797|449467848|FG001|Baseline Intervention|Relocation|0|||
124956565|NCT02123797|449467849|FG002|Baseline Intervention|Relocation|0|||
124956566|NCT02123797|449467850|FG003|Baseline Intervention|Relocation|0|||
124956567|NCT02123797|449467851|FG004|Baseline Intervention|Relocation|0|||
124956568|NCT02123797|449467847|FG000|Baseline Intervention|Out of window for initial survey|6|||
124956569|NCT02123797|449467848|FG001|Baseline Intervention|Out of window for initial survey|13|||
124460754|NCT01081912|447646019|FG000|Conversion/Titration|Lack of Efficacy|17|||
124707738|NCT00805389|448555873|FG000|Overall Study|Protocol Violation|0|||
124707739|NCT00805389|448555874|FG001|Overall Study|Protocol Violation|0|||
124956570|NCT02123797|449467849|FG002|Baseline Intervention|Out of window for initial survey|0|||
124956571|NCT02123797|449467850|FG003|Baseline Intervention|Out of window for initial survey|0|||
124956572|NCT02123797|449467851|FG004|Baseline Intervention|Out of window for initial survey|0|||
124956573|NCT02123797|449467847|FG000|Baseline Intervention|Lost to Follow-up|0|||
124956574|NCT02123797|449467848|FG001|Baseline Intervention|Lost to Follow-up|5|||
124956575|NCT02123797|449467849|FG002|Baseline Intervention|Lost to Follow-up|0|||
124956576|NCT02123797|449467850|FG003|Baseline Intervention|Lost to Follow-up|0|||
124460755|NCT01081912|447646020|FG001|Conversion/Titration|Lack of Efficacy|0|||
124707740|NCT00805389|448555875|FG002|Overall Study|Protocol Violation|1|||
124707741|NCT00805389|448555876|FG003|Overall Study|Protocol Violation|0|||
124707742|NCT00805389|448555877|FG004|Overall Study|Protocol Violation|0|||
124707743|NCT00805389|448555873|FG000|Overall Study|Withdrawal by Subject|3|||
124707744|NCT00805389|448555874|FG001|Overall Study|Withdrawal by Subject|2|||
124707745|NCT00805389|448555875|FG002|Overall Study|Withdrawal by Subject|4|||
124707746|NCT00805389|448555876|FG003|Overall Study|Withdrawal by Subject|5|||
124707747|NCT00805389|448555877|FG004|Overall Study|Withdrawal by Subject|4|||
124707748|NCT00557193|448555880|FG000|Induction|Adverse Event|2|||
124707749|NCT00557193|448555881|FG001|Induction|Adverse Event|0|||
124707750|NCT00557193|448555882|FG002|Induction|Adverse Event|0|||
124707751|NCT00557193|448555883|FG003|Induction|Adverse Event|0|||
124707752|NCT00557193|448555884|FG004|Induction|Adverse Event|0|||
124707753|NCT00557193|448555885|FG005|Induction|Adverse Event|0|||
124707754|NCT00557193|448555880|FG000|Induction|Death|6|||
124707755|NCT00557193|448555881|FG001|Induction|Death|0|||
124707756|NCT00557193|448555882|FG002|Induction|Death|0|||
124707757|NCT00557193|448555883|FG003|Induction|Death|0|||
124707758|NCT00557193|448555884|FG004|Induction|Death|0|||
124707759|NCT00557193|448555885|FG005|Induction|Death|0|||
124707760|NCT00557193|448555880|FG000|Induction|Physician Decision|3|||
124707761|NCT00557193|448555881|FG001|Induction|Physician Decision|0|||
124707762|NCT00557193|448555882|FG002|Induction|Physician Decision|0|||
124707763|NCT00557193|448555883|FG003|Induction|Physician Decision|0|||
124707764|NCT00557193|448555884|FG004|Induction|Physician Decision|0|||
124707765|NCT00557193|448555885|FG005|Induction|Physician Decision|0|||
124707766|NCT00557193|448555880|FG000|Induction|Withdrawal by Subject|1|||
124707767|NCT00557193|448555881|FG001|Induction|Withdrawal by Subject|0|||
124707768|NCT00557193|448555882|FG002|Induction|Withdrawal by Subject|0|||
124707769|NCT00557193|448555883|FG003|Induction|Withdrawal by Subject|0|||
124707770|NCT00557193|448555884|FG004|Induction|Withdrawal by Subject|0|||
124707771|NCT00557193|448555885|FG005|Induction|Withdrawal by Subject|0|||
124707772|NCT00557193|448555880|FG000|Induction|Refusal of Further Protocol Therapy|2|||
124707773|NCT00557193|448555881|FG001|Induction|Refusal of Further Protocol Therapy|0|||
124707774|NCT00557193|448555882|FG002|Induction|Refusal of Further Protocol Therapy|0|||
124707775|NCT00557193|448555883|FG003|Induction|Refusal of Further Protocol Therapy|0|||
124707776|NCT00557193|448555884|FG004|Induction|Refusal of Further Protocol Therapy|0|||
124707777|NCT00557193|448555885|FG005|Induction|Refusal of Further Protocol Therapy|0|||
124707778|NCT00557193|448555880|FG000|Induction|Ineligible|8|||
124707779|NCT00557193|448555881|FG001|Induction|Ineligible|0|||
124707780|NCT00557193|448555882|FG002|Induction|Ineligible|0|||
124707781|NCT00557193|448555883|FG003|Induction|Ineligible|0|||
124707782|NCT00557193|448555884|FG004|Induction|Ineligible|0|||
124707783|NCT00557193|448555885|FG005|Induction|Ineligible|0|||
124707784|NCT00557193|448555880|FG000|Induction|Inevaluable for post Induction|2|||
124707785|NCT00557193|448555881|FG001|Induction|Inevaluable for post Induction|0|||
124707786|NCT00557193|448555882|FG002|Induction|Inevaluable for post Induction|0|||
124707787|NCT00557193|448555883|FG003|Induction|Inevaluable for post Induction|0|||
124707788|NCT00557193|448555884|FG004|Induction|Inevaluable for post Induction|0|||
124707789|NCT00557193|448555885|FG005|Induction|Inevaluable for post Induction|0|||
124707790|NCT00557193|448555880|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
124707791|NCT00557193|448555881|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
124707792|NCT00557193|448555882|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
124707793|NCT00557193|448555883|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
124707794|NCT00557193|448555884|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
124707795|NCT00557193|448555885|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
124707796|NCT00557193|448555880|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
124707797|NCT00557193|448555881|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
124707798|NCT00557193|448555882|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
124707799|NCT00557193|448555883|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
124707800|NCT00557193|448555884|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
124707801|NCT00557193|448555885|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
124956577|NCT02123797|449467851|FG004|Baseline Intervention|Lost to Follow-up|0|||
124956578|NCT02123797|449467847|FG000|Baseline Intervention|Other Disease|3|||
124956579|NCT02123797|449467848|FG001|Baseline Intervention|Other Disease|0|||
124956580|NCT02123797|449467849|FG002|Baseline Intervention|Other Disease|0|||
124956581|NCT02123797|449467850|FG003|Baseline Intervention|Other Disease|0|||
124956582|NCT02123797|449467851|FG004|Baseline Intervention|Other Disease|0|||
124707802|NCT00557193|448555880|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
124956583|NCT02123797|449467847|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
124707803|NCT00557193|448555881|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
124707804|NCT00557193|448555882|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
124707805|NCT00557193|448555883|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
124707806|NCT00557193|448555884|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
124707807|NCT00557193|448555885|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
124766446|NCT05121766|448771736|FG000|Overall Study|Adverse Event|2|||
124956584|NCT02123797|449467848|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
124460756|NCT01081912|447646021|FG002|Conversion/Titration|Lack of Efficacy|0|||
124460757|NCT01081912|447646019|FG000|Conversion/Titration|Lost to Follow-up|5|||
124460758|NCT01081912|447646020|FG001|Conversion/Titration|Lost to Follow-up|0|||
124460759|NCT01081912|447646021|FG002|Conversion/Titration|Lost to Follow-up|0|||
124460760|NCT01081912|447646019|FG000|Conversion/Titration|Physician Decision|2|||
124460761|NCT01081912|447646020|FG001|Conversion/Titration|Physician Decision|0|||
124460762|NCT01081912|447646021|FG002|Conversion/Titration|Physician Decision|0|||
124460763|NCT01081912|447646019|FG000|Conversion/Titration|Protocol Violation|67|||
124460764|NCT01081912|447646020|FG001|Conversion/Titration|Protocol Violation|0|||
124460765|NCT01081912|447646021|FG002|Conversion/Titration|Protocol Violation|0|||
124460766|NCT01081912|447646019|FG000|Conversion/Titration|Withdrawal by Subject|23|||
124460767|NCT01081912|447646020|FG001|Conversion/Titration|Withdrawal by Subject|0|||
124460768|NCT01081912|447646021|FG002|Conversion/Titration|Withdrawal by Subject|0|||
124460769|NCT01081912|447646019|FG000|Conversion/Titration|Non-Compliance|47|||
124460770|NCT01081912|447646020|FG001|Conversion/Titration|Non-Compliance|0|||
124460771|NCT01081912|447646021|FG002|Conversion/Titration|Non-Compliance|0|||
124460772|NCT01081912|447646019|FG000|Maintenance Treatment|Adverse Event|0|||
124460773|NCT01081912|447646020|FG001|Maintenance Treatment|Adverse Event|2|||
124460774|NCT01081912|447646021|FG002|Maintenance Treatment|Adverse Event|12|||
124460775|NCT01081912|447646019|FG000|Maintenance Treatment|Lack of Efficacy|0|||
124460776|NCT01081912|447646020|FG001|Maintenance Treatment|Lack of Efficacy|14|||
124460777|NCT01081912|447646021|FG002|Maintenance Treatment|Lack of Efficacy|64|||
124460778|NCT01081912|447646019|FG000|Maintenance Treatment|Lost to Follow-up|0|||
124460779|NCT01081912|447646020|FG001|Maintenance Treatment|Lost to Follow-up|1|||
124460780|NCT01081912|447646021|FG002|Maintenance Treatment|Lost to Follow-up|0|||
124460781|NCT01081912|447646019|FG000|Maintenance Treatment|Physician Decision|0|||
124460782|NCT01081912|447646020|FG001|Maintenance Treatment|Physician Decision|0|||
124460783|NCT01081912|447646021|FG002|Maintenance Treatment|Physician Decision|1|||
124460784|NCT01081912|447646019|FG000|Maintenance Treatment|Protocol Violation|0|||
124460785|NCT01081912|447646020|FG001|Maintenance Treatment|Protocol Violation|1|||
124460786|NCT01081912|447646021|FG002|Maintenance Treatment|Protocol Violation|2|||
124460787|NCT01081912|447646019|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
124460788|NCT01081912|447646020|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
124460789|NCT01081912|447646021|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
124460790|NCT01081912|447646019|FG000|Maintenance Treatment|Non-Compliance|0|||
124460791|NCT01081912|447646020|FG001|Maintenance Treatment|Non-Compliance|4|||
124460792|NCT01081912|447646021|FG002|Maintenance Treatment|Non-Compliance|7|||
124460793|NCT01081912|447646019|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
124460794|NCT01081912|447646020|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
124460795|NCT01081912|447646021|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
124460796|NCT03776175|447646023|FG000|Treatment Period (42 Days)|Adverse Event|0|||
124460797|NCT03776175|447646024|FG001|Treatment Period (42 Days)|Adverse Event|1|||
124460798|NCT03776175|447646025|FG002|Treatment Period (42 Days)|Adverse Event|1|||
124460799|NCT03776175|447646026|FG003|Treatment Period (42 Days)|Adverse Event|0|||
124460800|NCT03776175|447646023|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
124460801|NCT03776175|447646024|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
124460802|NCT03776175|447646025|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
124460803|NCT03776175|447646026|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
124460804|NCT03776175|447646023|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
124460805|NCT03776175|447646024|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
124460806|NCT03776175|447646025|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
124460807|NCT03776175|447646026|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
124460808|NCT03776175|447646023|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
124460809|NCT03776175|447646024|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
124460810|NCT03776175|447646025|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
124460811|NCT03776175|447646026|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
124460812|NCT03776175|447646023|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
124460813|NCT03776175|447646024|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
124460814|NCT03776175|447646025|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
124460815|NCT03776175|447646026|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
124460816|NCT03776175|447646023|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
124460817|NCT03776175|447646024|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
124460818|NCT03776175|447646025|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
124460819|NCT03776175|447646026|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
124460820|NCT04677712|447646028|FG000|Overall Study|Lost to Follow-up|0|||
124460821|NCT04677712|447646029|FG001|Overall Study|Lost to Follow-up|1|||
124460822|NCT04677712|447646030|FG002|Overall Study|Lost to Follow-up|0|||
124460823|NCT04677712|447646031|FG003|Overall Study|Lost to Follow-up|0|||
124460824|NCT04677712|447646032|FG004|Overall Study|Lost to Follow-up|0|||
124460825|NCT04677712|447646033|FG005|Overall Study|Lost to Follow-up|0|||
124460826|NCT00711100|447646034|FG000|Overall Study|Lack of Efficacy|5|||
124460827|NCT00711100|447646034|FG000|Overall Study|Withdrawal by Subject|8|||
124460828|NCT05440539|447646036|FG000|Overall Study|Lost to Follow-up|4|||
124460829|NCT05440539|447646037|FG001|Overall Study|Lost to Follow-up|4|||
124460830|NCT05440539|447646036|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
124460831|NCT05440539|447646037|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
124460832|NCT03808077|447646038|FG000|Overall Study|Physician Decision|2|||
124460833|NCT03808077|447646039|FG001|Overall Study|Physician Decision|3|||
124460834|NCT03808077|447646038|FG000|Overall Study|Withdrawal by Subject|1|||
124460835|NCT03808077|447646039|FG001|Overall Study|Withdrawal by Subject|0|||
124460836|NCT03808077|447646038|FG000|Overall Study|Equipment Issues|2|||
124460837|NCT03808077|447646039|FG001|Overall Study|Equipment Issues|1|||
124956585|NCT02123797|449467849|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
124956586|NCT02123797|449467850|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
124956587|NCT02123797|449467851|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
124956588|NCT02123797|449467847|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
124956589|NCT02123797|449467848|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
124956590|NCT02123797|449467849|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
124956591|NCT02123797|449467850|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
124956592|NCT02123797|449467851|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
124956593|NCT02123797|449467847|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
124956594|NCT02123797|449467848|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
124956595|NCT02123797|449467849|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
124956596|NCT02123797|449467850|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
124956597|NCT02123797|449467851|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
124956598|NCT02123797|449467847|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
124956599|NCT02123797|449467848|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
124956600|NCT02123797|449467849|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
124956601|NCT02123797|449467850|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
124956602|NCT02123797|449467851|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
124956603|NCT02123797|449467847|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
124956604|NCT02123797|449467848|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
124956605|NCT02123797|449467849|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
124956606|NCT02123797|449467850|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
124956607|NCT02123797|449467851|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
124956608|NCT02123797|449467847|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
124956609|NCT02123797|449467848|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
124956610|NCT02123797|449467849|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
124956611|NCT02123797|449467850|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
124956612|NCT02123797|449467851|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
124956613|NCT02123797|449467847|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
124956614|NCT02123797|449467848|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
124956615|NCT02123797|449467849|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
124956616|NCT02123797|449467850|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
124956617|NCT02123797|449467851|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
124956618|NCT02123797|449467847|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
124956619|NCT02123797|449467848|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
124956620|NCT02123797|449467849|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
124956621|NCT02123797|449467850|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
124956622|NCT02123797|449467851|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
124956623|NCT02123797|449467847|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
124956624|NCT02123797|449467848|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
124956625|NCT02123797|449467849|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
124956626|NCT02123797|449467850|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
124956627|NCT02123797|449467851|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
124956628|NCT03997409|449467854|FG000|Overall Study|Protocol Violation|1|||
124956629|NCT03997409|449467855|FG001|Overall Study|Protocol Violation|1|||
124956630|NCT03997409|449467856|FG002|Overall Study|Protocol Violation|0|||
124956631|NCT03997409|449467854|FG000|Overall Study|Withdrawal by Subject|3|||
124956632|NCT03997409|449467855|FG001|Overall Study|Withdrawal by Subject|0|||
124956633|NCT03997409|449467856|FG002|Overall Study|Withdrawal by Subject|0|||
124956634|NCT03997409|449467854|FG000|Overall Study|Lost to Follow-up|0|||
124460838|NCT04152161|447646040|FG000|Overall Study|Death|0|||
124460839|NCT04152161|447646041|FG001|Overall Study|Death|1|||
124460840|NCT04152161|447646040|FG000|Overall Study|Physician Decision|0|||
124460841|NCT04152161|447646041|FG001|Overall Study|Physician Decision|1|||
124460842|NCT04152161|447646040|FG000|Overall Study|Lost to Follow-up|9|||
124460843|NCT04152161|447646041|FG001|Overall Study|Lost to Follow-up|3|||
124956635|NCT03997409|449467855|FG001|Overall Study|Lost to Follow-up|0|||
124460844|NCT04152161|447646040|FG000|Overall Study|Protocol Violation|1|||
124460845|NCT04152161|447646041|FG001|Overall Study|Protocol Violation|0|||
124956636|NCT03997409|449467856|FG002|Overall Study|Lost to Follow-up|1|||
124460846|NCT04152161|447646040|FG000|Overall Study|Withdrawal by Subject|29|||
124460847|NCT04152161|447646041|FG001|Overall Study|Withdrawal by Subject|28|||
124460848|NCT04152161|447646040|FG000|Overall Study|Sponsor termination of study|750|||
124460849|NCT04152161|447646041|FG001|Overall Study|Sponsor termination of study|755|||
124460850|NCT04152161|447646040|FG000|Overall Study|Other|20|||
124460851|NCT04152161|447646041|FG001|Overall Study|Other|18|||
124460852|NCT00001379|447646042|FG000|Initial Treatment|Disease progression|21|||
124460853|NCT00001379|447646043|FG001|Initial Treatment|Disease progression|3|||
124460854|NCT00001379|447646044|FG002|Initial Treatment|Disease progression|0|||
124460855|NCT00001379|447646045|FG003|Initial Treatment|Disease progression|0|||
124460856|NCT00001379|447646042|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
124460857|NCT00001379|447646043|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
124460858|NCT00001379|447646044|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
124460859|NCT00001379|447646045|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
124460860|NCT00001379|447646042|FG000|Initial Treatment|Received alternative treatment|2|||
124956637|NCT01753323|449467857|FG000|Overall Study|Lack of Efficacy|0|||
124956638|NCT01753323|449467858|FG001|Overall Study|Lack of Efficacy|0|||
124956639|NCT01753323|449467859|FG002|Overall Study|Lack of Efficacy|8|||
124956640|NCT01753323|449467857|FG000|Overall Study|Protocol deviation|1|||
124956641|NCT01753323|449467858|FG001|Overall Study|Protocol deviation|0|||
124956642|NCT01753323|449467859|FG002|Overall Study|Protocol deviation|0|||
124956643|NCT01753323|449467857|FG000|Overall Study|Adverse Event|0|||
124956644|NCT01753323|449467858|FG001|Overall Study|Adverse Event|0|||
124956645|NCT01753323|449467859|FG002|Overall Study|Adverse Event|1|||
124956646|NCT01498445|449467861|FG000|Overall Study|Lack of Efficacy|0|||
124956647|NCT01498445|449467862|FG001|Overall Study|Lack of Efficacy|0|||
124956648|NCT01498445|449467863|FG002|Overall Study|Lack of Efficacy|1|||
124956649|NCT01498445|449467864|FG003|Overall Study|Lack of Efficacy|2|||
124956650|NCT01498445|449467865|FG004|Overall Study|Lack of Efficacy|0|||
124956651|NCT01498445|449467866|FG005|Overall Study|Lack of Efficacy|0|||
124956652|NCT01498445|449467861|FG000|Overall Study|Screen Failure|0|||
124956653|NCT01498445|449467862|FG001|Overall Study|Screen Failure|0|||
124956654|NCT01498445|449467863|FG002|Overall Study|Screen Failure|0|||
124956655|NCT01498445|449467864|FG003|Overall Study|Screen Failure|0|||
124956656|NCT01498445|449467865|FG004|Overall Study|Screen Failure|1|||
124956657|NCT01498445|449467866|FG005|Overall Study|Screen Failure|1|||
124956658|NCT00730925|449467869|FG000|Overall Study|Progressive Disease|21|||
124956659|NCT00730925|449467869|FG000|Overall Study|Dose reducing Event|2|||
124956660|NCT00730925|449467869|FG000|Overall Study|Other Averse Event|7|||
124956661|NCT00730925|449467869|FG000|Overall Study|Protocol Violation|1|||
124460861|NCT00001379|447646043|FG001|Initial Treatment|Received alternative treatment|1|||
124460862|NCT00001379|447646044|FG002|Initial Treatment|Received alternative treatment|0|||
124460863|NCT00001379|447646045|FG003|Initial Treatment|Received alternative treatment|0|||
124956662|NCT00730925|449467869|FG000|Overall Study|Withdrawal by Subject|1|||
124956663|NCT00730925|449467869|FG000|Overall Study|Switch to combination therapy|8|||
124460864|NCT00001379|447646042|FG000|Initial Treatment|Refused further treatment|2|||
124460865|NCT00001379|447646043|FG001|Initial Treatment|Refused further treatment|0|||
124460866|NCT00001379|447646044|FG002|Initial Treatment|Refused further treatment|0|||
124460867|NCT00001379|447646045|FG003|Initial Treatment|Refused further treatment|0|||
124460868|NCT00001379|447646042|FG000|Initial Treatment|Did not receive protocol treatment|0|||
124460869|NCT00001379|447646043|FG001|Initial Treatment|Did not receive protocol treatment|0|||
124460870|NCT00001379|447646044|FG002|Initial Treatment|Did not receive protocol treatment|5|||
124460871|NCT00001379|447646045|FG003|Initial Treatment|Did not receive protocol treatment|0|||
124460872|NCT00001379|447646042|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
124460873|NCT00001379|447646043|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
124460874|NCT00001379|447646044|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
124460875|NCT00001379|447646045|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
124460876|NCT00001379|447646042|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
124956664|NCT00730925|449467869|FG000|Overall Study|Other|1|||
124956665|NCT00561678|449467870|FG000|Overall Study|Withdrawal by Subject|4|||
124460877|NCT00001379|447646043|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
124460878|NCT00001379|447646044|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
124460879|NCT00001379|447646045|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
124460880|NCT00001379|447646042|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
124460881|NCT00001379|447646043|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
124549067|NCT00445458|447965450|FG000|Overall Study|Death|0|||
124956666|NCT00561678|449467871|FG001|Overall Study|Withdrawal by Subject|3|||
124956667|NCT00561678|449467870|FG000|Overall Study|surgery cancelled|1|||
124956668|NCT00561678|449467871|FG001|Overall Study|surgery cancelled|1|||
124956669|NCT00561678|449467870|FG000|Overall Study|surgery rescheduled to different site|2|||
124956670|NCT00561678|449467871|FG001|Overall Study|surgery rescheduled to different site|2|||
124956671|NCT00561678|449467870|FG000|Overall Study|anesthesia provider refusal|1|||
124549068|NCT00445458|447965451|FG001|Overall Study|Death|1|||
124549069|NCT00445458|447965452|FG002|Overall Study|Death|2|||
124707808|NCT00557193|448555880|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
124707809|NCT00557193|448555881|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
124707810|NCT00557193|448555882|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
124707811|NCT00557193|448555883|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
124707812|NCT00557193|448555884|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
124707813|NCT00557193|448555885|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
124707814|NCT00557193|448555880|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
124707815|NCT00557193|448555881|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
124707816|NCT00557193|448555882|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
124707817|NCT00557193|448555883|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
124707818|NCT00557193|448555884|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
124707819|NCT00557193|448555885|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
124707820|NCT00557193|448555880|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
124707821|NCT00557193|448555881|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
124707822|NCT00557193|448555882|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
124707823|NCT00557193|448555883|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
124707824|NCT00557193|448555884|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
124707825|NCT00557193|448555885|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
124707826|NCT00557193|448555880|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
124707827|NCT00557193|448555881|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
124956672|NCT00561678|449467871|FG001|Overall Study|anesthesia provider refusal|0|||
124956673|NCT01732627|449467872|FG000|Overall Study|Withdrawal by Subject|1|||
124956674|NCT01732627|449467873|FG001|Overall Study|Withdrawal by Subject|0|||
124956675|NCT01072396|449467874|FG000|Period One|Adverse Event|1|||
124956676|NCT01072396|449467875|FG001|Period One|Adverse Event|1|||
124956677|NCT01072396|449467874|FG000|Period One|Protocol Violation|2|||
124956678|NCT01072396|449467875|FG001|Period One|Protocol Violation|1|||
124956679|NCT01072396|449467874|FG000|Period One|Withdrawal by Subject|2|||
124956680|NCT01072396|449467875|FG001|Period One|Withdrawal by Subject|0|||
124956681|NCT01072396|449467874|FG000|Washout Period|Missing termination information|0|||
124956682|NCT01072396|449467875|FG001|Washout Period|Missing termination information|1|||
124956683|NCT01072396|449467874|FG000|Period Two|Adverse Event|0|||
124956684|NCT01072396|449467875|FG001|Period Two|Adverse Event|3|||
124956685|NCT01072396|449467874|FG000|Period Two|Lost to Follow-up|1|||
124956686|NCT01072396|449467875|FG001|Period Two|Lost to Follow-up|0|||
124956687|NCT00005908|449467876|FG000|Overall Study|Withdrawal by Subject|1|||
124956688|NCT00005908|449467877|FG001|Overall Study|Withdrawal by Subject|0|||
124956689|NCT01106586|449467880|FG000|Overall Study|Adverse Event|9|||
124956690|NCT01106586|449467881|FG001|Overall Study|Adverse Event|15|||
124956691|NCT01106586|449467880|FG000|Overall Study|Death|1|||
124956692|NCT01106586|449467881|FG001|Overall Study|Death|3|||
124956693|NCT01106586|449467880|FG000|Overall Study|Pregnancy|2|||
124956694|NCT01106586|449467881|FG001|Overall Study|Pregnancy|2|||
124956695|NCT01106586|449467880|FG000|Overall Study|Lack of Efficacy|1|||
124956696|NCT01106586|449467881|FG001|Overall Study|Lack of Efficacy|0|||
124956697|NCT01106586|449467880|FG000|Overall Study|Investigator's Discretion|5|||
124707828|NCT00557193|448555882|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
124707829|NCT00557193|448555883|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
124956698|NCT01106586|449467881|FG001|Overall Study|Investigator's Discretion|8|||
124956699|NCT01106586|449467880|FG000|Overall Study|Withdrew Consent|18|||
124549070|NCT00445458|447965453|FG003|Overall Study|Death|0|||
124956700|NCT01106586|449467881|FG001|Overall Study|Withdrew Consent|30|||
124956701|NCT01106586|449467880|FG000|Overall Study|Lost to Follow-up|24|||
124956702|NCT01106586|449467881|FG001|Overall Study|Lost to Follow-up|20|||
124956703|NCT01106586|449467880|FG000|Overall Study|Participant Noncompliance|12|||
124956704|NCT01106586|449467881|FG001|Overall Study|Participant Noncompliance|10|||
124956705|NCT01106586|449467880|FG000|Overall Study|Protocol Violation|1|||
124956706|NCT01106586|449467881|FG001|Overall Study|Protocol Violation|0|||
124956707|NCT01106586|449467880|FG000|Overall Study|Participant Transferred to Another Study|212|||
124956708|NCT01106586|449467881|FG001|Overall Study|Participant Transferred to Another Study|197|||
124956709|NCT01379521|449467882|FG000|Overall Study -Treatment Period|Adverse Event|3|||
124956710|NCT01379521|449467883|FG001|Overall Study -Treatment Period|Adverse Event|0|||
124956711|NCT01379521|449467882|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
124956712|NCT01379521|449467883|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
124956713|NCT01379521|449467882|FG000|Overall Study -Treatment Period|Disease Progression|23|||
124956714|NCT01379521|449467883|FG001|Overall Study -Treatment Period|Disease Progression|22|||
124956715|NCT01379521|449467882|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
124956716|NCT01379521|449467883|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
124956717|NCT01379521|449467882|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
124956718|NCT01379521|449467883|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
124956719|NCT01379521|449467882|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
124956720|NCT01379521|449467883|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
124956721|NCT01379521|449467882|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
124956722|NCT01379521|449467883|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
124956723|NCT01379521|449467882|FG000|Overall Study -Treatment Period|Death|2|||
124956724|NCT01379521|449467883|FG001|Overall Study -Treatment Period|Death|1|||
124956725|NCT01379521|449467882|FG000|Post-Treatment Evaluations|Disease Progression|22|||
124956726|NCT01379521|449467883|FG001|Post-Treatment Evaluations|Disease Progression|20|||
124956727|NCT01379521|449467882|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
124956728|NCT01379521|449467883|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
124956729|NCT01379521|449467882|FG000|Post-Treatment Evaluations|Death|1|||
124956730|NCT01379521|449467883|FG001|Post-Treatment Evaluations|Death|0|||
124956731|NCT00938041|449467884|FG000|Overall Study|Lost to Follow-up|6|||
124956732|NCT00938041|449467884|FG000|Overall Study|Received Alternative Therapy|1|||
124956733|NCT00938041|449467884|FG000|Overall Study|Progressive Disease|5|||
124956734|NCT00938041|449467884|FG000|Overall Study|Death|12|||
124956735|NCT00938041|449467884|FG000|Overall Study|Adrenal Insufficiency|3|||
124956736|NCT01026103|449467885|FG000|Overall Study|Physician Decision|1|||
124956737|NCT01026103|449467885|FG000|Overall Study|did not receive study device bc of error|1|||
124956738|NCT00105521|449467886|FG000|Overall Study|Other|1|||
124956739|NCT00105521|449467887|FG001|Overall Study|Other|1|||
124956740|NCT00105521|449467888|FG002|Overall Study|Other|2|||
124956741|NCT00105521|449467889|FG003|Overall Study|Other|0|||
124956742|NCT00105521|449467886|FG000|Overall Study|Adverse Event|10|||
124956743|NCT00105521|449467887|FG001|Overall Study|Adverse Event|4|||
124956744|NCT00105521|449467888|FG002|Overall Study|Adverse Event|10|||
124956745|NCT00105521|449467889|FG003|Overall Study|Adverse Event|8|||
124956746|NCT00105521|449467886|FG000|Overall Study|Withdrawal by Subject|1|||
124956747|NCT00105521|449467887|FG001|Overall Study|Withdrawal by Subject|0|||
124956748|NCT00105521|449467888|FG002|Overall Study|Withdrawal by Subject|1|||
124956749|NCT00105521|449467889|FG003|Overall Study|Withdrawal by Subject|4|||
124956750|NCT00105521|449467886|FG000|Overall Study|Lack of Efficacy|0|||
124460882|NCT00001379|447646044|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
124460883|NCT00001379|447646045|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
124460884|NCT00001379|447646042|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
124460885|NCT00001379|447646043|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
124460886|NCT00001379|447646044|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
124460887|NCT00001379|447646045|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
124460888|NCT00001379|447646042|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
124460889|NCT00001379|447646043|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
124460890|NCT00001379|447646044|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
124460891|NCT00001379|447646045|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
124460892|NCT03246958|447646046|FG000|Overall Study|Withdrawal by Subject|0|||
124460893|NCT03246958|447646047|FG001|Overall Study|Withdrawal by Subject|1|||
124460894|NCT03246958|447646048|FG002|Overall Study|Withdrawal by Subject|0|||
124460895|NCT03246958|447646049|FG003|Overall Study|Withdrawal by Subject|0|||
124460896|NCT03246958|447646050|FG004|Overall Study|Withdrawal by Subject|0|||
124460897|NCT03246958|447646051|FG005|Overall Study|Withdrawal by Subject|1|||
124460898|NCT03246958|447646052|FG006|Overall Study|Withdrawal by Subject|0|||
124460899|NCT03246958|447646046|FG000|Overall Study|Progression|13|||
124460900|NCT03246958|447646047|FG001|Overall Study|Progression|9|||
124460901|NCT03246958|447646048|FG002|Overall Study|Progression|3|||
124460902|NCT03246958|447646049|FG003|Overall Study|Progression|2|||
124460903|NCT03246958|447646050|FG004|Overall Study|Progression|1|||
124460904|NCT03246958|447646051|FG005|Overall Study|Progression|2|||
124956751|NCT00105521|449467887|FG001|Overall Study|Lack of Efficacy|0|||
124956752|NCT00105521|449467888|FG002|Overall Study|Lack of Efficacy|0|||
124956753|NCT00105521|449467889|FG003|Overall Study|Lack of Efficacy|1|||
124956754|NCT00105521|449467886|FG000|Overall Study|Protocol Violation|3|||
124956755|NCT00105521|449467887|FG001|Overall Study|Protocol Violation|5|||
124956756|NCT00105521|449467888|FG002|Overall Study|Protocol Violation|4|||
124956757|NCT00105521|449467889|FG003|Overall Study|Protocol Violation|4|||
124460905|NCT03246958|447646052|FG006|Overall Study|Progression|1|||
124460906|NCT03246958|447646046|FG000|Overall Study|Adverse Event|2|||
124460907|NCT03246958|447646047|FG001|Overall Study|Adverse Event|2|||
124460908|NCT03246958|447646048|FG002|Overall Study|Adverse Event|0|||
124460909|NCT03246958|447646049|FG003|Overall Study|Adverse Event|1|||
124460910|NCT03246958|447646050|FG004|Overall Study|Adverse Event|1|||
124460911|NCT03246958|447646051|FG005|Overall Study|Adverse Event|0|||
124460912|NCT03246958|447646052|FG006|Overall Study|Adverse Event|2|||
124460913|NCT03246958|447646046|FG000|Overall Study|Death|0|||
124460914|NCT03246958|447646047|FG001|Overall Study|Death|1|||
124460915|NCT03246958|447646048|FG002|Overall Study|Death|0|||
124460916|NCT03246958|447646049|FG003|Overall Study|Death|0|||
124460917|NCT03246958|447646050|FG004|Overall Study|Death|0|||
124460918|NCT03246958|447646051|FG005|Overall Study|Death|0|||
124460919|NCT03246958|447646052|FG006|Overall Study|Death|0|||
124460920|NCT03246958|447646046|FG000|Overall Study|Physician Decision|0|||
124460921|NCT03246958|447646047|FG001|Overall Study|Physician Decision|0|||
124460922|NCT03246958|447646048|FG002|Overall Study|Physician Decision|0|||
124460923|NCT03246958|447646049|FG003|Overall Study|Physician Decision|1|||
124460924|NCT03246958|447646050|FG004|Overall Study|Physician Decision|0|||
124460925|NCT03246958|447646051|FG005|Overall Study|Physician Decision|0|||
124460926|NCT03246958|447646052|FG006|Overall Study|Physician Decision|0|||
124460927|NCT03246958|447646046|FG000|Overall Study|Never start treatment|1|||
124460928|NCT03246958|447646047|FG001|Overall Study|Never start treatment|0|||
124460929|NCT03246958|447646048|FG002|Overall Study|Never start treatment|0|||
124460930|NCT03246958|447646049|FG003|Overall Study|Never start treatment|0|||
124460931|NCT03246958|447646050|FG004|Overall Study|Never start treatment|0|||
124460932|NCT03246958|447646051|FG005|Overall Study|Never start treatment|0|||
124460933|NCT03246958|447646052|FG006|Overall Study|Never start treatment|0|||
124707830|NCT00557193|448555884|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
124707831|NCT00557193|448555885|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
124707832|NCT00557193|448555880|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
124707833|NCT00557193|448555881|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
124707834|NCT00557193|448555882|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
124460934|NCT03246958|447646046|FG000|Overall Study|Over enrollment|0|||
124707835|NCT00557193|448555883|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
124707836|NCT00557193|448555884|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
124707837|NCT00557193|448555885|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
124707838|NCT00557193|448555880|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
124707839|NCT00557193|448555881|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
124707840|NCT00557193|448555882|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
124707841|NCT00557193|448555883|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
124707842|NCT00557193|448555884|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
124707843|NCT00557193|448555885|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
124707844|NCT00976456|448555886|FG000|Overall Study|Adverse Event|17|||
124707845|NCT00976456|448555887|FG001|Overall Study|Adverse Event|22|||
124707846|NCT00976456|448555886|FG000|Overall Study|Death|7|||
124707847|NCT00976456|448555887|FG001|Overall Study|Death|9|||
124707848|NCT00976456|448555886|FG000|Overall Study|Lack of Efficacy|5|||
124707849|NCT00976456|448555887|FG001|Overall Study|Lack of Efficacy|2|||
124707850|NCT00976456|448555886|FG000|Overall Study|Withdrawal by Subject|3|||
124707851|NCT00976456|448555887|FG001|Overall Study|Withdrawal by Subject|1|||
124956758|NCT00105521|449467886|FG000|Overall Study|Lost to Follow-up|0|||
124956759|NCT00105521|449467887|FG001|Overall Study|Lost to Follow-up|1|||
124460935|NCT03246958|447646047|FG001|Overall Study|Over enrollment|2|||
124460936|NCT03246958|447646048|FG002|Overall Study|Over enrollment|0|||
124460937|NCT03246958|447646049|FG003|Overall Study|Over enrollment|0|||
124460938|NCT03246958|447646050|FG004|Overall Study|Over enrollment|0|||
124707852|NCT00976456|448555886|FG000|Overall Study|screening failure, unknown|11|||
124707853|NCT00976456|448555887|FG001|Overall Study|screening failure, unknown|4|||
124707854|NCT02037529|448555888|FG000|Overall Study|Withdrawal by Subject|1|||
124707855|NCT02037529|448555889|FG001|Overall Study|Withdrawal by Subject|3|||
124707856|NCT02037529|448555888|FG000|Overall Study|Adverse Event|0|||
124707857|NCT02037529|448555889|FG001|Overall Study|Adverse Event|1|||
124707858|NCT02131766|448555890|FG000|Overall Study|Withdrawal by Subject|4|||
124956760|NCT00105521|449467888|FG002|Overall Study|Lost to Follow-up|0|||
124460939|NCT03246958|447646051|FG005|Overall Study|Over enrollment|0|||
124460940|NCT03246958|447646052|FG006|Overall Study|Over enrollment|0|||
124460941|NCT03703102|447646053|FG000|Overall Study|Adverse Event|4|||
124460942|NCT03703102|447646054|FG001|Overall Study|Adverse Event|3|||
124460943|NCT03703102|447646055|FG002|Overall Study|Adverse Event|7|||
124460944|NCT03703102|447646056|FG003|Overall Study|Adverse Event|3|||
124460945|NCT03703102|447646057|FG004|Overall Study|Adverse Event|13|||
124460946|NCT03703102|447646053|FG000|Overall Study|Lack of Efficacy|4|||
124460947|NCT03703102|447646054|FG001|Overall Study|Lack of Efficacy|0|||
124460948|NCT03703102|447646055|FG002|Overall Study|Lack of Efficacy|1|||
124460949|NCT03703102|447646056|FG003|Overall Study|Lack of Efficacy|4|||
124460950|NCT03703102|447646057|FG004|Overall Study|Lack of Efficacy|1|||
124460951|NCT03703102|447646053|FG000|Overall Study|Lost to Follow-up|0|||
124460952|NCT03703102|447646054|FG001|Overall Study|Lost to Follow-up|0|||
124460953|NCT03703102|447646055|FG002|Overall Study|Lost to Follow-up|1|||
124460954|NCT03703102|447646056|FG003|Overall Study|Lost to Follow-up|2|||
124460955|NCT03703102|447646057|FG004|Overall Study|Lost to Follow-up|2|||
124460956|NCT03703102|447646053|FG000|Overall Study|Physician Decision|2|||
124549071|NCT00445458|447965450|FG000|Overall Study|Physician Decision|0|||
124549072|NCT00445458|447965451|FG001|Overall Study|Physician Decision|0|||
124549073|NCT00445458|447965452|FG002|Overall Study|Physician Decision|1|||
124549074|NCT00445458|447965453|FG003|Overall Study|Physician Decision|1|||
124549075|NCT00445458|447965450|FG000|Overall Study|Surgery|0|||
124549076|NCT00445458|447965451|FG001|Overall Study|Surgery|0|||
124549077|NCT00445458|447965452|FG002|Overall Study|Surgery|1|||
124460957|NCT03703102|447646054|FG001|Overall Study|Physician Decision|2|||
124460958|NCT03703102|447646055|FG002|Overall Study|Physician Decision|2|||
124460959|NCT03703102|447646056|FG003|Overall Study|Physician Decision|2|||
124460960|NCT03703102|447646057|FG004|Overall Study|Physician Decision|4|||
124460961|NCT03703102|447646053|FG000|Overall Study|Withdrawal by Subject|7|||
124460962|NCT03703102|447646054|FG001|Overall Study|Withdrawal by Subject|5|||
124460963|NCT03703102|447646055|FG002|Overall Study|Withdrawal by Subject|5|||
124460964|NCT03703102|447646056|FG003|Overall Study|Withdrawal by Subject|5|||
124460965|NCT03703102|447646057|FG004|Overall Study|Withdrawal by Subject|9|||
124460966|NCT03703102|447646053|FG000|Overall Study|Ineligibility|0|||
124460967|NCT03703102|447646054|FG001|Overall Study|Ineligibility|0|||
124460968|NCT03703102|447646055|FG002|Overall Study|Ineligibility|1|||
124460969|NCT03703102|447646056|FG003|Overall Study|Ineligibility|0|||
124460970|NCT03703102|447646057|FG004|Overall Study|Ineligibility|0|||
124460971|NCT03703102|447646053|FG000|Overall Study|Protocol Deviation|4|||
124460972|NCT03703102|447646054|FG001|Overall Study|Protocol Deviation|4|||
124460973|NCT03703102|447646055|FG002|Overall Study|Protocol Deviation|3|||
124460974|NCT03703102|447646056|FG003|Overall Study|Protocol Deviation|0|||
124460975|NCT03703102|447646057|FG004|Overall Study|Protocol Deviation|0|||
124460976|NCT03703102|447646053|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124460977|NCT03703102|447646054|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124460978|NCT03703102|447646055|FG002|Overall Study|Non-Compliance with Study Drug|2|||
124460979|NCT03703102|447646056|FG003|Overall Study|Non-Compliance with Study Drug|1|||
124460980|NCT03703102|447646057|FG004|Overall Study|Non-Compliance with Study Drug|4|||
124460981|NCT02311153|447646058|FG000|Overall Study|Lost to Follow-up|5|||
124956761|NCT00105521|449467889|FG003|Overall Study|Lost to Follow-up|0|||
124956762|NCT02475733|449467890|FG000|Overall Study|Withdrawal by Subject|1|||
124956763|NCT02475733|449467891|FG001|Overall Study|Withdrawal by Subject|0|||
124956764|NCT02475733|449467890|FG000|Overall Study|Physician Decision|1|||
124956765|NCT02475733|449467891|FG001|Overall Study|Physician Decision|0|||
124956766|NCT00404547|449467892|FG000|Overall Study|Adverse Event|39|||
124956767|NCT00404547|449467893|FG001|Overall Study|Adverse Event|6|||
124956768|NCT00404547|449467892|FG000|Overall Study|Withdrawal by Subject|19|||
124956769|NCT00404547|449467893|FG001|Overall Study|Withdrawal by Subject|2|||
124956770|NCT00404547|449467892|FG000|Overall Study|Protocol Violation|0|||
124956771|NCT00404547|449467893|FG001|Overall Study|Protocol Violation|1|||
124956772|NCT00404547|449467892|FG000|Overall Study|Lost to Follow-up|20|||
124956773|NCT00404547|449467893|FG001|Overall Study|Lost to Follow-up|9|||
124956774|NCT00404547|449467892|FG000|Overall Study|Lack of compliance|5|||
124956775|NCT00404547|449467893|FG001|Overall Study|Lack of compliance|1|||
124956776|NCT00404547|449467892|FG000|Overall Study|Other|4|||
124956777|NCT00404547|449467893|FG001|Overall Study|Other|0|||
124460982|NCT02311153|447646059|FG001|Overall Study|Lost to Follow-up|7|||
124460983|NCT01379274|447646060|FG000|Overall Study|funding withdrawn|1|||
124460984|NCT00405067|447646065|FG000|Overall Study|Adverse Event|4|||
124460985|NCT00405067|447646066|FG001|Overall Study|Adverse Event|9|||
124460986|NCT00405067|447646067|FG002|Overall Study|Adverse Event|4|||
124549078|NCT00445458|447965453|FG003|Overall Study|Surgery|0|||
124549079|NCT00728988|447965458|FG000|Overall Study|Not Treated|2|||
124549080|NCT00728988|447965459|FG001|Overall Study|Not Treated|2|||
124707859|NCT00718315|448555891|FG000|Overall Study|Adverse Event|1|||
124460987|NCT00405067|447646065|FG000|Overall Study|Lost to Follow-up|0|||
124460988|NCT00405067|447646066|FG001|Overall Study|Lost to Follow-up|0|||
124460989|NCT00405067|447646067|FG002|Overall Study|Lost to Follow-up|1|||
124460990|NCT01650636|447646068|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
124460991|NCT01650636|447646069|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
124460992|NCT01650636|447646068|FG000|Washout up to 5 Months|Physician Decision|2|||
124460993|NCT01650636|447646069|FG001|Washout up to 5 Months|Physician Decision|2|||
124549081|NCT00728988|447965458|FG000|Overall Study|Death|1|||
124549082|NCT00728988|447965459|FG001|Overall Study|Death|1|||
124956778|NCT00404547|449467892|FG000|Overall Study|Reason not stated|3|||
124956779|NCT00404547|449467893|FG001|Overall Study|Reason not stated|6|||
124956780|NCT02131155|449467896|FG000|Overall Study|Adverse Event|1|||
124956781|NCT02131155|449467897|FG001|Overall Study|Adverse Event|0|||
124460994|NCT01650636|447646068|FG000|Washout up to 5 Months|Death|1|||
124460995|NCT01650636|447646069|FG001|Washout up to 5 Months|Death|0|||
124460996|NCT01650636|447646068|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
124460997|NCT01650636|447646069|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
124460998|NCT01650636|447646068|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
124460999|NCT01650636|447646069|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
124461000|NCT01650636|447646068|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
124461001|NCT01650636|447646069|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
124461002|NCT01560780|447646070|FG000|Overall Study|Death|2|||
124461003|NCT01560780|447646071|FG001|Overall Study|Death|1|||
124461004|NCT01560780|447646070|FG000|Overall Study|Patient Preference|11|||
124461005|NCT01560780|447646071|FG001|Overall Study|Patient Preference|11|||
124461006|NCT03363321|447646072|FG000|Overall Study|Withdrawal by Subject|0|||
124461007|NCT03363321|447646073|FG001|Overall Study|Withdrawal by Subject|1|||
124461008|NCT03363321|447646074|FG002|Overall Study|Withdrawal by Subject|0|||
124461009|NCT03363321|447646075|FG003|Overall Study|Withdrawal by Subject|1|||
124461010|NCT03363321|447646076|FG004|Overall Study|Withdrawal by Subject|0|||
124461011|NCT02915523|447646077|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
124461012|NCT02915523|447646078|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
124461013|NCT02915523|447646079|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
124461014|NCT02915523|447646080|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
124461015|NCT02915523|447646077|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
124461016|NCT02915523|447646078|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
124461017|NCT02915523|447646079|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
124461018|NCT02915523|447646080|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
124461019|NCT02915523|447646077|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
124461020|NCT02915523|447646078|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
124461021|NCT02915523|447646079|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
124461022|NCT02915523|447646080|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
124461023|NCT02915523|447646077|FG000|Expansion Phase (Phase 2)|Death|0|||
124461024|NCT02915523|447646078|FG001|Expansion Phase (Phase 2)|Death|0|||
124461025|NCT02915523|447646079|FG002|Expansion Phase (Phase 2)|Death|26|||
124461026|NCT02915523|447646080|FG003|Expansion Phase (Phase 2)|Death|53|||
124461027|NCT02915523|447646077|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
124461028|NCT02915523|447646078|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
124461029|NCT02915523|447646079|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
124461030|NCT02915523|447646080|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
124461031|NCT02915523|447646077|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
124461032|NCT02915523|447646078|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
124461033|NCT02915523|447646079|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
124461034|NCT02915523|447646080|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
124461035|NCT02915523|447646077|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
124461036|NCT02915523|447646078|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
124461037|NCT02915523|447646079|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
124461038|NCT02915523|447646080|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
124461039|NCT00930761|447646081|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
124461040|NCT00930761|447646082|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
124461041|NCT00930761|447646081|FG000|Overall Study|less than 3 music therapy sessions|0|||
124956782|NCT02131155|449467896|FG000|Overall Study|Treatment completed|1|||
124956783|NCT02131155|449467897|FG001|Overall Study|Treatment completed|0|||
124956784|NCT02131155|449467896|FG000|Overall Study|Primary tumour recurrence|2|||
124956785|NCT02131155|449467897|FG001|Overall Study|Primary tumour recurrence|1|||
124956786|NCT02131155|449467896|FG000|Overall Study|Refused to continue study medication|1|||
124956787|NCT02131155|449467897|FG001|Overall Study|Refused to continue study medication|0|||
124956788|NCT02131155|449467896|FG000|Overall Study|Study early termination|20|||
124956789|NCT02131155|449467897|FG001|Overall Study|Study early termination|10|||
124956790|NCT01887418|449467898|FG000|Overall Study|Travelling difficulties|0|||
124956791|NCT01887418|449467899|FG001|Overall Study|Travelling difficulties|0|||
124461042|NCT00930761|447646082|FG001|Overall Study|less than 3 music therapy sessions|3|||
124461043|NCT00957008|447646083|FG000|Overall Study|Withdrawal by Subject|13|||
124461044|NCT00957008|447646084|FG001|Overall Study|Withdrawal by Subject|10|||
124461045|NCT00957008|447646085|FG002|Overall Study|Withdrawal by Subject|12|||
124461046|NCT00957008|447646086|FG003|Overall Study|Withdrawal by Subject|16|||
124461047|NCT00957008|447646083|FG000|Overall Study|Lost to Follow-up|3|||
124956792|NCT01887418|449467900|FG002|Overall Study|Travelling difficulties|1|||
124461048|NCT00957008|447646084|FG001|Overall Study|Lost to Follow-up|1|||
124461049|NCT00957008|447646085|FG002|Overall Study|Lost to Follow-up|3|||
124461050|NCT00957008|447646086|FG003|Overall Study|Lost to Follow-up|4|||
124461051|NCT00957008|447646083|FG000|Overall Study|Physician Decision|1|||
124461052|NCT00957008|447646084|FG001|Overall Study|Physician Decision|0|||
124461053|NCT00957008|447646085|FG002|Overall Study|Physician Decision|1|||
124461054|NCT00957008|447646086|FG003|Overall Study|Physician Decision|1|||
124956793|NCT02350127|449467904|FG000|4-Month Assessment|Withdrawal by Subject|10|||
124956794|NCT02350127|449467905|FG001|4-Month Assessment|Withdrawal by Subject|9|||
124461055|NCT00957008|447646083|FG000|Overall Study|Relocated; Family conflict|4|||
124461056|NCT00957008|447646084|FG001|Overall Study|Relocated; Family conflict|1|||
124461057|NCT00957008|447646085|FG002|Overall Study|Relocated; Family conflict|1|||
124461058|NCT00957008|447646086|FG003|Overall Study|Relocated; Family conflict|3|||
124461059|NCT00811135|447646087|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
124461060|NCT00811135|447646087|FG000|Overall Study|Death|3|||
124461061|NCT00811135|447646087|FG000|Overall Study|Protocol Violation|2|||
124461062|NCT00811135|447646087|FG000|Overall Study|Violation of Selection Criteria|1|||
124461063|NCT00811135|447646087|FG000|Overall Study|Refused Treatment|1|||
124461064|NCT00811135|447646087|FG000|Overall Study|Withdrawal by Subject|3|||
124461065|NCT00811135|447646087|FG000|Overall Study|Administrative/Other Unspecified|11|||
124461066|NCT00811135|447646087|FG000|Overall Study|Ongoing|59|||
124461067|NCT03548935|447646091|FG000|Overall Study|Withdrawal by Subject|26|||
124461068|NCT03548935|447646092|FG001|Overall Study|Withdrawal by Subject|17|||
124461069|NCT03548935|447646091|FG000|Overall Study|Lost to Follow-up|39|||
124461070|NCT03548935|447646092|FG001|Overall Study|Lost to Follow-up|28|||
124461071|NCT03548935|447646091|FG000|Overall Study|Death|1|||
124461072|NCT03548935|447646092|FG001|Overall Study|Death|1|||
124461073|NCT00763815|447646093|FG000|Overall Study|Adverse Event|14|||
124461074|NCT00763815|447646094|FG001|Overall Study|Adverse Event|29|||
124461075|NCT00763815|447646093|FG000|Overall Study|Lack of Efficacy|10|||
124461076|NCT00763815|447646094|FG001|Overall Study|Lack of Efficacy|11|||
124461077|NCT00763815|447646093|FG000|Overall Study|Poor Compliance to Protocol|6|||
124461078|NCT00763815|447646094|FG001|Overall Study|Poor Compliance to Protocol|6|||
124461079|NCT00763815|447646093|FG000|Overall Study|Lost to Follow-up|2|||
124461080|NCT00763815|447646094|FG001|Overall Study|Lost to Follow-up|4|||
124461081|NCT00763815|447646093|FG000|Overall Study|Early Termination|1|||
124461082|NCT00763815|447646094|FG001|Overall Study|Early Termination|0|||
124461083|NCT00763815|447646093|FG000|Overall Study|Familial and Personal Reasons|9|||
124461084|NCT00763815|447646094|FG001|Overall Study|Familial and Personal Reasons|16|||
124461085|NCT00763815|447646093|FG000|Overall Study|Physician Decision|1|||
124461086|NCT00763815|447646094|FG001|Overall Study|Physician Decision|0|||
124461087|NCT00763815|447646093|FG000|Overall Study|Withdrawal by Subject|7|||
124461088|NCT00763815|447646094|FG001|Overall Study|Withdrawal by Subject|12|||
124461089|NCT00763815|447646093|FG000|Overall Study|Protocol Violation|2|||
124461090|NCT00763815|447646094|FG001|Overall Study|Protocol Violation|5|||
124461091|NCT00763815|447646093|FG000|Overall Study|Sponsor's Decision|0|||
124461092|NCT00763815|447646094|FG001|Overall Study|Sponsor's Decision|1|||
124461093|NCT00283595|447646095|FG000|Overall Study|Withdrawal by Subject|1|||
124461094|NCT00283595|447646096|FG001|Overall Study|Withdrawal by Subject|2|||
124461095|NCT01263639|447646097|FG000|Overall Study|Lost to Follow-up|66|||
124461096|NCT01263639|447646098|FG001|Overall Study|Lost to Follow-up|70|||
124461097|NCT01263639|447646097|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
124461098|NCT01263639|447646098|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
124461099|NCT01576549|447646099|FG000|Overall Study|Sponsor Decision|2|||
124461100|NCT04951037|447646100|FG000|Overall Study|Lost to Follow-up|16|||
124461101|NCT04951037|447646100|FG000|Overall Study|Withdrawal by Subject|5|||
124461102|NCT04951037|447646100|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
124461103|NCT05630937|447646101|FG000|Overall Study|Study terminated by sponsor|1|||
124461104|NCT05630937|447646102|FG001|Overall Study|Study terminated by sponsor|1|||
124461105|NCT05630937|447646103|FG002|Overall Study|Study terminated by sponsor|8|||
124461106|NCT05630937|447646104|FG003|Overall Study|Study terminated by sponsor|0|||
124461107|NCT05630937|447646101|FG000|Overall Study|Lost to Follow-up|0|||
124461108|NCT05630937|447646102|FG001|Overall Study|Lost to Follow-up|0|||
124461109|NCT05630937|447646103|FG002|Overall Study|Lost to Follow-up|1|||
124766447|NCT05121766|448771737|FG001|Overall Study|Adverse Event|4|||
124956795|NCT02350127|449467904|FG000|4-Month Assessment|Death|1|||
124956796|NCT02350127|449467905|FG001|4-Month Assessment|Death|0|||
124956797|NCT02350127|449467904|FG000|8-Month Assessment|Death|1|||
124461110|NCT05630937|447646104|FG003|Overall Study|Lost to Follow-up|0|||
124461111|NCT05630937|447646101|FG000|Overall Study|Enrolled but not treated|0|||
124461112|NCT05630937|447646102|FG001|Overall Study|Enrolled but not treated|0|||
124461113|NCT05630937|447646103|FG002|Overall Study|Enrolled but not treated|0|||
124956798|NCT02350127|449467905|FG001|8-Month Assessment|Death|1|||
124956799|NCT02350127|449467904|FG000|8-Month Assessment|Withdrawal by Subject|5|||
124461114|NCT05630937|447646104|FG003|Overall Study|Enrolled but not treated|1|||
124461115|NCT01422915|447646113|FG000|Overall Study|Adverse Event|1|||
124461116|NCT01152021|447646115|FG000|Overall Study|Adverse Event|4|||
124461117|NCT01152021|447646116|FG001|Overall Study|Adverse Event|4|||
124461118|NCT01152021|447646115|FG000|Overall Study|Study drug had expired|1|||
124461119|NCT01152021|447646116|FG001|Overall Study|Study drug had expired|0|||
124461120|NCT01152021|447646115|FG000|Overall Study|Physician Decision|1|||
124461121|NCT01152021|447646116|FG001|Overall Study|Physician Decision|1|||
124461122|NCT01152021|447646115|FG000|Overall Study|No access to study drug in Pharmacy|0|||
124461123|NCT01152021|447646116|FG001|Overall Study|No access to study drug in Pharmacy|1|||
124461124|NCT00609791|447647921|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
124956800|NCT02350127|449467905|FG001|8-Month Assessment|Withdrawal by Subject|8|||
124956801|NCT01446042|449467906|FG000|Overall Study|Withdrawal by Subject|12|||
124956802|NCT01446042|449467907|FG001|Overall Study|Withdrawal by Subject|2|||
124956803|NCT01446042|449467908|FG002|Overall Study|Withdrawal by Subject|4|||
124956804|NCT01446042|449467906|FG000|Overall Study|Adverse Event|1|||
124956805|NCT01446042|449467907|FG001|Overall Study|Adverse Event|0|||
124956806|NCT01446042|449467908|FG002|Overall Study|Adverse Event|4|||
124549083|NCT00728988|447965458|FG000|Overall Study|Adverse Event|3|||
124549084|NCT00728988|447965459|FG001|Overall Study|Adverse Event|2|||
124549085|NCT00728988|447965458|FG000|Overall Study|Other|85|||
124549086|NCT00728988|447965459|FG001|Overall Study|Other|77|||
124549087|NCT00728988|447965458|FG000|Overall Study|Withdrawal by Subject|2|||
124549088|NCT00728988|447965459|FG001|Overall Study|Withdrawal by Subject|6|||
124549089|NCT00111007|447965462|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
124549090|NCT00111007|447965463|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
124549091|NCT00111007|447965462|FG000|Double-blind (DB) Treatment|Death|5|||
124549092|NCT00111007|447965463|FG001|Double-blind (DB) Treatment|Death|2|||
124549093|NCT00111007|447965462|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
124549094|NCT00111007|447965463|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
124549095|NCT00111007|447965462|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
124549096|NCT00111007|447965463|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
124549097|NCT00111007|447965462|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
124549098|NCT00111007|447965463|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
124549099|NCT00111007|447965462|FG000|Double-blind (DB) Treatment|Relapse|1|||
124549100|NCT00111007|447965463|FG001|Double-blind (DB) Treatment|Relapse|0|||
124549101|NCT00111007|447965462|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
124549102|NCT00111007|447965463|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
124549103|NCT00111007|447965462|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
124549104|NCT00111007|447965463|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
124549105|NCT00111007|447965462|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
124549106|NCT00111007|447965463|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
124549107|NCT00111007|447965462|FG000|Active Follow-up|Adverse Event|1|||
124549108|NCT00111007|447965463|FG001|Active Follow-up|Adverse Event|0|||
124549109|NCT00111007|447965462|FG000|Active Follow-up|Death|2|||
124549110|NCT00111007|447965463|FG001|Active Follow-up|Death|0|||
124707860|NCT00718315|448555892|FG001|Overall Study|Adverse Event|2|||
124956807|NCT01446042|449467906|FG000|Overall Study|Lost to Follow-up|5|||
124956808|NCT01446042|449467907|FG001|Overall Study|Lost to Follow-up|0|||
124549111|NCT00111007|447965462|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
124707861|NCT00718315|448555893|FG002|Overall Study|Adverse Event|3|||
124549112|NCT00111007|447965463|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
124956809|NCT01446042|449467908|FG002|Overall Study|Lost to Follow-up|0|||
124956810|NCT01446042|449467906|FG000|Overall Study|Other reasons|2|||
124956811|NCT01446042|449467907|FG001|Overall Study|Other reasons|1|||
124956812|NCT01446042|449467908|FG002|Overall Study|Other reasons|1|||
124461125|NCT02484911|447647922|FG000|Overall Study|Withdrawal by Subject|2|||
124461126|NCT02484911|447647923|FG001|Overall Study|Withdrawal by Subject|1|||
124461127|NCT02484911|447647922|FG000|Overall Study|Protocol Violation|2|||
124461128|NCT02484911|447647923|FG001|Overall Study|Protocol Violation|1|||
124461129|NCT04129528|447647924|FG000|Overall Study|Adverse Event|1|||
124461130|NCT04129528|447647925|FG001|Overall Study|Adverse Event|0|||
124461131|NCT04129528|447647924|FG000|Overall Study|Physician Decision|1|||
124461132|NCT04129528|447647925|FG001|Overall Study|Physician Decision|1|||
124461133|NCT04129528|447647924|FG000|Overall Study|Withdrawal by Subject|1|||
124461134|NCT04129528|447647925|FG001|Overall Study|Withdrawal by Subject|1|||
124956813|NCT03906240|449467909|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
124956814|NCT03906240|449467910|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
124956815|NCT03906240|449467909|FG000|Overall Study|Lost to Follow-up|1|||
124956816|NCT03906240|449467910|FG001|Overall Study|Lost to Follow-up|0|||
124956817|NCT03906240|449467909|FG000|Overall Study|Withdrawal by Subject|0|||
124956818|NCT03906240|449467910|FG001|Overall Study|Withdrawal by Subject|1|||
124956819|NCT00296504|449467915|FG000|Interim Analysis|Withdrawal by Subject|8|||
124956820|NCT00296504|449467916|FG001|Interim Analysis|Withdrawal by Subject|0|||
124956821|NCT00296504|449467917|FG002|Interim Analysis|Withdrawal by Subject|12|||
124956822|NCT00296504|449467918|FG003|Interim Analysis|Withdrawal by Subject|0|||
124956823|NCT00296504|449467919|FG004|Interim Analysis|Withdrawal by Subject|5|||
124956824|NCT00296504|449467920|FG005|Interim Analysis|Withdrawal by Subject|5|||
124956825|NCT00296504|449467921|FG006|Interim Analysis|Withdrawal by Subject|9|||
124956826|NCT00296504|449467922|FG007|Interim Analysis|Withdrawal by Subject|3|||
124956827|NCT00296504|449467923|FG008|Interim Analysis|Withdrawal by Subject|0|||
124461135|NCT01157078|447647930|FG000|Overall Study|Withdrawal by Subject|12|||
124461136|NCT01157078|447647931|FG001|Overall Study|Withdrawal by Subject|14|||
124461137|NCT01157078|447647930|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
124956828|NCT00296504|449467915|FG000|Interim Analysis|Lost to Follow-up|13|||
124956829|NCT00296504|449467916|FG001|Interim Analysis|Lost to Follow-up|3|||
124956830|NCT00296504|449467917|FG002|Interim Analysis|Lost to Follow-up|26|||
124956831|NCT00296504|449467918|FG003|Interim Analysis|Lost to Follow-up|8|||
124956832|NCT00296504|449467919|FG004|Interim Analysis|Lost to Follow-up|14|||
124956833|NCT00296504|449467920|FG005|Interim Analysis|Lost to Follow-up|4|||
124956834|NCT00296504|449467921|FG006|Interim Analysis|Lost to Follow-up|11|||
124956835|NCT00296504|449467922|FG007|Interim Analysis|Lost to Follow-up|4|||
124956836|NCT00296504|449467923|FG008|Interim Analysis|Lost to Follow-up|0|||
124956837|NCT00296504|449467915|FG000|Interim Analysis|Clinical Progression|1|||
124956838|NCT00296504|449467916|FG001|Interim Analysis|Clinical Progression|0|||
124956839|NCT00296504|449467917|FG002|Interim Analysis|Clinical Progression|1|||
124956840|NCT00296504|449467918|FG003|Interim Analysis|Clinical Progression|1|||
124956841|NCT00296504|449467919|FG004|Interim Analysis|Clinical Progression|0|||
124956842|NCT00296504|449467920|FG005|Interim Analysis|Clinical Progression|2|||
124956843|NCT00296504|449467921|FG006|Interim Analysis|Clinical Progression|1|||
124956844|NCT00296504|449467922|FG007|Interim Analysis|Clinical Progression|2|||
124956845|NCT00296504|449467923|FG008|Interim Analysis|Clinical Progression|0|||
124956846|NCT00296504|449467915|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
124956847|NCT00296504|449467916|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
124956848|NCT00296504|449467917|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
124956849|NCT00296504|449467918|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
124956850|NCT00296504|449467919|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
124956851|NCT00296504|449467920|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
124956852|NCT00296504|449467921|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
124956853|NCT00296504|449467922|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
124956854|NCT00296504|449467923|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
124956855|NCT00296504|449467915|FG000|Interim Analysis|Adverse Event|0|||
124707862|NCT00718315|448555891|FG000|Overall Study|Death|6|||
124461138|NCT01157078|447647931|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124461139|NCT01157078|447647930|FG000|Overall Study|Adverse Event|6|||
124461140|NCT01157078|447647931|FG001|Overall Study|Adverse Event|6|||
124461141|NCT01157078|447647930|FG000|Overall Study|Severe non-compliance to protocol|2|||
124461142|NCT01157078|447647931|FG001|Overall Study|Severe non-compliance to protocol|4|||
124707863|NCT00718315|448555892|FG001|Overall Study|Death|6|||
124461143|NCT01157078|447647930|FG000|Overall Study|Condition under investigation worsened|0|||
124461144|NCT01157078|447647931|FG001|Overall Study|Condition under investigation worsened|1|||
124461145|NCT01157078|447647930|FG000|Overall Study|Lack of Efficacy|2|||
124956856|NCT00296504|449467916|FG001|Interim Analysis|Adverse Event|0|||
124956857|NCT00296504|449467917|FG002|Interim Analysis|Adverse Event|13|||
124956858|NCT00296504|449467918|FG003|Interim Analysis|Adverse Event|4|||
124956859|NCT00296504|449467919|FG004|Interim Analysis|Adverse Event|6|||
124956860|NCT00296504|449467920|FG005|Interim Analysis|Adverse Event|3|||
124956861|NCT00296504|449467921|FG006|Interim Analysis|Adverse Event|4|||
124956862|NCT00296504|449467922|FG007|Interim Analysis|Adverse Event|5|||
124461146|NCT01157078|447647931|FG001|Overall Study|Lack of Efficacy|0|||
124461147|NCT01157078|447647930|FG000|Overall Study|Study-specific withdrawal criteria|2|||
124461148|NCT01157078|447647931|FG001|Overall Study|Study-specific withdrawal criteria|2|||
124461149|NCT01157078|447647930|FG000|Overall Study|Lost to Follow-up|7|||
124461150|NCT01157078|447647931|FG001|Overall Study|Lost to Follow-up|5|||
124461151|NCT01157078|447647930|FG000|Overall Study|Other|2|||
124461152|NCT01157078|447647931|FG001|Overall Study|Other|4|||
124461153|NCT00513409|447647933|FG000|Overall Study|Adverse Event|0|||
124461154|NCT00513409|447647934|FG001|Overall Study|Adverse Event|1|||
124461155|NCT00513409|447647933|FG000|Overall Study|Withdrawal by Subject|0|||
124461156|NCT00513409|447647934|FG001|Overall Study|Withdrawal by Subject|2|||
124461157|NCT00513409|447647933|FG000|Overall Study|Lost to Follow-up|0|||
124461158|NCT00513409|447647934|FG001|Overall Study|Lost to Follow-up|1|||
124461159|NCT00513409|447647933|FG000|Overall Study|Physician Decision|1|||
124461160|NCT00513409|447647934|FG001|Overall Study|Physician Decision|0|||
124461161|NCT00513409|447647933|FG000|Overall Study|Visit 3 not done|1|||
124461162|NCT00513409|447647934|FG001|Overall Study|Visit 3 not done|2|||
124461163|NCT03189446|447647935|FG000|Overall Study|Adverse Event|2|||
124461164|NCT03189446|447647935|FG000|Overall Study|Withdrawal by Subject|2|||
124461165|NCT03189446|447647935|FG000|Overall Study|Physician Decision|1|||
124461166|NCT04839978|447647936|FG000|Overall Study|Lost to Follow-up|135|||
124461167|NCT04839978|447647937|FG001|Overall Study|Lost to Follow-up|147|||
124461168|NCT00781456|447647938|FG000|Overall Study|Adverse Event|3|||
124461169|NCT00781456|447647939|FG001|Overall Study|Adverse Event|3|||
124461170|NCT00781456|447647938|FG000|Overall Study|Withdrawal by Subject|3|||
124461171|NCT00781456|447647939|FG001|Overall Study|Withdrawal by Subject|5|||
124461172|NCT00781456|447647938|FG000|Overall Study|Protocol Violation|4|||
124461173|NCT00781456|447647939|FG001|Overall Study|Protocol Violation|1|||
124461174|NCT00781456|447647938|FG000|Overall Study|Noncompliance With Protocol|1|||
124461175|NCT00781456|447647939|FG001|Overall Study|Noncompliance With Protocol|1|||
124766448|NCT05121766|448771736|FG000|Overall Study|Lost to Follow-up|0|||
124766449|NCT05121766|448771737|FG001|Overall Study|Lost to Follow-up|1|||
124766450|NCT01033240|448771741|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
124766451|NCT01033240|448771742|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
124766452|NCT01033240|448771743|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
124766453|NCT01033240|448771741|FG000|Overall Study|Death|2|||
124766454|NCT01033240|448771742|FG001|Overall Study|Death|0|||
124766455|NCT01033240|448771743|FG002|Overall Study|Death|0|||
124766456|NCT01033240|448771741|FG000|Overall Study|Withdrew Consent|2|||
124766457|NCT01033240|448771742|FG001|Overall Study|Withdrew Consent|9|||
124766458|NCT01033240|448771743|FG002|Overall Study|Withdrew Consent|2|||
124766459|NCT01033240|448771741|FG000|Overall Study|Disease Progression|35|||
124766460|NCT01033240|448771742|FG001|Overall Study|Disease Progression|32|||
124766461|NCT01033240|448771743|FG002|Overall Study|Disease Progression|41|||
124766462|NCT01033240|448771741|FG000|Overall Study|Investigator Discretion|0|||
124766463|NCT01033240|448771742|FG001|Overall Study|Investigator Discretion|0|||
124766464|NCT01033240|448771743|FG002|Overall Study|Investigator Discretion|2|||
124766465|NCT01033240|448771741|FG000|Overall Study|Other|0|||
124766466|NCT01033240|448771742|FG001|Overall Study|Other|1|||
124766467|NCT01033240|448771743|FG002|Overall Study|Other|2|||
124766468|NCT05468814|448771744|FG000|Overall Study|Lost to Follow-up|5|||
124766469|NCT05468814|448771745|FG001|Overall Study|Lost to Follow-up|6|||
124766470|NCT04716426|448771747|FG000|Overall Study|Vaccination|1|||
124956863|NCT00296504|449467923|FG008|Interim Analysis|Adverse Event|0|||
124956864|NCT00296504|449467915|FG000|Interim Analysis|Protocol Violation|0|||
124461176|NCT00781456|447647938|FG000|Overall Study|Lost to Follow-up|10|||
124461177|NCT00781456|447647939|FG001|Overall Study|Lost to Follow-up|5|||
124766471|NCT04716426|448771748|FG001|Overall Study|Vaccination|1|||
124766472|NCT04716426|448771747|FG000|Overall Study|Contamination|1|||
124766473|NCT04716426|448771748|FG001|Overall Study|Contamination|0|||
124956865|NCT00296504|449467916|FG001|Interim Analysis|Protocol Violation|0|||
124461178|NCT00781456|447647938|FG000|Overall Study|Other Reason, Unknown|0|||
124461179|NCT00781456|447647939|FG001|Overall Study|Other Reason, Unknown|1|||
124461180|NCT02513329|447647940|FG000|Overall Study|Lost to Follow-up|5|||
124461181|NCT02513329|447647941|FG001|Overall Study|Lost to Follow-up|2|||
124461182|NCT01294670|447647942|FG000|Overall Study|Not treated|1|||
124707864|NCT00718315|448555893|FG002|Overall Study|Death|5|||
124707865|NCT00718315|448555891|FG000|Overall Study|Lost to Follow-up|2|||
124707866|NCT00718315|448555892|FG001|Overall Study|Lost to Follow-up|3|||
124707867|NCT00718315|448555893|FG002|Overall Study|Lost to Follow-up|4|||
124707868|NCT00718315|448555891|FG000|Overall Study|Protocol Violation|5|||
124461183|NCT01294670|447647943|FG001|Overall Study|Not treated|0|||
124461184|NCT01294670|447647944|FG002|Overall Study|Not treated|0|||
124707869|NCT00718315|448555892|FG001|Overall Study|Protocol Violation|5|||
124707870|NCT00718315|448555893|FG002|Overall Study|Protocol Violation|3|||
124707871|NCT00718315|448555891|FG000|Overall Study|Erlotinib dose decreased|4|||
124766474|NCT00551759|448771749|FG000|Overall Study|Adverse Event|7|||
124766475|NCT00551759|448771749|FG000|Overall Study|Death|5|||
124766476|NCT00551759|448771749|FG000|Overall Study|Ineligible|1|||
124956866|NCT00296504|449467917|FG002|Interim Analysis|Protocol Violation|2|||
124461185|NCT01294670|447647945|FG003|Overall Study|Not treated|0|||
124461186|NCT01294670|447647946|FG004|Overall Study|Not treated|0|||
124461187|NCT02083380|447647949|FG000|Overall Study|Lack of Efficacy|68|||
124461188|NCT02083380|447647950|FG001|Overall Study|Lack of Efficacy|79|||
124461189|NCT02083380|447647951|FG002|Overall Study|Lack of Efficacy|64|||
124461190|NCT02083380|447647949|FG000|Overall Study|Withdrawal by Subject|9|||
124461191|NCT02083380|447647950|FG001|Overall Study|Withdrawal by Subject|3|||
124461192|NCT02083380|447647951|FG002|Overall Study|Withdrawal by Subject|7|||
124461193|NCT02083380|447647949|FG000|Overall Study|Physician Decision|1|||
124461194|NCT02083380|447647950|FG001|Overall Study|Physician Decision|6|||
124461195|NCT02083380|447647951|FG002|Overall Study|Physician Decision|3|||
124461196|NCT02083380|447647949|FG000|Overall Study|Adverse Event|0|||
124461197|NCT02083380|447647950|FG001|Overall Study|Adverse Event|0|||
124461198|NCT02083380|447647951|FG002|Overall Study|Adverse Event|1|||
124461199|NCT02083380|447647949|FG000|Overall Study|Lost to Follow-up|5|||
124461200|NCT02083380|447647950|FG001|Overall Study|Lost to Follow-up|3|||
124461201|NCT02083380|447647951|FG002|Overall Study|Lost to Follow-up|3|||
124461202|NCT02083380|447647949|FG000|Overall Study|Other|8|||
124461203|NCT02083380|447647950|FG001|Overall Study|Other|4|||
124461204|NCT02083380|447647951|FG002|Overall Study|Other|6|||
124461205|NCT02412787|447647952|FG000|Overall Study|Withdrawal by Subject|9|||
124461206|NCT02412787|447647952|FG000|Overall Study|Participation Terminated by Investigator|1|||
124461207|NCT02412787|447647952|FG000|Overall Study|Site Terminated by Sponsor|21|||
124461208|NCT02412787|447647952|FG000|Overall Study|Technical Problems|1|||
124461209|NCT02412787|447647952|FG000|Overall Study|Reason Not Specified|1|||
124461210|NCT00876187|447647958|FG000|Overall Study|Adverse Event|14|||
124461211|NCT00876187|447647959|FG001|Overall Study|Adverse Event|12|||
124461212|NCT00876187|447647960|FG002|Overall Study|Adverse Event|19|||
124461213|NCT00876187|447647961|FG003|Overall Study|Adverse Event|29|||
124461214|NCT00876187|447647962|FG004|Overall Study|Adverse Event|10|||
124461215|NCT00876187|447647958|FG000|Overall Study|Lack of Efficacy|59|||
124461216|NCT00876187|447647959|FG001|Overall Study|Lack of Efficacy|34|||
124461217|NCT00876187|447647960|FG002|Overall Study|Lack of Efficacy|45|||
124461218|NCT00876187|447647961|FG003|Overall Study|Lack of Efficacy|34|||
124461219|NCT00876187|447647962|FG004|Overall Study|Lack of Efficacy|59|||
124461220|NCT00876187|447647958|FG000|Overall Study|Lost to Follow-up|9|||
124461221|NCT00876187|447647959|FG001|Overall Study|Lost to Follow-up|10|||
124461222|NCT00876187|447647960|FG002|Overall Study|Lost to Follow-up|8|||
124461223|NCT00876187|447647961|FG003|Overall Study|Lost to Follow-up|8|||
124461224|NCT00876187|447647962|FG004|Overall Study|Lost to Follow-up|11|||
124461225|NCT00876187|447647958|FG000|Overall Study|Protocol Violation|6|||
124461226|NCT00876187|447647959|FG001|Overall Study|Protocol Violation|7|||
124461227|NCT00876187|447647960|FG002|Overall Study|Protocol Violation|7|||
124461228|NCT00876187|447647961|FG003|Overall Study|Protocol Violation|6|||
124461229|NCT00876187|447647962|FG004|Overall Study|Protocol Violation|3|||
124461230|NCT00876187|447647958|FG000|Overall Study|Withdrawal by Subject|16|||
124461231|NCT00876187|447647959|FG001|Overall Study|Withdrawal by Subject|26|||
124461232|NCT00876187|447647960|FG002|Overall Study|Withdrawal by Subject|32|||
124461233|NCT00876187|447647961|FG003|Overall Study|Withdrawal by Subject|38|||
124461234|NCT00876187|447647962|FG004|Overall Study|Withdrawal by Subject|37|||
124461235|NCT00876187|447647958|FG000|Overall Study|Entered extension study|101|||
124461236|NCT00876187|447647959|FG001|Overall Study|Entered extension study|120|||
124461237|NCT00876187|447647960|FG002|Overall Study|Entered extension study|156|||
124461238|NCT00876187|447647961|FG003|Overall Study|Entered extension study|151|||
124549113|NCT00111007|447965462|FG000|Long Term Follow-up|Death|34|||
124956867|NCT00296504|449467918|FG003|Interim Analysis|Protocol Violation|0|||
124956868|NCT00296504|449467919|FG004|Interim Analysis|Protocol Violation|1|||
124956869|NCT00296504|449467920|FG005|Interim Analysis|Protocol Violation|0|||
124956870|NCT00296504|449467921|FG006|Interim Analysis|Protocol Violation|0|||
124956871|NCT00296504|449467922|FG007|Interim Analysis|Protocol Violation|1|||
124956872|NCT00296504|449467923|FG008|Interim Analysis|Protocol Violation|0|||
124956873|NCT00296504|449467915|FG000|Interim Analysis|Insufficient CD4 Response|0|||
124956874|NCT00296504|449467916|FG001|Interim Analysis|Insufficient CD4 Response|0|||
124956875|NCT00296504|449467917|FG002|Interim Analysis|Insufficient CD4 Response|0|||
124956876|NCT00296504|449467918|FG003|Interim Analysis|Insufficient CD4 Response|0|||
124461239|NCT00876187|447647962|FG004|Overall Study|Entered extension study|144|||
124461240|NCT00876187|447647958|FG000|Overall Study|Randomized but not treated|3|||
124461241|NCT00876187|447647959|FG001|Overall Study|Randomized but not treated|1|||
124461242|NCT00876187|447647960|FG002|Overall Study|Randomized but not treated|3|||
124461243|NCT00876187|447647961|FG003|Overall Study|Randomized but not treated|2|||
124461244|NCT00876187|447647962|FG004|Overall Study|Randomized but not treated|3|||
124461245|NCT00876187|447647958|FG000|Overall Study|Other|2|||
124461246|NCT00876187|447647959|FG001|Overall Study|Other|5|||
124461247|NCT00876187|447647960|FG002|Overall Study|Other|9|||
124461248|NCT00876187|447647961|FG003|Overall Study|Other|7|||
124461249|NCT00876187|447647962|FG004|Overall Study|Other|4|||
124461250|NCT01032915|447647963|FG000|Overall Study|Adverse Event|2|||
124956877|NCT00296504|449467919|FG004|Interim Analysis|Insufficient CD4 Response|1|||
124956878|NCT00296504|449467920|FG005|Interim Analysis|Insufficient CD4 Response|1|||
124461251|NCT01032915|447647964|FG001|Overall Study|Adverse Event|2|||
124461252|NCT01032915|447647965|FG002|Overall Study|Adverse Event|1|||
124461253|NCT01032915|447647966|FG003|Overall Study|Adverse Event|1|||
124461254|NCT01032915|447647963|FG000|Overall Study|Abnormal test procedure result|0|||
124461255|NCT01032915|447647964|FG001|Overall Study|Abnormal test procedure result|0|||
124461256|NCT01032915|447647965|FG002|Overall Study|Abnormal test procedure result|1|||
124461257|NCT01032915|447647966|FG003|Overall Study|Abnormal test procedure result|0|||
124461258|NCT01032915|447647963|FG000|Overall Study|Withdrawal by Subject|0|||
124461259|NCT01032915|447647964|FG001|Overall Study|Withdrawal by Subject|3|||
124461260|NCT01032915|447647965|FG002|Overall Study|Withdrawal by Subject|1|||
124461261|NCT01032915|447647966|FG003|Overall Study|Withdrawal by Subject|1|||
124461262|NCT01032915|447647963|FG000|Overall Study|Administrative reasons|5|||
124461263|NCT01032915|447647964|FG001|Overall Study|Administrative reasons|6|||
124461264|NCT01032915|447647965|FG002|Overall Study|Administrative reasons|4|||
124461265|NCT01032915|447647966|FG003|Overall Study|Administrative reasons|4|||
124461266|NCT01032915|447647963|FG000|Overall Study|Protocol Violation|1|||
124461267|NCT01032915|447647964|FG001|Overall Study|Protocol Violation|0|||
124461268|NCT01032915|447647965|FG002|Overall Study|Protocol Violation|0|||
124461269|NCT01032915|447647966|FG003|Overall Study|Protocol Violation|1|||
124461270|NCT00915681|447647967|FG000|Overall Study|Screening failures|46|||
124461271|NCT01118351|447647968|FG000|Overall Study|Adverse Event|3|||
124461272|NCT01118351|447647968|FG000|Overall Study|Withdrawal by Subject|1|||
124461273|NCT04677959|447647981|FG000|Overall Study|Adverse Event|1|||
124461274|NCT04677959|447647982|FG001|Overall Study|Adverse Event|9|||
124461275|NCT04677959|447647981|FG000|Overall Study|Withdrawal by Subject|2|||
124461276|NCT04677959|447647982|FG001|Overall Study|Withdrawal by Subject|15|||
124461277|NCT04677959|447647981|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124461278|NCT04677959|447647982|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124461279|NCT04677959|447647981|FG000|Overall Study|Non-compliance with study drug|0|||
124461280|NCT04677959|447647982|FG001|Overall Study|Non-compliance with study drug|2|||
124766477|NCT02960217|448771750|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
124766478|NCT02960217|448771751|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
124766479|NCT02960217|448771750|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
124766480|NCT02960217|448771751|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
124766481|NCT02960217|448771750|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
124766482|NCT02960217|448771751|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
124766483|NCT02960217|448771750|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
124956879|NCT00296504|449467921|FG006|Interim Analysis|Insufficient CD4 Response|0|||
124956880|NCT00296504|449467922|FG007|Interim Analysis|Insufficient CD4 Response|0|||
124956881|NCT00296504|449467923|FG008|Interim Analysis|Insufficient CD4 Response|0|||
124956882|NCT00296504|449467915|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
124766484|NCT02960217|448771751|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
124766485|NCT02960217|448771750|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
124766486|NCT02960217|448771751|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
124766487|NCT02960217|448771750|FG000|Open-Label Extension Phase|Adverse Event|1|||
124766488|NCT02960217|448771751|FG001|Open-Label Extension Phase|Adverse Event|0|||
124766489|NCT02960217|448771750|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
124766490|NCT02960217|448771751|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
124766491|NCT02960217|448771750|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
124766492|NCT02960217|448771751|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
124766493|NCT02960217|448771750|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
124766494|NCT02960217|448771751|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
124766495|NCT00625131|448771754|FG000|Overall Study|Lost to Follow-up|3|||
124766496|NCT00625131|448771755|FG001|Overall Study|Lost to Follow-up|2|||
124766497|NCT00625131|448771756|FG002|Overall Study|Lost to Follow-up|0|||
124766498|NCT00625131|448771754|FG000|Overall Study|Withdrawal by Subject|1|||
124766499|NCT00625131|448771755|FG001|Overall Study|Withdrawal by Subject|0|||
124956883|NCT00296504|449467916|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
124956884|NCT00296504|449467917|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
124956885|NCT00296504|449467918|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
124956886|NCT00296504|449467919|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
124956887|NCT00296504|449467920|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
124461281|NCT04677959|447647981|FG000|Overall Study|Protocol deviation|0|||
124549114|NCT00111007|447965463|FG001|Long Term Follow-up|Death|39|||
124956888|NCT00296504|449467921|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
124956889|NCT00296504|449467922|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
124956890|NCT00296504|449467923|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
124461282|NCT04677959|447647982|FG001|Overall Study|Protocol deviation|11|||
124461283|NCT04677959|447647981|FG000|Overall Study|Lost to Follow-up|9|||
124461284|NCT04677959|447647982|FG001|Overall Study|Lost to Follow-up|13|||
124766500|NCT00625131|448771756|FG002|Overall Study|Withdrawal by Subject|5|||
124956891|NCT00296504|449467915|FG000|Interim Analysis|Pregnancy|4|||
124461285|NCT04677959|447647981|FG000|Overall Study|Other than specified|0|||
124461286|NCT04677959|447647982|FG001|Overall Study|Other than specified|8|||
124461287|NCT01970995|447647983|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
124461288|NCT01970995|447647984|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
124461289|NCT01970995|447647985|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
124461290|NCT01970995|447647983|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
124461291|NCT01970995|447647984|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
124461292|NCT01970995|447647985|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
124956892|NCT00296504|449467916|FG001|Interim Analysis|Pregnancy|1|||
124956893|NCT00296504|449467917|FG002|Interim Analysis|Pregnancy|4|||
124956894|NCT00296504|449467918|FG003|Interim Analysis|Pregnancy|2|||
124956895|NCT00296504|449467919|FG004|Interim Analysis|Pregnancy|0|||
124956896|NCT00296504|449467920|FG005|Interim Analysis|Pregnancy|1|||
124956897|NCT00296504|449467921|FG006|Interim Analysis|Pregnancy|1|||
124956898|NCT00296504|449467922|FG007|Interim Analysis|Pregnancy|1|||
124956899|NCT00296504|449467923|FG008|Interim Analysis|Pregnancy|0|||
124956900|NCT00296504|449467915|FG000|Interim Analysis|Death|1|||
124956901|NCT00296504|449467916|FG001|Interim Analysis|Death|0|||
124956902|NCT00296504|449467917|FG002|Interim Analysis|Death|3|||
124956903|NCT00296504|449467918|FG003|Interim Analysis|Death|0|||
124956904|NCT00296504|449467919|FG004|Interim Analysis|Death|0|||
124956905|NCT00296504|449467920|FG005|Interim Analysis|Death|0|||
124956906|NCT00296504|449467921|FG006|Interim Analysis|Death|0|||
124956907|NCT00296504|449467922|FG007|Interim Analysis|Death|0|||
124461293|NCT00845728|447647986|FG000|Overall Study|Abnormal laboratory value (s)|2|||
124461294|NCT00845728|447647987|FG001|Overall Study|Abnormal laboratory value (s)|2|||
124461295|NCT00845728|447647986|FG000|Overall Study|Patient's inability to use the device|4|||
124461296|NCT00845728|447647987|FG001|Overall Study|Patient's inability to use the device|6|||
124461297|NCT00845728|447647986|FG000|Overall Study|Abnormal test procedure result (s)|7|||
124461298|NCT00845728|447647987|FG001|Overall Study|Abnormal test procedure result (s)|2|||
124461299|NCT00845728|447647986|FG000|Overall Study|Lost to Follow-up|22|||
124461300|NCT00845728|447647987|FG001|Overall Study|Lost to Follow-up|13|||
124461301|NCT00845728|447647986|FG000|Overall Study|Death|24|||
124461302|NCT00845728|447647987|FG001|Overall Study|Death|26|||
124461303|NCT00845728|447647986|FG000|Overall Study|Administrative Problems|34|||
124461304|NCT00845728|447647987|FG001|Overall Study|Administrative Problems|26|||
124461305|NCT00845728|447647986|FG000|Overall Study|Protocol Violation|36|||
124461306|NCT00845728|447647987|FG001|Overall Study|Protocol Violation|24|||
124461307|NCT00845728|447647986|FG000|Overall Study|Lack of Efficacy|51|||
124461308|NCT00845728|447647987|FG001|Overall Study|Lack of Efficacy|39|||
124707872|NCT00718315|448555892|FG001|Overall Study|Erlotinib dose decreased|3|||
124707873|NCT00718315|448555893|FG002|Overall Study|Erlotinib dose decreased|1|||
124707874|NCT00718315|448555891|FG000|Overall Study|Use of Minocyclin|1|||
124707875|NCT00718315|448555892|FG001|Overall Study|Use of Minocyclin|1|||
124707876|NCT00718315|448555893|FG002|Overall Study|Use of Minocyclin|1|||
124707877|NCT00718315|448555891|FG000|Overall Study|Disease progression|0|||
124707878|NCT00718315|448555892|FG001|Overall Study|Disease progression|1|||
124707879|NCT00718315|448555893|FG002|Overall Study|Disease progression|1|||
124707880|NCT00718315|448555891|FG000|Overall Study|Other|0|||
124707881|NCT00718315|448555892|FG001|Overall Study|Other|0|||
124707882|NCT00718315|448555893|FG002|Overall Study|Other|1|||
124707883|NCT00718315|448555891|FG000|Overall Study|Use of ATB and Corticoids|0|||
124707884|NCT00718315|448555892|FG001|Overall Study|Use of ATB and Corticoids|1|||
124707885|NCT00718315|448555893|FG002|Overall Study|Use of ATB and Corticoids|2|||
124707886|NCT01170663|448555894|FG000|Overall Study|Lost to Follow-up|3|||
124707887|NCT01170663|448555895|FG001|Overall Study|Lost to Follow-up|9|||
124707888|NCT01170663|448555894|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
124707889|NCT01170663|448555895|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
124707890|NCT02746809|448555898|FG000|Enrollment|Inclusion Exclusion not met|9|||
124707891|NCT02746809|448555898|FG000|Enrollment|Withdrawal by Subject|1|||
124707892|NCT02746809|448555898|FG000|Enrollment|Expected Enrollment Met|2|||
124707893|NCT02746809|448555898|FG000|Procedure|Death|1|||
124707894|NCT02746809|448555898|FG000|1-Month|Death|5|||
124707895|NCT02746809|448555898|FG000|6-Month|Death|2|||
124707896|NCT02746809|448555898|FG000|6-Month|Withdrawal by Subject|1|||
124461309|NCT00845728|447647986|FG000|Overall Study|Adverse Event|101|||
124461310|NCT00845728|447647987|FG001|Overall Study|Adverse Event|96|||
124461311|NCT00845728|447647986|FG000|Overall Study|Withdrawal by Subject|105|||
124707897|NCT02746809|448555898|FG000|12-Month|Death|3|||
124707898|NCT02746809|448555898|FG000|12-Month|Withdrawal by Subject|2|||
124707899|NCT02746809|448555898|FG000|24-Month|Death|1|||
124707900|NCT02746809|448555898|FG000|24-Month|Withdrawal by Subject|1|||
124707901|NCT02746809|448555898|FG000|36-Month|Death|8|||
124956908|NCT00296504|449467923|FG008|Interim Analysis|Death|0|||
124956909|NCT00296504|449467915|FG000|Interim Analysis|Participant Non-compliant|0|||
124956910|NCT00296504|449467916|FG001|Interim Analysis|Participant Non-compliant|1|||
124956911|NCT00296504|449467917|FG002|Interim Analysis|Participant Non-compliant|2|||
124956912|NCT00296504|449467918|FG003|Interim Analysis|Participant Non-compliant|1|||
124766501|NCT00668148|448771772|FG000|Overall Study|Adverse Event|5|||
124766502|NCT00668148|448771772|FG000|Overall Study|Subject Non-compliance|1|||
124766503|NCT00668148|448771772|FG000|Overall Study|Progressive Disease Before Treatment|2|||
124766504|NCT00668148|448771772|FG000|Overall Study|Withdrawal of Consent|2|||
124766505|NCT01766050|448773700|FG000|Overall Study|Adverse Event|1|||
124766506|NCT01766050|448773700|FG000|Overall Study|Lost to Follow-up|1|||
124766507|NCT01766050|448773700|FG000|Overall Study|Withdrawal by Subject|2|||
124766508|NCT00089297|448773703|FG000|Overall Study|Adverse Event|9|||
124461312|NCT00845728|447647987|FG001|Overall Study|Withdrawal by Subject|108|||
124461313|NCT02599961|447647991|FG000|Overall Study|Withdrawal by Subject|1|||
124461314|NCT02599961|447647991|FG000|Overall Study|Subject Non-Compliance|2|||
124461315|NCT02599961|447647991|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
124461316|NCT02599961|447647991|FG000|Overall Study|Other, Not Specified|3|||
124461317|NCT00464334|447647992|FG000|Overall Study|Adverse Event|0|||
124766509|NCT00089297|448773703|FG000|Overall Study|Death|1|||
124461318|NCT00464334|447647993|FG001|Overall Study|Adverse Event|0|||
124461319|NCT00464334|447647994|FG002|Overall Study|Adverse Event|0|||
124461320|NCT00464334|447647995|FG003|Overall Study|Adverse Event|1|||
124461321|NCT00464334|447647996|FG004|Overall Study|Adverse Event|1|||
124461322|NCT00464334|447647997|FG005|Overall Study|Adverse Event|1|||
124461323|NCT00464334|447647998|FG006|Overall Study|Adverse Event|0|||
124461324|NCT00464334|447647999|FG007|Overall Study|Adverse Event|0|||
124461325|NCT00464334|447648000|FG008|Overall Study|Adverse Event|2|||
124461326|NCT00464334|447648001|FG009|Overall Study|Adverse Event|1|||
124461327|NCT00464334|447648002|FG010|Overall Study|Adverse Event|2|||
124461328|NCT00464334|447647992|FG000|Overall Study|Lack of Efficacy|0|||
124461329|NCT00464334|447647993|FG001|Overall Study|Lack of Efficacy|1|||
124461330|NCT00464334|447647994|FG002|Overall Study|Lack of Efficacy|0|||
124461331|NCT00464334|447647995|FG003|Overall Study|Lack of Efficacy|0|||
124461332|NCT00464334|447647996|FG004|Overall Study|Lack of Efficacy|0|||
124461333|NCT00464334|447647997|FG005|Overall Study|Lack of Efficacy|0|||
124461334|NCT00464334|447647998|FG006|Overall Study|Lack of Efficacy|0|||
124461335|NCT00464334|447647999|FG007|Overall Study|Lack of Efficacy|0|||
124461336|NCT00464334|447648000|FG008|Overall Study|Lack of Efficacy|0|||
124461337|NCT00464334|447648001|FG009|Overall Study|Lack of Efficacy|0|||
124461338|NCT00464334|447648002|FG010|Overall Study|Lack of Efficacy|0|||
124461339|NCT00464334|447647992|FG000|Overall Study|Lost to Follow-up|0|||
124461340|NCT00464334|447647993|FG001|Overall Study|Lost to Follow-up|0|||
124461341|NCT00464334|447647994|FG002|Overall Study|Lost to Follow-up|1|||
124461342|NCT00464334|447647995|FG003|Overall Study|Lost to Follow-up|0|||
124461343|NCT00464334|447647996|FG004|Overall Study|Lost to Follow-up|1|||
124461344|NCT00464334|447647997|FG005|Overall Study|Lost to Follow-up|0|||
124461345|NCT00464334|447647998|FG006|Overall Study|Lost to Follow-up|1|||
124461346|NCT00464334|447647999|FG007|Overall Study|Lost to Follow-up|0|||
124461347|NCT00464334|447648000|FG008|Overall Study|Lost to Follow-up|0|||
124461348|NCT00464334|447648001|FG009|Overall Study|Lost to Follow-up|0|||
124461349|NCT00464334|447648002|FG010|Overall Study|Lost to Follow-up|2|||
124461350|NCT00464334|447647992|FG000|Overall Study|Progressive Disease|0|||
124461351|NCT00464334|447647993|FG001|Overall Study|Progressive Disease|0|||
124461352|NCT00464334|447647994|FG002|Overall Study|Progressive Disease|0|||
124461353|NCT00464334|447647995|FG003|Overall Study|Progressive Disease|0|||
124461354|NCT00464334|447647996|FG004|Overall Study|Progressive Disease|0|||
124461355|NCT00464334|447647997|FG005|Overall Study|Progressive Disease|1|||
124461356|NCT00464334|447647998|FG006|Overall Study|Progressive Disease|0|||
124461357|NCT00464334|447647999|FG007|Overall Study|Progressive Disease|0|||
124461358|NCT00464334|447648000|FG008|Overall Study|Progressive Disease|1|||
124461359|NCT00464334|447648001|FG009|Overall Study|Progressive Disease|0|||
124461360|NCT00464334|447648002|FG010|Overall Study|Progressive Disease|0|||
124461361|NCT00464334|447647992|FG000|Overall Study|Study Terminated by Sponsor|0|||
124461362|NCT00464334|447647993|FG001|Overall Study|Study Terminated by Sponsor|0|||
124549115|NCT00111007|447965462|FG000|Long Term Follow-up|Lost to Follow-up|1|||
124549116|NCT00111007|447965463|FG001|Long Term Follow-up|Lost to Follow-up|1|||
124461363|NCT00464334|447647994|FG002|Overall Study|Study Terminated by Sponsor|0|||
124461364|NCT00464334|447647995|FG003|Overall Study|Study Terminated by Sponsor|1|||
124549117|NCT00111007|447965462|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
124549118|NCT00111007|447965463|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
124766510|NCT00089297|448773703|FG000|Overall Study|Withdrawal by Subject|12|||
124766511|NCT00089297|448773703|FG000|Overall Study|Disease progression|2|||
124461365|NCT00464334|447647996|FG004|Overall Study|Study Terminated by Sponsor|0|||
124461366|NCT00464334|447647997|FG005|Overall Study|Study Terminated by Sponsor|0|||
124461367|NCT00464334|447647998|FG006|Overall Study|Study Terminated by Sponsor|0|||
124766512|NCT00089297|448773703|FG000|Overall Study|Ineligible|11|||
124461368|NCT00464334|447647999|FG007|Overall Study|Study Terminated by Sponsor|0|||
124461369|NCT00464334|447648000|FG008|Overall Study|Study Terminated by Sponsor|0|||
124461370|NCT00464334|447648001|FG009|Overall Study|Study Terminated by Sponsor|0|||
124461371|NCT00464334|447648002|FG010|Overall Study|Study Terminated by Sponsor|0|||
124461372|NCT00464334|447647992|FG000|Overall Study|Withdrawal by Subject|1|||
124461373|NCT00464334|447647993|FG001|Overall Study|Withdrawal by Subject|7|||
124766513|NCT00089297|448773703|FG000|Overall Study|Secondary malignancy|1|||
124461374|NCT00464334|447647994|FG002|Overall Study|Withdrawal by Subject|4|||
124461375|NCT00464334|447647995|FG003|Overall Study|Withdrawal by Subject|2|||
124461376|NCT00464334|447647996|FG004|Overall Study|Withdrawal by Subject|2|||
124461377|NCT00464334|447647997|FG005|Overall Study|Withdrawal by Subject|2|||
124461378|NCT00464334|447647998|FG006|Overall Study|Withdrawal by Subject|2|||
124461379|NCT00464334|447647999|FG007|Overall Study|Withdrawal by Subject|1|||
124461380|NCT00464334|447648000|FG008|Overall Study|Withdrawal by Subject|3|||
124461381|NCT00464334|447648001|FG009|Overall Study|Withdrawal by Subject|0|||
124461382|NCT00464334|447648002|FG010|Overall Study|Withdrawal by Subject|0|||
124461383|NCT02432235|447648003|FG000|Overall Study|Death|1|||
124461384|NCT02432235|447648004|FG001|Overall Study|Death|1|||
124461385|NCT02432235|447648005|FG002|Overall Study|Death|2|||
124461386|NCT02432235|447648006|FG003|Overall Study|Death|2|||
124956913|NCT00296504|449467919|FG004|Interim Analysis|Participant Non-compliant|1|||
124956914|NCT00296504|449467920|FG005|Interim Analysis|Participant Non-compliant|3|||
124956915|NCT00296504|449467921|FG006|Interim Analysis|Participant Non-compliant|6|||
124956916|NCT00296504|449467922|FG007|Interim Analysis|Participant Non-compliant|2|||
124956917|NCT00296504|449467923|FG008|Interim Analysis|Participant Non-compliant|0|||
124956918|NCT00296504|449467915|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
124461387|NCT02432235|447648007|FG004|Overall Study|Death|1|||
124461388|NCT02432235|447648008|FG005|Overall Study|Death|3|||
124461389|NCT02432235|447648009|FG006|Overall Study|Death|11|||
124461390|NCT02432235|447648010|FG007|Overall Study|Death|15|||
124461391|NCT02432235|447648011|FG008|Overall Study|Death|15|||
124461392|NCT02432235|447648012|FG009|Overall Study|Death|3|||
124461393|NCT02432235|447648013|FG010|Overall Study|Death|1|||
124461394|NCT02432235|447648014|FG011|Overall Study|Death|0|||
124461395|NCT02432235|447648003|FG000|Overall Study|Withdrawal by Subject|0|||
124461396|NCT02432235|447648004|FG001|Overall Study|Withdrawal by Subject|1|||
124461397|NCT02432235|447648005|FG002|Overall Study|Withdrawal by Subject|0|||
124461398|NCT02432235|447648006|FG003|Overall Study|Withdrawal by Subject|0|||
124461399|NCT02432235|447648007|FG004|Overall Study|Withdrawal by Subject|0|||
124461400|NCT02432235|447648008|FG005|Overall Study|Withdrawal by Subject|2|||
124461401|NCT02432235|447648009|FG006|Overall Study|Withdrawal by Subject|5|||
124461402|NCT02432235|447648010|FG007|Overall Study|Withdrawal by Subject|3|||
124461403|NCT02432235|447648011|FG008|Overall Study|Withdrawal by Subject|1|||
124461404|NCT02432235|447648012|FG009|Overall Study|Withdrawal by Subject|0|||
124461405|NCT02432235|447648013|FG010|Overall Study|Withdrawal by Subject|0|||
124461406|NCT02432235|447648014|FG011|Overall Study|Withdrawal by Subject|0|||
124461407|NCT02432235|447648003|FG000|Overall Study|Lost to Follow-up|0|||
124461408|NCT02432235|447648004|FG001|Overall Study|Lost to Follow-up|0|||
124461409|NCT02432235|447648005|FG002|Overall Study|Lost to Follow-up|0|||
124461410|NCT02432235|447648006|FG003|Overall Study|Lost to Follow-up|0|||
124461411|NCT02432235|447648007|FG004|Overall Study|Lost to Follow-up|0|||
124461412|NCT02432235|447648008|FG005|Overall Study|Lost to Follow-up|1|||
124461413|NCT02432235|447648009|FG006|Overall Study|Lost to Follow-up|0|||
124461414|NCT02432235|447648010|FG007|Overall Study|Lost to Follow-up|0|||
124461415|NCT02432235|447648011|FG008|Overall Study|Lost to Follow-up|1|||
124461416|NCT02432235|447648012|FG009|Overall Study|Lost to Follow-up|0|||
124461417|NCT02432235|447648013|FG010|Overall Study|Lost to Follow-up|0|||
124461418|NCT02432235|447648014|FG011|Overall Study|Lost to Follow-up|0|||
124461419|NCT02432235|447648003|FG000|Overall Study|Miscellaneous|0|||
124461420|NCT02432235|447648004|FG001|Overall Study|Miscellaneous|0|||
124461421|NCT02432235|447648005|FG002|Overall Study|Miscellaneous|0|||
124461422|NCT02432235|447648006|FG003|Overall Study|Miscellaneous|0|||
124461423|NCT02432235|447648007|FG004|Overall Study|Miscellaneous|1|||
124461424|NCT02432235|447648008|FG005|Overall Study|Miscellaneous|6|||
124461425|NCT02432235|447648009|FG006|Overall Study|Miscellaneous|2|||
124461426|NCT02432235|447648010|FG007|Overall Study|Miscellaneous|2|||
124461427|NCT02432235|447648011|FG008|Overall Study|Miscellaneous|4|||
124461428|NCT02432235|447648012|FG009|Overall Study|Miscellaneous|0|||
124461429|NCT02432235|447648013|FG010|Overall Study|Miscellaneous|0|||
124766514|NCT00089297|448773703|FG000|Overall Study|IRB approval not ready|1|||
124956919|NCT00296504|449467916|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
124956920|NCT00296504|449467917|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
124461430|NCT02432235|447648014|FG011|Overall Study|Miscellaneous|1|||
124461431|NCT00794677|447648023|FG000|First Intervention|Withdrawal by Subject|2|||
124461432|NCT00794677|447648024|FG001|First Intervention|Withdrawal by Subject|0|||
124461433|NCT01965262|447648029|FG000|Second Intervention (7 Days)|Discontinued|0|||
124461434|NCT01965262|447648030|FG001|Second Intervention (7 Days)|Discontinued|1|||
124461435|NCT01965262|447648029|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
124461436|NCT01965262|447648030|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
124461437|NCT01965262|447648029|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
124461438|NCT01965262|447648030|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
124461439|NCT00143312|447648037|FG000|Overall Study|Death|11|||
124461440|NCT00143312|447648037|FG000|Overall Study|Adverse Event|2|||
124461441|NCT00143312|447648037|FG000|Overall Study|Lost to Follow-up|1|||
124461442|NCT00143312|447648037|FG000|Overall Study|Other|1|||
124461443|NCT00143312|447648037|FG000|Overall Study|Withdrawal by Subject|1|||
124461444|NCT01029366|447648038|FG000|Overall Study|Withdrawal by Subject|1|||
124461445|NCT01029366|447648039|FG001|Overall Study|Withdrawal by Subject|0|||
124461446|NCT01029366|447648038|FG000|Overall Study|Death|1|||
124461447|NCT01029366|447648039|FG001|Overall Study|Death|1|||
124461448|NCT01029366|447648038|FG000|Overall Study|disease progression|2|||
124461449|NCT01029366|447648039|FG001|Overall Study|disease progression|0|||
124461450|NCT01029366|447648038|FG000|Overall Study|manufacturing failure|0|||
124461451|NCT01029366|447648039|FG001|Overall Study|manufacturing failure|1|||
124461452|NCT00906087|447648045|FG000|Initial Washout|Withdrawal by Subject|1|||
124461453|NCT00906087|447648045|FG000|Initial Washout|Physician Decision|1|||
124461454|NCT00517829|447648046|FG000|Overall Study|Adverse Event|22|||
124461455|NCT00517829|447648047|FG001|Overall Study|Adverse Event|34|||
124461456|NCT00517829|447648046|FG000|Overall Study|Disease Progression|39|||
124461457|NCT00517829|447648047|FG001|Overall Study|Disease Progression|32|||
124461458|NCT00517829|447648046|FG000|Overall Study|Patient Request|6|||
124461459|NCT00517829|447648047|FG001|Overall Study|Patient Request|5|||
124461460|NCT00517829|447648046|FG000|Overall Study|Investigator Request|5|||
124461461|NCT00517829|447648047|FG001|Overall Study|Investigator Request|3|||
124461462|NCT00517829|447648046|FG000|Overall Study|Other|3|||
124461463|NCT00517829|447648047|FG001|Overall Study|Other|1|||
124461464|NCT00385255|447648048|FG000|Overall Study|Serious Adverse Event|1|||
124461465|NCT00385255|447648049|FG001|Overall Study|Serious Adverse Event|2|||
124461466|NCT00385255|447648048|FG000|Overall Study|Protocol Violation|0|||
124461467|NCT00385255|447648049|FG001|Overall Study|Protocol Violation|4|||
124461468|NCT00385255|447648048|FG000|Overall Study|Withdrawal by Subject|0|||
124461469|NCT00385255|447648049|FG001|Overall Study|Withdrawal by Subject|8|||
124461470|NCT00385255|447648048|FG000|Overall Study|Migrated/moved from study area|0|||
124461471|NCT00385255|447648049|FG001|Overall Study|Migrated/moved from study area|1|||
124461472|NCT00385255|447648048|FG000|Overall Study|Lost to Follow-up|20|||
124461473|NCT00385255|447648049|FG001|Overall Study|Lost to Follow-up|58|||
124461474|NCT02443883|447648050|FG000|Overall Study|Adverse Event|0|||
124461475|NCT02443883|447648051|FG001|Overall Study|Adverse Event|1|||
124461476|NCT02443883|447648052|FG002|Overall Study|Adverse Event|0|||
124461477|NCT02443883|447648053|FG003|Overall Study|Adverse Event|0|||
124461478|NCT02443883|447648050|FG000|Overall Study|Lost to Follow-up|3|||
124461479|NCT02443883|447648051|FG001|Overall Study|Lost to Follow-up|2|||
124461480|NCT02443883|447648052|FG002|Overall Study|Lost to Follow-up|1|||
124461481|NCT02443883|447648053|FG003|Overall Study|Lost to Follow-up|0|||
124461482|NCT02443883|447648050|FG000|Overall Study|Physician Decision|1|||
124461483|NCT02443883|447648051|FG001|Overall Study|Physician Decision|1|||
124461484|NCT02443883|447648052|FG002|Overall Study|Physician Decision|0|||
124461485|NCT02443883|447648053|FG003|Overall Study|Physician Decision|3|||
124461486|NCT02443883|447648050|FG000|Overall Study|Withdrawal by Subject|1|||
124461487|NCT02443883|447648051|FG001|Overall Study|Withdrawal by Subject|0|||
124461488|NCT02443883|447648052|FG002|Overall Study|Withdrawal by Subject|0|||
124461489|NCT02443883|447648053|FG003|Overall Study|Withdrawal by Subject|2|||
124461490|NCT02443883|447648050|FG000|Overall Study|Randomized, but never treated|1|||
124461491|NCT02443883|447648051|FG001|Overall Study|Randomized, but never treated|0|||
124461492|NCT02443883|447648052|FG002|Overall Study|Randomized, but never treated|0|||
124461493|NCT02443883|447648053|FG003|Overall Study|Randomized, but never treated|0|||
124461494|NCT00506883|447648065|FG000|Overall Study|Lost to Follow-up|1|||
124461495|NCT00506883|447648066|FG001|Overall Study|Lost to Follow-up|1|||
124461496|NCT00506883|447648067|FG002|Overall Study|Lost to Follow-up|1|||
124461497|NCT00506883|447648065|FG000|Overall Study|Withdrawal by Subject|1|||
124461498|NCT00506883|447648066|FG001|Overall Study|Withdrawal by Subject|0|||
124461499|NCT00506883|447648067|FG002|Overall Study|Withdrawal by Subject|1|||
124461500|NCT00506883|447648065|FG000|Overall Study|Lack of Efficacy|0|||
124461501|NCT00506883|447648066|FG001|Overall Study|Lack of Efficacy|1|||
124461502|NCT00506883|447648067|FG002|Overall Study|Lack of Efficacy|1|||
124461503|NCT00506883|447648065|FG000|Overall Study|Other|5|||
124461504|NCT00506883|447648066|FG001|Overall Study|Other|1|||
124461505|NCT00506883|447648067|FG002|Overall Study|Other|1|||
124461506|NCT01445951|447648068|FG000|Overall Study|Adverse Event|16|||
124461507|NCT01445951|447648069|FG001|Overall Study|Adverse Event|9|||
124956921|NCT00296504|449467918|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
124956922|NCT00296504|449467919|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
124956923|NCT00296504|449467920|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
124461508|NCT01445951|447648070|FG002|Overall Study|Adverse Event|0|||
124461509|NCT01445951|447648068|FG000|Overall Study|Protocol Violation|2|||
124461510|NCT01445951|447648069|FG001|Overall Study|Protocol Violation|2|||
124461511|NCT01445951|447648070|FG002|Overall Study|Protocol Violation|2|||
124461512|NCT01445951|447648068|FG000|Overall Study|Withdrawal by Subject|21|||
124461513|NCT01445951|447648069|FG001|Overall Study|Withdrawal by Subject|16|||
124461514|NCT01445951|447648070|FG002|Overall Study|Withdrawal by Subject|8|||
124461515|NCT01445951|447648068|FG000|Overall Study|Physician Decision|3|||
124461516|NCT01445951|447648069|FG001|Overall Study|Physician Decision|1|||
124461517|NCT01445951|447648070|FG002|Overall Study|Physician Decision|0|||
124461518|NCT01445951|447648068|FG000|Overall Study|Lost to Follow-up|1|||
124461519|NCT01445951|447648069|FG001|Overall Study|Lost to Follow-up|2|||
124461520|NCT01445951|447648070|FG002|Overall Study|Lost to Follow-up|4|||
124461521|NCT01445951|447648068|FG000|Overall Study|Pregnancy|0|||
124461522|NCT01445951|447648069|FG001|Overall Study|Pregnancy|1|||
124461523|NCT01445951|447648070|FG002|Overall Study|Pregnancy|4|||
124461524|NCT01445951|447648068|FG000|Overall Study|Death|0|||
124549119|NCT00111007|447965462|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
124549120|NCT00111007|447965463|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
124549121|NCT00111007|447965462|FG000|Long Term Follow-up|Missing|10|||
124549122|NCT00111007|447965463|FG001|Long Term Follow-up|Missing|3|||
124549123|NCT00605839|447965464|FG000|Overall Study|Protocol Violation|1|||
124549124|NCT00605839|447965465|FG001|Overall Study|Protocol Violation|0|||
124549125|NCT00605839|447965466|FG002|Overall Study|Protocol Violation|0|||
124549126|NCT01381068|447965467|FG000|Overall Study|Death|1|||
124549127|NCT01381068|447965468|FG001|Overall Study|Death|0|||
124549128|NCT00752895|447965471|FG000|Overall Study|Withdrawal by Subject|8|||
124549129|NCT00752895|447965472|FG001|Overall Study|Withdrawal by Subject|3|||
124549130|NCT00083226|447965473|FG000|Overall Study|Lack of Efficacy|19|||
124549131|NCT00083226|447965473|FG000|Overall Study|Adverse Event|9|||
124549132|NCT00083226|447965473|FG000|Overall Study|Death|4|||
124549133|NCT00083226|447965473|FG000|Overall Study|Withdrawal by Subject|4|||
124549134|NCT00083226|447965473|FG000|Overall Study|Other|2|||
124549135|NCT00083226|447965473|FG000|Overall Study|ineligible or not receiving treatment|4|||
124549136|NCT03993288|447966965|FG000|Overall Study|Lost to Follow-up|2|||
124549137|NCT03993288|447966966|FG001|Overall Study|Lost to Follow-up|1|||
124549138|NCT03993288|447966965|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
124549139|NCT03993288|447966966|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
124549140|NCT03993288|447966965|FG000|Overall Study|wrong randomization|0|||
124549141|NCT03993288|447966966|FG001|Overall Study|wrong randomization|1|||
124549142|NCT03993288|447966965|FG000|Overall Study|improper enrollment|0|||
124549143|NCT03993288|447966966|FG001|Overall Study|improper enrollment|1|||
124549144|NCT03993288|447966965|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
124549145|NCT03993288|447966966|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
124549146|NCT03993288|447966965|FG000|Overall Study|developed SAE|2|||
124549147|NCT03993288|447966966|FG001|Overall Study|developed SAE|0|||
124549148|NCT03993288|447966965|FG000|Overall Study|consent withdrawal|1|||
124461525|NCT01445951|447648069|FG001|Overall Study|Death|0|||
124956924|NCT00296504|449467921|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
124956925|NCT00296504|449467922|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
124956926|NCT00296504|449467923|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
124956927|NCT00296504|449467915|FG000|Interim Analysis|To Simplify Treatment|0|||
124956928|NCT00296504|449467916|FG001|Interim Analysis|To Simplify Treatment|0|||
124956929|NCT00296504|449467917|FG002|Interim Analysis|To Simplify Treatment|1|||
124956930|NCT00296504|449467918|FG003|Interim Analysis|To Simplify Treatment|0|||
124956931|NCT00296504|449467919|FG004|Interim Analysis|To Simplify Treatment|0|||
124956932|NCT00296504|449467920|FG005|Interim Analysis|To Simplify Treatment|0|||
124461526|NCT01445951|447648070|FG002|Overall Study|Death|1|||
124461527|NCT01445951|447648068|FG000|Overall Study|Non-compliance with study drug|1|||
124461528|NCT01445951|447648069|FG001|Overall Study|Non-compliance with study drug|2|||
124461529|NCT01445951|447648070|FG002|Overall Study|Non-compliance with study drug|0|||
124461530|NCT01445951|447648068|FG000|Overall Study|Non-compliance with protocol|0|||
124461531|NCT01445951|447648069|FG001|Overall Study|Non-compliance with protocol|1|||
124707902|NCT02746809|448555898|FG000|36-Month|Withdrawal by Subject|1|||
124956933|NCT00296504|449467921|FG006|Interim Analysis|To Simplify Treatment|2|||
124956934|NCT00296504|449467922|FG007|Interim Analysis|To Simplify Treatment|0|||
124956935|NCT00296504|449467923|FG008|Interim Analysis|To Simplify Treatment|0|||
124956936|NCT00296504|449467915|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
124956937|NCT00296504|449467916|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
124956938|NCT00296504|449467917|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
124461532|NCT01445951|447648070|FG002|Overall Study|Non-compliance with protocol|0|||
124461533|NCT01445951|447648068|FG000|Overall Study|Sponsor decision - subject travel|0|||
124461534|NCT01445951|447648069|FG001|Overall Study|Sponsor decision - subject travel|1|||
124707903|NCT02746809|448555898|FG000|48-Month|Death|7|||
124461535|NCT01445951|447648070|FG002|Overall Study|Sponsor decision - subject travel|0|||
124461536|NCT01445951|447648068|FG000|Overall Study|Cough|0|||
124707904|NCT02746809|448555898|FG000|48-Month|Withdrawal by Subject|1|||
124461537|NCT01445951|447648069|FG001|Overall Study|Cough|1|||
124461538|NCT01445951|447648070|FG002|Overall Study|Cough|0|||
124549149|NCT03993288|447966966|FG001|Overall Study|consent withdrawal|0|||
124549150|NCT03993288|447966965|FG000|Overall Study|did not follow the treatment schedule|1|||
124549151|NCT03993288|447966966|FG001|Overall Study|did not follow the treatment schedule|0|||
124707905|NCT02746809|448555898|FG000|60-Month|Death|1|||
124956939|NCT00296504|449467918|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
124956940|NCT00296504|449467919|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
124956941|NCT00296504|449467920|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
124461539|NCT00796315|447648071|FG000|Overall Study|Protocol Violation|0|||
124461540|NCT00796315|447648072|FG001|Overall Study|Protocol Violation|1|||
124461541|NCT00796315|447648073|FG002|Overall Study|Protocol Violation|0|||
124461542|NCT00889265|447648078|FG000|Overall Study|Adverse Event|1|||
124461543|NCT00889265|447648078|FG000|Overall Study|Lost to Follow-up|5|||
124461544|NCT00889265|447648078|FG000|Overall Study|Protocol Violation|1|||
124461545|NCT00254501|447648081|FG000|Overall Study|Lost to Follow-up|1|||
124461546|NCT00254501|447648082|FG001|Overall Study|Lost to Follow-up|1|||
124461547|NCT00923130|447648083|FG000|Overall Study|Stopped treatment due to progression|17|||
124461548|NCT00923130|447648083|FG000|Overall Study|Death|1|||
124461549|NCT00923130|447648083|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
124461550|NCT00923130|447648083|FG000|Overall Study|Switched to alternative treatment|2|||
124461551|NCT00923130|447648083|FG000|Overall Study|Refused further treatment|2|||
124461552|NCT00250835|447648084|FG000|Overall Study|Withdrawal by Subject|1|||
124461553|NCT03885089|447648086|FG000|Overall Study|No informed consent for publication of study results|2|||
124461554|NCT04489888|447648089|FG000|Overall Study|Death|75|||
124461555|NCT04489888|447648089|FG000|Overall Study|Sponsor Decision|26|||
124461556|NCT00278993|447648092|FG000|Overall Study|Adverse Event|24|||
124461557|NCT00278993|447648092|FG000|Overall Study|Withdrawal by Subject|5|||
124461558|NCT00278993|447648092|FG000|Overall Study|Progressive Disease|65|||
124461559|NCT00278993|447648092|FG000|Overall Study|Physician Decision|9|||
124461560|NCT00278993|447648092|FG000|Overall Study|Not Otherwise Specified|4|||
124461561|NCT02043548|447648096|FG000|Overall Study|Lack of Efficacy|1|||
124461562|NCT02043548|447648097|FG001|Overall Study|Lack of Efficacy|0|||
124461563|NCT02043548|447648096|FG000|Overall Study|Adverse Event|0|||
124461564|NCT02043548|447648097|FG001|Overall Study|Adverse Event|1|||
124461565|NCT01430455|447648100|FG000|Overall Study|Withdrawal by Subject|1|||
124461566|NCT01430455|447648100|FG000|Overall Study|Switched to follow-up phase|1|||
124461567|NCT01014689|447648102|FG000|Overall Study|Lack of Efficacy|0|||
124461568|NCT01014689|447648103|FG001|Overall Study|Lack of Efficacy|1|||
124461569|NCT01014689|447648102|FG000|Overall Study|Adverse Event|3|||
124461570|NCT01014689|447648103|FG001|Overall Study|Adverse Event|0|||
124461571|NCT01014689|447648102|FG000|Overall Study|Withdrawal by Subject|5|||
124461572|NCT01014689|447648103|FG001|Overall Study|Withdrawal by Subject|4|||
124461573|NCT01014689|447648102|FG000|Overall Study|Protocol Violation|1|||
124461574|NCT01014689|447648103|FG001|Overall Study|Protocol Violation|1|||
124461575|NCT01014689|447648102|FG000|Overall Study|Lost to Follow-up|3|||
124461576|NCT01014689|447648103|FG001|Overall Study|Lost to Follow-up|7|||
124461577|NCT01014689|447648102|FG000|Overall Study|Pregnancy|1|||
124461578|NCT01014689|447648103|FG001|Overall Study|Pregnancy|0|||
124461579|NCT05634577|447649279|FG000|Overall Study|Lost to Follow-up|1|||
124461580|NCT05634577|447649279|FG000|Overall Study|Withdrawal by Subject|1|||
124461581|NCT01902966|447649280|FG000|Overall Study|Death|1|||
124461582|NCT01902966|447649280|FG000|Overall Study|Physician Decision|1|||
124461583|NCT01902966|447649280|FG000|Overall Study|Withdrawal by Subject|1|||
124461584|NCT00783094|447649281|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
124461585|NCT00783094|447649282|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
124461586|NCT00783094|447649283|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
124461587|NCT00783094|447649281|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
124461588|NCT00783094|447649282|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
124461589|NCT00783094|447649283|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
124461590|NCT00783094|447649281|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
124461591|NCT00783094|447649282|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
124461592|NCT00783094|447649283|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
124461593|NCT00783094|447649281|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
124461594|NCT00783094|447649282|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
124461595|NCT00783094|447649283|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
124461596|NCT00783094|447649281|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
124461597|NCT00783094|447649282|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
124461598|NCT00783094|447649283|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
124461599|NCT00783094|447649281|FG000|Open-Label Extension Period|Adverse Event|12|||
124461600|NCT00783094|447649282|FG001|Open-Label Extension Period|Adverse Event|7|||
124461601|NCT00783094|447649283|FG002|Open-Label Extension Period|Adverse Event|16|||
124461602|NCT00783094|447649281|FG000|Open-Label Extension Period|Death|0|||
124461603|NCT00783094|447649282|FG001|Open-Label Extension Period|Death|0|||
124461604|NCT00783094|447649283|FG002|Open-Label Extension Period|Death|1|||
124461605|NCT00783094|447649281|FG000|Open-Label Extension Period|Protocol Violation|4|||
124461606|NCT00783094|447649282|FG001|Open-Label Extension Period|Protocol Violation|5|||
124461607|NCT00783094|447649283|FG002|Open-Label Extension Period|Protocol Violation|7|||
124461608|NCT00783094|447649281|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
124461609|NCT00783094|447649282|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
124461610|NCT00783094|447649283|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
124461611|NCT00783094|447649281|FG000|Open-Label Extension Period|Physician Decision|4|||
124461612|NCT00783094|447649282|FG001|Open-Label Extension Period|Physician Decision|2|||
124461613|NCT00783094|447649283|FG002|Open-Label Extension Period|Physician Decision|3|||
124461614|NCT00783094|447649281|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
124461615|NCT00783094|447649282|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
124461616|NCT00783094|447649283|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
124461617|NCT03287219|447649284|FG000|Overall Study|Protocol Violation|0|||
124461618|NCT03287219|447649285|FG001|Overall Study|Protocol Violation|2|||
124461619|NCT02429414|447649287|FG000|Overall Study|Physician Decision|0|||
124461620|NCT02429414|447649288|FG001|Overall Study|Physician Decision|1|||
124461621|NCT03245450|447649289|FG000|Overall Study|Radiological disease progression|3|||
124461622|NCT03245450|447649290|FG001|Overall Study|Radiological disease progression|3|||
124461623|NCT03245450|447649291|FG002|Overall Study|Radiological disease progression|2|||
124461624|NCT03245450|447649292|FG003|Overall Study|Radiological disease progression|2|||
124461625|NCT03245450|447649293|FG004|Overall Study|Radiological disease progression|7|||
124461626|NCT03245450|447649294|FG005|Overall Study|Radiological disease progression|6|||
124461627|NCT03245450|447649295|FG006|Overall Study|Radiological disease progression|6|||
124461628|NCT03245450|447649289|FG000|Overall Study|Clinical disease progression|0|||
124461629|NCT03245450|447649290|FG001|Overall Study|Clinical disease progression|0|||
124461630|NCT03245450|447649291|FG002|Overall Study|Clinical disease progression|1|||
124461631|NCT03245450|447649292|FG003|Overall Study|Clinical disease progression|0|||
124461632|NCT03245450|447649293|FG004|Overall Study|Clinical disease progression|0|||
124461633|NCT03245450|447649294|FG005|Overall Study|Clinical disease progression|2|||
124461634|NCT03245450|447649295|FG006|Overall Study|Clinical disease progression|0|||
124461635|NCT03245450|447649289|FG000|Overall Study|Other|0|||
124461636|NCT03245450|447649290|FG001|Overall Study|Other|0|||
124461637|NCT03245450|447649291|FG002|Overall Study|Other|0|||
124461638|NCT03245450|447649292|FG003|Overall Study|Other|1|||
124461639|NCT03245450|447649293|FG004|Overall Study|Other|1|||
124461640|NCT03245450|447649294|FG005|Overall Study|Other|1|||
124461641|NCT03245450|447649295|FG006|Overall Study|Other|1|||
124461642|NCT03245450|447649289|FG000|Overall Study|Withdrawal by Subject|0|||
124461643|NCT03245450|447649290|FG001|Overall Study|Withdrawal by Subject|1|||
124461644|NCT03245450|447649291|FG002|Overall Study|Withdrawal by Subject|0|||
124461645|NCT03245450|447649292|FG003|Overall Study|Withdrawal by Subject|0|||
124461646|NCT03245450|447649293|FG004|Overall Study|Withdrawal by Subject|0|||
124461647|NCT03245450|447649294|FG005|Overall Study|Withdrawal by Subject|0|||
124461648|NCT03245450|447649295|FG006|Overall Study|Withdrawal by Subject|0|||
124461649|NCT03245450|447649289|FG000|Overall Study|Adverse Event|0|||
124461650|NCT03245450|447649290|FG001|Overall Study|Adverse Event|0|||
124461651|NCT03245450|447649291|FG002|Overall Study|Adverse Event|0|||
124461652|NCT03245450|447649292|FG003|Overall Study|Adverse Event|0|||
124461653|NCT03245450|447649293|FG004|Overall Study|Adverse Event|1|||
124461654|NCT03245450|447649294|FG005|Overall Study|Adverse Event|0|||
124461655|NCT03245450|447649295|FG006|Overall Study|Adverse Event|2|||
124461656|NCT01784861|447649296|FG000|Overall Study|Adverse Event|0|||
124461657|NCT01784861|447649297|FG001|Overall Study|Adverse Event|0|||
124461658|NCT01784861|447649298|FG002|Overall Study|Adverse Event|1|||
124461659|NCT01784861|447649299|FG003|Overall Study|Adverse Event|2|||
124461660|NCT01784861|447649300|FG004|Overall Study|Adverse Event|1|||
124461661|NCT01784861|447649301|FG005|Overall Study|Adverse Event|0|||
124461662|NCT01784861|447649296|FG000|Overall Study|Withdrawal by Subject|0|||
124461663|NCT01784861|447649297|FG001|Overall Study|Withdrawal by Subject|0|||
124461664|NCT01784861|447649298|FG002|Overall Study|Withdrawal by Subject|0|||
124461665|NCT01784861|447649299|FG003|Overall Study|Withdrawal by Subject|1|||
124461666|NCT01784861|447649300|FG004|Overall Study|Withdrawal by Subject|0|||
124461667|NCT01784861|447649301|FG005|Overall Study|Withdrawal by Subject|0|||
124461668|NCT01784861|447649296|FG000|Overall Study|Physician Decision|0|||
124461669|NCT01784861|447649297|FG001|Overall Study|Physician Decision|0|||
124461670|NCT01784861|447649298|FG002|Overall Study|Physician Decision|0|||
124461671|NCT01784861|447649299|FG003|Overall Study|Physician Decision|2|||
124461672|NCT01784861|447649300|FG004|Overall Study|Physician Decision|0|||
124461673|NCT01784861|447649301|FG005|Overall Study|Physician Decision|1|||
124461674|NCT05098041|447649302|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
124956942|NCT00296504|449467921|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
124956943|NCT00296504|449467922|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
124956944|NCT00296504|449467923|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
124956945|NCT00296504|449467915|FG000|Interim Analysis|Participant Moved|1|||
124956946|NCT00296504|449467916|FG001|Interim Analysis|Participant Moved|0|||
124956947|NCT00296504|449467917|FG002|Interim Analysis|Participant Moved|1|||
124956948|NCT00296504|449467918|FG003|Interim Analysis|Participant Moved|0|||
124956949|NCT00296504|449467919|FG004|Interim Analysis|Participant Moved|0|||
124956950|NCT00296504|449467920|FG005|Interim Analysis|Participant Moved|1|||
124956951|NCT00296504|449467921|FG006|Interim Analysis|Participant Moved|1|||
124956952|NCT00296504|449467922|FG007|Interim Analysis|Participant Moved|0|||
124956953|NCT00296504|449467923|FG008|Interim Analysis|Participant Moved|0|||
124956954|NCT00296504|449467915|FG000|Interim Analysis|Participant Was Incarcerated|2|||
124956955|NCT00296504|449467916|FG001|Interim Analysis|Participant Was Incarcerated|0|||
124956956|NCT00296504|449467917|FG002|Interim Analysis|Participant Was Incarcerated|1|||
124956957|NCT00296504|449467918|FG003|Interim Analysis|Participant Was Incarcerated|0|||
124956958|NCT00296504|449467919|FG004|Interim Analysis|Participant Was Incarcerated|0|||
124956959|NCT00296504|449467920|FG005|Interim Analysis|Participant Was Incarcerated|0|||
124956960|NCT00296504|449467921|FG006|Interim Analysis|Participant Was Incarcerated|0|||
124956961|NCT00296504|449467922|FG007|Interim Analysis|Participant Was Incarcerated|0|||
124956962|NCT00296504|449467923|FG008|Interim Analysis|Participant Was Incarcerated|0|||
124956963|NCT00296504|449467915|FG000|Interim Analysis|Resistance to FPV|0|||
124956964|NCT00296504|449467916|FG001|Interim Analysis|Resistance to FPV|0|||
124956965|NCT00296504|449467917|FG002|Interim Analysis|Resistance to FPV|1|||
124461675|NCT03948178|447649303|FG000|Overall Study|Protocol Violation|1|||
124461676|NCT03948178|447649303|FG000|Overall Study|Lost to Follow-up|2|||
124461677|NCT03948178|447649303|FG000|Overall Study|Withdrawal by Subject|2|||
124461678|NCT03948178|447649303|FG000|Overall Study|Reason not known|2|||
124461679|NCT03948178|447649303|FG000|Overall Study|Personal reason|14|||
124461680|NCT03948178|447649303|FG000|Overall Study|Disease progression|30|||
124461681|NCT03948178|447649303|FG000|Overall Study|Adverse Event|12|||
124461682|NCT03948178|447649303|FG000|Overall Study|Sponsor terminated study|164|||
124461683|NCT00382993|447649304|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
124461684|NCT00382993|447649305|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
124461685|NCT00382993|447649304|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
124461686|NCT00382993|447649305|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
124461687|NCT00382993|447649304|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
124461688|NCT00382993|447649305|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
124461689|NCT00382993|447649304|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
124461690|NCT00382993|447649305|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
124461691|NCT00382993|447649304|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
124461692|NCT00382993|447649305|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
124461693|NCT00382993|447649304|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
124461694|NCT00382993|447649305|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
124461695|NCT00382993|447649304|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
124461696|NCT00382993|447649305|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
124461697|NCT00382993|447649304|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
124461698|NCT00382993|447649305|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
124461699|NCT00382993|447649304|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
124461700|NCT00382993|447649305|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
124461701|NCT00382993|447649304|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
124461702|NCT00382993|447649305|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
124461703|NCT01046877|447649306|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
124766515|NCT00089297|448773703|FG000|Overall Study|Non-compliance|1|||
124766516|NCT01910298|448773708|FG000|Overall Study|Adverse Event|1|||
124766517|NCT01910298|448773709|FG001|Overall Study|Adverse Event|0|||
124956966|NCT00296504|449467918|FG003|Interim Analysis|Resistance to FPV|0|||
124956967|NCT00296504|449467919|FG004|Interim Analysis|Resistance to FPV|0|||
124956968|NCT00296504|449467920|FG005|Interim Analysis|Resistance to FPV|0|||
124956969|NCT00296504|449467921|FG006|Interim Analysis|Resistance to FPV|0|||
124956970|NCT00296504|449467922|FG007|Interim Analysis|Resistance to FPV|0|||
124956971|NCT00296504|449467923|FG008|Interim Analysis|Resistance to FPV|0|||
124956972|NCT00296504|449467915|FG000|Interim Analysis|Physician Decision|0|||
124461704|NCT01046877|447649306|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
124461705|NCT00513500|447649309|FG000|Overall Study|Lost to Follow-up|35|||
124461706|NCT00513500|447649310|FG001|Overall Study|Lost to Follow-up|39|||
124461707|NCT00513500|447649309|FG000|Overall Study|Death|2|||
124461708|NCT00513500|447649310|FG001|Overall Study|Death|1|||
124461709|NCT00513500|447649309|FG000|Overall Study|Hospitalized|4|||
124461710|NCT00513500|447649310|FG001|Overall Study|Hospitalized|14|||
124461711|NCT00749996|447649313|FG000|Overall Study|Lost to Follow-up|7|||
124461712|NCT00749996|447649314|FG001|Overall Study|Lost to Follow-up|4|||
124461713|NCT00749996|447649313|FG000|Overall Study|Withdrawal by Subject|5|||
124461714|NCT00749996|447649314|FG001|Overall Study|Withdrawal by Subject|4|||
124461715|NCT00749996|447649313|FG000|Overall Study|Protocol Violation|2|||
124461716|NCT00749996|447649314|FG001|Overall Study|Protocol Violation|3|||
124461717|NCT00749996|447649313|FG000|Overall Study|Physician Decision|2|||
124461718|NCT00749996|447649314|FG001|Overall Study|Physician Decision|0|||
124461719|NCT00749996|447649313|FG000|Overall Study|Pregnancy|0|||
124461720|NCT00749996|447649314|FG001|Overall Study|Pregnancy|2|||
124461721|NCT00749996|447649313|FG000|Overall Study|Adverse Event|1|||
124461722|NCT00749996|447649314|FG001|Overall Study|Adverse Event|0|||
124461723|NCT00749996|447649313|FG000|Overall Study|Death|1|||
124461724|NCT00749996|447649314|FG001|Overall Study|Death|0|||
124461725|NCT00109707|447649315|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
124461726|NCT00109707|447649316|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
124461727|NCT00109707|447649317|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
124461728|NCT00109707|447649315|FG000|Overall Study|Abnormal laboratory values|1|||
124461729|NCT00109707|447649316|FG001|Overall Study|Abnormal laboratory values|0|||
124461730|NCT00109707|447649317|FG002|Overall Study|Abnormal laboratory values|0|||
124461731|NCT00109707|447649315|FG000|Overall Study|Administrative problems|2|||
124461732|NCT00109707|447649316|FG001|Overall Study|Administrative problems|0|||
124461733|NCT00109707|447649317|FG002|Overall Study|Administrative problems|1|||
124461734|NCT00109707|447649315|FG000|Overall Study|Adverse Event|10|||
124461735|NCT00109707|447649316|FG001|Overall Study|Adverse Event|2|||
124461736|NCT00109707|447649317|FG002|Overall Study|Adverse Event|3|||
124461737|NCT00109707|447649315|FG000|Overall Study|Death|4|||
124461738|NCT00109707|447649316|FG001|Overall Study|Death|0|||
124461739|NCT00109707|447649317|FG002|Overall Study|Death|0|||
124461740|NCT00109707|447649315|FG000|Overall Study|Disease progression|12|||
124461741|NCT00109707|447649316|FG001|Overall Study|Disease progression|4|||
124461742|NCT00109707|447649317|FG002|Overall Study|Disease progression|3|||
124461743|NCT00109707|447649315|FG000|Overall Study|Lost to Follow-up|3|||
124461744|NCT00109707|447649316|FG001|Overall Study|Lost to Follow-up|0|||
124461745|NCT00109707|447649317|FG002|Overall Study|Lost to Follow-up|0|||
124461746|NCT00109707|447649315|FG000|Overall Study|Protocol Violation|1|||
124461747|NCT00109707|447649316|FG001|Overall Study|Protocol Violation|0|||
124461748|NCT00109707|447649317|FG002|Overall Study|Protocol Violation|0|||
124461749|NCT00109707|447649315|FG000|Overall Study|Patient withdrew consent|6|||
124461750|NCT00109707|447649316|FG001|Overall Study|Patient withdrew consent|1|||
124956973|NCT00296504|449467916|FG001|Interim Analysis|Physician Decision|0|||
124956974|NCT00296504|449467917|FG002|Interim Analysis|Physician Decision|1|||
124956975|NCT00296504|449467918|FG003|Interim Analysis|Physician Decision|0|||
124956976|NCT00296504|449467919|FG004|Interim Analysis|Physician Decision|0|||
124956977|NCT00296504|449467920|FG005|Interim Analysis|Physician Decision|0|||
124956978|NCT00296504|449467921|FG006|Interim Analysis|Physician Decision|0|||
124956979|NCT00296504|449467922|FG007|Interim Analysis|Physician Decision|0|||
124956980|NCT00296504|449467923|FG008|Interim Analysis|Physician Decision|0|||
124956981|NCT00296504|449467915|FG000|Interim Analysis|Principle Investigator Discretion|2|||
124956982|NCT00296504|449467916|FG001|Interim Analysis|Principle Investigator Discretion|0|||
124956983|NCT00296504|449467917|FG002|Interim Analysis|Principle Investigator Discretion|1|||
124956984|NCT00296504|449467918|FG003|Interim Analysis|Principle Investigator Discretion|1|||
124956985|NCT00296504|449467919|FG004|Interim Analysis|Principle Investigator Discretion|0|||
124956986|NCT00296504|449467920|FG005|Interim Analysis|Principle Investigator Discretion|0|||
124956987|NCT00296504|449467921|FG006|Interim Analysis|Principle Investigator Discretion|0|||
124956988|NCT00296504|449467922|FG007|Interim Analysis|Principle Investigator Discretion|0|||
124956989|NCT00296504|449467923|FG008|Interim Analysis|Principle Investigator Discretion|0|||
124956990|NCT00296504|449467915|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
124956991|NCT00296504|449467916|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
124956992|NCT00296504|449467917|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
124956993|NCT00296504|449467918|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
124956994|NCT00296504|449467919|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
124956995|NCT00296504|449467920|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
124956996|NCT00296504|449467921|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
124956997|NCT00296504|449467922|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
124956998|NCT00296504|449467923|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
124956999|NCT00296504|449467915|FG000|Interim Analysis|Non-adherence|2|||
124461751|NCT00109707|447649317|FG002|Overall Study|Patient withdrew consent|0|||
124461752|NCT00606086|447649320|FG000|Overall Study|Adverse Event|1|||
124461753|NCT00606086|447649321|FG001|Overall Study|Adverse Event|1|||
124461754|NCT00606086|447649320|FG000|Overall Study|Lost to Follow-up|4|||
124461755|NCT00606086|447649321|FG001|Overall Study|Lost to Follow-up|8|||
124461756|NCT00606086|447649320|FG000|Overall Study|Protocol Violation|1|||
124461757|NCT00606086|447649321|FG001|Overall Study|Protocol Violation|0|||
124461758|NCT00606086|447649320|FG000|Overall Study|Withdrawal by Subject|5|||
124461759|NCT00606086|447649321|FG001|Overall Study|Withdrawal by Subject|3|||
124461760|NCT00606086|447649320|FG000|Overall Study|Non-compliance|0|||
124461761|NCT00606086|447649321|FG001|Overall Study|Non-compliance|1|||
124461762|NCT00606086|447649320|FG000|Overall Study|Randomized, not treated|1|||
124461763|NCT00606086|447649321|FG001|Overall Study|Randomized, not treated|2|||
124461764|NCT01627860|447649326|FG000|Overall Study|Adverse Event|9|||
124461765|NCT01627860|447649327|FG001|Overall Study|Adverse Event|4|||
124461766|NCT01627860|447649326|FG000|Overall Study|Withdrawal by Subject|2|||
124461767|NCT01627860|447649327|FG001|Overall Study|Withdrawal by Subject|1|||
124461768|NCT01627860|447649326|FG000|Overall Study|Seizure frequency doubled|0|||
124461769|NCT01627860|447649327|FG001|Overall Study|Seizure frequency doubled|1|||
124461770|NCT01627860|447649326|FG000|Overall Study|Protocol Violation|1|||
124461771|NCT01627860|447649327|FG001|Overall Study|Protocol Violation|0|||
124461772|NCT03215771|447649328|FG000|Overall Study|Withdrawal by Subject|2|||
124461773|NCT03215771|447649328|FG000|Overall Study|Physician Decision|1|||
124461774|NCT02039375|447649329|FG000|Overall Study|Lost to Follow-up|2|||
124461775|NCT04770389|447649330|FG000|Overall Study|Adverse Event|1|||
124461776|NCT04770389|447649331|FG001|Overall Study|Adverse Event|2|||
124461777|NCT04770389|447649332|FG002|Overall Study|Adverse Event|0|||
124461778|NCT04770389|447649333|FG003|Overall Study|Adverse Event|1|||
124461779|NCT04770389|447649330|FG000|Overall Study|Withdrawal by Subject|0|||
124461780|NCT04770389|447649331|FG001|Overall Study|Withdrawal by Subject|2|||
124461781|NCT04770389|447649332|FG002|Overall Study|Withdrawal by Subject|1|||
124461782|NCT04770389|447649333|FG003|Overall Study|Withdrawal by Subject|0|||
124461783|NCT04770389|447649330|FG000|Overall Study|Failed attempt to draw blood|1|||
124461784|NCT04770389|447649331|FG001|Overall Study|Failed attempt to draw blood|0|||
124461785|NCT04770389|447649332|FG002|Overall Study|Failed attempt to draw blood|0|||
124461786|NCT04770389|447649333|FG003|Overall Study|Failed attempt to draw blood|0|||
124461787|NCT04770389|447649330|FG000|Overall Study|Left the country|0|||
124461788|NCT04770389|447649331|FG001|Overall Study|Left the country|0|||
124461789|NCT04770389|447649332|FG002|Overall Study|Left the country|1|||
124461790|NCT04770389|447649333|FG003|Overall Study|Left the country|2|||
124461791|NCT04770389|447649330|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
124461792|NCT04770389|447649331|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
124461793|NCT04770389|447649332|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
124461794|NCT04770389|447649333|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
124461795|NCT04770389|447649330|FG000|Overall Study|Lost to Follow-up|0|||
124461796|NCT04770389|447649331|FG001|Overall Study|Lost to Follow-up|0|||
124461797|NCT04770389|447649332|FG002|Overall Study|Lost to Follow-up|0|||
124461798|NCT04770389|447649333|FG003|Overall Study|Lost to Follow-up|1|||
124461799|NCT04770389|447649330|FG000|Overall Study|Moved away from study site|0|||
124461800|NCT04770389|447649331|FG001|Overall Study|Moved away from study site|1|||
124461801|NCT04770389|447649332|FG002|Overall Study|Moved away from study site|0|||
124461802|NCT04770389|447649333|FG003|Overall Study|Moved away from study site|0|||
124461803|NCT00689871|447649338|FG000|Overall Study|Lost to Follow-up|123|||
124461804|NCT00689871|447649339|FG001|Overall Study|Lost to Follow-up|13|||
124461805|NCT00689871|447649340|FG002|Overall Study|Lost to Follow-up|37|||
124461806|NCT00689871|447649341|FG003|Overall Study|Lost to Follow-up|1|||
124461807|NCT00689871|447649338|FG000|Overall Study|Explanted of All Study Devices|36|||
124461808|NCT00689871|447649339|FG001|Overall Study|Explanted of All Study Devices|25|||
124461809|NCT00689871|447649340|FG002|Overall Study|Explanted of All Study Devices|29|||
124461810|NCT00689871|447649341|FG003|Overall Study|Explanted of All Study Devices|3|||
124461811|NCT00689871|447649338|FG000|Overall Study|Withdrawal by Subject|13|||
124461812|NCT00689871|447649339|FG001|Overall Study|Withdrawal by Subject|3|||
124461813|NCT00689871|447649340|FG002|Overall Study|Withdrawal by Subject|4|||
124461814|NCT00689871|447649341|FG003|Overall Study|Withdrawal by Subject|1|||
124461815|NCT00689871|447649338|FG000|Overall Study|Death|1|||
124461816|NCT00689871|447649339|FG001|Overall Study|Death|10|||
124461817|NCT00689871|447649340|FG002|Overall Study|Death|2|||
124461818|NCT00689871|447649341|FG003|Overall Study|Death|2|||
124461819|NCT00689871|447649338|FG000|Overall Study|Physician Decision|2|||
124461820|NCT00689871|447649339|FG001|Overall Study|Physician Decision|1|||
124461821|NCT00689871|447649340|FG002|Overall Study|Physician Decision|1|||
124461822|NCT00689871|447649341|FG003|Overall Study|Physician Decision|0|||
124461823|NCT00708123|447649348|FG000|Period 1|Protocol Violation|0|||
124461824|NCT00708123|447649349|FG001|Period 1|Protocol Violation|1|||
124461825|NCT00708123|447649350|FG002|Period 1|Protocol Violation|0|||
124461826|NCT00708123|447649351|FG003|Period 1|Protocol Violation|1|||
124461827|NCT00708123|447649352|FG004|Period 1|Protocol Violation|0|||
124461828|NCT00708123|447649348|FG000|Period 1|Adverse Event|0|||
124461829|NCT00708123|447649349|FG001|Period 1|Adverse Event|0|||
124461830|NCT00708123|447649350|FG002|Period 1|Adverse Event|1|||
124461831|NCT00708123|447649351|FG003|Period 1|Adverse Event|0|||
124461832|NCT00708123|447649352|FG004|Period 1|Adverse Event|0|||
124461833|NCT00708123|447649348|FG000|Period 2|Protocol Violation|0|||
124461834|NCT00708123|447649349|FG001|Period 2|Protocol Violation|0|||
124461835|NCT00708123|447649350|FG002|Period 2|Protocol Violation|0|||
124461836|NCT00708123|447649351|FG003|Period 2|Protocol Violation|1|||
124461837|NCT00708123|447649352|FG004|Period 2|Protocol Violation|0|||
124461838|NCT00708123|447649348|FG000|Period 2|Other Reason|1|||
124461839|NCT00708123|447649349|FG001|Period 2|Other Reason|0|||
124461840|NCT00708123|447649350|FG002|Period 2|Other Reason|0|||
124461841|NCT00708123|447649351|FG003|Period 2|Other Reason|0|||
124461842|NCT00708123|447649352|FG004|Period 2|Other Reason|0|||
124461843|NCT00708123|447649348|FG000|Period 3|Lost to Follow-up|0|||
124461844|NCT00708123|447649349|FG001|Period 3|Lost to Follow-up|0|||
124461845|NCT00708123|447649350|FG002|Period 3|Lost to Follow-up|1|||
124461846|NCT00708123|447649351|FG003|Period 3|Lost to Follow-up|1|||
124461847|NCT00708123|447649352|FG004|Period 3|Lost to Follow-up|0|||
124461848|NCT00708123|447649348|FG000|Period 4|Protocol Violation|0|||
124461849|NCT00708123|447649349|FG001|Period 4|Protocol Violation|1|||
124461850|NCT00708123|447649350|FG002|Period 4|Protocol Violation|0|||
124461851|NCT00708123|447649351|FG003|Period 4|Protocol Violation|0|||
124461852|NCT00708123|447649352|FG004|Period 4|Protocol Violation|0|||
124461853|NCT00814892|447649355|FG000|Overall Study|Disease Progression|1|||
124461854|NCT00814892|447649355|FG000|Overall Study|Study Termination|1|||
124461855|NCT04486950|447649356|FG000|Overall Study|Lost to Follow-up|0|||
124461856|NCT04486950|447649357|FG001|Overall Study|Lost to Follow-up|0|||
124461857|NCT04486950|447649358|FG002|Overall Study|Lost to Follow-up|0|||
124461858|NCT04486950|447649359|FG003|Overall Study|Lost to Follow-up|0|||
124461859|NCT04486950|447649360|FG004|Overall Study|Lost to Follow-up|0|||
124461860|NCT04486950|447649361|FG005|Overall Study|Lost to Follow-up|1|||
124461861|NCT04486950|447649362|FG006|Overall Study|Lost to Follow-up|0|||
124461862|NCT00550680|447649363|FG000|Overall Study|Administrative Reasons|1|||
124461863|NCT00550680|447649363|FG000|Overall Study|Adverse Event|5|||
124461864|NCT00550680|447649363|FG000|Overall Study|Death|3|||
124461865|NCT00550680|447649363|FG000|Overall Study|Early Improvement|1|||
124461866|NCT00550680|447649363|FG000|Overall Study|Lost to Follow-up|3|||
124461867|NCT00550680|447649363|FG000|Overall Study|Lack of Efficacy|1|||
124461868|NCT00550680|447649363|FG000|Overall Study|Other|10|||
124461869|NCT00550680|447649363|FG000|Overall Study|Protocol Violation|7|||
124461870|NCT00550680|447649363|FG000|Overall Study|Refused Treatment|19|||
124461871|NCT00550680|447649363|FG000|Overall Study|Screen Failure|6|||
124461872|NCT00562354|447649364|FG000|Overall Study|Physician Decision|0|||
124461873|NCT00562354|447649365|FG001|Overall Study|Physician Decision|1|||
124461874|NCT00562354|447649364|FG000|Overall Study|Lost to Follow-up|0|||
124461875|NCT00562354|447649365|FG001|Overall Study|Lost to Follow-up|1|||
124461876|NCT03693625|447649367|FG000|Overall Study|Adverse Event|2|||
124461877|NCT03693625|447649368|FG001|Overall Study|Adverse Event|0|||
124461878|NCT03693625|447649367|FG000|Overall Study|Study Terminated By Sponsor|20|||
124461879|NCT03693625|447649368|FG001|Overall Study|Study Terminated By Sponsor|7|||
124461880|NCT03693625|447649367|FG000|Overall Study|Withdrawal by Subject|1|||
124461881|NCT03693625|447649368|FG001|Overall Study|Withdrawal by Subject|1|||
124461882|NCT01187953|447649370|FG000|Overall Study|Death|11|||
124957000|NCT00296504|449467916|FG001|Interim Analysis|Non-adherence|0|||
124461883|NCT01187953|447649371|FG001|Overall Study|Death|13|||
124461884|NCT01187953|447649370|FG000|Overall Study|Adverse Event|1|||
124461885|NCT01187953|447649371|FG001|Overall Study|Adverse Event|2|||
124461886|NCT01187953|447649370|FG000|Overall Study|Lost to Follow-up|0|||
124461887|NCT01187953|447649371|FG001|Overall Study|Lost to Follow-up|3|||
124461888|NCT01187953|447649370|FG000|Overall Study|Withdrawal by Subject|3|||
124461889|NCT01187953|447649371|FG001|Overall Study|Withdrawal by Subject|3|||
124461890|NCT01464307|447649372|FG000|Main Period|Death|0|||
124461891|NCT01464307|447649373|FG001|Main Period|Death|1|||
124461892|NCT01464307|447649372|FG000|Main Period|Adverse Event|6|||
124461893|NCT01464307|447649373|FG001|Main Period|Adverse Event|1|||
124461894|NCT01464307|447649372|FG000|Main Period|Lack of Efficacy|2|||
124461895|NCT01464307|447649373|FG001|Main Period|Lack of Efficacy|0|||
124461896|NCT01464307|447649372|FG000|Main Period|Withdrawal by Subject|5|||
124461897|NCT01464307|447649373|FG001|Main Period|Withdrawal by Subject|2|||
124461898|NCT01464307|447649372|FG000|Main Period|Predefined discontinuation criteria|2|||
124461899|NCT01464307|447649373|FG001|Main Period|Predefined discontinuation criteria|1|||
124707906|NCT02746809|448555898|FG000|60-Month|Lost to Follow-up|2|||
124707907|NCT00894387|448555901|FG000|Overall Study|Adverse Event|44|||
124707908|NCT00894387|448555902|FG001|Overall Study|Adverse Event|45|||
124707909|NCT00894387|448555901|FG000|Overall Study|Abnormal Laboratory values|2|||
124707910|NCT00894387|448555902|FG001|Overall Study|Abnormal Laboratory values|2|||
124707911|NCT00894387|448555901|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124707912|NCT00894387|448555902|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124707913|NCT00894387|448555901|FG000|Overall Study|Lost to Follow-up|3|||
124461900|NCT01464307|447649372|FG000|Open-Label Extension Period|Adverse Event|15|||
124461901|NCT01464307|447649373|FG001|Open-Label Extension Period|Adverse Event|0|||
124461902|NCT01464307|447649372|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
124461903|NCT01464307|447649373|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
124461904|NCT01464307|447649372|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
124461905|NCT01464307|447649373|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
124461906|NCT01464307|447649372|FG000|Open-Label Extension Period|Death|1|||
124461907|NCT01464307|447649373|FG001|Open-Label Extension Period|Death|0|||
124461908|NCT01464307|447649372|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
124461909|NCT01464307|447649373|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
124461910|NCT01464307|447649372|FG000|Open-Label Extension Period|Non-compliance|9|||
124461911|NCT01464307|447649373|FG001|Open-Label Extension Period|Non-compliance|0|||
124461912|NCT01464307|447649372|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
124461913|NCT01464307|447649373|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
124461914|NCT00761514|447649376|FG000|Overall Study|Adverse Event|1|||
124461915|NCT00761514|447649376|FG000|Overall Study|Withdrawal by Subject|2|||
124461916|NCT00761514|447649376|FG000|Overall Study|Lost to Follow-up|1|||
124461917|NCT00761514|447649376|FG000|Overall Study|Health insurance didn't cover study drug|1|||
124461918|NCT00761514|447649376|FG000|Overall Study|Problem complying with study visit|1|||
124461919|NCT00761514|447649376|FG000|Overall Study|Unable to pay for medications|1|||
124461920|NCT02457637|447649377|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
124461921|NCT01836783|447649380|FG000|Overall Study|Withdrawal by Subject|0|||
124461922|NCT01836783|447649381|FG001|Overall Study|Withdrawal by Subject|2|||
124461923|NCT01273883|447649382|FG000|First Intervention|Adverse Event|2|||
124461924|NCT01273883|447649383|FG001|First Intervention|Adverse Event|1|||
124461925|NCT01273883|447649382|FG000|Second Intervention|Lost to Follow-up|1|||
124461926|NCT01273883|447649383|FG001|Second Intervention|Lost to Follow-up|1|||
124461927|NCT01273883|447649382|FG000|Second Intervention|Lack of Efficacy|1|||
124461928|NCT01273883|447649383|FG001|Second Intervention|Lack of Efficacy|0|||
124461929|NCT00159861|447649384|FG000|Core Study - 16 Weeks|Death|3|||
124461930|NCT00159861|447649385|FG001|Core Study - 16 Weeks|Death|0|||
124461931|NCT00159861|447649384|FG000|Core Study - 16 Weeks|Adverse Event|12|||
124461932|NCT00159861|447649385|FG001|Core Study - 16 Weeks|Adverse Event|6|||
124461933|NCT00159861|447649384|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
124461934|NCT00159861|447649385|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
124461935|NCT00159861|447649384|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
124461936|NCT00159861|447649385|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
124461937|NCT00159861|447649384|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
124461938|NCT00159861|447649385|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
124461939|NCT00159861|447649384|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
124461940|NCT00159861|447649385|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
124461941|NCT00159861|447649384|FG000|Extension Study - up to 3 Years|Death|24|||
124461942|NCT00159861|447649385|FG001|Extension Study - up to 3 Years|Death|28|||
124461943|NCT00159861|447649384|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
124461944|NCT00159861|447649385|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
124461945|NCT00159861|447649384|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
124461946|NCT00159861|447649385|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
124461947|NCT00159861|447649384|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
124461948|NCT00159861|447649385|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
124461949|NCT00159861|447649384|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
124461950|NCT00159861|447649385|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
124461951|NCT03349099|447649386|FG000|Overall Study|Physician Decision|3|||
124461952|NCT03349099|447649387|FG001|Overall Study|Physician Decision|4|||
124461953|NCT03349099|447649386|FG000|Overall Study|Stone migrated from the kidney|1|||
124461954|NCT03349099|447649387|FG001|Overall Study|Stone migrated from the kidney|0|||
124461955|NCT04194528|447649391|FG000|Overall Study|Adverse Event|1|||
124461956|NCT03829657|447649392|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
124766518|NCT01910298|448773708|FG000|Overall Study|Withdrawal by Subject|2|||
124766519|NCT01910298|448773709|FG001|Overall Study|Withdrawal by Subject|7|||
124766520|NCT01910298|448773708|FG000|Overall Study|Protocol Deviation|0|||
124461957|NCT03829657|447649393|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
124461958|NCT03829657|447649394|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
124461959|NCT03829657|447649395|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
124461960|NCT03829657|447649396|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
124461961|NCT03829657|447649392|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
124461962|NCT03829657|447649393|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
124461963|NCT03829657|447649394|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
124461964|NCT03829657|447649395|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
124461965|NCT03829657|447649396|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
124461966|NCT03829657|447649392|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
124461967|NCT03829657|447649393|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
124461968|NCT03829657|447649394|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
124461969|NCT03829657|447649395|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
124461970|NCT03829657|447649396|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
124461971|NCT03829657|447649392|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
124461972|NCT03829657|447649393|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
124461973|NCT03829657|447649394|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
124461974|NCT03829657|447649395|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
124461975|NCT03829657|447649396|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
124461976|NCT03829657|447649392|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
124461977|NCT03829657|447649393|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
124461978|NCT03829657|447649394|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
124461979|NCT03829657|447649395|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
124461980|NCT03829657|447649396|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
124461981|NCT03829657|447649392|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
124461982|NCT03829657|447649393|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
124461983|NCT03829657|447649394|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
124461984|NCT03829657|447649395|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
124461985|NCT03829657|447649396|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
124461986|NCT03829657|447649392|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
124461987|NCT03829657|447649393|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
124461988|NCT03829657|447649394|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
124461989|NCT03829657|447649395|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
124461990|NCT03829657|447649396|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
124461991|NCT03829657|447649392|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
124461992|NCT03829657|447649393|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
124461993|NCT03829657|447649394|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
124461994|NCT03829657|447649395|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
124461995|NCT03829657|447649396|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
124461996|NCT03829657|447649392|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
124461997|NCT03829657|447649393|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
124461998|NCT03829657|447649394|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
124461999|NCT03829657|447649395|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
124462000|NCT03829657|447649396|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
124462001|NCT03829657|447649392|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
124462002|NCT03829657|447649393|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
124707914|NCT00894387|448555902|FG001|Overall Study|Lost to Follow-up|5|||
124707915|NCT00894387|448555901|FG000|Overall Study|Administrative problems|2|||
124462003|NCT03829657|447649394|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
124462004|NCT03829657|447649395|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
124462005|NCT03829657|447649396|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
124462006|NCT00333359|447649400|FG000|Overall Study|Adverse Event|29|||
124462007|NCT00333359|447649401|FG001|Overall Study|Adverse Event|35|||
124462008|NCT00333359|447649400|FG000|Overall Study|Withdrawal by Subject|19|||
124462009|NCT00333359|447649401|FG001|Overall Study|Withdrawal by Subject|37|||
124462010|NCT00333359|447649400|FG000|Overall Study|Physician Decision|2|||
124462011|NCT00333359|447649401|FG001|Overall Study|Physician Decision|2|||
124462012|NCT00333359|447649400|FG000|Overall Study|Protocol Non-compliance|2|||
124462013|NCT00333359|447649401|FG001|Overall Study|Protocol Non-compliance|8|||
124462014|NCT00333359|447649400|FG000|Overall Study|Lost to Follow-up|15|||
124462015|NCT00333359|447649401|FG001|Overall Study|Lost to Follow-up|25|||
124462016|NCT00333359|447649400|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
124462017|NCT00333359|447649401|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
124462018|NCT00333359|447649400|FG000|Overall Study|Treatment Failure|3|||
124462019|NCT00333359|447649401|FG001|Overall Study|Treatment Failure|8|||
124462020|NCT00333359|447649400|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
124462021|NCT00333359|447649401|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
124462022|NCT02867995|447649403|FG000|Overall Study|Withdrawal by Subject|0|||
124462023|NCT02867995|447649404|FG001|Overall Study|Withdrawal by Subject|1|||
124462024|NCT02867995|447649403|FG000|Overall Study|Lost to Follow-up|0|||
124462025|NCT02867995|447649404|FG001|Overall Study|Lost to Follow-up|2|||
124462026|NCT01394939|447650795|FG000|Overall Study|Adverse Event|1|||
124462027|NCT01394939|447650796|FG001|Overall Study|Adverse Event|3|||
124707916|NCT00894387|448555902|FG001|Overall Study|Administrative problems|2|||
124462028|NCT01394939|447650797|FG002|Overall Study|Adverse Event|0|||
124462029|NCT01394939|447650798|FG003|Overall Study|Adverse Event|2|||
124707917|NCT00894387|448555901|FG000|Overall Study|Death|77|||
124707918|NCT00894387|448555902|FG001|Overall Study|Death|76|||
124462030|NCT01394939|447650795|FG000|Overall Study|Death|0|||
124462031|NCT01394939|447650796|FG001|Overall Study|Death|2|||
124462032|NCT01394939|447650797|FG002|Overall Study|Death|0|||
124462033|NCT01394939|447650798|FG003|Overall Study|Death|0|||
124462034|NCT01394939|447650795|FG000|Overall Study|Physician Decision|0|||
124462035|NCT01394939|447650796|FG001|Overall Study|Physician Decision|1|||
124462036|NCT01394939|447650797|FG002|Overall Study|Physician Decision|0|||
124462037|NCT01394939|447650798|FG003|Overall Study|Physician Decision|0|||
124462038|NCT01394939|447650795|FG000|Overall Study|Withdrawal by Subject|0|||
124462039|NCT01394939|447650796|FG001|Overall Study|Withdrawal by Subject|2|||
124462040|NCT01394939|447650797|FG002|Overall Study|Withdrawal by Subject|0|||
124462041|NCT01394939|447650798|FG003|Overall Study|Withdrawal by Subject|2|||
124462042|NCT01394939|447650795|FG000|Overall Study|Others|0|||
124462043|NCT01394939|447650796|FG001|Overall Study|Others|2|||
124462044|NCT01394939|447650797|FG002|Overall Study|Others|0|||
124462045|NCT01394939|447650798|FG003|Overall Study|Others|3|||
124462046|NCT01339559|447650802|FG000|Overall Study|Adverse Event|92|||
124462047|NCT01339559|447650802|FG000|Overall Study|Death|5|||
124462048|NCT01339559|447650802|FG000|Overall Study|Lack of Efficacy|164|||
124462049|NCT01339559|447650802|FG000|Overall Study|Lost to Follow-up|22|||
124462050|NCT01339559|447650802|FG000|Overall Study|Subject choice|89|||
124462051|NCT01339559|447650802|FG000|Overall Study|Protocol Violation|15|||
124462052|NCT01339559|447650802|FG000|Overall Study|Study closure at site|1|||
124462053|NCT01339559|447650802|FG000|Overall Study|Incarcerated|2|||
124462054|NCT01339559|447650802|FG000|Overall Study|Epilepsy surgery|1|||
124462055|NCT01339559|447650802|FG000|Overall Study|Pregnancy planned|2|||
124462056|NCT01339559|447650802|FG000|Overall Study|Left the country|1|||
124462057|NCT01339559|447650802|FG000|Overall Study|Investigator decision|2|||
124462058|NCT01339559|447650802|FG000|Overall Study|Patient didn't wish to continue|1|||
124462059|NCT01339559|447650802|FG000|Overall Study|PI decision|1|||
124462060|NCT00623480|447650803|FG000|Overall Study|Lost to Follow-up|0|||
124462061|NCT00623480|447650804|FG001|Overall Study|Lost to Follow-up|1|||
124462062|NCT00623480|447650803|FG000|Overall Study|Withdrawal by Subject|2|||
124462063|NCT00623480|447650804|FG001|Overall Study|Withdrawal by Subject|4|||
124462064|NCT00623480|447650803|FG000|Overall Study|Lack of Efficacy|1|||
124462065|NCT00623480|447650804|FG001|Overall Study|Lack of Efficacy|0|||
124462066|NCT00623480|447650803|FG000|Overall Study|Non-compliant with study medication|4|||
124462067|NCT00623480|447650804|FG001|Overall Study|Non-compliant with study medication|0|||
124462068|NCT00623480|447650803|FG000|Overall Study|Protocol Violation|0|||
124957001|NCT00296504|449467917|FG002|Interim Analysis|Non-adherence|0|||
124957002|NCT00296504|449467918|FG003|Interim Analysis|Non-adherence|0|||
124957003|NCT00296504|449467919|FG004|Interim Analysis|Non-adherence|1|||
124462069|NCT00623480|447650804|FG001|Overall Study|Protocol Violation|1|||
124462070|NCT00623480|447650803|FG000|Overall Study|Site closed by sponsor|0|||
124462071|NCT00623480|447650804|FG001|Overall Study|Site closed by sponsor|1|||
124462072|NCT03548558|447650805|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
124462073|NCT03548558|447650806|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
124462074|NCT03548558|447650807|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
124462075|NCT03548558|447650808|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
124462076|NCT03548558|447650809|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
124462077|NCT03548558|447650810|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
124462078|NCT03548558|447650811|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
124462079|NCT03548558|447650805|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
124462080|NCT03548558|447650806|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
124462081|NCT03548558|447650807|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
124462082|NCT03548558|447650808|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
124462083|NCT03548558|447650809|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
124462084|NCT03548558|447650810|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
124462085|NCT03548558|447650811|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
124462086|NCT03548558|447650805|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
124462087|NCT03548558|447650806|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
124462088|NCT03548558|447650807|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
124462089|NCT03548558|447650808|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
124462090|NCT03548558|447650809|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
124462091|NCT03548558|447650810|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
124462092|NCT03548558|447650811|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
124462093|NCT03548558|447650805|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
124462094|NCT03548558|447650806|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
124462095|NCT03548558|447650807|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
124462096|NCT03548558|447650808|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
124462097|NCT03548558|447650809|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
124462098|NCT03548558|447650810|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
124462099|NCT03548558|447650811|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
124707919|NCT00894387|448555901|FG000|Overall Study|Protocol Deviation|4|||
124957004|NCT00296504|449467920|FG005|Interim Analysis|Non-adherence|0|||
124549152|NCT03993288|447966965|FG000|Overall Study|did not follow the treatment regimen|1|||
124549153|NCT03993288|447966966|FG001|Overall Study|did not follow the treatment regimen|0|||
124549154|NCT03993288|447966965|FG000|Overall Study|Adverse Event|1|||
124549155|NCT03993288|447966966|FG001|Overall Study|Adverse Event|0|||
124549156|NCT03993288|447966965|FG000|Overall Study|Withdrawal by Subject|1|||
124549157|NCT03993288|447966966|FG001|Overall Study|Withdrawal by Subject|1|||
124549158|NCT00915473|447966967|FG000|Screening|Withdrawal by Subject|1|||
124549159|NCT00915473|447966968|FG001|Screening|Withdrawal by Subject|0|||
124549160|NCT00915473|447966967|FG000|4-week Follow Up|Lost to Follow-up|1|||
124549161|NCT00915473|447966968|FG001|4-week Follow Up|Lost to Follow-up|5|||
124549162|NCT03443973|447966969|FG000|Double-blind Treatment Period|Adverse Event|5|||
124549163|NCT03443973|447966970|FG001|Double-blind Treatment Period|Adverse Event|19|||
124549164|NCT03443973|447966971|FG002|Double-blind Treatment Period|Adverse Event|0|||
124549165|NCT03443973|447966972|FG003|Double-blind Treatment Period|Adverse Event|0|||
124549166|NCT03443973|447966969|FG000|Double-blind Treatment Period|Death|5|||
124549167|NCT03443973|447966970|FG001|Double-blind Treatment Period|Death|7|||
124549168|NCT03443973|447966971|FG002|Double-blind Treatment Period|Death|0|||
124549169|NCT03443973|447966972|FG003|Double-blind Treatment Period|Death|0|||
124549170|NCT03443973|447966969|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
124549171|NCT03443973|447966970|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
124549172|NCT03443973|447966971|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
124549173|NCT03443973|447966972|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
124549174|NCT03443973|447966969|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
124549175|NCT03443973|447966970|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
124549176|NCT03443973|447966971|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
124549177|NCT03443973|447966972|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
124549178|NCT03443973|447966969|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
124549179|NCT03443973|447966970|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
124549180|NCT03443973|447966971|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
124549181|NCT03443973|447966972|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
124549182|NCT03443973|447966969|FG000|Double-blind Treatment Period|Physician Decision|5|||
124549183|NCT03443973|447966970|FG001|Double-blind Treatment Period|Physician Decision|6|||
124549184|NCT03443973|447966971|FG002|Double-blind Treatment Period|Physician Decision|0|||
124549185|NCT03443973|447966972|FG003|Double-blind Treatment Period|Physician Decision|0|||
124549186|NCT03443973|447966969|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
124549187|NCT03443973|447966970|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
124549188|NCT03443973|447966971|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
124549189|NCT03443973|447966972|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
124549190|NCT03443973|447966969|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
124549191|NCT03443973|447966970|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
124549192|NCT03443973|447966971|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
124549193|NCT03443973|447966972|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
124549194|NCT03443973|447966969|FG000|Open-label Extension Period|Reason Not Specified|0|||
124549195|NCT03443973|447966970|FG001|Open-label Extension Period|Reason Not Specified|0|||
124549196|NCT03443973|447966971|FG002|Open-label Extension Period|Reason Not Specified|3|||
124549197|NCT03443973|447966972|FG003|Open-label Extension Period|Reason Not Specified|0|||
124549198|NCT03443973|447966969|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
124707920|NCT00894387|448555902|FG001|Overall Study|Protocol Deviation|0|||
124707921|NCT00894387|448555901|FG000|Overall Study|Patient's request|25|||
124707922|NCT00894387|448555902|FG001|Overall Study|Patient's request|30|||
124707923|NCT00894387|448555901|FG000|Overall Study|Other (Missing)|5|||
124462100|NCT03548558|447650805|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
124462101|NCT03548558|447650806|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
124462102|NCT03548558|447650807|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
124462103|NCT03548558|447650808|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
124462104|NCT03548558|447650809|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
124462105|NCT03548558|447650810|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
124462106|NCT03548558|447650811|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
124462107|NCT03548558|447650805|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
124462108|NCT03548558|447650806|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
124462109|NCT03548558|447650807|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
124462110|NCT03548558|447650808|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
124462111|NCT03548558|447650809|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
124462112|NCT03548558|447650810|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
124462113|NCT03548558|447650811|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
124462114|NCT03273166|447650814|FG000|Overall Study|Withdrawn prior to Completion|31|||
124462115|NCT02669017|447650815|FG000|Overall Study|Death|1|||
124462116|NCT02669017|447650816|FG001|Overall Study|Death|2|||
124462117|NCT02669017|447650817|FG002|Overall Study|Death|2|||
124462118|NCT02669017|447650818|FG003|Overall Study|Death|3|||
124462119|NCT02669017|447650819|FG004|Overall Study|Death|8|||
124462120|NCT02669017|447650820|FG005|Overall Study|Death|18|||
124462121|NCT02669017|447650821|FG006|Overall Study|Death|10|||
124462122|NCT02669017|447650822|FG007|Overall Study|Death|47|||
124462123|NCT02669017|447650823|FG008|Overall Study|Death|20|||
124462124|NCT02669017|447650815|FG000|Overall Study|Withdrawal by Subject|0|||
124462125|NCT02669017|447650816|FG001|Overall Study|Withdrawal by Subject|0|||
124462126|NCT02669017|447650817|FG002|Overall Study|Withdrawal by Subject|0|||
124462127|NCT02669017|447650818|FG003|Overall Study|Withdrawal by Subject|1|||
124462128|NCT02669017|447650819|FG004|Overall Study|Withdrawal by Subject|2|||
124462129|NCT02669017|447650820|FG005|Overall Study|Withdrawal by Subject|0|||
124462130|NCT02669017|447650821|FG006|Overall Study|Withdrawal by Subject|0|||
124462131|NCT02669017|447650822|FG007|Overall Study|Withdrawal by Subject|2|||
124707924|NCT00894387|448555902|FG001|Overall Study|Other (Missing)|3|||
124707925|NCT00894387|448555901|FG000|Overall Study|Mis-randomized|13|||
124462132|NCT02669017|447650823|FG008|Overall Study|Withdrawal by Subject|2|||
124462133|NCT02669017|447650815|FG000|Overall Study|Lost to Follow-up|0|||
124462134|NCT02669017|447650816|FG001|Overall Study|Lost to Follow-up|0|||
124462135|NCT02669017|447650817|FG002|Overall Study|Lost to Follow-up|0|||
124462136|NCT02669017|447650818|FG003|Overall Study|Lost to Follow-up|0|||
124462137|NCT02669017|447650819|FG004|Overall Study|Lost to Follow-up|0|||
124462138|NCT02669017|447650820|FG005|Overall Study|Lost to Follow-up|0|||
124462139|NCT02669017|447650821|FG006|Overall Study|Lost to Follow-up|0|||
124462140|NCT02669017|447650822|FG007|Overall Study|Lost to Follow-up|0|||
124462141|NCT02669017|447650823|FG008|Overall Study|Lost to Follow-up|1|||
124462142|NCT02669017|447650815|FG000|Overall Study|Miscellaneous|0|||
124462143|NCT02669017|447650816|FG001|Overall Study|Miscellaneous|0|||
124462144|NCT02669017|447650817|FG002|Overall Study|Miscellaneous|0|||
124462145|NCT02669017|447650818|FG003|Overall Study|Miscellaneous|0|||
124462146|NCT02669017|447650819|FG004|Overall Study|Miscellaneous|2|||
124462147|NCT02669017|447650820|FG005|Overall Study|Miscellaneous|1|||
124462148|NCT02669017|447650821|FG006|Overall Study|Miscellaneous|1|||
124462149|NCT02669017|447650822|FG007|Overall Study|Miscellaneous|13|||
124462150|NCT02669017|447650823|FG008|Overall Study|Miscellaneous|2|||
124462151|NCT02797808|447650828|FG000|Overall Study|Withdrawal by Subject|1|||
124462152|NCT02797808|447650829|FG001|Overall Study|Withdrawal by Subject|1|||
124462153|NCT02797808|447650828|FG000|Overall Study|Physician Decision|6|||
124462154|NCT02797808|447650829|FG001|Overall Study|Physician Decision|2|||
124462155|NCT03509350|447650830|FG000|Overall Study|Withdrawal by Subject|0|||
124462156|NCT03509350|447650831|FG001|Overall Study|Withdrawal by Subject|2|||
124462157|NCT01425203|447650834|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
124462158|NCT01425203|447650835|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
124462159|NCT01425203|447650836|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
124462160|NCT01425203|447650834|FG000|Treatment Phase|Failure at futility timepoint|8|||
124462161|NCT01425203|447650835|FG001|Treatment Phase|Failure at futility timepoint|27|||
124707926|NCT00894387|448555902|FG001|Overall Study|Mis-randomized|9|||
124707927|NCT00894387|448555901|FG000|Overall Study|GCP non-compliance|0|||
124707928|NCT00894387|448555902|FG001|Overall Study|GCP non-compliance|2|||
124707929|NCT01128569|448555903|FG000|Washout Period 1|Adverse Event|0|||
124462162|NCT01425203|447650836|FG002|Treatment Phase|Failure at futility timepoint|0|||
124462163|NCT01425203|447650834|FG000|Treatment Phase|Other virologic failure criteria|5|||
124462164|NCT01425203|447650835|FG001|Treatment Phase|Other virologic failure criteria|3|||
124462165|NCT01425203|447650836|FG002|Treatment Phase|Other virologic failure criteria|0|||
124462166|NCT01425203|447650834|FG000|Treatment Phase|Unidentified reasons|11|||
124462167|NCT01425203|447650835|FG001|Treatment Phase|Unidentified reasons|5|||
124707930|NCT01128569|448555904|FG001|Washout Period 1|Adverse Event|0|||
124462168|NCT01425203|447650836|FG002|Treatment Phase|Unidentified reasons|0|||
124462169|NCT01425203|447650834|FG000|Treatment Phase|Did not receive treatment|0|||
124462170|NCT01425203|447650835|FG001|Treatment Phase|Did not receive treatment|1|||
124462171|NCT01425203|447650836|FG002|Treatment Phase|Did not receive treatment|0|||
124462172|NCT01425203|447650834|FG000|Crossover Phase|Failure at futility timepoint|0|||
124462173|NCT01425203|447650835|FG001|Crossover Phase|Failure at futility timepoint|0|||
124462174|NCT01425203|447650836|FG002|Crossover Phase|Failure at futility timepoint|3|||
124462175|NCT01425203|447650834|FG000|Crossover Phase|Other virologic failure criteria|0|||
124462176|NCT01425203|447650835|FG001|Crossover Phase|Other virologic failure criteria|0|||
124462177|NCT01425203|447650836|FG002|Crossover Phase|Other virologic failure criteria|3|||
124462178|NCT00535132|447650837|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
124462179|NCT00535132|447650838|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
124462180|NCT00535132|447650837|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
124462181|NCT00535132|447650838|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
124462182|NCT02590588|447650839|FG000|Overall Study|Adverse Event|1|||
124462183|NCT00414453|447650840|FG000|Overall Study|Abnormal lab work|16|||
124462184|NCT00290433|447650846|FG000|Overall Study|Disease Progression|13|||
124462185|NCT00290433|447650846|FG000|Overall Study|Adverse Event|14|||
124462186|NCT00290433|447650846|FG000|Overall Study|Withdrawal by Subject|1|||
124462187|NCT00290433|447650846|FG000|Overall Study|Non-Compliance|1|||
124462188|NCT00290433|447650846|FG000|Overall Study|Congestive Heart Failure|1|||
124462189|NCT00290433|447650846|FG000|Overall Study|Transplant in CR|5|||
124462190|NCT00290433|447650846|FG000|Overall Study|Unrelated Infection/Death|1|||
124462191|NCT03031301|447650850|FG000|Overall Study|Protocol Violation|4|||
124462192|NCT03031301|447650851|FG001|Overall Study|Protocol Violation|8|||
124462193|NCT03031301|447650850|FG000|Overall Study|Withdrawal by Subject|7|||
124462194|NCT03031301|447650851|FG001|Overall Study|Withdrawal by Subject|4|||
124462195|NCT03031301|447650850|FG000|Overall Study|Lost to Follow-up|4|||
124462196|NCT03031301|447650851|FG001|Overall Study|Lost to Follow-up|12|||
124462197|NCT03031301|447650850|FG000|Overall Study|Noncompliance|1|||
124462198|NCT03031301|447650851|FG001|Overall Study|Noncompliance|3|||
124462199|NCT03031301|447650850|FG000|Overall Study|Technical issue|1|||
124462200|NCT03031301|447650851|FG001|Overall Study|Technical issue|1|||
124462201|NCT03031301|447650850|FG000|Overall Study|Adverse Event|1|||
124462202|NCT03031301|447650851|FG001|Overall Study|Adverse Event|0|||
124462203|NCT02898259|447650854|FG000|Overall Study|Adverse Event|0|||
124462204|NCT02898259|447650855|FG001|Overall Study|Adverse Event|0|||
124462205|NCT02898259|447650856|FG002|Overall Study|Adverse Event|1|||
124462206|NCT02898259|447650857|FG003|Overall Study|Adverse Event|0|||
124462207|NCT02898259|447650858|FG004|Overall Study|Adverse Event|0|||
124462208|NCT02898259|447650854|FG000|Overall Study|Lack of Efficacy|1|||
124462209|NCT02898259|447650855|FG001|Overall Study|Lack of Efficacy|1|||
124462210|NCT02898259|447650856|FG002|Overall Study|Lack of Efficacy|3|||
124462211|NCT02898259|447650857|FG003|Overall Study|Lack of Efficacy|0|||
124462212|NCT02898259|447650858|FG004|Overall Study|Lack of Efficacy|0|||
124462213|NCT02898259|447650854|FG000|Overall Study|Lost to Follow-up|0|||
124462214|NCT02898259|447650855|FG001|Overall Study|Lost to Follow-up|0|||
124462215|NCT02898259|447650856|FG002|Overall Study|Lost to Follow-up|1|||
124462216|NCT02898259|447650857|FG003|Overall Study|Lost to Follow-up|0|||
124462217|NCT02898259|447650858|FG004|Overall Study|Lost to Follow-up|0|||
124462218|NCT02898259|447650854|FG000|Overall Study|Transformation before study began|0|||
124462219|NCT02898259|447650855|FG001|Overall Study|Transformation before study began|0|||
124462220|NCT02898259|447650856|FG002|Overall Study|Transformation before study began|0|||
124462221|NCT02898259|447650857|FG003|Overall Study|Transformation before study began|1|||
124462222|NCT02898259|447650858|FG004|Overall Study|Transformation before study began|0|||
124462223|NCT03016325|447650859|FG000|Treatment Period|Participant withdrew consent|0|||
124707931|NCT01128569|448555905|FG002|Washout Period 1|Adverse Event|1|||
124707932|NCT01128569|448555906|FG003|Washout Period 1|Adverse Event|0|||
124707933|NCT01128569|448555907|FG004|Washout Period 1|Adverse Event|0|||
124707934|NCT01128569|448555908|FG005|Washout Period 1|Adverse Event|0|||
124707935|NCT01128569|448555903|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124462224|NCT03016325|447650860|FG001|Treatment Period|Participant withdrew consent|1|||
124462225|NCT03016325|447650861|FG002|Treatment Period|Participant withdrew consent|0|||
124462226|NCT03016325|447650862|FG003|Treatment Period|Participant withdrew consent|0|||
124462227|NCT03016325|447650863|FG004|Treatment Period|Participant withdrew consent|0|||
124462228|NCT03016325|447650864|FG005|Treatment Period|Participant withdrew consent|0|||
124462229|NCT03016325|447650865|FG006|Treatment Period|Participant withdrew consent|0|||
124707936|NCT01128569|448555904|FG001|Treatment Period 2|Withdrawal by Subject|1|||
124462230|NCT03016325|447650866|FG007|Treatment Period|Participant withdrew consent|0|||
124462231|NCT03016325|447650859|FG000|Treatment Period|Death|0|||
124462232|NCT03016325|447650860|FG001|Treatment Period|Death|0|||
124707937|NCT01128569|448555905|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124462233|NCT03016325|447650861|FG002|Treatment Period|Death|0|||
124462234|NCT03016325|447650862|FG003|Treatment Period|Death|0|||
124462235|NCT03016325|447650863|FG004|Treatment Period|Death|2|||
124462236|NCT03016325|447650864|FG005|Treatment Period|Death|0|||
124766521|NCT01910298|448773709|FG001|Overall Study|Protocol Deviation|5|||
124957005|NCT00296504|449467921|FG006|Interim Analysis|Non-adherence|0|||
124957006|NCT00296504|449467922|FG007|Interim Analysis|Non-adherence|1|||
124957007|NCT00296504|449467923|FG008|Interim Analysis|Non-adherence|0|||
124957008|NCT00296504|449467915|FG000|Interim Analysis|Site Closing|1|||
124957009|NCT00296504|449467916|FG001|Interim Analysis|Site Closing|0|||
124957010|NCT00296504|449467917|FG002|Interim Analysis|Site Closing|0|||
124957011|NCT00296504|449467918|FG003|Interim Analysis|Site Closing|0|||
124957012|NCT00296504|449467919|FG004|Interim Analysis|Site Closing|0|||
124957013|NCT00296504|449467920|FG005|Interim Analysis|Site Closing|1|||
124957014|NCT00296504|449467921|FG006|Interim Analysis|Site Closing|2|||
124957015|NCT00296504|449467922|FG007|Interim Analysis|Site Closing|0|||
124957016|NCT00296504|449467923|FG008|Interim Analysis|Site Closing|0|||
124957017|NCT00296504|449467915|FG000|Interim Analysis|Lack of Personnel at Site|1|||
124957018|NCT00296504|449467916|FG001|Interim Analysis|Lack of Personnel at Site|0|||
124957019|NCT00296504|449467917|FG002|Interim Analysis|Lack of Personnel at Site|0|||
124957020|NCT00296504|449467918|FG003|Interim Analysis|Lack of Personnel at Site|0|||
124957021|NCT00296504|449467919|FG004|Interim Analysis|Lack of Personnel at Site|0|||
124957022|NCT00296504|449467920|FG005|Interim Analysis|Lack of Personnel at Site|0|||
124957023|NCT00296504|449467921|FG006|Interim Analysis|Lack of Personnel at Site|0|||
124957024|NCT00296504|449467922|FG007|Interim Analysis|Lack of Personnel at Site|0|||
124957025|NCT00296504|449467923|FG008|Interim Analysis|Lack of Personnel at Site|0|||
124957026|NCT00296504|449467915|FG000|Interim Analysis|Missed Schedule Date|1|||
124957027|NCT00296504|449467916|FG001|Interim Analysis|Missed Schedule Date|0|||
124957028|NCT00296504|449467917|FG002|Interim Analysis|Missed Schedule Date|0|||
124957029|NCT00296504|449467918|FG003|Interim Analysis|Missed Schedule Date|0|||
124957030|NCT00296504|449467919|FG004|Interim Analysis|Missed Schedule Date|0|||
124957031|NCT00296504|449467920|FG005|Interim Analysis|Missed Schedule Date|0|||
124957032|NCT00296504|449467921|FG006|Interim Analysis|Missed Schedule Date|0|||
124957033|NCT00296504|449467922|FG007|Interim Analysis|Missed Schedule Date|0|||
124957034|NCT00296504|449467923|FG008|Interim Analysis|Missed Schedule Date|0|||
124957035|NCT00296504|449467915|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
124957036|NCT00296504|449467916|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
124957037|NCT00296504|449467917|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
124957038|NCT00296504|449467918|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
124462237|NCT03016325|447650865|FG006|Treatment Period|Death|0|||
124462238|NCT03016325|447650866|FG007|Treatment Period|Death|0|||
124462239|NCT03016325|447650859|FG000|Treatment Period|Participant refuses assessments|0|||
124462240|NCT03016325|447650860|FG001|Treatment Period|Participant refuses assessments|0|||
124462241|NCT03016325|447650861|FG002|Treatment Period|Participant refuses assessments|1|||
124462242|NCT03016325|447650862|FG003|Treatment Period|Participant refuses assessments|0|||
124462243|NCT03016325|447650863|FG004|Treatment Period|Participant refuses assessments|0|||
124462244|NCT03016325|447650864|FG005|Treatment Period|Participant refuses assessments|0|||
124462245|NCT03016325|447650865|FG006|Treatment Period|Participant refuses assessments|0|||
124462246|NCT03016325|447650866|FG007|Treatment Period|Participant refuses assessments|0|||
124462247|NCT03016325|447650859|FG000|32-Day Follow-Up Period|Death|2|||
124462248|NCT03016325|447650860|FG001|32-Day Follow-Up Period|Death|0|||
124462249|NCT03016325|447650861|FG002|32-Day Follow-Up Period|Death|5|||
124462250|NCT03016325|447650862|FG003|32-Day Follow-Up Period|Death|6|||
124462251|NCT03016325|447650863|FG004|32-Day Follow-Up Period|Death|3|||
124462252|NCT03016325|447650864|FG005|32-Day Follow-Up Period|Death|0|||
124462253|NCT03016325|447650865|FG006|32-Day Follow-Up Period|Death|0|||
124462254|NCT03016325|447650866|FG007|32-Day Follow-Up Period|Death|0|||
124462255|NCT03016325|447650859|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
124462256|NCT03016325|447650860|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
124462257|NCT03016325|447650861|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
124462258|NCT03016325|447650862|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
124462259|NCT03016325|447650863|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
124462260|NCT03016325|447650864|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
124462261|NCT03016325|447650865|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
124462262|NCT03016325|447650866|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
124957039|NCT00296504|449467919|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
124957040|NCT00296504|449467920|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
124957041|NCT00296504|449467921|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
124957042|NCT00296504|449467922|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
124957043|NCT00296504|449467923|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
124957044|NCT00296504|449467915|FG000|Interim Analysis|Participant Stopped|0|||
124957045|NCT00296504|449467916|FG001|Interim Analysis|Participant Stopped|0|||
124957046|NCT00296504|449467917|FG002|Interim Analysis|Participant Stopped|0|||
124957047|NCT00296504|449467918|FG003|Interim Analysis|Participant Stopped|0|||
124957048|NCT00296504|449467919|FG004|Interim Analysis|Participant Stopped|1|||
124957049|NCT00296504|449467920|FG005|Interim Analysis|Participant Stopped|0|||
124957050|NCT00296504|449467921|FG006|Interim Analysis|Participant Stopped|0|||
124957051|NCT00296504|449467922|FG007|Interim Analysis|Participant Stopped|0|||
124957052|NCT00296504|449467923|FG008|Interim Analysis|Participant Stopped|0|||
124957053|NCT00296504|449467915|FG000|Interim Analysis|Physician and Participant Decision|0|||
124957054|NCT00296504|449467916|FG001|Interim Analysis|Physician and Participant Decision|0|||
124957055|NCT00296504|449467917|FG002|Interim Analysis|Physician and Participant Decision|0|||
124957056|NCT00296504|449467918|FG003|Interim Analysis|Physician and Participant Decision|0|||
124957057|NCT00296504|449467919|FG004|Interim Analysis|Physician and Participant Decision|0|||
124462263|NCT03016325|447650859|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
124462264|NCT03016325|447650860|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
124462265|NCT03016325|447650861|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
124462266|NCT03016325|447650862|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
124462267|NCT03016325|447650863|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
124462268|NCT03016325|447650864|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
124462269|NCT03016325|447650865|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
124462270|NCT03016325|447650866|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
124462271|NCT03016325|447650859|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
124462272|NCT03016325|447650860|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
124462273|NCT03016325|447650861|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
124462274|NCT03016325|447650862|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
124462275|NCT03016325|447650863|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
124462276|NCT03016325|447650864|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
124462277|NCT03016325|447650865|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
124462278|NCT03016325|447650866|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
124462279|NCT03016325|447650859|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
124462280|NCT03016325|447650860|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
124462281|NCT03016325|447650861|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
124462282|NCT03016325|447650862|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
124462283|NCT03016325|447650863|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
124766522|NCT01910298|448773708|FG000|Overall Study|Lost to Follow-up|1|||
124957058|NCT00296504|449467920|FG005|Interim Analysis|Physician and Participant Decision|1|||
124957059|NCT00296504|449467921|FG006|Interim Analysis|Physician and Participant Decision|0|||
124957060|NCT00296504|449467922|FG007|Interim Analysis|Physician and Participant Decision|0|||
124957061|NCT00296504|449467923|FG008|Interim Analysis|Physician and Participant Decision|0|||
124957062|NCT00296504|449467915|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
124462284|NCT03016325|447650864|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
124462285|NCT03016325|447650865|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
124462286|NCT03016325|447650866|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
124462287|NCT03016325|447650859|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
124462288|NCT03016325|447650860|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
124462289|NCT03016325|447650861|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
124462290|NCT03016325|447650862|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
124462291|NCT03016325|447650863|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
124462292|NCT03016325|447650864|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
124462293|NCT03016325|447650865|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
124462294|NCT03016325|447650866|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
124462295|NCT03016325|447650859|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
124462296|NCT03016325|447650860|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
124462297|NCT03016325|447650861|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
124462298|NCT03016325|447650862|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
124462299|NCT03016325|447650863|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
124462300|NCT03016325|447650864|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
124462301|NCT03016325|447650865|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
124462302|NCT03016325|447650866|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
124462303|NCT03016325|447650859|FG000|182-Day Follow-Up Period|Death|3|||
124462304|NCT03016325|447650860|FG001|182-Day Follow-Up Period|Death|3|||
124462305|NCT03016325|447650861|FG002|182-Day Follow-Up Period|Death|11|||
124462306|NCT03016325|447650862|FG003|182-Day Follow-Up Period|Death|12|||
124462307|NCT03016325|447650863|FG004|182-Day Follow-Up Period|Death|9|||
124462308|NCT03016325|447650864|FG005|182-Day Follow-Up Period|Death|0|||
124707938|NCT01128569|448555906|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124957063|NCT00296504|449467916|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
124462309|NCT03016325|447650865|FG006|182-Day Follow-Up Period|Death|0|||
124462310|NCT03016325|447650866|FG007|182-Day Follow-Up Period|Death|1|||
124462311|NCT03016325|447650859|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
124462312|NCT03016325|447650860|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
124462313|NCT03016325|447650861|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
124462314|NCT03016325|447650862|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
124462315|NCT03016325|447650863|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
124462316|NCT03016325|447650864|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
124462317|NCT03016325|447650865|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
124462318|NCT03016325|447650866|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
124462319|NCT03016325|447650859|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
124462320|NCT03016325|447650860|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
124462321|NCT03016325|447650861|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
124462322|NCT03016325|447650862|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
124462323|NCT03016325|447650863|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
124462324|NCT03016325|447650864|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
124462325|NCT03016325|447650865|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
124462326|NCT03016325|447650866|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
124462327|NCT03016325|447650859|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
124462328|NCT03016325|447650860|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
124462329|NCT03016325|447650861|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
124462330|NCT03016325|447650862|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
124462331|NCT03016325|447650863|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
124462332|NCT03016325|447650864|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
124462333|NCT03016325|447650865|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
124462334|NCT03016325|447650866|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
124707939|NCT01128569|448555907|FG004|Treatment Period 2|Withdrawal by Subject|0|||
124462335|NCT03016325|447650859|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
124462336|NCT03016325|447650860|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
124462337|NCT03016325|447650861|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
124462338|NCT03016325|447650862|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
124462339|NCT03016325|447650863|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
124462340|NCT03016325|447650864|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
124462341|NCT03016325|447650865|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
124462342|NCT03016325|447650866|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
124462343|NCT03016325|447650859|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
124462344|NCT03016325|447650860|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
124957064|NCT00296504|449467917|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
124957065|NCT00296504|449467918|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
124462345|NCT03016325|447650861|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
124462346|NCT03016325|447650862|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
124462347|NCT03016325|447650863|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
124957066|NCT00296504|449467919|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
124957067|NCT00296504|449467920|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
124957068|NCT00296504|449467921|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
124957069|NCT00296504|449467922|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
124957070|NCT00296504|449467923|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
124957071|NCT00296504|449467915|FG000|Interim Analysis|Study Ended|0|||
124957072|NCT00296504|449467916|FG001|Interim Analysis|Study Ended|0|||
124957073|NCT00296504|449467917|FG002|Interim Analysis|Study Ended|0|||
124957074|NCT00296504|449467918|FG003|Interim Analysis|Study Ended|0|||
124957075|NCT00296504|449467919|FG004|Interim Analysis|Study Ended|0|||
124957076|NCT00296504|449467920|FG005|Interim Analysis|Study Ended|0|||
124957077|NCT00296504|449467921|FG006|Interim Analysis|Study Ended|1|||
124957078|NCT00296504|449467922|FG007|Interim Analysis|Study Ended|0|||
124957079|NCT00296504|449467923|FG008|Interim Analysis|Study Ended|0|||
124957080|NCT00296504|449467915|FG000|Interim Analysis|Participant Needed Interferon|0|||
124957081|NCT00296504|449467916|FG001|Interim Analysis|Participant Needed Interferon|0|||
124957082|NCT00296504|449467917|FG002|Interim Analysis|Participant Needed Interferon|0|||
124957083|NCT00296504|449467918|FG003|Interim Analysis|Participant Needed Interferon|0|||
124957084|NCT00296504|449467919|FG004|Interim Analysis|Participant Needed Interferon|0|||
124957085|NCT00296504|449467920|FG005|Interim Analysis|Participant Needed Interferon|0|||
124957086|NCT00296504|449467921|FG006|Interim Analysis|Participant Needed Interferon|0|||
124957087|NCT00296504|449467922|FG007|Interim Analysis|Participant Needed Interferon|1|||
124957088|NCT00296504|449467923|FG008|Interim Analysis|Participant Needed Interferon|0|||
124957089|NCT00296504|449467915|FG000|Interim Analysis|Ongoing|32|||
124957090|NCT00296504|449467916|FG001|Interim Analysis|Ongoing|12|||
124957091|NCT00296504|449467917|FG002|Interim Analysis|Ongoing|16|||
124957092|NCT00296504|449467918|FG003|Interim Analysis|Ongoing|22|||
124957093|NCT00296504|449467919|FG004|Interim Analysis|Ongoing|0|||
124957094|NCT00296504|449467920|FG005|Interim Analysis|Ongoing|0|||
124957095|NCT00296504|449467921|FG006|Interim Analysis|Ongoing|30|||
124957096|NCT00296504|449467922|FG007|Interim Analysis|Ongoing|1|||
124957097|NCT00296504|449467923|FG008|Interim Analysis|Ongoing|0|||
124462348|NCT03016325|447650864|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
124957098|NCT00296504|449467915|FG000|Final Analysis|Withdrawal by Subject|0|||
124957099|NCT00296504|449467916|FG001|Final Analysis|Withdrawal by Subject|0|||
124957100|NCT00296504|449467917|FG002|Final Analysis|Withdrawal by Subject|0|||
124957101|NCT00296504|449467918|FG003|Final Analysis|Withdrawal by Subject|0|||
124957102|NCT00296504|449467919|FG004|Final Analysis|Withdrawal by Subject|0|||
124957103|NCT00296504|449467920|FG005|Final Analysis|Withdrawal by Subject|0|||
124957104|NCT00296504|449467921|FG006|Final Analysis|Withdrawal by Subject|0|||
124957105|NCT00296504|449467922|FG007|Final Analysis|Withdrawal by Subject|0|||
124957106|NCT00296504|449467923|FG008|Final Analysis|Withdrawal by Subject|1|||
124957107|NCT00296504|449467915|FG000|Final Analysis|Lost to Follow-up|0|||
124957108|NCT00296504|449467916|FG001|Final Analysis|Lost to Follow-up|0|||
124957109|NCT00296504|449467917|FG002|Final Analysis|Lost to Follow-up|0|||
124957110|NCT00296504|449467918|FG003|Final Analysis|Lost to Follow-up|0|||
124957111|NCT00296504|449467919|FG004|Final Analysis|Lost to Follow-up|0|||
124957112|NCT00296504|449467920|FG005|Final Analysis|Lost to Follow-up|0|||
124957113|NCT00296504|449467921|FG006|Final Analysis|Lost to Follow-up|0|||
124957114|NCT00296504|449467922|FG007|Final Analysis|Lost to Follow-up|0|||
124957115|NCT00296504|449467923|FG008|Final Analysis|Lost to Follow-up|5|||
124957116|NCT00296504|449467915|FG000|Final Analysis|Insufficient Viral Load Response|0|||
124957117|NCT00296504|449467916|FG001|Final Analysis|Insufficient Viral Load Response|0|||
124957118|NCT00296504|449467917|FG002|Final Analysis|Insufficient Viral Load Response|0|||
124957119|NCT00296504|449467918|FG003|Final Analysis|Insufficient Viral Load Response|0|||
124957120|NCT00296504|449467919|FG004|Final Analysis|Insufficient Viral Load Response|0|||
124957121|NCT00296504|449467920|FG005|Final Analysis|Insufficient Viral Load Response|0|||
124957122|NCT00296504|449467921|FG006|Final Analysis|Insufficient Viral Load Response|0|||
124957123|NCT00296504|449467922|FG007|Final Analysis|Insufficient Viral Load Response|0|||
124957124|NCT00296504|449467923|FG008|Final Analysis|Insufficient Viral Load Response|6|||
124957125|NCT00296504|449467915|FG000|Final Analysis|Adverse Event|0|||
124957126|NCT00296504|449467916|FG001|Final Analysis|Adverse Event|0|||
124957127|NCT00296504|449467917|FG002|Final Analysis|Adverse Event|0|||
124957128|NCT00296504|449467918|FG003|Final Analysis|Adverse Event|0|||
124957129|NCT00296504|449467919|FG004|Final Analysis|Adverse Event|0|||
124957130|NCT00296504|449467920|FG005|Final Analysis|Adverse Event|0|||
124957131|NCT00296504|449467921|FG006|Final Analysis|Adverse Event|0|||
124957132|NCT00296504|449467922|FG007|Final Analysis|Adverse Event|0|||
124957133|NCT00296504|449467923|FG008|Final Analysis|Adverse Event|2|||
124957134|NCT00296504|449467915|FG000|Final Analysis|Pregnancy|0|||
124957135|NCT00296504|449467916|FG001|Final Analysis|Pregnancy|0|||
124957136|NCT00296504|449467917|FG002|Final Analysis|Pregnancy|0|||
124957137|NCT00296504|449467918|FG003|Final Analysis|Pregnancy|0|||
124957138|NCT00296504|449467919|FG004|Final Analysis|Pregnancy|0|||
124462349|NCT03016325|447650865|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
124462350|NCT03016325|447650866|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
124462351|NCT03016325|447650859|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
124462352|NCT03016325|447650860|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
124462353|NCT03016325|447650861|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
124462354|NCT03016325|447650862|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
124462355|NCT03016325|447650863|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
124462356|NCT03016325|447650864|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
124462357|NCT03016325|447650865|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
124462358|NCT03016325|447650866|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
124957139|NCT00296504|449467920|FG005|Final Analysis|Pregnancy|0|||
124957140|NCT00296504|449467921|FG006|Final Analysis|Pregnancy|0|||
124957141|NCT00296504|449467922|FG007|Final Analysis|Pregnancy|0|||
124957142|NCT00296504|449467923|FG008|Final Analysis|Pregnancy|4|||
124957143|NCT00296504|449467915|FG000|Final Analysis|Tuberculosis|0|||
124462359|NCT03016325|447650859|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
124462360|NCT03016325|447650860|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
124462361|NCT03016325|447650861|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
124957144|NCT00296504|449467916|FG001|Final Analysis|Tuberculosis|0|||
124957145|NCT00296504|449467917|FG002|Final Analysis|Tuberculosis|0|||
124957146|NCT00296504|449467918|FG003|Final Analysis|Tuberculosis|0|||
124957147|NCT00296504|449467919|FG004|Final Analysis|Tuberculosis|0|||
124957148|NCT00296504|449467920|FG005|Final Analysis|Tuberculosis|0|||
124957149|NCT00296504|449467921|FG006|Final Analysis|Tuberculosis|0|||
124957150|NCT00296504|449467922|FG007|Final Analysis|Tuberculosis|0|||
124957151|NCT00296504|449467923|FG008|Final Analysis|Tuberculosis|1|||
124549199|NCT03443973|447966970|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
124549200|NCT03443973|447966971|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
124549201|NCT03443973|447966972|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
124549202|NCT02209454|447966976|FG000|Second Period|Adverse Event|1|||
124549203|NCT02209454|447966977|FG001|Second Period|Adverse Event|0|||
124549204|NCT00366678|447966982|FG000|Infant Series|Withdrawal by Subject|8|||
124957152|NCT00296504|449467915|FG000|Final Analysis|Participant Moved to Another Country|0|||
124957153|NCT00296504|449467916|FG001|Final Analysis|Participant Moved to Another Country|0|||
124957154|NCT00296504|449467917|FG002|Final Analysis|Participant Moved to Another Country|0|||
124957155|NCT00296504|449467918|FG003|Final Analysis|Participant Moved to Another Country|0|||
124957156|NCT00296504|449467919|FG004|Final Analysis|Participant Moved to Another Country|0|||
124957157|NCT00296504|449467920|FG005|Final Analysis|Participant Moved to Another Country|0|||
124957158|NCT00296504|449467921|FG006|Final Analysis|Participant Moved to Another Country|0|||
124957159|NCT00296504|449467922|FG007|Final Analysis|Participant Moved to Another Country|0|||
124462362|NCT03016325|447650862|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
124462363|NCT03016325|447650863|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
124462364|NCT03016325|447650864|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
124462365|NCT03016325|447650865|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
124462366|NCT03016325|447650866|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
124462367|NCT02970292|447650867|FG000|Overall Study|Physician Decision|1|||
124462368|NCT02970292|447650868|FG001|Overall Study|Physician Decision|1|||
124462369|NCT02970292|447650867|FG000|Overall Study|Withdrawal by Subject|11|||
124462370|NCT02970292|447650868|FG001|Overall Study|Withdrawal by Subject|5|||
124462371|NCT02970292|447650867|FG000|Overall Study|Noncompliance with study drug|2|||
124462372|NCT02970292|447650868|FG001|Overall Study|Noncompliance with study drug|2|||
124462373|NCT02970292|447650867|FG000|Overall Study|Adverse Event|5|||
124462374|NCT02970292|447650868|FG001|Overall Study|Adverse Event|0|||
124462375|NCT02970292|447650867|FG000|Overall Study|Lack of Efficacy|1|||
124462376|NCT02970292|447650868|FG001|Overall Study|Lack of Efficacy|0|||
124462377|NCT02970292|447650867|FG000|Overall Study|Lost to Follow-up|1|||
124462378|NCT02970292|447650868|FG001|Overall Study|Lost to Follow-up|0|||
124462379|NCT02970292|447650867|FG000|Overall Study|Protocol Violation|2|||
124462380|NCT02970292|447650868|FG001|Overall Study|Protocol Violation|0|||
124549205|NCT00366678|447966983|FG001|Infant Series|Withdrawal by Subject|6|||
124549206|NCT00366678|447966984|FG002|Infant Series|Withdrawal by Subject|0|||
124957160|NCT00296504|449467923|FG008|Final Analysis|Participant Moved to Another Country|1|||
124957161|NCT00296504|449467915|FG000|Final Analysis|Poor Adherence|0|||
124957162|NCT00296504|449467916|FG001|Final Analysis|Poor Adherence|0|||
124957163|NCT00296504|449467917|FG002|Final Analysis|Poor Adherence|0|||
124549207|NCT00366678|447966982|FG000|Infant Series|Protocol Violation|4|||
124957164|NCT00296504|449467918|FG003|Final Analysis|Poor Adherence|0|||
124957165|NCT00296504|449467919|FG004|Final Analysis|Poor Adherence|0|||
124462381|NCT02970292|447650867|FG000|Overall Study|Other|1|||
124957166|NCT00296504|449467920|FG005|Final Analysis|Poor Adherence|0|||
124957167|NCT00296504|449467921|FG006|Final Analysis|Poor Adherence|0|||
124957168|NCT00296504|449467922|FG007|Final Analysis|Poor Adherence|0|||
124957169|NCT00296504|449467923|FG008|Final Analysis|Poor Adherence|1|||
124957170|NCT02162771|449467930|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
124957171|NCT02162771|449467931|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
124957172|NCT02162771|449467930|FG000|Core Study Period (Part 2)|Adverse Event|4|||
124957173|NCT02162771|449467931|FG001|Core Study Period (Part 2)|Adverse Event|1|||
124957174|NCT02162771|449467930|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
124957175|NCT02162771|449467931|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
124957176|NCT02162771|449467930|FG000|Core Study Period (Part 2)|Physician Decision|0|||
124957177|NCT02162771|449467931|FG001|Core Study Period (Part 2)|Physician Decision|2|||
124957178|NCT02162771|449467930|FG000|Core Study Period (Part 2)|Death|1|||
124957179|NCT02162771|449467931|FG001|Core Study Period (Part 2)|Death|0|||
124957180|NCT02162771|449467930|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
124957181|NCT02162771|449467931|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
124957182|NCT02162771|449467930|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
124957183|NCT02162771|449467931|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
124957184|NCT02162771|449467930|FG000|Maintenance Study Period (Part 2)|Death|2|||
124957185|NCT02162771|449467931|FG001|Maintenance Study Period (Part 2)|Death|1|||
124957186|NCT02162771|449467930|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
124957187|NCT02162771|449467931|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
124957188|NCT02162771|449467930|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
124957189|NCT02162771|449467931|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
124957190|NCT02162771|449467930|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
124957191|NCT02162771|449467931|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
124957192|NCT00449033|449467945|FG000|Treatment Period|Adverse Event|117|||
124957193|NCT00449033|449467946|FG001|Treatment Period|Adverse Event|83|||
124957194|NCT00449033|449467945|FG000|Treatment Period|Death|21|||
124957195|NCT00449033|449467946|FG001|Treatment Period|Death|12|||
124957196|NCT00449033|449467945|FG000|Treatment Period|Lost to Follow-up|0|||
124957197|NCT00449033|449467946|FG001|Treatment Period|Lost to Follow-up|2|||
124957198|NCT00449033|449467945|FG000|Treatment Period|Physician Decision|4|||
124957199|NCT00449033|449467946|FG001|Treatment Period|Physician Decision|5|||
124957200|NCT00449033|449467945|FG000|Treatment Period|Protocol Violation|8|||
124957201|NCT00449033|449467946|FG001|Treatment Period|Protocol Violation|7|||
124957202|NCT00449033|449467945|FG000|Treatment Period|Disease Progression|231|||
124957203|NCT00449033|449467946|FG001|Treatment Period|Disease Progression|288|||
124957204|NCT00449033|449467945|FG000|Treatment Period|Consent Withdrawn|36|||
124957205|NCT00449033|449467946|FG001|Treatment Period|Consent Withdrawn|20|||
124957206|NCT00449033|449467945|FG000|Treatment Period|Amended Protocol Criteria|22|||
124957207|NCT00449033|449467946|FG001|Treatment Period|Amended Protocol Criteria|18|||
124957208|NCT00449033|449467945|FG000|Treatment Period|Non-compliance|7|||
124957209|NCT00449033|449467946|FG001|Treatment Period|Non-compliance|8|||
124957210|NCT00449033|449467945|FG000|Treatment Period|Second Malignancy|0|||
124957211|NCT00449033|449467946|FG001|Treatment Period|Second Malignancy|1|||
124957212|NCT00449033|449467945|FG000|Treatment Period|Reason Missing|0|||
124957213|NCT00449033|449467946|FG001|Treatment Period|Reason Missing|4|||
124957214|NCT00449033|449467945|FG000|Treatment Period|Treatment Ongoing|6|||
124957215|NCT00449033|449467946|FG001|Treatment Period|Treatment Ongoing|4|||
124957216|NCT00449033|449467945|FG000|Follow-up Period|Death|299|||
124957217|NCT00449033|449467946|FG001|Follow-up Period|Death|311|||
124957218|NCT00449033|449467945|FG000|Follow-up Period|Lost to Follow-up|6|||
124957219|NCT00449033|449467946|FG001|Follow-up Period|Lost to Follow-up|10|||
124957220|NCT00449033|449467945|FG000|Follow-up Period|Reason Missing|120|||
124957221|NCT00449033|449467946|FG001|Follow-up Period|Reason Missing|113|||
124957222|NCT04393779|449467947|FG000|Overall Study|Death|1|||
124957223|NCT04393779|449467947|FG000|Overall Study|Device reintervention or explant|4|||
124957224|NCT01190228|449467948|FG000|Overall Study|Protocol Violation|4|||
124957225|NCT01190228|449467949|FG001|Overall Study|Protocol Violation|0|||
124957226|NCT01190228|449467950|FG002|Overall Study|Protocol Violation|0|||
124957227|NCT01190228|449467948|FG000|Overall Study|Withdrawal by Subject|1|||
124957228|NCT01190228|449467949|FG001|Overall Study|Withdrawal by Subject|0|||
124957229|NCT01190228|449467950|FG002|Overall Study|Withdrawal by Subject|0|||
124957230|NCT01770509|449467952|FG000|Overall Study|Injury|0|||
124957231|NCT01770509|449467953|FG001|Overall Study|Injury|1|||
124957232|NCT01770509|449467952|FG000|Overall Study|Lost to Follow-up|1|||
124957233|NCT01770509|449467953|FG001|Overall Study|Lost to Follow-up|2|||
124957234|NCT00905255|449467958|FG000|Overall Study|Adverse Event|7|||
124957235|NCT00905255|449467959|FG001|Overall Study|Adverse Event|5|||
124957236|NCT00905255|449467958|FG000|Overall Study|Withdrawal by Subject|5|||
124957237|NCT00905255|449467959|FG001|Overall Study|Withdrawal by Subject|4|||
124957238|NCT00905255|449467958|FG000|Overall Study|Familial and Personal Reasons|1|||
124957239|NCT00905255|449467959|FG001|Overall Study|Familial and Personal Reasons|0|||
124957240|NCT00390806|449467962|FG000|Overall Study|Lost to Follow-up|7|||
124957241|NCT00390806|449467963|FG001|Overall Study|Lost to Follow-up|6|||
124957242|NCT00390806|449467962|FG000|Overall Study|Protocol Violation|2|||
124957243|NCT00390806|449467963|FG001|Overall Study|Protocol Violation|2|||
124957244|NCT00390806|449467962|FG000|Overall Study|Withdrawal by Subject|12|||
124957245|NCT00390806|449467963|FG001|Overall Study|Withdrawal by Subject|15|||
124957246|NCT00390806|449467962|FG000|Overall Study|Investigator Decision|4|||
124957247|NCT00390806|449467963|FG001|Overall Study|Investigator Decision|6|||
124957248|NCT00390806|449467962|FG000|Overall Study|Death|1|||
124957249|NCT00390806|449467963|FG001|Overall Study|Death|0|||
124957250|NCT00390806|449467962|FG000|Overall Study|Physician Decision|0|||
124957251|NCT00390806|449467963|FG001|Overall Study|Physician Decision|1|||
124957252|NCT00390806|449467962|FG000|Overall Study|Ongoing|4|||
124957253|NCT00390806|449467963|FG001|Overall Study|Ongoing|2|||
124957254|NCT04150250|449467966|FG000|Overall Study|Lost to Follow-up|0|||
124957255|NCT04150250|449467967|FG001|Overall Study|Lost to Follow-up|2|||
124957256|NCT01786551|449467968|FG000|Overall Study|Participant withdrew consent|2|||
124957257|NCT00170950|449467970|FG000|Overall Study|Death|236|||
124957258|NCT00170950|449467971|FG001|Overall Study|Death|274|||
124957259|NCT00170950|449467970|FG000|Overall Study|Withdrawal by Subject|496|||
124957260|NCT00170950|449467971|FG001|Overall Study|Withdrawal by Subject|498|||
124957261|NCT00170950|449467970|FG000|Overall Study|Lost to Follow-up|134|||
124957262|NCT00170950|449467971|FG001|Overall Study|Lost to Follow-up|115|||
124957263|NCT00170950|449467970|FG000|Overall Study|Missing|2|||
124462382|NCT02970292|447650868|FG001|Overall Study|Other|0|||
124957264|NCT00170950|449467971|FG001|Overall Study|Missing|1|||
124957265|NCT00170950|449467970|FG000|Overall Study|Termination Data Not Recorded|17|||
124957266|NCT00170950|449467971|FG001|Overall Study|Termination Data Not Recorded|22|||
124957267|NCT00748098|449467972|FG000|First Treatment Intervention Period|Adverse Event|1|||
124462383|NCT00446511|447650873|FG000|Overall Study|Adverse Event|7|||
124462384|NCT00446511|447650874|FG001|Overall Study|Adverse Event|2|||
124462385|NCT00446511|447650875|FG002|Overall Study|Adverse Event|3|||
124462386|NCT00446511|447650876|FG003|Overall Study|Adverse Event|1|||
124462387|NCT00446511|447650873|FG000|Overall Study|Protocol Violation|0|||
124462388|NCT00446511|447650874|FG001|Overall Study|Protocol Violation|0|||
124462389|NCT00446511|447650875|FG002|Overall Study|Protocol Violation|0|||
124462390|NCT00446511|447650876|FG003|Overall Study|Protocol Violation|1|||
124462391|NCT00446511|447650873|FG000|Overall Study|Withdrawal by Subject|0|||
124462392|NCT00446511|447650874|FG001|Overall Study|Withdrawal by Subject|0|||
124462393|NCT00446511|447650875|FG002|Overall Study|Withdrawal by Subject|0|||
124462394|NCT00446511|447650876|FG003|Overall Study|Withdrawal by Subject|3|||
124462395|NCT00446511|447650873|FG000|Overall Study|Administrative Problems|3|||
124462396|NCT00446511|447650874|FG001|Overall Study|Administrative Problems|0|||
124462397|NCT00446511|447650875|FG002|Overall Study|Administrative Problems|4|||
124462398|NCT00446511|447650876|FG003|Overall Study|Administrative Problems|1|||
124462399|NCT00542269|447650881|FG000|Overall Study|Adverse Event|10|||
124462400|NCT00542269|447650882|FG001|Overall Study|Adverse Event|4|||
124462401|NCT00542269|447650883|FG002|Overall Study|Adverse Event|5|||
124462402|NCT00542269|447650881|FG000|Overall Study|Protocol Violation|1|||
124462403|NCT00542269|447650882|FG001|Overall Study|Protocol Violation|1|||
124462404|NCT00542269|447650883|FG002|Overall Study|Protocol Violation|0|||
124462405|NCT00542269|447650881|FG000|Overall Study|Withdrawal by Subject|1|||
124462406|NCT00542269|447650882|FG001|Overall Study|Withdrawal by Subject|0|||
124462407|NCT00542269|447650883|FG002|Overall Study|Withdrawal by Subject|0|||
124462408|NCT00542269|447650881|FG000|Overall Study|Administrative problems|1|||
124462409|NCT00542269|447650882|FG001|Overall Study|Administrative problems|1|||
124462410|NCT00542269|447650883|FG002|Overall Study|Administrative problems|1|||
124462411|NCT00652366|447650884|FG000|Overall Study|Adverse Event|8|||
124462412|NCT00652366|447650885|FG001|Overall Study|Adverse Event|4|||
124462413|NCT00652366|447650886|FG002|Overall Study|Adverse Event|7|||
124462414|NCT00652366|447650887|FG003|Overall Study|Adverse Event|17|||
124462415|NCT00652366|447650888|FG004|Overall Study|Adverse Event|13|||
124462416|NCT00652366|447650884|FG000|Overall Study|Death|5|||
124462417|NCT00652366|447650885|FG001|Overall Study|Death|4|||
124462418|NCT00652366|447650886|FG002|Overall Study|Death|1|||
124957268|NCT00748098|449467973|FG001|First Treatment Intervention Period|Adverse Event|1|||
124957269|NCT00748098|449467972|FG000|First Treatment Intervention Period|Protocol Violation|1|||
124957270|NCT00748098|449467973|FG001|First Treatment Intervention Period|Protocol Violation|0|||
124957271|NCT00748098|449467972|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
124957272|NCT00748098|449467973|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
124957273|NCT00748098|449467972|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
124957274|NCT00748098|449467973|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
124957275|NCT00748098|449467972|FG000|First Taper Period|Protocol Violation|1|||
124462419|NCT00652366|447650887|FG003|Overall Study|Death|8|||
124462420|NCT00652366|447650888|FG004|Overall Study|Death|5|||
124462421|NCT00652366|447650884|FG000|Overall Study|Lack of Efficacy|84|||
124957276|NCT00748098|449467973|FG001|First Taper Period|Protocol Violation|0|||
124957277|NCT00748098|449467972|FG000|First Taper Period|Withdrawal by Subject|2|||
124957278|NCT00748098|449467973|FG001|First Taper Period|Withdrawal by Subject|0|||
124957279|NCT00748098|449467972|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
124957280|NCT00748098|449467973|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
124957281|NCT00748098|449467972|FG000|1-Week Washout Period|Adverse Event|0|||
124957282|NCT00748098|449467973|FG001|1-Week Washout Period|Adverse Event|1|||
124957283|NCT00748098|449467972|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
124462422|NCT00652366|447650885|FG001|Overall Study|Lack of Efficacy|58|||
124462423|NCT00652366|447650886|FG002|Overall Study|Lack of Efficacy|53|||
124957284|NCT00748098|449467973|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
124462424|NCT00652366|447650887|FG003|Overall Study|Lack of Efficacy|133|||
124462425|NCT00652366|447650888|FG004|Overall Study|Lack of Efficacy|13|||
124462426|NCT00652366|447650884|FG000|Overall Study|Violation of Selection Criteria|0|||
124462427|NCT00652366|447650885|FG001|Overall Study|Violation of Selection Criteria|0|||
124462428|NCT00652366|447650886|FG002|Overall Study|Violation of Selection Criteria|1|||
124462429|NCT00652366|447650887|FG003|Overall Study|Violation of Selection Criteria|0|||
124462430|NCT00652366|447650888|FG004|Overall Study|Violation of Selection Criteria|0|||
124462431|NCT00652366|447650884|FG000|Overall Study|Protocol Violation|1|||
124462432|NCT00652366|447650885|FG001|Overall Study|Protocol Violation|0|||
124462433|NCT00652366|447650886|FG002|Overall Study|Protocol Violation|0|||
124462434|NCT00652366|447650887|FG003|Overall Study|Protocol Violation|0|||
124462435|NCT00652366|447650888|FG004|Overall Study|Protocol Violation|0|||
124462436|NCT00652366|447650884|FG000|Overall Study|Refused treatment|3|||
124462437|NCT00652366|447650885|FG001|Overall Study|Refused treatment|7|||
124462438|NCT00652366|447650886|FG002|Overall Study|Refused treatment|6|||
124462439|NCT00652366|447650887|FG003|Overall Study|Refused treatment|17|||
124957285|NCT00748098|449467972|FG000|Second Treatment Intervention Period|Adverse Event|4|||
124957286|NCT00748098|449467973|FG001|Second Treatment Intervention Period|Adverse Event|1|||
124462440|NCT00652366|447650888|FG004|Overall Study|Refused treatment|5|||
124462441|NCT00652366|447650884|FG000|Overall Study|Other|5|||
124462442|NCT00652366|447650885|FG001|Overall Study|Other|2|||
124462443|NCT00652366|447650886|FG002|Overall Study|Other|3|||
124462444|NCT00652366|447650887|FG003|Overall Study|Other|4|||
124462445|NCT00652366|447650888|FG004|Overall Study|Other|0|||
124462446|NCT03873714|447650892|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
124462447|NCT03028870|447650893|FG000|Overall Study|Adverse Event|7|||
124462448|NCT03028870|447650894|FG001|Overall Study|Adverse Event|4|||
124462449|NCT03028870|447650895|FG002|Overall Study|Adverse Event|3|||
124462450|NCT03028870|447650896|FG003|Overall Study|Adverse Event|3|||
124462451|NCT03028870|447650893|FG000|Overall Study|Withdrawal by Subject|1|||
124462452|NCT03028870|447650894|FG001|Overall Study|Withdrawal by Subject|1|||
124462453|NCT03028870|447650895|FG002|Overall Study|Withdrawal by Subject|1|||
124462454|NCT03028870|447650896|FG003|Overall Study|Withdrawal by Subject|2|||
124462455|NCT03028870|447650893|FG000|Overall Study|Lost to Follow-up|1|||
124462456|NCT03028870|447650894|FG001|Overall Study|Lost to Follow-up|0|||
124462457|NCT03028870|447650895|FG002|Overall Study|Lost to Follow-up|0|||
124462458|NCT03028870|447650896|FG003|Overall Study|Lost to Follow-up|0|||
124462459|NCT03028870|447650893|FG000|Overall Study|Lack of Efficacy|3|||
124957287|NCT00748098|449467972|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
124957288|NCT00748098|449467973|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
124957289|NCT00748098|449467972|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
124957290|NCT00748098|449467973|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
124957291|NCT02442622|449467974|FG000|Overall Study|Withdrawal by Subject|3|||
124957292|NCT02442622|449467975|FG001|Overall Study|Withdrawal by Subject|1|||
124957293|NCT01232569|449469690|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
124957294|NCT01232569|449469691|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
124957295|NCT01232569|449469692|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
124957296|NCT01232569|449469693|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
124957297|NCT01232569|449469690|FG000|Double-blind Treatment Period|Escape|2|||
124957298|NCT01232569|449469691|FG001|Double-blind Treatment Period|Escape|2|||
124957299|NCT01232569|449469692|FG002|Double-blind Treatment Period|Escape|0|||
124957300|NCT01232569|449469693|FG003|Double-blind Treatment Period|Escape|0|||
124957301|NCT01232569|449469690|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
124957302|NCT01232569|449469691|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
124957303|NCT01232569|449469692|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
124957304|NCT01232569|449469693|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
124957305|NCT01232569|449469690|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
124957306|NCT01232569|449469691|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
124957307|NCT01232569|449469692|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
124957308|NCT01232569|449469693|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
124957309|NCT01232569|449469690|FG000|Double-blind Treatment Period|Physician Decision|1|||
124957310|NCT01232569|449469691|FG001|Double-blind Treatment Period|Physician Decision|0|||
124957311|NCT01232569|449469692|FG002|Double-blind Treatment Period|Physician Decision|0|||
124957312|NCT01232569|449469693|FG003|Double-blind Treatment Period|Physician Decision|0|||
124957313|NCT01232569|449469690|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
124957314|NCT01232569|449469691|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
124957315|NCT01232569|449469692|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
124957316|NCT01232569|449469693|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
124957317|NCT01232569|449469690|FG000|Double-blind Treatment Period|Death|2|||
124957318|NCT01232569|449469691|FG001|Double-blind Treatment Period|Death|0|||
124957319|NCT01232569|449469692|FG002|Double-blind Treatment Period|Death|0|||
124957320|NCT01232569|449469693|FG003|Double-blind Treatment Period|Death|0|||
124957321|NCT04044352|449469694|FG000|Overall Study|Lost to Follow-up|9|||
124957322|NCT04044352|449469694|FG000|Overall Study|Withdrawal by Subject|2|||
124957323|NCT00651937|449469695|FG000|Overall Study|Withdrawal by Subject|4|||
124957324|NCT00651937|449469696|FG001|Overall Study|Withdrawal by Subject|1|||
124957325|NCT00511147|449469697|FG000|Overall Study|Withdrawal by Subject|1|||
124957326|NCT00511147|449469697|FG000|Overall Study|Disease progression|5|||
124462460|NCT03028870|447650894|FG001|Overall Study|Lack of Efficacy|0|||
124462461|NCT03028870|447650895|FG002|Overall Study|Lack of Efficacy|0|||
124462462|NCT03028870|447650896|FG003|Overall Study|Lack of Efficacy|0|||
124462463|NCT03028870|447650893|FG000|Overall Study|Administrative|5|||
124462464|NCT03028870|447650894|FG001|Overall Study|Administrative|5|||
124462465|NCT03028870|447650895|FG002|Overall Study|Administrative|12|||
124462466|NCT03028870|447650896|FG003|Overall Study|Administrative|4|||
124957327|NCT00511147|449469697|FG000|Overall Study|Required platelet transfusion|1|||
124957328|NCT00396097|449469699|FG000|Overall Study|Withdrawal by Subject|17|||
124957329|NCT00396097|449469700|FG001|Overall Study|Withdrawal by Subject|17|||
124957330|NCT00396097|449469699|FG000|Overall Study|Lost to Follow-up|4|||
124957331|NCT00396097|449469700|FG001|Overall Study|Lost to Follow-up|9|||
124957332|NCT00396097|449469699|FG000|Overall Study|Other|3|||
124957333|NCT00396097|449469700|FG001|Overall Study|Other|5|||
124766523|NCT01910298|448773709|FG001|Overall Study|Lost to Follow-up|1|||
124766524|NCT01910298|448773708|FG000|Overall Study|Study Terminated by Sponsor|1|||
124766525|NCT01910298|448773709|FG001|Overall Study|Study Terminated by Sponsor|17|||
124766526|NCT01910298|448773708|FG000|Overall Study|Other Miscellaneous Reasons|0|||
124549208|NCT00366678|447966983|FG001|Infant Series|Protocol Violation|3|||
124549209|NCT00366678|447966984|FG002|Infant Series|Protocol Violation|0|||
124549210|NCT00366678|447966982|FG000|Infant Series|Failed to return|1|||
124549211|NCT00366678|447966983|FG001|Infant Series|Failed to return|1|||
124549212|NCT00366678|447966984|FG002|Infant Series|Failed to return|0|||
124549213|NCT00366678|447966982|FG000|Infant Series|Adverse Event|1|||
124549214|NCT00366678|447966983|FG001|Infant Series|Adverse Event|0|||
124549215|NCT00366678|447966984|FG002|Infant Series|Adverse Event|0|||
124766527|NCT01910298|448773709|FG001|Overall Study|Other Miscellaneous Reasons|2|||
124766528|NCT03037385|448773713|FG000|Overall Study|Adverse Event|0|||
124766529|NCT03037385|448773714|FG001|Overall Study|Adverse Event|0|||
124766530|NCT03037385|448773715|FG002|Overall Study|Adverse Event|1|||
124766531|NCT03037385|448773716|FG003|Overall Study|Adverse Event|0|||
124957334|NCT00396097|449469699|FG000|Overall Study|Protocol Violation|0|||
124957335|NCT00396097|449469700|FG001|Overall Study|Protocol Violation|6|||
124957336|NCT00396097|449469699|FG000|Overall Study|Adverse Event|1|||
124957337|NCT00396097|449469700|FG001|Overall Study|Adverse Event|5|||
124957338|NCT00396097|449469699|FG000|Overall Study|Insufficient Clinical Response|1|||
124957339|NCT00396097|449469700|FG001|Overall Study|Insufficient Clinical Response|4|||
124957340|NCT03461211|449469701|FG000|Overall Study|Adverse Event|1|||
124957341|NCT03461211|449469702|FG001|Overall Study|Adverse Event|1|||
124957342|NCT03461211|449469701|FG000|Overall Study|Lack of Efficacy|0|||
124957343|NCT03461211|449469702|FG001|Overall Study|Lack of Efficacy|1|||
124957344|NCT04736602|449469709|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
124957345|NCT04736602|449469709|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
124766532|NCT03037385|448773717|FG004|Overall Study|Adverse Event|0|||
124549216|NCT00366678|447966982|FG000|After Infant|Withdrawal by Subject|8|||
124549217|NCT00366678|447966983|FG001|After Infant|Withdrawal by Subject|4|||
124549218|NCT00366678|447966984|FG002|After Infant|Withdrawal by Subject|0|||
124766533|NCT03037385|448773718|FG005|Overall Study|Adverse Event|0|||
124957346|NCT00475735|449469711|FG000|Treatment Period 1|Adverse Event|2|||
124957347|NCT00475735|449469712|FG001|Treatment Period 1|Adverse Event|0|||
124957348|NCT00475735|449469713|FG002|Treatment Period 1|Adverse Event|0|||
124957349|NCT00475735|449469714|FG003|Treatment Period 1|Adverse Event|0|||
124462467|NCT00845650|447650899|FG000|Overall Study|Withdrawal by Subject|0|||
124462468|NCT00845650|447650900|FG001|Overall Study|Withdrawal by Subject|0|||
124462469|NCT00845650|447650901|FG002|Overall Study|Withdrawal by Subject|0|||
124462470|NCT00845650|447650902|FG003|Overall Study|Withdrawal by Subject|0|||
124462471|NCT00845650|447650903|FG004|Overall Study|Withdrawal by Subject|2|||
124462472|NCT00845650|447650904|FG005|Overall Study|Withdrawal by Subject|0|||
124462473|NCT00845650|447650899|FG000|Overall Study|Lost to Follow-up|0|||
124462474|NCT00845650|447650900|FG001|Overall Study|Lost to Follow-up|0|||
124462475|NCT00845650|447650901|FG002|Overall Study|Lost to Follow-up|3|||
124462476|NCT00845650|447650902|FG003|Overall Study|Lost to Follow-up|1|||
124462477|NCT00845650|447650903|FG004|Overall Study|Lost to Follow-up|0|||
124462478|NCT00845650|447650904|FG005|Overall Study|Lost to Follow-up|1|||
124462479|NCT00845650|447650899|FG000|Overall Study|Sponsor hold on dosing|0|||
124462480|NCT00845650|447650900|FG001|Overall Study|Sponsor hold on dosing|0|||
124462481|NCT00845650|447650901|FG002|Overall Study|Sponsor hold on dosing|0|||
124462482|NCT00845650|447650902|FG003|Overall Study|Sponsor hold on dosing|0|||
124462483|NCT00845650|447650903|FG004|Overall Study|Sponsor hold on dosing|1|||
124462484|NCT00845650|447650904|FG005|Overall Study|Sponsor hold on dosing|1|||
124462485|NCT00845650|447650899|FG000|Overall Study|Unable to access IV line|1|||
124462486|NCT00845650|447650900|FG001|Overall Study|Unable to access IV line|0|||
124462487|NCT00845650|447650901|FG002|Overall Study|Unable to access IV line|0|||
124462488|NCT00845650|447650902|FG003|Overall Study|Unable to access IV line|0|||
124462489|NCT00845650|447650903|FG004|Overall Study|Unable to access IV line|0|||
124462490|NCT00845650|447650904|FG005|Overall Study|Unable to access IV line|0|||
124462491|NCT00137111|447650909|FG000|Total Therapy|Death|35|||
124462492|NCT00137111|447650910|FG001|Total Therapy|Death|0|||
124462493|NCT00137111|447650911|FG002|Total Therapy|Death|0|||
124462494|NCT00137111|447650912|FG003|Total Therapy|Death|0|||
124462495|NCT00137111|447650909|FG000|Total Therapy|Non Compliance|5|||
124462496|NCT00137111|447650910|FG001|Total Therapy|Non Compliance|0|||
124462497|NCT00137111|447650911|FG002|Total Therapy|Non Compliance|0|||
124462498|NCT00137111|447650912|FG003|Total Therapy|Non Compliance|0|||
124462499|NCT04703075|447650913|FG000|Overall Study|Adverse Event|11|||
124462500|NCT04703075|447650914|FG001|Overall Study|Adverse Event|7|||
124462501|NCT04703075|447650913|FG000|Overall Study|Lost to Follow-up|6|||
124462502|NCT04703075|447650914|FG001|Overall Study|Lost to Follow-up|12|||
124462503|NCT04703075|447650913|FG000|Overall Study|Physician Decision|3|||
124462504|NCT04703075|447650914|FG001|Overall Study|Physician Decision|0|||
124462505|NCT04703075|447650913|FG000|Overall Study|Moved|0|||
124462506|NCT04703075|447650914|FG001|Overall Study|Moved|2|||
124462507|NCT04703075|447650913|FG000|Overall Study|Index INH Resistant|0|||
124462508|NCT04703075|447650914|FG001|Overall Study|Index INH Resistant|1|||
124462509|NCT04703075|447650913|FG000|Overall Study|Lack of Efficacy|6|||
124462510|NCT04703075|447650914|FG001|Overall Study|Lack of Efficacy|18|||
124462511|NCT01119248|447650915|FG000|Overall Study|Physician Decision|5|||
124462512|NCT00317109|447650916|FG000|Overall Study|Withdrawal by Subject|2|||
124462513|NCT00317109|447650917|FG001|Overall Study|Withdrawal by Subject|0|||
124462514|NCT00317109|447650916|FG000|Overall Study|Migated/moved from study area|1|||
124462515|NCT00317109|447650917|FG001|Overall Study|Migated/moved from study area|0|||
124462516|NCT01508702|447650918|FG000|Overall Study|Adverse Event|7|||
124462517|NCT01508702|447650919|FG001|Overall Study|Adverse Event|3|||
124462518|NCT01508702|447650918|FG000|Overall Study|Gout flare|2|||
124462519|NCT01508702|447650919|FG001|Overall Study|Gout flare|0|||
124462520|NCT01508702|447650918|FG000|Overall Study|Protocol Violation|2|||
124462521|NCT01508702|447650919|FG001|Overall Study|Protocol Violation|1|||
124462522|NCT01508702|447650918|FG000|Overall Study|Lost to Follow-up|1|||
124462523|NCT01508702|447650919|FG001|Overall Study|Lost to Follow-up|2|||
124462524|NCT01508702|447650918|FG000|Overall Study|Withdrawal by Subject|11|||
124462525|NCT01508702|447650919|FG001|Overall Study|Withdrawal by Subject|7|||
124462526|NCT01883635|447650920|FG000|Overall Study|Withdrawal by Subject|4|||
124462527|NCT01883635|447650921|FG001|Overall Study|Withdrawal by Subject|0|||
124462528|NCT04942925|447650927|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
124462529|NCT04942925|447650928|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
124549219|NCT00366678|447966982|FG000|After Infant|Lost to Follow-up|2|||
124549220|NCT00366678|447966983|FG001|After Infant|Lost to Follow-up|1|||
124462530|NCT04942925|447650927|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
124462531|NCT04942925|447650928|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
124462532|NCT02124564|447650929|FG000|Treatment Period|Adverse Event|2|||
124462533|NCT02124564|447650929|FG000|Treatment Period|Lack of Efficacy|3|||
124462534|NCT02124564|447650929|FG000|Treatment Period|Withdrawal by Subject|2|||
124462535|NCT03315871|447650934|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
124462536|NCT03315871|447650935|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
124462537|NCT03315871|447650936|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
124462538|NCT03315871|447650934|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
124462539|NCT03315871|447650935|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
124462540|NCT03315871|447650936|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
124462541|NCT03315871|447650934|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
124549221|NCT00366678|447966984|FG002|After Infant|Lost to Follow-up|0|||
124957350|NCT00475735|449469715|FG004|Treatment Period 1|Adverse Event|0|||
124957351|NCT00475735|449469716|FG005|Treatment Period 1|Adverse Event|0|||
124957352|NCT00475735|449469711|FG000|Treatment Period 1|Lack of Efficacy|1|||
124957353|NCT00475735|449469712|FG001|Treatment Period 1|Lack of Efficacy|0|||
124957354|NCT00475735|449469713|FG002|Treatment Period 1|Lack of Efficacy|0|||
124957355|NCT00475735|449469714|FG003|Treatment Period 1|Lack of Efficacy|0|||
124957356|NCT00475735|449469715|FG004|Treatment Period 1|Lack of Efficacy|0|||
124957357|NCT00475735|449469716|FG005|Treatment Period 1|Lack of Efficacy|0|||
124957358|NCT00475735|449469711|FG000|Treatment Period 1|Lost to Follow-up|0|||
124957359|NCT00475735|449469712|FG001|Treatment Period 1|Lost to Follow-up|0|||
124957360|NCT00475735|449469713|FG002|Treatment Period 1|Lost to Follow-up|0|||
124957361|NCT00475735|449469714|FG003|Treatment Period 1|Lost to Follow-up|0|||
124957362|NCT00475735|449469715|FG004|Treatment Period 1|Lost to Follow-up|0|||
124957363|NCT00475735|449469716|FG005|Treatment Period 1|Lost to Follow-up|1|||
124957364|NCT00475735|449469711|FG000|Treatment Period 1|Protocol Violation|0|||
124957365|NCT00475735|449469712|FG001|Treatment Period 1|Protocol Violation|0|||
124462542|NCT03315871|447650935|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
124462543|NCT03315871|447650936|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
124462544|NCT03315871|447650934|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
124462545|NCT03315871|447650935|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
124462546|NCT03315871|447650936|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
124462547|NCT03315871|447650934|FG000|PROSTVAC + CV301|Progressive disease|0|||
124462548|NCT03315871|447650935|FG001|PROSTVAC + CV301|Progressive disease|0|||
124462549|NCT03315871|447650936|FG002|PROSTVAC + CV301|Progressive disease|1|||
124462550|NCT03315871|447650934|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
124462551|NCT03315871|447650935|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
124462552|NCT03315871|447650936|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
124462553|NCT05032157|447654708|FG000|Overall Study|Adverse Event|12|||
124462554|NCT05032157|447654709|FG001|Overall Study|Adverse Event|7|||
124462555|NCT05032157|447654708|FG000|Overall Study|Pregnancy|0|||
124462556|NCT05032157|447654709|FG001|Overall Study|Pregnancy|2|||
124462557|NCT05032157|447654708|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
124462558|NCT05032157|447654709|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
124462559|NCT05032157|447654708|FG000|Overall Study|Protocol Deviation|8|||
124462560|NCT05032157|447654709|FG001|Overall Study|Protocol Deviation|4|||
124462561|NCT05032157|447654708|FG000|Overall Study|Lost to Follow-up|1|||
124462562|NCT05032157|447654709|FG001|Overall Study|Lost to Follow-up|3|||
124462563|NCT05032157|447654708|FG000|Overall Study|Physician Decision|7|||
124462564|NCT05032157|447654709|FG001|Overall Study|Physician Decision|2|||
124462565|NCT05032157|447654708|FG000|Overall Study|Patient Decision|38|||
124462566|NCT05032157|447654709|FG001|Overall Study|Patient Decision|19|||
124462567|NCT00150592|447654710|FG000|Overall Study|Adverse Event|4|||
124462568|NCT00150592|447654711|FG001|Overall Study|Adverse Event|1|||
124462569|NCT00150592|447654710|FG000|Overall Study|Protocol Violation|1|||
124462570|NCT00150592|447654711|FG001|Overall Study|Protocol Violation|0|||
124462571|NCT00150592|447654710|FG000|Overall Study|Withdrawal by Subject|1|||
124549222|NCT00366678|447966982|FG000|After Infant|Failed to return|5|||
124549223|NCT00366678|447966983|FG001|After Infant|Failed to return|5|||
124549224|NCT00366678|447966984|FG002|After Infant|Failed to return|0|||
124549225|NCT00366678|447966982|FG000|After Infant|Adverse Event|1|||
124549226|NCT00366678|447966983|FG001|After Infant|Adverse Event|0|||
124549227|NCT00366678|447966984|FG002|After Infant|Adverse Event|0|||
124549228|NCT00366678|447966982|FG000|After Infant|Protocol Violation|1|||
124549229|NCT00366678|447966983|FG001|After Infant|Protocol Violation|0|||
124549230|NCT00366678|447966984|FG002|After Infant|Protocol Violation|0|||
124549231|NCT00366678|447966982|FG000|Toddler Dose|Protocol Violation|2|||
124549232|NCT00366678|447966983|FG001|Toddler Dose|Protocol Violation|1|||
124549233|NCT00366678|447966984|FG002|Toddler Dose|Protocol Violation|0|||
124549234|NCT00366678|447966982|FG000|Toddler Dose|Failed to return|1|||
124549235|NCT00366678|447966983|FG001|Toddler Dose|Failed to return|0|||
124549236|NCT00366678|447966984|FG002|Toddler Dose|Failed to return|0|||
124549237|NCT00366678|447966982|FG000|Toddler Dose|Withdrawal by Subject|1|||
124549238|NCT00366678|447966983|FG001|Toddler Dose|Withdrawal by Subject|0|||
124549239|NCT00366678|447966984|FG002|Toddler Dose|Withdrawal by Subject|0|||
124549240|NCT00366678|447966982|FG000|Toddler Dose|protocol deviation|1|||
124549241|NCT00366678|447966983|FG001|Toddler Dose|protocol deviation|0|||
124549242|NCT00366678|447966984|FG002|Toddler Dose|protocol deviation|0|||
124549243|NCT04292171|447966985|FG000|Overall Study|Pharmacy error|2|||
124549244|NCT04292171|447966986|FG001|Overall Study|Pharmacy error|0|||
124549245|NCT04292171|447966985|FG000|Overall Study|Delivered prior to procedure|0|||
124549246|NCT04292171|447966986|FG001|Overall Study|Delivered prior to procedure|1|||
124549247|NCT01777191|447966987|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
124549248|NCT01777191|447966988|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
124549249|NCT01777191|447966987|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
124549250|NCT01777191|447966988|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
124549251|NCT01777191|447966987|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
124549252|NCT01777191|447966988|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
124549253|NCT01777191|447966987|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
124549254|NCT01777191|447966988|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
124549255|NCT01777191|447966987|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
124549256|NCT01777191|447966988|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
124957366|NCT00475735|449469713|FG002|Treatment Period 1|Protocol Violation|0|||
124462572|NCT00150592|447654711|FG001|Overall Study|Withdrawal by Subject|2|||
124462573|NCT00150592|447654710|FG000|Overall Study|Non-compliance|1|||
124462574|NCT00150592|447654711|FG001|Overall Study|Non-compliance|0|||
124462575|NCT03047980|447654712|FG000|Overall Study|Adverse Event|1|||
124462576|NCT00874120|447654717|FG000|First Intervention|Adverse Event|0|||
124549257|NCT01777191|447966987|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
124549258|NCT01777191|447966988|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
124462577|NCT00874120|447654718|FG001|First Intervention|Adverse Event|1|||
124462578|NCT00874120|447654717|FG000|First Intervention|Withdrawal by Subject|2|||
124462579|NCT00874120|447654718|FG001|First Intervention|Withdrawal by Subject|0|||
124462580|NCT00874120|447654717|FG000|First Intervention|Lost to Follow-up|0|||
124462581|NCT00874120|447654718|FG001|First Intervention|Lost to Follow-up|1|||
124462582|NCT00874120|447654717|FG000|First Intervention|Protocol Violation|3|||
124462583|NCT00874120|447654718|FG001|First Intervention|Protocol Violation|0|||
124462584|NCT00874120|447654717|FG000|First Intervention|positive drug test|1|||
124462585|NCT00874120|447654718|FG001|First Intervention|positive drug test|0|||
124462586|NCT00874120|447654717|FG000|Second Intervention|Withdrawal by Subject|1|||
124462587|NCT00874120|447654718|FG001|Second Intervention|Withdrawal by Subject|0|||
124462588|NCT00874120|447654717|FG000|Second Intervention|Protocol Violation|1|||
124462589|NCT00874120|447654718|FG001|Second Intervention|Protocol Violation|0|||
124462590|NCT01823679|447654719|FG000|Overall Study|Death|1|||
124462591|NCT02164981|447654720|FG000|Started|Withdrawal by Subject|2|||
124462592|NCT02164981|447654721|FG001|Started|Withdrawal by Subject|1|||
124462593|NCT02164981|447654722|FG002|Started|Withdrawal by Subject|0|||
124462594|NCT02164981|447654720|FG000|Started|Protocol Violation|2|||
124462595|NCT02164981|447654721|FG001|Started|Protocol Violation|0|||
124462596|NCT02164981|447654722|FG002|Started|Protocol Violation|0|||
124462597|NCT02164981|447654720|FG000|Started|Adverse Event|1|||
124462598|NCT02164981|447654721|FG001|Started|Adverse Event|2|||
124462599|NCT02164981|447654722|FG002|Started|Adverse Event|0|||
124462600|NCT02164981|447654720|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
124462601|NCT02164981|447654721|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
124462602|NCT02164981|447654722|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
124462603|NCT02164981|447654720|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
124462604|NCT02164981|447654721|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
124462605|NCT02164981|447654722|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
124462606|NCT02164981|447654720|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
124462607|NCT02164981|447654721|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
124462608|NCT02164981|447654722|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
124462609|NCT02404103|447654723|FG000|Overall Study|Adverse Event|1|||
124462610|NCT02404103|447654724|FG001|Overall Study|Adverse Event|0|||
124462611|NCT02404103|447654723|FG000|Overall Study|Lost to Follow-up|3|||
124462612|NCT02404103|447654724|FG001|Overall Study|Lost to Follow-up|3|||
124462613|NCT00328627|447654725|FG000|Overall Study|Hyperglycemic Rescue|41|||
124462614|NCT00328627|447654726|FG001|Overall Study|Hyperglycemic Rescue|18|||
124462615|NCT00328627|447654727|FG002|Overall Study|Hyperglycemic Rescue|16|||
124462616|NCT00328627|447654728|FG003|Overall Study|Hyperglycemic Rescue|13|||
124462617|NCT00328627|447654729|FG004|Overall Study|Hyperglycemic Rescue|6|||
124462618|NCT00328627|447654730|FG005|Overall Study|Hyperglycemic Rescue|5|||
124462619|NCT00328627|447654731|FG006|Overall Study|Hyperglycemic Rescue|19|||
124462620|NCT00328627|447654732|FG007|Overall Study|Hyperglycemic Rescue|6|||
124462621|NCT00328627|447654733|FG008|Overall Study|Hyperglycemic Rescue|6|||
124462622|NCT00328627|447654734|FG009|Overall Study|Hyperglycemic Rescue|11|||
124462623|NCT00328627|447654735|FG010|Overall Study|Hyperglycemic Rescue|3|||
124462624|NCT00328627|447654736|FG011|Overall Study|Hyperglycemic Rescue|2|||
124462625|NCT00328627|447654725|FG000|Overall Study|Adverse Event|3|||
124462626|NCT00328627|447654726|FG001|Overall Study|Adverse Event|1|||
124462627|NCT00328627|447654727|FG002|Overall Study|Adverse Event|2|||
124462628|NCT00328627|447654728|FG003|Overall Study|Adverse Event|3|||
124462629|NCT00328627|447654729|FG004|Overall Study|Adverse Event|1|||
124462630|NCT00328627|447654730|FG005|Overall Study|Adverse Event|2|||
124462631|NCT00328627|447654731|FG006|Overall Study|Adverse Event|1|||
124462632|NCT00328627|447654732|FG007|Overall Study|Adverse Event|2|||
124707940|NCT01128569|448555908|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124707941|NCT02519842|448555909|FG000|Base Study: Cycle 1|Screening Failure|1|||
124707942|NCT02519842|448555910|FG001|Base Study: Cycle 1|Screening Failure|1|||
124707943|NCT02519842|448555911|FG002|Base Study: Cycle 1|Screening Failure|0|||
124707944|NCT02519842|448555909|FG000|Base Study: Cycle 1|Adverse Event|1|||
124707945|NCT02519842|448555910|FG001|Base Study: Cycle 1|Adverse Event|0|||
124707946|NCT02519842|448555911|FG002|Base Study: Cycle 1|Adverse Event|0|||
124462633|NCT00328627|447654733|FG008|Overall Study|Adverse Event|0|||
124462634|NCT00328627|447654734|FG009|Overall Study|Adverse Event|7|||
124462635|NCT00328627|447654735|FG010|Overall Study|Adverse Event|5|||
124462636|NCT00328627|447654736|FG011|Overall Study|Adverse Event|4|||
124462637|NCT00328627|447654725|FG000|Overall Study|Protocol Violation|2|||
124462638|NCT00328627|447654726|FG001|Overall Study|Protocol Violation|2|||
124462639|NCT00328627|447654727|FG002|Overall Study|Protocol Violation|2|||
124462640|NCT00328627|447654728|FG003|Overall Study|Protocol Violation|8|||
124462641|NCT00328627|447654729|FG004|Overall Study|Protocol Violation|5|||
124462642|NCT00328627|447654730|FG005|Overall Study|Protocol Violation|5|||
124462643|NCT00328627|447654731|FG006|Overall Study|Protocol Violation|6|||
124462644|NCT00328627|447654732|FG007|Overall Study|Protocol Violation|2|||
124462645|NCT00328627|447654733|FG008|Overall Study|Protocol Violation|1|||
124462646|NCT00328627|447654734|FG009|Overall Study|Protocol Violation|4|||
124462647|NCT00328627|447654735|FG010|Overall Study|Protocol Violation|6|||
124462648|NCT00328627|447654736|FG011|Overall Study|Protocol Violation|2|||
124462649|NCT00328627|447654725|FG000|Overall Study|Lost to Follow-up|4|||
124462650|NCT00328627|447654726|FG001|Overall Study|Lost to Follow-up|2|||
124462651|NCT00328627|447654727|FG002|Overall Study|Lost to Follow-up|2|||
124462652|NCT00328627|447654728|FG003|Overall Study|Lost to Follow-up|4|||
124462653|NCT00328627|447654729|FG004|Overall Study|Lost to Follow-up|0|||
124462654|NCT00328627|447654730|FG005|Overall Study|Lost to Follow-up|2|||
124462655|NCT00328627|447654731|FG006|Overall Study|Lost to Follow-up|3|||
124462656|NCT00328627|447654732|FG007|Overall Study|Lost to Follow-up|0|||
124462657|NCT00328627|447654733|FG008|Overall Study|Lost to Follow-up|3|||
124462658|NCT00328627|447654734|FG009|Overall Study|Lost to Follow-up|2|||
124462659|NCT00328627|447654735|FG010|Overall Study|Lost to Follow-up|0|||
124462660|NCT00328627|447654736|FG011|Overall Study|Lost to Follow-up|1|||
124462661|NCT00328627|447654725|FG000|Overall Study|Withdrawal by Subject|5|||
124462662|NCT00328627|447654726|FG001|Overall Study|Withdrawal by Subject|4|||
124462663|NCT00328627|447654727|FG002|Overall Study|Withdrawal by Subject|5|||
124462664|NCT00328627|447654728|FG003|Overall Study|Withdrawal by Subject|6|||
124462665|NCT00328627|447654729|FG004|Overall Study|Withdrawal by Subject|2|||
124462666|NCT00328627|447654730|FG005|Overall Study|Withdrawal by Subject|5|||
124462667|NCT00328627|447654731|FG006|Overall Study|Withdrawal by Subject|4|||
124462668|NCT00328627|447654732|FG007|Overall Study|Withdrawal by Subject|4|||
124462669|NCT00328627|447654733|FG008|Overall Study|Withdrawal by Subject|4|||
124462670|NCT00328627|447654734|FG009|Overall Study|Withdrawal by Subject|5|||
124462671|NCT00328627|447654735|FG010|Overall Study|Withdrawal by Subject|2|||
124462672|NCT00328627|447654736|FG011|Overall Study|Withdrawal by Subject|7|||
124462673|NCT00328627|447654725|FG000|Overall Study|Pregnancy|0|||
124462674|NCT00328627|447654726|FG001|Overall Study|Pregnancy|1|||
124462675|NCT00328627|447654727|FG002|Overall Study|Pregnancy|0|||
124462676|NCT00328627|447654728|FG003|Overall Study|Pregnancy|0|||
124462677|NCT00328627|447654729|FG004|Overall Study|Pregnancy|0|||
124462678|NCT00328627|447654730|FG005|Overall Study|Pregnancy|0|||
124462679|NCT00328627|447654731|FG006|Overall Study|Pregnancy|0|||
124462680|NCT00328627|447654732|FG007|Overall Study|Pregnancy|0|||
124462681|NCT00328627|447654733|FG008|Overall Study|Pregnancy|0|||
124462682|NCT00328627|447654734|FG009|Overall Study|Pregnancy|0|||
124462683|NCT00328627|447654735|FG010|Overall Study|Pregnancy|0|||
124462684|NCT00328627|447654736|FG011|Overall Study|Pregnancy|0|||
124462685|NCT00328627|447654725|FG000|Overall Study|Physician Decision|4|||
124462686|NCT00328627|447654726|FG001|Overall Study|Physician Decision|3|||
124462687|NCT00328627|447654727|FG002|Overall Study|Physician Decision|1|||
124462688|NCT00328627|447654728|FG003|Overall Study|Physician Decision|2|||
124462689|NCT00328627|447654729|FG004|Overall Study|Physician Decision|1|||
124462690|NCT00328627|447654730|FG005|Overall Study|Physician Decision|1|||
124462691|NCT00328627|447654731|FG006|Overall Study|Physician Decision|1|||
124462692|NCT00328627|447654732|FG007|Overall Study|Physician Decision|0|||
124462693|NCT00328627|447654733|FG008|Overall Study|Physician Decision|3|||
124462694|NCT00328627|447654734|FG009|Overall Study|Physician Decision|2|||
124462695|NCT00328627|447654735|FG010|Overall Study|Physician Decision|1|||
124462696|NCT00328627|447654736|FG011|Overall Study|Physician Decision|0|||
124462697|NCT00328627|447654725|FG000|Overall Study|Other|0|||
124462698|NCT00328627|447654726|FG001|Overall Study|Other|0|||
124462699|NCT00328627|447654727|FG002|Overall Study|Other|0|||
124462700|NCT00328627|447654728|FG003|Overall Study|Other|1|||
124462701|NCT00328627|447654729|FG004|Overall Study|Other|0|||
124462702|NCT00328627|447654730|FG005|Overall Study|Other|0|||
124462703|NCT00328627|447654731|FG006|Overall Study|Other|1|||
124462704|NCT00328627|447654732|FG007|Overall Study|Other|0|||
124462705|NCT00328627|447654733|FG008|Overall Study|Other|0|||
124462706|NCT00328627|447654734|FG009|Overall Study|Other|1|||
124462707|NCT00328627|447654735|FG010|Overall Study|Other|1|||
124462708|NCT00328627|447654736|FG011|Overall Study|Other|0|||
124957367|NCT00475735|449469714|FG003|Treatment Period 1|Protocol Violation|1|||
124957368|NCT00475735|449469715|FG004|Treatment Period 1|Protocol Violation|0|||
124957369|NCT00475735|449469716|FG005|Treatment Period 1|Protocol Violation|0|||
124462709|NCT04682405|447654737|FG000|Overall Study|Adverse Event|0|||
124462710|NCT04682405|447654738|FG001|Overall Study|Adverse Event|1|||
124462711|NCT01049035|447654741|FG000|Overall Study|Serious adverse event|0|||
124462712|NCT01049035|447654742|FG001|Overall Study|Serious adverse event|1|||
124462713|NCT01049035|447654743|FG002|Overall Study|Serious adverse event|1|||
124462714|NCT01049035|447654744|FG003|Overall Study|Serious adverse event|2|||
124462715|NCT01049035|447654745|FG004|Overall Study|Serious adverse event|0|||
124957370|NCT00475735|449469711|FG000|Treatment Period 1|Withdrawal by Subject|1|||
124462716|NCT01049035|447654746|FG005|Overall Study|Serious adverse event|0|||
124462717|NCT01049035|447654747|FG006|Overall Study|Serious adverse event|0|||
124462718|NCT01049035|447654741|FG000|Overall Study|Other adverse event (AE)|0|||
124462719|NCT01049035|447654742|FG001|Overall Study|Other adverse event (AE)|0|||
124462720|NCT01049035|447654743|FG002|Overall Study|Other adverse event (AE)|0|||
124462721|NCT01049035|447654744|FG003|Overall Study|Other adverse event (AE)|1|||
124462722|NCT01049035|447654745|FG004|Overall Study|Other adverse event (AE)|0|||
124462723|NCT01049035|447654746|FG005|Overall Study|Other adverse event (AE)|0|||
124957371|NCT00475735|449469712|FG001|Treatment Period 1|Withdrawal by Subject|1|||
124957372|NCT00475735|449469713|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124957373|NCT00475735|449469714|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124957374|NCT00475735|449469715|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124462724|NCT01049035|447654747|FG006|Overall Study|Other adverse event (AE)|0|||
124957375|NCT00475735|449469716|FG005|Treatment Period 1|Withdrawal by Subject|0|||
124957376|NCT00475735|449469711|FG000|Treatment Period 1|DC due to AE but continuing|0|||
124957377|NCT00475735|449469712|FG001|Treatment Period 1|DC due to AE but continuing|0|||
124957378|NCT00475735|449469713|FG002|Treatment Period 1|DC due to AE but continuing|0|||
124957379|NCT00475735|449469714|FG003|Treatment Period 1|DC due to AE but continuing|1|||
124957380|NCT00475735|449469715|FG004|Treatment Period 1|DC due to AE but continuing|2|||
124957381|NCT00475735|449469716|FG005|Treatment Period 1|DC due to AE but continuing|2|||
124957382|NCT00475735|449469711|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
124957383|NCT00475735|449469712|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
124957384|NCT00475735|449469713|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
124957385|NCT00475735|449469714|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
124957386|NCT00475735|449469715|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
124957387|NCT00475735|449469716|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
124462725|NCT01049035|447654741|FG000|Overall Study|Non-compliance with the protocol|12|||
124462726|NCT01049035|447654742|FG001|Overall Study|Non-compliance with the protocol|6|||
124462727|NCT01049035|447654743|FG002|Overall Study|Non-compliance with the protocol|14|||
124462728|NCT01049035|447654744|FG003|Overall Study|Non-compliance with the protocol|5|||
124462729|NCT01049035|447654745|FG004|Overall Study|Non-compliance with the protocol|3|||
124462730|NCT01049035|447654746|FG005|Overall Study|Non-compliance with the protocol|4|||
124462731|NCT01049035|447654747|FG006|Overall Study|Non-compliance with the protocol|10|||
124462732|NCT01049035|447654741|FG000|Overall Study|Lost to Follow-up|5|||
124462733|NCT01049035|447654742|FG001|Overall Study|Lost to Follow-up|4|||
124462734|NCT01049035|447654743|FG002|Overall Study|Lost to Follow-up|4|||
124462735|NCT01049035|447654744|FG003|Overall Study|Lost to Follow-up|1|||
124462736|NCT01049035|447654745|FG004|Overall Study|Lost to Follow-up|0|||
124462737|NCT01049035|447654746|FG005|Overall Study|Lost to Follow-up|3|||
124462738|NCT01049035|447654747|FG006|Overall Study|Lost to Follow-up|3|||
124462739|NCT01049035|447654741|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
124462740|NCT01049035|447654742|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
124462741|NCT01049035|447654743|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
124462742|NCT01049035|447654744|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
124462743|NCT01049035|447654745|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
124462744|NCT01049035|447654746|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
124462745|NCT01049035|447654747|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
124462746|NCT01137773|447654748|FG000|Overall Study|Death|3|||
124462747|NCT01137773|447654749|FG001|Overall Study|Death|3|||
124462748|NCT01137773|447654748|FG000|Overall Study|Lost to Follow-up|6|||
124462749|NCT01137773|447654749|FG001|Overall Study|Lost to Follow-up|0|||
124462750|NCT03927105|447654750|FG000|Overall Study|Death|1|||
124462751|NCT03927105|447654750|FG000|Overall Study|In observation for potential re-treatment|2|||
124462752|NCT03927105|447654750|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
124462753|NCT02684981|447654752|FG000|Overall Study|Permanently discontinued the treatment|157|||
124462754|NCT02684981|447654753|FG001|Overall Study|Permanently discontinued the treatment|161|||
124462755|NCT02684981|447654754|FG002|Overall Study|Permanently discontinued the treatment|110|||
124462756|NCT02684981|447654752|FG000|Overall Study|Other|83|||
124462757|NCT02684981|447654753|FG001|Overall Study|Other|49|||
124462758|NCT02684981|447654754|FG002|Overall Study|Other|17|||
124462759|NCT00820898|447654755|FG000|Overall Study|Inelgible - wrong primary site|1|||
124462760|NCT01652287|447654758|FG000|Overall Study|Withdrawal by Subject|2|||
124462761|NCT01652287|447654759|FG001|Overall Study|Withdrawal by Subject|0|||
124462762|NCT00763139|447654760|FG000|Overall Study|Adverse Event|4|||
124462763|NCT00763139|447654761|FG001|Overall Study|Adverse Event|2|||
124462764|NCT00763139|447654760|FG000|Overall Study|Withdrawal by Subject|0|||
124462765|NCT00763139|447654761|FG001|Overall Study|Withdrawal by Subject|1|||
124957388|NCT00475735|449469711|FG000|Treatment Washout|Lost to Follow-up|0|||
124957389|NCT00475735|449469712|FG001|Treatment Washout|Lost to Follow-up|1|||
124462766|NCT00763139|447654760|FG000|Overall Study|med change not allowed by protocol|1|||
124462767|NCT00763139|447654761|FG001|Overall Study|med change not allowed by protocol|0|||
124462768|NCT02095535|447654762|FG000|Recruitment|Protocol Violation|2|||
124462769|NCT01877187|447654763|FG000|Overall Study|Death|2|||
124957390|NCT00475735|449469713|FG002|Treatment Washout|Lost to Follow-up|0|||
124957391|NCT00475735|449469714|FG003|Treatment Washout|Lost to Follow-up|0|||
124957392|NCT00475735|449469715|FG004|Treatment Washout|Lost to Follow-up|0|||
124957393|NCT00475735|449469716|FG005|Treatment Washout|Lost to Follow-up|0|||
124957394|NCT00475735|449469711|FG000|Treatment Washout|Protocol Violation|0|||
124462770|NCT01877187|447654763|FG000|Overall Study|Withdrawal by Subject|4|||
124462771|NCT01877187|447654763|FG000|Overall Study|Lost to Follow-up|3|||
124462772|NCT01877187|447654763|FG000|Overall Study|Declining clinical status|11|||
124462773|NCT01877187|447654763|FG000|Overall Study|Liver transplant|2|||
124957395|NCT00475735|449469712|FG001|Treatment Washout|Protocol Violation|1|||
124957396|NCT00475735|449469713|FG002|Treatment Washout|Protocol Violation|0|||
124462774|NCT01289015|447654771|FG000|Overall Study|Protocol Violation|12|||
124462775|NCT01289015|447654772|FG001|Overall Study|Protocol Violation|9|||
124462776|NCT01289015|447654771|FG000|Overall Study|Adverse Event|3|||
124462777|NCT01289015|447654772|FG001|Overall Study|Adverse Event|0|||
124462778|NCT01289015|447654771|FG000|Overall Study|Lost to Follow-up|33|||
124462779|NCT01289015|447654772|FG001|Overall Study|Lost to Follow-up|17|||
124462780|NCT01289015|447654771|FG000|Overall Study|Withdrawal by Subject|17|||
124462781|NCT01289015|447654772|FG001|Overall Study|Withdrawal by Subject|8|||
124462782|NCT01289015|447654771|FG000|Overall Study|Disease progression|1|||
124462783|NCT01289015|447654772|FG001|Overall Study|Disease progression|0|||
124462784|NCT01289015|447654771|FG000|Overall Study|Negative baseline culture and others|33|||
124462785|NCT01289015|447654772|FG001|Overall Study|Negative baseline culture and others|20|||
124462786|NCT01709149|447654777|FG000|Open-label Lead-in Phase|Adverse Event|109|||
124462787|NCT01709149|447654778|FG001|Open-label Lead-in Phase|Adverse Event|0|||
124462788|NCT01709149|447654779|FG002|Open-label Lead-in Phase|Adverse Event|0|||
124462789|NCT01709149|447654777|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
124462790|NCT01709149|447654778|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
124462791|NCT01709149|447654779|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
124462792|NCT01709149|447654777|FG000|Open-label Lead-in Phase|Death|1|||
124462793|NCT01709149|447654778|FG001|Open-label Lead-in Phase|Death|0|||
124462794|NCT01709149|447654779|FG002|Open-label Lead-in Phase|Death|0|||
124462795|NCT01709149|447654777|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
124462796|NCT01709149|447654778|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
124462797|NCT01709149|447654779|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
124462798|NCT01709149|447654777|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
124462799|NCT01709149|447654778|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
124462800|NCT01709149|447654779|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
124462801|NCT01709149|447654777|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
124462802|NCT01709149|447654778|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
124462803|NCT01709149|447654779|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
124462804|NCT01709149|447654777|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
124462805|NCT01709149|447654778|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
124462806|NCT01709149|447654779|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
124462807|NCT01709149|447654777|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
124462808|NCT01709149|447654778|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
124462809|NCT01709149|447654779|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
124462810|NCT01709149|447654777|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
124462811|NCT01709149|447654778|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
124462812|NCT01709149|447654779|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
124462813|NCT01709149|447654777|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
124549259|NCT01777191|447966987|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
124549260|NCT01777191|447966988|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
124707947|NCT02519842|448555909|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
124707948|NCT02519842|448555910|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
124707949|NCT02519842|448555911|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
124707950|NCT02519842|448555909|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
124707951|NCT02519842|448555910|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
124707952|NCT02519842|448555911|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
124707953|NCT02519842|448555909|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
124707954|NCT02519842|448555910|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
124707955|NCT02519842|448555911|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
124707956|NCT02519842|448555909|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
124707957|NCT02519842|448555910|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
124707958|NCT02519842|448555911|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
124707959|NCT02519842|448555909|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
124707960|NCT02519842|448555910|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
124707961|NCT02519842|448555911|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
124707962|NCT02519842|448555909|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
124707963|NCT02519842|448555910|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
124707964|NCT02519842|448555911|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
124707965|NCT02519842|448555909|FG000|Optional Extension: Cycles 2-6|Death|0|||
124707966|NCT02519842|448555910|FG001|Optional Extension: Cycles 2-6|Death|0|||
124707967|NCT02519842|448555911|FG002|Optional Extension: Cycles 2-6|Death|1|||
124707968|NCT02519842|448555909|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
124707969|NCT02519842|448555910|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
124707970|NCT02519842|448555911|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
124707971|NCT02519842|448555909|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
124766534|NCT03037385|448773719|FG006|Overall Study|Adverse Event|0|||
124462814|NCT01709149|447654778|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
124462815|NCT01709149|447654779|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
124462816|NCT02192827|447654780|FG000|Overall Study|Lost to Follow-up|25|||
124462817|NCT02192827|447654781|FG001|Overall Study|Lost to Follow-up|27|||
124462818|NCT02192827|447654780|FG000|Overall Study|Given additional steroids with admission|13|||
124462819|NCT02192827|447654781|FG001|Overall Study|Given additional steroids with admission|11|||
124462820|NCT02559687|447654786|FG000|Overall Study|Death|112|||
124462821|NCT02559687|447654786|FG000|Overall Study|Sponsor Decision|5|||
124462822|NCT02559687|447654786|FG000|Overall Study|Withdrawal by Subject|4|||
124462823|NCT01857869|447654800|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
124462824|NCT01857869|447654801|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
124462825|NCT01857869|447654802|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
124462826|NCT01857869|447654803|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
124462827|NCT01857869|447654804|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
124462828|NCT01857869|447654805|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
124462829|NCT01857869|447654806|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
124462830|NCT01857869|447654807|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
124462831|NCT01857869|447654808|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
124462832|NCT01857869|447654809|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
124462833|NCT01857869|447654800|FG000|Primary/Challenge Phase|Pregnancy|1|||
124462834|NCT01857869|447654801|FG001|Primary/Challenge Phase|Pregnancy|0|||
124462835|NCT01857869|447654802|FG002|Primary/Challenge Phase|Pregnancy|0|||
124462836|NCT01857869|447654803|FG003|Primary/Challenge Phase|Pregnancy|0|||
124462837|NCT01857869|447654804|FG004|Primary/Challenge Phase|Pregnancy|0|||
124462838|NCT01857869|447654805|FG005|Primary/Challenge Phase|Pregnancy|0|||
124462839|NCT01857869|447654806|FG006|Primary/Challenge Phase|Pregnancy|0|||
124462840|NCT01857869|447654807|FG007|Primary/Challenge Phase|Pregnancy|0|||
124462841|NCT01857869|447654808|FG008|Primary/Challenge Phase|Pregnancy|0|||
124462842|NCT01857869|447654809|FG009|Primary/Challenge Phase|Pregnancy|0|||
124462843|NCT01857869|447654800|FG000|Primary/Challenge Phase|Protocol Violation|1|||
124462844|NCT01857869|447654801|FG001|Primary/Challenge Phase|Protocol Violation|0|||
124462845|NCT01857869|447654802|FG002|Primary/Challenge Phase|Protocol Violation|0|||
124462846|NCT01857869|447654803|FG003|Primary/Challenge Phase|Protocol Violation|0|||
124462847|NCT01857869|447654804|FG004|Primary/Challenge Phase|Protocol Violation|0|||
124462848|NCT01857869|447654805|FG005|Primary/Challenge Phase|Protocol Violation|0|||
124462849|NCT01857869|447654806|FG006|Primary/Challenge Phase|Protocol Violation|0|||
124462850|NCT01857869|447654807|FG007|Primary/Challenge Phase|Protocol Violation|0|||
124462851|NCT01857869|447654808|FG008|Primary/Challenge Phase|Protocol Violation|0|||
124462852|NCT01857869|447654809|FG009|Primary/Challenge Phase|Protocol Violation|0|||
124462853|NCT01857869|447654800|FG000|Primary/Challenge Phase|Other|1|||
124462854|NCT01857869|447654801|FG001|Primary/Challenge Phase|Other|1|||
124462855|NCT01857869|447654802|FG002|Primary/Challenge Phase|Other|0|||
124462856|NCT01857869|447654803|FG003|Primary/Challenge Phase|Other|0|||
124462857|NCT01857869|447654804|FG004|Primary/Challenge Phase|Other|0|||
124462858|NCT01857869|447654805|FG005|Primary/Challenge Phase|Other|0|||
124462859|NCT01857869|447654806|FG006|Primary/Challenge Phase|Other|0|||
124462860|NCT01857869|447654807|FG007|Primary/Challenge Phase|Other|0|||
124462861|NCT01857869|447654808|FG008|Primary/Challenge Phase|Other|0|||
124462862|NCT01857869|447654809|FG009|Primary/Challenge Phase|Other|0|||
124462863|NCT01857869|447654800|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
124462864|NCT01857869|447654801|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
124462865|NCT01857869|447654802|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
124462866|NCT01857869|447654803|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
124462867|NCT01857869|447654804|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
124462868|NCT01857869|447654805|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
124462869|NCT01857869|447654806|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
124957397|NCT00475735|449469714|FG003|Treatment Washout|Protocol Violation|0|||
124957398|NCT00475735|449469715|FG004|Treatment Washout|Protocol Violation|0|||
124957399|NCT00475735|449469716|FG005|Treatment Washout|Protocol Violation|0|||
124462870|NCT01857869|447654807|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
124462871|NCT01857869|447654808|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
124957400|NCT00475735|449469711|FG000|Treatment Period 2|Adverse Event|0|||
124957401|NCT00475735|449469712|FG001|Treatment Period 2|Adverse Event|1|||
124957402|NCT00475735|449469713|FG002|Treatment Period 2|Adverse Event|0|||
124462872|NCT01857869|447654809|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
124462873|NCT01857869|447654800|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
124462874|NCT01857869|447654801|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
124462875|NCT01857869|447654802|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
124462876|NCT01857869|447654803|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
124462877|NCT01857869|447654804|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
124462878|NCT01857869|447654805|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
124957403|NCT00475735|449469714|FG003|Treatment Period 2|Adverse Event|2|||
124957404|NCT00475735|449469715|FG004|Treatment Period 2|Adverse Event|0|||
124957405|NCT00475735|449469716|FG005|Treatment Period 2|Adverse Event|0|||
124462879|NCT01857869|447654806|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
124462880|NCT01857869|447654807|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
124462881|NCT01857869|447654808|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
124462882|NCT01857869|447654809|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
124462883|NCT01902290|447654843|FG000|Overall Study|Withdrawal by Subject|19|||
124462884|NCT01902290|447654844|FG001|Overall Study|Withdrawal by Subject|27|||
124462885|NCT01902290|447654843|FG000|Overall Study|Lost to Follow-up|2|||
124462886|NCT01902290|447654844|FG001|Overall Study|Lost to Follow-up|2|||
124462887|NCT01902290|447654843|FG000|Overall Study|Death|1|||
124462888|NCT01902290|447654844|FG001|Overall Study|Death|0|||
124462889|NCT01902290|447654843|FG000|Overall Study|Sponsor Decision|26|||
124462890|NCT01902290|447654844|FG001|Overall Study|Sponsor Decision|24|||
124462891|NCT02199080|447654853|FG000|Overall Study|Protocol Violation|12|||
124462892|NCT02250274|447654854|FG000|Overall Study|Insufficient blood draw amount|7|||
124462893|NCT02250274|447654855|FG001|Overall Study|Insufficient blood draw amount|6|||
124462894|NCT01277549|447654856|FG000|Overall Study|Failed to meet eligibility criteria|13|||
124462895|NCT01277549|447654857|FG001|Overall Study|Failed to meet eligibility criteria|9|||
124766535|NCT03037385|448773720|FG007|Overall Study|Adverse Event|0|||
124766536|NCT03037385|448773721|FG008|Overall Study|Adverse Event|0|||
124766537|NCT03037385|448773722|FG009|Overall Study|Adverse Event|6|||
124766538|NCT03037385|448773713|FG000|Overall Study|Death|1|||
124766539|NCT03037385|448773714|FG001|Overall Study|Death|4|||
124766540|NCT03037385|448773715|FG002|Overall Study|Death|2|||
124766541|NCT03037385|448773716|FG003|Overall Study|Death|2|||
124766542|NCT03037385|448773717|FG004|Overall Study|Death|5|||
124766543|NCT03037385|448773718|FG005|Overall Study|Death|2|||
124766544|NCT03037385|448773719|FG006|Overall Study|Death|1|||
124766545|NCT03037385|448773720|FG007|Overall Study|Death|4|||
124766546|NCT03037385|448773721|FG008|Overall Study|Death|3|||
124766547|NCT03037385|448773722|FG009|Overall Study|Death|240|||
124766548|NCT03037385|448773713|FG000|Overall Study|Initiation of Another Therapy|1|||
124766549|NCT03037385|448773714|FG001|Overall Study|Initiation of Another Therapy|0|||
124766550|NCT03037385|448773715|FG002|Overall Study|Initiation of Another Therapy|0|||
124766551|NCT03037385|448773716|FG003|Overall Study|Initiation of Another Therapy|0|||
124766552|NCT03037385|448773717|FG004|Overall Study|Initiation of Another Therapy|0|||
124766553|NCT03037385|448773718|FG005|Overall Study|Initiation of Another Therapy|0|||
124766554|NCT03037385|448773719|FG006|Overall Study|Initiation of Another Therapy|0|||
124766555|NCT03037385|448773720|FG007|Overall Study|Initiation of Another Therapy|1|||
124766556|NCT03037385|448773721|FG008|Overall Study|Initiation of Another Therapy|0|||
124766557|NCT03037385|448773722|FG009|Overall Study|Initiation of Another Therapy|2|||
124766558|NCT03037385|448773713|FG000|Overall Study|Lost to Follow-up|0|||
124766559|NCT03037385|448773714|FG001|Overall Study|Lost to Follow-up|0|||
124766560|NCT03037385|448773715|FG002|Overall Study|Lost to Follow-up|0|||
124766561|NCT03037385|448773716|FG003|Overall Study|Lost to Follow-up|0|||
124766562|NCT03037385|448773717|FG004|Overall Study|Lost to Follow-up|0|||
124766563|NCT03037385|448773718|FG005|Overall Study|Lost to Follow-up|1|||
124766564|NCT03037385|448773719|FG006|Overall Study|Lost to Follow-up|0|||
124766565|NCT03037385|448773720|FG007|Overall Study|Lost to Follow-up|0|||
124766566|NCT03037385|448773721|FG008|Overall Study|Lost to Follow-up|0|||
124766567|NCT03037385|448773722|FG009|Overall Study|Lost to Follow-up|16|||
124766568|NCT03037385|448773713|FG000|Overall Study|Physician Decision|0|||
124766569|NCT03037385|448773714|FG001|Overall Study|Physician Decision|0|||
124957406|NCT00475735|449469711|FG000|Treatment Period 2|Lack of Efficacy|0|||
124957407|NCT00475735|449469712|FG001|Treatment Period 2|Lack of Efficacy|0|||
124957408|NCT00475735|449469713|FG002|Treatment Period 2|Lack of Efficacy|0|||
124462896|NCT01277549|447654856|FG000|Overall Study|Withdrawal by Subject|1|||
124462897|NCT01277549|447654857|FG001|Overall Study|Withdrawal by Subject|3|||
124462898|NCT01277549|447654856|FG000|Overall Study|Protocol Violation|10|||
124462899|NCT01277549|447654857|FG001|Overall Study|Protocol Violation|1|||
124462900|NCT01277549|447654856|FG000|Overall Study|Physician Decision|2|||
124462901|NCT01277549|447654857|FG001|Overall Study|Physician Decision|1|||
124462902|NCT01618214|447654860|FG000|Overall Study|Adverse Event|3|||
124462903|NCT01618214|447654861|FG001|Overall Study|Adverse Event|1|||
124549261|NCT01777191|447966987|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
124549262|NCT01777191|447966988|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
124957409|NCT00475735|449469714|FG003|Treatment Period 2|Lack of Efficacy|0|||
124462904|NCT01618214|447654860|FG000|Overall Study|Lack of Efficacy|1|||
124766570|NCT03037385|448773715|FG002|Overall Study|Physician Decision|0|||
124766571|NCT03037385|448773716|FG003|Overall Study|Physician Decision|0|||
124766572|NCT03037385|448773717|FG004|Overall Study|Physician Decision|0|||
124766573|NCT03037385|448773718|FG005|Overall Study|Physician Decision|0|||
124957410|NCT00475735|449469715|FG004|Treatment Period 2|Lack of Efficacy|0|||
124462905|NCT01618214|447654861|FG001|Overall Study|Lack of Efficacy|1|||
124766574|NCT03037385|448773719|FG006|Overall Study|Physician Decision|0|||
124766575|NCT03037385|448773720|FG007|Overall Study|Physician Decision|0|||
124766576|NCT03037385|448773721|FG008|Overall Study|Physician Decision|0|||
124957411|NCT00475735|449469716|FG005|Treatment Period 2|Lack of Efficacy|1|||
124707972|NCT02519842|448555910|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
124707973|NCT02519842|448555911|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
124707974|NCT02519842|448555909|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
124707975|NCT02519842|448555910|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
124707976|NCT02519842|448555911|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
124707977|NCT02519842|448555909|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
124957412|NCT00475735|449469711|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124957413|NCT00475735|449469712|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124957414|NCT00475735|449469713|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124957415|NCT00475735|449469714|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124957416|NCT00475735|449469715|FG004|Treatment Period 2|Withdrawal by Subject|1|||
124957417|NCT00475735|449469716|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124957418|NCT03132753|449469717|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
124957419|NCT03132753|449469718|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
124957420|NCT03132753|449469717|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
124462906|NCT01618214|447654860|FG000|Overall Study|Protocol Violation|1|||
124957421|NCT03132753|449469718|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
124462907|NCT01618214|447654861|FG001|Overall Study|Protocol Violation|4|||
124462908|NCT01618214|447654860|FG000|Overall Study|Withdrawal Criteria|1|||
124462909|NCT01618214|447654861|FG001|Overall Study|Withdrawal Criteria|2|||
124462910|NCT01618214|447654860|FG000|Overall Study|Unclassified|4|||
124462911|NCT01618214|447654861|FG001|Overall Study|Unclassified|5|||
124462912|NCT00391222|447654862|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
124462913|NCT00391222|447654863|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
124462914|NCT00391222|447654864|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
124462915|NCT00391222|447654865|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
124462916|NCT00391222|447654862|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
124462917|NCT00391222|447654863|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
124462918|NCT00391222|447654864|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
124462919|NCT00391222|447654865|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
124462920|NCT00391222|447654862|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
124462921|NCT00391222|447654863|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
124462922|NCT00391222|447654864|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
124462923|NCT00391222|447654865|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
124462924|NCT00391222|447654862|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
124462925|NCT00391222|447654863|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
124462926|NCT00391222|447654864|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
124462927|NCT00391222|447654865|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
124462928|NCT00391222|447654862|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
124462929|NCT00391222|447654863|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
124462930|NCT00391222|447654864|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
124462931|NCT00391222|447654865|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
124462932|NCT00391222|447654862|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
124462933|NCT00391222|447654863|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
124462934|NCT00391222|447654864|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
124462935|NCT00391222|447654865|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
124462936|NCT00391222|447654862|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
124462937|NCT00391222|447654863|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
124462938|NCT00391222|447654864|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
124462939|NCT00391222|447654865|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
124462940|NCT00391222|447654862|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
124462941|NCT00391222|447654863|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
124462942|NCT00391222|447654864|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
124462943|NCT00391222|447654865|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
124462944|NCT00391222|447654862|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
124462945|NCT00391222|447654863|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
124462946|NCT00391222|447654864|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
124462947|NCT00391222|447654865|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
124462948|NCT00391222|447654862|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
124462949|NCT00391222|447654863|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
124462950|NCT00391222|447654864|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
124462951|NCT00391222|447654865|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
124462952|NCT00391222|447654862|FG000|Period III (Double-Blind Treatment)|Other|6|||
124462953|NCT00391222|447654863|FG001|Period III (Double-Blind Treatment)|Other|1|||
124462954|NCT00391222|447654864|FG002|Period III (Double-Blind Treatment)|Other|6|||
124462955|NCT00391222|447654865|FG003|Period III (Double-Blind Treatment)|Other|0|||
124462956|NCT00574275|447654866|FG000|Overall Study|Randomized but not treated|2|||
124462957|NCT00574275|447654867|FG001|Overall Study|Randomized but not treated|3|||
124462958|NCT00574275|447654866|FG000|Overall Study|Adverse Event|32|||
124462959|NCT00574275|447654867|FG001|Overall Study|Adverse Event|76|||
124549263|NCT01777191|447966987|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
124707978|NCT02519842|448555910|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
124707979|NCT02519842|448555911|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
124707980|NCT02115321|448555916|FG000|Overall Study|Death|1|||
124707981|NCT02115321|448555917|FG001|Overall Study|Death|0|||
124707982|NCT01493414|448555921|FG000|Overall Study|Adverse Event|405|||
124707983|NCT01493414|448555921|FG000|Overall Study|Disease progression|204|||
124707984|NCT01493414|448555921|FG000|Overall Study|Death|101|||
124707985|NCT01493414|448555921|FG000|Overall Study|Physician Decision|93|||
124707986|NCT01493414|448555921|FG000|Overall Study|Withdrawal by Subject|79|||
124707987|NCT01493414|448555921|FG000|Overall Study|Protocol deviation|27|||
124707988|NCT01493414|448555921|FG000|Overall Study|Administrative problems|25|||
124462960|NCT00574275|447654866|FG000|Overall Study|Disease progression|160|||
124707989|NCT01493414|448555921|FG000|Overall Study|Lost to Follow-up|16|||
124707990|NCT01119287|448555926|FG000|Overall Study|Patient Decision, not related to AE|0|||
124957422|NCT00125853|449469719|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
124462961|NCT00574275|447654867|FG001|Overall Study|Disease progression|146|||
124462962|NCT00574275|447654866|FG000|Overall Study|Lost to Follow-up|2|||
124462963|NCT00574275|447654867|FG001|Overall Study|Lost to Follow-up|1|||
124462964|NCT00574275|447654866|FG000|Overall Study|Study stopped based on DMC decision|62|||
124462965|NCT00574275|447654867|FG001|Overall Study|Study stopped based on DMC decision|23|||
124462966|NCT00574275|447654866|FG000|Overall Study|Withdrawal by Subject|15|||
124462967|NCT00574275|447654867|FG001|Overall Study|Withdrawal by Subject|17|||
124462968|NCT00574275|447654866|FG000|Overall Study|Error calculating tumor measurement|1|||
124462969|NCT00574275|447654867|FG001|Overall Study|Error calculating tumor measurement|0|||
124462970|NCT00574275|447654866|FG000|Overall Study|Physician Decision|1|||
124462971|NCT00574275|447654867|FG001|Overall Study|Physician Decision|1|||
124462972|NCT00574275|447654866|FG000|Overall Study|Protocol Violation|0|||
124462973|NCT00574275|447654867|FG001|Overall Study|Protocol Violation|1|||
124462974|NCT00574275|447654866|FG000|Overall Study|Patient and Investigator decision|0|||
124462975|NCT00574275|447654867|FG001|Overall Study|Patient and Investigator decision|1|||
124462976|NCT00574275|447654866|FG000|Overall Study|Insurance change|0|||
124462977|NCT00574275|447654867|FG001|Overall Study|Insurance change|1|||
124462978|NCT00574275|447654866|FG000|Overall Study|Operation for curative intent|0|||
124462979|NCT00574275|447654867|FG001|Overall Study|Operation for curative intent|1|||
124462980|NCT01181011|447654870|FG000|Overall Study|Adverse Event|2|||
124462981|NCT01181011|447654870|FG000|Overall Study|Lost to Follow-up|1|||
124462982|NCT02788747|447654871|FG000|Overall Study|Adverse Event|1|||
124462983|NCT02788747|447654872|FG001|Overall Study|Adverse Event|0|||
124462984|NCT02788747|447654873|FG002|Overall Study|Adverse Event|0|||
124462985|NCT01967550|447654874|FG000|Overall Study|Withdrawal by Subject|1|||
124766577|NCT03037385|448773722|FG009|Overall Study|Physician Decision|1|||
124462986|NCT01967550|447654875|FG001|Overall Study|Withdrawal by Subject|0|||
124462987|NCT01967550|447654874|FG000|Overall Study|Adverse Event|2|||
124462988|NCT01967550|447654875|FG001|Overall Study|Adverse Event|0|||
124766578|NCT03037385|448773713|FG000|Overall Study|Progressive Disease|0|||
124766579|NCT03037385|448773714|FG001|Overall Study|Progressive Disease|1|||
124766580|NCT03037385|448773715|FG002|Overall Study|Progressive Disease|1|||
124766581|NCT03037385|448773716|FG003|Overall Study|Progressive Disease|5|||
124766582|NCT03037385|448773717|FG004|Overall Study|Progressive Disease|2|||
124766583|NCT03037385|448773718|FG005|Overall Study|Progressive Disease|0|||
124766584|NCT03037385|448773719|FG006|Overall Study|Progressive Disease|1|||
124766585|NCT03037385|448773720|FG007|Overall Study|Progressive Disease|0|||
124462989|NCT01967550|447654874|FG000|Overall Study|Protocol Violation|2|||
124462990|NCT01967550|447654875|FG001|Overall Study|Protocol Violation|1|||
124462991|NCT01967550|447654874|FG000|Overall Study|Non Compliance|0|||
124462992|NCT01967550|447654875|FG001|Overall Study|Non Compliance|1|||
124462993|NCT00844753|447654876|FG000|Overall Study|Lack of Efficacy|1|||
124462994|NCT00844753|447654877|FG001|Overall Study|Lack of Efficacy|0|||
124462995|NCT00844753|447654878|FG002|Overall Study|Lack of Efficacy|2|||
124462996|NCT00844753|447654879|FG003|Overall Study|Lack of Efficacy|2|||
124462997|NCT00844753|447654876|FG000|Overall Study|Adverse Event|3|||
124462998|NCT00844753|447654877|FG001|Overall Study|Adverse Event|2|||
124462999|NCT00844753|447654878|FG002|Overall Study|Adverse Event|5|||
124463000|NCT00844753|447654879|FG003|Overall Study|Adverse Event|5|||
124463001|NCT00844753|447654876|FG000|Overall Study|Lost to Follow-up|1|||
124463002|NCT00844753|447654877|FG001|Overall Study|Lost to Follow-up|1|||
124463003|NCT00844753|447654878|FG002|Overall Study|Lost to Follow-up|0|||
124463004|NCT00844753|447654879|FG003|Overall Study|Lost to Follow-up|1|||
124463005|NCT00844753|447654876|FG000|Overall Study|could not swallow medication|2|||
124463006|NCT00844753|447654877|FG001|Overall Study|could not swallow medication|0|||
124463007|NCT00844753|447654878|FG002|Overall Study|could not swallow medication|0|||
124463008|NCT00844753|447654879|FG003|Overall Study|could not swallow medication|0|||
124463009|NCT00844753|447654876|FG000|Overall Study|Withdrawal by Subject|1|||
124463010|NCT00844753|447654877|FG001|Overall Study|Withdrawal by Subject|0|||
124463011|NCT00844753|447654878|FG002|Overall Study|Withdrawal by Subject|0|||
124463012|NCT00844753|447654879|FG003|Overall Study|Withdrawal by Subject|3|||
124549264|NCT01777191|447966988|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
124549265|NCT01777191|447966987|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
124766586|NCT03037385|448773721|FG008|Overall Study|Progressive Disease|0|||
124766587|NCT03037385|448773722|FG009|Overall Study|Progressive Disease|30|||
124766588|NCT03037385|448773713|FG000|Overall Study|Withdrawal by Subject|0|||
124766589|NCT03037385|448773714|FG001|Overall Study|Withdrawal by Subject|0|||
124463013|NCT02425826|447654880|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
124463014|NCT02425826|447654881|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
124549266|NCT01777191|447966988|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
124957423|NCT00125853|449469720|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
124957424|NCT03575572|449469724|FG000|Overall Study|Withdrawal by Subject|2|||
124957425|NCT03575572|449469724|FG000|Overall Study|Physician Decision|2|||
124463015|NCT02425826|447654882|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
124463016|NCT02425826|447654880|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
124549267|NCT01777191|447966987|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
124957426|NCT00157209|449469729|FG000|Overall Study|Ongoing at data cut-off|10|||
124957427|NCT00157209|449469730|FG001|Overall Study|Ongoing at data cut-off|0|||
124957428|NCT03751280|449469731|FG000|Overall Study|Adverse Event|0|||
124957429|NCT03751280|449469732|FG001|Overall Study|Adverse Event|1|||
124957430|NCT03751280|449469731|FG000|Overall Study|Lost to Follow-up|3|||
124957431|NCT03751280|449469732|FG001|Overall Study|Lost to Follow-up|5|||
124957432|NCT03751280|449469731|FG000|Overall Study|Physician Decision|0|||
124957433|NCT03751280|449469732|FG001|Overall Study|Physician Decision|2|||
124957434|NCT03751280|449469731|FG000|Overall Study|Protocol Violation|0|||
124957435|NCT03751280|449469732|FG001|Overall Study|Protocol Violation|2|||
124957436|NCT03751280|449469731|FG000|Overall Study|Withdrawal by Subject|5|||
124957437|NCT03751280|449469732|FG001|Overall Study|Withdrawal by Subject|2|||
124957438|NCT01257698|449469742|FG000|Overall Study|Protocol Violation|4|||
124957439|NCT01257698|449469743|FG001|Overall Study|Protocol Violation|0|||
124957440|NCT03023878|449469753|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
124957441|NCT03023878|449469753|FG000|Pre-Study Run-In Period|Death|1|||
124957442|NCT03023878|449469753|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
124957443|NCT03023878|449469753|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
124957444|NCT03023878|449469753|FG000|Treatment Period|Disease Progression|1|||
124957445|NCT03023878|449469753|FG000|Treatment Period|Withdrawal by Subject|1|||
124957446|NCT03023878|449469753|FG000|Treatment Period|Adverse Event|1|||
124957447|NCT03023878|449469753|FG000|Long Term Follow-Up Period|Death|2|||
124957448|NCT01247922|449469754|FG000|Overall Study|Disease progression|4|||
124957449|NCT01876823|449469757|FG000|Overall Study|Withdrawal by Subject|5|||
124957450|NCT01876823|449469757|FG000|Overall Study|Physician Decision|2|||
124957451|NCT01876823|449469757|FG000|Overall Study|Patients moved|2|||
124957452|NCT00577096|449469758|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
124957453|NCT00577096|449469759|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
124957454|NCT00577096|449469758|FG000|Short Term Participation|Withdrawal by Subject|3|||
124957455|NCT00577096|449469759|FG001|Short Term Participation|Withdrawal by Subject|5|||
124957456|NCT00577096|449469758|FG000|Short Term Participation|Death|1|||
124957457|NCT00577096|449469759|FG001|Short Term Participation|Death|1|||
124957458|NCT00794573|449469764|FG000|Overall Study|Death|3|||
124957459|NCT00794573|449469765|FG001|Overall Study|Death|0|||
124957460|NCT00794573|449469764|FG000|Overall Study|Withdrawal by Subject|9|||
124957461|NCT00794573|449469765|FG001|Overall Study|Withdrawal by Subject|12|||
124463017|NCT02425826|447654881|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
124463018|NCT02425826|447654882|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
124463019|NCT02425826|447654880|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
124463020|NCT02425826|447654881|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
124463021|NCT02425826|447654882|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
124463022|NCT02425826|447654880|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
124463023|NCT02425826|447654881|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
124463024|NCT02425826|447654882|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
124463025|NCT02425826|447654880|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
124463026|NCT02425826|447654881|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
124463027|NCT02425826|447654882|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
124463028|NCT02425826|447654880|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
124463029|NCT02425826|447654881|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
124463030|NCT02425826|447654882|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
124463031|NCT02425826|447654880|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
124463032|NCT02425826|447654881|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
124463033|NCT02425826|447654882|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
124463034|NCT02425826|447654880|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
124463035|NCT02425826|447654881|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
124463036|NCT02425826|447654882|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
124707991|NCT01119287|448555927|FG001|Overall Study|Patient Decision, not related to AE|0|||
124707992|NCT01119287|448555928|FG002|Overall Study|Patient Decision, not related to AE|2|||
124707993|NCT01119287|448555929|FG003|Overall Study|Patient Decision, not related to AE|2|||
124957462|NCT00794573|449469764|FG000|Overall Study|Lost to Follow-up|26|||
124957463|NCT00794573|449469765|FG001|Overall Study|Lost to Follow-up|33|||
124957464|NCT03928821|449469766|FG000|Overall Study|Death|0|||
124957465|NCT03928821|449469767|FG001|Overall Study|Death|1|||
124957466|NCT03928821|449469768|FG002|Overall Study|Death|0|||
124957467|NCT03928821|449469769|FG003|Overall Study|Death|0|||
124957468|NCT03928821|449469766|FG000|Overall Study|Lost to Follow-up|0|||
124957469|NCT03928821|449469767|FG001|Overall Study|Lost to Follow-up|2|||
124463037|NCT02425826|447654880|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
124463038|NCT02425826|447654881|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
124463039|NCT02425826|447654882|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
124463040|NCT02425826|447654880|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
124957470|NCT03928821|449469768|FG002|Overall Study|Lost to Follow-up|3|||
124957471|NCT03928821|449469769|FG003|Overall Study|Lost to Follow-up|0|||
124957472|NCT03928821|449469766|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
124957473|NCT03928821|449469767|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
124957474|NCT03928821|449469768|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
124957475|NCT03928821|449469769|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
124957476|NCT02784535|449469770|FG000|Overall Study|Adverse Event|1|||
124957477|NCT02784535|449469771|FG001|Overall Study|Adverse Event|0|||
124957478|NCT02784535|449469770|FG000|Overall Study|Withdrawal by Subject|0|||
124957479|NCT02784535|449469771|FG001|Overall Study|Withdrawal by Subject|1|||
124957480|NCT02784535|449469770|FG000|Overall Study|Physician Decision|0|||
124957481|NCT02784535|449469771|FG001|Overall Study|Physician Decision|1|||
124957482|NCT00985621|449469773|FG000|Overall Study|Adverse Event|2|||
124957483|NCT00985621|449469774|FG001|Overall Study|Adverse Event|3|||
124957484|NCT00985621|449469775|FG002|Overall Study|Adverse Event|4|||
124957485|NCT00985621|449469776|FG003|Overall Study|Adverse Event|16|||
124957486|NCT00985621|449469773|FG000|Overall Study|Lack of Efficacy|10|||
124957487|NCT00985621|449469774|FG001|Overall Study|Lack of Efficacy|6|||
124957488|NCT00985621|449469775|FG002|Overall Study|Lack of Efficacy|5|||
124957489|NCT00985621|449469776|FG003|Overall Study|Lack of Efficacy|12|||
124957490|NCT00985621|449469773|FG000|Overall Study|Lost to Follow-up|2|||
124957491|NCT00985621|449469774|FG001|Overall Study|Lost to Follow-up|3|||
124957492|NCT00985621|449469775|FG002|Overall Study|Lost to Follow-up|4|||
124957493|NCT00985621|449469776|FG003|Overall Study|Lost to Follow-up|4|||
124957494|NCT00985621|449469773|FG000|Overall Study|Study Terminated by Sponsor|89|||
124957495|NCT00985621|449469774|FG001|Overall Study|Study Terminated by Sponsor|108|||
124957496|NCT00985621|449469775|FG002|Overall Study|Study Terminated by Sponsor|99|||
124957497|NCT00985621|449469776|FG003|Overall Study|Study Terminated by Sponsor|92|||
124957498|NCT00985621|449469773|FG000|Overall Study|Protocol Violation|1|||
124957499|NCT00985621|449469774|FG001|Overall Study|Protocol Violation|1|||
124957500|NCT00985621|449469775|FG002|Overall Study|Protocol Violation|1|||
124957501|NCT00985621|449469776|FG003|Overall Study|Protocol Violation|0|||
124957502|NCT00985621|449469773|FG000|Overall Study|Withdrawal by Subject|8|||
124957503|NCT00985621|449469774|FG001|Overall Study|Withdrawal by Subject|10|||
124957504|NCT00985621|449469775|FG002|Overall Study|Withdrawal by Subject|8|||
124957505|NCT00985621|449469776|FG003|Overall Study|Withdrawal by Subject|12|||
124957506|NCT00985621|449469773|FG000|Overall Study|Other|1|||
124957507|NCT00985621|449469774|FG001|Overall Study|Other|0|||
124957508|NCT00985621|449469775|FG002|Overall Study|Other|0|||
124957509|NCT00985621|449469776|FG003|Overall Study|Other|0|||
124957510|NCT00985621|449469773|FG000|Overall Study|Randomized but not Treated|1|||
124957511|NCT00985621|449469774|FG001|Overall Study|Randomized but not Treated|0|||
124957512|NCT00985621|449469775|FG002|Overall Study|Randomized but not Treated|2|||
124957513|NCT00985621|449469776|FG003|Overall Study|Randomized but not Treated|1|||
124957514|NCT01911819|449469777|FG000|Overall Study|Adverse Event|0|||
124957515|NCT01911819|449469778|FG001|Overall Study|Adverse Event|1|||
124957516|NCT01911819|449469779|FG002|Overall Study|Adverse Event|0|||
124957517|NCT01911819|449469777|FG000|Overall Study|Withdrawal by Subject|1|||
124957518|NCT01911819|449469778|FG001|Overall Study|Withdrawal by Subject|1|||
124957519|NCT01911819|449469779|FG002|Overall Study|Withdrawal by Subject|0|||
124957520|NCT03849300|449469783|FG000|Overall Study|move out to different area|1|||
124957521|NCT03849300|449469784|FG001|Overall Study|move out to different area|3|||
124957522|NCT03849300|449469785|FG002|Overall Study|move out to different area|1|||
124957523|NCT03849300|449469786|FG003|Overall Study|move out to different area|4|||
124957524|NCT03849300|449469783|FG000|Overall Study|scheduling/transportation conflict|4|||
124957525|NCT03849300|449469784|FG001|Overall Study|scheduling/transportation conflict|4|||
124957526|NCT03849300|449469785|FG002|Overall Study|scheduling/transportation conflict|3|||
124957527|NCT03849300|449469786|FG003|Overall Study|scheduling/transportation conflict|2|||
124957528|NCT00464737|449469789|FG000|Overall Study|Adverse Event|12|||
124957529|NCT00464737|449469790|FG001|Overall Study|Adverse Event|17|||
124957530|NCT00464737|449469791|FG002|Overall Study|Adverse Event|33|||
124957531|NCT00464737|449469789|FG000|Overall Study|Lack of Efficacy|7|||
124957532|NCT00464737|449469790|FG001|Overall Study|Lack of Efficacy|7|||
124957533|NCT00464737|449469791|FG002|Overall Study|Lack of Efficacy|4|||
124957534|NCT00464737|449469789|FG000|Overall Study|Withdrawal by Subject|5|||
124957535|NCT00464737|449469790|FG001|Overall Study|Withdrawal by Subject|3|||
124957536|NCT00464737|449469791|FG002|Overall Study|Withdrawal by Subject|5|||
124957537|NCT00464737|449469789|FG000|Overall Study|Protocol Violation|1|||
124957538|NCT00464737|449469790|FG001|Overall Study|Protocol Violation|1|||
124957539|NCT00464737|449469791|FG002|Overall Study|Protocol Violation|5|||
124957540|NCT00464737|449469789|FG000|Overall Study|Non-compliance|0|||
124957541|NCT00464737|449469790|FG001|Overall Study|Non-compliance|1|||
124957542|NCT00464737|449469791|FG002|Overall Study|Non-compliance|1|||
124957543|NCT00464737|449469789|FG000|Overall Study|Lost to Follow-up|5|||
124957544|NCT00464737|449469790|FG001|Overall Study|Lost to Follow-up|2|||
124957545|NCT00464737|449469791|FG002|Overall Study|Lost to Follow-up|5|||
124957546|NCT00464737|449469789|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
124957547|NCT00464737|449469790|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
124957548|NCT00464737|449469791|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
124463041|NCT02425826|447654881|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
124463042|NCT02425826|447654882|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
124463043|NCT01471782|447654893|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
124463044|NCT01471782|447654894|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
124463045|NCT01471782|447654895|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
124463046|NCT01471782|447654896|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
124957549|NCT00464737|449469789|FG000|Overall Study|Other: Subject left town; family illness|1|||
124957550|NCT00464737|449469790|FG001|Overall Study|Other: Subject left town; family illness|0|||
124957551|NCT00464737|449469791|FG002|Overall Study|Other: Subject left town; family illness|0|||
124957552|NCT00464737|449469789|FG000|Overall Study|Other: Study demands too great|0|||
124957553|NCT00464737|449469790|FG001|Overall Study|Other: Study demands too great|1|||
124957554|NCT00464737|449469791|FG002|Overall Study|Other: Study demands too great|0|||
124957555|NCT00464737|449469789|FG000|Overall Study|Other: Personal family reasons|0|||
124957556|NCT00464737|449469790|FG001|Overall Study|Other: Personal family reasons|0|||
124957557|NCT00464737|449469791|FG002|Overall Study|Other: Personal family reasons|1|||
124957558|NCT00464737|449469789|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
124957559|NCT00464737|449469790|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
124957560|NCT00464737|449469791|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
124957561|NCT00676663|449469794|FG000|Overall Study|Death|43|||
124957562|NCT00676663|449469795|FG001|Overall Study|Death|27|||
124957563|NCT00676663|449469794|FG000|Overall Study|Withdrew Consent|1|||
124957564|NCT00676663|449469795|FG001|Overall Study|Withdrew Consent|8|||
124957565|NCT00676663|449469794|FG000|Overall Study|Lost to Follow-up|1|||
124957566|NCT00676663|449469795|FG001|Overall Study|Lost to Follow-up|3|||
124957567|NCT00580047|449469796|FG000|Overall Study|Lost to Follow-up|1|||
124463047|NCT01471782|447654897|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
124463048|NCT01471782|447654898|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
124463049|NCT01471782|447654893|FG000|Overall Study|Lack of Efficacy|1|||
124463050|NCT01471782|447654894|FG001|Overall Study|Lack of Efficacy|2|||
124463051|NCT01471782|447654895|FG002|Overall Study|Lack of Efficacy|1|||
124463052|NCT01471782|447654896|FG003|Overall Study|Lack of Efficacy|1|||
124463053|NCT01471782|447654897|FG004|Overall Study|Lack of Efficacy|5|||
124463054|NCT01471782|447654898|FG005|Overall Study|Lack of Efficacy|18|||
124463055|NCT01471782|447654893|FG000|Overall Study|Adverse Event|1|||
124463056|NCT01471782|447654894|FG001|Overall Study|Adverse Event|1|||
124463057|NCT01471782|447654895|FG002|Overall Study|Adverse Event|2|||
124463058|NCT01471782|447654896|FG003|Overall Study|Adverse Event|2|||
124463059|NCT01471782|447654897|FG004|Overall Study|Adverse Event|3|||
124463060|NCT01471782|447654898|FG005|Overall Study|Adverse Event|1|||
124463061|NCT01471782|447654893|FG000|Overall Study|Other|0|||
124463062|NCT01471782|447654894|FG001|Overall Study|Other|0|||
124463063|NCT01471782|447654895|FG002|Overall Study|Other|1|||
124463064|NCT01471782|447654896|FG003|Overall Study|Other|1|||
124463065|NCT01471782|447654897|FG004|Overall Study|Other|6|||
124463066|NCT01471782|447654898|FG005|Overall Study|Other|5|||
124463067|NCT01471782|447654893|FG000|Overall Study|Change of Chemotherapy|1|||
124463068|NCT01471782|447654894|FG001|Overall Study|Change of Chemotherapy|1|||
124463069|NCT01471782|447654895|FG002|Overall Study|Change of Chemotherapy|0|||
124463070|NCT01471782|447654896|FG003|Overall Study|Change of Chemotherapy|0|||
124463071|NCT01471782|447654897|FG004|Overall Study|Change of Chemotherapy|1|||
124463072|NCT01471782|447654898|FG005|Overall Study|Change of Chemotherapy|4|||
124463073|NCT01471782|447654893|FG000|Overall Study|Disease Relapse|0|||
124463074|NCT01471782|447654894|FG001|Overall Study|Disease Relapse|0|||
124463075|NCT01471782|447654895|FG002|Overall Study|Disease Relapse|0|||
124463076|NCT01471782|447654896|FG003|Overall Study|Disease Relapse|1|||
124463077|NCT01471782|447654897|FG004|Overall Study|Disease Relapse|2|||
124463078|NCT01471782|447654898|FG005|Overall Study|Disease Relapse|1|||
124463079|NCT01471782|447654893|FG000|Overall Study|Physician Decision|0|||
124766590|NCT03037385|448773715|FG002|Overall Study|Withdrawal by Subject|1|||
124766591|NCT03037385|448773716|FG003|Overall Study|Withdrawal by Subject|2|||
124957568|NCT00580047|449469797|FG001|Overall Study|Lost to Follow-up|1|||
124957569|NCT00580047|449469798|FG002|Overall Study|Lost to Follow-up|0|||
124957570|NCT00580047|449469796|FG000|Overall Study|Withdrawal by Subject|1|||
124957571|NCT00580047|449469797|FG001|Overall Study|Withdrawal by Subject|1|||
124957572|NCT00580047|449469798|FG002|Overall Study|Withdrawal by Subject|2|||
124957573|NCT00580047|449469796|FG000|Overall Study|Withdrawal by Subject|1|||
124463080|NCT01471782|447654894|FG001|Overall Study|Physician Decision|0|||
124463081|NCT01471782|447654895|FG002|Overall Study|Physician Decision|0|||
124463082|NCT01471782|447654896|FG003|Overall Study|Physician Decision|0|||
124463083|NCT01471782|447654897|FG004|Overall Study|Physician Decision|3|||
124463084|NCT01471782|447654898|FG005|Overall Study|Physician Decision|8|||
124463085|NCT01471782|447654893|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124957574|NCT00580047|449469797|FG001|Overall Study|Withdrawal by Subject|0|||
124463086|NCT01471782|447654894|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124463087|NCT01471782|447654895|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
124463088|NCT01471782|447654896|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
124463089|NCT01471782|447654897|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
124463090|NCT01471782|447654898|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
124463091|NCT01471782|447654893|FG000|Overall Study|Death|0|||
124463092|NCT01471782|447654894|FG001|Overall Study|Death|0|||
124463093|NCT01471782|447654895|FG002|Overall Study|Death|0|||
124463094|NCT01471782|447654896|FG003|Overall Study|Death|0|||
124463095|NCT01471782|447654897|FG004|Overall Study|Death|0|||
124463096|NCT01471782|447654898|FG005|Overall Study|Death|1|||
124463097|NCT01425008|447654899|FG000|Dose Escalation Phase|Progressive Disease|2|||
124463098|NCT01425008|447654900|FG001|Dose Escalation Phase|Progressive Disease|3|||
124463099|NCT01425008|447654901|FG002|Dose Escalation Phase|Progressive Disease|2|||
124463100|NCT01425008|447654902|FG003|Dose Escalation Phase|Progressive Disease|3|||
124463101|NCT01425008|447654903|FG004|Dose Escalation Phase|Progressive Disease|5|||
124463102|NCT01425008|447654904|FG005|Dose Escalation Phase|Progressive Disease|4|||
124463103|NCT01425008|447654905|FG006|Dose Escalation Phase|Progressive Disease|0|||
124463104|NCT01425008|447654906|FG007|Dose Escalation Phase|Progressive Disease|2|||
124463105|NCT01425008|447654907|FG008|Dose Escalation Phase|Progressive Disease|6|||
124463106|NCT01425008|447654908|FG009|Dose Escalation Phase|Progressive Disease|2|||
124463107|NCT01425008|447654909|FG010|Dose Escalation Phase|Progressive Disease|0|||
124463108|NCT01425008|447654910|FG011|Dose Escalation Phase|Progressive Disease|0|||
124463109|NCT01425008|447654911|FG012|Dose Escalation Phase|Progressive Disease|0|||
124463110|NCT01425008|447654912|FG013|Dose Escalation Phase|Progressive Disease|0|||
124463111|NCT01425008|447654913|FG014|Dose Escalation Phase|Progressive Disease|0|||
124463112|NCT01425008|447654914|FG015|Dose Escalation Phase|Progressive Disease|0|||
124463113|NCT01425008|447654915|FG016|Dose Escalation Phase|Progressive Disease|0|||
124463114|NCT01425008|447654916|FG017|Dose Escalation Phase|Progressive Disease|0|||
124463115|NCT01425008|447654917|FG018|Dose Escalation Phase|Progressive Disease|0|||
124463116|NCT01425008|447654899|FG000|Dose Escalation Phase|Adverse Event|2|||
124463117|NCT01425008|447654900|FG001|Dose Escalation Phase|Adverse Event|0|||
124463118|NCT01425008|447654901|FG002|Dose Escalation Phase|Adverse Event|0|||
124463119|NCT01425008|447654902|FG003|Dose Escalation Phase|Adverse Event|0|||
124463120|NCT01425008|447654903|FG004|Dose Escalation Phase|Adverse Event|0|||
124463121|NCT01425008|447654904|FG005|Dose Escalation Phase|Adverse Event|2|||
124463122|NCT01425008|447654905|FG006|Dose Escalation Phase|Adverse Event|0|||
124463123|NCT01425008|447654906|FG007|Dose Escalation Phase|Adverse Event|0|||
124463124|NCT01425008|447654907|FG008|Dose Escalation Phase|Adverse Event|2|||
124463125|NCT01425008|447654908|FG009|Dose Escalation Phase|Adverse Event|0|||
124463126|NCT01425008|447654909|FG010|Dose Escalation Phase|Adverse Event|0|||
124463127|NCT01425008|447654910|FG011|Dose Escalation Phase|Adverse Event|0|||
124463128|NCT01425008|447654911|FG012|Dose Escalation Phase|Adverse Event|0|||
124463129|NCT01425008|447654912|FG013|Dose Escalation Phase|Adverse Event|0|||
124463130|NCT01425008|447654913|FG014|Dose Escalation Phase|Adverse Event|0|||
124766592|NCT03037385|448773717|FG004|Overall Study|Withdrawal by Subject|1|||
124766593|NCT03037385|448773718|FG005|Overall Study|Withdrawal by Subject|3|||
124957575|NCT00580047|449469798|FG002|Overall Study|Withdrawal by Subject|0|||
124463131|NCT01425008|447654914|FG015|Dose Escalation Phase|Adverse Event|0|||
124463132|NCT01425008|447654915|FG016|Dose Escalation Phase|Adverse Event|0|||
124463133|NCT01425008|447654916|FG017|Dose Escalation Phase|Adverse Event|0|||
124463134|NCT01425008|447654917|FG018|Dose Escalation Phase|Adverse Event|0|||
124463135|NCT01425008|447654899|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124463136|NCT01425008|447654900|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124463137|NCT01425008|447654901|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124463138|NCT01425008|447654902|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124463139|NCT01425008|447654903|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
124957576|NCT04382053|449469804|FG000|Overall Study|Death|6|||
124957577|NCT04382053|449469805|FG001|Overall Study|Death|8|||
124957578|NCT04382053|449469804|FG000|Overall Study|Lost to Follow-up|0|||
124957579|NCT04382053|449469805|FG001|Overall Study|Lost to Follow-up|2|||
124957580|NCT04382053|449469804|FG000|Overall Study|Protocol Deviation|1|||
124957581|NCT04382053|449469805|FG001|Overall Study|Protocol Deviation|2|||
124957582|NCT04382053|449469804|FG000|Overall Study|Withdrawal by Subject|2|||
124957583|NCT04382053|449469805|FG001|Overall Study|Withdrawal by Subject|1|||
124957584|NCT00417989|449469811|FG000|Overall Study|Withdrawal by Subject|13|||
124463140|NCT01425008|447654904|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124957585|NCT00417989|449469812|FG001|Overall Study|Withdrawal by Subject|13|||
124957586|NCT00417989|449469811|FG000|Overall Study|Lost to Follow-up|1|||
124957587|NCT00417989|449469812|FG001|Overall Study|Lost to Follow-up|6|||
124957588|NCT00417989|449469811|FG000|Overall Study|Protocol Violation|1|||
124549268|NCT01777191|447966988|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
124766594|NCT03037385|448773719|FG006|Overall Study|Withdrawal by Subject|0|||
124463141|NCT01425008|447654905|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
124463142|NCT01425008|447654906|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
124766595|NCT03037385|448773720|FG007|Overall Study|Withdrawal by Subject|0|||
124957589|NCT00417989|449469812|FG001|Overall Study|Protocol Violation|0|||
124463143|NCT01425008|447654907|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
124957590|NCT00417989|449469811|FG000|Overall Study|Death|0|||
124463144|NCT01425008|447654908|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124463145|NCT01425008|447654909|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124463146|NCT01425008|447654910|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124463147|NCT01425008|447654911|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124463148|NCT01425008|447654912|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124463149|NCT01425008|447654913|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124463150|NCT01425008|447654914|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124463151|NCT01425008|447654915|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124463152|NCT01425008|447654916|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124463153|NCT01425008|447654917|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124463154|NCT01425008|447654899|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
124463155|NCT01425008|447654900|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
124463156|NCT01425008|447654901|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
124463157|NCT01425008|447654902|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
124463158|NCT01425008|447654903|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
124463159|NCT01425008|447654904|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
124463160|NCT01425008|447654905|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
124463161|NCT01425008|447654906|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
124463162|NCT01425008|447654907|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
124463163|NCT01425008|447654908|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
124463164|NCT01425008|447654909|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
124463165|NCT01425008|447654910|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
124463166|NCT01425008|447654911|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
124463167|NCT01425008|447654912|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
124463168|NCT01425008|447654913|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
124463169|NCT01425008|447654914|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
124463170|NCT01425008|447654915|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
124463171|NCT01425008|447654916|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
124463172|NCT01425008|447654917|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
124463173|NCT01425008|447654899|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
124463174|NCT01425008|447654900|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
124463175|NCT01425008|447654901|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
124463176|NCT01425008|447654902|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
124463177|NCT01425008|447654903|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
124463178|NCT01425008|447654904|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
124463179|NCT01425008|447654905|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
124463180|NCT01425008|447654906|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
124463181|NCT01425008|447654907|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
124463182|NCT01425008|447654908|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
124463183|NCT01425008|447654909|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
124463184|NCT01425008|447654910|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
124463185|NCT01425008|447654911|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
124463186|NCT01425008|447654912|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
124463187|NCT01425008|447654913|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
124463188|NCT01425008|447654914|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
124463189|NCT01425008|447654915|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
124463190|NCT01425008|447654916|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
124463191|NCT01425008|447654917|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
124463192|NCT01425008|447654899|FG000|Dose Escalation Phase|Other|0|||
124463193|NCT01425008|447654900|FG001|Dose Escalation Phase|Other|0|||
124463194|NCT01425008|447654901|FG002|Dose Escalation Phase|Other|0|||
124463195|NCT01425008|447654902|FG003|Dose Escalation Phase|Other|0|||
124463196|NCT01425008|447654903|FG004|Dose Escalation Phase|Other|0|||
124463197|NCT01425008|447654904|FG005|Dose Escalation Phase|Other|0|||
124463198|NCT01425008|447654905|FG006|Dose Escalation Phase|Other|0|||
124463199|NCT01425008|447654906|FG007|Dose Escalation Phase|Other|0|||
124463200|NCT01425008|447654907|FG008|Dose Escalation Phase|Other|1|||
124463201|NCT01425008|447654908|FG009|Dose Escalation Phase|Other|0|||
124463202|NCT01425008|447654909|FG010|Dose Escalation Phase|Other|0|||
124463203|NCT01425008|447654910|FG011|Dose Escalation Phase|Other|0|||
124463204|NCT01425008|447654911|FG012|Dose Escalation Phase|Other|0|||
124957591|NCT00417989|449469812|FG001|Overall Study|Death|1|||
124957592|NCT00417989|449469811|FG000|Overall Study|Physician Decision|5|||
124463205|NCT01425008|447654912|FG013|Dose Escalation Phase|Other|0|||
124463206|NCT01425008|447654913|FG014|Dose Escalation Phase|Other|0|||
124463207|NCT01425008|447654914|FG015|Dose Escalation Phase|Other|0|||
124463208|NCT01425008|447654915|FG016|Dose Escalation Phase|Other|0|||
124463209|NCT01425008|447654916|FG017|Dose Escalation Phase|Other|0|||
124463210|NCT01425008|447654917|FG018|Dose Escalation Phase|Other|0|||
124463211|NCT01425008|447654899|FG000|Dose Expansion Phase|Progressive Disease|0|||
124463212|NCT01425008|447654900|FG001|Dose Expansion Phase|Progressive Disease|0|||
124957593|NCT00417989|449469812|FG001|Overall Study|Physician Decision|2|||
124957594|NCT00497198|449469820|FG000|Overall Study|Adverse Event|4|||
124957595|NCT00497198|449469821|FG001|Overall Study|Adverse Event|2|||
124957596|NCT00497198|449469820|FG000|Overall Study|Physician Decision|1|||
124957597|NCT00497198|449469821|FG001|Overall Study|Physician Decision|2|||
124957598|NCT00497198|449469820|FG000|Overall Study|Withdrawal by Subject|0|||
124463213|NCT01425008|447654901|FG002|Dose Expansion Phase|Progressive Disease|0|||
124463214|NCT01425008|447654902|FG003|Dose Expansion Phase|Progressive Disease|0|||
124463215|NCT01425008|447654903|FG004|Dose Expansion Phase|Progressive Disease|0|||
124463216|NCT01425008|447654904|FG005|Dose Expansion Phase|Progressive Disease|0|||
124957599|NCT00497198|449469821|FG001|Overall Study|Withdrawal by Subject|1|||
124957600|NCT02799745|449469822|FG000|Overall Study|Participant moved out of state|1|||
124957601|NCT02799745|449469823|FG001|Overall Study|Participant moved out of state|0|||
124957602|NCT02799745|449469822|FG000|Overall Study|Discontinued due to planned surgery|1|||
124957603|NCT02799745|449469823|FG001|Overall Study|Discontinued due to planned surgery|0|||
124957604|NCT02799745|449469822|FG000|Overall Study|Withdrawal by Subject|16|||
124957605|NCT02799745|449469823|FG001|Overall Study|Withdrawal by Subject|25|||
124957606|NCT02799745|449469822|FG000|Overall Study|Protocol Deviation|4|||
124463217|NCT01425008|447654905|FG006|Dose Expansion Phase|Progressive Disease|0|||
124463218|NCT01425008|447654906|FG007|Dose Expansion Phase|Progressive Disease|0|||
124463219|NCT01425008|447654907|FG008|Dose Expansion Phase|Progressive Disease|0|||
124463220|NCT01425008|447654908|FG009|Dose Expansion Phase|Progressive Disease|0|||
124957607|NCT02799745|449469823|FG001|Overall Study|Protocol Deviation|5|||
124957608|NCT02799745|449469822|FG000|Overall Study|Progressive Disease|28|||
124957609|NCT02799745|449469823|FG001|Overall Study|Progressive Disease|38|||
124957610|NCT02799745|449469822|FG000|Overall Study|Lost to Follow-up|3|||
124957611|NCT02799745|449469823|FG001|Overall Study|Lost to Follow-up|2|||
124957612|NCT02799745|449469822|FG000|Overall Study|Death|3|||
124957613|NCT02799745|449469823|FG001|Overall Study|Death|0|||
124957614|NCT02799745|449469822|FG000|Overall Study|Adverse Event|0|||
124957615|NCT02799745|449469823|FG001|Overall Study|Adverse Event|1|||
124957616|NCT00814632|449471152|FG000|Overall Study|Lack of Efficacy|2|||
124957617|NCT00635570|449471154|FG000|Overall Study|Lost to Follow-up|8|||
124957618|NCT00635570|449471155|FG001|Overall Study|Lost to Follow-up|8|||
124463221|NCT01425008|447654909|FG010|Dose Expansion Phase|Progressive Disease|10|||
124463222|NCT01425008|447654910|FG011|Dose Expansion Phase|Progressive Disease|4|||
124463223|NCT01425008|447654911|FG012|Dose Expansion Phase|Progressive Disease|12|||
124463224|NCT01425008|447654912|FG013|Dose Expansion Phase|Progressive Disease|1|||
124463225|NCT01425008|447654913|FG014|Dose Expansion Phase|Progressive Disease|5|||
124957619|NCT00635570|449471154|FG000|Overall Study|Withdrawal by Subject|1|||
124957620|NCT00635570|449471155|FG001|Overall Study|Withdrawal by Subject|1|||
124957621|NCT00635570|449471154|FG000|Overall Study|Adverse Event|2|||
124957622|NCT00635570|449471155|FG001|Overall Study|Adverse Event|0|||
124957623|NCT00635570|449471154|FG000|Overall Study|Physician Decision|1|||
124463226|NCT01425008|447654914|FG015|Dose Expansion Phase|Progressive Disease|8|||
124463227|NCT01425008|447654915|FG016|Dose Expansion Phase|Progressive Disease|9|||
124463228|NCT01425008|447654916|FG017|Dose Expansion Phase|Progressive Disease|2|||
124463229|NCT01425008|447654917|FG018|Dose Expansion Phase|Progressive Disease|10|||
124463230|NCT01425008|447654899|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
124463231|NCT01425008|447654900|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
124463232|NCT01425008|447654901|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
124463233|NCT01425008|447654902|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
124463234|NCT01425008|447654903|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
124463235|NCT01425008|447654904|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
124463236|NCT01425008|447654905|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
124463237|NCT01425008|447654906|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
124463238|NCT01425008|447654907|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
124463239|NCT01425008|447654908|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
124957624|NCT00635570|449471155|FG001|Overall Study|Physician Decision|0|||
124957625|NCT00635570|449471154|FG000|Overall Study|Did not complete survey|2|||
124957626|NCT00635570|449471155|FG001|Overall Study|Did not complete survey|1|||
124957627|NCT00635570|449471154|FG000|Overall Study|Early termination(No sexual activity)|1|||
124957628|NCT00635570|449471155|FG001|Overall Study|Early termination(No sexual activity)|1|||
124957629|NCT02514577|449471166|FG000|Overall Study|Lost to Follow-up|6|||
124463240|NCT01425008|447654909|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
124463241|NCT01425008|447654910|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
124463242|NCT01425008|447654911|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
124463243|NCT01425008|447654912|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
124957630|NCT02514577|449471167|FG001|Overall Study|Lost to Follow-up|6|||
124463244|NCT01425008|447654913|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
124463245|NCT01425008|447654914|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
124463246|NCT01425008|447654915|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
124463247|NCT01425008|447654916|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
124957631|NCT02514577|449471166|FG000|Overall Study|Protocol Violation|1|||
124957632|NCT02514577|449471167|FG001|Overall Study|Protocol Violation|0|||
124957633|NCT02514577|449471166|FG000|Overall Study|Withdrawal by Subject|6|||
124463248|NCT01425008|447654917|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
124463249|NCT01425008|447654899|FG000|Dose Expansion Phase|Other|0|||
124463250|NCT01425008|447654900|FG001|Dose Expansion Phase|Other|0|||
124463251|NCT01425008|447654901|FG002|Dose Expansion Phase|Other|0|||
124463252|NCT01425008|447654902|FG003|Dose Expansion Phase|Other|0|||
124463253|NCT01425008|447654903|FG004|Dose Expansion Phase|Other|0|||
124463254|NCT01425008|447654904|FG005|Dose Expansion Phase|Other|0|||
124463255|NCT01425008|447654905|FG006|Dose Expansion Phase|Other|0|||
124463256|NCT01425008|447654906|FG007|Dose Expansion Phase|Other|0|||
124463257|NCT01425008|447654907|FG008|Dose Expansion Phase|Other|0|||
124463258|NCT01425008|447654908|FG009|Dose Expansion Phase|Other|0|||
124463259|NCT01425008|447654909|FG010|Dose Expansion Phase|Other|0|||
124463260|NCT01425008|447654910|FG011|Dose Expansion Phase|Other|0|||
124463261|NCT01425008|447654911|FG012|Dose Expansion Phase|Other|1|||
124463262|NCT01425008|447654912|FG013|Dose Expansion Phase|Other|0|||
124463263|NCT01425008|447654913|FG014|Dose Expansion Phase|Other|0|||
124463264|NCT01425008|447654914|FG015|Dose Expansion Phase|Other|0|||
124463265|NCT01425008|447654915|FG016|Dose Expansion Phase|Other|2|||
124463266|NCT01425008|447654916|FG017|Dose Expansion Phase|Other|0|||
124463267|NCT01425008|447654917|FG018|Dose Expansion Phase|Other|4|||
124463268|NCT01425008|447654899|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
124463269|NCT01425008|447654900|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
124463270|NCT01425008|447654901|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
124463271|NCT01425008|447654902|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
124463272|NCT01425008|447654903|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
124463273|NCT01425008|447654904|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
124463274|NCT01425008|447654905|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
124463275|NCT01425008|447654906|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
124463276|NCT01425008|447654907|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
124463277|NCT01425008|447654908|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
124463278|NCT01425008|447654909|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
124463279|NCT01425008|447654910|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
124463280|NCT01425008|447654911|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
124463281|NCT01425008|447654912|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
124463282|NCT01425008|447654913|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
124463283|NCT01425008|447654914|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
124463284|NCT01425008|447654915|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
124463285|NCT01425008|447654916|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
124463286|NCT01425008|447654917|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
124463287|NCT01425008|447654899|FG000|Dose Expansion Phase|Adverse Event|0|||
124463288|NCT01425008|447654900|FG001|Dose Expansion Phase|Adverse Event|0|||
124463289|NCT01425008|447654901|FG002|Dose Expansion Phase|Adverse Event|0|||
124707994|NCT01119287|448555930|FG004|Overall Study|Patient Decision, not related to AE|1|||
124707995|NCT01119287|448555931|FG005|Overall Study|Patient Decision, not related to AE|0|||
124707996|NCT01977222|448555932|FG000|Overall Study|Withdrawal by Subject|1|||
124707997|NCT00945659|448555942|FG000|Overall Study|Lost to Follow-up|7|||
124957634|NCT02514577|449471167|FG001|Overall Study|Withdrawal by Subject|6|||
124957635|NCT02514577|449471166|FG000|Overall Study|Adverse Event|1|||
124463290|NCT01425008|447654902|FG003|Dose Expansion Phase|Adverse Event|0|||
124463291|NCT01425008|447654903|FG004|Dose Expansion Phase|Adverse Event|0|||
124463292|NCT01425008|447654904|FG005|Dose Expansion Phase|Adverse Event|0|||
124463293|NCT01425008|447654905|FG006|Dose Expansion Phase|Adverse Event|0|||
124463294|NCT01425008|447654906|FG007|Dose Expansion Phase|Adverse Event|0|||
124463295|NCT01425008|447654907|FG008|Dose Expansion Phase|Adverse Event|0|||
124463296|NCT01425008|447654908|FG009|Dose Expansion Phase|Adverse Event|0|||
124463297|NCT01425008|447654909|FG010|Dose Expansion Phase|Adverse Event|2|||
124463298|NCT01425008|447654910|FG011|Dose Expansion Phase|Adverse Event|3|||
124463299|NCT01425008|447654911|FG012|Dose Expansion Phase|Adverse Event|3|||
124463300|NCT01425008|447654912|FG013|Dose Expansion Phase|Adverse Event|0|||
124463301|NCT01425008|447654913|FG014|Dose Expansion Phase|Adverse Event|1|||
124463302|NCT01425008|447654914|FG015|Dose Expansion Phase|Adverse Event|1|||
124463303|NCT01425008|447654915|FG016|Dose Expansion Phase|Adverse Event|5|||
124463304|NCT01425008|447654916|FG017|Dose Expansion Phase|Adverse Event|0|||
124463305|NCT01425008|447654917|FG018|Dose Expansion Phase|Adverse Event|3|||
124463306|NCT01425008|447654899|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
124707998|NCT00945659|448555943|FG001|Overall Study|Lost to Follow-up|20|||
124957636|NCT02514577|449471167|FG001|Overall Study|Adverse Event|1|||
124463307|NCT01425008|447654900|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
124463308|NCT01425008|447654901|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
124463309|NCT01425008|447654902|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
124463310|NCT01425008|447654903|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
124463311|NCT01425008|447654904|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
124463312|NCT01425008|447654905|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
124463313|NCT01425008|447654906|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
124463314|NCT01425008|447654907|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
124766596|NCT03037385|448773721|FG008|Overall Study|Withdrawal by Subject|0|||
124766597|NCT03037385|448773722|FG009|Overall Study|Withdrawal by Subject|52|||
124766598|NCT03037385|448773713|FG000|Overall Study|Reason Not Specified|0|||
124766599|NCT03037385|448773714|FG001|Overall Study|Reason Not Specified|1|||
124766600|NCT03037385|448773715|FG002|Overall Study|Reason Not Specified|0|||
124766601|NCT03037385|448773716|FG003|Overall Study|Reason Not Specified|4|||
124766602|NCT03037385|448773717|FG004|Overall Study|Reason Not Specified|3|||
124766603|NCT03037385|448773718|FG005|Overall Study|Reason Not Specified|6|||
124766604|NCT03037385|448773719|FG006|Overall Study|Reason Not Specified|2|||
124766605|NCT03037385|448773720|FG007|Overall Study|Reason Not Specified|0|||
124766606|NCT03037385|448773721|FG008|Overall Study|Reason Not Specified|1|||
124766607|NCT03037385|448773722|FG009|Overall Study|Reason Not Specified|181|||
124766608|NCT01838694|448773727|FG000|Overall Study|Adverse Event|0|||
124766609|NCT01838694|448773728|FG001|Overall Study|Adverse Event|1|||
124766610|NCT00672555|448773729|FG000|Overall Study|Lost to Follow-up|4|||
124766611|NCT00672555|448773729|FG000|Overall Study|Did not want to answer questionnaire|2|||
124766612|NCT03623243|448773730|FG000|Overall Study|Adverse Event|15|||
124766613|NCT03623243|448773730|FG000|Overall Study|Guardian Decision|1|||
124766614|NCT03623243|448773730|FG000|Overall Study|New Therapy for Study Indication|1|||
124766615|NCT03623243|448773730|FG000|Overall Study|Protocol Deviation|3|||
124766616|NCT03623243|448773730|FG000|Overall Study|Physician Decision|4|||
124766617|NCT03623243|448773730|FG000|Overall Study|Patient Decision|15|||
124766618|NCT02153086|448773733|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
124766619|NCT02153086|448773733|FG000|Overall Study|Other|2|||
124766620|NCT00446849|448773734|FG000|Acute Phase|Lack of Efficacy|64|||
124766621|NCT00446849|448773734|FG000|Acute Phase|Protocol Violation|10|||
124766622|NCT00446849|448773734|FG000|Acute Phase|Consent withdrawn|4|||
124766623|NCT00446849|448773734|FG000|Acute Phase|Lost to Follow-up|2|||
124766624|NCT00446849|448773734|FG000|Acute Phase|Physician Decision|1|||
124766625|NCT00446849|448773734|FG000|Acute Phase|noncompliance|1|||
124766626|NCT00446849|448773734|FG000|Maintenance Phase|Lack of Efficacy|40|||
124463315|NCT01425008|447654908|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
124463316|NCT01425008|447654909|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
124463317|NCT01425008|447654910|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
124463318|NCT01425008|447654911|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
124463319|NCT01425008|447654912|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
124463320|NCT01425008|447654913|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
124463321|NCT01425008|447654914|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
124463322|NCT01425008|447654915|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
124463323|NCT01425008|447654916|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
124463324|NCT01425008|447654917|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
124766627|NCT00446849|448773734|FG000|Maintenance Phase|Protocol Violation|7|||
124766628|NCT00446849|448773734|FG000|Maintenance Phase|Adverse Event|6|||
124766629|NCT00446849|448773734|FG000|Maintenance Phase|Consent withdrawn|5|||
124463325|NCT01425008|447654899|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124463326|NCT01425008|447654900|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124463327|NCT01425008|447654901|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124463328|NCT01425008|447654902|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124463329|NCT01425008|447654903|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124463330|NCT01425008|447654904|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124463331|NCT01425008|447654905|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124463332|NCT01425008|447654906|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124463333|NCT01425008|447654907|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124463334|NCT01425008|447654908|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124463335|NCT01425008|447654909|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124463336|NCT01425008|447654910|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124463337|NCT01425008|447654911|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124463338|NCT01425008|447654912|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124463339|NCT01425008|447654913|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124463340|NCT01425008|447654914|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124463341|NCT01425008|447654915|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124463342|NCT01425008|447654916|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124549269|NCT00388674|447966996|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
124549270|NCT00388674|447966997|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
124549271|NCT00388674|447966996|FG000|Initial Treatment|Adverse Event|22|||
124549272|NCT00388674|447966997|FG001|Initial Treatment|Adverse Event|87|||
124549273|NCT00388674|447966996|FG000|Initial Treatment|Death|215|||
124766630|NCT00446849|448773734|FG000|Maintenance Phase|Lost to Follow-up|3|||
124463343|NCT01425008|447654917|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
124549274|NCT00388674|447966997|FG001|Initial Treatment|Death|216|||
124549275|NCT00388674|447966996|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
124549276|NCT00388674|447966997|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
124766631|NCT00446849|448773734|FG000|Maintenance Phase|Pregnancy|1|||
124463344|NCT01314716|447654920|FG000|Double-Blind Phase|Randomized but not treated|1|||
124463345|NCT01314716|447654921|FG001|Double-Blind Phase|Randomized but not treated|1|||
124463346|NCT01314716|447654920|FG000|Double-Blind Phase|Adverse Event|10|||
124463347|NCT01314716|447654921|FG001|Double-Blind Phase|Adverse Event|4|||
124463348|NCT01314716|447654920|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
124463349|NCT01314716|447654921|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
124463350|NCT01314716|447654920|FG000|Double-Blind Phase|Lost to Follow-up|0|||
124463351|NCT01314716|447654921|FG001|Double-Blind Phase|Lost to Follow-up|1|||
124463352|NCT01314716|447654920|FG000|Double-Blind Phase|Sponsor request|1|||
124463353|NCT01314716|447654921|FG001|Double-Blind Phase|Sponsor request|2|||
124463354|NCT01314716|447654920|FG000|Double-Blind Phase|Physician Decision|0|||
124463355|NCT01314716|447654921|FG001|Double-Blind Phase|Physician Decision|1|||
124463356|NCT01314716|447654920|FG000|Open-Label Phase|Adverse Event|4|||
124463357|NCT01314716|447654921|FG001|Open-Label Phase|Adverse Event|6|||
124463358|NCT01314716|447654920|FG000|Open-Label Phase|Withdrawal by Subject|1|||
124463359|NCT01314716|447654921|FG001|Open-Label Phase|Withdrawal by Subject|2|||
124463360|NCT01314716|447654920|FG000|Open-Label Phase|Physician Decision|5|||
124463361|NCT01314716|447654921|FG001|Open-Label Phase|Physician Decision|4|||
124463362|NCT00562588|447654922|FG000|Overall Study|Adverse Event|40|||
124463363|NCT00562588|447654923|FG001|Overall Study|Adverse Event|58|||
124463364|NCT00562588|447654922|FG000|Overall Study|Protocol Violation|30|||
124463365|NCT00562588|447654923|FG001|Overall Study|Protocol Violation|26|||
124463366|NCT00562588|447654922|FG000|Overall Study|Lost to Follow-up|12|||
124463367|NCT00562588|447654923|FG001|Overall Study|Lost to Follow-up|4|||
124463368|NCT00562588|447654922|FG000|Overall Study|Withdrawal by Subject|10|||
124463369|NCT00562588|447654923|FG001|Overall Study|Withdrawal by Subject|9|||
124463370|NCT00562588|447654922|FG000|Overall Study|Other|0|||
124463371|NCT00562588|447654923|FG001|Overall Study|Other|2|||
124463372|NCT01452152|447654924|FG000|Overall Study|Study termination by sponsor|5|||
124463373|NCT01452152|447654925|FG001|Overall Study|Study termination by sponsor|0|||
124463374|NCT01452152|447654926|FG002|Overall Study|Study termination by sponsor|4|||
124463375|NCT04099251|447656495|FG000|Pre-Treatment|Other reasons|1|||
124463376|NCT04099251|447656496|FG001|Pre-Treatment|Other reasons|0|||
124463377|NCT04099251|447656495|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
124463378|NCT04099251|447656496|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
124463379|NCT04099251|447656495|FG000|Blinded Treatment Phase|Other reasons|16|||
124463380|NCT04099251|447656496|FG001|Blinded Treatment Phase|Other reasons|7|||
124463381|NCT04099251|447656495|FG000|Blinded Treatment Phase|Disease recurrence|26|||
124463382|NCT04099251|447656496|FG001|Blinded Treatment Phase|Disease recurrence|41|||
124463383|NCT04099251|447656495|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
124463384|NCT04099251|447656496|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
124463385|NCT04099251|447656495|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
124463386|NCT04099251|447656496|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
124463387|NCT04099251|447656495|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
124463388|NCT04099251|447656496|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
124463389|NCT04099251|447656495|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
124463390|NCT04099251|447656496|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
124463391|NCT04099251|447656495|FG000|Blinded Treatment Phase|Death|6|||
124463392|NCT04099251|447656496|FG001|Blinded Treatment Phase|Death|2|||
124463393|NCT04099251|447656495|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
124463394|NCT04099251|447656496|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
124707999|NCT00945659|448555944|FG002|Overall Study|Lost to Follow-up|17|||
124708000|NCT04562116|448555945|FG000|Overall Study|Lost to Follow-up|1|||
124708001|NCT04562116|448555945|FG000|Overall Study|Withdrawal by Subject|3|||
124957637|NCT04816708|449471170|FG000|Overall Study|Lost to Follow-up|10|||
124957638|NCT04816708|449471171|FG001|Overall Study|Lost to Follow-up|4|||
124957639|NCT02388932|449471172|FG000|Overall Study|Death|1|||
124463395|NCT04099251|447656495|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
124463396|NCT04099251|447656496|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
124463397|NCT04099251|447656495|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
124463398|NCT04099251|447656496|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
124463399|NCT04099251|447656495|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
124463400|NCT04099251|447656496|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
124463401|NCT04099251|447656495|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
124463402|NCT04099251|447656496|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
124463403|NCT04099251|447656495|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
124463404|NCT04099251|447656496|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
124463405|NCT04099251|447656495|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
124957640|NCT03568708|449471175|FG000|Overall Study|Withdrawal by Subject|1|||
124463406|NCT04099251|447656496|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
124463407|NCT04099251|447656495|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
124957641|NCT03568708|449471176|FG001|Overall Study|Withdrawal by Subject|1|||
124957642|NCT03568708|449471175|FG000|Overall Study|Lost to Follow-up|0|||
124957643|NCT03568708|449471176|FG001|Overall Study|Lost to Follow-up|1|||
124957644|NCT00809783|449471177|FG000|Overall Study|Death|1|||
124957645|NCT00809783|449471178|FG001|Overall Study|Death|0|||
124957646|NCT00809783|449471179|FG002|Overall Study|Death|0|||
124463408|NCT04099251|447656496|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
124463409|NCT04099251|447656495|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
124463410|NCT04099251|447656496|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
124463411|NCT01995071|447656497|FG000|Overall Study|Adverse Event|0|||
124463412|NCT01995071|447656498|FG001|Overall Study|Adverse Event|0|||
124463413|NCT01995071|447656499|FG002|Overall Study|Adverse Event|0|||
124463414|NCT01995071|447656500|FG003|Overall Study|Adverse Event|0|||
124463415|NCT01995071|447656501|FG004|Overall Study|Adverse Event|0|||
124463416|NCT01995071|447656502|FG005|Overall Study|Adverse Event|0|||
124463417|NCT01995071|447656503|FG006|Overall Study|Adverse Event|1|||
124463418|NCT01995071|447656504|FG007|Overall Study|Adverse Event|0|||
124463419|NCT01995071|447656505|FG008|Overall Study|Adverse Event|0|||
124463420|NCT01995071|447656506|FG009|Overall Study|Adverse Event|0|||
124463421|NCT01995071|447656507|FG010|Overall Study|Adverse Event|0|||
124463422|NCT01995071|447656508|FG011|Overall Study|Adverse Event|0|||
124463423|NCT01995071|447656497|FG000|Overall Study|Moved|0|||
124463424|NCT01995071|447656498|FG001|Overall Study|Moved|0|||
124463425|NCT01995071|447656499|FG002|Overall Study|Moved|1|||
124463426|NCT01995071|447656500|FG003|Overall Study|Moved|0|||
124463427|NCT01995071|447656501|FG004|Overall Study|Moved|1|||
124463428|NCT01995071|447656502|FG005|Overall Study|Moved|0|||
124463429|NCT01995071|447656503|FG006|Overall Study|Moved|0|||
124463430|NCT01995071|447656504|FG007|Overall Study|Moved|0|||
124463431|NCT01995071|447656505|FG008|Overall Study|Moved|0|||
124463432|NCT01995071|447656506|FG009|Overall Study|Moved|0|||
124463433|NCT01995071|447656507|FG010|Overall Study|Moved|1|||
124463434|NCT01995071|447656508|FG011|Overall Study|Moved|0|||
124463435|NCT01995071|447656497|FG000|Overall Study|Lost to Follow-up|1|||
124463436|NCT01995071|447656498|FG001|Overall Study|Lost to Follow-up|0|||
124463437|NCT01995071|447656499|FG002|Overall Study|Lost to Follow-up|0|||
124463438|NCT01995071|447656500|FG003|Overall Study|Lost to Follow-up|0|||
124463439|NCT01995071|447656501|FG004|Overall Study|Lost to Follow-up|0|||
124463440|NCT01995071|447656502|FG005|Overall Study|Lost to Follow-up|0|||
124463441|NCT01995071|447656503|FG006|Overall Study|Lost to Follow-up|0|||
124463442|NCT01995071|447656504|FG007|Overall Study|Lost to Follow-up|1|||
124463443|NCT01995071|447656505|FG008|Overall Study|Lost to Follow-up|1|||
124463444|NCT01995071|447656506|FG009|Overall Study|Lost to Follow-up|0|||
124463445|NCT01995071|447656507|FG010|Overall Study|Lost to Follow-up|0|||
124463446|NCT01995071|447656508|FG011|Overall Study|Lost to Follow-up|0|||
124957647|NCT00809783|449471177|FG000|Overall Study|Adverse Event|34|||
124957648|NCT00809783|449471178|FG001|Overall Study|Adverse Event|52|||
124957649|NCT00809783|449471179|FG002|Overall Study|Adverse Event|71|||
124957650|NCT00809783|449471177|FG000|Overall Study|Lack of Efficacy|39|||
124957651|NCT00809783|449471178|FG001|Overall Study|Lack of Efficacy|52|||
124957652|NCT00809783|449471179|FG002|Overall Study|Lack of Efficacy|63|||
124957653|NCT00809783|449471177|FG000|Overall Study|Lost to Follow-up|0|||
124957654|NCT00809783|449471178|FG001|Overall Study|Lost to Follow-up|3|||
124957655|NCT00809783|449471179|FG002|Overall Study|Lost to Follow-up|4|||
124957656|NCT00809783|449471177|FG000|Overall Study|Withdrawal by Subject|47|||
124957657|NCT00809783|449471178|FG001|Overall Study|Withdrawal by Subject|72|||
124957658|NCT00809783|449471179|FG002|Overall Study|Withdrawal by Subject|64|||
124957659|NCT00809783|449471177|FG000|Overall Study|Protocol Violation|2|||
124957660|NCT00809783|449471178|FG001|Overall Study|Protocol Violation|6|||
124957661|NCT00809783|449471179|FG002|Overall Study|Protocol Violation|5|||
124957662|NCT00809783|449471177|FG000|Overall Study|Randomized, but not treated|3|||
124957663|NCT00809783|449471178|FG001|Overall Study|Randomized, but not treated|0|||
124957664|NCT00809783|449471179|FG002|Overall Study|Randomized, but not treated|2|||
124957665|NCT00809783|449471177|FG000|Overall Study|Study Terminated by Sponsor|378|||
124463447|NCT01995071|447656497|FG000|Overall Study|Incarcerated|0|||
124463448|NCT01995071|447656498|FG001|Overall Study|Incarcerated|0|||
124463449|NCT01995071|447656499|FG002|Overall Study|Incarcerated|0|||
124463450|NCT01995071|447656500|FG003|Overall Study|Incarcerated|0|||
124463451|NCT01995071|447656501|FG004|Overall Study|Incarcerated|0|||
124463452|NCT01995071|447656502|FG005|Overall Study|Incarcerated|0|||
124463453|NCT01995071|447656503|FG006|Overall Study|Incarcerated|0|||
124957666|NCT00809783|449471178|FG001|Overall Study|Study Terminated by Sponsor|626|||
124957667|NCT00809783|449471179|FG002|Overall Study|Study Terminated by Sponsor|565|||
124957668|NCT00809783|449471177|FG000|Overall Study|Other|21|||
124463454|NCT01995071|447656504|FG007|Overall Study|Incarcerated|1|||
124463455|NCT01995071|447656505|FG008|Overall Study|Incarcerated|0|||
124463456|NCT01995071|447656506|FG009|Overall Study|Incarcerated|0|||
124463457|NCT01995071|447656507|FG010|Overall Study|Incarcerated|0|||
124463458|NCT01995071|447656508|FG011|Overall Study|Incarcerated|0|||
124463459|NCT01783678|447656509|FG000|Overall Study|Randomized but Not Treated|0|||
124957669|NCT00809783|449471178|FG001|Overall Study|Other|21|||
124957670|NCT00809783|449471179|FG002|Overall Study|Other|16|||
124957671|NCT00126555|449471180|FG000|Overall Study|Withdrawal by Subject|1|||
124957672|NCT00126555|449471180|FG000|Overall Study|Adverse Event|2|||
124957673|NCT00126555|449471180|FG000|Overall Study|Progressive Disease|3|||
124957674|NCT01284634|449471192|FG000|Overall Study|Adverse Event|1|||
124957675|NCT01284634|449471193|FG001|Overall Study|Adverse Event|0|||
124957676|NCT01284634|449471194|FG002|Overall Study|Adverse Event|2|||
124957677|NCT01284634|449471195|FG003|Overall Study|Adverse Event|1|||
124957678|NCT01059526|449471196|FG000|Overall Study|Patient enrolled but not treated|20|||
124957679|NCT01059526|449471197|FG001|Overall Study|Patient enrolled but not treated|17|||
124957680|NCT01059526|449471196|FG000|Overall Study|Adverse Event|2|||
124957681|NCT01059526|449471197|FG001|Overall Study|Adverse Event|2|||
124957682|NCT01059526|449471196|FG000|Overall Study|Protocol Violation|0|||
124957683|NCT01059526|449471197|FG001|Overall Study|Protocol Violation|1|||
124957684|NCT01059526|449471196|FG000|Overall Study|Withdrawal by Subject|3|||
124957685|NCT01059526|449471197|FG001|Overall Study|Withdrawal by Subject|1|||
124957686|NCT01059526|449471196|FG000|Overall Study|Lost to Follow-up|4|||
124957687|NCT01059526|449471197|FG001|Overall Study|Lost to Follow-up|1|||
124957688|NCT01059526|449471196|FG000|Overall Study|Patient found to be dermatographic|1|||
124957689|NCT01059526|449471197|FG001|Overall Study|Patient found to be dermatographic|0|||
124957690|NCT02720081|449471198|FG000|Overall Study|Adverse Event|0|||
124957691|NCT02720081|449471199|FG001|Overall Study|Adverse Event|3|||
124957692|NCT02720081|449471198|FG000|Overall Study|Protocol Violation|4|||
124957693|NCT02720081|449471199|FG001|Overall Study|Protocol Violation|1|||
124957694|NCT01732588|449471200|FG000|First Intervention (7 Days)|Adverse Event|0|||
124957695|NCT01732588|449471201|FG001|First Intervention (7 Days)|Adverse Event|1|||
124957696|NCT01732588|449471202|FG002|First Intervention (7 Days)|Adverse Event|0|||
124957697|NCT05012397|449471206|FG000|Overall Study|Death|10|||
124957698|NCT05012397|449471206|FG000|Overall Study|Physician Decision|9|||
124957699|NCT05012397|449471206|FG000|Overall Study|Withdrawal by Subject|5|||
124957700|NCT05012397|449471206|FG000|Overall Study|Lost to Follow-up|2|||
124957701|NCT03334747|449471207|FG000|Treatment Phase|Technical problems|0|||
124957702|NCT03334747|449471208|FG001|Treatment Phase|Technical problems|0|||
124957703|NCT03334747|449471209|FG002|Treatment Phase|Technical problems|0|||
124957704|NCT03334747|449471210|FG003|Treatment Phase|Technical problems|0|||
124957705|NCT03334747|449471211|FG004|Treatment Phase|Technical problems|1|||
124957706|NCT03334747|449471212|FG005|Treatment Phase|Technical problems|0|||
124957707|NCT03334747|449471213|FG006|Treatment Phase|Technical problems|0|||
124957708|NCT03334747|449471214|FG007|Treatment Phase|Technical problems|0|||
124957709|NCT03334747|449471215|FG008|Treatment Phase|Technical problems|0|||
124957710|NCT03334747|449471207|FG000|Treatment Phase|Subject/guardian decision|1|||
124957711|NCT03334747|449471208|FG001|Treatment Phase|Subject/guardian decision|0|||
124957712|NCT03334747|449471209|FG002|Treatment Phase|Subject/guardian decision|0|||
124957713|NCT03334747|449471210|FG003|Treatment Phase|Subject/guardian decision|0|||
124957714|NCT03334747|449471211|FG004|Treatment Phase|Subject/guardian decision|0|||
124957715|NCT03334747|449471212|FG005|Treatment Phase|Subject/guardian decision|1|||
124957716|NCT03334747|449471213|FG006|Treatment Phase|Subject/guardian decision|0|||
124957717|NCT03334747|449471214|FG007|Treatment Phase|Subject/guardian decision|0|||
124957718|NCT03334747|449471215|FG008|Treatment Phase|Subject/guardian decision|0|||
124957719|NCT03334747|449471207|FG000|Follow-Up Phase|Subject/guardian decision|0|||
124957720|NCT03334747|449471208|FG001|Follow-Up Phase|Subject/guardian decision|0|||
124957721|NCT03334747|449471209|FG002|Follow-Up Phase|Subject/guardian decision|0|||
124957722|NCT03334747|449471210|FG003|Follow-Up Phase|Subject/guardian decision|0|||
124957723|NCT03334747|449471211|FG004|Follow-Up Phase|Subject/guardian decision|0|||
124957724|NCT03334747|449471212|FG005|Follow-Up Phase|Subject/guardian decision|0|||
124957725|NCT03334747|449471213|FG006|Follow-Up Phase|Subject/guardian decision|1|||
124957726|NCT03334747|449471214|FG007|Follow-Up Phase|Subject/guardian decision|0|||
124957727|NCT03334747|449471215|FG008|Follow-Up Phase|Subject/guardian decision|1|||
124957728|NCT02567227|449471216|FG000|9 Weeks|Adverse Event|5|||
124957729|NCT02567227|449471217|FG001|9 Weeks|Adverse Event|5|||
124957730|NCT02567227|449471216|FG000|9 Weeks|Withdrawal by Subject|18|||
124957731|NCT02567227|449471217|FG001|9 Weeks|Withdrawal by Subject|8|||
124957732|NCT02567227|449471216|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
124957733|NCT02567227|449471217|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
124957734|NCT02567227|449471216|FG000|6 Month|Death|2|||
124957735|NCT02567227|449471217|FG001|6 Month|Death|0|||
124957736|NCT02567227|449471216|FG000|6 Month|Lost to Follow-up|43|||
124957737|NCT02567227|449471217|FG001|6 Month|Lost to Follow-up|40|||
124957738|NCT02567227|449471216|FG000|12 Months|Lost to Follow-up|31|||
124957739|NCT02567227|449471217|FG001|12 Months|Lost to Follow-up|32|||
124957740|NCT02567227|449471216|FG000|12 Months|Death|0|||
124957741|NCT02567227|449471217|FG001|12 Months|Death|2|||
124957742|NCT02498418|449471221|FG000|Overall Study|Lack of Efficacy|0|||
124957743|NCT02498418|449471222|FG001|Overall Study|Lack of Efficacy|0|||
124957744|NCT02498418|449471223|FG002|Overall Study|Lack of Efficacy|1|||
124957745|NCT02498418|449471221|FG000|Overall Study|Withdrawal by Subject|2|||
124957746|NCT02498418|449471222|FG001|Overall Study|Withdrawal by Subject|0|||
124957747|NCT02498418|449471223|FG002|Overall Study|Withdrawal by Subject|3|||
124957748|NCT02498418|449471221|FG000|Overall Study|Lost to Follow-up|0|||
124957749|NCT02498418|449471222|FG001|Overall Study|Lost to Follow-up|1|||
124957750|NCT02498418|449471223|FG002|Overall Study|Lost to Follow-up|1|||
124957751|NCT02498418|449471221|FG000|Overall Study|Participant taken prohibited medication|0|||
124957752|NCT02498418|449471222|FG001|Overall Study|Participant taken prohibited medication|1|||
124957753|NCT02498418|449471223|FG002|Overall Study|Participant taken prohibited medication|1|||
124957754|NCT00762502|449471224|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
124957755|NCT00762502|449471225|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
124957756|NCT00762502|449471226|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
124957757|NCT00762502|449471224|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
124957758|NCT00762502|449471225|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
124957759|NCT00762502|449471226|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
124957760|NCT00762502|449471224|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
124957761|NCT00762502|449471225|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
124957762|NCT00762502|449471226|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
124957763|NCT03042559|449471227|FG000|Overall Study|drop out|1|||
124957764|NCT03042559|449471228|FG001|Overall Study|drop out|1|||
124957765|NCT01485991|449471229|FG000|Overall Study|Adverse Event|0|||
124957766|NCT01485991|449471230|FG001|Overall Study|Adverse Event|4|||
124957767|NCT01485991|449471229|FG000|Overall Study|Lost to Follow-up|13|||
124957768|NCT01485991|449471230|FG001|Overall Study|Lost to Follow-up|10|||
124957769|NCT01485991|449471229|FG000|Overall Study|Withdrawal by Subject|13|||
124957770|NCT01485991|449471230|FG001|Overall Study|Withdrawal by Subject|20|||
124957771|NCT01485991|449471229|FG000|Overall Study|randomized but not treated|6|||
124957772|NCT01485991|449471230|FG001|Overall Study|randomized but not treated|2|||
124957773|NCT01475370|449471231|FG000|Overall Study|Exacerbation of primary disease|2|||
124957774|NCT01475370|449471232|FG001|Overall Study|Exacerbation of primary disease|2|||
124957775|NCT01475370|449471233|FG002|Overall Study|Exacerbation of primary disease|2|||
124957776|NCT01475370|449471231|FG000|Overall Study|Study drug administration difficult|0|||
124957777|NCT01475370|449471232|FG001|Overall Study|Study drug administration difficult|1|||
124957778|NCT01475370|449471233|FG002|Overall Study|Study drug administration difficult|1|||
124957779|NCT01475370|449471231|FG000|Overall Study|Other than specified|1|||
124957780|NCT01475370|449471232|FG001|Overall Study|Other than specified|0|||
124957781|NCT01475370|449471233|FG002|Overall Study|Other than specified|0|||
124957782|NCT01675050|449471236|FG000|Period One Treatment|Withdrawal by Subject|1|||
124957783|NCT01675050|449471237|FG001|Period One Treatment|Withdrawal by Subject|0|||
124957784|NCT04474691|449471238|FG000|Overall Study|Withdrawal by Subject|9|||
124957785|NCT02625922|449471239|FG000|Overall Study|Non-availability of IMP|1|||
124957786|NCT02625922|449471240|FG001|Overall Study|Non-availability of IMP|1|||
124957787|NCT02625922|449471239|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
124957788|NCT02625922|449471240|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
124957789|NCT01261793|449471247|FG000|Overall Study|Lack of Efficacy|44|||
124957790|NCT01261793|449471248|FG001|Overall Study|Lack of Efficacy|37|||
124957791|NCT01261793|449471249|FG002|Overall Study|Lack of Efficacy|32|||
124957792|NCT01261793|449471247|FG000|Overall Study|Protocol Violation|3|||
124957793|NCT01261793|449471248|FG001|Overall Study|Protocol Violation|5|||
124957794|NCT01261793|449471249|FG002|Overall Study|Protocol Violation|6|||
124957795|NCT01261793|449471247|FG000|Overall Study|Lost to Follow-up|10|||
124957796|NCT01261793|449471248|FG001|Overall Study|Lost to Follow-up|3|||
124957797|NCT01261793|449471249|FG002|Overall Study|Lost to Follow-up|7|||
124957798|NCT01261793|449471247|FG000|Overall Study|Withdrawal by Subject|12|||
124957799|NCT01261793|449471248|FG001|Overall Study|Withdrawal by Subject|14|||
124957800|NCT01261793|449471249|FG002|Overall Study|Withdrawal by Subject|14|||
124957801|NCT01261793|449471247|FG000|Overall Study|Death|3|||
124957802|NCT01261793|449471248|FG001|Overall Study|Death|1|||
124957803|NCT01261793|449471249|FG002|Overall Study|Death|0|||
124957804|NCT01261793|449471247|FG000|Overall Study|Adverse Event|9|||
124957805|NCT01261793|449471248|FG001|Overall Study|Adverse Event|24|||
124957806|NCT01261793|449471249|FG002|Overall Study|Adverse Event|19|||
124957807|NCT01261793|449471247|FG000|Overall Study|Patient non-availability|1|||
124957808|NCT01261793|449471248|FG001|Overall Study|Patient non-availability|1|||
124957809|NCT01261793|449471249|FG002|Overall Study|Patient non-availability|1|||
124957810|NCT01261793|449471247|FG000|Overall Study|Suspected pregnancy|1|||
124957811|NCT01261793|449471248|FG001|Overall Study|Suspected pregnancy|1|||
124957812|NCT01261793|449471249|FG002|Overall Study|Suspected pregnancy|0|||
124957813|NCT01261793|449471247|FG000|Overall Study|Patient non-compliance|1|||
124957814|NCT01261793|449471248|FG001|Overall Study|Patient non-compliance|0|||
124957815|NCT01261793|449471249|FG002|Overall Study|Patient non-compliance|1|||
124957816|NCT01261793|449471247|FG000|Overall Study|Patient pregnant|1|||
124957817|NCT01261793|449471248|FG001|Overall Study|Patient pregnant|0|||
124549277|NCT00388674|447966996|FG000|Initial Treatment|HCC|12|||
124957818|NCT01261793|449471249|FG002|Overall Study|Patient pregnant|0|||
124549278|NCT00388674|447966997|FG001|Initial Treatment|HCC|20|||
124957819|NCT01261793|449471247|FG000|Overall Study|Outside the study area|0|||
124708002|NCT02412670|448555948|FG000|Overall Study|Adverse Event|4|||
124957820|NCT01261793|449471248|FG001|Overall Study|Outside the study area|2|||
124957821|NCT01261793|449471249|FG002|Overall Study|Outside the study area|1|||
124957822|NCT01261793|449471247|FG000|Overall Study|Lack of efficacy & patient not available|0|||
124957823|NCT01261793|449471248|FG001|Overall Study|Lack of efficacy & patient not available|1|||
124957824|NCT01261793|449471249|FG002|Overall Study|Lack of efficacy & patient not available|0|||
124957825|NCT01261793|449471247|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
124957826|NCT01261793|449471248|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
124957827|NCT01261793|449471249|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
124957828|NCT01261793|449471247|FG000|Overall Study|Randomization error|0|||
124957829|NCT01261793|449471248|FG001|Overall Study|Randomization error|1|||
124957830|NCT01261793|449471249|FG002|Overall Study|Randomization error|0|||
124957831|NCT01261793|449471247|FG000|Overall Study|Patient unable to start IV line|0|||
124957832|NCT01261793|449471248|FG001|Overall Study|Patient unable to start IV line|0|||
124957833|NCT01261793|449471249|FG002|Overall Study|Patient unable to start IV line|1|||
124957834|NCT00832650|449471253|FG000|Overall Study|Randomized but not treated|0|||
124957835|NCT00832650|449471254|FG001|Overall Study|Randomized but not treated|0|||
124957836|NCT00832650|449471255|FG002|Overall Study|Randomized but not treated|1|||
124957837|NCT02335242|449471259|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
124957838|NCT02335242|449471260|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
124957839|NCT02335242|449471259|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
124957840|NCT02335242|449471260|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
124957841|NCT02335242|449471259|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
124957842|NCT02335242|449471260|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
124957843|NCT00257556|449471263|FG000|Overall Study|Adverse Event|1|||
124957844|NCT00257556|449471264|FG001|Overall Study|Adverse Event|4|||
124957845|NCT00257556|449471263|FG000|Overall Study|Physician Decision|6|||
124957846|NCT00257556|449471264|FG001|Overall Study|Physician Decision|0|||
124957847|NCT00257556|449471263|FG000|Overall Study|Did not meet hCG criterion|3|||
124957848|NCT00257556|449471264|FG001|Overall Study|Did not meet hCG criterion|0|||
124957849|NCT00257556|449471263|FG000|Overall Study|other reason|4|||
124957850|NCT00257556|449471264|FG001|Overall Study|other reason|6|||
124957851|NCT04839289|449471265|FG000|Overall Study|Withdrawal by Subject|1|||
124957852|NCT04839289|449471266|FG001|Overall Study|Withdrawal by Subject|0|||
124957853|NCT02418819|449471268|FG000|Overall Study|Adverse Event|0|||
124957854|NCT02418819|449471269|FG001|Overall Study|Adverse Event|0|||
124957855|NCT02418819|449471270|FG002|Overall Study|Adverse Event|1|||
124957856|NCT02418819|449471271|FG003|Overall Study|Adverse Event|0|||
124957857|NCT02418819|449471268|FG000|Overall Study|Lost to Follow-up|1|||
124957858|NCT02418819|449471269|FG001|Overall Study|Lost to Follow-up|0|||
124957859|NCT02418819|449471270|FG002|Overall Study|Lost to Follow-up|0|||
124957860|NCT02418819|449471271|FG003|Overall Study|Lost to Follow-up|0|||
124957861|NCT02418819|449471268|FG000|Overall Study|No longer meets eligibility criteria|0|||
124957862|NCT02418819|449471269|FG001|Overall Study|No longer meets eligibility criteria|0|||
124957863|NCT02418819|449471270|FG002|Overall Study|No longer meets eligibility criteria|1|||
124957864|NCT02418819|449471271|FG003|Overall Study|No longer meets eligibility criteria|0|||
124957865|NCT02418819|449471268|FG000|Overall Study|No longer willing to participate|0|||
124957866|NCT02418819|449471269|FG001|Overall Study|No longer willing to participate|0|||
124957867|NCT02418819|449471270|FG002|Overall Study|No longer willing to participate|2|||
124957868|NCT02418819|449471271|FG003|Overall Study|No longer willing to participate|1|||
124957869|NCT04743999|449471272|FG000|3-month Questionnaire|Death|1|||
124957870|NCT04743999|449471272|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
124957871|NCT04743999|449471272|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
124957872|NCT04743999|449471272|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
124957873|NCT01721759|449471273|FG000|Treatment Period|Disease Progression|85|||
124957874|NCT01721759|449471273|FG000|Treatment Period|Study drug toxicity|14|||
124957875|NCT01721759|449471273|FG000|Treatment Period|Death|1|||
124957876|NCT01721759|449471273|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
124957877|NCT01721759|449471273|FG000|Treatment Period|Participant request to withdraw|3|||
124957878|NCT01721759|449471273|FG000|Treatment Period|Other Reasons|3|||
124957879|NCT01721759|449471273|FG000|End of Study Period|Participant Withdrew Consent|5|||
124957880|NCT01721759|449471273|FG000|End of Study Period|Death|101|||
124766632|NCT00446849|448773734|FG000|Maintenance Phase|noncompliance|2|||
124957881|NCT01721759|449471273|FG000|End of Study Period|Lost to Follow-up|1|||
124957882|NCT01721759|449471273|FG000|End of Study Period|Other Reasons|10|||
124957883|NCT01399905|449471274|FG000|Overall Study|Withdrawal by Subject|1|||
124957884|NCT01399905|449471275|FG001|Overall Study|Withdrawal by Subject|1|||
124957885|NCT01804140|449471281|FG000|Overall Study|No sampling or biopsy procedures done|114|||
124957886|NCT02785900|449471282|FG000|Overall Study|Study Termination by Sponsor|64|||
124957887|NCT02785900|449471283|FG001|Overall Study|Study Termination by Sponsor|81|||
124957888|NCT02785900|449471282|FG000|Overall Study|Death|46|||
124957889|NCT02785900|449471283|FG001|Overall Study|Death|32|||
124957890|NCT02785900|449471282|FG000|Overall Study|Withdrawal by Subject|4|||
124957891|NCT02785900|449471283|FG001|Overall Study|Withdrawal by Subject|8|||
124957892|NCT02785900|449471282|FG000|Overall Study|Physician Decision|3|||
124957893|NCT02785900|449471283|FG001|Overall Study|Physician Decision|2|||
124957894|NCT01808144|449471284|FG000|Overall Study|Death|1|||
124957895|NCT01808144|449471285|FG001|Overall Study|Death|0|||
124957896|NCT01808144|449471284|FG000|Overall Study|Withdrawal by Subject|16|||
124957897|NCT01808144|449471285|FG001|Overall Study|Withdrawal by Subject|23|||
124957898|NCT01808144|449471284|FG000|Overall Study|Lost to Follow-up|6|||
124957899|NCT01808144|449471285|FG001|Overall Study|Lost to Follow-up|3|||
124957900|NCT01808144|449471284|FG000|Overall Study|Protocol Violation|6|||
124957901|NCT01808144|449471285|FG001|Overall Study|Protocol Violation|6|||
124957902|NCT01808144|449471284|FG000|Overall Study|Gout flare|0|||
124957903|NCT01808144|449471285|FG001|Overall Study|Gout flare|1|||
124957904|NCT01808144|449471284|FG000|Overall Study|Adverse Event|11|||
124957905|NCT01808144|449471285|FG001|Overall Study|Adverse Event|15|||
124957906|NCT00383500|449471286|FG000|Overall Study|Withdrawal by Subject|8|||
124957907|NCT00383500|449471287|FG001|Overall Study|Withdrawal by Subject|3|||
124957908|NCT00383500|449471288|FG002|Overall Study|Withdrawal by Subject|0|||
124957909|NCT00383500|449471286|FG000|Overall Study|Lost to Follow-up|0|||
124957910|NCT00383500|449471287|FG001|Overall Study|Lost to Follow-up|0|||
124957911|NCT00383500|449471288|FG002|Overall Study|Lost to Follow-up|2|||
124957912|NCT04341584|449471292|FG000|Overall Study|Withdrew consent|0|||
124957913|NCT04341584|449471293|FG001|Overall Study|Withdrew consent|2|||
124957914|NCT04341584|449471294|FG002|Overall Study|Withdrew consent|2|||
124957915|NCT04341584|449471295|FG003|Overall Study|Withdrew consent|1|||
124957916|NCT04853238|449471297|FG000|Overall Study|Death|4|||
124957917|NCT04853238|449471298|FG001|Overall Study|Death|0|||
124957918|NCT04853238|449471299|FG002|Overall Study|Death|2|||
124957919|NCT04853238|449471297|FG000|Overall Study|Lost to Follow-up|16|||
124957920|NCT04853238|449471298|FG001|Overall Study|Lost to Follow-up|2|||
124957921|NCT04853238|449471299|FG002|Overall Study|Lost to Follow-up|37|||
124957922|NCT04853238|449471297|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
124957923|NCT04853238|449471298|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
124957924|NCT04853238|449471299|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
124957925|NCT04853238|449471297|FG000|Overall Study|Withdrawal by Subject|6|||
124957926|NCT04853238|449471298|FG001|Overall Study|Withdrawal by Subject|0|||
124957927|NCT04853238|449471299|FG002|Overall Study|Withdrawal by Subject|21|||
124957928|NCT04853238|449471297|FG000|Overall Study|Physician Decision|0|||
124957929|NCT04853238|449471298|FG001|Overall Study|Physician Decision|0|||
124957930|NCT04853238|449471299|FG002|Overall Study|Physician Decision|2|||
124957931|NCT04853238|449471297|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
124957932|NCT04853238|449471298|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
124957933|NCT04853238|449471299|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
124957934|NCT02176356|449472667|FG000|Overall Study|Screen Failure|14|||
124957935|NCT02176356|449472667|FG000|Overall Study|Lost to Follow-up|4|||
124957936|NCT02176356|449472667|FG000|Overall Study|Personal Reasons|3|||
124957937|NCT02176356|449472667|FG000|Overall Study|Other Miscellaneous Reasons|2|||
124957938|NCT00792259|449472668|FG000|Overall Study|Poor Quality Scans|1|||
124957939|NCT00792259|449472669|FG001|Overall Study|Poor Quality Scans|0|||
124957940|NCT00792259|449472670|FG002|Overall Study|Poor Quality Scans|0|||
124957941|NCT00332488|449472671|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
124957942|NCT00332488|449472672|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
124957943|NCT00332488|449472673|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
124957944|NCT00332488|449472671|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
124957945|NCT00332488|449472672|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
124957946|NCT00332488|449472673|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
124957947|NCT00332488|449472671|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
124957948|NCT00332488|449472672|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
124957949|NCT00332488|449472673|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
124957950|NCT00332488|449472671|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
124957951|NCT00332488|449472672|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
124957952|NCT00332488|449472673|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
124957953|NCT00332488|449472671|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
124957954|NCT00332488|449472672|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
124957955|NCT00332488|449472673|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
124957956|NCT00332488|449472671|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
124957957|NCT00332488|449472672|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
124957958|NCT00332488|449472673|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
124957959|NCT00332488|449472671|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
124957960|NCT00332488|449472672|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
124957961|NCT00332488|449472673|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
124957962|NCT00332488|449472671|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
124957963|NCT00332488|449472672|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
124957964|NCT00332488|449472673|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
124957965|NCT00332488|449472671|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
124957966|NCT00332488|449472672|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
124957967|NCT00332488|449472673|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
124957968|NCT00332488|449472671|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
124957969|NCT00332488|449472672|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
124957970|NCT00332488|449472673|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
124957971|NCT00332488|449472671|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
124957972|NCT00332488|449472672|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
124957973|NCT00332488|449472673|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
124766633|NCT00446849|448773734|FG000|Maintenance Phase|prohibited medication use|2|||
124766634|NCT00446849|448773734|FG000|Maintenance Phase|antibiotic use|1|||
124766635|NCT00446849|448773734|FG000|Maintenance Phase|study closure|1|||
124766636|NCT00446849|448773734|FG000|Maintenance Phase|hydrocodone use|1|||
124766637|NCT00446849|448773734|FG000|Maintenance Phase|concomitant medication use|1|||
124766638|NCT05546476|448773737|FG000|Period 1: Part A|Adverse Event|2|||
124766639|NCT05546476|448773738|FG001|Period 1: Part A|Adverse Event|0|||
124766640|NCT05546476|448773739|FG002|Period 1: Part A|Adverse Event|0|||
124957974|NCT00332488|449472671|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
124957975|NCT00332488|449472672|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
124957976|NCT00332488|449472673|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
124957977|NCT00371462|449472674|FG000|Overall Study|Withdrawal by Subject|1|||
124957978|NCT00371462|449472675|FG001|Overall Study|Withdrawal by Subject|0|||
124957979|NCT00371462|449472674|FG000|Overall Study|Other|7|||
124766641|NCT05546476|448773740|FG003|Period 1: Part A|Adverse Event|1|||
124766642|NCT05546476|448773737|FG000|Period 1: Part A|Death|4|||
124766643|NCT05546476|448773738|FG001|Period 1: Part A|Death|4|||
124766644|NCT05546476|448773739|FG002|Period 1: Part A|Death|5|||
124766645|NCT05546476|448773740|FG003|Period 1: Part A|Death|6|||
124957980|NCT00371462|449472675|FG001|Overall Study|Other|8|||
124957981|NCT03721978|449472677|FG000|Overall Study|Withdrawal by Subject|6|||
124957982|NCT03721978|449472678|FG001|Overall Study|Withdrawal by Subject|1|||
124957983|NCT03721978|449472677|FG000|Overall Study|Adverse Event|1|||
124957984|NCT03721978|449472678|FG001|Overall Study|Adverse Event|1|||
124957985|NCT03721978|449472677|FG000|Overall Study|Progressive Disease|1|||
124957986|NCT03721978|449472678|FG001|Overall Study|Progressive Disease|0|||
124957987|NCT03721978|449472677|FG000|Overall Study|Lost to Follow-up|5|||
124957988|NCT03721978|449472678|FG001|Overall Study|Lost to Follow-up|1|||
124957989|NCT03721978|449472677|FG000|Overall Study|Reason not Specified|0|||
124957990|NCT03721978|449472678|FG001|Overall Study|Reason not Specified|2|||
124957991|NCT05244226|449472679|FG000|Overall Study|Adverse Event|1|||
124957992|NCT05244226|449472680|FG001|Overall Study|Adverse Event|0|||
124957993|NCT05244226|449472681|FG002|Overall Study|Adverse Event|0|||
124957994|NCT05244226|449472679|FG000|Overall Study|Lost to Follow-up|0|||
124957995|NCT05244226|449472680|FG001|Overall Study|Lost to Follow-up|0|||
124957996|NCT05244226|449472681|FG002|Overall Study|Lost to Follow-up|1|||
124957997|NCT05244226|449472679|FG000|Overall Study|Protocol Violation|0|||
124957998|NCT05244226|449472680|FG001|Overall Study|Protocol Violation|2|||
124957999|NCT05244226|449472681|FG002|Overall Study|Protocol Violation|2|||
124958000|NCT00733226|449472682|FG000|Overall Study|Withdrawal by Subject|1|||
124958001|NCT00733226|449472683|FG001|Overall Study|Withdrawal by Subject|0|||
124958002|NCT00733226|449472682|FG000|Overall Study|Lost to Follow-up|2|||
124958003|NCT00733226|449472683|FG001|Overall Study|Lost to Follow-up|0|||
124958004|NCT00733226|449472682|FG000|Overall Study|moved to another place|2|||
124958005|NCT00733226|449472683|FG001|Overall Study|moved to another place|0|||
124958006|NCT03722485|449472684|FG000|Overall Study|Withdrawal by Subject|1|||
124958007|NCT03722485|449472685|FG001|Overall Study|Withdrawal by Subject|0|||
124958008|NCT03722485|449472684|FG000|Overall Study|Adverse Event|0|||
124958009|NCT03722485|449472685|FG001|Overall Study|Adverse Event|2|||
124958010|NCT03722485|449472684|FG000|Overall Study|subject discharged prior to study completion|1|||
124958011|NCT03722485|449472685|FG001|Overall Study|subject discharged prior to study completion|5|||
124958012|NCT03722485|449472684|FG000|Overall Study|eligibility criteria not met|2|||
124958013|NCT03722485|449472685|FG001|Overall Study|eligibility criteria not met|0|||
124958014|NCT00349622|449472686|FG000|Overall Study|Death|168|||
124958015|NCT00349622|449472687|FG001|Overall Study|Death|86|||
124958016|NCT00349622|449472686|FG000|Overall Study|Lost to Follow-up|5|||
124958017|NCT00349622|449472687|FG001|Overall Study|Lost to Follow-up|1|||
124766646|NCT05546476|448773737|FG000|Period 1: Part A|Lack of Efficacy|0|||
124766647|NCT05546476|448773738|FG001|Period 1: Part A|Lack of Efficacy|0|||
124766648|NCT05546476|448773739|FG002|Period 1: Part A|Lack of Efficacy|0|||
124766649|NCT05546476|448773740|FG003|Period 1: Part A|Lack of Efficacy|1|||
124766650|NCT05546476|448773737|FG000|Period 1: Part A|Lost to Follow-up|0|||
124766651|NCT05546476|448773738|FG001|Period 1: Part A|Lost to Follow-up|0|||
124766652|NCT05546476|448773739|FG002|Period 1: Part A|Lost to Follow-up|0|||
124958018|NCT00349622|449472686|FG000|Overall Study|Withdrawal by Subject|5|||
124958019|NCT00349622|449472687|FG001|Overall Study|Withdrawal by Subject|9|||
124958020|NCT01902381|449472688|FG000|Overall Study|Withdrawal by Subject|1|||
124958021|NCT00755716|449472689|FG000|Overall Study|Adverse Event|1|||
124958022|NCT00755716|449472690|FG001|Overall Study|Adverse Event|4|||
124958023|NCT00755716|449472691|FG002|Overall Study|Adverse Event|1|||
124958024|NCT00755716|449472689|FG000|Overall Study|Lack of Efficacy|2|||
124958025|NCT00755716|449472690|FG001|Overall Study|Lack of Efficacy|0|||
124958026|NCT00755716|449472691|FG002|Overall Study|Lack of Efficacy|0|||
124958027|NCT00755716|449472689|FG000|Overall Study|Lost to Follow-up|5|||
124958028|NCT00755716|449472690|FG001|Overall Study|Lost to Follow-up|3|||
124958029|NCT00755716|449472691|FG002|Overall Study|Lost to Follow-up|1|||
124958030|NCT00755716|449472689|FG000|Overall Study|work schedule issues|0|||
124958031|NCT00755716|449472690|FG001|Overall Study|work schedule issues|1|||
124958032|NCT00755716|449472691|FG002|Overall Study|work schedule issues|1|||
124958033|NCT02762500|449472692|FG000|Overall Study|Lack of Efficacy|1|||
124958034|NCT02762500|449472693|FG001|Overall Study|Lack of Efficacy|0|||
124958035|NCT02762500|449472692|FG000|Overall Study|Withdrawal by Subject|1|||
124958036|NCT02762500|449472693|FG001|Overall Study|Withdrawal by Subject|1|||
124958037|NCT02762500|449472692|FG000|Overall Study|Adverse Event|0|||
124958038|NCT02762500|449472693|FG001|Overall Study|Adverse Event|2|||
124958039|NCT02229396|449472694|FG000|Overall Study|Adverse Event|6|||
124958040|NCT02229396|449472695|FG001|Overall Study|Adverse Event|12|||
124958041|NCT02229396|449472696|FG002|Overall Study|Adverse Event|12|||
124958042|NCT02229396|449472694|FG000|Overall Study|Death|2|||
124958043|NCT02229396|449472695|FG001|Overall Study|Death|3|||
124958044|NCT02229396|449472696|FG002|Overall Study|Death|1|||
124958045|NCT02229396|449472694|FG000|Overall Study|Lost to Follow-up|14|||
124958046|NCT02229396|449472695|FG001|Overall Study|Lost to Follow-up|14|||
124958047|NCT02229396|449472696|FG002|Overall Study|Lost to Follow-up|21|||
124958048|NCT02229396|449472694|FG000|Overall Study|Protocol Violation|2|||
124958049|NCT02229396|449472695|FG001|Overall Study|Protocol Violation|1|||
124958050|NCT02229396|449472696|FG002|Overall Study|Protocol Violation|0|||
124958051|NCT02229396|449472694|FG000|Overall Study|Patient Incorrectly Randomized|0|||
124958052|NCT02229396|449472695|FG001|Overall Study|Patient Incorrectly Randomized|0|||
124958053|NCT02229396|449472696|FG002|Overall Study|Patient Incorrectly Randomized|1|||
124958054|NCT02229396|449472694|FG000|Overall Study|Other|10|||
124958055|NCT02229396|449472695|FG001|Overall Study|Other|18|||
124958056|NCT02229396|449472696|FG002|Overall Study|Other|15|||
124958057|NCT02229396|449472694|FG000|Overall Study|Withdrawal by Subject|42|||
124958058|NCT02229396|449472695|FG001|Overall Study|Withdrawal by Subject|28|||
124958059|NCT02229396|449472696|FG002|Overall Study|Withdrawal by Subject|41|||
124958060|NCT02229396|449472694|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
124958061|NCT02229396|449472695|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
124958062|NCT02229396|449472696|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
124958063|NCT02229396|449472694|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
124958064|NCT02229396|449472695|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
124958065|NCT02229396|449472696|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
124958066|NCT03275402|449472698|FG000|Overall Study|Death|17|||
124958067|NCT03275402|449472698|FG000|Overall Study|Study terminated by sponsor|21|||
124958068|NCT03275402|449472698|FG000|Overall Study|Withdrawal by Subject|1|||
124958069|NCT05135156|449472702|FG000|Overall Study|Lost to Follow-up|0|||
124958070|NCT05135156|449472703|FG001|Overall Study|Lost to Follow-up|0|||
124958071|NCT05135156|449472704|FG002|Overall Study|Lost to Follow-up|2|||
124958072|NCT02402465|449472710|FG000|Overall Study|Withdrawal by Subject|0|||
124958073|NCT02402465|449472711|FG001|Overall Study|Withdrawal by Subject|0|||
124958074|NCT02402465|449472712|FG002|Overall Study|Withdrawal by Subject|0|||
124958075|NCT02402465|449472713|FG003|Overall Study|Withdrawal by Subject|0|||
124549279|NCT00388674|447966996|FG000|Initial Treatment|Lost to Follow-up|526|||
124958076|NCT02402465|449472714|FG004|Overall Study|Withdrawal by Subject|0|||
124958077|NCT02402465|449472715|FG005|Overall Study|Withdrawal by Subject|1|||
124958078|NCT02402465|449472710|FG000|Overall Study|Lost to Follow-up|0|||
124958079|NCT02402465|449472711|FG001|Overall Study|Lost to Follow-up|1|||
124958080|NCT02402465|449472712|FG002|Overall Study|Lost to Follow-up|0|||
124958081|NCT02402465|449472713|FG003|Overall Study|Lost to Follow-up|0|||
124958082|NCT02402465|449472714|FG004|Overall Study|Lost to Follow-up|1|||
124958083|NCT02402465|449472715|FG005|Overall Study|Lost to Follow-up|0|||
124958084|NCT03807700|449472716|FG000|Overall Study|Withdrawal by Subject|2|||
124708003|NCT02412670|448555949|FG001|Overall Study|Adverse Event|1|||
124958085|NCT03807700|449472717|FG001|Overall Study|Withdrawal by Subject|1|||
124708004|NCT02412670|448555948|FG000|Overall Study|Physician Decision|1|||
124958086|NCT02005029|449472719|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
124958087|NCT02005029|449472720|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
124958088|NCT02316847|449472721|FG000|Overall Study|Adverse Event|0|||
124958089|NCT02316847|449472722|FG001|Overall Study|Adverse Event|3|||
124958090|NCT02316847|449472721|FG000|Overall Study|Lost to Follow-up|0|||
124958091|NCT02316847|449472722|FG001|Overall Study|Lost to Follow-up|2|||
124958092|NCT02316847|449472721|FG000|Overall Study|Physician Decision|0|||
124958093|NCT02316847|449472722|FG001|Overall Study|Physician Decision|1|||
124958094|NCT02316847|449472721|FG000|Overall Study|Pregnancy|0|||
124958095|NCT02316847|449472722|FG001|Overall Study|Pregnancy|1|||
124958096|NCT02316847|449472721|FG000|Overall Study|Withdrawal by Subject|2|||
124958097|NCT02316847|449472722|FG001|Overall Study|Withdrawal by Subject|9|||
124958098|NCT02316847|449472721|FG000|Overall Study|Noncompliance with study drug|0|||
124958099|NCT02316847|449472722|FG001|Overall Study|Noncompliance with study drug|3|||
124958100|NCT02316847|449472721|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
124958101|NCT02316847|449472722|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
124958102|NCT01370018|449472723|FG000|Overall Study|Did not meet criteria for analysis|1|||
124958103|NCT01525641|449472724|FG000|Overall Study|Case report form not collected|25|||
124958104|NCT01525641|449472724|FG000|Overall Study|No visit since the first visit|16|||
124958105|NCT01525641|449472724|FG000|Overall Study|Adverse Event|73|||
124958106|NCT01525641|449472724|FG000|Overall Study|Lack of Efficacy|24|||
124958107|NCT01525641|449472724|FG000|Overall Study|Improvement|5|||
124958108|NCT01525641|449472724|FG000|Overall Study|Lost to follow-up (relocation)|1|||
124958109|NCT01525641|449472724|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
124958110|NCT01525641|449472724|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
124708005|NCT02412670|448555949|FG001|Overall Study|Physician Decision|0|||
124708006|NCT02412670|448555948|FG000|Overall Study|Withdrawal by Subject|1|||
124708007|NCT02412670|448555949|FG001|Overall Study|Withdrawal by Subject|0|||
124708008|NCT02412670|448555948|FG000|Overall Study|Ineligible|1|||
124708009|NCT02412670|448555949|FG001|Overall Study|Ineligible|0|||
124708010|NCT03342560|448555952|FG000|Overall Study|Lost to Follow-up|2|||
124708011|NCT03213509|448555953|FG000|Overall Study|Did not consent for verbal autopsy|4|||
124708012|NCT03213509|448555954|FG001|Overall Study|Did not consent for verbal autopsy|5|||
124708013|NCT04549454|448555960|FG000|T1 to T2|Lost to Follow-up|22|||
124708014|NCT04549454|448555961|FG001|T1 to T2|Lost to Follow-up|26|||
124708015|NCT04549454|448555960|FG000|T1 to T3|Lost to Follow-up|31|||
124708016|NCT04549454|448555961|FG001|T1 to T3|Lost to Follow-up|36|||
124708017|NCT00016354|448555969|FG000|Overall Study|Lack of Efficacy|0|||
124708018|NCT00016354|448555970|FG001|Overall Study|Lack of Efficacy|0|||
124708019|NCT00016354|448555971|FG002|Overall Study|Lack of Efficacy|0|||
124708020|NCT00016354|448555972|FG003|Overall Study|Lack of Efficacy|0|||
124708021|NCT00016354|448555973|FG004|Overall Study|Lack of Efficacy|0|||
124708022|NCT00016354|448555974|FG005|Overall Study|Lack of Efficacy|0|||
124708023|NCT00016354|448555975|FG006|Overall Study|Lack of Efficacy|0|||
124766653|NCT05546476|448773740|FG003|Period 1: Part A|Lost to Follow-up|1|||
124766654|NCT05546476|448773737|FG000|Period 1: Part A|Physician Decision|1|||
124766655|NCT05546476|448773738|FG001|Period 1: Part A|Physician Decision|0|||
124708024|NCT00016354|448555976|FG007|Overall Study|Lack of Efficacy|1|||
124958111|NCT01525641|449472724|FG000|Overall Study|Other than stated above|7|||
124766656|NCT05546476|448773739|FG002|Period 1: Part A|Physician Decision|0|||
124766657|NCT05546476|448773740|FG003|Period 1: Part A|Physician Decision|0|||
124708025|NCT02993263|448555979|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
124708026|NCT01405196|448555980|FG000|Overall Study|Study Terminated by Sponsor|0|||
124708027|NCT01405196|448555981|FG001|Overall Study|Study Terminated by Sponsor|0|||
124708028|NCT01405196|448555982|FG002|Overall Study|Study Terminated by Sponsor|9|||
124463460|NCT01783678|447656510|FG001|Overall Study|Randomized but Not Treated|0|||
124463461|NCT01783678|447656511|FG002|Overall Study|Randomized but Not Treated|0|||
124958112|NCT03772041|449472725|FG000|Overall Study|Adverse Event|8|||
124958113|NCT03772041|449472726|FG001|Overall Study|Adverse Event|3|||
124958114|NCT03772041|449472725|FG000|Overall Study|Withdrawal by Subject|0|||
124958115|NCT03772041|449472726|FG001|Overall Study|Withdrawal by Subject|2|||
124958116|NCT03772041|449472725|FG000|Overall Study|Protocol Violation|4|||
124958117|NCT03772041|449472726|FG001|Overall Study|Protocol Violation|2|||
124958118|NCT03772041|449472725|FG000|Overall Study|Physician Decision|2|||
124958119|NCT03772041|449472726|FG001|Overall Study|Physician Decision|3|||
124958120|NCT04748445|449472736|FG000|Overall Study|No longer met eligibility criteria|12|||
124958121|NCT04748445|449472736|FG000|Overall Study|Other|36|||
124958122|NCT04748445|449472736|FG000|Overall Study|Withdrawal by Subject|553|||
124958123|NCT04748445|449472736|FG000|Overall Study|Lost to Follow-up|30|||
124958124|NCT01536535|449472740|FG000|Overall Study|Withdrawal by Subject|10|||
124958125|NCT01536535|449472741|FG001|Overall Study|Withdrawal by Subject|5|||
124958126|NCT01536535|449472740|FG000|Overall Study|Lost to Follow-up|4|||
124958127|NCT01536535|449472741|FG001|Overall Study|Lost to Follow-up|6|||
124958128|NCT01536535|449472740|FG000|Overall Study|Physician Decision|1|||
124463462|NCT01783678|447656512|FG003|Overall Study|Randomized but Not Treated|1|||
124463463|NCT01783678|447656513|FG004|Overall Study|Randomized but Not Treated|0|||
124958129|NCT01536535|449472741|FG001|Overall Study|Physician Decision|1|||
124958130|NCT01536535|449472740|FG000|Overall Study|Participant moved|0|||
124958131|NCT01536535|449472741|FG001|Overall Study|Participant moved|1|||
124958132|NCT00385697|449472744|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
124958133|NCT00385697|449472745|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
124958134|NCT00385697|449472746|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
124958135|NCT00385697|449472747|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
124958136|NCT00385697|449472748|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
124958137|NCT00385697|449472744|FG000|Open-label Segment 1|Lost to Follow-up|1|||
124958138|NCT00385697|449472745|FG001|Open-label Segment 1|Lost to Follow-up|0|||
124958139|NCT00385697|449472746|FG002|Open-label Segment 1|Lost to Follow-up|0|||
124958140|NCT00385697|449472747|FG003|Open-label Segment 1|Lost to Follow-up|0|||
124958141|NCT00385697|449472748|FG004|Open-label Segment 1|Lost to Follow-up|0|||
124958142|NCT00385697|449472744|FG000|Double-blind Segment 2|Adverse Event|0|||
124958143|NCT00385697|449472745|FG001|Double-blind Segment 2|Adverse Event|3|||
124958144|NCT00385697|449472746|FG002|Double-blind Segment 2|Adverse Event|1|||
124958145|NCT00385697|449472747|FG003|Double-blind Segment 2|Adverse Event|0|||
124958146|NCT00385697|449472748|FG004|Double-blind Segment 2|Adverse Event|0|||
124958147|NCT00385697|449472744|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
124958148|NCT00385697|449472745|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
124708029|NCT01405196|448555983|FG003|Overall Study|Study Terminated by Sponsor|0|||
124708030|NCT01405196|448555980|FG000|Overall Study|Other|2|||
124958149|NCT00385697|449472746|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
124958150|NCT00385697|449472747|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
124958151|NCT00385697|449472748|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
124958152|NCT00385697|449472744|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
124958153|NCT00385697|449472745|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
124958154|NCT00385697|449472746|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
124958155|NCT00385697|449472747|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
124958156|NCT00385697|449472748|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
124958157|NCT00385697|449472744|FG000|Double-blind Segment 2|Other|0|||
124958158|NCT00385697|449472745|FG001|Double-blind Segment 2|Other|2|||
124958159|NCT00385697|449472746|FG002|Double-blind Segment 2|Other|0|||
124958160|NCT00385697|449472747|FG003|Double-blind Segment 2|Other|0|||
124958161|NCT00385697|449472748|FG004|Double-blind Segment 2|Other|0|||
124958162|NCT02538471|449472750|FG000|Overall Study|Progression of disease|2|||
124958163|NCT00084747|449472751|FG000|Overall Study|Relapsed|8|||
124958164|NCT00084747|449472751|FG000|Overall Study|Death|3|||
124958165|NCT00084747|449472751|FG000|Overall Study|Withdrawal by Subject|2|||
124958166|NCT02382406|449472756|FG000|Study Treatment|Disease Progression|8|||
124958167|NCT02382406|449472757|FG001|Study Treatment|Disease Progression|0|||
124958168|NCT02382406|449472758|FG002|Study Treatment|Disease Progression|20|||
124958169|NCT02382406|449472756|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
124958170|NCT02382406|449472757|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
124958171|NCT02382406|449472758|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
124958172|NCT02382406|449472756|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
124958173|NCT02382406|449472757|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
124958174|NCT02382406|449472758|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
124958175|NCT02382406|449472756|FG000|Study Treatment|symptomatic deterioration|1|||
124958176|NCT02382406|449472757|FG001|Study Treatment|symptomatic deterioration|0|||
124958177|NCT02382406|449472758|FG002|Study Treatment|symptomatic deterioration|1|||
124958178|NCT02382406|449472756|FG000|Study Treatment|Death|0|||
124958179|NCT02382406|449472757|FG001|Study Treatment|Death|0|||
124958180|NCT02382406|449472758|FG002|Study Treatment|Death|2|||
124958181|NCT02382406|449472756|FG000|Follow up|Death|11|||
124958182|NCT02382406|449472757|FG001|Follow up|Death|0|||
124958183|NCT02382406|449472758|FG002|Follow up|Death|19|||
124958184|NCT02382406|449472756|FG000|Follow up|Symptomatic deterioration|1|||
124958185|NCT02382406|449472757|FG001|Follow up|Symptomatic deterioration|0|||
124958186|NCT02382406|449472758|FG002|Follow up|Symptomatic deterioration|1|||
124958187|NCT02382406|449472756|FG000|Follow up|Patient Refused Follow-up|1|||
124958188|NCT02382406|449472757|FG001|Follow up|Patient Refused Follow-up|0|||
124958189|NCT02382406|449472758|FG002|Follow up|Patient Refused Follow-up|0|||
124958190|NCT02382406|449472756|FG000|Follow up|Study Terminated|1|||
124958191|NCT02382406|449472757|FG001|Follow up|Study Terminated|0|||
124958192|NCT02382406|449472758|FG002|Follow up|Study Terminated|8|||
124708031|NCT01405196|448555981|FG001|Overall Study|Other|2|||
124708032|NCT01405196|448555982|FG002|Overall Study|Other|5|||
124958193|NCT02382406|449472756|FG000|Follow up|Withdrawal by Subject|0|||
124958194|NCT02382406|449472757|FG001|Follow up|Withdrawal by Subject|0|||
124958195|NCT02382406|449472758|FG002|Follow up|Withdrawal by Subject|2|||
124958196|NCT03794609|449472761|FG000|Overall Study|Other|10|||
124958197|NCT03794609|449472761|FG000|Overall Study|Withdrawal by Subject|66|||
124958198|NCT03794609|449472761|FG000|Overall Study|The child is enrolled in an interventional study|70|||
124958199|NCT03794609|449472761|FG000|Overall Study|Inclusion/exclusion criteria|8|||
124958200|NCT03794609|449472761|FG000|Overall Study|At sponsor's request|151|||
124958201|NCT03794609|449472761|FG000|Overall Study|Physician Decision|1|||
124958202|NCT03794609|449472761|FG000|Overall Study|Lost to Follow-up|5|||
124708033|NCT01405196|448555983|FG003|Overall Study|Other|0|||
124708034|NCT01405196|448555980|FG000|Overall Study|Withdrawal by Subject|4|||
124958203|NCT04543942|449472762|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
124958204|NCT04543942|449472763|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
124958205|NCT04543942|449472762|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
124958206|NCT04543942|449472763|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
124958207|NCT02097056|449472768|FG000|Overall Study|Protocol Violation|2|||
124958208|NCT02097056|449472768|FG000|Overall Study|Withdrawal by Subject|15|||
124958209|NCT02097056|449472768|FG000|Overall Study|Lost to Follow-up|2|||
124958210|NCT02097056|449472768|FG000|Overall Study|Adverse Event|37|||
124958211|NCT02097056|449472768|FG000|Overall Study|Other|2|||
124958212|NCT01323309|449472769|FG000|Overall Study|Death|9|||
124958213|NCT01323309|449472770|FG001|Overall Study|Death|15|||
124958214|NCT01323309|449472771|FG002|Overall Study|Death|5|||
124958215|NCT01323309|449472769|FG000|Overall Study|Lost to Follow-up|11|||
124958216|NCT01323309|449472770|FG001|Overall Study|Lost to Follow-up|14|||
124958217|NCT01323309|449472771|FG002|Overall Study|Lost to Follow-up|24|||
124958218|NCT01323309|449472769|FG000|Overall Study|Withdrawal by Subject|14|||
124958219|NCT01323309|449472770|FG001|Overall Study|Withdrawal by Subject|14|||
124958220|NCT01323309|449472771|FG002|Overall Study|Withdrawal by Subject|18|||
124958221|NCT01323309|449472769|FG000|Overall Study|Disease progression|5|||
124958222|NCT01323309|449472770|FG001|Overall Study|Disease progression|11|||
124958223|NCT01323309|449472771|FG002|Overall Study|Disease progression|4|||
124958224|NCT02133131|449472776|FG000|Overall Study|Adverse Event|0|||
124958225|NCT02133131|449472777|FG001|Overall Study|Adverse Event|0|||
124958226|NCT02133131|449472778|FG002|Overall Study|Adverse Event|0|||
124958227|NCT02133131|449472779|FG003|Overall Study|Adverse Event|1|||
124958228|NCT02133131|449472780|FG004|Overall Study|Adverse Event|0|||
124958229|NCT02133131|449472781|FG005|Overall Study|Adverse Event|0|||
124958230|NCT02133131|449472782|FG006|Overall Study|Adverse Event|0|||
124958231|NCT02133131|449472776|FG000|Overall Study|Lost to Follow-up|1|||
124958232|NCT02133131|449472777|FG001|Overall Study|Lost to Follow-up|0|||
124958233|NCT02133131|449472778|FG002|Overall Study|Lost to Follow-up|0|||
124958234|NCT02133131|449472779|FG003|Overall Study|Lost to Follow-up|1|||
124958235|NCT02133131|449472780|FG004|Overall Study|Lost to Follow-up|0|||
124958236|NCT02133131|449472781|FG005|Overall Study|Lost to Follow-up|0|||
124958237|NCT02133131|449472782|FG006|Overall Study|Lost to Follow-up|0|||
124958238|NCT02133131|449472776|FG000|Overall Study|Status not recorded|4|||
124958239|NCT02133131|449472777|FG001|Overall Study|Status not recorded|5|||
124958240|NCT02133131|449472778|FG002|Overall Study|Status not recorded|1|||
124958241|NCT02133131|449472779|FG003|Overall Study|Status not recorded|4|||
124958242|NCT02133131|449472780|FG004|Overall Study|Status not recorded|0|||
124958243|NCT02133131|449472781|FG005|Overall Study|Status not recorded|0|||
124958244|NCT02133131|449472782|FG006|Overall Study|Status not recorded|0|||
124958245|NCT02133131|449472776|FG000|Overall Study|Ongoing in study|0|||
124958246|NCT02133131|449472777|FG001|Overall Study|Ongoing in study|0|||
124958247|NCT02133131|449472778|FG002|Overall Study|Ongoing in study|0|||
124958248|NCT02133131|449472779|FG003|Overall Study|Ongoing in study|0|||
124958249|NCT02133131|449472780|FG004|Overall Study|Ongoing in study|15|||
124958250|NCT02133131|449472781|FG005|Overall Study|Ongoing in study|14|||
124958251|NCT02133131|449472782|FG006|Overall Study|Ongoing in study|11|||
124958252|NCT02133131|449472776|FG000|Overall Study|Protocol Violation|0|||
124708035|NCT01405196|448555981|FG001|Overall Study|Withdrawal by Subject|6|||
124708036|NCT01405196|448555982|FG002|Overall Study|Withdrawal by Subject|3|||
124708037|NCT01405196|448555983|FG003|Overall Study|Withdrawal by Subject|6|||
124708038|NCT01405196|448555980|FG000|Overall Study|Adverse Event|2|||
124708039|NCT01405196|448555981|FG001|Overall Study|Adverse Event|2|||
124708040|NCT01405196|448555982|FG002|Overall Study|Adverse Event|0|||
124708041|NCT01405196|448555983|FG003|Overall Study|Adverse Event|2|||
124958253|NCT02133131|449472777|FG001|Overall Study|Protocol Violation|0|||
124958254|NCT02133131|449472778|FG002|Overall Study|Protocol Violation|0|||
124958255|NCT02133131|449472779|FG003|Overall Study|Protocol Violation|0|||
124958256|NCT02133131|449472780|FG004|Overall Study|Protocol Violation|0|||
124958257|NCT02133131|449472781|FG005|Overall Study|Protocol Violation|0|||
124958258|NCT02133131|449472782|FG006|Overall Study|Protocol Violation|1|||
124958259|NCT01544153|449472783|FG000|Overall Study|Under 18|0|||
124958260|NCT01544153|449472784|FG001|Overall Study|Under 18|1|||
124958261|NCT01544153|449472785|FG002|Overall Study|Under 18|0|||
124958262|NCT01544153|449472786|FG003|Overall Study|Under 18|0|||
124958263|NCT01544153|449472783|FG000|Overall Study|Non-smoker|0|||
124958264|NCT01544153|449472784|FG001|Overall Study|Non-smoker|0|||
124958265|NCT01544153|449472785|FG002|Overall Study|Non-smoker|1|||
124958266|NCT01544153|449472786|FG003|Overall Study|Non-smoker|0|||
124958267|NCT00884793|449472791|FG000|Overall Study|Withdrawal by Subject|1|||
124958268|NCT03169530|449472792|FG000|Overall Study|Study ended by NIH|15|||
124958269|NCT03169530|449472793|FG001|Overall Study|Study ended by NIH|17|||
124958270|NCT01032200|449472794|FG000|Overall Study|Death|1|||
124958271|NCT01032200|449472795|FG001|Overall Study|Death|1|||
124958272|NCT01032200|449472794|FG000|Overall Study|Withdrawal by Subject|1|||
124958273|NCT01032200|449472795|FG001|Overall Study|Withdrawal by Subject|3|||
124708042|NCT01405196|448555980|FG000|Overall Study|Death|1|||
124708043|NCT01405196|448555981|FG001|Overall Study|Death|0|||
124958274|NCT01032200|449472794|FG000|Overall Study|Toxicity|0|||
124958275|NCT01032200|449472795|FG001|Overall Study|Toxicity|2|||
124958276|NCT01032200|449472794|FG000|Overall Study|Progression|1|||
124958277|NCT01032200|449472795|FG001|Overall Study|Progression|0|||
124958278|NCT01032200|449472794|FG000|Overall Study|Multiple|1|||
124958279|NCT01032200|449472795|FG001|Overall Study|Multiple|1|||
124958280|NCT00714688|449472799|FG000|Overall Study|Lack of Efficacy|14|||
124958281|NCT00714688|449472800|FG001|Overall Study|Lack of Efficacy|1|||
124958282|NCT00714688|449472801|FG002|Overall Study|Lack of Efficacy|4|||
124958283|NCT00714688|449472799|FG000|Overall Study|Withdrawal by Subject|4|||
124958284|NCT00714688|449472800|FG001|Overall Study|Withdrawal by Subject|3|||
124958285|NCT00714688|449472801|FG002|Overall Study|Withdrawal by Subject|3|||
124958286|NCT00714688|449472799|FG000|Overall Study|Lost to Follow-up|5|||
124958287|NCT00714688|449472800|FG001|Overall Study|Lost to Follow-up|2|||
124958288|NCT00714688|449472801|FG002|Overall Study|Lost to Follow-up|0|||
124958289|NCT00714688|449472799|FG000|Overall Study|Adverse Event|2|||
124958290|NCT00714688|449472800|FG001|Overall Study|Adverse Event|15|||
124958291|NCT00714688|449472801|FG002|Overall Study|Adverse Event|19|||
124958292|NCT00714688|449472799|FG000|Overall Study|Subject Non-compliant|3|||
124958293|NCT00714688|449472800|FG001|Overall Study|Subject Non-compliant|5|||
124958294|NCT00714688|449472801|FG002|Overall Study|Subject Non-compliant|5|||
124958295|NCT00714688|449472799|FG000|Overall Study|Ineligible to Continue the Study|0|||
124958296|NCT00714688|449472800|FG001|Overall Study|Ineligible to Continue the Study|1|||
124958297|NCT00714688|449472801|FG002|Overall Study|Ineligible to Continue the Study|1|||
124958298|NCT00714688|449472799|FG000|Overall Study|Sponsor's Decision|0|||
124958299|NCT00714688|449472800|FG001|Overall Study|Sponsor's Decision|2|||
124958300|NCT00714688|449472801|FG002|Overall Study|Sponsor's Decision|0|||
124958301|NCT00714688|449472799|FG000|Overall Study|Other|1|||
124958302|NCT00714688|449472800|FG001|Overall Study|Other|6|||
124958303|NCT00714688|449472801|FG002|Overall Study|Other|5|||
124958304|NCT00500539|449472802|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
124958305|NCT00500539|449472802|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
124958306|NCT00500539|449472802|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
124958307|NCT00500539|449472802|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
124958308|NCT00500539|449472802|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
124958309|NCT00500539|449472802|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
124958310|NCT00500539|449472802|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
124958311|NCT00500539|449472802|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
124958312|NCT00500539|449472802|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
124958313|NCT00500539|449472802|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
124958314|NCT00500539|449472802|FG000|Follow-up Period (16 Weeks)|Death|1|||
124958315|NCT00500539|449472802|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
124958316|NCT00500539|449472802|FG000|Follow-up Period (16 Weeks)|Missing|3|||
124958317|NCT02316171|449472803|FG000|Overall Study|difficulties with urinary catheter|1|||
124958318|NCT02316171|449472804|FG001|Overall Study|difficulties with urinary catheter|0|||
124958319|NCT02316171|449472805|FG002|Overall Study|difficulties with urinary catheter|0|||
124958320|NCT02316171|449472806|FG003|Overall Study|difficulties with urinary catheter|0|||
124958321|NCT01524887|449472808|FG000|Overall Study|Withdrawal by Subject|6|||
124958322|NCT01524887|449472809|FG001|Overall Study|Withdrawal by Subject|2|||
124958323|NCT01524887|449472810|FG002|Overall Study|Withdrawal by Subject|3|||
124958324|NCT01524887|449472808|FG000|Overall Study|Adverse Event|5|||
124958325|NCT01524887|449472809|FG001|Overall Study|Adverse Event|1|||
124958326|NCT01524887|449472810|FG002|Overall Study|Adverse Event|1|||
124958327|NCT01524887|449472808|FG000|Overall Study|Protocol Violation|0|||
124958328|NCT01524887|449472809|FG001|Overall Study|Protocol Violation|0|||
124958329|NCT01524887|449472810|FG002|Overall Study|Protocol Violation|1|||
124958330|NCT01524887|449472808|FG000|Overall Study|Study termination|73|||
124958331|NCT01524887|449472809|FG001|Overall Study|Study termination|87|||
124958332|NCT01524887|449472810|FG002|Overall Study|Study termination|79|||
124958333|NCT01524887|449472808|FG000|Overall Study|Withdrawal by Caregiver|0|||
124958334|NCT01524887|449472809|FG001|Overall Study|Withdrawal by Caregiver|0|||
124958335|NCT01524887|449472810|FG002|Overall Study|Withdrawal by Caregiver|2|||
124958336|NCT01524887|449472808|FG000|Overall Study|Use of prohibited medication|1|||
124958337|NCT01524887|449472809|FG001|Overall Study|Use of prohibited medication|0|||
124958338|NCT01524887|449472810|FG002|Overall Study|Use of prohibited medication|0|||
124958339|NCT00547300|449472811|FG000|Overall Study|Study was Administratively Terminated|25|||
124958340|NCT00547300|449472812|FG001|Overall Study|Study was Administratively Terminated|24|||
124958341|NCT00547300|449472811|FG000|Overall Study|Did not Meet Entry Criteria|0|||
124463464|NCT01783678|447656514|FG005|Overall Study|Randomized but Not Treated|0|||
124958342|NCT00547300|449472812|FG001|Overall Study|Did not Meet Entry Criteria|2|||
124958343|NCT04380688|449472815|FG000|Overall Study|Death|2|||
124958344|NCT04380688|449472816|FG001|Overall Study|Death|2|||
124958345|NCT04380688|449472815|FG000|Overall Study|Lost to Follow-up|2|||
124958346|NCT04380688|449472816|FG001|Overall Study|Lost to Follow-up|4|||
124958347|NCT04380688|449472815|FG000|Overall Study|Withdrawal by Subject|3|||
124958348|NCT04380688|449472816|FG001|Overall Study|Withdrawal by Subject|3|||
124958349|NCT03993054|449472817|FG000|Overall Study|PI Decision|1|||
124958350|NCT04267393|449472820|FG000|Randomization|Adverse Event|1|||
124958351|NCT04267393|449472821|FG001|Randomization|Adverse Event|0|||
124958352|NCT04267393|449472822|FG002|Randomization|Adverse Event|0|||
124958353|NCT04267393|449472820|FG000|Randomization|Administrative Reasons by Sponsor|0|||
124958354|NCT04267393|449472821|FG001|Randomization|Administrative Reasons by Sponsor|1|||
124958355|NCT04267393|449472822|FG002|Randomization|Administrative Reasons by Sponsor|0|||
124958356|NCT04267393|449472820|FG000|Treatment Period|Adverse Event|0|||
124958357|NCT04267393|449472821|FG001|Treatment Period|Adverse Event|2|||
124958358|NCT04267393|449472822|FG002|Treatment Period|Adverse Event|3|||
124958359|NCT04267393|449472820|FG000|Treatment Period|Participant Withdrew Consent|0|||
124958360|NCT04267393|449472821|FG001|Treatment Period|Participant Withdrew Consent|0|||
124958361|NCT04267393|449472822|FG002|Treatment Period|Participant Withdrew Consent|1|||
124958362|NCT04267393|449472820|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
124958363|NCT04267393|449472821|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
124958364|NCT04267393|449472822|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
124958365|NCT02093897|449474503|FG000|Overall Study|Physician Decision|1|||
124958366|NCT02093897|449474503|FG000|Overall Study|Planned age group closure - no's reached|17|||
124958367|NCT02093897|449474503|FG000|Overall Study|Adverse event, non-fatal|1|||
124958368|NCT00088452|449474504|FG000|Overall Study|Did not receive intervention|1|||
124958369|NCT00088452|449474505|FG001|Overall Study|Did not receive intervention|0|||
124958370|NCT00088452|449474506|FG002|Overall Study|Did not receive intervention|1|||
124958371|NCT02081196|449474508|FG000|Overall Study|Lost to Follow-up|1|||
124958372|NCT03098797|449474511|FG000|Part 2 Open Label Extension|Adverse Event|2|||
124958373|NCT03098797|449474512|FG001|Part 2 Open Label Extension|Adverse Event|0|||
124958374|NCT00381888|449474515|FG000|Overall Study|Death|1|||
124958375|NCT00381888|449474515|FG000|Overall Study|Withdrawal by Subject|1|||
124958376|NCT00381888|449474515|FG000|Overall Study|Physician Decision|1|||
124958377|NCT00381888|449474515|FG000|Overall Study|Protocol Violation|9|||
124958378|NCT00381888|449474515|FG000|Overall Study|Had laparoscopic surgery|2|||
124958379|NCT00381888|449474515|FG000|Overall Study|Surgery was cancelled|2|||
124958380|NCT00381888|449474515|FG000|Overall Study|Adverse Event|1|||
124958381|NCT01231464|449474516|FG000|Overall Study|Adverse Event|0|||
124958382|NCT01231464|449474517|FG001|Overall Study|Adverse Event|1|||
124958383|NCT01231464|449474516|FG000|Overall Study|Protocol Violation|1|||
124958384|NCT01231464|449474517|FG001|Overall Study|Protocol Violation|2|||
124958385|NCT01231464|449474516|FG000|Overall Study|Lost to Follow-up|1|||
124958386|NCT01231464|449474517|FG001|Overall Study|Lost to Follow-up|2|||
124958387|NCT01231464|449474516|FG000|Overall Study|Withdrawal by Subject|3|||
124958388|NCT01231464|449474517|FG001|Overall Study|Withdrawal by Subject|2|||
124958389|NCT01589523|449474526|FG000|Overall Study|Withdrawal by Subject|1|||
124958390|NCT00961896|449474527|FG000|Overall Study|Abnormal laboratory value|0|||
124958391|NCT00961896|449474528|FG001|Overall Study|Abnormal laboratory value|0|||
124958392|NCT00961896|449474529|FG002|Overall Study|Abnormal laboratory value|1|||
124958393|NCT02507687|449474538|FG000|Overall Study|Adverse Event|3|||
124958394|NCT02507687|449474539|FG001|Overall Study|Adverse Event|2|||
124958395|NCT02507687|449474540|FG002|Overall Study|Adverse Event|2|||
124958396|NCT02507687|449474541|FG003|Overall Study|Adverse Event|2|||
124958397|NCT02507687|449474538|FG000|Overall Study|Withdrawal by Subject|1|||
124958398|NCT02507687|449474539|FG001|Overall Study|Withdrawal by Subject|4|||
124958399|NCT02507687|449474540|FG002|Overall Study|Withdrawal by Subject|6|||
124958400|NCT02507687|449474541|FG003|Overall Study|Withdrawal by Subject|6|||
124958401|NCT02507687|449474538|FG000|Overall Study|Protocol Violation|1|||
124958402|NCT02507687|449474539|FG001|Overall Study|Protocol Violation|0|||
124958403|NCT02507687|449474540|FG002|Overall Study|Protocol Violation|2|||
124958404|NCT02507687|449474541|FG003|Overall Study|Protocol Violation|0|||
124958405|NCT02507687|449474538|FG000|Overall Study|Lost to Follow-up|0|||
124958406|NCT02507687|449474539|FG001|Overall Study|Lost to Follow-up|0|||
124958407|NCT02507687|449474540|FG002|Overall Study|Lost to Follow-up|2|||
124958408|NCT02507687|449474541|FG003|Overall Study|Lost to Follow-up|1|||
124958409|NCT02507687|449474538|FG000|Overall Study|Screen Failure|0|||
124958410|NCT02507687|449474539|FG001|Overall Study|Screen Failure|0|||
124958411|NCT02507687|449474540|FG002|Overall Study|Screen Failure|1|||
124958412|NCT02507687|449474541|FG003|Overall Study|Screen Failure|0|||
124958413|NCT02507687|449474538|FG000|Overall Study|Other, Not Specified|0|||
124958414|NCT02507687|449474539|FG001|Overall Study|Other, Not Specified|0|||
124958415|NCT02507687|449474540|FG002|Overall Study|Other, Not Specified|2|||
124958416|NCT02507687|449474541|FG003|Overall Study|Other, Not Specified|4|||
124958417|NCT02675998|449474542|FG000|8-Week Treatment Period|Adverse Event|6|||
124958418|NCT02675998|449474543|FG001|8-Week Treatment Period|Adverse Event|5|||
124958419|NCT02675998|449474544|FG002|8-Week Treatment Period|Adverse Event|6|||
124958420|NCT02675998|449474545|FG003|8-Week Treatment Period|Adverse Event|0|||
124958421|NCT02675998|449474542|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
124958422|NCT02675998|449474543|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
124958423|NCT02675998|449474544|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
124958424|NCT02675998|449474545|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
124958425|NCT02675998|449474542|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
124958426|NCT02675998|449474543|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
124958427|NCT02675998|449474544|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
124958428|NCT02675998|449474545|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
124958429|NCT02675998|449474542|FG000|8-Week Treatment Period|Physician Decision|1|||
124958430|NCT02675998|449474543|FG001|8-Week Treatment Period|Physician Decision|0|||
124958431|NCT02675998|449474544|FG002|8-Week Treatment Period|Physician Decision|2|||
124958432|NCT02675998|449474545|FG003|8-Week Treatment Period|Physician Decision|0|||
124958433|NCT02675998|449474542|FG000|8-Week Treatment Period|GI side Effects|1|||
124958434|NCT02675998|449474543|FG001|8-Week Treatment Period|GI side Effects|4|||
124958435|NCT02675998|449474544|FG002|8-Week Treatment Period|GI side Effects|2|||
124958436|NCT02675998|449474545|FG003|8-Week Treatment Period|GI side Effects|0|||
124958437|NCT02675998|449474542|FG000|8-Week Treatment Period|Protocol Violation|1|||
124958438|NCT02675998|449474543|FG001|8-Week Treatment Period|Protocol Violation|1|||
124958439|NCT02675998|449474544|FG002|8-Week Treatment Period|Protocol Violation|1|||
124958440|NCT02675998|449474545|FG003|8-Week Treatment Period|Protocol Violation|0|||
124958441|NCT02675998|449474542|FG000|8-Week Treatment Period|Other|3|||
124958442|NCT02675998|449474543|FG001|8-Week Treatment Period|Other|1|||
124958443|NCT02675998|449474544|FG002|8-Week Treatment Period|Other|2|||
124958444|NCT02675998|449474545|FG003|8-Week Treatment Period|Other|0|||
124958445|NCT02675998|449474542|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
124958446|NCT02675998|449474543|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
124958447|NCT02675998|449474544|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
124958448|NCT02675998|449474545|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
124958449|NCT02675998|449474542|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
124958450|NCT02675998|449474543|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
124958451|NCT02675998|449474544|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
124958452|NCT02675998|449474545|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
124958453|NCT02675998|449474542|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
124958454|NCT02675998|449474543|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
124958455|NCT02675998|449474544|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
124958456|NCT02675998|449474545|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
124958457|NCT02675998|449474542|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
124958458|NCT02675998|449474543|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
124958459|NCT02675998|449474544|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
124958460|NCT02675998|449474545|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
124958461|NCT02675998|449474542|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
124958462|NCT02675998|449474543|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
124958463|NCT02675998|449474544|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
124958464|NCT02675998|449474545|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
124958465|NCT02916706|449474546|FG000|Overall Study|Adverse Event|0|||
124958466|NCT02916706|449474547|FG001|Overall Study|Adverse Event|1|||
124958467|NCT02916706|449474546|FG000|Overall Study|Lost to Follow-up|0|||
124958468|NCT02916706|449474547|FG001|Overall Study|Lost to Follow-up|1|||
124958469|NCT02916706|449474546|FG000|Overall Study|Physician Decision|1|||
124958470|NCT02916706|449474547|FG001|Overall Study|Physician Decision|0|||
124958471|NCT02916706|449474546|FG000|Overall Study|Protocol Violation|3|||
124958472|NCT02916706|449474547|FG001|Overall Study|Protocol Violation|1|||
124958473|NCT02916706|449474546|FG000|Overall Study|Withdrawal by Subject|6|||
124958474|NCT02916706|449474547|FG001|Overall Study|Withdrawal by Subject|9|||
124958475|NCT02916706|449474546|FG000|Overall Study|Other|5|||
124958476|NCT02916706|449474547|FG001|Overall Study|Other|19|||
124958477|NCT04357964|449474548|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
124958478|NCT04357964|449474549|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
124958479|NCT04357964|449474548|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
124958480|NCT04357964|449474549|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
124958481|NCT04357964|449474548|FG000|Overall Study|Adipose sample was insufficient quality|0|||
124463465|NCT01783678|447656509|FG000|Overall Study|Lack of Efficacy|1|||
124463466|NCT01783678|447656510|FG001|Overall Study|Lack of Efficacy|13|||
124463467|NCT01783678|447656511|FG002|Overall Study|Lack of Efficacy|1|||
124463468|NCT01783678|447656512|FG003|Overall Study|Lack of Efficacy|3|||
124463469|NCT01783678|447656513|FG004|Overall Study|Lack of Efficacy|6|||
124463470|NCT01783678|447656514|FG005|Overall Study|Lack of Efficacy|5|||
124463471|NCT01783678|447656509|FG000|Overall Study|Lost to Follow-up|0|||
124463472|NCT01783678|447656510|FG001|Overall Study|Lost to Follow-up|4|||
124958482|NCT04357964|449474549|FG001|Overall Study|Adipose sample was insufficient quality|1|||
124958483|NCT01194271|449474552|FG000|Overall Study|Withdrawal by Subject|1|||
124958484|NCT01194271|449474552|FG000|Overall Study|Ineligible, Screen Failure|1|||
124958485|NCT01194271|449474552|FG000|Overall Study|Death|1|||
124958486|NCT00381797|449474555|FG000|Overall Study|Withdrawal by Subject|1|||
124958487|NCT00381797|449474556|FG001|Overall Study|Withdrawal by Subject|1|||
124958488|NCT00381797|449474557|FG002|Overall Study|Withdrawal by Subject|0|||
124958489|NCT00381797|449474558|FG003|Overall Study|Withdrawal by Subject|0|||
124958490|NCT00381797|449474559|FG004|Overall Study|Withdrawal by Subject|2|||
124958491|NCT00381797|449474555|FG000|Overall Study|Ineligible|0|||
124958492|NCT00381797|449474556|FG001|Overall Study|Ineligible|0|||
124958493|NCT00381797|449474557|FG002|Overall Study|Ineligible|0|||
124958494|NCT00381797|449474558|FG003|Overall Study|Ineligible|1|||
124958495|NCT00381797|449474559|FG004|Overall Study|Ineligible|0|||
124958496|NCT00443898|449474562|FG000|Overall Study|Adverse Event|0|||
124958497|NCT00443898|449474563|FG001|Overall Study|Adverse Event|0|||
124958498|NCT00443898|449474564|FG002|Overall Study|Adverse Event|1|||
124958499|NCT00443898|449474565|FG003|Overall Study|Adverse Event|1|||
124958500|NCT00443898|449474562|FG000|Overall Study|Lack of Efficacy|2|||
124958501|NCT00443898|449474563|FG001|Overall Study|Lack of Efficacy|3|||
124958502|NCT00443898|449474564|FG002|Overall Study|Lack of Efficacy|3|||
124958503|NCT00443898|449474565|FG003|Overall Study|Lack of Efficacy|1|||
124958504|NCT00443898|449474562|FG000|Overall Study|Protocol Violation|1|||
124958505|NCT00443898|449474563|FG001|Overall Study|Protocol Violation|1|||
124958506|NCT00443898|449474564|FG002|Overall Study|Protocol Violation|1|||
124958507|NCT00443898|449474565|FG003|Overall Study|Protocol Violation|0|||
124958508|NCT00443898|449474562|FG000|Overall Study|Withdrawal by Subject|11|||
124958509|NCT00443898|449474563|FG001|Overall Study|Withdrawal by Subject|10|||
124958510|NCT00443898|449474564|FG002|Overall Study|Withdrawal by Subject|10|||
124958511|NCT00443898|449474565|FG003|Overall Study|Withdrawal by Subject|6|||
124958512|NCT00443898|449474562|FG000|Overall Study|Lost to Follow-up|10|||
124958513|NCT00443898|449474563|FG001|Overall Study|Lost to Follow-up|10|||
124958514|NCT00443898|449474564|FG002|Overall Study|Lost to Follow-up|14|||
124958515|NCT00443898|449474565|FG003|Overall Study|Lost to Follow-up|10|||
124958516|NCT00443898|449474562|FG000|Overall Study|Death|0|||
124958517|NCT00443898|449474563|FG001|Overall Study|Death|1|||
124958518|NCT00443898|449474564|FG002|Overall Study|Death|0|||
124958519|NCT00443898|449474565|FG003|Overall Study|Death|0|||
124958520|NCT00043186|449474566|FG000|Overall Study|Physician Decision|0|||
124958521|NCT00043186|449474567|FG001|Overall Study|Physician Decision|0|||
124958522|NCT00043186|449474568|FG002|Overall Study|Physician Decision|3|||
124958523|NCT00043186|449474569|FG003|Overall Study|Physician Decision|0|||
124958524|NCT00043186|449474570|FG004|Overall Study|Physician Decision|1|||
124958525|NCT00043186|449474571|FG005|Overall Study|Physician Decision|0|||
124958526|NCT00043186|449474572|FG006|Overall Study|Physician Decision|0|||
124958527|NCT00043186|449474573|FG007|Overall Study|Physician Decision|1|||
124958528|NCT00043186|449474574|FG008|Overall Study|Physician Decision|1|||
124958529|NCT00043186|449474566|FG000|Overall Study|Adverse Event|2|||
124958530|NCT00043186|449474567|FG001|Overall Study|Adverse Event|2|||
124958531|NCT00043186|449474568|FG002|Overall Study|Adverse Event|2|||
124958532|NCT00043186|449474569|FG003|Overall Study|Adverse Event|3|||
124958533|NCT00043186|449474570|FG004|Overall Study|Adverse Event|2|||
124958534|NCT00043186|449474571|FG005|Overall Study|Adverse Event|1|||
124958535|NCT00043186|449474572|FG006|Overall Study|Adverse Event|2|||
124958536|NCT00043186|449474573|FG007|Overall Study|Adverse Event|1|||
124958537|NCT00043186|449474574|FG008|Overall Study|Adverse Event|3|||
124958538|NCT00043186|449474566|FG000|Overall Study|Withdrawal by Subject|11|||
124958539|NCT00043186|449474567|FG001|Overall Study|Withdrawal by Subject|8|||
124958540|NCT00043186|449474568|FG002|Overall Study|Withdrawal by Subject|11|||
124958541|NCT00043186|449474569|FG003|Overall Study|Withdrawal by Subject|13|||
124958542|NCT00043186|449474570|FG004|Overall Study|Withdrawal by Subject|14|||
124958543|NCT00043186|449474571|FG005|Overall Study|Withdrawal by Subject|6|||
124958544|NCT00043186|449474572|FG006|Overall Study|Withdrawal by Subject|12|||
124958545|NCT00043186|449474573|FG007|Overall Study|Withdrawal by Subject|9|||
124958546|NCT00043186|449474574|FG008|Overall Study|Withdrawal by Subject|10|||
124958547|NCT00043186|449474566|FG000|Overall Study|Death|0|||
124958548|NCT00043186|449474567|FG001|Overall Study|Death|0|||
124958549|NCT00043186|449474568|FG002|Overall Study|Death|1|||
124958550|NCT00043186|449474569|FG003|Overall Study|Death|0|||
124958551|NCT00043186|449474570|FG004|Overall Study|Death|0|||
124958552|NCT00043186|449474571|FG005|Overall Study|Death|0|||
124958553|NCT00043186|449474572|FG006|Overall Study|Death|2|||
124958554|NCT00043186|449474573|FG007|Overall Study|Death|0|||
124958555|NCT00043186|449474574|FG008|Overall Study|Death|0|||
124958556|NCT00043186|449474566|FG000|Overall Study|Disease progression|1|||
124958557|NCT00043186|449474567|FG001|Overall Study|Disease progression|0|||
124958558|NCT00043186|449474568|FG002|Overall Study|Disease progression|0|||
124958559|NCT00043186|449474569|FG003|Overall Study|Disease progression|3|||
124958560|NCT00043186|449474570|FG004|Overall Study|Disease progression|0|||
124958561|NCT00043186|449474571|FG005|Overall Study|Disease progression|0|||
124958562|NCT00043186|449474572|FG006|Overall Study|Disease progression|0|||
124958563|NCT00043186|449474573|FG007|Overall Study|Disease progression|4|||
124958564|NCT00043186|449474574|FG008|Overall Study|Disease progression|0|||
124958565|NCT00043186|449474566|FG000|Overall Study|Ineligibility determined|0|||
124958566|NCT00043186|449474567|FG001|Overall Study|Ineligibility determined|0|||
124958567|NCT00043186|449474568|FG002|Overall Study|Ineligibility determined|0|||
124958568|NCT00043186|449474569|FG003|Overall Study|Ineligibility determined|0|||
124958569|NCT00043186|449474570|FG004|Overall Study|Ineligibility determined|0|||
124958570|NCT00043186|449474571|FG005|Overall Study|Ineligibility determined|0|||
124958571|NCT00043186|449474572|FG006|Overall Study|Ineligibility determined|0|||
124958572|NCT00043186|449474573|FG007|Overall Study|Ineligibility determined|0|||
124958573|NCT00043186|449474574|FG008|Overall Study|Ineligibility determined|1|||
124958574|NCT00043186|449474566|FG000|Overall Study|Lost to Follow-up|3|||
124958575|NCT00043186|449474567|FG001|Overall Study|Lost to Follow-up|5|||
124958576|NCT00043186|449474568|FG002|Overall Study|Lost to Follow-up|1|||
124958577|NCT00043186|449474569|FG003|Overall Study|Lost to Follow-up|1|||
124958578|NCT00043186|449474570|FG004|Overall Study|Lost to Follow-up|1|||
124958579|NCT00043186|449474571|FG005|Overall Study|Lost to Follow-up|1|||
124958580|NCT00043186|449474572|FG006|Overall Study|Lost to Follow-up|1|||
124958581|NCT00043186|449474573|FG007|Overall Study|Lost to Follow-up|1|||
124958582|NCT00043186|449474574|FG008|Overall Study|Lost to Follow-up|2|||
124958583|NCT00043186|449474566|FG000|Overall Study|Noncompliance|0|||
124958584|NCT00043186|449474567|FG001|Overall Study|Noncompliance|0|||
124958585|NCT00043186|449474568|FG002|Overall Study|Noncompliance|1|||
124958586|NCT00043186|449474569|FG003|Overall Study|Noncompliance|1|||
124958587|NCT00043186|449474570|FG004|Overall Study|Noncompliance|0|||
124958588|NCT00043186|449474571|FG005|Overall Study|Noncompliance|0|||
124958589|NCT00043186|449474572|FG006|Overall Study|Noncompliance|0|||
124958590|NCT00043186|449474573|FG007|Overall Study|Noncompliance|0|||
124958591|NCT00043186|449474574|FG008|Overall Study|Noncompliance|0|||
124958592|NCT00043186|449474566|FG000|Overall Study|Other|0|||
124958593|NCT00043186|449474567|FG001|Overall Study|Other|0|||
124549280|NCT00388674|447966997|FG001|Initial Treatment|Lost to Follow-up|624|||
124549281|NCT00388674|447966996|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
124708044|NCT01405196|448555982|FG002|Overall Study|Death|3|||
124958594|NCT00043186|449474568|FG002|Overall Study|Other|1|||
124958595|NCT00043186|449474569|FG003|Overall Study|Other|1|||
124958596|NCT00043186|449474570|FG004|Overall Study|Other|0|||
124958597|NCT00043186|449474571|FG005|Overall Study|Other|0|||
124958598|NCT00043186|449474572|FG006|Overall Study|Other|0|||
124958599|NCT00043186|449474573|FG007|Overall Study|Other|0|||
124958600|NCT00043186|449474574|FG008|Overall Study|Other|0|||
124958601|NCT00958711|449474575|FG000|Overall Study|Withdrawal by Subject|0|||
124958602|NCT00958711|449474576|FG001|Overall Study|Withdrawal by Subject|4|||
124958603|NCT00958711|449474575|FG000|Overall Study|Physician Decision|5|||
124958604|NCT00958711|449474576|FG001|Overall Study|Physician Decision|7|||
124958605|NCT00958711|449474575|FG000|Overall Study|Lost to Follow-up|4|||
124958606|NCT00958711|449474576|FG001|Overall Study|Lost to Follow-up|1|||
124958607|NCT00958711|449474575|FG000|Overall Study|Other|2|||
124708045|NCT01405196|448555983|FG003|Overall Study|Death|0|||
124708046|NCT01405196|448555980|FG000|Overall Study|Lost to Follow-up|2|||
124958608|NCT00958711|449474576|FG001|Overall Study|Other|5|||
124958609|NCT00958711|449474575|FG000|Overall Study|Death|1|||
124958610|NCT00958711|449474576|FG001|Overall Study|Death|2|||
124958611|NCT00958711|449474575|FG000|Overall Study|Adverse Event|1|||
124958612|NCT00958711|449474576|FG001|Overall Study|Adverse Event|2|||
124958613|NCT00550771|449474583|FG000|Overall Study|Adverse Event|11|||
124958614|NCT00550771|449474584|FG001|Overall Study|Adverse Event|3|||
124958615|NCT00550771|449474583|FG000|Overall Study|Discontinued for study-related reasons|0|||
124549282|NCT00388674|447966997|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
124958616|NCT00550771|449474584|FG001|Overall Study|Discontinued for study-related reasons|1|||
124708047|NCT01405196|448555981|FG001|Overall Study|Lost to Follow-up|2|||
124708048|NCT01405196|448555982|FG002|Overall Study|Lost to Follow-up|3|||
124958617|NCT00550771|449474583|FG000|Overall Study|Physician Decision|2|||
124958618|NCT00550771|449474584|FG001|Overall Study|Physician Decision|0|||
124958619|NCT00550771|449474583|FG000|Overall Study|Withdrawal by Subject|0|||
124958620|NCT00550771|449474584|FG001|Overall Study|Withdrawal by Subject|1|||
124958621|NCT00550771|449474583|FG000|Overall Study|Protocol Violation|4|||
124958622|NCT00550771|449474584|FG001|Overall Study|Protocol Violation|5|||
124958623|NCT00730847|449474585|FG000|Overall Study|Adverse Event|1|||
124958624|NCT00730847|449474585|FG000|Overall Study|Protocol Violation|2|||
124958625|NCT00730847|449474585|FG000|Overall Study|Withdrawal by Subject|16|||
124958626|NCT00730847|449474585|FG000|Overall Study|Lost to Follow-up|67|||
124958627|NCT00730847|449474585|FG000|Overall Study|Unknown completion status|21|||
124958628|NCT00730847|449474585|FG000|Overall Study|Other|24|||
124958629|NCT03022578|449474586|FG000|Overall Study|Adverse Event|1|||
124958630|NCT03022578|449474586|FG000|Overall Study|Lack of Efficacy|2|||
124958631|NCT03022578|449474586|FG000|Overall Study|Withdrawal by Subject|1|||
124958632|NCT03681353|449474592|FG000|Overall Study|Lost to Follow-up|2|||
124958633|NCT03681353|449474592|FG000|Overall Study|Withdrawal by Subject|3|||
124958634|NCT03681353|449474592|FG000|Overall Study|withdrawn by PI|2|||
124958635|NCT00726388|449474598|FG000|Overall Study|Withdrawal by Subject|5|||
124958636|NCT00726388|449474598|FG000|Overall Study|Adverse Event|3|||
124958637|NCT00726388|449474598|FG000|Overall Study|Lost to Follow-up|10|||
124958638|NCT00726388|449474598|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
124958639|NCT00726388|449474598|FG000|Overall Study|Other|5|||
124958640|NCT00726388|449474598|FG000|Overall Study|Enrolled, Not Treated|79|||
124958641|NCT00111839|449474599|FG000|Overall Study|Disease Progression|30|||
124958642|NCT00111839|449474600|FG001|Overall Study|Disease Progression|33|||
124958643|NCT00111839|449474601|FG002|Overall Study|Disease Progression|33|||
124958644|NCT00111839|449474599|FG000|Overall Study|Adverse Event|5|||
124958645|NCT00111839|449474600|FG001|Overall Study|Adverse Event|3|||
124958646|NCT00111839|449474601|FG002|Overall Study|Adverse Event|1|||
124958647|NCT00111839|449474599|FG000|Overall Study|Protocol Violation|2|||
124958648|NCT00111839|449474600|FG001|Overall Study|Protocol Violation|4|||
124958649|NCT00111839|449474601|FG002|Overall Study|Protocol Violation|2|||
124958650|NCT00111839|449474599|FG000|Overall Study|Death|1|||
124958651|NCT00111839|449474600|FG001|Overall Study|Death|1|||
124958652|NCT00111839|449474601|FG002|Overall Study|Death|6|||
124958653|NCT00111839|449474599|FG000|Overall Study|Withdrawal by Subject|2|||
124958654|NCT00111839|449474600|FG001|Overall Study|Withdrawal by Subject|2|||
124958655|NCT00111839|449474601|FG002|Overall Study|Withdrawal by Subject|2|||
124958656|NCT00111839|449474599|FG000|Overall Study|Lost to Follow-up|1|||
124958657|NCT00111839|449474600|FG001|Overall Study|Lost to Follow-up|0|||
124958658|NCT00111839|449474601|FG002|Overall Study|Lost to Follow-up|0|||
124958659|NCT00111839|449474599|FG000|Overall Study|Logistical Constraint|1|||
124958660|NCT00111839|449474600|FG001|Overall Study|Logistical Constraint|0|||
124958661|NCT00111839|449474601|FG002|Overall Study|Logistical Constraint|0|||
124958662|NCT00111839|449474599|FG000|Overall Study|Other|6|||
124958663|NCT00111839|449474600|FG001|Overall Study|Other|3|||
124958664|NCT00111839|449474601|FG002|Overall Study|Other|3|||
124958665|NCT00111839|449474599|FG000|Overall Study|Randomized but Not Treated|0|||
124958666|NCT00111839|449474600|FG001|Overall Study|Randomized but Not Treated|0|||
124958667|NCT00111839|449474601|FG002|Overall Study|Randomized but Not Treated|2|||
124958668|NCT00377312|449474604|FG000|Overall Study|Adverse Event|1|||
124958669|NCT00377312|449474605|FG001|Overall Study|Adverse Event|1|||
124958670|NCT02775214|449474606|FG000|Overall Study|Withdrawal by Subject|2|||
124958671|NCT02775214|449474607|FG001|Overall Study|Withdrawal by Subject|0|||
124958672|NCT00762723|449474608|FG000|Overall Study|Study Terminated slow enrollement|5|||
124958673|NCT00762723|449474609|FG001|Overall Study|Study Terminated slow enrollement|5|||
124958674|NCT00762723|449474610|FG002|Overall Study|Study Terminated slow enrollement|3|||
124958675|NCT00382408|449474611|FG000|Overall Study|Did not meet protocol requirement|3|||
124958676|NCT00382408|449474612|FG001|Overall Study|Did not meet protocol requirement|3|||
124958677|NCT00382408|449474611|FG000|Overall Study|Protocol Violation|2|||
124958678|NCT00382408|449474612|FG001|Overall Study|Protocol Violation|2|||
124958679|NCT00382408|449474611|FG000|Overall Study|Physician Decision|1|||
124958680|NCT00382408|449474612|FG001|Overall Study|Physician Decision|0|||
124958681|NCT00382408|449474611|FG000|Overall Study|Withdrawal by Subject|17|||
124958682|NCT00382408|449474612|FG001|Overall Study|Withdrawal by Subject|6|||
124958683|NCT00382408|449474611|FG000|Overall Study|Pregnancy|2|||
124958684|NCT00382408|449474612|FG001|Overall Study|Pregnancy|0|||
124958685|NCT00382408|449474611|FG000|Overall Study|Lost to Follow-up|19|||
124958686|NCT00382408|449474612|FG001|Overall Study|Lost to Follow-up|8|||
124958687|NCT00382408|449474611|FG000|Overall Study|Other|100|||
124958688|NCT00382408|449474612|FG001|Overall Study|Other|35|||
124958689|NCT01145417|449474613|FG000|Overall Study|Death|1|||
124958690|NCT01145417|449474614|FG001|Overall Study|Death|0|||
124958691|NCT01145417|449474613|FG000|Overall Study|Lost to Follow-up|2|||
124958692|NCT01145417|449474614|FG001|Overall Study|Lost to Follow-up|1|||
124958693|NCT01145417|449474613|FG000|Overall Study|Withdrawal by Subject|1|||
124958694|NCT01145417|449474614|FG001|Overall Study|Withdrawal by Subject|2|||
124958695|NCT01145417|449474613|FG000|Overall Study|Pregnancy|1|||
124958696|NCT01145417|449474614|FG001|Overall Study|Pregnancy|0|||
124766658|NCT05546476|448773737|FG000|Period 1: Part A|Progressive disease|3|||
124766659|NCT05546476|448773738|FG001|Period 1: Part A|Progressive disease|5|||
124766660|NCT05546476|448773739|FG002|Period 1: Part A|Progressive disease|0|||
124958697|NCT01145417|449474613|FG000|Overall Study|Adverse Event|0|||
124958698|NCT01145417|449474614|FG001|Overall Study|Adverse Event|1|||
124958699|NCT01145417|449474613|FG000|Overall Study|Study terminated by sponsor|35|||
124958700|NCT01145417|449474614|FG001|Overall Study|Study terminated by sponsor|43|||
124958701|NCT01145417|449474613|FG000|Overall Study|Other|1|||
124958702|NCT01145417|449474614|FG001|Overall Study|Other|0|||
124958703|NCT02435381|449474615|FG000|Overall Study|Lost to Follow-up|2|||
124958704|NCT02435381|449474616|FG001|Overall Study|Lost to Follow-up|1|||
124958705|NCT01191697|449474617|FG000|Overall Study|Death|1|||
124958706|NCT01191697|449474617|FG000|Overall Study|Physician Decision|2|||
124958707|NCT01191697|449474617|FG000|Overall Study|Pursue chemoradiation|2|||
124958708|NCT01191697|449474617|FG000|Overall Study|Break from chemotherapy|2|||
124958709|NCT01191697|449474617|FG000|Overall Study|Withdrawal by Subject|1|||
124958710|NCT01191697|449474617|FG000|Overall Study|Surveillance|1|||
124958711|NCT01191697|449474617|FG000|Overall Study|Adverse Event|2|||
124958712|NCT01191697|449474617|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
124958713|NCT01191697|449474617|FG000|Overall Study|Not completed but analyzed|25|||
124958714|NCT01066897|449474621|FG000|Overall Study|Withdrawal by Subject|1|||
124958715|NCT01066897|449474622|FG001|Overall Study|Withdrawal by Subject|0|||
124958716|NCT01066897|449474621|FG000|Overall Study|stopped study after developing the flu.|1|||
124958717|NCT01066897|449474622|FG001|Overall Study|stopped study after developing the flu.|0|||
124958718|NCT05372913|449474628|FG000|Overall Study|Withdrawal by Subject|0|||
124958719|NCT05372913|449474629|FG001|Overall Study|Withdrawal by Subject|2|||
124958720|NCT05372913|449474628|FG000|Overall Study|Protocol Violation|2|||
124958721|NCT05372913|449474629|FG001|Overall Study|Protocol Violation|2|||
124958722|NCT05372913|449474628|FG000|Overall Study|Adverse Event|0|||
124958723|NCT05372913|449474629|FG001|Overall Study|Adverse Event|1|||
124958724|NCT02986659|449474630|FG000|First Intervention Period|Adverse Event|3|||
124958725|NCT02986659|449474631|FG001|First Intervention Period|Adverse Event|1|||
124958726|NCT02986659|449474630|FG000|First Intervention Period|Lost to Follow-up|1|||
124958727|NCT02986659|449474631|FG001|First Intervention Period|Lost to Follow-up|0|||
124958728|NCT02986659|449474630|FG000|First Intervention Period|Withdrawal by Subject|0|||
124958729|NCT02986659|449474631|FG001|First Intervention Period|Withdrawal by Subject|1|||
124958730|NCT02986659|449474630|FG000|Second Intervention Period|Adverse Event|0|||
124958731|NCT02986659|449474631|FG001|Second Intervention Period|Adverse Event|6|||
124958732|NCT00191984|449474638|FG000|Overall Study|Disease Progression|21|||
124958733|NCT00191984|449474638|FG000|Overall Study|Adverse Event|4|||
124958734|NCT00191984|449474638|FG000|Overall Study|Death|2|||
124958735|NCT00191984|449474638|FG000|Overall Study|Entry Criteria Exclusion|1|||
124958736|NCT00191984|449474638|FG000|Overall Study|Withdrawal by Subject|7|||
124958737|NCT00191984|449474638|FG000|Overall Study|Physician Decision|4|||
124958738|NCT02137239|449474639|FG000|Overall Study|Discontinued Study Treatment|0|||
124958739|NCT02137239|449474640|FG001|Overall Study|Discontinued Study Treatment|3|||
124958740|NCT02137239|449474639|FG000|Overall Study|Withdrew Consent|1|||
124958741|NCT02137239|449474640|FG001|Overall Study|Withdrew Consent|1|||
124958742|NCT02137239|449474639|FG000|Overall Study|Adverse Event|2|||
124958743|NCT02137239|449474640|FG001|Overall Study|Adverse Event|2|||
124958744|NCT00139659|449474641|FG000|Overall Study|Adverse Event|12|||
124958745|NCT00139659|449474642|FG001|Overall Study|Adverse Event|1|||
124958746|NCT00139659|449474641|FG000|Overall Study|Lack of Efficacy|1|||
124958747|NCT00139659|449474642|FG001|Overall Study|Lack of Efficacy|1|||
124958748|NCT00139659|449474641|FG000|Overall Study|Lost to Follow-up|7|||
124958749|NCT00139659|449474642|FG001|Overall Study|Lost to Follow-up|3|||
124958750|NCT00139659|449474641|FG000|Overall Study|Reason not Specified|6|||
124958751|NCT00139659|449474642|FG001|Overall Study|Reason not Specified|3|||
124958752|NCT00139659|449474641|FG000|Overall Study|Withdrawal by Subject|14|||
124958753|NCT00139659|449474642|FG001|Overall Study|Withdrawal by Subject|10|||
124958754|NCT03048058|449474643|FG000|Overall Study|Lost to Follow-up|4|||
124958755|NCT03048058|449474644|FG001|Overall Study|Lost to Follow-up|0|||
124958756|NCT03048058|449474643|FG000|Overall Study|Withdrawal by Subject|0|||
124958757|NCT03048058|449474644|FG001|Overall Study|Withdrawal by Subject|4|||
124958758|NCT02359552|449474646|FG000|Overall Study|Lost to Follow-up|3|||
124958759|NCT02359552|449474647|FG001|Overall Study|Lost to Follow-up|4|||
124958760|NCT02391116|449474648|FG000|Treatment|Withdrawal by Subject|1|||
124958761|NCT02391116|449474648|FG000|Treatment|Protocol Violation|1|||
124958762|NCT02391116|449474648|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
124958763|NCT02391116|449474648|FG000|Treatment|AE with Clinical PD|3|||
124958764|NCT02391116|449474648|FG000|Safety Follow-up|Adverse Event|1|||
124958765|NCT02391116|449474648|FG000|Safety Follow-up|Withdrawal by Subject|4|||
124766661|NCT05546476|448773740|FG003|Period 1: Part A|Progressive disease|1|||
124766662|NCT05546476|448773737|FG000|Period 1: Part A|Withdrawal by Subject|1|||
124958766|NCT02391116|449474648|FG000|Safety Follow-up|Switching to Other Therapy|4|||
124958767|NCT02391116|449474648|FG000|Safety Follow-up|No Follow Up|1|||
124958768|NCT02391116|449474648|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
124958769|NCT02391116|449474648|FG000|Active Follow-up|Withdrawal by Subject|1|||
124958770|NCT02391116|449474648|FG000|Active Follow-up|Switching to Other Therapy|2|||
124958771|NCT02391116|449474648|FG000|Survival Follow-up|Withdrawal by Subject|3|||
124958772|NCT02391116|449474648|FG000|Survival Follow-up|Switching to Other Therapy|1|||
124958773|NCT02282917|449474650|FG000|Overall Study|Withdrawal by Subject|1|||
124958774|NCT02282917|449474650|FG000|Overall Study|Screen Failure/Not Eligible|1|||
124958775|NCT01747629|449474651|FG000|Overall Study|Adverse Event|1|||
124958776|NCT01747629|449474652|FG001|Overall Study|Adverse Event|2|||
124958777|NCT01747629|449474651|FG000|Overall Study|Withdrawal by Subject|2|||
124958778|NCT01747629|449474652|FG001|Overall Study|Withdrawal by Subject|2|||
124958779|NCT01747629|449474651|FG000|Overall Study|Noncompliance|1|||
124958780|NCT01747629|449474652|FG001|Overall Study|Noncompliance|1|||
124958781|NCT01747629|449474651|FG000|Overall Study|Inclusion criteria not met|1|||
124958782|NCT01747629|449474652|FG001|Overall Study|Inclusion criteria not met|0|||
124958783|NCT01747629|449474651|FG000|Overall Study|Not treated|1|||
124958784|NCT01747629|449474652|FG001|Overall Study|Not treated|0|||
124958785|NCT01747629|449474651|FG000|Overall Study|Other|2|||
124958786|NCT01747629|449474652|FG001|Overall Study|Other|1|||
124958787|NCT01395914|449474653|FG000|Overall Study|Unrelated to study drug AE|6|||
124958788|NCT01395914|449474654|FG001|Overall Study|Unrelated to study drug AE|1|||
124958789|NCT01395914|449474653|FG000|Overall Study|Death|23|||
124958790|NCT01395914|449474654|FG001|Overall Study|Death|17|||
124958791|NCT01395914|449474653|FG000|Overall Study|Other|9|||
124958792|NCT01395914|449474654|FG001|Overall Study|Other|3|||
124958793|NCT01395914|449474653|FG000|Overall Study|Withdrawal by patient|27|||
124958794|NCT01395914|449474654|FG001|Overall Study|Withdrawal by patient|14|||
124958795|NCT01395914|449474653|FG000|Overall Study|Study drug-related AE|1|||
124958796|NCT01395914|449474654|FG001|Overall Study|Study drug-related AE|0|||
124958797|NCT01395914|449474653|FG000|Overall Study|Lost to Follow-up|6|||
124958798|NCT01395914|449474654|FG001|Overall Study|Lost to Follow-up|2|||
124958799|NCT04414397|449474655|FG000|Control Period|Withdrawal by Subject|2|||
124958800|NCT04414397|449474656|FG001|Control Period|Withdrawal by Subject|2|||
124958801|NCT04414397|449474655|FG000|Control Period|Lost to Follow-up|0|||
124958802|NCT04414397|449474656|FG001|Control Period|Lost to Follow-up|4|||
124958803|NCT04414397|449474655|FG000|Control Period|Protocol deviation|0|||
124958804|NCT04414397|449474656|FG001|Control Period|Protocol deviation|1|||
124958805|NCT04414397|449474655|FG000|Post-Control Period|Withdrawal by Subject|3|||
124958806|NCT04414397|449474656|FG001|Post-Control Period|Withdrawal by Subject|6|||
124958807|NCT04414397|449474655|FG000|Post-Control Period|Lost to Follow-up|4|||
124958808|NCT04414397|449474656|FG001|Post-Control Period|Lost to Follow-up|9|||
124958809|NCT04414397|449474655|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
124958810|NCT04414397|449474656|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
124958811|NCT04414397|449474655|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
124958812|NCT04414397|449474656|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
124958813|NCT01920178|449474661|FG000|Overall Study|Lost to Follow-up|2|||
124958814|NCT01920178|449474662|FG001|Overall Study|Lost to Follow-up|1|||
124958815|NCT02391545|449474663|FG000|Overall Study|Death|0|||
124958816|NCT02391545|449474664|FG001|Overall Study|Death|2|||
124958817|NCT02391545|449474663|FG000|Overall Study|Lost to Follow-up|0|||
124958818|NCT02391545|449474664|FG001|Overall Study|Lost to Follow-up|1|||
124958819|NCT02391545|449474663|FG000|Overall Study|Termination of study by sponsor|20|||
124958820|NCT02391545|449474664|FG001|Overall Study|Termination of study by sponsor|20|||
124958821|NCT02391545|449474663|FG000|Overall Study|Withdrawal by Subject|0|||
124958822|NCT02391545|449474664|FG001|Overall Study|Withdrawal by Subject|1|||
124958823|NCT02391545|449474663|FG000|Overall Study|Other Reasons|6|||
124958824|NCT02391545|449474664|FG001|Overall Study|Other Reasons|4|||
124958825|NCT01002547|449477346|FG000|Overall Study|Withdrawal by Subject|4|||
124958826|NCT01002547|449477347|FG001|Overall Study|Withdrawal by Subject|0|||
124958827|NCT01002547|449477348|FG002|Overall Study|Withdrawal by Subject|5|||
124958828|NCT01002547|449477346|FG000|Overall Study|Lost to Follow-up|2|||
124958829|NCT01002547|449477347|FG001|Overall Study|Lost to Follow-up|1|||
124958830|NCT01002547|449477348|FG002|Overall Study|Lost to Follow-up|1|||
124958831|NCT01002547|449477346|FG000|Overall Study|Physician Decision|1|||
124958832|NCT01002547|449477347|FG001|Overall Study|Physician Decision|0|||
124958833|NCT01002547|449477348|FG002|Overall Study|Physician Decision|0|||
124958834|NCT01002547|449477346|FG000|Overall Study|Death|0|||
124958835|NCT01002547|449477347|FG001|Overall Study|Death|2|||
124958836|NCT01002547|449477348|FG002|Overall Study|Death|2|||
124958837|NCT01002547|449477346|FG000|Overall Study|Adverse Event|1|||
124958838|NCT01002547|449477347|FG001|Overall Study|Adverse Event|0|||
124958839|NCT01002547|449477348|FG002|Overall Study|Adverse Event|0|||
124958840|NCT00434577|449477351|FG000|Months 0-3|Serious Adverse Event|0|||
124958841|NCT00434577|449477352|FG001|Months 0-3|Serious Adverse Event|0|||
124958842|NCT00434577|449477353|FG002|Months 0-3|Serious Adverse Event|1|||
124958843|NCT00434577|449477354|FG003|Months 0-3|Serious Adverse Event|0|||
124958844|NCT00434577|449477355|FG004|Months 0-3|Serious Adverse Event|0|||
124958845|NCT00434577|449477351|FG000|Months 0-3|Adverse Event|0|||
124958846|NCT00434577|449477352|FG001|Months 0-3|Adverse Event|1|||
124958847|NCT00434577|449477353|FG002|Months 0-3|Adverse Event|1|||
124958848|NCT00434577|449477354|FG003|Months 0-3|Adverse Event|0|||
124958849|NCT00434577|449477355|FG004|Months 0-3|Adverse Event|0|||
124958850|NCT00434577|449477351|FG000|Months 0-3|Lost to Follow-up|0|||
124958851|NCT00434577|449477352|FG001|Months 0-3|Lost to Follow-up|0|||
124958852|NCT00434577|449477353|FG002|Months 0-3|Lost to Follow-up|0|||
124958853|NCT00434577|449477354|FG003|Months 0-3|Lost to Follow-up|0|||
124958854|NCT00434577|449477355|FG004|Months 0-3|Lost to Follow-up|2|||
124958855|NCT00434577|449477351|FG000|Months 0-3|Protocol Violation|1|||
124958856|NCT00434577|449477352|FG001|Months 0-3|Protocol Violation|0|||
124958857|NCT00434577|449477353|FG002|Months 0-3|Protocol Violation|1|||
124958858|NCT00434577|449477354|FG003|Months 0-3|Protocol Violation|0|||
124958859|NCT00434577|449477355|FG004|Months 0-3|Protocol Violation|0|||
124958860|NCT00434577|449477351|FG000|Months 0-3|Withdrawal by Subject|2|||
124958861|NCT00434577|449477352|FG001|Months 0-3|Withdrawal by Subject|1|||
124958862|NCT00434577|449477353|FG002|Months 0-3|Withdrawal by Subject|1|||
124958863|NCT00434577|449477354|FG003|Months 0-3|Withdrawal by Subject|1|||
124958864|NCT00434577|449477355|FG004|Months 0-3|Withdrawal by Subject|1|||
124958865|NCT01967719|449477356|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
124958866|NCT01967719|449477357|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
124958867|NCT01967719|449477358|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
124958868|NCT01967719|449477359|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
124958869|NCT01967719|449477356|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
124958870|NCT01967719|449477357|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
124958871|NCT01967719|449477358|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
124958872|NCT01967719|449477359|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
124958873|NCT02329223|449477360|FG000|Overall Study|Withdrawal by Subject|1|||
124958874|NCT02329223|449477361|FG001|Overall Study|Withdrawal by Subject|2|||
124958875|NCT02329223|449477362|FG002|Overall Study|Withdrawal by Subject|5|||
124958876|NCT02329223|449477360|FG000|Overall Study|Physician Decision|0|||
124958877|NCT02329223|449477361|FG001|Overall Study|Physician Decision|0|||
124958878|NCT02329223|449477362|FG002|Overall Study|Physician Decision|1|||
124958879|NCT02329223|449477360|FG000|Overall Study|Adverse Event|0|||
124958880|NCT02329223|449477361|FG001|Overall Study|Adverse Event|1|||
124958881|NCT02329223|449477362|FG002|Overall Study|Adverse Event|0|||
124958882|NCT00506922|449477368|FG000|Overall Study|Physician Decision|0|||
124958883|NCT00506922|449477369|FG001|Overall Study|Physician Decision|0|||
124958884|NCT00506922|449477370|FG002|Overall Study|Physician Decision|0|||
124958885|NCT00506922|449477371|FG003|Overall Study|Physician Decision|2|||
124958886|NCT00506922|449477372|FG004|Overall Study|Physician Decision|0|||
124958887|NCT00506922|449477368|FG000|Overall Study|Withdrawal by Subject|0|||
124958888|NCT00506922|449477369|FG001|Overall Study|Withdrawal by Subject|0|||
124958889|NCT00506922|449477370|FG002|Overall Study|Withdrawal by Subject|0|||
124958890|NCT00506922|449477371|FG003|Overall Study|Withdrawal by Subject|0|||
124958891|NCT00506922|449477372|FG004|Overall Study|Withdrawal by Subject|1|||
124958892|NCT00848393|449477380|FG000|Overall Study|Protocol Violation|0|||
124958893|NCT00848393|449477381|FG001|Overall Study|Protocol Violation|0|||
124958894|NCT00848393|449477382|FG002|Overall Study|Protocol Violation|1|||
124958895|NCT00848393|449477380|FG000|Overall Study|surgical complications unrelated to stud|0|||
124958896|NCT00848393|449477381|FG001|Overall Study|surgical complications unrelated to stud|0|||
124958897|NCT00848393|449477382|FG002|Overall Study|surgical complications unrelated to stud|2|||
124958898|NCT01011049|449477383|FG000|Overall Study|Protocol Violation|0|||
124958899|NCT01011049|449477384|FG001|Overall Study|Protocol Violation|0|||
124958900|NCT01011049|449477385|FG002|Overall Study|Protocol Violation|2|||
124958901|NCT01011049|449477386|FG003|Overall Study|Protocol Violation|0|||
124958902|NCT01011049|449477383|FG000|Overall Study|Lost to Follow-up|1|||
124958903|NCT01011049|449477384|FG001|Overall Study|Lost to Follow-up|2|||
124958904|NCT01011049|449477385|FG002|Overall Study|Lost to Follow-up|1|||
124958905|NCT01011049|449477386|FG003|Overall Study|Lost to Follow-up|0|||
124958906|NCT01011049|449477383|FG000|Overall Study|Withdrawal by Subject|0|||
124958907|NCT01011049|449477384|FG001|Overall Study|Withdrawal by Subject|0|||
124958908|NCT01011049|449477385|FG002|Overall Study|Withdrawal by Subject|1|||
124708049|NCT01405196|448555983|FG003|Overall Study|Lost to Follow-up|1|||
124708050|NCT01729039|448555984|FG000|Overall Study|disqualified|2|||
124958909|NCT01011049|449477386|FG003|Overall Study|Withdrawal by Subject|0|||
124958910|NCT00352053|449477392|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
124958911|NCT00352053|449477393|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
124958912|NCT00352053|449477392|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
124708051|NCT01729039|448555985|FG001|Overall Study|disqualified|5|||
124708052|NCT01729039|448555984|FG000|Overall Study|Withdrawal by Subject|8|||
124958913|NCT00352053|449477393|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
124958914|NCT00352053|449477392|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
124958915|NCT00352053|449477393|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
124958916|NCT00352053|449477392|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
124958917|NCT00352053|449477393|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
124958918|NCT00352053|449477392|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
124958919|NCT00352053|449477393|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
124958920|NCT00352053|449477392|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
124958921|NCT00352053|449477393|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
124958922|NCT00352053|449477392|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
124958923|NCT00352053|449477393|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
124958924|NCT00352053|449477392|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
124958925|NCT00352053|449477393|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
124958926|NCT00352053|449477392|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
124958927|NCT00352053|449477393|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
124958928|NCT00352053|449477392|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
124958929|NCT00352053|449477393|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
124549283|NCT00388674|447966996|FG000|Initial Treatment|Never Treated with Study Medication|1|||
124958930|NCT00352053|449477392|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
124958931|NCT00352053|449477393|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
124958932|NCT00352053|449477392|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
124958933|NCT00352053|449477393|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
124958934|NCT00352053|449477392|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
124958935|NCT00352053|449477393|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
124958936|NCT00520403|449477394|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
124958937|NCT00520403|449477394|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
124958938|NCT00520403|449477394|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
124958939|NCT00520403|449477394|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
124958940|NCT00520403|449477394|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
124958941|NCT00520403|449477394|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
124958942|NCT00520403|449477394|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
124958943|NCT00520403|449477394|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
124958944|NCT00405912|449477397|FG000|Overall Study|Withdrawal by Subject|12|||
124958945|NCT00405912|449477398|FG001|Overall Study|Withdrawal by Subject|11|||
124958946|NCT00405912|449477399|FG002|Overall Study|Withdrawal by Subject|12|||
124958947|NCT00405912|449477397|FG000|Overall Study|Lost to Follow-up|4|||
124958948|NCT00405912|449477398|FG001|Overall Study|Lost to Follow-up|8|||
124958949|NCT00405912|449477399|FG002|Overall Study|Lost to Follow-up|4|||
124958950|NCT03730662|449477400|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
124958951|NCT03730662|449477401|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
124958952|NCT03730662|449477402|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
124958953|NCT03730662|449477403|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
124958954|NCT03730662|449477400|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
124958955|NCT03730662|449477401|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
124958956|NCT03730662|449477402|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
124958957|NCT03730662|449477403|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
124958958|NCT03730662|449477400|FG000|Treatment Period (52 Weeks)|Death|6|||
124958959|NCT03730662|449477401|FG001|Treatment Period (52 Weeks)|Death|2|||
124958960|NCT03730662|449477402|FG002|Treatment Period (52 Weeks)|Death|2|||
124958961|NCT03730662|449477403|FG003|Treatment Period (52 Weeks)|Death|9|||
124958962|NCT03730662|449477400|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
124958963|NCT03730662|449477401|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
124958964|NCT03730662|449477402|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
124958965|NCT03730662|449477403|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
124958966|NCT03730662|449477400|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
124958967|NCT03730662|449477401|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
124958968|NCT03730662|449477402|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
124958969|NCT03730662|449477403|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
124958970|NCT03730662|449477400|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
124958971|NCT03730662|449477401|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
124708053|NCT01729039|448555985|FG001|Overall Study|Withdrawal by Subject|7|||
124708054|NCT00698841|448555986|FG000|Overall Study|Withdrawal by Subject|2|||
124958972|NCT03730662|449477402|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
124958973|NCT03730662|449477403|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
124958974|NCT03730662|449477400|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
124958975|NCT03730662|449477401|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
124958976|NCT03730662|449477402|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
124958977|NCT03730662|449477403|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
124958978|NCT03730662|449477400|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
124958979|NCT03730662|449477401|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
124958980|NCT03730662|449477402|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
124958981|NCT03730662|449477403|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
124549284|NCT00388674|447966997|FG001|Initial Treatment|Never Treated with Study Medication|7|||
124708055|NCT00698841|448555986|FG000|Overall Study|Adverse Event|3|||
124708056|NCT00698841|448555986|FG000|Overall Study|Disease progression|7|||
124958982|NCT03730662|449477400|FG000|Variable Treatment Period|Adverse Event|1|||
124958983|NCT03730662|449477401|FG001|Variable Treatment Period|Adverse Event|2|||
124958984|NCT03730662|449477402|FG002|Variable Treatment Period|Adverse Event|0|||
124958985|NCT03730662|449477403|FG003|Variable Treatment Period|Adverse Event|7|||
124958986|NCT03730662|449477400|FG000|Variable Treatment Period|Death|9|||
124958987|NCT03730662|449477401|FG001|Variable Treatment Period|Death|0|||
124958988|NCT03730662|449477402|FG002|Variable Treatment Period|Death|6|||
124958989|NCT03730662|449477403|FG003|Variable Treatment Period|Death|26|||
124958990|NCT03730662|449477400|FG000|Variable Treatment Period|Lost to Follow-up|2|||
124958991|NCT03730662|449477401|FG001|Variable Treatment Period|Lost to Follow-up|1|||
124958992|NCT03730662|449477402|FG002|Variable Treatment Period|Lost to Follow-up|4|||
124958993|NCT03730662|449477403|FG003|Variable Treatment Period|Lost to Follow-up|11|||
124958994|NCT03730662|449477400|FG000|Variable Treatment Period|Personal Reason|0|||
124958995|NCT03730662|449477401|FG001|Variable Treatment Period|Personal Reason|2|||
124958996|NCT03730662|449477402|FG002|Variable Treatment Period|Personal Reason|1|||
124958997|NCT03730662|449477403|FG003|Variable Treatment Period|Personal Reason|6|||
124958998|NCT03730662|449477400|FG000|Variable Treatment Period|Physician Decision|0|||
124958999|NCT03730662|449477401|FG001|Variable Treatment Period|Physician Decision|0|||
124959000|NCT03730662|449477402|FG002|Variable Treatment Period|Physician Decision|0|||
124959001|NCT03730662|449477403|FG003|Variable Treatment Period|Physician Decision|3|||
124959002|NCT03730662|449477400|FG000|Variable Treatment Period|Protocol Violation|0|||
124959003|NCT03730662|449477401|FG001|Variable Treatment Period|Protocol Violation|1|||
124959004|NCT03730662|449477402|FG002|Variable Treatment Period|Protocol Violation|1|||
124959005|NCT03730662|449477403|FG003|Variable Treatment Period|Protocol Violation|1|||
124959006|NCT03730662|449477400|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
124959007|NCT03730662|449477401|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
124959008|NCT03730662|449477402|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
124959009|NCT03730662|449477403|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
124959010|NCT01797562|449477404|FG000|Overall Study|Protocol Violation|5|||
124766663|NCT05546476|448773738|FG001|Period 1: Part A|Withdrawal by Subject|1|||
124766664|NCT05546476|448773739|FG002|Period 1: Part A|Withdrawal by Subject|1|||
124766665|NCT05546476|448773740|FG003|Period 1: Part A|Withdrawal by Subject|2|||
124959011|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
124959012|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
124959013|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
124959014|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
124959015|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Death|0|||
124959016|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Death|1|||
124959017|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
124959018|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
124959019|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
124959020|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
124959021|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
124959022|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
124959023|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
124959024|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
124959025|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
124959026|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
124959027|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
124959028|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
124959029|NCT01309243|449477405|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
124959030|NCT01309243|449477406|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
124959031|NCT01309243|449477405|FG000|Extension Phase|Lost to Follow-up|6|||
124959032|NCT01309243|449477406|FG001|Extension Phase|Lost to Follow-up|0|||
124959033|NCT00632931|449477409|FG000|Part 1, Period 1|Protocol Violation|1|||
124959034|NCT00632931|449477410|FG001|Part 1, Period 1|Protocol Violation|0|||
124959035|NCT00632931|449477411|FG002|Part 1, Period 1|Protocol Violation|0|||
124959036|NCT00632931|449477409|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
124959037|NCT00632931|449477410|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
124959038|NCT00632931|449477411|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
124959039|NCT00632931|449477409|FG000|Part 2|Adverse Event|0|||
124959040|NCT00632931|449477410|FG001|Part 2|Adverse Event|0|||
124959041|NCT00632931|449477411|FG002|Part 2|Adverse Event|3|||
124959042|NCT00632931|449477409|FG000|Part 2|Death|0|||
124959043|NCT00632931|449477410|FG001|Part 2|Death|0|||
124959044|NCT00632931|449477411|FG002|Part 2|Death|1|||
124959045|NCT00632931|449477409|FG000|Part 2|Lack of Efficacy|0|||
124959046|NCT00632931|449477410|FG001|Part 2|Lack of Efficacy|0|||
124959047|NCT00632931|449477411|FG002|Part 2|Lack of Efficacy|17|||
124959048|NCT00632931|449477409|FG000|Part 2|Withdrawal by Subject|0|||
124959049|NCT00632931|449477410|FG001|Part 2|Withdrawal by Subject|0|||
124959050|NCT00632931|449477411|FG002|Part 2|Withdrawal by Subject|3|||
124959051|NCT01441583|449477414|FG000|Overall Study|Withdrawal by Subject|1|||
124959052|NCT01441583|449477415|FG001|Overall Study|Withdrawal by Subject|1|||
124959053|NCT01441583|449477416|FG002|Overall Study|Withdrawal by Subject|1|||
124959054|NCT01441583|449477414|FG000|Overall Study|Death|1|||
124959055|NCT01441583|449477415|FG001|Overall Study|Death|0|||
124959056|NCT01441583|449477416|FG002|Overall Study|Death|4|||
124959057|NCT01441583|449477414|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
124959058|NCT01441583|449477415|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
124959059|NCT01441583|449477416|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
124959060|NCT03341312|449477417|FG000|Period 1|Withdrawal by Subject|0|||
124959061|NCT03341312|449477418|FG001|Period 1|Withdrawal by Subject|1|||
124959062|NCT03341312|449477419|FG002|Period 1|Withdrawal by Subject|0|||
124959063|NCT03341312|449477420|FG003|Period 1|Withdrawal by Subject|0|||
124959064|NCT00839306|449477421|FG000|Overall Study|Adverse Event|3|||
124959065|NCT00839306|449477422|FG001|Overall Study|Adverse Event|5|||
124959066|NCT00839306|449477421|FG000|Overall Study|Lost to Follow-up|6|||
124959067|NCT00839306|449477422|FG001|Overall Study|Lost to Follow-up|9|||
124959068|NCT00839306|449477421|FG000|Overall Study|Withdrawal by Subject|5|||
124959069|NCT00839306|449477422|FG001|Overall Study|Withdrawal by Subject|7|||
124959070|NCT00839306|449477421|FG000|Overall Study|Lack of Efficacy|5|||
124959071|NCT00839306|449477422|FG001|Overall Study|Lack of Efficacy|4|||
124959072|NCT00839306|449477421|FG000|Overall Study|Other|6|||
124959073|NCT00839306|449477422|FG001|Overall Study|Other|18|||
124959074|NCT01812707|449477423|FG000|Overall Study|Adverse Event|0|||
124959075|NCT01812707|449477424|FG001|Overall Study|Adverse Event|0|||
124959076|NCT01812707|449477425|FG002|Overall Study|Adverse Event|0|||
124959077|NCT01812707|449477426|FG003|Overall Study|Adverse Event|2|||
124959078|NCT01812707|449477423|FG000|Overall Study|Poor compliance to protocol|1|||
124959079|NCT01812707|449477424|FG001|Overall Study|Poor compliance to protocol|0|||
124959080|NCT01812707|449477425|FG002|Overall Study|Poor compliance to protocol|0|||
124959081|NCT01812707|449477426|FG003|Overall Study|Poor compliance to protocol|0|||
124959082|NCT01812707|449477423|FG000|Overall Study|Consent withdrawn by participant|1|||
124959083|NCT01812707|449477424|FG001|Overall Study|Consent withdrawn by participant|0|||
124959084|NCT01812707|449477425|FG002|Overall Study|Consent withdrawn by participant|0|||
124959085|NCT01812707|449477426|FG003|Overall Study|Consent withdrawn by participant|0|||
124959086|NCT05060237|449477427|FG000|Overall Study|Withdrawal by Subject|4|||
124959087|NCT05060237|449477427|FG000|Overall Study|Screening failure|8|||
124959088|NCT01697592|449477428|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
124959089|NCT01697592|449477429|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959090|NCT01697592|449477430|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959091|NCT01697592|449477431|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959092|NCT01697592|449477432|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959093|NCT01697592|449477433|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959094|NCT01697592|449477434|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959095|NCT01697592|449477435|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959096|NCT01697592|449477436|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959097|NCT01697592|449477437|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
124959098|NCT01697592|449477428|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124959099|NCT01697592|449477429|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124959100|NCT01697592|449477430|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124959101|NCT01697592|449477431|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124959102|NCT01697592|449477432|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124959103|NCT01697592|449477433|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
124549285|NCT00388674|447966996|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
124708057|NCT00698841|448555986|FG000|Overall Study|Failure to meet eligibility criteria|2|||
124959104|NCT01697592|449477434|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124708058|NCT00698841|448555986|FG000|Overall Study|Study drug toxicity|2|||
124549286|NCT00388674|447966997|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
124959105|NCT01697592|449477435|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124959106|NCT01697592|449477436|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124959107|NCT01697592|449477437|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
124959108|NCT01697592|449477428|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
124766666|NCT05546476|448773737|FG000|Period 1: Part A|Global deterioration of health status|2|||
124766667|NCT05546476|448773738|FG001|Period 1: Part A|Global deterioration of health status|2|||
124766668|NCT05546476|448773739|FG002|Period 1: Part A|Global deterioration of health status|1|||
124766669|NCT05546476|448773740|FG003|Period 1: Part A|Global deterioration of health status|4|||
124766670|NCT05546476|448773737|FG000|Period 1: Part A|Other: Unspecified|0|||
124766671|NCT05546476|448773738|FG001|Period 1: Part A|Other: Unspecified|2|||
124766672|NCT05546476|448773739|FG002|Period 1: Part A|Other: Unspecified|0|||
124766673|NCT05546476|448773740|FG003|Period 1: Part A|Other: Unspecified|0|||
124766674|NCT05546476|448773737|FG000|Period 2: Part B|Ongoing|26|||
124766675|NCT05546476|448773738|FG001|Period 2: Part B|Ongoing|27|||
124766676|NCT05546476|448773739|FG002|Period 2: Part B|Ongoing|35|||
124959109|NCT01697592|449477429|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124959110|NCT01697592|449477430|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124766677|NCT05546476|448773740|FG003|Period 2: Part B|Ongoing|29|||
124766678|NCT00807911|448773743|FG000|Overall Study|Withdrawal by Subject|12|||
124766679|NCT00807911|448773744|FG001|Overall Study|Withdrawal by Subject|10|||
124766680|NCT00807911|448773743|FG000|Overall Study|Ineligible|0|||
124766681|NCT00807911|448773744|FG001|Overall Study|Ineligible|4|||
124959111|NCT01697592|449477431|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124959112|NCT01697592|449477432|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124959113|NCT01697592|449477433|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124959114|NCT01697592|449477434|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124959115|NCT01697592|449477435|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124959116|NCT01697592|449477436|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124959117|NCT01697592|449477437|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
124959118|NCT01697592|449477428|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
124959119|NCT01697592|449477429|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
124766682|NCT02953652|448773745|FG000|Overall Study|Adverse Event|18|||
124766683|NCT02953652|448773745|FG000|Overall Study|Withdrawal by Subject|6|||
124766684|NCT02953652|448773745|FG000|Overall Study|Protocol Violation|1|||
124766685|NCT02953652|448773745|FG000|Overall Study|Disease Progression|27|||
124766686|NCT03780452|448773749|FG000|Overall Study|Screening failure|2|||
124766687|NCT03796728|448773755|FG000|Overall Study|Lost to Follow-up|8|||
124766688|NCT03796728|448773755|FG000|Overall Study|Reason not Specified|16|||
124766689|NCT00333775|448773756|FG000|Overall Study|Death|144|||
124766690|NCT00333775|448773757|FG001|Overall Study|Death|149|||
124766691|NCT00333775|448773758|FG002|Overall Study|Death|143|||
124766692|NCT00333775|448773756|FG000|Overall Study|In Follow-up When Study Stopped|87|||
124766693|NCT00333775|448773757|FG001|Overall Study|In Follow-up When Study Stopped|92|||
124766694|NCT00333775|448773758|FG002|Overall Study|In Follow-up When Study Stopped|96|||
124766695|NCT00333775|448773756|FG000|Overall Study|Lost to Follow-up|10|||
124766696|NCT00333775|448773757|FG001|Overall Study|Lost to Follow-up|7|||
124766697|NCT00333775|448773758|FG002|Overall Study|Lost to Follow-up|8|||
124766698|NCT01383928|448773762|FG000|Overall Study|Initiation of ASCT|2|||
124766699|NCT01383928|448773763|FG001|Overall Study|Initiation of ASCT|1|||
124959120|NCT01697592|449477430|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
124959121|NCT01697592|449477431|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
124959122|NCT01697592|449477432|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
124959123|NCT01697592|449477433|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
124959124|NCT01697592|449477434|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
124959125|NCT01697592|449477435|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
124959126|NCT01697592|449477436|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
124959127|NCT01697592|449477437|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
124959128|NCT01697592|449477428|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
124959129|NCT01697592|449477429|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
124959130|NCT01697592|449477430|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
124959131|NCT01697592|449477431|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
124766700|NCT01383928|448773764|FG002|Overall Study|Initiation of ASCT|18|||
124766701|NCT01383928|448773762|FG000|Overall Study|Adverse Event|1|||
124766702|NCT01383928|448773763|FG001|Overall Study|Adverse Event|2|||
124766703|NCT01383928|448773764|FG002|Overall Study|Adverse Event|8|||
124766704|NCT01383928|448773762|FG000|Overall Study|Other|1|||
124766705|NCT01383928|448773763|FG001|Overall Study|Other|3|||
124766706|NCT01383928|448773764|FG002|Overall Study|Other|4|||
124959132|NCT01697592|449477432|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
124959133|NCT01697592|449477433|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
124959134|NCT01697592|449477434|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
124766707|NCT01383928|448773762|FG000|Overall Study|Progressive Disease|1|||
124766708|NCT01383928|448773763|FG001|Overall Study|Progressive Disease|1|||
124766709|NCT01383928|448773764|FG002|Overall Study|Progressive Disease|5|||
124766710|NCT01383928|448773762|FG000|Overall Study|Withdrawal by Subject|0|||
124766711|NCT01383928|448773763|FG001|Overall Study|Withdrawal by Subject|0|||
124766712|NCT01383928|448773764|FG002|Overall Study|Withdrawal by Subject|4|||
124766713|NCT01383928|448773762|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
124766714|NCT01383928|448773763|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
124959135|NCT01697592|449477435|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
124959136|NCT01697592|449477436|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
124959137|NCT01697592|449477437|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
124959138|NCT01697592|449477428|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
124959139|NCT01697592|449477429|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
124959140|NCT01697592|449477430|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
124959141|NCT01697592|449477431|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
124959142|NCT01697592|449477432|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
124959143|NCT01697592|449477433|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
124959144|NCT01697592|449477434|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
124959145|NCT01697592|449477435|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
124959146|NCT01697592|449477436|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
124959147|NCT01697592|449477437|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
124959148|NCT01697592|449477428|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
124959149|NCT01697592|449477429|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
124959150|NCT01697592|449477430|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
124959151|NCT01697592|449477431|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
124959152|NCT01697592|449477432|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
124959153|NCT01697592|449477433|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
124959154|NCT01697592|449477434|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
124959155|NCT01697592|449477435|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
124959156|NCT01697592|449477436|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
124959157|NCT01697592|449477437|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
124959158|NCT01697592|449477428|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
124959159|NCT01697592|449477429|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
124959160|NCT01697592|449477430|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
124959161|NCT01697592|449477431|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
124959162|NCT01697592|449477432|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
124959163|NCT01697592|449477433|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
124959164|NCT01697592|449477434|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
124959165|NCT01697592|449477435|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
124959166|NCT01697592|449477436|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
124959167|NCT01697592|449477437|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
124959168|NCT02396758|449477438|FG000|Overall Study|Withdrawal by Subject|2|||
124959169|NCT02396758|449477439|FG001|Overall Study|Withdrawal by Subject|0|||
124959170|NCT02396758|449477440|FG002|Overall Study|Withdrawal by Subject|0|||
124959171|NCT02396758|449477441|FG003|Overall Study|Withdrawal by Subject|1|||
124959172|NCT02396758|449477438|FG000|Overall Study|Lost to Follow-up|8|||
124959173|NCT02396758|449477439|FG001|Overall Study|Lost to Follow-up|5|||
124959174|NCT02396758|449477440|FG002|Overall Study|Lost to Follow-up|3|||
124959175|NCT02396758|449477441|FG003|Overall Study|Lost to Follow-up|3|||
124959176|NCT02396758|449477438|FG000|Overall Study|Death|1|||
124959177|NCT02396758|449477439|FG001|Overall Study|Death|1|||
124959178|NCT02396758|449477440|FG002|Overall Study|Death|0|||
124959179|NCT02396758|449477441|FG003|Overall Study|Death|1|||
124959180|NCT02396758|449477438|FG000|Overall Study|Randomized but not treated|1|||
124959181|NCT02396758|449477439|FG001|Overall Study|Randomized but not treated|0|||
124959182|NCT02396758|449477440|FG002|Overall Study|Randomized but not treated|1|||
124959183|NCT02396758|449477441|FG003|Overall Study|Randomized but not treated|0|||
124959184|NCT00265096|449477442|FG000|Overall Study|Adverse Event|14|||
124959185|NCT00265096|449477443|FG001|Overall Study|Adverse Event|18|||
124708059|NCT00698841|448555986|FG000|Overall Study|Other|2|||
124708060|NCT00829998|448555987|FG000|Washout|Adverse Event|0|||
124708061|NCT00829998|448555988|FG001|Washout|Adverse Event|1|||
124708062|NCT02114177|448557300|FG000|Overall Study|Lost to Follow-up|1|||
124959186|NCT00265096|449477444|FG002|Overall Study|Adverse Event|18|||
124959187|NCT00265096|449477442|FG000|Overall Study|Lost to Follow-up|2|||
124959188|NCT00265096|449477443|FG001|Overall Study|Lost to Follow-up|5|||
124959189|NCT00265096|449477444|FG002|Overall Study|Lost to Follow-up|3|||
124959190|NCT00265096|449477442|FG000|Overall Study|Death|0|||
124959191|NCT00265096|449477443|FG001|Overall Study|Death|1|||
124959192|NCT00265096|449477444|FG002|Overall Study|Death|2|||
124959193|NCT00265096|449477442|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
124959194|NCT00265096|449477443|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
124959195|NCT00265096|449477444|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
124959196|NCT00265096|449477442|FG000|Overall Study|Other|11|||
124959197|NCT00265096|449477443|FG001|Overall Study|Other|19|||
124959198|NCT00265096|449477444|FG002|Overall Study|Other|10|||
124959199|NCT00774306|449477445|FG000|Overall Study|Adverse Event|3|||
124708063|NCT02114177|448557301|FG001|Overall Study|Lost to Follow-up|2|||
124959200|NCT00774306|449477446|FG001|Overall Study|Adverse Event|0|||
124959201|NCT00774306|449477447|FG002|Overall Study|Adverse Event|0|||
124959202|NCT00774306|449477448|FG003|Overall Study|Adverse Event|0|||
124959203|NCT00774306|449477445|FG000|Overall Study|Protocol Violation|2|||
124959204|NCT00774306|449477446|FG001|Overall Study|Protocol Violation|0|||
124959205|NCT00774306|449477447|FG002|Overall Study|Protocol Violation|3|||
124959206|NCT00774306|449477448|FG003|Overall Study|Protocol Violation|0|||
124959207|NCT00774306|449477445|FG000|Overall Study|Withdrawal by Subject|6|||
124959208|NCT00774306|449477446|FG001|Overall Study|Withdrawal by Subject|1|||
124959209|NCT00774306|449477447|FG002|Overall Study|Withdrawal by Subject|1|||
124959210|NCT00774306|449477448|FG003|Overall Study|Withdrawal by Subject|0|||
124959211|NCT00774306|449477445|FG000|Overall Study|Lost to Follow-up|6|||
124959212|NCT00774306|449477446|FG001|Overall Study|Lost to Follow-up|0|||
124959213|NCT00774306|449477447|FG002|Overall Study|Lost to Follow-up|4|||
124959214|NCT00774306|449477448|FG003|Overall Study|Lost to Follow-up|5|||
124959215|NCT00774306|449477445|FG000|Overall Study|Death|1|||
124959216|NCT00774306|449477446|FG001|Overall Study|Death|1|||
124959217|NCT00774306|449477447|FG002|Overall Study|Death|0|||
124959218|NCT00774306|449477448|FG003|Overall Study|Death|0|||
124959219|NCT00666835|449477451|FG000|Overall Study|Withdrawal by Subject|5|||
124959220|NCT00666835|449477452|FG001|Overall Study|Withdrawal by Subject|2|||
124959221|NCT00666835|449477451|FG000|Overall Study|Lack of Efficacy|0|||
124959222|NCT00666835|449477452|FG001|Overall Study|Lack of Efficacy|1|||
124959223|NCT00666835|449477451|FG000|Overall Study|Incl./excl. not fulfilled|7|||
124959224|NCT00666835|449477452|FG001|Overall Study|Incl./excl. not fulfilled|2|||
124959225|NCT00666835|449477451|FG000|Overall Study|Adverse Event|7|||
124959226|NCT00666835|449477452|FG001|Overall Study|Adverse Event|6|||
124959227|NCT00666835|449477451|FG000|Overall Study|Protocol Violation|2|||
124959228|NCT00666835|449477452|FG001|Overall Study|Protocol Violation|0|||
124959229|NCT00666835|449477451|FG000|Overall Study|Death|15|||
124959230|NCT00666835|449477452|FG001|Overall Study|Death|4|||
124959231|NCT00666835|449477451|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
124959232|NCT00666835|449477452|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
124959233|NCT00666835|449477451|FG000|Overall Study|Hemoglobulin concentration|4|||
124959234|NCT00666835|449477452|FG001|Overall Study|Hemoglobulin concentration|3|||
124959235|NCT00666835|449477451|FG000|Overall Study|Planned operation|2|||
124959236|NCT00666835|449477452|FG001|Overall Study|Planned operation|0|||
124959237|NCT00666835|449477451|FG000|Overall Study|Physician Decision|1|||
124959238|NCT00666835|449477452|FG001|Overall Study|Physician Decision|2|||
124959239|NCT01126879|449477453|FG000|Overall Study|Progressive Disease|3|||
124959240|NCT01126879|449477454|FG001|Overall Study|Progressive Disease|1|||
124959241|NCT01126879|449477453|FG000|Overall Study|Withdrawal by Subject|1|||
124959242|NCT01126879|449477454|FG001|Overall Study|Withdrawal by Subject|0|||
124959243|NCT01126879|449477453|FG000|Overall Study|Adverse Event|0|||
124959244|NCT01126879|449477454|FG001|Overall Study|Adverse Event|1|||
124959245|NCT01126879|449477453|FG000|Overall Study|Physician Decision|1|||
124959246|NCT01126879|449477454|FG001|Overall Study|Physician Decision|0|||
124959247|NCT03319719|449477455|FG000|Overall Study|Lost to Follow-up|1|||
124959248|NCT03193216|449477459|FG000|Overall Study|Lost to Follow-up|1|||
124959249|NCT03193216|449477460|FG001|Overall Study|Lost to Follow-up|0|||
124959250|NCT03193216|449477459|FG000|Overall Study|Withdrawal by Subject|5|||
124959251|NCT03193216|449477460|FG001|Overall Study|Withdrawal by Subject|0|||
124959252|NCT03193216|449477459|FG000|Overall Study|Physician Decision|4|||
124959253|NCT03193216|449477460|FG001|Overall Study|Physician Decision|0|||
124959254|NCT02236598|449477464|FG000|Overall Study|Adverse Event|0|||
124959255|NCT02236598|449477465|FG001|Overall Study|Adverse Event|1|||
124959256|NCT02236598|449477464|FG000|Overall Study|Withdrawal by Subject|0|||
124959257|NCT02236598|449477465|FG001|Overall Study|Withdrawal by Subject|1|||
124959258|NCT01264887|449477467|FG000|Overall Study|Adverse Event|5|||
124959259|NCT01264887|449477467|FG000|Overall Study|Death|7|||
124959260|NCT01264887|449477467|FG000|Overall Study|Lack of Efficacy|5|||
124959261|NCT01264887|449477467|FG000|Overall Study|Physician Decision|4|||
124959262|NCT01264887|449477467|FG000|Overall Study|Withdrawal by Subject|6|||
124959263|NCT01264887|449477467|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
124959264|NCT01264887|449477467|FG000|Overall Study|Other|2|||
124959265|NCT02959177|449477468|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
124959266|NCT02959177|449477469|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
124959267|NCT02959177|449477470|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
124959268|NCT02959177|449477468|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
124959269|NCT02959177|449477469|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
124959270|NCT02959177|449477470|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
124959271|NCT02959177|449477468|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
124959272|NCT02959177|449477469|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
124959273|NCT02959177|449477470|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
124959274|NCT02959177|449477468|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
124959275|NCT02959177|449477469|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
124959276|NCT02959177|449477470|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
124959277|NCT02959177|449477468|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
124959278|NCT02959177|449477469|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
124959279|NCT02959177|449477470|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
124959280|NCT02959177|449477468|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
124959281|NCT02959177|449477469|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
124959282|NCT02959177|449477470|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
124959283|NCT02959177|449477468|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
124959284|NCT02959177|449477469|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
124959285|NCT02959177|449477470|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
124959286|NCT01061775|449477473|FG000|Overall Study|Physician Decision|2|||
124959287|NCT01061775|449477473|FG000|Overall Study|Lost to Follow-up|1|||
124959288|NCT01313299|449477478|FG000|Overall Study|Adverse Event|3|||
124959289|NCT01313299|449477479|FG001|Overall Study|Adverse Event|1|||
124959290|NCT01313299|449477480|FG002|Overall Study|Adverse Event|1|||
124959291|NCT01313299|449477478|FG000|Overall Study|Lost to Follow-up|1|||
124959292|NCT01313299|449477479|FG001|Overall Study|Lost to Follow-up|0|||
124959293|NCT01313299|449477480|FG002|Overall Study|Lost to Follow-up|0|||
124959294|NCT01313299|449477478|FG000|Overall Study|Protocol Violation|2|||
124959295|NCT01313299|449477479|FG001|Overall Study|Protocol Violation|0|||
124959296|NCT01313299|449477480|FG002|Overall Study|Protocol Violation|0|||
124959297|NCT01313299|449477478|FG000|Overall Study|Withdrawal by Subject|1|||
124959298|NCT01313299|449477479|FG001|Overall Study|Withdrawal by Subject|0|||
124959299|NCT01313299|449477480|FG002|Overall Study|Withdrawal by Subject|2|||
124959300|NCT01313299|449477478|FG000|Overall Study|Family reason and moved out of state|0|||
124959301|NCT01313299|449477479|FG001|Overall Study|Family reason and moved out of state|2|||
124959302|NCT01313299|449477480|FG002|Overall Study|Family reason and moved out of state|0|||
124959303|NCT01313299|449477478|FG000|Overall Study|Lack of subject compliance|0|||
124959304|NCT01313299|449477479|FG001|Overall Study|Lack of subject compliance|0|||
124959305|NCT01313299|449477480|FG002|Overall Study|Lack of subject compliance|1|||
124959306|NCT04089332|449477484|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
124959307|NCT04089332|449477484|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
124959308|NCT04089332|449477484|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
124959309|NCT00050167|449477485|FG000|Overall Study|not eligible not invasive|1|||
124959310|NCT00050167|449477486|FG001|Overall Study|not eligible not invasive|1|||
124959311|NCT04754594|449477490|FG000|Blinded Period|Withdrawal by Subject|4|||
124959312|NCT04754594|449477491|FG001|Blinded Period|Withdrawal by Subject|9|||
124959313|NCT04754594|449477492|FG002|Blinded Period|Withdrawal by Subject|0|||
124959314|NCT04754594|449477493|FG003|Blinded Period|Withdrawal by Subject|0|||
124959315|NCT04754594|449477490|FG000|Blinded Period|Protocol Violation|2|||
124959316|NCT04754594|449477491|FG001|Blinded Period|Protocol Violation|2|||
124959317|NCT04754594|449477492|FG002|Blinded Period|Protocol Violation|0|||
124959318|NCT04754594|449477493|FG003|Blinded Period|Protocol Violation|0|||
124959319|NCT04754594|449477490|FG000|Blinded Period|Lost to Follow-up|1|||
124959320|NCT04754594|449477491|FG001|Blinded Period|Lost to Follow-up|1|||
124959321|NCT04754594|449477492|FG002|Blinded Period|Lost to Follow-up|0|||
124959322|NCT04754594|449477493|FG003|Blinded Period|Lost to Follow-up|0|||
124959323|NCT04754594|449477490|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
124959324|NCT04754594|449477491|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
124959325|NCT04754594|449477492|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
124959326|NCT04754594|449477493|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
124959327|NCT04754594|449477490|FG000|Unblinded Period|Withdrawal by Subject|6|||
124959328|NCT04754594|449477491|FG001|Unblinded Period|Withdrawal by Subject|8|||
124959329|NCT04754594|449477492|FG002|Unblinded Period|Withdrawal by Subject|0|||
124959330|NCT04754594|449477493|FG003|Unblinded Period|Withdrawal by Subject|0|||
124959331|NCT04754594|449477490|FG000|Unblinded Period|Lost to Follow-up|5|||
124959332|NCT04754594|449477491|FG001|Unblinded Period|Lost to Follow-up|3|||
124959333|NCT04754594|449477492|FG002|Unblinded Period|Lost to Follow-up|0|||
124959334|NCT04754594|449477493|FG003|Unblinded Period|Lost to Follow-up|0|||
124959335|NCT04754594|449477490|FG000|Unblinded Period|Protocol Violation|2|||
124959336|NCT04754594|449477491|FG001|Unblinded Period|Protocol Violation|4|||
124959337|NCT04754594|449477492|FG002|Unblinded Period|Protocol Violation|0|||
124959338|NCT04754594|449477493|FG003|Unblinded Period|Protocol Violation|0|||
124708064|NCT02114177|448557300|FG000|Overall Study|Withdrawal by Subject|6|||
124708065|NCT02114177|448557301|FG001|Overall Study|Withdrawal by Subject|1|||
124708066|NCT02114177|448557300|FG000|Overall Study|Other|2|||
124708067|NCT02114177|448557301|FG001|Overall Study|Other|1|||
124708068|NCT00140140|448557305|FG000|Overall Study|Unacceptable toxicity|1|||
124959339|NCT04754594|449477490|FG000|Unblinded Period|Other|3|||
124959340|NCT04754594|449477491|FG001|Unblinded Period|Other|0|||
124959341|NCT04754594|449477492|FG002|Unblinded Period|Other|0|||
124708069|NCT00140140|448557306|FG001|Overall Study|Unacceptable toxicity|1|||
124959342|NCT04754594|449477493|FG003|Unblinded Period|Other|0|||
124959343|NCT04754594|449477490|FG000|Infant Participants|Withdrawal by Subject|0|||
124959344|NCT04754594|449477491|FG001|Infant Participants|Withdrawal by Subject|0|||
124959345|NCT04754594|449477492|FG002|Infant Participants|Withdrawal by Subject|9|||
124959346|NCT04754594|449477493|FG003|Infant Participants|Withdrawal by Subject|17|||
124959347|NCT04754594|449477490|FG000|Infant Participants|Lost to Follow-up|0|||
124959348|NCT04754594|449477491|FG001|Infant Participants|Lost to Follow-up|0|||
124959349|NCT04754594|449477492|FG002|Infant Participants|Lost to Follow-up|4|||
124959350|NCT04754594|449477493|FG003|Infant Participants|Lost to Follow-up|10|||
124959351|NCT04754594|449477490|FG000|Infant Participants|Death|0|||
124959352|NCT04754594|449477491|FG001|Infant Participants|Death|0|||
124766715|NCT01383928|448773764|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
124766716|NCT03651765|448773769|FG000|Overall Study|Adverse Event|6|||
124766717|NCT03651765|448773769|FG000|Overall Study|Lack of Efficacy|18|||
124766718|NCT03651765|448773769|FG000|Overall Study|Lost to Follow-up|5|||
124766719|NCT03651765|448773769|FG000|Overall Study|Non-Compliance with Study Drug|4|||
124766720|NCT03651765|448773769|FG000|Overall Study|Physician Decision|6|||
124959353|NCT04754594|449477492|FG002|Infant Participants|Death|1|||
124959354|NCT04754594|449477493|FG003|Infant Participants|Death|1|||
124959355|NCT04754594|449477490|FG000|Infant Participants|Other|0|||
124959356|NCT04754594|449477491|FG001|Infant Participants|Other|0|||
124959357|NCT04754594|449477492|FG002|Infant Participants|Other|1|||
124959358|NCT04754594|449477493|FG003|Infant Participants|Other|1|||
124959359|NCT03340766|449477496|FG000|Overall Study|Withdrawal by Subject|2|||
124959360|NCT03340766|449477497|FG001|Overall Study|Withdrawal by Subject|1|||
124959361|NCT03340766|449477498|FG002|Overall Study|Withdrawal by Subject|3|||
124959362|NCT03340766|449477496|FG000|Overall Study|Lost to Follow-up|0|||
124959363|NCT03340766|449477497|FG001|Overall Study|Lost to Follow-up|0|||
124766721|NCT03651765|448773769|FG000|Overall Study|Pregnancy|1|||
124766722|NCT03651765|448773769|FG000|Overall Study|Discontinued by Sponsor|40|||
124766723|NCT03651765|448773769|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
124766724|NCT03651765|448773769|FG000|Overall Study|Withdrawal by Subject|24|||
124766725|NCT03651765|448773769|FG000|Overall Study|Miscellaneous|6|||
124766726|NCT04842747|448773779|FG000|Overall Study|Withdrawal by Subject|6|||
124766727|NCT04842747|448773780|FG001|Overall Study|Withdrawal by Subject|2|||
124766728|NCT04842747|448773779|FG000|Overall Study|Lost to Follow-up|1|||
124766729|NCT04842747|448773780|FG001|Overall Study|Lost to Follow-up|2|||
124766730|NCT04842747|448773779|FG000|Overall Study|Physician Decision|1|||
124766731|NCT04842747|448773780|FG001|Overall Study|Physician Decision|0|||
124766732|NCT04842747|448773779|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
124766733|NCT04842747|448773780|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
124766734|NCT01743469|448773781|FG000|Active Treatment Phase|Adverse Event|10|||
124766735|NCT01743469|448773782|FG001|Active Treatment Phase|Adverse Event|5|||
124766736|NCT01743469|448773783|FG002|Active Treatment Phase|Adverse Event|8|||
124766737|NCT01743469|448773784|FG003|Active Treatment Phase|Adverse Event|1|||
124766738|NCT01743469|448773781|FG000|Active Treatment Phase|Disease Progression|40|||
124766739|NCT01743469|448773782|FG001|Active Treatment Phase|Disease Progression|47|||
124766740|NCT01743469|448773783|FG002|Active Treatment Phase|Disease Progression|30|||
124766741|NCT01743469|448773784|FG003|Active Treatment Phase|Disease Progression|20|||
124766742|NCT01743469|448773781|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
124766743|NCT01743469|448773782|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
124766744|NCT01743469|448773783|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
124766745|NCT01743469|448773784|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
124766746|NCT01743469|448773781|FG000|Active Treatment Phase|Missing|1|||
124766747|NCT01743469|448773782|FG001|Active Treatment Phase|Missing|0|||
124766748|NCT01743469|448773783|FG002|Active Treatment Phase|Missing|0|||
124766749|NCT01743469|448773784|FG003|Active Treatment Phase|Missing|0|||
124766750|NCT01743469|448773781|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
124766751|NCT01743469|448773782|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
124766752|NCT01743469|448773783|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
124766753|NCT01743469|448773784|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
124766754|NCT01743469|448773781|FG000|Follow-up Period - Post-Treatment|Death|43|||
124766755|NCT01743469|448773782|FG001|Follow-up Period - Post-Treatment|Death|47|||
124766756|NCT01743469|448773783|FG002|Follow-up Period - Post-Treatment|Death|22|||
124766757|NCT01743469|448773784|FG003|Follow-up Period - Post-Treatment|Death|16|||
124766758|NCT01743469|448773781|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
124766759|NCT01743469|448773782|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
124766760|NCT01743469|448773783|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
124766761|NCT01743469|448773784|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
124766762|NCT01451606|448773785|FG000|Overall Study|Withdrawal by Subject|4|||
124766763|NCT01451606|448773786|FG001|Overall Study|Withdrawal by Subject|3|||
124959364|NCT03340766|449477498|FG002|Overall Study|Lost to Follow-up|1|||
124959365|NCT03340766|449477496|FG000|Overall Study|Death|6|||
124959366|NCT03340766|449477497|FG001|Overall Study|Death|7|||
124959367|NCT03340766|449477498|FG002|Overall Study|Death|4|||
124959368|NCT02849509|449477501|FG000|Overall Study|Worsening of disease under study|1|||
124959369|NCT02849509|449477502|FG001|Overall Study|Worsening of disease under study|1|||
124959370|NCT02849509|449477503|FG002|Overall Study|Worsening of disease under study|1|||
124959371|NCT02849509|449477501|FG000|Overall Study|Worsening of other pre-existing disease|0|||
124959372|NCT02849509|449477502|FG001|Overall Study|Worsening of other pre-existing disease|1|||
124959373|NCT02849509|449477503|FG002|Overall Study|Worsening of other pre-existing disease|2|||
124959374|NCT02849509|449477501|FG000|Overall Study|Other adverse event|36|||
124959375|NCT02849509|449477502|FG001|Overall Study|Other adverse event|41|||
124959376|NCT02849509|449477503|FG002|Overall Study|Other adverse event|8|||
124959377|NCT02849509|449477501|FG000|Overall Study|Withdrawal by Subject|6|||
124959378|NCT02849509|449477502|FG001|Overall Study|Withdrawal by Subject|17|||
124959379|NCT02849509|449477503|FG002|Overall Study|Withdrawal by Subject|12|||
124959380|NCT02849509|449477501|FG000|Overall Study|Lost to Follow-up|27|||
124959381|NCT02849509|449477502|FG001|Overall Study|Lost to Follow-up|67|||
124959382|NCT02849509|449477503|FG002|Overall Study|Lost to Follow-up|36|||
124959383|NCT02849509|449477501|FG000|Overall Study|Other, reason not specified|14|||
124959384|NCT02849509|449477502|FG001|Overall Study|Other, reason not specified|29|||
124959385|NCT02849509|449477503|FG002|Overall Study|Other, reason not specified|25|||
124959386|NCT02849509|449477501|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
124959387|NCT02849509|449477502|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
124959388|NCT02849509|449477503|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
124959389|NCT02256488|449477504|FG000|Overall Study|Lost to Follow-up|6|||
124959390|NCT02256488|449477505|FG001|Overall Study|Lost to Follow-up|6|||
124959391|NCT02256488|449477506|FG002|Overall Study|Lost to Follow-up|9|||
124959392|NCT02256488|449477507|FG003|Overall Study|Lost to Follow-up|3|||
124959393|NCT02256488|449477504|FG000|Overall Study|OTHER|1|||
124959394|NCT02256488|449477505|FG001|Overall Study|OTHER|0|||
124959395|NCT02256488|449477506|FG002|Overall Study|OTHER|1|||
124959396|NCT02256488|449477507|FG003|Overall Study|OTHER|1|||
124959397|NCT02256488|449477504|FG000|Overall Study|Withdrawal by Subject|1|||
124959398|NCT02256488|449477505|FG001|Overall Study|Withdrawal by Subject|0|||
124959399|NCT02256488|449477506|FG002|Overall Study|Withdrawal by Subject|0|||
124959400|NCT02256488|449477507|FG003|Overall Study|Withdrawal by Subject|2|||
124959401|NCT02864147|449477511|FG000|Overall Study|Withdrawal by Subject|3|||
124959402|NCT02864147|449477512|FG001|Overall Study|Withdrawal by Subject|2|||
124708070|NCT00140140|448557307|FG002|Overall Study|Unacceptable toxicity|2|||
124708071|NCT00140140|448557305|FG000|Overall Study|Physician Decision|1|||
124708072|NCT00140140|448557306|FG001|Overall Study|Physician Decision|1|||
124708073|NCT00140140|448557307|FG002|Overall Study|Physician Decision|0|||
124708074|NCT03376516|448557308|FG000|Overall Study|Not treated|1|||
124708075|NCT03376516|448557308|FG000|Overall Study|Consent withdrawn|1|||
124708076|NCT01359956|448557309|FG000|Overall Study|Death|58|||
124708077|NCT01359956|448557310|FG001|Overall Study|Death|60|||
124708078|NCT01359956|448557311|FG002|Overall Study|Death|66|||
124708079|NCT01359956|448557312|FG003|Overall Study|Death|57|||
124708080|NCT01359956|448557309|FG000|Overall Study|Lost to Follow-up|3|||
124708081|NCT01359956|448557310|FG001|Overall Study|Lost to Follow-up|4|||
124708082|NCT01359956|448557311|FG002|Overall Study|Lost to Follow-up|1|||
124708083|NCT01359956|448557312|FG003|Overall Study|Lost to Follow-up|1|||
124708084|NCT01784029|448557313|FG000|Overall Study|Lost to Follow-up|19|||
124708085|NCT01784029|448557314|FG001|Overall Study|Lost to Follow-up|20|||
124708086|NCT01784029|448557315|FG002|Overall Study|Lost to Follow-up|22|||
124708087|NCT00582907|448557316|FG000|1st Course|Withdrawal by Subject|1|||
124708088|NCT00582907|448557317|FG001|1st Course|Withdrawal by Subject|0|||
124708089|NCT00582907|448557318|FG002|1st Course|Withdrawal by Subject|0|||
124708090|NCT00582907|448557319|FG003|1st Course|Withdrawal by Subject|0|||
124708091|NCT00582907|448557316|FG000|1st Course|Lost to Follow-up|0|||
124708092|NCT00582907|448557317|FG001|1st Course|Lost to Follow-up|0|||
124708093|NCT00582907|448557318|FG002|1st Course|Lost to Follow-up|0|||
124708094|NCT00582907|448557319|FG003|1st Course|Lost to Follow-up|1|||
124708095|NCT00582907|448557316|FG000|2nd Course|Lack of Efficacy|1|||
124708096|NCT00582907|448557317|FG001|2nd Course|Lack of Efficacy|0|||
124708097|NCT00582907|448557318|FG002|2nd Course|Lack of Efficacy|0|||
124708098|NCT00582907|448557319|FG003|2nd Course|Lack of Efficacy|0|||
124708099|NCT03610048|448557326|FG000|Overall Study|Study terminated by sponsor|84|||
124708100|NCT03610048|448557326|FG000|Overall Study|Adverse Event|32|||
124959403|NCT02864147|449477513|FG002|Overall Study|Withdrawal by Subject|1|||
124959404|NCT02864147|449477511|FG000|Overall Study|Lost to Follow-up|0|||
124959405|NCT02864147|449477512|FG001|Overall Study|Lost to Follow-up|4|||
124959406|NCT02864147|449477513|FG002|Overall Study|Lost to Follow-up|0|||
124708101|NCT03610048|448557326|FG000|Overall Study|Withdrawal by Subject|31|||
124708102|NCT03610048|448557326|FG000|Overall Study|Lost to Follow-up|8|||
124708103|NCT03610048|448557326|FG000|Overall Study|Other|4|||
124708104|NCT03610048|448557326|FG000|Overall Study|Physician Decision|1|||
124708105|NCT03610048|448557326|FG000|Overall Study|Pregnancy|1|||
124708106|NCT01155050|448557327|FG000|Overall Study|Lost to Follow-up|15|||
124708107|NCT01155050|448557328|FG001|Overall Study|Lost to Follow-up|20|||
124708108|NCT01155050|448557329|FG002|Overall Study|Lost to Follow-up|19|||
124708109|NCT01155050|448557330|FG003|Overall Study|Lost to Follow-up|22|||
124959407|NCT02864147|449477511|FG000|Overall Study|Adverse Event|0|||
124959408|NCT02864147|449477512|FG001|Overall Study|Adverse Event|1|||
124959409|NCT02864147|449477513|FG002|Overall Study|Adverse Event|0|||
124959410|NCT02864147|449477511|FG000|Overall Study|Pregnancy|4|||
124959411|NCT02864147|449477512|FG001|Overall Study|Pregnancy|0|||
124959412|NCT02864147|449477513|FG002|Overall Study|Pregnancy|0|||
124959413|NCT02864147|449477511|FG000|Overall Study|Physician Decision|0|||
124959414|NCT02864147|449477512|FG001|Overall Study|Physician Decision|0|||
124959415|NCT02864147|449477513|FG002|Overall Study|Physician Decision|1|||
124959416|NCT02864147|449477511|FG000|Overall Study|Opted for excisional procedures|0|||
124959417|NCT02864147|449477512|FG001|Overall Study|Opted for excisional procedures|0|||
124959418|NCT02864147|449477513|FG002|Overall Study|Opted for excisional procedures|3|||
124463473|NCT01783678|447656511|FG002|Overall Study|Lost to Follow-up|0|||
124708110|NCT01146613|448557332|FG000|Overall Study|Lost to Follow-up|3|||
124708111|NCT01146613|448557333|FG001|Overall Study|Lost to Follow-up|8|||
124708112|NCT01146613|448557332|FG000|Overall Study|Lack of Efficacy|0|||
124708113|NCT01146613|448557333|FG001|Overall Study|Lack of Efficacy|1|||
124708114|NCT01146613|448557332|FG000|Overall Study|Death|1|||
124708115|NCT01146613|448557333|FG001|Overall Study|Death|0|||
124708116|NCT01146613|448557332|FG000|Overall Study|Physician Decision|1|||
124708117|NCT01146613|448557333|FG001|Overall Study|Physician Decision|0|||
124708118|NCT01146613|448557332|FG000|Overall Study|Withdrawal by Subject|0|||
124708119|NCT01146613|448557333|FG001|Overall Study|Withdrawal by Subject|3|||
124708120|NCT01146613|448557332|FG000|Overall Study|schedule conflict|1|||
124708121|NCT01146613|448557333|FG001|Overall Study|schedule conflict|0|||
124708122|NCT01146613|448557332|FG000|Overall Study|Outpatient detox|1|||
124708123|NCT01146613|448557333|FG001|Overall Study|Outpatient detox|0|||
124708124|NCT01959529|448557334|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
124708125|NCT01959529|448557335|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
124708126|NCT01959529|448557334|FG000|Overall Study|Lost to Follow-up|4|||
124708127|NCT01959529|448557335|FG001|Overall Study|Lost to Follow-up|1|||
124708128|NCT01959529|448557334|FG000|Overall Study|Other|70|||
124708129|NCT01959529|448557335|FG001|Overall Study|Other|68|||
124708130|NCT01959529|448557334|FG000|Overall Study|Hypoglycaemia|1|||
124708131|NCT01959529|448557335|FG001|Overall Study|Hypoglycaemia|1|||
124708132|NCT01959529|448557334|FG000|Overall Study|Lack of glycaemic control|1|||
124708133|NCT01959529|448557335|FG001|Overall Study|Lack of glycaemic control|1|||
124708134|NCT00652834|448557336|FG000|Overall Study|Withdrawal by Subject|3|||
124708135|NCT00652834|448557336|FG000|Overall Study|Lost to Follow-up|2|||
124708136|NCT00854360|448557344|FG000|Overall Study|Adverse Event|0|||
124708137|NCT00854360|448557345|FG001|Overall Study|Adverse Event|1|||
124708138|NCT00854360|448557346|FG002|Overall Study|Adverse Event|2|||
124708139|NCT00854360|448557347|FG003|Overall Study|Adverse Event|6|||
124708140|NCT00854360|448557344|FG000|Overall Study|Withdrawal by Subject|0|||
124708141|NCT00854360|448557345|FG001|Overall Study|Withdrawal by Subject|0|||
124708142|NCT00854360|448557346|FG002|Overall Study|Withdrawal by Subject|0|||
124708143|NCT00854360|448557347|FG003|Overall Study|Withdrawal by Subject|1|||
124708144|NCT00854360|448557344|FG000|Overall Study|Pregnancy|0|||
124708145|NCT00854360|448557345|FG001|Overall Study|Pregnancy|1|||
124708146|NCT00854360|448557346|FG002|Overall Study|Pregnancy|0|||
124708147|NCT00854360|448557347|FG003|Overall Study|Pregnancy|0|||
124708148|NCT00854360|448557344|FG000|Overall Study|Lack of Efficacy|2|||
124708149|NCT00854360|448557345|FG001|Overall Study|Lack of Efficacy|1|||
124708150|NCT00854360|448557346|FG002|Overall Study|Lack of Efficacy|0|||
124708151|NCT00854360|448557347|FG003|Overall Study|Lack of Efficacy|0|||
124708152|NCT00854360|448557344|FG000|Overall Study|Other|0|||
124708153|NCT00854360|448557345|FG001|Overall Study|Other|0|||
124708154|NCT00854360|448557346|FG002|Overall Study|Other|0|||
124708155|NCT00854360|448557347|FG003|Overall Study|Other|3|||
124708156|NCT02441218|448557348|FG000|Overall Study|Death|503|||
124766764|NCT04011540|448773792|FG000|Overall Study|Lost to Follow-up|9|||
124708157|NCT02441218|448557349|FG001|Overall Study|Death|553|||
124708158|NCT02441218|448557348|FG000|Overall Study|Withdrawal by Subject|73|||
124708159|NCT02441218|448557349|FG001|Overall Study|Withdrawal by Subject|58|||
124708160|NCT02441218|448557348|FG000|Overall Study|Lost to Follow-up|2|||
124708161|NCT02441218|448557349|FG001|Overall Study|Lost to Follow-up|1|||
124708162|NCT01541371|448557350|FG000|Overall Study|Withdrawal by Subject|14|||
124708163|NCT01541371|448557350|FG000|Overall Study|Lost to Follow-up|21|||
124708164|NCT01541371|448557350|FG000|Overall Study|Adverse Event|15|||
124708165|NCT01541371|448557350|FG000|Overall Study|Lack of Efficacy|12|||
124708166|NCT01541371|448557350|FG000|Overall Study|Protocol Violation|6|||
124708167|NCT01541371|448557350|FG000|Overall Study|Study medication non-compliance|3|||
124708168|NCT01541371|448557350|FG000|Overall Study|Other|6|||
124708169|NCT02271880|448557354|FG000|Overall Study|Premature discontinuation of study|3|||
124708170|NCT02271880|448557355|FG001|Overall Study|Premature discontinuation of study|4|||
124708171|NCT00806585|448557356|FG000|Overall Study|Study terminated by Sponsor|0|||
124708172|NCT00806585|448557357|FG001|Overall Study|Study terminated by Sponsor|0|||
124959419|NCT00975130|449477514|FG000|Study Part 1|Adverse Event|150|||
124959420|NCT00975130|449477515|FG001|Study Part 1|Adverse Event|0|||
124959421|NCT00975130|449477516|FG002|Study Part 1|Adverse Event|0|||
124959422|NCT00975130|449477514|FG000|Study Part 1|Lost to Follow-up|19|||
124959423|NCT00975130|449477515|FG001|Study Part 1|Lost to Follow-up|0|||
124959424|NCT00975130|449477516|FG002|Study Part 1|Lost to Follow-up|0|||
124959425|NCT00975130|449477514|FG000|Study Part 1|Withdrawal by Subject|61|||
124959426|NCT00975130|449477515|FG001|Study Part 1|Withdrawal by Subject|0|||
124959427|NCT00975130|449477516|FG002|Study Part 1|Withdrawal by Subject|0|||
124959428|NCT00975130|449477514|FG000|Study Part 1|Protocol Violation|13|||
124959429|NCT00975130|449477515|FG001|Study Part 1|Protocol Violation|0|||
124959430|NCT00975130|449477516|FG002|Study Part 1|Protocol Violation|0|||
124959431|NCT00975130|449477514|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
124959432|NCT00975130|449477515|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
124959433|NCT00975130|449477516|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
124766765|NCT04011540|448773793|FG001|Overall Study|Lost to Follow-up|6|||
124766766|NCT02138890|448773798|FG000|Overall Study|Adverse Event|1|||
124766767|NCT02138890|448773799|FG001|Overall Study|Adverse Event|0|||
124766768|NCT01446159|448773800|FG000|Overall Study|Withdrawal by Subject|1|||
124766769|NCT01446159|448773801|FG001|Overall Study|Withdrawal by Subject|0|||
124766770|NCT01446159|448773802|FG002|Overall Study|Withdrawal by Subject|14|||
124766771|NCT01446159|448773803|FG003|Overall Study|Withdrawal by Subject|11|||
124766772|NCT01446159|448773800|FG000|Overall Study|Lost to Follow-up|0|||
124766773|NCT01446159|448773801|FG001|Overall Study|Lost to Follow-up|0|||
124766774|NCT01446159|448773802|FG002|Overall Study|Lost to Follow-up|1|||
124766775|NCT01446159|448773803|FG003|Overall Study|Lost to Follow-up|2|||
124766776|NCT01446159|448773800|FG000|Overall Study|Death|2|||
124766777|NCT01446159|448773801|FG001|Overall Study|Death|3|||
124766778|NCT01446159|448773802|FG002|Overall Study|Death|43|||
124766779|NCT01446159|448773803|FG003|Overall Study|Death|36|||
124766780|NCT01446159|448773800|FG000|Overall Study|Other|0|||
124766781|NCT01446159|448773801|FG001|Overall Study|Other|0|||
124766782|NCT01446159|448773802|FG002|Overall Study|Other|13|||
124766783|NCT01446159|448773803|FG003|Overall Study|Other|13|||
124766784|NCT03668873|448773804|FG000|Overall Study|Lost to Follow-up|6|||
124766785|NCT03668873|448773805|FG001|Overall Study|Lost to Follow-up|3|||
124766786|NCT02183675|448773806|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
124766787|NCT02183675|448773807|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
124766788|NCT02183675|448773808|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
124766789|NCT02183675|448773809|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
124766790|NCT02183675|448773810|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
124766791|NCT02183675|448773811|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
124766792|NCT01521117|448773812|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
124766793|NCT01521117|448773813|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
124766794|NCT01521117|448773812|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
124766795|NCT01521117|448773813|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
124766796|NCT01521117|448773812|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
124766797|NCT01521117|448773813|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
124766798|NCT00795535|448773818|FG000|Overall Study|incomplete data and technical problems|20|||
124766799|NCT04576988|448773819|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
124766800|NCT04576988|448773820|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
124766801|NCT04576988|448773819|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
124766802|NCT04576988|448773820|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
124766803|NCT04576988|448773819|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
124766804|NCT04576988|448773820|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
124766805|NCT04576988|448773819|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
124766806|NCT04576988|448773820|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
124766807|NCT04576988|448773819|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
124766808|NCT04576988|448773820|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
124766809|NCT04576988|448773819|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
124766810|NCT04576988|448773820|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
124766811|NCT04576988|448773819|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
124959434|NCT00975130|449477514|FG000|Study Part 1|Administrative|4|||
124959435|NCT00975130|449477515|FG001|Study Part 1|Administrative|0|||
124959436|NCT00975130|449477516|FG002|Study Part 1|Administrative|0|||
124959437|NCT00975130|449477514|FG000|Study Part 1|Withdrew Consent|24|||
124959438|NCT00975130|449477515|FG001|Study Part 1|Withdrew Consent|0|||
124766812|NCT04576988|448773820|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
124766813|NCT04576988|448773819|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
124766814|NCT04576988|448773820|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
124766815|NCT04576988|448773819|FG000|Long Term Double Blind (LTDB)|Death|2|||
124959439|NCT00975130|449477516|FG002|Study Part 1|Withdrew Consent|0|||
124959440|NCT00975130|449477514|FG000|Study Part 2|Adverse Event|0|||
124959441|NCT00975130|449477515|FG001|Study Part 2|Adverse Event|14|||
124959442|NCT00975130|449477516|FG002|Study Part 2|Adverse Event|7|||
124959443|NCT00975130|449477514|FG000|Study Part 2|Lost to Follow-up|0|||
124959444|NCT00975130|449477515|FG001|Study Part 2|Lost to Follow-up|0|||
124959445|NCT00975130|449477516|FG002|Study Part 2|Lost to Follow-up|1|||
124959446|NCT00975130|449477514|FG000|Study Part 2|Withdrawal by Subject|0|||
124959447|NCT00975130|449477515|FG001|Study Part 2|Withdrawal by Subject|13|||
124959448|NCT00975130|449477516|FG002|Study Part 2|Withdrawal by Subject|5|||
124959449|NCT00975130|449477514|FG000|Study Part 2|Withdrew Consent|0|||
124959450|NCT00975130|449477515|FG001|Study Part 2|Withdrew Consent|6|||
124959451|NCT00975130|449477516|FG002|Study Part 2|Withdrew Consent|2|||
124959452|NCT00975130|449477514|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
124959453|NCT00975130|449477515|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
124959454|NCT00975130|449477516|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
124959455|NCT00975130|449477514|FG000|Study Part 2|Administrative|0|||
124959456|NCT00975130|449477515|FG001|Study Part 2|Administrative|1|||
124959457|NCT00975130|449477516|FG002|Study Part 2|Administrative|0|||
124959458|NCT00975130|449477514|FG000|Study Part 2|Protocol Violation|0|||
124959459|NCT00975130|449477515|FG001|Study Part 2|Protocol Violation|0|||
124959460|NCT00975130|449477516|FG002|Study Part 2|Protocol Violation|1|||
124959461|NCT00240097|449477517|FG000|Part I|Adverse Event|1|||
124959462|NCT00240097|449477517|FG000|Part I|Death|1|||
124959463|NCT00240097|449477517|FG000|Part I|histology|1|||
124959464|NCT00240097|449477517|FG000|Part I|unevaluable|1|||
124959465|NCT00240097|449477517|FG000|Part II|did not continue from Part I|23|||
124959466|NCT02383927|449477518|FG000|Overall Study|Disease Progression|8|||
124959467|NCT02383927|449477519|FG001|Overall Study|Disease Progression|8|||
124959468|NCT02383927|449477520|FG002|Overall Study|Disease Progression|15|||
124959469|NCT02383927|449477521|FG003|Overall Study|Disease Progression|4|||
124959470|NCT02383927|449477518|FG000|Overall Study|Physician Decision|0|||
124959471|NCT02383927|449477519|FG001|Overall Study|Physician Decision|0|||
124959472|NCT02383927|449477520|FG002|Overall Study|Physician Decision|2|||
124959473|NCT02383927|449477521|FG003|Overall Study|Physician Decision|0|||
124959474|NCT02383927|449477518|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
124959475|NCT02383927|449477519|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
124959476|NCT02383927|449477520|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
124959477|NCT02383927|449477521|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
124959478|NCT02383927|449477518|FG000|Overall Study|Adverse Event|4|||
124959479|NCT02383927|449477519|FG001|Overall Study|Adverse Event|1|||
124959480|NCT02383927|449477520|FG002|Overall Study|Adverse Event|3|||
124959481|NCT02383927|449477521|FG003|Overall Study|Adverse Event|5|||
124959482|NCT02383927|449477518|FG000|Overall Study|Miscellaneous|1|||
124959483|NCT02383927|449477519|FG001|Overall Study|Miscellaneous|0|||
124959484|NCT02383927|449477520|FG002|Overall Study|Miscellaneous|0|||
124959485|NCT02383927|449477521|FG003|Overall Study|Miscellaneous|1|||
124959486|NCT02383927|449477518|FG000|Overall Study|Withdrawal by Subject|0|||
124959487|NCT02383927|449477519|FG001|Overall Study|Withdrawal by Subject|1|||
124959488|NCT02383927|449477520|FG002|Overall Study|Withdrawal by Subject|4|||
124959489|NCT02383927|449477521|FG003|Overall Study|Withdrawal by Subject|0|||
124959490|NCT00734851|449477522|FG000|Overall Study|Withdrawal by Subject|2|||
124959491|NCT00734851|449477522|FG000|Overall Study|Lost to Follow-up|1|||
124766816|NCT04576988|448773820|FG001|Long Term Double Blind (LTDB)|Death|1|||
124766817|NCT04576988|448773819|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
124708173|NCT00806585|448557358|FG002|Overall Study|Study terminated by Sponsor|1|||
124708174|NCT00806585|448557359|FG003|Overall Study|Study terminated by Sponsor|2|||
124708175|NCT00806585|448557360|FG004|Overall Study|Study terminated by Sponsor|0|||
124708176|NCT00806585|448557356|FG000|Overall Study|Protocol Violation|3|||
124708177|NCT00806585|448557357|FG001|Overall Study|Protocol Violation|1|||
124708178|NCT00806585|448557358|FG002|Overall Study|Protocol Violation|2|||
124708179|NCT00806585|448557359|FG003|Overall Study|Protocol Violation|0|||
124708180|NCT00806585|448557360|FG004|Overall Study|Protocol Violation|0|||
124708181|NCT00806585|448557356|FG000|Overall Study|Physician Decision|0|||
124708182|NCT00806585|448557357|FG001|Overall Study|Physician Decision|2|||
124708183|NCT00806585|448557358|FG002|Overall Study|Physician Decision|3|||
124708184|NCT00806585|448557359|FG003|Overall Study|Physician Decision|0|||
124766818|NCT04576988|448773820|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
124959492|NCT00734851|449477522|FG000|Overall Study|Physician Decision|18|||
124959493|NCT03562117|449477525|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
124959494|NCT03562117|449477526|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
124959495|NCT03562117|449477527|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
124959496|NCT01294358|449477528|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
124959497|NCT01294358|449477529|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
124959498|NCT01294358|449477530|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
124708185|NCT00806585|448557360|FG004|Overall Study|Physician Decision|1|||
124708186|NCT00806585|448557356|FG000|Overall Study|Lost to Follow-up|2|||
124708187|NCT00806585|448557357|FG001|Overall Study|Lost to Follow-up|1|||
124708188|NCT00806585|448557358|FG002|Overall Study|Lost to Follow-up|2|||
124959499|NCT01294358|449477531|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
124959500|NCT01294358|449477532|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
124959501|NCT01294358|449477528|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
124959502|NCT01294358|449477529|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
124959503|NCT01294358|449477530|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
124959504|NCT01294358|449477531|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
124959505|NCT01294358|449477532|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
124959506|NCT01294358|449477528|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
124959507|NCT01294358|449477529|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
124959508|NCT01294358|449477530|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
124959509|NCT01294358|449477531|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
124766819|NCT01844765|448773821|FG000|Overall Study|Adverse Event|6|||
124766820|NCT01844765|448773822|FG001|Overall Study|Adverse Event|8|||
124766821|NCT01844765|448773821|FG000|Overall Study|Withdrawal by Subject|2|||
124766822|NCT01844765|448773822|FG001|Overall Study|Withdrawal by Subject|3|||
124766823|NCT01844765|448773821|FG000|Overall Study|Disease progression|1|||
124766824|NCT01844765|448773822|FG001|Overall Study|Disease progression|0|||
124766825|NCT01844765|448773821|FG000|Overall Study|Administrative problems|3|||
124766826|NCT01844765|448773822|FG001|Overall Study|Administrative problems|4|||
124766827|NCT01844765|448773821|FG000|Overall Study|Protocol deviation|2|||
124766828|NCT01844765|448773822|FG001|Overall Study|Protocol deviation|0|||
124766829|NCT01844765|448773821|FG000|Overall Study|Untreated|1|||
124766830|NCT01844765|448773822|FG001|Overall Study|Untreated|0|||
124766831|NCT00617734|448773823|FG000|Overall Study|Withdrew Consent|2|||
124766832|NCT00617734|448773824|FG001|Overall Study|Withdrew Consent|0|||
124766833|NCT00617734|448773823|FG000|Overall Study|Adverse Event|4|||
124766834|NCT00617734|448773824|FG001|Overall Study|Adverse Event|1|||
124766835|NCT00617734|448773823|FG000|Overall Study|Protocol Violation|1|||
124766836|NCT00617734|448773824|FG001|Overall Study|Protocol Violation|0|||
124766837|NCT00617734|448773823|FG000|Overall Study|Found Ineligible After Randomization|1|||
124766838|NCT00617734|448773824|FG001|Overall Study|Found Ineligible After Randomization|4|||
124766839|NCT00617734|448773823|FG000|Overall Study|Lost to Follow-up|0|||
124766840|NCT00617734|448773824|FG001|Overall Study|Lost to Follow-up|1|||
124766841|NCT00556075|448773830|FG000|Overall Study|Lost to Follow-up|3|||
124766842|NCT00556075|448773831|FG001|Overall Study|Lost to Follow-up|0|||
124766843|NCT00556075|448773832|FG002|Overall Study|Lost to Follow-up|3|||
124766844|NCT00556075|448773830|FG000|Overall Study|Withdrawal by Subject|3|||
124766845|NCT00556075|448773831|FG001|Overall Study|Withdrawal by Subject|3|||
124766846|NCT00556075|448773832|FG002|Overall Study|Withdrawal by Subject|0|||
124766847|NCT00556075|448773830|FG000|Overall Study|Protocol Violation|1|||
124766848|NCT00556075|448773831|FG001|Overall Study|Protocol Violation|1|||
124766849|NCT00556075|448773832|FG002|Overall Study|Protocol Violation|3|||
124766850|NCT00556075|448773830|FG000|Overall Study|Not eligible|1|||
124766851|NCT00556075|448773831|FG001|Overall Study|Not eligible|1|||
124766852|NCT00556075|448773832|FG002|Overall Study|Not eligible|2|||
124766853|NCT00556075|448773830|FG000|Overall Study|Adverse Event|1|||
124766854|NCT00556075|448773831|FG001|Overall Study|Adverse Event|2|||
124766855|NCT00556075|448773832|FG002|Overall Study|Adverse Event|0|||
124766856|NCT00556075|448773830|FG000|Overall Study|Personal issues|4|||
124766857|NCT00556075|448773831|FG001|Overall Study|Personal issues|1|||
124766858|NCT00556075|448773832|FG002|Overall Study|Personal issues|0|||
124766859|NCT00556075|448773830|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
124766860|NCT00556075|448773831|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
124766861|NCT00556075|448773832|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
124766862|NCT02485691|448773833|FG000|Overall Study|Adverse Event|25|||
124766863|NCT02485691|448773834|FG001|Overall Study|Adverse Event|11|||
124766864|NCT02485691|448773833|FG000|Overall Study|Poor compliance to protocol|0|||
124766865|NCT02485691|448773834|FG001|Overall Study|Poor compliance to protocol|1|||
124766866|NCT02485691|448773833|FG000|Overall Study|Disease progression|57|||
124766867|NCT02485691|448773834|FG001|Overall Study|Disease progression|92|||
124766868|NCT02485691|448773833|FG000|Overall Study|Investigator's decision|23|||
124766869|NCT02485691|448773834|FG001|Overall Study|Investigator's decision|5|||
124766870|NCT02485691|448773833|FG000|Overall Study|Participant's request|13|||
124766871|NCT02485691|448773834|FG001|Overall Study|Participant's request|6|||
124766872|NCT02485691|448773833|FG000|Overall Study|Other reason|8|||
124766873|NCT02485691|448773834|FG001|Overall Study|Other reason|9|||
124766874|NCT02485691|448773833|FG000|Overall Study|Randomized and not treated|3|||
124766875|NCT02485691|448773834|FG001|Overall Study|Randomized and not treated|2|||
124766876|NCT00604565|448773835|FG000|Overall Study|Study terminated|0|||
124766877|NCT00604565|448773836|FG001|Overall Study|Study terminated|3|||
124766878|NCT04292535|448773837|FG000|Overall Study|Withdrawal by Subject|0|||
124766879|NCT04292535|448773838|FG001|Overall Study|Withdrawal by Subject|0|||
124766880|NCT04292535|448773839|FG002|Overall Study|Withdrawal by Subject|0|||
124766881|NCT04292535|448773840|FG003|Overall Study|Withdrawal by Subject|0|||
124766882|NCT04292535|448773841|FG004|Overall Study|Withdrawal by Subject|0|||
124766883|NCT04292535|448773842|FG005|Overall Study|Withdrawal by Subject|0|||
124766884|NCT04292535|448773843|FG006|Overall Study|Withdrawal by Subject|0|||
124766885|NCT04292535|448773844|FG007|Overall Study|Withdrawal by Subject|1|||
124766886|NCT04292535|448773845|FG008|Overall Study|Withdrawal by Subject|0|||
124766887|NCT04292535|448773846|FG009|Overall Study|Withdrawal by Subject|0|||
124766888|NCT04292535|448773847|FG010|Overall Study|Withdrawal by Subject|0|||
124766889|NCT04292535|448773848|FG011|Overall Study|Withdrawal by Subject|0|||
124766890|NCT04292535|448773849|FG012|Overall Study|Withdrawal by Subject|0|||
124766891|NCT04292535|448773850|FG013|Overall Study|Withdrawal by Subject|0|||
124766892|NCT04292535|448773837|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
124766893|NCT04292535|448773838|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
124766894|NCT04292535|448773839|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
124766895|NCT04292535|448773840|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
124766896|NCT04292535|448773841|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
124766897|NCT04292535|448773842|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
124766898|NCT04292535|448773843|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
124766899|NCT04292535|448773844|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
124766900|NCT04292535|448773845|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
124766901|NCT04292535|448773846|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
124766902|NCT04292535|448773847|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
124766903|NCT04292535|448773848|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
124766904|NCT04292535|448773849|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
124766905|NCT04292535|448773850|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
124766906|NCT04292535|448773837|FG000|Overall Study|Report of Dizziness|0|||
124766907|NCT04292535|448773838|FG001|Overall Study|Report of Dizziness|0|||
124766908|NCT04292535|448773839|FG002|Overall Study|Report of Dizziness|0|||
124766909|NCT04292535|448773840|FG003|Overall Study|Report of Dizziness|0|||
124766910|NCT04292535|448773841|FG004|Overall Study|Report of Dizziness|0|||
124766911|NCT04292535|448773842|FG005|Overall Study|Report of Dizziness|0|||
124766912|NCT04292535|448773843|FG006|Overall Study|Report of Dizziness|0|||
124766913|NCT04292535|448773844|FG007|Overall Study|Report of Dizziness|0|||
124766914|NCT04292535|448773845|FG008|Overall Study|Report of Dizziness|0|||
124766915|NCT04292535|448773846|FG009|Overall Study|Report of Dizziness|0|||
124766916|NCT04292535|448773847|FG010|Overall Study|Report of Dizziness|0|||
124766917|NCT04292535|448773848|FG011|Overall Study|Report of Dizziness|0|||
124766918|NCT04292535|448773849|FG012|Overall Study|Report of Dizziness|0|||
124766919|NCT04292535|448773850|FG013|Overall Study|Report of Dizziness|1|||
124766920|NCT04292535|448773837|FG000|Overall Study|Equipment Failure|0|||
124766921|NCT04292535|448773838|FG001|Overall Study|Equipment Failure|0|||
124766922|NCT04292535|448773839|FG002|Overall Study|Equipment Failure|0|||
124766923|NCT04292535|448773840|FG003|Overall Study|Equipment Failure|0|||
124766924|NCT04292535|448773841|FG004|Overall Study|Equipment Failure|0|||
124766925|NCT04292535|448773842|FG005|Overall Study|Equipment Failure|0|||
124766926|NCT04292535|448773843|FG006|Overall Study|Equipment Failure|0|||
124766927|NCT04292535|448773844|FG007|Overall Study|Equipment Failure|0|||
124766928|NCT04292535|448773845|FG008|Overall Study|Equipment Failure|0|||
124766929|NCT04292535|448773846|FG009|Overall Study|Equipment Failure|0|||
124766930|NCT04292535|448773847|FG010|Overall Study|Equipment Failure|0|||
124766931|NCT04292535|448773848|FG011|Overall Study|Equipment Failure|1|||
124766932|NCT04292535|448773849|FG012|Overall Study|Equipment Failure|0|||
124766933|NCT04292535|448773850|FG013|Overall Study|Equipment Failure|0|||
124766934|NCT03836625|448773853|FG000|Overall Study|Lost to Follow-up|9|||
124766935|NCT03836625|448773854|FG001|Overall Study|Lost to Follow-up|9|||
124766936|NCT03836625|448773853|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
124766937|NCT03836625|448773854|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
124766938|NCT03836625|448773853|FG000|Overall Study|Death|0|||
124766939|NCT03836625|448773854|FG001|Overall Study|Death|1|||
124766940|NCT03836625|448773853|FG000|Overall Study|Refused follow-up|0|||
124766941|NCT03836625|448773854|FG001|Overall Study|Refused follow-up|1|||
124766942|NCT01420861|448773857|FG000|Overall Study|Adverse Event|2|||
124766943|NCT01420861|448773857|FG000|Overall Study|Study terminated by Sponsor|7|||
124766944|NCT01420861|448773857|FG000|Overall Study|Screen failure|7|||
124766945|NCT01420861|448773857|FG000|Overall Study|Randomized not Treated|2|||
124766946|NCT01247324|448773858|FG000|Overall Study|Death|6|||
124766947|NCT01247324|448773859|FG001|Overall Study|Death|10|||
124766948|NCT01247324|448773858|FG000|Overall Study|Physician Decision|2|||
124766949|NCT01247324|448773859|FG001|Overall Study|Physician Decision|3|||
124766950|NCT01247324|448773858|FG000|Overall Study|Non-compliance with study drug|3|||
124766951|NCT01247324|448773859|FG001|Overall Study|Non-compliance with study drug|0|||
124766952|NCT01247324|448773858|FG000|Overall Study|Lack of Efficacy|24|||
124766953|NCT01247324|448773859|FG001|Overall Study|Lack of Efficacy|14|||
124766954|NCT01247324|448773858|FG000|Overall Study|Non-compliance|3|||
124766955|NCT01247324|448773859|FG001|Overall Study|Non-compliance|2|||
124766956|NCT01247324|448773858|FG000|Overall Study|Pregnancy|5|||
124463474|NCT01783678|447656512|FG003|Overall Study|Lost to Follow-up|2|||
124766957|NCT01247324|448773859|FG001|Overall Study|Pregnancy|10|||
124766958|NCT01247324|448773858|FG000|Overall Study|Protocol Violation|1|||
124766959|NCT01247324|448773859|FG001|Overall Study|Protocol Violation|1|||
124766960|NCT01247324|448773858|FG000|Overall Study|Reason not specified|42|||
124766961|NCT01247324|448773859|FG001|Overall Study|Reason not specified|32|||
124766962|NCT01247324|448773858|FG000|Overall Study|Consent withdrawn by participant|41|||
124766963|NCT01247324|448773859|FG001|Overall Study|Consent withdrawn by participant|56|||
124766964|NCT01247324|448773858|FG000|Overall Study|Adverse Event|49|||
124766965|NCT01247324|448773859|FG001|Overall Study|Adverse Event|35|||
124766966|NCT01247324|448773858|FG000|Overall Study|Lost to Follow-up|3|||
124766967|NCT01247324|448773859|FG001|Overall Study|Lost to Follow-up|6|||
124766968|NCT01247324|448773858|FG000|Overall Study|Study Terminated by Sponsor|4|||
124766969|NCT01247324|448773859|FG001|Overall Study|Study Terminated by Sponsor|1|||
124766970|NCT01247324|448773858|FG000|Overall Study|Missing|2|||
124766971|NCT01247324|448773859|FG001|Overall Study|Missing|1|||
124766972|NCT01253291|448773860|FG000|Overall Study|Withdrawal by Subject|1|||
124766973|NCT01253291|448773861|FG001|Overall Study|Withdrawal by Subject|1|||
124766974|NCT01253291|448773862|FG002|Overall Study|Withdrawal by Subject|0|||
124766975|NCT01253291|448773863|FG003|Overall Study|Withdrawal by Subject|0|||
124766976|NCT01253291|448773864|FG004|Overall Study|Withdrawal by Subject|0|||
124766977|NCT01253291|448773860|FG000|Overall Study|Adverse Event|0|||
124766978|NCT01253291|448773861|FG001|Overall Study|Adverse Event|1|||
124766979|NCT01253291|448773862|FG002|Overall Study|Adverse Event|0|||
124766980|NCT01253291|448773863|FG003|Overall Study|Adverse Event|0|||
124766981|NCT01253291|448773864|FG004|Overall Study|Adverse Event|0|||
124766982|NCT01253291|448773860|FG000|Overall Study|Lack of Efficacy|1|||
124766983|NCT01253291|448773861|FG001|Overall Study|Lack of Efficacy|0|||
124766984|NCT01253291|448773862|FG002|Overall Study|Lack of Efficacy|0|||
124766985|NCT01253291|448773863|FG003|Overall Study|Lack of Efficacy|0|||
124766986|NCT01253291|448773864|FG004|Overall Study|Lack of Efficacy|0|||
124766987|NCT01253291|448773860|FG000|Overall Study|Physician Decision|2|||
124766988|NCT01253291|448773861|FG001|Overall Study|Physician Decision|0|||
124766989|NCT01253291|448773862|FG002|Overall Study|Physician Decision|0|||
124766990|NCT01253291|448773863|FG003|Overall Study|Physician Decision|0|||
124766991|NCT01253291|448773864|FG004|Overall Study|Physician Decision|2|||
124766992|NCT03905096|448773865|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
124766993|NCT03905096|448773866|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
124766994|NCT02016781|448773867|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
124766995|NCT02016781|448773868|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
124766996|NCT02016781|448773867|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
124766997|NCT02016781|448773868|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
124766998|NCT02016781|448773867|FG000|Final Database Lock|Withdrawal by Subject|2|||
124766999|NCT02016781|448773868|FG001|Final Database Lock|Withdrawal by Subject|1|||
124767000|NCT02016781|448773867|FG000|Final Database Lock|Lost to Follow-up|11|||
124767001|NCT02016781|448773868|FG001|Final Database Lock|Lost to Follow-up|4|||
124767002|NCT02016781|448773867|FG000|Final Database Lock|Missing data|0|||
124767003|NCT02016781|448773868|FG001|Final Database Lock|Missing data|3|||
124767004|NCT03724942|448773870|FG000|Overall Study|Adverse Event|20|||
124767005|NCT03724942|448773871|FG001|Overall Study|Adverse Event|14|||
124767006|NCT03724942|448773870|FG000|Overall Study|Lack of Efficacy|0|||
124767007|NCT03724942|448773871|FG001|Overall Study|Lack of Efficacy|1|||
124767008|NCT03724942|448773870|FG000|Overall Study|Physician Decision|5|||
124767009|NCT03724942|448773871|FG001|Overall Study|Physician Decision|2|||
124767010|NCT03724942|448773870|FG000|Overall Study|Protocol Violation|1|||
124767011|NCT03724942|448773871|FG001|Overall Study|Protocol Violation|0|||
124767012|NCT03724942|448773870|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
124767013|NCT03724942|448773871|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
124767014|NCT03724942|448773870|FG000|Overall Study|Withdrawal by Legal Representative|3|||
124767015|NCT03724942|448773871|FG001|Overall Study|Withdrawal by Legal Representative|0|||
124767016|NCT01021020|448775490|FG000|Period I|Protocol Violation|1|||
124767017|NCT01021020|448775490|FG000|Period I|Withdrawal by Subject|1|||
124767018|NCT01021020|448775490|FG000|14 Day Washout Period A|Physician Decision|1|||
124767019|NCT03598036|448775493|FG000|Overall Study|Withdrawal by Subject|1|||
124767020|NCT03598036|448775494|FG001|Overall Study|Withdrawal by Subject|0|||
124767021|NCT04607668|448775496|FG000|Overall Study|Death|49|||
124767022|NCT04607668|448775497|FG001|Overall Study|Death|26|||
124767023|NCT04607668|448775496|FG000|Overall Study|Lost to Follow-up|3|||
124767024|NCT04607668|448775497|FG001|Overall Study|Lost to Follow-up|4|||
124767025|NCT04607668|448775496|FG000|Overall Study|Study terminated by Sponsor|92|||
124767026|NCT04607668|448775497|FG001|Overall Study|Study terminated by Sponsor|114|||
124767027|NCT04607668|448775496|FG000|Overall Study|Withdrawal by Subject|12|||
124767028|NCT04607668|448775497|FG001|Overall Study|Withdrawal by Subject|11|||
124767029|NCT04607668|448775496|FG000|Overall Study|Other, unspecified|8|||
124767030|NCT04607668|448775497|FG001|Overall Study|Other, unspecified|7|||
124708189|NCT00806585|448557359|FG003|Overall Study|Lost to Follow-up|2|||
124708190|NCT00806585|448557360|FG004|Overall Study|Lost to Follow-up|5|||
124708191|NCT00806585|448557356|FG000|Overall Study|Lack of Efficacy|1|||
124708192|NCT00806585|448557357|FG001|Overall Study|Lack of Efficacy|0|||
124708193|NCT00806585|448557358|FG002|Overall Study|Lack of Efficacy|0|||
124708194|NCT00806585|448557359|FG003|Overall Study|Lack of Efficacy|0|||
124708195|NCT00806585|448557360|FG004|Overall Study|Lack of Efficacy|0|||
124708196|NCT00806585|448557356|FG000|Overall Study|Adverse Event|1|||
124708197|NCT00806585|448557357|FG001|Overall Study|Adverse Event|5|||
124708198|NCT00806585|448557358|FG002|Overall Study|Adverse Event|3|||
124708199|NCT00806585|448557359|FG003|Overall Study|Adverse Event|4|||
124708200|NCT00806585|448557360|FG004|Overall Study|Adverse Event|2|||
124708201|NCT00806585|448557356|FG000|Overall Study|Withdrawal by Subject|10|||
124708202|NCT00806585|448557357|FG001|Overall Study|Withdrawal by Subject|8|||
124708203|NCT00806585|448557358|FG002|Overall Study|Withdrawal by Subject|9|||
124708204|NCT00806585|448557359|FG003|Overall Study|Withdrawal by Subject|3|||
124708205|NCT00806585|448557360|FG004|Overall Study|Withdrawal by Subject|11|||
124708206|NCT00806585|448557356|FG000|Overall Study|Completion status unknown|15|||
124708207|NCT00806585|448557357|FG001|Overall Study|Completion status unknown|14|||
124708208|NCT00806585|448557358|FG002|Overall Study|Completion status unknown|12|||
124708209|NCT00806585|448557359|FG003|Overall Study|Completion status unknown|4|||
124708210|NCT00806585|448557360|FG004|Overall Study|Completion status unknown|12|||
124708211|NCT00474903|448557361|FG000|Overall Study|Protocol Violation|1|||
124708212|NCT00474903|448557362|FG001|Overall Study|Protocol Violation|5|||
124708213|NCT00474903|448557363|FG002|Overall Study|Protocol Violation|2|||
124708214|NCT00399529|448557364|FG000|Overall Study|Off Study Prior to Treatment|2|||
124708215|NCT03435380|448557365|FG000|Overall Study|Death|1|||
124708216|NCT03435380|448557366|FG001|Overall Study|Death|2|||
124708217|NCT03435380|448557367|FG002|Overall Study|Death|1|||
124708218|NCT03435380|448557365|FG000|Overall Study|Lost to Follow-up|12|||
124708219|NCT03435380|448557366|FG001|Overall Study|Lost to Follow-up|8|||
124708220|NCT03435380|448557367|FG002|Overall Study|Lost to Follow-up|6|||
124708221|NCT03435380|448557365|FG000|Overall Study|Physician Decision|1|||
124708222|NCT03435380|448557366|FG001|Overall Study|Physician Decision|0|||
124708223|NCT03435380|448557367|FG002|Overall Study|Physician Decision|0|||
124708224|NCT03435380|448557365|FG000|Overall Study|Withdrawal by Subject|0|||
124708225|NCT03435380|448557366|FG001|Overall Study|Withdrawal by Subject|1|||
124708226|NCT03435380|448557367|FG002|Overall Study|Withdrawal by Subject|1|||
124708227|NCT03435380|448557365|FG000|Overall Study|Ineligible|0|||
124708228|NCT03435380|448557366|FG001|Overall Study|Ineligible|1|||
124708229|NCT03435380|448557367|FG002|Overall Study|Ineligible|1|||
124708230|NCT01936831|448557373|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
124708231|NCT01936831|448557374|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
124708232|NCT01936831|448557375|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
124708233|NCT01936831|448557376|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
124708234|NCT01936831|448557377|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
124708235|NCT01936831|448557378|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
124708236|NCT01936831|448557379|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
124708237|NCT01936831|448557380|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
124708238|NCT01936831|448557381|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
124708239|NCT02133573|448557382|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
124708240|NCT02133573|448557383|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
124708241|NCT02133573|448557382|FG000|Overall Study|Child Deaths|3|||
124708242|NCT02133573|448557383|FG001|Overall Study|Child Deaths|5|||
124708243|NCT02133573|448557382|FG000|Overall Study|Child Declined Follow Ups|2|||
124708244|NCT02133573|448557383|FG001|Overall Study|Child Declined Follow Ups|1|||
124708245|NCT02133573|448557382|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
124708246|NCT02133573|448557383|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
124708247|NCT02493764|448557387|FG000|Overall Study|Adverse Event|2|||
124708248|NCT02493764|448557388|FG001|Overall Study|Adverse Event|2|||
124708249|NCT02493764|448557387|FG000|Overall Study|Death|44|||
124708250|NCT02493764|448557388|FG001|Overall Study|Death|58|||
124708251|NCT02493764|448557387|FG000|Overall Study|Lost to Follow-up|2|||
124708252|NCT02493764|448557388|FG001|Overall Study|Lost to Follow-up|1|||
124708253|NCT02493764|448557387|FG000|Overall Study|Protocol Violation|6|||
124708254|NCT02493764|448557388|FG001|Overall Study|Protocol Violation|7|||
124708255|NCT02493764|448557387|FG000|Overall Study|Physician Decision|1|||
124708256|NCT02493764|448557388|FG001|Overall Study|Physician Decision|1|||
124959510|NCT01294358|449477532|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
124959511|NCT01294358|449477528|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
124708257|NCT02493764|448557387|FG000|Overall Study|Participant moved|17|||
124708258|NCT02493764|448557388|FG001|Overall Study|Participant moved|5|||
124708259|NCT02493764|448557387|FG000|Overall Study|Withdrawal parent/guardian|0|||
124708260|NCT02493764|448557388|FG001|Overall Study|Withdrawal parent/guardian|1|||
124708261|NCT02493764|448557387|FG000|Overall Study|Withdrawal by Subject|11|||
124708262|NCT02493764|448557388|FG001|Overall Study|Withdrawal by Subject|7|||
124708263|NCT01307449|448557389|FG000|Overall Study|Adverse Event|1|||
124767031|NCT01488045|448775498|FG000|Overall Study|Withdrawal by Subject|6|||
124767032|NCT01488045|448775499|FG001|Overall Study|Withdrawal by Subject|11|||
124767033|NCT01488045|448775498|FG000|Overall Study|Failure to present for colonoscopy|3|||
124767034|NCT01488045|448775499|FG001|Overall Study|Failure to present for colonoscopy|6|||
124767035|NCT01488045|448775498|FG000|Overall Study|Failure to report exclusion criteria|0|||
124767036|NCT01488045|448775499|FG001|Overall Study|Failure to report exclusion criteria|1|||
124767037|NCT02230410|448775506|FG000|Overall Study|Screen Failure|3|||
124959512|NCT01294358|449477529|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
124959513|NCT01294358|449477530|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
124959514|NCT01294358|449477531|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
124959515|NCT01294358|449477532|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
124959516|NCT03356145|449477533|FG000|Overall Study|Withdrawal by Subject|2|||
124959517|NCT03356145|449477534|FG001|Overall Study|Withdrawal by Subject|1|||
124959518|NCT03356145|449477533|FG000|Overall Study|Did not meet inclusion criteria|1|||
124959519|NCT03356145|449477534|FG001|Overall Study|Did not meet inclusion criteria|0|||
124959520|NCT03613454|449477535|FG000|Overall Study|Protocol Violation|1|||
124959521|NCT03613454|449477536|FG001|Overall Study|Protocol Violation|0|||
124959522|NCT03613454|449477535|FG000|Overall Study|Protocol Violation|0|||
124959523|NCT03613454|449477536|FG001|Overall Study|Protocol Violation|1|||
124959524|NCT02963922|449477537|FG000|Overall Study|Adverse Event|15|||
124767038|NCT02388269|448775513|FG000|Overall Study|Adverse Event|2|||
124767039|NCT02388269|448775514|FG001|Overall Study|Adverse Event|0|||
124767040|NCT02388269|448775515|FG002|Overall Study|Adverse Event|0|||
124767041|NCT02388269|448775513|FG000|Overall Study|Withdrawal by Subject|1|||
124767042|NCT02388269|448775514|FG001|Overall Study|Withdrawal by Subject|2|||
124767043|NCT02388269|448775515|FG002|Overall Study|Withdrawal by Subject|0|||
124767044|NCT02388269|448775513|FG000|Overall Study|less than 50% stimulations|1|||
124767045|NCT02388269|448775514|FG001|Overall Study|less than 50% stimulations|0|||
124767046|NCT02388269|448775515|FG002|Overall Study|less than 50% stimulations|0|||
124767047|NCT02388269|448775513|FG000|Overall Study|no diary data|3|||
124767048|NCT02388269|448775514|FG001|Overall Study|no diary data|0|||
124767049|NCT02388269|448775515|FG002|Overall Study|no diary data|0|||
124767050|NCT02388269|448775513|FG000|Overall Study|Protocol Violation|2|||
124767051|NCT02388269|448775514|FG001|Overall Study|Protocol Violation|0|||
124767052|NCT02388269|448775515|FG002|Overall Study|Protocol Violation|0|||
124767053|NCT02388269|448775513|FG000|Overall Study|Screen Failure|0|||
124767054|NCT02388269|448775514|FG001|Overall Study|Screen Failure|0|||
124767055|NCT02388269|448775515|FG002|Overall Study|Screen Failure|10|||
124767056|NCT03448406|448775516|FG000|Overall Study|Noncompliance of scheduled visits|1|||
124767057|NCT03448406|448775517|FG001|Overall Study|Noncompliance of scheduled visits|2|||
124767058|NCT03448406|448775516|FG000|Overall Study|Withdrawal by Subject|1|||
124767059|NCT03448406|448775517|FG001|Overall Study|Withdrawal by Subject|2|||
124767060|NCT03448406|448775516|FG000|Overall Study|Protocol Violation|1|||
124767061|NCT03448406|448775517|FG001|Overall Study|Protocol Violation|0|||
124767062|NCT03448406|448775516|FG000|Overall Study|Adverse Event|8|||
124767063|NCT03448406|448775517|FG001|Overall Study|Adverse Event|9|||
124767064|NCT03405792|448775518|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
124767065|NCT03405792|448775519|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
124767066|NCT03405792|448775518|FG000|Overall Study|o Did not receive pembrolizumab|1|||
124767067|NCT03405792|448775519|FG001|Overall Study|o Did not receive pembrolizumab|0|||
124767068|NCT03962491|448775520|FG000|Overall Study|Lost to Follow-up|4|||
124767069|NCT03962491|448775521|FG001|Overall Study|Lost to Follow-up|5|||
124767070|NCT03882021|448775522|FG000|Enrollment|Procedure aborted/cancelled|2|||
124767071|NCT03882021|448775522|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
124767072|NCT03882021|448775522|FG000|Enrollment to 3-Month|Death|1|||
124767073|NCT03882021|448775522|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
124767074|NCT03882021|448775522|FG000|Enrollment to 3-Month|Missed Visit|4|||
124767075|NCT03882021|448775522|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
124767076|NCT03882021|448775522|FG000|6-Month to 12-Month Visit|Death|1|||
124767077|NCT03882021|448775522|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
124767078|NCT03186209|448775523|FG000|Overall Study|Withdrawal by Subject|11|||
124767079|NCT03186209|448775524|FG001|Overall Study|Withdrawal by Subject|22|||
124767080|NCT03186209|448775523|FG000|Overall Study|Pregnancy|1|||
124767081|NCT03186209|448775524|FG001|Overall Study|Pregnancy|0|||
124767082|NCT03186209|448775523|FG000|Overall Study|Adverse Event|4|||
124767083|NCT03186209|448775524|FG001|Overall Study|Adverse Event|0|||
124767084|NCT03186209|448775523|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
124767085|NCT03186209|448775524|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
124767086|NCT03186209|448775523|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
124767087|NCT03186209|448775524|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
124767088|NCT03186209|448775523|FG000|Overall Study|Fail to meet randomization criteria|0|||
124767089|NCT03186209|448775524|FG001|Overall Study|Fail to meet randomization criteria|1|||
124767090|NCT03186209|448775523|FG000|Overall Study|Lost to Follow-up|0|||
124767091|NCT03186209|448775524|FG001|Overall Study|Lost to Follow-up|1|||
124767092|NCT02559622|448775529|FG000|Overall Study|Progressive disease|0|||
124767093|NCT02559622|448775530|FG001|Overall Study|Progressive disease|1|||
124767094|NCT02559622|448775531|FG002|Overall Study|Progressive disease|0|||
124767095|NCT02559622|448775532|FG003|Overall Study|Progressive disease|0|||
124767096|NCT02559622|448775529|FG000|Overall Study|Adverse Event|0|||
124767097|NCT02559622|448775530|FG001|Overall Study|Adverse Event|2|||
124767098|NCT02559622|448775531|FG002|Overall Study|Adverse Event|2|||
124767099|NCT02559622|448775532|FG003|Overall Study|Adverse Event|2|||
124767100|NCT02559622|448775529|FG000|Overall Study|Patient/guardian decision|1|||
124767101|NCT02559622|448775530|FG001|Overall Study|Patient/guardian decision|2|||
124767102|NCT02559622|448775531|FG002|Overall Study|Patient/guardian decision|0|||
124767103|NCT02559622|448775532|FG003|Overall Study|Patient/guardian decision|1|||
124767104|NCT02163538|448775533|FG000|Overall Study|Protocol Violation|1|||
124767105|NCT02163538|448775534|FG001|Overall Study|Protocol Violation|0|||
124767106|NCT02163538|448775533|FG000|Overall Study|Physician Decision|0|||
124767107|NCT02163538|448775534|FG001|Overall Study|Physician Decision|1|||
124767108|NCT01339832|448775537|FG000|Overall Study|Lost to Follow-up|3|||
124767109|NCT01339832|448775537|FG000|Overall Study|Death|11|||
124767110|NCT01126749|448775538|FG000|Phase 1b|Other|0|||
124767111|NCT01126749|448775539|FG001|Phase 1b|Other|1|||
124767112|NCT01126749|448775540|FG002|Phase 1b|Other|0|||
124767113|NCT01126749|448775541|FG003|Phase 1b|Other|0|||
124767114|NCT01126749|448775538|FG000|Phase 1b|Withdrawal by Subject|0|||
124767115|NCT01126749|448775539|FG001|Phase 1b|Withdrawal by Subject|1|||
124767116|NCT01126749|448775540|FG002|Phase 1b|Withdrawal by Subject|0|||
124767117|NCT01126749|448775541|FG003|Phase 1b|Withdrawal by Subject|0|||
124767118|NCT01126749|448775538|FG000|Phase 1b|Death|3|||
124767119|NCT01126749|448775539|FG001|Phase 1b|Death|4|||
124767120|NCT01126749|448775540|FG002|Phase 1b|Death|0|||
124767121|NCT01126749|448775541|FG003|Phase 1b|Death|0|||
124767122|NCT01126749|448775538|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
124767123|NCT01126749|448775539|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
124767124|NCT01126749|448775540|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
124767125|NCT01126749|448775541|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
124767126|NCT01126749|448775538|FG000|Phase 2|Study Termination by Sponsor|0|||
124767127|NCT01126749|448775539|FG001|Phase 2|Study Termination by Sponsor|0|||
124767128|NCT01126749|448775540|FG002|Phase 2|Study Termination by Sponsor|12|||
124767129|NCT01126749|448775541|FG003|Phase 2|Study Termination by Sponsor|6|||
124767130|NCT01126749|448775538|FG000|Phase 2|Other|0|||
124767131|NCT01126749|448775539|FG001|Phase 2|Other|0|||
124767132|NCT01126749|448775540|FG002|Phase 2|Other|4|||
124767133|NCT01126749|448775541|FG003|Phase 2|Other|2|||
124767134|NCT01126749|448775538|FG000|Phase 2|Withdrawal by Subject|0|||
124767135|NCT01126749|448775539|FG001|Phase 2|Withdrawal by Subject|0|||
124767136|NCT01126749|448775540|FG002|Phase 2|Withdrawal by Subject|0|||
124767137|NCT01126749|448775541|FG003|Phase 2|Withdrawal by Subject|2|||
124767138|NCT01126749|448775538|FG000|Phase 2|Lost to Follow-up|0|||
124767139|NCT01126749|448775539|FG001|Phase 2|Lost to Follow-up|0|||
124767140|NCT01126749|448775540|FG002|Phase 2|Lost to Follow-up|0|||
124959525|NCT02963922|449477538|FG001|Overall Study|Adverse Event|6|||
124959526|NCT02963922|449477537|FG000|Overall Study|Protocol deviation|6|||
124959527|NCT02963922|449477538|FG001|Overall Study|Protocol deviation|6|||
124959528|NCT02963922|449477537|FG000|Overall Study|Lack of Efficacy|1|||
124767141|NCT01126749|448775541|FG003|Phase 2|Lost to Follow-up|1|||
124767142|NCT01126749|448775538|FG000|Phase 2|Death|0|||
124767143|NCT01126749|448775539|FG001|Phase 2|Death|0|||
124767144|NCT01126749|448775540|FG002|Phase 2|Death|22|||
124767145|NCT01126749|448775541|FG003|Phase 2|Death|22|||
124767146|NCT01126749|448775538|FG000|Phase 2|Adverse Event|0|||
124767147|NCT01126749|448775539|FG001|Phase 2|Adverse Event|0|||
124767148|NCT01126749|448775540|FG002|Phase 2|Adverse Event|0|||
124767149|NCT01126749|448775541|FG003|Phase 2|Adverse Event|1|||
124767150|NCT00627393|448775544|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
124767151|NCT00627393|448775545|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
124767152|NCT00627393|448775544|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
124767153|NCT00627393|448775545|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
124767154|NCT00627393|448775544|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
124767155|NCT00627393|448775545|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
124767156|NCT00627393|448775544|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
124767157|NCT00627393|448775545|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
124767158|NCT01056822|448775546|FG000|Overall Study|Adverse Event|0|||
124767159|NCT01056822|448775547|FG001|Overall Study|Adverse Event|1|||
124767160|NCT01056822|448775546|FG000|Overall Study|Protocol Violation|6|||
124959529|NCT02963922|449477538|FG001|Overall Study|Lack of Efficacy|1|||
124959530|NCT02963922|449477537|FG000|Overall Study|Lost to Follow-up|2|||
124959531|NCT02963922|449477538|FG001|Overall Study|Lost to Follow-up|3|||
124767161|NCT01056822|448775547|FG001|Overall Study|Protocol Violation|5|||
124767162|NCT01056822|448775546|FG000|Overall Study|Withdrawal by Subject|1|||
124959532|NCT02963922|449477537|FG000|Overall Study|Other|8|||
124767163|NCT01056822|448775547|FG001|Overall Study|Withdrawal by Subject|1|||
124767164|NCT01056822|448775546|FG000|Overall Study|Lost to Follow-up|1|||
124959533|NCT02963922|449477538|FG001|Overall Study|Other|14|||
124708264|NCT01307449|448557390|FG001|Overall Study|Adverse Event|0|||
124708265|NCT01307449|448557391|FG002|Overall Study|Adverse Event|0|||
124708266|NCT01307449|448557392|FG003|Overall Study|Adverse Event|0|||
124708267|NCT03218917|448557393|FG000|Overall Study|Adverse Event|3|||
124708268|NCT03218917|448557394|FG001|Overall Study|Adverse Event|3|||
124708269|NCT03218917|448557395|FG002|Overall Study|Adverse Event|2|||
124708270|NCT03218917|448557393|FG000|Overall Study|Subject withdrew consent|2|||
124708271|NCT03218917|448557394|FG001|Overall Study|Subject withdrew consent|4|||
124708272|NCT03218917|448557395|FG002|Overall Study|Subject withdrew consent|10|||
124708273|NCT03218917|448557393|FG000|Overall Study|Physician Decision|0|||
124708274|NCT03218917|448557394|FG001|Overall Study|Physician Decision|1|||
124708275|NCT03218917|448557395|FG002|Overall Study|Physician Decision|1|||
124708276|NCT03218917|448557393|FG000|Overall Study|Lost to Follow-up|1|||
124708277|NCT03218917|448557394|FG001|Overall Study|Lost to Follow-up|0|||
124708278|NCT03218917|448557395|FG002|Overall Study|Lost to Follow-up|0|||
124708279|NCT03218917|448557393|FG000|Overall Study|Reason Missing|0|||
124708280|NCT03218917|448557394|FG001|Overall Study|Reason Missing|2|||
124708281|NCT03218917|448557395|FG002|Overall Study|Reason Missing|0|||
124708282|NCT03218917|448557393|FG000|Overall Study|Death|0|||
124708283|NCT03218917|448557394|FG001|Overall Study|Death|1|||
124708284|NCT03218917|448557395|FG002|Overall Study|Death|0|||
124708285|NCT03218917|448557393|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124708286|NCT03218917|448557394|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124708287|NCT03218917|448557395|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124708288|NCT01561976|448557396|FG000|Period 1|Adverse Event|0|||
124708289|NCT01561976|448557397|FG001|Period 1|Adverse Event|0|||
124708290|NCT01561976|448557398|FG002|Period 1|Adverse Event|1|||
124708291|NCT01561976|448557399|FG003|Period 1|Adverse Event|0|||
124708292|NCT01561976|448557400|FG004|Period 1|Adverse Event|0|||
124708293|NCT01561976|448557401|FG005|Period 1|Adverse Event|0|||
124708294|NCT01561976|448557396|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
124708295|NCT01561976|448557397|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
124708296|NCT01561976|448557398|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
124708297|NCT01561976|448557399|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
124708298|NCT01561976|448557400|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
124708299|NCT01561976|448557401|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
124708300|NCT01561976|448557396|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124708301|NCT01561976|448557397|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124708302|NCT01561976|448557398|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124708303|NCT01561976|448557399|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124708304|NCT01561976|448557400|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
124708305|NCT01561976|448557401|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
124708306|NCT01561976|448557396|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
124708307|NCT01561976|448557397|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
124708308|NCT01561976|448557398|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
124708309|NCT01561976|448557399|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
124708310|NCT01561976|448557400|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
124708311|NCT01561976|448557401|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
124708312|NCT01463527|448557406|FG000|Overall Study|Protocol Violation|1|||
124708313|NCT01463527|448557407|FG001|Overall Study|Protocol Violation|1|||
124708314|NCT01463527|448557406|FG000|Overall Study|Crying >20% of sedation|5|||
124708315|NCT01463527|448557407|FG001|Overall Study|Crying >20% of sedation|6|||
124708316|NCT05136170|448557408|FG000|Overall Study|Withdrawal by Subject|2|||
124708317|NCT05136170|448557409|FG001|Overall Study|Withdrawal by Subject|2|||
124708318|NCT05136170|448557408|FG000|Overall Study|Can no longer make office visits|1|||
124708319|NCT05136170|448557409|FG001|Overall Study|Can no longer make office visits|0|||
124708320|NCT01788943|448557410|FG000|Overall Study|Withdrawal by Subject|1|||
124708321|NCT01788943|448557411|FG001|Overall Study|Withdrawal by Subject|0|||
124708322|NCT04403919|448557416|FG000|Overall Study|Lost to Follow-up|0|||
124708323|NCT04403919|448557417|FG001|Overall Study|Lost to Follow-up|0|||
124708324|NCT04403919|448557418|FG002|Overall Study|Lost to Follow-up|0|||
124708325|NCT04403919|448557419|FG003|Overall Study|Lost to Follow-up|1|||
124708326|NCT01612676|448557420|FG000|Overall Study|Adverse Event|2|||
124708327|NCT01612676|448557421|FG001|Overall Study|Adverse Event|3|||
124708328|NCT01612676|448557422|FG002|Overall Study|Adverse Event|1|||
124708329|NCT01612676|448557423|FG003|Overall Study|Adverse Event|3|||
124708330|NCT01612676|448557420|FG000|Overall Study|Protocol Violation|0|||
124708331|NCT01612676|448557421|FG001|Overall Study|Protocol Violation|1|||
124708332|NCT01612676|448557422|FG002|Overall Study|Protocol Violation|0|||
124708333|NCT01612676|448557423|FG003|Overall Study|Protocol Violation|0|||
124708334|NCT01156844|448557426|FG000|Overall Study|Adverse Event|0|||
124708335|NCT01156844|448557427|FG001|Overall Study|Adverse Event|0|||
124708336|NCT01156844|448557428|FG002|Overall Study|Adverse Event|1|||
124708337|NCT01156844|448557429|FG003|Overall Study|Adverse Event|1|||
124708338|NCT01156844|448557426|FG000|Overall Study|Abnormal test procedure result(s)|0|||
124708339|NCT01156844|448557427|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124708340|NCT01156844|448557428|FG002|Overall Study|Abnormal test procedure result(s)|2|||
124767165|NCT01056822|448775547|FG001|Overall Study|Lost to Follow-up|0|||
124767166|NCT05498649|448775548|FG000|Overall Study|Lost to Follow-up|1|||
124767167|NCT02761330|448775556|FG000|Treatment Week 1|Withdrawal by Subject|0|||
124767168|NCT02761330|448775557|FG001|Treatment Week 1|Withdrawal by Subject|0|||
124767169|NCT02761330|448775558|FG002|Treatment Week 1|Withdrawal by Subject|0|||
124767170|NCT02761330|448775559|FG003|Treatment Week 1|Withdrawal by Subject|1|||
124767171|NCT02761330|448775560|FG004|Treatment Week 1|Withdrawal by Subject|0|||
124767172|NCT02761330|448775561|FG005|Treatment Week 1|Withdrawal by Subject|1|||
124767173|NCT03043313|448775564|FG000|Overall Study|Withdrawal by Subject|5|||
124767174|NCT03043313|448775565|FG001|Overall Study|Withdrawal by Subject|1|||
124767175|NCT03043313|448775566|FG002|Overall Study|Withdrawal by Subject|1|||
124767176|NCT03043313|448775564|FG000|Overall Study|Lost to Follow-up|1|||
124767177|NCT03043313|448775565|FG001|Overall Study|Lost to Follow-up|1|||
124767178|NCT03043313|448775566|FG002|Overall Study|Lost to Follow-up|0|||
124767179|NCT03043313|448775564|FG000|Overall Study|Death|28|||
124767180|NCT03043313|448775565|FG001|Overall Study|Death|26|||
124767181|NCT03043313|448775566|FG002|Overall Study|Death|17|||
124767182|NCT03043313|448775564|FG000|Overall Study|Participation terminated by sponsor|11|||
124767183|NCT03043313|448775565|FG001|Overall Study|Participation terminated by sponsor|13|||
124767184|NCT03043313|448775566|FG002|Overall Study|Participation terminated by sponsor|13|||
124767185|NCT00980954|448775567|FG000|Overall Study|Protocol Violation|9|||
124767186|NCT00980954|448775568|FG001|Overall Study|Protocol Violation|15|||
124767187|NCT02657889|448775569|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
124767188|NCT02657889|448775570|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
124767189|NCT02657889|448775571|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
124767190|NCT02657889|448775572|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
124767191|NCT02657889|448775569|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
124767192|NCT02657889|448775570|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
124767193|NCT02657889|448775571|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
124463475|NCT01783678|447656513|FG004|Overall Study|Lost to Follow-up|1|||
124767194|NCT02657889|448775572|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
124767195|NCT02657889|448775569|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
124767196|NCT02657889|448775570|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
124767197|NCT02657889|448775571|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
124767198|NCT02657889|448775572|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
124463476|NCT01783678|447656514|FG005|Overall Study|Lost to Follow-up|0|||
124463477|NCT01783678|447656509|FG000|Overall Study|Withdrew Consent|1|||
124463478|NCT01783678|447656510|FG001|Overall Study|Withdrew Consent|1|||
124463479|NCT01783678|447656511|FG002|Overall Study|Withdrew Consent|0|||
124463480|NCT01783678|447656512|FG003|Overall Study|Withdrew Consent|2|||
124463481|NCT01783678|447656513|FG004|Overall Study|Withdrew Consent|0|||
124463482|NCT01783678|447656514|FG005|Overall Study|Withdrew Consent|0|||
124463483|NCT02049944|447656515|FG000|Overall Study|Protocol Violation|2|||
124463484|NCT00522431|447656516|FG000|Overall Study|Adverse Event|5|||
124463485|NCT00522431|447656516|FG000|Overall Study|Protocol Violation|2|||
124463486|NCT00522431|447656516|FG000|Overall Study|Withdrawal by Subject|2|||
124463487|NCT00522431|447656516|FG000|Overall Study|Subject non-compliance|1|||
124463488|NCT00522431|447656516|FG000|Overall Study|Other/unknown|1|||
124463489|NCT03548051|447656517|FG000|Overall Study|Death|1|||
124463490|NCT03548051|447656518|FG001|Overall Study|Death|1|||
124463491|NCT03548051|447656517|FG000|Overall Study|Withdrawal by Subject|1|||
124463492|NCT03548051|447656518|FG001|Overall Study|Withdrawal by Subject|0|||
124463493|NCT01745146|447656522|FG000|Overall Study|Withdrawal by Subject|1|||
124463494|NCT01745146|447656523|FG001|Overall Study|Withdrawal by Subject|3|||
124463495|NCT01745146|447656522|FG000|Overall Study|Lost to Follow-up|2|||
124463496|NCT01745146|447656523|FG001|Overall Study|Lost to Follow-up|0|||
124463497|NCT04623242|447656524|FG000|Overall Study|Withdrawal by Subject|7|||
124463498|NCT04623242|447656525|FG001|Overall Study|Withdrawal by Subject|12|||
124463499|NCT04623242|447656526|FG002|Overall Study|Withdrawal by Subject|5|||
124463500|NCT04623242|447656527|FG003|Overall Study|Withdrawal by Subject|7|||
124463501|NCT04623242|447656528|FG004|Overall Study|Withdrawal by Subject|0|||
124463502|NCT04623242|447656524|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
124463503|NCT04623242|447656525|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
124463504|NCT04623242|447656526|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
124463505|NCT04623242|447656527|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
124463506|NCT04623242|447656528|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
124463507|NCT04623242|447656524|FG000|Overall Study|Subject unblinded to mutation status|0|||
124463508|NCT04623242|447656525|FG001|Overall Study|Subject unblinded to mutation status|0|||
124463509|NCT04623242|447656526|FG002|Overall Study|Subject unblinded to mutation status|0|||
124463510|NCT04623242|447656527|FG003|Overall Study|Subject unblinded to mutation status|13|||
124767199|NCT02657889|448775569|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
124767200|NCT02657889|448775570|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
124959534|NCT00655668|449477551|FG000|Overall Study|Adverse Event|6|||
124767201|NCT02657889|448775571|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
124767202|NCT02657889|448775572|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
124767203|NCT02657889|448775569|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
124767204|NCT02657889|448775570|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
124767205|NCT02657889|448775571|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
124767206|NCT02657889|448775572|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
124767207|NCT02657889|448775569|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
124767208|NCT02657889|448775570|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
124767209|NCT02657889|448775571|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
124767210|NCT02657889|448775572|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
124767211|NCT02657889|448775569|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
124767212|NCT02657889|448775570|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
124767213|NCT02657889|448775571|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
124767214|NCT02657889|448775572|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
124767215|NCT02657889|448775569|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
124767216|NCT02657889|448775570|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
124767217|NCT02657889|448775571|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
124767218|NCT02657889|448775572|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
124767219|NCT02657889|448775569|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
124767220|NCT02657889|448775570|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
124767221|NCT02657889|448775571|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
124767222|NCT02657889|448775572|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
124767223|NCT02657889|448775569|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
124767224|NCT02657889|448775570|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
124767225|NCT02657889|448775571|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
124767226|NCT02657889|448775572|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
124767227|NCT02657889|448775569|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
124767228|NCT02657889|448775570|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
124767229|NCT02657889|448775571|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
124767230|NCT02657889|448775572|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
124767231|NCT02657889|448775569|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
124767232|NCT02657889|448775570|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
124767233|NCT02657889|448775571|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
124767234|NCT02657889|448775572|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
124767235|NCT00374140|448775573|FG000|Overall Study|Lost to Follow-up|1|||
124767236|NCT00374140|448775573|FG000|Overall Study|Protocol Violation|1|||
124767237|NCT01576341|448775574|FG000|Overall Study|Withdrawal by Subject|24|||
124767238|NCT01576341|448775574|FG000|Overall Study|Adverse Event|10|||
124767239|NCT01576341|448775574|FG000|Overall Study|Death|21|||
124767240|NCT01576341|448775574|FG000|Overall Study|Physician Decision|2|||
124767241|NCT01576341|448775574|FG000|Overall Study|Lost to Follow-up|2|||
124767242|NCT01576341|448775574|FG000|Overall Study|Kidney transplantation|10|||
124767243|NCT01576341|448775574|FG000|Overall Study|Protocol Violation|12|||
124767244|NCT01576341|448775574|FG000|Overall Study|Other|12|||
124767245|NCT00517296|448775578|FG000|Overall Study|Withdrawal by Subject|1|||
124767246|NCT00517296|448775579|FG001|Overall Study|Withdrawal by Subject|0|||
124767247|NCT04366349|448775580|FG000|Overall Study|Withdrawal by Subject|1|||
124767248|NCT04366349|448775581|FG001|Overall Study|Withdrawal by Subject|0|||
124767249|NCT04366349|448775582|FG002|Overall Study|Withdrawal by Subject|0|||
124767250|NCT04366349|448775583|FG003|Overall Study|Withdrawal by Subject|0|||
124767251|NCT04366349|448775584|FG004|Overall Study|Withdrawal by Subject|0|||
124767252|NCT04366349|448775585|FG005|Overall Study|Withdrawal by Subject|0|||
124767253|NCT03413891|448775590|FG000|Overall Study|Lost to Follow-up|2|||
124767254|NCT03413891|448775591|FG001|Overall Study|Lost to Follow-up|1|||
124767255|NCT03413891|448775590|FG000|Overall Study|Protocol Violation|0|||
124767256|NCT03413891|448775591|FG001|Overall Study|Protocol Violation|1|||
124767257|NCT04905134|448775595|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
124767258|NCT04905134|448775595|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
124767259|NCT03642873|448775596|FG000|Third Intervention (1 Day)|Screen failure|0|||
124767260|NCT03642873|448775597|FG001|Third Intervention (1 Day)|Screen failure|0|||
124767261|NCT03642873|448775598|FG002|Third Intervention (1 Day)|Screen failure|0|||
124767262|NCT03642873|448775599|FG003|Third Intervention (1 Day)|Screen failure|0|||
124767263|NCT03642873|448775600|FG004|Third Intervention (1 Day)|Screen failure|1|||
124767264|NCT03642873|448775601|FG005|Third Intervention (1 Day)|Screen failure|0|||
124767265|NCT05556265|448775602|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
124767266|NCT05556265|448775603|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
124959535|NCT00655668|449477551|FG000|Overall Study|Death|5|||
124959536|NCT00655668|449477551|FG000|Overall Study|Disease Progression|27|||
124767267|NCT05556265|448775604|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
124767268|NCT05556265|448775605|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
124767269|NCT05556265|448775606|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
124767270|NCT05556265|448775602|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
124767271|NCT05556265|448775603|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
124767272|NCT05556265|448775604|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
124767273|NCT05556265|448775605|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
124767274|NCT05556265|448775606|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
124767275|NCT05556265|448775602|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
124767276|NCT05556265|448775603|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
124767277|NCT05556265|448775604|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
124767278|NCT05556265|448775605|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
124767279|NCT05556265|448775606|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
124767280|NCT05556265|448775602|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
124767281|NCT05556265|448775603|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
124767282|NCT05556265|448775604|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
124767283|NCT05556265|448775605|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
124767284|NCT05556265|448775606|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
124767285|NCT05556265|448775602|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
124767286|NCT05556265|448775603|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
124767287|NCT05556265|448775604|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
124767288|NCT05556265|448775605|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
124767289|NCT05556265|448775606|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
124767290|NCT05556265|448775602|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
124767291|NCT05556265|448775603|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
124767292|NCT05556265|448775604|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
124767293|NCT05556265|448775605|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
124767294|NCT05556265|448775606|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
124767295|NCT05556265|448775602|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
124767296|NCT05556265|448775603|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
124767297|NCT05556265|448775604|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
124767298|NCT05556265|448775605|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
124767299|NCT05556265|448775606|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
124959537|NCT00655668|449477551|FG000|Overall Study|Study Terminated|9|||
124959538|NCT00655668|449477551|FG000|Overall Study|Other|1|||
124959539|NCT00655668|449477551|FG000|Overall Study|New Lymphoma Treatment Started|4|||
124959540|NCT00655668|449477551|FG000|Overall Study|Withdrawal by Subject|2|||
124959541|NCT03873038|449477554|FG000|Part 2|Withdrawal by Subject|0|||
124959542|NCT03873038|449477555|FG001|Part 2|Withdrawal by Subject|0|||
124959543|NCT03873038|449477556|FG002|Part 2|Withdrawal by Subject|0|||
124959544|NCT03873038|449477557|FG003|Part 2|Withdrawal by Subject|0|||
124959545|NCT03873038|449477558|FG004|Part 2|Withdrawal by Subject|0|||
124959546|NCT03873038|449477559|FG005|Part 2|Withdrawal by Subject|1|||
124959547|NCT03873038|449477554|FG000|Part 2|Unknon|0|||
124959548|NCT03873038|449477555|FG001|Part 2|Unknon|0|||
124959549|NCT03873038|449477556|FG002|Part 2|Unknon|0|||
124959550|NCT03873038|449477557|FG003|Part 2|Unknon|0|||
124959551|NCT03873038|449477558|FG004|Part 2|Unknon|1|||
124959552|NCT03873038|449477559|FG005|Part 2|Unknon|0|||
124959553|NCT04222088|449477561|FG000|Overall Study|Lost to Follow-up|5|||
124959554|NCT04222088|449477562|FG001|Overall Study|Lost to Follow-up|1|||
124959555|NCT04222088|449477561|FG000|Overall Study|Withdrawal by Subject|4|||
124959556|NCT04222088|449477562|FG001|Overall Study|Withdrawal by Subject|0|||
124959557|NCT00595764|449477563|FG000|Overall Study|Protocol Violation|24|||
124959558|NCT00595764|449477564|FG001|Overall Study|Protocol Violation|19|||
124959559|NCT00595764|449477563|FG000|Overall Study|Missed Medication >1 week|10|||
124959560|NCT00595764|449477564|FG001|Overall Study|Missed Medication >1 week|17|||
124959561|NCT00595764|449477563|FG000|Overall Study|Missed 3 PM visits|1|||
124959562|NCT00595764|449477564|FG001|Overall Study|Missed 3 PM visits|7|||
124959563|NCT00595764|449477563|FG000|Overall Study|Withdrawal by Subject|4|||
124767300|NCT05556265|448775602|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
124767301|NCT05556265|448775603|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
124767302|NCT05556265|448775604|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
124767303|NCT05556265|448775605|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
124767304|NCT05556265|448775606|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
124959564|NCT00595764|449477564|FG001|Overall Study|Withdrawal by Subject|0|||
124959565|NCT01071317|449477565|FG000|Overall Study|Lost to Follow-up|2|||
124959566|NCT01071317|449477566|FG001|Overall Study|Lost to Follow-up|2|||
124767305|NCT05556265|448775602|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
124767306|NCT05556265|448775603|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
124767307|NCT05556265|448775604|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
124767308|NCT05556265|448775605|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
124767309|NCT05556265|448775606|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
124767310|NCT03221556|448775609|FG000|Allocation|post-randomization exclusion|0|||
124767311|NCT03221556|448775610|FG001|Allocation|post-randomization exclusion|1|||
124767312|NCT03221556|448775609|FG000|Follow-Up|Withdrawal by Subject|0|||
124767313|NCT03221556|448775610|FG001|Follow-Up|Withdrawal by Subject|1|||
124767314|NCT02234843|448775613|FG000|Overall Study|Death|1|||
124767315|NCT02234843|448775614|FG001|Overall Study|Death|0|||
124767316|NCT02234843|448775615|FG002|Overall Study|Death|0|||
124767317|NCT02234843|448775616|FG003|Overall Study|Death|0|||
124767318|NCT02234843|448775617|FG004|Overall Study|Death|0|||
124767319|NCT02234843|448775618|FG005|Overall Study|Death|0|||
124767320|NCT02234843|448775619|FG006|Overall Study|Death|0|||
124767321|NCT02234843|448775620|FG007|Overall Study|Death|0|||
124767322|NCT02234843|448775621|FG008|Overall Study|Death|0|||
124767323|NCT02234843|448775622|FG009|Overall Study|Death|0|||
124767324|NCT02234843|448775613|FG000|Overall Study|Protocol Violation|1|||
124767325|NCT02234843|448775614|FG001|Overall Study|Protocol Violation|0|||
124767326|NCT02234843|448775615|FG002|Overall Study|Protocol Violation|1|||
124767327|NCT02234843|448775616|FG003|Overall Study|Protocol Violation|0|||
124767328|NCT02234843|448775617|FG004|Overall Study|Protocol Violation|0|||
124767329|NCT02234843|448775618|FG005|Overall Study|Protocol Violation|0|||
124767330|NCT02234843|448775619|FG006|Overall Study|Protocol Violation|0|||
124767331|NCT02234843|448775620|FG007|Overall Study|Protocol Violation|0|||
124767332|NCT02234843|448775621|FG008|Overall Study|Protocol Violation|0|||
124767333|NCT02234843|448775622|FG009|Overall Study|Protocol Violation|0|||
124767334|NCT02234843|448775613|FG000|Overall Study|Efficacy outcome reached|2|||
124767335|NCT02234843|448775614|FG001|Overall Study|Efficacy outcome reached|0|||
124767336|NCT02234843|448775615|FG002|Overall Study|Efficacy outcome reached|0|||
124767337|NCT02234843|448775616|FG003|Overall Study|Efficacy outcome reached|0|||
124767338|NCT02234843|448775617|FG004|Overall Study|Efficacy outcome reached|0|||
124767339|NCT02234843|448775618|FG005|Overall Study|Efficacy outcome reached|2|||
124767340|NCT02234843|448775619|FG006|Overall Study|Efficacy outcome reached|0|||
124767341|NCT02234843|448775620|FG007|Overall Study|Efficacy outcome reached|0|||
124767342|NCT02234843|448775621|FG008|Overall Study|Efficacy outcome reached|0|||
124767343|NCT02234843|448775622|FG009|Overall Study|Efficacy outcome reached|0|||
124767344|NCT02234843|448775613|FG000|Overall Study|Patient convenience|2|||
124767345|NCT02234843|448775614|FG001|Overall Study|Patient convenience|0|||
124767346|NCT02234843|448775615|FG002|Overall Study|Patient convenience|0|||
124767347|NCT02234843|448775616|FG003|Overall Study|Patient convenience|0|||
124767348|NCT02234843|448775617|FG004|Overall Study|Patient convenience|0|||
124767349|NCT02234843|448775618|FG005|Overall Study|Patient convenience|1|||
124767350|NCT02234843|448775619|FG006|Overall Study|Patient convenience|0|||
124767351|NCT02234843|448775620|FG007|Overall Study|Patient convenience|0|||
124767352|NCT02234843|448775621|FG008|Overall Study|Patient convenience|0|||
124959567|NCT01332318|449477568|FG000|Overall Study|Adverse Event|0|||
124959568|NCT01332318|449477569|FG001|Overall Study|Adverse Event|3|||
124959569|NCT01332318|449477570|FG002|Overall Study|Adverse Event|0|||
124959570|NCT01332318|449477571|FG003|Overall Study|Adverse Event|0|||
124959571|NCT01332318|449477568|FG000|Overall Study|Withdrawal by Subject|1|||
124959572|NCT01332318|449477569|FG001|Overall Study|Withdrawal by Subject|1|||
124959573|NCT01332318|449477570|FG002|Overall Study|Withdrawal by Subject|0|||
124959574|NCT01332318|449477571|FG003|Overall Study|Withdrawal by Subject|1|||
124959575|NCT01332318|449477568|FG000|Overall Study|Protocol Violation|1|||
124959576|NCT01332318|449477569|FG001|Overall Study|Protocol Violation|0|||
124959577|NCT01332318|449477570|FG002|Overall Study|Protocol Violation|1|||
124959578|NCT01332318|449477571|FG003|Overall Study|Protocol Violation|1|||
124959579|NCT02040532|449477572|FG000|Overall Study|Lost to Follow-up|1|||
124959580|NCT02040532|449477572|FG000|Overall Study|Physician Decision|4|||
124959581|NCT02040532|449477572|FG000|Overall Study|Adverse Event|4|||
124959582|NCT02040532|449477572|FG000|Overall Study|Withdrawal by Subject|3|||
124959583|NCT02820298|449477577|FG000|Overall Study|Withdrawal by Subject|0|||
124959584|NCT02820298|449477578|FG001|Overall Study|Withdrawal by Subject|1|||
124959585|NCT02820298|449477577|FG000|Overall Study|Physician Decision|1|||
124959586|NCT02820298|449477578|FG001|Overall Study|Physician Decision|0|||
124959587|NCT02820298|449477577|FG000|Overall Study|Protocol Violation|0|||
124959588|NCT02820298|449477578|FG001|Overall Study|Protocol Violation|1|||
124959589|NCT01894256|449477579|FG000|Part A|Adverse Event|0|||
124959590|NCT01894256|449477580|FG001|Part A|Adverse Event|1|||
124959591|NCT01894256|449477581|FG002|Part A|Adverse Event|0|||
124767353|NCT02234843|448775622|FG009|Overall Study|Patient convenience|0|||
124959592|NCT01894256|449477579|FG000|Part B|Death|0|||
124959593|NCT01894256|449477580|FG001|Part B|Death|1|||
124959594|NCT01894256|449477581|FG002|Part B|Death|1|||
124959595|NCT01894256|449477579|FG000|Part B|Withdrawal by Subject|0|||
124959596|NCT01894256|449477580|FG001|Part B|Withdrawal by Subject|1|||
124959597|NCT01894256|449477581|FG002|Part B|Withdrawal by Subject|0|||
124959598|NCT01894256|449477579|FG000|Part B|Lack of Efficacy|15|||
124959599|NCT01894256|449477580|FG001|Part B|Lack of Efficacy|12|||
124959600|NCT01894256|449477581|FG002|Part B|Lack of Efficacy|13|||
124959601|NCT01780584|449477582|FG000|Overall Study|Death|1|||
124959602|NCT01780584|449477583|FG001|Overall Study|Death|0|||
124959603|NCT01780584|449477584|FG002|Overall Study|Death|1|||
124959604|NCT01780584|449477582|FG000|Overall Study|Adverse Event|0|||
124959605|NCT01780584|449477583|FG001|Overall Study|Adverse Event|1|||
124959606|NCT01780584|449477584|FG002|Overall Study|Adverse Event|0|||
124959607|NCT01780584|449477582|FG000|Overall Study|Protocol Violation|0|||
124959608|NCT01780584|449477583|FG001|Overall Study|Protocol Violation|0|||
124959609|NCT01780584|449477584|FG002|Overall Study|Protocol Violation|1|||
124959610|NCT01772147|449479126|FG000|Overall Study|Adverse Event|13|||
124959611|NCT01772147|449479127|FG001|Overall Study|Adverse Event|10|||
124959612|NCT01772147|449479128|FG002|Overall Study|Adverse Event|6|||
124959613|NCT01772147|449479126|FG000|Overall Study|Withdrew Consent|7|||
124959614|NCT01772147|449479127|FG001|Overall Study|Withdrew Consent|8|||
124959615|NCT01772147|449479128|FG002|Overall Study|Withdrew Consent|4|||
124959616|NCT01772147|449479126|FG000|Overall Study|Lost to Follow-up|1|||
124959617|NCT01772147|449479127|FG001|Overall Study|Lost to Follow-up|0|||
124959618|NCT01772147|449479128|FG002|Overall Study|Lost to Follow-up|1|||
124959619|NCT01772147|449479126|FG000|Overall Study|Protocol Deviation|2|||
124959620|NCT01772147|449479127|FG001|Overall Study|Protocol Deviation|1|||
124959621|NCT01772147|449479128|FG002|Overall Study|Protocol Deviation|1|||
124959622|NCT01772147|449479126|FG000|Overall Study|Lack of Efficacy|8|||
124959623|NCT01772147|449479127|FG001|Overall Study|Lack of Efficacy|6|||
124549287|NCT00388674|447966996|FG000|Initial Treatment|Not Defined|125|||
124767354|NCT02234843|448775613|FG000|Overall Study|Withdrawal by Subject|5|||
124767355|NCT02234843|448775614|FG001|Overall Study|Withdrawal by Subject|1|||
124767356|NCT02234843|448775615|FG002|Overall Study|Withdrawal by Subject|1|||
124767357|NCT02234843|448775616|FG003|Overall Study|Withdrawal by Subject|0|||
124767358|NCT02234843|448775617|FG004|Overall Study|Withdrawal by Subject|0|||
124767359|NCT02234843|448775618|FG005|Overall Study|Withdrawal by Subject|7|||
124767360|NCT02234843|448775619|FG006|Overall Study|Withdrawal by Subject|0|||
124767361|NCT02234843|448775620|FG007|Overall Study|Withdrawal by Subject|0|||
124767362|NCT02234843|448775621|FG008|Overall Study|Withdrawal by Subject|0|||
124767363|NCT02234843|448775622|FG009|Overall Study|Withdrawal by Subject|0|||
124767364|NCT02234843|448775613|FG000|Overall Study|Recovery|1|||
124767365|NCT02234843|448775614|FG001|Overall Study|Recovery|0|||
124767366|NCT02234843|448775615|FG002|Overall Study|Recovery|0|||
124767367|NCT02234843|448775616|FG003|Overall Study|Recovery|0|||
124767368|NCT02234843|448775617|FG004|Overall Study|Recovery|0|||
124767369|NCT02234843|448775618|FG005|Overall Study|Recovery|0|||
124767370|NCT02234843|448775619|FG006|Overall Study|Recovery|0|||
124767371|NCT02234843|448775620|FG007|Overall Study|Recovery|0|||
124767372|NCT02234843|448775621|FG008|Overall Study|Recovery|0|||
124767373|NCT02234843|448775622|FG009|Overall Study|Recovery|0|||
124767374|NCT02234843|448775613|FG000|Overall Study|Other|0|||
124767375|NCT02234843|448775614|FG001|Overall Study|Other|2|||
124767376|NCT02234843|448775615|FG002|Overall Study|Other|0|||
124767377|NCT02234843|448775616|FG003|Overall Study|Other|1|||
124767378|NCT02234843|448775617|FG004|Overall Study|Other|0|||
124767379|NCT02234843|448775618|FG005|Overall Study|Other|1|||
124767380|NCT02234843|448775619|FG006|Overall Study|Other|0|||
124767381|NCT02234843|448775620|FG007|Overall Study|Other|1|||
124767382|NCT02234843|448775621|FG008|Overall Study|Other|0|||
124767383|NCT02234843|448775622|FG009|Overall Study|Other|0|||
124767384|NCT02234843|448775613|FG000|Overall Study|Physician Decision|4|||
124767385|NCT02234843|448775614|FG001|Overall Study|Physician Decision|1|||
124767386|NCT02234843|448775615|FG002|Overall Study|Physician Decision|0|||
124767387|NCT02234843|448775616|FG003|Overall Study|Physician Decision|1|||
124767388|NCT02234843|448775617|FG004|Overall Study|Physician Decision|0|||
124767389|NCT02234843|448775618|FG005|Overall Study|Physician Decision|0|||
124959624|NCT01772147|449479128|FG002|Overall Study|Lack of Efficacy|6|||
124959625|NCT00796614|449479133|FG000|Overall Study|Adverse Event|1|||
124959626|NCT00796614|449479134|FG001|Overall Study|Adverse Event|2|||
124767390|NCT02234843|448775619|FG006|Overall Study|Physician Decision|0|||
124767391|NCT02234843|448775620|FG007|Overall Study|Physician Decision|1|||
124767392|NCT02234843|448775621|FG008|Overall Study|Physician Decision|0|||
124767393|NCT02234843|448775622|FG009|Overall Study|Physician Decision|0|||
124767394|NCT02234843|448775613|FG000|Overall Study|Adverse Event|5|||
124767395|NCT02234843|448775614|FG001|Overall Study|Adverse Event|1|||
124959627|NCT00796614|449479135|FG002|Overall Study|Adverse Event|0|||
124959628|NCT00796614|449479136|FG003|Overall Study|Adverse Event|0|||
124959629|NCT00796614|449479133|FG000|Overall Study|Protocol Violation|0|||
124767396|NCT02234843|448775615|FG002|Overall Study|Adverse Event|1|||
124767397|NCT02234843|448775616|FG003|Overall Study|Adverse Event|3|||
124767398|NCT02234843|448775617|FG004|Overall Study|Adverse Event|2|||
124767399|NCT02234843|448775618|FG005|Overall Study|Adverse Event|1|||
124767400|NCT02234843|448775619|FG006|Overall Study|Adverse Event|0|||
124767401|NCT02234843|448775620|FG007|Overall Study|Adverse Event|0|||
124959630|NCT00796614|449479134|FG001|Overall Study|Protocol Violation|0|||
124959631|NCT00796614|449479135|FG002|Overall Study|Protocol Violation|2|||
124959632|NCT00796614|449479136|FG003|Overall Study|Protocol Violation|0|||
124959633|NCT00796614|449479133|FG000|Overall Study|Lost to Follow-up|2|||
124959634|NCT00796614|449479134|FG001|Overall Study|Lost to Follow-up|2|||
124959635|NCT00796614|449479135|FG002|Overall Study|Lost to Follow-up|1|||
124959636|NCT00796614|449479136|FG003|Overall Study|Lost to Follow-up|0|||
124959637|NCT00796614|449479133|FG000|Overall Study|Withdrawal by Subject|1|||
124959638|NCT00796614|449479134|FG001|Overall Study|Withdrawal by Subject|0|||
124959639|NCT00796614|449479135|FG002|Overall Study|Withdrawal by Subject|0|||
124767402|NCT02234843|448775621|FG008|Overall Study|Adverse Event|1|||
124767403|NCT02234843|448775622|FG009|Overall Study|Adverse Event|0|||
124767404|NCT02234843|448775613|FG000|Overall Study|Non-compliance with study drug|1|||
124767405|NCT02234843|448775614|FG001|Overall Study|Non-compliance with study drug|0|||
124767406|NCT02234843|448775615|FG002|Overall Study|Non-compliance with study drug|0|||
124767407|NCT02234843|448775616|FG003|Overall Study|Non-compliance with study drug|0|||
124767408|NCT02234843|448775617|FG004|Overall Study|Non-compliance with study drug|0|||
124767409|NCT02234843|448775618|FG005|Overall Study|Non-compliance with study drug|1|||
124767410|NCT02234843|448775619|FG006|Overall Study|Non-compliance with study drug|1|||
124767411|NCT02234843|448775620|FG007|Overall Study|Non-compliance with study drug|0|||
124767412|NCT02234843|448775621|FG008|Overall Study|Non-compliance with study drug|0|||
124767413|NCT02234843|448775622|FG009|Overall Study|Non-compliance with study drug|0|||
124767414|NCT02234843|448775613|FG000|Overall Study|Lost to Follow-up|0|||
124767415|NCT02234843|448775614|FG001|Overall Study|Lost to Follow-up|1|||
124767416|NCT02234843|448775615|FG002|Overall Study|Lost to Follow-up|0|||
124767417|NCT02234843|448775616|FG003|Overall Study|Lost to Follow-up|0|||
124767418|NCT02234843|448775617|FG004|Overall Study|Lost to Follow-up|0|||
124767419|NCT02234843|448775618|FG005|Overall Study|Lost to Follow-up|0|||
124767420|NCT02234843|448775619|FG006|Overall Study|Lost to Follow-up|1|||
124767421|NCT02234843|448775620|FG007|Overall Study|Lost to Follow-up|0|||
124767422|NCT02234843|448775621|FG008|Overall Study|Lost to Follow-up|0|||
124959640|NCT00796614|449479136|FG003|Overall Study|Withdrawal by Subject|1|||
124959641|NCT00796614|449479133|FG000|Overall Study|Other than stated|1|||
124959642|NCT00796614|449479134|FG001|Overall Study|Other than stated|0|||
124767423|NCT02234843|448775622|FG009|Overall Study|Lost to Follow-up|0|||
124767424|NCT02336282|448775623|FG000|Overall Study|Unrelated illness|1|||
124767425|NCT02336282|448775623|FG000|Overall Study|Uncomfortable with technology|1|||
124767426|NCT02336282|448775623|FG000|Overall Study|Lost to Follow-up|1|||
124767427|NCT02336282|448775623|FG000|Overall Study|Not enough time to complete sessions|2|||
124767428|NCT04875975|448775624|FG000|Overall Study|Adverse Event|1|||
124767429|NCT04875975|448775625|FG001|Overall Study|Adverse Event|2|||
124767430|NCT04875975|448775624|FG000|Overall Study|Lack of Efficacy|2|||
124767431|NCT04875975|448775625|FG001|Overall Study|Lack of Efficacy|2|||
124767432|NCT04875975|448775624|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
124767433|NCT04875975|448775625|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
124767434|NCT04875975|448775624|FG000|Overall Study|Relapse With Insults|0|||
124767435|NCT04875975|448775625|FG001|Overall Study|Relapse With Insults|1|||
124767436|NCT04875975|448775624|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
124767437|NCT04875975|448775625|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
124767438|NCT03253393|448775626|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
124767439|NCT03253393|448775627|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
124767440|NCT03253393|448775628|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
124767441|NCT04515771|448777348|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
124767442|NCT04515771|448777349|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
124767443|NCT04515771|448777348|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
124767444|NCT04515771|448777349|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
124767445|NCT04515771|448777348|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
124767446|NCT04515771|448777349|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
124767447|NCT00948246|448777350|FG000|Overall Study|Lost to Follow-up|11|||
124767448|NCT00948246|448777350|FG000|Overall Study|Adverse Event|11|||
124767449|NCT00948246|448777350|FG000|Overall Study|Death|1|||
124767450|NCT00948246|448777350|FG000|Overall Study|Withdrawal by Subject|1|||
124767451|NCT04199351|448777353|FG000|Overall Study|Decision by sponsor|0|||
124767452|NCT04199351|448777354|FG001|Overall Study|Decision by sponsor|0|||
124767453|NCT04199351|448777355|FG002|Overall Study|Decision by sponsor|0|||
124767454|NCT04199351|448777356|FG003|Overall Study|Decision by sponsor|2|||
124767455|NCT04199351|448777357|FG004|Overall Study|Decision by sponsor|0|||
124767456|NCT04199351|448777358|FG005|Overall Study|Decision by sponsor|0|||
124767457|NCT04199351|448777359|FG006|Overall Study|Decision by sponsor|0|||
124767458|NCT04199351|448777360|FG007|Overall Study|Decision by sponsor|0|||
124959643|NCT00796614|449479135|FG002|Overall Study|Other than stated|0|||
124767459|NCT04199351|448777361|FG008|Overall Study|Decision by sponsor|0|||
124767460|NCT04199351|448777362|FG009|Overall Study|Decision by sponsor|6|||
124767461|NCT04199351|448777353|FG000|Overall Study|Lost to Follow-up|0|||
124767462|NCT04199351|448777354|FG001|Overall Study|Lost to Follow-up|0|||
124767463|NCT04199351|448777355|FG002|Overall Study|Lost to Follow-up|1|||
124767464|NCT04199351|448777356|FG003|Overall Study|Lost to Follow-up|0|||
124767465|NCT04199351|448777357|FG004|Overall Study|Lost to Follow-up|0|||
124767466|NCT04199351|448777358|FG005|Overall Study|Lost to Follow-up|1|||
124767467|NCT04199351|448777359|FG006|Overall Study|Lost to Follow-up|0|||
124767468|NCT04199351|448777360|FG007|Overall Study|Lost to Follow-up|0|||
124767469|NCT04199351|448777361|FG008|Overall Study|Lost to Follow-up|0|||
124767470|NCT04199351|448777362|FG009|Overall Study|Lost to Follow-up|0|||
124549288|NCT00388674|447966997|FG001|Initial Treatment|Not Defined|172|||
124549289|NCT00388674|447966996|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
124549290|NCT00388674|447966997|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
124549291|NCT00388674|447966996|FG000|Initial Treatment|Pregnancy|26|||
124549292|NCT00388674|447966997|FG001|Initial Treatment|Pregnancy|16|||
124549293|NCT00388674|447966996|FG000|Initial Treatment|Study Drug Toxicity|5|||
124549294|NCT00388674|447966997|FG001|Initial Treatment|Study Drug Toxicity|92|||
124549295|NCT00388674|447966996|FG000|Initial Treatment|Participant Request|501|||
124549296|NCT00388674|447966997|FG001|Initial Treatment|Participant Request|673|||
124549297|NCT00388674|447966996|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
124549298|NCT00388674|447966997|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
124549299|NCT00388674|447966996|FG000|Initial Treatment|Not Reported|10|||
124549300|NCT00388674|447966997|FG001|Initial Treatment|Not Reported|12|||
124549301|NCT00388674|447966996|FG000|End of Study|Administrative Reason By Sponsor|299|||
124549302|NCT00388674|447966997|FG001|End of Study|Administrative Reason By Sponsor|253|||
124767471|NCT04199351|448777353|FG000|Overall Study|Withdrawal by Subject|0|||
124767472|NCT04199351|448777354|FG001|Overall Study|Withdrawal by Subject|1|||
124767473|NCT04199351|448777355|FG002|Overall Study|Withdrawal by Subject|0|||
124767474|NCT04199351|448777356|FG003|Overall Study|Withdrawal by Subject|0|||
124767475|NCT04199351|448777357|FG004|Overall Study|Withdrawal by Subject|1|||
124767476|NCT04199351|448777358|FG005|Overall Study|Withdrawal by Subject|4|||
124767477|NCT04199351|448777359|FG006|Overall Study|Withdrawal by Subject|2|||
124767478|NCT04199351|448777360|FG007|Overall Study|Withdrawal by Subject|0|||
124959644|NCT00796614|449479136|FG003|Overall Study|Other than stated|0|||
124959645|NCT00509821|449479137|FG000|Study Period 1 (Induction)|Death|0|||
124959646|NCT00509821|449479138|FG001|Study Period 1 (Induction)|Death|1|||
124959647|NCT00509821|449479137|FG000|Study Period 1 (Induction)|Adverse Event|0|||
124549303|NCT00388674|447966996|FG000|End of Study|Death|239|||
124549304|NCT00388674|447966997|FG001|End of Study|Death|262|||
124549305|NCT00388674|447966996|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
124549306|NCT00388674|447966997|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
124549307|NCT00388674|447966996|FG000|End of Study|HCC|8|||
124549308|NCT00388674|447966997|FG001|End of Study|HCC|7|||
124549309|NCT00388674|447966996|FG000|End of Study|Lost to Follow-up|587|||
124549310|NCT00388674|447966997|FG001|End of Study|Lost to Follow-up|715|||
124549311|NCT00388674|447966996|FG000|End of Study|Malignancy (Non-HCC)|1|||
124549312|NCT00388674|447966997|FG001|End of Study|Malignancy (Non-HCC)|1|||
124549313|NCT00388674|447966996|FG000|End of Study|Non-Study Related Comorbidities|3|||
124959648|NCT00509821|449479138|FG001|Study Period 1 (Induction)|Adverse Event|2|||
124959649|NCT00509821|449479137|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
124959650|NCT00509821|449479138|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
124959651|NCT01816685|449479139|FG000|Overall Study|Lost to Follow-up|7|||
124959652|NCT01816685|449479140|FG001|Overall Study|Lost to Follow-up|9|||
124959653|NCT01816685|449479139|FG000|Overall Study|Surgery Cancelled|3|||
124959654|NCT01816685|449479140|FG001|Overall Study|Surgery Cancelled|2|||
124959655|NCT03449134|449479141|FG000|52-Week Treatment Period|Death|2|||
124959656|NCT03449134|449479142|FG001|52-Week Treatment Period|Death|1|||
124959657|NCT03449134|449479143|FG002|52-Week Treatment Period|Death|0|||
124549314|NCT00388674|447966997|FG001|End of Study|Non-Study Related Comorbidities|4|||
124549315|NCT00388674|447966996|FG000|End of Study|Not Defined|135|||
124549316|NCT00388674|447966997|FG001|End of Study|Not Defined|214|||
124549317|NCT00388674|447966996|FG000|End of Study|Participant Withdrew Consent|437|||
124549318|NCT00388674|447966997|FG001|End of Study|Participant Withdrew Consent|673|||
124549319|NCT00388674|447966996|FG000|End of Study|No Off-Treatment Status Data|22|||
124549320|NCT00388674|447966997|FG001|End of Study|No Off-Treatment Status Data|30|||
124549321|NCT00388674|447966996|FG000|End of Study|Not Reported|0|||
124549322|NCT00388674|447966997|FG001|End of Study|Not Reported|1|||
124549323|NCT00759174|447966998|FG000|Overall Study|Other|0|||
124549324|NCT00759174|447966999|FG001|Overall Study|Other|2|||
124767479|NCT04199351|448777361|FG008|Overall Study|Withdrawal by Subject|3|||
124959658|NCT03449134|449479141|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
124959659|NCT03449134|449479142|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
124959660|NCT03449134|449479143|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
124959661|NCT03449134|449479141|FG000|52-Week Treatment Period|Physician Decision|2|||
124959662|NCT03449134|449479142|FG001|52-Week Treatment Period|Physician Decision|3|||
124959663|NCT03449134|449479143|FG002|52-Week Treatment Period|Physician Decision|3|||
124767480|NCT04199351|448777362|FG009|Overall Study|Withdrawal by Subject|0|||
124959664|NCT03449134|449479141|FG000|52-Week Treatment Period|Screen Failure|1|||
124959665|NCT03449134|449479142|FG001|52-Week Treatment Period|Screen Failure|0|||
124959666|NCT03449134|449479143|FG002|52-Week Treatment Period|Screen Failure|1|||
124959667|NCT03449134|449479141|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
124959668|NCT03449134|449479142|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
124959669|NCT03449134|449479143|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
124959670|NCT03449134|449479141|FG000|52-Week Treatment Period|Site Closure|1|||
124959671|NCT03449134|449479142|FG001|52-Week Treatment Period|Site Closure|0|||
124959672|NCT03449134|449479143|FG002|52-Week Treatment Period|Site Closure|0|||
124959673|NCT00957996|449479144|FG000|Overall Study|Death|4|||
124959674|NCT00957996|449479145|FG001|Overall Study|Death|10|||
124959675|NCT00957996|449479144|FG000|Overall Study|Lost to Follow-up|4|||
124959676|NCT00957996|449479145|FG001|Overall Study|Lost to Follow-up|7|||
124959677|NCT00957996|449479144|FG000|Overall Study|Withdrawal by Subject|9|||
124959678|NCT00957996|449479145|FG001|Overall Study|Withdrawal by Subject|2|||
124959679|NCT00957996|449479144|FG000|Overall Study|Adverse Event|2|||
124767481|NCT00474487|448777366|FG000|Overall Study|Withdrawal by Subject|6|||
124767482|NCT00474487|448777367|FG001|Overall Study|Withdrawal by Subject|0|||
124767483|NCT00474487|448777368|FG002|Overall Study|Withdrawal by Subject|0|||
124767484|NCT00474487|448777369|FG003|Overall Study|Withdrawal by Subject|0|||
124767485|NCT00474487|448777366|FG000|Overall Study|Lost to Follow-up|20|||
124767486|NCT00474487|448777367|FG001|Overall Study|Lost to Follow-up|1|||
124767487|NCT00474487|448777368|FG002|Overall Study|Lost to Follow-up|7|||
124767488|NCT00474487|448777369|FG003|Overall Study|Lost to Follow-up|0|||
124767489|NCT00474487|448777366|FG000|Overall Study|Inappropriate enrollment|4|||
124767490|NCT00474487|448777367|FG001|Overall Study|Inappropriate enrollment|0|||
124767491|NCT00474487|448777368|FG002|Overall Study|Inappropriate enrollment|7|||
124767492|NCT00474487|448777369|FG003|Overall Study|Inappropriate enrollment|0|||
124767493|NCT00474487|448777366|FG000|Overall Study|Death|0|||
124767494|NCT00474487|448777367|FG001|Overall Study|Death|1|||
124767495|NCT00474487|448777368|FG002|Overall Study|Death|0|||
124767496|NCT00474487|448777369|FG003|Overall Study|Death|0|||
124767497|NCT02443688|448777372|FG000|Overall Study|Adverse Event|2|||
124767498|NCT02443688|448777373|FG001|Overall Study|Adverse Event|3|||
124767499|NCT02443688|448777374|FG002|Overall Study|Adverse Event|2|||
124767500|NCT02443688|448777372|FG000|Overall Study|Lost to Follow-up|1|||
124767501|NCT02443688|448777373|FG001|Overall Study|Lost to Follow-up|0|||
124767502|NCT02443688|448777374|FG002|Overall Study|Lost to Follow-up|0|||
124767503|NCT02443688|448777372|FG000|Overall Study|Physician Decision|3|||
124767504|NCT02443688|448777373|FG001|Overall Study|Physician Decision|0|||
124767505|NCT02443688|448777374|FG002|Overall Study|Physician Decision|1|||
124767506|NCT02443688|448777372|FG000|Overall Study|Pregnancy|0|||
124767507|NCT02443688|448777373|FG001|Overall Study|Pregnancy|0|||
124767508|NCT02443688|448777374|FG002|Overall Study|Pregnancy|1|||
124767509|NCT02443688|448777372|FG000|Overall Study|Withdrawal by Subject|3|||
124767510|NCT02443688|448777373|FG001|Overall Study|Withdrawal by Subject|3|||
124767511|NCT02443688|448777374|FG002|Overall Study|Withdrawal by Subject|4|||
124767512|NCT02443688|448777372|FG000|Overall Study|Non-compliance with study drug|1|||
124767513|NCT02443688|448777373|FG001|Overall Study|Non-compliance with study drug|2|||
124767514|NCT02443688|448777374|FG002|Overall Study|Non-compliance with study drug|4|||
124767515|NCT02443688|448777372|FG000|Overall Study|Sponsor Request|2|||
124959680|NCT00957996|449479145|FG001|Overall Study|Adverse Event|1|||
124959681|NCT00957996|449479144|FG000|Overall Study|Physician Decision|1|||
124959682|NCT00957996|449479145|FG001|Overall Study|Physician Decision|1|||
124959683|NCT00957996|449479144|FG000|Overall Study|Influenza-related complication|0|||
124959684|NCT00957996|449479145|FG001|Overall Study|Influenza-related complication|1|||
124959685|NCT00957996|449479144|FG000|Overall Study|Missing|1|||
124959686|NCT00957996|449479145|FG001|Overall Study|Missing|0|||
124767516|NCT02443688|448777373|FG001|Overall Study|Sponsor Request|1|||
124959687|NCT00957996|449479144|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
124959688|NCT00957996|449479145|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
124959689|NCT00275301|449479148|FG000|Overall Study|Adverse Event|5|||
124959690|NCT02561078|449479151|FG000|Overall Study|Adverse Event|5|||
124959691|NCT02561078|449479152|FG001|Overall Study|Adverse Event|2|||
124959692|NCT02561078|449479151|FG000|Overall Study|Death|2|||
124959693|NCT02561078|449479152|FG001|Overall Study|Death|1|||
124767517|NCT02443688|448777374|FG002|Overall Study|Sponsor Request|0|||
124767518|NCT03182374|448777375|FG000|Overall Study|Lost to Follow-up|3|||
124767519|NCT03182374|448777376|FG001|Overall Study|Lost to Follow-up|2|||
124767520|NCT03182374|448777375|FG000|Overall Study|Lack of Efficacy|8|||
124767521|NCT03182374|448777376|FG001|Overall Study|Lack of Efficacy|14|||
124767522|NCT03182374|448777375|FG000|Overall Study|Withdrawal by Subject|1|||
124767523|NCT03182374|448777376|FG001|Overall Study|Withdrawal by Subject|1|||
124959694|NCT02561078|449479151|FG000|Overall Study|Lost to Follow-up|2|||
124959695|NCT02561078|449479152|FG001|Overall Study|Lost to Follow-up|6|||
124959696|NCT02561078|449479151|FG000|Overall Study|Non-Compliance with Study Drug|6|||
124767524|NCT03182374|448777375|FG000|Overall Study|exit for non-compliance|1|||
124767525|NCT03182374|448777376|FG001|Overall Study|exit for non-compliance|1|||
124959697|NCT02561078|449479152|FG001|Overall Study|Non-Compliance with Study Drug|3|||
124959698|NCT02561078|449479151|FG000|Overall Study|Physician Decision|2|||
124959699|NCT02561078|449479152|FG001|Overall Study|Physician Decision|3|||
124959700|NCT02561078|449479151|FG000|Overall Study|Withdrawal by Subject|13|||
124959701|NCT02561078|449479152|FG001|Overall Study|Withdrawal by Subject|10|||
124959702|NCT01983462|449479153|FG000|Overall Study|Adverse Event|1|||
124959703|NCT01983462|449479154|FG001|Overall Study|Adverse Event|0|||
124959704|NCT01983462|449479155|FG002|Overall Study|Adverse Event|0|||
124959705|NCT00684203|449479156|FG000|Overall Study|Adverse Event|6|||
124959706|NCT00684203|449479157|FG001|Overall Study|Adverse Event|4|||
124549325|NCT01890109|447967000|FG000|Overall Study|Withdrawal by Subject|0|||
124549326|NCT01890109|447967001|FG001|Overall Study|Withdrawal by Subject|3|||
124708341|NCT01156844|448557429|FG003|Overall Study|Abnormal test procedure result(s)|2|||
124708342|NCT01156844|448557426|FG000|Overall Study|Withdrawal by Subject|0|||
124708343|NCT01156844|448557427|FG001|Overall Study|Withdrawal by Subject|0|||
124708344|NCT01156844|448557428|FG002|Overall Study|Withdrawal by Subject|2|||
124708345|NCT01156844|448557429|FG003|Overall Study|Withdrawal by Subject|2|||
124708346|NCT01156844|448557426|FG000|Overall Study|Lost to Follow-up|0|||
124708347|NCT01156844|448557427|FG001|Overall Study|Lost to Follow-up|0|||
124708348|NCT01156844|448557428|FG002|Overall Study|Lost to Follow-up|1|||
124708349|NCT01156844|448557429|FG003|Overall Study|Lost to Follow-up|0|||
124708350|NCT01156844|448557426|FG000|Overall Study|Administrative problems|0|||
124708351|NCT01156844|448557427|FG001|Overall Study|Administrative problems|1|||
124708352|NCT01156844|448557428|FG002|Overall Study|Administrative problems|0|||
124708353|NCT01156844|448557429|FG003|Overall Study|Administrative problems|1|||
124708354|NCT01156844|448557426|FG000|Overall Study|Protocol deviation|2|||
124708355|NCT01156844|448557427|FG001|Overall Study|Protocol deviation|0|||
124708356|NCT01156844|448557428|FG002|Overall Study|Protocol deviation|0|||
124708357|NCT01156844|448557429|FG003|Overall Study|Protocol deviation|0|||
124708358|NCT00107276|448557433|FG000|Overall Study|Progression|46|||
124708359|NCT00107276|448557433|FG000|Overall Study|Adverse Event|6|||
124708360|NCT00107276|448557433|FG000|Overall Study|M.D. decision|2|||
124708361|NCT00107276|448557433|FG000|Overall Study|Patient refusal|1|||
124708362|NCT00107276|448557433|FG000|Overall Study|Death|1|||
124708363|NCT00107276|448557433|FG000|Overall Study|Ineligible|16|||
124708364|NCT04846231|448557434|FG000|Overall Study|Lost to Follow-up|1|||
124708365|NCT04846231|448557435|FG001|Overall Study|Lost to Follow-up|0|||
124708366|NCT04846231|448557436|FG002|Overall Study|Lost to Follow-up|0|||
124708367|NCT04846231|448557437|FG003|Overall Study|Lost to Follow-up|0|||
124708368|NCT04846231|448557438|FG004|Overall Study|Lost to Follow-up|0|||
124708369|NCT04846231|448557439|FG005|Overall Study|Lost to Follow-up|0|||
124708370|NCT04846231|448557440|FG006|Overall Study|Lost to Follow-up|0|||
124708371|NCT04846231|448557441|FG007|Overall Study|Lost to Follow-up|1|||
124708372|NCT04846231|448557434|FG000|Overall Study|Withdrawal by Subject|0|||
124708373|NCT04846231|448557435|FG001|Overall Study|Withdrawal by Subject|1|||
124708374|NCT04846231|448557436|FG002|Overall Study|Withdrawal by Subject|2|||
124708375|NCT04846231|448557437|FG003|Overall Study|Withdrawal by Subject|1|||
124708376|NCT04846231|448557438|FG004|Overall Study|Withdrawal by Subject|0|||
124708377|NCT04846231|448557439|FG005|Overall Study|Withdrawal by Subject|0|||
124708378|NCT04846231|448557440|FG006|Overall Study|Withdrawal by Subject|0|||
124708379|NCT04846231|448557441|FG007|Overall Study|Withdrawal by Subject|0|||
124708380|NCT04846231|448557434|FG000|Overall Study|Protocol Violation|0|||
124708381|NCT04846231|448557435|FG001|Overall Study|Protocol Violation|1|||
124708382|NCT04846231|448557436|FG002|Overall Study|Protocol Violation|0|||
124708383|NCT04846231|448557437|FG003|Overall Study|Protocol Violation|0|||
124708384|NCT04846231|448557438|FG004|Overall Study|Protocol Violation|0|||
124708385|NCT04846231|448557439|FG005|Overall Study|Protocol Violation|0|||
124708386|NCT04846231|448557440|FG006|Overall Study|Protocol Violation|0|||
124708387|NCT04846231|448557441|FG007|Overall Study|Protocol Violation|0|||
124708388|NCT04846231|448557434|FG000|Overall Study|Adverse Event|0|||
124708389|NCT04846231|448557435|FG001|Overall Study|Adverse Event|0|||
124708390|NCT04846231|448557436|FG002|Overall Study|Adverse Event|0|||
124708391|NCT04846231|448557437|FG003|Overall Study|Adverse Event|0|||
124708392|NCT04846231|448557438|FG004|Overall Study|Adverse Event|0|||
124708393|NCT04846231|448557439|FG005|Overall Study|Adverse Event|0|||
124708394|NCT04846231|448557440|FG006|Overall Study|Adverse Event|1|||
124708395|NCT04846231|448557441|FG007|Overall Study|Adverse Event|1|||
124708396|NCT02980107|448557442|FG000|Overall Study|Withdrawal by Subject|51|||
124708397|NCT02980107|448557443|FG001|Overall Study|Withdrawal by Subject|62|||
124708398|NCT01448616|448557445|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
124708399|NCT01448616|448557446|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
124708400|NCT01448616|448557447|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
124708401|NCT01448616|448557448|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
124708402|NCT01448616|448557445|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
124708403|NCT01448616|448557446|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
124708404|NCT01448616|448557447|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
124708405|NCT01448616|448557448|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
124959707|NCT00684203|449479158|FG002|Overall Study|Adverse Event|8|||
124959708|NCT00684203|449479159|FG003|Overall Study|Adverse Event|0|||
124767526|NCT03182374|448777375|FG000|Overall Study|one subject was randomized but not treated|1|||
124767527|NCT03182374|448777376|FG001|Overall Study|one subject was randomized but not treated|0|||
124767528|NCT03182374|448777375|FG000|Overall Study|Other reasons|0|||
124767529|NCT03182374|448777376|FG001|Overall Study|Other reasons|3|||
124959709|NCT00684203|449479160|FG004|Overall Study|Adverse Event|0|||
124767530|NCT03198715|448777384|FG000|Overall Study|Death|0|||
124767531|NCT03198715|448777385|FG001|Overall Study|Death|0|||
124767532|NCT03198715|448777386|FG002|Overall Study|Death|1|||
124767533|NCT03198715|448777387|FG003|Overall Study|Death|0|||
124767534|NCT03198715|448777388|FG004|Overall Study|Death|2|||
124767535|NCT03198715|448777384|FG000|Overall Study|Other|0|||
124959710|NCT00684203|449479161|FG005|Overall Study|Adverse Event|0|||
124959711|NCT00684203|449479156|FG000|Overall Study|Protocol-defined clinical event|3|||
124959712|NCT00684203|449479157|FG001|Overall Study|Protocol-defined clinical event|1|||
124959713|NCT00684203|449479158|FG002|Overall Study|Protocol-defined clinical event|0|||
124959714|NCT00684203|449479159|FG003|Overall Study|Protocol-defined clinical event|0|||
124959715|NCT00684203|449479160|FG004|Overall Study|Protocol-defined clinical event|0|||
124959716|NCT00684203|449479161|FG005|Overall Study|Protocol-defined clinical event|0|||
124959717|NCT00684203|449479156|FG000|Overall Study|Withdrawal by Subject|0|||
124959718|NCT00684203|449479157|FG001|Overall Study|Withdrawal by Subject|2|||
124959719|NCT00684203|449479158|FG002|Overall Study|Withdrawal by Subject|1|||
124959720|NCT00684203|449479159|FG003|Overall Study|Withdrawal by Subject|0|||
124959721|NCT00684203|449479160|FG004|Overall Study|Withdrawal by Subject|0|||
124959722|NCT00684203|449479161|FG005|Overall Study|Withdrawal by Subject|0|||
124959723|NCT00684203|449479156|FG000|Overall Study|Did not meet protocol eligibility|0|||
124959724|NCT00684203|449479157|FG001|Overall Study|Did not meet protocol eligibility|1|||
124959725|NCT00684203|449479158|FG002|Overall Study|Did not meet protocol eligibility|0|||
124959726|NCT00684203|449479159|FG003|Overall Study|Did not meet protocol eligibility|0|||
124959727|NCT00684203|449479160|FG004|Overall Study|Did not meet protocol eligibility|0|||
124549327|NCT01890109|447967000|FG000|Overall Study|Lost to Follow-up|1|||
124767536|NCT03198715|448777385|FG001|Overall Study|Other|1|||
124767537|NCT03198715|448777386|FG002|Overall Study|Other|1|||
124767538|NCT03198715|448777387|FG003|Overall Study|Other|0|||
124767539|NCT03198715|448777388|FG004|Overall Study|Other|0|||
124767540|NCT00616759|448777389|FG000|Overall Study|Physician Decision|2|||
124767541|NCT00616759|448777390|FG001|Overall Study|Physician Decision|0|||
124767542|NCT00616759|448777389|FG000|Overall Study|Withdrawal by Subject|1|||
124767543|NCT00616759|448777390|FG001|Overall Study|Withdrawal by Subject|2|||
124767544|NCT02007096|448777391|FG000|Overall Study|medication not available|2|||
124767545|NCT02007096|448777392|FG001|Overall Study|medication not available|0|||
124767546|NCT02007096|448777391|FG000|Overall Study|did not inject saline|0|||
124767547|NCT02007096|448777392|FG001|Overall Study|did not inject saline|3|||
124767548|NCT02007096|448777391|FG000|Overall Study|did not follow postoperative protocol|8|||
124767549|NCT02007096|448777392|FG001|Overall Study|did not follow postoperative protocol|11|||
124767550|NCT02007096|448777391|FG000|Overall Study|converted to open surgery|1|||
124767551|NCT02007096|448777392|FG001|Overall Study|converted to open surgery|1|||
124767552|NCT02007096|448777391|FG000|Overall Study|no mesh placed|0|||
124767553|NCT02007096|448777392|FG001|Overall Study|no mesh placed|1|||
124767554|NCT05365217|448777395|FG000|Treatment Period 1|Withdrawal by Subject|1|||
124767555|NCT05365217|448777396|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124767556|NCT01680341|448777400|FG000|Overall Study|Adverse Event|3|||
124767557|NCT01680341|448777401|FG001|Overall Study|Adverse Event|2|||
124767558|NCT01680341|448777400|FG000|Overall Study|Unclassified|18|||
124767559|NCT01680341|448777401|FG001|Overall Study|Unclassified|15|||
124767560|NCT02558894|448777404|FG000|Overall Study|Death; any cause, entire study duration|28|||
124767561|NCT02558894|448777405|FG001|Overall Study|Death; any cause, entire study duration|31|||
124767562|NCT02558894|448777404|FG000|Overall Study|Withdrawal by Subject|2|||
124767563|NCT02558894|448777405|FG001|Overall Study|Withdrawal by Subject|1|||
124767564|NCT02558894|448777404|FG000|Overall Study|Closure of Part A|2|||
124767565|NCT02558894|448777405|FG001|Overall Study|Closure of Part A|1|||
124767566|NCT02476617|448777411|FG000|Overall Study|Adverse Event|1|||
124767567|NCT02476617|448777411|FG000|Overall Study|Lost to Follow-up|1|||
124767568|NCT03486912|448777412|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
124767569|NCT03486912|448777413|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
124767570|NCT03486912|448777414|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
124767571|NCT03486912|448777415|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
124767572|NCT03486912|448777412|FG000|Treatment Period|Withdrawal by Subject|3|||
124767573|NCT03486912|448777413|FG001|Treatment Period|Withdrawal by Subject|3|||
124959728|NCT00684203|449479161|FG005|Overall Study|Did not meet protocol eligibility|0|||
124959729|NCT00719212|449479162|FG000|Overall Study|Death|41|||
124767574|NCT03486912|448777414|FG002|Treatment Period|Withdrawal by Subject|3|||
124767575|NCT03486912|448777415|FG003|Treatment Period|Withdrawal by Subject|2|||
124767576|NCT03486912|448777412|FG000|Treatment Period|Other Reasons|0|||
124767577|NCT03486912|448777413|FG001|Treatment Period|Other Reasons|2|||
124959730|NCT00719212|449479162|FG000|Overall Study|Lost to Follow-up|2|||
124959731|NCT00719212|449479162|FG000|Overall Study|Withdrawal by Subject|1|||
124767578|NCT03486912|448777414|FG002|Treatment Period|Other Reasons|1|||
124767579|NCT03486912|448777415|FG003|Treatment Period|Other Reasons|1|||
124767580|NCT03486912|448777412|FG000|Treatment Period|Adverse Event|0|||
124767581|NCT03486912|448777413|FG001|Treatment Period|Adverse Event|1|||
124767582|NCT03486912|448777414|FG002|Treatment Period|Adverse Event|1|||
124767583|NCT03486912|448777415|FG003|Treatment Period|Adverse Event|0|||
124767584|NCT03486912|448777412|FG000|Treatment Period|Lost to Follow-up|1|||
124767585|NCT03486912|448777413|FG001|Treatment Period|Lost to Follow-up|0|||
124959732|NCT00508274|449479163|FG000|Overall Study|Adverse Event|5|||
124959733|NCT00508274|449479163|FG000|Overall Study|Death|7|||
124959734|NCT00508274|449479163|FG000|Overall Study|Disease progression|32|||
124959735|NCT00508274|449479163|FG000|Overall Study|Withdrawal by Subject|1|||
124959736|NCT00508274|449479163|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
124959737|NCT00508274|449479163|FG000|Overall Study|Missing|3|||
124959738|NCT03296566|449479164|FG000|Overall Study|Lost to Follow-up|19|||
124959739|NCT03296566|449479165|FG001|Overall Study|Lost to Follow-up|46|||
124959740|NCT03296566|449479164|FG000|Overall Study|Withdrawal by Subject|0|||
124767586|NCT03486912|448777414|FG002|Treatment Period|Lost to Follow-up|0|||
124767587|NCT03486912|448777415|FG003|Treatment Period|Lost to Follow-up|2|||
124767588|NCT02491684|448777416|FG000|Treatment Phase|Adverse Event|2|||
124767589|NCT02491684|448777417|FG001|Treatment Phase|Adverse Event|2|||
124767590|NCT02491684|448777416|FG000|Treatment Phase|Incorrect randomisation|1|||
124767591|NCT02491684|448777417|FG001|Treatment Phase|Incorrect randomisation|0|||
124767592|NCT02491684|448777416|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
124767593|NCT02491684|448777417|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
124767594|NCT01263769|448777419|FG000|Overall Study|Non-Compliant with treatment|1|||
124959741|NCT03296566|449479165|FG001|Overall Study|Withdrawal by Subject|3|||
124959742|NCT03924947|449479170|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
124959743|NCT03924947|449479171|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
124959744|NCT03924947|449479172|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
124959745|NCT03924947|449479173|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
124959746|NCT03924947|449479174|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
124959747|NCT03924947|449479175|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
124959748|NCT01631825|449479176|FG000|Overall Study|Adverse Event|42|||
124959749|NCT01631825|449479176|FG000|Overall Study|Lack of Efficacy|7|||
124959750|NCT01631825|449479176|FG000|Overall Study|Withdrawal by Subject|9|||
124959751|NCT01631825|449479176|FG000|Overall Study|Protocol Violation|4|||
124959752|NCT01631825|449479176|FG000|Overall Study|Discontinuation criteria|1|||
124959753|NCT01631825|449479176|FG000|Overall Study|Physician Decision|2|||
124959754|NCT02499835|449479177|FG000|Overall Study|Withdrawal by Subject|1|||
124959755|NCT02499835|449479178|FG001|Overall Study|Withdrawal by Subject|0|||
124959756|NCT02499835|449479179|FG002|Overall Study|Withdrawal by Subject|0|||
124959757|NCT02499835|449479180|FG003|Overall Study|Withdrawal by Subject|1|||
124959758|NCT02499835|449479177|FG000|Overall Study|Physician Decision|0|||
124959759|NCT02499835|449479178|FG001|Overall Study|Physician Decision|3|||
124959760|NCT02499835|449479179|FG002|Overall Study|Physician Decision|18|||
124959761|NCT02499835|449479180|FG003|Overall Study|Physician Decision|7|||
124959762|NCT02499835|449479177|FG000|Overall Study|Adverse Event|0|||
124959763|NCT02499835|449479178|FG001|Overall Study|Adverse Event|0|||
124959764|NCT02499835|449479179|FG002|Overall Study|Adverse Event|0|||
124959765|NCT02499835|449479180|FG003|Overall Study|Adverse Event|1|||
124959766|NCT02499835|449479177|FG000|Overall Study|Disease progression|2|||
124959767|NCT02499835|449479178|FG001|Overall Study|Disease progression|1|||
124959768|NCT02499835|449479179|FG002|Overall Study|Disease progression|0|||
124959769|NCT02499835|449479180|FG003|Overall Study|Disease progression|7|||
124767595|NCT02242942|448777422|FG000|Overall Study|Death|17|||
124767596|NCT02242942|448777423|FG001|Overall Study|Death|20|||
124767597|NCT02242942|448777424|FG002|Overall Study|Death|2|||
124767598|NCT02242942|448777422|FG000|Overall Study|Physician Decision|1|||
124767599|NCT02242942|448777423|FG001|Overall Study|Physician Decision|0|||
124767600|NCT02242942|448777424|FG002|Overall Study|Physician Decision|0|||
124767601|NCT02242942|448777422|FG000|Overall Study|Withdrawal by Subject|8|||
124767602|NCT02242942|448777423|FG001|Overall Study|Withdrawal by Subject|10|||
124767603|NCT02242942|448777424|FG002|Overall Study|Withdrawal by Subject|0|||
124767604|NCT02242942|448777422|FG000|Overall Study|On-going in Study|190|||
124767605|NCT02242942|448777423|FG001|Overall Study|On-going in Study|186|||
124959770|NCT03226353|449479181|FG000|Overall Study|Withdrawal by Subject|1|||
124959771|NCT03226353|449479181|FG000|Overall Study|Screen Failure|5|||
124959772|NCT00498433|449479183|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
124959773|NCT00498433|449479184|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
124959774|NCT00498433|449479185|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
124959775|NCT00498433|449479183|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
124959776|NCT00498433|449479184|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
124767606|NCT02242942|448777424|FG002|Overall Study|On-going in Study|11|||
124767607|NCT03259230|448777425|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
124767608|NCT03259230|448777426|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
124767609|NCT00561652|448777427|FG000|Overall Study|Withdrawal by Subject|0|||
124767610|NCT00561652|448777428|FG001|Overall Study|Withdrawal by Subject|1|||
124959777|NCT00498433|449479185|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
124959778|NCT00498433|449479183|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
124959779|NCT00498433|449479184|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
124959780|NCT00498433|449479185|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
124959781|NCT00498433|449479183|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
124959782|NCT00498433|449479184|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
124959783|NCT00498433|449479185|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
124959784|NCT04491006|449479186|FG000|Overall Study|Adverse Event|0|||
124959785|NCT04491006|449479187|FG001|Overall Study|Adverse Event|3|||
124959786|NCT04491006|449479188|FG002|Overall Study|Adverse Event|5|||
124959787|NCT04491006|449479186|FG000|Overall Study|Withdrawal by Subject|1|||
124959788|NCT04491006|449479187|FG001|Overall Study|Withdrawal by Subject|0|||
124959789|NCT04491006|449479188|FG002|Overall Study|Withdrawal by Subject|2|||
124959790|NCT00744796|449479190|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
124959791|NCT02581189|449479195|FG000|Overall Study|Failure to return|36|||
124959792|NCT02581189|449479195|FG000|Overall Study|Withdrew consent|5|||
124767611|NCT03019406|448777432|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
124767612|NCT03019406|448777433|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
124767613|NCT03019406|448777434|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
124767614|NCT03019406|448777435|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
124767615|NCT00468169|448777438|FG000|Overall Study|Withdrawal by Subject|1|||
124767616|NCT00468169|448777439|FG001|Overall Study|Withdrawal by Subject|0|||
124767617|NCT00231816|448777440|FG000|Overall Study|Adverse Event|1|||
124767618|NCT00231816|448777441|FG001|Overall Study|Adverse Event|0|||
124767619|NCT00231816|448777440|FG000|Overall Study|Lost to Follow-up|8|||
124767620|NCT00231816|448777441|FG001|Overall Study|Lost to Follow-up|5|||
124767621|NCT00231816|448777440|FG000|Overall Study|Protocol Violation|2|||
124767622|NCT00231816|448777441|FG001|Overall Study|Protocol Violation|3|||
124767623|NCT00231816|448777440|FG000|Overall Study|Withdrawal by Subject|3|||
124767624|NCT00231816|448777441|FG001|Overall Study|Withdrawal by Subject|3|||
124959793|NCT02581189|449479195|FG000|Overall Study|Death|3|||
124959794|NCT02581189|449479195|FG000|Overall Study|Insufficient virological response|2|||
124959795|NCT02581189|449479195|FG000|Overall Study|Other, not specified|7|||
124959796|NCT01514864|449479196|FG000|Overall Study|Disease progression|7|||
124959797|NCT01514864|449479197|FG001|Overall Study|Disease progression|5|||
124959798|NCT01514864|449479196|FG000|Overall Study|Study drug toxicity|2|||
124959799|NCT01514864|449479197|FG001|Overall Study|Study drug toxicity|0|||
124959800|NCT02253147|449479198|FG000|Overall Study|Protocol Violation|30|||
124959801|NCT02253147|449479198|FG000|Overall Study|Did not consent to study extension|9|||
124959802|NCT02253147|449479198|FG000|Overall Study|Conditional re-treatment at W52|5|||
124959803|NCT02253147|449479198|FG000|Overall Study|Lost to Follow-up|2|||
124959804|NCT02253147|449479198|FG000|Overall Study|Withdrawal by Subject|1|||
124959805|NCT02254681|449479200|FG000|Overall Study|Lack of Efficacy|6|||
124959806|NCT00797511|449479201|FG000|Overall Study|Withdrawal by Subject|1|||
124959807|NCT00843115|449479202|FG000|Overall Study|Death|4|||
124959808|NCT00843115|449479202|FG000|Overall Study|Adverse Event|30|||
124959809|NCT00843115|449479202|FG000|Overall Study|Lost to Follow-up|4|||
124959810|NCT00843115|449479202|FG000|Overall Study|Withdrawal by Subject|17|||
124959811|NCT00843115|449479202|FG000|Overall Study|Family wanted meds stopped|1|||
124959812|NCT00843115|449479202|FG000|Overall Study|Family does not want continuation|1|||
124959813|NCT00843115|449479202|FG000|Overall Study|Patient forgot to take meds|1|||
124959814|NCT00843115|449479202|FG000|Overall Study|Does not meet entrance criteria|1|||
124959815|NCT00843115|449479202|FG000|Overall Study|Physician Decision|1|||
124959816|NCT00843115|449479202|FG000|Overall Study|Family discontinued meds|1|||
124959817|NCT00843115|449479202|FG000|Overall Study|patient took for 2 days then stopped|1|||
124959818|NCT00843115|449479202|FG000|Overall Study|patient never took the medication|1|||
124959819|NCT00843115|449479202|FG000|Overall Study|hospitalized due to deterioration|1|||
124959820|NCT00843115|449479202|FG000|Overall Study|week 12 not done|1|||
124959821|NCT00843115|449479202|FG000|Overall Study|Syndrome De Glissement|1|||
124959822|NCT02621047|449479203|FG000|Overall Study|Adverse Event|0|||
124959823|NCT02621047|449479204|FG001|Overall Study|Adverse Event|0|||
124767625|NCT00231816|448777440|FG000|Overall Study|Other|2|||
124767626|NCT00231816|448777441|FG001|Overall Study|Other|1|||
124767627|NCT01283139|448777447|FG000|Overall Study|Lost to Follow-up|5|||
124767628|NCT01283139|448777448|FG001|Overall Study|Lost to Follow-up|2|||
124767629|NCT01283139|448777449|FG002|Overall Study|Lost to Follow-up|3|||
124767630|NCT01283139|448777450|FG003|Overall Study|Lost to Follow-up|1|||
124767631|NCT01283139|448777447|FG000|Overall Study|Withdrawal by Subject|8|||
124767632|NCT01283139|448777448|FG001|Overall Study|Withdrawal by Subject|8|||
124767633|NCT01283139|448777449|FG002|Overall Study|Withdrawal by Subject|6|||
124767634|NCT01283139|448777450|FG003|Overall Study|Withdrawal by Subject|8|||
124959824|NCT02621047|449479205|FG002|Overall Study|Adverse Event|1|||
124959825|NCT01951261|449479206|FG000|Overall Study|Death|1|||
124767635|NCT01283139|448777447|FG000|Overall Study|Death|2|||
124767636|NCT01283139|448777448|FG001|Overall Study|Death|0|||
124767637|NCT01283139|448777449|FG002|Overall Study|Death|2|||
124767638|NCT01283139|448777450|FG003|Overall Study|Death|2|||
124767639|NCT01283139|448777447|FG000|Overall Study|Lack of Efficacy|1|||
124767640|NCT01283139|448777448|FG001|Overall Study|Lack of Efficacy|2|||
124767641|NCT01283139|448777449|FG002|Overall Study|Lack of Efficacy|2|||
124767642|NCT01283139|448777450|FG003|Overall Study|Lack of Efficacy|1|||
124767643|NCT01283139|448777447|FG000|Overall Study|Early termination due to AE/SAE|1|||
124767644|NCT01283139|448777448|FG001|Overall Study|Early termination due to AE/SAE|1|||
124767645|NCT01283139|448777449|FG002|Overall Study|Early termination due to AE/SAE|0|||
124767646|NCT01283139|448777450|FG003|Overall Study|Early termination due to AE/SAE|0|||
124767647|NCT01283139|448777447|FG000|Overall Study|Participant's refusal to continue|0|||
124767648|NCT01283139|448777448|FG001|Overall Study|Participant's refusal to continue|3|||
124767649|NCT01283139|448777449|FG002|Overall Study|Participant's refusal to continue|1|||
124767650|NCT01283139|448777450|FG003|Overall Study|Participant's refusal to continue|1|||
124767651|NCT01283139|448777447|FG000|Overall Study|Pregnancy|0|||
124767652|NCT01283139|448777448|FG001|Overall Study|Pregnancy|1|||
124767653|NCT01283139|448777449|FG002|Overall Study|Pregnancy|1|||
124767654|NCT01283139|448777450|FG003|Overall Study|Pregnancy|0|||
124767655|NCT01283139|448777447|FG000|Overall Study|Missed follow-up visit|0|||
124767656|NCT01283139|448777448|FG001|Overall Study|Missed follow-up visit|1|||
124767657|NCT01283139|448777449|FG002|Overall Study|Missed follow-up visit|2|||
124767658|NCT01283139|448777450|FG003|Overall Study|Missed follow-up visit|2|||
124767659|NCT01283139|448777447|FG000|Overall Study|Participant randomized in error|0|||
124767660|NCT01283139|448777448|FG001|Overall Study|Participant randomized in error|0|||
124767661|NCT01283139|448777449|FG002|Overall Study|Participant randomized in error|1|||
124767662|NCT01283139|448777450|FG003|Overall Study|Participant randomized in error|0|||
124767663|NCT01075243|448777451|FG000|Overall Study|Lost to Follow-up|5|||
124767664|NCT01075243|448777452|FG001|Overall Study|Lost to Follow-up|2|||
124767665|NCT01075243|448777453|FG002|Overall Study|Lost to Follow-up|0|||
124767666|NCT01075243|448777451|FG000|Overall Study|Withdrawal by Subject|1|||
124767667|NCT01075243|448777452|FG001|Overall Study|Withdrawal by Subject|1|||
124767668|NCT01075243|448777453|FG002|Overall Study|Withdrawal by Subject|0|||
124767669|NCT00976274|448777454|FG000|Overall Study|Lost to Follow-up|5|||
124767670|NCT00976274|448777455|FG001|Overall Study|Lost to Follow-up|5|||
124767671|NCT00976274|448777454|FG000|Overall Study|Withdrawal by Subject|1|||
124767672|NCT00976274|448777455|FG001|Overall Study|Withdrawal by Subject|1|||
124767673|NCT00976274|448777454|FG000|Overall Study|Physician Decision|1|||
124767674|NCT00976274|448777455|FG001|Overall Study|Physician Decision|2|||
124767675|NCT00784563|448777458|FG000|Years 1 & 2|Withdrawal by Subject|3|||
124767676|NCT00784563|448777459|FG001|Years 1 & 2|Withdrawal by Subject|2|||
124767677|NCT00784563|448777460|FG002|Years 1 & 2|Withdrawal by Subject|0|||
124767678|NCT00784563|448777458|FG000|Years 1 & 2|Adverse Event|0|||
124767679|NCT00784563|448777459|FG001|Years 1 & 2|Adverse Event|3|||
124767680|NCT00784563|448777460|FG002|Years 1 & 2|Adverse Event|0|||
124767681|NCT00784563|448777458|FG000|Year 3|Withdrawal by Subject|0|||
124767682|NCT00784563|448777459|FG001|Year 3|Withdrawal by Subject|0|||
124767683|NCT00784563|448777460|FG002|Year 3|Withdrawal by Subject|2|||
124767684|NCT00784563|448777458|FG000|Year 3|Adverse Event|0|||
124767685|NCT00784563|448777459|FG001|Year 3|Adverse Event|0|||
124767686|NCT00784563|448777460|FG002|Year 3|Adverse Event|1|||
124767687|NCT01614249|448777461|FG000|Overall Study|Lost to Follow-up|11|||
124767688|NCT01614249|448777462|FG001|Overall Study|Lost to Follow-up|23|||
124767689|NCT02954536|448777463|FG000|Overall Study|Adverse Event|2|||
124767690|NCT02954536|448777463|FG000|Overall Study|Death|12|||
124767691|NCT02946580|448777464|FG000|Overall Study|Withdrawal by Subject|1|||
124767692|NCT02946580|448777465|FG001|Overall Study|Withdrawal by Subject|2|||
124767693|NCT02946580|448777464|FG000|Overall Study|Adverse Event|0|||
124767694|NCT02946580|448777465|FG001|Overall Study|Adverse Event|2|||
124767695|NCT02946580|448777464|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
124767696|NCT02946580|448777465|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
124767697|NCT04764162|448777466|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
124767698|NCT04764162|448777467|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
124767699|NCT00791934|448777468|FG000|Overall Study|Withdrawal by Subject|2|||
124767700|NCT00791934|448777468|FG000|Overall Study|Did not consent for extended follow-up|13|||
124767701|NCT02018562|448777469|FG000|Overall Study|Withdrawal by Subject|2|||
124767702|NCT02018562|448777470|FG001|Overall Study|Withdrawal by Subject|0|||
124767703|NCT02018562|448777469|FG000|Overall Study|Discharged prior to study completion|1|||
124767704|NCT02018562|448777470|FG001|Overall Study|Discharged prior to study completion|0|||
124767705|NCT05194124|448777471|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
124767706|NCT05194124|448777472|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
124767707|NCT05194124|448777473|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
124767708|NCT05194124|448777474|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
124767709|NCT05194124|448777475|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
124767710|NCT05194124|448777476|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
124767711|NCT05194124|448777477|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
124767712|NCT05194124|448777478|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
124767713|NCT05194124|448777479|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
124767714|NCT05194124|448777480|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
124767715|NCT05194124|448777471|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
124767716|NCT05194124|448777472|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
124959826|NCT01951261|449479207|FG001|Overall Study|Death|0|||
124959827|NCT01951261|449479206|FG000|Overall Study|Lost to Follow-up|4|||
124767717|NCT05194124|448777473|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
124767718|NCT05194124|448777474|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
124767719|NCT05194124|448777475|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
124767720|NCT05194124|448777476|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
124767721|NCT05194124|448777477|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
124767722|NCT05194124|448777478|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
124959828|NCT01951261|449479207|FG001|Overall Study|Lost to Follow-up|3|||
124959829|NCT01951261|449479206|FG000|Overall Study|Protocol Violation|4|||
124959830|NCT01951261|449479207|FG001|Overall Study|Protocol Violation|3|||
124959831|NCT00495612|449479208|FG000|Overall Study|Lost to Follow-up|1|||
124959832|NCT00495612|449479209|FG001|Overall Study|Lost to Follow-up|0|||
124959833|NCT00495612|449479208|FG000|Overall Study|Subject's Decision to Withdraw|3|||
124959834|NCT00495612|449479209|FG001|Overall Study|Subject's Decision to Withdraw|0|||
124959835|NCT00818519|449479212|FG000|Overall Study|Adverse Event|2|||
124959836|NCT00818519|449479213|FG001|Overall Study|Adverse Event|2|||
124959837|NCT00818519|449479212|FG000|Overall Study|Lost to Follow-up|4|||
124959838|NCT00818519|449479213|FG001|Overall Study|Lost to Follow-up|6|||
124959839|NCT00818519|449479212|FG000|Overall Study|Protocol Violation|2|||
124959840|NCT00818519|449479213|FG001|Overall Study|Protocol Violation|1|||
124959841|NCT00818519|449479212|FG000|Overall Study|Pregnancy|0|||
124959842|NCT00818519|449479213|FG001|Overall Study|Pregnancy|1|||
124959843|NCT00818519|449479212|FG000|Overall Study|Withdrawal by Subject|4|||
124959844|NCT00818519|449479213|FG001|Overall Study|Withdrawal by Subject|9|||
124959845|NCT00818519|449479212|FG000|Overall Study|participant recovered completely|1|||
124959846|NCT00818519|449479213|FG001|Overall Study|participant recovered completely|0|||
124959847|NCT00818519|449479212|FG000|Overall Study|participant will leave for long tme|1|||
124959848|NCT00818519|449479213|FG001|Overall Study|participant will leave for long tme|0|||
124959849|NCT03740919|449479215|FG000|Lead-in Period|Lost to Follow-up|1|||
124959850|NCT03740919|449479216|FG001|Lead-in Period|Lost to Follow-up|0|||
124959851|NCT03740919|449479217|FG002|Lead-in Period|Lost to Follow-up|0|||
124959852|NCT03740919|449479218|FG003|Lead-in Period|Lost to Follow-up|0|||
124959853|NCT03740919|449479215|FG000|Lead-in Period|Physician Decision|2|||
124959854|NCT03740919|449479216|FG001|Lead-in Period|Physician Decision|0|||
124959855|NCT03740919|449479217|FG002|Lead-in Period|Physician Decision|0|||
124959856|NCT03740919|449479218|FG003|Lead-in Period|Physician Decision|0|||
124959857|NCT03740919|449479215|FG000|Lead-in Period|Protocol Violation|1|||
124959858|NCT03740919|449479216|FG001|Lead-in Period|Protocol Violation|0|||
124959859|NCT03740919|449479217|FG002|Lead-in Period|Protocol Violation|0|||
124959860|NCT03740919|449479218|FG003|Lead-in Period|Protocol Violation|0|||
124959861|NCT03740919|449479215|FG000|Lead-in Period|Withdrawal by Subject|10|||
124959862|NCT03740919|449479216|FG001|Lead-in Period|Withdrawal by Subject|0|||
124959863|NCT03740919|449479217|FG002|Lead-in Period|Withdrawal by Subject|0|||
124959864|NCT03740919|449479218|FG003|Lead-in Period|Withdrawal by Subject|0|||
124959865|NCT03740919|449479215|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
124959866|NCT03740919|449479216|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
124959867|NCT03740919|449479217|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
124959868|NCT03740919|449479218|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
124959869|NCT03740919|449479215|FG000|Lead-in Period|Study Task Too Burdensome|1|||
124959870|NCT03740919|449479216|FG001|Lead-in Period|Study Task Too Burdensome|0|||
124959871|NCT03740919|449479217|FG002|Lead-in Period|Study Task Too Burdensome|0|||
124959872|NCT03740919|449479218|FG003|Lead-in Period|Study Task Too Burdensome|0|||
124959873|NCT03740919|449479215|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
124767723|NCT05194124|448777479|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
124767724|NCT05194124|448777480|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
124767725|NCT04609319|448777481|FG000|Overall Study|Death|64|||
124767726|NCT04609319|448777482|FG001|Overall Study|Death|49|||
124767727|NCT04609319|448777483|FG002|Overall Study|Death|1|||
124959874|NCT03740919|449479216|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
124959875|NCT03740919|449479217|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
124959876|NCT03740919|449479218|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
124959877|NCT03740919|449479215|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
124959878|NCT03740919|449479216|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
124959879|NCT03740919|449479217|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
124959880|NCT03740919|449479218|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
124767728|NCT04609319|448777481|FG000|Overall Study|Withdrawal of consent|15|||
124767729|NCT04609319|448777482|FG001|Overall Study|Withdrawal of consent|3|||
124959881|NCT03740919|449479215|FG000|Treatment Period|Adverse Event|0|||
124959882|NCT03740919|449479216|FG001|Treatment Period|Adverse Event|0|||
124959883|NCT03740919|449479217|FG002|Treatment Period|Adverse Event|2|||
124959884|NCT03740919|449479218|FG003|Treatment Period|Adverse Event|0|||
124959885|NCT03740919|449479215|FG000|Treatment Period|Protocol Violation|0|||
124959886|NCT03740919|449479216|FG001|Treatment Period|Protocol Violation|1|||
124959887|NCT03740919|449479217|FG002|Treatment Period|Protocol Violation|0|||
124549328|NCT01890109|447967001|FG001|Overall Study|Lost to Follow-up|2|||
124549329|NCT00568776|447967004|FG000|Overall Study|Adverse Event|8|||
124767730|NCT04609319|448777483|FG002|Overall Study|Withdrawal of consent|0|||
124767731|NCT04609319|448777481|FG000|Overall Study|Lost to Follow-up|20|||
124767732|NCT04609319|448777482|FG001|Overall Study|Lost to Follow-up|33|||
124767733|NCT04609319|448777483|FG002|Overall Study|Lost to Follow-up|0|||
124767734|NCT04609319|448777481|FG000|Overall Study|Alive until end of follow-up|60|||
124767735|NCT04609319|448777482|FG001|Overall Study|Alive until end of follow-up|53|||
124767736|NCT04609319|448777483|FG002|Overall Study|Alive until end of follow-up|1|||
124767737|NCT03474588|448777494|FG000|Overall Study|Withdrawal by Subject|4|||
124767738|NCT03474588|448777495|FG001|Overall Study|Withdrawal by Subject|3|||
124767739|NCT03474588|448777494|FG000|Overall Study|Death|0|||
124767740|NCT03474588|448777495|FG001|Overall Study|Death|1|||
124767741|NCT03804528|448777497|FG000|Overall Study|Time Commitment|18|||
124767742|NCT03804528|448777497|FG000|Overall Study|Health Reasons|5|||
124767743|NCT01607957|448777498|FG000|Overall Study|Not treated|1|||
124767744|NCT01607957|448777499|FG001|Overall Study|Not treated|1|||
124767745|NCT01607957|448777498|FG000|Overall Study|Death|367|||
124767746|NCT01607957|448777499|FG001|Overall Study|Death|211|||
124767747|NCT01607957|448777498|FG000|Overall Study|Lost to Follow-up|3|||
124767748|NCT01607957|448777499|FG001|Overall Study|Lost to Follow-up|3|||
124767749|NCT01607957|448777498|FG000|Overall Study|Participant refusal|1|||
124767750|NCT01607957|448777499|FG001|Overall Study|Participant refusal|0|||
124767751|NCT03589859|448777508|FG000|Overall Study|Withdrawal by Subject|0|||
124708406|NCT01448616|448557445|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
124708407|NCT01448616|448557446|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
124708408|NCT01448616|448557447|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
124708409|NCT01448616|448557448|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
124708410|NCT01448616|448557445|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
124708411|NCT01448616|448557446|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
124708412|NCT01448616|448557447|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
124708413|NCT01448616|448557448|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
124708414|NCT01448616|448557445|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
124708415|NCT01448616|448557446|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
124708416|NCT01448616|448557447|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
124708417|NCT01448616|448557448|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
124708418|NCT00397540|448557451|FG000|Overall Study|short follow-up duration < 12 months|1|||
124708419|NCT00397540|448557452|FG001|Overall Study|short follow-up duration < 12 months|0|||
124708420|NCT00485173|448557456|FG000|Overall Study|Death|4|||
124708421|NCT00485173|448557457|FG001|Overall Study|Death|3|||
124708422|NCT00485173|448557456|FG000|Overall Study|Lost to Follow-up|32|||
124708423|NCT00485173|448557457|FG001|Overall Study|Lost to Follow-up|61|||
124708424|NCT00746811|448557458|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
124708425|NCT00746811|448557459|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
124708426|NCT00545779|448557460|FG000|Overall Study|Violation of selection criteria at entry|8|||
124708427|NCT00545779|448557460|FG000|Overall Study|Other protocol violation|1|||
124708428|NCT00545779|448557460|FG000|Overall Study|Did not cooperate|7|||
124708429|NCT00545779|448557460|FG000|Overall Study|Withdrawal by Subject|20|||
124708430|NCT00545779|448557460|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
124708431|NCT00545779|448557460|FG000|Overall Study|Failure to return|3|||
124708432|NCT04712669|448557465|FG000|Double Blind Phase|Adverse Event|4|||
124708433|NCT04712669|448557466|FG001|Double Blind Phase|Adverse Event|4|||
124708434|NCT04712669|448557467|FG002|Double Blind Phase|Adverse Event|3|||
124767752|NCT03589859|448777509|FG001|Overall Study|Withdrawal by Subject|6|||
124708435|NCT04712669|448557468|FG003|Double Blind Phase|Adverse Event|0|||
124708436|NCT04712669|448557469|FG004|Double Blind Phase|Adverse Event|0|||
124708437|NCT04712669|448557470|FG005|Double Blind Phase|Adverse Event|0|||
124708438|NCT04712669|448557471|FG006|Double Blind Phase|Adverse Event|0|||
124767753|NCT02331134|448777510|FG000|Overall Study|Withdrawal by Subject|1|||
124767754|NCT04966013|448777511|FG000|Overall Study|Withdrawal by Subject|0|||
124708439|NCT04712669|448557472|FG007|Double Blind Phase|Adverse Event|0|||
124767755|NCT04966013|448777512|FG001|Overall Study|Withdrawal by Subject|2|||
124767756|NCT04966013|448777513|FG002|Overall Study|Withdrawal by Subject|1|||
124767757|NCT04966013|448777511|FG000|Overall Study|Adverse Event|2|||
124767758|NCT04966013|448777512|FG001|Overall Study|Adverse Event|1|||
124959888|NCT03740919|449479218|FG003|Treatment Period|Protocol Violation|0|||
124959889|NCT03740919|449479215|FG000|Treatment Period|Withdrawal by Subject|0|||
124767759|NCT04966013|448777513|FG002|Overall Study|Adverse Event|1|||
124767760|NCT03518086|448777517|FG000|Overall Study|Adverse Event|23|||
124767761|NCT03518086|448777518|FG001|Overall Study|Adverse Event|15|||
124767762|NCT03518086|448777519|FG002|Overall Study|Adverse Event|3|||
124767763|NCT03518086|448777520|FG003|Overall Study|Adverse Event|2|||
124767764|NCT03518086|448777517|FG000|Overall Study|Withdrawal by Subject|8|||
124767765|NCT03518086|448777518|FG001|Overall Study|Withdrawal by Subject|5|||
124767766|NCT03518086|448777519|FG002|Overall Study|Withdrawal by Subject|1|||
124767767|NCT03518086|448777520|FG003|Overall Study|Withdrawal by Subject|0|||
124767768|NCT03518086|448777517|FG000|Overall Study|Lack of Efficacy|5|||
124767769|NCT03518086|448777518|FG001|Overall Study|Lack of Efficacy|5|||
124767770|NCT03518086|448777519|FG002|Overall Study|Lack of Efficacy|0|||
124767771|NCT03518086|448777520|FG003|Overall Study|Lack of Efficacy|2|||
124767772|NCT03518086|448777517|FG000|Overall Study|Protocol Violation|1|||
124767773|NCT03518086|448777518|FG001|Overall Study|Protocol Violation|5|||
124767774|NCT03518086|448777519|FG002|Overall Study|Protocol Violation|1|||
124767775|NCT03518086|448777520|FG003|Overall Study|Protocol Violation|3|||
124767776|NCT03518086|448777517|FG000|Overall Study|Lost to Follow-up|0|||
124767777|NCT03518086|448777518|FG001|Overall Study|Lost to Follow-up|3|||
124767778|NCT03518086|448777519|FG002|Overall Study|Lost to Follow-up|0|||
124767779|NCT03518086|448777520|FG003|Overall Study|Lost to Follow-up|0|||
124767780|NCT03518086|448777517|FG000|Overall Study|Insufficient Diary Data|0|||
124767781|NCT03518086|448777518|FG001|Overall Study|Insufficient Diary Data|2|||
124767782|NCT03518086|448777519|FG002|Overall Study|Insufficient Diary Data|0|||
124767783|NCT03518086|448777520|FG003|Overall Study|Insufficient Diary Data|0|||
124767784|NCT03518086|448777517|FG000|Overall Study|Non- compliance to Protocol|0|||
124767785|NCT03518086|448777518|FG001|Overall Study|Non- compliance to Protocol|1|||
124767786|NCT03518086|448777519|FG002|Overall Study|Non- compliance to Protocol|0|||
124767787|NCT03518086|448777520|FG003|Overall Study|Non- compliance to Protocol|0|||
124767788|NCT03518086|448777517|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
124767789|NCT03518086|448777518|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
124767790|NCT03518086|448777519|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
124767791|NCT03518086|448777520|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
124767792|NCT03518086|448777517|FG000|Overall Study|Site Terminated by Sponsor|0|||
124767793|NCT03518086|448777518|FG001|Overall Study|Site Terminated by Sponsor|1|||
124767794|NCT03518086|448777519|FG002|Overall Study|Site Terminated by Sponsor|0|||
124767795|NCT03518086|448777520|FG003|Overall Study|Site Terminated by Sponsor|0|||
124767796|NCT03518086|448777517|FG000|Overall Study|Pregnancy|0|||
124767797|NCT03518086|448777518|FG001|Overall Study|Pregnancy|0|||
124767798|NCT03518086|448777519|FG002|Overall Study|Pregnancy|0|||
124767799|NCT03518086|448777520|FG003|Overall Study|Pregnancy|2|||
124767800|NCT05967260|448777521|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
124767801|NCT05967260|448777522|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
124767802|NCT00626106|448777523|FG000|Overall Study|Withdrawal by Subject|2|||
124767803|NCT00626106|448777524|FG001|Overall Study|Withdrawal by Subject|1|||
124767804|NCT00626106|448777523|FG000|Overall Study|Lost to Follow-up|1|||
124767805|NCT00626106|448777524|FG001|Overall Study|Lost to Follow-up|4|||
124767806|NCT00626106|448777523|FG000|Overall Study|Death|64|||
124767807|NCT00626106|448777524|FG001|Overall Study|Death|19|||
124767808|NCT03007966|448779104|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
124767809|NCT03007966|448779105|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
124767810|NCT01428258|448779106|FG000|Intervention 1|Withdrawal by Subject|2|||
124767811|NCT01428258|448779107|FG001|Intervention 1|Withdrawal by Subject|0|||
124767812|NCT00248625|448779108|FG000|Overall Study|Withdrawal by Subject|0|||
124767813|NCT00248625|448779109|FG001|Overall Study|Withdrawal by Subject|2|||
124767814|NCT03085095|448779110|FG000|Overall Study|Adverse Event|23|||
124767815|NCT03085095|448779111|FG001|Overall Study|Adverse Event|8|||
124767816|NCT03085095|448779110|FG000|Overall Study|Protocol Violation|0|||
124767817|NCT03085095|448779111|FG001|Overall Study|Protocol Violation|1|||
124549330|NCT00568776|447967005|FG001|Overall Study|Adverse Event|8|||
124549331|NCT00568776|447967006|FG002|Overall Study|Adverse Event|10|||
124549332|NCT00568776|447967007|FG003|Overall Study|Adverse Event|8|||
124549333|NCT00568776|447967004|FG000|Overall Study|Death|0|||
124549334|NCT00568776|447967005|FG001|Overall Study|Death|1|||
124767818|NCT03085095|448779110|FG000|Overall Study|Lost to Follow-up|2|||
124767819|NCT03085095|448779111|FG001|Overall Study|Lost to Follow-up|1|||
124767820|NCT03085095|448779110|FG000|Overall Study|Withdrawal by Subject|17|||
124767821|NCT03085095|448779111|FG001|Overall Study|Withdrawal by Subject|6|||
124767822|NCT03085095|448779110|FG000|Overall Study|Physician Decision|9|||
124767823|NCT03085095|448779111|FG001|Overall Study|Physician Decision|3|||
124767824|NCT03085095|448779110|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
124767825|NCT03085095|448779111|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
124767826|NCT03085095|448779110|FG000|Overall Study|Did not Receive Study Drug|2|||
124767827|NCT03085095|448779111|FG001|Overall Study|Did not Receive Study Drug|2|||
124767828|NCT03085095|448779110|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
124767829|NCT03085095|448779111|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
124767830|NCT00408317|448779112|FG000|First Intervention Period|Adverse Event|0|||
124767831|NCT00408317|448779113|FG001|First Intervention Period|Adverse Event|1|||
124767832|NCT00408317|448779112|FG000|Second Intervention Period|Adverse Event|2|||
124767833|NCT00408317|448779113|FG001|Second Intervention Period|Adverse Event|0|||
124767834|NCT00408317|448779112|FG000|Second Intervention Period|Protocol Violation|0|||
124767835|NCT00408317|448779113|FG001|Second Intervention Period|Protocol Violation|1|||
124767836|NCT00408317|448779112|FG000|Second Intervention Period|Withdrawal of consent|0|||
124767837|NCT00408317|448779113|FG001|Second Intervention Period|Withdrawal of consent|1|||
124767838|NCT00286468|448779114|FG000|Overall Study|Hyperglycemic Rescue|28|||
124767839|NCT00286468|448779115|FG001|Overall Study|Hyperglycemic Rescue|30|||
124767840|NCT00286468|448779116|FG002|Overall Study|Hyperglycemic Rescue|31|||
124767841|NCT00286468|448779114|FG000|Overall Study|Adverse Event|2|||
124767842|NCT00286468|448779115|FG001|Overall Study|Adverse Event|6|||
124767843|NCT00286468|448779116|FG002|Overall Study|Adverse Event|4|||
124463511|NCT04623242|447656528|FG004|Overall Study|Subject unblinded to mutation status|0|||
124708440|NCT04712669|448557465|FG000|Double Blind Phase|Physician Decision|1|||
124708441|NCT04712669|448557466|FG001|Double Blind Phase|Physician Decision|0|||
124708442|NCT04712669|448557467|FG002|Double Blind Phase|Physician Decision|0|||
124708443|NCT04712669|448557468|FG003|Double Blind Phase|Physician Decision|0|||
124708444|NCT04712669|448557469|FG004|Double Blind Phase|Physician Decision|0|||
124708445|NCT04712669|448557470|FG005|Double Blind Phase|Physician Decision|0|||
124708446|NCT04712669|448557471|FG006|Double Blind Phase|Physician Decision|0|||
124708447|NCT04712669|448557472|FG007|Double Blind Phase|Physician Decision|0|||
124708448|NCT04712669|448557465|FG000|Double Blind Phase|Withdrawal by Subject|3|||
124708449|NCT04712669|448557466|FG001|Double Blind Phase|Withdrawal by Subject|6|||
124708450|NCT04712669|448557467|FG002|Double Blind Phase|Withdrawal by Subject|0|||
124708451|NCT04712669|448557468|FG003|Double Blind Phase|Withdrawal by Subject|0|||
124708452|NCT04712669|448557469|FG004|Double Blind Phase|Withdrawal by Subject|0|||
124708453|NCT04712669|448557470|FG005|Double Blind Phase|Withdrawal by Subject|0|||
124708454|NCT04712669|448557471|FG006|Double Blind Phase|Withdrawal by Subject|0|||
124708455|NCT04712669|448557472|FG007|Double Blind Phase|Withdrawal by Subject|0|||
124708456|NCT04712669|448557465|FG000|Double Blind Phase|Termination by Sponsor|0|||
124708457|NCT04712669|448557466|FG001|Double Blind Phase|Termination by Sponsor|0|||
124708458|NCT04712669|448557467|FG002|Double Blind Phase|Termination by Sponsor|1|||
124708459|NCT04712669|448557468|FG003|Double Blind Phase|Termination by Sponsor|0|||
124708460|NCT04712669|448557469|FG004|Double Blind Phase|Termination by Sponsor|0|||
124708461|NCT04712669|448557470|FG005|Double Blind Phase|Termination by Sponsor|0|||
124708462|NCT04712669|448557471|FG006|Double Blind Phase|Termination by Sponsor|0|||
124708463|NCT04712669|448557472|FG007|Double Blind Phase|Termination by Sponsor|0|||
124708464|NCT04712669|448557465|FG000|Open Label Phase|Adverse Event|0|||
124708465|NCT04712669|448557466|FG001|Open Label Phase|Adverse Event|0|||
124708466|NCT04712669|448557467|FG002|Open Label Phase|Adverse Event|0|||
124708467|NCT04712669|448557468|FG003|Open Label Phase|Adverse Event|1|||
124708468|NCT04712669|448557469|FG004|Open Label Phase|Adverse Event|1|||
124708469|NCT04712669|448557470|FG005|Open Label Phase|Adverse Event|3|||
124708470|NCT04712669|448557471|FG006|Open Label Phase|Adverse Event|1|||
124708471|NCT04712669|448557472|FG007|Open Label Phase|Adverse Event|2|||
124708472|NCT04712669|448557465|FG000|Open Label Phase|Death|0|||
124708473|NCT04712669|448557466|FG001|Open Label Phase|Death|0|||
124708474|NCT04712669|448557467|FG002|Open Label Phase|Death|0|||
124708475|NCT04712669|448557468|FG003|Open Label Phase|Death|1|||
124708476|NCT04712669|448557469|FG004|Open Label Phase|Death|0|||
124708477|NCT04712669|448557470|FG005|Open Label Phase|Death|0|||
124708478|NCT04712669|448557471|FG006|Open Label Phase|Death|0|||
124708479|NCT04712669|448557472|FG007|Open Label Phase|Death|0|||
124708480|NCT04712669|448557465|FG000|Open Label Phase|Lack of Efficacy|0|||
124708481|NCT04712669|448557466|FG001|Open Label Phase|Lack of Efficacy|0|||
124767844|NCT00286468|448779114|FG000|Overall Study|Protocol Violation|0|||
124767845|NCT00286468|448779115|FG001|Overall Study|Protocol Violation|3|||
124767846|NCT00286468|448779116|FG002|Overall Study|Protocol Violation|1|||
124767847|NCT00286468|448779114|FG000|Overall Study|Lost to Follow-up|1|||
124767848|NCT00286468|448779115|FG001|Overall Study|Lost to Follow-up|1|||
124959890|NCT03740919|449479216|FG001|Treatment Period|Withdrawal by Subject|7|||
124959891|NCT03740919|449479217|FG002|Treatment Period|Withdrawal by Subject|6|||
124708482|NCT04712669|448557467|FG002|Open Label Phase|Lack of Efficacy|0|||
124708483|NCT04712669|448557468|FG003|Open Label Phase|Lack of Efficacy|0|||
124708484|NCT04712669|448557469|FG004|Open Label Phase|Lack of Efficacy|1|||
124708485|NCT04712669|448557470|FG005|Open Label Phase|Lack of Efficacy|0|||
124708486|NCT04712669|448557471|FG006|Open Label Phase|Lack of Efficacy|0|||
124708487|NCT04712669|448557472|FG007|Open Label Phase|Lack of Efficacy|0|||
124708488|NCT04712669|448557465|FG000|Open Label Phase|Lost to Follow-up|0|||
124708489|NCT04712669|448557466|FG001|Open Label Phase|Lost to Follow-up|0|||
124708490|NCT04712669|448557467|FG002|Open Label Phase|Lost to Follow-up|0|||
124708491|NCT04712669|448557468|FG003|Open Label Phase|Lost to Follow-up|0|||
124767849|NCT00286468|448779116|FG002|Overall Study|Lost to Follow-up|2|||
124767850|NCT00286468|448779114|FG000|Overall Study|Withdrawal by Subject|3|||
124767851|NCT00286468|448779115|FG001|Overall Study|Withdrawal by Subject|8|||
124708492|NCT04712669|448557469|FG004|Open Label Phase|Lost to Follow-up|0|||
124549335|NCT00568776|447967006|FG002|Overall Study|Death|4|||
124549336|NCT00568776|447967007|FG003|Overall Study|Death|3|||
124549337|NCT00568776|447967004|FG000|Overall Study|Physician Decision|0|||
124549338|NCT00568776|447967005|FG001|Overall Study|Physician Decision|2|||
124549339|NCT00568776|447967006|FG002|Overall Study|Physician Decision|0|||
124549340|NCT00568776|447967007|FG003|Overall Study|Physician Decision|0|||
124549341|NCT00568776|447967004|FG000|Overall Study|Lack of Efficacy|2|||
124549342|NCT00568776|447967005|FG001|Overall Study|Lack of Efficacy|2|||
124549343|NCT00568776|447967006|FG002|Overall Study|Lack of Efficacy|2|||
124549344|NCT00568776|447967007|FG003|Overall Study|Lack of Efficacy|4|||
124549345|NCT00568776|447967004|FG000|Overall Study|Lost to Follow-up|1|||
124549346|NCT00568776|447967005|FG001|Overall Study|Lost to Follow-up|1|||
124549347|NCT00568776|447967006|FG002|Overall Study|Lost to Follow-up|1|||
124549348|NCT00568776|447967007|FG003|Overall Study|Lost to Follow-up|1|||
124549349|NCT00568776|447967004|FG000|Overall Study|Protocol Violation|1|||
124549350|NCT00568776|447967005|FG001|Overall Study|Protocol Violation|0|||
124549351|NCT00568776|447967006|FG002|Overall Study|Protocol Violation|1|||
124549352|NCT00568776|447967007|FG003|Overall Study|Protocol Violation|1|||
124549353|NCT00568776|447967004|FG000|Overall Study|Withdrawal by Subject|13|||
124549354|NCT00568776|447967005|FG001|Overall Study|Withdrawal by Subject|15|||
124549355|NCT00568776|447967006|FG002|Overall Study|Withdrawal by Subject|13|||
124549356|NCT00568776|447967007|FG003|Overall Study|Withdrawal by Subject|7|||
124549357|NCT00568776|447967004|FG000|Overall Study|Loss of Caregiver|0|||
124549358|NCT00568776|447967005|FG001|Overall Study|Loss of Caregiver|2|||
124549359|NCT00568776|447967006|FG002|Overall Study|Loss of Caregiver|1|||
124549360|NCT00568776|447967007|FG003|Overall Study|Loss of Caregiver|2|||
124549361|NCT00568776|447967004|FG000|Overall Study|Sponsor Decision|2|||
124549362|NCT00568776|447967005|FG001|Overall Study|Sponsor Decision|2|||
124549363|NCT00568776|447967006|FG002|Overall Study|Sponsor Decision|41|||
124549364|NCT00568776|447967007|FG003|Overall Study|Sponsor Decision|42|||
124549365|NCT00568776|447967004|FG000|Overall Study|Miscellaeneous|3|||
124549366|NCT00568776|447967005|FG001|Overall Study|Miscellaeneous|3|||
124549367|NCT00568776|447967006|FG002|Overall Study|Miscellaeneous|1|||
124549368|NCT00568776|447967007|FG003|Overall Study|Miscellaeneous|4|||
124549369|NCT00996632|447967008|FG000|Overall Study|Physician Decision|0|||
124549370|NCT00996632|447967009|FG001|Overall Study|Physician Decision|0|||
124549371|NCT02861534|447967012|FG000|Overall Study|Death|541|||
124549372|NCT02861534|447967013|FG001|Overall Study|Death|552|||
124549373|NCT02861534|447967012|FG000|Overall Study|Lost to Follow-up|14|||
124549374|NCT02861534|447967013|FG001|Overall Study|Lost to Follow-up|14|||
124549375|NCT02861534|447967012|FG000|Overall Study|Site Terminated by Sponsor|4|||
124549376|NCT02861534|447967013|FG001|Overall Study|Site Terminated by Sponsor|3|||
124549377|NCT02861534|447967012|FG000|Overall Study|Withdrawal by Subject|15|||
124549378|NCT02861534|447967013|FG001|Overall Study|Withdrawal by Subject|18|||
124549379|NCT02780115|447967014|FG000|Overall Study|Withdrawal by Subject|0|||
124549380|NCT02780115|447967015|FG001|Overall Study|Withdrawal by Subject|1|||
124549381|NCT02780115|447967016|FG002|Overall Study|Withdrawal by Subject|1|||
124549382|NCT02780115|447967017|FG003|Overall Study|Withdrawal by Subject|0|||
124708493|NCT04712669|448557470|FG005|Open Label Phase|Lost to Follow-up|0|||
124708494|NCT04712669|448557471|FG006|Open Label Phase|Lost to Follow-up|1|||
124708495|NCT04712669|448557472|FG007|Open Label Phase|Lost to Follow-up|1|||
124708496|NCT04712669|448557465|FG000|Open Label Phase|Physician Decision|0|||
124708497|NCT04712669|448557466|FG001|Open Label Phase|Physician Decision|0|||
124708498|NCT04712669|448557467|FG002|Open Label Phase|Physician Decision|0|||
124708499|NCT04712669|448557468|FG003|Open Label Phase|Physician Decision|1|||
124708500|NCT04712669|448557469|FG004|Open Label Phase|Physician Decision|0|||
124708501|NCT04712669|448557470|FG005|Open Label Phase|Physician Decision|0|||
124708502|NCT04712669|448557471|FG006|Open Label Phase|Physician Decision|0|||
124708503|NCT04712669|448557472|FG007|Open Label Phase|Physician Decision|0|||
124708504|NCT04712669|448557465|FG000|Open Label Phase|Withdrawal by Subject|0|||
124708505|NCT04712669|448557466|FG001|Open Label Phase|Withdrawal by Subject|0|||
124708506|NCT04712669|448557467|FG002|Open Label Phase|Withdrawal by Subject|0|||
124708507|NCT04712669|448557468|FG003|Open Label Phase|Withdrawal by Subject|1|||
124708508|NCT04712669|448557469|FG004|Open Label Phase|Withdrawal by Subject|5|||
124708509|NCT04712669|448557470|FG005|Open Label Phase|Withdrawal by Subject|5|||
124708510|NCT04712669|448557471|FG006|Open Label Phase|Withdrawal by Subject|0|||
124708511|NCT04712669|448557472|FG007|Open Label Phase|Withdrawal by Subject|4|||
124708512|NCT04712669|448557465|FG000|Open Label Phase|Termination by Sponsor|0|||
124708513|NCT04712669|448557466|FG001|Open Label Phase|Termination by Sponsor|0|||
124708514|NCT04712669|448557467|FG002|Open Label Phase|Termination by Sponsor|0|||
124708515|NCT04712669|448557468|FG003|Open Label Phase|Termination by Sponsor|11|||
124708516|NCT04712669|448557469|FG004|Open Label Phase|Termination by Sponsor|9|||
124708517|NCT04712669|448557470|FG005|Open Label Phase|Termination by Sponsor|14|||
124708518|NCT04712669|448557471|FG006|Open Label Phase|Termination by Sponsor|0|||
124549383|NCT02780115|447967018|FG004|Overall Study|Withdrawal by Subject|0|||
124549384|NCT02780115|447967014|FG000|Overall Study|Adverse Event|0|||
124708519|NCT04712669|448557472|FG007|Open Label Phase|Termination by Sponsor|14|||
124708520|NCT01819272|448559414|FG000|Overall Study|Adverse Event|1|||
124767852|NCT00286468|448779116|FG002|Overall Study|Withdrawal by Subject|11|||
124767853|NCT00286468|448779114|FG000|Overall Study|Physician Decision|3|||
124767854|NCT00286468|448779115|FG001|Overall Study|Physician Decision|2|||
124767855|NCT00286468|448779116|FG002|Overall Study|Physician Decision|1|||
124767856|NCT02923726|448779117|FG000|Overall Study|Death|196|||
124959892|NCT03740919|449479218|FG003|Treatment Period|Withdrawal by Subject|2|||
124959893|NCT03740919|449479215|FG000|Treatment Period|Terminated by Sponsor|0|||
124959894|NCT03740919|449479216|FG001|Treatment Period|Terminated by Sponsor|1|||
124959895|NCT03740919|449479217|FG002|Treatment Period|Terminated by Sponsor|0|||
124959896|NCT03740919|449479218|FG003|Treatment Period|Terminated by Sponsor|0|||
124959897|NCT03740919|449479215|FG000|Treatment Period|Issue with Insulin Pump|0|||
124959898|NCT03740919|449479216|FG001|Treatment Period|Issue with Insulin Pump|1|||
124959899|NCT03740919|449479217|FG002|Treatment Period|Issue with Insulin Pump|0|||
124959900|NCT03740919|449479218|FG003|Treatment Period|Issue with Insulin Pump|0|||
124959901|NCT03740919|449479215|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
124959902|NCT03740919|449479216|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
124959903|NCT03740919|449479217|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
124959904|NCT03740919|449479218|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
124959905|NCT03740919|449479215|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
124959906|NCT03740919|449479216|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
124959907|NCT03740919|449479217|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
124959908|NCT03740919|449479218|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
124959909|NCT03740919|449479215|FG000|Treatment Period|Not Completing Diary|0|||
124959910|NCT03740919|449479216|FG001|Treatment Period|Not Completing Diary|0|||
124959911|NCT03740919|449479217|FG002|Treatment Period|Not Completing Diary|1|||
124959912|NCT03740919|449479218|FG003|Treatment Period|Not Completing Diary|0|||
124959913|NCT03740919|449479215|FG000|Treatment Period|Insulin Painful to Participant|0|||
124959914|NCT03740919|449479216|FG001|Treatment Period|Insulin Painful to Participant|0|||
124959915|NCT03740919|449479217|FG002|Treatment Period|Insulin Painful to Participant|1|||
124959916|NCT03740919|449479218|FG003|Treatment Period|Insulin Painful to Participant|0|||
124959917|NCT03640754|449479219|FG000|Overall Study|Withdrawal by Subject|1|||
124959918|NCT03640754|449479220|FG001|Overall Study|Withdrawal by Subject|0|||
124959919|NCT03640754|449479219|FG000|Overall Study|Lost to Follow-up|0|||
124959920|NCT03640754|449479220|FG001|Overall Study|Lost to Follow-up|1|||
124959921|NCT01679613|449479226|FG000|Overall Study|other than stated above|0|||
124959922|NCT01679613|449479227|FG001|Overall Study|other than stated above|1|||
124959923|NCT01679613|449479228|FG002|Overall Study|other than stated above|2|||
124959924|NCT01679613|449479229|FG003|Overall Study|other than stated above|2|||
124959925|NCT04783519|449479230|FG000|Overall Study|Withdrawal by Subject|2|||
124959926|NCT04783519|449479231|FG001|Overall Study|Withdrawal by Subject|7|||
124959927|NCT04783519|449479232|FG002|Overall Study|Withdrawal by Subject|3|||
124959928|NCT04783519|449479230|FG000|Overall Study|Lost to Follow-up|9|||
124959929|NCT04783519|449479231|FG001|Overall Study|Lost to Follow-up|7|||
124959930|NCT04783519|449479232|FG002|Overall Study|Lost to Follow-up|6|||
124959931|NCT00727259|449479233|FG000|Overall Study|Not all questionnaires completed|1055|||
124959932|NCT01021683|449479234|FG000|Overall Study|Lack of Efficacy|12|||
124959933|NCT01021683|449479234|FG000|Overall Study|Recovery of neutrophil count|51|||
124959934|NCT01021683|449479234|FG000|Overall Study|Other|8|||
124959935|NCT00645099|449479235|FG000|Overall Study|Lack of Efficacy|15|||
124959936|NCT00645099|449479236|FG001|Overall Study|Lack of Efficacy|6|||
124959937|NCT00645099|449479235|FG000|Overall Study|Withdrawal by Subject|30|||
124549385|NCT02780115|447967015|FG001|Overall Study|Adverse Event|0|||
124549386|NCT02780115|447967016|FG002|Overall Study|Adverse Event|0|||
124549387|NCT02780115|447967017|FG003|Overall Study|Adverse Event|1|||
124959938|NCT00645099|449479236|FG001|Overall Study|Withdrawal by Subject|22|||
124959939|NCT00645099|449479235|FG000|Overall Study|Lost to Follow-up|6|||
124959940|NCT00645099|449479236|FG001|Overall Study|Lost to Follow-up|4|||
124959941|NCT00645099|449479235|FG000|Overall Study|Adverse Event|11|||
124959942|NCT00645099|449479236|FG001|Overall Study|Adverse Event|5|||
124549388|NCT02780115|447967018|FG004|Overall Study|Adverse Event|1|||
124767857|NCT02923726|448779118|FG001|Overall Study|Death|175|||
124767858|NCT02923726|448779117|FG000|Overall Study|Withdrawal by Subject|337|||
124767859|NCT02923726|448779118|FG001|Overall Study|Withdrawal by Subject|307|||
124767860|NCT00074711|448779119|FG000|Overall Study|Withdrawal by Subject|1|||
124767861|NCT00074711|448779120|FG001|Overall Study|Withdrawal by Subject|1|||
124767862|NCT00074711|448779119|FG000|Overall Study|Lost to Follow-up|10|||
124767863|NCT00074711|448779120|FG001|Overall Study|Lost to Follow-up|8|||
124767864|NCT00074711|448779119|FG000|Overall Study|Participant stopped study drug|4|||
124767865|NCT00074711|448779120|FG001|Overall Study|Participant stopped study drug|6|||
124959943|NCT00645099|449479235|FG000|Overall Study|Other|9|||
124959944|NCT00645099|449479236|FG001|Overall Study|Other|5|||
124959945|NCT01201915|449479237|FG000|Overall Study|Adverse Event|2|||
124959946|NCT01201915|449479238|FG001|Overall Study|Adverse Event|1|||
124959947|NCT01201915|449479239|FG002|Overall Study|Adverse Event|1|||
124959948|NCT01201915|449479237|FG000|Overall Study|Lost to Follow-up|0|||
124959949|NCT01201915|449479238|FG001|Overall Study|Lost to Follow-up|4|||
124959950|NCT01201915|449479239|FG002|Overall Study|Lost to Follow-up|0|||
124549389|NCT01179191|447967019|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
124549390|NCT01179191|447967019|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
124549391|NCT01179191|447967019|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
124549392|NCT01179191|447967019|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
124549393|NCT01179191|447967019|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
124959951|NCT01201915|449479237|FG000|Overall Study|Physician Decision|3|||
124959952|NCT01201915|449479238|FG001|Overall Study|Physician Decision|0|||
124959953|NCT01201915|449479239|FG002|Overall Study|Physician Decision|0|||
124959954|NCT01201915|449479237|FG000|Overall Study|Subject Decision|3|||
124959955|NCT01201915|449479238|FG001|Overall Study|Subject Decision|3|||
124959956|NCT01201915|449479239|FG002|Overall Study|Subject Decision|5|||
124959957|NCT01201915|449479237|FG000|Overall Study|Target Lesion Progression|0|||
124959958|NCT01201915|449479238|FG001|Overall Study|Target Lesion Progression|3|||
124959959|NCT01201915|449479239|FG002|Overall Study|Target Lesion Progression|0|||
124959960|NCT02154516|449479240|FG000|Overall Study|Withdrawal by Subject|0|||
124959961|NCT02154516|449479241|FG001|Overall Study|Withdrawal by Subject|1|||
124959962|NCT02154516|449479240|FG000|Overall Study|Lost to Follow-up|1|||
124959963|NCT02154516|449479241|FG001|Overall Study|Lost to Follow-up|0|||
124959964|NCT02154516|449479240|FG000|Overall Study|Removal/revision of device|1|||
124959965|NCT02154516|449479241|FG001|Overall Study|Removal/revision of device|0|||
124549394|NCT01179191|447967019|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
124549395|NCT01179191|447967019|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
124549396|NCT01179191|447967019|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
124549397|NCT01179191|447967019|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
124549398|NCT01179191|447967019|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
124549399|NCT01179191|447967019|FG000|Maintenance Phase (8 Weeks)|Other|66|||
124549400|NCT00916617|447967023|FG000|Overall Study|Adverse Event|3|||
124549401|NCT00916617|447967024|FG001|Overall Study|Adverse Event|2|||
124549402|NCT00916617|447967025|FG002|Overall Study|Adverse Event|6|||
124549403|NCT00916617|447967026|FG003|Overall Study|Adverse Event|3|||
124549404|NCT00916617|447967023|FG000|Overall Study|Withdrawal by Subject|3|||
124549405|NCT00916617|447967024|FG001|Overall Study|Withdrawal by Subject|2|||
124549406|NCT00916617|447967025|FG002|Overall Study|Withdrawal by Subject|0|||
124549407|NCT00916617|447967026|FG003|Overall Study|Withdrawal by Subject|1|||
124549408|NCT00916617|447967023|FG000|Overall Study|Caregiver Request|3|||
124549409|NCT00916617|447967024|FG001|Overall Study|Caregiver Request|2|||
124549410|NCT00916617|447967025|FG002|Overall Study|Caregiver Request|1|||
124549411|NCT00916617|447967026|FG003|Overall Study|Caregiver Request|0|||
124549412|NCT00916617|447967023|FG000|Overall Study|Physician Decision|1|||
124549413|NCT00916617|447967024|FG001|Overall Study|Physician Decision|1|||
124549414|NCT00916617|447967025|FG002|Overall Study|Physician Decision|0|||
124549415|NCT00916617|447967026|FG003|Overall Study|Physician Decision|0|||
124549416|NCT00916617|447967023|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
124549417|NCT00916617|447967024|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
124549418|NCT00916617|447967025|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
124549419|NCT00916617|447967026|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
124549420|NCT00916617|447967023|FG000|Overall Study|Lost to Follow-up|2|||
124549421|NCT00916617|447967024|FG001|Overall Study|Lost to Follow-up|1|||
124549422|NCT00916617|447967025|FG002|Overall Study|Lost to Follow-up|0|||
124549423|NCT00916617|447967026|FG003|Overall Study|Lost to Follow-up|0|||
124549424|NCT00916617|447967023|FG000|Overall Study|Lack of Efficacy|1|||
124549425|NCT00916617|447967024|FG001|Overall Study|Lack of Efficacy|0|||
124549426|NCT00916617|447967025|FG002|Overall Study|Lack of Efficacy|0|||
124549427|NCT00916617|447967026|FG003|Overall Study|Lack of Efficacy|0|||
124708521|NCT01819272|448559415|FG001|Overall Study|Adverse Event|0|||
124708522|NCT01819272|448559416|FG002|Overall Study|Adverse Event|0|||
124708523|NCT01819272|448559417|FG003|Overall Study|Adverse Event|2|||
124708524|NCT01819272|448559418|FG004|Overall Study|Adverse Event|0|||
124708525|NCT01819272|448559419|FG005|Overall Study|Adverse Event|0|||
124708526|NCT01819272|448559414|FG000|Overall Study|Lost to Follow-up|3|||
124708527|NCT01819272|448559415|FG001|Overall Study|Lost to Follow-up|0|||
124708528|NCT01819272|448559416|FG002|Overall Study|Lost to Follow-up|1|||
124708529|NCT01819272|448559417|FG003|Overall Study|Lost to Follow-up|0|||
124708530|NCT01819272|448559418|FG004|Overall Study|Lost to Follow-up|0|||
124708531|NCT01819272|448559419|FG005|Overall Study|Lost to Follow-up|3|||
124708532|NCT01819272|448559414|FG000|Overall Study|Protocol Violation|0|||
124708533|NCT01819272|448559415|FG001|Overall Study|Protocol Violation|0|||
124708534|NCT01819272|448559416|FG002|Overall Study|Protocol Violation|0|||
124549428|NCT00916617|447967023|FG000|Overall Study|Other|2|||
124549429|NCT00916617|447967024|FG001|Overall Study|Other|0|||
124549430|NCT00916617|447967025|FG002|Overall Study|Other|0|||
124708535|NCT01819272|448559417|FG003|Overall Study|Protocol Violation|1|||
124708536|NCT01819272|448559418|FG004|Overall Study|Protocol Violation|2|||
124959966|NCT02154516|449479240|FG000|Overall Study|Death|2|||
124959967|NCT02154516|449479241|FG001|Overall Study|Death|1|||
124959968|NCT03406507|449479242|FG000|Extension Period|Lack of Efficacy|0|||
124959969|NCT03406507|449479243|FG001|Extension Period|Lack of Efficacy|1|||
124959970|NCT00663923|449479244|FG000|Overall Study|Lost to Follow-up|2|||
124959971|NCT02965599|449479245|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
124959972|NCT02965599|449479246|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
124959973|NCT00230971|449479247|FG000|Randomization|No study drug administered|3|||
124959974|NCT00230971|449479248|FG001|Randomization|No study drug administered|3|||
124959975|NCT00230971|449479247|FG000|Baseline Participants|Lost to Follow-up|5|||
124959976|NCT00230971|449479248|FG001|Baseline Participants|Lost to Follow-up|12|||
124959977|NCT00230971|449479247|FG000|Baseline Participants|Death|6|||
124959978|NCT00230971|449479248|FG001|Baseline Participants|Death|5|||
124959979|NCT00230971|449479247|FG000|Baseline Participants|Withdrawal by Subject|7|||
124959980|NCT00230971|449479248|FG001|Baseline Participants|Withdrawal by Subject|1|||
124959981|NCT00230971|449479247|FG000|Baseline Participants|Adverse Event|1|||
124959982|NCT00230971|449479248|FG001|Baseline Participants|Adverse Event|0|||
124959983|NCT00230971|449479247|FG000|Baseline Participants|No bacteria observed|1|||
124959984|NCT00230971|449479248|FG001|Baseline Participants|No bacteria observed|0|||
124959985|NCT00230971|449479247|FG000|Baseline Participants|Failure to return|1|||
124959986|NCT00230971|449479248|FG001|Baseline Participants|Failure to return|1|||
124959987|NCT00230971|449479247|FG000|Baseline Participants|Reintervention|1|||
124959988|NCT00230971|449479248|FG001|Baseline Participants|Reintervention|0|||
124959989|NCT01960348|449480358|FG000|Overall Study|Adverse event, not serious|2|||
124959990|NCT01960348|449480359|FG001|Overall Study|Adverse event, not serious|2|||
124959991|NCT01960348|449480358|FG000|Overall Study|Adverse event, serious fatal|6|||
124959992|NCT01960348|449480359|FG001|Overall Study|Adverse event, serious fatal|5|||
124959993|NCT01960348|449480358|FG000|Overall Study|Adverse event, serious non-fatal|0|||
124959994|NCT01960348|449480359|FG001|Overall Study|Adverse event, serious non-fatal|3|||
124959995|NCT01960348|449480358|FG000|Overall Study|Withdrawal by Subject|1|||
124959996|NCT01960348|449480359|FG001|Overall Study|Withdrawal by Subject|11|||
124959997|NCT01960348|449480358|FG000|Overall Study|Physician Decision|0|||
124959998|NCT01960348|449480359|FG001|Overall Study|Physician Decision|1|||
124959999|NCT01960348|449480358|FG000|Overall Study|Protocol Violation|1|||
124960000|NCT01960348|449480359|FG001|Overall Study|Protocol Violation|0|||
124960001|NCT01580995|449480360|FG000|Overall Study|Lost to Follow-up|2|||
124960002|NCT01580995|449480361|FG001|Overall Study|Lost to Follow-up|2|||
124960003|NCT05109117|449480362|FG000|Overall Study|Lost to Follow-up|1|||
124960004|NCT05109117|449480362|FG000|Overall Study|Discontinued for non-compliance|1|||
124960005|NCT03371485|449480368|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
124960006|NCT03371485|449480368|FG000|2-year Follow-up|Death|5|||
124960007|NCT02204319|449480369|FG000|Overall Study|Pregnancy|1|||
124960008|NCT02204319|449480369|FG000|Overall Study|Withdrawal by Subject|2|||
124960009|NCT02171130|449480378|FG000|Overall Study|Death|1|||
124960010|NCT02171130|449480378|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
124960011|NCT02171130|449480378|FG000|Overall Study|Discontinued; Site Termination|5|||
124960012|NCT02171130|449480378|FG000|Overall Study|Withdrawal by Subject|3|||
124960013|NCT02171130|449480378|FG000|Overall Study|Physician Decision|1|||
124960014|NCT02171130|449480378|FG000|Overall Study|Lost to Follow-up|1|||
124960015|NCT02171130|449480378|FG000|Overall Study|Met Exclusion Criteria|1|||
124960016|NCT04531813|449480379|FG000|Overall Study|Protocol Violation|1|||
124960017|NCT04531813|449480379|FG000|Overall Study|Withdrawal by Subject|1|||
124960018|NCT02853305|449480380|FG000|Overall Study|Death|287|||
124960019|NCT02853305|449480381|FG001|Overall Study|Death|249|||
124960020|NCT02853305|449480382|FG002|Overall Study|Death|300|||
124960021|NCT02853305|449480380|FG000|Overall Study|Withdrawal by Subject|2|||
124960022|NCT02853305|449480381|FG001|Overall Study|Withdrawal by Subject|8|||
124960023|NCT02853305|449480382|FG002|Overall Study|Withdrawal by Subject|3|||
124960024|NCT02853305|449480380|FG000|Overall Study|Transferred to Extension Study|46|||
124960025|NCT02853305|449480381|FG001|Overall Study|Transferred to Extension Study|30|||
124960026|NCT02853305|449480382|FG002|Overall Study|Transferred to Extension Study|25|||
124960027|NCT02853305|449480380|FG000|Overall Study|Did Not Continue on Extension Study|16|||
124960028|NCT02853305|449480381|FG001|Overall Study|Did Not Continue on Extension Study|20|||
124960029|NCT02853305|449480382|FG002|Overall Study|Did Not Continue on Extension Study|24|||
124960030|NCT02381652|449480387|FG000|Overall Study|Withdrawal by Subject|0|||
124960031|NCT02381652|449480388|FG001|Overall Study|Withdrawal by Subject|0|||
124960032|NCT02381652|449480389|FG002|Overall Study|Withdrawal by Subject|1|||
124960033|NCT01340300|449480390|FG000|Overall Study|Lost to Follow-up|3|||
124960034|NCT01340300|449480391|FG001|Overall Study|Lost to Follow-up|0|||
124960035|NCT01340300|449480392|FG002|Overall Study|Lost to Follow-up|5|||
124960036|NCT01340300|449480393|FG003|Overall Study|Lost to Follow-up|10|||
124960037|NCT01340300|449480390|FG000|Overall Study|Withdrawal by Subject|5|||
124960038|NCT01340300|449480391|FG001|Overall Study|Withdrawal by Subject|6|||
124960039|NCT01340300|449480392|FG002|Overall Study|Withdrawal by Subject|6|||
124960040|NCT01340300|449480393|FG003|Overall Study|Withdrawal by Subject|3|||
124960041|NCT01340300|449480390|FG000|Overall Study|Adverse Event|1|||
124960042|NCT01340300|449480391|FG001|Overall Study|Adverse Event|0|||
124960043|NCT01340300|449480392|FG002|Overall Study|Adverse Event|4|||
124960044|NCT01340300|449480393|FG003|Overall Study|Adverse Event|0|||
124960045|NCT01340300|449480390|FG000|Overall Study|Physician Decision|0|||
124960046|NCT01340300|449480391|FG001|Overall Study|Physician Decision|1|||
124960047|NCT01340300|449480392|FG002|Overall Study|Physician Decision|0|||
124960048|NCT01340300|449480393|FG003|Overall Study|Physician Decision|0|||
124960049|NCT01340300|449480390|FG000|Overall Study|Unrelated sickness|0|||
124960050|NCT01340300|449480391|FG001|Overall Study|Unrelated sickness|2|||
124960051|NCT01340300|449480392|FG002|Overall Study|Unrelated sickness|0|||
124960052|NCT01340300|449480393|FG003|Overall Study|Unrelated sickness|1|||
124960053|NCT03544229|449480394|FG000|Overall Study|Adverse Event|1|||
124960054|NCT03544229|449480395|FG001|Overall Study|Adverse Event|0|||
124960055|NCT03544229|449480396|FG002|Overall Study|Adverse Event|1|||
124960056|NCT03544229|449480397|FG003|Overall Study|Adverse Event|0|||
124960057|NCT03544229|449480394|FG000|Overall Study|Protocol Deviation|0|||
124960058|NCT03544229|449480395|FG001|Overall Study|Protocol Deviation|0|||
124960059|NCT03544229|449480396|FG002|Overall Study|Protocol Deviation|1|||
124960060|NCT03544229|449480397|FG003|Overall Study|Protocol Deviation|0|||
124960061|NCT03544229|449480394|FG000|Overall Study|Lost to Follow-up|3|||
124960062|NCT03544229|449480395|FG001|Overall Study|Lost to Follow-up|0|||
124960063|NCT03544229|449480396|FG002|Overall Study|Lost to Follow-up|0|||
124960064|NCT03544229|449480397|FG003|Overall Study|Lost to Follow-up|2|||
124960065|NCT03544229|449480394|FG000|Overall Study|Voluntary Withdrawal|2|||
124960066|NCT03544229|449480395|FG001|Overall Study|Voluntary Withdrawal|1|||
124960067|NCT03544229|449480396|FG002|Overall Study|Voluntary Withdrawal|3|||
124960068|NCT03544229|449480397|FG003|Overall Study|Voluntary Withdrawal|0|||
124960069|NCT03544229|449480394|FG000|Overall Study|Lack of Efficacy|0|||
124960070|NCT03544229|449480395|FG001|Overall Study|Lack of Efficacy|1|||
124960071|NCT03544229|449480396|FG002|Overall Study|Lack of Efficacy|0|||
124960072|NCT03544229|449480397|FG003|Overall Study|Lack of Efficacy|0|||
124960073|NCT04772313|449480398|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
124960074|NCT04772313|449480398|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
124960075|NCT01836198|449480400|FG000|Part A, Period 2|Protocol Violation|0|||
124960076|NCT01836198|449480401|FG001|Part A, Period 2|Protocol Violation|1|||
124960077|NCT01836198|449480402|FG002|Part A, Period 2|Protocol Violation|0|||
124960078|NCT03187353|449480403|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
124960079|NCT03187353|449480404|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
124960080|NCT03187353|449480403|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
124960081|NCT03187353|449480404|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
124960082|NCT03187353|449480403|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
124960083|NCT03187353|449480404|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
124708537|NCT01819272|448559419|FG005|Overall Study|Protocol Violation|3|||
124708538|NCT01819272|448559414|FG000|Overall Study|Physician Decision|0|||
124708539|NCT01819272|448559415|FG001|Overall Study|Physician Decision|1|||
124708540|NCT01819272|448559416|FG002|Overall Study|Physician Decision|0|||
124708541|NCT01819272|448559417|FG003|Overall Study|Physician Decision|0|||
124708542|NCT01819272|448559418|FG004|Overall Study|Physician Decision|0|||
124708543|NCT01819272|448559419|FG005|Overall Study|Physician Decision|0|||
124708544|NCT01819272|448559414|FG000|Overall Study|Withdrawal of Consent|0|||
124708545|NCT01819272|448559415|FG001|Overall Study|Withdrawal of Consent|1|||
124708546|NCT01819272|448559416|FG002|Overall Study|Withdrawal of Consent|2|||
124708547|NCT01819272|448559417|FG003|Overall Study|Withdrawal of Consent|1|||
124708548|NCT01819272|448559418|FG004|Overall Study|Withdrawal of Consent|0|||
124708549|NCT01819272|448559419|FG005|Overall Study|Withdrawal of Consent|1|||
124708550|NCT01819272|448559414|FG000|Overall Study|Loss of Glucose Control|2|||
124708551|NCT01819272|448559415|FG001|Overall Study|Loss of Glucose Control|1|||
124708552|NCT01819272|448559416|FG002|Overall Study|Loss of Glucose Control|0|||
124708553|NCT01819272|448559417|FG003|Overall Study|Loss of Glucose Control|1|||
124960084|NCT03187353|449480403|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
124960085|NCT03187353|449480404|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
124960086|NCT03187353|449480403|FG000|Washout (2 Weeks)|Adverse Event|2|||
124960087|NCT03187353|449480404|FG001|Washout (2 Weeks)|Adverse Event|0|||
124960088|NCT03187353|449480403|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
124960089|NCT03187353|449480404|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
124960090|NCT02215954|449480405|FG000|Overall Study|Adverse Event|0|||
124960091|NCT02215954|449480406|FG001|Overall Study|Adverse Event|0|||
124960092|NCT02215954|449480407|FG002|Overall Study|Adverse Event|1|||
124960093|NCT02215954|449480405|FG000|Overall Study|Withdrawal by Subject|0|||
124708554|NCT01819272|448559418|FG004|Overall Study|Loss of Glucose Control|2|||
124708555|NCT01819272|448559419|FG005|Overall Study|Loss of Glucose Control|0|||
124708556|NCT00503984|448559420|FG000|Overall Study|Protocol Violation|0|||
124708557|NCT00503984|448559421|FG001|Overall Study|Protocol Violation|1|||
124960094|NCT02215954|449480406|FG001|Overall Study|Withdrawal by Subject|0|||
124960095|NCT02215954|449480407|FG002|Overall Study|Withdrawal by Subject|2|||
124960096|NCT02215954|449480405|FG000|Overall Study|Not exposed|1|||
124960097|NCT02215954|449480406|FG001|Overall Study|Not exposed|1|||
124960098|NCT02215954|449480407|FG002|Overall Study|Not exposed|3|||
124960099|NCT02460562|449480409|FG000|Overall Study|Lost to Follow-up|15|||
124960100|NCT02460562|449480410|FG001|Overall Study|Lost to Follow-up|16|||
124960101|NCT03303521|449480411|FG000|Overall Study|Withdrawal by Subject|2|||
124960102|NCT03303521|449480412|FG001|Overall Study|Withdrawal by Subject|0|||
124960103|NCT03303521|449480411|FG000|Overall Study|Death|1|||
124960104|NCT03303521|449480412|FG001|Overall Study|Death|0|||
124960105|NCT03303521|449480411|FG000|Overall Study|Kidney transplantation|0|||
124960106|NCT03303521|449480412|FG001|Overall Study|Kidney transplantation|1|||
124960107|NCT03303521|449480411|FG000|Overall Study|Investigational product discontinuation|0|||
124960108|NCT03303521|449480412|FG001|Overall Study|Investigational product discontinuation|1|||
124960109|NCT03303521|449480411|FG000|Overall Study|Transferred to non-study dialysis center|1|||
124960110|NCT03303521|449480412|FG001|Overall Study|Transferred to non-study dialysis center|0|||
124960111|NCT03303521|449480411|FG000|Overall Study|Non-comliance to study protocol|0|||
124960112|NCT03303521|449480412|FG001|Overall Study|Non-comliance to study protocol|1|||
124960113|NCT03303521|449480411|FG000|Overall Study|Adverse Event|1|||
124960114|NCT03303521|449480412|FG001|Overall Study|Adverse Event|0|||
124960115|NCT01654289|449480413|FG000|Overall Study|Withdrawal by Subject|10|||
124960116|NCT01654289|449480414|FG001|Overall Study|Withdrawal by Subject|8|||
124960117|NCT01654289|449480415|FG002|Overall Study|Withdrawal by Subject|5|||
124960118|NCT01654289|449480413|FG000|Overall Study|Withdrew from intervention only|17|||
124960119|NCT01654289|449480414|FG001|Overall Study|Withdrew from intervention only|20|||
124960120|NCT01654289|449480415|FG002|Overall Study|Withdrew from intervention only|0|||
124960121|NCT02642159|449480416|FG000|Overall Study|Randomized but not treated|1|||
124960122|NCT02642159|449480417|FG001|Overall Study|Randomized but not treated|0|||
124767866|NCT03466658|448779121|FG000|Overall Study|Withdrawal by Subject|3|||
124767867|NCT00129402|448779122|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
124767868|NCT00129402|448779123|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
124767869|NCT00129402|448779124|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
124767870|NCT00129402|448779125|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
124767871|NCT00129402|448779126|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
124767872|NCT00129402|448779127|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
124767873|NCT00129402|448779128|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
124960123|NCT02642159|449480416|FG000|Overall Study|Adverse Event|10|||
124549431|NCT00916617|447967026|FG003|Overall Study|Other|2|||
124549432|NCT01988337|447967029|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
124767874|NCT00129402|448779122|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
124767875|NCT00129402|448779123|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
124767876|NCT00129402|448779124|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
124767877|NCT00129402|448779125|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
124767878|NCT00129402|448779126|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
124767879|NCT00129402|448779127|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
124767880|NCT00129402|448779128|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
124767881|NCT00129402|448779122|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
124767882|NCT00129402|448779123|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
124767883|NCT00129402|448779124|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
124767884|NCT00129402|448779125|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
124767885|NCT00129402|448779126|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
124767886|NCT00129402|448779127|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
124767887|NCT00129402|448779128|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
124767888|NCT00129402|448779122|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
124767889|NCT00129402|448779123|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
124767890|NCT00129402|448779124|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
124767891|NCT00129402|448779125|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
124767892|NCT00129402|448779126|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
124767893|NCT00129402|448779127|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
124767894|NCT00129402|448779128|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
124767895|NCT00129402|448779122|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
124767896|NCT00129402|448779123|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
124767897|NCT00129402|448779124|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
124960124|NCT02642159|449480417|FG001|Overall Study|Adverse Event|4|||
124960125|NCT02642159|449480416|FG000|Overall Study|Withdrawal by Subject|9|||
124960126|NCT02642159|449480417|FG001|Overall Study|Withdrawal by Subject|1|||
124960127|NCT02642159|449480416|FG000|Overall Study|Poor compliance to study protocol|1|||
124960128|NCT02642159|449480417|FG001|Overall Study|Poor compliance to study protocol|0|||
124960129|NCT02642159|449480416|FG000|Overall Study|Other than specified above|10|||
124960130|NCT02642159|449480417|FG001|Overall Study|Other than specified above|3|||
124960131|NCT04194541|449480418|FG000|Day 1 Through 13|Lost to Follow-up|3|||
124960132|NCT04194541|449480418|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
124960133|NCT04194541|449480418|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
124960134|NCT03746483|449480419|FG000|Overall Study|Adverse Event|0|||
124960135|NCT03746483|449480420|FG001|Overall Study|Adverse Event|1|||
124767898|NCT00129402|448779125|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
124767899|NCT00129402|448779126|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
124767900|NCT00129402|448779127|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
124960136|NCT03746483|449480419|FG000|Overall Study|Lack of Efficacy|3|||
124960137|NCT03746483|449480420|FG001|Overall Study|Lack of Efficacy|2|||
124960138|NCT03746483|449480419|FG000|Overall Study|Lost to Follow-up|1|||
124960139|NCT03746483|449480420|FG001|Overall Study|Lost to Follow-up|0|||
124960140|NCT03746483|449480419|FG000|Overall Study|Protocol Violation|2|||
124960141|NCT03746483|449480420|FG001|Overall Study|Protocol Violation|0|||
124960142|NCT00187135|449480421|FG000|Visit One|Withdrawal by Subject|1|||
124960143|NCT00187135|449480422|FG001|Visit One|Withdrawal by Subject|0|||
124767901|NCT00129402|448779128|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
124767902|NCT00129402|448779122|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
124767903|NCT00129402|448779123|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
124767904|NCT00129402|448779124|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
124767905|NCT00129402|448779125|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
124767906|NCT00129402|448779126|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
124960144|NCT00187135|449480423|FG002|Visit One|Withdrawal by Subject|0|||
124960145|NCT00187135|449480424|FG003|Visit One|Withdrawal by Subject|0|||
124960146|NCT00187135|449480425|FG004|Visit One|Withdrawal by Subject|0|||
124960147|NCT00187135|449480426|FG005|Visit One|Withdrawal by Subject|1|||
124960148|NCT00187135|449480421|FG000|Visit One|Physician Decision|3|||
124960149|NCT00187135|449480422|FG001|Visit One|Physician Decision|1|||
124960150|NCT00187135|449480423|FG002|Visit One|Physician Decision|0|||
124960151|NCT00187135|449480424|FG003|Visit One|Physician Decision|0|||
124960152|NCT00187135|449480425|FG004|Visit One|Physician Decision|0|||
124960153|NCT00187135|449480426|FG005|Visit One|Physician Decision|1|||
124960154|NCT00187135|449480421|FG000|Visit Two|Death|0|||
124960155|NCT00187135|449480422|FG001|Visit Two|Death|0|||
124960156|NCT00187135|449480423|FG002|Visit Two|Death|0|||
124960157|NCT00187135|449480424|FG003|Visit Two|Death|1|||
124960158|NCT00187135|449480425|FG004|Visit Two|Death|0|||
124960159|NCT00187135|449480426|FG005|Visit Two|Death|1|||
124960160|NCT00187135|449480421|FG000|Visit Two|Physician Decision|1|||
124549433|NCT03466060|447967037|FG000|Period 1|Test Lens Damage|0|||
124549434|NCT03466060|447967038|FG001|Period 1|Test Lens Damage|2|||
124549435|NCT03466060|447967039|FG002|Period 1|Test Lens Damage|0|||
124549436|NCT03466060|447967040|FG003|Period 1|Test Lens Damage|0|||
124549437|NCT03466060|447967041|FG004|Period 1|Test Lens Damage|0|||
124549438|NCT03466060|447967042|FG005|Period 1|Test Lens Damage|0|||
124549439|NCT03466060|447967037|FG000|Period 1|Withdrawal by Subject|0|||
124549440|NCT03466060|447967038|FG001|Period 1|Withdrawal by Subject|0|||
124549441|NCT03466060|447967039|FG002|Period 1|Withdrawal by Subject|2|||
124549442|NCT03466060|447967040|FG003|Period 1|Withdrawal by Subject|0|||
124549443|NCT03466060|447967041|FG004|Period 1|Withdrawal by Subject|0|||
124549444|NCT03466060|447967042|FG005|Period 1|Withdrawal by Subject|0|||
124767907|NCT00129402|448779127|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
124767908|NCT00129402|448779128|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
124767909|NCT00129402|448779122|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
124767910|NCT00129402|448779123|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
124767911|NCT00129402|448779124|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
124767912|NCT00129402|448779125|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
124767913|NCT00129402|448779126|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
124767914|NCT00129402|448779127|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
124767915|NCT00129402|448779128|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
124767916|NCT00129402|448779122|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
124767917|NCT00129402|448779123|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
124767918|NCT00129402|448779124|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
124767919|NCT00129402|448779125|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
124767920|NCT00129402|448779126|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
124960161|NCT00187135|449480422|FG001|Visit Two|Physician Decision|0|||
124960162|NCT00187135|449480423|FG002|Visit Two|Physician Decision|0|||
124960163|NCT00187135|449480424|FG003|Visit Two|Physician Decision|0|||
124960164|NCT00187135|449480425|FG004|Visit Two|Physician Decision|0|||
124960165|NCT00187135|449480426|FG005|Visit Two|Physician Decision|0|||
124960166|NCT00187135|449480421|FG000|Visit Two|Withdrawal by Subject|1|||
124960167|NCT00187135|449480422|FG001|Visit Two|Withdrawal by Subject|1|||
124960168|NCT00187135|449480423|FG002|Visit Two|Withdrawal by Subject|1|||
124960169|NCT00187135|449480424|FG003|Visit Two|Withdrawal by Subject|0|||
124960170|NCT00187135|449480425|FG004|Visit Two|Withdrawal by Subject|1|||
124960171|NCT00187135|449480426|FG005|Visit Two|Withdrawal by Subject|1|||
124960172|NCT00187135|449480421|FG000|Visit Two|Study Discontinued|3|||
124960173|NCT00187135|449480422|FG001|Visit Two|Study Discontinued|2|||
124960174|NCT00187135|449480423|FG002|Visit Two|Study Discontinued|1|||
124960175|NCT00187135|449480424|FG003|Visit Two|Study Discontinued|7|||
124960176|NCT00187135|449480425|FG004|Visit Two|Study Discontinued|5|||
124767921|NCT00129402|448779127|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
124767922|NCT00129402|448779128|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
124767923|NCT00129402|448779122|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
124767924|NCT00129402|448779123|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
124767925|NCT00129402|448779124|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
124767926|NCT00129402|448779125|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
124767927|NCT00129402|448779126|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
124767928|NCT00129402|448779127|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
124767929|NCT00129402|448779128|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
124767930|NCT00129402|448779122|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
124767931|NCT00129402|448779123|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
124767932|NCT00129402|448779124|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
124767933|NCT00129402|448779125|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
124767934|NCT00129402|448779126|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
124767935|NCT00129402|448779127|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
124767936|NCT00129402|448779128|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
124767937|NCT00129402|448779122|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
124767938|NCT00129402|448779123|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
124767939|NCT00129402|448779124|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
124960177|NCT00187135|449480426|FG005|Visit Two|Study Discontinued|6|||
124960178|NCT00187135|449480421|FG000|Visit Three|Death|0|||
124960179|NCT00187135|449480422|FG001|Visit Three|Death|0|||
124960180|NCT00187135|449480423|FG002|Visit Three|Death|1|||
124960181|NCT00187135|449480424|FG003|Visit Three|Death|0|||
124960182|NCT00187135|449480425|FG004|Visit Three|Death|1|||
124767940|NCT00129402|448779125|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
124767941|NCT00129402|448779126|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
124767942|NCT00129402|448779127|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
124767943|NCT00129402|448779128|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
124767944|NCT00129402|448779122|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
124767945|NCT00129402|448779123|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
124767946|NCT00129402|448779124|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
124767947|NCT00129402|448779125|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
124767948|NCT00129402|448779126|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
124767949|NCT00129402|448779127|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
124767950|NCT00129402|448779128|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
124767951|NCT00129402|448779122|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
124767952|NCT00129402|448779123|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
124767953|NCT00129402|448779124|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
124767954|NCT00129402|448779125|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
124767955|NCT00129402|448779126|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
124767956|NCT00129402|448779127|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
124767957|NCT00129402|448779128|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
124767958|NCT01527149|448779129|FG000|Overall Study|Death|2|||
124767959|NCT00481832|448779130|FG000|Enrollment|Physician Decision|8|||
124767960|NCT00481832|448779130|FG000|Enrollment|Unable to collect enough stem cells|2|||
124767961|NCT00481832|448779130|FG000|Inter-transplant Period|Adverse Event|4|||
124767962|NCT00481832|448779130|FG000|Inter-transplant Period|Death|3|||
124767963|NCT00481832|448779130|FG000|Inter-transplant Period|Physician Decision|4|||
124767964|NCT00481832|448779130|FG000|Inter-transplant Period|Disease relapse|11|||
124767965|NCT00481832|448779130|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
124767966|NCT02992288|448779131|FG000|Overall Study|Adverse Event|8|||
124767967|NCT02992288|448779132|FG001|Overall Study|Adverse Event|2|||
124767968|NCT02992288|448779133|FG002|Overall Study|Adverse Event|2|||
124767969|NCT02992288|448779134|FG003|Overall Study|Adverse Event|2|||
124767970|NCT02992288|448779135|FG004|Overall Study|Adverse Event|2|||
124767971|NCT02992288|448779136|FG005|Overall Study|Adverse Event|7|||
124767972|NCT02992288|448779131|FG000|Overall Study|Non-compliance with study drug|0|||
124767973|NCT02992288|448779132|FG001|Overall Study|Non-compliance with study drug|1|||
124767974|NCT02992288|448779133|FG002|Overall Study|Non-compliance with study drug|1|||
124767975|NCT02992288|448779134|FG003|Overall Study|Non-compliance with study drug|0|||
124767976|NCT02992288|448779135|FG004|Overall Study|Non-compliance with study drug|1|||
124767977|NCT02992288|448779136|FG005|Overall Study|Non-compliance with study drug|0|||
124767978|NCT02992288|448779131|FG000|Overall Study|Physician Decision|3|||
124767979|NCT02992288|448779132|FG001|Overall Study|Physician Decision|0|||
124767980|NCT02992288|448779133|FG002|Overall Study|Physician Decision|1|||
124960183|NCT00187135|449480426|FG005|Visit Three|Death|0|||
124960184|NCT00187135|449480421|FG000|Visit Three|Withdrawal by Subject|0|||
124960185|NCT00187135|449480422|FG001|Visit Three|Withdrawal by Subject|1|||
124767981|NCT02992288|448779134|FG003|Overall Study|Physician Decision|0|||
124767982|NCT02992288|448779135|FG004|Overall Study|Physician Decision|0|||
124767983|NCT02992288|448779136|FG005|Overall Study|Physician Decision|1|||
124767984|NCT02992288|448779131|FG000|Overall Study|Death|2|||
124767985|NCT02992288|448779132|FG001|Overall Study|Death|0|||
124767986|NCT02992288|448779133|FG002|Overall Study|Death|2|||
124767987|NCT02992288|448779134|FG003|Overall Study|Death|1|||
124767988|NCT02992288|448779135|FG004|Overall Study|Death|2|||
124767989|NCT02992288|448779136|FG005|Overall Study|Death|0|||
124767990|NCT02992288|448779131|FG000|Overall Study|Lost to Follow-up|0|||
124767991|NCT02992288|448779132|FG001|Overall Study|Lost to Follow-up|0|||
124767992|NCT02992288|448779133|FG002|Overall Study|Lost to Follow-up|0|||
124767993|NCT02992288|448779134|FG003|Overall Study|Lost to Follow-up|1|||
124767994|NCT02992288|448779135|FG004|Overall Study|Lost to Follow-up|0|||
124767995|NCT02992288|448779136|FG005|Overall Study|Lost to Follow-up|0|||
124767996|NCT02992288|448779131|FG000|Overall Study|Protocol Violation|0|||
124767997|NCT02992288|448779132|FG001|Overall Study|Protocol Violation|0|||
124767998|NCT02992288|448779133|FG002|Overall Study|Protocol Violation|0|||
124767999|NCT02992288|448779134|FG003|Overall Study|Protocol Violation|0|||
124768000|NCT02992288|448779135|FG004|Overall Study|Protocol Violation|0|||
124768001|NCT02992288|448779136|FG005|Overall Study|Protocol Violation|1|||
124768002|NCT02992288|448779131|FG000|Overall Study|Withdrawal by Subject|4|||
124768003|NCT02992288|448779132|FG001|Overall Study|Withdrawal by Subject|2|||
124768004|NCT02992288|448779133|FG002|Overall Study|Withdrawal by Subject|1|||
124768005|NCT02992288|448779134|FG003|Overall Study|Withdrawal by Subject|5|||
124768006|NCT02992288|448779135|FG004|Overall Study|Withdrawal by Subject|3|||
124768007|NCT02992288|448779136|FG005|Overall Study|Withdrawal by Subject|4|||
124768008|NCT02006472|448779140|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
124768009|NCT02006472|448779141|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
124768010|NCT02006472|448779142|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
124768011|NCT02006472|448779143|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
124768012|NCT02006472|448779144|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
124768013|NCT02006472|448779140|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
124768014|NCT02006472|448779141|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
124768015|NCT02006472|448779142|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
124768016|NCT02006472|448779143|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
124768017|NCT02006472|448779144|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
124768018|NCT02006472|448779140|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
124768019|NCT02006472|448779141|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
124768020|NCT02006472|448779142|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
124768021|NCT02006472|448779143|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
124768022|NCT02006472|448779144|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
124768023|NCT02006472|448779140|FG000|Period 1 (Through Week 26)|Other|1|||
124768024|NCT02006472|448779141|FG001|Period 1 (Through Week 26)|Other|5|||
124768025|NCT02006472|448779142|FG002|Period 1 (Through Week 26)|Other|0|||
124960186|NCT00187135|449480423|FG002|Visit Three|Withdrawal by Subject|1|||
124960187|NCT00187135|449480424|FG003|Visit Three|Withdrawal by Subject|2|||
124960188|NCT00187135|449480425|FG004|Visit Three|Withdrawal by Subject|0|||
124960189|NCT00187135|449480426|FG005|Visit Three|Withdrawal by Subject|0|||
124960190|NCT00187135|449480421|FG000|Visit Three|Study Discontinued|7|||
124960191|NCT00187135|449480422|FG001|Visit Three|Study Discontinued|6|||
124960192|NCT00187135|449480423|FG002|Visit Three|Study Discontinued|7|||
124960193|NCT00187135|449480424|FG003|Visit Three|Study Discontinued|7|||
124960194|NCT00187135|449480425|FG004|Visit Three|Study Discontinued|7|||
124960195|NCT00187135|449480426|FG005|Visit Three|Study Discontinued|6|||
124960196|NCT01924806|449480427|FG000|Overall Study|Physician Decision|2|||
124960197|NCT01924806|449480428|FG001|Overall Study|Physician Decision|1|||
124768026|NCT02006472|448779143|FG003|Period 1 (Through Week 26)|Other|2|||
124768027|NCT02006472|448779144|FG004|Period 1 (Through Week 26)|Other|3|||
124768028|NCT02006472|448779140|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
124768029|NCT02006472|448779141|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
124768030|NCT02006472|448779142|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
124768031|NCT02006472|448779143|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
124768032|NCT02006472|448779144|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
124768033|NCT02006472|448779140|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
124768034|NCT02006472|448779141|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
124768035|NCT02006472|448779142|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
124768036|NCT02006472|448779143|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
124768037|NCT02006472|448779144|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
124768038|NCT02006472|448779140|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
124768039|NCT02006472|448779141|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
124768040|NCT02006472|448779142|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
124960198|NCT01954771|449480429|FG000|Overall Study|Missing HbA1c of end-point|1|||
124960199|NCT01954771|449480430|FG001|Overall Study|Missing HbA1c of end-point|1|||
124960200|NCT01954771|449480431|FG002|Overall Study|Missing HbA1c of end-point|0|||
124960201|NCT01954771|449480429|FG000|Overall Study|Missing CGMS of end-point|1|||
124960202|NCT01954771|449480430|FG001|Overall Study|Missing CGMS of end-point|1|||
124768041|NCT02006472|448779143|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
124768042|NCT02006472|448779144|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
124768043|NCT02006472|448779140|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
124768044|NCT02006472|448779141|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
124768045|NCT02006472|448779142|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
124768046|NCT02006472|448779143|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
124768047|NCT02006472|448779144|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
124768048|NCT02006472|448779140|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
124768049|NCT02006472|448779141|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
124768050|NCT02006472|448779142|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
124768051|NCT02006472|448779143|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
124768052|NCT02006472|448779144|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
124768053|NCT02006472|448779140|FG000|Period 2 (Through Week 52)|Other|0|||
124768054|NCT02006472|448779141|FG001|Period 2 (Through Week 52)|Other|1|||
124768055|NCT02006472|448779142|FG002|Period 2 (Through Week 52)|Other|0|||
124768056|NCT02006472|448779143|FG003|Period 2 (Through Week 52)|Other|1|||
124768057|NCT02006472|448779144|FG004|Period 2 (Through Week 52)|Other|0|||
124768058|NCT02006472|448779140|FG000|Period 2 (Through Week 52)|Not treated|0|||
124768059|NCT02006472|448779141|FG001|Period 2 (Through Week 52)|Not treated|0|||
124768060|NCT02006472|448779142|FG002|Period 2 (Through Week 52)|Not treated|2|||
124768061|NCT02006472|448779143|FG003|Period 2 (Through Week 52)|Not treated|0|||
124549445|NCT03466060|447967037|FG000|Period 1|Lost to Follow-up|0|||
124549446|NCT03466060|447967038|FG001|Period 1|Lost to Follow-up|0|||
124549447|NCT03466060|447967039|FG002|Period 1|Lost to Follow-up|0|||
124549448|NCT03466060|447967040|FG003|Period 1|Lost to Follow-up|1|||
124549449|NCT03466060|447967041|FG004|Period 1|Lost to Follow-up|0|||
124549450|NCT03466060|447967042|FG005|Period 1|Lost to Follow-up|0|||
124708558|NCT00503984|448559422|FG002|Overall Study|Protocol Violation|0|||
124708559|NCT00503984|448559423|FG003|Overall Study|Protocol Violation|0|||
124708560|NCT00503984|448559424|FG004|Overall Study|Protocol Violation|0|||
124708561|NCT00503984|448559425|FG005|Overall Study|Protocol Violation|0|||
124708562|NCT00503984|448559420|FG000|Overall Study|Adverse Event|0|||
124708563|NCT00503984|448559421|FG001|Overall Study|Adverse Event|1|||
124708564|NCT00503984|448559422|FG002|Overall Study|Adverse Event|0|||
124708565|NCT00503984|448559423|FG003|Overall Study|Adverse Event|0|||
124708566|NCT00503984|448559424|FG004|Overall Study|Adverse Event|0|||
124708567|NCT00503984|448559425|FG005|Overall Study|Adverse Event|0|||
124708568|NCT00503984|448559420|FG000|Overall Study|Death|0|||
124708569|NCT00503984|448559421|FG001|Overall Study|Death|0|||
124708570|NCT00503984|448559422|FG002|Overall Study|Death|0|||
124708571|NCT00503984|448559423|FG003|Overall Study|Death|0|||
124708572|NCT00503984|448559424|FG004|Overall Study|Death|1|||
124708573|NCT00503984|448559425|FG005|Overall Study|Death|0|||
124708574|NCT01246960|448559428|FG000|Overall Study|Lost to Follow-up|3|||
124708575|NCT01246960|448559429|FG001|Overall Study|Lost to Follow-up|1|||
124708576|NCT01246960|448559428|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
124708577|NCT01246960|448559429|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
124708578|NCT00639457|448559431|FG000|Overall Study|Withdrawal by Subject|2|||
124708579|NCT00639457|448559432|FG001|Overall Study|Withdrawal by Subject|3|||
124708580|NCT00370292|448559433|FG000|Overall Study|Disease Progression|4|||
124708581|NCT00370292|448559433|FG000|Overall Study|Adverse Event|7|||
124708582|NCT00370292|448559433|FG000|Overall Study|Physician Decision|2|||
124708583|NCT00276419|448559434|FG000|First Intervention|Adverse Event|1|||
124708584|NCT00276419|448559435|FG001|First Intervention|Adverse Event|0|||
124708585|NCT00276419|448559434|FG000|First Intervention|Withdrawal by Subject|0|||
124708586|NCT00276419|448559435|FG001|First Intervention|Withdrawal by Subject|2|||
124708587|NCT04778592|448559442|FG000|Overall Study|Adverse Event|1|||
124708588|NCT04778592|448559443|FG001|Overall Study|Adverse Event|2|||
124708589|NCT04778592|448559442|FG000|Overall Study|Withdrawal by Subject|1|||
124708590|NCT04778592|448559443|FG001|Overall Study|Withdrawal by Subject|2|||
124708591|NCT01192126|448559444|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
124708592|NCT01192126|448559445|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
124708593|NCT01192126|448559444|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
124708594|NCT01192126|448559445|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
124708595|NCT02660229|448559446|FG000|Overall Study|Adverse Event|2|||
124768062|NCT02006472|448779144|FG004|Period 2 (Through Week 52)|Not treated|0|||
124549451|NCT03466060|447967037|FG000|Period 1|Grade 2 Conjunctivitis|0|||
124549452|NCT03466060|447967038|FG001|Period 1|Grade 2 Conjunctivitis|0|||
124708596|NCT02660229|448559447|FG001|Overall Study|Adverse Event|0|||
124708597|NCT02660229|448559446|FG000|Overall Study|Withdrawal by Subject|0|||
124768063|NCT02006472|448779140|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
124708598|NCT02660229|448559447|FG001|Overall Study|Withdrawal by Subject|1|||
124708599|NCT02431325|448559450|FG000|Overall Study|Adverse Event|3|||
124708600|NCT02431325|448559451|FG001|Overall Study|Adverse Event|0|||
124708601|NCT02431325|448559450|FG000|Overall Study|Lost to Follow-up|0|||
124708602|NCT02431325|448559451|FG001|Overall Study|Lost to Follow-up|1|||
124708603|NCT02431325|448559450|FG000|Overall Study|Withdrawal by Subject|1|||
124768064|NCT02006472|448779141|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
124768065|NCT02006472|448779142|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
124960203|NCT01954771|449480431|FG002|Overall Study|Missing CGMS of end-point|0|||
124960204|NCT01954771|449480429|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
124960205|NCT01954771|449480430|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
124960206|NCT01954771|449480431|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
124960207|NCT03635775|449480434|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
124960208|NCT03635775|449480435|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
124960209|NCT03635775|449480436|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
124960210|NCT03635775|449480437|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
124960211|NCT00297778|449480440|FG000|Overall Study|Adverse Event|16|||
124960212|NCT00297778|449480441|FG001|Overall Study|Adverse Event|10|||
124960213|NCT00297778|449480440|FG000|Overall Study|Withdrawal by Subject|1|||
124960214|NCT00297778|449480441|FG001|Overall Study|Withdrawal by Subject|5|||
124960215|NCT00297778|449480440|FG000|Overall Study|Lack of Efficacy|2|||
124960216|NCT00297778|449480441|FG001|Overall Study|Lack of Efficacy|1|||
124960217|NCT00297778|449480440|FG000|Overall Study|Non-compliant with trial protocol|0|||
124960218|NCT00297778|449480441|FG001|Overall Study|Non-compliant with trial protocol|3|||
124960219|NCT00297778|449480440|FG000|Overall Study|Other|0|||
124960220|NCT00297778|449480441|FG001|Overall Study|Other|1|||
124960221|NCT00679549|449480442|FG000|Overall Study|dropout|2|||
124960222|NCT00679549|449480443|FG001|Overall Study|dropout|4|||
124960223|NCT00679549|449480442|FG000|Overall Study|missing outcome echocardiograms|4|||
124960224|NCT00679549|449480443|FG001|Overall Study|missing outcome echocardiograms|5|||
124960225|NCT03280108|449480444|FG000|Overall Study|Lost to Follow-up|2|||
124960226|NCT03280108|449480445|FG001|Overall Study|Lost to Follow-up|0|||
124960227|NCT02996097|449480446|FG000|Overall Study|Lost to Follow-up|11|||
124960228|NCT02996097|449480447|FG001|Overall Study|Lost to Follow-up|11|||
124960229|NCT02201771|449480448|FG000|Overall Study|Death|3|||
124960230|NCT02201771|449480449|FG001|Overall Study|Death|2|||
124960231|NCT02201771|449480450|FG002|Overall Study|Death|0|||
124960232|NCT02201771|449480448|FG000|Overall Study|Protocol Violation|10|||
124960233|NCT02201771|449480449|FG001|Overall Study|Protocol Violation|8|||
124960234|NCT02201771|449480450|FG002|Overall Study|Protocol Violation|10|||
124960235|NCT01820637|449480451|FG000|Overall Study|Death|2|||
124960236|NCT01820637|449480451|FG000|Overall Study|Withdrawal by Subject|1|||
124960237|NCT00264498|449480452|FG000|Randomized Treatment|Death|0|||
124960238|NCT00264498|449480453|FG001|Randomized Treatment|Death|3|||
124960239|NCT00264498|449480452|FG000|Randomized Treatment|Withdrawal by Subject|0|||
124960240|NCT00264498|449480453|FG001|Randomized Treatment|Withdrawal by Subject|1|||
124960241|NCT00264498|449480452|FG000|Randomized Treatment|Objective disease Progression|13|||
124960242|NCT00264498|449480453|FG001|Randomized Treatment|Objective disease Progression|14|||
124960243|NCT00264498|449480452|FG000|Randomized Treatment|Physician Decision|1|||
124960244|NCT00264498|449480453|FG001|Randomized Treatment|Physician Decision|0|||
124960245|NCT00264498|449480452|FG000|Randomized Treatment|Incorrectly randomized|1|||
124463512|NCT00647556|447656529|FG000|Overall Study|Adverse Event|0|||
124463513|NCT00647556|447656530|FG001|Overall Study|Adverse Event|1|||
124768066|NCT02006472|448779143|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
124768067|NCT02006472|448779144|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
124768068|NCT02006472|448779140|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
124768069|NCT02006472|448779141|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
124768070|NCT02006472|448779142|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
124768071|NCT02006472|448779143|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
124768072|NCT02006472|448779144|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
124768073|NCT00499486|448779145|FG000|Overall Study|Withdrawal by Subject|16|||
124768074|NCT00656513|448779146|FG000|Overall Study|Protocol Violation|1|||
124768075|NCT00656513|448779147|FG001|Overall Study|Protocol Violation|0|||
124960246|NCT00264498|449480453|FG001|Randomized Treatment|Incorrectly randomized|0|||
124960247|NCT00264498|449480452|FG000|Randomized Treatment|Study Closure|1|||
124960248|NCT00264498|449480453|FG001|Randomized Treatment|Study Closure|0|||
124960249|NCT00264498|449480452|FG000|Randomized Treatment|Protocol Violation|1|||
124960250|NCT00264498|449480453|FG001|Randomized Treatment|Protocol Violation|0|||
124960251|NCT00264498|449480452|FG000|Crossover Treatment|Death|1|||
124960252|NCT00264498|449480453|FG001|Crossover Treatment|Death|3|||
124960253|NCT00264498|449480452|FG000|Crossover Treatment|Objective disease progression|4|||
124960254|NCT00264498|449480453|FG001|Crossover Treatment|Objective disease progression|5|||
124960255|NCT00264498|449480452|FG000|Crossover Treatment|Study closure|0|||
124960256|NCT00264498|449480453|FG001|Crossover Treatment|Study closure|1|||
124960257|NCT00264498|449480452|FG000|Crossover Treatment|Withdrawal by Subject|1|||
124960258|NCT00264498|449480453|FG001|Crossover Treatment|Withdrawal by Subject|0|||
124960259|NCT00583115|449480454|FG000|Overall Study|Death|1|||
124960260|NCT02205476|449480455|FG000|Overall Study|Study termination by Sponsor|7|||
124768076|NCT00656513|448779148|FG002|Overall Study|Protocol Violation|2|||
124768077|NCT00656513|448779146|FG000|Overall Study|Withdrawal by Subject|0|||
124768078|NCT00656513|448779147|FG001|Overall Study|Withdrawal by Subject|11|||
124768079|NCT00656513|448779148|FG002|Overall Study|Withdrawal by Subject|4|||
124768080|NCT00656513|448779146|FG000|Overall Study|Death|0|||
124768081|NCT00656513|448779147|FG001|Overall Study|Death|0|||
124768082|NCT00656513|448779148|FG002|Overall Study|Death|1|||
124768083|NCT00656513|448779146|FG000|Overall Study|Missing data|0|||
124768084|NCT00656513|448779147|FG001|Overall Study|Missing data|11|||
124768085|NCT00656513|448779148|FG002|Overall Study|Missing data|9|||
124768086|NCT00656513|448779146|FG000|Overall Study|Incomplete treatment|3|||
124768087|NCT00656513|448779147|FG001|Overall Study|Incomplete treatment|0|||
124768088|NCT00656513|448779148|FG002|Overall Study|Incomplete treatment|0|||
124768089|NCT00656513|448779146|FG000|Overall Study|Treatment completed outside of timeframe|0|||
124768090|NCT00656513|448779147|FG001|Overall Study|Treatment completed outside of timeframe|3|||
124768091|NCT00656513|448779148|FG002|Overall Study|Treatment completed outside of timeframe|1|||
124768092|NCT00656513|448779146|FG000|Overall Study|Missing baseline form|0|||
124768093|NCT00656513|448779147|FG001|Overall Study|Missing baseline form|5|||
124768094|NCT00656513|448779148|FG002|Overall Study|Missing baseline form|5|||
124768095|NCT00087152|448779149|FG000|Overall Study|Ineligible|6|||
124768096|NCT01436149|448779153|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
124768097|NCT01436149|448779154|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
124768098|NCT01436149|448779155|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
124768099|NCT01436149|448779153|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
124768100|NCT01436149|448779154|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
124768101|NCT01436149|448779155|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
124768102|NCT01436149|448779153|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
124768103|NCT01436149|448779154|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
124768104|NCT01436149|448779155|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
124768105|NCT01436149|448779153|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
124768106|NCT01436149|448779154|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
124768107|NCT01436149|448779155|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
124768108|NCT01436149|448779153|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
124768109|NCT01436149|448779154|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
124768110|NCT01436149|448779155|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
124768111|NCT01436149|448779153|FG000|Antidepressant Lead-in Phase|Other|119|||
124768112|NCT01436149|448779154|FG001|Antidepressant Lead-in Phase|Other|0|||
124768113|NCT01436149|448779155|FG002|Antidepressant Lead-in Phase|Other|0|||
124768114|NCT01436149|448779153|FG000|Randomized Phase|Adverse Event|9|||
124768115|NCT01436149|448779154|FG001|Randomized Phase|Adverse Event|10|||
124768116|NCT01436149|448779155|FG002|Randomized Phase|Adverse Event|11|||
124768117|NCT01436149|448779153|FG000|Randomized Phase|Protocol Violation|4|||
124768118|NCT01436149|448779154|FG001|Randomized Phase|Protocol Violation|5|||
124768119|NCT01436149|448779155|FG002|Randomized Phase|Protocol Violation|0|||
124768120|NCT01436149|448779153|FG000|Randomized Phase|Withdrawal by Subject|16|||
124768121|NCT01436149|448779154|FG001|Randomized Phase|Withdrawal by Subject|10|||
124768122|NCT01436149|448779155|FG002|Randomized Phase|Withdrawal by Subject|10|||
124768123|NCT01436149|448779153|FG000|Randomized Phase|Lost to Follow-up|34|||
124768124|NCT01436149|448779154|FG001|Randomized Phase|Lost to Follow-up|5|||
124768125|NCT01436149|448779155|FG002|Randomized Phase|Lost to Follow-up|6|||
124768126|NCT01436149|448779153|FG000|Randomized Phase|Lack of Efficacy|0|||
124768127|NCT01436149|448779154|FG001|Randomized Phase|Lack of Efficacy|0|||
124768128|NCT01436149|448779155|FG002|Randomized Phase|Lack of Efficacy|1|||
124768129|NCT01436149|448779153|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
124768130|NCT01436149|448779154|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
124768131|NCT01436149|448779155|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
124768132|NCT01436149|448779153|FG000|Randomized Phase|Other|12|||
124768133|NCT01436149|448779154|FG001|Randomized Phase|Other|5|||
124768134|NCT01436149|448779155|FG002|Randomized Phase|Other|11|||
124768135|NCT01643668|448779159|FG000|Overall Study|Death|1|||
124768136|NCT00322881|448779160|FG000|Overall Study|Death|2|||
124768137|NCT00322881|448779160|FG000|Overall Study|Adverse Event|1|||
124768138|NCT00322881|448779160|FG000|Overall Study|Disease Progression|2|||
124768139|NCT03253796|448779163|FG000|Period 1: Run-In|Adverse Event|4|||
124768140|NCT03253796|448779164|FG001|Period 1: Run-In|Adverse Event|0|||
124768141|NCT03253796|448779165|FG002|Period 1: Run-In|Adverse Event|0|||
124768142|NCT03253796|448779166|FG003|Period 1: Run-In|Adverse Event|0|||
124768143|NCT03253796|448779167|FG004|Period 1: Run-In|Adverse Event|0|||
124768144|NCT03253796|448779163|FG000|Period 1: Run-In|Lack of Efficacy|1|||
124768145|NCT03253796|448779164|FG001|Period 1: Run-In|Lack of Efficacy|0|||
124768146|NCT03253796|448779165|FG002|Period 1: Run-In|Lack of Efficacy|0|||
124768147|NCT03253796|448779166|FG003|Period 1: Run-In|Lack of Efficacy|0|||
124768148|NCT03253796|448779167|FG004|Period 1: Run-In|Lack of Efficacy|0|||
124768149|NCT03253796|448779163|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
124768150|NCT03253796|448779164|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
124768151|NCT03253796|448779165|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
124768152|NCT03253796|448779166|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
124768153|NCT03253796|448779167|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
124768154|NCT03253796|448779163|FG000|Period 1: Run-In|Protocol Violation|5|||
124768155|NCT03253796|448779164|FG001|Period 1: Run-In|Protocol Violation|0|||
124768156|NCT03253796|448779165|FG002|Period 1: Run-In|Protocol Violation|0|||
124768157|NCT03253796|448779166|FG003|Period 1: Run-In|Protocol Violation|0|||
124768158|NCT03253796|448779167|FG004|Period 1: Run-In|Protocol Violation|0|||
124768159|NCT03253796|448779163|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
124768160|NCT03253796|448779164|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
124768161|NCT03253796|448779165|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
124768162|NCT03253796|448779166|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
124768163|NCT03253796|448779167|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
124768164|NCT03253796|448779163|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
124768165|NCT03253796|448779164|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
124768166|NCT03253796|448779165|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
124768167|NCT03253796|448779166|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
124768168|NCT03253796|448779167|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
124768169|NCT03253796|448779163|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
124768170|NCT03253796|448779164|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
124768171|NCT03253796|448779165|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
124768172|NCT03253796|448779166|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
124768173|NCT03253796|448779167|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
124768174|NCT03253796|448779163|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
124768175|NCT03253796|448779164|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
124768176|NCT03253796|448779165|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
124768177|NCT03253796|448779166|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
124768178|NCT03253796|448779167|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
124768179|NCT03253796|448779163|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
124960261|NCT02205476|449480456|FG001|Overall Study|Study termination by Sponsor|3|||
124960262|NCT02109107|449480457|FG000|Overall Study|Lost to Follow-up|2|||
124960263|NCT00607789|449480463|FG000|Overall Study|Adverse Event|3|||
124960264|NCT00607789|449480464|FG001|Overall Study|Adverse Event|0|||
124960265|NCT00607789|449480463|FG000|Overall Study|Lack of Efficacy|0|||
124960266|NCT00607789|449480464|FG001|Overall Study|Lack of Efficacy|1|||
124960267|NCT00607789|449480463|FG000|Overall Study|Inadequate adherence|3|||
124960268|NCT00607789|449480464|FG001|Overall Study|Inadequate adherence|0|||
124708604|NCT02431325|448559451|FG001|Overall Study|Withdrawal by Subject|2|||
124708605|NCT02431325|448559450|FG000|Overall Study|Declined to take study medication|1|||
124708606|NCT02431325|448559451|FG001|Overall Study|Declined to take study medication|0|||
124708607|NCT02431325|448559450|FG000|Overall Study|Withdrew before starting study medication|1|||
124708608|NCT02431325|448559451|FG001|Overall Study|Withdrew before starting study medication|0|||
124708609|NCT02431325|448559450|FG000|Overall Study|Placebo shortage|2|||
124708610|NCT02431325|448559451|FG001|Overall Study|Placebo shortage|0|||
124708611|NCT00744861|448559452|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
124708612|NCT00744861|448559453|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
124708613|NCT00744861|448559454|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
124708614|NCT00744861|448559455|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
124708615|NCT00744861|448559452|FG000|Feasibility Stage 1|Pregnancy|0|||
124708616|NCT00744861|448559453|FG001|Feasibility Stage 1|Pregnancy|1|||
124708617|NCT00744861|448559454|FG002|Feasibility Stage 1|Pregnancy|0|||
124708618|NCT00744861|448559455|FG003|Feasibility Stage 1|Pregnancy|0|||
124708619|NCT00744861|448559452|FG000|Pivotal Stage 2|Adverse Event|0|||
124708620|NCT00744861|448559453|FG001|Pivotal Stage 2|Adverse Event|0|||
124708621|NCT00744861|448559454|FG002|Pivotal Stage 2|Adverse Event|6|||
124708622|NCT00744861|448559455|FG003|Pivotal Stage 2|Adverse Event|11|||
124708623|NCT00744861|448559452|FG000|Pivotal Stage 2|Death|0|||
124708624|NCT00744861|448559453|FG001|Pivotal Stage 2|Death|0|||
124708625|NCT00744861|448559454|FG002|Pivotal Stage 2|Death|0|||
124708626|NCT00744861|448559455|FG003|Pivotal Stage 2|Death|1|||
124708627|NCT00744861|448559452|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
124708628|NCT00744861|448559453|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
124708629|NCT00744861|448559454|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
124708630|NCT00744861|448559455|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
124708631|NCT00744861|448559452|FG000|Pivotal Stage 2|Physician Decision|0|||
124708632|NCT00744861|448559453|FG001|Pivotal Stage 2|Physician Decision|0|||
124708633|NCT00744861|448559454|FG002|Pivotal Stage 2|Physician Decision|3|||
124708634|NCT00744861|448559455|FG003|Pivotal Stage 2|Physician Decision|1|||
124708635|NCT00744861|448559452|FG000|Pivotal Stage 2|Protocol Violation|0|||
124708636|NCT00744861|448559453|FG001|Pivotal Stage 2|Protocol Violation|0|||
124708637|NCT00744861|448559454|FG002|Pivotal Stage 2|Protocol Violation|0|||
124708638|NCT00744861|448559455|FG003|Pivotal Stage 2|Protocol Violation|1|||
124768180|NCT03253796|448779164|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
124960269|NCT00607789|449480463|FG000|Overall Study|Lost to Follow-up|0|||
124960270|NCT00607789|449480464|FG001|Overall Study|Lost to Follow-up|5|||
124768181|NCT03253796|448779165|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
124768182|NCT03253796|448779166|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
124768183|NCT03253796|448779167|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
124768184|NCT03253796|448779163|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
124768185|NCT03253796|448779164|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
124768186|NCT03253796|448779165|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
124768187|NCT03253796|448779166|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
124768188|NCT03253796|448779167|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
124768189|NCT03253796|448779163|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
124768190|NCT03253796|448779164|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
124768191|NCT03253796|448779165|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
124768192|NCT03253796|448779166|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
124768193|NCT03253796|448779167|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
124768194|NCT02285855|448779168|FG000|Overall Study|Withdrawal by Subject|2|||
124768195|NCT02285855|448779169|FG001|Overall Study|Withdrawal by Subject|1|||
124960271|NCT00607789|449480463|FG000|Overall Study|Withdrawal by Subject|1|||
124708639|NCT00744861|448559452|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
124768196|NCT00528112|448779170|FG000|Treatment up to 3 Years|Adverse Event|313|||
124768197|NCT00528112|448779171|FG001|Treatment up to 3 Years|Adverse Event|278|||
124960272|NCT00607789|449480464|FG001|Overall Study|Withdrawal by Subject|0|||
124960273|NCT01919398|449480465|FG000|Overall Study|Progressive Disease|0|||
124960274|NCT01919398|449480466|FG001|Overall Study|Progressive Disease|0|||
124960275|NCT01919398|449480467|FG002|Overall Study|Progressive Disease|4|||
124960276|NCT02016690|449480469|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
124960277|NCT02016690|449480469|FG000|Overall Study|Excluded from SAS: Duplication|2|||
124960278|NCT02016690|449480469|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
124960279|NCT02016690|449480469|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
124960280|NCT02016690|449480469|FG000|Overall Study|Did not meet inclusion criteria|13|||
124708640|NCT00744861|448559453|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
124708641|NCT00744861|448559454|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
124708642|NCT00744861|448559455|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
124708643|NCT00744861|448559452|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
124708644|NCT00744861|448559453|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
124708645|NCT00744861|448559454|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
124708646|NCT00744861|448559455|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
124708647|NCT01567722|448559466|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
124708648|NCT01567722|448559467|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
124708649|NCT01567722|448559468|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
124708650|NCT01567722|448559466|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
124708651|NCT01567722|448559467|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
124708652|NCT01567722|448559468|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
124708653|NCT01567722|448559466|FG000|Overall Study|Protocol closure by the OCG|2|||
124708654|NCT01567722|448559467|FG001|Overall Study|Protocol closure by the OCG|0|||
124708655|NCT01567722|448559468|FG002|Overall Study|Protocol closure by the OCG|0|||
124708656|NCT01567722|448559466|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
124708657|NCT01567722|448559467|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
124708658|NCT01567722|448559468|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
124708659|NCT00431964|448559469|FG000|Overall Study|Adverse Event|1|||
124708660|NCT00431964|448559470|FG001|Overall Study|Adverse Event|0|||
124708661|NCT00431964|448559469|FG000|Overall Study|Lost to Follow-up|1|||
124708662|NCT00431964|448559470|FG001|Overall Study|Lost to Follow-up|2|||
124708663|NCT00431964|448559469|FG000|Overall Study|Physician Decision|2|||
124708664|NCT00431964|448559470|FG001|Overall Study|Physician Decision|2|||
124708665|NCT00431964|448559469|FG000|Overall Study|Withdrawal by Subject|2|||
124708666|NCT00431964|448559470|FG001|Overall Study|Withdrawal by Subject|1|||
124708667|NCT00431964|448559469|FG000|Overall Study|Parental Consent Withdrawn|0|||
124708668|NCT00431964|448559470|FG001|Overall Study|Parental Consent Withdrawn|2|||
124708669|NCT00431964|448559469|FG000|Overall Study|Due to Unstable Health|0|||
124708670|NCT00431964|448559470|FG001|Overall Study|Due to Unstable Health|1|||
124708671|NCT00382174|448559472|FG000|Overall Study|Lost to Follow-up|1|||
124960281|NCT02016690|449480469|FG000|Overall Study|Hospitalized for RSV at study start|3|||
124708672|NCT00382174|448559473|FG001|Overall Study|Lost to Follow-up|4|||
124708673|NCT00382174|448559474|FG002|Overall Study|Lost to Follow-up|5|||
124708674|NCT00382174|448559472|FG000|Overall Study|Adverse Event|1|||
124708675|NCT00382174|448559473|FG001|Overall Study|Adverse Event|4|||
124708676|NCT00382174|448559474|FG002|Overall Study|Adverse Event|5|||
124463514|NCT00647556|447656529|FG000|Overall Study|Lost to Follow-up|1|||
124960282|NCT02865135|449480474|FG000|Overall Study|Death|0|||
124768198|NCT00528112|448779170|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
124768199|NCT00528112|448779171|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
124768200|NCT00528112|448779170|FG000|Treatment up to 3 Years|Protocol Violation|16|||
124768201|NCT00528112|448779171|FG001|Treatment up to 3 Years|Protocol Violation|16|||
124768202|NCT00528112|448779170|FG000|Treatment up to 3 Years|Death|0|||
124768203|NCT00528112|448779171|FG001|Treatment up to 3 Years|Death|1|||
124960283|NCT02865135|449480475|FG001|Overall Study|Death|1|||
124960284|NCT02865135|449480476|FG002|Overall Study|Death|0|||
124960285|NCT02865135|449480474|FG000|Overall Study|Progression|6|||
124960286|NCT02865135|449480475|FG001|Overall Study|Progression|2|||
124960287|NCT02865135|449480476|FG002|Overall Study|Progression|2|||
124960288|NCT01196741|449480479|FG000|Overall Study|Disease progression|34|||
124960289|NCT01196741|449480480|FG001|Overall Study|Disease progression|14|||
124960290|NCT01196741|449480479|FG000|Overall Study|Adverse Event|10|||
124960291|NCT01196741|449480480|FG001|Overall Study|Adverse Event|6|||
124960292|NCT01196741|449480479|FG000|Overall Study|Serious Adverse Event|3|||
124960293|NCT01196741|449480480|FG001|Overall Study|Serious Adverse Event|1|||
124960294|NCT01196741|449480479|FG000|Overall Study|Dose limiting Adverse Event|2|||
124960295|NCT01196741|449480480|FG001|Overall Study|Dose limiting Adverse Event|1|||
124960296|NCT01196741|449480479|FG000|Overall Study|Withdrawal by Subject|3|||
124960297|NCT01196741|449480480|FG001|Overall Study|Withdrawal by Subject|0|||
124960298|NCT01196741|449480479|FG000|Overall Study|Other reason|3|||
124960299|NCT01196741|449480480|FG001|Overall Study|Other reason|3|||
124960300|NCT01196741|449480479|FG000|Overall Study|Other|3|||
124960301|NCT01196741|449480480|FG001|Overall Study|Other|2|||
124960302|NCT01196741|449480479|FG000|Overall Study|Protocol Violation|2|||
124960303|NCT01196741|449480480|FG001|Overall Study|Protocol Violation|1|||
124960304|NCT02273180|449480481|FG000|Overall Study|Adverse Event|2|||
124960305|NCT02273180|449480482|FG001|Overall Study|Adverse Event|2|||
124960306|NCT02273180|449480481|FG000|Overall Study|Lack of Efficacy|1|||
124960307|NCT02273180|449480482|FG001|Overall Study|Lack of Efficacy|0|||
124960308|NCT02273180|449480481|FG000|Overall Study|Protocol Violation|1|||
124960309|NCT02273180|449480482|FG001|Overall Study|Protocol Violation|7|||
124768204|NCT00528112|448779170|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
124768205|NCT00528112|448779171|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
124768206|NCT00528112|448779170|FG000|Treatment up to 3 Years|Pregnancy|9|||
124768207|NCT00528112|448779171|FG001|Treatment up to 3 Years|Pregnancy|10|||
124768208|NCT00528112|448779170|FG000|Treatment up to 3 Years|Other reasons|186|||
124768209|NCT00528112|448779171|FG001|Treatment up to 3 Years|Other reasons|186|||
124768210|NCT00528112|448779170|FG000|Extension Phase|Withdrawal by Subject|0|||
124768211|NCT00528112|448779171|FG001|Extension Phase|Withdrawal by Subject|3|||
124768212|NCT00528112|448779170|FG000|Extension Phase|Other reasons|0|||
124768213|NCT00528112|448779171|FG001|Extension Phase|Other reasons|100|||
124960310|NCT02273180|449480481|FG000|Overall Study|Randomized but not treated|1|||
124960311|NCT02273180|449480482|FG001|Overall Study|Randomized but not treated|0|||
124768214|NCT00528112|448779170|FG000|Extension Phase|Pregnancy|0|||
124768215|NCT00528112|448779171|FG001|Extension Phase|Pregnancy|3|||
124960312|NCT02273180|449480481|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
124960313|NCT02273180|449480482|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
124768216|NCT00528112|448779170|FG000|Extension Phase|Lost to Follow-up|0|||
124768217|NCT00528112|448779171|FG001|Extension Phase|Lost to Follow-up|12|||
124768218|NCT00528112|448779170|FG000|Extension Phase|Death|0|||
124768219|NCT00528112|448779171|FG001|Extension Phase|Death|1|||
124768220|NCT00528112|448779170|FG000|Extension Phase|Adverse Event|0|||
124768221|NCT00528112|448779171|FG001|Extension Phase|Adverse Event|36|||
124768222|NCT00528112|448779170|FG000|Extension Phase|Protocol Violation|0|||
124768223|NCT00528112|448779171|FG001|Extension Phase|Protocol Violation|2|||
124768224|NCT02718898|448779172|FG000|Blinded Treatment Period|Adverse Event|5|||
124768225|NCT02718898|448779173|FG001|Blinded Treatment Period|Adverse Event|1|||
124768226|NCT02718898|448779174|FG002|Blinded Treatment Period|Adverse Event|0|||
124768227|NCT02718898|448779175|FG003|Blinded Treatment Period|Adverse Event|0|||
124768228|NCT02718898|448779176|FG004|Blinded Treatment Period|Adverse Event|0|||
124768229|NCT02718898|448779177|FG005|Blinded Treatment Period|Adverse Event|0|||
124768230|NCT02718898|448779178|FG006|Blinded Treatment Period|Adverse Event|0|||
124768231|NCT02718898|448779172|FG000|Blinded Treatment Period|Physician Decision|1|||
124768232|NCT02718898|448779173|FG001|Blinded Treatment Period|Physician Decision|0|||
124960314|NCT02273180|449480481|FG000|Overall Study|Other than specified above|21|||
124960315|NCT02273180|449480482|FG001|Overall Study|Other than specified above|10|||
124960316|NCT00509925|449480483|FG000|Overall Study|Personal reasons|0|||
124960317|NCT00509925|449480484|FG001|Overall Study|Personal reasons|1|||
124960318|NCT03302559|449480487|FG000|Overall Study|Adverse Event|2|||
124960319|NCT03302559|449480487|FG000|Overall Study|Lost to Follow-up|1|||
124960320|NCT03302559|449480487|FG000|Overall Study|Withdrew Consent|3|||
124960321|NCT00598871|449482425|FG000|Overall Study|Adverse Event|0|||
124768233|NCT02718898|448779174|FG002|Blinded Treatment Period|Physician Decision|0|||
124768234|NCT02718898|448779175|FG003|Blinded Treatment Period|Physician Decision|0|||
124768235|NCT02718898|448779176|FG004|Blinded Treatment Period|Physician Decision|0|||
124960322|NCT00598871|449482426|FG001|Overall Study|Adverse Event|1|||
124960323|NCT02151643|449482431|FG000|Overall Study|Adverse Event|2|||
124960324|NCT02151643|449482432|FG001|Overall Study|Adverse Event|0|||
124960325|NCT02151643|449482433|FG002|Overall Study|Adverse Event|1|||
124960326|NCT02151643|449482434|FG003|Overall Study|Adverse Event|4|||
124768236|NCT02718898|448779177|FG005|Blinded Treatment Period|Physician Decision|0|||
124768237|NCT02718898|448779178|FG006|Blinded Treatment Period|Physician Decision|0|||
124768238|NCT02718898|448779172|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
124768239|NCT02718898|448779173|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
124768240|NCT02718898|448779174|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
124768241|NCT02718898|448779175|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
124768242|NCT02718898|448779176|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
124768243|NCT02718898|448779177|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
124768244|NCT02718898|448779178|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
124768245|NCT02718898|448779172|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
124768246|NCT02718898|448779173|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
124768247|NCT02718898|448779174|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
124768248|NCT02718898|448779175|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
124960327|NCT02151643|449482435|FG004|Overall Study|Adverse Event|0|||
124960328|NCT02151643|449482431|FG000|Overall Study|Withdrawal by Subject|0|||
124768249|NCT02718898|448779176|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
124768250|NCT02718898|448779177|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
124768251|NCT02718898|448779178|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
124768252|NCT02718898|448779172|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
124768253|NCT02718898|448779173|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
124768254|NCT02718898|448779174|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
124768255|NCT02718898|448779175|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
124768256|NCT02718898|448779176|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
124768257|NCT02718898|448779177|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
124768258|NCT02718898|448779178|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
124768259|NCT02718898|448779172|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
124768260|NCT02718898|448779173|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
124768261|NCT02718898|448779174|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
124768262|NCT02718898|448779175|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
124768263|NCT02718898|448779176|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
124768264|NCT02718898|448779177|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
124768265|NCT02718898|448779178|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
124768266|NCT02718898|448779172|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
124768267|NCT02718898|448779173|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
124768268|NCT02718898|448779174|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
124768269|NCT02718898|448779175|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
124768270|NCT02718898|448779176|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
124768271|NCT02718898|448779177|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
124768272|NCT02718898|448779178|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
124768273|NCT02718898|448779172|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
124768274|NCT02718898|448779173|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
124768275|NCT02718898|448779174|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
124768276|NCT02718898|448779175|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
124768277|NCT02718898|448779176|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
124768278|NCT02718898|448779177|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
124768279|NCT02718898|448779178|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
124768280|NCT02718898|448779172|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
124768281|NCT02718898|448779173|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
124768282|NCT02718898|448779174|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
124768283|NCT02718898|448779175|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
124768284|NCT02718898|448779176|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
124768285|NCT02718898|448779177|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
124768286|NCT02718898|448779178|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
124768287|NCT02718898|448779172|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
124768288|NCT02718898|448779173|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
124768289|NCT02718898|448779174|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
124768290|NCT02718898|448779175|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
124768291|NCT02718898|448779176|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
124768292|NCT02718898|448779177|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
124768293|NCT02718898|448779178|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
124960329|NCT02151643|449482432|FG001|Overall Study|Withdrawal by Subject|1|||
124960330|NCT02151643|449482433|FG002|Overall Study|Withdrawal by Subject|1|||
124768294|NCT02718898|448779172|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
124768295|NCT02718898|448779173|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
124768296|NCT02718898|448779174|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
124768297|NCT02718898|448779175|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
124768298|NCT02718898|448779176|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
124768299|NCT02718898|448779177|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
124768300|NCT02718898|448779178|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
124768301|NCT02718898|448779172|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
124768302|NCT02718898|448779173|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
124768303|NCT02718898|448779174|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
124768304|NCT02718898|448779175|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
124768305|NCT02718898|448779176|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
124768306|NCT02718898|448779177|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
124768307|NCT02718898|448779178|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
124768308|NCT02718898|448779172|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
124768309|NCT02718898|448779173|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
124768310|NCT02718898|448779174|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
124768311|NCT02718898|448779175|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
124768312|NCT02718898|448779176|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
124768313|NCT02718898|448779177|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
124768314|NCT02718898|448779178|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
124768315|NCT00894803|448779179|FG000|Overall Study|Death|20|||
124768316|NCT00894803|448779180|FG001|Overall Study|Death|4|||
124768317|NCT00894803|448779179|FG000|Overall Study|Lost to Follow-up|0|||
124768318|NCT00894803|448779180|FG001|Overall Study|Lost to Follow-up|1|||
124768319|NCT04484961|448779181|FG000|Overall Study|Lost to Follow-up|9|||
124768320|NCT04484961|448779182|FG001|Overall Study|Lost to Follow-up|9|||
124768321|NCT01667900|448779183|FG000|Part B|Death|0|||
124768322|NCT01667900|448779184|FG001|Part B|Death|0|||
124768323|NCT01667900|448779185|FG002|Part B|Death|0|||
124768324|NCT01667900|448779186|FG003|Part B|Death|0|||
124768325|NCT01667900|448779187|FG004|Part B|Death|0|||
124768326|NCT01667900|448779188|FG005|Part B|Death|0|||
124768327|NCT01667900|448779189|FG006|Part B|Death|0|||
124768328|NCT01667900|448779190|FG007|Part B|Death|0|||
124768329|NCT01667900|448779191|FG008|Part B|Death|0|||
124768330|NCT01667900|448779192|FG009|Part B|Death|0|||
124768331|NCT01667900|448779193|FG010|Part B|Death|0|||
124768332|NCT01667900|448779194|FG011|Part B|Death|0|||
124768333|NCT01667900|448779195|FG012|Part B|Death|0|||
124768334|NCT01667900|448779196|FG013|Part B|Death|0|||
124768335|NCT01667900|448779197|FG014|Part B|Death|0|||
124768336|NCT01667900|448779198|FG015|Part B|Death|0|||
124768337|NCT01667900|448779199|FG016|Part B|Death|1|||
124768338|NCT01667900|448779200|FG017|Part B|Death|0|||
124768339|NCT01667900|448779201|FG018|Part B|Death|0|||
124768340|NCT01667900|448779202|FG019|Part B|Death|0|||
124768341|NCT00004563|448779207|FG000|Overall Study|Withdrawal by Subject|20|||
124768342|NCT00004563|448779208|FG001|Overall Study|Withdrawal by Subject|16|||
124768343|NCT00004563|448779207|FG000|Overall Study|Lack of Efficacy|3|||
124768344|NCT00004563|448779208|FG001|Overall Study|Lack of Efficacy|5|||
124768345|NCT00004563|448779207|FG000|Overall Study|Death|2|||
124768346|NCT00004563|448779208|FG001|Overall Study|Death|3|||
124768347|NCT03337308|448779209|FG000|Overall Study|Adverse Event|2|||
124768348|NCT03337308|448779210|FG001|Overall Study|Adverse Event|3|||
124768349|NCT03337308|448779211|FG002|Overall Study|Adverse Event|3|||
124768350|NCT03337308|448779212|FG003|Overall Study|Adverse Event|1|||
124768351|NCT03337308|448779209|FG000|Overall Study|Lost to Follow-up|1|||
124768352|NCT03337308|448779210|FG001|Overall Study|Lost to Follow-up|2|||
124768353|NCT03337308|448779211|FG002|Overall Study|Lost to Follow-up|0|||
124768354|NCT03337308|448779212|FG003|Overall Study|Lost to Follow-up|0|||
124768355|NCT03337308|448779209|FG000|Overall Study|Withdrawal by Subject|2|||
124768356|NCT03337308|448779210|FG001|Overall Study|Withdrawal by Subject|1|||
124768357|NCT03337308|448779211|FG002|Overall Study|Withdrawal by Subject|2|||
124768358|NCT03337308|448779212|FG003|Overall Study|Withdrawal by Subject|1|||
124960331|NCT02151643|449482434|FG003|Overall Study|Withdrawal by Subject|1|||
124960332|NCT02151643|449482435|FG004|Overall Study|Withdrawal by Subject|1|||
124768359|NCT03337308|448779209|FG000|Overall Study|Protocol Violation|0|||
124768360|NCT03337308|448779210|FG001|Overall Study|Protocol Violation|1|||
124768361|NCT03337308|448779211|FG002|Overall Study|Protocol Violation|0|||
124768362|NCT03337308|448779212|FG003|Overall Study|Protocol Violation|0|||
124768363|NCT00762164|448779215|FG000|Overall Study|Lost to Follow-up|1|||
124768364|NCT00762164|448779216|FG001|Overall Study|Lost to Follow-up|1|||
124768365|NCT00762164|448779215|FG000|Overall Study|Discontinued medication|2|||
124768366|NCT00762164|448779216|FG001|Overall Study|Discontinued medication|0|||
124768367|NCT00762164|448779215|FG000|Overall Study|Withdrawal by Subject|0|||
124768368|NCT00762164|448779216|FG001|Overall Study|Withdrawal by Subject|1|||
124768369|NCT03094416|448779219|FG000|Run-in|Screening failure|8|||
124768370|NCT03094416|448779219|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
124960333|NCT02151643|449482431|FG000|Overall Study|Hyperphosphataemia|1|||
124768371|NCT03094416|448779219|FG000|Run-in|Withdrawal by Subject|3|||
124768372|NCT03094416|448779219|FG000|Treatment Period|Withdrawal by Subject|2|||
124768373|NCT04528641|448779221|FG000|Overall Study|Withdrawal by Subject|0|||
124768374|NCT04528641|448779222|FG001|Overall Study|Withdrawal by Subject|0|||
124768375|NCT04528641|448779223|FG002|Overall Study|Withdrawal by Subject|0|||
124768376|NCT04528641|448779224|FG003|Overall Study|Withdrawal by Subject|1|||
124768377|NCT04528641|448779225|FG004|Overall Study|Withdrawal by Subject|0|||
124768378|NCT04528641|448779226|FG005|Overall Study|Withdrawal by Subject|1|||
124768379|NCT03341299|448779227|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
124768380|NCT03341299|448779228|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
124768381|NCT03341299|448779229|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
124768382|NCT03341299|448779230|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
124768383|NCT00945009|448779233|FG000|Overall Study|Lack of Efficacy|10|||
124768384|NCT00945009|448779234|FG001|Overall Study|Lack of Efficacy|0|||
124768385|NCT00945009|448779235|FG002|Overall Study|Lack of Efficacy|0|||
124768386|NCT00945009|448779233|FG000|Overall Study|Physician Decision|21|||
124768387|NCT00945009|448779234|FG001|Overall Study|Physician Decision|4|||
124768388|NCT00945009|448779235|FG002|Overall Study|Physician Decision|3|||
124768389|NCT00945009|448779233|FG000|Overall Study|Protocol Violation|6|||
124768390|NCT00945009|448779234|FG001|Overall Study|Protocol Violation|1|||
124768391|NCT00945009|448779235|FG002|Overall Study|Protocol Violation|0|||
124768392|NCT00945009|448779233|FG000|Overall Study|Withdrawal by Subject|1|||
124768393|NCT00945009|448779234|FG001|Overall Study|Withdrawal by Subject|0|||
124768394|NCT00945009|448779235|FG002|Overall Study|Withdrawal by Subject|0|||
124768395|NCT00945009|448779233|FG000|Overall Study|Ineligible|6|||
124768396|NCT00945009|448779234|FG001|Overall Study|Ineligible|1|||
124768397|NCT00945009|448779235|FG002|Overall Study|Ineligible|0|||
124768398|NCT00945009|448779233|FG000|Overall Study|Inevaluable|0|||
124768399|NCT00945009|448779234|FG001|Overall Study|Inevaluable|1|||
124960334|NCT02151643|449482432|FG001|Overall Study|Hyperphosphataemia|0|||
124960335|NCT02151643|449482433|FG002|Overall Study|Hyperphosphataemia|0|||
124960336|NCT02151643|449482434|FG003|Overall Study|Hyperphosphataemia|0|||
124960337|NCT02151643|449482435|FG004|Overall Study|Hyperphosphataemia|1|||
124463515|NCT00647556|447656530|FG001|Overall Study|Lost to Follow-up|0|||
124768400|NCT00945009|448779235|FG002|Overall Study|Inevaluable|0|||
124768401|NCT00945009|448779233|FG000|Overall Study|Refusal of further protocol|1|||
124768402|NCT00945009|448779234|FG001|Overall Study|Refusal of further protocol|0|||
124768403|NCT00945009|448779235|FG002|Overall Study|Refusal of further protocol|0|||
124768404|NCT04607005|448779236|FG000|Overall Study|Adverse Event|0|||
124768405|NCT04607005|448779237|FG001|Overall Study|Adverse Event|1|||
124768406|NCT04607005|448779236|FG000|Overall Study|Lack of Efficacy|1|||
124768407|NCT04607005|448779237|FG001|Overall Study|Lack of Efficacy|6|||
124768408|NCT04607005|448779236|FG000|Overall Study|Withdrawal by Subject|4|||
124768409|NCT04607005|448779237|FG001|Overall Study|Withdrawal by Subject|9|||
124768410|NCT04607005|448779236|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
124768411|NCT04607005|448779237|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
124768412|NCT03919773|448779246|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
124768413|NCT03919773|448779247|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
124768414|NCT03919773|448779246|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
124768415|NCT03919773|448779247|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
124768416|NCT04659044|448779250|FG000|Induction|Physician Decision|1|||
124768417|NCT04659044|448779250|FG000|Induction|Adverse Event|2|||
124768418|NCT05417438|448779252|FG000|Overall Study|Withdrawal by Subject|3|||
124768419|NCT02994108|448781085|FG000|Intervention Messages|Withdrawal by Subject|2|||
124768420|NCT02994108|448781086|FG001|Intervention Messages|Withdrawal by Subject|0|||
124768421|NCT02994108|448781085|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
124768422|NCT02994108|448781086|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
124768423|NCT02994108|448781085|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
124768424|NCT02994108|448781086|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
124768425|NCT02994108|448781085|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
124768426|NCT02994108|448781086|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
124768427|NCT00781768|448781093|FG000|Overall Study|Not transplanted.|0|||
124768428|NCT00781768|448781094|FG001|Overall Study|Not transplanted.|2|||
124768429|NCT00079417|448781097|FG000|Overall Study|Physician Decision|2|||
124768430|NCT00079417|448781097|FG000|Overall Study|Ineligible|7|||
124768431|NCT02458313|448781098|FG000|Overall Study|Withdrawal by Subject|6|||
124768432|NCT02458313|448781099|FG001|Overall Study|Withdrawal by Subject|8|||
124768433|NCT02458313|448781098|FG000|Overall Study|Excluded for motion during MRI|1|||
124768434|NCT02458313|448781099|FG001|Overall Study|Excluded for motion during MRI|2|||
124768435|NCT02081677|448781100|FG000|Overall Study|Adverse Event|0|||
124768436|NCT02081677|448781101|FG001|Overall Study|Adverse Event|0|||
124768437|NCT02081677|448781102|FG002|Overall Study|Adverse Event|1|||
124768438|NCT02081677|448781103|FG003|Overall Study|Adverse Event|0|||
124768439|NCT02081677|448781100|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
124768440|NCT02081677|448781101|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
124960338|NCT02151643|449482431|FG000|Overall Study|High Ferritin levels|3|||
124960339|NCT02151643|449482432|FG001|Overall Study|High Ferritin levels|3|||
124768441|NCT02081677|448781102|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
124768442|NCT02081677|448781103|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
124768443|NCT02081677|448781100|FG000|Overall Study|Not comfortable with lens care system|1|||
124768444|NCT02081677|448781101|FG001|Overall Study|Not comfortable with lens care system|0|||
124768445|NCT02081677|448781102|FG002|Overall Study|Not comfortable with lens care system|0|||
124768446|NCT02081677|448781103|FG003|Overall Study|Not comfortable with lens care system|0|||
124768447|NCT02081677|448781100|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
124768448|NCT02081677|448781101|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
124768449|NCT02081677|448781102|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
124768450|NCT02081677|448781103|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
124768451|NCT00904969|448781104|FG000|Overall Study|Lost to Follow-up|4|||
124768452|NCT00904969|448781104|FG000|Overall Study|Withdrawal by Subject|3|||
124768453|NCT00904969|448781104|FG000|Overall Study|Additional Treatments|11|||
124768454|NCT00904969|448781104|FG000|Overall Study|Case Aborted; Subject Exited|1|||
124768455|NCT01097668|448781105|FG000|Overall Study|Withdrawal by Subject|1|||
124768456|NCT01097668|448781106|FG001|Overall Study|Withdrawal by Subject|2|||
124768457|NCT01097668|448781105|FG000|Overall Study|Lost to Follow-up|1|||
124768458|NCT01097668|448781106|FG001|Overall Study|Lost to Follow-up|0|||
124768459|NCT00199381|448781113|FG000|Overall Study|Withdrawal by Subject|38|||
124768460|NCT00199381|448781113|FG000|Overall Study|Adverse Event|73|||
124768461|NCT00199381|448781113|FG000|Overall Study|Protocol Violation|6|||
124768462|NCT00199381|448781113|FG000|Overall Study|Lack of Efficacy|27|||
124768463|NCT00199381|448781113|FG000|Overall Study|Not including due to early termination|37|||
124768464|NCT00199381|448781113|FG000|Overall Study|Study termination by Sponsor|323|||
124768465|NCT00385671|448781115|FG000|Overall Study|Adverse Event|14|||
124768466|NCT00385671|448781116|FG001|Overall Study|Adverse Event|27|||
124768467|NCT00385671|448781117|FG002|Overall Study|Adverse Event|18|||
124768468|NCT00385671|448781115|FG000|Overall Study|Lack of Efficacy|5|||
124768469|NCT00385671|448781116|FG001|Overall Study|Lack of Efficacy|9|||
124768470|NCT00385671|448781117|FG002|Overall Study|Lack of Efficacy|5|||
124768471|NCT00385671|448781115|FG000|Overall Study|Lost to Follow-up|6|||
124768472|NCT00385671|448781116|FG001|Overall Study|Lost to Follow-up|6|||
124768473|NCT00385671|448781117|FG002|Overall Study|Lost to Follow-up|5|||
124768474|NCT00385671|448781115|FG000|Overall Study|Physician Decision|2|||
124768475|NCT00385671|448781116|FG001|Overall Study|Physician Decision|1|||
124768476|NCT00385671|448781117|FG002|Overall Study|Physician Decision|2|||
124768477|NCT00385671|448781115|FG000|Overall Study|Protocol Violation|5|||
124768478|NCT00385671|448781116|FG001|Overall Study|Protocol Violation|2|||
124768479|NCT00385671|448781117|FG002|Overall Study|Protocol Violation|1|||
124768480|NCT00385671|448781115|FG000|Overall Study|Sponsor Decision|2|||
124768481|NCT00385671|448781116|FG001|Overall Study|Sponsor Decision|2|||
124768482|NCT00385671|448781117|FG002|Overall Study|Sponsor Decision|1|||
124768483|NCT00385671|448781115|FG000|Overall Study|Withdrawal by Subject|4|||
124768484|NCT00385671|448781116|FG001|Overall Study|Withdrawal by Subject|4|||
124768485|NCT00385671|448781117|FG002|Overall Study|Withdrawal by Subject|4|||
124768486|NCT04944992|448781118|FG000|Overall Study|Lost to Follow-up|1|||
124768487|NCT04944992|448781119|FG001|Overall Study|Lost to Follow-up|1|||
124768488|NCT04944992|448781118|FG000|Overall Study|Physician Decision|1|||
124768489|NCT04944992|448781119|FG001|Overall Study|Physician Decision|0|||
124768490|NCT04944992|448781118|FG000|Overall Study|Withdrawal by Subject|6|||
124768491|NCT04944992|448781119|FG001|Overall Study|Withdrawal by Subject|1|||
124768492|NCT01295814|448781120|FG000|Overall Study|Lack of Efficacy|0|||
124768493|NCT01295814|448781121|FG001|Overall Study|Lack of Efficacy|2|||
124768494|NCT01295814|448781120|FG000|Overall Study|Withdrawal by Subject|2|||
124768495|NCT01295814|448781121|FG001|Overall Study|Withdrawal by Subject|0|||
124768496|NCT03414983|448781122|FG000|Pre-Treatment|Other reasons|1|||
124768497|NCT03414983|448781123|FG001|Pre-Treatment|Other reasons|0|||
124768498|NCT03414983|448781122|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
124768499|NCT03414983|448781123|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
124768500|NCT03414983|448781122|FG000|Pre-Treatment|Participant withdrew consent|1|||
124768501|NCT03414983|448781123|FG001|Pre-Treatment|Participant withdrew consent|3|||
124768502|NCT03414983|448781122|FG000|Treatment|Participant withdrew consent|4|||
124768503|NCT03414983|448781123|FG001|Treatment|Participant withdrew consent|3|||
124768504|NCT03414983|448781122|FG000|Treatment|Participant request to discontinue study treatment|8|||
124768505|NCT03414983|448781123|FG001|Treatment|Participant request to discontinue study treatment|10|||
124768506|NCT03414983|448781122|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
124768507|NCT03414983|448781123|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
124768508|NCT03414983|448781122|FG000|Treatment|Death|0|||
124768509|NCT03414983|448781123|FG001|Treatment|Death|1|||
124768510|NCT03414983|448781122|FG000|Treatment|Study Drug Toxicity|10|||
124768511|NCT03414983|448781123|FG001|Treatment|Study Drug Toxicity|5|||
124768512|NCT03414983|448781122|FG000|Treatment|Disease Progression|75|||
124768513|NCT03414983|448781123|FG001|Treatment|Disease Progression|29|||
124768514|NCT03414983|448781122|FG000|Treatment|Not reported|1|||
124768515|NCT03414983|448781123|FG001|Treatment|Not reported|0|||
124768516|NCT03414983|448781122|FG000|Treatment|Other reasons|3|||
124768517|NCT03414983|448781123|FG001|Treatment|Other reasons|2|||
124768518|NCT03414983|448781122|FG000|Treatment|Poor/non-compliance|2|||
124768519|NCT03414983|448781123|FG001|Treatment|Poor/non-compliance|0|||
124768520|NCT03414983|448781122|FG000|Treatment|Maximum clinical benefit|5|||
124768521|NCT03414983|448781123|FG001|Treatment|Maximum clinical benefit|9|||
124768522|NCT03414983|448781122|FG000|Treatment|Lost to Follow-up|0|||
124768523|NCT03414983|448781123|FG001|Treatment|Lost to Follow-up|1|||
124768524|NCT03414983|448781122|FG000|Treatment|Administrative reasons by sponsor|1|||
124768525|NCT03414983|448781123|FG001|Treatment|Administrative reasons by sponsor|0|||
124768526|NCT01775501|448781126|FG000|Overall Study|Discontinued prior to treatment|1|||
124768527|NCT03780244|448781134|FG000|Overall Study|Lost to Follow-up|1|||
124768528|NCT03780244|448781135|FG001|Overall Study|Lost to Follow-up|0|||
124768529|NCT00804908|448781138|FG000|Overall Study|Other|115|||
124768530|NCT00804908|448781139|FG001|Overall Study|Other|116|||
124768531|NCT00804908|448781140|FG002|Overall Study|Other|114|||
124768532|NCT01280903|448781141|FG000|Overall Study|Lost to Follow-up|23|||
124768533|NCT01280903|448781142|FG001|Overall Study|Lost to Follow-up|16|||
124768534|NCT03453164|448781143|FG000|Overall Study|Lack of Efficacy|16|||
124768535|NCT03453164|448781143|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
124768536|NCT03822117|448781145|FG000|Overall Study|Death|18|||
124768537|NCT03822117|448781146|FG001|Overall Study|Death|17|||
124768538|NCT03822117|448781147|FG002|Overall Study|Death|12|||
124768539|NCT03822117|448781148|FG003|Overall Study|Death|4|||
124768540|NCT03822117|448781145|FG000|Overall Study|Lost to Follow-up|1|||
124768541|NCT03822117|448781146|FG001|Overall Study|Lost to Follow-up|2|||
124768542|NCT03822117|448781147|FG002|Overall Study|Lost to Follow-up|3|||
124768543|NCT03822117|448781148|FG003|Overall Study|Lost to Follow-up|0|||
124768544|NCT03822117|448781145|FG000|Overall Study|Study Terminated by Sponsor|25|||
124768545|NCT03822117|448781146|FG001|Overall Study|Study Terminated by Sponsor|11|||
124768546|NCT03822117|448781147|FG002|Overall Study|Study Terminated by Sponsor|6|||
124768547|NCT03822117|448781148|FG003|Overall Study|Study Terminated by Sponsor|0|||
124768548|NCT03822117|448781145|FG000|Overall Study|Withdrawal by Subject|4|||
124768549|NCT03822117|448781146|FG001|Overall Study|Withdrawal by Subject|0|||
124768550|NCT03822117|448781147|FG002|Overall Study|Withdrawal by Subject|3|||
124768551|NCT03822117|448781148|FG003|Overall Study|Withdrawal by Subject|0|||
124768552|NCT03822117|448781145|FG000|Overall Study|Disease Progression|1|||
124768553|NCT03822117|448781146|FG001|Overall Study|Disease Progression|2|||
124768554|NCT03822117|448781147|FG002|Overall Study|Disease Progression|1|||
124768555|NCT03822117|448781148|FG003|Overall Study|Disease Progression|0|||
124768556|NCT03822117|448781145|FG000|Overall Study|Never Returned to Hospital|0|||
124768557|NCT03822117|448781146|FG001|Overall Study|Never Returned to Hospital|0|||
124768558|NCT03822117|448781147|FG002|Overall Study|Never Returned to Hospital|1|||
124768559|NCT03822117|448781148|FG003|Overall Study|Never Returned to Hospital|0|||
124768560|NCT01074502|448781149|FG000|Overall Study|Withdrawal by Subject|1|||
124768561|NCT03459079|448781150|FG000|Overall Study|Adverse Event|4|||
124768562|NCT03459079|448781151|FG001|Overall Study|Adverse Event|2|||
124768563|NCT03459079|448781152|FG002|Overall Study|Adverse Event|0|||
124768564|NCT03459079|448781150|FG000|Overall Study|Withdrawal by Subject|2|||
124768565|NCT03459079|448781151|FG001|Overall Study|Withdrawal by Subject|2|||
124768566|NCT03459079|448781152|FG002|Overall Study|Withdrawal by Subject|0|||
124768567|NCT00726063|448781156|FG000|Overall Study|Adverse Event|9|||
124768568|NCT00726063|448781157|FG001|Overall Study|Adverse Event|7|||
124768569|NCT05176314|448781159|FG000|Overall Study|Lost to Follow-up|2|||
124768570|NCT05176314|448781159|FG000|Overall Study|Physician Decision|1|||
124768571|NCT05176314|448781159|FG000|Overall Study|Adverse Event|1|||
124768572|NCT01231984|448781160|FG000|Study Period 1|Withdrawal by Subject|0|||
124768573|NCT01231984|448781161|FG001|Study Period 1|Withdrawal by Subject|0|||
124768574|NCT01231984|448781162|FG002|Study Period 1|Withdrawal by Subject|0|||
124768575|NCT01231984|448781163|FG003|Study Period 1|Withdrawal by Subject|1|||
124768576|NCT01231984|448781160|FG000|Study Period 1|Lost to Follow-up|1|||
124768577|NCT01231984|448781161|FG001|Study Period 1|Lost to Follow-up|1|||
124768578|NCT01231984|448781162|FG002|Study Period 1|Lost to Follow-up|1|||
124768579|NCT01231984|448781163|FG003|Study Period 1|Lost to Follow-up|0|||
124768580|NCT01231984|448781160|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
124768581|NCT01231984|448781161|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
124768582|NCT01231984|448781162|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
124768583|NCT01231984|448781163|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
124768584|NCT01231984|448781160|FG000|Study Period 1|Screen Failure|0|||
124768585|NCT01231984|448781161|FG001|Study Period 1|Screen Failure|0|||
124768586|NCT01231984|448781162|FG002|Study Period 1|Screen Failure|0|||
124768587|NCT01231984|448781163|FG003|Study Period 1|Screen Failure|1|||
124768588|NCT01231984|448781160|FG000|Study Period 1|Non-compliance with study requirements|5|||
124768589|NCT01231984|448781161|FG001|Study Period 1|Non-compliance with study requirements|0|||
124768590|NCT01231984|448781162|FG002|Study Period 1|Non-compliance with study requirements|2|||
124768591|NCT01231984|448781163|FG003|Study Period 1|Non-compliance with study requirements|1|||
124768592|NCT01231984|448781160|FG000|Study Period 1|Protocol Violation|3|||
124768593|NCT01231984|448781161|FG001|Study Period 1|Protocol Violation|4|||
124768594|NCT01231984|448781162|FG002|Study Period 1|Protocol Violation|2|||
124768595|NCT01231984|448781163|FG003|Study Period 1|Protocol Violation|3|||
124768596|NCT01231984|448781160|FG000|Study Period 1|Adverse Event|1|||
124768597|NCT01231984|448781161|FG001|Study Period 1|Adverse Event|0|||
124768598|NCT01231984|448781162|FG002|Study Period 1|Adverse Event|0|||
124960340|NCT02151643|449482433|FG002|Overall Study|High Ferritin levels|2|||
124960341|NCT02151643|449482434|FG003|Overall Study|High Ferritin levels|2|||
124960342|NCT02151643|449482435|FG004|Overall Study|High Ferritin levels|1|||
124960343|NCT01084239|449482440|FG000|28-Day Follow-up|Lost to Follow-up|4|||
124960344|NCT01084239|449482441|FG001|28-Day Follow-up|Lost to Follow-up|9|||
124960345|NCT02396953|449482442|FG000|Overall Study|Withdrawal by Subject|0|||
124960346|NCT02396953|449482443|FG001|Overall Study|Withdrawal by Subject|0|||
124960347|NCT02396953|449482444|FG002|Overall Study|Withdrawal by Subject|1|||
124960348|NCT02396953|449482442|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
124960349|NCT02396953|449482443|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
124960350|NCT02396953|449482444|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
124960351|NCT02396953|449482442|FG000|Overall Study|Personal Reasons|1|||
124960352|NCT02396953|449482443|FG001|Overall Study|Personal Reasons|1|||
124960353|NCT02396953|449482444|FG002|Overall Study|Personal Reasons|0|||
124960354|NCT02679079|449482445|FG000|Overall Study|Adverse Event|2|||
124960355|NCT02679079|449482446|FG001|Overall Study|Adverse Event|0|||
124960356|NCT02679079|449482447|FG002|Overall Study|Adverse Event|2|||
124960357|NCT02679079|449482445|FG000|Overall Study|Protocol Violation|0|||
124960358|NCT02679079|449482446|FG001|Overall Study|Protocol Violation|1|||
124960359|NCT02679079|449482447|FG002|Overall Study|Protocol Violation|0|||
124960360|NCT02679079|449482445|FG000|Overall Study|Withdrawal by Subject|2|||
124960361|NCT02679079|449482446|FG001|Overall Study|Withdrawal by Subject|1|||
124960362|NCT02679079|449482447|FG002|Overall Study|Withdrawal by Subject|0|||
124960363|NCT04150341|449482448|FG000|Overall Study|Physician Decision|0|||
124960364|NCT04150341|449482449|FG001|Overall Study|Physician Decision|0|||
124960365|NCT04150341|449482450|FG002|Overall Study|Physician Decision|1|||
124960366|NCT04150341|449482451|FG003|Overall Study|Physician Decision|0|||
124463516|NCT00647556|447656529|FG000|Overall Study|Protocol Violation|0|||
124708677|NCT00382174|448559472|FG000|Overall Study|Withdrawal by Subject|1|||
124708678|NCT00382174|448559473|FG001|Overall Study|Withdrawal by Subject|4|||
124708679|NCT00382174|448559474|FG002|Overall Study|Withdrawal by Subject|5|||
124708680|NCT00382174|448559472|FG000|Overall Study|Non compliance|1|||
124708681|NCT00382174|448559473|FG001|Overall Study|Non compliance|0|||
124708682|NCT00382174|448559474|FG002|Overall Study|Non compliance|1|||
124708683|NCT00382174|448559472|FG000|Overall Study|Physician Decision|0|||
124708684|NCT00382174|448559473|FG001|Overall Study|Physician Decision|2|||
124708685|NCT00382174|448559474|FG002|Overall Study|Physician Decision|2|||
124708686|NCT00382174|448559472|FG000|Overall Study|Failed to meet criteria|0|||
124708687|NCT00382174|448559473|FG001|Overall Study|Failed to meet criteria|1|||
124708688|NCT00382174|448559474|FG002|Overall Study|Failed to meet criteria|1|||
124708689|NCT00382174|448559472|FG000|Overall Study|Wounds merged|0|||
124708690|NCT00382174|448559473|FG001|Overall Study|Wounds merged|2|||
124708691|NCT00382174|448559474|FG002|Overall Study|Wounds merged|2|||
124708692|NCT02170064|448559480|FG000|Overall Study|Withdrawal by Subject|5|||
124708693|NCT02170064|448559481|FG001|Overall Study|Withdrawal by Subject|1|||
124708694|NCT02170064|448559482|FG002|Overall Study|Withdrawal by Subject|1|||
124708695|NCT02170064|448559480|FG000|Overall Study|Physician Decision|1|||
124708696|NCT02170064|448559481|FG001|Overall Study|Physician Decision|1|||
124708697|NCT02170064|448559482|FG002|Overall Study|Physician Decision|0|||
124768599|NCT01231984|448781163|FG003|Study Period 1|Adverse Event|0|||
124768600|NCT01231984|448781160|FG000|Study Period 1|Other|0|||
124768601|NCT01231984|448781161|FG001|Study Period 1|Other|0|||
124768602|NCT01231984|448781162|FG002|Study Period 1|Other|0|||
124768603|NCT01231984|448781163|FG003|Study Period 1|Other|1|||
124768604|NCT01231984|448781160|FG000|Study Period 2|Withdrawal by Subject|1|||
124768605|NCT01231984|448781161|FG001|Study Period 2|Withdrawal by Subject|1|||
124768606|NCT01231984|448781162|FG002|Study Period 2|Withdrawal by Subject|0|||
124768607|NCT01231984|448781163|FG003|Study Period 2|Withdrawal by Subject|0|||
124768608|NCT01231984|448781160|FG000|Study Period 2|Lost to Follow-up|1|||
124768609|NCT01231984|448781161|FG001|Study Period 2|Lost to Follow-up|0|||
124768610|NCT01231984|448781162|FG002|Study Period 2|Lost to Follow-up|0|||
124960367|NCT04150341|449482452|FG004|Overall Study|Physician Decision|0|||
124960368|NCT04150341|449482453|FG005|Overall Study|Physician Decision|0|||
124960369|NCT04150341|449482448|FG000|Overall Study|Adverse Event|0|||
124960370|NCT04150341|449482449|FG001|Overall Study|Adverse Event|0|||
124960371|NCT04150341|449482450|FG002|Overall Study|Adverse Event|0|||
124960372|NCT04150341|449482451|FG003|Overall Study|Adverse Event|0|||
124960373|NCT04150341|449482452|FG004|Overall Study|Adverse Event|1|||
124960374|NCT04150341|449482453|FG005|Overall Study|Adverse Event|0|||
124960375|NCT00833898|449482460|FG000|Overall Study|Withdrawal by Subject|33|||
124960376|NCT00833898|449482461|FG001|Overall Study|Withdrawal by Subject|27|||
124768611|NCT01231984|448781163|FG003|Study Period 2|Lost to Follow-up|3|||
124960377|NCT00833898|449482460|FG000|Overall Study|Lost to Follow-up|7|||
124960378|NCT00833898|449482461|FG001|Overall Study|Lost to Follow-up|7|||
124960379|NCT00833898|449482460|FG000|Overall Study|Patient did not receive transplant|0|||
124960380|NCT00833898|449482461|FG001|Overall Study|Patient did not receive transplant|2|||
124960381|NCT00805285|449482462|FG000|Overall Study|Lack of Efficacy|1|||
124960382|NCT00917462|449482463|FG000|Overall Study|Clinical Deterioration|1|||
124960383|NCT01402063|449482464|FG000|Overall Study|Withdrawal by Subject|3|||
124960384|NCT01402063|449482465|FG001|Overall Study|Withdrawal by Subject|3|||
124960385|NCT02110225|449482469|FG000|Overall Study|Lost to Follow-up|0|||
124960386|NCT02110225|449482470|FG001|Overall Study|Lost to Follow-up|1|||
124768612|NCT01231984|448781160|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
124768613|NCT01231984|448781161|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
124768614|NCT01231984|448781162|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
124768615|NCT01231984|448781163|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
124768616|NCT02766023|448781166|FG000|Overall Study|Lost to Follow-up|23|||
124768617|NCT02766023|448781167|FG001|Overall Study|Lost to Follow-up|11|||
124768618|NCT02766023|448781166|FG000|Overall Study|Pregnancy|1|||
124768619|NCT02766023|448781167|FG001|Overall Study|Pregnancy|0|||
124768620|NCT02766023|448781166|FG000|Overall Study|Adverse Event|1|||
124768621|NCT02766023|448781167|FG001|Overall Study|Adverse Event|0|||
124768622|NCT02766023|448781166|FG000|Overall Study|Withdrawal by Subject|4|||
124768623|NCT02766023|448781167|FG001|Overall Study|Withdrawal by Subject|5|||
124768624|NCT02766023|448781166|FG000|Overall Study|Physician Decision|1|||
124768625|NCT02766023|448781167|FG001|Overall Study|Physician Decision|0|||
124768626|NCT02766023|448781166|FG000|Overall Study|Not Eligible at Enrollment|0|||
124768627|NCT02766023|448781167|FG001|Overall Study|Not Eligible at Enrollment|1|||
124768628|NCT06271993|448781168|FG000|Overall Study|Not reactive to histamine|5|||
124768629|NCT06271993|448781169|FG001|Overall Study|Not reactive to histamine|5|||
124768630|NCT06271993|448781170|FG002|Overall Study|Not reactive to histamine|5|||
124768631|NCT04026113|448781175|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
124768632|NCT04026113|448781176|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
124768633|NCT04026113|448781177|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
124768634|NCT04026113|448781178|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
124768635|NCT04026113|448781175|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
124768636|NCT04026113|448781176|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
124768637|NCT04026113|448781177|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
124768638|NCT04026113|448781178|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
124768639|NCT04026113|448781175|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
124768640|NCT04026113|448781176|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
124768641|NCT04026113|448781177|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
124768642|NCT04026113|448781178|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
124768643|NCT04026113|448781175|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
124768644|NCT04026113|448781176|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
124768645|NCT04026113|448781177|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
124768646|NCT04026113|448781178|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
124768647|NCT04026113|448781175|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
124768648|NCT04026113|448781176|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
124768649|NCT04026113|448781177|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
124768650|NCT04026113|448781178|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
124768651|NCT04026113|448781175|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
124768652|NCT04026113|448781176|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
124768653|NCT04026113|448781177|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
124768654|NCT04026113|448781178|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
124768655|NCT04026113|448781175|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
124768656|NCT04026113|448781176|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
124768657|NCT04026113|448781177|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
124768658|NCT04026113|448781178|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
124768659|NCT04026113|448781175|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
124768660|NCT04026113|448781176|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
124768661|NCT04026113|448781177|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
124768662|NCT04026113|448781178|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
124768663|NCT04026113|448781175|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
124768664|NCT04026113|448781176|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
124768665|NCT04026113|448781177|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
124549453|NCT03466060|447967039|FG002|Period 1|Grade 2 Conjunctivitis|1|||
124960387|NCT02110225|449482471|FG002|Overall Study|Lost to Follow-up|0|||
124960388|NCT02176018|449482472|FG000|Overall Study|Adverse Event|0|||
124960389|NCT02176018|449482473|FG001|Overall Study|Adverse Event|2|||
124960390|NCT02176018|449482472|FG000|Overall Study|Lost to Follow-up|3|||
124960391|NCT02176018|449482473|FG001|Overall Study|Lost to Follow-up|1|||
124960392|NCT02176018|449482472|FG000|Overall Study|Protocol Violation|1|||
124960393|NCT02176018|449482473|FG001|Overall Study|Protocol Violation|1|||
124768666|NCT04026113|448781178|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
124768667|NCT04613362|448781180|FG000|3 Month Follow-up|Lost to Follow-up|1|||
124768668|NCT04613362|448781181|FG001|3 Month Follow-up|Lost to Follow-up|2|||
124768669|NCT04613362|448781180|FG000|6 Month Follow-up|Lost to Follow-up|0|||
124768670|NCT04613362|448781181|FG001|6 Month Follow-up|Lost to Follow-up|1|||
124768671|NCT02218372|448781182|FG000|Overall Study|Adverse Event|1|||
124768672|NCT02218372|448781183|FG001|Overall Study|Adverse Event|1|||
124768673|NCT02218372|448781182|FG000|Overall Study|Miscellaneous|2|||
124768674|NCT02218372|448781183|FG001|Overall Study|Miscellaneous|1|||
124768675|NCT02218372|448781182|FG000|Overall Study|Randomized but did not receive treatment|2|||
124768676|NCT02218372|448781183|FG001|Overall Study|Randomized but did not receive treatment|3|||
124768677|NCT02218372|448781182|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124768678|NCT02218372|448781183|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
124768679|NCT00671658|448781192|FG000|Overall Study|Physician Decision|5|||
124768680|NCT01921205|448781193|FG000|Overall Study|Adverse Event|12|||
124768681|NCT01921205|448781194|FG001|Overall Study|Adverse Event|7|||
124768682|NCT01921205|448781193|FG000|Overall Study|Lack of Efficacy|1|||
124768683|NCT01921205|448781194|FG001|Overall Study|Lack of Efficacy|0|||
124768684|NCT01921205|448781193|FG000|Overall Study|Protocol Violation|1|||
124768685|NCT01921205|448781194|FG001|Overall Study|Protocol Violation|3|||
124768686|NCT01921205|448781193|FG000|Overall Study|Lost to Follow-up|1|||
124768687|NCT01921205|448781194|FG001|Overall Study|Lost to Follow-up|1|||
124768688|NCT01921205|448781193|FG000|Overall Study|Withdrawal by Subject|6|||
124768689|NCT01921205|448781194|FG001|Overall Study|Withdrawal by Subject|5|||
124768690|NCT01921205|448781193|FG000|Overall Study|Use Of Prohibited Medication|0|||
124768691|NCT01921205|448781194|FG001|Overall Study|Use Of Prohibited Medication|1|||
124768692|NCT01921205|448781193|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
124768693|NCT01921205|448781194|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
124768694|NCT01921205|448781193|FG000|Overall Study|Non Compliance Of The Parent|0|||
124768695|NCT01921205|448781194|FG001|Overall Study|Non Compliance Of The Parent|1|||
124768696|NCT01921205|448781193|FG000|Overall Study|Non Compliance Of Child|0|||
124768697|NCT01921205|448781194|FG001|Overall Study|Non Compliance Of Child|1|||
124768698|NCT00456846|448781196|FG000|Overall Study|Adverse Event|2|||
124768699|NCT00456846|448781197|FG001|Overall Study|Adverse Event|15|||
124768700|NCT00456846|448781196|FG000|Overall Study|Physician Decision|11|||
124768701|NCT00456846|448781197|FG001|Overall Study|Physician Decision|6|||
124960394|NCT02176018|449482472|FG000|Overall Study|Withdrawal by Subject|1|||
124960395|NCT02176018|449482473|FG001|Overall Study|Withdrawal by Subject|2|||
124960396|NCT03022045|449482474|FG000|Overall Study|Adverse Event|0|||
124960397|NCT03022045|449482475|FG001|Overall Study|Adverse Event|1|||
124960398|NCT03022045|449482474|FG000|Overall Study|Withdrawal by Subject|1|||
124960399|NCT03022045|449482475|FG001|Overall Study|Withdrawal by Subject|1|||
124960400|NCT03972137|449482482|FG000|Overall Study|Lost to Follow-up|2|||
124960401|NCT03972137|449482482|FG000|Overall Study|Withdrawal by Subject|4|||
124960402|NCT00899379|449482483|FG000|Overall Study|Adverse Event|2|||
124960403|NCT00899379|449482484|FG001|Overall Study|Adverse Event|2|||
124960404|NCT00899379|449482485|FG002|Overall Study|Adverse Event|1|||
124960405|NCT00899379|449482486|FG003|Overall Study|Adverse Event|1|||
124960406|NCT00899379|449482487|FG004|Overall Study|Adverse Event|2|||
124960407|NCT00899379|449482483|FG000|Overall Study|Lack of Efficacy|0|||
124960408|NCT00899379|449482484|FG001|Overall Study|Lack of Efficacy|4|||
124960409|NCT00899379|449482485|FG002|Overall Study|Lack of Efficacy|3|||
124960410|NCT00899379|449482486|FG003|Overall Study|Lack of Efficacy|0|||
124960411|NCT00899379|449482487|FG004|Overall Study|Lack of Efficacy|1|||
124960412|NCT00899379|449482483|FG000|Overall Study|Lost to Follow-up|9|||
124960413|NCT00899379|449482484|FG001|Overall Study|Lost to Follow-up|3|||
124960414|NCT00899379|449482485|FG002|Overall Study|Lost to Follow-up|0|||
124549454|NCT03466060|447967040|FG003|Period 1|Grade 2 Conjunctivitis|0|||
124549455|NCT03466060|447967041|FG004|Period 1|Grade 2 Conjunctivitis|0|||
124768702|NCT00456846|448781196|FG000|Overall Study|Protocol Deviation|2|||
124768703|NCT00456846|448781197|FG001|Overall Study|Protocol Deviation|0|||
124768704|NCT00456846|448781196|FG000|Overall Study|Participant Discretion|1|||
124768705|NCT00456846|448781197|FG001|Overall Study|Participant Discretion|5|||
124768706|NCT00456846|448781196|FG000|Overall Study|Other|0|||
124768707|NCT00456846|448781197|FG001|Overall Study|Other|2|||
124768708|NCT03125395|448781199|FG000|Overall Study|Adverse Event|2|||
124768709|NCT03125395|448781199|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
124768710|NCT03125395|448781199|FG000|Overall Study|Physician Decision|2|||
124960415|NCT00899379|449482486|FG003|Overall Study|Lost to Follow-up|6|||
124960416|NCT00899379|449482487|FG004|Overall Study|Lost to Follow-up|2|||
124960417|NCT00899379|449482483|FG000|Overall Study|Protocol Violation|0|||
124960418|NCT00899379|449482484|FG001|Overall Study|Protocol Violation|0|||
124960419|NCT00899379|449482485|FG002|Overall Study|Protocol Violation|1|||
124960420|NCT00899379|449482486|FG003|Overall Study|Protocol Violation|1|||
124960421|NCT00899379|449482487|FG004|Overall Study|Protocol Violation|0|||
124960422|NCT00899379|449482483|FG000|Overall Study|Withdrawal by Subject|2|||
124960423|NCT00899379|449482484|FG001|Overall Study|Withdrawal by Subject|4|||
124960424|NCT00899379|449482485|FG002|Overall Study|Withdrawal by Subject|2|||
124960425|NCT00899379|449482486|FG003|Overall Study|Withdrawal by Subject|3|||
124960426|NCT00899379|449482487|FG004|Overall Study|Withdrawal by Subject|6|||
124960427|NCT00899379|449482483|FG000|Overall Study|Pregnancy|0|||
124549456|NCT03466060|447967042|FG005|Period 1|Grade 2 Conjunctivitis|0|||
124708698|NCT03323164|448559483|FG000|Overall Study|Poor quality imaging/scans|2|||
124708699|NCT03323164|448559484|FG001|Overall Study|Poor quality imaging/scans|2|||
124708700|NCT03434834|448559485|FG000|Overall Study|unable to swallow OCT probe|16|||
124708701|NCT04103450|448559486|FG000|Overall Study|Adverse Event|4|||
124708702|NCT04103450|448559487|FG001|Overall Study|Adverse Event|2|||
124708703|NCT04103450|448559486|FG000|Overall Study|Lack of Efficacy|3|||
124708704|NCT04103450|448559487|FG001|Overall Study|Lack of Efficacy|0|||
124708705|NCT04103450|448559486|FG000|Overall Study|Withdrawal by Subject|5|||
124708706|NCT04103450|448559487|FG001|Overall Study|Withdrawal by Subject|3|||
124708707|NCT04103450|448559486|FG000|Overall Study|Lost to Follow-up|1|||
124708708|NCT04103450|448559487|FG001|Overall Study|Lost to Follow-up|2|||
124708709|NCT04103450|448559486|FG000|Overall Study|Physician Decision|1|||
124708710|NCT04103450|448559487|FG001|Overall Study|Physician Decision|2|||
124708711|NCT04103450|448559486|FG000|Overall Study|Protocol Violation|1|||
124708712|NCT04103450|448559487|FG001|Overall Study|Protocol Violation|0|||
124708713|NCT04103450|448559486|FG000|Overall Study|Other|1|||
124708714|NCT04103450|448559487|FG001|Overall Study|Other|1|||
124708715|NCT03508050|448559495|FG000|Overall Study|Pleural adhesions|1|||
124708716|NCT03508050|448559496|FG001|Overall Study|Pleural adhesions|0|||
124708717|NCT03508050|448559495|FG000|Overall Study|Mucus plug|1|||
124708718|NCT03508050|448559496|FG001|Overall Study|Mucus plug|0|||
124708719|NCT03508050|448559495|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
124708720|NCT03508050|448559496|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
124708721|NCT03508050|448559495|FG000|Overall Study|Sustained desaturation|0|||
124708722|NCT03508050|448559496|FG001|Overall Study|Sustained desaturation|1|||
124708723|NCT03961308|448559502|FG000|Overall Study|Withdrawal by Subject|1|||
124708724|NCT03961308|448559503|FG001|Overall Study|Withdrawal by Subject|0|||
124708725|NCT03961308|448559502|FG000|Overall Study|Other|1|||
124708726|NCT03961308|448559503|FG001|Overall Study|Other|0|||
124708727|NCT03961308|448559502|FG000|Overall Study|Lost to Follow-up|0|||
124708728|NCT03961308|448559503|FG001|Overall Study|Lost to Follow-up|1|||
124708729|NCT03961308|448559502|FG000|Overall Study|Adverse Event|0|||
124708730|NCT03961308|448559503|FG001|Overall Study|Adverse Event|1|||
124708731|NCT03710889|448559504|FG000|Overall Study|Adverse Event|2|||
124708732|NCT03710889|448559504|FG000|Overall Study|Protocol Deviation|1|||
124708733|NCT00570713|448559505|FG000|Overall Study|Adverse Event|16|||
124708734|NCT00570713|448559506|FG001|Overall Study|Adverse Event|9|||
124708735|NCT00570713|448559505|FG000|Overall Study|Death|7|||
124708736|NCT00570713|448559506|FG001|Overall Study|Death|7|||
124708737|NCT00570713|448559505|FG000|Overall Study|Lack of Efficacy|40|||
124708738|NCT00570713|448559506|FG001|Overall Study|Lack of Efficacy|49|||
124708739|NCT00570713|448559505|FG000|Overall Study|Physician Decision|2|||
124708740|NCT00570713|448559506|FG001|Overall Study|Physician Decision|2|||
124708741|NCT00570713|448559505|FG000|Overall Study|Withdrawal by Subject|3|||
124708742|NCT00570713|448559506|FG001|Overall Study|Withdrawal by Subject|3|||
124708743|NCT00570713|448559505|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
124708744|NCT00570713|448559506|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
124708745|NCT04881760|448559507|FG000|Overall Study|Adverse Event|0|||
124708746|NCT04881760|448559508|FG001|Overall Study|Adverse Event|1|||
124708747|NCT04881760|448559509|FG002|Overall Study|Adverse Event|1|||
124708748|NCT04881760|448559510|FG003|Overall Study|Adverse Event|0|||
124708749|NCT04881760|448559511|FG004|Overall Study|Adverse Event|1|||
124708750|NCT04881760|448559512|FG005|Overall Study|Adverse Event|1|||
124708751|NCT04881760|448559513|FG006|Overall Study|Adverse Event|2|||
124708752|NCT04881760|448559507|FG000|Overall Study|Death|0|||
124708753|NCT04881760|448559508|FG001|Overall Study|Death|0|||
124708754|NCT04881760|448559509|FG002|Overall Study|Death|0|||
124708755|NCT04881760|448559510|FG003|Overall Study|Death|1|||
124708756|NCT04881760|448559511|FG004|Overall Study|Death|0|||
124708757|NCT04881760|448559512|FG005|Overall Study|Death|0|||
124708758|NCT04881760|448559513|FG006|Overall Study|Death|0|||
124708759|NCT04881760|448559507|FG000|Overall Study|Lost to Follow-up|5|||
124708760|NCT04881760|448559508|FG001|Overall Study|Lost to Follow-up|7|||
124708761|NCT04881760|448559509|FG002|Overall Study|Lost to Follow-up|5|||
124708762|NCT04881760|448559510|FG003|Overall Study|Lost to Follow-up|1|||
124708763|NCT04881760|448559511|FG004|Overall Study|Lost to Follow-up|2|||
124708764|NCT04881760|448559512|FG005|Overall Study|Lost to Follow-up|4|||
124708765|NCT04881760|448559513|FG006|Overall Study|Lost to Follow-up|4|||
124708766|NCT04881760|448559507|FG000|Overall Study|Withdrawal by Subject|13|||
124708767|NCT04881760|448559508|FG001|Overall Study|Withdrawal by Subject|1|||
124960428|NCT00899379|449482484|FG001|Overall Study|Pregnancy|0|||
124708768|NCT04881760|448559509|FG002|Overall Study|Withdrawal by Subject|1|||
124708769|NCT04881760|448559510|FG003|Overall Study|Withdrawal by Subject|4|||
124708770|NCT04881760|448559511|FG004|Overall Study|Withdrawal by Subject|2|||
124708771|NCT04881760|448559512|FG005|Overall Study|Withdrawal by Subject|1|||
124708772|NCT04881760|448559513|FG006|Overall Study|Withdrawal by Subject|2|||
124960429|NCT00899379|449482485|FG002|Overall Study|Pregnancy|1|||
124960430|NCT00899379|449482486|FG003|Overall Study|Pregnancy|0|||
124960431|NCT00899379|449482487|FG004|Overall Study|Pregnancy|1|||
124960432|NCT00899379|449482483|FG000|Overall Study|Patient Uncooperative|0|||
124768711|NCT03125395|448781199|FG000|Overall Study|Commercial drug is available|5|||
124768712|NCT01668784|448781200|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
124768713|NCT01668784|448781201|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
124768714|NCT01668784|448781200|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
124768715|NCT01668784|448781201|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
124768716|NCT01668784|448781200|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
124960433|NCT00899379|449482484|FG001|Overall Study|Patient Uncooperative|1|||
124960434|NCT00899379|449482485|FG002|Overall Study|Patient Uncooperative|0|||
124960435|NCT00899379|449482486|FG003|Overall Study|Patient Uncooperative|1|||
124960436|NCT00899379|449482487|FG004|Overall Study|Patient Uncooperative|2|||
124960437|NCT00899379|449482483|FG000|Overall Study|Abnormal Baseline ECG|0|||
124960438|NCT00899379|449482484|FG001|Overall Study|Abnormal Baseline ECG|0|||
124960439|NCT00899379|449482485|FG002|Overall Study|Abnormal Baseline ECG|0|||
124960440|NCT00899379|449482486|FG003|Overall Study|Abnormal Baseline ECG|1|||
124960441|NCT00899379|449482487|FG004|Overall Study|Abnormal Baseline ECG|0|||
124960442|NCT00899379|449482483|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
124960443|NCT00899379|449482484|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
124960444|NCT00899379|449482485|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
124960445|NCT00899379|449482486|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
124960446|NCT00899379|449482487|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
124960447|NCT00899379|449482483|FG000|Overall Study|Not Completed/Entered Extn|5|||
124960448|NCT00899379|449482484|FG001|Overall Study|Not Completed/Entered Extn|1|||
124960449|NCT00899379|449482485|FG002|Overall Study|Not Completed/Entered Extn|6|||
124960450|NCT00899379|449482486|FG003|Overall Study|Not Completed/Entered Extn|4|||
124960451|NCT00899379|449482487|FG004|Overall Study|Not Completed/Entered Extn|3|||
124960452|NCT00899379|449482483|FG000|Overall Study|Study Terminated|3|||
124960453|NCT00899379|449482484|FG001|Overall Study|Study Terminated|0|||
124960454|NCT00899379|449482485|FG002|Overall Study|Study Terminated|3|||
124960455|NCT00899379|449482486|FG003|Overall Study|Study Terminated|3|||
124960456|NCT00899379|449482487|FG004|Overall Study|Study Terminated|1|||
124960457|NCT00899379|449482483|FG000|Overall Study|Lost to Follow-up|3|||
124960458|NCT00899379|449482484|FG001|Overall Study|Lost to Follow-up|1|||
124960459|NCT00899379|449482485|FG002|Overall Study|Lost to Follow-up|0|||
124960460|NCT00899379|449482486|FG003|Overall Study|Lost to Follow-up|2|||
124960461|NCT00899379|449482487|FG004|Overall Study|Lost to Follow-up|5|||
124960462|NCT00899379|449482483|FG000|Overall Study|Withdrawal by Subject|4|||
124960463|NCT00899379|449482484|FG001|Overall Study|Withdrawal by Subject|7|||
124960464|NCT00899379|449482485|FG002|Overall Study|Withdrawal by Subject|4|||
124768717|NCT01668784|448781201|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
124768718|NCT01668784|448781200|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
124768719|NCT01668784|448781201|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
124768720|NCT01668784|448781200|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
124768721|NCT01668784|448781201|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
124768722|NCT01668784|448781200|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
124768723|NCT01668784|448781201|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
124768724|NCT01668784|448781200|FG000|Treatment Period|Disease Progression|316|||
124768725|NCT01668784|448781201|FG001|Treatment Period|Disease Progression|293|||
124768726|NCT01668784|448781200|FG000|Treatment Period|Study Drug Toxicity|46|||
124768727|NCT01668784|448781201|FG001|Treatment Period|Study Drug Toxicity|53|||
124768728|NCT01668784|448781200|FG000|Treatment Period|Death|1|||
124768729|NCT01668784|448781201|FG001|Treatment Period|Death|1|||
124768730|NCT01668784|448781200|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
124768731|NCT01668784|448781201|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
124768732|NCT01668784|448781200|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
124768733|NCT01668784|448781201|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
124768734|NCT01668784|448781200|FG000|Treatment Period|Withdrawal by Subject|5|||
124768735|NCT01668784|448781201|FG001|Treatment Period|Withdrawal by Subject|3|||
124768736|NCT01668784|448781200|FG000|Treatment Period|Maximal Clinical Benefit|3|||
124768737|NCT01668784|448781201|FG001|Treatment Period|Maximal Clinical Benefit|3|||
124960465|NCT00899379|449482486|FG003|Overall Study|Withdrawal by Subject|7|||
124960466|NCT00899379|449482487|FG004|Overall Study|Withdrawal by Subject|2|||
124960467|NCT00899379|449482483|FG000|Overall Study|Pregnancy|1|||
124960468|NCT00899379|449482484|FG001|Overall Study|Pregnancy|0|||
124960469|NCT00899379|449482485|FG002|Overall Study|Pregnancy|0|||
124960470|NCT00899379|449482486|FG003|Overall Study|Pregnancy|0|||
124960471|NCT00899379|449482487|FG004|Overall Study|Pregnancy|0|||
124960472|NCT00899379|449482483|FG000|Overall Study|Patient Uncooperative|0|||
124960473|NCT00899379|449482484|FG001|Overall Study|Patient Uncooperative|0|||
124960474|NCT00899379|449482485|FG002|Overall Study|Patient Uncooperative|0|||
124960475|NCT00899379|449482486|FG003|Overall Study|Patient Uncooperative|1|||
124960476|NCT00899379|449482487|FG004|Overall Study|Patient Uncooperative|0|||
124960477|NCT00899379|449482483|FG000|Overall Study|Abnormal Prestudy Labs|0|||
124960478|NCT00899379|449482484|FG001|Overall Study|Abnormal Prestudy Labs|0|||
124960479|NCT00899379|449482485|FG002|Overall Study|Abnormal Prestudy Labs|0|||
124960480|NCT00899379|449482486|FG003|Overall Study|Abnormal Prestudy Labs|0|||
124960481|NCT00899379|449482487|FG004|Overall Study|Abnormal Prestudy Labs|2|||
124960482|NCT00899379|449482483|FG000|Overall Study|Abnormal Baseline ECG|0|||
124708773|NCT04881760|448559507|FG000|Overall Study|Randomized but Never Treated|0|||
124708774|NCT04881760|448559508|FG001|Overall Study|Randomized but Never Treated|0|||
124708775|NCT04881760|448559509|FG002|Overall Study|Randomized but Never Treated|0|||
124708776|NCT04881760|448559510|FG003|Overall Study|Randomized but Never Treated|1|||
124708777|NCT04881760|448559511|FG004|Overall Study|Randomized but Never Treated|0|||
124708778|NCT04881760|448559512|FG005|Overall Study|Randomized but Never Treated|0|||
124708779|NCT04881760|448559513|FG006|Overall Study|Randomized but Never Treated|0|||
124708780|NCT04881760|448559507|FG000|Overall Study|Inadvertent Enrollment|2|||
124708781|NCT04881760|448559508|FG001|Overall Study|Inadvertent Enrollment|0|||
124708782|NCT04881760|448559509|FG002|Overall Study|Inadvertent Enrollment|0|||
124708783|NCT04881760|448559510|FG003|Overall Study|Inadvertent Enrollment|0|||
124708784|NCT04881760|448559511|FG004|Overall Study|Inadvertent Enrollment|0|||
124708785|NCT04881760|448559512|FG005|Overall Study|Inadvertent Enrollment|0|||
124708786|NCT04881760|448559513|FG006|Overall Study|Inadvertent Enrollment|0|||
124708787|NCT04881760|448559507|FG000|Overall Study|Site Closure|0|||
124708788|NCT04881760|448559508|FG001|Overall Study|Site Closure|0|||
124708789|NCT04881760|448559509|FG002|Overall Study|Site Closure|0|||
124708790|NCT04881760|448559510|FG003|Overall Study|Site Closure|1|||
124708791|NCT04881760|448559511|FG004|Overall Study|Site Closure|0|||
124708792|NCT04881760|448559512|FG005|Overall Study|Site Closure|0|||
124708793|NCT04881760|448559513|FG006|Overall Study|Site Closure|0|||
124708794|NCT01538199|448559517|FG000|Overall Study|Lost to Follow-up|1|||
124708795|NCT01538199|448559518|FG001|Overall Study|Lost to Follow-up|2|||
124708796|NCT01538199|448559519|FG002|Overall Study|Lost to Follow-up|1|||
124708797|NCT01538199|448559520|FG003|Overall Study|Lost to Follow-up|0|||
124708798|NCT01538199|448559517|FG000|Overall Study|participant did not have time|1|||
124708799|NCT01538199|448559518|FG001|Overall Study|participant did not have time|0|||
124708800|NCT01538199|448559519|FG002|Overall Study|participant did not have time|0|||
124708801|NCT01538199|448559520|FG003|Overall Study|participant did not have time|2|||
124708802|NCT01538199|448559517|FG000|Overall Study|Lack of Efficacy|0|||
124708803|NCT01538199|448559518|FG001|Overall Study|Lack of Efficacy|1|||
124708804|NCT01538199|448559519|FG002|Overall Study|Lack of Efficacy|0|||
124708805|NCT01538199|448559520|FG003|Overall Study|Lack of Efficacy|0|||
124708806|NCT02081586|448559521|FG000|Overall Study|Lost to Follow-up|0|||
124708807|NCT02081586|448559522|FG001|Overall Study|Lost to Follow-up|1|||
124708808|NCT02081586|448559523|FG002|Overall Study|Lost to Follow-up|0|||
124708809|NCT02081586|448559524|FG003|Overall Study|Lost to Follow-up|1|||
124708810|NCT02081586|448559521|FG000|Overall Study|Head injury not related to study|0|||
124708811|NCT02081586|448559522|FG001|Overall Study|Head injury not related to study|0|||
124708812|NCT02081586|448559523|FG002|Overall Study|Head injury not related to study|1|||
124708813|NCT02081586|448559524|FG003|Overall Study|Head injury not related to study|0|||
124708814|NCT01677988|448559527|FG000|Overall Study|Lack of Efficacy|2|||
124708815|NCT00659425|448559531|FG000|Overall Study|Disease progression|1|||
124708816|NCT00659425|448559532|FG001|Overall Study|Disease progression|0|||
124708817|NCT00659425|448559533|FG002|Overall Study|Disease progression|0|||
124708818|NCT00659425|448559534|FG003|Overall Study|Disease progression|1|||
124708819|NCT00659425|448559535|FG004|Overall Study|Disease progression|0|||
124708820|NCT00659425|448559536|FG005|Overall Study|Disease progression|2|||
124708821|NCT00659425|448559537|FG006|Overall Study|Disease progression|4|||
124708822|NCT00659425|448559538|FG007|Overall Study|Disease progression|3|||
124708823|NCT00659425|448559539|FG008|Overall Study|Disease progression|5|||
124708824|NCT00659425|448559540|FG009|Overall Study|Disease progression|3|||
124708825|NCT00659425|448559531|FG000|Overall Study|Death|0|||
124708826|NCT00659425|448559532|FG001|Overall Study|Death|0|||
124708827|NCT00659425|448559533|FG002|Overall Study|Death|0|||
124708828|NCT00659425|448559534|FG003|Overall Study|Death|1|||
124708829|NCT00659425|448559535|FG004|Overall Study|Death|0|||
124708830|NCT00659425|448559536|FG005|Overall Study|Death|0|||
124708831|NCT00659425|448559537|FG006|Overall Study|Death|1|||
124708832|NCT00659425|448559538|FG007|Overall Study|Death|0|||
124549457|NCT03466060|447967037|FG000|Period 2|Lens Handling Difficulties|0|||
124708833|NCT00659425|448559539|FG008|Overall Study|Death|0|||
124708834|NCT00659425|448559540|FG009|Overall Study|Death|0|||
124708835|NCT00659425|448559531|FG000|Overall Study|Adverse Event|0|||
124708836|NCT00659425|448559532|FG001|Overall Study|Adverse Event|0|||
124708837|NCT00659425|448559533|FG002|Overall Study|Adverse Event|0|||
124708838|NCT00659425|448559534|FG003|Overall Study|Adverse Event|0|||
124708839|NCT00659425|448559535|FG004|Overall Study|Adverse Event|0|||
124708840|NCT00659425|448559536|FG005|Overall Study|Adverse Event|1|||
124708841|NCT00659425|448559537|FG006|Overall Study|Adverse Event|0|||
124708842|NCT00659425|448559538|FG007|Overall Study|Adverse Event|3|||
124768738|NCT01668784|448781200|FG000|Treatment Period|Other|2|||
124768739|NCT01668784|448781201|FG001|Treatment Period|Other|8|||
124768740|NCT01668784|448781200|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
124768741|NCT01668784|448781201|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
124768742|NCT02783690|448781209|FG000|Overall Study|Withdrawal by Subject|3|||
124768743|NCT02783690|448781210|FG001|Overall Study|Withdrawal by Subject|3|||
124768744|NCT03157830|448781214|FG000|Overall Study|Lost to Follow-up|1|||
124768745|NCT03157830|448781214|FG000|Overall Study|Withdrawal by Subject|1|||
124768746|NCT05138653|448781217|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
124768747|NCT05138653|448781218|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
124768748|NCT05138653|448781219|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
124768749|NCT05138653|448781220|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
124768750|NCT05138653|448781221|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
124768751|NCT05138653|448781222|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
124768752|NCT05138653|448781223|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
124768753|NCT05138653|448781224|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
124768754|NCT05138653|448781225|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
124768755|NCT05138653|448781226|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
124768756|NCT05138653|448781227|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
124768757|NCT05138653|448781228|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
124768758|NCT05138653|448781229|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
124768759|NCT05138653|448781230|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
124768760|NCT05138653|448781231|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
124768761|NCT05138653|448781232|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
124768762|NCT05138653|448781217|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
124768763|NCT05138653|448781218|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
124768764|NCT05138653|448781219|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
124768765|NCT05138653|448781220|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
124768766|NCT05138653|448781221|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
124768767|NCT05138653|448781222|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
124768768|NCT05138653|448781223|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
124768769|NCT05138653|448781224|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
124768770|NCT05138653|448781225|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
124768771|NCT05138653|448781226|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
124768772|NCT05138653|448781227|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
124768773|NCT05138653|448781228|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
124768774|NCT05138653|448781229|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
124768775|NCT05138653|448781230|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
124768776|NCT05138653|448781231|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
124960483|NCT00899379|449482484|FG001|Overall Study|Abnormal Baseline ECG|0|||
124960484|NCT00899379|449482485|FG002|Overall Study|Abnormal Baseline ECG|1|||
124960485|NCT00899379|449482486|FG003|Overall Study|Abnormal Baseline ECG|1|||
124960486|NCT00899379|449482487|FG004|Overall Study|Abnormal Baseline ECG|0|||
124960487|NCT00899379|449482483|FG000|Overall Study|No Attack Pretreatment|3|||
124960488|NCT00899379|449482484|FG001|Overall Study|No Attack Pretreatment|5|||
124960489|NCT00899379|449482485|FG002|Overall Study|No Attack Pretreatment|5|||
124960490|NCT00899379|449482486|FG003|Overall Study|No Attack Pretreatment|6|||
124960491|NCT00899379|449482487|FG004|Overall Study|No Attack Pretreatment|4|||
124960492|NCT00899379|449482483|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
124960493|NCT00899379|449482484|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
124960494|NCT00899379|449482485|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
124960495|NCT00899379|449482486|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
124960496|NCT00899379|449482487|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
124960497|NCT00899379|449482483|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
124960498|NCT00899379|449482484|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
124960499|NCT00899379|449482485|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
124960500|NCT00899379|449482486|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
124960501|NCT00899379|449482487|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
124960502|NCT03220776|449482492|FG000|Overall Study|Claustrophobia|0|||
124960503|NCT03220776|449482493|FG001|Overall Study|Claustrophobia|1|||
124960504|NCT03220776|449482494|FG002|Overall Study|Claustrophobia|1|||
124960505|NCT03220776|449482495|FG003|Overall Study|Claustrophobia|0|||
124768777|NCT05138653|448781232|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
124960506|NCT03220776|449482496|FG004|Overall Study|Claustrophobia|1|||
124960507|NCT03220776|449482497|FG005|Overall Study|Claustrophobia|0|||
124960508|NCT03220776|449482492|FG000|Overall Study|MRI Equipment Failure|1|||
124960509|NCT03220776|449482493|FG001|Overall Study|MRI Equipment Failure|0|||
124960510|NCT03220776|449482494|FG002|Overall Study|MRI Equipment Failure|0|||
124960511|NCT03220776|449482495|FG003|Overall Study|MRI Equipment Failure|0|||
124960512|NCT03220776|449482496|FG004|Overall Study|MRI Equipment Failure|0|||
124960513|NCT03220776|449482497|FG005|Overall Study|MRI Equipment Failure|0|||
124960514|NCT03220776|449482492|FG000|Overall Study|Inclimate Weather|0|||
124960515|NCT03220776|449482493|FG001|Overall Study|Inclimate Weather|0|||
124960516|NCT03220776|449482494|FG002|Overall Study|Inclimate Weather|0|||
124960517|NCT03220776|449482495|FG003|Overall Study|Inclimate Weather|0|||
124960518|NCT03220776|449482496|FG004|Overall Study|Inclimate Weather|0|||
124960519|NCT03220776|449482497|FG005|Overall Study|Inclimate Weather|1|||
124960520|NCT03220776|449482492|FG000|Overall Study|Physician Decision|0|||
124960521|NCT03220776|449482493|FG001|Overall Study|Physician Decision|0|||
124960522|NCT03220776|449482494|FG002|Overall Study|Physician Decision|0|||
124960523|NCT03220776|449482495|FG003|Overall Study|Physician Decision|1|||
124960524|NCT03220776|449482496|FG004|Overall Study|Physician Decision|0|||
124960525|NCT03220776|449482497|FG005|Overall Study|Physician Decision|0|||
124960526|NCT03220776|449482492|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
124960527|NCT03220776|449482493|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
124960528|NCT03220776|449482494|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
124960529|NCT03220776|449482495|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
124960530|NCT03220776|449482496|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
124960531|NCT03220776|449482497|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
124960532|NCT03220776|449482492|FG000|Overall Study|Protocol Violation|0|||
124768778|NCT05138653|448781217|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
124960533|NCT03220776|449482493|FG001|Overall Study|Protocol Violation|0|||
124960534|NCT03220776|449482494|FG002|Overall Study|Protocol Violation|0|||
124960535|NCT03220776|449482495|FG003|Overall Study|Protocol Violation|2|||
124960536|NCT03220776|449482496|FG004|Overall Study|Protocol Violation|0|||
124960537|NCT03220776|449482497|FG005|Overall Study|Protocol Violation|1|||
124960538|NCT03220776|449482492|FG000|Overall Study|Withdrawal by Subject|1|||
124960539|NCT03220776|449482493|FG001|Overall Study|Withdrawal by Subject|0|||
124960540|NCT03220776|449482494|FG002|Overall Study|Withdrawal by Subject|0|||
124960541|NCT03220776|449482495|FG003|Overall Study|Withdrawal by Subject|0|||
124960542|NCT03220776|449482496|FG004|Overall Study|Withdrawal by Subject|0|||
124960543|NCT03220776|449482497|FG005|Overall Study|Withdrawal by Subject|0|||
124960544|NCT03441789|449482498|FG000|Overall Study|Withdrawal by Subject|1|||
124960545|NCT03441789|449482499|FG001|Overall Study|Withdrawal by Subject|1|||
124960546|NCT03441789|449482498|FG000|Overall Study|Adverse Event|0|||
124960547|NCT03441789|449482499|FG001|Overall Study|Adverse Event|1|||
124960548|NCT03441789|449482498|FG000|Overall Study|Protocol Violation|0|||
124960549|NCT03441789|449482499|FG001|Overall Study|Protocol Violation|1|||
124960550|NCT03441789|449482498|FG000|Overall Study|Lost to Follow-up|0|||
124960551|NCT03441789|449482499|FG001|Overall Study|Lost to Follow-up|1|||
124960552|NCT01780545|449482500|FG000|Overall Study|Withdrawal by Subject|3|||
124960553|NCT01780545|449482501|FG001|Overall Study|Withdrawal by Subject|1|||
124960554|NCT01780545|449482500|FG000|Overall Study|Lost to Follow-up|1|||
124960555|NCT01780545|449482501|FG001|Overall Study|Lost to Follow-up|1|||
124960556|NCT03168425|449482502|FG000|Overall Study|Lost to Follow-up|5|||
124960557|NCT03168425|449482503|FG001|Overall Study|Lost to Follow-up|8|||
124960558|NCT03168425|449482502|FG000|Overall Study|unable to confirm post op opioids|2|||
124960559|NCT03168425|449482503|FG001|Overall Study|unable to confirm post op opioids|3|||
124960560|NCT03029234|449482506|FG000|Overall Study|Sponsor Decision|1|||
124960561|NCT03029234|449482506|FG000|Overall Study|Withdrawal by Subject|5|||
124960562|NCT03029234|449482506|FG000|Overall Study|Death|91|||
124768779|NCT05138653|448781218|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
124768780|NCT05138653|448781219|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
124768781|NCT05138653|448781220|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
124960563|NCT03029234|449482506|FG000|Overall Study|Lost to Follow-up|2|||
124960564|NCT02166047|449482510|FG000|Overall Study|Withdrawal by Participant|0|||
124960565|NCT02166047|449482511|FG001|Overall Study|Withdrawal by Participant|1|||
124960566|NCT02166047|449482512|FG002|Overall Study|Withdrawal by Participant|2|||
124960567|NCT02166047|449482513|FG003|Overall Study|Withdrawal by Participant|0|||
124960568|NCT02166047|449482514|FG004|Overall Study|Withdrawal by Participant|0|||
124960569|NCT02166047|449482515|FG005|Overall Study|Withdrawal by Participant|0|||
124960570|NCT02166047|449482516|FG006|Overall Study|Withdrawal by Participant|1|||
124960571|NCT02166047|449482517|FG007|Overall Study|Withdrawal by Participant|0|||
124960572|NCT02166047|449482518|FG008|Overall Study|Withdrawal by Participant|0|||
124960573|NCT02166047|449482519|FG009|Overall Study|Withdrawal by Participant|0|||
124960574|NCT02166047|449482520|FG010|Overall Study|Withdrawal by Participant|0|||
124960575|NCT02166047|449482521|FG011|Overall Study|Withdrawal by Participant|0|||
124960576|NCT02166047|449482510|FG000|Overall Study|Adverse Event|0|||
124960577|NCT02166047|449482511|FG001|Overall Study|Adverse Event|0|||
124960578|NCT02166047|449482512|FG002|Overall Study|Adverse Event|0|||
124960579|NCT02166047|449482513|FG003|Overall Study|Adverse Event|0|||
124960580|NCT02166047|449482514|FG004|Overall Study|Adverse Event|1|||
124960581|NCT02166047|449482515|FG005|Overall Study|Adverse Event|0|||
124960582|NCT02166047|449482516|FG006|Overall Study|Adverse Event|1|||
124960583|NCT02166047|449482517|FG007|Overall Study|Adverse Event|0|||
124960584|NCT02166047|449482518|FG008|Overall Study|Adverse Event|0|||
124768782|NCT05138653|448781221|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
124768783|NCT05138653|448781222|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
124768784|NCT05138653|448781223|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
124768785|NCT05138653|448781224|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
124768786|NCT05138653|448781225|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
124768787|NCT05138653|448781226|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
124768788|NCT05138653|448781227|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
124768789|NCT05138653|448781228|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
124768790|NCT05138653|448781229|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
124768791|NCT05138653|448781230|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
124768792|NCT05138653|448781231|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
124768793|NCT05138653|448781232|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
124768794|NCT05138653|448781217|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
124768795|NCT05138653|448781218|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
124768796|NCT05138653|448781219|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
124768797|NCT05138653|448781220|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
124768798|NCT05138653|448781221|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
124768799|NCT05138653|448781222|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
124768800|NCT05138653|448781223|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
124768801|NCT05138653|448781224|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
124768802|NCT05138653|448781225|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
124768803|NCT05138653|448781226|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
124768804|NCT05138653|448781227|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
124768805|NCT05138653|448781228|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
124768806|NCT05138653|448781229|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
124768807|NCT05138653|448781230|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
124768808|NCT05138653|448781231|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
124768809|NCT05138653|448781232|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
124768810|NCT05138653|448781217|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
124960585|NCT02166047|449482519|FG009|Overall Study|Adverse Event|0|||
124960586|NCT02166047|449482520|FG010|Overall Study|Adverse Event|2|||
124960587|NCT02166047|449482521|FG011|Overall Study|Adverse Event|0|||
124960588|NCT01960114|449482522|FG000|Overall Study|Adverse Event|1|||
124960589|NCT01960114|449482523|FG001|Overall Study|Adverse Event|0|||
124960590|NCT01960114|449482522|FG000|Overall Study|Could not swallow study medication|0|||
124960591|NCT01960114|449482523|FG001|Overall Study|Could not swallow study medication|1|||
124960592|NCT02469077|449482524|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
124960593|NCT02469077|449482525|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
124960594|NCT02469077|449482524|FG000|Post Randomization/Intervention Period|Relocated|1|||
124960595|NCT02469077|449482525|FG001|Post Randomization/Intervention Period|Relocated|1|||
124960596|NCT02469077|449482524|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
124960597|NCT02469077|449482525|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
124960598|NCT02469077|449482524|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
124960599|NCT02469077|449482525|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
124960600|NCT00053352|449482531|FG000|Overall Study|Lost to Follow-up|0|||
124960601|NCT00053352|449482532|FG001|Overall Study|Lost to Follow-up|1|||
124960602|NCT00053352|449482531|FG000|Overall Study|Physician Decision|11|||
124960603|NCT00053352|449482532|FG001|Overall Study|Physician Decision|1|||
124960604|NCT00053352|449482531|FG000|Overall Study|Withdrawal by Subject|1|||
124960605|NCT00053352|449482532|FG001|Overall Study|Withdrawal by Subject|0|||
124960606|NCT00053352|449482531|FG000|Overall Study|Ineligible|8|||
124960607|NCT00053352|449482532|FG001|Overall Study|Ineligible|8|||
124960608|NCT00053352|449482531|FG000|Overall Study|Disease at new site|1|||
124960609|NCT00053352|449482532|FG001|Overall Study|Disease at new site|0|||
124960610|NCT00439647|449482533|FG000|Overall Study|Withdrawal by Subject|25|||
124960611|NCT00439647|449482534|FG001|Overall Study|Withdrawal by Subject|22|||
124960612|NCT00439647|449482533|FG000|Overall Study|Death|15|||
124960613|NCT00439647|449482534|FG001|Overall Study|Death|18|||
124960614|NCT00439647|449482533|FG000|Overall Study|Adverse Event|11|||
124960615|NCT00439647|449482534|FG001|Overall Study|Adverse Event|11|||
124960616|NCT00439647|449482533|FG000|Overall Study|Lost to Follow-up|4|||
124960617|NCT00439647|449482534|FG001|Overall Study|Lost to Follow-up|12|||
124960618|NCT00439647|449482533|FG000|Overall Study|Protocol Violation|3|||
124960619|NCT00439647|449482534|FG001|Overall Study|Protocol Violation|4|||
124960620|NCT00439647|449482533|FG000|Overall Study|Lack of Efficacy|0|||
124960621|NCT00439647|449482534|FG001|Overall Study|Lack of Efficacy|4|||
124960622|NCT02845375|449482535|FG000|Overall Study|upper airway obstruction|1|||
124960623|NCT02845375|449482536|FG001|Overall Study|upper airway obstruction|2|||
124960624|NCT02845375|449482537|FG002|Overall Study|upper airway obstruction|1|||
124549458|NCT03466060|447967038|FG001|Period 2|Lens Handling Difficulties|0|||
124549459|NCT03466060|447967039|FG002|Period 2|Lens Handling Difficulties|1|||
124549460|NCT03466060|447967040|FG003|Period 2|Lens Handling Difficulties|0|||
124960625|NCT01177137|449482541|FG000|Overall Study|Withdrawal by Subject|10|||
124960626|NCT01177137|449482542|FG001|Overall Study|Withdrawal by Subject|10|||
124960627|NCT01177137|449482543|FG002|Overall Study|Withdrawal by Subject|2|||
124960628|NCT01287416|449482544|FG000|Pre-post Training|Withdrawal by Subject|17|||
124960629|NCT01287416|449482545|FG001|Pre-post Training|Withdrawal by Subject|24|||
124960630|NCT01287416|449482544|FG000|Pre-post Training|Lost to Follow-up|5|||
124960631|NCT01287416|449482545|FG001|Pre-post Training|Lost to Follow-up|1|||
124960632|NCT01287416|449482544|FG000|6 Month Follow-up|Lost to Follow-up|3|||
124960633|NCT01287416|449482545|FG001|6 Month Follow-up|Lost to Follow-up|2|||
124960634|NCT02506881|449482547|FG000|First Intervention (Day 1)|Protocol Violation|0|||
124960635|NCT02506881|449482548|FG001|First Intervention (Day 1)|Protocol Violation|0|||
124960636|NCT02506881|449482549|FG002|First Intervention (Day 1)|Protocol Violation|1|||
124960637|NCT02506881|449482550|FG003|First Intervention (Day 1)|Protocol Violation|0|||
124960638|NCT02506881|449482547|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
124960639|NCT02506881|449482548|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
124960640|NCT02506881|449482549|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
124960641|NCT02506881|449482550|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
124960642|NCT02506881|449482547|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
124960643|NCT02506881|449482548|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
124960644|NCT02506881|449482549|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
124960645|NCT02506881|449482550|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
124960646|NCT01363297|449482554|FG000|Overall Study|Other|0|||
124960647|NCT01363297|449482555|FG001|Overall Study|Other|0|||
124960648|NCT01363297|449482556|FG002|Overall Study|Other|0|||
124960649|NCT01363297|449482557|FG003|Overall Study|Other|0|||
124960650|NCT01363297|449482558|FG004|Overall Study|Other|1|||
124960651|NCT01363297|449482554|FG000|Overall Study|Death|3|||
124960652|NCT01363297|449482555|FG001|Overall Study|Death|6|||
124960653|NCT01363297|449482556|FG002|Overall Study|Death|6|||
124960654|NCT01363297|449482557|FG003|Overall Study|Death|10|||
124960655|NCT01363297|449482558|FG004|Overall Study|Death|30|||
124960656|NCT02515097|449482559|FG000|Overall Study|Lost to Follow-up|4|||
124960657|NCT02515097|449482560|FG001|Overall Study|Lost to Follow-up|2|||
124960658|NCT02515097|449482559|FG000|Overall Study|Withdrawal by Subject|1|||
124960659|NCT02515097|449482560|FG001|Overall Study|Withdrawal by Subject|3|||
124960660|NCT02515097|449482559|FG000|Overall Study|Adverse Event|2|||
124960661|NCT02515097|449482560|FG001|Overall Study|Adverse Event|1|||
124960662|NCT06016127|449482563|FG000|Overall Study|Withdrawal by Subject|4|||
124960663|NCT06016127|449482564|FG001|Overall Study|Withdrawal by Subject|3|||
124960664|NCT03915951|449482565|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
124960665|NCT03915951|449482566|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
124960666|NCT03915951|449482565|FG000|Overall Study|Adverse Event|12|||
124960667|NCT03915951|449482566|FG001|Overall Study|Adverse Event|6|||
124960668|NCT03915951|449482565|FG000|Overall Study|Disease progression (radiological)|17|||
124960669|NCT03915951|449482566|FG001|Overall Study|Disease progression (radiological)|15|||
124960670|NCT03915951|449482565|FG000|Overall Study|Disease progression (clinical)|4|||
124960671|NCT03915951|449482566|FG001|Overall Study|Disease progression (clinical)|1|||
124960672|NCT03915951|449482565|FG000|Overall Study|Patient decision|0|||
124960673|NCT03915951|449482566|FG001|Overall Study|Patient decision|4|||
124960674|NCT03915951|449482565|FG000|Overall Study|Investigator decision|0|||
124960675|NCT03915951|449482566|FG001|Overall Study|Investigator decision|1|||
124960676|NCT03915951|449482565|FG000|Overall Study|Consent withdrawn|1|||
124960677|NCT03915951|449482566|FG001|Overall Study|Consent withdrawn|1|||
124960678|NCT03915951|449482565|FG000|Overall Study|Death|0|||
124960679|NCT03915951|449482566|FG001|Overall Study|Death|3|||
124960680|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
124960681|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
124960682|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
124960683|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
124960684|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
124960685|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
124960686|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
124960687|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
124960688|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
124960689|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
124960690|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
124960691|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
124960692|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
124960693|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
124960694|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
124960695|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
124960696|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
124960697|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
124960698|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
124960699|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
124960700|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
124960701|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
124960702|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
124960703|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
124960704|NCT02269917|449482568|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
124960705|NCT02269917|449482569|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
124960706|NCT02269917|449482570|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
124960707|NCT02269917|449482568|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
124960708|NCT02269917|449482569|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
124960709|NCT02269917|449482570|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
124960710|NCT02269917|449482568|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
124960711|NCT02269917|449482569|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
124960712|NCT02269917|449482570|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
124960713|NCT02269917|449482568|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
124960714|NCT02269917|449482569|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
124960715|NCT02269917|449482570|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
124960716|NCT02269917|449482568|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
124960717|NCT02269917|449482569|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
124960718|NCT02269917|449482570|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
124960719|NCT02269917|449482568|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
124960720|NCT02269917|449482569|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
124960721|NCT02269917|449482570|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
124960722|NCT02269917|449482568|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
124960723|NCT02269917|449482569|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
124960724|NCT02269917|449482570|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
124960725|NCT02269917|449482568|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
124960726|NCT02269917|449482569|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
124960727|NCT02269917|449482570|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
124960728|NCT01121185|449482577|FG000|Overall Study|Not infused|0|||
124960729|NCT01121185|449482578|FG001|Overall Study|Not infused|1|||
124960730|NCT01121185|449482577|FG000|Overall Study|Not transplanted|1|||
124960731|NCT01121185|449482578|FG001|Overall Study|Not transplanted|0|||
124960732|NCT03015181|449482579|FG000|Overall Study|Enrolled, but product never administered|1|||
124960733|NCT03015181|449482580|FG001|Overall Study|Enrolled, but product never administered|0|||
124960734|NCT03015181|449482581|FG002|Overall Study|Enrolled, but product never administered|0|||
124960735|NCT03015181|449482582|FG003|Overall Study|Enrolled, but product never administered|0|||
124960736|NCT03015181|449482583|FG004|Overall Study|Enrolled, but product never administered|0|||
124960737|NCT03015181|449482584|FG005|Overall Study|Enrolled, but product never administered|0|||
124960738|NCT03015181|449482585|FG006|Overall Study|Enrolled, but product never administered|0|||
124960739|NCT03015181|449482579|FG000|Overall Study|Withdrawal by Subject|0|||
124960740|NCT03015181|449482580|FG001|Overall Study|Withdrawal by Subject|0|||
124960741|NCT03015181|449482581|FG002|Overall Study|Withdrawal by Subject|0|||
124960742|NCT03015181|449482582|FG003|Overall Study|Withdrawal by Subject|0|||
124960743|NCT03015181|449482583|FG004|Overall Study|Withdrawal by Subject|0|||
124960744|NCT03015181|449482584|FG005|Overall Study|Withdrawal by Subject|1|||
124768811|NCT05138653|448781218|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
124768812|NCT05138653|448781219|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
124768813|NCT05138653|448781220|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
124768814|NCT05138653|448781221|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
124768815|NCT05138653|448781222|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
124768816|NCT05138653|448781223|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
124768817|NCT05138653|448781224|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
124768818|NCT05138653|448781225|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
124768819|NCT05138653|448781226|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
124768820|NCT05138653|448781227|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
124768821|NCT05138653|448781228|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
124960745|NCT03015181|449482585|FG006|Overall Study|Withdrawal by Subject|0|||
124960746|NCT03015181|449482579|FG000|Overall Study|Physician Decision|0|||
124768822|NCT05138653|448781229|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
124768823|NCT05138653|448781230|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
124768824|NCT05138653|448781231|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
124960747|NCT03015181|449482580|FG001|Overall Study|Physician Decision|0|||
124960748|NCT03015181|449482581|FG002|Overall Study|Physician Decision|0|||
124960749|NCT03015181|449482582|FG003|Overall Study|Physician Decision|0|||
124960750|NCT03015181|449482583|FG004|Overall Study|Physician Decision|0|||
124960751|NCT03015181|449482584|FG005|Overall Study|Physician Decision|0|||
124960752|NCT03015181|449482585|FG006|Overall Study|Physician Decision|1|||
124768825|NCT05138653|448781232|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
124768826|NCT05138653|448781217|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
124768827|NCT05138653|448781218|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
124768828|NCT05138653|448781219|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
124768829|NCT05138653|448781220|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
124768830|NCT05138653|448781221|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
124768831|NCT05138653|448781222|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
124768832|NCT05138653|448781223|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
124768833|NCT05138653|448781224|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
124768834|NCT05138653|448781225|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
124960753|NCT01064856|449482591|FG000|Double-blind (DB) Period|Adverse Event|1|||
124960754|NCT01064856|449482592|FG001|Double-blind (DB) Period|Adverse Event|0|||
124960755|NCT01064856|449482593|FG002|Double-blind (DB) Period|Adverse Event|0|||
124960756|NCT01064856|449482594|FG003|Double-blind (DB) Period|Adverse Event|0|||
124960757|NCT01064856|449482591|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
124960758|NCT01064856|449482592|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
124960759|NCT01064856|449482593|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
124960760|NCT01064856|449482594|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
124960761|NCT01064856|449482591|FG000|Open-label (OL) Period|Adverse Event|0|||
124960762|NCT01064856|449482592|FG001|Open-label (OL) Period|Adverse Event|0|||
124768835|NCT05138653|448781226|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
124768836|NCT05138653|448781227|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
124768837|NCT05138653|448781228|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
124768838|NCT05138653|448781229|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
124768839|NCT05138653|448781230|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
124768840|NCT05138653|448781231|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
124768841|NCT05138653|448781232|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
124768842|NCT05138653|448781217|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
124768843|NCT05138653|448781218|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
124768844|NCT05138653|448781219|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
124768845|NCT05138653|448781220|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
124768846|NCT05138653|448781221|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
124768847|NCT05138653|448781222|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
124768848|NCT05138653|448781223|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
124768849|NCT05138653|448781224|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
124768850|NCT05138653|448781225|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
124768851|NCT05138653|448781226|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
124768852|NCT05138653|448781227|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
124768853|NCT05138653|448781228|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
124768854|NCT05138653|448781229|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
124768855|NCT05138653|448781230|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
124768856|NCT05138653|448781231|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
124768857|NCT05138653|448781232|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
124768858|NCT04272242|448781233|FG000|Overall Study|Withdrawal by Subject|3|||
124768859|NCT04272242|448781233|FG000|Overall Study|Lost to Follow-up|1|||
124768860|NCT04272242|448781233|FG000|Overall Study|Adverse Event|1|||
124768861|NCT02702492|448781234|FG000|Overall Study|Disease progression|3|||
124768862|NCT02702492|448781235|FG001|Overall Study|Disease progression|3|||
124768863|NCT02702492|448781236|FG002|Overall Study|Disease progression|2|||
124768864|NCT02702492|448781237|FG003|Overall Study|Disease progression|4|||
124768865|NCT02702492|448781238|FG004|Overall Study|Disease progression|4|||
124768866|NCT02702492|448781239|FG005|Overall Study|Disease progression|1|||
124768867|NCT02702492|448781240|FG006|Overall Study|Disease progression|2|||
124768868|NCT02702492|448781241|FG007|Overall Study|Disease progression|8|||
124768869|NCT02702492|448781242|FG008|Overall Study|Disease progression|5|||
124768870|NCT02702492|448781243|FG009|Overall Study|Disease progression|1|||
124768871|NCT02702492|448781244|FG010|Overall Study|Disease progression|0|||
124768872|NCT02702492|448781245|FG011|Overall Study|Disease progression|3|||
124768873|NCT02702492|448781246|FG012|Overall Study|Disease progression|2|||
124768874|NCT02702492|448781234|FG000|Overall Study|Clinical progression|0|||
124768875|NCT02702492|448781235|FG001|Overall Study|Clinical progression|0|||
124768876|NCT02702492|448781236|FG002|Overall Study|Clinical progression|2|||
124768877|NCT02702492|448781237|FG003|Overall Study|Clinical progression|1|||
124768878|NCT02702492|448781238|FG004|Overall Study|Clinical progression|0|||
124960763|NCT01064856|449482593|FG002|Open-label (OL) Period|Adverse Event|12|||
124960764|NCT01064856|449482594|FG003|Open-label (OL) Period|Adverse Event|6|||
124960765|NCT01064856|449482591|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
124960766|NCT01064856|449482592|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
124960767|NCT01064856|449482593|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
124960768|NCT01064856|449482594|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
124960769|NCT01064856|449482591|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
124960770|NCT01064856|449482592|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
124960771|NCT01064856|449482593|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
124960772|NCT01064856|449482594|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
124960773|NCT01064856|449482591|FG000|Open-label (OL) Period|Other|0|||
124960774|NCT01064856|449482592|FG001|Open-label (OL) Period|Other|0|||
124960775|NCT01064856|449482593|FG002|Open-label (OL) Period|Other|7|||
124960776|NCT01064856|449482594|FG003|Open-label (OL) Period|Other|7|||
124960777|NCT01204775|449482597|FG000|Overall Study|Poor/non-compliance|0|||
124960778|NCT01204775|449482598|FG001|Overall Study|Poor/non-compliance|1|||
124960779|NCT01204775|449482597|FG000|Overall Study|Withdrawal by Subject|1|||
124960780|NCT01204775|449482598|FG001|Overall Study|Withdrawal by Subject|0|||
124960781|NCT01374971|449482599|FG000|Overall Study|Withdrawal by Subject|1|||
124960782|NCT03749616|449482602|FG000|Overall Study|Lost to Follow-up|4|||
124960783|NCT03749616|449482603|FG001|Overall Study|Lost to Follow-up|7|||
124960784|NCT03749616|449482602|FG000|Overall Study|Screen Failure|1|||
124768879|NCT02702492|448781239|FG005|Overall Study|Clinical progression|2|||
124960785|NCT03749616|449482603|FG001|Overall Study|Screen Failure|1|||
124960786|NCT03749616|449482602|FG000|Overall Study|Withdrawal by Subject|2|||
124960787|NCT03749616|449482603|FG001|Overall Study|Withdrawal by Subject|0|||
124960788|NCT04435522|449482604|FG000|Overall Study|Withdrawal by Subject|2|||
124960789|NCT00951171|449482605|FG000|Overall Study|Adverse Event|2|||
124960790|NCT00951171|449482606|FG001|Overall Study|Adverse Event|0|||
124768880|NCT02702492|448781240|FG006|Overall Study|Clinical progression|1|||
124768881|NCT02702492|448781241|FG007|Overall Study|Clinical progression|4|||
124768882|NCT02702492|448781242|FG008|Overall Study|Clinical progression|0|||
124960791|NCT00919061|449482607|FG000|Overall Study|Adverse Event|1|||
124960792|NCT00919061|449482607|FG000|Overall Study|Withdrawal by Subject|1|||
124960793|NCT05294328|449482616|FG000|Overall Study|Adverse Event|1|||
124960794|NCT05294328|449482617|FG001|Overall Study|Adverse Event|0|||
124960795|NCT05294328|449482618|FG002|Overall Study|Adverse Event|0|||
124960796|NCT05294328|449482616|FG000|Overall Study|Physician Decision|1|||
124960797|NCT05294328|449482617|FG001|Overall Study|Physician Decision|1|||
124960798|NCT05294328|449482618|FG002|Overall Study|Physician Decision|0|||
124960799|NCT05294328|449482616|FG000|Overall Study|Withdrawal by Subject|0|||
124960800|NCT05294328|449482617|FG001|Overall Study|Withdrawal by Subject|2|||
124960801|NCT05294328|449482618|FG002|Overall Study|Withdrawal by Subject|1|||
124960802|NCT05294328|449482616|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
124960803|NCT05294328|449482617|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
124960804|NCT05294328|449482618|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
124960805|NCT02056873|449482619|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
124960806|NCT02972242|449485048|FG000|Overall Study|Withdrawal by Subject|1|||
124960807|NCT02972242|449485049|FG001|Overall Study|Withdrawal by Subject|0|||
124960808|NCT04572997|449485050|FG000|Overall Study|Adverse Event|1|||
124960809|NCT02956278|449485051|FG000|Overall Study|Withdrawal by Subject|6|||
124960810|NCT02956278|449485052|FG001|Overall Study|Withdrawal by Subject|2|||
124960811|NCT02956278|449485053|FG002|Overall Study|Withdrawal by Subject|0|||
124960812|NCT00740597|449485062|FG000|Overall Study|insurance would not cover treatment|1|||
124960813|NCT00552513|449485066|FG000|Overall Study|Lost to Follow-up|5|||
124960814|NCT00552513|449485067|FG001|Overall Study|Lost to Follow-up|1|||
124960815|NCT02720185|449485068|FG000|Overall Study|Lost to Follow-up|1|||
124960816|NCT01157351|449485069|FG000|Overall Study|Adverse Event|5|||
124960817|NCT01157351|449485070|FG001|Overall Study|Adverse Event|4|||
124960818|NCT01157351|449485069|FG000|Overall Study|Death|1|||
124768883|NCT02702492|448781243|FG009|Overall Study|Clinical progression|0|||
124768884|NCT02702492|448781244|FG010|Overall Study|Clinical progression|1|||
124768885|NCT02702492|448781245|FG011|Overall Study|Clinical progression|2|||
124960819|NCT01157351|449485070|FG001|Overall Study|Death|0|||
124960820|NCT01157351|449485069|FG000|Overall Study|Lost to Follow-up|53|||
124960821|NCT01157351|449485070|FG001|Overall Study|Lost to Follow-up|55|||
124960822|NCT01157351|449485069|FG000|Overall Study|Withdrawal by Subject|37|||
124960823|NCT01157351|449485070|FG001|Overall Study|Withdrawal by Subject|27|||
124960824|NCT01157351|449485069|FG000|Overall Study|Physician Decision|5|||
124960825|NCT01157351|449485070|FG001|Overall Study|Physician Decision|4|||
124768886|NCT02702492|448781246|FG012|Overall Study|Clinical progression|0|||
124960826|NCT01157351|449485069|FG000|Overall Study|Protocol Violation|0|||
124960827|NCT01157351|449485070|FG001|Overall Study|Protocol Violation|1|||
124960828|NCT01157351|449485069|FG000|Overall Study|Other|32|||
124960829|NCT01157351|449485070|FG001|Overall Study|Other|36|||
124960830|NCT01157351|449485069|FG000|Overall Study|Noncompliance with Study Drug|0|||
124960831|NCT01157351|449485070|FG001|Overall Study|Noncompliance with Study Drug|3|||
124960832|NCT01157351|449485069|FG000|Overall Study|Randomized but not Treated|4|||
124960833|NCT01157351|449485070|FG001|Overall Study|Randomized but not Treated|2|||
124960834|NCT03418493|449485071|FG000|Overall Study|Adverse Event|1|||
124768887|NCT02702492|448781234|FG000|Overall Study|Adverse Event|0|||
124960835|NCT03418493|449485072|FG001|Overall Study|Adverse Event|0|||
124960836|NCT03418493|449485073|FG002|Overall Study|Adverse Event|0|||
124960837|NCT03418493|449485074|FG003|Overall Study|Adverse Event|0|||
124960838|NCT03418493|449485075|FG004|Overall Study|Adverse Event|0|||
124960839|NCT03418493|449485076|FG005|Overall Study|Adverse Event|0|||
124960840|NCT03418493|449485077|FG006|Overall Study|Adverse Event|0|||
124960841|NCT03418493|449485078|FG007|Overall Study|Adverse Event|0|||
124960842|NCT03418493|449485079|FG008|Overall Study|Adverse Event|0|||
124960843|NCT03418493|449485080|FG009|Overall Study|Adverse Event|0|||
124960844|NCT03418493|449485081|FG010|Overall Study|Adverse Event|0|||
124960845|NCT03418493|449485071|FG000|Overall Study|Protocol Violation|0|||
124960846|NCT03418493|449485072|FG001|Overall Study|Protocol Violation|0|||
124960847|NCT03418493|449485073|FG002|Overall Study|Protocol Violation|0|||
124960848|NCT03418493|449485074|FG003|Overall Study|Protocol Violation|0|||
124960849|NCT03418493|449485075|FG004|Overall Study|Protocol Violation|0|||
124960850|NCT03418493|449485076|FG005|Overall Study|Protocol Violation|0|||
124960851|NCT03418493|449485077|FG006|Overall Study|Protocol Violation|0|||
124960852|NCT03418493|449485078|FG007|Overall Study|Protocol Violation|0|||
124960853|NCT03418493|449485079|FG008|Overall Study|Protocol Violation|0|||
124960854|NCT03418493|449485080|FG009|Overall Study|Protocol Violation|1|||
124960855|NCT03418493|449485081|FG010|Overall Study|Protocol Violation|0|||
124960856|NCT05446714|449485085|FG000|Overall Study|Lost to Follow-up|1|||
124960857|NCT05446714|449485086|FG001|Overall Study|Lost to Follow-up|3|||
124960858|NCT05446714|449485087|FG002|Overall Study|Lost to Follow-up|2|||
124960859|NCT05446714|449485085|FG000|Overall Study|Protocol Violation|2|||
124960860|NCT05446714|449485086|FG001|Overall Study|Protocol Violation|0|||
124960861|NCT05446714|449485087|FG002|Overall Study|Protocol Violation|0|||
124960862|NCT00197106|449485090|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
124960863|NCT00197106|449485091|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
124960864|NCT00197106|449485092|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
124960865|NCT00197106|449485090|FG000|Overall Treatment Period|Lack of Efficacy|0|||
124960866|NCT00197106|449485091|FG001|Overall Treatment Period|Lack of Efficacy|1|||
124960867|NCT00197106|449485092|FG002|Overall Treatment Period|Lack of Efficacy|0|||
124960868|NCT00197106|449485090|FG000|Overall Treatment Period|Lost to Follow-up|0|||
124960869|NCT00197106|449485091|FG001|Overall Treatment Period|Lost to Follow-up|0|||
124960870|NCT00197106|449485092|FG002|Overall Treatment Period|Lost to Follow-up|2|||
124960871|NCT00197106|449485090|FG000|Overall Treatment Period|Protocol Violation|0|||
124960872|NCT00197106|449485091|FG001|Overall Treatment Period|Protocol Violation|0|||
124960873|NCT00197106|449485092|FG002|Overall Treatment Period|Protocol Violation|2|||
124960874|NCT00197106|449485090|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
124960875|NCT00197106|449485091|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
124960876|NCT00197106|449485092|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
124960877|NCT00329550|449485095|FG000|Overall Study|Adverse Event|3|||
124960878|NCT00329550|449485096|FG001|Overall Study|Adverse Event|4|||
124960879|NCT00329550|449485097|FG002|Overall Study|Adverse Event|2|||
124960880|NCT00329550|449485095|FG000|Overall Study|Withdrawal of Consent|1|||
124960881|NCT00329550|449485096|FG001|Overall Study|Withdrawal of Consent|0|||
124960882|NCT00329550|449485097|FG002|Overall Study|Withdrawal of Consent|1|||
124960883|NCT00329550|449485095|FG000|Overall Study|Due to Relocation|0|||
124960884|NCT00329550|449485096|FG001|Overall Study|Due to Relocation|0|||
124960885|NCT00329550|449485097|FG002|Overall Study|Due to Relocation|1|||
124960886|NCT01649557|449485104|FG000|Overall Study|Lost to Follow-up|5|||
124960887|NCT01649557|449485105|FG001|Overall Study|Lost to Follow-up|0|||
124960888|NCT01649557|449485106|FG002|Overall Study|Lost to Follow-up|3|||
124960889|NCT01649557|449485104|FG000|Overall Study|Adverse Event|7|||
124960890|NCT01649557|449485105|FG001|Overall Study|Adverse Event|5|||
124960891|NCT01649557|449485106|FG002|Overall Study|Adverse Event|1|||
124960892|NCT01649557|449485104|FG000|Overall Study|Met withdrawal criteria|4|||
124960893|NCT01649557|449485105|FG001|Overall Study|Met withdrawal criteria|0|||
124960894|NCT01649557|449485106|FG002|Overall Study|Met withdrawal criteria|0|||
124960895|NCT01649557|449485104|FG000|Overall Study|Physician Decision|8|||
124708843|NCT00659425|448559539|FG008|Overall Study|Adverse Event|1|||
124960896|NCT01649557|449485105|FG001|Overall Study|Physician Decision|2|||
124960897|NCT01649557|449485106|FG002|Overall Study|Physician Decision|1|||
124960898|NCT01649557|449485104|FG000|Overall Study|Withdrawal by Subject|15|||
124960899|NCT01649557|449485105|FG001|Overall Study|Withdrawal by Subject|5|||
124960900|NCT01649557|449485106|FG002|Overall Study|Withdrawal by Subject|4|||
124960901|NCT01649557|449485104|FG000|Overall Study|Protocol deviation|0|||
124960902|NCT01649557|449485105|FG001|Overall Study|Protocol deviation|2|||
124960903|NCT01649557|449485106|FG002|Overall Study|Protocol deviation|0|||
124960904|NCT01649557|449485104|FG000|Overall Study|Lack of Efficacy|5|||
124960905|NCT01649557|449485105|FG001|Overall Study|Lack of Efficacy|0|||
124960906|NCT01649557|449485106|FG002|Overall Study|Lack of Efficacy|0|||
124960907|NCT00666198|449485109|FG000|Overall Study|Protocol Violation|10|||
124960908|NCT00666198|449485109|FG000|Overall Study|No Visit After First Day of Treatment|13|||
124960909|NCT00666198|449485109|FG000|Overall Study|Safety Not Assessable|6|||
124960910|NCT00666198|449485109|FG000|Overall Study|No Drug Administration|4|||
124960911|NCT00922441|449485110|FG000|Overall Study|Protocol Violation|0|||
124960912|NCT00922441|449485111|FG001|Overall Study|Protocol Violation|0|||
124960913|NCT00922441|449485112|FG002|Overall Study|Protocol Violation|2|||
124960914|NCT00922441|449485110|FG000|Overall Study|Withdrawal by Subject|0|||
124960915|NCT00922441|449485111|FG001|Overall Study|Withdrawal by Subject|0|||
124960916|NCT00922441|449485112|FG002|Overall Study|Withdrawal by Subject|1|||
124960917|NCT01040403|449485115|FG000|Overall Study|Adverse Event|10|||
124960918|NCT01040403|449485115|FG000|Overall Study|Protocol Violation|2|||
124960919|NCT01040403|449485115|FG000|Overall Study|Lost to Follow-up|1|||
124960920|NCT01040403|449485115|FG000|Overall Study|Not treated|1|||
124960921|NCT01040403|449485115|FG000|Overall Study|Other reason not defined above|6|||
124960922|NCT02973477|449485116|FG000|First Intervention|Lost to Follow-up|0|||
124960923|NCT02973477|449485117|FG001|First Intervention|Lost to Follow-up|2|||
124960924|NCT02973477|449485116|FG000|Washout|Withdrawal by Subject|1|||
124960925|NCT02973477|449485117|FG001|Washout|Withdrawal by Subject|0|||
124960926|NCT02973477|449485116|FG000|Second Intervention|Lost to Follow-up|1|||
124960927|NCT02973477|449485117|FG001|Second Intervention|Lost to Follow-up|0|||
124960928|NCT01885936|449485118|FG000|Overall Study|Withdrawal by Subject|1|||
124960929|NCT01885936|449485119|FG001|Overall Study|Withdrawal by Subject|0|||
124960930|NCT03036150|449485120|FG000|Overall Study|Withdrawal by Subject|8|||
124960931|NCT03036150|449485121|FG001|Overall Study|Withdrawal by Subject|3|||
124960932|NCT03036150|449485120|FG000|Overall Study|Lost to Follow-up|2|||
124960933|NCT03036150|449485121|FG001|Overall Study|Lost to Follow-up|2|||
124960934|NCT00317603|449485122|FG000|Overall Study|Progressive Disease|3|||
124960935|NCT00523549|449485123|FG000|Overall Study|Adverse Event|6|||
124960936|NCT00523549|449485124|FG001|Overall Study|Adverse Event|3|||
124960937|NCT00523549|449485123|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124960938|NCT00523549|449485124|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124960939|NCT00523549|449485123|FG000|Overall Study|Protocol Deviation|3|||
124549461|NCT03466060|447967041|FG004|Period 2|Lens Handling Difficulties|0|||
124960940|NCT00523549|449485124|FG001|Overall Study|Protocol Deviation|1|||
124960941|NCT00523549|449485123|FG000|Overall Study|Patient withdrew consent|7|||
124960942|NCT00523549|449485124|FG001|Overall Study|Patient withdrew consent|6|||
124960943|NCT00523549|449485123|FG000|Overall Study|Lost to Follow-up|3|||
124960944|NCT00523549|449485124|FG001|Overall Study|Lost to Follow-up|5|||
124960945|NCT00427778|449485129|FG000|First Intervention (4 Weeks)|no longer interested|1|||
124549462|NCT03466060|447967042|FG005|Period 2|Lens Handling Difficulties|0|||
124960946|NCT00427778|449485130|FG001|First Intervention (4 Weeks)|no longer interested|0|||
124549463|NCT01612780|447967043|FG000|Overall Study|Treatment not completed|1|||
124708844|NCT00659425|448559540|FG009|Overall Study|Adverse Event|4|||
124708845|NCT00659425|448559531|FG000|Overall Study|Investigator Discretion|0|||
124708846|NCT00659425|448559532|FG001|Overall Study|Investigator Discretion|0|||
124708847|NCT00659425|448559533|FG002|Overall Study|Investigator Discretion|0|||
124708848|NCT00659425|448559534|FG003|Overall Study|Investigator Discretion|0|||
124708849|NCT00659425|448559535|FG004|Overall Study|Investigator Discretion|0|||
124708850|NCT00659425|448559536|FG005|Overall Study|Investigator Discretion|1|||
124708851|NCT00659425|448559537|FG006|Overall Study|Investigator Discretion|0|||
124708852|NCT00659425|448559538|FG007|Overall Study|Investigator Discretion|3|||
124708853|NCT00659425|448559539|FG008|Overall Study|Investigator Discretion|0|||
124708854|NCT00659425|448559540|FG009|Overall Study|Investigator Discretion|0|||
124708855|NCT00659425|448559531|FG000|Overall Study|Other|0|||
124708856|NCT00659425|448559532|FG001|Overall Study|Other|1|||
124708857|NCT00659425|448559533|FG002|Overall Study|Other|1|||
124708858|NCT00659425|448559534|FG003|Overall Study|Other|2|||
124708859|NCT00659425|448559535|FG004|Overall Study|Other|4|||
124708860|NCT00659425|448559536|FG005|Overall Study|Other|0|||
124708861|NCT00659425|448559537|FG006|Overall Study|Other|3|||
124708862|NCT00659425|448559538|FG007|Overall Study|Other|2|||
124708863|NCT00659425|448559539|FG008|Overall Study|Other|0|||
124708864|NCT00659425|448559540|FG009|Overall Study|Other|6|||
124708865|NCT00271544|448559541|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
124708866|NCT00271544|448559541|FG000|Overall Study|Model 4196 lead not attempted|9|||
124708867|NCT00271544|448559541|FG000|Overall Study|Implant not attempted|4|||
124708868|NCT03358030|448559542|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
124708869|NCT03358030|448559543|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
124708870|NCT03358030|448559544|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
124708871|NCT03358030|448559545|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
124708872|NCT03358030|448559542|FG000|Overall Study|Ineligibility|0|||
124708873|NCT03358030|448559543|FG001|Overall Study|Ineligibility|0|||
124708874|NCT03358030|448559544|FG002|Overall Study|Ineligibility|0|||
124708875|NCT03358030|448559545|FG003|Overall Study|Ineligibility|2|||
124960947|NCT00427778|449485129|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
124960948|NCT00427778|449485130|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
124960949|NCT00427778|449485129|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
124960950|NCT00427778|449485130|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
124708876|NCT03358030|448559542|FG000|Overall Study|Voluntary Withdrawal|1|||
124708877|NCT03358030|448559543|FG001|Overall Study|Voluntary Withdrawal|1|||
124768888|NCT02702492|448781235|FG001|Overall Study|Adverse Event|0|||
124768889|NCT02702492|448781236|FG002|Overall Study|Adverse Event|1|||
124768890|NCT02702492|448781237|FG003|Overall Study|Adverse Event|2|||
124768891|NCT02702492|448781238|FG004|Overall Study|Adverse Event|1|||
124768892|NCT02702492|448781239|FG005|Overall Study|Adverse Event|0|||
124768893|NCT02702492|448781240|FG006|Overall Study|Adverse Event|1|||
124768894|NCT02702492|448781241|FG007|Overall Study|Adverse Event|0|||
124768895|NCT02702492|448781242|FG008|Overall Study|Adverse Event|2|||
124768896|NCT02702492|448781243|FG009|Overall Study|Adverse Event|0|||
124768897|NCT02702492|448781244|FG010|Overall Study|Adverse Event|0|||
124768898|NCT02702492|448781245|FG011|Overall Study|Adverse Event|0|||
124768899|NCT02702492|448781246|FG012|Overall Study|Adverse Event|1|||
124768900|NCT02702492|448781234|FG000|Overall Study|Other|0|||
124768901|NCT02702492|448781235|FG001|Overall Study|Other|0|||
124768902|NCT02702492|448781236|FG002|Overall Study|Other|0|||
124768903|NCT02702492|448781237|FG003|Overall Study|Other|0|||
124768904|NCT02702492|448781238|FG004|Overall Study|Other|0|||
124768905|NCT02702492|448781239|FG005|Overall Study|Other|0|||
124768906|NCT02702492|448781240|FG006|Overall Study|Other|0|||
124768907|NCT02702492|448781241|FG007|Overall Study|Other|0|||
124768908|NCT02702492|448781242|FG008|Overall Study|Other|0|||
124768909|NCT02702492|448781243|FG009|Overall Study|Other|0|||
124960951|NCT00427778|449485129|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
124960952|NCT00427778|449485130|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
124960953|NCT01388478|449485131|FG000|Overall Study|Adverse Event|4|||
124960954|NCT01388478|449485131|FG000|Overall Study|Withdrawal by Subject|1|||
124960955|NCT01990664|449485132|FG000|Overall Study|Lost to Follow-up|2|||
124960956|NCT01990664|449485133|FG001|Overall Study|Lost to Follow-up|6|||
124960957|NCT01990664|449485132|FG000|Overall Study|Withdrawal by Subject|2|||
124960958|NCT01990664|449485133|FG001|Overall Study|Withdrawal by Subject|3|||
124960959|NCT01990664|449485132|FG000|Overall Study|Protocol Violation|1|||
124960960|NCT01990664|449485133|FG001|Overall Study|Protocol Violation|0|||
124960961|NCT01990664|449485132|FG000|Overall Study|Lens Discomfort|1|||
124960962|NCT01990664|449485133|FG001|Overall Study|Lens Discomfort|1|||
124960963|NCT01990664|449485132|FG000|Overall Study|Lens Handling Difficulties|1|||
124708878|NCT03358030|448559544|FG002|Overall Study|Voluntary Withdrawal|3|||
124708879|NCT03358030|448559545|FG003|Overall Study|Voluntary Withdrawal|1|||
124708880|NCT03358030|448559542|FG000|Overall Study|Other|0|||
124708881|NCT03358030|448559543|FG001|Overall Study|Other|0|||
124708882|NCT03358030|448559544|FG002|Overall Study|Other|1|||
124708883|NCT03358030|448559545|FG003|Overall Study|Other|0|||
124708884|NCT00829244|448559546|FG000|Overall Study|Adverse Event|1|||
124708885|NCT00829244|448559547|FG001|Overall Study|Adverse Event|3|||
124708886|NCT00829244|448559546|FG000|Overall Study|Protocol Violation|1|||
124708887|NCT00829244|448559547|FG001|Overall Study|Protocol Violation|0|||
124708888|NCT00829244|448559546|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
124708889|NCT00829244|448559547|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
124708890|NCT00829244|448559546|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
124708891|NCT00829244|448559547|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
124708892|NCT00829244|448559546|FG000|Overall Study|No fertilization|2|||
124708893|NCT00829244|448559547|FG001|Overall Study|No fertilization|2|||
124708894|NCT00829244|448559546|FG000|Overall Study|All embryos discarded|0|||
124708895|NCT00829244|448559547|FG001|Overall Study|All embryos discarded|3|||
124708896|NCT00829244|448559546|FG000|Overall Study|No embryo cleavage|0|||
124708897|NCT00829244|448559547|FG001|Overall Study|No embryo cleavage|2|||
124708898|NCT02604511|448559548|FG000|Overall Study|Adverse Event|3|||
124708899|NCT02604511|448559548|FG000|Overall Study|Disease Progression|4|||
124708900|NCT02604511|448559548|FG000|Overall Study|Withdrawal by Subject|3|||
124708901|NCT02604511|448559548|FG000|Overall Study|Participant ineligible|1|||
124708902|NCT02604511|448559548|FG000|Overall Study|Intercurrent illness|1|||
124768910|NCT02702492|448781244|FG010|Overall Study|Other|0|||
124960964|NCT01990664|449485133|FG001|Overall Study|Lens Handling Difficulties|0|||
124960965|NCT01990664|449485132|FG000|Overall Study|Unsatisfactory Visual Response|0|||
124960966|NCT01990664|449485133|FG001|Overall Study|Unsatisfactory Visual Response|1|||
124960967|NCT01037413|449485134|FG000|Part A: Skin Testing|Adverse Event|1|||
124960968|NCT01037413|449485135|FG001|Part A: Skin Testing|Adverse Event|0|||
124960969|NCT01037413|449485134|FG000|Part A: Skin Testing|Protocol Violation|1|||
124708903|NCT03770286|448559549|FG000|Overall Study|Lost to Follow-up|6|||
124708904|NCT03770286|448559550|FG001|Overall Study|Lost to Follow-up|4|||
124708905|NCT03770286|448559551|FG002|Overall Study|Lost to Follow-up|3|||
124708906|NCT03770286|448559549|FG000|Overall Study|Protocol Violation|1|||
124708907|NCT03770286|448559550|FG001|Overall Study|Protocol Violation|0|||
124768911|NCT02702492|448781245|FG011|Overall Study|Other|0|||
124768912|NCT02702492|448781246|FG012|Overall Study|Other|1|||
124768913|NCT01824836|448781247|FG000|Overall Study|Adverse Event|48|||
124768914|NCT01824836|448781247|FG000|Overall Study|Withdrawal by Subject|63|||
124768915|NCT01824836|448781247|FG000|Overall Study|Other complicating disease|116|||
124768916|NCT01824836|448781247|FG000|Overall Study|Disease progression|5|||
124960970|NCT01037413|449485135|FG001|Part A: Skin Testing|Protocol Violation|0|||
124960971|NCT01037413|449485134|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
124960972|NCT01037413|449485135|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
124960973|NCT01037413|449485134|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
124960974|NCT01037413|449485135|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
124960975|NCT00619983|449485136|FG000|Test Drug Alone|Withdrawal by Subject|1|||
124960976|NCT00619983|449485137|FG001|Test Drug Alone|Withdrawal by Subject|0|||
124960977|NCT00619983|449485138|FG002|Test Drug Alone|Withdrawal by Subject|0|||
124960978|NCT00619983|449485139|FG003|Test Drug Alone|Withdrawal by Subject|1|||
124960979|NCT00619983|449485136|FG000|Test Drug Alone|Failure of daily diary device|1|||
124960980|NCT00619983|449485137|FG001|Test Drug Alone|Failure of daily diary device|1|||
124960981|NCT00619983|449485138|FG002|Test Drug Alone|Failure of daily diary device|2|||
124960982|NCT00619983|449485139|FG003|Test Drug Alone|Failure of daily diary device|2|||
124960983|NCT00931918|449485140|FG000|Overall Study|Adverse Event|4|||
124960984|NCT00931918|449485141|FG001|Overall Study|Adverse Event|6|||
124960985|NCT00931918|449485140|FG000|Overall Study|Progressive Disease|2|||
124960986|NCT00931918|449485141|FG001|Overall Study|Progressive Disease|1|||
124960987|NCT00931918|449485140|FG000|Overall Study|Symptomatic Deterioration|1|||
124960988|NCT00931918|449485141|FG001|Overall Study|Symptomatic Deterioration|0|||
124960989|NCT00931918|449485140|FG000|Overall Study|Withdrawal by Patient|3|||
124960990|NCT00931918|449485141|FG001|Overall Study|Withdrawal by Patient|4|||
124960991|NCT00931918|449485140|FG000|Overall Study|Other Reason not Specified|4|||
124960992|NCT00931918|449485141|FG001|Overall Study|Other Reason not Specified|4|||
124960993|NCT00931918|449485140|FG000|Overall Study|Did not receive study drug|3|||
124960994|NCT00931918|449485141|FG001|Overall Study|Did not receive study drug|2|||
124960995|NCT00570921|449485142|FG000|Overall Study|Protocol Violation|1|||
124960996|NCT00570921|449485142|FG000|Overall Study|Physician Decision|1|||
124960997|NCT00784277|449485144|FG000|IR Treatment|Adverse Event|4|||
124768917|NCT01824836|448781247|FG000|Overall Study|Alternative therapy|2|||
124768918|NCT01824836|448781247|FG000|Overall Study|Depression|1|||
124768919|NCT01824836|448781247|FG000|Overall Study|Non-compliance|3|||
124768920|NCT01824836|448781247|FG000|Overall Study|Patient regained ovarian function|3|||
124768921|NCT01824836|448781247|FG000|Overall Study|Lost to Follow-up|8|||
124768922|NCT01824836|448781247|FG000|Overall Study|Physician Decision|2|||
124768923|NCT01824836|448781247|FG000|Overall Study|Research office was closed|3|||
124768924|NCT01824836|448781247|FG000|Overall Study|Relocation|3|||
124768925|NCT01824836|448781247|FG000|Overall Study|Insurance-related issue|1|||
124768926|NCT01824836|448781247|FG000|Overall Study|Transportation issue|1|||
124960998|NCT00784277|449485145|FG001|IR Treatment|Adverse Event|8|||
124960999|NCT00784277|449485146|FG002|IR Treatment|Adverse Event|19|||
124961000|NCT00784277|449485147|FG003|IR Treatment|Adverse Event|35|||
124961001|NCT00784277|449485148|FG004|IR Treatment|Adverse Event|0|||
124961002|NCT00784277|449485149|FG005|IR Treatment|Adverse Event|0|||
124961003|NCT00784277|449485150|FG006|IR Treatment|Adverse Event|0|||
124961004|NCT00784277|449485144|FG000|IR Treatment|Lack of Efficacy|4|||
124961005|NCT00784277|449485145|FG001|IR Treatment|Lack of Efficacy|4|||
124961006|NCT00784277|449485146|FG002|IR Treatment|Lack of Efficacy|1|||
124961007|NCT00784277|449485147|FG003|IR Treatment|Lack of Efficacy|0|||
124961008|NCT00784277|449485148|FG004|IR Treatment|Lack of Efficacy|0|||
124961009|NCT00784277|449485149|FG005|IR Treatment|Lack of Efficacy|0|||
124961010|NCT00784277|449485150|FG006|IR Treatment|Lack of Efficacy|0|||
124961011|NCT00784277|449485144|FG000|IR Treatment|Lost to Follow-up|1|||
124961012|NCT00784277|449485145|FG001|IR Treatment|Lost to Follow-up|0|||
124961013|NCT00784277|449485146|FG002|IR Treatment|Lost to Follow-up|1|||
124961014|NCT00784277|449485147|FG003|IR Treatment|Lost to Follow-up|0|||
124961015|NCT00784277|449485148|FG004|IR Treatment|Lost to Follow-up|0|||
124961016|NCT00784277|449485149|FG005|IR Treatment|Lost to Follow-up|0|||
124961017|NCT00784277|449485150|FG006|IR Treatment|Lost to Follow-up|0|||
124961018|NCT00784277|449485144|FG000|IR Treatment|Withdrawal by Subject|5|||
124961019|NCT00784277|449485145|FG001|IR Treatment|Withdrawal by Subject|1|||
124961020|NCT00784277|449485146|FG002|IR Treatment|Withdrawal by Subject|4|||
124961021|NCT00784277|449485147|FG003|IR Treatment|Withdrawal by Subject|6|||
124961022|NCT00784277|449485148|FG004|IR Treatment|Withdrawal by Subject|0|||
124549464|NCT01612780|447967043|FG000|Overall Study|Withdrawal by Subject|5|||
124768927|NCT01824836|448781247|FG000|Overall Study|Patient transferred care|1|||
124961023|NCT00784277|449485149|FG005|IR Treatment|Withdrawal by Subject|0|||
124549465|NCT00556166|447967044|FG000|Overall Study|Withdrawal by Subject|1|||
124961024|NCT00784277|449485150|FG006|IR Treatment|Withdrawal by Subject|0|||
124961025|NCT00784277|449485144|FG000|IR Treatment|Resolution Of Pain|0|||
124961026|NCT00784277|449485145|FG001|IR Treatment|Resolution Of Pain|1|||
124961027|NCT00784277|449485146|FG002|IR Treatment|Resolution Of Pain|0|||
124961028|NCT00784277|449485147|FG003|IR Treatment|Resolution Of Pain|0|||
124961029|NCT00784277|449485148|FG004|IR Treatment|Resolution Of Pain|0|||
124961030|NCT00784277|449485149|FG005|IR Treatment|Resolution Of Pain|0|||
124961031|NCT00784277|449485150|FG006|IR Treatment|Resolution Of Pain|0|||
124961032|NCT00784277|449485144|FG000|IR Treatment|Other|2|||
124961033|NCT00784277|449485145|FG001|IR Treatment|Other|3|||
124961034|NCT00784277|449485146|FG002|IR Treatment|Other|3|||
124961035|NCT00784277|449485147|FG003|IR Treatment|Other|2|||
124961036|NCT00784277|449485148|FG004|IR Treatment|Other|0|||
124961037|NCT00784277|449485149|FG005|IR Treatment|Other|0|||
124961038|NCT00784277|449485150|FG006|IR Treatment|Other|0|||
124961039|NCT00784277|449485144|FG000|ER Treatment|Adverse Event|0|||
124961040|NCT00784277|449485145|FG001|ER Treatment|Adverse Event|0|||
124961041|NCT00784277|449485146|FG002|ER Treatment|Adverse Event|0|||
124961042|NCT00784277|449485147|FG003|ER Treatment|Adverse Event|0|||
124961043|NCT00784277|449485148|FG004|ER Treatment|Adverse Event|1|||
124961044|NCT00784277|449485149|FG005|ER Treatment|Adverse Event|7|||
124961045|NCT00784277|449485150|FG006|ER Treatment|Adverse Event|7|||
124961046|NCT00784277|449485144|FG000|ER Treatment|Lack of Efficacy|0|||
124961047|NCT00784277|449485145|FG001|ER Treatment|Lack of Efficacy|0|||
124961048|NCT00784277|449485146|FG002|ER Treatment|Lack of Efficacy|0|||
124961049|NCT00784277|449485147|FG003|ER Treatment|Lack of Efficacy|0|||
124961050|NCT00784277|449485148|FG004|ER Treatment|Lack of Efficacy|3|||
124961051|NCT00784277|449485149|FG005|ER Treatment|Lack of Efficacy|4|||
124961052|NCT00784277|449485150|FG006|ER Treatment|Lack of Efficacy|0|||
124961053|NCT00784277|449485144|FG000|ER Treatment|Lost to Follow-up|0|||
124961054|NCT00784277|449485145|FG001|ER Treatment|Lost to Follow-up|0|||
124961055|NCT00784277|449485146|FG002|ER Treatment|Lost to Follow-up|0|||
124961056|NCT00784277|449485147|FG003|ER Treatment|Lost to Follow-up|0|||
124961057|NCT00784277|449485148|FG004|ER Treatment|Lost to Follow-up|0|||
124961058|NCT00784277|449485149|FG005|ER Treatment|Lost to Follow-up|2|||
124961059|NCT00784277|449485150|FG006|ER Treatment|Lost to Follow-up|0|||
124961060|NCT00784277|449485144|FG000|ER Treatment|Withdrawal by Subject|0|||
124961061|NCT00784277|449485145|FG001|ER Treatment|Withdrawal by Subject|0|||
124961062|NCT00784277|449485146|FG002|ER Treatment|Withdrawal by Subject|0|||
124961063|NCT00784277|449485147|FG003|ER Treatment|Withdrawal by Subject|0|||
124961064|NCT00784277|449485148|FG004|ER Treatment|Withdrawal by Subject|2|||
124961065|NCT00784277|449485149|FG005|ER Treatment|Withdrawal by Subject|5|||
124961066|NCT00784277|449485150|FG006|ER Treatment|Withdrawal by Subject|3|||
124961067|NCT00784277|449485144|FG000|ER Treatment|Study Medication Non-Compliant|0|||
124961068|NCT00784277|449485145|FG001|ER Treatment|Study Medication Non-Compliant|0|||
124961069|NCT00784277|449485146|FG002|ER Treatment|Study Medication Non-Compliant|0|||
124961070|NCT00784277|449485147|FG003|ER Treatment|Study Medication Non-Compliant|0|||
124961071|NCT00784277|449485148|FG004|ER Treatment|Study Medication Non-Compliant|2|||
124961072|NCT00784277|449485149|FG005|ER Treatment|Study Medication Non-Compliant|3|||
124961073|NCT00784277|449485150|FG006|ER Treatment|Study Medication Non-Compliant|3|||
124961074|NCT00784277|449485144|FG000|ER Treatment|Other|0|||
124961075|NCT00784277|449485145|FG001|ER Treatment|Other|0|||
124961076|NCT00784277|449485146|FG002|ER Treatment|Other|0|||
124961077|NCT00784277|449485147|FG003|ER Treatment|Other|0|||
124961078|NCT00784277|449485148|FG004|ER Treatment|Other|1|||
124961079|NCT00784277|449485149|FG005|ER Treatment|Other|3|||
124961080|NCT00784277|449485150|FG006|ER Treatment|Other|2|||
124961081|NCT02025985|449485159|FG000|Overall Study|Consent withdrawn|0|||
124961082|NCT02025985|449485160|FG001|Overall Study|Consent withdrawn|0|||
124961083|NCT02025985|449485161|FG002|Overall Study|Consent withdrawn|1|||
124961084|NCT02025985|449485162|FG003|Overall Study|Consent withdrawn|0|||
124961085|NCT02025985|449485163|FG004|Overall Study|Consent withdrawn|0|||
124961086|NCT02025985|449485159|FG000|Overall Study|Termination of study by Sponsor|4|||
124961087|NCT02025985|449485160|FG001|Overall Study|Termination of study by Sponsor|3|||
124961088|NCT02025985|449485161|FG002|Overall Study|Termination of study by Sponsor|1|||
124961089|NCT02025985|449485162|FG003|Overall Study|Termination of study by Sponsor|1|||
124961090|NCT02025985|449485163|FG004|Overall Study|Termination of study by Sponsor|3|||
124961091|NCT02025985|449485159|FG000|Overall Study|Death|21|||
124961092|NCT02025985|449485160|FG001|Overall Study|Death|20|||
124961093|NCT02025985|449485161|FG002|Overall Study|Death|23|||
124961094|NCT02025985|449485162|FG003|Overall Study|Death|20|||
124961095|NCT02025985|449485163|FG004|Overall Study|Death|17|||
124961096|NCT03041701|449485164|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
124961097|NCT03041701|449485165|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
124961098|NCT03041701|449485166|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
124961099|NCT03041701|449485164|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
124961100|NCT03041701|449485165|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
124961101|NCT03041701|449485166|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
124961102|NCT00745121|449485167|FG000|Overall Study|Death|3|||
124961103|NCT00745121|449485168|FG001|Overall Study|Death|0|||
124961104|NCT00745121|449485167|FG000|Overall Study|Adverse Event|1|||
124961105|NCT00745121|449485168|FG001|Overall Study|Adverse Event|0|||
124961106|NCT00745121|449485167|FG000|Overall Study|Lost to Follow-up|1|||
124961107|NCT00745121|449485168|FG001|Overall Study|Lost to Follow-up|0|||
124961108|NCT00745121|449485167|FG000|Overall Study|Withdrawal by Subject|4|||
124961109|NCT00745121|449485168|FG001|Overall Study|Withdrawal by Subject|2|||
124549466|NCT03345485|447967047|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
124549467|NCT03345485|447967048|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
124768928|NCT01824836|448781247|FG000|Overall Study|Unknown reasons|4|||
124768929|NCT01824836|448781247|FG000|Overall Study|Never started treatment|16|||
124768930|NCT00751296|448783512|FG000|Overall Study|Adverse Event|2|||
124768931|NCT01972217|448783513|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
124768932|NCT01972217|448783514|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
124961110|NCT01713998|449485169|FG000|Overall Study|Lost to Follow-up|2|||
124768933|NCT01972217|448783515|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
124768934|NCT01972217|448783516|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
124768935|NCT01972217|448783513|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
124768936|NCT01972217|448783514|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
124961111|NCT01713998|449485170|FG001|Overall Study|Lost to Follow-up|0|||
124961112|NCT01713998|449485171|FG002|Overall Study|Lost to Follow-up|2|||
124961113|NCT01713998|449485169|FG000|Overall Study|Withdrawal by Subject|1|||
124961114|NCT01713998|449485170|FG001|Overall Study|Withdrawal by Subject|0|||
124961115|NCT01713998|449485171|FG002|Overall Study|Withdrawal by Subject|0|||
124768937|NCT01972217|448783515|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
124961116|NCT02101268|449485172|FG000|Randomized Treatment Phase|Subject Decision|8|||
124961117|NCT02101268|449485173|FG001|Randomized Treatment Phase|Subject Decision|4|||
124961118|NCT02101268|449485174|FG002|Randomized Treatment Phase|Subject Decision|0|||
124961119|NCT02101268|449485175|FG003|Randomized Treatment Phase|Subject Decision|0|||
124961120|NCT02101268|449485172|FG000|Randomized Treatment Phase|Physician Decision|4|||
124961121|NCT02101268|449485173|FG001|Randomized Treatment Phase|Physician Decision|1|||
124961122|NCT02101268|449485174|FG002|Randomized Treatment Phase|Physician Decision|0|||
124961123|NCT02101268|449485175|FG003|Randomized Treatment Phase|Physician Decision|0|||
124961124|NCT02101268|449485172|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
124961125|NCT02101268|449485173|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
124961126|NCT02101268|449485174|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
124961127|NCT02101268|449485175|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
124961128|NCT02101268|449485172|FG000|Randomized Treatment Phase|Adverse Event|6|||
124961129|NCT02101268|449485173|FG001|Randomized Treatment Phase|Adverse Event|0|||
124961130|NCT02101268|449485174|FG002|Randomized Treatment Phase|Adverse Event|0|||
124961131|NCT02101268|449485175|FG003|Randomized Treatment Phase|Adverse Event|0|||
124961132|NCT02101268|449485172|FG000|Randomized Treatment Phase|Death|5|||
124961133|NCT02101268|449485173|FG001|Randomized Treatment Phase|Death|4|||
124961134|NCT02101268|449485174|FG002|Randomized Treatment Phase|Death|0|||
124961135|NCT02101268|449485175|FG003|Randomized Treatment Phase|Death|0|||
124961136|NCT02101268|449485172|FG000|Randomized Treatment Phase|Disease Progression|4|||
124961137|NCT02101268|449485173|FG001|Randomized Treatment Phase|Disease Progression|1|||
124961138|NCT02101268|449485174|FG002|Randomized Treatment Phase|Disease Progression|0|||
124961139|NCT02101268|449485175|FG003|Randomized Treatment Phase|Disease Progression|0|||
124961140|NCT02101268|449485172|FG000|Extended Treatment Phase|Subject Decision|0|||
124961141|NCT02101268|449485173|FG001|Extended Treatment Phase|Subject Decision|0|||
124961142|NCT02101268|449485174|FG002|Extended Treatment Phase|Subject Decision|3|||
124961143|NCT02101268|449485175|FG003|Extended Treatment Phase|Subject Decision|2|||
124961144|NCT02101268|449485172|FG000|Extended Treatment Phase|Physician Decision|0|||
124961145|NCT02101268|449485173|FG001|Extended Treatment Phase|Physician Decision|0|||
124961146|NCT02101268|449485174|FG002|Extended Treatment Phase|Physician Decision|5|||
124961147|NCT02101268|449485175|FG003|Extended Treatment Phase|Physician Decision|2|||
124961148|NCT02101268|449485172|FG000|Extended Treatment Phase|Adverse Event|0|||
124961149|NCT02101268|449485173|FG001|Extended Treatment Phase|Adverse Event|0|||
124961150|NCT02101268|449485174|FG002|Extended Treatment Phase|Adverse Event|14|||
124961151|NCT02101268|449485175|FG003|Extended Treatment Phase|Adverse Event|18|||
124961152|NCT02101268|449485172|FG000|Extended Treatment Phase|Death|0|||
124961153|NCT02101268|449485173|FG001|Extended Treatment Phase|Death|0|||
124961154|NCT02101268|449485174|FG002|Extended Treatment Phase|Death|5|||
124961155|NCT02101268|449485175|FG003|Extended Treatment Phase|Death|1|||
124961156|NCT02101268|449485172|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
124961157|NCT02101268|449485173|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
124961158|NCT02101268|449485174|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
124961159|NCT02101268|449485175|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
124961160|NCT02101268|449485172|FG000|Extended Treatment Phase|Disease Progression|0|||
124961161|NCT02101268|449485173|FG001|Extended Treatment Phase|Disease Progression|0|||
124961162|NCT02101268|449485174|FG002|Extended Treatment Phase|Disease Progression|13|||
124961163|NCT02101268|449485175|FG003|Extended Treatment Phase|Disease Progression|6|||
124961164|NCT02101268|449485172|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
124961165|NCT02101268|449485173|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
124961166|NCT02101268|449485174|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
124961167|NCT02101268|449485175|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
124961168|NCT00740870|449485176|FG000|Overall Study|Not Catheterized|4|||
124961169|NCT00740870|449485176|FG000|Overall Study|Further testing contraindicated implant|17|||
124961170|NCT00839332|449485178|FG000|Phase 1|Disease Progression|38|||
124961171|NCT00839332|449485179|FG001|Phase 1|Disease Progression|0|||
124961172|NCT00839332|449485180|FG002|Phase 1|Disease Progression|0|||
124961173|NCT00839332|449485178|FG000|Phase 1|Adverse Event|6|||
124961174|NCT00839332|449485179|FG001|Phase 1|Adverse Event|0|||
124463517|NCT00647556|447656530|FG001|Overall Study|Protocol Violation|1|||
124463518|NCT00647556|447656529|FG000|Overall Study|Withdrawal by Subject|1|||
124463519|NCT00647556|447656530|FG001|Overall Study|Withdrawal by Subject|0|||
124463520|NCT00647556|447656529|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
124463521|NCT00647556|447656530|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
124463522|NCT00179309|447656532|FG000|Treatment|Toxicity|2|||
124463523|NCT00179309|447656533|FG001|Treatment|Toxicity|3|||
124463524|NCT00179309|447656532|FG000|Treatment|Withdrawal by Subject|1|||
124463525|NCT00179309|447656533|FG001|Treatment|Withdrawal by Subject|2|||
124463526|NCT00179309|447656532|FG000|Treatment|Allergy|1|||
124463527|NCT00179309|447656533|FG001|Treatment|Allergy|0|||
124463528|NCT00488982|447656534|FG000|Course 1|Physician Decision|0|||
124463529|NCT00488982|447656535|FG001|Course 1|Physician Decision|2|||
124961175|NCT00839332|449485180|FG002|Phase 1|Adverse Event|0|||
124961176|NCT00839332|449485178|FG000|Phase 1|Withdrawal by Subject|4|||
124961177|NCT00839332|449485179|FG001|Phase 1|Withdrawal by Subject|0|||
124961178|NCT00839332|449485180|FG002|Phase 1|Withdrawal by Subject|0|||
124961179|NCT00839332|449485178|FG000|Phase 1|Physician Decision|2|||
124961180|NCT00839332|449485179|FG001|Phase 1|Physician Decision|0|||
124961181|NCT00839332|449485180|FG002|Phase 1|Physician Decision|0|||
124961182|NCT00839332|449485178|FG000|Phase 2|Protocol Violation|0|||
124961183|NCT00839332|449485179|FG001|Phase 2|Protocol Violation|1|||
124961184|NCT00839332|449485180|FG002|Phase 2|Protocol Violation|0|||
124961185|NCT00839332|449485178|FG000|Phase 2|Disease Progression|0|||
124961186|NCT00839332|449485179|FG001|Phase 2|Disease Progression|46|||
124961187|NCT00839332|449485180|FG002|Phase 2|Disease Progression|21|||
124961188|NCT00839332|449485178|FG000|Phase 2|Adverse Event|0|||
124961189|NCT00839332|449485179|FG001|Phase 2|Adverse Event|8|||
124961190|NCT00839332|449485180|FG002|Phase 2|Adverse Event|6|||
124961191|NCT00839332|449485178|FG000|Phase 2|Death|0|||
124961192|NCT00839332|449485179|FG001|Phase 2|Death|4|||
124961193|NCT00839332|449485180|FG002|Phase 2|Death|2|||
124961194|NCT00839332|449485178|FG000|Phase 2|Withdrawal by Subject|0|||
124961195|NCT00839332|449485179|FG001|Phase 2|Withdrawal by Subject|5|||
124961196|NCT00839332|449485180|FG002|Phase 2|Withdrawal by Subject|8|||
124961197|NCT00839332|449485178|FG000|Phase 2|Physician Decision|0|||
124961198|NCT00839332|449485179|FG001|Phase 2|Physician Decision|4|||
124961199|NCT00839332|449485180|FG002|Phase 2|Physician Decision|1|||
124961200|NCT00839332|449485178|FG000|Phase 2|Lost to Follow-up|0|||
124961201|NCT00839332|449485179|FG001|Phase 2|Lost to Follow-up|0|||
124961202|NCT00839332|449485180|FG002|Phase 2|Lost to Follow-up|1|||
124961203|NCT01200485|449485181|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
124961204|NCT01200485|449485182|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
124961205|NCT01200485|449485183|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
124961206|NCT01200485|449485181|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
124961207|NCT01200485|449485182|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
124961208|NCT01200485|449485183|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
124961209|NCT06080438|449485184|FG000|Overall Study|Lost to Follow-up|2|||
124961210|NCT03569475|449485185|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
124961211|NCT03569475|449485186|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
124961212|NCT03569475|449485187|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
124961213|NCT03569475|449485185|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
124463530|NCT00488982|447656536|FG002|Course 1|Physician Decision|4|||
124463531|NCT00488982|447656534|FG000|Course 1|Withdrawal by Subject|0|||
124961214|NCT03569475|449485186|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
124961215|NCT03569475|449485187|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
124961216|NCT03569475|449485185|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
124961217|NCT03569475|449485186|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
124961218|NCT03569475|449485187|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
124961219|NCT03569475|449485185|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
124961220|NCT03569475|449485186|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
124961221|NCT03569475|449485187|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
124961222|NCT03569475|449485185|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
124961223|NCT03569475|449485186|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
124961224|NCT03569475|449485187|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
124463532|NCT00488982|447656535|FG001|Course 1|Withdrawal by Subject|8|||
124463533|NCT00488982|447656536|FG002|Course 1|Withdrawal by Subject|2|||
124463534|NCT00488982|447656534|FG000|Course 1|nonprotocol therapy|0|||
124463535|NCT00488982|447656535|FG001|Course 1|nonprotocol therapy|2|||
124463536|NCT00488982|447656536|FG002|Course 1|nonprotocol therapy|2|||
124768938|NCT01972217|448783516|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
124768939|NCT01972217|448783513|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
124768940|NCT01972217|448783514|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
124768941|NCT01972217|448783515|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
124768942|NCT01972217|448783516|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
124768943|NCT01972217|448783513|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
124768944|NCT01972217|448783514|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
124768945|NCT01972217|448783515|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
124768946|NCT01972217|448783516|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
124768947|NCT01972217|448783513|FG000|Part B Double-blind, Randomised Period|Death|0|||
124768948|NCT01972217|448783514|FG001|Part B Double-blind, Randomised Period|Death|0|||
124768949|NCT01972217|448783515|FG002|Part B Double-blind, Randomised Period|Death|43|||
124768950|NCT01972217|448783516|FG003|Part B Double-blind, Randomised Period|Death|44|||
124768951|NCT01972217|448783513|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
124768952|NCT01972217|448783514|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
124768953|NCT01972217|448783515|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
124768954|NCT01972217|448783516|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
124768955|NCT01972217|448783513|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
124768956|NCT01972217|448783514|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
124768957|NCT01972217|448783515|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
124768958|NCT01972217|448783516|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
124768959|NCT01972217|448783513|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
124768960|NCT01972217|448783514|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
124768961|NCT01972217|448783515|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
124768962|NCT01972217|448783516|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
124768963|NCT01972217|448783513|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
124768964|NCT01972217|448783514|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
124768965|NCT01972217|448783515|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
124768966|NCT01972217|448783516|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
124768967|NCT04106557|448783518|FG000|Overall Study|Physician Decision|0|||
124768968|NCT04106557|448783519|FG001|Overall Study|Physician Decision|1|||
124768969|NCT04106557|448783520|FG002|Overall Study|Physician Decision|0|||
124768970|NCT04106557|448783518|FG000|Overall Study|Protocol Violation|0|||
124768971|NCT04106557|448783519|FG001|Overall Study|Protocol Violation|1|||
124768972|NCT04106557|448783520|FG002|Overall Study|Protocol Violation|0|||
124768973|NCT03175367|448783521|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
124768974|NCT03175367|448783522|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
124768975|NCT03175367|448783523|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
124768976|NCT03175367|448783524|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
124768977|NCT03175367|448783525|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
124768978|NCT03175367|448783526|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
124768979|NCT03175367|448783527|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
124768980|NCT03175367|448783521|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
124768981|NCT03175367|448783522|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
124768982|NCT03175367|448783523|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
124768983|NCT03175367|448783524|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
124768984|NCT03175367|448783525|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
124768985|NCT03175367|448783526|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
124768986|NCT03175367|448783527|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
124463537|NCT00488982|447656534|FG000|Course 1|Adverse Event|0|||
124463538|NCT00488982|447656535|FG001|Course 1|Adverse Event|0|||
124463539|NCT00488982|447656536|FG002|Course 1|Adverse Event|6|||
124463540|NCT02363686|447656537|FG000|Overall Study|Withdrawal by Subject|22|||
124463541|NCT02363686|447656537|FG000|Overall Study|incomplete FEES examinations|13|||
124463542|NCT01780831|447656538|FG000|Overall Study|Withdrawal by Subject|0|||
124463543|NCT01780831|447656539|FG001|Overall Study|Withdrawal by Subject|0|||
124463544|NCT01780831|447656540|FG002|Overall Study|Withdrawal by Subject|4|||
124463545|NCT01780831|447656541|FG003|Overall Study|Withdrawal by Subject|0|||
124463546|NCT01780831|447656538|FG000|Overall Study|Lost to Follow-up|0|||
124463547|NCT01780831|447656539|FG001|Overall Study|Lost to Follow-up|0|||
124463548|NCT01780831|447656540|FG002|Overall Study|Lost to Follow-up|0|||
124463549|NCT01780831|447656541|FG003|Overall Study|Lost to Follow-up|1|||
124463550|NCT01662895|447656547|FG000|Overall Study|Lost to Follow-up|0|||
124961225|NCT03569475|449485185|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
124961226|NCT03569475|449485186|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
124961227|NCT03569475|449485187|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
124961228|NCT03569475|449485185|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
124961229|NCT03569475|449485186|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
124961230|NCT03569475|449485187|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
124961231|NCT03569475|449485185|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
124961232|NCT03569475|449485186|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
124961233|NCT03569475|449485187|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
124961234|NCT03569475|449485185|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
124961235|NCT03569475|449485186|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
124961236|NCT03569475|449485187|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
124961237|NCT03638258|449485188|FG000|Overall Study|Adverse Event|1|||
124961238|NCT03638258|449485189|FG001|Overall Study|Adverse Event|0|||
124961239|NCT03638258|449485190|FG002|Overall Study|Adverse Event|2|||
124961240|NCT03638258|449485188|FG000|Overall Study|Lost to Follow-up|2|||
124961241|NCT03638258|449485189|FG001|Overall Study|Lost to Follow-up|4|||
124961242|NCT03638258|449485190|FG002|Overall Study|Lost to Follow-up|5|||
124961243|NCT03638258|449485188|FG000|Overall Study|Pregnancy|0|||
124961244|NCT03638258|449485189|FG001|Overall Study|Pregnancy|0|||
124961245|NCT03638258|449485190|FG002|Overall Study|Pregnancy|1|||
124961246|NCT03638258|449485188|FG000|Overall Study|Protocol Violation|0|||
124961247|NCT03638258|449485189|FG001|Overall Study|Protocol Violation|0|||
124961248|NCT03638258|449485190|FG002|Overall Study|Protocol Violation|1|||
124961249|NCT03638258|449485188|FG000|Overall Study|Withdrawal by Subject|4|||
124961250|NCT03638258|449485189|FG001|Overall Study|Withdrawal by Subject|5|||
124961251|NCT03638258|449485190|FG002|Overall Study|Withdrawal by Subject|12|||
124961252|NCT03638258|449485188|FG000|Overall Study|Lack of Efficacy|0|||
124961253|NCT03638258|449485189|FG001|Overall Study|Lack of Efficacy|0|||
124961254|NCT03638258|449485190|FG002|Overall Study|Lack of Efficacy|2|||
124961255|NCT02630706|449485192|FG000|Overall Study|Adverse Event|2|||
124961256|NCT02630706|449485193|FG001|Overall Study|Adverse Event|1|||
124961257|NCT02630706|449485194|FG002|Overall Study|Adverse Event|1|||
124961258|NCT02630706|449485192|FG000|Overall Study|Lost to Follow-up|0|||
124961259|NCT02630706|449485193|FG001|Overall Study|Lost to Follow-up|1|||
124961260|NCT02630706|449485194|FG002|Overall Study|Lost to Follow-up|2|||
124961261|NCT02630706|449485192|FG000|Overall Study|Physician Decision|1|||
124961262|NCT02630706|449485193|FG001|Overall Study|Physician Decision|1|||
124961263|NCT02630706|449485194|FG002|Overall Study|Physician Decision|0|||
124961264|NCT02630706|449485192|FG000|Overall Study|Pregnancy|0|||
124961265|NCT02630706|449485193|FG001|Overall Study|Pregnancy|1|||
124961266|NCT02630706|449485194|FG002|Overall Study|Pregnancy|0|||
124961267|NCT02630706|449485192|FG000|Overall Study|Withdrawal by Subject|4|||
124961268|NCT02630706|449485193|FG001|Overall Study|Withdrawal by Subject|5|||
124961269|NCT02630706|449485194|FG002|Overall Study|Withdrawal by Subject|7|||
124961270|NCT01678898|449485195|FG000|PB-102-F01|Adverse Event|0|||
124961271|NCT01678898|449485196|FG001|PB-102-F01|Adverse Event|1|||
124961272|NCT01678898|449485197|FG002|PB-102-F01|Adverse Event|0|||
124961273|NCT01678898|449485195|FG000|PB-102-F01|Physician Decision|0|||
124463551|NCT01662895|447656548|FG001|Overall Study|Lost to Follow-up|1|||
124463552|NCT00797732|447656549|FG000|Overall Study|Withdrawal by Subject|3|||
124961274|NCT01678898|449485196|FG001|PB-102-F01|Physician Decision|1|||
124961275|NCT01678898|449485197|FG002|PB-102-F01|Physician Decision|0|||
124961276|NCT01527500|449485200|FG000|Part A|Administrative|11|||
124961277|NCT01527500|449485201|FG001|Part A|Administrative|7|||
124961278|NCT01527500|449485200|FG000|Part A|Adverse Event|4|||
124961279|NCT01527500|449485201|FG001|Part A|Adverse Event|2|||
124961280|NCT01527500|449485200|FG000|Part A|Death|4|||
124961281|NCT01527500|449485201|FG001|Part A|Death|1|||
124961282|NCT01527500|449485200|FG000|Part A|Lost to Follow-up|0|||
124961283|NCT01527500|449485201|FG001|Part A|Lost to Follow-up|1|||
124961284|NCT01527500|449485200|FG000|Part A|Protocol Deviation|9|||
124463553|NCT00797732|447656550|FG001|Overall Study|Withdrawal by Subject|3|||
124961285|NCT01527500|449485201|FG001|Part A|Protocol Deviation|2|||
124961286|NCT01527500|449485200|FG000|Part A|Withdrawal by Subject|2|||
124961287|NCT01527500|449485201|FG001|Part A|Withdrawal by Subject|0|||
124961288|NCT01527500|449485200|FG000|Part B|Adverse Event|1|||
124961289|NCT01527500|449485201|FG001|Part B|Adverse Event|0|||
124961290|NCT03078751|449485209|FG000|Overall Study|Adverse Event|4|||
124961291|NCT03078751|449485210|FG001|Overall Study|Adverse Event|0|||
124961292|NCT03078751|449485209|FG000|Overall Study|Physician Decision|1|||
124961293|NCT03078751|449485210|FG001|Overall Study|Physician Decision|0|||
124961294|NCT03078751|449485209|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
124961295|NCT03078751|449485210|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
124961296|NCT03078751|449485209|FG000|Overall Study|Subject/guardian decision|8|||
124708908|NCT03770286|448559551|FG002|Overall Study|Protocol Violation|2|||
124463554|NCT00797732|447656551|FG002|Overall Study|Withdrawal by Subject|0|||
124463555|NCT00797732|447656549|FG000|Overall Study|Lost to Follow-up|1|||
124463556|NCT00797732|447656550|FG001|Overall Study|Lost to Follow-up|0|||
124463557|NCT00797732|447656551|FG002|Overall Study|Lost to Follow-up|0|||
124463558|NCT00797732|447656549|FG000|Overall Study|Death|1|||
124463559|NCT00797732|447656550|FG001|Overall Study|Death|0|||
124463560|NCT00797732|447656551|FG002|Overall Study|Death|0|||
124463561|NCT00797732|447656549|FG000|Overall Study|Not meet inclusion criteria|0|||
124463562|NCT00797732|447656550|FG001|Overall Study|Not meet inclusion criteria|0|||
124463563|NCT00797732|447656551|FG002|Overall Study|Not meet inclusion criteria|7|||
124463564|NCT00797732|447656549|FG000|Overall Study|Excluded due to time constraints|0|||
124463565|NCT00797732|447656550|FG001|Overall Study|Excluded due to time constraints|0|||
124463566|NCT00797732|447656551|FG002|Overall Study|Excluded due to time constraints|24|||
124463567|NCT00797732|447656549|FG000|Overall Study|Refused to Participate|0|||
124463568|NCT00797732|447656550|FG001|Overall Study|Refused to Participate|0|||
124463569|NCT00797732|447656551|FG002|Overall Study|Refused to Participate|123|||
124463570|NCT00401752|447656554|FG000|Overall Study|Adverse Event|2|||
124463571|NCT00401752|447656555|FG001|Overall Study|Adverse Event|5|||
124463572|NCT00401752|447656554|FG000|Overall Study|Withdrawal by Subject|2|||
124463573|NCT00401752|447656555|FG001|Overall Study|Withdrawal by Subject|6|||
124463574|NCT00401752|447656554|FG000|Overall Study|Lost to Follow-up|1|||
124463575|NCT00401752|447656555|FG001|Overall Study|Lost to Follow-up|4|||
124463576|NCT00401752|447656554|FG000|Overall Study|Development of any exclusion criteria|4|||
124463577|NCT00401752|447656555|FG001|Overall Study|Development of any exclusion criteria|2|||
124463578|NCT00401752|447656554|FG000|Overall Study|Physician Decision|1|||
124463579|NCT00401752|447656555|FG001|Overall Study|Physician Decision|1|||
124463580|NCT04607733|447656556|FG000|Overall Study|Lost to Follow-up|1|||
124463581|NCT04607733|447656557|FG001|Overall Study|Lost to Follow-up|0|||
124463582|NCT04607733|447656558|FG002|Overall Study|Lost to Follow-up|0|||
124463583|NCT04607733|447656559|FG003|Overall Study|Lost to Follow-up|1|||
124463584|NCT04607733|447656560|FG004|Overall Study|Lost to Follow-up|1|||
124463585|NCT04607733|447656561|FG005|Overall Study|Lost to Follow-up|0|||
124463586|NCT04607733|447656556|FG000|Overall Study|Withdrawal by Subject|0|||
124463587|NCT04607733|447656557|FG001|Overall Study|Withdrawal by Subject|0|||
124463588|NCT04607733|447656558|FG002|Overall Study|Withdrawal by Subject|0|||
124463589|NCT04607733|447656559|FG003|Overall Study|Withdrawal by Subject|0|||
124463590|NCT04607733|447656560|FG004|Overall Study|Withdrawal by Subject|1|||
124463591|NCT04607733|447656561|FG005|Overall Study|Withdrawal by Subject|0|||
124463592|NCT02941627|447656568|FG000|Overall Study|Death|1|||
124768987|NCT03175367|448783521|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
124768988|NCT03175367|448783522|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
124961297|NCT03078751|449485210|FG001|Overall Study|Subject/guardian decision|1|||
124961298|NCT03078751|449485209|FG000|Overall Study|Untreated|0|||
124961299|NCT03078751|449485210|FG001|Overall Study|Untreated|4|||
124961300|NCT01209286|449485211|FG000|Overall Study|Adverse Event|4|||
124961301|NCT01209286|449485212|FG001|Overall Study|Adverse Event|3|||
124961302|NCT01209286|449485213|FG002|Overall Study|Adverse Event|1|||
124961303|NCT01209286|449485211|FG000|Overall Study|Hematological Relapse After Remission|0|||
124961304|NCT01209286|449485212|FG001|Overall Study|Hematological Relapse After Remission|1|||
124961305|NCT01209286|449485213|FG002|Overall Study|Hematological Relapse After Remission|1|||
124961306|NCT01209286|449485211|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
124961307|NCT01209286|449485212|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
124961308|NCT01209286|449485213|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
124961309|NCT01209286|449485211|FG000|Overall Study|Physician Decision|0|||
124961310|NCT01209286|449485212|FG001|Overall Study|Physician Decision|2|||
124961311|NCT01209286|449485213|FG002|Overall Study|Physician Decision|0|||
124961312|NCT01209286|449485211|FG000|Overall Study|Other|0|||
124961313|NCT01209286|449485212|FG001|Overall Study|Other|1|||
124961314|NCT01209286|449485213|FG002|Overall Study|Other|0|||
124463593|NCT02941627|447656568|FG000|Overall Study|Surgical failure|1|||
124463594|NCT02941627|447656568|FG000|Overall Study|cholesteatoma prevented implantation|1|||
124463595|NCT03594227|447656570|FG000|Overall Study|Adverse Event|2|||
124463596|NCT03594227|447656571|FG001|Overall Study|Adverse Event|1|||
124463597|NCT03594227|447656572|FG002|Overall Study|Adverse Event|0|||
124463598|NCT03594227|447656573|FG003|Overall Study|Adverse Event|2|||
124549468|NCT03345485|447967049|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
124549469|NCT03345485|447967050|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
124961315|NCT00981578|449485214|FG000|Overall Study|Death|1|||
124961316|NCT00981578|449485214|FG000|Overall Study|Withdrawal by Subject|2|||
124463599|NCT03594227|447656570|FG000|Overall Study|Lost to Follow-up|1|||
124463600|NCT03594227|447656571|FG001|Overall Study|Lost to Follow-up|1|||
124463601|NCT03594227|447656572|FG002|Overall Study|Lost to Follow-up|1|||
124463602|NCT03594227|447656573|FG003|Overall Study|Lost to Follow-up|0|||
124463603|NCT03594227|447656570|FG000|Overall Study|Withdrawal by Subject|1|||
124463604|NCT03594227|447656571|FG001|Overall Study|Withdrawal by Subject|1|||
124961317|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
124961318|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
124961319|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
124961320|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Other|1|||
124961321|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Other|0|||
124961322|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Other|0|||
124961323|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Physician Decision|3|||
124961324|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Physician Decision|0|||
124961325|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Physician Decision|0|||
124961326|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
124961327|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
124961328|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
124961329|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
124961330|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
124961331|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
124961332|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Adverse Event|18|||
124961333|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Adverse Event|0|||
124961334|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Adverse Event|0|||
124961335|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
124961336|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
124961337|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
124961338|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
124961339|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
124961340|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
124961341|NCT03030599|449485215|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
124961342|NCT03030599|449485216|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
124961343|NCT03030599|449485217|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
124961344|NCT03030599|449485215|FG000|Stable Dose|Protocol deviation|3|||
124961345|NCT03030599|449485216|FG001|Stable Dose|Protocol deviation|0|||
124961346|NCT03030599|449485217|FG002|Stable Dose|Protocol deviation|0|||
124961347|NCT03030599|449485215|FG000|Stable Dose|Adverse Event|1|||
124961348|NCT03030599|449485216|FG001|Stable Dose|Adverse Event|0|||
124961349|NCT03030599|449485217|FG002|Stable Dose|Adverse Event|0|||
124961350|NCT03030599|449485215|FG000|Stable Dose|Lost to Follow-up|1|||
124961351|NCT03030599|449485216|FG001|Stable Dose|Lost to Follow-up|0|||
124961352|NCT03030599|449485217|FG002|Stable Dose|Lost to Follow-up|0|||
124961353|NCT03030599|449485215|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
124961354|NCT03030599|449485216|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
124961355|NCT03030599|449485217|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
124961356|NCT03030599|449485215|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
124961357|NCT03030599|449485216|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
124961358|NCT03030599|449485217|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
124961359|NCT03030599|449485215|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
124961360|NCT03030599|449485216|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
124961361|NCT03030599|449485217|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
124961362|NCT03030599|449485215|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
124961363|NCT03030599|449485216|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
124961364|NCT03030599|449485217|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
124961365|NCT03030599|449485215|FG000|Open-label Extension|Adverse Event|3|||
124961366|NCT03030599|449485216|FG001|Open-label Extension|Adverse Event|0|||
124961367|NCT03030599|449485217|FG002|Open-label Extension|Adverse Event|0|||
124961368|NCT03030599|449485215|FG000|Open-label Extension|Lost to Follow-up|2|||
124961369|NCT03030599|449485216|FG001|Open-label Extension|Lost to Follow-up|0|||
124961370|NCT03030599|449485217|FG002|Open-label Extension|Lost to Follow-up|0|||
124961371|NCT03030599|449485215|FG000|Open-label Extension|Lack of Efficacy|1|||
124961372|NCT03030599|449485216|FG001|Open-label Extension|Lack of Efficacy|0|||
124961373|NCT03030599|449485217|FG002|Open-label Extension|Lack of Efficacy|0|||
124961374|NCT03030599|449485215|FG000|Open-label Extension|Other Reason|1|||
124463605|NCT03594227|447656572|FG002|Overall Study|Withdrawal by Subject|1|||
124463606|NCT03594227|447656573|FG003|Overall Study|Withdrawal by Subject|1|||
124463607|NCT03594227|447656570|FG000|Overall Study|Pregnancy|0|||
124961375|NCT03030599|449485216|FG001|Open-label Extension|Other Reason|0|||
124961376|NCT03030599|449485217|FG002|Open-label Extension|Other Reason|0|||
124961377|NCT01180790|449485218|FG000|Overall Study|Adverse Event|1|||
124961378|NCT01180790|449485219|FG001|Overall Study|Adverse Event|1|||
124961379|NCT01180790|449485220|FG002|Overall Study|Adverse Event|2|||
124961380|NCT01180790|449485221|FG003|Overall Study|Adverse Event|0|||
124961381|NCT01180790|449485222|FG004|Overall Study|Adverse Event|1|||
124961382|NCT01180790|449485223|FG005|Overall Study|Adverse Event|3|||
124961383|NCT01180790|449485224|FG006|Overall Study|Adverse Event|0|||
124961384|NCT01180790|449485218|FG000|Overall Study|Withdrawal by Subject|3|||
124463608|NCT03594227|447656571|FG001|Overall Study|Pregnancy|1|||
124463609|NCT03594227|447656572|FG002|Overall Study|Pregnancy|0|||
124463610|NCT03594227|447656573|FG003|Overall Study|Pregnancy|0|||
124463611|NCT03594227|447656570|FG000|Overall Study|Sponsor Decision|0|||
124463612|NCT03594227|447656571|FG001|Overall Study|Sponsor Decision|0|||
124463613|NCT03594227|447656572|FG002|Overall Study|Sponsor Decision|0|||
124463614|NCT03594227|447656573|FG003|Overall Study|Sponsor Decision|1|||
124463615|NCT03594227|447656570|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
124463616|NCT03594227|447656571|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
124463617|NCT03594227|447656572|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
124463618|NCT03594227|447656573|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
124463619|NCT00790907|447656574|FG000|Overall Study|Adverse Event|9|||
124463620|NCT00790907|447656575|FG001|Overall Study|Adverse Event|7|||
124463621|NCT00790907|447656576|FG002|Overall Study|Adverse Event|6|||
124463622|NCT00790907|447656574|FG000|Overall Study|Physician Decision|304|||
124463623|NCT00790907|447656575|FG001|Overall Study|Physician Decision|271|||
124463624|NCT00790907|447656576|FG002|Overall Study|Physician Decision|255|||
124463625|NCT00790907|447656574|FG000|Overall Study|Withdrawal by Subject|1|||
124463626|NCT00790907|447656575|FG001|Overall Study|Withdrawal by Subject|7|||
124463627|NCT00790907|447656576|FG002|Overall Study|Withdrawal by Subject|5|||
124463628|NCT00790907|447656574|FG000|Overall Study|Bleeding Event|11|||
124463629|NCT00790907|447656575|FG001|Overall Study|Bleeding Event|16|||
124463630|NCT00790907|447656576|FG002|Overall Study|Bleeding Event|21|||
124463631|NCT00790907|447656574|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
124463632|NCT00790907|447656575|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
124463633|NCT00790907|447656576|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
124463634|NCT00790907|447656574|FG000|Overall Study|Qualifying Condition Not Present|29|||
124463635|NCT00790907|447656575|FG001|Overall Study|Qualifying Condition Not Present|14|||
124463636|NCT00790907|447656576|FG002|Overall Study|Qualifying Condition Not Present|16|||
124463637|NCT00790907|447656574|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
124463638|NCT00790907|447656575|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
124463639|NCT00790907|447656576|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
124463640|NCT00790907|447656574|FG000|Overall Study|Did Not Receive Study Drug|10|||
124463641|NCT00790907|447656575|FG001|Overall Study|Did Not Receive Study Drug|0|||
124463642|NCT00790907|447656576|FG002|Overall Study|Did Not Receive Study Drug|0|||
124463643|NCT01888640|447656577|FG000|Overall Study|Lost to Follow-up|1|||
124708909|NCT02505425|448559552|FG000|Overall Study|Lost to Follow-up|41|||
124961385|NCT01180790|449485219|FG001|Overall Study|Withdrawal by Subject|0|||
124961386|NCT01180790|449485220|FG002|Overall Study|Withdrawal by Subject|5|||
124961387|NCT01180790|449485221|FG003|Overall Study|Withdrawal by Subject|0|||
124961388|NCT01180790|449485222|FG004|Overall Study|Withdrawal by Subject|2|||
124961389|NCT01180790|449485223|FG005|Overall Study|Withdrawal by Subject|1|||
124961390|NCT01180790|449485224|FG006|Overall Study|Withdrawal by Subject|0|||
124961391|NCT01180790|449485218|FG000|Overall Study|Lost to Follow-up|3|||
124961392|NCT01180790|449485219|FG001|Overall Study|Lost to Follow-up|1|||
124961393|NCT01180790|449485220|FG002|Overall Study|Lost to Follow-up|0|||
124961394|NCT01180790|449485221|FG003|Overall Study|Lost to Follow-up|2|||
124961395|NCT01180790|449485222|FG004|Overall Study|Lost to Follow-up|1|||
124961396|NCT01180790|449485223|FG005|Overall Study|Lost to Follow-up|0|||
124961397|NCT01180790|449485224|FG006|Overall Study|Lost to Follow-up|1|||
124961398|NCT01180790|449485218|FG000|Overall Study|Physician Decision|1|||
124961399|NCT01180790|449485219|FG001|Overall Study|Physician Decision|0|||
124961400|NCT01180790|449485220|FG002|Overall Study|Physician Decision|0|||
124961401|NCT01180790|449485221|FG003|Overall Study|Physician Decision|1|||
124961402|NCT01180790|449485222|FG004|Overall Study|Physician Decision|0|||
124961403|NCT01180790|449485223|FG005|Overall Study|Physician Decision|0|||
124961404|NCT01180790|449485224|FG006|Overall Study|Physician Decision|0|||
124961405|NCT01180790|449485218|FG000|Overall Study|Lack of Efficacy|1|||
124961406|NCT01180790|449485219|FG001|Overall Study|Lack of Efficacy|2|||
124961407|NCT01180790|449485220|FG002|Overall Study|Lack of Efficacy|5|||
124463644|NCT01888640|447656578|FG001|Overall Study|Lost to Follow-up|2|||
124463645|NCT01888640|447656579|FG002|Overall Study|Lost to Follow-up|0|||
124708910|NCT02505425|448559553|FG001|Overall Study|Lost to Follow-up|61|||
124708911|NCT02505425|448559554|FG002|Overall Study|Lost to Follow-up|31|||
124961408|NCT01180790|449485221|FG003|Overall Study|Lack of Efficacy|6|||
124961409|NCT01180790|449485222|FG004|Overall Study|Lack of Efficacy|1|||
124961410|NCT01180790|449485223|FG005|Overall Study|Lack of Efficacy|3|||
124463646|NCT01888640|447656577|FG000|Overall Study|Withdrawal by Subject|15|||
124463647|NCT01888640|447656578|FG001|Overall Study|Withdrawal by Subject|11|||
124463648|NCT01888640|447656579|FG002|Overall Study|Withdrawal by Subject|4|||
124463649|NCT01888640|447656577|FG000|Overall Study|Minimum dose not met|10|||
124549470|NCT03345485|447967051|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
124961411|NCT01180790|449485224|FG006|Overall Study|Lack of Efficacy|0|||
124961412|NCT01180790|449485218|FG000|Overall Study|compliance|0|||
124961413|NCT01180790|449485219|FG001|Overall Study|compliance|1|||
124961414|NCT01180790|449485220|FG002|Overall Study|compliance|0|||
124961415|NCT01180790|449485221|FG003|Overall Study|compliance|0|||
124961416|NCT01180790|449485222|FG004|Overall Study|compliance|0|||
124961417|NCT01180790|449485223|FG005|Overall Study|compliance|0|||
124961418|NCT01180790|449485224|FG006|Overall Study|compliance|0|||
124463650|NCT01888640|447656578|FG001|Overall Study|Minimum dose not met|16|||
124463651|NCT01888640|447656579|FG002|Overall Study|Minimum dose not met|0|||
124463652|NCT01888640|447656577|FG000|Overall Study|Given wrong unit (placebo)|1|||
124463653|NCT01888640|447656578|FG001|Overall Study|Given wrong unit (placebo)|0|||
124463654|NCT01888640|447656579|FG002|Overall Study|Given wrong unit (placebo)|0|||
124463655|NCT01888640|447656577|FG000|Overall Study|Excluded for prior TENS|0|||
124961419|NCT01180790|449485218|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
124961420|NCT01180790|449485219|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
124961421|NCT01180790|449485220|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
124961422|NCT01180790|449485221|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
124961423|NCT01180790|449485222|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
124961424|NCT01180790|449485223|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
124961425|NCT01180790|449485224|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
124961426|NCT04582864|449485225|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
124961427|NCT04582864|449485225|FG000|Overall Study|Death|1|||
124961428|NCT00316589|449485226|FG000|Overall Study|Withdrawal by Subject|0|||
124961429|NCT00316589|449485227|FG001|Overall Study|Withdrawal by Subject|5|||
124961430|NCT00316589|449485228|FG002|Overall Study|Withdrawal by Subject|0|||
124961431|NCT00316589|449485229|FG003|Overall Study|Withdrawal by Subject|1|||
124961432|NCT00316589|449485226|FG000|Overall Study|Subject unwilling/unable to comply|0|||
124961433|NCT00316589|449485227|FG001|Overall Study|Subject unwilling/unable to comply|6|||
124961434|NCT00316589|449485228|FG002|Overall Study|Subject unwilling/unable to comply|0|||
124961435|NCT00316589|449485229|FG003|Overall Study|Subject unwilling/unable to comply|2|||
124961436|NCT00316589|449485226|FG000|Overall Study|Adverse Event|1|||
124961437|NCT00316589|449485227|FG001|Overall Study|Adverse Event|0|||
124961438|NCT00316589|449485228|FG002|Overall Study|Adverse Event|0|||
124961439|NCT00316589|449485229|FG003|Overall Study|Adverse Event|1|||
124961440|NCT00316589|449485226|FG000|Overall Study|Physician Decision|0|||
124961441|NCT00316589|449485227|FG001|Overall Study|Physician Decision|1|||
124961442|NCT00316589|449485228|FG002|Overall Study|Physician Decision|0|||
124961443|NCT00316589|449485229|FG003|Overall Study|Physician Decision|0|||
124961444|NCT00316589|449485226|FG000|Overall Study|Other reason|0|||
124961445|NCT00316589|449485227|FG001|Overall Study|Other reason|12|||
124961446|NCT00316589|449485228|FG002|Overall Study|Other reason|1|||
124961447|NCT00316589|449485229|FG003|Overall Study|Other reason|1|||
124961448|NCT01482819|449485230|FG000|Overall Study|Lost to Follow-up|2|||
124961449|NCT00562484|449485231|FG000|Overall Study|Adverse Event|6|||
124961450|NCT00562484|449485232|FG001|Overall Study|Adverse Event|1|||
124961451|NCT00562484|449485231|FG000|Overall Study|Protocol Violation|11|||
124961452|NCT00562484|449485232|FG001|Overall Study|Protocol Violation|2|||
124961453|NCT00562484|449485231|FG000|Overall Study|Withdrawal by Subject|12|||
124961454|NCT00562484|449485232|FG001|Overall Study|Withdrawal by Subject|9|||
124961455|NCT00562484|449485231|FG000|Overall Study|Moved away from the study area|20|||
124961456|NCT00562484|449485232|FG001|Overall Study|Moved away from the study area|9|||
124961457|NCT00562484|449485231|FG000|Overall Study|Lost to Follow-up|132|||
124961458|NCT00562484|449485232|FG001|Overall Study|Lost to Follow-up|71|||
124961459|NCT00562484|449485231|FG000|Overall Study|Reason not provided or not specified|25|||
124961460|NCT00562484|449485232|FG001|Overall Study|Reason not provided or not specified|12|||
124961461|NCT00702520|449485234|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
124961462|NCT00702520|449485235|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
124961463|NCT00702520|449485236|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
124961464|NCT00702520|449485237|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
124961465|NCT00702520|449485234|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
124961466|NCT00702520|449485235|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
124961467|NCT00702520|449485236|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
124961468|NCT00702520|449485237|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
124961469|NCT00702520|449485234|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
124961470|NCT00702520|449485235|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
124961471|NCT00702520|449485236|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
124961472|NCT00702520|449485237|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
124961473|NCT02481934|449485238|FG000|Overall Study|Death|2|||
124961474|NCT04130061|449485246|FG000|Overall Study|OR team forgot to request membrane|1|||
124961475|NCT04130061|449485247|FG001|Overall Study|OR team forgot to request membrane|0|||
124961476|NCT01568112|449485248|FG000|Overall Study|Randomized But Not Treated|0|||
124961477|NCT01568112|449485249|FG001|Overall Study|Randomized But Not Treated|1|||
124961478|NCT01568112|449485250|FG002|Overall Study|Randomized But Not Treated|0|||
124961479|NCT01568112|449485251|FG003|Overall Study|Randomized But Not Treated|0|||
124961480|NCT01568112|449485248|FG000|Overall Study|Withdrew due to Adverse Event|2|||
124961481|NCT01568112|449485249|FG001|Overall Study|Withdrew due to Adverse Event|4|||
124463656|NCT01888640|447656578|FG001|Overall Study|Excluded for prior TENS|1|||
124463657|NCT01888640|447656579|FG002|Overall Study|Excluded for prior TENS|0|||
124463658|NCT01888640|447656577|FG000|Overall Study|Researcher Termination of Participant|0|||
124768989|NCT03175367|448783523|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
124768990|NCT03175367|448783524|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
124768991|NCT03175367|448783525|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
124768992|NCT03175367|448783526|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
124768993|NCT03175367|448783527|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
124768994|NCT03175367|448783521|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
124463659|NCT01888640|447656578|FG001|Overall Study|Researcher Termination of Participant|1|||
124768995|NCT03175367|448783522|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
124768996|NCT03175367|448783523|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
124768997|NCT03175367|448783524|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
124768998|NCT03175367|448783525|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
124768999|NCT03175367|448783526|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
124769000|NCT03175367|448783527|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
124769001|NCT03175367|448783521|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
124769002|NCT03175367|448783522|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
124769003|NCT03175367|448783523|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
124769004|NCT03175367|448783524|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
124769005|NCT03175367|448783525|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
124769006|NCT03175367|448783526|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
124769007|NCT03175367|448783527|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
124769008|NCT03175367|448783521|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
124769009|NCT03175367|448783522|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
124769010|NCT03175367|448783523|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
124769011|NCT03175367|448783524|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
124769012|NCT03175367|448783525|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
124769013|NCT03175367|448783526|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
124769014|NCT03175367|448783527|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
124769015|NCT03175367|448783521|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
124769016|NCT03175367|448783522|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
124769017|NCT03175367|448783523|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
124769018|NCT03175367|448783524|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
124769019|NCT03175367|448783525|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
124769020|NCT03175367|448783526|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
124769021|NCT03175367|448783527|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
124769022|NCT02151058|448783528|FG000|Overall Study|Withdrawal by Subject|1|||
124769023|NCT02151058|448783529|FG001|Overall Study|Withdrawal by Subject|1|||
124769024|NCT02151058|448783530|FG002|Overall Study|Withdrawal by Subject|3|||
124463660|NCT01888640|447656579|FG002|Overall Study|Researcher Termination of Participant|1|||
124463661|NCT01265550|447656582|FG000|Pre Randomization|Withdrawal by Subject|0|||
124463662|NCT01265550|447656583|FG001|Pre Randomization|Withdrawal by Subject|0|||
124463663|NCT01265550|447656584|FG002|Pre Randomization|Withdrawal by Subject|0|||
124463664|NCT01265550|447656585|FG003|Pre Randomization|Withdrawal by Subject|70|||
124463665|NCT01265550|447656582|FG000|Pre Randomization|Technical Exclusions|0|||
124463666|NCT01265550|447656583|FG001|Pre Randomization|Technical Exclusions|0|||
124463667|NCT01265550|447656584|FG002|Pre Randomization|Technical Exclusions|0|||
124463668|NCT01265550|447656585|FG003|Pre Randomization|Technical Exclusions|54|||
124463669|NCT01265550|447656582|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
124463670|NCT01265550|447656583|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
124463671|NCT01265550|447656584|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
124463672|NCT01265550|447656585|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
124463673|NCT01265550|447656582|FG000|Pre Randomization|Non-GERD organic disorders|0|||
124463674|NCT01265550|447656583|FG001|Pre Randomization|Non-GERD organic disorders|0|||
124463675|NCT01265550|447656584|FG002|Pre Randomization|Non-GERD organic disorders|0|||
124463676|NCT01265550|447656585|FG003|Pre Randomization|Non-GERD organic disorders|23|||
124463677|NCT01265550|447656582|FG000|Pre Randomization|Functional heartburn|0|||
124463678|NCT01265550|447656583|FG001|Pre Randomization|Functional heartburn|0|||
124463679|NCT01265550|447656584|FG002|Pre Randomization|Functional heartburn|0|||
124463680|NCT01265550|447656585|FG003|Pre Randomization|Functional heartburn|99|||
124463681|NCT00623428|447656586|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
124463682|NCT00623428|447656587|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
124463683|NCT00623428|447656586|FG000|Treatment Period|Death|0|||
124769025|NCT02151058|448783528|FG000|Overall Study|Lost to Follow-up|1|||
124769026|NCT02151058|448783529|FG001|Overall Study|Lost to Follow-up|0|||
124463684|NCT00623428|447656587|FG001|Treatment Period|Death|1|||
124463685|NCT00623428|447656586|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
124463686|NCT00623428|447656587|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
124463687|NCT00623428|447656586|FG000|Treatment Period|Insufficient therapeutic response|0|||
124463688|NCT00623428|447656587|FG001|Treatment Period|Insufficient therapeutic response|2|||
124463689|NCT00623428|447656586|FG000|Treatment Period|Other|0|||
124463690|NCT00623428|447656587|FG001|Treatment Period|Other|1|||
124463691|NCT00623428|447656586|FG000|Treatment Period|Withdrawal by Subject|0|||
124463692|NCT00623428|447656587|FG001|Treatment Period|Withdrawal by Subject|1|||
124463693|NCT00623428|447656586|FG000|Follow-up Period|Relapse post-treatment|11|||
124463694|NCT00623428|447656587|FG001|Follow-up Period|Relapse post-treatment|3|||
124463695|NCT00623428|447656586|FG000|Follow-up Period|Failure to return|10|||
124463696|NCT00623428|447656587|FG001|Follow-up Period|Failure to return|2|||
124463697|NCT00623428|447656586|FG000|Follow-up Period|Patient withdrew consent|5|||
124463698|NCT00623428|447656587|FG001|Follow-up Period|Patient withdrew consent|4|||
124463699|NCT00623428|447656586|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
124463700|NCT00623428|447656587|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
124463701|NCT00623428|447656586|FG000|Follow-up Period|Did not cooperate|0|||
124463702|NCT00623428|447656587|FG001|Follow-up Period|Did not cooperate|3|||
124463703|NCT00623428|447656586|FG000|Follow-up Period|Reason not specified|1|||
124463704|NCT00623428|447656587|FG001|Follow-up Period|Reason not specified|1|||
124463705|NCT00623428|447656586|FG000|Follow-up Period|Death|0|||
124463706|NCT00623428|447656587|FG001|Follow-up Period|Death|1|||
124463707|NCT03436862|447656588|FG000|Overall Study|Adverse Event|4|||
124463708|NCT03436862|447656588|FG000|Overall Study|Progressive Disease|2|||
124463709|NCT01692301|447656592|FG000|Overall Study|Adverse Event|15|||
124463710|NCT01692301|447656593|FG001|Overall Study|Adverse Event|12|||
124463711|NCT01692301|447656592|FG000|Overall Study|Death|1|||
124463712|NCT01692301|447656593|FG001|Overall Study|Death|2|||
124463713|NCT01692301|447656592|FG000|Overall Study|Lack of Efficacy|0|||
124463714|NCT01692301|447656593|FG001|Overall Study|Lack of Efficacy|5|||
124463715|NCT01692301|447656592|FG000|Overall Study|Non-compliance with study treatment|1|||
124463716|NCT01692301|447656593|FG001|Overall Study|Non-compliance with study treatment|2|||
124463717|NCT01692301|447656592|FG000|Overall Study|Protocol deviation|9|||
124463718|NCT01692301|447656593|FG001|Overall Study|Protocol deviation|2|||
124463719|NCT01692301|447656592|FG000|Overall Study|Patient/guardian decision|16|||
124463720|NCT01692301|447656593|FG001|Overall Study|Patient/guardian decision|15|||
124463721|NCT01692301|447656592|FG000|Overall Study|Technical problems|0|||
124463722|NCT01692301|447656593|FG001|Overall Study|Technical problems|1|||
124463723|NCT01692301|447656592|FG000|Overall Study|Physician Decision|2|||
124463724|NCT01692301|447656593|FG001|Overall Study|Physician Decision|2|||
124463725|NCT01692301|447656592|FG000|Overall Study|Lost to Follow-up|1|||
124463726|NCT01692301|447656593|FG001|Overall Study|Lost to Follow-up|1|||
124463727|NCT01929408|447656595|FG000|Overall Study|received HCT as initial treatment|8|||
124463728|NCT02228590|447656596|FG000|Overall Study|Withdrawal by Subject|1|||
124463729|NCT02109484|447656597|FG000|Overall Study|Lost to Follow-up|0|||
124463730|NCT02109484|447656598|FG001|Overall Study|Lost to Follow-up|0|||
124463731|NCT02109484|447656599|FG002|Overall Study|Lost to Follow-up|0|||
124463732|NCT02109484|447656600|FG003|Overall Study|Lost to Follow-up|1|||
124463733|NCT02109484|447656601|FG004|Overall Study|Lost to Follow-up|1|||
124463734|NCT02109484|447656602|FG005|Overall Study|Lost to Follow-up|0|||
124463735|NCT02109484|447656603|FG006|Overall Study|Lost to Follow-up|1|||
124463736|NCT02109484|447656604|FG007|Overall Study|Lost to Follow-up|0|||
124463737|NCT02109484|447656597|FG000|Overall Study|Withdrawal by Subject|0|||
124463738|NCT02109484|447656598|FG001|Overall Study|Withdrawal by Subject|0|||
124463739|NCT02109484|447656599|FG002|Overall Study|Withdrawal by Subject|0|||
124463740|NCT02109484|447656600|FG003|Overall Study|Withdrawal by Subject|0|||
124463741|NCT02109484|447656601|FG004|Overall Study|Withdrawal by Subject|1|||
124463742|NCT02109484|447656602|FG005|Overall Study|Withdrawal by Subject|1|||
124463743|NCT02109484|447656603|FG006|Overall Study|Withdrawal by Subject|1|||
124961482|NCT01568112|449485250|FG002|Overall Study|Withdrew due to Adverse Event|6|||
124961483|NCT01568112|449485251|FG003|Overall Study|Withdrew due to Adverse Event|3|||
124961484|NCT01568112|449485248|FG000|Overall Study|Lost to Follow-up|0|||
124961485|NCT01568112|449485249|FG001|Overall Study|Lost to Follow-up|0|||
124961486|NCT01568112|449485250|FG002|Overall Study|Lost to Follow-up|0|||
124961487|NCT01568112|449485251|FG003|Overall Study|Lost to Follow-up|1|||
124961488|NCT01568112|449485248|FG000|Overall Study|Withdrawal by Subject|2|||
124961489|NCT01568112|449485249|FG001|Overall Study|Withdrawal by Subject|3|||
124961490|NCT01568112|449485250|FG002|Overall Study|Withdrawal by Subject|0|||
124961491|NCT01568112|449485251|FG003|Overall Study|Withdrawal by Subject|7|||
124463744|NCT02109484|447656604|FG007|Overall Study|Withdrawal by Subject|0|||
124961492|NCT01568112|449485248|FG000|Overall Study|Withdrawal by Physician|1|||
124961493|NCT01568112|449485249|FG001|Overall Study|Withdrawal by Physician|0|||
124463745|NCT02109484|447656597|FG000|Overall Study|Physician Decision|0|||
124463746|NCT02109484|447656598|FG001|Overall Study|Physician Decision|0|||
124463747|NCT02109484|447656599|FG002|Overall Study|Physician Decision|0|||
124463748|NCT02109484|447656600|FG003|Overall Study|Physician Decision|0|||
124463749|NCT02109484|447656601|FG004|Overall Study|Physician Decision|2|||
124463750|NCT02109484|447656602|FG005|Overall Study|Physician Decision|0|||
124463751|NCT02109484|447656603|FG006|Overall Study|Physician Decision|0|||
124463752|NCT02109484|447656604|FG007|Overall Study|Physician Decision|0|||
124463753|NCT02109484|447656597|FG000|Overall Study|Death|0|||
124463754|NCT02109484|447656598|FG001|Overall Study|Death|0|||
124961494|NCT01568112|449485250|FG002|Overall Study|Withdrawal by Physician|1|||
124961495|NCT01568112|449485251|FG003|Overall Study|Withdrawal by Physician|1|||
124961496|NCT00560313|449486474|FG000|Overall Study|Adverse Events or Death|2|||
124463755|NCT02109484|447656599|FG002|Overall Study|Death|0|||
124463756|NCT02109484|447656600|FG003|Overall Study|Death|0|||
124463757|NCT02109484|447656601|FG004|Overall Study|Death|0|||
124463758|NCT02109484|447656602|FG005|Overall Study|Death|0|||
124463759|NCT02109484|447656603|FG006|Overall Study|Death|0|||
124463760|NCT02109484|447656604|FG007|Overall Study|Death|2|||
124463761|NCT02109484|447656597|FG000|Overall Study|Moved away from study area|0|||
124463762|NCT02109484|447656598|FG001|Overall Study|Moved away from study area|0|||
124463763|NCT02109484|447656599|FG002|Overall Study|Moved away from study area|0|||
124463764|NCT02109484|447656600|FG003|Overall Study|Moved away from study area|0|||
124463765|NCT02109484|447656601|FG004|Overall Study|Moved away from study area|0|||
124463766|NCT02109484|447656602|FG005|Overall Study|Moved away from study area|0|||
124463767|NCT02109484|447656603|FG006|Overall Study|Moved away from study area|1|||
124463768|NCT02109484|447656604|FG007|Overall Study|Moved away from study area|1|||
124463769|NCT01097863|447656609|FG000|Overall Study|Discomfort|1|||
124463770|NCT01097863|447656610|FG001|Overall Study|Discomfort|0|||
124463771|NCT01097863|447656611|FG002|Overall Study|Discomfort|1|||
124463772|NCT01097863|447656609|FG000|Overall Study|Did not return for final visit|0|||
124463773|NCT01097863|447656610|FG001|Overall Study|Did not return for final visit|0|||
124463774|NCT01097863|447656611|FG002|Overall Study|Did not return for final visit|1|||
124463775|NCT00293579|447656612|FG000|Overall Study|Withdrawal by Subject|1|||
124463776|NCT03127384|447656613|FG000|Overall Study|Lost to Follow-up|4|||
124463777|NCT03127384|447656613|FG000|Overall Study|Subject request|2|||
124463778|NCT00960843|447656615|FG000|Overall Study|Lost to Follow-up|2|||
124463779|NCT00960843|447656616|FG001|Overall Study|Lost to Follow-up|0|||
124463780|NCT00960843|447656615|FG000|Overall Study|Protocol Violation|0|||
124463781|NCT00960843|447656616|FG001|Overall Study|Protocol Violation|4|||
124463782|NCT00960843|447656615|FG000|Overall Study|Repeated needle dislodgment|0|||
124463783|NCT00960843|447656616|FG001|Overall Study|Repeated needle dislodgment|1|||
124463784|NCT00490451|447656617|FG000|Overall Study|Adverse Event|3|||
124463785|NCT00490451|447656618|FG001|Overall Study|Adverse Event|3|||
124463786|NCT00490451|447656617|FG000|Overall Study|Death|3|||
124463787|NCT00490451|447656618|FG001|Overall Study|Death|1|||
124463788|NCT00490451|447656617|FG000|Overall Study|Withdrawal by Subject|2|||
124463789|NCT00490451|447656618|FG001|Overall Study|Withdrawal by Subject|0|||
124463790|NCT00490451|447656617|FG000|Overall Study|Investigator Decision|1|||
124463791|NCT00490451|447656618|FG001|Overall Study|Investigator Decision|0|||
124463792|NCT00490451|447656617|FG000|Overall Study|Protocol Violation|1|||
124549471|NCT03345485|447967052|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
124708912|NCT02505425|448559555|FG003|Overall Study|Lost to Follow-up|19|||
124708913|NCT02505425|448559552|FG000|Overall Study|Withdrawal by Subject|39|||
124708914|NCT02505425|448559553|FG001|Overall Study|Withdrawal by Subject|9|||
124708915|NCT02505425|448559554|FG002|Overall Study|Withdrawal by Subject|19|||
124708916|NCT02505425|448559555|FG003|Overall Study|Withdrawal by Subject|7|||
124708917|NCT02505425|448559552|FG000|Overall Study|Death|8|||
124708918|NCT02505425|448559553|FG001|Overall Study|Death|12|||
124708919|NCT02505425|448559554|FG002|Overall Study|Death|0|||
124708920|NCT02505425|448559555|FG003|Overall Study|Death|0|||
124708921|NCT02297412|448559556|FG000|Overall Study|Canceled|1|||
124708922|NCT02297412|448559557|FG001|Overall Study|Canceled|1|||
124708923|NCT02031302|448559558|FG000|Overall Study|Death|115|||
124708924|NCT02031302|448559559|FG001|Overall Study|Death|0|||
124708925|NCT02031302|448559558|FG000|Overall Study|Not treated with study valve system|18|||
124708926|NCT02031302|448559559|FG001|Overall Study|Not treated with study valve system|0|||
124708927|NCT02031302|448559558|FG000|Overall Study|Missed Follow Up|27|||
124708928|NCT02031302|448559559|FG001|Overall Study|Missed Follow Up|0|||
124708929|NCT02031302|448559558|FG000|Overall Study|Lost to Follow-up|4|||
124708930|NCT02031302|448559559|FG001|Overall Study|Lost to Follow-up|0|||
124708931|NCT03950856|448559563|FG000|Overall Study|Death|1|||
124708932|NCT03950856|448559564|FG001|Overall Study|Death|2|||
124708933|NCT03950856|448559565|FG002|Overall Study|Death|0|||
124463793|NCT00490451|447656618|FG001|Overall Study|Protocol Violation|0|||
124463794|NCT00490451|447656617|FG000|Overall Study|Progressive Disease|53|||
124463795|NCT00490451|447656618|FG001|Overall Study|Progressive Disease|34|||
124463796|NCT00784654|447656621|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
124549472|NCT03345485|447967053|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
124708934|NCT03950856|448559566|FG003|Overall Study|Death|0|||
124708935|NCT03950856|448559563|FG000|Overall Study|Lost to Follow-up|5|||
124961497|NCT00560313|449486474|FG000|Overall Study|Withdrawal by Subject|2|||
124463797|NCT00784654|447656622|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
124463798|NCT00784654|447656623|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
124463799|NCT00784654|447656621|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
124463800|NCT00784654|447656622|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
124708936|NCT03950856|448559564|FG001|Overall Study|Lost to Follow-up|6|||
124708937|NCT03950856|448559565|FG002|Overall Study|Lost to Follow-up|8|||
124708938|NCT03950856|448559566|FG003|Overall Study|Lost to Follow-up|2|||
124463801|NCT00784654|447656623|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
124463802|NCT00784654|447656621|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
124463803|NCT00784654|447656622|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
124463804|NCT00784654|447656623|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
124463805|NCT00784654|447656621|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
124708939|NCT03950856|448559563|FG000|Overall Study|Protocol Violation|2|||
124708940|NCT03950856|448559564|FG001|Overall Study|Protocol Violation|0|||
124708941|NCT03950856|448559565|FG002|Overall Study|Protocol Violation|0|||
124708942|NCT03950856|448559566|FG003|Overall Study|Protocol Violation|1|||
124708943|NCT03950856|448559563|FG000|Overall Study|Withdrawal by Subject|4|||
124708944|NCT03950856|448559564|FG001|Overall Study|Withdrawal by Subject|1|||
124708945|NCT03950856|448559565|FG002|Overall Study|Withdrawal by Subject|3|||
124708946|NCT03950856|448559566|FG003|Overall Study|Withdrawal by Subject|1|||
124708947|NCT03950856|448559563|FG000|Overall Study|Unable to phone|7|||
124708948|NCT03950856|448559564|FG001|Overall Study|Unable to phone|6|||
124708949|NCT03950856|448559565|FG002|Overall Study|Unable to phone|7|||
124708950|NCT03950856|448559566|FG003|Overall Study|Unable to phone|2|||
124708951|NCT05899829|448559567|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
124708952|NCT05899829|448559568|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
124708953|NCT05899829|448559567|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
124708954|NCT05899829|448559568|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
124708955|NCT02781558|448559572|FG000|Overall Study|Lost to Follow-up|2|||
124708956|NCT02781558|448559573|FG001|Overall Study|Lost to Follow-up|2|||
124708957|NCT02781558|448559572|FG000|Overall Study|Adverse Event|1|||
124708958|NCT02781558|448559573|FG001|Overall Study|Adverse Event|0|||
124708959|NCT03802396|448559576|FG000|Overall Study|Withdrawal by Subject|2|||
124708960|NCT03802396|448559577|FG001|Overall Study|Withdrawal by Subject|0|||
124708961|NCT03802396|448559576|FG000|Overall Study|Surgery Cancelled|1|||
124708962|NCT03802396|448559577|FG001|Overall Study|Surgery Cancelled|0|||
124708963|NCT02561962|448559581|FG000|Overall Study|Withdrawal by Subject|1|||
124708964|NCT02561962|448559582|FG001|Overall Study|Withdrawal by Subject|0|||
124708965|NCT02561962|448559583|FG002|Overall Study|Withdrawal by Subject|0|||
124708966|NCT02561962|448559584|FG003|Overall Study|Withdrawal by Subject|0|||
124708967|NCT02561962|448559585|FG004|Overall Study|Withdrawal by Subject|1|||
124708968|NCT02561962|448559586|FG005|Overall Study|Withdrawal by Subject|1|||
124708969|NCT02561962|448559587|FG006|Overall Study|Withdrawal by Subject|2|||
124708970|NCT02561962|448559588|FG007|Overall Study|Withdrawal by Subject|1|||
124708971|NCT02561962|448559589|FG008|Overall Study|Withdrawal by Subject|0|||
124708972|NCT02561962|448559581|FG000|Overall Study|Decision by sponsor|0|||
124708973|NCT02561962|448559582|FG001|Overall Study|Decision by sponsor|0|||
124708974|NCT02561962|448559583|FG002|Overall Study|Decision by sponsor|0|||
124708975|NCT02561962|448559584|FG003|Overall Study|Decision by sponsor|0|||
124708976|NCT02561962|448559585|FG004|Overall Study|Decision by sponsor|1|||
124708977|NCT02561962|448559586|FG005|Overall Study|Decision by sponsor|1|||
124708978|NCT02561962|448559587|FG006|Overall Study|Decision by sponsor|0|||
124769027|NCT02151058|448783530|FG002|Overall Study|Lost to Follow-up|2|||
124769028|NCT00674817|448783532|FG000|Period 1|Withdrawal by Subject|2|||
124463806|NCT00784654|447656622|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
124463807|NCT00784654|447656623|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
124708979|NCT02561962|448559588|FG007|Overall Study|Decision by sponsor|3|||
124708980|NCT02561962|448559589|FG008|Overall Study|Decision by sponsor|0|||
124708981|NCT02561962|448559581|FG000|Overall Study|Lost to Follow-up|0|||
124708982|NCT02561962|448559582|FG001|Overall Study|Lost to Follow-up|0|||
124708983|NCT02561962|448559583|FG002|Overall Study|Lost to Follow-up|0|||
124769029|NCT00674817|448783532|FG000|Period 1|Protocol Violation|1|||
124708984|NCT02561962|448559584|FG003|Overall Study|Lost to Follow-up|0|||
124708985|NCT02561962|448559585|FG004|Overall Study|Lost to Follow-up|0|||
124708986|NCT02561962|448559586|FG005|Overall Study|Lost to Follow-up|1|||
124708987|NCT02561962|448559587|FG006|Overall Study|Lost to Follow-up|0|||
124708988|NCT02561962|448559588|FG007|Overall Study|Lost to Follow-up|0|||
124708989|NCT02561962|448559589|FG008|Overall Study|Lost to Follow-up|0|||
124708990|NCT01150357|448559590|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
124708991|NCT01150357|448559591|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
124708992|NCT01150357|448559592|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
124708993|NCT01150357|448559590|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
124708994|NCT01150357|448559591|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
124708995|NCT01150357|448559592|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
124708996|NCT01150357|448559590|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
124708997|NCT01150357|448559591|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
124708998|NCT01150357|448559592|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
124708999|NCT01150357|448559590|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
124709000|NCT01150357|448559591|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
124709001|NCT01150357|448559592|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
124709002|NCT01150357|448559590|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
124709003|NCT01150357|448559591|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
124709004|NCT01150357|448559592|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
124709005|NCT01150357|448559590|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
124709006|NCT01150357|448559591|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
124709007|NCT01150357|448559592|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
124709008|NCT01150357|448559590|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
124709009|NCT01150357|448559591|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
124709010|NCT01150357|448559592|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
124769030|NCT00674817|448783532|FG000|Period 3|Adverse Event|1|||
124769031|NCT00674817|448783532|FG000|Period 3|Protocol Violation|1|||
124769032|NCT00674817|448783532|FG000|Period 4|Adverse Event|1|||
124769033|NCT03379818|448783533|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
124769034|NCT03379818|448783534|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
124769035|NCT03379818|448783533|FG000|Overall Study|Withdrawal by Subject|2|||
124769036|NCT03379818|448783534|FG001|Overall Study|Withdrawal by Subject|3|||
124769037|NCT03379818|448783533|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
124769038|NCT03379818|448783534|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
124769039|NCT03199976|448783535|FG000|Overall Study|Lack of Efficacy|3|||
124769040|NCT03199976|448783536|FG001|Overall Study|Lack of Efficacy|6|||
124769041|NCT03199976|448783537|FG002|Overall Study|Lack of Efficacy|13|||
124769042|NCT03199976|448783535|FG000|Overall Study|Withdrawal by Subject|1|||
124769043|NCT03199976|448783536|FG001|Overall Study|Withdrawal by Subject|0|||
124769044|NCT03199976|448783537|FG002|Overall Study|Withdrawal by Subject|0|||
124769045|NCT03199976|448783535|FG000|Overall Study|Lost to Follow-up|0|||
124769046|NCT03199976|448783536|FG001|Overall Study|Lost to Follow-up|1|||
124769047|NCT03199976|448783537|FG002|Overall Study|Lost to Follow-up|1|||
124769048|NCT01780506|448783544|FG000|Double-Blind Phase|Randomized but not Treated|3|||
124769049|NCT01780506|448783545|FG001|Double-Blind Phase|Randomized but not Treated|2|||
124769050|NCT01780506|448783544|FG000|Double-Blind Phase|Adverse Event|4|||
124769051|NCT01780506|448783545|FG001|Double-Blind Phase|Adverse Event|14|||
124769052|NCT01780506|448783544|FG000|Double-Blind Phase|Death|1|||
124769053|NCT01780506|448783545|FG001|Double-Blind Phase|Death|2|||
124769054|NCT01780506|448783544|FG000|Double-Blind Phase|Pregnancy|2|||
124769055|NCT01780506|448783545|FG001|Double-Blind Phase|Pregnancy|1|||
124769056|NCT01780506|448783544|FG000|Double-Blind Phase|Lack of Efficacy|1|||
124769057|NCT01780506|448783545|FG001|Double-Blind Phase|Lack of Efficacy|1|||
124769058|NCT01780506|448783544|FG000|Double-Blind Phase|Investigator's Discretion|5|||
124769059|NCT01780506|448783545|FG001|Double-Blind Phase|Investigator's Discretion|2|||
124769060|NCT01780506|448783544|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
124769061|NCT01780506|448783545|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
124769062|NCT01780506|448783544|FG000|Double-Blind Phase|Protocol Violation|4|||
124769063|NCT01780506|448783545|FG001|Double-Blind Phase|Protocol Violation|3|||
124769064|NCT01780506|448783544|FG000|Double-Blind Phase|Withdrew Consent|23|||
124769065|NCT01780506|448783545|FG001|Double-Blind Phase|Withdrew Consent|24|||
124769066|NCT01780506|448783544|FG000|Double-Blind Phase|Lost to Follow-up|23|||
124769067|NCT01780506|448783545|FG001|Double-Blind Phase|Lost to Follow-up|26|||
124769068|NCT01780506|448783544|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
124769069|NCT01780506|448783545|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
124769070|NCT05236270|448783546|FG000|Overall Study|Lost to Follow-up|3|||
124769071|NCT05236270|448783547|FG001|Overall Study|Lost to Follow-up|2|||
124769072|NCT05236270|448783548|FG002|Overall Study|Lost to Follow-up|0|||
124769073|NCT05236270|448783549|FG003|Overall Study|Lost to Follow-up|0|||
124769074|NCT05236270|448783550|FG004|Overall Study|Lost to Follow-up|2|||
124769075|NCT05236270|448783551|FG005|Overall Study|Lost to Follow-up|0|||
124769076|NCT05236270|448783552|FG006|Overall Study|Lost to Follow-up|1|||
124769077|NCT05236270|448783553|FG007|Overall Study|Lost to Follow-up|3|||
124769078|NCT04030143|448783554|FG000|Overall Study|Adverse Event|5|||
124769079|NCT04030143|448783555|FG001|Overall Study|Adverse Event|10|||
124769080|NCT04030143|448783554|FG000|Overall Study|Lost to Follow-up|3|||
124769081|NCT04030143|448783555|FG001|Overall Study|Lost to Follow-up|7|||
124769082|NCT04030143|448783554|FG000|Overall Study|Protocol Deviation|2|||
124769083|NCT04030143|448783555|FG001|Overall Study|Protocol Deviation|2|||
124769084|NCT04030143|448783554|FG000|Overall Study|Withdrawal by Subject|16|||
124769085|NCT04030143|448783555|FG001|Overall Study|Withdrawal by Subject|18|||
124769086|NCT04030143|448783554|FG000|Overall Study|Physician Decision|1|||
124769087|NCT04030143|448783555|FG001|Overall Study|Physician Decision|1|||
124769088|NCT04030143|448783554|FG000|Overall Study|Due to Covid-19|2|||
124769089|NCT04030143|448783555|FG001|Overall Study|Due to Covid-19|3|||
124769090|NCT04030143|448783554|FG000|Overall Study|Not Due to Covid-19|1|||
124769091|NCT04030143|448783555|FG001|Overall Study|Not Due to Covid-19|1|||
124769092|NCT01499940|448783556|FG000|Overall Study|Study was withdrawn before completion.|9|||
124769093|NCT00412984|448783557|FG000|Overall Study|Death|331|||
124769094|NCT00412984|448783558|FG001|Overall Study|Death|349|||
124769095|NCT00412984|448783557|FG000|Overall Study|Adverse Event|679|||
124769096|NCT00412984|448783558|FG001|Overall Study|Adverse Event|738|||
124769097|NCT00412984|448783557|FG000|Overall Study|Withdrawal by Subject|921|||
124769098|NCT00412984|448783558|FG001|Overall Study|Withdrawal by Subject|989|||
124769099|NCT00412984|448783557|FG000|Overall Study|Lost to Follow-up|51|||
124769100|NCT00412984|448783558|FG001|Overall Study|Lost to Follow-up|39|||
124769101|NCT00412984|448783557|FG000|Overall Study|Poor/Noncompliance|57|||
124769102|NCT00412984|448783558|FG001|Overall Study|Poor/Noncompliance|77|||
124463808|NCT00784654|447656621|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
124463809|NCT00784654|447656622|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
124463810|NCT00784654|447656623|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
124463811|NCT00784654|447656621|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
124463812|NCT00784654|447656622|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
124463813|NCT00784654|447656623|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
124463814|NCT00784654|447656621|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
124463815|NCT00784654|447656622|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
124463816|NCT00784654|447656623|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
124463817|NCT00784654|447656621|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
124463818|NCT00784654|447656622|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
124769103|NCT00412984|448783557|FG000|Overall Study|Pregnancy|1|||
124769104|NCT00412984|448783558|FG001|Overall Study|Pregnancy|0|||
124769105|NCT00412984|448783557|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
124769106|NCT00412984|448783558|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
124769107|NCT00412984|448783557|FG000|Overall Study|Administrative Reason by Sponsor|11|||
124769108|NCT00412984|448783558|FG001|Overall Study|Administrative Reason by Sponsor|8|||
124463819|NCT00784654|447656623|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
124463820|NCT00784654|447656621|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
124463821|NCT00784654|447656622|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
124463822|NCT00784654|447656623|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
124769109|NCT00412984|448783557|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
124961498|NCT00560313|449486474|FG000|Overall Study|Lost to Follow-up|1|||
124463823|NCT00784654|447656621|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
124463824|NCT00784654|447656622|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
124463825|NCT00784654|447656623|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
124463826|NCT00784654|447656621|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
124463827|NCT00784654|447656622|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
124463828|NCT00784654|447656623|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
124463829|NCT00784654|447656621|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
124463830|NCT00784654|447656622|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
124463831|NCT00784654|447656623|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
124463832|NCT00784654|447656621|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
124463833|NCT00784654|447656622|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
124463834|NCT00784654|447656623|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
124463835|NCT00784654|447656621|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124463836|NCT00784654|447656622|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
124463837|NCT00784654|447656623|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
124463838|NCT00784654|447656621|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
124463839|NCT00784654|447656622|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
124463840|NCT00784654|447656623|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
124463841|NCT00784654|447656621|FG000|Randomized Withdrawal Period|Adverse Event|0|||
124463842|NCT00784654|447656622|FG001|Randomized Withdrawal Period|Adverse Event|1|||
124769110|NCT00412984|448783558|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
124961499|NCT00560313|449486474|FG000|Overall Study|Protocol Violation|1|||
124961500|NCT00746785|449486475|FG000|Overall Study|Lost to Follow-up|29|||
124961501|NCT00746785|449486476|FG001|Overall Study|Lost to Follow-up|25|||
124961502|NCT00746785|449486477|FG002|Overall Study|Lost to Follow-up|27|||
124961503|NCT00966979|449486479|FG000|Overall Study|Death|1|||
124961504|NCT00966979|449486479|FG000|Overall Study|Lost to Follow-up|6|||
124961505|NCT00966979|449486479|FG000|Overall Study|Withdrawal by Subject|14|||
124961506|NCT00966979|449486479|FG000|Overall Study|Adverse Event|5|||
124961507|NCT00966979|449486479|FG000|Overall Study|Sponsor terminated early|49|||
124961508|NCT00966979|449486479|FG000|Overall Study|Censored because surgery not done|2|||
124961509|NCT00966979|449486479|FG000|Overall Study|Censored because study device was not implanted|14|||
124961510|NCT00966979|449486479|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
124961511|NCT04140266|449486480|FG000|Overall Study|Physician Decision|2|||
124961512|NCT04140266|449486481|FG001|Overall Study|Physician Decision|0|||
124961513|NCT04140266|449486480|FG000|Overall Study|Withdrawal by Subject|4|||
124961514|NCT04140266|449486481|FG001|Overall Study|Withdrawal by Subject|2|||
124961515|NCT01990313|449486482|FG000|Overall Study|Lost to Follow-up|1|||
124961516|NCT03511378|449486483|FG000|Overall Study|Withdrawal by Subject|2|||
124961517|NCT03511378|449486484|FG001|Overall Study|Withdrawal by Subject|2|||
124961518|NCT03511378|449486483|FG000|Overall Study|Patient not coming or schedule visit|1|||
124961519|NCT03511378|449486484|FG001|Overall Study|Patient not coming or schedule visit|0|||
124961520|NCT00837096|449486485|FG000|Overall Study|Physician Decision|1|||
124961521|NCT00837096|449486486|FG001|Overall Study|Physician Decision|1|||
124961522|NCT00837096|449486485|FG000|Overall Study|Not reported|9|||
124463843|NCT00784654|447656623|FG002|Randomized Withdrawal Period|Adverse Event|1|||
124463844|NCT00784654|447656621|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
124463845|NCT00784654|447656622|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
124463846|NCT00784654|447656623|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
124463847|NCT00784654|447656621|FG000|Randomized Withdrawal Period|Family reasons|0|||
124463848|NCT00784654|447656622|FG001|Randomized Withdrawal Period|Family reasons|0|||
124463849|NCT00784654|447656623|FG002|Randomized Withdrawal Period|Family reasons|1|||
124463850|NCT01026831|447656624|FG000|Overall Study|Adverse Event|4|||
124463851|NCT01026831|447656625|FG001|Overall Study|Adverse Event|3|||
124463852|NCT01026831|447656624|FG000|Overall Study|Lost to Follow-up|2|||
124463853|NCT01026831|447656625|FG001|Overall Study|Lost to Follow-up|0|||
124463854|NCT01026831|447656624|FG000|Overall Study|Physician Decision|1|||
124463855|NCT01026831|447656625|FG001|Overall Study|Physician Decision|1|||
124463856|NCT01026831|447656624|FG000|Overall Study|Protocol Violation|0|||
124463857|NCT01026831|447656625|FG001|Overall Study|Protocol Violation|2|||
124463858|NCT01026831|447656624|FG000|Overall Study|Withdrawal by Subject|7|||
124463859|NCT01026831|447656625|FG001|Overall Study|Withdrawal by Subject|5|||
124463860|NCT01180660|447656628|FG000|Overall Study|Changed to open surgery|1|||
124463861|NCT01180660|447656629|FG001|Overall Study|Changed to open surgery|0|||
124709011|NCT01732536|448561304|FG000|Overall Study|Withdrawal by Subject|1|||
124709012|NCT01732536|448561305|FG001|Overall Study|Withdrawal by Subject|1|||
124709013|NCT01581684|448561308|FG000|Overall Study|Other reason not defined|0|||
124709014|NCT01581684|448561309|FG001|Overall Study|Other reason not defined|0|||
124709015|NCT01581684|448561310|FG002|Overall Study|Other reason not defined|0|||
124709016|NCT01581684|448561311|FG003|Overall Study|Other reason not defined|0|||
124709017|NCT01581684|448561312|FG004|Overall Study|Other reason not defined|0|||
124709018|NCT01581684|448561313|FG005|Overall Study|Other reason not defined|0|||
124709019|NCT01581684|448561314|FG006|Overall Study|Other reason not defined|0|||
124709020|NCT01581684|448561315|FG007|Overall Study|Other reason not defined|0|||
124709021|NCT01581684|448561316|FG008|Overall Study|Other reason not defined|1|||
124709022|NCT01581684|448561317|FG009|Overall Study|Other reason not defined|0|||
124709023|NCT03728933|448561318|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
124961523|NCT00837096|449486486|FG001|Overall Study|Not reported|8|||
124961524|NCT05006417|449486487|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
124961525|NCT00280683|449486488|FG000|Overall Study|Withdrawal by Subject|1|||
124961526|NCT00280683|449486489|FG001|Overall Study|Withdrawal by Subject|2|||
124961527|NCT00280683|449486488|FG000|Overall Study|Adverse Event|1|||
124961528|NCT00280683|449486489|FG001|Overall Study|Adverse Event|1|||
124961529|NCT01243411|449486490|FG000|Overall Study|Withdrawal by Subject|18|||
124961530|NCT01243411|449486490|FG000|Overall Study|Lost to Follow-up|10|||
124961531|NCT01243411|449486490|FG000|Overall Study|Adverse Event|5|||
124961532|NCT01243411|449486490|FG000|Overall Study|Other|8|||
124961533|NCT00510198|449486493|FG000|Overall Study|Withdrawal by Subject|5|||
124961534|NCT00510198|449486494|FG001|Overall Study|Withdrawal by Subject|4|||
124961535|NCT03712449|449486501|FG000|Overall Study|Withdraw Consent|0|||
124961536|NCT03712449|449486502|FG001|Overall Study|Withdraw Consent|1|||
124961537|NCT05153499|449486506|FG000|Overall Study|Withdrawal by Subject|1|||
124961538|NCT05153499|449486507|FG001|Overall Study|Withdrawal by Subject|0|||
124961539|NCT05153499|449486506|FG000|Overall Study|Clinical Hold|1|||
124961540|NCT05153499|449486507|FG001|Overall Study|Clinical Hold|0|||
124961541|NCT05153499|449486506|FG000|Overall Study|Study Termination|6|||
124961542|NCT05153499|449486507|FG001|Overall Study|Study Termination|5|||
124961543|NCT01649297|449486509|FG000|Overall Study|Adverse Event|5|||
124961544|NCT01649297|449486510|FG001|Overall Study|Adverse Event|5|||
124961545|NCT01649297|449486511|FG002|Overall Study|Adverse Event|4|||
124961546|NCT01649297|449486512|FG003|Overall Study|Adverse Event|13|||
124961547|NCT01649297|449486513|FG004|Overall Study|Adverse Event|1|||
124463862|NCT02500121|447656632|FG000|Overall Study|Lost to Follow-up|0|||
124463863|NCT02500121|447656633|FG001|Overall Study|Lost to Follow-up|1|||
124463864|NCT02500121|447656632|FG000|Overall Study|Withdrawal by Subject|1|||
124709024|NCT03728933|448561319|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124709025|NCT03728933|448561320|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
124709026|NCT03728933|448561318|FG000|Overall Study|Withdrawal by Subject|0|||
124961548|NCT01649297|449486509|FG000|Overall Study|Lack of Efficacy|0|||
124961549|NCT01649297|449486510|FG001|Overall Study|Lack of Efficacy|0|||
124961550|NCT01649297|449486511|FG002|Overall Study|Lack of Efficacy|0|||
124961551|NCT01649297|449486512|FG003|Overall Study|Lack of Efficacy|0|||
124961552|NCT01649297|449486513|FG004|Overall Study|Lack of Efficacy|1|||
124961553|NCT01649297|449486509|FG000|Overall Study|Non compliant with Protocol|1|||
124961554|NCT01649297|449486510|FG001|Overall Study|Non compliant with Protocol|0|||
124961555|NCT01649297|449486511|FG002|Overall Study|Non compliant with Protocol|3|||
124961556|NCT01649297|449486512|FG003|Overall Study|Non compliant with Protocol|2|||
124961557|NCT01649297|449486513|FG004|Overall Study|Non compliant with Protocol|1|||
124961558|NCT01649297|449486509|FG000|Overall Study|Lost to Follow-up|1|||
124463865|NCT02500121|447656633|FG001|Overall Study|Withdrawal by Subject|1|||
124463866|NCT02500121|447656632|FG000|Overall Study|Death|26|||
124709027|NCT03728933|448561319|FG001|Overall Study|Withdrawal by Subject|0|||
124709028|NCT03728933|448561320|FG002|Overall Study|Withdrawal by Subject|1|||
124961559|NCT01649297|449486510|FG001|Overall Study|Lost to Follow-up|1|||
124961560|NCT01649297|449486511|FG002|Overall Study|Lost to Follow-up|4|||
124961561|NCT01649297|449486512|FG003|Overall Study|Lost to Follow-up|3|||
124961562|NCT01649297|449486513|FG004|Overall Study|Lost to Follow-up|0|||
124961563|NCT01649297|449486509|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
124961564|NCT01649297|449486510|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
124961565|NCT01649297|449486511|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
124961566|NCT01649297|449486512|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
124961567|NCT01649297|449486513|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
124961568|NCT01649297|449486509|FG000|Overall Study|For other reason|4|||
124961569|NCT01649297|449486510|FG001|Overall Study|For other reason|1|||
124961570|NCT01649297|449486511|FG002|Overall Study|For other reason|2|||
124961571|NCT01649297|449486512|FG003|Overall Study|For other reason|0|||
124961572|NCT01649297|449486513|FG004|Overall Study|For other reason|0|||
124961573|NCT01685047|449486514|FG000|Overall Study|Withdrawal by Subject|20|||
124961574|NCT01685047|449486514|FG000|Overall Study|Death|26|||
124961575|NCT01685047|449486514|FG000|Overall Study|Lost to Follow-up|8|||
124961576|NCT01685047|449486514|FG000|Overall Study|Physician Decision|25|||
124961577|NCT01685047|449486514|FG000|Overall Study|Adverse Event|5|||
124961578|NCT01685047|449486514|FG000|Overall Study|patient withdrawn by sponsor|1|||
124961579|NCT02490878|449486521|FG000|Overall Study|deemed ineligible|0|||
124961580|NCT02490878|449486522|FG001|Overall Study|deemed ineligible|1|||
124961581|NCT02490878|449486521|FG000|Overall Study|progression prior to treatment|0|||
124961582|NCT02490878|449486522|FG001|Overall Study|progression prior to treatment|1|||
124961583|NCT02490878|449486521|FG000|Overall Study|only submitted baseline QOL|0|||
124961584|NCT02490878|449486522|FG001|Overall Study|only submitted baseline QOL|1|||
124961585|NCT02544113|449486523|FG000|Overall Study|Death|3|||
124961586|NCT02544113|449486524|FG001|Overall Study|Death|4|||
124961587|NCT00451555|449486525|FG000|Overall Study|Protocol Violation|2|||
124961588|NCT00451555|449486526|FG001|Overall Study|Protocol Violation|2|||
124961589|NCT00451555|449486525|FG000|Overall Study|Adverse Event|3|||
124961590|NCT00451555|449486526|FG001|Overall Study|Adverse Event|1|||
124961591|NCT00451555|449486525|FG000|Overall Study|Withdrawal by Subject|6|||
124961592|NCT00451555|449486526|FG001|Overall Study|Withdrawal by Subject|0|||
124961593|NCT00451555|449486525|FG000|Overall Study|Physician Decision|2|||
124961594|NCT00451555|449486526|FG001|Overall Study|Physician Decision|1|||
124961595|NCT02847637|449486527|FG000|Overall Study|Withdrawal by Subject|0|||
124961596|NCT02847637|449486528|FG001|Overall Study|Withdrawal by Subject|1|||
124961597|NCT02847637|449486529|FG002|Overall Study|Withdrawal by Subject|1|||
124961598|NCT02847637|449486530|FG003|Overall Study|Withdrawal by Subject|0|||
124961599|NCT02847637|449486527|FG000|Overall Study|Lost to Follow-up|1|||
124961600|NCT02847637|449486528|FG001|Overall Study|Lost to Follow-up|1|||
124961601|NCT02847637|449486529|FG002|Overall Study|Lost to Follow-up|0|||
124961602|NCT02847637|449486530|FG003|Overall Study|Lost to Follow-up|0|||
124961603|NCT02741713|449486538|FG000|Overall Study|Surgery type changed intra-operatively|2|||
124961604|NCT02741713|449486539|FG001|Overall Study|Surgery type changed intra-operatively|1|||
124961605|NCT01093222|449486540|FG000|Overall Study|Ineligible|6|||
124961606|NCT01093222|449486540|FG000|Overall Study|Adverse Event|7|||
124961607|NCT01093222|449486540|FG000|Overall Study|Progression/relapse|24|||
124961608|NCT01093222|449486540|FG000|Overall Study|Death|2|||
124961609|NCT01093222|449486540|FG000|Overall Study|Not protocol specified|1|||
124961610|NCT00588341|449486541|FG000|Overall Study|Withdrawal by Subject|3|||
124961611|NCT00588341|449486541|FG000|Overall Study|Not treated due to metastatic disease|1|||
124961612|NCT00588341|449486541|FG000|Overall Study|Patient ineligible|1|||
124961613|NCT01670188|449486542|FG000|Overall Study|Death|0|||
124961614|NCT01670188|449486543|FG001|Overall Study|Death|1|||
124961615|NCT01281917|449486551|FG000|Overall Study|Withdrawal by Subject|1|||
124961616|NCT01187407|449486553|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
124961617|NCT01187407|449486554|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124961618|NCT01187407|449486555|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124961619|NCT01187407|449486556|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124961620|NCT01187407|449486557|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
124961621|NCT01187407|449486553|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
124961622|NCT01187407|449486554|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124961623|NCT01187407|449486555|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124961624|NCT01187407|449486556|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124961625|NCT01187407|449486557|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
124961626|NCT01187407|449486553|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
124961627|NCT01187407|449486554|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124961628|NCT01187407|449486555|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124961629|NCT01187407|449486556|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124961630|NCT01187407|449486557|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
124961631|NCT01187407|449486553|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
124709029|NCT03728933|448561318|FG000|Overall Study|Lost to Follow-up|0|||
124463867|NCT02500121|447656633|FG001|Overall Study|Death|24|||
124463868|NCT00852995|447656635|FG000|Overall Study|Adverse Event|1|||
124463869|NCT00852995|447656636|FG001|Overall Study|Adverse Event|0|||
124463870|NCT00852995|447656637|FG002|Overall Study|Adverse Event|4|||
124463871|NCT00852995|447656638|FG003|Overall Study|Adverse Event|0|||
124463872|NCT00852995|447656639|FG004|Overall Study|Adverse Event|0|||
124463873|NCT00852995|447656635|FG000|Overall Study|Lost to Follow-up|0|||
124463874|NCT00852995|447656636|FG001|Overall Study|Lost to Follow-up|1|||
124463875|NCT00852995|447656637|FG002|Overall Study|Lost to Follow-up|1|||
124463876|NCT00852995|447656638|FG003|Overall Study|Lost to Follow-up|0|||
124463877|NCT00852995|447656639|FG004|Overall Study|Lost to Follow-up|0|||
124463878|NCT00852995|447656635|FG000|Overall Study|Withdrawal by Subject|4|||
124463879|NCT00852995|447656636|FG001|Overall Study|Withdrawal by Subject|0|||
124463880|NCT00852995|447656637|FG002|Overall Study|Withdrawal by Subject|0|||
124463881|NCT00852995|447656638|FG003|Overall Study|Withdrawal by Subject|1|||
124463882|NCT00852995|447656639|FG004|Overall Study|Withdrawal by Subject|2|||
124463883|NCT00852995|447656635|FG000|Overall Study|Non-Compliance|0|||
124463884|NCT00852995|447656636|FG001|Overall Study|Non-Compliance|0|||
124463885|NCT00852995|447656637|FG002|Overall Study|Non-Compliance|0|||
124463886|NCT00852995|447656638|FG003|Overall Study|Non-Compliance|2|||
124463887|NCT00852995|447656639|FG004|Overall Study|Non-Compliance|0|||
124463888|NCT00852995|447656635|FG000|Overall Study|Progressive Disease|1|||
124463889|NCT00852995|447656636|FG001|Overall Study|Progressive Disease|0|||
124463890|NCT00852995|447656637|FG002|Overall Study|Progressive Disease|0|||
124463891|NCT00852995|447656638|FG003|Overall Study|Progressive Disease|2|||
124463892|NCT00852995|447656639|FG004|Overall Study|Progressive Disease|1|||
124463893|NCT00852995|447656635|FG000|Overall Study|Physician Decision|1|||
124709030|NCT03728933|448561319|FG001|Overall Study|Lost to Follow-up|1|||
124709031|NCT03728933|448561320|FG002|Overall Study|Lost to Follow-up|0|||
124961632|NCT01187407|449486554|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124961633|NCT01187407|449486555|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124961634|NCT01187407|449486556|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124961635|NCT01187407|449486557|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
124961636|NCT01187407|449486553|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
124961637|NCT01187407|449486554|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124961638|NCT01187407|449486555|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124961639|NCT01187407|449486556|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124961640|NCT01187407|449486557|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
124961641|NCT01187407|449486553|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
124961642|NCT01187407|449486554|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124961643|NCT01187407|449486555|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124961644|NCT01187407|449486556|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124961645|NCT01187407|449486557|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
124961646|NCT01187407|449486553|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
124961647|NCT01187407|449486554|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124961648|NCT01187407|449486555|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124961649|NCT01187407|449486556|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124961650|NCT01187407|449486557|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
124961651|NCT01187407|449486553|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
124961652|NCT01187407|449486554|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
124961653|NCT01187407|449486555|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
124961654|NCT01187407|449486556|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
124961655|NCT01187407|449486557|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
124961656|NCT01187407|449486553|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
124961657|NCT01187407|449486554|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
124961658|NCT01187407|449486555|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
124961659|NCT01187407|449486556|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
124961660|NCT01187407|449486557|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
124961661|NCT01187407|449486553|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
124961662|NCT01187407|449486554|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
124961663|NCT01187407|449486555|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
124961664|NCT01187407|449486556|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
124463894|NCT00852995|447656636|FG001|Overall Study|Physician Decision|0|||
124709032|NCT03728933|448561318|FG000|Overall Study|Adverse Event|1|||
124463895|NCT00852995|447656637|FG002|Overall Study|Physician Decision|0|||
124463896|NCT00852995|447656638|FG003|Overall Study|Physician Decision|0|||
124463897|NCT00852995|447656639|FG004|Overall Study|Physician Decision|0|||
124463898|NCT00852995|447656635|FG000|Overall Study|Protocol Violation|0|||
124463899|NCT00852995|447656636|FG001|Overall Study|Protocol Violation|0|||
124463900|NCT00852995|447656637|FG002|Overall Study|Protocol Violation|0|||
124463901|NCT00852995|447656638|FG003|Overall Study|Protocol Violation|0|||
124463902|NCT00852995|447656639|FG004|Overall Study|Protocol Violation|1|||
124463903|NCT00852995|447656635|FG000|Overall Study|Moved Out of Area|1|||
124463904|NCT00852995|447656636|FG001|Overall Study|Moved Out of Area|0|||
124463905|NCT00852995|447656637|FG002|Overall Study|Moved Out of Area|0|||
124463906|NCT00852995|447656638|FG003|Overall Study|Moved Out of Area|0|||
124463907|NCT00852995|447656639|FG004|Overall Study|Moved Out of Area|0|||
124463908|NCT00498173|447656640|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
124463909|NCT00498173|447656641|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
124463910|NCT00498173|447656642|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
124463911|NCT01110200|447656643|FG000|Overall Study|Adverse Event|28|||
124463912|NCT01110200|447656644|FG001|Overall Study|Adverse Event|28|||
124463913|NCT01110200|447656643|FG000|Overall Study|Withdrawal by Subject|25|||
124463914|NCT01110200|447656644|FG001|Overall Study|Withdrawal by Subject|32|||
124709033|NCT03728933|448561319|FG001|Overall Study|Adverse Event|0|||
124709034|NCT03728933|448561320|FG002|Overall Study|Adverse Event|0|||
124961665|NCT01187407|449486557|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
124961666|NCT01187407|449486553|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
124961667|NCT01187407|449486554|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
124961668|NCT01187407|449486555|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
124961669|NCT01187407|449486556|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
124961670|NCT01187407|449486557|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
124961671|NCT01187407|449486553|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
124961672|NCT01187407|449486554|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
124961673|NCT01187407|449486555|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
124961674|NCT01187407|449486556|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
124961675|NCT01187407|449486557|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
124961676|NCT01187407|449486553|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
124961677|NCT01187407|449486554|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
124961678|NCT01187407|449486555|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
124961679|NCT01187407|449486556|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
124961680|NCT01187407|449486557|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
124961681|NCT01187407|449486553|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
124961682|NCT01187407|449486554|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
124961683|NCT01187407|449486555|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
124961684|NCT01187407|449486556|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
124961685|NCT01187407|449486557|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
124961686|NCT00776984|449486560|FG000|Overall Study|Adverse Event|8|||
124961687|NCT00776984|449486561|FG001|Overall Study|Adverse Event|2|||
124961688|NCT00776984|449486560|FG000|Overall Study|Protocol Violation|4|||
124961689|NCT00776984|449486561|FG001|Overall Study|Protocol Violation|2|||
124961690|NCT00776984|449486560|FG000|Overall Study|Lost to Follow-up|2|||
124961691|NCT00776984|449486561|FG001|Overall Study|Lost to Follow-up|0|||
124961692|NCT00776984|449486560|FG000|Overall Study|Withdrawal by Subject|12|||
124961693|NCT00776984|449486561|FG001|Overall Study|Withdrawal by Subject|7|||
124961694|NCT00776984|449486560|FG000|Overall Study|Lack of Efficacy|0|||
124961695|NCT00776984|449486561|FG001|Overall Study|Lack of Efficacy|1|||
124961696|NCT00776984|449486560|FG000|Overall Study|Other|5|||
124961697|NCT00776984|449486561|FG001|Overall Study|Other|9|||
124961698|NCT02573883|449486569|FG000|Six Month Follow Up|Lost to Follow-up|1|||
124961699|NCT02573883|449486570|FG001|Six Month Follow Up|Lost to Follow-up|0|||
124961700|NCT02573883|449486571|FG002|Six Month Follow Up|Lost to Follow-up|0|||
124961701|NCT02573883|449486572|FG003|Six Month Follow Up|Lost to Follow-up|0|||
124961702|NCT02573883|449486569|FG000|One Year Follow Up|Lost to Follow-up|2|||
124961703|NCT02573883|449486570|FG001|One Year Follow Up|Lost to Follow-up|1|||
124961704|NCT02573883|449486571|FG002|One Year Follow Up|Lost to Follow-up|0|||
124961705|NCT02573883|449486572|FG003|One Year Follow Up|Lost to Follow-up|0|||
124961706|NCT01544309|449486573|FG000|Overall Study|Withdrawal by Subject|12|||
124961707|NCT01544309|449486574|FG001|Overall Study|Withdrawal by Subject|7|||
124961708|NCT01544309|449486573|FG000|Overall Study|Protocol Violation|2|||
124961709|NCT01544309|449486574|FG001|Overall Study|Protocol Violation|1|||
124961710|NCT01544309|449486573|FG000|Overall Study|Physician Decision|4|||
124961711|NCT01544309|449486574|FG001|Overall Study|Physician Decision|1|||
124961712|NCT01544309|449486573|FG000|Overall Study|Not performed pre-dose examination|1|||
124961713|NCT01544309|449486574|FG001|Overall Study|Not performed pre-dose examination|2|||
124961714|NCT01544309|449486573|FG000|Overall Study|Administered prohibit prior medication|1|||
124961715|NCT01544309|449486574|FG001|Overall Study|Administered prohibit prior medication|0|||
124961716|NCT00118703|449486575|FG000|Overall Study|Protocol Violation|1|||
124961717|NCT00118703|449486576|FG001|Overall Study|Protocol Violation|0|||
124961718|NCT00118703|449486575|FG000|Overall Study|Adverse Event|1|||
124961719|NCT00118703|449486576|FG001|Overall Study|Adverse Event|1|||
124463915|NCT01110200|447656643|FG000|Overall Study|Lack of Efficacy|16|||
124463916|NCT01110200|447656644|FG001|Overall Study|Lack of Efficacy|25|||
124961720|NCT00118703|449486575|FG000|Overall Study|Participant took two different treatment|0|||
124961721|NCT00118703|449486576|FG001|Overall Study|Participant took two different treatment|1|||
124961722|NCT00118703|449486575|FG000|Overall Study|Withdrawal by Subject|2|||
124961723|NCT00118703|449486576|FG001|Overall Study|Withdrawal by Subject|5|||
124961724|NCT00118703|449486575|FG000|Overall Study|Lost to Follow-up|1|||
124961725|NCT00118703|449486576|FG001|Overall Study|Lost to Follow-up|2|||
124961726|NCT03796208|449486581|FG000|Overall Study|Withdrawal by Subject|3|||
124961727|NCT03796208|449486582|FG001|Overall Study|Withdrawal by Subject|0|||
124961728|NCT03796208|449486581|FG000|Overall Study|Loss of pregnancy|1|||
124961729|NCT03796208|449486582|FG001|Overall Study|Loss of pregnancy|1|||
124961730|NCT03796208|449486581|FG000|Overall Study|Changed prenatal clinics|0|||
124961731|NCT03796208|449486582|FG001|Overall Study|Changed prenatal clinics|5|||
124961732|NCT03796208|449486581|FG000|Overall Study|Lost to Follow-up|20|||
124961733|NCT03796208|449486582|FG001|Overall Study|Lost to Follow-up|16|||
124961734|NCT01560585|449486583|FG000|Overall Study|Physician Decision|3|||
124961735|NCT02175745|449486584|FG000|Overall Study|Not Eligible|1|||
124961736|NCT04688086|449486585|FG000|Overall Study|Lost to Follow-up|164|||
124961737|NCT04688086|449486585|FG000|Overall Study|Imaging error;|64|||
124961738|NCT04206384|449486586|FG000|Overall Study|Withdrawal by Subject|8|||
124961739|NCT04206384|449486586|FG000|Overall Study|Adverse Event|2|||
124961740|NCT00006436|449486587|FG000|Overall Study|Refused further treatment|2|||
124961741|NCT00006436|449486587|FG000|Overall Study|Declined to participate (before treatment started)|1|||
124961742|NCT00942188|449486590|FG000|Overall Study|Adverse Event|0|||
124961743|NCT00942188|449486591|FG001|Overall Study|Adverse Event|3|||
124961744|NCT00942188|449486592|FG002|Overall Study|Adverse Event|2|||
124961745|NCT00942188|449486593|FG003|Overall Study|Adverse Event|0|||
124961746|NCT00942188|449486590|FG000|Overall Study|Lack of Efficacy|0|||
124961747|NCT00942188|449486591|FG001|Overall Study|Lack of Efficacy|0|||
124961748|NCT00942188|449486592|FG002|Overall Study|Lack of Efficacy|0|||
124961749|NCT00942188|449486593|FG003|Overall Study|Lack of Efficacy|1|||
124961750|NCT00942188|449486590|FG000|Overall Study|Protocol Violation|1|||
124961751|NCT00942188|449486591|FG001|Overall Study|Protocol Violation|1|||
124961752|NCT00942188|449486592|FG002|Overall Study|Protocol Violation|0|||
124961753|NCT00942188|449486593|FG003|Overall Study|Protocol Violation|0|||
124961754|NCT00942188|449486590|FG000|Overall Study|Lost to Follow-up|2|||
124961755|NCT00942188|449486591|FG001|Overall Study|Lost to Follow-up|1|||
124961756|NCT00942188|449486592|FG002|Overall Study|Lost to Follow-up|2|||
124961757|NCT00942188|449486593|FG003|Overall Study|Lost to Follow-up|0|||
124961758|NCT00942188|449486590|FG000|Overall Study|Withdrawal by Subject|1|||
124961759|NCT00942188|449486591|FG001|Overall Study|Withdrawal by Subject|3|||
124961760|NCT00942188|449486592|FG002|Overall Study|Withdrawal by Subject|4|||
124961761|NCT00942188|449486593|FG003|Overall Study|Withdrawal by Subject|2|||
124961762|NCT00942188|449486590|FG000|Overall Study|Physician Decision|0|||
124961763|NCT00942188|449486591|FG001|Overall Study|Physician Decision|0|||
124961764|NCT00942188|449486592|FG002|Overall Study|Physician Decision|1|||
124961765|NCT00942188|449486593|FG003|Overall Study|Physician Decision|0|||
124961766|NCT00942188|449486590|FG000|Overall Study|Sponsor Decision|0|||
124961767|NCT00942188|449486591|FG001|Overall Study|Sponsor Decision|2|||
124961768|NCT00942188|449486592|FG002|Overall Study|Sponsor Decision|0|||
124961769|NCT00942188|449486593|FG003|Overall Study|Sponsor Decision|1|||
124961770|NCT00276016|449486594|FG000|Intervention 1|Withdrawal by Subject|0|||
124961771|NCT00276016|449486595|FG001|Intervention 1|Withdrawal by Subject|1|||
124961772|NCT00276016|449486596|FG002|Intervention 1|Withdrawal by Subject|0|||
124961773|NCT00276016|449486597|FG003|Intervention 1|Withdrawal by Subject|0|||
124961774|NCT00276016|449486598|FG004|Intervention 1|Withdrawal by Subject|0|||
124961775|NCT00276016|449486599|FG005|Intervention 1|Withdrawal by Subject|0|||
124961776|NCT05041439|449486600|FG000|Overall Study|Withdrawal by Subject|1|||
124961777|NCT05041439|449486601|FG001|Overall Study|Withdrawal by Subject|1|||
124961778|NCT05041439|449486600|FG000|Overall Study|Death|1|||
124961779|NCT05041439|449486601|FG001|Overall Study|Death|0|||
124961780|NCT00113269|449488080|FG000|Overall Study|Not transplanted, donor issues|4|||
124961781|NCT00113269|449488081|FG001|Overall Study|Not transplanted, donor issues|0|||
124961782|NCT00113269|449488082|FG002|Overall Study|Not transplanted, donor issues|2|||
124961783|NCT00113269|449488083|FG003|Overall Study|Not transplanted, donor issues|2|||
124961784|NCT00113269|449488080|FG000|Overall Study|Not transplanted, recipient issues|2|||
124961785|NCT00113269|449488081|FG001|Overall Study|Not transplanted, recipient issues|1|||
124961786|NCT00113269|449488082|FG002|Overall Study|Not transplanted, recipient issues|7|||
124961787|NCT00113269|449488083|FG003|Overall Study|Not transplanted, recipient issues|4|||
124961788|NCT00113269|449488080|FG000|Overall Study|Early graft loss, technical|0|||
124961789|NCT00113269|449488081|FG001|Overall Study|Early graft loss, technical|0|||
124961790|NCT00113269|449488082|FG002|Overall Study|Early graft loss, technical|2|||
124961791|NCT00113269|449488083|FG003|Overall Study|Early graft loss, technical|0|||
124961792|NCT00113269|449488080|FG000|Overall Study|Death in operating room|0|||
124961793|NCT00113269|449488081|FG001|Overall Study|Death in operating room|0|||
124961794|NCT00113269|449488082|FG002|Overall Study|Death in operating room|0|||
124961795|NCT00113269|449488083|FG003|Overall Study|Death in operating room|1|||
124463917|NCT01110200|447656643|FG000|Overall Study|Protocol Violation|14|||
124463918|NCT01110200|447656644|FG001|Overall Study|Protocol Violation|12|||
124463919|NCT01110200|447656643|FG000|Overall Study|Physician Decision|13|||
124463920|NCT01110200|447656644|FG001|Overall Study|Physician Decision|17|||
124463921|NCT01110200|447656643|FG000|Overall Study|Lost to Follow-up|10|||
124463922|NCT01110200|447656644|FG001|Overall Study|Lost to Follow-up|7|||
124463923|NCT04518462|447656646|FG000|Overall Study|Withdrawal by Subject|0|||
124463924|NCT04518462|447656647|FG001|Overall Study|Withdrawal by Subject|0|||
124463925|NCT04518462|447656648|FG002|Overall Study|Withdrawal by Subject|1|||
124961796|NCT00113269|449488080|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
124961797|NCT00113269|449488081|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
124961798|NCT00113269|449488082|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
124961799|NCT00113269|449488083|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
124961800|NCT00113269|449488080|FG000|Overall Study|Adverse Event|2|||
124961801|NCT00113269|449488081|FG001|Overall Study|Adverse Event|7|||
124961802|NCT00113269|449488082|FG002|Overall Study|Adverse Event|11|||
124961803|NCT00113269|449488083|FG003|Overall Study|Adverse Event|7|||
124961804|NCT00113269|449488080|FG000|Overall Study|Withdrawal by Subject|4|||
124961805|NCT00113269|449488081|FG001|Overall Study|Withdrawal by Subject|3|||
124961806|NCT00113269|449488082|FG002|Overall Study|Withdrawal by Subject|4|||
124961807|NCT00113269|449488083|FG003|Overall Study|Withdrawal by Subject|2|||
124961808|NCT00113269|449488080|FG000|Overall Study|Graft loss|6|||
124961809|NCT00113269|449488081|FG001|Overall Study|Graft loss|6|||
124961810|NCT00113269|449488082|FG002|Overall Study|Graft loss|4|||
124961811|NCT00113269|449488083|FG003|Overall Study|Graft loss|9|||
124961812|NCT00113269|449488080|FG000|Overall Study|Protocol Violation|1|||
124961813|NCT00113269|449488081|FG001|Overall Study|Protocol Violation|0|||
124961814|NCT00113269|449488082|FG002|Overall Study|Protocol Violation|4|||
124961815|NCT00113269|449488083|FG003|Overall Study|Protocol Violation|2|||
124961816|NCT00113269|449488080|FG000|Overall Study|Lost to Follow-up|2|||
124961817|NCT00113269|449488081|FG001|Overall Study|Lost to Follow-up|3|||
124961818|NCT00113269|449488082|FG002|Overall Study|Lost to Follow-up|6|||
124961819|NCT00113269|449488083|FG003|Overall Study|Lost to Follow-up|3|||
124961820|NCT00113269|449488080|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
124961821|NCT00113269|449488081|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
124961822|NCT00113269|449488082|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
124961823|NCT00113269|449488083|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
124961824|NCT00113269|449488080|FG000|Overall Study|Discontinued due to rejection|0|||
124961825|NCT00113269|449488081|FG001|Overall Study|Discontinued due to rejection|0|||
124961826|NCT00113269|449488082|FG002|Overall Study|Discontinued due to rejection|1|||
124961827|NCT00113269|449488083|FG003|Overall Study|Discontinued due to rejection|0|||
124961828|NCT00113269|449488080|FG000|Overall Study|Moved|0|||
124961829|NCT00113269|449488081|FG001|Overall Study|Moved|1|||
124961830|NCT00113269|449488082|FG002|Overall Study|Moved|0|||
124961831|NCT00113269|449488083|FG003|Overall Study|Moved|3|||
124961832|NCT00113269|449488080|FG000|Overall Study|Received pancreas transplant|0|||
124961833|NCT00113269|449488081|FG001|Overall Study|Received pancreas transplant|0|||
124961834|NCT00113269|449488082|FG002|Overall Study|Received pancreas transplant|0|||
124961835|NCT00113269|449488083|FG003|Overall Study|Received pancreas transplant|2|||
124961836|NCT00113269|449488080|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
124961837|NCT00113269|449488081|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
124961838|NCT00113269|449488082|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
124961839|NCT00113269|449488083|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
124961840|NCT00113269|449488080|FG000|Overall Study|Did not meet eligibility criteria|1|||
124961841|NCT00113269|449488081|FG001|Overall Study|Did not meet eligibility criteria|0|||
124961842|NCT00113269|449488082|FG002|Overall Study|Did not meet eligibility criteria|0|||
124961843|NCT00113269|449488083|FG003|Overall Study|Did not meet eligibility criteria|1|||
124961844|NCT00113269|449488080|FG000|Overall Study|Unable to return for follow up|2|||
124961845|NCT00113269|449488081|FG001|Overall Study|Unable to return for follow up|1|||
124961846|NCT00113269|449488082|FG002|Overall Study|Unable to return for follow up|0|||
124463926|NCT04518462|447656646|FG000|Overall Study|Physician Decision|1|||
124463927|NCT04518462|447656647|FG001|Overall Study|Physician Decision|1|||
124961847|NCT00113269|449488083|FG003|Overall Study|Unable to return for follow up|0|||
124961848|NCT03119688|449488089|FG000|Overall Study|Adverse Event|4|||
124961849|NCT03226106|449488090|FG000|Overall Study|Withdrawal by Subject|2|||
124961850|NCT03226106|449488091|FG001|Overall Study|Withdrawal by Subject|0|||
124961851|NCT03226106|449488090|FG000|Overall Study|Adverse Event|1|||
124961852|NCT03226106|449488091|FG001|Overall Study|Adverse Event|0|||
124961853|NCT03226106|449488090|FG000|Overall Study|Lost to Follow-up|2|||
124961854|NCT03226106|449488091|FG001|Overall Study|Lost to Follow-up|0|||
124961855|NCT00721214|449488092|FG000|Overall Study|Chose another center for transplant|1|||
124961856|NCT00721214|449488092|FG000|Overall Study|Death|3|||
124961857|NCT00488319|449488095|FG000|Overall Study|Adverse Event|1|||
124463928|NCT04518462|447656648|FG002|Overall Study|Physician Decision|0|||
124463929|NCT04418076|447656652|FG000|Overall Study|Death|1|||
124463930|NCT04418076|447656653|FG001|Overall Study|Death|0|||
124709035|NCT03235050|448561321|FG000|Overall Study|Adverse Event|0|||
124961858|NCT00488319|449488096|FG001|Overall Study|Adverse Event|2|||
124961859|NCT00488319|449488097|FG002|Overall Study|Adverse Event|23|||
124961860|NCT00488319|449488095|FG000|Overall Study|Lack of Efficacy|6|||
124961861|NCT00488319|449488096|FG001|Overall Study|Lack of Efficacy|12|||
124961862|NCT00488319|449488097|FG002|Overall Study|Lack of Efficacy|27|||
124961863|NCT00488319|449488095|FG000|Overall Study|Lost to Follow-up|3|||
124961864|NCT00488319|449488096|FG001|Overall Study|Lost to Follow-up|5|||
124961865|NCT00488319|449488097|FG002|Overall Study|Lost to Follow-up|16|||
124961866|NCT00488319|449488095|FG000|Overall Study|Withdrawal by Subject|5|||
124961867|NCT00488319|449488096|FG001|Overall Study|Withdrawal by Subject|20|||
124961868|NCT00488319|449488097|FG002|Overall Study|Withdrawal by Subject|44|||
124961869|NCT00488319|449488095|FG000|Overall Study|Other reasons for withdrawal|0|||
124961870|NCT00488319|449488096|FG001|Overall Study|Other reasons for withdrawal|4|||
124961871|NCT00488319|449488097|FG002|Overall Study|Other reasons for withdrawal|12|||
124961872|NCT02158247|449488098|FG000|Overall Study|Invisible vocal cords|5|||
124961873|NCT00875615|449488105|FG000|Overall Study|Withdrawal by Subject|1|||
124961874|NCT01772823|449488106|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
124961875|NCT01772823|449488107|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
124961876|NCT01772823|449488106|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
124961877|NCT01772823|449488107|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
124961878|NCT01772823|449488106|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
124961879|NCT01772823|449488107|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
124961880|NCT01772823|449488106|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
124961881|NCT01772823|449488107|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
124961882|NCT01772823|449488106|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
124961883|NCT01772823|449488107|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
124961884|NCT01772823|449488106|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
124961885|NCT01772823|449488107|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
124961886|NCT01772823|449488106|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
124961887|NCT01772823|449488107|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
124961888|NCT01772823|449488106|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
124961889|NCT01772823|449488107|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
124961890|NCT01772823|449488106|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
124961891|NCT01772823|449488107|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
124961892|NCT01772823|449488106|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
124961893|NCT01772823|449488107|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
124961894|NCT01772823|449488106|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
124961895|NCT01772823|449488107|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
124961896|NCT01772823|449488106|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
124961897|NCT01772823|449488107|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
124961898|NCT01772823|449488106|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
124961899|NCT01772823|449488107|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
124961900|NCT01772823|449488106|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
124961901|NCT01772823|449488107|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
124961902|NCT01772823|449488106|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
124961903|NCT01772823|449488107|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
124961904|NCT01772823|449488106|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
124709036|NCT03235050|448561322|FG001|Overall Study|Adverse Event|0|||
124961905|NCT01772823|449488107|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
124961906|NCT01732926|449488109|FG000|Overall Study|Study Terminated by Sponsor|168|||
124961907|NCT01732926|449488110|FG001|Overall Study|Study Terminated by Sponsor|80|||
124961908|NCT01732926|449488109|FG000|Overall Study|Withdrawal by Subject|46|||
124961909|NCT01732926|449488110|FG001|Overall Study|Withdrawal by Subject|8|||
124961910|NCT01732926|449488109|FG000|Overall Study|Physician Decision|24|||
124961911|NCT01732926|449488110|FG001|Overall Study|Physician Decision|11|||
124961912|NCT01732926|449488109|FG000|Overall Study|Other Reason|21|||
124961913|NCT01732926|449488110|FG001|Overall Study|Other Reason|4|||
124961914|NCT01732926|449488109|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
124961915|NCT01732926|449488110|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
124961916|NCT01732926|449488109|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
124961917|NCT01732926|449488110|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
124961918|NCT02262364|449488114|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
124961919|NCT01049984|449488116|FG000|Overall Study|Withdrawal by Subject|1|||
124961920|NCT01049984|449488117|FG001|Overall Study|Withdrawal by Subject|5|||
124961921|NCT01049984|449488116|FG000|Overall Study|Protocol Violation|3|||
124961922|NCT01049984|449488117|FG001|Overall Study|Protocol Violation|4|||
124961923|NCT01049984|449488116|FG000|Overall Study|Lost to Follow-up|2|||
124961924|NCT01049984|449488117|FG001|Overall Study|Lost to Follow-up|1|||
124961925|NCT01049984|449488116|FG000|Overall Study|Adverse Event|13|||
124961926|NCT01049984|449488117|FG001|Overall Study|Adverse Event|7|||
124961927|NCT01049984|449488116|FG000|Overall Study|Treatment failure|0|||
124961928|NCT01049984|449488117|FG001|Overall Study|Treatment failure|2|||
124961929|NCT03503162|449488123|FG000|Overall Study|did not meet eligibility|1|||
124961930|NCT03891641|449488126|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
124961931|NCT03891641|449488127|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
124961932|NCT00920699|449488129|FG000|Overall Study|Withdrawal by Subject|2|||
124961933|NCT00920699|449488130|FG001|Overall Study|Withdrawal by Subject|0|||
124961934|NCT00920699|449488131|FG002|Overall Study|Withdrawal by Subject|2|||
124961935|NCT00920699|449488129|FG000|Overall Study|no longer met eligibility|0|||
124961936|NCT00920699|449488130|FG001|Overall Study|no longer met eligibility|1|||
124961937|NCT00920699|449488131|FG002|Overall Study|no longer met eligibility|0|||
124961938|NCT00920699|449488129|FG000|Overall Study|Lost to Follow-up|0|||
124961939|NCT00920699|449488130|FG001|Overall Study|Lost to Follow-up|0|||
124961940|NCT00920699|449488131|FG002|Overall Study|Lost to Follow-up|2|||
124961941|NCT03723915|449488135|FG000|Screening|Failed to meet screening requirements.|2|||
124961942|NCT03723915|449488135|FG000|On Treatment|Failed to meet treatment requirements|2|||
124961943|NCT01978236|449488138|FG000|Overall Study|Discontinued due to study close|2|||
124961944|NCT00634920|449488140|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
124961945|NCT00634920|449488141|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
124961946|NCT00634920|449488142|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
124961947|NCT00634920|449488140|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
124961948|NCT00634920|449488141|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
124961949|NCT00634920|449488142|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
124961950|NCT00634920|449488140|FG000|Period 1 - Pre-Randomization|Rejections|0|||
124961951|NCT00634920|449488141|FG001|Period 1 - Pre-Randomization|Rejections|0|||
124961952|NCT00634920|449488142|FG002|Period 1 - Pre-Randomization|Rejections|55|||
124961953|NCT00634920|449488140|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
124961954|NCT00634920|449488141|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
124961955|NCT00634920|449488142|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
124961956|NCT00634920|449488140|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
124961957|NCT00634920|449488141|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
124961958|NCT00634920|449488142|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
124961959|NCT00634920|449488140|FG000|Period 1 - Pre-Randomization|Other issues|0|||
124961960|NCT00634920|449488141|FG001|Period 1 - Pre-Randomization|Other issues|0|||
124961961|NCT00634920|449488142|FG002|Period 1 - Pre-Randomization|Other issues|6|||
124961962|NCT00634920|449488140|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
124709037|NCT03235050|448561323|FG002|Overall Study|Adverse Event|1|||
124709038|NCT03235050|448561324|FG003|Overall Study|Adverse Event|4|||
124709039|NCT03235050|448561325|FG004|Overall Study|Adverse Event|1|||
124961963|NCT00634920|449488141|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
124961964|NCT00634920|449488142|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
124961965|NCT00634920|449488140|FG000|Period 2 - Post-Randomization|Rejection|11|||
124961966|NCT00634920|449488141|FG001|Period 2 - Post-Randomization|Rejection|5|||
124961967|NCT00634920|449488142|FG002|Period 2 - Post-Randomization|Rejection|0|||
124961968|NCT00634920|449488140|FG000|Period 2 - Post-Randomization|Death|2|||
124961969|NCT00634920|449488141|FG001|Period 2 - Post-Randomization|Death|5|||
124961970|NCT00634920|449488142|FG002|Period 2 - Post-Randomization|Death|0|||
124961971|NCT00634920|449488140|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
124961972|NCT00634920|449488141|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
124709040|NCT03235050|448561321|FG000|Overall Study|Death|0|||
124709041|NCT03235050|448561322|FG001|Overall Study|Death|0|||
124463931|NCT04418076|447656654|FG002|Overall Study|Death|0|||
124463932|NCT04418076|447656655|FG003|Overall Study|Death|0|||
124463933|NCT04418076|447656652|FG000|Overall Study|Lost to Follow-up|2|||
124961973|NCT00634920|449488142|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
124961974|NCT00634920|449488140|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
124961975|NCT00634920|449488141|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
124961976|NCT00634920|449488142|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
124961977|NCT00819013|449488143|FG000|Overall Study|Not meeting continuing study eligibility|2|||
124961978|NCT00819013|449488144|FG001|Overall Study|Not meeting continuing study eligibility|1|||
124961979|NCT00819013|449488145|FG002|Overall Study|Not meeting continuing study eligibility|2|||
124961980|NCT00819013|449488146|FG003|Overall Study|Not meeting continuing study eligibility|1|||
124961981|NCT00819013|449488143|FG000|Overall Study|Adverse Event|0|||
124961982|NCT00819013|449488144|FG001|Overall Study|Adverse Event|0|||
124961983|NCT00819013|449488145|FG002|Overall Study|Adverse Event|1|||
124961984|NCT00819013|449488146|FG003|Overall Study|Adverse Event|0|||
124961985|NCT00819013|449488143|FG000|Overall Study|Withdrawal by Subject|1|||
124961986|NCT00819013|449488144|FG001|Overall Study|Withdrawal by Subject|0|||
124961987|NCT00819013|449488145|FG002|Overall Study|Withdrawal by Subject|1|||
124961988|NCT00819013|449488146|FG003|Overall Study|Withdrawal by Subject|0|||
124961989|NCT00819013|449488143|FG000|Overall Study|Lost to Follow-up|0|||
124961990|NCT00819013|449488144|FG001|Overall Study|Lost to Follow-up|0|||
124961991|NCT00819013|449488145|FG002|Overall Study|Lost to Follow-up|1|||
124961992|NCT00819013|449488146|FG003|Overall Study|Lost to Follow-up|2|||
124961993|NCT00819013|449488143|FG000|Overall Study|Death|0|||
124961994|NCT00819013|449488144|FG001|Overall Study|Death|0|||
124961995|NCT00819013|449488145|FG002|Overall Study|Death|0|||
124961996|NCT00819013|449488146|FG003|Overall Study|Death|1|||
124961997|NCT00363649|449488147|FG000|Overall Study|Withdrawal by Subject|1|||
124961998|NCT00363649|449488148|FG001|Overall Study|Withdrawal by Subject|1|||
124961999|NCT00363649|449488147|FG000|Overall Study|Adverse Event|6|||
124962000|NCT00363649|449488148|FG001|Overall Study|Adverse Event|0|||
124962001|NCT00607997|449488151|FG000|Overall Study|Lack of Efficacy|6|||
124962002|NCT00607997|449488152|FG001|Overall Study|Lack of Efficacy|20|||
124962003|NCT00607997|449488153|FG002|Overall Study|Lack of Efficacy|14|||
124962004|NCT00607997|449488154|FG003|Overall Study|Lack of Efficacy|10|||
124962005|NCT00607997|449488151|FG000|Overall Study|Death|8|||
124962006|NCT00607997|449488152|FG001|Overall Study|Death|5|||
124962007|NCT00607997|449488153|FG002|Overall Study|Death|2|||
124962008|NCT00607997|449488154|FG003|Overall Study|Death|5|||
124962009|NCT00607997|449488151|FG000|Overall Study|Adverse Event|3|||
124962010|NCT00607997|449488152|FG001|Overall Study|Adverse Event|1|||
124962011|NCT00607997|449488153|FG002|Overall Study|Adverse Event|2|||
124962012|NCT00607997|449488154|FG003|Overall Study|Adverse Event|0|||
124962013|NCT00607997|449488151|FG000|Overall Study|Physician Decision|4|||
124962014|NCT00607997|449488152|FG001|Overall Study|Physician Decision|1|||
124962015|NCT00607997|449488153|FG002|Overall Study|Physician Decision|0|||
124962016|NCT00607997|449488154|FG003|Overall Study|Physician Decision|0|||
124962017|NCT00607997|449488151|FG000|Overall Study|Relapse, recurrent illness|4|||
124962018|NCT00607997|449488152|FG001|Overall Study|Relapse, recurrent illness|0|||
124962019|NCT00607997|449488153|FG002|Overall Study|Relapse, recurrent illness|2|||
124962020|NCT00607997|449488154|FG003|Overall Study|Relapse, recurrent illness|0|||
124962021|NCT00607997|449488151|FG000|Overall Study|Other without explanation|2|||
124962022|NCT00607997|449488152|FG001|Overall Study|Other without explanation|0|||
124962023|NCT00607997|449488153|FG002|Overall Study|Other without explanation|4|||
124962024|NCT00607997|449488154|FG003|Overall Study|Other without explanation|1|||
124962025|NCT00576823|449488155|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
124962026|NCT00576823|449488156|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
124962027|NCT00576823|449488157|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
124962028|NCT00576823|449488155|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
124962029|NCT00576823|449488156|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
124962030|NCT00576823|449488157|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
124962031|NCT00510146|449488163|FG000|Double-Blind Treatment|Adverse Event|30|||
124962032|NCT00510146|449488164|FG001|Double-Blind Treatment|Adverse Event|13|||
124962033|NCT00510146|449488163|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
124962034|NCT00510146|449488164|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
124962035|NCT00510146|449488163|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
124962036|NCT00510146|449488164|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
124962037|NCT00510146|449488163|FG000|Double-Blind Treatment|Physician Decision|6|||
124962038|NCT00510146|449488164|FG001|Double-Blind Treatment|Physician Decision|0|||
124962039|NCT00510146|449488163|FG000|Double-Blind Treatment|Protocol Violation|1|||
124709042|NCT03235050|448561323|FG002|Overall Study|Death|0|||
124962040|NCT00510146|449488164|FG001|Double-Blind Treatment|Protocol Violation|2|||
124962041|NCT00510146|449488163|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
124962042|NCT00510146|449488164|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
124962043|NCT00510146|449488163|FG000|Double-Blind Treatment|Clinical Relapse|0|||
124463934|NCT04418076|447656653|FG001|Overall Study|Lost to Follow-up|5|||
124709043|NCT03235050|448561324|FG003|Overall Study|Death|2|||
124962044|NCT00510146|449488164|FG001|Double-Blind Treatment|Clinical Relapse|1|||
124962045|NCT00510146|449488163|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
124962046|NCT00510146|449488164|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
124962047|NCT00510146|449488163|FG000|Open-Label Treatment|Adverse Event|22|||
124962048|NCT00510146|449488164|FG001|Open-Label Treatment|Adverse Event|8|||
124962049|NCT00510146|449488163|FG000|Open-Label Treatment|Death|1|||
124962050|NCT00510146|449488164|FG001|Open-Label Treatment|Death|1|||
124962051|NCT00510146|449488163|FG000|Open-Label Treatment|Lack of Efficacy|4|||
124962052|NCT00510146|449488164|FG001|Open-Label Treatment|Lack of Efficacy|0|||
124962053|NCT00510146|449488163|FG000|Open-Label Treatment|Lost to Follow-up|10|||
124962054|NCT00510146|449488164|FG001|Open-Label Treatment|Lost to Follow-up|1|||
124962055|NCT00510146|449488163|FG000|Open-Label Treatment|Physician Decision|3|||
124962056|NCT00510146|449488164|FG001|Open-Label Treatment|Physician Decision|1|||
124962057|NCT00510146|449488163|FG000|Open-Label Treatment|Protocol Violation|4|||
124962058|NCT00510146|449488164|FG001|Open-Label Treatment|Protocol Violation|2|||
124962059|NCT00510146|449488163|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
124962060|NCT00510146|449488164|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
124962061|NCT00510146|449488163|FG000|Open-Label Treatment|Clinical Relapse|1|||
124962062|NCT00510146|449488164|FG001|Open-Label Treatment|Clinical Relapse|1|||
124962063|NCT00510146|449488163|FG000|Open-Label Treatment|Sponsor Decision|2|||
124962064|NCT00510146|449488164|FG001|Open-Label Treatment|Sponsor Decision|0|||
124962065|NCT01930214|449488166|FG000|Overall Study|Death|4|||
124962066|NCT01930214|449488167|FG001|Overall Study|Death|4|||
124962067|NCT01930214|449488168|FG002|Overall Study|Death|11|||
124962068|NCT01930214|449488166|FG000|Overall Study|Lost to Follow-up|12|||
124962069|NCT01930214|449488167|FG001|Overall Study|Lost to Follow-up|13|||
124962070|NCT01930214|449488168|FG002|Overall Study|Lost to Follow-up|12|||
124962071|NCT01930214|449488166|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
124962072|NCT01930214|449488167|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
124962073|NCT01930214|449488168|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
124962074|NCT01930214|449488166|FG000|Overall Study|Physician Decision|2|||
124962075|NCT01930214|449488167|FG001|Overall Study|Physician Decision|0|||
124962076|NCT01930214|449488168|FG002|Overall Study|Physician Decision|0|||
124962077|NCT02132117|449488169|FG000|Overall Study|Adverse Event|6|||
124962078|NCT02132117|449488170|FG001|Overall Study|Adverse Event|1|||
124962079|NCT02132117|449488169|FG000|Overall Study|Lost to Follow-up|2|||
124962080|NCT02132117|449488170|FG001|Overall Study|Lost to Follow-up|2|||
124962081|NCT02132117|449488169|FG000|Overall Study|Personal Reasons|1|||
124962082|NCT02132117|449488170|FG001|Overall Study|Personal Reasons|2|||
124962083|NCT02132117|449488169|FG000|Overall Study|Other Miscellaneous Reasons|2|||
124962084|NCT02132117|449488170|FG001|Overall Study|Other Miscellaneous Reasons|0|||
124962085|NCT03589300|449488171|FG000|Overall Study|Adverse Event|2|||
124962086|NCT03589300|449488171|FG000|Overall Study|Death|4|||
124962087|NCT03589300|449488171|FG000|Overall Study|Lost to Follow-up|12|||
124962088|NCT03589300|449488171|FG000|Overall Study|Withdrawal by Subject|5|||
124962089|NCT02864342|449488177|FG000|Overall Study|Eligibility Criteria Deviation|2|||
124962090|NCT02864342|449488178|FG001|Overall Study|Eligibility Criteria Deviation|3|||
124962091|NCT02864342|449488177|FG000|Overall Study|Withdrawal by Subject|4|||
124962092|NCT02864342|449488178|FG001|Overall Study|Withdrawal by Subject|2|||
124962093|NCT02864342|449488177|FG000|Overall Study|Device Technology Issue|6|||
124962094|NCT02864342|449488178|FG001|Overall Study|Device Technology Issue|7|||
124962095|NCT02864342|449488177|FG000|Overall Study|Death|0|||
124962096|NCT02864342|449488178|FG001|Overall Study|Death|1|||
124962097|NCT02864342|449488177|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
124962098|NCT02864342|449488178|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
124962099|NCT02864342|449488177|FG000|Overall Study|Lost to Follow-up|1|||
124962100|NCT02864342|449488178|FG001|Overall Study|Lost to Follow-up|5|||
124463935|NCT04418076|447656654|FG002|Overall Study|Lost to Follow-up|1|||
124463936|NCT04418076|447656655|FG003|Overall Study|Lost to Follow-up|2|||
124463937|NCT04418076|447656652|FG000|Overall Study|Withdrawal by Subject|1|||
124463938|NCT04418076|447656653|FG001|Overall Study|Withdrawal by Subject|0|||
124463939|NCT04418076|447656654|FG002|Overall Study|Withdrawal by Subject|1|||
124463940|NCT04418076|447656655|FG003|Overall Study|Withdrawal by Subject|1|||
124463941|NCT04418076|447656652|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
124962101|NCT02864342|449488177|FG000|Overall Study|Lost Device|1|||
124962102|NCT02864342|449488178|FG001|Overall Study|Lost Device|0|||
124962103|NCT02864342|449488177|FG000|Overall Study|Adverse Event|1|||
124962104|NCT02864342|449488178|FG001|Overall Study|Adverse Event|0|||
124962105|NCT02725008|449488183|FG000|Overall Study|Lost to Follow-up|7|||
124962106|NCT02725008|449488184|FG001|Overall Study|Lost to Follow-up|9|||
124962107|NCT02725008|449488183|FG000|Overall Study|Withdrawal by Subject|2|||
124962108|NCT02725008|449488184|FG001|Overall Study|Withdrawal by Subject|2|||
124962109|NCT02725008|449488183|FG000|Overall Study|Admitted to hospital|0|||
124962110|NCT02725008|449488184|FG001|Overall Study|Admitted to hospital|1|||
124962111|NCT00853021|449488191|FG000|Overall Study|Adverse Event|2|||
124962112|NCT00853021|449488191|FG000|Overall Study|Withdrawal by Subject|2|||
124463942|NCT04418076|447656653|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
124463943|NCT04418076|447656654|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
124463944|NCT04418076|447656655|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
124962113|NCT00853021|449488191|FG000|Overall Study|Death|1|||
124962114|NCT01329419|449488192|FG000|Overall Study|Protocol Violation|235|||
124962115|NCT02212197|449488198|FG000|Overall Study|Need for radiotherapy|1|||
124962116|NCT02212197|449488199|FG001|Overall Study|Need for radiotherapy|0|||
124962117|NCT02212197|449488200|FG002|Overall Study|Need for radiotherapy|0|||
124962118|NCT02551692|449488202|FG000|Overall Study|Lost to Follow-up|0|||
124962119|NCT02551692|449488203|FG001|Overall Study|Lost to Follow-up|1|||
124962120|NCT02551692|449488204|FG002|Overall Study|Lost to Follow-up|4|||
124962121|NCT02551692|449488202|FG000|Overall Study|Withdrawal by Subject|1|||
124962122|NCT02551692|449488203|FG001|Overall Study|Withdrawal by Subject|0|||
124962123|NCT02551692|449488204|FG002|Overall Study|Withdrawal by Subject|1|||
124962124|NCT01091519|449488205|FG000|Overall Study|Adverse Event|12|||
124962125|NCT01091519|449488206|FG001|Overall Study|Adverse Event|16|||
124962126|NCT01091519|449488205|FG000|Overall Study|Death|1|||
124962127|NCT01091519|449488206|FG001|Overall Study|Death|0|||
124962128|NCT01091519|449488205|FG000|Overall Study|Lack of Efficacy|16|||
124962129|NCT01091519|449488206|FG001|Overall Study|Lack of Efficacy|19|||
124962130|NCT01091519|449488205|FG000|Overall Study|Lost to Follow-up|14|||
124962131|NCT01091519|449488206|FG001|Overall Study|Lost to Follow-up|24|||
124962132|NCT01091519|449488205|FG000|Overall Study|Withdrawal by Subject|2|||
124962133|NCT01091519|449488206|FG001|Overall Study|Withdrawal by Subject|2|||
124962134|NCT01091519|449488205|FG000|Overall Study|Other|6|||
124962135|NCT01091519|449488206|FG001|Overall Study|Other|8|||
124962136|NCT01091519|449488205|FG000|Overall Study|Randomized not treated|4|||
124962137|NCT01091519|449488206|FG001|Overall Study|Randomized not treated|4|||
124962138|NCT01177228|449488209|FG000|Overall Study|Positive tuberculosis test|0|||
124962139|NCT01177228|449488210|FG001|Overall Study|Positive tuberculosis test|1|||
124962140|NCT01177228|449488211|FG002|Overall Study|Positive tuberculosis test|0|||
124962141|NCT01177228|449488212|FG003|Overall Study|Positive tuberculosis test|0|||
124962142|NCT01177228|449488209|FG000|Overall Study|Worsening disease activity|1|||
124962143|NCT01177228|449488210|FG001|Overall Study|Worsening disease activity|0|||
124962144|NCT01177228|449488211|FG002|Overall Study|Worsening disease activity|0|||
124962145|NCT01177228|449488212|FG003|Overall Study|Worsening disease activity|0|||
124962146|NCT01177228|449488209|FG000|Overall Study|Withdrawal by Subject|0|||
124962147|NCT01177228|449488210|FG001|Overall Study|Withdrawal by Subject|1|||
124962148|NCT01177228|449488211|FG002|Overall Study|Withdrawal by Subject|0|||
124962149|NCT01177228|449488212|FG003|Overall Study|Withdrawal by Subject|0|||
124962150|NCT01592383|449488213|FG000|Overall Study|Adverse Event|1|||
124962151|NCT04159805|449488214|FG000|Overall Study|Withdrawal by Subject|0|||
124962152|NCT04159805|449488215|FG001|Overall Study|Withdrawal by Subject|2|||
124962153|NCT04159805|449488216|FG002|Overall Study|Withdrawal by Subject|2|||
124962154|NCT04167085|449488217|FG000|Baseline|Withdrawal by Subject|2|||
124962155|NCT04167085|449488218|FG001|Baseline|Withdrawal by Subject|1|||
124962156|NCT04167085|449488217|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
124962157|NCT04167085|449488218|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
124962158|NCT01171183|449490206|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
124962159|NCT01171183|449490207|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
124962160|NCT01171183|449490206|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
124962161|NCT01171183|449490207|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
124962162|NCT01171183|449490206|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
124962163|NCT01171183|449490207|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
124962164|NCT01171183|449490206|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
124962165|NCT01171183|449490207|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
124962166|NCT01171183|449490206|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
124962167|NCT01171183|449490207|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
124709044|NCT03235050|448561325|FG004|Overall Study|Death|1|||
124962168|NCT01171183|449490206|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
124962169|NCT01171183|449490207|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
124962170|NCT01904136|449490211|FG000|Overall Study|Physician Decision|0|||
124962171|NCT01904136|449490212|FG001|Overall Study|Physician Decision|0|||
124962172|NCT01904136|449490213|FG002|Overall Study|Physician Decision|0|||
124709045|NCT03235050|448561321|FG000|Overall Study|Lost to Follow-up|1|||
124962173|NCT01904136|449490214|FG003|Overall Study|Physician Decision|0|||
124962174|NCT01904136|449490215|FG004|Overall Study|Physician Decision|0|||
124962175|NCT01904136|449490216|FG005|Overall Study|Physician Decision|1|||
124962176|NCT01904136|449490217|FG006|Overall Study|Physician Decision|0|||
124962177|NCT01904136|449490218|FG007|Overall Study|Physician Decision|0|||
124962178|NCT01904136|449490219|FG008|Overall Study|Physician Decision|0|||
124962179|NCT00853372|449490220|FG000|Overall Study|Death|30|||
124962180|NCT00853372|449490221|FG001|Overall Study|Death|26|||
124962181|NCT00853372|449490220|FG000|Overall Study|Lost to Follow-up|1|||
124962182|NCT00853372|449490221|FG001|Overall Study|Lost to Follow-up|2|||
124463945|NCT00805480|447656656|FG000|Overall Study|Withdrawal by Subject|13|||
124962183|NCT00853372|449490220|FG000|Overall Study|Full Consent Withdrawn|1|||
124962184|NCT00853372|449490221|FG001|Overall Study|Full Consent Withdrawn|1|||
124962185|NCT01821729|449490222|FG000|Overall Study|Withdrawal by Subject|1|||
124962186|NCT02517528|449490223|FG000|Overall Study|Withdrawal by Subject|1|||
124962187|NCT03713281|449490226|FG000|Overall Study|Lens handling difficuluties|2|||
124962188|NCT03713281|449490226|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
124962189|NCT00320398|449490227|FG000|Overall Study|Adverse Event|1|||
124962190|NCT00320398|449490228|FG001|Overall Study|Adverse Event|4|||
124962191|NCT00320398|449490227|FG000|Overall Study|Other|1|||
124962192|NCT00320398|449490228|FG001|Overall Study|Other|0|||
124962193|NCT02815735|449490231|FG000|First Intervention (4 Weeks)|Discomfort|1|||
124962194|NCT02815735|449490232|FG001|First Intervention (4 Weeks)|Discomfort|0|||
124962195|NCT02815735|449490231|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
124962196|NCT02815735|449490232|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
124962197|NCT02815735|449490231|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
124962198|NCT02815735|449490232|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
124962199|NCT02815735|449490231|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
124962200|NCT02815735|449490232|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
124962201|NCT01746108|449490235|FG000|Overall Study|Migrated /moved from study area|0|||
124962202|NCT01746108|449490236|FG001|Overall Study|Migrated /moved from study area|1|||
124962203|NCT01746108|449490237|FG002|Overall Study|Migrated /moved from study area|0|||
124962204|NCT01746108|449490235|FG000|Overall Study|Adverse event, non-fatal|0|||
124962205|NCT01746108|449490236|FG001|Overall Study|Adverse event, non-fatal|1|||
124962206|NCT01746108|449490237|FG002|Overall Study|Adverse event, non-fatal|0|||
124962207|NCT01746108|449490235|FG000|Overall Study|Withdrawal by Subject|0|||
124962208|NCT01746108|449490236|FG001|Overall Study|Withdrawal by Subject|1|||
124962209|NCT01746108|449490237|FG002|Overall Study|Withdrawal by Subject|0|||
124962210|NCT01746108|449490235|FG000|Overall Study|Lost to Follow-up|0|||
124962211|NCT01746108|449490236|FG001|Overall Study|Lost to Follow-up|1|||
124962212|NCT01746108|449490237|FG002|Overall Study|Lost to Follow-up|0|||
124962213|NCT00468858|449490239|FG000|Overall Study|Adverse Event|0|||
124962214|NCT00468858|449490240|FG001|Overall Study|Adverse Event|1|||
124962215|NCT00468858|449490241|FG002|Overall Study|Adverse Event|0|||
124962216|NCT00468858|449490239|FG000|Overall Study|Withdrawal by Subject|7|||
124962217|NCT00468858|449490240|FG001|Overall Study|Withdrawal by Subject|4|||
124962218|NCT00468858|449490241|FG002|Overall Study|Withdrawal by Subject|5|||
124962219|NCT00468858|449490239|FG000|Overall Study|Relocation|1|||
124962220|NCT00468858|449490240|FG001|Overall Study|Relocation|3|||
124962221|NCT00468858|449490241|FG002|Overall Study|Relocation|3|||
124962222|NCT00468858|449490239|FG000|Overall Study|Lost to Follow-up|1|||
124962223|NCT00468858|449490240|FG001|Overall Study|Lost to Follow-up|2|||
124962224|NCT00468858|449490241|FG002|Overall Study|Lost to Follow-up|5|||
124962225|NCT00468858|449490239|FG000|Overall Study|Other|0|||
124962226|NCT00468858|449490240|FG001|Overall Study|Other|0|||
124962227|NCT00468858|449490241|FG002|Overall Study|Other|1|||
124962228|NCT00809341|449490244|FG000|Overall Study|Physician Decision|0|||
124962229|NCT00809341|449490245|FG001|Overall Study|Physician Decision|1|||
124962230|NCT00225277|449490253|FG000|Overall Study|Adverse Event|30|||
124962231|NCT00225277|449490254|FG001|Overall Study|Adverse Event|34|||
124962232|NCT00225277|449490253|FG000|Overall Study|Lack of Efficacy|4|||
124962233|NCT00225277|449490254|FG001|Overall Study|Lack of Efficacy|1|||
124962234|NCT00225277|449490253|FG000|Overall Study|Lost to Follow-up|4|||
124962235|NCT00225277|449490254|FG001|Overall Study|Lost to Follow-up|6|||
124962236|NCT00225277|449490253|FG000|Overall Study|Physician Decision|6|||
124962237|NCT00225277|449490254|FG001|Overall Study|Physician Decision|8|||
124962238|NCT00225277|449490253|FG000|Overall Study|Protocol Violation|6|||
124962239|NCT00225277|449490254|FG001|Overall Study|Protocol Violation|3|||
124962240|NCT00225277|449490253|FG000|Overall Study|Withdrawal by Subject|40|||
124962241|NCT00225277|449490254|FG001|Overall Study|Withdrawal by Subject|34|||
124962242|NCT00225277|449490253|FG000|Overall Study|Other|7|||
124962243|NCT00225277|449490254|FG001|Overall Study|Other|9|||
124962244|NCT04582669|449490261|FG000|Overall Study|Subject missed appointment(s).|1|||
124962245|NCT04582669|449490262|FG001|Overall Study|Subject missed appointment(s).|0|||
124962246|NCT04582669|449490263|FG002|Overall Study|Subject missed appointment(s).|1|||
124962247|NCT04582669|449490264|FG003|Overall Study|Subject missed appointment(s).|2|||
124962248|NCT04582669|449490261|FG000|Overall Study|Protocol Violation|0|||
124962249|NCT04582669|449490262|FG001|Overall Study|Protocol Violation|1|||
124962250|NCT04582669|449490263|FG002|Overall Study|Protocol Violation|1|||
124962251|NCT04582669|449490264|FG003|Overall Study|Protocol Violation|0|||
124463946|NCT00805480|447656657|FG001|Overall Study|Withdrawal by Subject|5|||
124463947|NCT00805480|447656658|FG002|Overall Study|Withdrawal by Subject|11|||
124463948|NCT00805480|447656659|FG003|Overall Study|Withdrawal by Subject|5|||
124962252|NCT00591409|449490265|FG000|Overall Study|Not Treated|0|||
124962253|NCT00591409|449490266|FG001|Overall Study|Not Treated|0|||
124962254|NCT00591409|449490267|FG002|Overall Study|Not Treated|0|||
124962255|NCT00591409|449490268|FG003|Overall Study|Not Treated|0|||
124962256|NCT00591409|449490269|FG004|Overall Study|Not Treated|1|||
124463949|NCT00805480|447656656|FG000|Overall Study|Lost to Follow-up|1|||
124463950|NCT00805480|447656657|FG001|Overall Study|Lost to Follow-up|2|||
124463951|NCT00805480|447656658|FG002|Overall Study|Lost to Follow-up|0|||
124463952|NCT00805480|447656659|FG003|Overall Study|Lost to Follow-up|0|||
124463953|NCT00805480|447656656|FG000|Overall Study|Adverse Event|0|||
124463954|NCT00805480|447656657|FG001|Overall Study|Adverse Event|0|||
124463955|NCT00805480|447656658|FG002|Overall Study|Adverse Event|1|||
124549473|NCT03345485|447967054|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
124962257|NCT00591409|449490270|FG005|Overall Study|Not Treated|0|||
124962258|NCT00591409|449490271|FG006|Overall Study|Not Treated|0|||
124962259|NCT00591409|449490272|FG007|Overall Study|Not Treated|0|||
124962260|NCT00591409|449490273|FG008|Overall Study|Not Treated|0|||
124962261|NCT00591409|449490274|FG009|Overall Study|Not Treated|1|||
124962262|NCT00677092|449490275|FG000|Overall Study|Adverse Event|1|||
124962263|NCT00677092|449490275|FG000|Overall Study|Lost to Follow-up|1|||
124962264|NCT00677092|449490275|FG000|Overall Study|Withdrawal by Subject|3|||
124962265|NCT00677092|449490275|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
124962266|NCT02716298|449490276|FG000|First Intervention (1 Month)|Lens discomfort|1|||
124962267|NCT02716298|449490277|FG001|First Intervention (1 Month)|Lens discomfort|1|||
124962268|NCT00550446|449490278|FG000|Up To Week 12|Adverse Event|2|||
124962269|NCT00550446|449490279|FG001|Up To Week 12|Adverse Event|2|||
124962270|NCT00550446|449490280|FG002|Up To Week 12|Adverse Event|0|||
124962271|NCT00550446|449490281|FG003|Up To Week 12|Adverse Event|0|||
124962272|NCT00550446|449490282|FG004|Up To Week 12|Adverse Event|2|||
124962273|NCT00550446|449490283|FG005|Up To Week 12|Adverse Event|2|||
124962274|NCT00550446|449490284|FG006|Up To Week 12|Adverse Event|1|||
124962275|NCT00550446|449490285|FG007|Up To Week 12|Adverse Event|0|||
124962276|NCT00550446|449490286|FG008|Up To Week 12|Adverse Event|0|||
124962277|NCT00550446|449490287|FG009|Up To Week 12|Adverse Event|0|||
124962278|NCT00550446|449490288|FG010|Up To Week 12|Adverse Event|0|||
124962279|NCT00550446|449490278|FG000|Up To Week 12|Lack of Efficacy|3|||
124962280|NCT00550446|449490279|FG001|Up To Week 12|Lack of Efficacy|1|||
124962281|NCT00550446|449490280|FG002|Up To Week 12|Lack of Efficacy|0|||
124962282|NCT00550446|449490281|FG003|Up To Week 12|Lack of Efficacy|1|||
124962283|NCT00550446|449490282|FG004|Up To Week 12|Lack of Efficacy|0|||
124962284|NCT00550446|449490283|FG005|Up To Week 12|Lack of Efficacy|3|||
124962285|NCT00550446|449490284|FG006|Up To Week 12|Lack of Efficacy|3|||
124962286|NCT00550446|449490285|FG007|Up To Week 12|Lack of Efficacy|0|||
124962287|NCT00550446|449490286|FG008|Up To Week 12|Lack of Efficacy|0|||
124962288|NCT00550446|449490287|FG009|Up To Week 12|Lack of Efficacy|0|||
124962289|NCT00550446|449490288|FG010|Up To Week 12|Lack of Efficacy|0|||
124962290|NCT00550446|449490278|FG000|Up To Week 12|Lost to Follow-up|0|||
124962291|NCT00550446|449490279|FG001|Up To Week 12|Lost to Follow-up|1|||
124962292|NCT00550446|449490280|FG002|Up To Week 12|Lost to Follow-up|0|||
124962293|NCT00550446|449490281|FG003|Up To Week 12|Lost to Follow-up|0|||
124962294|NCT00550446|449490282|FG004|Up To Week 12|Lost to Follow-up|1|||
124962295|NCT00550446|449490283|FG005|Up To Week 12|Lost to Follow-up|1|||
124962296|NCT00550446|449490284|FG006|Up To Week 12|Lost to Follow-up|2|||
124962297|NCT00550446|449490285|FG007|Up To Week 12|Lost to Follow-up|0|||
124962298|NCT00550446|449490286|FG008|Up To Week 12|Lost to Follow-up|0|||
124962299|NCT00550446|449490287|FG009|Up To Week 12|Lost to Follow-up|0|||
124962300|NCT00550446|449490288|FG010|Up To Week 12|Lost to Follow-up|0|||
124962301|NCT00550446|449490278|FG000|Up To Week 12|Withdrawal by Subject|2|||
124962302|NCT00550446|449490279|FG001|Up To Week 12|Withdrawal by Subject|0|||
124962303|NCT00550446|449490280|FG002|Up To Week 12|Withdrawal by Subject|3|||
124962304|NCT00550446|449490281|FG003|Up To Week 12|Withdrawal by Subject|2|||
124962305|NCT00550446|449490282|FG004|Up To Week 12|Withdrawal by Subject|0|||
124463956|NCT00805480|447656659|FG003|Overall Study|Adverse Event|0|||
124463957|NCT04311502|447658021|FG000|Overall Study|Death|1|||
124463958|NCT04311502|447658022|FG001|Overall Study|Death|1|||
124549474|NCT03345485|447967055|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
124709046|NCT03235050|448561322|FG001|Overall Study|Lost to Follow-up|2|||
124962306|NCT00550446|449490283|FG005|Up To Week 12|Withdrawal by Subject|1|||
124962307|NCT00550446|449490284|FG006|Up To Week 12|Withdrawal by Subject|3|||
124962308|NCT00550446|449490285|FG007|Up To Week 12|Withdrawal by Subject|0|||
124463959|NCT04311502|447658023|FG002|Overall Study|Death|1|||
124962309|NCT00550446|449490286|FG008|Up To Week 12|Withdrawal by Subject|0|||
124962310|NCT00550446|449490287|FG009|Up To Week 12|Withdrawal by Subject|0|||
124962311|NCT00550446|449490288|FG010|Up To Week 12|Withdrawal by Subject|0|||
124962312|NCT00550446|449490278|FG000|Up To Week 12|Other|3|||
124463960|NCT04311502|447658021|FG000|Overall Study|Lost to Follow-up|2|||
124463961|NCT04311502|447658022|FG001|Overall Study|Lost to Follow-up|3|||
124463962|NCT04311502|447658023|FG002|Overall Study|Lost to Follow-up|0|||
124463963|NCT04311502|447658021|FG000|Overall Study|Participant is in prison|1|||
124962313|NCT00550446|449490279|FG001|Up To Week 12|Other|0|||
124962314|NCT00550446|449490280|FG002|Up To Week 12|Other|0|||
124962315|NCT00550446|449490281|FG003|Up To Week 12|Other|0|||
124962316|NCT00550446|449490282|FG004|Up To Week 12|Other|0|||
124463964|NCT04311502|447658022|FG001|Overall Study|Participant is in prison|0|||
124463965|NCT04311502|447658023|FG002|Overall Study|Participant is in prison|0|||
124769111|NCT00412984|448783557|FG000|Overall Study|Other Reason|80|||
124769112|NCT00412984|448783558|FG001|Overall Study|Other Reason|92|||
124769113|NCT00412984|448783557|FG000|Overall Study|Not Reported|11|||
124769114|NCT00412984|448783558|FG001|Overall Study|Not Reported|12|||
124769115|NCT04218240|448783559|FG000|Overall Study|Withdrawal by Subject|6|||
124769116|NCT04218240|448783560|FG001|Overall Study|Withdrawal by Subject|0|||
124769117|NCT04218240|448783559|FG000|Overall Study|Lack of Efficacy|24|||
124769118|NCT04218240|448783560|FG001|Overall Study|Lack of Efficacy|19|||
124769119|NCT04218240|448783559|FG000|Overall Study|Physician Decision|0|||
124769120|NCT04218240|448783560|FG001|Overall Study|Physician Decision|1|||
124769121|NCT04218240|448783559|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
124769122|NCT04218240|448783560|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
124769123|NCT04914364|448783561|FG000|Overall Study|No longer eligible for study|1|||
124769124|NCT04914364|448783561|FG000|Overall Study|Lost to Follow-up|2|||
124769125|NCT04097678|448783562|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
124769126|NCT04097678|448783563|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
124769127|NCT03694678|448783564|FG000|Overall Study|Withdrawal by Subject|2|||
124769128|NCT03694678|448783565|FG001|Overall Study|Withdrawal by Subject|0|||
124769129|NCT03694678|448783564|FG000|Overall Study|Lost to Follow-up|2|||
124769130|NCT03694678|448783565|FG001|Overall Study|Lost to Follow-up|3|||
124769131|NCT02435212|448783566|FG000|Core Phase|Adverse Event|8|||
124769132|NCT02435212|448783567|FG001|Core Phase|Adverse Event|5|||
124769133|NCT02435212|448783566|FG000|Core Phase|Withdrawal by Subject|3|||
124769134|NCT02435212|448783567|FG001|Core Phase|Withdrawal by Subject|0|||
124769135|NCT02435212|448783566|FG000|Core Phase|Withdrawal by parent/guardian|9|||
124769136|NCT02435212|448783567|FG001|Core Phase|Withdrawal by parent/guardian|4|||
124769137|NCT02435212|448783566|FG000|Core Phase|Protocol Violation|1|||
124769138|NCT02435212|448783567|FG001|Core Phase|Protocol Violation|2|||
124769139|NCT02435212|448783566|FG000|Core Phase|Physician Decision|3|||
124769140|NCT02435212|448783567|FG001|Core Phase|Physician Decision|0|||
124769141|NCT02435212|448783566|FG000|Core Phase|Lost to Follow-up|0|||
124769142|NCT02435212|448783567|FG001|Core Phase|Lost to Follow-up|1|||
124769143|NCT02435212|448783566|FG000|Core Phase|Lack of Efficacy|0|||
124769144|NCT02435212|448783567|FG001|Core Phase|Lack of Efficacy|1|||
124769145|NCT02435212|448783566|FG000|Core Phase|Recovery|1|||
124769146|NCT02435212|448783567|FG001|Core Phase|Recovery|0|||
124769147|NCT02435212|448783566|FG000|Optional Extension Phase|Adverse Event|3|||
124769148|NCT02435212|448783567|FG001|Optional Extension Phase|Adverse Event|9|||
124769149|NCT02435212|448783566|FG000|Optional Extension Phase|Physician Decision|6|||
124769150|NCT02435212|448783567|FG001|Optional Extension Phase|Physician Decision|8|||
124962317|NCT00550446|449490283|FG005|Up To Week 12|Other|1|||
124962318|NCT00550446|449490284|FG006|Up To Week 12|Other|4|||
124962319|NCT00550446|449490285|FG007|Up To Week 12|Other|0|||
124463966|NCT04311502|447658021|FG000|Overall Study|Participant moved out of country|1|||
124463967|NCT04311502|447658022|FG001|Overall Study|Participant moved out of country|0|||
124463968|NCT04311502|447658023|FG002|Overall Study|Participant moved out of country|0|||
124463969|NCT04311502|447658021|FG000|Overall Study|Withdrawal by Subject|2|||
124463970|NCT04311502|447658022|FG001|Overall Study|Withdrawal by Subject|0|||
124463971|NCT04311502|447658023|FG002|Overall Study|Withdrawal by Subject|0|||
124463972|NCT04311502|447658021|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
124463973|NCT04311502|447658022|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
124463974|NCT04311502|447658023|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
124463975|NCT03040999|447658024|FG000|Overall Study|Lost to Follow-up|2|||
124962320|NCT00550446|449490286|FG008|Up To Week 12|Other|0|||
124962321|NCT00550446|449490287|FG009|Up To Week 12|Other|0|||
124962322|NCT00550446|449490288|FG010|Up To Week 12|Other|0|||
124962323|NCT00550446|449490278|FG000|Up To Week 12|Randomized not treated|0|||
124962324|NCT00550446|449490279|FG001|Up To Week 12|Randomized not treated|1|||
124962325|NCT00550446|449490280|FG002|Up To Week 12|Randomized not treated|1|||
124962326|NCT00550446|449490281|FG003|Up To Week 12|Randomized not treated|0|||
124962327|NCT00550446|449490282|FG004|Up To Week 12|Randomized not treated|0|||
124962328|NCT00550446|449490283|FG005|Up To Week 12|Randomized not treated|0|||
124962329|NCT00550446|449490284|FG006|Up To Week 12|Randomized not treated|0|||
124962330|NCT00550446|449490285|FG007|Up To Week 12|Randomized not treated|0|||
124962331|NCT00550446|449490286|FG008|Up To Week 12|Randomized not treated|0|||
124962332|NCT00550446|449490287|FG009|Up To Week 12|Randomized not treated|0|||
124962333|NCT00550446|449490288|FG010|Up To Week 12|Randomized not treated|0|||
124962334|NCT00550446|449490278|FG000|Post Week 12|Adverse Event|2|||
124962335|NCT00550446|449490279|FG001|Post Week 12|Adverse Event|1|||
124962336|NCT00550446|449490280|FG002|Post Week 12|Adverse Event|1|||
124463976|NCT03040999|447658025|FG001|Overall Study|Lost to Follow-up|2|||
124463977|NCT03040999|447658024|FG000|Overall Study|Withdrawal by Subject|12|||
124463978|NCT03040999|447658025|FG001|Overall Study|Withdrawal by Subject|13|||
124549475|NCT03345485|447967056|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
124549476|NCT03345485|447967057|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
124549477|NCT03345485|447967058|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
124549478|NCT03345485|447967059|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
124549479|NCT02985515|447967060|FG000|Olfaction Testing|Lost to Follow-up|0|||
124549480|NCT02985515|447967061|FG001|Olfaction Testing|Lost to Follow-up|5|||
124463979|NCT03040999|447658024|FG000|Overall Study|Death|155|||
124463980|NCT03040999|447658025|FG001|Overall Study|Death|171|||
124463981|NCT03040999|447658024|FG000|Overall Study|Physician Decision|0|||
124549481|NCT02985515|447967060|FG000|Olfaction Testing|Protocol Violation|0|||
124709047|NCT03235050|448561323|FG002|Overall Study|Lost to Follow-up|1|||
124709048|NCT03235050|448561324|FG003|Overall Study|Lost to Follow-up|2|||
124709049|NCT03235050|448561325|FG004|Overall Study|Lost to Follow-up|0|||
124709050|NCT03235050|448561321|FG000|Overall Study|Withdrawal by Subject|3|||
124709051|NCT03235050|448561322|FG001|Overall Study|Withdrawal by Subject|2|||
124709052|NCT03235050|448561323|FG002|Overall Study|Withdrawal by Subject|2|||
124709053|NCT03235050|448561324|FG003|Overall Study|Withdrawal by Subject|5|||
124709054|NCT03235050|448561325|FG004|Overall Study|Withdrawal by Subject|7|||
124709055|NCT03235050|448561321|FG000|Overall Study|Other reasons|0|||
124709056|NCT03235050|448561322|FG001|Overall Study|Other reasons|1|||
124709057|NCT03235050|448561323|FG002|Overall Study|Other reasons|0|||
124709058|NCT03235050|448561324|FG003|Overall Study|Other reasons|1|||
124709059|NCT03235050|448561325|FG004|Overall Study|Other reasons|2|||
124709060|NCT03545672|448561326|FG000|Overall Study|Uncertain diagnosis|2|||
124709061|NCT03545672|448561327|FG001|Overall Study|Uncertain diagnosis|1|||
124709062|NCT03545672|448561326|FG000|Overall Study|Protocol Violation|2|||
124709063|NCT03545672|448561327|FG001|Overall Study|Protocol Violation|2|||
124709064|NCT01628913|448561328|FG000|Overall Study|Adverse Event|12|||
124709065|NCT01628913|448561329|FG001|Overall Study|Adverse Event|5|||
124709066|NCT01628913|448561328|FG000|Overall Study|Disease Progression|11|||
124709067|NCT01628913|448561329|FG001|Overall Study|Disease Progression|14|||
124709068|NCT01628913|448561328|FG000|Overall Study|Protocol Violation|1|||
124709069|NCT01628913|448561329|FG001|Overall Study|Protocol Violation|0|||
124709070|NCT01628913|448561328|FG000|Overall Study|Death|1|||
124709071|NCT01628913|448561329|FG001|Overall Study|Death|0|||
124709072|NCT01628913|448561328|FG000|Overall Study|study terminated by Sponsor|4|||
124709073|NCT01628913|448561329|FG001|Overall Study|study terminated by Sponsor|9|||
124709074|NCT01628913|448561328|FG000|Overall Study|Withdrawal by Subject|1|||
124709075|NCT01628913|448561329|FG001|Overall Study|Withdrawal by Subject|0|||
124709076|NCT01628913|448561328|FG000|Overall Study|Physician Decision|1|||
124962337|NCT00550446|449490281|FG003|Post Week 12|Adverse Event|1|||
124962338|NCT00550446|449490282|FG004|Post Week 12|Adverse Event|1|||
124463982|NCT03040999|447658025|FG001|Overall Study|Physician Decision|3|||
124962339|NCT00550446|449490283|FG005|Post Week 12|Adverse Event|1|||
124962340|NCT00550446|449490284|FG006|Post Week 12|Adverse Event|0|||
124769151|NCT02435212|448783566|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
124769152|NCT02435212|448783567|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
124769153|NCT02435212|448783566|FG000|Optional Extension Phase|Lack of Efficacy|2|||
124769154|NCT02435212|448783567|FG001|Optional Extension Phase|Lack of Efficacy|3|||
124769155|NCT02435212|448783566|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
124769156|NCT02435212|448783567|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
124769157|NCT02435212|448783566|FG000|Optional Extension Phase|Protocol Violation|0|||
124769158|NCT02435212|448783567|FG001|Optional Extension Phase|Protocol Violation|1|||
124769159|NCT02435212|448783566|FG000|Optional Extension Phase|Recovery|1|||
124769160|NCT02435212|448783567|FG001|Optional Extension Phase|Recovery|1|||
124769161|NCT02435212|448783566|FG000|Optional Extension Phase|Death|1|||
124769162|NCT02435212|448783567|FG001|Optional Extension Phase|Death|0|||
124769163|NCT02435212|448783566|FG000|Optional Extension Phase|Technical problems|2|||
124769164|NCT02435212|448783567|FG001|Optional Extension Phase|Technical problems|0|||
124769165|NCT05966142|448783577|FG000|Overall Study|Death|3|||
124769166|NCT05966142|448783578|FG001|Overall Study|Death|3|||
124769167|NCT05966142|448783577|FG000|Overall Study|Lost to Follow-up|55|||
124769168|NCT05966142|448783578|FG001|Overall Study|Lost to Follow-up|52|||
124769169|NCT05966142|448783577|FG000|Overall Study|Physician Decision|1|||
124769170|NCT05966142|448783578|FG001|Overall Study|Physician Decision|0|||
124769171|NCT05966142|448783577|FG000|Overall Study|Withdrawal by Subject|9|||
124769172|NCT05966142|448783578|FG001|Overall Study|Withdrawal by Subject|8|||
124769173|NCT05966142|448783577|FG000|Overall Study|Duplicate Enrollment|1|||
124769174|NCT05966142|448783578|FG001|Overall Study|Duplicate Enrollment|0|||
124463983|NCT03368170|447658026|FG000|Overall Study|Adverse Event|2|||
124463984|NCT03368170|447658027|FG001|Overall Study|Adverse Event|1|||
124769175|NCT05966142|448783577|FG000|Overall Study|Study Logistical Reason|1|||
124769176|NCT05966142|448783578|FG001|Overall Study|Study Logistical Reason|0|||
124769177|NCT05966142|448783577|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
124769178|NCT05966142|448783578|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
124463985|NCT02068547|447658028|FG000|Overall Study|Lost to Follow-up|3|||
124769179|NCT04852302|448783584|FG000|Overall Study|Withdrawal by Subject|2|||
124463986|NCT02068547|447658029|FG001|Overall Study|Lost to Follow-up|3|||
124463987|NCT02068547|447658028|FG000|Overall Study|Physician Decision|1|||
124463988|NCT02068547|447658029|FG001|Overall Study|Physician Decision|0|||
124769180|NCT04852302|448783584|FG000|Overall Study|Did not complete CALM therapy.|2|||
124769181|NCT03267277|448783585|FG000|Overall Study|Withdrawal by Subject|1|||
124769182|NCT04849364|448783586|FG000|Overall Study|Eligibility criteria not meet|0|||
124769183|NCT04849364|448783587|FG001|Overall Study|Eligibility criteria not meet|1|||
124463989|NCT03657043|447658030|FG000|Overall Study|Withdrawal by Subject|1|||
124463990|NCT03657043|447658031|FG001|Overall Study|Withdrawal by Subject|1|||
124463991|NCT03657043|447658032|FG002|Overall Study|Withdrawal by Subject|0|||
124463992|NCT03657043|447658033|FG003|Overall Study|Withdrawal by Subject|0|||
124463993|NCT03657043|447658034|FG004|Overall Study|Withdrawal by Subject|4|||
124463994|NCT03657043|447658030|FG000|Overall Study|Study closure by Sponsor|0|||
124463995|NCT03657043|447658031|FG001|Overall Study|Study closure by Sponsor|2|||
124463996|NCT03657043|447658032|FG002|Overall Study|Study closure by Sponsor|0|||
124463997|NCT03657043|447658033|FG003|Overall Study|Study closure by Sponsor|0|||
124463998|NCT03657043|447658034|FG004|Overall Study|Study closure by Sponsor|17|||
124463999|NCT03657043|447658030|FG000|Overall Study|Lost to Follow-up|0|||
124464000|NCT03657043|447658031|FG001|Overall Study|Lost to Follow-up|0|||
124464001|NCT03657043|447658032|FG002|Overall Study|Lost to Follow-up|0|||
124464002|NCT03657043|447658033|FG003|Overall Study|Lost to Follow-up|0|||
124464003|NCT03657043|447658034|FG004|Overall Study|Lost to Follow-up|4|||
124464004|NCT03657043|447658030|FG000|Overall Study|Death|6|||
124464005|NCT03657043|447658031|FG001|Overall Study|Death|5|||
124464006|NCT03657043|447658032|FG002|Overall Study|Death|0|||
124464007|NCT03657043|447658033|FG003|Overall Study|Death|0|||
124464008|NCT03657043|447658034|FG004|Overall Study|Death|53|||
124464009|NCT03657043|447658030|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
124464010|NCT03657043|447658031|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
124464011|NCT03657043|447658032|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
124464012|NCT03657043|447658033|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
124464013|NCT03657043|447658034|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
124464014|NCT03657043|447658030|FG000|Overall Study|Adverse Event|0|||
124464015|NCT03657043|447658031|FG001|Overall Study|Adverse Event|0|||
124464016|NCT03657043|447658032|FG002|Overall Study|Adverse Event|0|||
124464017|NCT03657043|447658033|FG003|Overall Study|Adverse Event|0|||
124464018|NCT03657043|447658034|FG004|Overall Study|Adverse Event|2|||
124464019|NCT03657043|447658030|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
124464020|NCT03657043|447658031|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
124464021|NCT03657043|447658032|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
124464022|NCT03657043|447658033|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
124464023|NCT03657043|447658034|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
124464024|NCT03657043|447658030|FG000|Overall Study|Withdrawal - declined follow-up|0|||
124464025|NCT03657043|447658031|FG001|Overall Study|Withdrawal - declined follow-up|0|||
124464026|NCT03657043|447658032|FG002|Overall Study|Withdrawal - declined follow-up|0|||
124464027|NCT03657043|447658033|FG003|Overall Study|Withdrawal - declined follow-up|0|||
124464028|NCT03657043|447658034|FG004|Overall Study|Withdrawal - declined follow-up|1|||
124464029|NCT01736579|447658035|FG000|Overall Study|Termination of Study by Sponsor|2|||
124464030|NCT01736579|447658036|FG001|Overall Study|Termination of Study by Sponsor|2|||
124464031|NCT02543528|447658042|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
124464032|NCT02543528|447658043|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
124464033|NCT02543528|447658044|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
124464034|NCT02543528|447658045|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
124464035|NCT02543528|447658046|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
124464036|NCT02543528|447658042|FG000|Adaptation Period|Lens Handling Difficultes|0|||
124709077|NCT01628913|448561329|FG001|Overall Study|Physician Decision|3|||
124709078|NCT02415556|448561330|FG000|Overall Study|Adverse Event|3|||
124709079|NCT02415556|448561331|FG001|Overall Study|Adverse Event|4|||
124709080|NCT02415556|448561332|FG002|Overall Study|Adverse Event|2|||
124709081|NCT02415556|448561333|FG003|Overall Study|Adverse Event|4|||
124962341|NCT00550446|449490285|FG007|Post Week 12|Adverse Event|0|||
124962342|NCT00550446|449490286|FG008|Post Week 12|Adverse Event|0|||
124962343|NCT00550446|449490287|FG009|Post Week 12|Adverse Event|4|||
124962344|NCT00550446|449490288|FG010|Post Week 12|Adverse Event|0|||
124962345|NCT00550446|449490278|FG000|Post Week 12|Lack of Efficacy|0|||
124962346|NCT00550446|449490279|FG001|Post Week 12|Lack of Efficacy|0|||
124962347|NCT00550446|449490280|FG002|Post Week 12|Lack of Efficacy|1|||
124962348|NCT00550446|449490281|FG003|Post Week 12|Lack of Efficacy|0|||
124962349|NCT00550446|449490282|FG004|Post Week 12|Lack of Efficacy|0|||
124962350|NCT00550446|449490283|FG005|Post Week 12|Lack of Efficacy|0|||
124962351|NCT00550446|449490284|FG006|Post Week 12|Lack of Efficacy|0|||
124962352|NCT00550446|449490285|FG007|Post Week 12|Lack of Efficacy|1|||
124962353|NCT00550446|449490286|FG008|Post Week 12|Lack of Efficacy|1|||
124962354|NCT00550446|449490287|FG009|Post Week 12|Lack of Efficacy|2|||
124962355|NCT00550446|449490288|FG010|Post Week 12|Lack of Efficacy|1|||
124962356|NCT00550446|449490278|FG000|Post Week 12|Lost to Follow-up|0|||
124962357|NCT00550446|449490279|FG001|Post Week 12|Lost to Follow-up|0|||
124962358|NCT00550446|449490280|FG002|Post Week 12|Lost to Follow-up|1|||
124962359|NCT00550446|449490281|FG003|Post Week 12|Lost to Follow-up|1|||
124709082|NCT02415556|448561330|FG000|Overall Study|Lost to Follow-up|4|||
124962360|NCT00550446|449490282|FG004|Post Week 12|Lost to Follow-up|0|||
124962361|NCT00550446|449490283|FG005|Post Week 12|Lost to Follow-up|0|||
124962362|NCT00550446|449490284|FG006|Post Week 12|Lost to Follow-up|1|||
124962363|NCT00550446|449490285|FG007|Post Week 12|Lost to Follow-up|0|||
124769184|NCT04849364|448783588|FG002|Overall Study|Eligibility criteria not meet|0|||
124962364|NCT00550446|449490286|FG008|Post Week 12|Lost to Follow-up|0|||
124962365|NCT00550446|449490287|FG009|Post Week 12|Lost to Follow-up|0|||
124962366|NCT00550446|449490288|FG010|Post Week 12|Lost to Follow-up|0|||
124962367|NCT00550446|449490278|FG000|Post Week 12|Withdrawal by Subject|0|||
124962368|NCT00550446|449490279|FG001|Post Week 12|Withdrawal by Subject|0|||
124962369|NCT00550446|449490280|FG002|Post Week 12|Withdrawal by Subject|0|||
124962370|NCT00550446|449490281|FG003|Post Week 12|Withdrawal by Subject|0|||
124962371|NCT00550446|449490282|FG004|Post Week 12|Withdrawal by Subject|1|||
124962372|NCT00550446|449490283|FG005|Post Week 12|Withdrawal by Subject|0|||
124962373|NCT00550446|449490284|FG006|Post Week 12|Withdrawal by Subject|0|||
124962374|NCT00550446|449490285|FG007|Post Week 12|Withdrawal by Subject|0|||
124962375|NCT00550446|449490286|FG008|Post Week 12|Withdrawal by Subject|0|||
124962376|NCT00550446|449490287|FG009|Post Week 12|Withdrawal by Subject|0|||
124962377|NCT00550446|449490288|FG010|Post Week 12|Withdrawal by Subject|0|||
124962378|NCT00550446|449490278|FG000|Post Week 12|Other|1|||
124962379|NCT00550446|449490279|FG001|Post Week 12|Other|1|||
124962380|NCT00550446|449490280|FG002|Post Week 12|Other|0|||
124962381|NCT00550446|449490281|FG003|Post Week 12|Other|1|||
124962382|NCT00550446|449490282|FG004|Post Week 12|Other|0|||
124962383|NCT00550446|449490283|FG005|Post Week 12|Other|0|||
124962384|NCT00550446|449490284|FG006|Post Week 12|Other|1|||
124962385|NCT00550446|449490285|FG007|Post Week 12|Other|0|||
124962386|NCT00550446|449490286|FG008|Post Week 12|Other|1|||
124962387|NCT00550446|449490287|FG009|Post Week 12|Other|1|||
124962388|NCT00550446|449490288|FG010|Post Week 12|Other|0|||
124962389|NCT02246218|449490289|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124962390|NCT02246218|449490290|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
124962391|NCT02246218|449490289|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
124962392|NCT02246218|449490290|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
124962393|NCT02246218|449490289|FG000|Overall Study|Adverse Event|1|||
124962394|NCT02246218|449490290|FG001|Overall Study|Adverse Event|1|||
124962395|NCT02246218|449490289|FG000|Overall Study|Lost to Follow-up|1|||
124962396|NCT02246218|449490290|FG001|Overall Study|Lost to Follow-up|0|||
124962397|NCT04952701|449490291|FG000|Control Lens|Physician Decision|4|||
124962398|NCT04952701|449490291|FG000|Test Lens|Physician Decision|1|||
124962399|NCT02212301|449490292|FG000|Period 1|Lost to Follow-up|0|||
124962400|NCT02212301|449490293|FG001|Period 1|Lost to Follow-up|1|||
124962401|NCT03927222|449490294|FG000|Overall Study|Progression|3|||
124962402|NCT03927222|449490294|FG000|Overall Study|CMV testing results inconclusive|1|||
124962403|NCT03927222|449490294|FG000|Overall Study|Unable to generate enough vaccines|1|||
124962404|NCT03927222|449490294|FG000|Overall Study|Early study termination|1|||
124962405|NCT00578318|449490299|FG000|Overall Study|Lost to Follow-up|2|||
124962406|NCT00578318|449490300|FG001|Overall Study|Lost to Follow-up|0|||
124962407|NCT00578318|449490299|FG000|Overall Study|Physician Decision|1|||
124962408|NCT00578318|449490300|FG001|Overall Study|Physician Decision|0|||
124962409|NCT00866918|449490301|FG000|Overall Study|Death|1|||
124962410|NCT00866918|449490302|FG001|Overall Study|Death|5|||
124962411|NCT00866918|449490301|FG000|Overall Study|Lack of Efficacy|1|||
124962412|NCT00866918|449490302|FG001|Overall Study|Lack of Efficacy|1|||
124962413|NCT00866918|449490301|FG000|Overall Study|Physician Decision|10|||
124962414|NCT00866918|449490302|FG001|Overall Study|Physician Decision|2|||
124962415|NCT00866918|449490301|FG000|Overall Study|Ineligible|2|||
124962416|NCT00866918|449490302|FG001|Overall Study|Ineligible|4|||
124962417|NCT00866918|449490301|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
124962418|NCT00866918|449490302|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
124962419|NCT00866918|449490301|FG000|Overall Study|Secondary malignancy|1|||
124962420|NCT00866918|449490302|FG001|Overall Study|Secondary malignancy|0|||
124962421|NCT00527514|449490304|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
124962422|NCT00527514|449490304|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
124962423|NCT00527514|449490304|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
124962424|NCT00527514|449490304|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
124709083|NCT02415556|448561331|FG001|Overall Study|Lost to Follow-up|5|||
124962425|NCT00527514|449490304|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
124962426|NCT00527514|449490304|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
124962427|NCT00527514|449490304|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
124962428|NCT00001941|449490321|FG000|Overall Study|not treated- rapidly progressing disease|0|||
124962429|NCT00001941|449490322|FG001|Overall Study|not treated- rapidly progressing disease|0|||
124962430|NCT00001941|449490323|FG002|Overall Study|not treated- rapidly progressing disease|0|||
124962431|NCT00001941|449490324|FG003|Overall Study|not treated- rapidly progressing disease|0|||
124962432|NCT00001941|449490325|FG004|Overall Study|not treated- rapidly progressing disease|1|||
124962433|NCT00640042|449490329|FG000|Enrollment|Did not receive study drug|83|||
124962434|NCT00519285|449490330|FG000|Overall Study|Adverse Event|127|||
124962435|NCT00519285|449490331|FG001|Overall Study|Adverse Event|266|||
124962436|NCT00519285|449490330|FG000|Overall Study|Disease progression|334|||
124962437|NCT00519285|449490331|FG001|Overall Study|Disease progression|186|||
124962438|NCT00519285|449490330|FG000|Overall Study|Physician Decision|75|||
124962439|NCT00519285|449490331|FG001|Overall Study|Physician Decision|47|||
124962440|NCT00519285|449490330|FG000|Overall Study|Participant's request|53|||
124962441|NCT00519285|449490331|FG001|Overall Study|Participant's request|84|||
124962442|NCT00519285|449490330|FG000|Overall Study|Consent withdrawn|4|||
124962443|NCT00519285|449490331|FG001|Overall Study|Consent withdrawn|5|||
124962444|NCT00519285|449490330|FG000|Overall Study|Poor compliance to protocol|5|||
124962445|NCT00519285|449490331|FG001|Overall Study|Poor compliance to protocol|7|||
124962446|NCT00519285|449490330|FG000|Overall Study|Reason unspecified|5|||
124962447|NCT00519285|449490331|FG001|Overall Study|Reason unspecified|8|||
124962448|NCT00519285|449490330|FG000|Overall Study|Not treated|8|||
124962449|NCT00519285|449490331|FG001|Overall Study|Not treated|7|||
124962450|NCT00519285|449490330|FG000|Overall Study|Treatment ongoing|1|||
124962451|NCT00519285|449490331|FG001|Overall Study|Treatment ongoing|2|||
124962452|NCT01020747|449490332|FG000|Overall Study|Withdrawal by Subject|1|||
124962453|NCT01222078|449490333|FG000|Overall Study|Early termination of the study|1|||
124962454|NCT02970305|449490334|FG000|Overall Study|Adverse Event|10|||
124962455|NCT02970305|449490335|FG001|Overall Study|Adverse Event|6|||
124962456|NCT02970305|449490334|FG000|Overall Study|Lack of Efficacy|1|||
124962457|NCT02970305|449490335|FG001|Overall Study|Lack of Efficacy|1|||
124962458|NCT02970305|449490334|FG000|Overall Study|Noncompliance with study drug|2|||
124962459|NCT02970305|449490335|FG001|Overall Study|Noncompliance with study drug|4|||
124962460|NCT02970305|449490334|FG000|Overall Study|Protocol Violation|2|||
124962461|NCT02970305|449490335|FG001|Overall Study|Protocol Violation|2|||
124962462|NCT02970305|449490334|FG000|Overall Study|Withdrawal by Subject|12|||
124962463|NCT02970305|449490335|FG001|Overall Study|Withdrawal by Subject|11|||
124962464|NCT02970305|449490334|FG000|Overall Study|Not further specified|1|||
124962465|NCT02970305|449490335|FG001|Overall Study|Not further specified|2|||
124962466|NCT02970305|449490334|FG000|Overall Study|Lost to Follow-up|1|||
124962467|NCT02970305|449490335|FG001|Overall Study|Lost to Follow-up|2|||
124962468|NCT00983892|449490336|FG000|Overall Study|Withdrawal by Subject|10|||
124962469|NCT00983892|449490337|FG001|Overall Study|Withdrawal by Subject|12|||
124962470|NCT00808899|449490339|FG000|Overall Study|Death|1|||
124962471|NCT00808899|449490339|FG000|Overall Study|Physician Decision|3|||
124962472|NCT03120949|449490344|FG000|Overall Study|randomized in error|1|||
124962473|NCT03120949|449490345|FG001|Overall Study|randomized in error|0|||
124962474|NCT03120949|449490344|FG000|Overall Study|Death|13|||
124962475|NCT03120949|449490345|FG001|Overall Study|Death|13|||
124962476|NCT03120949|449490344|FG000|Overall Study|Lost to Follow-up|23|||
124962477|NCT03120949|449490345|FG001|Overall Study|Lost to Follow-up|13|||
124962478|NCT03120949|449490344|FG000|Overall Study|Withdrawal by Subject|139|||
124962479|NCT03120949|449490345|FG001|Overall Study|Withdrawal by Subject|124|||
124709084|NCT02415556|448561332|FG002|Overall Study|Lost to Follow-up|4|||
124962480|NCT03120949|449490344|FG000|Overall Study|Covid-19|43|||
124962481|NCT03120949|449490345|FG001|Overall Study|Covid-19|34|||
124962482|NCT03120949|449490344|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
124962483|NCT03120949|449490345|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
124709085|NCT02415556|448561333|FG003|Overall Study|Lost to Follow-up|1|||
124709086|NCT02415556|448561330|FG000|Overall Study|Withdrawal by Subject|13|||
124709087|NCT02415556|448561331|FG001|Overall Study|Withdrawal by Subject|4|||
124962484|NCT03120949|449490344|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
124962485|NCT03120949|449490345|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
124962486|NCT03120949|449490344|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
124962487|NCT03120949|449490345|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
124962488|NCT03120949|449490344|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
124969642|NCT01234883|449517432|FG000|Overall Study|Early treatment release|8|||
124969643|NCT01234883|449517433|FG001|Overall Study|Early treatment release|10|||
124969644|NCT01234883|449517432|FG000|Overall Study|Parent/guardian withdrew consent|1|||
124969645|NCT01234883|449517433|FG001|Overall Study|Parent/guardian withdrew consent|2|||
124464037|NCT02543528|447658043|FG001|Adaptation Period|Lens Handling Difficultes|0|||
124464038|NCT02543528|447658044|FG002|Adaptation Period|Lens Handling Difficultes|0|||
124464039|NCT02543528|447658045|FG003|Adaptation Period|Lens Handling Difficultes|0|||
124769185|NCT03521570|448783590|FG000|Overall Study|Not eligible|11|||
124769186|NCT04531176|448783593|FG000|Overall Study|Study was stopped early|24|||
124769187|NCT04531176|448783594|FG001|Overall Study|Study was stopped early|26|||
124769188|NCT04531176|448783595|FG002|Overall Study|Study was stopped early|24|||
124769189|NCT01345240|448783608|FG000|Overall Study|Adverse Event|3|||
124464040|NCT02543528|447658046|FG004|Adaptation Period|Lens Handling Difficultes|8|||
124464041|NCT02543528|447658042|FG000|Adaptation Period|Lost to Follow-up|0|||
124769190|NCT01345240|448783609|FG001|Overall Study|Adverse Event|5|||
124769191|NCT01345240|448783610|FG002|Overall Study|Adverse Event|4|||
124769192|NCT01345240|448783611|FG003|Overall Study|Adverse Event|2|||
124769193|NCT01345240|448783612|FG004|Overall Study|Adverse Event|1|||
124769194|NCT01345240|448783608|FG000|Overall Study|Lost to Follow-up|8|||
124769195|NCT01345240|448783609|FG001|Overall Study|Lost to Follow-up|9|||
124769196|NCT01345240|448783610|FG002|Overall Study|Lost to Follow-up|14|||
124769197|NCT01345240|448783611|FG003|Overall Study|Lost to Follow-up|7|||
124769198|NCT01345240|448783612|FG004|Overall Study|Lost to Follow-up|9|||
124769199|NCT04298697|448783613|FG000|Overall Study|Lost to Follow-up|5|||
124769200|NCT04298697|448783614|FG001|Overall Study|Lost to Follow-up|5|||
124769201|NCT04298697|448783615|FG002|Overall Study|Lost to Follow-up|1|||
124769202|NCT04298697|448783616|FG003|Overall Study|Lost to Follow-up|0|||
124769203|NCT04298697|448783613|FG000|Overall Study|Withdrawal by Subject|0|||
124769204|NCT04298697|448783614|FG001|Overall Study|Withdrawal by Subject|3|||
124769205|NCT04298697|448783615|FG002|Overall Study|Withdrawal by Subject|2|||
124769206|NCT04298697|448783616|FG003|Overall Study|Withdrawal by Subject|3|||
124769207|NCT00449696|448783617|FG000|Overall Study|Other Treatment Required|6|||
124769208|NCT00449696|448783618|FG001|Overall Study|Other Treatment Required|1|||
124769209|NCT00449696|448783617|FG000|Overall Study|Withdrawal by Subject|5|||
124769210|NCT00449696|448783618|FG001|Overall Study|Withdrawal by Subject|5|||
124769211|NCT00449696|448783617|FG000|Overall Study|Lost to Follow-up|2|||
124769212|NCT00449696|448783618|FG001|Overall Study|Lost to Follow-up|3|||
124769213|NCT00449696|448783617|FG000|Overall Study|Others|7|||
124769214|NCT00449696|448783618|FG001|Overall Study|Others|0|||
124769215|NCT01903460|448783623|FG000|Overall Study|Adverse Event|0|||
124769216|NCT01903460|448783624|FG001|Overall Study|Adverse Event|0|||
124769217|NCT01903460|448783625|FG002|Overall Study|Adverse Event|0|||
124769218|NCT01903460|448783626|FG003|Overall Study|Adverse Event|1|||
124769219|NCT02246530|448783627|FG000|Overall Study|Lost to Follow-up|4|||
124769220|NCT02246530|448783628|FG001|Overall Study|Lost to Follow-up|0|||
124769221|NCT00888173|448783629|FG000|Overall Study|Wrong Primary|1|||
124769222|NCT00888173|448783629|FG000|Overall Study|Ineligible: required test not done|1|||
124769223|NCT01488890|448783630|FG000|Overall Study|Serious adverse event|2|||
124769224|NCT01488890|448783631|FG001|Overall Study|Serious adverse event|0|||
124769225|NCT01488890|448783632|FG002|Overall Study|Serious adverse event|0|||
124769226|NCT01488890|448783633|FG003|Overall Study|Serious adverse event|0|||
124769227|NCT01488890|448783630|FG000|Overall Study|Protocol Violation|3|||
124962489|NCT03120949|449490345|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
124962490|NCT03120949|449490344|FG000|Overall Study|Site was closed|2|||
124962491|NCT03120949|449490345|FG001|Overall Study|Site was closed|3|||
124962492|NCT03120949|449490344|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
124962493|NCT03120949|449490345|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
124962494|NCT03120949|449490344|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
124962495|NCT03120949|449490345|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
124962496|NCT03120949|449490344|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
124962497|NCT03120949|449490345|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
124962498|NCT03120949|449490344|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
124962499|NCT03120949|449490345|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
124962500|NCT03120949|449490344|FG000|Overall Study|Other: Adverse Event|0|||
124962501|NCT03120949|449490345|FG001|Overall Study|Other: Adverse Event|1|||
124464042|NCT02543528|447658043|FG001|Adaptation Period|Lost to Follow-up|0|||
124464043|NCT02543528|447658044|FG002|Adaptation Period|Lost to Follow-up|0|||
124769228|NCT01488890|448783631|FG001|Overall Study|Protocol Violation|0|||
124464044|NCT02543528|447658045|FG003|Adaptation Period|Lost to Follow-up|0|||
124769229|NCT01488890|448783632|FG002|Overall Study|Protocol Violation|4|||
124769230|NCT01488890|448783633|FG003|Overall Study|Protocol Violation|0|||
124769231|NCT01488890|448783630|FG000|Overall Study|Lost to Follow-up|13|||
124769232|NCT01488890|448783631|FG001|Overall Study|Lost to Follow-up|10|||
124769233|NCT01488890|448783632|FG002|Overall Study|Lost to Follow-up|20|||
124769234|NCT01488890|448783633|FG003|Overall Study|Lost to Follow-up|3|||
124769235|NCT01488890|448783630|FG000|Overall Study|Withdrawal by Subject|14|||
124464045|NCT02543528|447658046|FG004|Adaptation Period|Lost to Follow-up|14|||
124464046|NCT02543528|447658042|FG000|Adaptation Period|Adverse Event|0|||
124464047|NCT02543528|447658043|FG001|Adaptation Period|Adverse Event|0|||
124464048|NCT02543528|447658044|FG002|Adaptation Period|Adverse Event|0|||
124464049|NCT02543528|447658045|FG003|Adaptation Period|Adverse Event|0|||
124962502|NCT03120949|449490344|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
124962503|NCT03120949|449490345|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
124962504|NCT03120949|449490344|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
124962505|NCT03120949|449490345|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
124962506|NCT03120949|449490344|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
124464050|NCT02543528|447658046|FG004|Adaptation Period|Adverse Event|2|||
124464051|NCT02543528|447658042|FG000|Extended Wear Period|Adverse Event|17|||
124464052|NCT02543528|447658043|FG001|Extended Wear Period|Adverse Event|11|||
124464053|NCT02543528|447658044|FG002|Extended Wear Period|Adverse Event|16|||
124464054|NCT02543528|447658045|FG003|Extended Wear Period|Adverse Event|3|||
124464055|NCT02543528|447658046|FG004|Extended Wear Period|Adverse Event|0|||
124709088|NCT02415556|448561332|FG002|Overall Study|Withdrawal by Subject|14|||
124709089|NCT02415556|448561333|FG003|Overall Study|Withdrawal by Subject|12|||
124709090|NCT02415556|448561330|FG000|Overall Study|Physician Decision|1|||
124709091|NCT02415556|448561331|FG001|Overall Study|Physician Decision|3|||
124709092|NCT02415556|448561332|FG002|Overall Study|Physician Decision|1|||
124709093|NCT02415556|448561333|FG003|Overall Study|Physician Decision|2|||
124709094|NCT02415556|448561330|FG000|Overall Study|Censored - study completion|4|||
124709095|NCT02415556|448561331|FG001|Overall Study|Censored - study completion|5|||
124709096|NCT02415556|448561332|FG002|Overall Study|Censored - study completion|1|||
124709097|NCT02415556|448561333|FG003|Overall Study|Censored - study completion|0|||
124709098|NCT02415556|448561330|FG000|Overall Study|Family-related issues|0|||
124709099|NCT02415556|448561331|FG001|Overall Study|Family-related issues|0|||
124709100|NCT02415556|448561332|FG002|Overall Study|Family-related issues|0|||
124709101|NCT02415556|448561333|FG003|Overall Study|Family-related issues|1|||
124709102|NCT01621178|448561334|FG000|Overall Study|Adverse Event|5|||
124709103|NCT01621178|448561335|FG001|Overall Study|Adverse Event|2|||
124709104|NCT01621178|448561336|FG002|Overall Study|Adverse Event|8|||
124709105|NCT01621178|448561334|FG000|Overall Study|Death|6|||
124709106|NCT01621178|448561335|FG001|Overall Study|Death|7|||
124709107|NCT01621178|448561336|FG002|Overall Study|Death|2|||
124709108|NCT01621178|448561334|FG000|Overall Study|Lost to Follow-up|1|||
124709109|NCT01621178|448561335|FG001|Overall Study|Lost to Follow-up|2|||
124709110|NCT01621178|448561336|FG002|Overall Study|Lost to Follow-up|1|||
124709111|NCT01621178|448561334|FG000|Overall Study|Withdrawal by Subject|14|||
124709112|NCT01621178|448561335|FG001|Overall Study|Withdrawal by Subject|17|||
124709113|NCT01621178|448561336|FG002|Overall Study|Withdrawal by Subject|18|||
124709114|NCT01621178|448561334|FG000|Overall Study|Physician Decision|5|||
124709115|NCT01621178|448561335|FG001|Overall Study|Physician Decision|2|||
124709116|NCT01621178|448561336|FG002|Overall Study|Physician Decision|7|||
124709117|NCT00105534|448561337|FG000|Overall Study|Adverse Event|2|||
124709118|NCT00105534|448561338|FG001|Overall Study|Adverse Event|5|||
124709119|NCT00105534|448561337|FG000|Overall Study|Protocol Violation|1|||
124709120|NCT00105534|448561338|FG001|Overall Study|Protocol Violation|4|||
124709121|NCT00105534|448561337|FG000|Overall Study|Withdrawal by Subject|6|||
124709122|NCT00105534|448561338|FG001|Overall Study|Withdrawal by Subject|6|||
124709123|NCT00105534|448561337|FG000|Overall Study|Lost to Follow-up|5|||
124709124|NCT00105534|448561338|FG001|Overall Study|Lost to Follow-up|1|||
124709125|NCT00105534|448561337|FG000|Overall Study|Lack of Efficacy|7|||
124709126|NCT00105534|448561338|FG001|Overall Study|Lack of Efficacy|15|||
124709127|NCT00105534|448561337|FG000|Overall Study|Treatment unmasked|1|||
124709128|NCT00105534|448561338|FG001|Overall Study|Treatment unmasked|0|||
124709129|NCT00105534|448561337|FG000|Overall Study|Other Reason|0|||
124709130|NCT00105534|448561338|FG001|Overall Study|Other Reason|2|||
124769236|NCT01488890|448783631|FG001|Overall Study|Withdrawal by Subject|10|||
124962507|NCT03120949|449490345|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
124962508|NCT03120949|449490344|FG000|Overall Study|Personal Reasons|0|||
124962509|NCT03120949|449490345|FG001|Overall Study|Personal Reasons|1|||
124969646|NCT01234883|449517432|FG000|Overall Study|Technical difficulties with IV infusion|0|||
124464056|NCT02543528|447658042|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
124464057|NCT02543528|447658043|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
124464058|NCT02543528|447658044|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
124709131|NCT02935192|448561339|FG000|Overall Study|Withdrawal by Subject|8|||
124709132|NCT02935192|448561340|FG001|Overall Study|Withdrawal by Subject|4|||
124709133|NCT02896257|448561342|FG000|Providers|Without eligible patients|21|||
124709134|NCT02896257|448561343|FG001|Providers|Without eligible patients|28|||
124709135|NCT02896257|448561342|FG000|Patients|PFT entry criteria not met|43|||
124709136|NCT02896257|448561343|FG001|Patients|PFT entry criteria not met|50|||
124709137|NCT02896257|448561342|FG000|Patients|No capacity to review|8|||
124709138|NCT02896257|448561343|FG001|Patients|No capacity to review|11|||
124709139|NCT02896257|448561342|FG000|Patients|Appointment rescheduled/cancelled|5|||
124962510|NCT03120949|449490344|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
124962511|NCT03120949|449490345|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
124962512|NCT03120949|449490344|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
124962513|NCT03120949|449490345|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
124962514|NCT03120949|449490344|FG000|Overall Study|Compliance With Medication|0|||
124962515|NCT03120949|449490345|FG001|Overall Study|Compliance With Medication|1|||
124962516|NCT03120949|449490344|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
124962517|NCT03120949|449490345|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
124962518|NCT03120949|449490344|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
124962519|NCT03120949|449490345|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
124962520|NCT03120949|449490344|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
124962521|NCT03120949|449490345|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
124962522|NCT00988117|449490346|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
124962523|NCT00988117|449490346|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
124962524|NCT04522778|449490349|FG000|Overall Study|Patient did not want to wear the device|1|||
124962525|NCT04522778|449490350|FG001|Overall Study|Patient did not want to wear the device|0|||
124962526|NCT04522778|449490349|FG000|Overall Study|Lost to Follow-up|0|||
124962527|NCT04522778|449490350|FG001|Overall Study|Lost to Follow-up|1|||
124962528|NCT01225159|449490351|FG000|Overall Study|Change operation|1|||
124962529|NCT01225159|449490352|FG001|Overall Study|Change operation|0|||
124962530|NCT00312845|449490353|FG000|Overall Study|Adverse Event|19|||
124962531|NCT00312845|449490354|FG001|Overall Study|Adverse Event|5|||
124962532|NCT00312845|449490353|FG000|Overall Study|Death|2|||
124962533|NCT00312845|449490354|FG001|Overall Study|Death|2|||
124962534|NCT00312845|449490353|FG000|Overall Study|Withdrawal by Subject|14|||
124962535|NCT00312845|449490354|FG001|Overall Study|Withdrawal by Subject|6|||
124962536|NCT00312845|449490353|FG000|Overall Study|Disease Progression|56|||
124962537|NCT00312845|449490354|FG001|Overall Study|Disease Progression|77|||
124962538|NCT00312845|449490353|FG000|Overall Study|Lost to Follow-up|2|||
124962539|NCT00312845|449490354|FG001|Overall Study|Lost to Follow-up|0|||
124962540|NCT00312845|449490353|FG000|Overall Study|Other|6|||
124962541|NCT00312845|449490354|FG001|Overall Study|Other|5|||
124962542|NCT01220856|449490355|FG000|Overall Study|graft loss|3|||
124962543|NCT01220856|449490356|FG001|Overall Study|graft loss|3|||
124962544|NCT01220856|449490355|FG000|Overall Study|Lost to Follow-up|1|||
124962545|NCT01220856|449490356|FG001|Overall Study|Lost to Follow-up|0|||
124962546|NCT04088500|449490357|FG000|Overall Study|Reason unknown|1|||
124962547|NCT04088500|449490357|FG000|Overall Study|Participant withdrew consent|1|||
124962548|NCT04088500|449490357|FG000|Overall Study|Disease progression|3|||
124962549|NCT03821064|449490358|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
124962550|NCT03325608|449490367|FG000|Overall Study|Lost to Follow-up|23|||
124962551|NCT03325608|449490368|FG001|Overall Study|Lost to Follow-up|23|||
124962552|NCT03325608|449490369|FG002|Overall Study|Lost to Follow-up|30|||
124962553|NCT03325608|449490370|FG003|Overall Study|Lost to Follow-up|30|||
124962554|NCT03325608|449490367|FG000|Overall Study|Death of Caregiver|0|||
124962555|NCT03325608|449490368|FG001|Overall Study|Death of Caregiver|0|||
124962556|NCT03325608|449490369|FG002|Overall Study|Death of Caregiver|2|||
124962557|NCT03325608|449490370|FG003|Overall Study|Death of Caregiver|2|||
124962558|NCT03325608|449490367|FG000|Overall Study|Death of Care Recipient|34|||
124962559|NCT03325608|449490368|FG001|Overall Study|Death of Care Recipient|34|||
124962560|NCT03325608|449490369|FG002|Overall Study|Death of Care Recipient|28|||
124962561|NCT03325608|449490370|FG003|Overall Study|Death of Care Recipient|28|||
124962562|NCT03325608|449490367|FG000|Overall Study|Withdrawal by Subject|49|||
124962563|NCT03325608|449490368|FG001|Overall Study|Withdrawal by Subject|49|||
124962564|NCT03325608|449490369|FG002|Overall Study|Withdrawal by Subject|35|||
124962565|NCT03325608|449490370|FG003|Overall Study|Withdrawal by Subject|35|||
124962566|NCT03325608|449490367|FG000|Overall Study|Ineligible|7|||
124962567|NCT03325608|449490368|FG001|Overall Study|Ineligible|7|||
124962568|NCT03325608|449490369|FG002|Overall Study|Ineligible|5|||
124962569|NCT03325608|449490370|FG003|Overall Study|Ineligible|5|||
124962570|NCT02188784|449490371|FG000|Overall Study|Death|3|||
124962571|NCT02188784|449490372|FG001|Overall Study|Death|1|||
124962572|NCT02188784|449490371|FG000|Overall Study|Lost to Follow-up|1|||
124464059|NCT02543528|447658045|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
124464060|NCT02543528|447658046|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
124464061|NCT02543528|447658042|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
124464062|NCT02543528|447658043|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
124962573|NCT02188784|449490372|FG001|Overall Study|Lost to Follow-up|0|||
124962574|NCT02188784|449490371|FG000|Overall Study|Withdrawal by Subject|3|||
124962575|NCT02188784|449490372|FG001|Overall Study|Withdrawal by Subject|9|||
124962576|NCT02188784|449490371|FG000|Overall Study|Physician Decision|2|||
124962577|NCT02188784|449490372|FG001|Overall Study|Physician Decision|3|||
124962578|NCT01190449|449490373|FG000|Overall Study|Ineligible|0|||
124962579|NCT01190449|449490374|FG001|Overall Study|Ineligible|4|||
124962580|NCT01268098|449492086|FG000|Overall Study|Adverse Event|1|||
124962581|NCT01268098|449492087|FG001|Overall Study|Adverse Event|0|||
124962582|NCT01093599|449492094|FG000|Overall Study|Lost to Follow-up|32|||
124962583|NCT01093599|449492095|FG001|Overall Study|Lost to Follow-up|46|||
124962584|NCT01703845|449492096|FG000|Overall Study|Adverse Event|1|||
124962585|NCT01703845|449492097|FG001|Overall Study|Adverse Event|0|||
124962586|NCT01703845|449492096|FG000|Overall Study|Protocol Violation|1|||
124962587|NCT01703845|449492097|FG001|Overall Study|Protocol Violation|0|||
124962588|NCT01703845|449492096|FG000|Overall Study|other than stated above|1|||
124962589|NCT01703845|449492097|FG001|Overall Study|other than stated above|0|||
124962590|NCT01644188|449492098|FG000|Overall Study|Adverse Event|44|||
124962591|NCT01644188|449492099|FG001|Overall Study|Adverse Event|20|||
124962592|NCT01644188|449492098|FG000|Overall Study|Poor compliance to protocol|26|||
124962593|NCT01644188|449492099|FG001|Overall Study|Poor compliance to protocol|14|||
124962594|NCT01644188|449492098|FG000|Overall Study|Physician Decision|1|||
124962595|NCT01644188|449492099|FG001|Overall Study|Physician Decision|3|||
124962596|NCT01644188|449492098|FG000|Overall Study|Participant moved|7|||
124962597|NCT01644188|449492099|FG001|Overall Study|Participant moved|2|||
124962598|NCT01644188|449492098|FG000|Overall Study|Related to auto-injector administration|2|||
124962599|NCT01644188|449492099|FG001|Overall Study|Related to auto-injector administration|2|||
124962600|NCT01644188|449492098|FG000|Overall Study|Consent withdrawn by participant|14|||
124962601|NCT01644188|449492099|FG001|Overall Study|Consent withdrawn by participant|7|||
124962602|NCT01644188|449492098|FG000|Overall Study|Selection criteria finally not met|2|||
124962603|NCT01644188|449492099|FG001|Overall Study|Selection criteria finally not met|0|||
124962604|NCT01644188|449492098|FG000|Overall Study|Lost to Follow-up|1|||
124962605|NCT01644188|449492099|FG001|Overall Study|Lost to Follow-up|0|||
124962606|NCT01644188|449492098|FG000|Overall Study|Death|4|||
124962607|NCT01644188|449492099|FG001|Overall Study|Death|3|||
124962608|NCT01644188|449492098|FG000|Overall Study|Last visit outside protocol visit window|14|||
124962609|NCT01644188|449492099|FG001|Overall Study|Last visit outside protocol visit window|16|||
124962610|NCT01644188|449492098|FG000|Overall Study|Site closure|1|||
124962611|NCT01644188|449492099|FG001|Overall Study|Site closure|1|||
124962612|NCT01644188|449492098|FG000|Overall Study|Other than specified above|6|||
124962613|NCT01644188|449492099|FG001|Overall Study|Other than specified above|7|||
124962614|NCT01929876|449492101|FG000|Period 2|Non-Compliance|1|||
124962615|NCT01845649|449492102|FG000|Overall Study|Adverse Event|7|||
124962616|NCT01845649|449492103|FG001|Overall Study|Adverse Event|10|||
124962617|NCT01845649|449492102|FG000|Overall Study|Lack of Efficacy|1|||
124962618|NCT01845649|449492103|FG001|Overall Study|Lack of Efficacy|1|||
124962619|NCT01845649|449492102|FG000|Overall Study|Lost to Follow-up|2|||
124962620|NCT01845649|449492103|FG001|Overall Study|Lost to Follow-up|2|||
124962621|NCT01845649|449492102|FG000|Overall Study|Withdrew Consent|12|||
124962622|NCT01845649|449492103|FG001|Overall Study|Withdrew Consent|4|||
124962623|NCT01845649|449492102|FG000|Overall Study|Protocol Deviation|7|||
124962624|NCT01845649|449492103|FG001|Overall Study|Protocol Deviation|4|||
124962625|NCT01845649|449492102|FG000|Overall Study|Reason not Specified|2|||
124962626|NCT01845649|449492103|FG001|Overall Study|Reason not Specified|1|||
124962627|NCT03991988|449492104|FG000|Overall Study|Withdrawal by Subject|2|||
124962628|NCT03991988|449492105|FG001|Overall Study|Withdrawal by Subject|2|||
124962629|NCT01222533|449492107|FG000|Overall Study|Adverse Event|5|||
124962630|NCT01222533|449492107|FG000|Overall Study|Withdrawal by Subject|5|||
124962631|NCT01222533|449492107|FG000|Overall Study|Other|4|||
124962632|NCT01947517|449492108|FG000|Overall Study|Withdrawal by Subject|1|||
124962633|NCT01947517|449492109|FG001|Overall Study|Withdrawal by Subject|1|||
124962634|NCT02418845|449492113|FG000|Overall Study|Lost to Follow-up|7|||
124962635|NCT02418845|449492114|FG001|Overall Study|Lost to Follow-up|2|||
124962636|NCT02418845|449492113|FG000|Overall Study|Lack of Efficacy|0|||
124962637|NCT02418845|449492114|FG001|Overall Study|Lack of Efficacy|3|||
124962638|NCT02418845|449492113|FG000|Overall Study|Physician Decision|5|||
124962639|NCT02418845|449492114|FG001|Overall Study|Physician Decision|5|||
124962640|NCT02418845|449492113|FG000|Overall Study|Protocol Violation|1|||
124962641|NCT02418845|449492114|FG001|Overall Study|Protocol Violation|0|||
124769237|NCT01488890|448783632|FG002|Overall Study|Withdrawal by Subject|11|||
124962642|NCT02418845|449492113|FG000|Overall Study|Withdrawal by Subject|3|||
124962643|NCT02418845|449492114|FG001|Overall Study|Withdrawal by Subject|2|||
124962644|NCT00526097|449492115|FG000|Overall Study|Adverse Event|6|||
124962645|NCT00526097|449492116|FG001|Overall Study|Adverse Event|44|||
124962646|NCT00526097|449492115|FG000|Overall Study|Protocol Violation|4|||
124769238|NCT01488890|448783633|FG003|Overall Study|Withdrawal by Subject|2|||
124962647|NCT00526097|449492116|FG001|Overall Study|Protocol Violation|10|||
124962648|NCT00526097|449492115|FG000|Overall Study|Withdrawal by Subject|3|||
124962649|NCT00526097|449492116|FG001|Overall Study|Withdrawal by Subject|1|||
124962650|NCT00526097|449492115|FG000|Overall Study|Other|2|||
124962651|NCT00526097|449492116|FG001|Overall Study|Other|1|||
124962652|NCT00460564|449492117|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
124962653|NCT00460564|449492118|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
124962654|NCT00460564|449492119|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
124962655|NCT00460564|449492120|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
124464063|NCT02543528|447658044|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
124464064|NCT02543528|447658045|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
124464065|NCT02543528|447658046|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
124464066|NCT02543528|447658042|FG000|Extended Wear Period|Lost to Follow-up|0|||
124769239|NCT05712460|448783634|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
124769240|NCT05712460|448783635|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
124769241|NCT05712460|448783636|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
124769242|NCT05712460|448783637|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
124769243|NCT05712460|448783638|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
124962656|NCT00460564|449492121|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
124962657|NCT00460564|449492122|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
124962658|NCT00460564|449492123|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
124962659|NCT00460564|449492124|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
124962660|NCT00460564|449492117|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
124962661|NCT00460564|449492118|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
124962662|NCT00460564|449492119|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
124962663|NCT00460564|449492120|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
124962664|NCT00460564|449492121|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
124962665|NCT00460564|449492122|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
124962666|NCT00460564|449492123|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
124962667|NCT00460564|449492124|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
124962668|NCT00460564|449492117|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
124962669|NCT00460564|449492118|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
124962670|NCT00460564|449492119|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
124962671|NCT00460564|449492120|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
124962672|NCT00460564|449492121|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
124962673|NCT00460564|449492122|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
124962674|NCT00460564|449492123|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
124962675|NCT00460564|449492124|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
124962676|NCT00460564|449492117|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
124962677|NCT00460564|449492118|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
124962678|NCT00460564|449492119|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
124962679|NCT00460564|449492120|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
124962680|NCT00460564|449492121|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
124962681|NCT00460564|449492122|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
124962682|NCT00460564|449492123|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
124962683|NCT00460564|449492124|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
124962684|NCT00460564|449492117|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
124962685|NCT00460564|449492118|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
124962686|NCT00460564|449492119|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
124962687|NCT00460564|449492120|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
124962688|NCT00460564|449492121|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
124962689|NCT00460564|449492122|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
124464067|NCT02543528|447658043|FG001|Extended Wear Period|Lost to Follow-up|1|||
124464068|NCT02543528|447658044|FG002|Extended Wear Period|Lost to Follow-up|2|||
124962690|NCT00460564|449492123|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
124962691|NCT00460564|449492124|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
124962692|NCT00511836|449492125|FG000|Double-blind Period|Lost to Follow-up|1|||
124962693|NCT00511836|449492126|FG001|Double-blind Period|Lost to Follow-up|0|||
124962694|NCT00943618|449492130|FG000|Overall Study|Lost to Follow-up|38|||
124962695|NCT00943618|449492131|FG001|Overall Study|Lost to Follow-up|48|||
124962696|NCT00943618|449492132|FG002|Overall Study|Lost to Follow-up|20|||
124962697|NCT00943618|449492130|FG000|Overall Study|Discontinued Medication|17|||
124962698|NCT00943618|449492131|FG001|Overall Study|Discontinued Medication|29|||
124962699|NCT00943618|449492132|FG002|Overall Study|Discontinued Medication|11|||
124962700|NCT00487552|449492147|FG000|Overall Study|Unsuccessful magnet placements|3|||
124962701|NCT00487552|449492147|FG000|Overall Study|Death due to progressive malignancy|2|||
124962702|NCT00487552|449492147|FG000|Overall Study|Stent not placed|1|||
124962703|NCT02412111|449492148|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
124962704|NCT02412111|449492149|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
124962705|NCT02412111|449492150|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
124962706|NCT02412111|449492148|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
124962707|NCT02412111|449492149|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
124962708|NCT02412111|449492150|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
124962709|NCT02412111|449492148|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
124962710|NCT02412111|449492149|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
124962711|NCT02412111|449492150|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
124962712|NCT02412111|449492148|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
124962713|NCT02412111|449492149|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
124962714|NCT02412111|449492150|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
124962715|NCT02412111|449492148|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
124962716|NCT02412111|449492149|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
124962717|NCT02412111|449492150|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
124962718|NCT02412111|449492148|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
124962719|NCT02412111|449492149|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
124962720|NCT02412111|449492150|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
124962721|NCT02412111|449492148|FG000|Active Comparator Period (8 Weeks)|Other|0|||
124962722|NCT02412111|449492149|FG001|Active Comparator Period (8 Weeks)|Other|0|||
124962723|NCT02412111|449492150|FG002|Active Comparator Period (8 Weeks)|Other|2|||
124962724|NCT00630552|449492151|FG000|Overall Study|Adverse Event|0|||
124962725|NCT00630552|449492152|FG001|Overall Study|Adverse Event|1|||
124962726|NCT00630552|449492153|FG002|Overall Study|Adverse Event|5|||
124962727|NCT00630552|449492154|FG003|Overall Study|Adverse Event|4|||
124962728|NCT00630552|449492155|FG004|Overall Study|Adverse Event|2|||
124962729|NCT00630552|449492151|FG000|Overall Study|Disease progression|5|||
124962730|NCT00630552|449492152|FG001|Overall Study|Disease progression|6|||
124962731|NCT00630552|449492153|FG002|Overall Study|Disease progression|27|||
124962732|NCT00630552|449492154|FG003|Overall Study|Disease progression|22|||
124962733|NCT00630552|449492155|FG004|Overall Study|Disease progression|31|||
124962734|NCT00630552|449492151|FG000|Overall Study|Never received IP|0|||
124962735|NCT00630552|449492152|FG001|Overall Study|Never received IP|0|||
124962736|NCT00630552|449492153|FG002|Overall Study|Never received IP|0|||
124962737|NCT00630552|449492154|FG003|Overall Study|Never received IP|2|||
124962738|NCT00630552|449492155|FG004|Overall Study|Never received IP|2|||
124962739|NCT00630552|449492151|FG000|Overall Study|Ineligibility determined|0|||
124464069|NCT02543528|447658045|FG003|Extended Wear Period|Lost to Follow-up|1|||
124464070|NCT02543528|447658046|FG004|Extended Wear Period|Lost to Follow-up|0|||
124464071|NCT02543528|447658042|FG000|Extended Wear Period|Withdrawal by Subject|10|||
124464072|NCT02543528|447658043|FG001|Extended Wear Period|Withdrawal by Subject|9|||
124464073|NCT02543528|447658044|FG002|Extended Wear Period|Withdrawal by Subject|4|||
124464074|NCT02543528|447658045|FG003|Extended Wear Period|Withdrawal by Subject|5|||
124464075|NCT02543528|447658046|FG004|Extended Wear Period|Withdrawal by Subject|0|||
124464076|NCT01408147|447658047|FG000|Overall Study|Withdrawal by Subject|0|||
124709140|NCT02896257|448561343|FG001|Patients|Appointment rescheduled/cancelled|7|||
124709141|NCT02896257|448561342|FG000|Patients|PCP not assigned a clinic|4|||
124709142|NCT02896257|448561343|FG001|Patients|PCP not assigned a clinic|0|||
124709143|NCT02896257|448561342|FG000|Patients|No history of COPD|0|||
124709144|NCT02896257|448561343|FG001|Patients|No history of COPD|1|||
124709145|NCT02896257|448561342|FG000|Patients|Deceased between review and index date|0|||
124962740|NCT00630552|449492152|FG001|Overall Study|Ineligibility determined|0|||
124962741|NCT00630552|449492153|FG002|Overall Study|Ineligibility determined|0|||
124464077|NCT01408147|447658048|FG001|Overall Study|Withdrawal by Subject|1|||
124464078|NCT01765673|447658049|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
124709146|NCT02896257|448561343|FG001|Patients|Deceased between review and index date|1|||
124709147|NCT02896257|448561342|FG000|Patients|No ICS Rx upon review|1|||
124464079|NCT01042600|447658050|FG000|Overall Study|Ineligible|1|||
124709148|NCT02896257|448561343|FG001|Patients|No ICS Rx upon review|1|||
124709149|NCT02896257|448561342|FG000|Patients|Protocol Violation|2|||
124709150|NCT02896257|448561343|FG001|Patients|Protocol Violation|1|||
124709151|NCT02896257|448561342|FG000|Patients|Hospice care|0|||
124709152|NCT02896257|448561343|FG001|Patients|Hospice care|1|||
124709153|NCT02465931|448561344|FG000|Overall Study|Lost to Follow-up|9|||
124709154|NCT02465931|448561345|FG001|Overall Study|Lost to Follow-up|11|||
124709155|NCT02465931|448561344|FG000|Overall Study|Protocol Violation|1|||
124709156|NCT02465931|448561345|FG001|Overall Study|Protocol Violation|0|||
124709157|NCT02465931|448561344|FG000|Overall Study|Withdrawal by Subject|1|||
124709158|NCT02465931|448561345|FG001|Overall Study|Withdrawal by Subject|0|||
124709159|NCT00492557|448561346|FG000|Overall Study|Subject request|12|||
124709160|NCT00492557|448561347|FG001|Overall Study|Subject request|11|||
124709161|NCT00492557|448561346|FG000|Overall Study|Protocol Violation|7|||
124709162|NCT00492557|448561347|FG001|Overall Study|Protocol Violation|8|||
124709163|NCT00492557|448561346|FG000|Overall Study|Other|2|||
124709164|NCT00492557|448561347|FG001|Overall Study|Other|2|||
124709165|NCT00492557|448561346|FG000|Overall Study|Death|1|||
124709166|NCT00492557|448561347|FG001|Overall Study|Death|1|||
124709167|NCT00492557|448561346|FG000|Overall Study|Adverse Event|1|||
124709168|NCT00492557|448561347|FG001|Overall Study|Adverse Event|0|||
124709169|NCT00492557|448561346|FG000|Overall Study|Failed to return|1|||
124709170|NCT00492557|448561347|FG001|Overall Study|Failed to return|0|||
124709171|NCT00492557|448561346|FG000|Overall Study|Lost to Follow-up|0|||
124709172|NCT00492557|448561347|FG001|Overall Study|Lost to Follow-up|1|||
124709173|NCT04102007|448561349|FG000|Overall Study|Adverse Event|4|||
124709174|NCT04102007|448561349|FG000|Overall Study|Lost to Follow-up|3|||
124709175|NCT04102007|448561349|FG000|Overall Study|Withdrawal by Subject|12|||
124709176|NCT04102007|448561349|FG000|Overall Study|Eligibility Violation|5|||
124709177|NCT04102007|448561349|FG000|Overall Study|Lack of Efficacy|6|||
124709178|NCT04102007|448561349|FG000|Overall Study|Protocol Deviation|5|||
124709179|NCT04102007|448561349|FG000|Overall Study|Protocol Compliance|1|||
124709180|NCT04102007|448561349|FG000|Overall Study|Withdrew Treatment|2|||
124709181|NCT04102007|448561349|FG000|Overall Study|Pregnancy|1|||
124709182|NCT00892008|448561352|FG000|Overall Study|Death|5|||
124709183|NCT00892008|448561352|FG000|Overall Study|Lack of Efficacy|3|||
124709184|NCT00892008|448561352|FG000|Overall Study|Lost to Follow-up|142|||
124709185|NCT00892008|448561352|FG000|Overall Study|Other|378|||
124709186|NCT00892008|448561352|FG000|Overall Study|Adverse Event|37|||
124709187|NCT00329030|448561353|FG000|Overall Study|Withdrawal by Subject|1|||
124709188|NCT00329030|448561354|FG001|Overall Study|Withdrawal by Subject|3|||
124709189|NCT00329030|448561353|FG000|Overall Study|Progressive Disease|6|||
124709190|NCT00329030|448561354|FG001|Overall Study|Progressive Disease|2|||
124709191|NCT00329030|448561353|FG000|Overall Study|Ineligible Pathology|1|||
124709192|NCT00329030|448561354|FG001|Overall Study|Ineligible Pathology|1|||
124709193|NCT01627691|448561355|FG000|Overall Study|Death|11|||
124709194|NCT01627691|448561355|FG000|Overall Study|Lost to Follow-up|3|||
124709195|NCT01627691|448561355|FG000|Overall Study|Withdrawal by Subject|1|||
124464080|NCT01042600|447658051|FG001|Overall Study|Ineligible|0|||
124464081|NCT05048719|447658056|FG000|Overall Study|Withdrawal by Subject|2|||
124709196|NCT01627691|448561355|FG000|Overall Study|Missed the visit|3|||
124709197|NCT00181844|448561356|FG000|Signed Consent|Withdrawal by Subject|5|||
124709198|NCT00181844|448561356|FG000|Signed Consent|Did not meet entrance criteria|7|||
124709199|NCT00181844|448561356|FG000|Exposed to Study Medication|Adverse Event|10|||
124709200|NCT00181844|448561356|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
124709201|NCT00181844|448561356|FG000|Exposed to Study Medication|Non-compliance|2|||
124709202|NCT00181844|448561356|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
124709203|NCT00181844|448561356|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
124709204|NCT04661033|448561357|FG000|Overall Study|Adverse Event|0|||
124709205|NCT04661033|448561358|FG001|Overall Study|Adverse Event|0|||
124769244|NCT05712460|448783639|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
124769245|NCT05712460|448783640|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
124769246|NCT05712460|448783641|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
124769247|NCT05712460|448783642|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
124769248|NCT05712460|448783643|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
124769249|NCT05712460|448783644|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
124769250|NCT05712460|448783645|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
124769251|NCT00829426|448783649|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
124769252|NCT00829426|448783650|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
124769253|NCT05135767|448783655|FG000|Baseline|Lost to Follow-up|1|||
124769254|NCT05135767|448783656|FG001|Baseline|Lost to Follow-up|1|||
124769255|NCT05135767|448783655|FG000|Baseline|Withdrawal by Subject|0|||
124769256|NCT05135767|448783656|FG001|Baseline|Withdrawal by Subject|2|||
124769257|NCT05135767|448783655|FG000|Active Study Phase|Lost to Follow-up|2|||
124769258|NCT05135767|448783656|FG001|Active Study Phase|Lost to Follow-up|0|||
124769259|NCT02260934|448783660|FG000|Overall Study|Lost to Follow-up|2|||
124769260|NCT02260934|448783661|FG001|Overall Study|Lost to Follow-up|1|||
124769261|NCT02260934|448783660|FG000|Overall Study|Withdrawal by Subject|0|||
124464082|NCT05048719|447658057|FG001|Overall Study|Withdrawal by Subject|1|||
124769262|NCT02260934|448783661|FG001|Overall Study|Withdrawal by Subject|2|||
124769263|NCT02260934|448783660|FG000|Overall Study|Participant Relocated|1|||
124769264|NCT02260934|448783661|FG001|Overall Study|Participant Relocated|0|||
124769265|NCT02260934|448783660|FG000|Overall Study|Site error|0|||
124769266|NCT02260934|448783661|FG001|Overall Study|Site error|1|||
124769267|NCT03605667|448783662|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
124769268|NCT03605667|448783663|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
124769269|NCT03605667|448783662|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
124769270|NCT03605667|448783663|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
124769271|NCT03605667|448783662|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
124769272|NCT03605667|448783663|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
124769273|NCT03605667|448783662|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
124769274|NCT03605667|448783663|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
124769275|NCT03605667|448783662|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
124769276|NCT03605667|448783663|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
124769277|NCT03605667|448783662|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
124769278|NCT03605667|448783663|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
124769279|NCT03605667|448783662|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
124769280|NCT03605667|448783663|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
124769281|NCT03605667|448783662|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
124769282|NCT03605667|448783663|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
124769283|NCT03605667|448783662|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
124769284|NCT03605667|448783663|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
124769285|NCT03605667|448783662|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
124769286|NCT03605667|448783663|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
124769287|NCT03605667|448783662|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
124769288|NCT03605667|448783663|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
124769289|NCT03605667|448783662|FG000|OLE Phase (48 Weeks)|Other|6|||
124769290|NCT03605667|448783663|FG001|OLE Phase (48 Weeks)|Other|8|||
124769291|NCT03605667|448783662|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
124769292|NCT03605667|448783663|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
124769293|NCT03605667|448783662|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
124769294|NCT03605667|448783663|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
124769295|NCT03605667|448783662|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
124769296|NCT03605667|448783663|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
124769297|NCT03605667|448783662|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
124769298|NCT03605667|448783663|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
124962742|NCT00630552|449492154|FG003|Overall Study|Ineligibility determined|0|||
124962743|NCT00630552|449492155|FG004|Overall Study|Ineligibility determined|1|||
124962744|NCT00630552|449492151|FG000|Overall Study|Protocol Violation|0|||
124962745|NCT00630552|449492152|FG001|Overall Study|Protocol Violation|0|||
124962746|NCT00630552|449492153|FG002|Overall Study|Protocol Violation|0|||
124962747|NCT00630552|449492154|FG003|Overall Study|Protocol Violation|1|||
124962748|NCT00630552|449492155|FG004|Overall Study|Protocol Violation|0|||
124962749|NCT00630552|449492151|FG000|Overall Study|Physician Decision|0|||
124464083|NCT05048719|447658058|FG002|Overall Study|Withdrawal by Subject|3|||
124464084|NCT05048719|447658059|FG003|Overall Study|Withdrawal by Subject|1|||
124769299|NCT03605667|448783662|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
124769300|NCT03605667|448783663|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
124769301|NCT03605667|448783662|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
124769302|NCT03605667|448783663|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
124769303|NCT03605667|448783662|FG000|OLE Phase (48 Weeks)|Death|0|||
124769304|NCT03605667|448783663|FG001|OLE Phase (48 Weeks)|Death|2|||
124962750|NCT00630552|449492152|FG001|Overall Study|Physician Decision|0|||
124962751|NCT00630552|449492153|FG002|Overall Study|Physician Decision|0|||
124962752|NCT00630552|449492154|FG003|Overall Study|Physician Decision|0|||
124962753|NCT00630552|449492155|FG004|Overall Study|Physician Decision|1|||
124962754|NCT00630552|449492151|FG000|Overall Study|Death|0|||
124962755|NCT00630552|449492152|FG001|Overall Study|Death|0|||
124962756|NCT00630552|449492153|FG002|Overall Study|Death|1|||
124962757|NCT00630552|449492154|FG003|Overall Study|Death|2|||
124962758|NCT00630552|449492155|FG004|Overall Study|Death|2|||
124962759|NCT00630552|449492151|FG000|Overall Study|Withdrawal by Subject|0|||
124962760|NCT00630552|449492152|FG001|Overall Study|Withdrawal by Subject|0|||
124962761|NCT00630552|449492153|FG002|Overall Study|Withdrawal by Subject|0|||
124962762|NCT00630552|449492154|FG003|Overall Study|Withdrawal by Subject|1|||
124962763|NCT00630552|449492155|FG004|Overall Study|Withdrawal by Subject|0|||
124962764|NCT00630552|449492151|FG000|Overall Study|Other|0|||
124962765|NCT00630552|449492152|FG001|Overall Study|Other|0|||
124962766|NCT00630552|449492153|FG002|Overall Study|Other|4|||
124962767|NCT00630552|449492154|FG003|Overall Study|Other|2|||
124962768|NCT00630552|449492155|FG004|Overall Study|Other|0|||
124962769|NCT04349644|449492156|FG000|Allocation/Pretest|Lost to pretest|0|||
124962770|NCT04349644|449492157|FG001|Allocation/Pretest|Lost to pretest|3|||
124962771|NCT04349644|449492156|FG000|Posttest|Lost to posttest|0|||
124962772|NCT04349644|449492157|FG001|Posttest|Lost to posttest|8|||
124962773|NCT04349644|449492156|FG000|Posttest|Discontinued intervention|6|||
124962774|NCT04349644|449492157|FG001|Posttest|Discontinued intervention|0|||
124962775|NCT04349644|449492156|FG000|Follow-up|Lost to Follow-up|0|||
124962776|NCT04349644|449492157|FG001|Follow-up|Lost to Follow-up|2|||
124962777|NCT00983905|449492158|FG000|Theophylline Alone|Adverse Event|1|||
124962778|NCT00983905|449492158|FG000|Colchicine Alone|Adverse Event|2|||
124962779|NCT01114139|449492159|FG000|Overall Study|Adverse Event|3|||
124962780|NCT01114139|449492160|FG001|Overall Study|Adverse Event|2|||
124962781|NCT01114139|449492159|FG000|Overall Study|Lost to Follow-up|15|||
124962782|NCT01114139|449492160|FG001|Overall Study|Lost to Follow-up|3|||
124962783|NCT01114139|449492159|FG000|Overall Study|Withdrawal by Subject|17|||
124962784|NCT01114139|449492160|FG001|Overall Study|Withdrawal by Subject|6|||
124962785|NCT01114139|449492159|FG000|Overall Study|Other-Missed 1 visit|1|||
124962786|NCT01114139|449492160|FG001|Overall Study|Other-Missed 1 visit|0|||
124962787|NCT01114139|449492159|FG000|Overall Study|Other-Protocol Violation|1|||
124962788|NCT01114139|449492160|FG001|Overall Study|Other-Protocol Violation|0|||
124962789|NCT01114139|449492159|FG000|Overall Study|Other-Out of window for study drug dose|1|||
124769305|NCT03605667|448783662|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
124769306|NCT03605667|448783663|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
124769307|NCT03597347|448783666|FG000|Overall Study|Withdrawal by Subject|1|||
124769308|NCT03597347|448783667|FG001|Overall Study|Withdrawal by Subject|1|||
124769309|NCT03597347|448783668|FG002|Overall Study|Withdrawal by Subject|0|||
124769310|NCT03597347|448783666|FG000|Overall Study|Withdrawal due to Covid-19|3|||
124769311|NCT03597347|448783667|FG001|Overall Study|Withdrawal due to Covid-19|0|||
124769312|NCT03597347|448783668|FG002|Overall Study|Withdrawal due to Covid-19|0|||
124769313|NCT03597347|448783666|FG000|Overall Study|Sponsor decision to terminate study|3|||
124769314|NCT03597347|448783667|FG001|Overall Study|Sponsor decision to terminate study|2|||
124769315|NCT03597347|448783668|FG002|Overall Study|Sponsor decision to terminate study|4|||
124769316|NCT00107653|448783669|FG000|Overall Study|Adverse Event|24|||
124769317|NCT00107653|448783670|FG001|Overall Study|Adverse Event|43|||
124769318|NCT00107653|448783669|FG000|Overall Study|Insufficient Therapeutic Response|25|||
124769319|NCT00107653|448783670|FG001|Overall Study|Insufficient Therapeutic Response|11|||
124769320|NCT00107653|448783669|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
124769321|NCT00107653|448783670|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
124769322|NCT00107653|448783669|FG000|Overall Study|Protocol Violation|1|||
124769323|NCT00107653|448783670|FG001|Overall Study|Protocol Violation|0|||
124769324|NCT00107653|448783669|FG000|Overall Study|Withdrawal by Subject|12|||
124769325|NCT00107653|448783670|FG001|Overall Study|Withdrawal by Subject|13|||
124769326|NCT00107653|448783669|FG000|Overall Study|Lost to Follow-up|13|||
124769327|NCT00107653|448783670|FG001|Overall Study|Lost to Follow-up|5|||
124962790|NCT01114139|449492160|FG001|Overall Study|Other-Out of window for study drug dose|0|||
124769328|NCT00107653|448783669|FG000|Overall Study|Administrative Reasons|3|||
124962791|NCT01114139|449492159|FG000|Overall Study|Other-Participant falsified records|0|||
124962792|NCT01114139|449492160|FG001|Overall Study|Other-Participant falsified records|1|||
124962793|NCT01114139|449492159|FG000|Overall Study|Other-Participant went on hospice|0|||
124962794|NCT01114139|449492160|FG001|Overall Study|Other-Participant went on hospice|1|||
124962795|NCT01114139|449492159|FG000|Overall Study|Other-Physician changed treatment|1|||
124962796|NCT01114139|449492160|FG001|Overall Study|Other-Physician changed treatment|0|||
124769329|NCT00107653|448783670|FG001|Overall Study|Administrative Reasons|3|||
124962797|NCT01114139|449492159|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
124962798|NCT01114139|449492160|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
124962799|NCT01169636|449492161|FG000|Overall Study|Adverse Event|0|||
124549482|NCT02985515|447967061|FG001|Olfaction Testing|Protocol Violation|3|||
124549483|NCT03972709|447967067|FG000|Overall Study|Withdrawal by Subject|18|||
124549484|NCT03972709|447967068|FG001|Overall Study|Withdrawal by Subject|7|||
124709206|NCT04661033|448561359|FG002|Overall Study|Adverse Event|1|||
124709207|NCT04661033|448561360|FG003|Overall Study|Adverse Event|0|||
124709208|NCT04661033|448561357|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
124709209|NCT04661033|448561358|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
124709210|NCT04661033|448561359|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
124709211|NCT04661033|448561360|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
124709212|NCT04661033|448561357|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
124709213|NCT04661033|448561358|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
124709214|NCT04661033|448561359|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
124709215|NCT04661033|448561360|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
124709216|NCT04661033|448561357|FG000|Overall Study|Early discontinuation as per PI|1|||
124709217|NCT04661033|448561358|FG001|Overall Study|Early discontinuation as per PI|0|||
124709218|NCT04661033|448561359|FG002|Overall Study|Early discontinuation as per PI|0|||
124709219|NCT04661033|448561360|FG003|Overall Study|Early discontinuation as per PI|0|||
124709220|NCT00565409|448561364|FG000|Period 1 Open Label|Adverse Event|17|||
124709221|NCT00565409|448561365|FG001|Period 1 Open Label|Adverse Event|0|||
124709222|NCT00565409|448561366|FG002|Period 1 Open Label|Adverse Event|0|||
124709223|NCT00565409|448561367|FG003|Period 1 Open Label|Adverse Event|0|||
124709224|NCT00565409|448561364|FG000|Period 1 Open Label|Death|2|||
124709225|NCT00565409|448561365|FG001|Period 1 Open Label|Death|0|||
124709226|NCT00565409|448561366|FG002|Period 1 Open Label|Death|0|||
124709227|NCT00565409|448561367|FG003|Period 1 Open Label|Death|0|||
124709228|NCT00565409|448561364|FG000|Period 1 Open Label|Lost to Follow-up|1|||
124709229|NCT00565409|448561365|FG001|Period 1 Open Label|Lost to Follow-up|0|||
124709230|NCT00565409|448561366|FG002|Period 1 Open Label|Lost to Follow-up|0|||
124709231|NCT00565409|448561367|FG003|Period 1 Open Label|Lost to Follow-up|0|||
124709232|NCT00565409|448561364|FG000|Period 1 Open Label|Other|21|||
124709233|NCT00565409|448561365|FG001|Period 1 Open Label|Other|0|||
124709234|NCT00565409|448561366|FG002|Period 1 Open Label|Other|0|||
124709235|NCT00565409|448561367|FG003|Period 1 Open Label|Other|0|||
124709236|NCT00565409|448561364|FG000|Period 1 Open Label|Protocol Violation|14|||
124709237|NCT00565409|448561365|FG001|Period 1 Open Label|Protocol Violation|0|||
124709238|NCT00565409|448561366|FG002|Period 1 Open Label|Protocol Violation|0|||
124709239|NCT00565409|448561367|FG003|Period 1 Open Label|Protocol Violation|0|||
124709240|NCT00565409|448561364|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
124709241|NCT00565409|448561365|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
124709242|NCT00565409|448561366|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
124709243|NCT00565409|448561367|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
124709244|NCT00565409|448561364|FG000|Period 1 Open Label|no conclusion of participation record|1|||
124709245|NCT00565409|448561365|FG001|Period 1 Open Label|no conclusion of participation record|0|||
124709246|NCT00565409|448561366|FG002|Period 1 Open Label|no conclusion of participation record|0|||
124709247|NCT00565409|448561367|FG003|Period 1 Open Label|no conclusion of participation record|0|||
124709248|NCT00565409|448561364|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
124709249|NCT00565409|448561365|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
124709250|NCT00565409|448561366|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
124709251|NCT00565409|448561367|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
124709252|NCT00565409|448561364|FG000|Period 2 Double-Blind|Adverse Event|0|||
124709253|NCT00565409|448561365|FG001|Period 2 Double-Blind|Adverse Event|7|||
124709254|NCT00565409|448561366|FG002|Period 2 Double-Blind|Adverse Event|4|||
124709255|NCT00565409|448561367|FG003|Period 2 Double-Blind|Adverse Event|5|||
124709256|NCT00565409|448561364|FG000|Period 2 Double-Blind|Death|0|||
124709257|NCT00565409|448561365|FG001|Period 2 Double-Blind|Death|2|||
124709258|NCT00565409|448561366|FG002|Period 2 Double-Blind|Death|0|||
124709259|NCT00565409|448561367|FG003|Period 2 Double-Blind|Death|0|||
124709260|NCT00565409|448561364|FG000|Period 2 Double-Blind|Protocol Violation|0|||
124709261|NCT00565409|448561365|FG001|Period 2 Double-Blind|Protocol Violation|4|||
124709262|NCT00565409|448561366|FG002|Period 2 Double-Blind|Protocol Violation|6|||
124709263|NCT00565409|448561367|FG003|Period 2 Double-Blind|Protocol Violation|2|||
124709264|NCT00565409|448561364|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
124709265|NCT00565409|448561365|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
124709266|NCT00565409|448561366|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
124709267|NCT00565409|448561367|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
124709268|NCT00565409|448561364|FG000|Period 2 Double-Blind|Other|0|||
124709269|NCT00565409|448561365|FG001|Period 2 Double-Blind|Other|4|||
124709270|NCT00565409|448561366|FG002|Period 2 Double-Blind|Other|5|||
124709271|NCT00565409|448561367|FG003|Period 2 Double-Blind|Other|9|||
124709272|NCT00565409|448561364|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
124709273|NCT00565409|448561365|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
124709274|NCT00565409|448561366|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
124709275|NCT00565409|448561367|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
124769330|NCT01838395|448783676|FG000|Overall Study|Withdrawal by Subject|0|||
124769331|NCT01838395|448783677|FG001|Overall Study|Withdrawal by Subject|0|||
124769332|NCT01838395|448783678|FG002|Overall Study|Withdrawal by Subject|0|||
124769333|NCT01838395|448783679|FG003|Overall Study|Withdrawal by Subject|0|||
124769334|NCT01838395|448783680|FG004|Overall Study|Withdrawal by Subject|1|||
124769335|NCT01838395|448783681|FG005|Overall Study|Withdrawal by Subject|0|||
124769336|NCT01838395|448783676|FG000|Overall Study|Death|0|||
124769337|NCT01838395|448783677|FG001|Overall Study|Death|0|||
124769338|NCT01838395|448783678|FG002|Overall Study|Death|1|||
124769339|NCT01838395|448783679|FG003|Overall Study|Death|0|||
124769340|NCT01838395|448783680|FG004|Overall Study|Death|0|||
124769341|NCT01838395|448783681|FG005|Overall Study|Death|0|||
124769342|NCT01838395|448783676|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
124769343|NCT01838395|448783677|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
124769344|NCT01838395|448783678|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
124769345|NCT01838395|448783679|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
124769346|NCT01838395|448783680|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
124769347|NCT01838395|448783681|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
124769348|NCT02532517|448783682|FG000|Overall Study|Did not complete 24-Month visit|4|||
124769349|NCT02532517|448783682|FG000|Overall Study|Failed Angiographic eligibility|1|||
124769350|NCT02532517|448783682|FG000|Overall Study|Lost to Follow-up|4|||
124769351|NCT02532517|448783682|FG000|Overall Study|Withdrawal by Subject|4|||
124769352|NCT02532517|448783682|FG000|Overall Study|Death|4|||
124769353|NCT03312231|448783683|FG000|Overall Study|Lost to Follow-up|2|||
124769354|NCT03312231|448783684|FG001|Overall Study|Lost to Follow-up|6|||
124769355|NCT03312231|448783685|FG002|Overall Study|Lost to Follow-up|1|||
124769356|NCT03312231|448783686|FG003|Overall Study|Lost to Follow-up|3|||
124769357|NCT03312231|448783687|FG004|Overall Study|Lost to Follow-up|1|||
124769358|NCT03312231|448783683|FG000|Overall Study|Withdrawal by Subject|0|||
124769359|NCT03312231|448783684|FG001|Overall Study|Withdrawal by Subject|3|||
124769360|NCT03312231|448783685|FG002|Overall Study|Withdrawal by Subject|1|||
124769361|NCT03312231|448783686|FG003|Overall Study|Withdrawal by Subject|0|||
124769362|NCT03312231|448783687|FG004|Overall Study|Withdrawal by Subject|0|||
124769363|NCT03312231|448783683|FG000|Overall Study|Death|0|||
124769364|NCT03312231|448783684|FG001|Overall Study|Death|1|||
124769365|NCT03312231|448783685|FG002|Overall Study|Death|1|||
124769366|NCT03312231|448783686|FG003|Overall Study|Death|0|||
124769367|NCT03312231|448783687|FG004|Overall Study|Death|0|||
124769368|NCT03312231|448783683|FG000|Overall Study|Study Vaccination not Received|1|||
124769369|NCT03312231|448783684|FG001|Overall Study|Study Vaccination not Received|1|||
124769370|NCT03312231|448783685|FG002|Overall Study|Study Vaccination not Received|1|||
124769371|NCT03312231|448783686|FG003|Overall Study|Study Vaccination not Received|0|||
124769372|NCT03312231|448783687|FG004|Overall Study|Study Vaccination not Received|0|||
124769373|NCT05720897|448783688|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
124769374|NCT05720897|448783689|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
124464085|NCT05048719|447658060|FG004|Overall Study|Withdrawal by Subject|0|||
124464086|NCT05048719|447658061|FG005|Overall Study|Withdrawal by Subject|2|||
124464087|NCT05048719|447658062|FG006|Overall Study|Withdrawal by Subject|1|||
124464088|NCT05048719|447658063|FG007|Overall Study|Withdrawal by Subject|1|||
124464089|NCT05048719|447658064|FG008|Overall Study|Withdrawal by Subject|0|||
124769375|NCT00400179|448783690|FG000|Overall Study|Adverse Event|2|||
124769376|NCT00400179|448783691|FG001|Overall Study|Adverse Event|2|||
124769377|NCT00400179|448783690|FG000|Overall Study|Death|1|||
124464090|NCT05048719|447658056|FG000|Overall Study|Death|1|||
124464091|NCT05048719|447658057|FG001|Overall Study|Death|0|||
124464092|NCT05048719|447658058|FG002|Overall Study|Death|0|||
124464093|NCT05048719|447658059|FG003|Overall Study|Death|0|||
124464094|NCT05048719|447658060|FG004|Overall Study|Death|0|||
124464095|NCT05048719|447658061|FG005|Overall Study|Death|0|||
124464096|NCT05048719|447658062|FG006|Overall Study|Death|0|||
124464097|NCT05048719|447658063|FG007|Overall Study|Death|0|||
124464098|NCT05048719|447658064|FG008|Overall Study|Death|0|||
124769378|NCT00400179|448783691|FG001|Overall Study|Death|2|||
124464099|NCT05048719|447658056|FG000|Overall Study|Adverse Event|0|||
124464100|NCT05048719|447658057|FG001|Overall Study|Adverse Event|1|||
124769379|NCT00400179|448783690|FG000|Overall Study|Withdrew Consent|1|||
124769380|NCT00400179|448783691|FG001|Overall Study|Withdrew Consent|5|||
124464101|NCT05048719|447658058|FG002|Overall Study|Adverse Event|2|||
124464102|NCT05048719|447658059|FG003|Overall Study|Adverse Event|0|||
124464103|NCT05048719|447658060|FG004|Overall Study|Adverse Event|1|||
124464104|NCT05048719|447658061|FG005|Overall Study|Adverse Event|0|||
124464105|NCT05048719|447658062|FG006|Overall Study|Adverse Event|0|||
124769381|NCT00400179|448783690|FG000|Overall Study|Disease progression|1|||
124769382|NCT00400179|448783691|FG001|Overall Study|Disease progression|1|||
124464106|NCT05048719|447658063|FG007|Overall Study|Adverse Event|0|||
124464107|NCT05048719|447658064|FG008|Overall Study|Adverse Event|0|||
124464108|NCT05048719|447658056|FG000|Overall Study|Lost to Follow-up|0|||
124464109|NCT05048719|447658057|FG001|Overall Study|Lost to Follow-up|0|||
124464110|NCT05048719|447658058|FG002|Overall Study|Lost to Follow-up|1|||
124464111|NCT05048719|447658059|FG003|Overall Study|Lost to Follow-up|3|||
124464112|NCT05048719|447658060|FG004|Overall Study|Lost to Follow-up|1|||
124464113|NCT05048719|447658061|FG005|Overall Study|Lost to Follow-up|1|||
124464114|NCT05048719|447658062|FG006|Overall Study|Lost to Follow-up|1|||
124464115|NCT05048719|447658063|FG007|Overall Study|Lost to Follow-up|1|||
124464116|NCT05048719|447658064|FG008|Overall Study|Lost to Follow-up|0|||
124464117|NCT05048719|447658056|FG000|Overall Study|Physician Decision|0|||
124464118|NCT05048719|447658057|FG001|Overall Study|Physician Decision|0|||
124464119|NCT05048719|447658058|FG002|Overall Study|Physician Decision|0|||
124464120|NCT05048719|447658059|FG003|Overall Study|Physician Decision|0|||
124464121|NCT05048719|447658060|FG004|Overall Study|Physician Decision|0|||
124464122|NCT05048719|447658061|FG005|Overall Study|Physician Decision|0|||
124769383|NCT00400179|448783690|FG000|Overall Study|Intercurrent illness|0|||
124769384|NCT00400179|448783691|FG001|Overall Study|Intercurrent illness|1|||
124769385|NCT00400179|448783690|FG000|Overall Study|Investigator judgment|0|||
124769386|NCT00400179|448783691|FG001|Overall Study|Investigator judgment|1|||
124464123|NCT05048719|447658062|FG006|Overall Study|Physician Decision|0|||
124464124|NCT05048719|447658063|FG007|Overall Study|Physician Decision|1|||
124769387|NCT00400179|448783690|FG000|Overall Study|Randomization error/patient ineligible|1|||
124769388|NCT00400179|448783691|FG001|Overall Study|Randomization error/patient ineligible|6|||
124769389|NCT04780061|448783692|FG000|Overall Study|Withdrawal by Subject|5|||
124769390|NCT04780061|448783693|FG001|Overall Study|Withdrawal by Subject|8|||
124769391|NCT04780061|448783692|FG000|Overall Study|Adverse Event|2|||
124769392|NCT04780061|448783693|FG001|Overall Study|Adverse Event|2|||
124769393|NCT04780061|448783692|FG000|Overall Study|Lost to Follow-up|1|||
124769394|NCT04780061|448783693|FG001|Overall Study|Lost to Follow-up|5|||
124769395|NCT04825574|448783694|FG000|Overall Study|Commercial treatment became available|1|||
124769396|NCT04825574|448783694|FG000|Overall Study|Disease progression|1|||
124769397|NCT00303069|448785060|FG000|Overall Study|Lost to Follow-up|1|||
124769398|NCT00303069|448785061|FG001|Overall Study|Lost to Follow-up|0|||
124769399|NCT00303069|448785062|FG002|Overall Study|Lost to Follow-up|0|||
124769400|NCT00303069|448785063|FG003|Overall Study|Lost to Follow-up|2|||
124769401|NCT00303069|448785060|FG000|Overall Study|subject moved|1|||
124769402|NCT00303069|448785061|FG001|Overall Study|subject moved|0|||
124769403|NCT00303069|448785062|FG002|Overall Study|subject moved|0|||
124769404|NCT00303069|448785063|FG003|Overall Study|subject moved|0|||
124769405|NCT00303069|448785060|FG000|Overall Study|Recruitment into Army Reserves|0|||
124769406|NCT00303069|448785061|FG001|Overall Study|Recruitment into Army Reserves|0|||
124769407|NCT00303069|448785062|FG002|Overall Study|Recruitment into Army Reserves|1|||
124769408|NCT00303069|448785063|FG003|Overall Study|Recruitment into Army Reserves|0|||
124769409|NCT00092417|448785064|FG000|Overall Study|Lost to Follow-up|2|||
124464125|NCT05048719|447658064|FG008|Overall Study|Physician Decision|1|||
124464126|NCT05048719|447658056|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
124464127|NCT05048719|447658057|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
124464128|NCT05048719|447658058|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
124464129|NCT05048719|447658059|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
124464130|NCT05048719|447658060|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
124464131|NCT05048719|447658061|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
124464132|NCT05048719|447658062|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
124464133|NCT05048719|447658063|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
124464134|NCT05048719|447658064|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
124464135|NCT05048719|447658056|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
124464136|NCT05048719|447658057|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
124549485|NCT03972709|447967069|FG002|Overall Study|Withdrawal by Subject|14|||
124769410|NCT00092417|448785065|FG001|Overall Study|Lost to Follow-up|0|||
124769411|NCT00092417|448785064|FG000|Overall Study|Withdrawal by Subject|2|||
124962800|NCT01169636|449492162|FG001|Overall Study|Adverse Event|0|||
124962801|NCT01169636|449492163|FG002|Overall Study|Adverse Event|1|||
124962802|NCT01169636|449492164|FG003|Overall Study|Adverse Event|1|||
124962803|NCT01169636|449492165|FG004|Overall Study|Adverse Event|0|||
124962804|NCT01169636|449492161|FG000|Overall Study|Screen failure|0|||
124962805|NCT01169636|449492162|FG001|Overall Study|Screen failure|0|||
124962806|NCT01169636|449492163|FG002|Overall Study|Screen failure|2|||
124962807|NCT01169636|449492164|FG003|Overall Study|Screen failure|0|||
124962808|NCT01169636|449492165|FG004|Overall Study|Screen failure|0|||
124962809|NCT01169636|449492161|FG000|Overall Study|Withdrawal by Subject|0|||
124962810|NCT01169636|449492162|FG001|Overall Study|Withdrawal by Subject|0|||
124962811|NCT01169636|449492163|FG002|Overall Study|Withdrawal by Subject|0|||
124962812|NCT01169636|449492164|FG003|Overall Study|Withdrawal by Subject|0|||
124769412|NCT00092417|448785065|FG001|Overall Study|Withdrawal by Subject|1|||
124962813|NCT01169636|449492165|FG004|Overall Study|Withdrawal by Subject|3|||
124769413|NCT00092417|448785064|FG000|Overall Study|Other|1|||
124962814|NCT02705625|449492166|FG000|Overall Study|Protocol Violation|1|||
124769414|NCT00092417|448785065|FG001|Overall Study|Other|0|||
124962815|NCT02705625|449492167|FG001|Overall Study|Protocol Violation|0|||
124962816|NCT02705625|449492168|FG002|Overall Study|Protocol Violation|0|||
124962817|NCT02705625|449492166|FG000|Overall Study|Adverse Event|6|||
124962818|NCT02705625|449492167|FG001|Overall Study|Adverse Event|5|||
124962819|NCT02705625|449492168|FG002|Overall Study|Adverse Event|2|||
124962820|NCT02705625|449492166|FG000|Overall Study|Death|0|||
124962821|NCT02705625|449492167|FG001|Overall Study|Death|0|||
124962822|NCT02705625|449492168|FG002|Overall Study|Death|1|||
124962823|NCT02705625|449492166|FG000|Overall Study|Withdrawal by Subject|1|||
124962824|NCT02705625|449492167|FG001|Overall Study|Withdrawal by Subject|4|||
124962825|NCT02705625|449492168|FG002|Overall Study|Withdrawal by Subject|5|||
124962826|NCT02705625|449492166|FG000|Overall Study|Lost to Follow-up|0|||
124962827|NCT02705625|449492167|FG001|Overall Study|Lost to Follow-up|0|||
124962828|NCT02705625|449492168|FG002|Overall Study|Lost to Follow-up|1|||
124962829|NCT02705625|449492166|FG000|Overall Study|Non-compliance|0|||
124962830|NCT02705625|449492167|FG001|Overall Study|Non-compliance|1|||
124962831|NCT02705625|449492168|FG002|Overall Study|Non-compliance|1|||
124962832|NCT02705625|449492166|FG000|Overall Study|Overdosing|0|||
124962833|NCT02705625|449492167|FG001|Overall Study|Overdosing|0|||
124962834|NCT02705625|449492168|FG002|Overall Study|Overdosing|1|||
124962835|NCT00494026|449492169|FG000|Overall Study|Sponsor Decision|4|||
124962836|NCT01057251|449492171|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
124962837|NCT01057251|449492172|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
124962838|NCT01057251|449492171|FG000|Overall Study|Adverse Event|4|||
124962839|NCT01057251|449492172|FG001|Overall Study|Adverse Event|2|||
124962840|NCT01057251|449492171|FG000|Overall Study|Lack of Efficacy|2|||
124962841|NCT01057251|449492172|FG001|Overall Study|Lack of Efficacy|11|||
124962842|NCT01057251|449492171|FG000|Overall Study|Protocol Violation|6|||
124962843|NCT01057251|449492172|FG001|Overall Study|Protocol Violation|2|||
124962844|NCT01057251|449492171|FG000|Overall Study|Withdrawal by Subject|4|||
124962845|NCT01057251|449492172|FG001|Overall Study|Withdrawal by Subject|5|||
124962846|NCT01057251|449492171|FG000|Overall Study|Lost to Follow-up|7|||
124962847|NCT01057251|449492172|FG001|Overall Study|Lost to Follow-up|6|||
124962848|NCT01057251|449492171|FG000|Overall Study|Other Reason|1|||
124962849|NCT01057251|449492172|FG001|Overall Study|Other Reason|1|||
124962850|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
124962851|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
124962852|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
124962853|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
124962854|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
124962855|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
124962856|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
124962857|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
124962858|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
124962859|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
124962860|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
124962861|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
124962862|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
124962863|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
124962864|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
124962865|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
124962866|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
124962867|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
124962868|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
124962869|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
124962870|NCT02637856|449492173|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
124962871|NCT02637856|449492174|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
124962872|NCT02637856|449492173|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
124962873|NCT02637856|449492174|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
124962874|NCT02637856|449492173|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
124962875|NCT02637856|449492174|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
124962876|NCT00784147|449492175|FG000|Overall Study|Lost to Follow-up|2|||
124962877|NCT00784147|449492176|FG001|Overall Study|Lost to Follow-up|4|||
124962878|NCT00784147|449492175|FG000|Overall Study|Withdrawal by Subject|1|||
124962879|NCT00784147|449492176|FG001|Overall Study|Withdrawal by Subject|3|||
124962880|NCT00784147|449492175|FG000|Overall Study|Physician Decision|2|||
124962881|NCT00784147|449492176|FG001|Overall Study|Physician Decision|1|||
124962882|NCT00784147|449492175|FG000|Overall Study|Protocol Violation|1|||
124962883|NCT00784147|449492176|FG001|Overall Study|Protocol Violation|1|||
124769415|NCT02318706|448785069|FG000|Double-blind Phase|Adverse Event|7|||
124962884|NCT00784147|449492175|FG000|Overall Study|Death|2|||
124769416|NCT02318706|448785070|FG001|Double-blind Phase|Adverse Event|4|||
124464137|NCT05048719|447658058|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
124464138|NCT05048719|447658059|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
124464139|NCT05048719|447658060|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
124464140|NCT05048719|447658061|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
124464141|NCT05048719|447658062|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
124464142|NCT05048719|447658063|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
124464143|NCT05048719|447658064|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
124464144|NCT05048719|447658056|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
124464145|NCT05048719|447658057|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
124464146|NCT05048719|447658058|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
124769417|NCT02318706|448785071|FG002|Double-blind Phase|Adverse Event|3|||
124962885|NCT00784147|449492176|FG001|Overall Study|Death|0|||
124962886|NCT04544865|449492180|FG000|Overall Study|Death|0|||
124962887|NCT04544865|449492181|FG001|Overall Study|Death|2|||
124962888|NCT04544865|449492180|FG000|Overall Study|Lost to Follow-up|11|||
124962889|NCT04544865|449492181|FG001|Overall Study|Lost to Follow-up|7|||
124962890|NCT04544865|449492180|FG000|Overall Study|Withdrawal by Subject|0|||
124962891|NCT04544865|449492181|FG001|Overall Study|Withdrawal by Subject|1|||
124962892|NCT04544865|449492180|FG000|Overall Study|Other|0|||
124962893|NCT04544865|449492181|FG001|Overall Study|Other|1|||
124962894|NCT02287883|449492182|FG000|Overall Study|Death|8|||
124962895|NCT02287883|449492183|FG001|Overall Study|Death|7|||
124962896|NCT02287883|449492182|FG000|Overall Study|No longer eligible|222|||
124962897|NCT02287883|449492183|FG001|Overall Study|No longer eligible|182|||
124962898|NCT02287883|449492182|FG000|Overall Study|Non-response to survey|229|||
124962899|NCT02287883|449492183|FG001|Overall Study|Non-response to survey|237|||
124962900|NCT00802438|449492184|FG000|Overall Study|Screen Failure|20|||
124962901|NCT00802438|449492184|FG000|Overall Study|Withdrawal by Subject|7|||
124962902|NCT00802438|449492184|FG000|Overall Study|Physician Decision|1|||
124962903|NCT04016805|449492185|FG000|Overall Study|Sponsor's Discretion|30|||
124962904|NCT04016805|449492186|FG001|Overall Study|Sponsor's Discretion|6|||
124962905|NCT04016805|449492187|FG002|Overall Study|Sponsor's Discretion|5|||
124962906|NCT03175198|449492188|FG000|Overall Study|Adverse Event|480|||
124962907|NCT03175198|449492188|FG000|Overall Study|No actual visit|120|||
124962908|NCT03175198|449492188|FG000|Overall Study|Registration rule not followed|4|||
124962909|NCT03175198|449492188|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
124962910|NCT03175198|449492188|FG000|Overall Study|Other personal reason|509|||
124962911|NCT03175198|449492188|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
124962912|NCT03175198|449492188|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
124962913|NCT03175198|449492188|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
124962914|NCT03175198|449492188|FG000|Overall Study|To conduct invasive treatment of operation|53|||
124962915|NCT03175198|449492188|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
124962916|NCT01193218|449492190|FG000|0-12 Weeks|Adverse Event|6|||
124962917|NCT01193218|449492191|FG001|0-12 Weeks|Adverse Event|0|||
124962918|NCT01193218|449492192|FG002|0-12 Weeks|Adverse Event|1|||
124962919|NCT01193218|449492193|FG003|0-12 Weeks|Adverse Event|0|||
124962920|NCT01193218|449492194|FG004|0-12 Weeks|Adverse Event|0|||
124962921|NCT01193218|449492195|FG005|0-12 Weeks|Adverse Event|2|||
124962922|NCT01193218|449492196|FG006|0-12 Weeks|Adverse Event|2|||
124962923|NCT01193218|449492197|FG007|0-12 Weeks|Adverse Event|0|||
124962924|NCT01193218|449492190|FG000|0-12 Weeks|Protocol Violation|0|||
124962925|NCT01193218|449492191|FG001|0-12 Weeks|Protocol Violation|0|||
124962926|NCT01193218|449492192|FG002|0-12 Weeks|Protocol Violation|0|||
124962927|NCT01193218|449492193|FG003|0-12 Weeks|Protocol Violation|0|||
124962928|NCT01193218|449492194|FG004|0-12 Weeks|Protocol Violation|1|||
124962929|NCT01193218|449492195|FG005|0-12 Weeks|Protocol Violation|1|||
124962930|NCT01193218|449492196|FG006|0-12 Weeks|Protocol Violation|0|||
124962931|NCT01193218|449492197|FG007|0-12 Weeks|Protocol Violation|0|||
124962932|NCT01193218|449492190|FG000|0-12 Weeks|Withdrawal by Subject|3|||
124962933|NCT01193218|449492191|FG001|0-12 Weeks|Withdrawal by Subject|0|||
124962934|NCT01193218|449492192|FG002|0-12 Weeks|Withdrawal by Subject|2|||
124962935|NCT01193218|449492193|FG003|0-12 Weeks|Withdrawal by Subject|0|||
124962936|NCT01193218|449492194|FG004|0-12 Weeks|Withdrawal by Subject|0|||
124962937|NCT01193218|449492195|FG005|0-12 Weeks|Withdrawal by Subject|0|||
124962938|NCT01193218|449492196|FG006|0-12 Weeks|Withdrawal by Subject|1|||
124962939|NCT01193218|449492197|FG007|0-12 Weeks|Withdrawal by Subject|0|||
124962940|NCT01193218|449492190|FG000|12-52 Weeks|Adverse Event|1|||
124962941|NCT01193218|449492191|FG001|12-52 Weeks|Adverse Event|0|||
124962942|NCT01193218|449492192|FG002|12-52 Weeks|Adverse Event|1|||
124962943|NCT01193218|449492193|FG003|12-52 Weeks|Adverse Event|2|||
124962944|NCT01193218|449492194|FG004|12-52 Weeks|Adverse Event|3|||
124962945|NCT01193218|449492195|FG005|12-52 Weeks|Adverse Event|3|||
124962946|NCT01193218|449492196|FG006|12-52 Weeks|Adverse Event|1|||
124962947|NCT01193218|449492197|FG007|12-52 Weeks|Adverse Event|2|||
124962948|NCT01193218|449492190|FG000|12-52 Weeks|Lack of Efficacy|0|||
124962949|NCT01193218|449492191|FG001|12-52 Weeks|Lack of Efficacy|0|||
124962950|NCT01193218|449492192|FG002|12-52 Weeks|Lack of Efficacy|0|||
124962951|NCT01193218|449492193|FG003|12-52 Weeks|Lack of Efficacy|0|||
124962952|NCT01193218|449492194|FG004|12-52 Weeks|Lack of Efficacy|0|||
124962953|NCT01193218|449492195|FG005|12-52 Weeks|Lack of Efficacy|0|||
124962954|NCT01193218|449492196|FG006|12-52 Weeks|Lack of Efficacy|1|||
124962955|NCT01193218|449492197|FG007|12-52 Weeks|Lack of Efficacy|0|||
124962956|NCT01193218|449492190|FG000|12-52 Weeks|Withdrawal by Subject|3|||
124962957|NCT01193218|449492191|FG001|12-52 Weeks|Withdrawal by Subject|0|||
124962958|NCT01193218|449492192|FG002|12-52 Weeks|Withdrawal by Subject|3|||
124962959|NCT01193218|449492193|FG003|12-52 Weeks|Withdrawal by Subject|0|||
124962960|NCT01193218|449492194|FG004|12-52 Weeks|Withdrawal by Subject|0|||
124962961|NCT01193218|449492195|FG005|12-52 Weeks|Withdrawal by Subject|2|||
124962962|NCT01193218|449492196|FG006|12-52 Weeks|Withdrawal by Subject|1|||
124962963|NCT01193218|449492197|FG007|12-52 Weeks|Withdrawal by Subject|2|||
124962964|NCT01193218|449492190|FG000|12-52 Weeks|Other reason than above|1|||
124962965|NCT01193218|449492191|FG001|12-52 Weeks|Other reason than above|0|||
124962966|NCT01193218|449492192|FG002|12-52 Weeks|Other reason than above|0|||
124962967|NCT01193218|449492193|FG003|12-52 Weeks|Other reason than above|1|||
124962968|NCT01193218|449492194|FG004|12-52 Weeks|Other reason than above|1|||
124962969|NCT01193218|449492195|FG005|12-52 Weeks|Other reason than above|0|||
124464147|NCT05048719|447658059|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
124464148|NCT05048719|447658060|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
124464149|NCT05048719|447658061|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
124464150|NCT05048719|447658062|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
124464151|NCT05048719|447658063|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
124962970|NCT01193218|449492196|FG006|12-52 Weeks|Other reason than above|0|||
124962971|NCT01193218|449492197|FG007|12-52 Weeks|Other reason than above|0|||
124962972|NCT03811834|449492198|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
124962973|NCT01242371|449492199|FG000|Overall Study|Withdrawal by Subject|2|||
124962974|NCT01242371|449492200|FG001|Overall Study|Withdrawal by Subject|2|||
124962975|NCT01242371|449492199|FG000|Overall Study|Protocol Violation|0|||
124464152|NCT05048719|447658064|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
124962976|NCT01242371|449492200|FG001|Overall Study|Protocol Violation|3|||
124464153|NCT05048719|447658056|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
124464154|NCT05048719|447658057|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
124709276|NCT03440008|448561373|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
124709277|NCT03440008|448561374|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
124709278|NCT03440008|448561373|FG000|Overall Study|Withdrawal by Subject|1|||
124709279|NCT03440008|448561374|FG001|Overall Study|Withdrawal by Subject|0|||
124709280|NCT03498716|448561390|FG000|Overall Study|Withdrawal by Subject|88|||
124709281|NCT03498716|448561391|FG001|Overall Study|Withdrawal by Subject|73|||
124709282|NCT03498716|448561390|FG000|Overall Study|Study Terminated By Sponsor|933|||
124709283|NCT03498716|448561391|FG001|Overall Study|Study Terminated By Sponsor|927|||
124709284|NCT03498716|448561390|FG000|Overall Study|Lost to Follow-up|15|||
124709285|NCT03498716|448561391|FG001|Overall Study|Lost to Follow-up|26|||
124709286|NCT03498716|448561390|FG000|Overall Study|Disease Relapse|0|||
124709287|NCT03498716|448561391|FG001|Overall Study|Disease Relapse|1|||
124709288|NCT03498716|448561390|FG000|Overall Study|Death|58|||
124709289|NCT03498716|448561391|FG001|Overall Study|Death|72|||
124709290|NCT03498716|448561390|FG000|Overall Study|Physician Decision|4|||
124709291|NCT03498716|448561391|FG001|Overall Study|Physician Decision|2|||
124709292|NCT04064905|448561394|FG000|Overall Study|Lost to Follow-up|0|||
124709293|NCT04064905|448561395|FG001|Overall Study|Lost to Follow-up|3|||
124709294|NCT04064905|448561396|FG002|Overall Study|Lost to Follow-up|1|||
124709295|NCT04064905|448561397|FG003|Overall Study|Lost to Follow-up|4|||
124709296|NCT04064905|448561398|FG004|Overall Study|Lost to Follow-up|2|||
124709297|NCT02257684|448561399|FG000|Overall Study|Adverse Event|2|||
124709298|NCT02257684|448561399|FG000|Overall Study|Lack of Efficacy|1|||
124709299|NCT02257684|448561399|FG000|Overall Study|Sponsor's Decision|1|||
124709300|NCT01570387|448561403|FG000|Overall Study|Adverse Event|1|||
124709301|NCT01570387|448561404|FG001|Overall Study|Adverse Event|0|||
124709302|NCT01570387|448561405|FG002|Overall Study|Adverse Event|0|||
124709303|NCT01570387|448561406|FG003|Overall Study|Adverse Event|0|||
124709304|NCT01570387|448561403|FG000|Overall Study|Death|0|||
124709305|NCT01570387|448561404|FG001|Overall Study|Death|0|||
124962977|NCT03188536|449492201|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
124709306|NCT01570387|448561405|FG002|Overall Study|Death|0|||
124962978|NCT03188536|449492201|FG000|Overall Study|Not participated/met inclusion criteria|1|||
124962979|NCT04947436|449492204|FG000|Overall Study|Lost to Follow-up|3|||
124962980|NCT04947436|449492205|FG001|Overall Study|Lost to Follow-up|7|||
124962981|NCT04947436|449492206|FG002|Overall Study|Lost to Follow-up|5|||
124962982|NCT04947436|449492204|FG000|Overall Study|Death|1|||
124962983|NCT04947436|449492205|FG001|Overall Study|Death|1|||
124962984|NCT04947436|449492206|FG002|Overall Study|Death|1|||
124962985|NCT02161185|449492210|FG000|Treatment Phase|Administrative/Other|7|||
124464155|NCT05048719|447658058|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
124464156|NCT05048719|447658059|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
124464157|NCT05048719|447658060|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
124464158|NCT05048719|447658061|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
124464159|NCT05048719|447658062|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
124464160|NCT05048719|447658063|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
124464161|NCT05048719|447658064|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
124464162|NCT05048719|447658056|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
124464163|NCT05048719|447658057|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
124464164|NCT05048719|447658058|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
124464165|NCT05048719|447658059|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
124464166|NCT05048719|447658060|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
124464167|NCT05048719|447658061|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
124464168|NCT05048719|447658062|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
124464169|NCT05048719|447658063|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
124464170|NCT05048719|447658064|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
124464171|NCT04541004|447658065|FG000|Overall Study|Adverse Event|2|||
124464172|NCT00605085|447658067|FG000|Overall Study|Withdrawal by Subject|8|||
124464173|NCT00605085|447658068|FG001|Overall Study|Withdrawal by Subject|5|||
124464174|NCT00605085|447658067|FG000|Overall Study|Adverse Event|9|||
124464175|NCT00605085|447658068|FG001|Overall Study|Adverse Event|5|||
124549486|NCT03972709|447967067|FG000|Overall Study|Study Terminated by Sponsor|48|||
124549487|NCT03972709|447967068|FG001|Overall Study|Study Terminated by Sponsor|25|||
124709307|NCT01570387|448561406|FG003|Overall Study|Death|1|||
124962986|NCT00372255|449492211|FG000|Overall Study|Withdrawn for other reasons|2|||
124962987|NCT00372255|449492212|FG001|Overall Study|Withdrawn for other reasons|1|||
124962988|NCT01215032|449492218|FG000|Overall Study|Adverse Event|3|||
124962989|NCT01215032|449492218|FG000|Overall Study|Lack of Efficacy|17|||
124962990|NCT01424189|449492219|FG000|Overall Study|Adverse Event|1|||
124962991|NCT01424189|449492220|FG001|Overall Study|Adverse Event|0|||
124962992|NCT01424189|449492219|FG000|Overall Study|Lost to Follow-up|4|||
124962993|NCT01424189|449492220|FG001|Overall Study|Lost to Follow-up|1|||
124962994|NCT01424189|449492219|FG000|Overall Study|Withdrawal by Subject|4|||
124962995|NCT01424189|449492220|FG001|Overall Study|Withdrawal by Subject|4|||
124962996|NCT01424189|449492219|FG000|Overall Study|Subject moved|1|||
124962997|NCT01424189|449492220|FG001|Overall Study|Subject moved|0|||
124962998|NCT01424189|449492219|FG000|Overall Study|Death|3|||
124962999|NCT01424189|449492220|FG001|Overall Study|Death|1|||
124963000|NCT01078584|449492223|FG000|Overall Study|Final Status Unknown|1073|||
124963001|NCT01078584|449492223|FG000|Overall Study|Lost to Follow-up|670|||
124963002|NCT01078584|449492223|FG000|Overall Study|Non-serious Adverse Event|577|||
124963003|NCT01078584|449492223|FG000|Overall Study|Withdrawal of Consent|244|||
124963004|NCT01078584|449492223|FG000|Overall Study|Physician Withdrew from Study|90|||
124963005|NCT01078584|449492223|FG000|Overall Study|Non-compliance|67|||
124963006|NCT01078584|449492223|FG000|Overall Study|Blood Pressure Controlled|49|||
124963007|NCT01078584|449492223|FG000|Overall Study|Physician Switched Medication|26|||
124963008|NCT01078584|449492223|FG000|Overall Study|Physician Discontinued Patient|12|||
124963009|NCT01078584|449492223|FG000|Overall Study|Lack of Efficacy|98|||
124963010|NCT01078584|449492223|FG000|Overall Study|Protocol Violation|75|||
124963011|NCT01078584|449492223|FG000|Overall Study|Serious Adverse Event|27|||
124963012|NCT01078584|449492223|FG000|Overall Study|Multiple Reasons|2|||
124963013|NCT01208870|449492224|FG000|Overall Study|Lost to Follow-up|2|||
124963014|NCT01208870|449492225|FG001|Overall Study|Lost to Follow-up|8|||
124464176|NCT00605085|447658067|FG000|Overall Study|Pregnancy|2|||
124464177|NCT00605085|447658068|FG001|Overall Study|Pregnancy|0|||
124464178|NCT00605085|447658067|FG000|Overall Study|Protocol Violation|3|||
124464179|NCT00605085|447658068|FG001|Overall Study|Protocol Violation|2|||
124464180|NCT00605085|447658067|FG000|Overall Study|Lost to Follow-up|10|||
124464181|NCT00605085|447658068|FG001|Overall Study|Lost to Follow-up|5|||
124464182|NCT00605085|447658067|FG000|Overall Study|administrative reasons|18|||
124464183|NCT00605085|447658068|FG001|Overall Study|administrative reasons|8|||
124464184|NCT00621504|447658069|FG000|Overall Study|Adverse Event|1|||
124464185|NCT00621504|447658070|FG001|Overall Study|Adverse Event|3|||
124769418|NCT02318706|448785072|FG003|Double-blind Phase|Adverse Event|10|||
124963015|NCT01077622|449492226|FG000|Overall Study|Physician Decision|2|||
124963016|NCT01077622|449492226|FG000|Overall Study|Withdrawal by Subject|1|||
124963017|NCT00424177|449492227|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
124963018|NCT00424177|449492227|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
124963019|NCT00424177|449492227|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
124963020|NCT00424177|449492227|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
124963021|NCT00424177|449492227|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
124769419|NCT02318706|448785073|FG004|Double-blind Phase|Adverse Event|0|||
124769420|NCT02318706|448785069|FG000|Double-blind Phase|Lost to Follow-up|1|||
124769421|NCT02318706|448785070|FG001|Double-blind Phase|Lost to Follow-up|0|||
124769422|NCT02318706|448785071|FG002|Double-blind Phase|Lost to Follow-up|0|||
124769423|NCT02318706|448785072|FG003|Double-blind Phase|Lost to Follow-up|0|||
124769424|NCT02318706|448785073|FG004|Double-blind Phase|Lost to Follow-up|0|||
124769425|NCT02318706|448785069|FG000|Double-blind Phase|Protocol Violation|4|||
124769426|NCT02318706|448785070|FG001|Double-blind Phase|Protocol Violation|2|||
124769427|NCT02318706|448785071|FG002|Double-blind Phase|Protocol Violation|4|||
124769428|NCT02318706|448785072|FG003|Double-blind Phase|Protocol Violation|3|||
124769429|NCT02318706|448785073|FG004|Double-blind Phase|Protocol Violation|0|||
124769430|NCT02318706|448785069|FG000|Double-blind Phase|Withdrawal by Subject|9|||
124769431|NCT02318706|448785070|FG001|Double-blind Phase|Withdrawal by Subject|5|||
124769432|NCT02318706|448785071|FG002|Double-blind Phase|Withdrawal by Subject|7|||
124769433|NCT02318706|448785072|FG003|Double-blind Phase|Withdrawal by Subject|10|||
124769434|NCT02318706|448785073|FG004|Double-blind Phase|Withdrawal by Subject|0|||
124769435|NCT02318706|448785069|FG000|Double-blind Phase|Other|4|||
124769436|NCT02318706|448785070|FG001|Double-blind Phase|Other|1|||
124769437|NCT02318706|448785071|FG002|Double-blind Phase|Other|2|||
124769438|NCT02318706|448785072|FG003|Double-blind Phase|Other|1|||
124769439|NCT02318706|448785073|FG004|Double-blind Phase|Other|0|||
124769440|NCT02318706|448785069|FG000|Double-blind Phase|Death|0|||
124769441|NCT02318706|448785070|FG001|Double-blind Phase|Death|0|||
124769442|NCT02318706|448785071|FG002|Double-blind Phase|Death|2|||
124769443|NCT02318706|448785072|FG003|Double-blind Phase|Death|0|||
124769444|NCT02318706|448785073|FG004|Double-blind Phase|Death|0|||
124769445|NCT02318706|448785069|FG000|Open-label Extension Phase|Adverse Event|0|||
124769446|NCT02318706|448785070|FG001|Open-label Extension Phase|Adverse Event|0|||
124769447|NCT02318706|448785071|FG002|Open-label Extension Phase|Adverse Event|0|||
124769448|NCT02318706|448785072|FG003|Open-label Extension Phase|Adverse Event|0|||
124769449|NCT02318706|448785073|FG004|Open-label Extension Phase|Adverse Event|21|||
124769450|NCT02318706|448785069|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
124769451|NCT02318706|448785070|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
124769452|NCT02318706|448785071|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
124769453|NCT02318706|448785072|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
124769454|NCT02318706|448785073|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
124769455|NCT02318706|448785069|FG000|Open-label Extension Phase|Death|0|||
124769456|NCT02318706|448785070|FG001|Open-label Extension Phase|Death|0|||
124769457|NCT02318706|448785071|FG002|Open-label Extension Phase|Death|0|||
124769458|NCT02318706|448785072|FG003|Open-label Extension Phase|Death|0|||
124769459|NCT02318706|448785073|FG004|Open-label Extension Phase|Death|1|||
124769460|NCT02318706|448785069|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
124769461|NCT02318706|448785070|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
124769462|NCT02318706|448785071|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
124769463|NCT02318706|448785072|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
124769464|NCT02318706|448785073|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
124769465|NCT01456039|448785074|FG000|Phase 1 (First Step)|Disease Progression|1|||
124769466|NCT01456039|448785075|FG001|Phase 1 (First Step)|Disease Progression|1|||
124769467|NCT01456039|448785076|FG002|Phase 1 (First Step)|Disease Progression|0|||
124769468|NCT01456039|448785074|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
124769469|NCT01456039|448785075|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
124769470|NCT01456039|448785076|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
124769471|NCT01456039|448785074|FG000|Phase 1 (First Step)|Adverse Event|0|||
124769472|NCT01456039|448785075|FG001|Phase 1 (First Step)|Adverse Event|3|||
124769473|NCT01456039|448785076|FG002|Phase 1 (First Step)|Adverse Event|0|||
124709308|NCT01570387|448561403|FG000|Overall Study|Withdrawal by Subject|0|||
124709309|NCT01570387|448561404|FG001|Overall Study|Withdrawal by Subject|0|||
124709310|NCT01570387|448561405|FG002|Overall Study|Withdrawal by Subject|0|||
124709311|NCT01570387|448561406|FG003|Overall Study|Withdrawal by Subject|1|||
124709312|NCT01987557|448561407|FG000|Overall Study|Protocol Violation|1|||
124709313|NCT01987557|448561408|FG001|Overall Study|Protocol Violation|0|||
124709314|NCT01987557|448561409|FG002|Overall Study|Protocol Violation|1|||
124709315|NCT01987557|448561407|FG000|Overall Study|Withdrawal by Subject|2|||
124709316|NCT01987557|448561408|FG001|Overall Study|Withdrawal by Subject|1|||
124709317|NCT01987557|448561409|FG002|Overall Study|Withdrawal by Subject|2|||
124709318|NCT01987557|448561407|FG000|Overall Study|Adverse Event|0|||
124709319|NCT01987557|448561408|FG001|Overall Study|Adverse Event|2|||
124709320|NCT01987557|448561409|FG002|Overall Study|Adverse Event|0|||
124769474|NCT01456039|448785074|FG000|Phase 1 (First Step)|Other|0|||
124769475|NCT01456039|448785075|FG001|Phase 1 (First Step)|Other|1|||
124769476|NCT01456039|448785076|FG002|Phase 1 (First Step)|Other|0|||
124769477|NCT01456039|448785074|FG000|Phase 2 (Second Step)|Disease Progression|0|||
124769478|NCT01456039|448785075|FG001|Phase 2 (Second Step)|Disease Progression|0|||
124769479|NCT01456039|448785076|FG002|Phase 2 (Second Step)|Disease Progression|17|||
124769480|NCT01456039|448785074|FG000|Phase 2 (Second Step)|Adverse Event|0|||
124769481|NCT01456039|448785075|FG001|Phase 2 (Second Step)|Adverse Event|0|||
124769482|NCT01456039|448785076|FG002|Phase 2 (Second Step)|Adverse Event|10|||
124464186|NCT00621504|447658069|FG000|Overall Study|At the request of sponsor/investigator|1|||
124464187|NCT00621504|447658070|FG001|Overall Study|At the request of sponsor/investigator|0|||
124464188|NCT00621504|447658069|FG000|Overall Study|Withdrew consent|9|||
124464189|NCT00621504|447658070|FG001|Overall Study|Withdrew consent|6|||
124464190|NCT00621504|447658069|FG000|Overall Study|Lost to Follow-up|8|||
124464191|NCT00621504|447658070|FG001|Overall Study|Lost to Follow-up|10|||
124464192|NCT00621504|447658069|FG000|Overall Study|Other|1|||
124709321|NCT00760552|448561410|FG000|Overall Study|Death|2|||
124709322|NCT00760552|448561411|FG001|Overall Study|Death|0|||
124709323|NCT00760552|448561410|FG000|Overall Study|Lost to Follow-up|11|||
124709324|NCT00760552|448561411|FG001|Overall Study|Lost to Follow-up|10|||
124709325|NCT01657305|448561412|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
124709326|NCT01657305|448561412|FG000|Overall Study|Withdrawal by Subject|4|||
124709327|NCT01657305|448561412|FG000|Overall Study|Adverse Event|1|||
124709328|NCT01657305|448561412|FG000|Overall Study|Lost to Follow-up|1|||
124709329|NCT01657305|448561412|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
124709330|NCT01696643|448561422|FG000|Overall Study|Adverse Event|15|||
124709331|NCT01696643|448561423|FG001|Overall Study|Adverse Event|7|||
124709332|NCT01696643|448561422|FG000|Overall Study|Death|1|||
124709333|NCT01696643|448561423|FG001|Overall Study|Death|2|||
124709334|NCT01696643|448561422|FG000|Overall Study|Lack of Efficacy|3|||
124709335|NCT01696643|448561423|FG001|Overall Study|Lack of Efficacy|0|||
124709336|NCT01696643|448561422|FG000|Overall Study|Lost to Follow-up|67|||
124709337|NCT01696643|448561423|FG001|Overall Study|Lost to Follow-up|67|||
124709338|NCT01696643|448561422|FG000|Overall Study|Physician Decision|3|||
124709339|NCT01696643|448561423|FG001|Overall Study|Physician Decision|2|||
124709340|NCT01696643|448561422|FG000|Overall Study|Pregnancy|0|||
124709341|NCT01696643|448561423|FG001|Overall Study|Pregnancy|1|||
124709342|NCT01696643|448561422|FG000|Overall Study|Protocol Violation|7|||
124709343|NCT01696643|448561423|FG001|Overall Study|Protocol Violation|7|||
124709344|NCT01696643|448561422|FG000|Overall Study|Study Terminated by Sponsor|286|||
124709345|NCT01696643|448561423|FG001|Overall Study|Study Terminated by Sponsor|294|||
124709346|NCT01696643|448561422|FG000|Overall Study|Withdrawal by Subject|142|||
124709347|NCT01696643|448561423|FG001|Overall Study|Withdrawal by Subject|149|||
124709348|NCT01696643|448561422|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
124709349|NCT01696643|448561423|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
124709350|NCT01696643|448561422|FG000|Overall Study|Site Error|2|||
124709351|NCT01696643|448561423|FG001|Overall Study|Site Error|1|||
124709352|NCT01696643|448561422|FG000|Overall Study|Participant Incarcerated|0|||
124709353|NCT01696643|448561423|FG001|Overall Study|Participant Incarcerated|1|||
124709354|NCT01696643|448561422|FG000|Overall Study|Medical Monitor Decision|0|||
124709355|NCT01696643|448561423|FG001|Overall Study|Medical Monitor Decision|2|||
124709356|NCT01696643|448561422|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
124709357|NCT01696643|448561423|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
124709358|NCT00518180|448561424|FG000|Overall Study|Withdrawal by Subject|29|||
124709359|NCT00518180|448561425|FG001|Overall Study|Withdrawal by Subject|30|||
124709360|NCT00518180|448561426|FG002|Overall Study|Withdrawal by Subject|42|||
124709361|NCT00518180|448561424|FG000|Overall Study|Lost to Follow-up|30|||
124709362|NCT00518180|448561425|FG001|Overall Study|Lost to Follow-up|28|||
124709363|NCT00518180|448561426|FG002|Overall Study|Lost to Follow-up|34|||
124709364|NCT00518180|448561424|FG000|Overall Study|Administrative reason|0|||
124709365|NCT00518180|448561425|FG001|Overall Study|Administrative reason|2|||
124709366|NCT00518180|448561426|FG002|Overall Study|Administrative reason|2|||
124709367|NCT00518180|448561424|FG000|Overall Study|Protocol Violation|5|||
124709368|NCT00518180|448561425|FG001|Overall Study|Protocol Violation|7|||
124709369|NCT00518180|448561426|FG002|Overall Study|Protocol Violation|4|||
124709370|NCT00518180|448561424|FG000|Overall Study|Unable to classify|0|||
124709371|NCT00518180|448561425|FG001|Overall Study|Unable to classify|2|||
124709372|NCT00518180|448561426|FG002|Overall Study|Unable to classify|0|||
124709373|NCT00518180|448561424|FG000|Overall Study|Adverse Event|1|||
124709374|NCT00518180|448561425|FG001|Overall Study|Adverse Event|0|||
124709375|NCT00518180|448561426|FG002|Overall Study|Adverse Event|0|||
124709376|NCT00956293|448561430|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
124709377|NCT00956293|448561431|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
124709378|NCT00956293|448561432|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
124709379|NCT00956293|448561430|FG000|Main Period (Pre-randomization)|Death|0|||
124709380|NCT00956293|448561431|FG001|Main Period (Pre-randomization)|Death|0|||
124709381|NCT00956293|448561432|FG002|Main Period (Pre-randomization)|Death|1|||
124709382|NCT00956293|448561430|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
124709383|NCT00956293|448561431|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
124709384|NCT00956293|448561432|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
124709385|NCT00956293|448561430|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
124709386|NCT00956293|448561431|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
124709387|NCT00956293|448561432|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
124709388|NCT00956293|448561430|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
124709389|NCT00956293|448561431|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
124464193|NCT00621504|447658070|FG001|Overall Study|Other|0|||
124464194|NCT00621504|447658069|FG000|Overall Study|Death|6|||
124464195|NCT00621504|447658070|FG001|Overall Study|Death|6|||
124464196|NCT03257267|447658073|FG000|Overall Study|Adverse Event|17|||
124464197|NCT03257267|447658074|FG001|Overall Study|Adverse Event|7|||
124464198|NCT03257267|447658073|FG000|Overall Study|Death|96|||
124464199|NCT03257267|447658074|FG001|Overall Study|Death|98|||
124464200|NCT03257267|447658073|FG000|Overall Study|Lost to Follow-up|2|||
124464201|NCT03257267|447658074|FG001|Overall Study|Lost to Follow-up|2|||
124464202|NCT03257267|447658073|FG000|Overall Study|Non-compliance with Study Drug|0|||
124464203|NCT03257267|447658074|FG001|Overall Study|Non-compliance with Study Drug|2|||
124464204|NCT03257267|447658073|FG000|Overall Study|Participant Decision|35|||
124464205|NCT03257267|447658074|FG001|Overall Study|Participant Decision|43|||
124464206|NCT03257267|447658073|FG000|Overall Study|Sponsor Decision|1|||
124464207|NCT03257267|447658074|FG001|Overall Study|Sponsor Decision|0|||
124464208|NCT03257267|447658073|FG000|Overall Study|Physician Decision|1|||
124464209|NCT03257267|447658074|FG001|Overall Study|Physician Decision|3|||
124464210|NCT03257267|447658073|FG000|Overall Study|Disease Progression|109|||
124464211|NCT03257267|447658074|FG001|Overall Study|Disease Progression|121|||
124464212|NCT03257267|447658073|FG000|Overall Study|Withdrawal by Subject|8|||
124464213|NCT03257267|447658074|FG001|Overall Study|Withdrawal by Subject|26|||
124464214|NCT03257267|447658073|FG000|Overall Study|Other|0|||
124464215|NCT03257267|447658074|FG001|Overall Study|Other|2|||
124464216|NCT01979523|447658075|FG000|Overall Study|Withdrawal by Subject|1|||
124963022|NCT00424177|449492227|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
124963023|NCT00424177|449492227|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
124963024|NCT00424177|449492227|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
124963025|NCT00424177|449492227|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
124963026|NCT00424177|449492227|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
124963027|NCT00496834|449492233|FG000|Overall Study|Withdrawal by Subject|4|||
124963028|NCT00496834|449492234|FG001|Overall Study|Withdrawal by Subject|6|||
124963029|NCT00496834|449492233|FG000|Overall Study|Contraindicated medication administered|0|||
124963030|NCT00496834|449492234|FG001|Overall Study|Contraindicated medication administered|1|||
124963031|NCT00496834|449492233|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
124963032|NCT00496834|449492234|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
124963033|NCT00496834|449492233|FG000|Overall Study|Adverse Event|5|||
124963034|NCT00496834|449492234|FG001|Overall Study|Adverse Event|3|||
124963035|NCT00496834|449492233|FG000|Overall Study|IP administration violation|2|||
124963036|NCT00496834|449492234|FG001|Overall Study|IP administration violation|0|||
124963037|NCT00496834|449492233|FG000|Overall Study|Lost to Follow-up|2|||
124963038|NCT00496834|449492234|FG001|Overall Study|Lost to Follow-up|0|||
124963039|NCT00496834|449492233|FG000|Overall Study|Blood Pressure control failure|2|||
124963040|NCT00496834|449492234|FG001|Overall Study|Blood Pressure control failure|1|||
124963041|NCT04944784|449492237|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
124963042|NCT04944784|449492238|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
124963043|NCT04944784|449492239|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
124963044|NCT04944784|449492240|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
124963045|NCT04944784|449492237|FG000|Double-blind Period|Adverse Event|20|||
124963046|NCT04944784|449492238|FG001|Double-blind Period|Adverse Event|4|||
124963047|NCT04944784|449492239|FG002|Double-blind Period|Adverse Event|0|||
124963048|NCT04944784|449492240|FG003|Double-blind Period|Adverse Event|0|||
124963049|NCT04944784|449492237|FG000|Double-blind Period|Withdrawal by Subject|15|||
124963050|NCT04944784|449492238|FG001|Double-blind Period|Withdrawal by Subject|4|||
124963051|NCT04944784|449492239|FG002|Double-blind Period|Withdrawal by Subject|0|||
124963052|NCT04944784|449492240|FG003|Double-blind Period|Withdrawal by Subject|0|||
124963053|NCT04944784|449492237|FG000|Double-blind Period|Death|7|||
124963054|NCT04944784|449492238|FG001|Double-blind Period|Death|2|||
124963055|NCT04944784|449492239|FG002|Double-blind Period|Death|0|||
124963056|NCT04944784|449492240|FG003|Double-blind Period|Death|0|||
124963057|NCT04944784|449492237|FG000|Double-blind Period|Physician Decision|2|||
124464217|NCT01979523|447658076|FG001|Overall Study|Withdrawal by Subject|0|||
124464218|NCT03311711|447658077|FG000|Overall Study|Death|1|||
124549488|NCT03972709|447967069|FG002|Overall Study|Study Terminated by Sponsor|50|||
124963058|NCT04944784|449492238|FG001|Double-blind Period|Physician Decision|1|||
124963059|NCT04944784|449492239|FG002|Double-blind Period|Physician Decision|0|||
124963060|NCT04944784|449492240|FG003|Double-blind Period|Physician Decision|0|||
124963061|NCT04944784|449492237|FG000|Double-blind Period|Lack of Efficacy|0|||
124963062|NCT04944784|449492238|FG001|Double-blind Period|Lack of Efficacy|1|||
124963063|NCT04944784|449492239|FG002|Double-blind Period|Lack of Efficacy|0|||
124963064|NCT04944784|449492240|FG003|Double-blind Period|Lack of Efficacy|0|||
124464219|NCT03311711|447658078|FG001|Overall Study|Death|0|||
124464220|NCT03311711|447658079|FG002|Overall Study|Death|0|||
124464221|NCT03311711|447658080|FG003|Overall Study|Death|0|||
124464222|NCT03311711|447658081|FG004|Overall Study|Death|0|||
124464223|NCT03311711|447658082|FG005|Overall Study|Death|0|||
124549489|NCT03972709|447967067|FG000|Overall Study|Physician Decision|1|||
124963065|NCT04944784|449492237|FG000|Double-blind Period|Sponsor Request|2|||
124464224|NCT03311711|447658083|FG006|Overall Study|Death|1|||
124464225|NCT03311711|447658084|FG007|Overall Study|Death|0|||
124464226|NCT03311711|447658085|FG008|Overall Study|Death|1|||
124464227|NCT03311711|447658086|FG009|Overall Study|Death|0|||
124464228|NCT03311711|447658077|FG000|Overall Study|Death of dyad partner|0|||
124464229|NCT03311711|447658078|FG001|Overall Study|Death of dyad partner|1|||
124464230|NCT03311711|447658079|FG002|Overall Study|Death of dyad partner|0|||
124464231|NCT03311711|447658080|FG003|Overall Study|Death of dyad partner|0|||
124464232|NCT03311711|447658081|FG004|Overall Study|Death of dyad partner|0|||
124464233|NCT03311711|447658082|FG005|Overall Study|Death of dyad partner|0|||
124464234|NCT03311711|447658083|FG006|Overall Study|Death of dyad partner|0|||
124464235|NCT03311711|447658084|FG007|Overall Study|Death of dyad partner|1|||
124464236|NCT03311711|447658085|FG008|Overall Study|Death of dyad partner|0|||
124464237|NCT03311711|447658086|FG009|Overall Study|Death of dyad partner|1|||
124464238|NCT03311711|447658077|FG000|Overall Study|Lost to Follow-up|2|||
124464239|NCT03311711|447658078|FG001|Overall Study|Lost to Follow-up|2|||
124464240|NCT03311711|447658079|FG002|Overall Study|Lost to Follow-up|0|||
124464241|NCT03311711|447658080|FG003|Overall Study|Lost to Follow-up|0|||
124464242|NCT03311711|447658081|FG004|Overall Study|Lost to Follow-up|0|||
124963066|NCT04944784|449492238|FG001|Double-blind Period|Sponsor Request|1|||
124963067|NCT04944784|449492239|FG002|Double-blind Period|Sponsor Request|0|||
124963068|NCT04944784|449492240|FG003|Double-blind Period|Sponsor Request|0|||
124963069|NCT04944784|449492237|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
124963070|NCT04944784|449492238|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
124963071|NCT04944784|449492239|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
124963072|NCT04944784|449492240|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
124963073|NCT04944784|449492237|FG000|Double-blind Period|Participant Choice|1|||
124963074|NCT04944784|449492238|FG001|Double-blind Period|Participant Choice|1|||
124963075|NCT04944784|449492239|FG002|Double-blind Period|Participant Choice|0|||
124963076|NCT04944784|449492240|FG003|Double-blind Period|Participant Choice|0|||
124963077|NCT04944784|449492237|FG000|Double-blind Period|Progressive Disease|2|||
124963078|NCT04944784|449492238|FG001|Double-blind Period|Progressive Disease|2|||
124963079|NCT04944784|449492239|FG002|Double-blind Period|Progressive Disease|0|||
124963080|NCT04944784|449492240|FG003|Double-blind Period|Progressive Disease|0|||
124963081|NCT04944784|449492237|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
124963082|NCT04944784|449492238|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
124963083|NCT04944784|449492239|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
124963084|NCT04944784|449492240|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
124963085|NCT04944784|449492237|FG000|Active Drug Period|Adverse Event|0|||
124963086|NCT04944784|449492238|FG001|Active Drug Period|Adverse Event|0|||
124963087|NCT04944784|449492239|FG002|Active Drug Period|Adverse Event|3|||
124963088|NCT04944784|449492240|FG003|Active Drug Period|Adverse Event|6|||
124963089|NCT04944784|449492237|FG000|Active Drug Period|Withdrawal by Subject|0|||
124963090|NCT04944784|449492238|FG001|Active Drug Period|Withdrawal by Subject|0|||
124963091|NCT04944784|449492239|FG002|Active Drug Period|Withdrawal by Subject|4|||
124963092|NCT04944784|449492240|FG003|Active Drug Period|Withdrawal by Subject|7|||
124963093|NCT04944784|449492237|FG000|Active Drug Period|Death|0|||
124963094|NCT04944784|449492238|FG001|Active Drug Period|Death|0|||
124963095|NCT04944784|449492239|FG002|Active Drug Period|Death|3|||
124963096|NCT04944784|449492240|FG003|Active Drug Period|Death|4|||
124963097|NCT04944784|449492237|FG000|Active Drug Period|Lack of Efficacy|0|||
124963098|NCT04944784|449492238|FG001|Active Drug Period|Lack of Efficacy|0|||
124963099|NCT04944784|449492239|FG002|Active Drug Period|Lack of Efficacy|2|||
124963100|NCT04944784|449492240|FG003|Active Drug Period|Lack of Efficacy|2|||
124963101|NCT04944784|449492237|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
124963102|NCT04944784|449492238|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
124963103|NCT04944784|449492239|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
124963104|NCT04944784|449492240|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
124963105|NCT04944784|449492237|FG000|Active Drug Period|Participant Choice|0|||
124963106|NCT04944784|449492238|FG001|Active Drug Period|Participant Choice|0|||
124963107|NCT04944784|449492239|FG002|Active Drug Period|Participant Choice|0|||
124963108|NCT04944784|449492240|FG003|Active Drug Period|Participant Choice|1|||
124963109|NCT04944784|449492237|FG000|Active Drug Period|Progressive Disease|0|||
124963110|NCT04944784|449492238|FG001|Active Drug Period|Progressive Disease|0|||
124963111|NCT04944784|449492239|FG002|Active Drug Period|Progressive Disease|4|||
124963112|NCT04944784|449492240|FG003|Active Drug Period|Progressive Disease|4|||
124963113|NCT04944784|449492237|FG000|Active Drug Period|Lost to Follow-up|0|||
124464243|NCT03311711|447658082|FG005|Overall Study|Lost to Follow-up|0|||
124464244|NCT03311711|447658083|FG006|Overall Study|Lost to Follow-up|1|||
124963114|NCT04944784|449492238|FG001|Active Drug Period|Lost to Follow-up|0|||
124464245|NCT03311711|447658084|FG007|Overall Study|Lost to Follow-up|1|||
124464246|NCT03311711|447658085|FG008|Overall Study|Lost to Follow-up|0|||
124963115|NCT04944784|449492239|FG002|Active Drug Period|Lost to Follow-up|0|||
124464247|NCT03311711|447658086|FG009|Overall Study|Lost to Follow-up|0|||
124963116|NCT04944784|449492240|FG003|Active Drug Period|Lost to Follow-up|1|||
124963117|NCT02210208|449494026|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
124464248|NCT03311711|447658077|FG000|Overall Study|Withdrawal by Subject|1|||
124464249|NCT03311711|447658078|FG001|Overall Study|Withdrawal by Subject|1|||
124464250|NCT03311711|447658079|FG002|Overall Study|Withdrawal by Subject|0|||
124464251|NCT03311711|447658080|FG003|Overall Study|Withdrawal by Subject|0|||
124709390|NCT00956293|448561432|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
124709391|NCT00956293|448561430|FG000|Main Period (Pre-randomization)|Graft loss|0|||
124709392|NCT00956293|448561431|FG001|Main Period (Pre-randomization)|Graft loss|0|||
124709393|NCT00956293|448561432|FG002|Main Period (Pre-randomization)|Graft loss|7|||
124709394|NCT00956293|448561430|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
124709395|NCT00956293|448561431|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
124709396|NCT00956293|448561432|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
124709397|NCT00956293|448561430|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
124709398|NCT00956293|448561431|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
124709399|NCT00956293|448561432|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
124709400|NCT00956293|448561430|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
124709401|NCT00956293|448561431|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
124709402|NCT00956293|448561432|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
124709403|NCT00956293|448561430|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
124709404|NCT00956293|448561431|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
124709405|NCT00956293|448561432|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
124709406|NCT00956293|448561430|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
124709407|NCT00956293|448561431|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
124709408|NCT00956293|448561432|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
124709409|NCT00956293|448561430|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
124709410|NCT00956293|448561431|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
124709411|NCT00956293|448561432|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
124709412|NCT00956293|448561430|FG000|Main Period (Randomization)|Adverse Event|0|||
124709413|NCT00956293|448561431|FG001|Main Period (Randomization)|Adverse Event|15|||
124709414|NCT00956293|448561432|FG002|Main Period (Randomization)|Adverse Event|0|||
124709415|NCT00956293|448561430|FG000|Follow-up Period|Follow-up period was terminated.|20|||
124709416|NCT00956293|448561431|FG001|Follow-up Period|Follow-up period was terminated.|32|||
124709417|NCT00956293|448561432|FG002|Follow-up Period|Follow-up period was terminated.|0|||
124709418|NCT03383666|448561433|FG000|Overall Study|Withdrawal by Subject|2|||
124709419|NCT03383666|448561433|FG000|Overall Study|Lost to Follow-up|2|||
124709420|NCT02536664|448561434|FG000|Overall Study|Inadequate completion of documentation|2|||
124709421|NCT02536664|448561435|FG001|Overall Study|Inadequate completion of documentation|4|||
124709422|NCT02536664|448561434|FG000|Overall Study|Progression|13|||
124709423|NCT02536664|448561435|FG001|Overall Study|Progression|18|||
124709424|NCT02536664|448561434|FG000|Overall Study|Death due to lymphoma|2|||
124709425|NCT02536664|448561435|FG001|Overall Study|Death due to lymphoma|1|||
124709426|NCT02536664|448561434|FG000|Overall Study|Death due to other reason|3|||
124709427|NCT02536664|448561435|FG001|Overall Study|Death due to other reason|2|||
124709428|NCT02536664|448561434|FG000|Overall Study|Intolerability|8|||
124709429|NCT02536664|448561435|FG001|Overall Study|Intolerability|6|||
124709430|NCT02536664|448561434|FG000|Overall Study|Withdrawal by Subject|8|||
124709431|NCT02536664|448561435|FG001|Overall Study|Withdrawal by Subject|5|||
124709432|NCT02536664|448561434|FG000|Overall Study|Other|18|||
124709433|NCT02536664|448561435|FG001|Overall Study|Other|24|||
124709434|NCT02536664|448561434|FG000|Overall Study|Missing|53|||
124709435|NCT02536664|448561435|FG001|Overall Study|Missing|20|||
124709436|NCT01174563|448561444|FG000|Overall Study|Progressive Disease|45|||
124709437|NCT01174563|448561444|FG000|Overall Study|Death|5|||
124709438|NCT01174563|448561444|FG000|Overall Study|Investigator's Discretion|5|||
124709439|NCT01174563|448561444|FG000|Overall Study|Participant Withdrew Consent|3|||
124709440|NCT01174563|448561444|FG000|Overall Study|Rash Adverse Event|1|||
124709441|NCT01174563|448561444|FG000|Overall Study|Sponsor's decision|1|||
124709442|NCT03402841|448561445|FG000|Overall Study|Withdrawal by Subject|3|||
124709443|NCT03402841|448561445|FG000|Overall Study|Lost to Follow-up|2|||
124709444|NCT03402841|448561445|FG000|Overall Study|Death|146|||
124709445|NCT01542788|448561450|FG000|Overall Study|Randomized but Not Treated|2|||
124709446|NCT01542788|448561451|FG001|Overall Study|Randomized but Not Treated|0|||
124709447|NCT01542788|448561450|FG000|Overall Study|Lack of Efficacy|41|||
124709448|NCT01542788|448561451|FG001|Overall Study|Lack of Efficacy|71|||
124709449|NCT01542788|448561450|FG000|Overall Study|Lost to Follow-up|5|||
124709450|NCT01542788|448561451|FG001|Overall Study|Lost to Follow-up|0|||
124709451|NCT01542788|448561450|FG000|Overall Study|Death|3|||
124709452|NCT01542788|448561451|FG001|Overall Study|Death|0|||
124709453|NCT01542788|448561450|FG000|Overall Study|Protocol Violation|2|||
124709454|NCT01542788|448561451|FG001|Overall Study|Protocol Violation|0|||
124709455|NCT01542788|448561450|FG000|Overall Study|Physician Decision|1|||
124709456|NCT01542788|448561451|FG001|Overall Study|Physician Decision|0|||
124709457|NCT01542788|448561450|FG000|Overall Study|Withdrawal by Subject|1|||
124709458|NCT01542788|448561451|FG001|Overall Study|Withdrawal by Subject|0|||
124709459|NCT01280968|448561452|FG000|Overall Study|Lost to Follow-up|8|||
124709460|NCT01280968|448561453|FG001|Overall Study|Lost to Follow-up|2|||
124769483|NCT01456039|448785074|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
124769484|NCT01456039|448785075|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
124769485|NCT01456039|448785076|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
124769486|NCT01456039|448785074|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
124769487|NCT01456039|448785075|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
124769488|NCT01456039|448785076|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
124769489|NCT01456039|448785074|FG000|Phase 2 (Second Step)|Other|0|||
124769490|NCT01456039|448785075|FG001|Phase 2 (Second Step)|Other|0|||
124769491|NCT01456039|448785076|FG002|Phase 2 (Second Step)|Other|1|||
124769492|NCT00335777|448785080|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
124769493|NCT00335777|448785080|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
124769494|NCT00335777|448785080|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
124769495|NCT00335777|448785080|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
124769496|NCT00335777|448785080|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
124769497|NCT00992108|448785083|FG000|Overall Study|Lost to Follow-up|0|||
124769498|NCT00992108|448785084|FG001|Overall Study|Lost to Follow-up|1|||
124769499|NCT04639245|448785089|FG000|Overall Study|Death|1|||
124769500|NCT01702311|448785090|FG000|Overall Study|Withdrawal by Subject|3|||
124769501|NCT01702311|448785091|FG001|Overall Study|Withdrawal by Subject|2|||
124769502|NCT01702311|448785090|FG000|Overall Study|Discharge less than 24 hours|10|||
124769503|NCT01702311|448785091|FG001|Overall Study|Discharge less than 24 hours|7|||
124769504|NCT01702311|448785090|FG000|Overall Study|Physician Decision|3|||
124549490|NCT03972709|447967068|FG001|Overall Study|Physician Decision|0|||
124769505|NCT01702311|448785091|FG001|Overall Study|Physician Decision|4|||
124769506|NCT01209689|448785094|FG000|Overall Study|Insufficient Therapeutic Response|7|||
124769507|NCT01209689|448785095|FG001|Overall Study|Insufficient Therapeutic Response|2|||
124769508|NCT01209689|448785094|FG000|Overall Study|Refused Treatment|8|||
124769509|NCT01209689|448785095|FG001|Overall Study|Refused Treatment|3|||
124769510|NCT01209689|448785094|FG000|Overall Study|Adverse Event|4|||
124769511|NCT01209689|448785095|FG001|Overall Study|Adverse Event|0|||
124769512|NCT01209689|448785094|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
124769513|NCT01209689|448785095|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
124769514|NCT01209689|448785094|FG000|Overall Study|Failure to Return|3|||
124769515|NCT01209689|448785095|FG001|Overall Study|Failure to Return|0|||
124769516|NCT01209689|448785094|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
124769517|NCT01209689|448785095|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
124769518|NCT03337477|448785096|FG000|Overall Study|not categorized into the listed ones|11|||
124769519|NCT03337477|448785097|FG001|Overall Study|not categorized into the listed ones|9|||
124769520|NCT03337477|448785096|FG000|Overall Study|Withdrawal by Subject|0|||
124769521|NCT03337477|448785097|FG001|Overall Study|Withdrawal by Subject|1|||
124769522|NCT03337477|448785096|FG000|Overall Study|Death|0|||
124769523|NCT03337477|448785097|FG001|Overall Study|Death|1|||
124769524|NCT03337477|448785096|FG000|Overall Study|Lost to Follow-up|0|||
124769525|NCT03337477|448785097|FG001|Overall Study|Lost to Follow-up|2|||
124769526|NCT03181932|448785098|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
124769527|NCT03181932|448785099|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
124769528|NCT03181932|448785098|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
124769529|NCT03181932|448785099|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
124769530|NCT03181932|448785098|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
124769531|NCT03181932|448785099|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
124769532|NCT03181932|448785098|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
124769533|NCT03181932|448785099|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
124769534|NCT03181932|448785098|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
124769535|NCT03181932|448785099|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
124769536|NCT03181932|448785098|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
124769537|NCT03181932|448785099|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
124769538|NCT03181932|448785098|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
124769539|NCT03181932|448785099|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
124549491|NCT03972709|447967069|FG002|Overall Study|Physician Decision|0|||
124963118|NCT02210208|449494026|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
124963119|NCT02210208|449494026|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
124963120|NCT01066936|449494027|FG000|Overall Study|Death|2|||
124963121|NCT01066936|449494027|FG000|Overall Study|Device revised/removed|1|||
124963122|NCT01066936|449494027|FG000|Overall Study|Lost to Follow-up|3|||
124963123|NCT01066936|449494027|FG000|Overall Study|Withdrawal by Subject|4|||
124963124|NCT04984239|449494030|FG000|Overall Study|Lost to Follow-up|1|||
124709461|NCT01280968|448561452|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
124709462|NCT01280968|448561453|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
124709463|NCT01280968|448561452|FG000|Overall Study|Commuting Problems|2|||
124709464|NCT01280968|448561453|FG001|Overall Study|Commuting Problems|0|||
124709465|NCT01280968|448561452|FG000|Overall Study|Anxiety|2|||
124709466|NCT01280968|448561453|FG001|Overall Study|Anxiety|0|||
124709467|NCT01280968|448561452|FG000|Overall Study|Adverse Event|1|||
124709468|NCT01280968|448561453|FG001|Overall Study|Adverse Event|0|||
124709469|NCT01280968|448561452|FG000|Overall Study|Scheduling Conflicts|1|||
124709470|NCT01280968|448561453|FG001|Overall Study|Scheduling Conflicts|1|||
124709471|NCT01280968|448561452|FG000|Overall Study|Pre-existing Neurological Condition|1|||
124709472|NCT01280968|448561453|FG001|Overall Study|Pre-existing Neurological Condition|0|||
124709473|NCT01280968|448561452|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
124709474|NCT01280968|448561453|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
124709475|NCT04704193|448561454|FG000|Overall Study|Withdrawal by Subject|1|||
124709476|NCT00542178|448561455|FG000|Overall Study|did not complete year 4 follow-up|75|||
124709477|NCT00542178|448561456|FG001|Overall Study|did not complete year 4 follow-up|80|||
124709478|NCT00542178|448561457|FG002|Overall Study|did not complete year 4 follow-up|74|||
124709479|NCT00542178|448561458|FG003|Overall Study|did not complete year 4 follow-up|62|||
124709480|NCT00542178|448561459|FG004|Overall Study|did not complete year 4 follow-up|64|||
124709481|NCT00542178|448561460|FG005|Overall Study|did not complete year 4 follow-up|89|||
124709482|NCT00542178|448561461|FG006|Overall Study|did not complete year 4 follow-up|87|||
124709483|NCT00542178|448561462|FG007|Overall Study|did not complete year 4 follow-up|85|||
124709484|NCT03984188|448561468|FG000|Overall Study|Death|2|||
124709485|NCT03984188|448561469|FG001|Overall Study|Death|4|||
124709486|NCT03984188|448561468|FG000|Overall Study|Physician Decision|0|||
124709487|NCT03984188|448561469|FG001|Overall Study|Physician Decision|2|||
124709488|NCT03984188|448561468|FG000|Overall Study|Lost to Follow-up|3|||
124709489|NCT03984188|448561469|FG001|Overall Study|Lost to Follow-up|2|||
124709490|NCT03984188|448561468|FG000|Overall Study|Withdrawal by Subject|6|||
124709491|NCT03984188|448561469|FG001|Overall Study|Withdrawal by Subject|0|||
124709492|NCT01173679|448562921|FG000|Overall Study|Death|1|||
124709493|NCT01250054|448562922|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
124709494|NCT01250054|448562923|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
124709495|NCT02777086|448562924|FG000|Overall Study|Lost to Follow-up|96|||
124709496|NCT02777086|448562925|FG001|Overall Study|Lost to Follow-up|99|||
124709497|NCT01133665|448562930|FG000|Overall Study|Physician Decision|2|||
124709498|NCT02122380|448562931|FG000|First Intervention (30 Days)|Adverse Event|1|||
124709499|NCT02122380|448562932|FG001|First Intervention (30 Days)|Adverse Event|0|||
124709500|NCT02122380|448562931|FG000|First Intervention (30 Days)|Physician Decision|0|||
124709501|NCT02122380|448562932|FG001|First Intervention (30 Days)|Physician Decision|1|||
124709502|NCT02122380|448562931|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
124709503|NCT02122380|448562932|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
124709504|NCT02122380|448562931|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
124709505|NCT02122380|448562932|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
124709506|NCT02122380|448562931|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
124709507|NCT02122380|448562932|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
124709508|NCT00272792|448562933|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
124709509|NCT00272792|448562934|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
124709510|NCT00272792|448562933|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
124709511|NCT00272792|448562934|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
124709512|NCT00272792|448562933|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
124709513|NCT00272792|448562934|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
124709514|NCT00272792|448562933|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
124709515|NCT00272792|448562934|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
124709516|NCT02921789|448562935|FG000|Overall Study|Adverse Event|0|||
124709517|NCT02921789|448562936|FG001|Overall Study|Adverse Event|1|||
124709518|NCT02921789|448562935|FG000|Overall Study|Lost to Follow-up|1|||
124963125|NCT04190225|449494031|FG000|Overall Study|Lost to Follow-up|2|||
124963126|NCT04190225|449494032|FG001|Overall Study|Lost to Follow-up|3|||
124709519|NCT02921789|448562936|FG001|Overall Study|Lost to Follow-up|0|||
124709520|NCT02921789|448562935|FG000|Overall Study|Protocol Deviation|2|||
124709521|NCT02921789|448562936|FG001|Overall Study|Protocol Deviation|0|||
124709522|NCT02921789|448562935|FG000|Overall Study|Withdrawal by Subject|2|||
124963127|NCT04190225|449494031|FG000|Overall Study|Withdrawal by Subject|3|||
124963128|NCT04190225|449494032|FG001|Overall Study|Withdrawal by Subject|2|||
124464252|NCT03311711|447658081|FG004|Overall Study|Withdrawal by Subject|0|||
124464253|NCT03311711|447658082|FG005|Overall Study|Withdrawal by Subject|0|||
124464254|NCT03311711|447658083|FG006|Overall Study|Withdrawal by Subject|3|||
124464255|NCT03311711|447658084|FG007|Overall Study|Withdrawal by Subject|3|||
124464256|NCT03311711|447658085|FG008|Overall Study|Withdrawal by Subject|0|||
124464257|NCT03311711|447658086|FG009|Overall Study|Withdrawal by Subject|0|||
124464258|NCT02229552|447658087|FG000|Baseline|Withdrawal by Subject|6|||
124464259|NCT02229552|447658087|FG000|1-year Follow up|Withdrawal by Subject|7|||
124464260|NCT02229552|447658087|FG000|1-year Follow up|Lost to Follow-up|18|||
124963129|NCT04190225|449494031|FG000|Overall Study|Unrelated health condition|2|||
124963130|NCT04190225|449494032|FG001|Overall Study|Unrelated health condition|0|||
124963131|NCT02994784|449494033|FG000|6 Months Follow-up|Lost to Follow-up|3|||
124963132|NCT02466243|449494035|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
124963133|NCT02466243|449494036|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
124963134|NCT02466243|449494035|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
124963135|NCT02466243|449494036|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
124963136|NCT02466243|449494035|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
124963137|NCT02466243|449494036|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
124963138|NCT02466243|449494035|FG000|Part B Open-label Treatment Period|Missing|2|||
124963139|NCT02466243|449494036|FG001|Part B Open-label Treatment Period|Missing|2|||
124963140|NCT00477464|449494037|FG000|Overall Study|Lost to Follow-up|1|||
124963141|NCT00477464|449494037|FG000|Overall Study|Death|36|||
124963142|NCT00477464|449494037|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
124464261|NCT02229552|447658087|FG000|2-Year Follow up|Withdrawal by Subject|9|||
124464262|NCT02229552|447658087|FG000|2-Year Follow up|Lost to Follow-up|17|||
124464263|NCT01623271|447658092|FG000|Overall Study|Withdrawal by Subject|2|||
124464264|NCT00706134|447658093|FG000|Overall Study|Adverse Event|8|||
124464265|NCT00706134|447658094|FG001|Overall Study|Adverse Event|7|||
124464266|NCT00706134|447658095|FG002|Overall Study|Adverse Event|2|||
124464267|NCT00706134|447658096|FG003|Overall Study|Adverse Event|3|||
124549492|NCT03972709|447967067|FG000|Overall Study|COVID-19|0|||
124549493|NCT03972709|447967068|FG001|Overall Study|COVID-19|1|||
124464268|NCT00706134|447658093|FG000|Overall Study|Lost to Follow-up|0|||
124549494|NCT03972709|447967069|FG002|Overall Study|COVID-19|1|||
124549495|NCT03972709|447967067|FG000|Overall Study|Lost to Follow-up|6|||
124963143|NCT00639769|449494038|FG000|Overall Study|Death|2|||
124963144|NCT00639769|449494038|FG000|Overall Study|Adverse Event|7|||
124963145|NCT00639769|449494038|FG000|Overall Study|Lack of Efficacy|1|||
124963146|NCT00639769|449494038|FG000|Overall Study|Disease progression|26|||
124963147|NCT00639769|449494038|FG000|Overall Study|Withdrawal by Subject|4|||
124963148|NCT00863798|449494039|FG000|Overall Study|Adverse Event|5|||
124963149|NCT00863798|449494040|FG001|Overall Study|Adverse Event|2|||
124963150|NCT00863798|449494041|FG002|Overall Study|Adverse Event|4|||
124963151|NCT00863798|449494039|FG000|Overall Study|Participant failed to return|2|||
124963152|NCT00863798|449494040|FG001|Overall Study|Participant failed to return|1|||
124963153|NCT00863798|449494041|FG002|Overall Study|Participant failed to return|0|||
124963154|NCT00863798|449494039|FG000|Overall Study|Investigator request|1|||
124963155|NCT00863798|449494040|FG001|Overall Study|Investigator request|2|||
124464269|NCT00706134|447658094|FG001|Overall Study|Lost to Follow-up|1|||
124549496|NCT03972709|447967068|FG001|Overall Study|Lost to Follow-up|1|||
124769540|NCT03181932|448785098|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
124769541|NCT03181932|448785099|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
124769542|NCT03181932|448785098|FG000|Period 2 (Open-label Period)|Reason missing|2|||
124769543|NCT03181932|448785099|FG001|Period 2 (Open-label Period)|Reason missing|0|||
124769544|NCT02220920|448785100|FG000|Overall Study|Adverse Event|1|||
124769545|NCT02220920|448785101|FG001|Overall Study|Adverse Event|0|||
124769546|NCT02220920|448785100|FG000|Overall Study|Lack of Efficacy|0|||
124769547|NCT02220920|448785101|FG001|Overall Study|Lack of Efficacy|1|||
124769548|NCT02220920|448785100|FG000|Overall Study|Withdrawal by Subject|1|||
124464270|NCT00706134|447658095|FG002|Overall Study|Lost to Follow-up|0|||
124464271|NCT00706134|447658096|FG003|Overall Study|Lost to Follow-up|0|||
124464272|NCT00706134|447658093|FG000|Overall Study|Protocol Violation|0|||
124464273|NCT00706134|447658094|FG001|Overall Study|Protocol Violation|6|||
124464274|NCT00706134|447658095|FG002|Overall Study|Protocol Violation|0|||
124464275|NCT00706134|447658096|FG003|Overall Study|Protocol Violation|3|||
124769549|NCT02220920|448785101|FG001|Overall Study|Withdrawal by Subject|0|||
124769550|NCT02220920|448785100|FG000|Overall Study|Conflict with the stopping criteria|1|||
124769551|NCT02220920|448785101|FG001|Overall Study|Conflict with the stopping criteria|2|||
124464276|NCT00706134|447658093|FG000|Overall Study|Withdrawal by Subject|1|||
124464277|NCT00706134|447658094|FG001|Overall Study|Withdrawal by Subject|2|||
124963156|NCT00863798|449494041|FG002|Overall Study|Investigator request|1|||
124963157|NCT00863798|449494039|FG000|Overall Study|Lack of Efficacy|4|||
124963158|NCT00863798|449494040|FG001|Overall Study|Lack of Efficacy|3|||
124549497|NCT03972709|447967069|FG002|Overall Study|Lost to Follow-up|2|||
124464278|NCT00706134|447658095|FG002|Overall Study|Withdrawal by Subject|1|||
124549498|NCT03972709|447967067|FG000|Overall Study|Death|5|||
124549499|NCT03972709|447967068|FG001|Overall Study|Death|1|||
124549500|NCT03972709|447967069|FG002|Overall Study|Death|4|||
124549501|NCT03972709|447967067|FG000|Overall Study|Adverse Event|3|||
124549502|NCT03972709|447967068|FG001|Overall Study|Adverse Event|1|||
124549503|NCT03972709|447967069|FG002|Overall Study|Adverse Event|4|||
124549504|NCT03972709|447967067|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
124549505|NCT03972709|447967068|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
124769552|NCT00853307|448785102|FG000|Overall Study|Adverse Event|1|||
124769553|NCT00853307|448785103|FG001|Overall Study|Adverse Event|2|||
124769554|NCT00853307|448785102|FG000|Overall Study|Withdrawal by Subject|1|||
124769555|NCT00853307|448785103|FG001|Overall Study|Withdrawal by Subject|2|||
124769556|NCT00853307|448785102|FG000|Overall Study|Reason Not Specified|0|||
124769557|NCT00853307|448785103|FG001|Overall Study|Reason Not Specified|1|||
124963159|NCT00863798|449494041|FG002|Overall Study|Lack of Efficacy|6|||
124963160|NCT00863798|449494039|FG000|Overall Study|Lost to Follow-up|6|||
124963161|NCT00863798|449494040|FG001|Overall Study|Lost to Follow-up|9|||
124963162|NCT00863798|449494041|FG002|Overall Study|Lost to Follow-up|5|||
124963163|NCT00863798|449494039|FG000|Overall Study|Other|2|||
124963164|NCT00863798|449494040|FG001|Overall Study|Other|3|||
124963165|NCT00863798|449494041|FG002|Overall Study|Other|1|||
124963166|NCT00863798|449494039|FG000|Overall Study|Protocol Violation|0|||
124963167|NCT00863798|449494040|FG001|Overall Study|Protocol Violation|1|||
124963168|NCT00863798|449494041|FG002|Overall Study|Protocol Violation|1|||
124963169|NCT00863798|449494039|FG000|Overall Study|Withdrawal by Subject|8|||
124963170|NCT00863798|449494040|FG001|Overall Study|Withdrawal by Subject|7|||
124963171|NCT00863798|449494041|FG002|Overall Study|Withdrawal by Subject|4|||
124963172|NCT00863798|449494039|FG000|Overall Study|Randomized not treated|4|||
124963173|NCT00863798|449494040|FG001|Overall Study|Randomized not treated|2|||
124963174|NCT00863798|449494041|FG002|Overall Study|Randomized not treated|3|||
124963175|NCT04238520|449494042|FG000|Overall Study|Withdrawal by Subject|1|||
124963176|NCT04238520|449494043|FG001|Overall Study|Withdrawal by Subject|1|||
124963177|NCT04238520|449494042|FG000|Overall Study|Lost to Follow-up|1|||
124963178|NCT04238520|449494043|FG001|Overall Study|Lost to Follow-up|2|||
124963179|NCT04238520|449494042|FG000|Overall Study|Death|0|||
124963180|NCT04238520|449494043|FG001|Overall Study|Death|2|||
124963181|NCT04238520|449494042|FG000|Overall Study|Unsafe home environment for research staff|0|||
124963182|NCT04238520|449494043|FG001|Overall Study|Unsafe home environment for research staff|1|||
124963183|NCT01470599|449494044|FG000|Overall Study|Did not meet entrance criteria|1|||
124963184|NCT01470599|449494045|FG001|Overall Study|Did not meet entrance criteria|0|||
124963185|NCT01470599|449494044|FG000|Overall Study|Lost to Follow-up|2|||
124963186|NCT01470599|449494045|FG001|Overall Study|Lost to Follow-up|1|||
124963187|NCT01470599|449494044|FG000|Overall Study|Withdrawal by Subject|3|||
124963188|NCT01470599|449494045|FG001|Overall Study|Withdrawal by Subject|4|||
124963189|NCT01470599|449494044|FG000|Overall Study|Other|1|||
124963190|NCT01470599|449494045|FG001|Overall Study|Other|0|||
124963191|NCT01470599|449494044|FG000|Overall Study|Protocol Violation|3|||
124963192|NCT01470599|449494045|FG001|Overall Study|Protocol Violation|1|||
124963193|NCT01470599|449494044|FG000|Overall Study|Adverse event related to study drug|2|||
124963194|NCT01470599|449494045|FG001|Overall Study|Adverse event related to study drug|5|||
124963195|NCT01470599|449494044|FG000|Overall Study|Insufficient clinical response|6|||
124963196|NCT01470599|449494045|FG001|Overall Study|Insufficient clinical response|27|||
124963197|NCT01470599|449494044|FG000|Overall Study|Adverse event not related to study drug|1|||
124963198|NCT01470599|449494045|FG001|Overall Study|Adverse event not related to study drug|5|||
124963199|NCT00195442|449494046|FG000|Overall Study|Less than expected therapeutic effect|38|||
124963200|NCT00195442|449494046|FG000|Overall Study|Lost to Follow-up|27|||
124963201|NCT00195442|449494046|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
124963202|NCT00195442|449494046|FG000|Overall Study|Intermittent product shortage|21|||
124963203|NCT00195442|449494046|FG000|Overall Study|Death|7|||
124963204|NCT00195442|449494046|FG000|Overall Study|No reason specified|4|||
124963205|NCT00195442|449494046|FG000|Overall Study|Poor cooperation|2|||
124963206|NCT00195442|449494046|FG000|Overall Study|Other|14|||
124963207|NCT01917006|449494047|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
124963208|NCT01917006|449494048|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
124963209|NCT01917006|449494049|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
124963210|NCT01917006|449494050|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
124963211|NCT01917006|449494051|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
124963212|NCT01917006|449494052|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
124963213|NCT01917006|449494053|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
124963214|NCT01917006|449494054|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
124963215|NCT01917006|449494047|FG000|Randomized-treatment Period|Personal Reasons|0|||
124963216|NCT01917006|449494048|FG001|Randomized-treatment Period|Personal Reasons|0|||
124963217|NCT01917006|449494049|FG002|Randomized-treatment Period|Personal Reasons|0|||
124963218|NCT01917006|449494050|FG003|Randomized-treatment Period|Personal Reasons|0|||
124769558|NCT00473564|448785104|FG000|Overall Study|robot surgery aborted in OR|23|||
124769559|NCT01112917|448785105|FG000|Overall Study|Death|2|||
124963219|NCT01917006|449494051|FG004|Randomized-treatment Period|Personal Reasons|0|||
124963220|NCT01917006|449494052|FG005|Randomized-treatment Period|Personal Reasons|1|||
124963221|NCT01917006|449494053|FG006|Randomized-treatment Period|Personal Reasons|0|||
124963222|NCT01917006|449494054|FG007|Randomized-treatment Period|Personal Reasons|0|||
124963223|NCT01917006|449494047|FG000|Randomized-treatment Period|Protocol Violation|1|||
124963224|NCT01917006|449494048|FG001|Randomized-treatment Period|Protocol Violation|0|||
124963225|NCT01917006|449494049|FG002|Randomized-treatment Period|Protocol Violation|0|||
124963226|NCT01917006|449494050|FG003|Randomized-treatment Period|Protocol Violation|0|||
124963227|NCT01917006|449494051|FG004|Randomized-treatment Period|Protocol Violation|0|||
124963228|NCT01917006|449494052|FG005|Randomized-treatment Period|Protocol Violation|0|||
124963229|NCT01917006|449494053|FG006|Randomized-treatment Period|Protocol Violation|0|||
124963230|NCT01917006|449494054|FG007|Randomized-treatment Period|Protocol Violation|0|||
124963231|NCT01917006|449494047|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
124464279|NCT00706134|447658096|FG003|Overall Study|Withdrawal by Subject|0|||
124464280|NCT00706134|447658093|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
124464281|NCT00706134|447658094|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
124464282|NCT00706134|447658095|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
124464283|NCT00706134|447658096|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
124464284|NCT00706134|447658093|FG000|Overall Study|Did not meet study criteria|2|||
124464285|NCT00706134|447658094|FG001|Overall Study|Did not meet study criteria|0|||
124464286|NCT00706134|447658095|FG002|Overall Study|Did not meet study criteria|0|||
124464287|NCT00706134|447658096|FG003|Overall Study|Did not meet study criteria|0|||
124464288|NCT01982292|447658097|FG000|Overall Study|Adverse Event|2|||
124464289|NCT01982292|447658098|FG001|Overall Study|Adverse Event|0|||
124464290|NCT01982292|447658097|FG000|Overall Study|Death|1|||
124464291|NCT01982292|447658098|FG001|Overall Study|Death|0|||
124963232|NCT01917006|449494048|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
124464292|NCT01982292|447658097|FG000|Overall Study|Lost to Follow-up|2|||
124464293|NCT01982292|447658098|FG001|Overall Study|Lost to Follow-up|0|||
124464294|NCT01982292|447658097|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
124464295|NCT01982292|447658098|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
124464296|NCT01982292|447658097|FG000|Overall Study|Protocol Deviation|1|||
124464297|NCT01982292|447658098|FG001|Overall Study|Protocol Deviation|0|||
124464298|NCT01982292|447658097|FG000|Overall Study|Patient/Guardian Decision|3|||
124464299|NCT01982292|447658098|FG001|Overall Study|Patient/Guardian Decision|1|||
124464300|NCT01982292|447658097|FG000|Overall Study|Technical Problems|2|||
124464301|NCT01982292|447658098|FG001|Overall Study|Technical Problems|0|||
124464302|NCT00746252|447658100|FG000|Overall Study|weight gain >7.5 %|1|||
124464303|NCT00746252|447658101|FG001|Overall Study|weight gain >7.5 %|2|||
124464304|NCT00082888|447658102|FG000|Overall Study|Ineligible|1|||
124464305|NCT00082888|447658103|FG001|Overall Study|Ineligible|0|||
124464306|NCT00082888|447658104|FG002|Overall Study|Ineligible|0|||
124464307|NCT02239939|447658105|FG000|Overall Study|Adverse Event|1|||
124464308|NCT02239939|447658106|FG001|Overall Study|Adverse Event|0|||
124464309|NCT02239939|447658105|FG000|Overall Study|Withdrawal by Subject|1|||
124963233|NCT01917006|449494049|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
124963234|NCT01917006|449494050|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
124963235|NCT01917006|449494051|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
124963236|NCT01917006|449494052|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
124963237|NCT01917006|449494053|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
124464310|NCT02239939|447658106|FG001|Overall Study|Withdrawal by Subject|1|||
124464311|NCT02239939|447658105|FG000|Overall Study|Lost to Follow-up|0|||
124464312|NCT02239939|447658106|FG001|Overall Study|Lost to Follow-up|1|||
124464313|NCT01514682|447658107|FG000|Overall Study|Withdrawal by Subject|2|||
124464314|NCT01514682|447658108|FG001|Overall Study|Withdrawal by Subject|3|||
124464315|NCT01514682|447658107|FG000|Overall Study|Physician Decision|4|||
124464316|NCT01514682|447658108|FG001|Overall Study|Physician Decision|3|||
124464317|NCT01870401|447658109|FG000|Overall Study|Death|48|||
124464318|NCT01870401|447658110|FG001|Overall Study|Death|24|||
124464319|NCT01870401|447658109|FG000|Overall Study|Withdrawal by Subject|39|||
124464320|NCT01870401|447658110|FG001|Overall Study|Withdrawal by Subject|26|||
124464321|NCT01870401|447658109|FG000|Overall Study|Lost to Follow-up|19|||
124464322|NCT01870401|447658110|FG001|Overall Study|Lost to Follow-up|14|||
124464323|NCT01870401|447658109|FG000|Overall Study|Other|9|||
124464324|NCT01870401|447658110|FG001|Overall Study|Other|7|||
124464325|NCT01870401|447658109|FG000|Overall Study|On-going in the Study|35|||
124464326|NCT01870401|447658110|FG001|Overall Study|On-going in the Study|25|||
124464327|NCT02105454|447658113|FG000|Overall Study|Withdrawal by Subject|1|||
124464328|NCT00272038|447658115|FG000|Overall Study|withdrew before they received 2 cycles|7|||
124963238|NCT01917006|449494054|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
124464329|NCT00493870|447658116|FG000|Overall Study|Lost to Follow-up|12|||
124464330|NCT00493870|447658117|FG001|Overall Study|Lost to Follow-up|15|||
124963239|NCT01917006|449494047|FG000|Open-label Period|Adverse Event|0|||
124464331|NCT02721355|447658118|FG000|Overall Study|Lost to Follow-up|6|||
124464332|NCT02721355|447658119|FG001|Overall Study|Lost to Follow-up|1|||
124464333|NCT03605680|447658120|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
124464334|NCT03605680|447658121|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
124963240|NCT01917006|449494048|FG001|Open-label Period|Adverse Event|0|||
124963241|NCT01917006|449494049|FG002|Open-label Period|Adverse Event|0|||
124963242|NCT01917006|449494050|FG003|Open-label Period|Adverse Event|0|||
124963243|NCT01917006|449494051|FG004|Open-label Period|Adverse Event|0|||
124963244|NCT01917006|449494052|FG005|Open-label Period|Adverse Event|0|||
124963245|NCT01917006|449494053|FG006|Open-label Period|Adverse Event|0|||
124963246|NCT01917006|449494054|FG007|Open-label Period|Adverse Event|1|||
124963247|NCT01917006|449494047|FG000|Open-label Period|Lost to Follow-up|0|||
124963248|NCT01917006|449494048|FG001|Open-label Period|Lost to Follow-up|0|||
124963249|NCT01917006|449494049|FG002|Open-label Period|Lost to Follow-up|0|||
124963250|NCT01917006|449494050|FG003|Open-label Period|Lost to Follow-up|0|||
124963251|NCT01917006|449494051|FG004|Open-label Period|Lost to Follow-up|0|||
124963252|NCT01917006|449494052|FG005|Open-label Period|Lost to Follow-up|0|||
124963253|NCT01917006|449494053|FG006|Open-label Period|Lost to Follow-up|0|||
124963254|NCT01917006|449494054|FG007|Open-label Period|Lost to Follow-up|1|||
124963255|NCT00847132|449494057|FG000|Overall Study|Death|1|||
124963256|NCT00847132|449494058|FG001|Overall Study|Death|1|||
124963257|NCT03357471|449494064|FG000|Overall Study|Adverse Event|1|||
124464335|NCT03605680|447658122|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
124464336|NCT03605680|447658123|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
124464337|NCT03605680|447658120|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
124464338|NCT03605680|447658121|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
124464339|NCT03605680|447658122|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
124464340|NCT03605680|447658123|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
124464341|NCT03605680|447658120|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
124464342|NCT03605680|447658121|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
124464343|NCT03605680|447658122|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
124464344|NCT03605680|447658123|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
124464345|NCT03605680|447658120|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
124464346|NCT03605680|447658121|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
124464347|NCT03605680|447658122|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
124464348|NCT03605680|447658123|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
124464349|NCT03605680|447658120|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
124464350|NCT03605680|447658121|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
124464351|NCT03605680|447658122|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
124464352|NCT03605680|447658123|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
124464353|NCT03605680|447658120|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
124464354|NCT03605680|447658121|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
124464355|NCT03605680|447658122|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
124464356|NCT03605680|447658123|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
124963258|NCT03357471|449494065|FG001|Overall Study|Adverse Event|0|||
124464357|NCT03605680|447658120|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
124464358|NCT03605680|447658121|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
124464359|NCT03605680|447658122|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
124464360|NCT03605680|447658123|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
124464361|NCT03605680|447658120|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
124464362|NCT03605680|447658121|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
124963259|NCT03357471|449494064|FG000|Overall Study|Lost to Follow-up|1|||
124963260|NCT03357471|449494065|FG001|Overall Study|Lost to Follow-up|0|||
124963261|NCT02973802|449494066|FG000|Overall Study|Lost to Follow-up|1|||
124963262|NCT02973802|449494066|FG000|Overall Study|Withdrawal by Subject|1|||
124963263|NCT00706914|449494067|FG000|Overall Study|Lack of Efficacy|0|||
124963264|NCT00706914|449494068|FG001|Overall Study|Lack of Efficacy|1|||
124963265|NCT00706914|449494069|FG002|Overall Study|Lack of Efficacy|0|||
124963266|NCT00706914|449494067|FG000|Overall Study|Lost to Follow-up|1|||
124963267|NCT00706914|449494068|FG001|Overall Study|Lost to Follow-up|0|||
124963268|NCT00706914|449494069|FG002|Overall Study|Lost to Follow-up|0|||
124963269|NCT00706914|449494067|FG000|Overall Study|Adverse Event|2|||
124963270|NCT00706914|449494068|FG001|Overall Study|Adverse Event|2|||
124963271|NCT00706914|449494069|FG002|Overall Study|Adverse Event|0|||
124963272|NCT00706914|449494067|FG000|Overall Study|Protocol Violation|3|||
124963273|NCT00706914|449494068|FG001|Overall Study|Protocol Violation|1|||
124963274|NCT00706914|449494069|FG002|Overall Study|Protocol Violation|1|||
124963275|NCT03927690|449494074|FG000|Overall Study|Withdrawal by Subject|3|||
124963276|NCT03927690|449494075|FG001|Overall Study|Withdrawal by Subject|1|||
124963277|NCT03927690|449494076|FG002|Overall Study|Withdrawal by Subject|1|||
124963278|NCT03927690|449494074|FG000|Overall Study|Adverse Event|1|||
124963279|NCT03927690|449494075|FG001|Overall Study|Adverse Event|0|||
124963280|NCT03927690|449494076|FG002|Overall Study|Adverse Event|0|||
124963281|NCT03927690|449494074|FG000|Overall Study|Death|1|||
124963282|NCT03927690|449494075|FG001|Overall Study|Death|0|||
124963283|NCT03927690|449494076|FG002|Overall Study|Death|0|||
124963284|NCT03927690|449494074|FG000|Overall Study|Lost to Follow-up|2|||
124963285|NCT03927690|449494075|FG001|Overall Study|Lost to Follow-up|2|||
124963286|NCT03927690|449494076|FG002|Overall Study|Lost to Follow-up|1|||
124963287|NCT01850823|449494077|FG000|Overall Study|Early Visit Window|0|||
124963288|NCT01850823|449494078|FG001|Overall Study|Early Visit Window|1|||
124963289|NCT01850823|449494079|FG002|Overall Study|Early Visit Window|4|||
124963290|NCT01850823|449494077|FG000|Overall Study|Enrolled in Error|0|||
124963291|NCT01850823|449494078|FG001|Overall Study|Enrolled in Error|1|||
124963292|NCT01850823|449494079|FG002|Overall Study|Enrolled in Error|2|||
124963293|NCT01850823|449494077|FG000|Overall Study|Lack of Efficacy|1|||
124963294|NCT01850823|449494078|FG001|Overall Study|Lack of Efficacy|0|||
124963295|NCT01850823|449494079|FG002|Overall Study|Lack of Efficacy|0|||
124963296|NCT01850823|449494077|FG000|Overall Study|Lost to Follow-up|0|||
124963297|NCT01850823|449494078|FG001|Overall Study|Lost to Follow-up|0|||
124963298|NCT01850823|449494079|FG002|Overall Study|Lost to Follow-up|1|||
124963299|NCT01850823|449494077|FG000|Overall Study|Restricted Medication|0|||
124963300|NCT01850823|449494078|FG001|Overall Study|Restricted Medication|0|||
124963301|NCT01850823|449494079|FG002|Overall Study|Restricted Medication|2|||
124963302|NCT01850823|449494077|FG000|Overall Study|Significant worstening of SAR|0|||
124963303|NCT01850823|449494078|FG001|Overall Study|Significant worstening of SAR|1|||
124963304|NCT01850823|449494079|FG002|Overall Study|Significant worstening of SAR|0|||
124963305|NCT01850823|449494077|FG000|Overall Study|Withdrawal by Subject|2|||
124963306|NCT01850823|449494078|FG001|Overall Study|Withdrawal by Subject|0|||
124963307|NCT01850823|449494079|FG002|Overall Study|Withdrawal by Subject|1|||
124963308|NCT01751165|449494080|FG000|Overall Study|Adverse event, serious fatal|1|||
124963309|NCT01751165|449494081|FG001|Overall Study|Adverse event, serious fatal|0|||
124963310|NCT01751165|449494082|FG002|Overall Study|Adverse event, serious fatal|1|||
124963311|NCT01751165|449494080|FG000|Overall Study|Withdrawal by Subject|0|||
124769560|NCT01112917|448785106|FG001|Overall Study|Death|11|||
124769561|NCT01112917|448785105|FG000|Overall Study|Lost to Follow-up|1|||
124769562|NCT01112917|448785106|FG001|Overall Study|Lost to Follow-up|1|||
124769563|NCT01112917|448785105|FG000|Overall Study|Withdrawal by Subject|1|||
124769564|NCT01112917|448785106|FG001|Overall Study|Withdrawal by Subject|3|||
124769565|NCT01112917|448785105|FG000|Overall Study|Unable to Convert Filter|3|||
124769566|NCT01112917|448785106|FG001|Overall Study|Unable to Convert Filter|0|||
124769567|NCT02177123|448785107|FG000|Overall Study|Lost to Follow-up|6|||
124769568|NCT02177123|448785107|FG000|Overall Study|Withdrawal by Subject|4|||
124769569|NCT02177123|448785107|FG000|Overall Study|Adverse Event|4|||
124769570|NCT02177123|448785107|FG000|Overall Study|Physician Decision|3|||
124769571|NCT02177123|448785107|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
124769572|NCT02177123|448785107|FG000|Overall Study|Excluded for medical reasons|2|||
124963312|NCT01751165|449494081|FG001|Overall Study|Withdrawal by Subject|0|||
124963313|NCT01751165|449494082|FG002|Overall Study|Withdrawal by Subject|1|||
124963314|NCT01751165|449494080|FG000|Overall Study|Serious adverse event|0|||
124963315|NCT01751165|449494081|FG001|Overall Study|Serious adverse event|2|||
124963316|NCT01751165|449494082|FG002|Overall Study|Serious adverse event|0|||
124963317|NCT01751165|449494080|FG000|Overall Study|Lost to Follow-up|1|||
124769573|NCT02177123|448785107|FG000|Overall Study|Death|1|||
124963318|NCT01751165|449494081|FG001|Overall Study|Lost to Follow-up|1|||
124963319|NCT01751165|449494082|FG002|Overall Study|Lost to Follow-up|1|||
124963320|NCT00988533|449494087|FG000|Overall Study|Lost to Follow-up|3|||
124769574|NCT02177123|448785107|FG000|Overall Study|Other|1|||
124963321|NCT00943722|449494093|FG000|Base Study|Adverse Event|0|||
124963322|NCT00943722|449494094|FG001|Base Study|Adverse Event|0|||
124963323|NCT00943722|449494095|FG002|Base Study|Adverse Event|0|||
124963324|NCT00943722|449494096|FG003|Base Study|Adverse Event|1|||
124769575|NCT02177123|448785107|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
124963325|NCT00943722|449494097|FG004|Base Study|Adverse Event|0|||
124963326|NCT00943722|449494098|FG005|Base Study|Adverse Event|0|||
124963327|NCT00943722|449494099|FG006|Base Study|Adverse Event|0|||
124709523|NCT02921789|448562936|FG001|Overall Study|Withdrawal by Subject|1|||
124709524|NCT02921789|448562935|FG000|Overall Study|Miscellaneous|3|||
124963328|NCT00943722|449494093|FG000|Base Study|Lost to Follow-up|12|||
124963329|NCT00943722|449494094|FG001|Base Study|Lost to Follow-up|8|||
124963330|NCT00943722|449494095|FG002|Base Study|Lost to Follow-up|10|||
124963331|NCT00943722|449494096|FG003|Base Study|Lost to Follow-up|8|||
124963332|NCT00943722|449494097|FG004|Base Study|Lost to Follow-up|11|||
124963333|NCT00943722|449494098|FG005|Base Study|Lost to Follow-up|0|||
124963334|NCT00943722|449494099|FG006|Base Study|Lost to Follow-up|0|||
124963335|NCT00943722|449494093|FG000|Base Study|Physician Decision|1|||
124963336|NCT00943722|449494094|FG001|Base Study|Physician Decision|0|||
124963337|NCT00943722|449494095|FG002|Base Study|Physician Decision|0|||
124963338|NCT00943722|449494096|FG003|Base Study|Physician Decision|0|||
124963339|NCT00943722|449494097|FG004|Base Study|Physician Decision|1|||
124963340|NCT00943722|449494098|FG005|Base Study|Physician Decision|0|||
124963341|NCT00943722|449494099|FG006|Base Study|Physician Decision|0|||
124963342|NCT00943722|449494093|FG000|Base Study|Pregnancy|0|||
124963343|NCT00943722|449494094|FG001|Base Study|Pregnancy|0|||
124709525|NCT02921789|448562936|FG001|Overall Study|Miscellaneous|2|||
124709526|NCT04099277|448562937|FG000|Overall Study|Physician Decision|1|||
124709527|NCT04099277|448562937|FG000|Overall Study|Withdrawal by Subject|1|||
124709528|NCT00598650|448562940|FG000|Overall Study|Withdrawal by Subject|3|||
124709529|NCT00598650|448562940|FG000|Overall Study|Adverse Event|18|||
124709530|NCT00598650|448562940|FG000|Overall Study|No treatment for 3 weeks|1|||
124709531|NCT00598650|448562940|FG000|Overall Study|Not eligible|1|||
124709532|NCT00598650|448562940|FG000|Overall Study|Prohibited Concomitant Medication|2|||
124709533|NCT00598650|448562940|FG000|Overall Study|Physician Decision|2|||
124709534|NCT03423602|448562941|FG000|Overall Study|Death|1|||
124709535|NCT03423602|448562941|FG000|Overall Study|Lost to Follow-up|6|||
124709536|NCT03423602|448562941|FG000|Overall Study|Protocol Violation|1|||
124709537|NCT03423602|448562941|FG000|Overall Study|Withdrawal by Subject|4|||
124709538|NCT03423121|448562942|FG000|Overall Study|Lost to Follow-up|2|||
124709539|NCT03423121|448562943|FG001|Overall Study|Lost to Follow-up|6|||
124709540|NCT03423121|448562942|FG000|Overall Study|Adverse Event|1|||
124709541|NCT03423121|448562943|FG001|Overall Study|Adverse Event|0|||
124709542|NCT00560508|448562944|FG000|12 Week Double-blind Period|Adverse Event|3|||
124709543|NCT00560508|448562945|FG001|12 Week Double-blind Period|Adverse Event|2|||
124709544|NCT00560508|448562944|FG000|12 Week Double-blind Period|Protocol Violation|1|||
124709545|NCT00560508|448562945|FG001|12 Week Double-blind Period|Protocol Violation|0|||
124709546|NCT00560508|448562944|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
124709547|NCT00560508|448562945|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
124709548|NCT00560508|448562944|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
124709549|NCT00560508|448562945|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
124709550|NCT00560508|448562944|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
124709551|NCT00560508|448562945|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
124709552|NCT00560508|448562944|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
124709553|NCT00560508|448562945|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
124709554|NCT00560508|448562944|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
124709555|NCT00560508|448562945|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
124709556|NCT01354223|448562946|FG000|Overall Study|Withdrawal by Subject|3|||
124709557|NCT01354223|448562947|FG001|Overall Study|Withdrawal by Subject|1|||
124709558|NCT00948688|448562955|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
124709559|NCT00948688|448562956|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
124709560|NCT00948688|448562955|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
124709561|NCT00948688|448562956|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
124709562|NCT00948688|448562955|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
124963344|NCT00943722|449494095|FG002|Base Study|Pregnancy|1|||
124963345|NCT00943722|449494096|FG003|Base Study|Pregnancy|0|||
124963346|NCT00943722|449494097|FG004|Base Study|Pregnancy|2|||
124963347|NCT00943722|449494098|FG005|Base Study|Pregnancy|0|||
124549506|NCT03972709|447967069|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
124709563|NCT00948688|448562956|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
124769576|NCT02118584|448785111|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
124963348|NCT00943722|449494099|FG006|Base Study|Pregnancy|0|||
124709564|NCT01493089|448562957|FG000|Overall Study|Protocol Violation|2|||
124709565|NCT01493089|448562958|FG001|Overall Study|Protocol Violation|2|||
124709566|NCT01493089|448562957|FG000|Overall Study|Withdrawal by Subject|1|||
124963349|NCT00943722|449494093|FG000|Base Study|Protocol Violation|0|||
124963350|NCT00943722|449494094|FG001|Base Study|Protocol Violation|1|||
124963351|NCT00943722|449494095|FG002|Base Study|Protocol Violation|0|||
124709567|NCT01493089|448562958|FG001|Overall Study|Withdrawal by Subject|0|||
124709568|NCT01493089|448562957|FG000|Overall Study|Physician Decision|0|||
124709569|NCT01493089|448562958|FG001|Overall Study|Physician Decision|1|||
124464363|NCT03605680|447658122|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
124769577|NCT02118584|448785112|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
124769578|NCT02118584|448785113|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
124769579|NCT02118584|448785111|FG000|Part 1: Open Label Extension Period|Death|9|||
124769580|NCT02118584|448785112|FG001|Part 1: Open Label Extension Period|Death|0|||
124769581|NCT02118584|448785113|FG002|Part 1: Open Label Extension Period|Death|0|||
124769582|NCT02118584|448785111|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
124769583|NCT02118584|448785112|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
124769584|NCT02118584|448785113|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
124769585|NCT02118584|448785111|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
124769586|NCT02118584|448785112|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
124769587|NCT02118584|448785113|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
124769588|NCT02118584|448785111|FG000|Part 1: Open Label Extension Period|Other|135|||
124769589|NCT02118584|448785112|FG001|Part 1: Open Label Extension Period|Other|0|||
124769590|NCT02118584|448785113|FG002|Part 1: Open Label Extension Period|Other|0|||
124769591|NCT02118584|448785111|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
124769592|NCT02118584|448785112|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
124769593|NCT02118584|448785113|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
124769594|NCT02118584|448785111|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
124769595|NCT02118584|448785112|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
124769596|NCT02118584|448785113|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
124769597|NCT02118584|448785111|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
124769598|NCT02118584|448785112|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
124769599|NCT02118584|448785113|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
124769600|NCT02118584|448785111|FG000|Part 1: Open Label Extension Period|Other|3|||
124769601|NCT02118584|448785112|FG001|Part 1: Open Label Extension Period|Other|0|||
124769602|NCT02118584|448785113|FG002|Part 1: Open Label Extension Period|Other|0|||
124769603|NCT02118584|448785111|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
124769604|NCT02118584|448785112|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
124769605|NCT02118584|448785113|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
124769606|NCT02118584|448785111|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
124769607|NCT02118584|448785112|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
124769608|NCT02118584|448785113|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
124769609|NCT02118584|448785111|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
124769610|NCT02118584|448785112|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
124769611|NCT02118584|448785113|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
124769612|NCT02118584|448785111|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
124769613|NCT02118584|448785112|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
124769614|NCT02118584|448785113|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
124769615|NCT02118584|448785111|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
124769616|NCT02118584|448785112|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
124769617|NCT02118584|448785113|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
124769618|NCT02118584|448785111|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
124769619|NCT02118584|448785112|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
124769620|NCT02118584|448785113|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
124769621|NCT02118584|448785111|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
124769622|NCT02118584|448785112|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
124769623|NCT02118584|448785113|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
124769624|NCT02118584|448785111|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
124769625|NCT02118584|448785112|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
124769626|NCT02118584|448785113|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
124769627|NCT02118584|448785111|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
124769628|NCT02118584|448785112|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
124769629|NCT02118584|448785113|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
124464364|NCT03605680|447658123|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
124769630|NCT03103542|448785116|FG000|Overall Study|Physician Decision|2|||
124769631|NCT03103542|448785116|FG000|Overall Study|Adverse Event|2|||
124769632|NCT03103542|448785116|FG000|Overall Study|Other|2|||
124769633|NCT03103542|448785116|FG000|Overall Study|Withdrawal by Subject|1|||
124769634|NCT03406780|448785117|FG000|Overall Study|Withdrawal by Subject|1|||
124769635|NCT03406780|448785118|FG001|Overall Study|Withdrawal by Subject|1|||
124769636|NCT03406780|448785117|FG000|Overall Study|Other|0|||
124769637|NCT03406780|448785118|FG001|Overall Study|Other|2|||
124769638|NCT00837434|448785119|FG000|Overall Study|Physician Decision|3|||
124769639|NCT00837434|448785120|FG001|Overall Study|Physician Decision|0|||
124464365|NCT03605680|447658120|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
124464366|NCT03605680|447658121|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
124769640|NCT00837434|448785119|FG000|Overall Study|Lost to Follow-up|1|||
124769641|NCT00837434|448785120|FG001|Overall Study|Lost to Follow-up|1|||
124769642|NCT00837434|448785119|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
124769643|NCT00837434|448785120|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
124769644|NCT00837434|448785119|FG000|Overall Study|Noncompliant|2|||
124769645|NCT00837434|448785120|FG001|Overall Study|Noncompliant|0|||
124769646|NCT00837434|448785119|FG000|Overall Study|Baseline assessments not done in time|1|||
124769647|NCT00837434|448785120|FG001|Overall Study|Baseline assessments not done in time|0|||
124769648|NCT00837434|448785119|FG000|Overall Study|Unable to obtain study drug|1|||
124769649|NCT00837434|448785120|FG001|Overall Study|Unable to obtain study drug|0|||
124769650|NCT03041038|448785137|FG000|Overall Study|Withdrawal by Subject|4|||
124769651|NCT03041038|448785138|FG001|Overall Study|Withdrawal by Subject|0|||
124769652|NCT03041038|448785137|FG000|Overall Study|Lost to Follow-up|1|||
124769653|NCT03041038|448785138|FG001|Overall Study|Lost to Follow-up|1|||
124769654|NCT03041038|448785137|FG000|Overall Study|Protocol Violation|1|||
124769655|NCT03041038|448785138|FG001|Overall Study|Protocol Violation|1|||
124769656|NCT00360230|448785139|FG000|Overall Study|Withdrawal by Subject|1|||
124769657|NCT00360230|448785140|FG001|Overall Study|Withdrawal by Subject|1|||
124769658|NCT00360230|448785141|FG002|Overall Study|Withdrawal by Subject|0|||
124769659|NCT00360230|448785142|FG003|Overall Study|Withdrawal by Subject|1|||
124769660|NCT00360230|448785143|FG004|Overall Study|Withdrawal by Subject|1|||
124769661|NCT00360230|448785144|FG005|Overall Study|Withdrawal by Subject|1|||
124769662|NCT00360230|448785145|FG006|Overall Study|Withdrawal by Subject|0|||
124769663|NCT00360230|448785139|FG000|Overall Study|Migrated|4|||
124769664|NCT00360230|448785140|FG001|Overall Study|Migrated|1|||
124769665|NCT00360230|448785141|FG002|Overall Study|Migrated|3|||
124769666|NCT00360230|448785142|FG003|Overall Study|Migrated|1|||
124549507|NCT03972709|447967067|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
124549508|NCT03972709|447967068|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
124549509|NCT03972709|447967069|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
124549510|NCT03972709|447967067|FG000|Overall Study|Subject Unable to be Contacted|0|||
124549511|NCT03972709|447967068|FG001|Overall Study|Subject Unable to be Contacted|1|||
124549512|NCT03972709|447967069|FG002|Overall Study|Subject Unable to be Contacted|0|||
124549513|NCT03972709|447967067|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
124549514|NCT03972709|447967068|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
124549515|NCT03972709|447967069|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
124549516|NCT03972709|447967067|FG000|Overall Study|Subject Moved|0|||
124549517|NCT03972709|447967068|FG001|Overall Study|Subject Moved|1|||
124549518|NCT03972709|447967069|FG002|Overall Study|Subject Moved|0|||
124549519|NCT03972709|447967067|FG000|Overall Study|Missed Study Visits|1|||
124549520|NCT03972709|447967068|FG001|Overall Study|Missed Study Visits|0|||
124549521|NCT03972709|447967069|FG002|Overall Study|Missed Study Visits|0|||
124549522|NCT01339000|447967072|FG000|Overall Study|study closed due to lack of drug supply|1|||
124549523|NCT01339000|447967073|FG001|Overall Study|study closed due to lack of drug supply|0|||
124549524|NCT00938015|447967075|FG000|Overall Study|Death|2|||
124549525|NCT00938015|447967075|FG000|Overall Study|Lost to Follow-up|32|||
124549526|NCT00938015|447967075|FG000|Overall Study|Adverse Event|32|||
124549527|NCT00938015|447967075|FG000|Overall Study|Non-responder|52|||
124549528|NCT00938015|447967075|FG000|Overall Study|Reason not related to Etanercept|29|||
124549529|NCT02341482|447967076|FG000|Overall Study|Adverse Event|1|||
124549530|NCT00834366|447967079|FG000|Treatment Period 1|Adverse Event|1|||
124549531|NCT00834366|447967080|FG001|Treatment Period 1|Adverse Event|1|||
124549532|NCT00090259|447967081|FG000|Overall Study|Lost to Follow-up|30|||
124709570|NCT03012334|448562959|FG000|Period 1|Withdrawal by Subject|0|||
124709571|NCT03012334|448562960|FG001|Period 1|Withdrawal by Subject|0|||
124709572|NCT03012334|448562961|FG002|Period 1|Withdrawal by Subject|0|||
124709573|NCT03012334|448562962|FG003|Period 1|Withdrawal by Subject|0|||
124709574|NCT03012334|448562963|FG004|Period 1|Withdrawal by Subject|0|||
124709575|NCT03012334|448562964|FG005|Period 1|Withdrawal by Subject|0|||
124709576|NCT03012334|448562965|FG006|Period 1|Withdrawal by Subject|0|||
124709577|NCT03012334|448562966|FG007|Period 1|Withdrawal by Subject|0|||
124709578|NCT03012334|448562967|FG008|Period 1|Withdrawal by Subject|0|||
124709579|NCT03012334|448562968|FG009|Period 1|Withdrawal by Subject|1|||
124709580|NCT03012334|448562959|FG000|Period 2|Withdrawal by Subject|0|||
124709581|NCT03012334|448562960|FG001|Period 2|Withdrawal by Subject|1|||
124709582|NCT03012334|448562961|FG002|Period 2|Withdrawal by Subject|0|||
124709583|NCT03012334|448562962|FG003|Period 2|Withdrawal by Subject|0|||
124769667|NCT00360230|448785143|FG004|Overall Study|Migrated|4|||
124769668|NCT00360230|448785144|FG005|Overall Study|Migrated|1|||
124769669|NCT00360230|448785145|FG006|Overall Study|Migrated|1|||
124769670|NCT00360230|448785139|FG000|Overall Study|Other|1|||
124769671|NCT00360230|448785140|FG001|Overall Study|Other|0|||
124769672|NCT00360230|448785141|FG002|Overall Study|Other|0|||
124549533|NCT00090259|447967082|FG001|Overall Study|Lost to Follow-up|26|||
124549534|NCT00090259|447967081|FG000|Overall Study|Withdrawal by Subject|21|||
124709584|NCT03012334|448562963|FG004|Period 2|Withdrawal by Subject|0|||
124963352|NCT00943722|449494096|FG003|Base Study|Protocol Violation|0|||
124963353|NCT00943722|449494097|FG004|Base Study|Protocol Violation|2|||
124963354|NCT00943722|449494098|FG005|Base Study|Protocol Violation|0|||
124963355|NCT00943722|449494099|FG006|Base Study|Protocol Violation|0|||
124963356|NCT00943722|449494093|FG000|Base Study|Withdrawal by Subject|12|||
124963357|NCT00943722|449494094|FG001|Base Study|Withdrawal by Subject|13|||
124963358|NCT00943722|449494095|FG002|Base Study|Withdrawal by Subject|2|||
124963359|NCT00943722|449494096|FG003|Base Study|Withdrawal by Subject|13|||
124963360|NCT00943722|449494097|FG004|Base Study|Withdrawal by Subject|8|||
124963361|NCT00943722|449494098|FG005|Base Study|Withdrawal by Subject|0|||
124963362|NCT00943722|449494099|FG006|Base Study|Withdrawal by Subject|0|||
124963363|NCT00943722|449494093|FG000|Base Study|Month 12 visit not completed|0|||
124963364|NCT00943722|449494094|FG001|Base Study|Month 12 visit not completed|0|||
124963365|NCT00943722|449494095|FG002|Base Study|Month 12 visit not completed|0|||
124963366|NCT00943722|449494096|FG003|Base Study|Month 12 visit not completed|0|||
124963367|NCT00943722|449494097|FG004|Base Study|Month 12 visit not completed|2|||
124963368|NCT00943722|449494098|FG005|Base Study|Month 12 visit not completed|0|||
124963369|NCT00943722|449494099|FG006|Base Study|Month 12 visit not completed|0|||
124963370|NCT00943722|449494093|FG000|First Extension Study: EXT 1|Adverse Event|0|||
124963371|NCT00943722|449494094|FG001|First Extension Study: EXT 1|Adverse Event|0|||
124963372|NCT00943722|449494095|FG002|First Extension Study: EXT 1|Adverse Event|0|||
124963373|NCT00943722|449494096|FG003|First Extension Study: EXT 1|Adverse Event|0|||
124963374|NCT00943722|449494097|FG004|First Extension Study: EXT 1|Adverse Event|0|||
124963375|NCT00943722|449494098|FG005|First Extension Study: EXT 1|Adverse Event|1|||
124963376|NCT00943722|449494099|FG006|First Extension Study: EXT 1|Adverse Event|0|||
124709585|NCT03012334|448562964|FG005|Period 2|Withdrawal by Subject|0|||
124709586|NCT03012334|448562965|FG006|Period 2|Withdrawal by Subject|0|||
124709587|NCT03012334|448562966|FG007|Period 2|Withdrawal by Subject|0|||
124709588|NCT03012334|448562967|FG008|Period 2|Withdrawal by Subject|0|||
124709589|NCT03012334|448562968|FG009|Period 2|Withdrawal by Subject|0|||
124709590|NCT03012334|448562959|FG000|Period 2|Protocol Violation|0|||
124709591|NCT03012334|448562960|FG001|Period 2|Protocol Violation|0|||
124709592|NCT03012334|448562961|FG002|Period 2|Protocol Violation|1|||
124709593|NCT03012334|448562962|FG003|Period 2|Protocol Violation|0|||
124709594|NCT03012334|448562963|FG004|Period 2|Protocol Violation|0|||
124709595|NCT03012334|448562964|FG005|Period 2|Protocol Violation|0|||
124709596|NCT03012334|448562965|FG006|Period 2|Protocol Violation|0|||
124709597|NCT03012334|448562966|FG007|Period 2|Protocol Violation|1|||
124709598|NCT03012334|448562967|FG008|Period 2|Protocol Violation|0|||
124709599|NCT03012334|448562968|FG009|Period 2|Protocol Violation|0|||
124709600|NCT03012334|448562959|FG000|Period 4|Non-Compliance|0|||
124709601|NCT03012334|448562960|FG001|Period 4|Non-Compliance|0|||
124709602|NCT03012334|448562961|FG002|Period 4|Non-Compliance|0|||
124709603|NCT03012334|448562962|FG003|Period 4|Non-Compliance|0|||
124709604|NCT03012334|448562963|FG004|Period 4|Non-Compliance|0|||
124709605|NCT03012334|448562964|FG005|Period 4|Non-Compliance|0|||
124709606|NCT03012334|448562965|FG006|Period 4|Non-Compliance|1|||
124709607|NCT03012334|448562966|FG007|Period 4|Non-Compliance|0|||
124709608|NCT03012334|448562967|FG008|Period 4|Non-Compliance|0|||
124709609|NCT03012334|448562968|FG009|Period 4|Non-Compliance|0|||
124709610|NCT03012334|448562959|FG000|Period 4|Adverse Event|0|||
124709611|NCT03012334|448562960|FG001|Period 4|Adverse Event|0|||
124709612|NCT03012334|448562961|FG002|Period 4|Adverse Event|0|||
124709613|NCT03012334|448562962|FG003|Period 4|Adverse Event|0|||
124709614|NCT03012334|448562963|FG004|Period 4|Adverse Event|0|||
124709615|NCT03012334|448562964|FG005|Period 4|Adverse Event|0|||
124709616|NCT03012334|448562965|FG006|Period 4|Adverse Event|0|||
124709617|NCT03012334|448562966|FG007|Period 4|Adverse Event|0|||
124709618|NCT03012334|448562967|FG008|Period 4|Adverse Event|1|||
124709619|NCT03012334|448562968|FG009|Period 4|Adverse Event|0|||
124709620|NCT00325143|448562969|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
124709621|NCT00325143|448562969|FG000|Overall Study|Migrated/moved from study area|1|||
124709622|NCT00325143|448562969|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
124709623|NCT00325143|448562969|FG000|Overall Study|Withdrawal by Subject|8|||
124709624|NCT01870869|448562970|FG000|Overall Study|Implanted with nonstudy device|1|||
124709625|NCT01870869|448562971|FG001|Overall Study|Implanted with nonstudy device|3|||
124709626|NCT01870869|448562972|FG002|Overall Study|Implanted with nonstudy device|14|||
124709627|NCT01870869|448562973|FG003|Overall Study|Implanted with nonstudy device|4|||
124709628|NCT01870869|448562970|FG000|Overall Study|Death|0|||
124709629|NCT01870869|448562971|FG001|Overall Study|Death|0|||
124709630|NCT01870869|448562972|FG002|Overall Study|Death|7|||
124709631|NCT01870869|448562973|FG003|Overall Study|Death|1|||
124709632|NCT01870869|448562970|FG000|Overall Study|Subject choice|6|||
124709633|NCT01870869|448562971|FG001|Overall Study|Subject choice|2|||
124709634|NCT01870869|448562972|FG002|Overall Study|Subject choice|22|||
124963377|NCT00943722|449494093|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
124963378|NCT00943722|449494094|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
124963379|NCT00943722|449494095|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
124769673|NCT00360230|448785142|FG003|Overall Study|Other|0|||
124769674|NCT00360230|448785143|FG004|Overall Study|Other|0|||
124769675|NCT00360230|448785144|FG005|Overall Study|Other|0|||
124963380|NCT00943722|449494096|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
124963381|NCT00943722|449494097|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
124963382|NCT00943722|449494098|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
124963383|NCT00943722|449494099|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
124963384|NCT00943722|449494093|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
124963385|NCT00943722|449494094|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
124963386|NCT00943722|449494095|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
124963387|NCT00943722|449494096|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
124963388|NCT00943722|449494097|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
124963389|NCT00943722|449494098|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
124963390|NCT00943722|449494099|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
124963391|NCT00943722|449494093|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
124963392|NCT00943722|449494094|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
124963393|NCT00943722|449494095|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
124963394|NCT00943722|449494096|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
124963395|NCT00943722|449494097|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
124963396|NCT00943722|449494098|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
124963397|NCT00943722|449494099|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
124963398|NCT00943722|449494093|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
124963399|NCT00943722|449494094|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
124963400|NCT00943722|449494095|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
124963401|NCT00943722|449494096|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
124963402|NCT00943722|449494097|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
124963403|NCT00943722|449494098|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
124963404|NCT00943722|449494099|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
124963405|NCT00943722|449494093|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
124963406|NCT00943722|449494094|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
124963407|NCT00943722|449494095|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
124963408|NCT00943722|449494096|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
124963409|NCT00943722|449494097|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
124963410|NCT00943722|449494098|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
124963411|NCT00943722|449494099|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
124963412|NCT00943722|449494093|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
124963413|NCT00943722|449494094|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
124963414|NCT00943722|449494095|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
124963415|NCT00943722|449494096|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
124963416|NCT00943722|449494097|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
124963417|NCT00943722|449494098|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
124963418|NCT00943722|449494099|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
124963419|NCT00943722|449494093|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
124963420|NCT00943722|449494094|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
124963421|NCT00943722|449494095|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
124963422|NCT00943722|449494096|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
124963423|NCT00943722|449494097|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
124963424|NCT00943722|449494098|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
124963425|NCT00943722|449494099|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
124963426|NCT00943722|449494093|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
124963427|NCT00943722|449494094|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
124963428|NCT00943722|449494095|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
124963429|NCT00943722|449494096|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
124963430|NCT00943722|449494097|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
124963431|NCT00943722|449494098|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
124963432|NCT00943722|449494099|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
124963433|NCT01036165|449494100|FG000|Overall Study|Adverse Event|6|||
124769676|NCT00360230|448785145|FG006|Overall Study|Other|0|||
124769677|NCT00360230|448785139|FG000|Overall Study|Protocol Violation|0|||
124769678|NCT00360230|448785140|FG001|Overall Study|Protocol Violation|0|||
124769679|NCT00360230|448785141|FG002|Overall Study|Protocol Violation|0|||
124769680|NCT00360230|448785142|FG003|Overall Study|Protocol Violation|0|||
124769681|NCT00360230|448785143|FG004|Overall Study|Protocol Violation|0|||
124963434|NCT01036165|449494100|FG000|Overall Study|Lost to Follow-up|2|||
124963435|NCT01036165|449494100|FG000|Overall Study|Withdrawal by Subject|3|||
124963436|NCT01036165|449494100|FG000|Overall Study|Device Related Issues|3|||
124963437|NCT01036165|449494100|FG000|Overall Study|Problems finding proper area to inject|1|||
124963438|NCT00913523|449494106|FG000|Overall Study|Withdrawal by Subject|3|||
124769682|NCT00360230|448785144|FG005|Overall Study|Protocol Violation|1|||
124769683|NCT00360230|448785145|FG006|Overall Study|Protocol Violation|0|||
124769684|NCT00360230|448785139|FG000|Overall Study|Death|0|||
124769685|NCT00360230|448785140|FG001|Overall Study|Death|1|||
124769686|NCT00360230|448785141|FG002|Overall Study|Death|0|||
124769687|NCT00360230|448785142|FG003|Overall Study|Death|0|||
124769688|NCT00360230|448785143|FG004|Overall Study|Death|0|||
124769689|NCT00360230|448785144|FG005|Overall Study|Death|1|||
124769690|NCT00360230|448785145|FG006|Overall Study|Death|1|||
124769691|NCT00581308|448785146|FG000|Pre Discharge|Lost to Follow-up|1|||
124769692|NCT00581308|448785146|FG000|Pre Discharge|Device Removed|1|||
124769693|NCT00581308|448785146|FG000|Month 1|Lost to Follow-up|3|||
124769694|NCT00581308|448785146|FG000|Month 1|Withdrawal by Subject|2|||
124769695|NCT00581308|448785146|FG000|Month 1|Device Removed|2|||
124769696|NCT00581308|448785146|FG000|Month 1|Uknown|1|||
124769697|NCT00581308|448785146|FG000|Month 6|Lost to Follow-up|1|||
124769698|NCT00581308|448785146|FG000|Month 6|Withdrawal by Subject|2|||
124769699|NCT00581308|448785146|FG000|Month 12|Death|1|||
124769700|NCT00581308|448785146|FG000|Month 12|Lost to Follow-up|14|||
124769701|NCT00581308|448785146|FG000|Month 12|Withdrawal by Subject|3|||
124769702|NCT00581308|448785146|FG000|Month 12|Device Removed|1|||
124769703|NCT00581308|448785146|FG000|Month 12|Other|1|||
124709635|NCT01870869|448562973|FG003|Overall Study|Subject choice|8|||
124709636|NCT01870869|448562970|FG000|Overall Study|Lost to Follow-up|10|||
124709637|NCT01870869|448562971|FG001|Overall Study|Lost to Follow-up|2|||
124709638|NCT01870869|448562972|FG002|Overall Study|Lost to Follow-up|25|||
124709639|NCT01870869|448562973|FG003|Overall Study|Lost to Follow-up|3|||
124709640|NCT01870869|448562970|FG000|Overall Study|Reason not Specified|1|||
124709641|NCT01870869|448562971|FG001|Overall Study|Reason not Specified|2|||
124709642|NCT01870869|448562972|FG002|Overall Study|Reason not Specified|20|||
124709643|NCT01870869|448562973|FG003|Overall Study|Reason not Specified|4|||
124709644|NCT01870869|448562970|FG000|Overall Study|Not evaluable|10|||
124709645|NCT01870869|448562971|FG001|Overall Study|Not evaluable|5|||
124709646|NCT01870869|448562972|FG002|Overall Study|Not evaluable|42|||
124709647|NCT01870869|448562973|FG003|Overall Study|Not evaluable|10|||
124709648|NCT02286895|448562974|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
124709649|NCT02286895|448562975|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
124709650|NCT02286895|448562974|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
124709651|NCT02286895|448562975|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
124709652|NCT02286895|448562974|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
124709653|NCT02286895|448562975|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
124709654|NCT03036852|448562976|FG000|Overall Study|Death|2|||
124709655|NCT03036852|448562976|FG000|Overall Study|Lack of Efficacy|2|||
124709656|NCT03036852|448562976|FG000|Overall Study|Adverse Event|1|||
124709657|NCT03036852|448562976|FG000|Overall Study|Lost to Follow-up|1|||
124709658|NCT01073293|448562977|FG000|Overall Study|Lost to Follow-up|0|||
124709659|NCT01073293|448562978|FG001|Overall Study|Lost to Follow-up|1|||
124709660|NCT01073293|448562977|FG000|Overall Study|Withdrawal by Subject|5|||
124709661|NCT01073293|448562978|FG001|Overall Study|Withdrawal by Subject|10|||
124709662|NCT00002766|448562983|FG000|Overall Study|Withdrawal by Subject|0|||
124709663|NCT00002766|448562984|FG001|Overall Study|Withdrawal by Subject|1|||
124709664|NCT00002766|448562983|FG000|Overall Study|Patient Not Treated|1|||
124709665|NCT00002766|448562984|FG001|Overall Study|Patient Not Treated|2|||
124709666|NCT00002766|448562983|FG000|Overall Study|Adverse Event|1|||
124709667|NCT00002766|448562984|FG001|Overall Study|Adverse Event|1|||
124709668|NCT00002766|448562983|FG000|Overall Study|Protocol Violation|1|||
124709669|NCT00002766|448562984|FG001|Overall Study|Protocol Violation|0|||
124709670|NCT00077974|448562985|FG000|Overall Study|Adverse Event|22|||
124709671|NCT00077974|448562985|FG000|Overall Study|Protocol Violation|1|||
124769704|NCT00886379|448785147|FG000|Overall Study|Transferred Schools|0|||
124769705|NCT00886379|448785148|FG001|Overall Study|Transferred Schools|0|||
124769706|NCT00886379|448785149|FG002|Overall Study|Transferred Schools|2|||
124769707|NCT00886379|448785150|FG003|Overall Study|Transferred Schools|1|||
124769708|NCT00886379|448785151|FG004|Overall Study|Transferred Schools|1|||
124769709|NCT00886379|448785147|FG000|Overall Study|Final blood draw not obtained|3|||
124769710|NCT00886379|448785148|FG001|Overall Study|Final blood draw not obtained|3|||
124709672|NCT00077974|448562985|FG000|Overall Study|Withdrawal by Subject|3|||
124709673|NCT00077974|448562985|FG000|Overall Study|Lack of Efficacy|76|||
124709674|NCT00077974|448562985|FG000|Overall Study|Decision of Sponsor|2|||
124709675|NCT00256126|448562986|FG000|Overall Study|Adverse Event|1|||
124709676|NCT00256126|448562987|FG001|Overall Study|Adverse Event|0|||
124709677|NCT00256126|448562986|FG000|Overall Study|Other|1|||
124709678|NCT00256126|448562987|FG001|Overall Study|Other|2|||
124769711|NCT00886379|448785149|FG002|Overall Study|Final blood draw not obtained|4|||
124769712|NCT00886379|448785150|FG003|Overall Study|Final blood draw not obtained|2|||
124769713|NCT00886379|448785151|FG004|Overall Study|Final blood draw not obtained|2|||
124769714|NCT04558125|448785152|FG000|Overall Study|Death|1|||
124769715|NCT01614886|448785153|FG000|Overall Study|Adverse Event|15|||
124769716|NCT01614886|448785154|FG001|Overall Study|Adverse Event|20|||
124769717|NCT01614886|448785153|FG000|Overall Study|Withdrawal by Subject|4|||
124769718|NCT01614886|448785154|FG001|Overall Study|Withdrawal by Subject|4|||
124769719|NCT01614886|448785153|FG000|Overall Study|Death|1|||
124769720|NCT01614886|448785154|FG001|Overall Study|Death|0|||
124769721|NCT01614886|448785153|FG000|Overall Study|Protocol deviation|0|||
124769722|NCT01614886|448785154|FG001|Overall Study|Protocol deviation|2|||
124769723|NCT01207414|448785156|FG000|Overall Study|Adverse Event|25|||
124769724|NCT01207414|448785157|FG001|Overall Study|Adverse Event|39|||
124769725|NCT01207414|448785156|FG000|Overall Study|Abnormal test procedure results|0|||
124769726|NCT01207414|448785157|FG001|Overall Study|Abnormal test procedure results|1|||
124769727|NCT01207414|448785156|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
124769728|NCT01207414|448785157|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
124769729|NCT01207414|448785156|FG000|Overall Study|Patient withdrew consent|14|||
124769730|NCT01207414|448785157|FG001|Overall Study|Patient withdrew consent|11|||
124769731|NCT01207414|448785156|FG000|Overall Study|Lost to Follow-up|15|||
124769732|NCT01207414|448785157|FG001|Overall Study|Lost to Follow-up|17|||
124769733|NCT01207414|448785156|FG000|Overall Study|Administrative problems|1|||
124769734|NCT01207414|448785157|FG001|Overall Study|Administrative problems|1|||
124769735|NCT01207414|448785156|FG000|Overall Study|Protocol deviation|12|||
124769736|NCT01207414|448785157|FG001|Overall Study|Protocol deviation|9|||
124769737|NCT01207414|448785156|FG000|Overall Study|Randomized in error|1|||
124769738|NCT01207414|448785157|FG001|Overall Study|Randomized in error|0|||
124769739|NCT01527370|448785160|FG000|Overall Study|Withdrawal by Subject|4|||
124769740|NCT01527370|448785160|FG000|Overall Study|Physician Decision|1|||
124769741|NCT01527370|448785160|FG000|Overall Study|Death|1|||
124769742|NCT01748292|448785161|FG000|Overall Study|Adverse Event|2|||
124769743|NCT01748292|448785162|FG001|Overall Study|Adverse Event|4|||
124769744|NCT01748292|448785161|FG000|Overall Study|Lost to Follow-up|0|||
124769745|NCT01748292|448785162|FG001|Overall Study|Lost to Follow-up|3|||
124464367|NCT03605680|447658122|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
124709679|NCT02949011|448562996|FG000|Overall Study|Adverse Event|6|||
124709680|NCT02949011|448562997|FG001|Overall Study|Adverse Event|7|||
124709681|NCT02949011|448562998|FG002|Overall Study|Adverse Event|3|||
124709682|NCT02949011|448562996|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
124709683|NCT02949011|448562997|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
124709684|NCT02949011|448562998|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
124709685|NCT02949011|448562996|FG000|Overall Study|Protocol Deviation|5|||
124709686|NCT02949011|448562997|FG001|Overall Study|Protocol Deviation|3|||
124709687|NCT02949011|448562998|FG002|Overall Study|Protocol Deviation|3|||
124709688|NCT02949011|448562996|FG000|Overall Study|Lack of Efficacy|0|||
124709689|NCT02949011|448562997|FG001|Overall Study|Lack of Efficacy|2|||
124709690|NCT02949011|448562998|FG002|Overall Study|Lack of Efficacy|0|||
124709691|NCT02949011|448562996|FG000|Overall Study|Withdrawal by Subject|13|||
124709692|NCT02949011|448562997|FG001|Overall Study|Withdrawal by Subject|13|||
124709693|NCT02949011|448562998|FG002|Overall Study|Withdrawal by Subject|21|||
124709694|NCT02949011|448562996|FG000|Overall Study|Lost to Follow-up|7|||
124709695|NCT02949011|448562997|FG001|Overall Study|Lost to Follow-up|5|||
124709696|NCT02949011|448562998|FG002|Overall Study|Lost to Follow-up|5|||
124709697|NCT02949011|448562996|FG000|Overall Study|Death|0|||
124709698|NCT02949011|448562997|FG001|Overall Study|Death|0|||
124709699|NCT02949011|448562998|FG002|Overall Study|Death|1|||
124709700|NCT02949011|448562996|FG000|Overall Study|Miscellaneous|2|||
124709701|NCT02949011|448562997|FG001|Overall Study|Miscellaneous|4|||
124709702|NCT02949011|448562998|FG002|Overall Study|Miscellaneous|6|||
124709703|NCT00163189|448562999|FG000|Overall Study|Other|6|||
124709704|NCT00163189|448562999|FG000|Overall Study|Lost to Follow-up|1|||
124709705|NCT00163189|448562999|FG000|Overall Study|Protocol Violation|2|||
124709706|NCT00163189|448562999|FG000|Overall Study|Death|3|||
124709707|NCT00163189|448562999|FG000|Overall Study|Adverse Event|6|||
124769746|NCT01748292|448785161|FG000|Overall Study|Death|0|||
124769747|NCT01748292|448785162|FG001|Overall Study|Death|3|||
124769748|NCT01748292|448785161|FG000|Overall Study|Withdrawal by Subject|0|||
124769749|NCT01748292|448785162|FG001|Overall Study|Withdrawal by Subject|2|||
124769750|NCT02224560|448785163|FG000|Overall Study|Protocol Deviation|1|||
124769751|NCT02224560|448785164|FG001|Overall Study|Protocol Deviation|0|||
124709708|NCT00163189|448562999|FG000|Overall Study|Lack of Efficacy|7|||
124769752|NCT02224560|448785165|FG002|Overall Study|Protocol Deviation|0|||
124709709|NCT00163189|448562999|FG000|Overall Study|Study terminated by sponsor|11|||
124709710|NCT00163189|448562999|FG000|Overall Study|Withdrawal by Subject|11|||
124709711|NCT00163189|448562999|FG000|Overall Study|Did not meet continuation criterion|16|||
124709712|NCT02154061|448563000|FG000|Overall Study|Pregnancy|1|||
124709713|NCT02154061|448563001|FG001|Overall Study|Pregnancy|0|||
124709714|NCT02154061|448563000|FG000|Overall Study|enrolled but not vaccinated|1|||
124709715|NCT02154061|448563001|FG001|Overall Study|enrolled but not vaccinated|0|||
124709716|NCT00506142|448563002|FG000|Overall Study|Adverse Event|8|||
124769753|NCT02224560|448785163|FG000|Overall Study|Withdrawal by Subject|2|||
124769754|NCT02224560|448785164|FG001|Overall Study|Withdrawal by Subject|0|||
124769755|NCT02224560|448785165|FG002|Overall Study|Withdrawal by Subject|1|||
124769756|NCT02224560|448785163|FG000|Overall Study|Met Withdrawal Criteria|1|||
124769757|NCT02224560|448785164|FG001|Overall Study|Met Withdrawal Criteria|0|||
124769758|NCT02224560|448785165|FG002|Overall Study|Met Withdrawal Criteria|0|||
124769759|NCT02224560|448785163|FG000|Overall Study|Adverse Event|4|||
124769760|NCT02224560|448785164|FG001|Overall Study|Adverse Event|1|||
124769761|NCT02224560|448785165|FG002|Overall Study|Adverse Event|1|||
124769762|NCT02224560|448785163|FG000|Overall Study|Withdrawn by Investigator|1|||
124769763|NCT02224560|448785164|FG001|Overall Study|Withdrawn by Investigator|1|||
124769764|NCT02224560|448785165|FG002|Overall Study|Withdrawn by Investigator|0|||
124769765|NCT02383576|448785168|FG000|Overall Study|Death|53|||
124769766|NCT02383576|448785169|FG001|Overall Study|Death|33|||
124769767|NCT02383576|448785168|FG000|Overall Study|Lost to Follow-up|7|||
124549535|NCT00090259|447967082|FG001|Overall Study|Withdrawal by Subject|15|||
124549536|NCT00090259|447967081|FG000|Overall Study|Investigator site closed|11|||
124549537|NCT00090259|447967082|FG001|Overall Study|Investigator site closed|7|||
124549538|NCT00960687|447967085|FG000|Washout Period of 7 Days|Adverse Event|3|||
124549539|NCT00960687|447967086|FG001|Washout Period of 7 Days|Adverse Event|2|||
124549540|NCT00960687|447967085|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
124709717|NCT00506142|448563003|FG001|Overall Study|Adverse Event|7|||
124709718|NCT00506142|448563002|FG000|Overall Study|Lack of Efficacy|21|||
124709719|NCT00506142|448563003|FG001|Overall Study|Lack of Efficacy|7|||
124709720|NCT00506142|448563002|FG000|Overall Study|Withdrawal by Subject|4|||
124709721|NCT00506142|448563003|FG001|Overall Study|Withdrawal by Subject|5|||
124709722|NCT00506142|448563002|FG000|Overall Study|Physician Decision|1|||
124709723|NCT00506142|448563003|FG001|Overall Study|Physician Decision|0|||
124709724|NCT00506142|448563002|FG000|Overall Study|New health condition|1|||
124709725|NCT00506142|448563003|FG001|Overall Study|New health condition|0|||
124709726|NCT00454116|448563004|FG000|Overall Study|Adverse Event|5|||
124709727|NCT00454116|448563005|FG001|Overall Study|Adverse Event|11|||
124709728|NCT00454116|448563006|FG002|Overall Study|Adverse Event|9|||
124709729|NCT00454116|448563004|FG000|Overall Study|Condition under investigation worsened|17|||
124709730|NCT00454116|448563005|FG001|Overall Study|Condition under investigation worsened|13|||
124709731|NCT00454116|448563006|FG002|Overall Study|Condition under investigation worsened|18|||
124709732|NCT00454116|448563004|FG000|Overall Study|Withdrawal by Subject|3|||
124709733|NCT00454116|448563005|FG001|Overall Study|Withdrawal by Subject|3|||
124709734|NCT00454116|448563006|FG002|Overall Study|Withdrawal by Subject|1|||
124709735|NCT00454116|448563004|FG000|Overall Study|Other|2|||
124709736|NCT00454116|448563005|FG001|Overall Study|Other|2|||
124709737|NCT00454116|448563006|FG002|Overall Study|Other|0|||
124709738|NCT01917318|448563009|FG000|First Treatment|Withdrawal by Subject|0|||
124709739|NCT01917318|448563010|FG001|First Treatment|Withdrawal by Subject|1|||
124709740|NCT01008618|448563011|FG000|Period 1 (Titration Period)|Physician Decision|2|||
124709741|NCT01008618|448563012|FG001|Period 1 (Titration Period)|Physician Decision|0|||
124709742|NCT01008618|448563013|FG002|Period 1 (Titration Period)|Physician Decision|0|||
124709743|NCT01008618|448563011|FG000|Period 1 (Titration Period)|Adverse Event|33|||
124709744|NCT01008618|448563012|FG001|Period 1 (Titration Period)|Adverse Event|0|||
124709745|NCT01008618|448563013|FG002|Period 1 (Titration Period)|Adverse Event|0|||
124709746|NCT01008618|448563011|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
124709747|NCT01008618|448563012|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
124709748|NCT01008618|448563013|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
124709749|NCT01008618|448563011|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
124709750|NCT01008618|448563012|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
124709751|NCT01008618|448563013|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
124709752|NCT01008618|448563011|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
124709753|NCT01008618|448563012|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
124709754|NCT01008618|448563013|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
124709755|NCT01008618|448563011|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
124709756|NCT01008618|448563012|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
124709757|NCT01008618|448563013|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
124709758|NCT01008618|448563011|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
124709759|NCT01008618|448563012|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
124709760|NCT01008618|448563013|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
124709761|NCT01008618|448563011|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
124709762|NCT01008618|448563012|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
124549541|NCT00960687|447967086|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
124549542|NCT00285012|447967087|FG000|Assigned to Study Treatment (Tx)|Other|2|||
124549543|NCT00285012|447967088|FG001|Assigned to Study Treatment (Tx)|Other|3|||
124709763|NCT01008618|448563013|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
124709764|NCT01008618|448563011|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
124769768|NCT02383576|448785169|FG001|Overall Study|Lost to Follow-up|1|||
124549544|NCT00285012|447967087|FG000|Received Study Tx|Death|2|||
124963439|NCT00913523|449494107|FG001|Overall Study|Withdrawal by Subject|2|||
124963440|NCT00913523|449494108|FG002|Overall Study|Withdrawal by Subject|2|||
124963441|NCT00913523|449494106|FG000|Overall Study|Lost to Follow-up|1|||
124963442|NCT00913523|449494107|FG001|Overall Study|Lost to Follow-up|1|||
124963443|NCT00913523|449494108|FG002|Overall Study|Lost to Follow-up|1|||
124963444|NCT00913523|449494106|FG000|Overall Study|Adverse Event|1|||
124963445|NCT00913523|449494107|FG001|Overall Study|Adverse Event|0|||
124963446|NCT00913523|449494108|FG002|Overall Study|Adverse Event|0|||
124963447|NCT00913523|449494106|FG000|Overall Study|Protocol Violation|5|||
124963448|NCT00913523|449494107|FG001|Overall Study|Protocol Violation|8|||
124963449|NCT00913523|449494108|FG002|Overall Study|Protocol Violation|8|||
124963450|NCT00913523|449494106|FG000|Overall Study|Pregnancy|1|||
124963451|NCT00913523|449494107|FG001|Overall Study|Pregnancy|3|||
124963452|NCT00913523|449494108|FG002|Overall Study|Pregnancy|0|||
124963453|NCT00913523|449494106|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
124963454|NCT00913523|449494107|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
124963455|NCT00913523|449494108|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
124963456|NCT02895360|449494109|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
124963457|NCT02895360|449494110|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
124963458|NCT02895360|449494111|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
124963459|NCT02895360|449494112|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
124963460|NCT02895360|449494113|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
124963461|NCT02895360|449494114|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
124963462|NCT02895360|449494109|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
124963463|NCT02895360|449494110|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
124963464|NCT02895360|449494111|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
124963465|NCT02895360|449494112|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
124963466|NCT02895360|449494113|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
124963467|NCT02895360|449494114|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
124963468|NCT02895360|449494109|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
124963469|NCT02895360|449494110|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
124963470|NCT02895360|449494111|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
124963471|NCT02895360|449494112|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
124963472|NCT02895360|449494113|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
124963473|NCT02895360|449494114|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
124963474|NCT02895360|449494109|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
124963475|NCT02895360|449494110|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
124963476|NCT02895360|449494111|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
124963477|NCT02895360|449494112|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
124963478|NCT02895360|449494113|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
124963479|NCT02895360|449494114|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
124963480|NCT02895360|449494109|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
124963481|NCT02895360|449494110|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
124963482|NCT02895360|449494111|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
124963483|NCT02895360|449494112|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
124963484|NCT02895360|449494113|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
124963485|NCT02895360|449494114|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
124963486|NCT02895360|449494109|FG000|Phase 2a|Adverse Event|0|||
124963487|NCT02895360|449494110|FG001|Phase 2a|Adverse Event|0|||
124963488|NCT02895360|449494111|FG002|Phase 2a|Adverse Event|0|||
124963489|NCT02895360|449494112|FG003|Phase 2a|Adverse Event|0|||
124963490|NCT02895360|449494113|FG004|Phase 2a|Adverse Event|0|||
124963491|NCT02895360|449494114|FG005|Phase 2a|Adverse Event|1|||
124963492|NCT02895360|449494109|FG000|Phase 2a|Progressive disease|0|||
124963493|NCT02895360|449494110|FG001|Phase 2a|Progressive disease|0|||
124963494|NCT02895360|449494111|FG002|Phase 2a|Progressive disease|0|||
124464368|NCT03605680|447658123|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
124963495|NCT02895360|449494112|FG003|Phase 2a|Progressive disease|0|||
124963496|NCT02895360|449494113|FG004|Phase 2a|Progressive disease|11|||
124963497|NCT02895360|449494114|FG005|Phase 2a|Progressive disease|11|||
124963498|NCT00916305|449494115|FG000|Overall Study|Lost to Follow-up|21|||
124963499|NCT00916305|449494116|FG001|Overall Study|Lost to Follow-up|27|||
124963500|NCT00916305|449494115|FG000|Overall Study|Withdrawal by Subject|0|||
124963501|NCT00916305|449494116|FG001|Overall Study|Withdrawal by Subject|1|||
124963502|NCT01844726|449494117|FG000|Overall Study|Withdrawal by Subject|0|||
124963503|NCT01844726|449494118|FG001|Overall Study|Withdrawal by Subject|1|||
124464369|NCT03605680|447658120|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
124963504|NCT01844726|449494117|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
124963505|NCT01844726|449494118|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
124963506|NCT00307164|449494121|FG000|Overall Study|Death|1|||
124963507|NCT00307164|449494122|FG001|Overall Study|Death|0|||
124963508|NCT00307164|449494121|FG000|Overall Study|Severe debilitation, unable to continue|1|||
124963509|NCT00307164|449494122|FG001|Overall Study|Severe debilitation, unable to continue|0|||
124963510|NCT00307164|449494121|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
124464370|NCT03605680|447658121|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
124464371|NCT03605680|447658122|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
124464372|NCT03605680|447658123|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
124963511|NCT00307164|449494122|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
124963512|NCT00307164|449494121|FG000|Overall Study|Withdrawal by Subject|1|||
124963513|NCT00307164|449494122|FG001|Overall Study|Withdrawal by Subject|8|||
124963514|NCT00307164|449494121|FG000|Overall Study|Not compliant with requirements|4|||
124963515|NCT00307164|449494122|FG001|Overall Study|Not compliant with requirements|4|||
124963516|NCT00307164|449494121|FG000|Overall Study|Lost to Follow-up|6|||
124963517|NCT00307164|449494122|FG001|Overall Study|Lost to Follow-up|1|||
124963518|NCT01167192|449494128|FG000|Overall Study|Adverse Event|1|||
124963519|NCT01167192|449494128|FG000|Overall Study|Death|1|||
124963520|NCT01167192|449494128|FG000|Overall Study|Withdrawal by Subject|1|||
124963521|NCT01167192|449494128|FG000|Overall Study|Insurance denial|1|||
124963522|NCT02560389|449494129|FG000|Overall Study|Lost to Follow-up|1|||
124963523|NCT02560389|449494130|FG001|Overall Study|Lost to Follow-up|2|||
124963524|NCT02560389|449494131|FG002|Overall Study|Lost to Follow-up|2|||
124963525|NCT02560389|449494129|FG000|Overall Study|Tested positive for illicit substance|0|||
124963526|NCT02560389|449494130|FG001|Overall Study|Tested positive for illicit substance|1|||
124963527|NCT02560389|449494131|FG002|Overall Study|Tested positive for illicit substance|0|||
124963528|NCT01203956|449494142|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
124963529|NCT01203956|449494143|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
124963530|NCT00069277|449494144|FG000|Overall Study|Adverse Event|3|||
124963531|NCT00069277|449494144|FG000|Overall Study|Withdrawal by Subject|1|||
124963532|NCT00069277|449494144|FG000|Overall Study|Progressive Disease|15|||
124963533|NCT00069277|449494144|FG000|Overall Study|Physician Decision|2|||
124963534|NCT02230306|449494145|FG000|Overall Study|Did not receive study treatment|1|||
124963535|NCT00361842|449494152|FG000|Overall Study|Withdrawal by Subject|2|||
124963536|NCT00361842|449494153|FG001|Overall Study|Withdrawal by Subject|3|||
124963537|NCT00361842|449494152|FG000|Overall Study|Death|2|||
124963538|NCT00361842|449494153|FG001|Overall Study|Death|1|||
124963539|NCT00361842|449494152|FG000|Overall Study|Disease progression|19|||
124963540|NCT00361842|449494153|FG001|Overall Study|Disease progression|20|||
124963541|NCT00361842|449494152|FG000|Overall Study|Adverse Event|2|||
124963542|NCT00361842|449494153|FG001|Overall Study|Adverse Event|3|||
124963543|NCT00361842|449494152|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
124963544|NCT00361842|449494153|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
124963545|NCT00361842|449494152|FG000|Overall Study|Other|1|||
124963546|NCT00361842|449494153|FG001|Overall Study|Other|0|||
124963547|NCT00361842|449494152|FG000|Overall Study|Other|0|||
124963548|NCT00361842|449494153|FG001|Overall Study|Other|2|||
124963549|NCT03512288|449494154|FG000|Overall Study|Adverse Event|1|||
124963550|NCT03512288|449494155|FG001|Overall Study|Adverse Event|0|||
124963551|NCT03512288|449494154|FG000|Overall Study|Lost to Follow-up|12|||
124963552|NCT03512288|449494155|FG001|Overall Study|Lost to Follow-up|15|||
124963553|NCT03512288|449494154|FG000|Overall Study|Physician Decision|0|||
124963554|NCT03512288|449494155|FG001|Overall Study|Physician Decision|2|||
124963555|NCT03512288|449494154|FG000|Overall Study|Protocol Violation|6|||
124963556|NCT03512288|449494155|FG001|Overall Study|Protocol Violation|4|||
124963557|NCT03512288|449494154|FG000|Overall Study|Medication error without associated adverse event|1|||
124963558|NCT03512288|449494155|FG001|Overall Study|Medication error without associated adverse event|0|||
124963559|NCT03512288|449494154|FG000|Overall Study|No longer met eligibility criteria|5|||
124963560|NCT03512288|449494155|FG001|Overall Study|No longer met eligibility criteria|2|||
124963561|NCT03512288|449494154|FG000|Overall Study|Withdrawal by parent/guardian|14|||
124963562|NCT03512288|449494155|FG001|Overall Study|Withdrawal by parent/guardian|18|||
124963563|NCT03512288|449494154|FG000|Overall Study|Other|1|||
124963564|NCT03512288|449494155|FG001|Overall Study|Other|1|||
124963565|NCT03512288|449494154|FG000|Overall Study|Randomized but not treated|1|||
124963566|NCT03512288|449494155|FG001|Overall Study|Randomized but not treated|1|||
124963567|NCT04814992|449494156|FG000|Overall Study|Withdrawal by Subject|6|||
124464373|NCT03605680|447658120|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
124963568|NCT04814992|449494157|FG001|Overall Study|Withdrawal by Subject|3|||
124963569|NCT04814992|449494156|FG000|Overall Study|Lost to Follow-up|1|||
124963570|NCT04814992|449494157|FG001|Overall Study|Lost to Follow-up|4|||
124963571|NCT01260142|449494160|FG000|Treatment Period 1|Study on hold|1|||
124963572|NCT01260142|449494161|FG001|Treatment Period 1|Study on hold|1|||
124963573|NCT01260142|449494162|FG002|Treatment Period 1|Study on hold|0|||
124963574|NCT01260142|449494163|FG003|Treatment Period 1|Study on hold|0|||
124963575|NCT01260142|449494164|FG004|Treatment Period 1|Study on hold|1|||
124963576|NCT01260142|449494165|FG005|Treatment Period 1|Study on hold|2|||
124963577|NCT01260142|449494160|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
124963578|NCT01260142|449494161|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
124963579|NCT01260142|449494162|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
124963580|NCT01260142|449494163|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
124963581|NCT01260142|449494164|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
124963582|NCT01260142|449494165|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
124963583|NCT01260142|449494160|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124963584|NCT01260142|449494161|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124963585|NCT01260142|449494162|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124963586|NCT01260142|449494163|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124963587|NCT01260142|449494164|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124963588|NCT01260142|449494165|FG005|Treatment Period 1|Withdrawal by Subject|1|||
124963589|NCT00691678|449494166|FG000|Overall Study|Adverse Event|5|||
124963590|NCT00691678|449494166|FG000|Overall Study|life events, pain|11|||
124963591|NCT01227928|449494167|FG000|Overall Study|Lost to Follow-up|4|||
124963592|NCT01227928|449494168|FG001|Overall Study|Lost to Follow-up|2|||
124963593|NCT01227928|449494167|FG000|Overall Study|Withdrawal by Subject|4|||
124963594|NCT01227928|449494168|FG001|Overall Study|Withdrawal by Subject|3|||
124963595|NCT01227928|449494167|FG000|Overall Study|Death|14|||
124963596|NCT01227928|449494168|FG001|Overall Study|Death|12|||
124963597|NCT00934700|449494171|FG000|Overall Study|missing scan|5|||
124963598|NCT00934700|449494172|FG001|Overall Study|missing scan|9|||
124963599|NCT00934700|449494171|FG000|Overall Study|Death|8|||
124963600|NCT00934700|449494172|FG001|Overall Study|Death|3|||
124963601|NCT01494298|449494173|FG000|Overall Study|Protocol Violation|2|||
124963602|NCT01494298|449494174|FG001|Overall Study|Protocol Violation|8|||
124963603|NCT02930837|449494175|FG000|Overall Study|Adverse Event|6|||
124963604|NCT02930837|449494175|FG000|Overall Study|Lost to Follow-up|5|||
124963605|NCT02930837|449494175|FG000|Overall Study|Withdrawal by Subject|1|||
124963606|NCT01393613|449494178|FG000|Overall Study|Adverse Event|11|||
124963607|NCT01393613|449494179|FG001|Overall Study|Adverse Event|11|||
124963608|NCT01393613|449494180|FG002|Overall Study|Adverse Event|13|||
124963609|NCT01393613|449494181|FG003|Overall Study|Adverse Event|22|||
124963610|NCT01393613|449494178|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
124963611|NCT01393613|449494179|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
124963612|NCT01393613|449494180|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
124963613|NCT01393613|449494181|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
124963614|NCT01393613|449494178|FG000|Overall Study|Physician Decision|2|||
124963615|NCT01393613|449494179|FG001|Overall Study|Physician Decision|0|||
124963616|NCT01393613|449494180|FG002|Overall Study|Physician Decision|0|||
124963617|NCT01393613|449494181|FG003|Overall Study|Physician Decision|1|||
124963618|NCT01393613|449494178|FG000|Overall Study|Withdrawal by Subject|15|||
124963619|NCT01393613|449494179|FG001|Overall Study|Withdrawal by Subject|25|||
124963620|NCT01393613|449494180|FG002|Overall Study|Withdrawal by Subject|23|||
124963621|NCT01393613|449494181|FG003|Overall Study|Withdrawal by Subject|21|||
124963622|NCT01393613|449494178|FG000|Overall Study|Protocol Deviation|2|||
124963623|NCT01393613|449494179|FG001|Overall Study|Protocol Deviation|1|||
124963624|NCT01393613|449494180|FG002|Overall Study|Protocol Deviation|0|||
124963625|NCT01393613|449494181|FG003|Overall Study|Protocol Deviation|0|||
124963626|NCT01393613|449494178|FG000|Overall Study|Lack of Efficacy|9|||
124963627|NCT01393613|449494179|FG001|Overall Study|Lack of Efficacy|20|||
124963628|NCT01393613|449494180|FG002|Overall Study|Lack of Efficacy|16|||
124963629|NCT01393613|449494181|FG003|Overall Study|Lack of Efficacy|21|||
124963630|NCT01831726|449494182|FG000|Overall Study|Adverse Event|16|||
124963631|NCT01831726|449494182|FG000|Overall Study|Death|7|||
124963632|NCT01831726|449494182|FG000|Overall Study|Disease Progression|49|||
124963633|NCT01831726|449494182|FG000|Overall Study|Physician Decision|1|||
124963634|NCT01831726|449494182|FG000|Overall Study|Subject/guardian decision|7|||
124963635|NCT01283971|449494189|FG000|Overall Study|Adverse Event|3|||
124963636|NCT01283971|449494190|FG001|Overall Study|Adverse Event|5|||
124963637|NCT01283971|449494189|FG000|Overall Study|Insufficient therapeutic responses|3|||
124963638|NCT01283971|449494190|FG001|Overall Study|Insufficient therapeutic responses|3|||
124963639|NCT01283971|449494189|FG000|Overall Study|Protocol Violation|5|||
124963640|NCT01283971|449494190|FG001|Overall Study|Protocol Violation|1|||
124963641|NCT01283971|449494189|FG000|Overall Study|Refused treatment|3|||
124963642|NCT01283971|449494190|FG001|Overall Study|Refused treatment|1|||
124963643|NCT01283971|449494189|FG000|Overall Study|Failure to return|0|||
124963644|NCT01283971|449494190|FG001|Overall Study|Failure to return|1|||
124963645|NCT01283971|449494189|FG000|Overall Study|Administrative reasons|1|||
124963646|NCT01283971|449494190|FG001|Overall Study|Administrative reasons|1|||
124963647|NCT01502371|449494191|FG000|Overall Study|Withdrawal by Subject|1|||
124963648|NCT01502371|449494192|FG001|Overall Study|Withdrawal by Subject|2|||
124963649|NCT01502371|449494193|FG002|Overall Study|Withdrawal by Subject|1|||
124963650|NCT01502371|449494194|FG003|Overall Study|Withdrawal by Subject|1|||
124963651|NCT01502371|449494195|FG004|Overall Study|Withdrawal by Subject|1|||
124963652|NCT01502371|449494191|FG000|Overall Study|Adverse Event|2|||
124963653|NCT01502371|449494192|FG001|Overall Study|Adverse Event|1|||
124963654|NCT01502371|449494193|FG002|Overall Study|Adverse Event|0|||
124963655|NCT01502371|449494194|FG003|Overall Study|Adverse Event|4|||
124963656|NCT01502371|449494195|FG004|Overall Study|Adverse Event|3|||
124963657|NCT01502371|449494191|FG000|Overall Study|Treatment Failure|22|||
124963658|NCT01502371|449494192|FG001|Overall Study|Treatment Failure|20|||
124963659|NCT01502371|449494193|FG002|Overall Study|Treatment Failure|12|||
124549545|NCT00285012|447967088|FG001|Received Study Tx|Death|1|||
124549546|NCT00285012|447967087|FG000|Received Study Tx|Adverse Event|5|||
124549547|NCT00285012|447967088|FG001|Received Study Tx|Adverse Event|11|||
124549548|NCT00285012|447967087|FG000|Received Study Tx|Lack of Efficacy|0|||
124549549|NCT00285012|447967088|FG001|Received Study Tx|Lack of Efficacy|3|||
124549550|NCT00285012|447967087|FG000|Received Study Tx|Lost to Follow-up|29|||
124549551|NCT00285012|447967088|FG001|Received Study Tx|Lost to Follow-up|31|||
124549552|NCT00285012|447967087|FG000|Received Study Tx|Withdrawal by Subject|31|||
124549553|NCT00285012|447967088|FG001|Received Study Tx|Withdrawal by Subject|43|||
124549554|NCT00285012|447967087|FG000|Received Study Tx|Other|5|||
124549555|NCT00285012|447967088|FG001|Received Study Tx|Other|5|||
124549556|NCT02873195|447967089|FG000|Overall Study|Ineligible|5|||
124549557|NCT02873195|447967090|FG001|Overall Study|Ineligible|0|||
124549558|NCT05004181|447967091|FG000|Overall Study|Withdrawal of consent|0|||
124549559|NCT05004181|447967092|FG001|Overall Study|Withdrawal of consent|0|||
124549560|NCT05004181|447967093|FG002|Overall Study|Withdrawal of consent|1|||
124549561|NCT05004181|447967094|FG003|Overall Study|Withdrawal of consent|3|||
124549562|NCT05004181|447967095|FG004|Overall Study|Withdrawal of consent|3|||
124549563|NCT05004181|447967096|FG005|Overall Study|Withdrawal of consent|0|||
124549564|NCT05004181|447967097|FG006|Overall Study|Withdrawal of consent|30|||
124549565|NCT05004181|447967098|FG007|Overall Study|Withdrawal of consent|9|||
124549566|NCT05004181|447967099|FG008|Overall Study|Withdrawal of consent|3|||
124549567|NCT05004181|447967100|FG009|Overall Study|Withdrawal of consent|2|||
124549568|NCT05004181|447967101|FG010|Overall Study|Withdrawal of consent|5|||
124549569|NCT05004181|447967102|FG011|Overall Study|Withdrawal of consent|1|||
124549570|NCT05004181|447967091|FG000|Overall Study|Lost to Follow-up|2|||
124549571|NCT05004181|447967092|FG001|Overall Study|Lost to Follow-up|4|||
124549572|NCT05004181|447967093|FG002|Overall Study|Lost to Follow-up|2|||
124549573|NCT05004181|447967094|FG003|Overall Study|Lost to Follow-up|3|||
124549574|NCT05004181|447967095|FG004|Overall Study|Lost to Follow-up|5|||
124549575|NCT05004181|447967096|FG005|Overall Study|Lost to Follow-up|2|||
124549576|NCT05004181|447967097|FG006|Overall Study|Lost to Follow-up|15|||
124549577|NCT05004181|447967098|FG007|Overall Study|Lost to Follow-up|12|||
124549578|NCT05004181|447967099|FG008|Overall Study|Lost to Follow-up|38|||
124549579|NCT05004181|447967100|FG009|Overall Study|Lost to Follow-up|6|||
124549580|NCT05004181|447967101|FG010|Overall Study|Lost to Follow-up|6|||
124549581|NCT05004181|447967102|FG011|Overall Study|Lost to Follow-up|0|||
124549582|NCT05004181|447967091|FG000|Overall Study|Death|0|||
124549583|NCT05004181|447967092|FG001|Overall Study|Death|0|||
124549584|NCT05004181|447967093|FG002|Overall Study|Death|0|||
124549585|NCT05004181|447967094|FG003|Overall Study|Death|0|||
124549586|NCT05004181|447967095|FG004|Overall Study|Death|0|||
124549587|NCT05004181|447967096|FG005|Overall Study|Death|0|||
124549588|NCT05004181|447967097|FG006|Overall Study|Death|1|||
124549589|NCT05004181|447967098|FG007|Overall Study|Death|0|||
124549590|NCT05004181|447967099|FG008|Overall Study|Death|2|||
124549591|NCT05004181|447967100|FG009|Overall Study|Death|0|||
124709765|NCT01008618|448563012|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
124549592|NCT05004181|447967101|FG010|Overall Study|Death|0|||
124549593|NCT05004181|447967102|FG011|Overall Study|Death|0|||
124549594|NCT05004181|447967091|FG000|Overall Study|Physician Decision|0|||
124549595|NCT05004181|447967092|FG001|Overall Study|Physician Decision|0|||
124549596|NCT05004181|447967093|FG002|Overall Study|Physician Decision|0|||
124549597|NCT05004181|447967094|FG003|Overall Study|Physician Decision|0|||
124549598|NCT05004181|447967095|FG004|Overall Study|Physician Decision|0|||
124549599|NCT05004181|447967096|FG005|Overall Study|Physician Decision|0|||
124549600|NCT05004181|447967097|FG006|Overall Study|Physician Decision|2|||
124549601|NCT05004181|447967098|FG007|Overall Study|Physician Decision|0|||
124549602|NCT05004181|447967099|FG008|Overall Study|Physician Decision|7|||
124549603|NCT05004181|447967100|FG009|Overall Study|Physician Decision|0|||
124549604|NCT05004181|447967101|FG010|Overall Study|Physician Decision|0|||
124549605|NCT05004181|447967102|FG011|Overall Study|Physician Decision|0|||
124549606|NCT05004181|447967091|FG000|Overall Study|Withdrawal by Subject|2|||
124549607|NCT05004181|447967092|FG001|Overall Study|Withdrawal by Subject|3|||
124549608|NCT05004181|447967093|FG002|Overall Study|Withdrawal by Subject|2|||
124709766|NCT01008618|448563013|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
124709767|NCT01008618|448563011|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
124709768|NCT01008618|448563012|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
124709769|NCT01008618|448563013|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
124709770|NCT01008618|448563011|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
124709771|NCT01008618|448563012|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
124709772|NCT01008618|448563013|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
124709773|NCT01008618|448563011|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
124549609|NCT05004181|447967094|FG003|Overall Study|Withdrawal by Subject|2|||
124549610|NCT05004181|447967095|FG004|Overall Study|Withdrawal by Subject|4|||
124549611|NCT05004181|447967096|FG005|Overall Study|Withdrawal by Subject|2|||
124549612|NCT05004181|447967097|FG006|Overall Study|Withdrawal by Subject|4|||
124549613|NCT05004181|447967098|FG007|Overall Study|Withdrawal by Subject|22|||
124549614|NCT05004181|447967099|FG008|Overall Study|Withdrawal by Subject|8|||
124549615|NCT05004181|447967100|FG009|Overall Study|Withdrawal by Subject|1|||
124549616|NCT05004181|447967101|FG010|Overall Study|Withdrawal by Subject|3|||
124709774|NCT01008618|448563012|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
124549617|NCT05004181|447967102|FG011|Overall Study|Withdrawal by Subject|2|||
124549618|NCT05004181|447967091|FG000|Overall Study|Protocol Violation|2|||
124549619|NCT05004181|447967092|FG001|Overall Study|Protocol Violation|3|||
124549620|NCT05004181|447967093|FG002|Overall Study|Protocol Violation|0|||
124549621|NCT05004181|447967094|FG003|Overall Study|Protocol Violation|0|||
124549622|NCT05004181|447967095|FG004|Overall Study|Protocol Violation|1|||
124549623|NCT05004181|447967096|FG005|Overall Study|Protocol Violation|0|||
124549624|NCT05004181|447967097|FG006|Overall Study|Protocol Violation|16|||
124549625|NCT05004181|447967098|FG007|Overall Study|Protocol Violation|18|||
124549626|NCT05004181|447967099|FG008|Overall Study|Protocol Violation|2|||
124549627|NCT05004181|447967100|FG009|Overall Study|Protocol Violation|2|||
124549628|NCT05004181|447967101|FG010|Overall Study|Protocol Violation|2|||
124549629|NCT05004181|447967102|FG011|Overall Study|Protocol Violation|1|||
124549630|NCT05004181|447967091|FG000|Overall Study|Not further specified|1|||
124464374|NCT03605680|447658121|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
124464375|NCT03605680|447658122|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
124464376|NCT03605680|447658123|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
124464377|NCT03605680|447658120|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
124464378|NCT03605680|447658121|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
124464379|NCT03605680|447658122|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
124464380|NCT03605680|447658123|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
124464381|NCT03605680|447658120|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
124464382|NCT03605680|447658121|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
124464383|NCT03605680|447658122|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
124464384|NCT03605680|447658123|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
124464385|NCT03605680|447658120|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
124464386|NCT03605680|447658121|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
124464387|NCT03605680|447658122|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
124464388|NCT03605680|447658123|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
124549631|NCT05004181|447967092|FG001|Overall Study|Not further specified|0|||
124549632|NCT05004181|447967093|FG002|Overall Study|Not further specified|0|||
124549633|NCT05004181|447967094|FG003|Overall Study|Not further specified|0|||
124709775|NCT01008618|448563013|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
124709776|NCT00742625|448563014|FG000|Remission Induction|Progression|6|||
124709777|NCT00742625|448563014|FG000|Remission Induction|Failed induction|8|||
124709778|NCT00742625|448563014|FG000|Remission Induction|Adverse Event|3|||
124709779|NCT00742625|448563014|FG000|Remission Induction|Death|10|||
124709780|NCT00742625|448563014|FG000|Remission Induction|Refusal|5|||
124709781|NCT00742625|448563014|FG000|Remission Induction|Non protocol treatment|17|||
124709782|NCT00742625|448563014|FG000|Remission Induction|Other, not specified|5|||
124709783|NCT00742625|448563014|FG000|Consolidation|Progression|5|||
124709784|NCT00742625|448563014|FG000|Consolidation|Adverse Event|1|||
124709785|NCT00742625|448563014|FG000|Consolidation|Death|1|||
124709786|NCT00742625|448563014|FG000|Consolidation|Refused|1|||
124709787|NCT00742625|448563014|FG000|Consolidation|Non protocol therapy|13|||
124709788|NCT03338400|448563015|FG000|Overall Study|Lost to Follow-up|1|||
124709789|NCT03338400|448563016|FG001|Overall Study|Lost to Follow-up|2|||
124709790|NCT01865487|448563019|FG000|Overall Study|Lost to Follow-up|0|||
124709791|NCT01865487|448563020|FG001|Overall Study|Lost to Follow-up|0|||
124709792|NCT01865487|448563021|FG002|Overall Study|Lost to Follow-up|0|||
124709793|NCT01865487|448563022|FG003|Overall Study|Lost to Follow-up|1|||
124709794|NCT01865487|448563023|FG004|Overall Study|Lost to Follow-up|0|||
124709795|NCT01865487|448563024|FG005|Overall Study|Lost to Follow-up|0|||
124709796|NCT01865487|448563025|FG006|Overall Study|Lost to Follow-up|1|||
124709797|NCT01865487|448563026|FG007|Overall Study|Lost to Follow-up|0|||
124709798|NCT01865487|448563027|FG008|Overall Study|Lost to Follow-up|0|||
124709799|NCT01865487|448563028|FG009|Overall Study|Lost to Follow-up|0|||
124709800|NCT01865487|448563019|FG000|Overall Study|Withdrawal by Subject|0|||
124709801|NCT01865487|448563020|FG001|Overall Study|Withdrawal by Subject|0|||
124709802|NCT01865487|448563021|FG002|Overall Study|Withdrawal by Subject|0|||
124709803|NCT01865487|448563022|FG003|Overall Study|Withdrawal by Subject|0|||
124709804|NCT01865487|448563023|FG004|Overall Study|Withdrawal by Subject|1|||
124709805|NCT01865487|448563024|FG005|Overall Study|Withdrawal by Subject|0|||
124709806|NCT01865487|448563025|FG006|Overall Study|Withdrawal by Subject|0|||
124709807|NCT01865487|448563026|FG007|Overall Study|Withdrawal by Subject|0|||
124709808|NCT01865487|448563027|FG008|Overall Study|Withdrawal by Subject|0|||
124549634|NCT05004181|447967095|FG004|Overall Study|Not further specified|0|||
124709809|NCT01865487|448563028|FG009|Overall Study|Withdrawal by Subject|0|||
124709810|NCT01213082|448563032|FG000|Overall Study|Lost to Follow-up|6|||
124709811|NCT01213082|448563033|FG001|Overall Study|Lost to Follow-up|7|||
124709812|NCT01213082|448563034|FG002|Overall Study|Lost to Follow-up|4|||
124464389|NCT03605680|447658120|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
124464390|NCT03605680|447658121|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
124464391|NCT03605680|447658122|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
124464392|NCT03605680|447658123|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
124464393|NCT03605680|447658120|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
124464394|NCT03605680|447658121|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
124464395|NCT03605680|447658122|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
124464396|NCT03605680|447658123|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
124464397|NCT03605680|447658120|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
124464398|NCT03605680|447658121|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
124464399|NCT03605680|447658122|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
124464400|NCT03605680|447658123|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
124464401|NCT03605680|447658120|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
124464402|NCT03605680|447658121|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
124464403|NCT03605680|447658122|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
124464404|NCT03605680|447658123|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
124464405|NCT03605680|447658120|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
124464406|NCT03605680|447658121|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
124464407|NCT03605680|447658122|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
124464408|NCT03605680|447658123|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
124464409|NCT00356278|447658124|FG000|Overall Study|Withdrawal by Subject|25|||
124464410|NCT00356278|447658125|FG001|Overall Study|Withdrawal by Subject|15|||
124464411|NCT00356278|447658126|FG002|Overall Study|Withdrawal by Subject|19|||
124464412|NCT05594173|447658127|FG000|Overall Study|Adverse Event|1|||
124464413|NCT05594173|447658127|FG000|Overall Study|COVID-19 Pandemic|2|||
124464414|NCT01592760|447658130|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
124464415|NCT01592760|447658131|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
124464416|NCT01592760|447658132|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
124464417|NCT04312009|447658133|FG000|Overall Study|Withdrawal by Subject|2|||
124464418|NCT04312009|447658134|FG001|Overall Study|Withdrawal by Subject|1|||
124464419|NCT01678144|447658140|FG000|Stage 1: MAR Classic|Adverse Event|1|||
124464420|NCT02264990|447658142|FG000|Overall Study|Death|255|||
124464421|NCT02264990|447658143|FG001|Overall Study|Death|250|||
124464422|NCT02264990|447658142|FG000|Overall Study|Withdrawal by Subject|4|||
124464423|NCT02264990|447658143|FG001|Overall Study|Withdrawal by Subject|5|||
124464424|NCT02264990|447658142|FG000|Overall Study|Lost to Follow-up|1|||
124464425|NCT02264990|447658143|FG001|Overall Study|Lost to Follow-up|3|||
124464426|NCT02264990|447658142|FG000|Overall Study|Other|0|||
124464427|NCT02264990|447658143|FG001|Overall Study|Other|1|||
124464428|NCT00267748|447658144|FG000|Non-randomized Period|Progressive disease|10|||
124464429|NCT00267748|447658145|FG001|Non-randomized Period|Progressive disease|0|||
124464430|NCT00267748|447658146|FG002|Non-randomized Period|Progressive disease|0|||
124464431|NCT00267748|447658144|FG000|Non-randomized Period|Adverse Event|8|||
124464432|NCT00267748|447658145|FG001|Non-randomized Period|Adverse Event|0|||
124464433|NCT00267748|447658146|FG002|Non-randomized Period|Adverse Event|0|||
124464434|NCT00267748|447658144|FG000|Non-randomized Period|Death|1|||
124464435|NCT00267748|447658145|FG001|Non-randomized Period|Death|0|||
124464436|NCT00267748|447658146|FG002|Non-randomized Period|Death|0|||
124464437|NCT00267748|447658144|FG000|Non-randomized Period|Participant not willing to participate|1|||
124464438|NCT00267748|447658145|FG001|Non-randomized Period|Participant not willing to participate|0|||
124464439|NCT00267748|447658146|FG002|Non-randomized Period|Participant not willing to participate|0|||
124464440|NCT00267748|447658144|FG000|Non-randomized Period|Other|3|||
124464441|NCT00267748|447658145|FG001|Non-randomized Period|Other|0|||
124464442|NCT00267748|447658146|FG002|Non-randomized Period|Other|0|||
124464443|NCT00267748|447658144|FG000|Randomized Period|Death|0|||
124464444|NCT00267748|447658145|FG001|Randomized Period|Death|2|||
124709813|NCT01213082|448563032|FG000|Overall Study|Physician Decision|0|||
124963660|NCT01502371|449494194|FG003|Overall Study|Treatment Failure|19|||
124963661|NCT01502371|449494195|FG004|Overall Study|Treatment Failure|30|||
124963662|NCT01502371|449494191|FG000|Overall Study|Lack of Efficacy|3|||
124963663|NCT01502371|449494192|FG001|Overall Study|Lack of Efficacy|3|||
124963664|NCT01502371|449494193|FG002|Overall Study|Lack of Efficacy|2|||
124963665|NCT01502371|449494194|FG003|Overall Study|Lack of Efficacy|2|||
124963666|NCT01502371|449494195|FG004|Overall Study|Lack of Efficacy|4|||
124963667|NCT01502371|449494191|FG000|Overall Study|Physician Decision|3|||
124963668|NCT01502371|449494192|FG001|Overall Study|Physician Decision|0|||
124963669|NCT01502371|449494193|FG002|Overall Study|Physician Decision|0|||
124963670|NCT01502371|449494194|FG003|Overall Study|Physician Decision|0|||
124963671|NCT01502371|449494195|FG004|Overall Study|Physician Decision|1|||
124963672|NCT01502371|449494191|FG000|Overall Study|Noncompliance with Study Drug|0|||
124963673|NCT01502371|449494192|FG001|Overall Study|Noncompliance with Study Drug|0|||
124963674|NCT01502371|449494193|FG002|Overall Study|Noncompliance with Study Drug|1|||
124963675|NCT01502371|449494194|FG003|Overall Study|Noncompliance with Study Drug|2|||
124963676|NCT01502371|449494195|FG004|Overall Study|Noncompliance with Study Drug|1|||
124963677|NCT01502371|449494191|FG000|Overall Study|Technical Problems|1|||
124963678|NCT01502371|449494192|FG001|Overall Study|Technical Problems|0|||
124963679|NCT01502371|449494193|FG002|Overall Study|Technical Problems|2|||
124963680|NCT01502371|449494194|FG003|Overall Study|Technical Problems|4|||
124963681|NCT01502371|449494195|FG004|Overall Study|Technical Problems|1|||
124963682|NCT01502371|449494191|FG000|Overall Study|Protocol Violation|9|||
124963683|NCT01502371|449494192|FG001|Overall Study|Protocol Violation|5|||
124963684|NCT01502371|449494193|FG002|Overall Study|Protocol Violation|6|||
124963685|NCT01502371|449494194|FG003|Overall Study|Protocol Violation|5|||
124963686|NCT01502371|449494195|FG004|Overall Study|Protocol Violation|10|||
124963687|NCT01502371|449494191|FG000|Overall Study|Excluded Medication|0|||
124963688|NCT01502371|449494192|FG001|Overall Study|Excluded Medication|1|||
124963689|NCT01502371|449494193|FG002|Overall Study|Excluded Medication|1|||
124963690|NCT01502371|449494194|FG003|Overall Study|Excluded Medication|0|||
124963691|NCT01502371|449494195|FG004|Overall Study|Excluded Medication|1|||
124963692|NCT02598934|449494196|FG000|Overall Study|Adverse Event|11|||
124963693|NCT02598934|449494197|FG001|Overall Study|Adverse Event|13|||
124963694|NCT02598934|449494196|FG000|Overall Study|Failure to Return|3|||
124963695|NCT02598934|449494197|FG001|Overall Study|Failure to Return|3|||
124963696|NCT02598934|449494196|FG000|Overall Study|Withdrawal by Subject|2|||
124963697|NCT02598934|449494197|FG001|Overall Study|Withdrawal by Subject|3|||
124963698|NCT02598934|449494196|FG000|Overall Study|Administrative|2|||
124963699|NCT02598934|449494197|FG001|Overall Study|Administrative|1|||
124963700|NCT02598934|449494196|FG000|Overall Study|Protocol Violation|1|||
124963701|NCT02598934|449494197|FG001|Overall Study|Protocol Violation|2|||
124963702|NCT03049306|449494200|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
124963703|NCT03049306|449494201|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
124963704|NCT02154347|449494202|FG000|Double-blind Period|Adverse Event|1|||
124963705|NCT02154347|449494203|FG001|Double-blind Period|Adverse Event|2|||
124963706|NCT02154347|449494202|FG000|Double-blind Period|Lack of Efficacy|1|||
124963707|NCT02154347|449494203|FG001|Double-blind Period|Lack of Efficacy|0|||
124963708|NCT02154347|449494202|FG000|Double-blind Period|Physician Decision|0|||
124963709|NCT02154347|449494203|FG001|Double-blind Period|Physician Decision|1|||
124963710|NCT02154347|449494202|FG000|Double-blind Period|Withdrawal by Subject|1|||
124963711|NCT02154347|449494203|FG001|Double-blind Period|Withdrawal by Subject|1|||
124963712|NCT02154347|449494202|FG000|Open-label Period|Adverse Event|3|||
124963713|NCT02154347|449494203|FG001|Open-label Period|Adverse Event|4|||
124963714|NCT02154347|449494202|FG000|Open-label Period|Lack of Efficacy|4|||
124963715|NCT02154347|449494203|FG001|Open-label Period|Lack of Efficacy|19|||
124963716|NCT02154347|449494202|FG000|Open-label Period|Protocol Violation|0|||
124963717|NCT02154347|449494203|FG001|Open-label Period|Protocol Violation|1|||
124963718|NCT02154347|449494202|FG000|Open-label Period|Withdrawal by Subject|0|||
124963719|NCT02154347|449494203|FG001|Open-label Period|Withdrawal by Subject|1|||
124963720|NCT02473913|449494205|FG000|Overall Study|Lost to Follow-up|3|||
124963721|NCT02473913|449494206|FG001|Overall Study|Lost to Follow-up|3|||
124963722|NCT00605566|449495740|FG000|Overall Study|Adverse Event|1|||
124963723|NCT00605566|449495740|FG000|Overall Study|Clinical deterioration|1|||
124963724|NCT00605566|449495740|FG000|Overall Study|Poor compliance in run-in period|1|||
124963725|NCT04156399|449495741|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
124963726|NCT04156399|449495741|FG000|Overall Study|study suspension due to COVID pandemic|3|||
124963727|NCT03440047|449495742|FG000|Overall Study|Withdrawal by Subject|2|||
124963728|NCT01181609|449495743|FG000|Overall Study|Adverse Event|1|||
124963729|NCT01181609|449495743|FG000|Overall Study|Withdrawal by Subject|1|||
124963730|NCT01181609|449495743|FG000|Overall Study|Lost to Follow-up|1|||
124709814|NCT01213082|448563033|FG001|Overall Study|Physician Decision|0|||
124709815|NCT01213082|448563034|FG002|Overall Study|Physician Decision|1|||
124709816|NCT03848416|448563037|FG000|Overall Study|Withdrawal by Subject|1|||
124709817|NCT03848416|448563038|FG001|Overall Study|Withdrawal by Subject|0|||
124709818|NCT03848416|448563039|FG002|Overall Study|Withdrawal by Subject|0|||
124709819|NCT03848416|448563037|FG000|Overall Study|Death|0|||
124709820|NCT03848416|448563038|FG001|Overall Study|Death|0|||
124709821|NCT03848416|448563039|FG002|Overall Study|Death|1|||
124709822|NCT02639390|448563040|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
124709823|NCT02639390|448563041|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
124709824|NCT01908140|448563042|FG000|Overall Study|Other or Progressive Disease|5|||
124709825|NCT01908140|448563043|FG001|Overall Study|Other or Progressive Disease|12|||
124709826|NCT01908140|448563042|FG000|Overall Study|Lack of Efficacy|7|||
124709827|NCT01908140|448563043|FG001|Overall Study|Lack of Efficacy|5|||
124709828|NCT01908140|448563042|FG000|Overall Study|Withdrawal by Subject|23|||
124709829|NCT01908140|448563043|FG001|Overall Study|Withdrawal by Subject|24|||
124709830|NCT01908140|448563042|FG000|Overall Study|Lost to Follow-up|1|||
124709831|NCT01908140|448563043|FG001|Overall Study|Lost to Follow-up|6|||
124709832|NCT01908140|448563042|FG000|Overall Study|Protocol Violation|8|||
124709833|NCT01908140|448563043|FG001|Overall Study|Protocol Violation|9|||
124709834|NCT01908140|448563042|FG000|Overall Study|Adverse Event|22|||
124709835|NCT01908140|448563043|FG001|Overall Study|Adverse Event|23|||
124709836|NCT01436110|448563044|FG000|Overall Study|Lack of Efficacy|23|||
124709837|NCT01436110|448563045|FG001|Overall Study|Lack of Efficacy|14|||
124709838|NCT01436110|448563046|FG002|Overall Study|Lack of Efficacy|9|||
124709839|NCT01436110|448563044|FG000|Overall Study|Withdrawal by Subject|6|||
124709840|NCT01436110|448563045|FG001|Overall Study|Withdrawal by Subject|8|||
124709841|NCT01436110|448563046|FG002|Overall Study|Withdrawal by Subject|4|||
124549635|NCT05004181|447967096|FG005|Overall Study|Not further specified|0|||
124963731|NCT01181609|449495743|FG000|Overall Study|Death|50|||
124963732|NCT01333111|449495744|FG000|Overall Study|patient undergoing major surgery|0|||
124963733|NCT01333111|449495745|FG001|Overall Study|patient undergoing major surgery|2|||
124963734|NCT01333111|449495746|FG002|Overall Study|patient undergoing major surgery|0|||
124963735|NCT01333111|449495744|FG000|Overall Study|personal reasons|0|||
124963736|NCT01333111|449495745|FG001|Overall Study|personal reasons|0|||
124963737|NCT01333111|449495746|FG002|Overall Study|personal reasons|1|||
124963738|NCT01333111|449495744|FG000|Overall Study|unclassified|1|||
124963739|NCT01333111|449495745|FG001|Overall Study|unclassified|0|||
124963740|NCT01333111|449495746|FG002|Overall Study|unclassified|0|||
124963741|NCT01333111|449495744|FG000|Overall Study|withdrawal criteria|0|||
124963742|NCT01333111|449495745|FG001|Overall Study|withdrawal criteria|1|||
124963743|NCT01333111|449495746|FG002|Overall Study|withdrawal criteria|0|||
124963744|NCT01333111|449495744|FG000|Overall Study|Non-compliance|1|||
124963745|NCT01333111|449495745|FG001|Overall Study|Non-compliance|0|||
124963746|NCT01333111|449495746|FG002|Overall Study|Non-compliance|0|||
124963747|NCT01333111|449495744|FG000|Overall Study|Ineffective therapy|0|||
124963748|NCT01333111|449495745|FG001|Overall Study|Ineffective therapy|0|||
124963749|NCT01333111|449495746|FG002|Overall Study|Ineffective therapy|1|||
124963750|NCT04732871|449495747|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
124963751|NCT04732871|449495748|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
124963752|NCT04732871|449495749|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
124963753|NCT04732871|449495747|FG000|Overall Study|Lost to Follow-up|7|||
124963754|NCT04732871|449495748|FG001|Overall Study|Lost to Follow-up|4|||
124963755|NCT04732871|449495749|FG002|Overall Study|Lost to Follow-up|3|||
124963756|NCT04732871|449495747|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
124963757|NCT04732871|449495748|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
124963758|NCT04732871|449495749|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
124963759|NCT04732871|449495747|FG000|Overall Study|Migrated / moved from the study area|5|||
124963760|NCT04732871|449495748|FG001|Overall Study|Migrated / moved from the study area|0|||
124963761|NCT04732871|449495749|FG002|Overall Study|Migrated / moved from the study area|0|||
124963762|NCT04732871|449495747|FG000|Overall Study|Other|1|||
124963763|NCT04732871|449495748|FG001|Overall Study|Other|0|||
124963764|NCT04732871|449495749|FG002|Overall Study|Other|1|||
124963765|NCT04732871|449495747|FG000|Overall Study|Ongoing|6|||
124709842|NCT01436110|448563044|FG000|Overall Study|Adverse Event|2|||
124709843|NCT01436110|448563045|FG001|Overall Study|Adverse Event|1|||
124709844|NCT01436110|448563046|FG002|Overall Study|Adverse Event|2|||
124709845|NCT01436110|448563044|FG000|Overall Study|Physician Decision|3|||
124709846|NCT01436110|448563045|FG001|Overall Study|Physician Decision|1|||
124709847|NCT01436110|448563046|FG002|Overall Study|Physician Decision|1|||
124709848|NCT01436110|448563044|FG000|Overall Study|Lost to Follow-up|1|||
124709849|NCT01436110|448563045|FG001|Overall Study|Lost to Follow-up|1|||
124963766|NCT04732871|449495748|FG001|Overall Study|Ongoing|0|||
124963767|NCT04732871|449495749|FG002|Overall Study|Ongoing|1|||
124963768|NCT04732871|449495747|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
124963769|NCT04732871|449495748|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
124549636|NCT05004181|447967097|FG006|Overall Study|Not further specified|1|||
124549637|NCT05004181|447967098|FG007|Overall Study|Not further specified|0|||
124549638|NCT05004181|447967099|FG008|Overall Study|Not further specified|2|||
124549639|NCT05004181|447967100|FG009|Overall Study|Not further specified|1|||
124549640|NCT05004181|447967101|FG010|Overall Study|Not further specified|0|||
124549641|NCT05004181|447967102|FG011|Overall Study|Not further specified|1|||
124549642|NCT00633217|447967103|FG000|Overall Study|Adverse Event|5|||
124549643|NCT00633217|447967104|FG001|Overall Study|Adverse Event|9|||
124549644|NCT00633217|447967103|FG000|Overall Study|Lack of Efficacy|0|||
124549645|NCT00633217|447967104|FG001|Overall Study|Lack of Efficacy|2|||
124549646|NCT00633217|447967103|FG000|Overall Study|Protocol Violation|3|||
124549647|NCT00633217|447967104|FG001|Overall Study|Protocol Violation|7|||
124549648|NCT00633217|447967103|FG000|Overall Study|Lost to Follow-up|2|||
124963770|NCT04732871|449495749|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
124963771|NCT03294941|449495754|FG000|Overall Study|Withdrawal by Subject|0|||
124963772|NCT03294941|449495755|FG001|Overall Study|Withdrawal by Subject|2|||
124963773|NCT00702650|449495756|FG000|Overall Study|Withdrawal by Subject|9|||
124963774|NCT00702650|449495756|FG000|Overall Study|Non-Compliance of Study Drug|3|||
124963775|NCT00702650|449495756|FG000|Overall Study|Lost to Follow-up|2|||
124963776|NCT00702650|449495756|FG000|Overall Study|Non-Compliance with Site Directives|1|||
124963777|NCT00702650|449495756|FG000|Overall Study|Sponsor Request|1|||
124963778|NCT00702650|449495756|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
124963779|NCT00702650|449495756|FG000|Overall Study|Adverse Event|3|||
124963780|NCT01475461|449495762|FG000|Run-in Period|Not meet eligibility criteria|16|||
124963781|NCT01475461|449495763|FG001|Run-in Period|Not meet eligibility criteria|0|||
124963782|NCT01475461|449495764|FG002|Run-in Period|Not meet eligibility criteria|0|||
124963783|NCT01475461|449495765|FG003|Run-in Period|Not meet eligibility criteria|0|||
124963784|NCT01475461|449495766|FG004|Run-in Period|Not meet eligibility criteria|0|||
124963785|NCT01475461|449495767|FG005|Run-in Period|Not meet eligibility criteria|0|||
124963786|NCT01475461|449495768|FG006|Run-in Period|Not meet eligibility criteria|0|||
124963787|NCT01475461|449495762|FG000|Run-in Period|Lost to Follow-up|7|||
124963788|NCT01475461|449495763|FG001|Run-in Period|Lost to Follow-up|0|||
124963789|NCT01475461|449495764|FG002|Run-in Period|Lost to Follow-up|0|||
124963790|NCT01475461|449495765|FG003|Run-in Period|Lost to Follow-up|0|||
124963791|NCT01475461|449495766|FG004|Run-in Period|Lost to Follow-up|0|||
124963792|NCT01475461|449495767|FG005|Run-in Period|Lost to Follow-up|0|||
124963793|NCT01475461|449495768|FG006|Run-in Period|Lost to Follow-up|0|||
124963794|NCT01475461|449495762|FG000|Run-in Period|Withdrawal by Subject|11|||
124963795|NCT01475461|449495763|FG001|Run-in Period|Withdrawal by Subject|0|||
124963796|NCT01475461|449495764|FG002|Run-in Period|Withdrawal by Subject|0|||
124963797|NCT01475461|449495765|FG003|Run-in Period|Withdrawal by Subject|0|||
124963798|NCT01475461|449495766|FG004|Run-in Period|Withdrawal by Subject|0|||
124963799|NCT01475461|449495767|FG005|Run-in Period|Withdrawal by Subject|0|||
124963800|NCT01475461|449495768|FG006|Run-in Period|Withdrawal by Subject|0|||
124963801|NCT01475461|449495762|FG000|Run-in Period|Other|3|||
124963802|NCT01475461|449495763|FG001|Run-in Period|Other|0|||
124963803|NCT01475461|449495764|FG002|Run-in Period|Other|0|||
124963804|NCT01475461|449495765|FG003|Run-in Period|Other|0|||
124963805|NCT01475461|449495766|FG004|Run-in Period|Other|0|||
124963806|NCT01475461|449495767|FG005|Run-in Period|Other|0|||
124963807|NCT01475461|449495768|FG006|Run-in Period|Other|0|||
124963808|NCT01475461|449495762|FG000|Run-in Period|Protocol Violation|4|||
124963809|NCT01475461|449495763|FG001|Run-in Period|Protocol Violation|0|||
124963810|NCT01475461|449495764|FG002|Run-in Period|Protocol Violation|0|||
124963811|NCT01475461|449495765|FG003|Run-in Period|Protocol Violation|0|||
124963812|NCT01475461|449495766|FG004|Run-in Period|Protocol Violation|0|||
124963813|NCT01475461|449495767|FG005|Run-in Period|Protocol Violation|0|||
124963814|NCT01475461|449495768|FG006|Run-in Period|Protocol Violation|0|||
124963815|NCT01475461|449495762|FG000|Treatment Period|Death|0|||
124963816|NCT01475461|449495763|FG001|Treatment Period|Death|0|||
124963817|NCT01475461|449495764|FG002|Treatment Period|Death|0|||
124549649|NCT00633217|447967104|FG001|Overall Study|Lost to Follow-up|2|||
124549650|NCT00633217|447967103|FG000|Overall Study|Investigator Discretion|2|||
124549651|NCT00633217|447967104|FG001|Overall Study|Investigator Discretion|0|||
124963818|NCT01475461|449495765|FG003|Treatment Period|Death|1|||
124963819|NCT01475461|449495766|FG004|Treatment Period|Death|0|||
124963820|NCT01475461|449495767|FG005|Treatment Period|Death|0|||
124963821|NCT01475461|449495768|FG006|Treatment Period|Death|0|||
124963822|NCT01475461|449495762|FG000|Treatment Period|Lost to Follow-up|0|||
124963823|NCT01475461|449495763|FG001|Treatment Period|Lost to Follow-up|3|||
124963824|NCT01475461|449495764|FG002|Treatment Period|Lost to Follow-up|2|||
124963825|NCT01475461|449495765|FG003|Treatment Period|Lost to Follow-up|3|||
124549652|NCT00633217|447967103|FG000|Overall Study|Withdrew Consent|3|||
124549653|NCT00633217|447967104|FG001|Overall Study|Withdrew Consent|3|||
124549654|NCT00096031|447967105|FG000|Overall Study|Adverse Event|3|||
124549655|NCT00096031|447967105|FG000|Overall Study|Lack of Efficacy|42|||
124963826|NCT01475461|449495766|FG004|Treatment Period|Lost to Follow-up|1|||
124963827|NCT01475461|449495767|FG005|Treatment Period|Lost to Follow-up|2|||
124963828|NCT01475461|449495768|FG006|Treatment Period|Lost to Follow-up|1|||
124963829|NCT01475461|449495762|FG000|Treatment Period|Withdrawal by Subject|0|||
124963830|NCT01475461|449495763|FG001|Treatment Period|Withdrawal by Subject|2|||
124963831|NCT01475461|449495764|FG002|Treatment Period|Withdrawal by Subject|2|||
124963832|NCT01475461|449495765|FG003|Treatment Period|Withdrawal by Subject|0|||
124963833|NCT01475461|449495766|FG004|Treatment Period|Withdrawal by Subject|2|||
124963834|NCT01475461|449495767|FG005|Treatment Period|Withdrawal by Subject|2|||
124963835|NCT01475461|449495768|FG006|Treatment Period|Withdrawal by Subject|0|||
124963836|NCT01475461|449495762|FG000|Treatment Period|Other|0|||
124963837|NCT01475461|449495763|FG001|Treatment Period|Other|1|||
124963838|NCT01475461|449495764|FG002|Treatment Period|Other|0|||
124963839|NCT01475461|449495765|FG003|Treatment Period|Other|0|||
124963840|NCT01475461|449495766|FG004|Treatment Period|Other|0|||
124963841|NCT01475461|449495767|FG005|Treatment Period|Other|0|||
124963842|NCT01475461|449495768|FG006|Treatment Period|Other|0|||
124963843|NCT01475461|449495762|FG000|Treatment Period|Protocol Violation|0|||
124963844|NCT01475461|449495763|FG001|Treatment Period|Protocol Violation|1|||
124963845|NCT01475461|449495764|FG002|Treatment Period|Protocol Violation|0|||
124963846|NCT01475461|449495765|FG003|Treatment Period|Protocol Violation|0|||
124963847|NCT01475461|449495766|FG004|Treatment Period|Protocol Violation|0|||
124963848|NCT01475461|449495767|FG005|Treatment Period|Protocol Violation|0|||
124963849|NCT01475461|449495768|FG006|Treatment Period|Protocol Violation|1|||
124963850|NCT01475461|449495762|FG000|Treatment Period|Lack of Efficacy|0|||
124963851|NCT01475461|449495763|FG001|Treatment Period|Lack of Efficacy|2|||
124963852|NCT01475461|449495764|FG002|Treatment Period|Lack of Efficacy|0|||
124963853|NCT01475461|449495765|FG003|Treatment Period|Lack of Efficacy|2|||
124963854|NCT01475461|449495766|FG004|Treatment Period|Lack of Efficacy|1|||
124963855|NCT01475461|449495767|FG005|Treatment Period|Lack of Efficacy|1|||
124963856|NCT01475461|449495768|FG006|Treatment Period|Lack of Efficacy|0|||
124963857|NCT01475461|449495762|FG000|Treatment Period|Medication Error|0|||
124963858|NCT01475461|449495763|FG001|Treatment Period|Medication Error|0|||
124963859|NCT01475461|449495764|FG002|Treatment Period|Medication Error|0|||
124963860|NCT01475461|449495765|FG003|Treatment Period|Medication Error|1|||
124963861|NCT01475461|449495766|FG004|Treatment Period|Medication Error|0|||
124963862|NCT01475461|449495767|FG005|Treatment Period|Medication Error|0|||
124963863|NCT01475461|449495768|FG006|Treatment Period|Medication Error|0|||
124963864|NCT01475461|449495762|FG000|Treatment Period|Adverse Event|0|||
124963865|NCT01475461|449495763|FG001|Treatment Period|Adverse Event|0|||
124963866|NCT01475461|449495764|FG002|Treatment Period|Adverse Event|0|||
124963867|NCT01475461|449495765|FG003|Treatment Period|Adverse Event|1|||
124963868|NCT01475461|449495766|FG004|Treatment Period|Adverse Event|0|||
124963869|NCT01475461|449495767|FG005|Treatment Period|Adverse Event|0|||
124963870|NCT01475461|449495768|FG006|Treatment Period|Adverse Event|0|||
124963871|NCT02512861|449495771|FG000|Overall Study|Protocol Violation|3|||
124963872|NCT02512861|449495772|FG001|Overall Study|Protocol Violation|7|||
124963873|NCT02512861|449495771|FG000|Overall Study|Physician Decision|3|||
124963874|NCT02512861|449495772|FG001|Overall Study|Physician Decision|1|||
124963875|NCT02512861|449495771|FG000|Overall Study|Withdrawal by Subject|0|||
124963876|NCT02512861|449495772|FG001|Overall Study|Withdrawal by Subject|1|||
124963877|NCT01774019|449495773|FG000|Overall Study|No longer meets protocol criteria|2|||
124963878|NCT01774019|449495774|FG001|Overall Study|No longer meets protocol criteria|0|||
124963879|NCT01774019|449495773|FG000|Overall Study|Withdrawal by Subject|1|||
124963880|NCT01774019|449495774|FG001|Overall Study|Withdrawal by Subject|0|||
124963881|NCT01774019|449495773|FG000|Overall Study|Surgery delayed > 120 days|1|||
124963882|NCT01774019|449495774|FG001|Overall Study|Surgery delayed > 120 days|0|||
124963883|NCT01774019|449495773|FG000|Overall Study|Patient refused surgery|1|||
124963884|NCT01774019|449495774|FG001|Overall Study|Patient refused surgery|1|||
124963885|NCT01774019|449495773|FG000|Overall Study|Unable to implant study device|1|||
124963886|NCT01774019|449495774|FG001|Overall Study|Unable to implant study device|0|||
124963887|NCT01774019|449495773|FG000|Overall Study|Lost to Follow-up|0|||
124963888|NCT01774019|449495774|FG001|Overall Study|Lost to Follow-up|3|||
124963889|NCT03214250|449495777|FG000|Overall Study|Death|5|||
124963890|NCT03214250|449495778|FG001|Overall Study|Death|5|||
124963891|NCT03214250|449495779|FG002|Overall Study|Death|7|||
124963892|NCT03214250|449495780|FG003|Overall Study|Death|4|||
124963893|NCT03214250|449495781|FG004|Overall Study|Death|23|||
124963894|NCT03214250|449495782|FG005|Overall Study|Death|23|||
124963895|NCT03214250|449495783|FG006|Overall Study|Death|24|||
124963896|NCT03214250|449495777|FG000|Overall Study|Lost to Follow-up|0|||
124963897|NCT03214250|449495778|FG001|Overall Study|Lost to Follow-up|0|||
124963898|NCT03214250|449495779|FG002|Overall Study|Lost to Follow-up|0|||
124963899|NCT03214250|449495780|FG003|Overall Study|Lost to Follow-up|1|||
124963900|NCT03214250|449495781|FG004|Overall Study|Lost to Follow-up|1|||
124963901|NCT03214250|449495782|FG005|Overall Study|Lost to Follow-up|2|||
124549656|NCT00096031|447967105|FG000|Overall Study|Death|4|||
124963902|NCT03214250|449495783|FG006|Overall Study|Lost to Follow-up|0|||
124963903|NCT03214250|449495777|FG000|Overall Study|Other|0|||
124963904|NCT03214250|449495778|FG001|Overall Study|Other|0|||
124963905|NCT03214250|449495779|FG002|Overall Study|Other|0|||
124963906|NCT03214250|449495780|FG003|Overall Study|Other|0|||
124963907|NCT03214250|449495781|FG004|Overall Study|Other|1|||
124963908|NCT03214250|449495782|FG005|Overall Study|Other|1|||
124963909|NCT03214250|449495783|FG006|Overall Study|Other|2|||
124963910|NCT03214250|449495777|FG000|Overall Study|Remains on Study|2|||
124963911|NCT03214250|449495778|FG001|Overall Study|Remains on Study|2|||
124963912|NCT03214250|449495779|FG002|Overall Study|Remains on Study|0|||
124963913|NCT03214250|449495780|FG003|Overall Study|Remains on Study|1|||
124963914|NCT03214250|449495781|FG004|Overall Study|Remains on Study|7|||
124963915|NCT03214250|449495782|FG005|Overall Study|Remains on Study|5|||
124963916|NCT03214250|449495783|FG006|Overall Study|Remains on Study|3|||
124963917|NCT03214250|449495777|FG000|Overall Study|Withdrawal by Subject|0|||
124963918|NCT03214250|449495778|FG001|Overall Study|Withdrawal by Subject|0|||
124963919|NCT03214250|449495779|FG002|Overall Study|Withdrawal by Subject|1|||
124963920|NCT03214250|449495780|FG003|Overall Study|Withdrawal by Subject|2|||
124963921|NCT03214250|449495781|FG004|Overall Study|Withdrawal by Subject|5|||
124963922|NCT03214250|449495782|FG005|Overall Study|Withdrawal by Subject|0|||
124963923|NCT03214250|449495783|FG006|Overall Study|Withdrawal by Subject|2|||
124963924|NCT03463577|449495789|FG000|Overall Study|Lost to Follow-up|238|||
124963925|NCT03463577|449495790|FG001|Overall Study|Lost to Follow-up|435|||
124963926|NCT03463577|449495791|FG002|Overall Study|Lost to Follow-up|0|||
124963927|NCT03463577|449495792|FG003|Overall Study|Lost to Follow-up|0|||
124963928|NCT03463577|449495793|FG004|Overall Study|Lost to Follow-up|0|||
124963929|NCT03463577|449495794|FG005|Overall Study|Lost to Follow-up|0|||
124963930|NCT03463577|449495789|FG000|Overall Study|With unknown pregnancy outcome|0|||
124963931|NCT03463577|449495790|FG001|Overall Study|With unknown pregnancy outcome|5|||
124963932|NCT03463577|449495791|FG002|Overall Study|With unknown pregnancy outcome|0|||
124963933|NCT03463577|449495792|FG003|Overall Study|With unknown pregnancy outcome|0|||
124963934|NCT03463577|449495793|FG004|Overall Study|With unknown pregnancy outcome|0|||
124963935|NCT03463577|449495794|FG005|Overall Study|With unknown pregnancy outcome|0|||
124963936|NCT03463577|449495789|FG000|Overall Study|Maternal death|2|||
124963937|NCT03463577|449495790|FG001|Overall Study|Maternal death|0|||
124963938|NCT03463577|449495791|FG002|Overall Study|Maternal death|0|||
124963939|NCT03463577|449495792|FG003|Overall Study|Maternal death|0|||
124963940|NCT03463577|449495793|FG004|Overall Study|Maternal death|0|||
124963941|NCT03463577|449495794|FG005|Overall Study|Maternal death|0|||
124963942|NCT03463577|449495789|FG000|Overall Study|Neonatal death|0|||
124963943|NCT03463577|449495790|FG001|Overall Study|Neonatal death|0|||
124963944|NCT03463577|449495791|FG002|Overall Study|Neonatal death|0|||
124963945|NCT03463577|449495792|FG003|Overall Study|Neonatal death|15|||
124963946|NCT03463577|449495793|FG004|Overall Study|Neonatal death|17|||
124963947|NCT03463577|449495794|FG005|Overall Study|Neonatal death|0|||
124963948|NCT00292981|449495796|FG000|Overall Study|Adverse Event|1|||
124963949|NCT00292981|449495796|FG000|Overall Study|Lost to Follow-up|13|||
124963950|NCT00292981|449495796|FG000|Overall Study|Withdrawal by Subject|22|||
124963951|NCT00292981|449495796|FG000|Overall Study|Other|3|||
124963952|NCT00594178|449495797|FG000|Overall Study|Physician Decision|5|||
124963953|NCT02172950|449495798|FG000|Overall Study|Physician Decision|3|||
124963954|NCT02172950|449495799|FG001|Overall Study|Physician Decision|3|||
124963955|NCT02172950|449495798|FG000|Overall Study|Lack of Efficacy|1|||
124963956|NCT02172950|449495799|FG001|Overall Study|Lack of Efficacy|0|||
124963957|NCT02172950|449495798|FG000|Overall Study|Adverse Event|4|||
124963958|NCT02172950|449495799|FG001|Overall Study|Adverse Event|1|||
124963959|NCT02172950|449495798|FG000|Overall Study|Withdrawal by Subject|10|||
124963960|NCT02172950|449495799|FG001|Overall Study|Withdrawal by Subject|0|||
124963961|NCT02172950|449495798|FG000|Overall Study|Protocol Violation|1|||
124963962|NCT02172950|449495799|FG001|Overall Study|Protocol Violation|0|||
124963963|NCT02172950|449495798|FG000|Overall Study|Lost to Follow-up|1|||
124963964|NCT02172950|449495799|FG001|Overall Study|Lost to Follow-up|0|||
124963965|NCT02172950|449495798|FG000|Overall Study|Death|1|||
124963966|NCT02172950|449495799|FG001|Overall Study|Death|0|||
124963967|NCT02172950|449495798|FG000|Overall Study|Patient traveling|1|||
124963968|NCT02172950|449495799|FG001|Overall Study|Patient traveling|0|||
124963969|NCT02172950|449495798|FG000|Overall Study|Patient went to other country|1|||
124549657|NCT00096031|447967105|FG000|Overall Study|Withdrawal by Subject|1|||
124549658|NCT00096031|447967105|FG000|Overall Study|Ineligible|8|||
124549659|NCT00096031|447967105|FG000|Overall Study|Not protocol specified|5|||
124963970|NCT02172950|449495799|FG001|Overall Study|Patient went to other country|0|||
124549660|NCT00909857|447967106|FG000|Overall Study|Withdrawal by Subject|6|||
124963971|NCT02172950|449495798|FG000|Overall Study|Patient relocated overseas|1|||
124963972|NCT02172950|449495799|FG001|Overall Study|Patient relocated overseas|1|||
124963973|NCT02172950|449495798|FG000|Overall Study|Patient moving|1|||
124963974|NCT02172950|449495799|FG001|Overall Study|Patient moving|0|||
124963975|NCT00496626|449495800|FG000|Overall Study|Lost to Follow-up|0|||
124549661|NCT00909857|447967107|FG001|Overall Study|Withdrawal by Subject|10|||
124549662|NCT00909857|447967106|FG000|Overall Study|Adverse Event|5|||
124549663|NCT00909857|447967107|FG001|Overall Study|Adverse Event|5|||
124963976|NCT00496626|449495801|FG001|Overall Study|Lost to Follow-up|1|||
124963977|NCT00496626|449495800|FG000|Overall Study|Protocol Violation|1|||
124963978|NCT00496626|449495801|FG001|Overall Study|Protocol Violation|0|||
124963979|NCT00496626|449495800|FG000|Overall Study|Withdrawal by Subject|5|||
124963980|NCT00496626|449495801|FG001|Overall Study|Withdrawal by Subject|4|||
124963981|NCT00496626|449495800|FG000|Overall Study|Relocated|0|||
124963982|NCT00496626|449495801|FG001|Overall Study|Relocated|1|||
124963983|NCT00611715|449495802|FG000|Overall Study|Disease Progression|24|||
124963984|NCT00611715|449495803|FG001|Overall Study|Disease Progression|4|||
124963985|NCT00611715|449495802|FG000|Overall Study|Withdrawal by Subject|5|||
124963986|NCT00611715|449495803|FG001|Overall Study|Withdrawal by Subject|1|||
124963987|NCT00611715|449495802|FG000|Overall Study|Adverse Event|9|||
124963988|NCT00611715|449495803|FG001|Overall Study|Adverse Event|1|||
124963989|NCT00611715|449495802|FG000|Overall Study|Death|1|||
124963990|NCT00611715|449495803|FG001|Overall Study|Death|0|||
124963991|NCT00611715|449495802|FG000|Overall Study|two patients are still on treatment|2|||
124963992|NCT00611715|449495803|FG001|Overall Study|two patients are still on treatment|0|||
124963993|NCT00107978|449495804|FG000|Overall Study|Adverse Event|1|||
124963994|NCT00107978|449495805|FG001|Overall Study|Adverse Event|5|||
124963995|NCT00107978|449495804|FG000|Overall Study|Death|3|||
124963996|NCT00107978|449495805|FG001|Overall Study|Death|3|||
124963997|NCT00107978|449495804|FG000|Overall Study|Lost to Follow-up|20|||
124963998|NCT00107978|449495805|FG001|Overall Study|Lost to Follow-up|28|||
124963999|NCT00107978|449495804|FG000|Overall Study|Withdrawal by Subject|4|||
124964000|NCT00107978|449495805|FG001|Overall Study|Withdrawal by Subject|9|||
124964001|NCT00107978|449495804|FG000|Overall Study|Protocol Violation|0|||
124964002|NCT00107978|449495805|FG001|Overall Study|Protocol Violation|1|||
124964003|NCT00107978|449495804|FG000|Overall Study|Other|5|||
124964004|NCT00107978|449495805|FG001|Overall Study|Other|4|||
124964005|NCT00727415|449495806|FG000|Phase I|Dose Limiting Toxicity|2|||
124964006|NCT04191148|449495808|FG000|Overall Study|Withdrawal by Subject|1|||
124964007|NCT04191148|449495809|FG001|Overall Study|Withdrawal by Subject|0|||
124964008|NCT04191148|449495808|FG000|Overall Study|Adverse Event|1|||
124964009|NCT04191148|449495809|FG001|Overall Study|Adverse Event|0|||
124964010|NCT01274559|449495814|FG000|Overall Study|Adverse Event|57|||
124964011|NCT01274559|449495815|FG001|Overall Study|Adverse Event|13|||
124964012|NCT01274559|449495814|FG000|Overall Study|Death|1|||
124964013|NCT01274559|449495815|FG001|Overall Study|Death|1|||
124964014|NCT01274559|449495814|FG000|Overall Study|Lost to Follow-up|3|||
124964015|NCT01274559|449495815|FG001|Overall Study|Lost to Follow-up|3|||
124964016|NCT01274559|449495814|FG000|Overall Study|Non-compliance with Study Drug|2|||
124964017|NCT01274559|449495815|FG001|Overall Study|Non-compliance with Study Drug|4|||
124964018|NCT01274559|449495814|FG000|Overall Study|Physician Decision|2|||
124964019|NCT01274559|449495815|FG001|Overall Study|Physician Decision|1|||
124964020|NCT01274559|449495814|FG000|Overall Study|Protocol Violation|28|||
124964021|NCT01274559|449495815|FG001|Overall Study|Protocol Violation|23|||
124964022|NCT01274559|449495814|FG000|Overall Study|Study Terminated by Sponsor|79|||
124964023|NCT01274559|449495815|FG001|Overall Study|Study Terminated by Sponsor|87|||
124964024|NCT01274559|449495814|FG000|Overall Study|Withdrawal by Subject|25|||
124964025|NCT01274559|449495815|FG001|Overall Study|Withdrawal by Subject|13|||
124964026|NCT02971228|449495816|FG000|Overall Study|Withdrawal by Subject|1|||
124964027|NCT02971228|449495817|FG001|Overall Study|Withdrawal by Subject|1|||
124964028|NCT02971228|449495818|FG002|Overall Study|Withdrawal by Subject|0|||
124964029|NCT02971228|449495819|FG003|Overall Study|Withdrawal by Subject|0|||
124964030|NCT02971228|449495820|FG004|Overall Study|Withdrawal by Subject|0|||
124964031|NCT02971228|449495816|FG000|Overall Study|Logistical challenges|0|||
124964032|NCT02971228|449495817|FG001|Overall Study|Logistical challenges|1|||
124964033|NCT02971228|449495818|FG002|Overall Study|Logistical challenges|0|||
124709850|NCT01436110|448563046|FG002|Overall Study|Lost to Follow-up|3|||
124964034|NCT02971228|449495819|FG003|Overall Study|Logistical challenges|0|||
124964035|NCT02971228|449495820|FG004|Overall Study|Logistical challenges|0|||
124964036|NCT01664923|449495821|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
124964037|NCT01664923|449495822|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
124964038|NCT01664923|449495821|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
124964039|NCT01664923|449495822|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
124964040|NCT01664923|449495821|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
124709851|NCT01436110|448563044|FG000|Overall Study|Protocol Violation|3|||
124709852|NCT01436110|448563045|FG001|Overall Study|Protocol Violation|1|||
124464445|NCT00267748|447658146|FG002|Randomized Period|Death|3|||
124464446|NCT00267748|447658144|FG000|Randomized Period|Adverse Event|0|||
124709853|NCT01436110|448563046|FG002|Overall Study|Protocol Violation|1|||
124709854|NCT01436110|448563044|FG000|Overall Study|Did Not Receive Trial Medication|1|||
124709855|NCT01436110|448563045|FG001|Overall Study|Did Not Receive Trial Medication|0|||
124709856|NCT01436110|448563046|FG002|Overall Study|Did Not Receive Trial Medication|3|||
124709857|NCT01088503|448563048|FG000|Overall Study|Withdrawal by Subject|118|||
124964041|NCT01664923|449495822|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
124964042|NCT01664923|449495821|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
124964043|NCT01664923|449495822|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
124964044|NCT01664923|449495821|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
124964045|NCT01664923|449495822|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
124709858|NCT01088503|448563049|FG001|Overall Study|Withdrawal by Subject|327|||
124709859|NCT01088503|448563050|FG002|Overall Study|Withdrawal by Subject|10|||
124709860|NCT01088503|448563048|FG000|Overall Study|Death|64|||
124709861|NCT01088503|448563049|FG001|Overall Study|Death|358|||
124709862|NCT01088503|448563050|FG002|Overall Study|Death|7|||
124709863|NCT01531998|448563051|FG000|Overall Study|Withdrawal by Subject|3|||
124709864|NCT00186628|448563056|FG000|Overall Study|Death|2|||
124709865|NCT00186628|448563056|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
124964046|NCT01664923|449495821|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
124964047|NCT01664923|449495822|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
124964048|NCT01664923|449495821|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
124964049|NCT01664923|449495822|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
124964050|NCT01664923|449495821|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
124964051|NCT01664923|449495822|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
124964052|NCT01664923|449495821|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
124964053|NCT01664923|449495822|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
124964054|NCT01664923|449495821|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
124964055|NCT01664923|449495822|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
124964056|NCT01664923|449495821|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
124464447|NCT00267748|447658145|FG001|Randomized Period|Adverse Event|23|||
124464448|NCT00267748|447658146|FG002|Randomized Period|Adverse Event|25|||
124464449|NCT00267748|447658144|FG000|Randomized Period|Global deterioration of health status|0|||
124464450|NCT00267748|447658145|FG001|Randomized Period|Global deterioration of health status|6|||
124464451|NCT00267748|447658146|FG002|Randomized Period|Global deterioration of health status|7|||
124964057|NCT01664923|449495822|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
124964058|NCT01664923|449495821|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
124964059|NCT01664923|449495822|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
124964060|NCT01664923|449495821|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
124964061|NCT01664923|449495822|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
124964062|NCT01664923|449495821|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
124964063|NCT01664923|449495822|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
124964064|NCT03409731|449495827|FG000|Overall Study|Withdrawal by Subject|17|||
124964065|NCT03409731|449495827|FG000|Overall Study|Death|4|||
124964066|NCT00827775|449495832|FG000|Overall Study|Withdrawal by Subject|0|||
124964067|NCT00827775|449495833|FG001|Overall Study|Withdrawal by Subject|5|||
124964068|NCT02427958|449495834|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
124964069|NCT02427958|449495834|FG000|Overall Study|Lost to Follow-up|6|||
124964070|NCT02427958|449495834|FG000|Overall Study|Withdrawal by Subject|14|||
124964071|NCT02427958|449495834|FG000|Overall Study|Lack of Efficacy|1|||
124964072|NCT03410108|449495835|FG000|Overall Study|Ongoing|41|||
124964073|NCT03410108|449495835|FG000|Overall Study|Adverse Event|4|||
124964074|NCT03410108|449495835|FG000|Overall Study|Progressive Disease|58|||
124964075|NCT03410108|449495835|FG000|Overall Study|Withdrawal by Subject|1|||
124964076|NCT01013740|449495838|FG000|Overall Study|Lost to Follow-up|3|||
124964077|NCT01013740|449495839|FG001|Overall Study|Lost to Follow-up|5|||
124964078|NCT01013740|449495838|FG000|Overall Study|Physician Decision|2|||
124964079|NCT01013740|449495839|FG001|Overall Study|Physician Decision|0|||
124964080|NCT01013740|449495838|FG000|Overall Study|Withdrawal by Subject|2|||
124964081|NCT01013740|449495839|FG001|Overall Study|Withdrawal by Subject|10|||
124964082|NCT01013740|449495838|FG000|Overall Study|study close / terminated : done in error|2|||
124964083|NCT01013740|449495839|FG001|Overall Study|study close / terminated : done in error|1|||
124964084|NCT01013740|449495838|FG000|Overall Study|Missing|2|||
124964085|NCT01013740|449495839|FG001|Overall Study|Missing|1|||
124464452|NCT00267748|447658144|FG000|Randomized Period|Lost to Follow-up|0|||
124464453|NCT00267748|447658145|FG001|Randomized Period|Lost to Follow-up|1|||
124464454|NCT00267748|447658146|FG002|Randomized Period|Lost to Follow-up|0|||
124709866|NCT02927795|448563057|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
124709867|NCT02927795|448563057|FG000|Overall Study|Not Treated|4|||
124709868|NCT01076010|448563058|FG000|Overall Study|Death|15|||
124709869|NCT01076010|448563059|FG001|Overall Study|Death|1|||
124709870|NCT01076010|448563060|FG002|Overall Study|Death|0|||
124709871|NCT01076010|448563058|FG000|Overall Study|Adverse Event|7|||
124464455|NCT00267748|447658144|FG000|Randomized Period|Objective progression or relapse|0|||
124464456|NCT00267748|447658145|FG001|Randomized Period|Objective progression or relapse|77|||
124464457|NCT00267748|447658146|FG002|Randomized Period|Objective progression or relapse|86|||
124464458|NCT00267748|447658144|FG000|Randomized Period|Withdrawal by Subject|0|||
124464459|NCT00267748|447658145|FG001|Randomized Period|Withdrawal by Subject|9|||
124464460|NCT00267748|447658146|FG002|Randomized Period|Withdrawal by Subject|2|||
124464461|NCT00267748|447658144|FG000|Randomized Period|Other|0|||
124464462|NCT00267748|447658145|FG001|Randomized Period|Other|9|||
124464463|NCT00267748|447658146|FG002|Randomized Period|Other|6|||
124549664|NCT00909857|447967106|FG000|Overall Study|Lost to Follow-up|2|||
124709872|NCT01076010|448563059|FG001|Overall Study|Adverse Event|2|||
124964086|NCT01013740|449495838|FG000|Overall Study|Ongoing: Study records not completed|0|||
124964087|NCT01013740|449495839|FG001|Overall Study|Ongoing: Study records not completed|2|||
124964088|NCT00338949|449495840|FG000|Subject Screening|Screen failures|11|||
124964089|NCT00338949|449495841|FG001|Subject Screening|Screen failures|11|||
124964090|NCT00338949|449495840|FG000|Randomization|Withdrawal by Subject|1|||
124964091|NCT00338949|449495841|FG001|Randomization|Withdrawal by Subject|0|||
124964092|NCT00338949|449495840|FG000|Randomization|Adverse Event|0|||
124964093|NCT00338949|449495841|FG001|Randomization|Adverse Event|5|||
124964094|NCT00025662|449495842|FG000|Overall Study|Withdrawal by Subject|2|||
124964095|NCT00025662|449495842|FG000|Overall Study|Technical failure of manipulation|1|||
124964096|NCT00582114|449495843|FG000|Overall Study|Death|4|||
124964097|NCT00582114|449495844|FG001|Overall Study|Death|4|||
124964098|NCT00582114|449495843|FG000|Overall Study|Kidney Transplant|3|||
124964099|NCT00582114|449495844|FG001|Overall Study|Kidney Transplant|1|||
124964100|NCT00582114|449495843|FG000|Overall Study|Lost to Follow-up|7|||
124964101|NCT00582114|449495844|FG001|Overall Study|Lost to Follow-up|6|||
124964102|NCT00582114|449495843|FG000|Overall Study|Withdrawal by Subject|8|||
124964103|NCT00582114|449495844|FG001|Overall Study|Withdrawal by Subject|16|||
124964104|NCT00582114|449495843|FG000|Overall Study|Adverse Event|1|||
124964105|NCT00582114|449495844|FG001|Overall Study|Adverse Event|1|||
124964106|NCT00582114|449495843|FG000|Overall Study|Physician Decision|0|||
124964107|NCT00582114|449495844|FG001|Overall Study|Physician Decision|6|||
124964108|NCT00582114|449495843|FG000|Overall Study|Stopped by data safety monitoring board|19|||
124964109|NCT00582114|449495844|FG001|Overall Study|Stopped by data safety monitoring board|20|||
124964110|NCT02604342|449495845|FG000|Overall Study|Death|32|||
124964111|NCT02604342|449495846|FG001|Overall Study|Death|16|||
124964112|NCT02604342|449495845|FG000|Overall Study|Progression of disease|1|||
124964113|NCT02604342|449495846|FG001|Overall Study|Progression of disease|0|||
124964114|NCT02604342|449495845|FG000|Overall Study|Withdrawal by Subject|5|||
124964115|NCT02604342|449495846|FG001|Overall Study|Withdrawal by Subject|6|||
124964116|NCT02604342|449495845|FG000|Overall Study|Other|1|||
124964117|NCT02604342|449495846|FG001|Overall Study|Other|0|||
124964118|NCT02604342|449495845|FG000|Overall Study|Study Termination by Sponsor|1|||
124964119|NCT02604342|449495846|FG001|Overall Study|Study Termination by Sponsor|0|||
124964120|NCT02604342|449495845|FG000|Overall Study|Lost to Follow-up|1|||
124964121|NCT02604342|449495846|FG001|Overall Study|Lost to Follow-up|1|||
124964122|NCT02604342|449495845|FG000|Overall Study|Physician Decision|2|||
124964123|NCT02604342|449495846|FG001|Overall Study|Physician Decision|0|||
124964124|NCT00130728|449495847|FG000|Overall Study|Death|258|||
124964125|NCT00130728|449495848|FG001|Overall Study|Death|258|||
124964126|NCT00130728|449495847|FG000|Overall Study|Lost to Follow-up|4|||
124964127|NCT00130728|449495848|FG001|Overall Study|Lost to Follow-up|0|||
124964128|NCT00130728|449495847|FG000|Overall Study|Withdrawal by Subject|0|||
124964129|NCT00130728|449495848|FG001|Overall Study|Withdrawal by Subject|2|||
124964130|NCT02881047|449495851|FG000|Overall Study|Adverse Event|1|||
124964131|NCT02881047|449495851|FG000|Overall Study|Withdrawal by Subject|1|||
124964132|NCT03028012|449495852|FG000|Overall Study|Lost to Follow-up|2|||
124964133|NCT03028012|449495853|FG001|Overall Study|Lost to Follow-up|3|||
124964134|NCT03028012|449495854|FG002|Overall Study|Lost to Follow-up|3|||
124964135|NCT02484547|449495863|FG000|Placebo-Controlled Period|Adverse Event|10|||
124964136|NCT02484547|449495864|FG001|Placebo-Controlled Period|Adverse Event|13|||
124964137|NCT02484547|449495865|FG002|Placebo-Controlled Period|Adverse Event|20|||
124964138|NCT02484547|449495866|FG003|Placebo-Controlled Period|Adverse Event|0|||
124964139|NCT02484547|449495867|FG004|Placebo-Controlled Period|Adverse Event|0|||
124964140|NCT02484547|449495868|FG005|Placebo-Controlled Period|Adverse Event|0|||
124964141|NCT02484547|449495869|FG006|Placebo-Controlled Period|Adverse Event|0|||
124964142|NCT02484547|449495863|FG000|Placebo-Controlled Period|Change of Treatment|0|||
124964143|NCT02484547|449495864|FG001|Placebo-Controlled Period|Change of Treatment|0|||
124964144|NCT02484547|449495865|FG002|Placebo-Controlled Period|Change of Treatment|1|||
124964145|NCT02484547|449495866|FG003|Placebo-Controlled Period|Change of Treatment|0|||
124964146|NCT02484547|449495867|FG004|Placebo-Controlled Period|Change of Treatment|0|||
124964147|NCT02484547|449495868|FG005|Placebo-Controlled Period|Change of Treatment|0|||
124964148|NCT02484547|449495869|FG006|Placebo-Controlled Period|Change of Treatment|0|||
124964149|NCT02484547|449495863|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
124964150|NCT02484547|449495864|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
124964151|NCT02484547|449495865|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
124964152|NCT02484547|449495866|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
124964153|NCT02484547|449495867|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
124964154|NCT02484547|449495868|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
124964155|NCT02484547|449495869|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
124964156|NCT02484547|449495863|FG000|Placebo-Controlled Period|Death|5|||
124964157|NCT02484547|449495864|FG001|Placebo-Controlled Period|Death|0|||
124964158|NCT02484547|449495865|FG002|Placebo-Controlled Period|Death|6|||
124964159|NCT02484547|449495866|FG003|Placebo-Controlled Period|Death|0|||
124464464|NCT00267748|447658144|FG000|Randomized Period|randomized but not treated|0|||
124464465|NCT00267748|447658145|FG001|Randomized Period|randomized but not treated|0|||
124464466|NCT00267748|447658146|FG002|Randomized Period|randomized but not treated|3|||
124549665|NCT00909857|447967107|FG001|Overall Study|Lost to Follow-up|5|||
124549666|NCT00909857|447967106|FG000|Overall Study|Protocol Violation|2|||
124549667|NCT00909857|447967107|FG001|Overall Study|Protocol Violation|1|||
124549668|NCT00909857|447967106|FG000|Overall Study|Pregnancy|1|||
124964160|NCT02484547|449495867|FG004|Placebo-Controlled Period|Death|0|||
124964161|NCT02484547|449495868|FG005|Placebo-Controlled Period|Death|0|||
124964162|NCT02484547|449495869|FG006|Placebo-Controlled Period|Death|0|||
124964163|NCT02484547|449495863|FG000|Placebo-Controlled Period|Disease Progression|2|||
124964164|NCT02484547|449495864|FG001|Placebo-Controlled Period|Disease Progression|0|||
124964165|NCT02484547|449495865|FG002|Placebo-Controlled Period|Disease Progression|1|||
124964166|NCT02484547|449495866|FG003|Placebo-Controlled Period|Disease Progression|0|||
124964167|NCT02484547|449495867|FG004|Placebo-Controlled Period|Disease Progression|0|||
124964168|NCT02484547|449495868|FG005|Placebo-Controlled Period|Disease Progression|0|||
124964169|NCT02484547|449495869|FG006|Placebo-Controlled Period|Disease Progression|0|||
124964170|NCT02484547|449495863|FG000|Placebo-Controlled Period|Investigator Decision|2|||
124964171|NCT02484547|449495864|FG001|Placebo-Controlled Period|Investigator Decision|2|||
124964172|NCT02484547|449495865|FG002|Placebo-Controlled Period|Investigator Decision|5|||
124964173|NCT02484547|449495866|FG003|Placebo-Controlled Period|Investigator Decision|0|||
124964174|NCT02484547|449495867|FG004|Placebo-Controlled Period|Investigator Decision|0|||
124964175|NCT02484547|449495868|FG005|Placebo-Controlled Period|Investigator Decision|0|||
124964176|NCT02484547|449495869|FG006|Placebo-Controlled Period|Investigator Decision|0|||
124964177|NCT02484547|449495863|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
124964178|NCT02484547|449495864|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
124964179|NCT02484547|449495865|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
124964180|NCT02484547|449495866|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
124964181|NCT02484547|449495867|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
124964182|NCT02484547|449495868|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
124964183|NCT02484547|449495869|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
124964184|NCT02484547|449495863|FG000|Placebo-Controlled Period|Relocation|1|||
124464467|NCT01294800|447658147|FG000|Overall Study|Adverse Event|7|||
124464468|NCT01294800|447658148|FG001|Overall Study|Adverse Event|6|||
124464469|NCT01294800|447658149|FG002|Overall Study|Adverse Event|12|||
124464470|NCT01294800|447658150|FG003|Overall Study|Adverse Event|5|||
124464471|NCT01294800|447658147|FG000|Overall Study|Subject Withdrew Consent|2|||
124464472|NCT01294800|447658148|FG001|Overall Study|Subject Withdrew Consent|2|||
124464473|NCT01294800|447658149|FG002|Overall Study|Subject Withdrew Consent|2|||
124464474|NCT01294800|447658150|FG003|Overall Study|Subject Withdrew Consent|11|||
124464475|NCT01294800|447658147|FG000|Overall Study|Lost to Follow-up|0|||
124464476|NCT01294800|447658148|FG001|Overall Study|Lost to Follow-up|0|||
124464477|NCT01294800|447658149|FG002|Overall Study|Lost to Follow-up|1|||
124464478|NCT01294800|447658150|FG003|Overall Study|Lost to Follow-up|0|||
124464479|NCT01294800|447658147|FG000|Overall Study|Non-compliance With Protocol|0|||
124464480|NCT01294800|447658148|FG001|Overall Study|Non-compliance With Protocol|1|||
124464481|NCT01294800|447658149|FG002|Overall Study|Non-compliance With Protocol|1|||
124464482|NCT01294800|447658150|FG003|Overall Study|Non-compliance With Protocol|0|||
124464483|NCT01294800|447658147|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
124464484|NCT01294800|447658148|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
124464485|NCT01294800|447658149|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
124464486|NCT01294800|447658150|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
124464487|NCT01895322|447658151|FG000|Overall Study|Adverse Event|1|||
124464488|NCT01895322|447658151|FG000|Overall Study|Withdrawal by Subject|2|||
124464489|NCT01895322|447658151|FG000|Overall Study|Protocol Violation|10|||
124464490|NCT02275338|447658152|FG000|Overall Study|Adverse Event|15|||
124464491|NCT02275338|447658152|FG000|Overall Study|Lack of Efficacy|3|||
124464492|NCT02275338|447658152|FG000|Overall Study|Withdrawal by Subject|4|||
124464493|NCT02275338|447658152|FG000|Overall Study|Disease progression (death)|1|||
124464494|NCT02275338|447658152|FG000|Overall Study|Ineligible to start Phase 2|4|||
124464495|NCT02275338|447658152|FG000|Overall Study|Reason not specified|5|||
124464496|NCT02275338|447658152|FG000|Overall Study|Does not meet entry criteria|1|||
124464497|NCT01827670|447658162|FG000|Overall Study|Withdrawal of Consent|3|||
124464498|NCT01827670|447658163|FG001|Overall Study|Withdrawal of Consent|2|||
124464499|NCT01827670|447658162|FG000|Overall Study|Lost to Follow-up|0|||
124464500|NCT01827670|447658163|FG001|Overall Study|Lost to Follow-up|1|||
124464501|NCT03603496|447658167|FG000|Overall Study|Death|19|||
124464502|NCT03603496|447658168|FG001|Overall Study|Death|24|||
124464503|NCT03603496|447658167|FG000|Overall Study|Lost to Follow-up|141|||
124464504|NCT03603496|447658168|FG001|Overall Study|Lost to Follow-up|141|||
124464505|NCT03603496|447658167|FG000|Overall Study|Withdrawal by Subject|26|||
124464506|NCT03603496|447658168|FG001|Overall Study|Withdrawal by Subject|20|||
124464507|NCT00774345|447658169|FG000|Pre-treatment|Other reasons|2|||
124464508|NCT00774345|447658170|FG001|Pre-treatment|Other reasons|0|||
124464509|NCT00774345|447658169|FG000|Treatment|Adverse Event|61|||
124464510|NCT00774345|447658170|FG001|Treatment|Adverse Event|15|||
124464511|NCT00774345|447658169|FG000|Treatment|Progressive Disease without histologic transformation|51|||
124549669|NCT00909857|447967107|FG001|Overall Study|Pregnancy|0|||
124464512|NCT00774345|447658170|FG001|Treatment|Progressive Disease without histologic transformation|111|||
124464513|NCT00774345|447658169|FG000|Treatment|Progressive Disease with histologic transformation|4|||
124464514|NCT00774345|447658170|FG001|Treatment|Progressive Disease with histologic transformation|2|||
124464515|NCT00774345|447658169|FG000|Treatment|Withdrawal by Subject|5|||
124964185|NCT02484547|449495864|FG001|Placebo-Controlled Period|Relocation|1|||
124964186|NCT02484547|449495865|FG002|Placebo-Controlled Period|Relocation|1|||
124964187|NCT02484547|449495866|FG003|Placebo-Controlled Period|Relocation|0|||
124964188|NCT02484547|449495867|FG004|Placebo-Controlled Period|Relocation|0|||
124964189|NCT02484547|449495868|FG005|Placebo-Controlled Period|Relocation|0|||
124964190|NCT02484547|449495869|FG006|Placebo-Controlled Period|Relocation|0|||
124964191|NCT02484547|449495863|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
124964192|NCT02484547|449495864|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
124964193|NCT02484547|449495865|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
124964194|NCT02484547|449495866|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
124964195|NCT02484547|449495867|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
124964196|NCT02484547|449495868|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
124964197|NCT02484547|449495869|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
124964198|NCT02484547|449495863|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
124964199|NCT02484547|449495864|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
124964200|NCT02484547|449495865|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
124964201|NCT02484547|449495866|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
124964202|NCT02484547|449495867|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
124964203|NCT02484547|449495868|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
124964204|NCT02484547|449495869|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
124964205|NCT02484547|449495863|FG000|Placebo-Controlled Period|Reason not Specified|216|||
124964206|NCT02484547|449495864|FG001|Placebo-Controlled Period|Reason not Specified|194|||
124964207|NCT02484547|449495865|FG002|Placebo-Controlled Period|Reason not Specified|183|||
124964208|NCT02484547|449495866|FG003|Placebo-Controlled Period|Reason not Specified|0|||
124964209|NCT02484547|449495867|FG004|Placebo-Controlled Period|Reason not Specified|0|||
124964210|NCT02484547|449495868|FG005|Placebo-Controlled Period|Reason not Specified|0|||
124964211|NCT02484547|449495869|FG006|Placebo-Controlled Period|Reason not Specified|0|||
124964212|NCT02484547|449495863|FG000|Long-Term Extension Period|Adverse Event|0|||
124964213|NCT02484547|449495864|FG001|Long-Term Extension Period|Adverse Event|0|||
124964214|NCT02484547|449495865|FG002|Long-Term Extension Period|Adverse Event|0|||
124964215|NCT02484547|449495866|FG003|Long-Term Extension Period|Adverse Event|0|||
124964216|NCT02484547|449495867|FG004|Long-Term Extension Period|Adverse Event|1|||
124964217|NCT02484547|449495868|FG005|Long-Term Extension Period|Adverse Event|3|||
124964218|NCT02484547|449495869|FG006|Long-Term Extension Period|Adverse Event|2|||
124964219|NCT02484547|449495863|FG000|Long-Term Extension Period|Death|0|||
124964220|NCT02484547|449495864|FG001|Long-Term Extension Period|Death|0|||
124964221|NCT02484547|449495865|FG002|Long-Term Extension Period|Death|0|||
124964222|NCT02484547|449495866|FG003|Long-Term Extension Period|Death|0|||
124964223|NCT02484547|449495867|FG004|Long-Term Extension Period|Death|0|||
124964224|NCT02484547|449495868|FG005|Long-Term Extension Period|Death|3|||
124964225|NCT02484547|449495869|FG006|Long-Term Extension Period|Death|0|||
124964226|NCT02484547|449495863|FG000|Long-Term Extension Period|Disease Progression|0|||
124964227|NCT02484547|449495864|FG001|Long-Term Extension Period|Disease Progression|0|||
124964228|NCT02484547|449495865|FG002|Long-Term Extension Period|Disease Progression|0|||
124964229|NCT02484547|449495866|FG003|Long-Term Extension Period|Disease Progression|0|||
124964230|NCT02484547|449495867|FG004|Long-Term Extension Period|Disease Progression|2|||
124964231|NCT02484547|449495868|FG005|Long-Term Extension Period|Disease Progression|4|||
124964232|NCT02484547|449495869|FG006|Long-Term Extension Period|Disease Progression|0|||
124964233|NCT02484547|449495863|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
124964234|NCT02484547|449495864|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
124964235|NCT02484547|449495865|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
124964236|NCT02484547|449495866|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
124964237|NCT02484547|449495867|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
124964238|NCT02484547|449495868|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
124964239|NCT02484547|449495869|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
124964240|NCT02484547|449495863|FG000|Long-Term Extension Period|Loss of Capacity|0|||
124964241|NCT02484547|449495864|FG001|Long-Term Extension Period|Loss of Capacity|0|||
124964242|NCT02484547|449495865|FG002|Long-Term Extension Period|Loss of Capacity|0|||
124964243|NCT02484547|449495866|FG003|Long-Term Extension Period|Loss of Capacity|0|||
124964244|NCT02484547|449495867|FG004|Long-Term Extension Period|Loss of Capacity|1|||
124964245|NCT02484547|449495868|FG005|Long-Term Extension Period|Loss of Capacity|0|||
124964246|NCT02484547|449495869|FG006|Long-Term Extension Period|Loss of Capacity|0|||
124464516|NCT00774345|447658170|FG001|Treatment|Withdrawal by Subject|2|||
124964247|NCT02484547|449495863|FG000|Long-Term Extension Period|Change of Treatment|0|||
124464517|NCT00774345|447658169|FG000|Treatment|Lost to Follow-up|1|||
124464518|NCT00774345|447658170|FG001|Treatment|Lost to Follow-up|1|||
124464519|NCT00774345|447658169|FG000|Treatment|Death|4|||
124964248|NCT02484547|449495864|FG001|Long-Term Extension Period|Change of Treatment|0|||
124549670|NCT00909857|447967106|FG000|Overall Study|Other|1|||
124549671|NCT00909857|447967107|FG001|Overall Study|Other|0|||
124549672|NCT00909857|447967106|FG000|Overall Study|Did not receive study medication|19|||
124549673|NCT00909857|447967107|FG001|Overall Study|Did not receive study medication|24|||
124549674|NCT00604175|447967108|FG000|Entry Through Week 28|Death|2|||
124549675|NCT00604175|447967109|FG001|Entry Through Week 28|Death|0|||
124549676|NCT00604175|447967110|FG002|Entry Through Week 28|Death|0|||
124549677|NCT00604175|447967108|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
124549678|NCT00604175|447967109|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
124549679|NCT00604175|447967110|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
124549680|NCT00604175|447967108|FG000|Entry Through Week 28|Lost to Follow-up|4|||
124549681|NCT00604175|447967109|FG001|Entry Through Week 28|Lost to Follow-up|3|||
124549682|NCT00604175|447967110|FG002|Entry Through Week 28|Lost to Follow-up|0|||
124549683|NCT00604175|447967108|FG000|Entry Through Week 28|Ineligible|1|||
124549684|NCT00604175|447967109|FG001|Entry Through Week 28|Ineligible|0|||
124549685|NCT00604175|447967110|FG002|Entry Through Week 28|Ineligible|0|||
124549686|NCT00604175|447967108|FG000|Entry Through Week 28|Did not start intervention|2|||
124549687|NCT00604175|447967109|FG001|Entry Through Week 28|Did not start intervention|0|||
124549688|NCT00604175|447967110|FG002|Entry Through Week 28|Did not start intervention|1|||
124549689|NCT00604175|447967108|FG000|Week 29 Through Week 72|Death|0|||
124549690|NCT00604175|447967109|FG001|Week 29 Through Week 72|Death|0|||
124549691|NCT00604175|447967110|FG002|Week 29 Through Week 72|Death|1|||
124549692|NCT00604175|447967108|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
124549693|NCT00604175|447967109|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
124549694|NCT00604175|447967110|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
124549695|NCT00604175|447967108|FG000|Week 29 Through Week 72|Site closure|0|||
124549696|NCT00604175|447967109|FG001|Week 29 Through Week 72|Site closure|1|||
124464520|NCT00774345|447658170|FG001|Treatment|Death|0|||
124464521|NCT00774345|447658169|FG000|Treatment|Other Reasons|32|||
124464522|NCT00774345|447658170|FG001|Treatment|Other Reasons|26|||
124464523|NCT00835237|447658171|FG000|Overall Study|Lost to Follow-up|4|||
124464524|NCT00835237|447658172|FG001|Overall Study|Lost to Follow-up|0|||
124464525|NCT00835237|447658171|FG000|Overall Study|Withdrawal by Subject|2|||
124464526|NCT00835237|447658172|FG001|Overall Study|Withdrawal by Subject|0|||
124464527|NCT00075504|447658173|FG000|Overall Study|Withdrawal by Subject|9|||
124464528|NCT00075504|447658174|FG001|Overall Study|Withdrawal by Subject|7|||
124464529|NCT00264238|447658185|FG000|Overall Study|Protocol Violation|1|||
124549697|NCT00604175|447967110|FG002|Week 29 Through Week 72|Site closure|0|||
124549698|NCT00604175|447967108|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
124549699|NCT00604175|447967109|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
124549700|NCT00604175|447967110|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
124549701|NCT03205163|447967111|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
124549702|NCT03205163|447967112|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
124549703|NCT05257109|447967113|FG000|Overall Study|Withdrawal by Subject|1|||
124549704|NCT05257109|447967114|FG001|Overall Study|Withdrawal by Subject|0|||
124549705|NCT05257109|447967115|FG002|Overall Study|Withdrawal by Subject|0|||
124549706|NCT05257109|447967116|FG003|Overall Study|Withdrawal by Subject|0|||
124549707|NCT01389024|447968869|FG000|Overall Study|Withdrawal by Subject|0|||
124549708|NCT01389024|447968870|FG001|Overall Study|Withdrawal by Subject|1|||
124549709|NCT01389024|447968869|FG000|Overall Study|Lost to Follow-up|1|||
124549710|NCT01389024|447968870|FG001|Overall Study|Lost to Follow-up|0|||
124549711|NCT00819091|447968871|FG000|Overall Study|Adverse Event|3|||
124549712|NCT00819091|447968872|FG001|Overall Study|Adverse Event|5|||
124549713|NCT00819091|447968871|FG000|Overall Study|Protocol Violation|0|||
124549714|NCT00819091|447968872|FG001|Overall Study|Protocol Violation|1|||
124964249|NCT02484547|449495865|FG002|Long-Term Extension Period|Change of Treatment|0|||
124964250|NCT02484547|449495866|FG003|Long-Term Extension Period|Change of Treatment|0|||
124964251|NCT02484547|449495867|FG004|Long-Term Extension Period|Change of Treatment|0|||
124964252|NCT02484547|449495868|FG005|Long-Term Extension Period|Change of Treatment|0|||
124464530|NCT01411085|447658186|FG000|Overall Study|Physician Decision|1|||
124549715|NCT00819091|447968871|FG000|Overall Study|Lost to Follow-up|2|||
124549716|NCT00819091|447968872|FG001|Overall Study|Lost to Follow-up|0|||
124549717|NCT00819091|447968871|FG000|Overall Study|Withdrawal by Subject|1|||
124549718|NCT00819091|447968872|FG001|Overall Study|Withdrawal by Subject|2|||
124549719|NCT00819091|447968871|FG000|Overall Study|Other|1|||
124964253|NCT02484547|449495869|FG006|Long-Term Extension Period|Change of Treatment|1|||
124549720|NCT00819091|447968872|FG001|Overall Study|Other|2|||
124964254|NCT02484547|449495863|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
124964255|NCT02484547|449495864|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
124964256|NCT02484547|449495865|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
124964257|NCT02484547|449495866|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
124964258|NCT02484547|449495867|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
124549721|NCT01461369|447968875|FG000|Overall Study|Lack of Efficacy|2|||
124549722|NCT01461369|447968876|FG001|Overall Study|Lack of Efficacy|0|||
124464531|NCT01411085|447658186|FG000|Overall Study|Protocol Violation|1|||
124549723|NCT01461369|447968877|FG002|Overall Study|Lack of Efficacy|6|||
124964259|NCT02484547|449495868|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
124964260|NCT02484547|449495869|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
124964261|NCT02484547|449495863|FG000|Long-Term Extension Period|Investigator Decision|0|||
124964262|NCT02484547|449495864|FG001|Long-Term Extension Period|Investigator Decision|0|||
124964263|NCT02484547|449495865|FG002|Long-Term Extension Period|Investigator Decision|0|||
124964264|NCT02484547|449495866|FG003|Long-Term Extension Period|Investigator Decision|2|||
124964265|NCT02484547|449495867|FG004|Long-Term Extension Period|Investigator Decision|1|||
124964266|NCT02484547|449495868|FG005|Long-Term Extension Period|Investigator Decision|0|||
124964267|NCT02484547|449495869|FG006|Long-Term Extension Period|Investigator Decision|1|||
124964268|NCT02484547|449495863|FG000|Long-Term Extension Period|Relocation|0|||
124964269|NCT02484547|449495864|FG001|Long-Term Extension Period|Relocation|0|||
124964270|NCT02484547|449495865|FG002|Long-Term Extension Period|Relocation|0|||
124964271|NCT02484547|449495866|FG003|Long-Term Extension Period|Relocation|1|||
124964272|NCT02484547|449495867|FG004|Long-Term Extension Period|Relocation|1|||
124964273|NCT02484547|449495868|FG005|Long-Term Extension Period|Relocation|0|||
124964274|NCT02484547|449495869|FG006|Long-Term Extension Period|Relocation|0|||
124964275|NCT02484547|449495863|FG000|Long-Term Extension Period|Study Visit Burden|0|||
124964276|NCT02484547|449495864|FG001|Long-Term Extension Period|Study Visit Burden|0|||
124964277|NCT02484547|449495865|FG002|Long-Term Extension Period|Study Visit Burden|0|||
124964278|NCT02484547|449495866|FG003|Long-Term Extension Period|Study Visit Burden|2|||
124964279|NCT02484547|449495867|FG004|Long-Term Extension Period|Study Visit Burden|0|||
124964280|NCT02484547|449495868|FG005|Long-Term Extension Period|Study Visit Burden|0|||
124964281|NCT02484547|449495869|FG006|Long-Term Extension Period|Study Visit Burden|3|||
124964282|NCT02484547|449495863|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
124964283|NCT02484547|449495864|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
124964284|NCT02484547|449495865|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
124964285|NCT02484547|449495866|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
124964286|NCT02484547|449495867|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
124964287|NCT02484547|449495868|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
124964288|NCT02484547|449495869|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
124964289|NCT02484547|449495863|FG000|Long-Term Extension Period|Reason not Specified|0|||
124964290|NCT02484547|449495864|FG001|Long-Term Extension Period|Reason not Specified|0|||
124964291|NCT02484547|449495865|FG002|Long-Term Extension Period|Reason not Specified|0|||
124964292|NCT02484547|449495866|FG003|Long-Term Extension Period|Reason not Specified|119|||
124964293|NCT02484547|449495867|FG004|Long-Term Extension Period|Reason not Specified|117|||
124964294|NCT02484547|449495868|FG005|Long-Term Extension Period|Reason not Specified|223|||
124964295|NCT02484547|449495869|FG006|Long-Term Extension Period|Reason not Specified|231|||
124964296|NCT01813305|449495870|FG000|Overall Study|Withdrawal by Subject|12|||
124964297|NCT01813305|449495871|FG001|Overall Study|Withdrawal by Subject|5|||
124964298|NCT01813305|449495870|FG000|Overall Study|Safety Concern|4|||
124964299|NCT01813305|449495871|FG001|Overall Study|Safety Concern|0|||
124964300|NCT01813305|449495870|FG000|Overall Study|Ulcer became worse|4|||
124964301|NCT01813305|449495871|FG001|Overall Study|Ulcer became worse|0|||
124964302|NCT01813305|449495870|FG000|Overall Study|Physician Decision|4|||
124964303|NCT01813305|449495871|FG001|Overall Study|Physician Decision|0|||
124964304|NCT01813305|449495870|FG000|Overall Study|Lost to Follow-up|3|||
124964305|NCT01813305|449495871|FG001|Overall Study|Lost to Follow-up|1|||
124964306|NCT01813305|449495870|FG000|Overall Study|Protocol Violation|1|||
124964307|NCT01813305|449495871|FG001|Overall Study|Protocol Violation|0|||
124964308|NCT01813305|449495870|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
124964309|NCT01813305|449495871|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
124964310|NCT01665599|449495875|FG000|Overall Study|Adverse Event|1|||
124964311|NCT01665599|449495875|FG000|Overall Study|Consent Withdrawn|1|||
124964312|NCT01665599|449495875|FG000|Overall Study|Investigator/Sponsor decision|1|||
124964313|NCT01665599|449495875|FG000|Overall Study|Death|1|||
124964314|NCT01665599|449495875|FG000|Overall Study|Lost to Follow-up|2|||
124964315|NCT01665599|449495875|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
124964316|NCT01665599|449495875|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
124964317|NCT01837797|449495876|FG000|Period 1|Adverse Event|9|||
124964318|NCT01837797|449495877|FG001|Period 1|Adverse Event|0|||
124964319|NCT01837797|449495878|FG002|Period 1|Adverse Event|0|||
124964320|NCT01837797|449495879|FG003|Period 1|Adverse Event|0|||
124964321|NCT01837797|449495880|FG004|Period 1|Adverse Event|0|||
124964322|NCT01837797|449495876|FG000|Period 1|Withdrawal by Subject|6|||
124964323|NCT01837797|449495877|FG001|Period 1|Withdrawal by Subject|0|||
124964324|NCT01837797|449495878|FG002|Period 1|Withdrawal by Subject|0|||
124964325|NCT01837797|449495879|FG003|Period 1|Withdrawal by Subject|0|||
124964326|NCT01837797|449495880|FG004|Period 1|Withdrawal by Subject|0|||
124964327|NCT01837797|449495876|FG000|Period 1|Administrative reasons|76|||
124964328|NCT01837797|449495877|FG001|Period 1|Administrative reasons|0|||
124964329|NCT01837797|449495878|FG002|Period 1|Administrative reasons|0|||
124964330|NCT01837797|449495879|FG003|Period 1|Administrative reasons|0|||
124964331|NCT01837797|449495880|FG004|Period 1|Administrative reasons|0|||
124964332|NCT01837797|449495876|FG000|Period 1|Withdrawal of consent before treatment|1|||
124464532|NCT01411085|447658186|FG000|Overall Study|Adverse Event|1|||
124464533|NCT02627495|447659775|FG000|Overall Study|Withdrawal by Subject|4|||
124464534|NCT00880893|447659776|FG000|Overall Study|Protocol Violation|13|||
124464535|NCT00880893|447659777|FG001|Overall Study|Protocol Violation|1|||
124464536|NCT00880893|447659776|FG000|Overall Study|Withdrawal by Subject|15|||
124464537|NCT00880893|447659777|FG001|Overall Study|Withdrawal by Subject|11|||
124464538|NCT00880893|447659776|FG000|Overall Study|Lost to Follow-up|76|||
124464539|NCT00880893|447659777|FG001|Overall Study|Lost to Follow-up|33|||
124464540|NCT00880893|447659776|FG000|Overall Study|Serious adverse event|3|||
124464541|NCT00880893|447659777|FG001|Overall Study|Serious adverse event|0|||
124464542|NCT01662440|447659780|FG000|Overall Study|Adverse Event|1|||
124464543|NCT01662440|447659781|FG001|Overall Study|Adverse Event|0|||
124464544|NCT01662440|447659782|FG002|Overall Study|Adverse Event|0|||
124464545|NCT01662440|447659783|FG003|Overall Study|Adverse Event|1|||
124464546|NCT01662440|447659780|FG000|Overall Study|Death|0|||
124464547|NCT01662440|447659781|FG001|Overall Study|Death|1|||
124464548|NCT01662440|447659782|FG002|Overall Study|Death|0|||
124464549|NCT01662440|447659783|FG003|Overall Study|Death|0|||
124464550|NCT01662440|447659780|FG000|Overall Study|Lost to Follow-up|2|||
124709873|NCT01076010|448563060|FG002|Overall Study|Adverse Event|0|||
124964333|NCT01837797|449495877|FG001|Period 1|Withdrawal of consent before treatment|0|||
124964334|NCT01837797|449495878|FG002|Period 1|Withdrawal of consent before treatment|0|||
124964335|NCT01837797|449495879|FG003|Period 1|Withdrawal of consent before treatment|0|||
124964336|NCT01837797|449495880|FG004|Period 1|Withdrawal of consent before treatment|0|||
124964337|NCT01837797|449495876|FG000|Period 1|Other|10|||
124964338|NCT01837797|449495877|FG001|Period 1|Other|0|||
124964339|NCT01837797|449495878|FG002|Period 1|Other|0|||
124964340|NCT01837797|449495879|FG003|Period 1|Other|0|||
124964341|NCT01837797|449495880|FG004|Period 1|Other|0|||
124964342|NCT01837797|449495876|FG000|Period 2|Administrative or other reasons|0|||
124964343|NCT01837797|449495877|FG001|Period 2|Administrative or other reasons|5|||
124964344|NCT01837797|449495878|FG002|Period 2|Administrative or other reasons|2|||
124964345|NCT01837797|449495879|FG003|Period 2|Administrative or other reasons|4|||
124964346|NCT01837797|449495880|FG004|Period 2|Administrative or other reasons|0|||
124964347|NCT01837797|449495876|FG000|Period 2|Adverse Event|0|||
124964348|NCT01837797|449495877|FG001|Period 2|Adverse Event|0|||
124964349|NCT01837797|449495878|FG002|Period 2|Adverse Event|0|||
124964350|NCT01837797|449495879|FG003|Period 2|Adverse Event|1|||
124964351|NCT01837797|449495880|FG004|Period 2|Adverse Event|0|||
124964352|NCT01837797|449495876|FG000|Period 3|Adverse Event|0|||
124964353|NCT01837797|449495877|FG001|Period 3|Adverse Event|0|||
124964354|NCT01837797|449495878|FG002|Period 3|Adverse Event|0|||
124964355|NCT01837797|449495879|FG003|Period 3|Adverse Event|0|||
124964356|NCT01837797|449495880|FG004|Period 3|Adverse Event|1|||
124964357|NCT01837797|449495876|FG000|Period 3|Administrative reasons|0|||
124964358|NCT01837797|449495877|FG001|Period 3|Administrative reasons|0|||
124964359|NCT01837797|449495878|FG002|Period 3|Administrative reasons|0|||
124964360|NCT01837797|449495879|FG003|Period 3|Administrative reasons|0|||
124964361|NCT01837797|449495880|FG004|Period 3|Administrative reasons|20|||
124964362|NCT01837797|449495876|FG000|Period 3|Other|0|||
124964363|NCT01837797|449495877|FG001|Period 3|Other|0|||
124964364|NCT01837797|449495878|FG002|Period 3|Other|0|||
124964365|NCT01837797|449495879|FG003|Period 3|Other|0|||
124964366|NCT01837797|449495880|FG004|Period 3|Other|2|||
124964367|NCT01705145|449495881|FG000|Part B|Adverse Event|1|||
124964368|NCT01503164|449495890|FG000|Overall Study|Withdrawal by Subject|2|||
124964369|NCT01503164|449495891|FG001|Overall Study|Withdrawal by Subject|1|||
124964370|NCT04088136|449495892|FG000|Overall Study|Withdrawal by Subject|5|||
124964371|NCT04088136|449495893|FG001|Overall Study|Withdrawal by Subject|0|||
124964372|NCT04088136|449495892|FG000|Overall Study|Lack of Efficacy|0|||
124964373|NCT04088136|449495893|FG001|Overall Study|Lack of Efficacy|1|||
124464551|NCT01662440|447659781|FG001|Overall Study|Lost to Follow-up|2|||
124464552|NCT01662440|447659782|FG002|Overall Study|Lost to Follow-up|4|||
124964374|NCT00143598|449495902|FG000|Overall Study|Lost to Follow-up|23|||
124964375|NCT00143598|449495903|FG001|Overall Study|Lost to Follow-up|21|||
124964376|NCT00143598|449495902|FG000|Overall Study|Withdrawal by Subject|33|||
124964377|NCT00143598|449495903|FG001|Overall Study|Withdrawal by Subject|37|||
124964378|NCT00143598|449495902|FG000|Overall Study|Death|36|||
124964379|NCT00143598|449495903|FG001|Overall Study|Death|36|||
124464553|NCT01662440|447659783|FG003|Overall Study|Lost to Follow-up|1|||
124464554|NCT01662440|447659780|FG000|Overall Study|Subject moved to another country.|0|||
124464555|NCT01662440|447659781|FG001|Overall Study|Subject moved to another country.|1|||
124964380|NCT03900715|449495906|FG000|Overall Study|Protocol Deviation|1|||
124964381|NCT03900715|449495906|FG000|Overall Study|Lack of Efficacy|1|||
124964382|NCT03900715|449495906|FG000|Overall Study|Progressive Disease|6|||
124464556|NCT01662440|447659782|FG002|Overall Study|Subject moved to another country.|0|||
124549724|NCT01461369|447968875|FG000|Overall Study|Lost to Follow-up|0|||
124964383|NCT03900715|449495906|FG000|Overall Study|Adverse Event|2|||
124964384|NCT03900715|449495906|FG000|Overall Study|Other reasons|11|||
124964385|NCT01878383|449497670|FG000|Overall Study|Lost to Follow-up|0|||
124964386|NCT01878383|449497671|FG001|Overall Study|Lost to Follow-up|1499|||
124964387|NCT03464383|449497672|FG000|Overall Study|Lost to Follow-up|1|||
124549725|NCT01461369|447968876|FG001|Overall Study|Lost to Follow-up|0|||
124549726|NCT01461369|447968877|FG002|Overall Study|Lost to Follow-up|3|||
124549727|NCT01461369|447968875|FG000|Overall Study|Adverse Event|9|||
124549728|NCT01461369|447968876|FG001|Overall Study|Adverse Event|12|||
124549729|NCT01461369|447968877|FG002|Overall Study|Adverse Event|4|||
124549730|NCT01461369|447968875|FG000|Overall Study|Protocol Violation|1|||
124549731|NCT01461369|447968876|FG001|Overall Study|Protocol Violation|2|||
124549732|NCT01461369|447968877|FG002|Overall Study|Protocol Violation|2|||
124549733|NCT01461369|447968875|FG000|Overall Study|Withdrawal by Subject|1|||
124549734|NCT01461369|447968876|FG001|Overall Study|Withdrawal by Subject|3|||
124549735|NCT01461369|447968877|FG002|Overall Study|Withdrawal by Subject|2|||
124549736|NCT00734617|447968884|FG000|Overall Study|Adverse Event|4|||
124549737|NCT00734617|447968885|FG001|Overall Study|Adverse Event|7|||
124549738|NCT00734617|447968884|FG000|Overall Study|Withdrawal by Subject|103|||
124549739|NCT00734617|447968885|FG001|Overall Study|Withdrawal by Subject|95|||
124549740|NCT02367729|447968886|FG000|Overall Study|Organic disorder diagnosed|2|||
124549741|NCT02367729|447968887|FG001|Overall Study|Organic disorder diagnosed|1|||
124549742|NCT02367729|447968886|FG000|Overall Study|Adverse Event|1|||
124549743|NCT02367729|447968887|FG001|Overall Study|Adverse Event|2|||
124549744|NCT02367729|447968886|FG000|Overall Study|Withdrawal by Subject|0|||
124549745|NCT02367729|447968887|FG001|Overall Study|Withdrawal by Subject|5|||
124549746|NCT02742818|447968894|FG000|Overall Study|Adverse Event|0|||
124549747|NCT02742818|447968895|FG001|Overall Study|Adverse Event|1|||
124549748|NCT02742818|447968894|FG000|Overall Study|Protocol Violation|0|||
124549749|NCT02742818|447968895|FG001|Overall Study|Protocol Violation|1|||
124549750|NCT01260194|447968897|FG000|Overall Study|Withdrawal of Consent|1|||
124549751|NCT04854707|447968898|FG000|Overall Study|Lack of Efficacy|78|||
124549752|NCT04854707|447968899|FG001|Overall Study|Lack of Efficacy|59|||
124549753|NCT04854707|447968900|FG002|Overall Study|Lack of Efficacy|30|||
124549754|NCT00537056|447968901|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
124549755|NCT05674721|447968913|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
124549756|NCT05674721|447968914|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
124549757|NCT05674721|447968913|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
124549758|NCT05674721|447968914|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
124549759|NCT03891875|447968915|FG000|Overall Study|Withdrawal by Subject|20|||
124549760|NCT03891875|447968916|FG001|Overall Study|Withdrawal by Subject|3|||
124549761|NCT03891875|447968915|FG000|Overall Study|Adverse Event|10|||
124549762|NCT03891875|447968916|FG001|Overall Study|Adverse Event|4|||
124549763|NCT03891875|447968915|FG000|Overall Study|Physician Decision|1|||
124549764|NCT03891875|447968916|FG001|Overall Study|Physician Decision|1|||
124549765|NCT03891875|447968915|FG000|Overall Study|Protocol Violation|1|||
124549766|NCT03891875|447968916|FG001|Overall Study|Protocol Violation|0|||
124549767|NCT03891875|447968915|FG000|Overall Study|Lost to Follow-up|1|||
124549768|NCT03891875|447968916|FG001|Overall Study|Lost to Follow-up|0|||
124549769|NCT03891875|447968915|FG000|Overall Study|COVID-19 infection|1|||
124549770|NCT03891875|447968916|FG001|Overall Study|COVID-19 infection|0|||
124549771|NCT05013749|447968927|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
124549772|NCT05013749|447968928|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
124549773|NCT05013749|447968927|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
124549774|NCT05013749|447968928|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
124549775|NCT02017535|447968931|FG000|Overall Study|Withdrawal by Subject|1|||
124549776|NCT02017535|447968932|FG001|Overall Study|Withdrawal by Subject|0|||
124549777|NCT02017535|447968933|FG002|Overall Study|Withdrawal by Subject|0|||
124549778|NCT02017535|447968934|FG003|Overall Study|Withdrawal by Subject|0|||
124549779|NCT01393626|447968935|FG000|Overall Study|Adverse Event|2|||
124549780|NCT01393626|447968936|FG001|Overall Study|Adverse Event|1|||
124549781|NCT01393626|447968937|FG002|Overall Study|Adverse Event|5|||
124549782|NCT01393626|447968938|FG003|Overall Study|Adverse Event|0|||
124549783|NCT01393626|447968935|FG000|Overall Study|Did not meet entrance criteria|1|||
124549784|NCT01393626|447968936|FG001|Overall Study|Did not meet entrance criteria|0|||
124549785|NCT01393626|447968937|FG002|Overall Study|Did not meet entrance criteria|0|||
124549786|NCT01393626|447968938|FG003|Overall Study|Did not meet entrance criteria|0|||
124464557|NCT01662440|447659783|FG003|Overall Study|Subject moved to another country.|0|||
124464558|NCT01662440|447659780|FG000|Overall Study|Protocol Violation|1|||
124464559|NCT01662440|447659781|FG001|Overall Study|Protocol Violation|0|||
124464560|NCT01662440|447659782|FG002|Overall Study|Protocol Violation|0|||
124464561|NCT01662440|447659783|FG003|Overall Study|Protocol Violation|0|||
124549787|NCT01393626|447968935|FG000|Overall Study|Lack of Efficacy|6|||
124464562|NCT01662440|447659780|FG000|Overall Study|Withdrawal by Subject|5|||
124464563|NCT01662440|447659781|FG001|Overall Study|Withdrawal by Subject|2|||
124464564|NCT01662440|447659782|FG002|Overall Study|Withdrawal by Subject|2|||
124464565|NCT01662440|447659783|FG003|Overall Study|Withdrawal by Subject|2|||
124464566|NCT00112905|447659784|FG000|Overall Study|Adverse Event|4|||
124464567|NCT00112905|447659784|FG000|Overall Study|Death|1|||
124464568|NCT00112905|447659784|FG000|Overall Study|Ineligibility|5|||
124549788|NCT01393626|447968936|FG001|Overall Study|Lack of Efficacy|6|||
124549789|NCT01393626|447968937|FG002|Overall Study|Lack of Efficacy|4|||
124549790|NCT01393626|447968938|FG003|Overall Study|Lack of Efficacy|1|||
124549791|NCT01393626|447968935|FG000|Overall Study|Lost to Follow-up|1|||
124549792|NCT01393626|447968936|FG001|Overall Study|Lost to Follow-up|1|||
124549793|NCT01393626|447968937|FG002|Overall Study|Lost to Follow-up|1|||
124549794|NCT01393626|447968938|FG003|Overall Study|Lost to Follow-up|0|||
124549795|NCT01393626|447968935|FG000|Overall Study|Withdrawal by Subject|6|||
124549796|NCT01393626|447968936|FG001|Overall Study|Withdrawal by Subject|4|||
124549797|NCT01393626|447968937|FG002|Overall Study|Withdrawal by Subject|0|||
124549798|NCT01393626|447968938|FG003|Overall Study|Withdrawal by Subject|0|||
124549799|NCT01393626|447968935|FG000|Overall Study|Other|1|||
124549800|NCT01393626|447968936|FG001|Overall Study|Other|0|||
124549801|NCT01393626|447968937|FG002|Overall Study|Other|0|||
124549802|NCT01393626|447968938|FG003|Overall Study|Other|0|||
124549803|NCT01393626|447968935|FG000|Overall Study|Protocol Violation|1|||
124549804|NCT01393626|447968936|FG001|Overall Study|Protocol Violation|0|||
124549805|NCT01393626|447968937|FG002|Overall Study|Protocol Violation|2|||
124549806|NCT01393626|447968938|FG003|Overall Study|Protocol Violation|0|||
124549807|NCT03506425|447968939|FG000|Overall Study|Adverse Event|1|||
124549808|NCT03506425|447968940|FG001|Overall Study|Adverse Event|3|||
124549809|NCT03506425|447968941|FG002|Overall Study|Adverse Event|0|||
124549810|NCT03506425|447968939|FG000|Overall Study|Death|1|||
124549811|NCT03506425|447968940|FG001|Overall Study|Death|0|||
124549812|NCT03506425|447968941|FG002|Overall Study|Death|0|||
124549813|NCT03506425|447968939|FG000|Overall Study|Withdrawal by Subject|0|||
124549814|NCT03506425|447968940|FG001|Overall Study|Withdrawal by Subject|0|||
124549815|NCT03506425|447968941|FG002|Overall Study|Withdrawal by Subject|1|||
124549816|NCT02643394|447968944|FG000|Overall Study|Protocol Violation|4|||
124549817|NCT02643394|447968945|FG001|Overall Study|Protocol Violation|5|||
124549818|NCT04088734|447968946|FG000|Overall Study|Other, Not Specified|5|||
124549819|NCT03083639|447968953|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
124549820|NCT03083639|447968954|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
124464569|NCT00112905|447659784|FG000|Overall Study|Alternative treatment|1|||
124464570|NCT00112905|447659784|FG000|Overall Study|performance status was deteiorating|1|||
124464571|NCT02600507|447659785|FG000|Overall Study|Adverse Event|3|||
124464572|NCT02600507|447659786|FG001|Overall Study|Adverse Event|15|||
124464573|NCT02600507|447659787|FG002|Overall Study|Adverse Event|5|||
124464574|NCT02600507|447659785|FG000|Overall Study|Lack of Efficacy|3|||
124464575|NCT02600507|447659786|FG001|Overall Study|Lack of Efficacy|8|||
124464576|NCT02600507|447659787|FG002|Overall Study|Lack of Efficacy|5|||
124464577|NCT02600507|447659785|FG000|Overall Study|Lost to Follow-up|3|||
124464578|NCT02600507|447659786|FG001|Overall Study|Lost to Follow-up|5|||
124464579|NCT02600507|447659787|FG002|Overall Study|Lost to Follow-up|2|||
124464580|NCT02600507|447659785|FG000|Overall Study|Protocol Violation|12|||
124464581|NCT02600507|447659786|FG001|Overall Study|Protocol Violation|4|||
124464582|NCT02600507|447659787|FG002|Overall Study|Protocol Violation|4|||
124464583|NCT02600507|447659785|FG000|Overall Study|Physician Decision|1|||
124549821|NCT03083639|447968953|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
124549822|NCT03083639|447968954|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
124549823|NCT02125734|447968955|FG000|Period 2|Adverse Event|0|||
124549824|NCT02125734|447968956|FG001|Period 2|Adverse Event|1|||
124549825|NCT01591499|447968957|FG000|Baseline Visit|Withdrawal by Subject|0|||
124464584|NCT02600507|447659786|FG001|Overall Study|Physician Decision|0|||
124464585|NCT02600507|447659787|FG002|Overall Study|Physician Decision|1|||
124464586|NCT02600507|447659785|FG000|Overall Study|Withdrawal by Subject|7|||
124464587|NCT02600507|447659786|FG001|Overall Study|Withdrawal by Subject|11|||
124464588|NCT02600507|447659787|FG002|Overall Study|Withdrawal by Subject|7|||
124549826|NCT01591499|447968958|FG001|Baseline Visit|Withdrawal by Subject|2|||
124549827|NCT01591499|447968959|FG002|Baseline Visit|Withdrawal by Subject|0|||
124464589|NCT02600507|447659785|FG000|Overall Study|Other|0|||
124464590|NCT02600507|447659786|FG001|Overall Study|Other|1|||
124464591|NCT02600507|447659787|FG002|Overall Study|Other|1|||
124464592|NCT04872101|447659791|FG000|Overall Study|Withdrawal by Subject|10|||
124549828|NCT01591499|447968960|FG003|Baseline Visit|Withdrawal by Subject|2|||
124549829|NCT01591499|447968957|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
124549830|NCT01591499|447968958|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
124549831|NCT01591499|447968959|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
124549832|NCT01591499|447968960|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
124549833|NCT01591499|447968957|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
124549834|NCT01591499|447968958|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
124549835|NCT01591499|447968959|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
124549836|NCT01591499|447968960|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
124549837|NCT02704130|447968961|FG000|Overall Study|Physician Decision|5|||
124464593|NCT04872101|447659792|FG001|Overall Study|Withdrawal by Subject|16|||
124549838|NCT02704130|447968962|FG001|Overall Study|Physician Decision|3|||
124549839|NCT02666768|447968963|FG000|Overall Study|Withdrawal by Subject|4|||
124549840|NCT03940742|447968966|FG000|Overall Study|Lost to Follow-up|0|||
124964388|NCT03464383|449497673|FG001|Overall Study|Lost to Follow-up|0|||
124964389|NCT03464383|449497674|FG002|Overall Study|Lost to Follow-up|0|||
124964390|NCT03464383|449497672|FG000|Overall Study|Withdrawal by Subject|0|||
124964391|NCT03464383|449497673|FG001|Overall Study|Withdrawal by Subject|1|||
124964392|NCT03464383|449497674|FG002|Overall Study|Withdrawal by Subject|0|||
124964393|NCT00695136|449497679|FG000|Overall Study|Withdrawal by Subject|1|||
124964394|NCT00695136|449497679|FG000|Overall Study|unrelated adverse event|1|||
124964395|NCT01726049|449497681|FG000|Overall Study|Death|1|||
124964396|NCT01726049|449497682|FG001|Overall Study|Death|1|||
124964397|NCT01726049|449497681|FG000|Overall Study|Adverse Event|4|||
124964398|NCT01726049|449497682|FG001|Overall Study|Adverse Event|1|||
124964399|NCT01726049|449497681|FG000|Overall Study|refused second HC|0|||
124964400|NCT01726049|449497682|FG001|Overall Study|refused second HC|2|||
124964401|NCT02806505|449497684|FG000|Overall Study|Adverse event/intercurrent illness|1|||
124964402|NCT02806505|449497685|FG001|Overall Study|Adverse event/intercurrent illness|3|||
124964403|NCT02806505|449497684|FG000|Overall Study|Death|4|||
124964404|NCT02806505|449497685|FG001|Overall Study|Death|0|||
124964405|NCT02806505|449497684|FG000|Overall Study|Did not cooperate/refused treatment|3|||
124964406|NCT02806505|449497685|FG001|Overall Study|Did not cooperate/refused treatment|3|||
124964407|NCT02806505|449497684|FG000|Overall Study|Failure to return|0|||
124964408|NCT02806505|449497685|FG001|Overall Study|Failure to return|1|||
124964409|NCT02806505|449497684|FG000|Overall Study|Insufficient therapeutic response|2|||
124964410|NCT02806505|449497685|FG001|Overall Study|Insufficient therapeutic response|4|||
124964411|NCT01722045|449497692|FG000|Overall Study|Adverse Event|8|||
124964412|NCT01722045|449497692|FG000|Overall Study|Death|3|||
124964413|NCT01722045|449497692|FG000|Overall Study|Withdrawal by Subject|8|||
124964414|NCT01722045|449497692|FG000|Overall Study|Lost to Follow-up|4|||
124964415|NCT01722045|449497692|FG000|Overall Study|Protocol Deviation|1|||
124964416|NCT01722045|449497692|FG000|Overall Study|Physician Decision|3|||
124964417|NCT01722045|449497692|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
124964418|NCT00263211|449497697|FG000|Overall Study|Death|1|||
124964419|NCT00263211|449497698|FG001|Overall Study|Death|0|||
124964420|NCT00263211|449497697|FG000|Overall Study|Withdrawal by Subject|3|||
124964421|NCT00263211|449497698|FG001|Overall Study|Withdrawal by Subject|0|||
124964422|NCT00263211|449497697|FG000|Overall Study|Protocol Violation|1|||
124964423|NCT00263211|449497698|FG001|Overall Study|Protocol Violation|0|||
124964424|NCT00263211|449497697|FG000|Overall Study|Disease Progression|0|||
124964425|NCT00263211|449497698|FG001|Overall Study|Disease Progression|1|||
124964426|NCT00760513|449497699|FG000|Overall Study|Withdrawal by Subject|5|||
124964427|NCT00760513|449497700|FG001|Overall Study|Withdrawal by Subject|7|||
124964428|NCT00908349|449497703|FG000|Overall Study|Adverse Event|10|||
124964429|NCT00908349|449497703|FG000|Overall Study|Withdrawal by Subject|9|||
124964430|NCT00908349|449497703|FG000|Overall Study|Physician Decision|5|||
124964431|NCT00908349|449497703|FG000|Overall Study|Lost to Follow-up|5|||
124964432|NCT00908349|449497703|FG000|Overall Study|Various|6|||
124964433|NCT03834623|449497707|FG000|Overall Study|Progression|0|||
124964434|NCT03834623|449497708|FG001|Overall Study|Progression|1|||
124964435|NCT00478647|449497709|FG000|Overall Study|Adverse Event|1|||
124964436|NCT00478647|449497709|FG000|Overall Study|Withdrawal by Subject|1|||
124964437|NCT01755546|449497712|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
124964438|NCT01755546|449497712|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
124964439|NCT01755546|449497712|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
124964440|NCT01755546|449497712|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
124964441|NCT01755546|449497712|FG000|Titration Phase|Adverse Event|11|||
124964442|NCT01755546|449497712|FG000|Titration Phase|Lack of Efficacy|18|||
124964443|NCT01755546|449497712|FG000|Titration Phase|Protocol Violation|9|||
124964444|NCT01755546|449497712|FG000|Titration Phase|Lost to Follow-up|2|||
124964445|NCT01755546|449497712|FG000|Titration Phase|Other and Continuing|22|||
124964446|NCT01755546|449497712|FG000|Titration Phase|Withdrawal by Subject|8|||
124964447|NCT01755546|449497712|FG000|Long Term Treatment|Adverse Event|12|||
124964448|NCT01755546|449497712|FG000|Long Term Treatment|Lack of Efficacy|6|||
124964449|NCT01755546|449497712|FG000|Long Term Treatment|Protocol Violation|10|||
124964450|NCT01755546|449497712|FG000|Long Term Treatment|Withdrawal by Subject|35|||
124964451|NCT01755546|449497712|FG000|Long Term Treatment|Lost to Follow-up|17|||
124964452|NCT01755546|449497712|FG000|Long Term Treatment|other and ongoing|41|||
124964453|NCT00362375|449497713|FG000|Overall Study|Lost to Follow-up|40|||
124964454|NCT00362375|449497714|FG001|Overall Study|Lost to Follow-up|35|||
124964455|NCT04606199|449497715|FG000|Overall Study|Withdrawal by Subject|2|||
124964456|NCT02624869|449497720|FG000|Overall Study|Lost to Follow-up|0|||
124964457|NCT02624869|449497721|FG001|Overall Study|Lost to Follow-up|0|||
124964458|NCT02624869|449497722|FG002|Overall Study|Lost to Follow-up|1|||
124964459|NCT02624869|449497720|FG000|Overall Study|Withdrawal by Subject|1|||
124964460|NCT02624869|449497721|FG001|Overall Study|Withdrawal by Subject|3|||
124464594|NCT04872101|447659791|FG000|Overall Study|Lack of Efficacy|6|||
124964461|NCT02624869|449497722|FG002|Overall Study|Withdrawal by Subject|1|||
124964462|NCT03596242|449497725|FG000|Overall Study|Lost to Follow-up|2|||
124964463|NCT03596242|449497726|FG001|Overall Study|Lost to Follow-up|2|||
124964464|NCT02509312|449497727|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
124964465|NCT02509312|449497728|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
124964466|NCT02509312|449497727|FG000|Overall Study|Obstetrician refusal|0|||
124964467|NCT02509312|449497728|FG001|Overall Study|Obstetrician refusal|1|||
124964468|NCT02509312|449497727|FG000|Overall Study|Patient elected for TOLAC|1|||
124964469|NCT02509312|449497728|FG001|Overall Study|Patient elected for TOLAC|0|||
124964470|NCT02509312|449497727|FG000|Overall Study|Cesarean deemed stat|1|||
124964471|NCT02509312|449497728|FG001|Overall Study|Cesarean deemed stat|0|||
124964472|NCT02509312|449497727|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
124964473|NCT02509312|449497728|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
124964474|NCT04051242|449497731|FG000|Overall Study|Withdrawal by Subject|1|||
124964475|NCT04051242|449497731|FG000|Overall Study|Physician Decision|1|||
124964476|NCT00704171|449497732|FG000|Overall Study|Withdrawal by Subject|1|||
124964477|NCT00704171|449497733|FG001|Overall Study|Withdrawal by Subject|0|||
124964478|NCT01874665|449497734|FG000|Overall Study|Adverse Event|6|||
124964479|NCT01874665|449497735|FG001|Overall Study|Adverse Event|2|||
124964480|NCT01874665|449497734|FG000|Overall Study|Withdrawal by Subject|4|||
124964481|NCT01874665|449497735|FG001|Overall Study|Withdrawal by Subject|1|||
124964482|NCT01874665|449497734|FG000|Overall Study|Physician Decision|3|||
124964483|NCT01874665|449497735|FG001|Overall Study|Physician Decision|0|||
124964484|NCT01874665|449497734|FG000|Overall Study|Clinical Progressive Disease|4|||
124964485|NCT01874665|449497735|FG001|Overall Study|Clinical Progressive Disease|3|||
124964486|NCT01874665|449497734|FG000|Overall Study|Study Terminated by Sponsor|0|||
124964487|NCT01874665|449497735|FG001|Overall Study|Study Terminated by Sponsor|2|||
124964488|NCT01874665|449497734|FG000|Overall Study|Documented Progressive Disease|11|||
124964489|NCT01874665|449497735|FG001|Overall Study|Documented Progressive Disease|7|||
124964490|NCT01874665|449497734|FG000|Overall Study|Other|2|||
124964491|NCT01874665|449497735|FG001|Overall Study|Other|0|||
124964492|NCT04962698|449497740|FG000|Motor Imagery|Technical difficulty|1|||
124964493|NCT04962698|449497741|FG001|Motor Imagery|Technical difficulty|0|||
124964494|NCT04962698|449497740|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
124964495|NCT04962698|449497741|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
124964496|NCT04962698|449497740|FG000|Kinesthetic MI|Technical difficulty|1|||
124964497|NCT04962698|449497741|FG001|Kinesthetic MI|Technical difficulty|0|||
124964498|NCT04962698|449497740|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
124964499|NCT04962698|449497741|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
124964500|NCT04962698|449497740|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
124964501|NCT04962698|449497741|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
124964502|NCT04962698|449497740|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
124964503|NCT04962698|449497741|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
124964504|NCT04962698|449497740|FG000|Virtual-hand Interaction|Technical difficulty|1|||
124964505|NCT04962698|449497741|FG001|Virtual-hand Interaction|Technical difficulty|0|||
124964506|NCT04962698|449497740|FG000|Robotic Action Observation|Technical difficulty|1|||
124964507|NCT04962698|449497741|FG001|Robotic Action Observation|Technical difficulty|0|||
124964508|NCT04962698|449497740|FG000|Rest|Technical difficulty|1|||
124964509|NCT04962698|449497741|FG001|Rest|Technical difficulty|0|||
124964510|NCT04962698|449497740|FG000|Rest|Exclusion criteria met after enrollment|0|||
124964511|NCT04962698|449497741|FG001|Rest|Exclusion criteria met after enrollment|2|||
124964512|NCT00853229|449497742|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
124964513|NCT00853229|449497743|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
124964514|NCT03201900|449497747|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
124964515|NCT03201900|449497747|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
124964516|NCT03201900|449497747|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
124964517|NCT03201900|449497747|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
124964518|NCT03201900|449497747|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
124964519|NCT03201900|449497747|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
124964520|NCT03201900|449497747|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
124964521|NCT03201900|449497747|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
124964522|NCT03201900|449497747|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
124964523|NCT03201900|449497747|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
124964524|NCT03201900|449497747|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
124964525|NCT03201900|449497747|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
124964526|NCT03201900|449497747|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
124964527|NCT00776659|449497766|FG000|Overall Study|Lost to Follow-up|15|||
124964528|NCT00776659|449497766|FG000|Overall Study|Withdrawal by Subject|10|||
124549841|NCT03940742|447968967|FG001|Overall Study|Lost to Follow-up|0|||
124549842|NCT03940742|447968968|FG002|Overall Study|Lost to Follow-up|0|||
124549843|NCT03940742|447968969|FG003|Overall Study|Lost to Follow-up|1|||
124549844|NCT02032823|447968970|FG000|Overall Study|Death|75|||
124549845|NCT02032823|447968971|FG001|Overall Study|Death|109|||
124549846|NCT02032823|447968970|FG000|Overall Study|Lost to Follow-up|18|||
124549847|NCT02032823|447968971|FG001|Overall Study|Lost to Follow-up|17|||
124549848|NCT02032823|447968970|FG000|Overall Study|Withdrawal by Subject|70|||
124549849|NCT02032823|447968971|FG001|Overall Study|Withdrawal by Subject|53|||
124549850|NCT02032823|447968970|FG000|Overall Study|Ongoing study at data cut-off|755|||
124549851|NCT02032823|447968971|FG001|Overall Study|Ongoing study at data cut-off|731|||
124549852|NCT02032823|447968970|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
124549853|NCT02032823|447968971|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
124964529|NCT00776659|449497766|FG000|Overall Study|Study Terminated by Sponsor|1|||
124964530|NCT02835092|449497772|FG000|Overall Study|Withdrawal by Subject|3|||
124964531|NCT02835092|449497773|FG001|Overall Study|Withdrawal by Subject|6|||
124964532|NCT02835092|449497774|FG002|Overall Study|Withdrawal by Subject|3|||
124964533|NCT02835092|449497772|FG000|Overall Study|Lost to Follow-up|0|||
124964534|NCT02835092|449497773|FG001|Overall Study|Lost to Follow-up|2|||
124964535|NCT02835092|449497774|FG002|Overall Study|Lost to Follow-up|0|||
124964536|NCT00025506|449497776|FG000|Overall Study|Ineligible: clerical error|1|||
124964537|NCT00025506|449497776|FG000|Overall Study|Ineligible: wrong cell type|5|||
124964538|NCT00025506|449497776|FG000|Overall Study|Ineligible: inadequate pathology|2|||
124964539|NCT00025506|449497776|FG000|Overall Study|Never Treated|2|||
124964540|NCT01321723|449497777|FG000|Overall Study|Adverse Event|3|||
124964541|NCT01321723|449497778|FG001|Overall Study|Adverse Event|5|||
124964542|NCT01321723|449497779|FG002|Overall Study|Adverse Event|2|||
124964543|NCT01321723|449497777|FG000|Overall Study|Withdrawal by Subject|2|||
124964544|NCT01321723|449497778|FG001|Overall Study|Withdrawal by Subject|0|||
124964545|NCT01321723|449497779|FG002|Overall Study|Withdrawal by Subject|2|||
124964546|NCT00713206|449497780|FG000|Overall Study|Lost to Follow-up|4|||
124964547|NCT00713206|449497781|FG001|Overall Study|Lost to Follow-up|4|||
124964548|NCT00713206|449497780|FG000|Overall Study|Death|1|||
124964549|NCT00713206|449497781|FG001|Overall Study|Death|0|||
124964550|NCT02561806|449497782|FG000|Induction Period|Adverse Event|0|||
124964551|NCT02561806|449497783|FG001|Induction Period|Adverse Event|2|||
124964552|NCT02561806|449497782|FG000|Induction Period|Lack of Efficacy|1|||
124964553|NCT02561806|449497783|FG001|Induction Period|Lack of Efficacy|0|||
124964554|NCT02561806|449497782|FG000|Induction Period|Withdrawal by Subject|0|||
124964555|NCT02561806|449497783|FG001|Induction Period|Withdrawal by Subject|2|||
124964556|NCT02561806|449497782|FG000|Induction Period|Site staff became unblinded|1|||
124964557|NCT02561806|449497783|FG001|Induction Period|Site staff became unblinded|0|||
124964558|NCT02561806|449497782|FG000|Induction Period|Randomized but not treated|0|||
124964559|NCT02561806|449497783|FG001|Induction Period|Randomized but not treated|1|||
124964560|NCT02561806|449497782|FG000|Maintenance Period|Adverse Event|2|||
124964561|NCT02561806|449497783|FG001|Maintenance Period|Adverse Event|1|||
124964562|NCT02561806|449497782|FG000|Maintenance Period|Lack of Efficacy|3|||
124964563|NCT02561806|449497783|FG001|Maintenance Period|Lack of Efficacy|1|||
124964564|NCT02561806|449497782|FG000|Maintenance Period|Lost to Follow-up|2|||
124964565|NCT02561806|449497783|FG001|Maintenance Period|Lost to Follow-up|2|||
124964566|NCT02561806|449497782|FG000|Maintenance Period|Protocol Violation|1|||
124964567|NCT02561806|449497783|FG001|Maintenance Period|Protocol Violation|0|||
124964568|NCT02561806|449497782|FG000|Maintenance Period|Withdrawal by Subject|5|||
124964569|NCT02561806|449497783|FG001|Maintenance Period|Withdrawal by Subject|3|||
124964570|NCT02561806|449497782|FG000|Maintenance Period|Site staff became unblinded|0|||
124964571|NCT02561806|449497783|FG001|Maintenance Period|Site staff became unblinded|1|||
124964572|NCT02561806|449497782|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
124964573|NCT02561806|449497783|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
124964574|NCT02561806|449497782|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
124964575|NCT02561806|449497783|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
124964576|NCT02547441|449497784|FG000|Double-Blind Study Period|Adverse Event|4|||
124549854|NCT03428217|447968972|FG000|Overall Study|Death|89|||
124549855|NCT03428217|447968973|FG001|Overall Study|Death|93|||
124549856|NCT03428217|447968972|FG000|Overall Study|Withdrawal by Subject|8|||
124964577|NCT02547441|449497785|FG001|Double-Blind Study Period|Adverse Event|9|||
124964578|NCT02547441|449497784|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
124964579|NCT02547441|449497785|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
124964580|NCT02547441|449497784|FG000|Double-Blind Study Period|Physician Decision|1|||
124964581|NCT02547441|449497785|FG001|Double-Blind Study Period|Physician Decision|0|||
124964582|NCT02547441|449497784|FG000|Double-Blind Study Period|Protocol Violation|1|||
124964583|NCT02547441|449497785|FG001|Double-Blind Study Period|Protocol Violation|2|||
124964584|NCT02547441|449497784|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
124549857|NCT03428217|447968973|FG001|Overall Study|Withdrawal by Subject|7|||
124549858|NCT03428217|447968972|FG000|Overall Study|Lost to Follow-up|1|||
124964585|NCT02547441|449497785|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
124964586|NCT02547441|449497784|FG000|Double-Blind Study Period|Sponsor Decision|1|||
124964587|NCT02547441|449497785|FG001|Double-Blind Study Period|Sponsor Decision|0|||
124964588|NCT02547441|449497784|FG000|Open-Label Study Period|Adverse Event|10|||
124964589|NCT02547441|449497785|FG001|Open-Label Study Period|Adverse Event|11|||
124964590|NCT02547441|449497784|FG000|Open-Label Study Period|Lack of Efficacy|3|||
124964591|NCT02547441|449497785|FG001|Open-Label Study Period|Lack of Efficacy|2|||
124964592|NCT02547441|449497784|FG000|Open-Label Study Period|Lost to Follow-up|7|||
124964593|NCT02547441|449497785|FG001|Open-Label Study Period|Lost to Follow-up|8|||
124964594|NCT02547441|449497784|FG000|Open-Label Study Period|Physician Decision|1|||
124964595|NCT02547441|449497785|FG001|Open-Label Study Period|Physician Decision|0|||
124964596|NCT02547441|449497784|FG000|Open-Label Study Period|Protocol Violation|2|||
124964597|NCT02547441|449497785|FG001|Open-Label Study Period|Protocol Violation|0|||
124964598|NCT02547441|449497784|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
124964599|NCT02547441|449497785|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
124964600|NCT02547441|449497784|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
124964601|NCT02547441|449497785|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
124964602|NCT01322009|449497787|FG000|Overall Study|Death|0|||
124964603|NCT01322009|449497788|FG001|Overall Study|Death|1|||
124964604|NCT01322009|449497787|FG000|Overall Study|Adverse Event|0|||
124964605|NCT01322009|449497788|FG001|Overall Study|Adverse Event|1|||
124964606|NCT01322009|449497787|FG000|Overall Study|ng tube discontinued|0|||
124964607|NCT01322009|449497788|FG001|Overall Study|ng tube discontinued|1|||
124964608|NCT01657877|449497789|FG000|Overall Study|Withdrawal by Subject|4|||
124964609|NCT01657877|449497789|FG000|Overall Study|Protocol Violation|6|||
124964610|NCT01657877|449497789|FG000|Overall Study|Adverse Event|2|||
124964611|NCT01657877|449497789|FG000|Overall Study|Other Reason|2|||
124964612|NCT02872311|449497793|FG000|Overall Study|Death|2|||
124964613|NCT02872311|449497794|FG001|Overall Study|Death|0|||
124964614|NCT02872311|449497795|FG002|Overall Study|Death|0|||
124964615|NCT02872311|449497796|FG003|Overall Study|Death|0|||
124964616|NCT02872311|449497797|FG004|Overall Study|Death|0|||
124964617|NCT02872311|449497793|FG000|Overall Study|Lost to Follow-up|2|||
124964618|NCT02872311|449497794|FG001|Overall Study|Lost to Follow-up|0|||
124964619|NCT02872311|449497795|FG002|Overall Study|Lost to Follow-up|0|||
124964620|NCT02872311|449497796|FG003|Overall Study|Lost to Follow-up|0|||
124964621|NCT02872311|449497797|FG004|Overall Study|Lost to Follow-up|0|||
124964622|NCT02872311|449497793|FG000|Overall Study|Protocol Violation|0|||
124964623|NCT02872311|449497794|FG001|Overall Study|Protocol Violation|2|||
124964624|NCT02872311|449497795|FG002|Overall Study|Protocol Violation|1|||
124964625|NCT02872311|449497796|FG003|Overall Study|Protocol Violation|0|||
124964626|NCT02872311|449497797|FG004|Overall Study|Protocol Violation|0|||
124964627|NCT00511797|449497798|FG000|Overall Study|Adverse Event|1|||
124964628|NCT00511797|449497799|FG001|Overall Study|Adverse Event|2|||
124964629|NCT00511797|449497800|FG002|Overall Study|Adverse Event|2|||
124964630|NCT00511797|449497801|FG003|Overall Study|Adverse Event|2|||
124964631|NCT00511797|449497798|FG000|Overall Study|Lost to Follow-up|1|||
124964632|NCT00511797|449497799|FG001|Overall Study|Lost to Follow-up|0|||
124964633|NCT00511797|449497800|FG002|Overall Study|Lost to Follow-up|0|||
124964634|NCT00511797|449497801|FG003|Overall Study|Lost to Follow-up|1|||
124964635|NCT00511797|449497798|FG000|Overall Study|Pregnancy|0|||
124964636|NCT00511797|449497799|FG001|Overall Study|Pregnancy|0|||
124964637|NCT00511797|449497800|FG002|Overall Study|Pregnancy|0|||
124964638|NCT00511797|449497801|FG003|Overall Study|Pregnancy|1|||
124964639|NCT00511797|449497798|FG000|Overall Study|Protocol Violation|0|||
124964640|NCT00511797|449497799|FG001|Overall Study|Protocol Violation|2|||
124964641|NCT00511797|449497800|FG002|Overall Study|Protocol Violation|2|||
124964642|NCT00511797|449497801|FG003|Overall Study|Protocol Violation|3|||
124964643|NCT00511797|449497798|FG000|Overall Study|Withdrawal by Subject|3|||
124964644|NCT00511797|449497799|FG001|Overall Study|Withdrawal by Subject|3|||
124964645|NCT00511797|449497800|FG002|Overall Study|Withdrawal by Subject|4|||
124964646|NCT00511797|449497801|FG003|Overall Study|Withdrawal by Subject|2|||
124964647|NCT00511797|449497798|FG000|Overall Study|Never dispensed|1|||
124964648|NCT00511797|449497799|FG001|Overall Study|Never dispensed|0|||
124964649|NCT00511797|449497800|FG002|Overall Study|Never dispensed|1|||
124964650|NCT00511797|449497801|FG003|Overall Study|Never dispensed|3|||
124964651|NCT00511797|449497798|FG000|Overall Study|Study drug not taken|0|||
124964652|NCT00511797|449497799|FG001|Overall Study|Study drug not taken|1|||
124964653|NCT00511797|449497800|FG002|Overall Study|Study drug not taken|0|||
124964654|NCT00511797|449497801|FG003|Overall Study|Study drug not taken|1|||
124964655|NCT00511797|449497798|FG000|Overall Study|Partially missing diary|0|||
124964656|NCT00511797|449497799|FG001|Overall Study|Partially missing diary|0|||
124964657|NCT00511797|449497800|FG002|Overall Study|Partially missing diary|1|||
124964658|NCT00511797|449497801|FG003|Overall Study|Partially missing diary|0|||
124964659|NCT00511797|449497798|FG000|Overall Study|Other (moving etc)|1|||
124964660|NCT00511797|449497799|FG001|Overall Study|Other (moving etc)|0|||
124964661|NCT00511797|449497800|FG002|Overall Study|Other (moving etc)|1|||
124964662|NCT00511797|449497801|FG003|Overall Study|Other (moving etc)|2|||
124964663|NCT03974100|449497802|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
124964664|NCT03974100|449497803|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
124964665|NCT03974100|449497804|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
124964666|NCT03974100|449497805|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
124964667|NCT03974100|449497806|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
124964668|NCT03974100|449497802|FG000|TP1 - Day 1 to Week 52|Death|1|||
124964669|NCT03974100|449497803|FG001|TP1 - Day 1 to Week 52|Death|0|||
124964670|NCT03974100|449497804|FG002|TP1 - Day 1 to Week 52|Death|0|||
124964671|NCT03974100|449497805|FG003|TP1 - Day 1 to Week 52|Death|0|||
124964672|NCT03974100|449497806|FG004|TP1 - Day 1 to Week 52|Death|0|||
124964673|NCT03974100|449497802|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
124964674|NCT03974100|449497803|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
124464595|NCT04872101|447659792|FG001|Overall Study|Lack of Efficacy|14|||
124464596|NCT04872101|447659791|FG000|Overall Study|Adverse Event|1|||
124464597|NCT04872101|447659792|FG001|Overall Study|Adverse Event|6|||
124464598|NCT04872101|447659791|FG000|Overall Study|Lost to Follow-up|2|||
124464599|NCT04872101|447659792|FG001|Overall Study|Lost to Follow-up|1|||
124464600|NCT04872101|447659791|FG000|Overall Study|Pregnancy|2|||
124464601|NCT04872101|447659792|FG001|Overall Study|Pregnancy|0|||
124464602|NCT04872101|447659791|FG000|Overall Study|Prohibited Medication|1|||
124464603|NCT04872101|447659792|FG001|Overall Study|Prohibited Medication|0|||
124464604|NCT04872101|447659791|FG000|Overall Study|Not dosed|1|||
124464605|NCT04872101|447659792|FG001|Overall Study|Not dosed|0|||
124464606|NCT00971945|447659793|FG000|Overall Study|Progressive Disease|3|||
124464607|NCT00971945|447659793|FG000|Overall Study|Change in treatment policy|1|||
124464608|NCT00971945|447659793|FG000|Overall Study|Other reasons|2|||
124464609|NCT03354663|447659794|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
124464610|NCT03354663|447659794|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
124464611|NCT03354663|447659794|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
124464612|NCT03354663|447659794|FG000|Completed 30-day Visit|Missed Visit|1|||
124464613|NCT03691974|447659795|FG000|Overall Study|Physician Decision|1|||
124464614|NCT03691974|447659796|FG001|Overall Study|Physician Decision|0|||
124464615|NCT03691974|447659795|FG000|Overall Study|Adverse Event|1|||
124464616|NCT03691974|447659796|FG001|Overall Study|Adverse Event|0|||
124464617|NCT03691974|447659795|FG000|Overall Study|Withdrawal by Subject|11|||
124464618|NCT03691974|447659796|FG001|Overall Study|Withdrawal by Subject|9|||
124464619|NCT03691974|447659795|FG000|Overall Study|Protocol Violation|1|||
124709874|NCT01076010|448563058|FG000|Overall Study|Progressive disease|90|||
124709875|NCT01076010|448563059|FG001|Overall Study|Progressive disease|30|||
124709876|NCT01076010|448563060|FG002|Overall Study|Progressive disease|1|||
124709877|NCT01076010|448563058|FG000|Overall Study|Lack of Efficacy|4|||
124709878|NCT01076010|448563059|FG001|Overall Study|Lack of Efficacy|0|||
124709879|NCT01076010|448563060|FG002|Overall Study|Lack of Efficacy|0|||
124709880|NCT01076010|448563058|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
124709881|NCT01076010|448563059|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
124964675|NCT03974100|449497804|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
124964676|NCT03974100|449497805|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
124964677|NCT03974100|449497806|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
124464620|NCT03691974|447659796|FG001|Overall Study|Protocol Violation|0|||
124709882|NCT01076010|448563060|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
124709883|NCT01076010|448563058|FG000|Overall Study|Significant Surgical Procedure|0|||
124709884|NCT01076010|448563059|FG001|Overall Study|Significant Surgical Procedure|1|||
124709885|NCT01076010|448563060|FG002|Overall Study|Significant Surgical Procedure|0|||
124709886|NCT01076010|448563058|FG000|Overall Study|Protocol Violation|0|||
124709887|NCT01076010|448563059|FG001|Overall Study|Protocol Violation|1|||
124709888|NCT01076010|448563060|FG002|Overall Study|Protocol Violation|0|||
124709889|NCT01076010|448563058|FG000|Overall Study|Noncompliance|1|||
124709890|NCT01076010|448563059|FG001|Overall Study|Noncompliance|1|||
124709891|NCT01076010|448563060|FG002|Overall Study|Noncompliance|0|||
124709892|NCT01076010|448563058|FG000|Overall Study|Withdrawal by Subject|3|||
124464621|NCT03691974|447659795|FG000|Overall Study|Lost to Follow-up|8|||
124709893|NCT01076010|448563059|FG001|Overall Study|Withdrawal by Subject|0|||
124964678|NCT03974100|449497802|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
124964679|NCT03974100|449497803|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
124964680|NCT03974100|449497804|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
124964681|NCT03974100|449497805|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
124964682|NCT03974100|449497806|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
124964683|NCT03974100|449497802|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
124964684|NCT03974100|449497803|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
124964685|NCT03974100|449497804|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
124964686|NCT03974100|449497805|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
124964687|NCT03974100|449497806|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
124964688|NCT03974100|449497802|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
124964689|NCT03974100|449497803|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
124964690|NCT03974100|449497804|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
124964691|NCT03974100|449497805|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
124964692|NCT03974100|449497806|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
124964693|NCT03974100|449497802|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
124964694|NCT03974100|449497803|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
124964695|NCT03974100|449497804|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
124964696|NCT03974100|449497805|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
124964697|NCT03974100|449497806|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
124964698|NCT02019641|449497807|FG000|10-Week Follow up|Withdrawal by investigator|2|||
124964699|NCT02019641|449497808|FG001|10-Week Follow up|Withdrawal by investigator|0|||
124964700|NCT02019641|449497809|FG002|10-Week Follow up|Withdrawal by investigator|0|||
124964701|NCT02019641|449497807|FG000|10-Week Follow up|Withdrawal by Subject|1|||
124964702|NCT02019641|449497808|FG001|10-Week Follow up|Withdrawal by Subject|1|||
124964703|NCT02019641|449497809|FG002|10-Week Follow up|Withdrawal by Subject|0|||
124964704|NCT02019641|449497807|FG000|20-Week Follow up|Withdrawal by investigator|0|||
124964705|NCT02019641|449497808|FG001|20-Week Follow up|Withdrawal by investigator|0|||
124964706|NCT02019641|449497809|FG002|20-Week Follow up|Withdrawal by investigator|1|||
124964707|NCT00545571|449497812|FG000|Overall Study|Administrative Reasons|1|||
124964708|NCT00545571|449497812|FG000|Overall Study|Adverse Event|2|||
124964709|NCT00545571|449497812|FG000|Overall Study|Death|5|||
124964710|NCT00545571|449497812|FG000|Overall Study|Lack of Efficacy|1|||
124964711|NCT00545571|449497812|FG000|Overall Study|Protocol Violation|2|||
124964712|NCT00545571|449497812|FG000|Overall Study|Refused Treatment|1|||
124964713|NCT00545571|449497812|FG000|Overall Study|Screen Failure|16|||
124964714|NCT00545571|449497812|FG000|Overall Study|Transfusion|12|||
124964715|NCT00545571|449497812|FG000|Overall Study|Early Termination of Study|24|||
124964716|NCT00545571|449497812|FG000|Overall Study|Kidney Transplantation|3|||
124964717|NCT03269695|449497813|FG000|Overall Study|Adverse Event|2|||
124964718|NCT03269695|449497814|FG001|Overall Study|Adverse Event|1|||
124964719|NCT03269695|449497813|FG000|Overall Study|Lack of Efficacy|0|||
124964720|NCT03269695|449497814|FG001|Overall Study|Lack of Efficacy|1|||
124964721|NCT03269695|449497813|FG000|Overall Study|Withdrawal by Subject|0|||
124964722|NCT03269695|449497814|FG001|Overall Study|Withdrawal by Subject|1|||
124964723|NCT02024750|449497815|FG000|Overall Study|Withdrawal by Subject|2|||
124964724|NCT02024750|449497816|FG001|Overall Study|Withdrawal by Subject|1|||
124964725|NCT01349036|449497817|FG000|Overall Study|Disease progression|13|||
124964726|NCT01349036|449497818|FG001|Overall Study|Disease progression|22|||
124964727|NCT01349036|449497817|FG000|Overall Study|Other|1|||
124964728|NCT01349036|449497818|FG001|Overall Study|Other|0|||
124964729|NCT01349036|449497817|FG000|Overall Study|Withdrawal by Subject|0|||
124964730|NCT01349036|449497818|FG001|Overall Study|Withdrawal by Subject|2|||
124964731|NCT00746356|449497819|FG000|Overall Study|Withdrawal by Subject|2|||
124964732|NCT00746356|449497820|FG001|Overall Study|Withdrawal by Subject|3|||
124964733|NCT00746356|449497819|FG000|Overall Study|Death|7|||
124549859|NCT03428217|447968973|FG001|Overall Study|Lost to Follow-up|3|||
124549860|NCT03428217|447968972|FG000|Overall Study|Study terminated by sponsor|124|||
124549861|NCT03428217|447968973|FG001|Overall Study|Study terminated by sponsor|118|||
124964734|NCT00746356|449497820|FG001|Overall Study|Death|3|||
124964735|NCT00746356|449497819|FG000|Overall Study|Lost to Follow-up|1|||
124964736|NCT00746356|449497820|FG001|Overall Study|Lost to Follow-up|0|||
124964737|NCT00746356|449497819|FG000|Overall Study|Removal of Device|0|||
124964738|NCT00746356|449497820|FG001|Overall Study|Removal of Device|1|||
124964739|NCT00746356|449497819|FG000|Overall Study|Patient relocated|1|||
124964740|NCT00746356|449497820|FG001|Overall Study|Patient relocated|0|||
124964741|NCT03605368|449497823|FG000|Overall Study|Lost to Follow-up|2|||
124964742|NCT03605368|449497824|FG001|Overall Study|Lost to Follow-up|1|||
124549862|NCT03428217|447968972|FG000|Overall Study|Other, Not Specified|1|||
124964743|NCT03605368|449497825|FG002|Overall Study|Lost to Follow-up|3|||
124964744|NCT03605368|449497826|FG003|Overall Study|Lost to Follow-up|2|||
124964745|NCT03605368|449497823|FG000|Overall Study|Withdrawal by Subject|0|||
124964746|NCT03605368|449497824|FG001|Overall Study|Withdrawal by Subject|0|||
124964747|NCT03605368|449497825|FG002|Overall Study|Withdrawal by Subject|4|||
124964748|NCT03605368|449497826|FG003|Overall Study|Withdrawal by Subject|3|||
124964749|NCT01125566|449497827|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
124964750|NCT01125566|449497828|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
124964751|NCT01125566|449497829|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
124964752|NCT01125566|449497827|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
124964753|NCT01125566|449497828|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
124964754|NCT01125566|449497829|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
124964755|NCT01125566|449497827|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
124964756|NCT01125566|449497828|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
124964757|NCT01125566|449497829|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
124964758|NCT01125566|449497827|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
124964759|NCT01125566|449497828|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
124964760|NCT01125566|449497829|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
124964761|NCT01125566|449497827|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
124964762|NCT01125566|449497828|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
124969647|NCT01234883|449517433|FG001|Overall Study|Technical difficulties with IV infusion|1|||
124464622|NCT03691974|447659796|FG001|Overall Study|Lost to Follow-up|7|||
124464623|NCT01661140|447659799|FG000|Open-Label Period|Adverse Event|44|||
124464624|NCT01661140|447659800|FG001|Open-Label Period|Adverse Event|0|||
124464625|NCT01661140|447659801|FG002|Open-Label Period|Adverse Event|0|||
124464626|NCT01661140|447659799|FG000|Open-Label Period|Protocol Violation|3|||
124464627|NCT01661140|447659800|FG001|Open-Label Period|Protocol Violation|0|||
124464628|NCT01661140|447659801|FG002|Open-Label Period|Protocol Violation|0|||
124464629|NCT01661140|447659799|FG000|Open-Label Period|Withdrawal by Subject|5|||
124464630|NCT01661140|447659800|FG001|Open-Label Period|Withdrawal by Subject|0|||
124464631|NCT01661140|447659801|FG002|Open-Label Period|Withdrawal by Subject|0|||
124464632|NCT01661140|447659799|FG000|Open-Label Period|Investigator Decision|3|||
124464633|NCT01661140|447659800|FG001|Open-Label Period|Investigator Decision|0|||
124464634|NCT01661140|447659801|FG002|Open-Label Period|Investigator Decision|0|||
124464635|NCT01661140|447659799|FG000|Open-Label Period|Death|1|||
124464636|NCT01661140|447659800|FG001|Open-Label Period|Death|0|||
124464637|NCT01661140|447659801|FG002|Open-Label Period|Death|0|||
124464638|NCT01661140|447659799|FG000|Open-Label Period|Administrative/Other|1|||
124464639|NCT01661140|447659800|FG001|Open-Label Period|Administrative/Other|0|||
124464640|NCT01661140|447659801|FG002|Open-Label Period|Administrative/Other|0|||
124464641|NCT01661140|447659799|FG000|Open-Label Period|Sponsor termination|16|||
124464642|NCT01661140|447659800|FG001|Open-Label Period|Sponsor termination|0|||
124464643|NCT01661140|447659801|FG002|Open-Label Period|Sponsor termination|0|||
124464644|NCT01661140|447659799|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
124464645|NCT01661140|447659800|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
124464646|NCT01661140|447659801|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
124464647|NCT01661140|447659799|FG000|Open-Label Period|Lost to Follow-up|2|||
124464648|NCT01661140|447659800|FG001|Open-Label Period|Lost to Follow-up|0|||
124464649|NCT01661140|447659801|FG002|Open-Label Period|Lost to Follow-up|0|||
124464650|NCT01661140|447659799|FG000|Double-Blind Period|Refused Treatment|0|||
124464651|NCT01661140|447659800|FG001|Double-Blind Period|Refused Treatment|0|||
124464652|NCT01661140|447659801|FG002|Double-Blind Period|Refused Treatment|1|||
124464653|NCT01661140|447659799|FG000|Double-Blind Period|Adverse Event|0|||
124464654|NCT01661140|447659800|FG001|Double-Blind Period|Adverse Event|16|||
124464655|NCT01661140|447659801|FG002|Double-Blind Period|Adverse Event|18|||
124464656|NCT01661140|447659799|FG000|Double-Blind Period|Protocol Violation|0|||
124464657|NCT01661140|447659800|FG001|Double-Blind Period|Protocol Violation|2|||
124464658|NCT01661140|447659801|FG002|Double-Blind Period|Protocol Violation|3|||
124464659|NCT01661140|447659799|FG000|Double-Blind Period|Withdrawal by Subject|0|||
124464660|NCT01661140|447659800|FG001|Double-Blind Period|Withdrawal by Subject|1|||
124464661|NCT01661140|447659801|FG002|Double-Blind Period|Withdrawal by Subject|3|||
124464662|NCT01661140|447659799|FG000|Double-Blind Period|Investigator's Decision|0|||
124464663|NCT01661140|447659800|FG001|Double-Blind Period|Investigator's Decision|1|||
124464664|NCT01661140|447659801|FG002|Double-Blind Period|Investigator's Decision|2|||
124464665|NCT01661140|447659799|FG000|Double-Blind Period|Sponsor Termination|0|||
124464666|NCT01661140|447659800|FG001|Double-Blind Period|Sponsor Termination|14|||
124464667|NCT01661140|447659801|FG002|Double-Blind Period|Sponsor Termination|17|||
124464668|NCT01661140|447659799|FG000|Double-Blind Period|Administrative/Other|0|||
124464669|NCT01661140|447659800|FG001|Double-Blind Period|Administrative/Other|7|||
124464670|NCT01661140|447659801|FG002|Double-Blind Period|Administrative/Other|6|||
124464671|NCT00691483|447659802|FG000|Overall Study|Adverse Event|14|||
124464672|NCT00691483|447659803|FG001|Overall Study|Adverse Event|6|||
124464673|NCT00691483|447659802|FG000|Overall Study|Lost to Follow-up|17|||
124464674|NCT00691483|447659803|FG001|Overall Study|Lost to Follow-up|10|||
124464675|NCT00691483|447659802|FG000|Overall Study|Withdrawal by Subject|24|||
124464676|NCT00691483|447659803|FG001|Overall Study|Withdrawal by Subject|7|||
124464677|NCT00691483|447659802|FG000|Overall Study|Other known cause|6|||
124464678|NCT00691483|447659803|FG001|Overall Study|Other known cause|1|||
124464679|NCT00691483|447659802|FG000|Overall Study|Randomized by not treated|7|||
124464680|NCT00691483|447659803|FG001|Overall Study|Randomized by not treated|1|||
124464681|NCT01391000|447659805|FG000|Overall Study|Lost to Follow-up|2|||
124464682|NCT01391000|447659806|FG001|Overall Study|Lost to Follow-up|0|||
124464683|NCT00049673|447659807|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
124769769|NCT02383576|448785168|FG000|Overall Study|Withdrew Consent|1|||
124709894|NCT01076010|448563060|FG002|Overall Study|Withdrawal by Subject|1|||
124709895|NCT01076010|448563058|FG000|Overall Study|Other|5|||
124709896|NCT01076010|448563059|FG001|Overall Study|Other|2|||
124709897|NCT01076010|448563060|FG002|Overall Study|Other|0|||
124709898|NCT02271529|448563069|FG000|Overall Study|Withdrawal by Subject|1|||
124709899|NCT03507127|448563070|FG000|Overall Study|Withdrawal by Subject|1|||
124709900|NCT03507127|448563071|FG001|Overall Study|Withdrawal by Subject|0|||
124709901|NCT03507127|448563070|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
124709902|NCT03507127|448563071|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
124709903|NCT00907621|448563076|FG000|Overall Study|Lost to Follow-up|6|||
124709904|NCT00907621|448563077|FG001|Overall Study|Lost to Follow-up|3|||
124709905|NCT00907621|448563076|FG000|Overall Study|intercurrent febrile illness|1|||
124709906|NCT00907621|448563077|FG001|Overall Study|intercurrent febrile illness|1|||
124709907|NCT04290624|448563078|FG000|Overall Study|Adverse Event|1|||
124709908|NCT04290624|448563079|FG001|Overall Study|Adverse Event|0|||
124709909|NCT00656370|448563081|FG000|Overall Study|Screen Failures|7|||
124709910|NCT00656370|448563081|FG000|Overall Study|Alternates|3|||
124709911|NCT02121509|448563082|FG000|Washout Period (35 Days)|Adverse Event|1|||
124709912|NCT02121509|448563083|FG001|Washout Period (35 Days)|Adverse Event|1|||
124709913|NCT02121509|448563084|FG002|Washout Period (35 Days)|Adverse Event|0|||
124709914|NCT02121509|448563085|FG003|Washout Period (35 Days)|Adverse Event|0|||
124709915|NCT02121509|448563082|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
124709916|NCT02121509|448563083|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
124709917|NCT02121509|448563084|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
124709918|NCT02121509|448563085|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
124709919|NCT02121509|448563082|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
124709920|NCT02121509|448563083|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
124709921|NCT02121509|448563084|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
124709922|NCT02121509|448563085|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
124709923|NCT03069716|448563088|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
124709924|NCT03069716|448563089|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
124709925|NCT03069716|448563090|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
124709926|NCT03069716|448563088|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
124709927|NCT03069716|448563089|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
124709928|NCT03069716|448563090|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
124709929|NCT03069716|448563088|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
124709930|NCT03069716|448563089|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
124709931|NCT03069716|448563090|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
124709932|NCT03069716|448563088|FG000|Randomized Treatment|Withdrawal by Subject|0|||
124709933|NCT03069716|448563089|FG001|Randomized Treatment|Withdrawal by Subject|2|||
124709934|NCT03069716|448563090|FG002|Randomized Treatment|Withdrawal by Subject|0|||
124709935|NCT03391882|448563091|FG000|Study Overall|Adverse Event|3|||
124709936|NCT03391882|448563092|FG001|Study Overall|Adverse Event|6|||
124709937|NCT03391882|448563093|FG002|Study Overall|Adverse Event|1|||
124709938|NCT03391882|448563094|FG003|Study Overall|Adverse Event|1|||
124709939|NCT03391882|448563095|FG004|Study Overall|Adverse Event|3|||
124709940|NCT03391882|448563096|FG005|Study Overall|Adverse Event|1|||
124709941|NCT03391882|448563091|FG000|Study Overall|Lack of Efficacy|13|||
124709942|NCT03391882|448563092|FG001|Study Overall|Lack of Efficacy|9|||
124709943|NCT03391882|448563093|FG002|Study Overall|Lack of Efficacy|0|||
124709944|NCT03391882|448563094|FG003|Study Overall|Lack of Efficacy|0|||
124709945|NCT03391882|448563095|FG004|Study Overall|Lack of Efficacy|0|||
124709946|NCT03391882|448563096|FG005|Study Overall|Lack of Efficacy|0|||
124709947|NCT03391882|448563091|FG000|Study Overall|Withdrawal by Subject|3|||
124709948|NCT03391882|448563092|FG001|Study Overall|Withdrawal by Subject|3|||
124464684|NCT00049673|447659808|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
124464685|NCT00817531|447659809|FG000|Overall Study|Adverse Event|1|||
124464686|NCT00817531|447659809|FG000|Overall Study|Lack of Efficacy|1|||
124464687|NCT02475681|447659812|FG000|Overall Study|Death|16|||
124464688|NCT02475681|447659813|FG001|Overall Study|Death|6|||
124464689|NCT02475681|447659814|FG002|Overall Study|Death|9|||
124709949|NCT03391882|448563093|FG002|Study Overall|Withdrawal by Subject|2|||
124709950|NCT03391882|448563094|FG003|Study Overall|Withdrawal by Subject|2|||
124709951|NCT03391882|448563095|FG004|Study Overall|Withdrawal by Subject|1|||
124709952|NCT03391882|448563096|FG005|Study Overall|Withdrawal by Subject|3|||
124709953|NCT03391882|448563091|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
124709954|NCT03391882|448563092|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
124709955|NCT03391882|448563093|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
124709956|NCT03391882|448563094|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
124709957|NCT03391882|448563095|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
124709958|NCT03391882|448563096|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
124709959|NCT03391882|448563091|FG000|Study Overall|Protocol Violation|1|||
124709960|NCT03391882|448563092|FG001|Study Overall|Protocol Violation|0|||
124709961|NCT03391882|448563093|FG002|Study Overall|Protocol Violation|0|||
124709962|NCT03391882|448563094|FG003|Study Overall|Protocol Violation|0|||
124709963|NCT03391882|448563095|FG004|Study Overall|Protocol Violation|0|||
124709964|NCT03391882|448563096|FG005|Study Overall|Protocol Violation|0|||
124709965|NCT03391882|448563091|FG000|Part A - Titration Phase|Adverse Event|3|||
124709966|NCT03391882|448563092|FG001|Part A - Titration Phase|Adverse Event|6|||
124709967|NCT03391882|448563093|FG002|Part A - Titration Phase|Adverse Event|0|||
124709968|NCT03391882|448563094|FG003|Part A - Titration Phase|Adverse Event|0|||
124709969|NCT03391882|448563095|FG004|Part A - Titration Phase|Adverse Event|0|||
124709970|NCT03391882|448563096|FG005|Part A - Titration Phase|Adverse Event|0|||
124709971|NCT03391882|448563091|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
124709972|NCT03391882|448563092|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
124709973|NCT03391882|448563093|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
124709974|NCT03391882|448563094|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
124709975|NCT03391882|448563095|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
124709976|NCT03391882|448563096|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
124709977|NCT03391882|448563091|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
124709978|NCT03391882|448563092|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
124709979|NCT03391882|448563093|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
124709980|NCT03391882|448563094|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
124709981|NCT03391882|448563095|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
124709982|NCT03391882|448563096|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
124709983|NCT03391882|448563091|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
124709984|NCT03391882|448563092|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
124709985|NCT03391882|448563093|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
124709986|NCT03391882|448563094|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
124709987|NCT03391882|448563095|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
124709988|NCT03391882|448563096|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
124709989|NCT03391882|448563091|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
124709990|NCT03391882|448563092|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
124709991|NCT03391882|448563093|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
124709992|NCT03391882|448563094|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
124709993|NCT03391882|448563095|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
124709994|NCT03391882|448563096|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
124709995|NCT03391882|448563091|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
124464690|NCT02475681|447659812|FG000|Overall Study|Physician Decision|0|||
124709996|NCT03391882|448563092|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
124769770|NCT02383576|448785169|FG001|Overall Study|Withdrew Consent|6|||
124964763|NCT01125566|449497829|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
124964764|NCT01125566|449497827|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
124964765|NCT01125566|449497828|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
124964766|NCT01125566|449497829|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
124964767|NCT01125566|449497827|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
124964768|NCT01125566|449497828|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
124964769|NCT01125566|449497829|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
124964770|NCT01125566|449497827|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
124964771|NCT01125566|449497828|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
124964772|NCT01125566|449497829|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
124964773|NCT01125566|449497827|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
124964774|NCT01125566|449497828|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
124964775|NCT01125566|449497829|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
124964776|NCT01125566|449497827|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
124964777|NCT01125566|449497828|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
124964778|NCT01125566|449497829|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
124964779|NCT01125566|449497827|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
124964780|NCT01125566|449497828|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
124964781|NCT01125566|449497829|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
124964782|NCT01125566|449497827|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
124964783|NCT01125566|449497828|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
124964784|NCT01125566|449497829|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
124964785|NCT03151551|449497830|FG000|Open-Label Treatment Period|Adverse Event|0|||
124964786|NCT03151551|449497831|FG001|Open-Label Treatment Period|Adverse Event|2|||
124964787|NCT03151551|449497830|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
124964788|NCT03151551|449497831|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
124964789|NCT03151551|449497830|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
124964790|NCT03151551|449497831|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
124964791|NCT03151551|449497830|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
124964792|NCT03151551|449497831|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
124964793|NCT03151551|449497830|FG000|Open-Label Treatment Period|Physician Decision|3|||
124964794|NCT03151551|449497831|FG001|Open-Label Treatment Period|Physician Decision|0|||
124964795|NCT03151551|449497830|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
124964796|NCT03151551|449497831|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
124964797|NCT03151551|449497830|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
124964798|NCT03151551|449497831|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
124964799|NCT03151551|449497830|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
124964800|NCT03151551|449497831|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
124964801|NCT03151551|449497830|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
124964802|NCT03151551|449497831|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
124964803|NCT03151551|449497830|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
124964804|NCT03151551|449497831|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
124964805|NCT00514813|449497832|FG000|Overall Study|Study terminated|14|||
124964806|NCT00514813|449497833|FG001|Overall Study|Study terminated|74|||
124964807|NCT00514813|449497834|FG002|Overall Study|Study terminated|40|||
124964808|NCT00514813|449497835|FG003|Overall Study|Study terminated|2|||
124964809|NCT00514813|449497832|FG000|Overall Study|Adverse Event|0|||
124964810|NCT00514813|449497833|FG001|Overall Study|Adverse Event|2|||
124964811|NCT00514813|449497834|FG002|Overall Study|Adverse Event|2|||
124964812|NCT00514813|449497835|FG003|Overall Study|Adverse Event|0|||
124964813|NCT00514813|449497832|FG000|Overall Study|Protocol Violation|1|||
124964814|NCT00514813|449497833|FG001|Overall Study|Protocol Violation|0|||
124964815|NCT00514813|449497834|FG002|Overall Study|Protocol Violation|0|||
124964816|NCT00514813|449497835|FG003|Overall Study|Protocol Violation|0|||
124964817|NCT00514813|449497832|FG000|Overall Study|Withdrawal by Subject|0|||
124964818|NCT00514813|449497833|FG001|Overall Study|Withdrawal by Subject|1|||
124964819|NCT00514813|449497834|FG002|Overall Study|Withdrawal by Subject|0|||
124964820|NCT00514813|449497835|FG003|Overall Study|Withdrawal by Subject|0|||
124964821|NCT00514813|449497832|FG000|Overall Study|Lack of Efficacy|0|||
124964822|NCT00514813|449497833|FG001|Overall Study|Lack of Efficacy|1|||
124964823|NCT00514813|449497834|FG002|Overall Study|Lack of Efficacy|0|||
124964824|NCT00514813|449497835|FG003|Overall Study|Lack of Efficacy|0|||
124964825|NCT00514813|449497832|FG000|Overall Study|Kidney transplant|0|||
124964826|NCT00514813|449497833|FG001|Overall Study|Kidney transplant|6|||
124964827|NCT00514813|449497834|FG002|Overall Study|Kidney transplant|2|||
124964828|NCT00514813|449497835|FG003|Overall Study|Kidney transplant|0|||
124964829|NCT00514813|449497832|FG000|Overall Study|Death|0|||
124964830|NCT00514813|449497833|FG001|Overall Study|Death|2|||
124964831|NCT00514813|449497834|FG002|Overall Study|Death|3|||
124964832|NCT00514813|449497835|FG003|Overall Study|Death|2|||
124549863|NCT03428217|447968973|FG001|Overall Study|Other, Not Specified|0|||
124549864|NCT03889197|447968974|FG000|Overall Study|Withdrawal by Subject|1|||
124549865|NCT03889197|447968975|FG001|Overall Study|Withdrawal by Subject|0|||
124549866|NCT03889197|447968974|FG000|Overall Study|Physician Decision|0|||
124549867|NCT03889197|447968975|FG001|Overall Study|Physician Decision|1|||
124549868|NCT03889197|447968974|FG000|Overall Study|met exclusion criteria|0|||
124549869|NCT03889197|447968975|FG001|Overall Study|met exclusion criteria|1|||
124549870|NCT03889197|447968974|FG000|Overall Study|Protocol Violation|1|||
124549871|NCT03889197|447968975|FG001|Overall Study|Protocol Violation|0|||
124549872|NCT05246111|447968976|FG000|Period 01|NOT ELIGIBLE IC5|1|||
124549873|NCT05246111|447968977|FG001|Period 01|NOT ELIGIBLE IC5|0|||
124549874|NCT05473247|447968978|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
124549875|NCT03078192|447968980|FG000|Overall Study|Withdrawal by Subject|2|||
124549876|NCT03078192|447968981|FG001|Overall Study|Withdrawal by Subject|1|||
124549877|NCT03078192|447968980|FG000|Overall Study|screen failure|0|||
124549878|NCT03078192|447968981|FG001|Overall Study|screen failure|3|||
124549879|NCT02508649|447968984|FG000|Overall Study|Withdrawal by Subject|4|||
124549880|NCT02508649|447968985|FG001|Overall Study|Withdrawal by Subject|6|||
124549881|NCT02508649|447968986|FG002|Overall Study|Withdrawal by Subject|5|||
124549882|NCT02508649|447968987|FG003|Overall Study|Withdrawal by Subject|6|||
124549883|NCT02508649|447968984|FG000|Overall Study|Investigator withdrew the subject|1|||
124549884|NCT02508649|447968985|FG001|Overall Study|Investigator withdrew the subject|2|||
124549885|NCT02508649|447968986|FG002|Overall Study|Investigator withdrew the subject|1|||
124549886|NCT02508649|447968987|FG003|Overall Study|Investigator withdrew the subject|0|||
124549887|NCT02508649|447968984|FG000|Overall Study|Post randomization screening failure|12|||
124964833|NCT02979613|449497836|FG000|Double-Blind Phase|Withdrew Consent|2|||
124964834|NCT02979613|449497837|FG001|Double-Blind Phase|Withdrew Consent|4|||
124964835|NCT02979613|449497836|FG000|Double-Blind Phase|Pregnancy|2|||
124964836|NCT02979613|449497837|FG001|Double-Blind Phase|Pregnancy|2|||
124964837|NCT02979613|449497836|FG000|Double-Blind Phase|Adverse Event|2|||
124964838|NCT02979613|449497837|FG001|Double-Blind Phase|Adverse Event|0|||
124964839|NCT02979613|449497836|FG000|Double-Blind Phase|Lost to Follow-up|1|||
124964840|NCT02979613|449497837|FG001|Double-Blind Phase|Lost to Follow-up|1|||
124964841|NCT02979613|449497836|FG000|Double-Blind Phase|Protocol Violation|1|||
124964842|NCT02979613|449497837|FG001|Double-Blind Phase|Protocol Violation|1|||
124964843|NCT02979613|449497836|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
124964844|NCT02979613|449497837|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
124964845|NCT02979613|449497836|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
124964846|NCT02979613|449497837|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
124964847|NCT02979613|449497836|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
124964848|NCT02979613|449497837|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
124964849|NCT02979613|449497836|FG000|Open-Label Extension (OLE) Phase|Death|0|||
124964850|NCT02979613|449497837|FG001|Open-Label Extension (OLE) Phase|Death|1|||
124964851|NCT02979613|449497836|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
124964852|NCT02979613|449497837|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
124964853|NCT01075100|449497840|FG000|Overall Study|Adverse Event|15|||
124964854|NCT01075100|449497841|FG001|Overall Study|Adverse Event|18|||
124964855|NCT01075100|449497840|FG000|Overall Study|Patient Request|4|||
124964856|NCT01075100|449497841|FG001|Overall Study|Patient Request|4|||
124964857|NCT01075100|449497840|FG000|Overall Study|Investigator Request|2|||
124964858|NCT01075100|449497841|FG001|Overall Study|Investigator Request|1|||
124964859|NCT01075100|449497840|FG000|Overall Study|Disease Progression|25|||
124964860|NCT01075100|449497841|FG001|Overall Study|Disease Progression|29|||
124964861|NCT01075100|449497840|FG000|Overall Study|Other|3|||
124964862|NCT01075100|449497841|FG001|Overall Study|Other|1|||
124964863|NCT02250183|449497842|FG000|Overall Study|Withdrawal by Subject|2|||
124964864|NCT02250183|449497842|FG000|Overall Study|Adverse Event|5|||
124964865|NCT02250183|449497842|FG000|Overall Study|Lost to Follow-up|1|||
124964866|NCT03282799|449497843|FG000|Overall Study|Pregnancy|1|||
124964867|NCT03282799|449497844|FG001|Overall Study|Pregnancy|0|||
124964868|NCT03282799|449497843|FG000|Overall Study|Physician Decision|1|||
124964869|NCT03282799|449497844|FG001|Overall Study|Physician Decision|0|||
124964870|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
124549888|NCT02508649|447968985|FG001|Overall Study|Post randomization screening failure|4|||
124549889|NCT02508649|447968986|FG002|Overall Study|Post randomization screening failure|9|||
124549890|NCT02508649|447968987|FG003|Overall Study|Post randomization screening failure|3|||
124549891|NCT02508649|447968984|FG000|Overall Study|Lost to Follow-up|1|||
124549892|NCT02508649|447968985|FG001|Overall Study|Lost to Follow-up|1|||
124709997|NCT03391882|448563093|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
124964871|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
124964872|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
124964873|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
124964874|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
124964875|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
124464691|NCT02475681|447659813|FG001|Overall Study|Physician Decision|3|||
124464692|NCT02475681|447659814|FG002|Overall Study|Physician Decision|1|||
124464693|NCT02475681|447659812|FG000|Overall Study|Withdrawal by Subject|12|||
124464694|NCT02475681|447659813|FG001|Overall Study|Withdrawal by Subject|6|||
124464695|NCT02475681|447659814|FG002|Overall Study|Withdrawal by Subject|9|||
124464696|NCT02475681|447659812|FG000|Overall Study|Lost to Follow-up|2|||
124464697|NCT02475681|447659813|FG001|Overall Study|Lost to Follow-up|1|||
124464698|NCT02475681|447659814|FG002|Overall Study|Lost to Follow-up|3|||
124464699|NCT02475681|447659812|FG000|Overall Study|Ongoing in Study|0|||
124464700|NCT02475681|447659813|FG001|Overall Study|Ongoing in Study|163|||
124464701|NCT02475681|447659814|FG002|Overall Study|Ongoing in Study|157|||
124549893|NCT02508649|447968986|FG002|Overall Study|Lost to Follow-up|0|||
124964876|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
124964877|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
124964878|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
124964879|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
124964880|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
124964881|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
124964882|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
124964883|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
124964884|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
124964885|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
124964886|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
124964887|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
124964888|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
124964889|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
124964890|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
124964891|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
124964892|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
124964893|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
124964894|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
124964895|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
124964896|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
124964897|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
124964898|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
124964899|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
124964900|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
124964901|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
124964902|NCT00092521|449499213|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
124964903|NCT00092521|449499214|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
124964904|NCT00092521|449499215|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
124964905|NCT00092521|449499216|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
124964906|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
124964907|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
124964908|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
124964909|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
124964910|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
124964911|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
124964912|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
124964913|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
124964914|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
124964915|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
124964916|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
124964917|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
124964918|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Death|2|||
124964919|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Death|0|||
124964920|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Death|1|||
124964921|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Death|0|||
124964922|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
124964923|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
124964924|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
124964925|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
124964926|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
124964927|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
124464702|NCT02475681|447659812|FG000|Overall Study|Reasons other than above listed|2|||
124464703|NCT02475681|447659813|FG001|Overall Study|Reasons other than above listed|0|||
124464704|NCT02475681|447659814|FG002|Overall Study|Reasons other than above listed|0|||
124464705|NCT03325673|447659824|FG000|Overall Study|Adverse Event|4|||
124964928|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
124964929|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
124964930|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
124964931|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
124964932|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
124964933|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
124964934|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Moved|32|||
124964935|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Moved|2|||
124964936|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Moved|28|||
124964937|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Moved|0|||
124964938|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
124964939|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
124964940|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
124964941|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
124964942|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Travel|2|||
124964943|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Travel|0|||
124964944|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Travel|0|||
124964945|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Travel|0|||
124964946|NCT00092521|449499213|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
124964947|NCT00092521|449499214|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
124964948|NCT00092521|449499215|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
124964949|NCT00092521|449499216|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
124964950|NCT00092521|449499213|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
124964951|NCT00092521|449499214|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
124964952|NCT00092521|449499215|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
124964953|NCT00092521|449499216|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
124964954|NCT00092521|449499213|FG000|Extension Study (Group 4)|Adverse Event|0|||
124964955|NCT00092521|449499214|FG001|Extension Study (Group 4)|Adverse Event|0|||
124964956|NCT00092521|449499215|FG002|Extension Study (Group 4)|Adverse Event|0|||
124964957|NCT00092521|449499216|FG003|Extension Study (Group 4)|Adverse Event|2|||
124964958|NCT00092521|449499213|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
124964959|NCT00092521|449499214|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
124964960|NCT00092521|449499215|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
124964961|NCT00092521|449499216|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
124964962|NCT00092521|449499213|FG000|Extension Study (Group 4)|Pregnancy|0|||
124964963|NCT00092521|449499214|FG001|Extension Study (Group 4)|Pregnancy|0|||
124964964|NCT00092521|449499215|FG002|Extension Study (Group 4)|Pregnancy|0|||
124964965|NCT00092521|449499216|FG003|Extension Study (Group 4)|Pregnancy|4|||
124964966|NCT00092521|449499213|FG000|Extension Study (Group 4)|Protocol Violation|0|||
124964967|NCT00092521|449499214|FG001|Extension Study (Group 4)|Protocol Violation|0|||
124964968|NCT00092521|449499215|FG002|Extension Study (Group 4)|Protocol Violation|0|||
124964969|NCT00092521|449499216|FG003|Extension Study (Group 4)|Protocol Violation|2|||
124964970|NCT00092521|449499213|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
124964971|NCT00092521|449499214|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
124964972|NCT00092521|449499215|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
124964973|NCT00092521|449499216|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
124964974|NCT00092521|449499213|FG000|Extension Study (Group 4)|Moved|0|||
124964975|NCT00092521|449499214|FG001|Extension Study (Group 4)|Moved|0|||
124964976|NCT00092521|449499215|FG002|Extension Study (Group 4)|Moved|0|||
124964977|NCT00092521|449499216|FG003|Extension Study (Group 4)|Moved|16|||
124549894|NCT02508649|447968987|FG003|Overall Study|Lost to Follow-up|1|||
124549895|NCT03594175|447968995|FG000|Overall Study|Not treated|8|||
124549896|NCT03594175|447968996|FG001|Overall Study|Not treated|1|||
124549897|NCT03594175|447968997|FG002|Overall Study|Not treated|5|||
124549898|NCT03594175|447968995|FG000|Overall Study|Adverse Event|3|||
124549899|NCT03594175|447968996|FG001|Overall Study|Adverse Event|0|||
124549900|NCT03594175|447968997|FG002|Overall Study|Adverse Event|0|||
124549901|NCT03594175|447968995|FG000|Overall Study|Withdrawal by Subject|3|||
124549902|NCT03594175|447968996|FG001|Overall Study|Withdrawal by Subject|0|||
124549903|NCT03594175|447968997|FG002|Overall Study|Withdrawal by Subject|0|||
124549904|NCT03594175|447968995|FG000|Overall Study|Protocol Violation|2|||
124549905|NCT03594175|447968996|FG001|Overall Study|Protocol Violation|2|||
124549906|NCT03594175|447968997|FG002|Overall Study|Protocol Violation|2|||
124549907|NCT01915498|447968998|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
124549908|NCT01915498|447968999|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
124549909|NCT01915498|447969000|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
124549910|NCT01915498|447969001|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
124549911|NCT01915498|447969002|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
124549912|NCT01915498|447969003|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
124549913|NCT01915498|447969004|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
124549914|NCT01915498|447969005|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
124549915|NCT01915498|447969006|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
124549916|NCT01915498|447969007|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
124549917|NCT01915498|447969008|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
124549918|NCT01915498|447969009|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
124549919|NCT01915498|447969010|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
124549920|NCT01915498|447969011|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
124464706|NCT03325673|447659825|FG001|Overall Study|Adverse Event|0|||
124964978|NCT00092521|449499213|FG000|Extension Study (Group 4)|Site Terminated|0|||
124964979|NCT00092521|449499214|FG001|Extension Study (Group 4)|Site Terminated|0|||
124964980|NCT00092521|449499215|FG002|Extension Study (Group 4)|Site Terminated|0|||
124964981|NCT00092521|449499216|FG003|Extension Study (Group 4)|Site Terminated|4|||
124964982|NCT00092521|449499213|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
124964983|NCT00092521|449499214|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
124964984|NCT00092521|449499215|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
124964985|NCT00092521|449499216|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
124964986|NCT03475056|449499217|FG000|Overall Study|Lost to Follow-up|0|||
124964987|NCT03475056|449499218|FG001|Overall Study|Lost to Follow-up|1|||
124964988|NCT03475056|449499217|FG000|Overall Study|Moved from Area|0|||
124964989|NCT03475056|449499218|FG001|Overall Study|Moved from Area|2|||
124964990|NCT01932762|449499219|FG000|Overall Study|Withdrawal by Subject|1|||
124964991|NCT01932762|449499220|FG001|Overall Study|Withdrawal by Subject|2|||
124964992|NCT01932762|449499221|FG002|Overall Study|Withdrawal by Subject|0|||
124964993|NCT01932762|449499222|FG003|Overall Study|Withdrawal by Subject|0|||
124964994|NCT01932762|449499219|FG000|Overall Study|Lost to Follow-up|4|||
124964995|NCT01932762|449499220|FG001|Overall Study|Lost to Follow-up|0|||
124964996|NCT01932762|449499221|FG002|Overall Study|Lost to Follow-up|0|||
124964997|NCT01932762|449499222|FG003|Overall Study|Lost to Follow-up|1|||
124964998|NCT01932762|449499219|FG000|Overall Study|Physician Decision|1|||
124964999|NCT01932762|449499220|FG001|Overall Study|Physician Decision|0|||
124965000|NCT01932762|449499221|FG002|Overall Study|Physician Decision|0|||
124965001|NCT01932762|449499222|FG003|Overall Study|Physician Decision|0|||
124965002|NCT01101334|449499226|FG000|Overall Study|Adverse Event|9|||
124965003|NCT01101334|449499227|FG001|Overall Study|Adverse Event|4|||
124965004|NCT01101334|449499226|FG000|Overall Study|Death|7|||
124965005|NCT01101334|449499227|FG001|Overall Study|Death|1|||
124965006|NCT01101334|449499226|FG000|Overall Study|Withdrawal by Subject|4|||
124965007|NCT01101334|449499227|FG001|Overall Study|Withdrawal by Subject|3|||
124965008|NCT01101334|449499226|FG000|Overall Study|Withdrawal by Sponsor|1|||
124965009|NCT01101334|449499227|FG001|Overall Study|Withdrawal by Sponsor|1|||
124965010|NCT01101334|449499226|FG000|Overall Study|Progressive Disease|22|||
124965011|NCT01101334|449499227|FG001|Overall Study|Progressive Disease|35|||
124965012|NCT01101334|449499226|FG000|Overall Study|Other|2|||
124965013|NCT01101334|449499227|FG001|Overall Study|Other|1|||
124965014|NCT03864341|449499230|FG000|Overall Study|Withdrawal by Subject|1|||
124965015|NCT00612352|449499233|FG000|Overall Study|Adverse Event|1|||
124965016|NCT00612352|449499234|FG001|Overall Study|Adverse Event|0|||
124965017|NCT00612352|449499233|FG000|Overall Study|Withdrawal by Subject|3|||
124965018|NCT00612352|449499234|FG001|Overall Study|Withdrawal by Subject|5|||
124965019|NCT00612352|449499233|FG000|Overall Study|moved out of state|1|||
124965020|NCT00612352|449499234|FG001|Overall Study|moved out of state|0|||
124965021|NCT00612352|449499233|FG000|Overall Study|didn't return calls/show up on test date|4|||
124965022|NCT00612352|449499234|FG001|Overall Study|didn't return calls/show up on test date|1|||
124965023|NCT02161406|449499235|FG000|Overall Study|Death|2|||
124965024|NCT02161406|449499236|FG001|Overall Study|Death|1|||
124965025|NCT02161406|449499235|FG000|Overall Study|Lost to Follow-up|2|||
124965026|NCT02161406|449499236|FG001|Overall Study|Lost to Follow-up|1|||
124965027|NCT02161406|449499235|FG000|Overall Study|Withdrawal by Subject|2|||
124965028|NCT02161406|449499236|FG001|Overall Study|Withdrawal by Subject|4|||
124965029|NCT02161406|449499235|FG000|Overall Study|investigator withdrew subject|3|||
124965030|NCT02161406|449499236|FG001|Overall Study|investigator withdrew subject|1|||
124965031|NCT02161406|449499235|FG000|Overall Study|Lack of Efficacy|1|||
124965032|NCT02161406|449499236|FG001|Overall Study|Lack of Efficacy|1|||
124965033|NCT02161406|449499235|FG000|Overall Study|relocation|0|||
124965034|NCT02161406|449499236|FG001|Overall Study|relocation|1|||
124965035|NCT02034162|449499237|FG000|Double-blind|Lost to Follow-up|3|||
124965036|NCT02034162|449499238|FG001|Double-blind|Lost to Follow-up|0|||
124965037|NCT02034162|449499239|FG002|Double-blind|Lost to Follow-up|0|||
124965038|NCT02034162|449499237|FG000|Double-blind|Physician Decision|1|||
124965039|NCT02034162|449499238|FG001|Double-blind|Physician Decision|0|||
124965040|NCT02034162|449499239|FG002|Double-blind|Physician Decision|0|||
124965041|NCT02034162|449499237|FG000|Double-blind|Protocol Violation|0|||
124965042|NCT02034162|449499238|FG001|Double-blind|Protocol Violation|1|||
124965043|NCT02034162|449499239|FG002|Double-blind|Protocol Violation|0|||
124965044|NCT02034162|449499237|FG000|Double-blind|Withdrawal by Subject|5|||
124965045|NCT02034162|449499238|FG001|Double-blind|Withdrawal by Subject|7|||
124965046|NCT02034162|449499239|FG002|Double-blind|Withdrawal by Subject|0|||
124965047|NCT03458728|449499241|FG000|Overall Study|Adverse Event|1|||
124965048|NCT03458728|449499242|FG001|Overall Study|Adverse Event|0|||
124965049|NCT03458728|449499241|FG000|Overall Study|Physician Decision|1|||
124965050|NCT03458728|449499242|FG001|Overall Study|Physician Decision|0|||
124965051|NCT03458728|449499241|FG000|Overall Study|Progressive disease - clinical assessment|1|||
124965052|NCT03458728|449499242|FG001|Overall Study|Progressive disease - clinical assessment|0|||
124965053|NCT03458728|449499241|FG000|Overall Study|Progressive disease - radiological progression|21|||
124709998|NCT03391882|448563094|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
124709999|NCT03391882|448563095|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
124710000|NCT03391882|448563096|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
124710001|NCT03391882|448563091|FG000|Part B - Treatment Phase|Adverse Event|0|||
124710002|NCT03391882|448563092|FG001|Part B - Treatment Phase|Adverse Event|0|||
124710003|NCT03391882|448563093|FG002|Part B - Treatment Phase|Adverse Event|1|||
124710004|NCT03391882|448563094|FG003|Part B - Treatment Phase|Adverse Event|1|||
124710005|NCT03391882|448563095|FG004|Part B - Treatment Phase|Adverse Event|3|||
124710006|NCT03391882|448563096|FG005|Part B - Treatment Phase|Adverse Event|1|||
124710007|NCT03391882|448563091|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
124710008|NCT03391882|448563092|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
124710009|NCT03391882|448563093|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
124710010|NCT03391882|448563094|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
124710011|NCT03391882|448563095|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
124710012|NCT03391882|448563096|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
124710013|NCT03913130|448563097|FG000|Overall Study|Sponsor Decision|1|||
124710014|NCT01492426|448565277|FG000|Treatment|Death|0|||
124710015|NCT01492426|448565278|FG001|Treatment|Death|1|||
124710016|NCT01492426|448565277|FG000|Treatment|Other|1|||
124710017|NCT01492426|448565278|FG001|Treatment|Other|0|||
124710018|NCT01492426|448565277|FG000|Treatment|Adverse Event|25|||
124710019|NCT01492426|448565278|FG001|Treatment|Adverse Event|25|||
124710020|NCT01492426|448565277|FG000|Treatment|Lack of Efficacy|38|||
124710021|NCT01492426|448565278|FG001|Treatment|Lack of Efficacy|5|||
124710022|NCT01492426|448565277|FG000|Treatment|Participant withdrew consent|1|||
124710023|NCT01492426|448565278|FG001|Treatment|Participant withdrew consent|2|||
124710024|NCT01492426|448565277|FG000|Treatment|Poor compliance/noncompliance|1|||
124710025|NCT01492426|448565278|FG001|Treatment|Poor compliance/noncompliance|0|||
124710026|NCT01492426|448565277|FG000|Treatment|Subject requested discontinue study drug|7|||
124710027|NCT01492426|448565278|FG001|Treatment|Subject requested discontinue study drug|3|||
124710028|NCT01492426|448565277|FG000|Treatment|Lost to Follow-up|9|||
124710029|NCT01492426|448565278|FG001|Treatment|Lost to Follow-up|4|||
124710030|NCT01492426|448565277|FG000|Treatment|Participant does not meet study criteria|1|||
124710031|NCT01492426|448565278|FG001|Treatment|Participant does not meet study criteria|0|||
124710032|NCT01492426|448565277|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
124710033|NCT01492426|448565278|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
124710034|NCT01492426|448565277|FG000|Follow-Up|Death|1|||
124710035|NCT01492426|448565278|FG001|Follow-Up|Death|0|||
124710036|NCT01492426|448565277|FG000|Follow-Up|Other|4|||
124710037|NCT01492426|448565278|FG001|Follow-Up|Other|2|||
124710038|NCT01492426|448565277|FG000|Follow-Up|Participant Withdrew Consent|6|||
124710039|NCT01492426|448565278|FG001|Follow-Up|Participant Withdrew Consent|1|||
124710040|NCT01492426|448565277|FG000|Follow-Up|Lost to Follow-up|12|||
124710041|NCT01492426|448565278|FG001|Follow-Up|Lost to Follow-up|6|||
124710042|NCT00322049|448565279|FG000|Overall Study|Moved out of area|0|||
124710043|NCT00322049|448565280|FG001|Overall Study|Moved out of area|0|||
124710044|NCT00322049|448565281|FG002|Overall Study|Moved out of area|0|||
124710045|NCT00322049|448565282|FG003|Overall Study|Moved out of area|1|||
124710046|NCT00322049|448565279|FG000|Overall Study|Infected with Dengue during study|0|||
124710047|NCT00322049|448565280|FG001|Overall Study|Infected with Dengue during study|1|||
124710048|NCT00322049|448565281|FG002|Overall Study|Infected with Dengue during study|0|||
124710049|NCT00322049|448565282|FG003|Overall Study|Infected with Dengue during study|0|||
124710050|NCT01978145|448565283|FG000|Treatment Period 1|Adverse Event|1|||
124710051|NCT01978145|448565284|FG001|Treatment Period 1|Adverse Event|9|||
124710052|NCT01978145|448565283|FG000|Treatment Period 1|Physician Decision|1|||
124710053|NCT01978145|448565284|FG001|Treatment Period 1|Physician Decision|0|||
124710054|NCT01978145|448565283|FG000|Treatment Period 1|Withdrawal by Subject|5|||
124549921|NCT01915498|447969012|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
124549922|NCT01915498|447969013|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
124549923|NCT01915498|447969014|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
124549924|NCT01915498|447969015|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
124549925|NCT01915498|447969016|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
124549926|NCT01915498|447968998|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
124549927|NCT01915498|447968999|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
124549928|NCT01915498|447969000|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
124549929|NCT01915498|447969001|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
124549930|NCT01915498|447969002|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
124549931|NCT01915498|447969003|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
124549932|NCT01915498|447969004|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
124549933|NCT01915498|447969005|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
124549934|NCT01915498|447969006|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
124549935|NCT01915498|447969007|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
124549936|NCT01915498|447969008|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
124549937|NCT01915498|447969009|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
124549938|NCT01915498|447969010|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
124549939|NCT01915498|447969011|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
124549940|NCT01915498|447969012|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
124549941|NCT01915498|447969013|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
124549942|NCT01915498|447969014|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
124549943|NCT01915498|447969015|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
124549944|NCT01915498|447969016|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
124549945|NCT01915498|447968998|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
124549946|NCT01915498|447968999|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
124549947|NCT01915498|447969000|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
124549948|NCT01915498|447969001|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
124549949|NCT01915498|447969002|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
124549950|NCT01915498|447969003|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
124549951|NCT01915498|447969004|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
124549952|NCT01915498|447969005|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
124549953|NCT01915498|447969006|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
124549954|NCT01915498|447969007|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
124549955|NCT01915498|447969008|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
124549956|NCT01915498|447969009|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
124549957|NCT01915498|447969010|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
124464707|NCT01659320|447659826|FG000|Overall Study|Withdrawal by Subject|2|||
124464708|NCT01659320|447659826|FG000|Overall Study|Physician Decision|1|||
124464709|NCT00590590|447659827|FG000|Overall Study|Lack of Efficacy|1|||
124464710|NCT00590590|447659828|FG001|Overall Study|Lack of Efficacy|2|||
124464711|NCT00590590|447659829|FG002|Overall Study|Lack of Efficacy|0|||
124464712|NCT00590590|447659827|FG000|Overall Study|Adverse Event|1|||
124464713|NCT00590590|447659828|FG001|Overall Study|Adverse Event|0|||
124464714|NCT00590590|447659829|FG002|Overall Study|Adverse Event|0|||
124464715|NCT00590590|447659827|FG000|Overall Study|Protocol Violation|0|||
124710055|NCT01978145|448565284|FG001|Treatment Period 1|Withdrawal by Subject|4|||
124710056|NCT01978145|448565283|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
124710057|NCT01978145|448565284|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
124710058|NCT01978145|448565283|FG000|Washout Period 1|Adverse Event|0|||
124464716|NCT00590590|447659828|FG001|Overall Study|Protocol Violation|0|||
124710059|NCT01978145|448565284|FG001|Washout Period 1|Adverse Event|1|||
124710060|NCT01978145|448565283|FG000|Washout Period 1|Withdrawal by Subject|1|||
124710061|NCT01978145|448565284|FG001|Washout Period 1|Withdrawal by Subject|1|||
124710062|NCT01978145|448565283|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
124710063|NCT01978145|448565284|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
124710064|NCT01978145|448565283|FG000|Treatment Period 2|Adverse Event|3|||
124710065|NCT01978145|448565284|FG001|Treatment Period 2|Adverse Event|3|||
124710066|NCT01978145|448565283|FG000|Treatment Period 2|Protocol Violation|0|||
124464717|NCT00590590|447659829|FG002|Overall Study|Protocol Violation|2|||
124549958|NCT01915498|447969011|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
124549959|NCT01915498|447969012|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
124549960|NCT01915498|447969013|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
124464718|NCT00590590|447659827|FG000|Overall Study|Lost to Follow-up|4|||
124464719|NCT00590590|447659828|FG001|Overall Study|Lost to Follow-up|1|||
124464720|NCT00590590|447659829|FG002|Overall Study|Lost to Follow-up|2|||
124464721|NCT00590590|447659827|FG000|Overall Study|Withdrawal by Subject|0|||
124464722|NCT00590590|447659828|FG001|Overall Study|Withdrawal by Subject|1|||
124464723|NCT00590590|447659829|FG002|Overall Study|Withdrawal by Subject|1|||
124965054|NCT03458728|449499242|FG001|Overall Study|Progressive disease - radiological progression|6|||
124965055|NCT03458728|449499241|FG000|Overall Study|Withdrawal by Subject|0|||
124965056|NCT03458728|449499242|FG001|Overall Study|Withdrawal by Subject|1|||
124965057|NCT00858247|449499244|FG000|Baseline Assessment|Withdrawal by Subject|1|||
124965058|NCT00858247|449499245|FG001|Baseline Assessment|Withdrawal by Subject|1|||
124965059|NCT00858247|449499244|FG000|Baseline Assessment|Poor IV access|1|||
124965060|NCT00858247|449499245|FG001|Baseline Assessment|Poor IV access|0|||
124965061|NCT00858247|449499244|FG000|Baseline Assessment|Protocol Violation|0|||
124965062|NCT00858247|449499245|FG001|Baseline Assessment|Protocol Violation|1|||
124965063|NCT00858247|449499244|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
124965064|NCT00858247|449499245|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
124965065|NCT00337285|449499246|FG000|Overall Study|Withdrawal by Subject|42|||
124965066|NCT00337285|449499246|FG000|Overall Study|Lost to Follow-up|41|||
124965067|NCT00337285|449499246|FG000|Overall Study|Adverse Event|28|||
124965068|NCT00337285|449499246|FG000|Overall Study|Protocol Violation|27|||
124965069|NCT00337285|449499246|FG000|Overall Study|Lack of Efficacy|11|||
124965070|NCT00337285|449499246|FG000|Overall Study|Death|1|||
124965071|NCT00337285|449499246|FG000|Overall Study|Physician Decision|1|||
124965072|NCT00337285|449499246|FG000|Overall Study|Lack of protocol compliance|7|||
124965073|NCT00553605|449499247|FG000|Overall Study|Did not meet entrance criteria|1|||
124965074|NCT00553605|449499248|FG001|Overall Study|Did not meet entrance criteria|3|||
124965075|NCT00553605|449499247|FG000|Overall Study|Did not receive full dose|1|||
124965076|NCT00553605|449499248|FG001|Overall Study|Did not receive full dose|0|||
124965077|NCT00553605|449499247|FG000|Overall Study|Randomized but not treated|2|||
124965078|NCT00553605|449499248|FG001|Overall Study|Randomized but not treated|0|||
124965079|NCT03481556|449499249|FG000|Overall Study|Adverse Event|1|||
124965080|NCT03481556|449499250|FG001|Overall Study|Adverse Event|0|||
124965081|NCT03481556|449499251|FG002|Overall Study|Adverse Event|0|||
124965082|NCT03481556|449499252|FG003|Overall Study|Adverse Event|0|||
124965083|NCT03481556|449499249|FG000|Overall Study|Death|4|||
124965084|NCT03481556|449499250|FG001|Overall Study|Death|2|||
124965085|NCT03481556|449499251|FG002|Overall Study|Death|3|||
124965086|NCT03481556|449499252|FG003|Overall Study|Death|16|||
124965087|NCT03481556|449499249|FG000|Overall Study|Study Terminated by Sponsor|10|||
124965088|NCT03481556|449499250|FG001|Overall Study|Study Terminated by Sponsor|5|||
124965089|NCT03481556|449499251|FG002|Overall Study|Study Terminated by Sponsor|2|||
124965090|NCT03481556|449499252|FG003|Overall Study|Study Terminated by Sponsor|9|||
124965091|NCT01085812|449499253|FG000|Open-Label Period|Adverse Event|0|||
124965092|NCT01085812|449499254|FG001|Open-Label Period|Adverse Event|80|||
124965093|NCT01085812|449499253|FG000|Open-Label Period|Lack of Efficacy|0|||
124965094|NCT01085812|449499254|FG001|Open-Label Period|Lack of Efficacy|26|||
124965095|NCT01085812|449499253|FG000|Open-Label Period|Protocol Violation|0|||
124965096|NCT01085812|449499254|FG001|Open-Label Period|Protocol Violation|39|||
124965097|NCT01085812|449499253|FG000|Open-Label Period|Withdrawal by Subject|0|||
124965098|NCT01085812|449499254|FG001|Open-Label Period|Withdrawal by Subject|53|||
124965099|NCT01085812|449499253|FG000|Open-Label Period|Lost to Follow-up|0|||
124965100|NCT01085812|449499254|FG001|Open-Label Period|Lost to Follow-up|42|||
124965101|NCT01085812|449499253|FG000|Double-Blind Period|Adverse Event|3|||
124965102|NCT01085812|449499254|FG001|Double-Blind Period|Adverse Event|8|||
124965103|NCT01085812|449499253|FG000|Double-Blind Period|Protocol Violation|2|||
124965104|NCT01085812|449499254|FG001|Double-Blind Period|Protocol Violation|7|||
124965105|NCT01085812|449499253|FG000|Double-Blind Period|Withdrawal by Subject|11|||
124965106|NCT01085812|449499254|FG001|Double-Blind Period|Withdrawal by Subject|24|||
124965107|NCT01085812|449499253|FG000|Double-Blind Period|Lost to Follow-up|5|||
124965108|NCT01085812|449499254|FG001|Double-Blind Period|Lost to Follow-up|17|||
124965109|NCT01085812|449499253|FG000|Double-Blind Period|Other Reasons|0|||
124965110|NCT01085812|449499254|FG001|Double-Blind Period|Other Reasons|2|||
124965111|NCT01085812|449499253|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
124965112|NCT01085812|449499254|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
124965113|NCT01085812|449499253|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
124965114|NCT01085812|449499254|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
124965115|NCT01085812|449499253|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
124965116|NCT01085812|449499254|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
124965117|NCT01085812|449499253|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
124965118|NCT01085812|449499254|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
124965119|NCT01085812|449499253|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
124965120|NCT01085812|449499254|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
124965121|NCT01101997|449499255|FG000|Overall Study|Withdrawal by Subject|2|||
124965122|NCT02669407|449499258|FG000|Overall Study|Physician Decision|3|||
124965123|NCT03634839|449499259|FG000|First Intervention (2 Hours)|Adverse Event|0|||
124965124|NCT03634839|449499260|FG001|First Intervention (2 Hours)|Adverse Event|2|||
124965125|NCT00350298|449499261|FG000|Overall Study|Death|7|||
124965126|NCT00350298|449499262|FG001|Overall Study|Death|8|||
124965127|NCT00350298|449499261|FG000|Overall Study|Lost to Follow-up|1|||
124965128|NCT00350298|449499262|FG001|Overall Study|Lost to Follow-up|2|||
124965129|NCT00350298|449499261|FG000|Overall Study|Withdrawal by Subject|1|||
124965130|NCT00350298|449499262|FG001|Overall Study|Withdrawal by Subject|3|||
124965131|NCT02447432|449499263|FG000|Epoch 001|Adverse Event|1|||
124965132|NCT02447432|449499264|FG001|Epoch 001|Adverse Event|1|||
124965133|NCT02447432|449499263|FG000|Epoch 001|Withdrawal by Subject|0|||
124965134|NCT02447432|449499264|FG001|Epoch 001|Withdrawal by Subject|4|||
124965135|NCT02447432|449499263|FG000|Epoch 001|Migrated/moved from study area|3|||
124965136|NCT02447432|449499264|FG001|Epoch 001|Migrated/moved from study area|5|||
124965137|NCT02447432|449499263|FG000|Epoch 001|Lost to Follow-up|1|||
124965138|NCT02447432|449499264|FG001|Epoch 001|Lost to Follow-up|3|||
124965139|NCT02647788|449499265|FG000|Overall Study|Lost to Follow-up|13|||
124965140|NCT02647788|449499266|FG001|Overall Study|Lost to Follow-up|11|||
124965141|NCT02647788|449499265|FG000|Overall Study|Did not want opiate|0|||
124965142|NCT02647788|449499266|FG001|Overall Study|Did not want opiate|1|||
124965143|NCT02647788|449499265|FG000|Overall Study|Withdrawal by Subject|1|||
124965144|NCT02647788|449499266|FG001|Overall Study|Withdrawal by Subject|0|||
124965145|NCT02647788|449499265|FG000|Overall Study|Felt itchy with assigned medication|1|||
124965146|NCT02647788|449499266|FG001|Overall Study|Felt itchy with assigned medication|0|||
124965147|NCT02647788|449499265|FG000|Overall Study|Felt nauseous with assigned medication|1|||
124965148|NCT02647788|449499266|FG001|Overall Study|Felt nauseous with assigned medication|1|||
124965149|NCT00233389|449499269|FG000|Overall Study|Adverse Event|5|||
124965150|NCT00233389|449499270|FG001|Overall Study|Adverse Event|5|||
124965151|NCT00233389|449499269|FG000|Overall Study|Lack of Efficacy|11|||
124965152|NCT00233389|449499270|FG001|Overall Study|Lack of Efficacy|8|||
124965153|NCT00233389|449499269|FG000|Overall Study|Lost to Follow-up|1|||
124965154|NCT00233389|449499270|FG001|Overall Study|Lost to Follow-up|1|||
124965155|NCT00233389|449499269|FG000|Overall Study|Physician Decision|1|||
124965156|NCT00233389|449499270|FG001|Overall Study|Physician Decision|0|||
124965157|NCT00233389|449499269|FG000|Overall Study|Protocol Violation|0|||
124965158|NCT00233389|449499270|FG001|Overall Study|Protocol Violation|1|||
124965159|NCT00233389|449499269|FG000|Overall Study|Withdrawal by Subject|0|||
124965160|NCT00233389|449499270|FG001|Overall Study|Withdrawal by Subject|1|||
124965161|NCT00302159|449499273|FG000|Overall Study|pt declined before treatment started|1|||
124965162|NCT00302159|449499273|FG000|Overall Study|pt started Avastin|1|||
124965163|NCT01233999|449499276|FG000|Overall Study|Withdrawal by Subject|1|||
124965164|NCT01233999|449499276|FG000|Overall Study|Lost to Follow-up|1|||
124965165|NCT00129649|449499283|FG000|Overall Study|Withdrawal by Subject|76|||
124965166|NCT00129649|449499284|FG001|Overall Study|Withdrawal by Subject|65|||
124965167|NCT00905034|449499286|FG000|Overall Study|Withdrawal by Subject|1|||
124965168|NCT00394589|449499287|FG000|Overall Study|Adverse Event|2|||
124965169|NCT00394589|449499288|FG001|Overall Study|Adverse Event|1|||
124965170|NCT00394589|449499289|FG002|Overall Study|Adverse Event|2|||
124965171|NCT00394589|449499287|FG000|Overall Study|Lack of Efficacy|2|||
124965172|NCT00394589|449499288|FG001|Overall Study|Lack of Efficacy|2|||
124965173|NCT00394589|449499289|FG002|Overall Study|Lack of Efficacy|3|||
124965174|NCT00394589|449499287|FG000|Overall Study|Protocol Violation|4|||
124965175|NCT00394589|449499288|FG001|Overall Study|Protocol Violation|0|||
124965176|NCT00394589|449499289|FG002|Overall Study|Protocol Violation|2|||
124965177|NCT04081389|449499290|FG000|Overall Study|Withdrawal by Subject|0|||
124965178|NCT04081389|449499291|FG001|Overall Study|Withdrawal by Subject|0|||
124965179|NCT04081389|449499292|FG002|Overall Study|Withdrawal by Subject|1|||
124965180|NCT04081389|449499293|FG003|Overall Study|Withdrawal by Subject|0|||
124965181|NCT01114672|449499294|FG000|Overall Study|Death|0|||
124965182|NCT01114672|449499295|FG001|Overall Study|Death|1|||
124965183|NCT01114672|449499294|FG000|Overall Study|Withdrawal by Subject|2|||
124965184|NCT01114672|449499295|FG001|Overall Study|Withdrawal by Subject|1|||
124965185|NCT01114672|449499294|FG000|Overall Study|Lost to Follow-up|1|||
124965186|NCT01114672|449499295|FG001|Overall Study|Lost to Follow-up|0|||
124965187|NCT01114672|449499294|FG000|Overall Study|transplanted|1|||
124965188|NCT01114672|449499295|FG001|Overall Study|transplanted|0|||
124965189|NCT01710800|449499298|FG000|Overall Study|Withdrawal by Subject|21|||
124965190|NCT01710800|449499298|FG000|Overall Study|Protocol Violation|1|||
124965191|NCT02586415|449499299|FG000|Overall Study|Death|13|||
124965192|NCT02586415|449499300|FG001|Overall Study|Death|23|||
124965193|NCT02586415|449499299|FG000|Overall Study|Lost to Follow-up|1|||
124965194|NCT02586415|449499300|FG001|Overall Study|Lost to Follow-up|2|||
124965195|NCT01585298|449499301|FG000|Overall Study|Study completion was not documented.|1|||
124965196|NCT01585298|449499301|FG000|Overall Study|Protocol deviation|1|||
124965197|NCT01585298|449499301|FG000|Overall Study|Administrative problems|4|||
124965198|NCT01585298|449499301|FG000|Overall Study|Lost to Follow-up|2|||
124965199|NCT01585298|449499301|FG000|Overall Study|Withdrawal by Subject|4|||
124965200|NCT01585298|449499301|FG000|Overall Study|Abnormal test procedure results|1|||
124965201|NCT01585298|449499301|FG000|Overall Study|Adverse Event|24|||
124965202|NCT04545476|449499302|FG000|Overall Study|Lost to Follow-up|1|||
124965203|NCT04545476|449499303|FG001|Overall Study|Lost to Follow-up|1|||
124965204|NCT04545476|449499304|FG002|Overall Study|Lost to Follow-up|0|||
124965205|NCT04545476|449499305|FG003|Overall Study|Lost to Follow-up|0|||
124965206|NCT03318783|449499308|FG000|Overall Study|Withdrawal by Subject|0|||
124965207|NCT03318783|449499309|FG001|Overall Study|Withdrawal by Subject|1|||
124965208|NCT03318783|449499308|FG000|Overall Study|Death|0|||
124965209|NCT03318783|449499309|FG001|Overall Study|Death|1|||
124965210|NCT04035577|449499312|FG000|Overall Study|Lost to Follow-up|1|||
124965211|NCT04035577|449499312|FG000|Overall Study|Withdrawal by Subject|1|||
124965212|NCT01313624|449499314|FG000|Double-Blind Phase|Adverse Event|27|||
124965213|NCT01313624|449499315|FG001|Double-Blind Phase|Adverse Event|4|||
124965214|NCT01313624|449499314|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
124965215|NCT01313624|449499315|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
124965216|NCT01313624|449499314|FG000|Double-Blind Phase|Lost to Follow-up|0|||
124965217|NCT01313624|449499315|FG001|Double-Blind Phase|Lost to Follow-up|2|||
124965218|NCT01313624|449499314|FG000|Double-Blind Phase|Physician Decision|1|||
124965219|NCT01313624|449499315|FG001|Double-Blind Phase|Physician Decision|0|||
124965220|NCT01313624|449499314|FG000|Double-Blind Phase|Lack of Efficacy|1|||
124965221|NCT01313624|449499315|FG001|Double-Blind Phase|Lack of Efficacy|0|||
124965222|NCT01313624|449499314|FG000|Open-Label Phase|Adverse Event|1|||
124965223|NCT01313624|449499315|FG001|Open-Label Phase|Adverse Event|10|||
124965224|NCT01313624|449499314|FG000|Open-Label Phase|Withdrawal by Subject|2|||
124965225|NCT01313624|449499315|FG001|Open-Label Phase|Withdrawal by Subject|2|||
124965226|NCT01313624|449499314|FG000|Open-Label Phase|Lost to Follow-up|1|||
124965227|NCT01313624|449499315|FG001|Open-Label Phase|Lost to Follow-up|1|||
124965228|NCT00104637|449499316|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
124965229|NCT00104637|449499317|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
124965230|NCT00505414|449499318|FG000|Titration Phase|Adverse Event|0|||
124965231|NCT00505414|449499319|FG001|Titration Phase|Adverse Event|0|||
124965232|NCT00505414|449499320|FG002|Titration Phase|Adverse Event|0|||
124965233|NCT00505414|449499321|FG003|Titration Phase|Adverse Event|8|||
124965234|NCT00505414|449499322|FG004|Titration Phase|Adverse Event|3|||
124965235|NCT00505414|449499318|FG000|Titration Phase|Death|0|||
124965236|NCT00505414|449499319|FG001|Titration Phase|Death|0|||
124965237|NCT00505414|449499320|FG002|Titration Phase|Death|0|||
124965238|NCT00505414|449499321|FG003|Titration Phase|Death|2|||
124965239|NCT00505414|449499322|FG004|Titration Phase|Death|0|||
124965240|NCT00505414|449499318|FG000|Titration Phase|Lack of Efficacy|0|||
124965241|NCT00505414|449499319|FG001|Titration Phase|Lack of Efficacy|0|||
124965242|NCT00505414|449499320|FG002|Titration Phase|Lack of Efficacy|0|||
124965243|NCT00505414|449499321|FG003|Titration Phase|Lack of Efficacy|10|||
124965244|NCT00505414|449499322|FG004|Titration Phase|Lack of Efficacy|1|||
124965245|NCT00505414|449499318|FG000|Titration Phase|Protocol Violation|0|||
124965246|NCT00505414|449499319|FG001|Titration Phase|Protocol Violation|0|||
124965247|NCT00505414|449499320|FG002|Titration Phase|Protocol Violation|0|||
124965248|NCT00505414|449499321|FG003|Titration Phase|Protocol Violation|0|||
124965249|NCT00505414|449499322|FG004|Titration Phase|Protocol Violation|1|||
124965250|NCT00505414|449499318|FG000|Titration Phase|Withdrawal by Subject|0|||
124965251|NCT00505414|449499319|FG001|Titration Phase|Withdrawal by Subject|0|||
124965252|NCT00505414|449499320|FG002|Titration Phase|Withdrawal by Subject|0|||
124965253|NCT00505414|449499321|FG003|Titration Phase|Withdrawal by Subject|3|||
124965254|NCT00505414|449499322|FG004|Titration Phase|Withdrawal by Subject|4|||
124965255|NCT00505414|449499318|FG000|Titration Phase|Underlying disease and therapy required|0|||
124965256|NCT00505414|449499319|FG001|Titration Phase|Underlying disease and therapy required|0|||
124965257|NCT00505414|449499320|FG002|Titration Phase|Underlying disease and therapy required|0|||
124965258|NCT00505414|449499321|FG003|Titration Phase|Underlying disease and therapy required|7|||
124965259|NCT00505414|449499322|FG004|Titration Phase|Underlying disease and therapy required|3|||
124965260|NCT00505414|449499318|FG000|Maintenance Phase|Adverse Event|2|||
124965261|NCT00505414|449499319|FG001|Maintenance Phase|Adverse Event|2|||
124965262|NCT00505414|449499320|FG002|Maintenance Phase|Adverse Event|3|||
124965263|NCT00505414|449499321|FG003|Maintenance Phase|Adverse Event|0|||
124965264|NCT00505414|449499322|FG004|Maintenance Phase|Adverse Event|0|||
124965265|NCT00505414|449499318|FG000|Maintenance Phase|Death|2|||
124965266|NCT00505414|449499319|FG001|Maintenance Phase|Death|0|||
124710067|NCT01978145|448565284|FG001|Treatment Period 2|Protocol Violation|1|||
124965267|NCT00505414|449499320|FG002|Maintenance Phase|Death|1|||
124965268|NCT00505414|449499321|FG003|Maintenance Phase|Death|0|||
124965269|NCT00505414|449499322|FG004|Maintenance Phase|Death|0|||
124965270|NCT00505414|449499318|FG000|Maintenance Phase|Lack of Efficacy|2|||
124965271|NCT00505414|449499319|FG001|Maintenance Phase|Lack of Efficacy|1|||
124965272|NCT00505414|449499320|FG002|Maintenance Phase|Lack of Efficacy|1|||
124965273|NCT00505414|449499321|FG003|Maintenance Phase|Lack of Efficacy|0|||
124965274|NCT00505414|449499322|FG004|Maintenance Phase|Lack of Efficacy|0|||
124965275|NCT00505414|449499318|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124965276|NCT00505414|449499319|FG001|Maintenance Phase|Withdrawal by Subject|0|||
124965277|NCT00505414|449499320|FG002|Maintenance Phase|Withdrawal by Subject|1|||
124965278|NCT00505414|449499321|FG003|Maintenance Phase|Withdrawal by Subject|0|||
124965279|NCT00505414|449499322|FG004|Maintenance Phase|Withdrawal by Subject|0|||
124965280|NCT00505414|449499318|FG000|Maintenance Phase|underlying disease and therapy required|0|||
124965281|NCT00505414|449499319|FG001|Maintenance Phase|underlying disease and therapy required|2|||
124965282|NCT00505414|449499320|FG002|Maintenance Phase|underlying disease and therapy required|2|||
124965283|NCT00505414|449499321|FG003|Maintenance Phase|underlying disease and therapy required|0|||
124965284|NCT00505414|449499322|FG004|Maintenance Phase|underlying disease and therapy required|0|||
124965285|NCT01560871|449499323|FG000|Overall Study|transportation issues|2|||
124965286|NCT01560871|449499324|FG001|Overall Study|transportation issues|1|||
124965287|NCT01560871|449499323|FG000|Overall Study|relocation|1|||
124965288|NCT01560871|449499324|FG001|Overall Study|relocation|0|||
124965289|NCT01560871|449499323|FG000|Overall Study|readmission to a hospital|2|||
124965290|NCT01560871|449499324|FG001|Overall Study|readmission to a hospital|1|||
124965291|NCT01560871|449499323|FG000|Overall Study|Lost to Follow-up|1|||
124965292|NCT01560871|449499324|FG001|Overall Study|Lost to Follow-up|0|||
124965293|NCT00644878|449499325|FG000|Overall Study|Adverse Event|2|||
124965294|NCT00644878|449499325|FG000|Overall Study|Abnormal laboratory value|3|||
124965295|NCT00644878|449499325|FG000|Overall Study|Protocol deviation|2|||
124965296|NCT00644878|449499325|FG000|Overall Study|Treatment duration completed as per protocol|11|||
124965297|NCT00591591|449499328|FG000|Overall Study|Withdrawal by Subject|1|||
124965298|NCT00591591|449499329|FG001|Overall Study|Withdrawal by Subject|37|||
124965299|NCT00591591|449499328|FG000|Overall Study|Lack of Efficacy|10|||
124965300|NCT00591591|449499329|FG001|Overall Study|Lack of Efficacy|2|||
124965301|NCT01841112|449499335|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
124965302|NCT01841112|449499336|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
124965303|NCT01841112|449499337|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
124965304|NCT01841112|449499338|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
124965305|NCT01841112|449499339|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
124965306|NCT00878553|449499340|FG000|Sleep Study|Withdrawal by Subject|2|||
124965307|NCT00878553|449499341|FG001|Sleep Study|Withdrawal by Subject|0|||
124965308|NCT00878553|449499342|FG002|Sleep Study|Withdrawal by Subject|0|||
124965309|NCT00878553|449499343|FG003|Sleep Study|Withdrawal by Subject|0|||
124965310|NCT00878553|449499344|FG004|Sleep Study|Withdrawal by Subject|0|||
124965311|NCT00878553|449499340|FG000|Sleep Study|Lost to Follow-up|1|||
124965312|NCT00878553|449499341|FG001|Sleep Study|Lost to Follow-up|0|||
124965313|NCT00878553|449499342|FG002|Sleep Study|Lost to Follow-up|0|||
124965314|NCT00878553|449499343|FG003|Sleep Study|Lost to Follow-up|0|||
124965315|NCT00878553|449499344|FG004|Sleep Study|Lost to Follow-up|0|||
124965316|NCT00878553|449499340|FG000|Sleep Study|car accident|1|||
124965317|NCT00878553|449499341|FG001|Sleep Study|car accident|0|||
124965318|NCT00878553|449499342|FG002|Sleep Study|car accident|0|||
124965319|NCT00878553|449499343|FG003|Sleep Study|car accident|0|||
124965320|NCT00878553|449499344|FG004|Sleep Study|car accident|0|||
124965321|NCT00878553|449499340|FG000|Sleep Study|family emergency|1|||
124965322|NCT00878553|449499341|FG001|Sleep Study|family emergency|0|||
124965323|NCT00878553|449499342|FG002|Sleep Study|family emergency|0|||
124965324|NCT00878553|449499343|FG003|Sleep Study|family emergency|0|||
124965325|NCT00878553|449499344|FG004|Sleep Study|family emergency|0|||
124965326|NCT00878553|449499340|FG000|PK Study|Withdrawal by Subject|0|||
124965327|NCT00878553|449499341|FG001|PK Study|Withdrawal by Subject|0|||
124965328|NCT00878553|449499342|FG002|PK Study|Withdrawal by Subject|0|||
124965329|NCT00878553|449499343|FG003|PK Study|Withdrawal by Subject|1|||
124965330|NCT00878553|449499344|FG004|PK Study|Withdrawal by Subject|0|||
124965331|NCT00461123|449499345|FG000|Overall Study|Adverse Event|1|||
124965332|NCT00461123|449499346|FG001|Overall Study|Adverse Event|0|||
124965333|NCT00461123|449499345|FG000|Overall Study|Lost to Follow-up|1|||
124965334|NCT00461123|449499346|FG001|Overall Study|Lost to Follow-up|1|||
124965335|NCT00461123|449499345|FG000|Overall Study|Protocol Violation|3|||
124965336|NCT00461123|449499346|FG001|Overall Study|Protocol Violation|2|||
124965337|NCT00461123|449499345|FG000|Overall Study|Withdrawal by Subject|1|||
124965338|NCT00461123|449499346|FG001|Overall Study|Withdrawal by Subject|3|||
124965339|NCT05896696|449499351|FG000|Overall Study|Screening Failure|7|||
124965340|NCT05896696|449499351|FG000|Overall Study|Withdrawal by Subject|2|||
124965341|NCT02080403|449501785|FG000|Overall Study|Adverse Event|5|||
124965342|NCT02080403|449501786|FG001|Overall Study|Adverse Event|1|||
124965343|NCT02080403|449501785|FG000|Overall Study|Death|0|||
124965344|NCT02080403|449501786|FG001|Overall Study|Death|2|||
124965345|NCT02080403|449501785|FG000|Overall Study|Lost to Follow-up|2|||
124965346|NCT02080403|449501786|FG001|Overall Study|Lost to Follow-up|0|||
124965347|NCT02080403|449501785|FG000|Overall Study|Pregnancy|0|||
124965348|NCT02080403|449501786|FG001|Overall Study|Pregnancy|1|||
124965349|NCT02080403|449501785|FG000|Overall Study|Protocol Violation|3|||
124965350|NCT02080403|449501786|FG001|Overall Study|Protocol Violation|7|||
124965351|NCT02080403|449501785|FG000|Overall Study|Withdrawal by Subject|5|||
124965352|NCT02080403|449501786|FG001|Overall Study|Withdrawal by Subject|1|||
124965353|NCT01999972|449501787|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
124965354|NCT01999972|449501788|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
124549961|NCT01915498|447969014|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
124549962|NCT01915498|447969015|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
124549963|NCT01915498|447969016|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
124549964|NCT01915498|447968998|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
124549965|NCT01915498|447968999|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
124549966|NCT01915498|447969000|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
124549967|NCT01915498|447969001|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
124549968|NCT01915498|447969002|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
124549969|NCT01915498|447969003|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
124549970|NCT01915498|447969004|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
124549971|NCT01915498|447969005|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
124710068|NCT01978145|448565283|FG000|Treatment Period 2|Lost to Follow-up|1|||
124710069|NCT01978145|448565284|FG001|Treatment Period 2|Lost to Follow-up|1|||
124710070|NCT01978145|448565283|FG000|Treatment Period 2|Withdrawal by Subject|7|||
124965355|NCT01999972|449501789|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
124965356|NCT01999972|449501790|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
124965357|NCT01999972|449501791|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
124965358|NCT01999972|449501792|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
124965359|NCT01999972|449501787|FG000|Dose Escalation Part|Death|0|||
124965360|NCT01999972|449501788|FG001|Dose Escalation Part|Death|1|||
124965361|NCT01999972|449501789|FG002|Dose Escalation Part|Death|0|||
124965362|NCT01999972|449501790|FG003|Dose Escalation Part|Death|0|||
124965363|NCT01999972|449501791|FG004|Dose Escalation Part|Death|0|||
124965364|NCT01999972|449501792|FG005|Dose Escalation Part|Death|0|||
124965365|NCT01999972|449501787|FG000|Dose Escalation Part|Enrolled but not treated|0|||
124965366|NCT01999972|449501788|FG001|Dose Escalation Part|Enrolled but not treated|0|||
124965367|NCT01999972|449501789|FG002|Dose Escalation Part|Enrolled but not treated|1|||
124965368|NCT01999972|449501790|FG003|Dose Escalation Part|Enrolled but not treated|1|||
124965369|NCT01999972|449501791|FG004|Dose Escalation Part|Enrolled but not treated|0|||
124965370|NCT01999972|449501792|FG005|Dose Escalation Part|Enrolled but not treated|0|||
124965371|NCT01999972|449501787|FG000|Dose Escalation Part|Disease progression|3|||
124965372|NCT01999972|449501788|FG001|Dose Escalation Part|Disease progression|2|||
124965373|NCT01999972|449501789|FG002|Dose Escalation Part|Disease progression|3|||
124965374|NCT01999972|449501790|FG003|Dose Escalation Part|Disease progression|6|||
124965375|NCT01999972|449501791|FG004|Dose Escalation Part|Disease progression|0|||
124965376|NCT01999972|449501792|FG005|Dose Escalation Part|Disease progression|0|||
124710071|NCT01978145|448565284|FG001|Treatment Period 2|Withdrawal by Subject|4|||
124710072|NCT01978145|448565283|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
124710073|NCT01978145|448565284|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
124710074|NCT02026011|448565285|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
124710075|NCT02026011|448565286|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
124710076|NCT02026011|448565285|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
124710077|NCT02026011|448565286|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
124710078|NCT02026011|448565285|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
124710079|NCT02026011|448565286|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
124710080|NCT02026011|448565285|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
124710081|NCT02026011|448565286|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
124710082|NCT01770743|448565287|FG000|Overall Study|Adverse Event|1|||
124710083|NCT01770743|448565288|FG001|Overall Study|Adverse Event|0|||
124710084|NCT01770743|448565289|FG002|Overall Study|Adverse Event|0|||
124710085|NCT01770743|448565290|FG003|Overall Study|Adverse Event|0|||
124710086|NCT01770743|448565291|FG004|Overall Study|Adverse Event|0|||
124965377|NCT01999972|449501787|FG000|Dose Escalation Part|Adverse Event|0|||
124965378|NCT01999972|449501788|FG001|Dose Escalation Part|Adverse Event|0|||
124965379|NCT01999972|449501789|FG002|Dose Escalation Part|Adverse Event|0|||
124965380|NCT01999972|449501790|FG003|Dose Escalation Part|Adverse Event|2|||
124965381|NCT01999972|449501791|FG004|Dose Escalation Part|Adverse Event|0|||
124710087|NCT01770743|448565287|FG000|Overall Study|Withdrawal by Subject|0|||
124710088|NCT01770743|448565288|FG001|Overall Study|Withdrawal by Subject|0|||
124710089|NCT01770743|448565289|FG002|Overall Study|Withdrawal by Subject|1|||
124464724|NCT00590590|447659827|FG000|Overall Study|Did not complete due to study closure|1|||
124464725|NCT00590590|447659828|FG001|Overall Study|Did not complete due to study closure|1|||
124464726|NCT00590590|447659829|FG002|Overall Study|Did not complete due to study closure|1|||
124464727|NCT00590590|447659827|FG000|Overall Study|Did not complete study|0|||
124965382|NCT01999972|449501792|FG005|Dose Escalation Part|Adverse Event|0|||
124965383|NCT01999972|449501787|FG000|Dose Escalation Part|Global deterioration of health status|1|||
124965384|NCT01999972|449501788|FG001|Dose Escalation Part|Global deterioration of health status|0|||
124965385|NCT01999972|449501789|FG002|Dose Escalation Part|Global deterioration of health status|0|||
124965386|NCT01999972|449501790|FG003|Dose Escalation Part|Global deterioration of health status|1|||
124965387|NCT01999972|449501791|FG004|Dose Escalation Part|Global deterioration of health status|0|||
124965388|NCT01999972|449501792|FG005|Dose Escalation Part|Global deterioration of health status|0|||
124965389|NCT01999972|449501787|FG000|Dose Expansion Part|Death|0|||
124965390|NCT01999972|449501788|FG001|Dose Expansion Part|Death|0|||
124965391|NCT01999972|449501789|FG002|Dose Expansion Part|Death|0|||
124965392|NCT01999972|449501790|FG003|Dose Expansion Part|Death|0|||
124965393|NCT01999972|449501791|FG004|Dose Expansion Part|Death|2|||
124965394|NCT01999972|449501792|FG005|Dose Expansion Part|Death|1|||
124965395|NCT01999972|449501787|FG000|Dose Expansion Part|Disease progression|0|||
124965396|NCT01999972|449501788|FG001|Dose Expansion Part|Disease progression|0|||
124965397|NCT01999972|449501789|FG002|Dose Expansion Part|Disease progression|0|||
124965398|NCT01999972|449501790|FG003|Dose Expansion Part|Disease progression|0|||
124965399|NCT01999972|449501791|FG004|Dose Expansion Part|Disease progression|9|||
124965400|NCT01999972|449501792|FG005|Dose Expansion Part|Disease progression|3|||
124965401|NCT01999972|449501787|FG000|Dose Expansion Part|Sponsor decision|0|||
124965402|NCT01999972|449501788|FG001|Dose Expansion Part|Sponsor decision|0|||
124965403|NCT01999972|449501789|FG002|Dose Expansion Part|Sponsor decision|0|||
124965404|NCT01999972|449501790|FG003|Dose Expansion Part|Sponsor decision|0|||
124965405|NCT01999972|449501791|FG004|Dose Expansion Part|Sponsor decision|1|||
124965406|NCT01999972|449501792|FG005|Dose Expansion Part|Sponsor decision|0|||
124965407|NCT01999972|449501787|FG000|Dose Expansion Part|Adverse Event|0|||
124965408|NCT01999972|449501788|FG001|Dose Expansion Part|Adverse Event|0|||
124965409|NCT01999972|449501789|FG002|Dose Expansion Part|Adverse Event|0|||
124965410|NCT01999972|449501790|FG003|Dose Expansion Part|Adverse Event|0|||
124965411|NCT01999972|449501791|FG004|Dose Expansion Part|Adverse Event|4|||
124965412|NCT01999972|449501792|FG005|Dose Expansion Part|Adverse Event|2|||
124965413|NCT01999972|449501787|FG000|Dose Expansion Part|Participant's non-compliance|0|||
124965414|NCT01999972|449501788|FG001|Dose Expansion Part|Participant's non-compliance|0|||
124965415|NCT01999972|449501789|FG002|Dose Expansion Part|Participant's non-compliance|0|||
124965416|NCT01999972|449501790|FG003|Dose Expansion Part|Participant's non-compliance|0|||
124965417|NCT01999972|449501791|FG004|Dose Expansion Part|Participant's non-compliance|0|||
124965418|NCT01999972|449501792|FG005|Dose Expansion Part|Participant's non-compliance|1|||
124965419|NCT01999972|449501787|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
124965420|NCT01999972|449501788|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
124965421|NCT01999972|449501789|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
124965422|NCT01999972|449501790|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
124965423|NCT01999972|449501791|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
124965424|NCT01999972|449501792|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
124965425|NCT01999972|449501787|FG000|Dose Expansion Part|Changed to standard of care|0|||
124464728|NCT00590590|447659828|FG001|Overall Study|Did not complete study|1|||
124464729|NCT00590590|447659829|FG002|Overall Study|Did not complete study|0|||
124464730|NCT00132132|447659832|FG000|Overall Study|Lost to Follow-up|7|||
124464731|NCT00132132|447659833|FG001|Overall Study|Lost to Follow-up|2|||
124464732|NCT00494091|447659834|FG000|Overall Study|Death|5|||
124965426|NCT01999972|449501788|FG001|Dose Expansion Part|Changed to standard of care|0|||
124965427|NCT01999972|449501789|FG002|Dose Expansion Part|Changed to standard of care|0|||
124965428|NCT01999972|449501790|FG003|Dose Expansion Part|Changed to standard of care|0|||
124965429|NCT01999972|449501791|FG004|Dose Expansion Part|Changed to standard of care|1|||
124965430|NCT01999972|449501792|FG005|Dose Expansion Part|Changed to standard of care|0|||
124965431|NCT02826798|449501794|FG000|Overall Study|Withdrawal by Subject|0|||
124965432|NCT02826798|449501795|FG001|Overall Study|Withdrawal by Subject|1|||
124965433|NCT02826798|449501796|FG002|Overall Study|Withdrawal by Subject|0|||
124965434|NCT02826798|449501797|FG003|Overall Study|Withdrawal by Subject|1|||
124965435|NCT02826798|449501798|FG004|Overall Study|Withdrawal by Subject|0|||
124965436|NCT01986114|449501802|FG000|Overall Study|Adverse Event|59|||
124965437|NCT01986114|449501802|FG000|Overall Study|Lack of Efficacy|23|||
124965438|NCT01986114|449501802|FG000|Overall Study|Withdrawal by Subject|58|||
124965439|NCT01986114|449501802|FG000|Overall Study|Noncompliance|3|||
124965440|NCT01986114|449501802|FG000|Overall Study|Protocol Violation|1|||
124965441|NCT01986114|449501802|FG000|Overall Study|Lost to Follow-up|5|||
124464733|NCT00494091|447659835|FG001|Overall Study|Death|54|||
124464734|NCT00494091|447659834|FG000|Overall Study|Lost to Follow-up|0|||
124965442|NCT01986114|449501802|FG000|Overall Study|Other reason|7|||
124965443|NCT00664105|449501803|FG000|Overall Study|Death|3|||
124965444|NCT00664105|449501803|FG000|Overall Study|Withdrawal by Subject|5|||
124965445|NCT00664105|449501803|FG000|Overall Study|Adverse Event|9|||
124965446|NCT00664105|449501803|FG000|Overall Study|Disease progression|7|||
124965447|NCT04702893|449501804|FG000|Overall Study|Other reasons than listed|11|||
124965448|NCT04702893|449501804|FG000|Overall Study|Withdrawal by Subject|3|||
124965449|NCT04702893|449501804|FG000|Overall Study|Lost to Follow-up|7|||
124965450|NCT04702893|449501804|FG000|Overall Study|Death|10|||
124965451|NCT04702893|449501804|FG000|Overall Study|Not treated|6|||
124965452|NCT04469465|449501805|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
124965453|NCT04469465|449501806|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
124965454|NCT04469465|449501805|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
124965455|NCT04469465|449501806|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
124965456|NCT04469465|449501805|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
124965457|NCT04469465|449501806|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
124965458|NCT04469465|449501805|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
124965459|NCT04469465|449501806|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
124965460|NCT04469465|449501805|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
124965461|NCT04469465|449501806|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
124965462|NCT04469465|449501805|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
124965463|NCT04469465|449501806|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
124965464|NCT04469465|449501805|FG000|Long-Term Extension (LTE)|Death|0|||
124965465|NCT04469465|449501806|FG001|Long-Term Extension (LTE)|Death|1|||
124965466|NCT04469465|449501805|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
124965467|NCT04469465|449501806|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
124965468|NCT01951378|449501807|FG000|Overall Study|Study Terminated-Not completed|23|||
124965469|NCT01951378|449501808|FG001|Overall Study|Study Terminated-Not completed|17|||
124965470|NCT01660256|449501809|FG000|Overall Study|Adverse Event|4|||
124965471|NCT01660256|449501810|FG001|Overall Study|Adverse Event|0|||
124965472|NCT01660256|449501811|FG002|Overall Study|Adverse Event|2|||
124965473|NCT01660256|449501809|FG000|Overall Study|Withdrawal by Subject|1|||
124965474|NCT01660256|449501810|FG001|Overall Study|Withdrawal by Subject|0|||
124965475|NCT01660256|449501811|FG002|Overall Study|Withdrawal by Subject|2|||
124965476|NCT03491215|449501812|FG000|Overall Study|Death|6|||
124965477|NCT03491215|449501813|FG001|Overall Study|Death|2|||
124965478|NCT03491215|449501814|FG002|Overall Study|Death|1|||
124965479|NCT03491215|449501815|FG003|Overall Study|Death|0|||
124965480|NCT03491215|449501812|FG000|Overall Study|Physician Decision|1|||
124965481|NCT03491215|449501813|FG001|Overall Study|Physician Decision|0|||
124965482|NCT03491215|449501814|FG002|Overall Study|Physician Decision|0|||
124965483|NCT03491215|449501815|FG003|Overall Study|Physician Decision|0|||
124965484|NCT00551135|449501821|FG000|Overall Study|Adverse Event|1|||
124965485|NCT00551135|449501822|FG001|Overall Study|Adverse Event|0|||
124965486|NCT00551135|449501823|FG002|Overall Study|Adverse Event|1|||
124965487|NCT00551135|449501824|FG003|Overall Study|Adverse Event|1|||
124965488|NCT00551135|449501821|FG000|Overall Study|Lost to Follow-up|0|||
124965489|NCT00551135|449501822|FG001|Overall Study|Lost to Follow-up|0|||
124965490|NCT00551135|449501823|FG002|Overall Study|Lost to Follow-up|0|||
124965491|NCT00551135|449501824|FG003|Overall Study|Lost to Follow-up|1|||
124965492|NCT00551135|449501821|FG000|Overall Study|Other|3|||
124965493|NCT00551135|449501822|FG001|Overall Study|Other|2|||
124965494|NCT00551135|449501823|FG002|Overall Study|Other|1|||
124965495|NCT00551135|449501824|FG003|Overall Study|Other|2|||
124965496|NCT00551135|449501821|FG000|Overall Study|Withdrawal by Subject|1|||
124965497|NCT00551135|449501822|FG001|Overall Study|Withdrawal by Subject|0|||
124965498|NCT00551135|449501823|FG002|Overall Study|Withdrawal by Subject|3|||
124965499|NCT00551135|449501824|FG003|Overall Study|Withdrawal by Subject|1|||
124965500|NCT01202409|449501825|FG000|Overall Study|Adverse Event|1|||
124965501|NCT01202409|449501825|FG000|Overall Study|Ineligible - KRAS mutants|7|||
124965502|NCT01004185|449501826|FG000|Overall Study|Adverse Event|1|||
124965503|NCT01004185|449501827|FG001|Overall Study|Adverse Event|1|||
124965504|NCT01004185|449501826|FG000|Overall Study|Lost to Follow-up|0|||
124965505|NCT01004185|449501827|FG001|Overall Study|Lost to Follow-up|1|||
124464735|NCT00494091|447659835|FG001|Overall Study|Lost to Follow-up|4|||
124464736|NCT00494091|447659834|FG000|Overall Study|Other|1|||
124965506|NCT01004185|449501826|FG000|Overall Study|Lack of Efficacy|2|||
124965507|NCT01004185|449501827|FG001|Overall Study|Lack of Efficacy|1|||
124965508|NCT01004185|449501826|FG000|Overall Study|Sponsor Terminated Study|4|||
124965509|NCT01004185|449501827|FG001|Overall Study|Sponsor Terminated Study|5|||
124965510|NCT01004185|449501826|FG000|Overall Study|Withdrawal by Subject|2|||
124965511|NCT01004185|449501827|FG001|Overall Study|Withdrawal by Subject|1|||
124965512|NCT01172639|449501832|FG000|Overall Study|Death|1|||
124965513|NCT01172639|449501833|FG001|Overall Study|Death|1|||
124965514|NCT01172639|449501834|FG002|Overall Study|Death|0|||
124464737|NCT00494091|447659835|FG001|Overall Study|Other|11|||
124965515|NCT01172639|449501835|FG003|Overall Study|Death|0|||
124965516|NCT01172639|449501836|FG004|Overall Study|Death|0|||
124965517|NCT01172639|449501832|FG000|Overall Study|Lost to Follow-up|9|||
124965518|NCT01172639|449501833|FG001|Overall Study|Lost to Follow-up|7|||
124965519|NCT01172639|449501834|FG002|Overall Study|Lost to Follow-up|11|||
124965520|NCT01172639|449501835|FG003|Overall Study|Lost to Follow-up|6|||
124965521|NCT01172639|449501836|FG004|Overall Study|Lost to Follow-up|6|||
124965522|NCT01172639|449501832|FG000|Overall Study|Withdrawal by Subject|3|||
124965523|NCT01172639|449501833|FG001|Overall Study|Withdrawal by Subject|3|||
124965524|NCT01172639|449501834|FG002|Overall Study|Withdrawal by Subject|5|||
124965525|NCT01172639|449501835|FG003|Overall Study|Withdrawal by Subject|5|||
124965526|NCT01172639|449501836|FG004|Overall Study|Withdrawal by Subject|0|||
124965527|NCT00469456|449501839|FG000|Overall Study|Adverse Event|4|||
124965528|NCT00469456|449501840|FG001|Overall Study|Adverse Event|3|||
124965529|NCT00469456|449501839|FG000|Overall Study|Protocol Violation|1|||
124965530|NCT00469456|449501840|FG001|Overall Study|Protocol Violation|0|||
124965531|NCT00469456|449501839|FG000|Overall Study|Withdrawal by Subject|4|||
124965532|NCT00469456|449501840|FG001|Overall Study|Withdrawal by Subject|1|||
124965533|NCT00719043|449501853|FG000|Overall Study|Adverse Event|5|||
124965534|NCT00719043|449501854|FG001|Overall Study|Adverse Event|1|||
124965535|NCT00719043|449501855|FG002|Overall Study|Adverse Event|2|||
124965536|NCT00719043|449501856|FG003|Overall Study|Adverse Event|2|||
124965537|NCT00719043|449501857|FG004|Overall Study|Adverse Event|1|||
124965538|NCT00719043|449501858|FG005|Overall Study|Adverse Event|4|||
124965539|NCT00719043|449501859|FG006|Overall Study|Adverse Event|4|||
124965540|NCT00719043|449501853|FG000|Overall Study|Lost to Follow-up|14|||
124965541|NCT00719043|449501854|FG001|Overall Study|Lost to Follow-up|10|||
124965542|NCT00719043|449501855|FG002|Overall Study|Lost to Follow-up|8|||
124965543|NCT00719043|449501856|FG003|Overall Study|Lost to Follow-up|9|||
124965544|NCT00719043|449501857|FG004|Overall Study|Lost to Follow-up|10|||
124965545|NCT00719043|449501858|FG005|Overall Study|Lost to Follow-up|9|||
124965546|NCT00719043|449501859|FG006|Overall Study|Lost to Follow-up|9|||
124965547|NCT00719043|449501853|FG000|Overall Study|Protocol Violation|0|||
124965548|NCT00719043|449501854|FG001|Overall Study|Protocol Violation|0|||
124965549|NCT00719043|449501855|FG002|Overall Study|Protocol Violation|0|||
124965550|NCT00719043|449501856|FG003|Overall Study|Protocol Violation|0|||
124965551|NCT00719043|449501857|FG004|Overall Study|Protocol Violation|0|||
124965552|NCT00719043|449501858|FG005|Overall Study|Protocol Violation|1|||
124965553|NCT00719043|449501859|FG006|Overall Study|Protocol Violation|0|||
124965554|NCT00719043|449501853|FG000|Overall Study|Other|1|||
124965555|NCT00719043|449501854|FG001|Overall Study|Other|0|||
124965556|NCT00719043|449501855|FG002|Overall Study|Other|1|||
124965557|NCT00719043|449501856|FG003|Overall Study|Other|2|||
124965558|NCT00719043|449501857|FG004|Overall Study|Other|0|||
124965559|NCT00719043|449501858|FG005|Overall Study|Other|2|||
124965560|NCT00719043|449501859|FG006|Overall Study|Other|1|||
124965561|NCT00719043|449501853|FG000|Overall Study|Withdrawal by Subject|12|||
124965562|NCT00719043|449501854|FG001|Overall Study|Withdrawal by Subject|14|||
124965563|NCT00719043|449501855|FG002|Overall Study|Withdrawal by Subject|9|||
124965564|NCT00719043|449501856|FG003|Overall Study|Withdrawal by Subject|10|||
124965565|NCT00719043|449501857|FG004|Overall Study|Withdrawal by Subject|16|||
124965566|NCT00719043|449501858|FG005|Overall Study|Withdrawal by Subject|18|||
124965567|NCT00719043|449501859|FG006|Overall Study|Withdrawal by Subject|14|||
124965568|NCT01588366|449501860|FG000|Overall Study|Adverse Event|0|||
124965569|NCT01588366|449501861|FG001|Overall Study|Adverse Event|1|||
124965570|NCT01588366|449501862|FG002|Overall Study|Adverse Event|0|||
124965571|NCT01588366|449501863|FG003|Overall Study|Adverse Event|1|||
124965572|NCT01588366|449501864|FG004|Overall Study|Adverse Event|0|||
124965573|NCT01588366|449501865|FG005|Overall Study|Adverse Event|2|||
124965574|NCT03245619|449501866|FG000|Part A (Up to Day 22)|Physician Decision|4|||
124965575|NCT03245619|449501867|FG001|Part A (Up to Day 22)|Physician Decision|6|||
124965576|NCT03245619|449501868|FG002|Part A (Up to Day 22)|Physician Decision|6|||
124965577|NCT03245619|449501869|FG003|Part A (Up to Day 22)|Physician Decision|0|||
124965578|NCT03245619|449501870|FG004|Part A (Up to Day 22)|Physician Decision|0|||
124965579|NCT03245619|449501871|FG005|Part A (Up to Day 22)|Physician Decision|0|||
124965580|NCT03245619|449501872|FG006|Part A (Up to Day 22)|Physician Decision|0|||
124965581|NCT03245619|449501873|FG007|Part A (Up to Day 22)|Physician Decision|0|||
124965582|NCT03245619|449501874|FG008|Part A (Up to Day 22)|Physician Decision|0|||
124965583|NCT03245619|449501875|FG009|Part A (Up to Day 22)|Physician Decision|0|||
124965584|NCT03245619|449501876|FG010|Part A (Up to Day 22)|Physician Decision|0|||
124965585|NCT03245619|449501877|FG011|Part A (Up to Day 22)|Physician Decision|0|||
124464738|NCT00494091|447659834|FG000|Overall Study|Withdrawal by Subject|0|||
124464739|NCT00494091|447659835|FG001|Overall Study|Withdrawal by Subject|7|||
124710090|NCT01770743|448565290|FG003|Overall Study|Withdrawal by Subject|1|||
124965586|NCT03245619|449501878|FG012|Part A (Up to Day 22)|Physician Decision|0|||
124965587|NCT03245619|449501879|FG013|Part A (Up to Day 22)|Physician Decision|0|||
124965588|NCT03245619|449501880|FG014|Part A (Up to Day 22)|Physician Decision|0|||
124965589|NCT03245619|449501881|FG015|Part A (Up to Day 22)|Physician Decision|0|||
124965590|NCT03245619|449501882|FG016|Part A (Up to Day 22)|Physician Decision|0|||
124965591|NCT01704547|449501883|FG000|Overall Study|Physician Decision|4|||
124965592|NCT01704547|449501883|FG000|Overall Study|Withdrawal by Subject|1|||
124965593|NCT00690378|449501890|FG000|Overall Study|Adverse Event|1|||
124965594|NCT00690378|449501891|FG001|Overall Study|Adverse Event|0|||
124965595|NCT00690378|449501890|FG000|Overall Study|Withdrawal by Subject|2|||
124965596|NCT00690378|449501891|FG001|Overall Study|Withdrawal by Subject|0|||
124965597|NCT00690378|449501890|FG000|Overall Study|Protocol Violation|1|||
124965598|NCT00690378|449501891|FG001|Overall Study|Protocol Violation|0|||
124965599|NCT00690378|449501890|FG000|Overall Study|Lost to Follow-up|2|||
124965600|NCT00690378|449501891|FG001|Overall Study|Lost to Follow-up|3|||
124965601|NCT00690378|449501890|FG000|Overall Study|Did not meet inc/exc criteria|13|||
124965602|NCT00690378|449501891|FG001|Overall Study|Did not meet inc/exc criteria|11|||
124965603|NCT00690378|449501890|FG000|Overall Study|Social problem|1|||
124965604|NCT00690378|449501891|FG001|Overall Study|Social problem|0|||
124965605|NCT00846768|449501893|FG000|Overall Study|Adverse Event|0|||
124965606|NCT00846768|449501894|FG001|Overall Study|Adverse Event|1|||
124965607|NCT00846768|449501895|FG002|Overall Study|Adverse Event|0|||
124965608|NCT00846768|449501896|FG003|Overall Study|Adverse Event|0|||
124965609|NCT00912223|449501901|FG000|Overall Study|Withdrawal by Subject|1|||
124965610|NCT00912223|449501901|FG000|Overall Study|Not transplanted|1|||
124965611|NCT00912223|449501901|FG000|Overall Study|Transformed disease|1|||
124965612|NCT01099579|449501902|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
124965613|NCT01099579|449501903|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
124965614|NCT01099579|449501904|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
124965615|NCT01099579|449501902|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
124965616|NCT01099579|449501903|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
124965617|NCT01099579|449501904|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
124965618|NCT01099579|449501902|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
124965619|NCT01099579|449501903|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
124965620|NCT01099579|449501904|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
124965621|NCT01099579|449501902|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
124965622|NCT01099579|449501903|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
124965623|NCT01099579|449501904|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
124965624|NCT01099579|449501902|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
124965625|NCT01099579|449501903|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
124965626|NCT01099579|449501904|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
124965627|NCT01099579|449501902|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
124965628|NCT01099579|449501903|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
124965629|NCT01099579|449501904|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
124965630|NCT01099579|449501902|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
124965631|NCT01099579|449501903|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
124965632|NCT01099579|449501904|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
124965633|NCT01099579|449501902|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
124965634|NCT01099579|449501903|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
124965635|NCT01099579|449501904|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
124965636|NCT01099579|449501902|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
124965637|NCT01099579|449501903|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
124965638|NCT01099579|449501904|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
124965639|NCT01099579|449501902|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
124965640|NCT01099579|449501903|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
124965641|NCT01099579|449501904|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
124965642|NCT00909532|449501905|FG000|Overall Study|Adverse Event|4|||
124965643|NCT00909532|449501906|FG001|Overall Study|Adverse Event|1|||
124965644|NCT00909532|449501905|FG000|Overall Study|Pregnancy|0|||
124965645|NCT00909532|449501906|FG001|Overall Study|Pregnancy|1|||
124965646|NCT00909532|449501905|FG000|Overall Study|Prohibited Medication|2|||
124965647|NCT00909532|449501906|FG001|Overall Study|Prohibited Medication|1|||
124965648|NCT00909532|449501905|FG000|Overall Study|Withdrawal of Consent|1|||
124965649|NCT00909532|449501906|FG001|Overall Study|Withdrawal of Consent|1|||
124965650|NCT00909532|449501905|FG000|Overall Study|Noncompliance with Study Requirements|0|||
124965651|NCT00909532|449501906|FG001|Overall Study|Noncompliance with Study Requirements|2|||
124965652|NCT00909532|449501905|FG000|Overall Study|Physician Decision|1|||
124965653|NCT00909532|449501906|FG001|Overall Study|Physician Decision|0|||
124965654|NCT00909532|449501905|FG000|Overall Study|Wrong Genotype|1|||
124965655|NCT00909532|449501906|FG001|Overall Study|Wrong Genotype|0|||
124965656|NCT00909532|449501905|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
124464740|NCT00452699|447659838|FG000|Overall Study|Adverse Event|10|||
124464741|NCT00452699|447659839|FG001|Overall Study|Adverse Event|3|||
124464742|NCT00452699|447659838|FG000|Overall Study|Lack of Efficacy|6|||
124464743|NCT00452699|447659839|FG001|Overall Study|Lack of Efficacy|4|||
124965657|NCT00909532|449501906|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
124965658|NCT01157377|449501909|FG000|Overall Study|Lost to Follow-up|0|||
124965659|NCT01157377|449501910|FG001|Overall Study|Lost to Follow-up|0|||
124965660|NCT01157377|449501911|FG002|Overall Study|Lost to Follow-up|1|||
124965661|NCT01157377|449501912|FG003|Overall Study|Lost to Follow-up|0|||
124965662|NCT01157377|449501913|FG004|Overall Study|Lost to Follow-up|1|||
124965663|NCT01157377|449501914|FG005|Overall Study|Lost to Follow-up|1|||
124965664|NCT01157377|449501915|FG006|Overall Study|Lost to Follow-up|0|||
124965665|NCT01157377|449501909|FG000|Overall Study|Personal Reasons|2|||
124965666|NCT01157377|449501910|FG001|Overall Study|Personal Reasons|1|||
124965667|NCT01157377|449501911|FG002|Overall Study|Personal Reasons|0|||
124965668|NCT01157377|449501912|FG003|Overall Study|Personal Reasons|1|||
124965669|NCT01157377|449501913|FG004|Overall Study|Personal Reasons|0|||
124965670|NCT01157377|449501914|FG005|Overall Study|Personal Reasons|0|||
124965671|NCT01157377|449501915|FG006|Overall Study|Personal Reasons|0|||
124965672|NCT01157377|449501909|FG000|Overall Study|Protocol Violation|0|||
124965673|NCT01157377|449501910|FG001|Overall Study|Protocol Violation|0|||
124965674|NCT01157377|449501911|FG002|Overall Study|Protocol Violation|0|||
124965675|NCT01157377|449501912|FG003|Overall Study|Protocol Violation|0|||
124965676|NCT01157377|449501913|FG004|Overall Study|Protocol Violation|0|||
124965677|NCT01157377|449501914|FG005|Overall Study|Protocol Violation|1|||
124965678|NCT01157377|449501915|FG006|Overall Study|Protocol Violation|0|||
124965679|NCT01157377|449501909|FG000|Overall Study|Lack of Efficacy|0|||
124965680|NCT01157377|449501910|FG001|Overall Study|Lack of Efficacy|0|||
124965681|NCT01157377|449501911|FG002|Overall Study|Lack of Efficacy|0|||
124965682|NCT01157377|449501912|FG003|Overall Study|Lack of Efficacy|0|||
124965683|NCT01157377|449501913|FG004|Overall Study|Lack of Efficacy|0|||
124965684|NCT01157377|449501914|FG005|Overall Study|Lack of Efficacy|0|||
124965685|NCT01157377|449501915|FG006|Overall Study|Lack of Efficacy|1|||
124965686|NCT01157377|449501909|FG000|Overall Study|Other Miscellaneous Reasons|0|||
124965687|NCT01157377|449501910|FG001|Overall Study|Other Miscellaneous Reasons|2|||
124965688|NCT01157377|449501911|FG002|Overall Study|Other Miscellaneous Reasons|0|||
124965689|NCT01157377|449501912|FG003|Overall Study|Other Miscellaneous Reasons|0|||
124965690|NCT01157377|449501913|FG004|Overall Study|Other Miscellaneous Reasons|1|||
124965691|NCT01157377|449501914|FG005|Overall Study|Other Miscellaneous Reasons|1|||
124965692|NCT01157377|449501915|FG006|Overall Study|Other Miscellaneous Reasons|1|||
124965693|NCT00927901|449501916|FG000|Treatment Period 1|Subject withdrew consent|0|||
124965694|NCT00927901|449501917|FG001|Treatment Period 1|Subject withdrew consent|0|||
124965695|NCT00927901|449501918|FG002|Treatment Period 1|Subject withdrew consent|1|||
124965696|NCT00927901|449501919|FG003|Treatment Period 1|Subject withdrew consent|0|||
124965697|NCT00927901|449501916|FG000|Treatment Period 4|Adverse Event|0|||
124965698|NCT00927901|449501917|FG001|Treatment Period 4|Adverse Event|0|||
124965699|NCT00927901|449501918|FG002|Treatment Period 4|Adverse Event|0|||
124965700|NCT00927901|449501919|FG003|Treatment Period 4|Adverse Event|1|||
124965701|NCT00927901|449501916|FG000|Treatment Period 4|Subject withdrew consent|0|||
124965702|NCT00927901|449501917|FG001|Treatment Period 4|Subject withdrew consent|0|||
124965703|NCT00927901|449501918|FG002|Treatment Period 4|Subject withdrew consent|1|||
124965704|NCT00927901|449501919|FG003|Treatment Period 4|Subject withdrew consent|0|||
124965705|NCT01263925|449501924|FG000|Overall Study|Protocol Violation|1|||
124965706|NCT01263925|449501925|FG001|Overall Study|Protocol Violation|0|||
124965707|NCT01263925|449501924|FG000|Overall Study|Lack of Efficacy|0|||
124965708|NCT01263925|449501925|FG001|Overall Study|Lack of Efficacy|1|||
124965709|NCT01263925|449501924|FG000|Overall Study|Adverse Event|23|||
124464744|NCT00452699|447659838|FG000|Overall Study|Lost to Follow-up|6|||
124464745|NCT00452699|447659839|FG001|Overall Study|Lost to Follow-up|9|||
124965710|NCT01263925|449501925|FG001|Overall Study|Adverse Event|22|||
124965711|NCT01263925|449501924|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
124464746|NCT00452699|447659838|FG000|Overall Study|Protocol Violation|21|||
124710091|NCT01770743|448565291|FG004|Overall Study|Withdrawal by Subject|1|||
124965712|NCT01263925|449501925|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
124965713|NCT01263925|449501924|FG000|Overall Study|Withdrawal by Subject|6|||
124965714|NCT01263925|449501925|FG001|Overall Study|Withdrawal by Subject|8|||
124965715|NCT01263925|449501924|FG000|Overall Study|Other|4|||
124965716|NCT01263925|449501925|FG001|Overall Study|Other|4|||
124965717|NCT01263925|449501924|FG000|Overall Study|Lost to Follow-up|3|||
124965718|NCT01263925|449501925|FG001|Overall Study|Lost to Follow-up|1|||
124464747|NCT00452699|447659839|FG001|Overall Study|Protocol Violation|25|||
124464748|NCT00452699|447659838|FG000|Overall Study|Withdrawal by Subject|26|||
124965719|NCT01263925|449501924|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
124965720|NCT01263925|449501925|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
124965721|NCT01263925|449501924|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
124965722|NCT01263925|449501925|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
124965723|NCT01263925|449501924|FG000|Overall Study|AE/ Withdrawal|1|||
124965724|NCT01263925|449501925|FG001|Overall Study|AE/ Withdrawal|4|||
124710092|NCT01770743|448565287|FG000|Overall Study|Lost to Follow-up|0|||
124965725|NCT01263925|449501924|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
124965726|NCT01263925|449501925|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
124965727|NCT01263925|449501924|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
124965728|NCT01263925|449501925|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
124965729|NCT01263925|449501924|FG000|Overall Study|Withdrawal/ Not specified|0|||
124965730|NCT01263925|449501925|FG001|Overall Study|Withdrawal/ Not specified|1|||
124965731|NCT03029819|449501926|FG000|Overall Study|Lost to Follow-up|3|||
124965732|NCT03029819|449501927|FG001|Overall Study|Lost to Follow-up|5|||
124965733|NCT03029819|449501926|FG000|Overall Study|Removed due to disruptive behavior|0|||
124965734|NCT03029819|449501927|FG001|Overall Study|Removed due to disruptive behavior|1|||
124965735|NCT02650466|449501934|FG000|Overall Study|Physician Decision|1|||
124965736|NCT02650466|449501934|FG000|Overall Study|Withdrawal by Subject|5|||
124965737|NCT02650466|449501934|FG000|Overall Study|Lost to Follow-up|1|||
124965738|NCT01726517|449501935|FG000|Overall Study|Withdrawal by Subject|0|||
124965739|NCT01726517|449501936|FG001|Overall Study|Withdrawal by Subject|0|||
124965740|NCT01726517|449501937|FG002|Overall Study|Withdrawal by Subject|1|||
124965741|NCT01726517|449501938|FG003|Overall Study|Withdrawal by Subject|0|||
124965742|NCT01726517|449501939|FG004|Overall Study|Withdrawal by Subject|0|||
124965743|NCT00573651|449501940|FG000|Overall Study|Lost to Follow-up|3|||
124965744|NCT00573651|449501940|FG000|Overall Study|Withdrawal by Subject|1|||
124965745|NCT03765164|449501941|FG000|Pre-intervention|Withdrawal by Subject|5|||
124965746|NCT03765164|449501942|FG001|Pre-intervention|Withdrawal by Subject|6|||
124965747|NCT03797989|449501964|FG000|VAC069A|Withdrawal by Subject|0|||
124965748|NCT03797989|449501965|FG001|VAC069A|Withdrawal by Subject|0|||
124965749|NCT03797989|449501966|FG002|VAC069A|Withdrawal by Subject|1|||
124965750|NCT03797989|449501967|FG003|VAC069A|Withdrawal by Subject|0|||
124965751|NCT03797989|449501968|FG004|VAC069A|Withdrawal by Subject|0|||
124965752|NCT03797989|449501969|FG005|VAC069A|Withdrawal by Subject|0|||
124965753|NCT03797989|449501970|FG006|VAC069A|Withdrawal by Subject|0|||
124965754|NCT03797989|449501971|FG007|VAC069A|Withdrawal by Subject|0|||
124965755|NCT03797989|449501972|FG008|VAC069A|Withdrawal by Subject|0|||
124965756|NCT03797989|449501973|FG009|VAC069A|Withdrawal by Subject|0|||
124965757|NCT03797989|449501974|FG010|VAC069A|Withdrawal by Subject|0|||
124965758|NCT03797989|449501975|FG011|VAC069A|Withdrawal by Subject|0|||
124965759|NCT04052997|449501976|FG000|Overall Study|Withdrawal by Subject|17|||
124965760|NCT04052997|449501976|FG000|Overall Study|Physician Decision|50|||
124965761|NCT04052997|449501976|FG000|Overall Study|Death|43|||
124965762|NCT04052997|449501976|FG000|Overall Study|Lost to Follow-up|5|||
124965763|NCT04052997|449501976|FG000|Overall Study|Progression of Disease|1|||
124965764|NCT01024036|449501977|FG000|Blinded Treatment|Adverse Event|1|||
124965765|NCT01024036|449501978|FG001|Blinded Treatment|Adverse Event|1|||
124965766|NCT01024036|449501977|FG000|Blinded Treatment|Lack of Efficacy|16|||
124965767|NCT01024036|449501978|FG001|Blinded Treatment|Lack of Efficacy|14|||
124965768|NCT01024036|449501977|FG000|Blinded Treatment|Physician Decision|1|||
124965769|NCT01024036|449501978|FG001|Blinded Treatment|Physician Decision|0|||
124965770|NCT01024036|449501977|FG000|Blinded Treatment|Death|0|||
124965771|NCT01024036|449501978|FG001|Blinded Treatment|Death|2|||
124965772|NCT01024036|449501977|FG000|Blinded Treatment|Withdrawal by Subject|4|||
124965773|NCT01024036|449501978|FG001|Blinded Treatment|Withdrawal by Subject|3|||
124965774|NCT01024036|449501977|FG000|Unblinded Treatment|Adverse Event|0|||
124965775|NCT01024036|449501978|FG001|Unblinded Treatment|Adverse Event|1|||
124965776|NCT01024036|449501977|FG000|Unblinded Treatment|Lack of Efficacy|0|||
124965777|NCT01024036|449501978|FG001|Unblinded Treatment|Lack of Efficacy|2|||
124965778|NCT01024036|449501977|FG000|Follow-Up Period|Lost to Follow-up|1|||
124965779|NCT01024036|449501978|FG001|Follow-Up Period|Lost to Follow-up|1|||
124965780|NCT01024036|449501977|FG000|Follow-Up Period|Withdrawal by Subject|0|||
124965781|NCT01024036|449501978|FG001|Follow-Up Period|Withdrawal by Subject|1|||
124965782|NCT01024036|449501977|FG000|Follow-Up Period|Adverse Event|4|||
124965783|NCT01024036|449501978|FG001|Follow-Up Period|Adverse Event|1|||
124965784|NCT00604188|449501983|FG000|Overall Study|Adverse Event|1|||
124965785|NCT00604188|449501984|FG001|Overall Study|Adverse Event|4|||
124965786|NCT00604188|449501983|FG000|Overall Study|Lost to Follow-up|17|||
124965787|NCT00604188|449501984|FG001|Overall Study|Lost to Follow-up|15|||
124965788|NCT00604188|449501983|FG000|Overall Study|Withdrawal by Subject|5|||
124710093|NCT01770743|448565288|FG001|Overall Study|Lost to Follow-up|2|||
124965789|NCT00604188|449501984|FG001|Overall Study|Withdrawal by Subject|1|||
124965790|NCT00604188|449501983|FG000|Overall Study|Non-compliance with protocol|4|||
124965791|NCT00604188|449501984|FG001|Overall Study|Non-compliance with protocol|4|||
124965792|NCT00604188|449501983|FG000|Overall Study|Did not receive study drug|0|||
124965793|NCT00604188|449501984|FG001|Overall Study|Did not receive study drug|1|||
124965794|NCT00356759|449501989|FG000|Overall Study|Death|5|||
124965795|NCT00356759|449501990|FG001|Overall Study|Death|2|||
124965796|NCT00356759|449501989|FG000|Overall Study|Withdrawal by Subject|2|||
124965797|NCT00356759|449501990|FG001|Overall Study|Withdrawal by Subject|2|||
124965798|NCT00356759|449501989|FG000|Overall Study|Adverse Event|1|||
124965799|NCT00356759|449501990|FG001|Overall Study|Adverse Event|3|||
124965800|NCT00356759|449501989|FG000|Overall Study|Lost to Follow-up|1|||
124965801|NCT00356759|449501990|FG001|Overall Study|Lost to Follow-up|1|||
124965802|NCT00356759|449501989|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
124965803|NCT00356759|449501990|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
124965804|NCT00474383|449501992|FG000|Main Study|Adverse Event|11|||
124965805|NCT00474383|449501993|FG001|Main Study|Adverse Event|0|||
124965806|NCT00474383|449501992|FG000|Main Study|Symptomatic Deterioration|1|||
124965807|NCT00474383|449501993|FG001|Main Study|Symptomatic Deterioration|0|||
124965808|NCT00474383|449501992|FG000|Main Study|Progressive Disease|23|||
124965809|NCT00474383|449501993|FG001|Main Study|Progressive Disease|0|||
124965810|NCT00474383|449501992|FG000|Main Study|Other|1|||
124965811|NCT00474383|449501993|FG001|Main Study|Other|0|||
124965812|NCT00474383|449501992|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
124965813|NCT00474383|449501993|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
124965814|NCT00474383|449501992|FG000|Extension|Progressive Disease|0|||
124965815|NCT00474383|449501993|FG001|Extension|Progressive Disease|5|||
124965816|NCT02998918|449501994|FG000|Overall Study|Withdrawal by Subject|1|||
124965817|NCT02998918|449501995|FG001|Overall Study|Withdrawal by Subject|0|||
124965818|NCT00443599|449502001|FG000|Overall Study|Physician Decision|2|||
124965819|NCT00443599|449502002|FG001|Overall Study|Physician Decision|1|||
124965820|NCT00443599|449502001|FG000|Overall Study|Death|1|||
124965821|NCT00443599|449502002|FG001|Overall Study|Death|1|||
124965822|NCT00443599|449502001|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
124965823|NCT00443599|449502002|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
124965824|NCT02202109|449503904|FG000|Overall Study|Lost to Follow-up|88|||
124965825|NCT02202109|449503905|FG001|Overall Study|Lost to Follow-up|87|||
124965826|NCT02202109|449503904|FG000|Overall Study|Withdrawal by Subject|2|||
124965827|NCT02202109|449503905|FG001|Overall Study|Withdrawal by Subject|0|||
124965828|NCT01256671|449503907|FG000|Overall Study|Adverse Event|29|||
124965829|NCT01256671|449503907|FG000|Overall Study|Lost to Follow-up|16|||
124965830|NCT01256671|449503907|FG000|Overall Study|Withdrawal by Subject|31|||
124965831|NCT01256671|449503907|FG000|Overall Study|Physician Decision|3|||
124965832|NCT01256671|449503907|FG000|Overall Study|Lack of Efficacy|4|||
124965833|NCT01256671|449503907|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
124965834|NCT01468077|449503914|FG000|Overall Study|Adverse Event|2|||
124965835|NCT01468077|449503915|FG001|Overall Study|Adverse Event|2|||
124965836|NCT01468077|449503914|FG000|Overall Study|Lack of Efficacy|1|||
124965837|NCT01468077|449503915|FG001|Overall Study|Lack of Efficacy|1|||
124965838|NCT01468077|449503914|FG000|Overall Study|Physician Decision|1|||
124965839|NCT01468077|449503915|FG001|Overall Study|Physician Decision|0|||
124965840|NCT00761956|449503916|FG000|Overall Study|Lost to Follow-up|6|||
124965841|NCT00761956|449503917|FG001|Overall Study|Lost to Follow-up|11|||
124965842|NCT00761956|449503916|FG000|Overall Study|Withdrawal by Subject|3|||
124965843|NCT00761956|449503917|FG001|Overall Study|Withdrawal by Subject|8|||
124965844|NCT00761956|449503916|FG000|Overall Study|Death|0|||
124965845|NCT00761956|449503917|FG001|Overall Study|Death|1|||
124965846|NCT00761956|449503916|FG000|Overall Study|Adverse Event|26|||
124965847|NCT00761956|449503917|FG001|Overall Study|Adverse Event|34|||
124965848|NCT03024996|449503918|FG000|Overall Study|Death|57|||
124965849|NCT03024996|449503919|FG001|Overall Study|Death|55|||
124965850|NCT03024996|449503918|FG000|Overall Study|Disease relapse|1|||
124965851|NCT03024996|449503919|FG001|Overall Study|Disease relapse|0|||
124965852|NCT03024996|449503918|FG000|Overall Study|Lost to Follow-up|5|||
124965853|NCT03024996|449503919|FG001|Overall Study|Lost to Follow-up|10|||
124710094|NCT01770743|448565289|FG002|Overall Study|Lost to Follow-up|0|||
124965854|NCT03024996|449503918|FG000|Overall Study|Other|3|||
124965855|NCT03024996|449503919|FG001|Overall Study|Other|3|||
124965856|NCT03024996|449503918|FG000|Overall Study|Physician Decision|0|||
124965857|NCT03024996|449503919|FG001|Overall Study|Physician Decision|1|||
124965858|NCT03024996|449503918|FG000|Overall Study|Study terminated by sponsor|303|||
124965859|NCT03024996|449503919|FG001|Overall Study|Study terminated by sponsor|283|||
124965860|NCT03024996|449503918|FG000|Overall Study|Withdrawal by Subject|21|||
124965861|NCT03024996|449503919|FG001|Overall Study|Withdrawal by Subject|36|||
124965862|NCT00030823|449503924|FG000|Overall Study|Withdrawal by Subject|1|||
124965863|NCT04333147|449503926|FG000|Overall Study|Adverse Event|43|||
124965864|NCT04333147|449503927|FG001|Overall Study|Adverse Event|40|||
124965865|NCT04333147|449503926|FG000|Overall Study|Lack of Efficacy|49|||
124464749|NCT00452699|447659839|FG001|Overall Study|Withdrawal by Subject|25|||
124464750|NCT00452699|447659838|FG000|Overall Study|Other|12|||
124464751|NCT00452699|447659839|FG001|Overall Study|Other|7|||
124965866|NCT04333147|449503927|FG001|Overall Study|Lack of Efficacy|48|||
124965867|NCT04333147|449503926|FG000|Overall Study|Lost to Follow-up|19|||
124965868|NCT04333147|449503927|FG001|Overall Study|Lost to Follow-up|16|||
124965869|NCT04333147|449503926|FG000|Overall Study|Physician Decision|17|||
124965870|NCT04333147|449503927|FG001|Overall Study|Physician Decision|20|||
124965871|NCT04333147|449503926|FG000|Overall Study|Withdrawal by Subject|65|||
124965872|NCT04333147|449503927|FG001|Overall Study|Withdrawal by Subject|68|||
124965873|NCT04333147|449503926|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
124965874|NCT04333147|449503927|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
124965875|NCT04333147|449503926|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
124965876|NCT04333147|449503927|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
124965877|NCT04333147|449503926|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
124965878|NCT04333147|449503927|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
124965879|NCT02106195|449503928|FG000|Overall Study|Adverse Event|2|||
124965880|NCT02106195|449503928|FG000|Overall Study|Protocol Violation|1|||
124965881|NCT00408928|449503929|FG000|Overall Study|Withdrawal by Subject|1|||
124965882|NCT00408928|449503929|FG000|Overall Study|Death|1|||
124965883|NCT00408928|449503929|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
124965884|NCT03194867|449503930|FG000|Overall Study|Incorrect completion of end of study form|0|||
124965885|NCT03194867|449503931|FG001|Overall Study|Incorrect completion of end of study form|0|||
124965886|NCT03194867|449503932|FG002|Overall Study|Incorrect completion of end of study form|1|||
124965887|NCT03194867|449503933|FG003|Overall Study|Incorrect completion of end of study form|0|||
124965888|NCT00464945|449503934|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
124965889|NCT00464945|449503935|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
124965890|NCT00464945|449503934|FG000|Infant Series|Protocol Violation|1|||
124965891|NCT00464945|449503935|FG001|Infant Series|Protocol Violation|0|||
124965892|NCT00464945|449503934|FG000|Infant Series|Lost to Follow-up|1|||
124965893|NCT00464945|449503935|FG001|Infant Series|Lost to Follow-up|0|||
124965894|NCT00464945|449503934|FG000|After Infant Series|Withdrawal by Subject|0|||
124965895|NCT00464945|449503935|FG001|After Infant Series|Withdrawal by Subject|2|||
124965896|NCT00464945|449503934|FG000|Toddler Dose|Lost to Follow-up|0|||
124965897|NCT00464945|449503935|FG001|Toddler Dose|Lost to Follow-up|1|||
124965898|NCT03305809|449503938|FG000|Overall Study|Adverse Event|2|||
124965899|NCT03305809|449503939|FG001|Overall Study|Adverse Event|2|||
124965900|NCT03305809|449503940|FG002|Overall Study|Adverse Event|6|||
124965901|NCT03305809|449503941|FG003|Overall Study|Adverse Event|6|||
124965902|NCT03305809|449503938|FG000|Overall Study|Death|0|||
124965903|NCT03305809|449503939|FG001|Overall Study|Death|0|||
124965904|NCT03305809|449503940|FG002|Overall Study|Death|1|||
124965905|NCT03305809|449503941|FG003|Overall Study|Death|1|||
124965906|NCT03305809|449503938|FG000|Overall Study|Lost to Follow-up|1|||
124965907|NCT03305809|449503939|FG001|Overall Study|Lost to Follow-up|2|||
124965908|NCT03305809|449503940|FG002|Overall Study|Lost to Follow-up|0|||
124965909|NCT03305809|449503941|FG003|Overall Study|Lost to Follow-up|0|||
124965910|NCT03305809|449503938|FG000|Overall Study|Sponsor Decision|1|||
124965911|NCT03305809|449503939|FG001|Overall Study|Sponsor Decision|0|||
124965912|NCT03305809|449503940|FG002|Overall Study|Sponsor Decision|1|||
124965913|NCT03305809|449503941|FG003|Overall Study|Sponsor Decision|8|||
124965914|NCT03305809|449503938|FG000|Overall Study|Physician Decision|0|||
124965915|NCT03305809|449503939|FG001|Overall Study|Physician Decision|0|||
124965916|NCT03305809|449503940|FG002|Overall Study|Physician Decision|2|||
124965917|NCT03305809|449503941|FG003|Overall Study|Physician Decision|4|||
124965918|NCT03305809|449503938|FG000|Overall Study|Progressive Disease|0|||
124965919|NCT03305809|449503939|FG001|Overall Study|Progressive Disease|0|||
124965920|NCT03305809|449503940|FG002|Overall Study|Progressive Disease|1|||
124965921|NCT03305809|449503941|FG003|Overall Study|Progressive Disease|0|||
124965922|NCT03305809|449503938|FG000|Overall Study|Protocol Violation|1|||
124965923|NCT03305809|449503939|FG001|Overall Study|Protocol Violation|0|||
124965924|NCT03305809|449503940|FG002|Overall Study|Protocol Violation|2|||
124464752|NCT00326898|447659840|FG000|Overall Study|Disease progression|52|||
124464753|NCT00326898|447659841|FG001|Overall Study|Disease progression|54|||
124464754|NCT00326898|447659842|FG002|Overall Study|Disease progression|102|||
124464755|NCT00326898|447659840|FG000|Overall Study|Adverse Event|124|||
124464756|NCT00326898|447659841|FG001|Overall Study|Adverse Event|128|||
124965925|NCT03305809|449503941|FG003|Overall Study|Protocol Violation|3|||
124965926|NCT03305809|449503938|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
124965927|NCT03305809|449503939|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
124965928|NCT03305809|449503940|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
124965929|NCT03305809|449503941|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
124965930|NCT03305809|449503938|FG000|Overall Study|Withdrawal by Subject|2|||
124965931|NCT03305809|449503939|FG001|Overall Study|Withdrawal by Subject|4|||
124965932|NCT03305809|449503940|FG002|Overall Study|Withdrawal by Subject|5|||
124464757|NCT00326898|447659842|FG002|Overall Study|Adverse Event|33|||
124464758|NCT00326898|447659840|FG000|Overall Study|Death|2|||
124965933|NCT03305809|449503941|FG003|Overall Study|Withdrawal by Subject|2|||
124965934|NCT03305809|449503938|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
124965935|NCT03305809|449503939|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
124965936|NCT03305809|449503940|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
124965937|NCT03305809|449503941|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
124965938|NCT00816556|449503942|FG000|Overall Study|Adverse Event|1|||
124965939|NCT00816556|449503943|FG001|Overall Study|Adverse Event|1|||
124965940|NCT00816556|449503944|FG002|Overall Study|Adverse Event|1|||
124965941|NCT00816556|449503942|FG000|Overall Study|Withdrawal by Subject|1|||
124965942|NCT00816556|449503943|FG001|Overall Study|Withdrawal by Subject|1|||
124965943|NCT00816556|449503944|FG002|Overall Study|Withdrawal by Subject|1|||
124965944|NCT00816556|449503942|FG000|Overall Study|Lost to Follow-up|0|||
124965945|NCT00816556|449503943|FG001|Overall Study|Lost to Follow-up|0|||
124965946|NCT00816556|449503944|FG002|Overall Study|Lost to Follow-up|1|||
124965947|NCT02438371|449503945|FG000|Overall Study|Lost to Follow-up|3|||
124965948|NCT02438371|449503946|FG001|Overall Study|Lost to Follow-up|2|||
124965949|NCT02438371|449503945|FG000|Overall Study|Withdrawal by Subject|1|||
124965950|NCT02438371|449503946|FG001|Overall Study|Withdrawal by Subject|1|||
124965951|NCT03546816|449503947|FG000|Overall Study|Adverse Event|5|||
124965952|NCT03546816|449503948|FG001|Overall Study|Adverse Event|3|||
124965953|NCT03546816|449503947|FG000|Overall Study|Lack of Efficacy|2|||
124965954|NCT03546816|449503948|FG001|Overall Study|Lack of Efficacy|4|||
124965955|NCT03546816|449503947|FG000|Overall Study|Pregnancy|1|||
124965956|NCT03546816|449503948|FG001|Overall Study|Pregnancy|0|||
124965957|NCT03546816|449503947|FG000|Overall Study|Physician Decision|2|||
124965958|NCT03546816|449503948|FG001|Overall Study|Physician Decision|0|||
124965959|NCT03546816|449503947|FG000|Overall Study|Withdrawal by Subject|8|||
124965960|NCT03546816|449503948|FG001|Overall Study|Withdrawal by Subject|10|||
124965961|NCT03546816|449503947|FG000|Overall Study|Lost to Follow-up|3|||
124965962|NCT03546816|449503948|FG001|Overall Study|Lost to Follow-up|2|||
124965963|NCT01161446|449503949|FG000|Overall Study|Lost to Follow-up|18|||
124965964|NCT01161446|449503950|FG001|Overall Study|Lost to Follow-up|14|||
124965965|NCT01161446|449503949|FG000|Overall Study|Withdrawal by Subject|0|||
124965966|NCT01161446|449503950|FG001|Overall Study|Withdrawal by Subject|1|||
124965967|NCT03065933|449503951|FG000|Overall Study|study terminated|5|||
124965968|NCT02330562|449503952|FG000|Overall Study|Adverse Event|0|||
124965969|NCT02330562|449503953|FG001|Overall Study|Adverse Event|0|||
124965970|NCT02330562|449503954|FG002|Overall Study|Adverse Event|3|||
124965971|NCT02330562|449503955|FG003|Overall Study|Adverse Event|0|||
124965972|NCT02330562|449503956|FG004|Overall Study|Adverse Event|3|||
124965973|NCT02330562|449503957|FG005|Overall Study|Adverse Event|1|||
124965974|NCT02330562|449503958|FG006|Overall Study|Adverse Event|0|||
124965975|NCT02330562|449503959|FG007|Overall Study|Adverse Event|0|||
124965976|NCT02330562|449503960|FG008|Overall Study|Adverse Event|0|||
124965977|NCT02330562|449503961|FG009|Overall Study|Adverse Event|1|||
124965978|NCT02330562|449503962|FG010|Overall Study|Adverse Event|1|||
124965979|NCT02330562|449503952|FG000|Overall Study|Participant decision|1|||
124965980|NCT02330562|449503953|FG001|Overall Study|Participant decision|0|||
124965981|NCT02330562|449503954|FG002|Overall Study|Participant decision|4|||
124965982|NCT02330562|449503955|FG003|Overall Study|Participant decision|1|||
124965983|NCT02330562|449503956|FG004|Overall Study|Participant decision|5|||
124965984|NCT02330562|449503957|FG005|Overall Study|Participant decision|2|||
124965985|NCT02330562|449503958|FG006|Overall Study|Participant decision|0|||
124965986|NCT02330562|449503959|FG007|Overall Study|Participant decision|0|||
124965987|NCT02330562|449503960|FG008|Overall Study|Participant decision|0|||
124965988|NCT02330562|449503961|FG009|Overall Study|Participant decision|3|||
124965989|NCT02330562|449503962|FG010|Overall Study|Participant decision|0|||
124965990|NCT02330562|449503952|FG000|Overall Study|Disease progression|5|||
124965991|NCT02330562|449503953|FG001|Overall Study|Disease progression|3|||
124965992|NCT02330562|449503954|FG002|Overall Study|Disease progression|20|||
124965993|NCT02330562|449503955|FG003|Overall Study|Disease progression|28|||
124965994|NCT02330562|449503956|FG004|Overall Study|Disease progression|23|||
124965995|NCT02330562|449503957|FG005|Overall Study|Disease progression|7|||
124965996|NCT02330562|449503958|FG006|Overall Study|Disease progression|1|||
124965997|NCT02330562|449503959|FG007|Overall Study|Disease progression|1|||
124965998|NCT02330562|449503960|FG008|Overall Study|Disease progression|1|||
124965999|NCT02330562|449503961|FG009|Overall Study|Disease progression|0|||
124966000|NCT02330562|449503962|FG010|Overall Study|Disease progression|5|||
124966001|NCT02330562|449503952|FG000|Overall Study|Other reasons|0|||
124966002|NCT02330562|449503953|FG001|Overall Study|Other reasons|0|||
124966003|NCT02330562|449503954|FG002|Overall Study|Other reasons|0|||
124966004|NCT02330562|449503955|FG003|Overall Study|Other reasons|1|||
124966005|NCT02330562|449503956|FG004|Overall Study|Other reasons|0|||
124966006|NCT02330562|449503957|FG005|Overall Study|Other reasons|0|||
124966007|NCT02330562|449503958|FG006|Overall Study|Other reasons|0|||
124966008|NCT02330562|449503959|FG007|Overall Study|Other reasons|0|||
124966009|NCT02330562|449503960|FG008|Overall Study|Other reasons|0|||
124966010|NCT02330562|449503961|FG009|Overall Study|Other reasons|0|||
124966011|NCT02330562|449503962|FG010|Overall Study|Other reasons|0|||
124464759|NCT00326898|447659841|FG001|Overall Study|Death|0|||
124464760|NCT00326898|447659842|FG002|Overall Study|Death|0|||
124464761|NCT00326898|447659840|FG000|Overall Study|Withdrawal by Subject|134|||
124464762|NCT00326898|447659841|FG001|Overall Study|Withdrawal by Subject|128|||
124464763|NCT00326898|447659842|FG002|Overall Study|Withdrawal by Subject|32|||
124464764|NCT00326898|447659840|FG000|Overall Study|Alternative therapy|1|||
124464765|NCT00326898|447659841|FG001|Overall Study|Alternative therapy|0|||
124464766|NCT00326898|447659842|FG002|Overall Study|Alternative therapy|0|||
124464767|NCT00326898|447659840|FG000|Overall Study|Other complicating disease|5|||
124464768|NCT00326898|447659841|FG001|Overall Study|Other complicating disease|5|||
124464769|NCT00326898|447659842|FG002|Overall Study|Other complicating disease|4|||
124464770|NCT00326898|447659840|FG000|Overall Study|Other/Missing/Unknown|33|||
124464771|NCT00326898|447659841|FG001|Overall Study|Other/Missing/Unknown|28|||
124464772|NCT00326898|447659842|FG002|Overall Study|Other/Missing/Unknown|32|||
124966012|NCT02330562|449503952|FG000|Overall Study|Withdrawal by Subject|0|||
124966013|NCT02330562|449503953|FG001|Overall Study|Withdrawal by Subject|0|||
124966014|NCT02330562|449503954|FG002|Overall Study|Withdrawal by Subject|0|||
124966015|NCT02330562|449503955|FG003|Overall Study|Withdrawal by Subject|0|||
124966016|NCT02330562|449503956|FG004|Overall Study|Withdrawal by Subject|0|||
124966017|NCT02330562|449503957|FG005|Overall Study|Withdrawal by Subject|0|||
124966018|NCT02330562|449503958|FG006|Overall Study|Withdrawal by Subject|0|||
124966019|NCT02330562|449503959|FG007|Overall Study|Withdrawal by Subject|0|||
124966020|NCT02330562|449503960|FG008|Overall Study|Withdrawal by Subject|0|||
124966021|NCT02330562|449503961|FG009|Overall Study|Withdrawal by Subject|1|||
124966022|NCT02330562|449503962|FG010|Overall Study|Withdrawal by Subject|0|||
124464773|NCT03847987|447659843|FG000|Overall Study|Lost to Follow-up|1|||
124464774|NCT03847987|447659844|FG001|Overall Study|Lost to Follow-up|0|||
124464775|NCT03847987|447659843|FG000|Overall Study|Adverse Event|2|||
124966023|NCT01162135|449503966|FG000|Overall Study|Withdrawal by Subject|1|||
124966024|NCT01162135|449503966|FG000|Overall Study|Severe back pain|1|||
124464776|NCT03847987|447659844|FG001|Overall Study|Adverse Event|0|||
124464777|NCT03733392|447659848|FG000|Overall Study|Withdrawal by Subject|11|||
124464778|NCT03733392|447659849|FG001|Overall Study|Withdrawal by Subject|1|||
124966025|NCT01162135|449503966|FG000|Overall Study|Ineligible|1|||
124966026|NCT01379703|449503967|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
124966027|NCT01379703|449503968|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
124966028|NCT01379703|449503969|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
124966029|NCT01379703|449503967|FG000|Study Start Through 9 Months|Adverse Event|0|||
124966030|NCT01379703|449503968|FG001|Study Start Through 9 Months|Adverse Event|14|||
124966031|NCT01379703|449503969|FG002|Study Start Through 9 Months|Adverse Event|10|||
124966032|NCT01379703|449503967|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
124966033|NCT01379703|449503968|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
124966034|NCT01379703|449503969|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
124966035|NCT01379703|449503967|FG000|Study Start Through 9 Months|Treatment Failure|0|||
124966036|NCT01379703|449503968|FG001|Study Start Through 9 Months|Treatment Failure|2|||
124966037|NCT01379703|449503969|FG002|Study Start Through 9 Months|Treatment Failure|2|||
124966038|NCT01379703|449503967|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
124966039|NCT01379703|449503968|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
124966040|NCT01379703|449503969|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
124966041|NCT01379703|449503967|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
124966042|NCT01379703|449503968|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
124966043|NCT01379703|449503969|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
124966044|NCT01379703|449503967|FG000|Study Start Through 9 Months|Medication not available|0|||
124966045|NCT01379703|449503968|FG001|Study Start Through 9 Months|Medication not available|2|||
124966046|NCT01379703|449503969|FG002|Study Start Through 9 Months|Medication not available|1|||
124966047|NCT01379703|449503967|FG000|Study Start Through 9 Months|Poor general condition|0|||
124966048|NCT01379703|449503968|FG001|Study Start Through 9 Months|Poor general condition|1|||
124966049|NCT01379703|449503969|FG002|Study Start Through 9 Months|Poor general condition|0|||
124966050|NCT01379703|449503967|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
124966051|NCT01379703|449503968|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
124966052|NCT01379703|449503969|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
124966053|NCT01379703|449503967|FG000|Study Start Through 9 Months|Reason unknown|2|||
124966054|NCT01379703|449503968|FG001|Study Start Through 9 Months|Reason unknown|31|||
124966055|NCT01379703|449503969|FG002|Study Start Through 9 Months|Reason unknown|24|||
124966056|NCT01379703|449503967|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
124966057|NCT01379703|449503968|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
124966058|NCT01379703|449503969|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
124966059|NCT01379703|449503967|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
124966060|NCT01379703|449503968|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
124966061|NCT01379703|449503969|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
124966062|NCT01379703|449503967|FG000|9 Months Through 18 Months|Adverse Event|0|||
124966063|NCT01379703|449503968|FG001|9 Months Through 18 Months|Adverse Event|6|||
124966064|NCT01379703|449503969|FG002|9 Months Through 18 Months|Adverse Event|0|||
124966065|NCT01379703|449503967|FG000|9 Months Through 18 Months|Treatment failure|0|||
124966066|NCT01379703|449503968|FG001|9 Months Through 18 Months|Treatment failure|5|||
124966067|NCT01379703|449503969|FG002|9 Months Through 18 Months|Treatment failure|0|||
124966068|NCT01379703|449503967|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
124966069|NCT01379703|449503968|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
124966070|NCT01379703|449503969|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
124966071|NCT01379703|449503967|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
124966072|NCT01379703|449503968|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
124966073|NCT01379703|449503969|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
124966074|NCT01379703|449503967|FG000|9 Months Through 18 Months|Fatigue|0|||
124966075|NCT01379703|449503968|FG001|9 Months Through 18 Months|Fatigue|1|||
124966076|NCT01379703|449503969|FG002|9 Months Through 18 Months|Fatigue|0|||
124966077|NCT01379703|449503967|FG000|9 Months Through 18 Months|Reason Unknown|0|||
124966078|NCT01379703|449503968|FG001|9 Months Through 18 Months|Reason Unknown|23|||
124966079|NCT01379703|449503969|FG002|9 Months Through 18 Months|Reason Unknown|0|||
124966080|NCT01316887|449503970|FG000|Overall Study|Adverse Event|13|||
124966081|NCT01316887|449503971|FG001|Overall Study|Adverse Event|21|||
124966082|NCT01316887|449503972|FG002|Overall Study|Adverse Event|17|||
124966083|NCT01316887|449503970|FG000|Overall Study|Lack of Efficacy|9|||
124966084|NCT01316887|449503971|FG001|Overall Study|Lack of Efficacy|3|||
124966085|NCT01316887|449503972|FG002|Overall Study|Lack of Efficacy|1|||
124966086|NCT01316887|449503970|FG000|Overall Study|Protocol Violation|2|||
124966087|NCT01316887|449503971|FG001|Overall Study|Protocol Violation|6|||
124966088|NCT01316887|449503972|FG002|Overall Study|Protocol Violation|6|||
124966089|NCT01316887|449503970|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
124966090|NCT01316887|449503971|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
124966091|NCT01316887|449503972|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
124966092|NCT01316887|449503970|FG000|Overall Study|Study Closed/Terminated|2|||
124966093|NCT01316887|449503971|FG001|Overall Study|Study Closed/Terminated|4|||
124966094|NCT01316887|449503972|FG002|Overall Study|Study Closed/Terminated|3|||
124966095|NCT01316887|449503970|FG000|Overall Study|Lost to Follow-up|1|||
124966096|NCT01316887|449503971|FG001|Overall Study|Lost to Follow-up|7|||
124464779|NCT03733392|447659848|FG000|Overall Study|Death|1|||
124464780|NCT03733392|447659849|FG001|Overall Study|Death|0|||
124966097|NCT01316887|449503972|FG002|Overall Study|Lost to Follow-up|5|||
124966098|NCT01316887|449503970|FG000|Overall Study|Withdrawal by Subject|8|||
124966099|NCT01316887|449503971|FG001|Overall Study|Withdrawal by Subject|16|||
124966100|NCT01316887|449503972|FG002|Overall Study|Withdrawal by Subject|15|||
124966101|NCT00813098|449503973|FG000|Overall Study|Adverse Event|2|||
124966102|NCT00813098|449503974|FG001|Overall Study|Adverse Event|4|||
124966103|NCT00813098|449503975|FG002|Overall Study|Adverse Event|1|||
124966104|NCT00813098|449503973|FG000|Overall Study|Withdrawal by Subject|0|||
124966105|NCT00813098|449503974|FG001|Overall Study|Withdrawal by Subject|1|||
124966106|NCT00813098|449503975|FG002|Overall Study|Withdrawal by Subject|0|||
124966107|NCT00813098|449503973|FG000|Overall Study|Inability to complete study procedures|1|||
124966108|NCT00813098|449503974|FG001|Overall Study|Inability to complete study procedures|0|||
124966109|NCT00813098|449503975|FG002|Overall Study|Inability to complete study procedures|0|||
124966110|NCT00813098|449503973|FG000|Overall Study|Lost to Follow-up|0|||
124966111|NCT00813098|449503974|FG001|Overall Study|Lost to Follow-up|1|||
124966112|NCT00813098|449503975|FG002|Overall Study|Lost to Follow-up|0|||
124966113|NCT00813098|449503973|FG000|Overall Study|Protocol Violation|0|||
124966114|NCT00813098|449503974|FG001|Overall Study|Protocol Violation|0|||
124966115|NCT00813098|449503975|FG002|Overall Study|Protocol Violation|1|||
124966116|NCT00813098|449503973|FG000|Overall Study|Principal Investigator decision|0|||
124966117|NCT00813098|449503974|FG001|Overall Study|Principal Investigator decision|1|||
124966118|NCT00813098|449503975|FG002|Overall Study|Principal Investigator decision|0|||
124966119|NCT00813098|449503973|FG000|Overall Study|Withdrew Consent|0|||
124966120|NCT00813098|449503974|FG001|Overall Study|Withdrew Consent|1|||
124966121|NCT00813098|449503975|FG002|Overall Study|Withdrew Consent|0|||
124966122|NCT03470545|449503978|FG000|Overall Study|Death|0|||
124966123|NCT03470545|449503979|FG001|Overall Study|Death|1|||
124966124|NCT03470545|449503978|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
124966125|NCT03470545|449503979|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
124966126|NCT03470545|449503978|FG000|Overall Study|Adverse Event|2|||
124966127|NCT03470545|449503979|FG001|Overall Study|Adverse Event|0|||
124966128|NCT03470545|449503978|FG000|Overall Study|Withdrawal by Subject|1|||
124966129|NCT03470545|449503979|FG001|Overall Study|Withdrawal by Subject|1|||
124966130|NCT03470545|449503978|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
124966131|NCT03470545|449503979|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
124966132|NCT02312206|449503980|FG000|Overall Study|Adverse Event|3|||
124966133|NCT02312206|449503981|FG001|Overall Study|Adverse Event|6|||
124966134|NCT02312206|449503980|FG000|Overall Study|Withdrawal by Subject|6|||
124966135|NCT02312206|449503981|FG001|Overall Study|Withdrawal by Subject|6|||
124966136|NCT02312206|449503980|FG000|Overall Study|Physician Decision|7|||
124966137|NCT02312206|449503981|FG001|Overall Study|Physician Decision|6|||
124966138|NCT02312206|449503980|FG000|Overall Study|Death|31|||
124966139|NCT02312206|449503981|FG001|Overall Study|Death|36|||
124966140|NCT02312206|449503980|FG000|Overall Study|Study Terminated by Sponsor|81|||
124966141|NCT02312206|449503981|FG001|Overall Study|Study Terminated by Sponsor|74|||
124966142|NCT02312206|449503980|FG000|Overall Study|Patient transferred to hospice|0|||
124966143|NCT02312206|449503981|FG001|Overall Study|Patient transferred to hospice|1|||
124966144|NCT02312206|449503980|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
124966145|NCT02312206|449503981|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
124966146|NCT02312206|449503980|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
124966147|NCT02312206|449503981|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
124966148|NCT02312206|449503980|FG000|Overall Study|Disease Progression|1|||
124966149|NCT02312206|449503981|FG001|Overall Study|Disease Progression|0|||
124966150|NCT00585975|449503982|FG000|Overall Study|Withdrawal by Subject|3|||
124966151|NCT00585975|449503983|FG001|Overall Study|Withdrawal by Subject|3|||
124966152|NCT00585975|449503982|FG000|Overall Study|Lost to Follow-up|2|||
124966153|NCT00585975|449503983|FG001|Overall Study|Lost to Follow-up|1|||
124966154|NCT00585975|449503982|FG000|Overall Study|Enrollment met/over-enrolled|10|||
124966155|NCT00585975|449503983|FG001|Overall Study|Enrollment met/over-enrolled|9|||
124966156|NCT03082612|449503984|FG000|Overall Study|Lost to Follow-up|2|||
124966157|NCT03082612|449503985|FG001|Overall Study|Lost to Follow-up|0|||
124966158|NCT01336205|449503986|FG000|Overall Study|Other|22|||
124966159|NCT01336205|449503987|FG001|Overall Study|Other|9|||
124966160|NCT01336205|449503986|FG000|Overall Study|Lost to Follow-up|40|||
124966161|NCT01336205|449503987|FG001|Overall Study|Lost to Follow-up|20|||
124966162|NCT01336205|449503986|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
124966163|NCT01336205|449503987|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
124966164|NCT01336205|449503986|FG000|Overall Study|Lack of Efficacy|4|||
124966165|NCT01336205|449503987|FG001|Overall Study|Lack of Efficacy|0|||
124549972|NCT01915498|447969006|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
124549973|NCT01915498|447969007|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
124710095|NCT01770743|448565290|FG003|Overall Study|Lost to Follow-up|0|||
124966166|NCT01336205|449503986|FG000|Overall Study|Severe noncompliance with protocol|9|||
124549974|NCT01915498|447969008|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
124549975|NCT01915498|447969009|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
124549976|NCT01915498|447969010|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
124549977|NCT01915498|447969011|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
124549978|NCT01915498|447969012|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
124549979|NCT01915498|447969013|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
124549980|NCT01915498|447969014|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
124549981|NCT01915498|447969015|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
124549982|NCT01915498|447969016|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
124549983|NCT01915498|447968998|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
124549984|NCT01915498|447968999|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
124549985|NCT01915498|447969000|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
124549986|NCT01915498|447969001|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
124549987|NCT01915498|447969002|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
124549988|NCT01915498|447969003|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
124549989|NCT01915498|447969004|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
124549990|NCT01915498|447969005|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
124549991|NCT01915498|447969006|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
124549992|NCT01915498|447969007|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
124549993|NCT01915498|447969008|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
124549994|NCT01915498|447969009|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
124549995|NCT01915498|447969010|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
124549996|NCT01915498|447969011|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
124549997|NCT01915498|447969012|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
124549998|NCT01915498|447969013|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
124549999|NCT01915498|447969014|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
124550000|NCT01915498|447969015|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
124550001|NCT01915498|447969016|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
124550002|NCT01915498|447968998|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
124550003|NCT01915498|447968999|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
124550004|NCT01915498|447969000|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
124550005|NCT01915498|447969001|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
124550006|NCT01915498|447969002|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
124550007|NCT01915498|447969003|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
124550008|NCT01915498|447969004|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
124550009|NCT01915498|447969005|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
124550010|NCT01915498|447969006|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
124550011|NCT01915498|447969007|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
124550012|NCT01915498|447969008|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
124550013|NCT01915498|447969009|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
124550014|NCT01915498|447969010|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
124550015|NCT01915498|447969011|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
124550016|NCT01915498|447969012|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
124550017|NCT01915498|447969013|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
124550018|NCT01915498|447969014|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
124550019|NCT01915498|447969015|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
124550020|NCT01915498|447969016|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
124550021|NCT01915498|447968998|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
124550022|NCT01915498|447968999|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
124550023|NCT01915498|447969000|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
124550024|NCT01915498|447969001|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
124550025|NCT01915498|447969002|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
124710096|NCT01770743|448565291|FG004|Overall Study|Lost to Follow-up|1|||
124550026|NCT01915498|447969003|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
124550027|NCT01915498|447969004|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
124550028|NCT01915498|447969005|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
124550029|NCT01915498|447969006|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
124550030|NCT01915498|447969007|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
124464781|NCT03733392|447659848|FG000|Overall Study|Lost to Follow-up|5|||
124464782|NCT03733392|447659849|FG001|Overall Study|Lost to Follow-up|0|||
124464783|NCT03733392|447659848|FG000|Overall Study|Protocol Violation|0|||
124464784|NCT03733392|447659849|FG001|Overall Study|Protocol Violation|1|||
124464785|NCT03733392|447659848|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
124464786|NCT03733392|447659849|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
124464787|NCT03733392|447659848|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
124464788|NCT03733392|447659849|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
124464789|NCT03733392|447659848|FG000|Overall Study|Patient Non-Compliance|2|||
124464790|NCT03733392|447659849|FG001|Overall Study|Patient Non-Compliance|1|||
124464791|NCT03733392|447659848|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
124464792|NCT03733392|447659849|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
124464793|NCT03733392|447659848|FG000|Overall Study|Withdrawal prior to procedure|5|||
124464794|NCT03733392|447659849|FG001|Overall Study|Withdrawal prior to procedure|2|||
124464795|NCT00883337|447659852|FG000|Core Treatment Period|Adverse Event|9|||
124464796|NCT00883337|447659853|FG001|Core Treatment Period|Adverse Event|12|||
124464797|NCT00883337|447659854|FG002|Core Treatment Period|Adverse Event|22|||
124464798|NCT00883337|447659852|FG000|Core Treatment Period|Lack of Efficacy|7|||
124464799|NCT00883337|447659853|FG001|Core Treatment Period|Lack of Efficacy|4|||
124464800|NCT00883337|447659854|FG002|Core Treatment Period|Lack of Efficacy|2|||
124464801|NCT00883337|447659852|FG000|Core Treatment Period|Lost to Follow-up|1|||
124464802|NCT00883337|447659853|FG001|Core Treatment Period|Lost to Follow-up|1|||
124464803|NCT00883337|447659854|FG002|Core Treatment Period|Lost to Follow-up|0|||
124464804|NCT00883337|447659852|FG000|Core Treatment Period|Withdrawal by Subject|2|||
124464805|NCT00883337|447659853|FG001|Core Treatment Period|Withdrawal by Subject|2|||
124464806|NCT00883337|447659854|FG002|Core Treatment Period|Withdrawal by Subject|6|||
124464807|NCT00883337|447659852|FG000|Core Treatment Period|Wish to be pregnant|1|||
124464808|NCT00883337|447659853|FG001|Core Treatment Period|Wish to be pregnant|2|||
124464809|NCT00883337|447659854|FG002|Core Treatment Period|Wish to be pregnant|1|||
124464810|NCT00883337|447659852|FG000|Core Treatment Period|Poor compliance to protocol|0|||
124464811|NCT00883337|447659853|FG001|Core Treatment Period|Poor compliance to protocol|0|||
124464812|NCT00883337|447659854|FG002|Core Treatment Period|Poor compliance to protocol|1|||
124464813|NCT00883337|447659852|FG000|Core Treatment Period|Other than above|0|||
124464814|NCT00883337|447659853|FG001|Core Treatment Period|Other than above|1|||
124464815|NCT00883337|447659854|FG002|Core Treatment Period|Other than above|1|||
124464816|NCT00883337|447659852|FG000|Extension Treatment Period|Adverse Event|8|||
124464817|NCT00883337|447659853|FG001|Extension Treatment Period|Adverse Event|5|||
124464818|NCT00883337|447659854|FG002|Extension Treatment Period|Adverse Event|5|||
124464819|NCT00883337|447659852|FG000|Extension Treatment Period|Lack of Efficacy|8|||
124464820|NCT00883337|447659853|FG001|Extension Treatment Period|Lack of Efficacy|8|||
124464821|NCT00883337|447659854|FG002|Extension Treatment Period|Lack of Efficacy|8|||
124464822|NCT00883337|447659852|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
124464823|NCT00883337|447659853|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
124464824|NCT00883337|447659854|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
124464825|NCT00883337|447659852|FG000|Extension Treatment Period|Lost to Follow-up|1|||
124464826|NCT00883337|447659853|FG001|Extension Treatment Period|Lost to Follow-up|0|||
124464827|NCT00883337|447659854|FG002|Extension Treatment Period|Lost to Follow-up|0|||
124464828|NCT00883337|447659852|FG000|Extension Treatment Period|Other than above|10|||
124464829|NCT00883337|447659853|FG001|Extension Treatment Period|Other than above|9|||
124464830|NCT00883337|447659854|FG002|Extension Treatment Period|Other than above|5|||
124550031|NCT01915498|447969008|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
124550032|NCT01915498|447969009|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
124550033|NCT01915498|447969010|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
124550034|NCT01915498|447969011|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
124550035|NCT01915498|447969012|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
124550036|NCT01915498|447969013|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
124550037|NCT01915498|447969014|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
124550038|NCT01915498|447969015|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
124550039|NCT01915498|447969016|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
124550040|NCT01915498|447968998|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
124550041|NCT01915498|447968999|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
124550042|NCT01915498|447969000|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
124550043|NCT01915498|447969001|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
124550044|NCT01915498|447969002|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
124550045|NCT01915498|447969003|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
124550046|NCT01915498|447969004|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
124550047|NCT01915498|447969005|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
124550048|NCT01915498|447969006|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
124550049|NCT01915498|447969007|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
124550050|NCT01915498|447969008|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
124550051|NCT01915498|447969009|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
124550052|NCT01915498|447969010|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
124550053|NCT01915498|447969011|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
124550054|NCT01915498|447969012|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
124550055|NCT01915498|447969013|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
124550056|NCT01915498|447969014|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
124550057|NCT01915498|447969015|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
124550058|NCT01915498|447969016|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
124550059|NCT01915498|447968998|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550060|NCT01915498|447968999|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550061|NCT01915498|447969000|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550062|NCT01915498|447969001|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550063|NCT01915498|447969002|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550064|NCT01915498|447969003|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550065|NCT01915498|447969004|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550066|NCT01915498|447969005|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550067|NCT01915498|447969006|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550068|NCT01915498|447969007|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550069|NCT01915498|447969008|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
124550070|NCT01915498|447969009|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550071|NCT01915498|447969010|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550072|NCT01915498|447969011|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550073|NCT01915498|447969012|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550074|NCT01915498|447969013|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550075|NCT01915498|447969014|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550076|NCT01915498|447969015|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550077|NCT01915498|447969016|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
124550078|NCT01915498|447968998|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
124550079|NCT01915498|447968999|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
124550080|NCT01915498|447969000|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
124550081|NCT01915498|447969001|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
124550082|NCT01915498|447969002|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
124550083|NCT01915498|447969003|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
124550084|NCT01915498|447969004|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
124550085|NCT01915498|447969005|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
124550086|NCT01915498|447969006|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
124550087|NCT01915498|447969007|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
124550088|NCT01915498|447969008|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
124966167|NCT01336205|449503987|FG001|Overall Study|Severe noncompliance with protocol|2|||
124966168|NCT01336205|449503986|FG000|Overall Study|Adverse Event|56|||
124966169|NCT01336205|449503987|FG001|Overall Study|Adverse Event|6|||
124966170|NCT01336205|449503986|FG000|Overall Study|Death|1|||
124966171|NCT01336205|449503987|FG001|Overall Study|Death|1|||
124966172|NCT01336205|449503986|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
124966173|NCT01336205|449503987|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
124966174|NCT01336205|449503986|FG000|Overall Study|Withdrawal by Subject|72|||
124966175|NCT01336205|449503987|FG001|Overall Study|Withdrawal by Subject|38|||
124966176|NCT01336205|449503986|FG000|Overall Study|Did not receive treatment|4|||
124966177|NCT01336205|449503987|FG001|Overall Study|Did not receive treatment|0|||
124966178|NCT01006616|449503988|FG000|Period 1 (6 Months)|Adverse Event|10|||
124966179|NCT01006616|449503989|FG001|Period 1 (6 Months)|Adverse Event|31|||
124966180|NCT01006616|449503990|FG002|Period 1 (6 Months)|Adverse Event|37|||
124966181|NCT01006616|449503991|FG003|Period 1 (6 Months)|Adverse Event|9|||
124966182|NCT01006616|449503988|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
124966183|NCT01006616|449503989|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
124966184|NCT01006616|449503990|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
124966185|NCT01006616|449503991|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
124966186|NCT01006616|449503988|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
124966187|NCT01006616|449503989|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
124966188|NCT01006616|449503990|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
124966189|NCT01006616|449503991|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
124966190|NCT01006616|449503988|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
124966191|NCT01006616|449503989|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
124966192|NCT01006616|449503990|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
124966193|NCT01006616|449503991|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
124966194|NCT01006616|449503988|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
124966195|NCT01006616|449503989|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
124966196|NCT01006616|449503990|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
124966197|NCT01006616|449503991|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
124966198|NCT01006616|449503988|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
124966199|NCT01006616|449503989|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
124966200|NCT01006616|449503990|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
124966201|NCT01006616|449503991|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
124966202|NCT01006616|449503988|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
124966203|NCT01006616|449503989|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
124966204|NCT01006616|449503990|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
124966205|NCT01006616|449503991|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
124966206|NCT01006616|449503988|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
124966207|NCT01006616|449503989|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
124966208|NCT01006616|449503990|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
124966209|NCT01006616|449503991|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
124966210|NCT01006616|449503988|FG000|Period 1 (6 Months)|Not Treated|0|||
124966211|NCT01006616|449503989|FG001|Period 1 (6 Months)|Not Treated|0|||
124966212|NCT01006616|449503990|FG002|Period 1 (6 Months)|Not Treated|1|||
124966213|NCT01006616|449503991|FG003|Period 1 (6 Months)|Not Treated|1|||
124966214|NCT01006616|449503988|FG000|Period 2 (18 Months)|Adverse Event|6|||
124966215|NCT01006616|449503989|FG001|Period 2 (18 Months)|Adverse Event|6|||
124966216|NCT01006616|449503990|FG002|Period 2 (18 Months)|Adverse Event|6|||
124966217|NCT01006616|449503991|FG003|Period 2 (18 Months)|Adverse Event|4|||
124966218|NCT01006616|449503988|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
124966219|NCT01006616|449503989|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
124966220|NCT01006616|449503990|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
124966221|NCT01006616|449503991|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
124966222|NCT01006616|449503988|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
124966223|NCT01006616|449503989|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
124966224|NCT01006616|449503990|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
124966225|NCT01006616|449503991|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
124966226|NCT01006616|449503988|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
124966227|NCT01006616|449503989|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
124966228|NCT01006616|449503990|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
124966229|NCT01006616|449503991|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
124966230|NCT01006616|449503988|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
124966231|NCT01006616|449503989|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
124966232|NCT01006616|449503990|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
124966233|NCT01006616|449503991|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
124550089|NCT01915498|447969009|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
124966234|NCT01006616|449503988|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
124966235|NCT01006616|449503989|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
124966236|NCT01006616|449503990|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
124966237|NCT01006616|449503991|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
124966238|NCT01006616|449503988|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
124966239|NCT01006616|449503989|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
124966240|NCT01006616|449503990|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
124966241|NCT01006616|449503991|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
124966242|NCT01006616|449503988|FG000|Period 2 (18 Months)|Study Terminated|63|||
124966243|NCT01006616|449503989|FG001|Period 2 (18 Months)|Study Terminated|46|||
124966244|NCT01006616|449503990|FG002|Period 2 (18 Months)|Study Terminated|44|||
124966245|NCT01006616|449503991|FG003|Period 2 (18 Months)|Study Terminated|70|||
124966246|NCT03672175|449503994|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
124966247|NCT03672175|449503995|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
124966248|NCT03672175|449503996|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
124966249|NCT03672175|449503994|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
124966250|NCT03672175|449503995|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
124966251|NCT03672175|449503996|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
124966252|NCT03672175|449503994|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
124966253|NCT03672175|449503995|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
124966254|NCT03672175|449503996|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
124710097|NCT01770743|448565287|FG000|Overall Study|Sponsor Terminated Subject|1|||
124710098|NCT01770743|448565288|FG001|Overall Study|Sponsor Terminated Subject|0|||
124710099|NCT01770743|448565289|FG002|Overall Study|Sponsor Terminated Subject|0|||
124710100|NCT01770743|448565290|FG003|Overall Study|Sponsor Terminated Subject|1|||
124966255|NCT03672175|449503994|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
124966256|NCT03672175|449503995|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
124966257|NCT03672175|449503996|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
124966258|NCT03672175|449503994|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
124966259|NCT03672175|449503995|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
124966260|NCT03672175|449503996|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
124966261|NCT03672175|449503994|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
124966262|NCT03672175|449503995|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
124966263|NCT03672175|449503996|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
124966264|NCT03672175|449503994|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
124966265|NCT03672175|449503995|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
124966266|NCT03672175|449503996|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
124966267|NCT03672175|449503994|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
124966268|NCT03672175|449503995|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
124966269|NCT03672175|449503996|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
124966270|NCT03672175|449503994|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
124966271|NCT03672175|449503995|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
124966272|NCT03672175|449503996|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
124966273|NCT03672175|449503994|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
124966274|NCT03672175|449503995|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
124710101|NCT01770743|448565291|FG004|Overall Study|Sponsor Terminated Subject|0|||
124710102|NCT01770743|448565287|FG000|Overall Study|Moving Out of State|0|||
124710103|NCT01770743|448565288|FG001|Overall Study|Moving Out of State|1|||
124710104|NCT01770743|448565289|FG002|Overall Study|Moving Out of State|0|||
124710105|NCT01770743|448565290|FG003|Overall Study|Moving Out of State|0|||
124710106|NCT01770743|448565291|FG004|Overall Study|Moving Out of State|0|||
124710107|NCT00755807|448565292|FG000|Acute Phase|Adverse Event|16|||
124710108|NCT00755807|448565293|FG001|Acute Phase|Adverse Event|5|||
124710109|NCT00755807|448565292|FG000|Acute Phase|Protocol Violation|1|||
124710110|NCT00755807|448565293|FG001|Acute Phase|Protocol Violation|3|||
124710111|NCT00755807|448565292|FG000|Acute Phase|Withdrawal by Subject|1|||
124710112|NCT00755807|448565293|FG001|Acute Phase|Withdrawal by Subject|2|||
124710113|NCT00755807|448565292|FG000|Acute Phase|Lack of Efficacy|0|||
124710114|NCT00755807|448565293|FG001|Acute Phase|Lack of Efficacy|1|||
124710115|NCT00755807|448565292|FG000|Acute Phase|Physician Decision|0|||
124710116|NCT00755807|448565293|FG001|Acute Phase|Physician Decision|1|||
124710117|NCT00755807|448565292|FG000|Open-label Extension Phase|Adverse Event|7|||
124710118|NCT00755807|448565293|FG001|Open-label Extension Phase|Adverse Event|7|||
124710119|NCT00755807|448565292|FG000|Open-label Extension Phase|Protocol Violation|5|||
124710120|NCT00755807|448565293|FG001|Open-label Extension Phase|Protocol Violation|2|||
124710121|NCT00755807|448565292|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
124710122|NCT00755807|448565293|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
124710123|NCT00755807|448565292|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
124710124|NCT00755807|448565293|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
124710125|NCT00755807|448565292|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
124710126|NCT00755807|448565293|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
124710127|NCT00755807|448565292|FG000|Open-label Extension Phase|Sponsor Decision|0|||
124710128|NCT00755807|448565293|FG001|Open-label Extension Phase|Sponsor Decision|1|||
124710129|NCT00529243|448565296|FG000|Overall Study|Adverse Event|1|||
124710130|NCT00529243|448565296|FG000|Overall Study|Death|1|||
124966275|NCT03672175|449503996|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
124966276|NCT03672175|449503994|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
124966277|NCT03672175|449503995|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
124966278|NCT03672175|449503996|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
124966279|NCT03672175|449503994|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
124966280|NCT03672175|449503995|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
124966281|NCT03672175|449503996|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
124966282|NCT02482935|449503997|FG000|Period 1|Withdrawal by Subject|1|||
124966283|NCT02482935|449503998|FG001|Period 1|Withdrawal by Subject|0|||
124966284|NCT03414047|449503999|FG000|Overall Study|Adverse Event|0|||
124966285|NCT03414047|449504000|FG001|Overall Study|Adverse Event|0|||
124966286|NCT03414047|449504001|FG002|Overall Study|Adverse Event|1|||
124966287|NCT03414047|449504002|FG003|Overall Study|Adverse Event|1|||
124966288|NCT03414047|449503999|FG000|Overall Study|Physician Decision|1|||
124966289|NCT03414047|449504000|FG001|Overall Study|Physician Decision|0|||
124966290|NCT03414047|449504001|FG002|Overall Study|Physician Decision|0|||
124966291|NCT03414047|449504002|FG003|Overall Study|Physician Decision|1|||
124966292|NCT03414047|449503999|FG000|Overall Study|Withdrawal by Subject|1|||
124966293|NCT03414047|449504000|FG001|Overall Study|Withdrawal by Subject|0|||
124966294|NCT03414047|449504001|FG002|Overall Study|Withdrawal by Subject|2|||
124966295|NCT03414047|449504002|FG003|Overall Study|Withdrawal by Subject|0|||
124966296|NCT00217022|449504010|FG000|Overall Study|Withdrawal by Subject|1|||
124966297|NCT00217022|449504011|FG001|Overall Study|Withdrawal by Subject|1|||
124966298|NCT02777242|449504015|FG000|Overall Study|Other|2|||
124966299|NCT02777242|449504015|FG000|Overall Study|Lost to Follow-up|1|||
124966300|NCT02777242|449504015|FG000|Overall Study|Multiple|1|||
124966301|NCT02777242|449504015|FG000|Overall Study|Sponsor's request|1|||
124966302|NCT02777242|449504015|FG000|Overall Study|Withdrawal by Subject|1|||
124966303|NCT01898442|449504016|FG000|Overall Study|Hemolysis/technical problems|1|||
124966304|NCT01898442|449504017|FG001|Overall Study|Hemolysis/technical problems|2|||
124966305|NCT01898442|449504018|FG002|Overall Study|Hemolysis/technical problems|2|||
124966306|NCT01898442|449504016|FG000|Overall Study|Patient vomited pills|0|||
124966307|NCT01898442|449504017|FG001|Overall Study|Patient vomited pills|0|||
124966308|NCT01898442|449504018|FG002|Overall Study|Patient vomited pills|1|||
124966309|NCT05178979|449504019|FG000|Overall Study|Death|0|||
124966310|NCT05178979|449504020|FG001|Overall Study|Death|5|||
124966311|NCT05178979|449504021|FG002|Overall Study|Death|0|||
124966312|NCT05178979|449504022|FG003|Overall Study|Death|3|||
124966313|NCT05178979|449504019|FG000|Overall Study|Adverse Event|0|||
124966314|NCT05178979|449504020|FG001|Overall Study|Adverse Event|1|||
124966315|NCT05178979|449504021|FG002|Overall Study|Adverse Event|0|||
124966316|NCT05178979|449504022|FG003|Overall Study|Adverse Event|0|||
124966317|NCT05178979|449504019|FG000|Overall Study|Lost to Follow-up|1|||
124966318|NCT05178979|449504020|FG001|Overall Study|Lost to Follow-up|8|||
124966319|NCT05178979|449504021|FG002|Overall Study|Lost to Follow-up|3|||
124966320|NCT05178979|449504022|FG003|Overall Study|Lost to Follow-up|8|||
124966321|NCT02980705|449504029|FG000|Overall Study|Adverse Event|0|||
124966322|NCT02980705|449504030|FG001|Overall Study|Adverse Event|1|||
124966323|NCT02980705|449504029|FG000|Overall Study|Withdrawal by Subject|6|||
124966324|NCT02980705|449504030|FG001|Overall Study|Withdrawal by Subject|9|||
124966325|NCT02980705|449504029|FG000|Overall Study|withdrew participation|0|||
124966326|NCT02980705|449504030|FG001|Overall Study|withdrew participation|1|||
124966327|NCT02980705|449504029|FG000|Overall Study|Lost to Follow-up|2|||
124966328|NCT02980705|449504030|FG001|Overall Study|Lost to Follow-up|0|||
124966329|NCT01721746|449504031|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
124966330|NCT01721746|449504032|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
124966331|NCT01721746|449504031|FG000|Pre-Treatment|Withdrawal by Subject|1|||
124966332|NCT01721746|449504032|FG001|Pre-Treatment|Withdrawal by Subject|16|||
124966333|NCT01721746|449504031|FG000|Pre-Treatment|Poor/Non-compliance|1|||
124966334|NCT01721746|449504032|FG001|Pre-Treatment|Poor/Non-compliance|0|||
124966335|NCT01721746|449504031|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
124966336|NCT01721746|449504032|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
124966337|NCT01721746|449504031|FG000|Treatment|Disease Progression|192|||
124966338|NCT01721746|449504032|FG001|Treatment|Disease Progression|74|||
124966339|NCT01721746|449504031|FG000|Treatment|Study Drug Toxicity|19|||
124966340|NCT01721746|449504032|FG001|Treatment|Study Drug Toxicity|11|||
124966341|NCT01721746|449504031|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
124966342|NCT01721746|449504032|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
124966343|NCT01721746|449504031|FG000|Treatment|Participant request to discontinue Study treatment|26|||
124966344|NCT01721746|449504032|FG001|Treatment|Participant request to discontinue Study treatment|7|||
124966345|NCT01721746|449504031|FG000|Treatment|Participant withdrew consent|4|||
124966346|NCT01721746|449504032|FG001|Treatment|Participant withdrew consent|2|||
124966347|NCT01721746|449504031|FG000|Treatment|Maximum Clinical Benefit|9|||
124966348|NCT01721746|449504032|FG001|Treatment|Maximum Clinical Benefit|3|||
124966349|NCT01721746|449504031|FG000|Treatment|Poor/Non-compliance|2|||
124966350|NCT01721746|449504032|FG001|Treatment|Poor/Non-compliance|0|||
124550090|NCT01915498|447969010|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
124550091|NCT01915498|447969011|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
124550092|NCT01915498|447969012|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
124550093|NCT01915498|447969013|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
124550094|NCT01915498|447969014|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
124550095|NCT01915498|447969015|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
124550096|NCT01915498|447969016|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
124550097|NCT01915498|447968998|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
124550098|NCT01915498|447968999|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
124550099|NCT01915498|447969000|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
124550100|NCT01915498|447969001|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
124550101|NCT01915498|447969002|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
124550102|NCT01915498|447969003|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
124550103|NCT01915498|447969004|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
124550104|NCT01915498|447969005|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
124550105|NCT01915498|447969006|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
124550106|NCT01915498|447969007|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
124550107|NCT01915498|447969008|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
124550108|NCT01915498|447969009|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
124550109|NCT01915498|447969010|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
124550110|NCT01915498|447969011|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
124550111|NCT01915498|447969012|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
124550112|NCT01915498|447969013|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
124550113|NCT01915498|447969014|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
124550114|NCT01915498|447969015|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
124550115|NCT01915498|447969016|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
124550116|NCT01915498|447968998|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550117|NCT01915498|447968999|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550118|NCT01915498|447969000|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550119|NCT01915498|447969001|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550120|NCT01915498|447969002|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550121|NCT01915498|447969003|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550122|NCT01915498|447969004|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550123|NCT01915498|447969005|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550124|NCT01915498|447969006|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550125|NCT01915498|447969007|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550126|NCT01915498|447969008|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550127|NCT01915498|447969009|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550128|NCT01915498|447969010|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550129|NCT01915498|447969011|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550130|NCT01915498|447969012|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550131|NCT01915498|447969013|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550132|NCT01915498|447969014|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550133|NCT01915498|447969015|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
124550134|NCT01915498|447969016|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
124550135|NCT01915498|447968998|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550136|NCT01915498|447968999|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550137|NCT01915498|447969000|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550138|NCT01915498|447969001|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550139|NCT01915498|447969002|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550140|NCT01915498|447969003|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550141|NCT01915498|447969004|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550142|NCT01915498|447969005|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550143|NCT01915498|447969006|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550144|NCT01915498|447969007|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550145|NCT01915498|447969008|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550146|NCT01915498|447969009|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550147|NCT01915498|447969010|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550148|NCT01915498|447969011|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550149|NCT01915498|447969012|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550150|NCT01915498|447969013|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550151|NCT01915498|447969014|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550152|NCT01915498|447969015|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
124550153|NCT01915498|447969016|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
124550154|NCT01915498|447968998|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124550155|NCT01915498|447968999|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124550156|NCT01915498|447969000|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124550157|NCT01915498|447969001|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124464831|NCT00527605|447659855|FG000|Overall Study|Adverse Event|3|||
124464832|NCT00527605|447659856|FG001|Overall Study|Adverse Event|0|||
124464833|NCT00527605|447659855|FG000|Overall Study|Withdrawal by Subject|3|||
124464834|NCT00527605|447659856|FG001|Overall Study|Withdrawal by Subject|7|||
124464835|NCT00527605|447659855|FG000|Overall Study|Lost to Follow-up|6|||
124966351|NCT01721746|449504031|FG000|Treatment|Participant no longer met Study criteria|4|||
124966352|NCT01721746|449504032|FG001|Treatment|Participant no longer met Study criteria|0|||
124966353|NCT01721746|449504031|FG000|Treatment|Other reasons|6|||
124966354|NCT01721746|449504032|FG001|Treatment|Other reasons|2|||
124966355|NCT04358068|449504033|FG000|Overall Study|Did not initiate study treatment|2|||
124966356|NCT04358068|449504034|FG001|Overall Study|Did not initiate study treatment|2|||
124966357|NCT00239681|449504035|FG000|Overall Study|Adverse Event|100|||
124464836|NCT00527605|447659856|FG001|Overall Study|Lost to Follow-up|2|||
124464837|NCT00527605|447659855|FG000|Overall Study|Protocol Violation|1|||
124464838|NCT00527605|447659856|FG001|Overall Study|Protocol Violation|2|||
124464839|NCT01363986|447659857|FG000|Overall Study|Disease progression|1|||
124464840|NCT01637142|447659858|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
124464841|NCT02111564|447659859|FG000|Overall Study|Death|109|||
124464842|NCT02111564|447659860|FG001|Overall Study|Death|120|||
124464843|NCT02111564|447659859|FG000|Overall Study|Lost to Follow-up|2|||
124464844|NCT02111564|447659860|FG001|Overall Study|Lost to Follow-up|3|||
124464845|NCT02111564|447659859|FG000|Overall Study|Withdrawal by Subject|20|||
124464846|NCT02111564|447659860|FG001|Overall Study|Withdrawal by Subject|20|||
124464847|NCT00687362|447659861|FG000|Overall Study|Protocol Violation|2|||
124464848|NCT00687362|447659861|FG000|Overall Study|Withdrawal by Subject|1|||
124464849|NCT02354703|447659862|FG000|Overall Study|Withdrawal by Subject|1|||
124464850|NCT02354703|447659863|FG001|Overall Study|Withdrawal by Subject|1|||
124464851|NCT02354703|447659864|FG002|Overall Study|Withdrawal by Subject|1|||
124464852|NCT02354703|447659865|FG003|Overall Study|Withdrawal by Subject|1|||
124464853|NCT02354703|447659862|FG000|Overall Study|Lost to Follow-up|2|||
124464854|NCT02354703|447659863|FG001|Overall Study|Lost to Follow-up|7|||
124464855|NCT02354703|447659864|FG002|Overall Study|Lost to Follow-up|9|||
124464856|NCT02354703|447659865|FG003|Overall Study|Lost to Follow-up|2|||
124464857|NCT02354703|447659862|FG000|Overall Study|Adverse Event|0|||
124464858|NCT02354703|447659863|FG001|Overall Study|Adverse Event|0|||
124464859|NCT02354703|447659864|FG002|Overall Study|Adverse Event|1|||
124464860|NCT02354703|447659865|FG003|Overall Study|Adverse Event|0|||
124464861|NCT03468309|447659868|FG000|Overall Study|Lost to Follow-up|4|||
124464862|NCT03468309|447659868|FG000|Overall Study|Withdrawal by Subject|2|||
124464863|NCT01485627|447659874|FG000|Overall Study|Patient withdrew|6|||
124464864|NCT01485627|447659875|FG001|Overall Study|Patient withdrew|5|||
124464865|NCT01485627|447659874|FG000|Overall Study|Patient died|3|||
124464866|NCT01485627|447659875|FG001|Overall Study|Patient died|1|||
124464867|NCT01485627|447659874|FG000|Overall Study|Patient lost to followup|0|||
124464868|NCT01485627|447659875|FG001|Overall Study|Patient lost to followup|1|||
124550158|NCT01915498|447969002|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124550159|NCT01915498|447969003|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124550160|NCT01915498|447969004|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124550161|NCT01915498|447969005|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124550162|NCT01915498|447969006|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124550163|NCT01915498|447969007|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124550164|NCT01915498|447969008|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124550165|NCT01915498|447969009|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124550166|NCT01915498|447969010|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124550167|NCT01915498|447969011|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124464869|NCT01485627|447659874|FG000|Overall Study|Caregiver withdrew|3|||
124464870|NCT01485627|447659875|FG001|Overall Study|Caregiver withdrew|3|||
124550168|NCT01915498|447969012|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124550169|NCT01915498|447969013|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124550170|NCT01915498|447969014|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124550171|NCT01915498|447969015|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
124550172|NCT01915498|447969016|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
124464871|NCT01485627|447659874|FG000|Overall Study|Caregiver lost to follow up|11|||
124464872|NCT01485627|447659875|FG001|Overall Study|Caregiver lost to follow up|12|||
124550173|NCT01907516|447969017|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
124550174|NCT01907516|447969018|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
124550175|NCT01907516|447969017|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
124550176|NCT01907516|447969018|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
124550177|NCT01907516|447969017|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
124550178|NCT01907516|447969018|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
124550179|NCT01907516|447969017|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
124550180|NCT01907516|447969018|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
124550181|NCT04278872|447969021|FG000|Overall Study|Adverse Event|1|||
124550182|NCT04278872|447969022|FG001|Overall Study|Adverse Event|0|||
124550183|NCT04278872|447969021|FG000|Overall Study|Protocol Violation|0|||
124550184|NCT04278872|447969022|FG001|Overall Study|Protocol Violation|1|||
124550185|NCT04278872|447969021|FG000|Overall Study|Study Termination|2|||
124550186|NCT04278872|447969022|FG001|Overall Study|Study Termination|0|||
124550187|NCT00891527|447970592|FG000|Overall Study|Withdrawal by Subject|2|||
124550188|NCT02953262|447970595|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
124550189|NCT02953262|447970596|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
124550190|NCT02953262|447970597|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
124550191|NCT02953262|447970598|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
124550192|NCT00740480|447970599|FG000|Overall Study|Adverse Event|1|||
124550193|NCT00740480|447970599|FG000|Overall Study|Physician Decision|1|||
124550194|NCT03349437|447970604|FG000|Screening|Screen Fail|4|||
124550195|NCT03349437|447970605|FG001|Screening|Screen Fail|0|||
124550196|NCT03349437|447970606|FG002|Screening|Screen Fail|0|||
124550197|NCT03349437|447970604|FG000|Screening|Withdrawn|1|||
124550198|NCT03349437|447970605|FG001|Screening|Withdrawn|0|||
124464873|NCT01485627|447659874|FG000|Overall Study|Caregiver died|1|||
124464874|NCT01485627|447659875|FG001|Overall Study|Caregiver died|0|||
124464875|NCT01485627|447659874|FG000|Overall Study|caregiver was not bereaved|42|||
124464876|NCT01485627|447659875|FG001|Overall Study|caregiver was not bereaved|35|||
124464877|NCT02728830|447659882|FG000|Overall Study|Exclusionary Surgery|9|||
124464878|NCT02728830|447659882|FG000|Overall Study|Exclusionary Pathology|6|||
124464879|NCT02728830|447659882|FG000|Overall Study|Physician Decision|3|||
124464880|NCT02728830|447659882|FG000|Overall Study|Withdrawal by Subject|2|||
124464881|NCT02728830|447659882|FG000|Overall Study|Lost to Follow-up|1|||
124464882|NCT02728830|447659882|FG000|Overall Study|Exclusionary Lab Values|1|||
124464883|NCT02728830|447659882|FG000|Overall Study|Contraindicated Illness|1|||
124464884|NCT02728830|447659882|FG000|Overall Study|Language Barrier|1|||
124464885|NCT01142726|447659883|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
124464886|NCT01142726|447659884|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
124464887|NCT01142726|447659885|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
124464888|NCT01142726|447659883|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
124464889|NCT01142726|447659884|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
124464890|NCT01142726|447659885|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
124464891|NCT01142726|447659883|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
124464892|NCT01142726|447659884|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
124464893|NCT01142726|447659885|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
124464894|NCT01142726|447659883|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
124464895|NCT01142726|447659884|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
124464896|NCT01142726|447659885|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
124464897|NCT01142726|447659883|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
124464898|NCT01142726|447659884|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
124710131|NCT00529243|448565296|FG000|Overall Study|Relocated|1|||
124710132|NCT01466491|448565301|FG000|Overall Study|Protocol Violation|0|||
124710133|NCT01466491|448565302|FG001|Overall Study|Protocol Violation|3|||
124710134|NCT01466491|448565303|FG002|Overall Study|Protocol Violation|2|||
124966358|NCT00239681|449504036|FG001|Overall Study|Adverse Event|99|||
124966359|NCT00239681|449504035|FG000|Overall Study|Withdrawal by Subject|458|||
124966360|NCT00239681|449504036|FG001|Overall Study|Withdrawal by Subject|489|||
124966361|NCT00239681|449504035|FG000|Overall Study|Lost to Follow-up|28|||
124966362|NCT00239681|449504036|FG001|Overall Study|Lost to Follow-up|22|||
124966363|NCT00239681|449504035|FG000|Overall Study|Protocol Violation|4|||
124966364|NCT00239681|449504036|FG001|Overall Study|Protocol Violation|4|||
124966365|NCT00239681|449504035|FG000|Overall Study|Physician Decision|13|||
124966366|NCT00239681|449504036|FG001|Overall Study|Physician Decision|17|||
124966367|NCT00239681|449504035|FG000|Overall Study|No information chacked on CaseReportForm|90|||
124966368|NCT00239681|449504036|FG001|Overall Study|No information chacked on CaseReportForm|84|||
124966369|NCT02447718|449504037|FG000|Overall Study|Lost to Follow-up|8|||
124966370|NCT02447718|449504038|FG001|Overall Study|Lost to Follow-up|0|||
124966371|NCT02447718|449504037|FG000|Overall Study|Withdrawal by Subject|3|||
124966372|NCT02447718|449504038|FG001|Overall Study|Withdrawal by Subject|0|||
124966373|NCT02447718|449504037|FG000|Overall Study|Screen Failure|1|||
124966374|NCT02447718|449504038|FG001|Overall Study|Screen Failure|0|||
124966375|NCT03599622|449504039|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
124966376|NCT03599622|449504040|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
124966377|NCT03599622|449504041|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
124966378|NCT03599622|449504042|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
124966379|NCT03599622|449504039|FG000|Pre-Treatment Period|Other reasons|1|||
124966380|NCT03599622|449504040|FG001|Pre-Treatment Period|Other reasons|1|||
124966381|NCT03599622|449504041|FG002|Pre-Treatment Period|Other reasons|1|||
124966382|NCT03599622|449504042|FG003|Pre-Treatment Period|Other reasons|0|||
124966383|NCT03599622|449504039|FG000|Treatment Period|Adverse Event|11|||
124966384|NCT03599622|449504040|FG001|Treatment Period|Adverse Event|20|||
124966385|NCT03599622|449504041|FG002|Treatment Period|Adverse Event|18|||
124966386|NCT03599622|449504042|FG003|Treatment Period|Adverse Event|2|||
124966387|NCT03599622|449504039|FG000|Treatment Period|Lack of Efficacy|18|||
124966388|NCT03599622|449504040|FG001|Treatment Period|Lack of Efficacy|12|||
124966389|NCT03599622|449504041|FG002|Treatment Period|Lack of Efficacy|13|||
124966390|NCT03599622|449504042|FG003|Treatment Period|Lack of Efficacy|2|||
124966391|NCT03599622|449504039|FG000|Treatment Period|Withdrawal by Subject|5|||
124966392|NCT03599622|449504040|FG001|Treatment Period|Withdrawal by Subject|11|||
124966393|NCT03599622|449504041|FG002|Treatment Period|Withdrawal by Subject|16|||
124966394|NCT03599622|449504042|FG003|Treatment Period|Withdrawal by Subject|1|||
124464899|NCT01142726|447659885|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
124464900|NCT01142726|447659883|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
124464901|NCT01142726|447659884|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
124464902|NCT01142726|447659885|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
124464903|NCT01142726|447659883|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
124464904|NCT01142726|447659884|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
124464905|NCT01142726|447659885|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
124464906|NCT01142726|447659883|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
124464907|NCT01142726|447659884|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
124464908|NCT01142726|447659885|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
124464909|NCT01142726|447659883|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
124464910|NCT01142726|447659884|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
124464911|NCT01142726|447659885|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
124464912|NCT01142726|447659883|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
124464913|NCT01142726|447659884|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
124550199|NCT03349437|447970606|FG002|Screening|Withdrawn|0|||
124550200|NCT02406742|447970607|FG000|Overall Study|Progression of Disease|5|||
124550201|NCT02406742|447970608|FG001|Overall Study|Progression of Disease|1|||
124550202|NCT02406742|447970609|FG002|Overall Study|Progression of Disease|6|||
124966395|NCT03599622|449504039|FG000|Treatment Period|Other reasons|4|||
124966396|NCT03599622|449504040|FG001|Treatment Period|Other reasons|6|||
124966397|NCT03599622|449504041|FG002|Treatment Period|Other reasons|7|||
124966398|NCT03599622|449504042|FG003|Treatment Period|Other reasons|0|||
124966399|NCT03599622|449504039|FG000|Treatment Period|Lost to Follow-up|1|||
124966400|NCT03599622|449504040|FG001|Treatment Period|Lost to Follow-up|0|||
124966401|NCT03599622|449504041|FG002|Treatment Period|Lost to Follow-up|0|||
124966402|NCT03599622|449504042|FG003|Treatment Period|Lost to Follow-up|0|||
124966403|NCT03599622|449504039|FG000|Treatment Period|Study terminated by sponsor|7|||
124966404|NCT03599622|449504040|FG001|Treatment Period|Study terminated by sponsor|20|||
124966405|NCT03599622|449504041|FG002|Treatment Period|Study terminated by sponsor|15|||
124966406|NCT03599622|449504042|FG003|Treatment Period|Study terminated by sponsor|0|||
124966407|NCT03599622|449504039|FG000|Treatment Period|Site terminated by sponsor|0|||
124966408|NCT03599622|449504040|FG001|Treatment Period|Site terminated by sponsor|1|||
124966409|NCT03599622|449504041|FG002|Treatment Period|Site terminated by sponsor|0|||
124966410|NCT03599622|449504042|FG003|Treatment Period|Site terminated by sponsor|0|||
124966411|NCT00468130|449504044|FG000|Overall Study|Adverse Event|2|||
124966412|NCT00468130|449504045|FG001|Overall Study|Adverse Event|1|||
124966413|NCT00468130|449504044|FG000|Overall Study|Withdrawal by Subject|0|||
124966414|NCT00468130|449504045|FG001|Overall Study|Withdrawal by Subject|1|||
124966415|NCT00436956|449504046|FG000|Overall Study|Not evaluable|1|||
124966416|NCT00436956|449504047|FG001|Overall Study|Not evaluable|0|||
124966417|NCT01006889|449504048|FG000|Overall Study|Withdrawal by Subject|3|||
124966418|NCT01130168|449504049|FG000|Period 1|Withdrawal by Subject|0|||
124966419|NCT01130168|449504050|FG001|Period 1|Withdrawal by Subject|1|||
124966420|NCT01130168|449504051|FG002|Period 1|Withdrawal by Subject|0|||
124966421|NCT01130168|449504052|FG003|Period 1|Withdrawal by Subject|1|||
124966422|NCT01130168|449504053|FG004|Period 1|Withdrawal by Subject|0|||
124966423|NCT01130168|449504054|FG005|Period 1|Withdrawal by Subject|0|||
124966424|NCT01130168|449504049|FG000|Period 1|Discontinued For Other Reason|0|||
124966425|NCT01130168|449504050|FG001|Period 1|Discontinued For Other Reason|0|||
124966426|NCT01130168|449504051|FG002|Period 1|Discontinued For Other Reason|1|||
124966427|NCT01130168|449504052|FG003|Period 1|Discontinued For Other Reason|1|||
124464914|NCT01142726|447659885|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
124464915|NCT01142726|447659883|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
124464916|NCT01142726|447659884|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
124464917|NCT01142726|447659885|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
124464918|NCT01142726|447659883|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
124464919|NCT01142726|447659884|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
124464920|NCT01142726|447659885|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
124464921|NCT01142726|447659883|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
124464922|NCT01142726|447659884|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
124464923|NCT01142726|447659885|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
124464924|NCT01142726|447659883|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
124464925|NCT01142726|447659884|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
124464926|NCT01142726|447659885|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
124464927|NCT01142726|447659883|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
124464928|NCT01142726|447659884|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
124464929|NCT01142726|447659885|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
124464930|NCT01142726|447659883|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
124464931|NCT01142726|447659884|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
124464932|NCT01142726|447659885|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
124464933|NCT01568593|447659886|FG000|Overall Study|Lack of Efficacy|4|||
124464934|NCT01568593|447659887|FG001|Overall Study|Lack of Efficacy|1|||
124464935|NCT01568593|447659886|FG000|Overall Study|Adverse Event|3|||
124464936|NCT01568593|447659887|FG001|Overall Study|Adverse Event|2|||
124464937|NCT00143455|447659888|FG000|Cohort 1|Adverse Event|8|||
124464938|NCT00143455|447659889|FG001|Cohort 1|Adverse Event|4|||
124464939|NCT00143455|447659890|FG002|Cohort 1|Adverse Event|0|||
124464940|NCT00143455|447659891|FG003|Cohort 1|Adverse Event|0|||
124464941|NCT00143455|447659888|FG000|Cohort 1|Death|5|||
124966428|NCT01130168|449504053|FG004|Period 1|Discontinued For Other Reason|0|||
124464942|NCT00143455|447659889|FG001|Cohort 1|Death|2|||
124464943|NCT00143455|447659890|FG002|Cohort 1|Death|0|||
124464944|NCT00143455|447659891|FG003|Cohort 1|Death|0|||
124464945|NCT00143455|447659888|FG000|Cohort 1|Progressive Disease|0|||
124464946|NCT00143455|447659889|FG001|Cohort 1|Progressive Disease|6|||
124464947|NCT00143455|447659890|FG002|Cohort 1|Progressive Disease|0|||
124464948|NCT00143455|447659891|FG003|Cohort 1|Progressive Disease|0|||
124464949|NCT00143455|447659888|FG000|Cohort 1|Withdrawal by Subject|1|||
124966429|NCT01130168|449504054|FG005|Period 1|Discontinued For Other Reason|0|||
124966430|NCT01130168|449504049|FG000|Period 1|Adverse Event|0|||
124464950|NCT00143455|447659889|FG001|Cohort 1|Withdrawal by Subject|4|||
124464951|NCT00143455|447659890|FG002|Cohort 1|Withdrawal by Subject|0|||
124464952|NCT00143455|447659891|FG003|Cohort 1|Withdrawal by Subject|0|||
124464953|NCT00143455|447659888|FG000|Cohort 1|Randomized But Not Treated|0|||
124464954|NCT00143455|447659889|FG001|Cohort 1|Randomized But Not Treated|1|||
124966431|NCT01130168|449504050|FG001|Period 1|Adverse Event|0|||
124966432|NCT01130168|449504051|FG002|Period 1|Adverse Event|0|||
124966433|NCT01130168|449504052|FG003|Period 1|Adverse Event|1|||
124710135|NCT01466491|448565304|FG003|Overall Study|Protocol Violation|0|||
124710136|NCT01466491|448565301|FG000|Overall Study|Missing Data|0|||
124710137|NCT01466491|448565302|FG001|Overall Study|Missing Data|0|||
124710138|NCT01466491|448565303|FG002|Overall Study|Missing Data|1|||
124710139|NCT01466491|448565304|FG003|Overall Study|Missing Data|0|||
124710140|NCT02727322|448565305|FG000|Overall Study|Withdrawal by Subject|1|||
124710141|NCT02727322|448565306|FG001|Overall Study|Withdrawal by Subject|1|||
124710142|NCT02727322|448565305|FG000|Overall Study|Protocol Violation|1|||
124710143|NCT02727322|448565306|FG001|Overall Study|Protocol Violation|0|||
124710144|NCT02852967|448565307|FG000|Overall Study|Adverse Event|3|||
124710145|NCT02852967|448565308|FG001|Overall Study|Adverse Event|1|||
124710146|NCT02852967|448565309|FG002|Overall Study|Adverse Event|0|||
124710147|NCT02852967|448565310|FG003|Overall Study|Adverse Event|1|||
124710148|NCT02852967|448565311|FG004|Overall Study|Adverse Event|0|||
124710149|NCT02852967|448565307|FG000|Overall Study|Death|1|||
124710150|NCT02852967|448565308|FG001|Overall Study|Death|0|||
124710151|NCT02852967|448565309|FG002|Overall Study|Death|0|||
124710152|NCT02852967|448565310|FG003|Overall Study|Death|0|||
124710153|NCT02852967|448565311|FG004|Overall Study|Death|0|||
124710154|NCT02852967|448565307|FG000|Overall Study|Lost to Follow-up|1|||
124710155|NCT02852967|448565308|FG001|Overall Study|Lost to Follow-up|2|||
124710156|NCT02852967|448565309|FG002|Overall Study|Lost to Follow-up|3|||
124710157|NCT02852967|448565310|FG003|Overall Study|Lost to Follow-up|4|||
124710158|NCT02852967|448565311|FG004|Overall Study|Lost to Follow-up|4|||
124710159|NCT02852967|448565307|FG000|Overall Study|Withdrawal by Subject|6|||
124710160|NCT02852967|448565308|FG001|Overall Study|Withdrawal by Subject|12|||
124710161|NCT02852967|448565309|FG002|Overall Study|Withdrawal by Subject|7|||
124710162|NCT02852967|448565310|FG003|Overall Study|Withdrawal by Subject|10|||
124966434|NCT01130168|449504053|FG004|Period 1|Adverse Event|0|||
124966435|NCT01130168|449504054|FG005|Period 1|Adverse Event|0|||
124966436|NCT01702519|449504055|FG000|Washout Period|Lost to Follow-up|1|||
124966437|NCT01702519|449504056|FG001|Washout Period|Lost to Follow-up|0|||
124966438|NCT01702519|449504055|FG000|Washout Period|Withdrawal by Subject|0|||
124966439|NCT01702519|449504056|FG001|Washout Period|Withdrawal by Subject|2|||
124966440|NCT03738397|449504059|FG000|Overall Study|Adverse Event|3|||
124966441|NCT03738397|449504060|FG001|Overall Study|Adverse Event|7|||
124966442|NCT03738397|449504059|FG000|Overall Study|Withdrawal by Subject|8|||
124966443|NCT03738397|449504060|FG001|Overall Study|Withdrawal by Subject|11|||
124966444|NCT03738397|449504059|FG000|Overall Study|Lost to Follow-up|7|||
124966445|NCT03738397|449504060|FG001|Overall Study|Lost to Follow-up|5|||
124966446|NCT03738397|449504059|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
124966447|NCT03738397|449504060|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
124966448|NCT03738397|449504059|FG000|Overall Study|Other|4|||
124966449|NCT03738397|449504060|FG001|Overall Study|Other|6|||
124966450|NCT00904722|449504061|FG000|Overall Study|Physician Decision|1|||
124966451|NCT01891890|449504062|FG000|Overall Study|Lost to Follow-up|0|||
124966452|NCT01891890|449504063|FG001|Overall Study|Lost to Follow-up|0|||
124966453|NCT01891890|449504064|FG002|Overall Study|Lost to Follow-up|1|||
124966454|NCT01891890|449504062|FG000|Overall Study|Study ended before endpoint reached|7|||
124966455|NCT01891890|449504063|FG001|Overall Study|Study ended before endpoint reached|3|||
124966456|NCT01891890|449504064|FG002|Overall Study|Study ended before endpoint reached|6|||
124966457|NCT03448536|449504071|FG000|Overall Study|Protocol Violation|2|||
124966458|NCT03448536|449504072|FG001|Overall Study|Protocol Violation|0|||
124966459|NCT03448536|449504071|FG000|Overall Study|Pregnancy|1|||
124966460|NCT03448536|449504072|FG001|Overall Study|Pregnancy|0|||
124966461|NCT03448536|449504071|FG000|Overall Study|Withdrawal by Subject|1|||
124966462|NCT03448536|449504072|FG001|Overall Study|Withdrawal by Subject|2|||
124966463|NCT03448536|449504071|FG000|Overall Study|Lost to Follow-up|3|||
124966464|NCT03448536|449504072|FG001|Overall Study|Lost to Follow-up|2|||
124464955|NCT00143455|447659890|FG002|Cohort 1|Randomized But Not Treated|0|||
124464956|NCT00143455|447659891|FG003|Cohort 1|Randomized But Not Treated|0|||
124464957|NCT00143455|447659888|FG000|Cohort 2|Adverse Event|0|||
124464958|NCT00143455|447659889|FG001|Cohort 2|Adverse Event|0|||
124966465|NCT03448536|449504071|FG000|Overall Study|Inadequate pain reporter|1|||
124966466|NCT03448536|449504072|FG001|Overall Study|Inadequate pain reporter|0|||
124966467|NCT03448536|449504071|FG000|Overall Study|Other|3|||
124966468|NCT03448536|449504072|FG001|Overall Study|Other|0|||
124464959|NCT00143455|447659890|FG002|Cohort 2|Adverse Event|42|||
124710163|NCT02852967|448565311|FG004|Overall Study|Withdrawal by Subject|10|||
124710164|NCT02852967|448565307|FG000|Overall Study|SAE|0|||
124710165|NCT02852967|448565308|FG001|Overall Study|SAE|0|||
124966469|NCT03448536|449504071|FG000|Overall Study|Physician Decision|1|||
124966470|NCT03448536|449504072|FG001|Overall Study|Physician Decision|0|||
124966471|NCT04811339|449504077|FG000|Overall Study|lack of transportation not wanting to return|4|||
124710166|NCT02852967|448565309|FG002|Overall Study|SAE|0|||
124966472|NCT04811339|449504078|FG001|Overall Study|lack of transportation not wanting to return|8|||
124966473|NCT04811339|449504079|FG002|Overall Study|lack of transportation not wanting to return|0|||
124966474|NCT04811339|449504077|FG000|Overall Study|Adverse Event|3|||
124966475|NCT04811339|449504078|FG001|Overall Study|Adverse Event|0|||
124966476|NCT04811339|449504079|FG002|Overall Study|Adverse Event|0|||
124966477|NCT04811339|449504077|FG000|Overall Study|Lost to Follow-up|1|||
124966478|NCT04811339|449504078|FG001|Overall Study|Lost to Follow-up|0|||
124966479|NCT04811339|449504079|FG002|Overall Study|Lost to Follow-up|0|||
124966480|NCT04811339|449504077|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
124966481|NCT04811339|449504078|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
124966482|NCT04811339|449504079|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
124966483|NCT04811339|449504077|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
124966484|NCT04811339|449504078|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
124966485|NCT04811339|449504079|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
124966486|NCT04811339|449504077|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
124966487|NCT04811339|449504078|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
124966488|NCT04811339|449504079|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
124966489|NCT04811339|449504077|FG000|Overall Study|Withdrawal by Subject|0|||
124966490|NCT04811339|449504078|FG001|Overall Study|Withdrawal by Subject|3|||
124966491|NCT04811339|449504079|FG002|Overall Study|Withdrawal by Subject|0|||
124966492|NCT04811339|449504077|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
124966493|NCT04811339|449504078|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
124966494|NCT04811339|449504079|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
124966495|NCT04811339|449504077|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
124966496|NCT04811339|449504078|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
124966497|NCT04811339|449504079|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
124966498|NCT02536742|449505638|FG000|Overall Study|Did not start protocol therapy|1|||
124966499|NCT02536742|449505638|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
124966500|NCT04629443|449505639|FG000|Overall Study|Adverse Event|2|||
124966501|NCT04629443|449505640|FG001|Overall Study|Adverse Event|1|||
124966502|NCT04629443|449505641|FG002|Overall Study|Adverse Event|2|||
124966503|NCT04629443|449505639|FG000|Overall Study|Progressive Disease|2|||
124966504|NCT04629443|449505640|FG001|Overall Study|Progressive Disease|3|||
124966505|NCT04629443|449505641|FG002|Overall Study|Progressive Disease|3|||
124966506|NCT04629443|449505639|FG000|Overall Study|Physician Decision|1|||
124966507|NCT04629443|449505640|FG001|Overall Study|Physician Decision|3|||
124966508|NCT04629443|449505641|FG002|Overall Study|Physician Decision|0|||
124966509|NCT01547117|449505642|FG000|Overall Study|Physician Decision|0|||
124966510|NCT01547117|449505643|FG001|Overall Study|Physician Decision|1|||
124966511|NCT01547117|449505644|FG002|Overall Study|Physician Decision|1|||
124966512|NCT01547117|449505645|FG003|Overall Study|Physician Decision|3|||
124966513|NCT01547117|449505642|FG000|Overall Study|Withdrawal by Subject|1|||
124966514|NCT01547117|449505643|FG001|Overall Study|Withdrawal by Subject|2|||
124966515|NCT01547117|449505644|FG002|Overall Study|Withdrawal by Subject|1|||
124966516|NCT01547117|449505645|FG003|Overall Study|Withdrawal by Subject|2|||
124966517|NCT03021551|449505646|FG000|Overall Study|Equipment Issues|2|||
124966518|NCT03021551|449505646|FG000|Overall Study|Protocol Violation|1|||
124966519|NCT02088554|449505650|FG000|Overall Study|Exited before procedure|130|||
124966520|NCT02088554|449505650|FG000|Overall Study|Attempted but not implanted|31|||
124966521|NCT02088554|449505650|FG000|Overall Study|Implant not attempted|19|||
124966522|NCT02088554|449505650|FG000|Overall Study|Pending next visit|532|||
124966523|NCT02088554|449505650|FG000|Overall Study|Death|170|||
124966524|NCT02088554|449505650|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
124966525|NCT02088554|449505650|FG000|Overall Study|Lost to Follow-up|23|||
124966526|NCT02088554|449505650|FG000|Overall Study|Explanted|32|||
124966527|NCT02088554|449505650|FG000|Overall Study|Any other reason not covered by previous categories|11|||
124966528|NCT03898960|449505653|FG000|Overall Study|Death|10|||
124966529|NCT00548847|449505654|FG000|Overall Study|Disease progression|7|||
124464960|NCT00143455|447659891|FG003|Cohort 2|Adverse Event|30|||
124464961|NCT00143455|447659888|FG000|Cohort 2|No Longer Required Study Treatment|0|||
124464962|NCT00143455|447659889|FG001|Cohort 2|No Longer Required Study Treatment|0|||
124464963|NCT00143455|447659890|FG002|Cohort 2|No Longer Required Study Treatment|1|||
124464964|NCT00143455|447659891|FG003|Cohort 2|No Longer Required Study Treatment|0|||
124464965|NCT00143455|447659888|FG000|Cohort 2|Protocol Violation|0|||
124966530|NCT01086384|449505655|FG000|2-week Run-in Period|Adverse Event|1|||
124464966|NCT00143455|447659889|FG001|Cohort 2|Protocol Violation|0|||
124464967|NCT00143455|447659890|FG002|Cohort 2|Protocol Violation|1|||
124464968|NCT00143455|447659891|FG003|Cohort 2|Protocol Violation|1|||
124464969|NCT00143455|447659888|FG000|Cohort 2|Lost to Follow-up|0|||
124464970|NCT00143455|447659889|FG001|Cohort 2|Lost to Follow-up|0|||
124710167|NCT02852967|448565310|FG003|Overall Study|SAE|3|||
124710168|NCT02852967|448565311|FG004|Overall Study|SAE|0|||
124710169|NCT02852967|448565307|FG000|Overall Study|Elevated Liver Enzymes|2|||
124710170|NCT02852967|448565308|FG001|Overall Study|Elevated Liver Enzymes|0|||
124966531|NCT01086384|449505656|FG001|2-week Run-in Period|Adverse Event|0|||
124966532|NCT01086384|449505657|FG002|2-week Run-in Period|Adverse Event|0|||
124966533|NCT01086384|449505655|FG000|2-week Run-in Period|Protocol Violation|1|||
124966534|NCT01086384|449505656|FG001|2-week Run-in Period|Protocol Violation|0|||
124966535|NCT01086384|449505657|FG002|2-week Run-in Period|Protocol Violation|0|||
124966536|NCT01086384|449505655|FG000|2-week Run-in Period|Lost to Follow-up|1|||
124966537|NCT01086384|449505656|FG001|2-week Run-in Period|Lost to Follow-up|0|||
124966538|NCT01086384|449505657|FG002|2-week Run-in Period|Lost to Follow-up|0|||
124966539|NCT01086384|449505655|FG000|2-week Run-in Period|Physician Decision|6|||
124966540|NCT01086384|449505656|FG001|2-week Run-in Period|Physician Decision|0|||
124966541|NCT01086384|449505657|FG002|2-week Run-in Period|Physician Decision|0|||
124966542|NCT01086384|449505655|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
124966543|NCT01086384|449505656|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
124966544|NCT01086384|449505657|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
124966545|NCT01086384|449505655|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
124966546|NCT01086384|449505656|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
124966547|NCT01086384|449505657|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
124966548|NCT01086384|449505655|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
124966549|NCT01086384|449505656|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
124966550|NCT01086384|449505657|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
124966551|NCT01086384|449505655|FG000|2-week Run-in Period|Randomized in Error|1|||
124966552|NCT01086384|449505656|FG001|2-week Run-in Period|Randomized in Error|0|||
124966553|NCT01086384|449505657|FG002|2-week Run-in Period|Randomized in Error|0|||
124966554|NCT01086384|449505655|FG000|Treatment Period|Withdrawal by Subject|0|||
124966555|NCT01086384|449505656|FG001|Treatment Period|Withdrawal by Subject|53|||
124966556|NCT01086384|449505657|FG002|Treatment Period|Withdrawal by Subject|55|||
124966557|NCT01086384|449505655|FG000|Treatment Period|Protocol Violation|0|||
124966558|NCT01086384|449505656|FG001|Treatment Period|Protocol Violation|26|||
124966559|NCT01086384|449505657|FG002|Treatment Period|Protocol Violation|17|||
124966560|NCT01086384|449505655|FG000|Treatment Period|Lack of Efficacy|0|||
124966561|NCT01086384|449505656|FG001|Treatment Period|Lack of Efficacy|22|||
124710171|NCT02852967|448565309|FG002|Overall Study|Elevated Liver Enzymes|0|||
124710172|NCT02852967|448565310|FG003|Overall Study|Elevated Liver Enzymes|2|||
124710173|NCT02852967|448565311|FG004|Overall Study|Elevated Liver Enzymes|2|||
124966562|NCT01086384|449505657|FG002|Treatment Period|Lack of Efficacy|13|||
124966563|NCT01086384|449505655|FG000|Treatment Period|Adverse Event|0|||
124966564|NCT01086384|449505656|FG001|Treatment Period|Adverse Event|19|||
124966565|NCT01086384|449505657|FG002|Treatment Period|Adverse Event|15|||
124966566|NCT01086384|449505655|FG000|Treatment Period|Lost to Follow-up|0|||
124966567|NCT01086384|449505656|FG001|Treatment Period|Lost to Follow-up|11|||
124966568|NCT01086384|449505657|FG002|Treatment Period|Lost to Follow-up|9|||
124966569|NCT01086384|449505655|FG000|Treatment Period|Physician Decision|0|||
124966570|NCT01086384|449505656|FG001|Treatment Period|Physician Decision|9|||
124966571|NCT01086384|449505657|FG002|Treatment Period|Physician Decision|6|||
124966572|NCT01086384|449505655|FG000|Treatment Period|Study Closed/Terminated|0|||
124966573|NCT01086384|449505656|FG001|Treatment Period|Study Closed/Terminated|7|||
124966574|NCT01086384|449505657|FG002|Treatment Period|Study Closed/Terminated|8|||
124966575|NCT01086384|449505655|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
124966576|NCT01086384|449505656|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
124966577|NCT01086384|449505657|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
124966578|NCT01086384|449505655|FG000|Treatment Period|Received Treatment in Error|0|||
124966579|NCT01086384|449505656|FG001|Treatment Period|Received Treatment in Error|1|||
124966580|NCT01086384|449505657|FG002|Treatment Period|Received Treatment in Error|0|||
124966581|NCT02250534|449505660|FG000|Overall Study|Lost to Follow-up|18|||
124966582|NCT02250534|449505661|FG001|Overall Study|Lost to Follow-up|28|||
124966583|NCT02250534|449505662|FG002|Overall Study|Lost to Follow-up|33|||
124966584|NCT02250534|449505660|FG000|Overall Study|Personal reasons|7|||
124966585|NCT02250534|449505661|FG001|Overall Study|Personal reasons|8|||
124966586|NCT02250534|449505662|FG002|Overall Study|Personal reasons|14|||
124966587|NCT02250534|449505660|FG000|Overall Study|Adverse Event|6|||
124966588|NCT02250534|449505661|FG001|Overall Study|Adverse Event|3|||
124966589|NCT02250534|449505662|FG002|Overall Study|Adverse Event|8|||
124966590|NCT02250534|449505660|FG000|Overall Study|incarcerated|2|||
124966591|NCT02250534|449505661|FG001|Overall Study|incarcerated|1|||
124966592|NCT02250534|449505662|FG002|Overall Study|incarcerated|2|||
124966593|NCT02250534|449505660|FG000|Overall Study|Withdrawal by Subject|0|||
124966594|NCT02250534|449505661|FG001|Overall Study|Withdrawal by Subject|1|||
124966595|NCT02250534|449505662|FG002|Overall Study|Withdrawal by Subject|2|||
124966596|NCT02250534|449505660|FG000|Overall Study|Death|0|||
124966597|NCT02250534|449505661|FG001|Overall Study|Death|1|||
124966598|NCT02250534|449505662|FG002|Overall Study|Death|1|||
124966599|NCT02250534|449505660|FG000|Overall Study|Physician Decision|1|||
124966600|NCT02250534|449505661|FG001|Overall Study|Physician Decision|3|||
124966601|NCT02250534|449505662|FG002|Overall Study|Physician Decision|1|||
124966602|NCT02250534|449505660|FG000|Overall Study|Protocol Violation|1|||
124966603|NCT02250534|449505661|FG001|Overall Study|Protocol Violation|0|||
124966604|NCT02250534|449505662|FG002|Overall Study|Protocol Violation|1|||
124966605|NCT02250534|449505660|FG000|Overall Study|Reason unknown|1|||
124966606|NCT02250534|449505661|FG001|Overall Study|Reason unknown|0|||
124966607|NCT02250534|449505662|FG002|Overall Study|Reason unknown|0|||
124966608|NCT02725567|449505664|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
124966609|NCT02725567|449505665|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
124966610|NCT02725567|449505664|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
124966611|NCT02725567|449505665|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
124966612|NCT02725567|449505664|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
124966613|NCT02725567|449505665|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
124966614|NCT00255944|449505666|FG000|Overall Study|Lost to Follow-up|797|||
124966615|NCT00255944|449505667|FG001|Overall Study|Lost to Follow-up|834|||
124966616|NCT01129115|449505669|FG000|Overall Study|Adverse Event|1|||
124966617|NCT01129115|449505670|FG001|Overall Study|Adverse Event|2|||
124966618|NCT01129115|449505671|FG002|Overall Study|Adverse Event|3|||
124966619|NCT01129115|449505672|FG003|Overall Study|Adverse Event|3|||
124966620|NCT01129115|449505669|FG000|Overall Study|Withdrawal by Subject|1|||
124966621|NCT01129115|449505670|FG001|Overall Study|Withdrawal by Subject|3|||
124966622|NCT01129115|449505671|FG002|Overall Study|Withdrawal by Subject|1|||
124966623|NCT01129115|449505672|FG003|Overall Study|Withdrawal by Subject|4|||
124966624|NCT01129115|449505669|FG000|Overall Study|Protocol Violation|0|||
124966625|NCT01129115|449505670|FG001|Overall Study|Protocol Violation|2|||
124464971|NCT00143455|447659890|FG002|Cohort 2|Lost to Follow-up|1|||
124464972|NCT00143455|447659891|FG003|Cohort 2|Lost to Follow-up|4|||
124464973|NCT00143455|447659888|FG000|Cohort 2|Death|0|||
124710174|NCT02852967|448565307|FG000|Overall Study|Physician Decision|0|||
124966626|NCT01129115|449505671|FG002|Overall Study|Protocol Violation|2|||
124966627|NCT01129115|449505672|FG003|Overall Study|Protocol Violation|2|||
124464974|NCT00143455|447659889|FG001|Cohort 2|Death|0|||
124966628|NCT01747837|449505674|FG000|Overall Study|Lost to Follow-up|5|||
124966629|NCT01747837|449505675|FG001|Overall Study|Lost to Follow-up|2|||
124966630|NCT01747837|449505674|FG000|Overall Study|Death|4|||
124966631|NCT01747837|449505675|FG001|Overall Study|Death|4|||
124966632|NCT01435798|449505677|FG000|Overall Study|Withdrawal by Subject|1|||
124966633|NCT01253447|449505678|FG000|Overall Study|Adverse Event|2|||
124966634|NCT00817336|449505679|FG000|Overall Study|Withdrawal by Subject|1|||
124966635|NCT00817336|449505680|FG001|Overall Study|Withdrawal by Subject|1|||
124966636|NCT02299427|449505681|FG000|Overall Study|Withdrawal by Subject|1|||
124966637|NCT02299427|449505682|FG001|Overall Study|Withdrawal by Subject|0|||
124966638|NCT02299427|449505681|FG000|Overall Study|Lost to Follow-up|1|||
124966639|NCT02299427|449505682|FG001|Overall Study|Lost to Follow-up|3|||
124966640|NCT02299427|449505681|FG000|Overall Study|not adherent to dog website use|21|||
124966641|NCT02299427|449505682|FG001|Overall Study|not adherent to dog website use|0|||
124966642|NCT02108652|449505683|FG000|Overall Study|Death|253|||
124966643|NCT02108652|449505683|FG000|Overall Study|Lost to Follow-up|2|||
124966644|NCT02108652|449505683|FG000|Overall Study|Withdrawal by Subject|16|||
124966645|NCT02108652|449505683|FG000|Overall Study|Study Terminated By Sponsor|31|||
124966646|NCT02108652|449505683|FG000|Overall Study|Non-Compliance|1|||
124966647|NCT02108652|449505683|FG000|Overall Study|Physician Decision|6|||
124966648|NCT02108652|449505683|FG000|Overall Study|Progression Of Disease|1|||
124966649|NCT01182181|449505686|FG000|First Intervention|Adverse Event|1|||
124966650|NCT01182181|449505687|FG001|First Intervention|Adverse Event|0|||
124966651|NCT01182181|449505686|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
124966652|NCT01182181|449505687|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
124966653|NCT01121913|449505688|FG000|First Intervention Period|Adverse Event|0|||
124966654|NCT01121913|449505689|FG001|First Intervention Period|Adverse Event|0|||
124966655|NCT01121913|449505690|FG002|First Intervention Period|Adverse Event|1|||
124966656|NCT01121913|449505691|FG003|First Intervention Period|Adverse Event|0|||
124966657|NCT01121913|449505688|FG000|First Washout Period|Withdrawal by Subject|1|||
124966658|NCT01121913|449505689|FG001|First Washout Period|Withdrawal by Subject|0|||
124966659|NCT01121913|449505690|FG002|First Washout Period|Withdrawal by Subject|0|||
124966660|NCT01121913|449505691|FG003|First Washout Period|Withdrawal by Subject|0|||
124966661|NCT01121913|449505688|FG000|Second Intervention Period|Adverse Event|0|||
124966662|NCT01121913|449505689|FG001|Second Intervention Period|Adverse Event|0|||
124966663|NCT01121913|449505690|FG002|Second Intervention Period|Adverse Event|1|||
124966664|NCT01121913|449505691|FG003|Second Intervention Period|Adverse Event|0|||
124966665|NCT01121913|449505688|FG000|Second Washout Period|Withdrawal by Subject|0|||
124966666|NCT01121913|449505689|FG001|Second Washout Period|Withdrawal by Subject|0|||
124966667|NCT01121913|449505690|FG002|Second Washout Period|Withdrawal by Subject|1|||
124966668|NCT01121913|449505691|FG003|Second Washout Period|Withdrawal by Subject|0|||
124966669|NCT01121913|449505688|FG000|Third Washout Period|Adverse Event|1|||
124966670|NCT01121913|449505689|FG001|Third Washout Period|Adverse Event|0|||
124966671|NCT01121913|449505690|FG002|Third Washout Period|Adverse Event|0|||
124966672|NCT01121913|449505691|FG003|Third Washout Period|Adverse Event|0|||
124966673|NCT02564718|449505694|FG000|Overall Study|Withdrew from treatment|0|||
124966674|NCT02564718|449505695|FG001|Overall Study|Withdrew from treatment|1|||
124966675|NCT00937521|449505696|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
124966676|NCT00937521|449505697|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
124966677|NCT00937521|449505698|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
124966678|NCT00937521|449505699|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
124966679|NCT00937521|449505700|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
124966680|NCT00937521|449505701|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
124966681|NCT00937521|449505702|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
124966682|NCT00937521|449505703|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
124966683|NCT00937521|449505696|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
124966684|NCT00937521|449505697|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
124966685|NCT00937521|449505698|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
124966686|NCT00937521|449505699|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
124966687|NCT00937521|449505700|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
124966688|NCT00937521|449505701|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
124966689|NCT00937521|449505702|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
124966690|NCT00937521|449505703|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
124966691|NCT00937521|449505696|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
124966692|NCT00937521|449505697|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
124966693|NCT00937521|449505698|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
124966694|NCT00937521|449505699|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
124966695|NCT00937521|449505700|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
124966696|NCT00937521|449505701|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
124966697|NCT00937521|449505702|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
124966698|NCT00937521|449505703|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
124966699|NCT00937521|449505696|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
124966700|NCT00937521|449505697|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
124966701|NCT00937521|449505698|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
124464975|NCT00143455|447659890|FG002|Cohort 2|Death|20|||
124966702|NCT00937521|449505699|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
124966703|NCT00937521|449505700|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
124966704|NCT00937521|449505701|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
124966705|NCT00937521|449505702|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
124966706|NCT00937521|449505703|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
124966707|NCT00937521|449505696|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
124966708|NCT00937521|449505697|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
124966709|NCT00937521|449505698|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
124966710|NCT00937521|449505699|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
124966711|NCT00937521|449505700|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
124966712|NCT00937521|449505701|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
124966713|NCT00937521|449505702|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
124966714|NCT00937521|449505703|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
124966715|NCT00937521|449505696|FG000|Booster Phase|Adverse Event|0|||
124966716|NCT00937521|449505697|FG001|Booster Phase|Adverse Event|0|||
124966717|NCT00937521|449505698|FG002|Booster Phase|Adverse Event|0|||
124966718|NCT00937521|449505699|FG003|Booster Phase|Adverse Event|0|||
124966719|NCT00937521|449505700|FG004|Booster Phase|Adverse Event|0|||
124966720|NCT00937521|449505701|FG005|Booster Phase|Adverse Event|0|||
124966721|NCT00937521|449505702|FG006|Booster Phase|Adverse Event|1|||
124966722|NCT00937521|449505703|FG007|Booster Phase|Adverse Event|0|||
124966723|NCT00937521|449505696|FG000|Booster Phase|Withdrawal by Subject|1|||
124966724|NCT00937521|449505697|FG001|Booster Phase|Withdrawal by Subject|0|||
124966725|NCT00937521|449505698|FG002|Booster Phase|Withdrawal by Subject|0|||
124966726|NCT00937521|449505699|FG003|Booster Phase|Withdrawal by Subject|1|||
124966727|NCT00937521|449505700|FG004|Booster Phase|Withdrawal by Subject|0|||
124966728|NCT00937521|449505701|FG005|Booster Phase|Withdrawal by Subject|0|||
124966729|NCT00937521|449505702|FG006|Booster Phase|Withdrawal by Subject|0|||
124966730|NCT00937521|449505703|FG007|Booster Phase|Withdrawal by Subject|2|||
124966731|NCT00937521|449505696|FG000|Booster Phase|Lost to Follow-up|2|||
124966732|NCT00937521|449505697|FG001|Booster Phase|Lost to Follow-up|2|||
124966733|NCT00937521|449505698|FG002|Booster Phase|Lost to Follow-up|4|||
124966734|NCT00937521|449505699|FG003|Booster Phase|Lost to Follow-up|2|||
124966735|NCT00937521|449505700|FG004|Booster Phase|Lost to Follow-up|4|||
124966736|NCT00937521|449505701|FG005|Booster Phase|Lost to Follow-up|4|||
124966737|NCT00937521|449505702|FG006|Booster Phase|Lost to Follow-up|3|||
124966738|NCT00937521|449505703|FG007|Booster Phase|Lost to Follow-up|0|||
124966739|NCT00937521|449505696|FG000|Booster Phase|Administrative Reason|0|||
124966740|NCT00937521|449505697|FG001|Booster Phase|Administrative Reason|0|||
124966741|NCT00937521|449505698|FG002|Booster Phase|Administrative Reason|1|||
124966742|NCT00937521|449505699|FG003|Booster Phase|Administrative Reason|0|||
124966743|NCT00937521|449505700|FG004|Booster Phase|Administrative Reason|1|||
124966744|NCT00937521|449505701|FG005|Booster Phase|Administrative Reason|1|||
124966745|NCT00937521|449505702|FG006|Booster Phase|Administrative Reason|0|||
124966746|NCT00937521|449505703|FG007|Booster Phase|Administrative Reason|0|||
124966747|NCT00937521|449505696|FG000|Booster Phase|Protocol Deviation|0|||
124966748|NCT00937521|449505697|FG001|Booster Phase|Protocol Deviation|0|||
124966749|NCT00937521|449505698|FG002|Booster Phase|Protocol Deviation|0|||
124966750|NCT00937521|449505699|FG003|Booster Phase|Protocol Deviation|0|||
124966751|NCT00937521|449505700|FG004|Booster Phase|Protocol Deviation|0|||
124966752|NCT00937521|449505701|FG005|Booster Phase|Protocol Deviation|0|||
124966753|NCT00937521|449505702|FG006|Booster Phase|Protocol Deviation|1|||
124966754|NCT00937521|449505703|FG007|Booster Phase|Protocol Deviation|0|||
124966755|NCT04353817|449505704|FG000|Overall Study|Adverse Event|0|||
124966756|NCT04353817|449505705|FG001|Overall Study|Adverse Event|1|||
124966757|NCT00770588|449505706|FG000|Overall Study|Adverse Event|9|||
124966758|NCT00770588|449505707|FG001|Overall Study|Adverse Event|2|||
124966759|NCT00770588|449505706|FG000|Overall Study|Death caused by progression of disease|70|||
124966760|NCT00770588|449505707|FG001|Overall Study|Death caused by progression of disease|91|||
124966761|NCT00770588|449505706|FG000|Overall Study|Lost to Follow-up|1|||
124966762|NCT00770588|449505707|FG001|Overall Study|Lost to Follow-up|1|||
124966763|NCT00770588|449505706|FG000|Overall Study|Withdrawal by Subject|1|||
124966764|NCT00770588|449505707|FG001|Overall Study|Withdrawal by Subject|1|||
124966765|NCT00002597|449505708|FG000|Overall Study|Protocol Violation|19|||
124966766|NCT00002597|449505709|FG001|Overall Study|Protocol Violation|17|||
124966767|NCT00002597|449505708|FG000|Overall Study|Withdrawal by Subject|7|||
124966768|NCT00002597|449505709|FG001|Overall Study|Withdrawal by Subject|6|||
124966769|NCT02485899|449505711|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
124966770|NCT02485899|449505712|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
124966771|NCT02485899|449505711|FG000|Overall Study|Withdrawal by Subject|1|||
124966772|NCT02485899|449505712|FG001|Overall Study|Withdrawal by Subject|0|||
124966773|NCT02485899|449505711|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
124966774|NCT02485899|449505712|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
124966775|NCT01918371|449505713|FG000|Overall Study|Missing Data|1|||
124966776|NCT01918371|449505714|FG001|Overall Study|Missing Data|1|||
124966777|NCT02143063|449505715|FG000|Overall Study|Lost to Follow-up|16|||
124966778|NCT02143063|449505716|FG001|Overall Study|Lost to Follow-up|28|||
124966779|NCT02143063|449505717|FG002|Overall Study|Lost to Follow-up|29|||
124966780|NCT02143063|449505715|FG000|Overall Study|Withdrawal by Subject|0|||
124966781|NCT02143063|449505716|FG001|Overall Study|Withdrawal by Subject|1|||
124966782|NCT02143063|449505717|FG002|Overall Study|Withdrawal by Subject|0|||
124966783|NCT02143063|449505715|FG000|Overall Study|Death|0|||
124966784|NCT02143063|449505716|FG001|Overall Study|Death|1|||
124966785|NCT02143063|449505717|FG002|Overall Study|Death|1|||
124966786|NCT00623363|449505720|FG000|Overall Study|Adverse Event|2|||
124966787|NCT00623363|449505721|FG001|Overall Study|Adverse Event|2|||
124966788|NCT01880437|449505723|FG000|Overall Study|Death|12|||
124966789|NCT01880437|449505724|FG001|Overall Study|Death|4|||
124966790|NCT01880437|449505725|FG002|Overall Study|Death|17|||
124966791|NCT01880437|449505723|FG000|Overall Study|Study terminated by Sponsor|3|||
124966792|NCT01880437|449505724|FG001|Overall Study|Study terminated by Sponsor|0|||
124966793|NCT01880437|449505725|FG002|Overall Study|Study terminated by Sponsor|2|||
124966794|NCT00823836|449505726|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
124966795|NCT00823836|449505727|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
124966796|NCT00823836|449505726|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
124966797|NCT00823836|449505727|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
124966798|NCT00823836|449505726|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
124966799|NCT00823836|449505727|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
124966800|NCT00823836|449505726|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
124966801|NCT00823836|449505727|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
124966802|NCT00823836|449505726|FG000|Long-term Phase|Adverse Event|3|||
124966803|NCT00823836|449505727|FG001|Long-term Phase|Adverse Event|2|||
124966804|NCT00823836|449505726|FG000|Long-term Phase|Physician Decision|1|||
124966805|NCT00823836|449505727|FG001|Long-term Phase|Physician Decision|2|||
124966806|NCT00823836|449505726|FG000|Long-term Phase|Withdrawal by Subject|1|||
124966807|NCT00823836|449505727|FG001|Long-term Phase|Withdrawal by Subject|1|||
124966808|NCT03713320|449505728|FG000|Randomized Period|Adverse Event|1|||
124966809|NCT03713320|449505729|FG001|Randomized Period|Adverse Event|5|||
124966810|NCT03713320|449505730|FG002|Randomized Period|Adverse Event|0|||
124966811|NCT03713320|449505728|FG000|Randomized Period|Physician Decision|1|||
124966812|NCT03713320|449505729|FG001|Randomized Period|Physician Decision|1|||
124966813|NCT03713320|449505730|FG002|Randomized Period|Physician Decision|0|||
124966814|NCT03713320|449505728|FG000|Randomized Period|Withdrawal by Subject|4|||
124966815|NCT03713320|449505729|FG001|Randomized Period|Withdrawal by Subject|0|||
124966816|NCT03713320|449505730|FG002|Randomized Period|Withdrawal by Subject|0|||
124966817|NCT03713320|449505728|FG000|Randomized Period|Participant decision|3|||
124966818|NCT03713320|449505729|FG001|Randomized Period|Participant decision|1|||
124966819|NCT03713320|449505730|FG002|Randomized Period|Participant decision|0|||
124966820|NCT03713320|449505728|FG000|Randomized Period|Study terminated by sponsor|6|||
124966821|NCT03713320|449505729|FG001|Randomized Period|Study terminated by sponsor|3|||
124966822|NCT03713320|449505730|FG002|Randomized Period|Study terminated by sponsor|0|||
124966823|NCT03713320|449505728|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
124966824|NCT03713320|449505729|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
124966825|NCT03713320|449505730|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
124966826|NCT03713320|449505728|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
124966827|NCT03713320|449505729|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
124966828|NCT03713320|449505730|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
124966829|NCT04354168|449505735|FG000|Overall Study|Lost to Follow-up|22|||
124966830|NCT01438840|449505738|FG000|Core Study|Adverse Event|0|||
124966831|NCT01438840|449505739|FG001|Core Study|Adverse Event|3|||
124966832|NCT01438840|449505740|FG002|Core Study|Adverse Event|0|||
124966833|NCT01438840|449505738|FG000|Core Study|Lack of Efficacy|15|||
124966834|NCT01438840|449505739|FG001|Core Study|Lack of Efficacy|7|||
124966835|NCT01438840|449505740|FG002|Core Study|Lack of Efficacy|0|||
124966836|NCT01438840|449505738|FG000|Core Study|Withdrawal of consent|1|||
124966837|NCT01438840|449505739|FG001|Core Study|Withdrawal of consent|0|||
124966838|NCT01438840|449505740|FG002|Core Study|Withdrawal of consent|0|||
124966839|NCT01438840|449505738|FG000|Extension Phase|Adverse Event|0|||
124966840|NCT01438840|449505739|FG001|Extension Phase|Adverse Event|0|||
124966841|NCT01438840|449505740|FG002|Extension Phase|Adverse Event|3|||
124966842|NCT01438840|449505738|FG000|Extension Phase|Lost to Follow-up|0|||
124966843|NCT01438840|449505739|FG001|Extension Phase|Lost to Follow-up|0|||
124966844|NCT01438840|449505740|FG002|Extension Phase|Lost to Follow-up|1|||
124966845|NCT01438840|449505738|FG000|Extension Phase|Withdrawal by Subject|0|||
124966846|NCT01438840|449505739|FG001|Extension Phase|Withdrawal by Subject|0|||
124966847|NCT01438840|449505740|FG002|Extension Phase|Withdrawal by Subject|3|||
124966848|NCT01438840|449505738|FG000|Extension Phase|Lack of Efficacy|0|||
124966849|NCT01438840|449505739|FG001|Extension Phase|Lack of Efficacy|0|||
124966850|NCT01438840|449505740|FG002|Extension Phase|Lack of Efficacy|2|||
124966851|NCT01438840|449505738|FG000|Extension Phase|Other|0|||
124966852|NCT01438840|449505739|FG001|Extension Phase|Other|0|||
124966853|NCT01438840|449505740|FG002|Extension Phase|Other|1|||
124966854|NCT02062645|449505743|FG000|Overall Study|Adverse Event|2|||
124966855|NCT02062645|449505743|FG000|Overall Study|Protocol Violation|8|||
124966856|NCT02062645|449505743|FG000|Overall Study|Lost to Follow-up|5|||
124966857|NCT02804399|449505744|FG000|Period 2|Adverse Event|0|||
124966858|NCT02804399|449505745|FG001|Period 2|Adverse Event|1|||
124966859|NCT01774305|449505746|FG000|Overall Study|Physician Decision|1|||
124966860|NCT01774305|449505747|FG001|Overall Study|Physician Decision|0|||
124966861|NCT04211389|449505748|FG000|Overall Study|Adverse Event|1|||
124966862|NCT04211389|449505749|FG001|Overall Study|Adverse Event|2|||
124966863|NCT04211389|449505748|FG000|Overall Study|Lost to Follow-up|15|||
124966864|NCT04211389|449505749|FG001|Overall Study|Lost to Follow-up|7|||
124966865|NCT04211389|449505748|FG000|Overall Study|Protocol Violation|0|||
124966866|NCT04211389|449505749|FG001|Overall Study|Protocol Violation|1|||
124966867|NCT04211389|449505748|FG000|Overall Study|Withdrawal by Subject|10|||
124966868|NCT04211389|449505749|FG001|Overall Study|Withdrawal by Subject|11|||
124966869|NCT00087555|449505753|FG000|Overall Study|Adverse Event|3|||
124966870|NCT00087555|449505754|FG001|Overall Study|Adverse Event|6|||
124966871|NCT00087555|449505755|FG002|Overall Study|Adverse Event|14|||
124966872|NCT00087555|449505753|FG000|Overall Study|Lost to Follow-up|0|||
124966873|NCT00087555|449505754|FG001|Overall Study|Lost to Follow-up|1|||
124966874|NCT00087555|449505755|FG002|Overall Study|Lost to Follow-up|1|||
124966875|NCT00087555|449505753|FG000|Overall Study|Non - Compliance|1|||
124966876|NCT00087555|449505754|FG001|Overall Study|Non - Compliance|0|||
124966877|NCT00087555|449505755|FG002|Overall Study|Non - Compliance|0|||
124966878|NCT00087555|449505753|FG000|Overall Study|Protocol Violation|0|||
124966879|NCT00087555|449505754|FG001|Overall Study|Protocol Violation|0|||
124966880|NCT00087555|449505755|FG002|Overall Study|Protocol Violation|2|||
124966881|NCT00087555|449505753|FG000|Overall Study|Screen Failure|1|||
124966882|NCT00087555|449505754|FG001|Overall Study|Screen Failure|1|||
124966883|NCT00087555|449505755|FG002|Overall Study|Screen Failure|0|||
124966884|NCT00087555|449505753|FG000|Overall Study|Pregnancy|0|||
124966885|NCT00087555|449505754|FG001|Overall Study|Pregnancy|1|||
124966886|NCT00087555|449505755|FG002|Overall Study|Pregnancy|1|||
124966887|NCT00087555|449505753|FG000|Overall Study|Withdrawal by Subject|3|||
124966888|NCT00087555|449505754|FG001|Overall Study|Withdrawal by Subject|2|||
124966889|NCT00087555|449505755|FG002|Overall Study|Withdrawal by Subject|1|||
124966890|NCT00087555|449505753|FG000|Overall Study|Lack of Efficacy|2|||
124966891|NCT00087555|449505754|FG001|Overall Study|Lack of Efficacy|0|||
124966892|NCT00087555|449505755|FG002|Overall Study|Lack of Efficacy|1|||
124966893|NCT00087555|449505753|FG000|Overall Study|Non Compliance|0|||
124966894|NCT00087555|449505754|FG001|Overall Study|Non Compliance|0|||
124966895|NCT00087555|449505755|FG002|Overall Study|Non Compliance|1|||
124966896|NCT00087555|449505753|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
124966897|NCT00087555|449505754|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
124966898|NCT00087555|449505755|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
124966899|NCT00087555|449505753|FG000|Overall Study|Patient wanted to go back on Med|1|||
124966900|NCT00087555|449505754|FG001|Overall Study|Patient wanted to go back on Med|0|||
124966901|NCT00087555|449505755|FG002|Overall Study|Patient wanted to go back on Med|0|||
124966902|NCT01062971|449505758|FG000|Overall Study|Protocol Violation|1|||
124966903|NCT01062971|449505759|FG001|Overall Study|Protocol Violation|3|||
124966904|NCT01062971|449505758|FG000|Overall Study|Lost to Follow-up|3|||
124966905|NCT01062971|449505759|FG001|Overall Study|Lost to Follow-up|4|||
124966906|NCT05523219|449505760|FG000|Overall Study|Wrong inclusion|1|||
124966907|NCT05523219|449505760|FG000|Overall Study|Lost to Follow-up|7|||
124966908|NCT02261285|449505761|FG000|Overall Study|Disease progression|0|||
124966909|NCT02261285|449505762|FG001|Overall Study|Disease progression|0|||
124966910|NCT02261285|449505763|FG002|Overall Study|Disease progression|1|||
124966911|NCT02760485|449505764|FG000|Phase 1|Death|3|||
124966912|NCT02760485|449505765|FG001|Phase 1|Death|6|||
124966913|NCT02760485|449505766|FG002|Phase 1|Death|0|||
124966914|NCT02760485|449505764|FG000|Phase 1|Withdrawal by Subject|2|||
124966915|NCT02760485|449505765|FG001|Phase 1|Withdrawal by Subject|0|||
124966916|NCT02760485|449505766|FG002|Phase 1|Withdrawal by Subject|0|||
124966917|NCT02760485|449505764|FG000|Phase 1|Progressive Disease|1|||
124966918|NCT02760485|449505765|FG001|Phase 1|Progressive Disease|0|||
124966919|NCT02760485|449505766|FG002|Phase 1|Progressive Disease|0|||
124966920|NCT02760485|449505764|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
124966921|NCT02760485|449505765|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
124966922|NCT02760485|449505766|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
124966923|NCT02760485|449505764|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
124966924|NCT02760485|449505765|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
124966925|NCT02760485|449505766|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
124966926|NCT02760485|449505764|FG000|Phase 2|Death|0|||
124966927|NCT02760485|449505765|FG001|Phase 2|Death|0|||
124966928|NCT02760485|449505766|FG002|Phase 2|Death|12|||
124966929|NCT02760485|449505764|FG000|Phase 2|Withdrawal by Subject|0|||
124966930|NCT02760485|449505765|FG001|Phase 2|Withdrawal by Subject|0|||
124966931|NCT02760485|449505766|FG002|Phase 2|Withdrawal by Subject|3|||
124966932|NCT02760485|449505764|FG000|Phase 2|Progressive Disease|0|||
124966933|NCT02760485|449505765|FG001|Phase 2|Progressive Disease|0|||
124966934|NCT02760485|449505766|FG002|Phase 2|Progressive Disease|1|||
124966935|NCT02760485|449505764|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
124966936|NCT02760485|449505765|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
124966937|NCT02760485|449505766|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
124966938|NCT01182207|449505767|FG000|First Intervention|Positive Hepatitis Results|0|||
124966939|NCT01182207|449505768|FG001|First Intervention|Positive Hepatitis Results|1|||
124966940|NCT01182207|449505767|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
124966941|NCT01182207|449505768|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
124966942|NCT01087814|449505769|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
124966943|NCT01087814|449505770|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
124966944|NCT01087814|449505769|FG000|Second Intervention (5 Days)|Physician Decision|1|||
124966945|NCT01087814|449505770|FG001|Second Intervention (5 Days)|Physician Decision|0|||
124966946|NCT01161628|449505771|FG000|Overall Study|Death|6|||
124966947|NCT01161628|449505771|FG000|Overall Study|Lack of Efficacy|2|||
124966948|NCT00715117|449505772|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
124966949|NCT00715117|449505773|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
124966950|NCT01482429|449505774|FG000|Care Usual|Protocol Violation|0|||
124966951|NCT01482429|449505775|FG001|Care Usual|Protocol Violation|172|||
124966952|NCT01482429|449505774|FG000|Care Usual|Lost to Follow-up|0|||
124966953|NCT01482429|449505775|FG001|Care Usual|Lost to Follow-up|1|||
124966954|NCT01482429|449505774|FG000|Protocol|Protocol Violation|275|||
124966955|NCT01482429|449505775|FG001|Protocol|Protocol Violation|0|||
124966956|NCT04680637|449505776|FG000|Overall Study|Lost to Follow-up|0|||
124966957|NCT04680637|449505777|FG001|Overall Study|Lost to Follow-up|1|||
124966958|NCT04680637|449505778|FG002|Overall Study|Lost to Follow-up|0|||
124966959|NCT04680637|449505779|FG003|Overall Study|Lost to Follow-up|1|||
124966960|NCT04680637|449505776|FG000|Overall Study|Death|1|||
124966961|NCT04680637|449505777|FG001|Overall Study|Death|0|||
124966962|NCT04680637|449505778|FG002|Overall Study|Death|0|||
124966963|NCT04680637|449505779|FG003|Overall Study|Death|0|||
124966964|NCT04680637|449505776|FG000|Overall Study|Withdrawal by Subject|7|||
124550203|NCT02406742|447970607|FG000|Overall Study|Adverse Event|3|||
124550204|NCT02406742|447970608|FG001|Overall Study|Adverse Event|0|||
124550205|NCT02406742|447970609|FG002|Overall Study|Adverse Event|2|||
124550206|NCT02406742|447970607|FG000|Overall Study|Death|1|||
124550207|NCT02406742|447970608|FG001|Overall Study|Death|0|||
124550208|NCT02406742|447970609|FG002|Overall Study|Death|0|||
124550209|NCT02406742|447970607|FG000|Overall Study|Lack of Efficacy|0|||
124966965|NCT04680637|449505777|FG001|Overall Study|Withdrawal by Subject|10|||
124966966|NCT04680637|449505778|FG002|Overall Study|Withdrawal by Subject|17|||
124966967|NCT04680637|449505779|FG003|Overall Study|Withdrawal by Subject|15|||
124966968|NCT04680637|449505776|FG000|Overall Study|Decision by Sponsor|21|||
124966969|NCT04680637|449505777|FG001|Overall Study|Decision by Sponsor|15|||
124966970|NCT04680637|449505778|FG002|Overall Study|Decision by Sponsor|7|||
124966971|NCT04680637|449505779|FG003|Overall Study|Decision by Sponsor|32|||
124966972|NCT02037256|449505780|FG000|Overall Study|Protocol Violation|0|||
124966973|NCT02037256|449505781|FG001|Overall Study|Protocol Violation|1|||
124966974|NCT02037256|449505780|FG000|Overall Study|Withdrawn prior to Velcade|0|||
124966975|NCT02037256|449505781|FG001|Overall Study|Withdrawn prior to Velcade|2|||
124550210|NCT02406742|447970608|FG001|Overall Study|Lack of Efficacy|0|||
124966976|NCT00497874|449507335|FG000|Overall Study|Withdrawal by Subject|48|||
124966977|NCT00497874|449507336|FG001|Overall Study|Withdrawal by Subject|17|||
124966978|NCT00497874|449507335|FG000|Overall Study|Illness|8|||
124966979|NCT00497874|449507336|FG001|Overall Study|Illness|4|||
124966980|NCT00497874|449507335|FG000|Overall Study|Death|2|||
124966981|NCT00497874|449507336|FG001|Overall Study|Death|4|||
124966982|NCT00497874|449507335|FG000|Overall Study|Unable to contact|52|||
124966983|NCT00497874|449507336|FG001|Overall Study|Unable to contact|67|||
124966984|NCT00497874|449507335|FG000|Overall Study|Unable to schedule|37|||
124966985|NCT00497874|449507336|FG001|Overall Study|Unable to schedule|24|||
124966986|NCT04843579|449507340|FG000|Overall Study|Adverse Event|1|||
124966987|NCT04843579|449507340|FG000|Overall Study|Disease Progression|1|||
124966988|NCT04009629|449507341|FG000|Overall Study|Withdrawal by Subject|2|||
124966989|NCT04009629|449507342|FG001|Overall Study|Withdrawal by Subject|0|||
124966990|NCT04398368|449507343|FG000|Overall Study|Withdrawal by Subject|2|||
124966991|NCT02808975|449507345|FG000|Overall Study|Adverse Event|3|||
124966992|NCT02808975|449507346|FG001|Overall Study|Adverse Event|4|||
124966993|NCT02808975|449507345|FG000|Overall Study|Withdrew consent|9|||
124966994|NCT02808975|449507346|FG001|Overall Study|Withdrew consent|8|||
124966995|NCT02808975|449507345|FG000|Overall Study|Lost to Follow-up|4|||
124966996|NCT02808975|449507346|FG001|Overall Study|Lost to Follow-up|6|||
124966997|NCT02808975|449507345|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
124966998|NCT02808975|449507346|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
124966999|NCT02808975|449507345|FG000|Overall Study|Other, not specified|5|||
124967000|NCT02808975|449507346|FG001|Overall Study|Other, not specified|1|||
124967001|NCT03602586|449507347|FG000|Overall Study|Withdrawal by Subject|3|||
124967002|NCT00891046|449507354|FG000|Overall Study|Protocol Violation|1|||
124967003|NCT00891046|449507355|FG001|Overall Study|Protocol Violation|1|||
124967004|NCT00891046|449507356|FG002|Overall Study|Protocol Violation|0|||
124967005|NCT00891046|449507357|FG003|Overall Study|Protocol Violation|0|||
124967006|NCT00891046|449507358|FG004|Overall Study|Protocol Violation|1|||
124967007|NCT00891046|449507354|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
124967008|NCT00891046|449507355|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124967009|NCT00891046|449507356|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
124967010|NCT00891046|449507357|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
124464976|NCT00143455|447659891|FG003|Cohort 2|Death|12|||
124710175|NCT02852967|448565308|FG001|Overall Study|Physician Decision|0|||
124710176|NCT02852967|448565309|FG002|Overall Study|Physician Decision|0|||
124710177|NCT02852967|448565310|FG003|Overall Study|Physician Decision|1|||
124710178|NCT02852967|448565311|FG004|Overall Study|Physician Decision|0|||
124710179|NCT02852967|448565307|FG000|Overall Study|Lack of Efficacy|0|||
124710180|NCT02852967|448565308|FG001|Overall Study|Lack of Efficacy|1|||
124710181|NCT02852967|448565309|FG002|Overall Study|Lack of Efficacy|0|||
124710182|NCT02852967|448565310|FG003|Overall Study|Lack of Efficacy|0|||
124710183|NCT02852967|448565311|FG004|Overall Study|Lack of Efficacy|0|||
124710184|NCT02852967|448565307|FG000|Overall Study|Non-compliance|0|||
124710185|NCT02852967|448565308|FG001|Overall Study|Non-compliance|0|||
124710186|NCT02852967|448565309|FG002|Overall Study|Non-compliance|1|||
124710187|NCT02852967|448565310|FG003|Overall Study|Non-compliance|1|||
124710188|NCT02852967|448565311|FG004|Overall Study|Non-compliance|0|||
124710189|NCT02852967|448565307|FG000|Overall Study|Dispensing Drug Violation|0|||
124710190|NCT02852967|448565308|FG001|Overall Study|Dispensing Drug Violation|0|||
124710191|NCT02852967|448565309|FG002|Overall Study|Dispensing Drug Violation|1|||
124710192|NCT02852967|448565310|FG003|Overall Study|Dispensing Drug Violation|0|||
124710193|NCT02852967|448565311|FG004|Overall Study|Dispensing Drug Violation|0|||
124710194|NCT02852967|448565307|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
124710195|NCT02852967|448565308|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
124710196|NCT02852967|448565309|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
124710197|NCT02852967|448565310|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
124710198|NCT02852967|448565311|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
124710199|NCT01123148|448565312|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
124710200|NCT01123148|448565312|FG000|Overall Study|Didn't meet milestone criteria|1|||
124710201|NCT00355030|448565313|FG000|Study Period 1 Treatment|Adverse Event|1|||
124710202|NCT00355030|448565314|FG001|Study Period 1 Treatment|Adverse Event|1|||
124710203|NCT00355030|448565313|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
124710204|NCT00355030|448565314|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
124710205|NCT00355030|448565313|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
124464977|NCT00143455|447659888|FG000|Cohort 2|Progressive Disease|0|||
124710206|NCT00355030|448565314|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
124710207|NCT00355030|448565313|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
124710208|NCT00355030|448565314|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
124967011|NCT00891046|449507358|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
124967012|NCT00891046|449507354|FG000|Overall Study|Administrative problems|0|||
124967013|NCT00891046|449507355|FG001|Overall Study|Administrative problems|0|||
124967014|NCT00891046|449507356|FG002|Overall Study|Administrative problems|0|||
124967015|NCT00891046|449507357|FG003|Overall Study|Administrative problems|0|||
124464978|NCT00143455|447659889|FG001|Cohort 2|Progressive Disease|0|||
124464979|NCT00143455|447659890|FG002|Cohort 2|Progressive Disease|20|||
124464980|NCT00143455|447659891|FG003|Cohort 2|Progressive Disease|27|||
124464981|NCT00143455|447659888|FG000|Cohort 2|Withdrawal by Subject|0|||
124464982|NCT00143455|447659889|FG001|Cohort 2|Withdrawal by Subject|0|||
124464983|NCT00143455|447659890|FG002|Cohort 2|Withdrawal by Subject|13|||
124464984|NCT00143455|447659891|FG003|Cohort 2|Withdrawal by Subject|12|||
124464985|NCT00143455|447659888|FG000|Cohort 2|Other|0|||
124464986|NCT00143455|447659889|FG001|Cohort 2|Other|0|||
124464987|NCT00143455|447659890|FG002|Cohort 2|Other|7|||
124464988|NCT00143455|447659891|FG003|Cohort 2|Other|6|||
124967016|NCT00891046|449507358|FG004|Overall Study|Administrative problems|1|||
124967017|NCT00891046|449507354|FG000|Overall Study|Participant no longer required drug|0|||
124967018|NCT00891046|449507355|FG001|Overall Study|Participant no longer required drug|2|||
124967019|NCT00891046|449507356|FG002|Overall Study|Participant no longer required drug|0|||
124967020|NCT00891046|449507357|FG003|Overall Study|Participant no longer required drug|0|||
124967021|NCT00891046|449507358|FG004|Overall Study|Participant no longer required drug|1|||
124967022|NCT00891046|449507354|FG000|Overall Study|Adverse Event|4|||
124967023|NCT00891046|449507355|FG001|Overall Study|Adverse Event|3|||
124967024|NCT00891046|449507356|FG002|Overall Study|Adverse Event|2|||
124967025|NCT00891046|449507357|FG003|Overall Study|Adverse Event|0|||
124967026|NCT00891046|449507358|FG004|Overall Study|Adverse Event|14|||
124967027|NCT00891046|449507354|FG000|Overall Study|Withdrawal by Subject|2|||
124967028|NCT00891046|449507355|FG001|Overall Study|Withdrawal by Subject|1|||
124967029|NCT00891046|449507356|FG002|Overall Study|Withdrawal by Subject|2|||
124967030|NCT00891046|449507357|FG003|Overall Study|Withdrawal by Subject|1|||
124967031|NCT00891046|449507358|FG004|Overall Study|Withdrawal by Subject|1|||
124967032|NCT00891046|449507354|FG000|Overall Study|Lost to Follow-up|0|||
124967033|NCT00891046|449507355|FG001|Overall Study|Lost to Follow-up|0|||
124967034|NCT00891046|449507356|FG002|Overall Study|Lost to Follow-up|0|||
124967035|NCT00891046|449507357|FG003|Overall Study|Lost to Follow-up|0|||
124967036|NCT00891046|449507358|FG004|Overall Study|Lost to Follow-up|1|||
124967037|NCT02166476|449507359|FG000|Overall Study|Withdrawal by Subject|5|||
124967038|NCT02166476|449507360|FG001|Overall Study|Withdrawal by Subject|7|||
124967039|NCT02166476|449507359|FG000|Overall Study|Adverse Event|3|||
124967040|NCT02166476|449507360|FG001|Overall Study|Adverse Event|3|||
124967041|NCT02166476|449507359|FG000|Overall Study|Lost to Follow-up|5|||
124967042|NCT02166476|449507360|FG001|Overall Study|Lost to Follow-up|10|||
124967043|NCT02166476|449507359|FG000|Overall Study|Physician Decision|1|||
124967044|NCT02166476|449507360|FG001|Overall Study|Physician Decision|0|||
124967045|NCT02166476|449507359|FG000|Overall Study|Unable to Come for Visit|0|||
124967046|NCT02166476|449507360|FG001|Overall Study|Unable to Come for Visit|3|||
124967047|NCT04523207|449507364|FG000|Overall Study|Adverse Event|5|||
124967048|NCT04523207|449507365|FG001|Overall Study|Adverse Event|1|||
124967049|NCT04523207|449507364|FG000|Overall Study|Lost to Follow-up|2|||
124967050|NCT04523207|449507365|FG001|Overall Study|Lost to Follow-up|0|||
124967051|NCT04523207|449507364|FG000|Overall Study|Withdrawal by Subject|2|||
124967052|NCT04523207|449507365|FG001|Overall Study|Withdrawal by Subject|0|||
124464989|NCT00143455|447659888|FG000|Cohort 2|Randomized But Not Treated|0|||
124464990|NCT00143455|447659889|FG001|Cohort 2|Randomized But Not Treated|0|||
124464991|NCT00143455|447659890|FG002|Cohort 2|Randomized But Not Treated|1|||
124464992|NCT00143455|447659891|FG003|Cohort 2|Randomized But Not Treated|1|||
124464993|NCT01325428|447659892|FG000|Part A|Progressive disease according to RECIST|9|||
124464994|NCT01325428|447659892|FG000|Part A|Clinical signs, symptoms of progression|2|||
124967053|NCT04523207|449507364|FG000|Overall Study|Progressive Disease|2|||
124967054|NCT04523207|449507365|FG001|Overall Study|Progressive Disease|1|||
124967055|NCT04523207|449507364|FG000|Overall Study|Other|7|||
124967056|NCT04523207|449507365|FG001|Overall Study|Other|1|||
124967057|NCT03113383|449507366|FG000|Overall Study|Death|4|||
124967058|NCT03113383|449507367|FG001|Overall Study|Death|0|||
124967059|NCT03062449|449507369|FG000|Overall Study|Withdrawal by Subject|7|||
124464995|NCT01325428|447659892|FG000|Part A|Other adverse event|1|||
124967060|NCT03062449|449507370|FG001|Overall Study|Withdrawal by Subject|1|||
124967061|NCT02053610|449507372|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
124967062|NCT02053610|449507373|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
124967063|NCT02053610|449507372|FG000|Overall Study|Withdrew Consent|2|||
124967064|NCT02053610|449507373|FG001|Overall Study|Withdrew Consent|9|||
124967065|NCT02053610|449507372|FG000|Overall Study|Death|5|||
124967066|NCT02053610|449507373|FG001|Overall Study|Death|5|||
124967067|NCT02053610|449507372|FG000|Overall Study|Administrative/Other|1|||
124967068|NCT02053610|449507373|FG001|Overall Study|Administrative/Other|1|||
124967069|NCT02053610|449507372|FG000|Overall Study|Disease Progression|2|||
124967070|NCT02053610|449507373|FG001|Overall Study|Disease Progression|3|||
124967071|NCT02053610|449507372|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
124967072|NCT02053610|449507373|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
124967073|NCT02053610|449507372|FG000|Overall Study|Did not Receive Treatment|4|||
124967074|NCT02053610|449507373|FG001|Overall Study|Did not Receive Treatment|2|||
124967075|NCT02053610|449507372|FG000|Overall Study|Insufficient Therapeutic Response|1|||
124967076|NCT02053610|449507373|FG001|Overall Study|Insufficient Therapeutic Response|1|||
124967077|NCT02053610|449507372|FG000|Overall Study|Violation of Selection Criteria|1|||
124967078|NCT02053610|449507373|FG001|Overall Study|Violation of Selection Criteria|0|||
124967079|NCT03568812|449507374|FG000|Overall Study|Physician Decision|0|||
124967080|NCT03568812|449507375|FG001|Overall Study|Physician Decision|1|||
124967081|NCT00543062|449507379|FG000|Overall Study|Withdrawal by Subject|1|||
124967082|NCT00543062|449507380|FG001|Overall Study|Withdrawal by Subject|0|||
124967083|NCT00543062|449507381|FG002|Overall Study|Withdrawal by Subject|2|||
124967084|NCT00543062|449507382|FG003|Overall Study|Withdrawal by Subject|0|||
124967085|NCT00543062|449507379|FG000|Overall Study|Adverse Event|0|||
124967086|NCT00543062|449507380|FG001|Overall Study|Adverse Event|1|||
124967087|NCT00543062|449507381|FG002|Overall Study|Adverse Event|1|||
124967088|NCT00543062|449507382|FG003|Overall Study|Adverse Event|1|||
124967089|NCT00543062|449507379|FG000|Overall Study|Protocol Violation|1|||
124967090|NCT00543062|449507380|FG001|Overall Study|Protocol Violation|0|||
124967091|NCT00543062|449507381|FG002|Overall Study|Protocol Violation|0|||
124967092|NCT00543062|449507382|FG003|Overall Study|Protocol Violation|0|||
124967093|NCT00328562|449507385|FG000|Overall Study|Disease progression|1|||
124967094|NCT04014790|449507386|FG000|Overall Study|Death|4|||
124967095|NCT04014790|449507386|FG000|Overall Study|Adverse Event|1|||
124967096|NCT04014790|449507386|FG000|Overall Study|Withdrawal by Subject|1|||
124967097|NCT01010204|449507389|FG000|Overall Study|Lost to Follow-up|2|||
124967098|NCT01010204|449507390|FG001|Overall Study|Lost to Follow-up|2|||
124967099|NCT01010204|449507389|FG000|Overall Study|Adverse Event|1|||
124967100|NCT01010204|449507390|FG001|Overall Study|Adverse Event|3|||
124967101|NCT01010204|449507389|FG000|Overall Study|Withdrawal by Subject|2|||
124967102|NCT01010204|449507390|FG001|Overall Study|Withdrawal by Subject|3|||
124967103|NCT01010204|449507389|FG000|Overall Study|psychiatric hospitalization|2|||
124967104|NCT01010204|449507390|FG001|Overall Study|psychiatric hospitalization|1|||
124967105|NCT01513330|449507391|FG000|SenSura Mio First,|Adverse Event|2|||
124967106|NCT01513330|449507392|FG001|SenSura Mio First,|Adverse Event|0|||
124967107|NCT01513330|449507391|FG000|SenSura Mio First,|Lack of Efficacy|0|||
124967108|NCT01513330|449507392|FG001|SenSura Mio First,|Lack of Efficacy|1|||
124967109|NCT01513330|449507391|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
124967110|NCT01513330|449507392|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
124967111|NCT01513330|449507391|FG000|SenSura Mio First,|Other|1|||
124967112|NCT01513330|449507392|FG001|SenSura Mio First,|Other|0|||
124967113|NCT01513330|449507391|FG000|Standard Care First,|Lack of Efficacy|2|||
124967114|NCT01513330|449507392|FG001|Standard Care First,|Lack of Efficacy|2|||
124967115|NCT01513330|449507391|FG000|Standard Care First,|Withdrawal by Subject|1|||
124967116|NCT01513330|449507392|FG001|Standard Care First,|Withdrawal by Subject|2|||
124967117|NCT01513330|449507391|FG000|Standard Care First,|Other|1|||
124967118|NCT01513330|449507392|FG001|Standard Care First,|Other|0|||
124967119|NCT01519778|449507393|FG000|Overall Study|Withdrawal by Subject|3|||
124967120|NCT01519778|449507393|FG000|Overall Study|Lost to Follow-up|10|||
124967121|NCT01519778|449507393|FG000|Overall Study|Physician Decision|1|||
124967122|NCT01657799|449507394|FG000|Overall Study|Adverse Event Related to progression|6|||
124967123|NCT01657799|449507395|FG001|Overall Study|Adverse Event Related to progression|8|||
124967124|NCT01657799|449507396|FG002|Overall Study|Adverse Event Related to progression|12|||
124967125|NCT01657799|449507394|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
124967126|NCT01657799|449507395|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
124967127|NCT01657799|449507396|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
124967128|NCT01657799|449507394|FG000|Overall Study|Withdrawal by Subject|13|||
124967129|NCT01657799|449507395|FG001|Overall Study|Withdrawal by Subject|10|||
124967130|NCT01657799|449507396|FG002|Overall Study|Withdrawal by Subject|10|||
124967131|NCT01657799|449507394|FG000|Overall Study|Lost to Follow-up|1|||
124967132|NCT01657799|449507395|FG001|Overall Study|Lost to Follow-up|0|||
124464996|NCT01325428|447659892|FG000|Part A|Refused continue taking trial medication|2|||
124967133|NCT01657799|449507396|FG002|Overall Study|Lost to Follow-up|1|||
124967134|NCT01657799|449507394|FG000|Overall Study|Disease Progression|2|||
124967135|NCT01657799|449507395|FG001|Overall Study|Disease Progression|4|||
124967136|NCT01657799|449507396|FG002|Overall Study|Disease Progression|4|||
124967137|NCT01657799|449507394|FG000|Overall Study|Progressive Disease Clinical|7|||
124967138|NCT01657799|449507395|FG001|Overall Study|Progressive Disease Clinical|4|||
124464997|NCT01325428|447659892|FG000|Part A|Other reason not defined above|2|||
124464998|NCT01325428|447659892|FG000|Part B|Refused continue taking trial medication|2|||
124464999|NCT01325428|447659892|FG000|Part B|Other reason not defined above|1|||
124465000|NCT03713944|447659893|FG000|Study Treatment|Patient non-compliance|1|||
124465001|NCT03713944|447659893|FG000|Study Treatment|Alternative Cancer Therapy|3|||
124465002|NCT03713944|447659893|FG000|Study Treatment|Disease Progression|18|||
124465003|NCT03713944|447659893|FG000|Study Treatment|AE/Side Effects/Complications|2|||
124465004|NCT03713944|447659893|FG000|Study Treatment|Death|2|||
124465005|NCT03713944|447659893|FG000|Study Treatment|Withdrawal by Subject|1|||
124465006|NCT03713944|447659893|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
124465007|NCT03713944|447659893|FG000|Study Treatment|Symptomatic Deterioration|2|||
124465008|NCT03713944|447659893|FG000|Follow up|Withdrawal by Subject|2|||
124465009|NCT03713944|447659893|FG000|Follow up|Death|11|||
124465010|NCT03713944|447659893|FG000|Follow up|Study Terminated|3|||
124465011|NCT02111993|447659894|FG000|Overall Study|Physician Decision|5|||
124465012|NCT02111993|447659895|FG001|Overall Study|Physician Decision|4|||
124465013|NCT00419380|447659896|FG000|Overall Study|Lack of Efficacy|1|||
124465014|NCT00419380|447659897|FG001|Overall Study|Lack of Efficacy|7|||
124465015|NCT00419380|447659896|FG000|Overall Study|Physician Decision|0|||
124465016|NCT00419380|447659897|FG001|Overall Study|Physician Decision|1|||
124465017|NCT00419380|447659896|FG000|Overall Study|Lost to Follow-up|0|||
124967139|NCT01657799|449507396|FG002|Overall Study|Progressive Disease Clinical|7|||
124967140|NCT01657799|449507394|FG000|Overall Study|Radiographic & Clinical Progression|16|||
124967141|NCT01657799|449507395|FG001|Overall Study|Radiographic & Clinical Progression|11|||
124967142|NCT01657799|449507396|FG002|Overall Study|Radiographic & Clinical Progression|15|||
124967143|NCT01657799|449507394|FG000|Overall Study|Other|52|||
124967144|NCT01657799|449507395|FG001|Overall Study|Other|62|||
124967145|NCT01657799|449507396|FG002|Overall Study|Other|49|||
124967146|NCT00412880|449507397|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
124967147|NCT00412880|449507397|FG000|Overall Study|Consent withdrawn|1|||
124967148|NCT00412880|449507397|FG000|Overall Study|Adverse Event|1|||
124967149|NCT00412880|449507397|FG000|Overall Study|Progressive disease|20|||
124967150|NCT03297398|449507398|FG000|Overall Study|Sponsor's decision|6|||
124967151|NCT03297398|449507399|FG001|Overall Study|Sponsor's decision|9|||
124967152|NCT03297398|449507400|FG002|Overall Study|Sponsor's decision|7|||
124967153|NCT03297398|449507398|FG000|Overall Study|Adverse Event|1|||
124967154|NCT03297398|449507399|FG001|Overall Study|Adverse Event|4|||
124967155|NCT03297398|449507400|FG002|Overall Study|Adverse Event|4|||
124967156|NCT03297398|449507398|FG000|Overall Study|Withdrawal by Subject|1|||
124967157|NCT03297398|449507399|FG001|Overall Study|Withdrawal by Subject|2|||
124967158|NCT03297398|449507400|FG002|Overall Study|Withdrawal by Subject|2|||
124967159|NCT03297398|449507398|FG000|Overall Study|Protocol Violation|0|||
124967160|NCT03297398|449507399|FG001|Overall Study|Protocol Violation|2|||
124967161|NCT03297398|449507400|FG002|Overall Study|Protocol Violation|0|||
124967162|NCT03297398|449507398|FG000|Overall Study|Physician Decision|0|||
124967163|NCT03297398|449507399|FG001|Overall Study|Physician Decision|0|||
124967164|NCT03297398|449507400|FG002|Overall Study|Physician Decision|1|||
124967165|NCT03297398|449507398|FG000|Overall Study|Lost to Follow-up|0|||
124967166|NCT03297398|449507399|FG001|Overall Study|Lost to Follow-up|0|||
124967167|NCT03297398|449507400|FG002|Overall Study|Lost to Follow-up|1|||
124967168|NCT01772563|449507403|FG000|Cycle 1|Dose limiting toxicity|2|||
124967169|NCT01772563|449507403|FG000|Cycle 1|Progressive disease|2|||
124967170|NCT01772563|449507403|FG000|Cycle 2 and Beyond|Progressive disease|17|||
124967171|NCT01772563|449507403|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
124967172|NCT01772563|449507403|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
124967173|NCT01192776|449507405|FG000|Overall Study|Death|8|||
124967174|NCT01192776|449507406|FG001|Overall Study|Death|15|||
124967175|NCT01192776|449507407|FG002|Overall Study|Death|18|||
124967176|NCT01192776|449507408|FG003|Overall Study|Death|15|||
124967177|NCT01192776|449507405|FG000|Overall Study|Lost to Follow-up|3|||
124967178|NCT01192776|449507406|FG001|Overall Study|Lost to Follow-up|6|||
124967179|NCT01192776|449507407|FG002|Overall Study|Lost to Follow-up|3|||
124967180|NCT01192776|449507408|FG003|Overall Study|Lost to Follow-up|5|||
124967181|NCT03732820|449507416|FG000|Overall Study|Death|168|||
124465018|NCT00419380|447659897|FG001|Overall Study|Lost to Follow-up|1|||
124465019|NCT00419380|447659896|FG000|Overall Study|Withdrawal by Subject|0|||
124465020|NCT00419380|447659897|FG001|Overall Study|Withdrawal by Subject|1|||
124465021|NCT02703311|447659908|FG000|Overall Study|Death|5|||
124465022|NCT02703311|447659908|FG000|Overall Study|Withdrawal by Subject|3|||
124465023|NCT01294579|447659909|FG000|Overall Study|Disease progression|12|||
124465024|NCT01294579|447659909|FG000|Overall Study|Adverse Event|11|||
124465025|NCT01294579|447659909|FG000|Overall Study|Study closed/terminated|3|||
124465026|NCT01294579|447659909|FG000|Overall Study|Lost to Follow-up|1|||
124465027|NCT01294579|447659909|FG000|Overall Study|Physician Decision|3|||
124465028|NCT01294579|447659909|FG000|Overall Study|Withdrawal by Subject|5|||
124967182|NCT03732820|449507417|FG001|Overall Study|Death|203|||
124967183|NCT03732820|449507416|FG000|Overall Study|Other|2|||
124967184|NCT03732820|449507417|FG001|Overall Study|Other|2|||
124967185|NCT03732820|449507416|FG000|Overall Study|Failure to meet randomisation criteria|1|||
124967186|NCT03732820|449507417|FG001|Overall Study|Failure to meet randomisation criteria|1|||
124967187|NCT03732820|449507416|FG000|Overall Study|Patient decision|14|||
124967188|NCT03732820|449507417|FG001|Overall Study|Patient decision|10|||
124967189|NCT03732820|449507416|FG000|Overall Study|Screen failure|0|||
124967190|NCT03732820|449507417|FG001|Overall Study|Screen failure|1|||
124967191|NCT03732820|449507416|FG000|Overall Study|Patients ongoing study at data cut off|210|||
124967192|NCT03732820|449507417|FG001|Overall Study|Patients ongoing study at data cut off|178|||
124967193|NCT03732820|449507416|FG000|Overall Study|Lost to Follow-up|4|||
124967194|NCT03732820|449507417|FG001|Overall Study|Lost to Follow-up|2|||
124967195|NCT00992992|449507418|FG000|Overall Study|Lost to Follow-up|3|||
124465029|NCT02069899|447659910|FG000|Overall Study|Adverse Event|6|||
124465030|NCT02069899|447659911|FG001|Overall Study|Adverse Event|0|||
124465031|NCT02069899|447659912|FG002|Overall Study|Adverse Event|1|||
124967196|NCT00992992|449507418|FG000|Overall Study|Death|16|||
124967197|NCT00992992|449507418|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
124967198|NCT00992992|449507418|FG000|Overall Study|Sponsor Closed the Study|4|||
124967199|NCT00832000|449507419|FG000|Overall Study|Adverse Event|2|||
124967200|NCT00832000|449507420|FG001|Overall Study|Adverse Event|0|||
124967201|NCT00832000|449507419|FG000|Overall Study|Withdrawal by Subject|1|||
124967202|NCT00832000|449507420|FG001|Overall Study|Withdrawal by Subject|0|||
124967203|NCT00832000|449507419|FG000|Overall Study|No calls to IVR in either period|1|||
124967204|NCT00832000|449507420|FG001|Overall Study|No calls to IVR in either period|1|||
124967205|NCT00832000|449507419|FG000|Overall Study|No calls to IVR in period 2|2|||
124967206|NCT00832000|449507420|FG001|Overall Study|No calls to IVR in period 2|0|||
124967207|NCT03845075|449507421|FG000|Part 1 - DB|Withdrawal by Subject|1|||
124967208|NCT03845075|449507422|FG001|Part 1 - DB|Withdrawal by Subject|1|||
124967209|NCT03845075|449507423|FG002|Part 1 - DB|Withdrawal by Subject|0|||
124967210|NCT03845075|449507424|FG003|Part 1 - DB|Withdrawal by Subject|0|||
124967211|NCT03845075|449507421|FG000|Part 1 - DB|Adverse Event|0|||
124967212|NCT03845075|449507422|FG001|Part 1 - DB|Adverse Event|1|||
124967213|NCT03845075|449507423|FG002|Part 1 - DB|Adverse Event|0|||
124967214|NCT03845075|449507424|FG003|Part 1 - DB|Adverse Event|0|||
124967215|NCT03845075|449507421|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
124967216|NCT03845075|449507422|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
124967217|NCT03845075|449507423|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
124967218|NCT03845075|449507424|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
124967219|NCT00935259|449507425|FG000|Period 1|Administrative (scheduling conflict)|1|||
124967220|NCT00935259|449507426|FG001|Period 1|Administrative (scheduling conflict)|1|||
124967221|NCT03856047|449507427|FG000|Overall Study|Withdrawal by Subject|0|||
124967222|NCT03856047|449507428|FG001|Overall Study|Withdrawal by Subject|1|||
124967223|NCT03856047|449507429|FG002|Overall Study|Withdrawal by Subject|1|||
124967224|NCT03856047|449507430|FG003|Overall Study|Withdrawal by Subject|0|||
124967225|NCT03856047|449507431|FG004|Overall Study|Withdrawal by Subject|3|||
124967226|NCT03856047|449507432|FG005|Overall Study|Withdrawal by Subject|0|||
124967227|NCT03856047|449507433|FG006|Overall Study|Withdrawal by Subject|2|||
124967228|NCT03856047|449507427|FG000|Overall Study|Lost to Follow-up|4|||
124967229|NCT03856047|449507428|FG001|Overall Study|Lost to Follow-up|2|||
124967230|NCT03856047|449507429|FG002|Overall Study|Lost to Follow-up|3|||
124967231|NCT03856047|449507430|FG003|Overall Study|Lost to Follow-up|1|||
124465032|NCT02069899|447659910|FG000|Overall Study|Withdrawal by Participant|2|||
124465033|NCT02069899|447659911|FG001|Overall Study|Withdrawal by Participant|0|||
124465034|NCT02069899|447659912|FG002|Overall Study|Withdrawal by Participant|0|||
124465035|NCT02069899|447659910|FG000|Overall Study|Lost to Follow-up|1|||
124465036|NCT02069899|447659911|FG001|Overall Study|Lost to Follow-up|0|||
124465037|NCT02069899|447659912|FG002|Overall Study|Lost to Follow-up|1|||
124465038|NCT02069899|447659910|FG000|Overall Study|Other|4|||
124465039|NCT02069899|447659911|FG001|Overall Study|Other|0|||
124465040|NCT02069899|447659912|FG002|Overall Study|Other|0|||
124465041|NCT02069899|447659910|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
124465042|NCT02069899|447659911|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
124465043|NCT02069899|447659912|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
124465044|NCT02069899|447659910|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
124465045|NCT02069899|447659911|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
124465046|NCT02069899|447659912|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
124465047|NCT04417894|447659915|FG000|Overall Study|Lost to Follow-up|3|||
124465048|NCT04417894|447659916|FG001|Overall Study|Lost to Follow-up|0|||
124465049|NCT04417894|447659915|FG000|Overall Study|Withdrawal by Subject|7|||
124465050|NCT04417894|447659916|FG001|Overall Study|Withdrawal by Subject|6|||
124465051|NCT04417894|447659915|FG000|Overall Study|Lack of Efficacy|3|||
124465052|NCT04417894|447659916|FG001|Overall Study|Lack of Efficacy|1|||
124465053|NCT00262873|447659917|FG000|Overall Study|Adverse Event|3|||
124465054|NCT00262873|447659917|FG000|Overall Study|Withdrawal by Subject|5|||
124465055|NCT03440814|447659918|FG000|Overall Study|Adverse Event|2|||
124465056|NCT03440814|447659919|FG001|Overall Study|Adverse Event|1|||
124967232|NCT03856047|449507431|FG004|Overall Study|Lost to Follow-up|4|||
124967233|NCT03856047|449507432|FG005|Overall Study|Lost to Follow-up|4|||
124967234|NCT03856047|449507433|FG006|Overall Study|Lost to Follow-up|4|||
124967235|NCT00874497|449507437|FG000|Overall Study|Lost to Follow-up|2|||
124967236|NCT00874497|449507438|FG001|Overall Study|Lost to Follow-up|4|||
124967237|NCT00874497|449507437|FG000|Overall Study|Adverse Event|9|||
124967238|NCT00874497|449507438|FG001|Overall Study|Adverse Event|4|||
124967239|NCT00874497|449507437|FG000|Overall Study|Sponsor Discontinued Trial|7|||
124967240|NCT00874497|449507438|FG001|Overall Study|Sponsor Discontinued Trial|3|||
124967241|NCT00874497|449507437|FG000|Overall Study|Met Withdrawal Criteria|4|||
124967242|NCT00874497|449507438|FG001|Overall Study|Met Withdrawal Criteria|2|||
124465057|NCT03440814|447659918|FG000|Overall Study|Lost to Follow-up|2|||
124465058|NCT03440814|447659919|FG001|Overall Study|Lost to Follow-up|0|||
124465059|NCT03440814|447659918|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
124465060|NCT03440814|447659919|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
124465061|NCT02751502|447659920|FG000|Overall Study|Lack of funding|4|||
124967243|NCT00874497|449507437|FG000|Overall Study|Physician Decision|1|||
124465062|NCT02678390|447659921|FG000|AE (1 Day)|Withdrawal by Subject|0|||
124465063|NCT02678390|447659922|FG001|AE (1 Day)|Withdrawal by Subject|1|||
124465064|NCT01437397|447659923|FG000|Overall Study|Lost to Follow-up|9|||
124465065|NCT01437397|447659924|FG001|Overall Study|Lost to Follow-up|4|||
124465066|NCT01437397|447659925|FG002|Overall Study|Lost to Follow-up|2|||
124465067|NCT01437397|447659926|FG003|Overall Study|Lost to Follow-up|4|||
124465068|NCT01437397|447659927|FG004|Overall Study|Lost to Follow-up|5|||
124465069|NCT01437397|447659923|FG000|Overall Study|Withdrawal by Subject|11|||
124465070|NCT01437397|447659924|FG001|Overall Study|Withdrawal by Subject|12|||
124465071|NCT01437397|447659925|FG002|Overall Study|Withdrawal by Subject|24|||
124465072|NCT01437397|447659926|FG003|Overall Study|Withdrawal by Subject|11|||
124465073|NCT01437397|447659927|FG004|Overall Study|Withdrawal by Subject|22|||
124465074|NCT01437397|447659923|FG000|Overall Study|Protocol Violation|10|||
124465075|NCT01437397|447659924|FG001|Overall Study|Protocol Violation|12|||
124465076|NCT01437397|447659925|FG002|Overall Study|Protocol Violation|13|||
124465077|NCT01437397|447659926|FG003|Overall Study|Protocol Violation|21|||
124465078|NCT01437397|447659927|FG004|Overall Study|Protocol Violation|19|||
124465079|NCT01437397|447659923|FG000|Overall Study|Lack of Efficacy|5|||
124465080|NCT01437397|447659924|FG001|Overall Study|Lack of Efficacy|4|||
124465081|NCT01437397|447659925|FG002|Overall Study|Lack of Efficacy|8|||
124465082|NCT01437397|447659926|FG003|Overall Study|Lack of Efficacy|10|||
124465083|NCT01437397|447659927|FG004|Overall Study|Lack of Efficacy|20|||
124465084|NCT01437397|447659923|FG000|Overall Study|Adverse Event|21|||
124465085|NCT01437397|447659924|FG001|Overall Study|Adverse Event|22|||
124465086|NCT01437397|447659925|FG002|Overall Study|Adverse Event|16|||
124465087|NCT01437397|447659926|FG003|Overall Study|Adverse Event|14|||
124465088|NCT01437397|447659927|FG004|Overall Study|Adverse Event|21|||
124465089|NCT01437397|447659923|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
124465090|NCT01437397|447659924|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
124465091|NCT01437397|447659925|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
124465092|NCT01437397|447659926|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
124465093|NCT01437397|447659927|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
124465094|NCT00371865|447659928|FG000|Overall Study|Lack of Efficacy|0|||
124465095|NCT00371865|447659929|FG001|Overall Study|Lack of Efficacy|2|||
124465096|NCT00371865|447659928|FG000|Overall Study|Protocol Violation|3|||
124465097|NCT00371865|447659929|FG001|Overall Study|Protocol Violation|2|||
124465098|NCT00371865|447659928|FG000|Overall Study|Withdrawal by Subject|12|||
124465099|NCT00371865|447659929|FG001|Overall Study|Withdrawal by Subject|10|||
124465100|NCT01632566|447659931|FG000|Overall Study|Withdrawal by Subject|0|||
124465101|NCT01632566|447659932|FG001|Overall Study|Withdrawal by Subject|1|||
124465102|NCT01632566|447659933|FG002|Overall Study|Withdrawal by Subject|0|||
124465103|NCT01632566|447659934|FG003|Overall Study|Withdrawal by Subject|0|||
124967244|NCT00874497|449507438|FG001|Overall Study|Physician Decision|1|||
124967245|NCT00874497|449507437|FG000|Overall Study|Withdrawal by Subject|5|||
124465104|NCT01632566|447659935|FG004|Overall Study|Withdrawal by Subject|0|||
124465105|NCT01632566|447659931|FG000|Overall Study|Sponsor Decision|0|||
124465106|NCT01632566|447659932|FG001|Overall Study|Sponsor Decision|2|||
124465107|NCT01632566|447659933|FG002|Overall Study|Sponsor Decision|9|||
124465108|NCT01632566|447659934|FG003|Overall Study|Sponsor Decision|2|||
124465109|NCT01632566|447659935|FG004|Overall Study|Sponsor Decision|2|||
124465110|NCT01318109|447659936|FG000|Overall Study|Adverse Event|0|||
124465111|NCT01318109|447659937|FG001|Overall Study|Adverse Event|2|||
124465112|NCT01318109|447659938|FG002|Overall Study|Adverse Event|0|||
124465113|NCT01318109|447659936|FG000|Overall Study|Withdrawal by Subject|1|||
124465114|NCT01318109|447659937|FG001|Overall Study|Withdrawal by Subject|0|||
124465115|NCT01318109|447659938|FG002|Overall Study|Withdrawal by Subject|0|||
124465116|NCT01318109|447659936|FG000|Overall Study|Schedule Conflict|0|||
124465117|NCT01318109|447659937|FG001|Overall Study|Schedule Conflict|1|||
124465118|NCT01318109|447659938|FG002|Overall Study|Schedule Conflict|0|||
124465119|NCT01328951|447659939|FG000|Overall Study|Disease Progression|17|||
124465120|NCT01328951|447659940|FG001|Overall Study|Disease Progression|14|||
124465121|NCT01328951|447659939|FG000|Overall Study|Adverse Event|2|||
124465122|NCT01328951|447659940|FG001|Overall Study|Adverse Event|0|||
124465123|NCT01328951|447659939|FG000|Overall Study|Death|243|||
124465124|NCT01328951|447659940|FG001|Overall Study|Death|258|||
124465125|NCT01328951|447659939|FG000|Overall Study|Lost to Follow-up|6|||
124465126|NCT01328951|447659940|FG001|Overall Study|Lost to Follow-up|7|||
124465127|NCT01328951|447659939|FG000|Overall Study|Withdrawal by Subject|6|||
124465128|NCT01328951|447659940|FG001|Overall Study|Withdrawal by Subject|6|||
124465129|NCT01328951|447659939|FG000|Overall Study|Study Closed by the Sponsor|36|||
124465130|NCT01328951|447659940|FG001|Overall Study|Study Closed by the Sponsor|31|||
124465131|NCT01328951|447659939|FG000|Overall Study|Other|11|||
124465132|NCT01328951|447659940|FG001|Overall Study|Other|6|||
124465133|NCT04042103|447659941|FG000|Overall Study|Lost to Follow-up|1|||
124465134|NCT04042103|447659941|FG000|Overall Study|Withdrawal by Subject|1|||
124465135|NCT02193074|447659943|FG000|Overall Study|Withdrawal by Subject|1|||
124465136|NCT02193074|447659944|FG001|Overall Study|Withdrawal by Subject|2|||
124465137|NCT02193074|447659943|FG000|Overall Study|Adverse Event|16|||
124465138|NCT02193074|447659944|FG001|Overall Study|Adverse Event|13|||
124465139|NCT01534533|447659945|FG000|Overall Study|Lost to Follow-up|3|||
124465140|NCT01534533|447659946|FG001|Overall Study|Lost to Follow-up|0|||
124465141|NCT01534533|447659947|FG002|Overall Study|Lost to Follow-up|4|||
124465142|NCT01534533|447659948|FG003|Overall Study|Lost to Follow-up|3|||
124465143|NCT01534533|447659945|FG000|Overall Study|Withdrawal by Subject|5|||
124465144|NCT01534533|447659946|FG001|Overall Study|Withdrawal by Subject|3|||
124465145|NCT01534533|447659947|FG002|Overall Study|Withdrawal by Subject|4|||
124465146|NCT01534533|447659948|FG003|Overall Study|Withdrawal by Subject|1|||
124465147|NCT02615990|447661400|FG000|Overall Study|study terminated|1|||
124465148|NCT02615990|447661401|FG001|Overall Study|study terminated|1|||
124465149|NCT00925015|447661405|FG000|Overall Study|Adverse Event|1|||
124465150|NCT00925015|447661406|FG001|Overall Study|Adverse Event|2|||
124465151|NCT00925015|447661407|FG002|Overall Study|Adverse Event|1|||
124465152|NCT00925015|447661405|FG000|Overall Study|Physician Decision|0|||
124465153|NCT00925015|447661406|FG001|Overall Study|Physician Decision|1|||
124465154|NCT00925015|447661407|FG002|Overall Study|Physician Decision|0|||
124465155|NCT00925015|447661405|FG000|Overall Study|Progressive Disease|7|||
124465156|NCT00925015|447661406|FG001|Overall Study|Progressive Disease|3|||
124465157|NCT00925015|447661407|FG002|Overall Study|Progressive Disease|4|||
124465158|NCT00925015|447661405|FG000|Overall Study|Withdrawal by Subject|0|||
124465159|NCT00925015|447661406|FG001|Overall Study|Withdrawal by Subject|0|||
124465160|NCT00925015|447661407|FG002|Overall Study|Withdrawal by Subject|1|||
124465161|NCT01368835|447661410|FG000|Overall Study|Inclusion criteria/photography quality|22|||
124465162|NCT01368835|447661410|FG000|Overall Study|Lost to Follow-up|11|||
124465163|NCT02754726|447661411|FG000|Overall Study|Progressive Disease by RECIST|13|||
124465164|NCT02754726|447661411|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
124465165|NCT02754726|447661411|FG000|Overall Study|Clinical Disease Progression|5|||
124465166|NCT02754726|447661411|FG000|Overall Study|Adverse Event|3|||
124465167|NCT02754726|447661411|FG000|Overall Study|Withdrawal by Subject|1|||
124465168|NCT02754726|447661411|FG000|Overall Study|Tolerability|1|||
124465169|NCT01777152|447661412|FG000|Overall Study|Withdrawal by Subject|22|||
124465170|NCT01777152|447661413|FG001|Overall Study|Withdrawal by Subject|16|||
124465171|NCT01777152|447661412|FG000|Overall Study|Lost to Follow-up|3|||
124465172|NCT01777152|447661413|FG001|Overall Study|Lost to Follow-up|5|||
124465173|NCT01777152|447661412|FG000|Overall Study|Death|68|||
124465174|NCT01777152|447661413|FG001|Overall Study|Death|89|||
124465175|NCT01777152|447661412|FG000|Overall Study|Not eligible, no study drug received|1|||
124465176|NCT01777152|447661413|FG001|Overall Study|Not eligible, no study drug received|0|||
124465177|NCT01777152|447661412|FG000|Overall Study|Change of diagnosis|1|||
124465178|NCT01777152|447661413|FG001|Overall Study|Change of diagnosis|0|||
124465179|NCT02792842|447661414|FG000|Overall Study|Adverse Event|4|||
124465180|NCT02792842|447661415|FG001|Overall Study|Adverse Event|2|||
124465181|NCT02792842|447661416|FG002|Overall Study|Adverse Event|3|||
124465182|NCT02792842|447661414|FG000|Overall Study|Withdrawal by Subject|0|||
124465183|NCT02792842|447661415|FG001|Overall Study|Withdrawal by Subject|1|||
124465184|NCT02792842|447661416|FG002|Overall Study|Withdrawal by Subject|2|||
124465185|NCT02792842|447661414|FG000|Overall Study|Lost to Follow-up|0|||
124465186|NCT02792842|447661415|FG001|Overall Study|Lost to Follow-up|0|||
124465187|NCT02792842|447661416|FG002|Overall Study|Lost to Follow-up|1|||
124465188|NCT02792842|447661414|FG000|Overall Study|Schedule delay|0|||
124465189|NCT02792842|447661415|FG001|Overall Study|Schedule delay|1|||
124465190|NCT02792842|447661416|FG002|Overall Study|Schedule delay|1|||
124465191|NCT01496885|447661420|FG000|Overall Study|Lost to Follow-up|13|||
124465192|NCT01496885|447661420|FG000|Overall Study|Withdrawal by Subject|7|||
124465193|NCT01496885|447661420|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
124465194|NCT01496885|447661420|FG000|Overall Study|Death|1|||
124465195|NCT03446885|447661421|FG000|Overall Study|Lost to Follow-up|1|||
124465196|NCT03446885|447661422|FG001|Overall Study|Lost to Follow-up|0|||
124465197|NCT03446885|447661421|FG000|Overall Study|Did not complete entire visit|1|||
124465198|NCT03446885|447661422|FG001|Overall Study|Did not complete entire visit|0|||
124465199|NCT01098071|447661430|FG000|Overall Study|Surgery (adenoidectomy)|2|||
124465200|NCT01098071|447661430|FG000|Overall Study|Lost to Follow-up|13|||
124465201|NCT01081795|447661432|FG000|Overall Study|Adverse Event|18|||
124465202|NCT01081795|447661433|FG001|Overall Study|Adverse Event|23|||
124465203|NCT01081795|447661434|FG002|Overall Study|Adverse Event|6|||
124465204|NCT01081795|447661432|FG000|Overall Study|Lack of Efficacy|7|||
124465205|NCT01081795|447661433|FG001|Overall Study|Lack of Efficacy|5|||
124465206|NCT01081795|447661434|FG002|Overall Study|Lack of Efficacy|19|||
124465207|NCT01081795|447661432|FG000|Overall Study|Subject's schedule|1|||
124465208|NCT01081795|447661433|FG001|Overall Study|Subject's schedule|1|||
124465209|NCT01081795|447661434|FG002|Overall Study|Subject's schedule|2|||
124465210|NCT01081795|447661432|FG000|Overall Study|Revocation of informed consent|2|||
124465211|NCT01081795|447661433|FG001|Overall Study|Revocation of informed consent|0|||
124465212|NCT01081795|447661434|FG002|Overall Study|Revocation of informed consent|0|||
124465213|NCT01081795|447661432|FG000|Overall Study|Ineligible for participation|1|||
124465214|NCT01081795|447661433|FG001|Overall Study|Ineligible for participation|0|||
124967246|NCT00874497|449507438|FG001|Overall Study|Withdrawal by Subject|4|||
124967247|NCT01017263|449507439|FG000|Overall Study|not eligible|12|||
124967248|NCT00665223|449507444|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
124967249|NCT00665223|449507445|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
124967250|NCT00665223|449507446|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
124465215|NCT01081795|447661434|FG002|Overall Study|Ineligible for participation|0|||
124465216|NCT01081795|447661432|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
124465217|NCT01081795|447661433|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
124465218|NCT01081795|447661434|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
124465219|NCT01081795|447661432|FG000|Overall Study|Using drug with restricted days of use|2|||
124465220|NCT01081795|447661433|FG001|Overall Study|Using drug with restricted days of use|3|||
124465221|NCT01081795|447661434|FG002|Overall Study|Using drug with restricted days of use|2|||
124465222|NCT01081795|447661432|FG000|Overall Study|Other|1|||
124465223|NCT01081795|447661433|FG001|Overall Study|Other|2|||
124465224|NCT01081795|447661434|FG002|Overall Study|Other|0|||
124465225|NCT00661271|447661435|FG000|Overall Study|Lost to Follow-up|28|||
124465226|NCT00661271|447661436|FG001|Overall Study|Lost to Follow-up|25|||
124465227|NCT01707693|447661437|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
124465228|NCT01707693|447661438|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
124465229|NCT01707693|447661437|FG000|Overall Study Allocation|Protocol Violation|4|||
124465230|NCT01707693|447661438|FG001|Overall Study Allocation|Protocol Violation|3|||
124465231|NCT01707693|447661437|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
124465232|NCT01707693|447661438|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
124465233|NCT01707693|447661437|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
124465234|NCT01707693|447661438|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
124465235|NCT03847610|447661441|FG000|Overall Study|Withdrawal by Subject|1|||
124465236|NCT03298022|447661442|FG000|Overall Study|Lack of Efficacy|4|||
124465237|NCT03298022|447661442|FG000|Overall Study|Withdrawal by Subject|7|||
124465238|NCT03298022|447661442|FG000|Overall Study|Adverse Event|1|||
124465239|NCT03298022|447661442|FG000|Overall Study|disease relapse|1|||
124465240|NCT03099707|447661445|FG000|Overall Study|Withdrawal by Subject|0|||
124465241|NCT03099707|447661446|FG001|Overall Study|Withdrawal by Subject|3|||
124465242|NCT03099707|447661445|FG000|Overall Study|Lost to Follow-up|0|||
124465243|NCT03099707|447661446|FG001|Overall Study|Lost to Follow-up|1|||
124465244|NCT01445769|447661447|FG000|Overall Study|Consent Withdrawn|2|||
124465245|NCT01445769|447661447|FG000|Overall Study|Disease Progression|1|||
124465246|NCT01445769|447661447|FG000|Overall Study|Lost to Follow-up|5|||
124465247|NCT00343889|447661458|FG000|Overall Study|Lost to Follow-up|2|||
124465248|NCT00343889|447661459|FG001|Overall Study|Lost to Follow-up|0|||
124465249|NCT00343889|447661458|FG000|Overall Study|Withdrawal by Subject|0|||
124465250|NCT00343889|447661459|FG001|Overall Study|Withdrawal by Subject|1|||
124465251|NCT00343889|447661458|FG000|Overall Study|Protocol Violation|1|||
124465252|NCT00343889|447661459|FG001|Overall Study|Protocol Violation|0|||
124465253|NCT01967537|447661462|FG000|Overall Study|Withdrawal by Subject|52|||
124465254|NCT01967537|447661462|FG000|Overall Study|Refuse treatment|2|||
124465255|NCT01967537|447661462|FG000|Overall Study|Lost to Follow-up|6|||
124465256|NCT05130463|447661463|FG000|Overall Study|Unspecified reasons|2|||
124710209|NCT00355030|448565313|FG000|Study Period 1 Treatment|Physician Decision|0|||
124710210|NCT00355030|448565314|FG001|Study Period 1 Treatment|Physician Decision|1|||
124710211|NCT00355030|448565313|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
124710212|NCT00355030|448565314|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
124710213|NCT00355030|448565313|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
124710214|NCT00355030|448565314|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
124710215|NCT00355030|448565313|FG000|Study Period 1 Treatment|Other|2|||
124710216|NCT00355030|448565314|FG001|Study Period 1 Treatment|Other|6|||
124710217|NCT00355030|448565313|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
124710218|NCT00355030|448565314|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
124710219|NCT00355030|448565313|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
124710220|NCT00355030|448565314|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
124710221|NCT01693367|448565317|FG000|Overall Study|Withdrawal by Subject|1|||
124710222|NCT01693367|448565318|FG001|Overall Study|Withdrawal by Subject|1|||
124710223|NCT01693367|448565317|FG000|Overall Study|Physician Decision|0|||
124710224|NCT01693367|448565318|FG001|Overall Study|Physician Decision|1|||
124710225|NCT02136914|448565319|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
124710226|NCT02136914|448565320|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
124710227|NCT02136914|448565319|FG000|Overall Study|Withdrawal by Subject|3|||
124710228|NCT02136914|448565320|FG001|Overall Study|Withdrawal by Subject|10|||
124710229|NCT02136914|448565319|FG000|Overall Study|Subject Unwilling to Proceed|7|||
124710230|NCT02136914|448565320|FG001|Overall Study|Subject Unwilling to Proceed|2|||
124710231|NCT02136914|448565319|FG000|Overall Study|Lost to Follow-up|1|||
124710232|NCT02136914|448565320|FG001|Overall Study|Lost to Follow-up|1|||
124710233|NCT02136914|448565319|FG000|Overall Study|Did Not Receive Study Drug|2|||
124710234|NCT02136914|448565320|FG001|Overall Study|Did Not Receive Study Drug|0|||
124710235|NCT02136914|448565319|FG000|Overall Study|Lack of Efficacy|1|||
124967251|NCT00665223|449507444|FG000|Randomized Phase (26 Weeks)|Death|0|||
124465257|NCT05130463|447661463|FG000|Overall Study|off-label indication dose|435|||
124465258|NCT03652662|447661469|FG000|Overall Study|Withdrawal by Subject|2|||
124465259|NCT03652662|447661470|FG001|Overall Study|Withdrawal by Subject|1|||
124465260|NCT03652662|447661469|FG000|Overall Study|Lost to Follow-up|1|||
124465261|NCT03652662|447661470|FG001|Overall Study|Lost to Follow-up|0|||
124465262|NCT03861559|447661471|FG000|Overall Study|Adverse Event|0|||
124465263|NCT03861559|447661472|FG001|Overall Study|Adverse Event|2|||
124465264|NCT03861559|447661471|FG000|Overall Study|Treatment failure|0|||
124465265|NCT03861559|447661472|FG001|Overall Study|Treatment failure|2|||
124465266|NCT03861559|447661471|FG000|Overall Study|Noncompliance|1|||
124465267|NCT03861559|447661472|FG001|Overall Study|Noncompliance|1|||
124465268|NCT03861559|447661471|FG000|Overall Study|Did not meet eligibility requirements|1|||
124465269|NCT03861559|447661472|FG001|Overall Study|Did not meet eligibility requirements|0|||
124465270|NCT00487539|447661473|FG000|Overall Study|Adverse Event|3|||
124465271|NCT00487539|447661474|FG001|Overall Study|Adverse Event|2|||
124465272|NCT00487539|447661475|FG002|Overall Study|Adverse Event|1|||
124465273|NCT00487539|447661476|FG003|Overall Study|Adverse Event|1|||
124465274|NCT00487539|447661473|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124465275|NCT00487539|447661474|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124465276|NCT00487539|447661475|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
124465277|NCT00487539|447661476|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
124465278|NCT00487539|447661473|FG000|Overall Study|Other|3|||
124465279|NCT00487539|447661474|FG001|Overall Study|Other|1|||
124465280|NCT00487539|447661475|FG002|Overall Study|Other|2|||
124465281|NCT00487539|447661476|FG003|Overall Study|Other|2|||
124465282|NCT00879697|447661477|FG000|Overall Study|Physician Decision|2|||
124465283|NCT00879697|447661478|FG001|Overall Study|Physician Decision|2|||
124465284|NCT00088374|447661479|FG000|Overall Study|patient did not receive any 17AAG|1|||
124465285|NCT00088374|447661479|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
124465286|NCT03499028|447661480|FG000|Overall Study|Lost to Follow-up|12|||
124465287|NCT03499028|447661481|FG001|Overall Study|Lost to Follow-up|9|||
124465288|NCT03499028|447661480|FG000|Overall Study|Withdrawal by Subject|5|||
124465289|NCT03499028|447661481|FG001|Overall Study|Withdrawal by Subject|8|||
124465290|NCT03499028|447661480|FG000|Overall Study|Unplanned SNF discharge|5|||
124465291|NCT03499028|447661481|FG001|Overall Study|Unplanned SNF discharge|8|||
124465292|NCT03595553|447661482|FG000|Overall Study|Withdrawal by Subject|20|||
124465293|NCT03595553|447661483|FG001|Overall Study|Withdrawal by Subject|8|||
124465294|NCT03595553|447661482|FG000|Overall Study|Physician Decision|3|||
124465295|NCT03595553|447661483|FG001|Overall Study|Physician Decision|2|||
124465296|NCT03595553|447661482|FG000|Overall Study|Adverse Event|2|||
124465297|NCT03595553|447661483|FG001|Overall Study|Adverse Event|5|||
124465298|NCT03595553|447661482|FG000|Overall Study|Death|24|||
124465299|NCT03595553|447661483|FG001|Overall Study|Death|22|||
124465300|NCT03595553|447661482|FG000|Overall Study|Lost to Follow-up|6|||
124465301|NCT03595553|447661483|FG001|Overall Study|Lost to Follow-up|7|||
124465302|NCT03595553|447661482|FG000|Overall Study|Other as indicated in CSR|3|||
124465303|NCT03595553|447661483|FG001|Overall Study|Other as indicated in CSR|3|||
124465304|NCT03595553|447661482|FG000|Overall Study|Sponsor Decision|0|||
124465305|NCT03595553|447661483|FG001|Overall Study|Sponsor Decision|1|||
124465306|NCT00903175|447661484|FG000|Period 1 - First Line|Adverse Event|36|||
124465307|NCT00903175|447661485|FG001|Period 1 - First Line|Adverse Event|50|||
124465308|NCT00903175|447661484|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
124465309|NCT00903175|447661485|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
124465310|NCT00903175|447661484|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
124465311|NCT00903175|447661485|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
124465312|NCT00903175|447661484|FG000|Period 1 - First Line|Protocol Violation|3|||
124465313|NCT00903175|447661485|FG001|Period 1 - First Line|Protocol Violation|3|||
124465314|NCT00903175|447661484|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
124465315|NCT00903175|447661485|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
124967252|NCT00665223|449507445|FG001|Randomized Phase (26 Weeks)|Death|0|||
124967253|NCT00665223|449507446|FG002|Randomized Phase (26 Weeks)|Death|1|||
124967254|NCT00665223|449507444|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
124967255|NCT00665223|449507445|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
124465316|NCT00903175|447661484|FG000|Period 1 - First Line|Administrative problems|12|||
124465317|NCT00903175|447661485|FG001|Period 1 - First Line|Administrative problems|13|||
124967256|NCT00665223|449507446|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
124465318|NCT00903175|447661484|FG000|Period 1 - First Line|Death|17|||
124465319|NCT00903175|447661485|FG001|Period 1 - First Line|Death|10|||
124465320|NCT00903175|447661484|FG000|Period 2 - Second Line|Missing|1|||
124465321|NCT00903175|447661485|FG001|Period 2 - Second Line|Missing|0|||
124465322|NCT00903175|447661484|FG000|Period 2 - Second Line|Adverse Event|16|||
124465323|NCT00903175|447661485|FG001|Period 2 - Second Line|Adverse Event|20|||
124465324|NCT00903175|447661484|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
124465325|NCT00903175|447661485|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
124465326|NCT00903175|447661484|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
124465327|NCT00903175|447661485|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
124465328|NCT00903175|447661484|FG000|Period 2 - Second Line|Administrative problems|19|||
124465329|NCT00903175|447661485|FG001|Period 2 - Second Line|Administrative problems|9|||
124465330|NCT00903175|447661484|FG000|Period 2 - Second Line|Death|5|||
124465331|NCT00903175|447661485|FG001|Period 2 - Second Line|Death|2|||
124465332|NCT01687712|447661488|FG000|Cycle 1|Not Biochemically Pregnant|386|||
124465333|NCT01687712|447661489|FG001|Cycle 1|Not Biochemically Pregnant|348|||
124465334|NCT01687712|447661488|FG000|Cycle 1|Early Pregnancy Loss|43|||
124465335|NCT01687712|447661489|FG001|Cycle 1|Early Pregnancy Loss|60|||
124465336|NCT01687712|447661488|FG000|Cycle 1|Ectopic Pregnancy|5|||
124465337|NCT01687712|447661489|FG001|Cycle 1|Ectopic Pregnancy|5|||
124465338|NCT01687712|447661488|FG000|Cycle 1|Heterotropic Pregnancy|1|||
124465339|NCT01687712|447661489|FG001|Cycle 1|Heterotropic Pregnancy|0|||
124465340|NCT01687712|447661488|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
124465341|NCT01687712|447661489|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
124465342|NCT01687712|447661488|FG000|Cycle 1|Abortion|3|||
124465343|NCT01687712|447661489|FG001|Cycle 1|Abortion|0|||
124465344|NCT01687712|447661488|FG000|Cycle 1|Intrauterine Fetal Death|0|||
124465345|NCT01687712|447661489|FG001|Cycle 1|Intrauterine Fetal Death|1|||
124465346|NCT01687712|447661488|FG000|Cycle 1|Lost to Follow-up|1|||
124465347|NCT01687712|447661489|FG001|Cycle 1|Lost to Follow-up|1|||
124465348|NCT01687712|447661488|FG000|Cycle 2|Not Biochemically Pregnant|74|||
124465349|NCT01687712|447661489|FG001|Cycle 2|Not Biochemically Pregnant|77|||
124465350|NCT01687712|447661488|FG000|Cycle 2|Early Pregnancy Loss|18|||
124465351|NCT01687712|447661489|FG001|Cycle 2|Early Pregnancy Loss|16|||
124465352|NCT01687712|447661488|FG000|Cycle 2|Ectopic Pregnancy|0|||
124465353|NCT01687712|447661489|FG001|Cycle 2|Ectopic Pregnancy|1|||
124465354|NCT01687712|447661488|FG000|Cycle 2|Still Birth|1|||
124465355|NCT01687712|447661489|FG001|Cycle 2|Still Birth|0|||
124465356|NCT01687712|447661488|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
124465357|NCT01687712|447661489|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
124465358|NCT01687712|447661488|FG000|Cycle 3|Not Biochemically Pregnant|21|||
124465359|NCT01687712|447661489|FG001|Cycle 3|Not Biochemically Pregnant|22|||
124465360|NCT01687712|447661488|FG000|Cycle 3|Early Pregnancy Loss|1|||
124465361|NCT01687712|447661489|FG001|Cycle 3|Early Pregnancy Loss|2|||
124465362|NCT01687712|447661488|FG000|Cycle 3|Ectopic Pregnancy|1|||
124465363|NCT01687712|447661489|FG001|Cycle 3|Ectopic Pregnancy|0|||
124465364|NCT01687712|447661488|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
124465365|NCT01687712|447661489|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
124465366|NCT03074474|447661492|FG000|Overall Study|Lost to Follow-up|10|||
124465367|NCT03074474|447661492|FG000|Overall Study|Withdrawal by Subject|10|||
124465368|NCT03074474|447661492|FG000|Overall Study|Death|4|||
124465369|NCT03074474|447661492|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
124465370|NCT01627899|447661495|FG000|Overall Study|Study terminated early by sponsor.|5|||
124465371|NCT01003210|447661499|FG000|Overall Study|Lost to Follow-up|1|||
124465372|NCT01003210|447661500|FG001|Overall Study|Lost to Follow-up|3|||
124465373|NCT00271817|447661501|FG000|Part 1|Adverse Event|68|||
124465374|NCT00271817|447661502|FG001|Part 1|Adverse Event|25|||
124465375|NCT00271817|447661503|FG002|Part 1|Adverse Event|156|||
124465376|NCT00271817|447661501|FG000|Part 1|Lost to Follow-up|6|||
124465377|NCT00271817|447661502|FG001|Part 1|Lost to Follow-up|8|||
124465378|NCT00271817|447661503|FG002|Part 1|Lost to Follow-up|24|||
124465379|NCT00271817|447661501|FG000|Part 1|Protocol Violation|5|||
124465380|NCT00271817|447661502|FG001|Part 1|Protocol Violation|4|||
124465381|NCT00271817|447661503|FG002|Part 1|Protocol Violation|7|||
124465382|NCT00271817|447661501|FG000|Part 1|Patient Moved|3|||
124465383|NCT00271817|447661502|FG001|Part 1|Patient Moved|1|||
124465384|NCT00271817|447661503|FG002|Part 1|Patient Moved|5|||
124465385|NCT00271817|447661501|FG000|Part 1|Withdrawal by Subject|23|||
124465386|NCT00271817|447661502|FG001|Part 1|Withdrawal by Subject|17|||
124465387|NCT00271817|447661503|FG002|Part 1|Withdrawal by Subject|45|||
124465388|NCT00271817|447661501|FG000|Part 1|LDL < 50 mg/dL|1|||
124465389|NCT00271817|447661502|FG001|Part 1|LDL < 50 mg/dL|4|||
124465390|NCT00271817|447661503|FG002|Part 1|LDL < 50 mg/dL|48|||
124465391|NCT00271817|447661501|FG000|Part 2|Adverse Event|0|||
124465392|NCT00271817|447661502|FG001|Part 2|Adverse Event|17|||
124465393|NCT00271817|447661503|FG002|Part 2|Adverse Event|33|||
124465394|NCT00271817|447661501|FG000|Part 2|Lack of Efficacy|0|||
124465395|NCT00271817|447661502|FG001|Part 2|Lack of Efficacy|1|||
124465396|NCT00271817|447661503|FG002|Part 2|Lack of Efficacy|6|||
124465397|NCT00271817|447661501|FG000|Part 2|Lost to Follow-up|0|||
124465398|NCT00271817|447661502|FG001|Part 2|Lost to Follow-up|6|||
124465399|NCT00271817|447661503|FG002|Part 2|Lost to Follow-up|18|||
124465400|NCT00271817|447661501|FG000|Part 2|Protocol Violation|0|||
124465401|NCT00271817|447661502|FG001|Part 2|Protocol Violation|3|||
124465402|NCT00271817|447661503|FG002|Part 2|Protocol Violation|5|||
124465403|NCT00271817|447661501|FG000|Part 2|Patient Moved|0|||
124465404|NCT00271817|447661502|FG001|Part 2|Patient Moved|0|||
124465405|NCT00271817|447661503|FG002|Part 2|Patient Moved|5|||
124465406|NCT00271817|447661501|FG000|Part 2|Withdrawal by Subject|0|||
124465407|NCT00271817|447661502|FG001|Part 2|Withdrawal by Subject|2|||
124465408|NCT00271817|447661503|FG002|Part 2|Withdrawal by Subject|13|||
124465409|NCT00271817|447661501|FG000|Part 2|LDL < 50 mg/dL|0|||
124465410|NCT00271817|447661502|FG001|Part 2|LDL < 50 mg/dL|3|||
124465411|NCT00271817|447661503|FG002|Part 2|LDL < 50 mg/dL|4|||
124465412|NCT04153188|447661506|FG000|Overall Study|Lost to Follow-up|1|||
124465413|NCT04153188|447661507|FG001|Overall Study|Lost to Follow-up|1|||
124465414|NCT04153188|447661506|FG000|Overall Study|Withdrawal by Subject|2|||
124465415|NCT04153188|447661507|FG001|Overall Study|Withdrawal by Subject|0|||
124465416|NCT04153188|447661506|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
124465417|NCT04153188|447661507|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
124465418|NCT00700271|447661508|FG000|Overall Study|Adverse Event|4|||
124465419|NCT00700271|447661509|FG001|Overall Study|Adverse Event|6|||
124465420|NCT00700271|447661508|FG000|Overall Study|Protocol Violation|1|||
124465421|NCT00700271|447661509|FG001|Overall Study|Protocol Violation|0|||
124465422|NCT00700271|447661508|FG000|Overall Study|Administrative Reasons|1|||
124465423|NCT00700271|447661509|FG001|Overall Study|Administrative Reasons|0|||
124465424|NCT00700271|447661508|FG000|Overall Study|Withdrawal by Subject|6|||
124465425|NCT00700271|447661509|FG001|Overall Study|Withdrawal by Subject|4|||
124465426|NCT00700271|447661508|FG000|Overall Study|Lost to Follow-up|2|||
124465427|NCT00700271|447661509|FG001|Overall Study|Lost to Follow-up|2|||
124465428|NCT00861744|447661510|FG000|Overall Study|Adverse Event|0|||
124465429|NCT00861744|447661511|FG001|Overall Study|Adverse Event|0|||
124465430|NCT00861744|447661512|FG002|Overall Study|Adverse Event|0|||
124465431|NCT00861744|447661513|FG003|Overall Study|Adverse Event|1|||
124465432|NCT00861744|447661510|FG000|Overall Study|Lost to Follow-up|7|||
124465433|NCT00861744|447661511|FG001|Overall Study|Lost to Follow-up|19|||
124465434|NCT00861744|447661512|FG002|Overall Study|Lost to Follow-up|17|||
124465435|NCT00861744|447661513|FG003|Overall Study|Lost to Follow-up|12|||
124465436|NCT00861744|447661510|FG000|Overall Study|Withdrawal by Subject|10|||
124465437|NCT00861744|447661511|FG001|Overall Study|Withdrawal by Subject|6|||
124465438|NCT00861744|447661512|FG002|Overall Study|Withdrawal by Subject|6|||
124465439|NCT00861744|447661513|FG003|Overall Study|Withdrawal by Subject|19|||
124465440|NCT00861744|447661510|FG000|Overall Study|Protocol Violation|0|||
124465441|NCT00861744|447661511|FG001|Overall Study|Protocol Violation|1|||
124465442|NCT00861744|447661512|FG002|Overall Study|Protocol Violation|0|||
124465443|NCT00861744|447661513|FG003|Overall Study|Protocol Violation|0|||
124465444|NCT00861744|447661510|FG000|Overall Study|Migration from study area|0|||
124465445|NCT00861744|447661511|FG001|Overall Study|Migration from study area|3|||
124465446|NCT00861744|447661512|FG002|Overall Study|Migration from study area|1|||
124465447|NCT00861744|447661513|FG003|Overall Study|Migration from study area|0|||
124465448|NCT00861744|447661510|FG000|Overall Study|Blood draws|0|||
124465449|NCT00861744|447661511|FG001|Overall Study|Blood draws|0|||
124465450|NCT00861744|447661512|FG002|Overall Study|Blood draws|0|||
124465451|NCT00861744|447661513|FG003|Overall Study|Blood draws|1|||
124465452|NCT05107765|447661514|FG000|Overall Study|Lost to Follow-up|4|||
124465453|NCT05107765|447661515|FG001|Overall Study|Lost to Follow-up|1|||
124465454|NCT05107765|447661514|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
124465455|NCT05107765|447661515|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
124465456|NCT05107765|447661514|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
124465457|NCT05107765|447661515|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
124465458|NCT03124563|447661518|FG000|Overall Study|Lost to Follow-up|1|||
124465459|NCT03124563|447661519|FG001|Overall Study|Lost to Follow-up|1|||
124465460|NCT03124563|447661518|FG000|Overall Study|Withdrawal by Subject|1|||
124465461|NCT03124563|447661519|FG001|Overall Study|Withdrawal by Subject|1|||
124465462|NCT00264004|447662884|FG000|Overall Study|Adverse Event|2|||
124465463|NCT00264004|447662885|FG001|Overall Study|Adverse Event|3|||
124465464|NCT00264004|447662886|FG002|Overall Study|Adverse Event|6|||
124465465|NCT00264004|447662887|FG003|Overall Study|Adverse Event|4|||
124465466|NCT00264004|447662884|FG000|Overall Study|Withdrawal by Subject|0|||
124465467|NCT00264004|447662885|FG001|Overall Study|Withdrawal by Subject|1|||
124465468|NCT00264004|447662886|FG002|Overall Study|Withdrawal by Subject|2|||
124465469|NCT00264004|447662887|FG003|Overall Study|Withdrawal by Subject|2|||
124465470|NCT00264004|447662884|FG000|Overall Study|Other|2|||
124465471|NCT00264004|447662885|FG001|Overall Study|Other|2|||
124465472|NCT00264004|447662886|FG002|Overall Study|Other|0|||
124465473|NCT00264004|447662887|FG003|Overall Study|Other|3|||
124465474|NCT00264004|447662884|FG000|Overall Study|Development study specific disc. crit.|1|||
124465475|NCT00264004|447662885|FG001|Overall Study|Development study specific disc. crit.|0|||
124465476|NCT00264004|447662886|FG002|Overall Study|Development study specific disc. crit.|1|||
124465477|NCT00264004|447662887|FG003|Overall Study|Development study specific disc. crit.|0|||
124465478|NCT00264004|447662884|FG000|Overall Study|Cond. under inv. worsened|9|||
124550211|NCT02406742|447970609|FG002|Overall Study|Lack of Efficacy|1|||
124465479|NCT00264004|447662885|FG001|Overall Study|Cond. under inv. worsened|5|||
124465480|NCT00264004|447662886|FG002|Overall Study|Cond. under inv. worsened|3|||
124465481|NCT00264004|447662887|FG003|Overall Study|Cond. under inv. worsened|4|||
124465482|NCT00264004|447662884|FG000|Overall Study|Not treated|3|||
124465483|NCT00264004|447662885|FG001|Overall Study|Not treated|0|||
124550212|NCT02406742|447970607|FG000|Overall Study|Withdrawal by Participant|1|||
124465484|NCT00264004|447662886|FG002|Overall Study|Not treated|2|||
124465485|NCT00264004|447662887|FG003|Overall Study|Not treated|2|||
124465486|NCT01535729|447662888|FG000|Overall Study|Withdrawal by Subject|2|||
124465487|NCT01535729|447662888|FG000|Overall Study|Disease progression|230|||
124465488|NCT01535729|447662888|FG000|Overall Study|Discontinued treatment|25|||
124465489|NCT01535729|447662888|FG000|Overall Study|Lost to Follow-up|8|||
124465490|NCT01535729|447662888|FG000|Overall Study|Death|52|||
124465491|NCT01535729|447662888|FG000|Overall Study|Other|19|||
124465492|NCT01535729|447662888|FG000|Overall Study|Did not sign informed consent|1|||
124465493|NCT01535729|447662888|FG000|Overall Study|No previous chemotherapy|33|||
124465494|NCT01535729|447662888|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
124465495|NCT01535729|447662888|FG000|Overall Study|Protocol Violation|11|||
124465496|NCT01535729|447662888|FG000|Overall Study|Screening failure|1|||
124465497|NCT01535729|447662888|FG000|Overall Study|Not treated|9|||
124465498|NCT01535729|447662888|FG000|Overall Study|No participant record available|5|||
124465499|NCT01262365|447662889|FG000|Overall Study|Lack of Efficacy|35|||
124465500|NCT01262365|447662890|FG001|Overall Study|Lack of Efficacy|30|||
124465501|NCT01262365|447662891|FG002|Overall Study|Lack of Efficacy|47|||
124465502|NCT01262365|447662889|FG000|Overall Study|Protocol Violation|3|||
124465503|NCT01262365|447662890|FG001|Overall Study|Protocol Violation|1|||
124465504|NCT01262365|447662891|FG002|Overall Study|Protocol Violation|1|||
124465505|NCT01262365|447662889|FG000|Overall Study|Lost to Follow-up|3|||
124465506|NCT01262365|447662890|FG001|Overall Study|Lost to Follow-up|7|||
124465507|NCT01262365|447662891|FG002|Overall Study|Lost to Follow-up|6|||
124465508|NCT01262365|447662889|FG000|Overall Study|Withdrawal by Subject|17|||
124465509|NCT01262365|447662890|FG001|Overall Study|Withdrawal by Subject|22|||
124465510|NCT01262365|447662891|FG002|Overall Study|Withdrawal by Subject|22|||
124465511|NCT01262365|447662889|FG000|Overall Study|Death|1|||
124465512|NCT01262365|447662890|FG001|Overall Study|Death|2|||
124465513|NCT01262365|447662891|FG002|Overall Study|Death|1|||
124465514|NCT01262365|447662889|FG000|Overall Study|Adverse Event|26|||
124465515|NCT01262365|447662890|FG001|Overall Study|Adverse Event|16|||
124465516|NCT01262365|447662891|FG002|Overall Study|Adverse Event|11|||
124465517|NCT01262365|447662889|FG000|Overall Study|sponsor decision|1|||
124465518|NCT01262365|447662890|FG001|Overall Study|sponsor decision|1|||
124465519|NCT01262365|447662891|FG002|Overall Study|sponsor decision|0|||
124465520|NCT01262365|447662889|FG000|Overall Study|Randomization error|1|||
124465521|NCT01262365|447662890|FG001|Overall Study|Randomization error|0|||
124465522|NCT01262365|447662891|FG002|Overall Study|Randomization error|2|||
124465523|NCT01262365|447662889|FG000|Overall Study|Non-compliance|1|||
124465524|NCT01262365|447662890|FG001|Overall Study|Non-compliance|0|||
124465525|NCT01262365|447662891|FG002|Overall Study|Non-compliance|2|||
124465526|NCT01262365|447662889|FG000|Overall Study|Suspected pregnancy|1|||
124465527|NCT01262365|447662890|FG001|Overall Study|Suspected pregnancy|0|||
124465528|NCT01262365|447662891|FG002|Overall Study|Suspected pregnancy|0|||
124465529|NCT01262365|447662889|FG000|Overall Study|Patient pregnant|1|||
124465530|NCT01262365|447662890|FG001|Overall Study|Patient pregnant|0|||
124465531|NCT01262365|447662891|FG002|Overall Study|Patient pregnant|1|||
124465532|NCT01262365|447662889|FG000|Overall Study|Toxicity related to study drug|0|||
124710236|NCT02136914|448565320|FG001|Overall Study|Lack of Efficacy|0|||
124710237|NCT02136914|448565319|FG000|Overall Study|Death|0|||
124710238|NCT02136914|448565320|FG001|Overall Study|Death|1|||
124710239|NCT05518461|448565327|FG000|Overall Study|Lost to Follow-up|25|||
124710240|NCT03179761|448565328|FG000|Overall Study|Death|2|||
124710241|NCT03179761|448565329|FG001|Overall Study|Death|5|||
124967257|NCT00665223|449507444|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
124967258|NCT00665223|449507445|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
124967259|NCT00665223|449507446|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
124967260|NCT00665223|449507444|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
124967261|NCT00665223|449507445|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
124967262|NCT00665223|449507446|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
124967263|NCT00665223|449507444|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
124967264|NCT00665223|449507445|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
124967265|NCT00665223|449507446|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
124967266|NCT00665223|449507444|FG000|Open-Label Period (26 Weeks)|Death|0|||
124967267|NCT00665223|449507445|FG001|Open-Label Period (26 Weeks)|Death|1|||
124967268|NCT00665223|449507446|FG002|Open-Label Period (26 Weeks)|Death|0|||
124967269|NCT00665223|449507444|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
124967270|NCT00665223|449507445|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
124967271|NCT00665223|449507446|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
124967272|NCT00665223|449507444|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
124967273|NCT00665223|449507445|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
124967274|NCT00665223|449507446|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
124967275|NCT00665223|449507444|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
124967276|NCT00665223|449507445|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
124465533|NCT01262365|447662890|FG001|Overall Study|Toxicity related to study drug|1|||
124465534|NCT01262365|447662891|FG002|Overall Study|Toxicity related to study drug|0|||
124465535|NCT01262365|447662889|FG000|Overall Study|Cannot tolerate the protocol|0|||
124710242|NCT03179761|448565328|FG000|Overall Study|Lost to Follow-up|2|||
124465536|NCT01262365|447662890|FG001|Overall Study|Cannot tolerate the protocol|1|||
124465537|NCT01262365|447662891|FG002|Overall Study|Cannot tolerate the protocol|0|||
124465538|NCT01262365|447662889|FG000|Overall Study|Patient unavailable|0|||
124465539|NCT01262365|447662890|FG001|Overall Study|Patient unavailable|0|||
124465540|NCT01262365|447662891|FG002|Overall Study|Patient unavailable|1|||
124465541|NCT02322710|447662892|FG000|Overall Study|No efficacy assessment post-baseline|0|||
124465542|NCT02322710|447662893|FG001|Overall Study|No efficacy assessment post-baseline|1|||
124465543|NCT02322710|447662892|FG000|Overall Study|Protocol Violation|20|||
124465544|NCT02322710|447662893|FG001|Overall Study|Protocol Violation|25|||
124465545|NCT04161131|447662894|FG000|Overall Study|Ineligible|2|||
124465546|NCT04161131|447662894|FG000|Overall Study|Lost to Follow-up|4|||
124465547|NCT03905863|447662895|FG000|Overall Study|Adverse Event|2|||
124465548|NCT03905863|447662896|FG001|Overall Study|Adverse Event|4|||
124465549|NCT03905863|447662895|FG000|Overall Study|Withdrawal by Subject|2|||
124465550|NCT03905863|447662896|FG001|Overall Study|Withdrawal by Subject|2|||
124465551|NCT03905863|447662895|FG000|Overall Study|Physician Decision|0|||
124465552|NCT03905863|447662896|FG001|Overall Study|Physician Decision|3|||
124465553|NCT03905863|447662895|FG000|Overall Study|Lost to Follow-up|1|||
124465554|NCT03905863|447662896|FG001|Overall Study|Lost to Follow-up|0|||
124465555|NCT03905863|447662895|FG000|Overall Study|Protocol Violation|0|||
124710243|NCT03179761|448565329|FG001|Overall Study|Lost to Follow-up|2|||
124710244|NCT03179761|448565328|FG000|Overall Study|Protocol Violation|1|||
124710245|NCT03179761|448565329|FG001|Overall Study|Protocol Violation|0|||
124710246|NCT03179761|448565328|FG000|Overall Study|Withdrawal by Subject|1|||
124710247|NCT03179761|448565329|FG001|Overall Study|Withdrawal by Subject|4|||
124710248|NCT03179761|448565328|FG000|Overall Study|Investigator Request|0|||
124710249|NCT03179761|448565329|FG001|Overall Study|Investigator Request|2|||
124710250|NCT00448448|448565331|FG000|Overall Study|Withdrawal by Subject|13|||
124710251|NCT00448448|448565332|FG001|Overall Study|Withdrawal by Subject|2|||
124710252|NCT00448448|448565331|FG000|Overall Study|On protocol when study ended|83|||
124710253|NCT00448448|448565332|FG001|Overall Study|On protocol when study ended|36|||
124710254|NCT00448448|448565331|FG000|Overall Study|Lost to Follow-up|2|||
124710255|NCT00448448|448565332|FG001|Overall Study|Lost to Follow-up|1|||
124710256|NCT00448448|448565331|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
124710257|NCT00448448|448565332|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
124710258|NCT00448448|448565331|FG000|Overall Study|Signed consent lost|0|||
124710259|NCT00448448|448565332|FG001|Overall Study|Signed consent lost|1|||
124710260|NCT02284191|448565333|FG000|Overall Study|Withdrawal by Subject|1|||
124710261|NCT02284191|448565334|FG001|Overall Study|Withdrawal by Subject|3|||
124710262|NCT02284191|448565333|FG000|Overall Study|Lost to Follow-up|1|||
124710263|NCT02284191|448565334|FG001|Overall Study|Lost to Follow-up|0|||
124710264|NCT01188967|448565335|FG000|Overall Study|Withdrawal by Subject|1|||
124710265|NCT01188967|448565336|FG001|Overall Study|Withdrawal by Subject|1|||
124710266|NCT01188967|448565335|FG000|Overall Study|Physician Decision|1|||
124710267|NCT01188967|448565336|FG001|Overall Study|Physician Decision|1|||
124710268|NCT01188967|448565335|FG000|Overall Study|Lost to Follow-up|3|||
124710269|NCT01188967|448565336|FG001|Overall Study|Lost to Follow-up|2|||
124710270|NCT01832727|448565341|FG000|Overall Study|Adverse Event|4|||
124710271|NCT01832727|448565342|FG001|Overall Study|Adverse Event|6|||
124710272|NCT01832727|448565343|FG002|Overall Study|Adverse Event|1|||
124710273|NCT01832727|448565344|FG003|Overall Study|Adverse Event|0|||
124710274|NCT01832727|448565345|FG004|Overall Study|Adverse Event|1|||
124710275|NCT01832727|448565346|FG005|Overall Study|Adverse Event|1|||
124710276|NCT01832727|448565347|FG006|Overall Study|Adverse Event|2|||
124710277|NCT01832727|448565348|FG007|Overall Study|Adverse Event|1|||
124710278|NCT01832727|448565349|FG008|Overall Study|Adverse Event|9|||
124710279|NCT01832727|448565341|FG000|Overall Study|Disease progression|3|||
124710280|NCT01832727|448565342|FG001|Overall Study|Disease progression|0|||
124710281|NCT01832727|448565343|FG002|Overall Study|Disease progression|2|||
124710282|NCT01832727|448565344|FG003|Overall Study|Disease progression|1|||
124710283|NCT01832727|448565345|FG004|Overall Study|Disease progression|3|||
124465556|NCT03905863|447662896|FG001|Overall Study|Protocol Violation|2|||
124465557|NCT03905863|447662895|FG000|Overall Study|Death|0|||
124465558|NCT03905863|447662896|FG001|Overall Study|Death|1|||
124710284|NCT01832727|448565346|FG005|Overall Study|Disease progression|3|||
124710285|NCT01832727|448565347|FG006|Overall Study|Disease progression|6|||
124710286|NCT01832727|448565348|FG007|Overall Study|Disease progression|2|||
124710287|NCT01832727|448565349|FG008|Overall Study|Disease progression|7|||
124710288|NCT01832727|448565341|FG000|Overall Study|Lost to Follow-up|0|||
124465559|NCT05499559|447662900|FG000|Overall Study|Lost to Follow-up|467|||
124465560|NCT04681170|447662901|FG000|Stratified Enrolment & run-in|Death|1|||
124710289|NCT01832727|448565342|FG001|Overall Study|Lost to Follow-up|0|||
124710290|NCT01832727|448565343|FG002|Overall Study|Lost to Follow-up|0|||
124710291|NCT01832727|448565344|FG003|Overall Study|Lost to Follow-up|1|||
124710292|NCT01832727|448565345|FG004|Overall Study|Lost to Follow-up|0|||
124710293|NCT01832727|448565346|FG005|Overall Study|Lost to Follow-up|0|||
124710294|NCT01832727|448565347|FG006|Overall Study|Lost to Follow-up|0|||
124710295|NCT01832727|448565348|FG007|Overall Study|Lost to Follow-up|0|||
124710296|NCT01832727|448565349|FG008|Overall Study|Lost to Follow-up|0|||
124465561|NCT04681170|447662902|FG001|Stratified Enrolment & run-in|Death|0|||
124465562|NCT04681170|447662901|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
124465563|NCT04681170|447662902|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
124465564|NCT04681170|447662901|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
124465565|NCT04681170|447662902|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
124465566|NCT04681170|447662901|FG000|Open Label Efficacy Phase|Adverse Event|0|||
124967277|NCT00665223|449507446|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
124967278|NCT00665223|449507444|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
124967279|NCT00665223|449507445|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
124967280|NCT00665223|449507446|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
124967281|NCT01278615|449507447|FG000|Overall Study|Withdrawal by Subject|2|||
124967282|NCT00905359|449507448|FG000|Overall Study|Lost to Follow-up|17|||
124967283|NCT00905359|449507449|FG001|Overall Study|Lost to Follow-up|10|||
124967284|NCT00905359|449507448|FG000|Overall Study|Death|2|||
124967285|NCT00905359|449507449|FG001|Overall Study|Death|0|||
124967286|NCT00905359|449507448|FG000|Overall Study|Withdrawal consent|5|||
124967287|NCT00905359|449507449|FG001|Overall Study|Withdrawal consent|6|||
124967288|NCT02654132|449507450|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
124967289|NCT02654132|449507451|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
124967290|NCT02654132|449507450|FG000|Treatment Period|Disease progression|43|||
124967291|NCT02654132|449507451|FG001|Treatment Period|Disease progression|38|||
124967292|NCT02654132|449507450|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
124967293|NCT02654132|449507451|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
124465567|NCT04681170|447662902|FG001|Open Label Efficacy Phase|Adverse Event|2|||
124465568|NCT04681170|447662901|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
124465569|NCT04681170|447662902|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
124465570|NCT04681170|447662901|FG000|Open Label Safety Phase|AEs and none compliance|0|||
124465571|NCT04681170|447662902|FG001|Open Label Safety Phase|AEs and none compliance|1|||
124465572|NCT04986202|447662903|FG000|Overall Study|Death|10|||
124465573|NCT04986202|447662904|FG001|Overall Study|Death|3|||
124465574|NCT04986202|447662905|FG002|Overall Study|Death|10|||
124465575|NCT04986202|447662903|FG000|Overall Study|Physician Decision|3|||
124465576|NCT04986202|447662904|FG001|Overall Study|Physician Decision|1|||
124465577|NCT04986202|447662905|FG002|Overall Study|Physician Decision|2|||
124465578|NCT04986202|447662903|FG000|Overall Study|Withdrawal by Subject|4|||
124465579|NCT04986202|447662904|FG001|Overall Study|Withdrawal by Subject|2|||
124465580|NCT04986202|447662905|FG002|Overall Study|Withdrawal by Subject|4|||
124465581|NCT02468648|447662906|FG000|Overall Study|Death|1|||
124465582|NCT02118792|447662907|FG000|Overall Study|Withdrawal by Subject|6|||
124465583|NCT02118792|447662908|FG001|Overall Study|Withdrawal by Subject|3|||
124465584|NCT02118792|447662907|FG000|Overall Study|Lost to Follow-up|4|||
124465585|NCT02118792|447662908|FG001|Overall Study|Lost to Follow-up|4|||
124465586|NCT02118792|447662907|FG000|Overall Study|Adverse Event|5|||
124465587|NCT02118792|447662908|FG001|Overall Study|Adverse Event|4|||
124465588|NCT02118792|447662907|FG000|Overall Study|Withdrawal by parent/guardian|14|||
124465589|NCT02118792|447662908|FG001|Overall Study|Withdrawal by parent/guardian|20|||
124465590|NCT02118792|447662907|FG000|Overall Study|Other|1|||
124465591|NCT02118792|447662908|FG001|Overall Study|Other|6|||
124465592|NCT02118792|447662907|FG000|Overall Study|Randomised but not treated|1|||
124465593|NCT02118792|447662908|FG001|Overall Study|Randomised but not treated|0|||
124465594|NCT05131204|447662909|FG000|Overall Study|Sponsor request|2|||
124465595|NCT05131204|447662910|FG001|Overall Study|Sponsor request|1|||
124465596|NCT04656652|447662911|FG000|Overall Study|Lost to Follow-up|2|||
124465597|NCT04656652|447662912|FG001|Overall Study|Lost to Follow-up|2|||
124465598|NCT04656652|447662911|FG000|Overall Study|Death|213|||
124465599|NCT04656652|447662912|FG001|Overall Study|Death|212|||
124550213|NCT02406742|447970608|FG001|Overall Study|Withdrawal by Participant|2|||
124550214|NCT02406742|447970609|FG002|Overall Study|Withdrawal by Participant|0|||
124550215|NCT02406742|447970607|FG000|Overall Study|Physician Decision|1|||
124550216|NCT02406742|447970608|FG001|Overall Study|Physician Decision|2|||
124550217|NCT02406742|447970609|FG002|Overall Study|Physician Decision|1|||
124550218|NCT02406742|447970607|FG000|Overall Study|Transition to other treatment|2|||
124967294|NCT02654132|449507450|FG000|Treatment Period|Other reasons|4|||
124465600|NCT04656652|447662911|FG000|Overall Study|Other|1|||
124465601|NCT04656652|447662912|FG001|Overall Study|Other|0|||
124967295|NCT02654132|449507451|FG001|Treatment Period|Other reasons|2|||
124967296|NCT02654132|449507450|FG000|Treatment Period|Study drug toxicity|2|||
124967297|NCT02654132|449507451|FG001|Treatment Period|Study drug toxicity|2|||
124967298|NCT02654132|449507450|FG000|Treatment Period|Withdrawal by Subject|2|||
124967299|NCT02654132|449507451|FG001|Treatment Period|Withdrawal by Subject|1|||
124967300|NCT02654132|449507450|FG000|Treatment Period|Maximum Clinical Benefit|0|||
124465602|NCT04656652|447662911|FG000|Overall Study|Withdrawal by Subject|15|||
124465603|NCT04656652|447662912|FG001|Overall Study|Withdrawal by Subject|29|||
124550219|NCT02406742|447970608|FG001|Overall Study|Transition to other treatment|0|||
124550220|NCT02406742|447970609|FG002|Overall Study|Transition to other treatment|1|||
124967301|NCT02654132|449507451|FG001|Treatment Period|Maximum Clinical Benefit|2|||
124465604|NCT02787863|447662913|FG000|Overall Study|Death|1|||
124465605|NCT02787863|447662914|FG001|Overall Study|Death|0|||
124465606|NCT02787863|447662915|FG002|Overall Study|Death|1|||
124967302|NCT02654132|449507450|FG000|Treatment Period|Participant request to discontinue|2|||
124967303|NCT02654132|449507451|FG001|Treatment Period|Participant request to discontinue|0|||
124967304|NCT02654132|449507450|FG000|Treatment Period|Administrative reasons by sponsor|0|||
124967305|NCT02654132|449507451|FG001|Treatment Period|Administrative reasons by sponsor|1|||
124465607|NCT02787863|447662916|FG003|Overall Study|Death|0|||
124465608|NCT02787863|447662917|FG004|Overall Study|Death|0|||
124465609|NCT02787863|447662918|FG005|Overall Study|Death|0|||
124465610|NCT02787863|447662919|FG006|Overall Study|Death|0|||
124465611|NCT02787863|447662920|FG007|Overall Study|Death|0|||
124465612|NCT02787863|447662913|FG000|Overall Study|Withdrawal by Subject|0|||
124465613|NCT02787863|447662914|FG001|Overall Study|Withdrawal by Subject|1|||
124465614|NCT02787863|447662915|FG002|Overall Study|Withdrawal by Subject|1|||
124465615|NCT02787863|447662916|FG003|Overall Study|Withdrawal by Subject|0|||
124465616|NCT02787863|447662917|FG004|Overall Study|Withdrawal by Subject|0|||
124465617|NCT02787863|447662918|FG005|Overall Study|Withdrawal by Subject|0|||
124465618|NCT02787863|447662919|FG006|Overall Study|Withdrawal by Subject|0|||
124465619|NCT02787863|447662920|FG007|Overall Study|Withdrawal by Subject|0|||
124465620|NCT01978093|447662921|FG000|Overall Study|Death|1|||
124465621|NCT01978093|447662922|FG001|Overall Study|Death|0|||
124465622|NCT01978093|447662921|FG000|Overall Study|Adverse Event|0|||
124465623|NCT01978093|447662922|FG001|Overall Study|Adverse Event|5|||
124465624|NCT01978093|447662921|FG000|Overall Study|Protocol Violation|8|||
124465625|NCT01978093|447662922|FG001|Overall Study|Protocol Violation|2|||
124465626|NCT01978093|447662921|FG000|Overall Study|Withdrawal by Subject|29|||
124465627|NCT01978093|447662922|FG001|Overall Study|Withdrawal by Subject|25|||
124465628|NCT01978093|447662921|FG000|Overall Study|Lost to Follow-up|11|||
124465629|NCT01978093|447662922|FG001|Overall Study|Lost to Follow-up|15|||
124967306|NCT02654132|449507450|FG000|Treatment Period|Death|1|||
124967307|NCT02654132|449507451|FG001|Treatment Period|Death|0|||
124967308|NCT00621192|449507452|FG000|Overall Study|Withdrawal by Subject|0|||
124967309|NCT00621192|449507453|FG001|Overall Study|Withdrawal by Subject|0|||
124967310|NCT00621192|449507454|FG002|Overall Study|Withdrawal by Subject|2|||
124967311|NCT00621192|449507455|FG003|Overall Study|Withdrawal by Subject|0|||
124967312|NCT00621192|449507452|FG000|Overall Study|Physician Decision|1|||
124967313|NCT00621192|449507453|FG001|Overall Study|Physician Decision|3|||
124967314|NCT00621192|449507454|FG002|Overall Study|Physician Decision|0|||
124967315|NCT00621192|449507455|FG003|Overall Study|Physician Decision|0|||
124967316|NCT00621192|449507452|FG000|Overall Study|Protocol Violation|1|||
124967317|NCT00621192|449507453|FG001|Overall Study|Protocol Violation|0|||
124967318|NCT00621192|449507454|FG002|Overall Study|Protocol Violation|0|||
124967319|NCT00621192|449507455|FG003|Overall Study|Protocol Violation|1|||
124967320|NCT00621192|449507452|FG000|Overall Study|Adverse Event|0|||
124967321|NCT00621192|449507453|FG001|Overall Study|Adverse Event|1|||
124967322|NCT00621192|449507454|FG002|Overall Study|Adverse Event|0|||
124967323|NCT00621192|449507455|FG003|Overall Study|Adverse Event|1|||
124967324|NCT00621192|449507452|FG000|Overall Study|Death|2|||
124967325|NCT00621192|449507453|FG001|Overall Study|Death|5|||
124967326|NCT00621192|449507454|FG002|Overall Study|Death|0|||
124967327|NCT00621192|449507455|FG003|Overall Study|Death|0|||
124967328|NCT00621192|449507452|FG000|Overall Study|Final Assessments not Completed|0|||
124967329|NCT00621192|449507453|FG001|Overall Study|Final Assessments not Completed|0|||
124967330|NCT00621192|449507454|FG002|Overall Study|Final Assessments not Completed|3|||
124967331|NCT00621192|449507455|FG003|Overall Study|Final Assessments not Completed|1|||
124465630|NCT01978093|447662921|FG000|Overall Study|Migrated/moved from study area|11|||
124465631|NCT01978093|447662922|FG001|Overall Study|Migrated/moved from study area|13|||
124465632|NCT01978093|447662921|FG000|Overall Study|Loss of kaiser coverage|4|||
124465633|NCT01978093|447662922|FG001|Overall Study|Loss of kaiser coverage|10|||
124465634|NCT01978093|447662921|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
124465635|NCT01978093|447662922|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
124465636|NCT01978093|447662921|FG000|Overall Study|Mother lost custody of child|0|||
124465637|NCT01978093|447662922|FG001|Overall Study|Mother lost custody of child|1|||
124465638|NCT01978093|447662921|FG000|Overall Study|Child was in care of grandmother|0|||
124465639|NCT01978093|447662922|FG001|Overall Study|Child was in care of grandmother|1|||
124465640|NCT01978093|447662921|FG000|Overall Study|N/A for vaccine administration|0|||
124967332|NCT04706793|449507456|FG000|Treatment|Disease worsening|10|||
124967333|NCT04706793|449507457|FG001|Treatment|Disease worsening|10|||
124967334|NCT04706793|449507456|FG000|Follow-up|Lack of Efficacy|1|||
124967335|NCT04706793|449507457|FG001|Follow-up|Lack of Efficacy|0|||
124967336|NCT04706793|449507456|FG000|Follow-up|Disease worsening|8|||
124967337|NCT04706793|449507457|FG001|Follow-up|Disease worsening|10|||
124465641|NCT01978093|447662922|FG001|Overall Study|N/A for vaccine administration|1|||
124967338|NCT04706793|449507456|FG000|Follow-up|Adverse Event|1|||
124967339|NCT04706793|449507457|FG001|Follow-up|Adverse Event|0|||
124967340|NCT02601209|449507459|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
124967341|NCT02601209|449507460|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
124967342|NCT02601209|449507461|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
124967343|NCT02601209|449507462|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
124967344|NCT02601209|449507463|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
124967345|NCT02601209|449507464|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
124967346|NCT02601209|449507465|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
124967347|NCT02601209|449507466|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
124967348|NCT02601209|449507467|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
124967349|NCT02601209|449507459|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
124967350|NCT02601209|449507460|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
124967351|NCT02601209|449507461|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
124967352|NCT02601209|449507462|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
124967353|NCT02601209|449507463|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
124967354|NCT02601209|449507464|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
124967355|NCT02601209|449507465|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
124967356|NCT02601209|449507466|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
124967357|NCT02601209|449507467|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
124967358|NCT03636373|449507468|FG000|Overall Study|Study closure due to Covid-19|1|||
124967359|NCT03636373|449507469|FG001|Overall Study|Study closure due to Covid-19|0|||
124967360|NCT00572533|449507470|FG000|Overall Study|Death|4|||
124967361|NCT00572533|449507471|FG001|Overall Study|Death|1|||
124967362|NCT00572533|449507470|FG000|Overall Study|Received Kidney Transplant|2|||
124967363|NCT00572533|449507471|FG001|Overall Study|Received Kidney Transplant|1|||
124967364|NCT00572533|449507470|FG000|Overall Study|Social Issues|1|||
124967365|NCT00572533|449507471|FG001|Overall Study|Social Issues|0|||
124967366|NCT00572533|449507470|FG000|Overall Study|Transfer out of Facility|0|||
124967367|NCT00572533|449507471|FG001|Overall Study|Transfer out of Facility|1|||
124967368|NCT01530087|449507475|FG000|Overall Study|Physician Decision|2|||
124967369|NCT02344173|449507480|FG000|Procedure|Ablation Procedure Not Performed|7|||
124967370|NCT02344173|449507480|FG000|12-month Visit|Death|8|||
124967371|NCT02344173|449507480|FG000|12-month Visit|Withdrawal by Subject|30|||
124967372|NCT02344173|449507480|FG000|12-month Visit|Lost to Follow-up|58|||
124967373|NCT00661713|449507481|FG000|Overall Study|Death|1|||
124967374|NCT00661713|449507482|FG001|Overall Study|Death|0|||
124967375|NCT00661713|449507483|FG002|Overall Study|Death|0|||
124967376|NCT00661713|449507484|FG003|Overall Study|Death|0|||
124967377|NCT00661713|449507485|FG004|Overall Study|Death|1|||
124967378|NCT00661713|449507486|FG005|Overall Study|Death|0|||
124967379|NCT00661713|449507487|FG006|Overall Study|Death|0|||
124967380|NCT00661713|449507488|FG007|Overall Study|Death|0|||
124967381|NCT00661713|449507481|FG000|Overall Study|Unable to Classify|1|||
124967382|NCT00661713|449507482|FG001|Overall Study|Unable to Classify|0|||
124967383|NCT00661713|449507483|FG002|Overall Study|Unable to Classify|0|||
124967384|NCT00661713|449507484|FG003|Overall Study|Unable to Classify|0|||
124967385|NCT00661713|449507485|FG004|Overall Study|Unable to Classify|0|||
124967386|NCT00661713|449507486|FG005|Overall Study|Unable to Classify|0|||
124967387|NCT00661713|449507487|FG006|Overall Study|Unable to Classify|0|||
124967388|NCT00661713|449507488|FG007|Overall Study|Unable to Classify|0|||
124967389|NCT00661713|449507481|FG000|Overall Study|Protocol Violation|1|||
124967390|NCT00661713|449507482|FG001|Overall Study|Protocol Violation|6|||
124967391|NCT00661713|449507483|FG002|Overall Study|Protocol Violation|3|||
124967392|NCT00661713|449507484|FG003|Overall Study|Protocol Violation|3|||
124967393|NCT00661713|449507485|FG004|Overall Study|Protocol Violation|0|||
124967394|NCT00661713|449507486|FG005|Overall Study|Protocol Violation|2|||
124967395|NCT00661713|449507487|FG006|Overall Study|Protocol Violation|2|||
124967396|NCT00661713|449507488|FG007|Overall Study|Protocol Violation|1|||
124967397|NCT00661713|449507481|FG000|Overall Study|Withdrawal by Subject|11|||
124967398|NCT00661713|449507482|FG001|Overall Study|Withdrawal by Subject|25|||
124967399|NCT00661713|449507483|FG002|Overall Study|Withdrawal by Subject|12|||
124967400|NCT00661713|449507484|FG003|Overall Study|Withdrawal by Subject|21|||
124967401|NCT00661713|449507485|FG004|Overall Study|Withdrawal by Subject|12|||
124967402|NCT00661713|449507486|FG005|Overall Study|Withdrawal by Subject|26|||
124967403|NCT00661713|449507487|FG006|Overall Study|Withdrawal by Subject|45|||
124967404|NCT00661713|449507488|FG007|Overall Study|Withdrawal by Subject|9|||
124967405|NCT00661713|449507481|FG000|Overall Study|Lost to Follow-up|2|||
124967406|NCT00661713|449507482|FG001|Overall Study|Lost to Follow-up|7|||
124967407|NCT00661713|449507483|FG002|Overall Study|Lost to Follow-up|2|||
124967408|NCT00661713|449507484|FG003|Overall Study|Lost to Follow-up|2|||
124967409|NCT00661713|449507485|FG004|Overall Study|Lost to Follow-up|5|||
124967410|NCT00661713|449507486|FG005|Overall Study|Lost to Follow-up|7|||
124967411|NCT00661713|449507487|FG006|Overall Study|Lost to Follow-up|14|||
124967412|NCT00661713|449507488|FG007|Overall Study|Lost to Follow-up|1|||
124967413|NCT00661713|449507481|FG000|Overall Study|Administrative Reason|0|||
124967414|NCT00661713|449507482|FG001|Overall Study|Administrative Reason|1|||
124967415|NCT00661713|449507483|FG002|Overall Study|Administrative Reason|0|||
124967416|NCT00661713|449507484|FG003|Overall Study|Administrative Reason|2|||
124967417|NCT00661713|449507485|FG004|Overall Study|Administrative Reason|2|||
124967418|NCT00661713|449507486|FG005|Overall Study|Administrative Reason|2|||
124967419|NCT00661713|449507487|FG006|Overall Study|Administrative Reason|1|||
124967420|NCT00661713|449507488|FG007|Overall Study|Administrative Reason|0|||
124967421|NCT00661713|449507481|FG000|Overall Study|Adverse Event|0|||
124967422|NCT00661713|449507482|FG001|Overall Study|Adverse Event|0|||
124967423|NCT00661713|449507483|FG002|Overall Study|Adverse Event|0|||
124967424|NCT00661713|449507484|FG003|Overall Study|Adverse Event|0|||
124967425|NCT00661713|449507485|FG004|Overall Study|Adverse Event|0|||
124967426|NCT00661713|449507486|FG005|Overall Study|Adverse Event|0|||
124967427|NCT00661713|449507487|FG006|Overall Study|Adverse Event|1|||
124967428|NCT00661713|449507488|FG007|Overall Study|Adverse Event|0|||
124967429|NCT00661713|449507481|FG000|Overall Study|Inappropriate Enrollment|0|||
124967430|NCT00661713|449507482|FG001|Overall Study|Inappropriate Enrollment|0|||
124967431|NCT00661713|449507483|FG002|Overall Study|Inappropriate Enrollment|0|||
124967432|NCT00661713|449507484|FG003|Overall Study|Inappropriate Enrollment|0|||
124967433|NCT00661713|449507485|FG004|Overall Study|Inappropriate Enrollment|0|||
124967434|NCT00661713|449507486|FG005|Overall Study|Inappropriate Enrollment|0|||
124967435|NCT00661713|449507487|FG006|Overall Study|Inappropriate Enrollment|1|||
124967436|NCT00661713|449507488|FG007|Overall Study|Inappropriate Enrollment|0|||
124967437|NCT00416598|449509479|FG000|Induction & Intensification|Adverse Event|38|||
124967438|NCT00416598|449509479|FG000|Induction & Intensification|Death|32|||
124967439|NCT00416598|449509479|FG000|Induction & Intensification|Withdrawal by Subject|46|||
124967440|NCT00416598|449509479|FG000|Induction & Intensification|Alternative Treatment|135|||
124967441|NCT00416598|449509479|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
124967442|NCT00416598|449509479|FG000|Induction & Intensification|Relapse/progression|29|||
124967443|NCT00416598|449509479|FG000|Induction & Intensification|Failed induction|87|||
124967444|NCT00416598|449509479|FG000|Decitabine Maintenance|Adverse Event|5|||
124967445|NCT00416598|449509479|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
124967446|NCT00416598|449509479|FG000|Decitabine Maintenance|Progression/relapse|38|||
124967447|NCT00416598|449509479|FG000|Decitabine Maintenance|Alternative treatment|2|||
124967448|NCT00416598|449509479|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
124967449|NCT00810342|449509484|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
124967450|NCT00810342|449509485|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
124967451|NCT00810342|449509484|FG000|Month 1 Follow-up|Pregnancy|1|||
124967452|NCT00810342|449509485|FG001|Month 1 Follow-up|Pregnancy|0|||
124967453|NCT00810342|449509484|FG000|6-month Follow-up|Lost to Follow-up|18|||
124967454|NCT00810342|449509485|FG001|6-month Follow-up|Lost to Follow-up|6|||
124967455|NCT00810342|449509484|FG000|6-month Follow-up|Pregnancy|6|||
124967456|NCT00810342|449509485|FG001|6-month Follow-up|Pregnancy|2|||
124465642|NCT01885000|447662923|FG000|Overall Study|Adverse Event|1|||
124967457|NCT00810342|449509484|FG000|12-month Followup|Pregnancy|9|||
124967458|NCT00810342|449509485|FG001|12-month Followup|Pregnancy|10|||
124967459|NCT00810342|449509484|FG000|12-month Followup|Lost to Follow-up|3|||
124967460|NCT00810342|449509485|FG001|12-month Followup|Lost to Follow-up|1|||
124967461|NCT04504630|449509486|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
124967462|NCT04504630|449509487|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
124967463|NCT04504630|449509486|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
124967464|NCT04504630|449509487|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
124967465|NCT04486313|449509488|FG000|Overall Study|Lost to Follow-up|7|||
124967466|NCT04486313|449509489|FG001|Overall Study|Lost to Follow-up|9|||
124967467|NCT04486313|449509488|FG000|Overall Study|Withdrawal by Subject|8|||
124967468|NCT04486313|449509489|FG001|Overall Study|Withdrawal by Subject|6|||
124465643|NCT01885000|447662924|FG001|Overall Study|Adverse Event|0|||
124465644|NCT01885000|447662923|FG000|Overall Study|Withdrawal by Subject|1|||
124465645|NCT01885000|447662924|FG001|Overall Study|Withdrawal by Subject|1|||
124465646|NCT01885000|447662923|FG000|Overall Study|Protocol Violation|0|||
124465647|NCT01885000|447662924|FG001|Overall Study|Protocol Violation|1|||
124465648|NCT03124784|447662925|FG000|Overall Study|Adverse Event|1|||
124465649|NCT03124784|447662925|FG000|Overall Study|Computer/Equip Malfunction|1|||
124465650|NCT01415752|447662937|FG000|Induction (Step 1)|Ineligible|4|||
124465651|NCT01415752|447662938|FG001|Induction (Step 1)|Ineligible|3|||
124465652|NCT01415752|447662939|FG002|Induction (Step 1)|Ineligible|4|||
124465653|NCT01415752|447662940|FG003|Induction (Step 1)|Ineligible|4|||
124465654|NCT01415752|447662937|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
124465655|NCT01415752|447662938|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
124465656|NCT01415752|447662939|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
124465657|NCT01415752|447662940|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
124967469|NCT04486313|449509488|FG000|Overall Study|Physician Decision|1|||
124967470|NCT04486313|449509489|FG001|Overall Study|Physician Decision|1|||
124967471|NCT04486313|449509488|FG000|Overall Study|Death|2|||
124967472|NCT04486313|449509489|FG001|Overall Study|Death|0|||
124967473|NCT04486313|449509488|FG000|Overall Study|Protocol Violation|1|||
124967474|NCT04486313|449509489|FG001|Overall Study|Protocol Violation|1|||
124967475|NCT01496365|449509490|FG000|Overall Study|Adverse Event|2|||
124967476|NCT01496365|449509491|FG001|Overall Study|Adverse Event|3|||
124967477|NCT01496365|449509492|FG002|Overall Study|Adverse Event|3|||
124967478|NCT01496365|449509493|FG003|Overall Study|Adverse Event|2|||
124967479|NCT01496365|449509494|FG004|Overall Study|Adverse Event|5|||
124967480|NCT01496365|449509495|FG005|Overall Study|Adverse Event|6|||
124967481|NCT01496365|449509496|FG006|Overall Study|Adverse Event|4|||
124967482|NCT01496365|449509490|FG000|Overall Study|Withdrawal by Subject|6|||
124967483|NCT01496365|449509491|FG001|Overall Study|Withdrawal by Subject|6|||
124967484|NCT01496365|449509492|FG002|Overall Study|Withdrawal by Subject|0|||
124967485|NCT01496365|449509493|FG003|Overall Study|Withdrawal by Subject|1|||
124967486|NCT01496365|449509494|FG004|Overall Study|Withdrawal by Subject|3|||
124967487|NCT01496365|449509495|FG005|Overall Study|Withdrawal by Subject|2|||
124967488|NCT01496365|449509496|FG006|Overall Study|Withdrawal by Subject|1|||
124967489|NCT01496365|449509490|FG000|Overall Study|Protocol Violation|2|||
124967490|NCT01496365|449509491|FG001|Overall Study|Protocol Violation|1|||
124967491|NCT01496365|449509492|FG002|Overall Study|Protocol Violation|1|||
124967492|NCT01496365|449509493|FG003|Overall Study|Protocol Violation|0|||
124967493|NCT01496365|449509494|FG004|Overall Study|Protocol Violation|0|||
124550221|NCT02406742|447970607|FG000|Overall Study|Other Reasons|1|||
124550222|NCT02406742|447970608|FG001|Overall Study|Other Reasons|11|||
124550223|NCT02406742|447970609|FG002|Overall Study|Other Reasons|5|||
124550224|NCT01563029|447970612|FG000|Overall Study|Adverse Event|1|||
124550225|NCT01563029|447970613|FG001|Overall Study|Adverse Event|0|||
124550226|NCT01563029|447970614|FG002|Overall Study|Adverse Event|1|||
124550227|NCT01563029|447970615|FG003|Overall Study|Adverse Event|2|||
124550228|NCT01563029|447970616|FG004|Overall Study|Adverse Event|1|||
124550229|NCT01563029|447970612|FG000|Overall Study|Lack of Efficacy|42|||
124550230|NCT01563029|447970613|FG001|Overall Study|Lack of Efficacy|16|||
124550231|NCT01563029|447970614|FG002|Overall Study|Lack of Efficacy|23|||
124550232|NCT01563029|447970615|FG003|Overall Study|Lack of Efficacy|21|||
124550233|NCT01563029|447970616|FG004|Overall Study|Lack of Efficacy|19|||
124967494|NCT01496365|449509495|FG005|Overall Study|Protocol Violation|1|||
124967495|NCT01496365|449509496|FG006|Overall Study|Protocol Violation|0|||
124465658|NCT01415752|447662937|FG000|Maintenance (Step 2)|Adverse Event|3|||
124465659|NCT01415752|447662938|FG001|Maintenance (Step 2)|Adverse Event|4|||
124465660|NCT01415752|447662939|FG002|Maintenance (Step 2)|Adverse Event|9|||
124465661|NCT01415752|447662940|FG003|Maintenance (Step 2)|Adverse Event|6|||
124550234|NCT01563029|447970612|FG000|Overall Study|Protocol Violation|1|||
124550235|NCT01563029|447970613|FG001|Overall Study|Protocol Violation|2|||
124550236|NCT01563029|447970614|FG002|Overall Study|Protocol Violation|3|||
124967496|NCT01496365|449509490|FG000|Overall Study|Lack of Efficacy|1|||
124967497|NCT01496365|449509491|FG001|Overall Study|Lack of Efficacy|0|||
124967498|NCT01496365|449509492|FG002|Overall Study|Lack of Efficacy|0|||
124967499|NCT01496365|449509493|FG003|Overall Study|Lack of Efficacy|0|||
124967500|NCT01496365|449509494|FG004|Overall Study|Lack of Efficacy|0|||
124967501|NCT01496365|449509495|FG005|Overall Study|Lack of Efficacy|1|||
124967502|NCT01496365|449509496|FG006|Overall Study|Lack of Efficacy|0|||
124967503|NCT01496365|449509490|FG000|Overall Study|Lost to Follow-up|0|||
124967504|NCT01496365|449509491|FG001|Overall Study|Lost to Follow-up|1|||
124967505|NCT01496365|449509492|FG002|Overall Study|Lost to Follow-up|0|||
124967506|NCT01496365|449509493|FG003|Overall Study|Lost to Follow-up|0|||
124967507|NCT01496365|449509494|FG004|Overall Study|Lost to Follow-up|2|||
124967508|NCT01496365|449509495|FG005|Overall Study|Lost to Follow-up|0|||
124967509|NCT01496365|449509496|FG006|Overall Study|Lost to Follow-up|0|||
124967510|NCT01496365|449509490|FG000|Overall Study|Other|4|||
124967511|NCT01496365|449509491|FG001|Overall Study|Other|4|||
124967512|NCT01496365|449509492|FG002|Overall Study|Other|2|||
124967513|NCT01496365|449509493|FG003|Overall Study|Other|1|||
124967514|NCT01496365|449509494|FG004|Overall Study|Other|3|||
124967515|NCT01496365|449509495|FG005|Overall Study|Other|0|||
124967516|NCT01496365|449509496|FG006|Overall Study|Other|1|||
124967517|NCT02706951|449509498|FG000|Period 1|Adverse Event|1|||
124550237|NCT01563029|447970615|FG003|Overall Study|Protocol Violation|1|||
124550238|NCT01563029|447970616|FG004|Overall Study|Protocol Violation|3|||
124550239|NCT01563029|447970612|FG000|Overall Study|Protocol defined stopping criteria|1|||
124550240|NCT01563029|447970613|FG001|Overall Study|Protocol defined stopping criteria|0|||
124550241|NCT01563029|447970614|FG002|Overall Study|Protocol defined stopping criteria|0|||
124550242|NCT01563029|447970615|FG003|Overall Study|Protocol defined stopping criteria|0|||
124550243|NCT01563029|447970616|FG004|Overall Study|Protocol defined stopping criteria|0|||
124550244|NCT01563029|447970612|FG000|Overall Study|Lost to Follow-up|1|||
124550245|NCT01563029|447970613|FG001|Overall Study|Lost to Follow-up|0|||
124550246|NCT01563029|447970614|FG002|Overall Study|Lost to Follow-up|1|||
124967518|NCT02706951|449509499|FG001|Period 1|Adverse Event|5|||
124967519|NCT02706951|449509500|FG002|Period 1|Adverse Event|3|||
124967520|NCT02706951|449509501|FG003|Period 1|Adverse Event|0|||
124967521|NCT02706951|449509502|FG004|Period 1|Adverse Event|0|||
124967522|NCT02706951|449509498|FG000|Period 1|Withdrawal by Subject|10|||
124967523|NCT02706951|449509499|FG001|Period 1|Withdrawal by Subject|6|||
124967524|NCT02706951|449509500|FG002|Period 1|Withdrawal by Subject|6|||
124967525|NCT02706951|449509501|FG003|Period 1|Withdrawal by Subject|0|||
124967526|NCT02706951|449509502|FG004|Period 1|Withdrawal by Subject|0|||
124967527|NCT02706951|449509498|FG000|Period 1|Lost to Follow-up|0|||
124967528|NCT02706951|449509499|FG001|Period 1|Lost to Follow-up|4|||
124967529|NCT02706951|449509500|FG002|Period 1|Lost to Follow-up|1|||
124967530|NCT02706951|449509501|FG003|Period 1|Lost to Follow-up|0|||
124967531|NCT02706951|449509502|FG004|Period 1|Lost to Follow-up|0|||
124967532|NCT02706951|449509498|FG000|Period 1|Other|2|||
124967533|NCT02706951|449509499|FG001|Period 1|Other|1|||
124967534|NCT02706951|449509500|FG002|Period 1|Other|0|||
124967535|NCT02706951|449509501|FG003|Period 1|Other|0|||
124967536|NCT02706951|449509502|FG004|Period 1|Other|0|||
124967537|NCT02706951|449509498|FG000|Period 2|Adverse Event|0|||
124967538|NCT02706951|449509499|FG001|Period 2|Adverse Event|0|||
124967539|NCT02706951|449509500|FG002|Period 2|Adverse Event|0|||
124550247|NCT01563029|447970615|FG003|Overall Study|Lost to Follow-up|1|||
124550248|NCT01563029|447970616|FG004|Overall Study|Lost to Follow-up|1|||
124550249|NCT01563029|447970612|FG000|Overall Study|Physician Decision|3|||
124550250|NCT01563029|447970613|FG001|Overall Study|Physician Decision|5|||
124710297|NCT01832727|448565341|FG000|Overall Study|Physician Decision|1|||
124967540|NCT02706951|449509501|FG003|Period 2|Adverse Event|25|||
124967541|NCT02706951|449509502|FG004|Period 2|Adverse Event|34|||
124967542|NCT02706951|449509498|FG000|Period 2|Withdrawal by Subject|0|||
124967543|NCT02706951|449509499|FG001|Period 2|Withdrawal by Subject|0|||
124550251|NCT01563029|447970614|FG002|Overall Study|Physician Decision|2|||
124550252|NCT01563029|447970615|FG003|Overall Study|Physician Decision|4|||
124967544|NCT02706951|449509500|FG002|Period 2|Withdrawal by Subject|0|||
124967545|NCT02706951|449509501|FG003|Period 2|Withdrawal by Subject|38|||
124967546|NCT02706951|449509502|FG004|Period 2|Withdrawal by Subject|44|||
124967547|NCT02706951|449509498|FG000|Period 2|Lost to Follow-up|0|||
124967548|NCT02706951|449509499|FG001|Period 2|Lost to Follow-up|0|||
124967549|NCT02706951|449509500|FG002|Period 2|Lost to Follow-up|0|||
124967550|NCT02706951|449509501|FG003|Period 2|Lost to Follow-up|17|||
124967551|NCT02706951|449509502|FG004|Period 2|Lost to Follow-up|9|||
124967552|NCT02706951|449509498|FG000|Period 2|COVID-19 Related|0|||
124967553|NCT02706951|449509499|FG001|Period 2|COVID-19 Related|0|||
124967554|NCT02706951|449509500|FG002|Period 2|COVID-19 Related|0|||
124967555|NCT02706951|449509501|FG003|Period 2|COVID-19 Related|1|||
124967556|NCT02706951|449509502|FG004|Period 2|COVID-19 Related|2|||
124967557|NCT02706951|449509498|FG000|Period 2|Other|0|||
124967558|NCT02706951|449509499|FG001|Period 2|Other|0|||
124967559|NCT02706951|449509500|FG002|Period 2|Other|0|||
124967560|NCT02706951|449509501|FG003|Period 2|Other|37|||
124967561|NCT02706951|449509502|FG004|Period 2|Other|31|||
124967562|NCT01843777|449509503|FG000|Overall Study|Withdrawal by Subject|1|||
124967563|NCT01843777|449509504|FG001|Overall Study|Withdrawal by Subject|0|||
124967564|NCT01777334|449509509|FG000|Overall Study|Adverse Event|18|||
124967565|NCT01777334|449509510|FG001|Overall Study|Adverse Event|14|||
124967566|NCT01777334|449509509|FG000|Overall Study|Lack of Efficacy|15|||
124967567|NCT01777334|449509510|FG001|Overall Study|Lack of Efficacy|29|||
124967568|NCT01777334|449509509|FG000|Overall Study|Protocol Violation|3|||
124967569|NCT01777334|449509510|FG001|Overall Study|Protocol Violation|7|||
124967570|NCT01777334|449509509|FG000|Overall Study|Lost to Follow-up|3|||
124967571|NCT01777334|449509510|FG001|Overall Study|Lost to Follow-up|2|||
124967572|NCT01777334|449509509|FG000|Overall Study|Withdrawal by Subject|14|||
124967573|NCT01777334|449509510|FG001|Overall Study|Withdrawal by Subject|11|||
124967574|NCT04599855|449509517|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
124967575|NCT04599855|449509518|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
124967576|NCT04599855|449509519|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
124967577|NCT04599855|449509517|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
124967578|NCT04599855|449509518|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
124967579|NCT04599855|449509519|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
124967580|NCT04599855|449509517|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
124967581|NCT04599855|449509518|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
124967582|NCT04599855|449509519|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
124967583|NCT04599855|449509517|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
124967584|NCT04599855|449509518|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
124967585|NCT04599855|449509519|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
124967586|NCT04599855|449509517|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
124967587|NCT04599855|449509518|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
124967588|NCT04599855|449509519|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
124967589|NCT04599855|449509517|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
124967590|NCT04599855|449509518|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
124967591|NCT04599855|449509519|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
124967592|NCT04599855|449509517|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
124967593|NCT04599855|449509518|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
124967594|NCT04599855|449509519|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
124967595|NCT04599855|449509517|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
124967596|NCT04599855|449509518|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
124967597|NCT04599855|449509519|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
124967598|NCT04599855|449509517|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
124967599|NCT04599855|449509518|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
124967600|NCT04599855|449509519|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
124967601|NCT04599855|449509517|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
124967602|NCT04599855|449509518|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
124967603|NCT04599855|449509519|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
124967604|NCT04599855|449509517|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
124967605|NCT04599855|449509518|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
124967606|NCT04599855|449509519|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
124465662|NCT01415752|447662937|FG000|Maintenance (Step 2)|Death|1|||
124465663|NCT01415752|447662938|FG001|Maintenance (Step 2)|Death|1|||
124967607|NCT04599855|449509517|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
124967608|NCT04599855|449509518|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
124967609|NCT04599855|449509519|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
124967610|NCT04599855|449509517|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
124967611|NCT04599855|449509518|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
124967612|NCT04599855|449509519|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
124967613|NCT04599855|449509517|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
124967614|NCT04599855|449509518|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
124967615|NCT04599855|449509519|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
124967616|NCT02165397|449509520|FG000|Overall Study|Death|7|||
124967617|NCT02165397|449509521|FG001|Overall Study|Death|10|||
124967618|NCT02165397|449509522|FG002|Overall Study|Death|8|||
124967619|NCT02165397|449509520|FG000|Overall Study|Lost to Follow-up|1|||
124967620|NCT02165397|449509521|FG001|Overall Study|Lost to Follow-up|3|||
124967621|NCT02165397|449509522|FG002|Overall Study|Lost to Follow-up|0|||
124967622|NCT02165397|449509520|FG000|Overall Study|Withdrawal by Subject|6|||
124967623|NCT02165397|449509521|FG001|Overall Study|Withdrawal by Subject|6|||
124967624|NCT02165397|449509522|FG002|Overall Study|Withdrawal by Subject|1|||
124967625|NCT02165397|449509520|FG000|Overall Study|Other, Not Specified|0|||
124967626|NCT02165397|449509521|FG001|Overall Study|Other, Not Specified|0|||
124967627|NCT02165397|449509522|FG002|Overall Study|Other, Not Specified|1|||
124967628|NCT00236184|449509525|FG000|Overall Study|Adverse Event|5|||
124967629|NCT00236184|449509526|FG001|Overall Study|Adverse Event|2|||
124967630|NCT00236184|449509525|FG000|Overall Study|Lack of Efficacy|0|||
124967631|NCT00236184|449509526|FG001|Overall Study|Lack of Efficacy|1|||
124967632|NCT00236184|449509525|FG000|Overall Study|Lost to Follow-up|3|||
124967633|NCT00236184|449509526|FG001|Overall Study|Lost to Follow-up|4|||
124967634|NCT00236184|449509525|FG000|Overall Study|Physician Decision|1|||
124967635|NCT00236184|449509526|FG001|Overall Study|Physician Decision|1|||
124967636|NCT00236184|449509525|FG000|Overall Study|Withdrawal by Subject|3|||
124967637|NCT00236184|449509526|FG001|Overall Study|Withdrawal by Subject|0|||
124967638|NCT00236184|449509525|FG000|Overall Study|Protocol Violation|3|||
124967639|NCT00236184|449509526|FG001|Overall Study|Protocol Violation|0|||
124967640|NCT00236184|449509525|FG000|Overall Study|non-compliance with study drug|2|||
124967641|NCT00236184|449509526|FG001|Overall Study|non-compliance with study drug|1|||
124967642|NCT00236184|449509525|FG000|Overall Study|other|1|||
124967643|NCT00236184|449509526|FG001|Overall Study|other|2|||
124967644|NCT02599688|449509527|FG000|Overall Study|Lack of Efficacy|1|||
124967645|NCT02599688|449509527|FG000|Overall Study|Withdrawal by Subject|1|||
124967646|NCT02599688|449509527|FG000|Overall Study|Termination by Sponsor|2|||
124967647|NCT01841697|449509528|FG000|Overall Study|Death|0|||
124967648|NCT01841697|449509529|FG001|Overall Study|Death|1|||
124967649|NCT01841697|449509528|FG000|Overall Study|Lost to Follow-up|4|||
124967650|NCT01841697|449509529|FG001|Overall Study|Lost to Follow-up|1|||
124967651|NCT01841697|449509528|FG000|Overall Study|Withdrawal by Subject|16|||
124967652|NCT01841697|449509529|FG001|Overall Study|Withdrawal by Subject|16|||
124967653|NCT00756457|449509530|FG000|Overall Study|Lost to Follow-up|1|||
124967654|NCT00756457|449509531|FG001|Overall Study|Lost to Follow-up|2|||
124967655|NCT01777490|449509535|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
124967656|NCT01777490|449509536|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
124967657|NCT01777490|449509537|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
124967658|NCT01777490|449509538|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
124967659|NCT00822770|449509543|FG000|Overall Study|Not treated|1|||
124967660|NCT00822770|449509544|FG001|Overall Study|Not treated|0|||
124967661|NCT00822770|449509543|FG000|Overall Study|Complication/Incomplete treatment|1|||
124967662|NCT00822770|449509544|FG001|Overall Study|Complication/Incomplete treatment|0|||
124967663|NCT00822770|449509543|FG000|Overall Study|Death|1|||
124967664|NCT00822770|449509544|FG001|Overall Study|Death|1|||
124465664|NCT01415752|447662939|FG002|Maintenance (Step 2)|Death|2|||
124465665|NCT01415752|447662940|FG003|Maintenance (Step 2)|Death|0|||
124465666|NCT01415752|447662937|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
124465667|NCT01415752|447662938|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
124465668|NCT01415752|447662939|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
124465669|NCT01415752|447662940|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
124465670|NCT01415752|447662937|FG000|Maintenance (Step 2)|Alternative therapy|0|||
124465671|NCT01415752|447662938|FG001|Maintenance (Step 2)|Alternative therapy|1|||
124710298|NCT01832727|448565342|FG001|Overall Study|Physician Decision|0|||
124710299|NCT01832727|448565343|FG002|Overall Study|Physician Decision|0|||
124710300|NCT01832727|448565344|FG003|Overall Study|Physician Decision|1|||
124710301|NCT01832727|448565345|FG004|Overall Study|Physician Decision|0|||
124967665|NCT02818998|449509545|FG000|Overall Study|Adverse Event|3|||
124967666|NCT02818998|449509546|FG001|Overall Study|Adverse Event|2|||
124967667|NCT02818998|449509547|FG002|Overall Study|Adverse Event|1|||
124465672|NCT01415752|447662939|FG002|Maintenance (Step 2)|Alternative therapy|0|||
124465673|NCT01415752|447662940|FG003|Maintenance (Step 2)|Alternative therapy|0|||
124967668|NCT02818998|449509545|FG000|Overall Study|Lost to Follow-up|4|||
124967669|NCT02818998|449509546|FG001|Overall Study|Lost to Follow-up|1|||
124967670|NCT02818998|449509547|FG002|Overall Study|Lost to Follow-up|2|||
124967671|NCT02818998|449509545|FG000|Overall Study|Withdrawal by sponsor|0|||
124967672|NCT02818998|449509546|FG001|Overall Study|Withdrawal by sponsor|1|||
124967673|NCT02818998|449509547|FG002|Overall Study|Withdrawal by sponsor|1|||
124967674|NCT02818998|449509545|FG000|Overall Study|Death|3|||
124967675|NCT02818998|449509546|FG001|Overall Study|Death|6|||
124967676|NCT02818998|449509547|FG002|Overall Study|Death|8|||
124967677|NCT02818998|449509545|FG000|Overall Study|Withdrawal by Subject|7|||
124967678|NCT02818998|449509546|FG001|Overall Study|Withdrawal by Subject|6|||
124967679|NCT02818998|449509547|FG002|Overall Study|Withdrawal by Subject|6|||
124967680|NCT02818998|449509545|FG000|Overall Study|Physician Decision|1|||
124967681|NCT02818998|449509546|FG001|Overall Study|Physician Decision|0|||
124967682|NCT02818998|449509547|FG002|Overall Study|Physician Decision|0|||
124967683|NCT00632021|449509551|FG000|Overall Study|Withdrawal/death|4|||
124967684|NCT00632021|449509552|FG001|Overall Study|Withdrawal/death|7|||
124967685|NCT00458393|449509553|FG000|Overall Study|Withdrawal by Subject|67|||
124967686|NCT00458393|449509554|FG001|Overall Study|Withdrawal by Subject|80|||
124967687|NCT00458393|449509553|FG000|Overall Study|Physician Decision|31|||
124967688|NCT00458393|449509554|FG001|Overall Study|Physician Decision|22|||
124967689|NCT00458393|449509553|FG000|Overall Study|Relocated|77|||
124967690|NCT00458393|449509554|FG001|Overall Study|Relocated|81|||
124967691|NCT00458393|449509553|FG000|Overall Study|Lost to Follow-up|115|||
124967692|NCT00458393|449509554|FG001|Overall Study|Lost to Follow-up|92|||
124967693|NCT00458393|449509553|FG000|Overall Study|Sites marked other on the form.|19|||
124967694|NCT00458393|449509554|FG001|Overall Study|Sites marked other on the form.|20|||
124967695|NCT01101061|449509557|FG000|Overall Study|Adverse Event|0|||
124967696|NCT01101061|449509558|FG001|Overall Study|Adverse Event|0|||
124967697|NCT01101061|449509559|FG002|Overall Study|Adverse Event|1|||
124967698|NCT01101061|449509560|FG003|Overall Study|Adverse Event|0|||
124967699|NCT01101061|449509561|FG004|Overall Study|Adverse Event|0|||
124967700|NCT01101061|449509562|FG005|Overall Study|Adverse Event|0|||
124967701|NCT00857233|449509563|FG000|Overall Study|Adverse Event|24|||
124967702|NCT00857233|449509563|FG000|Overall Study|Lack of Efficacy|1|||
124967703|NCT00857233|449509563|FG000|Overall Study|Non-compliance|1|||
124967704|NCT00857233|449509563|FG000|Overall Study|Withdrawal of Consent|9|||
124967705|NCT00857233|449509563|FG000|Overall Study|Lost to Follow-up|4|||
124967706|NCT00857233|449509563|FG000|Overall Study|Nursing Home Placement|14|||
124967707|NCT00857233|449509563|FG000|Overall Study|Other Reasons|2|||
124967708|NCT05043883|449509564|FG000|Overall Study|Minimum required measurements could not be taken|4|||
124967709|NCT01587118|449509565|FG000|Overall Study|Adverse Event|3|||
124967710|NCT01587118|449509565|FG000|Overall Study|Lost to Follow-up|2|||
124967711|NCT01587118|449509565|FG000|Overall Study|Relocation|1|||
124967712|NCT01587118|449509565|FG000|Overall Study|nonresponse|1|||
124967713|NCT00263575|449509566|FG000|Titration Period|Adverse Event|14|||
124967714|NCT00263575|449509566|FG000|Titration Period|Withdrawal by Subject|10|||
124967715|NCT00263575|449509566|FG000|Titration Period|Protocol Violation|9|||
124967716|NCT00263575|449509566|FG000|Titration Period|Sponsor Decision|2|||
124967717|NCT00263575|449509566|FG000|Titration Period|Other|2|||
124967718|NCT00263575|449509566|FG000|Titration Period|Lack of Efficacy|6|||
124967719|NCT00263575|449509566|FG000|Maintence Period|Adverse Event|23|||
124967720|NCT00263575|449509566|FG000|Maintence Period|Withdrawal by Subject|8|||
124967721|NCT00263575|449509566|FG000|Maintence Period|Protocol Violation|4|||
124967722|NCT00263575|449509566|FG000|Maintence Period|Lack of Efficacy|4|||
124967723|NCT00263575|449509566|FG000|Maintence Period|Physician Decision|6|||
124967724|NCT00263575|449509566|FG000|Maintence Period|Lost to Follow-up|1|||
124967725|NCT00263575|449509566|FG000|Maintence Period|Sponsor Decision|24|||
124967726|NCT00263575|449509566|FG000|Maintence Period|Other|7|||
124967727|NCT01728623|449509570|FG000|Overall Study|Disease progression|26|||
124967728|NCT01728623|449509570|FG000|Overall Study|Adverse Event|1|||
124967729|NCT01728623|449509570|FG000|Overall Study|Withdrawal by Subject|1|||
124967730|NCT00243022|449509571|FG000|Overall Study|Withdrawal by Subject|1|||
124967731|NCT00243022|449509572|FG001|Overall Study|Withdrawal by Subject|0|||
124967732|NCT00243022|449509571|FG000|Overall Study|Death|1|||
124967733|NCT00243022|449509572|FG001|Overall Study|Death|0|||
124967734|NCT00243022|449509571|FG000|Overall Study|Difficult Travel Distance|0|||
124967735|NCT00243022|449509572|FG001|Overall Study|Difficult Travel Distance|1|||
124967736|NCT01390441|449509573|FG000|Treatment Period|Protocol Violation|0|||
124967737|NCT01390441|449509574|FG001|Treatment Period|Protocol Violation|1|||
124967738|NCT01390441|449509575|FG002|Treatment Period|Protocol Violation|0|||
124967739|NCT01390441|449509576|FG003|Treatment Period|Protocol Violation|0|||
124967740|NCT01390441|449509577|FG004|Treatment Period|Protocol Violation|0|||
124967741|NCT01390441|449509573|FG000|Treatment Period|Physician Decision|0|||
124967742|NCT01390441|449509574|FG001|Treatment Period|Physician Decision|0|||
124967743|NCT01390441|449509575|FG002|Treatment Period|Physician Decision|0|||
124967744|NCT01390441|449509576|FG003|Treatment Period|Physician Decision|1|||
124967745|NCT01390441|449509577|FG004|Treatment Period|Physician Decision|0|||
124967746|NCT01390441|449509573|FG000|Treatment Period|Lack of Efficacy|0|||
124967747|NCT01390441|449509574|FG001|Treatment Period|Lack of Efficacy|0|||
124967748|NCT01390441|449509575|FG002|Treatment Period|Lack of Efficacy|0|||
124967749|NCT01390441|449509576|FG003|Treatment Period|Lack of Efficacy|0|||
124967750|NCT01390441|449509577|FG004|Treatment Period|Lack of Efficacy|1|||
124967751|NCT01390441|449509573|FG000|Treatment Period|Unknown due to early stopping of study|0|||
124967752|NCT01390441|449509574|FG001|Treatment Period|Unknown due to early stopping of study|0|||
124967753|NCT01390441|449509575|FG002|Treatment Period|Unknown due to early stopping of study|8|||
124550253|NCT01563029|447970616|FG004|Overall Study|Physician Decision|2|||
124550254|NCT01563029|447970612|FG000|Overall Study|Withdrawal by Subject|4|||
124550255|NCT01563029|447970613|FG001|Overall Study|Withdrawal by Subject|1|||
124550256|NCT01563029|447970614|FG002|Overall Study|Withdrawal by Subject|3|||
124550257|NCT01563029|447970615|FG003|Overall Study|Withdrawal by Subject|4|||
124550258|NCT01563029|447970616|FG004|Overall Study|Withdrawal by Subject|3|||
124550259|NCT01569594|447970617|FG000|Overall Study|Physician Decision|4|||
124550260|NCT01569594|447970617|FG000|Overall Study|Death|13|||
124550261|NCT01569594|447970617|FG000|Overall Study|Lost to Follow-up|22|||
124550262|NCT01569594|447970617|FG000|Overall Study|Adverse Event|2|||
124550263|NCT01569594|447970617|FG000|Overall Study|Withdrawal by Subject|13|||
124550264|NCT01569594|447970617|FG000|Overall Study|Other|4|||
124550265|NCT01569594|447970617|FG000|Overall Study|No ECM used|9|||
124550266|NCT01826201|447970622|FG000|Overall Study|Non compliance with protocol|4|||
124550267|NCT01615822|447970623|FG000|Period 1|Withdrawal by Subject|0|||
124550268|NCT01615822|447970624|FG001|Period 1|Withdrawal by Subject|1|||
124550269|NCT01615822|447970625|FG002|Period 1|Withdrawal by Subject|0|||
124550270|NCT01615822|447970623|FG000|Period 1|Adverse Event|1|||
124550271|NCT01615822|447970624|FG001|Period 1|Adverse Event|1|||
124550272|NCT01615822|447970625|FG002|Period 1|Adverse Event|0|||
124550273|NCT01615822|447970623|FG000|Period 2|Lost to Follow-up|0|||
124550274|NCT01615822|447970624|FG001|Period 2|Lost to Follow-up|1|||
124550275|NCT01615822|447970625|FG002|Period 2|Lost to Follow-up|2|||
124550276|NCT02628418|447970630|FG000|Overall Study|Lost to Follow-up|1|||
124550277|NCT02628418|447970631|FG001|Overall Study|Lost to Follow-up|2|||
124550278|NCT01071083|447970632|FG000|Overall Study|Adverse Event|1|||
124550279|NCT01071083|447970633|FG001|Overall Study|Adverse Event|0|||
124550280|NCT01071083|447970634|FG002|Overall Study|Adverse Event|1|||
124550281|NCT01071083|447970635|FG003|Overall Study|Adverse Event|0|||
124550282|NCT01071083|447970636|FG004|Overall Study|Adverse Event|1|||
124550283|NCT01071083|447970632|FG000|Overall Study|Withdrawal by Subject|3|||
124550284|NCT01071083|447970633|FG001|Overall Study|Withdrawal by Subject|0|||
124550285|NCT01071083|447970634|FG002|Overall Study|Withdrawal by Subject|2|||
124550286|NCT01071083|447970635|FG003|Overall Study|Withdrawal by Subject|0|||
124550287|NCT01071083|447970636|FG004|Overall Study|Withdrawal by Subject|3|||
124550288|NCT01071083|447970632|FG000|Overall Study|Physician Decision|1|||
124550289|NCT01071083|447970633|FG001|Overall Study|Physician Decision|0|||
124550290|NCT01071083|447970634|FG002|Overall Study|Physician Decision|0|||
124550291|NCT01071083|447970635|FG003|Overall Study|Physician Decision|1|||
124550292|NCT01071083|447970636|FG004|Overall Study|Physician Decision|1|||
124550293|NCT01071083|447970632|FG000|Overall Study|Early Rescue|1|||
124550294|NCT01071083|447970633|FG001|Overall Study|Early Rescue|0|||
124967754|NCT01390441|449509576|FG003|Treatment Period|Unknown due to early stopping of study|11|||
124967755|NCT01390441|449509577|FG004|Treatment Period|Unknown due to early stopping of study|7|||
124967756|NCT01390441|449509573|FG000|Treatment Period|Adverse Event|0|||
124967757|NCT01390441|449509574|FG001|Treatment Period|Adverse Event|0|||
124967758|NCT01390441|449509575|FG002|Treatment Period|Adverse Event|1|||
124967759|NCT01390441|449509576|FG003|Treatment Period|Adverse Event|1|||
124967760|NCT01390441|449509577|FG004|Treatment Period|Adverse Event|2|||
124967761|NCT01390441|449509573|FG000|Treatment Period|Withdrawal by Subject|0|||
124967762|NCT01390441|449509574|FG001|Treatment Period|Withdrawal by Subject|0|||
124967763|NCT01390441|449509575|FG002|Treatment Period|Withdrawal by Subject|1|||
124967764|NCT01390441|449509576|FG003|Treatment Period|Withdrawal by Subject|0|||
124967765|NCT01390441|449509577|FG004|Treatment Period|Withdrawal by Subject|1|||
124550295|NCT01071083|447970634|FG002|Overall Study|Early Rescue|0|||
124967766|NCT01390441|449509573|FG000|Treatment Period|Lost to Follow-up|1|||
124550296|NCT01071083|447970635|FG003|Overall Study|Early Rescue|0|||
124550297|NCT01071083|447970636|FG004|Overall Study|Early Rescue|1|||
124550298|NCT01071083|447970632|FG000|Overall Study|Subject Moved|0|||
124550299|NCT01071083|447970633|FG001|Overall Study|Subject Moved|1|||
124550300|NCT01071083|447970634|FG002|Overall Study|Subject Moved|0|||
124550301|NCT01071083|447970635|FG003|Overall Study|Subject Moved|0|||
124550302|NCT01071083|447970636|FG004|Overall Study|Subject Moved|0|||
124550303|NCT01071083|447970632|FG000|Overall Study|Images Not Usable (Motion)|0|||
124550304|NCT01071083|447970633|FG001|Overall Study|Images Not Usable (Motion)|1|||
124967767|NCT01390441|449509574|FG001|Treatment Period|Lost to Follow-up|0|||
124967768|NCT01390441|449509575|FG002|Treatment Period|Lost to Follow-up|0|||
124967769|NCT01390441|449509576|FG003|Treatment Period|Lost to Follow-up|0|||
124550305|NCT01071083|447970634|FG002|Overall Study|Images Not Usable (Motion)|0|||
124550306|NCT01071083|447970635|FG003|Overall Study|Images Not Usable (Motion)|0|||
124550307|NCT01071083|447970636|FG004|Overall Study|Images Not Usable (Motion)|0|||
124550308|NCT01071083|447970632|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
124550309|NCT01071083|447970633|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
124550310|NCT01071083|447970634|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
124550311|NCT01071083|447970635|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
124550312|NCT01071083|447970636|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
124550313|NCT01071083|447970632|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
124967770|NCT01390441|449509577|FG004|Treatment Period|Lost to Follow-up|0|||
124967771|NCT01390441|449509573|FG000|Extension Period|Protocol Violation|3|||
124967772|NCT01390441|449509574|FG001|Extension Period|Protocol Violation|1|||
124967773|NCT01390441|449509575|FG002|Extension Period|Protocol Violation|0|||
124967774|NCT01390441|449509576|FG003|Extension Period|Protocol Violation|1|||
124967775|NCT01390441|449509577|FG004|Extension Period|Protocol Violation|0|||
124967776|NCT03517111|449509578|FG000|Enrolled|Withdrawal by Subject|0|||
124967777|NCT03517111|449509579|FG001|Enrolled|Withdrawal by Subject|1|||
124967778|NCT03517111|449509580|FG002|Enrolled|Withdrawal by Subject|0|||
124967779|NCT03517111|449509578|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
124967780|NCT03517111|449509579|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
124967781|NCT03517111|449509580|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
124967782|NCT03517111|449509578|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
124967783|NCT03517111|449509579|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
124967784|NCT03517111|449509580|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
124967785|NCT03517111|449509578|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
124967786|NCT03517111|449509579|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
124967787|NCT03517111|449509580|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
124710302|NCT01832727|448565346|FG005|Overall Study|Physician Decision|1|||
124710303|NCT01832727|448565347|FG006|Overall Study|Physician Decision|0|||
124710304|NCT01832727|448565348|FG007|Overall Study|Physician Decision|0|||
124710305|NCT01832727|448565349|FG008|Overall Study|Physician Decision|0|||
124710306|NCT01832727|448565341|FG000|Overall Study|Withdrawal by Subject|1|||
124710307|NCT01832727|448565342|FG001|Overall Study|Withdrawal by Subject|1|||
124710308|NCT01832727|448565343|FG002|Overall Study|Withdrawal by Subject|0|||
124710309|NCT01832727|448565344|FG003|Overall Study|Withdrawal by Subject|1|||
124710310|NCT01832727|448565345|FG004|Overall Study|Withdrawal by Subject|0|||
124710311|NCT01832727|448565346|FG005|Overall Study|Withdrawal by Subject|1|||
124710312|NCT01832727|448565347|FG006|Overall Study|Withdrawal by Subject|0|||
124710313|NCT01832727|448565348|FG007|Overall Study|Withdrawal by Subject|2|||
124710314|NCT01832727|448565349|FG008|Overall Study|Withdrawal by Subject|1|||
124710315|NCT01832727|448565341|FG000|Overall Study|Study terminated by sponsor|0|||
124710316|NCT01832727|448565342|FG001|Overall Study|Study terminated by sponsor|0|||
124710317|NCT01832727|448565343|FG002|Overall Study|Study terminated by sponsor|0|||
124710318|NCT01832727|448565344|FG003|Overall Study|Study terminated by sponsor|0|||
124710319|NCT01832727|448565345|FG004|Overall Study|Study terminated by sponsor|0|||
124710320|NCT01832727|448565346|FG005|Overall Study|Study terminated by sponsor|0|||
124710321|NCT01832727|448565347|FG006|Overall Study|Study terminated by sponsor|0|||
124710322|NCT01832727|448565348|FG007|Overall Study|Study terminated by sponsor|1|||
124710323|NCT01832727|448565349|FG008|Overall Study|Study terminated by sponsor|1|||
124710324|NCT02216526|448565350|FG000|Overall Study|Adverse Event|1|||
124967788|NCT03517111|449509578|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
124967789|NCT03517111|449509579|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
124967790|NCT03517111|449509580|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
124967791|NCT01781832|449509583|FG000|Overall Study|Withdrawal by Subject|1|||
124967792|NCT01163474|449509584|FG000|Overall Study|Withdrawal by Subject|1|||
124465674|NCT01415752|447662937|FG000|Maintenance (Step 2)|Other reasons|3|||
124465675|NCT01415752|447662938|FG001|Maintenance (Step 2)|Other reasons|6|||
124967793|NCT01163474|449509584|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
124967794|NCT01163474|449509584|FG000|Overall Study|Lost to Follow-up|3|||
124967795|NCT03432390|449509587|FG000|Apnea Period|Protocol Violation|2|||
124967796|NCT03432390|449509588|FG001|Apnea Period|Protocol Violation|2|||
124967797|NCT00798304|449509591|FG000|Overall Study|Adverse Event|0|||
124967798|NCT00798304|449509592|FG001|Overall Study|Adverse Event|1|||
124967799|NCT00798304|449509593|FG002|Overall Study|Adverse Event|1|||
124967800|NCT00798304|449509591|FG000|Overall Study|Discontinuation by Sponsor|14|||
124967801|NCT00798304|449509592|FG001|Overall Study|Discontinuation by Sponsor|21|||
124967802|NCT00798304|449509593|FG002|Overall Study|Discontinuation by Sponsor|9|||
124967803|NCT02689453|449509604|FG000|Overall Study|Progressive disease|0|||
124967804|NCT02689453|449509605|FG001|Overall Study|Progressive disease|1|||
124967805|NCT02689453|449509606|FG002|Overall Study|Progressive disease|1|||
124967806|NCT04206085|449509607|FG000|Overall Study|Lost to Follow-up|0|||
124967807|NCT04206085|449509608|FG001|Overall Study|Lost to Follow-up|1|||
124967808|NCT04206085|449509609|FG002|Overall Study|Lost to Follow-up|0|||
124967809|NCT04206085|449509607|FG000|Overall Study|Lost to Follow-up|0|||
124967810|NCT04206085|449509608|FG001|Overall Study|Lost to Follow-up|0|||
124967811|NCT04206085|449509609|FG002|Overall Study|Lost to Follow-up|1|||
124967812|NCT00763451|449509610|FG000|Overall Study|Adverse Event|4|||
124465676|NCT01415752|447662939|FG002|Maintenance (Step 2)|Other reasons|4|||
124465677|NCT01415752|447662940|FG003|Maintenance (Step 2)|Other reasons|6|||
124465678|NCT01415752|447662937|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
124465679|NCT01415752|447662938|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
124465680|NCT01415752|447662939|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
124465681|NCT01415752|447662940|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
124465682|NCT01415752|447662937|FG000|Maintenance (Step 2)|ineligible|1|||
124710325|NCT02216526|448565351|FG001|Overall Study|Adverse Event|1|||
124710326|NCT02216526|448565352|FG002|Overall Study|Adverse Event|0|||
124710327|NCT02216526|448565350|FG000|Overall Study|Death|0|||
124967813|NCT00763451|449509611|FG001|Overall Study|Adverse Event|6|||
124967814|NCT00763451|449509612|FG002|Overall Study|Adverse Event|19|||
124967815|NCT00763451|449509613|FG003|Overall Study|Adverse Event|14|||
124967816|NCT00763451|449509610|FG000|Overall Study|Lack of Efficacy|1|||
124967817|NCT00763451|449509611|FG001|Overall Study|Lack of Efficacy|4|||
124967818|NCT00763451|449509612|FG002|Overall Study|Lack of Efficacy|3|||
124967819|NCT00763451|449509613|FG003|Overall Study|Lack of Efficacy|2|||
124967820|NCT00763451|449509610|FG000|Overall Study|Withdrawal by Subject|1|||
124967821|NCT00763451|449509611|FG001|Overall Study|Withdrawal by Subject|6|||
124465683|NCT01415752|447662938|FG001|Maintenance (Step 2)|ineligible|1|||
124465684|NCT01415752|447662939|FG002|Maintenance (Step 2)|ineligible|1|||
124710328|NCT02216526|448565351|FG001|Overall Study|Death|1|||
124710329|NCT02216526|448565352|FG002|Overall Study|Death|3|||
124710330|NCT02216526|448565350|FG000|Overall Study|Protocol Violation|2|||
124710331|NCT02216526|448565351|FG001|Overall Study|Protocol Violation|0|||
124710332|NCT02216526|448565352|FG002|Overall Study|Protocol Violation|2|||
124710333|NCT02216526|448565350|FG000|Overall Study|Hospitalization|2|||
124710334|NCT02216526|448565351|FG001|Overall Study|Hospitalization|1|||
124710335|NCT02216526|448565352|FG002|Overall Study|Hospitalization|3|||
124710336|NCT00696878|448565355|FG000|Overall Study|Adverse Event|8|||
124710337|NCT00696878|448565355|FG000|Overall Study|Withdrawal by Subject|87|||
124710338|NCT00696878|448565355|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
124710339|NCT00696878|448565355|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
124710340|NCT00696878|448565355|FG000|Overall Study|Trial stopped|32|||
124710341|NCT00696878|448565355|FG000|Overall Study|Other reason (not specified)|55|||
124710342|NCT04436744|448565357|FG000|Overall Study|Adverse Event|1|||
124710343|NCT04436744|448565358|FG001|Overall Study|Adverse Event|1|||
124710344|NCT04436744|448565357|FG000|Overall Study|Death|1|||
124710345|NCT04436744|448565358|FG001|Overall Study|Death|0|||
124967822|NCT00763451|449509612|FG002|Overall Study|Withdrawal by Subject|9|||
124967823|NCT00763451|449509613|FG003|Overall Study|Withdrawal by Subject|7|||
124967824|NCT00763451|449509610|FG000|Overall Study|Protocol Violation|0|||
124967825|NCT00763451|449509611|FG001|Overall Study|Protocol Violation|0|||
124465685|NCT01415752|447662940|FG003|Maintenance (Step 2)|ineligible|0|||
124465686|NCT01415752|447662937|FG000|Maintenance (Step 2)|Missing|4|||
124465687|NCT01415752|447662938|FG001|Maintenance (Step 2)|Missing|1|||
124967826|NCT00763451|449509612|FG002|Overall Study|Protocol Violation|1|||
124967827|NCT00763451|449509613|FG003|Overall Study|Protocol Violation|0|||
124967828|NCT00763451|449509610|FG000|Overall Study|Poor Compliance to Protocol|1|||
124465688|NCT01415752|447662939|FG002|Maintenance (Step 2)|Missing|4|||
124465689|NCT01415752|447662940|FG003|Maintenance (Step 2)|Missing|3|||
124710346|NCT04436744|448565357|FG000|Overall Study|Lost to Follow-up|0|||
124710347|NCT04436744|448565358|FG001|Overall Study|Lost to Follow-up|2|||
124710348|NCT04436744|448565357|FG000|Overall Study|Physician Decision|0|||
124967829|NCT00763451|449509611|FG001|Overall Study|Poor Compliance to Protocol|1|||
124550314|NCT01071083|447970633|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
124550315|NCT01071083|447970634|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
124550316|NCT01071083|447970635|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
124550317|NCT01071083|447970636|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
124550318|NCT01071083|447970632|FG000|Overall Study|Subject Refused to Continue|1|||
124967830|NCT00763451|449509612|FG002|Overall Study|Poor Compliance to Protocol|2|||
124967831|NCT00763451|449509613|FG003|Overall Study|Poor Compliance to Protocol|2|||
124967832|NCT00763451|449509610|FG000|Overall Study|Familial and Personal Reasons|5|||
124967833|NCT00763451|449509611|FG001|Overall Study|Familial and Personal Reasons|3|||
124967834|NCT00763451|449509612|FG002|Overall Study|Familial and Personal Reasons|5|||
124967835|NCT00763451|449509613|FG003|Overall Study|Familial and Personal Reasons|4|||
124967836|NCT00763451|449509610|FG000|Overall Study|Randomized but not Treated|1|||
124967837|NCT00763451|449509611|FG001|Overall Study|Randomized but not Treated|1|||
124550319|NCT01071083|447970633|FG001|Overall Study|Subject Refused to Continue|0|||
124550320|NCT01071083|447970634|FG002|Overall Study|Subject Refused to Continue|0|||
124550321|NCT01071083|447970635|FG003|Overall Study|Subject Refused to Continue|0|||
124550322|NCT01071083|447970636|FG004|Overall Study|Subject Refused to Continue|0|||
124550323|NCT04732728|447970637|FG000|Overall Study|Death|12|||
124550324|NCT04732728|447970637|FG000|Overall Study|Withdrawn|136|||
124550325|NCT02426125|447970640|FG000|Overall Study|Lost to Follow-up|14|||
124550326|NCT02426125|447970641|FG001|Overall Study|Lost to Follow-up|12|||
124550327|NCT02426125|447970640|FG000|Overall Study|Withdrawal by Subject|13|||
124550328|NCT02426125|447970641|FG001|Overall Study|Withdrawal by Subject|14|||
124550329|NCT02426125|447970640|FG000|Overall Study|Death|185|||
124550330|NCT02426125|447970641|FG001|Overall Study|Death|200|||
124550331|NCT02426125|447970640|FG000|Overall Study|Randomized, But Never Treated|5|||
124550332|NCT02426125|447970641|FG001|Overall Study|Randomized, But Never Treated|2|||
124550333|NCT02858076|447970642|FG000|Overall Study|Death|6|||
124550334|NCT02858076|447970643|FG001|Overall Study|Death|3|||
124550335|NCT02858076|447970642|FG000|Overall Study|Withdrawal by Subject|1|||
124550336|NCT02858076|447970643|FG001|Overall Study|Withdrawal by Subject|5|||
124550337|NCT02858076|447970642|FG000|Overall Study|Lost to Follow-up|2|||
124550338|NCT02858076|447970643|FG001|Overall Study|Lost to Follow-up|7|||
124967838|NCT00763451|449509612|FG002|Overall Study|Randomized but not Treated|0|||
124967839|NCT00763451|449509613|FG003|Overall Study|Randomized but not Treated|0|||
124550339|NCT02858076|447970642|FG000|Overall Study|Completed Out of Window|1|||
124550340|NCT02858076|447970643|FG001|Overall Study|Completed Out of Window|3|||
124550341|NCT00096200|447970644|FG000|Overall Study|Adverse Event|0|||
124550342|NCT00096200|447970645|FG001|Overall Study|Adverse Event|4|||
124550343|NCT00096200|447970646|FG002|Overall Study|Adverse Event|0|||
124550344|NCT00096200|447970644|FG000|Overall Study|Withdrawal by Subject|1|||
124550345|NCT00096200|447970645|FG001|Overall Study|Withdrawal by Subject|2|||
124550346|NCT00096200|447970646|FG002|Overall Study|Withdrawal by Subject|0|||
124550347|NCT00096200|447970644|FG000|Overall Study|Ineligible pathology|0|||
124550348|NCT00096200|447970645|FG001|Overall Study|Ineligible pathology|1|||
124550349|NCT00096200|447970646|FG002|Overall Study|Ineligible pathology|0|||
124550350|NCT00664066|447970648|FG000|Overall Study|Study terminated|3|||
124550351|NCT01495793|447970651|FG000|Overall Study|Lost to Follow-up|1|||
124550352|NCT01495793|447970651|FG000|Overall Study|Violation of inclusion criteria|1|||
124550353|NCT03014570|447970654|FG000|Overall Study|COVID-19 Restrictions|38|||
124550354|NCT03014570|447970655|FG001|Overall Study|COVID-19 Restrictions|24|||
124550355|NCT03014570|447970654|FG000|Overall Study|Death|70|||
124550356|NCT03014570|447970655|FG001|Overall Study|Death|79|||
124550357|NCT03014570|447970654|FG000|Overall Study|Transfer from facility|11|||
124550358|NCT03014570|447970655|FG001|Overall Study|Transfer from facility|14|||
124550359|NCT03014570|447970654|FG000|Overall Study|Hospitalized|5|||
124550360|NCT03014570|447970655|FG001|Overall Study|Hospitalized|3|||
124550361|NCT03014570|447970654|FG000|Overall Study|Transfer within facility|1|||
124550362|NCT03014570|447970655|FG001|Overall Study|Transfer within facility|0|||
124967840|NCT00763451|449509610|FG000|Overall Study|Study Site Reason|0|||
124967841|NCT00763451|449509611|FG001|Overall Study|Study Site Reason|1|||
124967842|NCT00763451|449509612|FG002|Overall Study|Study Site Reason|1|||
124550363|NCT03014570|447970654|FG000|Overall Study|Site refusal|0|||
124967843|NCT00763451|449509613|FG003|Overall Study|Study Site Reason|1|||
124967844|NCT00725543|449509617|FG000|Overall Study|Adverse Event|10|||
124967845|NCT00725543|449509617|FG000|Overall Study|Lack of Efficacy|3|||
124967846|NCT00725543|449509617|FG000|Overall Study|Withdrawal by Subject|10|||
124967847|NCT00725543|449509617|FG000|Overall Study|Physician Decision|5|||
124967848|NCT00725543|449509617|FG000|Overall Study|Lost to Follow-up|4|||
124967849|NCT00725543|449509617|FG000|Overall Study|Non-compliance|2|||
124967850|NCT00725543|449509617|FG000|Overall Study|Other|119|||
124967851|NCT05594589|449509618|FG000|Overall Study|Other|0|||
124550364|NCT03014570|447970655|FG001|Overall Study|Site refusal|11|||
124550365|NCT03701516|447970661|FG000|Period 1|Lost to Follow-up|0|||
124550366|NCT03701516|447970662|FG001|Period 1|Lost to Follow-up|1|||
124550367|NCT03701516|447970661|FG000|Period 1|Adverse Event|0|||
124550368|NCT03701516|447970662|FG001|Period 1|Adverse Event|2|||
124550369|NCT03701516|447970661|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
124550370|NCT03701516|447970662|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
124550371|NCT03701516|447970661|FG000|Period 1|Non Compliance to Protocol|2|||
124550372|NCT03701516|447970662|FG001|Period 1|Non Compliance to Protocol|1|||
124550373|NCT03701516|447970661|FG000|Period 1|Withdrawal by Subject|0|||
124550374|NCT03701516|447970662|FG001|Period 1|Withdrawal by Subject|1|||
124550375|NCT03701516|447970661|FG000|Period 2|failed to meet all eligibility creiteria|1|||
124550376|NCT03701516|447970662|FG001|Period 2|failed to meet all eligibility creiteria|0|||
124550377|NCT03701516|447970661|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
124550378|NCT03701516|447970662|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
124550379|NCT00478673|447970663|FG000|30-Days Post-Procedure|Death|2|||
124550380|NCT00478673|447970663|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
124550381|NCT00478673|447970663|FG000|30-Days Post-Procedure|Missed Visit|7|||
124550382|NCT00478673|447970663|FG000|12-Months Post-Procedure|Death|23|||
124550383|NCT00478673|447970663|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
124710349|NCT04436744|448565358|FG001|Overall Study|Physician Decision|1|||
124710350|NCT04436744|448565357|FG000|Overall Study|Progressive Disease|0|||
124710351|NCT04436744|448565358|FG001|Overall Study|Progressive Disease|4|||
124710352|NCT04436744|448565357|FG000|Overall Study|Protocol Deviation|1|||
124710353|NCT04436744|448565358|FG001|Overall Study|Protocol Deviation|1|||
124710354|NCT04436744|448565357|FG000|Overall Study|Withdrawal by Subject|1|||
124710355|NCT04436744|448565358|FG001|Overall Study|Withdrawal by Subject|2|||
124710356|NCT02712788|448565362|FG000|Overall Study|Physician Decision|1|||
124710357|NCT02712788|448565363|FG001|Overall Study|Physician Decision|0|||
124710358|NCT02712788|448565362|FG000|Overall Study|Protocol Violation|1|||
124710359|NCT02712788|448565363|FG001|Overall Study|Protocol Violation|0|||
124710360|NCT01133847|448565364|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
124710361|NCT01133847|448565365|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
124710362|NCT01133847|448565366|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
124710363|NCT01133847|448565364|FG000|Follow-Up Phase|Lost to Follow-up|1|||
124710364|NCT01133847|448565365|FG001|Follow-Up Phase|Lost to Follow-up|3|||
124710365|NCT01133847|448565366|FG002|Follow-Up Phase|Lost to Follow-up|7|||
124710366|NCT00940602|448565367|FG000|Overall Study|Administrative problems|1|||
124710367|NCT00940602|448565368|FG001|Overall Study|Administrative problems|1|||
124710368|NCT00940602|448565367|FG000|Overall Study|Patient/guardian decision|13|||
124710369|NCT00940602|448565368|FG001|Overall Study|Patient/guardian decision|28|||
124710370|NCT00940602|448565367|FG000|Overall Study|Physician Decision|8|||
124710371|NCT00940602|448565368|FG001|Overall Study|Physician Decision|5|||
124710372|NCT00940602|448565367|FG000|Overall Study|Pregnancy|1|||
124710373|NCT00940602|448565368|FG001|Overall Study|Pregnancy|0|||
124710374|NCT00940602|448565367|FG000|Overall Study|Protocol Deviation (untreated)|1|||
124710375|NCT00940602|448565368|FG001|Overall Study|Protocol Deviation (untreated)|0|||
124710376|NCT00940602|448565367|FG000|Overall Study|Disease progression|8|||
124710377|NCT00940602|448565368|FG001|Overall Study|Disease progression|2|||
124710378|NCT00940602|448565367|FG000|Overall Study|Death|38|||
124710379|NCT00940602|448565368|FG001|Overall Study|Death|19|||
124710380|NCT00940602|448565367|FG000|Overall Study|Lost to Follow-up|3|||
124710381|NCT00940602|448565368|FG001|Overall Study|Lost to Follow-up|1|||
124710382|NCT00940602|448565367|FG000|Overall Study|Patient withdrew consent|26|||
124710383|NCT00940602|448565368|FG001|Overall Study|Patient withdrew consent|13|||
124710384|NCT00940602|448565367|FG000|Overall Study|Adverse Event|7|||
124710385|NCT00940602|448565368|FG001|Overall Study|Adverse Event|2|||
124710386|NCT00940602|448565367|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
124710387|NCT00940602|448565368|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
124710388|NCT01880957|448565369|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
124710389|NCT01880957|448565370|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
124710390|NCT01880957|448565369|FG000|Overall Study|Lost to Follow-up|11|||
124710391|NCT01880957|448565370|FG001|Overall Study|Lost to Follow-up|0|||
124710392|NCT01880957|448565369|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
124710393|NCT01880957|448565370|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
124710394|NCT01463033|448565371|FG000|Overall Study|Lost to Follow-up|4|||
124710395|NCT01463033|448565372|FG001|Overall Study|Lost to Follow-up|4|||
124550384|NCT00478673|447970663|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
124550385|NCT00478673|447970663|FG000|12-Months Post-Procedure|Missed Visit|25|||
124550386|NCT00478673|447970663|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
124710396|NCT01463033|448565371|FG000|Overall Study|Death|3|||
124710397|NCT01463033|448565372|FG001|Overall Study|Death|2|||
124710398|NCT00967616|448565373|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
124710399|NCT00967616|448565374|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
124710400|NCT00967616|448565373|FG000|Overall Study|Death|0|||
124710401|NCT00967616|448565374|FG001|Overall Study|Death|3|||
124710402|NCT00967616|448565373|FG000|Overall Study|Withdrawal by Subject|8|||
124710403|NCT00967616|448565374|FG001|Overall Study|Withdrawal by Subject|4|||
124710404|NCT00967616|448565373|FG000|Overall Study|Progressive Disease|31|||
124550387|NCT00981019|447970664|FG000|Overall Study|Did not respond|65|||
124550388|NCT00981019|447970664|FG000|Overall Study|Did not match target population|94|||
124967852|NCT05594589|449509619|FG001|Overall Study|Other|1|||
124967853|NCT05594589|449509620|FG002|Overall Study|Other|0|||
124967854|NCT02168478|449509627|FG000|Overall Study|Withdrawal by Subject|1|||
124967855|NCT02168478|449509627|FG000|Overall Study|Did Not Consent to Participation|2|||
124967856|NCT02168478|449509627|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
124967857|NCT03845023|449509632|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
124967858|NCT03845023|449509633|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
124967859|NCT03845023|449509634|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
124710405|NCT00967616|448565374|FG001|Overall Study|Progressive Disease|18|||
124710406|NCT00967616|448565373|FG000|Overall Study|Other|8|||
124710407|NCT00967616|448565374|FG001|Overall Study|Other|8|||
124710408|NCT00967616|448565373|FG000|Overall Study|Protocol Violation|1|||
124710409|NCT00967616|448565374|FG001|Overall Study|Protocol Violation|0|||
124710410|NCT01368614|448565375|FG000|Screening Period|Screen Failure|58|||
124710411|NCT01368614|448565376|FG001|Screening Period|Screen Failure|0|||
124710412|NCT01368614|448565377|FG002|Screening Period|Screen Failure|0|||
124710413|NCT01368614|448565378|FG003|Screening Period|Screen Failure|0|||
124710414|NCT01368614|448565375|FG000|Study Period|Withdrawal by Subject|0|||
124710415|NCT01368614|448565376|FG001|Study Period|Withdrawal by Subject|1|||
124710416|NCT01368614|448565377|FG002|Study Period|Withdrawal by Subject|1|||
124710417|NCT01368614|448565378|FG003|Study Period|Withdrawal by Subject|3|||
124710418|NCT01368614|448565375|FG000|Study Period|Lost to Follow-up|0|||
124710419|NCT01368614|448565376|FG001|Study Period|Lost to Follow-up|0|||
124710420|NCT01368614|448565377|FG002|Study Period|Lost to Follow-up|1|||
124710421|NCT01368614|448565378|FG003|Study Period|Lost to Follow-up|0|||
124710422|NCT02951780|448565379|FG000|Period 1|Adverse Event|0|||
124710423|NCT02951780|448565380|FG001|Period 1|Adverse Event|0|||
124710424|NCT02951780|448565381|FG002|Period 1|Adverse Event|0|||
124710425|NCT02951780|448565382|FG003|Period 1|Adverse Event|1|||
124710426|NCT02951780|448565383|FG004|Period 1|Adverse Event|0|||
124710427|NCT02951780|448565384|FG005|Period 1|Adverse Event|0|||
124710428|NCT02951780|448565385|FG006|Period 1|Adverse Event|0|||
124710429|NCT02951780|448565386|FG007|Period 1|Adverse Event|0|||
124710430|NCT02951780|448565387|FG008|Period 1|Adverse Event|0|||
124710431|NCT02951780|448565379|FG000|Period 1|Scheduling Conflicts|0|||
124710432|NCT02951780|448565380|FG001|Period 1|Scheduling Conflicts|0|||
124710433|NCT02951780|448565381|FG002|Period 1|Scheduling Conflicts|0|||
124710434|NCT02951780|448565382|FG003|Period 1|Scheduling Conflicts|0|||
124710435|NCT02951780|448565383|FG004|Period 1|Scheduling Conflicts|0|||
124710436|NCT02951780|448565384|FG005|Period 1|Scheduling Conflicts|0|||
124710437|NCT02951780|448565385|FG006|Period 1|Scheduling Conflicts|0|||
124710438|NCT02951780|448565386|FG007|Period 1|Scheduling Conflicts|1|||
124710439|NCT02951780|448565387|FG008|Period 1|Scheduling Conflicts|0|||
124710440|NCT02951780|448565379|FG000|Period 2|Scheduling Conflicts|0|||
124710441|NCT02951780|448565380|FG001|Period 2|Scheduling Conflicts|0|||
124710442|NCT02951780|448565381|FG002|Period 2|Scheduling Conflicts|0|||
124710443|NCT02951780|448565382|FG003|Period 2|Scheduling Conflicts|0|||
124710444|NCT02951780|448565383|FG004|Period 2|Scheduling Conflicts|0|||
124710445|NCT02951780|448565384|FG005|Period 2|Scheduling Conflicts|0|||
124710446|NCT02951780|448565385|FG006|Period 2|Scheduling Conflicts|0|||
124710447|NCT02951780|448565386|FG007|Period 2|Scheduling Conflicts|1|||
124710448|NCT02951780|448565387|FG008|Period 2|Scheduling Conflicts|0|||
124710449|NCT01374425|448565388|FG000|Overall Study|Radiographic Disease Progression|86|||
124710450|NCT01374425|448565389|FG001|Overall Study|Radiographic Disease Progression|81|||
124710451|NCT01374425|448565388|FG000|Overall Study|Clinical Disease Progression|9|||
124710452|NCT01374425|448565389|FG001|Overall Study|Clinical Disease Progression|6|||
124710453|NCT01374425|448565388|FG000|Overall Study|Adverse Event|29|||
124710454|NCT01374425|448565389|FG001|Overall Study|Adverse Event|18|||
124710455|NCT01374425|448565388|FG000|Overall Study|Death (Progression of Disease)|1|||
124710456|NCT01374425|448565389|FG001|Overall Study|Death (Progression of Disease)|0|||
124710457|NCT01374425|448565388|FG000|Overall Study|Death (Adverse Event)|2|||
124710458|NCT01374425|448565389|FG001|Overall Study|Death (Adverse Event)|4|||
124710459|NCT01374425|448565388|FG000|Overall Study|Withdrawal by Subject|6|||
124710460|NCT01374425|448565389|FG001|Overall Study|Withdrawal by Subject|7|||
124710461|NCT01374425|448565388|FG000|Overall Study|Refused Treatment|10|||
124710462|NCT01374425|448565389|FG001|Overall Study|Refused Treatment|24|||
124710463|NCT01374425|448565388|FG000|Overall Study|Protocol Violation|2|||
124710464|NCT01374425|448565389|FG001|Overall Study|Protocol Violation|3|||
124710465|NCT01374425|448565388|FG000|Overall Study|Sponsor Decision|0|||
124710466|NCT01374425|448565389|FG001|Overall Study|Sponsor Decision|1|||
124710467|NCT01374425|448565388|FG000|Overall Study|Lost to Follow-up|2|||
124710468|NCT01374425|448565389|FG001|Overall Study|Lost to Follow-up|1|||
124710469|NCT01374425|448565388|FG000|Overall Study|Other|41|||
124710470|NCT01374425|448565389|FG001|Overall Study|Other|43|||
124967860|NCT03845023|449509635|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
124710471|NCT02359903|448565390|FG000|Overall Study|Adverse Event|0|||
124710472|NCT02359903|448565391|FG001|Overall Study|Adverse Event|2|||
124710473|NCT00546481|448565392|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
124710474|NCT00546481|448565393|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
124550389|NCT00981019|447970664|FG000|Overall Study|Inadvertent exclusion|239|||
124550390|NCT00981019|447970664|FG000|Overall Study|Hit the survey after closure|79|||
124550391|NCT00358670|447970665|FG000|Overall Study|Adverse Event|26|||
124550392|NCT00358670|447970666|FG001|Overall Study|Adverse Event|29|||
124550393|NCT00358670|447970665|FG000|Overall Study|Lack of Efficacy|20|||
124550394|NCT00358670|447970666|FG001|Overall Study|Lack of Efficacy|23|||
124550395|NCT00358670|447970665|FG000|Overall Study|Protocol Violation|6|||
124550396|NCT00358670|447970666|FG001|Overall Study|Protocol Violation|9|||
124550397|NCT00358670|447970665|FG000|Overall Study|Lost to Follow-up|4|||
124550398|NCT00358670|447970666|FG001|Overall Study|Lost to Follow-up|5|||
124550399|NCT00358670|447970665|FG000|Overall Study|Withdrawal by Subject|13|||
124550400|NCT00358670|447970666|FG001|Overall Study|Withdrawal by Subject|24|||
124550401|NCT00358670|447970665|FG000|Overall Study|Protocol Defined Clinical Event|0|||
124550402|NCT00358670|447970666|FG001|Overall Study|Protocol Defined Clinical Event|1|||
124967861|NCT03845023|449509632|FG000|Follow-Up (14 Days)|Adverse Event|0|||
124967862|NCT03845023|449509633|FG001|Follow-Up (14 Days)|Adverse Event|0|||
124967863|NCT03845023|449509634|FG002|Follow-Up (14 Days)|Adverse Event|1|||
124967864|NCT03845023|449509635|FG003|Follow-Up (14 Days)|Adverse Event|1|||
124550403|NCT00358670|447970665|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
124550404|NCT00358670|447970666|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
124550405|NCT00358670|447970665|FG000|Overall Study|Administrative|153|||
124550406|NCT00358670|447970666|FG001|Overall Study|Administrative|125|||
124550407|NCT05083559|447970667|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
124550408|NCT05083559|447970668|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
124550409|NCT05083559|447970667|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
124550410|NCT05083559|447970668|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
124550411|NCT05083559|447970667|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
124710475|NCT00546481|448565394|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
124967865|NCT02554383|449509639|FG000|Overall Study|Ineligible|3|||
124967866|NCT02554383|449509640|FG001|Overall Study|Ineligible|2|||
124967867|NCT02554383|449509639|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
124967868|NCT02554383|449509640|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
124967869|NCT02554383|449509639|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
124967870|NCT02554383|449509640|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
124967871|NCT02554383|449509639|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
124465690|NCT00705939|447662950|FG000|Overall Study|Protocol Violation|0|||
124465691|NCT00705939|447662951|FG001|Overall Study|Protocol Violation|0|||
124465692|NCT00705939|447662952|FG002|Overall Study|Protocol Violation|1|||
124465693|NCT00705939|447662950|FG000|Overall Study|Withdrawal by Subject|0|||
124465694|NCT00705939|447662951|FG001|Overall Study|Withdrawal by Subject|1|||
124465695|NCT00705939|447662952|FG002|Overall Study|Withdrawal by Subject|3|||
124465696|NCT00705939|447662950|FG000|Overall Study|Physician Decision|0|||
124465697|NCT00705939|447662951|FG001|Overall Study|Physician Decision|1|||
124465698|NCT00705939|447662952|FG002|Overall Study|Physician Decision|0|||
124465699|NCT03345472|447662957|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
124465700|NCT03345472|447662957|FG000|Implant to 3 Months|Physician Decision|1|||
124465701|NCT03345472|447662957|FG000|Implant to 3 Months|Adverse Event|1|||
124465702|NCT03345472|447662957|FG000|3 Months to 12 Months|Physician Decision|3|||
124465703|NCT03345472|447662957|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
124465704|NCT03345472|447662957|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
124465705|NCT03345472|447662957|FG000|3 Months to 12 Months|Adverse Event|1|||
124465706|NCT03345472|447662957|FG000|3 Months to 12 Months|Death|1|||
124465707|NCT01926782|447662958|FG000|Overall Study|Participant moved|2|||
124465708|NCT01926782|447662959|FG001|Overall Study|Participant moved|0|||
124465709|NCT01926782|447662960|FG002|Overall Study|Participant moved|1|||
124465710|NCT01926782|447662961|FG003|Overall Study|Participant moved|1|||
124465711|NCT01926782|447662962|FG004|Overall Study|Participant moved|0|||
124465712|NCT01926782|447662963|FG005|Overall Study|Participant moved|3|||
124465713|NCT01926782|447662958|FG000|Overall Study|Physician Decision|0|||
124465714|NCT01926782|447662959|FG001|Overall Study|Physician Decision|2|||
124465715|NCT01926782|447662960|FG002|Overall Study|Physician Decision|1|||
124465716|NCT01926782|447662961|FG003|Overall Study|Physician Decision|1|||
124465717|NCT01926782|447662962|FG004|Overall Study|Physician Decision|0|||
124465718|NCT01926782|447662963|FG005|Overall Study|Physician Decision|0|||
124465719|NCT01926782|447662958|FG000|Overall Study|Other than specified|2|||
124465720|NCT01926782|447662959|FG001|Overall Study|Other than specified|3|||
124465721|NCT01926782|447662960|FG002|Overall Study|Other than specified|5|||
124465722|NCT01926782|447662961|FG003|Overall Study|Other than specified|12|||
124465723|NCT01926782|447662962|FG004|Overall Study|Other than specified|4|||
124465724|NCT01926782|447662963|FG005|Overall Study|Other than specified|11|||
124465725|NCT01926782|447662958|FG000|Overall Study|Adverse Event|13|||
124465726|NCT01926782|447662959|FG001|Overall Study|Adverse Event|4|||
124465727|NCT01926782|447662960|FG002|Overall Study|Adverse Event|17|||
124465728|NCT01926782|447662961|FG003|Overall Study|Adverse Event|4|||
124465729|NCT01926782|447662962|FG004|Overall Study|Adverse Event|3|||
124465730|NCT01926782|447662963|FG005|Overall Study|Adverse Event|14|||
124465731|NCT01926782|447662958|FG000|Overall Study|Poor compliance to protocol|5|||
124465732|NCT01926782|447662959|FG001|Overall Study|Poor compliance to protocol|3|||
124465733|NCT01926782|447662960|FG002|Overall Study|Poor compliance to protocol|8|||
124465734|NCT01926782|447662961|FG003|Overall Study|Poor compliance to protocol|0|||
124465735|NCT01926782|447662962|FG004|Overall Study|Poor compliance to protocol|1|||
124465736|NCT01926782|447662963|FG005|Overall Study|Poor compliance to protocol|6|||
124465737|NCT01926782|447662958|FG000|Overall Study|Randomized and not treated|0|||
124465738|NCT01926782|447662959|FG001|Overall Study|Randomized and not treated|0|||
124465739|NCT01926782|447662960|FG002|Overall Study|Randomized and not treated|0|||
124465740|NCT01926782|447662961|FG003|Overall Study|Randomized and not treated|1|||
124465741|NCT01926782|447662962|FG004|Overall Study|Randomized and not treated|0|||
124465742|NCT01926782|447662963|FG005|Overall Study|Randomized and not treated|0|||
124465743|NCT01926782|447662958|FG000|Overall Study|Withdrawal by Subject|6|||
124465744|NCT01926782|447662959|FG001|Overall Study|Withdrawal by Subject|1|||
124465745|NCT01926782|447662960|FG002|Overall Study|Withdrawal by Subject|8|||
124465746|NCT01926782|447662961|FG003|Overall Study|Withdrawal by Subject|1|||
124465747|NCT01926782|447662962|FG004|Overall Study|Withdrawal by Subject|0|||
124465748|NCT01926782|447662963|FG005|Overall Study|Withdrawal by Subject|5|||
124465749|NCT01926782|447662958|FG000|Overall Study|Related to study drug administration|0|||
124465750|NCT01926782|447662959|FG001|Overall Study|Related to study drug administration|0|||
124465751|NCT01926782|447662960|FG002|Overall Study|Related to study drug administration|0|||
124465752|NCT01926782|447662961|FG003|Overall Study|Related to study drug administration|0|||
124465753|NCT01926782|447662962|FG004|Overall Study|Related to study drug administration|0|||
124465754|NCT01926782|447662963|FG005|Overall Study|Related to study drug administration|2|||
124465755|NCT04372927|447662966|FG000|Overall Study|Death|1|||
124465756|NCT01665807|447662967|FG000|Overall Study|Withdrawal by Subject|2|||
124465757|NCT01665807|447662968|FG001|Overall Study|Withdrawal by Subject|0|||
124465758|NCT01665807|447662969|FG002|Overall Study|Withdrawal by Subject|1|||
124465759|NCT03461757|447662974|FG000|Overall Study|Adverse Event|1|||
124465760|NCT03461757|447662975|FG001|Overall Study|Adverse Event|0|||
124465761|NCT03461757|447662974|FG000|Overall Study|Lost to Follow-up|13|||
124465762|NCT03461757|447662975|FG001|Overall Study|Lost to Follow-up|7|||
124465763|NCT03461757|447662974|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
124465764|NCT03461757|447662975|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
124465765|NCT03461757|447662974|FG000|Overall Study|Non-compliance with study treatment|0|||
124465766|NCT03461757|447662975|FG001|Overall Study|Non-compliance with study treatment|1|||
124465767|NCT03461757|447662974|FG000|Overall Study|Pregnancy|2|||
124465768|NCT03461757|447662975|FG001|Overall Study|Pregnancy|0|||
124465769|NCT03461757|447662974|FG000|Overall Study|Protocol Violation|1|||
124465770|NCT03461757|447662975|FG001|Overall Study|Protocol Violation|1|||
124465771|NCT03461757|447662974|FG000|Overall Study|Withdrawal by Subject|7|||
124465772|NCT03461757|447662975|FG001|Overall Study|Withdrawal by Subject|7|||
124465773|NCT03461757|447662974|FG000|Overall Study|Other Reasons|1|||
124465774|NCT03461757|447662975|FG001|Overall Study|Other Reasons|4|||
124465775|NCT00720109|447662976|FG000|Induction Period|Did not meet eligibility criteria|3|||
124465776|NCT00720109|447662977|FG001|Induction Period|Did not meet eligibility criteria|0|||
124465777|NCT00720109|447662978|FG002|Induction Period|Did not meet eligibility criteria|0|||
124465778|NCT00720109|447662976|FG000|Induction Period|Bone Marrow Transplant|2|||
124465779|NCT00720109|447662977|FG001|Induction Period|Bone Marrow Transplant|0|||
124465780|NCT00720109|447662978|FG002|Induction Period|Bone Marrow Transplant|0|||
124465781|NCT00720109|447662976|FG000|Induction Period|Physician Decision|1|||
124465782|NCT00720109|447662977|FG001|Induction Period|Physician Decision|0|||
124465783|NCT00720109|447662978|FG002|Induction Period|Physician Decision|0|||
124465784|NCT00720109|447662976|FG000|Risk Stratification Period|Adverse Event|0|||
124465785|NCT00720109|447662977|FG001|Risk Stratification Period|Adverse Event|1|||
124465786|NCT00720109|447662978|FG002|Risk Stratification Period|Adverse Event|0|||
124465787|NCT00720109|447662976|FG000|Risk Stratification Period|Physician Decision|0|||
124465788|NCT00720109|447662977|FG001|Risk Stratification Period|Physician Decision|2|||
124465789|NCT00720109|447662978|FG002|Risk Stratification Period|Physician Decision|1|||
124465790|NCT00720109|447662976|FG000|Risk Stratification Period|Bone marrow transplant|0|||
124465791|NCT00720109|447662977|FG001|Risk Stratification Period|Bone marrow transplant|9|||
124465792|NCT00720109|447662978|FG002|Risk Stratification Period|Bone marrow transplant|7|||
124465793|NCT00720109|447662976|FG000|Risk Stratification Period|Disease progression or relapse|0|||
124550412|NCT05083559|447970668|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
124550413|NCT05899218|447970670|FG000|Overall Study|Lost to Follow-up|2|||
124550414|NCT05899218|447970671|FG001|Overall Study|Lost to Follow-up|2|||
124550415|NCT05899218|447970670|FG000|Overall Study|deemed ineligible out of country|1|||
124550416|NCT05899218|447970671|FG001|Overall Study|deemed ineligible out of country|0|||
124550417|NCT03151226|447970672|FG000|Overall Study|Withdrawal by Subject|2|||
124550418|NCT03151226|447970672|FG000|Overall Study|not wear device correctly|1|||
124550419|NCT02304302|447970675|FG000|Overall Study|Adverse Event|2|||
124550420|NCT02304302|447970676|FG001|Overall Study|Adverse Event|3|||
124550421|NCT02304302|447970675|FG000|Overall Study|Lost to Follow-up|1|||
124550422|NCT02304302|447970676|FG001|Overall Study|Lost to Follow-up|4|||
124550423|NCT02304302|447970675|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
124550424|NCT02304302|447970676|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
124550425|NCT00391118|447970677|FG000|Overall Study|Adverse Event|3|||
124550426|NCT00391118|447970678|FG001|Overall Study|Adverse Event|10|||
124550427|NCT00391118|447970679|FG002|Overall Study|Adverse Event|7|||
124550428|NCT00391118|447970677|FG000|Overall Study|Lost to Follow-up|0|||
124550429|NCT00391118|447970678|FG001|Overall Study|Lost to Follow-up|2|||
124550430|NCT00391118|447970679|FG002|Overall Study|Lost to Follow-up|3|||
124550431|NCT00391118|447970677|FG000|Overall Study|Withdrawal by Subject|0|||
124550432|NCT00391118|447970678|FG001|Overall Study|Withdrawal by Subject|9|||
124550433|NCT00391118|447970679|FG002|Overall Study|Withdrawal by Subject|1|||
124550434|NCT00391118|447970677|FG000|Overall Study|Death|0|||
124967872|NCT02554383|449509640|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
124967873|NCT02918292|449509641|FG000|Study Enrollment Prior to Transplant|Death|1|||
124967874|NCT02918292|449509641|FG000|Study Follow up After Transplant|Death|6|||
124550435|NCT00391118|447970678|FG001|Overall Study|Death|1|||
124550436|NCT00391118|447970679|FG002|Overall Study|Death|0|||
124550437|NCT00391118|447970677|FG000|Overall Study|Physician Decision|0|||
124967875|NCT01801982|449509642|FG000|Overall Study|Lost to Follow-up|1|||
124967876|NCT01185171|449509645|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
124967877|NCT01185171|449509645|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
124550438|NCT00391118|447970678|FG001|Overall Study|Physician Decision|3|||
124550439|NCT00391118|447970679|FG002|Overall Study|Physician Decision|0|||
124550440|NCT00391118|447970677|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
124550441|NCT00391118|447970678|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
124550442|NCT00391118|447970679|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
124967878|NCT01185171|449509645|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
124550443|NCT00391118|447970677|FG000|Overall Study|Progressive Disease|7|||
124550444|NCT00391118|447970678|FG001|Overall Study|Progressive Disease|26|||
124550445|NCT00391118|447970679|FG002|Overall Study|Progressive Disease|43|||
124550446|NCT00391118|447970677|FG000|Overall Study|Sponsor Decision|0|||
124967879|NCT01185171|449509645|FG000|Maintenance|Elevated liver transaminases|3|||
124967880|NCT01185171|449509645|FG000|Maintenance|Rush|2|||
124967881|NCT01185171|449509645|FG000|Maintenance|Diarrhea|1|||
124967882|NCT01185171|449509645|FG000|Maintenance|Xerostomia|1|||
124967883|NCT01185171|449509645|FG000|Maintenance|Nausea|1|||
124967884|NCT01185171|449509645|FG000|Maintenance|Comorbid Illness|2|||
124967885|NCT01185171|449509645|FG000|Maintenance|Withdrawal by Subject|1|||
124967886|NCT01185171|449509645|FG000|Maintenance|Disease Recurrence|1|||
124465794|NCT00720109|447662977|FG001|Risk Stratification Period|Disease progression or relapse|2|||
124465795|NCT00720109|447662978|FG002|Risk Stratification Period|Disease progression or relapse|0|||
124465796|NCT00720109|447662976|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
124465797|NCT00720109|447662977|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
124465798|NCT00720109|447662978|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
124465799|NCT01035905|447662981|FG000|Overall Study|Lack of Efficacy|1|||
124465800|NCT01035905|447662982|FG001|Overall Study|Lack of Efficacy|1|||
124465801|NCT03977467|447662984|FG000|Overall Study|Disease Progression|1|||
124465802|NCT03977467|447662985|FG001|Overall Study|Disease Progression|1|||
124465803|NCT03977467|447662986|FG002|Overall Study|Disease Progression|30|||
124465804|NCT03977467|447662987|FG003|Overall Study|Disease Progression|0|||
124465805|NCT03977467|447662984|FG000|Overall Study|Adverse Event|0|||
124465806|NCT03977467|447662985|FG001|Overall Study|Adverse Event|1|||
124465807|NCT03977467|447662986|FG002|Overall Study|Adverse Event|0|||
124465808|NCT03977467|447662987|FG003|Overall Study|Adverse Event|0|||
124465809|NCT03977467|447662984|FG000|Overall Study|Death|0|||
124465810|NCT03977467|447662985|FG001|Overall Study|Death|0|||
124465811|NCT03977467|447662986|FG002|Overall Study|Death|3|||
124465812|NCT03977467|447662987|FG003|Overall Study|Death|0|||
124465813|NCT03977467|447662984|FG000|Overall Study|Lack of Efficacy|0|||
124465814|NCT03977467|447662985|FG001|Overall Study|Lack of Efficacy|0|||
124465815|NCT03977467|447662986|FG002|Overall Study|Lack of Efficacy|1|||
124465816|NCT03977467|447662987|FG003|Overall Study|Lack of Efficacy|0|||
124465817|NCT03977467|447662984|FG000|Overall Study|Withdrawal by Subject|2|||
124465818|NCT03977467|447662985|FG001|Overall Study|Withdrawal by Subject|1|||
124465819|NCT03977467|447662986|FG002|Overall Study|Withdrawal by Subject|4|||
124465820|NCT03977467|447662987|FG003|Overall Study|Withdrawal by Subject|0|||
124465821|NCT03977467|447662984|FG000|Overall Study|Study Terminated|1|||
124465822|NCT03977467|447662985|FG001|Overall Study|Study Terminated|0|||
124465823|NCT03977467|447662986|FG002|Overall Study|Study Terminated|0|||
124465824|NCT03977467|447662987|FG003|Overall Study|Study Terminated|1|||
124465825|NCT05913232|447662988|FG000|Overall Study|Adverse Event|0|||
124967887|NCT00727506|449509646|FG000|Overall Study|Adverse Event|0|||
124465826|NCT05913232|447662989|FG001|Overall Study|Adverse Event|2|||
124465827|NCT05913232|447662990|FG002|Overall Study|Adverse Event|1|||
124465828|NCT05913232|447662991|FG003|Overall Study|Adverse Event|1|||
124465829|NCT04158648|447663000|FG000|Overall Study|Ongoing in the Study|69|||
124465830|NCT04158648|447663000|FG000|Overall Study|Withdrawal by Subject|4|||
124465831|NCT03809611|447663001|FG000|Overall Study|Withdrawal by Subject|1|||
124465832|NCT03809611|447663002|FG001|Overall Study|Withdrawal by Subject|1|||
124465833|NCT02926950|447663003|FG000|Overall Study|Adverse Event|4|||
124465834|NCT02926950|447663004|FG001|Overall Study|Adverse Event|6|||
124465835|NCT02926950|447663003|FG000|Overall Study|At the participant's own request|21|||
124465836|NCT02926950|447663004|FG001|Overall Study|At the participant's own request|25|||
124465837|NCT02926950|447663003|FG000|Overall Study|Reason not Specified|17|||
124465838|NCT02926950|447663004|FG001|Overall Study|Reason not Specified|9|||
124465839|NCT02926950|447663003|FG000|Overall Study|Lost to Follow-up|7|||
124465840|NCT02926950|447663004|FG001|Overall Study|Lost to Follow-up|8|||
124465841|NCT04622046|447663005|FG000|Intervention Period|Adverse Event|1|||
124465842|NCT04622046|447663005|FG000|Intervention Period|Withdrawal by Subject|2|||
124465843|NCT04622046|447663005|FG000|Extension Period|Ongoing in the Extension Period|21|||
124465844|NCT04647253|447663006|FG000|Overall Study|Death ≤ 365 Days|16|||
124465845|NCT04647253|447663007|FG001|Overall Study|Death ≤ 365 Days|7|||
124465846|NCT04647253|447663006|FG000|Overall Study|Physician Decision|0|||
124465847|NCT04647253|447663007|FG001|Overall Study|Physician Decision|1|||
124465848|NCT04647253|447663006|FG000|Overall Study|Withdrawal by Subject|7|||
124710476|NCT00546481|448565392|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
124967888|NCT00727506|449509647|FG001|Overall Study|Adverse Event|0|||
124465849|NCT04647253|447663007|FG001|Overall Study|Withdrawal by Subject|2|||
124967889|NCT00727506|449509648|FG002|Overall Study|Adverse Event|4|||
124967890|NCT00727506|449509649|FG003|Overall Study|Adverse Event|4|||
124967891|NCT00727506|449509650|FG004|Overall Study|Adverse Event|1|||
124967892|NCT00727506|449509651|FG005|Overall Study|Adverse Event|8|||
124967893|NCT00727506|449509646|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
124465850|NCT04647253|447663006|FG000|Overall Study|Missed 12-Month Visit|9|||
124465851|NCT04647253|447663007|FG001|Overall Study|Missed 12-Month Visit|7|||
124465852|NCT04647253|447663006|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
124465853|NCT04647253|447663007|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
124465854|NCT02787850|447664466|FG000|Overall Study|Withdrawal by Subject|0|||
124967894|NCT00727506|449509647|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124550447|NCT00391118|447970678|FG001|Overall Study|Sponsor Decision|1|||
124550448|NCT00391118|447970679|FG002|Overall Study|Sponsor Decision|3|||
124550449|NCT00391118|447970677|FG000|Overall Study|Protocol Violation|1|||
124550450|NCT00391118|447970678|FG001|Overall Study|Protocol Violation|0|||
124550451|NCT00391118|447970679|FG002|Overall Study|Protocol Violation|0|||
124550452|NCT01345058|447970680|FG000|Overall Study|Withdrawal by Subject|1|||
124550453|NCT01345058|447970681|FG001|Overall Study|Withdrawal by Subject|0|||
124550454|NCT01345058|447970680|FG000|Overall Study|Participant Reported Increase in Events|1|||
124550455|NCT01345058|447970681|FG001|Overall Study|Participant Reported Increase in Events|0|||
124550456|NCT01345058|447970680|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
124550457|NCT01345058|447970681|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
124550458|NCT01345058|447970680|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
124550459|NCT01345058|447970681|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
124550460|NCT01345058|447970680|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
124550461|NCT01345058|447970681|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
124550462|NCT01892020|447970687|FG000|Period 1|Adverse Event|1|||
124550463|NCT01892020|447970688|FG001|Period 1|Adverse Event|1|||
124550464|NCT01892020|447970687|FG000|Period 1|Protocol Violation|2|||
124550465|NCT01892020|447970688|FG001|Period 1|Protocol Violation|4|||
124550466|NCT01892020|447970687|FG000|Period 1|Unclassified|0|||
124550467|NCT01892020|447970688|FG001|Period 1|Unclassified|1|||
124550468|NCT01892020|447970687|FG000|Period 2|Protocol Violation|1|||
124550469|NCT01892020|447970688|FG001|Period 2|Protocol Violation|0|||
124550470|NCT00402779|447970689|FG000|Overall Study|Screen Failure|77|||
124550471|NCT00402779|447970690|FG001|Overall Study|Screen Failure|76|||
124550472|NCT03107715|447970691|FG000|Overall Study|did not deliver at the home hospital|4|||
124550473|NCT03107715|447970692|FG001|Overall Study|did not deliver at the home hospital|6|||
124550474|NCT03107715|447970691|FG000|Overall Study|infant stillborn|0|||
124550475|NCT03107715|447970692|FG001|Overall Study|infant stillborn|1|||
124550476|NCT02149199|447970694|FG000|Overall Study|Study specific withdrawal criteria|4|||
124550477|NCT02149199|447970695|FG001|Overall Study|Study specific withdrawal criteria|21|||
124550478|NCT02149199|447970696|FG002|Overall Study|Study specific withdrawal criteria|6|||
124550479|NCT02149199|447970694|FG000|Overall Study|Other|20|||
124550480|NCT02149199|447970695|FG001|Overall Study|Other|25|||
124550481|NCT02149199|447970696|FG002|Overall Study|Other|20|||
124550482|NCT02149199|447970694|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
124550483|NCT02149199|447970695|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
124550484|NCT02149199|447970696|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
124550485|NCT02149199|447970694|FG000|Overall Study|Withdrawal by Subject|75|||
124550486|NCT02149199|447970695|FG001|Overall Study|Withdrawal by Subject|93|||
124550487|NCT02149199|447970696|FG002|Overall Study|Withdrawal by Subject|77|||
124550488|NCT02149199|447970694|FG000|Overall Study|Protocol Violation|16|||
124550489|NCT02149199|447970695|FG001|Overall Study|Protocol Violation|13|||
124550490|NCT02149199|447970696|FG002|Overall Study|Protocol Violation|15|||
124967895|NCT00727506|449509648|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
124967896|NCT00727506|449509649|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124967897|NCT00727506|449509650|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124967898|NCT00727506|449509651|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124967899|NCT00727506|449509646|FG000|Overall Study|Progressive disease|4|||
124465855|NCT02787850|447664467|FG001|Overall Study|Withdrawal by Subject|1|||
124465856|NCT02921971|447664470|FG000|Overall Study|Adverse Event|1|||
124465857|NCT02921971|447664471|FG001|Overall Study|Adverse Event|2|||
124465858|NCT02921971|447664470|FG000|Overall Study|Lack of Efficacy|3|||
124465859|NCT02921971|447664471|FG001|Overall Study|Lack of Efficacy|1|||
124465860|NCT02921971|447664470|FG000|Overall Study|Other than specified above|2|||
124465861|NCT02921971|447664471|FG001|Overall Study|Other than specified above|1|||
124465862|NCT04316585|447664472|FG000|Overall Study|Adverse Event|2|||
124465863|NCT04316585|447664473|FG001|Overall Study|Adverse Event|1|||
124465864|NCT04316585|447664472|FG000|Overall Study|Lost to Follow-up|1|||
124465865|NCT04316585|447664473|FG001|Overall Study|Lost to Follow-up|0|||
124465866|NCT04316585|447664472|FG000|Overall Study|Withdrawal by Subject|2|||
124465867|NCT04316585|447664473|FG001|Overall Study|Withdrawal by Subject|3|||
124465868|NCT04316585|447664472|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
124465869|NCT04316585|447664473|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
124465870|NCT04316585|447664472|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
124465871|NCT04316585|447664473|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
124465872|NCT00130832|447664474|FG000|Overall Study|Adverse Event|1|||
124465873|NCT00130832|447664475|FG001|Overall Study|Adverse Event|1|||
124465874|NCT00130832|447664474|FG000|Overall Study|Lost to Follow-up|1|||
124550491|NCT02149199|447970694|FG000|Overall Study|Lost to Follow-up|3|||
124550492|NCT02149199|447970695|FG001|Overall Study|Lost to Follow-up|12|||
124550493|NCT02149199|447970696|FG002|Overall Study|Lost to Follow-up|11|||
124550494|NCT02149199|447970694|FG000|Overall Study|Death|0|||
124550495|NCT02149199|447970695|FG001|Overall Study|Death|0|||
124550496|NCT02149199|447970696|FG002|Overall Study|Death|1|||
124550497|NCT02149199|447970694|FG000|Overall Study|Adverse Event|6|||
124550498|NCT02149199|447970695|FG001|Overall Study|Adverse Event|15|||
124550499|NCT02149199|447970696|FG002|Overall Study|Adverse Event|9|||
124550500|NCT03252756|447970697|FG000|Overall Study|Protocol Violation|2|||
124550501|NCT03252756|447970698|FG001|Overall Study|Protocol Violation|4|||
124550502|NCT03252756|447970697|FG000|Overall Study|COVID-19 Pandemic|1|||
124550503|NCT03252756|447970698|FG001|Overall Study|COVID-19 Pandemic|1|||
124550504|NCT03252756|447970697|FG000|Overall Study|Study Drug Expiration|0|||
124550505|NCT03252756|447970698|FG001|Overall Study|Study Drug Expiration|1|||
124550506|NCT01500434|447970701|FG000|Overall Study|Death|1|||
124550507|NCT01500434|447970701|FG000|Overall Study|Withdrawal by Subject|1|||
124550508|NCT01500434|447970701|FG000|Overall Study|Missed 12-month follow-up|5|||
124550509|NCT04881448|447970705|FG000|Overall Study|Study cancelled by sponsor|220|||
124550510|NCT04881448|447970705|FG000|Overall Study|Withdrawal by Subject|2|||
124550511|NCT04881448|447970705|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
124550512|NCT02662556|447970706|FG000|Overall Study|Adverse Event|4|||
124550513|NCT02662556|447970706|FG000|Overall Study|Lack of Efficacy|4|||
124550514|NCT00005879|447970711|FG000|Overall Study|Withdrawal by Subject|8|||
124550515|NCT00005879|447970712|FG001|Overall Study|Withdrawal by Subject|10|||
124550516|NCT05022121|447970716|FG000|Overall Study|Lack of Efficacy|1|||
124550517|NCT05022121|447970717|FG001|Overall Study|Lack of Efficacy|0|||
124550518|NCT05022121|447970716|FG000|Overall Study|Lost to Follow-up|0|||
124550519|NCT05022121|447970717|FG001|Overall Study|Lost to Follow-up|2|||
124550520|NCT02395536|447970722|FG000|Overall Study|Lost to Follow-up|4|||
124550521|NCT02395536|447970723|FG001|Overall Study|Lost to Follow-up|4|||
124550522|NCT02395536|447970722|FG000|Overall Study|Death|2|||
124550523|NCT02395536|447970723|FG001|Overall Study|Death|0|||
124550524|NCT02395536|447970722|FG000|Overall Study|Physician Decision|4|||
124550525|NCT02395536|447970723|FG001|Overall Study|Physician Decision|6|||
124550526|NCT02395536|447970722|FG000|Overall Study|Withdrawal by Subject|9|||
124550527|NCT02395536|447970723|FG001|Overall Study|Withdrawal by Subject|17|||
124550528|NCT02395536|447970722|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
124550529|NCT02395536|447970723|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
124550530|NCT02395536|447970722|FG000|Overall Study|Insurance issue|0|||
124550531|NCT02395536|447970723|FG001|Overall Study|Insurance issue|1|||
124550532|NCT00131937|447970724|FG000|Overall Study|Adverse Event|3|||
124550533|NCT00131937|447970724|FG000|Overall Study|Withdrawal by Subject|2|||
124550534|NCT00131937|447970724|FG000|Overall Study|Physician Decision|1|||
124550535|NCT00131937|447970724|FG000|Overall Study|Disease Progression|7|||
124550536|NCT00131937|447970724|FG000|Overall Study|Alternative therapy|1|||
124550537|NCT01640964|447970727|FG000|Overall Study|Lost to Follow-up|0|||
124550538|NCT01640964|447970728|FG001|Overall Study|Lost to Follow-up|0|||
124550539|NCT01640964|447970729|FG002|Overall Study|Lost to Follow-up|1|||
124550540|NCT01640964|447970727|FG000|Overall Study|Protocol Deviation|1|||
124550541|NCT01640964|447970728|FG001|Overall Study|Protocol Deviation|1|||
124550542|NCT01640964|447970729|FG002|Overall Study|Protocol Deviation|2|||
124550543|NCT02787746|447970730|FG000|Overall Study|Adverse Event|42|||
124550544|NCT02787746|447970730|FG000|Overall Study|Withdrawal by Subject|65|||
124550545|NCT02787746|447970730|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
124550546|NCT01186744|447972988|FG000|Overall Study|Lack of Efficacy|156|||
124550547|NCT01186744|447972989|FG001|Overall Study|Lack of Efficacy|99|||
124550548|NCT01186744|447972990|FG002|Overall Study|Lack of Efficacy|0|||
124550549|NCT01186744|447972991|FG003|Overall Study|Lack of Efficacy|2|||
124550550|NCT01186744|447972992|FG004|Overall Study|Lack of Efficacy|2|||
124550551|NCT01186744|447972993|FG005|Overall Study|Lack of Efficacy|5|||
124550552|NCT01186744|447972988|FG000|Overall Study|Protocol Violation|1|||
124550553|NCT01186744|447972989|FG001|Overall Study|Protocol Violation|2|||
124550554|NCT01186744|447972990|FG002|Overall Study|Protocol Violation|0|||
124550555|NCT01186744|447972991|FG003|Overall Study|Protocol Violation|1|||
124550556|NCT01186744|447972992|FG004|Overall Study|Protocol Violation|1|||
124550557|NCT01186744|447972993|FG005|Overall Study|Protocol Violation|2|||
124550558|NCT01186744|447972988|FG000|Overall Study|Lost to Follow-up|15|||
124550559|NCT01186744|447972989|FG001|Overall Study|Lost to Follow-up|16|||
124550560|NCT01186744|447972990|FG002|Overall Study|Lost to Follow-up|2|||
124550561|NCT01186744|447972991|FG003|Overall Study|Lost to Follow-up|1|||
124550562|NCT01186744|447972992|FG004|Overall Study|Lost to Follow-up|1|||
124550563|NCT01186744|447972993|FG005|Overall Study|Lost to Follow-up|4|||
124550564|NCT01186744|447972988|FG000|Overall Study|Screen failure|1|||
124550565|NCT01186744|447972989|FG001|Overall Study|Screen failure|1|||
124550566|NCT01186744|447972990|FG002|Overall Study|Screen failure|0|||
124550567|NCT01186744|447972991|FG003|Overall Study|Screen failure|1|||
124550568|NCT01186744|447972992|FG004|Overall Study|Screen failure|0|||
124550569|NCT01186744|447972993|FG005|Overall Study|Screen failure|0|||
124550570|NCT01186744|447972988|FG000|Overall Study|Withdrawal by Subject|14|||
124550571|NCT01186744|447972989|FG001|Overall Study|Withdrawal by Subject|10|||
124550572|NCT01186744|447972990|FG002|Overall Study|Withdrawal by Subject|2|||
124550573|NCT01186744|447972991|FG003|Overall Study|Withdrawal by Subject|5|||
124550574|NCT01186744|447972992|FG004|Overall Study|Withdrawal by Subject|0|||
124550575|NCT01186744|447972993|FG005|Overall Study|Withdrawal by Subject|6|||
124465875|NCT00130832|447664475|FG001|Overall Study|Lost to Follow-up|2|||
124465876|NCT00130832|447664474|FG000|Overall Study|Protocol Violation|6|||
124465877|NCT00130832|447664475|FG001|Overall Study|Protocol Violation|8|||
124465878|NCT00130832|447664474|FG000|Overall Study|Withdrawal by Subject|6|||
124465879|NCT00130832|447664475|FG001|Overall Study|Withdrawal by Subject|1|||
124465880|NCT00130832|447664474|FG000|Overall Study|Moved|2|||
124465881|NCT00130832|447664475|FG001|Overall Study|Moved|2|||
124465882|NCT00130832|447664474|FG000|Overall Study|Other|0|||
124465883|NCT00130832|447664475|FG001|Overall Study|Other|3|||
124465884|NCT02944448|447664476|FG000|Overall Study|Adverse Event|37|||
124465885|NCT02944448|447664477|FG001|Overall Study|Adverse Event|6|||
124465886|NCT02944448|447664476|FG000|Overall Study|Lack of Efficacy|8|||
124465887|NCT02944448|447664477|FG001|Overall Study|Lack of Efficacy|5|||
124465888|NCT02944448|447664476|FG000|Overall Study|Lost to Follow-up|3|||
124465889|NCT02944448|447664477|FG001|Overall Study|Lost to Follow-up|1|||
124465890|NCT02944448|447664476|FG000|Overall Study|Protocol Violation|25|||
124465891|NCT02944448|447664477|FG001|Overall Study|Protocol Violation|7|||
124465892|NCT02944448|447664476|FG000|Overall Study|Withdrawal by Subject|14|||
124465893|NCT02944448|447664477|FG001|Overall Study|Withdrawal by Subject|4|||
124465894|NCT02944448|447664476|FG000|Overall Study|Sponsor did not supply drug in time|0|||
124465895|NCT02944448|447664477|FG001|Overall Study|Sponsor did not supply drug in time|1|||
124465896|NCT02944448|447664476|FG000|Overall Study|Noncompliant with dosing|1|||
124465897|NCT02944448|447664477|FG001|Overall Study|Noncompliant with dosing|0|||
124465898|NCT02944448|447664476|FG000|Overall Study|Abnormal laboratory values|1|||
124465899|NCT02944448|447664477|FG001|Overall Study|Abnormal laboratory values|0|||
124465900|NCT03704194|447664483|FG000|Overall Study|Withdrawal by Subject|0|||
124465901|NCT03704194|447664484|FG001|Overall Study|Withdrawal by Subject|1|||
124465902|NCT03118297|447664489|FG000|Overall Study|Lost to Follow-up|0|||
124465903|NCT03118297|447664490|FG001|Overall Study|Lost to Follow-up|2|||
124465904|NCT02479802|447664491|FG000|Overall Study|Lost to Follow-up|1|||
124465905|NCT02479802|447664491|FG000|Overall Study|Adverse Event|1|||
124465906|NCT02469090|447664495|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
124465907|NCT02469090|447664496|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
124465908|NCT02469090|447664497|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
124465909|NCT02469090|447664495|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
124465910|NCT02469090|447664496|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
124465911|NCT02469090|447664497|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
124465912|NCT02469090|447664495|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
124465913|NCT02469090|447664496|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
124465914|NCT02469090|447664497|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
124465915|NCT02469090|447664495|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
124465916|NCT02469090|447664496|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
124465917|NCT02469090|447664497|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
124465918|NCT02469090|447664495|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
124465919|NCT02469090|447664496|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
124465920|NCT02469090|447664497|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
124465921|NCT02469090|447664495|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
124465922|NCT02469090|447664496|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
124465923|NCT02469090|447664497|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
124465924|NCT02469090|447664495|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
124465925|NCT02469090|447664496|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
124465926|NCT02469090|447664497|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
124465927|NCT02469090|447664495|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
124465928|NCT02469090|447664496|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
124465929|NCT02469090|447664497|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
124465930|NCT01391507|447664500|FG000|Overall Study|Death|0|||
124465931|NCT01391507|447664501|FG001|Overall Study|Death|0|||
124465932|NCT01391507|447664502|FG002|Overall Study|Death|0|||
124465933|NCT01391507|447664503|FG003|Overall Study|Death|1|||
124465934|NCT01391507|447664500|FG000|Overall Study|Adverse Event|1|||
124465935|NCT01391507|447664501|FG001|Overall Study|Adverse Event|1|||
124465936|NCT01391507|447664502|FG002|Overall Study|Adverse Event|2|||
124465937|NCT01391507|447664503|FG003|Overall Study|Adverse Event|2|||
124465938|NCT01391507|447664500|FG000|Overall Study|Withdrawal by Subject|1|||
124710477|NCT00546481|448565393|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
124465939|NCT01391507|447664501|FG001|Overall Study|Withdrawal by Subject|2|||
124465940|NCT01391507|447664502|FG002|Overall Study|Withdrawal by Subject|1|||
124465941|NCT01391507|447664503|FG003|Overall Study|Withdrawal by Subject|1|||
124465942|NCT01391507|447664500|FG000|Overall Study|Lack of Efficacy|0|||
124465943|NCT01391507|447664501|FG001|Overall Study|Lack of Efficacy|0|||
124465944|NCT01391507|447664502|FG002|Overall Study|Lack of Efficacy|0|||
124465945|NCT01391507|447664503|FG003|Overall Study|Lack of Efficacy|1|||
124465946|NCT01391507|447664500|FG000|Overall Study|Protocol Violation|2|||
124465947|NCT01391507|447664501|FG001|Overall Study|Protocol Violation|1|||
124465948|NCT01391507|447664502|FG002|Overall Study|Protocol Violation|1|||
124967900|NCT00727506|449509647|FG001|Overall Study|Progressive disease|7|||
124967901|NCT00727506|449509648|FG002|Overall Study|Progressive disease|9|||
124967902|NCT00727506|449509649|FG003|Overall Study|Progressive disease|28|||
124967903|NCT00727506|449509650|FG004|Overall Study|Progressive disease|38|||
124967904|NCT00727506|449509651|FG005|Overall Study|Progressive disease|28|||
124967905|NCT00727506|449509646|FG000|Overall Study|Refused to continue medication|0|||
124967906|NCT00727506|449509647|FG001|Overall Study|Refused to continue medication|1|||
124967907|NCT00727506|449509648|FG002|Overall Study|Refused to continue medication|2|||
124967908|NCT00727506|449509649|FG003|Overall Study|Refused to continue medication|3|||
124967909|NCT00727506|449509650|FG004|Overall Study|Refused to continue medication|1|||
124967910|NCT00727506|449509651|FG005|Overall Study|Refused to continue medication|2|||
124967911|NCT00727506|449509646|FG000|Overall Study|Other reason not described above|0|||
124967912|NCT00727506|449509647|FG001|Overall Study|Other reason not described above|0|||
124967913|NCT00727506|449509648|FG002|Overall Study|Other reason not described above|1|||
124967914|NCT00727506|449509649|FG003|Overall Study|Other reason not described above|4|||
124967915|NCT00727506|449509650|FG004|Overall Study|Other reason not described above|1|||
124967916|NCT00727506|449509651|FG005|Overall Study|Other reason not described above|1|||
124967917|NCT03561597|449509652|FG000|Overall Study|Lost to Follow-up|20|||
124967918|NCT03783689|449509654|FG000|Overall Study|Adverse Event|2|||
124967919|NCT03783689|449509655|FG001|Overall Study|Adverse Event|0|||
124967920|NCT03783689|449509654|FG000|Overall Study|Lost to Follow-up|2|||
124967921|NCT03783689|449509655|FG001|Overall Study|Lost to Follow-up|1|||
124967922|NCT03783689|449509654|FG000|Overall Study|Physician Decision|2|||
124967923|NCT03783689|449509655|FG001|Overall Study|Physician Decision|1|||
124967924|NCT03783689|449509654|FG000|Overall Study|Withdrawal by Subject|3|||
124967925|NCT03783689|449509655|FG001|Overall Study|Withdrawal by Subject|3|||
124967926|NCT01255761|449509658|FG000|Overall Study|Adverse Event|29|||
124967927|NCT01255761|449509659|FG001|Overall Study|Adverse Event|43|||
124967928|NCT01255761|449509658|FG000|Overall Study|Lack of Efficacy|86|||
124967929|NCT01255761|449509659|FG001|Overall Study|Lack of Efficacy|74|||
124967930|NCT01255761|449509658|FG000|Overall Study|Protocol Violation|9|||
124967931|NCT01255761|449509659|FG001|Overall Study|Protocol Violation|5|||
124967932|NCT01255761|449509658|FG000|Overall Study|Lost to Follow-up|10|||
124967933|NCT01255761|449509659|FG001|Overall Study|Lost to Follow-up|8|||
124967934|NCT01255761|449509658|FG000|Overall Study|Withdrawal by Subject|11|||
124967935|NCT01255761|449509659|FG001|Overall Study|Withdrawal by Subject|27|||
124967936|NCT01255761|449509658|FG000|Overall Study|Other Reasons|37|||
124967937|NCT01255761|449509659|FG001|Overall Study|Other Reasons|18|||
124967938|NCT03783871|449509665|FG000|Overall Study|Withdrawal by Subject|15|||
124967939|NCT03783871|449509665|FG000|Overall Study|Death|13|||
124967940|NCT03783871|449509665|FG000|Overall Study|Lost to Follow-up|2|||
124967941|NCT04594733|449509667|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
124967942|NCT04594733|449509668|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
124967943|NCT04594733|449509667|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
124967944|NCT04594733|449509668|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
124967945|NCT04594733|449509667|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
124967946|NCT04594733|449509668|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
124967947|NCT02647645|449509671|FG000|Overall Study|Lost to Follow-up|2|||
124967948|NCT02647645|449509672|FG001|Overall Study|Lost to Follow-up|1|||
124967949|NCT00356811|449509673|FG000|Overall Study|Death|35|||
124967950|NCT00356811|449509673|FG000|Overall Study|Lost to Follow-up|2|||
124967951|NCT00356811|449509673|FG000|Overall Study|Withdrawal by Subject|6|||
124967952|NCT00356811|449509673|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
124967953|NCT00356811|449509673|FG000|Overall Study|Study Is Terminating|3|||
124967954|NCT00356811|449509673|FG000|Overall Study|Site Closed during Follow-up|2|||
124967955|NCT02386839|449509674|FG000|Overall Study|Death|1|||
124967956|NCT02386839|449509675|FG001|Overall Study|Death|0|||
124710478|NCT00546481|448565394|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
124967957|NCT02386839|449509674|FG000|Overall Study|Withdrawal by Subject|9|||
124967958|NCT02386839|449509675|FG001|Overall Study|Withdrawal by Subject|10|||
124967959|NCT02386839|449509674|FG000|Overall Study|Lost to Follow-up|4|||
124967960|NCT02386839|449509675|FG001|Overall Study|Lost to Follow-up|4|||
124967961|NCT02386839|449509674|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
124967962|NCT02386839|449509675|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
124967963|NCT02386839|449509674|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
124967964|NCT02386839|449509675|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
124967965|NCT02386839|449509674|FG000|Overall Study|Other (unspecified)|1|||
124967966|NCT02386839|449509675|FG001|Overall Study|Other (unspecified)|0|||
124967967|NCT02101983|449509676|FG000|Overall Study|Physician Decision|1|||
124967968|NCT02101983|449509677|FG001|Overall Study|Physician Decision|0|||
124967969|NCT00826228|449511262|FG000|Overall Study|Withdrawal by Subject|1|||
124967970|NCT00903760|449511263|FG000|Overall Study|Disease Progression/Death|8|||
124967971|NCT00903760|449511264|FG001|Overall Study|Disease Progression/Death|6|||
124967972|NCT00903760|449511263|FG000|Overall Study|Stem Cell Transplant|8|||
124967973|NCT00903760|449511264|FG001|Overall Study|Stem Cell Transplant|4|||
124967974|NCT00903760|449511263|FG000|Overall Study|Physician Decision|1|||
124465949|NCT01391507|447664503|FG003|Overall Study|Protocol Violation|2|||
124465950|NCT01562548|447664508|FG000|Overall Study|Lost to Follow-up|0|||
124465951|NCT01562548|447664509|FG001|Overall Study|Lost to Follow-up|0|||
124465952|NCT01562548|447664510|FG002|Overall Study|Lost to Follow-up|1|||
124710479|NCT00546481|448565392|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
124710480|NCT00546481|448565393|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
124710481|NCT00546481|448565394|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
124710482|NCT00546481|448565392|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
124710483|NCT00546481|448565393|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
124710484|NCT00546481|448565394|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
124710485|NCT00546481|448565392|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
124710486|NCT00546481|448565393|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
124710487|NCT00546481|448565394|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
124710488|NCT00546481|448565392|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
124710489|NCT00546481|448565393|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
124710490|NCT00546481|448565394|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
124710491|NCT00546481|448565392|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
124967975|NCT00903760|449511264|FG001|Overall Study|Physician Decision|2|||
124967976|NCT00903760|449511263|FG000|Overall Study|Death|0|||
124967977|NCT00903760|449511264|FG001|Overall Study|Death|1|||
124967978|NCT00903760|449511263|FG000|Overall Study|Lost to Follow-up|1|||
124710492|NCT00546481|448565393|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
124710493|NCT00546481|448565394|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
124710494|NCT00546481|448565392|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
124710495|NCT00546481|448565393|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
124967979|NCT00903760|449511264|FG001|Overall Study|Lost to Follow-up|0|||
124967980|NCT00903760|449511263|FG000|Overall Study|Withdrawal by Subject|1|||
124967981|NCT00903760|449511264|FG001|Overall Study|Withdrawal by Subject|2|||
124967982|NCT00903760|449511263|FG000|Overall Study|Off treatment for long period|0|||
124967983|NCT00903760|449511264|FG001|Overall Study|Off treatment for long period|1|||
124967984|NCT01845805|449511266|FG000|Overall Study|Withdrawal by Subject|1|||
124967985|NCT01845805|449511267|FG001|Overall Study|Withdrawal by Subject|2|||
124967986|NCT01845805|449511266|FG000|Overall Study|Disease Progression|13|||
124967987|NCT01845805|449511267|FG001|Overall Study|Disease Progression|14|||
124967988|NCT01845805|449511266|FG000|Overall Study|Drug-related Toxicity|4|||
124967989|NCT01845805|449511267|FG001|Overall Study|Drug-related Toxicity|0|||
124967990|NCT00589303|449511274|FG000|Overall Study|Withdrawal by Subject|2|||
124967991|NCT00589303|449511275|FG001|Overall Study|Withdrawal by Subject|1|||
124967992|NCT04367480|449511276|FG000|Overall Study|Adverse Event|1|||
124967993|NCT04367480|449511277|FG001|Overall Study|Adverse Event|1|||
124465953|NCT01562548|447664511|FG003|Overall Study|Lost to Follow-up|0|||
124465954|NCT00252057|447664512|FG000|Overall Study|Withdrawal by Subject|2|||
124465955|NCT00252057|447664513|FG001|Overall Study|Withdrawal by Subject|5|||
124465956|NCT00252057|447664512|FG000|Overall Study|Death|1|||
124465957|NCT00252057|447664513|FG001|Overall Study|Death|2|||
124465958|NCT00252057|447664512|FG000|Overall Study|Participant previously enrolled|0|||
124465959|NCT00252057|447664513|FG001|Overall Study|Participant previously enrolled|1|||
124465960|NCT01496066|447664514|FG000|Overall Study|Lost to Follow-up|8|||
124465961|NCT01496066|447664515|FG001|Overall Study|Lost to Follow-up|5|||
124465962|NCT01496066|447664514|FG000|Overall Study|Explant|3|||
124465963|NCT01496066|447664515|FG001|Overall Study|Explant|0|||
124465964|NCT01496066|447664514|FG000|Overall Study|Death|1|||
124465965|NCT01496066|447664515|FG001|Overall Study|Death|4|||
124465966|NCT02926209|447664516|FG000|Study Cohort|Poor Bowel Preparation|1|||
124465967|NCT02926209|447664517|FG001|Study Cohort|Poor Bowel Preparation|0|||
124465968|NCT01903837|447664519|FG000|Part A|Withdrawal by Subject|4|||
124465969|NCT01903837|447664520|FG001|Part A|Withdrawal by Subject|9|||
124465970|NCT01903837|447664521|FG002|Part A|Withdrawal by Subject|8|||
124465971|NCT01903837|447664522|FG003|Part A|Withdrawal by Subject|5|||
124465972|NCT01903837|447664519|FG000|Part A|Adverse Event|3|||
124465973|NCT01903837|447664520|FG001|Part A|Adverse Event|6|||
124465974|NCT01903837|447664521|FG002|Part A|Adverse Event|9|||
124465975|NCT01903837|447664522|FG003|Part A|Adverse Event|6|||
124465976|NCT01903837|447664519|FG000|Part A|Lost to Follow-up|9|||
124465977|NCT01903837|447664520|FG001|Part A|Lost to Follow-up|7|||
124465978|NCT01903837|447664521|FG002|Part A|Lost to Follow-up|7|||
124465979|NCT01903837|447664522|FG003|Part A|Lost to Follow-up|2|||
124465980|NCT01903837|447664519|FG000|Part A|Non-compliance with study drug|1|||
124465981|NCT01903837|447664520|FG001|Part A|Non-compliance with study drug|4|||
124465982|NCT01903837|447664521|FG002|Part A|Non-compliance with study drug|4|||
124465983|NCT01903837|447664522|FG003|Part A|Non-compliance with study drug|0|||
124465984|NCT01903837|447664519|FG000|Part A|Physician Decision|1|||
124465985|NCT01903837|447664520|FG001|Part A|Physician Decision|1|||
124465986|NCT01903837|447664521|FG002|Part A|Physician Decision|0|||
124465987|NCT01903837|447664522|FG003|Part A|Physician Decision|0|||
124967994|NCT04367480|449511276|FG000|Overall Study|Death|1|||
124967995|NCT04367480|449511277|FG001|Overall Study|Death|0|||
124967996|NCT04367480|449511276|FG000|Overall Study|Lost to Follow-up|1|||
124967997|NCT04367480|449511277|FG001|Overall Study|Lost to Follow-up|1|||
124967998|NCT04367480|449511276|FG000|Overall Study|Withdrawal by Subject|0|||
124967999|NCT04367480|449511277|FG001|Overall Study|Withdrawal by Subject|3|||
124968000|NCT04367480|449511276|FG000|Overall Study|App glitch during the study|1|||
124968001|NCT04367480|449511277|FG001|Overall Study|App glitch during the study|0|||
124968002|NCT04367480|449511276|FG000|Overall Study|Device Distribution Error|0|||
124465988|NCT01903837|447664519|FG000|Part A|Protocol Violation|1|||
124465989|NCT01903837|447664520|FG001|Part A|Protocol Violation|1|||
124710496|NCT00546481|448565394|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
124710497|NCT00546481|448565392|FG000|Maintenance Phase (CERA)|Other Reason|0|||
124710498|NCT00546481|448565393|FG001|Maintenance Phase (CERA)|Other Reason|0|||
124710499|NCT00546481|448565394|FG002|Maintenance Phase (CERA)|Other Reason|1|||
124710500|NCT01240863|448565397|FG000|Open-label Titration Period|Adverse Event|47|||
124710501|NCT01240863|448565398|FG001|Open-label Titration Period|Adverse Event|0|||
124710502|NCT01240863|448565399|FG002|Open-label Titration Period|Adverse Event|0|||
124710503|NCT01240863|448565397|FG000|Open-label Titration Period|Lack of Efficacy|19|||
124710504|NCT01240863|448565398|FG001|Open-label Titration Period|Lack of Efficacy|0|||
124710505|NCT01240863|448565399|FG002|Open-label Titration Period|Lack of Efficacy|0|||
124710506|NCT01240863|448565397|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
124710507|NCT01240863|448565398|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
124710508|NCT01240863|448565399|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
124710509|NCT01240863|448565397|FG000|Open-label Titration Period|Protocol Violation|7|||
124710510|NCT01240863|448565398|FG001|Open-label Titration Period|Protocol Violation|0|||
124710511|NCT01240863|448565399|FG002|Open-label Titration Period|Protocol Violation|0|||
124710512|NCT01240863|448565397|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
124710513|NCT01240863|448565398|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
124710514|NCT01240863|448565399|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
124710515|NCT01240863|448565397|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
124710516|NCT01240863|448565398|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
124710517|NCT01240863|448565399|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
124710518|NCT01240863|448565397|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
124710519|NCT01240863|448565398|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
124710520|NCT01240863|448565399|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
124710521|NCT01240863|448565397|FG000|Open-label Titration Period|Other|7|||
124710522|NCT01240863|448565398|FG001|Open-label Titration Period|Other|0|||
124710523|NCT01240863|448565399|FG002|Open-label Titration Period|Other|0|||
124710524|NCT01240863|448565397|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
124710525|NCT01240863|448565398|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
124710526|NCT01240863|448565399|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
124710527|NCT01240863|448565397|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
124710528|NCT01240863|448565398|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
124710529|NCT01240863|448565399|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
124710530|NCT01240863|448565397|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
124710531|NCT01240863|448565398|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
124710532|NCT01240863|448565399|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
124710533|NCT01240863|448565397|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
124710534|NCT01240863|448565398|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
124710535|NCT01240863|448565399|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
124710536|NCT01240863|448565397|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
124710537|NCT01240863|448565398|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
124710538|NCT01240863|448565399|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
124710539|NCT01240863|448565397|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
124710540|NCT01240863|448565398|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
124710541|NCT01240863|448565399|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
124710542|NCT01240863|448565397|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
124710543|NCT01240863|448565398|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
124710544|NCT01240863|448565399|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
124710545|NCT01240863|448565397|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
124710546|NCT01240863|448565398|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
124968003|NCT04367480|449511277|FG001|Overall Study|Device Distribution Error|2|||
124968004|NCT04367480|449511276|FG000|Overall Study|Ineligible after Randomization|0|||
124710547|NCT01240863|448565399|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
124710548|NCT03783780|448565404|FG000|Overall Study|Withdrawn prior to completion|1|||
124710549|NCT03768427|448565405|FG000|Overall Study|Death|0|||
124710550|NCT03768427|448565406|FG001|Overall Study|Death|0|||
124968005|NCT04367480|449511277|FG001|Overall Study|Ineligible after Randomization|1|||
124968006|NCT04367480|449511276|FG000|Overall Study|Other Medical Reasons|0|||
124710551|NCT03768427|448565407|FG002|Overall Study|Death|1|||
124710552|NCT03768427|448565408|FG003|Overall Study|Death|0|||
124710553|NCT03768427|448565405|FG000|Overall Study|Lost to Follow-up|2|||
124710554|NCT03768427|448565406|FG001|Overall Study|Lost to Follow-up|0|||
124710555|NCT03768427|448565407|FG002|Overall Study|Lost to Follow-up|0|||
124710556|NCT03768427|448565408|FG003|Overall Study|Lost to Follow-up|0|||
124710557|NCT03768427|448565405|FG000|Overall Study|Physician Decision|3|||
124710558|NCT03768427|448565406|FG001|Overall Study|Physician Decision|2|||
124710559|NCT03768427|448565407|FG002|Overall Study|Physician Decision|4|||
124710560|NCT03768427|448565408|FG003|Overall Study|Physician Decision|4|||
124710561|NCT03768427|448565405|FG000|Overall Study|Withdrawal by Subject|7|||
124710562|NCT03768427|448565406|FG001|Overall Study|Withdrawal by Subject|2|||
124710563|NCT03768427|448565407|FG002|Overall Study|Withdrawal by Subject|6|||
124710564|NCT03768427|448565408|FG003|Overall Study|Withdrawal by Subject|7|||
124710565|NCT00776789|448565409|FG000|Overall Study|Consent refusal|2|||
124710566|NCT00776789|448565410|FG001|Overall Study|Consent refusal|2|||
124710567|NCT00776789|448565409|FG000|Overall Study|Poor quality video|1|||
124710568|NCT00776789|448565410|FG001|Overall Study|Poor quality video|1|||
124710569|NCT02629861|448565416|FG000|Overall Study|Adverse Event|7|||
124710570|NCT02629861|448565417|FG001|Overall Study|Adverse Event|5|||
124465990|NCT01903837|447664521|FG002|Part A|Protocol Violation|0|||
124465991|NCT01903837|447664522|FG003|Part A|Protocol Violation|0|||
124465992|NCT01903837|447664519|FG000|Part B|Lost to Follow-up|0|||
124465993|NCT01903837|447664520|FG001|Part B|Lost to Follow-up|3|||
124465994|NCT01903837|447664521|FG002|Part B|Lost to Follow-up|3|||
124465995|NCT01903837|447664522|FG003|Part B|Lost to Follow-up|4|||
124710571|NCT02629861|448565418|FG002|Overall Study|Adverse Event|4|||
124710572|NCT02629861|448565416|FG000|Overall Study|Withdrawal by Subject|5|||
124710573|NCT02629861|448565417|FG001|Overall Study|Withdrawal by Subject|8|||
124710574|NCT02629861|448565418|FG002|Overall Study|Withdrawal by Subject|13|||
124465996|NCT01903837|447664519|FG000|Part B|Withdrawal by Subject|1|||
124465997|NCT01903837|447664520|FG001|Part B|Withdrawal by Subject|2|||
124465998|NCT01903837|447664521|FG002|Part B|Withdrawal by Subject|0|||
124465999|NCT01903837|447664522|FG003|Part B|Withdrawal by Subject|3|||
124466000|NCT01903837|447664519|FG000|Part B|Adverse Event|3|||
124466001|NCT01903837|447664520|FG001|Part B|Adverse Event|0|||
124466002|NCT01903837|447664521|FG002|Part B|Adverse Event|2|||
124466003|NCT01903837|447664522|FG003|Part B|Adverse Event|0|||
124466004|NCT01903837|447664519|FG000|Part B|Non-compliance with study drug|2|||
124466005|NCT01903837|447664520|FG001|Part B|Non-compliance with study drug|0|||
124710575|NCT02629861|448565416|FG000|Overall Study|Protocol Violation|2|||
124710576|NCT02629861|448565417|FG001|Overall Study|Protocol Violation|3|||
124466006|NCT01903837|447664521|FG002|Part B|Non-compliance with study drug|0|||
124550576|NCT01186744|447972988|FG000|Overall Study|Study terminated by Sponsor|1|||
124550577|NCT01186744|447972989|FG001|Overall Study|Study terminated by Sponsor|0|||
124710577|NCT02629861|448565418|FG002|Overall Study|Protocol Violation|7|||
124710578|NCT02629861|448565416|FG000|Overall Study|Lost to Follow-up|12|||
124710579|NCT02629861|448565417|FG001|Overall Study|Lost to Follow-up|9|||
124710580|NCT02629861|448565418|FG002|Overall Study|Lost to Follow-up|4|||
124710581|NCT02629861|448565416|FG000|Overall Study|Other|1|||
124710582|NCT02629861|448565417|FG001|Overall Study|Other|1|||
124710583|NCT02629861|448565418|FG002|Overall Study|Other|0|||
124710584|NCT02629861|448565416|FG000|Overall Study|Pregnancy|2|||
124710585|NCT02629861|448565417|FG001|Overall Study|Pregnancy|1|||
124710586|NCT02629861|448565418|FG002|Overall Study|Pregnancy|0|||
124710587|NCT00902330|448565421|FG000|Overall Study|Too overwhelmed by treatment|2|||
124710588|NCT00902330|448565422|FG001|Overall Study|Too overwhelmed by treatment|5|||
124710589|NCT00902330|448565421|FG000|Overall Study|Adverse Event|1|||
124710590|NCT00902330|448565422|FG001|Overall Study|Adverse Event|0|||
124710591|NCT00902330|448565421|FG000|Overall Study|No post baseline data|1|||
124710592|NCT00902330|448565422|FG001|Overall Study|No post baseline data|0|||
124710593|NCT00165789|448565423|FG000|Overall Study|Adverse Event|0|||
124710594|NCT00165789|448565424|FG001|Overall Study|Adverse Event|3|||
124710595|NCT00165789|448565425|FG002|Overall Study|Adverse Event|0|||
124466007|NCT01903837|447664522|FG003|Part B|Non-compliance with study drug|1|||
124466008|NCT01903837|447664519|FG000|Part B|Incarceration|2|||
124466009|NCT01903837|447664520|FG001|Part B|Incarceration|0|||
124466010|NCT01903837|447664521|FG002|Part B|Incarceration|0|||
124550578|NCT01186744|447972990|FG002|Overall Study|Study terminated by Sponsor|0|||
124550579|NCT01186744|447972991|FG003|Overall Study|Study terminated by Sponsor|0|||
124710596|NCT00165789|448565426|FG003|Overall Study|Adverse Event|12|||
124710597|NCT00165789|448565423|FG000|Overall Study|Withdrawal by Subject|0|||
124710598|NCT00165789|448565424|FG001|Overall Study|Withdrawal by Subject|1|||
124710599|NCT00165789|448565425|FG002|Overall Study|Withdrawal by Subject|1|||
124710600|NCT00165789|448565426|FG003|Overall Study|Withdrawal by Subject|2|||
124710601|NCT01816048|448565427|FG000|Overall Study|Adverse Event|1|||
124710602|NCT01816048|448565427|FG000|Overall Study|Death|1|||
124710603|NCT01816048|448565427|FG000|Overall Study|Withdrawal by Subject|1|||
124710604|NCT01816048|448565427|FG000|Overall Study|Disease Progression|3|||
124710605|NCT01816984|448565431|FG000|Overall Study|declining health status|1|||
124710606|NCT01342094|448565434|FG000|Overall Study|Adverse Event|5|||
124710607|NCT01342094|448565435|FG001|Overall Study|Adverse Event|0|||
124710608|NCT01342094|448565434|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
124710609|NCT01342094|448565435|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
124710610|NCT01342094|448565434|FG000|Overall Study|Withdrawal by Subject|0|||
124710611|NCT01342094|448565435|FG001|Overall Study|Withdrawal by Subject|2|||
124710612|NCT04021290|448565440|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
124710613|NCT04021290|448565441|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
124710614|NCT04021290|448565442|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
124710615|NCT04021290|448565440|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
124710616|NCT04021290|448565441|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
124710617|NCT04021290|448565442|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
124710618|NCT04021290|448565440|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
124710619|NCT04021290|448565441|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
124710620|NCT04021290|448565442|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
124710621|NCT04021290|448565440|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
124710622|NCT04021290|448565441|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
124710623|NCT04021290|448565442|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
124710624|NCT04021290|448565440|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
124710625|NCT04021290|448565441|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
124710626|NCT04021290|448565442|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
124710627|NCT04021290|448565440|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
124710628|NCT04021290|448565441|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
124710629|NCT04021290|448565442|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
124710630|NCT04021290|448565440|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
124710631|NCT04021290|448565441|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
124710632|NCT04021290|448565442|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
124710633|NCT04021290|448565440|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
124710634|NCT04021290|448565441|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
124710635|NCT04021290|448565442|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
124710636|NCT04021290|448565440|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
124710637|NCT04021290|448565441|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
124710638|NCT04021290|448565442|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
124968007|NCT04367480|449511277|FG001|Overall Study|Other Medical Reasons|2|||
124968008|NCT00730015|449511279|FG000|Overall Study|Adverse Event|11|||
124968009|NCT00730015|449511280|FG001|Overall Study|Adverse Event|10|||
124968010|NCT00730015|449511281|FG002|Overall Study|Adverse Event|8|||
124968011|NCT00730015|449511279|FG000|Overall Study|Protocol Violation|2|||
124968012|NCT00730015|449511280|FG001|Overall Study|Protocol Violation|6|||
124968013|NCT00730015|449511281|FG002|Overall Study|Protocol Violation|4|||
124466011|NCT01903837|447664522|FG003|Part B|Incarceration|1|||
124466012|NCT01903837|447664519|FG000|Part B|Physician Decision|1|||
124466013|NCT01903837|447664520|FG001|Part B|Physician Decision|0|||
124466014|NCT01903837|447664521|FG002|Part B|Physician Decision|0|||
124466015|NCT01903837|447664522|FG003|Part B|Physician Decision|2|||
124466016|NCT01903837|447664519|FG000|Part B|Lack of Efficacy|0|||
124466017|NCT01903837|447664520|FG001|Part B|Lack of Efficacy|1|||
124466018|NCT01903837|447664521|FG002|Part B|Lack of Efficacy|0|||
124466019|NCT01903837|447664522|FG003|Part B|Lack of Efficacy|0|||
124466020|NCT05048342|447664523|FG000|Overall Study|Adverse Event|1|||
124466021|NCT05048342|447664523|FG000|Overall Study|Subject decision|2|||
124466022|NCT02462473|447664524|FG000|Overall Study|Death|1|||
124466023|NCT02462473|447664524|FG000|Overall Study|Other|3|||
124466024|NCT01400451|447664526|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
124466025|NCT01400451|447664527|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
124466026|NCT01400451|447664528|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
124466027|NCT01400451|447664526|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
124466028|NCT01400451|447664527|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
124466029|NCT01400451|447664528|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
124466030|NCT01400451|447664526|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
124466031|NCT01400451|447664527|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
124466032|NCT01400451|447664528|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
124466033|NCT01400451|447664526|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
124466034|NCT01400451|447664527|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
124466035|NCT01400451|447664528|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
124466036|NCT01400451|447664526|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
124466037|NCT01400451|447664527|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
124466038|NCT01400451|447664528|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
124466039|NCT01079182|447664545|FG000|Overall Study|Lost to Follow-up|1634|||
124466040|NCT01079182|447664545|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
124466041|NCT01079182|447664545|FG000|Overall Study|Lack of Efficacy|514|||
124466042|NCT01079182|447664545|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
124968014|NCT00730015|449511279|FG000|Overall Study|Withdrawal by Subject|12|||
124968015|NCT00730015|449511280|FG001|Overall Study|Withdrawal by Subject|12|||
124968016|NCT00730015|449511281|FG002|Overall Study|Withdrawal by Subject|8|||
124710639|NCT04021290|448565440|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
124710640|NCT04021290|448565441|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
124710641|NCT04021290|448565442|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
124710642|NCT04021290|448565440|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
124710643|NCT04021290|448565441|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
124710644|NCT04021290|448565442|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
124710645|NCT04021290|448565440|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
124710646|NCT04021290|448565441|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
124710647|NCT04021290|448565442|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
124710648|NCT00636181|448565443|FG000|Overall Study|Withdrawal by Subject|8|||
124710649|NCT00636181|448565444|FG001|Overall Study|Withdrawal by Subject|6|||
124710650|NCT00636181|448565445|FG002|Overall Study|Withdrawal by Subject|10|||
124710651|NCT05076045|448565453|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
124710652|NCT05076045|448565454|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
124710653|NCT01085214|448565457|FG000|Overall Study|Alternate treatment required|1|||
124710654|NCT01634152|448565471|FG000|Overall Study|Adverse Event|2|||
124710655|NCT01634152|448565472|FG001|Overall Study|Adverse Event|0|||
124710656|NCT01634152|448565473|FG002|Overall Study|Adverse Event|2|||
124710657|NCT01634152|448565471|FG000|Overall Study|Consent withdrawn not due to AE|1|||
124710658|NCT01634152|448565472|FG001|Overall Study|Consent withdrawn not due to AE|0|||
124710659|NCT01634152|448565473|FG002|Overall Study|Consent withdrawn not due to AE|1|||
124968017|NCT00730015|449511279|FG000|Overall Study|Lost to Follow-up|4|||
124968018|NCT00730015|449511280|FG001|Overall Study|Lost to Follow-up|10|||
124968019|NCT00730015|449511281|FG002|Overall Study|Lost to Follow-up|3|||
124968020|NCT00730015|449511279|FG000|Overall Study|Lack of Efficacy|1|||
124968021|NCT00730015|449511280|FG001|Overall Study|Lack of Efficacy|2|||
124968022|NCT00730015|449511281|FG002|Overall Study|Lack of Efficacy|8|||
124968023|NCT00730015|449511279|FG000|Overall Study|Other Reason|1|||
124968024|NCT00730015|449511280|FG001|Overall Study|Other Reason|0|||
124968025|NCT00730015|449511281|FG002|Overall Study|Other Reason|1|||
124968026|NCT04120376|449511282|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
124968027|NCT04120376|449511283|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
124968028|NCT00634842|449511284|FG000|Overall Study|Adverse Event|2|||
124968029|NCT00634842|449511285|FG001|Overall Study|Adverse Event|3|||
124968030|NCT00634842|449511284|FG000|Overall Study|Protocol Violation|8|||
124968031|NCT00634842|449511285|FG001|Overall Study|Protocol Violation|4|||
124968032|NCT00634842|449511284|FG000|Overall Study|Move to another state|1|||
124968033|NCT00634842|449511285|FG001|Overall Study|Move to another state|0|||
124968034|NCT00634842|449511284|FG000|Overall Study|Inclusion criteria were not met|1|||
124968035|NCT00634842|449511285|FG001|Overall Study|Inclusion criteria were not met|0|||
124968036|NCT00634842|449511284|FG000|Overall Study|Lost to Follow-up|1|||
124968037|NCT00634842|449511285|FG001|Overall Study|Lost to Follow-up|2|||
124968038|NCT00634842|449511284|FG000|Overall Study|Physician Decision|1|||
124968039|NCT00634842|449511285|FG001|Overall Study|Physician Decision|0|||
124968040|NCT00634842|449511284|FG000|Overall Study|Withdrawal by Subject|1|||
124968041|NCT00634842|449511285|FG001|Overall Study|Withdrawal by Subject|3|||
124968042|NCT00634842|449511284|FG000|Overall Study|Lack of time and intolerance to drug|0|||
124968043|NCT00634842|449511285|FG001|Overall Study|Lack of time and intolerance to drug|1|||
124968044|NCT00634842|449511284|FG000|Overall Study|Discontinued due to injection|0|||
124968045|NCT00634842|449511285|FG001|Overall Study|Discontinued due to injection|2|||
124968046|NCT00634842|449511284|FG000|Overall Study|No need of study drug to treat diabetes|0|||
124968047|NCT00634842|449511285|FG001|Overall Study|No need of study drug to treat diabetes|1|||
124968048|NCT00634842|449511284|FG000|Overall Study|No wish to keep taking Avandia|0|||
124968049|NCT00634842|449511285|FG001|Overall Study|No wish to keep taking Avandia|1|||
124968050|NCT00634842|449511284|FG000|Overall Study|Subject off study drug for too long|0|||
124968051|NCT00634842|449511285|FG001|Overall Study|Subject off study drug for too long|1|||
124968052|NCT00943787|449511309|FG000|Overall Study|Physician Decision|4|||
124968053|NCT00943787|449511309|FG000|Overall Study|Withdrawal by Subject|3|||
124968054|NCT01288209|449511311|FG000|Overall Study|Withdrawal by Subject|1|||
124968055|NCT01288209|449511312|FG001|Overall Study|Withdrawal by Subject|3|||
124968056|NCT01288209|449511311|FG000|Overall Study|Other|1|||
124968057|NCT01288209|449511312|FG001|Overall Study|Other|0|||
124968058|NCT01015677|449511313|FG000|Overall Study|Adverse Event|0|||
124968059|NCT01015677|449511314|FG001|Overall Study|Adverse Event|1|||
124968060|NCT01015677|449511315|FG002|Overall Study|Adverse Event|0|||
124968061|NCT01015677|449511313|FG000|Overall Study|Lack of Efficacy|0|||
124968062|NCT01015677|449511314|FG001|Overall Study|Lack of Efficacy|1|||
124710660|NCT01634152|448565471|FG000|Overall Study|Not treated|0|||
124968063|NCT01015677|449511315|FG002|Overall Study|Lack of Efficacy|0|||
124968064|NCT01015677|449511313|FG000|Overall Study|Protocol Violation|0|||
124968065|NCT01015677|449511314|FG001|Overall Study|Protocol Violation|1|||
124968066|NCT01015677|449511315|FG002|Overall Study|Protocol Violation|0|||
124968067|NCT01015677|449511313|FG000|Overall Study|Withdrawal by Subject|1|||
124968068|NCT01015677|449511314|FG001|Overall Study|Withdrawal by Subject|1|||
124968069|NCT01015677|449511315|FG002|Overall Study|Withdrawal by Subject|0|||
124968070|NCT02232399|449511316|FG000|Overall Study|Adverse Event|1|||
124968071|NCT02232399|449511317|FG001|Overall Study|Adverse Event|0|||
124710661|NCT01634152|448565472|FG001|Overall Study|Not treated|1|||
124710662|NCT01634152|448565473|FG002|Overall Study|Not treated|0|||
124710663|NCT01634152|448565471|FG000|Overall Study|Other reason not defined above|1|||
124710664|NCT01634152|448565472|FG001|Overall Study|Other reason not defined above|0|||
124710665|NCT01634152|448565473|FG002|Overall Study|Other reason not defined above|1|||
124710666|NCT01985022|448565477|FG000|Overall Study|Lost to Follow-up|0|||
124710667|NCT01985022|448565478|FG001|Overall Study|Lost to Follow-up|1|||
124710668|NCT01985022|448565477|FG000|Overall Study|Protocol Violation|0|||
124710669|NCT01985022|448565478|FG001|Overall Study|Protocol Violation|1|||
124710670|NCT01985022|448565477|FG000|Overall Study|Withdrawal by Subject|4|||
124710671|NCT01985022|448565478|FG001|Overall Study|Withdrawal by Subject|1|||
124710672|NCT01152437|448565479|FG000|Overall Study|Other Adverse Event|8|||
124710673|NCT01152437|448565480|FG001|Overall Study|Other Adverse Event|1|||
124710674|NCT01152437|448565481|FG002|Overall Study|Other Adverse Event|7|||
124710675|NCT01152437|448565479|FG000|Overall Study|Not treated|0|||
124710676|NCT01152437|448565480|FG001|Overall Study|Not treated|1|||
124710677|NCT01152437|448565481|FG002|Overall Study|Not treated|2|||
124710678|NCT01152437|448565479|FG000|Overall Study|Progressive disease|27|||
124710679|NCT01152437|448565480|FG001|Overall Study|Progressive disease|13|||
124710680|NCT01152437|448565481|FG002|Overall Study|Progressive disease|32|||
124710681|NCT01152437|448565479|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
124710682|NCT01152437|448565480|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
124710683|NCT01152437|448565481|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
124710684|NCT00279214|448565482|FG000|Overall Study|Physician Decision|3|||
124710685|NCT00279214|448565483|FG001|Overall Study|Physician Decision|2|||
124710686|NCT01214837|448565484|FG000|Overall Study|Death|0|||
124710687|NCT01214837|448565485|FG001|Overall Study|Death|0|||
124710688|NCT01214837|448565486|FG002|Overall Study|Death|1|||
124710689|NCT01214837|448565484|FG000|Overall Study|Adverse Event|1|||
124710690|NCT01214837|448565485|FG001|Overall Study|Adverse Event|2|||
124710691|NCT01214837|448565486|FG002|Overall Study|Adverse Event|1|||
124710692|NCT01214837|448565484|FG000|Overall Study|Withdrawal by Subject|27|||
124710693|NCT01214837|448565485|FG001|Overall Study|Withdrawal by Subject|36|||
124710694|NCT01214837|448565486|FG002|Overall Study|Withdrawal by Subject|28|||
124710695|NCT01214837|448565484|FG000|Overall Study|Lost to Follow-up|20|||
124710696|NCT01214837|448565485|FG001|Overall Study|Lost to Follow-up|15|||
124710697|NCT01214837|448565486|FG002|Overall Study|Lost to Follow-up|21|||
124710698|NCT01214837|448565484|FG000|Overall Study|Inappropriate Enrolment|0|||
124710699|NCT01214837|448565485|FG001|Overall Study|Inappropriate Enrolment|1|||
124710700|NCT01214837|448565486|FG002|Overall Study|Inappropriate Enrolment|2|||
124710701|NCT01214837|448565484|FG000|Overall Study|Administrative Reason|2|||
124710702|NCT01214837|448565485|FG001|Overall Study|Administrative Reason|6|||
124710703|NCT01214837|448565486|FG002|Overall Study|Administrative Reason|4|||
124710704|NCT01214837|448565484|FG000|Overall Study|Protocol Violation|3|||
124710705|NCT01214837|448565485|FG001|Overall Study|Protocol Violation|1|||
124710706|NCT01214837|448565486|FG002|Overall Study|Protocol Violation|5|||
124710707|NCT01214837|448565484|FG000|Overall Study|Unable to Classify|1|||
124710708|NCT01214837|448565485|FG001|Overall Study|Unable to Classify|3|||
124710709|NCT01214837|448565486|FG002|Overall Study|Unable to Classify|0|||
124710710|NCT00457626|448565487|FG000|Overall Study|Adverse Event|3|||
124710711|NCT00457626|448565487|FG000|Overall Study|Administrative Problems|2|||
124710712|NCT00457626|448565487|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
124710713|NCT03549338|448567665|FG000|Overall Study|Progressive Disease|1|||
124710714|NCT03549338|448567666|FG001|Overall Study|Progressive Disease|0|||
124710715|NCT03549338|448567667|FG002|Overall Study|Progressive Disease|0|||
124968072|NCT02232399|449511316|FG000|Overall Study|Withdrawal by Subject|0|||
124710716|NCT03549338|448567665|FG000|Overall Study|Clinical Progression|0|||
124710717|NCT03549338|448567666|FG001|Overall Study|Clinical Progression|1|||
124710718|NCT03549338|448567667|FG002|Overall Study|Clinical Progression|0|||
124710719|NCT00269113|448567668|FG000|Overall Study|Adverse Event|14|||
124710720|NCT00269113|448567669|FG001|Overall Study|Adverse Event|7|||
124710721|NCT00269113|448567668|FG000|Overall Study|Lack of Efficacy|35|||
124710722|NCT00269113|448567669|FG001|Overall Study|Lack of Efficacy|18|||
124710723|NCT00269113|448567668|FG000|Overall Study|Early Improvement|2|||
124710724|NCT00269113|448567669|FG001|Overall Study|Early Improvement|0|||
124710725|NCT00269113|448567668|FG000|Overall Study|Withdrawal by Subject|0|||
124710726|NCT00269113|448567669|FG001|Overall Study|Withdrawal by Subject|2|||
124710727|NCT00269113|448567668|FG000|Overall Study|Death|6|||
124968073|NCT02232399|449511317|FG001|Overall Study|Withdrawal by Subject|1|||
124968074|NCT01646385|449511320|FG000|Overall Study|Death|202|||
124968075|NCT01646385|449511321|FG001|Overall Study|Death|222|||
124968076|NCT01646385|449511320|FG000|Overall Study|Switched to alternate biologic|636|||
124968077|NCT01646385|449511321|FG001|Overall Study|Switched to alternate biologic|649|||
124968078|NCT01216072|449511322|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
124968079|NCT01216072|449511323|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
124968080|NCT01216072|449511322|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
124968081|NCT01216072|449511323|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
124968082|NCT01216072|449511322|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
124968083|NCT01216072|449511323|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
124968084|NCT01216072|449511322|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
124968085|NCT01216072|449511323|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
124968086|NCT01216072|449511322|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
124968087|NCT01216072|449511323|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
124968088|NCT01216072|449511322|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
124968089|NCT01216072|449511323|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
124968090|NCT01216072|449511322|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
124968091|NCT01216072|449511323|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
124968092|NCT01216072|449511322|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
124968093|NCT01216072|449511323|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
124968094|NCT01216072|449511322|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
124968095|NCT01216072|449511323|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
124968096|NCT01216072|449511322|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
124466043|NCT01079182|447664545|FG000|Overall Study|Reasons not Evaluated|271|||
124466044|NCT00903929|447664546|FG000|Overall Study|Withdrawal by Subject|0|||
124466045|NCT00903929|447664547|FG001|Overall Study|Withdrawal by Subject|0|||
124466046|NCT00903929|447664548|FG002|Overall Study|Withdrawal by Subject|1|||
124466047|NCT00903929|447664549|FG003|Overall Study|Withdrawal by Subject|2|||
124466048|NCT00903929|447664546|FG000|Overall Study|Adverse Event|0|||
124466049|NCT00903929|447664547|FG001|Overall Study|Adverse Event|0|||
124466050|NCT00903929|447664548|FG002|Overall Study|Adverse Event|0|||
124710728|NCT00269113|448567669|FG001|Overall Study|Death|2|||
124710729|NCT00269113|448567668|FG000|Overall Study|Lost to Follow-up|2|||
124710730|NCT00269113|448567669|FG001|Overall Study|Lost to Follow-up|1|||
124710731|NCT00269113|448567668|FG000|Overall Study|Protocol Violation|15|||
124710732|NCT00269113|448567669|FG001|Overall Study|Protocol Violation|5|||
124710733|NCT00269113|448567668|FG000|Overall Study|Other|0|||
124710734|NCT00269113|448567669|FG001|Overall Study|Other|2|||
124968097|NCT01216072|449511323|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
124968098|NCT04294667|449511325|FG000|Overall Study|Lack of Efficacy|4|||
124968099|NCT04294667|449511326|FG001|Overall Study|Lack of Efficacy|4|||
124968100|NCT04294667|449511325|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
124968101|NCT04294667|449511326|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
124968102|NCT04294667|449511325|FG000|Overall Study|Patient has a Renal Flare|1|||
124968103|NCT04294667|449511326|FG001|Overall Study|Patient has a Renal Flare|0|||
124968104|NCT04294667|449511325|FG000|Overall Study|SLE Worsening|0|||
124968105|NCT04294667|449511326|FG001|Overall Study|SLE Worsening|1|||
124968106|NCT04294667|449511325|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
124968107|NCT04294667|449511326|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
124968108|NCT04294667|449511325|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
124968109|NCT04294667|449511326|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
124968110|NCT04294667|449511325|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
124968111|NCT04294667|449511326|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
124968112|NCT04294667|449511325|FG000|Overall Study|Subject Moved to Another State|0|||
124968113|NCT04294667|449511326|FG001|Overall Study|Subject Moved to Another State|1|||
124968114|NCT04294667|449511325|FG000|Overall Study|Adverse event, serious fatal|0|||
124968115|NCT04294667|449511326|FG001|Overall Study|Adverse event, serious fatal|1|||
124968116|NCT04294667|449511325|FG000|Overall Study|Adverse event, non-fatal|3|||
124968117|NCT04294667|449511326|FG001|Overall Study|Adverse event, non-fatal|4|||
124968118|NCT04799418|449511327|FG000|Overall Study|Death|1|||
124968119|NCT04799418|449511328|FG001|Overall Study|Death|1|||
124466051|NCT00903929|447664549|FG003|Overall Study|Adverse Event|1|||
124466052|NCT03208231|447664550|FG000|Overall Study|Death|1|||
124710735|NCT00652743|448567670|FG000|Months 12-18|Lost to Follow-up|1|||
124968120|NCT04799418|449511327|FG000|Overall Study|Lack of Efficacy|14|||
124968121|NCT04799418|449511328|FG001|Overall Study|Lack of Efficacy|14|||
124968122|NCT04799418|449511327|FG000|Overall Study|Withdrawal by Subject|10|||
124968123|NCT04799418|449511328|FG001|Overall Study|Withdrawal by Subject|7|||
124968124|NCT04799418|449511327|FG000|Overall Study|Adverse Event|3|||
124968125|NCT04799418|449511328|FG001|Overall Study|Adverse Event|2|||
124968126|NCT00952848|449511331|FG000|Overall Study|Withdrawal by Subject|4|||
124466053|NCT03208231|447664551|FG001|Overall Study|Death|2|||
124710736|NCT00652743|448567671|FG001|Months 12-18|Lost to Follow-up|2|||
124710737|NCT00652743|448567672|FG002|Months 12-18|Lost to Follow-up|7|||
124710738|NCT00652743|448567670|FG000|Months 24-30|Other|5|||
124710739|NCT00652743|448567671|FG001|Months 24-30|Other|1|||
124710740|NCT00652743|448567672|FG002|Months 24-30|Other|11|||
124710741|NCT00652743|448567670|FG000|Months 36-42|Serious Adverse Events|0|||
124710742|NCT00652743|448567671|FG001|Months 36-42|Serious Adverse Events|1|||
124710743|NCT00652743|448567672|FG002|Months 36-42|Serious Adverse Events|1|||
124710744|NCT00652743|448567670|FG000|Months 36-42|Withdrawal by Subject|1|||
124710745|NCT00652743|448567671|FG001|Months 36-42|Withdrawal by Subject|1|||
124710746|NCT00652743|448567672|FG002|Months 36-42|Withdrawal by Subject|0|||
124710747|NCT00652743|448567670|FG000|Months 36-42|Lost to Follow-up|0|||
124710748|NCT00652743|448567671|FG001|Months 36-42|Lost to Follow-up|1|||
124710749|NCT00652743|448567672|FG002|Months 36-42|Lost to Follow-up|0|||
124710750|NCT00652743|448567670|FG000|Months 36-42|Migrated/moved from study area|1|||
124710751|NCT00652743|448567671|FG001|Months 36-42|Migrated/moved from study area|0|||
124710752|NCT00652743|448567672|FG002|Months 36-42|Migrated/moved from study area|0|||
124710753|NCT00652743|448567670|FG000|Months 36-42|Other|4|||
124710754|NCT00652743|448567671|FG001|Months 36-42|Other|2|||
124710755|NCT00652743|448567672|FG002|Months 36-42|Other|8|||
124710756|NCT05111145|448567677|FG000|Overall Study|Commercial drug is available for participant|76|||
124710757|NCT05111145|448567677|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
124710758|NCT02336815|448567678|FG000|Overall Study|Disease Progression|45|||
124550580|NCT01186744|447972992|FG004|Overall Study|Study terminated by Sponsor|0|||
124550581|NCT01186744|447972993|FG005|Overall Study|Study terminated by Sponsor|0|||
124968127|NCT00537329|449511332|FG000|Overall Study|Death|10|||
124968128|NCT00537329|449511332|FG000|Overall Study|Adverse Event|3|||
124968129|NCT00537329|449511332|FG000|Overall Study|Lack of Efficacy|2|||
124968130|NCT00537329|449511332|FG000|Overall Study|Lost to Follow-up|6|||
124968131|NCT00537329|449511332|FG000|Overall Study|Withdrawal by Subject|4|||
124968132|NCT00537329|449511332|FG000|Overall Study|Other|1|||
124550582|NCT01186744|447972988|FG000|Overall Study|Other|9|||
124550583|NCT01186744|447972989|FG001|Overall Study|Other|10|||
124550584|NCT01186744|447972990|FG002|Overall Study|Other|1|||
124550585|NCT01186744|447972991|FG003|Overall Study|Other|2|||
124550586|NCT01186744|447972992|FG004|Overall Study|Other|1|||
124550587|NCT01186744|447972993|FG005|Overall Study|Other|5|||
124550588|NCT01186744|447972988|FG000|Overall Study|Adverse Event|10|||
124550589|NCT01186744|447972989|FG001|Overall Study|Adverse Event|14|||
124968133|NCT02049515|449511333|FG000|Overall Study|Adverse Event|46|||
124968134|NCT02049515|449511334|FG001|Overall Study|Adverse Event|2|||
124968135|NCT02049515|449511333|FG000|Overall Study|Protocol-specified Disease Progression|23|||
124968136|NCT02049515|449511334|FG001|Overall Study|Protocol-specified Disease Progression|2|||
124968137|NCT02049515|449511333|FG000|Overall Study|Death|6|||
124968138|NCT02049515|449511334|FG001|Overall Study|Death|0|||
124968139|NCT02049515|449511333|FG000|Overall Study|Physician Decision|5|||
124968140|NCT02049515|449511334|FG001|Overall Study|Physician Decision|1|||
124968141|NCT02049515|449511333|FG000|Overall Study|Withdrawal by Subject|3|||
124968142|NCT02049515|449511334|FG001|Overall Study|Withdrawal by Subject|0|||
124968143|NCT02049515|449511333|FG000|Overall Study|Termination of the Study by Sponsor|2|||
124968144|NCT02049515|449511334|FG001|Overall Study|Termination of the Study by Sponsor|0|||
124968145|NCT02049515|449511333|FG000|Overall Study|Protocol Violation|1|||
124968146|NCT02049515|449511334|FG001|Overall Study|Protocol Violation|1|||
124968147|NCT02049515|449511333|FG000|Overall Study|Clinical Deterioration|1|||
124968148|NCT02049515|449511334|FG001|Overall Study|Clinical Deterioration|0|||
124968149|NCT02049515|449511333|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
124968150|NCT02049515|449511334|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
124968151|NCT02049515|449511333|FG000|Overall Study|Treatment Interruption >42 Days|1|||
124710759|NCT02336815|448567679|FG001|Overall Study|Disease Progression|70|||
124710760|NCT02336815|448567678|FG000|Overall Study|Adverse Event|18|||
124550590|NCT01186744|447972990|FG002|Overall Study|Adverse Event|1|||
124550591|NCT01186744|447972991|FG003|Overall Study|Adverse Event|0|||
124550592|NCT01186744|447972992|FG004|Overall Study|Adverse Event|1|||
124550593|NCT01186744|447972993|FG005|Overall Study|Adverse Event|4|||
124550594|NCT01186744|447972988|FG000|Overall Study|Death|1|||
124710761|NCT02336815|448567679|FG001|Overall Study|Adverse Event|39|||
124710762|NCT02336815|448567678|FG000|Overall Study|Physician Decision|11|||
124710763|NCT02336815|448567679|FG001|Overall Study|Physician Decision|4|||
124710764|NCT02336815|448567678|FG000|Overall Study|Withdrawal by Subject|3|||
124968152|NCT02049515|449511334|FG001|Overall Study|Treatment Interruption >42 Days|0|||
124968153|NCT02049515|449511333|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
124968154|NCT02049515|449511334|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
124968155|NCT02138253|449511336|FG000|Overall Study|Adverse Event|3|||
124968156|NCT02138253|449511337|FG001|Overall Study|Adverse Event|3|||
124968157|NCT02138253|449511336|FG000|Overall Study|Lost to Follow-up|2|||
124968158|NCT02138253|449511337|FG001|Overall Study|Lost to Follow-up|1|||
124550595|NCT01186744|447972989|FG001|Overall Study|Death|0|||
124968159|NCT02138253|449511336|FG000|Overall Study|Physician Decision|2|||
124968160|NCT02138253|449511337|FG001|Overall Study|Physician Decision|0|||
124968161|NCT02138253|449511336|FG000|Overall Study|Non compliance|1|||
124968162|NCT02138253|449511337|FG001|Overall Study|Non compliance|0|||
124968163|NCT02138253|449511336|FG000|Overall Study|Withdrawal by Subject|1|||
124968164|NCT02138253|449511337|FG001|Overall Study|Withdrawal by Subject|0|||
124968165|NCT01426113|449511338|FG000|Overall Study|Study Discontinued|1|||
124968166|NCT01426113|449511339|FG001|Overall Study|Study Discontinued|1|||
124968167|NCT01426113|449511338|FG000|Overall Study|Adverse Event|0|||
124968168|NCT01426113|449511339|FG001|Overall Study|Adverse Event|1|||
124968169|NCT00224029|449511340|FG000|Overall Study|Lost to Follow-up|1|||
124968170|NCT00224029|449511340|FG000|Overall Study|Withdrawal by Subject|4|||
124968171|NCT00224029|449511340|FG000|Overall Study|Other|1|||
124968172|NCT02872012|449511341|FG000|Overall Study|Withdrawal by Subject|1|||
124968173|NCT02872012|449511342|FG001|Overall Study|Withdrawal by Subject|0|||
124968174|NCT02872012|449511343|FG002|Overall Study|Withdrawal by Subject|0|||
124968175|NCT02872012|449511344|FG003|Overall Study|Withdrawal by Subject|0|||
124968176|NCT02872012|449511345|FG004|Overall Study|Withdrawal by Subject|0|||
124968177|NCT02725528|449511348|FG000|Overall Study|Lost to Follow-up|1|||
124968178|NCT02725528|449511349|FG001|Overall Study|Lost to Follow-up|4|||
124968179|NCT02725528|449511348|FG000|Overall Study|Withdrawal by Subject|0|||
124968180|NCT02725528|449511349|FG001|Overall Study|Withdrawal by Subject|1|||
124968181|NCT02569957|449511350|FG000|Overall Study|Withdrawal by Subject|0|||
124968182|NCT02569957|449511351|FG001|Overall Study|Withdrawal by Subject|1|||
124968183|NCT02635386|449511352|FG000|Overall Study|Pregnancy|2|||
124968184|NCT02635386|449511353|FG001|Overall Study|Pregnancy|0|||
124968185|NCT02635386|449511354|FG002|Overall Study|Pregnancy|0|||
124968186|NCT02635386|449511355|FG003|Overall Study|Pregnancy|0|||
124968187|NCT02635386|449511356|FG004|Overall Study|Pregnancy|2|||
124968188|NCT02635386|449511352|FG000|Overall Study|Withdrawal by Subject|1|||
124968189|NCT02635386|449511353|FG001|Overall Study|Withdrawal by Subject|1|||
124968190|NCT02635386|449511354|FG002|Overall Study|Withdrawal by Subject|0|||
124968191|NCT02635386|449511355|FG003|Overall Study|Withdrawal by Subject|1|||
124968192|NCT02635386|449511356|FG004|Overall Study|Withdrawal by Subject|0|||
124968193|NCT02635386|449511352|FG000|Overall Study|Physician Decision|0|||
124968194|NCT02635386|449511353|FG001|Overall Study|Physician Decision|1|||
124968195|NCT02635386|449511354|FG002|Overall Study|Physician Decision|0|||
124466054|NCT03208231|447664550|FG000|Overall Study|Moved and unable to get to clinic|1|||
124466055|NCT03208231|447664551|FG001|Overall Study|Moved and unable to get to clinic|0|||
124466056|NCT03208231|447664550|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
124466057|NCT03208231|447664551|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
124466058|NCT02158091|447664557|FG000|Overall Study|DLT|2|||
124466059|NCT02158091|447664558|FG001|Overall Study|DLT|1|||
124466060|NCT02158091|447664559|FG002|Overall Study|DLT|0|||
124466061|NCT01358864|447664560|FG000|Overall Study|Adverse Event|0|||
124466062|NCT01358864|447664561|FG001|Overall Study|Adverse Event|6|||
124466063|NCT01358864|447664562|FG002|Overall Study|Adverse Event|9|||
124466064|NCT01358864|447664563|FG003|Overall Study|Adverse Event|0|||
124466065|NCT01358864|447664564|FG004|Overall Study|Adverse Event|4|||
124466066|NCT01358864|447664565|FG005|Overall Study|Adverse Event|8|||
124466067|NCT01358864|447664566|FG006|Overall Study|Adverse Event|12|||
124466068|NCT01358864|447664567|FG007|Overall Study|Adverse Event|7|||
124466069|NCT01358864|447664560|FG000|Overall Study|Lack of Efficacy|26|||
124466070|NCT01358864|447664561|FG001|Overall Study|Lack of Efficacy|3|||
124466071|NCT01358864|447664562|FG002|Overall Study|Lack of Efficacy|4|||
124466072|NCT01358864|447664563|FG003|Overall Study|Lack of Efficacy|19|||
124466073|NCT01358864|447664564|FG004|Overall Study|Lack of Efficacy|7|||
124466074|NCT01358864|447664565|FG005|Overall Study|Lack of Efficacy|4|||
124466075|NCT01358864|447664566|FG006|Overall Study|Lack of Efficacy|49|||
124466076|NCT01358864|447664567|FG007|Overall Study|Lack of Efficacy|44|||
124466077|NCT01358864|447664560|FG000|Overall Study|Lost to Follow-up|0|||
124466078|NCT01358864|447664561|FG001|Overall Study|Lost to Follow-up|0|||
124466079|NCT01358864|447664562|FG002|Overall Study|Lost to Follow-up|1|||
124466080|NCT01358864|447664563|FG003|Overall Study|Lost to Follow-up|0|||
124466081|NCT01358864|447664564|FG004|Overall Study|Lost to Follow-up|0|||
124466082|NCT01358864|447664565|FG005|Overall Study|Lost to Follow-up|0|||
124466083|NCT01358864|447664566|FG006|Overall Study|Lost to Follow-up|0|||
124466084|NCT01358864|447664567|FG007|Overall Study|Lost to Follow-up|1|||
124466085|NCT01358864|447664560|FG000|Overall Study|Withdrawal by Subject|3|||
124466086|NCT01358864|447664561|FG001|Overall Study|Withdrawal by Subject|4|||
124466087|NCT01358864|447664562|FG002|Overall Study|Withdrawal by Subject|2|||
124466088|NCT01358864|447664563|FG003|Overall Study|Withdrawal by Subject|0|||
124466089|NCT01358864|447664564|FG004|Overall Study|Withdrawal by Subject|0|||
124466090|NCT01358864|447664565|FG005|Overall Study|Withdrawal by Subject|1|||
124466091|NCT01358864|447664566|FG006|Overall Study|Withdrawal by Subject|1|||
124466092|NCT01358864|447664567|FG007|Overall Study|Withdrawal by Subject|3|||
124466093|NCT01358864|447664560|FG000|Overall Study|Other reason not defined above|2|||
124466094|NCT01358864|447664561|FG001|Overall Study|Other reason not defined above|0|||
124968196|NCT02635386|449511355|FG003|Overall Study|Physician Decision|0|||
124968197|NCT02635386|449511356|FG004|Overall Study|Physician Decision|0|||
124710765|NCT02336815|448567679|FG001|Overall Study|Withdrawal by Subject|2|||
124710766|NCT02336815|448567678|FG000|Overall Study|Lost to Follow-up|1|||
124710767|NCT02336815|448567679|FG001|Overall Study|Lost to Follow-up|3|||
124710768|NCT02336815|448567678|FG000|Overall Study|Other|1|||
124710769|NCT02336815|448567679|FG001|Overall Study|Other|5|||
124710770|NCT00952705|448567680|FG000|Overall Study|Lost to Follow-up|24|||
124710771|NCT00952705|448567681|FG001|Overall Study|Lost to Follow-up|8|||
124710772|NCT00952705|448567682|FG002|Overall Study|Lost to Follow-up|9|||
124710773|NCT00952705|448567680|FG000|Overall Study|Withdrawal by Subject|2|||
124710774|NCT00952705|448567681|FG001|Overall Study|Withdrawal by Subject|1|||
124710775|NCT00952705|448567682|FG002|Overall Study|Withdrawal by Subject|1|||
124710776|NCT00952705|448567680|FG000|Overall Study|Death|2|||
124710777|NCT00952705|448567681|FG001|Overall Study|Death|0|||
124710778|NCT00952705|448567682|FG002|Overall Study|Death|0|||
124710779|NCT00952705|448567680|FG000|Overall Study|Incarcerated post dose|5|||
124710780|NCT00952705|448567681|FG001|Overall Study|Incarcerated post dose|0|||
124710781|NCT00952705|448567682|FG002|Overall Study|Incarcerated post dose|0|||
124710782|NCT00952705|448567680|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
124710783|NCT00952705|448567681|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
124710784|NCT00952705|448567682|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
124710785|NCT03759600|448567684|FG000|Overall Study|Adverse Event|2|||
124710786|NCT03759600|448567684|FG000|Overall Study|Progressive Disease|15|||
124710787|NCT03759600|448567684|FG000|Overall Study|Site Terminated by Sponsor|3|||
124968198|NCT02635386|449511352|FG000|Overall Study|Moved Out of State|0|||
124968199|NCT02635386|449511353|FG001|Overall Study|Moved Out of State|1|||
124968200|NCT02635386|449511354|FG002|Overall Study|Moved Out of State|0|||
124968201|NCT02635386|449511355|FG003|Overall Study|Moved Out of State|0|||
124968202|NCT02635386|449511356|FG004|Overall Study|Moved Out of State|0|||
124968203|NCT02635386|449511352|FG000|Overall Study|Noncompliant|0|||
124968204|NCT02635386|449511353|FG001|Overall Study|Noncompliant|2|||
124968205|NCT02635386|449511354|FG002|Overall Study|Noncompliant|1|||
124968206|NCT02635386|449511355|FG003|Overall Study|Noncompliant|1|||
124968207|NCT02635386|449511356|FG004|Overall Study|Noncompliant|1|||
124968208|NCT02635386|449511352|FG000|Overall Study|side effects|0|||
124968209|NCT02635386|449511353|FG001|Overall Study|side effects|0|||
124968210|NCT02635386|449511354|FG002|Overall Study|side effects|1|||
124968211|NCT02635386|449511355|FG003|Overall Study|side effects|4|||
124968212|NCT02635386|449511356|FG004|Overall Study|side effects|6|||
124968213|NCT02635386|449511352|FG000|Overall Study|needed other major surgery|0|||
124710788|NCT05173974|448567685|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
124710789|NCT05173974|448567686|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
124710790|NCT05173974|448567687|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
124968214|NCT02635386|449511353|FG001|Overall Study|needed other major surgery|1|||
124968215|NCT02635386|449511354|FG002|Overall Study|needed other major surgery|0|||
124968216|NCT02635386|449511355|FG003|Overall Study|needed other major surgery|0|||
124968217|NCT02635386|449511356|FG004|Overall Study|needed other major surgery|0|||
124968218|NCT02635386|449511352|FG000|Overall Study|Other medical problems not drug related|0|||
124968219|NCT02635386|449511353|FG001|Overall Study|Other medical problems not drug related|0|||
124710791|NCT05173974|448567688|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
124710792|NCT05173974|448567685|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
124710793|NCT05173974|448567686|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
124710794|NCT05173974|448567687|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
124710795|NCT05173974|448567688|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
124710796|NCT03257358|448567690|FG000|Overall Study|Adverse Event|25|||
124710797|NCT03257358|448567691|FG001|Overall Study|Adverse Event|12|||
124710798|NCT03257358|448567690|FG000|Overall Study|Lack of Efficacy|1|||
124710799|NCT03257358|448567691|FG001|Overall Study|Lack of Efficacy|1|||
124710800|NCT03257358|448567690|FG000|Overall Study|Lost to Follow-up|12|||
124710801|NCT03257358|448567691|FG001|Overall Study|Lost to Follow-up|4|||
124710802|NCT03257358|448567690|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
124710803|NCT03257358|448567691|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
124710804|NCT03257358|448567690|FG000|Overall Study|Physician Decision|2|||
124710805|NCT03257358|448567691|FG001|Overall Study|Physician Decision|2|||
124710806|NCT03257358|448567690|FG000|Overall Study|Protocol Violation|5|||
124710807|NCT03257358|448567691|FG001|Overall Study|Protocol Violation|3|||
124710808|NCT03257358|448567690|FG000|Overall Study|Technical problems|4|||
124710809|NCT03257358|448567691|FG001|Overall Study|Technical problems|1|||
124710810|NCT03257358|448567690|FG000|Overall Study|Withdrawal by Subject|8|||
124710811|NCT03257358|448567691|FG001|Overall Study|Withdrawal by Subject|3|||
124710812|NCT03257358|448567690|FG000|Overall Study|Withdrawal of informed consent|9|||
124710813|NCT03257358|448567691|FG001|Overall Study|Withdrawal of informed consent|5|||
124710814|NCT03257358|448567690|FG000|Overall Study|New therapy for study indication|1|||
124710815|NCT03257358|448567691|FG001|Overall Study|New therapy for study indication|0|||
124710816|NCT03257358|448567690|FG000|Overall Study|No longer requires treatment|0|||
124710817|NCT03257358|448567691|FG001|Overall Study|No longer requires treatment|1|||
124710818|NCT03289143|448567692|FG000|Overall Study|Caregiver Unavailability|1|||
124710819|NCT03289143|448567693|FG001|Overall Study|Caregiver Unavailability|1|||
124710820|NCT03289143|448567694|FG002|Overall Study|Caregiver Unavailability|0|||
124710821|NCT03289143|448567695|FG003|Overall Study|Caregiver Unavailability|0|||
124710822|NCT03289143|448567692|FG000|Overall Study|Research Department Closure|0|||
124710823|NCT03289143|448567693|FG001|Overall Study|Research Department Closure|0|||
124710824|NCT03289143|448567694|FG002|Overall Study|Research Department Closure|1|||
124710825|NCT03289143|448567695|FG003|Overall Study|Research Department Closure|0|||
124710826|NCT03289143|448567692|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
124710827|NCT03289143|448567693|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
124710828|NCT03289143|448567694|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
124710829|NCT03289143|448567695|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
124710830|NCT03289143|448567692|FG000|Overall Study|Medical Monitor Decision|1|||
124710831|NCT03289143|448567693|FG001|Overall Study|Medical Monitor Decision|0|||
124710832|NCT03289143|448567694|FG002|Overall Study|Medical Monitor Decision|0|||
124710833|NCT03289143|448567695|FG003|Overall Study|Medical Monitor Decision|0|||
124710834|NCT03289143|448567692|FG000|Overall Study|Participant Non-Compliance|0|||
124710835|NCT03289143|448567693|FG001|Overall Study|Participant Non-Compliance|0|||
124710836|NCT03289143|448567694|FG002|Overall Study|Participant Non-Compliance|1|||
124710837|NCT03289143|448567695|FG003|Overall Study|Participant Non-Compliance|0|||
124710838|NCT03289143|448567692|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
124710839|NCT03289143|448567693|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
124710840|NCT03289143|448567694|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
124710841|NCT03289143|448567695|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
124710842|NCT03289143|448567692|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
124710843|NCT03289143|448567693|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
124710844|NCT03289143|448567694|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
124710845|NCT03289143|448567695|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
124710846|NCT03289143|448567692|FG000|Overall Study|Caregiver Passed Away|1|||
124710847|NCT03289143|448567693|FG001|Overall Study|Caregiver Passed Away|0|||
124710848|NCT03289143|448567694|FG002|Overall Study|Caregiver Passed Away|0|||
124710849|NCT03289143|448567695|FG003|Overall Study|Caregiver Passed Away|0|||
124968220|NCT02635386|449511354|FG002|Overall Study|Other medical problems not drug related|0|||
124968221|NCT02635386|449511355|FG003|Overall Study|Other medical problems not drug related|1|||
124968222|NCT02635386|449511356|FG004|Overall Study|Other medical problems not drug related|0|||
124710850|NCT03289143|448567692|FG000|Overall Study|Physician Decision|0|||
124710851|NCT03289143|448567693|FG001|Overall Study|Physician Decision|2|||
124710852|NCT03289143|448567694|FG002|Overall Study|Physician Decision|2|||
124710853|NCT03289143|448567695|FG003|Overall Study|Physician Decision|2|||
124710854|NCT03289143|448567692|FG000|Overall Study|Protocol Deviation|2|||
124710855|NCT03289143|448567693|FG001|Overall Study|Protocol Deviation|1|||
124710856|NCT03289143|448567694|FG002|Overall Study|Protocol Deviation|3|||
124550596|NCT01186744|447972990|FG002|Overall Study|Death|0|||
124550597|NCT01186744|447972991|FG003|Overall Study|Death|0|||
124550598|NCT01186744|447972992|FG004|Overall Study|Death|0|||
124550599|NCT01186744|447972993|FG005|Overall Study|Death|0|||
124550600|NCT01020773|447972996|FG000|Overall Study|Withdrawal by Subject|4|||
124550601|NCT01020773|447972997|FG001|Overall Study|Withdrawal by Subject|3|||
124550602|NCT02675426|447972998|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
124550603|NCT02675426|447972999|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
124550604|NCT02675426|447973000|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
124550605|NCT02675426|447973001|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
124550606|NCT02675426|447972998|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
124550607|NCT02675426|447972999|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
124550608|NCT02675426|447973000|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
124550609|NCT02675426|447973001|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
124550610|NCT02675426|447972998|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
124550611|NCT02675426|447972999|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
124550612|NCT02675426|447973000|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
124550613|NCT02675426|447973001|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
124550614|NCT02675426|447972998|FG000|Period 1: Week 1 to Week 12|Other|2|||
124550615|NCT02675426|447972999|FG001|Period 1: Week 1 to Week 12|Other|1|||
124550616|NCT02675426|447973000|FG002|Period 1: Week 1 to Week 12|Other|0|||
124550617|NCT02675426|447973001|FG003|Period 1: Week 1 to Week 12|Other|2|||
124550618|NCT02675426|447972998|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
124550619|NCT02675426|447972999|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
124550620|NCT02675426|447973000|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
124550621|NCT02675426|447973001|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
124550622|NCT02675426|447972998|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
124550623|NCT02675426|447972999|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
124550624|NCT02675426|447973000|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
124550625|NCT02675426|447973001|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
124968223|NCT01209598|449511357|FG000|Overall Study|Withdrawal by Subject|1|||
124968224|NCT01209598|449511358|FG001|Overall Study|Withdrawal by Subject|0|||
124968225|NCT02719743|449511359|FG000|Overall Study|Consent withdrawal|0|||
124710857|NCT03289143|448567695|FG003|Overall Study|Protocol Deviation|1|||
124710858|NCT03289143|448567692|FG000|Overall Study|Study Terminated By Sponsor|101|||
124710859|NCT03289143|448567693|FG001|Overall Study|Study Terminated By Sponsor|75|||
124710860|NCT03289143|448567694|FG002|Overall Study|Study Terminated By Sponsor|100|||
124710861|NCT03289143|448567695|FG003|Overall Study|Study Terminated By Sponsor|69|||
124710862|NCT03289143|448567692|FG000|Overall Study|Withdrawal by Subject|14|||
124710863|NCT03289143|448567693|FG001|Overall Study|Withdrawal by Subject|6|||
124710864|NCT03289143|448567694|FG002|Overall Study|Withdrawal by Subject|14|||
124710865|NCT03289143|448567695|FG003|Overall Study|Withdrawal by Subject|12|||
124710866|NCT03289143|448567692|FG000|Overall Study|Adverse Event|10|||
124710867|NCT03289143|448567693|FG001|Overall Study|Adverse Event|7|||
124710868|NCT03289143|448567694|FG002|Overall Study|Adverse Event|6|||
124710869|NCT03289143|448567695|FG003|Overall Study|Adverse Event|5|||
124710870|NCT03289143|448567692|FG000|Overall Study|Death|2|||
124710871|NCT03289143|448567693|FG001|Overall Study|Death|0|||
124710872|NCT03289143|448567694|FG002|Overall Study|Death|2|||
124710873|NCT03289143|448567695|FG003|Overall Study|Death|1|||
124710874|NCT03289143|448567692|FG000|Overall Study|Lost to Follow-up|2|||
124710875|NCT03289143|448567693|FG001|Overall Study|Lost to Follow-up|1|||
124710876|NCT03289143|448567694|FG002|Overall Study|Lost to Follow-up|1|||
124710877|NCT03289143|448567695|FG003|Overall Study|Lost to Follow-up|0|||
124710878|NCT03289143|448567692|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
124710879|NCT03289143|448567693|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
124710880|NCT03289143|448567694|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
124710881|NCT03289143|448567695|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
124710882|NCT03289143|448567692|FG000|Overall Study|Withdrawal by Caregiver|0|||
124710883|NCT03289143|448567693|FG001|Overall Study|Withdrawal by Caregiver|1|||
124710884|NCT03289143|448567694|FG002|Overall Study|Withdrawal by Caregiver|0|||
124968226|NCT02719743|449511360|FG001|Overall Study|Consent withdrawal|2|||
124968227|NCT02719743|449511361|FG002|Overall Study|Consent withdrawal|0|||
124710885|NCT03289143|448567695|FG003|Overall Study|Withdrawal by Caregiver|0|||
124710886|NCT03289143|448567692|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
124710887|NCT03289143|448567693|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
124550626|NCT02675426|447972998|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
124550627|NCT02675426|447972999|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
124550628|NCT02675426|447973000|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
124550629|NCT02675426|447973001|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
124550630|NCT02675426|447972998|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
124710888|NCT03289143|448567694|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
124710889|NCT03289143|448567695|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
124968228|NCT02719743|449511362|FG003|Overall Study|Consent withdrawal|1|||
124550631|NCT02675426|447972999|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
124550632|NCT02675426|447973000|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
124550633|NCT02675426|447973001|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
124550634|NCT02675426|447972998|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
124550635|NCT02675426|447972999|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
124550636|NCT02675426|447973000|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
124550637|NCT02675426|447973001|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
124550638|NCT02675426|447972998|FG000|Period 2: Week 12 to Week 260|Other|8|||
124550639|NCT02675426|447972999|FG001|Period 2: Week 12 to Week 260|Other|12|||
124550640|NCT02675426|447973000|FG002|Period 2: Week 12 to Week 260|Other|23|||
124550641|NCT02675426|447973001|FG003|Period 2: Week 12 to Week 260|Other|15|||
124550642|NCT00953927|447973002|FG000|Overall Study|Lost to Follow-up|61|||
124550643|NCT00953927|447973003|FG001|Overall Study|Lost to Follow-up|65|||
124550644|NCT00953927|447973002|FG000|Overall Study|Withdrawal by Subject|36|||
124550645|NCT00953927|447973003|FG001|Overall Study|Withdrawal by Subject|25|||
124550646|NCT00953927|447973002|FG000|Overall Study|Death|7|||
124550647|NCT00953927|447973003|FG001|Overall Study|Death|4|||
124550648|NCT00953927|447973002|FG000|Overall Study|Other study discontinuation|1|||
124550649|NCT00953927|447973003|FG001|Overall Study|Other study discontinuation|1|||
124550650|NCT01652573|447973004|FG000|Overall Study|Adverse Event|0|||
124550651|NCT01652573|447973005|FG001|Overall Study|Adverse Event|1|||
124550652|NCT00934622|447973006|FG000|Overall Study|Lost to Follow-up|7|||
124550653|NCT00934622|447973006|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
124550654|NCT01856686|447973011|FG000|Overall Study|Lost to Follow-up|5|||
124550655|NCT01856686|447973012|FG001|Overall Study|Lost to Follow-up|11|||
124550656|NCT03284424|447973013|FG000|Overall Study|Death|70|||
124550657|NCT03284424|447973014|FG001|Overall Study|Death|24|||
124550658|NCT03284424|447973013|FG000|Overall Study|Lost to Follow-up|3|||
124550659|NCT03284424|447973014|FG001|Overall Study|Lost to Follow-up|1|||
124550660|NCT03284424|447973013|FG000|Overall Study|Physician Decision|1|||
124550661|NCT03284424|447973014|FG001|Overall Study|Physician Decision|2|||
124550662|NCT03284424|447973013|FG000|Overall Study|Withdrawal by Subject|4|||
124550663|NCT03284424|447973014|FG001|Overall Study|Withdrawal by Subject|5|||
124550664|NCT03284424|447973013|FG000|Overall Study|Sponsor's decision|27|||
124550665|NCT03284424|447973014|FG001|Overall Study|Sponsor's decision|22|||
124550666|NCT00602979|447973017|FG000|Overall Study|Lost to Follow-up|3|||
124550667|NCT00602979|447973018|FG001|Overall Study|Lost to Follow-up|2|||
124550668|NCT00602979|447973019|FG002|Overall Study|Lost to Follow-up|3|||
124550669|NCT00602979|447973020|FG003|Overall Study|Lost to Follow-up|2|||
124550670|NCT00602979|447973021|FG004|Overall Study|Lost to Follow-up|3|||
124550671|NCT00602979|447973017|FG000|Overall Study|Failed Intubation|0|||
124550672|NCT00602979|447973018|FG001|Overall Study|Failed Intubation|1|||
124550673|NCT00602979|447973019|FG002|Overall Study|Failed Intubation|0|||
124968229|NCT02719743|449511363|FG004|Overall Study|Consent withdrawal|0|||
124968230|NCT02719743|449511359|FG000|Overall Study|Migrated/moved from study area|0|||
124968231|NCT02719743|449511360|FG001|Overall Study|Migrated/moved from study area|0|||
124550674|NCT00602979|447973020|FG003|Overall Study|Failed Intubation|1|||
124550675|NCT00602979|447973021|FG004|Overall Study|Failed Intubation|0|||
124550676|NCT02962739|447973022|FG000|Overall Study|Withdrawal by Subject|0|||
124550677|NCT02962739|447973023|FG001|Overall Study|Withdrawal by Subject|1|||
124550678|NCT02962739|447973024|FG002|Overall Study|Withdrawal by Subject|0|||
124710890|NCT03289143|448567692|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
124710891|NCT03289143|448567693|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
124710892|NCT03289143|448567694|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
124710893|NCT03289143|448567695|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
124710894|NCT00730756|448567696|FG000|Overall Study|Adverse Event|2|||
124710895|NCT00730756|448567697|FG001|Overall Study|Adverse Event|0|||
124710896|NCT00730756|448567696|FG000|Overall Study|Lack of Efficacy|1|||
124710897|NCT00730756|448567697|FG001|Overall Study|Lack of Efficacy|1|||
124710898|NCT00730756|448567696|FG000|Overall Study|Protocol Deviation|1|||
124710899|NCT00730756|448567697|FG001|Overall Study|Protocol Deviation|2|||
124710900|NCT00730756|448567696|FG000|Overall Study|Lost to Follow-up|0|||
124710901|NCT00730756|448567697|FG001|Overall Study|Lost to Follow-up|1|||
124710902|NCT00730756|448567696|FG000|Overall Study|Withdrew Consent|0|||
124710903|NCT00730756|448567697|FG001|Overall Study|Withdrew Consent|1|||
124710904|NCT00305877|448567698|FG000|Overall Study|Lack of Efficacy|6|||
124710905|NCT00305877|448567699|FG001|Overall Study|Lack of Efficacy|9|||
124710906|NCT00305877|448567698|FG000|Overall Study|Adverse Event|9|||
124710907|NCT00305877|448567699|FG001|Overall Study|Adverse Event|14|||
124710908|NCT00305877|448567698|FG000|Overall Study|Death|0|||
124550679|NCT02962739|447973025|FG003|Overall Study|Withdrawal by Subject|0|||
124550680|NCT02962739|447973026|FG004|Overall Study|Withdrawal by Subject|0|||
124550681|NCT02962739|447973027|FG005|Overall Study|Withdrawal by Subject|0|||
124550682|NCT02962739|447973022|FG000|Overall Study|Protocol Violation|0|||
124710909|NCT00305877|448567699|FG001|Overall Study|Death|1|||
124968232|NCT02719743|449511361|FG002|Overall Study|Migrated/moved from study area|0|||
124710910|NCT00305877|448567698|FG000|Overall Study|Withdrawal by Subject|4|||
124710911|NCT00305877|448567699|FG001|Overall Study|Withdrawal by Subject|2|||
124710912|NCT00305877|448567698|FG000|Overall Study|Physician Decision|1|||
124710913|NCT00305877|448567699|FG001|Overall Study|Physician Decision|1|||
124710914|NCT00305877|448567698|FG000|Overall Study|Never start treatment|2|||
124710915|NCT00305877|448567699|FG001|Overall Study|Never start treatment|5|||
124710916|NCT00305877|448567698|FG000|Overall Study|Ineligible|2|||
124710917|NCT00305877|448567699|FG001|Overall Study|Ineligible|1|||
124710918|NCT00305877|448567698|FG000|Overall Study|Transportation issue with daily RT|0|||
124710919|NCT00305877|448567699|FG001|Overall Study|Transportation issue with daily RT|1|||
124710920|NCT01126190|448567702|FG000|Double-Blind Phase|Death|0|||
124710921|NCT01126190|448567703|FG001|Double-Blind Phase|Death|1|||
124710922|NCT01126190|448567704|FG002|Double-Blind Phase|Death|0|||
124550683|NCT02962739|447973023|FG001|Overall Study|Protocol Violation|0|||
124550684|NCT02962739|447973024|FG002|Overall Study|Protocol Violation|1|||
124550685|NCT02962739|447973025|FG003|Overall Study|Protocol Violation|0|||
124550686|NCT02962739|447973026|FG004|Overall Study|Protocol Violation|1|||
124550687|NCT02962739|447973027|FG005|Overall Study|Protocol Violation|0|||
124550688|NCT01268683|447973031|FG000|Overall Study|Lost to Follow-up|1|||
124550689|NCT01268683|447973031|FG000|Overall Study|Death|1|||
124550690|NCT02216214|447973032|FG000|Overall Study|Randomized Never Received Study Drug|1|||
124550691|NCT02216214|447973033|FG001|Overall Study|Randomized Never Received Study Drug|0|||
124550692|NCT02216214|447973032|FG000|Overall Study|Adverse Event|10|||
124550693|NCT02216214|447973033|FG001|Overall Study|Adverse Event|8|||
124550694|NCT02216214|447973032|FG000|Overall Study|Lack of Efficacy|2|||
124550695|NCT02216214|447973033|FG001|Overall Study|Lack of Efficacy|2|||
124550696|NCT02216214|447973032|FG000|Overall Study|Lost to Follow-up|3|||
124550697|NCT02216214|447973033|FG001|Overall Study|Lost to Follow-up|2|||
124550698|NCT02216214|447973032|FG000|Overall Study|Protocol Violation|4|||
124550699|NCT02216214|447973033|FG001|Overall Study|Protocol Violation|2|||
124550700|NCT02216214|447973032|FG000|Overall Study|Withdrawal by Subject|22|||
124550701|NCT02216214|447973033|FG001|Overall Study|Withdrawal by Subject|20|||
124550702|NCT02216214|447973032|FG000|Overall Study|Study Terminated By Sponsor|0|||
124550703|NCT02216214|447973033|FG001|Overall Study|Study Terminated By Sponsor|1|||
124550704|NCT02216214|447973032|FG000|Overall Study|Miscellaneous|1|||
124550705|NCT02216214|447973033|FG001|Overall Study|Miscellaneous|1|||
124550706|NCT00713830|447973034|FG000|Overall Study|Adverse Event|23|||
124550707|NCT00713830|447973035|FG001|Overall Study|Adverse Event|71|||
124550708|NCT00713830|447973034|FG000|Overall Study|Lack of Efficacy|24|||
124550709|NCT00713830|447973035|FG001|Overall Study|Lack of Efficacy|16|||
124550710|NCT00713830|447973034|FG000|Overall Study|Lost to Follow-up|2|||
124550711|NCT00713830|447973035|FG001|Overall Study|Lost to Follow-up|9|||
124550712|NCT00713830|447973034|FG000|Overall Study|Withdrawal by Subject|13|||
124550713|NCT00713830|447973035|FG001|Overall Study|Withdrawal by Subject|23|||
124550714|NCT00713830|447973034|FG000|Overall Study|Poor Compliance to Protocol|7|||
124550715|NCT00713830|447973035|FG001|Overall Study|Poor Compliance to Protocol|14|||
124550716|NCT00713830|447973034|FG000|Overall Study|Familial and Personal Reasons|9|||
124550717|NCT00713830|447973035|FG001|Overall Study|Familial and Personal Reasons|34|||
124550718|NCT00713830|447973034|FG000|Overall Study|Sponsor Decision|4|||
124550719|NCT00713830|447973035|FG001|Overall Study|Sponsor Decision|10|||
124550720|NCT03981614|447973036|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
124550721|NCT03981614|447973037|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
124550722|NCT03981614|447973038|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
124550723|NCT00499252|447973039|FG000|Overall Study|Adverse Event|3|||
124550724|NCT00499252|447973039|FG000|Overall Study|Refused further treatment|2|||
124550725|NCT00499252|447973039|FG000|Overall Study|Ineligible|4|||
124550726|NCT00499252|447973039|FG000|Overall Study|<no further label>|3|||
124550727|NCT00566631|447973040|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
124550728|NCT00566631|447973040|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
124550729|NCT00566631|447973040|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
124550730|NCT00566631|447973040|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
124550731|NCT00566631|447973040|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
124550732|NCT00566631|447973040|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
124550733|NCT00566631|447973040|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
124550734|NCT00566631|447973040|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
124550735|NCT00566631|447973040|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
124550736|NCT00566631|447973040|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
124466095|NCT01358864|447664562|FG002|Overall Study|Other reason not defined above|0|||
124466096|NCT01358864|447664563|FG003|Overall Study|Other reason not defined above|0|||
124466097|NCT01358864|447664564|FG004|Overall Study|Other reason not defined above|0|||
124466098|NCT01358864|447664565|FG005|Overall Study|Other reason not defined above|0|||
124466099|NCT01358864|447664566|FG006|Overall Study|Other reason not defined above|2|||
124466100|NCT01358864|447664567|FG007|Overall Study|Other reason not defined above|0|||
124466101|NCT01358864|447664560|FG000|Overall Study|Not treated|0|||
124550737|NCT00566631|447973040|FG000|Part 2: Extension Phase|Adverse Event|11|||
124710923|NCT01126190|448567702|FG000|Double-Blind Phase|Adverse Event|1|||
124710924|NCT01126190|448567703|FG001|Double-Blind Phase|Adverse Event|2|||
124710925|NCT01126190|448567704|FG002|Double-Blind Phase|Adverse Event|0|||
124710926|NCT01126190|448567702|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
124710927|NCT01126190|448567703|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
124710928|NCT01126190|448567704|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
124710929|NCT01126190|448567702|FG000|Double-Blind Phase|Request of Investigator|1|||
124710930|NCT01126190|448567703|FG001|Double-Blind Phase|Request of Investigator|0|||
124710931|NCT01126190|448567704|FG002|Double-Blind Phase|Request of Investigator|0|||
124710932|NCT01126190|448567702|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
124710933|NCT01126190|448567703|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
124466102|NCT01358864|447664561|FG001|Overall Study|Not treated|0|||
124710934|NCT01126190|448567704|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
124710935|NCT01126190|448567702|FG000|Double-Blind Phase|Non-compliance|1|||
124710936|NCT01126190|448567703|FG001|Double-Blind Phase|Non-compliance|0|||
124710937|NCT01126190|448567704|FG002|Double-Blind Phase|Non-compliance|0|||
124710938|NCT01126190|448567702|FG000|Double-Blind Phase|Lost to Follow-up|1|||
124710939|NCT01126190|448567703|FG001|Double-Blind Phase|Lost to Follow-up|3|||
124710940|NCT01126190|448567704|FG002|Double-Blind Phase|Lost to Follow-up|0|||
124710941|NCT01126190|448567702|FG000|Open-Label Phase|Death|0|||
124710942|NCT01126190|448567703|FG001|Open-Label Phase|Death|0|||
124710943|NCT01126190|448567704|FG002|Open-Label Phase|Death|1|||
124710944|NCT01126190|448567702|FG000|Open-Label Phase|Adverse Event|0|||
124710945|NCT01126190|448567703|FG001|Open-Label Phase|Adverse Event|0|||
124710946|NCT01126190|448567704|FG002|Open-Label Phase|Adverse Event|4|||
124710947|NCT01126190|448567702|FG000|Open-Label Phase|Withdrawal by Subject|0|||
124710948|NCT01126190|448567703|FG001|Open-Label Phase|Withdrawal by Subject|0|||
124710949|NCT01126190|448567704|FG002|Open-Label Phase|Withdrawal by Subject|6|||
124710950|NCT00524121|448567705|FG000|Overall Study|Disease progression|6|||
124710951|NCT00524121|448567705|FG000|Overall Study|Adverse Event|4|||
124710952|NCT00524121|448567705|FG000|Overall Study|Patient refused|2|||
124710953|NCT00524121|448567705|FG000|Overall Study|Other|1|||
124710954|NCT00524121|448567705|FG000|Overall Study|Death|1|||
124710955|NCT00524121|448567705|FG000|Overall Study|Not treated (became ineligible)|4|||
124710956|NCT00524121|448567705|FG000|Overall Study|Not treated (changed mind)|1|||
124710957|NCT01114737|448567706|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
124710958|NCT01114737|448567707|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
124710959|NCT01114737|448567706|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
124710960|NCT01114737|448567707|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
124710961|NCT01114737|448567706|FG000|Randomized Treatment Period|Pregnancy|1|||
124710962|NCT01114737|448567707|FG001|Randomized Treatment Period|Pregnancy|0|||
124710963|NCT01114737|448567706|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
124710964|NCT01114737|448567707|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
124710965|NCT01114737|448567706|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
124710966|NCT01114737|448567707|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
124710967|NCT01114737|448567706|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
124710968|NCT01114737|448567707|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
124710969|NCT01446874|448567708|FG000|Overall Study|Not eligible|1|||
124710970|NCT01446874|448567709|FG001|Overall Study|Not eligible|0|||
124710971|NCT01446874|448567710|FG002|Overall Study|Not eligible|0|||
124710972|NCT01446874|448567708|FG000|Overall Study|No surgery/No qualifying surgery|1|||
124710973|NCT01446874|448567709|FG001|Overall Study|No surgery/No qualifying surgery|0|||
124710974|NCT01446874|448567710|FG002|Overall Study|No surgery/No qualifying surgery|12|||
124710975|NCT01446874|448567708|FG000|Overall Study|Non-compliance|0|||
124710976|NCT01446874|448567709|FG001|Overall Study|Non-compliance|4|||
124710977|NCT01446874|448567710|FG002|Overall Study|Non-compliance|0|||
124710978|NCT01446874|448567708|FG000|Overall Study|Antibiotics for pre-op infection|0|||
124710979|NCT01446874|448567709|FG001|Overall Study|Antibiotics for pre-op infection|0|||
124710980|NCT01446874|448567710|FG002|Overall Study|Antibiotics for pre-op infection|2|||
124710981|NCT01446874|448567708|FG000|Overall Study|Withdrawal by Subject|0|||
124710982|NCT01446874|448567709|FG001|Overall Study|Withdrawal by Subject|0|||
124710983|NCT01446874|448567710|FG002|Overall Study|Withdrawal by Subject|4|||
124710984|NCT00457392|448567711|FG000|Overall Study|Objective Progression or Relapse|229|||
124710985|NCT00457392|448567712|FG001|Overall Study|Objective Progression or Relapse|296|||
124710986|NCT00457392|448567711|FG000|Overall Study|Death|106|||
124710987|NCT00457392|448567712|FG001|Overall Study|Death|106|||
124710988|NCT00457392|448567711|FG000|Overall Study|Adverse Event|84|||
124710989|NCT00457392|448567712|FG001|Overall Study|Adverse Event|41|||
124710990|NCT00457392|448567711|FG000|Overall Study|Global Deterioration of Health Status|22|||
124710991|NCT00457392|448567712|FG001|Overall Study|Global Deterioration of Health Status|8|||
124710992|NCT00457392|448567711|FG000|Overall Study|Withdrawal by Subject|14|||
124710993|NCT00457392|448567712|FG001|Overall Study|Withdrawal by Subject|8|||
124710994|NCT00457392|448567711|FG000|Overall Study|Lost to Follow-up|6|||
124710995|NCT00457392|448567712|FG001|Overall Study|Lost to Follow-up|7|||
124710996|NCT00457392|448567711|FG000|Overall Study|Protocol Violation|4|||
124710997|NCT00457392|448567712|FG001|Overall Study|Protocol Violation|3|||
124710998|NCT00457392|448567711|FG000|Overall Study|Other|7|||
124710999|NCT00457392|448567712|FG001|Overall Study|Other|4|||
124711000|NCT00457392|448567711|FG000|Overall Study|Study Terminated by Sponsor|1|||
124711001|NCT00457392|448567712|FG001|Overall Study|Study Terminated by Sponsor|4|||
124711002|NCT00457392|448567711|FG000|Overall Study|Randomized, Not Treated|7|||
124711003|NCT00457392|448567712|FG001|Overall Study|Randomized, Not Treated|3|||
124711004|NCT01135992|448567713|FG000|Overall Study|Adverse Event|1|||
124711005|NCT01135992|448567713|FG000|Overall Study|Lack of Efficacy|1|||
124711006|NCT01135992|448567713|FG000|Overall Study|Protocol Violation|2|||
124711007|NCT01135992|448567713|FG000|Overall Study|Withdrawal criteria|10|||
124711008|NCT01135992|448567713|FG000|Overall Study|Unclassified|7|||
124711009|NCT01977898|448567714|FG000|Overall Study|Non functioning catheter|1|||
124550738|NCT00566631|447973040|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
124550739|NCT00566631|447973040|FG000|Part 2: Extension Phase|Death|1|||
124550740|NCT00566631|447973040|FG000|Part 2: Extension Phase|Other|5|||
124550741|NCT03387735|447973041|FG000|Overall Study|Lost to Follow-up|4|||
124550742|NCT03387735|447973042|FG001|Overall Study|Lost to Follow-up|8|||
124550743|NCT03387735|447973041|FG000|Overall Study|Death|4|||
124550744|NCT03387735|447973042|FG001|Overall Study|Death|8|||
124550745|NCT03020966|447973044|FG000|Overall Study|Withdrawal by Subject|2|||
124550746|NCT03020966|447973045|FG001|Overall Study|Withdrawal by Subject|0|||
124968233|NCT02719743|449511362|FG003|Overall Study|Migrated/moved from study area|0|||
124968234|NCT02719743|449511363|FG004|Overall Study|Migrated/moved from study area|2|||
124968235|NCT02719743|449511359|FG000|Overall Study|Lost to Follow-up|1|||
124968236|NCT02719743|449511360|FG001|Overall Study|Lost to Follow-up|1|||
124968237|NCT02719743|449511361|FG002|Overall Study|Lost to Follow-up|0|||
124968238|NCT02719743|449511362|FG003|Overall Study|Lost to Follow-up|0|||
124466103|NCT01358864|447664562|FG002|Overall Study|Not treated|0|||
124466104|NCT01358864|447664563|FG003|Overall Study|Not treated|0|||
124466105|NCT01358864|447664564|FG004|Overall Study|Not treated|0|||
124466106|NCT01358864|447664565|FG005|Overall Study|Not treated|0|||
124466107|NCT01358864|447664566|FG006|Overall Study|Not treated|1|||
124466108|NCT01358864|447664567|FG007|Overall Study|Not treated|0|||
124466109|NCT04209855|447664573|FG000|Overall Study|Death|161|||
124466110|NCT04209855|447664574|FG001|Overall Study|Death|177|||
124466111|NCT04209855|447664573|FG000|Overall Study|PI Discretion|1|||
124466112|NCT04209855|447664574|FG001|Overall Study|PI Discretion|1|||
124466113|NCT04209855|447664573|FG000|Overall Study|Lost to Follow-up|5|||
124968239|NCT02719743|449511363|FG004|Overall Study|Lost to Follow-up|0|||
124466114|NCT04209855|447664574|FG001|Overall Study|Lost to Follow-up|2|||
124466115|NCT04209855|447664573|FG000|Overall Study|Withdrew consent|10|||
124711010|NCT01977898|448567715|FG001|Overall Study|Non functioning catheter|1|||
124711011|NCT01049373|448567723|FG000|Overall Study|Protocol Violation|9|||
124711012|NCT01049373|448567724|FG001|Overall Study|Protocol Violation|9|||
124711013|NCT01049373|448567723|FG000|Overall Study|Withdrawal by Subject|8|||
124711014|NCT01049373|448567724|FG001|Overall Study|Withdrawal by Subject|5|||
124711015|NCT01049373|448567723|FG000|Overall Study|Adverse Event|3|||
124711016|NCT01049373|448567724|FG001|Overall Study|Adverse Event|3|||
124711017|NCT01049373|448567723|FG000|Overall Study|Lost to Follow-up|9|||
124711018|NCT01049373|448567724|FG001|Overall Study|Lost to Follow-up|4|||
124711019|NCT01049373|448567723|FG000|Overall Study|no evaluable study values|9|||
124711020|NCT01049373|448567724|FG001|Overall Study|no evaluable study values|21|||
124711021|NCT01049373|448567723|FG000|Overall Study|Other|1|||
124711022|NCT01049373|448567724|FG001|Overall Study|Other|1|||
124711023|NCT01049373|448567723|FG000|Overall Study|Non-cooperation|0|||
124711024|NCT01049373|448567724|FG001|Overall Study|Non-cooperation|1|||
124711025|NCT00339040|448567725|FG000|Stage I|Not able to attend clinic|1|||
124711026|NCT00339040|448567726|FG001|Stage I|Not able to attend clinic|0|||
124711027|NCT00339040|448567725|FG000|Stage I|Protocol Violation|1|||
124711028|NCT00339040|448567726|FG001|Stage I|Protocol Violation|1|||
124711029|NCT00339040|448567725|FG000|Stage II|Lost to Follow-up|3|||
124711030|NCT00339040|448567726|FG001|Stage II|Lost to Follow-up|0|||
124711031|NCT00339040|448567725|FG000|Stage II|Withdrawal by Subject|1|||
124711032|NCT00339040|448567726|FG001|Stage II|Withdrawal by Subject|2|||
124711033|NCT00339040|448567725|FG000|Stage II|Protocol Violation|3|||
124711034|NCT00339040|448567726|FG001|Stage II|Protocol Violation|0|||
124711035|NCT00339040|448567725|FG000|Stage II|Not able to attend clinic|1|||
124711036|NCT00339040|448567726|FG001|Stage II|Not able to attend clinic|0|||
124711037|NCT00339040|448567725|FG000|Stage II|Site closing|2|||
124711038|NCT00339040|448567726|FG001|Stage II|Site closing|0|||
124711039|NCT00812955|448567729|FG000|Overall Study|Adverse Event|7|||
124711040|NCT00812955|448567730|FG001|Overall Study|Adverse Event|6|||
124711041|NCT00812955|448567731|FG002|Overall Study|Adverse Event|3|||
124711042|NCT00812955|448567732|FG003|Overall Study|Adverse Event|4|||
124711043|NCT00812955|448567729|FG000|Overall Study|Lost to Follow-up|2|||
124711044|NCT00812955|448567730|FG001|Overall Study|Lost to Follow-up|1|||
124711045|NCT00812955|448567731|FG002|Overall Study|Lost to Follow-up|1|||
124466116|NCT04209855|447664574|FG001|Overall Study|Withdrew consent|24|||
124466117|NCT04209855|447664573|FG000|Overall Study|Sponsor decision|44|||
124550747|NCT03747939|447973050|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
124711046|NCT00812955|448567732|FG003|Overall Study|Lost to Follow-up|2|||
124711047|NCT00812955|448567729|FG000|Overall Study|Withdrawal by Subject|1|||
124711048|NCT00812955|448567730|FG001|Overall Study|Withdrawal by Subject|0|||
124711049|NCT00812955|448567731|FG002|Overall Study|Withdrawal by Subject|1|||
124711050|NCT00812955|448567732|FG003|Overall Study|Withdrawal by Subject|2|||
124550748|NCT03747939|447973051|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
124711051|NCT00812955|448567729|FG000|Overall Study|randomized in error|0|||
124968240|NCT02287233|449511364|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
124466118|NCT04209855|447664574|FG001|Overall Study|Sponsor decision|18|||
124466119|NCT04209855|447664573|FG000|Overall Study|Other than specified|6|||
124466120|NCT04209855|447664574|FG001|Overall Study|Other than specified|4|||
124711052|NCT00812955|448567730|FG001|Overall Study|randomized in error|0|||
124550749|NCT03747939|447973052|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
124550750|NCT03747939|447973053|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
124550751|NCT03747939|447973050|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
124550752|NCT03747939|447973051|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
124550753|NCT03747939|447973052|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
124550754|NCT03747939|447973053|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
124550755|NCT03747939|447973050|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
124550756|NCT03747939|447973051|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
124550757|NCT03747939|447973052|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
124550758|NCT03747939|447973053|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
124550759|NCT03747939|447973050|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
124550760|NCT03747939|447973051|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
124550761|NCT03747939|447973052|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
124550762|NCT03747939|447973053|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
124550763|NCT03747939|447973050|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
124550764|NCT03747939|447973051|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
124550765|NCT03747939|447973052|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
124550766|NCT03747939|447973053|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
124550767|NCT03747939|447973050|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
124550768|NCT03747939|447973051|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
124550769|NCT03747939|447973052|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
124550770|NCT03747939|447973053|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
124550771|NCT03747939|447973050|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
124550772|NCT03747939|447973051|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
124550773|NCT03747939|447973052|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
124550774|NCT03747939|447973053|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
124550775|NCT03747939|447973050|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
124550776|NCT03747939|447973051|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
124550777|NCT03747939|447973052|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
124711053|NCT00812955|448567731|FG002|Overall Study|randomized in error|1|||
124711054|NCT00812955|448567732|FG003|Overall Study|randomized in error|0|||
124711055|NCT02391311|448567733|FG000|Overall Study|Lost to Follow-up|2|||
124711056|NCT02391311|448567734|FG001|Overall Study|Lost to Follow-up|1|||
124711057|NCT02391311|448567733|FG000|Overall Study|deemed ineligible after baseline|1|||
124711058|NCT02391311|448567734|FG001|Overall Study|deemed ineligible after baseline|1|||
124711059|NCT01815424|448567737|FG000|Week 0 to 16|Adverse Event|1|||
124711060|NCT01815424|448567738|FG001|Week 0 to 16|Adverse Event|3|||
124711061|NCT01815424|448567739|FG002|Week 0 to 16|Adverse Event|3|||
124711062|NCT01815424|448567740|FG003|Week 0 to 16|Adverse Event|0|||
124711063|NCT01815424|448567741|FG004|Week 0 to 16|Adverse Event|0|||
124711064|NCT01815424|448567737|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
124711065|NCT01815424|448567738|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
124711066|NCT01815424|448567739|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
124711067|NCT01815424|448567740|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
124711068|NCT01815424|448567741|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
124711069|NCT01815424|448567737|FG000|Week 0 to 16|Lost to Follow-up|0|||
124711070|NCT01815424|448567738|FG001|Week 0 to 16|Lost to Follow-up|1|||
124711071|NCT01815424|448567739|FG002|Week 0 to 16|Lost to Follow-up|0|||
124711072|NCT01815424|448567740|FG003|Week 0 to 16|Lost to Follow-up|0|||
124711073|NCT01815424|448567741|FG004|Week 0 to 16|Lost to Follow-up|0|||
124711074|NCT01815424|448567737|FG000|Week 0 to 16|Withdrawal by Subject|0|||
124711075|NCT01815424|448567738|FG001|Week 0 to 16|Withdrawal by Subject|0|||
124711076|NCT01815424|448567739|FG002|Week 0 to 16|Withdrawal by Subject|1|||
124711077|NCT01815424|448567740|FG003|Week 0 to 16|Withdrawal by Subject|0|||
124711078|NCT01815424|448567741|FG004|Week 0 to 16|Withdrawal by Subject|0|||
124711079|NCT01815424|448567737|FG000|Week 0 to 16|Other|1|||
124711080|NCT01815424|448567738|FG001|Week 0 to 16|Other|0|||
124711081|NCT01815424|448567739|FG002|Week 0 to 16|Other|3|||
124711082|NCT01815424|448567740|FG003|Week 0 to 16|Other|0|||
124711083|NCT01815424|448567741|FG004|Week 0 to 16|Other|0|||
124711084|NCT01815424|448567737|FG000|Week 0 to 16|Protocol Violation|1|||
124711085|NCT01815424|448567738|FG001|Week 0 to 16|Protocol Violation|0|||
124711086|NCT01815424|448567739|FG002|Week 0 to 16|Protocol Violation|0|||
124711087|NCT01815424|448567740|FG003|Week 0 to 16|Protocol Violation|0|||
124711088|NCT01815424|448567741|FG004|Week 0 to 16|Protocol Violation|0|||
124550778|NCT03747939|447973053|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
124711089|NCT01815424|448567737|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
124711090|NCT01815424|448567738|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
124711091|NCT01815424|448567739|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
124711092|NCT01815424|448567740|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
124711093|NCT01815424|448567741|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
124550779|NCT03747939|447973050|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
124550780|NCT03747939|447973051|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
124550781|NCT03747939|447973052|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
124550782|NCT03747939|447973053|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
124550783|NCT03747939|447973050|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
124550784|NCT03747939|447973051|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
124550785|NCT03747939|447973052|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
124550786|NCT03747939|447973053|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
124550787|NCT03747939|447973050|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
124550788|NCT03747939|447973051|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
124550789|NCT03747939|447973052|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
124550790|NCT03747939|447973053|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
124550791|NCT03747939|447973050|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
124550792|NCT03747939|447973051|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
124550793|NCT03747939|447973052|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
124550794|NCT03747939|447973053|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
124550795|NCT03747939|447973050|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
124550796|NCT03747939|447973051|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
124550797|NCT03747939|447973052|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
124550798|NCT03747939|447973053|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
124550799|NCT03747939|447973050|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
124550800|NCT03747939|447973051|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
124550801|NCT03747939|447973052|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
124550802|NCT03747939|447973053|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
124550803|NCT01215955|447973054|FG000|Overall Study|Adverse Event|1|||
124550804|NCT01215955|447973055|FG001|Overall Study|Adverse Event|4|||
124550805|NCT01215955|447973056|FG002|Overall Study|Adverse Event|2|||
124550806|NCT01215955|447973057|FG003|Overall Study|Adverse Event|3|||
124550807|NCT01215955|447973054|FG000|Overall Study|Death|2|||
124550808|NCT01215955|447973055|FG001|Overall Study|Death|0|||
124550809|NCT01215955|447973056|FG002|Overall Study|Death|1|||
124550810|NCT01215955|447973057|FG003|Overall Study|Death|3|||
124550811|NCT01215955|447973054|FG000|Overall Study|Entry Criteria Not Met|1|||
124550812|NCT01215955|447973055|FG001|Overall Study|Entry Criteria Not Met|3|||
124550813|NCT01215955|447973056|FG002|Overall Study|Entry Criteria Not Met|4|||
124550814|NCT01215955|447973057|FG003|Overall Study|Entry Criteria Not Met|7|||
124550815|NCT01215955|447973054|FG000|Overall Study|Lack of Efficacy|1|||
124550816|NCT01215955|447973055|FG001|Overall Study|Lack of Efficacy|2|||
124550817|NCT01215955|447973056|FG002|Overall Study|Lack of Efficacy|1|||
124550818|NCT01215955|447973057|FG003|Overall Study|Lack of Efficacy|0|||
124550819|NCT01215955|447973054|FG000|Overall Study|Lost to Follow-up|4|||
124550820|NCT01215955|447973055|FG001|Overall Study|Lost to Follow-up|4|||
124550821|NCT01215955|447973056|FG002|Overall Study|Lost to Follow-up|8|||
124550822|NCT01215955|447973057|FG003|Overall Study|Lost to Follow-up|9|||
124550823|NCT01215955|447973054|FG000|Overall Study|Physician Decision|4|||
124550824|NCT01215955|447973055|FG001|Overall Study|Physician Decision|10|||
124550825|NCT01215955|447973056|FG002|Overall Study|Physician Decision|8|||
124550826|NCT01215955|447973057|FG003|Overall Study|Physician Decision|11|||
124550827|NCT01215955|447973054|FG000|Overall Study|Protocol Violation|17|||
124550828|NCT01215955|447973055|FG001|Overall Study|Protocol Violation|13|||
124550829|NCT01215955|447973056|FG002|Overall Study|Protocol Violation|8|||
124550830|NCT01215955|447973057|FG003|Overall Study|Protocol Violation|8|||
124550831|NCT01215955|447973054|FG000|Overall Study|Sponsor Decision|1|||
124550832|NCT01215955|447973055|FG001|Overall Study|Sponsor Decision|2|||
124550833|NCT01215955|447973056|FG002|Overall Study|Sponsor Decision|0|||
124550834|NCT01215955|447973057|FG003|Overall Study|Sponsor Decision|1|||
124550835|NCT01215955|447973054|FG000|Overall Study|Withdrawal by Subject|14|||
124550836|NCT01215955|447973055|FG001|Overall Study|Withdrawal by Subject|15|||
124550837|NCT01215955|447973056|FG002|Overall Study|Withdrawal by Subject|13|||
124550838|NCT01215955|447973057|FG003|Overall Study|Withdrawal by Subject|9|||
124550839|NCT01215955|447973054|FG000|Overall Study|Quality Issues|0|||
124550840|NCT01215955|447973055|FG001|Overall Study|Quality Issues|0|||
124968241|NCT02287233|449511365|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
124968242|NCT02287233|449511366|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
124550841|NCT01215955|447973056|FG002|Overall Study|Quality Issues|3|||
124550842|NCT01215955|447973057|FG003|Overall Study|Quality Issues|2|||
124550843|NCT01447628|447973058|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
124550844|NCT01447628|447973059|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
124550845|NCT01447628|447973060|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
124550846|NCT01447628|447973061|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
124550847|NCT03087773|447973062|FG000|Overall Study|Withdrawal by Subject|8|||
124550848|NCT03087773|447973063|FG001|Overall Study|Withdrawal by Subject|4|||
124550849|NCT03087773|447973062|FG000|Overall Study|Lost to Follow-up|12|||
124711094|NCT01815424|448567737|FG000|Week 16 to 52|Other|0|||
124711095|NCT01815424|448567738|FG001|Week 16 to 52|Other|1|||
124711096|NCT01815424|448567739|FG002|Week 16 to 52|Other|0|||
124711097|NCT01815424|448567740|FG003|Week 16 to 52|Other|0|||
124711098|NCT01815424|448567741|FG004|Week 16 to 52|Other|0|||
124711099|NCT01815424|448567737|FG000|Week 16 to 52|Adverse Event|0|||
124711100|NCT01815424|448567738|FG001|Week 16 to 52|Adverse Event|0|||
124711101|NCT01815424|448567739|FG002|Week 16 to 52|Adverse Event|0|||
124711102|NCT01815424|448567740|FG003|Week 16 to 52|Adverse Event|0|||
124711103|NCT01815424|448567741|FG004|Week 16 to 52|Adverse Event|1|||
124711104|NCT01815424|448567737|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
124711105|NCT01815424|448567738|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
124711106|NCT01815424|448567739|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
124711107|NCT01815424|448567740|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
124711108|NCT01815424|448567741|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
124711109|NCT01815424|448567737|FG000|Week 16 to 52|Lost to Follow-up|0|||
124711110|NCT01815424|448567738|FG001|Week 16 to 52|Lost to Follow-up|2|||
124711111|NCT01815424|448567739|FG002|Week 16 to 52|Lost to Follow-up|0|||
124711112|NCT01815424|448567740|FG003|Week 16 to 52|Lost to Follow-up|2|||
124711113|NCT01815424|448567741|FG004|Week 16 to 52|Lost to Follow-up|1|||
124711114|NCT01815424|448567737|FG000|Week 16 to 52|Withdrawal by Subject|1|||
124711115|NCT01815424|448567738|FG001|Week 16 to 52|Withdrawal by Subject|2|||
124711116|NCT01815424|448567739|FG002|Week 16 to 52|Withdrawal by Subject|0|||
124711117|NCT01815424|448567740|FG003|Week 16 to 52|Withdrawal by Subject|0|||
124711118|NCT01815424|448567741|FG004|Week 16 to 52|Withdrawal by Subject|0|||
124711119|NCT01309204|448567742|FG000|Overall Study|Adverse Event|48|||
124711120|NCT01309204|448567743|FG001|Overall Study|Adverse Event|58|||
124711121|NCT01309204|448567742|FG000|Overall Study|Lost to Follow-up|2|||
124711122|NCT01309204|448567743|FG001|Overall Study|Lost to Follow-up|2|||
124711123|NCT01309204|448567742|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
124711124|NCT01309204|448567743|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
124711125|NCT01309204|448567742|FG000|Overall Study|Inadequate control of IOP|4|||
124711126|NCT01309204|448567743|FG001|Overall Study|Inadequate control of IOP|4|||
124711127|NCT01309204|448567742|FG000|Overall Study|Other|4|||
124711128|NCT01309204|448567743|FG001|Overall Study|Other|1|||
124711129|NCT03046446|448567744|FG000|Overall Study|Lack of Efficacy|7|||
124711130|NCT03046446|448567744|FG000|Overall Study|Adverse Event|6|||
124711131|NCT03046446|448567744|FG000|Overall Study|Lost to Follow-up|3|||
124711132|NCT03046446|448567744|FG000|Overall Study|Withdrawal by Subject|14|||
124711133|NCT03046446|448567744|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
124711134|NCT03046446|448567744|FG000|Overall Study|Disease Progression (see caveats)|25|||
124711135|NCT03046446|448567744|FG000|Overall Study|Non OA related knee surgery|1|||
124711136|NCT02808897|448567745|FG000|Overall Study|Lost to Follow-up|9|||
124711137|NCT02808897|448567746|FG001|Overall Study|Lost to Follow-up|11|||
124711138|NCT00925002|448567747|FG000|Overall Study|Other|1|||
124711139|NCT00925002|448567748|FG001|Overall Study|Other|4|||
124711140|NCT00925002|448567749|FG002|Overall Study|Other|0|||
124711141|NCT00925002|448567747|FG000|Overall Study|Death|1|||
124711142|NCT00925002|448567748|FG001|Overall Study|Death|1|||
124711143|NCT00925002|448567749|FG002|Overall Study|Death|5|||
124711144|NCT00925002|448567747|FG000|Overall Study|Adverse Event|3|||
124711145|NCT00925002|448567748|FG001|Overall Study|Adverse Event|1|||
124711146|NCT00925002|448567749|FG002|Overall Study|Adverse Event|2|||
124711147|NCT00925002|448567747|FG000|Overall Study|Participant withdrew consent|1|||
124711148|NCT00925002|448567748|FG001|Overall Study|Participant withdrew consent|3|||
124711149|NCT00925002|448567749|FG002|Overall Study|Participant withdrew consent|3|||
124711150|NCT01496287|448567750|FG000|Overall Study|Lost to Follow-up|1|||
124711151|NCT01496287|448567750|FG000|Overall Study|Incomplete anesthesia|5|||
124711152|NCT00305448|448567751|FG000|Overall Study|Protocol Violation|0|||
124711153|NCT00305448|448567752|FG001|Overall Study|Protocol Violation|1|||
124711154|NCT00305448|448567753|FG002|Overall Study|Protocol Violation|0|||
124711155|NCT00305448|448567751|FG000|Overall Study|Withdrawal by Subject|2|||
124711156|NCT00305448|448567752|FG001|Overall Study|Withdrawal by Subject|0|||
124711157|NCT00305448|448567753|FG002|Overall Study|Withdrawal by Subject|1|||
124711158|NCT00305448|448567751|FG000|Overall Study|Adverse Event|1|||
124711159|NCT00305448|448567752|FG001|Overall Study|Adverse Event|0|||
124711160|NCT00305448|448567753|FG002|Overall Study|Adverse Event|1|||
124711161|NCT00305448|448567751|FG000|Overall Study|Disease Progression|27|||
124711162|NCT00305448|448567752|FG001|Overall Study|Disease Progression|31|||
124711163|NCT00305448|448567753|FG002|Overall Study|Disease Progression|28|||
124711164|NCT00305448|448567751|FG000|Overall Study|Subjective Disease Progression|1|||
124711165|NCT00305448|448567752|FG001|Overall Study|Subjective Disease Progression|2|||
124711166|NCT00305448|448567753|FG002|Overall Study|Subjective Disease Progression|2|||
124711167|NCT00305448|448567751|FG000|Overall Study|Tumor Marker Elevation|0|||
124711168|NCT00305448|448567752|FG001|Overall Study|Tumor Marker Elevation|0|||
124711169|NCT00305448|448567753|FG002|Overall Study|Tumor Marker Elevation|1|||
124711170|NCT00328172|448567754|FG000|Overall Study|Adverse Event|3|||
124711171|NCT00328172|448567755|FG001|Overall Study|Adverse Event|2|||
124711172|NCT00328172|448567756|FG002|Overall Study|Adverse Event|1|||
124711173|NCT00328172|448567757|FG003|Overall Study|Adverse Event|2|||
124711174|NCT00328172|448567758|FG004|Overall Study|Adverse Event|1|||
124711175|NCT00328172|448567754|FG000|Overall Study|Protocol Violation|0|||
124711176|NCT00328172|448567755|FG001|Overall Study|Protocol Violation|1|||
124711177|NCT00328172|448567756|FG002|Overall Study|Protocol Violation|1|||
124711178|NCT00328172|448567757|FG003|Overall Study|Protocol Violation|0|||
124711179|NCT00328172|448567758|FG004|Overall Study|Protocol Violation|0|||
124711180|NCT00328172|448567754|FG000|Overall Study|Lost to Follow-up|1|||
124711181|NCT00328172|448567755|FG001|Overall Study|Lost to Follow-up|1|||
124711182|NCT00328172|448567756|FG002|Overall Study|Lost to Follow-up|2|||
124711183|NCT00328172|448567757|FG003|Overall Study|Lost to Follow-up|1|||
124711184|NCT00328172|448567758|FG004|Overall Study|Lost to Follow-up|1|||
124711185|NCT00328172|448567754|FG000|Overall Study|Withdrawal by Subject|1|||
124711186|NCT00328172|448567755|FG001|Overall Study|Withdrawal by Subject|1|||
124711187|NCT00328172|448567756|FG002|Overall Study|Withdrawal by Subject|1|||
124711188|NCT00328172|448567757|FG003|Overall Study|Withdrawal by Subject|6|||
124711189|NCT00328172|448567758|FG004|Overall Study|Withdrawal by Subject|0|||
124711190|NCT00328172|448567754|FG000|Overall Study|Lack of Efficacy|14|||
124711191|NCT00328172|448567755|FG001|Overall Study|Lack of Efficacy|9|||
124711192|NCT00328172|448567756|FG002|Overall Study|Lack of Efficacy|4|||
124711193|NCT00328172|448567757|FG003|Overall Study|Lack of Efficacy|4|||
124711194|NCT00328172|448567758|FG004|Overall Study|Lack of Efficacy|3|||
124711195|NCT00328172|448567754|FG000|Overall Study|Other reason (not specified)|3|||
124711196|NCT00328172|448567755|FG001|Overall Study|Other reason (not specified)|0|||
124711197|NCT00328172|448567756|FG002|Overall Study|Other reason (not specified)|1|||
124711198|NCT00328172|448567757|FG003|Overall Study|Other reason (not specified)|0|||
124711199|NCT00328172|448567758|FG004|Overall Study|Other reason (not specified)|0|||
124711200|NCT00558636|448567763|FG000|Treatment|Adverse Event|9|||
124711201|NCT00558636|448567764|FG001|Treatment|Adverse Event|2|||
124711202|NCT00558636|448567763|FG000|Treatment|Withdrawal by Subject|2|||
124711203|NCT00558636|448567764|FG001|Treatment|Withdrawal by Subject|0|||
124711204|NCT00558636|448567763|FG000|Treatment|Premature termination of the study|35|||
124711205|NCT00558636|448567764|FG001|Treatment|Premature termination of the study|37|||
124711206|NCT00558636|448567763|FG000|Treatment|Disease progression|1|||
124711207|NCT00558636|448567764|FG001|Treatment|Disease progression|5|||
124711208|NCT00558636|448567763|FG000|Follow-up|Premature termination of the study|12|||
124711209|NCT00558636|448567764|FG001|Follow-up|Premature termination of the study|7|||
124711210|NCT01990742|448567765|FG000|Overall Study|Withdrawal by facility|407|||
124711211|NCT01990742|448567766|FG001|Overall Study|Withdrawal by facility|1083|||
124711212|NCT01990742|448567765|FG000|Overall Study|Facility closed|0|||
124711213|NCT01990742|448567766|FG001|Overall Study|Facility closed|270|||
124711214|NCT03443687|448567767|FG000|Overall Study|Lost to Follow-up|3|||
124711215|NCT03443687|448567768|FG001|Overall Study|Lost to Follow-up|5|||
124711216|NCT03443687|448567767|FG000|Overall Study|Withdrawal by Subject|1|||
124711217|NCT03443687|448567768|FG001|Overall Study|Withdrawal by Subject|0|||
124711218|NCT03443687|448567767|FG000|Overall Study|Discontinued intervention|1|||
124711219|NCT03443687|448567768|FG001|Overall Study|Discontinued intervention|1|||
124711220|NCT04108273|448567769|FG000|Overall Study|COVID Pandemic|1|||
124711221|NCT04108273|448567770|FG001|Overall Study|COVID Pandemic|0|||
124711222|NCT02897115|448567774|FG000|Overall Study|Early termination of study by sponsor|11|||
124711223|NCT02897115|448567775|FG001|Overall Study|Early termination of study by sponsor|8|||
124711224|NCT00487981|448567776|FG000|Overall Study|Hypothyroidism diagnosis|1|||
124711225|NCT02808429|448567781|FG000|Overall Study|Lost to Follow-up|1|||
124711226|NCT02808429|448567782|FG001|Overall Study|Lost to Follow-up|0|||
124711227|NCT02808429|448567783|FG002|Overall Study|Lost to Follow-up|0|||
124711228|NCT02808429|448567781|FG000|Overall Study|Protocol Violation|0|||
124711229|NCT02808429|448567782|FG001|Overall Study|Protocol Violation|1|||
124711230|NCT02808429|448567783|FG002|Overall Study|Protocol Violation|0|||
124711231|NCT02808429|448567781|FG000|Overall Study|Premature study termination by sponsor|2|||
124711232|NCT02808429|448567782|FG001|Overall Study|Premature study termination by sponsor|0|||
124711233|NCT02808429|448567783|FG002|Overall Study|Premature study termination by sponsor|1|||
124711234|NCT02808429|448567781|FG000|Overall Study|Relocation|0|||
124711235|NCT02808429|448567782|FG001|Overall Study|Relocation|0|||
124711236|NCT02808429|448567783|FG002|Overall Study|Relocation|1|||
124711237|NCT00698828|448567787|FG000|Overall Study|Adverse Event|3|||
124711238|NCT00698828|448567788|FG001|Overall Study|Adverse Event|4|||
124711239|NCT00698828|448567789|FG002|Overall Study|Adverse Event|4|||
124711240|NCT00698828|448567787|FG000|Overall Study|Death|0|||
124711241|NCT00698828|448567788|FG001|Overall Study|Death|0|||
124711242|NCT00698828|448567789|FG002|Overall Study|Death|1|||
124711243|NCT00698828|448567787|FG000|Overall Study|Exacerbation of COPD|1|||
124711244|NCT00698828|448567788|FG001|Overall Study|Exacerbation of COPD|3|||
124711245|NCT00698828|448567789|FG002|Overall Study|Exacerbation of COPD|0|||
124711246|NCT00698828|448567787|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
124711247|NCT00698828|448567788|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
124711248|NCT00698828|448567789|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
124711249|NCT00698828|448567787|FG000|Overall Study|Investigator/Sponsor decision|1|||
124711250|NCT00698828|448567788|FG001|Overall Study|Investigator/Sponsor decision|0|||
124968243|NCT02287233|449511364|FG000|Overall Study|Adverse Event Related to Progression|0|||
124968244|NCT02287233|449511365|FG001|Overall Study|Adverse Event Related to Progression|2|||
124968245|NCT02287233|449511366|FG002|Overall Study|Adverse Event Related to Progression|8|||
124968246|NCT02287233|449511364|FG000|Overall Study|Physician Decision|1|||
124968247|NCT02287233|449511365|FG001|Overall Study|Physician Decision|2|||
124711251|NCT00698828|448567789|FG002|Overall Study|Investigator/Sponsor decision|2|||
124711252|NCT00698828|448567787|FG000|Overall Study|Lost to Follow-up|1|||
124711253|NCT00698828|448567788|FG001|Overall Study|Lost to Follow-up|1|||
124711254|NCT00698828|448567789|FG002|Overall Study|Lost to Follow-up|0|||
124711255|NCT00698828|448567787|FG000|Overall Study|Withdrew consent|0|||
124711256|NCT00698828|448567788|FG001|Overall Study|Withdrew consent|7|||
124711257|NCT00698828|448567789|FG002|Overall Study|Withdrew consent|4|||
124711258|NCT00698828|448567787|FG000|Overall Study|Withdrew consent (not treated)|2|||
124711259|NCT00698828|448567788|FG001|Overall Study|Withdrew consent (not treated)|0|||
124711260|NCT00698828|448567789|FG002|Overall Study|Withdrew consent (not treated)|0|||
124711261|NCT02013609|448567790|FG000|Overall Study|Withdrawal by Subject|9|||
124711262|NCT02013609|448567790|FG000|Overall Study|Lost to Follow-up|3|||
124711263|NCT02013609|448567790|FG000|Overall Study|Adverse Event|3|||
124711264|NCT02013609|448567790|FG000|Overall Study|Met Withdrawal Criteria|3|||
124711265|NCT00856609|448567791|FG000|Overall Study|Adverse Event|1|||
124711266|NCT00856609|448567792|FG001|Overall Study|Adverse Event|0|||
124711267|NCT00783432|448567793|FG000|Overall Study|Adverse Event|22|||
124711268|NCT00783432|448567794|FG001|Overall Study|Adverse Event|17|||
124711269|NCT00783432|448567793|FG000|Overall Study|Lack of Efficacy|20|||
124711270|NCT00783432|448567794|FG001|Overall Study|Lack of Efficacy|21|||
124711271|NCT00783432|448567793|FG000|Overall Study|Lost to Follow-up|11|||
124711272|NCT00783432|448567794|FG001|Overall Study|Lost to Follow-up|6|||
124711273|NCT00783432|448567793|FG000|Overall Study|Withdrawal by Subject|23|||
124711274|NCT00783432|448567794|FG001|Overall Study|Withdrawal by Subject|20|||
124711275|NCT00783432|448567793|FG000|Overall Study|subject moved|3|||
124711276|NCT00783432|448567794|FG001|Overall Study|subject moved|5|||
124711277|NCT00783432|448567793|FG000|Overall Study|Protocol Violation|6|||
124711278|NCT00783432|448567794|FG001|Overall Study|Protocol Violation|9|||
124711279|NCT03273907|448567795|FG000|Overall Study|Death|1|||
124711280|NCT03273907|448567795|FG000|Overall Study|Lost to Follow-up|4|||
124711281|NCT03273907|448567795|FG000|Overall Study|Withdrawal by Subject|2|||
124711282|NCT03273907|448567795|FG000|Overall Study|COVID 19|2|||
124711283|NCT02581891|448567797|FG000|Overall Study|Adverse Event|4|||
124711284|NCT02581891|448567798|FG001|Overall Study|Adverse Event|6|||
124711285|NCT02581891|448567797|FG000|Overall Study|Death|3|||
124711286|NCT02581891|448567798|FG001|Overall Study|Death|4|||
124711287|NCT02581891|448567797|FG000|Overall Study|Lost to Follow-up|1|||
124711288|NCT02581891|448567798|FG001|Overall Study|Lost to Follow-up|2|||
124711289|NCT02581891|448567797|FG000|Overall Study|Physician Decision|0|||
124711290|NCT02581891|448567798|FG001|Overall Study|Physician Decision|1|||
124711291|NCT02581891|448567797|FG000|Overall Study|Withdrawal by Subject|4|||
124711292|NCT02581891|448567798|FG001|Overall Study|Withdrawal by Subject|5|||
124711293|NCT02581891|448567797|FG000|Overall Study|Other Reasons|3|||
124711294|NCT02581891|448567798|FG001|Overall Study|Other Reasons|1|||
124711295|NCT02581891|448567797|FG000|Overall Study|Discontinued during followup|1|||
124711296|NCT02581891|448567798|FG001|Overall Study|Discontinued during followup|0|||
124711297|NCT04828707|448567799|FG000|Overall Study|Lost to Follow-up|3|||
124711298|NCT04828707|448567800|FG001|Overall Study|Lost to Follow-up|2|||
124711299|NCT04828707|448567799|FG000|Overall Study|Withdrawal by Subject|2|||
124711300|NCT04828707|448567800|FG001|Overall Study|Withdrawal by Subject|1|||
124711301|NCT03139448|448567801|FG000|Overall Study|Lack of Efficacy|6|||
124711302|NCT03139448|448567802|FG001|Overall Study|Lack of Efficacy|7|||
124711303|NCT03139448|448567801|FG000|Overall Study|Location of procedure changed|2|||
124711304|NCT03139448|448567802|FG001|Overall Study|Location of procedure changed|8|||
124711305|NCT03139448|448567801|FG000|Overall Study|Withdrawal by Subject|3|||
124711306|NCT03139448|448567802|FG001|Overall Study|Withdrawal by Subject|6|||
124711307|NCT03139448|448567801|FG000|Overall Study|Screen fail|1|||
124711308|NCT03139448|448567802|FG001|Overall Study|Screen fail|3|||
124711309|NCT03139448|448567801|FG000|Overall Study|Physician Decision|0|||
124711310|NCT03139448|448567802|FG001|Overall Study|Physician Decision|2|||
124711311|NCT00523978|448567803|FG000|Overall Study|Withdrawal by Subject|3|||
124711312|NCT00523978|448567804|FG001|Overall Study|Withdrawal by Subject|7|||
124711313|NCT00523978|448567803|FG000|Overall Study|Screen Failures|5|||
124968248|NCT02287233|449511366|FG002|Overall Study|Physician Decision|4|||
124968249|NCT02287233|449511364|FG000|Overall Study|Progressive Disease with Death|0|||
124711314|NCT00523978|448567804|FG001|Overall Study|Screen Failures|1|||
124711315|NCT00523978|448567803|FG000|Overall Study|Death|1|||
124711316|NCT00523978|448567804|FG001|Overall Study|Death|0|||
124711317|NCT02750514|448567805|FG000|Track 1|Disease progression|20|||
124711318|NCT02750514|448567806|FG001|Track 1|Disease progression|1|||
124711319|NCT02750514|448567807|FG002|Track 1|Disease progression|0|||
124968250|NCT02287233|449511365|FG001|Overall Study|Progressive Disease with Death|0|||
124968251|NCT02287233|449511366|FG002|Overall Study|Progressive Disease with Death|10|||
124968252|NCT02287233|449511364|FG000|Overall Study|Progressive Disease Without Death|2|||
124968253|NCT02287233|449511365|FG001|Overall Study|Progressive Disease Without Death|3|||
124968254|NCT02287233|449511366|FG002|Overall Study|Progressive Disease Without Death|20|||
124968255|NCT02287233|449511364|FG000|Overall Study|Withdrawal by Subject|1|||
124968256|NCT02287233|449511365|FG001|Overall Study|Withdrawal by Subject|1|||
124968257|NCT02287233|449511366|FG002|Overall Study|Withdrawal by Subject|7|||
124968258|NCT02287233|449511364|FG000|Overall Study|Other|3|||
124968259|NCT02287233|449511365|FG001|Overall Study|Other|0|||
124968260|NCT02287233|449511366|FG002|Overall Study|Other|15|||
124968261|NCT02287233|449511364|FG000|Overall Study|Did Not Receive Treatment|0|||
124968262|NCT02287233|449511365|FG001|Overall Study|Did Not Receive Treatment|0|||
124968263|NCT02287233|449511366|FG002|Overall Study|Did Not Receive Treatment|2|||
124968264|NCT03772613|449511367|FG000|Overall Study|Lost to Follow-up|0|||
124968265|NCT03772613|449511368|FG001|Overall Study|Lost to Follow-up|1|||
124968266|NCT03772613|449511369|FG002|Overall Study|Lost to Follow-up|1|||
124968267|NCT01427738|449511370|FG000|Overall Study|Death|12|||
124968268|NCT01427738|449511371|FG001|Overall Study|Death|9|||
124968269|NCT01427738|449511370|FG000|Overall Study|Severe debilitation, unable to continue|0|||
124968270|NCT01427738|449511371|FG001|Overall Study|Severe debilitation, unable to continue|1|||
124968271|NCT01427738|449511370|FG000|Overall Study|Subject unable to get to clinic|5|||
124968272|NCT01427738|449511371|FG001|Overall Study|Subject unable to get to clinic|2|||
124968273|NCT01427738|449511370|FG000|Overall Study|Withdrawal by Subject|0|||
124968274|NCT01427738|449511371|FG001|Overall Study|Withdrawal by Subject|2|||
124968275|NCT01427738|449511370|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
124711320|NCT02750514|448567808|FG003|Track 1|Disease progression|1|||
124711321|NCT02750514|448567809|FG004|Track 1|Disease progression|0|||
124711322|NCT02750514|448567805|FG000|Track 1|Adverse event unrelated to study drug|1|||
124711323|NCT02750514|448567806|FG001|Track 1|Adverse event unrelated to study drug|0|||
124711324|NCT02750514|448567807|FG002|Track 1|Adverse event unrelated to study drug|0|||
124711325|NCT02750514|448567808|FG003|Track 1|Adverse event unrelated to study drug|0|||
124711326|NCT02750514|448567809|FG004|Track 1|Adverse event unrelated to study drug|0|||
124711327|NCT02750514|448567805|FG000|Track 1|Study drug toxicity|4|||
124711328|NCT02750514|448567806|FG001|Track 1|Study drug toxicity|1|||
124711329|NCT02750514|448567807|FG002|Track 1|Study drug toxicity|0|||
124711330|NCT02750514|448567808|FG003|Track 1|Study drug toxicity|1|||
124711331|NCT02750514|448567809|FG004|Track 1|Study drug toxicity|0|||
124711332|NCT02750514|448567805|FG000|Track 1|Participant request to discontinue|1|||
124711333|NCT02750514|448567806|FG001|Track 1|Participant request to discontinue|0|||
124711334|NCT02750514|448567807|FG002|Track 1|Participant request to discontinue|0|||
124711335|NCT02750514|448567808|FG003|Track 1|Participant request to discontinue|0|||
124711336|NCT02750514|448567809|FG004|Track 1|Participant request to discontinue|0|||
124711337|NCT02750514|448567805|FG000|Track 1|Other reasons|1|||
124711338|NCT02750514|448567806|FG001|Track 1|Other reasons|0|||
124711339|NCT02750514|448567807|FG002|Track 1|Other reasons|0|||
124711340|NCT02750514|448567808|FG003|Track 1|Other reasons|0|||
124711341|NCT02750514|448567809|FG004|Track 1|Other reasons|0|||
124711342|NCT02750514|448567805|FG000|Track 2|Disease progression|4|||
124711343|NCT02750514|448567806|FG001|Track 2|Disease progression|5|||
124711344|NCT02750514|448567807|FG002|Track 2|Disease progression|2|||
124711345|NCT02750514|448567808|FG003|Track 2|Disease progression|5|||
124711346|NCT02750514|448567809|FG004|Track 2|Disease progression|0|||
124711347|NCT02750514|448567805|FG000|Track 2|Adverse event unrelated to study drug|1|||
124711348|NCT02750514|448567806|FG001|Track 2|Adverse event unrelated to study drug|0|||
124711349|NCT02750514|448567807|FG002|Track 2|Adverse event unrelated to study drug|0|||
124711350|NCT02750514|448567808|FG003|Track 2|Adverse event unrelated to study drug|0|||
124968276|NCT01427738|449511371|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
124968277|NCT01427738|449511370|FG000|Overall Study|Lost to Follow-up|1|||
124968278|NCT01427738|449511371|FG001|Overall Study|Lost to Follow-up|5|||
124968279|NCT05314374|449511372|FG000|Overall Study|Adverse Event|2|||
124968280|NCT05314374|449511373|FG001|Overall Study|Adverse Event|2|||
124711351|NCT02750514|448567809|FG004|Track 2|Adverse event unrelated to study drug|0|||
124711352|NCT02750514|448567805|FG000|Track 2|Study drug toxicity|1|||
124711353|NCT02750514|448567806|FG001|Track 2|Study drug toxicity|2|||
124711354|NCT02750514|448567807|FG002|Track 2|Study drug toxicity|0|||
124711355|NCT02750514|448567808|FG003|Track 2|Study drug toxicity|2|||
124711356|NCT02750514|448567809|FG004|Track 2|Study drug toxicity|0|||
124711357|NCT02750514|448567805|FG000|Track 2|Participant withdrew consent|0|||
124711358|NCT02750514|448567806|FG001|Track 2|Participant withdrew consent|1|||
124711359|NCT02750514|448567807|FG002|Track 2|Participant withdrew consent|0|||
124711360|NCT02750514|448567808|FG003|Track 2|Participant withdrew consent|0|||
124711361|NCT02750514|448567809|FG004|Track 2|Participant withdrew consent|0|||
124711362|NCT02750514|448567805|FG000|Track 3|Disease progression|0|||
124711363|NCT02750514|448567806|FG001|Track 3|Disease progression|24|||
124711364|NCT02750514|448567807|FG002|Track 3|Disease progression|13|||
124711365|NCT02750514|448567808|FG003|Track 3|Disease progression|14|||
124711366|NCT02750514|448567809|FG004|Track 3|Disease progression|0|||
124711367|NCT02750514|448567805|FG000|Track 3|Adverse event unrelated to study drug|0|||
124711368|NCT02750514|448567806|FG001|Track 3|Adverse event unrelated to study drug|1|||
124711369|NCT02750514|448567807|FG002|Track 3|Adverse event unrelated to study drug|1|||
124711370|NCT02750514|448567808|FG003|Track 3|Adverse event unrelated to study drug|1|||
124711371|NCT02750514|448567809|FG004|Track 3|Adverse event unrelated to study drug|0|||
124711372|NCT02750514|448567805|FG000|Track 3|Study drug toxicity|0|||
124711373|NCT02750514|448567806|FG001|Track 3|Study drug toxicity|3|||
124711374|NCT02750514|448567807|FG002|Track 3|Study drug toxicity|0|||
124711375|NCT02750514|448567808|FG003|Track 3|Study drug toxicity|1|||
124711376|NCT02750514|448567809|FG004|Track 3|Study drug toxicity|0|||
124711377|NCT02750514|448567805|FG000|Track 3|Participant request to discontinue|0|||
124711378|NCT02750514|448567806|FG001|Track 3|Participant request to discontinue|2|||
124711379|NCT02750514|448567807|FG002|Track 3|Participant request to discontinue|0|||
124711380|NCT02750514|448567808|FG003|Track 3|Participant request to discontinue|0|||
124711381|NCT02750514|448567809|FG004|Track 3|Participant request to discontinue|0|||
124711382|NCT02750514|448567805|FG000|Track 3|Participant withdrew consent|0|||
124711383|NCT02750514|448567806|FG001|Track 3|Participant withdrew consent|3|||
124711384|NCT02750514|448567807|FG002|Track 3|Participant withdrew consent|1|||
124550850|NCT03087773|447973063|FG001|Overall Study|Lost to Follow-up|8|||
124550851|NCT00185731|447973064|FG000|Overall Study|Withdrawal by Subject|1|||
124550852|NCT00185731|447973064|FG000|Overall Study|Not Eligible|1|||
124550853|NCT02494583|447973067|FG000|Overall Study|Death|224|||
124550854|NCT02494583|447973068|FG001|Overall Study|Death|214|||
124550855|NCT02494583|447973069|FG002|Overall Study|Death|225|||
124550856|NCT02494583|447973067|FG000|Overall Study|Lost to Follow-up|1|||
124550857|NCT02494583|447973068|FG001|Overall Study|Lost to Follow-up|0|||
124711385|NCT02750514|448567808|FG003|Track 3|Participant withdrew consent|0|||
124711386|NCT02750514|448567809|FG004|Track 3|Participant withdrew consent|0|||
124711387|NCT02750514|448567805|FG000|Track 3|Other reasons|0|||
124711388|NCT02750514|448567806|FG001|Track 3|Other reasons|3|||
124711389|NCT02750514|448567807|FG002|Track 3|Other reasons|0|||
124711390|NCT02750514|448567808|FG003|Track 3|Other reasons|0|||
124711391|NCT02750514|448567809|FG004|Track 3|Other reasons|0|||
124711392|NCT02750514|448567805|FG000|Track 4|Study drug toxicity|0|||
124711393|NCT02750514|448567806|FG001|Track 4|Study drug toxicity|6|||
124711394|NCT02750514|448567807|FG002|Track 4|Study drug toxicity|0|||
124711395|NCT02750514|448567808|FG003|Track 4|Study drug toxicity|5|||
124711396|NCT02750514|448567809|FG004|Track 4|Study drug toxicity|0|||
124711397|NCT02750514|448567805|FG000|Track 4|Participant request to discontinue|0|||
124711398|NCT02750514|448567806|FG001|Track 4|Participant request to discontinue|1|||
124711399|NCT02750514|448567807|FG002|Track 4|Participant request to discontinue|0|||
124711400|NCT02750514|448567808|FG003|Track 4|Participant request to discontinue|1|||
124711401|NCT02750514|448567809|FG004|Track 4|Participant request to discontinue|0|||
124711402|NCT02750514|448567805|FG000|Track 4|Participant withdrew consent|0|||
124711403|NCT02750514|448567806|FG001|Track 4|Participant withdrew consent|1|||
124711404|NCT02750514|448567807|FG002|Track 4|Participant withdrew consent|0|||
124711405|NCT02750514|448567808|FG003|Track 4|Participant withdrew consent|0|||
124711406|NCT02750514|448567809|FG004|Track 4|Participant withdrew consent|0|||
124711407|NCT02750514|448567805|FG000|Track 4|Other reasons|0|||
124711408|NCT02750514|448567806|FG001|Track 4|Other reasons|5|||
124711409|NCT02750514|448567807|FG002|Track 4|Other reasons|0|||
124711410|NCT02750514|448567808|FG003|Track 4|Other reasons|3|||
124711411|NCT02750514|448567809|FG004|Track 4|Other reasons|0|||
124711412|NCT02750514|448567805|FG000|Track 4|Disease progression|0|||
124711413|NCT02750514|448567806|FG001|Track 4|Disease progression|33|||
124711414|NCT02750514|448567807|FG002|Track 4|Disease progression|0|||
124711415|NCT02750514|448567808|FG003|Track 4|Disease progression|32|||
124711416|NCT02750514|448567809|FG004|Track 4|Disease progression|0|||
124711417|NCT02750514|448567805|FG000|Track 4|Adverse event unrelated to study drug|0|||
124711418|NCT02750514|448567806|FG001|Track 4|Adverse event unrelated to study drug|5|||
124711419|NCT02750514|448567807|FG002|Track 4|Adverse event unrelated to study drug|0|||
124711420|NCT02750514|448567808|FG003|Track 4|Adverse event unrelated to study drug|0|||
124711421|NCT02750514|448567809|FG004|Track 4|Adverse event unrelated to study drug|0|||
124711422|NCT02750514|448567805|FG000|Track 4|Death|0|||
124711423|NCT02750514|448567806|FG001|Track 4|Death|0|||
124711424|NCT02750514|448567807|FG002|Track 4|Death|0|||
124711425|NCT02750514|448567808|FG003|Track 4|Death|1|||
124711426|NCT02750514|448567809|FG004|Track 4|Death|0|||
124711427|NCT02750514|448567805|FG000|Track 5|Disease progression|0|||
124711428|NCT02750514|448567806|FG001|Track 5|Disease progression|0|||
124711429|NCT02750514|448567807|FG002|Track 5|Disease progression|0|||
124711430|NCT02750514|448567808|FG003|Track 5|Disease progression|0|||
124711431|NCT02750514|448567809|FG004|Track 5|Disease progression|34|||
124711432|NCT02750514|448567805|FG000|Track 5|Adverse event unrelated to study drug|0|||
124711433|NCT02750514|448567806|FG001|Track 5|Adverse event unrelated to study drug|0|||
124711434|NCT02750514|448567807|FG002|Track 5|Adverse event unrelated to study drug|0|||
124711435|NCT02750514|448567808|FG003|Track 5|Adverse event unrelated to study drug|0|||
124711436|NCT02750514|448567809|FG004|Track 5|Adverse event unrelated to study drug|2|||
124550858|NCT02494583|447973069|FG002|Overall Study|Lost to Follow-up|0|||
124711437|NCT02750514|448567805|FG000|Track 5|Study drug toxicity|0|||
124711438|NCT02750514|448567806|FG001|Track 5|Study drug toxicity|0|||
124550859|NCT02494583|447973067|FG000|Overall Study|Protocol Violation|1|||
124550860|NCT02494583|447973068|FG001|Overall Study|Protocol Violation|2|||
124550861|NCT02494583|447973069|FG002|Overall Study|Protocol Violation|0|||
124550862|NCT02494583|447973067|FG000|Overall Study|Screen Failure|0|||
124550863|NCT02494583|447973068|FG001|Overall Study|Screen Failure|1|||
124550864|NCT02494583|447973069|FG002|Overall Study|Screen Failure|0|||
124550865|NCT02494583|447973067|FG000|Overall Study|Transferred to Extension Study|15|||
124550866|NCT02494583|447973068|FG001|Overall Study|Transferred to Extension Study|15|||
124550867|NCT02494583|447973069|FG002|Overall Study|Transferred to Extension Study|6|||
124550868|NCT02494583|447973067|FG000|Overall Study|Did Not Continue on Extension Study|8|||
124550869|NCT02494583|447973068|FG001|Overall Study|Did Not Continue on Extension Study|10|||
124550870|NCT02494583|447973069|FG002|Overall Study|Did Not Continue on Extension Study|4|||
124550871|NCT02494583|447973067|FG000|Overall Study|Withdrawal by Subject|7|||
124550872|NCT02494583|447973068|FG001|Overall Study|Withdrawal by Subject|15|||
124550873|NCT02494583|447973069|FG002|Overall Study|Withdrawal by Subject|15|||
124550874|NCT02072174|447973070|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
124550875|NCT02072174|447973071|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
124550876|NCT02072174|447973070|FG000|Overall Study|Protocol Violation|16|||
124550877|NCT02072174|447973071|FG001|Overall Study|Protocol Violation|23|||
124550878|NCT02072174|447973070|FG000|Overall Study|Physician Decision|0|||
124550879|NCT02072174|447973071|FG001|Overall Study|Physician Decision|1|||
124466121|NCT02289950|447664575|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
124466122|NCT02289950|447664576|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
124466123|NCT02289950|447664575|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
124466124|NCT02289950|447664576|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
124466125|NCT02289950|447664575|FG000|Overall Study|Lost to Follow-up|1|||
124466126|NCT02289950|447664576|FG001|Overall Study|Lost to Follow-up|0|||
124466127|NCT02289950|447664575|FG000|Overall Study|Physician Decision|9|||
124466128|NCT02289950|447664576|FG001|Overall Study|Physician Decision|3|||
124466129|NCT02289950|447664575|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
124466130|NCT02289950|447664576|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
124466131|NCT02289950|447664575|FG000|Overall Study|Withdrawal by Subject|1|||
124466132|NCT02289950|447664576|FG001|Overall Study|Withdrawal by Subject|3|||
124466133|NCT02289950|447664575|FG000|Overall Study|Test article held for greater than 28 days|0|||
124466134|NCT02289950|447664576|FG001|Overall Study|Test article held for greater than 28 days|1|||
124466135|NCT02289950|447664575|FG000|Overall Study|Adverse Event|11|||
124466136|NCT02289950|447664576|FG001|Overall Study|Adverse Event|3|||
124466137|NCT02289950|447664575|FG000|Overall Study|Death|1|||
124466138|NCT02289950|447664576|FG001|Overall Study|Death|1|||
124466139|NCT02289950|447664575|FG000|Overall Study|Other|5|||
124466140|NCT02289950|447664576|FG001|Overall Study|Other|2|||
124466141|NCT02289950|447664575|FG000|Overall Study|Not Treated|2|||
124466142|NCT02289950|447664576|FG001|Overall Study|Not Treated|1|||
124466143|NCT01250379|447664579|FG000|Overall Study|Death|141|||
124466144|NCT01250379|447664580|FG001|Overall Study|Death|148|||
124550880|NCT02072174|447973070|FG000|Overall Study|Non-compliance with protocol requirement|2|||
124550881|NCT02072174|447973071|FG001|Overall Study|Non-compliance with protocol requirement|0|||
124550882|NCT01787188|447973072|FG000|Overall Study|Adverse Event|2|||
124550883|NCT01787188|447973073|FG001|Overall Study|Adverse Event|4|||
124550884|NCT01787188|447973074|FG002|Overall Study|Adverse Event|6|||
124550885|NCT01787188|447973072|FG000|Overall Study|Lack of Efficacy|7|||
124550886|NCT01787188|447973073|FG001|Overall Study|Lack of Efficacy|3|||
124550887|NCT01787188|447973074|FG002|Overall Study|Lack of Efficacy|5|||
124550888|NCT01787188|447973072|FG000|Overall Study|Non-compliance with Study Drug|0|||
124550889|NCT01787188|447973073|FG001|Overall Study|Non-compliance with Study Drug|1|||
124550890|NCT01787188|447973074|FG002|Overall Study|Non-compliance with Study Drug|0|||
124550891|NCT01787188|447973072|FG000|Overall Study|Withdrawal by Subject|4|||
124550892|NCT01787188|447973073|FG001|Overall Study|Withdrawal by Subject|3|||
124550893|NCT01787188|447973074|FG002|Overall Study|Withdrawal by Subject|2|||
124550894|NCT01787188|447973072|FG000|Overall Study|Protocol Violation|3|||
124550895|NCT01787188|447973073|FG001|Overall Study|Protocol Violation|2|||
124550896|NCT01787188|447973074|FG002|Overall Study|Protocol Violation|3|||
124550897|NCT01787188|447973072|FG000|Overall Study|Lost to Follow-up|1|||
124550898|NCT01787188|447973073|FG001|Overall Study|Lost to Follow-up|2|||
124550899|NCT01787188|447973074|FG002|Overall Study|Lost to Follow-up|2|||
124550900|NCT01787188|447973072|FG000|Overall Study|Other, including patient moved|0|||
124550901|NCT01787188|447973073|FG001|Overall Study|Other, including patient moved|3|||
124550902|NCT01787188|447973074|FG002|Overall Study|Other, including patient moved|0|||
124550903|NCT02756078|447973077|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
124550904|NCT02756078|447973078|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
124550905|NCT02756078|447973077|FG000|Period 1|Lost to Follow-up|0|||
124550906|NCT02756078|447973078|FG001|Period 1|Lost to Follow-up|2|||
124550907|NCT02756078|447973077|FG000|Period 1|Protocol Violation|0|||
124550908|NCT02756078|447973078|FG001|Period 1|Protocol Violation|1|||
124550909|NCT02756078|447973077|FG000|Period 1|Adverse Event|1|||
124550910|NCT02756078|447973078|FG001|Period 1|Adverse Event|10|||
124550911|NCT02756078|447973077|FG000|Period 1|Withdrawal by Subject|6|||
124550912|NCT02756078|447973078|FG001|Period 1|Withdrawal by Subject|6|||
124550913|NCT02756078|447973077|FG000|Period 1|Lens Discomfort|2|||
124550914|NCT02756078|447973078|FG001|Period 1|Lens Discomfort|2|||
124550915|NCT02756078|447973077|FG000|Period 2|Adverse Event|3|||
124550916|NCT02756078|447973078|FG001|Period 2|Adverse Event|5|||
124550917|NCT02756078|447973077|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
124550918|NCT02756078|447973078|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
124550919|NCT02756078|447973077|FG000|Period 2|Withdrawal by Subject|3|||
124550920|NCT02756078|447973078|FG001|Period 2|Withdrawal by Subject|1|||
124550921|NCT05349188|447973079|FG000|Overall Study|Withdrawal by Subject|1|||
124550922|NCT05349188|447973080|FG001|Overall Study|Withdrawal by Subject|0|||
124550923|NCT00943384|447973081|FG000|Overall Study|Dispositioned prior to treatment|23|||
124550924|NCT00943384|447973081|FG000|Overall Study|Treated off protocol-protocol violation|5|||
124550925|NCT00943384|447973081|FG000|Overall Study|Lost to Follow-up|16|||
124550926|NCT00943384|447973081|FG000|Overall Study|Withdrawal by Subject|5|||
124550927|NCT00835068|447973082|FG000|Overall Study|Death|1|||
124550928|NCT00835068|447973083|FG001|Overall Study|Death|0|||
124550929|NCT00835068|447973082|FG000|Overall Study|Adverse Event|0|||
124550930|NCT00835068|447973083|FG001|Overall Study|Adverse Event|1|||
124550931|NCT00835068|447973082|FG000|Overall Study|Other|8|||
124550932|NCT00835068|447973083|FG001|Overall Study|Other|0|||
124968281|NCT02658175|449511374|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
124466145|NCT01250379|447664579|FG000|Overall Study|Withdrawal by Subject|32|||
124466146|NCT01250379|447664580|FG001|Overall Study|Withdrawal by Subject|20|||
124466147|NCT01250379|447664579|FG000|Overall Study|Physician Decision|11|||
124466148|NCT01250379|447664580|FG001|Overall Study|Physician Decision|3|||
124466149|NCT01250379|447664579|FG000|Overall Study|Protocol Violation|2|||
124466150|NCT01250379|447664580|FG001|Overall Study|Protocol Violation|8|||
124466151|NCT01250379|447664579|FG000|Overall Study|Lost to Follow-up|9|||
124550933|NCT00835068|447973082|FG000|Overall Study|Withdrawal by Subject|1|||
124550934|NCT00835068|447973083|FG001|Overall Study|Withdrawal by Subject|0|||
124550935|NCT02575807|447973084|FG000|Overall Study|Death|8|||
124550936|NCT02575807|447973085|FG001|Overall Study|Death|3|||
124550937|NCT02575807|447973086|FG002|Overall Study|Death|7|||
124550938|NCT02575807|447973087|FG003|Overall Study|Death|0|||
124968282|NCT02658175|449511375|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
124550939|NCT02575807|447973088|FG004|Overall Study|Death|1|||
124550940|NCT02575807|447973084|FG000|Overall Study|Study terminated by Sponsor|0|||
124550941|NCT02575807|447973085|FG001|Overall Study|Study terminated by Sponsor|1|||
124968283|NCT02658175|449511376|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
124550942|NCT02575807|447973086|FG002|Overall Study|Study terminated by Sponsor|7|||
124550943|NCT02575807|447973087|FG003|Overall Study|Study terminated by Sponsor|0|||
124550944|NCT02575807|447973088|FG004|Overall Study|Study terminated by Sponsor|1|||
124550945|NCT02575807|447973084|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
124550946|NCT02575807|447973085|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
124550947|NCT02575807|447973086|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
124550948|NCT02575807|447973087|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
124550949|NCT02575807|447973088|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
124466152|NCT01250379|447664580|FG001|Overall Study|Lost to Follow-up|6|||
124550950|NCT02575807|447973084|FG000|Overall Study|Terminated due to physician decision|0|||
124550951|NCT02575807|447973085|FG001|Overall Study|Terminated due to physician decision|0|||
124550952|NCT02575807|447973086|FG002|Overall Study|Terminated due to physician decision|1|||
124550953|NCT02575807|447973087|FG003|Overall Study|Terminated due to physician decision|0|||
124550954|NCT02575807|447973088|FG004|Overall Study|Terminated due to physician decision|0|||
124550955|NCT02575807|447973084|FG000|Overall Study|Subject ineligible - medical implant|0|||
124550956|NCT02575807|447973085|FG001|Overall Study|Subject ineligible - medical implant|0|||
124550957|NCT02575807|447973086|FG002|Overall Study|Subject ineligible - medical implant|0|||
124550958|NCT02575807|447973087|FG003|Overall Study|Subject ineligible - medical implant|1|||
124550959|NCT02575807|447973088|FG004|Overall Study|Subject ineligible - medical implant|0|||
124550960|NCT02575807|447973084|FG000|Overall Study|Withdrawal by Subject|0|||
124550961|NCT02575807|447973085|FG001|Overall Study|Withdrawal by Subject|0|||
124550962|NCT02575807|447973086|FG002|Overall Study|Withdrawal by Subject|1|||
124550963|NCT02575807|447973087|FG003|Overall Study|Withdrawal by Subject|1|||
124550964|NCT02575807|447973088|FG004|Overall Study|Withdrawal by Subject|2|||
124550965|NCT02180659|447973089|FG000|Overall Study|Adverse Event|1|||
124550966|NCT02180659|447973090|FG001|Overall Study|Adverse Event|0|||
124550967|NCT02180659|447973089|FG000|Overall Study|Lost to Follow-up|4|||
124550968|NCT02180659|447973090|FG001|Overall Study|Lost to Follow-up|2|||
124466153|NCT01250379|447664579|FG000|Overall Study|Adverse Event|5|||
124466154|NCT01250379|447664580|FG001|Overall Study|Adverse Event|4|||
124466155|NCT01250379|447664579|FG000|Overall Study|Other|0|||
124466156|NCT01250379|447664580|FG001|Overall Study|Other|4|||
124466157|NCT01250379|447664579|FG000|Overall Study|Participant noncompliance|2|||
124466158|NCT01250379|447664580|FG001|Overall Study|Participant noncompliance|0|||
124466159|NCT05902364|447664581|FG000|Overall Study|Adverse Event|1|||
124466160|NCT05902364|447664582|FG001|Overall Study|Adverse Event|0|||
124466161|NCT02270242|447664583|FG000|Overall Study|Withdrawal by Subject|18|||
124466162|NCT02270242|447664584|FG001|Overall Study|Withdrawal by Subject|25|||
124466163|NCT02270242|447664583|FG000|Overall Study|Lost to Follow-up|41|||
124466164|NCT02270242|447664584|FG001|Overall Study|Lost to Follow-up|27|||
124466165|NCT02270242|447664583|FG000|Overall Study|Physician Decision|0|||
124466166|NCT02270242|447664584|FG001|Overall Study|Physician Decision|1|||
124466167|NCT02321436|447664587|FG000|Overall Study|Withdrawal by Subject|1|||
124466168|NCT02321436|447664588|FG001|Overall Study|Withdrawal by Subject|0|||
124466169|NCT02321436|447664587|FG000|Overall Study|Lost to Follow-up|0|||
124466170|NCT02321436|447664588|FG001|Overall Study|Lost to Follow-up|1|||
124466171|NCT00644787|447664589|FG000|Period 1: Titration Phase|Adverse Event|11|||
124466172|NCT00644787|447664590|FG001|Period 1: Titration Phase|Adverse Event|0|||
124466173|NCT00644787|447664591|FG002|Period 1: Titration Phase|Adverse Event|0|||
124466174|NCT00644787|447664589|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
124466175|NCT00644787|447664590|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
124466176|NCT00644787|447664591|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
124466177|NCT00644787|447664589|FG000|Period 1: Titration Phase|Physician Decision|1|||
124466178|NCT00644787|447664590|FG001|Period 1: Titration Phase|Physician Decision|0|||
124466179|NCT00644787|447664591|FG002|Period 1: Titration Phase|Physician Decision|0|||
124466180|NCT00644787|447664589|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
124466181|NCT00644787|447664590|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
124466182|NCT00644787|447664591|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
124466183|NCT00644787|447664589|FG000|Period 1: Titration Phase|Worsening of complications|1|||
124466184|NCT00644787|447664590|FG001|Period 1: Titration Phase|Worsening of complications|0|||
124466185|NCT00644787|447664591|FG002|Period 1: Titration Phase|Worsening of complications|0|||
124466186|NCT00644787|447664589|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
124466187|NCT00644787|447664590|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
124466188|NCT00644787|447664591|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
124550969|NCT02180659|447973089|FG000|Overall Study|Subject incarcerated during conduct|1|||
124968284|NCT02658175|449511374|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
124968285|NCT02658175|449511375|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
124968286|NCT02658175|449511376|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
124466189|NCT00644787|447664589|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
124466190|NCT00644787|447664590|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
124466191|NCT00644787|447664591|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
124550970|NCT02180659|447973090|FG001|Overall Study|Subject incarcerated during conduct|0|||
124550971|NCT02180659|447973089|FG000|Overall Study|Withdrawal by Subject|0|||
124466192|NCT00644787|447664589|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
124466193|NCT00644787|447664590|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
124466194|NCT00644787|447664591|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
124466195|NCT00644787|447664589|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
124550972|NCT02180659|447973090|FG001|Overall Study|Withdrawal by Subject|2|||
124711439|NCT02750514|448567807|FG002|Track 5|Study drug toxicity|0|||
124711440|NCT02750514|448567808|FG003|Track 5|Study drug toxicity|0|||
124711441|NCT02750514|448567809|FG004|Track 5|Study drug toxicity|2|||
124711442|NCT02750514|448567805|FG000|Track 5|Participant request to discontinue|0|||
124711443|NCT02750514|448567806|FG001|Track 5|Participant request to discontinue|0|||
124711444|NCT02750514|448567807|FG002|Track 5|Participant request to discontinue|0|||
124711445|NCT02750514|448567808|FG003|Track 5|Participant request to discontinue|0|||
124711446|NCT02750514|448567809|FG004|Track 5|Participant request to discontinue|3|||
124711447|NCT02750514|448567805|FG000|Track 5|Other reasons|0|||
124711448|NCT02750514|448567806|FG001|Track 5|Other reasons|0|||
124711449|NCT02750514|448567807|FG002|Track 5|Other reasons|0|||
124711450|NCT02750514|448567808|FG003|Track 5|Other reasons|0|||
124711451|NCT02750514|448567809|FG004|Track 5|Other reasons|2|||
124711452|NCT02259114|448567810|FG000|Overall Study|Progressive Disease|14|||
124711453|NCT02259114|448567811|FG001|Overall Study|Progressive Disease|2|||
124968287|NCT02658175|449511374|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
124969648|NCT01234883|449517432|FG000|Overall Study|Inclusion/exclusion failure|1|||
124466196|NCT00644787|447664590|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
124466197|NCT00644787|447664591|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
124466198|NCT00644787|447664589|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
124711454|NCT02259114|448567812|FG002|Overall Study|Progressive Disease|10|||
124711455|NCT02259114|448567813|FG003|Overall Study|Progressive Disease|2|||
124711456|NCT02259114|448567814|FG004|Overall Study|Progressive Disease|5|||
124711457|NCT02259114|448567810|FG000|Overall Study|Adverse Event|2|||
124711458|NCT02259114|448567811|FG001|Overall Study|Adverse Event|1|||
124711459|NCT02259114|448567812|FG002|Overall Study|Adverse Event|0|||
124711460|NCT02259114|448567813|FG003|Overall Study|Adverse Event|0|||
124711461|NCT02259114|448567814|FG004|Overall Study|Adverse Event|1|||
124711462|NCT02259114|448567810|FG000|Overall Study|Death|3|||
124711463|NCT02259114|448567811|FG001|Overall Study|Death|0|||
124711464|NCT02259114|448567812|FG002|Overall Study|Death|1|||
124711465|NCT02259114|448567813|FG003|Overall Study|Death|0|||
124711466|NCT02259114|448567814|FG004|Overall Study|Death|0|||
124711467|NCT02259114|448567810|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
124711468|NCT02259114|448567811|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
124711469|NCT02259114|448567812|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
124711470|NCT02259114|448567813|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
124711471|NCT02259114|448567814|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
124711472|NCT02259114|448567810|FG000|Overall Study|Withdrawal by Subject|0|||
124711473|NCT02259114|448567811|FG001|Overall Study|Withdrawal by Subject|0|||
124711474|NCT02259114|448567812|FG002|Overall Study|Withdrawal by Subject|1|||
124711475|NCT02259114|448567813|FG003|Overall Study|Withdrawal by Subject|1|||
124711476|NCT02259114|448567814|FG004|Overall Study|Withdrawal by Subject|0|||
124711477|NCT02259114|448567810|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
124711478|NCT02259114|448567811|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
124711479|NCT02259114|448567812|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
124711480|NCT02259114|448567813|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
124711481|NCT02259114|448567814|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
124711482|NCT02259114|448567810|FG000|Overall Study|Not Treated|1|||
124711483|NCT02259114|448567811|FG001|Overall Study|Not Treated|0|||
124711484|NCT02259114|448567812|FG002|Overall Study|Not Treated|0|||
124711485|NCT02259114|448567813|FG003|Overall Study|Not Treated|0|||
124711486|NCT02259114|448567814|FG004|Overall Study|Not Treated|0|||
124711487|NCT03937479|448567815|FG000|Overall Study|Adverse Event|2|||
124711488|NCT03937479|448567816|FG001|Overall Study|Adverse Event|3|||
124711489|NCT03937479|448567817|FG002|Overall Study|Adverse Event|0|||
124711490|NCT03937479|448567818|FG003|Overall Study|Adverse Event|0|||
124711491|NCT03937479|448567819|FG004|Overall Study|Adverse Event|1|||
124711492|NCT03937479|448567815|FG000|Overall Study|Withdrawal by Subject|3|||
124711493|NCT03937479|448567816|FG001|Overall Study|Withdrawal by Subject|5|||
124711494|NCT03937479|448567817|FG002|Overall Study|Withdrawal by Subject|2|||
124711495|NCT03937479|448567818|FG003|Overall Study|Withdrawal by Subject|2|||
124711496|NCT03937479|448567819|FG004|Overall Study|Withdrawal by Subject|1|||
124711497|NCT03937479|448567815|FG000|Overall Study|Protocol Violation|5|||
124711498|NCT03937479|448567816|FG001|Overall Study|Protocol Violation|6|||
124711499|NCT03937479|448567817|FG002|Overall Study|Protocol Violation|4|||
124711500|NCT03937479|448567818|FG003|Overall Study|Protocol Violation|3|||
124711501|NCT03937479|448567819|FG004|Overall Study|Protocol Violation|2|||
124711502|NCT03937479|448567815|FG000|Overall Study|Lost to Follow-up|0|||
124711503|NCT03937479|448567816|FG001|Overall Study|Lost to Follow-up|1|||
124711504|NCT03937479|448567817|FG002|Overall Study|Lost to Follow-up|0|||
124711505|NCT03937479|448567818|FG003|Overall Study|Lost to Follow-up|1|||
124711506|NCT03937479|448567819|FG004|Overall Study|Lost to Follow-up|0|||
124711507|NCT03937479|448567815|FG000|Overall Study|Physician Decision|0|||
124711508|NCT03937479|448567816|FG001|Overall Study|Physician Decision|0|||
124711509|NCT03937479|448567817|FG002|Overall Study|Physician Decision|1|||
124711510|NCT03937479|448567818|FG003|Overall Study|Physician Decision|0|||
124711511|NCT03937479|448567819|FG004|Overall Study|Physician Decision|1|||
124711512|NCT01378117|448567822|FG000|Overall Study|withdrawal|2|||
124711513|NCT01378117|448567823|FG001|Overall Study|withdrawal|1|||
124711514|NCT01378117|448567824|FG002|Overall Study|withdrawal|2|||
124711515|NCT01378117|448567822|FG000|Overall Study|discharged before med given|2|||
124711516|NCT01378117|448567823|FG001|Overall Study|discharged before med given|0|||
124711517|NCT01378117|448567824|FG002|Overall Study|discharged before med given|1|||
124711518|NCT02961244|448567828|FG000|Overall Study|Protocol Violation|0|||
124711519|NCT02961244|448567829|FG001|Overall Study|Protocol Violation|1|||
124711520|NCT02961244|448567828|FG000|Overall Study|Withdrawal by Subject|1|||
124711521|NCT02961244|448567829|FG001|Overall Study|Withdrawal by Subject|2|||
124711522|NCT02961244|448567828|FG000|Overall Study|Surgery plan change after study approval|0|||
124711523|NCT02961244|448567829|FG001|Overall Study|Surgery plan change after study approval|2|||
124711524|NCT02961244|448567828|FG000|Overall Study|Lost to Follow-up|0|||
124711525|NCT02961244|448567829|FG001|Overall Study|Lost to Follow-up|2|||
124711526|NCT02961244|448567828|FG000|Overall Study|İnadequate data|0|||
124711527|NCT02961244|448567829|FG001|Overall Study|İnadequate data|2|||
124711528|NCT01854528|448567830|FG000|Overall Study|Adverse Event|0|||
124711529|NCT01854528|448567831|FG001|Overall Study|Adverse Event|4|||
124711530|NCT01854528|448567830|FG000|Overall Study|Withdrawal by Subject|0|||
124711531|NCT01854528|448567831|FG001|Overall Study|Withdrawal by Subject|2|||
124711532|NCT01854528|448567830|FG000|Overall Study|Virologic Failure|0|||
124711533|NCT01854528|448567831|FG001|Overall Study|Virologic Failure|9|||
124711534|NCT03789292|448567832|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
124711535|NCT03789292|448567833|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
124711536|NCT03789292|448567834|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
124711537|NCT03789292|448567832|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
124711538|NCT03789292|448567833|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
124711539|NCT03789292|448567834|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
124711540|NCT03789292|448567832|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
124711541|NCT03789292|448567833|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
124711542|NCT03789292|448567834|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
124711543|NCT03789292|448567832|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
124711544|NCT03789292|448567833|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
124711545|NCT03789292|448567834|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
124711546|NCT03789292|448567832|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
124711547|NCT03789292|448567833|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
124711548|NCT03789292|448567834|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
124711549|NCT03789292|448567832|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
124711550|NCT03789292|448567833|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
124711551|NCT03789292|448567834|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
124711552|NCT03789292|448567832|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
124711553|NCT03789292|448567833|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
124711554|NCT03789292|448567834|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
124711555|NCT03789292|448567832|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
124711556|NCT03789292|448567833|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
124711557|NCT03789292|448567834|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
124711558|NCT03789292|448567832|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
124968288|NCT02658175|449511375|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
124968289|NCT02658175|449511376|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
124968290|NCT02658175|449511374|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
124711559|NCT03789292|448567833|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
124968291|NCT02658175|449511375|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
124968292|NCT02658175|449511376|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
124968293|NCT02658175|449511374|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
124968294|NCT02658175|449511375|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
124968295|NCT02658175|449511376|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
124968296|NCT02658175|449511374|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
124968297|NCT02658175|449511375|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
124968298|NCT02658175|449511376|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
124968299|NCT02658175|449511374|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
124968300|NCT02658175|449511375|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
124968301|NCT02658175|449511376|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
124968302|NCT02658175|449511374|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
124968303|NCT02658175|449511375|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
124968304|NCT02658175|449511376|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
124968305|NCT02658175|449511374|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
124968306|NCT02658175|449511375|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
124968307|NCT02658175|449511376|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
124466199|NCT00644787|447664590|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
124466200|NCT00644787|447664591|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
124711560|NCT03789292|448567834|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
124711561|NCT03789292|448567832|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
124711562|NCT03789292|448567833|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
124711563|NCT03789292|448567834|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
124711564|NCT03789292|448567832|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
124711565|NCT03789292|448567833|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
124711566|NCT03789292|448567834|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
124711567|NCT03789292|448567832|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
124466201|NCT00644787|447664589|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
124550973|NCT02180659|447973089|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
124550974|NCT02180659|447973090|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
124550975|NCT00481871|447973093|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
124550976|NCT00481871|447973094|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
124550977|NCT00481871|447973095|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
124550978|NCT00481871|447973096|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
124550979|NCT00481871|447973097|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
124550980|NCT03332212|447973098|FG000|Overall Study|Not treated|0|||
124550981|NCT03332212|447973099|FG001|Overall Study|Not treated|1|||
124550982|NCT03332212|447973100|FG002|Overall Study|Not treated|0|||
124550983|NCT03332212|447973101|FG003|Overall Study|Not treated|0|||
124550984|NCT03332212|447973098|FG000|Overall Study|Adverse Event|0|||
124550985|NCT03332212|447973099|FG001|Overall Study|Adverse Event|0|||
124711568|NCT03789292|448567833|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
124711569|NCT03789292|448567834|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
124711570|NCT03789292|448567832|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
124711571|NCT03789292|448567833|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
124711572|NCT03789292|448567834|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
124550986|NCT03332212|447973100|FG002|Overall Study|Adverse Event|0|||
124550987|NCT03332212|447973101|FG003|Overall Study|Adverse Event|1|||
124550988|NCT03332212|447973098|FG000|Overall Study|worsening of disease under study|1|||
124550989|NCT03332212|447973099|FG001|Overall Study|worsening of disease under study|1|||
124550990|NCT03332212|447973100|FG002|Overall Study|worsening of disease under study|0|||
124711573|NCT00575666|448567835|FG000|Overall Study|Withdrawal by Subject|3|||
124711574|NCT00575666|448567836|FG001|Overall Study|Withdrawal by Subject|2|||
124711575|NCT00575666|448567835|FG000|Overall Study|Physician Decision|1|||
124711576|NCT00575666|448567836|FG001|Overall Study|Physician Decision|1|||
124711577|NCT00508482|448567837|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
124711578|NCT00508482|448567838|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
124466202|NCT00644787|447664590|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
124466203|NCT00644787|447664591|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
124466204|NCT00644787|447664589|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
124466205|NCT00644787|447664590|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
124466206|NCT00644787|447664591|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
124466207|NCT03355300|447664592|FG000|Overall Study|Physician Decision|0|||
124466208|NCT03355300|447664593|FG001|Overall Study|Physician Decision|1|||
124466209|NCT03355300|447664592|FG000|Overall Study|Lack of Efficacy|2|||
124466210|NCT03355300|447664593|FG001|Overall Study|Lack of Efficacy|1|||
124466211|NCT03355300|447664592|FG000|Overall Study|Other reason|1|||
124466212|NCT03355300|447664593|FG001|Overall Study|Other reason|0|||
124466213|NCT01489527|447664595|FG000|Overall Study|Pregnancy|9|||
124711579|NCT00508482|448567839|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
124711580|NCT00508482|448567837|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
124711581|NCT00508482|448567838|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
124711582|NCT00508482|448567839|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
124466214|NCT01489527|447664596|FG001|Overall Study|Pregnancy|14|||
124711583|NCT00508482|448567837|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
124550991|NCT03332212|447973101|FG003|Overall Study|worsening of disease under study|0|||
124550992|NCT02058368|447973106|FG000|Overall Study|Adverse Event|15|||
124550993|NCT02058368|447973107|FG001|Overall Study|Adverse Event|20|||
124550994|NCT02058368|447973106|FG000|Overall Study|Lack of Efficacy|0|||
124550995|NCT02058368|447973107|FG001|Overall Study|Lack of Efficacy|1|||
124550996|NCT02058368|447973106|FG000|Overall Study|Protocol Violation|0|||
124550997|NCT02058368|447973107|FG001|Overall Study|Protocol Violation|4|||
124550998|NCT02058368|447973106|FG000|Overall Study|Lost to Follow-up|2|||
124550999|NCT02058368|447973107|FG001|Overall Study|Lost to Follow-up|0|||
124551000|NCT02058368|447973106|FG000|Overall Study|Physician Decision|2|||
124551001|NCT02058368|447973107|FG001|Overall Study|Physician Decision|3|||
124551002|NCT02058368|447973106|FG000|Overall Study|Withdrawal by Subject|22|||
124551003|NCT02058368|447973107|FG001|Overall Study|Withdrawal by Subject|26|||
124551004|NCT01652872|447973112|FG000|Overall Study|Death|36|||
124551005|NCT01652872|447973113|FG001|Overall Study|Death|39|||
124551006|NCT01652872|447973112|FG000|Overall Study|Lost to Follow-up|28|||
124551007|NCT01652872|447973113|FG001|Overall Study|Lost to Follow-up|23|||
124551008|NCT01652872|447973112|FG000|Overall Study|Decision by sponsor|5|||
124551009|NCT01652872|447973113|FG001|Overall Study|Decision by sponsor|7|||
124551010|NCT01652872|447973112|FG000|Overall Study|Withdrawal by Subject|76|||
124551011|NCT01652872|447973113|FG001|Overall Study|Withdrawal by Subject|84|||
124551012|NCT01216319|447973114|FG000|Overall Study|Lost to Follow-up|2|||
124551013|NCT01216319|447973114|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
124551014|NCT04529096|447973115|FG000|Overall Study|Adverse Event|6|||
124551015|NCT04529096|447973116|FG001|Overall Study|Adverse Event|1|||
124551016|NCT04529096|447973115|FG000|Overall Study|Lack of Efficacy|1|||
124551017|NCT04529096|447973116|FG001|Overall Study|Lack of Efficacy|0|||
124551018|NCT04529096|447973115|FG000|Overall Study|Lost to Follow-up|1|||
124551019|NCT04529096|447973116|FG001|Overall Study|Lost to Follow-up|1|||
124551020|NCT04529096|447973115|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124551021|NCT04529096|447973116|FG001|Overall Study|Non-Compliance With Study Drug|1|||
124551022|NCT04529096|447973115|FG000|Overall Study|Physician Decision|1|||
124551023|NCT04529096|447973116|FG001|Overall Study|Physician Decision|3|||
124551024|NCT04529096|447973115|FG000|Overall Study|Withdrawal by Subject|5|||
124551025|NCT04529096|447973116|FG001|Overall Study|Withdrawal by Subject|0|||
124551026|NCT00390572|447973120|FG000|Overall Study|Lost to Follow-up|8|||
124551027|NCT00390572|447973121|FG001|Overall Study|Lost to Follow-up|4|||
124551028|NCT00390572|447973120|FG000|Overall Study|health condition|0|||
124551029|NCT00390572|447973121|FG001|Overall Study|health condition|1|||
124551030|NCT02392559|447973122|FG000|Overall Study|Withdrawal by Subject|0|||
124551031|NCT02392559|447973123|FG001|Overall Study|Withdrawal by Subject|1|||
124551032|NCT01966107|447973124|FG000|Overall Study|excluded from FAS|21|||
124551033|NCT01966107|447973125|FG001|Overall Study|excluded from FAS|20|||
124551034|NCT01966107|447973124|FG000|Overall Study|discontinued treatment|345|||
124551035|NCT01966107|447973125|FG001|Overall Study|discontinued treatment|372|||
124551036|NCT01966107|447973124|FG000|Overall Study|due to study closure|164|||
124551037|NCT01966107|447973125|FG001|Overall Study|due to study closure|186|||
124551038|NCT01966107|447973124|FG000|Overall Study|withdrew from the study|272|||
124551039|NCT01966107|447973125|FG001|Overall Study|withdrew from the study|303|||
124551040|NCT00532779|447973126|FG000|Overall Study|Adverse Event|122|||
124551041|NCT00532779|447973127|FG001|Overall Study|Adverse Event|112|||
124551042|NCT00532779|447973128|FG002|Overall Study|Adverse Event|56|||
124551043|NCT00532779|447973126|FG000|Overall Study|Lost to Follow-up|76|||
124551044|NCT00532779|447973127|FG001|Overall Study|Lost to Follow-up|65|||
124551045|NCT00532779|447973128|FG002|Overall Study|Lost to Follow-up|66|||
124551046|NCT00532779|447973126|FG000|Overall Study|Withdrawal by Subject|63|||
124551047|NCT00532779|447973127|FG001|Overall Study|Withdrawal by Subject|60|||
124551048|NCT00532779|447973128|FG002|Overall Study|Withdrawal by Subject|90|||
124551049|NCT00532779|447973126|FG000|Overall Study|Lack of Efficacy|12|||
124551050|NCT00532779|447973127|FG001|Overall Study|Lack of Efficacy|12|||
124551051|NCT00532779|447973128|FG002|Overall Study|Lack of Efficacy|40|||
124551052|NCT00532779|447973126|FG000|Overall Study|Protocol Violation|5|||
124551053|NCT00532779|447973127|FG001|Overall Study|Protocol Violation|9|||
124551054|NCT00532779|447973128|FG002|Overall Study|Protocol Violation|7|||
124551055|NCT00532779|447973126|FG000|Overall Study|Pregnancy|2|||
124551056|NCT00532779|447973127|FG001|Overall Study|Pregnancy|5|||
124551057|NCT00532779|447973128|FG002|Overall Study|Pregnancy|3|||
124551058|NCT00532779|447973126|FG000|Overall Study|Death|0|||
124551059|NCT00532779|447973127|FG001|Overall Study|Death|1|||
124551060|NCT00532779|447973128|FG002|Overall Study|Death|0|||
124551061|NCT00532779|447973126|FG000|Overall Study|Drug noncompliance, moved, other|14|||
124551062|NCT00532779|447973127|FG001|Overall Study|Drug noncompliance, moved, other|23|||
124551063|NCT00532779|447973128|FG002|Overall Study|Drug noncompliance, moved, other|29|||
124551064|NCT00689273|447973129|FG000|Overall Study|Adverse Event|3|||
124551065|NCT00689273|447973130|FG001|Overall Study|Adverse Event|1|||
124551066|NCT00689273|447973129|FG000|Overall Study|Lack of Efficacy|3|||
124551067|NCT00689273|447973130|FG001|Overall Study|Lack of Efficacy|0|||
124551068|NCT00689273|447973129|FG000|Overall Study|Lost to Follow-up|0|||
124551069|NCT00689273|447973130|FG001|Overall Study|Lost to Follow-up|2|||
124466215|NCT01489527|447664595|FG000|Overall Study|Participant moved|6|||
124466216|NCT01489527|447664596|FG001|Overall Study|Participant moved|7|||
124711584|NCT00508482|448567838|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
124711585|NCT00508482|448567839|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
124711586|NCT02289469|448567840|FG000|Overall Study|Unable to match a control|6|||
124711587|NCT02289469|448567841|FG001|Overall Study|Unable to match a control|0|||
124711588|NCT01904721|448567846|FG000|Overall Study|Other Reasons|0|||
124711589|NCT01904721|448567847|FG001|Overall Study|Other Reasons|0|||
124711590|NCT01904721|448567848|FG002|Overall Study|Other Reasons|1|||
124711591|NCT01904721|448567849|FG003|Overall Study|Other Reasons|1|||
124711592|NCT01904721|448567850|FG004|Overall Study|Other Reasons|2|||
124711593|NCT01904721|448567851|FG005|Overall Study|Other Reasons|2|||
124711594|NCT01904721|448567852|FG006|Overall Study|Other Reasons|2|||
124711595|NCT01904721|448567846|FG000|Overall Study|Personal Reasons|0|||
124711596|NCT01904721|448567847|FG001|Overall Study|Personal Reasons|0|||
124711597|NCT01904721|448567848|FG002|Overall Study|Personal Reasons|0|||
124711598|NCT01904721|448567849|FG003|Overall Study|Personal Reasons|0|||
124711599|NCT01904721|448567850|FG004|Overall Study|Personal Reasons|2|||
124711600|NCT01904721|448567851|FG005|Overall Study|Personal Reasons|3|||
124711601|NCT01904721|448567852|FG006|Overall Study|Personal Reasons|3|||
124711602|NCT01904721|448567846|FG000|Overall Study|Lost to Follow-up|0|||
124711603|NCT01904721|448567847|FG001|Overall Study|Lost to Follow-up|0|||
124711604|NCT01904721|448567848|FG002|Overall Study|Lost to Follow-up|0|||
124711605|NCT01904721|448567849|FG003|Overall Study|Lost to Follow-up|0|||
124711606|NCT01904721|448567850|FG004|Overall Study|Lost to Follow-up|1|||
124711607|NCT01904721|448567851|FG005|Overall Study|Lost to Follow-up|3|||
124711608|NCT01904721|448567852|FG006|Overall Study|Lost to Follow-up|1|||
124711609|NCT01904721|448567846|FG000|Overall Study|Lack of Efficacy|0|||
124711610|NCT01904721|448567847|FG001|Overall Study|Lack of Efficacy|0|||
124711611|NCT01904721|448567848|FG002|Overall Study|Lack of Efficacy|0|||
124711612|NCT01904721|448567849|FG003|Overall Study|Lack of Efficacy|0|||
124711613|NCT01904721|448567850|FG004|Overall Study|Lack of Efficacy|0|||
124711614|NCT01904721|448567851|FG005|Overall Study|Lack of Efficacy|0|||
124711615|NCT01904721|448567852|FG006|Overall Study|Lack of Efficacy|1|||
124711616|NCT01904721|448567846|FG000|Overall Study|Adverse Event|0|||
124711617|NCT01904721|448567847|FG001|Overall Study|Adverse Event|0|||
124711618|NCT01904721|448567848|FG002|Overall Study|Adverse Event|0|||
124711619|NCT01904721|448567849|FG003|Overall Study|Adverse Event|0|||
124711620|NCT01904721|448567850|FG004|Overall Study|Adverse Event|3|||
124711621|NCT01904721|448567851|FG005|Overall Study|Adverse Event|1|||
124711622|NCT01904721|448567852|FG006|Overall Study|Adverse Event|0|||
124711623|NCT00950651|448567853|FG000|Overall Study|Adverse Event|17|||
124711624|NCT00950651|448567854|FG001|Overall Study|Adverse Event|20|||
124711625|NCT00950651|448567853|FG000|Overall Study|Death|1|||
124711626|NCT00950651|448567854|FG001|Overall Study|Death|0|||
124711627|NCT00950651|448567853|FG000|Overall Study|Lack of Efficacy|2|||
124711628|NCT00950651|448567854|FG001|Overall Study|Lack of Efficacy|2|||
124711629|NCT00950651|448567853|FG000|Overall Study|Protocol Violation|3|||
124711630|NCT00950651|448567854|FG001|Overall Study|Protocol Violation|4|||
124711631|NCT00950651|448567853|FG000|Overall Study|Withdrawal by Subject|8|||
124711632|NCT00950651|448567854|FG001|Overall Study|Withdrawal by Subject|9|||
124968308|NCT02658175|449511374|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
124968309|NCT02658175|449511375|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
124968310|NCT02658175|449511376|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
124968311|NCT01214421|449511377|FG000|Overall Study|Lost to Follow-up|7|||
124968312|NCT01214421|449511378|FG001|Overall Study|Lost to Follow-up|3|||
124968313|NCT01214421|449511379|FG002|Overall Study|Lost to Follow-up|7|||
124968314|NCT01214421|449511380|FG003|Overall Study|Lost to Follow-up|3|||
124968315|NCT01214421|449511377|FG000|Overall Study|Adverse Event|16|||
124968316|NCT01214421|449511378|FG001|Overall Study|Adverse Event|35|||
124466217|NCT01489527|447664595|FG000|Overall Study|Withdrawal by Subject|0|||
124466218|NCT01489527|447664596|FG001|Overall Study|Withdrawal by Subject|4|||
124466219|NCT01489527|447664595|FG000|Overall Study|Lost to Follow-up|5|||
124466220|NCT01489527|447664596|FG001|Overall Study|Lost to Follow-up|1|||
124466221|NCT01489527|447664595|FG000|Overall Study|Procedures|1|||
124711633|NCT01944020|448569374|FG000|Overall Study|Withdrawal by Subject|5|||
124466222|NCT01489527|447664596|FG001|Overall Study|Procedures|0|||
124711634|NCT01944020|448569375|FG001|Overall Study|Withdrawal by Subject|0|||
124711635|NCT00110214|448569380|FG000|Overall Study|Never started treatment|21|||
124711636|NCT00110214|448569381|FG001|Overall Study|Never started treatment|20|||
124466223|NCT01489527|447664595|FG000|Overall Study|Not compliant|1|||
124466224|NCT01489527|447664596|FG001|Overall Study|Not compliant|0|||
124711637|NCT00110214|448569380|FG000|Overall Study|Disease progression or death|260|||
124711638|NCT00110214|448569381|FG001|Overall Study|Disease progression or death|151|||
124711639|NCT00110214|448569380|FG000|Overall Study|Adverse Event|115|||
124711640|NCT00110214|448569381|FG001|Overall Study|Adverse Event|192|||
124711641|NCT00110214|448569380|FG000|Overall Study|Refused further treatment|52|||
124711642|NCT00110214|448569381|FG001|Overall Study|Refused further treatment|65|||
124711643|NCT00110214|448569380|FG000|Overall Study|Other (not specified)|61|||
124711644|NCT00110214|448569381|FG001|Overall Study|Other (not specified)|75|||
124551070|NCT00689273|447973129|FG000|Overall Study|Other|6|||
124551071|NCT00689273|447973130|FG001|Overall Study|Other|2|||
124711645|NCT00811954|448569383|FG000|Overall Study|Death|10|||
124711646|NCT00811954|448569384|FG001|Overall Study|Death|6|||
124968317|NCT01214421|449511379|FG002|Overall Study|Adverse Event|14|||
124968318|NCT01214421|449511380|FG003|Overall Study|Adverse Event|3|||
124968319|NCT01214421|449511377|FG000|Overall Study|Sponsor Discontinued Site|1|||
124968320|NCT01214421|449511378|FG001|Overall Study|Sponsor Discontinued Site|2|||
124968321|NCT01214421|449511379|FG002|Overall Study|Sponsor Discontinued Site|0|||
124968322|NCT01214421|449511380|FG003|Overall Study|Sponsor Discontinued Site|0|||
124968323|NCT01214421|449511377|FG000|Overall Study|Withdrawal Criteria Met|3|||
124968324|NCT01214421|449511378|FG001|Overall Study|Withdrawal Criteria Met|0|||
124968325|NCT01214421|449511379|FG002|Overall Study|Withdrawal Criteria Met|2|||
124968326|NCT01214421|449511380|FG003|Overall Study|Withdrawal Criteria Met|1|||
124968327|NCT01214421|449511377|FG000|Overall Study|Physician Decision|2|||
124968328|NCT01214421|449511378|FG001|Overall Study|Physician Decision|0|||
124968329|NCT01214421|449511379|FG002|Overall Study|Physician Decision|4|||
124968330|NCT01214421|449511380|FG003|Overall Study|Physician Decision|0|||
124968331|NCT01214421|449511377|FG000|Overall Study|Withdrawal by Subject|21|||
124968332|NCT01214421|449511378|FG001|Overall Study|Withdrawal by Subject|18|||
124968333|NCT01214421|449511379|FG002|Overall Study|Withdrawal by Subject|11|||
124968334|NCT01214421|449511380|FG003|Overall Study|Withdrawal by Subject|2|||
124968335|NCT02581059|449511385|FG000|Study Treatment|Disease Progression|1|||
124968336|NCT02581059|449511386|FG001|Study Treatment|Disease Progression|1|||
124968337|NCT02581059|449511385|FG000|Study Treatment|Adverse Event|2|||
124968338|NCT02581059|449511386|FG001|Study Treatment|Adverse Event|1|||
124968339|NCT02581059|449511385|FG000|Study Treatment|Death|1|||
124968340|NCT02581059|449511386|FG001|Study Treatment|Death|1|||
124968341|NCT02581059|449511385|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
124968342|NCT02581059|449511386|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
124968343|NCT02581059|449511385|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
124968344|NCT02581059|449511386|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
124968345|NCT02581059|449511385|FG000|Follow up|Death|1|||
124968346|NCT02581059|449511386|FG001|Follow up|Death|3|||
124968347|NCT02581059|449511385|FG000|Follow up|study terminated|1|||
124968348|NCT02581059|449511386|FG001|Follow up|study terminated|1|||
124968349|NCT02581059|449511385|FG000|Follow up|screen failure|0|||
124968350|NCT02581059|449511386|FG001|Follow up|screen failure|1|||
124968351|NCT02581059|449511385|FG000|Follow up|Patient started new clinical trial|1|||
124968352|NCT02581059|449511386|FG001|Follow up|Patient started new clinical trial|0|||
124968353|NCT02392104|449511387|FG000|Overall Study|discontinuation of warfarin|3|||
124968354|NCT02392104|449511387|FG000|Overall Study|bleeding event|1|||
124968355|NCT02392104|449511387|FG000|Overall Study|transferred care to another doctor|2|||
124968356|NCT02392104|449511387|FG000|Overall Study|INR goal range changed|1|||
124968357|NCT02392104|449511387|FG000|Overall Study|admitted to skilled nursing facility|3|||
124968358|NCT02392104|449511387|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
124968359|NCT04887506|449511388|FG000|Overall Study|Death|1|||
124968360|NCT04887506|449511389|FG001|Overall Study|Death|1|||
124968361|NCT04887506|449511388|FG000|Overall Study|Withdrawal by Subject|0|||
124968362|NCT04887506|449511389|FG001|Overall Study|Withdrawal by Subject|3|||
124466225|NCT03048422|447664597|FG000|Overall Study|Death|1|||
124466226|NCT03048422|447664598|FG001|Overall Study|Death|0|||
124466227|NCT03048422|447664599|FG002|Overall Study|Death|0|||
124466228|NCT03048422|447664597|FG000|Overall Study|Lost to Follow-up|5|||
124466229|NCT03048422|447664598|FG001|Overall Study|Lost to Follow-up|0|||
124466230|NCT03048422|447664599|FG002|Overall Study|Lost to Follow-up|1|||
124466231|NCT03048422|447664597|FG000|Overall Study|Withdrawal by Subject|5|||
124466232|NCT03048422|447664598|FG001|Overall Study|Withdrawal by Subject|7|||
124466233|NCT03048422|447664599|FG002|Overall Study|Withdrawal by Subject|4|||
124466234|NCT03048422|447664597|FG000|Overall Study|Moved|3|||
124466235|NCT03048422|447664598|FG001|Overall Study|Moved|2|||
124466236|NCT03048422|447664599|FG002|Overall Study|Moved|2|||
124466237|NCT03048422|447664597|FG000|Overall Study|Noncompliant with Study Requirements|2|||
124968363|NCT04887506|449511388|FG000|Overall Study|Adverse Event|4|||
124968364|NCT04887506|449511389|FG001|Overall Study|Adverse Event|3|||
124968365|NCT04887506|449511388|FG000|Overall Study|Other - Not Reported|1|||
124968366|NCT04887506|449511389|FG001|Overall Study|Other - Not Reported|1|||
124968367|NCT02394665|449511392|FG000|Overall Study|Physician Decision|1|||
124968368|NCT02394665|449511393|FG001|Overall Study|Physician Decision|0|||
124466238|NCT03048422|447664598|FG001|Overall Study|Noncompliant with Study Requirements|1|||
124551072|NCT00689273|447973129|FG000|Overall Study|Randomized but not Treated|1|||
124551073|NCT00689273|447973130|FG001|Overall Study|Randomized but not Treated|0|||
124968369|NCT02394665|449511394|FG002|Overall Study|Physician Decision|0|||
124968370|NCT02636608|449511395|FG000|Overall Study|Failure to Return|4|||
124968371|NCT02636608|449511395|FG000|Overall Study|Insufficient Virological Response|1|||
124968372|NCT02636608|449511395|FG000|Overall Study|Death|3|||
124968373|NCT02636608|449511395|FG000|Overall Study|Other|2|||
124968374|NCT02636608|449511395|FG000|Overall Study|Did Not Receive Treatment|1|||
124711647|NCT00811954|448569385|FG002|Overall Study|Death|13|||
124711648|NCT00811954|448569383|FG000|Overall Study|Lost to Follow-up|29|||
124711649|NCT00811954|448569384|FG001|Overall Study|Lost to Follow-up|23|||
124711650|NCT00811954|448569385|FG002|Overall Study|Lost to Follow-up|34|||
124711651|NCT00811954|448569383|FG000|Overall Study|Not able to get to clinic|28|||
124711652|NCT00811954|448569384|FG001|Overall Study|Not able to get to clinic|35|||
124711653|NCT00811954|448569385|FG002|Overall Study|Not able to get to clinic|30|||
124711654|NCT00811954|448569383|FG000|Overall Study|Not willing to adhere to requirements|12|||
124711655|NCT00811954|448569384|FG001|Overall Study|Not willing to adhere to requirements|2|||
124711656|NCT00811954|448569385|FG002|Overall Study|Not willing to adhere to requirements|16|||
124711657|NCT00811954|448569383|FG000|Overall Study|Withdraw consent prior study completion|4|||
124711658|NCT00811954|448569384|FG001|Overall Study|Withdraw consent prior study completion|6|||
124711659|NCT00811954|448569385|FG002|Overall Study|Withdraw consent prior study completion|5|||
124711660|NCT00811954|448569383|FG000|Overall Study|Site Closure|4|||
124711661|NCT00811954|448569384|FG001|Overall Study|Site Closure|0|||
124711662|NCT00811954|448569385|FG002|Overall Study|Site Closure|1|||
124711663|NCT00811954|448569383|FG000|Overall Study|Severe Debilitation|2|||
124711664|NCT00811954|448569384|FG001|Overall Study|Severe Debilitation|0|||
124711665|NCT00811954|448569385|FG002|Overall Study|Severe Debilitation|1|||
124711666|NCT00811954|448569383|FG000|Overall Study|Complete Protocol: No follow-up|0|||
124711667|NCT00811954|448569384|FG001|Overall Study|Complete Protocol: No follow-up|0|||
124711668|NCT00811954|448569385|FG002|Overall Study|Complete Protocol: No follow-up|1|||
124711669|NCT01016067|448569386|FG000|Overall Study|Lost to Follow-up|1|||
124711670|NCT01016067|448569387|FG001|Overall Study|Lost to Follow-up|2|||
124551074|NCT01556165|447973131|FG000|Overall Study|Adverse Event|5|||
124551075|NCT01556165|447973132|FG001|Overall Study|Adverse Event|3|||
124551076|NCT01556165|447973131|FG000|Overall Study|Protocol Violation|0|||
124551077|NCT01556165|447973132|FG001|Overall Study|Protocol Violation|3|||
124551078|NCT01556165|447973131|FG000|Overall Study|Withdrawal of Consent|7|||
124551079|NCT01556165|447973132|FG001|Overall Study|Withdrawal of Consent|1|||
124551080|NCT01238172|447973133|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
124551081|NCT01238172|447973134|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
124551082|NCT01238172|447973133|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
124551083|NCT01238172|447973134|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
124551084|NCT02531698|447973135|FG000|Overall Study|Adverse Event|2|||
124551085|NCT02531698|447973136|FG001|Overall Study|Adverse Event|1|||
124551086|NCT02531698|447973135|FG000|Overall Study|Withdrawal by Subject|6|||
124711671|NCT01016067|448569386|FG000|Overall Study|Physician Decision|1|||
124968375|NCT05613088|449511398|FG000|Treatment|Ongoing Study Treatment|9|||
124968376|NCT05613088|449511399|FG001|Treatment|Ongoing Study Treatment|2|||
124968377|NCT05613088|449511398|FG000|Treatment|Adverse Event|3|||
124968378|NCT05613088|449511399|FG001|Treatment|Adverse Event|1|||
124968379|NCT05613088|449511398|FG000|Treatment|Other Reasons|0|||
124968380|NCT05613088|449511399|FG001|Treatment|Other Reasons|1|||
124968381|NCT05613088|449511398|FG000|Treatment|Progressive Disease|58|||
124968382|NCT05613088|449511399|FG001|Treatment|Progressive Disease|26|||
124968383|NCT05613088|449511398|FG000|Treatment|Withdrawal by Subject|0|||
124968384|NCT05613088|449511399|FG001|Treatment|Withdrawal by Subject|4|||
124968385|NCT03912532|449511400|FG000|Overall Study|Adverse Event|3|||
124968386|NCT03912532|449511401|FG001|Overall Study|Adverse Event|3|||
124968387|NCT03912532|449511402|FG002|Overall Study|Adverse Event|2|||
124968388|NCT03912532|449511403|FG003|Overall Study|Adverse Event|2|||
124968389|NCT03912532|449511400|FG000|Overall Study|Lost to Follow-up|3|||
124968390|NCT03912532|449511401|FG001|Overall Study|Lost to Follow-up|2|||
124968391|NCT03912532|449511402|FG002|Overall Study|Lost to Follow-up|1|||
124968392|NCT03912532|449511403|FG003|Overall Study|Lost to Follow-up|2|||
124968393|NCT03912532|449511400|FG000|Overall Study|Withdrawal by Subject|1|||
124711672|NCT01016067|448569387|FG001|Overall Study|Physician Decision|1|||
124711673|NCT01016067|448569386|FG000|Overall Study|Withdrew due to Relocation|0|||
124711674|NCT01016067|448569387|FG001|Overall Study|Withdrew due to Relocation|1|||
124711675|NCT01534481|448569394|FG000|Overall Study|Lost to Follow-up|29|||
124551087|NCT02531698|447973136|FG001|Overall Study|Withdrawal by Subject|1|||
124551088|NCT02531698|447973135|FG000|Overall Study|Protocol Violation|2|||
124711676|NCT01534481|448569395|FG001|Overall Study|Lost to Follow-up|24|||
124711677|NCT01534481|448569394|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
124711678|NCT01534481|448569395|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
124968394|NCT03912532|449511401|FG001|Overall Study|Withdrawal by Subject|1|||
124968395|NCT03912532|449511402|FG002|Overall Study|Withdrawal by Subject|2|||
124968396|NCT03912532|449511403|FG003|Overall Study|Withdrawal by Subject|0|||
124968397|NCT03912532|449511400|FG000|Overall Study|Physician Decision|1|||
124968398|NCT03912532|449511401|FG001|Overall Study|Physician Decision|0|||
124551089|NCT02531698|447973136|FG001|Overall Study|Protocol Violation|0|||
124551090|NCT02531698|447973135|FG000|Overall Study|Lost to Follow-up|1|||
124551091|NCT02531698|447973136|FG001|Overall Study|Lost to Follow-up|0|||
124551092|NCT00701558|447973137|FG000|Overall Study|Death|7|||
124551093|NCT00701558|447973137|FG000|Overall Study|Lost to Follow-up|8|||
124551094|NCT04822701|447973140|FG000|Overall Study|Not treated|2|||
124551095|NCT04822701|447973141|FG001|Overall Study|Not treated|0|||
124551096|NCT04822701|447973140|FG000|Overall Study|Lost to Follow-up|1|||
124551097|NCT04822701|447973141|FG001|Overall Study|Lost to Follow-up|0|||
124551098|NCT04822701|447973140|FG000|Overall Study|Withdrawal by Subject|1|||
124551099|NCT04822701|447973141|FG001|Overall Study|Withdrawal by Subject|0|||
124551100|NCT02038959|447974643|FG000|Overall Study|Withdrawal by Subject|6|||
124551101|NCT02038959|447974644|FG001|Overall Study|Withdrawal by Subject|8|||
124551102|NCT01788163|447974652|FG000|Overall Study|Other|53|||
124551103|NCT01788163|447974653|FG001|Overall Study|Other|0|||
124551104|NCT01788163|447974654|FG002|Overall Study|Other|0|||
124551105|NCT01788163|447974655|FG003|Overall Study|Other|0|||
124551106|NCT01788163|447974656|FG004|Overall Study|Other|0|||
124551107|NCT01788163|447974657|FG005|Overall Study|Other|7|||
124551108|NCT01788163|447974658|FG006|Overall Study|Other|1|||
124551109|NCT01788163|447974659|FG007|Overall Study|Other|48|||
124711679|NCT01130337|448569396|FG000|Overall Study|Withdrawal by Subject|3|||
124711680|NCT01130337|448569396|FG000|Overall Study|Principal investigator decision|1|||
124711681|NCT01130337|448569396|FG000|Overall Study|Death|1|||
124711682|NCT01130337|448569396|FG000|Overall Study|Disease progression|1|||
124711683|NCT01130337|448569396|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
124711684|NCT01130337|448569396|FG000|Overall Study|Surgical resection (R2)|1|||
124968399|NCT03912532|449511402|FG002|Overall Study|Physician Decision|0|||
124968400|NCT03912532|449511403|FG003|Overall Study|Physician Decision|3|||
124968401|NCT03912532|449511400|FG000|Overall Study|Other|0|||
124968402|NCT03912532|449511401|FG001|Overall Study|Other|1|||
124968403|NCT03912532|449511402|FG002|Overall Study|Other|1|||
124968404|NCT03912532|449511403|FG003|Overall Study|Other|0|||
124968405|NCT04199052|449511406|FG000|Overall Study|Lost to Follow-up|11|||
124968406|NCT04199052|449511407|FG001|Overall Study|Lost to Follow-up|18|||
124968407|NCT03569891|449511408|FG000|Lead-in|Ineligible during lead-in|8|||
124968408|NCT03569891|449511408|FG000|Lead-in|Withdrawal by Subject|3|||
124968409|NCT03569891|449511408|FG000|Lead-in|Risks related to COVID-19|2|||
124968410|NCT03569891|449511408|FG000|AMT-061|Adverse Event|1|||
124968411|NCT00815919|449511409|FG000|Overall Study|Unrelated Fungal Infection|1|||
124968412|NCT00815919|449511409|FG000|Overall Study|AML Relapse|1|||
124968413|NCT00815919|449511409|FG000|Overall Study|Lack of Efficacy|2|||
124968414|NCT03614676|449513346|FG000|Overall Study|Delivery before planned visit|2|||
124968415|NCT03614676|449513347|FG001|Overall Study|Delivery before planned visit|0|||
124968416|NCT03614676|449513346|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
124968417|NCT03614676|449513347|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
124968418|NCT03614676|449513346|FG000|Overall Study|Migrated / moved from the study area|30|||
124968419|NCT03614676|449513347|FG001|Overall Study|Migrated / moved from the study area|22|||
124968420|NCT03614676|449513346|FG000|Overall Study|Lost to Follow-up|17|||
124968421|NCT03614676|449513347|FG001|Overall Study|Lost to Follow-up|42|||
124968422|NCT03614676|449513346|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
124968423|NCT03614676|449513347|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
124968424|NCT03614676|449513346|FG000|Overall Study|Other|16|||
124968425|NCT03614676|449513347|FG001|Overall Study|Other|47|||
124968426|NCT03614676|449513346|FG000|Overall Study|Protocol Violation|0|||
124968427|NCT03614676|449513347|FG001|Overall Study|Protocol Violation|2|||
124968428|NCT03614676|449513346|FG000|Overall Study|Neonatal event of interest|0|||
124968429|NCT03614676|449513347|FG001|Overall Study|Neonatal event of interest|6|||
124968430|NCT03614676|449513346|FG000|Overall Study|Death in infant greater than 28 days old|0|||
124968431|NCT03614676|449513347|FG001|Overall Study|Death in infant greater than 28 days old|12|||
124968432|NCT03614676|449513346|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
124968433|NCT03614676|449513347|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
124968434|NCT02825251|449513350|FG000|Overall Study|Adverse Event|0|||
124968435|NCT02825251|449513351|FG001|Overall Study|Adverse Event|1|||
124968436|NCT02825251|449513350|FG000|Overall Study|Lost to Follow-up|0|||
124968437|NCT02825251|449513351|FG001|Overall Study|Lost to Follow-up|1|||
124551110|NCT01788163|447974660|FG008|Overall Study|Other|15|||
124551111|NCT01788163|447974652|FG000|Overall Study|Withdrawal by Subject|2|||
124968438|NCT02825251|449513350|FG000|Overall Study|Withdrawal by Subject|1|||
124968439|NCT02825251|449513351|FG001|Overall Study|Withdrawal by Subject|4|||
124968440|NCT02825251|449513350|FG000|Overall Study|Unclassified|2|||
124968441|NCT02825251|449513351|FG001|Overall Study|Unclassified|0|||
124968442|NCT00487825|449513352|FG000|Overall Study|Adverse Event|2|||
124968443|NCT00487825|449513353|FG001|Overall Study|Adverse Event|2|||
124551112|NCT01788163|447974653|FG001|Overall Study|Withdrawal by Subject|0|||
124466239|NCT03048422|447664599|FG002|Overall Study|Noncompliant with Study Requirements|2|||
124466240|NCT03048422|447664597|FG000|Overall Study|Not Able to Get to Clinic|1|||
124466241|NCT03048422|447664598|FG001|Overall Study|Not Able to Get to Clinic|0|||
124466242|NCT03048422|447664599|FG002|Overall Study|Not Able to Get to Clinic|0|||
124466243|NCT01984268|447664600|FG000|Overall Study|Study Terminated|15|||
124466244|NCT04899232|447664601|FG000|Screening Period|Physician Decision|1|||
124466245|NCT04899232|447664602|FG001|Screening Period|Physician Decision|0|||
124466246|NCT04899232|447664603|FG002|Screening Period|Physician Decision|0|||
124466247|NCT04899232|447664601|FG000|Screening Period|Withdrawal by Subject|1|||
124466248|NCT04899232|447664602|FG001|Screening Period|Withdrawal by Subject|0|||
124466249|NCT04899232|447664603|FG002|Screening Period|Withdrawal by Subject|0|||
124551113|NCT01788163|447974654|FG002|Overall Study|Withdrawal by Subject|0|||
124551114|NCT01788163|447974655|FG003|Overall Study|Withdrawal by Subject|0|||
124551115|NCT01788163|447974656|FG004|Overall Study|Withdrawal by Subject|0|||
124551116|NCT01788163|447974657|FG005|Overall Study|Withdrawal by Subject|0|||
124551117|NCT01788163|447974658|FG006|Overall Study|Withdrawal by Subject|0|||
124551118|NCT01788163|447974659|FG007|Overall Study|Withdrawal by Subject|0|||
124551119|NCT01788163|447974660|FG008|Overall Study|Withdrawal by Subject|1|||
124551120|NCT00545441|447974661|FG000|Overall Study|Fistula draining at 6 months|2|||
124551121|NCT00545441|447974662|FG001|Overall Study|Fistula draining at 6 months|4|||
124551122|NCT00545441|447974661|FG000|Overall Study|Lost to Follow-up|9|||
124711685|NCT05525910|448569397|FG000|Period 4|Per sponsor due to study timelines|0|||
124711686|NCT05525910|448569398|FG001|Period 4|Per sponsor due to study timelines|0|||
124551123|NCT00545441|447974662|FG001|Overall Study|Lost to Follow-up|5|||
124551124|NCT00545441|447974661|FG000|Overall Study|Technical failure|0|||
124551125|NCT00545441|447974662|FG001|Overall Study|Technical failure|1|||
124551126|NCT00545441|447974661|FG000|Overall Study|Withdrawal by Subject|1|||
124551127|NCT00545441|447974662|FG001|Overall Study|Withdrawal by Subject|1|||
124551128|NCT00545441|447974661|FG000|Overall Study|Persistence or recurrence of fistula|5|||
124968444|NCT00487825|449513352|FG000|Overall Study|Lack of Efficacy|1|||
124968445|NCT00487825|449513353|FG001|Overall Study|Lack of Efficacy|1|||
124968446|NCT00487825|449513352|FG000|Overall Study|Other|3|||
124968447|NCT00487825|449513353|FG001|Overall Study|Other|2|||
124968448|NCT01639742|449513356|FG000|Overall Study|Study Ongoing|17|||
124968449|NCT01639742|449513356|FG000|Overall Study|Lost to Follow-up|1|||
124968450|NCT01190644|449513358|FG000|Overall Study|Death|2|||
124968451|NCT01190644|449513358|FG000|Overall Study|Disease progression|1|||
124968452|NCT02366143|449513359|FG000|Overall Study|Death|307|||
124968453|NCT02366143|449513360|FG001|Overall Study|Death|278|||
124968454|NCT02366143|449513361|FG002|Overall Study|Death|280|||
124968455|NCT02366143|449513359|FG000|Overall Study|Lost to Follow-up|2|||
124968456|NCT02366143|449513360|FG001|Overall Study|Lost to Follow-up|4|||
124968457|NCT02366143|449513361|FG002|Overall Study|Lost to Follow-up|2|||
124968458|NCT02366143|449513359|FG000|Overall Study|Physician Decision|1|||
124968459|NCT02366143|449513360|FG001|Overall Study|Physician Decision|2|||
124968460|NCT02366143|449513361|FG002|Overall Study|Physician Decision|1|||
124968461|NCT02366143|449513359|FG000|Overall Study|Protocol Violation|0|||
124968462|NCT02366143|449513360|FG001|Overall Study|Protocol Violation|0|||
124968463|NCT02366143|449513361|FG002|Overall Study|Protocol Violation|2|||
124968464|NCT02366143|449513359|FG000|Overall Study|Withdrawal by Subject|16|||
124968465|NCT02366143|449513360|FG001|Overall Study|Withdrawal by Subject|17|||
124968466|NCT02366143|449513361|FG002|Overall Study|Withdrawal by Subject|22|||
124968467|NCT02366143|449513359|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
124968468|NCT02366143|449513360|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
124968469|NCT02366143|449513361|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
124968470|NCT02366143|449513359|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
124968471|NCT02366143|449513360|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
124968472|NCT02366143|449513361|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
124968473|NCT02366143|449513359|FG000|Overall Study|Randomization Error|1|||
124968474|NCT02366143|449513360|FG001|Overall Study|Randomization Error|0|||
124968475|NCT02366143|449513361|FG002|Overall Study|Randomization Error|0|||
124968476|NCT02366143|449513359|FG000|Overall Study|PI Move and Site Closure|1|||
124968477|NCT02366143|449513360|FG001|Overall Study|PI Move and Site Closure|0|||
124551129|NCT00545441|447974662|FG001|Overall Study|Persistence or recurrence of fistula|2|||
124551130|NCT00545441|447974661|FG000|Overall Study|Patients were not treated|1|||
124711687|NCT05525910|448569399|FG002|Period 4|Per sponsor due to study timelines|1|||
124711688|NCT05525910|448569400|FG003|Period 4|Per sponsor due to study timelines|1|||
124968478|NCT02366143|449513361|FG002|Overall Study|PI Move and Site Closure|1|||
124466250|NCT04899232|447664601|FG000|Screening Period|Participant discharged before receiving intervention|3|||
124968479|NCT02366143|449513359|FG000|Overall Study|Study Terminated By Sponsor|0|||
124968480|NCT02366143|449513360|FG001|Overall Study|Study Terminated By Sponsor|0|||
124968481|NCT02366143|449513361|FG002|Overall Study|Study Terminated By Sponsor|2|||
124968482|NCT02366143|449513359|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
124968483|NCT02366143|449513360|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
124551131|NCT00545441|447974662|FG001|Overall Study|Patients were not treated|3|||
124968484|NCT02366143|449513361|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
124968485|NCT02366143|449513359|FG000|Overall Study|Patient moved to roll-over study|1|||
124968486|NCT02366143|449513360|FG001|Overall Study|Patient moved to roll-over study|19|||
124968487|NCT02366143|449513361|FG002|Overall Study|Patient moved to roll-over study|28|||
124968488|NCT02366143|449513359|FG000|Overall Study|Patient moved to commercial stock|0|||
124968489|NCT02366143|449513360|FG001|Overall Study|Patient moved to commercial stock|0|||
124968490|NCT02366143|449513361|FG002|Overall Study|Patient moved to commercial stock|1|||
124968491|NCT02366143|449513359|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
124968492|NCT02366143|449513360|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
124968493|NCT02366143|449513361|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
124968494|NCT02366143|449513359|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
124968495|NCT02366143|449513360|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
124968496|NCT02366143|449513361|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
124968497|NCT02366143|449513359|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
124968498|NCT02366143|449513360|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
124968499|NCT02366143|449513361|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
124968500|NCT02366143|449513359|FG000|Overall Study|Requester's instructions|1|||
124968501|NCT02366143|449513360|FG001|Overall Study|Requester's instructions|1|||
124968502|NCT02366143|449513361|FG002|Overall Study|Requester's instructions|1|||
124968503|NCT02366143|449513359|FG000|Overall Study|Uneligible|0|||
124968504|NCT02366143|449513360|FG001|Overall Study|Uneligible|1|||
124968505|NCT02366143|449513361|FG002|Overall Study|Uneligible|0|||
124968506|NCT02366143|449513359|FG000|Overall Study|Post Trial Migration|0|||
124968507|NCT02366143|449513360|FG001|Overall Study|Post Trial Migration|1|||
124968508|NCT02366143|449513361|FG002|Overall Study|Post Trial Migration|0|||
124968509|NCT02366143|449513359|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
124968510|NCT02366143|449513360|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
124968511|NCT02366143|449513361|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
124968512|NCT02366143|449513359|FG000|Overall Study|Patient switched to PTAP|0|||
124968513|NCT02366143|449513360|FG001|Overall Study|Patient switched to PTAP|1|||
124968514|NCT02366143|449513361|FG002|Overall Study|Patient switched to PTAP|0|||
124968515|NCT02366143|449513359|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
124968516|NCT02366143|449513360|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
124968517|NCT02366143|449513361|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
124968518|NCT04411186|449513362|FG000|Overall Study|Withdrawn due to protocol violation|0|||
124968519|NCT04411186|449513363|FG001|Overall Study|Withdrawn due to protocol violation|1|||
124551132|NCT00265239|447974663|FG000|Overall Study|Adverse Event|2|||
124968520|NCT00575042|449513364|FG000|Overall Study|Adverse Event|2|||
124968521|NCT00575042|449513364|FG000|Overall Study|Lost to Follow-up|1|||
124968522|NCT01053247|449513365|FG000|Overall Study|Withdrawal by Subject|9|||
124968523|NCT01053247|449513366|FG001|Overall Study|Withdrawal by Subject|4|||
124968524|NCT01053247|449513367|FG002|Overall Study|Withdrawal by Subject|15|||
124968525|NCT01053247|449513365|FG000|Overall Study|Lack of Efficacy|1|||
124968526|NCT01053247|449513366|FG001|Overall Study|Lack of Efficacy|0|||
124968527|NCT01053247|449513367|FG002|Overall Study|Lack of Efficacy|1|||
124968528|NCT01053247|449513365|FG000|Overall Study|Protocol Violation|2|||
124968529|NCT01053247|449513366|FG001|Overall Study|Protocol Violation|1|||
124968530|NCT01053247|449513367|FG002|Overall Study|Protocol Violation|2|||
124968531|NCT01053247|449513365|FG000|Overall Study|Lost to Follow-up|8|||
124968532|NCT01053247|449513366|FG001|Overall Study|Lost to Follow-up|5|||
124968533|NCT01053247|449513367|FG002|Overall Study|Lost to Follow-up|7|||
124968534|NCT01053247|449513365|FG000|Overall Study|Adverse Event|0|||
124968535|NCT01053247|449513366|FG001|Overall Study|Adverse Event|9|||
124968536|NCT01053247|449513367|FG002|Overall Study|Adverse Event|3|||
124968537|NCT04795336|449513368|FG000|Overall Study|Withdrawal by Subject|3|||
124968538|NCT04795336|449513369|FG001|Overall Study|Withdrawal by Subject|4|||
124968539|NCT04795336|449513370|FG002|Overall Study|Withdrawal by Subject|3|||
124968540|NCT04795336|449513371|FG003|Overall Study|Withdrawal by Subject|12|||
124968541|NCT04795336|449513368|FG000|Overall Study|Lost study logs|0|||
124968542|NCT04795336|449513369|FG001|Overall Study|Lost study logs|1|||
124968543|NCT04795336|449513370|FG002|Overall Study|Lost study logs|0|||
124968544|NCT04795336|449513371|FG003|Overall Study|Lost study logs|2|||
124968545|NCT04795336|449513368|FG000|Overall Study|Did not take study medication|2|||
124968546|NCT04795336|449513369|FG001|Overall Study|Did not take study medication|0|||
124968547|NCT04795336|449513370|FG002|Overall Study|Did not take study medication|0|||
124968548|NCT04795336|449513371|FG003|Overall Study|Did not take study medication|0|||
124968549|NCT03898700|449513372|FG000|Overall Study|Withdrawal by Subject|2|||
124968550|NCT03023722|449513373|FG000|Overall Study|No follow-up assessment|4|||
124968551|NCT03616964|449513374|FG000|Overall Study|Adverse Event|15|||
124968552|NCT03616964|449513375|FG001|Overall Study|Adverse Event|10|||
124968553|NCT03616964|449513376|FG002|Overall Study|Adverse Event|16|||
124968554|NCT03616964|449513374|FG000|Overall Study|Death|3|||
124968555|NCT03616964|449513375|FG001|Overall Study|Death|0|||
124968556|NCT03616964|449513376|FG002|Overall Study|Death|4|||
124968557|NCT03616964|449513374|FG000|Overall Study|Lack of Efficacy|4|||
124968558|NCT03616964|449513375|FG001|Overall Study|Lack of Efficacy|8|||
124968559|NCT03616964|449513376|FG002|Overall Study|Lack of Efficacy|8|||
124968560|NCT03616964|449513374|FG000|Overall Study|Lost to Follow-up|2|||
124968561|NCT03616964|449513375|FG001|Overall Study|Lost to Follow-up|1|||
124968562|NCT03616964|449513376|FG002|Overall Study|Lost to Follow-up|3|||
124968563|NCT03616964|449513374|FG000|Overall Study|Withdrawal by Subject|18|||
124968564|NCT03616964|449513375|FG001|Overall Study|Withdrawal by Subject|14|||
124968565|NCT03616964|449513376|FG002|Overall Study|Withdrawal by Subject|21|||
124968566|NCT03616964|449513374|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
124968567|NCT03616964|449513375|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
124968568|NCT03616964|449513376|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
124968569|NCT03616964|449513374|FG000|Overall Study|Sponsor's Decision|1|||
124968570|NCT03616964|449513375|FG001|Overall Study|Sponsor's Decision|0|||
124968571|NCT03616964|449513376|FG002|Overall Study|Sponsor's Decision|0|||
124968572|NCT03616964|449513374|FG000|Overall Study|Physician Decision|0|||
124968573|NCT03616964|449513375|FG001|Overall Study|Physician Decision|2|||
124968574|NCT03616964|449513376|FG002|Overall Study|Physician Decision|0|||
124968575|NCT03616964|449513374|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
124551133|NCT00265239|447974664|FG001|Overall Study|Adverse Event|1|||
124968576|NCT03616964|449513375|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
124968577|NCT03616964|449513376|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
124968578|NCT03616964|449513374|FG000|Overall Study|Protocol Violation|0|||
124968579|NCT03616964|449513375|FG001|Overall Study|Protocol Violation|1|||
124968580|NCT03616964|449513376|FG002|Overall Study|Protocol Violation|0|||
124968581|NCT03616964|449513374|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
124968582|NCT03616964|449513375|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
124968583|NCT03616964|449513376|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
124968584|NCT03616964|449513374|FG000|Overall Study|Randomized but Never Treated|1|||
124968585|NCT03616964|449513375|FG001|Overall Study|Randomized but Never Treated|1|||
124968586|NCT03616964|449513376|FG002|Overall Study|Randomized but Never Treated|1|||
124968587|NCT02641587|449513386|FG000|Confinement Period|Adverse Event|1|||
124968588|NCT02641587|449513387|FG001|Confinement Period|Adverse Event|0|||
124968589|NCT02641587|449513386|FG000|Confinement Period|Withdrawal by Subject|2|||
124968590|NCT02641587|449513387|FG001|Confinement Period|Withdrawal by Subject|1|||
124968591|NCT02641587|449513386|FG000|Ambulatory Period|Withdrawal by Subject|1|||
124968592|NCT02641587|449513387|FG001|Ambulatory Period|Withdrawal by Subject|0|||
124968593|NCT01165177|449513388|FG000|Overall Study|Serious Adverse Event|227|||
124711689|NCT05525910|448569401|FG004|Period 4|Per sponsor due to study timelines|1|||
124711690|NCT03886493|448569402|FG000|Overall Study|Adverse Event|1|||
124711691|NCT03326063|448569403|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
124711692|NCT03326063|448569404|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
124711693|NCT02553629|448569405|FG000|Overall Study|Logistic reasons|3|||
124711694|NCT02553629|448569406|FG001|Overall Study|Logistic reasons|6|||
124711695|NCT01812057|448569407|FG000|Overall Study|Protocol Violation|1|||
124711696|NCT01812057|448569408|FG001|Overall Study|Protocol Violation|0|||
124968594|NCT01165177|449513389|FG001|Overall Study|Serious Adverse Event|235|||
124968595|NCT01165177|449513388|FG000|Overall Study|Withdrawal by Subject|368|||
124968596|NCT01165177|449513389|FG001|Overall Study|Withdrawal by Subject|354|||
124968597|NCT01165177|449513388|FG000|Overall Study|Protocol Violation|19|||
124968598|NCT01165177|449513389|FG001|Overall Study|Protocol Violation|21|||
124968599|NCT01165177|449513388|FG000|Overall Study|Non-serious adverse event|30|||
124968600|NCT01165177|449513389|FG001|Overall Study|Non-serious adverse event|18|||
124968601|NCT01165177|449513388|FG000|Overall Study|Other unspecified reasons|47|||
124968602|NCT01165177|449513389|FG001|Overall Study|Other unspecified reasons|35|||
124968603|NCT01165177|449513388|FG000|Overall Study|Suspected HZ episode|0|||
124968604|NCT01165177|449513389|FG001|Overall Study|Suspected HZ episode|2|||
124968605|NCT01165177|449513388|FG000|Overall Study|Lost to Follow-up|183|||
124968606|NCT01165177|449513389|FG001|Overall Study|Lost to Follow-up|194|||
124968607|NCT01165177|449513388|FG000|Overall Study|Migrated/ moved from study area|48|||
124968608|NCT01165177|449513389|FG001|Overall Study|Migrated/ moved from study area|43|||
124968609|NCT01663506|449513390|FG000|Overall Study|Lack of Efficacy|3|||
124968610|NCT01663506|449513390|FG000|Overall Study|Consent Withdrawal by Subject|1|||
124968611|NCT01663506|449513390|FG000|Overall Study|Lost to Follow-up|1|||
124968612|NCT01663506|449513390|FG000|Overall Study|Adverse Event|1|||
124968613|NCT01663506|449513390|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
124968614|NCT03210519|449513394|FG000|Overall Study|Adverse Event|2|||
124968615|NCT03210519|449513395|FG001|Overall Study|Adverse Event|0|||
124968616|NCT04351269|449513396|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
124968617|NCT04351269|449513397|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
124968618|NCT04351269|449513398|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
124968619|NCT04351269|449513396|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
124968620|NCT04351269|449513397|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
124968621|NCT04351269|449513398|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
124968622|NCT04351269|449513396|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
124968623|NCT04351269|449513397|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
124968624|NCT04351269|449513398|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
124968625|NCT04351269|449513396|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
124968626|NCT04351269|449513397|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
124968627|NCT04351269|449513398|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
124968628|NCT04351269|449513396|FG000|Overall Study|Lost to Follow-up|1|||
124968629|NCT04351269|449513397|FG001|Overall Study|Lost to Follow-up|3|||
124968630|NCT04351269|449513398|FG002|Overall Study|Lost to Follow-up|0|||
124968631|NCT02229578|449513403|FG000|Overall Study|Withdrawal by Subject|1|||
124968632|NCT02229578|449513404|FG001|Overall Study|Withdrawal by Subject|3|||
124968633|NCT02229578|449513403|FG000|Overall Study|Protocol Violation|2|||
124968634|NCT02229578|449513404|FG001|Overall Study|Protocol Violation|0|||
124968635|NCT01407276|449513411|FG000|Overall Study|Withdrawal by Subject|0|||
124968636|NCT01407276|449513412|FG001|Overall Study|Withdrawal by Subject|0|||
124968637|NCT01407276|449513413|FG002|Overall Study|Withdrawal by Subject|0|||
124968638|NCT01407276|449513414|FG003|Overall Study|Withdrawal by Subject|0|||
124968639|NCT01407276|449513415|FG004|Overall Study|Withdrawal by Subject|0|||
124968640|NCT01407276|449513416|FG005|Overall Study|Withdrawal by Subject|0|||
124968641|NCT01407276|449513417|FG006|Overall Study|Withdrawal by Subject|0|||
124968642|NCT01407276|449513418|FG007|Overall Study|Withdrawal by Subject|1|||
124968643|NCT00085566|449513422|FG000|Overall Study|Adverse Event|0|||
124968644|NCT00085566|449513423|FG001|Overall Study|Adverse Event|0|||
124968645|NCT00085566|449513424|FG002|Overall Study|Adverse Event|10|||
124968646|NCT00085566|449513422|FG000|Overall Study|Patient Not treated|0|||
124968647|NCT00085566|449513423|FG001|Overall Study|Patient Not treated|0|||
124968648|NCT00085566|449513424|FG002|Overall Study|Patient Not treated|3|||
124968649|NCT00085566|449513422|FG000|Overall Study|Clinical progression|0|||
124968650|NCT00085566|449513423|FG001|Overall Study|Clinical progression|0|||
124968651|NCT00085566|449513424|FG002|Overall Study|Clinical progression|1|||
124968652|NCT00745498|449513425|FG000|Overall Study|Lost to Follow-up|1|||
124968653|NCT00745498|449513426|FG001|Overall Study|Lost to Follow-up|1|||
124968654|NCT00745498|449513427|FG002|Overall Study|Lost to Follow-up|3|||
124968655|NCT00745498|449513425|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
124968656|NCT00745498|449513426|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
124968657|NCT00745498|449513427|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
124968658|NCT00745498|449513425|FG000|Overall Study|Non-PDR related VH|0|||
124968659|NCT00745498|449513426|FG001|Overall Study|Non-PDR related VH|1|||
124968660|NCT00745498|449513427|FG002|Overall Study|Non-PDR related VH|1|||
124968661|NCT00745498|449513425|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
124968662|NCT00745498|449513426|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
124968663|NCT00745498|449513427|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
124968664|NCT03174782|449513428|FG000|Overall Study|Protocol Violation|1|||
124968665|NCT03174782|449513429|FG001|Overall Study|Protocol Violation|0|||
124968666|NCT03174782|449513428|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
124968667|NCT03174782|449513429|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
124968668|NCT00778921|449513430|FG000|Overall Study|Adverse Event|9|||
124968669|NCT00778921|449513431|FG001|Overall Study|Adverse Event|10|||
124968670|NCT00778921|449513432|FG002|Overall Study|Adverse Event|14|||
124968671|NCT00778921|449513430|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
124968672|NCT00778921|449513431|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
124968673|NCT00778921|449513432|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
124968674|NCT00778921|449513430|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
124968675|NCT00778921|449513431|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
124968676|NCT00778921|449513432|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
124968677|NCT00778921|449513430|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
124968678|NCT00778921|449513431|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
124968679|NCT00778921|449513432|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
124968680|NCT00778921|449513430|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
124968681|NCT00778921|449513431|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
124968682|NCT00778921|449513432|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
124968683|NCT00778921|449513430|FG000|Overall Study|Patient withdrew request|3|||
124968684|NCT00778921|449513431|FG001|Overall Study|Patient withdrew request|1|||
124968685|NCT00778921|449513432|FG002|Overall Study|Patient withdrew request|6|||
124968686|NCT00778921|449513430|FG000|Overall Study|Lost to Follow-up|0|||
124968687|NCT00778921|449513431|FG001|Overall Study|Lost to Follow-up|2|||
124968688|NCT00778921|449513432|FG002|Overall Study|Lost to Follow-up|1|||
124968689|NCT00778921|449513430|FG000|Overall Study|Administrative Problems|1|||
124968690|NCT00778921|449513431|FG001|Overall Study|Administrative Problems|2|||
124968691|NCT00778921|449513432|FG002|Overall Study|Administrative Problems|0|||
124968692|NCT00778921|449513430|FG000|Overall Study|Protocol Violation|3|||
124968693|NCT00778921|449513431|FG001|Overall Study|Protocol Violation|0|||
124968694|NCT00778921|449513432|FG002|Overall Study|Protocol Violation|2|||
124968695|NCT00778921|449513430|FG000|Overall Study|Not treated|0|||
124968696|NCT00778921|449513431|FG001|Overall Study|Not treated|2|||
124968697|NCT00778921|449513432|FG002|Overall Study|Not treated|2|||
124968698|NCT04805073|449513433|FG000|Overall Study|study personnel not available|2|||
124968699|NCT04805073|449513434|FG001|Overall Study|study personnel not available|0|||
124968700|NCT04805073|449513433|FG000|Overall Study|spinal anesthesia failure|0|||
124968701|NCT04805073|449513434|FG001|Overall Study|spinal anesthesia failure|1|||
124968702|NCT04805073|449513433|FG000|Overall Study|Lost to Follow-up|0|||
124968703|NCT04805073|449513434|FG001|Overall Study|Lost to Follow-up|2|||
124968704|NCT03178045|449513435|FG000|Overall Study|Withdrawal by Subject|5|||
124968705|NCT03178045|449513436|FG001|Overall Study|Withdrawal by Subject|7|||
124968706|NCT03178045|449513435|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
124968707|NCT03178045|449513436|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
124968708|NCT03178045|449513435|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
124968709|NCT03178045|449513436|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
124968710|NCT01078922|449513444|FG000|Overall Study|Adverse Event|1|||
124968711|NCT02706847|449513445|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
124968712|NCT02706847|449513446|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
124968713|NCT02706847|449513447|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
124968714|NCT02706847|449513448|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
124968715|NCT02706847|449513445|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
124968716|NCT02706847|449513446|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
124968717|NCT02706847|449513447|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
124968718|NCT02706847|449513448|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
124968719|NCT02706847|449513445|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
124968720|NCT02706847|449513446|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
124968721|NCT02706847|449513447|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
124968722|NCT02706847|449513448|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
124968723|NCT02706847|449513445|FG000|Period 1: Day 1 to Week 12|Other|4|||
124968724|NCT02706847|449513446|FG001|Period 1: Day 1 to Week 12|Other|4|||
124968725|NCT02706847|449513447|FG002|Period 1: Day 1 to Week 12|Other|2|||
124968726|NCT02706847|449513448|FG003|Period 1: Day 1 to Week 12|Other|2|||
124968727|NCT02706847|449513445|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
124968728|NCT02706847|449513446|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
124968729|NCT02706847|449513447|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
124968730|NCT02706847|449513448|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
124968731|NCT02706847|449513445|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
124968732|NCT02706847|449513446|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
124968733|NCT02706847|449513447|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
124968734|NCT02706847|449513448|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
124968735|NCT02706847|449513445|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
124968736|NCT02706847|449513446|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
124968737|NCT02706847|449513447|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
124968738|NCT02706847|449513448|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
124968739|NCT02706847|449513445|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
124968740|NCT02706847|449513446|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
124968741|NCT02706847|449513447|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
124968742|NCT02706847|449513448|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
124968743|NCT02706847|449513445|FG000|Period 1: Week 12 to Week 24|Other|1|||
124968744|NCT02706847|449513446|FG001|Period 1: Week 12 to Week 24|Other|0|||
124968745|NCT02706847|449513447|FG002|Period 1: Week 12 to Week 24|Other|1|||
124968746|NCT02706847|449513448|FG003|Period 1: Week 12 to Week 24|Other|4|||
124968747|NCT02706847|449513445|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
124968748|NCT02706847|449513446|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
124968749|NCT02706847|449513447|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
124968750|NCT02706847|449513448|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
124968751|NCT02706847|449513445|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
124968752|NCT02706847|449513446|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
124968753|NCT02706847|449513447|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
124466251|NCT04899232|447664602|FG001|Screening Period|Participant discharged before receiving intervention|0|||
124466252|NCT04899232|447664603|FG002|Screening Period|Participant discharged before receiving intervention|0|||
124466253|NCT00936208|447664604|FG000|Overall Study|Protocol Violation|37|||
124466254|NCT00936208|447664605|FG001|Overall Study|Protocol Violation|22|||
124466255|NCT01344876|447664609|FG000|Overall Study|Adverse Event|0|||
124466256|NCT01344876|447664610|FG001|Overall Study|Adverse Event|0|||
124466257|NCT01344876|447664611|FG002|Overall Study|Adverse Event|0|||
124551134|NCT02803138|447974669|FG000|Overall Study|Failure to return|38|||
124968754|NCT02706847|449513448|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
124968755|NCT02706847|449513445|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
124968756|NCT02706847|449513446|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
124968757|NCT02706847|449513447|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
124968758|NCT02706847|449513448|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
124968759|NCT02706847|449513445|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
124968760|NCT02706847|449513446|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
124968761|NCT02706847|449513447|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
124968762|NCT02706847|449513448|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
124968763|NCT02706847|449513445|FG000|Period 2: Week 24 to Week 260|Other|8|||
124968764|NCT02706847|449513446|FG001|Period 2: Week 24 to Week 260|Other|5|||
124968765|NCT02706847|449513447|FG002|Period 2: Week 24 to Week 260|Other|15|||
124968766|NCT02706847|449513448|FG003|Period 2: Week 24 to Week 260|Other|15|||
124968767|NCT01174264|449513451|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
124968768|NCT01174264|449513452|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
124968769|NCT01174264|449513453|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
124968770|NCT01174264|449513451|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
124968771|NCT01174264|449513452|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
124968772|NCT01174264|449513453|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
124968773|NCT01174264|449513451|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
124968774|NCT01174264|449513452|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
124968775|NCT01174264|449513453|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
124968776|NCT02058836|449513455|FG000|Overall Study|Withdrawal by Subject|1|||
124968777|NCT02058836|449513456|FG001|Overall Study|Withdrawal by Subject|1|||
124968778|NCT00267098|449513457|FG000|Overall Study|Death|0|||
124968779|NCT00267098|449513458|FG001|Overall Study|Death|0|||
124968780|NCT00267098|449513459|FG002|Overall Study|Death|57|||
124968781|NCT00267098|449513460|FG003|Overall Study|Death|66|||
124968782|NCT00267098|449513461|FG004|Overall Study|Death|14|||
124968783|NCT00267098|449513462|FG005|Overall Study|Death|23|||
124968784|NCT00267098|449513463|FG006|Overall Study|Death|28|||
124968785|NCT00267098|449513464|FG007|Overall Study|Death|9|||
124968786|NCT00267098|449513457|FG000|Overall Study|Lost to Follow-up|0|||
124968787|NCT00267098|449513458|FG001|Overall Study|Lost to Follow-up|0|||
124968788|NCT00267098|449513459|FG002|Overall Study|Lost to Follow-up|6|||
124968789|NCT00267098|449513460|FG003|Overall Study|Lost to Follow-up|5|||
124968790|NCT00267098|449513461|FG004|Overall Study|Lost to Follow-up|2|||
124968791|NCT00267098|449513462|FG005|Overall Study|Lost to Follow-up|3|||
124968792|NCT00267098|449513463|FG006|Overall Study|Lost to Follow-up|1|||
124968793|NCT00267098|449513464|FG007|Overall Study|Lost to Follow-up|1|||
124968794|NCT00267098|449513457|FG000|Overall Study|Withdrawal by Subject|8|||
124968795|NCT00267098|449513458|FG001|Overall Study|Withdrawal by Subject|0|||
124968796|NCT00267098|449513459|FG002|Overall Study|Withdrawal by Subject|24|||
124968797|NCT00267098|449513460|FG003|Overall Study|Withdrawal by Subject|21|||
124968798|NCT00267098|449513461|FG004|Overall Study|Withdrawal by Subject|12|||
124968799|NCT00267098|449513462|FG005|Overall Study|Withdrawal by Subject|9|||
124968800|NCT00267098|449513463|FG006|Overall Study|Withdrawal by Subject|12|||
124968801|NCT00267098|449513464|FG007|Overall Study|Withdrawal by Subject|5|||
124968802|NCT00267098|449513457|FG000|Overall Study|Physician Decision|5|||
124968803|NCT00267098|449513458|FG001|Overall Study|Physician Decision|0|||
124968804|NCT00267098|449513459|FG002|Overall Study|Physician Decision|7|||
124968805|NCT00267098|449513460|FG003|Overall Study|Physician Decision|11|||
124968806|NCT00267098|449513461|FG004|Overall Study|Physician Decision|5|||
124968807|NCT00267098|449513462|FG005|Overall Study|Physician Decision|4|||
124968808|NCT00267098|449513463|FG006|Overall Study|Physician Decision|3|||
124968809|NCT00267098|449513464|FG007|Overall Study|Physician Decision|0|||
124968810|NCT00267098|449513457|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
124968811|NCT00267098|449513458|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124968812|NCT00267098|449513459|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124968813|NCT00267098|449513460|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124968814|NCT00267098|449513461|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
124968815|NCT00267098|449513462|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124968816|NCT00267098|449513463|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124968817|NCT00267098|449513464|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124968818|NCT00267098|449513457|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
124968819|NCT00267098|449513458|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
124968820|NCT00267098|449513459|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
124968821|NCT00267098|449513460|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
124968822|NCT00267098|449513461|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
124968823|NCT00267098|449513462|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
124968824|NCT00267098|449513463|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
124968825|NCT00267098|449513464|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
124968826|NCT00267098|449513457|FG000|Overall Study|Site closure|0|||
124968827|NCT00267098|449513458|FG001|Overall Study|Site closure|0|||
124968828|NCT00267098|449513459|FG002|Overall Study|Site closure|0|||
124968829|NCT00267098|449513460|FG003|Overall Study|Site closure|1|||
124968830|NCT00267098|449513461|FG004|Overall Study|Site closure|0|||
124968831|NCT00267098|449513462|FG005|Overall Study|Site closure|1|||
124968832|NCT00267098|449513463|FG006|Overall Study|Site closure|1|||
124968833|NCT00267098|449513464|FG007|Overall Study|Site closure|0|||
124968834|NCT00267098|449513457|FG000|Overall Study|Explanted Medtronic device|0|||
124968835|NCT00267098|449513458|FG001|Overall Study|Explanted Medtronic device|0|||
124968836|NCT00267098|449513459|FG002|Overall Study|Explanted Medtronic device|0|||
124968837|NCT00267098|449513460|FG003|Overall Study|Explanted Medtronic device|1|||
124968838|NCT00267098|449513461|FG004|Overall Study|Explanted Medtronic device|0|||
124968839|NCT00267098|449513462|FG005|Overall Study|Explanted Medtronic device|0|||
124968840|NCT00267098|449513463|FG006|Overall Study|Explanted Medtronic device|0|||
124968841|NCT00267098|449513464|FG007|Overall Study|Explanted Medtronic device|0|||
124968842|NCT00267098|449513457|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
124968843|NCT00267098|449513458|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
124968844|NCT00267098|449513459|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
124968845|NCT00267098|449513460|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
124968846|NCT00267098|449513461|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
124968847|NCT00267098|449513462|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
124968848|NCT00267098|449513463|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
124968849|NCT00267098|449513464|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
124968850|NCT00267098|449513457|FG000|Overall Study|Subject listed for heart transplant|0|||
124968851|NCT00267098|449513458|FG001|Overall Study|Subject listed for heart transplant|0|||
124968852|NCT00267098|449513459|FG002|Overall Study|Subject listed for heart transplant|0|||
124968853|NCT00267098|449513460|FG003|Overall Study|Subject listed for heart transplant|0|||
124968854|NCT00267098|449513461|FG004|Overall Study|Subject listed for heart transplant|0|||
124968855|NCT00267098|449513462|FG005|Overall Study|Subject listed for heart transplant|0|||
124968856|NCT00267098|449513463|FG006|Overall Study|Subject listed for heart transplant|1|||
124968857|NCT00267098|449513464|FG007|Overall Study|Subject listed for heart transplant|0|||
124968858|NCT00267098|449513457|FG000|Overall Study|Sponsor withdrew subject|0|||
124968859|NCT00267098|449513458|FG001|Overall Study|Sponsor withdrew subject|0|||
124968860|NCT00267098|449513459|FG002|Overall Study|Sponsor withdrew subject|0|||
124968861|NCT00267098|449513460|FG003|Overall Study|Sponsor withdrew subject|1|||
124968862|NCT00267098|449513461|FG004|Overall Study|Sponsor withdrew subject|0|||
124968863|NCT00267098|449513462|FG005|Overall Study|Sponsor withdrew subject|0|||
124968864|NCT00267098|449513463|FG006|Overall Study|Sponsor withdrew subject|0|||
124968865|NCT00267098|449513464|FG007|Overall Study|Sponsor withdrew subject|0|||
124968866|NCT00547534|449513465|FG000|Overall Study|Adverse Event|7|||
124968867|NCT00547534|449513465|FG000|Overall Study|Disease Progression|4|||
124968868|NCT02688530|449513467|FG000|Overall Study|Withdrawal by Subject|0|||
124968869|NCT02688530|449513468|FG001|Overall Study|Withdrawal by Subject|1|||
124968870|NCT02688530|449513469|FG002|Overall Study|Withdrawal by Subject|0|||
124968871|NCT02688530|449513470|FG003|Overall Study|Withdrawal by Subject|0|||
124968872|NCT02688530|449513467|FG000|Overall Study|Lost to Follow-up|0|||
124968873|NCT02688530|449513468|FG001|Overall Study|Lost to Follow-up|0|||
124968874|NCT02688530|449513469|FG002|Overall Study|Lost to Follow-up|2|||
124968875|NCT02688530|449513470|FG003|Overall Study|Lost to Follow-up|0|||
124968876|NCT01658020|449513471|FG000|Overall Study|Adverse Event|3|||
124968877|NCT01658020|449513472|FG001|Overall Study|Adverse Event|3|||
124968878|NCT01658020|449513471|FG000|Overall Study|Lost to Follow-up|1|||
124968879|NCT01658020|449513472|FG001|Overall Study|Lost to Follow-up|0|||
124968880|NCT01658020|449513471|FG000|Overall Study|Withdrawal by Subject|4|||
124968881|NCT01658020|449513472|FG001|Overall Study|Withdrawal by Subject|5|||
124968882|NCT01658020|449513471|FG000|Overall Study|Protocol Violation|0|||
124968883|NCT01658020|449513472|FG001|Overall Study|Protocol Violation|1|||
124968884|NCT02353871|449513473|FG000|Overall Study|Protocol deviation|0|||
124968885|NCT02353871|449513474|FG001|Overall Study|Protocol deviation|1|||
124968886|NCT02353871|449513473|FG000|Overall Study|Consent withdrawn|1|||
124968887|NCT02353871|449513474|FG001|Overall Study|Consent withdrawn|8|||
124968888|NCT02353871|449513473|FG000|Overall Study|Lost to Follow-up|2|||
124968889|NCT02353871|449513474|FG001|Overall Study|Lost to Follow-up|0|||
124711697|NCT01812057|448569407|FG000|Overall Study|Physician Decision|1|||
124711698|NCT01812057|448569408|FG001|Overall Study|Physician Decision|0|||
124711699|NCT01882465|448569411|FG000|Period 1|Lens Discomfort|0|||
124711700|NCT01882465|448569412|FG001|Period 1|Lens Discomfort|0|||
124968890|NCT00115336|449513475|FG000|Overall Study|Hospital discharge before study drug|0|||
124968891|NCT00115336|449513476|FG001|Overall Study|Hospital discharge before study drug|1|||
124968892|NCT04599907|449513483|FG000|Overall Study|Withdrawal by Subject|1|||
124968893|NCT04599907|449513484|FG001|Overall Study|Withdrawal by Subject|7|||
124968894|NCT04599907|449513485|FG002|Overall Study|Withdrawal by Subject|6|||
124968895|NCT04599907|449513483|FG000|Overall Study|Lost to Follow-up|0|||
124968896|NCT04599907|449513484|FG001|Overall Study|Lost to Follow-up|1|||
124968897|NCT04599907|449513485|FG002|Overall Study|Lost to Follow-up|0|||
124968898|NCT01466790|449513488|FG000|Overall Study|Adverse Event|1|||
124968899|NCT01466790|449513489|FG001|Overall Study|Adverse Event|0|||
124711701|NCT01882465|448569413|FG002|Period 1|Lens Discomfort|0|||
124711702|NCT01882465|448569414|FG003|Period 1|Lens Discomfort|1|||
124711703|NCT01882465|448569415|FG004|Period 1|Lens Discomfort|0|||
124711704|NCT01882465|448569416|FG005|Period 1|Lens Discomfort|0|||
124711705|NCT01882465|448569417|FG006|Period 1|Lens Discomfort|0|||
124711706|NCT01882465|448569411|FG000|Period 1|Withdrawal by Subject|0|||
124711707|NCT01882465|448569412|FG001|Period 1|Withdrawal by Subject|0|||
124711708|NCT01882465|448569413|FG002|Period 1|Withdrawal by Subject|0|||
124551135|NCT02803138|447974669|FG000|Overall Study|Insufficient virological response|2|||
124551136|NCT02803138|447974669|FG000|Overall Study|Withdrawn consent|1|||
124968900|NCT01466790|449513490|FG002|Overall Study|Adverse Event|0|||
124968901|NCT01466790|449513491|FG003|Overall Study|Adverse Event|0|||
124968902|NCT01466790|449513492|FG004|Overall Study|Adverse Event|2|||
124968903|NCT01466790|449513493|FG005|Overall Study|Adverse Event|0|||
124968904|NCT01466790|449513494|FG006|Overall Study|Adverse Event|0|||
124968905|NCT01466790|449513495|FG007|Overall Study|Adverse Event|0|||
124968906|NCT01466790|449513488|FG000|Overall Study|Lost to Follow-up|2|||
124968907|NCT01466790|449513489|FG001|Overall Study|Lost to Follow-up|0|||
124968908|NCT01466790|449513490|FG002|Overall Study|Lost to Follow-up|0|||
124968909|NCT01466790|449513491|FG003|Overall Study|Lost to Follow-up|0|||
124968910|NCT01466790|449513492|FG004|Overall Study|Lost to Follow-up|0|||
124968911|NCT01466790|449513493|FG005|Overall Study|Lost to Follow-up|0|||
124968912|NCT01466790|449513494|FG006|Overall Study|Lost to Follow-up|0|||
124968913|NCT01466790|449513495|FG007|Overall Study|Lost to Follow-up|0|||
124968914|NCT01466790|449513488|FG000|Overall Study|Withdrawal by Subject|1|||
124968915|NCT01466790|449513489|FG001|Overall Study|Withdrawal by Subject|1|||
124968916|NCT01466790|449513490|FG002|Overall Study|Withdrawal by Subject|0|||
124968917|NCT01466790|449513491|FG003|Overall Study|Withdrawal by Subject|0|||
124968918|NCT01466790|449513492|FG004|Overall Study|Withdrawal by Subject|1|||
124968919|NCT01466790|449513493|FG005|Overall Study|Withdrawal by Subject|0|||
124968920|NCT01466790|449513494|FG006|Overall Study|Withdrawal by Subject|1|||
124968921|NCT01466790|449513495|FG007|Overall Study|Withdrawal by Subject|1|||
124968922|NCT02242643|449513497|FG000|Overall Study|Protocol Violation|1|||
124968923|NCT02242643|449513498|FG001|Overall Study|Protocol Violation|2|||
124968924|NCT02242643|449513497|FG000|Overall Study|Withdrawal by Subject|15|||
124968925|NCT02242643|449513498|FG001|Overall Study|Withdrawal by Subject|10|||
124968926|NCT02242643|449513497|FG000|Overall Study|Migrated/moved from study area|1|||
124968927|NCT02242643|449513498|FG001|Overall Study|Migrated/moved from study area|3|||
124968928|NCT02242643|449513497|FG000|Overall Study|Lost to Follow-up|54|||
124968929|NCT02242643|449513498|FG001|Overall Study|Lost to Follow-up|61|||
124968930|NCT02242643|449513497|FG000|Overall Study|Child placed in foster care by family|0|||
124968931|NCT02242643|449513498|FG001|Overall Study|Child placed in foster care by family|1|||
124968932|NCT02242643|449513497|FG000|Overall Study|Non-compliance|1|||
124968933|NCT02242643|449513498|FG001|Overall Study|Non-compliance|0|||
124968934|NCT02242643|449513497|FG000|Overall Study|Consent withdrawal by parent|1|||
124968935|NCT02242643|449513498|FG001|Overall Study|Consent withdrawal by parent|0|||
124711709|NCT01882465|448569414|FG003|Period 1|Withdrawal by Subject|0|||
124711710|NCT01882465|448569415|FG004|Period 1|Withdrawal by Subject|0|||
124711711|NCT01882465|448569416|FG005|Period 1|Withdrawal by Subject|0|||
124711712|NCT01882465|448569417|FG006|Period 1|Withdrawal by Subject|1|||
124711713|NCT01882465|448569411|FG000|Period 2|Protocol Violation|0|||
124711714|NCT01882465|448569412|FG001|Period 2|Protocol Violation|0|||
124711715|NCT01882465|448569413|FG002|Period 2|Protocol Violation|0|||
124968936|NCT02242643|449513497|FG000|Overall Study|Protocol requirements not followed|1|||
124968937|NCT02242643|449513498|FG001|Overall Study|Protocol requirements not followed|0|||
124968938|NCT02242643|449513497|FG000|Overall Study|Language barrier|1|||
124968939|NCT02242643|449513498|FG001|Overall Study|Language barrier|0|||
124968940|NCT02242643|449513497|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
124711716|NCT01882465|448569414|FG003|Period 2|Protocol Violation|0|||
124968941|NCT02242643|449513498|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
124711717|NCT01882465|448569415|FG004|Period 2|Protocol Violation|1|||
124711718|NCT01882465|448569416|FG005|Period 2|Protocol Violation|0|||
124968942|NCT01251887|449513499|FG000|Overall Study|Scheduling conflict|1|||
124968943|NCT01251887|449513500|FG001|Overall Study|Scheduling conflict|2|||
124711719|NCT01882465|448569417|FG006|Period 2|Protocol Violation|0|||
124711720|NCT01957865|448569422|FG000|Overall Study|Found HIV negative|0|||
124711721|NCT01957865|448569423|FG001|Overall Study|Found HIV negative|0|||
124711722|NCT01957865|448569424|FG002|Overall Study|Found HIV negative|1|||
124711723|NCT01957865|448569422|FG000|Overall Study|Lost to Follow-up|0|||
124711724|NCT01957865|448569423|FG001|Overall Study|Lost to Follow-up|2|||
124711725|NCT01957865|448569424|FG002|Overall Study|Lost to Follow-up|2|||
124711726|NCT01082614|448569425|FG000|Overall Study|Adverse Event|1|||
124711727|NCT01082614|448569426|FG001|Overall Study|Adverse Event|4|||
124711728|NCT01082614|448569425|FG000|Overall Study|Equipment Malfunction|0|||
124711729|NCT01082614|448569426|FG001|Overall Study|Equipment Malfunction|1|||
124711730|NCT01082614|448569425|FG000|Overall Study|Physician Decision|2|||
124711731|NCT01082614|448569426|FG001|Overall Study|Physician Decision|0|||
124711732|NCT00811720|448569430|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
124711733|NCT00811720|448569431|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
124711734|NCT00811720|448569430|FG000|All Treated Patients|Adverse Event|20|||
124711735|NCT00811720|448569431|FG001|All Treated Patients|Adverse Event|62|||
124711736|NCT00811720|448569430|FG000|All Treated Patients|Lack of Efficacy|22|||
124711737|NCT00811720|448569431|FG001|All Treated Patients|Lack of Efficacy|18|||
124711738|NCT00811720|448569430|FG000|All Treated Patients|Non-compliance|0|||
124711739|NCT00811720|448569431|FG001|All Treated Patients|Non-compliance|14|||
124711740|NCT00811720|448569430|FG000|All Treated Patients|Protocol Violation|9|||
124711741|NCT00811720|448569431|FG001|All Treated Patients|Protocol Violation|16|||
124711742|NCT00811720|448569430|FG000|All Treated Patients|Withdrawal by Subject|28|||
124711743|NCT00811720|448569431|FG001|All Treated Patients|Withdrawal by Subject|34|||
124711744|NCT00811720|448569430|FG000|All Treated Patients|Lost to Follow-up|10|||
124711745|NCT00811720|448569431|FG001|All Treated Patients|Lost to Follow-up|16|||
124711746|NCT00811720|448569430|FG000|All Treated Patients|Other Reason|7|||
124711747|NCT00811720|448569431|FG001|All Treated Patients|Other Reason|4|||
124711748|NCT01077063|448569432|FG000|Overall Study|Adverse Event|3|||
124711749|NCT01077063|448569433|FG001|Overall Study|Adverse Event|0|||
124711750|NCT01077063|448569432|FG000|Overall Study|Death|1|||
124711751|NCT01077063|448569433|FG001|Overall Study|Death|1|||
124968944|NCT01251887|449513501|FG002|Overall Study|Scheduling conflict|2|||
124968945|NCT01251887|449513499|FG000|Overall Study|Physician Decision|0|||
124968946|NCT01251887|449513500|FG001|Overall Study|Physician Decision|1|||
124968947|NCT01251887|449513501|FG002|Overall Study|Physician Decision|0|||
124968948|NCT02633397|449513502|FG000|Overall Study|Adverse Event|8|||
124968949|NCT02633397|449513503|FG001|Overall Study|Adverse Event|8|||
124968950|NCT02633397|449513502|FG000|Overall Study|Study Burden|4|||
124968951|NCT02633397|449513503|FG001|Overall Study|Study Burden|1|||
124968952|NCT02633397|449513502|FG000|Overall Study|Treatment interruption|2|||
124968953|NCT02633397|449513503|FG001|Overall Study|Treatment interruption|5|||
124968954|NCT02633397|449513502|FG000|Overall Study|Death|2|||
124968955|NCT02633397|449513503|FG001|Overall Study|Death|2|||
124968956|NCT02633397|449513502|FG000|Overall Study|Physician Decision|0|||
124968957|NCT02633397|449513503|FG001|Overall Study|Physician Decision|1|||
124968958|NCT03595878|449513504|FG000|Overall Study|Death|2|||
124968959|NCT03595878|449513505|FG001|Overall Study|Death|1|||
124968960|NCT03595878|449513506|FG002|Overall Study|Death|0|||
124968961|NCT03595878|449513504|FG000|Overall Study|Disease progression|2|||
124968962|NCT03595878|449513505|FG001|Overall Study|Disease progression|1|||
124968963|NCT03595878|449513506|FG002|Overall Study|Disease progression|2|||
124968964|NCT03668223|449513507|FG000|Overall Study|Death|10|||
124968965|NCT03668223|449513508|FG001|Overall Study|Death|5|||
124968966|NCT03668223|449513507|FG000|Overall Study|Lost to Follow-up|12|||
124968967|NCT03668223|449513508|FG001|Overall Study|Lost to Follow-up|12|||
124466258|NCT01344876|447664612|FG003|Overall Study|Adverse Event|0|||
124466259|NCT01344876|447664613|FG004|Overall Study|Adverse Event|1|||
124711752|NCT01077063|448569432|FG000|Overall Study|Withdrawal by Subject|0|||
124711753|NCT01077063|448569433|FG001|Overall Study|Withdrawal by Subject|2|||
124968968|NCT03668223|449513507|FG000|Overall Study|Withdrawal by Subject|8|||
124968969|NCT03668223|449513508|FG001|Overall Study|Withdrawal by Subject|3|||
124711754|NCT02750930|448569434|FG000|Overall Study|Study closed/terminated|8|||
124711755|NCT03894891|448569435|FG000|Overall Study|Withdrawal by Subject|1|||
124711756|NCT03894891|448569435|FG000|Overall Study|Completed protocol treatment per protocol|5|||
124711757|NCT00553631|448569440|FG000|Overall Study|Withdrawal by Subject|0|||
124711758|NCT00553631|448569441|FG001|Overall Study|Withdrawal by Subject|1|||
124711759|NCT00553631|448569440|FG000|Overall Study|Lost to Follow-up|1|||
124711760|NCT00553631|448569441|FG001|Overall Study|Lost to Follow-up|0|||
124968970|NCT01103232|449513509|FG000|Overall Study|Withdrawal by Subject|1|||
124968971|NCT01103232|449513510|FG001|Overall Study|Withdrawal by Subject|1|||
124968972|NCT01103232|449513509|FG000|Overall Study|Protocol Violation|0|||
124968973|NCT01103232|449513510|FG001|Overall Study|Protocol Violation|1|||
124968974|NCT03036124|449513511|FG000|Overall Study|Lost to Follow-up|0|||
124968975|NCT03036124|449513512|FG001|Overall Study|Lost to Follow-up|2|||
124711761|NCT02761642|448569442|FG000|Overall Study|Did not Receive Study Treatment|3|||
124968976|NCT03036124|449513511|FG000|Overall Study|Withdrawal by Subject|5|||
124711762|NCT02761642|448569442|FG000|Overall Study|Adverse Event|13|||
124551137|NCT02803138|447974669|FG000|Overall Study|Death|1|||
124551138|NCT02803138|447974669|FG000|Overall Study|Other, not specified|28|||
124551139|NCT00424515|447974670|FG000|Overall Study|Progressive Disease|10|||
124551140|NCT00424515|447974671|FG001|Overall Study|Progressive Disease|11|||
124551141|NCT00424515|447974670|FG000|Overall Study|Adverse Event|0|||
124551142|NCT00424515|447974671|FG001|Overall Study|Adverse Event|1|||
124551143|NCT00424515|447974670|FG000|Overall Study|Intercurrent Illness|0|||
124551144|NCT00424515|447974671|FG001|Overall Study|Intercurrent Illness|1|||
124711763|NCT02761642|448569442|FG000|Overall Study|Withdrawal by Subject|2|||
124711764|NCT02761642|448569442|FG000|Overall Study|Non-compliant|7|||
124711765|NCT02761642|448569442|FG000|Overall Study|Death|3|||
124711766|NCT02761642|448569442|FG000|Overall Study|Lack of Efficacy|20|||
124711767|NCT02761642|448569442|FG000|Overall Study|Physician Decision|1|||
124711768|NCT02761642|448569442|FG000|Overall Study|Reason Unspecified|21|||
124711769|NCT01644643|448569447|FG000|Overall Study|Death|1|||
124711770|NCT01644643|448569448|FG001|Overall Study|Death|0|||
124711771|NCT01644643|448569449|FG002|Overall Study|Death|3|||
124711772|NCT01644643|448569450|FG003|Overall Study|Death|3|||
124711773|NCT01644643|448569447|FG000|Overall Study|Lost to Follow-up|0|||
124711774|NCT01644643|448569448|FG001|Overall Study|Lost to Follow-up|0|||
124711775|NCT01644643|448569449|FG002|Overall Study|Lost to Follow-up|0|||
124711776|NCT01644643|448569450|FG003|Overall Study|Lost to Follow-up|4|||
124711777|NCT01644643|448569447|FG000|Overall Study|Withdrawal by Subject|1|||
124711778|NCT01644643|448569448|FG001|Overall Study|Withdrawal by Subject|0|||
124711779|NCT01644643|448569449|FG002|Overall Study|Withdrawal by Subject|2|||
124711780|NCT01644643|448569450|FG003|Overall Study|Withdrawal by Subject|1|||
124711781|NCT01644643|448569447|FG000|Overall Study|Other Eligibility criteria|0|||
124711782|NCT01644643|448569448|FG001|Overall Study|Other Eligibility criteria|0|||
124711783|NCT01644643|448569449|FG002|Overall Study|Other Eligibility criteria|0|||
124711784|NCT01644643|448569450|FG003|Overall Study|Other Eligibility criteria|2|||
124711785|NCT02756403|448569451|FG000|Overall Study|Unable to swallow medication|0|||
124711786|NCT02756403|448569452|FG001|Overall Study|Unable to swallow medication|1|||
124711787|NCT02756403|448569453|FG002|Overall Study|Unable to swallow medication|1|||
124711788|NCT02756403|448569454|FG003|Overall Study|Unable to swallow medication|1|||
124711789|NCT02756403|448569451|FG000|Overall Study|Did not complete Procedure|0|||
124711790|NCT02756403|448569452|FG001|Overall Study|Did not complete Procedure|1|||
124466260|NCT01344876|447664609|FG000|Overall Study|Withdrawal by Subject|0|||
124466261|NCT01344876|447664610|FG001|Overall Study|Withdrawal by Subject|0|||
124466262|NCT01344876|447664611|FG002|Overall Study|Withdrawal by Subject|1|||
124466263|NCT01344876|447664612|FG003|Overall Study|Withdrawal by Subject|0|||
124711791|NCT02756403|448569453|FG002|Overall Study|Did not complete Procedure|0|||
124968977|NCT03036124|449513512|FG001|Overall Study|Withdrawal by Subject|4|||
124968978|NCT04650698|449515226|FG000|Overall Study|Protocol Violation|2|||
124968979|NCT04650698|449515227|FG001|Overall Study|Protocol Violation|1|||
124968980|NCT04650698|449515226|FG000|Overall Study|Withdrawal by Subject|0|||
124968981|NCT04650698|449515227|FG001|Overall Study|Withdrawal by Subject|1|||
124968982|NCT01090011|449515228|FG000|Overall Study|Progressive disease|128|||
124968983|NCT01090011|449515228|FG000|Overall Study|Adverse Event|32|||
124968984|NCT01090011|449515228|FG000|Overall Study|Protocol Violation|1|||
124968985|NCT01090011|449515228|FG000|Overall Study|Refusal to start/continue medication|5|||
124968986|NCT01090011|449515228|FG000|Overall Study|Other reason not defined above|5|||
124968987|NCT00307047|449515229|FG000|Overall Study|Lost to Follow-up|35|||
124968988|NCT00307047|449515230|FG001|Overall Study|Lost to Follow-up|24|||
124968989|NCT00307047|449515229|FG000|Overall Study|Withdrawal by Subject|6|||
124968990|NCT00307047|449515230|FG001|Overall Study|Withdrawal by Subject|6|||
124968991|NCT00307047|449515229|FG000|Overall Study|Physician Decision|1|||
124968992|NCT00307047|449515230|FG001|Overall Study|Physician Decision|2|||
124968993|NCT00307047|449515229|FG000|Overall Study|Lost to follow-up for other reasons|0|||
124968994|NCT00307047|449515230|FG001|Overall Study|Lost to follow-up for other reasons|1|||
124968995|NCT00307047|449515229|FG000|Overall Study|All death, all MI, all Revascularization|27|||
124968996|NCT00307047|449515230|FG001|Overall Study|All death, all MI, all Revascularization|16|||
124968997|NCT00379769|449515231|FG000|Main Study|Death|57|||
124968998|NCT00379769|449515232|FG001|Main Study|Death|67|||
124968999|NCT00379769|449515233|FG002|Main Study|Death|54|||
124969000|NCT00379769|449515234|FG003|Main Study|Death|72|||
124969001|NCT00379769|449515235|FG004|Main Study|Death|0|||
124969002|NCT00379769|449515236|FG005|Main Study|Death|0|||
124969003|NCT00379769|449515231|FG000|Main Study|Adverse Event|5|||
124969004|NCT00379769|449515232|FG001|Main Study|Adverse Event|8|||
124969005|NCT00379769|449515233|FG002|Main Study|Adverse Event|10|||
124969006|NCT00379769|449515234|FG003|Main Study|Adverse Event|11|||
124969007|NCT00379769|449515235|FG004|Main Study|Adverse Event|0|||
124969008|NCT00379769|449515236|FG005|Main Study|Adverse Event|0|||
124969009|NCT00379769|449515231|FG000|Main Study|Lost to Follow-up|29|||
124969010|NCT00379769|449515232|FG001|Main Study|Lost to Follow-up|29|||
124969011|NCT00379769|449515233|FG002|Main Study|Lost to Follow-up|25|||
124969012|NCT00379769|449515234|FG003|Main Study|Lost to Follow-up|26|||
124969013|NCT00379769|449515235|FG004|Main Study|Lost to Follow-up|0|||
124969014|NCT00379769|449515236|FG005|Main Study|Lost to Follow-up|0|||
124969015|NCT00379769|449515231|FG000|Main Study|Withdrawal by Subject|46|||
124969016|NCT00379769|449515232|FG001|Main Study|Withdrawal by Subject|56|||
124969017|NCT00379769|449515233|FG002|Main Study|Withdrawal by Subject|72|||
124969018|NCT00379769|449515234|FG003|Main Study|Withdrawal by Subject|70|||
124969019|NCT00379769|449515235|FG004|Main Study|Withdrawal by Subject|0|||
124969020|NCT00379769|449515236|FG005|Main Study|Withdrawal by Subject|0|||
124969021|NCT00379769|449515231|FG000|Main Study|Moved to survival status follow-up only|27|||
124969022|NCT00379769|449515232|FG001|Main Study|Moved to survival status follow-up only|25|||
124969023|NCT00379769|449515233|FG002|Main Study|Moved to survival status follow-up only|32|||
124969024|NCT00379769|449515234|FG003|Main Study|Moved to survival status follow-up only|36|||
124969025|NCT00379769|449515235|FG004|Main Study|Moved to survival status follow-up only|0|||
124969026|NCT00379769|449515236|FG005|Main Study|Moved to survival status follow-up only|0|||
124969027|NCT00379769|449515231|FG000|Main Study|Participant moved|3|||
124969028|NCT00379769|449515232|FG001|Main Study|Participant moved|2|||
124969029|NCT00379769|449515233|FG002|Main Study|Participant moved|3|||
124969030|NCT00379769|449515234|FG003|Main Study|Participant moved|3|||
124969031|NCT00379769|449515235|FG004|Main Study|Participant moved|0|||
124969032|NCT00379769|449515236|FG005|Main Study|Participant moved|0|||
124969033|NCT00379769|449515231|FG000|Main Study|Poor compliance|3|||
124969034|NCT00379769|449515232|FG001|Main Study|Poor compliance|2|||
124969035|NCT00379769|449515233|FG002|Main Study|Poor compliance|2|||
124969036|NCT00379769|449515234|FG003|Main Study|Poor compliance|1|||
124969037|NCT00379769|449515235|FG004|Main Study|Poor compliance|0|||
124969038|NCT00379769|449515236|FG005|Main Study|Poor compliance|0|||
124969039|NCT00379769|449515231|FG000|Main Study|Prohibited glucose lowering medication|0|||
124969040|NCT00379769|449515232|FG001|Main Study|Prohibited glucose lowering medication|3|||
124969041|NCT00379769|449515233|FG002|Main Study|Prohibited glucose lowering medication|0|||
124969042|NCT00379769|449515234|FG003|Main Study|Prohibited glucose lowering medication|1|||
124969043|NCT00379769|449515235|FG004|Main Study|Prohibited glucose lowering medication|0|||
124969044|NCT00379769|449515236|FG005|Main Study|Prohibited glucose lowering medication|0|||
124969045|NCT00379769|449515231|FG000|Main Study|Site closed|4|||
124969046|NCT00379769|449515232|FG001|Main Study|Site closed|4|||
124969047|NCT00379769|449515233|FG002|Main Study|Site closed|4|||
124969048|NCT00379769|449515234|FG003|Main Study|Site closed|8|||
124969049|NCT00379769|449515235|FG004|Main Study|Site closed|0|||
124969050|NCT00379769|449515236|FG005|Main Study|Site closed|0|||
124969051|NCT00379769|449515231|FG000|Main Study|Entry criteria violation|0|||
124969052|NCT00379769|449515232|FG001|Main Study|Entry criteria violation|0|||
124969053|NCT00379769|449515233|FG002|Main Study|Entry criteria violation|1|||
124969054|NCT00379769|449515234|FG003|Main Study|Entry criteria violation|1|||
124969055|NCT00379769|449515235|FG004|Main Study|Entry criteria violation|0|||
124969056|NCT00379769|449515236|FG005|Main Study|Entry criteria violation|0|||
124969057|NCT00379769|449515231|FG000|Main Study|Participant did not take study drug|0|||
124969058|NCT00379769|449515232|FG001|Main Study|Participant did not take study drug|0|||
124969059|NCT00379769|449515233|FG002|Main Study|Participant did not take study drug|1|||
124969060|NCT00379769|449515234|FG003|Main Study|Participant did not take study drug|0|||
124969061|NCT00379769|449515235|FG004|Main Study|Participant did not take study drug|0|||
124969062|NCT00379769|449515236|FG005|Main Study|Participant did not take study drug|0|||
124969063|NCT00379769|449515231|FG000|Main Study|Physician Decision|2|||
124969064|NCT00379769|449515232|FG001|Main Study|Physician Decision|2|||
124969065|NCT00379769|449515233|FG002|Main Study|Physician Decision|1|||
124969066|NCT00379769|449515234|FG003|Main Study|Physician Decision|1|||
124969067|NCT00379769|449515235|FG004|Main Study|Physician Decision|0|||
124969068|NCT00379769|449515236|FG005|Main Study|Physician Decision|0|||
124969069|NCT00379769|449515231|FG000|Main Study|Participant completed study at visit 27|1|||
124969070|NCT00379769|449515232|FG001|Main Study|Participant completed study at visit 27|0|||
124969071|NCT00379769|449515233|FG002|Main Study|Participant completed study at visit 27|0|||
124969072|NCT00379769|449515234|FG003|Main Study|Participant completed study at visit 27|0|||
124969073|NCT00379769|449515235|FG004|Main Study|Participant completed study at visit 27|0|||
124969074|NCT00379769|449515236|FG005|Main Study|Participant completed study at visit 27|0|||
124969075|NCT00379769|449515231|FG000|Main Study|Personal reasons|1|||
124969076|NCT00379769|449515232|FG001|Main Study|Personal reasons|0|||
124969077|NCT00379769|449515233|FG002|Main Study|Personal reasons|0|||
124969078|NCT00379769|449515234|FG003|Main Study|Personal reasons|0|||
124969079|NCT00379769|449515235|FG004|Main Study|Personal reasons|0|||
124969080|NCT00379769|449515236|FG005|Main Study|Personal reasons|0|||
124969081|NCT00379769|449515231|FG000|Main Study|Risk of heart failure|0|||
124969082|NCT00379769|449515232|FG001|Main Study|Risk of heart failure|1|||
124969083|NCT00379769|449515233|FG002|Main Study|Risk of heart failure|0|||
124969084|NCT00379769|449515234|FG003|Main Study|Risk of heart failure|0|||
124969085|NCT00379769|449515235|FG004|Main Study|Risk of heart failure|0|||
124969086|NCT00379769|449515236|FG005|Main Study|Risk of heart failure|0|||
124969087|NCT00379769|449515231|FG000|Main Study|Investigator refused to log temperature|0|||
124969088|NCT00379769|449515232|FG001|Main Study|Investigator refused to log temperature|0|||
124969089|NCT00379769|449515233|FG002|Main Study|Investigator refused to log temperature|1|||
124969090|NCT00379769|449515234|FG003|Main Study|Investigator refused to log temperature|0|||
124969091|NCT00379769|449515235|FG004|Main Study|Investigator refused to log temperature|0|||
124969092|NCT00379769|449515236|FG005|Main Study|Investigator refused to log temperature|0|||
124969093|NCT00379769|449515231|FG000|Main Study|Reason unspecified|0|||
124969094|NCT00379769|449515232|FG001|Main Study|Reason unspecified|0|||
124969095|NCT00379769|449515233|FG002|Main Study|Reason unspecified|1|||
124969096|NCT00379769|449515234|FG003|Main Study|Reason unspecified|0|||
124969097|NCT00379769|449515235|FG004|Main Study|Reason unspecified|0|||
124969098|NCT00379769|449515236|FG005|Main Study|Reason unspecified|0|||
124969099|NCT00379769|449515231|FG000|Observational Follow-up|Death|0|||
124969100|NCT00379769|449515232|FG001|Observational Follow-up|Death|0|||
124969101|NCT00379769|449515233|FG002|Observational Follow-up|Death|0|||
124969102|NCT00379769|449515234|FG003|Observational Follow-up|Death|0|||
124969103|NCT00379769|449515235|FG004|Observational Follow-up|Death|78|||
124969104|NCT00379769|449515236|FG005|Observational Follow-up|Death|70|||
124969105|NCT00379769|449515231|FG000|Observational Follow-up|Adverse Event|0|||
124969106|NCT00379769|449515232|FG001|Observational Follow-up|Adverse Event|0|||
124969107|NCT00379769|449515233|FG002|Observational Follow-up|Adverse Event|0|||
124969108|NCT00379769|449515234|FG003|Observational Follow-up|Adverse Event|0|||
124969109|NCT00379769|449515235|FG004|Observational Follow-up|Adverse Event|1|||
124969110|NCT00379769|449515236|FG005|Observational Follow-up|Adverse Event|0|||
124969111|NCT00379769|449515231|FG000|Observational Follow-up|Lost to Follow-up|0|||
124969112|NCT00379769|449515232|FG001|Observational Follow-up|Lost to Follow-up|0|||
124969113|NCT00379769|449515233|FG002|Observational Follow-up|Lost to Follow-up|0|||
124969114|NCT00379769|449515234|FG003|Observational Follow-up|Lost to Follow-up|0|||
124969115|NCT00379769|449515235|FG004|Observational Follow-up|Lost to Follow-up|25|||
124969116|NCT00379769|449515236|FG005|Observational Follow-up|Lost to Follow-up|27|||
124969117|NCT00379769|449515231|FG000|Observational Follow-up|Withdrawal by Subject|0|||
124969118|NCT00379769|449515232|FG001|Observational Follow-up|Withdrawal by Subject|0|||
124969119|NCT00379769|449515233|FG002|Observational Follow-up|Withdrawal by Subject|0|||
124969120|NCT00379769|449515234|FG003|Observational Follow-up|Withdrawal by Subject|0|||
124969121|NCT00379769|449515235|FG004|Observational Follow-up|Withdrawal by Subject|12|||
124969122|NCT00379769|449515236|FG005|Observational Follow-up|Withdrawal by Subject|12|||
124969123|NCT00379769|449515231|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
124969124|NCT00379769|449515232|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
124969125|NCT00379769|449515233|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
124969126|NCT00379769|449515234|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
124969127|NCT00379769|449515235|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
124969128|NCT00379769|449515236|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
124969129|NCT00379769|449515231|FG000|Observational Follow-up|Physician Decision|0|||
124969130|NCT00379769|449515232|FG001|Observational Follow-up|Physician Decision|0|||
124969131|NCT00379769|449515233|FG002|Observational Follow-up|Physician Decision|0|||
124969132|NCT00379769|449515234|FG003|Observational Follow-up|Physician Decision|0|||
124969133|NCT00379769|449515235|FG004|Observational Follow-up|Physician Decision|8|||
124969134|NCT00379769|449515236|FG005|Observational Follow-up|Physician Decision|8|||
124969135|NCT00379769|449515231|FG000|Observational Follow-up|Site Closed Early|0|||
124969136|NCT00379769|449515232|FG001|Observational Follow-up|Site Closed Early|0|||
124969137|NCT00379769|449515233|FG002|Observational Follow-up|Site Closed Early|0|||
124969138|NCT00379769|449515234|FG003|Observational Follow-up|Site Closed Early|0|||
124969139|NCT00379769|449515235|FG004|Observational Follow-up|Site Closed Early|6|||
124969140|NCT00379769|449515236|FG005|Observational Follow-up|Site Closed Early|7|||
124969141|NCT00379769|449515231|FG000|Observational Follow-up|Participant Moved|0|||
124969142|NCT00379769|449515232|FG001|Observational Follow-up|Participant Moved|0|||
124969143|NCT00379769|449515233|FG002|Observational Follow-up|Participant Moved|0|||
124969144|NCT00379769|449515234|FG003|Observational Follow-up|Participant Moved|0|||
124969145|NCT00379769|449515235|FG004|Observational Follow-up|Participant Moved|0|||
124969146|NCT00379769|449515236|FG005|Observational Follow-up|Participant Moved|1|||
124969147|NCT00379769|449515231|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
124969148|NCT00379769|449515232|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
124969149|NCT00379769|449515233|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
124969150|NCT00379769|449515234|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
124969151|NCT00379769|449515235|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
124969152|NCT00379769|449515236|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
124969153|NCT03778294|449515237|FG000|Overall Study|Death|1|||
124969154|NCT03778294|449515237|FG000|Overall Study|Issues with insurance|1|||
124969155|NCT03778294|449515237|FG000|Overall Study|disease progression before treatment|2|||
124969156|NCT02388347|449515238|FG000|Overall Study|Withdrawal by Subject|0|||
124969157|NCT02388347|449515239|FG001|Overall Study|Withdrawal by Subject|0|||
124969158|NCT02388347|449515240|FG002|Overall Study|Withdrawal by Subject|1|||
124969159|NCT02388347|449515241|FG003|Overall Study|Withdrawal by Subject|0|||
124969160|NCT02388347|449515242|FG004|Overall Study|Withdrawal by Subject|0|||
124969161|NCT02820597|449515244|FG000|Overall Study|Lost to Follow-up|12|||
124969162|NCT00701909|449515247|FG000|Overall Study|Withdrawal by Subject|0|||
124969163|NCT00701909|449515248|FG001|Overall Study|Withdrawal by Subject|1|||
124969164|NCT02666664|449515255|FG000|Overall Study|Physician Decision|0|||
124969165|NCT02666664|449515256|FG001|Overall Study|Physician Decision|1|||
124969166|NCT02666664|449515255|FG000|Overall Study|Protocol Violation|0|||
124969167|NCT02666664|449515256|FG001|Overall Study|Protocol Violation|2|||
124969168|NCT02666664|449515255|FG000|Overall Study|Other|0|||
124969169|NCT02666664|449515256|FG001|Overall Study|Other|1|||
124969170|NCT02666664|449515255|FG000|Overall Study|Adverse Event|12|||
124969171|NCT02666664|449515256|FG001|Overall Study|Adverse Event|37|||
124969172|NCT02666664|449515255|FG000|Overall Study|Withdrawal by participant|23|||
124969173|NCT02666664|449515256|FG001|Overall Study|Withdrawal by participant|40|||
124969174|NCT02666664|449515255|FG000|Overall Study|Sponsor decision|0|||
124969175|NCT02666664|449515256|FG001|Overall Study|Sponsor decision|1|||
124969176|NCT02666664|449515255|FG000|Overall Study|Lost to Follow-up|1|||
124969177|NCT02666664|449515256|FG001|Overall Study|Lost to Follow-up|2|||
124969178|NCT00971997|449515257|FG000|Overall Study|Adverse Event|2|||
124969179|NCT00971997|449515257|FG000|Overall Study|Death|1|||
124969180|NCT00971997|449515257|FG000|Overall Study|Protocol Violation|4|||
124969181|NCT00971997|449515257|FG000|Overall Study|Withdrawal by Subject|5|||
124969182|NCT00971997|449515257|FG000|Overall Study|Physician Decision|7|||
124969183|NCT01385748|449515258|FG000|Overall Study|Withdrawal by Subject|7|||
124969184|NCT01385748|449515259|FG001|Overall Study|Withdrawal by Subject|4|||
124466264|NCT01344876|447664613|FG004|Overall Study|Withdrawal by Subject|0|||
124969185|NCT01385748|449515260|FG002|Overall Study|Withdrawal by Subject|5|||
124969186|NCT01385748|449515258|FG000|Overall Study|Noncompliance|3|||
124969187|NCT01385748|449515259|FG001|Overall Study|Noncompliance|1|||
124969188|NCT01385748|449515260|FG002|Overall Study|Noncompliance|6|||
124969189|NCT01385748|449515258|FG000|Overall Study|Other|1|||
124969190|NCT01385748|449515259|FG001|Overall Study|Other|7|||
124969191|NCT01385748|449515260|FG002|Overall Study|Other|1|||
124969192|NCT01385748|449515258|FG000|Overall Study|Adverse Event|4|||
124969193|NCT01385748|449515259|FG001|Overall Study|Adverse Event|2|||
124969194|NCT01385748|449515260|FG002|Overall Study|Adverse Event|1|||
124969195|NCT01266018|449515263|FG000|Overall Study|Physician Decision|1|||
124969196|NCT01266018|449515264|FG001|Overall Study|Physician Decision|0|||
124969197|NCT01266018|449515263|FG000|Overall Study|Progressive disease|0|||
124969198|NCT01266018|449515264|FG001|Overall Study|Progressive disease|1|||
124969199|NCT03167151|449515265|FG000|Overall Study|Withdrawal by Subject|1|||
124969200|NCT03167151|449515266|FG001|Overall Study|Withdrawal by Subject|0|||
124969201|NCT03167151|449515267|FG002|Overall Study|Withdrawal by Subject|0|||
124969202|NCT03167151|449515265|FG000|Overall Study|No evidence of tumour at surgery|0|||
124969203|NCT03167151|449515266|FG001|Overall Study|No evidence of tumour at surgery|1|||
124969204|NCT03167151|449515267|FG002|Overall Study|No evidence of tumour at surgery|1|||
124969205|NCT01458522|449515268|FG000|Overall Study|Withdrawal by Subject|2|||
124969206|NCT01458522|449515269|FG001|Overall Study|Withdrawal by Subject|2|||
124969207|NCT01458522|449515268|FG000|Overall Study|Physician Decision|1|||
124969208|NCT01458522|449515269|FG001|Overall Study|Physician Decision|9|||
124969209|NCT02684123|449515270|FG000|Phase 1|Lack of Efficacy|5|||
124969210|NCT02684123|449515271|FG001|Phase 1|Lack of Efficacy|0|||
124969211|NCT02684123|449515270|FG000|Phase 1|Adverse Event|3|||
124969212|NCT02684123|449515271|FG001|Phase 1|Adverse Event|0|||
124969213|NCT02684123|449515270|FG000|Phase 1|Lost to Follow-up|0|||
124969214|NCT02684123|449515271|FG001|Phase 1|Lost to Follow-up|1|||
124969215|NCT02684123|449515270|FG000|Phase 2|Lack of Efficacy|1|||
124969216|NCT02684123|449515271|FG001|Phase 2|Lack of Efficacy|8|||
124969217|NCT00516139|449515272|FG000|Overall Study|Adverse Event|27|||
124969218|NCT00516139|449515272|FG000|Overall Study|Lost to Follow-up|1|||
124969219|NCT00516139|449515272|FG000|Overall Study|Protocol Violation|1|||
124969220|NCT00516139|449515272|FG000|Overall Study|Withdrawal by Subject|8|||
124969221|NCT00516139|449515272|FG000|Overall Study|Lack of Efficacy|1|||
124969222|NCT03382561|449515273|FG000|Overall Study|Disease progression|47|||
124969223|NCT03382561|449515274|FG001|Overall Study|Disease progression|6|||
124969224|NCT03382561|449515273|FG000|Overall Study|Adverse Event|10|||
124969225|NCT03382561|449515274|FG001|Overall Study|Adverse Event|2|||
124969226|NCT03382561|449515273|FG000|Overall Study|Death|8|||
124969227|NCT03382561|449515274|FG001|Overall Study|Death|3|||
124969228|NCT03382561|449515273|FG000|Overall Study|Withdrawal by Subject|6|||
124969229|NCT03382561|449515274|FG001|Overall Study|Withdrawal by Subject|5|||
124969230|NCT03382561|449515273|FG000|Overall Study|Alternative therapy|2|||
124969231|NCT03382561|449515274|FG001|Overall Study|Alternative therapy|8|||
124969232|NCT03382561|449515273|FG000|Overall Study|Never started treatment|3|||
124969233|NCT03382561|449515274|FG001|Overall Study|Never started treatment|6|||
124969234|NCT03382561|449515273|FG000|Overall Study|Lack of Efficacy|0|||
124969235|NCT03382561|449515274|FG001|Overall Study|Lack of Efficacy|1|||
124969236|NCT03382561|449515273|FG000|Overall Study|Physician Decision|0|||
124969237|NCT03382561|449515274|FG001|Overall Study|Physician Decision|1|||
124969238|NCT03382561|449515273|FG000|Overall Study|Other complicating disease|0|||
124969239|NCT03382561|449515274|FG001|Overall Study|Other complicating disease|1|||
124969240|NCT01131104|449515275|FG000|Overall Study|Withdrawal by Subject|3|||
124551145|NCT00424515|447974670|FG000|Overall Study|Withdrawal by Subject|1|||
124969241|NCT01131104|449515275|FG000|Overall Study|Physician Decision|4|||
124969242|NCT01131104|449515275|FG000|Overall Study|Information Not Available|5|||
124969243|NCT01131104|449515275|FG000|Overall Study|No Information on Index Date of Onset|1|||
124969244|NCT02370251|449515278|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
124969245|NCT02370251|449515278|FG000|Overall Study|Death|4|||
124969246|NCT02270671|449515279|FG000|Overall Study|Withdrawal by Subject|1|||
124969247|NCT02270671|449515280|FG001|Overall Study|Withdrawal by Subject|1|||
124969248|NCT02270671|449515279|FG000|Overall Study|Protocol Violation|0|||
124969249|NCT02270671|449515280|FG001|Overall Study|Protocol Violation|1|||
124969250|NCT02270671|449515279|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
124969251|NCT02270671|449515280|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
124551146|NCT00424515|447974671|FG001|Overall Study|Withdrawal by Subject|0|||
124969252|NCT02270671|449515279|FG000|Overall Study|Lost to Follow-up|2|||
124969253|NCT02270671|449515280|FG001|Overall Study|Lost to Follow-up|1|||
124969254|NCT02367352|449515292|FG000|Overall Study|Progressive disease|7|||
124969255|NCT02367352|449515293|FG001|Overall Study|Progressive disease|0|||
124969256|NCT02367352|449515294|FG002|Overall Study|Progressive disease|0|||
124969257|NCT02367352|449515292|FG000|Overall Study|Participant Received Alternative Therapy|1|||
124969258|NCT02367352|449515293|FG001|Overall Study|Participant Received Alternative Therapy|0|||
124969259|NCT02367352|449515294|FG002|Overall Study|Participant Received Alternative Therapy|0|||
124969260|NCT02367352|449515292|FG000|Overall Study|Adverse Event|1|||
124969261|NCT02367352|449515293|FG001|Overall Study|Adverse Event|0|||
124969262|NCT02367352|449515294|FG002|Overall Study|Adverse Event|0|||
124969263|NCT00174447|449515295|FG000|Overall Study|Adverse Event|19|||
124969264|NCT00174447|449515295|FG000|Overall Study|Withdrawal by Subject|15|||
124969265|NCT00174447|449515295|FG000|Overall Study|Protocol Violation|1|||
124969266|NCT00174447|449515295|FG000|Overall Study|Lack of Efficacy|1|||
124711792|NCT02756403|448569454|FG003|Overall Study|Did not complete Procedure|0|||
124711793|NCT02756403|448569451|FG000|Overall Study|Changed Mind About Procedure|0|||
124711794|NCT02756403|448569452|FG001|Overall Study|Changed Mind About Procedure|0|||
124711795|NCT02756403|448569453|FG002|Overall Study|Changed Mind About Procedure|1|||
124711796|NCT02756403|448569454|FG003|Overall Study|Changed Mind About Procedure|0|||
124711797|NCT02756403|448569451|FG000|Overall Study|Protocol Violation|0|||
124711798|NCT02756403|448569452|FG001|Overall Study|Protocol Violation|1|||
124711799|NCT02756403|448569453|FG002|Overall Study|Protocol Violation|0|||
124711800|NCT02756403|448569454|FG003|Overall Study|Protocol Violation|1|||
124711801|NCT02850978|448569460|FG000|Overall Study|Uncollectable CRF|27|||
124711802|NCT02850978|448569460|FG000|Overall Study|No visit since the first visit|35|||
124711803|NCT02850978|448569460|FG000|Overall Study|Adverse Event|81|||
124711804|NCT02850978|448569460|FG000|Overall Study|Lack of Efficacy|40|||
124711805|NCT02850978|448569460|FG000|Overall Study|Improvement in condition|34|||
124711806|NCT02850978|448569460|FG000|Overall Study|Lost to Follow-up|121|||
124711807|NCT02850978|448569460|FG000|Overall Study|Reason not listed|88|||
124711808|NCT03188263|448569464|FG000|Overall Study|Withdrawal by Subject|3|||
124711809|NCT03188263|448569465|FG001|Overall Study|Withdrawal by Subject|0|||
124711810|NCT03188263|448569464|FG000|Overall Study|Physician Decision|1|||
124969267|NCT00174447|449515295|FG000|Overall Study|Administrative reason/Other|2|||
124969268|NCT01437423|449515296|FG000|Overall Study|Lost to Follow-up|12|||
124969269|NCT01437423|449515296|FG000|Overall Study|Off label usage|3|||
124969270|NCT05878873|449515297|FG000|Overall Study|Lost to Follow-up|2|||
124969271|NCT05878873|449515298|FG001|Overall Study|Lost to Follow-up|0|||
124969272|NCT00633945|449515300|FG000|Overall Study|Physician Decision|2|||
124969273|NCT03865953|449515301|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
124969274|NCT03865953|449515302|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
124969275|NCT03865953|449515301|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
124711811|NCT03188263|448569465|FG001|Overall Study|Physician Decision|0|||
124711812|NCT01030822|448569466|FG000|Overall Study|Moved/migrated from study area|6|||
124711813|NCT01030822|448569467|FG001|Overall Study|Moved/migrated from study area|7|||
124711814|NCT01030822|448569468|FG002|Overall Study|Moved/migrated from study area|3|||
124711815|NCT01030822|448569466|FG000|Overall Study|Withdrawal by Subject|16|||
124711816|NCT01030822|448569467|FG001|Overall Study|Withdrawal by Subject|13|||
124711817|NCT01030822|448569468|FG002|Overall Study|Withdrawal by Subject|16|||
124711818|NCT01030822|448569466|FG000|Overall Study|Lost to Follow-up|9|||
124711819|NCT01030822|448569467|FG001|Overall Study|Lost to Follow-up|4|||
124711820|NCT01030822|448569468|FG002|Overall Study|Lost to Follow-up|7|||
124711821|NCT00539240|448569469|FG000|Overall Study|Withdrawal by Subject|0|||
124711822|NCT00539240|448569470|FG001|Overall Study|Withdrawal by Subject|2|||
124711823|NCT00539240|448569471|FG002|Overall Study|Withdrawal by Subject|0|||
124711824|NCT00539240|448569469|FG000|Overall Study|Protocol Violation|1|||
124711825|NCT00539240|448569470|FG001|Overall Study|Protocol Violation|1|||
124711826|NCT00539240|448569471|FG002|Overall Study|Protocol Violation|4|||
124711827|NCT00539240|448569469|FG000|Overall Study|Lost to Follow-up|2|||
124711828|NCT00539240|448569470|FG001|Overall Study|Lost to Follow-up|3|||
124711829|NCT00539240|448569471|FG002|Overall Study|Lost to Follow-up|1|||
124711830|NCT00539240|448569469|FG000|Overall Study|Adverse Event|3|||
124711831|NCT00539240|448569470|FG001|Overall Study|Adverse Event|1|||
124711832|NCT00539240|448569471|FG002|Overall Study|Adverse Event|10|||
124711833|NCT01055613|448569473|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
124711834|NCT01055613|448569474|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
124711835|NCT01055613|448569473|FG000|Overall Study|Unacceptable lens fit|1|||
124711836|NCT01055613|448569474|FG001|Overall Study|Unacceptable lens fit|0|||
124711837|NCT01055613|448569473|FG000|Overall Study|Discomfort|2|||
124711838|NCT01055613|448569474|FG001|Overall Study|Discomfort|1|||
124711839|NCT01055613|448569473|FG000|Overall Study|Lost to Follow-up|1|||
124969276|NCT03865953|449515302|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
124969277|NCT03865953|449515301|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
124969278|NCT03865953|449515302|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
124711840|NCT01055613|448569474|FG001|Overall Study|Lost to Follow-up|1|||
124969279|NCT00882115|449515303|FG000|Overall Study|Withdrawal by Subject|3|||
124711841|NCT01055613|448569473|FG000|Overall Study|Protocol Violation|1|||
124551147|NCT00267020|447974672|FG000|Overall Study|Adverse Event|22|||
124551148|NCT00267020|447974673|FG001|Overall Study|Adverse Event|5|||
124551149|NCT00267020|447974672|FG000|Overall Study|Death|2|||
124551150|NCT00267020|447974673|FG001|Overall Study|Death|1|||
124711842|NCT01055613|448569474|FG001|Overall Study|Protocol Violation|1|||
124711843|NCT01055613|448569473|FG000|Overall Study|Subject Disinterest|1|||
124711844|NCT01055613|448569474|FG001|Overall Study|Subject Disinterest|1|||
124711845|NCT02765399|448569475|FG000|Overall Study|Nausea|1|||
124711846|NCT02765399|448569476|FG001|Overall Study|Nausea|0|||
124711847|NCT01182298|448569485|FG000|Overall Study|Lack of Efficacy|4|||
124711848|NCT01182298|448569485|FG000|Overall Study|Withdrawal by Subject|2|||
124711849|NCT04540367|448569499|FG000|Overall Study|Withdrawal by Subject|0|||
124711850|NCT04540367|448569500|FG001|Overall Study|Withdrawal by Subject|0|||
124711851|NCT04540367|448569501|FG002|Overall Study|Withdrawal by Subject|0|||
124466265|NCT01344876|447664609|FG000|Overall Study|Definite progression of primary disease|1|||
124466266|NCT01344876|447664610|FG001|Overall Study|Definite progression of primary disease|0|||
124466267|NCT01344876|447664611|FG002|Overall Study|Definite progression of primary disease|0|||
124466268|NCT01344876|447664612|FG003|Overall Study|Definite progression of primary disease|3|||
124466269|NCT01344876|447664613|FG004|Overall Study|Definite progression of primary disease|0|||
124466270|NCT04428424|447664614|FG000|Overall Study|Does not meet entrance criteria|132|||
124466271|NCT04428424|447664614|FG000|Overall Study|Lost to Follow-up|115|||
124466272|NCT03110224|447664618|FG000|Overall Study|Death|3|||
124466273|NCT03110224|447664618|FG000|Overall Study|Lost to Follow-up|132|||
124466274|NCT03110224|447664618|FG000|Overall Study|Physician Decision|2|||
124466275|NCT03110224|447664618|FG000|Overall Study|Site Closed by Physician|35|||
124466276|NCT03110224|447664618|FG000|Overall Study|Site Closed by Sponsor|202|||
124466277|NCT03110224|447664618|FG000|Overall Study|Withdrawal by Subject|9|||
124969280|NCT00882115|449515303|FG000|Overall Study|did not respond to DEP challe|6|||
124969281|NCT01271504|449515304|FG000|Overall Study|Death|7|||
124969282|NCT01271504|449515305|FG001|Overall Study|Death|6|||
124969283|NCT01271504|449515306|FG002|Overall Study|Death|32|||
124969284|NCT01271504|449515307|FG003|Overall Study|Death|32|||
124969285|NCT01271504|449515304|FG000|Overall Study|Lost to Follow-up|0|||
124969286|NCT01271504|449515305|FG001|Overall Study|Lost to Follow-up|1|||
124969287|NCT01271504|449515306|FG002|Overall Study|Lost to Follow-up|3|||
124969288|NCT01271504|449515307|FG003|Overall Study|Lost to Follow-up|1|||
124969289|NCT01271504|449515304|FG000|Overall Study|Protocol Violation|0|||
124969290|NCT01271504|449515305|FG001|Overall Study|Protocol Violation|0|||
124969291|NCT01271504|449515306|FG002|Overall Study|Protocol Violation|0|||
124969292|NCT01271504|449515307|FG003|Overall Study|Protocol Violation|2|||
124969293|NCT01271504|449515304|FG000|Overall Study|Administrative Reasons|0|||
124969294|NCT01271504|449515305|FG001|Overall Study|Administrative Reasons|0|||
124969295|NCT01271504|449515306|FG002|Overall Study|Administrative Reasons|6|||
124969296|NCT01271504|449515307|FG003|Overall Study|Administrative Reasons|5|||
124969297|NCT01271504|449515304|FG000|Overall Study|Withdrawal by Subject|0|||
124969298|NCT01271504|449515305|FG001|Overall Study|Withdrawal by Subject|0|||
124969299|NCT01271504|449515306|FG002|Overall Study|Withdrawal by Subject|1|||
124969300|NCT01271504|449515307|FG003|Overall Study|Withdrawal by Subject|3|||
124969301|NCT01271504|449515304|FG000|Overall Study|Other|0|||
124969302|NCT01271504|449515305|FG001|Overall Study|Other|1|||
124969303|NCT01271504|449515306|FG002|Overall Study|Other|2|||
124969304|NCT01271504|449515307|FG003|Overall Study|Other|0|||
124969305|NCT02552147|449515308|FG000|First Intervention (7 Days)|Protocol Violation|1|||
124969306|NCT02552147|449515309|FG001|First Intervention (7 Days)|Protocol Violation|0|||
124969307|NCT02552147|449515308|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
124969308|NCT02552147|449515309|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
124969309|NCT02375347|449515310|FG000|Overall Study|Protocol Violation|1|||
124969310|NCT02031536|449515312|FG000|Overall Study|ineligible|1|||
124969311|NCT02031536|449515313|FG001|Overall Study|ineligible|0|||
124969312|NCT04147858|449515324|FG000|Overall Study|Adverse Event|6|||
124969313|NCT04147858|449515325|FG001|Overall Study|Adverse Event|6|||
124969314|NCT04147858|449515326|FG002|Overall Study|Adverse Event|6|||
124969315|NCT04147858|449515324|FG000|Overall Study|Lack of Efficacy|3|||
124969316|NCT04147858|449515325|FG001|Overall Study|Lack of Efficacy|3|||
124969317|NCT04147858|449515326|FG002|Overall Study|Lack of Efficacy|1|||
124969318|NCT04147858|449515324|FG000|Overall Study|Lost to Follow-up|1|||
124969319|NCT04147858|449515325|FG001|Overall Study|Lost to Follow-up|6|||
124969320|NCT04147858|449515326|FG002|Overall Study|Lost to Follow-up|2|||
124969321|NCT04147858|449515324|FG000|Overall Study|Withdrawal by Subject|3|||
124969322|NCT04147858|449515325|FG001|Overall Study|Withdrawal by Subject|4|||
124969323|NCT04147858|449515326|FG002|Overall Study|Withdrawal by Subject|10|||
124969324|NCT04147858|449515324|FG000|Overall Study|Subject Noncompliance, Other|4|||
124969325|NCT04147858|449515325|FG001|Overall Study|Subject Noncompliance, Other|3|||
124969326|NCT04147858|449515326|FG002|Overall Study|Subject Noncompliance, Other|1|||
124969327|NCT01191008|449515327|FG000|Overall Study|Protocol Violation|7|||
124969328|NCT01191008|449515327|FG000|Overall Study|Lost to Follow-up|8|||
124969329|NCT04905849|449515330|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
124969330|NCT04905849|449515331|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
124969331|NCT00838929|449515336|FG000|Overall Study|Protocol Violation|0|||
124969332|NCT00838929|449515337|FG001|Overall Study|Protocol Violation|1|||
124466278|NCT04818593|447664619|FG000|Overall Study|Low Oocyte Yield|8|||
124466279|NCT04818593|447664620|FG001|Overall Study|Low Oocyte Yield|8|||
124969333|NCT00838929|449515338|FG002|Overall Study|Protocol Violation|0|||
124969334|NCT00838929|449515336|FG000|Overall Study|Disease progression|0|||
124969335|NCT00838929|449515337|FG001|Overall Study|Disease progression|2|||
124969336|NCT00838929|449515338|FG002|Overall Study|Disease progression|1|||
124551151|NCT00267020|447974672|FG000|Overall Study|Withdrawal by Subject|17|||
124969337|NCT03522389|449515342|FG000|Overall Study|Lost to Follow-up|1|||
124466280|NCT04818593|447664619|FG000|Overall Study|Not ICSI Insemination|7|||
124969338|NCT03522389|449515343|FG001|Overall Study|Lost to Follow-up|1|||
124466281|NCT04818593|447664620|FG001|Overall Study|Not ICSI Insemination|7|||
124466282|NCT04818593|447664619|FG000|Overall Study|Poor Sperm Quality|2|||
124466283|NCT04818593|447664620|FG001|Overall Study|Poor Sperm Quality|2|||
124466284|NCT04818593|447664619|FG000|Overall Study|Withdrawal by Subject|2|||
124466285|NCT04818593|447664620|FG001|Overall Study|Withdrawal by Subject|2|||
124466286|NCT04818593|447664619|FG000|Overall Study|Conversion to IUI due to low response|1|||
124466287|NCT04818593|447664620|FG001|Overall Study|Conversion to IUI due to low response|1|||
124466288|NCT01564862|447664621|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
124466289|NCT01564862|447664622|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
124466290|NCT01564862|447664623|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
124969339|NCT03522389|449515344|FG002|Overall Study|Lost to Follow-up|2|||
124969340|NCT03522389|449515342|FG000|Overall Study|had herniated nucleus pulposus|0|||
124969341|NCT03522389|449515343|FG001|Overall Study|had herniated nucleus pulposus|1|||
124969342|NCT03522389|449515344|FG002|Overall Study|had herniated nucleus pulposus|0|||
124969343|NCT03522389|449515342|FG000|Overall Study|go to work in other province|1|||
124969344|NCT03522389|449515343|FG001|Overall Study|go to work in other province|0|||
124969345|NCT03522389|449515344|FG002|Overall Study|go to work in other province|0|||
124969346|NCT02257918|449515345|FG000|Overall Study|Lost to Follow-up|4|||
124969347|NCT02257918|449515346|FG001|Overall Study|Lost to Follow-up|1|||
124969348|NCT02257918|449515347|FG002|Overall Study|Lost to Follow-up|0|||
124969349|NCT02257918|449515345|FG000|Overall Study|Withdrawal by Subject|0|||
124969350|NCT02257918|449515346|FG001|Overall Study|Withdrawal by Subject|0|||
124969351|NCT02257918|449515347|FG002|Overall Study|Withdrawal by Subject|1|||
124969352|NCT02257918|449515345|FG000|Overall Study|Pregnancy|0|||
124969353|NCT02257918|449515346|FG001|Overall Study|Pregnancy|0|||
124969354|NCT02257918|449515347|FG002|Overall Study|Pregnancy|1|||
124969355|NCT03494985|449515356|FG000|Overall Study|Adverse Event|3|||
124969356|NCT03494985|449515357|FG001|Overall Study|Adverse Event|2|||
124969357|NCT03494985|449515358|FG002|Overall Study|Adverse Event|3|||
124969358|NCT03494985|449515359|FG003|Overall Study|Adverse Event|0|||
124969359|NCT03494985|449515356|FG000|Overall Study|Other (Withdrawal of consent)|2|||
124969360|NCT03494985|449515357|FG001|Overall Study|Other (Withdrawal of consent)|3|||
124969361|NCT03494985|449515358|FG002|Overall Study|Other (Withdrawal of consent)|2|||
124969362|NCT03494985|449515359|FG003|Overall Study|Other (Withdrawal of consent)|5|||
124969363|NCT03494985|449515356|FG000|Overall Study|Other (Not specified)|0|||
124969364|NCT03494985|449515357|FG001|Overall Study|Other (Not specified)|1|||
124969365|NCT03494985|449515358|FG002|Overall Study|Other (Not specified)|1|||
124969366|NCT03494985|449515359|FG003|Overall Study|Other (Not specified)|0|||
124969367|NCT02282059|449515360|FG000|Overall Study|Other|15|||
124969368|NCT02282059|449515361|FG001|Overall Study|Other|3|||
124969369|NCT02282059|449515360|FG000|Overall Study|Participant refused further follow-up|8|||
124969370|NCT02282059|449515361|FG001|Overall Study|Participant refused further follow-up|4|||
124969371|NCT02282059|449515360|FG000|Overall Study|Lost to Follow-up|19|||
124969372|NCT02282059|449515361|FG001|Overall Study|Lost to Follow-up|3|||
124969373|NCT02282059|449515360|FG000|Overall Study|Death|40|||
124969374|NCT02282059|449515361|FG001|Overall Study|Death|8|||
124969375|NCT05093504|449515362|FG000|Overall Study|Death|0|||
124969376|NCT05093504|449515363|FG001|Overall Study|Death|1|||
124969377|NCT02394925|449515364|FG000|Overall Study|Adverse Event|1|||
124969378|NCT02394925|449515364|FG000|Overall Study|Lens Discomfort|3|||
124969379|NCT02394925|449515364|FG000|Overall Study|Lens handling difficulities|5|||
124969380|NCT02394925|449515364|FG000|Overall Study|Lost to Follow-up|9|||
124969381|NCT02394925|449515364|FG000|Overall Study|Protocol Violation|5|||
124969382|NCT02394925|449515364|FG000|Overall Study|No longer meet eligibility criteria|1|||
124969383|NCT02394925|449515364|FG000|Overall Study|Unsatisfactory Visual Response|5|||
124969384|NCT05347485|449515373|FG000|Overall Study|Death|14|||
124969385|NCT05347485|449515373|FG000|Overall Study|Lost to Follow-up|2|||
124969386|NCT05347485|449515373|FG000|Overall Study|Withdrawal by Subject|13|||
124969387|NCT05347485|449515373|FG000|Overall Study|Progressive Disease|1|||
124969388|NCT05347485|449515373|FG000|Overall Study|Study Terminated by Sponsor|49|||
124969389|NCT05347485|449515373|FG000|Overall Study|Other|1|||
124969390|NCT05347485|449515373|FG000|Overall Study|Enrolled (consented) but not treated|4|||
124969391|NCT05347485|449515373|FG000|Overall Study|Disease Relapse|2|||
124969392|NCT04886518|449515374|FG000|Overall Study|Noncompliance with study drug|1|||
124969393|NCT04886518|449515375|FG001|Overall Study|Noncompliance with study drug|0|||
124969394|NCT04886518|449515376|FG002|Overall Study|Noncompliance with study drug|0|||
124969395|NCT04886518|449515374|FG000|Overall Study|Adverse Event|0|||
124969396|NCT04886518|449515375|FG001|Overall Study|Adverse Event|1|||
124969397|NCT04886518|449515376|FG002|Overall Study|Adverse Event|0|||
124969398|NCT04886518|449515374|FG000|Overall Study|Withdrawal by Subject|1|||
124969399|NCT04886518|449515375|FG001|Overall Study|Withdrawal by Subject|0|||
124969400|NCT04886518|449515376|FG002|Overall Study|Withdrawal by Subject|0|||
124969401|NCT03733899|449515377|FG000|Period 1|Protocol Violation|0|||
124969402|NCT03733899|449515378|FG001|Period 1|Protocol Violation|0|||
124969403|NCT03733899|449515379|FG002|Period 1|Protocol Violation|0|||
124969404|NCT03733899|449515380|FG003|Period 1|Protocol Violation|0|||
124969405|NCT03733899|449515381|FG004|Period 1|Protocol Violation|0|||
124466291|NCT01564862|447664621|FG000|Overall Study|Major Protocol Deviation|3|||
124466292|NCT01564862|447664622|FG001|Overall Study|Major Protocol Deviation|3|||
124466293|NCT01564862|447664623|FG002|Overall Study|Major Protocol Deviation|4|||
124466294|NCT01564862|447664621|FG000|Overall Study|Lost to Follow-up|10|||
124466295|NCT01564862|447664622|FG001|Overall Study|Lost to Follow-up|8|||
124466296|NCT01564862|447664623|FG002|Overall Study|Lost to Follow-up|6|||
124711852|NCT04540367|448569502|FG003|Overall Study|Withdrawal by Subject|2|||
124711853|NCT04540367|448569499|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
124711854|NCT04540367|448569500|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
124711855|NCT04540367|448569501|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
124711856|NCT04540367|448569502|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
124711857|NCT04540367|448569499|FG000|Overall Study|Adverse Event|0|||
124969406|NCT03733899|449515382|FG005|Period 1|Protocol Violation|1|||
124969407|NCT03733899|449515377|FG000|Period 2|Unscuccessful Treatment|0|||
124969408|NCT03733899|449515378|FG001|Period 2|Unscuccessful Treatment|1|||
124969409|NCT03733899|449515379|FG002|Period 2|Unscuccessful Treatment|0|||
124969410|NCT03733899|449515380|FG003|Period 2|Unscuccessful Treatment|0|||
124969411|NCT03733899|449515381|FG004|Period 2|Unscuccessful Treatment|0|||
124969412|NCT03733899|449515382|FG005|Period 2|Unscuccessful Treatment|0|||
124969413|NCT03733899|449515377|FG000|Period 3|Withdrawal by Subject|1|||
124969414|NCT03733899|449515378|FG001|Period 3|Withdrawal by Subject|0|||
124969415|NCT03733899|449515379|FG002|Period 3|Withdrawal by Subject|0|||
124969416|NCT03733899|449515380|FG003|Period 3|Withdrawal by Subject|0|||
124969417|NCT03733899|449515381|FG004|Period 3|Withdrawal by Subject|0|||
124969418|NCT03733899|449515382|FG005|Period 3|Withdrawal by Subject|0|||
124969419|NCT01689363|449517381|FG000|Overall Study|Protocol Violation|0|||
124969420|NCT01689363|449517382|FG001|Overall Study|Protocol Violation|1|||
124969421|NCT01689363|449517383|FG002|Overall Study|Protocol Violation|0|||
124969422|NCT01689363|449517384|FG003|Overall Study|Protocol Violation|0|||
124969423|NCT01689363|449517385|FG004|Overall Study|Protocol Violation|0|||
124969424|NCT01689363|449517386|FG005|Overall Study|Protocol Violation|0|||
124969425|NCT01689363|449517387|FG006|Overall Study|Protocol Violation|0|||
124969426|NCT01689363|449517388|FG007|Overall Study|Protocol Violation|0|||
124969427|NCT02104505|449517389|FG000|First Intervention (14 Days)|Adverse Event|2|||
124969428|NCT02104505|449517390|FG001|First Intervention (14 Days)|Adverse Event|0|||
124969429|NCT02104505|449517389|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
124969430|NCT02104505|449517390|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
124969431|NCT02104505|449517389|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
124969432|NCT02104505|449517390|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
124969433|NCT02104505|449517389|FG000|First Intervention (14 Days)|exclusionary condition|0|||
124969434|NCT02104505|449517390|FG001|First Intervention (14 Days)|exclusionary condition|1|||
124969435|NCT02104505|449517389|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
124969436|NCT02104505|449517390|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
124969437|NCT02104505|449517389|FG000|Second Intervention (14 Days)|Adverse Event|2|||
124969438|NCT02104505|449517390|FG001|Second Intervention (14 Days)|Adverse Event|0|||
124969439|NCT02859064|449517391|FG000|Overall Study|Progressive Disease|3|||
124711858|NCT04540367|448569500|FG001|Overall Study|Adverse Event|0|||
124711859|NCT04540367|448569501|FG002|Overall Study|Adverse Event|1|||
124711860|NCT04540367|448569502|FG003|Overall Study|Adverse Event|1|||
124711861|NCT03958331|448569504|FG000|Overall Study|Withdrawal by Subject|3|||
124711862|NCT03958331|448569505|FG001|Overall Study|Withdrawal by Subject|1|||
124711863|NCT03958331|448569506|FG002|Overall Study|Withdrawal by Subject|5|||
124711864|NCT03958331|448569504|FG000|Overall Study|Weaned from medicine|2|||
124711865|NCT03958331|448569505|FG001|Overall Study|Weaned from medicine|0|||
124711866|NCT03958331|448569506|FG002|Overall Study|Weaned from medicine|0|||
124711867|NCT03958331|448569504|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
124711868|NCT03958331|448569505|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
124711869|NCT03958331|448569506|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
124711870|NCT04422431|448569509|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
124711871|NCT04422431|448569509|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
124711872|NCT04422431|448569509|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
124711873|NCT04422431|448569509|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
124711874|NCT04422431|448569509|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
124551152|NCT00267020|447974673|FG001|Overall Study|Withdrawal by Subject|7|||
124711875|NCT04422431|448569509|FG000|Extension Period (48 Weeks)|Other than specified|2|||
124711876|NCT02317627|448569512|FG000|Overall Study|Withdrawal by Subject|0|||
124969440|NCT02859064|449517391|FG000|Overall Study|Physician Decision|1|||
124969441|NCT02859064|449517391|FG000|Overall Study|Withdrawal by Subject|1|||
124969442|NCT02859064|449517391|FG000|Overall Study|Death|1|||
124969443|NCT00321685|449517392|FG000|Overall Study|Adverse Event|18|||
124466297|NCT01564862|447664621|FG000|Overall Study|Voluntary Withdrawal|9|||
124466298|NCT01564862|447664622|FG001|Overall Study|Voluntary Withdrawal|6|||
124466299|NCT01564862|447664623|FG002|Overall Study|Voluntary Withdrawal|8|||
124466300|NCT01564862|447664621|FG000|Overall Study|Lack of Efficacy|1|||
124466301|NCT01564862|447664622|FG001|Overall Study|Lack of Efficacy|5|||
124466302|NCT01564862|447664623|FG002|Overall Study|Lack of Efficacy|6|||
124466303|NCT01564862|447664621|FG000|Overall Study|Other reason(s)|1|||
124466304|NCT01564862|447664622|FG001|Overall Study|Other reason(s)|0|||
124466305|NCT01564862|447664623|FG002|Overall Study|Other reason(s)|0|||
124466306|NCT04526665|447664624|FG000|Overall Study|Withdrawal by Subject|6|||
124466307|NCT04526665|447664625|FG001|Overall Study|Withdrawal by Subject|3|||
124466308|NCT04526665|447664624|FG000|Overall Study|Adverse Event|4|||
124466309|NCT04526665|447664625|FG001|Overall Study|Adverse Event|1|||
124466310|NCT04526665|447664624|FG000|Overall Study|Physician Decision|2|||
124466311|NCT04526665|447664625|FG001|Overall Study|Physician Decision|2|||
124466312|NCT04526665|447664624|FG000|Overall Study|Death|2|||
124466313|NCT04526665|447664625|FG001|Overall Study|Death|0|||
124466314|NCT04526665|447664624|FG000|Overall Study|Other|0|||
124466315|NCT04526665|447664625|FG001|Overall Study|Other|1|||
124466316|NCT01844986|447664626|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
124466317|NCT01844986|447664627|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
124466318|NCT01844986|447664626|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
124466319|NCT01844986|447664627|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
124466320|NCT01844986|447664626|FG000|Overall Study (Global Cohort)|Death|55|||
124466321|NCT01844986|447664627|FG001|Overall Study (Global Cohort)|Death|26|||
124466322|NCT01844986|447664626|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
124466323|NCT01844986|447664627|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
124466324|NCT01844986|447664626|FG000|Overall Study (China Cohort)|Death|10|||
124466325|NCT01844986|447664627|FG001|Overall Study (China Cohort)|Death|6|||
124466326|NCT02396589|447664633|FG000|Intervention|Lost to Follow-up|1|||
124466327|NCT02396589|447664634|FG001|Intervention|Lost to Follow-up|0|||
124466328|NCT02396589|447664633|FG000|6 Month Follow-up|change in health status|0|||
124466329|NCT02396589|447664634|FG001|6 Month Follow-up|change in health status|1|||
124466330|NCT02396589|447664633|FG000|9 Month Follow-up|Death|0|||
124466331|NCT02396589|447664634|FG001|9 Month Follow-up|Death|1|||
124466332|NCT02396589|447664633|FG000|12 Month Follow up|Lost to Follow-up|0|||
124466333|NCT02396589|447664634|FG001|12 Month Follow up|Lost to Follow-up|2|||
124466334|NCT04341948|447664635|FG000|Overall Study|Adverse Event|0|||
124466335|NCT04341948|447664636|FG001|Overall Study|Adverse Event|1|||
124466336|NCT04341948|447664635|FG000|Overall Study|Lost to Follow-up|6|||
124711877|NCT02317627|448569513|FG001|Overall Study|Withdrawal by Subject|1|||
124711878|NCT02317627|448569514|FG002|Overall Study|Withdrawal by Subject|1|||
124711879|NCT02317627|448569512|FG000|Overall Study|Lost to Follow-up|2|||
124711880|NCT02317627|448569513|FG001|Overall Study|Lost to Follow-up|0|||
124711881|NCT02317627|448569514|FG002|Overall Study|Lost to Follow-up|0|||
124711882|NCT02317627|448569512|FG000|Overall Study|Stopped by Investigator|0|||
124711883|NCT02317627|448569513|FG001|Overall Study|Stopped by Investigator|1|||
124711884|NCT02317627|448569514|FG002|Overall Study|Stopped by Investigator|0|||
124711885|NCT02317627|448569512|FG000|Overall Study|Adverse Event|0|||
124711886|NCT02317627|448569513|FG001|Overall Study|Adverse Event|2|||
124969444|NCT00321685|449517392|FG000|Overall Study|Death|2|||
124969445|NCT00321685|449517392|FG000|Overall Study|Withdrawal by Subject|8|||
124969446|NCT00321685|449517392|FG000|Overall Study|Alternative therapy|1|||
124969447|NCT00321685|449517392|FG000|Overall Study|Complicating disese|1|||
124969448|NCT00321685|449517392|FG000|Overall Study|Other|5|||
124969449|NCT00321685|449517392|FG000|Overall Study|Not start protocol therapy|2|||
124969450|NCT00321685|449517392|FG000|Overall Study|Ineligible|2|||
124969451|NCT00127842|449517393|FG000|Overall Study|Adverse Event|15|||
124969452|NCT00127842|449517393|FG000|Overall Study|Withdrawal by Subject|3|||
124969453|NCT00127842|449517393|FG000|Overall Study|Lost to Follow-up|1|||
124969454|NCT00127842|449517393|FG000|Overall Study|Lack of Efficacy|12|||
124969455|NCT00127842|449517393|FG000|Overall Study|Noncompliance|2|||
124969456|NCT00127842|449517393|FG000|Overall Study|Protocol Violation|1|||
124466337|NCT04341948|447664636|FG001|Overall Study|Lost to Follow-up|1|||
124466338|NCT04341948|447664635|FG000|Overall Study|Physician Decision|1|||
124466339|NCT04341948|447664636|FG001|Overall Study|Physician Decision|2|||
124466340|NCT04341948|447664635|FG000|Overall Study|Withdrawal by Participant|6|||
124466341|NCT04341948|447664636|FG001|Overall Study|Withdrawal by Participant|3|||
124466342|NCT04341948|447664635|FG000|Overall Study|Lack of compliance by Participant|1|||
124466343|NCT04341948|447664636|FG001|Overall Study|Lack of compliance by Participant|0|||
124466344|NCT01761266|447666364|FG000|Overall Study|Death|415|||
124711887|NCT02317627|448569514|FG002|Overall Study|Adverse Event|3|||
124969457|NCT00127842|449517393|FG000|Overall Study|Other|5|||
124969458|NCT01638390|449517396|FG000|Overall Study|screening failures|21|||
124969459|NCT01377389|449517397|FG000|Overall Study|Withdrawal by Subject|1|||
124466345|NCT01761266|447666365|FG001|Overall Study|Death|402|||
124466346|NCT01761266|447666364|FG000|Overall Study|Lost to Follow-up|8|||
124466347|NCT01761266|447666365|FG001|Overall Study|Lost to Follow-up|12|||
124466348|NCT01761266|447666364|FG000|Overall Study|Withdrawal by Subject|14|||
124466349|NCT01761266|447666365|FG001|Overall Study|Withdrawal by Subject|10|||
124466350|NCT01761266|447666364|FG000|Overall Study|Sponsor Decision|41|||
124466351|NCT01761266|447666365|FG001|Overall Study|Sponsor Decision|52|||
124466352|NCT01284114|447666366|FG000|Overall Study|viral infection|1|||
124711888|NCT02317627|448569512|FG000|Overall Study|Non-compliance with study drug|0|||
124711889|NCT02317627|448569513|FG001|Overall Study|Non-compliance with study drug|1|||
124711890|NCT02317627|448569514|FG002|Overall Study|Non-compliance with study drug|0|||
124711891|NCT00806260|448569515|FG000|Period 1 (1 Day)|Adverse Event|0|||
124711892|NCT00806260|448569516|FG001|Period 1 (1 Day)|Adverse Event|0|||
124711893|NCT00806260|448569517|FG002|Period 1 (1 Day)|Adverse Event|0|||
124711894|NCT00806260|448569518|FG003|Period 1 (1 Day)|Adverse Event|0|||
124711895|NCT00806260|448569519|FG004|Period 1 (1 Day)|Adverse Event|3|||
124711896|NCT00806260|448569520|FG005|Period 1 (1 Day)|Adverse Event|0|||
124711897|NCT00806260|448569515|FG000|Period 2|Adverse Event|0|||
124711898|NCT00806260|448569516|FG001|Period 2|Adverse Event|0|||
124711899|NCT00806260|448569517|FG002|Period 2|Adverse Event|0|||
124711900|NCT00806260|448569518|FG003|Period 2|Adverse Event|1|||
124711901|NCT00806260|448569519|FG004|Period 2|Adverse Event|0|||
124711902|NCT00806260|448569520|FG005|Period 2|Adverse Event|0|||
124711903|NCT00806260|448569515|FG000|Period 2|Protocol Violation|1|||
124711904|NCT00806260|448569516|FG001|Period 2|Protocol Violation|0|||
124711905|NCT00806260|448569517|FG002|Period 2|Protocol Violation|1|||
124711906|NCT00806260|448569518|FG003|Period 2|Protocol Violation|0|||
124711907|NCT00806260|448569519|FG004|Period 2|Protocol Violation|0|||
124711908|NCT00806260|448569520|FG005|Period 2|Protocol Violation|0|||
124711909|NCT00806260|448569515|FG000|Period 2|Need to take concomitant medication|1|||
124711910|NCT00806260|448569516|FG001|Period 2|Need to take concomitant medication|0|||
124711911|NCT00806260|448569517|FG002|Period 2|Need to take concomitant medication|0|||
124711912|NCT00806260|448569518|FG003|Period 2|Need to take concomitant medication|0|||
124711913|NCT00806260|448569519|FG004|Period 2|Need to take concomitant medication|0|||
124711914|NCT00806260|448569520|FG005|Period 2|Need to take concomitant medication|0|||
124711915|NCT00806260|448569515|FG000|Period 2|sponsor request|0|||
124711916|NCT00806260|448569516|FG001|Period 2|sponsor request|0|||
124711917|NCT00806260|448569517|FG002|Period 2|sponsor request|1|||
124711918|NCT00806260|448569518|FG003|Period 2|sponsor request|1|||
124711919|NCT00806260|448569519|FG004|Period 2|sponsor request|0|||
124711920|NCT00806260|448569520|FG005|Period 2|sponsor request|0|||
124711921|NCT00806260|448569515|FG000|Period 3|Protocol Violation|0|||
124711922|NCT00806260|448569516|FG001|Period 3|Protocol Violation|1|||
124711923|NCT00806260|448569517|FG002|Period 3|Protocol Violation|1|||
124711924|NCT00806260|448569518|FG003|Period 3|Protocol Violation|0|||
124711925|NCT00806260|448569519|FG004|Period 3|Protocol Violation|0|||
124711926|NCT00806260|448569520|FG005|Period 3|Protocol Violation|0|||
124711927|NCT00806260|448569515|FG000|Period 3|Pregnancy|1|||
124711928|NCT00806260|448569516|FG001|Period 3|Pregnancy|0|||
124711929|NCT00806260|448569517|FG002|Period 3|Pregnancy|0|||
124711930|NCT00806260|448569518|FG003|Period 3|Pregnancy|0|||
124711931|NCT00806260|448569519|FG004|Period 3|Pregnancy|0|||
124711932|NCT00806260|448569520|FG005|Period 3|Pregnancy|0|||
124711933|NCT01088906|448569522|FG000|Overall Study|Inclusion error|1|||
124711934|NCT01088906|448569522|FG000|Overall Study|Did not receive study treatment|3|||
124711935|NCT01088906|448569522|FG000|Overall Study|Missing data|1|||
124711936|NCT00027560|448569523|FG000|Overall Study|Withdrawal by Subject|1|||
124711937|NCT03384875|448569524|FG000|Overall Study|Death|1|||
124711938|NCT03384875|448569525|FG001|Overall Study|Death|1|||
124711939|NCT03384875|448569526|FG002|Overall Study|Death|0|||
124711940|NCT03384875|448569524|FG000|Overall Study|Reason not provided|1|||
124711941|NCT03384875|448569525|FG001|Overall Study|Reason not provided|0|||
124711942|NCT03384875|448569526|FG002|Overall Study|Reason not provided|0|||
124711943|NCT01772550|448570686|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
124711944|NCT01772550|448570687|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
124711945|NCT01772550|448570688|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
124711946|NCT01772550|448570686|FG000|Overall Study|Adverse Event|0|||
124466353|NCT01284114|447666366|FG000|Overall Study|From the results of ALLTITUDE study|1|||
124466354|NCT01284114|447666366|FG000|Overall Study|Symptomatic hypotension|1|||
124466355|NCT01284114|447666366|FG000|Overall Study|dizziness|1|||
124711947|NCT01772550|448570687|FG001|Overall Study|Adverse Event|0|||
124711948|NCT01772550|448570688|FG002|Overall Study|Adverse Event|1|||
124711949|NCT03374358|448570692|FG000|Overall Study|Withdrawal by Subject|0|||
124711950|NCT03374358|448570693|FG001|Overall Study|Withdrawal by Subject|2|||
124711951|NCT03183063|448570694|FG000|Overall Study|Withdrawal by Subject|2|||
124711952|NCT03183063|448570695|FG001|Overall Study|Withdrawal by Subject|0|||
124711953|NCT03183063|448570696|FG002|Overall Study|Withdrawal by Subject|0|||
124711954|NCT03183063|448570694|FG000|Overall Study|Physician Decision|3|||
124711955|NCT03183063|448570695|FG001|Overall Study|Physician Decision|4|||
124711956|NCT03183063|448570696|FG002|Overall Study|Physician Decision|4|||
124711957|NCT01127633|448570697|FG000|Overall Study|Adverse Event|74|||
124711958|NCT01127633|448570698|FG001|Overall Study|Adverse Event|73|||
124711959|NCT01127633|448570697|FG000|Overall Study|Death|40|||
124711960|NCT01127633|448570698|FG001|Overall Study|Death|43|||
124711961|NCT01127633|448570697|FG000|Overall Study|Lost to Follow-up|4|||
124711962|NCT01127633|448570698|FG001|Overall Study|Lost to Follow-up|0|||
124711963|NCT01127633|448570697|FG000|Overall Study|Parent/Caregiver Decision|246|||
124711964|NCT01127633|448570698|FG001|Overall Study|Parent/Caregiver Decision|228|||
124551212|NCT04071366|447974678|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
124551213|NCT00021229|447974679|FG000|Overall Study|Adverse Event|10|||
124551214|NCT00021229|447974680|FG001|Overall Study|Adverse Event|5|||
124551215|NCT00021229|447974681|FG002|Overall Study|Adverse Event|2|||
124551216|NCT00021229|447974679|FG000|Overall Study|Death|0|||
124551217|NCT00021229|447974680|FG001|Overall Study|Death|1|||
124551218|NCT00021229|447974681|FG002|Overall Study|Death|0|||
124551219|NCT00021229|447974679|FG000|Overall Study|Withdrawal by Subject|7|||
124551220|NCT00021229|447974680|FG001|Overall Study|Withdrawal by Subject|7|||
124551221|NCT00021229|447974681|FG002|Overall Study|Withdrawal by Subject|1|||
124551222|NCT00021229|447974679|FG000|Overall Study|Progressive Disease|15|||
124551223|NCT00021229|447974680|FG001|Overall Study|Progressive Disease|19|||
124551224|NCT00021229|447974681|FG002|Overall Study|Progressive Disease|12|||
124551225|NCT00021229|447974679|FG000|Overall Study|Protocol Violation|1|||
124551226|NCT00021229|447974680|FG001|Overall Study|Protocol Violation|1|||
124551227|NCT00021229|447974681|FG002|Overall Study|Protocol Violation|0|||
124551228|NCT00021229|447974679|FG000|Overall Study|Physician Decision|0|||
124551229|NCT00021229|447974680|FG001|Overall Study|Physician Decision|0|||
124551230|NCT00021229|447974681|FG002|Overall Study|Physician Decision|1|||
124551231|NCT00021229|447974679|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
124551232|NCT00021229|447974680|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
124551233|NCT00021229|447974681|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
124551234|NCT02237118|447974682|FG000|Overall Study|Protocol Violation|0|||
124551235|NCT02237118|447974683|FG001|Overall Study|Protocol Violation|1|||
124551236|NCT02237118|447974682|FG000|Overall Study|consent withdrawn|1|||
124551237|NCT02237118|447974683|FG001|Overall Study|consent withdrawn|0|||
124551238|NCT00399490|447974684|FG000|Overall Study|Adverse Event|19|||
124551239|NCT00399490|447974684|FG000|Overall Study|Lack of Efficacy|31|||
124551240|NCT00399490|447974684|FG000|Overall Study|Lost to Follow-up|5|||
124969649|NCT01234883|449517433|FG001|Overall Study|Inclusion/exclusion failure|0|||
124969650|NCT00126659|449517439|FG000|Overall Study|Adverse Event|0|||
124969651|NCT00126659|449517440|FG001|Overall Study|Adverse Event|0|||
124969652|NCT00126659|449517441|FG002|Overall Study|Adverse Event|2|||
124969653|NCT01013961|449517442|FG000|Overall Study|Adverse Event|2|||
124969654|NCT01013961|449517443|FG001|Overall Study|Adverse Event|2|||
124969655|NCT01013961|449517442|FG000|Overall Study|Withdrawal by Subject|1|||
124969656|NCT01013961|449517443|FG001|Overall Study|Withdrawal by Subject|0|||
124969657|NCT01013961|449517442|FG000|Overall Study|Physician Decision|0|||
124969658|NCT01013961|449517443|FG001|Overall Study|Physician Decision|1|||
124969659|NCT01375751|449517448|FG000|Overall Study|Other|0|||
124969660|NCT01375751|449517449|FG001|Overall Study|Other|1|||
124969661|NCT01375751|449517450|FG002|Overall Study|Other|0|||
124969662|NCT02980523|449517451|FG000|Overall Study|Lost to Follow-up|1|||
124969663|NCT02980523|449517452|FG001|Overall Study|Lost to Follow-up|4|||
124969664|NCT02980523|449517453|FG002|Overall Study|Lost to Follow-up|1|||
124969665|NCT02980523|449517454|FG003|Overall Study|Lost to Follow-up|2|||
124969666|NCT02980523|449517455|FG004|Overall Study|Lost to Follow-up|1|||
124969667|NCT02980523|449517451|FG000|Overall Study|Excluded from analysis|1|||
124969668|NCT02980523|449517452|FG001|Overall Study|Excluded from analysis|3|||
124969669|NCT02980523|449517453|FG002|Overall Study|Excluded from analysis|1|||
124969670|NCT02980523|449517454|FG003|Overall Study|Excluded from analysis|1|||
124969671|NCT02980523|449517455|FG004|Overall Study|Excluded from analysis|1|||
124969672|NCT02980523|449517451|FG000|Overall Study|Lack of Efficacy|1|||
124969673|NCT02980523|449517452|FG001|Overall Study|Lack of Efficacy|4|||
124969674|NCT02980523|449517453|FG002|Overall Study|Lack of Efficacy|4|||
124969675|NCT02980523|449517454|FG003|Overall Study|Lack of Efficacy|5|||
124969676|NCT02980523|449517455|FG004|Overall Study|Lack of Efficacy|8|||
124969677|NCT02980523|449517451|FG000|Overall Study|Did not receive intervention|0|||
124969678|NCT02980523|449517452|FG001|Overall Study|Did not receive intervention|0|||
124969679|NCT02980523|449517453|FG002|Overall Study|Did not receive intervention|0|||
124969680|NCT02980523|449517454|FG003|Overall Study|Did not receive intervention|1|||
124969681|NCT02980523|449517455|FG004|Overall Study|Did not receive intervention|0|||
124969682|NCT01547598|449517459|FG000|Overall Study|Withdrew consent|1|||
124969683|NCT01547598|449517460|FG001|Overall Study|Withdrew consent|1|||
124969684|NCT01547598|449517459|FG000|Overall Study|Lost to Follow-up|1|||
124551241|NCT00399490|447974684|FG000|Overall Study|Withdrawal by Subject|18|||
124969685|NCT01547598|449517460|FG001|Overall Study|Lost to Follow-up|1|||
124969686|NCT01547598|449517459|FG000|Overall Study|Adverse Event|1|||
124969687|NCT01547598|449517460|FG001|Overall Study|Adverse Event|1|||
124969688|NCT01547598|449517459|FG000|Overall Study|Protocol Violation|1|||
124969689|NCT01547598|449517460|FG001|Overall Study|Protocol Violation|1|||
124969690|NCT01547598|449517459|FG000|Overall Study|Other Miscellaneous Reasons|2|||
124551242|NCT00399490|447974684|FG000|Overall Study|Other|25|||
124551243|NCT02499406|447974685|FG000|Overall Study|missed 3 treatment sessions|4|||
124551244|NCT00902265|447974686|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
124969691|NCT01547598|449517460|FG001|Overall Study|Other Miscellaneous Reasons|1|||
124969692|NCT02229227|449517466|FG000|Overall Study|Adverse Event|14|||
124969693|NCT02229227|449517467|FG001|Overall Study|Adverse Event|9|||
124969694|NCT02229227|449517466|FG000|Overall Study|Lack of Efficacy|3|||
124712018|NCT00800735|448570712|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
124712019|NCT00800735|448570712|FG000|Overall Study|Withdrew Consent|3|||
124712020|NCT02805790|448570713|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
124712021|NCT02805790|448570714|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
124712022|NCT04460183|448570715|FG000|Overall Study|Lost to Follow-up|3|||
124712023|NCT04460183|448570716|FG001|Overall Study|Lost to Follow-up|1|||
124712024|NCT04460183|448570715|FG000|Overall Study|Withdrawal by Subject|1|||
124712025|NCT04460183|448570716|FG001|Overall Study|Withdrawal by Subject|0|||
124712026|NCT00856323|448570717|FG000|Overall Study|Withdrawal by Subject|2|||
124712027|NCT01847092|448570718|FG000|Overall Study|Adverse Event|12|||
124712028|NCT01847092|448570719|FG001|Overall Study|Adverse Event|3|||
124712029|NCT01847092|448570718|FG000|Overall Study|Withdrawal by Subject|5|||
124712030|NCT01847092|448570719|FG001|Overall Study|Withdrawal by Subject|5|||
124712031|NCT01847092|448570718|FG000|Overall Study|Protocol Specified|8|||
124551245|NCT00902265|447974686|FG000|Overall Study|Adverse Event|2|||
124712032|NCT01847092|448570719|FG001|Overall Study|Protocol Specified|0|||
124712033|NCT01847092|448570718|FG000|Overall Study|Physician Decision|1|||
124551246|NCT00902265|447974686|FG000|Overall Study|Lack of Efficacy|2|||
124551247|NCT00902265|447974686|FG000|Overall Study|Protocol Violation|1|||
124551248|NCT04701658|447974687|FG000|Overall Study|Lost to Follow-up|6|||
124551249|NCT02866695|447974690|FG000|Overall Study|Adverse Event|1|||
124551250|NCT02866695|447974690|FG000|Overall Study|Lost to Follow-up|1|||
124551251|NCT03224234|447974691|FG000|Main Study|Lost to Follow-up|5|||
124551252|NCT03224234|447974692|FG001|Main Study|Lost to Follow-up|5|||
124551253|NCT05016765|447974693|FG000|Overall Study|Lost to Follow-up|4|||
124551254|NCT01346501|447974696|FG000|Overall Study|Initiated Other Biological Agents|3|||
124551255|NCT01346501|447974697|FG001|Overall Study|Initiated Other Biological Agents|1|||
124551256|NCT01346501|447974696|FG000|Overall Study|Other|8|||
124551257|NCT01346501|447974697|FG001|Overall Study|Other|12|||
124551258|NCT02564952|447974698|FG000|Overall Study|Adverse Event|6|||
124551259|NCT02564952|447974698|FG000|Overall Study|Lost to Follow-up|1|||
124551260|NCT02564952|447974698|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
124551261|NCT02564952|447974698|FG000|Overall Study|Withdrawal by Subject|1|||
124466471|NCT02574637|447666421|FG005|Double-blind Period|Lack of Efficacy|0|||
124466472|NCT02574637|447666422|FG006|Double-blind Period|Lack of Efficacy|0|||
124466473|NCT02574637|447666423|FG007|Double-blind Period|Lack of Efficacy|0|||
124466474|NCT02574637|447666424|FG008|Double-blind Period|Lack of Efficacy|0|||
124466475|NCT02574637|447666425|FG009|Double-blind Period|Lack of Efficacy|0|||
124466476|NCT02574637|447666416|FG000|Double-blind Period|Protocol Deviation|1|||
124466477|NCT02574637|447666417|FG001|Double-blind Period|Protocol Deviation|0|||
124466478|NCT02574637|447666418|FG002|Double-blind Period|Protocol Deviation|0|||
124466479|NCT02574637|447666419|FG003|Double-blind Period|Protocol Deviation|0|||
124466480|NCT02574637|447666420|FG004|Double-blind Period|Protocol Deviation|0|||
124466481|NCT02574637|447666421|FG005|Double-blind Period|Protocol Deviation|0|||
124466482|NCT02574637|447666422|FG006|Double-blind Period|Protocol Deviation|0|||
124466483|NCT02574637|447666423|FG007|Double-blind Period|Protocol Deviation|0|||
124551262|NCT02564952|447974698|FG000|Overall Study|Low Efficacy|1|||
124551263|NCT02564952|447974698|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
124551264|NCT00756652|447974699|FG000|Original Phase|Withdrawal by Subject|864|||
124551265|NCT00756652|447974700|FG001|Original Phase|Withdrawal by Subject|23|||
124551266|NCT00756652|447974699|FG000|Original Phase|Lost to Follow-up|601|||
124551267|NCT00756652|447974700|FG001|Original Phase|Lost to Follow-up|0|||
124551268|NCT00756652|447974699|FG000|Original Phase|Other Discontinuation|797|||
124551269|NCT00756652|447974700|FG001|Original Phase|Other Discontinuation|5|||
124551270|NCT00756652|447974699|FG000|Original Phase|Participant Noncompliance|18622|||
124551271|NCT00756652|447974700|FG001|Original Phase|Participant Noncompliance|424|||
124551272|NCT00756652|447974699|FG000|Original Phase|Unknown Discontinuation Reason|2|||
124551273|NCT00756652|447974700|FG001|Original Phase|Unknown Discontinuation Reason|0|||
124551274|NCT00756652|447974699|FG000|Original Phase|Participants without data|3259|||
124551275|NCT00756652|447974700|FG001|Original Phase|Participants without data|466|||
124551276|NCT00756652|447974699|FG000|Original Phase|Death|168|||
124551277|NCT00756652|447974700|FG001|Original Phase|Death|1|||
124551278|NCT00756652|447974699|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
124712034|NCT01847092|448570719|FG001|Overall Study|Physician Decision|1|||
124466484|NCT02574637|447666424|FG008|Double-blind Period|Protocol Deviation|0|||
124466485|NCT02574637|447666425|FG009|Double-blind Period|Protocol Deviation|0|||
124466486|NCT02574637|447666416|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
124466487|NCT02574637|447666417|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
124466488|NCT02574637|447666418|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
124466489|NCT02574637|447666419|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
124466490|NCT02574637|447666420|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
124466491|NCT02574637|447666421|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
124466492|NCT02574637|447666422|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
124466493|NCT02574637|447666423|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
124466494|NCT02574637|447666424|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
124466495|NCT02574637|447666425|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
124466496|NCT02574637|447666416|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
124466497|NCT02574637|447666417|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
124466498|NCT02574637|447666418|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
124466499|NCT02574637|447666419|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
124466500|NCT02574637|447666420|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
124466501|NCT02574637|447666421|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
124466502|NCT02574637|447666422|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
124466503|NCT02574637|447666423|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
124466504|NCT02574637|447666424|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
124466505|NCT02574637|447666425|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
124466506|NCT02574637|447666416|FG000|Double-blind Period|Reason Not Specified|0|||
124466507|NCT02574637|447666417|FG001|Double-blind Period|Reason Not Specified|0|||
124551279|NCT00756652|447974700|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
124551280|NCT00756652|447974699|FG000|Re-Op Phase|Withdrawal by Subject|62|||
124551281|NCT00756652|447974700|FG001|Re-Op Phase|Withdrawal by Subject|0|||
124551282|NCT00756652|447974699|FG000|Re-Op Phase|Death|6|||
124551283|NCT00756652|447974700|FG001|Re-Op Phase|Death|0|||
124551284|NCT00756652|447974699|FG000|Re-Op Phase|Lost to Follow-up|340|||
124466508|NCT02574637|447666418|FG002|Double-blind Period|Reason Not Specified|0|||
124466509|NCT02574637|447666419|FG003|Double-blind Period|Reason Not Specified|1|||
124466510|NCT02574637|447666420|FG004|Double-blind Period|Reason Not Specified|0|||
124466511|NCT02574637|447666421|FG005|Double-blind Period|Reason Not Specified|0|||
124466512|NCT02574637|447666422|FG006|Double-blind Period|Reason Not Specified|0|||
124466513|NCT02574637|447666423|FG007|Double-blind Period|Reason Not Specified|0|||
124466514|NCT02574637|447666424|FG008|Double-blind Period|Reason Not Specified|0|||
124466515|NCT02574637|447666425|FG009|Double-blind Period|Reason Not Specified|0|||
124466516|NCT02574637|447666416|FG000|Open-label (OL) Period|Adverse Event|0|||
124466517|NCT02574637|447666417|FG001|Open-label (OL) Period|Adverse Event|0|||
124466518|NCT02574637|447666418|FG002|Open-label (OL) Period|Adverse Event|0|||
124466519|NCT02574637|447666419|FG003|Open-label (OL) Period|Adverse Event|0|||
124466520|NCT02574637|447666420|FG004|Open-label (OL) Period|Adverse Event|0|||
124466521|NCT02574637|447666421|FG005|Open-label (OL) Period|Adverse Event|0|||
124466522|NCT02574637|447666422|FG006|Open-label (OL) Period|Adverse Event|0|||
124466523|NCT02574637|447666423|FG007|Open-label (OL) Period|Adverse Event|0|||
124466524|NCT02574637|447666424|FG008|Open-label (OL) Period|Adverse Event|1|||
124466525|NCT02574637|447666425|FG009|Open-label (OL) Period|Adverse Event|0|||
124466526|NCT02574637|447666416|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
124466527|NCT02574637|447666417|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
124466528|NCT02574637|447666418|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
124551285|NCT00756652|447974700|FG001|Re-Op Phase|Lost to Follow-up|0|||
124551286|NCT00756652|447974699|FG000|Re-Op Phase|Site Closed|2454|||
124551287|NCT00756652|447974700|FG001|Re-Op Phase|Site Closed|0|||
124712035|NCT01847092|448570718|FG000|Overall Study|Protocol Violation|0|||
124712036|NCT01847092|448570719|FG001|Overall Study|Protocol Violation|2|||
124712037|NCT00825994|448570720|FG000|Overall Study|Withdrawal by Subject|2|||
124712038|NCT00825994|448570720|FG000|Overall Study|Lost to Follow-up|1|||
124712039|NCT00825994|448570720|FG000|Overall Study|Protocol Violation|1|||
124712040|NCT00825994|448570720|FG000|Overall Study|Placebo Responder at V2|1|||
124712041|NCT01331681|448570721|FG000|Overall Study|Adverse Event|10|||
124712042|NCT01331681|448570722|FG001|Overall Study|Adverse Event|13|||
124712043|NCT01331681|448570723|FG002|Overall Study|Adverse Event|10|||
124712044|NCT01331681|448570721|FG000|Overall Study|Death|6|||
124712045|NCT01331681|448570722|FG001|Overall Study|Death|6|||
124969695|NCT02229227|449517467|FG001|Overall Study|Lack of Efficacy|3|||
124969696|NCT02229227|449517466|FG000|Overall Study|Protocol Violation|6|||
124969697|NCT02229227|449517467|FG001|Overall Study|Protocol Violation|8|||
124969698|NCT02229227|449517466|FG000|Overall Study|Protocol defined stopping criteria|1|||
124969699|NCT02229227|449517467|FG001|Overall Study|Protocol defined stopping criteria|3|||
124969700|NCT02229227|449517466|FG000|Overall Study|Lost to Follow-up|3|||
124969701|NCT02229227|449517467|FG001|Overall Study|Lost to Follow-up|3|||
124969702|NCT02229227|449517466|FG000|Overall Study|Study terminated by sponsor|11|||
124969703|NCT02229227|449517467|FG001|Overall Study|Study terminated by sponsor|11|||
124969704|NCT02229227|449517466|FG000|Overall Study|Withdrawal by Subject|8|||
124969705|NCT02229227|449517467|FG001|Overall Study|Withdrawal by Subject|12|||
124969706|NCT02229227|449517466|FG000|Overall Study|Other|0|||
124969707|NCT02229227|449517467|FG001|Overall Study|Other|1|||
124969708|NCT02229227|449517466|FG000|Overall Study|Physician Decision|5|||
124969709|NCT02229227|449517467|FG001|Overall Study|Physician Decision|12|||
124969710|NCT04071301|449517468|FG000|Overall Study|Withdrawal by Subject|6|||
124969711|NCT04071301|449517468|FG000|Overall Study|Death|1|||
124969712|NCT05186311|449517469|FG000|Part A: Serum|Withdrawal by Subject|1|||
124969713|NCT02125279|449517470|FG000|Overall Study|Lack of Efficacy|2|||
124969714|NCT02125279|449517470|FG000|Overall Study|Withdrawal by Subject|6|||
124969715|NCT02125279|449517470|FG000|Overall Study|Protocol Violation|1|||
124969716|NCT02125279|449517470|FG000|Overall Study|Lost to Follow-up|4|||
124969717|NCT01850589|449517478|FG000|Overall Study|Withdrawal by Subject|8|||
124969718|NCT01850589|449517479|FG001|Overall Study|Withdrawal by Subject|0|||
124969719|NCT04468230|449517484|FG000|Overall Study|Adverse Event|2|||
124969720|NCT03721705|449517487|FG000|Overall Study|Adverse Event|2|||
124969721|NCT03721705|449517488|FG001|Overall Study|Adverse Event|0|||
124969722|NCT03721705|449517487|FG000|Overall Study|Withdrawal by Subject|4|||
124969723|NCT03721705|449517488|FG001|Overall Study|Withdrawal by Subject|10|||
124969724|NCT03721705|449517487|FG000|Overall Study|No Suitable Study Partner|1|||
124969725|NCT03721705|449517488|FG001|Overall Study|No Suitable Study Partner|0|||
124969726|NCT03721705|449517487|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
124969727|NCT03721705|449517488|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
124969728|NCT03721705|449517487|FG000|Overall Study|Death|0|||
124969729|NCT03721705|449517488|FG001|Overall Study|Death|1|||
124969730|NCT03721172|449517489|FG000|Placebo-controlled Phase|Adverse Event|7|||
124969731|NCT03721172|449517490|FG001|Placebo-controlled Phase|Adverse Event|7|||
124969732|NCT03721172|449517491|FG002|Placebo-controlled Phase|Adverse Event|0|||
124969733|NCT03721172|449517489|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
124969734|NCT03721172|449517490|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
124969735|NCT03721172|449517491|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
124969736|NCT03721172|449517489|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
124969737|NCT03721172|449517490|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
124969738|NCT03721172|449517491|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
124969739|NCT03721172|449517489|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
124969740|NCT03721172|449517490|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
124969741|NCT03721172|449517491|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
124969742|NCT03721172|449517489|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
124969743|NCT03721172|449517490|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
124969744|NCT03721172|449517491|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
124969745|NCT03721172|449517489|FG000|Placebo-controlled Phase|Other|3|||
124969746|NCT03721172|449517490|FG001|Placebo-controlled Phase|Other|0|||
124969747|NCT03721172|449517491|FG002|Placebo-controlled Phase|Other|0|||
124969748|NCT03721172|449517489|FG000|Apremilast Extension Phase|Adverse Event|0|||
124551288|NCT00756652|447974699|FG000|Re-Op Phase|Withdrawn after explant|14|||
124551289|NCT00756652|447974700|FG001|Re-Op Phase|Withdrawn after explant|0|||
124551290|NCT01850108|447974701|FG000|Overall Study|Lost to Follow-up|4|||
124551291|NCT01850108|447974701|FG000|Overall Study|Not eligible|1|||
124551292|NCT01850108|447974701|FG000|Overall Study|Failed engraftment|2|||
124551293|NCT01850108|447974701|FG000|Overall Study|Physician Decision|1|||
124551294|NCT00038467|447974702|FG000|Overall Study|Adverse Event|170|||
124551295|NCT00038467|447974703|FG001|Overall Study|Adverse Event|145|||
124551296|NCT00038467|447974702|FG000|Overall Study|Withdrawal by Subject|150|||
124551297|NCT00038467|447974703|FG001|Overall Study|Withdrawal by Subject|107|||
124551298|NCT00038467|447974702|FG000|Overall Study|Protocol Violation|19|||
124551299|NCT00038467|447974703|FG001|Overall Study|Protocol Violation|22|||
124551300|NCT00038467|447974702|FG000|Overall Study|Death|22|||
124969749|NCT03721172|449517490|FG001|Apremilast Extension Phase|Adverse Event|0|||
124969750|NCT03721172|449517491|FG002|Apremilast Extension Phase|Adverse Event|10|||
124969751|NCT03721172|449517489|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
124969752|NCT03721172|449517490|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
124969753|NCT03721172|449517491|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
124969754|NCT03721172|449517489|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
124969755|NCT03721172|449517490|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
124466529|NCT02574637|447666419|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
124466530|NCT02574637|447666420|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
124466531|NCT02574637|447666421|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
124466532|NCT02574637|447666422|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
124466533|NCT02574637|447666423|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
124466534|NCT02574637|447666424|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
124466535|NCT02574637|447666425|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
124466536|NCT02574637|447666416|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
124466537|NCT02574637|447666417|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
124466538|NCT02574637|447666418|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
124466539|NCT02574637|447666419|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
124466540|NCT02574637|447666420|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
124466541|NCT02574637|447666421|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
124466542|NCT02574637|447666422|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
124466543|NCT02574637|447666423|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
124466544|NCT02574637|447666424|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
124466545|NCT02574637|447666425|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
124466546|NCT00070941|447666427|FG000|Overall Study|Adverse Event|10|||
124466547|NCT00070941|447666428|FG001|Overall Study|Adverse Event|8|||
124466548|NCT00070941|447666429|FG002|Overall Study|Adverse Event|4|||
124466549|NCT00953758|447666434|FG000|Overall Study|Death|2|||
124466550|NCT00953758|447666435|FG001|Overall Study|Death|0|||
124466551|NCT00953758|447666436|FG002|Overall Study|Death|1|||
124466552|NCT00953758|447666437|FG003|Overall Study|Death|1|||
124466553|NCT00953758|447666438|FG004|Overall Study|Death|1|||
124466554|NCT00953758|447666439|FG005|Overall Study|Death|1|||
124466555|NCT00953758|447666440|FG006|Overall Study|Death|1|||
124466556|NCT00953758|447666441|FG007|Overall Study|Death|3|||
124466557|NCT00953758|447666442|FG008|Overall Study|Death|1|||
124466558|NCT00953758|447666443|FG009|Overall Study|Death|0|||
124466559|NCT00953758|447666434|FG000|Overall Study|Participant refused further follow-up|0|||
124466560|NCT00953758|447666435|FG001|Overall Study|Participant refused further follow-up|0|||
124466561|NCT00953758|447666436|FG002|Overall Study|Participant refused further follow-up|1|||
124466562|NCT00953758|447666437|FG003|Overall Study|Participant refused further follow-up|0|||
124466563|NCT00953758|447666438|FG004|Overall Study|Participant refused further follow-up|3|||
124466564|NCT00953758|447666439|FG005|Overall Study|Participant refused further follow-up|0|||
124466565|NCT00953758|447666440|FG006|Overall Study|Participant refused further follow-up|0|||
124466566|NCT00953758|447666441|FG007|Overall Study|Participant refused further follow-up|0|||
124466567|NCT00953758|447666442|FG008|Overall Study|Participant refused further follow-up|1|||
124466568|NCT00953758|447666443|FG009|Overall Study|Participant refused further follow-up|0|||
124466569|NCT00953758|447666434|FG000|Overall Study|Lost to Follow-up|0|||
124466570|NCT00953758|447666435|FG001|Overall Study|Lost to Follow-up|0|||
124466571|NCT00953758|447666436|FG002|Overall Study|Lost to Follow-up|0|||
124466572|NCT00953758|447666437|FG003|Overall Study|Lost to Follow-up|1|||
124466573|NCT00953758|447666438|FG004|Overall Study|Lost to Follow-up|0|||
124466574|NCT00953758|447666439|FG005|Overall Study|Lost to Follow-up|0|||
124466575|NCT00953758|447666440|FG006|Overall Study|Lost to Follow-up|0|||
124466576|NCT00953758|447666441|FG007|Overall Study|Lost to Follow-up|1|||
124466577|NCT00953758|447666442|FG008|Overall Study|Lost to Follow-up|0|||
124466578|NCT00953758|447666443|FG009|Overall Study|Lost to Follow-up|1|||
124466579|NCT00953758|447666434|FG000|Overall Study|Physician Decision|0|||
124466580|NCT00953758|447666435|FG001|Overall Study|Physician Decision|0|||
124466581|NCT00953758|447666436|FG002|Overall Study|Physician Decision|0|||
124466582|NCT00953758|447666437|FG003|Overall Study|Physician Decision|0|||
124466583|NCT00953758|447666438|FG004|Overall Study|Physician Decision|1|||
124466584|NCT00953758|447666439|FG005|Overall Study|Physician Decision|0|||
124466585|NCT00953758|447666440|FG006|Overall Study|Physician Decision|0|||
124551301|NCT00038467|447974703|FG001|Overall Study|Death|16|||
124551302|NCT00038467|447974702|FG000|Overall Study|Lost to Follow-up|15|||
124466586|NCT00953758|447666441|FG007|Overall Study|Physician Decision|0|||
124466587|NCT00953758|447666442|FG008|Overall Study|Physician Decision|0|||
124466588|NCT00953758|447666443|FG009|Overall Study|Physician Decision|0|||
124466589|NCT00953758|447666434|FG000|Overall Study|Disease progression|0|||
124551303|NCT00038467|447974703|FG001|Overall Study|Lost to Follow-up|10|||
124969756|NCT03721172|449517491|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
124969757|NCT03721172|449517489|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
124969758|NCT03721172|449517490|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
124969759|NCT03721172|449517491|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
124969760|NCT03721172|449517489|FG000|Apremilast Extension Phase|Protocol Violation|0|||
124969761|NCT03721172|449517490|FG001|Apremilast Extension Phase|Protocol Violation|0|||
124969762|NCT03721172|449517491|FG002|Apremilast Extension Phase|Protocol Violation|1|||
124969763|NCT03721172|449517489|FG000|Apremilast Extension Phase|Physician Decision|0|||
124969764|NCT03721172|449517490|FG001|Apremilast Extension Phase|Physician Decision|0|||
124969765|NCT03721172|449517491|FG002|Apremilast Extension Phase|Physician Decision|1|||
124969766|NCT03721172|449517489|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
124969767|NCT03721172|449517490|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
124969768|NCT03721172|449517491|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
124969769|NCT03721172|449517489|FG000|Apremilast Extension Phase|Other|0|||
124969770|NCT03721172|449517490|FG001|Apremilast Extension Phase|Other|0|||
124969771|NCT03721172|449517491|FG002|Apremilast Extension Phase|Other|3|||
124969772|NCT03721172|449517489|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
124969773|NCT03721172|449517490|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
124969774|NCT03721172|449517491|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
124969775|NCT02417441|449517494|FG000|Overall Study|Inconclusive due to missing data|52|||
124969776|NCT02417441|449517495|FG001|Overall Study|Inconclusive due to missing data|19|||
124969777|NCT00983853|449517500|FG000|Overall Study|Lost to Follow-up|1|||
124969778|NCT00983853|449517501|FG001|Overall Study|Lost to Follow-up|1|||
124969779|NCT00983853|449517502|FG002|Overall Study|Lost to Follow-up|2|||
124969780|NCT00983853|449517503|FG003|Overall Study|Lost to Follow-up|2|||
124969781|NCT00983853|449517504|FG004|Overall Study|Lost to Follow-up|2|||
124969782|NCT00983853|449517505|FG005|Overall Study|Lost to Follow-up|1|||
124969783|NCT00983853|449517500|FG000|Overall Study|Withdrawal by Subject|0|||
124969784|NCT00983853|449517501|FG001|Overall Study|Withdrawal by Subject|0|||
124969785|NCT00983853|449517502|FG002|Overall Study|Withdrawal by Subject|1|||
124969786|NCT00983853|449517503|FG003|Overall Study|Withdrawal by Subject|0|||
124969787|NCT00983853|449517504|FG004|Overall Study|Withdrawal by Subject|1|||
124551304|NCT00038467|447974702|FG000|Overall Study|Recurrence|109|||
124551305|NCT00038467|447974703|FG001|Overall Study|Recurrence|179|||
124551306|NCT00038467|447974702|FG000|Overall Study|Randomized, but not treated|31|||
124551307|NCT00038467|447974703|FG001|Overall Study|Randomized, but not treated|35|||
124551308|NCT00038467|447974702|FG000|Overall Study|Other|26|||
124551309|NCT00038467|447974703|FG001|Overall Study|Other|28|||
124551310|NCT01988493|447974704|FG000|Overall Study|Randomized but not treated|0|||
124551311|NCT01988493|447974705|FG001|Overall Study|Randomized but not treated|0|||
124551312|NCT01988493|447974706|FG002|Overall Study|Randomized but not treated|0|||
124551313|NCT01988493|447974707|FG003|Overall Study|Randomized but not treated|0|||
124712046|NCT01331681|448570723|FG002|Overall Study|Death|2|||
124551314|NCT01988493|447974708|FG004|Overall Study|Randomized but not treated|1|||
124712047|NCT01331681|448570721|FG000|Overall Study|Lack of Efficacy|0|||
124551315|NCT01523301|447974709|FG000|Overall Study|Adverse Event|25|||
124969788|NCT00983853|449517505|FG005|Overall Study|Withdrawal by Subject|0|||
124969789|NCT00983853|449517500|FG000|Overall Study|Unable to come to study follow-up visits|0|||
124969790|NCT00983853|449517501|FG001|Overall Study|Unable to come to study follow-up visits|1|||
124969791|NCT00983853|449517502|FG002|Overall Study|Unable to come to study follow-up visits|0|||
124969792|NCT00983853|449517503|FG003|Overall Study|Unable to come to study follow-up visits|0|||
124712048|NCT01331681|448570722|FG001|Overall Study|Lack of Efficacy|1|||
124712049|NCT01331681|448570723|FG002|Overall Study|Lack of Efficacy|0|||
124712050|NCT01331681|448570721|FG000|Overall Study|Withdrawal by Subject|12|||
124712051|NCT01331681|448570722|FG001|Overall Study|Withdrawal by Subject|8|||
124712052|NCT01331681|448570723|FG002|Overall Study|Withdrawal by Subject|15|||
124712053|NCT01331681|448570721|FG000|Overall Study|Protocol Violation|1|||
124712054|NCT01331681|448570722|FG001|Overall Study|Protocol Violation|1|||
124712055|NCT01331681|448570723|FG002|Overall Study|Protocol Violation|0|||
124712056|NCT01331681|448570721|FG000|Overall Study|Lost to Follow-up|2|||
124712057|NCT01331681|448570722|FG001|Overall Study|Lost to Follow-up|4|||
124712058|NCT01331681|448570723|FG002|Overall Study|Lost to Follow-up|1|||
124712059|NCT01331681|448570721|FG000|Overall Study|Physician Decision|2|||
124712060|NCT01331681|448570722|FG001|Overall Study|Physician Decision|0|||
124712061|NCT01331681|448570723|FG002|Overall Study|Physician Decision|4|||
124712062|NCT01331681|448570721|FG000|Overall Study|Therapeutic procedure required|1|||
124712063|NCT01331681|448570722|FG001|Overall Study|Therapeutic procedure required|0|||
124712064|NCT01331681|448570723|FG002|Overall Study|Therapeutic procedure required|0|||
124712065|NCT01331681|448570721|FG000|Overall Study|Sponsor decision|1|||
124712066|NCT01331681|448570722|FG001|Overall Study|Sponsor decision|1|||
124712067|NCT01331681|448570723|FG002|Overall Study|Sponsor decision|0|||
124551316|NCT01523301|447974710|FG001|Overall Study|Adverse Event|16|||
124551317|NCT01523301|447974709|FG000|Overall Study|Lack of Efficacy|0|||
124551318|NCT01523301|447974710|FG001|Overall Study|Lack of Efficacy|2|||
124712068|NCT01331681|448570721|FG000|Overall Study|Switching to other therapy|0|||
124712069|NCT01331681|448570722|FG001|Overall Study|Switching to other therapy|0|||
124712070|NCT01331681|448570723|FG002|Overall Study|Switching to other therapy|1|||
124712071|NCT01331681|448570721|FG000|Overall Study|Not Received Study Treatment|0|||
124712072|NCT01331681|448570722|FG001|Overall Study|Not Received Study Treatment|0|||
124712073|NCT01331681|448570723|FG002|Overall Study|Not Received Study Treatment|2|||
124712074|NCT00658541|448570725|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
124712075|NCT00658541|448570726|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
124466590|NCT00953758|447666435|FG001|Overall Study|Disease progression|0|||
124466591|NCT00953758|447666436|FG002|Overall Study|Disease progression|0|||
124466592|NCT00953758|447666437|FG003|Overall Study|Disease progression|0|||
124466593|NCT00953758|447666438|FG004|Overall Study|Disease progression|1|||
124466594|NCT00953758|447666439|FG005|Overall Study|Disease progression|0|||
124466595|NCT00953758|447666440|FG006|Overall Study|Disease progression|0|||
124466596|NCT00953758|447666441|FG007|Overall Study|Disease progression|0|||
124466597|NCT00953758|447666442|FG008|Overall Study|Disease progression|0|||
124551319|NCT01523301|447974709|FG000|Overall Study|Protocol Violation|3|||
124551320|NCT01523301|447974710|FG001|Overall Study|Protocol Violation|4|||
124551321|NCT01523301|447974709|FG000|Overall Study|Lost to Follow-up|1|||
124551322|NCT01523301|447974710|FG001|Overall Study|Lost to Follow-up|0|||
124551323|NCT01523301|447974709|FG000|Overall Study|Withdrawal by Subject|6|||
124551324|NCT01523301|447974710|FG001|Overall Study|Withdrawal by Subject|8|||
124551325|NCT01523301|447974709|FG000|Overall Study|Other Reason|0|||
124551326|NCT01523301|447974710|FG001|Overall Study|Other Reason|2|||
124551327|NCT03151707|447974719|FG000|Overall Study|Lost to Follow-up|6|||
124551328|NCT01308762|447974721|FG000|Overall Study|Protocol Violation|0|||
124551329|NCT01308762|447974722|FG001|Overall Study|Protocol Violation|1|||
124551330|NCT01308762|447974723|FG002|Overall Study|Protocol Violation|0|||
124551331|NCT02617446|447974724|FG000|Overall Study|Withdrawal by Subject|0|||
124551332|NCT02617446|447974725|FG001|Overall Study|Withdrawal by Subject|2|||
124551333|NCT02617446|447974726|FG002|Overall Study|Withdrawal by Subject|0|||
124551334|NCT02617446|447974724|FG000|Overall Study|Adverse Event|1|||
124551335|NCT02617446|447974725|FG001|Overall Study|Adverse Event|0|||
124551336|NCT02617446|447974726|FG002|Overall Study|Adverse Event|5|||
124551337|NCT02617446|447974724|FG000|Overall Study|Lost to Follow-up|3|||
124551338|NCT02617446|447974725|FG001|Overall Study|Lost to Follow-up|0|||
124551339|NCT02617446|447974726|FG002|Overall Study|Lost to Follow-up|0|||
124551340|NCT02617446|447974724|FG000|Overall Study|Death|0|||
124551341|NCT02617446|447974725|FG001|Overall Study|Death|0|||
124551342|NCT02617446|447974726|FG002|Overall Study|Death|2|||
124551343|NCT00530088|447974727|FG000|Overall Study|Disease Progression|4|||
124551344|NCT00530088|447974727|FG000|Overall Study|Physician Decision|4|||
124551345|NCT00530088|447974727|FG000|Overall Study|Other Not Specified|2|||
124551346|NCT00902278|447974728|FG000|Overall Study|Physician Decision|1|||
124969793|NCT00983853|449517504|FG004|Overall Study|Unable to come to study follow-up visits|0|||
124969794|NCT00983853|449517505|FG005|Overall Study|Unable to come to study follow-up visits|0|||
124969795|NCT02947100|449517510|FG000|Overall Study|study terminated early|3|||
124969796|NCT02947100|449517510|FG000|Overall Study|did not meet inclusion criteria|1|||
124969797|NCT02402322|449517511|FG000|Pretreatment|Withdrawal by Subject|3|||
124969798|NCT02402322|449517512|FG001|Pretreatment|Withdrawal by Subject|1|||
124969799|NCT02402322|449517513|FG002|Pretreatment|Withdrawal by Subject|1|||
124969800|NCT02402322|449517511|FG000|Follow-up|Withdrawal by Subject|6|||
124969801|NCT02402322|449517512|FG001|Follow-up|Withdrawal by Subject|3|||
124969802|NCT02402322|449517513|FG002|Follow-up|Withdrawal by Subject|24|||
124969803|NCT02472145|449517516|FG000|Overall Study|Death|10|||
124969804|NCT02472145|449517517|FG001|Overall Study|Death|101|||
124969805|NCT02472145|449517518|FG002|Overall Study|Death|99|||
124969806|NCT02472145|449517516|FG000|Overall Study|Lost to Follow-up|0|||
124969807|NCT02472145|449517517|FG001|Overall Study|Lost to Follow-up|1|||
124969808|NCT02472145|449517518|FG002|Overall Study|Lost to Follow-up|0|||
124969809|NCT02472145|449517516|FG000|Overall Study|Withdrawal by Subject|0|||
124969810|NCT02472145|449517517|FG001|Overall Study|Withdrawal by Subject|9|||
124969811|NCT02472145|449517518|FG002|Overall Study|Withdrawal by Subject|13|||
124969812|NCT02472145|449517516|FG000|Overall Study|Sponsor decision|0|||
124969813|NCT02472145|449517517|FG001|Overall Study|Sponsor decision|3|||
124969814|NCT02472145|449517518|FG002|Overall Study|Sponsor decision|2|||
124969815|NCT02472145|449517516|FG000|Overall Study|Other|0|||
124969816|NCT02472145|449517517|FG001|Overall Study|Other|45|||
124969817|NCT02472145|449517518|FG002|Overall Study|Other|43|||
124969818|NCT01080326|449517519|FG000|Overall Study|Patient deterioration prior to procedure|3|||
124969819|NCT01080326|449517519|FG000|Overall Study|Surgeon decision|1|||
124969820|NCT01318876|449517520|FG000|Day 8 Survey|email address invalid|96|||
124969821|NCT01318876|449517520|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
124969822|NCT01318876|449517520|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
124969823|NCT01296555|449517521|FG000|Overall Study|Adverse Event|0|||
124969824|NCT01296555|449517522|FG001|Overall Study|Adverse Event|0|||
124969825|NCT01296555|449517523|FG002|Overall Study|Adverse Event|1|||
124969826|NCT01296555|449517524|FG003|Overall Study|Adverse Event|1|||
124551347|NCT00902278|447974729|FG001|Overall Study|Physician Decision|0|||
124969827|NCT01296555|449517525|FG004|Overall Study|Adverse Event|2|||
124969828|NCT01296555|449517526|FG005|Overall Study|Adverse Event|4|||
124969829|NCT01296555|449517527|FG006|Overall Study|Adverse Event|1|||
124969830|NCT01296555|449517528|FG007|Overall Study|Adverse Event|4|||
124551348|NCT00902278|447974730|FG002|Overall Study|Physician Decision|2|||
124551349|NCT00902278|447974731|FG003|Overall Study|Physician Decision|0|||
124551350|NCT00902278|447974732|FG004|Overall Study|Physician Decision|1|||
124551351|NCT00902278|447974728|FG000|Overall Study|Lost to Follow-up|3|||
124551352|NCT00902278|447974729|FG001|Overall Study|Lost to Follow-up|2|||
124551353|NCT00902278|447974730|FG002|Overall Study|Lost to Follow-up|3|||
124551354|NCT00902278|447974731|FG003|Overall Study|Lost to Follow-up|0|||
124551355|NCT00902278|447974732|FG004|Overall Study|Lost to Follow-up|1|||
124969831|NCT01296555|449517529|FG008|Overall Study|Adverse Event|3|||
124969832|NCT01296555|449517530|FG009|Overall Study|Adverse Event|1|||
124969833|NCT01296555|449517531|FG010|Overall Study|Adverse Event|0|||
124969834|NCT01296555|449517532|FG011|Overall Study|Adverse Event|4|||
124466598|NCT00953758|447666443|FG009|Overall Study|Disease progression|0|||
124466599|NCT00953758|447666434|FG000|Overall Study|Participant went for transplant|0|||
124466600|NCT00953758|447666435|FG001|Overall Study|Participant went for transplant|0|||
124466601|NCT00953758|447666436|FG002|Overall Study|Participant went for transplant|0|||
124466602|NCT00953758|447666437|FG003|Overall Study|Participant went for transplant|0|||
124466603|NCT00953758|447666438|FG004|Overall Study|Participant went for transplant|0|||
124712076|NCT00658541|448570725|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
124712077|NCT00658541|448570726|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
124712078|NCT01063348|448570727|FG000|Overall Study|Lost to Follow-up|3|||
124712079|NCT01063348|448570728|FG001|Overall Study|Lost to Follow-up|10|||
124466604|NCT00953758|447666439|FG005|Overall Study|Participant went for transplant|0|||
124466605|NCT00953758|447666440|FG006|Overall Study|Participant went for transplant|0|||
124466606|NCT00953758|447666441|FG007|Overall Study|Participant went for transplant|0|||
124551356|NCT02362646|447974733|FG000|Overall Study|Death|15|||
124712080|NCT01876381|448570729|FG000|Overall Study|Lack of Efficacy|5|||
124712081|NCT01876381|448570729|FG000|Overall Study|Physician Decision|1|||
124551357|NCT02362646|447974734|FG001|Overall Study|Death|8|||
124551358|NCT02362646|447974733|FG000|Overall Study|Withdrawal by Subject|2|||
124551359|NCT02362646|447974734|FG001|Overall Study|Withdrawal by Subject|2|||
124551360|NCT02362646|447974733|FG000|Overall Study|received transplant|21|||
124551361|NCT02362646|447974734|FG001|Overall Study|received transplant|14|||
124551362|NCT00865306|447974735|FG000|Controlled Trial|Lost to Follow-up|1|||
124551363|NCT00865306|447974736|FG001|Controlled Trial|Lost to Follow-up|1|||
124551364|NCT00865306|447974735|FG000|Controlled Trial|Difficulty commuting|2|||
124551365|NCT00865306|447974736|FG001|Controlled Trial|Difficulty commuting|0|||
124551366|NCT00865306|447974735|FG000|Controlled Trial|Improved btw baseline and first session|1|||
124551367|NCT00865306|447974736|FG001|Controlled Trial|Improved btw baseline and first session|0|||
124551368|NCT00865306|447974735|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
124551369|NCT00865306|447974736|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
124551370|NCT00865306|447974735|FG000|Controlled Trial|Withdrawal by Subject|0|||
124551371|NCT00865306|447974736|FG001|Controlled Trial|Withdrawal by Subject|1|||
124551372|NCT02181842|447974738|FG000|Overall Study|Case Report Forms Uncollected|2|||
124551373|NCT00929864|447974739|FG000|Overall Study|Death|1|||
124551374|NCT00929864|447974740|FG001|Overall Study|Death|1|||
124551375|NCT00929864|447974739|FG000|Overall Study|Adverse Event|11|||
124551376|NCT00929864|447974740|FG001|Overall Study|Adverse Event|30|||
124551377|NCT00929864|447974739|FG000|Overall Study|Lack of Efficacy|19|||
124551378|NCT00929864|447974740|FG001|Overall Study|Lack of Efficacy|16|||
124551379|NCT00929864|447974739|FG000|Overall Study|Lost to Follow-up|7|||
124551380|NCT00929864|447974740|FG001|Overall Study|Lost to Follow-up|12|||
124551381|NCT00929864|447974739|FG000|Overall Study|Withdrawal by Subject|20|||
124551382|NCT00929864|447974740|FG001|Overall Study|Withdrawal by Subject|9|||
124551383|NCT00929864|447974739|FG000|Overall Study|No longer met criteria|2|||
124551384|NCT00929864|447974740|FG001|Overall Study|No longer met criteria|1|||
124551385|NCT00929864|447974739|FG000|Overall Study|Poor or non-compliance|3|||
124551386|NCT00929864|447974740|FG001|Overall Study|Poor or non-compliance|3|||
124551387|NCT00929864|447974739|FG000|Overall Study|Pregnancy|0|||
124551388|NCT00929864|447974740|FG001|Overall Study|Pregnancy|3|||
124551389|NCT00929864|447974739|FG000|Overall Study|Administrative reason by Sponsor|1|||
124551390|NCT00929864|447974740|FG001|Overall Study|Administrative reason by Sponsor|1|||
124551391|NCT00929864|447974739|FG000|Overall Study|Non-specified|2|||
124551392|NCT00929864|447974740|FG001|Overall Study|Non-specified|7|||
124551393|NCT03454672|447974752|FG000|Overall Study|Adverse Event|1|||
124712082|NCT01876381|448570729|FG000|Overall Study|Withdrawal by Subject|1|||
124712083|NCT00461708|448570730|FG000|Overall Study|Adverse Event|17|||
124712084|NCT00461708|448570731|FG001|Overall Study|Adverse Event|7|||
124712085|NCT00461708|448570730|FG000|Overall Study|Lack of Efficacy|68|||
124712086|NCT00461708|448570731|FG001|Overall Study|Lack of Efficacy|20|||
124712087|NCT00461708|448570730|FG000|Overall Study|Physician Decision|10|||
124712088|NCT00461708|448570731|FG001|Overall Study|Physician Decision|4|||
124969835|NCT01296555|449517533|FG012|Overall Study|Adverse Event|1|||
124969836|NCT01296555|449517534|FG013|Overall Study|Adverse Event|4|||
124969837|NCT01296555|449517535|FG014|Overall Study|Adverse Event|0|||
124969838|NCT01296555|449517536|FG015|Overall Study|Adverse Event|0|||
124969839|NCT01296555|449517537|FG016|Overall Study|Adverse Event|0|||
124969840|NCT01296555|449517538|FG017|Overall Study|Adverse Event|0|||
124969841|NCT01296555|449517539|FG018|Overall Study|Adverse Event|0|||
124969842|NCT01296555|449517540|FG019|Overall Study|Adverse Event|1|||
124969843|NCT01296555|449517541|FG020|Overall Study|Adverse Event|0|||
124969844|NCT01296555|449517542|FG021|Overall Study|Adverse Event|0|||
124969845|NCT01296555|449517543|FG022|Overall Study|Adverse Event|0|||
124969846|NCT01296555|449517544|FG023|Overall Study|Adverse Event|0|||
124969847|NCT01296555|449517545|FG024|Overall Study|Adverse Event|0|||
124969848|NCT01296555|449517546|FG025|Overall Study|Adverse Event|0|||
124969849|NCT01296555|449517547|FG026|Overall Study|Adverse Event|0|||
124969850|NCT01296555|449517548|FG027|Overall Study|Adverse Event|0|||
124969851|NCT01296555|449517549|FG028|Overall Study|Adverse Event|0|||
124969852|NCT01296555|449517521|FG000|Overall Study|Reason Not Specified|0|||
124969853|NCT01296555|449517522|FG001|Overall Study|Reason Not Specified|0|||
124969854|NCT01296555|449517523|FG002|Overall Study|Reason Not Specified|0|||
124969855|NCT01296555|449517524|FG003|Overall Study|Reason Not Specified|0|||
124969856|NCT01296555|449517525|FG004|Overall Study|Reason Not Specified|0|||
124969857|NCT01296555|449517526|FG005|Overall Study|Reason Not Specified|0|||
124969858|NCT01296555|449517527|FG006|Overall Study|Reason Not Specified|0|||
124969859|NCT01296555|449517528|FG007|Overall Study|Reason Not Specified|0|||
124969860|NCT01296555|449517529|FG008|Overall Study|Reason Not Specified|0|||
124969861|NCT01296555|449517530|FG009|Overall Study|Reason Not Specified|0|||
124712089|NCT00461708|448570730|FG000|Overall Study|Withdrawal by Subject|8|||
124712090|NCT00461708|448570731|FG001|Overall Study|Withdrawal by Subject|2|||
124712091|NCT00461708|448570730|FG000|Overall Study|Other|4|||
124712092|NCT00461708|448570731|FG001|Overall Study|Other|4|||
124969862|NCT01296555|449517531|FG010|Overall Study|Reason Not Specified|0|||
124969863|NCT01296555|449517532|FG011|Overall Study|Reason Not Specified|0|||
124969864|NCT01296555|449517533|FG012|Overall Study|Reason Not Specified|0|||
124969865|NCT01296555|449517534|FG013|Overall Study|Reason Not Specified|1|||
124969866|NCT01296555|449517535|FG014|Overall Study|Reason Not Specified|2|||
124969867|NCT01296555|449517536|FG015|Overall Study|Reason Not Specified|3|||
124969868|NCT01296555|449517537|FG016|Overall Study|Reason Not Specified|7|||
124969869|NCT01296555|449517538|FG017|Overall Study|Reason Not Specified|4|||
124969870|NCT01296555|449517539|FG018|Overall Study|Reason Not Specified|3|||
124969871|NCT01296555|449517540|FG019|Overall Study|Reason Not Specified|7|||
124969872|NCT01296555|449517541|FG020|Overall Study|Reason Not Specified|11|||
124969873|NCT01296555|449517542|FG021|Overall Study|Reason Not Specified|5|||
124969874|NCT01296555|449517543|FG022|Overall Study|Reason Not Specified|5|||
124969875|NCT01296555|449517544|FG023|Overall Study|Reason Not Specified|7|||
124969876|NCT01296555|449517545|FG024|Overall Study|Reason Not Specified|2|||
124969877|NCT01296555|449517546|FG025|Overall Study|Reason Not Specified|2|||
124969878|NCT01296555|449517547|FG026|Overall Study|Reason Not Specified|19|||
124969879|NCT01296555|449517548|FG027|Overall Study|Reason Not Specified|11|||
124969880|NCT01296555|449517549|FG028|Overall Study|Reason Not Specified|9|||
124969881|NCT01296555|449517521|FG000|Overall Study|Physician Decision|0|||
124969882|NCT01296555|449517522|FG001|Overall Study|Physician Decision|0|||
124969883|NCT01296555|449517523|FG002|Overall Study|Physician Decision|0|||
124969884|NCT01296555|449517524|FG003|Overall Study|Physician Decision|0|||
124969885|NCT01296555|449517525|FG004|Overall Study|Physician Decision|1|||
124969886|NCT01296555|449517526|FG005|Overall Study|Physician Decision|0|||
124969887|NCT01296555|449517527|FG006|Overall Study|Physician Decision|0|||
124969888|NCT01296555|449517528|FG007|Overall Study|Physician Decision|0|||
124969889|NCT01296555|449517529|FG008|Overall Study|Physician Decision|0|||
124969890|NCT01296555|449517530|FG009|Overall Study|Physician Decision|0|||
124969891|NCT01296555|449517531|FG010|Overall Study|Physician Decision|0|||
124969892|NCT01296555|449517532|FG011|Overall Study|Physician Decision|0|||
124969893|NCT01296555|449517533|FG012|Overall Study|Physician Decision|0|||
124969894|NCT01296555|449517534|FG013|Overall Study|Physician Decision|1|||
124969895|NCT01296555|449517535|FG014|Overall Study|Physician Decision|0|||
124969896|NCT01296555|449517536|FG015|Overall Study|Physician Decision|0|||
124969897|NCT01296555|449517537|FG016|Overall Study|Physician Decision|0|||
124969898|NCT01296555|449517538|FG017|Overall Study|Physician Decision|0|||
124969899|NCT01296555|449517539|FG018|Overall Study|Physician Decision|0|||
124969900|NCT01296555|449517540|FG019|Overall Study|Physician Decision|1|||
124969901|NCT01296555|449517541|FG020|Overall Study|Physician Decision|0|||
124969902|NCT01296555|449517542|FG021|Overall Study|Physician Decision|0|||
124969903|NCT01296555|449517543|FG022|Overall Study|Physician Decision|0|||
124969904|NCT01296555|449517544|FG023|Overall Study|Physician Decision|0|||
124969905|NCT01296555|449517545|FG024|Overall Study|Physician Decision|0|||
124969906|NCT01296555|449517546|FG025|Overall Study|Physician Decision|0|||
124969907|NCT01296555|449517547|FG026|Overall Study|Physician Decision|0|||
124969908|NCT01296555|449517548|FG027|Overall Study|Physician Decision|0|||
124969909|NCT01296555|449517549|FG028|Overall Study|Physician Decision|0|||
124969910|NCT01296555|449517521|FG000|Overall Study|Progressive Disease|6|||
124969911|NCT01296555|449517522|FG001|Overall Study|Progressive Disease|3|||
124969912|NCT01296555|449517523|FG002|Overall Study|Progressive Disease|3|||
124969913|NCT01296555|449517524|FG003|Overall Study|Progressive Disease|7|||
124969914|NCT01296555|449517525|FG004|Overall Study|Progressive Disease|6|||
124969915|NCT01296555|449517526|FG005|Overall Study|Progressive Disease|16|||
124712093|NCT00461708|448570730|FG000|Overall Study|Death|8|||
124712094|NCT00461708|448570731|FG001|Overall Study|Death|1|||
124969916|NCT01296555|449517527|FG006|Overall Study|Progressive Disease|16|||
124969917|NCT01296555|449517528|FG007|Overall Study|Progressive Disease|8|||
124969918|NCT01296555|449517529|FG008|Overall Study|Progressive Disease|7|||
124969919|NCT01296555|449517530|FG009|Overall Study|Progressive Disease|18|||
124969920|NCT01296555|449517531|FG010|Overall Study|Progressive Disease|7|||
124969921|NCT01296555|449517532|FG011|Overall Study|Progressive Disease|14|||
124969922|NCT01296555|449517533|FG012|Overall Study|Progressive Disease|5|||
124969923|NCT01296555|449517534|FG013|Overall Study|Progressive Disease|12|||
124969924|NCT01296555|449517535|FG014|Overall Study|Progressive Disease|1|||
124969925|NCT01296555|449517536|FG015|Overall Study|Progressive Disease|1|||
124969926|NCT01296555|449517537|FG016|Overall Study|Progressive Disease|0|||
124969927|NCT01296555|449517538|FG017|Overall Study|Progressive Disease|0|||
124969928|NCT01296555|449517539|FG018|Overall Study|Progressive Disease|0|||
124969929|NCT01296555|449517540|FG019|Overall Study|Progressive Disease|1|||
124969930|NCT01296555|449517541|FG020|Overall Study|Progressive Disease|0|||
124969931|NCT01296555|449517542|FG021|Overall Study|Progressive Disease|0|||
124969932|NCT01296555|449517543|FG022|Overall Study|Progressive Disease|0|||
124969933|NCT01296555|449517544|FG023|Overall Study|Progressive Disease|0|||
124969934|NCT01296555|449517545|FG024|Overall Study|Progressive Disease|1|||
124712095|NCT02394561|448570732|FG000|CORE Phase|Adverse Event|7|||
124969935|NCT01296555|449517546|FG025|Overall Study|Progressive Disease|0|||
124969936|NCT01296555|449517547|FG026|Overall Study|Progressive Disease|5|||
124551394|NCT03454672|447974753|FG001|Overall Study|Adverse Event|1|||
124551395|NCT03454672|447974752|FG000|Overall Study|Lost to Follow-up|1|||
124551396|NCT03454672|447974753|FG001|Overall Study|Lost to Follow-up|3|||
124551397|NCT03454672|447974752|FG000|Overall Study|painful|1|||
124551398|NCT03454672|447974753|FG001|Overall Study|painful|2|||
124551399|NCT03454672|447974752|FG000|Overall Study|Non-compliance|2|||
124551400|NCT03454672|447974753|FG001|Overall Study|Non-compliance|4|||
124551401|NCT03454672|447974752|FG000|Overall Study|personal reasons|3|||
124551402|NCT03454672|447974753|FG001|Overall Study|personal reasons|2|||
124551403|NCT03454672|447974752|FG000|Overall Study|Withdrawal by Subject|1|||
124969937|NCT01296555|449517548|FG027|Overall Study|Progressive Disease|1|||
124969938|NCT01296555|449517549|FG028|Overall Study|Progressive Disease|0|||
124969939|NCT01296555|449517521|FG000|Overall Study|Protocol Violation|0|||
124969940|NCT01296555|449517522|FG001|Overall Study|Protocol Violation|0|||
124969941|NCT01296555|449517523|FG002|Overall Study|Protocol Violation|0|||
124969942|NCT01296555|449517524|FG003|Overall Study|Protocol Violation|0|||
124551404|NCT03454672|447974753|FG001|Overall Study|Withdrawal by Subject|0|||
124551405|NCT03985293|447974755|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
124551406|NCT03985293|447974756|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
124551407|NCT03985293|447974757|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
124551408|NCT03985293|447974758|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
124551409|NCT03985293|447974759|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
124551410|NCT03985293|447974760|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
124551411|NCT03985293|447974755|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
124769824|NCT03694353|448785213|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
124769825|NCT00651742|448785214|FG000|Overall Study|Objective Disease Progression|22|||
124769826|NCT00651742|448785214|FG000|Overall Study|Toxicity|3|||
124969943|NCT01296555|449517525|FG004|Overall Study|Protocol Violation|0|||
124969944|NCT01296555|449517526|FG005|Overall Study|Protocol Violation|0|||
124969945|NCT01296555|449517527|FG006|Overall Study|Protocol Violation|0|||
124969946|NCT01296555|449517528|FG007|Overall Study|Protocol Violation|0|||
124969947|NCT01296555|449517529|FG008|Overall Study|Protocol Violation|0|||
124969948|NCT01296555|449517530|FG009|Overall Study|Protocol Violation|0|||
124969949|NCT01296555|449517531|FG010|Overall Study|Protocol Violation|0|||
124969950|NCT01296555|449517532|FG011|Overall Study|Protocol Violation|0|||
124969951|NCT01296555|449517533|FG012|Overall Study|Protocol Violation|0|||
124969952|NCT01296555|449517534|FG013|Overall Study|Protocol Violation|1|||
124969953|NCT01296555|449517535|FG014|Overall Study|Protocol Violation|0|||
124969954|NCT01296555|449517536|FG015|Overall Study|Protocol Violation|0|||
124969955|NCT01296555|449517537|FG016|Overall Study|Protocol Violation|0|||
124969956|NCT01296555|449517538|FG017|Overall Study|Protocol Violation|0|||
124969957|NCT01296555|449517539|FG018|Overall Study|Protocol Violation|0|||
124969958|NCT01296555|449517540|FG019|Overall Study|Protocol Violation|0|||
124969959|NCT01296555|449517541|FG020|Overall Study|Protocol Violation|0|||
124969960|NCT01296555|449517542|FG021|Overall Study|Protocol Violation|0|||
124969961|NCT01296555|449517543|FG022|Overall Study|Protocol Violation|0|||
124969962|NCT01296555|449517544|FG023|Overall Study|Protocol Violation|0|||
124969963|NCT01296555|449517545|FG024|Overall Study|Protocol Violation|0|||
124969964|NCT01296555|449517546|FG025|Overall Study|Protocol Violation|0|||
124969965|NCT01296555|449517547|FG026|Overall Study|Protocol Violation|0|||
124969966|NCT01296555|449517548|FG027|Overall Study|Protocol Violation|0|||
124969967|NCT01296555|449517549|FG028|Overall Study|Protocol Violation|0|||
124551412|NCT03985293|447974756|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
124551413|NCT03985293|447974757|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
124969968|NCT01296555|449517521|FG000|Overall Study|Study Terminated By Sponsor|0|||
124969969|NCT01296555|449517522|FG001|Overall Study|Study Terminated By Sponsor|0|||
124769827|NCT00651742|448785214|FG000|Overall Study|Investigator Judgment|1|||
124769828|NCT00651742|448785214|FG000|Overall Study|Withdrawal of Consent|1|||
124769829|NCT00651742|448785214|FG000|Overall Study|Enrolled but not treated|1|||
124769830|NCT01535040|448785215|FG000|Overall Study|Physician Decision|0|||
124769831|NCT01535040|448785216|FG001|Overall Study|Physician Decision|1|||
124769832|NCT01535040|448785215|FG000|Overall Study|Withdrawal by Subject|13|||
124969970|NCT01296555|449517523|FG002|Overall Study|Study Terminated By Sponsor|0|||
124969971|NCT01296555|449517524|FG003|Overall Study|Study Terminated By Sponsor|0|||
124969972|NCT01296555|449517525|FG004|Overall Study|Study Terminated By Sponsor|0|||
124969973|NCT01296555|449517526|FG005|Overall Study|Study Terminated By Sponsor|0|||
124969974|NCT01296555|449517527|FG006|Overall Study|Study Terminated By Sponsor|0|||
124969975|NCT01296555|449517528|FG007|Overall Study|Study Terminated By Sponsor|0|||
124969976|NCT01296555|449517529|FG008|Overall Study|Study Terminated By Sponsor|0|||
124969977|NCT01296555|449517530|FG009|Overall Study|Study Terminated By Sponsor|0|||
124969978|NCT01296555|449517531|FG010|Overall Study|Study Terminated By Sponsor|0|||
124969979|NCT01296555|449517532|FG011|Overall Study|Study Terminated By Sponsor|0|||
124969980|NCT01296555|449517533|FG012|Overall Study|Study Terminated By Sponsor|0|||
124969981|NCT01296555|449517534|FG013|Overall Study|Study Terminated By Sponsor|0|||
124969982|NCT01296555|449517535|FG014|Overall Study|Study Terminated By Sponsor|0|||
124969983|NCT01296555|449517536|FG015|Overall Study|Study Terminated By Sponsor|0|||
124969984|NCT01296555|449517537|FG016|Overall Study|Study Terminated By Sponsor|0|||
124969985|NCT01296555|449517538|FG017|Overall Study|Study Terminated By Sponsor|0|||
124969986|NCT01296555|449517539|FG018|Overall Study|Study Terminated By Sponsor|0|||
124969987|NCT01296555|449517540|FG019|Overall Study|Study Terminated By Sponsor|0|||
124969988|NCT01296555|449517541|FG020|Overall Study|Study Terminated By Sponsor|0|||
124969989|NCT01296555|449517542|FG021|Overall Study|Study Terminated By Sponsor|0|||
124969990|NCT01296555|449517543|FG022|Overall Study|Study Terminated By Sponsor|0|||
124969991|NCT01296555|449517544|FG023|Overall Study|Study Terminated By Sponsor|0|||
124969992|NCT01296555|449517545|FG024|Overall Study|Study Terminated By Sponsor|0|||
124969993|NCT01296555|449517546|FG025|Overall Study|Study Terminated By Sponsor|1|||
124969994|NCT01296555|449517547|FG026|Overall Study|Study Terminated By Sponsor|0|||
124969995|NCT01296555|449517548|FG027|Overall Study|Study Terminated By Sponsor|0|||
124969996|NCT01296555|449517549|FG028|Overall Study|Study Terminated By Sponsor|0|||
124969997|NCT01296555|449517521|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124969998|NCT01296555|449517522|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124969999|NCT01296555|449517523|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970000|NCT01296555|449517524|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970001|NCT01296555|449517525|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970002|NCT01296555|449517526|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970003|NCT01296555|449517527|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970004|NCT01296555|449517528|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970005|NCT01296555|449517529|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970006|NCT01296555|449517530|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970007|NCT01296555|449517531|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970008|NCT01296555|449517532|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970009|NCT01296555|449517533|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970010|NCT01296555|449517534|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970011|NCT01296555|449517535|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970012|NCT01296555|449517536|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970013|NCT01296555|449517537|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970014|NCT01296555|449517538|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970015|NCT01296555|449517539|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970016|NCT01296555|449517540|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
124970017|NCT01296555|449517541|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970018|NCT01296555|449517542|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970019|NCT01296555|449517543|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970020|NCT01296555|449517544|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970021|NCT01296555|449517545|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970022|NCT01296555|449517546|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970023|NCT01296555|449517547|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970024|NCT01296555|449517548|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970025|NCT01296555|449517549|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
124970026|NCT01296555|449517521|FG000|Overall Study|Death|0|||
124970027|NCT01296555|449517522|FG001|Overall Study|Death|0|||
124970028|NCT01296555|449517523|FG002|Overall Study|Death|0|||
124970029|NCT01296555|449517524|FG003|Overall Study|Death|2|||
124970030|NCT01296555|449517525|FG004|Overall Study|Death|1|||
124970031|NCT01296555|449517526|FG005|Overall Study|Death|0|||
124970032|NCT01296555|449517527|FG006|Overall Study|Death|2|||
124970033|NCT01296555|449517528|FG007|Overall Study|Death|0|||
124769833|NCT01535040|448785216|FG001|Overall Study|Withdrawal by Subject|10|||
124970034|NCT01296555|449517529|FG008|Overall Study|Death|0|||
124712096|NCT02394561|448570733|FG001|CORE Phase|Adverse Event|9|||
124712097|NCT02394561|448570732|FG000|CORE Phase|Death|0|||
124466607|NCT00953758|447666442|FG008|Overall Study|Participant went for transplant|1|||
124466608|NCT00953758|447666443|FG009|Overall Study|Participant went for transplant|0|||
124466609|NCT01703858|447666446|FG000|Overall Study|Withdrawal by Subject|0|||
124466610|NCT01703858|447666447|FG001|Overall Study|Withdrawal by Subject|1|||
124466611|NCT01703858|447666448|FG002|Overall Study|Withdrawal by Subject|0|||
124466612|NCT00706030|447666452|FG000|Overall Study|Disease Progression|4|||
124466613|NCT00706030|447666453|FG001|Overall Study|Disease Progression|6|||
124466614|NCT00706030|447666454|FG002|Overall Study|Disease Progression|46|||
124466615|NCT00706030|447666455|FG003|Overall Study|Disease Progression|12|||
124466616|NCT00706030|447666452|FG000|Overall Study|Adverse Event|1|||
124466617|NCT00706030|447666453|FG001|Overall Study|Adverse Event|0|||
124466618|NCT00706030|447666454|FG002|Overall Study|Adverse Event|4|||
124466619|NCT00706030|447666455|FG003|Overall Study|Adverse Event|2|||
124466620|NCT00706030|447666452|FG000|Overall Study|Withdrawal by Subject|1|||
124466621|NCT00706030|447666453|FG001|Overall Study|Withdrawal by Subject|0|||
124466622|NCT00706030|447666454|FG002|Overall Study|Withdrawal by Subject|2|||
124466623|NCT00706030|447666455|FG003|Overall Study|Withdrawal by Subject|0|||
124466624|NCT00706030|447666452|FG000|Overall Study|Physician Decision|0|||
124466625|NCT00706030|447666453|FG001|Overall Study|Physician Decision|0|||
124466626|NCT00706030|447666454|FG002|Overall Study|Physician Decision|2|||
124466627|NCT00706030|447666455|FG003|Overall Study|Physician Decision|0|||
124466628|NCT00706030|447666452|FG000|Overall Study|Not recorded|0|||
124466629|NCT00706030|447666453|FG001|Overall Study|Not recorded|0|||
124466630|NCT00706030|447666454|FG002|Overall Study|Not recorded|2|||
124466631|NCT00706030|447666455|FG003|Overall Study|Not recorded|0|||
124466632|NCT00706030|447666452|FG000|Overall Study|Protocol Violation|0|||
124466633|NCT00706030|447666453|FG001|Overall Study|Protocol Violation|0|||
124466634|NCT00706030|447666454|FG002|Overall Study|Protocol Violation|1|||
124466635|NCT00706030|447666455|FG003|Overall Study|Protocol Violation|1|||
124466636|NCT00706030|447666452|FG000|Overall Study|Failed to return|0|||
124466637|NCT00706030|447666453|FG001|Overall Study|Failed to return|0|||
124466638|NCT00706030|447666454|FG002|Overall Study|Failed to return|1|||
124466639|NCT00706030|447666455|FG003|Overall Study|Failed to return|0|||
124466640|NCT00706030|447666452|FG000|Overall Study|Symptomatic Deterioration|0|||
124466641|NCT00706030|447666453|FG001|Overall Study|Symptomatic Deterioration|0|||
124712098|NCT02394561|448570733|FG001|CORE Phase|Death|1|||
124466642|NCT00706030|447666454|FG002|Overall Study|Symptomatic Deterioration|1|||
124466643|NCT00706030|447666455|FG003|Overall Study|Symptomatic Deterioration|0|||
124712099|NCT02394561|448570732|FG000|CORE Phase|Pregnancy|1|||
124712100|NCT02394561|448570733|FG001|CORE Phase|Pregnancy|0|||
124712101|NCT02394561|448570732|FG000|CORE Phase|Lost to Follow-up|1|||
124712102|NCT02394561|448570733|FG001|CORE Phase|Lost to Follow-up|0|||
124466644|NCT00706030|447666452|FG000|Overall Study|No treatment received|0|||
124712103|NCT02394561|448570732|FG000|CORE Phase|Physician Decision|1|||
124712104|NCT02394561|448570733|FG001|CORE Phase|Physician Decision|1|||
124466645|NCT00706030|447666453|FG001|Overall Study|No treatment received|0|||
124466646|NCT00706030|447666454|FG002|Overall Study|No treatment received|0|||
124712105|NCT02394561|448570732|FG000|CORE Phase|Withdrawal by Subject|2|||
124712106|NCT02394561|448570733|FG001|CORE Phase|Withdrawal by Subject|2|||
124712107|NCT02394561|448570732|FG000|CORE Phase|Lack of Efficacy|1|||
124466647|NCT00706030|447666455|FG003|Overall Study|No treatment received|1|||
124466648|NCT00706030|447666452|FG000|Overall Study|Death|0|||
124466649|NCT00706030|447666453|FG001|Overall Study|Death|0|||
124466650|NCT00706030|447666454|FG002|Overall Study|Death|1|||
124466651|NCT00706030|447666455|FG003|Overall Study|Death|0|||
124466652|NCT01276236|447666456|FG000|Overall Study|Lack of Efficacy|2|||
124466653|NCT01276236|447666456|FG000|Overall Study|Withdrawal by Subject|4|||
124466654|NCT00044512|447666457|FG000|Follow Up|Lost to Follow-up|2|||
124466655|NCT02695628|447666461|FG000|Overall Study|Withdrawal by Subject|1|||
124466656|NCT00516737|447666465|FG000|Overall Study|Lost to Follow-up|2|||
124466657|NCT00516737|447666466|FG001|Overall Study|Lost to Follow-up|0|||
124466658|NCT00516737|447666465|FG000|Overall Study|Physician Decision|0|||
124466659|NCT00516737|447666466|FG001|Overall Study|Physician Decision|1|||
124466660|NCT00516737|447666465|FG000|Overall Study|Withdrawal by Subject|0|||
124466661|NCT00516737|447666466|FG001|Overall Study|Withdrawal by Subject|1|||
124466662|NCT00516737|447666465|FG000|Overall Study|Lack of Qualifying Event|9|||
124466663|NCT00516737|447666466|FG001|Overall Study|Lack of Qualifying Event|6|||
124466664|NCT01844895|447666467|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
124466665|NCT01844895|447666467|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
124466666|NCT01844895|447666467|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
124466667|NCT01844895|447666467|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
124466668|NCT01844895|447666467|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
124466669|NCT01844895|447666467|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
124466670|NCT01844895|447666467|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
124466671|NCT00512798|447666468|FG000|Overall Study|Death|0|||
124466672|NCT00512798|447666469|FG001|Overall Study|Death|3|||
124466673|NCT00512798|447666468|FG000|Overall Study|Adverse Event|2|||
124466674|NCT00512798|447666469|FG001|Overall Study|Adverse Event|4|||
124466675|NCT00512798|447666468|FG000|Overall Study|Progression of disease|14|||
124466676|NCT00512798|447666469|FG001|Overall Study|Progression of disease|20|||
124466677|NCT00512798|447666468|FG000|Overall Study|Withdrawal by Subject|3|||
124466678|NCT00512798|447666469|FG001|Overall Study|Withdrawal by Subject|0|||
124466679|NCT02508194|447666472|FG000|Overall Study|Death|5|||
124466680|NCT02508194|447666473|FG001|Overall Study|Death|3|||
124466681|NCT02508194|447666472|FG000|Overall Study|Lost to Follow-up|25|||
124712108|NCT02394561|448570733|FG001|CORE Phase|Lack of Efficacy|6|||
124970035|NCT01296555|449517530|FG009|Overall Study|Death|1|||
124970036|NCT01296555|449517531|FG010|Overall Study|Death|0|||
124970037|NCT01296555|449517532|FG011|Overall Study|Death|1|||
124970038|NCT01296555|449517533|FG012|Overall Study|Death|0|||
124970039|NCT01296555|449517534|FG013|Overall Study|Death|2|||
124970040|NCT01296555|449517535|FG014|Overall Study|Death|27|||
124970041|NCT01296555|449517536|FG015|Overall Study|Death|15|||
124970042|NCT01296555|449517537|FG016|Overall Study|Death|11|||
124970043|NCT01296555|449517538|FG017|Overall Study|Death|11|||
124970044|NCT01296555|449517539|FG018|Overall Study|Death|17|||
124970045|NCT01296555|449517540|FG019|Overall Study|Death|12|||
124970046|NCT01296555|449517541|FG020|Overall Study|Death|13|||
124970047|NCT01296555|449517542|FG021|Overall Study|Death|12|||
124970048|NCT01296555|449517543|FG022|Overall Study|Death|12|||
124970049|NCT01296555|449517544|FG023|Overall Study|Death|13|||
124970050|NCT01296555|449517545|FG024|Overall Study|Death|7|||
124970051|NCT01296555|449517546|FG025|Overall Study|Death|7|||
124970052|NCT01296555|449517547|FG026|Overall Study|Death|35|||
124970053|NCT01296555|449517548|FG027|Overall Study|Death|92|||
124970054|NCT01296555|449517549|FG028|Overall Study|Death|44|||
124970055|NCT01296555|449517521|FG000|Overall Study|Lost to Follow-up|0|||
124970056|NCT01296555|449517522|FG001|Overall Study|Lost to Follow-up|0|||
124970057|NCT01296555|449517523|FG002|Overall Study|Lost to Follow-up|0|||
124970058|NCT01296555|449517524|FG003|Overall Study|Lost to Follow-up|0|||
124970059|NCT01296555|449517525|FG004|Overall Study|Lost to Follow-up|0|||
124970060|NCT01296555|449517526|FG005|Overall Study|Lost to Follow-up|0|||
124970061|NCT01296555|449517527|FG006|Overall Study|Lost to Follow-up|0|||
124970062|NCT01296555|449517528|FG007|Overall Study|Lost to Follow-up|0|||
124970063|NCT01296555|449517529|FG008|Overall Study|Lost to Follow-up|0|||
124970064|NCT01296555|449517530|FG009|Overall Study|Lost to Follow-up|0|||
124970065|NCT01296555|449517531|FG010|Overall Study|Lost to Follow-up|0|||
124970066|NCT01296555|449517532|FG011|Overall Study|Lost to Follow-up|0|||
124970067|NCT01296555|449517533|FG012|Overall Study|Lost to Follow-up|0|||
124970068|NCT01296555|449517534|FG013|Overall Study|Lost to Follow-up|0|||
124970069|NCT01296555|449517535|FG014|Overall Study|Lost to Follow-up|2|||
124970070|NCT01296555|449517536|FG015|Overall Study|Lost to Follow-up|1|||
124970071|NCT01296555|449517537|FG016|Overall Study|Lost to Follow-up|0|||
124970072|NCT01296555|449517538|FG017|Overall Study|Lost to Follow-up|2|||
124970073|NCT01296555|449517539|FG018|Overall Study|Lost to Follow-up|0|||
124970074|NCT01296555|449517540|FG019|Overall Study|Lost to Follow-up|2|||
124970075|NCT01296555|449517541|FG020|Overall Study|Lost to Follow-up|3|||
124970076|NCT01296555|449517542|FG021|Overall Study|Lost to Follow-up|2|||
124970077|NCT01296555|449517543|FG022|Overall Study|Lost to Follow-up|0|||
124970078|NCT01296555|449517544|FG023|Overall Study|Lost to Follow-up|0|||
124970079|NCT01296555|449517545|FG024|Overall Study|Lost to Follow-up|0|||
124970080|NCT01296555|449517546|FG025|Overall Study|Lost to Follow-up|0|||
124970081|NCT01296555|449517547|FG026|Overall Study|Lost to Follow-up|3|||
124970082|NCT01296555|449517548|FG027|Overall Study|Lost to Follow-up|13|||
124970083|NCT01296555|449517549|FG028|Overall Study|Lost to Follow-up|5|||
124970084|NCT01296555|449517521|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124970085|NCT01296555|449517522|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124970086|NCT01296555|449517523|FG002|Overall Study|Non-Compliance With Study Drug|0|||
124970087|NCT01296555|449517524|FG003|Overall Study|Non-Compliance With Study Drug|0|||
124970088|NCT01296555|449517525|FG004|Overall Study|Non-Compliance With Study Drug|0|||
124970089|NCT01296555|449517526|FG005|Overall Study|Non-Compliance With Study Drug|0|||
124970090|NCT01296555|449517527|FG006|Overall Study|Non-Compliance With Study Drug|0|||
124970091|NCT01296555|449517528|FG007|Overall Study|Non-Compliance With Study Drug|1|||
124970092|NCT01296555|449517529|FG008|Overall Study|Non-Compliance With Study Drug|0|||
124970093|NCT01296555|449517530|FG009|Overall Study|Non-Compliance With Study Drug|0|||
124970094|NCT01296555|449517531|FG010|Overall Study|Non-Compliance With Study Drug|0|||
124970095|NCT01296555|449517532|FG011|Overall Study|Non-Compliance With Study Drug|0|||
124970096|NCT01296555|449517533|FG012|Overall Study|Non-Compliance With Study Drug|0|||
124970097|NCT01296555|449517534|FG013|Overall Study|Non-Compliance With Study Drug|0|||
124970098|NCT01296555|449517535|FG014|Overall Study|Non-Compliance With Study Drug|0|||
124970099|NCT01296555|449517536|FG015|Overall Study|Non-Compliance With Study Drug|0|||
124970100|NCT01296555|449517537|FG016|Overall Study|Non-Compliance With Study Drug|0|||
124970101|NCT01296555|449517538|FG017|Overall Study|Non-Compliance With Study Drug|0|||
124970102|NCT01296555|449517539|FG018|Overall Study|Non-Compliance With Study Drug|0|||
124970103|NCT01296555|449517540|FG019|Overall Study|Non-Compliance With Study Drug|0|||
124970104|NCT01296555|449517541|FG020|Overall Study|Non-Compliance With Study Drug|0|||
124970105|NCT01296555|449517542|FG021|Overall Study|Non-Compliance With Study Drug|0|||
124970106|NCT01296555|449517543|FG022|Overall Study|Non-Compliance With Study Drug|0|||
124970107|NCT01296555|449517544|FG023|Overall Study|Non-Compliance With Study Drug|0|||
124970108|NCT01296555|449517545|FG024|Overall Study|Non-Compliance With Study Drug|0|||
124970109|NCT01296555|449517546|FG025|Overall Study|Non-Compliance With Study Drug|0|||
124970110|NCT01296555|449517547|FG026|Overall Study|Non-Compliance With Study Drug|0|||
124970111|NCT01296555|449517548|FG027|Overall Study|Non-Compliance With Study Drug|0|||
124970112|NCT01296555|449517549|FG028|Overall Study|Non-Compliance With Study Drug|0|||
124970113|NCT01296555|449517521|FG000|Overall Study|Withdrawal by Subject|0|||
124970114|NCT01296555|449517522|FG001|Overall Study|Withdrawal by Subject|0|||
124970115|NCT01296555|449517523|FG002|Overall Study|Withdrawal by Subject|0|||
124970116|NCT01296555|449517524|FG003|Overall Study|Withdrawal by Subject|0|||
124970117|NCT01296555|449517525|FG004|Overall Study|Withdrawal by Subject|1|||
124970118|NCT01296555|449517526|FG005|Overall Study|Withdrawal by Subject|0|||
124970119|NCT01296555|449517527|FG006|Overall Study|Withdrawal by Subject|1|||
124970120|NCT01296555|449517528|FG007|Overall Study|Withdrawal by Subject|0|||
124970121|NCT01296555|449517529|FG008|Overall Study|Withdrawal by Subject|0|||
124970122|NCT01296555|449517530|FG009|Overall Study|Withdrawal by Subject|0|||
124970123|NCT01296555|449517531|FG010|Overall Study|Withdrawal by Subject|1|||
124970124|NCT01296555|449517532|FG011|Overall Study|Withdrawal by Subject|1|||
124970125|NCT01296555|449517533|FG012|Overall Study|Withdrawal by Subject|0|||
124970126|NCT01296555|449517534|FG013|Overall Study|Withdrawal by Subject|0|||
124970127|NCT01296555|449517535|FG014|Overall Study|Withdrawal by Subject|3|||
124970128|NCT01296555|449517536|FG015|Overall Study|Withdrawal by Subject|0|||
124970129|NCT01296555|449517537|FG016|Overall Study|Withdrawal by Subject|2|||
124970130|NCT01296555|449517538|FG017|Overall Study|Withdrawal by Subject|1|||
124970131|NCT01296555|449517539|FG018|Overall Study|Withdrawal by Subject|0|||
124970132|NCT01296555|449517540|FG019|Overall Study|Withdrawal by Subject|1|||
124970133|NCT01296555|449517541|FG020|Overall Study|Withdrawal by Subject|1|||
124970134|NCT01296555|449517542|FG021|Overall Study|Withdrawal by Subject|1|||
124970135|NCT01296555|449517543|FG022|Overall Study|Withdrawal by Subject|3|||
124970136|NCT01296555|449517544|FG023|Overall Study|Withdrawal by Subject|0|||
124970137|NCT01296555|449517545|FG024|Overall Study|Withdrawal by Subject|0|||
124970138|NCT01296555|449517546|FG025|Overall Study|Withdrawal by Subject|0|||
124970139|NCT01296555|449517547|FG026|Overall Study|Withdrawal by Subject|8|||
124970140|NCT01296555|449517548|FG027|Overall Study|Withdrawal by Subject|4|||
124970141|NCT01296555|449517549|FG028|Overall Study|Withdrawal by Subject|2|||
124970142|NCT00409409|449517550|FG000|Overall Study|Adverse Event|7|||
124970143|NCT00409409|449517551|FG001|Overall Study|Adverse Event|2|||
124970144|NCT00409409|449517550|FG000|Overall Study|Withdrawal by Subject|1|||
124970145|NCT00409409|449517551|FG001|Overall Study|Withdrawal by Subject|1|||
124970146|NCT00409409|449517550|FG000|Overall Study|Any other reason not above-mentioned|0|||
124970147|NCT00409409|449517551|FG001|Overall Study|Any other reason not above-mentioned|1|||
124970148|NCT03635086|449517556|FG000|Overall Study|Withdrawal of consent|0|||
124970149|NCT03635086|449517557|FG001|Overall Study|Withdrawal of consent|0|||
124970150|NCT03635086|449517558|FG002|Overall Study|Withdrawal of consent|1|||
124970151|NCT03635086|449517559|FG003|Overall Study|Withdrawal of consent|0|||
124970152|NCT03635086|449517560|FG004|Overall Study|Withdrawal of consent|0|||
124970153|NCT03635086|449517556|FG000|Overall Study|Adverse Event|0|||
124970154|NCT03635086|449517557|FG001|Overall Study|Adverse Event|1|||
124970155|NCT03635086|449517558|FG002|Overall Study|Adverse Event|0|||
124970156|NCT03635086|449517559|FG003|Overall Study|Adverse Event|0|||
124970157|NCT03635086|449517560|FG004|Overall Study|Adverse Event|0|||
124970158|NCT03635086|449517556|FG000|Overall Study|Lost to Follow-up|1|||
124970159|NCT03635086|449517557|FG001|Overall Study|Lost to Follow-up|0|||
124970160|NCT03635086|449517558|FG002|Overall Study|Lost to Follow-up|0|||
124970161|NCT03635086|449517559|FG003|Overall Study|Lost to Follow-up|0|||
124970162|NCT03635086|449517560|FG004|Overall Study|Lost to Follow-up|0|||
124970163|NCT03000348|449517561|FG000|Overall Study|Adverse Event|1|||
124970164|NCT03000348|449517562|FG001|Overall Study|Adverse Event|1|||
124970165|NCT03000348|449517563|FG002|Overall Study|Adverse Event|1|||
124970166|NCT03000348|449517564|FG003|Overall Study|Adverse Event|1|||
124970167|NCT03000348|449517565|FG004|Overall Study|Adverse Event|1|||
124970168|NCT03000348|449517566|FG005|Overall Study|Adverse Event|1|||
124970169|NCT03000348|449517561|FG000|Overall Study|Lost to Follow-up|0|||
124970170|NCT03000348|449517562|FG001|Overall Study|Lost to Follow-up|0|||
124970171|NCT03000348|449517563|FG002|Overall Study|Lost to Follow-up|1|||
124970172|NCT03000348|449517564|FG003|Overall Study|Lost to Follow-up|0|||
124970173|NCT03000348|449517565|FG004|Overall Study|Lost to Follow-up|0|||
124970174|NCT03000348|449517566|FG005|Overall Study|Lost to Follow-up|0|||
124970175|NCT03000348|449517561|FG000|Overall Study|Withdrawal by Subject|0|||
124970176|NCT03000348|449517562|FG001|Overall Study|Withdrawal by Subject|1|||
124970177|NCT03000348|449517563|FG002|Overall Study|Withdrawal by Subject|0|||
124970178|NCT03000348|449517564|FG003|Overall Study|Withdrawal by Subject|0|||
124970179|NCT03000348|449517565|FG004|Overall Study|Withdrawal by Subject|0|||
124712109|NCT02394561|448570732|FG000|Extension Phase|Adverse Event|6|||
124712110|NCT02394561|448570733|FG001|Extension Phase|Adverse Event|1|||
124712111|NCT02394561|448570732|FG000|Extension Phase|Death|0|||
124712112|NCT02394561|448570733|FG001|Extension Phase|Death|1|||
124712113|NCT02394561|448570732|FG000|Extension Phase|Protocol Violation|1|||
124712114|NCT02394561|448570733|FG001|Extension Phase|Protocol Violation|0|||
124712115|NCT02394561|448570732|FG000|Extension Phase|Lost to Follow-up|1|||
124712116|NCT02394561|448570733|FG001|Extension Phase|Lost to Follow-up|0|||
124712117|NCT02394561|448570732|FG000|Extension Phase|Physician Decision|0|||
124712118|NCT02394561|448570733|FG001|Extension Phase|Physician Decision|2|||
124712119|NCT02394561|448570732|FG000|Extension Phase|Withdrawal by Subject|0|||
124712120|NCT02394561|448570733|FG001|Extension Phase|Withdrawal by Subject|5|||
124712121|NCT02394561|448570732|FG000|Extension Phase|Lack of Efficacy|3|||
124712122|NCT02394561|448570733|FG001|Extension Phase|Lack of Efficacy|3|||
124466682|NCT02508194|447666473|FG001|Overall Study|Lost to Follow-up|18|||
124466683|NCT02508194|447666472|FG000|Overall Study|Withdrawal by Subject|20|||
124466684|NCT02508194|447666473|FG001|Overall Study|Withdrawal by Subject|18|||
124466685|NCT02508194|447666472|FG000|Overall Study|Error in Randomization|1|||
124466686|NCT02508194|447666473|FG001|Overall Study|Error in Randomization|3|||
124466687|NCT02508194|447666472|FG000|Overall Study|Principal Investigator Decision|1|||
124466688|NCT02508194|447666473|FG001|Overall Study|Principal Investigator Decision|2|||
124466689|NCT00511355|447666474|FG000|Overall Study|Adverse Event|4|||
124466690|NCT00511355|447666475|FG001|Overall Study|Adverse Event|4|||
124466691|NCT00511355|447666474|FG000|Overall Study|Pregnancy Wish|1|||
124466692|NCT00511355|447666475|FG001|Overall Study|Pregnancy Wish|0|||
124466693|NCT00511355|447666474|FG000|Overall Study|Lost to Follow-up|2|||
124466694|NCT00511355|447666475|FG001|Overall Study|Lost to Follow-up|1|||
124466695|NCT00511355|447666474|FG000|Overall Study|Other Reason|0|||
124466696|NCT00511355|447666475|FG001|Overall Study|Other Reason|1|||
124466697|NCT00511355|447666474|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
124466698|NCT00511355|447666475|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
124466699|NCT00511355|447666474|FG000|Overall Study|Withdrawal of informed consent|0|||
124466700|NCT00511355|447666475|FG001|Overall Study|Withdrawal of informed consent|1|||
124466701|NCT00511355|447666474|FG000|Overall Study|Other reason pre-treatment|0|||
124466702|NCT00511355|447666475|FG001|Overall Study|Other reason pre-treatment|1|||
124466703|NCT00454805|447666482|FG000|Overall Study|Withdrawal by Subject|9|||
124466704|NCT00454805|447666483|FG001|Overall Study|Withdrawal by Subject|2|||
124466705|NCT00454805|447666482|FG000|Overall Study|Death|0|||
124466706|NCT00454805|447666483|FG001|Overall Study|Death|2|||
124466707|NCT00454805|447666482|FG000|Overall Study|Disease progression|16|||
124466708|NCT00454805|447666483|FG001|Overall Study|Disease progression|19|||
124466709|NCT00454805|447666482|FG000|Overall Study|In order to begin radiotherapy|1|||
124466710|NCT00454805|447666483|FG001|Overall Study|In order to begin radiotherapy|0|||
124466711|NCT03742037|447666484|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
124466712|NCT03742037|447666485|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
124466713|NCT03742037|447666486|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
124466714|NCT03742037|447666487|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
124466715|NCT03742037|447666488|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
124466716|NCT03742037|447666489|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
124466717|NCT03742037|447666490|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
124466718|NCT03742037|447666484|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
124466719|NCT03742037|447666485|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
124466720|NCT03742037|447666486|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
124466721|NCT03742037|447666487|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
124551414|NCT03985293|447974758|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
124551415|NCT03985293|447974759|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
124551416|NCT03985293|447974760|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
124551417|NCT03985293|447974755|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
124551418|NCT03985293|447974756|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
124551419|NCT03985293|447974757|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
124551420|NCT03985293|447974758|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
124551421|NCT03985293|447974759|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
124551422|NCT03985293|447974760|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
124551423|NCT03985293|447974755|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
124551424|NCT03985293|447974756|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
124551425|NCT03985293|447974757|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
124551426|NCT03985293|447974758|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
124551427|NCT03985293|447974759|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
124551428|NCT03985293|447974760|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
124551429|NCT03985293|447974755|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
124712123|NCT00501644|448570734|FG000|Overall Study|Adverse Event|4|||
124712124|NCT00501644|448570734|FG000|Overall Study|Withdrawal by Subject|1|||
124712125|NCT02803203|448570735|FG000|Overall Study|Adverse Event|4|||
124712126|NCT02803203|448570735|FG000|Overall Study|Death|4|||
124712127|NCT02803203|448570735|FG000|Overall Study|Progressive disease|29|||
124712128|NCT02803203|448570735|FG000|Overall Study|Withdrawal by Subject|8|||
124712129|NCT02803203|448570735|FG000|Overall Study|Complete resection of target disease|2|||
124712130|NCT02803203|448570735|FG000|Overall Study|Switched to commercial Osi|1|||
124712131|NCT02803203|448570735|FG000|Overall Study|Participant moved away|1|||
124712132|NCT04577781|448570736|FG000|Overall Study|Adverse Event|2|||
124712133|NCT04577781|448570737|FG001|Overall Study|Adverse Event|2|||
124712134|NCT04577781|448570736|FG000|Overall Study|Physician Decision|1|||
124466722|NCT03742037|447666488|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
124466723|NCT03742037|447666489|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
124466724|NCT03742037|447666490|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
124712135|NCT04577781|448570737|FG001|Overall Study|Physician Decision|0|||
124712136|NCT00114127|448570738|FG000|Overall Study|Adverse Event|2|||
124712137|NCT00114127|448570739|FG001|Overall Study|Adverse Event|1|||
124712138|NCT00114127|448570738|FG000|Overall Study|Lost to Follow-up|1|||
124712139|NCT00114127|448570739|FG001|Overall Study|Lost to Follow-up|0|||
124712140|NCT00114127|448570738|FG000|Overall Study|Withdrawal by Subject|1|||
124712141|NCT00114127|448570739|FG001|Overall Study|Withdrawal by Subject|3|||
124712142|NCT00699413|448570740|FG000|Overall Study|Withdrawal by Subject|0|||
124970180|NCT03000348|449517566|FG005|Overall Study|Withdrawal by Subject|0|||
124970181|NCT03000348|449517561|FG000|Overall Study|Consent|0|||
124970182|NCT03000348|449517562|FG001|Overall Study|Consent|0|||
124970183|NCT03000348|449517563|FG002|Overall Study|Consent|0|||
124970184|NCT03000348|449517564|FG003|Overall Study|Consent|0|||
124970185|NCT03000348|449517565|FG004|Overall Study|Consent|1|||
124970186|NCT03000348|449517566|FG005|Overall Study|Consent|0|||
124970187|NCT03000348|449517561|FG000|Overall Study|Failure to expectorate sputum|1|||
124970188|NCT03000348|449517562|FG001|Overall Study|Failure to expectorate sputum|0|||
124970189|NCT03000348|449517563|FG002|Overall Study|Failure to expectorate sputum|1|||
124970190|NCT03000348|449517564|FG003|Overall Study|Failure to expectorate sputum|0|||
124970191|NCT03000348|449517565|FG004|Overall Study|Failure to expectorate sputum|1|||
124970192|NCT03000348|449517566|FG005|Overall Study|Failure to expectorate sputum|0|||
124970193|NCT03000348|449517561|FG000|Overall Study|No gram negative|1|||
124970194|NCT03000348|449517562|FG001|Overall Study|No gram negative|2|||
124970195|NCT03000348|449517563|FG002|Overall Study|No gram negative|1|||
124970196|NCT03000348|449517564|FG003|Overall Study|No gram negative|1|||
124970197|NCT03000348|449517565|FG004|Overall Study|No gram negative|1|||
124970198|NCT03000348|449517566|FG005|Overall Study|No gram negative|1|||
124970199|NCT03000348|449517561|FG000|Overall Study|Patient had no transport|0|||
124970200|NCT03000348|449517562|FG001|Overall Study|Patient had no transport|0|||
124970201|NCT03000348|449517563|FG002|Overall Study|Patient had no transport|0|||
124970202|NCT03000348|449517564|FG003|Overall Study|Patient had no transport|1|||
124970203|NCT03000348|449517565|FG004|Overall Study|Patient had no transport|0|||
124970204|NCT03000348|449517566|FG005|Overall Study|Patient had no transport|0|||
124970205|NCT03000348|449517561|FG000|Overall Study|Dosing|0|||
124970206|NCT03000348|449517562|FG001|Overall Study|Dosing|0|||
124970207|NCT03000348|449517563|FG002|Overall Study|Dosing|0|||
124970208|NCT03000348|449517564|FG003|Overall Study|Dosing|0|||
124970209|NCT03000348|449517565|FG004|Overall Study|Dosing|1|||
124970210|NCT03000348|449517566|FG005|Overall Study|Dosing|0|||
124970211|NCT04042077|449517567|FG000|Overall Study|Adverse Event|0|||
124970212|NCT04042077|449517568|FG001|Overall Study|Adverse Event|1|||
124970213|NCT04042077|449517567|FG000|Overall Study|Death|2|||
124970214|NCT04042077|449517568|FG001|Overall Study|Death|1|||
124970215|NCT04042077|449517567|FG000|Overall Study|Physician Decision|2|||
124970216|NCT04042077|449517568|FG001|Overall Study|Physician Decision|0|||
124970217|NCT04042077|449517567|FG000|Overall Study|Withdrawal by Subject|3|||
124970218|NCT04042077|449517568|FG001|Overall Study|Withdrawal by Subject|2|||
124970219|NCT04042077|449517567|FG000|Overall Study|Lack of Efficacy|0|||
124970220|NCT04042077|449517568|FG001|Overall Study|Lack of Efficacy|1|||
124970221|NCT01236352|449517582|FG000|Overall Study|Death|0|||
124970222|NCT01236352|449517583|FG001|Overall Study|Death|0|||
124970223|NCT01236352|449517584|FG002|Overall Study|Death|0|||
124970224|NCT01236352|449517585|FG003|Overall Study|Death|0|||
124970225|NCT01236352|449517586|FG004|Overall Study|Death|0|||
124970226|NCT01236352|449517587|FG005|Overall Study|Death|0|||
124970227|NCT01236352|449517588|FG006|Overall Study|Death|0|||
124970228|NCT01236352|449517589|FG007|Overall Study|Death|1|||
124970229|NCT01236352|449517590|FG008|Overall Study|Death|0|||
124970230|NCT01236352|449517591|FG009|Overall Study|Death|0|||
124970231|NCT01236352|449517592|FG010|Overall Study|Death|0|||
124970232|NCT01236352|449517582|FG000|Overall Study|Withdrawal by Subject|0|||
124970233|NCT01236352|449517583|FG001|Overall Study|Withdrawal by Subject|0|||
124970234|NCT01236352|449517584|FG002|Overall Study|Withdrawal by Subject|0|||
124970235|NCT01236352|449517585|FG003|Overall Study|Withdrawal by Subject|0|||
124970236|NCT01236352|449517586|FG004|Overall Study|Withdrawal by Subject|0|||
124970237|NCT01236352|449517587|FG005|Overall Study|Withdrawal by Subject|0|||
124970238|NCT01236352|449517588|FG006|Overall Study|Withdrawal by Subject|0|||
124970239|NCT01236352|449517589|FG007|Overall Study|Withdrawal by Subject|0|||
124970240|NCT01236352|449517590|FG008|Overall Study|Withdrawal by Subject|0|||
124970241|NCT01236352|449517591|FG009|Overall Study|Withdrawal by Subject|2|||
124970242|NCT01236352|449517592|FG010|Overall Study|Withdrawal by Subject|1|||
124970243|NCT01236352|449517582|FG000|Overall Study|Adverse Event|0|||
124970244|NCT01236352|449517583|FG001|Overall Study|Adverse Event|0|||
124970245|NCT01236352|449517584|FG002|Overall Study|Adverse Event|0|||
124970246|NCT01236352|449517585|FG003|Overall Study|Adverse Event|0|||
124970247|NCT01236352|449517586|FG004|Overall Study|Adverse Event|0|||
124970248|NCT01236352|449517587|FG005|Overall Study|Adverse Event|0|||
124970249|NCT01236352|449517588|FG006|Overall Study|Adverse Event|2|||
124970250|NCT01236352|449517589|FG007|Overall Study|Adverse Event|0|||
124970251|NCT01236352|449517590|FG008|Overall Study|Adverse Event|0|||
124970252|NCT01236352|449517591|FG009|Overall Study|Adverse Event|4|||
124970253|NCT01236352|449517592|FG010|Overall Study|Adverse Event|1|||
124970254|NCT01236352|449517582|FG000|Overall Study|Study drug toxicity|0|||
124970255|NCT01236352|449517583|FG001|Overall Study|Study drug toxicity|0|||
124970256|NCT01236352|449517584|FG002|Overall Study|Study drug toxicity|0|||
124712143|NCT00699413|448570741|FG001|Overall Study|Withdrawal by Subject|2|||
124712144|NCT00699413|448570740|FG000|Overall Study|Study terminated by sponsor|4|||
124712145|NCT00699413|448570741|FG001|Overall Study|Study terminated by sponsor|2|||
124712146|NCT00881894|448570742|FG000|Overall Study|Consent withdrawn|0|||
124551430|NCT03985293|447974756|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
124551431|NCT03985293|447974757|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
124769834|NCT01535040|448785215|FG000|Overall Study|Never Started|9|||
124769835|NCT01535040|448785216|FG001|Overall Study|Never Started|4|||
124769836|NCT01535040|448785215|FG000|Overall Study|Toxicity|7|||
124769837|NCT01535040|448785216|FG001|Overall Study|Toxicity|5|||
124769838|NCT01535040|448785215|FG000|Overall Study|Multiple Reasons|1|||
124466725|NCT03742037|447666484|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
124769839|NCT01535040|448785216|FG001|Overall Study|Multiple Reasons|1|||
124769840|NCT05430854|448785217|FG000|Overall Study|Trial terminated by Sponsor|39|||
124970257|NCT01236352|449517585|FG003|Overall Study|Study drug toxicity|0|||
124970258|NCT01236352|449517586|FG004|Overall Study|Study drug toxicity|0|||
124970259|NCT01236352|449517587|FG005|Overall Study|Study drug toxicity|1|||
124970260|NCT01236352|449517588|FG006|Overall Study|Study drug toxicity|1|||
124970261|NCT01236352|449517589|FG007|Overall Study|Study drug toxicity|0|||
124970262|NCT01236352|449517590|FG008|Overall Study|Study drug toxicity|0|||
124970263|NCT01236352|449517591|FG009|Overall Study|Study drug toxicity|2|||
124970264|NCT01236352|449517592|FG010|Overall Study|Study drug toxicity|2|||
124970265|NCT01236352|449517582|FG000|Overall Study|Disease progression|1|||
124970266|NCT01236352|449517583|FG001|Overall Study|Disease progression|2|||
124970267|NCT01236352|449517584|FG002|Overall Study|Disease progression|1|||
124970268|NCT01236352|449517585|FG003|Overall Study|Disease progression|2|||
124970269|NCT01236352|449517586|FG004|Overall Study|Disease progression|2|||
124970270|NCT01236352|449517587|FG005|Overall Study|Disease progression|2|||
124970271|NCT01236352|449517588|FG006|Overall Study|Disease progression|1|||
124970272|NCT01236352|449517589|FG007|Overall Study|Disease progression|3|||
124970273|NCT01236352|449517590|FG008|Overall Study|Disease progression|2|||
124970274|NCT01236352|449517591|FG009|Overall Study|Disease progression|2|||
124970275|NCT01236352|449517592|FG010|Overall Study|Disease progression|2|||
124970276|NCT01236352|449517582|FG000|Overall Study|Poor/Non-compliance|1|||
124970277|NCT01236352|449517583|FG001|Overall Study|Poor/Non-compliance|0|||
124970278|NCT01236352|449517584|FG002|Overall Study|Poor/Non-compliance|0|||
124970279|NCT01236352|449517585|FG003|Overall Study|Poor/Non-compliance|0|||
124970280|NCT01236352|449517586|FG004|Overall Study|Poor/Non-compliance|0|||
124970281|NCT01236352|449517587|FG005|Overall Study|Poor/Non-compliance|0|||
124970282|NCT01236352|449517588|FG006|Overall Study|Poor/Non-compliance|0|||
124970283|NCT01236352|449517589|FG007|Overall Study|Poor/Non-compliance|0|||
124970284|NCT01236352|449517590|FG008|Overall Study|Poor/Non-compliance|0|||
124970285|NCT01236352|449517591|FG009|Overall Study|Poor/Non-compliance|0|||
124970286|NCT01236352|449517592|FG010|Overall Study|Poor/Non-compliance|0|||
124970287|NCT01236352|449517582|FG000|Overall Study|Maximum clinical benefit|1|||
124970288|NCT01236352|449517583|FG001|Overall Study|Maximum clinical benefit|1|||
124970289|NCT01236352|449517584|FG002|Overall Study|Maximum clinical benefit|1|||
124970290|NCT01236352|449517585|FG003|Overall Study|Maximum clinical benefit|0|||
124970291|NCT01236352|449517586|FG004|Overall Study|Maximum clinical benefit|2|||
124970292|NCT01236352|449517587|FG005|Overall Study|Maximum clinical benefit|0|||
124970293|NCT01236352|449517588|FG006|Overall Study|Maximum clinical benefit|3|||
124970294|NCT01236352|449517589|FG007|Overall Study|Maximum clinical benefit|1|||
124970295|NCT01236352|449517590|FG008|Overall Study|Maximum clinical benefit|1|||
124970296|NCT01236352|449517591|FG009|Overall Study|Maximum clinical benefit|4|||
124970297|NCT01236352|449517592|FG010|Overall Study|Maximum clinical benefit|2|||
124970298|NCT01236352|449517582|FG000|Overall Study|Subject request to discontinue treatment|0|||
124970299|NCT01236352|449517583|FG001|Overall Study|Subject request to discontinue treatment|0|||
124970300|NCT01236352|449517584|FG002|Overall Study|Subject request to discontinue treatment|1|||
124970301|NCT01236352|449517585|FG003|Overall Study|Subject request to discontinue treatment|1|||
124970302|NCT01236352|449517586|FG004|Overall Study|Subject request to discontinue treatment|0|||
124970303|NCT01236352|449517587|FG005|Overall Study|Subject request to discontinue treatment|1|||
124970304|NCT01236352|449517588|FG006|Overall Study|Subject request to discontinue treatment|0|||
124970305|NCT01236352|449517589|FG007|Overall Study|Subject request to discontinue treatment|0|||
124970306|NCT01236352|449517590|FG008|Overall Study|Subject request to discontinue treatment|0|||
124970307|NCT01236352|449517591|FG009|Overall Study|Subject request to discontinue treatment|1|||
124970308|NCT01236352|449517592|FG010|Overall Study|Subject request to discontinue treatment|4|||
124970309|NCT01236352|449517582|FG000|Overall Study|Subject to receive drug via EAP|1|||
124970310|NCT01236352|449517583|FG001|Overall Study|Subject to receive drug via EAP|1|||
124970311|NCT01236352|449517584|FG002|Overall Study|Subject to receive drug via EAP|1|||
124970312|NCT01236352|449517585|FG003|Overall Study|Subject to receive drug via EAP|0|||
124970313|NCT01236352|449517586|FG004|Overall Study|Subject to receive drug via EAP|0|||
124970314|NCT01236352|449517587|FG005|Overall Study|Subject to receive drug via EAP|0|||
124970315|NCT01236352|449517588|FG006|Overall Study|Subject to receive drug via EAP|0|||
124970316|NCT01236352|449517589|FG007|Overall Study|Subject to receive drug via EAP|2|||
124970317|NCT01236352|449517590|FG008|Overall Study|Subject to receive drug via EAP|0|||
124970318|NCT01236352|449517591|FG009|Overall Study|Subject to receive drug via EAP|4|||
124970319|NCT01236352|449517592|FG010|Overall Study|Subject to receive drug via EAP|0|||
124970320|NCT01236352|449517582|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
124970321|NCT01236352|449517583|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
124970322|NCT01236352|449517584|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
124970323|NCT01236352|449517585|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
124970324|NCT01236352|449517586|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
124970325|NCT01236352|449517587|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
124970326|NCT01236352|449517588|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
124970327|NCT01236352|449517589|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
124970328|NCT01236352|449517590|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
124970329|NCT01236352|449517591|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
124970330|NCT01236352|449517592|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
124970331|NCT01236352|449517582|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124970332|NCT01236352|449517583|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124769841|NCT05430854|448785218|FG001|Overall Study|Trial terminated by Sponsor|50|||
124769842|NCT05430854|448785219|FG002|Overall Study|Trial terminated by Sponsor|46|||
124769843|NCT05430854|448785217|FG000|Overall Study|Withdrawal by Subject|0|||
124970333|NCT01236352|449517584|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124712147|NCT00881894|448570743|FG001|Overall Study|Consent withdrawn|1|||
124712148|NCT00881894|448570742|FG000|Overall Study|Other reasons for premature termination|1|||
124712149|NCT00881894|448570743|FG001|Overall Study|Other reasons for premature termination|2|||
124712150|NCT00421148|448570744|FG000|Overall Study|Lost to Follow-up|0|||
124712151|NCT00421148|448570745|FG001|Overall Study|Lost to Follow-up|0|||
124712152|NCT00421148|448570746|FG002|Overall Study|Lost to Follow-up|0|||
124712153|NCT00421148|448570747|FG003|Overall Study|Lost to Follow-up|0|||
124712154|NCT00421148|448570748|FG004|Overall Study|Lost to Follow-up|0|||
124712155|NCT00421148|448570749|FG005|Overall Study|Lost to Follow-up|0|||
124712156|NCT00421148|448570750|FG006|Overall Study|Lost to Follow-up|0|||
124712157|NCT00421148|448570751|FG007|Overall Study|Lost to Follow-up|0|||
124712158|NCT00421148|448570752|FG008|Overall Study|Lost to Follow-up|0|||
124712159|NCT00421148|448570753|FG009|Overall Study|Lost to Follow-up|0|||
124712160|NCT00421148|448570754|FG010|Overall Study|Lost to Follow-up|0|||
124712161|NCT00421148|448570755|FG011|Overall Study|Lost to Follow-up|0|||
124712162|NCT00421148|448570756|FG012|Overall Study|Lost to Follow-up|0|||
124712163|NCT00421148|448570757|FG013|Overall Study|Lost to Follow-up|0|||
124712164|NCT00421148|448570758|FG014|Overall Study|Lost to Follow-up|0|||
124712165|NCT00421148|448570759|FG015|Overall Study|Lost to Follow-up|0|||
124712166|NCT00421148|448570760|FG016|Overall Study|Lost to Follow-up|0|||
124712167|NCT00421148|448570761|FG017|Overall Study|Lost to Follow-up|1|||
124712168|NCT00421148|448570762|FG018|Overall Study|Lost to Follow-up|0|||
124712169|NCT00421148|448570763|FG019|Overall Study|Lost to Follow-up|0|||
124712170|NCT00421148|448570744|FG000|Overall Study|Withdrawal by Subject|0|||
124712171|NCT00421148|448570745|FG001|Overall Study|Withdrawal by Subject|0|||
124712172|NCT00421148|448570746|FG002|Overall Study|Withdrawal by Subject|0|||
124769844|NCT05430854|448785218|FG001|Overall Study|Withdrawal by Subject|3|||
124769845|NCT05430854|448785219|FG002|Overall Study|Withdrawal by Subject|0|||
124970334|NCT01236352|449517585|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124970335|NCT01236352|449517586|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124970336|NCT01236352|449517587|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124712173|NCT00421148|448570747|FG003|Overall Study|Withdrawal by Subject|0|||
124712174|NCT00421148|448570748|FG004|Overall Study|Withdrawal by Subject|0|||
124712175|NCT00421148|448570749|FG005|Overall Study|Withdrawal by Subject|0|||
124712176|NCT00421148|448570750|FG006|Overall Study|Withdrawal by Subject|0|||
124712177|NCT00421148|448570751|FG007|Overall Study|Withdrawal by Subject|0|||
124712178|NCT00421148|448570752|FG008|Overall Study|Withdrawal by Subject|0|||
124970337|NCT01236352|449517588|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124970338|NCT01236352|449517589|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124970339|NCT01236352|449517590|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124970340|NCT01236352|449517591|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
124970341|NCT01236352|449517592|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
124970342|NCT01236352|449517582|FG000|Overall Study|Lack of response to drug|0|||
124970343|NCT01236352|449517583|FG001|Overall Study|Lack of response to drug|0|||
124970344|NCT01236352|449517584|FG002|Overall Study|Lack of response to drug|0|||
124466726|NCT03742037|447666485|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
124466727|NCT03742037|447666486|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
124466728|NCT03742037|447666487|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
124466729|NCT03742037|447666488|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
124466730|NCT03742037|447666489|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
124466731|NCT03742037|447666490|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
124466732|NCT03742037|447666484|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
124466733|NCT03742037|447666485|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
124466734|NCT03742037|447666486|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
124466735|NCT03742037|447666487|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
124466736|NCT03742037|447666488|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
124466737|NCT03742037|447666489|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
124466738|NCT03742037|447666490|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
124466739|NCT03742037|447666484|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
124466740|NCT03742037|447666485|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
124466741|NCT03742037|447666486|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
124466742|NCT03742037|447666487|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
124466743|NCT03742037|447666488|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
124466744|NCT03742037|447666489|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
124466745|NCT03742037|447666490|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
124466746|NCT03742037|447666484|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
124466747|NCT03742037|447666485|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
124466748|NCT03742037|447666486|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
124466749|NCT03742037|447666487|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
124637175|NCT00954941|448288727|FG001|Overall Study|Adverse Event|1|||
124637176|NCT00812981|448288728|FG000|Overall Study|Other|0|||
124637177|NCT00812981|448288729|FG001|Overall Study|Other|1|||
124637178|NCT02199795|448288730|FG000|Overall Study|no longer met inclusion criteria|1|||
124637179|NCT02199795|448288731|FG001|Overall Study|no longer met inclusion criteria|0|||
124637180|NCT02199795|448288730|FG000|Overall Study|withdrew due to shoulder pain|1|||
124637181|NCT02199795|448288731|FG001|Overall Study|withdrew due to shoulder pain|0|||
124637182|NCT01791894|448288738|FG000|Overall Study|Adverse Event|1|||
124637183|NCT02268916|448288739|FG000|Overall Study|Lost to Follow-up|1|||
124637184|NCT02268916|448288740|FG001|Overall Study|Lost to Follow-up|1|||
124637185|NCT02268916|448288739|FG000|Overall Study|Withdrawal by Subject|6|||
124637186|NCT02268916|448288740|FG001|Overall Study|Withdrawal by Subject|5|||
124637187|NCT02268916|448288739|FG000|Overall Study|Participant did not have diabetes|1|||
124637188|NCT02268916|448288740|FG001|Overall Study|Participant did not have diabetes|0|||
124637189|NCT02268916|448288739|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
124637190|NCT02268916|448288740|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
124637191|NCT02418949|448288741|FG000|Overall Study|Withdrawal by Subject|1|||
124637192|NCT02418949|448288742|FG001|Overall Study|Withdrawal by Subject|0|||
124637193|NCT02418949|448288743|FG002|Overall Study|Withdrawal by Subject|1|||
124637194|NCT02418949|448288744|FG003|Overall Study|Withdrawal by Subject|1|||
124637195|NCT02418949|448288741|FG000|Overall Study|Lost to Follow-up|1|||
124637196|NCT02418949|448288742|FG001|Overall Study|Lost to Follow-up|0|||
124637197|NCT02418949|448288743|FG002|Overall Study|Lost to Follow-up|1|||
124637198|NCT02418949|448288744|FG003|Overall Study|Lost to Follow-up|0|||
124637199|NCT02418949|448288741|FG000|Overall Study|Physician Decision|1|||
124637200|NCT02418949|448288742|FG001|Overall Study|Physician Decision|1|||
124637201|NCT02418949|448288743|FG002|Overall Study|Physician Decision|1|||
124637202|NCT02418949|448288744|FG003|Overall Study|Physician Decision|0|||
124637203|NCT02684097|448288747|FG000|Overall Study|Lack of Efficacy|13|||
124637204|NCT02684097|448288748|FG001|Overall Study|Lack of Efficacy|6|||
124637205|NCT00460811|448288749|FG000|Overall Study|Adverse Event|4|||
124637206|NCT00460811|448288750|FG001|Overall Study|Adverse Event|6|||
124637207|NCT00460811|448288751|FG002|Overall Study|Adverse Event|3|||
124637208|NCT00460811|448288752|FG003|Overall Study|Adverse Event|10|||
124637209|NCT00460811|448288753|FG004|Overall Study|Adverse Event|2|||
124637210|NCT00460811|448288749|FG000|Overall Study|Noncompliance|1|||
124637211|NCT00460811|448288750|FG001|Overall Study|Noncompliance|0|||
124637212|NCT00460811|448288751|FG002|Overall Study|Noncompliance|0|||
124637213|NCT00460811|448288752|FG003|Overall Study|Noncompliance|2|||
124637214|NCT00460811|448288753|FG004|Overall Study|Noncompliance|1|||
124637215|NCT00460811|448288749|FG000|Overall Study|Withdrawal by Subject|7|||
124637216|NCT00460811|448288750|FG001|Overall Study|Withdrawal by Subject|7|||
124637217|NCT00460811|448288751|FG002|Overall Study|Withdrawal by Subject|6|||
124637218|NCT00460811|448288752|FG003|Overall Study|Withdrawal by Subject|3|||
124637219|NCT00460811|448288753|FG004|Overall Study|Withdrawal by Subject|11|||
124637220|NCT00460811|448288749|FG000|Overall Study|Physician Decision|1|||
124637221|NCT00460811|448288750|FG001|Overall Study|Physician Decision|0|||
124637222|NCT00460811|448288751|FG002|Overall Study|Physician Decision|0|||
124637223|NCT00460811|448288752|FG003|Overall Study|Physician Decision|0|||
124637224|NCT00460811|448288753|FG004|Overall Study|Physician Decision|0|||
124637225|NCT00460811|448288749|FG000|Overall Study|Lost to Follow-up|3|||
124637226|NCT00460811|448288750|FG001|Overall Study|Lost to Follow-up|2|||
124637227|NCT00460811|448288751|FG002|Overall Study|Lost to Follow-up|5|||
124637228|NCT00460811|448288752|FG003|Overall Study|Lost to Follow-up|3|||
124637229|NCT00460811|448288753|FG004|Overall Study|Lost to Follow-up|6|||
124637230|NCT02097745|448288754|FG000|Overall Study|Adverse Event|25|||
124637231|NCT02097745|448288754|FG000|Overall Study|Death|16|||
124637232|NCT02097745|448288754|FG000|Overall Study|Failure to Return|14|||
124637233|NCT02097745|448288754|FG000|Overall Study|Administrative/Other|27|||
124637234|NCT02097745|448288754|FG000|Overall Study|Reason Not Specified|96|||
124637235|NCT00425750|448288755|FG000|Overall Study|Death|1|||
124637236|NCT00425750|448288755|FG000|Overall Study|Withdrawal by Subject|3|||
124637237|NCT00425750|448288755|FG000|Overall Study|Adverse Event|3|||
124637238|NCT00425750|448288755|FG000|Overall Study|Progression of disease|18|||
124637239|NCT01757184|448288756|FG000|Double-blind Period|Adverse Event|1|||
124637240|NCT01757184|448288757|FG001|Double-blind Period|Adverse Event|0|||
124637241|NCT01757184|448288758|FG002|Double-blind Period|Adverse Event|0|||
124637242|NCT01757184|448288759|FG003|Double-blind Period|Adverse Event|0|||
124637243|NCT01757184|448288756|FG000|Open-label Period|Lost to Follow-up|0|||
124637244|NCT01757184|448288757|FG001|Open-label Period|Lost to Follow-up|0|||
124637245|NCT01757184|448288758|FG002|Open-label Period|Lost to Follow-up|2|||
124637246|NCT01757184|448288759|FG003|Open-label Period|Lost to Follow-up|0|||
124637247|NCT01757184|448288756|FG000|Open-label Period|Withdrawal by Subject|0|||
124637248|NCT01757184|448288757|FG001|Open-label Period|Withdrawal by Subject|0|||
124637249|NCT01757184|448288758|FG002|Open-label Period|Withdrawal by Subject|1|||
124637250|NCT01757184|448288759|FG003|Open-label Period|Withdrawal by Subject|1|||
124637251|NCT01757184|448288756|FG000|Open-label Period|Discontinued by Sponsor|0|||
124637252|NCT01757184|448288757|FG001|Open-label Period|Discontinued by Sponsor|0|||
124637253|NCT01757184|448288758|FG002|Open-label Period|Discontinued by Sponsor|1|||
124637254|NCT01757184|448288759|FG003|Open-label Period|Discontinued by Sponsor|2|||
124637255|NCT04331067|448288761|FG000|Overall Study|Adverse Event|1|||
124637256|NCT04331067|448288762|FG001|Overall Study|Adverse Event|3|||
124637257|NCT04331067|448288763|FG002|Overall Study|Adverse Event|1|||
124637258|NCT04331067|448288761|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
124637259|NCT04331067|448288762|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
124637260|NCT04331067|448288763|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
124637261|NCT04339062|448288764|FG000|Overall Study|Death|0|||
124637262|NCT04339062|448288765|FG001|Overall Study|Death|1|||
124637263|NCT05870371|448288766|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
124637264|NCT05870371|448288767|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
124637265|NCT02801617|448290455|FG000|Overall Study|Protocol Violation|2|||
124637266|NCT02801617|448290456|FG001|Overall Study|Protocol Violation|6|||
124637267|NCT01372618|448290457|FG000|Overall Study|PI Died. Study Terminated|9|||
124637268|NCT01954056|448290458|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
124637269|NCT01954056|448290459|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
124637270|NCT01081769|448290460|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
124769846|NCT04314284|448785220|FG000|Overall Study|Withdrawal by Subject|4|||
124769847|NCT04314284|448785221|FG001|Overall Study|Withdrawal by Subject|7|||
124769848|NCT04314284|448785220|FG000|Overall Study|Consented but did not complete survey|0|||
124769849|NCT04314284|448785221|FG001|Overall Study|Consented but did not complete survey|6|||
124769850|NCT01652235|448785222|FG000|Overall Study|Death|9|||
124769851|NCT01652235|448785222|FG000|Overall Study|Lost to Follow-up|5|||
124769852|NCT01652235|448785222|FG000|Overall Study|Withdrawal by Subject|2|||
124769853|NCT02023086|448785223|FG000|Overall Study|Withdrawal by Subject|2|||
124769854|NCT02023086|448785224|FG001|Overall Study|Withdrawal by Subject|0|||
124769855|NCT02608684|448786751|FG000|Overall Study|Physician Decision|2|||
124769856|NCT02608684|448786751|FG000|Overall Study|Withdrawal by Subject|1|||
124466750|NCT03742037|447666488|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
124466751|NCT03742037|447666489|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
124466752|NCT03742037|447666490|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
124466753|NCT03742037|447666484|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
124466754|NCT03742037|447666485|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
124466755|NCT03742037|447666486|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
124466756|NCT03742037|447666487|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
124712179|NCT00421148|448570753|FG009|Overall Study|Withdrawal by Subject|0|||
124712180|NCT00421148|448570754|FG010|Overall Study|Withdrawal by Subject|0|||
124712181|NCT00421148|448570755|FG011|Overall Study|Withdrawal by Subject|0|||
124712182|NCT00421148|448570756|FG012|Overall Study|Withdrawal by Subject|0|||
124712183|NCT00421148|448570757|FG013|Overall Study|Withdrawal by Subject|0|||
124712184|NCT00421148|448570758|FG014|Overall Study|Withdrawal by Subject|0|||
124712185|NCT00421148|448570759|FG015|Overall Study|Withdrawal by Subject|0|||
124712186|NCT00421148|448570760|FG016|Overall Study|Withdrawal by Subject|0|||
124712187|NCT00421148|448570761|FG017|Overall Study|Withdrawal by Subject|1|||
124712188|NCT00421148|448570762|FG018|Overall Study|Withdrawal by Subject|0|||
124712189|NCT00421148|448570763|FG019|Overall Study|Withdrawal by Subject|0|||
124712190|NCT00421148|448570744|FG000|Overall Study|Protocol Violation|0|||
124712191|NCT00421148|448570745|FG001|Overall Study|Protocol Violation|0|||
124712192|NCT00421148|448570746|FG002|Overall Study|Protocol Violation|0|||
124712193|NCT00421148|448570747|FG003|Overall Study|Protocol Violation|0|||
124712194|NCT00421148|448570748|FG004|Overall Study|Protocol Violation|0|||
124712195|NCT00421148|448570749|FG005|Overall Study|Protocol Violation|1|||
124712196|NCT00421148|448570750|FG006|Overall Study|Protocol Violation|0|||
124712197|NCT00421148|448570751|FG007|Overall Study|Protocol Violation|0|||
124712198|NCT00421148|448570752|FG008|Overall Study|Protocol Violation|0|||
124712199|NCT00421148|448570753|FG009|Overall Study|Protocol Violation|0|||
124712200|NCT00421148|448570754|FG010|Overall Study|Protocol Violation|0|||
124712201|NCT00421148|448570755|FG011|Overall Study|Protocol Violation|0|||
124712202|NCT00421148|448570756|FG012|Overall Study|Protocol Violation|0|||
124712203|NCT00421148|448570757|FG013|Overall Study|Protocol Violation|0|||
124712204|NCT00421148|448570758|FG014|Overall Study|Protocol Violation|0|||
124712205|NCT00421148|448570759|FG015|Overall Study|Protocol Violation|0|||
124712206|NCT00421148|448570760|FG016|Overall Study|Protocol Violation|0|||
124712207|NCT00421148|448570761|FG017|Overall Study|Protocol Violation|0|||
124712208|NCT00421148|448570762|FG018|Overall Study|Protocol Violation|1|||
124712209|NCT00421148|448570763|FG019|Overall Study|Protocol Violation|0|||
124712210|NCT00469833|448570765|FG000|Overall Study|No IV access|2|||
124712211|NCT01253369|448570766|FG000|Overall Study|Adverse Event|4|||
124712212|NCT01253369|448570766|FG000|Overall Study|Withdrawal by Subject|2|||
124712213|NCT01253369|448570766|FG000|Overall Study|Death|1|||
124712214|NCT01253369|448570766|FG000|Overall Study|Progressive disease|23|||
124712215|NCT01253369|448570766|FG000|Overall Study|Not Evaluable|3|||
124712216|NCT03289533|448570767|FG000|Overall Study|Death|12|||
124712217|NCT03289533|448570767|FG000|Overall Study|Terminated from study by sponsor|10|||
124769857|NCT00755183|448786753|FG000|Overall Study|Adverse Event|5|||
124769858|NCT00755183|448786754|FG001|Overall Study|Adverse Event|2|||
124712218|NCT04016714|448570768|FG000|Overall Study|Death|1|||
124712219|NCT04016714|448570769|FG001|Overall Study|Death|0|||
124712220|NCT04016714|448570768|FG000|Overall Study|Lost to Follow-up|3|||
124712221|NCT04016714|448570769|FG001|Overall Study|Lost to Follow-up|1|||
124712222|NCT04016714|448570768|FG000|Overall Study|Physician Decision|3|||
124712223|NCT04016714|448570769|FG001|Overall Study|Physician Decision|3|||
124712224|NCT04016714|448570768|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
124712225|NCT04016714|448570769|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
124712226|NCT01822665|448570776|FG000|Overall Study|Adverse Event|3|||
124466757|NCT03742037|447666488|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
124466758|NCT03742037|447666489|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
124466759|NCT03742037|447666490|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
124466760|NCT03742037|447666484|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
124466761|NCT03742037|447666485|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
124466762|NCT03742037|447666486|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
124466763|NCT03742037|447666487|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
124466764|NCT03742037|447666488|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
124466765|NCT03742037|447666489|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
124466766|NCT03742037|447666490|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
124466767|NCT03742037|447666484|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
124466768|NCT03742037|447666485|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
124712227|NCT01822665|448570776|FG000|Overall Study|Other Reason|5|||
124712228|NCT00959907|448570778|FG000|Overall Study|Protocol Violation|0|||
124712229|NCT00959907|448570779|FG001|Overall Study|Protocol Violation|1|||
124712230|NCT00959907|448570778|FG000|Overall Study|Adverse Event|1|||
124712231|NCT00959907|448570779|FG001|Overall Study|Adverse Event|0|||
124712232|NCT00959907|448570778|FG000|Overall Study|Withdrawal by Subject|2|||
124712233|NCT00959907|448570779|FG001|Overall Study|Withdrawal by Subject|0|||
124712234|NCT01932788|448570785|FG000|Overall Study|Protocol Violation|18|||
124712235|NCT01932788|448570786|FG001|Overall Study|Protocol Violation|0|||
124712236|NCT01932788|448570785|FG000|Overall Study|Lost to Follow-up|18|||
124712237|NCT01932788|448570786|FG001|Overall Study|Lost to Follow-up|46|||
124712238|NCT01932788|448570785|FG000|Overall Study|Lack of Efficacy|2|||
124712239|NCT01932788|448570786|FG001|Overall Study|Lack of Efficacy|0|||
124712240|NCT01932788|448570785|FG000|Overall Study|Withdrawal by Subject|0|||
124712241|NCT01932788|448570786|FG001|Overall Study|Withdrawal by Subject|5|||
124712242|NCT01171677|448570787|FG000|Overall Study|Withdrawal by Subject|0|||
124712243|NCT01171677|448570788|FG001|Overall Study|Withdrawal by Subject|3|||
124712244|NCT01171677|448570787|FG000|Overall Study|Adverse Event|1|||
124712245|NCT01171677|448570788|FG001|Overall Study|Adverse Event|0|||
124712246|NCT01171677|448570787|FG000|Overall Study|completed <70% IntenSati classes|5|||
124712247|NCT01171677|448570788|FG001|Overall Study|completed <70% IntenSati classes|0|||
124712248|NCT01847443|448570789|FG000|Study Period 1|Withdrawal by Subject|0|||
124712249|NCT01847443|448570790|FG001|Study Period 1|Withdrawal by Subject|1|||
124712250|NCT01847443|448570791|FG002|Study Period 1|Withdrawal by Subject|0|||
124712251|NCT01847443|448570792|FG003|Study Period 1|Withdrawal by Subject|0|||
124712252|NCT01847443|448570789|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
124712253|NCT01847443|448570790|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
124712254|NCT01847443|448570791|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
124712255|NCT01847443|448570792|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
124712256|NCT01847443|448570789|FG000|Washout Period Before Study Period 2|Other reason|1|||
124712257|NCT01847443|448570790|FG001|Washout Period Before Study Period 2|Other reason|0|||
124712258|NCT01847443|448570791|FG002|Washout Period Before Study Period 2|Other reason|0|||
124712259|NCT01847443|448570792|FG003|Washout Period Before Study Period 2|Other reason|0|||
124712260|NCT01847443|448570789|FG000|Washout Period Before Study Period 3|Other reason|1|||
124712261|NCT01847443|448570790|FG001|Washout Period Before Study Period 3|Other reason|0|||
124712262|NCT01847443|448570791|FG002|Washout Period Before Study Period 3|Other reason|0|||
124712263|NCT01847443|448570792|FG003|Washout Period Before Study Period 3|Other reason|0|||
124712264|NCT01847443|448570789|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
124712265|NCT01847443|448570790|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
124712266|NCT01847443|448570791|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
124712267|NCT01847443|448570792|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
124712268|NCT01847443|448570789|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
124712269|NCT01847443|448570790|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
124712270|NCT01847443|448570791|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
124769859|NCT00755183|448786753|FG000|Overall Study|Protocol Violation|0|||
124712271|NCT01847443|448570792|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
124712272|NCT03571971|448570793|FG000|Overall Study|Lost to Follow-up|2|||
124712273|NCT03571971|448570794|FG001|Overall Study|Lost to Follow-up|2|||
124712274|NCT03571971|448570793|FG000|Overall Study|Protocol Violation|2|||
124712275|NCT03571971|448570794|FG001|Overall Study|Protocol Violation|3|||
124712276|NCT03571971|448570793|FG000|Overall Study|Withdrawal by Subject|2|||
124769860|NCT00755183|448786754|FG001|Overall Study|Protocol Violation|1|||
124769861|NCT00755183|448786753|FG000|Overall Study|Withdrawal by Subject|0|||
124769862|NCT00755183|448786754|FG001|Overall Study|Withdrawal by Subject|2|||
124769863|NCT00755183|448786753|FG000|Overall Study|Administrative|2|||
124769864|NCT00755183|448786754|FG001|Overall Study|Administrative|1|||
124769865|NCT00148317|448786755|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
124769866|NCT00148317|448786755|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
124769867|NCT00148317|448786755|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
124769868|NCT00124943|448786756|FG000|Phase II|Adverse Event|0|||
124769869|NCT00124943|448786757|FG001|Phase II|Adverse Event|2|||
124769870|NCT00124943|448786758|FG002|Phase II|Adverse Event|0|||
124769871|NCT00124943|448786759|FG003|Phase II|Adverse Event|1|||
124769872|NCT00124943|448786756|FG000|Phase II|Protocol Violation|0|||
124769873|NCT00124943|448786757|FG001|Phase II|Protocol Violation|0|||
124769874|NCT00124943|448786758|FG002|Phase II|Protocol Violation|0|||
124769875|NCT00124943|448786759|FG003|Phase II|Protocol Violation|1|||
124769876|NCT00124943|448786756|FG000|Phase II|Lost to Follow-up|0|||
124769877|NCT00124943|448786757|FG001|Phase II|Lost to Follow-up|0|||
124970345|NCT01236352|449517585|FG003|Overall Study|Lack of response to drug|0|||
124769878|NCT00124943|448786758|FG002|Phase II|Lost to Follow-up|0|||
124769879|NCT00124943|448786759|FG003|Phase II|Lost to Follow-up|1|||
124769880|NCT00124943|448786756|FG000|Phase II|Withdrawal by Subject|0|||
124769881|NCT00124943|448786757|FG001|Phase II|Withdrawal by Subject|0|||
124769882|NCT00124943|448786758|FG002|Phase II|Withdrawal by Subject|0|||
124769883|NCT00124943|448786759|FG003|Phase II|Withdrawal by Subject|2|||
124970346|NCT01236352|449517586|FG004|Overall Study|Lack of response to drug|0|||
124970347|NCT01236352|449517587|FG005|Overall Study|Lack of response to drug|0|||
124970348|NCT01236352|449517588|FG006|Overall Study|Lack of response to drug|0|||
124970349|NCT01236352|449517589|FG007|Overall Study|Lack of response to drug|0|||
124970350|NCT01236352|449517590|FG008|Overall Study|Lack of response to drug|0|||
124970351|NCT01236352|449517591|FG009|Overall Study|Lack of response to drug|1|||
124970352|NCT01236352|449517592|FG010|Overall Study|Lack of response to drug|1|||
124970353|NCT01236352|449517582|FG000|Overall Study|Patient transferred to IST|0|||
124970354|NCT01236352|449517583|FG001|Overall Study|Patient transferred to IST|0|||
124970355|NCT01236352|449517584|FG002|Overall Study|Patient transferred to IST|0|||
124970356|NCT01236352|449517585|FG003|Overall Study|Patient transferred to IST|0|||
124970357|NCT01236352|449517586|FG004|Overall Study|Patient transferred to IST|0|||
124970358|NCT01236352|449517587|FG005|Overall Study|Patient transferred to IST|0|||
124970359|NCT01236352|449517588|FG006|Overall Study|Patient transferred to IST|0|||
124970360|NCT01236352|449517589|FG007|Overall Study|Patient transferred to IST|0|||
124970361|NCT01236352|449517590|FG008|Overall Study|Patient transferred to IST|0|||
124970362|NCT01236352|449517591|FG009|Overall Study|Patient transferred to IST|2|||
124970363|NCT01236352|449517592|FG010|Overall Study|Patient transferred to IST|6|||
124970364|NCT04913948|449517599|FG000|Overall Study|Withdrawal by Subject|2|||
124970365|NCT04913948|449517599|FG000|Overall Study|Sample processing issues|1|||
124970366|NCT04913948|449517599|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
124970367|NCT01068210|449517602|FG000|Overall Study|Lost to Follow-up|1|||
124970368|NCT01068210|449517603|FG001|Overall Study|Lost to Follow-up|2|||
124970369|NCT01068210|449517604|FG002|Overall Study|Lost to Follow-up|2|||
124970370|NCT01068210|449517605|FG003|Overall Study|Lost to Follow-up|1|||
124970371|NCT01068210|449517602|FG000|Overall Study|Second cancer|0|||
124970372|NCT01068210|449517603|FG001|Overall Study|Second cancer|1|||
124970373|NCT01068210|449517604|FG002|Overall Study|Second cancer|0|||
124970374|NCT01068210|449517605|FG003|Overall Study|Second cancer|0|||
124970375|NCT01068210|449517602|FG000|Overall Study|Disease progression|0|||
124970376|NCT01068210|449517603|FG001|Overall Study|Disease progression|0|||
124970377|NCT01068210|449517604|FG002|Overall Study|Disease progression|0|||
124970378|NCT01068210|449517605|FG003|Overall Study|Disease progression|2|||
124970379|NCT05990387|449517606|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
124970380|NCT05990387|449517607|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
124970381|NCT04750577|449517608|FG000|Overall Study|Adverse Event|2|||
124970382|NCT04750577|449517609|FG001|Overall Study|Adverse Event|10|||
124970383|NCT04750577|449517610|FG002|Overall Study|Adverse Event|8|||
124970384|NCT04750577|449517611|FG003|Overall Study|Adverse Event|1|||
124970385|NCT04750577|449517608|FG000|Overall Study|Change of residence|0|||
124970386|NCT04750577|449517609|FG001|Overall Study|Change of residence|0|||
124970387|NCT04750577|449517610|FG002|Overall Study|Change of residence|1|||
124769884|NCT02939287|448786761|FG000|Overall Study|met exclusion criteria|1|||
124769885|NCT02939287|448786762|FG001|Overall Study|met exclusion criteria|1|||
124769886|NCT02939287|448786763|FG002|Overall Study|met exclusion criteria|1|||
124769887|NCT02939287|448786761|FG000|Overall Study|Did not complete survey|2|||
124769888|NCT02939287|448786762|FG001|Overall Study|Did not complete survey|2|||
124769889|NCT02939287|448786763|FG002|Overall Study|Did not complete survey|0|||
124769890|NCT02939287|448786761|FG000|Overall Study|Withdrawal by Subject|1|||
124769891|NCT02939287|448786762|FG001|Overall Study|Withdrawal by Subject|1|||
124970388|NCT04750577|449517611|FG003|Overall Study|Change of residence|0|||
124970389|NCT04750577|449517608|FG000|Overall Study|Burden of study procedures|0|||
124970390|NCT04750577|449517609|FG001|Overall Study|Burden of study procedures|2|||
124769892|NCT02939287|448786763|FG002|Overall Study|Withdrawal by Subject|0|||
124769893|NCT02903771|448786764|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
124970391|NCT04750577|449517610|FG002|Overall Study|Burden of study procedures|2|||
124970392|NCT04750577|449517611|FG003|Overall Study|Burden of study procedures|0|||
124970393|NCT04750577|449517608|FG000|Overall Study|Prematurely discontinued|0|||
124970394|NCT04750577|449517609|FG001|Overall Study|Prematurely discontinued|0|||
124970395|NCT04750577|449517610|FG002|Overall Study|Prematurely discontinued|0|||
124970396|NCT04750577|449517611|FG003|Overall Study|Prematurely discontinued|2|||
124970397|NCT04750577|449517608|FG000|Overall Study|Protocol deviation|1|||
124970398|NCT04750577|449517609|FG001|Overall Study|Protocol deviation|1|||
124970399|NCT04750577|449517610|FG002|Overall Study|Protocol deviation|1|||
124970400|NCT04750577|449517611|FG003|Overall Study|Protocol deviation|1|||
124970401|NCT04750577|449517608|FG000|Overall Study|Other than listed|3|||
124970402|NCT04750577|449517609|FG001|Overall Study|Other than listed|2|||
124970403|NCT04750577|449517610|FG002|Overall Study|Other than listed|2|||
124970404|NCT04750577|449517611|FG003|Overall Study|Other than listed|1|||
124970405|NCT04750577|449517608|FG000|Overall Study|Not treated|0|||
124970406|NCT04750577|449517609|FG001|Overall Study|Not treated|0|||
124970407|NCT04750577|449517610|FG002|Overall Study|Not treated|0|||
124970408|NCT04750577|449517611|FG003|Overall Study|Not treated|2|||
124970409|NCT03371823|449517614|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
124970410|NCT03371823|449517615|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
124970411|NCT01263054|449517617|FG000|Overall Study|Death|1|||
124970412|NCT01263054|449517618|FG001|Overall Study|Death|0|||
124970413|NCT01263054|449517617|FG000|Overall Study|Lost to Follow-up|2|||
124970414|NCT01263054|449517618|FG001|Overall Study|Lost to Follow-up|2|||
124970415|NCT01263054|449517617|FG000|Overall Study|Withdrawal by Subject|1|||
124970416|NCT01263054|449517618|FG001|Overall Study|Withdrawal by Subject|3|||
124970417|NCT01263054|449517617|FG000|Overall Study|Qualification Violation|1|||
124970418|NCT01263054|449517618|FG001|Overall Study|Qualification Violation|0|||
124970419|NCT01263054|449517617|FG000|Overall Study|Other|0|||
124970420|NCT01263054|449517618|FG001|Overall Study|Other|1|||
124970421|NCT02035696|449519267|FG000|Overall Study|Lost to Follow-up|0|||
124970422|NCT02035696|449519268|FG001|Overall Study|Lost to Follow-up|3|||
124970423|NCT02035696|449519269|FG002|Overall Study|Lost to Follow-up|1|||
124970424|NCT02035696|449519270|FG003|Overall Study|Lost to Follow-up|2|||
124970425|NCT02035696|449519267|FG000|Overall Study|Withdrawal by Subject|3|||
124970426|NCT02035696|449519268|FG001|Overall Study|Withdrawal by Subject|0|||
124970427|NCT02035696|449519269|FG002|Overall Study|Withdrawal by Subject|2|||
124970428|NCT02035696|449519270|FG003|Overall Study|Withdrawal by Subject|1|||
124970429|NCT00966264|449519271|FG000|Overall Study|Lost to Follow-up|4|||
124970430|NCT00966264|449519272|FG001|Overall Study|Lost to Follow-up|3|||
124970431|NCT01246999|449519273|FG000|Overall Study|Lost to Follow-up|0|||
124970432|NCT01246999|449519274|FG001|Overall Study|Lost to Follow-up|1|||
124970433|NCT01246999|449519275|FG002|Overall Study|Lost to Follow-up|0|||
124970434|NCT01246999|449519276|FG003|Overall Study|Lost to Follow-up|0|||
124970435|NCT01246999|449519273|FG000|Overall Study|Withdrawal by Subject|0|||
124970436|NCT01246999|449519274|FG001|Overall Study|Withdrawal by Subject|0|||
124970437|NCT01246999|449519275|FG002|Overall Study|Withdrawal by Subject|0|||
124970438|NCT01246999|449519276|FG003|Overall Study|Withdrawal by Subject|2|||
124970439|NCT01867047|449519277|FG000|Overall Study|Lost to Follow-up|3|||
124970440|NCT01867047|449519278|FG001|Overall Study|Lost to Follow-up|3|||
124970441|NCT01867047|449519277|FG000|Overall Study|Withdrawal by Subject|2|||
124970442|NCT01867047|449519278|FG001|Overall Study|Withdrawal by Subject|0|||
124970443|NCT01867047|449519277|FG000|Overall Study|Physician Decision|2|||
124970444|NCT01867047|449519278|FG001|Overall Study|Physician Decision|0|||
124970445|NCT01867047|449519277|FG000|Overall Study|surgery not indicated in protocol|1|||
124970446|NCT01867047|449519278|FG001|Overall Study|surgery not indicated in protocol|2|||
124970447|NCT01536587|449519281|FG000|Overall Study|Adverse Event|2|||
124970448|NCT02354651|449519282|FG000|Overall Study|Withdrawal by Subject|2|||
124970449|NCT02354651|449519282|FG000|Overall Study|Physician Decision|1|||
124970450|NCT01245140|449519289|FG000|Overall Study|Adverse Event|1|||
124970451|NCT01245140|449519290|FG001|Overall Study|Adverse Event|3|||
124970452|NCT01245140|449519289|FG000|Overall Study|Lack of Efficacy|2|||
124970453|NCT01245140|449519290|FG001|Overall Study|Lack of Efficacy|4|||
124970454|NCT01245140|449519289|FG000|Overall Study|Protocol Violation|0|||
124769894|NCT02903771|448786765|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
124970455|NCT01245140|449519290|FG001|Overall Study|Protocol Violation|1|||
124466769|NCT03742037|447666486|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
124769895|NCT02903771|448786766|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
124769896|NCT02903771|448786767|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
124769897|NCT02903771|448786768|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
124769898|NCT02903771|448786769|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
124769899|NCT02903771|448786770|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
124769900|NCT02903771|448786764|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
124769901|NCT02903771|448786765|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
124769902|NCT02903771|448786766|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
124769903|NCT02903771|448786767|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
124769904|NCT02903771|448786768|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
124769905|NCT02903771|448786769|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
124769906|NCT02903771|448786770|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
124769907|NCT02903771|448786764|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
124970456|NCT01245140|449519289|FG000|Overall Study|Withdrawal by Subject|0|||
124970457|NCT01245140|449519290|FG001|Overall Study|Withdrawal by Subject|1|||
124970458|NCT01245140|449519289|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
124970459|NCT01245140|449519290|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
124970460|NCT04836559|449519291|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
124970461|NCT04836559|449519292|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
124970462|NCT04836559|449519293|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
124970463|NCT04836559|449519294|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
124970464|NCT04836559|449519295|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
124970465|NCT04836559|449519296|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
124970466|NCT04836559|449519297|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
124970467|NCT04836559|449519298|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
124970468|NCT04836559|449519291|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
124970469|NCT04836559|449519292|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
124970470|NCT04836559|449519293|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
124970471|NCT04836559|449519294|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
124970472|NCT04836559|449519295|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
124970473|NCT04836559|449519296|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
124970474|NCT04836559|449519297|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
124466770|NCT03742037|447666487|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
124466771|NCT03742037|447666488|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
124466772|NCT03742037|447666489|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
124466773|NCT03742037|447666490|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
124769908|NCT02903771|448786765|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
124466774|NCT03742037|447666484|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
124466775|NCT03742037|447666485|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
124466776|NCT03742037|447666486|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
124466777|NCT03742037|447666487|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
124466778|NCT03742037|447666488|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
124466779|NCT03742037|447666489|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
124466780|NCT03742037|447666490|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
124466781|NCT03742037|447666484|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
124466782|NCT03742037|447666485|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
124466783|NCT03742037|447666486|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
124466784|NCT03742037|447666487|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
124466785|NCT03742037|447666488|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
124466786|NCT03742037|447666489|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
124466787|NCT03742037|447666490|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
124466788|NCT03742037|447666484|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
124466789|NCT03742037|447666485|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
124769909|NCT02903771|448786766|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
124466790|NCT03742037|447666486|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
124466791|NCT03742037|447666487|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
124712277|NCT03571971|448570794|FG001|Overall Study|Withdrawal by Subject|0|||
124712278|NCT03571971|448570793|FG000|Overall Study|Incomplete primary outcome data|2|||
124712279|NCT03571971|448570794|FG001|Overall Study|Incomplete primary outcome data|0|||
124712280|NCT02806414|448570801|FG000|Overall Study|Lost to Follow-up|2|||
124712281|NCT04046939|448570807|FG000|Primary Assessment Period|Adverse Event|1|||
124712282|NCT04046939|448570808|FG001|Primary Assessment Period|Adverse Event|0|||
124712283|NCT04046939|448570809|FG002|Primary Assessment Period|Adverse Event|0|||
124712284|NCT04046939|448570810|FG003|Primary Assessment Period|Adverse Event|0|||
124712285|NCT04046939|448570807|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
124712286|NCT04046939|448570808|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
124712287|NCT04046939|448570809|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
124712288|NCT04046939|448570810|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
124712289|NCT04046939|448570807|FG000|Primary Assessment Period|Physician Decision|0|||
124712290|NCT04046939|448570808|FG001|Primary Assessment Period|Physician Decision|0|||
124712291|NCT04046939|448570809|FG002|Primary Assessment Period|Physician Decision|1|||
124712292|NCT04046939|448570810|FG003|Primary Assessment Period|Physician Decision|0|||
124712293|NCT04046939|448570807|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
124712294|NCT04046939|448570808|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
124712295|NCT04046939|448570809|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
124712296|NCT04046939|448570810|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
124712297|NCT00403130|448570811|FG000|2 Years From Start of Treatment|Not Eligible|3|||
124712298|NCT00403130|448570811|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
124712299|NCT00403130|448570811|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
124712300|NCT00403130|448570811|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
124712301|NCT03559270|448570812|FG000|Overall Study|Adverse Event|6|||
124712302|NCT03559270|448570813|FG001|Overall Study|Adverse Event|5|||
124712303|NCT03559270|448570814|FG002|Overall Study|Adverse Event|3|||
124712304|NCT03559270|448570815|FG003|Overall Study|Adverse Event|0|||
124712305|NCT03559270|448570812|FG000|Overall Study|Lack of Efficacy|34|||
124712306|NCT03559270|448570813|FG001|Overall Study|Lack of Efficacy|52|||
124712307|NCT03559270|448570814|FG002|Overall Study|Lack of Efficacy|37|||
124712308|NCT03559270|448570815|FG003|Overall Study|Lack of Efficacy|2|||
124712309|NCT03559270|448570812|FG000|Overall Study|Death|0|||
124712310|NCT03559270|448570813|FG001|Overall Study|Death|2|||
124712311|NCT03559270|448570814|FG002|Overall Study|Death|0|||
124712312|NCT03559270|448570815|FG003|Overall Study|Death|0|||
124712313|NCT03559270|448570812|FG000|Overall Study|Lost to Follow-up|16|||
124712314|NCT03559270|448570813|FG001|Overall Study|Lost to Follow-up|4|||
124712315|NCT03559270|448570814|FG002|Overall Study|Lost to Follow-up|12|||
124712316|NCT03559270|448570815|FG003|Overall Study|Lost to Follow-up|3|||
124712317|NCT03559270|448570812|FG000|Overall Study|Sponsor Decision|38|||
124712318|NCT03559270|448570813|FG001|Overall Study|Sponsor Decision|31|||
124712319|NCT03559270|448570814|FG002|Overall Study|Sponsor Decision|35|||
124712320|NCT03559270|448570815|FG003|Overall Study|Sponsor Decision|18|||
124712321|NCT03559270|448570812|FG000|Overall Study|Withdrawal by Subject|19|||
124712322|NCT03559270|448570813|FG001|Overall Study|Withdrawal by Subject|21|||
124712323|NCT03559270|448570814|FG002|Overall Study|Withdrawal by Subject|18|||
124712324|NCT03559270|448570815|FG003|Overall Study|Withdrawal by Subject|7|||
124712325|NCT03559270|448570812|FG000|Overall Study|Physician Decision|3|||
124712326|NCT03559270|448570813|FG001|Overall Study|Physician Decision|2|||
124712327|NCT03559270|448570814|FG002|Overall Study|Physician Decision|1|||
124712328|NCT03559270|448570815|FG003|Overall Study|Physician Decision|0|||
124712329|NCT03559270|448570812|FG000|Overall Study|Pregnancy|0|||
124712330|NCT03559270|448570813|FG001|Overall Study|Pregnancy|1|||
124712331|NCT03559270|448570814|FG002|Overall Study|Pregnancy|0|||
124712332|NCT03559270|448570815|FG003|Overall Study|Pregnancy|0|||
124970475|NCT04836559|449519298|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
124970476|NCT04836559|449519291|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
124970477|NCT04836559|449519292|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
124970478|NCT04836559|449519293|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
124970479|NCT04836559|449519294|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
124712333|NCT03559270|448570812|FG000|Overall Study|Protocol Violation|1|||
124712334|NCT03559270|448570813|FG001|Overall Study|Protocol Violation|0|||
124712335|NCT03559270|448570814|FG002|Overall Study|Protocol Violation|2|||
124712336|NCT03559270|448570815|FG003|Overall Study|Protocol Violation|0|||
124712337|NCT02735421|448572333|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
124712338|NCT02735421|448572333|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
124712339|NCT02735421|448572333|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
124712340|NCT02735421|448572333|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
124712341|NCT02735421|448572333|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
124712342|NCT02735421|448572333|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
124712343|NCT02735421|448572333|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
124712344|NCT00939107|448572334|FG000|Overall Study|Lost to Follow-up|14|||
124712345|NCT00939107|448572335|FG001|Overall Study|Lost to Follow-up|12|||
124712346|NCT05010070|448572336|FG000|Overall Study|Lost to Follow-up|1|||
124712347|NCT05010070|448572336|FG000|Overall Study|Withdrawal by Subject|1|||
124712348|NCT03247829|448572342|FG000|Overall Study|Death|3|||
124712349|NCT03247829|448572343|FG001|Overall Study|Death|4|||
124712350|NCT03247829|448572342|FG000|Overall Study|Enter Hospice Care|1|||
124712351|NCT03247829|448572343|FG001|Overall Study|Enter Hospice Care|0|||
124970480|NCT04836559|449519295|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
124970481|NCT04836559|449519296|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
124970482|NCT04836559|449519297|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
124970483|NCT04836559|449519298|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
124970484|NCT04836559|449519291|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
124970485|NCT04836559|449519292|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
124970486|NCT04836559|449519293|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
124970487|NCT04836559|449519294|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
124970488|NCT04836559|449519295|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
124970489|NCT04836559|449519296|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
124970490|NCT04836559|449519297|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
124970491|NCT04836559|449519298|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
124970492|NCT04836559|449519291|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
124970493|NCT04836559|449519292|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
124970494|NCT04836559|449519293|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
124970495|NCT04836559|449519294|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
124970496|NCT04836559|449519295|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
124970497|NCT04836559|449519296|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
124970498|NCT04836559|449519297|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
124970499|NCT04836559|449519298|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
124970500|NCT04836559|449519291|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
124970501|NCT04836559|449519292|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
124970502|NCT04836559|449519293|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
124970503|NCT04836559|449519294|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
124970504|NCT04836559|449519295|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
124970505|NCT04836559|449519296|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
124970506|NCT04836559|449519297|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
124970507|NCT04836559|449519298|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
124970508|NCT04836559|449519291|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
124970509|NCT04836559|449519292|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
124970510|NCT04836559|449519293|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
124970511|NCT04836559|449519294|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
124970512|NCT04836559|449519295|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
124712352|NCT03247829|448572342|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
124712353|NCT03247829|448572343|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
124712354|NCT03247829|448572342|FG000|Overall Study|LVAD Explant|1|||
124712355|NCT03247829|448572343|FG001|Overall Study|LVAD Explant|1|||
124712356|NCT03247829|448572342|FG000|Overall Study|Transplant|1|||
124712357|NCT03247829|448572343|FG001|Overall Study|Transplant|1|||
124970513|NCT04836559|449519296|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
124712358|NCT01783444|448572344|FG000|Treatment Phase|Adverse Event|9|||
124712359|NCT01783444|448572345|FG001|Treatment Phase|Adverse Event|20|||
124769910|NCT02903771|448786767|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
124769911|NCT02903771|448786768|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
124769912|NCT02903771|448786769|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
124769913|NCT02903771|448786770|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
124769914|NCT02903771|448786764|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
124769915|NCT02903771|448786765|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
124769916|NCT02903771|448786766|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
124466792|NCT03742037|447666488|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
124712360|NCT01783444|448572346|FG002|Treatment Phase|Adverse Event|19|||
124712361|NCT01783444|448572344|FG000|Treatment Phase|Disease Progression|76|||
124712362|NCT01783444|448572345|FG001|Treatment Phase|Disease Progression|66|||
124712363|NCT01783444|448572346|FG002|Treatment Phase|Disease Progression|64|||
124712364|NCT01783444|448572344|FG000|Treatment Phase|Death|2|||
124712365|NCT01783444|448572345|FG001|Treatment Phase|Death|2|||
124712366|NCT01783444|448572346|FG002|Treatment Phase|Death|2|||
124712367|NCT01783444|448572344|FG000|Treatment Phase|Protocol Violation|1|||
124712368|NCT01783444|448572345|FG001|Treatment Phase|Protocol Violation|1|||
124712369|NCT01783444|448572346|FG002|Treatment Phase|Protocol Violation|2|||
124712370|NCT01783444|448572344|FG000|Treatment Phase|Withdrawal by Subject|6|||
124712371|NCT01783444|448572345|FG001|Treatment Phase|Withdrawal by Subject|8|||
124712372|NCT01783444|448572346|FG002|Treatment Phase|Withdrawal by Subject|9|||
124712373|NCT01783444|448572344|FG000|Treatment Phase|Administrative problems|2|||
124712374|NCT01783444|448572345|FG001|Treatment Phase|Administrative problems|0|||
124712375|NCT01783444|448572346|FG002|Treatment Phase|Administrative problems|1|||
124712376|NCT01783444|448572344|FG000|Treatment Phase|Physician Decision|8|||
124712377|NCT01783444|448572345|FG001|Treatment Phase|Physician Decision|6|||
124712378|NCT01783444|448572346|FG002|Treatment Phase|Physician Decision|5|||
124712379|NCT01783444|448572344|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
124712380|NCT01783444|448572345|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
124712381|NCT01783444|448572346|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
124712382|NCT01783444|448572344|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
124712383|NCT01783444|448572345|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
124712384|NCT01783444|448572346|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
124712385|NCT01783444|448572344|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
124712386|NCT01783444|448572345|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
124712387|NCT01783444|448572346|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
124712388|NCT01783444|448572344|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
124712389|NCT01783444|448572345|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
124712390|NCT01783444|448572346|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
124712391|NCT01783444|448572344|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
124712392|NCT01783444|448572345|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
124712393|NCT01783444|448572346|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
124712394|NCT01783444|448572344|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
124712395|NCT01783444|448572345|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
124712396|NCT01783444|448572346|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
124712397|NCT00441272|448572355|FG000|Overall Study|Study terminated prior to enrollment|25|||
124712398|NCT00441272|448572356|FG001|Overall Study|Study terminated prior to enrollment|25|||
124712399|NCT01856322|448572357|FG000|Overall Study|off study due to lack of accrual|0|||
124712400|NCT01856322|448572358|FG001|Overall Study|off study due to lack of accrual|0|||
124712401|NCT01856322|448572359|FG002|Overall Study|off study due to lack of accrual|3|||
124712402|NCT00427011|448572360|FG000|Overall Study|Adverse Event|10|||
124712403|NCT00427011|448572360|FG000|Overall Study|Withdrawal by Subject|1|||
124712404|NCT00427011|448572360|FG000|Overall Study|Lack of Efficacy|2|||
124712405|NCT00427011|448572360|FG000|Overall Study|Other|12|||
124712406|NCT01047007|448572361|FG000|Overall Study|Adverse Event|0|||
124712407|NCT01047007|448572362|FG001|Overall Study|Adverse Event|2|||
124712408|NCT01047007|448572363|FG002|Overall Study|Adverse Event|1|||
124712409|NCT01047007|448572364|FG003|Overall Study|Adverse Event|0|||
124712410|NCT01047007|448572361|FG000|Overall Study|Progressive Disease|2|||
124712411|NCT01047007|448572362|FG001|Overall Study|Progressive Disease|4|||
124712412|NCT01047007|448572363|FG002|Overall Study|Progressive Disease|1|||
124712413|NCT01047007|448572364|FG003|Overall Study|Progressive Disease|0|||
124712414|NCT04776161|448572365|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
124712415|NCT04776161|448572366|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
124712416|NCT04776161|448572367|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
124712417|NCT04776161|448572365|FG000|Overall Study|Withdrawal by Subject|1|||
124712418|NCT04776161|448572366|FG001|Overall Study|Withdrawal by Subject|0|||
124712419|NCT04776161|448572367|FG002|Overall Study|Withdrawal by Subject|1|||
124712420|NCT04776161|448572365|FG000|Overall Study|Adverse Event|0|||
124466793|NCT03742037|447666489|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
124769917|NCT02903771|448786767|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
124769918|NCT02903771|448786768|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
124769919|NCT02903771|448786769|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
124769920|NCT02903771|448786770|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
124769921|NCT02903771|448786764|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
124769922|NCT02903771|448786765|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
124769923|NCT02903771|448786766|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
124769924|NCT02903771|448786767|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
124769925|NCT02903771|448786768|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
124769926|NCT02903771|448786769|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
124769927|NCT02903771|448786770|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
124769928|NCT02903771|448786764|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
124769929|NCT02903771|448786765|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
124769930|NCT02903771|448786766|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
124769931|NCT02903771|448786767|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
124769932|NCT02903771|448786768|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
124769933|NCT02903771|448786769|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
124769934|NCT02903771|448786770|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
124769935|NCT02903771|448786764|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
124769936|NCT02903771|448786765|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
124769937|NCT02903771|448786766|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
124769938|NCT02903771|448786767|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
124769939|NCT02903771|448786768|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
124769940|NCT02903771|448786769|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
124769941|NCT02903771|448786770|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
124769942|NCT02903771|448786764|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
124769943|NCT02903771|448786765|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
124769944|NCT02903771|448786766|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
124769945|NCT02903771|448786767|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
124769946|NCT02903771|448786768|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
124769947|NCT02903771|448786769|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
124769948|NCT02903771|448786770|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
124769949|NCT02903771|448786764|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
124769950|NCT02903771|448786765|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
124769951|NCT02903771|448786766|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
124769952|NCT02903771|448786767|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
124769953|NCT02903771|448786768|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
124769954|NCT02903771|448786769|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
124769955|NCT02903771|448786770|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
124769956|NCT02903771|448786764|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
124769957|NCT02903771|448786765|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
124769958|NCT02903771|448786766|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
124769959|NCT02903771|448786767|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
124769960|NCT02903771|448786768|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
124769961|NCT02903771|448786769|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
124466794|NCT03742037|447666490|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
124712421|NCT04776161|448572366|FG001|Overall Study|Adverse Event|1|||
124712422|NCT04776161|448572367|FG002|Overall Study|Adverse Event|1|||
124712423|NCT01334554|448572368|FG000|Overall Study|Adverse Event|4|||
124712424|NCT01334554|448572369|FG001|Overall Study|Adverse Event|2|||
124712425|NCT02393859|448572371|FG000|Overall Study|Decision by Sponsor|2|||
124712426|NCT02393859|448572372|FG001|Overall Study|Decision by Sponsor|4|||
124712427|NCT02393859|448572371|FG000|Overall Study|Withdrawal by Subject|11|||
124712428|NCT02393859|448572372|FG001|Overall Study|Withdrawal by Subject|6|||
124712429|NCT02393859|448572371|FG000|Overall Study|Death|27|||
124712430|NCT02393859|448572372|FG001|Overall Study|Death|10|||
124712431|NCT02393859|448572371|FG000|Overall Study|Lost to Follow-up|1|||
124712432|NCT02393859|448572372|FG001|Overall Study|Lost to Follow-up|1|||
124712433|NCT00954447|448572373|FG000|Overall Study|Adverse Event|33|||
124712434|NCT00954447|448572374|FG001|Overall Study|Adverse Event|25|||
124712435|NCT00954447|448572373|FG000|Overall Study|Lack of Efficacy|17|||
124712436|NCT00954447|448572374|FG001|Overall Study|Lack of Efficacy|3|||
124769962|NCT02903771|448786770|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
124769963|NCT02903771|448786764|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
124769964|NCT02903771|448786765|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
124769965|NCT02903771|448786766|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
124712437|NCT00954447|448572373|FG000|Overall Study|Protocol Violation|5|||
124712438|NCT00954447|448572374|FG001|Overall Study|Protocol Violation|7|||
124712439|NCT00954447|448572373|FG000|Overall Study|Lost to Follow-up|8|||
124769966|NCT02903771|448786767|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
124769967|NCT02903771|448786768|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
124769968|NCT02903771|448786769|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
124769969|NCT02903771|448786770|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
124769970|NCT01435382|448786778|FG000|Overall Study|Lost to Follow-up|1|||
124769971|NCT01435382|448786779|FG001|Overall Study|Lost to Follow-up|0|||
124769972|NCT01435382|448786780|FG002|Overall Study|Lost to Follow-up|1|||
124769973|NCT01435382|448786781|FG003|Overall Study|Lost to Follow-up|0|||
124769974|NCT01435382|448786778|FG000|Overall Study|Withdrawal by Subject|0|||
124769975|NCT01435382|448786779|FG001|Overall Study|Withdrawal by Subject|2|||
124769976|NCT01435382|448786780|FG002|Overall Study|Withdrawal by Subject|0|||
124769977|NCT01435382|448786781|FG003|Overall Study|Withdrawal by Subject|1|||
124769978|NCT00910650|448786782|FG000|Overall Study|Death|2|||
124769979|NCT03367793|448786783|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
124769980|NCT03367793|448786784|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
124769981|NCT03367793|448786785|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
124769982|NCT03367793|448786786|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
124769983|NCT03367793|448786787|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
124769984|NCT03367793|448786788|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
124769985|NCT02435992|448786789|FG000|Overall Study|non compliance with protocol|2|||
124769986|NCT02435992|448786790|FG001|Overall Study|non compliance with protocol|0|||
124769987|NCT02435992|448786791|FG002|Overall Study|non compliance with protocol|1|||
124769988|NCT02435992|448786792|FG003|Overall Study|non compliance with protocol|0|||
124769989|NCT02435992|448786793|FG004|Overall Study|non compliance with protocol|0|||
124769990|NCT02435992|448786789|FG000|Overall Study|Adverse Event|11|||
124769991|NCT02435992|448786790|FG001|Overall Study|Adverse Event|6|||
124769992|NCT02435992|448786791|FG002|Overall Study|Adverse Event|12|||
124769993|NCT02435992|448786792|FG003|Overall Study|Adverse Event|0|||
124769994|NCT02435992|448786793|FG004|Overall Study|Adverse Event|0|||
124769995|NCT02435992|448786789|FG000|Overall Study|Lack of Efficacy|4|||
124769996|NCT02435992|448786790|FG001|Overall Study|Lack of Efficacy|10|||
124769997|NCT02435992|448786791|FG002|Overall Study|Lack of Efficacy|9|||
124769998|NCT02435992|448786792|FG003|Overall Study|Lack of Efficacy|0|||
124769999|NCT02435992|448786793|FG004|Overall Study|Lack of Efficacy|0|||
124770000|NCT02435992|448786789|FG000|Overall Study|Withdrawal by Subject|10|||
124770001|NCT02435992|448786790|FG001|Overall Study|Withdrawal by Subject|8|||
124770002|NCT02435992|448786791|FG002|Overall Study|Withdrawal by Subject|20|||
124770003|NCT02435992|448786792|FG003|Overall Study|Withdrawal by Subject|0|||
124770004|NCT02435992|448786793|FG004|Overall Study|Withdrawal by Subject|0|||
124770005|NCT02435992|448786789|FG000|Overall Study|Other Reason|1|||
124770006|NCT02435992|448786790|FG001|Overall Study|Other Reason|0|||
124770007|NCT02435992|448786791|FG002|Overall Study|Other Reason|0|||
124770008|NCT02435992|448786792|FG003|Overall Study|Other Reason|0|||
124770009|NCT02435992|448786793|FG004|Overall Study|Other Reason|0|||
124770010|NCT02435992|448786789|FG000|Overall Study|Physician Decision|0|||
124770011|NCT02435992|448786790|FG001|Overall Study|Physician Decision|0|||
124770012|NCT02435992|448786791|FG002|Overall Study|Physician Decision|1|||
124770013|NCT02435992|448786792|FG003|Overall Study|Physician Decision|0|||
124770014|NCT02435992|448786793|FG004|Overall Study|Physician Decision|0|||
124770015|NCT00260533|448786794|FG000|Overall Study|Other|3|||
124770016|NCT00260533|448786795|FG001|Overall Study|Other|3|||
124770017|NCT01761877|448786796|FG000|Overall Study|Adverse Event|7|||
124770018|NCT01761877|448786797|FG001|Overall Study|Adverse Event|0|||
124770019|NCT01761877|448786796|FG000|Overall Study|Withdrawal by Subject|6|||
124770020|NCT01761877|448786797|FG001|Overall Study|Withdrawal by Subject|4|||
124770021|NCT01761877|448786796|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
124770022|NCT01761877|448786797|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
124770023|NCT01761877|448786796|FG000|Overall Study|Death|0|||
124770024|NCT01761877|448786797|FG001|Overall Study|Death|1|||
124770025|NCT01761877|448786796|FG000|Overall Study|MRI intolerant|1|||
124770026|NCT01761877|448786797|FG001|Overall Study|MRI intolerant|6|||
124770027|NCT01310777|448786799|FG000|Overall Study|Adverse Event|23|||
124770028|NCT01310777|448786800|FG001|Overall Study|Adverse Event|1|||
124770029|NCT01310777|448786801|FG002|Overall Study|Adverse Event|15|||
124770030|NCT01310777|448786799|FG000|Overall Study|Lost to Follow-up|0|||
124770031|NCT01310777|448786800|FG001|Overall Study|Lost to Follow-up|4|||
124770032|NCT01310777|448786801|FG002|Overall Study|Lost to Follow-up|1|||
124770033|NCT01310777|448786799|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
124770034|NCT01310777|448786800|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
124770035|NCT01310777|448786801|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
124770036|NCT01310777|448786799|FG000|Overall Study|Inadequate Control of IOP|5|||
124770037|NCT01310777|448786800|FG001|Overall Study|Inadequate Control of IOP|7|||
124770038|NCT01310777|448786801|FG002|Overall Study|Inadequate Control of IOP|10|||
124466795|NCT03742037|447666484|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
124466796|NCT03742037|447666485|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
124466797|NCT03742037|447666486|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
124466798|NCT03742037|447666487|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
124466799|NCT03742037|447666488|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
124466800|NCT03742037|447666489|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
124466801|NCT03742037|447666490|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
124466802|NCT03742037|447666484|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
124466803|NCT03742037|447666485|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
124466804|NCT03742037|447666486|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
124466805|NCT03742037|447666487|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
124466806|NCT03742037|447666488|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
124466807|NCT03742037|447666489|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
124466808|NCT03742037|447666490|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
124466809|NCT03742037|447666484|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
124466810|NCT03742037|447666485|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
124466811|NCT03742037|447666486|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
124466812|NCT03742037|447666487|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
124466813|NCT03742037|447666488|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
124466814|NCT03742037|447666489|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
124466815|NCT03742037|447666490|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
124466816|NCT04347239|447666509|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
124466817|NCT04347239|447666510|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
124466818|NCT04347239|447666511|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
124466819|NCT04347239|447666509|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
124466820|NCT04347239|447666510|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
124466821|NCT04347239|447666511|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
124466822|NCT02028455|447666513|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
124466823|NCT02028455|447666514|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
124466824|NCT02028455|447666515|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
124466825|NCT02028455|447666516|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
124466826|NCT02028455|447666517|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
124466827|NCT02028455|447666518|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
124466828|NCT02028455|447666519|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
124466829|NCT02028455|447666520|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
124466830|NCT02028455|447666513|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
124466831|NCT02028455|447666514|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
124466832|NCT02028455|447666515|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
124466833|NCT02028455|447666516|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
124466834|NCT02028455|447666517|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
124466835|NCT02028455|447666518|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
124466836|NCT02028455|447666519|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
124466837|NCT02028455|447666520|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
124466838|NCT02028455|447666513|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
124466839|NCT02028455|447666514|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
124466840|NCT02028455|447666515|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
124466841|NCT02028455|447666516|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
124466842|NCT02028455|447666517|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
124466843|NCT02028455|447666518|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
124466844|NCT02028455|447666519|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
124466845|NCT02028455|447666520|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
124551432|NCT03985293|447974758|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
124551433|NCT03985293|447974759|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
124712440|NCT00954447|448572374|FG001|Overall Study|Lost to Follow-up|14|||
124712441|NCT00954447|448572373|FG000|Overall Study|Withdrawal by Subject|26|||
124712442|NCT00954447|448572374|FG001|Overall Study|Withdrawal by Subject|21|||
124712443|NCT00954447|448572373|FG000|Overall Study|Other|21|||
124712444|NCT00954447|448572374|FG001|Overall Study|Other|18|||
124712445|NCT04592341|448572375|FG000|Overall Study|Physician Decision|5|||
124712446|NCT04592341|448572375|FG000|Overall Study|Study Terminated by Sponsor|5|||
124712447|NCT04592341|448572375|FG000|Overall Study|Withdrawal by Subject|53|||
124712448|NCT04592341|448572375|FG000|Overall Study|Lost to Follow-up|3|||
124712449|NCT04592341|448572375|FG000|Overall Study|Death|1|||
124712450|NCT04592341|448572375|FG000|Overall Study|Adverse Event|5|||
124712451|NCT04592341|448572375|FG000|Overall Study|other|4|||
124712452|NCT00692003|448572376|FG000|Overall Study|Sponsor Decision|5|||
124712453|NCT00692003|448572377|FG001|Overall Study|Sponsor Decision|1|||
124712454|NCT01248793|448572378|FG000|Overall Study|Lost to Follow-up|0|||
124712455|NCT01248793|448572379|FG001|Overall Study|Lost to Follow-up|1|||
124712456|NCT01248793|448572378|FG000|Overall Study|Adverse Event|1|||
124712457|NCT01248793|448572379|FG001|Overall Study|Adverse Event|1|||
124712458|NCT01248793|448572378|FG000|Overall Study|Protocol Violation|0|||
124712459|NCT01248793|448572379|FG001|Overall Study|Protocol Violation|1|||
124712460|NCT01248793|448572378|FG000|Overall Study|Withdrawal by Subject|3|||
124712461|NCT01248793|448572379|FG001|Overall Study|Withdrawal by Subject|3|||
124712462|NCT00517699|448572380|FG000|Overall Study|Withdrawal by Subject|1|||
124712463|NCT00517699|448572380|FG000|Overall Study|Lack of Efficacy|1|||
124712464|NCT00517699|448572380|FG000|Overall Study|Administrative error|1|||
124712465|NCT00517699|448572380|FG000|Overall Study|Study terminated by Sponsor|2|||
124712466|NCT02332187|448572383|FG000|Overall Study|Withdrawal by Subject|2|||
124712467|NCT02332187|448572384|FG001|Overall Study|Withdrawal by Subject|2|||
124712468|NCT02332187|448572383|FG000|Overall Study|Adverse Event|0|||
124712469|NCT02332187|448572384|FG001|Overall Study|Adverse Event|1|||
124712470|NCT01840943|448572385|FG000|Overall Study|Withdrawal by Subject|5|||
124712471|NCT01840943|448572386|FG001|Overall Study|Withdrawal by Subject|6|||
124712472|NCT01840943|448572385|FG000|Overall Study|Physician Decision|4|||
124712473|NCT01840943|448572386|FG001|Overall Study|Physician Decision|2|||
124712474|NCT01840943|448572385|FG000|Overall Study|Lost to Follow-up|4|||
124712475|NCT01840943|448572386|FG001|Overall Study|Lost to Follow-up|4|||
124712476|NCT02580877|448572389|FG000|Overall Study|Withdrawal by Subject|1|||
124712477|NCT02580877|448572390|FG001|Overall Study|Withdrawal by Subject|3|||
124712478|NCT02580877|448572389|FG000|Overall Study|Adverse Event|0|||
124712479|NCT02580877|448572390|FG001|Overall Study|Adverse Event|1|||
124712480|NCT00980148|448572391|FG000|Overall Study|Discharged from facility|89|||
124712481|NCT00980148|448572392|FG001|Overall Study|Discharged from facility|96|||
124712482|NCT00980148|448572391|FG000|Overall Study|Received other antichlamydia treatment|20|||
124712483|NCT00980148|448572392|FG001|Overall Study|Received other antichlamydia treatment|14|||
124712484|NCT00980148|448572391|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
124712485|NCT00980148|448572392|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
124712486|NCT00980148|448572391|FG000|Overall Study|Various other reasons|8|||
124712487|NCT00980148|448572392|FG001|Overall Study|Various other reasons|9|||
124712488|NCT00551031|448572393|FG000|Overall Study|Adverse Event|0|||
124712489|NCT00551031|448572394|FG001|Overall Study|Adverse Event|1|||
124712490|NCT00551031|448572395|FG002|Overall Study|Adverse Event|0|||
124712491|NCT00551031|448572396|FG003|Overall Study|Adverse Event|0|||
124712492|NCT00551031|448572397|FG004|Overall Study|Adverse Event|0|||
124712493|NCT00551031|448572393|FG000|Overall Study|Protocol Violation|1|||
124712494|NCT00551031|448572394|FG001|Overall Study|Protocol Violation|1|||
124712495|NCT00551031|448572395|FG002|Overall Study|Protocol Violation|0|||
124712496|NCT00551031|448572396|FG003|Overall Study|Protocol Violation|0|||
124712497|NCT00551031|448572397|FG004|Overall Study|Protocol Violation|0|||
124712498|NCT00551031|448572393|FG000|Overall Study|Lost to Follow-up|0|||
124712499|NCT00551031|448572394|FG001|Overall Study|Lost to Follow-up|1|||
124712500|NCT00551031|448572395|FG002|Overall Study|Lost to Follow-up|0|||
124712501|NCT00551031|448572396|FG003|Overall Study|Lost to Follow-up|1|||
124712502|NCT00551031|448572397|FG004|Overall Study|Lost to Follow-up|1|||
124712503|NCT00551031|448572393|FG000|Overall Study|Withdrawal by Subject|0|||
124712504|NCT00551031|448572394|FG001|Overall Study|Withdrawal by Subject|4|||
124712505|NCT00551031|448572395|FG002|Overall Study|Withdrawal by Subject|1|||
124712506|NCT00551031|448572396|FG003|Overall Study|Withdrawal by Subject|2|||
124712507|NCT00551031|448572397|FG004|Overall Study|Withdrawal by Subject|0|||
124712508|NCT00551031|448572393|FG000|Overall Study|Serious Adverse Event|0|||
124712509|NCT00551031|448572394|FG001|Overall Study|Serious Adverse Event|2|||
124770039|NCT01310777|448786799|FG000|Overall Study|Other|4|||
124551434|NCT03985293|447974760|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
124712510|NCT00551031|448572395|FG002|Overall Study|Serious Adverse Event|1|||
124770040|NCT01310777|448786800|FG001|Overall Study|Other|1|||
124770041|NCT01310777|448786801|FG002|Overall Study|Other|2|||
124712511|NCT00551031|448572396|FG003|Overall Study|Serious Adverse Event|0|||
124712512|NCT00551031|448572397|FG004|Overall Study|Serious Adverse Event|0|||
124712513|NCT00551031|448572393|FG000|Overall Study|Did not receive vaccine|1|||
124712514|NCT00551031|448572394|FG001|Overall Study|Did not receive vaccine|2|||
124712515|NCT00551031|448572395|FG002|Overall Study|Did not receive vaccine|0|||
124770042|NCT03697252|448786802|FG000|Overall Study|Adverse Event|3|||
124712516|NCT00551031|448572396|FG003|Overall Study|Did not receive vaccine|0|||
124712517|NCT00551031|448572397|FG004|Overall Study|Did not receive vaccine|0|||
124712518|NCT02903823|448572398|FG000|Overall Study|Physician Decision|5|||
124712519|NCT02903823|448572398|FG000|Overall Study|Could not advance catheter|1|||
124712520|NCT02903823|448572398|FG000|Overall Study|Catheter dislodgement|1|||
124970514|NCT04836559|449519297|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
124970515|NCT04836559|449519298|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
124970516|NCT04836559|449519291|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
124970517|NCT04836559|449519292|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
124970518|NCT04836559|449519293|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
124970519|NCT04836559|449519294|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
124970520|NCT04836559|449519295|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
124970521|NCT04836559|449519296|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
124970522|NCT04836559|449519297|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
124970523|NCT04836559|449519298|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
124970524|NCT04836559|449519291|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
124970525|NCT04836559|449519292|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
124970526|NCT04836559|449519293|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
124970527|NCT04836559|449519294|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
124970528|NCT04836559|449519295|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
124970529|NCT04836559|449519296|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
124970530|NCT04836559|449519297|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
124970531|NCT04836559|449519298|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
124970532|NCT02635360|449519299|FG000|Overall Study|Adverse Event|0|||
124970533|NCT02635360|449519300|FG001|Overall Study|Adverse Event|3|||
124970534|NCT02635360|449519299|FG000|Overall Study|Withdrawal by Subject|2|||
124970535|NCT02635360|449519300|FG001|Overall Study|Withdrawal by Subject|0|||
124970536|NCT02635360|449519299|FG000|Overall Study|Non-Compliance|3|||
124970537|NCT02635360|449519300|FG001|Overall Study|Non-Compliance|1|||
124970538|NCT02635360|449519299|FG000|Overall Study|Disease Progression|0|||
124970539|NCT02635360|449519300|FG001|Overall Study|Disease Progression|2|||
124970540|NCT02635360|449519299|FG000|Overall Study|Lost to Follow-up|1|||
124970541|NCT02635360|449519300|FG001|Overall Study|Lost to Follow-up|1|||
124970542|NCT04978350|449519301|FG000|Overall Study|Lost to Follow-up|6|||
124970543|NCT05765435|449519304|FG000|Overall Study|Lost to Follow-up|0|||
124970544|NCT05765435|449519305|FG001|Overall Study|Lost to Follow-up|1|||
124970545|NCT05765435|449519306|FG002|Overall Study|Lost to Follow-up|0|||
124970546|NCT05765435|449519304|FG000|Overall Study|Withdrawal by Subject|0|||
124466846|NCT02028455|447666513|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
124466847|NCT02028455|447666514|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
124466848|NCT02028455|447666515|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
124466849|NCT02028455|447666516|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
124466850|NCT02028455|447666517|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
124466851|NCT02028455|447666518|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
124466852|NCT02028455|447666519|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
124466853|NCT02028455|447666520|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
124466854|NCT01790503|447668789|FG000|Overall Study|Adverse Event|1|||
124466855|NCT01790503|447668790|FG001|Overall Study|Adverse Event|0|||
124466856|NCT01790503|447668791|FG002|Overall Study|Adverse Event|0|||
124466857|NCT01790503|447668792|FG003|Overall Study|Adverse Event|0|||
124466858|NCT01790503|447668793|FG004|Overall Study|Adverse Event|0|||
124466859|NCT01790503|447668794|FG005|Overall Study|Adverse Event|2|||
124466860|NCT01790503|447668795|FG006|Overall Study|Adverse Event|0|||
124970547|NCT05765435|449519305|FG001|Overall Study|Withdrawal by Subject|0|||
124466861|NCT01790503|447668796|FG007|Overall Study|Adverse Event|0|||
124970548|NCT05765435|449519306|FG002|Overall Study|Withdrawal by Subject|1|||
124970549|NCT00781937|449519315|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
124970550|NCT00781937|449519316|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
124970551|NCT00781937|449519315|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
124970552|NCT00781937|449519316|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
124970553|NCT00781937|449519315|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
124970554|NCT00781937|449519316|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
124466862|NCT01790503|447668797|FG008|Overall Study|Adverse Event|2|||
124466863|NCT01790503|447668798|FG009|Overall Study|Adverse Event|4|||
124466864|NCT01790503|447668799|FG010|Overall Study|Adverse Event|7|||
124466865|NCT01790503|447668789|FG000|Overall Study|Withdrawal by Subject|0|||
124466866|NCT01790503|447668790|FG001|Overall Study|Withdrawal by Subject|0|||
124466867|NCT01790503|447668791|FG002|Overall Study|Withdrawal by Subject|1|||
124466868|NCT01790503|447668792|FG003|Overall Study|Withdrawal by Subject|1|||
124466869|NCT01790503|447668793|FG004|Overall Study|Withdrawal by Subject|1|||
124466870|NCT01790503|447668794|FG005|Overall Study|Withdrawal by Subject|2|||
124466871|NCT01790503|447668795|FG006|Overall Study|Withdrawal by Subject|1|||
124466872|NCT01790503|447668796|FG007|Overall Study|Withdrawal by Subject|0|||
124466873|NCT01790503|447668797|FG008|Overall Study|Withdrawal by Subject|0|||
124466874|NCT01790503|447668798|FG009|Overall Study|Withdrawal by Subject|0|||
124466875|NCT01790503|447668799|FG010|Overall Study|Withdrawal by Subject|1|||
124466876|NCT01790503|447668789|FG000|Overall Study|Disease progression|2|||
124466877|NCT01790503|447668790|FG001|Overall Study|Disease progression|1|||
124466878|NCT01790503|447668791|FG002|Overall Study|Disease progression|0|||
124466879|NCT01790503|447668792|FG003|Overall Study|Disease progression|1|||
124712521|NCT01747915|448572399|FG000|Overall Study|Other|1|||
124712522|NCT01747915|448572400|FG001|Overall Study|Other|1|||
124712523|NCT01747915|448572401|FG002|Overall Study|Other|1|||
124712524|NCT01747915|448572399|FG000|Overall Study|Adverse Event|8|||
124712525|NCT01747915|448572400|FG001|Overall Study|Adverse Event|5|||
124712526|NCT01747915|448572401|FG002|Overall Study|Adverse Event|2|||
124712527|NCT01747915|448572399|FG000|Overall Study|Death|0|||
124712528|NCT01747915|448572400|FG001|Overall Study|Death|0|||
124712529|NCT01747915|448572401|FG002|Overall Study|Death|1|||
124712530|NCT01747915|448572399|FG000|Overall Study|Lack of Efficacy|0|||
124712531|NCT01747915|448572400|FG001|Overall Study|Lack of Efficacy|1|||
124712532|NCT01747915|448572401|FG002|Overall Study|Lack of Efficacy|0|||
124712533|NCT01747915|448572399|FG000|Overall Study|Lost to Follow-up|1|||
124712534|NCT01747915|448572400|FG001|Overall Study|Lost to Follow-up|0|||
124712535|NCT01747915|448572401|FG002|Overall Study|Lost to Follow-up|0|||
124712536|NCT01747915|448572399|FG000|Overall Study|Withdrawal by Subject|4|||
124712537|NCT01747915|448572400|FG001|Overall Study|Withdrawal by Subject|4|||
124712538|NCT01747915|448572401|FG002|Overall Study|Withdrawal by Subject|1|||
124712539|NCT01747915|448572399|FG000|Overall Study|Protocol Violation|1|||
124712540|NCT01747915|448572400|FG001|Overall Study|Protocol Violation|0|||
124712541|NCT01747915|448572401|FG002|Overall Study|Protocol Violation|0|||
124712542|NCT01747915|448572399|FG000|Overall Study|Pregnancy|0|||
124970555|NCT00781937|449519315|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
124970556|NCT00781937|449519316|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
124970557|NCT00781937|449519315|FG000|Main Trial Period Through Week 56|Unclassified|10|||
124970558|NCT00781937|449519316|FG001|Main Trial Period Through Week 56|Unclassified|15|||
124712543|NCT01747915|448572400|FG001|Overall Study|Pregnancy|0|||
124970559|NCT00781937|449519315|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
124970560|NCT00781937|449519316|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
124466880|NCT01790503|447668793|FG004|Overall Study|Disease progression|2|||
124466881|NCT01790503|447668794|FG005|Overall Study|Disease progression|1|||
124712544|NCT01747915|448572401|FG002|Overall Study|Pregnancy|1|||
124712545|NCT03341637|448572402|FG000|Overall Study|Lost to Follow-up|1|||
124712546|NCT03341637|448572403|FG001|Overall Study|Lost to Follow-up|0|||
124712547|NCT03341637|448572402|FG000|Overall Study|Withdrawal by Subject|3|||
124712548|NCT03341637|448572403|FG001|Overall Study|Withdrawal by Subject|3|||
124712549|NCT03341637|448572402|FG000|Overall Study|Reason not Specified|1|||
124712550|NCT03341637|448572403|FG001|Overall Study|Reason not Specified|1|||
124712551|NCT00887159|448572404|FG000|Overall Study|Disease progression|6|||
124712552|NCT00887159|448572405|FG001|Overall Study|Disease progression|39|||
124712553|NCT00887159|448572406|FG002|Overall Study|Disease progression|33|||
124712554|NCT00887159|448572404|FG000|Overall Study|Adverse Event|3|||
124712555|NCT00887159|448572405|FG001|Overall Study|Adverse Event|4|||
124712556|NCT00887159|448572406|FG002|Overall Study|Adverse Event|17|||
124712557|NCT00887159|448572404|FG000|Overall Study|Death|2|||
124712558|NCT00887159|448572405|FG001|Overall Study|Death|2|||
124712559|NCT00887159|448572406|FG002|Overall Study|Death|0|||
124712560|NCT00887159|448572404|FG000|Overall Study|Withdrawal by Subject|4|||
124712561|NCT00887159|448572405|FG001|Overall Study|Withdrawal by Subject|4|||
124712562|NCT00887159|448572406|FG002|Overall Study|Withdrawal by Subject|2|||
124712563|NCT00887159|448572404|FG000|Overall Study|Alternative therapy|2|||
124712564|NCT00887159|448572405|FG001|Overall Study|Alternative therapy|0|||
124712565|NCT00887159|448572406|FG002|Overall Study|Alternative therapy|0|||
124712566|NCT00887159|448572404|FG000|Overall Study|Physician Decision|1|||
124712567|NCT00887159|448572405|FG001|Overall Study|Physician Decision|1|||
124712568|NCT00887159|448572406|FG002|Overall Study|Physician Decision|0|||
124712569|NCT00887159|448572404|FG000|Overall Study|Sympomatic deterioration|1|||
124712570|NCT00887159|448572405|FG001|Overall Study|Sympomatic deterioration|0|||
124712571|NCT00887159|448572406|FG002|Overall Study|Sympomatic deterioration|0|||
124712572|NCT00887159|448572404|FG000|Overall Study|Treatment delayed|1|||
124712573|NCT00887159|448572405|FG001|Overall Study|Treatment delayed|1|||
124712574|NCT00887159|448572406|FG002|Overall Study|Treatment delayed|0|||
124712575|NCT00887159|448572404|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
124712576|NCT00887159|448572405|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
124712577|NCT00887159|448572406|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
124712578|NCT00887159|448572404|FG000|Overall Study|Received more tx instead of observation|1|||
124712579|NCT00887159|448572405|FG001|Overall Study|Received more tx instead of observation|0|||
124712580|NCT00887159|448572406|FG002|Overall Study|Received more tx instead of observation|0|||
124712581|NCT00887159|448572404|FG000|Overall Study|Ineligible|5|||
124712582|NCT00887159|448572405|FG001|Overall Study|Ineligible|1|||
124712583|NCT00887159|448572406|FG002|Overall Study|Ineligible|0|||
124712584|NCT00887159|448572404|FG000|Overall Study|Never started assigned therapy|3|||
124770043|NCT03697252|448786803|FG001|Overall Study|Adverse Event|2|||
124770044|NCT03697252|448786802|FG000|Overall Study|Withdrawal by Subject|14|||
124770045|NCT03697252|448786803|FG001|Overall Study|Withdrawal by Subject|14|||
124770046|NCT03697252|448786802|FG000|Overall Study|Lost to Follow-up|0|||
124770047|NCT03697252|448786803|FG001|Overall Study|Lost to Follow-up|1|||
124770048|NCT03697252|448786802|FG000|Overall Study|Physician Decision|1|||
124770049|NCT03697252|448786803|FG001|Overall Study|Physician Decision|1|||
124770050|NCT03697252|448786802|FG000|Overall Study|Other|0|||
124770051|NCT03697252|448786803|FG001|Overall Study|Other|1|||
124770052|NCT04711850|448786804|FG000|Overall Study|Graft loss|2|||
124770053|NCT04711850|448786805|FG001|Overall Study|Graft loss|1|||
124770054|NCT04711850|448786804|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
124770055|NCT04711850|448786805|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
124770056|NCT04711850|448786804|FG000|Overall Study|Study terminated by sponsor|5|||
124770057|NCT04711850|448786805|FG001|Overall Study|Study terminated by sponsor|3|||
124770058|NCT04711850|448786804|FG000|Overall Study|Sponsor decision|0|||
124770059|NCT04711850|448786805|FG001|Overall Study|Sponsor decision|2|||
124770060|NCT00774046|448786806|FG000|Screening|Not eligible|56|||
124770061|NCT00774046|448786806|FG000|Enrollment|Desired other therapy/refused|28|||
124770062|NCT00774046|448786806|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
124770063|NCT01353898|448786818|FG000|Overall Study|Study site terminated|0|||
124770064|NCT01353898|448786819|FG001|Overall Study|Study site terminated|0|||
124770065|NCT01353898|448786820|FG002|Overall Study|Study site terminated|0|||
124770066|NCT01353898|448786821|FG003|Overall Study|Study site terminated|0|||
124770067|NCT01353898|448786822|FG004|Overall Study|Study site terminated|0|||
124770068|NCT01353898|448786823|FG005|Overall Study|Study site terminated|1|||
124770069|NCT03558737|448786824|FG000|Overall Study|Death|1|||
124770070|NCT03558737|448786825|FG001|Overall Study|Death|1|||
124770071|NCT03041181|448786828|FG000|Overall Study|Disease Progression|1|||
124770072|NCT03041181|448786829|FG001|Overall Study|Disease Progression|2|||
124770073|NCT03050801|448786836|FG000|Experiment 1|Lost to Follow-up|0|||
124770074|NCT03050801|448786837|FG001|Experiment 1|Lost to Follow-up|1|||
124770075|NCT03050801|448786838|FG002|Experiment 1|Lost to Follow-up|0|||
124970561|NCT00781937|449519315|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
124970562|NCT00781937|449519316|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
124970563|NCT04698915|449519317|FG000|Overall Study|Adverse Event|2|||
124970564|NCT04698915|449519318|FG001|Overall Study|Adverse Event|0|||
124970565|NCT04698915|449519317|FG000|Overall Study|Death|23|||
124970566|NCT04698915|449519318|FG001|Overall Study|Death|20|||
124970567|NCT04698915|449519317|FG000|Overall Study|Physician Decision|1|||
124466882|NCT01790503|447668795|FG006|Overall Study|Disease progression|0|||
124466883|NCT01790503|447668796|FG007|Overall Study|Disease progression|1|||
124466884|NCT01790503|447668797|FG008|Overall Study|Disease progression|0|||
124466885|NCT01790503|447668798|FG009|Overall Study|Disease progression|17|||
124466886|NCT01790503|447668799|FG010|Overall Study|Disease progression|7|||
124466887|NCT01790503|447668789|FG000|Overall Study|Protocol Violation|0|||
124466888|NCT01790503|447668790|FG001|Overall Study|Protocol Violation|0|||
124466889|NCT01790503|447668791|FG002|Overall Study|Protocol Violation|0|||
124466890|NCT01790503|447668792|FG003|Overall Study|Protocol Violation|0|||
124466891|NCT01790503|447668793|FG004|Overall Study|Protocol Violation|0|||
124466892|NCT01790503|447668794|FG005|Overall Study|Protocol Violation|0|||
124466893|NCT01790503|447668795|FG006|Overall Study|Protocol Violation|0|||
124466894|NCT01790503|447668796|FG007|Overall Study|Protocol Violation|0|||
124466895|NCT01790503|447668797|FG008|Overall Study|Protocol Violation|0|||
124466896|NCT01790503|447668798|FG009|Overall Study|Protocol Violation|1|||
124466897|NCT01790503|447668799|FG010|Overall Study|Protocol Violation|0|||
124770076|NCT03050801|448786839|FG003|Experiment 1|Lost to Follow-up|0|||
124770077|NCT03050801|448786840|FG004|Experiment 1|Lost to Follow-up|0|||
124770078|NCT03050801|448786841|FG005|Experiment 1|Lost to Follow-up|0|||
124770079|NCT03050801|448786836|FG000|Experiment 1|Physician Decision|0|||
124970568|NCT04698915|449519318|FG001|Overall Study|Physician Decision|1|||
124970569|NCT04698915|449519317|FG000|Overall Study|Lost to Follow-up|1|||
124712585|NCT00887159|448572405|FG001|Overall Study|Never started assigned therapy|3|||
124712586|NCT00887159|448572406|FG002|Overall Study|Never started assigned therapy|4|||
124712587|NCT03500211|448572411|FG000|Overall Study|Withdrawal by Subject|1|||
124712588|NCT03500211|448572412|FG001|Overall Study|Withdrawal by Subject|1|||
124712589|NCT01639469|448572418|FG000|Overall Study|Death|4|||
124712590|NCT01639469|448572419|FG001|Overall Study|Death|2|||
124712591|NCT01639469|448572418|FG000|Overall Study|Lost to Follow-up|1|||
124712592|NCT01639469|448572419|FG001|Overall Study|Lost to Follow-up|1|||
124712593|NCT01119443|448572420|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
124712594|NCT01119443|448572421|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
124712595|NCT00420381|448572422|FG000|Overall Study|Protocol Violation|1|||
124712596|NCT00775268|448572425|FG000|Baseline|Drug not synthesize dose|1|||
124712597|NCT00775268|448572426|FG001|Baseline|Drug not synthesize dose|0|||
124712598|NCT00775268|448572425|FG000|Baseline|Not treated-ineligible per CT|0|||
124712599|NCT00775268|448572426|FG001|Baseline|Not treated-ineligible per CT|1|||
124712600|NCT00775268|448572425|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
124712601|NCT00775268|448572426|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
124712602|NCT00775268|448572425|FG000|After Completion|Participant missed scan appointment|1|||
124712603|NCT00775268|448572426|FG001|After Completion|Participant missed scan appointment|0|||
124712604|NCT03604497|448572427|FG000|Overall Study|Protocol Violation|52|||
124712605|NCT00589797|448572433|FG000|Overall Study|Death|1|||
124712606|NCT00589797|448572434|FG001|Overall Study|Death|0|||
124712607|NCT00589797|448572433|FG000|Overall Study|Lost to Follow-up|12|||
124712608|NCT00589797|448572434|FG001|Overall Study|Lost to Follow-up|9|||
124712609|NCT00589797|448572433|FG000|Overall Study|Physician Decision|8|||
124712610|NCT00589797|448572434|FG001|Overall Study|Physician Decision|3|||
124712611|NCT00589797|448572433|FG000|Overall Study|Withdrawal by Subject|6|||
124712612|NCT00589797|448572434|FG001|Overall Study|Withdrawal by Subject|5|||
124712613|NCT00589797|448572433|FG000|Overall Study|Non-Randomized Training Subjects|46|||
124712614|NCT00589797|448572434|FG001|Overall Study|Non-Randomized Training Subjects|6|||
124712615|NCT01881009|448572435|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
124712616|NCT01881009|448572436|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
124712617|NCT01194245|448572437|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
124712618|NCT01194245|448572438|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
124712619|NCT01194245|448572439|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
124712620|NCT01194245|448572440|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
124712621|NCT01194245|448572441|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
124712622|NCT01194245|448572437|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
124712623|NCT01194245|448572438|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
124712624|NCT01194245|448572439|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
124712625|NCT01194245|448572440|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
124712626|NCT01194245|448572441|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
124712627|NCT01194245|448572437|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
124712628|NCT01194245|448572438|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
124712629|NCT01194245|448572439|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
124712630|NCT01194245|448572440|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
124712631|NCT01194245|448572441|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
124712632|NCT01194245|448572437|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
124712633|NCT01194245|448572438|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
124712634|NCT01194245|448572439|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
124712635|NCT01194245|448572440|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
124712636|NCT01194245|448572441|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
124712637|NCT01194245|448572437|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124712638|NCT01194245|448572438|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124712639|NCT01194245|448572439|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124712640|NCT01194245|448572440|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124712641|NCT01194245|448572441|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
124712642|NCT01194245|448572437|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
124712643|NCT01194245|448572438|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
124712644|NCT01194245|448572439|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
124712645|NCT01194245|448572440|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
124712646|NCT01194245|448572441|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
124712647|NCT00269087|448572442|FG000|Overall Study|Adverse Event|20|||
124712648|NCT00269087|448572442|FG000|Overall Study|Withdrawal by Subject|1|||
124712649|NCT00269087|448572442|FG000|Overall Study|Exacerbation of COPD|13|||
124712650|NCT00041470|448572446|FG000|Overall Study|Loss of Funding|38|||
124712651|NCT02230189|448572453|FG000|Overall Study|Withdrawal by Subject|3|||
124712652|NCT02230189|448572454|FG001|Overall Study|Withdrawal by Subject|0|||
124712653|NCT02230189|448572455|FG002|Overall Study|Withdrawal by Subject|1|||
124712654|NCT02230189|448572453|FG000|Overall Study|Lost to Follow-up|1|||
124712655|NCT02230189|448572454|FG001|Overall Study|Lost to Follow-up|0|||
124712656|NCT02230189|448572455|FG002|Overall Study|Lost to Follow-up|0|||
124712657|NCT02230189|448572453|FG000|Overall Study|Physician Decision|1|||
124712658|NCT02230189|448572454|FG001|Overall Study|Physician Decision|0|||
124712659|NCT02230189|448572455|FG002|Overall Study|Physician Decision|0|||
124712660|NCT01193101|448572461|FG000|Overall Study|Adverse Event|0|||
124970570|NCT04698915|449519318|FG001|Overall Study|Lost to Follow-up|0|||
124970571|NCT04698915|449519317|FG000|Overall Study|Study Terminated by Sponsor|55|||
124970572|NCT04698915|449519318|FG001|Overall Study|Study Terminated by Sponsor|60|||
124970573|NCT04698915|449519317|FG000|Overall Study|Withdrawal by Subject|2|||
124970574|NCT04698915|449519318|FG001|Overall Study|Withdrawal by Subject|3|||
124970575|NCT01150045|449519319|FG000|Overall Study|Protocol Violation|0|||
124970576|NCT01150045|449519320|FG001|Overall Study|Protocol Violation|1|||
124970577|NCT01150045|449519321|FG002|Overall Study|Protocol Violation|0|||
124970578|NCT01150045|449519322|FG003|Overall Study|Protocol Violation|1|||
124970579|NCT01790295|449519324|FG000|Overall Study|Adverse Event|1|||
124970580|NCT01790295|449519324|FG000|Overall Study|Death|4|||
124970581|NCT01790295|449519324|FG000|Overall Study|Lack of Efficacy|2|||
124970582|NCT01790295|449519324|FG000|Overall Study|Study closure|4|||
124970583|NCT00420784|449519331|FG000|Overall Study|Adverse Event|11|||
124970584|NCT00420784|449519332|FG001|Overall Study|Adverse Event|29|||
124970585|NCT00420784|449519333|FG002|Overall Study|Adverse Event|10|||
124970586|NCT00420784|449519334|FG003|Overall Study|Adverse Event|5|||
124970587|NCT00420784|449519331|FG000|Overall Study|Withdrawal by Subject|0|||
124970588|NCT00420784|449519332|FG001|Overall Study|Withdrawal by Subject|1|||
124970589|NCT00420784|449519333|FG002|Overall Study|Withdrawal by Subject|0|||
124970590|NCT00420784|449519334|FG003|Overall Study|Withdrawal by Subject|0|||
124970591|NCT00420784|449519331|FG000|Overall Study|Lost to Follow-up|0|||
124970592|NCT00420784|449519332|FG001|Overall Study|Lost to Follow-up|0|||
124970593|NCT00420784|449519333|FG002|Overall Study|Lost to Follow-up|2|||
124551435|NCT03985293|447974755|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
124712661|NCT01193101|448572462|FG001|Overall Study|Adverse Event|1|||
124712662|NCT01193101|448572463|FG002|Overall Study|Adverse Event|1|||
124970594|NCT00420784|449519334|FG003|Overall Study|Lost to Follow-up|1|||
124970595|NCT00420784|449519331|FG000|Overall Study|Virologic Stopping Rule|17|||
124970596|NCT00420784|449519332|FG001|Overall Study|Virologic Stopping Rule|26|||
124970597|NCT00420784|449519333|FG002|Overall Study|Virologic Stopping Rule|41|||
124970598|NCT00420784|449519334|FG003|Overall Study|Virologic Stopping Rule|67|||
124712663|NCT01193101|448572464|FG003|Overall Study|Adverse Event|3|||
124712664|NCT01193101|448572461|FG000|Overall Study|Lack of Efficacy|3|||
124712665|NCT01193101|448572462|FG001|Overall Study|Lack of Efficacy|1|||
124712666|NCT01193101|448572463|FG002|Overall Study|Lack of Efficacy|0|||
124712667|NCT01193101|448572464|FG003|Overall Study|Lack of Efficacy|8|||
124712668|NCT01193101|448572461|FG000|Overall Study|Withdrawal by Subject|2|||
124712669|NCT01193101|448572462|FG001|Overall Study|Withdrawal by Subject|4|||
124712670|NCT01193101|448572463|FG002|Overall Study|Withdrawal by Subject|1|||
124712671|NCT01193101|448572464|FG003|Overall Study|Withdrawal by Subject|1|||
124712672|NCT01193101|448572461|FG000|Overall Study|Administrative problems|0|||
124712673|NCT01193101|448572462|FG001|Overall Study|Administrative problems|0|||
124712674|NCT01193101|448572463|FG002|Overall Study|Administrative problems|1|||
124712675|NCT01193101|448572464|FG003|Overall Study|Administrative problems|0|||
124712676|NCT01193101|448572461|FG000|Overall Study|Abnormal test procedure results|0|||
124712677|NCT01193101|448572462|FG001|Overall Study|Abnormal test procedure results|1|||
124712678|NCT01193101|448572463|FG002|Overall Study|Abnormal test procedure results|0|||
124712679|NCT01193101|448572464|FG003|Overall Study|Abnormal test procedure results|0|||
124712680|NCT02347085|448572465|FG000|Overall Study|Adverse Event|2|||
124712681|NCT02347085|448572465|FG000|Overall Study|Lack of Efficacy|1|||
124712682|NCT02347085|448572465|FG000|Overall Study|Withdrawal by Subject|4|||
124712683|NCT02347085|448572465|FG000|Overall Study|Lost to Follow-up|1|||
124712684|NCT02347085|448572465|FG000|Overall Study|Protocol Criteria|2|||
124712685|NCT02834819|448572466|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
124712686|NCT02834819|448572467|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
124712687|NCT00527618|448572470|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
124712688|NCT00527618|448572471|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
124712689|NCT00527618|448572470|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
124712690|NCT00527618|448572471|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
124712691|NCT00527618|448572470|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
124712692|NCT00527618|448572471|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
124712693|NCT00527618|448572470|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
124712694|NCT00527618|448572471|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
124712695|NCT00527618|448572470|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
124712696|NCT00527618|448572471|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
124712697|NCT00527618|448572470|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
124712698|NCT00527618|448572471|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
124712699|NCT00363311|448572482|FG000|Overall Study|Adverse Event|6|||
124712700|NCT00363311|448572483|FG001|Overall Study|Adverse Event|4|||
124712701|NCT00363311|448572482|FG000|Overall Study|Lost to Follow-up|3|||
124712702|NCT00363311|448572483|FG001|Overall Study|Lost to Follow-up|0|||
124712703|NCT00363311|448572482|FG000|Overall Study|Protocol Violation|1|||
124712704|NCT00363311|448572483|FG001|Overall Study|Protocol Violation|2|||
124712705|NCT00363311|448572482|FG000|Overall Study|Withdrawal by Subject|12|||
124712706|NCT00363311|448572483|FG001|Overall Study|Withdrawal by Subject|6|||
124712707|NCT00363311|448572482|FG000|Overall Study|Physician Decision|1|||
124712708|NCT00363311|448572483|FG001|Overall Study|Physician Decision|1|||
124712709|NCT00363311|448572482|FG000|Overall Study|Sponsor Terminated Study|2|||
124712710|NCT00363311|448572483|FG001|Overall Study|Sponsor Terminated Study|2|||
124712711|NCT00363311|448572482|FG000|Overall Study|Disease Progression|46|||
124770080|NCT03050801|448786837|FG001|Experiment 1|Physician Decision|3|||
124970599|NCT00420784|449519331|FG000|Overall Study|Other|1|||
124970600|NCT00420784|449519332|FG001|Overall Study|Other|2|||
124970601|NCT00420784|449519333|FG002|Overall Study|Other|0|||
124970602|NCT00420784|449519334|FG003|Overall Study|Other|5|||
124970603|NCT03603639|449519335|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
124970604|NCT03603639|449519336|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
124970605|NCT03603639|449519337|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
124970606|NCT03603639|449519338|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
124970607|NCT03603639|449519339|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
124970608|NCT03603639|449519340|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
124970609|NCT03603639|449519335|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
124970610|NCT03603639|449519336|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
124970611|NCT03603639|449519337|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
124970612|NCT03603639|449519338|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
124970613|NCT03603639|449519339|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
124970614|NCT03603639|449519340|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
124970615|NCT03016598|449519344|FG000|Overall Study|Lost to Follow-up|0|||
124970616|NCT03016598|449519345|FG001|Overall Study|Lost to Follow-up|2|||
124970617|NCT04593823|449519347|FG000|Overall Study|Withdrawal by Subject|1|||
124970618|NCT04593823|449519348|FG001|Overall Study|Withdrawal by Subject|1|||
124712712|NCT00363311|448572483|FG001|Overall Study|Disease Progression|26|||
124712713|NCT00363311|448572482|FG000|Overall Study|Non-Compliance|1|||
124712714|NCT00363311|448572483|FG001|Overall Study|Non-Compliance|1|||
124712715|NCT00363311|448572482|FG000|Overall Study|Participant Refused Biopsy|1|||
124712716|NCT00363311|448572483|FG001|Overall Study|Participant Refused Biopsy|0|||
124712717|NCT00363311|448572482|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
124712718|NCT00363311|448572483|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
124712719|NCT00363311|448572482|FG000|Overall Study|Participant Opted for Treatment|1|||
124712720|NCT00363311|448572483|FG001|Overall Study|Participant Opted for Treatment|0|||
124712721|NCT00363311|448572482|FG000|Overall Study|Participant Moved to Another Country|1|||
124712722|NCT00363311|448572483|FG001|Overall Study|Participant Moved to Another Country|0|||
124712723|NCT00363311|448572482|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
124712724|NCT00363311|448572483|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
124712725|NCT00363311|448572482|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
124712726|NCT00363311|448572483|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
124712727|NCT00363311|448572482|FG000|Overall Study|Participant Moved to Louisiana|0|||
124712728|NCT00363311|448572483|FG001|Overall Study|Participant Moved to Louisiana|1|||
124712729|NCT00120627|448572486|FG000|Overall Study|Withdrawal by Subject|5|||
124712730|NCT00120627|448572487|FG001|Overall Study|Withdrawal by Subject|5|||
124712731|NCT01595529|448572488|FG000|Overall Study|Adverse Event|2|||
124712732|NCT01595529|448572489|FG001|Overall Study|Adverse Event|0|||
124712733|NCT01595529|448572488|FG000|Overall Study|Subject Non-Compliant|2|||
124712734|NCT01595529|448572489|FG001|Overall Study|Subject Non-Compliant|0|||
124712735|NCT01595529|448572488|FG000|Overall Study|Lost to Follow-up|8|||
124712736|NCT01595529|448572489|FG001|Overall Study|Lost to Follow-up|14|||
124712737|NCT01595529|448572488|FG000|Overall Study|Protocol Violation|1|||
124712738|NCT01595529|448572489|FG001|Overall Study|Protocol Violation|2|||
124712739|NCT01595529|448572488|FG000|Overall Study|Physician Decision|1|||
124712740|NCT01595529|448572489|FG001|Overall Study|Physician Decision|0|||
124712741|NCT01595529|448572488|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
124712742|NCT01595529|448572489|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
124712743|NCT01595529|448572488|FG000|Overall Study|Administrative Decision|1|||
124712744|NCT01595529|448572489|FG001|Overall Study|Administrative Decision|0|||
124712745|NCT01595529|448572488|FG000|Overall Study|Entry Failure/Screening Failure|6|||
124712746|NCT01595529|448572489|FG001|Overall Study|Entry Failure/Screening Failure|1|||
124712747|NCT01508910|448572490|FG000|Treatment|Death|2|||
124712748|NCT01508910|448572491|FG001|Treatment|Death|3|||
124712749|NCT01508910|448572492|FG002|Treatment|Death|2|||
124712750|NCT01508910|448572493|FG003|Treatment|Death|0|||
124712751|NCT01508910|448572490|FG000|Treatment|Lost to Follow-up|0|||
124712752|NCT01508910|448572491|FG001|Treatment|Lost to Follow-up|0|||
124712753|NCT01508910|448572492|FG002|Treatment|Lost to Follow-up|2|||
124712754|NCT01508910|448572493|FG003|Treatment|Lost to Follow-up|1|||
124712755|NCT01508910|448572490|FG000|Treatment|Withdrawal by Subject|0|||
124712756|NCT01508910|448572491|FG001|Treatment|Withdrawal by Subject|1|||
124712757|NCT01508910|448572492|FG002|Treatment|Withdrawal by Subject|6|||
124712758|NCT01508910|448572493|FG003|Treatment|Withdrawal by Subject|1|||
124712759|NCT01508910|448572490|FG000|Treatment|Sponsor Decision|0|||
124712760|NCT01508910|448572491|FG001|Treatment|Sponsor Decision|0|||
124712761|NCT01508910|448572492|FG002|Treatment|Sponsor Decision|0|||
124712762|NCT01508910|448572493|FG003|Treatment|Sponsor Decision|1|||
124712763|NCT00730886|448572494|FG000|Overall Study|Lost to Follow-up|1|||
124712764|NCT00730886|448572495|FG001|Overall Study|Lost to Follow-up|0|||
124712765|NCT00730886|448572494|FG000|Overall Study|Physician Decision|1|||
124712766|NCT00730886|448572495|FG001|Overall Study|Physician Decision|0|||
124712767|NCT01991483|448572496|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
124712768|NCT01991483|448572497|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
124712769|NCT01991483|448572498|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
124712770|NCT01991483|448572499|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
124712771|NCT01991483|448572496|FG000|Dose Level 600 mg|Physician Decision|0|||
124770081|NCT03050801|448786838|FG002|Experiment 1|Physician Decision|0|||
124970619|NCT04593823|449519347|FG000|Overall Study|Lost to Follow-up|0|||
124970620|NCT04593823|449519348|FG001|Overall Study|Lost to Follow-up|1|||
124970621|NCT00742326|449519349|FG000|Overall Study|Physician Decision|0|||
124970622|NCT00742326|449519350|FG001|Overall Study|Physician Decision|1|||
124970623|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
124970624|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
124970625|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
124970626|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
124970627|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
124970628|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
124970629|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
124970630|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
124970631|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
124712772|NCT01991483|448572497|FG001|Dose Level 600 mg|Physician Decision|0|||
124712773|NCT01991483|448572498|FG002|Dose Level 600 mg|Physician Decision|1|||
124712774|NCT01991483|448572499|FG003|Dose Level 600 mg|Physician Decision|0|||
124712775|NCT01991483|448572496|FG000|Dose Level 1000 mg|Protocol Violation|0|||
124770082|NCT03050801|448786839|FG003|Experiment 1|Physician Decision|0|||
124770083|NCT03050801|448786840|FG004|Experiment 1|Physician Decision|0|||
124770084|NCT03050801|448786841|FG005|Experiment 1|Physician Decision|0|||
124770085|NCT03050801|448786836|FG000|Experiment 1|Change of experimental design|0|||
124770086|NCT03050801|448786837|FG001|Experiment 1|Change of experimental design|3|||
124770087|NCT03050801|448786838|FG002|Experiment 1|Change of experimental design|0|||
124770088|NCT03050801|448786839|FG003|Experiment 1|Change of experimental design|0|||
124770089|NCT03050801|448786840|FG004|Experiment 1|Change of experimental design|0|||
124770090|NCT03050801|448786841|FG005|Experiment 1|Change of experimental design|0|||
124770091|NCT03050801|448786836|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
124770092|NCT03050801|448786837|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
124770093|NCT03050801|448786838|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
124770094|NCT03050801|448786839|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
124770095|NCT03050801|448786840|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
124770096|NCT03050801|448786841|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
124770097|NCT03050801|448786836|FG000|Experiment 2|Lost to Follow-up|0|||
124770098|NCT03050801|448786837|FG001|Experiment 2|Lost to Follow-up|0|||
124770099|NCT03050801|448786838|FG002|Experiment 2|Lost to Follow-up|0|||
124770100|NCT03050801|448786839|FG003|Experiment 2|Lost to Follow-up|1|||
124770101|NCT03050801|448786840|FG004|Experiment 2|Lost to Follow-up|1|||
124770102|NCT03050801|448786841|FG005|Experiment 2|Lost to Follow-up|0|||
124770103|NCT03050801|448786836|FG000|Experiment 2|Physician Decision|0|||
124712776|NCT01991483|448572497|FG001|Dose Level 1000 mg|Protocol Violation|0|||
124712777|NCT01991483|448572498|FG002|Dose Level 1000 mg|Protocol Violation|0|||
124712778|NCT01991483|448572499|FG003|Dose Level 1000 mg|Protocol Violation|1|||
124712779|NCT04819113|448572502|FG000|Overall Study|Withdrawal by parent/guardian|3|||
124712780|NCT04819113|448572502|FG000|Overall Study|Lost to Follow-up|1|||
124712781|NCT04819113|448572502|FG000|Overall Study|Withdrawn before vaccination|2|||
124712782|NCT00833027|448572503|FG000|Overall Study|Adverse Event|33|||
124770104|NCT03050801|448786837|FG001|Experiment 2|Physician Decision|0|||
124770105|NCT03050801|448786838|FG002|Experiment 2|Physician Decision|0|||
124770106|NCT03050801|448786839|FG003|Experiment 2|Physician Decision|0|||
124770107|NCT03050801|448786840|FG004|Experiment 2|Physician Decision|1|||
124770108|NCT03050801|448786841|FG005|Experiment 2|Physician Decision|0|||
124770109|NCT03050801|448786836|FG000|Experiment 2|Pregnancy|0|||
124770110|NCT03050801|448786837|FG001|Experiment 2|Pregnancy|0|||
124970632|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
124970633|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
124712783|NCT00833027|448572503|FG000|Overall Study|Death|1|||
124712784|NCT00833027|448572503|FG000|Overall Study|Lack of Efficacy|12|||
124712785|NCT00833027|448572503|FG000|Overall Study|Lost to Follow-up|24|||
124712786|NCT00833027|448572503|FG000|Overall Study|Protocol Violation|115|||
124770111|NCT03050801|448786838|FG002|Experiment 2|Pregnancy|0|||
124770112|NCT03050801|448786839|FG003|Experiment 2|Pregnancy|0|||
124770113|NCT03050801|448786840|FG004|Experiment 2|Pregnancy|1|||
124770114|NCT03050801|448786841|FG005|Experiment 2|Pregnancy|0|||
124770115|NCT03050801|448786836|FG000|Experiment 2|Withdrawal by Subject|0|||
124770116|NCT03050801|448786837|FG001|Experiment 2|Withdrawal by Subject|0|||
124770117|NCT03050801|448786838|FG002|Experiment 2|Withdrawal by Subject|0|||
124970634|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
124970635|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
124970636|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
124970637|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
124970638|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
124970639|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
124970640|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
124970641|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Missing|2|||
124970642|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Missing|1|||
124551436|NCT03985293|447974756|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
124551437|NCT03985293|447974757|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
124551438|NCT03985293|447974758|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
124551439|NCT03985293|447974759|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
124551440|NCT03985293|447974760|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
124551441|NCT03985293|447974755|FG000|FOLLOW-UP|Lost to Follow-up|0|||
124551442|NCT03985293|447974756|FG001|FOLLOW-UP|Lost to Follow-up|0|||
124551443|NCT03985293|447974757|FG002|FOLLOW-UP|Lost to Follow-up|1|||
124551444|NCT03985293|447974758|FG003|FOLLOW-UP|Lost to Follow-up|0|||
124551445|NCT03985293|447974759|FG004|FOLLOW-UP|Lost to Follow-up|0|||
124551446|NCT03985293|447974760|FG005|FOLLOW-UP|Lost to Follow-up|0|||
124551447|NCT03302299|447976436|FG000|Overall Study|Protocol Violation|1|||
124551448|NCT00858234|447976437|FG000|Overall Study|Adverse Event|6|||
124551449|NCT00858234|447976437|FG000|Overall Study|Progressive disease|2|||
124551450|NCT00858234|447976437|FG000|Overall Study|Status unknown|1|||
124551451|NCT04318535|447976438|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
124712787|NCT00833027|448572503|FG000|Overall Study|Withdrawal by Subject|16|||
124712788|NCT00833027|448572503|FG000|Overall Study|Missing|10|||
124712789|NCT03092479|448572510|FG000|Overall Study|Lost to Follow-up|3|||
124970643|NCT00443209|449519352|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
124970644|NCT00443209|449519353|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
124970645|NCT00443209|449519352|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
124970646|NCT00443209|449519353|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
124970647|NCT00443209|449519352|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
124970648|NCT00443209|449519353|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
124970649|NCT00443209|449519352|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
124970650|NCT00443209|449519353|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
124970651|NCT00443209|449519352|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
124970652|NCT00443209|449519353|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
124970653|NCT00443209|449519352|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
124970654|NCT00443209|449519353|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
124970655|NCT00443209|449519352|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
124970656|NCT00443209|449519353|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
124970657|NCT01628692|449519354|FG000|Overall Study|Lack of Efficacy|4|||
124970658|NCT01628692|449519355|FG001|Overall Study|Lack of Efficacy|4|||
124970659|NCT01628692|449519356|FG002|Overall Study|Lack of Efficacy|5|||
124970660|NCT01628692|449519357|FG003|Overall Study|Lack of Efficacy|1|||
124970661|NCT01628692|449519358|FG004|Overall Study|Lack of Efficacy|4|||
124970662|NCT01628692|449519359|FG005|Overall Study|Lack of Efficacy|7|||
124970663|NCT01628692|449519354|FG000|Overall Study|Adverse Event|2|||
124970664|NCT01628692|449519355|FG001|Overall Study|Adverse Event|0|||
124970665|NCT01628692|449519356|FG002|Overall Study|Adverse Event|2|||
124970666|NCT01628692|449519357|FG003|Overall Study|Adverse Event|0|||
124970667|NCT01628692|449519358|FG004|Overall Study|Adverse Event|0|||
124970668|NCT01628692|449519359|FG005|Overall Study|Adverse Event|0|||
124970669|NCT01628692|449519354|FG000|Overall Study|Withdrawal by Subject|0|||
124970670|NCT01628692|449519355|FG001|Overall Study|Withdrawal by Subject|1|||
124970671|NCT01628692|449519356|FG002|Overall Study|Withdrawal by Subject|1|||
124970672|NCT01628692|449519357|FG003|Overall Study|Withdrawal by Subject|0|||
124712790|NCT03092479|448572511|FG001|Overall Study|Lost to Follow-up|2|||
124712791|NCT03092479|448572510|FG000|Overall Study|Withdrawal by Subject|4|||
124970673|NCT01628692|449519358|FG004|Overall Study|Withdrawal by Subject|0|||
124970674|NCT01628692|449519359|FG005|Overall Study|Withdrawal by Subject|0|||
124712792|NCT03092479|448572511|FG001|Overall Study|Withdrawal by Subject|0|||
124712793|NCT01475721|448574433|FG000|Overall Study|Death|3|||
124712794|NCT01475721|448574434|FG001|Overall Study|Death|6|||
124712795|NCT01475721|448574433|FG000|Overall Study|Withdrawal by Subject|8|||
124712796|NCT01475721|448574434|FG001|Overall Study|Withdrawal by Subject|8|||
124712797|NCT00803738|448574436|FG000|Overall Study|Adverse Event|3|||
124712798|NCT00803738|448574437|FG001|Overall Study|Adverse Event|5|||
124712799|NCT00803738|448574436|FG000|Overall Study|Lost to Follow-up|4|||
124712800|NCT00803738|448574437|FG001|Overall Study|Lost to Follow-up|4|||
124712801|NCT00803738|448574436|FG000|Overall Study|Protocol Violation|18|||
124712802|NCT00803738|448574437|FG001|Overall Study|Protocol Violation|10|||
124712803|NCT00803738|448574436|FG000|Overall Study|Withdrawal by Subject|1|||
124712804|NCT00803738|448574437|FG001|Overall Study|Withdrawal by Subject|4|||
124712805|NCT00803738|448574436|FG000|Overall Study|Lack of Efficacy|10|||
124712806|NCT00803738|448574437|FG001|Overall Study|Lack of Efficacy|16|||
124712807|NCT00803738|448574436|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
124712808|NCT00803738|448574437|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
124712809|NCT00803738|448574436|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
124712810|NCT00803738|448574437|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
124712811|NCT02364037|448574438|FG000|Overall Study|Withdrawal by Subject|7|||
124712812|NCT02364037|448574439|FG001|Overall Study|Withdrawal by Subject|4|||
124712813|NCT02364037|448574438|FG000|Overall Study|Lost to Follow-up|37|||
124712814|NCT02364037|448574439|FG001|Overall Study|Lost to Follow-up|49|||
124712815|NCT04567524|448574440|FG000|Overall Study|Adverse Event|1|||
124712816|NCT04567524|448574441|FG001|Overall Study|Adverse Event|1|||
124712817|NCT04567524|448574442|FG002|Overall Study|Adverse Event|0|||
124712818|NCT04567524|448574443|FG003|Overall Study|Adverse Event|0|||
124712819|NCT04567524|448574440|FG000|Overall Study|Withdrawal by Subject|2|||
124712820|NCT04567524|448574441|FG001|Overall Study|Withdrawal by Subject|0|||
124970675|NCT01628692|449519354|FG000|Overall Study|Death|0|||
124970676|NCT01628692|449519355|FG001|Overall Study|Death|1|||
124712821|NCT04567524|448574442|FG002|Overall Study|Withdrawal by Subject|0|||
124712822|NCT04567524|448574443|FG003|Overall Study|Withdrawal by Subject|1|||
124970677|NCT01628692|449519356|FG002|Overall Study|Death|0|||
124970678|NCT01628692|449519357|FG003|Overall Study|Death|0|||
124970679|NCT01628692|449519358|FG004|Overall Study|Death|0|||
124970680|NCT01628692|449519359|FG005|Overall Study|Death|0|||
124970681|NCT01628692|449519354|FG000|Overall Study|Poor compliance/noncompliance|1|||
124970682|NCT01628692|449519355|FG001|Overall Study|Poor compliance/noncompliance|0|||
124970683|NCT01628692|449519356|FG002|Overall Study|Poor compliance/noncompliance|0|||
124970684|NCT01628692|449519357|FG003|Overall Study|Poor compliance/noncompliance|0|||
124970685|NCT01628692|449519358|FG004|Overall Study|Poor compliance/noncompliance|0|||
124970686|NCT01628692|449519359|FG005|Overall Study|Poor compliance/noncompliance|0|||
124970687|NCT01628692|449519354|FG000|Overall Study|Administrative reason by sponsor|0|||
124970688|NCT01628692|449519355|FG001|Overall Study|Administrative reason by sponsor|0|||
124970689|NCT01628692|449519356|FG002|Overall Study|Administrative reason by sponsor|0|||
124970690|NCT01628692|449519357|FG003|Overall Study|Administrative reason by sponsor|0|||
124970691|NCT01628692|449519358|FG004|Overall Study|Administrative reason by sponsor|0|||
124970692|NCT01628692|449519359|FG005|Overall Study|Administrative reason by sponsor|1|||
124970693|NCT01628692|449519354|FG000|Overall Study|Completed 12 Week only|0|||
124970694|NCT01628692|449519355|FG001|Overall Study|Completed 12 Week only|0|||
124970695|NCT01628692|449519356|FG002|Overall Study|Completed 12 Week only|0|||
124970696|NCT01628692|449519357|FG003|Overall Study|Completed 12 Week only|0|||
124970697|NCT01628692|449519358|FG004|Overall Study|Completed 12 Week only|0|||
124970698|NCT01628692|449519359|FG005|Overall Study|Completed 12 Week only|1|||
124970699|NCT02196077|449519361|FG000|Overall Study|Adverse Event|4|||
124970700|NCT02196077|449519361|FG000|Overall Study|Lack of Efficacy|1|||
124970701|NCT02196077|449519361|FG000|Overall Study|Withdrawal by Subject|14|||
124970702|NCT02196077|449519361|FG000|Overall Study|Physician Decision|1|||
124970703|NCT02196077|449519361|FG000|Overall Study|Lost to Follow-up|3|||
124970704|NCT02196077|449519361|FG000|Overall Study|Protocol Violation|24|||
124970705|NCT02781311|449519366|FG000|Overall Study|Adverse Event|2|||
124970706|NCT02781311|449519367|FG001|Overall Study|Adverse Event|6|||
124970707|NCT02781311|449519368|FG002|Overall Study|Adverse Event|1|||
124970708|NCT02781311|449519366|FG000|Overall Study|Withdrawal of Consent|11|||
124970709|NCT02781311|449519367|FG001|Overall Study|Withdrawal of Consent|12|||
124970710|NCT02781311|449519368|FG002|Overall Study|Withdrawal of Consent|2|||
124970711|NCT02781311|449519366|FG000|Overall Study|Lost to Follow-up|11|||
124970712|NCT02781311|449519367|FG001|Overall Study|Lost to Follow-up|8|||
124970713|NCT02781311|449519368|FG002|Overall Study|Lost to Follow-up|1|||
124970714|NCT02781311|449519366|FG000|Overall Study|Non-Compliance with Study Drug|2|||
124551452|NCT04318535|447976439|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
124970715|NCT02781311|449519367|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124970716|NCT02781311|449519368|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124970717|NCT01056263|449519369|FG000|Overall Study|Adverse Event|12|||
124970718|NCT01056263|449519369|FG000|Overall Study|Death|1|||
124970719|NCT01056263|449519369|FG000|Overall Study|Withdrawal by Subject|1|||
124970720|NCT01056263|449519369|FG000|Overall Study|Lack of Efficacy|29|||
124970721|NCT01056263|449519369|FG000|Overall Study|Progressive disease|2|||
124551453|NCT04318535|447976440|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
124551454|NCT01678924|447976442|FG000|Overall Study|Adverse Event|1|||
124466898|NCT01790503|447668789|FG000|Overall Study|Physician Decision|0|||
124466899|NCT01790503|447668790|FG001|Overall Study|Physician Decision|0|||
124466900|NCT01790503|447668791|FG002|Overall Study|Physician Decision|0|||
124466901|NCT01790503|447668792|FG003|Overall Study|Physician Decision|0|||
124466902|NCT01790503|447668793|FG004|Overall Study|Physician Decision|0|||
124466903|NCT01790503|447668794|FG005|Overall Study|Physician Decision|0|||
124466904|NCT01790503|447668795|FG006|Overall Study|Physician Decision|0|||
124466905|NCT01790503|447668796|FG007|Overall Study|Physician Decision|0|||
124466906|NCT01790503|447668797|FG008|Overall Study|Physician Decision|0|||
124466907|NCT01790503|447668798|FG009|Overall Study|Physician Decision|1|||
124466908|NCT01790503|447668799|FG010|Overall Study|Physician Decision|1|||
124466909|NCT01790503|447668789|FG000|Overall Study|Death|0|||
124466910|NCT01790503|447668790|FG001|Overall Study|Death|0|||
124466911|NCT01790503|447668791|FG002|Overall Study|Death|0|||
124466912|NCT01790503|447668792|FG003|Overall Study|Death|0|||
124466913|NCT01790503|447668793|FG004|Overall Study|Death|0|||
124466914|NCT01790503|447668794|FG005|Overall Study|Death|0|||
124466915|NCT01790503|447668795|FG006|Overall Study|Death|0|||
124466916|NCT01790503|447668796|FG007|Overall Study|Death|0|||
124466917|NCT01790503|447668797|FG008|Overall Study|Death|0|||
124466918|NCT01790503|447668798|FG009|Overall Study|Death|1|||
124466919|NCT01790503|447668799|FG010|Overall Study|Death|0|||
124551455|NCT01678924|447976443|FG001|Overall Study|Adverse Event|1|||
124551456|NCT01678924|447976444|FG002|Overall Study|Adverse Event|0|||
124466920|NCT01790503|447668789|FG000|Overall Study|Non Compliance|0|||
124466921|NCT01790503|447668790|FG001|Overall Study|Non Compliance|0|||
124466922|NCT01790503|447668791|FG002|Overall Study|Non Compliance|0|||
124466923|NCT01790503|447668792|FG003|Overall Study|Non Compliance|0|||
124466924|NCT01790503|447668793|FG004|Overall Study|Non Compliance|1|||
124466925|NCT01790503|447668794|FG005|Overall Study|Non Compliance|0|||
124466926|NCT01790503|447668795|FG006|Overall Study|Non Compliance|0|||
124712823|NCT02848092|448574446|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
124712824|NCT02848092|448574447|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
124712825|NCT02848092|448574446|FG000|1-month Post-training Follow-up|Adverse Event|2|||
124712826|NCT02848092|448574447|FG001|1-month Post-training Follow-up|Adverse Event|1|||
124712827|NCT02848092|448574446|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
124712828|NCT02848092|448574447|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
124712829|NCT02848092|448574446|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
124970722|NCT01056263|449519369|FG000|Overall Study|Neoplasm progression|1|||
124970723|NCT01056263|449519369|FG000|Overall Study|Objective progression or relapse|1|||
124970724|NCT01056263|449519369|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
124970725|NCT01262092|449519370|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
124970726|NCT01262092|449519371|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
124970727|NCT01262092|449519370|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
124970728|NCT01262092|449519371|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
124970729|NCT01262092|449519370|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
124970730|NCT01262092|449519371|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
124970731|NCT01262092|449519370|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
124970732|NCT01262092|449519371|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
124970733|NCT00699842|449519374|FG000|Overall Study|Death|0|||
124970734|NCT00699842|449519375|FG001|Overall Study|Death|1|||
124970735|NCT00699842|449519376|FG002|Overall Study|Death|0|||
124970736|NCT03023423|449519377|FG000|Overall Study|Death|5|||
124970737|NCT03023423|449519378|FG001|Overall Study|Death|12|||
124970738|NCT03023423|449519379|FG002|Overall Study|Death|20|||
124970739|NCT03023423|449519377|FG000|Overall Study|Other|0|||
124970740|NCT03023423|449519378|FG001|Overall Study|Other|2|||
124970741|NCT03023423|449519379|FG002|Overall Study|Other|2|||
124970742|NCT03023423|449519377|FG000|Overall Study|Ongoing|2|||
124970743|NCT03023423|449519378|FG001|Overall Study|Ongoing|32|||
124970744|NCT03023423|449519379|FG002|Overall Study|Ongoing|24|||
124970745|NCT03512197|449519380|FG000|Overall Study|Guardian decision|1|||
124970746|NCT03512197|449519381|FG001|Overall Study|Guardian decision|1|||
124970747|NCT03512197|449519380|FG000|Overall Study|Lack of Efficacy|19|||
124970748|NCT03512197|449519381|FG001|Overall Study|Lack of Efficacy|11|||
124970749|NCT03512197|449519380|FG000|Overall Study|New Therapy for Study Indication|16|||
124970750|NCT03512197|449519381|FG001|Overall Study|New Therapy for Study Indication|16|||
124970751|NCT03512197|449519380|FG000|Overall Study|Physician Decision|60|||
124970752|NCT03512197|449519381|FG001|Overall Study|Physician Decision|60|||
124970753|NCT03512197|449519380|FG000|Overall Study|Protocol Violation|0|||
124970754|NCT03512197|449519381|FG001|Overall Study|Protocol Violation|2|||
124970755|NCT03512197|449519380|FG000|Overall Study|Terminated by Sponsored|46|||
124970756|NCT03512197|449519381|FG001|Overall Study|Terminated by Sponsored|50|||
124970757|NCT03512197|449519380|FG000|Overall Study|Subject Decision|15|||
124970758|NCT03512197|449519381|FG001|Overall Study|Subject Decision|12|||
124970759|NCT03512197|449519380|FG000|Overall Study|Withdrawal of informed consent|20|||
124970760|NCT03512197|449519381|FG001|Overall Study|Withdrawal of informed consent|14|||
124970761|NCT03512197|449519380|FG000|Overall Study|Adverse Event|30|||
124970762|NCT03512197|449519381|FG001|Overall Study|Adverse Event|34|||
124970763|NCT03512197|449519380|FG000|Overall Study|Death|14|||
124970764|NCT03512197|449519381|FG001|Overall Study|Death|9|||
124970765|NCT03512197|449519380|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
124970766|NCT03512197|449519381|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
124970767|NCT03512197|449519380|FG000|Overall Study|Missing|3|||
124970768|NCT03512197|449519381|FG001|Overall Study|Missing|13|||
124970769|NCT03842436|449519382|FG000|Overall Study|Lost to Follow-up|1|||
124970770|NCT01806389|449519383|FG000|Overall Study|Withdrawal by Subject|4|||
124970771|NCT01310699|449519386|FG000|Overall Study|Patients did not complete tandem.|4|||
124970772|NCT01310699|449519387|FG001|Overall Study|Patients did not complete tandem.|6|||
124970773|NCT00936598|449519388|FG000|Overall Study|Withdrawal by Subject|1|||
124970774|NCT00936598|449519389|FG001|Overall Study|Withdrawal by Subject|0|||
124970775|NCT00936598|449519388|FG000|Overall Study|Ineligible after consent|1|||
124970776|NCT00936598|449519389|FG001|Overall Study|Ineligible after consent|0|||
124712830|NCT02848092|448574447|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
124712831|NCT02848092|448574446|FG000|1-month Post-training Follow-up|fatigue|0|||
124970777|NCT00926575|449519390|FG000|Overall Study|Adverse Event|1|||
124970778|NCT00926575|449519391|FG001|Overall Study|Adverse Event|1|||
124970779|NCT00926575|449519390|FG000|Overall Study|Death|4|||
124970780|NCT00926575|449519391|FG001|Overall Study|Death|4|||
124970781|NCT00926575|449519390|FG000|Overall Study|Lost to Follow-up|1|||
124970782|NCT00926575|449519391|FG001|Overall Study|Lost to Follow-up|1|||
124970783|NCT00926575|449519390|FG000|Overall Study|Physician Decision|1|||
124970784|NCT00926575|449519391|FG001|Overall Study|Physician Decision|2|||
124970785|NCT00926575|449519390|FG000|Overall Study|Protocol Violation|1|||
124712832|NCT02848092|448574447|FG001|1-month Post-training Follow-up|fatigue|1|||
124712833|NCT02848092|448574446|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
124712834|NCT02848092|448574447|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
124712835|NCT02848092|448574446|FG000|6-month Post-training Follow-up|Adverse Event|1|||
124712836|NCT02848092|448574447|FG001|6-month Post-training Follow-up|Adverse Event|1|||
124712837|NCT02848092|448574446|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
124712838|NCT02848092|448574447|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
124712839|NCT02848092|448574446|FG000|6-month Post-training Follow-up|frustrated with task|1|||
124712840|NCT02848092|448574447|FG001|6-month Post-training Follow-up|frustrated with task|0|||
124770118|NCT03050801|448786839|FG003|Experiment 2|Withdrawal by Subject|1|||
124770119|NCT03050801|448786840|FG004|Experiment 2|Withdrawal by Subject|0|||
124770120|NCT03050801|448786841|FG005|Experiment 2|Withdrawal by Subject|0|||
124770121|NCT03050801|448786836|FG000|Experiment 2|Poor data quality|0|||
124770122|NCT03050801|448786837|FG001|Experiment 2|Poor data quality|0|||
124770123|NCT03050801|448786838|FG002|Experiment 2|Poor data quality|0|||
124770124|NCT03050801|448786839|FG003|Experiment 2|Poor data quality|4|||
124770125|NCT03050801|448786840|FG004|Experiment 2|Poor data quality|1|||
124770126|NCT03050801|448786841|FG005|Experiment 2|Poor data quality|0|||
124770127|NCT03050801|448786836|FG000|Experiment 2|Discomfort during stimulation|0|||
124770128|NCT03050801|448786837|FG001|Experiment 2|Discomfort during stimulation|0|||
124770129|NCT03050801|448786838|FG002|Experiment 2|Discomfort during stimulation|0|||
124770130|NCT03050801|448786839|FG003|Experiment 2|Discomfort during stimulation|0|||
124770131|NCT03050801|448786840|FG004|Experiment 2|Discomfort during stimulation|0|||
124770132|NCT03050801|448786841|FG005|Experiment 2|Discomfort during stimulation|2|||
124770133|NCT03600909|448786842|FG000|Overall Study|Not treated|0|||
124770134|NCT03600909|448786843|FG001|Overall Study|Not treated|3|||
124770135|NCT03600909|448786844|FG002|Overall Study|Not treated|0|||
124770136|NCT04973449|448786845|FG000|Overall Study|Withdrawal by Subject|3|||
124770137|NCT04973449|448786846|FG001|Overall Study|Withdrawal by Subject|3|||
124770138|NCT04973449|448786847|FG002|Overall Study|Withdrawal by Subject|2|||
124770139|NCT04973449|448786848|FG003|Overall Study|Withdrawal by Subject|5|||
124770140|NCT04973449|448786849|FG004|Overall Study|Withdrawal by Subject|5|||
124770141|NCT04973449|448786850|FG005|Overall Study|Withdrawal by Subject|4|||
124770142|NCT04973449|448786851|FG006|Overall Study|Withdrawal by Subject|7|||
124770143|NCT04973449|448786852|FG007|Overall Study|Withdrawal by Subject|5|||
124770144|NCT04973449|448786845|FG000|Overall Study|Lost to Follow-up|15|||
124770145|NCT04973449|448786846|FG001|Overall Study|Lost to Follow-up|16|||
124770146|NCT04973449|448786847|FG002|Overall Study|Lost to Follow-up|16|||
124770147|NCT04973449|448786848|FG003|Overall Study|Lost to Follow-up|13|||
124770148|NCT04973449|448786849|FG004|Overall Study|Lost to Follow-up|5|||
124770149|NCT04973449|448786850|FG005|Overall Study|Lost to Follow-up|6|||
124770150|NCT04973449|448786851|FG006|Overall Study|Lost to Follow-up|10|||
124770151|NCT04973449|448786852|FG007|Overall Study|Lost to Follow-up|6|||
124970786|NCT00926575|449519391|FG001|Overall Study|Protocol Violation|0|||
124970787|NCT00926575|449519390|FG000|Overall Study|Withdrawal by Subject|8|||
124970788|NCT00926575|449519391|FG001|Overall Study|Withdrawal by Subject|9|||
124970789|NCT00490698|449519394|FG000|Overall Study|Withdrawal by Subject|1|||
124970790|NCT00490698|449519394|FG000|Overall Study|Disease Progression|7|||
124970791|NCT00490698|449519394|FG000|Overall Study|Physician Decision|2|||
124970792|NCT02201901|449519395|FG000|Overall Study|Randomized but never treated|0|||
124970793|NCT02201901|449519396|FG001|Overall Study|Randomized but never treated|1|||
124970794|NCT02201901|449519397|FG002|Overall Study|Randomized but never treated|0|||
124970795|NCT02201901|449519395|FG000|Overall Study|Lack of Efficacy|7|||
124712841|NCT02848092|448574446|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
124712842|NCT02848092|448574447|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
124712843|NCT02848092|448574446|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
124712844|NCT02848092|448574447|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
124712845|NCT02329743|448574451|FG000|Overall Study|Adverse Event|1|||
124712846|NCT02329743|448574452|FG001|Overall Study|Adverse Event|1|||
124712847|NCT02329743|448574453|FG002|Overall Study|Adverse Event|3|||
124712848|NCT02329743|448574451|FG000|Overall Study|Lost to Follow-up|1|||
124712849|NCT02329743|448574452|FG001|Overall Study|Lost to Follow-up|0|||
124770152|NCT04973449|448786845|FG000|Overall Study|Death|1|||
124770153|NCT04973449|448786846|FG001|Overall Study|Death|0|||
124770154|NCT04973449|448786847|FG002|Overall Study|Death|0|||
124770155|NCT04973449|448786848|FG003|Overall Study|Death|0|||
124770156|NCT04973449|448786849|FG004|Overall Study|Death|0|||
124770157|NCT04973449|448786850|FG005|Overall Study|Death|1|||
124770158|NCT04973449|448786851|FG006|Overall Study|Death|0|||
124770159|NCT04973449|448786852|FG007|Overall Study|Death|0|||
124770160|NCT04973449|448786845|FG000|Overall Study|Other|1|||
124770161|NCT04973449|448786846|FG001|Overall Study|Other|1|||
124770162|NCT04973449|448786847|FG002|Overall Study|Other|2|||
124770163|NCT04973449|448786848|FG003|Overall Study|Other|1|||
124770164|NCT04973449|448786849|FG004|Overall Study|Other|4|||
124970796|NCT02201901|449519396|FG001|Overall Study|Lack of Efficacy|1|||
124466927|NCT01790503|447668796|FG007|Overall Study|Non Compliance|0|||
124551457|NCT01678924|447976445|FG003|Overall Study|Adverse Event|1|||
124712850|NCT02329743|448574453|FG002|Overall Study|Lost to Follow-up|1|||
124712851|NCT02329743|448574451|FG000|Overall Study|Withdrawal by Subject|4|||
124712852|NCT02329743|448574452|FG001|Overall Study|Withdrawal by Subject|4|||
124712853|NCT02329743|448574453|FG002|Overall Study|Withdrawal by Subject|1|||
124712854|NCT02329743|448574451|FG000|Overall Study|Other|0|||
124712855|NCT02329743|448574452|FG001|Overall Study|Other|2|||
124712856|NCT02329743|448574453|FG002|Overall Study|Other|3|||
124712857|NCT02078752|448574461|FG000|Overall Study|Death|0|||
124712858|NCT02078752|448574462|FG001|Overall Study|Death|3|||
124712859|NCT02078752|448574463|FG002|Overall Study|Death|0|||
124712860|NCT02078752|448574464|FG003|Overall Study|Death|0|||
124712861|NCT02078752|448574465|FG004|Overall Study|Death|0|||
124712862|NCT02078752|448574466|FG005|Overall Study|Death|1|||
124712863|NCT02078752|448574467|FG006|Overall Study|Death|0|||
124712864|NCT02078752|448574468|FG007|Overall Study|Death|1|||
124712865|NCT02078752|448574469|FG008|Overall Study|Death|0|||
124712866|NCT02078752|448574470|FG009|Overall Study|Death|4|||
124712867|NCT02078752|448574461|FG000|Overall Study|Lost to Follow-up|1|||
124712868|NCT02078752|448574462|FG001|Overall Study|Lost to Follow-up|0|||
124712869|NCT02078752|448574463|FG002|Overall Study|Lost to Follow-up|0|||
124712870|NCT02078752|448574464|FG003|Overall Study|Lost to Follow-up|1|||
124712871|NCT02078752|448574465|FG004|Overall Study|Lost to Follow-up|0|||
124712872|NCT02078752|448574466|FG005|Overall Study|Lost to Follow-up|0|||
124712873|NCT02078752|448574467|FG006|Overall Study|Lost to Follow-up|0|||
124712874|NCT02078752|448574468|FG007|Overall Study|Lost to Follow-up|0|||
124712875|NCT02078752|448574469|FG008|Overall Study|Lost to Follow-up|0|||
124712876|NCT02078752|448574470|FG009|Overall Study|Lost to Follow-up|0|||
124712877|NCT02078752|448574461|FG000|Overall Study|Withdrawal by Subject|1|||
124712878|NCT02078752|448574462|FG001|Overall Study|Withdrawal by Subject|1|||
124712879|NCT02078752|448574463|FG002|Overall Study|Withdrawal by Subject|1|||
124712880|NCT02078752|448574464|FG003|Overall Study|Withdrawal by Subject|1|||
124712881|NCT02078752|448574465|FG004|Overall Study|Withdrawal by Subject|0|||
124712882|NCT02078752|448574466|FG005|Overall Study|Withdrawal by Subject|3|||
124712883|NCT02078752|448574467|FG006|Overall Study|Withdrawal by Subject|2|||
124712884|NCT02078752|448574468|FG007|Overall Study|Withdrawal by Subject|1|||
124712885|NCT02078752|448574469|FG008|Overall Study|Withdrawal by Subject|0|||
124712886|NCT02078752|448574470|FG009|Overall Study|Withdrawal by Subject|1|||
124770165|NCT04973449|448786850|FG005|Overall Study|Other|0|||
124770166|NCT04973449|448786851|FG006|Overall Study|Other|2|||
124712887|NCT02078752|448574461|FG000|Overall Study|Other|0|||
124712888|NCT02078752|448574462|FG001|Overall Study|Other|3|||
124712889|NCT02078752|448574463|FG002|Overall Study|Other|0|||
124712890|NCT02078752|448574464|FG003|Overall Study|Other|0|||
124712891|NCT02078752|448574465|FG004|Overall Study|Other|1|||
124712892|NCT02078752|448574466|FG005|Overall Study|Other|0|||
124551458|NCT01678924|447976442|FG000|Overall Study|Lack of Efficacy|7|||
124712893|NCT02078752|448574467|FG006|Overall Study|Other|0|||
124712894|NCT02078752|448574468|FG007|Overall Study|Other|1|||
124712895|NCT02078752|448574469|FG008|Overall Study|Other|0|||
124712896|NCT02078752|448574470|FG009|Overall Study|Other|0|||
124770167|NCT04973449|448786852|FG007|Overall Study|Other|2|||
124770168|NCT00521079|448786853|FG000|Overall Study|Adverse Event|7|||
124770169|NCT00521079|448786854|FG001|Overall Study|Adverse Event|1|||
124770170|NCT00521079|448786853|FG000|Overall Study|Lost to Follow-up|2|||
124770171|NCT00521079|448786854|FG001|Overall Study|Lost to Follow-up|1|||
124770172|NCT00521079|448786853|FG000|Overall Study|Withdrawal by Subject|5|||
124770173|NCT00521079|448786854|FG001|Overall Study|Withdrawal by Subject|3|||
124770174|NCT02651675|448786855|FG000|Overall Study|Death|0|||
124770175|NCT02651675|448786856|FG001|Overall Study|Death|0|||
124770176|NCT02651675|448786857|FG002|Overall Study|Death|1|||
124770177|NCT03674411|448786858|FG000|Overall Study|Non-treatment|4|||
124770178|NCT01506596|448786860|FG000|Overall Study|ineligible pathology|1|||
124770179|NCT04606134|448786867|FG000|Overall Study|Adverse Event|0|||
124770180|NCT04606134|448786868|FG001|Overall Study|Adverse Event|1|||
124770181|NCT01099267|448786869|FG000|MDS-003 Study|Adverse Event|37|||
124770182|NCT01099267|448786869|FG000|MDS-003 Study|Lack of Efficacy|52|||
124770183|NCT01099267|448786869|FG000|MDS-003 Study|Withdrawal by Subject|8|||
124770184|NCT01099267|448786869|FG000|MDS-003 Study|Lost to Follow-up|1|||
124770185|NCT01099267|448786869|FG000|MDS-003 Study|Death|11|||
124770186|NCT01099267|448786869|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
124770187|NCT01099267|448786869|FG000|MDS-003 Study|Disease Progression|7|||
124770188|NCT01099267|448786869|FG000|MDS-003 Study|Investigator Decision|2|||
124770189|NCT01099267|448786869|FG000|MDS-003 Study|Non-Compliance|2|||
124770190|NCT01099267|448786869|FG000|MDS-003 Study|Loss of Response|1|||
124770191|NCT01099267|448786869|FG000|MDS-003 Study|Secondary Malign Disease|1|||
124770192|NCT04050553|448786878|FG000|Period 1|Physician Decision|2|||
124770193|NCT04050553|448786879|FG001|Period 1|Physician Decision|2|||
124770194|NCT04050553|448786878|FG000|Period 1|Adverse Event|1|||
124770195|NCT04050553|448786879|FG001|Period 1|Adverse Event|1|||
124770196|NCT04050553|448786878|FG000|Period 1|Withdrawal by Subject|0|||
124770197|NCT04050553|448786879|FG001|Period 1|Withdrawal by Subject|1|||
124770198|NCT04050553|448786878|FG000|Wash-out|Adverse Event|0|||
124770199|NCT04050553|448786879|FG001|Wash-out|Adverse Event|1|||
124770200|NCT04050553|448786878|FG000|Wash-out|Withdrawal by Subject|0|||
124770201|NCT04050553|448786879|FG001|Wash-out|Withdrawal by Subject|1|||
124770202|NCT03472885|448786882|FG000|24-Week Treatment Period|Adverse Event|1|||
124770203|NCT02201953|448786883|FG000|Overall Study|Randomized but Never Treated|1|||
124770204|NCT02201953|448786884|FG001|Overall Study|Randomized but Never Treated|5|||
124770205|NCT02201953|448786883|FG000|Overall Study|Lack of Efficacy|9|||
124770206|NCT02201953|448786884|FG001|Overall Study|Lack of Efficacy|30|||
124770207|NCT02201953|448786883|FG000|Overall Study|Lost to Follow-up|8|||
124770208|NCT02201953|448786884|FG001|Overall Study|Lost to Follow-up|8|||
124770209|NCT02201953|448786883|FG000|Overall Study|Withdrew Consent|2|||
124770210|NCT02201953|448786884|FG001|Overall Study|Withdrew Consent|5|||
124770211|NCT02201953|448786883|FG000|Overall Study|Adverse Event|0|||
124770212|NCT02201953|448786884|FG001|Overall Study|Adverse Event|5|||
124770213|NCT02201953|448786883|FG000|Overall Study|Death|0|||
124770214|NCT02201953|448786884|FG001|Overall Study|Death|3|||
124770215|NCT01615939|448788729|FG000|Overall Study|Lost to Follow-up|5|||
124770216|NCT01615939|448788730|FG001|Overall Study|Lost to Follow-up|0|||
124770217|NCT02892344|448788734|FG000|Overall Study|Protocol deviation|3|||
124770218|NCT02892344|448788735|FG001|Overall Study|Protocol deviation|4|||
124770219|NCT02892344|448788734|FG000|Overall Study|Adverse Event|1|||
124770220|NCT02892344|448788735|FG001|Overall Study|Adverse Event|8|||
124770221|NCT02892344|448788734|FG000|Overall Study|Lost to Follow-up|0|||
124770222|NCT02892344|448788735|FG001|Overall Study|Lost to Follow-up|1|||
124770223|NCT02892344|448788734|FG000|Overall Study|Non-compliance with study treatment|0|||
124770224|NCT02892344|448788735|FG001|Overall Study|Non-compliance with study treatment|1|||
124770225|NCT02892344|448788734|FG000|Overall Study|Physician Decision|0|||
124770226|NCT02892344|448788735|FG001|Overall Study|Physician Decision|2|||
124970797|NCT02201901|449519397|FG002|Overall Study|Lack of Efficacy|6|||
124970798|NCT02201901|449519395|FG000|Overall Study|Death|3|||
124770227|NCT02892344|448788734|FG000|Overall Study|Subject/guardian decision|0|||
124770228|NCT02892344|448788735|FG001|Overall Study|Subject/guardian decision|4|||
124770229|NCT02892344|448788734|FG000|Overall Study|Technical problems|0|||
124770230|NCT02892344|448788735|FG001|Overall Study|Technical problems|1|||
124770231|NCT01520506|448788736|FG000|Overall Study|Missed Visit|4|||
124770232|NCT01520506|448788736|FG000|Overall Study|Lost to Follow-up|1|||
124770233|NCT01520506|448788736|FG000|Overall Study|Withdrawal by Subject|1|||
124770234|NCT00425269|448788737|FG000|Overall Study|Pregnancy|5|||
124770235|NCT00425269|448788738|FG001|Overall Study|Pregnancy|7|||
124770236|NCT00425269|448788737|FG000|Overall Study|Lost to Follow-up|9|||
124970799|NCT02201901|449519396|FG001|Overall Study|Death|3|||
124770237|NCT00425269|448788738|FG001|Overall Study|Lost to Follow-up|9|||
124770238|NCT00425269|448788737|FG000|Overall Study|moved or medical reason|5|||
124770239|NCT00425269|448788738|FG001|Overall Study|moved or medical reason|4|||
124770240|NCT01084655|448788743|FG000|Overall Study|Radiographic disease progression|3|||
124770241|NCT01084655|448788744|FG001|Overall Study|Radiographic disease progression|2|||
124770242|NCT01084655|448788745|FG002|Overall Study|Radiographic disease progression|8|||
124770243|NCT01084655|448788743|FG000|Overall Study|Withdrawal by Subject|1|||
124712897|NCT02078752|448574461|FG000|Overall Study|Study terminated by sponsor|0|||
124712898|NCT02078752|448574462|FG001|Overall Study|Study terminated by sponsor|0|||
124712899|NCT02078752|448574463|FG002|Overall Study|Study terminated by sponsor|0|||
124712900|NCT02078752|448574464|FG003|Overall Study|Study terminated by sponsor|0|||
124970800|NCT02201901|449519397|FG002|Overall Study|Death|3|||
124970801|NCT02201901|449519395|FG000|Overall Study|Lost to Follow-up|2|||
124970802|NCT02201901|449519396|FG001|Overall Study|Lost to Follow-up|3|||
124970803|NCT02201901|449519397|FG002|Overall Study|Lost to Follow-up|2|||
124970804|NCT02201901|449519395|FG000|Overall Study|Withdrew Consent|2|||
124970805|NCT02201901|449519396|FG001|Overall Study|Withdrew Consent|0|||
124970806|NCT02201901|449519397|FG002|Overall Study|Withdrew Consent|2|||
124970807|NCT02201901|449519395|FG000|Overall Study|Adverse Event|1|||
124970808|NCT02201901|449519396|FG001|Overall Study|Adverse Event|1|||
124970809|NCT02201901|449519397|FG002|Overall Study|Adverse Event|0|||
124970810|NCT03358238|449519401|FG000|Overall Study|Withdrawal by Subject|0|||
124970811|NCT03358238|449519402|FG001|Overall Study|Withdrawal by Subject|1|||
124970812|NCT04277507|449519405|FG000|Overall Study|Lost to Follow-up|17|||
124970813|NCT04277507|449519405|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
124970814|NCT04277507|449519405|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
124970815|NCT04277507|449519405|FG000|Overall Study|Withdrawal by Subject|3|||
124970816|NCT04277507|449519405|FG000|Overall Study|Death due to COVID-19|1|||
124970817|NCT04277507|449519405|FG000|Overall Study|Data missing for full evaluation|5|||
124970818|NCT01431950|449519406|FG000|Overall Study|Study Site Closed/Terminated|7|||
124970819|NCT01431950|449519407|FG001|Overall Study|Study Site Closed/Terminated|3|||
124970820|NCT01431950|449519406|FG000|Overall Study|Withdrawal by Subject|4|||
124970821|NCT01431950|449519407|FG001|Overall Study|Withdrawal by Subject|3|||
124970822|NCT01431950|449519406|FG000|Overall Study|Protocol Violation|2|||
124970823|NCT01431950|449519407|FG001|Overall Study|Protocol Violation|3|||
124970824|NCT01431950|449519406|FG000|Overall Study|Adverse Event|2|||
124970825|NCT01431950|449519407|FG001|Overall Study|Adverse Event|2|||
124970826|NCT01431950|449519406|FG000|Overall Study|Physician Decision|2|||
124970827|NCT01431950|449519407|FG001|Overall Study|Physician Decision|1|||
124970828|NCT01431950|449519406|FG000|Overall Study|Lack of Efficacy|2|||
124970829|NCT01431950|449519407|FG001|Overall Study|Lack of Efficacy|1|||
124970830|NCT01431950|449519406|FG000|Overall Study|Lost to Follow-up|0|||
124970831|NCT01431950|449519407|FG001|Overall Study|Lost to Follow-up|1|||
124970832|NCT01431950|449519406|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
124970833|NCT01431950|449519407|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
124970834|NCT04577573|449519410|FG000|Overall Study|Technical - invalid protocol|0|||
124970835|NCT04577573|449519411|FG001|Overall Study|Technical - invalid protocol|2|||
124970836|NCT04577573|449519412|FG002|Overall Study|Technical - invalid protocol|0|||
124970837|NCT06719986|449519413|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
124970838|NCT06719986|449519414|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
124970839|NCT06719986|449519415|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
124970840|NCT06719986|449519413|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
124970841|NCT06719986|449519414|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
124970842|NCT06719986|449519415|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
124970843|NCT05992922|449519417|FG000|Overall Study|Adverse Event|6|||
124970844|NCT05992922|449519418|FG001|Overall Study|Adverse Event|0|||
124970845|NCT05992922|449519417|FG000|Overall Study|Sponsor Termination of Study|14|||
124970846|NCT05992922|449519418|FG001|Overall Study|Sponsor Termination of Study|20|||
124970847|NCT04596995|449521056|FG000|Overall Study|Lack of Efficacy|8|||
124970848|NCT04596995|449521056|FG000|Overall Study|Lost to Follow-up|3|||
124970849|NCT04596995|449521056|FG000|Overall Study|Withdrawal by Subject|12|||
124970850|NCT04596995|449521056|FG000|Overall Study|Sponsor decision|3|||
124970851|NCT04596995|449521056|FG000|Overall Study|Enrolled in managed access program|3|||
124970852|NCT00590564|449521058|FG000|Overall Study|Withdrawal by Subject|4|||
124970853|NCT00590564|449521058|FG000|Overall Study|Lost to Follow-up|6|||
124970854|NCT00590564|449521058|FG000|Overall Study|Protocol Violation|1|||
124712901|NCT02078752|448574465|FG004|Overall Study|Study terminated by sponsor|0|||
124712902|NCT02078752|448574466|FG005|Overall Study|Study terminated by sponsor|0|||
124712903|NCT02078752|448574467|FG006|Overall Study|Study terminated by sponsor|0|||
124970855|NCT00590564|449521058|FG000|Overall Study|Patient Found to be Ineligible|1|||
124970856|NCT00590564|449521058|FG000|Overall Study|Patient Non-compliance|6|||
124970857|NCT01434680|449521059|FG000|Overall Study|Withdrawal by Subject|1|||
124970858|NCT01434680|449521060|FG001|Overall Study|Withdrawal by Subject|0|||
124970859|NCT01434680|449521061|FG002|Overall Study|Withdrawal by Subject|2|||
124970860|NCT01434680|449521062|FG003|Overall Study|Withdrawal by Subject|0|||
124970861|NCT01434680|449521059|FG000|Overall Study|Lost to Follow-up|1|||
124970862|NCT01434680|449521060|FG001|Overall Study|Lost to Follow-up|1|||
124970863|NCT01434680|449521061|FG002|Overall Study|Lost to Follow-up|0|||
124970864|NCT01434680|449521062|FG003|Overall Study|Lost to Follow-up|0|||
124970865|NCT01434680|449521059|FG000|Overall Study|Protocol Violation|1|||
124712904|NCT02078752|448574468|FG007|Overall Study|Study terminated by sponsor|0|||
124712905|NCT02078752|448574469|FG008|Overall Study|Study terminated by sponsor|0|||
124712906|NCT02078752|448574470|FG009|Overall Study|Study terminated by sponsor|5|||
124970866|NCT01434680|449521060|FG001|Overall Study|Protocol Violation|1|||
124970867|NCT01434680|449521061|FG002|Overall Study|Protocol Violation|0|||
124970868|NCT01434680|449521062|FG003|Overall Study|Protocol Violation|0|||
124970869|NCT00983749|449521064|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
124970870|NCT00983749|449521065|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
124970871|NCT01952847|449521066|FG000|Overall Study|Ineligible|1|||
124970872|NCT01952847|449521067|FG001|Overall Study|Ineligible|0|||
124970873|NCT01952847|449521068|FG002|Overall Study|Ineligible|0|||
124970874|NCT01952847|449521069|FG003|Overall Study|Ineligible|0|||
124970875|NCT01952847|449521066|FG000|Overall Study|Lack of Insurance Coverage|0|||
124970876|NCT01952847|449521067|FG001|Overall Study|Lack of Insurance Coverage|1|||
124970877|NCT01952847|449521068|FG002|Overall Study|Lack of Insurance Coverage|0|||
124970878|NCT01952847|449521069|FG003|Overall Study|Lack of Insurance Coverage|0|||
124970879|NCT01952847|449521066|FG000|Overall Study|Withdrawal by Subject|1|||
124970880|NCT01952847|449521067|FG001|Overall Study|Withdrawal by Subject|1|||
124970881|NCT01952847|449521068|FG002|Overall Study|Withdrawal by Subject|0|||
124970882|NCT01952847|449521069|FG003|Overall Study|Withdrawal by Subject|1|||
124970883|NCT01907906|449521070|FG000|Overall Study|Withdrawal by Subject|1|||
124970884|NCT01907906|449521071|FG001|Overall Study|Withdrawal by Subject|0|||
124970885|NCT01907906|449521070|FG000|Overall Study|Physician Decision|3|||
124970886|NCT01907906|449521071|FG001|Overall Study|Physician Decision|1|||
124970887|NCT00121667|449521073|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
124970888|NCT00121667|449521074|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
124970889|NCT00121667|449521075|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
124970890|NCT00121667|449521076|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
124970891|NCT00121667|449521073|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
124970892|NCT00121667|449521074|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
124970893|NCT00121667|449521075|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
124970894|NCT00121667|449521076|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
124970895|NCT00121667|449521073|FG000|Short Term (ST) Period|Adverse Event|5|||
124970896|NCT00121667|449521074|FG001|Short Term (ST) Period|Adverse Event|6|||
124970897|NCT00121667|449521075|FG002|Short Term (ST) Period|Adverse Event|5|||
124970898|NCT00121667|449521076|FG003|Short Term (ST) Period|Adverse Event|3|||
124970899|NCT00121667|449521073|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
124970900|NCT00121667|449521074|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
124970901|NCT00121667|449521075|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
124970902|NCT00121667|449521076|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
124970903|NCT00121667|449521073|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
124970904|NCT00121667|449521074|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
124970905|NCT00121667|449521075|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
124970906|NCT00121667|449521076|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
124970907|NCT00121667|449521073|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
124970908|NCT00121667|449521074|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
124970909|NCT00121667|449521075|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
124970910|NCT00121667|449521076|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
124970911|NCT00121667|449521073|FG000|Short Term (ST) Period|Other Reason|3|||
124970912|NCT00121667|449521074|FG001|Short Term (ST) Period|Other Reason|0|||
124970913|NCT00121667|449521075|FG002|Short Term (ST) Period|Other Reason|0|||
124970914|NCT00121667|449521076|FG003|Short Term (ST) Period|Other Reason|0|||
124970915|NCT00121667|449521073|FG000|Short Term (ST) Period|Death|0|||
124970916|NCT00121667|449521074|FG001|Short Term (ST) Period|Death|0|||
124970917|NCT00121667|449521075|FG002|Short Term (ST) Period|Death|0|||
124970918|NCT00121667|449521076|FG003|Short Term (ST) Period|Death|1|||
124970919|NCT00121667|449521073|FG000|Short Term (ST) Period|Pregnancy|0|||
124970920|NCT00121667|449521074|FG001|Short Term (ST) Period|Pregnancy|0|||
124970921|NCT00121667|449521075|FG002|Short Term (ST) Period|Pregnancy|0|||
124970922|NCT00121667|449521076|FG003|Short Term (ST) Period|Pregnancy|1|||
124970923|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
124970924|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
124970925|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
124970926|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
124970927|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
124970928|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
124970929|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
124970930|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
124970931|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
124970932|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
124970933|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
124970934|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
124970935|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
124712907|NCT00616642|448574476|FG000|Overall Study|Withdrawal by Subject|0|||
124712908|NCT00616642|448574477|FG001|Overall Study|Withdrawal by Subject|1|||
124712909|NCT02141672|448574484|FG000|Overall Study|Adverse Event|0|||
124712910|NCT02141672|448574485|FG001|Overall Study|Adverse Event|1|||
124712911|NCT02141672|448574486|FG002|Overall Study|Adverse Event|0|||
124970936|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
124970937|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
124970938|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
124970939|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
124970940|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
124970941|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
124970942|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
124970943|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
124970944|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
124970945|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
124970946|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
124970947|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
124970948|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
124970949|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
124970950|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
124970951|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
124970952|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
124970953|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
124970954|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
124970955|NCT00121667|449521073|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
124970956|NCT00121667|449521074|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
124970957|NCT00121667|449521075|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
124970958|NCT00121667|449521076|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
124970959|NCT01453023|449521077|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
124970960|NCT01453023|449521078|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
124970961|NCT01453023|449521077|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
124970962|NCT01453023|449521078|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
124970963|NCT01453023|449521077|FG000|Treatment Period 2|Protocol Violation|0|||
124970964|NCT01453023|449521078|FG001|Treatment Period 2|Protocol Violation|1|||
124970965|NCT02879383|449521079|FG000|First 24 Weeks|Physician Decision|0|||
124970966|NCT02879383|449521080|FG001|First 24 Weeks|Physician Decision|1|||
124970967|NCT02879383|449521081|FG002|First 24 Weeks|Physician Decision|0|||
124970968|NCT02879383|449521082|FG003|First 24 Weeks|Physician Decision|0|||
124970969|NCT02413593|449521094|FG000|Overall Study|Lost to Follow-up|3|||
124970970|NCT02413593|449521094|FG000|Overall Study|Adverse Event|1|||
124970971|NCT00723125|449521095|FG000|Overall Study|Met Dx|1|||
124970972|NCT00723125|449521096|FG001|Overall Study|Met Dx|0|||
124970973|NCT00723125|449521095|FG000|Overall Study|Withdrawal by Subject|15|||
124970974|NCT00723125|449521096|FG001|Overall Study|Withdrawal by Subject|6|||
124970975|NCT00723125|449521095|FG000|Overall Study|Adverse Event|2|||
124712912|NCT02141672|448574484|FG000|Overall Study|Death|10|||
124712913|NCT02141672|448574485|FG001|Overall Study|Death|2|||
124712914|NCT02141672|448574486|FG002|Overall Study|Death|1|||
124712915|NCT02141672|448574484|FG000|Overall Study|Lack of Efficacy|0|||
124712916|NCT02141672|448574485|FG001|Overall Study|Lack of Efficacy|0|||
124712917|NCT02141672|448574486|FG002|Overall Study|Lack of Efficacy|2|||
124712918|NCT02141672|448574484|FG000|Overall Study|Lost to Follow-up|1|||
124970976|NCT00723125|449521096|FG001|Overall Study|Adverse Event|0|||
124970977|NCT03482752|449521100|FG000|Overall Study|Withdrawal by Subject|2|||
124970978|NCT03482752|449521100|FG000|Overall Study|Lost to Follow-up|1|||
124970979|NCT03482752|449521100|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
124970980|NCT01080300|449521102|FG000|Overall Study|Adverse Event|49|||
124712919|NCT02141672|448574485|FG001|Overall Study|Lost to Follow-up|1|||
124466928|NCT01790503|447668797|FG008|Overall Study|Non Compliance|0|||
124712920|NCT02141672|448574486|FG002|Overall Study|Lost to Follow-up|3|||
124712921|NCT02141672|448574484|FG000|Overall Study|Physician Decision|1|||
124712922|NCT02141672|448574485|FG001|Overall Study|Physician Decision|2|||
124770244|NCT01084655|448788744|FG001|Overall Study|Withdrawal by Subject|0|||
124770245|NCT01084655|448788745|FG002|Overall Study|Withdrawal by Subject|4|||
124770246|NCT01084655|448788743|FG000|Overall Study|Adverse Event|2|||
124770247|NCT01084655|448788744|FG001|Overall Study|Adverse Event|1|||
124770248|NCT01084655|448788745|FG002|Overall Study|Adverse Event|2|||
124770249|NCT01084655|448788743|FG000|Overall Study|Other|0|||
124770250|NCT01084655|448788744|FG001|Overall Study|Other|3|||
124770251|NCT01084655|448788745|FG002|Overall Study|Other|2|||
124770252|NCT01084655|448788743|FG000|Overall Study|Symptomatic deterioration|0|||
124770253|NCT01084655|448788744|FG001|Overall Study|Symptomatic deterioration|0|||
124770254|NCT01084655|448788745|FG002|Overall Study|Symptomatic deterioration|2|||
124770255|NCT01084655|448788743|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
124770256|NCT01084655|448788744|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
124770257|NCT01084655|448788745|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
124770258|NCT02419001|448788748|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
124770259|NCT02419001|448788749|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
124770260|NCT00535496|448788750|FG000|Overall Study|Lost to Follow-up|0|||
124770261|NCT00535496|448788751|FG001|Overall Study|Lost to Follow-up|1|||
124551459|NCT01678924|447976443|FG001|Overall Study|Lack of Efficacy|2|||
124770262|NCT00535496|448788752|FG002|Overall Study|Lost to Follow-up|0|||
124770263|NCT00535496|448788753|FG003|Overall Study|Lost to Follow-up|0|||
124770264|NCT00535496|448788750|FG000|Overall Study|Not treated with sugammadex|0|||
124770265|NCT00535496|448788751|FG001|Overall Study|Not treated with sugammadex|1|||
124770266|NCT00535496|448788752|FG002|Overall Study|Not treated with sugammadex|0|||
124466929|NCT01790503|447668798|FG009|Overall Study|Non Compliance|0|||
124466930|NCT01790503|447668799|FG010|Overall Study|Non Compliance|0|||
124466931|NCT01790503|447668789|FG000|Overall Study|Other|0|||
124466932|NCT01790503|447668790|FG001|Overall Study|Other|0|||
124466933|NCT01790503|447668791|FG002|Overall Study|Other|0|||
124466934|NCT01790503|447668792|FG003|Overall Study|Other|0|||
124466935|NCT01790503|447668793|FG004|Overall Study|Other|1|||
124466936|NCT01790503|447668794|FG005|Overall Study|Other|0|||
124466937|NCT01790503|447668795|FG006|Overall Study|Other|0|||
124466938|NCT01790503|447668796|FG007|Overall Study|Other|0|||
124466939|NCT01790503|447668797|FG008|Overall Study|Other|1|||
124466940|NCT01790503|447668798|FG009|Overall Study|Other|2|||
124466941|NCT01790503|447668799|FG010|Overall Study|Other|0|||
124466942|NCT02740478|447668802|FG000|Overall Study|Withdrawal by Subject|1|||
124466943|NCT01449708|447668805|FG000|Overall Study|Protocol Violation|0|||
124466944|NCT01449708|447668806|FG001|Overall Study|Protocol Violation|1|||
124466945|NCT01449708|447668805|FG000|Overall Study|surgical complication|1|||
124466946|NCT01449708|447668806|FG001|Overall Study|surgical complication|2|||
124466947|NCT01449708|447668805|FG000|Overall Study|respiratory failure|1|||
124466948|NCT01449708|447668806|FG001|Overall Study|respiratory failure|0|||
124466949|NCT00223496|447668809|FG000|Overall Study|screen failure|9|||
124466950|NCT00223496|447668809|FG000|Overall Study|Lost to Follow-up|4|||
124466951|NCT00223496|447668809|FG000|Overall Study|Lack of Efficacy|6|||
124712923|NCT02141672|448574486|FG002|Overall Study|Physician Decision|5|||
124712924|NCT02141672|448574484|FG000|Overall Study|Protocol Violation|0|||
124712925|NCT02141672|448574485|FG001|Overall Study|Protocol Violation|0|||
124712926|NCT02141672|448574486|FG002|Overall Study|Protocol Violation|1|||
124712927|NCT02141672|448574484|FG000|Overall Study|Withdrawal by Subject|3|||
124712928|NCT02141672|448574485|FG001|Overall Study|Withdrawal by Subject|2|||
124712929|NCT02141672|448574486|FG002|Overall Study|Withdrawal by Subject|5|||
124712930|NCT02141672|448574484|FG000|Overall Study|refused to follow-up|1|||
124712931|NCT02141672|448574485|FG001|Overall Study|refused to follow-up|0|||
124712932|NCT02141672|448574486|FG002|Overall Study|refused to follow-up|1|||
124712933|NCT00332696|448574494|FG000|Overall Study|Death|24|||
124712934|NCT00332696|448574495|FG001|Overall Study|Death|14|||
124970981|NCT01080300|449521103|FG001|Overall Study|Adverse Event|35|||
124970982|NCT01080300|449521102|FG000|Overall Study|Lack of Efficacy|12|||
124970983|NCT01080300|449521103|FG001|Overall Study|Lack of Efficacy|15|||
124970984|NCT01080300|449521102|FG000|Overall Study|Protocol Violation|7|||
124970985|NCT01080300|449521103|FG001|Overall Study|Protocol Violation|13|||
124970986|NCT01080300|449521102|FG000|Overall Study|Lost to Follow-up|10|||
124970987|NCT01080300|449521103|FG001|Overall Study|Lost to Follow-up|6|||
124970988|NCT01080300|449521102|FG000|Overall Study|Death|0|||
124970989|NCT01080300|449521103|FG001|Overall Study|Death|1|||
124970990|NCT01080300|449521102|FG000|Overall Study|Withdrawal by Subject|12|||
124970991|NCT01080300|449521103|FG001|Overall Study|Withdrawal by Subject|28|||
124970992|NCT01080300|449521102|FG000|Overall Study|Reasons not specified|4|||
124970993|NCT01080300|449521103|FG001|Overall Study|Reasons not specified|6|||
124970994|NCT01807182|449521104|FG000|Overall Study|Death|1|||
124970995|NCT01807182|449521104|FG000|Overall Study|New therapy|1|||
124970996|NCT01807182|449521104|FG000|Overall Study|Moved to hospice care|1|||
124970997|NCT01776008|449521105|FG000|Overall Study|ineligible|2|||
124970998|NCT03513068|449521108|FG000|Overall Study|Death|1|||
124970999|NCT03513068|449521109|FG001|Overall Study|Death|0|||
124971000|NCT03513068|449521108|FG000|Overall Study|Withdrawal by Subject|4|||
124971001|NCT03513068|449521109|FG001|Overall Study|Withdrawal by Subject|6|||
124971002|NCT00478205|449521110|FG000|Overall Study|Adverse Event|182|||
124971003|NCT00478205|449521111|FG001|Overall Study|Adverse Event|39|||
124971004|NCT00478205|449521110|FG000|Overall Study|Medication Non-compliance|9|||
124971005|NCT00478205|449521111|FG001|Overall Study|Medication Non-compliance|4|||
124971006|NCT00478205|449521110|FG000|Overall Study|Protocol Violation|15|||
124971007|NCT00478205|449521111|FG001|Overall Study|Protocol Violation|5|||
124971008|NCT00478205|449521110|FG000|Overall Study|Request of Investigator or Sponsor|4|||
124971009|NCT00478205|449521111|FG001|Overall Study|Request of Investigator or Sponsor|5|||
124466952|NCT00223496|447668809|FG000|Overall Study|Withdrawal by Subject|1|||
124466953|NCT00223496|447668809|FG000|Overall Study|Physician Decision|2|||
124466954|NCT05702515|447668810|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
124466955|NCT01784965|447668814|FG000|Overall Study|Withdrawal by Subject|6|||
124466956|NCT01784965|447668815|FG001|Overall Study|Withdrawal by Subject|3|||
124466957|NCT01784965|447668814|FG000|Overall Study|Adverse Event|0|||
124466958|NCT01784965|447668815|FG001|Overall Study|Adverse Event|8|||
124466959|NCT01491178|447668816|FG000|Overall Study|Adverse Event|1016|||
124712935|NCT00332696|448574494|FG000|Overall Study|Insufficient therapeutic effect|4|||
124971010|NCT00478205|449521110|FG000|Overall Study|Withdrawal by Subject|61|||
124971011|NCT00478205|449521111|FG001|Overall Study|Withdrawal by Subject|22|||
124971012|NCT00478205|449521110|FG000|Overall Study|Lack of Efficacy|1|||
124971013|NCT00478205|449521111|FG001|Overall Study|Lack of Efficacy|0|||
124466960|NCT01491178|447668816|FG000|Overall Study|Improvement of NVAF|210|||
124712936|NCT00332696|448574495|FG001|Overall Study|Insufficient therapeutic effect|11|||
124971014|NCT00478205|449521110|FG000|Overall Study|Other|24|||
124551460|NCT01678924|447976444|FG002|Overall Study|Lack of Efficacy|0|||
124971015|NCT00478205|449521111|FG001|Overall Study|Other|12|||
124971016|NCT00003477|449521114|FG000|Overall Study|Not evalauable|4|||
124971017|NCT01575873|449521115|FG000|Overall Study|Withdrawal by Subject|15|||
124971018|NCT01575873|449521116|FG001|Overall Study|Withdrawal by Subject|20|||
124971019|NCT01575873|449521117|FG002|Overall Study|Withdrawal by Subject|34|||
124971020|NCT01575873|449521118|FG003|Overall Study|Withdrawal by Subject|34|||
124971021|NCT01575873|449521115|FG000|Overall Study|Adverse Event|7|||
124971022|NCT01575873|449521116|FG001|Overall Study|Adverse Event|7|||
124971023|NCT01575873|449521117|FG002|Overall Study|Adverse Event|9|||
124971024|NCT01575873|449521118|FG003|Overall Study|Adverse Event|12|||
124971025|NCT01575873|449521115|FG000|Overall Study|Lost to Follow-up|1|||
124971026|NCT01575873|449521116|FG001|Overall Study|Lost to Follow-up|3|||
124971027|NCT01575873|449521117|FG002|Overall Study|Lost to Follow-up|13|||
124971028|NCT01575873|449521118|FG003|Overall Study|Lost to Follow-up|5|||
124971029|NCT01575873|449521115|FG000|Overall Study|Death|3|||
124971030|NCT01575873|449521116|FG001|Overall Study|Death|2|||
124971031|NCT01575873|449521117|FG002|Overall Study|Death|8|||
124971032|NCT01575873|449521118|FG003|Overall Study|Death|9|||
124971033|NCT01575873|449521115|FG000|Overall Study|Noncompliance|1|||
124971034|NCT01575873|449521116|FG001|Overall Study|Noncompliance|2|||
124971035|NCT01575873|449521117|FG002|Overall Study|Noncompliance|4|||
124971036|NCT01575873|449521118|FG003|Overall Study|Noncompliance|3|||
124971037|NCT01575873|449521115|FG000|Overall Study|Administrative decision|1|||
124971038|NCT01575873|449521116|FG001|Overall Study|Administrative decision|1|||
124971039|NCT01575873|449521117|FG002|Overall Study|Administrative decision|1|||
124971040|NCT01575873|449521118|FG003|Overall Study|Administrative decision|0|||
124971041|NCT01575873|449521115|FG000|Overall Study|Protocol deviation|0|||
124971042|NCT01575873|449521116|FG001|Overall Study|Protocol deviation|1|||
124971043|NCT01575873|449521117|FG002|Overall Study|Protocol deviation|0|||
124971044|NCT01575873|449521118|FG003|Overall Study|Protocol deviation|1|||
124971045|NCT01575873|449521115|FG000|Overall Study|Requirement for Alternative Therapy|0|||
124971046|NCT01575873|449521116|FG001|Overall Study|Requirement for Alternative Therapy|0|||
124971047|NCT01575873|449521117|FG002|Overall Study|Requirement for Alternative Therapy|1|||
124971048|NCT01575873|449521118|FG003|Overall Study|Requirement for Alternative Therapy|1|||
124971049|NCT01575873|449521115|FG000|Overall Study|Other|0|||
124971050|NCT01575873|449521116|FG001|Overall Study|Other|0|||
124971051|NCT01575873|449521117|FG002|Overall Study|Other|4|||
124971052|NCT01575873|449521118|FG003|Overall Study|Other|2|||
124551461|NCT01678924|447976445|FG003|Overall Study|Lack of Efficacy|5|||
124551462|NCT01678924|447976442|FG000|Overall Study|Lost to Follow-up|0|||
124551463|NCT01678924|447976443|FG001|Overall Study|Lost to Follow-up|4|||
124551464|NCT01678924|447976444|FG002|Overall Study|Lost to Follow-up|0|||
124551465|NCT01678924|447976445|FG003|Overall Study|Lost to Follow-up|2|||
124551466|NCT01678924|447976442|FG000|Overall Study|Personal Reasons|2|||
124551467|NCT01678924|447976443|FG001|Overall Study|Personal Reasons|2|||
124551468|NCT01678924|447976444|FG002|Overall Study|Personal Reasons|2|||
124551469|NCT01678924|447976445|FG003|Overall Study|Personal Reasons|7|||
124551470|NCT01678924|447976442|FG000|Overall Study|Withdrawal by Subject|0|||
124551471|NCT01678924|447976443|FG001|Overall Study|Withdrawal by Subject|3|||
124551472|NCT01678924|447976444|FG002|Overall Study|Withdrawal by Subject|0|||
124551473|NCT01678924|447976445|FG003|Overall Study|Withdrawal by Subject|2|||
124551474|NCT01678924|447976442|FG000|Overall Study|Unable to attend scheduled visits|0|||
124551475|NCT01678924|447976443|FG001|Overall Study|Unable to attend scheduled visits|0|||
124551476|NCT01678924|447976444|FG002|Overall Study|Unable to attend scheduled visits|0|||
124551477|NCT01678924|447976445|FG003|Overall Study|Unable to attend scheduled visits|1|||
124551478|NCT00640614|447976448|FG000|Overall Study|Lost to Follow-up|1|||
124971053|NCT01850030|449521119|FG000|Overall Study|Adverse Event|64|||
124551479|NCT00640614|447976449|FG001|Overall Study|Lost to Follow-up|0|||
124551480|NCT00529802|447976450|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
124971054|NCT01850030|449521120|FG001|Overall Study|Adverse Event|82|||
124971055|NCT01850030|449521119|FG000|Overall Study|Lack of Efficacy|3|||
124971056|NCT01850030|449521120|FG001|Overall Study|Lack of Efficacy|1|||
124971057|NCT01850030|449521119|FG000|Overall Study|Lost to Follow-up|5|||
124971058|NCT01850030|449521120|FG001|Overall Study|Lost to Follow-up|5|||
124971059|NCT01850030|449521119|FG000|Overall Study|Withdrawal by Subject|3|||
124971060|NCT01850030|449521120|FG001|Overall Study|Withdrawal by Subject|4|||
124971061|NCT01850030|449521119|FG000|Overall Study|Protocol Violation|24|||
124971062|NCT01850030|449521120|FG001|Overall Study|Protocol Violation|28|||
124971063|NCT01850030|449521119|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
124971064|NCT01850030|449521120|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
124971065|NCT00762476|449521121|FG000|Overall Study|Adverse Event|7|||
124971066|NCT00762476|449521122|FG001|Overall Study|Adverse Event|1|||
124971067|NCT00762476|449521121|FG000|Overall Study|Lost to Follow-up|2|||
124971068|NCT00762476|449521122|FG001|Overall Study|Lost to Follow-up|0|||
124971069|NCT00762476|449521121|FG000|Overall Study|Protocol Violation|5|||
124551481|NCT00529802|447976450|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
124551482|NCT00529802|447976450|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
124551483|NCT00529802|447976450|FG000|Evaluable for Primary Endpoint|Death|1|||
124971070|NCT00762476|449521122|FG001|Overall Study|Protocol Violation|6|||
124971071|NCT00762476|449521121|FG000|Overall Study|Physician Decision|2|||
124770267|NCT00535496|448788753|FG003|Overall Study|Not treated with sugammadex|0|||
124770268|NCT02326155|448788755|FG000|Overall Study|Adverse Event|21|||
124770269|NCT02326155|448788756|FG001|Overall Study|Adverse Event|5|||
124770270|NCT02326155|448788755|FG000|Overall Study|Death|3|||
124770271|NCT02326155|448788756|FG001|Overall Study|Death|0|||
124770272|NCT02326155|448788755|FG000|Overall Study|Lack of Efficacy|49|||
124770273|NCT02326155|448788756|FG001|Overall Study|Lack of Efficacy|5|||
124770274|NCT02326155|448788755|FG000|Overall Study|Lost to Follow-up|14|||
124770275|NCT02326155|448788756|FG001|Overall Study|Lost to Follow-up|3|||
124770276|NCT02326155|448788755|FG000|Overall Study|Protocol Violation|2|||
124770277|NCT02326155|448788756|FG001|Overall Study|Protocol Violation|0|||
124770278|NCT02326155|448788755|FG000|Overall Study|Withdrawal by Subject|34|||
124770279|NCT02326155|448788756|FG001|Overall Study|Withdrawal by Subject|11|||
124770280|NCT02326155|448788755|FG000|Overall Study|Disease progression|37|||
124770281|NCT02326155|448788756|FG001|Overall Study|Disease progression|4|||
124770282|NCT02326155|448788755|FG000|Overall Study|Study close|188|||
124770283|NCT02326155|448788756|FG001|Overall Study|Study close|21|||
124770284|NCT02326155|448788755|FG000|Overall Study|except for study close|46|||
124770285|NCT02326155|448788756|FG001|Overall Study|except for study close|13|||
124770286|NCT05024032|448788757|FG000|Overall Study|Withdrawal by Subject|0|||
124770287|NCT05024032|448788758|FG001|Overall Study|Withdrawal by Subject|3|||
124770288|NCT05024032|448788759|FG002|Overall Study|Withdrawal by Subject|4|||
124770289|NCT05024032|448788757|FG000|Overall Study|Adverse Event|0|||
124770290|NCT05024032|448788758|FG001|Overall Study|Adverse Event|1|||
124770291|NCT05024032|448788759|FG002|Overall Study|Adverse Event|0|||
124770292|NCT05024032|448788757|FG000|Overall Study|Protocol Deviation|1|||
124770293|NCT05024032|448788758|FG001|Overall Study|Protocol Deviation|0|||
124770294|NCT05024032|448788759|FG002|Overall Study|Protocol Deviation|0|||
124770295|NCT03591406|448788762|FG000|Overall Study|Adverse Event|5|||
124770296|NCT03591406|448788763|FG001|Overall Study|Adverse Event|3|||
124770297|NCT03591406|448788762|FG000|Overall Study|Protocol Violation|2|||
124770298|NCT03591406|448788763|FG001|Overall Study|Protocol Violation|1|||
124770299|NCT03591406|448788762|FG000|Overall Study|Withdrawal by Subject|0|||
124770300|NCT03591406|448788763|FG001|Overall Study|Withdrawal by Subject|5|||
124770301|NCT02066181|448788764|FG000|Overall Study|Withdrawal by Subject|1|||
124770302|NCT02066181|448788765|FG001|Overall Study|Withdrawal by Subject|1|||
124770303|NCT01083771|448788766|FG000|Overall Study|non-compliant|2|||
124770304|NCT01083771|448788766|FG000|Overall Study|Withdrawal by Subject|3|||
124770305|NCT00939393|448788769|FG000|Overall Study|Withdrawal by Subject|1|||
124770306|NCT00939393|448788770|FG001|Overall Study|Withdrawal by Subject|0|||
124770307|NCT00939393|448788769|FG000|Overall Study|Lost to Follow-up|3|||
124770308|NCT00939393|448788770|FG001|Overall Study|Lost to Follow-up|0|||
124770309|NCT02851615|448788771|FG000|Overall Study|Cognitive Issue|1|||
124770310|NCT02851615|448788772|FG001|Overall Study|Cognitive Issue|0|||
124770311|NCT02851615|448788771|FG000|Overall Study|Lost to Follow-up|0|||
124770312|NCT02851615|448788772|FG001|Overall Study|Lost to Follow-up|4|||
124770313|NCT03714672|448788781|FG000|Overall Study|Adverse Event|0|||
124770314|NCT03714672|448788782|FG001|Overall Study|Adverse Event|0|||
124551484|NCT00529802|447976450|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
124551485|NCT00529802|447976450|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
124551486|NCT00529802|447976450|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
124551487|NCT02428231|447976456|FG000|Overall Study|Other|10|||
124551488|NCT02428231|447976457|FG001|Overall Study|Other|16|||
124551489|NCT02428231|447976456|FG000|Overall Study|Required Symptomatic Therapy|0|||
124551490|NCT02428231|447976457|FG001|Overall Study|Required Symptomatic Therapy|1|||
124551491|NCT02428231|447976456|FG000|Overall Study|Adverse Event|3|||
124551492|NCT02428231|447976457|FG001|Overall Study|Adverse Event|0|||
124551493|NCT02156466|447976460|FG000|Overall Study|Adverse Event|0|||
124551494|NCT02156466|447976461|FG001|Overall Study|Adverse Event|0|||
124551495|NCT02156466|447976462|FG002|Overall Study|Adverse Event|1|||
124551496|NCT02156466|447976463|FG003|Overall Study|Adverse Event|1|||
124551497|NCT02156466|447976464|FG004|Overall Study|Adverse Event|0|||
124551498|NCT02156466|447976460|FG000|Overall Study|Quantiferon Positivity|0|||
124551499|NCT02156466|447976461|FG001|Overall Study|Quantiferon Positivity|0|||
124551500|NCT02156466|447976462|FG002|Overall Study|Quantiferon Positivity|0|||
124551501|NCT02156466|447976463|FG003|Overall Study|Quantiferon Positivity|1|||
124551502|NCT02156466|447976464|FG004|Overall Study|Quantiferon Positivity|0|||
124770315|NCT03714672|448788783|FG002|Overall Study|Adverse Event|3|||
124770316|NCT03714672|448788784|FG003|Overall Study|Adverse Event|0|||
124770317|NCT03714672|448788781|FG000|Overall Study|Physician Decision|0|||
124770318|NCT03714672|448788782|FG001|Overall Study|Physician Decision|1|||
124770319|NCT03714672|448788783|FG002|Overall Study|Physician Decision|0|||
124770320|NCT03714672|448788784|FG003|Overall Study|Physician Decision|0|||
124551503|NCT01784419|447976465|FG000|Overall Study|Adverse Event|3|||
124770321|NCT03714672|448788781|FG000|Overall Study|Other Reason|1|||
124770322|NCT03714672|448788782|FG001|Overall Study|Other Reason|2|||
124770323|NCT03714672|448788783|FG002|Overall Study|Other Reason|1|||
124770324|NCT03714672|448788784|FG003|Overall Study|Other Reason|1|||
124770325|NCT03714672|448788781|FG000|Overall Study|Lost to Follow-up|1|||
124971072|NCT00762476|449521122|FG001|Overall Study|Physician Decision|14|||
124971073|NCT00762476|449521121|FG000|Overall Study|Withdrawal by Subject|6|||
124971074|NCT00762476|449521122|FG001|Overall Study|Withdrawal by Subject|12|||
124971075|NCT00762476|449521121|FG000|Overall Study|antibiotic use|0|||
124971076|NCT00762476|449521122|FG001|Overall Study|antibiotic use|1|||
124971077|NCT00762476|449521121|FG000|Overall Study|non-compliance with study visits|0|||
124971078|NCT00762476|449521122|FG001|Overall Study|non-compliance with study visits|2|||
124971079|NCT00762476|449521121|FG000|Overall Study|Seasonal allergies|1|||
124971080|NCT00762476|449521122|FG001|Overall Study|Seasonal allergies|0|||
124971081|NCT00965497|449521124|FG000|Overall Study|Physician Decision|1|||
124971082|NCT02638103|449521126|FG000|Overall Study|Adverse Event|13|||
124971083|NCT02638103|449521127|FG001|Overall Study|Adverse Event|12|||
124971084|NCT02638103|449521128|FG002|Overall Study|Adverse Event|19|||
124971085|NCT02638103|449521129|FG003|Overall Study|Adverse Event|12|||
124971086|NCT02638103|449521126|FG000|Overall Study|Withdrawal by Subject|43|||
124971087|NCT02638103|449521127|FG001|Overall Study|Withdrawal by Subject|53|||
124971088|NCT02638103|449521128|FG002|Overall Study|Withdrawal by Subject|30|||
124971089|NCT02638103|449521129|FG003|Overall Study|Withdrawal by Subject|61|||
124971090|NCT02638103|449521126|FG000|Overall Study|Protocol Violation|1|||
124971091|NCT02638103|449521127|FG001|Overall Study|Protocol Violation|2|||
124971092|NCT02638103|449521128|FG002|Overall Study|Protocol Violation|1|||
124971093|NCT02638103|449521129|FG003|Overall Study|Protocol Violation|4|||
124971094|NCT02638103|449521126|FG000|Overall Study|Pregnancy|2|||
124971095|NCT02638103|449521127|FG001|Overall Study|Pregnancy|3|||
124971096|NCT02638103|449521128|FG002|Overall Study|Pregnancy|0|||
124971097|NCT02638103|449521129|FG003|Overall Study|Pregnancy|1|||
124971098|NCT02638103|449521126|FG000|Overall Study|Non-compliance to Study Procedures|2|||
124971099|NCT02638103|449521127|FG001|Overall Study|Non-compliance to Study Procedures|1|||
124971100|NCT02638103|449521128|FG002|Overall Study|Non-compliance to Study Procedures|1|||
124971101|NCT02638103|449521129|FG003|Overall Study|Non-compliance to Study Procedures|1|||
124971102|NCT02638103|449521126|FG000|Overall Study|Lost to Follow-up|26|||
124971103|NCT02638103|449521127|FG001|Overall Study|Lost to Follow-up|33|||
124971104|NCT02638103|449521128|FG002|Overall Study|Lost to Follow-up|20|||
124971105|NCT02638103|449521129|FG003|Overall Study|Lost to Follow-up|37|||
124971106|NCT02638103|449521126|FG000|Overall Study|Lack of Efficacy|14|||
124971107|NCT02638103|449521127|FG001|Overall Study|Lack of Efficacy|10|||
124971108|NCT02638103|449521128|FG002|Overall Study|Lack of Efficacy|12|||
124551504|NCT02253654|447976466|FG000|Overall Study|Withdrawal by Subject|12|||
124551505|NCT02253654|447976467|FG001|Overall Study|Withdrawal by Subject|4|||
124551506|NCT02253654|447976466|FG000|Overall Study|Decision by Sponsor|1|||
124551507|NCT02253654|447976467|FG001|Overall Study|Decision by Sponsor|1|||
124551508|NCT02253654|447976466|FG000|Overall Study|Lost to Follow-up|2|||
124551509|NCT02253654|447976467|FG001|Overall Study|Lost to Follow-up|5|||
124551510|NCT02253654|447976466|FG000|Overall Study|Death|4|||
124551511|NCT02253654|447976467|FG001|Overall Study|Death|7|||
124551512|NCT02253654|447976466|FG000|Overall Study|Did Not Receive Study Treatment|4|||
124551513|NCT02253654|447976467|FG001|Overall Study|Did Not Receive Study Treatment|1|||
124551514|NCT03044431|447976470|FG000|Overall Study|Lost to Follow-up|59|||
124551515|NCT03456726|447976471|FG000|Overall Study|Disease Progression|6|||
124551516|NCT03456726|447976472|FG001|Overall Study|Disease Progression|1|||
124551517|NCT03456726|447976471|FG000|Overall Study|Adverse Event|4|||
124712937|NCT00332696|448574494|FG000|Overall Study|Adverse Event|1|||
124712938|NCT00332696|448574495|FG001|Overall Study|Adverse Event|2|||
124712939|NCT00332696|448574494|FG000|Overall Study|Condition does not justify treatment|0|||
124712940|NCT00332696|448574495|FG001|Overall Study|Condition does not justify treatment|2|||
124712941|NCT00332696|448574494|FG000|Overall Study|Lost to Follow-up|0|||
124712942|NCT00332696|448574495|FG001|Overall Study|Lost to Follow-up|1|||
124712943|NCT00332696|448574494|FG000|Overall Study|Withdrawal by Subject|1|||
124712944|NCT00332696|448574495|FG001|Overall Study|Withdrawal by Subject|0|||
124712945|NCT01061385|448574497|FG000|Overall Study|Lost to Follow-up|1|||
124712946|NCT01061385|448574498|FG001|Overall Study|Lost to Follow-up|0|||
124712947|NCT01061385|448574497|FG000|Overall Study|subject decision not related to AE|0|||
124712948|NCT01061385|448574498|FG001|Overall Study|subject decision not related to AE|1|||
124712949|NCT00533429|448574499|FG000|Overall Study|Adverse Event|3|||
124712950|NCT00533429|448574500|FG001|Overall Study|Adverse Event|1|||
124712951|NCT00533429|448574499|FG000|Overall Study|Death|1|||
124712952|NCT00533429|448574500|FG001|Overall Study|Death|0|||
124971109|NCT02638103|449521129|FG003|Overall Study|Lack of Efficacy|22|||
124971110|NCT02638103|449521126|FG000|Overall Study|Other than specified|5|||
124971111|NCT02638103|449521127|FG001|Overall Study|Other than specified|4|||
124971112|NCT02638103|449521128|FG002|Overall Study|Other than specified|2|||
124971113|NCT02638103|449521129|FG003|Overall Study|Other than specified|4|||
124971114|NCT01827046|449521134|FG000|Overall Study|Lost to Follow-up|1|||
124551518|NCT03456726|447976472|FG001|Overall Study|Adverse Event|2|||
124712953|NCT00533429|448574499|FG000|Overall Study|Withdrawal by Subject|2|||
124971115|NCT01827046|449521135|FG001|Overall Study|Lost to Follow-up|5|||
124971116|NCT01827046|449521134|FG000|Overall Study|Withdrawal by Subject|0|||
124971117|NCT01827046|449521135|FG001|Overall Study|Withdrawal by Subject|4|||
124466961|NCT01491178|447668816|FG000|Overall Study|To conduct invasive treatment|59|||
124466962|NCT01491178|447668816|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
124466963|NCT01491178|447668816|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
124466964|NCT01491178|447668816|FG000|Overall Study|To take a contraindication|20|||
124466965|NCT01491178|447668816|FG000|Overall Study|Other than specified above|657|||
124466966|NCT03178487|447668818|FG000|Period 1|Adverse Event|1|||
124712954|NCT00533429|448574500|FG001|Overall Study|Withdrawal by Subject|0|||
124712955|NCT00533429|448574499|FG000|Overall Study|Progressive Disease|12|||
124712956|NCT00533429|448574500|FG001|Overall Study|Progressive Disease|13|||
124712957|NCT00533429|448574499|FG000|Overall Study|Symptomatic deterioration|1|||
124712958|NCT00533429|448574500|FG001|Overall Study|Symptomatic deterioration|2|||
124712959|NCT01464879|448574501|FG000|Overall Study|Physician Decision|1|||
124712960|NCT01464879|448574501|FG000|Overall Study|Non-compliance|1|||
124712961|NCT00244621|448574502|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
124712962|NCT00244621|448574503|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
124712963|NCT00244621|448574504|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
124712964|NCT00244621|448574502|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
124712965|NCT00244621|448574503|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
124712966|NCT00244621|448574504|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
124712967|NCT00244621|448574502|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
124712968|NCT00244621|448574503|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
124712969|NCT00244621|448574504|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
124712970|NCT00244621|448574502|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
124712971|NCT00244621|448574503|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
124712972|NCT00244621|448574504|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
124712973|NCT00244621|448574502|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
124712974|NCT00244621|448574503|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
124712975|NCT00244621|448574504|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
124712976|NCT00244621|448574502|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
124712977|NCT00244621|448574503|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
124712978|NCT00244621|448574504|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
124712979|NCT00244621|448574502|FG000|Open-label Treatment Period|Adverse Event|0|||
124712980|NCT00244621|448574503|FG001|Open-label Treatment Period|Adverse Event|0|||
124712981|NCT00244621|448574504|FG002|Open-label Treatment Period|Adverse Event|1|||
124712982|NCT00244621|448574502|FG000|Open-label Treatment Period|Moved abroad|0|||
124712983|NCT00244621|448574503|FG001|Open-label Treatment Period|Moved abroad|0|||
124712984|NCT00244621|448574504|FG002|Open-label Treatment Period|Moved abroad|1|||
124712985|NCT00800982|448574505|FG000|Overall Study|Lost to Follow-up|1|||
124712986|NCT00800982|448574506|FG001|Overall Study|Lost to Follow-up|2|||
124712987|NCT00800982|448574505|FG000|Overall Study|Withdrawal by Subject|0|||
124712988|NCT00800982|448574506|FG001|Overall Study|Withdrawal by Subject|1|||
124712989|NCT00800982|448574505|FG000|Overall Study|Patient moved out of state|1|||
124712990|NCT00800982|448574506|FG001|Overall Study|Patient moved out of state|0|||
124712991|NCT01824290|448574507|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
124712992|NCT01824290|448574508|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
124712993|NCT01824290|448574509|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
124712994|NCT01824290|448574510|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
124712995|NCT01824290|448574507|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
124712996|NCT01824290|448574508|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
124712997|NCT01824290|448574509|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
124712998|NCT01824290|448574510|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
124712999|NCT01824290|448574507|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
124713000|NCT01824290|448574508|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
124713001|NCT01824290|448574509|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
124713002|NCT01824290|448574510|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
124713003|NCT01824290|448574507|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
124713004|NCT01824290|448574508|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
124713005|NCT01824290|448574509|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
124713006|NCT01824290|448574510|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
124713007|NCT01824290|448574507|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
124713008|NCT01824290|448574508|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
124713009|NCT01824290|448574509|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
124770326|NCT03714672|448788782|FG001|Overall Study|Lost to Follow-up|1|||
124770327|NCT03714672|448788783|FG002|Overall Study|Lost to Follow-up|0|||
124466967|NCT03178487|447668819|FG001|Period 1|Adverse Event|2|||
124713010|NCT01824290|448574510|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
124713011|NCT01824290|448574507|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
124713012|NCT01824290|448574508|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
124466968|NCT03178487|447668818|FG000|Period 1|Withdrawal by Subject|2|||
124466969|NCT03178487|447668819|FG001|Period 1|Withdrawal by Subject|1|||
124713013|NCT01824290|448574509|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
124770328|NCT03714672|448788784|FG003|Overall Study|Lost to Follow-up|0|||
124971118|NCT02734004|449521136|FG000|Overall Study|Death|36|||
124466970|NCT03178487|447668818|FG000|Period 1|Lost to Follow-up|1|||
124713014|NCT01824290|448574510|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
124713015|NCT00648037|448574513|FG000|Overall Study|Not Treated|1|||
124713016|NCT00648037|448574513|FG000|Overall Study|Withdrawal by Subject|1|||
124713017|NCT00648037|448574513|FG000|Overall Study|Adverse Event|11|||
124713018|NCT00648037|448574513|FG000|Overall Study|Relapse|2|||
124713019|NCT00648037|448574513|FG000|Overall Study|Other|1|||
124713020|NCT02967679|448574515|FG000|Overall Study|Adverse Event|1|||
124713021|NCT00003631|448574517|FG000|Overall Study|Patient not treated|1|||
124713022|NCT00003631|448574518|FG001|Overall Study|Patient not treated|0|||
124713023|NCT00003631|448574519|FG002|Overall Study|Patient not treated|1|||
124713024|NCT00003631|448574517|FG000|Overall Study|Protocol Violation|1|||
124713025|NCT00003631|448574518|FG001|Overall Study|Protocol Violation|0|||
124713026|NCT00003631|448574519|FG002|Overall Study|Protocol Violation|0|||
124713027|NCT00003631|448574517|FG000|Overall Study|Adverse Event|1|||
124713028|NCT00003631|448574518|FG001|Overall Study|Adverse Event|1|||
124713029|NCT00003631|448574519|FG002|Overall Study|Adverse Event|5|||
124713030|NCT00003631|448574517|FG000|Overall Study|Death|0|||
124713031|NCT00003631|448574518|FG001|Overall Study|Death|0|||
124713032|NCT00003631|448574519|FG002|Overall Study|Death|1|||
124971119|NCT02734004|449521137|FG001|Overall Study|Death|24|||
124971120|NCT02734004|449521138|FG002|Overall Study|Death|26|||
124971121|NCT02734004|449521139|FG003|Overall Study|Death|35|||
124971122|NCT02734004|449521140|FG004|Overall Study|Death|13|||
124466971|NCT03178487|447668819|FG001|Period 1|Lost to Follow-up|0|||
124466972|NCT03178487|447668818|FG000|Period 1|Other|0|||
124466973|NCT03178487|447668819|FG001|Period 1|Other|1|||
124713033|NCT00003631|448574517|FG000|Overall Study|Evaluable for toxicity only|0|||
124971123|NCT02734004|449521141|FG005|Overall Study|Death|17|||
124971124|NCT02734004|449521142|FG006|Overall Study|Death|20|||
124971125|NCT02734004|449521136|FG000|Overall Study|Lost to Follow-up|1|||
124971126|NCT02734004|449521137|FG001|Overall Study|Lost to Follow-up|1|||
124971127|NCT02734004|449521138|FG002|Overall Study|Lost to Follow-up|0|||
124971128|NCT02734004|449521139|FG003|Overall Study|Lost to Follow-up|0|||
124971129|NCT02734004|449521140|FG004|Overall Study|Lost to Follow-up|1|||
124971130|NCT02734004|449521141|FG005|Overall Study|Lost to Follow-up|0|||
124971131|NCT02734004|449521142|FG006|Overall Study|Lost to Follow-up|0|||
124971132|NCT02734004|449521136|FG000|Overall Study|Withdrawal by Subject|3|||
124971133|NCT02734004|449521137|FG001|Overall Study|Withdrawal by Subject|1|||
124971134|NCT02734004|449521138|FG002|Overall Study|Withdrawal by Subject|1|||
124971135|NCT02734004|449521139|FG003|Overall Study|Withdrawal by Subject|1|||
124971136|NCT02734004|449521140|FG004|Overall Study|Withdrawal by Subject|3|||
124971137|NCT02734004|449521141|FG005|Overall Study|Withdrawal by Subject|0|||
124971138|NCT02734004|449521142|FG006|Overall Study|Withdrawal by Subject|2|||
124971139|NCT02734004|449521136|FG000|Overall Study|Other|0|||
124971140|NCT02734004|449521137|FG001|Overall Study|Other|8|||
124971141|NCT02734004|449521138|FG002|Overall Study|Other|7|||
124971142|NCT02734004|449521139|FG003|Overall Study|Other|4|||
124971143|NCT02734004|449521140|FG004|Overall Study|Other|34|||
124971144|NCT02734004|449521141|FG005|Overall Study|Other|14|||
124971145|NCT02734004|449521142|FG006|Overall Study|Other|10|||
124971146|NCT01294436|449521143|FG000|Overall Study|Adverse Event|10|||
124971147|NCT01294436|449521144|FG001|Overall Study|Adverse Event|17|||
124971148|NCT01294436|449521143|FG000|Overall Study|Withdrawal by Subject|11|||
124971149|NCT01294436|449521144|FG001|Overall Study|Withdrawal by Subject|28|||
124971150|NCT01294436|449521143|FG000|Overall Study|subject no longer meets study criteria|5|||
124971151|NCT01294436|449521144|FG001|Overall Study|subject no longer meets study criteria|20|||
124971152|NCT01294436|449521143|FG000|Overall Study|poor/non-compliance|2|||
124971153|NCT01294436|449521144|FG001|Overall Study|poor/non-compliance|5|||
124971154|NCT02296892|449521151|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
124971155|NCT02296892|449521152|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
124713034|NCT00003631|448574518|FG001|Overall Study|Evaluable for toxicity only|0|||
124713035|NCT00003631|448574519|FG002|Overall Study|Evaluable for toxicity only|2|||
124971156|NCT02296892|449521153|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
124971157|NCT02296892|449521151|FG000|Overall Study|Lost to Follow-up|5|||
124971158|NCT02296892|449521152|FG001|Overall Study|Lost to Follow-up|0|||
124971159|NCT02296892|449521153|FG002|Overall Study|Lost to Follow-up|1|||
124971160|NCT00585078|449521154|FG000|Overall Study|Withdrawal by Subject|4|||
124971161|NCT00585078|449521154|FG000|Overall Study|Poor performance status|1|||
124971162|NCT00585078|449521154|FG000|Overall Study|Disease Progression|24|||
124466974|NCT03178487|447668818|FG000|Period 2|Adverse Event|4|||
124713036|NCT00600067|448574520|FG000|Overall Study|Adverse Event|0|||
124713037|NCT00600067|448574521|FG001|Overall Study|Adverse Event|1|||
124713038|NCT00600067|448574520|FG000|Overall Study|Lost to Follow-up|2|||
124713039|NCT00600067|448574521|FG001|Overall Study|Lost to Follow-up|3|||
124971163|NCT00585078|449521154|FG000|Overall Study|Adverse Event|10|||
124466975|NCT03178487|447668819|FG001|Period 2|Adverse Event|4|||
124713040|NCT00600067|448574520|FG000|Overall Study|protocol non-compliance|0|||
124971164|NCT00585078|449521154|FG000|Overall Study|Death|1|||
124971165|NCT01018732|449521155|FG000|Overall Study|Lost to Follow-up|0|||
124466976|NCT03178487|447668818|FG000|Period 2|Withdrawal by Subject|6|||
124466977|NCT03178487|447668819|FG001|Period 2|Withdrawal by Subject|6|||
124466978|NCT03178487|447668818|FG000|Period 2|Lost to Follow-up|2|||
124466979|NCT03178487|447668819|FG001|Period 2|Lost to Follow-up|2|||
124466980|NCT03178487|447668818|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
124466981|NCT03178487|447668819|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
124466982|NCT03178487|447668818|FG000|Period 2|Other|8|||
124466983|NCT03178487|447668819|FG001|Period 2|Other|7|||
124466984|NCT03655756|447668822|FG000|Overall Study|Death|1|||
124466985|NCT00253630|447668823|FG000|Overall Study|ineligible|2|||
124466986|NCT03237065|447668824|FG000|Overall Study|Adverse Event|0|||
124466987|NCT03237065|447668825|FG001|Overall Study|Adverse Event|2|||
124466988|NCT03237065|447668824|FG000|Overall Study|Protocol Violation|0|||
124466989|NCT03237065|447668825|FG001|Overall Study|Protocol Violation|1|||
124466990|NCT03237065|447668824|FG000|Overall Study|Withdrawal by Subject|3|||
124466991|NCT03237065|447668825|FG001|Overall Study|Withdrawal by Subject|0|||
124466992|NCT03237065|447668824|FG000|Overall Study|Lost to Follow-up|1|||
124466993|NCT03237065|447668825|FG001|Overall Study|Lost to Follow-up|0|||
124466994|NCT03237065|447668824|FG000|Overall Study|Unable to obtain venous access|0|||
124466995|NCT03237065|447668825|FG001|Overall Study|Unable to obtain venous access|1|||
124466996|NCT00209339|447668826|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
124466997|NCT00209339|447668826|FG000|At 12 Months Follow-up|Death|1|||
124466998|NCT00209339|447668826|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
124466999|NCT00209339|447668826|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
124467000|NCT00209339|447668826|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
124467001|NCT00209339|447668826|FG000|At 24 Months Follow-up|Death|1|||
124467002|NCT00209339|447668826|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
124467003|NCT00209339|447668826|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
124467004|NCT00209339|447668826|FG000|At 4 Years Follow-up|Death|1|||
124467005|NCT00209339|447668826|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
124467006|NCT00209339|447668826|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
124467007|NCT00209339|447668826|FG000|At 5 Years Follow-up|Death|1|||
124467008|NCT00429858|447668827|FG000|Overall Study|Withdrawal by Subject|1|||
124467009|NCT00429858|447668827|FG000|Overall Study|Study Termination|1|||
124467010|NCT01587079|447668828|FG000|Overall Study|Protocol-specified criteria|9|||
124467011|NCT01587079|447668828|FG000|Overall Study|Protocol Violation|5|||
124467012|NCT01587079|447668828|FG000|Overall Study|Lost to Follow-up|2|||
124467013|NCT01587079|447668828|FG000|Overall Study|Physician Decision|2|||
124467014|NCT01587079|447668828|FG000|Overall Study|Withdrawal by Subject|7|||
124467015|NCT01587079|447668828|FG000|Overall Study|Adverse Event|14|||
124467016|NCT02268058|447668829|FG000|Overall Study|Protocol Violation|1|||
124467017|NCT02268058|447668830|FG001|Overall Study|Protocol Violation|0|||
124467018|NCT02268058|447668831|FG002|Overall Study|Protocol Violation|0|||
124467019|NCT02268058|447668832|FG003|Overall Study|Protocol Violation|0|||
124467020|NCT00493038|447668833|FG000|Treatment|Adverse Event|8|||
124467021|NCT00493038|447668834|FG001|Treatment|Adverse Event|4|||
124467022|NCT00493038|447668833|FG000|Treatment|Lost to Follow-up|5|||
124467023|NCT00493038|447668834|FG001|Treatment|Lost to Follow-up|3|||
124467024|NCT00493038|447668833|FG000|Treatment|Withdrawal by Subject|11|||
124467025|NCT00493038|447668834|FG001|Treatment|Withdrawal by Subject|12|||
124467026|NCT00493038|447668833|FG000|Treatment|Other|0|||
124467027|NCT00493038|447668834|FG001|Treatment|Other|1|||
124467028|NCT00493038|447668833|FG000|Follow-up|Lost to Follow-up|1|||
124467029|NCT00493038|447668834|FG001|Follow-up|Lost to Follow-up|0|||
124467030|NCT04781816|447668835|FG000|Overall Study|Adverse Event|0|||
124467031|NCT04781816|447668836|FG001|Overall Study|Adverse Event|1|||
124467032|NCT04781816|447668835|FG000|Overall Study|Withdrawal by Subject|1|||
124467033|NCT04781816|447668836|FG001|Overall Study|Withdrawal by Subject|1|||
124467034|NCT04781816|447668835|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
124467035|NCT04781816|447668836|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
124467036|NCT01121393|447668837|FG000|Overall Study|Progressive disease|201|||
124467037|NCT01121393|447668838|FG001|Overall Study|Progressive disease|20|||
124467038|NCT01121393|447668837|FG000|Overall Study|Other Adverse events|24|||
124467039|NCT01121393|447668838|FG001|Overall Study|Other Adverse events|45|||
124467040|NCT01121393|447668837|FG000|Overall Study|Non-compliant with protocol|0|||
124467041|NCT01121393|447668838|FG001|Overall Study|Non-compliant with protocol|3|||
124467042|NCT01121393|447668837|FG000|Overall Study|Lost to Follow-up|1|||
124713041|NCT00600067|448574521|FG001|Overall Study|protocol non-compliance|3|||
124713042|NCT00600067|448574520|FG000|Overall Study|Lack of Efficacy|1|||
124467043|NCT01121393|447668838|FG001|Overall Study|Lost to Follow-up|0|||
124713043|NCT00600067|448574521|FG001|Overall Study|Lack of Efficacy|0|||
124713044|NCT04339413|448574524|FG000|Overall Study|Reason Not Specified|2|||
124971166|NCT01018732|449521156|FG001|Overall Study|Lost to Follow-up|0|||
124971167|NCT01018732|449521157|FG002|Overall Study|Lost to Follow-up|3|||
124971168|NCT01018732|449521155|FG000|Overall Study|Protocol Violation|1|||
124971169|NCT01018732|449521156|FG001|Overall Study|Protocol Violation|1|||
124971170|NCT01018732|449521157|FG002|Overall Study|Protocol Violation|0|||
124971171|NCT01018732|449521155|FG000|Overall Study|Inappropriate Enrollment|0|||
124971172|NCT01018732|449521156|FG001|Overall Study|Inappropriate Enrollment|1|||
124971173|NCT01018732|449521157|FG002|Overall Study|Inappropriate Enrollment|0|||
124971174|NCT01018732|449521155|FG000|Overall Study|Unable to Classify|0|||
124971175|NCT01018732|449521156|FG001|Overall Study|Unable to Classify|0|||
124971176|NCT01018732|449521157|FG002|Overall Study|Unable to Classify|1|||
124971177|NCT01536171|449521158|FG000|Overall Study|Withdrawal by Subject|1|||
124971178|NCT02165826|449521162|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
124971179|NCT02165826|449521163|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
124971180|NCT02165826|449521164|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
124971181|NCT02165826|449521162|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
124971182|NCT02165826|449521163|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
124971183|NCT02165826|449521164|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
124971184|NCT02165826|449521162|FG000|Main Treatment Period|Lost to Follow-up|4|||
124971185|NCT02165826|449521163|FG001|Main Treatment Period|Lost to Follow-up|2|||
124971186|NCT02165826|449521164|FG002|Main Treatment Period|Lost to Follow-up|1|||
124971187|NCT02165826|449521162|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
124971188|NCT02165826|449521163|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
124971189|NCT02165826|449521164|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
124971190|NCT02165826|449521162|FG000|Main Treatment Period|Lack of Efficacy|2|||
124971191|NCT02165826|449521163|FG001|Main Treatment Period|Lack of Efficacy|0|||
124971192|NCT02165826|449521164|FG002|Main Treatment Period|Lack of Efficacy|0|||
124971193|NCT02165826|449521162|FG000|Main Treatment Period|Reason Not Specified|8|||
124971194|NCT02165826|449521163|FG001|Main Treatment Period|Reason Not Specified|5|||
124971195|NCT02165826|449521164|FG002|Main Treatment Period|Reason Not Specified|16|||
124971196|NCT02165826|449521162|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
124971197|NCT02165826|449521163|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
124971198|NCT02165826|449521164|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
124971199|NCT02165826|449521162|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
124971200|NCT02165826|449521163|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
124971201|NCT02165826|449521164|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
124971202|NCT02165826|449521162|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
124971203|NCT02165826|449521163|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
124971204|NCT02165826|449521164|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
124971205|NCT02165826|449521162|FG000|Down-Titration Period|Reason Not Specified|1|||
124971206|NCT02165826|449521163|FG001|Down-Titration Period|Reason Not Specified|0|||
124971207|NCT02165826|449521164|FG002|Down-Titration Period|Reason Not Specified|2|||
124971208|NCT04547023|449521171|FG000|Overall Study|Did Not Receive Intervention|3|||
124971209|NCT04547023|449521172|FG001|Overall Study|Did Not Receive Intervention|2|||
124971210|NCT04547023|449521171|FG000|Overall Study|Lost to Follow-up|1|||
124971211|NCT04547023|449521172|FG001|Overall Study|Lost to Follow-up|1|||
124971212|NCT00250432|449521173|FG000|Overall Study|Adverse Event|25|||
124971213|NCT00250432|449521174|FG001|Overall Study|Adverse Event|29|||
124971214|NCT00250432|449521173|FG000|Overall Study|Lack of Efficacy|2|||
124971215|NCT00250432|449521174|FG001|Overall Study|Lack of Efficacy|1|||
124971216|NCT00250432|449521173|FG000|Overall Study|Lost to Follow-up|6|||
124971217|NCT00250432|449521174|FG001|Overall Study|Lost to Follow-up|5|||
124971218|NCT00250432|449521173|FG000|Overall Study|Patient Moved|0|||
124971219|NCT00250432|449521174|FG001|Overall Study|Patient Moved|1|||
124971220|NCT00250432|449521173|FG000|Overall Study|Protocol Violation|0|||
124971221|NCT00250432|449521174|FG001|Overall Study|Protocol Violation|3|||
124971222|NCT00250432|449521173|FG000|Overall Study|Withdrawal by Subject|6|||
124971223|NCT00250432|449521174|FG001|Overall Study|Withdrawal by Subject|2|||
124971224|NCT00250432|449521173|FG000|Overall Study|Pt died out of posttherapy report period|6|||
124971225|NCT00250432|449521174|FG001|Overall Study|Pt died out of posttherapy report period|5|||
124971226|NCT00250432|449521173|FG000|Overall Study|Pt was considered untreatable|0|||
124971227|NCT00250432|449521174|FG001|Overall Study|Pt was considered untreatable|1|||
124971228|NCT01011868|449521175|FG000|After Week 18 Follow-up|Adverse Event|8|||
124551519|NCT03456726|447976471|FG000|Overall Study|Withdrawal by Subject|1|||
124551520|NCT03456726|447976472|FG001|Overall Study|Withdrawal by Subject|0|||
124971229|NCT01011868|449521176|FG001|After Week 18 Follow-up|Adverse Event|6|||
124971230|NCT01011868|449521177|FG002|After Week 18 Follow-up|Adverse Event|13|||
124971231|NCT01011868|449521175|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
124971232|NCT01011868|449521176|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
124971233|NCT01011868|449521177|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
124971234|NCT01011868|449521175|FG000|After Week 18 Follow-up|Protocol Violation|1|||
124971235|NCT01011868|449521176|FG001|After Week 18 Follow-up|Protocol Violation|1|||
124971236|NCT01011868|449521177|FG002|After Week 18 Follow-up|Protocol Violation|1|||
124467044|NCT01121393|447668837|FG000|Overall Study|Refused cont. medication|7|||
124467045|NCT01121393|447668838|FG001|Overall Study|Refused cont. medication|7|||
124467046|NCT01121393|447668837|FG000|Overall Study|Not treated|3|||
124467047|NCT01121393|447668838|FG001|Overall Study|Not treated|9|||
124467048|NCT01121393|447668837|FG000|Overall Study|Other than listed|6|||
124467049|NCT01121393|447668838|FG001|Overall Study|Other than listed|0|||
124467050|NCT01100944|447668839|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
124467051|NCT01100944|447668840|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
124467052|NCT01100944|447668841|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
124467053|NCT01100944|447668839|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
124467054|NCT01100944|447668840|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
124467055|NCT01100944|447668841|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
124467056|NCT01100944|447668839|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
124467057|NCT01100944|447668840|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
124467058|NCT01100944|447668841|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
124467059|NCT01100944|447668839|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
124467060|NCT01100944|447668840|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
124467061|NCT01100944|447668841|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
124467062|NCT00577993|447668842|FG000|Overall Study|Adverse Event|1|||
124467063|NCT00577993|447668843|FG001|Overall Study|Adverse Event|0|||
124467064|NCT00577993|447668844|FG002|Overall Study|Adverse Event|0|||
124467065|NCT00577993|447668842|FG000|Overall Study|Death|0|||
124467066|NCT00577993|447668843|FG001|Overall Study|Death|1|||
124467067|NCT00577993|447668844|FG002|Overall Study|Death|1|||
124467068|NCT00577993|447668842|FG000|Overall Study|Lack of Efficacy|0|||
124467069|NCT00577993|447668843|FG001|Overall Study|Lack of Efficacy|1|||
124467070|NCT00577993|447668844|FG002|Overall Study|Lack of Efficacy|0|||
124467071|NCT00577993|447668842|FG000|Overall Study|Protocol Violation|2|||
124467072|NCT00577993|447668843|FG001|Overall Study|Protocol Violation|3|||
124467073|NCT00577993|447668844|FG002|Overall Study|Protocol Violation|0|||
124467074|NCT00577993|447668842|FG000|Overall Study|Withdrawal by Subject|1|||
124467075|NCT00577993|447668843|FG001|Overall Study|Withdrawal by Subject|0|||
124551521|NCT03456726|447976471|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
124551522|NCT03456726|447976472|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
124551523|NCT04470622|447976473|FG000|Overall Study|Withdrawal by Subject|0|||
124551524|NCT04470622|447976474|FG001|Overall Study|Withdrawal by Subject|1|||
124971237|NCT01011868|449521175|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
124971238|NCT01011868|449521176|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
124971239|NCT01011868|449521177|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
124713045|NCT04339413|448574525|FG001|Overall Study|Reason Not Specified|7|||
124713046|NCT04339413|448574524|FG000|Overall Study|Study Terminated by Sponsor|30|||
124713047|NCT04339413|448574525|FG001|Overall Study|Study Terminated by Sponsor|33|||
124971240|NCT01011868|449521175|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
124971241|NCT01011868|449521176|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
124971242|NCT01011868|449521177|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
124971243|NCT01011868|449521175|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
124971244|NCT01011868|449521176|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
124971245|NCT01011868|449521177|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
124971246|NCT01011868|449521175|FG000|After Week 78 Follow-up|Adverse Event|14|||
124971247|NCT01011868|449521176|FG001|After Week 78 Follow-up|Adverse Event|18|||
124971248|NCT01011868|449521177|FG002|After Week 78 Follow-up|Adverse Event|21|||
124971249|NCT01011868|449521175|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
124971250|NCT01011868|449521176|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
124467076|NCT00577993|447668844|FG002|Overall Study|Withdrawal by Subject|2|||
124713048|NCT04339413|448574524|FG000|Overall Study|Progressive Disease|9|||
124971251|NCT01011868|449521177|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
124467077|NCT00577993|447668842|FG000|Overall Study|Conversion|2|||
124551525|NCT04470622|447976473|FG000|Overall Study|Screen Failure|0|||
124551526|NCT04470622|447976474|FG001|Overall Study|Screen Failure|1|||
124713049|NCT04339413|448574525|FG001|Overall Study|Progressive Disease|6|||
124713050|NCT04339413|448574524|FG000|Overall Study|Withdrawal by Subject|9|||
124971252|NCT01011868|449521175|FG000|After Week 78 Follow-up|Protocol Violation|9|||
124971253|NCT01011868|449521176|FG001|After Week 78 Follow-up|Protocol Violation|1|||
124971254|NCT01011868|449521177|FG002|After Week 78 Follow-up|Protocol Violation|2|||
124971255|NCT01011868|449521175|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
124971256|NCT01011868|449521176|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
124971257|NCT01011868|449521177|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
124551527|NCT04470622|447976473|FG000|Overall Study|Death|0|||
124713051|NCT04339413|448574525|FG001|Overall Study|Withdrawal by Subject|10|||
124467078|NCT00577993|447668843|FG001|Overall Study|Conversion|5|||
124467079|NCT00577993|447668844|FG002|Overall Study|Conversion|0|||
124467080|NCT00577993|447668842|FG000|Overall Study|Uninsured|1|||
124467081|NCT00577993|447668843|FG001|Overall Study|Uninsured|0|||
124467082|NCT00577993|447668844|FG002|Overall Study|Uninsured|0|||
124971258|NCT01011868|449521175|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
124971259|NCT01011868|449521176|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
124971260|NCT01011868|449521177|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
124971261|NCT01011868|449521175|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
124971262|NCT01011868|449521176|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
124971263|NCT01011868|449521177|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
124971264|NCT03784820|449521178|FG000|Overall Study|Lost to Follow-up|5|||
124971265|NCT03784820|449521179|FG001|Overall Study|Lost to Follow-up|5|||
124971266|NCT03784820|449521180|FG002|Overall Study|Lost to Follow-up|3|||
124971267|NCT03784820|449521181|FG003|Overall Study|Lost to Follow-up|3|||
124971268|NCT00658606|449521184|FG000|Overall Study|Adverse Event|2|||
124971269|NCT00658606|449521185|FG001|Overall Study|Adverse Event|1|||
124971270|NCT00658606|449521184|FG000|Overall Study|Lack of Efficacy|6|||
124971271|NCT00658606|449521185|FG001|Overall Study|Lack of Efficacy|3|||
124971272|NCT00658606|449521184|FG000|Overall Study|Lost to Follow-up|1|||
124971273|NCT00658606|449521185|FG001|Overall Study|Lost to Follow-up|0|||
124971274|NCT00658606|449521184|FG000|Overall Study|Withdrawal by Subject|7|||
124971275|NCT00658606|449521185|FG001|Overall Study|Withdrawal by Subject|16|||
124971276|NCT00658606|449521184|FG000|Overall Study|Lack of Compliance|0|||
124971277|NCT00658606|449521185|FG001|Overall Study|Lack of Compliance|3|||
124971278|NCT00365547|449521188|FG000|Overall Study|Insurance did not cover Avastin|1|||
124971279|NCT00365547|449521188|FG000|Overall Study|Screen failure|1|||
124971280|NCT00365547|449521188|FG000|Overall Study|Withdrawal by Subject|1|||
124971281|NCT03170518|449521189|FG000|Overall Study|Lost to Follow-up|4|||
124971282|NCT03170518|449521190|FG001|Overall Study|Lost to Follow-up|1|||
124971283|NCT03170518|449521191|FG002|Overall Study|Lost to Follow-up|0|||
124971284|NCT03170518|449521189|FG000|Overall Study|Physician Decision|1|||
124971285|NCT03170518|449521190|FG001|Overall Study|Physician Decision|0|||
124971286|NCT03170518|449521191|FG002|Overall Study|Physician Decision|0|||
124971287|NCT03170518|449521189|FG000|Overall Study|Withdrawal by Subject|4|||
124971288|NCT03170518|449521190|FG001|Overall Study|Withdrawal by Subject|5|||
124971289|NCT03170518|449521191|FG002|Overall Study|Withdrawal by Subject|2|||
124971290|NCT03170518|449521189|FG000|Overall Study|Site terminated by sponsor|0|||
124971291|NCT03170518|449521190|FG001|Overall Study|Site terminated by sponsor|1|||
124971292|NCT03170518|449521191|FG002|Overall Study|Site terminated by sponsor|0|||
124971293|NCT03170518|449521189|FG000|Overall Study|Non-compliance with study drug|1|||
124971294|NCT03170518|449521190|FG001|Overall Study|Non-compliance with study drug|0|||
124971295|NCT03170518|449521191|FG002|Overall Study|Non-compliance with study drug|1|||
124971296|NCT03170518|449521189|FG000|Overall Study|Withdrawal by parent/guardian|2|||
124971297|NCT03170518|449521190|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124971298|NCT03170518|449521191|FG002|Overall Study|Withdrawal by parent/guardian|0|||
124971299|NCT04428476|449521192|FG000|Overall Study|Withdrawal by Subject|1|||
124971300|NCT04428476|449521192|FG000|Overall Study|Still on treatment|12|||
124971301|NCT00546078|449521193|FG000|Overall Study|Lost to Follow-up|1|||
124971302|NCT00546078|449521194|FG001|Overall Study|Lost to Follow-up|3|||
124971303|NCT00546078|449521193|FG000|Overall Study|Withdrawal by Subject|2|||
124971304|NCT00546078|449521194|FG001|Overall Study|Withdrawal by Subject|3|||
124971305|NCT00546078|449521193|FG000|Overall Study|Other reason|1|||
124971306|NCT00546078|449521194|FG001|Overall Study|Other reason|1|||
124971307|NCT01261247|449521198|FG000|Overall Study|Ineligible|2|||
124971308|NCT02559310|449521199|FG000|Overall Study|Death|4|||
124971309|NCT02559310|449521200|FG001|Overall Study|Death|3|||
124971310|NCT02559310|449521199|FG000|Overall Study|Lost to Follow-up|5|||
124971311|NCT02559310|449521200|FG001|Overall Study|Lost to Follow-up|3|||
124971312|NCT02559310|449521199|FG000|Overall Study|Physician Decision|2|||
124971313|NCT02559310|449521200|FG001|Overall Study|Physician Decision|1|||
124971314|NCT02559310|449521199|FG000|Overall Study|Withdrawal by Subject|13|||
124971315|NCT02559310|449521200|FG001|Overall Study|Withdrawal by Subject|9|||
124971316|NCT02559310|449521199|FG000|Overall Study|Sponsor Decision|0|||
124971317|NCT02559310|449521200|FG001|Overall Study|Sponsor Decision|1|||
124971318|NCT02559310|449521199|FG000|Overall Study|Randomized but not treated|3|||
124971319|NCT02559310|449521200|FG001|Overall Study|Randomized but not treated|2|||
124971320|NCT01740154|449521201|FG000|Overall Study|Adverse Event|1|||
124971321|NCT02737826|449523238|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
124971322|NCT02737826|449523239|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
124971323|NCT02737826|449523240|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
124971324|NCT00129935|449523241|FG000|Overall Study|Adverse Event|18|||
124971325|NCT00129935|449523242|FG001|Overall Study|Adverse Event|56|||
124971326|NCT00129935|449523241|FG000|Overall Study|Death|1|||
124971327|NCT00129935|449523242|FG001|Overall Study|Death|1|||
124971328|NCT00129935|449523241|FG000|Overall Study|Withdrawal by Subject|7|||
124971329|NCT00129935|449523242|FG001|Overall Study|Withdrawal by Subject|20|||
124971330|NCT00129935|449523241|FG000|Overall Study|Protocol Violation|0|||
124971331|NCT00129935|449523242|FG001|Overall Study|Protocol Violation|4|||
124971332|NCT00129935|449523241|FG000|Overall Study|Physician Decision|3|||
124467083|NCT01847885|447668846|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
124467084|NCT01847885|447668847|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
124467085|NCT01847885|447668848|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
124467086|NCT01847885|447668846|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
124467087|NCT01847885|447668847|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
124467088|NCT01847885|447668848|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
124467089|NCT01847885|447668846|FG000|Initial Enrollment (Consented)|Screen failure|39|||
124467090|NCT01847885|447668847|FG001|Initial Enrollment (Consented)|Screen failure|0|||
124467091|NCT01847885|447668848|FG002|Initial Enrollment (Consented)|Screen failure|0|||
124467092|NCT01847885|447668846|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
124467093|NCT01847885|447668847|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
124467094|NCT01847885|447668848|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
124467095|NCT01847885|447668846|FG000|Randomization|Protocol Violation|0|||
124467096|NCT01847885|447668847|FG001|Randomization|Protocol Violation|1|||
124467097|NCT01847885|447668848|FG002|Randomization|Protocol Violation|0|||
124467098|NCT01847885|447668846|FG000|Randomization|Withdrawal by Subject|0|||
124467099|NCT01847885|447668847|FG001|Randomization|Withdrawal by Subject|0|||
124467100|NCT01847885|447668848|FG002|Randomization|Withdrawal by Subject|2|||
124467101|NCT01847885|447668846|FG000|Randomization|Screen Failure|0|||
124467102|NCT01847885|447668847|FG001|Randomization|Screen Failure|3|||
124467103|NCT01847885|447668848|FG002|Randomization|Screen Failure|0|||
124971333|NCT00129935|449523242|FG001|Overall Study|Physician Decision|4|||
124971334|NCT00129935|449523241|FG000|Overall Study|Recurrence|1|||
124971335|NCT00129935|449523242|FG001|Overall Study|Recurrence|3|||
124971336|NCT00129935|449523241|FG000|Overall Study|Second primary|0|||
124971337|NCT00129935|449523242|FG001|Overall Study|Second primary|1|||
124971338|NCT00129935|449523241|FG000|Overall Study|Other|3|||
124971339|NCT00129935|449523242|FG001|Overall Study|Other|2|||
124971340|NCT00129935|449523241|FG000|Overall Study|Crossed to the other arm|2|||
124971341|NCT00129935|449523242|FG001|Overall Study|Crossed to the other arm|1|||
124971342|NCT00129935|449523241|FG000|Overall Study|Incorrect study treatment|1|||
124971343|NCT00129935|449523242|FG001|Overall Study|Incorrect study treatment|0|||
124971344|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
124971345|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
124971346|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
124971347|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Death|4|||
124971348|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Death|2|||
124971349|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Death|3|||
124971350|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
124971351|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
124971352|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
124971353|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
124971354|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
124971355|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
124971356|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
124971357|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
124971358|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
124971359|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
124971360|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
124971361|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
124971362|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
124971363|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
124971364|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
124971365|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
124971366|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
124971367|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
124971368|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
124971369|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
124971370|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
124467104|NCT02064387|447668852|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
124467105|NCT02064387|447668853|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
124467106|NCT02064387|447668854|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
124467107|NCT02064387|447668855|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
124770329|NCT00371150|448788785|FG000|Overall Study|Lost to Follow-up|3|||
124971371|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
124971372|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
124467108|NCT02064387|447668856|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
124467109|NCT02064387|447668857|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
124770330|NCT00371150|448788786|FG001|Overall Study|Lost to Follow-up|2|||
124551528|NCT04470622|447976474|FG001|Overall Study|Death|1|||
124467110|NCT02064387|447668858|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
124467111|NCT02064387|447668859|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
124467112|NCT02064387|447668860|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
124467113|NCT02064387|447668861|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
124713052|NCT04339413|448574524|FG000|Overall Study|Physician Decision|3|||
124713053|NCT04339413|448574525|FG001|Overall Study|Physician Decision|1|||
124713054|NCT04339413|448574524|FG000|Overall Study|Death|2|||
124467114|NCT02064387|447668862|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
124467115|NCT02064387|447668863|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
124467116|NCT02064387|447668852|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
124467117|NCT02064387|447668853|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
124467118|NCT02064387|447668854|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
124467119|NCT02064387|447668855|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
124467120|NCT02064387|447668856|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
124467121|NCT02064387|447668857|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
124467122|NCT02064387|447668858|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
124467123|NCT02064387|447668859|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
124467124|NCT02064387|447668860|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
124467125|NCT02064387|447668861|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
124467126|NCT02064387|447668862|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
124467127|NCT02064387|447668863|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
124467128|NCT02064387|447668852|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
124467129|NCT02064387|447668853|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
124467130|NCT02064387|447668854|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
124467131|NCT02064387|447668855|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
124467132|NCT02064387|447668856|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
124467133|NCT02064387|447668857|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
124467134|NCT02064387|447668858|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
124467135|NCT02064387|447668859|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
124467136|NCT02064387|447668860|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
124467137|NCT02064387|447668861|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
124467138|NCT02064387|447668862|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
124467139|NCT02064387|447668863|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
124467140|NCT02064387|447668852|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
124467141|NCT02064387|447668853|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
124467142|NCT02064387|447668854|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
124467143|NCT02064387|447668855|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
124467144|NCT02064387|447668856|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
124467145|NCT02064387|447668857|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
124467146|NCT02064387|447668858|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
124467147|NCT02064387|447668859|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
124467148|NCT02064387|447668860|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
124467149|NCT02064387|447668861|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
124467150|NCT02064387|447668862|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
124467151|NCT02064387|447668863|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
124467152|NCT02064387|447668852|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
124467153|NCT02064387|447668853|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
124467154|NCT02064387|447668854|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
124467155|NCT02064387|447668855|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
124467156|NCT02064387|447668856|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
124713055|NCT04339413|448574525|FG001|Overall Study|Death|0|||
124551529|NCT02576054|447976475|FG000|Overall Study|Withdrawal by Subject|1|||
124551530|NCT01190098|447976479|FG000|Overall Study|Adverse Event|2|||
124551531|NCT01190098|447976480|FG001|Overall Study|Adverse Event|0|||
124713056|NCT04339413|448574524|FG000|Overall Study|Adverse Event|3|||
124713057|NCT04339413|448574525|FG001|Overall Study|Adverse Event|0|||
124713058|NCT00401843|448574529|FG000|Overall Study|Achieved Complete Response|1|||
124713059|NCT00401843|448574530|FG001|Overall Study|Achieved Complete Response|5|||
124713060|NCT00401843|448574531|FG002|Overall Study|Achieved Complete Response|11|||
124713061|NCT00401843|448574529|FG000|Overall Study|Adverse Event|7|||
124713062|NCT00401843|448574530|FG001|Overall Study|Adverse Event|26|||
124551532|NCT01190098|447976479|FG000|Overall Study|Patient coomorbidity|0|||
124551533|NCT01190098|447976480|FG001|Overall Study|Patient coomorbidity|1|||
124713063|NCT00401843|448574531|FG002|Overall Study|Adverse Event|27|||
124713064|NCT00401843|448574529|FG000|Overall Study|Death|0|||
124713065|NCT00401843|448574530|FG001|Overall Study|Death|8|||
124713066|NCT00401843|448574531|FG002|Overall Study|Death|10|||
124713067|NCT00401843|448574529|FG000|Overall Study|Disease progression|10|||
124713068|NCT00401843|448574530|FG001|Overall Study|Disease progression|60|||
124467157|NCT02064387|447668857|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
124713069|NCT00401843|448574531|FG002|Overall Study|Disease progression|49|||
124971373|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
124971374|NCT02783573|449523243|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
124971375|NCT02783573|449523244|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
124971376|NCT02783573|449523245|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
124971377|NCT02783573|449523243|FG000|Delayed-Start Period|Sponsor Decision|0|||
124971378|NCT02783573|449523244|FG001|Delayed-Start Period|Sponsor Decision|17|||
124971379|NCT02783573|449523245|FG002|Delayed-Start Period|Sponsor Decision|12|||
124971380|NCT02797522|449523253|FG000|Overall Study|Study Terminated by Sponsor|0|||
124971381|NCT02797522|449523254|FG001|Overall Study|Study Terminated by Sponsor|0|||
124971382|NCT02797522|449523255|FG002|Overall Study|Study Terminated by Sponsor|0|||
124971383|NCT02797522|449523256|FG003|Overall Study|Study Terminated by Sponsor|0|||
124971384|NCT02797522|449523257|FG004|Overall Study|Study Terminated by Sponsor|0|||
124971385|NCT02797522|449523258|FG005|Overall Study|Study Terminated by Sponsor|0|||
124971386|NCT02797522|449523259|FG006|Overall Study|Study Terminated by Sponsor|0|||
124971387|NCT02797522|449523260|FG007|Overall Study|Study Terminated by Sponsor|4|||
124971388|NCT02797522|449523261|FG008|Overall Study|Study Terminated by Sponsor|2|||
124971389|NCT02797522|449523262|FG009|Overall Study|Study Terminated by Sponsor|4|||
124971390|NCT02797522|449523263|FG010|Overall Study|Study Terminated by Sponsor|1|||
124971391|NCT00725712|449523264|FG000|Overall Study|Withdrawal by Subject|2|||
124971392|NCT00725712|449523265|FG001|Overall Study|Withdrawal by Subject|1|||
124971393|NCT00725712|449523264|FG000|Overall Study|Protocol Violation|1|||
124971394|NCT00725712|449523265|FG001|Overall Study|Protocol Violation|0|||
124971395|NCT00725712|449523264|FG000|Overall Study|Progressive disease|37|||
124971396|NCT00725712|449523265|FG001|Overall Study|Progressive disease|16|||
124971397|NCT00725712|449523264|FG000|Overall Study|Clinical progression not based on RECIST|0|||
124971398|NCT00725712|449523265|FG001|Overall Study|Clinical progression not based on RECIST|3|||
124971399|NCT00725712|449523264|FG000|Overall Study|Adverse Event|5|||
124971400|NCT00725712|449523265|FG001|Overall Study|Adverse Event|5|||
124971401|NCT00725712|449523264|FG000|Overall Study|Death|2|||
124971402|NCT00725712|449523265|FG001|Overall Study|Death|0|||
124971403|NCT00725712|449523264|FG000|Overall Study|Other: Death|1|||
124971404|NCT00725712|449523265|FG001|Overall Study|Other: Death|0|||
124971405|NCT00725712|449523264|FG000|Overall Study|Hospitalized, unable to continue|0|||
124971406|NCT00725712|449523265|FG001|Overall Study|Hospitalized, unable to continue|1|||
124971407|NCT03020069|449523266|FG000|Overall Study|Lost to Follow-up|0|||
124971408|NCT03020069|449523267|FG001|Overall Study|Lost to Follow-up|1|||
124971409|NCT00132678|449523270|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
124971410|NCT00132678|449523271|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
124971411|NCT00132678|449523272|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
124971412|NCT00132678|449523270|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
124971413|NCT00132678|449523271|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
124971414|NCT00132678|449523272|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
124971415|NCT00132678|449523270|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
124971416|NCT00132678|449523271|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
124971417|NCT00132678|449523272|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
124971418|NCT00132678|449523270|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
124971419|NCT00132678|449523271|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
124971420|NCT00132678|449523272|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
124971421|NCT00132678|449523270|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
124971422|NCT00132678|449523271|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
124971423|NCT00132678|449523272|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
124971424|NCT00132678|449523270|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
124971425|NCT00132678|449523271|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
124971426|NCT00132678|449523272|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
124971427|NCT00132678|449523270|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
124971428|NCT00132678|449523271|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
124971429|NCT00132678|449523272|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
124971430|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Death|2|||
124971431|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Death|0|||
124971432|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Death|0|||
124971433|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
124971434|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
124971435|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
124971436|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
124971437|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
124971438|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
124971439|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
124713070|NCT00401843|448574529|FG000|Overall Study|End of Study|1|||
124467158|NCT02064387|447668858|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
124467159|NCT02064387|447668859|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
124467160|NCT02064387|447668860|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
124770331|NCT02345070|448788788|FG000|Overall Study|Adverse Event|12|||
124467161|NCT02064387|447668861|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
124467162|NCT02064387|447668862|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
124551534|NCT01190098|447976479|FG000|Overall Study|Lack of transportation|1|||
124551535|NCT01190098|447976480|FG001|Overall Study|Lack of transportation|0|||
124551536|NCT01190098|447976479|FG000|Overall Study|Other|0|||
124551537|NCT01190098|447976480|FG001|Overall Study|Other|1|||
124551538|NCT02957682|447976481|FG000|Overall Study|Adverse Event|64|||
124551539|NCT02957682|447976482|FG001|Overall Study|Adverse Event|67|||
124551540|NCT02957682|447976481|FG000|Overall Study|Poor Compliance to Protocol|30|||
124551541|NCT02957682|447976482|FG001|Overall Study|Poor Compliance to Protocol|26|||
124551542|NCT02957682|447976481|FG000|Overall Study|Physician Decision|4|||
124551543|NCT02957682|447976482|FG001|Overall Study|Physician Decision|4|||
124551544|NCT02957682|447976481|FG000|Overall Study|Study Terminated by Sponsor|4|||
124551545|NCT02957682|447976482|FG001|Overall Study|Study Terminated by Sponsor|3|||
124551546|NCT02957682|447976481|FG000|Overall Study|Subject Moved|10|||
124551547|NCT02957682|447976482|FG001|Overall Study|Subject Moved|16|||
124551548|NCT02957682|447976481|FG000|Overall Study|Withdrawal by Subject|64|||
124551549|NCT02957682|447976482|FG001|Overall Study|Withdrawal by Subject|33|||
124551550|NCT02957682|447976481|FG000|Overall Study|Related to IMP Administration|3|||
124551551|NCT02957682|447976482|FG001|Overall Study|Related to IMP Administration|6|||
124551552|NCT02957682|447976481|FG000|Overall Study|Non-disclosed|16|||
124551553|NCT02957682|447976482|FG001|Overall Study|Non-disclosed|12|||
124551554|NCT02957682|447976481|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
124551555|NCT02957682|447976482|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
124551556|NCT02284373|447976483|FG000|Overall Study|Withdrawal by Subject|0|||
124551557|NCT02284373|447976484|FG001|Overall Study|Withdrawal by Subject|1|||
124551558|NCT02284373|447976485|FG002|Overall Study|Withdrawal by Subject|0|||
124551559|NCT02284373|447976483|FG000|Overall Study|Other|0|||
124551560|NCT02284373|447976484|FG001|Overall Study|Other|1|||
124551561|NCT02284373|447976485|FG002|Overall Study|Other|0|||
124551562|NCT02284373|447976483|FG000|Overall Study|Lost to Follow-up|0|||
124551563|NCT02284373|447976484|FG001|Overall Study|Lost to Follow-up|1|||
124551564|NCT02284373|447976485|FG002|Overall Study|Lost to Follow-up|0|||
124551565|NCT04651218|447976486|FG000|Overall Study|Withdrawal by Subject|0|||
124551566|NCT04651218|447976487|FG001|Overall Study|Withdrawal by Subject|2|||
124551567|NCT00765999|447976488|FG000|Overall Study|Adverse Event|203|||
124551568|NCT00765999|447976488|FG000|Overall Study|Insufficient Therapeutic Response|100|||
124551569|NCT00765999|447976488|FG000|Overall Study|Protocol Violation|95|||
124551570|NCT00765999|447976488|FG000|Overall Study|Consent Withdrawn|202|||
124551571|NCT00765999|447976488|FG000|Overall Study|Lost to Follow-up|131|||
124551572|NCT00765999|447976488|FG000|Overall Study|Study Terminated by Sponsor|2|||
124551573|NCT00765999|447976488|FG000|Overall Study|Other Miscellaneous Reasons|51|||
124551574|NCT00414011|447976489|FG000|Overall Study|Physician Decision|3|||
124551575|NCT00414011|447976489|FG000|Overall Study|Withdrawal by Subject|2|||
124551576|NCT02476851|447976490|FG000|Overall Study|Protocol Violation|1|||
124551577|NCT02476851|447976491|FG001|Overall Study|Protocol Violation|1|||
124551578|NCT01399125|447976492|FG000|Overall Study|Adverse Event|32|||
124551579|NCT01399125|447976493|FG001|Overall Study|Adverse Event|30|||
124551580|NCT01399125|447976492|FG000|Overall Study|Abnormal Lab values|0|||
124551581|NCT01399125|447976493|FG001|Overall Study|Abnormal Lab values|1|||
124551582|NCT01399125|447976492|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124551583|NCT01399125|447976493|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
124713071|NCT00401843|448574530|FG001|Overall Study|End of Study|1|||
124551584|NCT01399125|447976492|FG000|Overall Study|Withdrawal by Subject|5|||
124551585|NCT01399125|447976493|FG001|Overall Study|Withdrawal by Subject|8|||
124713072|NCT00401843|448574531|FG002|Overall Study|End of Study|2|||
124713073|NCT00401843|448574529|FG000|Overall Study|Lost to Follow-up|0|||
124971440|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
124971441|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
124971442|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
124971443|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
124971444|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
124971445|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
124971446|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
124971447|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
124971448|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
124971449|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
124971450|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
124971451|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
124971452|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
124971453|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
124971454|NCT00132678|449523270|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
124971455|NCT00132678|449523271|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
124971456|NCT00132678|449523272|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
124971457|NCT00132678|449523270|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
124971458|NCT00132678|449523271|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
124713074|NCT00401843|448574530|FG001|Overall Study|Lost to Follow-up|0|||
124713075|NCT00401843|448574531|FG002|Overall Study|Lost to Follow-up|2|||
124713076|NCT00401843|448574529|FG000|Overall Study|Other Unspecified|0|||
124713077|NCT00401843|448574530|FG001|Overall Study|Other Unspecified|3|||
124713078|NCT00401843|448574531|FG002|Overall Study|Other Unspecified|5|||
124713079|NCT00401843|448574529|FG000|Overall Study|Physician Decision|0|||
124713080|NCT00401843|448574530|FG001|Overall Study|Physician Decision|16|||
124713081|NCT00401843|448574531|FG002|Overall Study|Physician Decision|10|||
124713082|NCT00401843|448574529|FG000|Overall Study|Protocol Violation|0|||
124713083|NCT00401843|448574530|FG001|Overall Study|Protocol Violation|0|||
124713084|NCT00401843|448574531|FG002|Overall Study|Protocol Violation|1|||
124713085|NCT00401843|448574529|FG000|Overall Study|Withdrawal by Subject|1|||
124713086|NCT00401843|448574530|FG001|Overall Study|Withdrawal by Subject|5|||
124713087|NCT00401843|448574531|FG002|Overall Study|Withdrawal by Subject|5|||
124713088|NCT00401843|448574529|FG000|Overall Study|Withdrawal of consent to study agent|1|||
124467163|NCT02064387|447668863|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
124713089|NCT00401843|448574530|FG001|Overall Study|Withdrawal of consent to study agent|15|||
124713090|NCT00401843|448574531|FG002|Overall Study|Withdrawal of consent to study agent|17|||
124713091|NCT00401843|448574529|FG000|Overall Study|Randomized but not Treated|0|||
124713092|NCT00401843|448574530|FG001|Overall Study|Randomized but not Treated|2|||
124713093|NCT00401843|448574531|FG002|Overall Study|Randomized but not Treated|3|||
124713094|NCT00401843|448574529|FG000|Overall Study|Received incorrect treatment|0|||
124713095|NCT00401843|448574530|FG001|Overall Study|Received incorrect treatment|3|||
124713096|NCT00401843|448574531|FG002|Overall Study|Received incorrect treatment|0|||
124713097|NCT02103062|448574532|FG000|Overall Study|Adverse Event|1|||
124713098|NCT02103062|448574533|FG001|Overall Study|Adverse Event|2|||
124467164|NCT02706730|447668864|FG000|Overall Study|Adverse Event|3|||
124467165|NCT02706730|447668864|FG000|Overall Study|Lack of Efficacy|5|||
124467166|NCT02706730|447668864|FG000|Overall Study|Withdrawal by Subject|11|||
124467167|NCT02706730|447668864|FG000|Overall Study|Study Terminated by Sponsor|11|||
124467168|NCT02706730|447668864|FG000|Overall Study|Subject chose not to receive injection|3|||
124467169|NCT02499029|447668865|FG000|Overall Study|Lost to Follow-up|2|||
124467170|NCT02499029|447668866|FG001|Overall Study|Lost to Follow-up|2|||
124467171|NCT02499029|447668865|FG000|Overall Study|Physician Decision|2|||
124467172|NCT02499029|447668866|FG001|Overall Study|Physician Decision|1|||
124467173|NCT02499029|447668865|FG000|Overall Study|Death|1|||
124467174|NCT02499029|447668866|FG001|Overall Study|Death|0|||
124467175|NCT00094055|447668867|FG000|Overall Study|Adverse Event|11|||
124467176|NCT00094055|447668867|FG000|Overall Study|Death|4|||
124467177|NCT00094055|447668867|FG000|Overall Study|Lack of Efficacy|17|||
124467178|NCT00094055|447668867|FG000|Overall Study|Lost to Follow-up|2|||
124467179|NCT00094055|447668867|FG000|Overall Study|progressive disease|2|||
124467180|NCT00094055|447668867|FG000|Overall Study|clinical progression|1|||
124467181|NCT00094055|447668867|FG000|Overall Study|roll-over to another study|14|||
124467182|NCT00094055|447668867|FG000|Overall Study|Withdrawal by Subject|9|||
124467183|NCT00411554|447668870|FG000|Overall Study|Adverse Event|2|||
124467184|NCT00411554|447668871|FG001|Overall Study|Adverse Event|4|||
124713099|NCT02103062|448574532|FG000|Overall Study|Progressive Disease|17|||
124467185|NCT00411554|447668870|FG000|Overall Study|Lack of Efficacy|2|||
124467186|NCT00411554|447668871|FG001|Overall Study|Lack of Efficacy|5|||
124467187|NCT00411554|447668870|FG000|Overall Study|Withdrawal by Subject|3|||
124713100|NCT02103062|448574533|FG001|Overall Study|Progressive Disease|20|||
124713101|NCT02103062|448574532|FG000|Overall Study|Death|0|||
124713102|NCT02103062|448574533|FG001|Overall Study|Death|1|||
124971459|NCT00132678|449523272|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
124971460|NCT00132678|449523270|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
124971461|NCT00132678|449523271|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
124971462|NCT00132678|449523272|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
124971463|NCT00132678|449523270|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
124971464|NCT00132678|449523271|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
124971465|NCT00132678|449523272|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
124971466|NCT00132678|449523270|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
124971467|NCT00132678|449523271|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
124971468|NCT00132678|449523272|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
124971469|NCT00132678|449523270|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
124971470|NCT00132678|449523271|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
124971471|NCT00132678|449523272|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
124971472|NCT00132678|449523270|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
124971473|NCT00132678|449523271|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
124971474|NCT00132678|449523272|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
124971475|NCT00132678|449523270|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
124971476|NCT00132678|449523271|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
124971477|NCT00132678|449523272|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
124971478|NCT00953147|449523273|FG000|Overall Study|Adverse Event|8|||
124971479|NCT00953147|449523274|FG001|Overall Study|Adverse Event|16|||
124971480|NCT00953147|449523275|FG002|Overall Study|Adverse Event|6|||
124971481|NCT00953147|449523273|FG000|Overall Study|Protocol Violation|2|||
124971482|NCT00953147|449523274|FG001|Overall Study|Protocol Violation|8|||
124971483|NCT00953147|449523275|FG002|Overall Study|Protocol Violation|4|||
124971484|NCT00953147|449523273|FG000|Overall Study|Withdrawal by Subject|13|||
124971485|NCT00953147|449523274|FG001|Overall Study|Withdrawal by Subject|15|||
124971486|NCT00953147|449523275|FG002|Overall Study|Withdrawal by Subject|12|||
124971487|NCT00953147|449523273|FG000|Overall Study|Lost to Follow-up|8|||
124971488|NCT00953147|449523274|FG001|Overall Study|Lost to Follow-up|9|||
124971489|NCT00953147|449523275|FG002|Overall Study|Lost to Follow-up|4|||
124971490|NCT00953147|449523273|FG000|Overall Study|Physician Decision|2|||
124971491|NCT00953147|449523274|FG001|Overall Study|Physician Decision|7|||
124971492|NCT00953147|449523275|FG002|Overall Study|Physician Decision|3|||
124971493|NCT00953147|449523273|FG000|Overall Study|Other|4|||
124971494|NCT00953147|449523274|FG001|Overall Study|Other|11|||
124971495|NCT00953147|449523275|FG002|Overall Study|Other|13|||
124971496|NCT01367847|449523276|FG000|Overall Study|Withdrawal by Subject|2|||
124971497|NCT01367847|449523277|FG001|Overall Study|Withdrawal by Subject|2|||
124971498|NCT02056626|449523278|FG000|Overall Study|patient did not follow directions|3|||
124971499|NCT02056626|449523279|FG001|Overall Study|patient did not follow directions|1|||
124971500|NCT02056626|449523280|FG002|Overall Study|patient did not follow directions|0|||
124971501|NCT02056626|449523281|FG003|Overall Study|patient did not follow directions|0|||
124971502|NCT00863512|449523282|FG000|Overall Study|Adverse Event|2|||
124971503|NCT00863512|449523283|FG001|Overall Study|Adverse Event|0|||
124971504|NCT00863512|449523282|FG000|Overall Study|Withdrawal by Subject|11|||
124971505|NCT00863512|449523283|FG001|Overall Study|Withdrawal by Subject|0|||
124971506|NCT00863512|449523282|FG000|Overall Study|Physician Decision|1|||
124971507|NCT00863512|449523283|FG001|Overall Study|Physician Decision|0|||
124971508|NCT00078338|449523284|FG000|Overall Study|Adverse Event|31|||
124971509|NCT00078338|449523285|FG001|Overall Study|Adverse Event|24|||
124971510|NCT00078338|449523284|FG000|Overall Study|Lost to Follow-up|17|||
124971511|NCT00078338|449523285|FG001|Overall Study|Lost to Follow-up|2|||
124971512|NCT00078338|449523284|FG000|Overall Study|Protocol Violation|2|||
124971513|NCT00078338|449523285|FG001|Overall Study|Protocol Violation|2|||
124971514|NCT00078338|449523284|FG000|Overall Study|Disease Progression|4|||
124971515|NCT00078338|449523285|FG001|Overall Study|Disease Progression|7|||
124971516|NCT00078338|449523284|FG000|Overall Study|Other|28|||
124971517|NCT00078338|449523285|FG001|Overall Study|Other|16|||
124971518|NCT00078338|449523284|FG000|Overall Study|Subjects randomized, but not treated|3|||
124971519|NCT00078338|449523285|FG001|Overall Study|Subjects randomized, but not treated|3|||
124971520|NCT02037477|449523286|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
124971521|NCT02037477|449523287|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
124971522|NCT02037477|449523288|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
124971523|NCT02037477|449523289|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
124467188|NCT00411554|447668871|FG001|Overall Study|Withdrawal by Subject|0|||
124467189|NCT00411554|447668870|FG000|Overall Study|Patient Moved|1|||
124467190|NCT00411554|447668871|FG001|Overall Study|Patient Moved|0|||
124467191|NCT00699907|447668872|FG000|Overall Study|Withdrawal by Subject|2|||
124467192|NCT00699907|447668873|FG001|Overall Study|Withdrawal by Subject|1|||
124467193|NCT00699907|447668874|FG002|Overall Study|Withdrawal by Subject|0|||
124467194|NCT00699907|447668872|FG000|Overall Study|No usable sample|0|||
124467195|NCT00699907|447668873|FG001|Overall Study|No usable sample|9|||
124467196|NCT00699907|447668874|FG002|Overall Study|No usable sample|8|||
124467197|NCT02161211|447668875|FG000|Overall Study|Lost to Follow-up|21|||
124467198|NCT02161211|447668876|FG001|Overall Study|Lost to Follow-up|27|||
124467199|NCT02161211|447668877|FG002|Overall Study|Lost to Follow-up|21|||
124467200|NCT02161211|447668875|FG000|Overall Study|Dropped|12|||
124971524|NCT01454739|449523291|FG000|Overall Study|Protocol Violation|2|||
124971525|NCT01454739|449523292|FG001|Overall Study|Protocol Violation|3|||
124971526|NCT01454739|449523291|FG000|Overall Study|Withdrawal by Subject|2|||
124971527|NCT01454739|449523292|FG001|Overall Study|Withdrawal by Subject|6|||
124971528|NCT01454739|449523291|FG000|Overall Study|Other|3|||
124971529|NCT01454739|449523292|FG001|Overall Study|Other|5|||
124971530|NCT01454739|449523291|FG000|Overall Study|Physician Decision|0|||
124971531|NCT01454739|449523292|FG001|Overall Study|Physician Decision|5|||
124971532|NCT01454739|449523291|FG000|Overall Study|Lost to Follow-up|0|||
124971533|NCT01454739|449523292|FG001|Overall Study|Lost to Follow-up|1|||
124971534|NCT01454739|449523291|FG000|Overall Study|Adverse Event|0|||
124971535|NCT01454739|449523292|FG001|Overall Study|Adverse Event|1|||
124971536|NCT01784523|449523293|FG000|Overall Study|Study closed early|7|||
124971537|NCT01784523|449523294|FG001|Overall Study|Study closed early|4|||
124971538|NCT02577003|449523297|FG000|Overall Study|Adverse Event|2|||
124971539|NCT02577003|449523298|FG001|Overall Study|Adverse Event|4|||
124971540|NCT02577003|449523297|FG000|Overall Study|Withdrawal by Subject|0|||
124971541|NCT02577003|449523298|FG001|Overall Study|Withdrawal by Subject|1|||
124971542|NCT02786004|449523299|FG000|Overall Study|Withdrawal by Subject|0|||
124971543|NCT02786004|449523300|FG001|Overall Study|Withdrawal by Subject|1|||
124971544|NCT01677299|449523301|FG000|Overall Study|Adverse Event|0|||
124971545|NCT01677299|449523302|FG001|Overall Study|Adverse Event|2|||
124971546|NCT01677299|449523303|FG002|Overall Study|Adverse Event|1|||
124971547|NCT01677299|449523304|FG003|Overall Study|Adverse Event|0|||
124971548|NCT01677299|449523301|FG000|Overall Study|Withdrawal by Subject|0|||
124971549|NCT01677299|449523302|FG001|Overall Study|Withdrawal by Subject|1|||
124971550|NCT01677299|449523303|FG002|Overall Study|Withdrawal by Subject|0|||
124971551|NCT01677299|449523304|FG003|Overall Study|Withdrawal by Subject|1|||
124971552|NCT00559377|449523306|FG000|Overall Study|Withdrawal by Subject|9|||
124971553|NCT00940875|449523307|FG000|Treatment Phase|Adverse Event|9|||
124971554|NCT00940875|449523308|FG001|Treatment Phase|Adverse Event|3|||
124971555|NCT00940875|449523307|FG000|Treatment Phase|Death|3|||
124971556|NCT00940875|449523308|FG001|Treatment Phase|Death|5|||
124971557|NCT00940875|449523307|FG000|Treatment Phase|Lack of Efficacy|1|||
124971558|NCT00940875|449523308|FG001|Treatment Phase|Lack of Efficacy|0|||
124971559|NCT00940875|449523307|FG000|Treatment Phase|Withdrawal by Subject|3|||
124971560|NCT00940875|449523308|FG001|Treatment Phase|Withdrawal by Subject|0|||
124971561|NCT00940875|449523307|FG000|Treatment Phase|Disease progression|9|||
124971562|NCT00940875|449523308|FG001|Treatment Phase|Disease progression|11|||
124971563|NCT00940875|449523307|FG000|Treatment Phase|Physician Decision|1|||
124971564|NCT00940875|449523308|FG001|Treatment Phase|Physician Decision|0|||
124971565|NCT00940875|449523307|FG000|Post-Study Treatment|Death|0|||
124971566|NCT00940875|449523308|FG001|Post-Study Treatment|Death|1|||
124971567|NCT00940875|449523307|FG000|Post-Study Treatment|Disease Progression|0|||
124971568|NCT00940875|449523308|FG001|Post-Study Treatment|Disease Progression|2|||
124971569|NCT00490945|449523309|FG000|Overall Study|Adverse Event|0|||
124971570|NCT00490945|449523310|FG001|Overall Study|Adverse Event|1|||
124971571|NCT00490945|449523311|FG002|Overall Study|Adverse Event|0|||
124971572|NCT00490945|449523312|FG003|Overall Study|Adverse Event|0|||
124971573|NCT00490945|449523313|FG004|Overall Study|Adverse Event|0|||
124971574|NCT03334253|449523314|FG000|Overall Study|Withdrawal by Subject|1|||
124971575|NCT03334253|449523315|FG001|Overall Study|Withdrawal by Subject|0|||
124971576|NCT03334253|449523314|FG000|Overall Study|Lost to Follow-up|4|||
124467201|NCT02161211|447668876|FG001|Overall Study|Dropped|5|||
124971577|NCT03334253|449523315|FG001|Overall Study|Lost to Follow-up|3|||
124971578|NCT03334253|449523314|FG000|Overall Study|Moved residence|2|||
124971579|NCT03334253|449523315|FG001|Overall Study|Moved residence|2|||
124971580|NCT00203047|449523316|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
124971581|NCT00203047|449523317|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
124971582|NCT00203047|449523316|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
124971583|NCT00203047|449523317|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
124971584|NCT00203047|449523316|FG000|Overall Study|Withdrawal by Subject|13|||
124971585|NCT00203047|449523317|FG001|Overall Study|Withdrawal by Subject|47|||
124467202|NCT02161211|447668877|FG002|Overall Study|Dropped|9|||
124971586|NCT00203047|449523316|FG000|Overall Study|Teva requested participant withdrawal|1|||
124971587|NCT00203047|449523317|FG001|Overall Study|Teva requested participant withdrawal|1|||
124971588|NCT00203047|449523316|FG000|Overall Study|Physician Decision|8|||
124971589|NCT00203047|449523317|FG001|Overall Study|Physician Decision|7|||
124971590|NCT00203047|449523316|FG000|Overall Study|Non-compliance|4|||
124971591|NCT00203047|449523317|FG001|Overall Study|Non-compliance|8|||
124971592|NCT00203047|449523316|FG000|Overall Study|Protocol Violation|1|||
124467203|NCT00430508|447668878|FG000|Overall Study|Adverse Event|2|||
124467204|NCT00430508|447668879|FG001|Overall Study|Adverse Event|3|||
124971593|NCT00203047|449523317|FG001|Overall Study|Protocol Violation|0|||
124971594|NCT00203047|449523316|FG000|Overall Study|Lost to Follow-up|11|||
124971595|NCT00203047|449523317|FG001|Overall Study|Lost to Follow-up|5|||
124971596|NCT00203047|449523316|FG000|Overall Study|Adverse Event|8|||
124971597|NCT00203047|449523317|FG001|Overall Study|Adverse Event|18|||
124971598|NCT00203047|449523316|FG000|Overall Study|Death|1|||
124971599|NCT00203047|449523317|FG001|Overall Study|Death|2|||
124971600|NCT00203047|449523316|FG000|Overall Study|Pregnancy|3|||
124971601|NCT00203047|449523317|FG001|Overall Study|Pregnancy|0|||
124971602|NCT00203047|449523316|FG000|Overall Study|Other|5|||
124971603|NCT00203047|449523317|FG001|Overall Study|Other|5|||
124971604|NCT00872001|449523320|FG000|Overall Study|Adverse Event|34|||
124971605|NCT00872001|449523321|FG001|Overall Study|Adverse Event|23|||
124971606|NCT00872001|449523320|FG000|Overall Study|Protocol Defined Clinical Event|5|||
124971607|NCT00872001|449523321|FG001|Overall Study|Protocol Defined Clinical Event|7|||
124971608|NCT00872001|449523320|FG000|Overall Study|Lost to Follow-up|13|||
124971609|NCT00872001|449523321|FG001|Overall Study|Lost to Follow-up|12|||
124971610|NCT00872001|449523320|FG000|Overall Study|Withdrawal by Subject|18|||
124971611|NCT00872001|449523321|FG001|Overall Study|Withdrawal by Subject|30|||
124971612|NCT00872001|449523320|FG000|Overall Study|Protocol Violation|5|||
124971613|NCT00872001|449523321|FG001|Overall Study|Protocol Violation|8|||
124971614|NCT00872001|449523320|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
124971615|NCT00872001|449523321|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
124971616|NCT00872001|449523320|FG000|Overall Study|Administrative|23|||
124971617|NCT00872001|449523321|FG001|Overall Study|Administrative|15|||
124971618|NCT00340704|449523322|FG000|PK Study|Adverse Event|0|||
124971619|NCT00340704|449523323|FG001|PK Study|Adverse Event|1|||
124971620|NCT00340704|449523324|FG002|PK Study|Adverse Event|0|||
124971621|NCT00340704|449523325|FG003|PK Study|Adverse Event|0|||
124971622|NCT00340704|449523326|FG004|PK Study|Adverse Event|0|||
124971623|NCT00340704|449523327|FG005|PK Study|Adverse Event|0|||
124971624|NCT00340704|449523328|FG006|PK Study|Adverse Event|0|||
124971625|NCT00340704|449523329|FG007|PK Study|Adverse Event|0|||
124971626|NCT00340704|449523330|FG008|PK Study|Adverse Event|0|||
124971627|NCT00340704|449523322|FG000|PK Study|Not treated|0|||
124971628|NCT00340704|449523323|FG001|PK Study|Not treated|0|||
124971629|NCT00340704|449523324|FG002|PK Study|Not treated|1|||
124971630|NCT00340704|449523325|FG003|PK Study|Not treated|0|||
124971631|NCT00340704|449523326|FG004|PK Study|Not treated|0|||
124971632|NCT00340704|449523327|FG005|PK Study|Not treated|0|||
124971633|NCT00340704|449523328|FG006|PK Study|Not treated|0|||
124971634|NCT00340704|449523329|FG007|PK Study|Not treated|0|||
124971635|NCT00340704|449523330|FG008|PK Study|Not treated|0|||
124971636|NCT00340704|449523322|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
124971637|NCT00340704|449523323|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
124971638|NCT00340704|449523324|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
124971639|NCT00340704|449523325|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
124971640|NCT00340704|449523326|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
124971641|NCT00340704|449523327|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
124971642|NCT00340704|449523328|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
124971643|NCT00340704|449523329|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
124971644|NCT00340704|449523330|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
124971645|NCT00340704|449523322|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
124971646|NCT00340704|449523323|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
124971647|NCT00340704|449523324|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
124971648|NCT00340704|449523325|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
124971649|NCT00340704|449523326|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
124971650|NCT00340704|449523327|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
124971651|NCT00340704|449523328|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
124971652|NCT00340704|449523329|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
124971653|NCT00340704|449523330|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
124467205|NCT00430508|447668880|FG002|Overall Study|Adverse Event|5|||
124467206|NCT00430508|447668881|FG003|Overall Study|Adverse Event|3|||
124467207|NCT00430508|447668878|FG000|Overall Study|Withdrawal by Subject|0|||
124467208|NCT00430508|447668879|FG001|Overall Study|Withdrawal by Subject|1|||
124467209|NCT00430508|447668880|FG002|Overall Study|Withdrawal by Subject|1|||
124713103|NCT02030821|448574535|FG000|Overall Study|Physician Decision|2|||
124713104|NCT02030821|448574536|FG001|Overall Study|Physician Decision|2|||
124971654|NCT00340704|449523322|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
124713105|NCT02030821|448574537|FG002|Overall Study|Physician Decision|5|||
124971655|NCT00340704|449523323|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
124971656|NCT00340704|449523324|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
124971657|NCT00340704|449523325|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
124971658|NCT00340704|449523326|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
124971659|NCT00340704|449523327|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
124551586|NCT01399125|447976492|FG000|Overall Study|Lost to Follow-up|2|||
124551587|NCT01399125|447976493|FG001|Overall Study|Lost to Follow-up|3|||
124551588|NCT01399125|447976492|FG000|Overall Study|Administrative Problems|7|||
124551589|NCT01399125|447976493|FG001|Overall Study|Administrative Problems|11|||
124551590|NCT01399125|447976492|FG000|Overall Study|Death|0|||
124551591|NCT01399125|447976493|FG001|Overall Study|Death|1|||
124551592|NCT01399125|447976492|FG000|Overall Study|Protocol Deviation|5|||
124551593|NCT01399125|447976493|FG001|Overall Study|Protocol Deviation|2|||
124551594|NCT00647426|447976496|FG000|Overall Study|Withdrawal by Subject|2|||
124551595|NCT03343054|447976501|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
124551596|NCT03343054|447976502|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
124551597|NCT03343054|447976503|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
124551598|NCT03343054|447976501|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
124551599|NCT03343054|447976502|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
124551600|NCT03343054|447976503|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
124551601|NCT03343054|447976501|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
124551602|NCT03343054|447976502|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
124551603|NCT03343054|447976503|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
124551604|NCT03343054|447976501|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
124551605|NCT03343054|447976502|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
124551606|NCT03343054|447976503|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
124551607|NCT03578276|447976504|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
124551608|NCT03578276|447976505|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
124551609|NCT02626182|447976506|FG000|Overall Study|Adverse Event|2|||
124551610|NCT02626182|447976507|FG001|Overall Study|Adverse Event|0|||
124551611|NCT00883740|447976508|FG000|First Intervention|Lost to Follow-up|1|||
124551612|NCT00883740|447976509|FG001|First Intervention|Lost to Follow-up|0|||
124551613|NCT00883740|447976508|FG000|First Intervention|No longer willing to participate|2|||
124551614|NCT00883740|447976509|FG001|First Intervention|No longer willing to participate|0|||
124551615|NCT00883740|447976508|FG000|First Intervention|Protocol Violation|3|||
124551616|NCT00883740|447976509|FG001|First Intervention|Protocol Violation|6|||
124551617|NCT00883740|447976508|FG000|First Intervention|Adverse Event|1|||
124551618|NCT00883740|447976509|FG001|First Intervention|Adverse Event|2|||
124551619|NCT00883740|447976508|FG000|Second Intervention|Protocol Violation|1|||
124551620|NCT00883740|447976509|FG001|Second Intervention|Protocol Violation|0|||
124551621|NCT00883740|447976508|FG000|Second Intervention|No longer willing to participate|0|||
124551622|NCT00883740|447976509|FG001|Second Intervention|No longer willing to participate|1|||
124551623|NCT00981409|447976510|FG000|Overall Study|Adverse Event|4|||
124551624|NCT00981409|447976511|FG001|Overall Study|Adverse Event|0|||
124551625|NCT00981409|447976510|FG000|Overall Study|Protocol Violation|0|||
124551626|NCT00981409|447976511|FG001|Overall Study|Protocol Violation|1|||
124551627|NCT00981409|447976510|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
124551628|NCT00981409|447976511|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
124551629|NCT03869684|447976520|FG000|Overall Study|Adverse Event|0|||
124551630|NCT03869684|447976521|FG001|Overall Study|Adverse Event|3|||
124551631|NCT03869684|447976522|FG002|Overall Study|Adverse Event|1|||
124551632|NCT03869684|447976520|FG000|Overall Study|Withdrawal by Subject|1|||
124551633|NCT03869684|447976521|FG001|Overall Study|Withdrawal by Subject|0|||
124551634|NCT03869684|447976522|FG002|Overall Study|Withdrawal by Subject|0|||
124551635|NCT03869684|447976520|FG000|Overall Study|Lost to Follow-up|1|||
124551636|NCT03869684|447976521|FG001|Overall Study|Lost to Follow-up|0|||
124551637|NCT03869684|447976522|FG002|Overall Study|Lost to Follow-up|0|||
124551638|NCT03869684|447976520|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
124551639|NCT03869684|447976521|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
124551640|NCT03869684|447976522|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
124551641|NCT00078312|447976523|FG000|Overall Study|Adverse Event|43|||
124551642|NCT00078312|447976523|FG000|Overall Study|Lack of Efficacy|15|||
124551643|NCT00078312|447976523|FG000|Overall Study|Lost to Follow-up|41|||
124551644|NCT00078312|447976523|FG000|Overall Study|Physician Decision|9|||
124551645|NCT00078312|447976523|FG000|Overall Study|Protocol Violation|3|||
124713106|NCT02030821|448574538|FG003|Overall Study|Physician Decision|2|||
124713107|NCT03192137|448574539|FG000|Overall Study|Adverse Event|10|||
124713108|NCT03192137|448574540|FG001|Overall Study|Adverse Event|11|||
124713109|NCT03192137|448574539|FG000|Overall Study|Physician Decision|1|||
124971660|NCT00340704|449523328|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
124971661|NCT00340704|449523329|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
124551646|NCT00078312|447976523|FG000|Overall Study|Withdrawal by Subject|33|||
124551647|NCT00078312|447976523|FG000|Overall Study|Miscellaneous|33|||
124551648|NCT04840901|447976524|FG000|Overall Study|Lost to Follow-up|3|||
124551649|NCT04840901|447976525|FG001|Overall Study|Lost to Follow-up|1|||
124551650|NCT04840901|447976524|FG000|Overall Study|Moved|1|||
124551651|NCT04840901|447976525|FG001|Overall Study|Moved|0|||
124551652|NCT04840901|447976524|FG000|Overall Study|Unable to comply with study schedule|0|||
124971662|NCT00340704|449523330|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
124971663|NCT00340704|449523322|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
124971664|NCT00340704|449523323|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
124971665|NCT00340704|449523324|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
124971666|NCT00340704|449523325|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
124971667|NCT00340704|449523326|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
124971668|NCT00340704|449523327|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
124971669|NCT00340704|449523328|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
124971670|NCT00340704|449523329|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
124971671|NCT00340704|449523330|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
124971672|NCT00246090|449523337|FG000|Overall Study|Adverse Event|25|||
124971673|NCT00246090|449523337|FG000|Overall Study|Withdrawal by Subject|7|||
124971674|NCT00246090|449523337|FG000|Overall Study|Progressive Disease|212|||
124971675|NCT00246090|449523337|FG000|Overall Study|Clinical Progression|30|||
124971676|NCT00246090|449523337|FG000|Overall Study|Physician Decision|11|||
124467210|NCT00430508|447668881|FG003|Overall Study|Withdrawal by Subject|1|||
124467211|NCT00430508|447668878|FG000|Overall Study|responder at visit 4|0|||
124467212|NCT00430508|447668879|FG001|Overall Study|responder at visit 4|0|||
124467213|NCT00430508|447668880|FG002|Overall Study|responder at visit 4|2|||
124467214|NCT00430508|447668881|FG003|Overall Study|responder at visit 4|0|||
124467215|NCT00430508|447668878|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
124467216|NCT00430508|447668879|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
124467217|NCT00430508|447668880|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
124467218|NCT00430508|447668881|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
124467219|NCT00430508|447668878|FG000|Overall Study|Other|1|||
124467220|NCT00430508|447668879|FG001|Overall Study|Other|1|||
124467221|NCT00430508|447668880|FG002|Overall Study|Other|3|||
124770332|NCT02345070|448788789|FG001|Overall Study|Adverse Event|8|||
124770333|NCT02345070|448788790|FG002|Overall Study|Adverse Event|16|||
124770334|NCT02345070|448788788|FG000|Overall Study|Poor compliance to protocol|2|||
124770335|NCT02345070|448788789|FG001|Overall Study|Poor compliance to protocol|0|||
124971677|NCT00246090|449523337|FG000|Overall Study|Not Otherwise Specified|10|||
124971678|NCT02595372|449523338|FG000|Overall Study|Adverse Event|6|||
124971679|NCT02595372|449523338|FG000|Overall Study|Physician Decision|2|||
124971680|NCT02595372|449523338|FG000|Overall Study|Disease Progression|1|||
124971681|NCT00953615|449523339|FG000|Overall Study|Adverse Event|1|||
124971682|NCT01299480|449523340|FG000|Overall Study|No longer willing to participate|19|||
124971683|NCT01299480|449523341|FG001|Overall Study|No longer willing to participate|17|||
124971684|NCT01299480|449523342|FG002|Overall Study|No longer willing to participate|14|||
124971685|NCT01299480|449523343|FG003|Overall Study|No longer willing to participate|13|||
124971686|NCT01299480|449523344|FG004|Overall Study|No longer willing to participate|10|||
124971687|NCT01299480|449523340|FG000|Overall Study|Protocol Violation|7|||
124971688|NCT01299480|449523341|FG001|Overall Study|Protocol Violation|5|||
124971689|NCT01299480|449523342|FG002|Overall Study|Protocol Violation|8|||
124971690|NCT01299480|449523343|FG003|Overall Study|Protocol Violation|1|||
124971691|NCT01299480|449523344|FG004|Overall Study|Protocol Violation|1|||
124971692|NCT01299480|449523340|FG000|Overall Study|Withdrawal by Subject|3|||
124971693|NCT01299480|449523341|FG001|Overall Study|Withdrawal by Subject|4|||
124971694|NCT01299480|449523342|FG002|Overall Study|Withdrawal by Subject|7|||
124971695|NCT01299480|449523343|FG003|Overall Study|Withdrawal by Subject|3|||
124971696|NCT01299480|449523344|FG004|Overall Study|Withdrawal by Subject|4|||
124971697|NCT01299480|449523340|FG000|Overall Study|Adverse Event|6|||
124971698|NCT01299480|449523341|FG001|Overall Study|Adverse Event|4|||
124971699|NCT01299480|449523342|FG002|Overall Study|Adverse Event|5|||
124971700|NCT01299480|449523343|FG003|Overall Study|Adverse Event|4|||
124971701|NCT01299480|449523344|FG004|Overall Study|Adverse Event|0|||
124971702|NCT01299480|449523340|FG000|Overall Study|Withdrawal due to pregnancy|0|||
124971703|NCT01299480|449523341|FG001|Overall Study|Withdrawal due to pregnancy|1|||
124971704|NCT01299480|449523342|FG002|Overall Study|Withdrawal due to pregnancy|1|||
124971705|NCT01299480|449523343|FG003|Overall Study|Withdrawal due to pregnancy|0|||
124971706|NCT01299480|449523344|FG004|Overall Study|Withdrawal due to pregnancy|0|||
124971707|NCT01299480|449523340|FG000|Overall Study|Physician Decision|1|||
124971708|NCT01299480|449523341|FG001|Overall Study|Physician Decision|1|||
124971709|NCT01299480|449523342|FG002|Overall Study|Physician Decision|0|||
124971710|NCT01299480|449523343|FG003|Overall Study|Physician Decision|2|||
124971711|NCT01299480|449523344|FG004|Overall Study|Physician Decision|0|||
124971712|NCT01299480|449523340|FG000|Overall Study|Lost to Follow-up|3|||
124971713|NCT01299480|449523341|FG001|Overall Study|Lost to Follow-up|1|||
124971714|NCT01299480|449523342|FG002|Overall Study|Lost to Follow-up|2|||
124971715|NCT01299480|449523343|FG003|Overall Study|Lost to Follow-up|1|||
124971716|NCT01299480|449523344|FG004|Overall Study|Lost to Follow-up|2|||
124971717|NCT01299480|449523340|FG000|Overall Study|Other|3|||
124971718|NCT01299480|449523341|FG001|Overall Study|Other|2|||
124971719|NCT01299480|449523342|FG002|Overall Study|Other|3|||
124971720|NCT01299480|449523343|FG003|Overall Study|Other|0|||
124971721|NCT01299480|449523344|FG004|Overall Study|Other|3|||
124971722|NCT01299480|449523340|FG000|Overall Study|Started, but not vaccinated|0|||
124971723|NCT01299480|449523341|FG001|Overall Study|Started, but not vaccinated|0|||
124971724|NCT01299480|449523342|FG002|Overall Study|Started, but not vaccinated|1|||
124971725|NCT01299480|449523343|FG003|Overall Study|Started, but not vaccinated|1|||
124971726|NCT01299480|449523344|FG004|Overall Study|Started, but not vaccinated|0|||
124971727|NCT02389764|449523345|FG000|Overall Study|Lack of Efficacy|9|||
124971728|NCT00583947|449523346|FG000|Cross-over Period|Adverse Event|2|||
124971729|NCT00583947|449523347|FG001|Cross-over Period|Adverse Event|0|||
124971730|NCT00583947|449523346|FG000|Cross-over Period|Withdrawal by Subject|2|||
124971731|NCT00583947|449523347|FG001|Cross-over Period|Withdrawal by Subject|0|||
124971732|NCT00583947|449523346|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
124971733|NCT00583947|449523347|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
124971734|NCT00583947|449523346|FG000|Cross-over Period|Other|1|||
124971735|NCT00583947|449523347|FG001|Cross-over Period|Other|1|||
124971736|NCT00738283|449523348|FG000|Overall Study|Death|1|||
124713110|NCT03192137|448574540|FG001|Overall Study|Physician Decision|0|||
124713111|NCT03192137|448574539|FG000|Overall Study|Lack of Efficacy|20|||
124713112|NCT03192137|448574540|FG001|Overall Study|Lack of Efficacy|37|||
124713113|NCT03192137|448574539|FG000|Overall Study|Withdrawal by Subject|3|||
124713114|NCT03192137|448574540|FG001|Overall Study|Withdrawal by Subject|3|||
124713115|NCT03192137|448574539|FG000|Overall Study|Protocol Violation|4|||
124713116|NCT03192137|448574540|FG001|Overall Study|Protocol Violation|3|||
124971737|NCT00738283|449523348|FG000|Overall Study|Transfer to another facility|2|||
124971738|NCT00738283|449523348|FG000|Overall Study|Discharge home prior to end of study|1|||
124971739|NCT00486252|449523351|FG000|Overall Study|Adverse Event|7|||
124971740|NCT00486252|449523351|FG000|Overall Study|Lack of Efficacy|9|||
124971741|NCT00486252|449523351|FG000|Overall Study|Lost to Follow-up|24|||
124971742|NCT00486252|449523351|FG000|Overall Study|Other|18|||
124971743|NCT01210651|449523352|FG000|Overall Study|Lost to Follow-up|1|||
124971744|NCT01210651|449523353|FG001|Overall Study|Lost to Follow-up|1|||
124971745|NCT01210651|449523352|FG000|Overall Study|schedule conflicts|1|||
124971746|NCT01210651|449523353|FG001|Overall Study|schedule conflicts|5|||
124971747|NCT01210651|449523352|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
124971748|NCT01210651|449523353|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
124971749|NCT01210651|449523352|FG000|Overall Study|Withdrawal by Subject|1|||
124971750|NCT01210651|449523353|FG001|Overall Study|Withdrawal by Subject|1|||
124971751|NCT01210651|449523352|FG000|Overall Study|Injury outside study|2|||
124971752|NCT01210651|449523353|FG001|Overall Study|Injury outside study|0|||
124971753|NCT02592707|449523357|FG000|Overall Study|Consent Withdrawn|0|||
124971754|NCT02592707|449523358|FG001|Overall Study|Consent Withdrawn|1|||
124971755|NCT02592707|449523359|FG002|Overall Study|Consent Withdrawn|2|||
124971756|NCT02592707|449523360|FG003|Overall Study|Consent Withdrawn|0|||
124971757|NCT02592707|449523357|FG000|Overall Study|Death|1|||
124971758|NCT02592707|449523358|FG001|Overall Study|Death|0|||
124971759|NCT02592707|449523359|FG002|Overall Study|Death|0|||
124971760|NCT02592707|449523360|FG003|Overall Study|Death|0|||
124971761|NCT02592707|449523357|FG000|Overall Study|Progressive Disease|4|||
124971762|NCT02592707|449523358|FG001|Overall Study|Progressive Disease|4|||
124971763|NCT02592707|449523359|FG002|Overall Study|Progressive Disease|3|||
124971764|NCT02592707|449523360|FG003|Overall Study|Progressive Disease|3|||
124971765|NCT02592707|449523357|FG000|Overall Study|Other|0|||
124971766|NCT02592707|449523358|FG001|Overall Study|Other|0|||
124971767|NCT02592707|449523359|FG002|Overall Study|Other|1|||
124971768|NCT02592707|449523360|FG003|Overall Study|Other|2|||
124971769|NCT02592707|449523357|FG000|Overall Study|Never entered LTFU period|1|||
124971770|NCT02592707|449523358|FG001|Overall Study|Never entered LTFU period|0|||
124971771|NCT02592707|449523359|FG002|Overall Study|Never entered LTFU period|0|||
124971772|NCT02592707|449523360|FG003|Overall Study|Never entered LTFU period|2|||
124971773|NCT00469859|449523361|FG000|Overall Study|Inevaluable|0|||
124971774|NCT00469859|449523362|FG001|Overall Study|Inevaluable|2|||
124467222|NCT00430508|447668881|FG003|Overall Study|Other|0|||
124467223|NCT03728309|447668882|FG000|Overall Study|Randomized but not Treated|0|||
124467224|NCT03728309|447668883|FG001|Overall Study|Randomized but not Treated|1|||
124467225|NCT03728309|447668882|FG000|Overall Study|Adverse Event|0|||
124467226|NCT03728309|447668883|FG001|Overall Study|Adverse Event|1|||
124551653|NCT04840901|447976525|FG001|Overall Study|Unable to comply with study schedule|1|||
124551654|NCT04840901|447976524|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
124551655|NCT04840901|447976525|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
124551656|NCT05354206|447976526|FG000|Overall Study|Withdrawal by Subject|1|||
124467227|NCT03728309|447668882|FG000|Overall Study|Withdrawal by Subject|2|||
124467228|NCT03728309|447668883|FG001|Overall Study|Withdrawal by Subject|8|||
124467229|NCT03728309|447668882|FG000|Overall Study|Lost to Follow-up|9|||
124467230|NCT03728309|447668883|FG001|Overall Study|Lost to Follow-up|10|||
124467231|NCT03728309|447668882|FG000|Overall Study|Protocol Deviation|0|||
124551657|NCT05354206|447976527|FG001|Overall Study|Withdrawal by Subject|0|||
124551658|NCT04285983|447976528|FG000|Overall Study|Protocol Violation|6|||
124551659|NCT04936334|447976529|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
124551660|NCT00422058|447976530|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
124551661|NCT00422058|447976531|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
124551662|NCT00422058|447976532|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
124551663|NCT00422058|447976533|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
124551664|NCT00422058|447976534|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
124551665|NCT00422058|447976535|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
124971775|NCT04855734|449523363|FG000|Overall Study|Lost to Follow-up|2|||
124971776|NCT04855734|449523364|FG001|Overall Study|Lost to Follow-up|2|||
124971777|NCT02520310|449523365|FG000|At 6 Months Clinical Follow-up|Death|1|||
124971778|NCT02520310|449523365|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
124971779|NCT02520310|449523365|FG000|AT 3 Year Clinical Follow-up|Death|2|||
124551666|NCT00422058|447976530|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
124971780|NCT02520310|449523365|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
124971781|NCT02520310|449523365|FG000|AT 4 Year Clinical Follow-up|Death|1|||
124467232|NCT03728309|447668883|FG001|Overall Study|Protocol Deviation|1|||
124467233|NCT03728309|447668882|FG000|Overall Study|Due to COVID|1|||
124551667|NCT00422058|447976531|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
124971782|NCT02520310|449523365|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
124971783|NCT01340014|449523366|FG000|Period 1, First 7 Days|Adverse Event|1|||
124971784|NCT01340014|449523367|FG001|Period 1, First 7 Days|Adverse Event|0|||
124971785|NCT01340014|449523366|FG000|Period 1, First 7 Days|Personal Reasons|1|||
124467234|NCT03728309|447668883|FG001|Overall Study|Due to COVID|3|||
124971786|NCT01340014|449523367|FG001|Period 1, First 7 Days|Personal Reasons|0|||
124971787|NCT01340014|449523366|FG000|Period 2, Second 7 Days|Adverse Event|0|||
124971788|NCT01340014|449523367|FG001|Period 2, Second 7 Days|Adverse Event|1|||
124971789|NCT04535544|449523370|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
124971790|NCT04535544|449523371|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
124971791|NCT04535544|449523372|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
124971792|NCT04535544|449523373|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
124971793|NCT04535544|449523370|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
124971794|NCT04535544|449523371|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
124971795|NCT04535544|449523372|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
124971796|NCT04535544|449523373|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
124971797|NCT04535544|449523370|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
124971798|NCT04535544|449523371|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
124971799|NCT04535544|449523372|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
124971800|NCT04535544|449523373|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
124971801|NCT04535544|449523370|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
124971802|NCT04535544|449523371|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
124971803|NCT04535544|449523372|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
124971804|NCT04535544|449523373|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
124971805|NCT04535544|449523370|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
124971806|NCT04535544|449523371|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
124971807|NCT04535544|449523372|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
124971808|NCT04535544|449523373|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
124971809|NCT04535544|449523370|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
124971810|NCT04535544|449523371|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
124971811|NCT04535544|449523372|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
124971812|NCT04535544|449523373|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
124971813|NCT04535544|449523370|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
124971814|NCT04535544|449523371|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
124971815|NCT04535544|449523372|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
124971816|NCT04535544|449523373|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
124971817|NCT04535544|449523370|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
124971818|NCT04535544|449523371|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
124971819|NCT04535544|449523372|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
124971820|NCT04535544|449523373|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
124971821|NCT05131477|449523376|FG000|PART 1|Withdrawal by Subject|2|||
124971822|NCT05131477|449523377|FG001|PART 1|Withdrawal by Subject|9|||
124971823|NCT05131477|449523378|FG002|PART 1|Withdrawal by Subject|6|||
124971824|NCT05131477|449523379|FG003|PART 1|Withdrawal by Subject|2|||
124971825|NCT05131477|449523380|FG004|PART 1|Withdrawal by Subject|8|||
124971826|NCT05131477|449523381|FG005|PART 1|Withdrawal by Subject|0|||
124971827|NCT05131477|449523382|FG006|PART 1|Withdrawal by Subject|0|||
124971828|NCT05131477|449523383|FG007|PART 1|Withdrawal by Subject|0|||
124971829|NCT05131477|449523384|FG008|PART 1|Withdrawal by Subject|0|||
124971830|NCT05131477|449523385|FG009|PART 1|Withdrawal by Subject|0|||
124971831|NCT05131477|449523386|FG010|PART 1|Withdrawal by Subject|0|||
124971832|NCT05131477|449523387|FG011|PART 1|Withdrawal by Subject|0|||
124971833|NCT05131477|449523388|FG012|PART 1|Withdrawal by Subject|0|||
124971834|NCT05131477|449523389|FG013|PART 1|Withdrawal by Subject|0|||
124971835|NCT05131477|449523376|FG000|PART 1|Physician Decision|1|||
124971836|NCT05131477|449523377|FG001|PART 1|Physician Decision|0|||
124971837|NCT05131477|449523378|FG002|PART 1|Physician Decision|0|||
124971838|NCT05131477|449523379|FG003|PART 1|Physician Decision|0|||
124971839|NCT05131477|449523380|FG004|PART 1|Physician Decision|0|||
124971840|NCT05131477|449523381|FG005|PART 1|Physician Decision|0|||
124713117|NCT03192137|448574539|FG000|Overall Study|Surgery Cancelled|4|||
124713118|NCT03192137|448574540|FG001|Overall Study|Surgery Cancelled|1|||
124713119|NCT03192137|448574539|FG000|Overall Study|Other - Various Administrative Reasons|8|||
124713120|NCT03192137|448574540|FG001|Overall Study|Other - Various Administrative Reasons|3|||
124971841|NCT05131477|449523382|FG006|PART 1|Physician Decision|0|||
124971842|NCT05131477|449523383|FG007|PART 1|Physician Decision|0|||
124971843|NCT05131477|449523384|FG008|PART 1|Physician Decision|0|||
124971844|NCT05131477|449523385|FG009|PART 1|Physician Decision|0|||
124971845|NCT05131477|449523386|FG010|PART 1|Physician Decision|0|||
124971846|NCT05131477|449523387|FG011|PART 1|Physician Decision|0|||
124971847|NCT05131477|449523388|FG012|PART 1|Physician Decision|0|||
124971848|NCT05131477|449523389|FG013|PART 1|Physician Decision|0|||
124971849|NCT05131477|449523376|FG000|PART 1|Adverse Event|3|||
124971850|NCT05131477|449523377|FG001|PART 1|Adverse Event|5|||
124971851|NCT05131477|449523378|FG002|PART 1|Adverse Event|1|||
124971852|NCT05131477|449523379|FG003|PART 1|Adverse Event|6|||
124971853|NCT05131477|449523380|FG004|PART 1|Adverse Event|4|||
124971854|NCT05131477|449523381|FG005|PART 1|Adverse Event|0|||
124713121|NCT00657267|448574543|FG000|Overall Study|Progressive disease|45|||
124971855|NCT05131477|449523382|FG006|PART 1|Adverse Event|0|||
124971856|NCT05131477|449523383|FG007|PART 1|Adverse Event|0|||
124713122|NCT00657267|448574543|FG000|Overall Study|Adverse Event|9|||
124713123|NCT02737501|448574547|FG000|Randomized Phase|Died|41|||
124713124|NCT02737501|448574548|FG001|Randomized Phase|Died|29|||
124713125|NCT02737501|448574549|FG002|Randomized Phase|Died|0|||
124713126|NCT02737501|448574547|FG000|Randomized Phase|Withdrawal by Subject|16|||
124713127|NCT02737501|448574548|FG001|Randomized Phase|Withdrawal by Subject|6|||
124713128|NCT02737501|448574549|FG002|Randomized Phase|Withdrawal by Subject|0|||
124713129|NCT02737501|448574547|FG000|Randomized Phase|Lost to Follow-up|0|||
124971857|NCT05131477|449523384|FG008|PART 1|Adverse Event|0|||
124551668|NCT00422058|447976532|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
124551669|NCT00422058|447976533|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
124551670|NCT00422058|447976534|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
124551671|NCT00422058|447976535|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
124551672|NCT00422058|447976530|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
124551673|NCT00422058|447976531|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
124551674|NCT00422058|447976532|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
124551675|NCT00422058|447976533|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
124551676|NCT00422058|447976534|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
124551677|NCT00422058|447976535|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
124551678|NCT00422058|447976530|FG000|Double-Blind, Week 0-20|Other|11|||
124551679|NCT00422058|447976531|FG001|Double-Blind, Week 0-20|Other|3|||
124551680|NCT00422058|447976532|FG002|Double-Blind, Week 0-20|Other|8|||
124551681|NCT00422058|447976533|FG003|Double-Blind, Week 0-20|Other|8|||
124551682|NCT00422058|447976534|FG004|Double-Blind, Week 0-20|Other|4|||
124551683|NCT00422058|447976535|FG005|Double-Blind, Week 0-20|Other|10|||
124551684|NCT00422058|447976530|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
124551685|NCT00422058|447976531|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
124551686|NCT00422058|447976532|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
124551687|NCT00422058|447976533|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
124551688|NCT00422058|447976534|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
124551689|NCT00422058|447976535|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
124551690|NCT00422058|447976530|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
124551691|NCT00422058|447976531|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
124551692|NCT00422058|447976532|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
124551693|NCT00422058|447976533|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
124551694|NCT00422058|447976534|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
124551695|NCT00422058|447976535|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
124551696|NCT00422058|447976530|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
124551697|NCT00422058|447976531|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
124551698|NCT00422058|447976532|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
124551699|NCT00422058|447976533|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
124551700|NCT00422058|447976534|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
124551701|NCT00422058|447976535|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
124551702|NCT00422058|447976530|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
124551703|NCT00422058|447976531|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
124551704|NCT00422058|447976532|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
124551705|NCT00422058|447976533|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
124551706|NCT00422058|447976534|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
124551707|NCT00422058|447976535|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
124551708|NCT00422058|447976530|FG000|Open-Label Extension, Week 20-104|Other|13|||
124551709|NCT00422058|447976531|FG001|Open-Label Extension, Week 20-104|Other|14|||
124551710|NCT00422058|447976532|FG002|Open-Label Extension, Week 20-104|Other|6|||
124551711|NCT00422058|447976533|FG003|Open-Label Extension, Week 20-104|Other|13|||
124551712|NCT00422058|447976534|FG004|Open-Label Extension, Week 20-104|Other|16|||
124551713|NCT00422058|447976535|FG005|Open-Label Extension, Week 20-104|Other|18|||
124551714|NCT05144477|447976538|FG000|Overall Study|Withdrawal by Subject|1|||
124551715|NCT05144477|447976539|FG001|Overall Study|Withdrawal by Subject|1|||
124713130|NCT02737501|448574548|FG001|Randomized Phase|Lost to Follow-up|1|||
124971858|NCT05131477|449523385|FG009|PART 1|Adverse Event|0|||
124971859|NCT05131477|449523386|FG010|PART 1|Adverse Event|0|||
124971860|NCT05131477|449523387|FG011|PART 1|Adverse Event|0|||
124971861|NCT05131477|449523388|FG012|PART 1|Adverse Event|0|||
124971862|NCT05131477|449523389|FG013|PART 1|Adverse Event|0|||
124551716|NCT03273712|447976540|FG000|Overall Study|Death|5|||
124551717|NCT03273712|447976540|FG000|Overall Study|Adverse Event|1|||
124971863|NCT05131477|449523376|FG000|PART 1|unclassified|1|||
124551718|NCT03273712|447976540|FG000|Overall Study|Disease Progression|1|||
124551719|NCT00627458|447976541|FG000|Overall Study|Migrated from study area|1|||
124551720|NCT00627458|447976542|FG001|Overall Study|Migrated from study area|0|||
124551721|NCT00627458|447976543|FG002|Overall Study|Migrated from study area|1|||
124551722|NCT00627458|447976541|FG000|Overall Study|Withdrawal by Subject|2|||
124551723|NCT00627458|447976542|FG001|Overall Study|Withdrawal by Subject|6|||
124971864|NCT05131477|449523377|FG001|PART 1|unclassified|1|||
124971865|NCT05131477|449523378|FG002|PART 1|unclassified|0|||
124971866|NCT05131477|449523379|FG003|PART 1|unclassified|0|||
124971867|NCT05131477|449523380|FG004|PART 1|unclassified|4|||
124971868|NCT05131477|449523381|FG005|PART 1|unclassified|0|||
124971869|NCT05131477|449523382|FG006|PART 1|unclassified|0|||
124971870|NCT05131477|449523383|FG007|PART 1|unclassified|0|||
124971871|NCT05131477|449523384|FG008|PART 1|unclassified|0|||
124971872|NCT05131477|449523385|FG009|PART 1|unclassified|0|||
124971873|NCT05131477|449523386|FG010|PART 1|unclassified|0|||
124971874|NCT05131477|449523387|FG011|PART 1|unclassified|0|||
124971875|NCT05131477|449523388|FG012|PART 1|unclassified|0|||
124971876|NCT05131477|449523389|FG013|PART 1|unclassified|0|||
124971877|NCT05131477|449523376|FG000|PART 1|Randomized and not treated|0|||
124971878|NCT05131477|449523377|FG001|PART 1|Randomized and not treated|0|||
124971879|NCT05131477|449523378|FG002|PART 1|Randomized and not treated|0|||
124971880|NCT05131477|449523379|FG003|PART 1|Randomized and not treated|1|||
124971881|NCT05131477|449523380|FG004|PART 1|Randomized and not treated|1|||
124971882|NCT05131477|449523381|FG005|PART 1|Randomized and not treated|0|||
124971883|NCT05131477|449523382|FG006|PART 1|Randomized and not treated|0|||
124971884|NCT05131477|449523383|FG007|PART 1|Randomized and not treated|0|||
124971885|NCT05131477|449523384|FG008|PART 1|Randomized and not treated|0|||
124971886|NCT05131477|449523385|FG009|PART 1|Randomized and not treated|0|||
124971887|NCT05131477|449523386|FG010|PART 1|Randomized and not treated|0|||
124971888|NCT05131477|449523387|FG011|PART 1|Randomized and not treated|0|||
124971889|NCT05131477|449523388|FG012|PART 1|Randomized and not treated|0|||
124971890|NCT05131477|449523389|FG013|PART 1|Randomized and not treated|0|||
124971891|NCT05131477|449523376|FG000|PART 1|Protocol Violation|2|||
124971892|NCT05131477|449523377|FG001|PART 1|Protocol Violation|0|||
124971893|NCT05131477|449523378|FG002|PART 1|Protocol Violation|0|||
124971894|NCT05131477|449523379|FG003|PART 1|Protocol Violation|1|||
124971895|NCT05131477|449523380|FG004|PART 1|Protocol Violation|0|||
124971896|NCT05131477|449523381|FG005|PART 1|Protocol Violation|0|||
124971897|NCT05131477|449523382|FG006|PART 1|Protocol Violation|0|||
124971898|NCT05131477|449523383|FG007|PART 1|Protocol Violation|0|||
124971899|NCT05131477|449523384|FG008|PART 1|Protocol Violation|0|||
124971900|NCT05131477|449523385|FG009|PART 1|Protocol Violation|0|||
124971901|NCT05131477|449523386|FG010|PART 1|Protocol Violation|0|||
124971902|NCT05131477|449523387|FG011|PART 1|Protocol Violation|0|||
124971903|NCT05131477|449523388|FG012|PART 1|Protocol Violation|0|||
124971904|NCT05131477|449523389|FG013|PART 1|Protocol Violation|0|||
124971905|NCT05131477|449523376|FG000|PART 1|Lack of Efficacy|0|||
124971906|NCT05131477|449523377|FG001|PART 1|Lack of Efficacy|1|||
124971907|NCT05131477|449523378|FG002|PART 1|Lack of Efficacy|1|||
124971908|NCT05131477|449523379|FG003|PART 1|Lack of Efficacy|2|||
124971909|NCT05131477|449523380|FG004|PART 1|Lack of Efficacy|5|||
124971910|NCT05131477|449523381|FG005|PART 1|Lack of Efficacy|0|||
124971911|NCT05131477|449523382|FG006|PART 1|Lack of Efficacy|0|||
124971912|NCT05131477|449523383|FG007|PART 1|Lack of Efficacy|0|||
124971913|NCT05131477|449523384|FG008|PART 1|Lack of Efficacy|0|||
124971914|NCT05131477|449523385|FG009|PART 1|Lack of Efficacy|0|||
124971915|NCT05131477|449523386|FG010|PART 1|Lack of Efficacy|0|||
124971916|NCT05131477|449523387|FG011|PART 1|Lack of Efficacy|0|||
124971917|NCT05131477|449523388|FG012|PART 1|Lack of Efficacy|0|||
124971918|NCT05131477|449523389|FG013|PART 1|Lack of Efficacy|0|||
124971919|NCT05131477|449523376|FG000|PART 2|Withdrawal by Subject|0|||
124971920|NCT05131477|449523377|FG001|PART 2|Withdrawal by Subject|0|||
124971921|NCT05131477|449523378|FG002|PART 2|Withdrawal by Subject|0|||
124971922|NCT05131477|449523379|FG003|PART 2|Withdrawal by Subject|0|||
124971923|NCT05131477|449523380|FG004|PART 2|Withdrawal by Subject|0|||
124971924|NCT05131477|449523381|FG005|PART 2|Withdrawal by Subject|0|||
124971925|NCT05131477|449523382|FG006|PART 2|Withdrawal by Subject|2|||
124971926|NCT05131477|449523383|FG007|PART 2|Withdrawal by Subject|0|||
124971927|NCT05131477|449523384|FG008|PART 2|Withdrawal by Subject|0|||
124971928|NCT05131477|449523385|FG009|PART 2|Withdrawal by Subject|0|||
124971929|NCT05131477|449523386|FG010|PART 2|Withdrawal by Subject|2|||
124971930|NCT05131477|449523387|FG011|PART 2|Withdrawal by Subject|0|||
124971931|NCT05131477|449523388|FG012|PART 2|Withdrawal by Subject|2|||
124971932|NCT05131477|449523389|FG013|PART 2|Withdrawal by Subject|2|||
124971933|NCT05131477|449523376|FG000|PART 2|Other|0|||
124971934|NCT05131477|449523377|FG001|PART 2|Other|0|||
124971935|NCT05131477|449523378|FG002|PART 2|Other|0|||
124971936|NCT05131477|449523379|FG003|PART 2|Other|0|||
124971937|NCT05131477|449523380|FG004|PART 2|Other|0|||
124971938|NCT05131477|449523381|FG005|PART 2|Other|0|||
124971939|NCT05131477|449523382|FG006|PART 2|Other|0|||
124971940|NCT05131477|449523383|FG007|PART 2|Other|0|||
124971941|NCT05131477|449523384|FG008|PART 2|Other|1|||
124971942|NCT05131477|449523385|FG009|PART 2|Other|1|||
124971943|NCT05131477|449523386|FG010|PART 2|Other|0|||
124971944|NCT05131477|449523387|FG011|PART 2|Other|0|||
124971945|NCT05131477|449523388|FG012|PART 2|Other|1|||
124971946|NCT05131477|449523389|FG013|PART 2|Other|0|||
124971947|NCT05131477|449523376|FG000|PART 2|Lack of Efficacy|0|||
124467235|NCT01164722|447668884|FG000|Overall Study|Adverse Event|0|||
124467236|NCT01164722|447668885|FG001|Overall Study|Adverse Event|1|||
124467237|NCT01164722|447668884|FG000|Overall Study|Withdrawal by Subject|3|||
124467238|NCT01164722|447668885|FG001|Overall Study|Withdrawal by Subject|4|||
124467239|NCT01164722|447668884|FG000|Overall Study|Lost to Follow-up|3|||
124467240|NCT01164722|447668885|FG001|Overall Study|Lost to Follow-up|6|||
124467241|NCT01164722|447668884|FG000|Overall Study|met protocol criteria for non-treatment|11|||
124467242|NCT01164722|447668885|FG001|Overall Study|met protocol criteria for non-treatment|1|||
124467243|NCT01164722|447668884|FG000|Overall Study|enrolled on other study, concomitant med|1|||
124467244|NCT01164722|447668885|FG001|Overall Study|enrolled on other study, concomitant med|3|||
124467245|NCT00999908|447668886|FG000|Treatment Period 1|Subject withdrew consent|2|||
124467246|NCT00999908|447668887|FG001|Treatment Period 1|Subject withdrew consent|0|||
124467247|NCT00999908|447668888|FG002|Treatment Period 1|Subject withdrew consent|0|||
124467248|NCT00999908|447668886|FG000|Treatment Period 2|Protocol Violation|1|||
124467249|NCT00999908|447668887|FG001|Treatment Period 2|Protocol Violation|0|||
124467250|NCT00999908|447668888|FG002|Treatment Period 2|Protocol Violation|0|||
124467251|NCT02556255|447668893|FG000|Overall Study|Lost to Follow-up|4|||
124467252|NCT01290692|447668894|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
124467253|NCT00993031|447668898|FG000|Overall Study|Death|0|||
124467254|NCT00993031|447668899|FG001|Overall Study|Death|1|||
124467255|NCT00993031|447668898|FG000|Overall Study|Physician Decision|0|||
124467256|NCT00993031|447668899|FG001|Overall Study|Physician Decision|2|||
124467257|NCT00993031|447668898|FG000|Overall Study|Withdrawal by Subject|3|||
124467258|NCT00993031|447668899|FG001|Overall Study|Withdrawal by Subject|3|||
124467259|NCT00993031|447668898|FG000|Overall Study|Lost to Follow-up|19|||
124467260|NCT00993031|447668899|FG001|Overall Study|Lost to Follow-up|13|||
124467261|NCT03115151|447668900|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
124467262|NCT03115151|447668901|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
124467263|NCT03115151|447668900|FG000|Overall Study|Epidural catheter removal|1|||
124467264|NCT03115151|447668901|FG001|Overall Study|Epidural catheter removal|0|||
124467265|NCT03115151|447668900|FG000|Overall Study|Withdrawal by Subject|0|||
124467266|NCT03115151|447668901|FG001|Overall Study|Withdrawal by Subject|1|||
124467267|NCT03115151|447668900|FG000|Overall Study|Intervention not received according to the protocol.|1|||
124467268|NCT03115151|447668901|FG001|Overall Study|Intervention not received according to the protocol.|1|||
124467269|NCT03115151|447668900|FG000|Overall Study|Physician Decision|1|||
124467270|NCT03115151|447668901|FG001|Overall Study|Physician Decision|0|||
124467271|NCT03115151|447668900|FG000|Overall Study|Randomization not applied|1|||
124467272|NCT03115151|447668901|FG001|Overall Study|Randomization not applied|1|||
124467273|NCT01543087|447668904|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
124467274|NCT01543087|447668905|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
124467275|NCT01543087|447668906|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
124467276|NCT01543087|447668907|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
124467277|NCT01543087|447668908|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
124467278|NCT01543087|447668909|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
124467279|NCT01543087|447668904|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
124467280|NCT01543087|447668905|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
124467281|NCT01543087|447668906|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
124467282|NCT01543087|447668907|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
124467283|NCT01543087|447668908|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
124467284|NCT01543087|447668909|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
124467285|NCT01543087|447668904|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
124467286|NCT01543087|447668905|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
124467287|NCT01543087|447668906|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
124467288|NCT01543087|447668907|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
124467289|NCT01543087|447668908|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
124467290|NCT01543087|447668909|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
124467291|NCT01543087|447668904|FG000|Stage 1 (48 Months)|Other than specified|5|||
124467292|NCT01543087|447668905|FG001|Stage 1 (48 Months)|Other than specified|0|||
124467293|NCT01543087|447668906|FG002|Stage 1 (48 Months)|Other than specified|9|||
124467294|NCT01543087|447668907|FG003|Stage 1 (48 Months)|Other than specified|0|||
124467295|NCT01543087|447668908|FG004|Stage 1 (48 Months)|Other than specified|0|||
124467296|NCT01543087|447668909|FG005|Stage 1 (48 Months)|Other than specified|0|||
124551724|NCT00627458|447976543|FG002|Overall Study|Withdrawal by Subject|5|||
124551725|NCT00627458|447976541|FG000|Overall Study|Lost to Follow-up|1|||
124971948|NCT05131477|449523377|FG001|PART 2|Lack of Efficacy|0|||
124971949|NCT05131477|449523378|FG002|PART 2|Lack of Efficacy|0|||
124971950|NCT05131477|449523379|FG003|PART 2|Lack of Efficacy|0|||
124971951|NCT05131477|449523380|FG004|PART 2|Lack of Efficacy|0|||
124971952|NCT05131477|449523381|FG005|PART 2|Lack of Efficacy|1|||
124971953|NCT05131477|449523382|FG006|PART 2|Lack of Efficacy|1|||
124971954|NCT05131477|449523383|FG007|PART 2|Lack of Efficacy|0|||
124971955|NCT05131477|449523384|FG008|PART 2|Lack of Efficacy|3|||
124971956|NCT05131477|449523385|FG009|PART 2|Lack of Efficacy|0|||
124971957|NCT05131477|449523386|FG010|PART 2|Lack of Efficacy|1|||
124971958|NCT05131477|449523387|FG011|PART 2|Lack of Efficacy|0|||
124971959|NCT05131477|449523388|FG012|PART 2|Lack of Efficacy|2|||
124971960|NCT05131477|449523389|FG013|PART 2|Lack of Efficacy|0|||
124971961|NCT05131477|449523376|FG000|PART 2|Unclassified|0|||
124971962|NCT05131477|449523377|FG001|PART 2|Unclassified|0|||
124971963|NCT05131477|449523378|FG002|PART 2|Unclassified|0|||
124971964|NCT05131477|449523379|FG003|PART 2|Unclassified|0|||
124971965|NCT05131477|449523380|FG004|PART 2|Unclassified|0|||
124971966|NCT05131477|449523381|FG005|PART 2|Unclassified|0|||
124971967|NCT05131477|449523382|FG006|PART 2|Unclassified|0|||
124971968|NCT05131477|449523383|FG007|PART 2|Unclassified|0|||
124971969|NCT05131477|449523384|FG008|PART 2|Unclassified|0|||
124971970|NCT05131477|449523385|FG009|PART 2|Unclassified|0|||
124971971|NCT05131477|449523386|FG010|PART 2|Unclassified|1|||
124971972|NCT05131477|449523387|FG011|PART 2|Unclassified|0|||
124971973|NCT05131477|449523388|FG012|PART 2|Unclassified|0|||
124971974|NCT05131477|449523389|FG013|PART 2|Unclassified|0|||
124971975|NCT05131477|449523376|FG000|PART 2|Re-randomized and not treated|0|||
124971976|NCT05131477|449523377|FG001|PART 2|Re-randomized and not treated|0|||
124971977|NCT05131477|449523378|FG002|PART 2|Re-randomized and not treated|0|||
124971978|NCT05131477|449523379|FG003|PART 2|Re-randomized and not treated|0|||
124971979|NCT05131477|449523380|FG004|PART 2|Re-randomized and not treated|0|||
124971980|NCT05131477|449523381|FG005|PART 2|Re-randomized and not treated|0|||
124971981|NCT05131477|449523382|FG006|PART 2|Re-randomized and not treated|0|||
124971982|NCT05131477|449523383|FG007|PART 2|Re-randomized and not treated|1|||
124971983|NCT05131477|449523384|FG008|PART 2|Re-randomized and not treated|0|||
124971984|NCT05131477|449523385|FG009|PART 2|Re-randomized and not treated|0|||
124971985|NCT05131477|449523386|FG010|PART 2|Re-randomized and not treated|1|||
124971986|NCT05131477|449523387|FG011|PART 2|Re-randomized and not treated|0|||
124971987|NCT05131477|449523388|FG012|PART 2|Re-randomized and not treated|1|||
124971988|NCT05131477|449523389|FG013|PART 2|Re-randomized and not treated|1|||
124971989|NCT02194829|449523390|FG000|Overall Study|Adverse Event|2|||
124971990|NCT02194829|449523391|FG001|Overall Study|Adverse Event|2|||
124971991|NCT02194829|449523390|FG000|Overall Study|Death|0|||
124971992|NCT02194829|449523391|FG001|Overall Study|Death|1|||
124971993|NCT02194829|449523390|FG000|Overall Study|Disease progression|0|||
124971994|NCT02194829|449523391|FG001|Overall Study|Disease progression|1|||
124971995|NCT02194829|449523390|FG000|Overall Study|Withdrawal by Subject|0|||
124971996|NCT02194829|449523391|FG001|Overall Study|Withdrawal by Subject|1|||
124971997|NCT02194829|449523390|FG000|Overall Study|Never started protocol therapy|0|||
124971998|NCT02194829|449523391|FG001|Overall Study|Never started protocol therapy|1|||
124971999|NCT01124838|449523392|FG000|Overall Study|Miscellaneous|4|||
124972000|NCT01124838|449523393|FG001|Overall Study|Miscellaneous|2|||
124972001|NCT01124838|449523392|FG000|Overall Study|Adverse Event|7|||
124972002|NCT01124838|449523393|FG001|Overall Study|Adverse Event|11|||
124972003|NCT01124838|449523392|FG000|Overall Study|Lack of Efficacy|2|||
124972004|NCT01124838|449523393|FG001|Overall Study|Lack of Efficacy|0|||
124972005|NCT01124838|449523392|FG000|Overall Study|Withdrawal by Subject|3|||
124972006|NCT01124838|449523393|FG001|Overall Study|Withdrawal by Subject|2|||
124972007|NCT01124838|449523392|FG000|Overall Study|Lost to Follow-up|2|||
124972008|NCT01124838|449523393|FG001|Overall Study|Lost to Follow-up|0|||
124972009|NCT04297618|449523394|FG000|Overall Study|Adverse Event|1|||
124972010|NCT04297618|449523394|FG000|Overall Study|Withdrawal by Subject|1|||
124972011|NCT02726945|449523396|FG000|Overall Study|Withdrawal by Subject|0|||
124972012|NCT02726945|449523397|FG001|Overall Study|Withdrawal by Subject|0|||
124972013|NCT02726945|449523398|FG002|Overall Study|Withdrawal by Subject|1|||
124972014|NCT02726945|449523396|FG000|Overall Study|Elected to have total knee replacement|0|||
124972015|NCT02726945|449523397|FG001|Overall Study|Elected to have total knee replacement|1|||
124972016|NCT02726945|449523398|FG002|Overall Study|Elected to have total knee replacement|0|||
124972017|NCT02172911|449525499|FG000|Overall Study|Serious Adverse Event|0|||
124551726|NCT00627458|447976542|FG001|Overall Study|Lost to Follow-up|1|||
124551727|NCT00627458|447976543|FG002|Overall Study|Lost to Follow-up|0|||
124972018|NCT02172911|449525500|FG001|Overall Study|Serious Adverse Event|1|||
124972019|NCT02172911|449525499|FG000|Overall Study|Progression of Disease|0|||
124972020|NCT02172911|449525500|FG001|Overall Study|Progression of Disease|1|||
124972021|NCT02172911|449525499|FG000|Overall Study|Loss of insurance coverage|1|||
124972022|NCT02172911|449525500|FG001|Overall Study|Loss of insurance coverage|0|||
124972023|NCT01606319|449525503|FG000|Overall Study|Lost to Follow-up|17|||
124551728|NCT02587325|447976546|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
124551729|NCT02587325|447976547|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
124551730|NCT02587325|447976548|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
124551731|NCT02587325|447976549|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
124551732|NCT02587325|447976550|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
124551733|NCT02587325|447976546|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
124551734|NCT02587325|447976547|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
124551735|NCT02587325|447976548|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
124551736|NCT02587325|447976549|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
124551737|NCT02587325|447976550|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
124551738|NCT02587325|447976546|FG000|32-Week Optional Extension Part|Adverse Event|0|||
124551739|NCT02587325|447976547|FG001|32-Week Optional Extension Part|Adverse Event|0|||
124551740|NCT02587325|447976548|FG002|32-Week Optional Extension Part|Adverse Event|1|||
124551741|NCT02587325|447976549|FG003|32-Week Optional Extension Part|Adverse Event|0|||
124551742|NCT02587325|447976550|FG004|32-Week Optional Extension Part|Adverse Event|0|||
124551743|NCT02587325|447976546|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
124551744|NCT02587325|447976547|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
124551745|NCT02587325|447976548|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
124551746|NCT02587325|447976549|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
124551747|NCT02587325|447976550|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
124551748|NCT01831596|447976551|FG000|Overall Study|Other|8|||
124551749|NCT00883129|447976557|FG000|Overall Study|Adverse Event|7|||
124713131|NCT02737501|448574549|FG002|Randomized Phase|Lost to Follow-up|0|||
124713132|NCT02737501|448574547|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
124713133|NCT02737501|448574548|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
124713134|NCT02737501|448574549|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
124713135|NCT02737501|448574547|FG000|Randomized Phase|Reason not Specified|1|||
124713136|NCT02737501|448574548|FG001|Randomized Phase|Reason not Specified|1|||
124551750|NCT00883129|447976558|FG001|Overall Study|Adverse Event|15|||
124551751|NCT00883129|447976557|FG000|Overall Study|Withdrawal by Subject|8|||
124551752|NCT00883129|447976558|FG001|Overall Study|Withdrawal by Subject|9|||
124551753|NCT00883129|447976557|FG000|Overall Study|Non-compliance|3|||
124551754|NCT00883129|447976558|FG001|Overall Study|Non-compliance|6|||
124770336|NCT02345070|448788790|FG002|Overall Study|Poor compliance to protocol|0|||
124770337|NCT02345070|448788788|FG000|Overall Study|Other than specified above|6|||
124467297|NCT01543087|447668904|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
124467298|NCT01543087|447668905|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
124467299|NCT01543087|447668906|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
124467300|NCT01543087|447668907|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
124467301|NCT01543087|447668908|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
124467302|NCT01543087|447668909|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
124467303|NCT01543087|447668904|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
124467304|NCT01543087|447668905|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
124551755|NCT00883129|447976557|FG000|Overall Study|Lost to Follow-up|1|||
124551756|NCT00883129|447976558|FG001|Overall Study|Lost to Follow-up|2|||
124770338|NCT02345070|448788789|FG001|Overall Study|Other than specified above|3|||
124972024|NCT01606319|449525504|FG001|Overall Study|Lost to Follow-up|14|||
124972025|NCT01606319|449525503|FG000|Overall Study|Withdrawal by Subject|9|||
124972026|NCT01606319|449525504|FG001|Overall Study|Withdrawal by Subject|12|||
124972027|NCT01606319|449525503|FG000|Overall Study|Physician Decision|1|||
124972028|NCT01606319|449525504|FG001|Overall Study|Physician Decision|2|||
124972029|NCT01606319|449525503|FG000|Overall Study|Lack of Efficacy|6|||
124972030|NCT01606319|449525504|FG001|Overall Study|Lack of Efficacy|8|||
124972031|NCT01606319|449525503|FG000|Overall Study|Adverse Event|1|||
124972032|NCT01606319|449525504|FG001|Overall Study|Adverse Event|4|||
124972033|NCT01124097|449525508|FG000|Overall Study|Withdrawal by Subject|4|||
124972034|NCT01124097|449525509|FG001|Overall Study|Withdrawal by Subject|3|||
124972035|NCT01124097|449525510|FG002|Overall Study|Withdrawal by Subject|2|||
124972036|NCT01124097|449525511|FG003|Overall Study|Withdrawal by Subject|3|||
124972037|NCT01124097|449525508|FG000|Overall Study|Lack of Efficacy|2|||
124972038|NCT01124097|449525509|FG001|Overall Study|Lack of Efficacy|3|||
124972039|NCT01124097|449525510|FG002|Overall Study|Lack of Efficacy|1|||
124972040|NCT01124097|449525511|FG003|Overall Study|Lack of Efficacy|3|||
124972041|NCT01124097|449525508|FG000|Overall Study|Adverse Event|24|||
124972042|NCT01124097|449525509|FG001|Overall Study|Adverse Event|15|||
124972043|NCT01124097|449525510|FG002|Overall Study|Adverse Event|15|||
124972044|NCT01124097|449525511|FG003|Overall Study|Adverse Event|7|||
124972045|NCT01124097|449525508|FG000|Overall Study|Protocol Violation|2|||
124972046|NCT01124097|449525509|FG001|Overall Study|Protocol Violation|0|||
124972047|NCT01124097|449525510|FG002|Overall Study|Protocol Violation|2|||
124972048|NCT01124097|449525511|FG003|Overall Study|Protocol Violation|1|||
124972049|NCT01124097|449525508|FG000|Overall Study|Physician Decision|2|||
124972050|NCT01124097|449525509|FG001|Overall Study|Physician Decision|1|||
124972051|NCT01124097|449525510|FG002|Overall Study|Physician Decision|0|||
124972052|NCT01124097|449525511|FG003|Overall Study|Physician Decision|0|||
124972053|NCT01821937|449525512|FG000|Overall Study|Adverse Event|0|||
124972054|NCT01821937|449525513|FG001|Overall Study|Adverse Event|3|||
124972055|NCT02153905|449525514|FG000|Overall Study|Death|1|||
124972056|NCT02153905|449525515|FG001|Overall Study|Death|0|||
124972057|NCT00193479|449525516|FG000|Induction Chemotherapy|Adverse Event|2|||
124972058|NCT00193479|449525516|FG000|Induction Chemotherapy|Disease Progression|1|||
124972059|NCT00193479|449525516|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
124972060|NCT00193479|449525516|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
124972061|NCT01304498|449525517|FG000|Overall Study|Adverse Event|1|||
124972062|NCT01304498|449525518|FG001|Overall Study|Adverse Event|1|||
124972063|NCT01304498|449525517|FG000|Overall Study|Withdrawal by Subject|2|||
124972064|NCT01304498|449525518|FG001|Overall Study|Withdrawal by Subject|3|||
124972065|NCT01304498|449525517|FG000|Overall Study|Protocol Violation|1|||
124972066|NCT01304498|449525518|FG001|Overall Study|Protocol Violation|0|||
124972067|NCT01304498|449525517|FG000|Overall Study|Lost to Follow-up|2|||
124972068|NCT01304498|449525518|FG001|Overall Study|Lost to Follow-up|1|||
124972069|NCT01834586|449525520|FG000|Overall Study|Adverse Event|1|||
124972070|NCT01667549|449525521|FG000|Overall Study|Withdrawal by Subject|3|||
124972071|NCT01667549|449525522|FG001|Overall Study|Withdrawal by Subject|5|||
124972072|NCT01667549|449525523|FG002|Overall Study|Withdrawal by Subject|7|||
124972073|NCT01667549|449525524|FG003|Overall Study|Withdrawal by Subject|6|||
124972074|NCT01667549|449525525|FG004|Overall Study|Withdrawal by Subject|1|||
124972075|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
124972076|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
124972077|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
124972078|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
124972079|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
124972080|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
124972081|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
124972082|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
124972083|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
124972084|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
124972085|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
124551757|NCT00883129|447976557|FG000|Overall Study|Death|1|||
124551758|NCT00883129|447976558|FG001|Overall Study|Death|2|||
124972086|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
124972087|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
124972088|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
124972089|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
124972090|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
124972091|NCT04210843|449525526|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
124972092|NCT04210843|449525527|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
124972093|NCT04210843|449525526|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
124467305|NCT01543087|447668906|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
124467306|NCT01543087|447668907|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
124467307|NCT01543087|447668908|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
124467308|NCT01543087|447668909|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
124467309|NCT01543087|447668904|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
124467310|NCT01543087|447668905|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
124467311|NCT01543087|447668906|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
124467312|NCT01543087|447668907|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
124467313|NCT01543087|447668908|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
124770339|NCT02345070|448788790|FG002|Overall Study|Other than specified above|7|||
124770340|NCT00321620|448788796|FG000|Overall Study|Death|269|||
124770341|NCT00321620|448788797|FG001|Overall Study|Death|294|||
124467314|NCT01543087|447668909|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
124467315|NCT04673786|447668910|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
124770342|NCT00321620|448788796|FG000|Overall Study|Withdrawal by Subject|164|||
124713137|NCT02737501|448574549|FG002|Randomized Phase|Reason not Specified|0|||
124713138|NCT02737501|448574547|FG000|Randomized Phase|Never Treated|1|||
124713139|NCT02737501|448574548|FG001|Randomized Phase|Never Treated|1|||
124713140|NCT02737501|448574549|FG002|Randomized Phase|Never Treated|0|||
124713141|NCT02737501|448574547|FG000|Crossover Phase|Died|0|||
124972094|NCT04210843|449525527|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
124972095|NCT04210843|449525526|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
124972096|NCT04210843|449525527|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
124972097|NCT04210843|449525526|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
124972098|NCT04210843|449525527|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
124972099|NCT04210843|449525526|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
124972100|NCT04210843|449525527|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
124972101|NCT04210843|449525526|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
124972102|NCT04210843|449525527|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
124972103|NCT04210843|449525526|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
124972104|NCT04210843|449525527|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
124972105|NCT04210843|449525526|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
124972106|NCT04210843|449525527|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
124972107|NCT04210843|449525526|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
124972108|NCT04210843|449525527|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
124972109|NCT04210843|449525526|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
124972110|NCT04210843|449525527|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
124972111|NCT04210843|449525526|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
124972112|NCT04210843|449525527|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
124972113|NCT04210843|449525526|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
124972114|NCT04210843|449525527|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
124972115|NCT04210843|449525526|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
124972116|NCT04210843|449525527|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
124972117|NCT04210843|449525526|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
124972118|NCT04210843|449525527|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
124972119|NCT04210843|449525526|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
124972120|NCT04210843|449525527|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
124972121|NCT04210843|449525526|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
124972122|NCT04210843|449525527|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
124972123|NCT02844777|449525528|FG000|Overall Study|Withdrawal by Subject|2|||
124972124|NCT02844777|449525529|FG001|Overall Study|Withdrawal by Subject|0|||
124972125|NCT02844777|449525530|FG002|Overall Study|Withdrawal by Subject|0|||
124972126|NCT00150618|449525531|FG000|Overall Study|Adverse Event|2|||
124972127|NCT00150618|449525532|FG001|Overall Study|Adverse Event|2|||
124972128|NCT00150618|449525533|FG002|Overall Study|Adverse Event|6|||
124972129|NCT00150618|449525534|FG003|Overall Study|Adverse Event|9|||
124972130|NCT00150618|449525535|FG004|Overall Study|Adverse Event|5|||
124972131|NCT00150618|449525531|FG000|Overall Study|Withdrawal by Subject|6|||
124972132|NCT00150618|449525532|FG001|Overall Study|Withdrawal by Subject|8|||
124972133|NCT00150618|449525533|FG002|Overall Study|Withdrawal by Subject|8|||
124972134|NCT00150618|449525534|FG003|Overall Study|Withdrawal by Subject|4|||
124972135|NCT00150618|449525535|FG004|Overall Study|Withdrawal by Subject|5|||
124972136|NCT00150618|449525531|FG000|Overall Study|Lost to Follow-up|4|||
124972137|NCT00150618|449525532|FG001|Overall Study|Lost to Follow-up|1|||
124972138|NCT00150618|449525533|FG002|Overall Study|Lost to Follow-up|5|||
124972139|NCT00150618|449525534|FG003|Overall Study|Lost to Follow-up|8|||
124972140|NCT00150618|449525535|FG004|Overall Study|Lost to Follow-up|4|||
124972141|NCT00150618|449525531|FG000|Overall Study|Protocol Violation|1|||
124972142|NCT00150618|449525532|FG001|Overall Study|Protocol Violation|0|||
124972143|NCT00150618|449525533|FG002|Overall Study|Protocol Violation|0|||
124972144|NCT00150618|449525534|FG003|Overall Study|Protocol Violation|0|||
124972145|NCT00150618|449525535|FG004|Overall Study|Protocol Violation|1|||
124972146|NCT00150618|449525531|FG000|Overall Study|Lack of Efficacy|1|||
124972147|NCT00150618|449525532|FG001|Overall Study|Lack of Efficacy|4|||
124972148|NCT00150618|449525533|FG002|Overall Study|Lack of Efficacy|7|||
124972149|NCT00150618|449525534|FG003|Overall Study|Lack of Efficacy|4|||
124972150|NCT00150618|449525535|FG004|Overall Study|Lack of Efficacy|6|||
124972151|NCT00150618|449525531|FG000|Overall Study|No study meds|0|||
124713142|NCT02737501|448574548|FG001|Crossover Phase|Died|0|||
124972152|NCT00150618|449525532|FG001|Overall Study|No study meds|0|||
124972153|NCT00150618|449525533|FG002|Overall Study|No study meds|0|||
124551759|NCT00883129|447976557|FG000|Overall Study|Defined Treatment Failure|0|||
124713143|NCT02737501|448574549|FG002|Crossover Phase|Died|22|||
124713144|NCT02737501|448574547|FG000|Crossover Phase|Withdrew Consent|0|||
124713145|NCT02737501|448574548|FG001|Crossover Phase|Withdrew Consent|0|||
124972154|NCT00150618|449525534|FG003|Overall Study|No study meds|0|||
124972155|NCT00150618|449525535|FG004|Overall Study|No study meds|2|||
124972156|NCT00150618|449525531|FG000|Overall Study|Physician Decision|0|||
124972157|NCT00150618|449525532|FG001|Overall Study|Physician Decision|2|||
124972158|NCT00150618|449525533|FG002|Overall Study|Physician Decision|0|||
124972159|NCT00150618|449525534|FG003|Overall Study|Physician Decision|0|||
124972160|NCT00150618|449525535|FG004|Overall Study|Physician Decision|1|||
124972161|NCT00150618|449525531|FG000|Overall Study|Lack of compliance|2|||
124972162|NCT00150618|449525532|FG001|Overall Study|Lack of compliance|1|||
124972163|NCT00150618|449525533|FG002|Overall Study|Lack of compliance|1|||
124972164|NCT00150618|449525534|FG003|Overall Study|Lack of compliance|0|||
124972165|NCT00150618|449525535|FG004|Overall Study|Lack of compliance|1|||
124972166|NCT00150618|449525531|FG000|Overall Study|Abnormal ECG|1|||
124972167|NCT00150618|449525532|FG001|Overall Study|Abnormal ECG|0|||
124972168|NCT00150618|449525533|FG002|Overall Study|Abnormal ECG|0|||
124972169|NCT00150618|449525534|FG003|Overall Study|Abnormal ECG|0|||
124972170|NCT00150618|449525535|FG004|Overall Study|Abnormal ECG|0|||
124972171|NCT00150618|449525531|FG000|Overall Study|Sponsor's decision|0|||
124972172|NCT00150618|449525532|FG001|Overall Study|Sponsor's decision|0|||
124972173|NCT00150618|449525533|FG002|Overall Study|Sponsor's decision|0|||
124972174|NCT00150618|449525534|FG003|Overall Study|Sponsor's decision|1|||
124972175|NCT00150618|449525535|FG004|Overall Study|Sponsor's decision|0|||
124972176|NCT01012947|449525536|FG000|Overall Study|Lost to Follow-up|131|||
124972177|NCT01012947|449525537|FG001|Overall Study|Lost to Follow-up|135|||
124972178|NCT01012947|449525538|FG002|Overall Study|Lost to Follow-up|130|||
124972179|NCT01012947|449525539|FG003|Overall Study|Lost to Follow-up|118|||
124972180|NCT01012947|449525540|FG004|Overall Study|Lost to Follow-up|142|||
124972181|NCT01791413|449525541|FG000|Overall Study|Lost to Follow-up|5|||
124972182|NCT01791413|449525542|FG001|Overall Study|Lost to Follow-up|1|||
124972183|NCT00825305|449525544|FG000|Overall Study|Adverse Event|1|||
124972184|NCT00825305|449525545|FG001|Overall Study|Adverse Event|1|||
124972185|NCT00825305|449525544|FG000|Overall Study|Withdrawal by Subject|6|||
124972186|NCT00825305|449525545|FG001|Overall Study|Withdrawal by Subject|12|||
124972187|NCT00825305|449525544|FG000|Overall Study|Inappropriate inclusion|1|||
124972188|NCT00825305|449525545|FG001|Overall Study|Inappropriate inclusion|0|||
124972189|NCT00825305|449525544|FG000|Overall Study|Protocol Violation|9|||
124972190|NCT00825305|449525545|FG001|Overall Study|Protocol Violation|9|||
124972191|NCT00825305|449525544|FG000|Overall Study|Can not be classified|0|||
124972192|NCT00825305|449525545|FG001|Overall Study|Can not be classified|1|||
124972193|NCT04016272|449525546|FG000|Overall Study|Withdrawal by Subject|1|||
124972194|NCT04016272|449525547|FG001|Overall Study|Withdrawal by Subject|2|||
124972195|NCT02493946|449525550|FG000|DB Period|Withdrawal by Subject|8|||
124972196|NCT02493946|449525551|FG001|DB Period|Withdrawal by Subject|5|||
124972197|NCT02493946|449525552|FG002|DB Period|Withdrawal by Subject|0|||
124972198|NCT02493946|449525550|FG000|Open Label Period|Withdrawal by Subject|0|||
124972199|NCT02493946|449525551|FG001|Open Label Period|Withdrawal by Subject|0|||
124972200|NCT02493946|449525552|FG002|Open Label Period|Withdrawal by Subject|74|||
124972201|NCT02493946|449525550|FG000|Open Label Period|Adverse Event|0|||
124972202|NCT02493946|449525551|FG001|Open Label Period|Adverse Event|0|||
124972203|NCT02493946|449525552|FG002|Open Label Period|Adverse Event|4|||
124972204|NCT02493946|449525550|FG000|Open Label Period|Lost to Follow-up|0|||
124972205|NCT02493946|449525551|FG001|Open Label Period|Lost to Follow-up|0|||
124972206|NCT02493946|449525552|FG002|Open Label Period|Lost to Follow-up|1|||
124972207|NCT02493946|449525550|FG000|Open Label Period|Investigator decision, non-compliance|0|||
124972208|NCT02493946|449525551|FG001|Open Label Period|Investigator decision, non-compliance|0|||
124972209|NCT02493946|449525552|FG002|Open Label Period|Investigator decision, non-compliance|2|||
124972210|NCT02493946|449525550|FG000|Open Label Period|Investigator decision, non-availability|0|||
124972211|NCT02493946|449525551|FG001|Open Label Period|Investigator decision, non-availability|0|||
124972212|NCT02493946|449525552|FG002|Open Label Period|Investigator decision, non-availability|1|||
124972213|NCT02493946|449525550|FG000|Open Label Period|Pregnancy|0|||
124972214|NCT02493946|449525551|FG001|Open Label Period|Pregnancy|0|||
124972215|NCT02493946|449525552|FG002|Open Label Period|Pregnancy|3|||
124972216|NCT02493946|449525550|FG000|Open Label Period|Site error|0|||
124972217|NCT02493946|449525551|FG001|Open Label Period|Site error|0|||
124972218|NCT02493946|449525552|FG002|Open Label Period|Site error|1|||
124972219|NCT03355209|449525553|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
124972220|NCT03355209|449525554|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
124972221|NCT03355209|449525555|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
124972222|NCT03355209|449525556|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
124972223|NCT03355209|449525557|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
124972224|NCT03355209|449525558|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
124972225|NCT03355209|449525553|FG000|Part 1: Double-Blind Period|Death|0|||
124972226|NCT03355209|449525554|FG001|Part 1: Double-Blind Period|Death|0|||
124972227|NCT03355209|449525555|FG002|Part 1: Double-Blind Period|Death|1|||
124972228|NCT03355209|449525556|FG003|Part 1: Double-Blind Period|Death|0|||
124972229|NCT03355209|449525557|FG004|Part 1: Double-Blind Period|Death|0|||
124713146|NCT02737501|448574549|FG002|Crossover Phase|Withdrew Consent|9|||
124713147|NCT02737501|448574547|FG000|Crossover Phase|Physician Decision|0|||
124713148|NCT02737501|448574548|FG001|Crossover Phase|Physician Decision|0|||
124713149|NCT02737501|448574549|FG002|Crossover Phase|Physician Decision|1|||
124713150|NCT02737501|448574547|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
124972230|NCT03355209|449525558|FG005|Part 1: Double-Blind Period|Death|0|||
124972231|NCT03355209|449525553|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
124972232|NCT03355209|449525554|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
124972233|NCT03355209|449525555|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
124972234|NCT03355209|449525556|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
124972235|NCT03355209|449525557|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
124972236|NCT03355209|449525558|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
124972237|NCT03355209|449525553|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
124972238|NCT03355209|449525554|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
124972239|NCT03355209|449525555|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
124972240|NCT03355209|449525556|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
124972241|NCT03355209|449525557|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
124972242|NCT03355209|449525558|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
124972243|NCT03355209|449525553|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
124972244|NCT03355209|449525554|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
124972245|NCT03355209|449525555|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
124972246|NCT03355209|449525556|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
124972247|NCT03355209|449525557|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
124972248|NCT03355209|449525558|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
124972249|NCT03355209|449525553|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
124972250|NCT03355209|449525554|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
124972251|NCT03355209|449525555|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
124972252|NCT03355209|449525556|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
124972253|NCT03355209|449525557|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
124972254|NCT03355209|449525558|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
124972255|NCT03355209|449525553|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
124972256|NCT03355209|449525554|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
124972257|NCT03355209|449525555|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
124972258|NCT03355209|449525556|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
124972259|NCT03355209|449525557|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
124972260|NCT03355209|449525558|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
124972261|NCT03355209|449525553|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
124972262|NCT03355209|449525554|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
124972263|NCT03355209|449525555|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
124972264|NCT03355209|449525556|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
124972265|NCT03355209|449525557|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
124972266|NCT03355209|449525558|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
124972267|NCT03355209|449525553|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
124972268|NCT03355209|449525554|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
124467316|NCT04673786|447668911|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
124467317|NCT04673786|447668912|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
124467318|NCT04673786|447668910|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
124467319|NCT04673786|447668911|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
124467320|NCT04673786|447668912|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
124467321|NCT04673786|447668910|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
124467322|NCT04673786|447668911|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
124467323|NCT04673786|447668912|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
124467324|NCT04673786|447668910|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
124467325|NCT04673786|447668911|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
124467326|NCT04673786|447668912|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
124467327|NCT04673786|447668910|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
124467328|NCT04673786|447668911|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
124467329|NCT04673786|447668912|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
124467330|NCT04673786|447668910|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
124467331|NCT04673786|447668911|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
124467332|NCT04673786|447668912|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
124467333|NCT02682901|447668915|FG000|Overall Study|Adverse Event|10|||
124467334|NCT02682901|447668916|FG001|Overall Study|Adverse Event|3|||
124467335|NCT02682901|447668915|FG000|Overall Study|Lack of Efficacy|0|||
124972269|NCT03355209|449525555|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
124972270|NCT03355209|449525556|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
124972271|NCT03355209|449525557|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
124467336|NCT02682901|447668916|FG001|Overall Study|Lack of Efficacy|1|||
124467337|NCT03870555|447668917|FG000|Period 3 (2 Days)|Adverse Event|1|||
124467338|NCT03870555|447668918|FG001|Period 3 (2 Days)|Adverse Event|0|||
124467339|NCT03870555|447668919|FG002|Period 3 (2 Days)|Adverse Event|0|||
124467340|NCT02340663|447668920|FG000|Overall Study|Lost to Follow-up|1|||
124467341|NCT02340663|447668921|FG001|Overall Study|Lost to Follow-up|0|||
124467342|NCT02340663|447668920|FG000|Overall Study|Protocol Violation|1|||
124467343|NCT02340663|447668921|FG001|Overall Study|Protocol Violation|0|||
124467344|NCT02340663|447668920|FG000|Overall Study|Withdrawal by Subject|3|||
124467345|NCT02340663|447668921|FG001|Overall Study|Withdrawal by Subject|1|||
124467346|NCT03694925|447668923|FG000|Overall Study|Inadequate laboratory testing|0|||
124467347|NCT03694925|447668924|FG001|Overall Study|Inadequate laboratory testing|3|||
124467348|NCT03694925|447668925|FG002|Overall Study|Inadequate laboratory testing|0|||
124467349|NCT01422239|447668928|FG000|Overall Study|Lost to Follow-up|4|||
124467350|NCT01422239|447668929|FG001|Overall Study|Lost to Follow-up|3|||
124467351|NCT03167073|447668931|FG000|Overall Study|Stillbirth|1|||
124467352|NCT03167073|447668932|FG001|Overall Study|Stillbirth|0|||
124467353|NCT00357500|447668933|FG000|Overall Study|Adverse Event|3|||
124467354|NCT00357500|447668933|FG000|Overall Study|Withdrawal by Subject|5|||
124467355|NCT00357500|447668933|FG000|Overall Study|Progressive Disease|65|||
124467356|NCT00357500|447668933|FG000|Overall Study|Not Started Protocol Therapy|4|||
124467357|NCT03033875|447668934|FG000|Overall Study|Withdrawal by Subject|5|||
124467358|NCT03033875|447668935|FG001|Overall Study|Withdrawal by Subject|9|||
124467359|NCT03033875|447668936|FG002|Overall Study|Withdrawal by Subject|4|||
124467360|NCT03033875|447668934|FG000|Overall Study|Other|14|||
124467361|NCT03033875|447668935|FG001|Overall Study|Other|15|||
124467362|NCT03033875|447668936|FG002|Overall Study|Other|8|||
124467363|NCT02573155|447668938|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
124467364|NCT02573155|447668939|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
124467365|NCT02573155|447668938|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
124467366|NCT02573155|447668939|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
124467367|NCT02573155|447668938|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
124467368|NCT02573155|447668939|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
124467369|NCT02573155|447668938|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
124467370|NCT02573155|447668939|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
124467371|NCT02573155|447668938|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
124467372|NCT02573155|447668939|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
124467373|NCT02573155|447668938|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
124467374|NCT02573155|447668939|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
124467375|NCT02573155|447668938|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
124467376|NCT02573155|447668939|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
124467377|NCT02573155|447668938|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
124467378|NCT02573155|447668939|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
124467379|NCT01681433|447668940|FG000|Overall Study|Lack of Efficacy|23|||
124467380|NCT01681433|447668941|FG001|Overall Study|Lack of Efficacy|23|||
124467381|NCT01681433|447668940|FG000|Overall Study|Withdrawal by Subject|5|||
124467382|NCT01681433|447668941|FG001|Overall Study|Withdrawal by Subject|5|||
124467383|NCT01681433|447668940|FG000|Overall Study|Protocol Violation|2|||
124467384|NCT01681433|447668941|FG001|Overall Study|Protocol Violation|0|||
124467385|NCT01681433|447668940|FG000|Overall Study|Adverse Event|2|||
124467386|NCT01681433|447668941|FG001|Overall Study|Adverse Event|4|||
124467387|NCT01681433|447668940|FG000|Overall Study|Lost to Follow-up|0|||
124467388|NCT01681433|447668941|FG001|Overall Study|Lost to Follow-up|1|||
124467389|NCT02301403|447668942|FG000|Overall Study|Withdrawal by Subject|28|||
124467390|NCT02301403|447668943|FG001|Overall Study|Withdrawal by Subject|41|||
124467391|NCT00730639|447668944|FG000|Overall Study|Adverse Event|3|||
124467392|NCT00730639|447668945|FG001|Overall Study|Adverse Event|0|||
124467393|NCT00730639|447668946|FG002|Overall Study|Adverse Event|9|||
124467394|NCT00730639|447668947|FG003|Overall Study|Adverse Event|8|||
124770343|NCT00321620|448788797|FG001|Overall Study|Withdrawal by Subject|147|||
124770344|NCT00321620|448788796|FG000|Overall Study|Disease progression|113|||
124770345|NCT00321620|448788797|FG001|Overall Study|Disease progression|117|||
124770346|NCT00321620|448788796|FG000|Overall Study|Adverse Event|43|||
124770347|NCT00321620|448788797|FG001|Overall Study|Adverse Event|56|||
124770348|NCT00321620|448788796|FG000|Overall Study|Lost to Follow-up|13|||
124467395|NCT00730639|447668948|FG004|Overall Study|Adverse Event|23|||
124467396|NCT00730639|447668944|FG000|Overall Study|Complete Response|0|||
124467397|NCT00730639|447668945|FG001|Overall Study|Complete Response|0|||
124467398|NCT00730639|447668946|FG002|Overall Study|Complete Response|2|||
124467399|NCT00730639|447668947|FG003|Overall Study|Complete Response|2|||
124467400|NCT00730639|447668948|FG004|Overall Study|Complete Response|1|||
124467401|NCT00730639|447668944|FG000|Overall Study|Completed Maximum Cycles|0|||
124467402|NCT00730639|447668945|FG001|Overall Study|Completed Maximum Cycles|0|||
124467403|NCT00730639|447668946|FG002|Overall Study|Completed Maximum Cycles|11|||
124467404|NCT00730639|447668947|FG003|Overall Study|Completed Maximum Cycles|3|||
124551760|NCT00883129|447976558|FG001|Overall Study|Defined Treatment Failure|2|||
124770349|NCT00321620|448788797|FG001|Overall Study|Lost to Follow-up|9|||
124551761|NCT01898884|447976559|FG000|Multiple Dose Period|Adverse Event|0|||
124551762|NCT01898884|447976560|FG001|Multiple Dose Period|Adverse Event|0|||
124551763|NCT01898884|447976561|FG002|Multiple Dose Period|Adverse Event|0|||
124551764|NCT01898884|447976562|FG003|Multiple Dose Period|Adverse Event|0|||
124551765|NCT01898884|447976563|FG004|Multiple Dose Period|Adverse Event|0|||
124551766|NCT01898884|447976564|FG005|Multiple Dose Period|Adverse Event|0|||
124551767|NCT01898884|447976565|FG006|Multiple Dose Period|Adverse Event|1|||
124551768|NCT01898884|447976566|FG007|Multiple Dose Period|Adverse Event|0|||
124551769|NCT01898884|447976567|FG008|Multiple Dose Period|Adverse Event|0|||
124551770|NCT01898884|447976559|FG000|Multiple Dose Period|Randomized Not Treated|0|||
124551771|NCT01898884|447976560|FG001|Multiple Dose Period|Randomized Not Treated|0|||
124551772|NCT01898884|447976561|FG002|Multiple Dose Period|Randomized Not Treated|0|||
124972272|NCT03355209|449525558|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
124972273|NCT03355209|449525553|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
124972274|NCT03355209|449525554|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
124972275|NCT03355209|449525555|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
124972276|NCT03355209|449525556|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
124972277|NCT03355209|449525557|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
124972278|NCT03355209|449525558|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
124972279|NCT03355209|449525553|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
124972280|NCT03355209|449525554|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
124972281|NCT03355209|449525555|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
124972282|NCT03355209|449525556|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
124972283|NCT03355209|449525557|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
124972284|NCT03355209|449525558|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
124972285|NCT01727505|449525560|FG000|First 24 Hours|Adverse Event|0|||
124972286|NCT01727505|449525561|FG001|First 24 Hours|Adverse Event|1|||
124972287|NCT01727505|449525560|FG000|Second 24 Hours|Missing data|0|||
124972288|NCT01727505|449525561|FG001|Second 24 Hours|Missing data|1|||
124972289|NCT02878603|449525562|FG000|Overall Study|Lost to Follow-up|4|||
124972290|NCT02878603|449525563|FG001|Overall Study|Lost to Follow-up|1|||
124972291|NCT02878603|449525562|FG000|Overall Study|Withdrawal by Subject|1|||
124972292|NCT02878603|449525563|FG001|Overall Study|Withdrawal by Subject|1|||
124972293|NCT02878603|449525562|FG000|Overall Study|Death|1|||
124972294|NCT02878603|449525563|FG001|Overall Study|Death|0|||
124972295|NCT02878603|449525562|FG000|Overall Study|Physician Decision|0|||
124972296|NCT02878603|449525563|FG001|Overall Study|Physician Decision|3|||
124972297|NCT00358644|449525564|FG000|Overall Study|Progressive Disease|21|||
124972298|NCT00358644|449525564|FG000|Overall Study|Adverse Event|7|||
124551773|NCT01898884|447976562|FG003|Multiple Dose Period|Randomized Not Treated|0|||
124551774|NCT01898884|447976563|FG004|Multiple Dose Period|Randomized Not Treated|0|||
124551775|NCT01898884|447976564|FG005|Multiple Dose Period|Randomized Not Treated|0|||
124551776|NCT01898884|447976565|FG006|Multiple Dose Period|Randomized Not Treated|0|||
124770350|NCT00321620|448788796|FG000|Overall Study|Physician Decision|4|||
124972299|NCT00358644|449525564|FG000|Overall Study|Death|11|||
124467405|NCT00730639|447668948|FG004|Overall Study|Completed Maximum Cycles|6|||
124467406|NCT00730639|447668944|FG000|Overall Study|Death|0|||
124467407|NCT00730639|447668945|FG001|Overall Study|Death|0|||
124467408|NCT00730639|447668946|FG002|Overall Study|Death|0|||
124467409|NCT00730639|447668947|FG003|Overall Study|Death|0|||
124467410|NCT00730639|447668948|FG004|Overall Study|Death|2|||
124467411|NCT00730639|447668944|FG000|Overall Study|Disease Progression|12|||
124467412|NCT00730639|447668945|FG001|Overall Study|Disease Progression|13|||
124467413|NCT00730639|447668946|FG002|Overall Study|Disease Progression|48|||
124467414|NCT00730639|447668947|FG003|Overall Study|Disease Progression|32|||
124467415|NCT00730639|447668948|FG004|Overall Study|Disease Progression|88|||
124467416|NCT00730639|447668944|FG000|Overall Study|non-specified|0|||
124467417|NCT00730639|447668945|FG001|Overall Study|non-specified|0|||
124467418|NCT00730639|447668946|FG002|Overall Study|non-specified|4|||
124972300|NCT00358644|449525564|FG000|Overall Study|Withdrawal by Subject|4|||
124972301|NCT00358644|449525564|FG000|Overall Study|Physician Decision|6|||
124972302|NCT00358644|449525564|FG000|Overall Study|Patient not eligible for study|1|||
124972303|NCT03327831|449525565|FG000|Overall Study|Lost to Follow-up|2|||
124972304|NCT02838134|449525566|FG000|Overall Study|Lost to Follow-up|1|||
124972305|NCT02838134|449525567|FG001|Overall Study|Lost to Follow-up|2|||
124467419|NCT00730639|447668947|FG003|Overall Study|non-specified|2|||
124467420|NCT00730639|447668948|FG004|Overall Study|non-specified|3|||
124467421|NCT00730639|447668944|FG000|Overall Study|Protocol Violation|0|||
124467422|NCT00730639|447668945|FG001|Overall Study|Protocol Violation|0|||
124467423|NCT00730639|447668946|FG002|Overall Study|Protocol Violation|1|||
124467424|NCT00730639|447668947|FG003|Overall Study|Protocol Violation|0|||
124467425|NCT00730639|447668948|FG004|Overall Study|Protocol Violation|0|||
124467426|NCT00730639|447668944|FG000|Overall Study|Withdrawal by Subject|0|||
124467427|NCT00730639|447668945|FG001|Overall Study|Withdrawal by Subject|0|||
124467428|NCT00730639|447668946|FG002|Overall Study|Withdrawal by Subject|6|||
124467429|NCT00730639|447668947|FG003|Overall Study|Withdrawal by Subject|3|||
124551777|NCT01898884|447976566|FG007|Multiple Dose Period|Randomized Not Treated|0|||
124551778|NCT01898884|447976567|FG008|Multiple Dose Period|Randomized Not Treated|1|||
124713151|NCT02737501|448574548|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
124972306|NCT02838134|449525566|FG000|Overall Study|logistic problems|1|||
124972307|NCT02838134|449525567|FG001|Overall Study|logistic problems|1|||
124972308|NCT04674189|449525568|FG000|Overall Study|Adverse Event|0|||
124972309|NCT04674189|449525569|FG001|Overall Study|Adverse Event|0|||
124972310|NCT04674189|449525570|FG002|Overall Study|Adverse Event|1|||
124972311|NCT04674189|449525568|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
124972312|NCT04674189|449525569|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
124972313|NCT04674189|449525570|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
124972314|NCT04674189|449525568|FG000|Overall Study|Physician Decision|1|||
124972315|NCT04674189|449525569|FG001|Overall Study|Physician Decision|0|||
124972316|NCT04674189|449525570|FG002|Overall Study|Physician Decision|0|||
124972317|NCT04674189|449525568|FG000|Overall Study|Withdrawal by Participant|83|||
124972318|NCT04674189|449525569|FG001|Overall Study|Withdrawal by Participant|71|||
124972319|NCT04674189|449525570|FG002|Overall Study|Withdrawal by Participant|142|||
124972320|NCT04674189|449525568|FG000|Overall Study|Lost to Follow-up|55|||
124972321|NCT04674189|449525569|FG001|Overall Study|Lost to Follow-up|53|||
124972322|NCT04674189|449525570|FG002|Overall Study|Lost to Follow-up|44|||
124972323|NCT04674189|449525568|FG000|Overall Study|Miscellaneous|27|||
124972324|NCT04674189|449525569|FG001|Overall Study|Miscellaneous|23|||
124972325|NCT04674189|449525570|FG002|Overall Study|Miscellaneous|207|||
124972326|NCT04674189|449525568|FG000|Overall Study|Did Not Receive Treatment|3|||
124972327|NCT04674189|449525569|FG001|Overall Study|Did Not Receive Treatment|1|||
124972328|NCT04674189|449525570|FG002|Overall Study|Did Not Receive Treatment|2|||
124972329|NCT01564277|449525574|FG000|Overall Study|Protocol Violation|0|||
124972330|NCT01564277|449525575|FG001|Overall Study|Protocol Violation|1|||
124972331|NCT01564277|449525574|FG000|Overall Study|Physician Decision|1|||
124972332|NCT01564277|449525575|FG001|Overall Study|Physician Decision|0|||
124972333|NCT01637077|449525576|FG000|Overall Study|Cancel|1|||
124972334|NCT01637077|449525577|FG001|Overall Study|Cancel|1|||
124972335|NCT01637077|449525576|FG000|Overall Study|Withdrawal by Subject|1|||
124972336|NCT01637077|449525577|FG001|Overall Study|Withdrawal by Subject|0|||
124467430|NCT00730639|447668948|FG004|Overall Study|Withdrawal by Subject|4|||
124467431|NCT00730639|447668944|FG000|Overall Study|Treatment on-going|2|||
124467432|NCT00730639|447668945|FG001|Overall Study|Treatment on-going|5|||
124467433|NCT00730639|447668946|FG002|Overall Study|Treatment on-going|5|||
124467434|NCT00730639|447668947|FG003|Overall Study|Treatment on-going|4|||
124972337|NCT01637077|449525576|FG000|Overall Study|No cycle 1 questionnaire data|2|||
124972338|NCT01637077|449525577|FG001|Overall Study|No cycle 1 questionnaire data|0|||
124972339|NCT00794924|449525578|FG000|Overall Study|Lost to Follow-up|6|||
124467435|NCT00730639|447668948|FG004|Overall Study|Treatment on-going|4|||
124467436|NCT02665286|447668949|FG000|Overall Study|Lost to Follow-up|3|||
124467437|NCT02665286|447668950|FG001|Overall Study|Lost to Follow-up|2|||
124972340|NCT00794924|449525579|FG001|Overall Study|Lost to Follow-up|8|||
124972341|NCT00794924|449525578|FG000|Overall Study|Withdrawal by Subject|48|||
124972342|NCT00794924|449525579|FG001|Overall Study|Withdrawal by Subject|60|||
124467438|NCT02665286|447668951|FG002|Overall Study|Lost to Follow-up|1|||
124467439|NCT03434977|447668958|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
124467440|NCT03434977|447668959|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
124467441|NCT03064841|447668960|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
124467442|NCT03064841|447668960|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
124467443|NCT03064841|447668960|FG000|Overall Study|Screen failure|2|||
124467444|NCT00217087|447668961|FG000|Overall Study|decided to have esophagectomy|1|||
124467445|NCT00217087|447668962|FG001|Overall Study|decided to have esophagectomy|2|||
124467446|NCT00217087|447668961|FG000|Overall Study|completed less than 12 months return|10|||
124467447|NCT00217087|447668962|FG001|Overall Study|completed less than 12 months return|18|||
124467448|NCT03920670|447668963|FG000|Overall Study|Protocol Violation|2|||
124467449|NCT03920670|447668964|FG001|Overall Study|Protocol Violation|2|||
124467450|NCT03920670|447668963|FG000|Overall Study|Adverse Event|1|||
124467451|NCT03920670|447668964|FG001|Overall Study|Adverse Event|0|||
124467452|NCT05574062|447668970|FG000|Pre Run-In|Screening failure|3|||
124467453|NCT05574062|447668971|FG001|Pre Run-In|Screening failure|0|||
124467454|NCT05574062|447668972|FG002|Pre Run-In|Screening failure|0|||
124467455|NCT05574062|447668973|FG003|Pre Run-In|Screening failure|0|||
124467456|NCT05574062|447668974|FG004|Pre Run-In|Screening failure|0|||
124467457|NCT05574062|447668970|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
124467458|NCT05574062|447668971|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
124467459|NCT05574062|447668972|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
124467460|NCT05574062|447668973|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
124467461|NCT05574062|447668974|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
124467462|NCT05574062|447668970|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
124467463|NCT05574062|447668971|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
124467464|NCT05574062|447668972|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
124467465|NCT05574062|447668973|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
124467466|NCT05574062|447668974|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
124467467|NCT05574062|447668970|FG000|Continuation Phase Period 1|Physician Decision|1|||
124467468|NCT05574062|447668971|FG001|Continuation Phase Period 1|Physician Decision|0|||
124467469|NCT05574062|447668972|FG002|Continuation Phase Period 1|Physician Decision|0|||
124551779|NCT01336608|447978516|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
124551780|NCT01336608|447978517|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
124770351|NCT00321620|448788797|FG001|Overall Study|Physician Decision|1|||
124770352|NCT00321620|448788796|FG000|Overall Study|Noncompliance|14|||
124770353|NCT00321620|448788797|FG001|Overall Study|Noncompliance|7|||
124467470|NCT05574062|447668973|FG003|Continuation Phase Period 1|Physician Decision|0|||
124467471|NCT05574062|447668974|FG004|Continuation Phase Period 1|Physician Decision|0|||
124467472|NCT05574062|447668970|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
124467473|NCT05574062|447668971|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
124770354|NCT00321620|448788796|FG000|Overall Study|Protocol deviation|4|||
124467474|NCT05574062|447668972|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
124467475|NCT05574062|447668973|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
124467476|NCT05574062|447668974|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
124467477|NCT05574062|447668970|FG000|Continuation Phase Period 1|Adverse Event|1|||
124467478|NCT05574062|447668971|FG001|Continuation Phase Period 1|Adverse Event|0|||
124467479|NCT05574062|447668972|FG002|Continuation Phase Period 1|Adverse Event|0|||
124467480|NCT05574062|447668973|FG003|Continuation Phase Period 1|Adverse Event|0|||
124467481|NCT05574062|447668974|FG004|Continuation Phase Period 1|Adverse Event|0|||
124467482|NCT05574062|447668970|FG000|Continuation Phase Period 1|Death|1|||
124467483|NCT05574062|447668971|FG001|Continuation Phase Period 1|Death|0|||
124467484|NCT05574062|447668972|FG002|Continuation Phase Period 1|Death|0|||
124467485|NCT05574062|447668973|FG003|Continuation Phase Period 1|Death|0|||
124467486|NCT05574062|447668974|FG004|Continuation Phase Period 1|Death|0|||
124467487|NCT05574062|447668970|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
124467488|NCT05574062|447668971|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
124467489|NCT05574062|447668972|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
124467490|NCT05574062|447668973|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
124467491|NCT05574062|447668974|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
124713152|NCT02737501|448574549|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
124713153|NCT01261975|448574550|FG000|Overall Study|Surgical complication|1|||
124713154|NCT00716274|448574551|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
124770355|NCT00321620|448788797|FG001|Overall Study|Protocol deviation|3|||
124972343|NCT00794924|449525578|FG000|Overall Study|Adverse Event|6|||
124972344|NCT00794924|449525579|FG001|Overall Study|Adverse Event|2|||
124972345|NCT01594970|449525580|FG000|Overall Study|Non-Adverse Event Related|4|||
124972346|NCT01594970|449525581|FG001|Overall Study|Non-Adverse Event Related|5|||
124972347|NCT01594970|449525582|FG002|Overall Study|Non-Adverse Event Related|6|||
124972348|NCT01594970|449525580|FG000|Overall Study|Adverse Event|17|||
124972349|NCT01594970|449525581|FG001|Overall Study|Adverse Event|23|||
124972350|NCT01594970|449525582|FG002|Overall Study|Adverse Event|23|||
124972351|NCT01594970|449525580|FG000|Overall Study|Lost to Follow-up|54|||
124972352|NCT01594970|449525581|FG001|Overall Study|Lost to Follow-up|54|||
124972353|NCT01594970|449525582|FG002|Overall Study|Lost to Follow-up|37|||
124972354|NCT03332784|449525585|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972355|NCT03332784|449525586|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
124972356|NCT03332784|449525587|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972357|NCT03332784|449525588|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972358|NCT03332784|449525589|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972359|NCT03332784|449525590|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972360|NCT03332784|449525591|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972361|NCT03332784|449525592|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124467492|NCT03505021|447668975|FG000|Overall Study|Protocol Violation|1|||
124467493|NCT03505021|447668976|FG001|Overall Study|Protocol Violation|0|||
124467494|NCT03505021|447668975|FG000|Overall Study|Death|9|||
124467495|NCT03505021|447668976|FG001|Overall Study|Death|8|||
124467496|NCT03505021|447668975|FG000|Overall Study|Consent withdrawn by subject|6|||
124467497|NCT03505021|447668976|FG001|Overall Study|Consent withdrawn by subject|1|||
124467498|NCT03505021|447668975|FG000|Overall Study|Lost to Follow-up|5|||
124467499|NCT03505021|447668976|FG001|Overall Study|Lost to Follow-up|3|||
124467500|NCT03505021|447668975|FG000|Overall Study|Adverse Event|26|||
124467501|NCT03505021|447668976|FG001|Overall Study|Adverse Event|9|||
124972362|NCT03332784|449525593|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972363|NCT03332784|449525594|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972364|NCT03332784|449525595|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972365|NCT03332784|449525596|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972366|NCT03332784|449525597|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972367|NCT03332784|449525598|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972368|NCT03332784|449525599|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
124972369|NCT03332784|449525600|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972370|NCT03332784|449525601|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972371|NCT03332784|449525602|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972372|NCT03332784|449525603|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972373|NCT03332784|449525604|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
124972374|NCT02498236|449525610|FG000|Overall Study|Did not show for testing|1|||
124972375|NCT02498236|449525611|FG001|Overall Study|Did not show for testing|0|||
124972376|NCT02498236|449525612|FG002|Overall Study|Did not show for testing|0|||
124972377|NCT02498236|449525613|FG003|Overall Study|Did not show for testing|0|||
124972378|NCT02498236|449525614|FG004|Overall Study|Did not show for testing|0|||
124972379|NCT02498236|449525615|FG005|Overall Study|Did not show for testing|0|||
124972380|NCT02498236|449525616|FG006|Overall Study|Did not show for testing|0|||
124972381|NCT02498236|449525617|FG007|Overall Study|Did not show for testing|1|||
124467502|NCT03505021|447668975|FG000|Overall Study|Disease progression|33|||
124467503|NCT03505021|447668976|FG001|Overall Study|Disease progression|17|||
124467504|NCT03505021|447668975|FG000|Overall Study|Other|11|||
124467505|NCT03505021|447668976|FG001|Overall Study|Other|5|||
124467506|NCT03505021|447668975|FG000|Overall Study|Personal reason|21|||
124467507|NCT03505021|447668976|FG001|Overall Study|Personal reason|12|||
124467508|NCT03087955|447670863|FG000|Overall Study|Death|4|||
124467509|NCT03087955|447670864|FG001|Overall Study|Death|0|||
124467510|NCT03087955|447670863|FG000|Overall Study|Lack of Efficacy|2|||
124467511|NCT03087955|447670864|FG001|Overall Study|Lack of Efficacy|0|||
124467512|NCT03087955|447670863|FG000|Overall Study|Lost to Follow-up|1|||
124467513|NCT03087955|447670864|FG001|Overall Study|Lost to Follow-up|0|||
124467514|NCT04705051|447670865|FG000|Overall Study|Enrolled but not treated|1|||
124467515|NCT04705051|447670865|FG000|Overall Study|Study terminated by sponsor|23|||
124467516|NCT00482014|447670866|FG000|Overall Study|Withdrawal by Subject|1|||
124467517|NCT00482014|447670867|FG001|Overall Study|Withdrawal by Subject|2|||
124467518|NCT00482014|447670868|FG002|Overall Study|Withdrawal by Subject|3|||
124467519|NCT00482014|447670869|FG003|Overall Study|Withdrawal by Subject|4|||
124467520|NCT00482014|447670866|FG000|Overall Study|Adverse Event|3|||
124467521|NCT00482014|447670867|FG001|Overall Study|Adverse Event|0|||
124467522|NCT00482014|447670868|FG002|Overall Study|Adverse Event|2|||
124467523|NCT00482014|447670869|FG003|Overall Study|Adverse Event|8|||
124467524|NCT00482014|447670866|FG000|Overall Study|Death|1|||
124467525|NCT00482014|447670867|FG001|Overall Study|Death|2|||
124467526|NCT00482014|447670868|FG002|Overall Study|Death|1|||
124467527|NCT00482014|447670869|FG003|Overall Study|Death|4|||
124467528|NCT00482014|447670866|FG000|Overall Study|Lack of Efficacy|1|||
124770356|NCT00321620|448788796|FG000|Overall Study|Ineligibility determined|2|||
124467529|NCT00482014|447670867|FG001|Overall Study|Lack of Efficacy|0|||
124467530|NCT00482014|447670868|FG002|Overall Study|Lack of Efficacy|4|||
124467531|NCT00482014|447670869|FG003|Overall Study|Lack of Efficacy|6|||
124467532|NCT00482014|447670866|FG000|Overall Study|Sponsor Decision|1|||
124467533|NCT00482014|447670867|FG001|Overall Study|Sponsor Decision|2|||
124467534|NCT00482014|447670868|FG002|Overall Study|Sponsor Decision|1|||
124467535|NCT00482014|447670869|FG003|Overall Study|Sponsor Decision|1|||
124467536|NCT01178138|447670870|FG000|Overall Study|Lost to Follow-up|8|||
124467537|NCT01178138|447670870|FG000|Overall Study|Withdrawal by Subject|7|||
124467538|NCT01178138|447670870|FG000|Overall Study|Physician Decision|8|||
124467539|NCT03718143|447670871|FG000|Overall Study|Death|1|||
124467540|NCT03718143|447670872|FG001|Overall Study|Death|0|||
124467541|NCT03718143|447670873|FG002|Overall Study|Death|0|||
124467542|NCT03718143|447670871|FG000|Overall Study|Progression of Disease|1|||
124467543|NCT03718143|447670872|FG001|Overall Study|Progression of Disease|0|||
124467544|NCT03718143|447670873|FG002|Overall Study|Progression of Disease|0|||
124467545|NCT03718143|447670871|FG000|Overall Study|Withdrawal of Informed Consent|1|||
124467546|NCT03718143|447670872|FG001|Overall Study|Withdrawal of Informed Consent|2|||
124467547|NCT03718143|447670873|FG002|Overall Study|Withdrawal of Informed Consent|1|||
124467548|NCT05064059|447670874|FG000|Overall Study|Death|199|||
124467549|NCT05064059|447670875|FG001|Overall Study|Death|196|||
124467550|NCT05064059|447670874|FG000|Overall Study|Physician Decision|4|||
124467551|NCT05064059|447670875|FG001|Overall Study|Physician Decision|2|||
124467552|NCT05064059|447670874|FG000|Overall Study|Sponsor Decision|14|||
124467553|NCT05064059|447670875|FG001|Overall Study|Sponsor Decision|11|||
124467554|NCT05064059|447670874|FG000|Overall Study|Withdrawal by Subject|4|||
124467555|NCT05064059|447670875|FG001|Overall Study|Withdrawal by Subject|11|||
124467556|NCT00984204|447670886|FG000|Overall Study|Death|1|||
124467557|NCT00984204|447670886|FG000|Overall Study|Lost to Follow-up|4|||
124467558|NCT00984204|447670886|FG000|Overall Study|Lack of Efficacy|10|||
124467559|NCT00699348|447670894|FG000|Overall Study|Death|6|||
124467560|NCT00699348|447670894|FG000|Overall Study|Adverse Event|15|||
124467561|NCT00699348|447670894|FG000|Overall Study|Withdrawal by Subject|11|||
124770357|NCT00321620|448788797|FG001|Overall Study|Ineligibility determined|3|||
124770358|NCT00321620|448788796|FG000|Overall Study|Participant request|75|||
124770359|NCT00321620|448788797|FG001|Overall Study|Participant request|52|||
124770360|NCT00321620|448788796|FG000|Overall Study|Other|42|||
124770361|NCT00321620|448788797|FG001|Overall Study|Other|33|||
124467562|NCT00699348|447670894|FG000|Overall Study|Protocol Violation|10|||
124467563|NCT00699348|447670894|FG000|Overall Study|Lack of Efficacy|8|||
124467564|NCT00699348|447670894|FG000|Overall Study|Failure to return|1|||
124467565|NCT00699348|447670894|FG000|Overall Study|Blood transfusion|24|||
124467566|NCT00699348|447670894|FG000|Overall Study|Renal transplantation|10|||
124467567|NCT00699348|447670894|FG000|Overall Study|Other|5|||
124467568|NCT01268293|447670895|FG000|Overall Study|Disease progression|7|||
124467569|NCT01268293|447670895|FG000|Overall Study|Adverse Event|1|||
124467570|NCT01268293|447670895|FG000|Overall Study|Subject choice|1|||
124972382|NCT02498236|449525610|FG000|Overall Study|Equipment failure|0|||
124972383|NCT02498236|449525611|FG001|Overall Study|Equipment failure|0|||
124972384|NCT02498236|449525612|FG002|Overall Study|Equipment failure|0|||
124972385|NCT02498236|449525613|FG003|Overall Study|Equipment failure|0|||
124972386|NCT02498236|449525614|FG004|Overall Study|Equipment failure|0|||
124972387|NCT02498236|449525615|FG005|Overall Study|Equipment failure|0|||
124972388|NCT02498236|449525616|FG006|Overall Study|Equipment failure|1|||
124972389|NCT02498236|449525617|FG007|Overall Study|Equipment failure|0|||
124972390|NCT02498236|449525610|FG000|Overall Study|Withdrawal by Subject|0|||
124972391|NCT02498236|449525611|FG001|Overall Study|Withdrawal by Subject|0|||
124972392|NCT02498236|449525612|FG002|Overall Study|Withdrawal by Subject|0|||
124972393|NCT02498236|449525613|FG003|Overall Study|Withdrawal by Subject|0|||
124972394|NCT02498236|449525614|FG004|Overall Study|Withdrawal by Subject|1|||
124972395|NCT02498236|449525615|FG005|Overall Study|Withdrawal by Subject|0|||
124972396|NCT02498236|449525616|FG006|Overall Study|Withdrawal by Subject|0|||
124972397|NCT02498236|449525617|FG007|Overall Study|Withdrawal by Subject|0|||
124972398|NCT00383123|449525618|FG000|Overall Study|Adverse Event|1|||
124972399|NCT00383123|449525619|FG001|Overall Study|Adverse Event|0|||
124972400|NCT00383123|449525618|FG000|Overall Study|Lost to Follow-up|68|||
124972401|NCT00383123|449525619|FG001|Overall Study|Lost to Follow-up|61|||
124972402|NCT00383123|449525618|FG000|Overall Study|Protocol Violation|5|||
124972403|NCT00383123|449525619|FG001|Overall Study|Protocol Violation|1|||
124637271|NCT01081769|448290461|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
124637272|NCT01081769|448290460|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
124637273|NCT01081769|448290461|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
124637274|NCT01081769|448290460|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
124637275|NCT01081769|448290461|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
124637276|NCT01081769|448290460|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
124637277|NCT01081769|448290461|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
124637278|NCT01081769|448290460|FG000|CORE Intent-To-Treat|Adverse Event|14|||
124637279|NCT01081769|448290461|FG001|CORE Intent-To-Treat|Adverse Event|11|||
124637280|NCT01081769|448290460|FG000|CORE Intent-To-Treat|Death|1|||
124637281|NCT01081769|448290461|FG001|CORE Intent-To-Treat|Death|1|||
124637282|NCT01081769|448290460|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
124972404|NCT00383123|449525618|FG000|Overall Study|Withdrawal by Subject|27|||
124972405|NCT00383123|449525619|FG001|Overall Study|Withdrawal by Subject|18|||
124972406|NCT00383123|449525618|FG000|Overall Study|Other reason|10|||
124972407|NCT00383123|449525619|FG001|Overall Study|Other reason|6|||
124972408|NCT01814072|449525620|FG000|Overall Study|Lost to Follow-up|2|||
124972409|NCT01814072|449525621|FG001|Overall Study|Lost to Follow-up|2|||
124972410|NCT01814072|449525622|FG002|Overall Study|Lost to Follow-up|2|||
124972411|NCT01814072|449525623|FG003|Overall Study|Lost to Follow-up|0|||
124972412|NCT01814072|449525624|FG004|Overall Study|Lost to Follow-up|2|||
124972413|NCT01814072|449525625|FG005|Overall Study|Lost to Follow-up|3|||
124972414|NCT01814072|449525626|FG006|Overall Study|Lost to Follow-up|3|||
124972415|NCT01814072|449525627|FG007|Overall Study|Lost to Follow-up|1|||
124972416|NCT01814072|449525628|FG008|Overall Study|Lost to Follow-up|2|||
124972417|NCT01814072|449525629|FG009|Overall Study|Lost to Follow-up|3|||
124972418|NCT01814072|449525630|FG010|Overall Study|Lost to Follow-up|1|||
124972419|NCT01814072|449525631|FG011|Overall Study|Lost to Follow-up|2|||
124972420|NCT01814072|449525632|FG012|Overall Study|Lost to Follow-up|2|||
124467571|NCT00618748|447670896|FG000|Overall Study|Adverse Event|4|||
124467572|NCT00618748|447670897|FG001|Overall Study|Adverse Event|3|||
124467573|NCT00618748|447670898|FG002|Overall Study|Adverse Event|8|||
124467574|NCT00618748|447670896|FG000|Overall Study|Physician Decision|3|||
124467575|NCT00618748|447670897|FG001|Overall Study|Physician Decision|1|||
124467576|NCT00618748|447670898|FG002|Overall Study|Physician Decision|1|||
124467577|NCT00618748|447670896|FG000|Overall Study|Withdrawal by Subject|4|||
124467578|NCT00618748|447670897|FG001|Overall Study|Withdrawal by Subject|1|||
124770362|NCT03829228|448788798|FG000|Overall Study|Protocol Violation|1|||
124770363|NCT03304626|448788801|FG000|Overall Study|Adverse Event|1|||
124770364|NCT03304626|448788802|FG001|Overall Study|Adverse Event|0|||
124770365|NCT03304626|448788801|FG000|Overall Study|Lack of Efficacy|1|||
124770366|NCT03304626|448788802|FG001|Overall Study|Lack of Efficacy|1|||
124770367|NCT01462370|448788809|FG000|Overall Study|Lack of Qualifying Event|1|||
124770368|NCT01462370|448788810|FG001|Overall Study|Lack of Qualifying Event|1|||
124770369|NCT01462370|448788809|FG000|Overall Study|Physician Decision|0|||
124770370|NCT01462370|448788810|FG001|Overall Study|Physician Decision|1|||
124770371|NCT01462370|448788809|FG000|Overall Study|Withdrawal by Subject|0|||
124770372|NCT01462370|448788810|FG001|Overall Study|Withdrawal by Subject|3|||
124770373|NCT04385277|448788813|FG000|Overall Study|Physician Decision|2|||
124467579|NCT00618748|447670898|FG002|Overall Study|Withdrawal by Subject|5|||
124467580|NCT01396005|447670903|FG000|Overall Study|Withdrawal by Subject|0|||
124467581|NCT01396005|447670904|FG001|Overall Study|Withdrawal by Subject|1|||
124972421|NCT01814072|449525633|FG013|Overall Study|Lost to Follow-up|1|||
124972422|NCT01814072|449525634|FG014|Overall Study|Lost to Follow-up|2|||
124972423|NCT01814072|449525635|FG015|Overall Study|Lost to Follow-up|1|||
124972424|NCT01814072|449525636|FG016|Overall Study|Lost to Follow-up|3|||
124972425|NCT01814072|449525637|FG017|Overall Study|Lost to Follow-up|1|||
124972426|NCT01814072|449525638|FG018|Overall Study|Lost to Follow-up|3|||
124972427|NCT01814072|449525639|FG019|Overall Study|Lost to Follow-up|3|||
124972428|NCT01814072|449525640|FG020|Overall Study|Lost to Follow-up|2|||
124972429|NCT01814072|449525641|FG021|Overall Study|Lost to Follow-up|1|||
124972430|NCT01814072|449525642|FG022|Overall Study|Lost to Follow-up|3|||
124972431|NCT01814072|449525643|FG023|Overall Study|Lost to Follow-up|1|||
124972432|NCT01814072|449525644|FG024|Overall Study|Lost to Follow-up|4|||
124972433|NCT01814072|449525645|FG025|Overall Study|Lost to Follow-up|1|||
124972434|NCT01814072|449525646|FG026|Overall Study|Lost to Follow-up|1|||
124972435|NCT01814072|449525647|FG027|Overall Study|Lost to Follow-up|2|||
124972436|NCT01814072|449525648|FG028|Overall Study|Lost to Follow-up|3|||
124972437|NCT01814072|449525649|FG029|Overall Study|Lost to Follow-up|3|||
124972438|NCT01814072|449525650|FG030|Overall Study|Lost to Follow-up|2|||
124972439|NCT01814072|449525651|FG031|Overall Study|Lost to Follow-up|0|||
124972440|NCT01814072|449525620|FG000|Overall Study|Withdrawal by Subject|2|||
124972441|NCT01814072|449525621|FG001|Overall Study|Withdrawal by Subject|0|||
124972442|NCT01814072|449525622|FG002|Overall Study|Withdrawal by Subject|1|||
124972443|NCT01814072|449525623|FG003|Overall Study|Withdrawal by Subject|0|||
124972444|NCT01814072|449525624|FG004|Overall Study|Withdrawal by Subject|2|||
124972445|NCT01814072|449525625|FG005|Overall Study|Withdrawal by Subject|3|||
124972446|NCT01814072|449525626|FG006|Overall Study|Withdrawal by Subject|1|||
124972447|NCT01814072|449525627|FG007|Overall Study|Withdrawal by Subject|0|||
124972448|NCT01814072|449525628|FG008|Overall Study|Withdrawal by Subject|1|||
124972449|NCT01814072|449525629|FG009|Overall Study|Withdrawal by Subject|2|||
124972450|NCT01814072|449525630|FG010|Overall Study|Withdrawal by Subject|0|||
124972451|NCT01814072|449525631|FG011|Overall Study|Withdrawal by Subject|0|||
124972452|NCT01814072|449525632|FG012|Overall Study|Withdrawal by Subject|1|||
124972453|NCT01814072|449525633|FG013|Overall Study|Withdrawal by Subject|1|||
124972454|NCT01814072|449525634|FG014|Overall Study|Withdrawal by Subject|1|||
124972455|NCT01814072|449525635|FG015|Overall Study|Withdrawal by Subject|1|||
124972456|NCT01814072|449525636|FG016|Overall Study|Withdrawal by Subject|0|||
124972457|NCT01814072|449525637|FG017|Overall Study|Withdrawal by Subject|0|||
124972458|NCT01814072|449525638|FG018|Overall Study|Withdrawal by Subject|0|||
124972459|NCT01814072|449525639|FG019|Overall Study|Withdrawal by Subject|2|||
124972460|NCT01814072|449525640|FG020|Overall Study|Withdrawal by Subject|0|||
124972461|NCT01814072|449525641|FG021|Overall Study|Withdrawal by Subject|0|||
124972462|NCT01814072|449525642|FG022|Overall Study|Withdrawal by Subject|1|||
124972463|NCT01814072|449525643|FG023|Overall Study|Withdrawal by Subject|0|||
124972464|NCT01814072|449525644|FG024|Overall Study|Withdrawal by Subject|2|||
124972465|NCT01814072|449525645|FG025|Overall Study|Withdrawal by Subject|1|||
124972466|NCT01814072|449525646|FG026|Overall Study|Withdrawal by Subject|1|||
124972467|NCT01814072|449525647|FG027|Overall Study|Withdrawal by Subject|2|||
124972468|NCT01814072|449525648|FG028|Overall Study|Withdrawal by Subject|1|||
124972469|NCT01814072|449525649|FG029|Overall Study|Withdrawal by Subject|0|||
124972470|NCT01814072|449525650|FG030|Overall Study|Withdrawal by Subject|0|||
124972471|NCT01814072|449525651|FG031|Overall Study|Withdrawal by Subject|0|||
124972472|NCT02336425|449525652|FG000|Overall Study|Study terminated.|2|||
124972473|NCT02336425|449525653|FG001|Overall Study|Study terminated.|2|||
124972474|NCT02336425|449525654|FG002|Overall Study|Study terminated.|3|||
124972475|NCT02336425|449525655|FG003|Overall Study|Study terminated.|3|||
124972476|NCT00978562|449525656|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
124972477|NCT01782690|449525657|FG000|Overall Study|Not reported|7|||
124972478|NCT01782690|449525657|FG000|Overall Study|Toxicity of gemcitabine|1|||
124972479|NCT01782690|449525657|FG000|Overall Study|Toxicity of erlotinib|1|||
124972480|NCT01782690|449525657|FG000|Overall Study|Lost to Follow-up|31|||
124972481|NCT01782690|449525657|FG000|Overall Study|Withdrawal of informed consent|2|||
124972482|NCT01782690|449525657|FG000|Overall Study|Absent rash|9|||
124972483|NCT01782690|449525657|FG000|Overall Study|Physician Decision|13|||
124972484|NCT01782690|449525657|FG000|Overall Study|Patient's wish|21|||
124972485|NCT01782690|449525657|FG000|Overall Study|Tumor progression|74|||
124467582|NCT01396005|447670903|FG000|Overall Study|Non-compliance with protocol|0|||
124467583|NCT01396005|447670904|FG001|Overall Study|Non-compliance with protocol|1|||
124467584|NCT00424827|447670905|FG000|Overall Study|Adverse Event|1|||
124467585|NCT01467492|447670906|FG000|Overall Study|Withdrawal by Subject|6|||
124467586|NCT01467492|447670907|FG001|Overall Study|Withdrawal by Subject|4|||
124467587|NCT01467492|447670906|FG000|Overall Study|Study Terminated by Sponsor|6|||
124467588|NCT01467492|447670907|FG001|Overall Study|Study Terminated by Sponsor|4|||
124467589|NCT01467492|447670906|FG000|Overall Study|Adverse Event|4|||
124467590|NCT01467492|447670907|FG001|Overall Study|Adverse Event|3|||
124467591|NCT01467492|447670906|FG000|Overall Study|Lost to Follow-up|3|||
124467592|NCT01467492|447670907|FG001|Overall Study|Lost to Follow-up|2|||
124467593|NCT01467492|447670906|FG000|Overall Study|Undefined|2|||
124467594|NCT01467492|447670907|FG001|Overall Study|Undefined|0|||
124467595|NCT01467492|447670906|FG000|Overall Study|Enrolled But Not Treated|1|||
124467596|NCT01467492|447670907|FG001|Overall Study|Enrolled But Not Treated|0|||
124467597|NCT00159432|447670909|FG000|Overall Study|Adverse Event|1|||
124467598|NCT00159432|447670909|FG000|Overall Study|Death|1|||
124467599|NCT00159432|447670909|FG000|Overall Study|Lack of Efficacy|8|||
124467600|NCT05218499|447670910|FG000|Overall Study|Not treated|1|||
124467601|NCT05218499|447670911|FG001|Overall Study|Not treated|1|||
124467602|NCT05218499|447670912|FG002|Overall Study|Not treated|8|||
124467603|NCT05218499|447670910|FG000|Overall Study|Death|2|||
124467604|NCT05218499|447670911|FG001|Overall Study|Death|0|||
124467605|NCT05218499|447670912|FG002|Overall Study|Death|0|||
124467606|NCT05218499|447670910|FG000|Overall Study|Other than listed|3|||
124467607|NCT05218499|447670911|FG001|Overall Study|Other than listed|7|||
124467608|NCT05218499|447670912|FG002|Overall Study|Other than listed|10|||
124467609|NCT05218499|447670910|FG000|Overall Study|Protocol deviation|5|||
124467610|NCT05218499|447670911|FG001|Overall Study|Protocol deviation|6|||
124467611|NCT05218499|447670912|FG002|Overall Study|Protocol deviation|4|||
124467612|NCT05218499|447670910|FG000|Overall Study|Technical problems|0|||
124467613|NCT05218499|447670911|FG001|Overall Study|Technical problems|1|||
124467614|NCT05218499|447670912|FG002|Overall Study|Technical problems|0|||
124467615|NCT05218499|447670910|FG000|Overall Study|Burden of trial procedures|0|||
124467616|NCT05218499|447670911|FG001|Overall Study|Burden of trial procedures|1|||
124467617|NCT05218499|447670912|FG002|Overall Study|Burden of trial procedures|2|||
124467618|NCT05218499|447670910|FG000|Overall Study|Clinical disease progression|6|||
124467619|NCT05218499|447670911|FG001|Overall Study|Clinical disease progression|6|||
124467620|NCT05218499|447670912|FG002|Overall Study|Clinical disease progression|11|||
124467621|NCT05218499|447670910|FG000|Overall Study|Objective disease progression|44|||
124467622|NCT05218499|447670911|FG001|Overall Study|Objective disease progression|61|||
124467623|NCT05218499|447670912|FG002|Overall Study|Objective disease progression|42|||
124467624|NCT05218499|447670910|FG000|Overall Study|Adverse Event|11|||
124467625|NCT05218499|447670911|FG001|Overall Study|Adverse Event|36|||
124467626|NCT05218499|447670912|FG002|Overall Study|Adverse Event|9|||
124467627|NCT05218499|447670910|FG000|Overall Study|On treatment at time of snapshot|18|||
124467628|NCT05218499|447670911|FG001|Overall Study|On treatment at time of snapshot|29|||
124467629|NCT05218499|447670912|FG002|Overall Study|On treatment at time of snapshot|0|||
124551781|NCT01336608|447978518|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
124551782|NCT01336608|447978519|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
124551783|NCT01336608|447978516|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
124551784|NCT01336608|447978517|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
124467630|NCT05689047|447670913|FG000|Overall Study|Lost to Follow-up|0|||
124467631|NCT05689047|447670914|FG001|Overall Study|Lost to Follow-up|1|||
124467632|NCT05689047|447670913|FG000|Overall Study|Protocol Deviation|1|||
124467633|NCT05689047|447670914|FG001|Overall Study|Protocol Deviation|0|||
124467634|NCT01604512|447670915|FG000|Overall Study|Withdrawal by Subject|3|||
124467635|NCT01604512|447670915|FG000|Overall Study|Not treated|4|||
124467636|NCT04161495|447670916|FG000|Overall Study|Withdrawal by Subject|3|||
124467637|NCT04161495|447670917|FG001|Overall Study|Withdrawal by Subject|0|||
124467638|NCT04161495|447670916|FG000|Overall Study|Protocol Violation|1|||
124467639|NCT04161495|447670917|FG001|Overall Study|Protocol Violation|0|||
124467640|NCT04161495|447670916|FG000|Overall Study|Prohibited concomitant medication|3|||
124467641|NCT04161495|447670917|FG001|Overall Study|Prohibited concomitant medication|0|||
124467642|NCT04161495|447670916|FG000|Overall Study|Adverse Event|1|||
124467643|NCT04161495|447670917|FG001|Overall Study|Adverse Event|0|||
124467644|NCT04161495|447670916|FG000|Overall Study|Other - Unspecified|1|||
124467645|NCT04161495|447670917|FG001|Overall Study|Other - Unspecified|0|||
124467646|NCT04161495|447670916|FG000|Overall Study|Death|0|||
124467647|NCT04161495|447670917|FG001|Overall Study|Death|1|||
124467648|NCT01239160|447670919|FG000|Overall Study|Lost to Follow-up|3|||
124467649|NCT01239160|447670920|FG001|Overall Study|Lost to Follow-up|5|||
124467650|NCT01239160|447670921|FG002|Overall Study|Lost to Follow-up|0|||
124467651|NCT01239160|447670919|FG000|Overall Study|Withdrawal by Subject|17|||
124467652|NCT01239160|447670920|FG001|Overall Study|Withdrawal by Subject|6|||
124467653|NCT01239160|447670921|FG002|Overall Study|Withdrawal by Subject|2|||
124467654|NCT01239160|447670919|FG000|Overall Study|Physician Decision|5|||
124467655|NCT01239160|447670920|FG001|Overall Study|Physician Decision|7|||
124467656|NCT01239160|447670921|FG002|Overall Study|Physician Decision|2|||
124467657|NCT01239160|447670919|FG000|Overall Study|Early Termination Due to Study Closure|0|||
124467658|NCT01239160|447670920|FG001|Overall Study|Early Termination Due to Study Closure|1|||
124467659|NCT01239160|447670921|FG002|Overall Study|Early Termination Due to Study Closure|6|||
124467660|NCT01789970|447670922|FG000|Open-label Titration Period|Adverse Event|68|||
124551785|NCT01336608|447978518|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
124551786|NCT01336608|447978519|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
124551787|NCT01336608|447978516|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
124551788|NCT01336608|447978517|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
124551789|NCT01336608|447978518|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
124467661|NCT01789970|447670923|FG001|Open-label Titration Period|Adverse Event|0|||
124467662|NCT01789970|447670924|FG002|Open-label Titration Period|Adverse Event|0|||
124467663|NCT01789970|447670922|FG000|Open-label Titration Period|Lack of Efficacy|31|||
124467664|NCT01789970|447670923|FG001|Open-label Titration Period|Lack of Efficacy|0|||
124467665|NCT01789970|447670924|FG002|Open-label Titration Period|Lack of Efficacy|0|||
124467666|NCT01789970|447670922|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
124467667|NCT01789970|447670923|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
124467668|NCT01789970|447670924|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
124467669|NCT01789970|447670922|FG000|Open-label Titration Period|Protocol Violation|18|||
124467670|NCT01789970|447670923|FG001|Open-label Titration Period|Protocol Violation|0|||
124467671|NCT01789970|447670924|FG002|Open-label Titration Period|Protocol Violation|0|||
124467672|NCT01789970|447670922|FG000|Open-label Titration Period|Lost to Follow-up|5|||
124467673|NCT01789970|447670923|FG001|Open-label Titration Period|Lost to Follow-up|0|||
124467674|NCT01789970|447670924|FG002|Open-label Titration Period|Lost to Follow-up|0|||
124467675|NCT01789970|447670922|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
124467676|NCT01789970|447670923|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
124467677|NCT01789970|447670924|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
124467678|NCT01789970|447670922|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
124467679|NCT01789970|447670923|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
124467680|NCT01789970|447670924|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
124467681|NCT01789970|447670922|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
124467682|NCT01789970|447670923|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
124467683|NCT01789970|447670924|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
124467684|NCT01789970|447670922|FG000|Open-label Titration Period|Pregnancy|2|||
124467685|NCT01789970|447670923|FG001|Open-label Titration Period|Pregnancy|0|||
124467686|NCT01789970|447670924|FG002|Open-label Titration Period|Pregnancy|0|||
124467687|NCT01789970|447670922|FG000|Open-label Titration Period|Other|76|||
124467688|NCT01789970|447670923|FG001|Open-label Titration Period|Other|0|||
124467689|NCT01789970|447670924|FG002|Open-label Titration Period|Other|0|||
124467690|NCT01789970|447670922|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
124467691|NCT01789970|447670923|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
124467692|NCT01789970|447670924|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
124467693|NCT01789970|447670922|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
124467694|NCT01789970|447670923|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
124467695|NCT01789970|447670924|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
124467696|NCT01789970|447670922|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
124467697|NCT01789970|447670923|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
124467698|NCT01789970|447670924|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
124551790|NCT01336608|447978519|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
124467699|NCT01789970|447670922|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
124467700|NCT01789970|447670923|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
124467701|NCT01789970|447670924|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
124467702|NCT01789970|447670922|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
124467703|NCT01789970|447670923|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
124467704|NCT01789970|447670924|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
124467705|NCT01789970|447670922|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
124551791|NCT01336608|447978516|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
124770374|NCT04385277|448788813|FG000|Overall Study|Ineligible|1|||
124467706|NCT01789970|447670923|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
124467707|NCT01789970|447670924|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
124467708|NCT01789970|447670922|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
124467709|NCT01789970|447670923|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
124467710|NCT01789970|447670924|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
124467711|NCT01789970|447670922|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
124467712|NCT01789970|447670923|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
124467713|NCT01789970|447670924|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
124467714|NCT01789970|447670922|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
124467715|NCT01789970|447670923|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
124467716|NCT01789970|447670924|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
124467717|NCT01789970|447670922|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
124467718|NCT01789970|447670923|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
124467719|NCT01789970|447670924|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
124467720|NCT01789970|447670922|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
124467721|NCT01789970|447670923|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
124467722|NCT01789970|447670924|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
124467723|NCT02296242|447670929|FG000|Overall Study|Death|1|||
124467724|NCT02296242|447670930|FG001|Overall Study|Death|1|||
124467725|NCT02296242|447670931|FG002|Overall Study|Death|1|||
124467726|NCT02296242|447670932|FG003|Overall Study|Death|1|||
124467727|NCT02296242|447670933|FG004|Overall Study|Death|1|||
124467728|NCT02296242|447670929|FG000|Overall Study|Withdrawal by Subject|0|||
124467729|NCT02296242|447670930|FG001|Overall Study|Withdrawal by Subject|0|||
124467730|NCT02296242|447670931|FG002|Overall Study|Withdrawal by Subject|1|||
124551792|NCT01336608|447978517|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
124551793|NCT01336608|447978518|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
124551794|NCT01336608|447978519|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
124713155|NCT00716274|448574552|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
124972486|NCT01782690|449525657|FG000|Overall Study|Death|133|||
124972487|NCT01782690|449525657|FG000|Overall Study|Study completion unknown|7|||
124972488|NCT04946942|449525659|FG000|Overall Study|Lost to Follow-up|6|||
124972489|NCT04946942|449525660|FG001|Overall Study|Lost to Follow-up|2|||
124972490|NCT04946942|449525661|FG002|Overall Study|Lost to Follow-up|0|||
124972491|NCT04907357|449525662|FG000|Overall Study|Death|0|||
124972492|NCT04907357|449525663|FG001|Overall Study|Death|1|||
124972493|NCT04907357|449525662|FG000|Overall Study|Lost to Follow-up|9|||
124972494|NCT04907357|449525663|FG001|Overall Study|Lost to Follow-up|18|||
124972495|NCT04907357|449525662|FG000|Overall Study|Physician Decision|1|||
124972496|NCT04907357|449525663|FG001|Overall Study|Physician Decision|0|||
124972497|NCT04907357|449525662|FG000|Overall Study|Withdrawal by Subject|0|||
124972498|NCT04907357|449525663|FG001|Overall Study|Withdrawal by Subject|1|||
124972499|NCT04907357|449525662|FG000|Overall Study|Unable to attend visits|1|||
124972500|NCT04907357|449525663|FG001|Overall Study|Unable to attend visits|0|||
124972501|NCT04907357|449525662|FG000|Overall Study|Incarcerated|1|||
124972502|NCT04907357|449525663|FG001|Overall Study|Incarcerated|1|||
124972503|NCT01948076|449525664|FG000|Overall Study|Withdrawal by Subject|0|||
124972504|NCT01948076|449525665|FG001|Overall Study|Withdrawal by Subject|1|||
124972505|NCT04124471|449525672|FG000|Overall Study|screen failure|1|||
124972506|NCT05226130|449525673|FG000|Overall Study|Lost to Follow-up|0|||
124972507|NCT05226130|449525674|FG001|Overall Study|Lost to Follow-up|1|||
124972508|NCT05226130|449525673|FG000|Overall Study|Not treatment adherent|0|||
124972509|NCT05226130|449525674|FG001|Overall Study|Not treatment adherent|2|||
124972510|NCT03358472|449525675|FG000|Overall Study|Death|6|||
124972511|NCT03358472|449525676|FG001|Overall Study|Death|3|||
124972512|NCT03358472|449525677|FG002|Overall Study|Death|10|||
124972513|NCT03358472|449525675|FG000|Overall Study|Physician Decision|0|||
124972514|NCT03358472|449525676|FG001|Overall Study|Physician Decision|1|||
124972515|NCT03358472|449525677|FG002|Overall Study|Physician Decision|0|||
124972516|NCT03358472|449525675|FG000|Overall Study|Withdrawal by Subject|0|||
124972517|NCT03358472|449525676|FG001|Overall Study|Withdrawal by Subject|0|||
124972518|NCT03358472|449525677|FG002|Overall Study|Withdrawal by Subject|1|||
124972519|NCT03358472|449525675|FG000|Overall Study|On-going at clinical cut off date|9|||
124972520|NCT03358472|449525676|FG001|Overall Study|On-going at clinical cut off date|6|||
124972521|NCT03358472|449525677|FG002|Overall Study|On-going at clinical cut off date|5|||
124972522|NCT03732677|449525678|FG000|Overall Study|Terminated the study|154|||
124972523|NCT03732677|449525679|FG001|Overall Study|Terminated the study|197|||
124972524|NCT03732677|449525678|FG000|Overall Study|Continuing study off treatment|379|||
124972525|NCT03732677|449525679|FG001|Overall Study|Continuing study off treatment|333|||
124972526|NCT04013971|449525680|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
124972527|NCT04013971|449525681|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
124972528|NCT04013971|449525680|FG000|Overall Study|Missing biomechanical data|0|||
124467731|NCT02296242|447670932|FG003|Overall Study|Withdrawal by Subject|1|||
124467732|NCT02296242|447670933|FG004|Overall Study|Withdrawal by Subject|3|||
124467733|NCT02296242|447670929|FG000|Overall Study|Disease Progression|1|||
124467734|NCT02296242|447670930|FG001|Overall Study|Disease Progression|3|||
124467735|NCT02296242|447670931|FG002|Overall Study|Disease Progression|2|||
124467736|NCT02296242|447670932|FG003|Overall Study|Disease Progression|8|||
124467737|NCT02296242|447670933|FG004|Overall Study|Disease Progression|11|||
124467738|NCT02296242|447670929|FG000|Overall Study|Unacceptable Toxicity|0|||
124467739|NCT02296242|447670930|FG001|Overall Study|Unacceptable Toxicity|0|||
124467740|NCT02296242|447670931|FG002|Overall Study|Unacceptable Toxicity|0|||
124467741|NCT02296242|447670932|FG003|Overall Study|Unacceptable Toxicity|0|||
124467742|NCT02296242|447670933|FG004|Overall Study|Unacceptable Toxicity|1|||
124467743|NCT02296242|447670929|FG000|Overall Study|Patient Condition Changed|0|||
124467744|NCT02296242|447670930|FG001|Overall Study|Patient Condition Changed|0|||
124467745|NCT02296242|447670931|FG002|Overall Study|Patient Condition Changed|2|||
124713156|NCT00716274|448574553|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
124467746|NCT02296242|447670932|FG003|Overall Study|Patient Condition Changed|0|||
124467747|NCT02296242|447670933|FG004|Overall Study|Patient Condition Changed|1|||
124467748|NCT02296242|447670929|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
124467749|NCT02296242|447670930|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
124467750|NCT02296242|447670931|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
124467751|NCT02296242|447670932|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
124467752|NCT02296242|447670933|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
124467753|NCT02296242|447670929|FG000|Overall Study|Lost to Follow-up|1|||
124467754|NCT02296242|447670930|FG001|Overall Study|Lost to Follow-up|0|||
124467755|NCT02296242|447670931|FG002|Overall Study|Lost to Follow-up|0|||
124467756|NCT02296242|447670932|FG003|Overall Study|Lost to Follow-up|0|||
124467757|NCT02296242|447670933|FG004|Overall Study|Lost to Follow-up|0|||
124467758|NCT02296242|447670929|FG000|Overall Study|Need for Hydroxyurea|2|||
124467759|NCT02296242|447670930|FG001|Overall Study|Need for Hydroxyurea|0|||
124467760|NCT02296242|447670931|FG002|Overall Study|Need for Hydroxyurea|0|||
124467761|NCT02296242|447670932|FG003|Overall Study|Need for Hydroxyurea|0|||
124467762|NCT02296242|447670933|FG004|Overall Study|Need for Hydroxyurea|0|||
124467763|NCT02296242|447670929|FG000|Overall Study|Screened for Other Protocol|0|||
124467764|NCT02296242|447670930|FG001|Overall Study|Screened for Other Protocol|1|||
124467765|NCT02296242|447670931|FG002|Overall Study|Screened for Other Protocol|0|||
124467766|NCT02296242|447670932|FG003|Overall Study|Screened for Other Protocol|0|||
124467767|NCT02296242|447670933|FG004|Overall Study|Screened for Other Protocol|0|||
124467768|NCT02296242|447670929|FG000|Overall Study|Physician Decision|0|||
124467769|NCT02296242|447670930|FG001|Overall Study|Physician Decision|1|||
124467770|NCT02296242|447670931|FG002|Overall Study|Physician Decision|0|||
124467771|NCT02296242|447670932|FG003|Overall Study|Physician Decision|1|||
124467772|NCT02296242|447670933|FG004|Overall Study|Physician Decision|0|||
124467773|NCT02296242|447670929|FG000|Overall Study|Alternative Treatment|0|||
124467774|NCT02296242|447670930|FG001|Overall Study|Alternative Treatment|0|||
124467775|NCT02296242|447670931|FG002|Overall Study|Alternative Treatment|0|||
124467776|NCT02296242|447670932|FG003|Overall Study|Alternative Treatment|1|||
124467777|NCT02296242|447670933|FG004|Overall Study|Alternative Treatment|0|||
124467778|NCT02296242|447670929|FG000|Overall Study|Adverse Event|0|||
124467779|NCT02296242|447670930|FG001|Overall Study|Adverse Event|0|||
124467780|NCT02296242|447670931|FG002|Overall Study|Adverse Event|0|||
124467781|NCT02296242|447670932|FG003|Overall Study|Adverse Event|1|||
124467782|NCT02296242|447670933|FG004|Overall Study|Adverse Event|0|||
124467783|NCT02296242|447670929|FG000|Overall Study|Lack of Efficacy|0|||
124467784|NCT02296242|447670930|FG001|Overall Study|Lack of Efficacy|0|||
124467785|NCT02296242|447670931|FG002|Overall Study|Lack of Efficacy|0|||
124467786|NCT02296242|447670932|FG003|Overall Study|Lack of Efficacy|0|||
124467787|NCT02296242|447670933|FG004|Overall Study|Lack of Efficacy|3|||
124467788|NCT02217566|447670934|FG000|Overall Study|Lost to Follow-up|2|||
124713157|NCT00716274|448574554|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
124713158|NCT00716274|448574555|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
124713159|NCT00716274|448574556|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
124713160|NCT00716274|448574551|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
124467789|NCT02217566|447670934|FG000|Overall Study|Death|3|||
124467790|NCT02217566|447670934|FG000|Overall Study|Early study termination|6|||
124467791|NCT01639833|447670939|FG000|Overall Study|Death|4|||
124467792|NCT01639833|447670940|FG001|Overall Study|Death|2|||
124467793|NCT01639833|447670939|FG000|Overall Study|Withdrawal by Subject|2|||
124467794|NCT01639833|447670940|FG001|Overall Study|Withdrawal by Subject|2|||
124467795|NCT02450578|447670941|FG000|Overall Study|ECG abnormality so not treated|1|||
124467796|NCT02450578|447670942|FG001|Overall Study|ECG abnormality so not treated|0|||
124467797|NCT02450578|447670943|FG002|Overall Study|ECG abnormality so not treated|0|||
124467798|NCT02450578|447670944|FG003|Overall Study|ECG abnormality so not treated|0|||
124467799|NCT04016311|447670945|FG000|Overall Study|Withdrawal by Subject|1|||
124467800|NCT04016311|447670946|FG001|Overall Study|Withdrawal by Subject|0|||
124467801|NCT04029519|447670947|FG000|Overall Study|Protocol Violation|1|||
124467802|NCT04029519|447670947|FG000|Overall Study|Withdrawal by Subject|3|||
124467803|NCT04029519|447670947|FG000|Overall Study|Lost to Follow-up|1|||
124467804|NCT01999582|447670952|FG000|Overall Study|Withdrawal by Subject|0|||
124467805|NCT01999582|447670953|FG001|Overall Study|Withdrawal by Subject|0|||
124467806|NCT01999582|447670954|FG002|Overall Study|Withdrawal by Subject|0|||
124467807|NCT01999582|447670955|FG003|Overall Study|Withdrawal by Subject|1|||
124467808|NCT01999582|447670956|FG004|Overall Study|Withdrawal by Subject|0|||
124467809|NCT01999582|447670957|FG005|Overall Study|Withdrawal by Subject|0|||
124467810|NCT01999582|447670952|FG000|Overall Study|Adverse Event|0|||
124467811|NCT01999582|447670953|FG001|Overall Study|Adverse Event|0|||
124467812|NCT01999582|447670954|FG002|Overall Study|Adverse Event|3|||
124467813|NCT01999582|447670955|FG003|Overall Study|Adverse Event|0|||
124467814|NCT01999582|447670956|FG004|Overall Study|Adverse Event|1|||
124467815|NCT01999582|447670957|FG005|Overall Study|Adverse Event|0|||
124467816|NCT01999582|447670952|FG000|Overall Study|Other Reasons|1|||
124467817|NCT01999582|447670953|FG001|Overall Study|Other Reasons|0|||
124467818|NCT01999582|447670954|FG002|Overall Study|Other Reasons|3|||
124467819|NCT01999582|447670955|FG003|Overall Study|Other Reasons|1|||
124467820|NCT01999582|447670956|FG004|Overall Study|Other Reasons|1|||
124467821|NCT01999582|447670957|FG005|Overall Study|Other Reasons|2|||
124467822|NCT01999582|447670952|FG000|Overall Study|Protocol Violation|1|||
124467823|NCT01999582|447670953|FG001|Overall Study|Protocol Violation|0|||
124467824|NCT01999582|447670954|FG002|Overall Study|Protocol Violation|0|||
124467825|NCT01999582|447670955|FG003|Overall Study|Protocol Violation|0|||
124467826|NCT01999582|447670956|FG004|Overall Study|Protocol Violation|0|||
124467827|NCT01999582|447670957|FG005|Overall Study|Protocol Violation|1|||
124467828|NCT01999582|447670952|FG000|Overall Study|Lack of Efficacy|1|||
124467829|NCT01999582|447670953|FG001|Overall Study|Lack of Efficacy|3|||
124467830|NCT01999582|447670954|FG002|Overall Study|Lack of Efficacy|0|||
124467831|NCT01999582|447670955|FG003|Overall Study|Lack of Efficacy|1|||
124467832|NCT01999582|447670956|FG004|Overall Study|Lack of Efficacy|0|||
124467833|NCT01999582|447670957|FG005|Overall Study|Lack of Efficacy|0|||
124467834|NCT02436876|447670962|FG000|Overall Study|Lost to Follow-up|0|||
124467835|NCT02436876|447670963|FG001|Overall Study|Lost to Follow-up|1|||
124467836|NCT02436876|447670964|FG002|Overall Study|Lost to Follow-up|1|||
124467837|NCT02436876|447670965|FG003|Overall Study|Lost to Follow-up|1|||
124467838|NCT02436876|447670962|FG000|Overall Study|Withdrawal by Subject|1|||
124467839|NCT02436876|447670963|FG001|Overall Study|Withdrawal by Subject|0|||
124467840|NCT02436876|447670964|FG002|Overall Study|Withdrawal by Subject|0|||
124467841|NCT02436876|447670965|FG003|Overall Study|Withdrawal by Subject|1|||
124467842|NCT02436876|447670962|FG000|Overall Study|Physician Decision|0|||
124467843|NCT02436876|447670963|FG001|Overall Study|Physician Decision|2|||
124551795|NCT01336608|447978516|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
124467844|NCT02436876|447670964|FG002|Overall Study|Physician Decision|1|||
124467845|NCT02436876|447670965|FG003|Overall Study|Physician Decision|0|||
124467846|NCT02436876|447670962|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
124467847|NCT02436876|447670963|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
124467848|NCT02436876|447670964|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
124467849|NCT02436876|447670965|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
124467850|NCT01536860|447670968|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
124467851|NCT01536860|447670969|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
124770375|NCT04385277|448788813|FG000|Overall Study|Patient/Parent Refusal|2|||
124467852|NCT01536860|447670970|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
124467853|NCT02809833|447670971|FG000|Overall Study|Death|3|||
124467854|NCT02809833|447670971|FG000|Overall Study|Intolerance|54|||
124467855|NCT02809833|447670971|FG000|Overall Study|Lack of Efficacy|89|||
124467856|NCT02809833|447670971|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
124467857|NCT02809833|447670971|FG000|Overall Study|Noncompliance|1|||
124467858|NCT02809833|447670971|FG000|Overall Study|Withdrawal by Subject|34|||
124467859|NCT02809833|447670971|FG000|Overall Study|Lost to Follow-up|35|||
124467860|NCT02809833|447670971|FG000|Overall Study|Adverse Event (AE)|24|||
124467861|NCT02809833|447670971|FG000|Overall Study|Other|5|||
124467862|NCT02809833|447670971|FG000|Overall Study|Missing Information|52|||
124467863|NCT03889639|447670972|FG000|Overall Study|Withdrawal by Subject|0|||
124467864|NCT03889639|447670973|FG001|Overall Study|Withdrawal by Subject|0|||
124467865|NCT03889639|447670974|FG002|Overall Study|Withdrawal by Subject|0|||
124467866|NCT03889639|447670975|FG003|Overall Study|Withdrawal by Subject|0|||
124467867|NCT03889639|447670976|FG004|Overall Study|Withdrawal by Subject|0|||
124467868|NCT03889639|447670977|FG005|Overall Study|Withdrawal by Subject|0|||
124467869|NCT03889639|447670978|FG006|Overall Study|Withdrawal by Subject|0|||
124467870|NCT03889639|447670979|FG007|Overall Study|Withdrawal by Subject|1|||
124467871|NCT00927095|447670980|FG000|Overall Study|Adverse Event|3|||
124467872|NCT00927095|447670981|FG001|Overall Study|Adverse Event|1|||
124467873|NCT00927095|447670982|FG002|Overall Study|Adverse Event|0|||
124467874|NCT00927095|447670980|FG000|Overall Study|Withdrawal by Subject|2|||
124551796|NCT01336608|447978517|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
124467875|NCT00927095|447670981|FG001|Overall Study|Withdrawal by Subject|1|||
124467876|NCT00927095|447670982|FG002|Overall Study|Withdrawal by Subject|1|||
124467877|NCT00927095|447670980|FG000|Overall Study|Physician Decision|1|||
124467878|NCT00927095|447670981|FG001|Overall Study|Physician Decision|2|||
124467879|NCT00927095|447670982|FG002|Overall Study|Physician Decision|1|||
124467880|NCT02387580|447670987|FG000|Overall Study|Withdrawal by Subject|0|||
124467881|NCT02387580|447670988|FG001|Overall Study|Withdrawal by Subject|0|||
124467882|NCT02387580|447670989|FG002|Overall Study|Withdrawal by Subject|0|||
124467883|NCT02387580|447670990|FG003|Overall Study|Withdrawal by Subject|1|||
124467884|NCT02387580|447670991|FG004|Overall Study|Withdrawal by Subject|0|||
124467885|NCT02387580|447670992|FG005|Overall Study|Withdrawal by Subject|0|||
124467886|NCT00725075|447670993|FG000|Overall Study|Use of Excluded Medication|0|||
124467887|NCT00725075|447670994|FG001|Overall Study|Use of Excluded Medication|1|||
124467888|NCT00725075|447670995|FG002|Overall Study|Use of Excluded Medication|0|||
124467889|NCT00725075|447670993|FG000|Overall Study|Protocol Violation|0|||
124551797|NCT01336608|447978518|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
124551798|NCT01336608|447978519|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
124551799|NCT01336608|447978516|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
124551800|NCT01336608|447978517|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
124551801|NCT01336608|447978518|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
124551802|NCT01336608|447978519|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
124551803|NCT01336608|447978516|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
124551804|NCT01336608|447978517|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
124551805|NCT01336608|447978518|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
124551806|NCT01336608|447978519|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
124551807|NCT01336608|447978516|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
124551808|NCT01336608|447978517|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
124551809|NCT01336608|447978518|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
124551810|NCT01336608|447978519|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
124551811|NCT01336608|447978516|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
124551812|NCT01336608|447978517|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
124551813|NCT01336608|447978518|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
124551814|NCT01336608|447978519|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
124551815|NCT01336608|447978516|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
124551816|NCT01336608|447978517|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
124551817|NCT01336608|447978518|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
124467890|NCT00725075|447670994|FG001|Overall Study|Protocol Violation|0|||
124467891|NCT00725075|447670995|FG002|Overall Study|Protocol Violation|1|||
124467892|NCT00725075|447670993|FG000|Overall Study|Lost to Follow-up|1|||
124467893|NCT00725075|447670994|FG001|Overall Study|Lost to Follow-up|0|||
124467894|NCT00725075|447670995|FG002|Overall Study|Lost to Follow-up|0|||
124467895|NCT00725075|447670993|FG000|Overall Study|Withdrawal by Subject|4|||
124467896|NCT00725075|447670994|FG001|Overall Study|Withdrawal by Subject|5|||
124467897|NCT00725075|447670995|FG002|Overall Study|Withdrawal by Subject|4|||
124467898|NCT00725075|447670993|FG000|Overall Study|Adverse Event|2|||
124467899|NCT00725075|447670994|FG001|Overall Study|Adverse Event|1|||
124467900|NCT00725075|447670995|FG002|Overall Study|Adverse Event|1|||
124467901|NCT00725075|447670993|FG000|Overall Study|Worsening of Disease|2|||
124467902|NCT00725075|447670994|FG001|Overall Study|Worsening of Disease|1|||
124467903|NCT00725075|447670995|FG002|Overall Study|Worsening of Disease|2|||
124467904|NCT00725075|447670993|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
124467905|NCT00725075|447670994|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
124467906|NCT00725075|447670995|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
124467907|NCT00725075|447670993|FG000|Overall Study|Other|1|||
124467908|NCT00725075|447670994|FG001|Overall Study|Other|0|||
124467909|NCT00725075|447670995|FG002|Overall Study|Other|0|||
124467910|NCT02979431|447670996|FG000|Overall Study|Parent/guardian withdrew consent|2|||
124467911|NCT02979431|447670997|FG001|Overall Study|Parent/guardian withdrew consent|1|||
124467912|NCT02979431|447670998|FG002|Overall Study|Parent/guardian withdrew consent|1|||
124467913|NCT02979431|447670999|FG003|Overall Study|Parent/guardian withdrew consent|1|||
124467914|NCT02979431|447670996|FG000|Overall Study|Randomized but received no study drug|1|||
124467915|NCT02979431|447670997|FG001|Overall Study|Randomized but received no study drug|1|||
124467916|NCT02979431|447670998|FG002|Overall Study|Randomized but received no study drug|0|||
124467917|NCT02979431|447670999|FG003|Overall Study|Randomized but received no study drug|0|||
124467918|NCT02979431|447670996|FG000|Overall Study|Adverse Event|0|||
124467919|NCT02979431|447670997|FG001|Overall Study|Adverse Event|0|||
124467920|NCT02979431|447670998|FG002|Overall Study|Adverse Event|1|||
124467921|NCT02979431|447670999|FG003|Overall Study|Adverse Event|0|||
124467922|NCT02979431|447670996|FG000|Overall Study|Subject left country after Day14|1|||
124467923|NCT02979431|447670997|FG001|Overall Study|Subject left country after Day14|0|||
124467924|NCT02979431|447670998|FG002|Overall Study|Subject left country after Day14|0|||
124467925|NCT02979431|447670999|FG003|Overall Study|Subject left country after Day14|0|||
124467926|NCT01656434|447671000|FG000|Overall Study|Adverse Event|199|||
124467927|NCT01656434|447671001|FG001|Overall Study|Adverse Event|63|||
124467928|NCT01656434|447671000|FG000|Overall Study|Enrollment terminated at trial site|2|||
124467929|NCT01656434|447671001|FG001|Overall Study|Enrollment terminated at trial site|0|||
124467930|NCT01656434|447671000|FG000|Overall Study|Lost to Follow-up|309|||
124467931|NCT01656434|447671001|FG001|Overall Study|Lost to Follow-up|76|||
124467932|NCT01656434|447671000|FG000|Overall Study|Site discontinued study participation|24|||
124467933|NCT01656434|447671001|FG001|Overall Study|Site discontinued study participation|9|||
124467934|NCT01656434|447671000|FG000|Overall Study|Screen failure|2|||
124467935|NCT01656434|447671001|FG001|Overall Study|Screen failure|0|||
124467936|NCT01656434|447671000|FG000|Overall Study|Protocol Violation|7|||
124467937|NCT01656434|447671001|FG001|Overall Study|Protocol Violation|0|||
124467938|NCT01656434|447671000|FG000|Overall Study|Pregnancy wish|18|||
124467939|NCT01656434|447671001|FG001|Overall Study|Pregnancy wish|6|||
124467940|NCT01656434|447671000|FG000|Overall Study|Pregnancy|45|||
124467941|NCT01656434|447671001|FG001|Overall Study|Pregnancy|10|||
124467942|NCT01656434|447671000|FG000|Overall Study|Physician Decision|7|||
124467943|NCT01656434|447671001|FG001|Overall Study|Physician Decision|2|||
124467944|NCT01656434|447671000|FG000|Overall Study|Non-compliance with study drug|48|||
124467945|NCT01656434|447671001|FG001|Overall Study|Non-compliance with study drug|9|||
124467946|NCT01656434|447671000|FG000|Overall Study|Study terminated by sponsor|1501|||
124467947|NCT01656434|447671001|FG001|Overall Study|Study terminated by sponsor|348|||
124467948|NCT01656434|447671000|FG000|Overall Study|Participant discontinued; drug related|13|||
124467949|NCT01656434|447671001|FG001|Overall Study|Participant discontinued; drug related|4|||
124467950|NCT01656434|447671000|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
124467951|NCT01656434|447671001|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
124467952|NCT01656434|447671000|FG000|Overall Study|Non-compliance with protocol|39|||
124467953|NCT01656434|447671001|FG001|Overall Study|Non-compliance with protocol|15|||
124467954|NCT01656434|447671000|FG000|Overall Study|Participant moved|40|||
124467955|NCT01656434|447671001|FG001|Overall Study|Participant moved|12|||
124467956|NCT01656434|447671000|FG000|Overall Study|Participant withdrew consent|28|||
124467957|NCT01656434|447671001|FG001|Overall Study|Participant withdrew consent|9|||
124467958|NCT01656434|447671000|FG000|Overall Study|Withdrawal by Subject|64|||
124467959|NCT01656434|447671001|FG001|Overall Study|Withdrawal by Subject|7|||
124467960|NCT02799069|447671004|FG000|Overall Study|Adverse Event|0|||
124467961|NCT02799069|447671005|FG001|Overall Study|Adverse Event|2|||
124467962|NCT02799069|447671006|FG002|Overall Study|Adverse Event|2|||
124467963|NCT02799069|447671004|FG000|Overall Study|Lack of Efficacy|2|||
124972529|NCT04013971|449525681|FG001|Overall Study|Missing biomechanical data|1|||
124972530|NCT00344032|449525686|FG000|Overall Study|Adverse Event|0|||
124972531|NCT00344032|449525687|FG001|Overall Study|Adverse Event|1|||
124972532|NCT00344032|449525686|FG000|Overall Study|Withdrawal by Subject|6|||
124972533|NCT00344032|449525687|FG001|Overall Study|Withdrawal by Subject|2|||
124972534|NCT00344032|449525686|FG000|Overall Study|Lost to Follow-up|4|||
124972535|NCT00344032|449525687|FG001|Overall Study|Lost to Follow-up|6|||
124467964|NCT02799069|447671005|FG001|Overall Study|Lack of Efficacy|0|||
124467965|NCT02799069|447671006|FG002|Overall Study|Lack of Efficacy|0|||
124467966|NCT02799069|447671004|FG000|Overall Study|Lost to Follow-up|1|||
124467967|NCT02799069|447671005|FG001|Overall Study|Lost to Follow-up|1|||
124467968|NCT02799069|447671006|FG002|Overall Study|Lost to Follow-up|0|||
124467969|NCT02799069|447671004|FG000|Overall Study|Withdrawal by Subject|4|||
124467970|NCT02799069|447671005|FG001|Overall Study|Withdrawal by Subject|4|||
124467971|NCT02799069|447671006|FG002|Overall Study|Withdrawal by Subject|3|||
124467972|NCT02799069|447671004|FG000|Overall Study|Protocol Violation|1|||
124467973|NCT02799069|447671005|FG001|Overall Study|Protocol Violation|0|||
124467974|NCT02799069|447671006|FG002|Overall Study|Protocol Violation|2|||
124467975|NCT01614093|447671007|FG000|Overall Study|Withdrawal by Subject|1|||
124467976|NCT00848354|447671008|FG000|Phase 1|Adverse Event|5|||
124467977|NCT00848354|447671009|FG001|Phase 1|Adverse Event|4|||
124467978|NCT00848354|447671008|FG000|Phase 1|Discontinuation of study by sponsor|2|||
124467979|NCT00848354|447671009|FG001|Phase 1|Discontinuation of study by sponsor|1|||
124467980|NCT00848354|447671008|FG000|Phase 1|Failed to return|0|||
124467981|NCT00848354|447671009|FG001|Phase 1|Failed to return|1|||
124467982|NCT00848354|447671008|FG000|Phase 1|Lost to Follow-up|1|||
124467983|NCT00848354|447671009|FG001|Phase 1|Lost to Follow-up|1|||
124467984|NCT00848354|447671008|FG000|Phase 1|Unspecified Reason|1|||
124467985|NCT00848354|447671009|FG001|Phase 1|Unspecified Reason|1|||
124467986|NCT00848354|447671008|FG000|Phase 1|Protocol Violation|1|||
124467987|NCT00848354|447671009|FG001|Phase 1|Protocol Violation|1|||
124467988|NCT00848354|447671008|FG000|Phase 1|Withdrawal by Subject|2|||
124467989|NCT00848354|447671009|FG001|Phase 1|Withdrawal by Subject|4|||
124467990|NCT00848354|447671008|FG000|Phase 1|Lack of Efficacy|0|||
124467991|NCT00848354|447671009|FG001|Phase 1|Lack of Efficacy|1|||
124467992|NCT00848354|447671008|FG000|Phase 2 Year 1|Adverse Event|7|||
124467993|NCT00848354|447671009|FG001|Phase 2 Year 1|Adverse Event|2|||
124467994|NCT00848354|447671008|FG000|Phase 2 Year 1|Death|1|||
124467995|NCT00848354|447671009|FG001|Phase 2 Year 1|Death|0|||
124467996|NCT00848354|447671008|FG000|Phase 2 Year 1|Failed to Return|1|||
124467997|NCT00848354|447671009|FG001|Phase 2 Year 1|Failed to Return|1|||
124467998|NCT00848354|447671008|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
124467999|NCT00848354|447671009|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
124468000|NCT00848354|447671008|FG000|Phase 2 Year 1|Unspecified Reason|3|||
124468001|NCT00848354|447671009|FG001|Phase 2 Year 1|Unspecified Reason|0|||
124468002|NCT00848354|447671008|FG000|Phase 2 Year 1|Protocol Violation|4|||
124468003|NCT00848354|447671009|FG001|Phase 2 Year 1|Protocol Violation|1|||
124468004|NCT00848354|447671008|FG000|Phase 2 Year 1|Subject Request|1|||
124468005|NCT00848354|447671009|FG001|Phase 2 Year 1|Subject Request|2|||
124468006|NCT00848354|447671008|FG000|Phase 2 Year 2|Adverse Event|12|||
124468007|NCT00848354|447671009|FG001|Phase 2 Year 2|Adverse Event|2|||
124468008|NCT00848354|447671008|FG000|Phase 2 Year 2|Death|2|||
124468009|NCT00848354|447671009|FG001|Phase 2 Year 2|Death|0|||
124468010|NCT00848354|447671008|FG000|Phase 2 Year 2|Failed to return|3|||
124468011|NCT00848354|447671009|FG001|Phase 2 Year 2|Failed to return|0|||
124468012|NCT00848354|447671008|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
124468013|NCT00848354|447671009|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
124468014|NCT00848354|447671008|FG000|Phase 2 Year 2|Unspecified Reason|1|||
124468015|NCT00848354|447671009|FG001|Phase 2 Year 2|Unspecified Reason|0|||
124468016|NCT00848354|447671008|FG000|Phase 2 Year 2|Protocol Violation|1|||
124468017|NCT00848354|447671009|FG001|Phase 2 Year 2|Protocol Violation|1|||
124468018|NCT00848354|447671008|FG000|Phase 2 Year 2|Subject Request|1|||
124468019|NCT00848354|447671009|FG001|Phase 2 Year 2|Subject Request|1|||
124468020|NCT00848354|447671008|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
124468021|NCT00848354|447671009|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
124468022|NCT01972074|447671012|FG000|Overall Study|Adverse Event|4|||
124468023|NCT01972074|447671013|FG001|Overall Study|Adverse Event|1|||
124468024|NCT01972074|447671014|FG002|Overall Study|Adverse Event|0|||
124468025|NCT01972074|447671012|FG000|Overall Study|Lack of Efficacy|1|||
124468026|NCT01972074|447671013|FG001|Overall Study|Lack of Efficacy|1|||
124468027|NCT01972074|447671014|FG002|Overall Study|Lack of Efficacy|0|||
124468028|NCT01972074|447671012|FG000|Overall Study|Lost to Follow-up|0|||
124972536|NCT00344032|449525686|FG000|Overall Study|Physician Decision|4|||
124468029|NCT01972074|447671013|FG001|Overall Study|Lost to Follow-up|1|||
124468030|NCT01972074|447671014|FG002|Overall Study|Lost to Follow-up|1|||
124468031|NCT01972074|447671012|FG000|Overall Study|Withdrawal by Subject|1|||
124468032|NCT01972074|447671013|FG001|Overall Study|Withdrawal by Subject|1|||
124468033|NCT01972074|447671014|FG002|Overall Study|Withdrawal by Subject|1|||
124468034|NCT01972074|447671012|FG000|Overall Study|Scanner Unavailable|0|||
124468035|NCT01972074|447671013|FG001|Overall Study|Scanner Unavailable|0|||
124468036|NCT01972074|447671014|FG002|Overall Study|Scanner Unavailable|1|||
124468037|NCT04770779|447671017|FG000|Overall Study|Randomized, never treated|0|||
124468038|NCT04770779|447671018|FG001|Overall Study|Randomized, never treated|1|||
124468039|NCT04770779|447671017|FG000|Overall Study|Adverse Event|9|||
124468040|NCT04770779|447671018|FG001|Overall Study|Adverse Event|1|||
124468041|NCT04770779|447671017|FG000|Overall Study|Withdrawal by Subject|7|||
124468042|NCT04770779|447671018|FG001|Overall Study|Withdrawal by Subject|1|||
124468043|NCT04770779|447671017|FG000|Overall Study|Pregnancy|0|||
124468044|NCT04770779|447671018|FG001|Overall Study|Pregnancy|1|||
124713161|NCT00716274|448574552|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
124713162|NCT00716274|448574553|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
124713163|NCT00716274|448574554|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
124713164|NCT00716274|448574555|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
124713165|NCT00716274|448574556|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
124713166|NCT00716274|448574551|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
124713167|NCT00716274|448574552|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
124972537|NCT00344032|449525687|FG001|Overall Study|Physician Decision|1|||
124972538|NCT05101993|449525694|FG000|Overall Study|Withdrawal by Subject|1|||
124972539|NCT02065882|449525695|FG000|Part I: PK/PD|Screening failure|5|||
124972540|NCT02065882|449525695|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
124972541|NCT02065882|449525695|FG000|Part I: PK/PD|Adverse Event|1|||
124972542|NCT02065882|449525695|FG000|Part II: Clinical Efficacy|Screening failure|7|||
124972543|NCT02065882|449525695|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
124972544|NCT02065882|449525695|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
124972545|NCT02065882|449525695|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
124972546|NCT02065882|449525695|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
124972547|NCT02065882|449525695|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
124972548|NCT02600897|449525696|FG000|Overall Study|Death|1|||
124972549|NCT02600897|449525697|FG001|Overall Study|Death|2|||
124972550|NCT02600897|449525698|FG002|Overall Study|Death|1|||
124972551|NCT02600897|449525699|FG003|Overall Study|Death|2|||
124972552|NCT02600897|449525700|FG004|Overall Study|Death|3|||
124972553|NCT02600897|449525701|FG005|Overall Study|Death|2|||
124972554|NCT02600897|449525702|FG006|Overall Study|Death|10|||
124972555|NCT02600897|449525703|FG007|Overall Study|Death|7|||
124972556|NCT02600897|449525704|FG008|Overall Study|Death|20|||
124972557|NCT02600897|449525696|FG000|Overall Study|Lost to Follow-up|1|||
124972558|NCT02600897|449525697|FG001|Overall Study|Lost to Follow-up|0|||
124972559|NCT02600897|449525698|FG002|Overall Study|Lost to Follow-up|0|||
124972560|NCT02600897|449525699|FG003|Overall Study|Lost to Follow-up|0|||
124972561|NCT02600897|449525700|FG004|Overall Study|Lost to Follow-up|0|||
124972562|NCT02600897|449525701|FG005|Overall Study|Lost to Follow-up|0|||
124972563|NCT02600897|449525702|FG006|Overall Study|Lost to Follow-up|0|||
124972564|NCT02600897|449525703|FG007|Overall Study|Lost to Follow-up|1|||
124972565|NCT02600897|449525704|FG008|Overall Study|Lost to Follow-up|0|||
124972566|NCT02600897|449525696|FG000|Overall Study|Withdrawal by Subject|0|||
124972567|NCT02600897|449525697|FG001|Overall Study|Withdrawal by Subject|0|||
124972568|NCT02600897|449525698|FG002|Overall Study|Withdrawal by Subject|0|||
124972569|NCT02600897|449525699|FG003|Overall Study|Withdrawal by Subject|0|||
124972570|NCT02600897|449525700|FG004|Overall Study|Withdrawal by Subject|0|||
124972571|NCT02600897|449525701|FG005|Overall Study|Withdrawal by Subject|0|||
124972572|NCT02600897|449525702|FG006|Overall Study|Withdrawal by Subject|0|||
124972573|NCT02600897|449525703|FG007|Overall Study|Withdrawal by Subject|4|||
124972574|NCT02600897|449525704|FG008|Overall Study|Withdrawal by Subject|2|||
124972575|NCT02600897|449525696|FG000|Overall Study|Reason Not Specified|0|||
124972576|NCT02600897|449525697|FG001|Overall Study|Reason Not Specified|0|||
124972577|NCT02600897|449525698|FG002|Overall Study|Reason Not Specified|0|||
124972578|NCT02600897|449525699|FG003|Overall Study|Reason Not Specified|0|||
124972579|NCT02600897|449525700|FG004|Overall Study|Reason Not Specified|0|||
124972580|NCT02600897|449525701|FG005|Overall Study|Reason Not Specified|0|||
124972581|NCT02600897|449525702|FG006|Overall Study|Reason Not Specified|0|||
124972582|NCT02600897|449525703|FG007|Overall Study|Reason Not Specified|0|||
124972583|NCT02600897|449525704|FG008|Overall Study|Reason Not Specified|1|||
124972584|NCT06840769|449525705|FG000|Overall Study|Withdrawal by Subject|1|||
124468045|NCT04820309|447671019|FG000|Overall Study|Adverse Event|96|||
124468046|NCT04820309|447671019|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
124468047|NCT04820309|447671019|FG000|Overall Study|Consent Withdrawn|93|||
124468048|NCT04820309|447671019|FG000|Overall Study|failure to adhere to protocol|32|||
124972585|NCT06840769|449525706|FG001|Overall Study|Withdrawal by Subject|0|||
124551818|NCT01336608|447978519|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
124551819|NCT01336608|447978516|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
124551820|NCT01336608|447978517|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
124551821|NCT01336608|447978518|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
124551822|NCT01336608|447978519|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
124551823|NCT01336608|447978516|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
124551824|NCT01336608|447978517|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
124551825|NCT01336608|447978518|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
124551826|NCT01336608|447978519|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
124551827|NCT01336608|447978516|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
124551828|NCT01336608|447978517|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
124551829|NCT01336608|447978518|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
124551830|NCT01336608|447978519|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
124551831|NCT00080288|447978520|FG000|Overall Study|Adverse Event|7|||
124551832|NCT00080288|447978521|FG001|Overall Study|Adverse Event|4|||
124551833|NCT00080288|447978520|FG000|Overall Study|Lost to Follow-up|3|||
124551834|NCT00080288|447978521|FG001|Overall Study|Lost to Follow-up|5|||
124551835|NCT00080288|447978520|FG000|Overall Study|Physician Decision|6|||
124713168|NCT00716274|448574553|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
124713169|NCT00716274|448574554|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
124713170|NCT00716274|448574555|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
124713171|NCT00716274|448574556|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
124551836|NCT00080288|447978521|FG001|Overall Study|Physician Decision|2|||
124551837|NCT00080288|447978520|FG000|Overall Study|Withdrawal by Subject|3|||
124551838|NCT00080288|447978521|FG001|Overall Study|Withdrawal by Subject|16|||
124551839|NCT00080288|447978520|FG000|Overall Study|Miscellaneous|11|||
124551840|NCT00080288|447978521|FG001|Overall Study|Miscellaneous|11|||
124551841|NCT02328547|447978522|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
124551842|NCT02328547|447978523|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
124713172|NCT00716274|448574551|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
124551843|NCT02328547|447978522|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
124551844|NCT02328547|447978523|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
124551845|NCT00344305|447978524|FG000|Overall Study|Lost to Follow-up|2|||
124551846|NCT00344305|447978525|FG001|Overall Study|Lost to Follow-up|0|||
124551847|NCT00344305|447978524|FG000|Overall Study|Participant was not contacted in window|0|||
124551848|NCT00344305|447978525|FG001|Overall Study|Participant was not contacted in window|1|||
124551849|NCT01726335|447978532|FG000|Overall Study|Lost to Follow-up|2|||
124551850|NCT01726335|447978532|FG000|Overall Study|Withdrawal by Subject|15|||
124551851|NCT01726335|447978532|FG000|Overall Study|Adverse Event|4|||
124551852|NCT01726335|447978532|FG000|Overall Study|Lost to Follow-up|2|||
124551853|NCT01726335|447978532|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
124551854|NCT01796860|447978538|FG000|Overall Study|Withdrawal by Subject|3|||
124551855|NCT02703454|447978546|FG000|Overall Study|Not treated|1|||
124551856|NCT02703454|447978547|FG001|Overall Study|Not treated|3|||
124551857|NCT02703454|447978546|FG000|Overall Study|Withdrawal by Subject|4|||
124551858|NCT02703454|447978547|FG001|Overall Study|Withdrawal by Subject|3|||
124551859|NCT02703454|447978546|FG000|Overall Study|Lost to Follow-up|1|||
124551860|NCT02703454|447978547|FG001|Overall Study|Lost to Follow-up|2|||
124551861|NCT02703454|447978546|FG000|Overall Study|Study discontinuation|5|||
124551862|NCT02703454|447978547|FG001|Overall Study|Study discontinuation|8|||
124551863|NCT00791154|447978548|FG000|Overall Study|Noncompliance|0|||
124551864|NCT00791154|447978549|FG001|Overall Study|Noncompliance|1|||
124551865|NCT00791154|447978550|FG002|Overall Study|Noncompliance|0|||
124551866|NCT00791154|447978551|FG003|Overall Study|Noncompliance|0|||
124551867|NCT00791154|447978552|FG004|Overall Study|Noncompliance|1|||
124551868|NCT00791154|447978553|FG005|Overall Study|Noncompliance|1|||
124551869|NCT00791154|447978554|FG006|Overall Study|Noncompliance|1|||
124551870|NCT00791154|447978548|FG000|Overall Study|Adverse Event|0|||
124551871|NCT00791154|447978549|FG001|Overall Study|Adverse Event|0|||
124551872|NCT00791154|447978550|FG002|Overall Study|Adverse Event|0|||
124551873|NCT00791154|447978551|FG003|Overall Study|Adverse Event|0|||
124551874|NCT00791154|447978552|FG004|Overall Study|Adverse Event|2|||
124713173|NCT00716274|448574552|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
124713174|NCT00716274|448574553|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
124713175|NCT00716274|448574554|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
124468049|NCT04820309|447671019|FG000|Overall Study|alcohol or drug use|6|||
124468050|NCT04820309|447671019|FG000|Overall Study|Lost to Follow-up|46|||
124468051|NCT04820309|447671019|FG000|Overall Study|Death|2|||
124468052|NCT04820309|447671019|FG000|Overall Study|Pregnancy|1|||
124468053|NCT04820309|447671019|FG000|Overall Study|Other reasons|12|||
124468054|NCT03692052|447671020|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
124468055|NCT03692052|447671020|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
124468056|NCT03692052|447671020|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
124468057|NCT03692052|447671020|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
124468058|NCT05600309|447671023|FG000|Overall Study|Death|41|||
124468059|NCT05600309|447671024|FG001|Overall Study|Death|38|||
124468060|NCT05600309|447671023|FG000|Overall Study|Sponsor Decision|9|||
124468061|NCT05600309|447671024|FG001|Overall Study|Sponsor Decision|6|||
124468062|NCT03864653|447671029|FG000|Overall Study|Withdrawal by Subject|1|||
124468063|NCT00546052|447671030|FG000|Overall Study|Adverse Event|47|||
124468064|NCT00546052|447671030|FG000|Overall Study|Lost to Follow-up|144|||
124468065|NCT00546052|447671030|FG000|Overall Study|Protocol Violation|9|||
124468066|NCT00546052|447671030|FG000|Overall Study|Withdrawal by Subject|20|||
124468067|NCT00546052|447671030|FG000|Overall Study|Non Compliance|7|||
124468068|NCT02482129|447671031|FG000|Overall Study|Adverse Event-prior to treatment|0|||
124468069|NCT02482129|447671032|FG001|Overall Study|Adverse Event-prior to treatment|1|||
124468070|NCT02482129|447671031|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
124468071|NCT02482129|447671032|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
124468072|NCT02482129|447671031|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
124468073|NCT02482129|447671032|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
124468074|NCT02482129|447671031|FG000|Overall Study|Criteria not met-prior to treatment|1|||
124468075|NCT02482129|447671032|FG001|Overall Study|Criteria not met-prior to treatment|0|||
124468076|NCT02482129|447671031|FG000|Overall Study|Adverse Event|1|||
124468077|NCT02482129|447671032|FG001|Overall Study|Adverse Event|0|||
124551875|NCT00791154|447978553|FG005|Overall Study|Adverse Event|0|||
124551876|NCT00791154|447978554|FG006|Overall Study|Adverse Event|1|||
124551877|NCT00791154|447978548|FG000|Overall Study|Full Consent withdrawn|1|||
124551878|NCT00791154|447978549|FG001|Overall Study|Full Consent withdrawn|3|||
124551879|NCT00791154|447978550|FG002|Overall Study|Full Consent withdrawn|0|||
124551880|NCT00791154|447978551|FG003|Overall Study|Full Consent withdrawn|0|||
124551881|NCT00791154|447978552|FG004|Overall Study|Full Consent withdrawn|1|||
124713176|NCT00716274|448574555|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
124713177|NCT00716274|448574556|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
124551882|NCT00791154|447978553|FG005|Overall Study|Full Consent withdrawn|3|||
124551883|NCT00791154|447978554|FG006|Overall Study|Full Consent withdrawn|1|||
124468078|NCT02482129|447671031|FG000|Overall Study|Withdrawal by Subject|2|||
124713178|NCT00716274|448574551|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
124713179|NCT00716274|448574552|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
124713180|NCT00716274|448574553|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
124713181|NCT00716274|448574554|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
124713182|NCT00716274|448574555|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
124713183|NCT00716274|448574556|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
124713184|NCT00716274|448574551|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
124713185|NCT00716274|448574552|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
124713186|NCT00716274|448574553|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
124713187|NCT00716274|448574554|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
124713188|NCT00716274|448574555|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
124713189|NCT00716274|448574556|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
124468079|NCT02482129|447671032|FG001|Overall Study|Withdrawal by Subject|0|||
124468080|NCT02482129|447671031|FG000|Overall Study|Criteria not met|1|||
124468081|NCT02482129|447671032|FG001|Overall Study|Criteria not met|0|||
124468082|NCT01928381|447671033|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
124468083|NCT01928381|447671034|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
124468084|NCT01928381|447671035|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
124468085|NCT01928381|447671036|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
124468086|NCT01928381|447671037|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
124468087|NCT01928381|447671038|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
124468088|NCT01928381|447671039|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
124468089|NCT01928381|447671033|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
124468090|NCT01928381|447671034|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
124468091|NCT01928381|447671035|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
124468092|NCT01928381|447671036|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
124468093|NCT01928381|447671037|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
124468094|NCT01928381|447671038|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
124468095|NCT01928381|447671039|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
124468096|NCT01928381|447671033|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
124468097|NCT01928381|447671034|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
124713190|NCT00716274|448574551|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
124713191|NCT00716274|448574552|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
124713192|NCT00716274|448574553|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
124713193|NCT00716274|448574554|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
124468098|NCT01928381|447671035|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
124468099|NCT01928381|447671036|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
124713194|NCT00716274|448574555|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
124551884|NCT00791154|447978548|FG000|Overall Study|Lost to Follow-up|0|||
124551885|NCT00791154|447978549|FG001|Overall Study|Lost to Follow-up|0|||
124551886|NCT00791154|447978550|FG002|Overall Study|Lost to Follow-up|0|||
124551887|NCT00791154|447978551|FG003|Overall Study|Lost to Follow-up|1|||
124972586|NCT06840769|449525707|FG002|Overall Study|Withdrawal by Subject|0|||
124972587|NCT06840769|449525708|FG003|Overall Study|Withdrawal by Subject|0|||
124972588|NCT06840769|449525709|FG004|Overall Study|Withdrawal by Subject|0|||
124972589|NCT03258723|449527270|FG000|Overall Study|COVID Interruption of study|54|||
124972590|NCT03258723|449527270|FG000|Overall Study|Lost to Follow-up|8|||
124972591|NCT00592293|449527272|FG000|Overall Study|Withdrawal by Subject|1|||
124972592|NCT00944229|449527273|FG000|Overall Study|Withdrawal by Subject|11|||
124972593|NCT00944229|449527273|FG000|Overall Study|Physician Decision|14|||
124972594|NCT04292470|449527274|FG000|Overall Study|Withdrawal by Subject|0|||
124972595|NCT04292470|449527275|FG001|Overall Study|Withdrawal by Subject|1|||
124972596|NCT02906020|449527276|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
124972597|NCT02906020|449527277|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
124972598|NCT02906020|449527278|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
124972599|NCT02906020|449527279|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
124972600|NCT02906020|449527280|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
124972601|NCT02906020|449527281|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
124972602|NCT02906020|449527282|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
124972603|NCT02906020|449527283|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
124972604|NCT02906020|449527284|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
124972605|NCT02906020|449527285|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
124972606|NCT02906020|449527286|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
124972607|NCT02906020|449527287|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
124972608|NCT02906020|449527288|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
124972609|NCT02906020|449527289|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
124972610|NCT02906020|449527290|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
124972611|NCT02906020|449527291|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
124972612|NCT02906020|449527276|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124713195|NCT00716274|448574556|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
124713196|NCT00716274|448574551|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
124713197|NCT00716274|448574552|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
124713198|NCT00716274|448574553|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
124713199|NCT00716274|448574554|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
124972613|NCT02906020|449527277|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972614|NCT02906020|449527278|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972615|NCT02906020|449527279|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972616|NCT02906020|449527280|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972617|NCT02906020|449527281|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972618|NCT02906020|449527282|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972619|NCT02906020|449527283|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972620|NCT02906020|449527284|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
124468100|NCT01928381|447671037|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
124468101|NCT01928381|447671038|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
124468102|NCT01928381|447671039|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
124468103|NCT01928381|447671033|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
124468104|NCT01928381|447671034|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
124468105|NCT01928381|447671035|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
124468106|NCT01928381|447671036|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
124468107|NCT01928381|447671037|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
124468108|NCT01928381|447671038|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
124468109|NCT01928381|447671039|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
124468110|NCT01928381|447671033|FG000|Part 1 - Pain Training|Protocol Violation|1|||
124468111|NCT01928381|447671034|FG001|Part 1 - Pain Training|Protocol Violation|0|||
124468112|NCT01928381|447671035|FG002|Part 1 - Pain Training|Protocol Violation|0|||
124468113|NCT01928381|447671036|FG003|Part 1 - Pain Training|Protocol Violation|0|||
124468114|NCT01928381|447671037|FG004|Part 1 - Pain Training|Protocol Violation|0|||
124468115|NCT01928381|447671038|FG005|Part 1 - Pain Training|Protocol Violation|0|||
124713200|NCT00716274|448574555|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
124972621|NCT02906020|449527285|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
124468116|NCT01928381|447671039|FG006|Part 1 - Pain Training|Protocol Violation|0|||
124551888|NCT00791154|447978552|FG004|Overall Study|Lost to Follow-up|2|||
124972622|NCT02906020|449527286|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972623|NCT02906020|449527287|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124468117|NCT01928381|447671033|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
124468118|NCT01928381|447671034|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
124468119|NCT01928381|447671035|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
124551889|NCT00791154|447978553|FG005|Overall Study|Lost to Follow-up|0|||
124713201|NCT00716274|448574556|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
124468120|NCT01928381|447671036|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
124468121|NCT01928381|447671037|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
124468122|NCT01928381|447671038|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
124468123|NCT01928381|447671039|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
124468124|NCT01928381|447671033|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
124468125|NCT01928381|447671034|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
124468126|NCT01928381|447671035|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
124468127|NCT01928381|447671036|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
124468128|NCT01928381|447671037|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
124468129|NCT01928381|447671038|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
124468130|NCT01928381|447671039|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
124468131|NCT01928381|447671033|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
124468132|NCT01928381|447671034|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
124468133|NCT01928381|447671035|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
124468134|NCT01928381|447671036|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
124468135|NCT01928381|447671037|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
124713202|NCT00716274|448574551|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
124713203|NCT00716274|448574552|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
124713204|NCT00716274|448574553|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
124468136|NCT01928381|447671038|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
124468137|NCT01928381|447671039|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
124468138|NCT01928381|447671033|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
124468139|NCT01928381|447671034|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
124468140|NCT01928381|447671035|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
124468141|NCT01928381|447671036|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
124468142|NCT01928381|447671037|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
124468143|NCT01928381|447671038|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
124468144|NCT01928381|447671039|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
124972624|NCT02906020|449527288|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972625|NCT02906020|449527289|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124468145|NCT01928381|447671033|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
124468146|NCT01928381|447671034|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
124468147|NCT01928381|447671035|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
124468148|NCT01928381|447671036|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
124468149|NCT01928381|447671037|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
124468150|NCT01928381|447671038|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
124468151|NCT01928381|447671039|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
124468152|NCT01928381|447671033|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
124468153|NCT01928381|447671034|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
124972626|NCT02906020|449527290|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972627|NCT02906020|449527291|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
124972628|NCT02906020|449527276|FG000|Part 2: Double-blind Treatment Period|Other|0|||
124972629|NCT02906020|449527277|FG001|Part 2: Double-blind Treatment Period|Other|0|||
124972630|NCT02906020|449527278|FG002|Part 2: Double-blind Treatment Period|Other|0|||
124972631|NCT02906020|449527279|FG003|Part 2: Double-blind Treatment Period|Other|0|||
124972632|NCT02906020|449527280|FG004|Part 2: Double-blind Treatment Period|Other|0|||
124972633|NCT02906020|449527281|FG005|Part 2: Double-blind Treatment Period|Other|0|||
124972634|NCT02906020|449527282|FG006|Part 2: Double-blind Treatment Period|Other|0|||
124972635|NCT02906020|449527283|FG007|Part 2: Double-blind Treatment Period|Other|0|||
124972636|NCT02906020|449527284|FG008|Part 2: Double-blind Treatment Period|Other|6|||
124972637|NCT02906020|449527285|FG009|Part 2: Double-blind Treatment Period|Other|10|||
124972638|NCT02906020|449527286|FG010|Part 2: Double-blind Treatment Period|Other|0|||
124972639|NCT02906020|449527287|FG011|Part 2: Double-blind Treatment Period|Other|0|||
124972640|NCT02906020|449527288|FG012|Part 2: Double-blind Treatment Period|Other|0|||
124972641|NCT02906020|449527289|FG013|Part 2: Double-blind Treatment Period|Other|0|||
124972642|NCT02906020|449527290|FG014|Part 2: Double-blind Treatment Period|Other|0|||
124972643|NCT02906020|449527291|FG015|Part 2: Double-blind Treatment Period|Other|0|||
124972644|NCT02906020|449527276|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972645|NCT02906020|449527277|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972646|NCT02906020|449527278|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972647|NCT02906020|449527279|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972648|NCT02906020|449527280|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124468154|NCT01928381|447671035|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
124468155|NCT01928381|447671036|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
124468156|NCT01928381|447671037|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
124972649|NCT02906020|449527281|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124713205|NCT00716274|448574554|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
124713206|NCT00716274|448574555|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
124713207|NCT00716274|448574556|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
124713208|NCT00716274|448574551|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
124713209|NCT00716274|448574552|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
124713210|NCT00716274|448574553|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
124713211|NCT00716274|448574554|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
124713212|NCT00716274|448574555|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
124713213|NCT00716274|448574556|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
124713214|NCT04067492|448574559|FG000|Overall Study|Lost to Follow-up|0|||
124713215|NCT04067492|448574560|FG001|Overall Study|Lost to Follow-up|0|||
124972650|NCT02906020|449527282|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972651|NCT02906020|449527283|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972652|NCT02906020|449527284|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972653|NCT02906020|449527285|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972654|NCT02906020|449527286|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972655|NCT02906020|449527287|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972656|NCT02906020|449527288|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
124972657|NCT02906020|449527289|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
124972658|NCT02906020|449527290|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972659|NCT02906020|449527291|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
124972660|NCT02906020|449527276|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972661|NCT02906020|449527277|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972662|NCT02906020|449527278|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972663|NCT02906020|449527279|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972664|NCT02906020|449527280|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972665|NCT02906020|449527281|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972666|NCT02906020|449527282|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972667|NCT02906020|449527283|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972668|NCT02906020|449527284|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972669|NCT02906020|449527285|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972670|NCT02906020|449527286|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972671|NCT02906020|449527287|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972672|NCT02906020|449527288|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
124972673|NCT02906020|449527289|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
124972674|NCT02906020|449527290|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
124972675|NCT02906020|449527291|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
124972676|NCT02906020|449527276|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972677|NCT02906020|449527277|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972678|NCT02906020|449527278|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972679|NCT02906020|449527279|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972680|NCT02906020|449527280|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972681|NCT02906020|449527281|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972682|NCT02906020|449527282|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972683|NCT02906020|449527283|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972684|NCT02906020|449527284|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972685|NCT02906020|449527285|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972686|NCT02906020|449527286|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124468157|NCT01928381|447671038|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
124468158|NCT01928381|447671039|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
124468159|NCT01928381|447671033|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
124468160|NCT01928381|447671034|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
124713216|NCT04067492|448574561|FG002|Overall Study|Lost to Follow-up|0|||
124770376|NCT03566511|448788814|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
124770377|NCT03566511|448788815|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
124770378|NCT00981656|448788824|FG000|Overall Study|Protocol Violation|1|||
124770379|NCT00981656|448788824|FG000|Overall Study|Did not start protocol treatment|2|||
124972687|NCT02906020|449527287|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972688|NCT02906020|449527288|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
124972689|NCT02906020|449527289|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
124972690|NCT02906020|449527290|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972691|NCT02906020|449527291|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
124972692|NCT02906020|449527276|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972693|NCT02906020|449527277|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972694|NCT02906020|449527278|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972695|NCT02906020|449527279|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972696|NCT02906020|449527280|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972697|NCT02906020|449527281|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972698|NCT02906020|449527282|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972699|NCT02906020|449527283|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972700|NCT02906020|449527284|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972701|NCT02906020|449527285|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972702|NCT02906020|449527286|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972703|NCT02906020|449527287|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972704|NCT02906020|449527288|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
124972705|NCT02906020|449527289|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
124972706|NCT02906020|449527290|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972707|NCT02906020|449527291|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
124972708|NCT02906020|449527276|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972709|NCT02906020|449527277|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972710|NCT02906020|449527278|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972711|NCT02906020|449527279|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972712|NCT02906020|449527280|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972713|NCT02906020|449527281|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972714|NCT02906020|449527282|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972715|NCT02906020|449527283|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972716|NCT02906020|449527284|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972717|NCT02906020|449527285|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972718|NCT02906020|449527286|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972719|NCT02906020|449527287|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
124972720|NCT02906020|449527288|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
124972721|NCT02906020|449527289|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
124972722|NCT02906020|449527290|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
124972723|NCT02906020|449527291|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
124551890|NCT00791154|447978554|FG006|Overall Study|Lost to Follow-up|4|||
124551891|NCT00791154|447978548|FG000|Overall Study|Death|5|||
124551892|NCT00791154|447978549|FG001|Overall Study|Death|4|||
124551893|NCT00791154|447978550|FG002|Overall Study|Death|4|||
124551894|NCT00791154|447978551|FG003|Overall Study|Death|7|||
124551895|NCT00791154|447978552|FG004|Overall Study|Death|54|||
124551896|NCT00791154|447978553|FG005|Overall Study|Death|54|||
124551897|NCT00791154|447978554|FG006|Overall Study|Death|52|||
124551898|NCT00791154|447978548|FG000|Overall Study|Other event|0|||
124551899|NCT00791154|447978549|FG001|Overall Study|Other event|0|||
124551900|NCT00791154|447978550|FG002|Overall Study|Other event|2|||
124551901|NCT00791154|447978551|FG003|Overall Study|Other event|0|||
124551902|NCT00791154|447978552|FG004|Overall Study|Other event|2|||
124551903|NCT00791154|447978553|FG005|Overall Study|Other event|4|||
124551904|NCT00791154|447978554|FG006|Overall Study|Other event|2|||
124551905|NCT01396161|447978556|FG000|Overall Study|Withdrawal by Subject|0|||
124551906|NCT01396161|447978557|FG001|Overall Study|Withdrawal by Subject|0|||
124551907|NCT01396161|447978558|FG002|Overall Study|Withdrawal by Subject|0|||
124551908|NCT01396161|447978559|FG003|Overall Study|Withdrawal by Subject|0|||
124551909|NCT01396161|447978560|FG004|Overall Study|Withdrawal by Subject|1|||
124551910|NCT01396161|447978561|FG005|Overall Study|Withdrawal by Subject|0|||
124551911|NCT01396161|447978562|FG006|Overall Study|Withdrawal by Subject|0|||
124551912|NCT01396161|447978556|FG000|Overall Study|Other|0|||
124551913|NCT01396161|447978557|FG001|Overall Study|Other|0|||
124551914|NCT01396161|447978558|FG002|Overall Study|Other|0|||
124551915|NCT01396161|447978559|FG003|Overall Study|Other|0|||
124551916|NCT01396161|447978560|FG004|Overall Study|Other|0|||
124551917|NCT01396161|447978561|FG005|Overall Study|Other|0|||
124551918|NCT01396161|447978562|FG006|Overall Study|Other|1|||
124551919|NCT00552617|447978563|FG000|Overall Study|Not Treated|0|||
124551920|NCT00552617|447978564|FG001|Overall Study|Not Treated|0|||
124468161|NCT01928381|447671035|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
124468162|NCT01928381|447671036|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
124468163|NCT01928381|447671037|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
124468164|NCT01928381|447671038|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
124468165|NCT01928381|447671039|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
124468166|NCT01928381|447671033|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
124468167|NCT01928381|447671034|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
124468168|NCT01928381|447671035|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
124468169|NCT01928381|447671036|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
124468170|NCT01928381|447671037|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
124468171|NCT01928381|447671038|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
124468172|NCT01928381|447671039|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
124468173|NCT01928381|447671033|FG000|Washout First Intervention|Protocol Violation|0|||
124468174|NCT01928381|447671034|FG001|Washout First Intervention|Protocol Violation|0|||
124468175|NCT01928381|447671035|FG002|Washout First Intervention|Protocol Violation|0|||
124551921|NCT00552617|447978565|FG002|Overall Study|Not Treated|1|||
124551922|NCT00552617|447978566|FG003|Overall Study|Not Treated|0|||
124551923|NCT00552617|447978567|FG004|Overall Study|Not Treated|0|||
124551924|NCT00552617|447978568|FG005|Overall Study|Not Treated|0|||
124551925|NCT00552617|447978569|FG006|Overall Study|Not Treated|0|||
124551926|NCT00552617|447978570|FG007|Overall Study|Not Treated|0|||
124551927|NCT00552617|447978571|FG008|Overall Study|Not Treated|0|||
124551928|NCT00552617|447978572|FG009|Overall Study|Not Treated|1|||
124551929|NCT00552617|447978563|FG000|Overall Study|Lost to Follow-up|0|||
124713217|NCT04067492|448574562|FG003|Overall Study|Lost to Follow-up|0|||
124713218|NCT04067492|448574563|FG004|Overall Study|Lost to Follow-up|0|||
124770380|NCT00687596|448788825|FG000|Overall Study|Adverse Event (AE)|10|||
124551930|NCT00552617|447978564|FG001|Overall Study|Lost to Follow-up|0|||
124551931|NCT00552617|447978565|FG002|Overall Study|Lost to Follow-up|0|||
124551932|NCT00552617|447978566|FG003|Overall Study|Lost to Follow-up|1|||
124551933|NCT00552617|447978567|FG004|Overall Study|Lost to Follow-up|0|||
124713219|NCT04067492|448574564|FG005|Overall Study|Lost to Follow-up|1|||
124468176|NCT01928381|447671036|FG003|Washout First Intervention|Protocol Violation|0|||
124468177|NCT01928381|447671037|FG004|Washout First Intervention|Protocol Violation|1|||
124713220|NCT04067492|448574559|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
124713221|NCT04067492|448574560|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
124468178|NCT01928381|447671038|FG005|Washout First Intervention|Protocol Violation|0|||
124468179|NCT01928381|447671039|FG006|Washout First Intervention|Protocol Violation|0|||
124468180|NCT01928381|447671033|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
124468181|NCT01928381|447671034|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
124468182|NCT01928381|447671035|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
124468183|NCT01928381|447671036|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
124713222|NCT04067492|448574561|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
124713223|NCT04067492|448574562|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
124713224|NCT04067492|448574563|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
124713225|NCT04067492|448574564|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
124972724|NCT02906020|449527276|FG000|Part 2: Long-term Follow-up Period|Other|0|||
124972725|NCT02906020|449527277|FG001|Part 2: Long-term Follow-up Period|Other|0|||
124972726|NCT02906020|449527278|FG002|Part 2: Long-term Follow-up Period|Other|0|||
124972727|NCT02906020|449527279|FG003|Part 2: Long-term Follow-up Period|Other|0|||
124972728|NCT02906020|449527280|FG004|Part 2: Long-term Follow-up Period|Other|0|||
124972729|NCT02906020|449527281|FG005|Part 2: Long-term Follow-up Period|Other|0|||
124972730|NCT02906020|449527282|FG006|Part 2: Long-term Follow-up Period|Other|0|||
124972731|NCT02906020|449527283|FG007|Part 2: Long-term Follow-up Period|Other|0|||
124972732|NCT02906020|449527284|FG008|Part 2: Long-term Follow-up Period|Other|0|||
124972733|NCT02906020|449527285|FG009|Part 2: Long-term Follow-up Period|Other|0|||
124972734|NCT02906020|449527286|FG010|Part 2: Long-term Follow-up Period|Other|0|||
124972735|NCT02906020|449527287|FG011|Part 2: Long-term Follow-up Period|Other|0|||
124972736|NCT02906020|449527288|FG012|Part 2: Long-term Follow-up Period|Other|13|||
124972737|NCT02906020|449527289|FG013|Part 2: Long-term Follow-up Period|Other|8|||
124972738|NCT02906020|449527290|FG014|Part 2: Long-term Follow-up Period|Other|3|||
124972739|NCT02906020|449527291|FG015|Part 2: Long-term Follow-up Period|Other|2|||
124972740|NCT04340947|449527294|FG000|7-day Washout Period|Lost to Follow-up|5|||
124972741|NCT04340947|449527295|FG001|7-day Washout Period|Lost to Follow-up|4|||
124972742|NCT00884650|449527297|FG000|Overall Study|Did not return complete pain diaries|7|||
124972743|NCT00884650|449527298|FG001|Overall Study|Did not return complete pain diaries|7|||
124972744|NCT00884650|449527297|FG000|Overall Study|Admitted Post-Op|1|||
124972745|NCT00884650|449527298|FG001|Overall Study|Admitted Post-Op|0|||
124972746|NCT00884650|449527297|FG000|Overall Study|Femoral Stress Fracture|1|||
124972747|NCT00884650|449527298|FG001|Overall Study|Femoral Stress Fracture|0|||
124972748|NCT00884650|449527297|FG000|Overall Study|Pain Pump Complication|0|||
124972749|NCT00884650|449527298|FG001|Overall Study|Pain Pump Complication|1|||
124972750|NCT01594827|449527303|FG000|Overall Study|Adverse Event|1|||
124972751|NCT01594827|449527304|FG001|Overall Study|Adverse Event|0|||
124972752|NCT01594827|449527303|FG000|Overall Study|Physician Decision|3|||
124972753|NCT01594827|449527304|FG001|Overall Study|Physician Decision|0|||
124972754|NCT02030002|449527306|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
124972755|NCT02030002|449527306|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
124972756|NCT02030002|449527306|FG000|Follow-up|Lost to Follow-up|2|||
124972757|NCT01592045|449527307|FG000|Overall Study|Disease Progression|1|||
124972758|NCT01592045|449527308|FG001|Overall Study|Disease Progression|1|||
124972759|NCT01592045|449527307|FG000|Overall Study|Adverse Event|1|||
124972760|NCT01592045|449527308|FG001|Overall Study|Adverse Event|1|||
124972761|NCT01592045|449527307|FG000|Overall Study|Withdrawal by Subject|1|||
124972762|NCT01592045|449527308|FG001|Overall Study|Withdrawal by Subject|0|||
124972763|NCT01592045|449527307|FG000|Overall Study|Moved out of country|2|||
124972764|NCT01592045|449527308|FG001|Overall Study|Moved out of country|0|||
124972765|NCT03994731|449527309|FG000|Pegloticase + IMM Period|Death|2|||
124972766|NCT03994731|449527310|FG001|Pegloticase + IMM Period|Death|0|||
124972767|NCT03994731|449527309|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
124972768|NCT03994731|449527310|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
124972769|NCT03994731|449527309|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
124972770|NCT03994731|449527310|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
124972771|NCT00609947|449527311|FG000|Overall Study|Death|1|||
124972772|NCT03812029|449527317|FG000|Overall Study|Protocol Violation|1|||
124972773|NCT03812029|449527318|FG001|Overall Study|Protocol Violation|0|||
124972774|NCT03812029|449527319|FG002|Overall Study|Protocol Violation|0|||
124468184|NCT01928381|447671037|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
124972775|NCT03812029|449527320|FG003|Overall Study|Protocol Violation|1|||
124972776|NCT03812029|449527321|FG004|Overall Study|Protocol Violation|0|||
124972777|NCT03812029|449527317|FG000|Overall Study|Withdrawal by Subject|1|||
124972778|NCT03812029|449527318|FG001|Overall Study|Withdrawal by Subject|0|||
124972779|NCT03812029|449527319|FG002|Overall Study|Withdrawal by Subject|0|||
124972780|NCT03812029|449527320|FG003|Overall Study|Withdrawal by Subject|2|||
124468185|NCT01928381|447671038|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
124468186|NCT01928381|447671039|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
124468187|NCT01928381|447671033|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
124468188|NCT01928381|447671034|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
124468189|NCT01928381|447671035|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
124468190|NCT01928381|447671036|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
124468191|NCT01928381|447671037|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
124468192|NCT01928381|447671038|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
124468193|NCT01928381|447671039|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
124468194|NCT05036083|447671040|FG000|Overall Study|Physician Decision|1|||
124468195|NCT05036083|447671040|FG000|Overall Study|Withdrawal by Subject|1|||
124468196|NCT05036083|447671040|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
124468197|NCT05036083|447671040|FG000|Overall Study|IV not sustainable|1|||
124468198|NCT04441905|447673000|FG000|Overall Study|Lost to Follow-up|1|||
124468199|NCT04441905|447673001|FG001|Overall Study|Lost to Follow-up|0|||
124468200|NCT04441905|447673002|FG002|Overall Study|Lost to Follow-up|0|||
124468201|NCT04441905|447673003|FG003|Overall Study|Lost to Follow-up|0|||
124468202|NCT04441905|447673004|FG004|Overall Study|Lost to Follow-up|0|||
124468203|NCT04441905|447673005|FG005|Overall Study|Lost to Follow-up|0|||
124468204|NCT04441905|447673000|FG000|Overall Study|Enrolled but treatment not administered|0|||
124468205|NCT04441905|447673001|FG001|Overall Study|Enrolled but treatment not administered|1|||
124468206|NCT04441905|447673002|FG002|Overall Study|Enrolled but treatment not administered|0|||
124468207|NCT04441905|447673003|FG003|Overall Study|Enrolled but treatment not administered|0|||
124468208|NCT04441905|447673004|FG004|Overall Study|Enrolled but treatment not administered|0|||
124468209|NCT04441905|447673005|FG005|Overall Study|Enrolled but treatment not administered|0|||
124468210|NCT04441905|447673000|FG000|Overall Study|Became ineligible after enrollment|0|||
124468211|NCT04441905|447673001|FG001|Overall Study|Became ineligible after enrollment|0|||
124468212|NCT04441905|447673002|FG002|Overall Study|Became ineligible after enrollment|0|||
124468213|NCT04441905|447673003|FG003|Overall Study|Became ineligible after enrollment|0|||
124468214|NCT04441905|447673004|FG004|Overall Study|Became ineligible after enrollment|1|||
124468215|NCT04441905|447673005|FG005|Overall Study|Became ineligible after enrollment|0|||
124468216|NCT02392429|447673006|FG000|Screening|Screen failure|15|||
124468217|NCT02392429|447673006|FG000|Enrolled Participants|Ineligible due to disease|3|||
124468218|NCT02392429|447673006|FG000|Enrolled Participants|Withdrawal by Subject|4|||
124468219|NCT02392429|447673006|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
124468220|NCT02392429|447673006|FG000|Evaluable|Death|5|||
124468221|NCT02392429|447673006|FG000|Evaluable|Withdrawal by Subject|1|||
124468222|NCT02392429|447673006|FG000|Evaluable|Adverse Event|1|||
124468223|NCT02392429|447673006|FG000|Evaluable|remission bone marrow biopsy|3|||
124468224|NCT03266016|447673010|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
124468225|NCT03266016|447673011|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
124468226|NCT03266016|447673012|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
124468227|NCT03266016|447673013|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
124468228|NCT03266016|447673010|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
124468229|NCT03266016|447673011|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
124468230|NCT03266016|447673012|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
124551934|NCT00552617|447978568|FG005|Overall Study|Lost to Follow-up|2|||
124468231|NCT03266016|447673013|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
124468232|NCT03656562|447673014|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
124468233|NCT03656562|447673015|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
124468234|NCT03656562|447673016|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
124468235|NCT03656562|447673017|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
124468236|NCT03656562|447673014|FG000|Overall Study|Physician Decision|1|||
124468237|NCT03656562|447673015|FG001|Overall Study|Physician Decision|2|||
124468238|NCT03656562|447673016|FG002|Overall Study|Physician Decision|0|||
124468239|NCT03656562|447673017|FG003|Overall Study|Physician Decision|0|||
124468240|NCT03656562|447673014|FG000|Overall Study|Subject Decision|3|||
124468241|NCT03656562|447673015|FG001|Overall Study|Subject Decision|5|||
124468242|NCT03656562|447673016|FG002|Overall Study|Subject Decision|0|||
124468243|NCT03656562|447673017|FG003|Overall Study|Subject Decision|2|||
124468244|NCT03686397|447673018|FG000|Overall Study|Lack of Efficacy|3|||
124468245|NCT03686397|447673019|FG001|Overall Study|Lack of Efficacy|5|||
124468246|NCT03686397|447673018|FG000|Overall Study|Adverse Event|0|||
124468247|NCT03686397|447673019|FG001|Overall Study|Adverse Event|1|||
124468248|NCT03686397|447673018|FG000|Overall Study|Protocol Violation|0|||
124468249|NCT03686397|447673019|FG001|Overall Study|Protocol Violation|1|||
124468250|NCT03686397|447673018|FG000|Overall Study|Withdrawal by Subject|0|||
124468251|NCT03686397|447673019|FG001|Overall Study|Withdrawal by Subject|1|||
124468252|NCT03686397|447673018|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
124468253|NCT03686397|447673019|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
124468254|NCT01241708|447673023|FG000|Overall Study|Withdrawal by Subject|6|||
124468255|NCT01241708|447673023|FG000|Overall Study|Screen Failure|6|||
124551935|NCT00552617|447978569|FG006|Overall Study|Lost to Follow-up|0|||
124713226|NCT04067492|448574559|FG000|Overall Study|COVID-19 epidemiological situation|0|||
124713227|NCT04067492|448574560|FG001|Overall Study|COVID-19 epidemiological situation|0|||
124713228|NCT04067492|448574561|FG002|Overall Study|COVID-19 epidemiological situation|0|||
124551936|NCT00552617|447978570|FG007|Overall Study|Lost to Follow-up|0|||
124713229|NCT04067492|448574562|FG003|Overall Study|COVID-19 epidemiological situation|1|||
124468256|NCT01241708|447673023|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
124468257|NCT01241708|447673023|FG000|Overall Study|Lost to Follow-up|5|||
124468258|NCT02968810|447673026|FG000|Overall Study|Lost to Follow-up|1|||
124468259|NCT02968810|447673027|FG001|Overall Study|Lost to Follow-up|0|||
124468260|NCT02968810|447673026|FG000|Overall Study|Physician Decision|1|||
124468261|NCT02968810|447673027|FG001|Overall Study|Physician Decision|0|||
124468262|NCT02968810|447673026|FG000|Overall Study|Withdrawal by Subject|1|||
124770381|NCT00687596|448788826|FG001|Overall Study|Adverse Event (AE)|3|||
124468263|NCT02968810|447673027|FG001|Overall Study|Withdrawal by Subject|3|||
124468264|NCT02968810|447673026|FG000|Overall Study|Disease Progression|0|||
124468265|NCT02968810|447673027|FG001|Overall Study|Disease Progression|1|||
124468266|NCT04137887|447673028|FG000|Overall Study|Death|102|||
124468267|NCT04137887|447673029|FG001|Overall Study|Death|92|||
124468268|NCT04137887|447673028|FG000|Overall Study|Withdrawal by Subject|2|||
124468269|NCT04137887|447673029|FG001|Overall Study|Withdrawal by Subject|3|||
124713230|NCT04067492|448574563|FG004|Overall Study|COVID-19 epidemiological situation|0|||
124713231|NCT04067492|448574564|FG005|Overall Study|COVID-19 epidemiological situation|0|||
124713232|NCT00786422|448574565|FG000|Rivaroxaban Treatment|Death|2|||
124713233|NCT00786422|448574565|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
124713234|NCT00786422|448574565|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
124713235|NCT00786422|448574565|FG000|Rivaroxaban Treatment|Physician Decision|1|||
124713236|NCT00786422|448574565|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
124770382|NCT00687596|448788825|FG000|Overall Study|Radiological Disease Progression|6|||
124770383|NCT00687596|448788826|FG001|Overall Study|Radiological Disease Progression|2|||
124770384|NCT00687596|448788825|FG000|Overall Study|Clinical Disease Progression|1|||
124770385|NCT00687596|448788826|FG001|Overall Study|Clinical Disease Progression|3|||
124770386|NCT00687596|448788825|FG000|Overall Study|Investigator Discretion|3|||
124770387|NCT00687596|448788826|FG001|Overall Study|Investigator Discretion|1|||
124770388|NCT00687596|448788825|FG000|Overall Study|Sponsor Terminated Study|6|||
124770389|NCT00687596|448788826|FG001|Overall Study|Sponsor Terminated Study|17|||
124770390|NCT03331315|448788831|FG000|Overall Study|Physician Decision|18|||
124770391|NCT03331315|448788832|FG001|Overall Study|Physician Decision|14|||
124770392|NCT02461758|448788836|FG000|Overall Study|Lost to Follow-up|0|||
124713237|NCT00786422|448574565|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
124713238|NCT00786422|448574565|FG000|Rivaroxaban Treatment|Adverse Event|2|||
124713239|NCT00786422|448574565|FG000|Follow-up Period|Death|1|||
124713240|NCT00786422|448574565|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
124713241|NCT00543985|448574568|FG000|Overall Study|Withdrawal by Subject|4|||
124713242|NCT02015039|448574569|FG000|Overall Study|Not eligible|0|||
124713243|NCT02015039|448574570|FG001|Overall Study|Not eligible|1|||
124713244|NCT04570384|448574571|FG000|Overall Study|Adverse Event|2|||
124713245|NCT04570384|448574572|FG001|Overall Study|Adverse Event|1|||
124713246|NCT04570384|448574571|FG000|Overall Study|Death|2|||
124713247|NCT04570384|448574572|FG001|Overall Study|Death|5|||
124713248|NCT04570384|448574571|FG000|Overall Study|Lost to Follow-up|1|||
124713249|NCT04570384|448574572|FG001|Overall Study|Lost to Follow-up|0|||
124713250|NCT04570384|448574571|FG000|Overall Study|Other|1|||
124770393|NCT02461758|448788837|FG001|Overall Study|Lost to Follow-up|1|||
124713251|NCT04570384|448574572|FG001|Overall Study|Other|0|||
124713252|NCT04570384|448574571|FG000|Overall Study|Protocol Violation|0|||
124713253|NCT04570384|448574572|FG001|Overall Study|Protocol Violation|1|||
124713254|NCT04570384|448574571|FG000|Overall Study|Sponsor Decision|1|||
124713255|NCT04570384|448574572|FG001|Overall Study|Sponsor Decision|0|||
124468270|NCT04137887|447673028|FG000|Overall Study|Randomized but not treated|0|||
124468271|NCT04137887|447673029|FG001|Overall Study|Randomized but not treated|1|||
124468272|NCT04183335|447673033|FG000|Overall Study|Adverse Event|1|||
124468273|NCT04183335|447673034|FG001|Overall Study|Adverse Event|0|||
124468274|NCT04183335|447673033|FG000|Overall Study|Withdrawal by Subject|12|||
124468275|NCT04183335|447673034|FG001|Overall Study|Withdrawal by Subject|3|||
124468276|NCT02605642|447673035|FG000|Overall Study|Other|11|||
124468277|NCT02605642|447673036|FG001|Overall Study|Other|1|||
124468278|NCT02605642|447673035|FG000|Overall Study|Participant non-compliance|2|||
124468279|NCT02605642|447673036|FG001|Overall Study|Participant non-compliance|4|||
124468280|NCT02605642|447673035|FG000|Overall Study|Physician Decision|10|||
124468281|NCT02605642|447673036|FG001|Overall Study|Physician Decision|0|||
124468282|NCT02605642|447673035|FG000|Overall Study|Lost to Follow-up|12|||
124770394|NCT02461758|448788838|FG002|Overall Study|Lost to Follow-up|1|||
124770395|NCT02461758|448788839|FG003|Overall Study|Lost to Follow-up|0|||
124770396|NCT03773978|448788851|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
124770397|NCT03773978|448788852|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
124468283|NCT02605642|447673036|FG001|Overall Study|Lost to Follow-up|1|||
124468284|NCT02605642|447673035|FG000|Overall Study|Adverse Event|14|||
124468285|NCT02605642|447673036|FG001|Overall Study|Adverse Event|2|||
124551937|NCT00552617|447978571|FG008|Overall Study|Lost to Follow-up|2|||
124551938|NCT00552617|447978572|FG009|Overall Study|Lost to Follow-up|0|||
124551939|NCT01508325|447978578|FG000|Overall Study|Withdrawal by Subject|8|||
124770398|NCT03773978|448788851|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
124468286|NCT02605642|447673035|FG000|Overall Study|Withdrawal by Subject|23|||
124468287|NCT02605642|447673036|FG001|Overall Study|Withdrawal by Subject|2|||
124468288|NCT02605642|447673035|FG000|Overall Study|Lack of response|24|||
124468289|NCT02605642|447673036|FG001|Overall Study|Lack of response|11|||
124468290|NCT01934140|447673037|FG000|Persistence Phase (Year 6-10)|Other|24|||
124551940|NCT01508325|447978579|FG001|Overall Study|Withdrawal by Subject|9|||
124551941|NCT01508325|447978578|FG000|Overall Study|Protocol Violation|0|||
124551942|NCT01508325|447978579|FG001|Overall Study|Protocol Violation|3|||
124551943|NCT01508325|447978578|FG000|Overall Study|Physician Decision|2|||
124551944|NCT01508325|447978579|FG001|Overall Study|Physician Decision|1|||
124551945|NCT01508325|447978578|FG000|Overall Study|Adverse Event|1|||
124551946|NCT01508325|447978579|FG001|Overall Study|Adverse Event|0|||
124551947|NCT01508325|447978578|FG000|Overall Study|Lost to Follow-up|5|||
124551948|NCT01508325|447978579|FG001|Overall Study|Lost to Follow-up|6|||
124551949|NCT01508325|447978578|FG000|Overall Study|Other|2|||
124551950|NCT01508325|447978579|FG001|Overall Study|Other|2|||
124551951|NCT03543046|447978580|FG000|Overall Study|Adverse Event|1|||
124551952|NCT03543046|447978581|FG001|Overall Study|Adverse Event|1|||
124551953|NCT03543046|447978580|FG000|Overall Study|Physician Decision|1|||
124551954|NCT03543046|447978581|FG001|Overall Study|Physician Decision|1|||
124551955|NCT03543046|447978580|FG000|Overall Study|Protocol Violation|1|||
124551956|NCT03543046|447978581|FG001|Overall Study|Protocol Violation|0|||
124551957|NCT01227954|447978582|FG000|Overall Study|Protocol Violation|6|||
124551958|NCT01227954|447978582|FG000|Overall Study|No protocol treatment|7|||
124551959|NCT01296152|447978583|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
124551960|NCT01682512|447978588|FG000|Overall Study|Adverse Event|6|||
124551961|NCT01682512|447978589|FG001|Overall Study|Adverse Event|5|||
124551962|NCT01682512|447978590|FG002|Overall Study|Adverse Event|2|||
124551963|NCT01682512|447978588|FG000|Overall Study|Withdrawal by Subject|2|||
124551964|NCT01682512|447978589|FG001|Overall Study|Withdrawal by Subject|6|||
124551965|NCT01682512|447978590|FG002|Overall Study|Withdrawal by Subject|3|||
124551966|NCT01682512|447978588|FG000|Overall Study|Physician Decision|0|||
124551967|NCT01682512|447978589|FG001|Overall Study|Physician Decision|2|||
124551968|NCT01682512|447978590|FG002|Overall Study|Physician Decision|0|||
124713256|NCT04570384|448574571|FG000|Overall Study|Withdrawal by Subject|4|||
124713257|NCT04570384|448574572|FG001|Overall Study|Withdrawal by Subject|2|||
124713258|NCT01673126|448574573|FG000|Overall Study|change of diagnosis|4|||
124468291|NCT01934140|447673038|FG001|Persistence Phase (Year 6-10)|Other|6|||
124468292|NCT01934140|447673037|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
124468293|NCT01934140|447673038|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
124468294|NCT01934140|447673037|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
124468295|NCT01934140|447673038|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
124468296|NCT01934140|447673037|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
124468297|NCT01934140|447673038|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
124468298|NCT01934140|447673037|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
124468299|NCT01934140|447673038|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
124468300|NCT01934140|447673037|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
124468301|NCT01934140|447673038|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
124468302|NCT01934140|447673037|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
124468303|NCT01934140|447673038|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
124468304|NCT01934140|447673037|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
124551969|NCT01682512|447978588|FG000|Overall Study|Study terminated by sponsor|46|||
124551970|NCT01682512|447978589|FG001|Overall Study|Study terminated by sponsor|43|||
124551971|NCT01682512|447978590|FG002|Overall Study|Study terminated by sponsor|0|||
124551972|NCT01682512|447978588|FG000|Overall Study|Lost to Follow-up|3|||
124551973|NCT01682512|447978589|FG001|Overall Study|Lost to Follow-up|0|||
124468305|NCT01934140|447673038|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
124468306|NCT00805740|447673039|FG000|Overall Study|Death|7|||
124468307|NCT00805740|447673040|FG001|Overall Study|Death|4|||
124468308|NCT00805740|447673039|FG000|Overall Study|Withdrawal by Subject|1|||
124468309|NCT00805740|447673040|FG001|Overall Study|Withdrawal by Subject|0|||
124468310|NCT00805740|447673039|FG000|Overall Study|Lost to Follow-up|1|||
124468311|NCT00805740|447673040|FG001|Overall Study|Lost to Follow-up|0|||
124551974|NCT01682512|447978590|FG002|Overall Study|Lost to Follow-up|2|||
124551975|NCT01682512|447978588|FG000|Overall Study|Protocol Violation|2|||
124468312|NCT00805740|447673039|FG000|Overall Study|Randomized, but not treated|2|||
124551976|NCT01682512|447978589|FG001|Overall Study|Protocol Violation|3|||
124551977|NCT01682512|447978590|FG002|Overall Study|Protocol Violation|2|||
124551978|NCT01682512|447978588|FG000|Overall Study|Primary lack of efficacy|10|||
124713259|NCT01673126|448574574|FG001|Overall Study|change of diagnosis|3|||
124551979|NCT01682512|447978589|FG001|Overall Study|Primary lack of efficacy|7|||
124713260|NCT00237042|448574575|FG000|Treatment|Became ineligible post-randomization|0|||
124713261|NCT00237042|448574576|FG001|Treatment|Became ineligible post-randomization|1|||
124713262|NCT00237042|448574577|FG002|Treatment|Became ineligible post-randomization|16|||
124713263|NCT00237042|448574575|FG000|Treatment|Moved out of state|1|||
124713264|NCT00237042|448574576|FG001|Treatment|Moved out of state|1|||
124713265|NCT00237042|448574577|FG002|Treatment|Moved out of state|1|||
124713266|NCT00237042|448574575|FG000|Treatment|Completed no treatment|5|||
124713267|NCT00237042|448574576|FG001|Treatment|Completed no treatment|5|||
124713268|NCT00237042|448574577|FG002|Treatment|Completed no treatment|21|||
124713269|NCT00237042|448574575|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
124713270|NCT00237042|448574576|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
124713271|NCT00237042|448574577|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
124713272|NCT00237042|448574575|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
124713273|NCT00237042|448574576|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
124713274|NCT00237042|448574577|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
124713275|NCT01897532|448574584|FG000|Discontinuation From Treatment|Not Treated|7|||
124713276|NCT01897532|448574585|FG001|Discontinuation From Treatment|Not Treated|5|||
124713277|NCT01897532|448574584|FG000|Discontinuation From Treatment|Other reason than specified|196|||
124713278|NCT01897532|448574585|FG001|Discontinuation From Treatment|Other reason than specified|176|||
124713279|NCT01897532|448574584|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
124713280|NCT01897532|448574585|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
124713281|NCT01897532|448574584|FG000|Discontinuation From Treatment|Non compliance|24|||
124713282|NCT01897532|448574585|FG001|Discontinuation From Treatment|Non compliance|15|||
124713283|NCT01897532|448574584|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
124713284|NCT01897532|448574585|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
124713285|NCT01897532|448574584|FG000|Discontinuation From Trial|Not Treated|7|||
124713286|NCT01897532|448574585|FG001|Discontinuation From Trial|Not Treated|5|||
124713287|NCT01897532|448574584|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
124713288|NCT01897532|448574585|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
124713289|NCT03132467|448574586|FG000|Overall Study|Adverse Event|2|||
124713290|NCT03132467|448574586|FG000|Overall Study|Withdrawal by Subject|2|||
124713291|NCT00038948|448574587|FG000|Overall Study|Adverse Event|131|||
124713292|NCT00038948|448574588|FG001|Overall Study|Adverse Event|43|||
124713293|NCT00038948|448574587|FG000|Overall Study|Lost to Follow-up|4|||
124713294|NCT00038948|448574588|FG001|Overall Study|Lost to Follow-up|4|||
124713295|NCT00038948|448574587|FG000|Overall Study|Nonmedical event|5|||
124713296|NCT00038948|448574588|FG001|Overall Study|Nonmedical event|7|||
124713297|NCT00038948|448574587|FG000|Overall Study|Withdrawal by Subject|23|||
124713298|NCT00038948|448574588|FG001|Overall Study|Withdrawal by Subject|10|||
124468313|NCT00805740|447673040|FG001|Overall Study|Randomized, but not treated|0|||
124468314|NCT00200850|447673041|FG000|Overall Study|relocation|1|||
124468315|NCT00200850|447673042|FG001|Overall Study|relocation|0|||
124468316|NCT00200850|447673043|FG002|Overall Study|relocation|1|||
124468317|NCT00200850|447673041|FG000|Overall Study|too busy|1|||
124468318|NCT00200850|447673042|FG001|Overall Study|too busy|0|||
124468319|NCT00200850|447673043|FG002|Overall Study|too busy|0|||
124468320|NCT00200850|447673041|FG000|Overall Study|Pregnancy|0|||
124468321|NCT00200850|447673042|FG001|Overall Study|Pregnancy|0|||
124468322|NCT00200850|447673043|FG002|Overall Study|Pregnancy|1|||
124468323|NCT00200850|447673041|FG000|Overall Study|Poor adherence|0|||
124468324|NCT00200850|447673042|FG001|Overall Study|Poor adherence|0|||
124468325|NCT00200850|447673043|FG002|Overall Study|Poor adherence|1|||
124468326|NCT00200850|447673041|FG000|Overall Study|optic neuritis|0|||
124468327|NCT00200850|447673042|FG001|Overall Study|optic neuritis|0|||
124551980|NCT01682512|447978590|FG002|Overall Study|Primary lack of efficacy|7|||
124713299|NCT00038948|448574587|FG000|Overall Study|Protocol Violation|3|||
124713300|NCT00038948|448574588|FG001|Overall Study|Protocol Violation|7|||
124713301|NCT00038948|448574587|FG000|Overall Study|Lack of Efficacy|3|||
124713302|NCT00038948|448574588|FG001|Overall Study|Lack of Efficacy|6|||
124713303|NCT01404234|448574591|FG000|Overall Study|Withdrawal by Subject|2|||
124713304|NCT02670473|448574592|FG000|Overall Study|Withdrawal by Subject|1|||
124713305|NCT05223673|448574593|FG000|Overall Study|Protocol Violation|1|||
124713306|NCT05223673|448574593|FG000|Overall Study|Study termination|6|||
124713307|NCT00937495|448576428|FG000|Overall Study|Protocol Violation|2|||
124713308|NCT00443703|448576429|FG000|Overall Study|Never Treated|3|||
124713309|NCT00443703|448576430|FG001|Overall Study|Never Treated|1|||
124713310|NCT00443703|448576429|FG000|Overall Study|Adverse Event|7|||
124713311|NCT00443703|448576430|FG001|Overall Study|Adverse Event|3|||
124713312|NCT00443703|448576429|FG000|Overall Study|Lack of Efficacy|3|||
124713313|NCT00443703|448576430|FG001|Overall Study|Lack of Efficacy|1|||
124468328|NCT00200850|447673043|FG002|Overall Study|optic neuritis|1|||
124468329|NCT00200850|447673041|FG000|Overall Study|Adverse Event|1|||
124468330|NCT00200850|447673042|FG001|Overall Study|Adverse Event|1|||
124468331|NCT00200850|447673043|FG002|Overall Study|Adverse Event|2|||
124468332|NCT02595879|447673044|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
124468333|NCT02595879|447673045|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
124468334|NCT05227690|447673051|FG000|Overall Study|Adverse Event|5|||
124468335|NCT05227690|447673052|FG001|Overall Study|Adverse Event|6|||
124468336|NCT05227690|447673053|FG002|Overall Study|Adverse Event|10|||
124468337|NCT05227690|447673051|FG000|Overall Study|Lack of Efficacy|2|||
124468338|NCT05227690|447673052|FG001|Overall Study|Lack of Efficacy|4|||
124468339|NCT05227690|447673053|FG002|Overall Study|Lack of Efficacy|1|||
124468340|NCT05227690|447673051|FG000|Overall Study|Physician Decision|6|||
124468341|NCT05227690|447673052|FG001|Overall Study|Physician Decision|0|||
124468342|NCT05227690|447673053|FG002|Overall Study|Physician Decision|4|||
124468343|NCT05227690|447673051|FG000|Overall Study|Withdrawal of consent|28|||
124468344|NCT05227690|447673052|FG001|Overall Study|Withdrawal of consent|27|||
124468345|NCT05227690|447673053|FG002|Overall Study|Withdrawal of consent|21|||
124468346|NCT05227690|447673051|FG000|Overall Study|Other, not specified|2|||
124468347|NCT05227690|447673052|FG001|Overall Study|Other, not specified|2|||
124468348|NCT05227690|447673053|FG002|Overall Study|Other, not specified|1|||
124468349|NCT04294459|447673054|FG000|Overall Study|Adverse Event|0|||
124468350|NCT04294459|447673055|FG001|Overall Study|Adverse Event|1|||
124468351|NCT03757988|447673056|FG000|Overall Study|Withdrawal by Subject|1|||
124468352|NCT03806127|447673057|FG000|Overall Study|Withdrawal by Subject|4|||
124468353|NCT03806127|447673058|FG001|Overall Study|Withdrawal by Subject|5|||
124468354|NCT03806127|447673057|FG000|Overall Study|Protocol Violation|3|||
124468355|NCT03806127|447673058|FG001|Overall Study|Protocol Violation|1|||
124468356|NCT03806127|447673057|FG000|Overall Study|Adverse Event|3|||
124468357|NCT03806127|447673058|FG001|Overall Study|Adverse Event|0|||
124468358|NCT03806127|447673057|FG000|Overall Study|Unable to Complete Procedures|0|||
124468359|NCT03806127|447673058|FG001|Overall Study|Unable to Complete Procedures|1|||
124468360|NCT03806127|447673057|FG000|Overall Study|Pregnancy|0|||
124468361|NCT03806127|447673058|FG001|Overall Study|Pregnancy|1|||
124468362|NCT03806127|447673057|FG000|Overall Study|Lost to Follow-up|5|||
124468363|NCT03806127|447673058|FG001|Overall Study|Lost to Follow-up|1|||
124468364|NCT03806127|447673057|FG000|Overall Study|Physician Decision|1|||
124468365|NCT03806127|447673058|FG001|Overall Study|Physician Decision|1|||
124468366|NCT03806127|447673057|FG000|Overall Study|Could Not Come Due to Covid|1|||
124468367|NCT03806127|447673058|FG001|Overall Study|Could Not Come Due to Covid|0|||
124468368|NCT03806127|447673057|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
124468369|NCT03806127|447673058|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
124551981|NCT01682512|447978588|FG000|Overall Study|Secondary lack of efficacy|1|||
124770399|NCT03773978|448788852|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
124972781|NCT03812029|449527321|FG004|Overall Study|Withdrawal by Subject|2|||
124972782|NCT03812029|449527317|FG000|Overall Study|Stopping rules|0|||
124972783|NCT03812029|449527318|FG001|Overall Study|Stopping rules|1|||
124972784|NCT03812029|449527319|FG002|Overall Study|Stopping rules|0|||
124972785|NCT03812029|449527320|FG003|Overall Study|Stopping rules|0|||
124972786|NCT03812029|449527321|FG004|Overall Study|Stopping rules|0|||
124972787|NCT03812029|449527317|FG000|Overall Study|Adverse Event|0|||
124972788|NCT03812029|449527318|FG001|Overall Study|Adverse Event|9|||
124972789|NCT03812029|449527319|FG002|Overall Study|Adverse Event|0|||
124972790|NCT03812029|449527320|FG003|Overall Study|Adverse Event|3|||
124972791|NCT03812029|449527321|FG004|Overall Study|Adverse Event|5|||
124972792|NCT03812029|449527317|FG000|Overall Study|Lost to Follow-up|0|||
124972793|NCT03812029|449527318|FG001|Overall Study|Lost to Follow-up|0|||
124972794|NCT03812029|449527319|FG002|Overall Study|Lost to Follow-up|0|||
124972795|NCT03812029|449527320|FG003|Overall Study|Lost to Follow-up|0|||
124972796|NCT03812029|449527321|FG004|Overall Study|Lost to Follow-up|3|||
124972797|NCT03149042|449527322|FG000|Overall Study|Invasive FFR not performed|21|||
124972798|NCT03149042|449527322|FG000|Overall Study|Poor CT Image Quality|1|||
124972799|NCT03149042|449527322|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
124972800|NCT00790205|449527323|FG000|Overall Study|Lost to Follow-up|61|||
124972801|NCT00790205|449527324|FG001|Overall Study|Lost to Follow-up|71|||
124972802|NCT00790205|449527323|FG000|Overall Study|Withdrawal by Subject|299|||
124972803|NCT00790205|449527324|FG001|Overall Study|Withdrawal by Subject|363|||
124972804|NCT04092452|449527340|FG000|Overall Study|Adverse Event|1|||
124972805|NCT04092452|449527341|FG001|Overall Study|Adverse Event|3|||
124972806|NCT04092452|449527342|FG002|Overall Study|Adverse Event|3|||
124468370|NCT03806127|447673057|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
124551982|NCT01682512|447978589|FG001|Overall Study|Secondary lack of efficacy|1|||
124468371|NCT03806127|447673058|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
124468372|NCT03806127|447673057|FG000|Overall Study|Covid 19 Restrictions|2|||
124468373|NCT03806127|447673058|FG001|Overall Study|Covid 19 Restrictions|0|||
124468374|NCT03806127|447673057|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
124551983|NCT01682512|447978590|FG002|Overall Study|Secondary lack of efficacy|0|||
124551984|NCT01682512|447978588|FG000|Overall Study|Other than stated above|2|||
124972807|NCT04092452|449527343|FG003|Overall Study|Adverse Event|7|||
124972808|NCT04092452|449527340|FG000|Overall Study|Lack of Efficacy|1|||
124972809|NCT04092452|449527341|FG001|Overall Study|Lack of Efficacy|1|||
124972810|NCT04092452|449527342|FG002|Overall Study|Lack of Efficacy|1|||
124972811|NCT04092452|449527343|FG003|Overall Study|Lack of Efficacy|0|||
124972812|NCT04092452|449527340|FG000|Overall Study|Lost to Follow-up|4|||
124468375|NCT03806127|447673058|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
124468376|NCT03806127|447673057|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
124468377|NCT03806127|447673058|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
124468378|NCT03823391|447673062|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
124468379|NCT03823391|447673063|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
124468380|NCT03823391|447673062|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
124468381|NCT03823391|447673063|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
124468382|NCT02450487|447673064|FG000|Overall Study|Lost to Follow-up|3|||
124468383|NCT03946670|447673067|FG000|Overall Study|Progressive Disease|26|||
124468384|NCT03946670|447673068|FG001|Overall Study|Progressive Disease|23|||
124468385|NCT03946670|447673067|FG000|Overall Study|Adverse Event|7|||
124468386|NCT03946670|447673068|FG001|Overall Study|Adverse Event|9|||
124468387|NCT03946670|447673067|FG000|Overall Study|Death|5|||
124468388|NCT03946670|447673068|FG001|Overall Study|Death|6|||
124468389|NCT03946670|447673067|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
124468390|NCT03946670|447673068|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
124468391|NCT03946670|447673067|FG000|Overall Study|Subject Decision|4|||
124468392|NCT03946670|447673068|FG001|Overall Study|Subject Decision|4|||
124468393|NCT03946670|447673067|FG000|Overall Study|Physician Decision|3|||
124468394|NCT03946670|447673068|FG001|Overall Study|Physician Decision|3|||
124468395|NCT03946670|447673067|FG000|Overall Study|New Therapy for Study Indication|1|||
124468396|NCT03946670|447673068|FG001|Overall Study|New Therapy for Study Indication|0|||
124468397|NCT03946670|447673067|FG000|Overall Study|Not treated|1|||
124468398|NCT03946670|447673068|FG001|Overall Study|Not treated|1|||
124468399|NCT03132636|447673069|FG000|Overall Study|Adverse Event|1|||
124468400|NCT03132636|447673070|FG001|Overall Study|Adverse Event|2|||
124468401|NCT03132636|447673069|FG000|Overall Study|Death|4|||
124468402|NCT03132636|447673070|FG001|Overall Study|Death|7|||
124468403|NCT03132636|447673069|FG000|Overall Study|Lost to Follow-up|3|||
124468404|NCT03132636|447673070|FG001|Overall Study|Lost to Follow-up|2|||
124468405|NCT03132636|447673069|FG000|Overall Study|Non compliance with protocol by participant|1|||
124468406|NCT03132636|447673070|FG001|Overall Study|Non compliance with protocol by participant|1|||
124468407|NCT03132636|447673069|FG000|Overall Study|Subject decision|1|||
124468408|NCT03132636|447673070|FG001|Overall Study|Subject decision|9|||
124468409|NCT03132636|447673069|FG000|Overall Study|Sponsor decision|0|||
124468410|NCT03132636|447673070|FG001|Overall Study|Sponsor decision|1|||
124468411|NCT03132636|447673069|FG000|Overall Study|Physician Decision|1|||
124468412|NCT03132636|447673070|FG001|Overall Study|Physician Decision|0|||
124468413|NCT03132636|447673069|FG000|Overall Study|Progressive disease|33|||
124468414|NCT03132636|447673070|FG001|Overall Study|Progressive disease|36|||
124468415|NCT03132636|447673069|FG000|Overall Study|Withdrawal of consent|2|||
124468416|NCT03132636|447673070|FG001|Overall Study|Withdrawal of consent|5|||
124468417|NCT03132636|447673069|FG000|Overall Study|Did not re-consent|1|||
124468418|NCT03132636|447673070|FG001|Overall Study|Did not re-consent|0|||
124468419|NCT03132636|447673069|FG000|Overall Study|Lost insurance coverage|1|||
124468420|NCT03132636|447673070|FG001|Overall Study|Lost insurance coverage|0|||
124468421|NCT03132636|447673069|FG000|Overall Study|Related to radiological outcomes|0|||
124468422|NCT03132636|447673070|FG001|Overall Study|Related to radiological outcomes|1|||
124468423|NCT03132636|447673069|FG000|Overall Study|Unable to come to site for continued visits|0|||
124468424|NCT03132636|447673070|FG001|Overall Study|Unable to come to site for continued visits|1|||
124468425|NCT04537208|447673075|FG000|Overall Study|Adverse Event|0|||
124468426|NCT04537208|447673076|FG001|Overall Study|Adverse Event|0|||
124468427|NCT04537208|447673077|FG002|Overall Study|Adverse Event|0|||
124468428|NCT04537208|447673078|FG003|Overall Study|Adverse Event|0|||
124468429|NCT04537208|447673079|FG004|Overall Study|Adverse Event|0|||
124468430|NCT04537208|447673080|FG005|Overall Study|Adverse Event|0|||
124468431|NCT04537208|447673081|FG006|Overall Study|Adverse Event|0|||
124468432|NCT04537208|447673082|FG007|Overall Study|Adverse Event|0|||
124468433|NCT04537208|447673083|FG008|Overall Study|Adverse Event|1|||
124468434|NCT04537208|447673084|FG009|Overall Study|Adverse Event|0|||
124468435|NCT04537208|447673085|FG010|Overall Study|Adverse Event|0|||
124468436|NCT04537208|447673075|FG000|Overall Study|Protocol deviation|0|||
124468437|NCT04537208|447673076|FG001|Overall Study|Protocol deviation|0|||
124468438|NCT04537208|447673077|FG002|Overall Study|Protocol deviation|2|||
124468439|NCT04537208|447673078|FG003|Overall Study|Protocol deviation|0|||
124468440|NCT04537208|447673079|FG004|Overall Study|Protocol deviation|0|||
124468441|NCT04537208|447673080|FG005|Overall Study|Protocol deviation|2|||
124468442|NCT04537208|447673081|FG006|Overall Study|Protocol deviation|4|||
124468443|NCT04537208|447673082|FG007|Overall Study|Protocol deviation|0|||
124468444|NCT04537208|447673083|FG008|Overall Study|Protocol deviation|1|||
124468445|NCT04537208|447673084|FG009|Overall Study|Protocol deviation|0|||
124468446|NCT04537208|447673085|FG010|Overall Study|Protocol deviation|2|||
124468447|NCT04537208|447673075|FG000|Overall Study|Withdrawal by Subject|4|||
124468448|NCT04537208|447673076|FG001|Overall Study|Withdrawal by Subject|2|||
124468449|NCT04537208|447673077|FG002|Overall Study|Withdrawal by Subject|1|||
124468450|NCT04537208|447673078|FG003|Overall Study|Withdrawal by Subject|3|||
124468451|NCT04537208|447673079|FG004|Overall Study|Withdrawal by Subject|5|||
124551985|NCT01682512|447978589|FG001|Overall Study|Other than stated above|4|||
124551986|NCT01682512|447978590|FG002|Overall Study|Other than stated above|2|||
124551987|NCT01414062|447978591|FG000|Overall Study|Lost to Follow-up|3|||
124551988|NCT01414062|447978592|FG001|Overall Study|Lost to Follow-up|2|||
124551989|NCT01414062|447978591|FG000|Overall Study|Left Country|1|||
124551990|NCT01414062|447978592|FG001|Overall Study|Left Country|1|||
124551991|NCT01414062|447978591|FG000|Overall Study|Family Disapproval|1|||
124551992|NCT01414062|447978592|FG001|Overall Study|Family Disapproval|0|||
124551993|NCT01414062|447978591|FG000|Overall Study|Withdrawal by Subject|0|||
124551994|NCT01414062|447978592|FG001|Overall Study|Withdrawal by Subject|1|||
124551995|NCT04057118|447978595|FG000|Overall Study|Adverse Event|1|||
124551996|NCT04057118|447978596|FG001|Overall Study|Adverse Event|0|||
124551997|NCT04057118|447978597|FG002|Overall Study|Adverse Event|1|||
124551998|NCT04057118|447978598|FG003|Overall Study|Adverse Event|1|||
124551999|NCT04057118|447978595|FG000|Overall Study|Physician Decision|0|||
124552000|NCT04057118|447978596|FG001|Overall Study|Physician Decision|0|||
124552001|NCT04057118|447978597|FG002|Overall Study|Physician Decision|1|||
124552002|NCT04057118|447978598|FG003|Overall Study|Physician Decision|1|||
124552003|NCT04057118|447978595|FG000|Overall Study|Withdrawal by Subject|2|||
124552004|NCT04057118|447978596|FG001|Overall Study|Withdrawal by Subject|2|||
124552005|NCT04057118|447978597|FG002|Overall Study|Withdrawal by Subject|0|||
124552006|NCT04057118|447978598|FG003|Overall Study|Withdrawal by Subject|2|||
124552007|NCT04057118|447978595|FG000|Overall Study|Not Specific|0|||
124552008|NCT04057118|447978596|FG001|Overall Study|Not Specific|0|||
124552009|NCT04057118|447978597|FG002|Overall Study|Not Specific|1|||
124552010|NCT04057118|447978598|FG003|Overall Study|Not Specific|1|||
124552011|NCT02787785|447978601|FG000|Overall Study|Death|3|||
124552012|NCT02787785|447978602|FG001|Overall Study|Death|4|||
124552013|NCT02787785|447978601|FG000|Overall Study|Lost to Follow-up|1|||
124552014|NCT02787785|447978602|FG001|Overall Study|Lost to Follow-up|1|||
124552015|NCT02787785|447978601|FG000|Overall Study|Withdrawal by Subject|0|||
124713314|NCT00443703|448576429|FG000|Overall Study|Lost to Follow-up|0|||
124713315|NCT00443703|448576430|FG001|Overall Study|Lost to Follow-up|4|||
124713316|NCT00443703|448576429|FG000|Overall Study|Physician Decision|4|||
124972813|NCT04092452|449527341|FG001|Overall Study|Lost to Follow-up|3|||
124972814|NCT04092452|449527342|FG002|Overall Study|Lost to Follow-up|5|||
124972815|NCT04092452|449527343|FG003|Overall Study|Lost to Follow-up|1|||
124972816|NCT04092452|449527340|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124468452|NCT04537208|447673080|FG005|Overall Study|Withdrawal by Subject|1|||
124468453|NCT04537208|447673081|FG006|Overall Study|Withdrawal by Subject|6|||
124468454|NCT04537208|447673082|FG007|Overall Study|Withdrawal by Subject|1|||
124468455|NCT04537208|447673083|FG008|Overall Study|Withdrawal by Subject|7|||
124468456|NCT04537208|447673084|FG009|Overall Study|Withdrawal by Subject|2|||
124468457|NCT04537208|447673085|FG010|Overall Study|Withdrawal by Subject|4|||
124468458|NCT04537208|447673075|FG000|Overall Study|Lost to Follow-up|4|||
124468459|NCT04537208|447673076|FG001|Overall Study|Lost to Follow-up|1|||
124468460|NCT04537208|447673077|FG002|Overall Study|Lost to Follow-up|3|||
124468461|NCT04537208|447673078|FG003|Overall Study|Lost to Follow-up|4|||
124468462|NCT04537208|447673079|FG004|Overall Study|Lost to Follow-up|3|||
124468463|NCT04537208|447673080|FG005|Overall Study|Lost to Follow-up|2|||
124468464|NCT04537208|447673081|FG006|Overall Study|Lost to Follow-up|3|||
124468465|NCT04537208|447673082|FG007|Overall Study|Lost to Follow-up|2|||
124468466|NCT04537208|447673083|FG008|Overall Study|Lost to Follow-up|7|||
124468467|NCT04537208|447673084|FG009|Overall Study|Lost to Follow-up|2|||
124468468|NCT04537208|447673085|FG010|Overall Study|Lost to Follow-up|2|||
124468469|NCT03042468|447673087|FG000|Overall Study|Death|0|||
124468470|NCT03042468|447673088|FG001|Overall Study|Death|1|||
124468471|NCT03042468|447673089|FG002|Overall Study|Death|1|||
124468472|NCT03042468|447673090|FG003|Overall Study|Death|0|||
124468473|NCT03042468|447673091|FG004|Overall Study|Death|0|||
124468474|NCT03042468|447673092|FG005|Overall Study|Death|0|||
124468475|NCT03042468|447673087|FG000|Overall Study|Withdrawal by Subject|0|||
124468476|NCT03042468|447673088|FG001|Overall Study|Withdrawal by Subject|0|||
124552016|NCT02787785|447978602|FG001|Overall Study|Withdrawal by Subject|5|||
124552017|NCT00110084|447978606|FG000|Overall Study|Adverse Event|9|||
124468477|NCT03042468|447673089|FG002|Overall Study|Withdrawal by Subject|0|||
124552018|NCT00110084|447978606|FG000|Overall Study|Death|1|||
124552019|NCT00110084|447978606|FG000|Overall Study|Patient Refusal|10|||
124468478|NCT03042468|447673090|FG003|Overall Study|Withdrawal by Subject|0|||
124468479|NCT03042468|447673091|FG004|Overall Study|Withdrawal by Subject|0|||
124468480|NCT03042468|447673092|FG005|Overall Study|Withdrawal by Subject|1|||
124468481|NCT03042468|447673087|FG000|Overall Study|Lost to Follow-up|0|||
124552020|NCT00110084|447978606|FG000|Overall Study|Alternate Therapy|5|||
124552021|NCT00110084|447978606|FG000|Overall Study|Intercurrent Illness|1|||
124552022|NCT00110084|447978606|FG000|Overall Study|Other|2|||
124552023|NCT00103259|447978607|FG000|Overall Study|Death|3|||
124468482|NCT03042468|447673088|FG001|Overall Study|Lost to Follow-up|0|||
124552024|NCT00103259|447978608|FG001|Overall Study|Death|2|||
124552025|NCT00103259|447978607|FG000|Overall Study|Withdrawal by Subject|2|||
124713317|NCT00443703|448576430|FG001|Overall Study|Physician Decision|2|||
124468483|NCT03042468|447673089|FG002|Overall Study|Lost to Follow-up|0|||
124468484|NCT03042468|447673090|FG003|Overall Study|Lost to Follow-up|0|||
124468485|NCT03042468|447673091|FG004|Overall Study|Lost to Follow-up|1|||
124468486|NCT03042468|447673092|FG005|Overall Study|Lost to Follow-up|1|||
124468487|NCT03083886|447673093|FG000|Overall Study|Withdrawal by Subject|51|||
124468488|NCT03083886|447673094|FG001|Overall Study|Withdrawal by Subject|73|||
124468489|NCT03083886|447673095|FG002|Overall Study|Withdrawal by Subject|104|||
124468490|NCT03083886|447673093|FG000|Overall Study|Missing Baseline data|43|||
124468491|NCT03083886|447673094|FG001|Overall Study|Missing Baseline data|42|||
124468492|NCT03083886|447673095|FG002|Overall Study|Missing Baseline data|31|||
124468493|NCT03083886|447673093|FG000|Overall Study|Investigator terminated|1|||
124468494|NCT03083886|447673094|FG001|Overall Study|Investigator terminated|6|||
124468495|NCT03083886|447673095|FG002|Overall Study|Investigator terminated|3|||
124468496|NCT01764633|447673096|FG000|Overall Study|Withdrawal by Subject|105|||
124468497|NCT01764633|447673097|FG001|Overall Study|Withdrawal by Subject|88|||
124468498|NCT01764633|447673096|FG000|Overall Study|Lost to Follow-up|13|||
124468499|NCT01764633|447673097|FG001|Overall Study|Lost to Follow-up|5|||
124468500|NCT00704964|447673099|FG000|Overall Study|Not completed on time|328|||
124468501|NCT02062658|447673100|FG000|Overall Study|Withdrawal by Subject|1|||
124468502|NCT02062658|447673100|FG000|Overall Study|Lack of Efficacy|1|||
124468503|NCT04418765|447673101|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
124468504|NCT04418765|447673102|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
124468505|NCT04418765|447673103|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
124468506|NCT04418765|447673101|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
124468507|NCT04418765|447673102|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
124468508|NCT04418765|447673103|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
124468509|NCT04418765|447673101|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
124468510|NCT04418765|447673102|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
124468511|NCT04418765|447673103|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
124468512|NCT04418765|447673101|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
124468513|NCT04418765|447673102|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
124468514|NCT04418765|447673103|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
124468515|NCT04418765|447673101|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
124468516|NCT04418765|447673102|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
124468517|NCT04418765|447673103|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
124468518|NCT04418765|447673101|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
124468519|NCT04418765|447673102|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
124468520|NCT04418765|447673103|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
124468521|NCT04418765|447673101|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
124468522|NCT04418765|447673102|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
124468523|NCT04418765|447673103|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
124468524|NCT04418765|447673101|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
124468525|NCT04418765|447673102|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
124468526|NCT04418765|447673103|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
124468527|NCT04418765|447673101|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
124468528|NCT04418765|447673102|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
124468529|NCT04418765|447673103|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
124972817|NCT04092452|449527341|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124972818|NCT04092452|449527342|FG002|Overall Study|Non-Compliance With Study Drug|1|||
124972819|NCT04092452|449527343|FG003|Overall Study|Non-Compliance With Study Drug|1|||
124972820|NCT04092452|449527340|FG000|Overall Study|Physician Decision|1|||
124972821|NCT04092452|449527341|FG001|Overall Study|Physician Decision|0|||
124972822|NCT04092452|449527342|FG002|Overall Study|Physician Decision|1|||
124972823|NCT04092452|449527343|FG003|Overall Study|Physician Decision|0|||
124972824|NCT04092452|449527340|FG000|Overall Study|Pregnancy|2|||
124972825|NCT04092452|449527341|FG001|Overall Study|Pregnancy|0|||
124972826|NCT04092452|449527342|FG002|Overall Study|Pregnancy|0|||
124972827|NCT04092452|449527343|FG003|Overall Study|Pregnancy|0|||
124972828|NCT04092452|449527340|FG000|Overall Study|Protocol Deviation|1|||
124972829|NCT04092452|449527341|FG001|Overall Study|Protocol Deviation|0|||
124972830|NCT04092452|449527342|FG002|Overall Study|Protocol Deviation|0|||
124972831|NCT04092452|449527343|FG003|Overall Study|Protocol Deviation|0|||
124972832|NCT04092452|449527340|FG000|Overall Study|Withdrawal by Subject|3|||
124468530|NCT04418765|447673101|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
124468531|NCT04418765|447673102|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
124468532|NCT04418765|447673103|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
124468533|NCT04418765|447673101|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
124468534|NCT04418765|447673102|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
124468535|NCT04418765|447673103|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
124972833|NCT04092452|449527341|FG001|Overall Study|Withdrawal by Subject|10|||
124972834|NCT04092452|449527342|FG002|Overall Study|Withdrawal by Subject|3|||
124972835|NCT04092452|449527343|FG003|Overall Study|Withdrawal by Subject|5|||
124552026|NCT00103259|447978608|FG001|Overall Study|Withdrawal by Subject|3|||
124552027|NCT00103259|447978607|FG000|Overall Study|alternative therapy|1|||
124552028|NCT00103259|447978608|FG001|Overall Study|alternative therapy|0|||
124552029|NCT00103259|447978607|FG000|Overall Study|other (reasons were not specified)|2|||
124552030|NCT00103259|447978608|FG001|Overall Study|other (reasons were not specified)|1|||
124552031|NCT00103259|447978607|FG000|Overall Study|ineligible/no protocol therapy|4|||
124552032|NCT00103259|447978608|FG001|Overall Study|ineligible/no protocol therapy|6|||
124552033|NCT04101721|447978611|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
124552034|NCT04101721|447978612|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
124552035|NCT04101721|447978611|FG000|Overall Study|Death|0|||
124552036|NCT04101721|447978612|FG001|Overall Study|Death|1|||
124552037|NCT04101721|447978611|FG000|Overall Study|Lost to Follow-up|0|||
124552038|NCT04101721|447978612|FG001|Overall Study|Lost to Follow-up|3|||
124552039|NCT02610842|447978613|FG000|Overall Study|Lost to Follow-up|5|||
124552040|NCT04736576|447978614|FG000|Overall Study|Progressive disease|3|||
124552041|NCT04736576|447978615|FG001|Overall Study|Progressive disease|1|||
124972836|NCT04092452|449527340|FG000|Overall Study|Other|0|||
124972837|NCT04092452|449527341|FG001|Overall Study|Other|0|||
124972838|NCT04092452|449527342|FG002|Overall Study|Other|1|||
124972839|NCT04092452|449527343|FG003|Overall Study|Other|2|||
124972840|NCT02127125|449527344|FG000|Overall Study|Lost to Follow-up|0|||
124972841|NCT02127125|449527345|FG001|Overall Study|Lost to Follow-up|0|||
124972842|NCT02127125|449527346|FG002|Overall Study|Lost to Follow-up|0|||
124972843|NCT02127125|449527347|FG003|Overall Study|Lost to Follow-up|0|||
124972844|NCT02127125|449527348|FG004|Overall Study|Lost to Follow-up|2|||
124972845|NCT02127125|449527349|FG005|Overall Study|Lost to Follow-up|1|||
124972846|NCT02127125|449527350|FG006|Overall Study|Lost to Follow-up|0|||
124972847|NCT02127125|449527351|FG007|Overall Study|Lost to Follow-up|0|||
124972848|NCT02127125|449527352|FG008|Overall Study|Lost to Follow-up|0|||
124972849|NCT02127125|449527344|FG000|Overall Study|Withdrawal by Subject|0|||
124972850|NCT02127125|449527345|FG001|Overall Study|Withdrawal by Subject|0|||
124972851|NCT02127125|449527346|FG002|Overall Study|Withdrawal by Subject|0|||
124972852|NCT02127125|449527347|FG003|Overall Study|Withdrawal by Subject|1|||
124972853|NCT02127125|449527348|FG004|Overall Study|Withdrawal by Subject|0|||
124972854|NCT02127125|449527349|FG005|Overall Study|Withdrawal by Subject|0|||
124972855|NCT02127125|449527350|FG006|Overall Study|Withdrawal by Subject|0|||
124972856|NCT02127125|449527351|FG007|Overall Study|Withdrawal by Subject|0|||
124972857|NCT02127125|449527352|FG008|Overall Study|Withdrawal by Subject|0|||
124972858|NCT02127125|449527344|FG000|Overall Study|Physician Decision|0|||
124972859|NCT02127125|449527345|FG001|Overall Study|Physician Decision|0|||
124972860|NCT02127125|449527346|FG002|Overall Study|Physician Decision|1|||
124972861|NCT02127125|449527347|FG003|Overall Study|Physician Decision|0|||
124972862|NCT02127125|449527348|FG004|Overall Study|Physician Decision|1|||
124972863|NCT02127125|449527349|FG005|Overall Study|Physician Decision|2|||
124972864|NCT02127125|449527350|FG006|Overall Study|Physician Decision|0|||
124972865|NCT02127125|449527351|FG007|Overall Study|Physician Decision|0|||
124972866|NCT02127125|449527352|FG008|Overall Study|Physician Decision|0|||
124972867|NCT02353468|449527353|FG000|Overall Study|Study terminated|3|||
124972868|NCT02344342|449527354|FG000|Overall Study|Industry partner dropped out|11|||
124972869|NCT02344342|449527355|FG001|Overall Study|Industry partner dropped out|9|||
124972870|NCT02344342|449527356|FG002|Overall Study|Industry partner dropped out|14|||
124972871|NCT02344342|449527357|FG003|Overall Study|Industry partner dropped out|10|||
124972872|NCT00848484|449527358|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
124972873|NCT00848484|449527359|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
124972874|NCT00848484|449527358|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
124972875|NCT00848484|449527359|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
124972876|NCT00848484|449527358|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
124972877|NCT00848484|449527359|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
124972878|NCT00848484|449527358|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
124972879|NCT00848484|449527359|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
124972880|NCT00848484|449527358|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
124552042|NCT04736576|447978614|FG000|Overall Study|Death|1|||
124552043|NCT04736576|447978615|FG001|Overall Study|Death|0|||
124552044|NCT04330482|447978620|FG000|Overall Study|Lost to Follow-up|2|||
124972881|NCT00848484|449527359|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
124552045|NCT04330482|447978621|FG001|Overall Study|Lost to Follow-up|1|||
124552046|NCT04330482|447978620|FG000|Overall Study|Withdrawal by Subject|0|||
124552047|NCT04330482|447978621|FG001|Overall Study|Withdrawal by Subject|3|||
124770400|NCT03773978|448788851|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
124972882|NCT03017742|449527367|FG000|Overall Study|Protocol Violation|36|||
124972883|NCT03017742|449527367|FG000|Overall Study|Withdrawal by Subject|37|||
124972884|NCT02975102|449527368|FG000|Overall Study|Adverse Event|2|||
124972885|NCT02975102|449527369|FG001|Overall Study|Adverse Event|1|||
124972886|NCT01441635|449527374|FG000|Overall Study|Adverse Event|4|||
124972887|NCT01441635|449527375|FG001|Overall Study|Adverse Event|3|||
124972888|NCT01441635|449527376|FG002|Overall Study|Adverse Event|1|||
124552048|NCT02268045|447978625|FG000|Overall Study|Death|4|||
124552049|NCT02268045|447978626|FG001|Overall Study|Death|4|||
124552050|NCT02268045|447978625|FG000|Overall Study|Disease Progression|2|||
124552051|NCT02268045|447978626|FG001|Overall Study|Disease Progression|1|||
124552052|NCT02268045|447978625|FG000|Overall Study|Adverse Event|7|||
124552053|NCT02268045|447978626|FG001|Overall Study|Adverse Event|7|||
124552054|NCT02268045|447978625|FG000|Overall Study|Withdrawal by Subject|2|||
124552055|NCT02268045|447978626|FG001|Overall Study|Withdrawal by Subject|6|||
124552056|NCT02268045|447978625|FG000|Overall Study|Physician Decision|0|||
124552057|NCT02268045|447978626|FG001|Overall Study|Physician Decision|1|||
124552058|NCT02268045|447978625|FG000|Overall Study|Protocol Violation|1|||
124552059|NCT02268045|447978626|FG001|Overall Study|Protocol Violation|1|||
124552060|NCT01154673|447978627|FG000|Overall Study|Lost to Follow-up|1|||
124552061|NCT01154673|447978628|FG001|Overall Study|Lost to Follow-up|0|||
124552062|NCT01154673|447978627|FG000|Overall Study|moved out of province|1|||
124552063|NCT01154673|447978628|FG001|Overall Study|moved out of province|0|||
124552064|NCT00646282|447978629|FG000|Overall Study|Protocol terminated|4|||
124552065|NCT00646282|447978630|FG001|Overall Study|Protocol terminated|4|||
124552066|NCT01289990|447978631|FG000|Overall Study|Death|0|||
124552067|NCT01289990|447978632|FG001|Overall Study|Death|0|||
124552068|NCT01289990|447978633|FG002|Overall Study|Death|0|||
124552069|NCT01289990|447978634|FG003|Overall Study|Death|1|||
124552070|NCT01289990|447978635|FG004|Overall Study|Death|2|||
124552071|NCT01289990|447978636|FG005|Overall Study|Death|1|||
124552072|NCT01289990|447978637|FG006|Overall Study|Death|0|||
124552073|NCT01289990|447978638|FG007|Overall Study|Death|0|||
124552074|NCT01289990|447978639|FG008|Overall Study|Death|0|||
124552075|NCT01289990|447978640|FG009|Overall Study|Death|0|||
124552076|NCT01289990|447978641|FG010|Overall Study|Death|0|||
124552077|NCT01289990|447978642|FG011|Overall Study|Death|1|||
124552078|NCT01289990|447978643|FG012|Overall Study|Death|0|||
124552079|NCT01289990|447978631|FG000|Overall Study|Lost to Follow-up|3|||
124552080|NCT01289990|447978632|FG001|Overall Study|Lost to Follow-up|2|||
124552081|NCT01289990|447978633|FG002|Overall Study|Lost to Follow-up|5|||
124552082|NCT01289990|447978634|FG003|Overall Study|Lost to Follow-up|5|||
124552083|NCT01289990|447978635|FG004|Overall Study|Lost to Follow-up|3|||
124552084|NCT01289990|447978636|FG005|Overall Study|Lost to Follow-up|4|||
124552085|NCT01289990|447978637|FG006|Overall Study|Lost to Follow-up|2|||
124552086|NCT01289990|447978638|FG007|Overall Study|Lost to Follow-up|2|||
124552087|NCT01289990|447978639|FG008|Overall Study|Lost to Follow-up|1|||
124552088|NCT01289990|447978640|FG009|Overall Study|Lost to Follow-up|4|||
124552089|NCT01289990|447978641|FG010|Overall Study|Lost to Follow-up|2|||
124552090|NCT01289990|447978642|FG011|Overall Study|Lost to Follow-up|1|||
124552091|NCT01289990|447978643|FG012|Overall Study|Lost to Follow-up|2|||
124552092|NCT01289990|447978631|FG000|Overall Study|Withdrawal by Subject|15|||
124552093|NCT01289990|447978632|FG001|Overall Study|Withdrawal by Subject|14|||
124552094|NCT01289990|447978633|FG002|Overall Study|Withdrawal by Subject|12|||
124552095|NCT01289990|447978634|FG003|Overall Study|Withdrawal by Subject|13|||
124552096|NCT01289990|447978635|FG004|Overall Study|Withdrawal by Subject|8|||
124552097|NCT01289990|447978636|FG005|Overall Study|Withdrawal by Subject|7|||
124552098|NCT01289990|447978637|FG006|Overall Study|Withdrawal by Subject|13|||
124552099|NCT01289990|447978638|FG007|Overall Study|Withdrawal by Subject|9|||
124552100|NCT01289990|447978639|FG008|Overall Study|Withdrawal by Subject|12|||
124552101|NCT01289990|447978640|FG009|Overall Study|Withdrawal by Subject|13|||
124552102|NCT01289990|447978641|FG010|Overall Study|Withdrawal by Subject|11|||
124552103|NCT01289990|447978642|FG011|Overall Study|Withdrawal by Subject|13|||
124552104|NCT01289990|447978643|FG012|Overall Study|Withdrawal by Subject|16|||
124972889|NCT01441635|449527377|FG003|Overall Study|Adverse Event|5|||
124972890|NCT01441635|449527378|FG004|Overall Study|Adverse Event|1|||
124972891|NCT01441635|449527379|FG005|Overall Study|Adverse Event|2|||
124972892|NCT01441635|449527380|FG006|Overall Study|Adverse Event|2|||
124972893|NCT01441635|449527381|FG007|Overall Study|Adverse Event|2|||
124552105|NCT01289990|447978631|FG000|Overall Study|discontinued in preceding trial|18|||
124552106|NCT01289990|447978632|FG001|Overall Study|discontinued in preceding trial|20|||
124552107|NCT01289990|447978633|FG002|Overall Study|discontinued in preceding trial|41|||
124552108|NCT01289990|447978634|FG003|Overall Study|discontinued in preceding trial|17|||
124972894|NCT01441635|449527382|FG008|Overall Study|Adverse Event|1|||
124972895|NCT01441635|449527383|FG009|Overall Study|Adverse Event|0|||
124972896|NCT01441635|449527374|FG000|Overall Study|Withdrawal by Subject|1|||
124552109|NCT01289990|447978635|FG004|Overall Study|discontinued in preceding trial|11|||
124770401|NCT03773978|448788852|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
124552110|NCT01289990|447978636|FG005|Overall Study|discontinued in preceding trial|12|||
124552111|NCT01289990|447978637|FG006|Overall Study|discontinued in preceding trial|18|||
124552112|NCT01289990|447978638|FG007|Overall Study|discontinued in preceding trial|8|||
124552113|NCT01289990|447978639|FG008|Overall Study|discontinued in preceding trial|17|||
124552114|NCT01289990|447978640|FG009|Overall Study|discontinued in preceding trial|21|||
124552115|NCT01289990|447978641|FG010|Overall Study|discontinued in preceding trial|17|||
124972897|NCT01441635|449527375|FG001|Overall Study|Withdrawal by Subject|1|||
124972898|NCT01441635|449527376|FG002|Overall Study|Withdrawal by Subject|0|||
124468536|NCT04418765|447673101|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
124468537|NCT04418765|447673102|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
124468538|NCT04418765|447673103|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
124468539|NCT04418765|447673101|FG000|Extension Period (48 Weeks)|Other than specified|0|||
124468540|NCT04418765|447673102|FG001|Extension Period (48 Weeks)|Other than specified|5|||
124468541|NCT04418765|447673103|FG002|Extension Period (48 Weeks)|Other than specified|2|||
124468542|NCT02161562|447673104|FG000|Overall Study|Withdrawal by Subject|5|||
124468543|NCT02161562|447673105|FG001|Overall Study|Withdrawal by Subject|8|||
124468544|NCT02161562|447673104|FG000|Overall Study|Protocol Violation|9|||
124468545|NCT02161562|447673105|FG001|Overall Study|Protocol Violation|4|||
124468546|NCT02161562|447673104|FG000|Overall Study|Pregnancy|1|||
124468547|NCT02161562|447673105|FG001|Overall Study|Pregnancy|2|||
124468548|NCT02161562|447673104|FG000|Overall Study|Lost to Follow-up|3|||
124468549|NCT02161562|447673105|FG001|Overall Study|Lost to Follow-up|1|||
124468550|NCT02161562|447673104|FG000|Overall Study|Lack of Efficacy|4|||
124468551|NCT02161562|447673105|FG001|Overall Study|Lack of Efficacy|1|||
124468552|NCT02161562|447673104|FG000|Overall Study|Adverse Event|1|||
124468553|NCT02161562|447673105|FG001|Overall Study|Adverse Event|1|||
124468554|NCT02161562|447673104|FG000|Overall Study|Participant moved back to home country|1|||
124468555|NCT02161562|447673105|FG001|Overall Study|Participant moved back to home country|0|||
124468556|NCT02161562|447673104|FG000|Overall Study|Withdrew due to being out of the country|1|||
124468557|NCT02161562|447673105|FG001|Overall Study|Withdrew due to being out of the country|0|||
124468558|NCT02161562|447673104|FG000|Overall Study|Participant moved out of province|1|||
124468559|NCT02161562|447673105|FG001|Overall Study|Participant moved out of province|0|||
124468560|NCT03033745|447673108|FG000|Overall Study|Protocol Violation|0|||
124468561|NCT03033745|447673109|FG001|Overall Study|Protocol Violation|0|||
124468562|NCT03033745|447673110|FG002|Overall Study|Protocol Violation|1|||
124468563|NCT03033745|447673108|FG000|Overall Study|Adverse Event|1|||
124468564|NCT03033745|447673109|FG001|Overall Study|Adverse Event|0|||
124468565|NCT03033745|447673110|FG002|Overall Study|Adverse Event|1|||
124468566|NCT03033745|447673108|FG000|Overall Study|Withdrawal by Subject|0|||
124468567|NCT03033745|447673109|FG001|Overall Study|Withdrawal by Subject|1|||
124468568|NCT03033745|447673110|FG002|Overall Study|Withdrawal by Subject|0|||
124468569|NCT00323557|447673111|FG000|Overall Study|Physician Decision|1|||
124468570|NCT00323557|447673112|FG001|Overall Study|Physician Decision|0|||
124468571|NCT00662792|447673113|FG000|Period 1|Personal Reasons|0|||
124468572|NCT00662792|447673114|FG001|Period 1|Personal Reasons|0|||
124468573|NCT00662792|447673115|FG002|Period 1|Personal Reasons|1|||
124468574|NCT00662792|447673116|FG003|Period 1|Personal Reasons|0|||
124468575|NCT00662792|447673113|FG000|Period 1|Refused continuing medication|0|||
124468576|NCT00662792|447673114|FG001|Period 1|Refused continuing medication|1|||
124468577|NCT00662792|447673115|FG002|Period 1|Refused continuing medication|1|||
124468578|NCT00662792|447673116|FG003|Period 1|Refused continuing medication|0|||
124468579|NCT00662792|447673113|FG000|Period 1|Lost to Follow-up|1|||
124468580|NCT00662792|447673114|FG001|Period 1|Lost to Follow-up|0|||
124468581|NCT00662792|447673115|FG002|Period 1|Lost to Follow-up|0|||
124468582|NCT00662792|447673116|FG003|Period 1|Lost to Follow-up|0|||
124468583|NCT00662792|447673113|FG000|Period 1|Other adverse event (AE)|0|||
124468584|NCT00662792|447673114|FG001|Period 1|Other adverse event (AE)|2|||
124468585|NCT00662792|447673115|FG002|Period 1|Other adverse event (AE)|0|||
124468586|NCT00662792|447673116|FG003|Period 1|Other adverse event (AE)|0|||
124468587|NCT00662792|447673113|FG000|Period 1|Worsening of disease under study (AE)|1|||
124468588|NCT00662792|447673114|FG001|Period 1|Worsening of disease under study (AE)|3|||
124468589|NCT00662792|447673115|FG002|Period 1|Worsening of disease under study (AE)|2|||
124468590|NCT00662792|447673116|FG003|Period 1|Worsening of disease under study (AE)|0|||
124713318|NCT00443703|448576429|FG000|Overall Study|Protocol Violation|1|||
124713319|NCT00443703|448576430|FG001|Overall Study|Protocol Violation|1|||
124972899|NCT01441635|449527377|FG003|Overall Study|Withdrawal by Subject|1|||
124972900|NCT01441635|449527378|FG004|Overall Study|Withdrawal by Subject|0|||
124972901|NCT01441635|449527379|FG005|Overall Study|Withdrawal by Subject|0|||
124972902|NCT01441635|449527380|FG006|Overall Study|Withdrawal by Subject|2|||
124972903|NCT01441635|449527381|FG007|Overall Study|Withdrawal by Subject|0|||
124972904|NCT01441635|449527382|FG008|Overall Study|Withdrawal by Subject|1|||
124713320|NCT00443703|448576429|FG000|Overall Study|Withdrawal by Subject|9|||
124972905|NCT01441635|449527383|FG009|Overall Study|Withdrawal by Subject|1|||
124972906|NCT01441635|449527374|FG000|Overall Study|Lost to Follow-up|0|||
124468591|NCT00662792|447673113|FG000|Period 1|Not treated|0|||
124713321|NCT00443703|448576430|FG001|Overall Study|Withdrawal by Subject|6|||
124468592|NCT00662792|447673114|FG001|Period 1|Not treated|1|||
124468593|NCT00662792|447673115|FG002|Period 1|Not treated|0|||
124468594|NCT00662792|447673116|FG003|Period 1|Not treated|0|||
124468595|NCT00662792|447673113|FG000|Period 2|Worsening of disease under study|1|||
124468596|NCT00662792|447673114|FG001|Period 2|Worsening of disease under study|0|||
124468597|NCT00662792|447673115|FG002|Period 2|Worsening of disease under study|0|||
124468598|NCT00662792|447673116|FG003|Period 2|Worsening of disease under study|3|||
124713322|NCT00443703|448576429|FG000|Overall Study|Progressive Disease|1|||
124972907|NCT01441635|449527375|FG001|Overall Study|Lost to Follow-up|1|||
124552116|NCT01289990|447978642|FG011|Overall Study|discontinued in preceding trial|17|||
124552117|NCT01289990|447978643|FG012|Overall Study|discontinued in preceding trial|24|||
124552118|NCT01289990|447978631|FG000|Overall Study|did not continue in extension|41|||
124713323|NCT00443703|448576430|FG001|Overall Study|Progressive Disease|0|||
124713324|NCT00661830|448576433|FG000|Overall Study|Death|37|||
124713325|NCT00661830|448576434|FG001|Overall Study|Death|33|||
124713326|NCT00661830|448576433|FG000|Overall Study|Lost to Follow-up|1|||
124713327|NCT00661830|448576434|FG001|Overall Study|Lost to Follow-up|3|||
124972908|NCT01441635|449527376|FG002|Overall Study|Lost to Follow-up|1|||
124972909|NCT01441635|449527377|FG003|Overall Study|Lost to Follow-up|1|||
124972910|NCT01441635|449527378|FG004|Overall Study|Lost to Follow-up|1|||
124972911|NCT01441635|449527379|FG005|Overall Study|Lost to Follow-up|3|||
124972912|NCT01441635|449527380|FG006|Overall Study|Lost to Follow-up|1|||
124972913|NCT01441635|449527381|FG007|Overall Study|Lost to Follow-up|1|||
124972914|NCT01441635|449527382|FG008|Overall Study|Lost to Follow-up|0|||
124972915|NCT01441635|449527383|FG009|Overall Study|Lost to Follow-up|1|||
124972916|NCT01441635|449527374|FG000|Overall Study|Noncompliance|0|||
124972917|NCT01441635|449527375|FG001|Overall Study|Noncompliance|1|||
124972918|NCT01441635|449527376|FG002|Overall Study|Noncompliance|0|||
124972919|NCT01441635|449527377|FG003|Overall Study|Noncompliance|0|||
124972920|NCT01441635|449527378|FG004|Overall Study|Noncompliance|0|||
124972921|NCT01441635|449527379|FG005|Overall Study|Noncompliance|0|||
124972922|NCT01441635|449527380|FG006|Overall Study|Noncompliance|1|||
124972923|NCT01441635|449527381|FG007|Overall Study|Noncompliance|0|||
124972924|NCT01441635|449527382|FG008|Overall Study|Noncompliance|0|||
124972925|NCT01441635|449527383|FG009|Overall Study|Noncompliance|0|||
124972926|NCT01441635|449527374|FG000|Overall Study|Surgery or Invasive Intervention|0|||
124972927|NCT01441635|449527375|FG001|Overall Study|Surgery or Invasive Intervention|0|||
124972928|NCT01441635|449527376|FG002|Overall Study|Surgery or Invasive Intervention|1|||
124972929|NCT01441635|449527377|FG003|Overall Study|Surgery or Invasive Intervention|0|||
124972930|NCT01441635|449527378|FG004|Overall Study|Surgery or Invasive Intervention|0|||
124972931|NCT01441635|449527379|FG005|Overall Study|Surgery or Invasive Intervention|0|||
124972932|NCT01441635|449527380|FG006|Overall Study|Surgery or Invasive Intervention|0|||
124972933|NCT01441635|449527381|FG007|Overall Study|Surgery or Invasive Intervention|0|||
124972934|NCT01441635|449527382|FG008|Overall Study|Surgery or Invasive Intervention|0|||
124972935|NCT01441635|449527383|FG009|Overall Study|Surgery or Invasive Intervention|0|||
124972936|NCT01441635|449527374|FG000|Overall Study|Received Exclusionary Medication|1|||
124972937|NCT01441635|449527375|FG001|Overall Study|Received Exclusionary Medication|0|||
124972938|NCT01441635|449527376|FG002|Overall Study|Received Exclusionary Medication|0|||
124972939|NCT01441635|449527377|FG003|Overall Study|Received Exclusionary Medication|0|||
124972940|NCT01441635|449527378|FG004|Overall Study|Received Exclusionary Medication|0|||
124972941|NCT01441635|449527379|FG005|Overall Study|Received Exclusionary Medication|0|||
124972942|NCT01441635|449527380|FG006|Overall Study|Received Exclusionary Medication|0|||
124972943|NCT01441635|449527381|FG007|Overall Study|Received Exclusionary Medication|0|||
124972944|NCT01441635|449527382|FG008|Overall Study|Received Exclusionary Medication|0|||
124972945|NCT01441635|449527383|FG009|Overall Study|Received Exclusionary Medication|0|||
124972946|NCT01441635|449527374|FG000|Overall Study|Other|0|||
124972947|NCT01441635|449527375|FG001|Overall Study|Other|0|||
124972948|NCT01441635|449527376|FG002|Overall Study|Other|0|||
124972949|NCT01441635|449527377|FG003|Overall Study|Other|0|||
124972950|NCT01441635|449527378|FG004|Overall Study|Other|0|||
124972951|NCT01441635|449527379|FG005|Overall Study|Other|0|||
124972952|NCT01441635|449527380|FG006|Overall Study|Other|0|||
124972953|NCT01441635|449527381|FG007|Overall Study|Other|1|||
124972954|NCT01441635|449527382|FG008|Overall Study|Other|0|||
124552119|NCT01289990|447978632|FG001|Overall Study|did not continue in extension|45|||
124552120|NCT01289990|447978633|FG002|Overall Study|did not continue in extension|51|||
124552121|NCT01289990|447978634|FG003|Overall Study|did not continue in extension|51|||
124552122|NCT01289990|447978635|FG004|Overall Study|did not continue in extension|48|||
124552123|NCT01289990|447978636|FG005|Overall Study|did not continue in extension|50|||
124552124|NCT01289990|447978637|FG006|Overall Study|did not continue in extension|54|||
124552125|NCT01289990|447978638|FG007|Overall Study|did not continue in extension|36|||
124552126|NCT01289990|447978639|FG008|Overall Study|did not continue in extension|44|||
124552127|NCT01289990|447978640|FG009|Overall Study|did not continue in extension|48|||
124552128|NCT01289990|447978641|FG010|Overall Study|did not continue in extension|45|||
124552129|NCT01289990|447978642|FG011|Overall Study|did not continue in extension|34|||
124552130|NCT01289990|447978643|FG012|Overall Study|did not continue in extension|56|||
124972955|NCT01441635|449527383|FG009|Overall Study|Other|0|||
124972956|NCT01825577|449527384|FG000|Overall Study|Physician Decision|2|||
124972957|NCT01825577|449527384|FG000|Overall Study|Withdrawal by Subject|1|||
124972958|NCT01825577|449527384|FG000|Overall Study|Withdrawn by family members|2|||
124972959|NCT01825577|449527384|FG000|Overall Study|Lack of Efficacy|3|||
124972960|NCT01358331|449527385|FG000|Overall Study|Lost to Follow-up|0|||
124972961|NCT01358331|449527386|FG001|Overall Study|Lost to Follow-up|0|||
124972962|NCT01358331|449527387|FG002|Overall Study|Lost to Follow-up|0|||
124972963|NCT01358331|449527388|FG003|Overall Study|Lost to Follow-up|1|||
124972964|NCT01358331|449527389|FG004|Overall Study|Lost to Follow-up|0|||
124972965|NCT01358331|449527390|FG005|Overall Study|Lost to Follow-up|0|||
124972966|NCT01358331|449527385|FG000|Overall Study|Withdrawal by Subject|0|||
124972967|NCT01358331|449527386|FG001|Overall Study|Withdrawal by Subject|0|||
124972968|NCT01358331|449527387|FG002|Overall Study|Withdrawal by Subject|0|||
124972969|NCT01358331|449527388|FG003|Overall Study|Withdrawal by Subject|1|||
124972970|NCT01358331|449527389|FG004|Overall Study|Withdrawal by Subject|1|||
124972971|NCT01358331|449527390|FG005|Overall Study|Withdrawal by Subject|1|||
124972972|NCT01358331|449527385|FG000|Overall Study|Adverse Events|1|||
124972973|NCT01358331|449527386|FG001|Overall Study|Adverse Events|1|||
124972974|NCT01358331|449527387|FG002|Overall Study|Adverse Events|1|||
124972975|NCT01358331|449527388|FG003|Overall Study|Adverse Events|0|||
124552131|NCT01289990|447978631|FG000|Overall Study|Not treated|0|||
124972976|NCT01358331|449527389|FG004|Overall Study|Adverse Events|1|||
124972977|NCT01358331|449527390|FG005|Overall Study|Adverse Events|5|||
124972978|NCT01358331|449527385|FG000|Overall Study|Symptomatic Deterioration|0|||
124972979|NCT01358331|449527386|FG001|Overall Study|Symptomatic Deterioration|0|||
124468599|NCT00662792|447673113|FG000|Period 3|Refused continuing medication|1|||
124468600|NCT00662792|447673114|FG001|Period 3|Refused continuing medication|0|||
124468601|NCT00662792|447673115|FG002|Period 3|Refused continuing medication|1|||
124468602|NCT00662792|447673116|FG003|Period 3|Refused continuing medication|0|||
124468603|NCT00662792|447673113|FG000|Period 3|Other adverse event (AE)|0|||
124468604|NCT00662792|447673114|FG001|Period 3|Other adverse event (AE)|0|||
124468605|NCT00662792|447673115|FG002|Period 3|Other adverse event (AE)|1|||
124468606|NCT00662792|447673116|FG003|Period 3|Other adverse event (AE)|1|||
124468607|NCT00662792|447673113|FG000|Period 4|Refused continuing medication|0|||
124468608|NCT00662792|447673114|FG001|Period 4|Refused continuing medication|1|||
124468609|NCT00662792|447673115|FG002|Period 4|Refused continuing medication|0|||
124468610|NCT00662792|447673116|FG003|Period 4|Refused continuing medication|0|||
124468611|NCT00662792|447673113|FG000|Period 4|Other adverse event (AE)|1|||
124468612|NCT00662792|447673114|FG001|Period 4|Other adverse event (AE)|0|||
124468613|NCT00662792|447673115|FG002|Period 4|Other adverse event (AE)|0|||
124468614|NCT00662792|447673116|FG003|Period 4|Other adverse event (AE)|0|||
124468615|NCT00662792|447673113|FG000|Period 4|Worsening of disease under study (AE)|0|||
124468616|NCT00662792|447673114|FG001|Period 4|Worsening of disease under study (AE)|0|||
124468617|NCT00662792|447673115|FG002|Period 4|Worsening of disease under study (AE)|0|||
124468618|NCT00662792|447673116|FG003|Period 4|Worsening of disease under study (AE)|1|||
124468619|NCT00090545|447673117|FG000|Overall Study|Disease progression on study|21|||
124468620|NCT00090545|447673118|FG001|Overall Study|Disease progression on study|17|||
124972980|NCT01358331|449527387|FG002|Overall Study|Symptomatic Deterioration|0|||
124972981|NCT01358331|449527388|FG003|Overall Study|Symptomatic Deterioration|0|||
124972982|NCT01358331|449527389|FG004|Overall Study|Symptomatic Deterioration|1|||
124972983|NCT01358331|449527390|FG005|Overall Study|Symptomatic Deterioration|0|||
124972984|NCT01358331|449527385|FG000|Overall Study|Participants did not wish to continue|0|||
124972985|NCT01358331|449527386|FG001|Overall Study|Participants did not wish to continue|0|||
124972986|NCT01358331|449527387|FG002|Overall Study|Participants did not wish to continue|0|||
124972987|NCT01358331|449527388|FG003|Overall Study|Participants did not wish to continue|0|||
124972988|NCT01358331|449527389|FG004|Overall Study|Participants did not wish to continue|1|||
124972989|NCT01358331|449527390|FG005|Overall Study|Participants did not wish to continue|0|||
124972990|NCT01358331|449527385|FG000|Overall Study|Progress of disease under investigation|1|||
124972991|NCT01358331|449527386|FG001|Overall Study|Progress of disease under investigation|2|||
124972992|NCT01358331|449527387|FG002|Overall Study|Progress of disease under investigation|3|||
124972993|NCT01358331|449527388|FG003|Overall Study|Progress of disease under investigation|1|||
124972994|NCT01358331|449527389|FG004|Overall Study|Progress of disease under investigation|3|||
124972995|NCT01358331|449527390|FG005|Overall Study|Progress of disease under investigation|0|||
124972996|NCT01969851|449527395|FG000|Overall Study|Adverse Event|0|||
124972997|NCT01969851|449527396|FG001|Overall Study|Adverse Event|0|||
124972998|NCT01969851|449527397|FG002|Overall Study|Adverse Event|3|||
124972999|NCT01969851|449527395|FG000|Overall Study|Lack of Efficacy|0|||
124973000|NCT01969851|449527396|FG001|Overall Study|Lack of Efficacy|3|||
124973001|NCT01969851|449527397|FG002|Overall Study|Lack of Efficacy|1|||
124468621|NCT00090545|447673117|FG000|Overall Study|Refused further treatment|1|||
124468622|NCT00090545|447673118|FG001|Overall Study|Refused further treatment|4|||
124468623|NCT00090545|447673117|FG000|Overall Study|Death|0|||
124468624|NCT00090545|447673118|FG001|Overall Study|Death|1|||
124468625|NCT00090545|447673117|FG000|Overall Study|Adverse Event|0|||
124468626|NCT00090545|447673118|FG001|Overall Study|Adverse Event|2|||
124468627|NCT02347176|447673119|FG000|Overall Study|Lost to Follow-up|2|||
124468628|NCT02347176|447673120|FG001|Overall Study|Lost to Follow-up|3|||
124468629|NCT02347176|447673121|FG002|Overall Study|Lost to Follow-up|1|||
124468630|NCT02347176|447673122|FG003|Overall Study|Lost to Follow-up|1|||
124468631|NCT02347176|447673119|FG000|Overall Study|Withdrawal by Subject|9|||
124468632|NCT02347176|447673120|FG001|Overall Study|Withdrawal by Subject|5|||
124468633|NCT02347176|447673121|FG002|Overall Study|Withdrawal by Subject|5|||
124468634|NCT02347176|447673122|FG003|Overall Study|Withdrawal by Subject|3|||
124468635|NCT02347176|447673119|FG000|Overall Study|Other|1|||
124468636|NCT02347176|447673120|FG001|Overall Study|Other|2|||
124468637|NCT02347176|447673121|FG002|Overall Study|Other|2|||
124468638|NCT02347176|447673122|FG003|Overall Study|Other|0|||
124468639|NCT05779072|447673128|FG000|Overall Study|Lost to Follow-up|0|||
124468640|NCT05779072|447673129|FG001|Overall Study|Lost to Follow-up|1|||
124468641|NCT05779072|447673128|FG000|Overall Study|Withdrawal by Subject|1|||
124468642|NCT05779072|447673129|FG001|Overall Study|Withdrawal by Subject|5|||
124468643|NCT03984305|447673131|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
124468644|NCT03984305|447673132|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
124468645|NCT03984305|447673131|FG000|Overall Study|Withdrawal by Subject|3|||
124468646|NCT03984305|447673132|FG001|Overall Study|Withdrawal by Subject|3|||
124468647|NCT03984305|447673131|FG000|Overall Study|Lost to Follow-up|1|||
124468648|NCT03984305|447673132|FG001|Overall Study|Lost to Follow-up|0|||
124468649|NCT02004873|447673133|FG000|Overall Study|Implant unsuccessful|6|||
124468650|NCT02004873|447673133|FG000|Overall Study|Awaiting 6-month visit|390|||
124468651|NCT02004873|447673133|FG000|Overall Study|Missed 6-month visit|4|||
124468652|NCT02004873|447673133|FG000|Overall Study|Death|23|||
124468653|NCT02004873|447673133|FG000|Overall Study|Withdrawal by Subject|1|||
124468654|NCT04925752|447673137|FG000|Overall Study|Still on Study|1826|||
124468655|NCT04925752|447673138|FG001|Overall Study|Still on Study|926|||
124468656|NCT04925752|447673137|FG000|Overall Study|Withdrew Consent|128|||
124468657|NCT04925752|447673138|FG001|Overall Study|Withdrew Consent|59|||
124468658|NCT04925752|447673137|FG000|Overall Study|Lost to Follow-up|73|||
124468659|NCT04925752|447673138|FG001|Overall Study|Lost to Follow-up|47|||
124468660|NCT04925752|447673137|FG000|Overall Study|Randomized but Never Treated|12|||
124468661|NCT04925752|447673138|FG001|Overall Study|Randomized but Never Treated|9|||
124468662|NCT04925752|447673137|FG000|Overall Study|Hiv-1 Infection|6|||
124468663|NCT04925752|447673138|FG001|Overall Study|Hiv-1 Infection|7|||
124468664|NCT04925752|447673137|FG000|Overall Study|Investigator's discretion|8|||
124468665|NCT04925752|447673138|FG001|Overall Study|Investigator's discretion|5|||
124468666|NCT04925752|447673137|FG000|Overall Study|Non-compliance with Study Drug|8|||
124468667|NCT04925752|447673138|FG001|Overall Study|Non-compliance with Study Drug|5|||
124468668|NCT04925752|447673137|FG000|Overall Study|Adverse Event|5|||
124468669|NCT04925752|447673138|FG001|Overall Study|Adverse Event|2|||
124468670|NCT04925752|447673137|FG000|Overall Study|Death|4|||
124468671|NCT04925752|447673138|FG001|Overall Study|Death|2|||
124468672|NCT04925752|447673137|FG000|Overall Study|Protocol Violation|1|||
124468673|NCT04925752|447673138|FG001|Overall Study|Protocol Violation|3|||
124468674|NCT04925752|447673137|FG000|Overall Study|Withdrew Assent|1|||
124468675|NCT04925752|447673138|FG001|Overall Study|Withdrew Assent|0|||
124468676|NCT00866307|447673139|FG000|Induction|Adverse Event|5|||
124468677|NCT00866307|447673140|FG001|Induction|Adverse Event|0|||
124468678|NCT00866307|447673141|FG002|Induction|Adverse Event|0|||
124468679|NCT00866307|447673139|FG000|Induction|Death|2|||
124468680|NCT00866307|447673140|FG001|Induction|Death|0|||
124468681|NCT00866307|447673141|FG002|Induction|Death|0|||
124468682|NCT00866307|447673139|FG000|Induction|Physician Decision|5|||
124468683|NCT00866307|447673140|FG001|Induction|Physician Decision|0|||
124468684|NCT00866307|447673141|FG002|Induction|Physician Decision|0|||
124468685|NCT00866307|447673139|FG000|Induction|Progressive Disease|1|||
124468686|NCT00866307|447673140|FG001|Induction|Progressive Disease|0|||
124468687|NCT00866307|447673141|FG002|Induction|Progressive Disease|0|||
124468688|NCT00866307|447673139|FG000|Induction|Identification of Patients with Day 29 M|3|||
124468689|NCT00866307|447673140|FG001|Induction|Identification of Patients with Day 29 M|0|||
124468690|NCT00866307|447673141|FG002|Induction|Identification of Patients with Day 29 M|0|||
124468691|NCT00866307|447673139|FG000|Induction|Inadequate cytognetic samples th|1|||
124468692|NCT00866307|447673140|FG001|Induction|Inadequate cytognetic samples th|0|||
124468693|NCT00866307|447673141|FG002|Induction|Inadequate cytognetic samples th|0|||
124468694|NCT00866307|447673139|FG000|Induction|Improper post-induction consent|2|||
124468695|NCT00866307|447673140|FG001|Induction|Improper post-induction consent|0|||
124468696|NCT00866307|447673141|FG002|Induction|Improper post-induction consent|0|||
124468697|NCT00866307|447673139|FG000|Induction|Study was closed at the time|1|||
124468698|NCT00866307|447673140|FG001|Induction|Study was closed at the time|0|||
124552132|NCT01289990|447978632|FG001|Overall Study|Not treated|0|||
124552133|NCT01289990|447978633|FG002|Overall Study|Not treated|0|||
124713328|NCT00661830|448576433|FG000|Overall Study|Withdrawal by Subject|1|||
124713329|NCT00661830|448576434|FG001|Overall Study|Withdrawal by Subject|1|||
124713330|NCT00661830|448576433|FG000|Overall Study|Other reason|1|||
124713331|NCT00661830|448576434|FG001|Overall Study|Other reason|5|||
124713332|NCT00488514|448576435|FG000|Overall Study|Adverse Event|41|||
124713333|NCT00488514|448576435|FG000|Overall Study|Lost to Follow-up|44|||
124713334|NCT00488514|448576435|FG000|Overall Study|Protocol Violation|32|||
124713335|NCT00488514|448576435|FG000|Overall Study|Withdrawal by Subject|106|||
124973002|NCT01969851|449527395|FG000|Overall Study|Withdrawal by Subject|1|||
124973003|NCT01969851|449527396|FG001|Overall Study|Withdrawal by Subject|0|||
124973004|NCT01969851|449527397|FG002|Overall Study|Withdrawal by Subject|1|||
124973005|NCT01969851|449527395|FG000|Overall Study|No effective dose in Titration period|0|||
124973006|NCT01969851|449527396|FG001|Overall Study|No effective dose in Titration period|0|||
124973007|NCT01969851|449527397|FG002|Overall Study|No effective dose in Titration period|1|||
124973008|NCT01969851|449527395|FG000|Overall Study|Sponsor decision|0|||
124973009|NCT01969851|449527396|FG001|Overall Study|Sponsor decision|0|||
124973010|NCT01969851|449527397|FG002|Overall Study|Sponsor decision|1|||
124973011|NCT01430468|449527406|FG000|Overall Study|Physician Decision|2|||
124973012|NCT01430468|449527407|FG001|Overall Study|Physician Decision|1|||
124973013|NCT01430468|449527406|FG000|Overall Study|Withdrawal by Subject|5|||
124973014|NCT01430468|449527407|FG001|Overall Study|Withdrawal by Subject|5|||
124973015|NCT00617929|449527410|FG000|Overall Study|Physician Decision|1|||
124973016|NCT01426347|449527411|FG000|Overall Study|Lost to Follow-up|0|||
124973017|NCT01426347|449527412|FG001|Overall Study|Lost to Follow-up|3|||
124973018|NCT01426347|449527411|FG000|Overall Study|Protocol Violation|2|||
124973019|NCT01426347|449527412|FG001|Overall Study|Protocol Violation|0|||
124973020|NCT01426347|449527411|FG000|Overall Study|Withdrawal by Subject|5|||
124973021|NCT01426347|449527412|FG001|Overall Study|Withdrawal by Subject|0|||
124973022|NCT01151423|449527414|FG000|Overall Study|Study terminated by Sponsor|9|||
124973023|NCT01151423|449527415|FG001|Overall Study|Study terminated by Sponsor|10|||
124973024|NCT01151423|449527414|FG000|Overall Study|Protocol Violation|0|||
124973025|NCT01151423|449527415|FG001|Overall Study|Protocol Violation|1|||
124973026|NCT01151423|449527414|FG000|Overall Study|Physician Decision|1|||
124973027|NCT01151423|449527415|FG001|Overall Study|Physician Decision|1|||
124973028|NCT01151423|449527414|FG000|Overall Study|Pregnancy|0|||
124973029|NCT01151423|449527415|FG001|Overall Study|Pregnancy|1|||
124973030|NCT01151423|449527414|FG000|Overall Study|Death|0|||
124973031|NCT01151423|449527415|FG001|Overall Study|Death|1|||
124973032|NCT01151423|449527414|FG000|Overall Study|Adverse Event|3|||
124973033|NCT01151423|449527415|FG001|Overall Study|Adverse Event|0|||
124973034|NCT01151423|449527414|FG000|Overall Study|Withdrawal by Subject|1|||
124973035|NCT01151423|449527415|FG001|Overall Study|Withdrawal by Subject|3|||
124973036|NCT01151423|449527414|FG000|Overall Study|Lost to Follow-up|1|||
124973037|NCT01151423|449527415|FG001|Overall Study|Lost to Follow-up|0|||
124973038|NCT01151423|449527414|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
124973039|NCT01151423|449527415|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
124973040|NCT01151423|449527414|FG000|Overall Study|Participated in other clinical trial|1|||
124973041|NCT01151423|449527415|FG001|Overall Study|Participated in other clinical trial|0|||
124973042|NCT03192462|449529231|FG000|Overall Study|Death|13|||
124973043|NCT03192462|449529232|FG001|Overall Study|Death|11|||
124973044|NCT03192462|449529233|FG002|Overall Study|Death|9|||
124552134|NCT01289990|447978634|FG003|Overall Study|Not treated|0|||
124973045|NCT03192462|449529231|FG000|Overall Study|Lost to Follow-up|0|||
124973046|NCT03192462|449529232|FG001|Overall Study|Lost to Follow-up|1|||
124973047|NCT03192462|449529233|FG002|Overall Study|Lost to Follow-up|0|||
124973048|NCT03192462|449529231|FG000|Overall Study|On follow up|0|||
124973049|NCT03192462|449529232|FG001|Overall Study|On follow up|0|||
124973050|NCT03192462|449529233|FG002|Overall Study|On follow up|3|||
124973051|NCT02419417|449529234|FG000|Overall Study|Disease progression|5|||
124973052|NCT02419417|449529235|FG001|Overall Study|Disease progression|4|||
124973053|NCT02419417|449529236|FG002|Overall Study|Disease progression|13|||
124973054|NCT02419417|449529237|FG003|Overall Study|Disease progression|10|||
124973055|NCT02419417|449529238|FG004|Overall Study|Disease progression|10|||
124973056|NCT02419417|449529239|FG005|Overall Study|Disease progression|3|||
124973057|NCT02419417|449529240|FG006|Overall Study|Disease progression|4|||
124468699|NCT00866307|447673141|FG002|Induction|Study was closed at the time|0|||
124468700|NCT00866307|447673139|FG000|Consolidation/Maintenance|Adverse Event|0|||
124468701|NCT00866307|447673140|FG001|Consolidation/Maintenance|Adverse Event|0|||
124468702|NCT00866307|447673141|FG002|Consolidation/Maintenance|Adverse Event|8|||
124468703|NCT00866307|447673139|FG000|Consolidation/Maintenance|Death|0|||
124468704|NCT00866307|447673140|FG001|Consolidation/Maintenance|Death|0|||
124468705|NCT00866307|447673141|FG002|Consolidation/Maintenance|Death|1|||
124468706|NCT00866307|447673139|FG000|Consolidation/Maintenance|Physician Decision|0|||
124468707|NCT00866307|447673140|FG001|Consolidation/Maintenance|Physician Decision|3|||
124468708|NCT00866307|447673141|FG002|Consolidation/Maintenance|Physician Decision|2|||
124468709|NCT00866307|447673139|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
124468710|NCT00866307|447673140|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
124468711|NCT00866307|447673141|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
124468712|NCT00866307|447673139|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
124468713|NCT00866307|447673140|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
124468714|NCT00866307|447673141|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
124468715|NCT00866307|447673139|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
124468716|NCT00866307|447673140|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
124468717|NCT00866307|447673141|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
124468718|NCT00866307|447673139|FG000|Consolidation/Maintenance|Therapy error|0|||
124468719|NCT00866307|447673140|FG001|Consolidation/Maintenance|Therapy error|1|||
124468720|NCT00866307|447673141|FG002|Consolidation/Maintenance|Therapy error|0|||
124468721|NCT00866307|447673139|FG000|Consolidation/Maintenance|Non-compliance|0|||
124468722|NCT00866307|447673140|FG001|Consolidation/Maintenance|Non-compliance|0|||
124468723|NCT00866307|447673141|FG002|Consolidation/Maintenance|Non-compliance|1|||
124468724|NCT00866307|447673139|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
124468725|NCT00866307|447673140|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
124468726|NCT00866307|447673141|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
124468727|NCT01060059|447673144|FG000|Overall Study|Adverse Event|1|||
124468728|NCT01060059|447673145|FG001|Overall Study|Adverse Event|1|||
124468729|NCT01060059|447673144|FG000|Overall Study|Death|2|||
124468730|NCT01060059|447673145|FG001|Overall Study|Death|3|||
124468731|NCT01060059|447673144|FG000|Overall Study|Lost to Follow-up|18|||
124468732|NCT01060059|447673145|FG001|Overall Study|Lost to Follow-up|34|||
124468733|NCT01060059|447673144|FG000|Overall Study|entry criteria not met|4|||
124468734|NCT01060059|447673145|FG001|Overall Study|entry criteria not met|3|||
124468735|NCT01060059|447673144|FG000|Overall Study|Withdrawal by Subject|35|||
124468736|NCT01060059|447673145|FG001|Overall Study|Withdrawal by Subject|23|||
124468737|NCT01060059|447673144|FG000|Overall Study|lack of glycemic control|2|||
124468738|NCT01060059|447673145|FG001|Overall Study|lack of glycemic control|1|||
124468739|NCT01060059|447673144|FG000|Overall Study|lack of compliance|5|||
124468740|NCT01060059|447673145|FG001|Overall Study|lack of compliance|2|||
124468741|NCT00980538|447673148|FG000|Overall Study|Lost to Follow-up|20|||
124468742|NCT00980538|447673148|FG000|Overall Study|Sponsor's Decision|4|||
124468743|NCT00980538|447673148|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
124468744|NCT00980538|447673148|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
124468745|NCT00980538|447673148|FG000|Overall Study|Switch to Commercially Available Medication|25|||
124468746|NCT00980538|447673148|FG000|Overall Study|Participant Non-Compliant|9|||
124468747|NCT00980538|447673148|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
124468748|NCT00980538|447673148|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
124468749|NCT00980538|447673148|FG000|Overall Study|Other|60|||
124468750|NCT00980538|447673148|FG000|Overall Study|Other|1|||
124468751|NCT04770753|447674670|FG000|Overall Study|Randomized, never treated|1|||
124468752|NCT04770753|447674671|FG001|Overall Study|Randomized, never treated|1|||
124468753|NCT04770753|447674670|FG000|Overall Study|Withdrawal by Subject|3|||
124468754|NCT04770753|447674671|FG001|Overall Study|Withdrawal by Subject|1|||
124468755|NCT04770753|447674670|FG000|Overall Study|Adverse Event|2|||
124468756|NCT04770753|447674671|FG001|Overall Study|Adverse Event|0|||
124468757|NCT04770753|447674670|FG000|Overall Study|Pregnancy|1|||
124468758|NCT04770753|447674671|FG001|Overall Study|Pregnancy|0|||
124468759|NCT04770753|447674670|FG000|Overall Study|Other un-specified|1|||
124468760|NCT04770753|447674671|FG001|Overall Study|Other un-specified|0|||
124468761|NCT02775851|447674672|FG000|Overall Study|Adverse Event|1|||
124468762|NCT02775851|447674673|FG001|Overall Study|Adverse Event|10|||
124468763|NCT02775851|447674672|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
124468764|NCT02775851|447674673|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
124468765|NCT02775851|447674672|FG000|Overall Study|Progression/Relapse|0|||
124468766|NCT02775851|447674673|FG001|Overall Study|Progression/Relapse|4|||
124468767|NCT02775851|447674672|FG000|Overall Study|Other - Not Protocol Specified|0|||
124468768|NCT02775851|447674673|FG001|Overall Study|Other - Not Protocol Specified|7|||
124468769|NCT02775851|447674672|FG000|Overall Study|Withdrawal by Subject|1|||
124468770|NCT02775851|447674673|FG001|Overall Study|Withdrawal by Subject|0|||
124468771|NCT00598975|447674674|FG000|Overall Study|Adverse Event|1|||
124468772|NCT00598975|447674675|FG001|Overall Study|Adverse Event|1|||
124468773|NCT00598975|447674674|FG000|Overall Study|Brain metastases|1|||
124468774|NCT00598975|447674675|FG001|Overall Study|Brain metastases|0|||
124468775|NCT00598975|447674674|FG000|Overall Study|Withdrawal by Subject|1|||
124468776|NCT00598975|447674675|FG001|Overall Study|Withdrawal by Subject|1|||
124468777|NCT00598975|447674674|FG000|Overall Study|Withdrawal of consent|0|||
124468778|NCT00598975|447674675|FG001|Overall Study|Withdrawal of consent|1|||
124468779|NCT00598975|447674674|FG000|Overall Study|Disease progression|8|||
124468780|NCT00598975|447674675|FG001|Overall Study|Disease progression|3|||
124468781|NCT00598975|447674674|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
124468782|NCT00598975|447674675|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
124973058|NCT02419417|449529241|FG007|Overall Study|Disease progression|5|||
124973059|NCT02419417|449529242|FG008|Overall Study|Disease progression|13|||
124973060|NCT02419417|449529243|FG009|Overall Study|Disease progression|9|||
124973061|NCT02419417|449529244|FG010|Overall Study|Disease progression|0|||
124973062|NCT02419417|449529234|FG000|Overall Study|Study drug toxicity|0|||
124973063|NCT02419417|449529235|FG001|Overall Study|Study drug toxicity|0|||
124973064|NCT02419417|449529236|FG002|Overall Study|Study drug toxicity|0|||
124468783|NCT04033367|447674676|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
124468784|NCT04033367|447674677|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
124468785|NCT04033367|447674676|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
124468786|NCT04033367|447674677|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
124468787|NCT04033367|447674676|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
124973065|NCT02419417|449529237|FG003|Overall Study|Study drug toxicity|0|||
124973066|NCT02419417|449529238|FG004|Overall Study|Study drug toxicity|1|||
124973067|NCT02419417|449529239|FG005|Overall Study|Study drug toxicity|0|||
124973068|NCT02419417|449529240|FG006|Overall Study|Study drug toxicity|0|||
124973069|NCT02419417|449529241|FG007|Overall Study|Study drug toxicity|0|||
124973070|NCT02419417|449529242|FG008|Overall Study|Study drug toxicity|0|||
124973071|NCT02419417|449529243|FG009|Overall Study|Study drug toxicity|0|||
124973072|NCT02419417|449529244|FG010|Overall Study|Study drug toxicity|0|||
124973073|NCT02419417|449529234|FG000|Overall Study|Adverse event unrelated to study drug|0|||
124973074|NCT02419417|449529235|FG001|Overall Study|Adverse event unrelated to study drug|0|||
124973075|NCT02419417|449529236|FG002|Overall Study|Adverse event unrelated to study drug|0|||
124973076|NCT02419417|449529237|FG003|Overall Study|Adverse event unrelated to study drug|0|||
124973077|NCT02419417|449529238|FG004|Overall Study|Adverse event unrelated to study drug|2|||
124973078|NCT02419417|449529239|FG005|Overall Study|Adverse event unrelated to study drug|1|||
124973079|NCT02419417|449529240|FG006|Overall Study|Adverse event unrelated to study drug|0|||
124973080|NCT02419417|449529241|FG007|Overall Study|Adverse event unrelated to study drug|1|||
124973081|NCT02419417|449529242|FG008|Overall Study|Adverse event unrelated to study drug|0|||
124973082|NCT02419417|449529243|FG009|Overall Study|Adverse event unrelated to study drug|0|||
124973083|NCT02419417|449529244|FG010|Overall Study|Adverse event unrelated to study drug|0|||
124973084|NCT02419417|449529234|FG000|Overall Study|Participant request to discontinue|0|||
124973085|NCT02419417|449529235|FG001|Overall Study|Participant request to discontinue|0|||
124973086|NCT02419417|449529236|FG002|Overall Study|Participant request to discontinue|0|||
124973087|NCT02419417|449529237|FG003|Overall Study|Participant request to discontinue|0|||
124973088|NCT02419417|449529238|FG004|Overall Study|Participant request to discontinue|0|||
124973089|NCT02419417|449529239|FG005|Overall Study|Participant request to discontinue|0|||
124973090|NCT02419417|449529240|FG006|Overall Study|Participant request to discontinue|0|||
124973091|NCT02419417|449529241|FG007|Overall Study|Participant request to discontinue|0|||
124973092|NCT02419417|449529242|FG008|Overall Study|Participant request to discontinue|0|||
124468788|NCT04033367|447674677|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
124468789|NCT04033367|447674676|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
124468790|NCT04033367|447674677|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
124468791|NCT02908880|447674678|FG000|Overall Study|Lost to Follow-up|4|||
124468792|NCT02908880|447674678|FG000|Overall Study|Explantation of the device|1|||
124973093|NCT02419417|449529243|FG009|Overall Study|Participant request to discontinue|1|||
124713336|NCT00488514|448576435|FG000|Overall Study|Lack of Efficacy|28|||
124713337|NCT00488514|448576435|FG000|Overall Study|Did not meet criteria for treatment|30|||
124713338|NCT00488514|448576435|FG000|Overall Study|Postive drug screen|1|||
124713339|NCT00488514|448576435|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
124713340|NCT00488514|448576435|FG000|Overall Study|Investigator decision|1|||
124713341|NCT00488514|448576435|FG000|Overall Study|Participant had too few migraines|5|||
124713342|NCT00488514|448576435|FG000|Overall Study|Increase in number of migraines|2|||
124713343|NCT00488514|448576435|FG000|Overall Study|Increased use of concomitant medication|1|||
124713344|NCT01669902|448576436|FG000|Overall Study|Adverse Event|11|||
124713345|NCT01669902|448576436|FG000|Overall Study|Lack of Efficacy|10|||
124713346|NCT01669902|448576436|FG000|Overall Study|Other|8|||
124713347|NCT01535287|448576437|FG000|Overall Study|drug not prepared in time|5|||
124713348|NCT01535287|448576438|FG001|Overall Study|drug not prepared in time|6|||
124713349|NCT00387088|448576445|FG000|Overall Study|Adverse Event|143|||
124713350|NCT00387088|448576446|FG001|Overall Study|Adverse Event|156|||
124713351|NCT00387088|448576445|FG000|Overall Study|Protocol Violation|47|||
124713352|NCT00387088|448576446|FG001|Overall Study|Protocol Violation|35|||
124713353|NCT00387088|448576445|FG000|Overall Study|Withdrawal by Subject|20|||
124713354|NCT00387088|448576446|FG001|Overall Study|Withdrawal by Subject|35|||
124713355|NCT00387088|448576445|FG000|Overall Study|Lack of Efficacy|28|||
124713356|NCT00387088|448576446|FG001|Overall Study|Lack of Efficacy|67|||
124713357|NCT00387088|448576445|FG000|Overall Study|Lost to Follow-up|22|||
124713358|NCT00387088|448576446|FG001|Overall Study|Lost to Follow-up|28|||
124713359|NCT00387088|448576445|FG000|Overall Study|Other|58|||
124713360|NCT00387088|448576446|FG001|Overall Study|Other|52|||
124713361|NCT01428219|448576453|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
124973094|NCT02419417|449529244|FG010|Overall Study|Participant request to discontinue|0|||
124973095|NCT02419417|449529234|FG000|Overall Study|Withdrawal by Subject|0|||
124973096|NCT02419417|449529235|FG001|Overall Study|Withdrawal by Subject|0|||
124973097|NCT02419417|449529236|FG002|Overall Study|Withdrawal by Subject|0|||
124973098|NCT02419417|449529237|FG003|Overall Study|Withdrawal by Subject|0|||
124973099|NCT02419417|449529238|FG004|Overall Study|Withdrawal by Subject|0|||
124973100|NCT02419417|449529239|FG005|Overall Study|Withdrawal by Subject|0|||
124973101|NCT02419417|449529240|FG006|Overall Study|Withdrawal by Subject|0|||
124973102|NCT02419417|449529241|FG007|Overall Study|Withdrawal by Subject|0|||
124973103|NCT02419417|449529242|FG008|Overall Study|Withdrawal by Subject|0|||
124973104|NCT02419417|449529243|FG009|Overall Study|Withdrawal by Subject|0|||
124973105|NCT02419417|449529244|FG010|Overall Study|Withdrawal by Subject|1|||
124973106|NCT00078377|449529245|FG000|Overall Study|Adverse Event|2|||
124973107|NCT00078377|449529246|FG001|Overall Study|Adverse Event|5|||
124973108|NCT00078377|449529247|FG002|Overall Study|Adverse Event|1|||
124973109|NCT00078377|449529245|FG000|Overall Study|Lack of Efficacy|2|||
124973110|NCT00078377|449529246|FG001|Overall Study|Lack of Efficacy|0|||
124973111|NCT00078377|449529247|FG002|Overall Study|Lack of Efficacy|2|||
124973112|NCT00078377|449529245|FG000|Overall Study|Lost to Follow-up|0|||
124973113|NCT00078377|449529246|FG001|Overall Study|Lost to Follow-up|1|||
124973114|NCT00078377|449529247|FG002|Overall Study|Lost to Follow-up|1|||
124973115|NCT00078377|449529245|FG000|Overall Study|Physician Decision|2|||
124973116|NCT00078377|449529246|FG001|Overall Study|Physician Decision|0|||
124973117|NCT00078377|449529247|FG002|Overall Study|Physician Decision|0|||
124973118|NCT00078377|449529245|FG000|Overall Study|Withdrawal by Subject|3|||
124973119|NCT00078377|449529246|FG001|Overall Study|Withdrawal by Subject|4|||
124973120|NCT00078377|449529247|FG002|Overall Study|Withdrawal by Subject|4|||
124973121|NCT00078377|449529245|FG000|Overall Study|Miscellaneous|2|||
124973122|NCT00078377|449529246|FG001|Overall Study|Miscellaneous|6|||
124973123|NCT00078377|449529247|FG002|Overall Study|Miscellaneous|1|||
124973124|NCT00233480|449529248|FG000|Overall Study|Underwent status II heart transplant|0|||
124973125|NCT00233480|449529249|FG001|Overall Study|Underwent status II heart transplant|1|||
124973126|NCT00581893|449529250|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
124973127|NCT00581893|449529251|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
124973128|NCT00790400|449529254|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
124973129|NCT00790400|449529255|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
124973130|NCT00790400|449529254|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
124973131|NCT00790400|449529255|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
124973132|NCT00790400|449529254|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
124713362|NCT00592631|448576456|FG000|Overall Study|Lost to Follow-up|0|||
124713363|NCT00592631|448576457|FG001|Overall Study|Lost to Follow-up|2|||
124713364|NCT03745768|448576459|FG000|Overall Study|discontinued study|2|||
124713365|NCT03745768|448576460|FG001|Overall Study|discontinued study|0|||
124713366|NCT00443118|448576461|FG000|Overall Study|unknown primary outcome|3|||
124713367|NCT00443118|448576462|FG001|Overall Study|unknown primary outcome|1|||
124973133|NCT00790400|449529255|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
124973134|NCT00790400|449529254|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
124973135|NCT00790400|449529255|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
124973136|NCT00790400|449529254|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
124713368|NCT00443118|448576463|FG002|Overall Study|unknown primary outcome|0|||
124713369|NCT00443118|448576461|FG000|Overall Study|Withdrawal by Subject|1|||
124713370|NCT00443118|448576462|FG001|Overall Study|Withdrawal by Subject|0|||
124713371|NCT00443118|448576463|FG002|Overall Study|Withdrawal by Subject|0|||
124713372|NCT01023217|448576466|FG000|Overall Study|Withdrawal by Subject|1|||
124713373|NCT01023217|448576467|FG001|Overall Study|Withdrawal by Subject|0|||
124713374|NCT01106157|448576468|FG000|Overall Study|Withdrawal by Subject|1|||
124713375|NCT01106157|448576469|FG001|Overall Study|Withdrawal by Subject|0|||
124713376|NCT01673646|448576473|FG000|Overall Study|Adverse Event|2|||
124713377|NCT01673646|448576474|FG001|Overall Study|Adverse Event|1|||
124973137|NCT00790400|449529255|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
124973138|NCT00790400|449529254|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
124973139|NCT00790400|449529255|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
124973140|NCT00790400|449529254|FG000|Double-blind Period (Core Phase)|Death|1|||
124973141|NCT00790400|449529255|FG001|Double-blind Period (Core Phase)|Death|0|||
124973142|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
124973143|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
124973144|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
124973145|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
124973146|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
124973147|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
124973148|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
124973149|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
124973150|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
124973151|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
124973152|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|Death|1|||
124973153|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|Death|0|||
124973154|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
124973155|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
124973156|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
124973157|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
124973158|NCT00790400|449529254|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
124973159|NCT00790400|449529255|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
124973160|NCT01107899|449529261|FG000|Overall Study|Physician Decision|5|||
124973161|NCT01107899|449529262|FG001|Overall Study|Physician Decision|0|||
124973162|NCT01107899|449529263|FG002|Overall Study|Physician Decision|3|||
124973163|NCT01107899|449529261|FG000|Overall Study|Withdrawal by Subject|0|||
124973164|NCT01107899|449529262|FG001|Overall Study|Withdrawal by Subject|0|||
124973165|NCT01107899|449529263|FG002|Overall Study|Withdrawal by Subject|1|||
124973166|NCT00974259|449529264|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
124973167|NCT00974259|449529265|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
124973168|NCT01810939|449529285|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
124973169|NCT01810939|449529286|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
124973170|NCT01810939|449529287|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
124973171|NCT01810939|449529285|FG000|Part A Treatment Period|Protocol Violation|2|||
124973172|NCT01810939|449529286|FG001|Part A Treatment Period|Protocol Violation|0|||
124973173|NCT01810939|449529287|FG002|Part A Treatment Period|Protocol Violation|0|||
124973174|NCT01810939|449529285|FG000|Part A Treatment Period|Adverse Event|10|||
124973175|NCT01810939|449529286|FG001|Part A Treatment Period|Adverse Event|0|||
124973176|NCT01810939|449529287|FG002|Part A Treatment Period|Adverse Event|0|||
124973177|NCT01810939|449529285|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
124973178|NCT01810939|449529286|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
124973179|NCT01810939|449529287|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
124973180|NCT01810939|449529285|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
124973181|NCT01810939|449529286|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
124973182|NCT01810939|449529287|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
124973183|NCT01810939|449529285|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
124973184|NCT01810939|449529286|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
124973185|NCT01810939|449529287|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
124973186|NCT01810939|449529285|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
124973187|NCT01810939|449529286|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
124973188|NCT01810939|449529287|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
124973189|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
124973190|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
124973191|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
124713378|NCT01673646|448576475|FG002|Overall Study|Adverse Event|1|||
124973192|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
124973193|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
124973194|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
124973195|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
124973196|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
124713379|NCT01673646|448576473|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124468793|NCT02908880|447674678|FG000|Overall Study|Withdrawal by Subject|17|||
124468794|NCT02908880|447674678|FG000|Overall Study|Death|5|||
124468795|NCT00491179|447674685|FG000|Overall Study|Adverse Event|5|||
124468796|NCT00491179|447674686|FG001|Overall Study|Adverse Event|1|||
124468797|NCT00491179|447674685|FG000|Overall Study|Withdrawal by Subject|2|||
124468798|NCT00491179|447674686|FG001|Overall Study|Withdrawal by Subject|1|||
124468799|NCT01790048|447674687|FG000|Overall Study|Incorrect Age|9|||
124468800|NCT01790048|447674688|FG001|Overall Study|Incorrect Age|14|||
124468801|NCT01790048|447674687|FG000|Overall Study|data entry error|0|||
124468802|NCT01790048|447674688|FG001|Overall Study|data entry error|1|||
124468803|NCT01790048|447674687|FG000|Overall Study|Other|0|||
124468804|NCT01790048|447674688|FG001|Overall Study|Other|2|||
124468805|NCT01790048|447674687|FG000|Overall Study|SAM at Enrollment|2|||
124468806|NCT01790048|447674688|FG001|Overall Study|SAM at Enrollment|0|||
124468807|NCT01790048|447674687|FG000|Overall Study|Measurement error|1|||
124468808|NCT01790048|447674688|FG001|Overall Study|Measurement error|0|||
124468809|NCT04269395|447674689|FG000|Overall Study|Lost to Follow-up|1|||
124468810|NCT04269395|447674690|FG001|Overall Study|Lost to Follow-up|0|||
124468811|NCT04269395|447674689|FG000|Overall Study|Study terminated by Sponsor|13|||
124468812|NCT04269395|447674690|FG001|Overall Study|Study terminated by Sponsor|10|||
124713380|NCT01673646|448576474|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124713381|NCT01673646|448576475|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
124713382|NCT01673646|448576473|FG000|Overall Study|Condition no longer requires study drug|0|||
124713383|NCT01673646|448576474|FG001|Overall Study|Condition no longer requires study drug|1|||
124468813|NCT00584233|447674691|FG000|Overall Study|Withdrawal by Subject|5|||
124468814|NCT00584233|447674691|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
124468815|NCT02222714|447674692|FG000|Overall Study|Death|0|||
124552135|NCT01289990|447978635|FG004|Overall Study|Not treated|0|||
124468816|NCT02222714|447674693|FG001|Overall Study|Death|2|||
124468817|NCT02222714|447674694|FG002|Overall Study|Death|3|||
124468818|NCT02222714|447674695|FG003|Overall Study|Death|4|||
124468819|NCT02222714|447674696|FG004|Overall Study|Death|6|||
124468820|NCT02222714|447674692|FG000|Overall Study|Withdrawal by Subject|0|||
124468821|NCT02222714|447674693|FG001|Overall Study|Withdrawal by Subject|0|||
124468822|NCT02222714|447674694|FG002|Overall Study|Withdrawal by Subject|1|||
124468823|NCT02222714|447674695|FG003|Overall Study|Withdrawal by Subject|0|||
124468824|NCT02222714|447674696|FG004|Overall Study|Withdrawal by Subject|1|||
124468825|NCT05030311|447674697|FG000|Overall Study|Technical problems|0|||
124973197|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
124973198|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
124973199|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
124973200|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
124973201|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
124973202|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
124973203|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
124973204|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
124973205|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
124973206|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
124973207|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
124973208|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
124973209|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
124973210|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
124973211|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
124973212|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
124973213|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
124973214|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
124973215|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
124973216|NCT01810939|449529285|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
124973217|NCT01810939|449529286|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
124973218|NCT01810939|449529287|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
124468826|NCT05030311|447674698|FG001|Overall Study|Technical problems|1|||
124468827|NCT05030311|447674697|FG000|Overall Study|Withdrawal by Subject|31|||
124468828|NCT05030311|447674698|FG001|Overall Study|Withdrawal by Subject|17|||
124468829|NCT05030311|447674697|FG000|Overall Study|Adverse Event|13|||
124468830|NCT05030311|447674698|FG001|Overall Study|Adverse Event|5|||
124468831|NCT05030311|447674697|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
124468832|NCT05030311|447674698|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
124468833|NCT05030311|447674697|FG000|Overall Study|Physician Decision|5|||
124468834|NCT05030311|447674698|FG001|Overall Study|Physician Decision|2|||
124468835|NCT05030311|447674697|FG000|Overall Study|Lost to Follow-up|5|||
124468836|NCT05030311|447674698|FG001|Overall Study|Lost to Follow-up|1|||
124468837|NCT05030311|447674697|FG000|Overall Study|Protocol Violation|4|||
124468838|NCT05030311|447674698|FG001|Overall Study|Protocol Violation|4|||
124468839|NCT03529773|447674699|FG000|Overall Study|Adverse Event|0|||
124468840|NCT03529773|447674700|FG001|Overall Study|Adverse Event|0|||
124468841|NCT03529773|447674701|FG002|Overall Study|Adverse Event|0|||
124468842|NCT03529773|447674702|FG003|Overall Study|Adverse Event|0|||
124468843|NCT03529773|447674703|FG004|Overall Study|Adverse Event|0|||
124468844|NCT03529773|447674704|FG005|Overall Study|Adverse Event|0|||
124468845|NCT03529773|447674705|FG006|Overall Study|Adverse Event|0|||
124468846|NCT03529773|447674706|FG007|Overall Study|Adverse Event|0|||
124468847|NCT03529773|447674707|FG008|Overall Study|Adverse Event|0|||
124468848|NCT03529773|447674708|FG009|Overall Study|Adverse Event|0|||
124468849|NCT03529773|447674709|FG010|Overall Study|Adverse Event|0|||
124468850|NCT03529773|447674710|FG011|Overall Study|Adverse Event|0|||
124468851|NCT03529773|447674711|FG012|Overall Study|Adverse Event|0|||
124468852|NCT03529773|447674712|FG013|Overall Study|Adverse Event|0|||
124468853|NCT03529773|447674713|FG014|Overall Study|Adverse Event|0|||
124468854|NCT03529773|447674714|FG015|Overall Study|Adverse Event|0|||
124468855|NCT03529773|447674715|FG016|Overall Study|Adverse Event|0|||
124468856|NCT03529773|447674716|FG017|Overall Study|Adverse Event|0|||
124468857|NCT03529773|447674717|FG018|Overall Study|Adverse Event|0|||
124468858|NCT03529773|447674718|FG019|Overall Study|Adverse Event|0|||
124468859|NCT03529773|447674719|FG020|Overall Study|Adverse Event|0|||
124468860|NCT03529773|447674720|FG021|Overall Study|Adverse Event|0|||
124468861|NCT03529773|447674721|FG022|Overall Study|Adverse Event|0|||
124468862|NCT03529773|447674722|FG023|Overall Study|Adverse Event|0|||
124468863|NCT03529773|447674723|FG024|Overall Study|Adverse Event|0|||
124468864|NCT03529773|447674724|FG025|Overall Study|Adverse Event|0|||
124468865|NCT03529773|447674725|FG026|Overall Study|Adverse Event|0|||
124468866|NCT03529773|447674726|FG027|Overall Study|Adverse Event|0|||
124468867|NCT03529773|447674727|FG028|Overall Study|Adverse Event|0|||
124468868|NCT03529773|447674728|FG029|Overall Study|Adverse Event|0|||
124713384|NCT01673646|448576475|FG002|Overall Study|Condition no longer requires study drug|0|||
124713385|NCT01673646|448576473|FG000|Overall Study|Withdrawal by Subject|0|||
124770402|NCT03773978|448788851|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
124770403|NCT03773978|448788852|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
124770404|NCT03773978|448788851|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
124770405|NCT03773978|448788852|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
124973219|NCT02963090|449529288|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
124973220|NCT02963090|449529289|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
124973221|NCT01375673|449529290|FG000|Overall Study|Withdrawal by Subject|0|||
124973222|NCT01375673|449529291|FG001|Overall Study|Withdrawal by Subject|1|||
124973223|NCT00979953|449529294|FG000|Overall Study|Adverse Event|5|||
124973224|NCT00979953|449529295|FG001|Overall Study|Adverse Event|2|||
124973225|NCT00979953|449529296|FG002|Overall Study|Adverse Event|17|||
124973226|NCT00979953|449529297|FG003|Overall Study|Adverse Event|4|||
124973227|NCT00979953|449529294|FG000|Overall Study|Lack of Efficacy|1|||
124973228|NCT00979953|449529295|FG001|Overall Study|Lack of Efficacy|2|||
124973229|NCT00979953|449529296|FG002|Overall Study|Lack of Efficacy|0|||
124973230|NCT00979953|449529297|FG003|Overall Study|Lack of Efficacy|0|||
124973231|NCT00979953|449529294|FG000|Overall Study|Lost to Follow-up|1|||
124973232|NCT00979953|449529295|FG001|Overall Study|Lost to Follow-up|1|||
124973233|NCT00979953|449529296|FG002|Overall Study|Lost to Follow-up|1|||
124973234|NCT00979953|449529297|FG003|Overall Study|Lost to Follow-up|0|||
124973235|NCT00979953|449529294|FG000|Overall Study|Withdrawal by Subject|0|||
124973236|NCT00979953|449529295|FG001|Overall Study|Withdrawal by Subject|0|||
124973237|NCT00979953|449529296|FG002|Overall Study|Withdrawal by Subject|2|||
124973238|NCT00979953|449529297|FG003|Overall Study|Withdrawal by Subject|1|||
124973239|NCT00979953|449529294|FG000|Overall Study|Protocol Violation|1|||
124973240|NCT00979953|449529295|FG001|Overall Study|Protocol Violation|0|||
124973241|NCT00979953|449529296|FG002|Overall Study|Protocol Violation|2|||
124973242|NCT00979953|449529297|FG003|Overall Study|Protocol Violation|2|||
124973243|NCT01607879|449529303|FG000|Overall Study|Death|1|||
124973244|NCT01607879|449529304|FG001|Overall Study|Death|0|||
124973245|NCT02406248|449529307|FG000|Overall Study|Death|7|||
124973246|NCT02406248|449529307|FG000|Overall Study|Withdrawal by Subject|2|||
124973247|NCT02643628|449529308|FG000|Overall Study|Lost to Follow-up|1|||
124973248|NCT02643628|449529309|FG001|Overall Study|Lost to Follow-up|4|||
124973249|NCT02643628|449529308|FG000|Overall Study|Withdrawal by Subject|0|||
124973250|NCT02643628|449529309|FG001|Overall Study|Withdrawal by Subject|1|||
124973251|NCT02643628|449529308|FG000|Overall Study|Relocated out of state|0|||
124973252|NCT02643628|449529309|FG001|Overall Study|Relocated out of state|1|||
124973253|NCT00706654|449529310|FG000|Conversion Phase|Lost to Follow-up|4|||
124973254|NCT00706654|449529311|FG001|Conversion Phase|Lost to Follow-up|0|||
124973255|NCT00706654|449529312|FG002|Conversion Phase|Lost to Follow-up|0|||
124973256|NCT00706654|449529313|FG003|Conversion Phase|Lost to Follow-up|0|||
124973257|NCT00706654|449529310|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
124973258|NCT00706654|449529311|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
124973259|NCT00706654|449529312|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
124973260|NCT00706654|449529313|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
124973261|NCT00706654|449529310|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
124973262|NCT00706654|449529311|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
124973263|NCT00706654|449529312|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
124973264|NCT00706654|449529313|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
124973265|NCT00706654|449529310|FG000|Conversion Phase|Withdrawn by Investigator|14|||
124973266|NCT00706654|449529311|FG001|Conversion Phase|Withdrawn by Investigator|0|||
124973267|NCT00706654|449529312|FG002|Conversion Phase|Withdrawn by Investigator|0|||
124973268|NCT00706654|449529313|FG003|Conversion Phase|Withdrawn by Investigator|0|||
124973269|NCT00706654|449529310|FG000|Conversion Phase|Withdrew Consent|38|||
124973270|NCT00706654|449529311|FG001|Conversion Phase|Withdrew Consent|0|||
124973271|NCT00706654|449529312|FG002|Conversion Phase|Withdrew Consent|0|||
124973272|NCT00706654|449529313|FG003|Conversion Phase|Withdrew Consent|0|||
124973273|NCT00706654|449529310|FG000|Conversion Phase|Adverse Event|18|||
124973274|NCT00706654|449529311|FG001|Conversion Phase|Adverse Event|0|||
124973275|NCT00706654|449529312|FG002|Conversion Phase|Adverse Event|0|||
124973276|NCT00706654|449529313|FG003|Conversion Phase|Adverse Event|0|||
124770406|NCT03773978|448788851|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
124770407|NCT03773978|448788852|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
124973277|NCT00706654|449529310|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
124973278|NCT00706654|449529311|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
124973279|NCT00706654|449529312|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
124973280|NCT00706654|449529313|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
124973281|NCT00706654|449529310|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
124973282|NCT00706654|449529311|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
124973283|NCT00706654|449529312|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
124973284|NCT00706654|449529313|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
124973285|NCT00706654|449529310|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
124552136|NCT01289990|447978636|FG005|Overall Study|Not treated|0|||
124552137|NCT01289990|447978637|FG006|Overall Study|Not treated|1|||
124552138|NCT01289990|447978638|FG007|Overall Study|Not treated|0|||
124552139|NCT01289990|447978639|FG008|Overall Study|Not treated|1|||
124552140|NCT01289990|447978640|FG009|Overall Study|Not treated|0|||
124552141|NCT01289990|447978641|FG010|Overall Study|Not treated|1|||
124552142|NCT01289990|447978642|FG011|Overall Study|Not treated|2|||
124552143|NCT01289990|447978643|FG012|Overall Study|Not treated|0|||
124552144|NCT00683904|447978644|FG000|Dose Level 1|Disease progression|2|||
124552145|NCT00683904|447978645|FG001|Dose Level 1|Disease progression|0|||
124552146|NCT00683904|447978644|FG000|Dose Level 1|Adverse Event|1|||
124552147|NCT00683904|447978645|FG001|Dose Level 1|Adverse Event|0|||
124552148|NCT00683904|447978644|FG000|Dose Level 2|Adverse Event|0|||
124713386|NCT01673646|448576474|FG001|Overall Study|Withdrawal by Subject|2|||
124973286|NCT00706654|449529311|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
124973287|NCT00706654|449529312|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
124973288|NCT00706654|449529313|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
124973289|NCT00706654|449529310|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
124973290|NCT00706654|449529311|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
124973291|NCT00706654|449529312|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
124973292|NCT00706654|449529313|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
124973293|NCT00706654|449529310|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
124973294|NCT00706654|449529311|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
124973295|NCT00706654|449529312|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
124973296|NCT00706654|449529313|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
124973297|NCT00706654|449529310|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
124973298|NCT00706654|449529311|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
124973299|NCT00706654|449529312|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
124973300|NCT00706654|449529313|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
124973301|NCT00706654|449529310|FG000|Oral Stabilization Phase|Withdrew consent|55|||
124973302|NCT00706654|449529311|FG001|Oral Stabilization Phase|Withdrew consent|0|||
124973303|NCT00706654|449529312|FG002|Oral Stabilization Phase|Withdrew consent|0|||
124973304|NCT00706654|449529313|FG003|Oral Stabilization Phase|Withdrew consent|0|||
124973305|NCT00706654|449529310|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
124973306|NCT00706654|449529311|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
124973307|NCT00706654|449529312|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
124973308|NCT00706654|449529313|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
124973309|NCT00706654|449529310|FG000|Oral Stabilization Phase|Adverse Event|21|||
124973310|NCT00706654|449529311|FG001|Oral Stabilization Phase|Adverse Event|0|||
124973311|NCT00706654|449529312|FG002|Oral Stabilization Phase|Adverse Event|0|||
124973312|NCT00706654|449529313|FG003|Oral Stabilization Phase|Adverse Event|0|||
124973313|NCT00706654|449529310|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
124973314|NCT00706654|449529311|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
124973315|NCT00706654|449529312|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
124973316|NCT00706654|449529313|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
124973317|NCT00706654|449529310|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
124973318|NCT00706654|449529311|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
124973319|NCT00706654|449529312|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
124973320|NCT00706654|449529313|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
124973321|NCT00706654|449529310|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
124973322|NCT00706654|449529311|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
124973323|NCT00706654|449529312|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
124973324|NCT00706654|449529313|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
124973325|NCT00706654|449529310|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
124973326|NCT00706654|449529311|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
124973327|NCT00706654|449529312|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
124973328|NCT00706654|449529313|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
124973329|NCT00706654|449529310|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
124973330|NCT00706654|449529311|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
124973331|NCT00706654|449529312|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
124973332|NCT00706654|449529313|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
124713387|NCT01673646|448576475|FG002|Overall Study|Withdrawal by Subject|2|||
124973333|NCT00706654|449529310|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
124552149|NCT00683904|447978645|FG001|Dose Level 2|Adverse Event|2|||
124973334|NCT00706654|449529311|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
124973335|NCT00706654|449529312|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
124973336|NCT00706654|449529313|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
124973337|NCT00706654|449529310|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
124973338|NCT00706654|449529311|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
124552150|NCT01488071|447978646|FG000|Overall Study|Adverse Event|15|||
124552151|NCT01488071|447978647|FG001|Overall Study|Adverse Event|23|||
124552152|NCT01488071|447978646|FG000|Overall Study|Lack of Efficacy|11|||
124552153|NCT01488071|447978647|FG001|Overall Study|Lack of Efficacy|17|||
124552154|NCT01488071|447978646|FG000|Overall Study|Non-compliance with study drug|2|||
124552155|NCT01488071|447978647|FG001|Overall Study|Non-compliance with study drug|0|||
124552156|NCT01488071|447978646|FG000|Overall Study|Protocol Violation|5|||
124552157|NCT01488071|447978647|FG001|Overall Study|Protocol Violation|7|||
124552158|NCT01488071|447978646|FG000|Overall Study|Withdrawal of Consent|14|||
124552159|NCT01488071|447978647|FG001|Overall Study|Withdrawal of Consent|12|||
124552160|NCT01488071|447978646|FG000|Overall Study|Lost to Follow-up|1|||
124552161|NCT01488071|447978647|FG001|Overall Study|Lost to Follow-up|0|||
124552162|NCT01488071|447978646|FG000|Overall Study|Administrative or Other Reason(s)|5|||
124552163|NCT01488071|447978647|FG001|Overall Study|Administrative or Other Reason(s)|4|||
124552164|NCT04449354|447978648|FG000|Overall Study|Withdrawal by Subject|1|||
124552165|NCT05789420|447978649|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
124552166|NCT05789420|447978649|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
124713388|NCT01673646|448576473|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
124713389|NCT01673646|448576474|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
124713390|NCT01673646|448576475|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
124973339|NCT00706654|449529312|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
124973340|NCT00706654|449529313|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
124973341|NCT00706654|449529310|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
124973342|NCT00706654|449529311|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
124973343|NCT00706654|449529312|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
124973344|NCT00706654|449529313|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
124973345|NCT00706654|449529310|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
124973346|NCT00706654|449529311|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
124973347|NCT00706654|449529312|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
124973348|NCT00706654|449529313|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
124973349|NCT00706654|449529310|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
124973350|NCT00706654|449529311|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
124973351|NCT00706654|449529312|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
124973352|NCT00706654|449529313|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
124973353|NCT01001390|449529317|FG000|Overall Study|Failure to wear AFO device|2|||
124973354|NCT01001390|449529318|FG001|Overall Study|Failure to wear AFO device|0|||
124973355|NCT03690427|449529319|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
124973356|NCT03690427|449529320|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
124973357|NCT01151215|449529324|FG000|Overall Study|Worsening of condition under study|1|||
124973358|NCT01151215|449529325|FG001|Overall Study|Worsening of condition under study|1|||
124973359|NCT01151215|449529326|FG002|Overall Study|Worsening of condition under study|1|||
124973360|NCT01151215|449529324|FG000|Overall Study|Death|16|||
124973361|NCT01151215|449529325|FG001|Overall Study|Death|20|||
124973362|NCT01151215|449529326|FG002|Overall Study|Death|11|||
124973363|NCT01151215|449529324|FG000|Overall Study|Lost to Follow-up|0|||
124973364|NCT01151215|449529325|FG001|Overall Study|Lost to Follow-up|0|||
124973365|NCT01151215|449529326|FG002|Overall Study|Lost to Follow-up|3|||
124973366|NCT01151215|449529324|FG000|Overall Study|Withdrawal by Subject|3|||
124973367|NCT01151215|449529325|FG001|Overall Study|Withdrawal by Subject|1|||
124973368|NCT01151215|449529326|FG002|Overall Study|Withdrawal by Subject|2|||
124973369|NCT01151215|449529324|FG000|Overall Study|Disease progression|0|||
124973370|NCT01151215|449529325|FG001|Overall Study|Disease progression|1|||
124973371|NCT01151215|449529326|FG002|Overall Study|Disease progression|1|||
124973372|NCT01151215|449529324|FG000|Overall Study|Safety as judged by the investigator|0|||
124973373|NCT01151215|449529325|FG001|Overall Study|Safety as judged by the investigator|0|||
124973374|NCT01151215|449529326|FG002|Overall Study|Safety as judged by the investigator|1|||
124973375|NCT01721954|449529327|FG000|Overall Study|Death|58|||
124973376|NCT01721954|449529328|FG001|Overall Study|Death|64|||
124973377|NCT01721954|449529327|FG000|Overall Study|Withdrawal by Subject|8|||
124973378|NCT01721954|449529328|FG001|Overall Study|Withdrawal by Subject|4|||
124973379|NCT01721954|449529327|FG000|Overall Study|Adverse Event|2|||
124973380|NCT01721954|449529328|FG001|Overall Study|Adverse Event|0|||
124973381|NCT01721954|449529327|FG000|Overall Study|Lost to Follow-up|2|||
124973382|NCT01721954|449529328|FG001|Overall Study|Lost to Follow-up|1|||
124973383|NCT02956837|449529332|FG000|Overall Study|Serious Adverse Events|0|||
124973384|NCT02956837|449529333|FG001|Overall Study|Serious Adverse Events|1|||
124973385|NCT02956837|449529334|FG002|Overall Study|Serious Adverse Events|0|||
124552167|NCT02720094|447978650|FG000|Overall Study|Scheduled exit visit/end of study|2|||
124713391|NCT03064074|448576476|FG000|Overall Study|Physician Decision|0|||
124973386|NCT02956837|449529335|FG003|Overall Study|Serious Adverse Events|0|||
124973387|NCT02956837|449529332|FG000|Overall Study|Withdrawal by Subject|0|||
124973388|NCT02956837|449529333|FG001|Overall Study|Withdrawal by Subject|1|||
124973389|NCT02956837|449529334|FG002|Overall Study|Withdrawal by Subject|0|||
124973390|NCT02956837|449529335|FG003|Overall Study|Withdrawal by Subject|3|||
124973391|NCT02956837|449529332|FG000|Overall Study|Lost to Follow-up|0|||
124468869|NCT03529773|447674729|FG030|Overall Study|Adverse Event|1|||
124468870|NCT03529773|447674730|FG031|Overall Study|Adverse Event|0|||
124468871|NCT03529773|447674731|FG032|Overall Study|Adverse Event|0|||
124468872|NCT03529773|447674732|FG033|Overall Study|Adverse Event|0|||
124468873|NCT03529773|447674733|FG034|Overall Study|Adverse Event|0|||
124468874|NCT03529773|447674734|FG035|Overall Study|Adverse Event|1|||
124468875|NCT03529773|447674735|FG036|Overall Study|Adverse Event|0|||
124468876|NCT03529773|447674736|FG037|Overall Study|Adverse Event|0|||
124468877|NCT03529773|447674737|FG038|Overall Study|Adverse Event|1|||
124468878|NCT03529773|447674738|FG039|Overall Study|Adverse Event|1|||
124468879|NCT03529773|447674699|FG000|Overall Study|Death|0|||
124468880|NCT03529773|447674700|FG001|Overall Study|Death|0|||
124468881|NCT03529773|447674701|FG002|Overall Study|Death|0|||
124468882|NCT03529773|447674702|FG003|Overall Study|Death|0|||
124468883|NCT03529773|447674703|FG004|Overall Study|Death|0|||
124468884|NCT03529773|447674704|FG005|Overall Study|Death|0|||
124468885|NCT03529773|447674705|FG006|Overall Study|Death|0|||
124468886|NCT03529773|447674706|FG007|Overall Study|Death|0|||
124468887|NCT03529773|447674707|FG008|Overall Study|Death|0|||
124468888|NCT03529773|447674708|FG009|Overall Study|Death|0|||
124468889|NCT03529773|447674709|FG010|Overall Study|Death|0|||
124468890|NCT03529773|447674710|FG011|Overall Study|Death|0|||
124468891|NCT03529773|447674711|FG012|Overall Study|Death|1|||
124468892|NCT03529773|447674712|FG013|Overall Study|Death|0|||
124468893|NCT03529773|447674713|FG014|Overall Study|Death|0|||
124468894|NCT03529773|447674714|FG015|Overall Study|Death|0|||
124468895|NCT03529773|447674715|FG016|Overall Study|Death|0|||
124468896|NCT03529773|447674716|FG017|Overall Study|Death|0|||
124468897|NCT03529773|447674717|FG018|Overall Study|Death|0|||
124468898|NCT03529773|447674718|FG019|Overall Study|Death|1|||
124468899|NCT03529773|447674719|FG020|Overall Study|Death|0|||
124468900|NCT03529773|447674720|FG021|Overall Study|Death|0|||
124468901|NCT03529773|447674721|FG022|Overall Study|Death|1|||
124468902|NCT03529773|447674722|FG023|Overall Study|Death|0|||
124468903|NCT03529773|447674723|FG024|Overall Study|Death|0|||
124468904|NCT03529773|447674724|FG025|Overall Study|Death|0|||
124468905|NCT03529773|447674725|FG026|Overall Study|Death|0|||
124468906|NCT03529773|447674726|FG027|Overall Study|Death|0|||
124468907|NCT03529773|447674727|FG028|Overall Study|Death|0|||
124468908|NCT03529773|447674728|FG029|Overall Study|Death|0|||
124468909|NCT03529773|447674729|FG030|Overall Study|Death|0|||
124468910|NCT03529773|447674730|FG031|Overall Study|Death|0|||
124468911|NCT03529773|447674731|FG032|Overall Study|Death|0|||
124468912|NCT03529773|447674732|FG033|Overall Study|Death|1|||
124468913|NCT03529773|447674733|FG034|Overall Study|Death|1|||
124468914|NCT03529773|447674734|FG035|Overall Study|Death|0|||
124468915|NCT03529773|447674735|FG036|Overall Study|Death|1|||
124468916|NCT03529773|447674736|FG037|Overall Study|Death|0|||
124468917|NCT03529773|447674737|FG038|Overall Study|Death|0|||
124468918|NCT03529773|447674738|FG039|Overall Study|Death|0|||
124468919|NCT03529773|447674699|FG000|Overall Study|Lost to Follow-up|0|||
124468920|NCT03529773|447674700|FG001|Overall Study|Lost to Follow-up|0|||
124468921|NCT03529773|447674701|FG002|Overall Study|Lost to Follow-up|1|||
124468922|NCT03529773|447674702|FG003|Overall Study|Lost to Follow-up|0|||
124770408|NCT03773978|448788851|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
124770409|NCT03773978|448788852|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
124468923|NCT03529773|447674703|FG004|Overall Study|Lost to Follow-up|1|||
124468924|NCT03529773|447674704|FG005|Overall Study|Lost to Follow-up|1|||
124468925|NCT03529773|447674705|FG006|Overall Study|Lost to Follow-up|0|||
124468926|NCT03529773|447674706|FG007|Overall Study|Lost to Follow-up|0|||
124468927|NCT03529773|447674707|FG008|Overall Study|Lost to Follow-up|0|||
124468928|NCT03529773|447674708|FG009|Overall Study|Lost to Follow-up|0|||
124468929|NCT03529773|447674709|FG010|Overall Study|Lost to Follow-up|0|||
124468930|NCT03529773|447674710|FG011|Overall Study|Lost to Follow-up|0|||
124468931|NCT03529773|447674711|FG012|Overall Study|Lost to Follow-up|0|||
124468932|NCT03529773|447674712|FG013|Overall Study|Lost to Follow-up|1|||
124552168|NCT02720094|447978651|FG001|Overall Study|Scheduled exit visit/end of study|1|||
124468933|NCT03529773|447674713|FG014|Overall Study|Lost to Follow-up|4|||
124468934|NCT03529773|447674714|FG015|Overall Study|Lost to Follow-up|1|||
124468935|NCT03529773|447674715|FG016|Overall Study|Lost to Follow-up|1|||
124468936|NCT03529773|447674716|FG017|Overall Study|Lost to Follow-up|0|||
124973392|NCT02956837|449529333|FG001|Overall Study|Lost to Follow-up|1|||
124973393|NCT02956837|449529334|FG002|Overall Study|Lost to Follow-up|2|||
124973394|NCT02956837|449529335|FG003|Overall Study|Lost to Follow-up|0|||
124973395|NCT02597712|449529336|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
124973396|NCT02597712|449529337|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
124973397|NCT02597712|449529336|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
124973398|NCT02597712|449529337|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
124973399|NCT02597712|449529336|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
124973400|NCT02597712|449529337|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
124973401|NCT02637323|449529338|FG000|Overall Study|Lost to Follow-up|2|||
124973402|NCT02637323|449529339|FG001|Overall Study|Lost to Follow-up|0|||
124973403|NCT02637323|449529338|FG000|Overall Study|Protocol Violation|0|||
124973404|NCT02637323|449529339|FG001|Overall Study|Protocol Violation|1|||
124973405|NCT00513708|449529340|FG000|Overall Study|Lost to Follow-up|4|||
124973406|NCT00513708|449529341|FG001|Overall Study|Lost to Follow-up|4|||
124973407|NCT00513708|449529342|FG002|Overall Study|Lost to Follow-up|4|||
124973408|NCT01162486|449529343|FG000|Overall Study|low ANC|1|||
124973409|NCT01162486|449529344|FG001|Overall Study|low ANC|0|||
124973410|NCT01162486|449529345|FG002|Overall Study|low ANC|0|||
124973411|NCT01162486|449529346|FG003|Overall Study|low ANC|0|||
124973412|NCT01162486|449529347|FG004|Overall Study|low ANC|0|||
124973413|NCT01162486|449529343|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
124973414|NCT01162486|449529344|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
124973415|NCT01162486|449529345|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
124973416|NCT01162486|449529346|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
124973417|NCT01162486|449529347|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
124973418|NCT01162486|449529343|FG000|Overall Study|elevated LFTs|0|||
124973419|NCT01162486|449529344|FG001|Overall Study|elevated LFTs|0|||
124973420|NCT01162486|449529345|FG002|Overall Study|elevated LFTs|1|||
124973421|NCT01162486|449529346|FG003|Overall Study|elevated LFTs|0|||
124552169|NCT02720094|447978650|FG000|Overall Study|Death|4|||
124552170|NCT02720094|447978651|FG001|Overall Study|Death|7|||
124552171|NCT02720094|447978650|FG000|Overall Study|Withdrawal by Subject|55|||
124552172|NCT02720094|447978651|FG001|Overall Study|Withdrawal by Subject|56|||
124552173|NCT02720094|447978650|FG000|Overall Study|Lost to Follow-up|2|||
124713392|NCT03064074|448576477|FG001|Overall Study|Physician Decision|0|||
124552174|NCT02720094|447978651|FG001|Overall Study|Lost to Follow-up|7|||
124552175|NCT02720094|447978650|FG000|Overall Study|Physician Decision|1|||
124713393|NCT03064074|448576478|FG002|Overall Study|Physician Decision|0|||
124713394|NCT03064074|448576479|FG003|Overall Study|Physician Decision|1|||
124713395|NCT02651116|448576481|FG000|Overall Study|Adverse Event|0|||
124713396|NCT02651116|448576482|FG001|Overall Study|Adverse Event|1|||
124973422|NCT01162486|449529347|FG004|Overall Study|elevated LFTs|0|||
124973423|NCT01162486|449529343|FG000|Overall Study|Pregnancy|0|||
124973424|NCT01162486|449529344|FG001|Overall Study|Pregnancy|0|||
124973425|NCT01162486|449529345|FG002|Overall Study|Pregnancy|0|||
124973426|NCT01162486|449529346|FG003|Overall Study|Pregnancy|1|||
124973427|NCT01162486|449529347|FG004|Overall Study|Pregnancy|0|||
124973428|NCT03274895|449529353|FG000|Overall Study|Lack of Efficacy|1|||
124468937|NCT03529773|447674717|FG018|Overall Study|Lost to Follow-up|1|||
124468938|NCT03529773|447674718|FG019|Overall Study|Lost to Follow-up|1|||
124468939|NCT03529773|447674719|FG020|Overall Study|Lost to Follow-up|2|||
124468940|NCT03529773|447674720|FG021|Overall Study|Lost to Follow-up|4|||
124468941|NCT03529773|447674721|FG022|Overall Study|Lost to Follow-up|3|||
124468942|NCT03529773|447674722|FG023|Overall Study|Lost to Follow-up|4|||
124468943|NCT03529773|447674723|FG024|Overall Study|Lost to Follow-up|3|||
124468944|NCT03529773|447674724|FG025|Overall Study|Lost to Follow-up|5|||
124468945|NCT03529773|447674725|FG026|Overall Study|Lost to Follow-up|5|||
124468946|NCT03529773|447674726|FG027|Overall Study|Lost to Follow-up|0|||
124468947|NCT03529773|447674727|FG028|Overall Study|Lost to Follow-up|0|||
124468948|NCT03529773|447674728|FG029|Overall Study|Lost to Follow-up|0|||
124468949|NCT03529773|447674729|FG030|Overall Study|Lost to Follow-up|1|||
124468950|NCT03529773|447674730|FG031|Overall Study|Lost to Follow-up|0|||
124468951|NCT03529773|447674731|FG032|Overall Study|Lost to Follow-up|0|||
124468952|NCT03529773|447674732|FG033|Overall Study|Lost to Follow-up|1|||
124468953|NCT03529773|447674733|FG034|Overall Study|Lost to Follow-up|1|||
124468954|NCT03529773|447674734|FG035|Overall Study|Lost to Follow-up|0|||
124468955|NCT03529773|447674735|FG036|Overall Study|Lost to Follow-up|0|||
124468956|NCT03529773|447674736|FG037|Overall Study|Lost to Follow-up|3|||
124468957|NCT03529773|447674737|FG038|Overall Study|Lost to Follow-up|1|||
124973429|NCT03274895|449529354|FG001|Overall Study|Lack of Efficacy|0|||
124973430|NCT03274895|449529353|FG000|Overall Study|Adverse Event|8|||
124973431|NCT03274895|449529354|FG001|Overall Study|Adverse Event|7|||
124973432|NCT03274895|449529353|FG000|Overall Study|Lost to Follow-up|1|||
124973433|NCT03274895|449529354|FG001|Overall Study|Lost to Follow-up|0|||
124973434|NCT03274895|449529353|FG000|Overall Study|Diagnosis not confirmed|3|||
124973435|NCT03274895|449529354|FG001|Overall Study|Diagnosis not confirmed|4|||
124973436|NCT03229486|449529360|FG000|Overall Study|Protocol Violation|0|||
124973437|NCT03229486|449529361|FG001|Overall Study|Protocol Violation|1|||
124973438|NCT01461005|449529362|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
124973439|NCT00760747|449529367|FG000|Study Period II|Adverse Event|3|||
124973440|NCT00760747|449529368|FG001|Study Period II|Adverse Event|4|||
124973441|NCT00760747|449529367|FG000|Study Period II|Lack of Efficacy|0|||
124973442|NCT00760747|449529368|FG001|Study Period II|Lack of Efficacy|6|||
124973443|NCT00760747|449529367|FG000|Study Period II|Parent/Caregiver Decision|3|||
124973444|NCT00760747|449529368|FG001|Study Period II|Parent/Caregiver Decision|0|||
124973445|NCT00760747|449529367|FG000|Study Period II|Protocol Violation|6|||
124973446|NCT00760747|449529368|FG001|Study Period II|Protocol Violation|3|||
124973447|NCT00760747|449529367|FG000|Study Period II|Withdrawal by Subject|1|||
124973448|NCT00760747|449529368|FG001|Study Period II|Withdrawal by Subject|0|||
124973449|NCT00760747|449529367|FG000|Study Period II|No drug administered|0|||
124973450|NCT00760747|449529368|FG001|Study Period II|No drug administered|1|||
124973451|NCT00760747|449529367|FG000|Study Period III|Adverse Event|1|||
124973452|NCT00760747|449529368|FG001|Study Period III|Adverse Event|0|||
124973453|NCT00760747|449529367|FG000|Study Period III|Lack of Efficacy|1|||
124973454|NCT00760747|449529368|FG001|Study Period III|Lack of Efficacy|0|||
124973455|NCT00760747|449529367|FG000|Study Period III|Parent/Caregiver Decision|0|||
124973456|NCT00760747|449529368|FG001|Study Period III|Parent/Caregiver Decision|1|||
124973457|NCT00760747|449529367|FG000|Study Period III|Protocol Violation|1|||
124973458|NCT00760747|449529368|FG001|Study Period III|Protocol Violation|1|||
124468958|NCT03529773|447674738|FG039|Overall Study|Lost to Follow-up|1|||
124468959|NCT03529773|447674699|FG000|Overall Study|No longer meets eligibility criteria|0|||
124468960|NCT03529773|447674700|FG001|Overall Study|No longer meets eligibility criteria|0|||
124468961|NCT03529773|447674701|FG002|Overall Study|No longer meets eligibility criteria|0|||
124468962|NCT03529773|447674702|FG003|Overall Study|No longer meets eligibility criteria|0|||
124468963|NCT03529773|447674703|FG004|Overall Study|No longer meets eligibility criteria|0|||
124468964|NCT03529773|447674704|FG005|Overall Study|No longer meets eligibility criteria|0|||
124468965|NCT03529773|447674705|FG006|Overall Study|No longer meets eligibility criteria|0|||
124468966|NCT03529773|447674706|FG007|Overall Study|No longer meets eligibility criteria|0|||
124468967|NCT03529773|447674707|FG008|Overall Study|No longer meets eligibility criteria|0|||
124468968|NCT03529773|447674708|FG009|Overall Study|No longer meets eligibility criteria|0|||
124468969|NCT03529773|447674709|FG010|Overall Study|No longer meets eligibility criteria|0|||
124713397|NCT02651116|448576481|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
124713398|NCT02651116|448576482|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
124713399|NCT02457247|448576483|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
124973459|NCT00760747|449529367|FG000|Study Period III|Physician Decision|0|||
124468970|NCT03529773|447674710|FG011|Overall Study|No longer meets eligibility criteria|0|||
124468971|NCT03529773|447674711|FG012|Overall Study|No longer meets eligibility criteria|0|||
124468972|NCT03529773|447674712|FG013|Overall Study|No longer meets eligibility criteria|0|||
124468973|NCT03529773|447674713|FG014|Overall Study|No longer meets eligibility criteria|0|||
124468974|NCT03529773|447674714|FG015|Overall Study|No longer meets eligibility criteria|0|||
124713400|NCT02457247|448576484|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
124973460|NCT00760747|449529368|FG001|Study Period III|Physician Decision|1|||
124973461|NCT01443923|449529369|FG000|Overall Study|Adverse Event|1|||
124973462|NCT01443923|449529370|FG001|Overall Study|Adverse Event|0|||
124973463|NCT03566979|449529373|FG000|Overall Study|Withdrawal by Subject|2|||
124973464|NCT03566979|449529374|FG001|Overall Study|Withdrawal by Subject|0|||
124973465|NCT03566979|449529375|FG002|Overall Study|Withdrawal by Subject|1|||
124552176|NCT02720094|447978651|FG001|Overall Study|Physician Decision|3|||
124552177|NCT02720094|447978650|FG000|Overall Study|Inappropriate enrollment|1|||
124552178|NCT02720094|447978651|FG001|Overall Study|Inappropriate enrollment|3|||
124552179|NCT02720094|447978650|FG000|Overall Study|Ongoing|2210|||
124552180|NCT02720094|447978651|FG001|Overall Study|Ongoing|2203|||
124552181|NCT02720094|447978650|FG000|Overall Study|Relocation|1|||
124552182|NCT02720094|447978651|FG001|Overall Study|Relocation|1|||
124552183|NCT01220128|447978652|FG000|Overall Study|Progressive disease|0|||
124552184|NCT01220128|447978653|FG001|Overall Study|Progressive disease|0|||
124552185|NCT01220128|447978654|FG002|Overall Study|Progressive disease|2|||
124552186|NCT01220128|447978655|FG003|Overall Study|Progressive disease|0|||
124552187|NCT01220128|447978656|FG004|Overall Study|Progressive disease|0|||
124552188|NCT01220128|447978657|FG005|Overall Study|Progressive disease|0|||
124552189|NCT01220128|447978658|FG006|Overall Study|Progressive disease|0|||
124552190|NCT01220128|447978652|FG000|Overall Study|Sponsor study termination|0|||
124552191|NCT01220128|447978653|FG001|Overall Study|Sponsor study termination|1|||
124552192|NCT01220128|447978654|FG002|Overall Study|Sponsor study termination|0|||
124552193|NCT01220128|447978655|FG003|Overall Study|Sponsor study termination|0|||
124552194|NCT01220128|447978656|FG004|Overall Study|Sponsor study termination|0|||
124552195|NCT01220128|447978657|FG005|Overall Study|Sponsor study termination|0|||
124552196|NCT01220128|447978658|FG006|Overall Study|Sponsor study termination|1|||
124973466|NCT03566979|449529376|FG003|Overall Study|Withdrawal by Subject|1|||
124973467|NCT03566979|449529373|FG000|Overall Study|Lost to Follow-up|2|||
124973468|NCT03566979|449529374|FG001|Overall Study|Lost to Follow-up|7|||
124973469|NCT03566979|449529375|FG002|Overall Study|Lost to Follow-up|9|||
124973470|NCT03566979|449529376|FG003|Overall Study|Lost to Follow-up|5|||
124973471|NCT03566979|449529373|FG000|Overall Study|Adverse Event|1|||
124973472|NCT03566979|449529374|FG001|Overall Study|Adverse Event|0|||
124973473|NCT03566979|449529375|FG002|Overall Study|Adverse Event|0|||
124973474|NCT03566979|449529376|FG003|Overall Study|Adverse Event|0|||
124973475|NCT01889069|449529381|FG000|Overall Study|Death|18|||
124973476|NCT01889069|449529381|FG000|Overall Study|Progression of Disease|14|||
124973477|NCT01889069|449529381|FG000|Overall Study|Lost to Follow-up|6|||
124552197|NCT01220128|447978652|FG000|Overall Study|Adverse event, serious fatal|2|||
124552198|NCT01220128|447978653|FG001|Overall Study|Adverse event, serious fatal|0|||
124552199|NCT01220128|447978654|FG002|Overall Study|Adverse event, serious fatal|0|||
124552200|NCT01220128|447978655|FG003|Overall Study|Adverse event, serious fatal|0|||
124552201|NCT01220128|447978656|FG004|Overall Study|Adverse event, serious fatal|0|||
124552202|NCT01220128|447978657|FG005|Overall Study|Adverse event, serious fatal|0|||
124552203|NCT01220128|447978658|FG006|Overall Study|Adverse event, serious fatal|1|||
124973478|NCT01889069|449529381|FG000|Overall Study|Other|4|||
124973479|NCT01889069|449529381|FG000|Overall Study|Consent Withdrawal|3|||
124973480|NCT01228175|449529382|FG000|Overall Study|Lost to Follow-up|64|||
124973481|NCT01228175|449529383|FG001|Overall Study|Lost to Follow-up|50|||
124973482|NCT01228175|449529382|FG000|Overall Study|Withdrawal by Subject|1|||
124973483|NCT01228175|449529383|FG001|Overall Study|Withdrawal by Subject|2|||
124973484|NCT01228175|449529382|FG000|Overall Study|Physician Decision|1|||
124973485|NCT01228175|449529383|FG001|Overall Study|Physician Decision|1|||
124973486|NCT00108745|449529384|FG000|Overall Study|Withdrawal by Subject|19|||
124973487|NCT00108745|449529385|FG001|Overall Study|Withdrawal by Subject|12|||
124973488|NCT00108745|449529386|FG002|Overall Study|Withdrawal by Subject|12|||
124973489|NCT00108745|449529384|FG000|Overall Study|Never Treated|8|||
124973490|NCT00108745|449529385|FG001|Overall Study|Never Treated|10|||
124973491|NCT00108745|449529386|FG002|Overall Study|Never Treated|12|||
124973492|NCT00108745|449529384|FG000|Overall Study|Ineligible|7|||
124973493|NCT00108745|449529385|FG001|Overall Study|Ineligible|13|||
124973494|NCT00108745|449529386|FG002|Overall Study|Ineligible|13|||
124973495|NCT00455741|449529388|FG000|Overall Study|Physician Decision|0|||
124973496|NCT00455741|449529389|FG001|Overall Study|Physician Decision|1|||
124973497|NCT01245374|449529393|FG000|Overall Study|Protocol Violation|1|||
124973498|NCT01245374|449529393|FG000|Overall Study|Withdrawal by Subject|3|||
124973499|NCT00935532|449529396|FG000|Overall Study|Adverse Event|11|||
124973500|NCT00935532|449529397|FG001|Overall Study|Adverse Event|6|||
124973501|NCT00935532|449529396|FG000|Overall Study|Death|1|||
124973502|NCT00935532|449529397|FG001|Overall Study|Death|0|||
124973503|NCT00935532|449529396|FG000|Overall Study|Lost to Follow-up|1|||
124973504|NCT00935532|449529397|FG001|Overall Study|Lost to Follow-up|0|||
124973505|NCT00935532|449529396|FG000|Overall Study|Physician Decision|1|||
124973506|NCT00935532|449529397|FG001|Overall Study|Physician Decision|2|||
124973507|NCT00935532|449529396|FG000|Overall Study|Protocol Violation|2|||
124973508|NCT00935532|449529397|FG001|Overall Study|Protocol Violation|1|||
124973509|NCT00935532|449529396|FG000|Overall Study|Subject Decision|2|||
124973510|NCT00935532|449529397|FG001|Overall Study|Subject Decision|1|||
124973511|NCT00935532|449529396|FG000|Overall Study|Sponsor Decision|0|||
124973512|NCT00935532|449529397|FG001|Overall Study|Sponsor Decision|1|||
124973513|NCT00935532|449529396|FG000|Overall Study|Loss Glucose Control|4|||
124973514|NCT00935532|449529397|FG001|Overall Study|Loss Glucose Control|0|||
124973515|NCT02227992|449529398|FG000|Overall Study|Lost to Follow-up|1|||
124973516|NCT02227992|449529399|FG001|Overall Study|Lost to Follow-up|1|||
124973517|NCT04954326|449529400|FG000|Overall Study|Protocol Violation|0|||
124973518|NCT04954326|449529401|FG001|Overall Study|Protocol Violation|1|||
124973519|NCT04954326|449529400|FG000|Overall Study|Death|0|||
124973520|NCT04954326|449529401|FG001|Overall Study|Death|2|||
124973521|NCT04954326|449529400|FG000|Overall Study|Physician Decision|0|||
124973522|NCT04954326|449529401|FG001|Overall Study|Physician Decision|1|||
124973523|NCT04982575|449529402|FG000|Overall Study|Withdrawal by Subject|2|||
124973524|NCT04982575|449529403|FG001|Overall Study|Withdrawal by Subject|0|||
124973525|NCT04982575|449529404|FG002|Overall Study|Withdrawal by Subject|2|||
124468975|NCT03529773|447674715|FG016|Overall Study|No longer meets eligibility criteria|0|||
124468976|NCT03529773|447674716|FG017|Overall Study|No longer meets eligibility criteria|0|||
124973526|NCT00475228|449529405|FG000|Overall Study|Lost to Follow-up|17|||
124973527|NCT00475228|449529406|FG001|Overall Study|Lost to Follow-up|17|||
124973528|NCT04949802|449531544|FG000|Overall Study|Lost to Follow-up|3|||
124973529|NCT02473965|449531545|FG000|Overall Study|Adverse Event|6|||
124973530|NCT02473965|449531546|FG001|Overall Study|Adverse Event|4|||
124973531|NCT02473965|449531545|FG000|Overall Study|MG worsening|4|||
124973532|NCT02473965|449531546|FG001|Overall Study|MG worsening|1|||
124973533|NCT02473965|449531545|FG000|Overall Study|Withdrawal by Subject|2|||
124973534|NCT02473965|449531546|FG001|Overall Study|Withdrawal by Subject|3|||
124973535|NCT02473965|449531545|FG000|Overall Study|Physician Decision|0|||
124973536|NCT02473965|449531546|FG001|Overall Study|Physician Decision|2|||
124973537|NCT01183390|449531547|FG000|First Intervention|Adverse Event|0|||
124973538|NCT01183390|449531548|FG001|First Intervention|Adverse Event|1|||
124973539|NCT03816761|449531549|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
124973540|NCT03816761|449531550|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
124973541|NCT03816761|449531551|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
124973542|NCT03816761|449531552|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
124973543|NCT03816761|449531553|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
124973544|NCT03816761|449531554|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
124973545|NCT03816761|449531549|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
124973546|NCT03816761|449531550|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
124973547|NCT03816761|449531551|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
124973548|NCT03816761|449531552|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
124973549|NCT03816761|449531553|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
124973550|NCT03816761|449531554|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
124973551|NCT01240551|449531555|FG000|Overall Study|Refused further treatment|3|||
124973552|NCT01240551|449531556|FG001|Overall Study|Refused further treatment|2|||
124973553|NCT01240551|449531555|FG000|Overall Study|Lost to Follow-up|1|||
124973554|NCT01240551|449531556|FG001|Overall Study|Lost to Follow-up|1|||
124973555|NCT01730950|449531562|FG000|Overall Study|Protocol Violation|6|||
124713401|NCT02457247|448576485|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
124713402|NCT02457247|448576486|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
124713403|NCT02457247|448576483|FG000|Period 1|Significant Protocol Deviation|1|||
124713404|NCT02457247|448576484|FG001|Period 1|Significant Protocol Deviation|1|||
124713405|NCT02457247|448576485|FG002|Period 1|Significant Protocol Deviation|0|||
124713406|NCT02457247|448576486|FG003|Period 1|Significant Protocol Deviation|0|||
124713407|NCT02457247|448576483|FG000|Period 1|Voluntary Withdrawal|1|||
124713408|NCT02457247|448576484|FG001|Period 1|Voluntary Withdrawal|0|||
124713409|NCT02457247|448576485|FG002|Period 1|Voluntary Withdrawal|0|||
124713410|NCT02457247|448576486|FG003|Period 1|Voluntary Withdrawal|0|||
124713411|NCT02457247|448576483|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
124713412|NCT02457247|448576484|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
124713413|NCT02457247|448576485|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
124770410|NCT03773978|448788851|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
124770411|NCT03773978|448788852|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
124713414|NCT02457247|448576486|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
124973556|NCT01730950|449531563|FG001|Overall Study|Protocol Violation|6|||
124973557|NCT00667459|449531564|FG000|Overall Study|Death|0|||
124973558|NCT00667459|449531565|FG001|Overall Study|Death|2|||
124973559|NCT00667459|449531564|FG000|Overall Study|Lost to Follow-up|8|||
124973560|NCT00667459|449531565|FG001|Overall Study|Lost to Follow-up|43|||
124973561|NCT02568397|449531566|FG000|Period 2|Withdrawal by Subject|0|||
124973562|NCT02568397|449531567|FG001|Period 2|Withdrawal by Subject|1|||
124973563|NCT02568397|449531566|FG000|Period 2|Physician Decision|0|||
124973564|NCT02568397|449531567|FG001|Period 2|Physician Decision|1|||
124973565|NCT01200342|449531568|FG000|Overall Study|Disease Progression|1|||
124973566|NCT04546217|449531571|FG000|Overall Study|Withdrawal by Subject|2|||
124973567|NCT04546217|449531572|FG001|Overall Study|Withdrawal by Subject|0|||
124973568|NCT04546217|449531571|FG000|Overall Study|Uncontrolled hypertension|1|||
124973569|NCT04546217|449531572|FG001|Overall Study|Uncontrolled hypertension|0|||
124973570|NCT02550938|449531573|FG000|Overall Study|Lost to Follow-up|8|||
124973571|NCT02550938|449531574|FG001|Overall Study|Lost to Follow-up|7|||
124973572|NCT02550938|449531575|FG002|Overall Study|Lost to Follow-up|12|||
124973573|NCT02550938|449531576|FG003|Overall Study|Lost to Follow-up|11|||
124973574|NCT01484431|449531577|FG000|Period 1: High Dose|Physician Decision|0|||
124973575|NCT01484431|449531578|FG001|Period 1: High Dose|Physician Decision|1|||
124973576|NCT01484431|449531579|FG002|Period 1: High Dose|Physician Decision|0|||
124973577|NCT01484431|449531577|FG000|Period 2|Death|0|||
124973578|NCT01484431|449531578|FG001|Period 2|Death|1|||
124973579|NCT01484431|449531579|FG002|Period 2|Death|1|||
124973580|NCT01484431|449531577|FG000|Period 2|Physician Decision|0|||
124973581|NCT01484431|449531578|FG001|Period 2|Physician Decision|0|||
124973582|NCT01484431|449531579|FG002|Period 2|Physician Decision|1|||
124973583|NCT01484431|449531577|FG000|Period 2|Non-Compliance with Study Drug|1|||
124973584|NCT01484431|449531578|FG001|Period 2|Non-Compliance with Study Drug|0|||
124973585|NCT01484431|449531579|FG002|Period 2|Non-Compliance with Study Drug|0|||
124973586|NCT01888874|449531583|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
124973587|NCT01888874|449531584|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
124973588|NCT01888874|449531585|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
124973589|NCT01888874|449531586|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
124973590|NCT01888874|449531587|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
124973591|NCT01888874|449531588|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
124973592|NCT01888874|449531589|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
124973593|NCT01888874|449531583|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
124973594|NCT01888874|449531584|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
124973595|NCT01888874|449531585|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
124973596|NCT01888874|449531586|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
124973597|NCT01888874|449531587|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
124973598|NCT01888874|449531588|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
124973599|NCT01888874|449531589|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
124973600|NCT01888874|449531583|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
124973601|NCT01888874|449531584|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
124973602|NCT01888874|449531585|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
124973603|NCT01888874|449531586|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
124973604|NCT01888874|449531587|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
124973605|NCT01888874|449531588|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
124973606|NCT01888874|449531589|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
124973607|NCT01888874|449531583|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
124973608|NCT01888874|449531584|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
124973609|NCT01888874|449531585|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
124973610|NCT01888874|449531586|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
124973611|NCT01888874|449531587|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
124973612|NCT01888874|449531588|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
124973613|NCT01888874|449531589|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
124973614|NCT01888874|449531583|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
124973615|NCT01888874|449531584|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
124973616|NCT01888874|449531585|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
124973617|NCT01888874|449531586|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
124973618|NCT01888874|449531587|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
124973619|NCT01888874|449531588|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
124468977|NCT03529773|447674717|FG018|Overall Study|No longer meets eligibility criteria|0|||
124468978|NCT03529773|447674718|FG019|Overall Study|No longer meets eligibility criteria|0|||
124468979|NCT03529773|447674719|FG020|Overall Study|No longer meets eligibility criteria|0|||
124468980|NCT03529773|447674720|FG021|Overall Study|No longer meets eligibility criteria|0|||
124468981|NCT03529773|447674721|FG022|Overall Study|No longer meets eligibility criteria|1|||
124468982|NCT03529773|447674722|FG023|Overall Study|No longer meets eligibility criteria|0|||
124468983|NCT03529773|447674723|FG024|Overall Study|No longer meets eligibility criteria|0|||
124468984|NCT03529773|447674724|FG025|Overall Study|No longer meets eligibility criteria|0|||
124468985|NCT03529773|447674725|FG026|Overall Study|No longer meets eligibility criteria|0|||
124468986|NCT03529773|447674726|FG027|Overall Study|No longer meets eligibility criteria|0|||
124468987|NCT03529773|447674727|FG028|Overall Study|No longer meets eligibility criteria|0|||
124468988|NCT03529773|447674728|FG029|Overall Study|No longer meets eligibility criteria|0|||
124468989|NCT03529773|447674729|FG030|Overall Study|No longer meets eligibility criteria|0|||
124468990|NCT03529773|447674730|FG031|Overall Study|No longer meets eligibility criteria|0|||
124468991|NCT03529773|447674731|FG032|Overall Study|No longer meets eligibility criteria|0|||
124468992|NCT03529773|447674732|FG033|Overall Study|No longer meets eligibility criteria|0|||
124468993|NCT03529773|447674733|FG034|Overall Study|No longer meets eligibility criteria|0|||
124468994|NCT03529773|447674734|FG035|Overall Study|No longer meets eligibility criteria|0|||
124468995|NCT03529773|447674735|FG036|Overall Study|No longer meets eligibility criteria|0|||
124468996|NCT03529773|447674736|FG037|Overall Study|No longer meets eligibility criteria|0|||
124468997|NCT03529773|447674737|FG038|Overall Study|No longer meets eligibility criteria|1|||
124468998|NCT03529773|447674738|FG039|Overall Study|No longer meets eligibility criteria|0|||
124973620|NCT01888874|449531589|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
124973621|NCT01888874|449531583|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
124973622|NCT01888874|449531584|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
124973623|NCT01888874|449531585|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
124973624|NCT01888874|449531586|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
124973625|NCT01888874|449531587|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
124973626|NCT01888874|449531588|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
124973627|NCT01888874|449531589|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
124973628|NCT01888874|449531583|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
124973629|NCT01888874|449531584|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
124973630|NCT01888874|449531585|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
124973631|NCT01888874|449531586|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
124973632|NCT01888874|449531587|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
124973633|NCT01888874|449531588|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
124973634|NCT01888874|449531589|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
124973635|NCT01888874|449531583|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
124973636|NCT01888874|449531584|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
124973637|NCT01888874|449531585|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
124973638|NCT01888874|449531586|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
124973639|NCT01888874|449531587|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
124973640|NCT01888874|449531588|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
124973641|NCT01888874|449531589|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
124973642|NCT01888874|449531583|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
124973643|NCT01888874|449531584|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
124973644|NCT01888874|449531585|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
124973645|NCT01888874|449531586|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
124973646|NCT01888874|449531587|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
124973647|NCT01888874|449531588|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
124973648|NCT01888874|449531589|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
124973649|NCT01888874|449531583|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
124973650|NCT01888874|449531584|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
124973651|NCT01888874|449531585|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
124973652|NCT01888874|449531586|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
124973653|NCT01888874|449531587|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
124973654|NCT01888874|449531588|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
124973655|NCT01888874|449531589|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
124973656|NCT01888874|449531583|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
124973657|NCT01888874|449531584|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
124973658|NCT01888874|449531585|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
124973659|NCT01888874|449531586|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
124973660|NCT01888874|449531587|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
124973661|NCT01888874|449531588|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
124973662|NCT01888874|449531589|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
124973663|NCT01888874|449531583|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
124973664|NCT01888874|449531584|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
124973665|NCT01888874|449531585|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
124973666|NCT01888874|449531586|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
124973667|NCT01888874|449531587|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
124468999|NCT03529773|447674699|FG000|Overall Study|Other|0|||
124469000|NCT03529773|447674700|FG001|Overall Study|Other|0|||
124973668|NCT01888874|449531588|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
124973669|NCT01888874|449531589|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
124973670|NCT01888874|449531583|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
124973671|NCT01888874|449531584|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
124973672|NCT01888874|449531585|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
124973673|NCT01888874|449531586|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
124973674|NCT01888874|449531587|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
124973675|NCT01888874|449531588|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
124469001|NCT03529773|447674701|FG002|Overall Study|Other|0|||
124469002|NCT03529773|447674702|FG003|Overall Study|Other|0|||
124469003|NCT03529773|447674703|FG004|Overall Study|Other|0|||
124469004|NCT03529773|447674704|FG005|Overall Study|Other|0|||
124469005|NCT03529773|447674705|FG006|Overall Study|Other|0|||
124469006|NCT03529773|447674706|FG007|Overall Study|Other|0|||
124469007|NCT03529773|447674707|FG008|Overall Study|Other|0|||
124469008|NCT03529773|447674708|FG009|Overall Study|Other|0|||
124469009|NCT03529773|447674709|FG010|Overall Study|Other|0|||
124469010|NCT03529773|447674710|FG011|Overall Study|Other|0|||
124469011|NCT03529773|447674711|FG012|Overall Study|Other|1|||
124469012|NCT03529773|447674712|FG013|Overall Study|Other|0|||
124469013|NCT03529773|447674713|FG014|Overall Study|Other|2|||
124469014|NCT03529773|447674714|FG015|Overall Study|Other|0|||
124469015|NCT03529773|447674715|FG016|Overall Study|Other|0|||
124469016|NCT03529773|447674716|FG017|Overall Study|Other|3|||
124469017|NCT03529773|447674717|FG018|Overall Study|Other|0|||
124469018|NCT03529773|447674718|FG019|Overall Study|Other|0|||
124469019|NCT03529773|447674719|FG020|Overall Study|Other|1|||
124469020|NCT03529773|447674720|FG021|Overall Study|Other|0|||
124469021|NCT03529773|447674721|FG022|Overall Study|Other|1|||
124469022|NCT03529773|447674722|FG023|Overall Study|Other|0|||
124469023|NCT03529773|447674723|FG024|Overall Study|Other|3|||
124469024|NCT03529773|447674724|FG025|Overall Study|Other|2|||
124469025|NCT03529773|447674725|FG026|Overall Study|Other|2|||
124469026|NCT03529773|447674726|FG027|Overall Study|Other|0|||
124469027|NCT03529773|447674727|FG028|Overall Study|Other|0|||
124469028|NCT03529773|447674728|FG029|Overall Study|Other|0|||
124469029|NCT03529773|447674729|FG030|Overall Study|Other|0|||
124469030|NCT03529773|447674730|FG031|Overall Study|Other|0|||
124469031|NCT03529773|447674731|FG032|Overall Study|Other|0|||
124469032|NCT03529773|447674732|FG033|Overall Study|Other|0|||
124469033|NCT03529773|447674733|FG034|Overall Study|Other|1|||
124469034|NCT03529773|447674734|FG035|Overall Study|Other|1|||
124469035|NCT03529773|447674735|FG036|Overall Study|Other|0|||
124469036|NCT03529773|447674736|FG037|Overall Study|Other|0|||
124469037|NCT03529773|447674737|FG038|Overall Study|Other|0|||
124469038|NCT03529773|447674738|FG039|Overall Study|Other|0|||
124469039|NCT03529773|447674699|FG000|Overall Study|Physician Decision|0|||
124469040|NCT03529773|447674700|FG001|Overall Study|Physician Decision|0|||
124469041|NCT03529773|447674701|FG002|Overall Study|Physician Decision|0|||
124469042|NCT03529773|447674702|FG003|Overall Study|Physician Decision|0|||
124469043|NCT03529773|447674703|FG004|Overall Study|Physician Decision|0|||
124469044|NCT03529773|447674704|FG005|Overall Study|Physician Decision|0|||
124469045|NCT03529773|447674705|FG006|Overall Study|Physician Decision|0|||
124469046|NCT03529773|447674706|FG007|Overall Study|Physician Decision|0|||
124469047|NCT03529773|447674707|FG008|Overall Study|Physician Decision|0|||
124469048|NCT03529773|447674708|FG009|Overall Study|Physician Decision|0|||
124469049|NCT03529773|447674709|FG010|Overall Study|Physician Decision|0|||
124469050|NCT03529773|447674710|FG011|Overall Study|Physician Decision|0|||
124469051|NCT03529773|447674711|FG012|Overall Study|Physician Decision|0|||
124469052|NCT03529773|447674712|FG013|Overall Study|Physician Decision|0|||
124469053|NCT03529773|447674713|FG014|Overall Study|Physician Decision|0|||
124469054|NCT03529773|447674714|FG015|Overall Study|Physician Decision|0|||
124469055|NCT03529773|447674715|FG016|Overall Study|Physician Decision|0|||
124469056|NCT03529773|447674716|FG017|Overall Study|Physician Decision|0|||
124469057|NCT03529773|447674717|FG018|Overall Study|Physician Decision|0|||
124469058|NCT03529773|447674718|FG019|Overall Study|Physician Decision|1|||
124469059|NCT03529773|447674719|FG020|Overall Study|Physician Decision|1|||
124469060|NCT03529773|447674720|FG021|Overall Study|Physician Decision|0|||
124469061|NCT03529773|447674721|FG022|Overall Study|Physician Decision|0|||
124469062|NCT03529773|447674722|FG023|Overall Study|Physician Decision|0|||
124469063|NCT03529773|447674723|FG024|Overall Study|Physician Decision|0|||
124469064|NCT03529773|447674724|FG025|Overall Study|Physician Decision|0|||
124469065|NCT03529773|447674725|FG026|Overall Study|Physician Decision|0|||
124469066|NCT03529773|447674726|FG027|Overall Study|Physician Decision|0|||
124469067|NCT03529773|447674727|FG028|Overall Study|Physician Decision|0|||
124469068|NCT03529773|447674728|FG029|Overall Study|Physician Decision|0|||
124469069|NCT03529773|447674729|FG030|Overall Study|Physician Decision|0|||
124469070|NCT03529773|447674730|FG031|Overall Study|Physician Decision|0|||
124469071|NCT03529773|447674731|FG032|Overall Study|Physician Decision|0|||
124469072|NCT03529773|447674732|FG033|Overall Study|Physician Decision|0|||
124469073|NCT03529773|447674733|FG034|Overall Study|Physician Decision|0|||
124469074|NCT03529773|447674734|FG035|Overall Study|Physician Decision|0|||
124469075|NCT03529773|447674735|FG036|Overall Study|Physician Decision|0|||
124469076|NCT03529773|447674736|FG037|Overall Study|Physician Decision|0|||
124469077|NCT03529773|447674737|FG038|Overall Study|Physician Decision|0|||
124469078|NCT03529773|447674738|FG039|Overall Study|Physician Decision|0|||
124469079|NCT03529773|447674699|FG000|Overall Study|Protocol Violation|0|||
124469080|NCT03529773|447674700|FG001|Overall Study|Protocol Violation|0|||
124469081|NCT03529773|447674701|FG002|Overall Study|Protocol Violation|0|||
124469082|NCT03529773|447674702|FG003|Overall Study|Protocol Violation|0|||
124469083|NCT03529773|447674703|FG004|Overall Study|Protocol Violation|0|||
124770412|NCT03773978|448788851|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
124770413|NCT03773978|448788852|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
124770414|NCT03773978|448788851|FG000|DBW Period|Adverse Event|2|||
124973676|NCT01888874|449531589|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
124973677|NCT02763215|449531590|FG000|Overall Study|Participants withdrew from study|3|||
124973678|NCT02763215|449531590|FG000|Overall Study|Missed visit|1|||
124973679|NCT02763215|449531590|FG000|Overall Study|Visit outside visit-window|1|||
124973680|NCT02763215|449531590|FG000|Overall Study|Death|1|||
124973681|NCT02763215|449531590|FG000|Overall Study|Lost to Follow-up|1|||
124973682|NCT00475644|449531592|FG000|Overall Study|Protocol Violation|13|||
124973683|NCT01411241|449531593|FG000|Overall Study|Protocol Violation|0|||
124973684|NCT01411241|449531594|FG001|Overall Study|Protocol Violation|5|||
124973685|NCT01411241|449531593|FG000|Overall Study|Withdrawal by Subject|9|||
124973686|NCT01411241|449531594|FG001|Overall Study|Withdrawal by Subject|10|||
124973687|NCT01411241|449531593|FG000|Overall Study|Serious Adverse Event|0|||
124973688|NCT01411241|449531594|FG001|Overall Study|Serious Adverse Event|3|||
124973689|NCT01411241|449531593|FG000|Overall Study|Lost to Follow-up|2|||
124973690|NCT01411241|449531594|FG001|Overall Study|Lost to Follow-up|4|||
124973691|NCT02980042|449531599|FG000|Overall Study|Lost to Follow-up|5|||
124973692|NCT02980042|449531600|FG001|Overall Study|Lost to Follow-up|0|||
124973693|NCT02980042|449531599|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
124973694|NCT02980042|449531600|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
124973695|NCT01483144|449531605|FG000|Overall Study|Adverse Event|9|||
124973696|NCT01483144|449531606|FG001|Overall Study|Adverse Event|4|||
124973697|NCT01483144|449531607|FG002|Overall Study|Adverse Event|6|||
124469084|NCT03529773|447674704|FG005|Overall Study|Protocol Violation|0|||
124469085|NCT03529773|447674705|FG006|Overall Study|Protocol Violation|0|||
124469086|NCT03529773|447674706|FG007|Overall Study|Protocol Violation|0|||
124469087|NCT03529773|447674707|FG008|Overall Study|Protocol Violation|0|||
124469088|NCT03529773|447674708|FG009|Overall Study|Protocol Violation|0|||
124469089|NCT03529773|447674709|FG010|Overall Study|Protocol Violation|0|||
124469090|NCT03529773|447674710|FG011|Overall Study|Protocol Violation|0|||
124469091|NCT03529773|447674711|FG012|Overall Study|Protocol Violation|0|||
124469092|NCT03529773|447674712|FG013|Overall Study|Protocol Violation|0|||
124973698|NCT01483144|449531605|FG000|Overall Study|Withdrawal by Subject|0|||
124973699|NCT01483144|449531606|FG001|Overall Study|Withdrawal by Subject|2|||
124973700|NCT01483144|449531607|FG002|Overall Study|Withdrawal by Subject|5|||
124973701|NCT01483144|449531605|FG000|Overall Study|Physician Decision|1|||
124973702|NCT01483144|449531606|FG001|Overall Study|Physician Decision|0|||
124973703|NCT01483144|449531607|FG002|Overall Study|Physician Decision|0|||
124973704|NCT01483144|449531605|FG000|Overall Study|Lost to Follow-up|2|||
124973705|NCT01483144|449531606|FG001|Overall Study|Lost to Follow-up|4|||
124973706|NCT01483144|449531607|FG002|Overall Study|Lost to Follow-up|1|||
124973707|NCT01483144|449531605|FG000|Overall Study|Protocol Violation|3|||
124973708|NCT01483144|449531606|FG001|Overall Study|Protocol Violation|3|||
124770415|NCT03773978|448788852|FG001|DBW Period|Adverse Event|2|||
124770416|NCT03773978|448788851|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
124770417|NCT03773978|448788852|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
124770418|NCT03773978|448788851|FG000|DBW Period|Withdrawal by Subject|2|||
124770419|NCT03773978|448788852|FG001|DBW Period|Withdrawal by Subject|1|||
124973709|NCT01483144|449531607|FG002|Overall Study|Protocol Violation|3|||
124973710|NCT02460575|449531608|FG000|Overall Study|Lost to Follow-up|1|||
124973711|NCT02460575|449531609|FG001|Overall Study|Lost to Follow-up|0|||
124973712|NCT00425607|449531610|FG000|Overall Study|Death|1|||
124973713|NCT00425607|449531610|FG000|Overall Study|Withdrawal by Subject|1|||
124973714|NCT00079339|449531611|FG000|Overall Study|Adverse Event|1|||
124973715|NCT00079339|449531612|FG001|Overall Study|Adverse Event|7|||
124973716|NCT00079339|449531613|FG002|Overall Study|Adverse Event|2|||
124973717|NCT00079339|449531611|FG000|Overall Study|Death|1|||
124973718|NCT00079339|449531612|FG001|Overall Study|Death|0|||
124973719|NCT00079339|449531613|FG002|Overall Study|Death|0|||
124973720|NCT00079339|449531611|FG000|Overall Study|Non-compliance|0|||
124973721|NCT00079339|449531612|FG001|Overall Study|Non-compliance|0|||
124973722|NCT00079339|449531613|FG002|Overall Study|Non-compliance|1|||
124973723|NCT00079339|449531611|FG000|Overall Study|Withdrawal by Subject|0|||
124973724|NCT00079339|449531612|FG001|Overall Study|Withdrawal by Subject|4|||
124973725|NCT00079339|449531613|FG002|Overall Study|Withdrawal by Subject|1|||
124973726|NCT00079339|449531611|FG000|Overall Study|Disease progression|3|||
124973727|NCT00079339|449531612|FG001|Overall Study|Disease progression|28|||
124973728|NCT00079339|449531613|FG002|Overall Study|Disease progression|2|||
124973729|NCT02563548|449531614|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
124973730|NCT02563548|449531615|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
124973731|NCT02563548|449531616|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
124973732|NCT02563548|449531617|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
124973733|NCT02563548|449531618|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
124973734|NCT02563548|449531619|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
124770420|NCT03773978|448788851|FG000|DBW Period|Due to epidemic or pandemic|5|||
124770421|NCT03773978|448788852|FG001|DBW Period|Due to epidemic or pandemic|6|||
124770422|NCT03773978|448788851|FG000|DBW Period|Study team decision|1|||
124770423|NCT03773978|448788852|FG001|DBW Period|Study team decision|0|||
124770424|NCT01033019|448788856|FG000|Overall Study|Withdrawal by Subject|1|||
124770425|NCT01033019|448788857|FG001|Overall Study|Withdrawal by Subject|0|||
124770426|NCT00888134|448788858|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
124770427|NCT00888134|448788858|FG000|Follow-up|being followed for long-term survival|1|||
124770428|NCT03224819|448788860|FG000|Overall Study|Withdrawal by Subject|0|||
124770429|NCT03224819|448788861|FG001|Overall Study|Withdrawal by Subject|0|||
124770430|NCT03224819|448788862|FG002|Overall Study|Withdrawal by Subject|0|||
124770431|NCT03224819|448788863|FG003|Overall Study|Withdrawal by Subject|0|||
124770432|NCT03224819|448788864|FG004|Overall Study|Withdrawal by Subject|0|||
124770433|NCT03224819|448788865|FG005|Overall Study|Withdrawal by Subject|0|||
124973735|NCT02563548|449531614|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
124973736|NCT02563548|449531615|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
124973737|NCT02563548|449531616|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
124973738|NCT02563548|449531617|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
124973739|NCT02563548|449531618|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
124973740|NCT02563548|449531619|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
124973741|NCT02563548|449531614|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
124973742|NCT02563548|449531615|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
124973743|NCT02563548|449531616|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
124973744|NCT02563548|449531617|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
124973745|NCT02563548|449531618|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
124973746|NCT02563548|449531619|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
124973747|NCT02563548|449531614|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
124973748|NCT02563548|449531615|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
124973749|NCT02563548|449531616|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
124469093|NCT03529773|447674713|FG014|Overall Study|Protocol Violation|0|||
124469094|NCT03529773|447674714|FG015|Overall Study|Protocol Violation|0|||
124469095|NCT03529773|447674715|FG016|Overall Study|Protocol Violation|0|||
124469096|NCT03529773|447674716|FG017|Overall Study|Protocol Violation|0|||
124469097|NCT03529773|447674717|FG018|Overall Study|Protocol Violation|0|||
124469098|NCT03529773|447674718|FG019|Overall Study|Protocol Violation|0|||
124469099|NCT03529773|447674719|FG020|Overall Study|Protocol Violation|0|||
124973750|NCT02563548|449531617|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
124973751|NCT02563548|449531618|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
124973752|NCT02563548|449531619|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
124973753|NCT02563548|449531614|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
124469100|NCT03529773|447674720|FG021|Overall Study|Protocol Violation|0|||
124469101|NCT03529773|447674721|FG022|Overall Study|Protocol Violation|0|||
124469102|NCT03529773|447674722|FG023|Overall Study|Protocol Violation|0|||
124713415|NCT02457247|448576483|FG000|Period 2|Significant Protocol Deviation|1|||
124713416|NCT02457247|448576484|FG001|Period 2|Significant Protocol Deviation|0|||
124469103|NCT03529773|447674723|FG024|Overall Study|Protocol Violation|0|||
124469104|NCT03529773|447674724|FG025|Overall Study|Protocol Violation|0|||
124469105|NCT03529773|447674725|FG026|Overall Study|Protocol Violation|0|||
124469106|NCT03529773|447674726|FG027|Overall Study|Protocol Violation|0|||
124469107|NCT03529773|447674727|FG028|Overall Study|Protocol Violation|0|||
124469108|NCT03529773|447674728|FG029|Overall Study|Protocol Violation|0|||
124469109|NCT03529773|447674729|FG030|Overall Study|Protocol Violation|1|||
124469110|NCT03529773|447674730|FG031|Overall Study|Protocol Violation|0|||
124469111|NCT03529773|447674731|FG032|Overall Study|Protocol Violation|0|||
124469112|NCT03529773|447674732|FG033|Overall Study|Protocol Violation|0|||
124469113|NCT03529773|447674733|FG034|Overall Study|Protocol Violation|0|||
124469114|NCT03529773|447674734|FG035|Overall Study|Protocol Violation|0|||
124552204|NCT01220128|447978652|FG000|Overall Study|Adverse event, non-fatal|1|||
124713417|NCT02457247|448576485|FG002|Period 2|Significant Protocol Deviation|0|||
124713418|NCT02457247|448576486|FG003|Period 2|Significant Protocol Deviation|0|||
124713419|NCT02457247|448576483|FG000|Period 2|Lost to Follow-up|0|||
124713420|NCT02457247|448576484|FG001|Period 2|Lost to Follow-up|1|||
124973754|NCT02563548|449531615|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
124973755|NCT02563548|449531616|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
124973756|NCT02563548|449531617|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
124973757|NCT02563548|449531618|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
124973758|NCT02563548|449531619|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
124973759|NCT02563548|449531614|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
124973760|NCT02563548|449531615|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
124973761|NCT02563548|449531616|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
124973762|NCT02563548|449531617|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
124973763|NCT02563548|449531618|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
124973764|NCT02563548|449531619|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
124973765|NCT02563548|449531614|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
124973766|NCT02563548|449531615|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
124973767|NCT02563548|449531616|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
124973768|NCT02563548|449531617|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
124973769|NCT02563548|449531618|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
124973770|NCT02563548|449531619|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
124973771|NCT02563548|449531614|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
124973772|NCT02563548|449531615|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
124973773|NCT02563548|449531616|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
124973774|NCT02563548|449531617|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
124973775|NCT02563548|449531618|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
124469115|NCT03529773|447674735|FG036|Overall Study|Protocol Violation|0|||
124469116|NCT03529773|447674736|FG037|Overall Study|Protocol Violation|0|||
124469117|NCT03529773|447674737|FG038|Overall Study|Protocol Violation|0|||
124469118|NCT03529773|447674738|FG039|Overall Study|Protocol Violation|0|||
124469119|NCT03529773|447674699|FG000|Overall Study|Withdrawal by Subject|0|||
124469120|NCT03529773|447674700|FG001|Overall Study|Withdrawal by Subject|0|||
124469121|NCT03529773|447674701|FG002|Overall Study|Withdrawal by Subject|0|||
124469122|NCT03529773|447674702|FG003|Overall Study|Withdrawal by Subject|0|||
124469123|NCT03529773|447674703|FG004|Overall Study|Withdrawal by Subject|0|||
124469124|NCT03529773|447674704|FG005|Overall Study|Withdrawal by Subject|0|||
124469125|NCT03529773|447674705|FG006|Overall Study|Withdrawal by Subject|0|||
124713421|NCT02457247|448576485|FG002|Period 2|Lost to Follow-up|0|||
124713422|NCT02457247|448576486|FG003|Period 2|Lost to Follow-up|0|||
124713423|NCT02457247|448576483|FG000|Period 2|Voluntary Withdrawal|1|||
124713424|NCT02457247|448576484|FG001|Period 2|Voluntary Withdrawal|1|||
124973776|NCT02563548|449531619|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
124973777|NCT02563548|449531614|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
124973778|NCT02563548|449531615|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
124973779|NCT02563548|449531616|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
124973780|NCT02563548|449531617|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
124973781|NCT02563548|449531618|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
124973782|NCT02563548|449531619|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
124973783|NCT02563548|449531614|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
124973784|NCT02563548|449531615|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
124469126|NCT03529773|447674706|FG007|Overall Study|Withdrawal by Subject|1|||
124469127|NCT03529773|447674707|FG008|Overall Study|Withdrawal by Subject|0|||
124469128|NCT03529773|447674708|FG009|Overall Study|Withdrawal by Subject|1|||
124469129|NCT03529773|447674709|FG010|Overall Study|Withdrawal by Subject|1|||
124469130|NCT03529773|447674710|FG011|Overall Study|Withdrawal by Subject|0|||
124469131|NCT03529773|447674711|FG012|Overall Study|Withdrawal by Subject|0|||
124469132|NCT03529773|447674712|FG013|Overall Study|Withdrawal by Subject|0|||
124469133|NCT03529773|447674713|FG014|Overall Study|Withdrawal by Subject|0|||
124469134|NCT03529773|447674714|FG015|Overall Study|Withdrawal by Subject|3|||
124469135|NCT03529773|447674715|FG016|Overall Study|Withdrawal by Subject|0|||
124469136|NCT03529773|447674716|FG017|Overall Study|Withdrawal by Subject|2|||
124469137|NCT03529773|447674717|FG018|Overall Study|Withdrawal by Subject|3|||
124469138|NCT03529773|447674718|FG019|Overall Study|Withdrawal by Subject|1|||
124552205|NCT01220128|447978653|FG001|Overall Study|Adverse event, non-fatal|0|||
124713425|NCT02457247|448576485|FG002|Period 2|Voluntary Withdrawal|0|||
124469139|NCT03529773|447674719|FG020|Overall Study|Withdrawal by Subject|3|||
124469140|NCT03529773|447674720|FG021|Overall Study|Withdrawal by Subject|1|||
124469141|NCT03529773|447674721|FG022|Overall Study|Withdrawal by Subject|1|||
124469142|NCT03529773|447674722|FG023|Overall Study|Withdrawal by Subject|2|||
124469143|NCT03529773|447674723|FG024|Overall Study|Withdrawal by Subject|2|||
124770434|NCT03224819|448788866|FG006|Overall Study|Withdrawal by Subject|0|||
124973785|NCT02563548|449531616|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
124973786|NCT02563548|449531617|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
124973787|NCT02563548|449531618|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
124973788|NCT02563548|449531619|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
124973789|NCT02563548|449531614|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
124973790|NCT02563548|449531615|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
124973791|NCT02563548|449531616|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
124973792|NCT02563548|449531617|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
124973793|NCT02563548|449531618|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
124973794|NCT02563548|449531619|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
124973795|NCT02563548|449531614|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
124973796|NCT02563548|449531615|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
124973797|NCT02563548|449531616|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
124973798|NCT02563548|449531617|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
124973799|NCT02563548|449531618|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
124973800|NCT02563548|449531619|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
124973801|NCT00520845|449531620|FG000|Overall Study|Death|3|||
124973802|NCT00520845|449531620|FG000|Overall Study|Adverse Event|4|||
124973803|NCT00520845|449531620|FG000|Overall Study|Disease Progression, relapse|13|||
124973804|NCT00520845|449531620|FG000|Overall Study|Withdrawal by Subject|1|||
124973805|NCT00520845|449531620|FG000|Overall Study|Alternative Therapy|1|||
124973806|NCT03274453|449531623|FG000|Overall Study|Lost to Follow-up|2|||
124973807|NCT03274453|449531624|FG001|Overall Study|Lost to Follow-up|5|||
124973808|NCT03274453|449531625|FG002|Overall Study|Lost to Follow-up|4|||
124973809|NCT03274453|449531626|FG003|Overall Study|Lost to Follow-up|1|||
124973810|NCT03274453|449531623|FG000|Overall Study|Physician Decision|2|||
124973811|NCT03274453|449531624|FG001|Overall Study|Physician Decision|0|||
124973812|NCT03274453|449531625|FG002|Overall Study|Physician Decision|0|||
124973813|NCT03274453|449531626|FG003|Overall Study|Physician Decision|3|||
124973814|NCT03274453|449531623|FG000|Overall Study|Surgery Cancelled|0|||
124973815|NCT03274453|449531624|FG001|Overall Study|Surgery Cancelled|1|||
124973816|NCT03274453|449531625|FG002|Overall Study|Surgery Cancelled|0|||
124973817|NCT03274453|449531626|FG003|Overall Study|Surgery Cancelled|0|||
124973818|NCT01732549|449531628|FG000|Overall Study|Adverse Event|13|||
124973819|NCT01732549|449531629|FG001|Overall Study|Adverse Event|3|||
124973820|NCT01732549|449531628|FG000|Overall Study|Consent withdrawn|13|||
124973821|NCT01732549|449531629|FG001|Overall Study|Consent withdrawn|6|||
124973822|NCT01732549|449531628|FG000|Overall Study|Disease progression|37|||
124973823|NCT01732549|449531629|FG001|Overall Study|Disease progression|50|||
124973824|NCT01732549|449531628|FG000|Overall Study|Other|8|||
124973825|NCT01732549|449531629|FG001|Overall Study|Other|14|||
124973826|NCT01516749|449531630|FG000|Active Therapy|Lost to Follow-up|1|||
124973827|NCT01516749|449531630|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
124973828|NCT00351377|449531631|FG000|Overall Study|Adverse Event|5|||
124973829|NCT00351377|449531631|FG000|Overall Study|Death|1|||
124973830|NCT00351377|449531631|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124973831|NCT02493062|449531636|FG000|Overall Study|Physician Decision|12|||
124973832|NCT03845140|449531639|FG000|Overall Study|Participant travelled outside study area|0|||
124973833|NCT03845140|449531640|FG001|Overall Study|Participant travelled outside study area|1|||
124973834|NCT03845140|449531641|FG002|Overall Study|Participant travelled outside study area|0|||
124973835|NCT03845140|449531642|FG003|Overall Study|Participant travelled outside study area|0|||
124973836|NCT03845140|449531643|FG004|Overall Study|Participant travelled outside study area|0|||
124973837|NCT03845140|449531644|FG005|Overall Study|Participant travelled outside study area|0|||
124973838|NCT03054337|449531645|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
124973839|NCT03054337|449531646|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
124973840|NCT03054337|449531647|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
124973841|NCT03054337|449531648|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
124973842|NCT03054337|449531649|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
124973843|NCT03054337|449531650|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
124973844|NCT01681992|449531653|FG000|Overall Study|Adverse Event|3|||
124973845|NCT01681992|449531654|FG001|Overall Study|Adverse Event|2|||
124973846|NCT01681992|449531655|FG002|Overall Study|Adverse Event|3|||
124973847|NCT01681992|449531653|FG000|Overall Study|Lost to Follow-up|36|||
124973848|NCT01681992|449531654|FG001|Overall Study|Lost to Follow-up|38|||
124973849|NCT01681992|449531655|FG002|Overall Study|Lost to Follow-up|53|||
124770435|NCT03224819|448788867|FG007|Overall Study|Withdrawal by Subject|0|||
124770436|NCT03224819|448788868|FG008|Overall Study|Withdrawal by Subject|0|||
124973850|NCT01681992|449531653|FG000|Overall Study|As Per Sponsor Decision|0|||
124973851|NCT01681992|449531654|FG001|Overall Study|As Per Sponsor Decision|0|||
124973852|NCT01681992|449531655|FG002|Overall Study|As Per Sponsor Decision|1|||
124973853|NCT01681992|449531653|FG000|Overall Study|Protocol Violation|0|||
124973854|NCT01681992|449531654|FG001|Overall Study|Protocol Violation|0|||
124973855|NCT01681992|449531655|FG002|Overall Study|Protocol Violation|1|||
124973856|NCT01681992|449531653|FG000|Overall Study|Withdrawal by Subject|27|||
124973857|NCT01681992|449531654|FG001|Overall Study|Withdrawal by Subject|30|||
124973858|NCT01681992|449531655|FG002|Overall Study|Withdrawal by Subject|25|||
124973859|NCT01327612|449531656|FG000|Overall Study|Withdrawal by Subject|0|||
124973860|NCT01327612|449531657|FG001|Overall Study|Withdrawal by Subject|0|||
124973861|NCT01327612|449531658|FG002|Overall Study|Withdrawal by Subject|0|||
124973862|NCT01327612|449531659|FG003|Overall Study|Withdrawal by Subject|0|||
124973863|NCT01327612|449531660|FG004|Overall Study|Withdrawal by Subject|0|||
124973864|NCT01327612|449531661|FG005|Overall Study|Withdrawal by Subject|1|||
124973865|NCT01327612|449531662|FG006|Overall Study|Withdrawal by Subject|0|||
124973866|NCT01327612|449531656|FG000|Overall Study|Disease Progression|1|||
124973867|NCT01327612|449531657|FG001|Overall Study|Disease Progression|1|||
124973868|NCT01327612|449531658|FG002|Overall Study|Disease Progression|1|||
124973869|NCT01327612|449531659|FG003|Overall Study|Disease Progression|0|||
124973870|NCT01327612|449531660|FG004|Overall Study|Disease Progression|1|||
124973871|NCT01327612|449531661|FG005|Overall Study|Disease Progression|2|||
124973872|NCT01327612|449531662|FG006|Overall Study|Disease Progression|2|||
124973873|NCT01327612|449531656|FG000|Overall Study|Administrative Decision|0|||
124973874|NCT01327612|449531657|FG001|Overall Study|Administrative Decision|0|||
124973875|NCT01327612|449531658|FG002|Overall Study|Administrative Decision|0|||
124973876|NCT01327612|449531659|FG003|Overall Study|Administrative Decision|1|||
124973877|NCT01327612|449531660|FG004|Overall Study|Administrative Decision|0|||
124973878|NCT01327612|449531661|FG005|Overall Study|Administrative Decision|0|||
124973879|NCT01327612|449531662|FG006|Overall Study|Administrative Decision|0|||
124973880|NCT01327612|449531656|FG000|Overall Study|Death|0|||
124973881|NCT01327612|449531657|FG001|Overall Study|Death|0|||
124973882|NCT01327612|449531658|FG002|Overall Study|Death|0|||
124973883|NCT01327612|449531659|FG003|Overall Study|Death|0|||
124973884|NCT01327612|449531660|FG004|Overall Study|Death|1|||
124973885|NCT01327612|449531661|FG005|Overall Study|Death|0|||
124973886|NCT01327612|449531662|FG006|Overall Study|Death|0|||
124973887|NCT01967069|449531668|FG000|Overall Study|Adverse Event|2|||
124973888|NCT01967069|449531669|FG001|Overall Study|Adverse Event|2|||
124973889|NCT01967069|449531668|FG000|Overall Study|Lost to Follow-up|5|||
124973890|NCT01967069|449531669|FG001|Overall Study|Lost to Follow-up|2|||
124973891|NCT01967069|449531668|FG000|Overall Study|Withdrawal by Subject|1|||
124973892|NCT01967069|449531669|FG001|Overall Study|Withdrawal by Subject|3|||
124973893|NCT01967069|449531668|FG000|Overall Study|Lack of Efficacy|0|||
124973894|NCT01967069|449531669|FG001|Overall Study|Lack of Efficacy|1|||
124973895|NCT01661205|449531672|FG000|Overall Study|Physician Decision|2|||
124973896|NCT05569421|449531677|FG000|Overall Study|Withdrawal by Subject|1|||
124973897|NCT05569421|449531678|FG001|Overall Study|Withdrawal by Subject|0|||
124469144|NCT03529773|447674724|FG025|Overall Study|Withdrawal by Subject|4|||
124469145|NCT03529773|447674725|FG026|Overall Study|Withdrawal by Subject|2|||
124469146|NCT03529773|447674726|FG027|Overall Study|Withdrawal by Subject|1|||
124469147|NCT03529773|447674727|FG028|Overall Study|Withdrawal by Subject|1|||
124469148|NCT03529773|447674728|FG029|Overall Study|Withdrawal by Subject|0|||
124469149|NCT03529773|447674729|FG030|Overall Study|Withdrawal by Subject|0|||
124469150|NCT03529773|447674730|FG031|Overall Study|Withdrawal by Subject|0|||
124469151|NCT03529773|447674731|FG032|Overall Study|Withdrawal by Subject|0|||
124469152|NCT03529773|447674732|FG033|Overall Study|Withdrawal by Subject|0|||
124469153|NCT03529773|447674733|FG034|Overall Study|Withdrawal by Subject|1|||
124469154|NCT03529773|447674734|FG035|Overall Study|Withdrawal by Subject|2|||
124469155|NCT03529773|447674735|FG036|Overall Study|Withdrawal by Subject|0|||
124469156|NCT03529773|447674736|FG037|Overall Study|Withdrawal by Subject|2|||
124713426|NCT02457247|448576486|FG003|Period 2|Voluntary Withdrawal|0|||
124973898|NCT05569421|449531679|FG002|Overall Study|Withdrawal by Subject|0|||
124973899|NCT03111095|449531680|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
124973900|NCT03111095|449531681|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
124973901|NCT03111095|449531680|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
124973902|NCT03111095|449531681|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
124973903|NCT00504075|449531682|FG000|Overall Study|Adverse Event|1|||
124973904|NCT00504075|449531682|FG000|Overall Study|Lost to Follow-up|5|||
124973905|NCT00504075|449531682|FG000|Overall Study|Withdrawal by Subject|1|||
124973906|NCT00504075|449531682|FG000|Overall Study|Required other therapeutic intervention|1|||
124973907|NCT03106753|449531686|FG000|Overall Study|Withdrawal by Subject|0|||
124973908|NCT03106753|449531687|FG001|Overall Study|Withdrawal by Subject|1|||
124973909|NCT04245345|449531690|FG000|Overall Study|Death|1|||
124973910|NCT04245345|449531690|FG000|Overall Study|Exited prior to implant|5|||
124973911|NCT04245345|449531690|FG000|Overall Study|Exited prior to 1-month|9|||
124973912|NCT04245345|449531690|FG000|Overall Study|Missed 1-month visit|3|||
124973913|NCT04245345|449531690|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
124973914|NCT04245345|449531690|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
124973915|NCT02609672|449531693|FG000|Overall Study|Lost to Follow-up|3|||
124973916|NCT02609672|449531694|FG001|Overall Study|Lost to Follow-up|1|||
124973917|NCT03392168|449531695|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
124973918|NCT03392168|449531696|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
124973919|NCT03392168|449531697|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
124973920|NCT03392168|449531698|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
124973921|NCT03392168|449531695|FG000|Period 2: Cohort 2|Other|0|||
124973922|NCT03392168|449531696|FG001|Period 2: Cohort 2|Other|1|||
124973923|NCT03392168|449531697|FG002|Period 2: Cohort 2|Other|0|||
124973924|NCT03392168|449531698|FG003|Period 2: Cohort 2|Other|0|||
124973925|NCT00401258|449531699|FG000|Overall Study|Adverse Event|7|||
124973926|NCT00844597|449531700|FG000|Overall Study|Adverse Event|0|||
124973927|NCT00844597|449531701|FG001|Overall Study|Adverse Event|0|||
124973928|NCT00844597|449531702|FG002|Overall Study|Adverse Event|0|||
124973929|NCT00844597|449531703|FG003|Overall Study|Adverse Event|1|||
124973930|NCT00844597|449531704|FG004|Overall Study|Adverse Event|0|||
124973931|NCT00844597|449531705|FG005|Overall Study|Adverse Event|0|||
124973932|NCT04160988|449531706|FG000|Overall Study|poor image quality|28|||
124973933|NCT02670122|449531707|FG000|Overall Study|Lost to Follow-up|4|||
124973934|NCT02762903|449531709|FG000|Overall Study|Lost to Follow-up|0|||
124973935|NCT02762903|449531710|FG001|Overall Study|Lost to Follow-up|1|||
124973936|NCT00243074|449531711|FG000|Overall Study|Ineligible|6|||
124973937|NCT00243074|449531711|FG000|Overall Study|Adverse Event|6|||
124973938|NCT00243074|449531711|FG000|Overall Study|Withdrawal by Subject|2|||
124973939|NCT00243074|449531711|FG000|Overall Study|Lack of Efficacy|36|||
124973940|NCT00243074|449531711|FG000|Overall Study|Death|2|||
124973941|NCT00243074|449531711|FG000|Overall Study|not protocol specified|1|||
124973942|NCT00243074|449531711|FG000|Overall Study|Did not receive any treatment|1|||
124973943|NCT00664534|449531712|FG000|Overall Study|Adverse Event|2|||
124973944|NCT00664534|449531713|FG001|Overall Study|Adverse Event|3|||
124973945|NCT00664534|449531712|FG000|Overall Study|Lost to Follow-up|6|||
124973946|NCT00664534|449531713|FG001|Overall Study|Lost to Follow-up|10|||
124973947|NCT00664534|449531712|FG000|Overall Study|Protocol Violation|10|||
124973948|NCT00664534|449531713|FG001|Overall Study|Protocol Violation|8|||
124973949|NCT00664534|449531712|FG000|Overall Study|Withdrawal by Subject|7|||
124973950|NCT00664534|449531713|FG001|Overall Study|Withdrawal by Subject|6|||
124973951|NCT00664534|449531712|FG000|Overall Study|Physician Decision|8|||
124973952|NCT00664534|449531713|FG001|Overall Study|Physician Decision|0|||
124973953|NCT00664534|449531712|FG000|Overall Study|Sponsor decision|8|||
124973954|NCT00664534|449531713|FG001|Overall Study|Sponsor decision|6|||
124973955|NCT03041792|449531714|FG000|Overall Study|Adverse Event|4|||
124973956|NCT03041792|449531715|FG001|Overall Study|Adverse Event|0|||
124973957|NCT03041792|449531714|FG000|Overall Study|Death in the family|0|||
124973958|NCT03041792|449531715|FG001|Overall Study|Death in the family|2|||
124973959|NCT03041792|449531714|FG000|Overall Study|Randomized but not treated|0|||
124973960|NCT03041792|449531715|FG001|Overall Study|Randomized but not treated|1|||
124973961|NCT04978090|449531716|FG000|Overall Study|unable to adequately fit device|2|||
124469157|NCT03529773|447674737|FG038|Overall Study|Withdrawal by Subject|1|||
124469158|NCT03529773|447674738|FG039|Overall Study|Withdrawal by Subject|1|||
124469159|NCT03529773|447674699|FG000|Overall Study|Screen Failure|0|||
124469160|NCT03529773|447674700|FG001|Overall Study|Screen Failure|0|||
124469161|NCT03529773|447674701|FG002|Overall Study|Screen Failure|0|||
124469162|NCT03529773|447674702|FG003|Overall Study|Screen Failure|0|||
124469163|NCT03529773|447674703|FG004|Overall Study|Screen Failure|0|||
124469164|NCT03529773|447674704|FG005|Overall Study|Screen Failure|0|||
124469165|NCT03529773|447674705|FG006|Overall Study|Screen Failure|0|||
124469166|NCT03529773|447674706|FG007|Overall Study|Screen Failure|0|||
124469167|NCT03529773|447674707|FG008|Overall Study|Screen Failure|0|||
124469168|NCT03529773|447674708|FG009|Overall Study|Screen Failure|0|||
124469169|NCT03529773|447674709|FG010|Overall Study|Screen Failure|0|||
124469170|NCT03529773|447674710|FG011|Overall Study|Screen Failure|0|||
124469171|NCT03529773|447674711|FG012|Overall Study|Screen Failure|0|||
124469172|NCT03529773|447674712|FG013|Overall Study|Screen Failure|0|||
124469173|NCT03529773|447674713|FG014|Overall Study|Screen Failure|0|||
124469174|NCT03529773|447674714|FG015|Overall Study|Screen Failure|0|||
124469175|NCT03529773|447674715|FG016|Overall Study|Screen Failure|0|||
124469176|NCT03529773|447674716|FG017|Overall Study|Screen Failure|0|||
124973962|NCT03075527|449531719|FG000|Overall Study|Death|1|||
124973963|NCT03075527|449531719|FG000|Overall Study|Withdrawal by Subject|1|||
124973964|NCT03075527|449531719|FG000|Overall Study|Physician Decision|3|||
124973965|NCT03075527|449531719|FG000|Overall Study|Progression/Relapse|14|||
124973966|NCT06926673|449531720|FG000|Overall Study|Lost to Follow-up|0|||
124973967|NCT06926673|449531721|FG001|Overall Study|Lost to Follow-up|0|||
124973968|NCT06926673|449531722|FG002|Overall Study|Lost to Follow-up|0|||
124973969|NCT06926673|449531723|FG003|Overall Study|Lost to Follow-up|1|||
124973970|NCT06926673|449531724|FG004|Overall Study|Lost to Follow-up|0|||
124973971|NCT06926673|449531725|FG005|Overall Study|Lost to Follow-up|0|||
124973972|NCT06926673|449531726|FG006|Overall Study|Lost to Follow-up|0|||
124973973|NCT06926673|449531720|FG000|Overall Study|Physician Decision|0|||
124973974|NCT06926673|449531721|FG001|Overall Study|Physician Decision|0|||
124973975|NCT06926673|449531722|FG002|Overall Study|Physician Decision|0|||
124973976|NCT06926673|449531723|FG003|Overall Study|Physician Decision|0|||
124973977|NCT06926673|449531724|FG004|Overall Study|Physician Decision|0|||
124973978|NCT06926673|449531725|FG005|Overall Study|Physician Decision|0|||
124973979|NCT06926673|449531726|FG006|Overall Study|Physician Decision|1|||
124973980|NCT06926673|449531720|FG000|Overall Study|Withdrawal by Subject|0|||
124973981|NCT06926673|449531721|FG001|Overall Study|Withdrawal by Subject|3|||
124973982|NCT06926673|449531722|FG002|Overall Study|Withdrawal by Subject|2|||
124973983|NCT06926673|449531723|FG003|Overall Study|Withdrawal by Subject|1|||
124973984|NCT06926673|449531724|FG004|Overall Study|Withdrawal by Subject|0|||
124973985|NCT06926673|449531725|FG005|Overall Study|Withdrawal by Subject|2|||
124973986|NCT06926673|449531726|FG006|Overall Study|Withdrawal by Subject|0|||
124973987|NCT02358668|449534377|FG000|Overall Study|Adverse Event|2|||
124973988|NCT02358668|449534378|FG001|Overall Study|Adverse Event|0|||
124973989|NCT02358668|449534379|FG002|Overall Study|Adverse Event|0|||
124973990|NCT02358668|449534377|FG000|Overall Study|Withdrawal by Subject|0|||
124973991|NCT02358668|449534378|FG001|Overall Study|Withdrawal by Subject|1|||
124973992|NCT02358668|449534379|FG002|Overall Study|Withdrawal by Subject|0|||
124973993|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Adverse Event|2|||
124973994|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Adverse Event|0|||
124973995|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Adverse Event|0|||
124973996|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Adverse Event|0|||
124973997|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
124973998|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
124973999|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
124974000|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
124974001|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
124974002|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
124974003|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
124974004|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
124974005|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Physician Decision|1|||
124974006|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Physician Decision|0|||
124974007|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Physician Decision|0|||
124974008|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Physician Decision|0|||
124974009|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Pregnancy|1|||
124974010|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Pregnancy|0|||
124469177|NCT03529773|447674717|FG018|Overall Study|Screen Failure|0|||
124469178|NCT03529773|447674718|FG019|Overall Study|Screen Failure|0|||
124469179|NCT03529773|447674719|FG020|Overall Study|Screen Failure|0|||
124469180|NCT03529773|447674720|FG021|Overall Study|Screen Failure|0|||
124469181|NCT03529773|447674721|FG022|Overall Study|Screen Failure|0|||
124469182|NCT03529773|447674722|FG023|Overall Study|Screen Failure|0|||
124469183|NCT03529773|447674723|FG024|Overall Study|Screen Failure|0|||
124469184|NCT03529773|447674724|FG025|Overall Study|Screen Failure|0|||
124974011|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Pregnancy|0|||
124469185|NCT03529773|447674725|FG026|Overall Study|Screen Failure|0|||
124469186|NCT03529773|447674726|FG027|Overall Study|Screen Failure|0|||
124469187|NCT03529773|447674727|FG028|Overall Study|Screen Failure|0|||
124469188|NCT03529773|447674728|FG029|Overall Study|Screen Failure|0|||
124469189|NCT03529773|447674729|FG030|Overall Study|Screen Failure|0|||
124469190|NCT03529773|447674730|FG031|Overall Study|Screen Failure|0|||
124469191|NCT03529773|447674731|FG032|Overall Study|Screen Failure|0|||
124469192|NCT03529773|447674732|FG033|Overall Study|Screen Failure|0|||
124469193|NCT03529773|447674733|FG034|Overall Study|Screen Failure|0|||
124469194|NCT03529773|447674734|FG035|Overall Study|Screen Failure|0|||
124469195|NCT03529773|447674735|FG036|Overall Study|Screen Failure|1|||
124469196|NCT03529773|447674736|FG037|Overall Study|Screen Failure|1|||
124469197|NCT03529773|447674737|FG038|Overall Study|Screen Failure|0|||
124469198|NCT03529773|447674738|FG039|Overall Study|Screen Failure|1|||
124469199|NCT03529773|447674699|FG000|Overall Study|Randomized but not vaccinated|0|||
124469200|NCT03529773|447674700|FG001|Overall Study|Randomized but not vaccinated|0|||
124469201|NCT03529773|447674701|FG002|Overall Study|Randomized but not vaccinated|0|||
124469202|NCT03529773|447674702|FG003|Overall Study|Randomized but not vaccinated|0|||
124469203|NCT03529773|447674703|FG004|Overall Study|Randomized but not vaccinated|0|||
124469204|NCT03529773|447674704|FG005|Overall Study|Randomized but not vaccinated|0|||
124469205|NCT03529773|447674705|FG006|Overall Study|Randomized but not vaccinated|0|||
124469206|NCT03529773|447674706|FG007|Overall Study|Randomized but not vaccinated|0|||
124469207|NCT03529773|447674707|FG008|Overall Study|Randomized but not vaccinated|0|||
124469208|NCT03529773|447674708|FG009|Overall Study|Randomized but not vaccinated|0|||
124469209|NCT03529773|447674709|FG010|Overall Study|Randomized but not vaccinated|0|||
124469210|NCT03529773|447674710|FG011|Overall Study|Randomized but not vaccinated|0|||
124469211|NCT03529773|447674711|FG012|Overall Study|Randomized but not vaccinated|0|||
124552206|NCT01220128|447978654|FG002|Overall Study|Adverse event, non-fatal|0|||
124552207|NCT01220128|447978655|FG003|Overall Study|Adverse event, non-fatal|0|||
124974012|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Pregnancy|0|||
124974013|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
124974014|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
124974015|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
124974016|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
124974017|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
124974018|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
124974019|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
124974020|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
124974021|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
124974022|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
124974023|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
124974024|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
124974025|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
124974026|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
124974027|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
124974028|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
124974029|NCT04057573|449534380|FG000|24-Week Double-Blind Period|Not Treated|1|||
124974030|NCT04057573|449534381|FG001|24-Week Double-Blind Period|Not Treated|0|||
124974031|NCT04057573|449534382|FG002|24-Week Double-Blind Period|Not Treated|0|||
124974032|NCT04057573|449534383|FG003|24-Week Double-Blind Period|Not Treated|0|||
124974033|NCT04057573|449534380|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
124469212|NCT03529773|447674712|FG013|Overall Study|Randomized but not vaccinated|0|||
124469213|NCT03529773|447674713|FG014|Overall Study|Randomized but not vaccinated|0|||
124469214|NCT03529773|447674714|FG015|Overall Study|Randomized but not vaccinated|0|||
124552208|NCT01220128|447978656|FG004|Overall Study|Adverse event, non-fatal|0|||
124552209|NCT01220128|447978657|FG005|Overall Study|Adverse event, non-fatal|0|||
124469215|NCT03529773|447674715|FG016|Overall Study|Randomized but not vaccinated|0|||
124469216|NCT03529773|447674716|FG017|Overall Study|Randomized but not vaccinated|1|||
124469217|NCT03529773|447674717|FG018|Overall Study|Randomized but not vaccinated|0|||
124469218|NCT03529773|447674718|FG019|Overall Study|Randomized but not vaccinated|0|||
124469219|NCT03529773|447674719|FG020|Overall Study|Randomized but not vaccinated|0|||
124469220|NCT03529773|447674720|FG021|Overall Study|Randomized but not vaccinated|0|||
124469221|NCT03529773|447674721|FG022|Overall Study|Randomized but not vaccinated|0|||
124469222|NCT03529773|447674722|FG023|Overall Study|Randomized but not vaccinated|0|||
124469223|NCT03529773|447674723|FG024|Overall Study|Randomized but not vaccinated|0|||
124469224|NCT03529773|447674724|FG025|Overall Study|Randomized but not vaccinated|0|||
124469225|NCT03529773|447674725|FG026|Overall Study|Randomized but not vaccinated|0|||
124713427|NCT01492088|448576487|FG000|Overall Study|Withdrawal by Patient|0|||
124713428|NCT01492088|448576488|FG001|Overall Study|Withdrawal by Patient|2|||
124713429|NCT01492088|448576489|FG002|Overall Study|Withdrawal by Patient|0|||
124974034|NCT04057573|449534381|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
124974035|NCT04057573|449534382|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
124974036|NCT04057573|449534383|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
124974037|NCT04057573|449534380|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
124974038|NCT04057573|449534381|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
124974039|NCT04057573|449534382|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
124974040|NCT04057573|449534383|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
124974041|NCT04057573|449534380|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
124974042|NCT04057573|449534381|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
124974043|NCT04057573|449534382|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
124974044|NCT04057573|449534383|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
124974045|NCT04057573|449534380|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
124974046|NCT04057573|449534381|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
124974047|NCT04057573|449534382|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
124974048|NCT04057573|449534383|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
124974049|NCT04057573|449534380|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
124974050|NCT04057573|449534381|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
124974051|NCT04057573|449534382|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
124974052|NCT04057573|449534383|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
124974053|NCT01317875|449534386|FG000|Overall Study|Other|0|||
124974054|NCT01317875|449534387|FG001|Overall Study|Other|0|||
124974055|NCT01317875|449534388|FG002|Overall Study|Other|1|||
124974056|NCT01317875|449534389|FG003|Overall Study|Other|0|||
124974057|NCT01317875|449534390|FG004|Overall Study|Other|0|||
124974058|NCT01317875|449534391|FG005|Overall Study|Other|0|||
124974059|NCT01317875|449534392|FG006|Overall Study|Other|0|||
124974060|NCT01317875|449534393|FG007|Overall Study|Other|0|||
124974061|NCT01317875|449534394|FG008|Overall Study|Other|0|||
124974062|NCT01317875|449534395|FG009|Overall Study|Other|0|||
124974063|NCT01317875|449534386|FG000|Overall Study|Noncompliance with study drug|0|||
124974064|NCT01317875|449534387|FG001|Overall Study|Noncompliance with study drug|0|||
124974065|NCT01317875|449534388|FG002|Overall Study|Noncompliance with study drug|1|||
124974066|NCT01317875|449534389|FG003|Overall Study|Noncompliance with study drug|0|||
124974067|NCT01317875|449534390|FG004|Overall Study|Noncompliance with study drug|0|||
124974068|NCT01317875|449534391|FG005|Overall Study|Noncompliance with study drug|0|||
124974069|NCT01317875|449534392|FG006|Overall Study|Noncompliance with study drug|0|||
124974070|NCT01317875|449534393|FG007|Overall Study|Noncompliance with study drug|0|||
124974071|NCT01317875|449534394|FG008|Overall Study|Noncompliance with study drug|0|||
124974072|NCT01317875|449534395|FG009|Overall Study|Noncompliance with study drug|0|||
124974073|NCT01317875|449534386|FG000|Overall Study|Progressive Disease|1|||
124974074|NCT01317875|449534387|FG001|Overall Study|Progressive Disease|0|||
124974075|NCT01317875|449534388|FG002|Overall Study|Progressive Disease|2|||
124974076|NCT01317875|449534389|FG003|Overall Study|Progressive Disease|0|||
124974077|NCT01317875|449534390|FG004|Overall Study|Progressive Disease|1|||
124713430|NCT01492088|448576487|FG000|Overall Study|Death|1|||
124713431|NCT01492088|448576488|FG001|Overall Study|Death|6|||
124713432|NCT01492088|448576489|FG002|Overall Study|Death|2|||
124713433|NCT01492088|448576487|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
124974078|NCT01317875|449534391|FG005|Overall Study|Progressive Disease|0|||
124713434|NCT01492088|448576488|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
124974079|NCT01317875|449534392|FG006|Overall Study|Progressive Disease|0|||
124974080|NCT01317875|449534393|FG007|Overall Study|Progressive Disease|1|||
124974081|NCT01317875|449534394|FG008|Overall Study|Progressive Disease|0|||
124974082|NCT01317875|449534395|FG009|Overall Study|Progressive Disease|0|||
124469226|NCT03529773|447674726|FG027|Overall Study|Randomized but not vaccinated|1|||
124469227|NCT03529773|447674727|FG028|Overall Study|Randomized but not vaccinated|0|||
124469228|NCT03529773|447674728|FG029|Overall Study|Randomized but not vaccinated|0|||
124974083|NCT01317875|449534386|FG000|Overall Study|Withdrawal by Subject|0|||
124469229|NCT03529773|447674729|FG030|Overall Study|Randomized but not vaccinated|0|||
124974084|NCT01317875|449534387|FG001|Overall Study|Withdrawal by Subject|0|||
124974085|NCT01317875|449534388|FG002|Overall Study|Withdrawal by Subject|0|||
124974086|NCT01317875|449534389|FG003|Overall Study|Withdrawal by Subject|0|||
124974087|NCT01317875|449534390|FG004|Overall Study|Withdrawal by Subject|1|||
124469230|NCT03529773|447674730|FG031|Overall Study|Randomized but not vaccinated|0|||
124469231|NCT03529773|447674731|FG032|Overall Study|Randomized but not vaccinated|0|||
124469232|NCT03529773|447674732|FG033|Overall Study|Randomized but not vaccinated|0|||
124469233|NCT03529773|447674733|FG034|Overall Study|Randomized but not vaccinated|0|||
124469234|NCT03529773|447674734|FG035|Overall Study|Randomized but not vaccinated|0|||
124469235|NCT03529773|447674735|FG036|Overall Study|Randomized but not vaccinated|0|||
124469236|NCT03529773|447674736|FG037|Overall Study|Randomized but not vaccinated|0|||
124469237|NCT03529773|447674737|FG038|Overall Study|Randomized but not vaccinated|0|||
124469238|NCT03529773|447674738|FG039|Overall Study|Randomized but not vaccinated|0|||
124469239|NCT01537211|447674743|FG000|Overall Study|Lost to Follow-up|0|||
124469240|NCT01537211|447674744|FG001|Overall Study|Lost to Follow-up|1|||
124469241|NCT00257010|447674765|FG000|Overall Study|Lack of Efficacy|11|||
124469242|NCT00257010|447674765|FG000|Overall Study|Lost to Follow-up|53|||
124469243|NCT00257010|447674765|FG000|Overall Study|Withdrawal by Subject|34|||
124469244|NCT00257010|447674765|FG000|Overall Study|Adverse Event|10|||
124469245|NCT00257010|447674765|FG000|Overall Study|various|11|||
124469246|NCT00257010|447674765|FG000|Overall Study|no headache reported|9|||
124469247|NCT00608985|447674766|FG000|Overall Study|Adverse Event|2|||
124469248|NCT00608985|447674767|FG001|Overall Study|Adverse Event|7|||
124469249|NCT00608985|447674768|FG002|Overall Study|Adverse Event|4|||
124469250|NCT00608985|447674769|FG003|Overall Study|Adverse Event|6|||
124469251|NCT00608985|447674766|FG000|Overall Study|Administrative/Other|7|||
124469252|NCT00608985|447674767|FG001|Overall Study|Administrative/Other|4|||
124469253|NCT00608985|447674768|FG002|Overall Study|Administrative/Other|1|||
124469254|NCT00608985|447674769|FG003|Overall Study|Administrative/Other|2|||
124469255|NCT00608985|447674766|FG000|Overall Study|Withdrawal of Consent|5|||
124469256|NCT00608985|447674767|FG001|Overall Study|Withdrawal of Consent|1|||
124469257|NCT00608985|447674768|FG002|Overall Study|Withdrawal of Consent|1|||
124469258|NCT00608985|447674769|FG003|Overall Study|Withdrawal of Consent|1|||
124469259|NCT00608985|447674766|FG000|Overall Study|Lost to Follow-up|2|||
124469260|NCT00608985|447674767|FG001|Overall Study|Lost to Follow-up|1|||
124469261|NCT00608985|447674768|FG002|Overall Study|Lost to Follow-up|0|||
124469262|NCT00608985|447674769|FG003|Overall Study|Lost to Follow-up|0|||
124469263|NCT01699087|447674771|FG000|Overall Study|Lost to Follow-up|7|||
124552210|NCT01220128|447978658|FG006|Overall Study|Adverse event, non-fatal|3|||
124552211|NCT01220128|447978652|FG000|Overall Study|Other|0|||
124552212|NCT01220128|447978653|FG001|Overall Study|Other|0|||
124552213|NCT01220128|447978654|FG002|Overall Study|Other|1|||
124974088|NCT01317875|449534391|FG005|Overall Study|Withdrawal by Subject|0|||
124974089|NCT01317875|449534392|FG006|Overall Study|Withdrawal by Subject|0|||
124974090|NCT01317875|449534393|FG007|Overall Study|Withdrawal by Subject|3|||
124974091|NCT01317875|449534394|FG008|Overall Study|Withdrawal by Subject|0|||
124974092|NCT01317875|449534395|FG009|Overall Study|Withdrawal by Subject|0|||
124974093|NCT01317875|449534386|FG000|Overall Study|Physician Decision|0|||
124974094|NCT01317875|449534387|FG001|Overall Study|Physician Decision|1|||
124974095|NCT01317875|449534388|FG002|Overall Study|Physician Decision|1|||
124974096|NCT01317875|449534389|FG003|Overall Study|Physician Decision|0|||
124974097|NCT01317875|449534390|FG004|Overall Study|Physician Decision|2|||
124974098|NCT01317875|449534391|FG005|Overall Study|Physician Decision|0|||
124974099|NCT01317875|449534392|FG006|Overall Study|Physician Decision|0|||
124974100|NCT01317875|449534393|FG007|Overall Study|Physician Decision|2|||
124974101|NCT01317875|449534394|FG008|Overall Study|Physician Decision|0|||
124974102|NCT01317875|449534395|FG009|Overall Study|Physician Decision|0|||
124974103|NCT01317875|449534386|FG000|Overall Study|Death|0|||
124469264|NCT01699087|447674771|FG000|Overall Study|Screen failure (prior to treatment)|15|||
124469265|NCT01699087|447674771|FG000|Overall Study|Unable to make future visits|2|||
124469266|NCT00744874|447674774|FG000|Overall Study|Lost to Follow-up|1|||
124469267|NCT00744874|447674774|FG000|Overall Study|Withdrawal by Subject|1|||
124552214|NCT01220128|447978655|FG003|Overall Study|Other|0|||
124974104|NCT01317875|449534387|FG001|Overall Study|Death|0|||
124469268|NCT00744874|447674774|FG000|Overall Study|Study Device not available at procedure|1|||
124469269|NCT00744874|447674774|FG000|Overall Study|Unable to accomodate schedule|1|||
124469270|NCT03403205|447674775|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
124469271|NCT03403205|447674776|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
124469272|NCT03403205|447674777|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
124469273|NCT03403205|447674778|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
124469274|NCT03403205|447674779|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
124552215|NCT01220128|447978656|FG004|Overall Study|Other|0|||
124552216|NCT01220128|447978657|FG005|Overall Study|Other|0|||
124974105|NCT01317875|449534388|FG002|Overall Study|Death|2|||
124974106|NCT01317875|449534389|FG003|Overall Study|Death|1|||
124974107|NCT01317875|449534390|FG004|Overall Study|Death|0|||
124770437|NCT03224819|448788869|FG009|Overall Study|Withdrawal by Subject|0|||
124974108|NCT01317875|449534391|FG005|Overall Study|Death|1|||
124974109|NCT01317875|449534392|FG006|Overall Study|Death|0|||
124974110|NCT01317875|449534393|FG007|Overall Study|Death|4|||
124974111|NCT01317875|449534394|FG008|Overall Study|Death|0|||
124974112|NCT01317875|449534395|FG009|Overall Study|Death|0|||
124974113|NCT01317875|449534386|FG000|Overall Study|Adverse Event|2|||
124974114|NCT01317875|449534387|FG001|Overall Study|Adverse Event|1|||
124974115|NCT01317875|449534388|FG002|Overall Study|Adverse Event|2|||
124974116|NCT01317875|449534389|FG003|Overall Study|Adverse Event|1|||
124974117|NCT01317875|449534390|FG004|Overall Study|Adverse Event|5|||
124770438|NCT03224819|448788870|FG010|Overall Study|Withdrawal by Subject|0|||
124974118|NCT01317875|449534391|FG005|Overall Study|Adverse Event|1|||
124974119|NCT01317875|449534392|FG006|Overall Study|Adverse Event|2|||
124974120|NCT01317875|449534393|FG007|Overall Study|Adverse Event|5|||
124469275|NCT03403205|447674780|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
124469276|NCT03403205|447674775|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
124469277|NCT03403205|447674776|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
124469278|NCT03403205|447674777|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
124469279|NCT03403205|447674778|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
124469280|NCT03403205|447674779|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
124469281|NCT03403205|447674780|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
124469282|NCT03403205|447674775|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
124469283|NCT03403205|447674776|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
124469284|NCT03403205|447674777|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
124469285|NCT03403205|447674778|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
124469286|NCT03403205|447674779|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
124469287|NCT03403205|447674780|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
124469288|NCT03403205|447674775|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
124469289|NCT03403205|447674776|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
124469290|NCT03403205|447674777|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
124469291|NCT03403205|447674778|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
124469292|NCT03403205|447674779|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
124469293|NCT03403205|447674780|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
124469294|NCT03403205|447674775|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
124469295|NCT03403205|447674776|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
124469296|NCT03403205|447674777|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
124469297|NCT03403205|447674778|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
124469298|NCT03403205|447674779|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
124469299|NCT03403205|447674780|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
124469300|NCT03403205|447674775|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
124469301|NCT03403205|447674776|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
124469302|NCT03403205|447674777|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
124469303|NCT03403205|447674778|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
124469304|NCT03403205|447674779|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
124469305|NCT03403205|447674780|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
124469306|NCT03403205|447674775|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
124974121|NCT01317875|449534394|FG008|Overall Study|Adverse Event|0|||
124974122|NCT01317875|449534395|FG009|Overall Study|Adverse Event|0|||
124974123|NCT02271984|449534400|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974124|NCT02271984|449534401|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974125|NCT02271984|449534402|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974126|NCT02271984|449534403|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974127|NCT02271984|449534404|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974128|NCT02271984|449534405|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
124974129|NCT02271984|449534406|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974130|NCT02271984|449534407|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
124974131|NCT02271984|449534408|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974132|NCT02271984|449534409|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974133|NCT02271984|449534410|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974134|NCT02271984|449534411|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124974135|NCT01020877|449534412|FG000|Second Intervention|Withdrawal by Subject|1|||
124974136|NCT01020877|449534413|FG001|Second Intervention|Withdrawal by Subject|0|||
124974137|NCT04307940|449534415|FG000|Overall Study|Adverse Event|1|||
124974138|NCT04307940|449534416|FG001|Overall Study|Adverse Event|0|||
124469307|NCT03403205|447674776|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
124469308|NCT03403205|447674777|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
124469309|NCT03403205|447674778|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
124469310|NCT03403205|447674779|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
124469311|NCT03403205|447674780|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
124469312|NCT03403205|447674775|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
124469313|NCT03403205|447674776|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
124469314|NCT03403205|447674777|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
124469315|NCT03403205|447674778|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
124469316|NCT03403205|447674779|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
124469317|NCT03403205|447674780|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
124469318|NCT03403205|447674775|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
124469319|NCT03403205|447674776|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
124469320|NCT03403205|447674777|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
124974139|NCT04307940|449534417|FG002|Overall Study|Adverse Event|0|||
124974140|NCT04307940|449534415|FG000|Overall Study|Withdrawal by Subject|2|||
124974141|NCT04307940|449534416|FG001|Overall Study|Withdrawal by Subject|3|||
124974142|NCT04307940|449534417|FG002|Overall Study|Withdrawal by Subject|1|||
124552217|NCT01220128|447978658|FG006|Overall Study|Other|0|||
124552218|NCT01220128|447978652|FG000|Overall Study|Consent withdrawn by subject|1|||
124552219|NCT01220128|447978653|FG001|Overall Study|Consent withdrawn by subject|0|||
124552220|NCT01220128|447978654|FG002|Overall Study|Consent withdrawn by subject|0|||
124552221|NCT01220128|447978655|FG003|Overall Study|Consent withdrawn by subject|0|||
124552222|NCT01220128|447978656|FG004|Overall Study|Consent withdrawn by subject|0|||
124552223|NCT01220128|447978657|FG005|Overall Study|Consent withdrawn by subject|0|||
124713435|NCT01492088|448576489|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
124974143|NCT04307940|449534415|FG000|Overall Study|Lost to Follow-up|2|||
124974144|NCT04307940|449534416|FG001|Overall Study|Lost to Follow-up|0|||
124974145|NCT04307940|449534417|FG002|Overall Study|Lost to Follow-up|1|||
124974146|NCT04624243|449534418|FG000|Overall Study|Death|0|||
124974147|NCT04624243|449534419|FG001|Overall Study|Death|1|||
124974148|NCT04624243|449534420|FG002|Overall Study|Death|0|||
124974149|NCT04624243|449534421|FG003|Overall Study|Death|0|||
124974150|NCT04624243|449534422|FG004|Overall Study|Death|0|||
124974151|NCT04624243|449534418|FG000|Overall Study|Lost to Follow-up|2|||
124974152|NCT04624243|449534419|FG001|Overall Study|Lost to Follow-up|3|||
124552224|NCT01220128|447978658|FG006|Overall Study|Consent withdrawn by subject|0|||
124713436|NCT01492088|448576487|FG000|Overall Study|Alive at Last Follow-up|0|||
124713437|NCT01492088|448576488|FG001|Overall Study|Alive at Last Follow-up|6|||
124974153|NCT04624243|449534420|FG002|Overall Study|Lost to Follow-up|7|||
124469321|NCT03403205|447674778|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
124469322|NCT03403205|447674779|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
124469323|NCT03403205|447674780|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
124469324|NCT03403205|447674775|FG000|Extension Period (Up to 60 Months)|Death|1|||
124713438|NCT01492088|448576489|FG002|Overall Study|Alive at Last Follow-up|11|||
124713439|NCT02379052|448576490|FG000|Overall Study|Protocol Violation|0|||
124713440|NCT02379052|448576491|FG001|Overall Study|Protocol Violation|1|||
124713441|NCT02379052|448576490|FG000|Overall Study|Adverse Event|0|||
124713442|NCT02379052|448576491|FG001|Overall Study|Adverse Event|1|||
124469325|NCT03403205|447674776|FG001|Extension Period (Up to 60 Months)|Death|0|||
124469326|NCT03403205|447674777|FG002|Extension Period (Up to 60 Months)|Death|0|||
124469327|NCT03403205|447674778|FG003|Extension Period (Up to 60 Months)|Death|0|||
124469328|NCT03403205|447674779|FG004|Extension Period (Up to 60 Months)|Death|0|||
124469329|NCT03403205|447674780|FG005|Extension Period (Up to 60 Months)|Death|0|||
124469330|NCT03403205|447674775|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
124469331|NCT03403205|447674776|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
124469332|NCT03403205|447674777|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
124469333|NCT03403205|447674778|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
124469334|NCT03403205|447674779|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
124469335|NCT03403205|447674780|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
124469336|NCT03403205|447674775|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
124469337|NCT03403205|447674776|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
124469338|NCT03403205|447674777|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
124469339|NCT03403205|447674778|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
124469340|NCT03403205|447674779|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
124469341|NCT03403205|447674780|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
124469342|NCT03403205|447674775|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
124469343|NCT03403205|447674776|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
124469344|NCT03403205|447674777|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
124469345|NCT03403205|447674778|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
124469346|NCT03403205|447674779|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
124469347|NCT03403205|447674780|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
124469348|NCT03403205|447674775|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
124469349|NCT03403205|447674776|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
124469350|NCT03403205|447674777|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
124469351|NCT03403205|447674778|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
124469352|NCT03403205|447674779|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
124974154|NCT04624243|449534421|FG003|Overall Study|Lost to Follow-up|1|||
124974155|NCT04624243|449534422|FG004|Overall Study|Lost to Follow-up|3|||
124713443|NCT02379052|448576490|FG000|Overall Study|Physician Decision|1|||
124713444|NCT02379052|448576491|FG001|Overall Study|Physician Decision|1|||
124770439|NCT03224819|448788871|FG011|Overall Study|Withdrawal by Subject|0|||
124770440|NCT03224819|448788872|FG012|Overall Study|Withdrawal by Subject|1|||
124974156|NCT04624243|449534418|FG000|Overall Study|Physician Decision|3|||
124974157|NCT04624243|449534419|FG001|Overall Study|Physician Decision|8|||
124974158|NCT04624243|449534420|FG002|Overall Study|Physician Decision|15|||
124974159|NCT04624243|449534421|FG003|Overall Study|Physician Decision|2|||
124974160|NCT04624243|449534422|FG004|Overall Study|Physician Decision|11|||
124974161|NCT04624243|449534418|FG000|Overall Study|Withdrawal by Subject|19|||
124974162|NCT04624243|449534419|FG001|Overall Study|Withdrawal by Subject|44|||
124974163|NCT04624243|449534420|FG002|Overall Study|Withdrawal by Subject|40|||
124974164|NCT04624243|449534421|FG003|Overall Study|Withdrawal by Subject|21|||
124974165|NCT04624243|449534422|FG004|Overall Study|Withdrawal by Subject|39|||
124974166|NCT04624243|449534418|FG000|Overall Study|Miscellaneous|3|||
124974167|NCT04624243|449534419|FG001|Overall Study|Miscellaneous|12|||
124974168|NCT04624243|449534420|FG002|Overall Study|Miscellaneous|9|||
124974169|NCT04624243|449534421|FG003|Overall Study|Miscellaneous|4|||
124974170|NCT04624243|449534422|FG004|Overall Study|Miscellaneous|6|||
124974171|NCT05543174|449534423|FG000|Overall Study|Ongoing|7|||
124974172|NCT00953771|449534424|FG000|Overall Study|Death|1|||
124974173|NCT00953771|449534425|FG001|Overall Study|Death|0|||
124974174|NCT04896008|449534426|FG000|Overall Study|Ongoing|70|||
124974175|NCT04896008|449534427|FG001|Overall Study|Ongoing|38|||
124974176|NCT04896008|449534426|FG000|Overall Study|Adverse Event|0|||
124974177|NCT04896008|449534427|FG001|Overall Study|Adverse Event|2|||
124974178|NCT04896008|449534426|FG000|Overall Study|Death|5|||
124974179|NCT04896008|449534427|FG001|Overall Study|Death|10|||
124974180|NCT04896008|449534426|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
124713445|NCT02379052|448576490|FG000|Overall Study|Withdrawal by Subject|2|||
124974181|NCT04896008|449534427|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
124974182|NCT04896008|449534426|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
124974183|NCT04896008|449534427|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
124974184|NCT04896008|449534426|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
124974185|NCT04896008|449534427|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
124552225|NCT02913261|447978659|FG000|Overall Study|Technical problems|0|||
124713446|NCT02379052|448576491|FG001|Overall Study|Withdrawal by Subject|0|||
124974186|NCT04896008|449534426|FG000|Overall Study|Withdrawal by Subject|1|||
124974187|NCT04896008|449534427|FG001|Overall Study|Withdrawal by Subject|4|||
124974188|NCT04896008|449534426|FG000|Overall Study|Investigator Decision|2|||
124974189|NCT04896008|449534427|FG001|Overall Study|Investigator Decision|0|||
124974190|NCT04896008|449534426|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
124974191|NCT04896008|449534427|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
124974192|NCT01270828|449534432|FG000|Pregabalin CR SB|Reason Unspecified|0|||
124469353|NCT03403205|447674780|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
124469354|NCT03403205|447674775|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
124469355|NCT03403205|447674776|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
124469356|NCT03403205|447674777|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
124469357|NCT03403205|447674778|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
124469358|NCT03403205|447674779|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
124469359|NCT03403205|447674780|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
124469360|NCT03403205|447674775|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
124469361|NCT03403205|447674776|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
124469362|NCT03403205|447674777|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
124469363|NCT03403205|447674778|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
124469364|NCT03403205|447674779|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
124469365|NCT03403205|447674780|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
124469366|NCT01834729|447674781|FG000|Overall Study|Did not return bowel diaries|0|||
124469367|NCT01834729|447674782|FG001|Overall Study|Did not return bowel diaries|0|||
124469368|NCT01834729|447674783|FG002|Overall Study|Did not return bowel diaries|3|||
124469369|NCT01834729|447674784|FG003|Overall Study|Did not return bowel diaries|0|||
124469370|NCT01834729|447674781|FG000|Overall Study|Withdrawal by Subject|1|||
124469371|NCT01834729|447674782|FG001|Overall Study|Withdrawal by Subject|1|||
124469372|NCT01834729|447674783|FG002|Overall Study|Withdrawal by Subject|0|||
124469373|NCT01834729|447674784|FG003|Overall Study|Withdrawal by Subject|0|||
124469374|NCT01834729|447674781|FG000|Overall Study|Adverse Event|0|||
124469375|NCT01834729|447674782|FG001|Overall Study|Adverse Event|0|||
124469376|NCT01834729|447674783|FG002|Overall Study|Adverse Event|0|||
124469377|NCT01834729|447674784|FG003|Overall Study|Adverse Event|2|||
124469378|NCT02971670|447674785|FG000|Overall Study|Withdrawal by Subject|4|||
124469379|NCT02971670|447674786|FG001|Overall Study|Withdrawal by Subject|1|||
124469380|NCT02971670|447674787|FG002|Overall Study|Withdrawal by Subject|1|||
124469381|NCT02971670|447674788|FG003|Overall Study|Withdrawal by Subject|2|||
124713447|NCT02379052|448576490|FG000|Overall Study|Lost to Follow-up|2|||
124713448|NCT02379052|448576491|FG001|Overall Study|Lost to Follow-up|1|||
124713449|NCT02379052|448576490|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
124713450|NCT02379052|448576491|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
124974193|NCT01270828|449534433|FG001|Pregabalin CR SB|Reason Unspecified|0|||
124974194|NCT01270828|449534434|FG002|Pregabalin CR SB|Reason Unspecified|8|||
124974195|NCT01270828|449534432|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
124974196|NCT01270828|449534433|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
124974197|NCT01270828|449534434|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
124974198|NCT01270828|449534432|FG000|Pregabalin CR SB|Related adverse event|0|||
124974199|NCT01270828|449534433|FG001|Pregabalin CR SB|Related adverse event|0|||
124974200|NCT01270828|449534434|FG002|Pregabalin CR SB|Related adverse event|46|||
124974201|NCT01270828|449534432|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
124974202|NCT01270828|449534433|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
124974203|NCT01270828|449534434|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
124974204|NCT01270828|449534432|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
124974205|NCT01270828|449534433|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
124974206|NCT01270828|449534434|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
124974207|NCT01270828|449534432|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
124974208|NCT01270828|449534433|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
124974209|NCT01270828|449534434|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
124974210|NCT01270828|449534432|FG000|Pregabalin CR SB|Unrelated AE|0|||
124974211|NCT01270828|449534433|FG001|Pregabalin CR SB|Unrelated AE|0|||
124974212|NCT01270828|449534434|FG002|Pregabalin CR SB|Unrelated AE|8|||
124974213|NCT01270828|449534432|FG000|Pregabalin CR SB|Protocol Violation|0|||
124469382|NCT00288080|447674789|FG000|Overall Study|Withdrawal by Subject|1|||
124469383|NCT00288080|447674790|FG001|Overall Study|Withdrawal by Subject|3|||
124469384|NCT00288080|447674789|FG000|Overall Study|Protocol Violation|25|||
124469385|NCT00288080|447674790|FG001|Overall Study|Protocol Violation|20|||
124469386|NCT01017952|447674791|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
124469387|NCT01017952|447674792|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
124469388|NCT01017952|447674793|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
124469389|NCT01017952|447674794|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
124469390|NCT01017952|447674795|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
124469391|NCT01017952|447674791|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
124469392|NCT01017952|447674792|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
124974214|NCT01270828|449534433|FG001|Pregabalin CR SB|Protocol Violation|0|||
124469393|NCT01017952|447674793|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
124469394|NCT01017952|447674794|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
124469395|NCT01017952|447674795|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
124469396|NCT01017952|447674791|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
124469397|NCT01017952|447674792|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
124469398|NCT01017952|447674793|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
124469399|NCT01017952|447674794|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
124469400|NCT01017952|447674795|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
124469401|NCT01017952|447674791|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
124469402|NCT01017952|447674792|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
124469403|NCT01017952|447674793|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
124469404|NCT01017952|447674794|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
124469405|NCT01017952|447674795|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
124469406|NCT01017952|447674791|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
124469407|NCT01017952|447674792|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
124469408|NCT01017952|447674793|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
124469409|NCT01017952|447674794|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
124469410|NCT01017952|447674795|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
124469411|NCT01017952|447674791|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
124469412|NCT01017952|447674792|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
124713451|NCT02379052|448576490|FG000|Overall Study|Subject was Incarcerated|0|||
124713452|NCT02379052|448576491|FG001|Overall Study|Subject was Incarcerated|1|||
124469413|NCT01017952|447674793|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
124469414|NCT01017952|447674794|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
124469415|NCT01017952|447674795|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
124713453|NCT03824392|448576492|FG000|Overall Study|Adverse Event|1|||
124713454|NCT03824392|448576493|FG001|Overall Study|Adverse Event|0|||
124713455|NCT03824392|448576494|FG002|Overall Study|Adverse Event|0|||
124713456|NCT03824392|448576495|FG003|Overall Study|Adverse Event|0|||
124713457|NCT03824392|448576492|FG000|Overall Study|Investigator Decision|0|||
124713458|NCT03824392|448576493|FG001|Overall Study|Investigator Decision|1|||
124974215|NCT01270828|449534434|FG002|Pregabalin CR SB|Protocol Violation|8|||
124974216|NCT01270828|449534432|FG000|Double Blind Phase|Death|0|||
124974217|NCT01270828|449534433|FG001|Double Blind Phase|Death|1|||
124974218|NCT01270828|449534434|FG002|Double Blind Phase|Death|0|||
124974219|NCT01270828|449534432|FG000|Double Blind Phase|Protocol Violation|0|||
124974220|NCT01270828|449534433|FG001|Double Blind Phase|Protocol Violation|1|||
124974221|NCT01270828|449534434|FG002|Double Blind Phase|Protocol Violation|0|||
124974222|NCT01270828|449534432|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
124974223|NCT01270828|449534433|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
124974224|NCT01270828|449534434|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
124974225|NCT01270828|449534432|FG000|Double Blind Phase|Reason Unspecified|7|||
124974226|NCT01270828|449534433|FG001|Double Blind Phase|Reason Unspecified|4|||
124974227|NCT01270828|449534434|FG002|Double Blind Phase|Reason Unspecified|0|||
124974228|NCT01270828|449534432|FG000|Double Blind Phase|Withdrawal by Subject|6|||
124974229|NCT01270828|449534433|FG001|Double Blind Phase|Withdrawal by Subject|15|||
124974230|NCT01270828|449534434|FG002|Double Blind Phase|Withdrawal by Subject|0|||
124974231|NCT01270828|449534432|FG000|Double Blind Phase|Lost to Follow-up|1|||
124974232|NCT01270828|449534433|FG001|Double Blind Phase|Lost to Follow-up|2|||
124974233|NCT01270828|449534434|FG002|Double Blind Phase|Lost to Follow-up|0|||
124974234|NCT01270828|449534432|FG000|Double Blind Phase|Lack of Efficacy|2|||
124974235|NCT01270828|449534433|FG001|Double Blind Phase|Lack of Efficacy|11|||
124974236|NCT01270828|449534434|FG002|Double Blind Phase|Lack of Efficacy|0|||
124974237|NCT01270828|449534432|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
124974238|NCT01270828|449534433|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
124974239|NCT01270828|449534434|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
124974240|NCT01270828|449534432|FG000|Double Blind Phase|Adverse event related to study drug|5|||
124974241|NCT01270828|449534433|FG001|Double Blind Phase|Adverse event related to study drug|7|||
124974242|NCT01270828|449534434|FG002|Double Blind Phase|Adverse event related to study drug|0|||
124974243|NCT00709228|449534442|FG000|Overall Study|Not treated|14|||
124974244|NCT00709228|449534442|FG000|Overall Study|Eligibility criteria not met|281|||
124974245|NCT00709228|449534442|FG000|Overall Study|Adverse events|2|||
124974246|NCT00709228|449534442|FG000|Overall Study|Discontinued treatment|14|||
124974247|NCT00709228|449534442|FG000|Overall Study|Did not enter follow-up|4|||
124974248|NCT00709228|449534442|FG000|Overall Study|Discontinued follow-up|5|||
124974249|NCT00709228|449534442|FG000|Overall Study|Disease progression|1|||
124974250|NCT00709228|449534442|FG000|Overall Study|Lost to Follow-up|6|||
124974251|NCT00709228|449534442|FG000|Overall Study|Non-compliance|5|||
124974252|NCT02870972|449534445|FG000|Overall Study|Adverse Event|1|||
124974253|NCT02870972|449534446|FG001|Overall Study|Adverse Event|0|||
124974254|NCT02870972|449534447|FG002|Overall Study|Adverse Event|0|||
124974255|NCT02870972|449534448|FG003|Overall Study|Adverse Event|0|||
124974256|NCT02870972|449534449|FG004|Overall Study|Adverse Event|0|||
124974257|NCT04497389|449534450|FG000|Overall Study|Withdrawal by Subject|1|||
124974258|NCT04497389|449534451|FG001|Overall Study|Withdrawal by Subject|0|||
124974259|NCT02179177|449534452|FG000|Overall Study|Lost to Follow-up|1|||
124974260|NCT02179177|449534453|FG001|Overall Study|Lost to Follow-up|1|||
124974261|NCT02179177|449534452|FG000|Overall Study|Withdrawal by Subject|1|||
124974262|NCT02179177|449534453|FG001|Overall Study|Withdrawal by Subject|1|||
124974263|NCT03322540|449534454|FG000|Overall Study|Death|21|||
124974264|NCT03322540|449534455|FG001|Overall Study|Death|28|||
124974265|NCT03322540|449534454|FG000|Overall Study|Lost to Follow-up|0|||
124974266|NCT03322540|449534455|FG001|Overall Study|Lost to Follow-up|1|||
124974267|NCT03322540|449534454|FG000|Overall Study|Physician Decision|7|||
124974268|NCT03322540|449534455|FG001|Overall Study|Physician Decision|6|||
124974269|NCT03322540|449534454|FG000|Overall Study|Withdrawal by Subject|3|||
124974270|NCT03322540|449534455|FG001|Overall Study|Withdrawal by Subject|1|||
124974271|NCT03322540|449534454|FG000|Overall Study|Study terminated by sponsor|0|||
124552226|NCT02913261|447978660|FG001|Overall Study|Technical problems|1|||
124974272|NCT03322540|449534455|FG001|Overall Study|Study terminated by sponsor|1|||
124974273|NCT04052425|449534456|FG000|24-Week Double-blind Period|Adverse Event|0|||
124974274|NCT04052425|449534457|FG001|24-Week Double-blind Period|Adverse Event|1|||
124974275|NCT04052425|449534458|FG002|24-Week Double-blind Period|Adverse Event|0|||
124974276|NCT04052425|449534459|FG003|24-Week Double-blind Period|Adverse Event|0|||
124713459|NCT03824392|448576494|FG002|Overall Study|Investigator Decision|0|||
124974277|NCT04052425|449534456|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
124974278|NCT04052425|449534457|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
124974279|NCT04052425|449534458|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
124974280|NCT04052425|449534459|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
124974281|NCT04052425|449534456|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
124974282|NCT04052425|449534457|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
124974283|NCT04052425|449534458|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
124770441|NCT03224819|448788873|FG013|Overall Study|Withdrawal by Subject|0|||
124974284|NCT04052425|449534459|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
124974285|NCT04052425|449534456|FG000|24-Week Double-blind Period|Physician Decision|1|||
124974286|NCT04052425|449534457|FG001|24-Week Double-blind Period|Physician Decision|0|||
124974287|NCT04052425|449534458|FG002|24-Week Double-blind Period|Physician Decision|0|||
124974288|NCT04052425|449534459|FG003|24-Week Double-blind Period|Physician Decision|0|||
124974289|NCT04052425|449534456|FG000|24-Week Double-blind Period|Protocol Violation|1|||
124974290|NCT04052425|449534457|FG001|24-Week Double-blind Period|Protocol Violation|0|||
124974291|NCT04052425|449534458|FG002|24-Week Double-blind Period|Protocol Violation|0|||
124974292|NCT04052425|449534459|FG003|24-Week Double-blind Period|Protocol Violation|0|||
124974293|NCT04052425|449534456|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
124974294|NCT04052425|449534457|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
124974295|NCT04052425|449534458|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
124974296|NCT04052425|449534459|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
124974297|NCT04052425|449534456|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
124974298|NCT04052425|449534457|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
124974299|NCT04052425|449534458|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
124974300|NCT04052425|449534459|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
124974301|NCT04052425|449534456|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
124974302|NCT04052425|449534457|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
124974303|NCT04052425|449534458|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
124974304|NCT04052425|449534459|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
124974305|NCT04052425|449534456|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
124974306|NCT04052425|449534457|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
124974307|NCT04052425|449534458|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
124974308|NCT04052425|449534459|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
124974309|NCT04052425|449534456|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
124974310|NCT04052425|449534457|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
124974311|NCT04052425|449534458|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
124974312|NCT04052425|449534459|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
124974313|NCT04052425|449534456|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
124974314|NCT04052425|449534457|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
124974315|NCT04052425|449534458|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
124974316|NCT04052425|449534459|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
124974317|NCT04052425|449534456|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
124974318|NCT04052425|449534457|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
124974319|NCT04052425|449534458|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
124974320|NCT04052425|449534459|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
124974321|NCT04052425|449534456|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
124974322|NCT04052425|449534457|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
124974323|NCT04052425|449534458|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
124974324|NCT04052425|449534459|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
124974325|NCT04052425|449534456|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
124974326|NCT04052425|449534457|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
124974327|NCT04052425|449534458|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
124974328|NCT04052425|449534459|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
124974329|NCT04334278|449534460|FG000|Overall Study|Lost to Follow-up|0|||
124974330|NCT04334278|449534461|FG001|Overall Study|Lost to Follow-up|3|||
124974331|NCT04334278|449534460|FG000|Overall Study|Withdrawal by Subject|4|||
124974332|NCT04334278|449534461|FG001|Overall Study|Withdrawal by Subject|2|||
124974333|NCT04829747|449534464|FG000|Overall Study|Protocol Violation|1|||
124974334|NCT03445533|449534467|FG000|Overall Study|Progressive Disease|48|||
124974335|NCT03445533|449534468|FG001|Overall Study|Progressive Disease|81|||
124974336|NCT03445533|449534467|FG000|Overall Study|Adverse Event|60|||
124974337|NCT03445533|449534468|FG001|Overall Study|Adverse Event|64|||
124974338|NCT03445533|449534467|FG000|Overall Study|Death|9|||
124974339|NCT03445533|449534468|FG001|Overall Study|Death|19|||
124974340|NCT03445533|449534467|FG000|Overall Study|Miscellaneous|0|||
124974341|NCT03445533|449534468|FG001|Overall Study|Miscellaneous|16|||
124974342|NCT03445533|449534467|FG000|Overall Study|Withdrawal by Subject|3|||
124974343|NCT03445533|449534468|FG001|Overall Study|Withdrawal by Subject|4|||
124974344|NCT03445533|449534467|FG000|Overall Study|Physician Decision|1|||
124974345|NCT03445533|449534468|FG001|Overall Study|Physician Decision|3|||
124974346|NCT03445533|449534467|FG000|Overall Study|Sponsor Decision|0|||
124974347|NCT03445533|449534468|FG001|Overall Study|Sponsor Decision|1|||
124974348|NCT03445533|449534467|FG000|Overall Study|Lost to Follow-up|0|||
124974349|NCT03445533|449534468|FG001|Overall Study|Lost to Follow-up|1|||
124974350|NCT03445533|449534467|FG000|Overall Study|Never Received any Study Treatment|7|||
124974351|NCT03445533|449534468|FG001|Overall Study|Never Received any Study Treatment|4|||
124974352|NCT02615509|449534469|FG000|Overall Study|Lost to Follow-up|134|||
124469416|NCT01017952|447674791|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
124469417|NCT01017952|447674792|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
124469418|NCT01017952|447674793|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
124469419|NCT01017952|447674794|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
124469420|NCT01017952|447674795|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
124469421|NCT01017952|447674791|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
124469422|NCT01017952|447674792|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
124469423|NCT01017952|447674793|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
124469424|NCT01017952|447674794|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
124469425|NCT01017952|447674795|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
124469426|NCT01017952|447674791|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
124469427|NCT01017952|447674792|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
124469428|NCT01017952|447674793|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
124469429|NCT01017952|447674794|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
124469430|NCT01017952|447674795|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
124469431|NCT01017952|447674791|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
124469432|NCT01017952|447674792|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
124469433|NCT01017952|447674793|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
124469434|NCT01017952|447674794|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
124469435|NCT01017952|447674795|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
124469436|NCT01017952|447674791|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
124469437|NCT01017952|447674792|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
124469438|NCT01017952|447674793|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
124469439|NCT01017952|447674794|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
124469440|NCT01017952|447674795|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
124469441|NCT01017952|447674791|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
124469442|NCT01017952|447674792|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
124469443|NCT01017952|447674793|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
124469444|NCT01017952|447674794|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
124469445|NCT01017952|447674795|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
124469446|NCT01017952|447674791|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
124469447|NCT01017952|447674792|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
124469448|NCT01017952|447674793|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
124469449|NCT01017952|447674794|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
124469450|NCT01017952|447674795|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
124974353|NCT02615509|449534469|FG000|Overall Study|Death|4|||
124974354|NCT02615509|449534469|FG000|Overall Study|Withdrawal by Subject|8|||
124974355|NCT00945672|449534471|FG000|Overall Study|Withdrawal by Subject|0|||
124974356|NCT00945672|449534472|FG001|Overall Study|Withdrawal by Subject|0|||
124974357|NCT00945672|449534473|FG002|Overall Study|Withdrawal by Subject|0|||
124974358|NCT00945672|449534474|FG003|Overall Study|Withdrawal by Subject|1|||
124974359|NCT00968526|449534475|FG000|Overall Study|Adverse Event|2|||
124974360|NCT00968526|449534476|FG001|Overall Study|Adverse Event|0|||
124974361|NCT00968526|449534475|FG000|Overall Study|Migrated/moved from study area|1|||
124974362|NCT00968526|449534476|FG001|Overall Study|Migrated/moved from study area|0|||
124974363|NCT03926195|449534478|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
124974364|NCT03926195|449534479|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
124974365|NCT03926195|449534478|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
124974366|NCT03926195|449534479|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
124974367|NCT03926195|449534478|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
124974368|NCT03926195|449534479|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
124974369|NCT03926195|449534478|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
124469451|NCT01017952|447674791|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
124469452|NCT01017952|447674792|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
124469453|NCT01017952|447674793|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
124469454|NCT01017952|447674794|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
124469455|NCT01017952|447674795|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
124469456|NCT01235962|447674796|FG000|Overall Study|Withdrawal by Subject|20|||
124469457|NCT01235962|447674797|FG001|Overall Study|Withdrawal by Subject|19|||
124469458|NCT01235962|447674798|FG002|Overall Study|Withdrawal by Subject|62|||
124469459|NCT01235962|447674799|FG003|Overall Study|Withdrawal by Subject|49|||
124469460|NCT01235962|447674796|FG000|Overall Study|Lost to Follow-up|21|||
124974370|NCT03926195|449534479|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
124974371|NCT03926195|449534478|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
124974372|NCT03926195|449534479|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
124974373|NCT03926195|449534478|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
124974374|NCT03926195|449534479|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
124974375|NCT00447590|449534486|FG000|Overall Study|Withdrawal by Subject|26|||
124974376|NCT00447590|449534486|FG000|Overall Study|Lost to Follow-up|24|||
124974377|NCT00447590|449534486|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
124974378|NCT01689857|449534487|FG000|Overall Study|Lost to Follow-up|5|||
124974379|NCT01689857|449534488|FG001|Overall Study|Lost to Follow-up|2|||
124974380|NCT05105087|449534489|FG000|Overall Study|Withdrawal by Subject|2|||
124974381|NCT05105087|449534489|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
124974382|NCT01736540|449534490|FG000|Overall Study|Did not complete scan within 45 days|2|||
124974383|NCT01736540|449534490|FG000|Overall Study|Death|1|||
124974384|NCT01736540|449534490|FG000|Overall Study|Abnormal test procedure|1|||
124974385|NCT01736540|449534490|FG000|Overall Study|Withdrawal by Subject|5|||
124974386|NCT01736540|449534490|FG000|Overall Study|Protocol Violation|1|||
124974387|NCT01736540|449534490|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
124974388|NCT01736540|449534490|FG000|Overall Study|No show for MRI appointment|1|||
124974389|NCT01736540|449534490|FG000|Overall Study|Unable to make MRI appointment|3|||
124974390|NCT00479882|449534491|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
124974391|NCT00479882|449534492|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
124974392|NCT00479882|449534493|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
124974393|NCT00479882|449534494|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
124974394|NCT00479882|449534491|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
124974395|NCT00479882|449534492|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
124974396|NCT00479882|449534493|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
124974397|NCT00479882|449534494|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
124974398|NCT00479882|449534491|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
124974399|NCT00479882|449534492|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
124974400|NCT00479882|449534493|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
124974401|NCT00479882|449534494|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
124974402|NCT00479882|449534491|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
124974403|NCT00479882|449534492|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
124974404|NCT00479882|449534493|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
124974405|NCT00479882|449534494|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
124974406|NCT00479882|449534491|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
124974407|NCT00479882|449534492|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
124974408|NCT00479882|449534493|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
124974409|NCT00479882|449534494|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
124974410|NCT00479882|449534491|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
124974411|NCT00479882|449534492|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
124974412|NCT00479882|449534493|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
124974413|NCT00479882|449534494|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
124974414|NCT00479882|449534491|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
124974415|NCT00479882|449534492|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
124974416|NCT00479882|449534493|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
124974417|NCT00479882|449534494|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
124974418|NCT00479882|449534491|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
124974419|NCT00479882|449534492|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
124974420|NCT00479882|449534493|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
124974421|NCT00479882|449534494|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
124974422|NCT00479882|449534491|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
124974423|NCT00479882|449534492|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
124469461|NCT01235962|447674797|FG001|Overall Study|Lost to Follow-up|16|||
124552227|NCT02913261|447978659|FG000|Overall Study|Lack of Efficacy|32|||
124469462|NCT01235962|447674798|FG002|Overall Study|Lost to Follow-up|47|||
124469463|NCT01235962|447674799|FG003|Overall Study|Lost to Follow-up|32|||
124469464|NCT01235962|447674796|FG000|Overall Study|Physician Decision|5|||
124469465|NCT01235962|447674797|FG001|Overall Study|Physician Decision|0|||
124469466|NCT01235962|447674798|FG002|Overall Study|Physician Decision|9|||
124713460|NCT03824392|448576495|FG003|Overall Study|Investigator Decision|0|||
124713461|NCT03824392|448576492|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
124713462|NCT03824392|448576493|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
124713463|NCT03824392|448576494|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
124713464|NCT03824392|448576495|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
124713465|NCT00127855|448576496|FG000|Primary Vaccination Course|Adverse Event|0|||
124974424|NCT00479882|449534493|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
124974425|NCT00479882|449534494|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
124974426|NCT00479882|449534491|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
124974427|NCT00479882|449534492|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
124974428|NCT00479882|449534493|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
124974429|NCT00479882|449534494|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
124974430|NCT00479882|449534491|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
124974431|NCT00479882|449534492|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
124974432|NCT00479882|449534493|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
124974433|NCT00479882|449534494|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
124974434|NCT00479882|449534491|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
124974435|NCT00479882|449534492|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
124974436|NCT00479882|449534493|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
124974437|NCT00479882|449534494|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
124974438|NCT00479882|449534491|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
124974439|NCT00479882|449534492|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
124974440|NCT00479882|449534493|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
124974441|NCT00479882|449534494|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
124974442|NCT00479882|449534491|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
124974443|NCT00479882|449534492|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
124974444|NCT00479882|449534493|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
124974445|NCT00479882|449534494|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
124974446|NCT03738475|449534495|FG000|Overall Study|Participant Non-Compliance|1|||
124974447|NCT03738475|449534496|FG001|Overall Study|Participant Non-Compliance|0|||
124974448|NCT02159040|449534499|FG000|Overall Study|Death|1|||
124974449|NCT02803593|449534502|FG000|Overall Study|Lost to Follow-up|17|||
124974450|NCT02803593|449534503|FG001|Overall Study|Lost to Follow-up|35|||
124974451|NCT03443414|449534506|FG000|Overall Study|Adverse Event|6|||
124974452|NCT03443414|449534507|FG001|Overall Study|Adverse Event|0|||
124974453|NCT03443414|449534508|FG002|Overall Study|Adverse Event|4|||
124974454|NCT03443414|449534509|FG003|Overall Study|Adverse Event|2|||
124974455|NCT03443414|449534510|FG004|Overall Study|Adverse Event|3|||
124974456|NCT03443414|449534506|FG000|Overall Study|Withdrawal by Subject|3|||
124974457|NCT03443414|449534507|FG001|Overall Study|Withdrawal by Subject|2|||
124974458|NCT03443414|449534508|FG002|Overall Study|Withdrawal by Subject|2|||
124974459|NCT03443414|449534509|FG003|Overall Study|Withdrawal by Subject|2|||
124974460|NCT03443414|449534510|FG004|Overall Study|Withdrawal by Subject|1|||
124974461|NCT03443414|449534506|FG000|Overall Study|Death|0|||
124974462|NCT03443414|449534507|FG001|Overall Study|Death|1|||
124974463|NCT03443414|449534508|FG002|Overall Study|Death|0|||
124974464|NCT03443414|449534509|FG003|Overall Study|Death|1|||
124974465|NCT03443414|449534510|FG004|Overall Study|Death|0|||
124974466|NCT03443414|449534506|FG000|Overall Study|Reason not specified|2|||
124974467|NCT03443414|449534507|FG001|Overall Study|Reason not specified|0|||
124974468|NCT03443414|449534508|FG002|Overall Study|Reason not specified|0|||
124974469|NCT03443414|449534509|FG003|Overall Study|Reason not specified|0|||
124974470|NCT03443414|449534510|FG004|Overall Study|Reason not specified|1|||
124974471|NCT00732992|449534511|FG000|Overall Study|Adverse Event|1|||
124974472|NCT00732992|449534512|FG001|Overall Study|Adverse Event|1|||
124974473|NCT00732992|449534511|FG000|Overall Study|Objective Progression or Relapse|3|||
124974474|NCT00732992|449534512|FG001|Overall Study|Objective Progression or Relapse|5|||
124974475|NCT00732992|449534511|FG000|Overall Study|Global Deterioration of Health Status|1|||
124974476|NCT00732992|449534512|FG001|Overall Study|Global Deterioration of Health Status|0|||
124974477|NCT00732992|449534511|FG000|Overall Study|Withdrawal by Subject|1|||
124974478|NCT00732992|449534512|FG001|Overall Study|Withdrawal by Subject|0|||
124974479|NCT03933462|449534515|FG000|Overall Study|Adverse Event|2|||
124974480|NCT03933462|449534516|FG001|Overall Study|Adverse Event|0|||
124974481|NCT00422734|449534522|FG000|Overall Study|Physician Decision|1|||
124974482|NCT00422734|449534523|FG001|Overall Study|Physician Decision|1|||
124974483|NCT00422734|449534522|FG000|Overall Study|Protocol Violation|1|||
124974484|NCT00422734|449534523|FG001|Overall Study|Protocol Violation|6|||
124974485|NCT00422734|449534522|FG000|Overall Study|Withdrawal by Subject|12|||
124469467|NCT01235962|447674799|FG003|Overall Study|Physician Decision|5|||
124974486|NCT00422734|449534523|FG001|Overall Study|Withdrawal by Subject|8|||
124974487|NCT00422734|449534522|FG000|Overall Study|Adverse Event|0|||
124974488|NCT00422734|449534523|FG001|Overall Study|Adverse Event|3|||
124974489|NCT00422734|449534522|FG000|Overall Study|Partner Decision|0|||
124974490|NCT00422734|449534523|FG001|Overall Study|Partner Decision|3|||
124974491|NCT00368875|449534531|FG000|Overall Study|Adverse Event|0|||
124974492|NCT00368875|449534532|FG001|Overall Study|Adverse Event|12|||
124974493|NCT00368875|449534531|FG000|Overall Study|Progressive disease|3|||
124974494|NCT00368875|449534532|FG001|Overall Study|Progressive disease|27|||
124974495|NCT00368875|449534531|FG000|Overall Study|Withdrawal by Subject|2|||
124974496|NCT00368875|449534532|FG001|Overall Study|Withdrawal by Subject|6|||
124974497|NCT00368875|449534531|FG000|Overall Study|Other Reason|0|||
124974498|NCT00368875|449534532|FG001|Overall Study|Other Reason|2|||
124974499|NCT00368875|449534531|FG000|Overall Study|Alternative Therapy|1|||
124974500|NCT00368875|449534532|FG001|Overall Study|Alternative Therapy|1|||
124974501|NCT00996606|449534540|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
124974502|NCT00996606|449534540|FG000|Overall Study|Insufficient Therapeutic Response|2|||
124974503|NCT00996606|449534540|FG000|Overall Study|Protocol Violation|1|||
124974504|NCT00996606|449534540|FG000|Overall Study|Withdrawal by Subject|3|||
124974505|NCT00632502|449534543|FG000|Overall Study|Adverse Event|0|||
124974506|NCT00632502|449534544|FG001|Overall Study|Adverse Event|1|||
124974507|NCT00632502|449534543|FG000|Overall Study|Randomized not treated|3|||
124974508|NCT00632502|449534544|FG001|Overall Study|Randomized not treated|0|||
124974509|NCT00681668|449534547|FG000|Overall Study|Protocol Violation|1|||
124974510|NCT00681668|449534547|FG000|Overall Study|Withdrawal by Subject|1|||
124974511|NCT02209181|449534548|FG000|Overall Study|Adverse Event|1|||
124974512|NCT02209181|449534549|FG001|Overall Study|Adverse Event|0|||
124974513|NCT02209181|449534550|FG002|Overall Study|Adverse Event|1|||
124974514|NCT02209181|449534551|FG003|Overall Study|Adverse Event|0|||
124974515|NCT02209181|449534548|FG000|Overall Study|Withdrawal by Subject|0|||
124974516|NCT02209181|449534549|FG001|Overall Study|Withdrawal by Subject|1|||
124974517|NCT02209181|449534550|FG002|Overall Study|Withdrawal by Subject|0|||
124974518|NCT02209181|449534551|FG003|Overall Study|Withdrawal by Subject|0|||
124974519|NCT02548078|449534552|FG000|Overall Study|Serious adverse event/Adverse event|1|||
124974520|NCT02548078|449534553|FG001|Overall Study|Serious adverse event/Adverse event|0|||
124974521|NCT02548078|449534552|FG000|Overall Study|Moved from study area|3|||
124974522|NCT02548078|449534553|FG001|Overall Study|Moved from study area|3|||
124974523|NCT02548078|449534552|FG000|Overall Study|Lost to Follow-up|1|||
124974524|NCT02548078|449534553|FG001|Overall Study|Lost to Follow-up|3|||
124974525|NCT03128671|449534558|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
124974526|NCT03128671|449534559|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
124974527|NCT03128671|449534558|FG000|Allocation|Death|1|||
124974528|NCT03128671|449534559|FG001|Allocation|Death|0|||
124974529|NCT03128671|449534558|FG000|Allocation|Withdrawal by Subject|4|||
124974530|NCT03128671|449534559|FG001|Allocation|Withdrawal by Subject|0|||
124974531|NCT03128671|449534558|FG000|Intervention|Withdrawal by Subject|11|||
124974532|NCT03128671|449534559|FG001|Intervention|Withdrawal by Subject|10|||
124974533|NCT03128671|449534558|FG000|Intervention|Palliative/hospice care initiated|9|||
124974534|NCT03128671|449534559|FG001|Intervention|Palliative/hospice care initiated|10|||
124974535|NCT03128671|449534558|FG000|Intervention|Death|13|||
124974536|NCT03128671|449534559|FG001|Intervention|Death|11|||
124974537|NCT03128671|449534558|FG000|Intervention|Interrupted by hurricane|1|||
124974538|NCT03128671|449534559|FG001|Intervention|Interrupted by hurricane|0|||
124974539|NCT03128671|449534558|FG000|Intervention|Physician Decision|2|||
124974540|NCT03128671|449534559|FG001|Intervention|Physician Decision|3|||
124974541|NCT04641962|449534561|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
124974542|NCT04641962|449534562|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
124974543|NCT04641962|449534563|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
124974544|NCT04641962|449534564|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
124974545|NCT04641962|449534565|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
124974546|NCT04641962|449534561|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
124974547|NCT04641962|449534562|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
124974548|NCT04641962|449534563|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
124974549|NCT04641962|449534564|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
124974550|NCT04641962|449534565|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
124974551|NCT04641962|449534561|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
124974552|NCT04641962|449534562|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
124974553|NCT04641962|449534563|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
124974554|NCT04641962|449534564|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
124974555|NCT04641962|449534565|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
124974556|NCT04641962|449534561|FG000|DBT Period: Up to 52 Weeks|Death|1|||
124974557|NCT04641962|449534562|FG001|DBT Period: Up to 52 Weeks|Death|0|||
124974558|NCT04641962|449534563|FG002|DBT Period: Up to 52 Weeks|Death|0|||
124974559|NCT04641962|449534564|FG003|DBT Period: Up to 52 Weeks|Death|0|||
124770442|NCT03224819|448788860|FG000|Overall Study|Sponsor Decision|0|||
124974560|NCT04641962|449534565|FG004|DBT Period: Up to 52 Weeks|Death|0|||
124469468|NCT00087646|447674800|FG000|Overall Study|Adverse Event|37|||
124469469|NCT00087646|447674801|FG001|Overall Study|Adverse Event|6|||
124469470|NCT00087646|447674802|FG002|Overall Study|Adverse Event|18|||
124469471|NCT00087646|447674803|FG003|Overall Study|Adverse Event|20|||
124469472|NCT00087646|447674800|FG000|Overall Study|Death|0|||
124469473|NCT00087646|447674801|FG001|Overall Study|Death|1|||
124469474|NCT00087646|447674802|FG002|Overall Study|Death|0|||
124469475|NCT00087646|447674803|FG003|Overall Study|Death|0|||
124469476|NCT00087646|447674800|FG000|Overall Study|Withdrawal by Subject|6|||
124469477|NCT00087646|447674801|FG001|Overall Study|Withdrawal by Subject|1|||
124469478|NCT00087646|447674802|FG002|Overall Study|Withdrawal by Subject|2|||
124974561|NCT04641962|449534561|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
124974562|NCT04641962|449534562|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
124974563|NCT04641962|449534563|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
124974564|NCT04641962|449534564|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
124974565|NCT04641962|449534565|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
124974566|NCT04641962|449534561|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
124974567|NCT04641962|449534562|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
124974568|NCT04641962|449534563|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
124974569|NCT04641962|449534564|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
124974570|NCT04641962|449534565|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
124974571|NCT04641962|449534561|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
124974572|NCT04641962|449534562|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
124974573|NCT04641962|449534563|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
124713466|NCT00127855|448576497|FG001|Primary Vaccination Course|Adverse Event|0|||
124974574|NCT04641962|449534564|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
124469479|NCT00087646|447674803|FG003|Overall Study|Withdrawal by Subject|2|||
124469480|NCT00087646|447674800|FG000|Overall Study|Insufficient therapeutic response|64|||
124469481|NCT00087646|447674801|FG001|Overall Study|Insufficient therapeutic response|24|||
124974575|NCT04641962|449534565|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
124974576|NCT00862836|449534567|FG000|Overall Study|Withdrawal by Subject|1|||
124974577|NCT04463680|449534568|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
124974578|NCT04463680|449534568|FG000|Overall Study|Not eligible due to implant duration of use|1|||
124974579|NCT04463680|449534568|FG000|Overall Study|Withdrawal by Subject|3|||
124974580|NCT05239598|449534571|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
124974581|NCT05239598|449534572|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
124974582|NCT05239598|449534571|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
124974583|NCT05239598|449534572|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
124974584|NCT05823012|449534575|FG000|Titration Period|Adverse Event|1|||
124974585|NCT05823012|449534575|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
124974586|NCT05823012|449534575|FG000|Maintenance Period|Adverse Event|1|||
124974587|NCT05823012|449534575|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
124974588|NCT05823012|449534575|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
124974589|NCT01381575|449536426|FG000|Overall Study|Serious Adverse Event|1|||
124974590|NCT01381575|449536427|FG001|Overall Study|Serious Adverse Event|0|||
124974591|NCT01381575|449536428|FG002|Overall Study|Serious Adverse Event|0|||
124974592|NCT01381575|449536426|FG000|Overall Study|Non-Serious Adverse Event|0|||
124974593|NCT01381575|449536427|FG001|Overall Study|Non-Serious Adverse Event|0|||
124974594|NCT01381575|449536428|FG002|Overall Study|Non-Serious Adverse Event|1|||
124974595|NCT01381575|449536426|FG000|Overall Study|Protocol Violation|0|||
124974596|NCT01381575|449536427|FG001|Overall Study|Protocol Violation|1|||
124974597|NCT01381575|449536428|FG002|Overall Study|Protocol Violation|1|||
124974598|NCT01381575|449536426|FG000|Overall Study|Withdrawal by Subject|15|||
124469482|NCT00087646|447674802|FG002|Overall Study|Insufficient therapeutic response|38|||
124469483|NCT00087646|447674803|FG003|Overall Study|Insufficient therapeutic response|51|||
124469484|NCT00087646|447674800|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
124552228|NCT02913261|447978660|FG001|Overall Study|Lack of Efficacy|69|||
124552229|NCT02913261|447978659|FG000|Overall Study|Adverse Event|27|||
124552230|NCT02913261|447978660|FG001|Overall Study|Adverse Event|5|||
124552231|NCT02913261|447978659|FG000|Overall Study|Death|25|||
124552232|NCT02913261|447978660|FG001|Overall Study|Death|22|||
124974599|NCT01381575|449536427|FG001|Overall Study|Withdrawal by Subject|9|||
124974600|NCT01381575|449536428|FG002|Overall Study|Withdrawal by Subject|7|||
124974601|NCT01381575|449536426|FG000|Overall Study|Migrated/moved from study area|2|||
124974602|NCT01381575|449536427|FG001|Overall Study|Migrated/moved from study area|12|||
124974603|NCT01381575|449536428|FG002|Overall Study|Migrated/moved from study area|2|||
124974604|NCT01381575|449536426|FG000|Overall Study|Lost to Follow-up|8|||
124974605|NCT01381575|449536427|FG001|Overall Study|Lost to Follow-up|17|||
124974606|NCT01381575|449536428|FG002|Overall Study|Lost to Follow-up|9|||
124974607|NCT01920477|449536429|FG000|Overall Study|Adverse Event|0|||
124469485|NCT00087646|447674801|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
124469486|NCT00087646|447674802|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
124469487|NCT00087646|447674803|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
124469488|NCT00087646|447674800|FG000|Overall Study|Failure to Return|5|||
124469489|NCT00087646|447674801|FG001|Overall Study|Failure to Return|2|||
124552233|NCT02913261|447978659|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
124552234|NCT02913261|447978660|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
124552235|NCT02913261|447978659|FG000|Overall Study|Disease relapse|8|||
124552236|NCT02913261|447978660|FG001|Overall Study|Disease relapse|13|||
124552237|NCT02913261|447978659|FG000|Overall Study|Physician Decision|8|||
124552238|NCT02913261|447978660|FG001|Overall Study|Physician Decision|9|||
124552239|NCT02913261|447978659|FG000|Overall Study|Subject/guardian decision|4|||
124552240|NCT02913261|447978660|FG001|Overall Study|Subject/guardian decision|6|||
124552241|NCT02913261|447978659|FG000|Overall Study|Graft loss|2|||
124552242|NCT02913261|447978660|FG001|Overall Study|Graft loss|0|||
124552243|NCT02340078|447978661|FG000|Overall Study|Protocol Violation|1|||
124552244|NCT00567996|447978662|FG000|Overall Study|Adverse Event|18|||
124770443|NCT03224819|448788861|FG001|Overall Study|Sponsor Decision|0|||
124770444|NCT03224819|448788862|FG002|Overall Study|Sponsor Decision|0|||
124770445|NCT03224819|448788863|FG003|Overall Study|Sponsor Decision|1|||
124770446|NCT03224819|448788864|FG004|Overall Study|Sponsor Decision|1|||
124770447|NCT03224819|448788865|FG005|Overall Study|Sponsor Decision|2|||
124770448|NCT03224819|448788866|FG006|Overall Study|Sponsor Decision|1|||
124770449|NCT03224819|448788867|FG007|Overall Study|Sponsor Decision|1|||
124770450|NCT03224819|448788868|FG008|Overall Study|Sponsor Decision|1|||
124770451|NCT03224819|448788869|FG009|Overall Study|Sponsor Decision|2|||
124770452|NCT03224819|448788870|FG010|Overall Study|Sponsor Decision|1|||
124770453|NCT03224819|448788871|FG011|Overall Study|Sponsor Decision|1|||
124770454|NCT03224819|448788872|FG012|Overall Study|Sponsor Decision|1|||
124770455|NCT03224819|448788873|FG013|Overall Study|Sponsor Decision|0|||
124770456|NCT03224819|448788860|FG000|Overall Study|Lost to Follow-up|0|||
124770457|NCT03224819|448788861|FG001|Overall Study|Lost to Follow-up|0|||
124770458|NCT03224819|448788862|FG002|Overall Study|Lost to Follow-up|0|||
124770459|NCT03224819|448788863|FG003|Overall Study|Lost to Follow-up|0|||
124770460|NCT03224819|448788864|FG004|Overall Study|Lost to Follow-up|0|||
124770461|NCT03224819|448788865|FG005|Overall Study|Lost to Follow-up|0|||
124552245|NCT00567996|447978663|FG001|Overall Study|Adverse Event|16|||
124770462|NCT03224819|448788866|FG006|Overall Study|Lost to Follow-up|0|||
124770463|NCT03224819|448788867|FG007|Overall Study|Lost to Follow-up|0|||
124770464|NCT03224819|448788868|FG008|Overall Study|Lost to Follow-up|1|||
124552246|NCT00567996|447978664|FG002|Overall Study|Adverse Event|13|||
124552247|NCT00567996|447978662|FG000|Overall Study|Protocol Deviation|9|||
124552248|NCT00567996|447978663|FG001|Overall Study|Protocol Deviation|11|||
124552249|NCT00567996|447978664|FG002|Overall Study|Protocol Deviation|13|||
124552250|NCT00567996|447978662|FG000|Overall Study|Withdrawal by Subject|8|||
124552251|NCT00567996|447978663|FG001|Overall Study|Withdrawal by Subject|12|||
124974608|NCT01920477|449536430|FG001|Overall Study|Adverse Event|1|||
124974609|NCT01920477|449536429|FG000|Overall Study|Lack of Efficacy|1|||
124974610|NCT01920477|449536430|FG001|Overall Study|Lack of Efficacy|0|||
124974611|NCT01920477|449536429|FG000|Overall Study|Study closed/terminated|14|||
124974612|NCT01920477|449536430|FG001|Overall Study|Study closed/terminated|15|||
124974613|NCT01920477|449536429|FG000|Overall Study|Withdrawal by Subject|0|||
124974614|NCT01920477|449536430|FG001|Overall Study|Withdrawal by Subject|1|||
124974615|NCT01443403|449536431|FG000|Overall Study|Adverse Event|1|||
124974616|NCT01443403|449536432|FG001|Overall Study|Adverse Event|1|||
124974617|NCT01443403|449536433|FG002|Overall Study|Adverse Event|4|||
124974618|NCT01443403|449536434|FG003|Overall Study|Adverse Event|5|||
124974619|NCT01443403|449536431|FG000|Overall Study|Withdrawal by Subject|0|||
124974620|NCT01443403|449536432|FG001|Overall Study|Withdrawal by Subject|1|||
124974621|NCT01443403|449536433|FG002|Overall Study|Withdrawal by Subject|2|||
124974622|NCT01443403|449536434|FG003|Overall Study|Withdrawal by Subject|1|||
124974623|NCT01443403|449536431|FG000|Overall Study|Lost to Follow-up|0|||
124974624|NCT01443403|449536432|FG001|Overall Study|Lost to Follow-up|0|||
124974625|NCT01443403|449536433|FG002|Overall Study|Lost to Follow-up|0|||
124974626|NCT01443403|449536434|FG003|Overall Study|Lost to Follow-up|1|||
124974627|NCT01443403|449536431|FG000|Overall Study|Protocol Violation|2|||
124974628|NCT01443403|449536432|FG001|Overall Study|Protocol Violation|1|||
124974629|NCT01443403|449536433|FG002|Overall Study|Protocol Violation|1|||
124552252|NCT00567996|447978664|FG002|Overall Study|Withdrawal by Subject|22|||
124552253|NCT00567996|447978662|FG000|Overall Study|Abnormal Lab value(s)|2|||
124974630|NCT01443403|449536434|FG003|Overall Study|Protocol Violation|1|||
124974631|NCT01443403|449536431|FG000|Overall Study|Use of Prohibited Treatment|2|||
124469490|NCT00087646|447674802|FG002|Overall Study|Failure to Return|2|||
124469491|NCT00087646|447674803|FG003|Overall Study|Failure to Return|3|||
124469492|NCT00087646|447674800|FG000|Overall Study|Administrative/Other|6|||
124974632|NCT01443403|449536432|FG001|Overall Study|Use of Prohibited Treatment|3|||
124974633|NCT01443403|449536433|FG002|Overall Study|Use of Prohibited Treatment|0|||
124974634|NCT01443403|449536434|FG003|Overall Study|Use of Prohibited Treatment|0|||
124974635|NCT01443403|449536431|FG000|Overall Study|Other - Miscellaneous|1|||
124974636|NCT01443403|449536432|FG001|Overall Study|Other - Miscellaneous|0|||
124974637|NCT01443403|449536433|FG002|Overall Study|Other - Miscellaneous|0|||
124974638|NCT01443403|449536434|FG003|Overall Study|Other - Miscellaneous|1|||
124974639|NCT01681277|449536435|FG000|Overall Study|Adverse Event|1|||
124974640|NCT01681277|449536436|FG001|Overall Study|Adverse Event|0|||
124974641|NCT01681277|449536437|FG002|Overall Study|Adverse Event|0|||
124974642|NCT01681277|449536438|FG003|Overall Study|Adverse Event|0|||
124974643|NCT01681277|449536439|FG004|Overall Study|Adverse Event|0|||
124974644|NCT00474526|449536440|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
124974645|NCT00474526|449536441|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
124974646|NCT00474526|449536442|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
124974647|NCT00474526|449536443|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
124974648|NCT00474526|449536444|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
124974649|NCT00474526|449536445|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
124974650|NCT00474526|449536446|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
124974651|NCT00474526|449536447|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
124974652|NCT00474526|449536448|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
124974653|NCT00474526|449536449|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
124974654|NCT00474526|449536450|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
124974655|NCT00474526|449536451|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
124974656|NCT00474526|449536452|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
124974657|NCT00474526|449536453|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
124974658|NCT00474526|449536454|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
124974659|NCT00474526|449536455|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
124974660|NCT00474526|449536456|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
124974661|NCT00474526|449536440|FG000|Overall Study|Adverse Event|2|||
124974662|NCT00474526|449536441|FG001|Overall Study|Adverse Event|0|||
124974663|NCT00474526|449536442|FG002|Overall Study|Adverse Event|2|||
124974664|NCT00474526|449536443|FG003|Overall Study|Adverse Event|4|||
124974665|NCT00474526|449536444|FG004|Overall Study|Adverse Event|2|||
124974666|NCT00474526|449536445|FG005|Overall Study|Adverse Event|1|||
124974667|NCT00474526|449536446|FG006|Overall Study|Adverse Event|1|||
124974668|NCT00474526|449536447|FG007|Overall Study|Adverse Event|0|||
124974669|NCT00474526|449536448|FG008|Overall Study|Adverse Event|0|||
124974670|NCT00474526|449536449|FG009|Overall Study|Adverse Event|0|||
124974671|NCT00474526|449536450|FG010|Overall Study|Adverse Event|0|||
124974672|NCT00474526|449536451|FG011|Overall Study|Adverse Event|0|||
124974673|NCT00474526|449536452|FG012|Overall Study|Adverse Event|0|||
124974674|NCT00474526|449536453|FG013|Overall Study|Adverse Event|0|||
124974675|NCT00474526|449536454|FG014|Overall Study|Adverse Event|1|||
124974676|NCT00474526|449536455|FG015|Overall Study|Adverse Event|1|||
124974677|NCT00474526|449536456|FG016|Overall Study|Adverse Event|0|||
124974678|NCT00474526|449536440|FG000|Overall Study|Death|0|||
124974679|NCT00474526|449536441|FG001|Overall Study|Death|0|||
124974680|NCT00474526|449536442|FG002|Overall Study|Death|0|||
124974681|NCT00474526|449536443|FG003|Overall Study|Death|0|||
124974682|NCT00474526|449536444|FG004|Overall Study|Death|0|||
124974683|NCT00474526|449536445|FG005|Overall Study|Death|0|||
124974684|NCT00474526|449536446|FG006|Overall Study|Death|0|||
124974685|NCT00474526|449536447|FG007|Overall Study|Death|0|||
124974686|NCT00474526|449536448|FG008|Overall Study|Death|0|||
124974687|NCT00474526|449536449|FG009|Overall Study|Death|0|||
124974688|NCT00474526|449536450|FG010|Overall Study|Death|0|||
124974689|NCT00474526|449536451|FG011|Overall Study|Death|0|||
124974690|NCT00474526|449536452|FG012|Overall Study|Death|0|||
124974691|NCT00474526|449536453|FG013|Overall Study|Death|3|||
124974692|NCT00474526|449536454|FG014|Overall Study|Death|0|||
124974693|NCT00474526|449536455|FG015|Overall Study|Death|0|||
124974694|NCT00474526|449536456|FG016|Overall Study|Death|0|||
124974695|NCT00474526|449536440|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974696|NCT00474526|449536441|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
124974697|NCT00474526|449536442|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974698|NCT00474526|449536443|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
124974699|NCT00474526|449536444|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
124469493|NCT00087646|447674801|FG001|Overall Study|Administrative/Other|1|||
124974700|NCT00474526|449536445|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124469494|NCT00087646|447674802|FG002|Overall Study|Administrative/Other|1|||
124974701|NCT00474526|449536446|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974702|NCT00474526|449536447|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974703|NCT00474526|449536448|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974704|NCT00474526|449536449|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974705|NCT00474526|449536450|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124469495|NCT00087646|447674803|FG003|Overall Study|Administrative/Other|2|||
124469496|NCT00087646|447674800|FG000|Overall Study|Other Protocol Violation|3|||
124469497|NCT00087646|447674801|FG001|Overall Study|Other Protocol Violation|1|||
124469498|NCT00087646|447674802|FG002|Overall Study|Other Protocol Violation|0|||
124469499|NCT00087646|447674803|FG003|Overall Study|Other Protocol Violation|0|||
124469500|NCT00087646|447674800|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
124469501|NCT00087646|447674801|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
124469502|NCT00087646|447674802|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
124469503|NCT00087646|447674803|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
124469504|NCT01580397|447674806|FG000|Overall Study|Lack of Efficacy|14|||
124469505|NCT02902120|447674807|FG000|Overall Study|Lack of Efficacy|1|||
124469506|NCT06098729|447674823|FG000|Overall Study|Withdrawal by Subject|1|||
124469507|NCT03467958|447674834|FG000|Overall Study|Adverse Event|20|||
124713467|NCT00127855|448576498|FG002|Primary Vaccination Course|Adverse Event|1|||
124469508|NCT03467958|447674835|FG001|Overall Study|Adverse Event|32|||
124469509|NCT03467958|447674836|FG002|Overall Study|Adverse Event|5|||
124469510|NCT03467958|447674837|FG003|Overall Study|Adverse Event|3|||
124469511|NCT03467958|447674838|FG004|Overall Study|Adverse Event|3|||
124469512|NCT03467958|447674839|FG005|Overall Study|Adverse Event|3|||
124469513|NCT03467958|447674840|FG006|Overall Study|Adverse Event|6|||
124469514|NCT03467958|447674841|FG007|Overall Study|Adverse Event|5|||
124469515|NCT03467958|447674842|FG008|Overall Study|Adverse Event|0|||
124469516|NCT03467958|447674834|FG000|Overall Study|Lack of Efficacy|59|||
124469517|NCT03467958|447674835|FG001|Overall Study|Lack of Efficacy|120|||
124469518|NCT03467958|447674836|FG002|Overall Study|Lack of Efficacy|6|||
124469519|NCT03467958|447674837|FG003|Overall Study|Lack of Efficacy|9|||
124469520|NCT03467958|447674838|FG004|Overall Study|Lack of Efficacy|8|||
124469521|NCT03467958|447674839|FG005|Overall Study|Lack of Efficacy|9|||
124469522|NCT03467958|447674840|FG006|Overall Study|Lack of Efficacy|11|||
124469523|NCT03467958|447674841|FG007|Overall Study|Lack of Efficacy|9|||
124469524|NCT03467958|447674842|FG008|Overall Study|Lack of Efficacy|3|||
124469525|NCT03467958|447674834|FG000|Overall Study|Lost to Follow-up|1|||
124469526|NCT03467958|447674835|FG001|Overall Study|Lost to Follow-up|2|||
124469527|NCT03467958|447674836|FG002|Overall Study|Lost to Follow-up|1|||
124469528|NCT03467958|447674837|FG003|Overall Study|Lost to Follow-up|0|||
124552254|NCT00567996|447978663|FG001|Overall Study|Abnormal Lab value(s)|1|||
124552255|NCT00567996|447978664|FG002|Overall Study|Abnormal Lab value(s)|2|||
124552256|NCT00567996|447978662|FG000|Overall Study|Abnormal test procedure result(s)|2|||
124552257|NCT00567996|447978663|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124552258|NCT00567996|447978664|FG002|Overall Study|Abnormal test procedure result(s)|1|||
124552259|NCT00567996|447978662|FG000|Overall Study|Lost to Follow-up|2|||
124552260|NCT00567996|447978663|FG001|Overall Study|Lost to Follow-up|5|||
124552261|NCT00567996|447978664|FG002|Overall Study|Lost to Follow-up|2|||
124552262|NCT00567996|447978662|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124552263|NCT00567996|447978663|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124713468|NCT00127855|448576499|FG003|Primary Vaccination Course|Adverse Event|0|||
124713469|NCT00127855|448576500|FG004|Primary Vaccination Course|Adverse Event|0|||
124713470|NCT00127855|448576496|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
124713471|NCT00127855|448576497|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
124974706|NCT00474526|449536451|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974707|NCT00474526|449536452|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974708|NCT00474526|449536453|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
124974709|NCT00474526|449536454|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
124974710|NCT00474526|449536455|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974711|NCT00474526|449536456|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
124974712|NCT00474526|449536440|FG000|Overall Study|Lost to Follow-up|8|||
124974713|NCT00474526|449536441|FG001|Overall Study|Lost to Follow-up|6|||
124974714|NCT00474526|449536442|FG002|Overall Study|Lost to Follow-up|13|||
124974715|NCT00474526|449536443|FG003|Overall Study|Lost to Follow-up|29|||
124974716|NCT00474526|449536444|FG004|Overall Study|Lost to Follow-up|11|||
124974717|NCT00474526|449536445|FG005|Overall Study|Lost to Follow-up|5|||
124974718|NCT00474526|449536446|FG006|Overall Study|Lost to Follow-up|8|||
124974719|NCT00474526|449536447|FG007|Overall Study|Lost to Follow-up|1|||
124974720|NCT00474526|449536448|FG008|Overall Study|Lost to Follow-up|0|||
124974721|NCT00474526|449536449|FG009|Overall Study|Lost to Follow-up|6|||
124974722|NCT00474526|449536450|FG010|Overall Study|Lost to Follow-up|2|||
124974723|NCT00474526|449536451|FG011|Overall Study|Lost to Follow-up|4|||
124469529|NCT03467958|447674838|FG004|Overall Study|Lost to Follow-up|4|||
124469530|NCT03467958|447674839|FG005|Overall Study|Lost to Follow-up|0|||
124469531|NCT03467958|447674840|FG006|Overall Study|Lost to Follow-up|0|||
124469532|NCT03467958|447674841|FG007|Overall Study|Lost to Follow-up|0|||
124552264|NCT00567996|447978664|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
124770465|NCT03224819|448788869|FG009|Overall Study|Lost to Follow-up|0|||
124469533|NCT03467958|447674842|FG008|Overall Study|Lost to Follow-up|0|||
124469534|NCT03467958|447674834|FG000|Overall Study|Other reasons|8|||
124469535|NCT03467958|447674835|FG001|Overall Study|Other reasons|14|||
124974724|NCT00474526|449536452|FG012|Overall Study|Lost to Follow-up|6|||
124974725|NCT00474526|449536453|FG013|Overall Study|Lost to Follow-up|74|||
124713472|NCT00127855|448576498|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
124713473|NCT00127855|448576499|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
124713474|NCT00127855|448576500|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
124713475|NCT00127855|448576496|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
124974726|NCT00474526|449536454|FG014|Overall Study|Lost to Follow-up|29|||
124974727|NCT00474526|449536455|FG015|Overall Study|Lost to Follow-up|4|||
124974728|NCT00474526|449536456|FG016|Overall Study|Lost to Follow-up|5|||
124974729|NCT00474526|449536440|FG000|Overall Study|Protocol Violation|2|||
124974730|NCT00474526|449536441|FG001|Overall Study|Protocol Violation|6|||
124974731|NCT00474526|449536442|FG002|Overall Study|Protocol Violation|4|||
124974732|NCT00474526|449536443|FG003|Overall Study|Protocol Violation|12|||
124974733|NCT00474526|449536444|FG004|Overall Study|Protocol Violation|3|||
124974734|NCT00474526|449536445|FG005|Overall Study|Protocol Violation|1|||
124974735|NCT00474526|449536446|FG006|Overall Study|Protocol Violation|3|||
124974736|NCT00474526|449536447|FG007|Overall Study|Protocol Violation|0|||
124974737|NCT00474526|449536448|FG008|Overall Study|Protocol Violation|0|||
124974738|NCT00474526|449536449|FG009|Overall Study|Protocol Violation|4|||
124974739|NCT00474526|449536450|FG010|Overall Study|Protocol Violation|2|||
124974740|NCT00474526|449536451|FG011|Overall Study|Protocol Violation|2|||
124974741|NCT00474526|449536452|FG012|Overall Study|Protocol Violation|4|||
124974742|NCT00474526|449536453|FG013|Overall Study|Protocol Violation|19|||
124974743|NCT00474526|449536454|FG014|Overall Study|Protocol Violation|9|||
124974744|NCT00474526|449536455|FG015|Overall Study|Protocol Violation|6|||
124974745|NCT00474526|449536456|FG016|Overall Study|Protocol Violation|2|||
124974746|NCT00474526|449536440|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
124974747|NCT00474526|449536441|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
124974748|NCT00474526|449536442|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
124974749|NCT00474526|449536443|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
124974750|NCT00474526|449536444|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
124974751|NCT00474526|449536445|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
124974752|NCT00474526|449536446|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
124974753|NCT00474526|449536447|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
124974754|NCT00474526|449536448|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
124974755|NCT00474526|449536449|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
124974756|NCT00474526|449536450|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
124974757|NCT00474526|449536451|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
124974758|NCT00474526|449536452|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
124974759|NCT00474526|449536453|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
124974760|NCT00474526|449536454|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
124974761|NCT00474526|449536455|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
124974762|NCT00474526|449536456|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
124974763|NCT00474526|449536440|FG000|Overall Study|Withdrawal by Subject|9|||
124469536|NCT03467958|447674836|FG002|Overall Study|Other reasons|2|||
124770466|NCT03224819|448788870|FG010|Overall Study|Lost to Follow-up|0|||
124974764|NCT00474526|449536441|FG001|Overall Study|Withdrawal by Subject|24|||
124974765|NCT00474526|449536442|FG002|Overall Study|Withdrawal by Subject|21|||
124974766|NCT00474526|449536443|FG003|Overall Study|Withdrawal by Subject|52|||
124974767|NCT00474526|449536444|FG004|Overall Study|Withdrawal by Subject|38|||
124974768|NCT00474526|449536445|FG005|Overall Study|Withdrawal by Subject|6|||
124469537|NCT03467958|447674837|FG003|Overall Study|Other reasons|1|||
124469538|NCT03467958|447674838|FG004|Overall Study|Other reasons|4|||
124469539|NCT03467958|447674839|FG005|Overall Study|Other reasons|0|||
124469540|NCT03467958|447674840|FG006|Overall Study|Other reasons|1|||
124469541|NCT03467958|447674841|FG007|Overall Study|Other reasons|0|||
124469542|NCT03467958|447674842|FG008|Overall Study|Other reasons|1|||
124469543|NCT03467958|447674834|FG000|Overall Study|Pregnancy|1|||
124469544|NCT03467958|447674835|FG001|Overall Study|Pregnancy|0|||
124469545|NCT03467958|447674836|FG002|Overall Study|Pregnancy|0|||
124469546|NCT03467958|447674837|FG003|Overall Study|Pregnancy|0|||
124469547|NCT03467958|447674838|FG004|Overall Study|Pregnancy|0|||
124469548|NCT03467958|447674839|FG005|Overall Study|Pregnancy|1|||
124469549|NCT03467958|447674840|FG006|Overall Study|Pregnancy|0|||
124469550|NCT03467958|447674841|FG007|Overall Study|Pregnancy|0|||
124469551|NCT03467958|447674842|FG008|Overall Study|Pregnancy|0|||
124469552|NCT03467958|447674834|FG000|Overall Study|Study terminated by sponsor|65|||
124469553|NCT03467958|447674835|FG001|Overall Study|Study terminated by sponsor|117|||
124469554|NCT03467958|447674836|FG002|Overall Study|Study terminated by sponsor|45|||
124469555|NCT03467958|447674837|FG003|Overall Study|Study terminated by sponsor|64|||
124469556|NCT03467958|447674838|FG004|Overall Study|Study terminated by sponsor|66|||
124469557|NCT03467958|447674839|FG005|Overall Study|Study terminated by sponsor|17|||
124469558|NCT03467958|447674840|FG006|Overall Study|Study terminated by sponsor|11|||
124469559|NCT03467958|447674841|FG007|Overall Study|Study terminated by sponsor|5|||
124469560|NCT03467958|447674842|FG008|Overall Study|Study terminated by sponsor|5|||
124469561|NCT03467958|447674834|FG000|Overall Study|Withdrawal by Subject|25|||
124469562|NCT03467958|447674835|FG001|Overall Study|Withdrawal by Subject|44|||
124469563|NCT03467958|447674836|FG002|Overall Study|Withdrawal by Subject|7|||
124469564|NCT03467958|447674837|FG003|Overall Study|Withdrawal by Subject|8|||
124469565|NCT03467958|447674838|FG004|Overall Study|Withdrawal by Subject|6|||
124469566|NCT03467958|447674839|FG005|Overall Study|Withdrawal by Subject|8|||
124469567|NCT03467958|447674840|FG006|Overall Study|Withdrawal by Subject|4|||
124469568|NCT03467958|447674841|FG007|Overall Study|Withdrawal by Subject|1|||
124469569|NCT03467958|447674842|FG008|Overall Study|Withdrawal by Subject|4|||
124469570|NCT02925156|447674843|FG000|Overall Study|Lost to Follow-up|27|||
124469571|NCT02925156|447674844|FG001|Overall Study|Lost to Follow-up|53|||
124552265|NCT00567996|447978662|FG000|Overall Study|Administrative problems|1|||
124469572|NCT02925156|447674845|FG002|Overall Study|Lost to Follow-up|51|||
124552266|NCT00567996|447978663|FG001|Overall Study|Administrative problems|1|||
124552267|NCT00567996|447978664|FG002|Overall Study|Administrative problems|0|||
124552268|NCT00567996|447978662|FG000|Overall Study|Death|1|||
124552269|NCT00567996|447978663|FG001|Overall Study|Death|0|||
124552270|NCT00567996|447978664|FG002|Overall Study|Death|2|||
124469573|NCT02925156|447674846|FG003|Overall Study|Lost to Follow-up|59|||
124469574|NCT02925156|447674847|FG004|Overall Study|Lost to Follow-up|89|||
124469575|NCT02925156|447674848|FG005|Overall Study|Lost to Follow-up|107|||
124469576|NCT02925156|447674849|FG006|Overall Study|Lost to Follow-up|34|||
124552271|NCT00567996|447978662|FG000|Overall Study|Patient's inability to use the device|0|||
124469577|NCT02925156|447674850|FG007|Overall Study|Lost to Follow-up|36|||
124469578|NCT02925156|447674851|FG008|Overall Study|Lost to Follow-up|73|||
124469579|NCT02925156|447674852|FG009|Overall Study|Lost to Follow-up|34|||
124469580|NCT03434379|447674853|FG000|Global Period|Lost to Follow-up|3|||
124469581|NCT03434379|447674854|FG001|Global Period|Lost to Follow-up|6|||
124469582|NCT03434379|447674855|FG002|Global Period|Lost to Follow-up|0|||
124469583|NCT03434379|447674856|FG003|Global Period|Lost to Follow-up|0|||
124469584|NCT03434379|447674853|FG000|Global Period|Death|115|||
124469585|NCT03434379|447674854|FG001|Global Period|Death|228|||
124469586|NCT03434379|447674855|FG002|Global Period|Death|0|||
124469587|NCT03434379|447674856|FG003|Global Period|Death|0|||
124469588|NCT03434379|447674853|FG000|Global Period|Withdrawal by Subject|20|||
124469589|NCT03434379|447674854|FG001|Global Period|Withdrawal by Subject|21|||
124469590|NCT03434379|447674855|FG002|Global Period|Withdrawal by Subject|0|||
124469591|NCT03434379|447674856|FG003|Global Period|Withdrawal by Subject|0|||
124469592|NCT03434379|447674853|FG000|Global Period|Reason Unspecified|0|||
124469593|NCT03434379|447674854|FG001|Global Period|Reason Unspecified|1|||
124469594|NCT03434379|447674855|FG002|Global Period|Reason Unspecified|0|||
124469595|NCT03434379|447674856|FG003|Global Period|Reason Unspecified|0|||
124469596|NCT03434379|447674853|FG000|Global Period|Study Ended by Sponsor|26|||
124713476|NCT00127855|448576497|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
124713477|NCT00127855|448576498|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
124713478|NCT00127855|448576499|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
124713479|NCT00127855|448576500|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
124469597|NCT03434379|447674854|FG001|Global Period|Study Ended by Sponsor|80|||
124469598|NCT03434379|447674855|FG002|Global Period|Study Ended by Sponsor|0|||
124469599|NCT03434379|447674856|FG003|Global Period|Study Ended by Sponsor|0|||
124713480|NCT00127855|448576496|FG000|Primary Vaccination Course|Other|0|||
124713481|NCT00127855|448576497|FG001|Primary Vaccination Course|Other|0|||
124713482|NCT00127855|448576498|FG002|Primary Vaccination Course|Other|0|||
124469600|NCT03434379|447674853|FG000|Global Period|Physician Decision|1|||
124469601|NCT03434379|447674854|FG001|Global Period|Physician Decision|0|||
124469602|NCT03434379|447674855|FG002|Global Period|Physician Decision|0|||
124469603|NCT03434379|447674856|FG003|Global Period|Physician Decision|0|||
124469604|NCT03434379|447674853|FG000|China Extension Period|Lost to Follow-up|0|||
124469605|NCT03434379|447674854|FG001|China Extension Period|Lost to Follow-up|0|||
124469606|NCT03434379|447674855|FG002|China Extension Period|Lost to Follow-up|2|||
124469607|NCT03434379|447674856|FG003|China Extension Period|Lost to Follow-up|3|||
124469608|NCT03434379|447674853|FG000|China Extension Period|Death|0|||
124469609|NCT03434379|447674854|FG001|China Extension Period|Death|0|||
124469610|NCT03434379|447674855|FG002|China Extension Period|Death|46|||
124469611|NCT03434379|447674856|FG003|China Extension Period|Death|88|||
124469612|NCT03434379|447674853|FG000|China Extension Period|Withdrawal by Subject|0|||
124552272|NCT00567996|447978663|FG001|Overall Study|Patient's inability to use the device|1|||
124552273|NCT00567996|447978664|FG002|Overall Study|Patient's inability to use the device|0|||
124974769|NCT00474526|449536446|FG006|Overall Study|Withdrawal by Subject|12|||
124974770|NCT00474526|449536447|FG007|Overall Study|Withdrawal by Subject|4|||
124974771|NCT00474526|449536448|FG008|Overall Study|Withdrawal by Subject|4|||
124974772|NCT00474526|449536449|FG009|Overall Study|Withdrawal by Subject|13|||
124974773|NCT00474526|449536450|FG010|Overall Study|Withdrawal by Subject|5|||
124974774|NCT00474526|449536451|FG011|Overall Study|Withdrawal by Subject|4|||
124974775|NCT00474526|449536452|FG012|Overall Study|Withdrawal by Subject|4|||
124974776|NCT00474526|449536453|FG013|Overall Study|Withdrawal by Subject|37|||
124974777|NCT00474526|449536454|FG014|Overall Study|Withdrawal by Subject|22|||
124974778|NCT00474526|449536455|FG015|Overall Study|Withdrawal by Subject|1|||
124974779|NCT00474526|449536456|FG016|Overall Study|Withdrawal by Subject|1|||
124974780|NCT01251770|449536460|FG000|Overall Study|Protocol Violation|13|||
124974781|NCT01251770|449536461|FG001|Overall Study|Protocol Violation|7|||
124974782|NCT02113124|449536462|FG000|Overall Study|Unable to retrieve blood sample|1|||
124974783|NCT02113124|449536463|FG001|Overall Study|Unable to retrieve blood sample|1|||
124974784|NCT02514239|449536464|FG000|Overall Study|Refused to continue trial medication|0|||
124974785|NCT02514239|449536465|FG001|Overall Study|Refused to continue trial medication|0|||
124974786|NCT02514239|449536466|FG002|Overall Study|Refused to continue trial medication|0|||
124974787|NCT02514239|449536467|FG003|Overall Study|Refused to continue trial medication|0|||
124974788|NCT02514239|449536468|FG004|Overall Study|Refused to continue trial medication|0|||
124974789|NCT02514239|449536469|FG005|Overall Study|Refused to continue trial medication|0|||
124974790|NCT02514239|449536470|FG006|Overall Study|Refused to continue trial medication|0|||
124974791|NCT02514239|449536471|FG007|Overall Study|Refused to continue trial medication|0|||
124974792|NCT02514239|449536472|FG008|Overall Study|Refused to continue trial medication|0|||
124974793|NCT02514239|449536473|FG009|Overall Study|Refused to continue trial medication|1|||
124974794|NCT02514239|449536464|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
124974795|NCT02514239|449536465|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
124974796|NCT02514239|449536466|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
124974797|NCT02514239|449536467|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
124974798|NCT02514239|449536468|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
124974799|NCT02514239|449536469|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
124974800|NCT02514239|449536470|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
124974801|NCT02514239|449536471|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
124974802|NCT02514239|449536472|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
124974803|NCT02514239|449536473|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
124974804|NCT02514239|449536464|FG000|Overall Study|Not treated|0|||
124974805|NCT02514239|449536465|FG001|Overall Study|Not treated|1|||
124974806|NCT02514239|449536466|FG002|Overall Study|Not treated|0|||
124974807|NCT02514239|449536467|FG003|Overall Study|Not treated|0|||
124974808|NCT02514239|449536468|FG004|Overall Study|Not treated|0|||
124974809|NCT02514239|449536469|FG005|Overall Study|Not treated|0|||
124974810|NCT02514239|449536470|FG006|Overall Study|Not treated|0|||
124974811|NCT02514239|449536471|FG007|Overall Study|Not treated|0|||
124974812|NCT02514239|449536472|FG008|Overall Study|Not treated|0|||
124974813|NCT02514239|449536473|FG009|Overall Study|Not treated|0|||
124974814|NCT02514239|449536464|FG000|Overall Study|Other Adverse Events|2|||
124974815|NCT02514239|449536465|FG001|Overall Study|Other Adverse Events|0|||
124974816|NCT02514239|449536466|FG002|Overall Study|Other Adverse Events|0|||
124974817|NCT02514239|449536467|FG003|Overall Study|Other Adverse Events|1|||
124469613|NCT03434379|447674854|FG001|China Extension Period|Withdrawal by Subject|0|||
124469614|NCT03434379|447674855|FG002|China Extension Period|Withdrawal by Subject|8|||
124552274|NCT02524665|447978667|FG000|Overall Study|Lost to Follow-up|1|||
124552275|NCT02602080|447978668|FG000|Overall Study|Protocol Violation|6|||
124974818|NCT02514239|449536468|FG004|Overall Study|Other Adverse Events|0|||
124974819|NCT02514239|449536469|FG005|Overall Study|Other Adverse Events|1|||
124974820|NCT02514239|449536470|FG006|Overall Study|Other Adverse Events|0|||
124974821|NCT02514239|449536471|FG007|Overall Study|Other Adverse Events|1|||
124469615|NCT03434379|447674856|FG003|China Extension Period|Withdrawal by Subject|6|||
124469616|NCT03434379|447674853|FG000|China Extension Period|Study Ended by Sponsor|0|||
124552276|NCT02602080|447978669|FG001|Overall Study|Protocol Violation|1|||
124713483|NCT00127855|448576499|FG003|Primary Vaccination Course|Other|0|||
124713484|NCT00127855|448576500|FG004|Primary Vaccination Course|Other|1|||
124713485|NCT02343302|448576501|FG000|Overall Study|Physician Decision|1|||
124713486|NCT02343302|448576502|FG001|Overall Study|Physician Decision|1|||
124713487|NCT01887717|448576503|FG000|Overall Study|Withdrawal by Subject|1|||
124713488|NCT01887717|448576504|FG001|Overall Study|Withdrawal by Subject|7|||
124713489|NCT01887717|448576503|FG000|Overall Study|Physician Decision|0|||
124713490|NCT01887717|448576504|FG001|Overall Study|Physician Decision|2|||
124713491|NCT01887717|448576503|FG000|Overall Study|Administrative reasons|5|||
124713492|NCT01887717|448576504|FG001|Overall Study|Administrative reasons|2|||
124713493|NCT02655887|448576505|FG000|Overall Study|Lost to Follow-up|3|||
124713494|NCT02655887|448576505|FG000|Overall Study|Death|4|||
124974822|NCT02514239|449536472|FG008|Overall Study|Other Adverse Events|2|||
124974823|NCT02514239|449536473|FG009|Overall Study|Other Adverse Events|0|||
124974824|NCT02514239|449536464|FG000|Overall Study|Progressive disease|3|||
124974825|NCT02514239|449536465|FG001|Overall Study|Progressive disease|3|||
124974826|NCT02514239|449536466|FG002|Overall Study|Progressive disease|2|||
124974827|NCT02514239|449536467|FG003|Overall Study|Progressive disease|2|||
124974828|NCT02514239|449536468|FG004|Overall Study|Progressive disease|3|||
124974829|NCT02514239|449536469|FG005|Overall Study|Progressive disease|3|||
124974830|NCT02514239|449536470|FG006|Overall Study|Progressive disease|4|||
124974831|NCT02514239|449536471|FG007|Overall Study|Progressive disease|2|||
124974832|NCT02514239|449536472|FG008|Overall Study|Progressive disease|5|||
124974833|NCT02514239|449536473|FG009|Overall Study|Progressive disease|0|||
124974834|NCT03104075|449536474|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
124974835|NCT03104075|449536475|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
124974836|NCT04024462|449536476|FG000|Overall Study|Withdrawal by Subject|6|||
124974837|NCT04024462|449536477|FG001|Overall Study|Withdrawal by Subject|7|||
124974838|NCT04024462|449536476|FG000|Overall Study|Progressive Disease|0|||
124974839|NCT04024462|449536477|FG001|Overall Study|Progressive Disease|1|||
124974840|NCT04024462|449536476|FG000|Overall Study|Adverse Event|0|||
124974841|NCT04024462|449536477|FG001|Overall Study|Adverse Event|1|||
124974842|NCT04024462|449536476|FG000|Overall Study|Death|0|||
124974843|NCT04024462|449536477|FG001|Overall Study|Death|1|||
124974844|NCT04024462|449536476|FG000|Overall Study|Lost to Follow-up|1|||
124974845|NCT04024462|449536477|FG001|Overall Study|Lost to Follow-up|0|||
124974846|NCT04024462|449536476|FG000|Overall Study|Ongoing in the Study|94|||
124974847|NCT04024462|449536477|FG001|Overall Study|Ongoing in the Study|89|||
124974848|NCT00789360|449536480|FG000|Overall Study|Protocol Violation|3|||
124974849|NCT00789360|449536481|FG001|Overall Study|Protocol Violation|1|||
124974850|NCT04400487|449536482|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
124974851|NCT04400487|449536482|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
124974852|NCT04400487|449536482|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
124974853|NCT00022659|449536483|FG000|Overall Study|Ineligible: wrong primary|1|||
124974854|NCT00022659|449536483|FG000|Overall Study|Never treated|1|||
124974855|NCT03559062|449536484|FG000|Overall Study|Other|0|||
124974856|NCT03559062|449536485|FG001|Overall Study|Other|1|||
124974857|NCT03559062|449536486|FG002|Overall Study|Other|0|||
124974858|NCT00426127|449536487|FG000|Overall Study|Adverse Event|1|||
124974859|NCT00426127|449536487|FG000|Overall Study|Removed due to disease progression|1|||
124974860|NCT05048238|449536490|FG000|Overall Study|Withdrawal by Subject|1|||
124974861|NCT01730378|449536491|FG000|Overall Study|Lost to Follow-up|1|||
124974862|NCT01730378|449536492|FG001|Overall Study|Lost to Follow-up|0|||
124974863|NCT00955708|449536493|FG000|Overall Study|Death|269|||
124974864|NCT00955708|449536493|FG000|Overall Study|Lost to Follow-up|72|||
124974865|NCT00955708|449536493|FG000|Overall Study|Physician Decision|36|||
124974866|NCT00955708|449536493|FG000|Overall Study|Protocol Violation|134|||
124974867|NCT00955708|449536493|FG000|Overall Study|Registry Conclusion|186|||
124974868|NCT00955708|449536493|FG000|Overall Study|Product removed from service|94|||
124974869|NCT00955708|449536493|FG000|Overall Study|Patient Refused to participate further|116|||
124974870|NCT00955708|449536493|FG000|Overall Study|Closure of study location|60|||
124974871|NCT00955708|449536493|FG000|Overall Study|Patient changed care provider/moved|91|||
124974872|NCT01016262|449536494|FG000|Double-blind Phase|Adverse Event|0|||
124974873|NCT01016262|449536495|FG001|Double-blind Phase|Adverse Event|0|||
124770467|NCT03224819|448788871|FG011|Overall Study|Lost to Follow-up|0|||
124974874|NCT01016262|449536496|FG002|Double-blind Phase|Adverse Event|1|||
124974875|NCT01016262|449536497|FG003|Double-blind Phase|Adverse Event|0|||
124974876|NCT01016262|449536498|FG004|Double-blind Phase|Adverse Event|0|||
124974877|NCT01016262|449536499|FG005|Double-blind Phase|Adverse Event|0|||
124974878|NCT01016262|449536494|FG000|Double-blind Phase|Lack of Efficacy|1|||
124713495|NCT02655887|448576505|FG000|Overall Study|Withdrawal by Subject|3|||
124770468|NCT03224819|448788872|FG012|Overall Study|Lost to Follow-up|0|||
124974879|NCT01016262|449536495|FG001|Double-blind Phase|Lack of Efficacy|0|||
124713496|NCT02655887|448576505|FG000|Overall Study|Missed 12-month follow-up visit|4|||
124770469|NCT03224819|448788873|FG013|Overall Study|Lost to Follow-up|0|||
124974880|NCT01016262|449536496|FG002|Double-blind Phase|Lack of Efficacy|5|||
124974881|NCT01016262|449536497|FG003|Double-blind Phase|Lack of Efficacy|0|||
124974882|NCT01016262|449536498|FG004|Double-blind Phase|Lack of Efficacy|0|||
124974883|NCT01016262|449536499|FG005|Double-blind Phase|Lack of Efficacy|0|||
124974884|NCT01016262|449536494|FG000|Double-blind Phase|Disease Progression|0|||
124974885|NCT01016262|449536495|FG001|Double-blind Phase|Disease Progression|1|||
124974886|NCT01016262|449536496|FG002|Double-blind Phase|Disease Progression|2|||
124974887|NCT01016262|449536497|FG003|Double-blind Phase|Disease Progression|0|||
124974888|NCT01016262|449536498|FG004|Double-blind Phase|Disease Progression|0|||
124974889|NCT01016262|449536499|FG005|Double-blind Phase|Disease Progression|0|||
124974890|NCT01016262|449536494|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
124974891|NCT01016262|449536495|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
124974892|NCT01016262|449536496|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
124974893|NCT01016262|449536497|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
124974894|NCT01016262|449536498|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
124974895|NCT01016262|449536499|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
124974896|NCT01016262|449536494|FG000|Open-Label Phase|Adverse Event|0|||
124974897|NCT01016262|449536495|FG001|Open-Label Phase|Adverse Event|0|||
124974898|NCT01016262|449536496|FG002|Open-Label Phase|Adverse Event|0|||
124974899|NCT01016262|449536497|FG003|Open-Label Phase|Adverse Event|1|||
124974900|NCT01016262|449536498|FG004|Open-Label Phase|Adverse Event|0|||
124974901|NCT01016262|449536499|FG005|Open-Label Phase|Adverse Event|0|||
124974902|NCT01016262|449536494|FG000|Open-Label Phase|Lost to Follow-up|0|||
124974903|NCT01016262|449536495|FG001|Open-Label Phase|Lost to Follow-up|0|||
124974904|NCT01016262|449536496|FG002|Open-Label Phase|Lost to Follow-up|0|||
124974905|NCT01016262|449536497|FG003|Open-Label Phase|Lost to Follow-up|0|||
124974906|NCT01016262|449536498|FG004|Open-Label Phase|Lost to Follow-up|1|||
124974907|NCT01016262|449536499|FG005|Open-Label Phase|Lost to Follow-up|0|||
124974908|NCT01016262|449536494|FG000|Open-Label Phase|Lack of Efficacy|0|||
124974909|NCT01016262|449536495|FG001|Open-Label Phase|Lack of Efficacy|0|||
124974910|NCT01016262|449536496|FG002|Open-Label Phase|Lack of Efficacy|0|||
124974911|NCT01016262|449536497|FG003|Open-Label Phase|Lack of Efficacy|1|||
124974912|NCT01016262|449536498|FG004|Open-Label Phase|Lack of Efficacy|0|||
124974913|NCT01016262|449536499|FG005|Open-Label Phase|Lack of Efficacy|0|||
124974914|NCT01016262|449536494|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
124974915|NCT01016262|449536495|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
124974916|NCT01016262|449536496|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
124974917|NCT01016262|449536497|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
124974918|NCT01016262|449536498|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
124974919|NCT01016262|449536499|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
124974920|NCT00737477|449536500|FG000|Overall Study|Adverse Event|9|||
124974921|NCT00737477|449536500|FG000|Overall Study|Death|9|||
124974922|NCT00737477|449536500|FG000|Overall Study|Treatment Refusal|1|||
124974923|NCT00737477|449536500|FG000|Overall Study|Withdrawal by Subject|1|||
124974924|NCT00737477|449536500|FG000|Overall Study|Renal Transplantation|10|||
124974925|NCT00737477|449536500|FG000|Overall Study|Other|4|||
124974926|NCT01370655|449536501|FG000|Period 1|Adverse Event|2|||
124974927|NCT01370655|449536502|FG001|Period 1|Adverse Event|0|||
124974928|NCT01370655|449536503|FG002|Period 1|Adverse Event|0|||
124974929|NCT01370655|449536504|FG003|Period 1|Adverse Event|0|||
124974930|NCT01370655|449536505|FG004|Period 1|Adverse Event|0|||
124974931|NCT01370655|449536506|FG005|Period 1|Adverse Event|0|||
124974932|NCT01370655|449536507|FG006|Period 1|Adverse Event|1|||
124974933|NCT01370655|449536508|FG007|Period 1|Adverse Event|0|||
124974934|NCT01370655|449536509|FG008|Period 1|Adverse Event|0|||
124974935|NCT01370655|449536510|FG009|Period 1|Adverse Event|0|||
124974936|NCT01370655|449536511|FG010|Period 1|Adverse Event|0|||
124974937|NCT01370655|449536512|FG011|Period 1|Adverse Event|0|||
124974938|NCT01370655|449536501|FG000|Period 2|Adverse Event|0|||
124974939|NCT01370655|449536502|FG001|Period 2|Adverse Event|0|||
124770470|NCT03224819|448788860|FG000|Overall Study|Death|0|||
124974940|NCT01370655|449536503|FG002|Period 2|Adverse Event|1|||
124974941|NCT01370655|449536504|FG003|Period 2|Adverse Event|0|||
124974942|NCT01370655|449536505|FG004|Period 2|Adverse Event|1|||
124974943|NCT01370655|449536506|FG005|Period 2|Adverse Event|0|||
124974944|NCT01370655|449536507|FG006|Period 2|Adverse Event|0|||
124974945|NCT01370655|449536508|FG007|Period 2|Adverse Event|1|||
124974946|NCT01370655|449536509|FG008|Period 2|Adverse Event|0|||
124974947|NCT01370655|449536510|FG009|Period 2|Adverse Event|0|||
124974948|NCT01370655|449536511|FG010|Period 2|Adverse Event|0|||
124974949|NCT01370655|449536512|FG011|Period 2|Adverse Event|0|||
124974950|NCT01370655|449536501|FG000|Period 2|met protocol specified stopping criteria|0|||
124974951|NCT01370655|449536502|FG001|Period 2|met protocol specified stopping criteria|0|||
124974952|NCT01370655|449536503|FG002|Period 2|met protocol specified stopping criteria|1|||
124469617|NCT03434379|447674854|FG001|China Extension Period|Study Ended by Sponsor|0|||
124469618|NCT03434379|447674855|FG002|China Extension Period|Study Ended by Sponsor|5|||
124469619|NCT03434379|447674856|FG003|China Extension Period|Study Ended by Sponsor|36|||
124469620|NCT04202679|447674863|FG000|Overall Study|Adverse Event|2|||
124469621|NCT04202679|447674864|FG001|Overall Study|Adverse Event|0|||
124469622|NCT04202679|447674863|FG000|Overall Study|Poor compliance to protocol|1|||
124469623|NCT04202679|447674864|FG001|Overall Study|Poor compliance to protocol|0|||
124469624|NCT04202679|447674863|FG000|Overall Study|Withdrawal by Subject|23|||
124469625|NCT04202679|447674864|FG001|Overall Study|Withdrawal by Subject|6|||
124469626|NCT03406897|447674867|FG000|Overall Study|Lost to Follow-up|1|||
124469627|NCT03406897|447674868|FG001|Overall Study|Lost to Follow-up|2|||
124469628|NCT03406897|447674867|FG000|Overall Study|Withdrawal by Subject|4|||
124770471|NCT03224819|448788861|FG001|Overall Study|Death|1|||
124770472|NCT03224819|448788862|FG002|Overall Study|Death|0|||
124469629|NCT03406897|447674868|FG001|Overall Study|Withdrawal by Subject|4|||
124469630|NCT03406897|447674867|FG000|Overall Study|Physician Decision|0|||
124469631|NCT03406897|447674868|FG001|Overall Study|Physician Decision|1|||
124974953|NCT01370655|449536504|FG003|Period 2|met protocol specified stopping criteria|0|||
124974954|NCT01370655|449536505|FG004|Period 2|met protocol specified stopping criteria|0|||
124974955|NCT01370655|449536506|FG005|Period 2|met protocol specified stopping criteria|0|||
124974956|NCT01370655|449536507|FG006|Period 2|met protocol specified stopping criteria|1|||
124974957|NCT01370655|449536508|FG007|Period 2|met protocol specified stopping criteria|0|||
124974958|NCT01370655|449536509|FG008|Period 2|met protocol specified stopping criteria|1|||
124974959|NCT01370655|449536510|FG009|Period 2|met protocol specified stopping criteria|0|||
124974960|NCT01370655|449536511|FG010|Period 2|met protocol specified stopping criteria|1|||
124974961|NCT01370655|449536512|FG011|Period 2|met protocol specified stopping criteria|0|||
124974962|NCT01370655|449536501|FG000|Period 2|Withdrawal by Subject|0|||
124974963|NCT01370655|449536502|FG001|Period 2|Withdrawal by Subject|0|||
124974964|NCT01370655|449536503|FG002|Period 2|Withdrawal by Subject|0|||
124974965|NCT01370655|449536504|FG003|Period 2|Withdrawal by Subject|0|||
124974966|NCT01370655|449536505|FG004|Period 2|Withdrawal by Subject|0|||
124974967|NCT01370655|449536506|FG005|Period 2|Withdrawal by Subject|0|||
124974968|NCT01370655|449536507|FG006|Period 2|Withdrawal by Subject|0|||
124974969|NCT01370655|449536508|FG007|Period 2|Withdrawal by Subject|0|||
124974970|NCT01370655|449536509|FG008|Period 2|Withdrawal by Subject|1|||
124974971|NCT01370655|449536510|FG009|Period 2|Withdrawal by Subject|0|||
124974972|NCT01370655|449536511|FG010|Period 2|Withdrawal by Subject|0|||
124974973|NCT01370655|449536512|FG011|Period 2|Withdrawal by Subject|0|||
124974974|NCT00581477|449536513|FG000|Overall Study|Physician Decision|2|||
124974975|NCT02069366|449536514|FG000|Overall Study|Lost to Follow-up|0|||
124974976|NCT02069366|449536515|FG001|Overall Study|Lost to Follow-up|0|||
124974977|NCT02069366|449536516|FG002|Overall Study|Lost to Follow-up|1|||
124974978|NCT02069366|449536517|FG003|Overall Study|Lost to Follow-up|0|||
124974979|NCT02069366|449536518|FG004|Overall Study|Lost to Follow-up|0|||
124974980|NCT02069366|449536519|FG005|Overall Study|Lost to Follow-up|2|||
124974981|NCT02069366|449536514|FG000|Overall Study|Protocol Violation|0|||
124974982|NCT02069366|449536515|FG001|Overall Study|Protocol Violation|0|||
124974983|NCT02069366|449536516|FG002|Overall Study|Protocol Violation|1|||
124974984|NCT02069366|449536517|FG003|Overall Study|Protocol Violation|0|||
124974985|NCT02069366|449536518|FG004|Overall Study|Protocol Violation|0|||
124974986|NCT02069366|449536519|FG005|Overall Study|Protocol Violation|0|||
124974987|NCT02069366|449536514|FG000|Overall Study|Withdrawal by Subject|1|||
124974988|NCT02069366|449536515|FG001|Overall Study|Withdrawal by Subject|0|||
124974989|NCT02069366|449536516|FG002|Overall Study|Withdrawal by Subject|1|||
124974990|NCT02069366|449536517|FG003|Overall Study|Withdrawal by Subject|2|||
124974991|NCT02069366|449536518|FG004|Overall Study|Withdrawal by Subject|0|||
124974992|NCT02069366|449536519|FG005|Overall Study|Withdrawal by Subject|0|||
124974993|NCT02057575|449536521|FG000|Overall Study|Adverse Event|0|||
124974994|NCT02057575|449536522|FG001|Overall Study|Adverse Event|2|||
124974995|NCT02057575|449536523|FG002|Overall Study|Adverse Event|0|||
124974996|NCT02057575|449536524|FG003|Overall Study|Adverse Event|1|||
124974997|NCT02057575|449536521|FG000|Overall Study|Withdrawal by Subject|1|||
124974998|NCT02057575|449536522|FG001|Overall Study|Withdrawal by Subject|0|||
124974999|NCT02057575|449536523|FG002|Overall Study|Withdrawal by Subject|0|||
124975000|NCT02057575|449536524|FG003|Overall Study|Withdrawal by Subject|0|||
124975001|NCT02057575|449536521|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
124469632|NCT00975156|447676206|FG000|Overall Study|Protocol Violation|0|||
124469633|NCT00975156|447676207|FG001|Overall Study|Protocol Violation|1|||
124469634|NCT02723201|447676208|FG000|Second Intervention Period|Protocol Violation|1|||
124469635|NCT02723201|447676209|FG001|Second Intervention Period|Protocol Violation|0|||
124469636|NCT02723201|447676210|FG002|Second Intervention Period|Protocol Violation|0|||
124469637|NCT02723201|447676208|FG000|Second Intervention Period|Adverse Event|1|||
124469638|NCT02723201|447676209|FG001|Second Intervention Period|Adverse Event|0|||
124469639|NCT02723201|447676210|FG002|Second Intervention Period|Adverse Event|0|||
124469640|NCT03472560|447676211|FG000|Overall Study|Subject transfer to continuation protocol|0|||
124469641|NCT03472560|447676212|FG001|Overall Study|Subject transfer to continuation protocol|1|||
124469642|NCT03472560|447676211|FG000|Overall Study|Withdrawal by Subject|4|||
124469643|NCT03472560|447676212|FG001|Overall Study|Withdrawal by Subject|0|||
124975002|NCT02057575|449536522|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
124975003|NCT02057575|449536523|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
124975004|NCT02057575|449536524|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
124975005|NCT02057575|449536521|FG000|Overall Study|Protocol Violation|0|||
124975006|NCT02057575|449536522|FG001|Overall Study|Protocol Violation|1|||
124975007|NCT02057575|449536523|FG002|Overall Study|Protocol Violation|0|||
124975008|NCT02057575|449536524|FG003|Overall Study|Protocol Violation|0|||
124975009|NCT00332462|449536525|FG000|Overall Study|Adverse Event|5|||
124975010|NCT00332462|449536525|FG000|Overall Study|Abnormal Lab Value|1|||
124469644|NCT03472560|447676211|FG000|Overall Study|Progressive disease|24|||
124975011|NCT00332462|449536525|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
124975012|NCT00332462|449536525|FG000|Overall Study|no longer requires study drug|1|||
124975013|NCT00332462|449536525|FG000|Overall Study|Death|3|||
124975014|NCT00332462|449536525|FG000|Overall Study|Graft Loss|2|||
124975015|NCT01643044|449536526|FG000|Overall Study|Lost to Follow-up|1|||
124975016|NCT01643044|449536527|FG001|Overall Study|Lost to Follow-up|1|||
124770473|NCT03224819|448788863|FG003|Overall Study|Death|0|||
124975017|NCT01643044|449536526|FG000|Overall Study|Miscarried baby|2|||
124975018|NCT01643044|449536527|FG001|Overall Study|Miscarried baby|2|||
124975019|NCT01643044|449536526|FG000|Overall Study|Delivered outside of hospital|1|||
124975020|NCT01643044|449536527|FG001|Overall Study|Delivered outside of hospital|2|||
124975021|NCT01735175|449536530|FG000|Overall Study|Withdrawal by Subject|9|||
124975022|NCT01735175|449536531|FG001|Overall Study|Withdrawal by Subject|2|||
124975023|NCT01735175|449536530|FG000|Overall Study|Lost to Follow-up|4|||
124975024|NCT01735175|449536531|FG001|Overall Study|Lost to Follow-up|2|||
124975025|NCT01735175|449536530|FG000|Overall Study|Death|3|||
124975026|NCT01735175|449536531|FG001|Overall Study|Death|2|||
124975027|NCT01735175|449536530|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
124975028|NCT01735175|449536531|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
124975029|NCT01853475|449536532|FG000|Overall Study|Withdrawal by Subject|0|||
124975030|NCT01853475|449536533|FG001|Overall Study|Withdrawal by Subject|1|||
124975031|NCT01853475|449536534|FG002|Overall Study|Withdrawal by Subject|0|||
124975032|NCT01023958|449536537|FG000|Overall Study|Progressive disease|48|||
124975033|NCT01023958|449536537|FG000|Overall Study|Other adverse event|1|||
124975034|NCT01023958|449536537|FG000|Overall Study|Refused to continue medication|1|||
124975035|NCT03080493|449536538|FG000|Overall Study|Did not provide NRS pain results|1|||
124975036|NCT03080493|449536539|FG001|Overall Study|Did not provide NRS pain results|0|||
124975037|NCT03080493|449536538|FG000|Overall Study|Adverse Event|0|||
124975038|NCT03080493|449536539|FG001|Overall Study|Adverse Event|1|||
124975039|NCT03080493|449536538|FG000|Overall Study|Randomization error (parity group)|0|||
124975040|NCT03080493|449536539|FG001|Overall Study|Randomization error (parity group)|1|||
124975041|NCT00755417|449536540|FG000|Overall Study|Adverse Event|28|||
124975042|NCT00755417|449536541|FG001|Overall Study|Adverse Event|20|||
124975043|NCT00755417|449536542|FG002|Overall Study|Adverse Event|7|||
124975044|NCT00755417|449536540|FG000|Overall Study|Lack of Efficacy|8|||
124975045|NCT00755417|449536541|FG001|Overall Study|Lack of Efficacy|4|||
124975046|NCT00755417|449536542|FG002|Overall Study|Lack of Efficacy|9|||
124975047|NCT00755417|449536540|FG000|Overall Study|Protocol Violation|2|||
124975048|NCT00755417|449536541|FG001|Overall Study|Protocol Violation|1|||
124975049|NCT00755417|449536542|FG002|Overall Study|Protocol Violation|1|||
124975050|NCT00755417|449536540|FG000|Overall Study|Lost to Follow-up|3|||
124975051|NCT00755417|449536541|FG001|Overall Study|Lost to Follow-up|0|||
124975052|NCT00755417|449536542|FG002|Overall Study|Lost to Follow-up|1|||
124975053|NCT00755417|449536540|FG000|Overall Study|Withdrawal by Subject|12|||
124975054|NCT00755417|449536541|FG001|Overall Study|Withdrawal by Subject|12|||
124975055|NCT00755417|449536542|FG002|Overall Study|Withdrawal by Subject|12|||
124975056|NCT00755417|449536540|FG000|Overall Study|Not specified or missing data|9|||
124975057|NCT00755417|449536541|FG001|Overall Study|Not specified or missing data|18|||
124975058|NCT00755417|449536542|FG002|Overall Study|Not specified or missing data|12|||
124975059|NCT02362503|449536543|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
124975060|NCT02362503|449536544|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
124975061|NCT02362503|449536545|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
124975062|NCT02362503|449536543|FG000|Double-blind Period-Up to 8 Days|Death|1|||
124975063|NCT02362503|449536544|FG001|Double-blind Period-Up to 8 Days|Death|0|||
124975064|NCT02362503|449536545|FG002|Double-blind Period-Up to 8 Days|Death|0|||
124975065|NCT02362503|449536543|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
124975066|NCT02362503|449536544|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
124975067|NCT02362503|449536545|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
124975068|NCT02362503|449536543|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
124975069|NCT02362503|449536544|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
124975070|NCT02362503|449536545|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
124975071|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
124975072|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
124975073|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
124975074|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
124975075|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
124975076|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
124975077|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
124975078|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
124975079|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
124975080|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
124975081|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
124975082|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
124975083|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
124975084|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
124975085|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
124975086|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
124770474|NCT03224819|448788864|FG004|Overall Study|Death|0|||
124469645|NCT03472560|447676212|FG001|Overall Study|Progressive disease|8|||
124469646|NCT03472560|447676211|FG000|Overall Study|Physician Decision|1|||
124469647|NCT03472560|447676212|FG001|Overall Study|Physician Decision|0|||
124469648|NCT03472560|447676211|FG000|Overall Study|Death|7|||
124469649|NCT03472560|447676212|FG001|Overall Study|Death|4|||
124469650|NCT03472560|447676211|FG000|Overall Study|Adverse Event|5|||
124469651|NCT03472560|447676212|FG001|Overall Study|Adverse Event|3|||
124469652|NCT03472560|447676211|FG000|Overall Study|Global deterioration of health status|0|||
124469653|NCT03472560|447676212|FG001|Overall Study|Global deterioration of health status|4|||
124469654|NCT01946178|447676213|FG000|Overall Study|Pregnancy|1|||
124469655|NCT01946178|447676213|FG000|Overall Study|Lost to Follow-up|1|||
124469656|NCT01534676|447676214|FG000|Overall Study|Study closed due to poor enrollment|2|||
124469657|NCT01534676|447676215|FG001|Overall Study|Study closed due to poor enrollment|1|||
124469658|NCT02421887|447676217|FG000|Overall Study|Lost to Follow-up|5|||
124469659|NCT02421887|447676218|FG001|Overall Study|Lost to Follow-up|0|||
124469660|NCT02421887|447676217|FG000|Overall Study|Withdrawal by Subject|8|||
124552277|NCT02602080|447978670|FG002|Overall Study|Protocol Violation|3|||
124552278|NCT03022799|447978671|FG000|Overall Study|Adverse Event|0|||
124552279|NCT03022799|447978672|FG001|Overall Study|Adverse Event|0|||
124552280|NCT03022799|447978673|FG002|Overall Study|Adverse Event|0|||
124975087|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
124975088|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
124975089|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
124975090|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
124975091|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
124975092|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
124975093|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
124975094|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
124975095|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
124975096|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
124975097|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
124975098|NCT02362503|449536543|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
124975099|NCT02362503|449536544|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
124975100|NCT02362503|449536545|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
124975101|NCT05143138|449536546|FG000|Overall Study|Death|5|||
124975102|NCT05143138|449536547|FG001|Overall Study|Death|35|||
124975103|NCT05143138|449536548|FG002|Overall Study|Death|1|||
124975104|NCT05143138|449536546|FG000|Overall Study|Lost to Follow-up|2|||
124975105|NCT05143138|449536547|FG001|Overall Study|Lost to Follow-up|4|||
124975106|NCT05143138|449536548|FG002|Overall Study|Lost to Follow-up|0|||
124975107|NCT05143138|449536546|FG000|Overall Study|withdrawal|1|||
124975108|NCT05143138|449536547|FG001|Overall Study|withdrawal|1|||
124975109|NCT05143138|449536548|FG002|Overall Study|withdrawal|0|||
124975110|NCT03325777|449536551|FG000|Overall Study|Lost to Follow-up|9|||
124975111|NCT03325777|449536552|FG001|Overall Study|Lost to Follow-up|12|||
124975112|NCT01099917|449536555|FG000|Overall Study|Adverse Event|3|||
124975113|NCT01099917|449536555|FG000|Overall Study|Not Treated|24|||
124975114|NCT02990468|449536562|FG000|Phase 2: MTD|Change in treatment|0|||
124975115|NCT02990468|449536563|FG001|Phase 2: MTD|Change in treatment|0|||
124975116|NCT02990468|449536564|FG002|Phase 2: MTD|Change in treatment|1|||
124975117|NCT01485120|449536566|FG000|Overall Study|Withdrawal by Subject|2|||
124975118|NCT02567708|449536567|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
124975119|NCT02567708|449536568|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
124975120|NCT02567708|449536567|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
124975121|NCT02567708|449536568|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
124975122|NCT02567708|449536567|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
124975123|NCT02567708|449536568|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
124975124|NCT02567708|449536567|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
124975125|NCT02567708|449536568|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
124975126|NCT01154140|449536573|FG000|Overall Study|Death|71|||
124975127|NCT01154140|449536574|FG001|Overall Study|Death|81|||
124975128|NCT01154140|449536573|FG000|Overall Study|Lost to Follow-up|4|||
124975129|NCT01154140|449536574|FG001|Overall Study|Lost to Follow-up|5|||
124975130|NCT01154140|449536573|FG000|Overall Study|Withdrawal by Subject|12|||
124975131|NCT01154140|449536574|FG001|Overall Study|Withdrawal by Subject|13|||
124975132|NCT01154140|449536573|FG000|Overall Study|Other|3|||
124975133|NCT01154140|449536574|FG001|Overall Study|Other|1|||
124975134|NCT01154140|449536573|FG000|Overall Study|Randomized but not treated|1|||
124975135|NCT01154140|449536574|FG001|Overall Study|Randomized but not treated|2|||
124975136|NCT01818531|449536578|FG000|Overall Study|Withdrawn for case delay after block|1|||
124975137|NCT01818531|449536579|FG001|Overall Study|Withdrawn for case delay after block|0|||
124469661|NCT02421887|447676218|FG001|Overall Study|Withdrawal by Subject|5|||
124469662|NCT02421887|447676217|FG000|Overall Study|Physician Decision|2|||
124975138|NCT01818531|449536578|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
124552281|NCT03022799|447978674|FG003|Overall Study|Adverse Event|0|||
124469663|NCT02421887|447676218|FG001|Overall Study|Physician Decision|4|||
124469664|NCT02421887|447676217|FG000|Overall Study|Adverse Event|2|||
124469665|NCT02421887|447676218|FG001|Overall Study|Adverse Event|0|||
124469666|NCT01285908|447676221|FG000|Baseline Measurement|unable to insert catheter|1|||
124469667|NCT01285908|447676222|FG001|Baseline Measurement|unable to insert catheter|0|||
124469668|NCT01285908|447676223|FG002|Baseline Measurement|unable to insert catheter|0|||
124469669|NCT01285908|447676221|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
124469670|NCT01285908|447676222|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
124469671|NCT01285908|447676223|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
124469672|NCT01285908|447676221|FG000|Baseline Measurement|unable to tolerate procedure|1|||
124469673|NCT01285908|447676222|FG001|Baseline Measurement|unable to tolerate procedure|0|||
124469674|NCT01285908|447676223|FG002|Baseline Measurement|unable to tolerate procedure|0|||
124770475|NCT03224819|448788865|FG005|Overall Study|Death|0|||
124770476|NCT03224819|448788866|FG006|Overall Study|Death|0|||
124469675|NCT01340209|447676224|FG000|Overall Study|Adverse Event|1|||
124469676|NCT01340209|447676225|FG001|Overall Study|Adverse Event|1|||
124469677|NCT01340209|447676226|FG002|Overall Study|Adverse Event|2|||
124469678|NCT01340209|447676224|FG000|Overall Study|Protocol Violation|1|||
124469679|NCT01340209|447676225|FG001|Overall Study|Protocol Violation|2|||
124469680|NCT01340209|447676226|FG002|Overall Study|Protocol Violation|1|||
124469681|NCT01340209|447676224|FG000|Overall Study|Withdrawal by Subject|0|||
124469682|NCT01340209|447676225|FG001|Overall Study|Withdrawal by Subject|0|||
124469683|NCT01340209|447676226|FG002|Overall Study|Withdrawal by Subject|1|||
124469684|NCT01340209|447676224|FG000|Overall Study|Other reason not defined above|3|||
124469685|NCT01340209|447676225|FG001|Overall Study|Other reason not defined above|5|||
124469686|NCT01340209|447676226|FG002|Overall Study|Other reason not defined above|4|||
124469687|NCT02475655|447676229|FG000|Overall Study|Lost to Follow-up|0|||
124469688|NCT02475655|447676230|FG001|Overall Study|Lost to Follow-up|1|||
124469689|NCT03021642|447676238|FG000|Washout Period (21 Days)|Adverse Event|1|||
124469690|NCT03021642|447676239|FG001|Washout Period (21 Days)|Adverse Event|1|||
124469691|NCT00441545|447676240|FG000|First Intervention|Adverse Event|6|||
124469692|NCT00441545|447676241|FG001|First Intervention|Adverse Event|5|||
124469693|NCT00441545|447676240|FG000|First Intervention|Protocol Violation|2|||
124469694|NCT00441545|447676241|FG001|First Intervention|Protocol Violation|2|||
124469695|NCT00441545|447676240|FG000|First Intervention|Withdrawal by Subject|3|||
124469696|NCT00441545|447676241|FG001|First Intervention|Withdrawal by Subject|3|||
124469697|NCT00441545|447676240|FG000|First Intervention|Kidney transplant|1|||
124469698|NCT00441545|447676241|FG001|First Intervention|Kidney transplant|1|||
124469699|NCT00441545|447676240|FG000|First Intervention|Lack of Efficacy|2|||
124469700|NCT00441545|447676241|FG001|First Intervention|Lack of Efficacy|0|||
124469701|NCT00441545|447676240|FG000|First Intervention|Subject exceeded safety criteria|0|||
124469702|NCT00441545|447676241|FG001|First Intervention|Subject exceeded safety criteria|1|||
124469703|NCT00441545|447676240|FG000|First Intervention|Subject met an exclusionary criteria|1|||
124469704|NCT00441545|447676241|FG001|First Intervention|Subject met an exclusionary criteria|0|||
124469705|NCT00441545|447676240|FG000|First Intervention|Extended hospitalization|1|||
124469706|NCT00441545|447676241|FG001|First Intervention|Extended hospitalization|0|||
124469707|NCT00441545|447676240|FG000|First Intervention|Site error|1|||
124469708|NCT00441545|447676241|FG001|First Intervention|Site error|0|||
124469709|NCT00441545|447676240|FG000|First Intervention|Sponsor's request|1|||
124469710|NCT00441545|447676241|FG001|First Intervention|Sponsor's request|0|||
124469711|NCT00441545|447676240|FG000|Second Intervention|Adverse Event|5|||
124469712|NCT00441545|447676241|FG001|Second Intervention|Adverse Event|2|||
124469713|NCT00441545|447676240|FG000|Second Intervention|Protocol Violation|4|||
124469714|NCT00441545|447676241|FG001|Second Intervention|Protocol Violation|1|||
124469715|NCT00441545|447676240|FG000|Second Intervention|Withdrawal by Subject|1|||
124469716|NCT00441545|447676241|FG001|Second Intervention|Withdrawal by Subject|1|||
124469717|NCT00441545|447676240|FG000|Second Intervention|Kidney Transplant|1|||
124469718|NCT00441545|447676241|FG001|Second Intervention|Kidney Transplant|1|||
124770477|NCT03224819|448788867|FG007|Overall Study|Death|1|||
124770478|NCT03224819|448788868|FG008|Overall Study|Death|0|||
124770479|NCT03224819|448788869|FG009|Overall Study|Death|0|||
124975139|NCT01818531|449536579|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
124975140|NCT01818531|449536578|FG000|Overall Study|Withdrawn for failure to place block|0|||
124975141|NCT01818531|449536579|FG001|Overall Study|Withdrawn for failure to place block|1|||
124975142|NCT00477490|449536580|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
124975143|NCT00477490|449536581|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
124975144|NCT00477490|449536582|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
124975145|NCT00477490|449536583|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
124975146|NCT00477490|449536584|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
124975147|NCT00477490|449536585|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
124975148|NCT00477490|449536586|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
124975149|NCT00477490|449536587|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
124975150|NCT00477490|449536588|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
124975151|NCT00477490|449536580|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
124975152|NCT00477490|449536581|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
124975153|NCT00477490|449536582|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
124975154|NCT00477490|449536583|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
124975155|NCT00477490|449536584|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
124975156|NCT00477490|449536585|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
124975157|NCT00477490|449536586|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
124975158|NCT00477490|449536587|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
124469719|NCT00441545|447676240|FG000|Second Intervention|Lack of Efficacy|0|||
124469720|NCT00441545|447676241|FG001|Second Intervention|Lack of Efficacy|1|||
124469721|NCT00441545|447676240|FG000|Second Intervention|Subject exceeded safety criteria|1|||
124469722|NCT00441545|447676241|FG001|Second Intervention|Subject exceeded safety criteria|0|||
124469723|NCT00441545|447676240|FG000|Second Intervention|Subject moved|0|||
124469724|NCT00441545|447676241|FG001|Second Intervention|Subject moved|1|||
124469725|NCT02474082|447676242|FG000|Overall Study|Adverse Event|2|||
124770480|NCT03224819|448788870|FG010|Overall Study|Death|0|||
124975159|NCT00477490|449536588|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
124975160|NCT00477490|449536580|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
124975161|NCT00477490|449536581|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
124975162|NCT00477490|449536582|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
124975163|NCT00477490|449536583|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
124975164|NCT00477490|449536584|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
124975165|NCT00477490|449536585|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
124975166|NCT00477490|449536586|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
124975167|NCT00477490|449536587|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
124975168|NCT00477490|449536588|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
124975169|NCT00477490|449536580|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
124975170|NCT00477490|449536581|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
124975171|NCT00477490|449536582|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
124975172|NCT00477490|449536583|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
124975173|NCT00477490|449536584|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
124975174|NCT00477490|449536585|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
124975175|NCT00477490|449536586|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
124975176|NCT00477490|449536587|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
124975177|NCT00477490|449536588|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
124975178|NCT00477490|449536580|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
124975179|NCT00477490|449536581|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
124975180|NCT00477490|449536582|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
124975181|NCT00477490|449536583|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
124975182|NCT00477490|449536584|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
124469726|NCT02474082|447676243|FG001|Overall Study|Adverse Event|32|||
124469727|NCT02474082|447676242|FG000|Overall Study|Withdrawal of informed consent|1|||
124469728|NCT02474082|447676243|FG001|Overall Study|Withdrawal of informed consent|11|||
124469729|NCT02474082|447676242|FG000|Overall Study|Lost to Follow-up|2|||
124469730|NCT02474082|447676243|FG001|Overall Study|Lost to Follow-up|2|||
124469731|NCT02474082|447676242|FG000|Overall Study|Dose tapering not achieved|0|||
124469732|NCT02474082|447676243|FG001|Overall Study|Dose tapering not achieved|4|||
124469733|NCT02474082|447676242|FG000|Overall Study|Participant/guardian decision|1|||
124469734|NCT02474082|447676243|FG001|Overall Study|Participant/guardian decision|2|||
124469735|NCT02474082|447676242|FG000|Overall Study|Non-compliance with study treatment|0|||
124469736|NCT02474082|447676243|FG001|Overall Study|Non-compliance with study treatment|2|||
124469737|NCT02474082|447676242|FG000|Overall Study|Protocol deviation|0|||
124469738|NCT02474082|447676243|FG001|Overall Study|Protocol deviation|1|||
124469739|NCT04317274|447676246|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
124469740|NCT04317274|447676247|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
124469741|NCT04317274|447676248|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
124552282|NCT03022799|447978675|FG004|Overall Study|Adverse Event|0|||
124975183|NCT00477490|449536585|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
124975184|NCT00477490|449536586|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
124975185|NCT00477490|449536587|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
124975186|NCT00477490|449536588|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
124975187|NCT00477490|449536580|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
124975188|NCT00477490|449536581|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
124975189|NCT00477490|449536582|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
124975190|NCT00477490|449536583|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
124975191|NCT00477490|449536584|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
124975192|NCT00477490|449536585|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
124975193|NCT00477490|449536586|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
124975194|NCT00477490|449536587|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
124975195|NCT00477490|449536588|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
124975196|NCT00477490|449536580|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
124975197|NCT00477490|449536581|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
124975198|NCT00477490|449536582|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
124975199|NCT00477490|449536583|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
124975200|NCT00477490|449536584|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
124975201|NCT00477490|449536585|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
124975202|NCT00477490|449536586|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
124975203|NCT00477490|449536587|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
124975204|NCT00477490|449536588|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
124975205|NCT00477490|449536580|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
124469742|NCT04317274|447676249|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
124469743|NCT01064167|447676256|FG000|Overall Study|Protocol Violation|14|||
124469744|NCT01064167|447676257|FG001|Overall Study|Protocol Violation|15|||
124469745|NCT02435914|447676258|FG000|Overall Study|Ocular Adverse Event|1|||
124552283|NCT03022799|447978676|FG005|Overall Study|Adverse Event|0|||
124713497|NCT00532844|448576506|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
124713498|NCT00532844|448576507|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
124713499|NCT00532844|448576506|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
124713500|NCT00532844|448576507|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
124975206|NCT00477490|449536581|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
124975207|NCT00477490|449536582|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
124975208|NCT00477490|449536583|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
124975209|NCT00477490|449536584|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
124975210|NCT00477490|449536585|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
124975211|NCT00477490|449536586|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
124975212|NCT00477490|449536587|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
124975213|NCT00477490|449536588|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
124975214|NCT00477490|449536580|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
124975215|NCT00477490|449536581|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
124975216|NCT00477490|449536582|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
124975217|NCT00477490|449536583|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
124975218|NCT00477490|449536584|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
124975219|NCT00477490|449536585|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
124975220|NCT00477490|449536586|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
124975221|NCT00477490|449536587|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
124975222|NCT00477490|449536588|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
124975223|NCT00477490|449536580|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
124975224|NCT00477490|449536581|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
124975225|NCT00477490|449536582|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
124975226|NCT00477490|449536583|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
124975227|NCT00477490|449536584|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
124975228|NCT00477490|449536585|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
124975229|NCT00477490|449536586|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
124975230|NCT00477490|449536587|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
124975231|NCT00477490|449536588|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
124975232|NCT00477490|449536580|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
124975233|NCT00477490|449536581|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
124975234|NCT00477490|449536582|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
124975235|NCT00477490|449536583|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
124975236|NCT00477490|449536584|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
124975237|NCT00477490|449536585|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
124975238|NCT00477490|449536586|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
124975239|NCT00477490|449536587|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
124975240|NCT00477490|449536588|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
124975241|NCT00477490|449536580|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
124975242|NCT00477490|449536581|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
124975243|NCT00477490|449536582|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
124975244|NCT00477490|449536583|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
124975245|NCT00477490|449536584|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
124975246|NCT00477490|449536585|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
124975247|NCT00477490|449536586|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
124975248|NCT00477490|449536587|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
124975249|NCT00477490|449536588|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
124975250|NCT00477490|449536580|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
124975251|NCT00477490|449536581|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
124975252|NCT00477490|449536582|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
124975253|NCT00477490|449536583|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
124975254|NCT00477490|449536584|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
124975255|NCT00477490|449536585|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
124713501|NCT00532844|448576506|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
124975256|NCT00477490|449536586|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
124975257|NCT00477490|449536587|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
124975258|NCT00477490|449536588|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
124713502|NCT00532844|448576507|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
124713503|NCT00532844|448576506|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
124713504|NCT00532844|448576507|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
124713505|NCT00532844|448576506|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
124975259|NCT00477490|449536580|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
124975260|NCT00477490|449536581|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
124975261|NCT00477490|449536582|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
124975262|NCT00477490|449536583|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
124975263|NCT00477490|449536584|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
124975264|NCT00477490|449536585|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
124975265|NCT00477490|449536586|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
124975266|NCT00477490|449536587|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
124975267|NCT00477490|449536588|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
124975268|NCT01646177|449536589|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
124975269|NCT01646177|449536590|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
124975270|NCT01646177|449536591|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
124975271|NCT01646177|449536592|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
124975272|NCT01646177|449536593|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
124975273|NCT01646177|449536594|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
124975274|NCT01646177|449536595|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
124975275|NCT01646177|449536596|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
124975276|NCT01646177|449536597|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
124975277|NCT01646177|449536598|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
124975278|NCT01646177|449536599|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
124975279|NCT01646177|449536600|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
124975280|NCT01646177|449536589|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
124975281|NCT01646177|449536590|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
124975282|NCT01646177|449536591|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
124975283|NCT01646177|449536592|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
124975284|NCT01646177|449536593|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
124975285|NCT01646177|449536594|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
124975286|NCT01646177|449536595|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
124975287|NCT01646177|449536596|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
124975288|NCT01646177|449536597|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
124975289|NCT01646177|449536598|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
124975290|NCT01646177|449536599|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
124975291|NCT01646177|449536600|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
124975292|NCT01646177|449536589|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
124975293|NCT01646177|449536590|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
124975294|NCT01646177|449536591|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
124975295|NCT01646177|449536592|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
124975296|NCT01646177|449536593|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
124975297|NCT01646177|449536594|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
124975298|NCT01646177|449536595|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
124975299|NCT01646177|449536596|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
124975300|NCT01646177|449536597|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
124975301|NCT01646177|449536598|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
124975302|NCT01646177|449536599|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
124975303|NCT01646177|449536600|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
124975304|NCT01646177|449536589|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
124975305|NCT01646177|449536590|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
124975306|NCT01646177|449536591|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
124975307|NCT01646177|449536592|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
124975308|NCT01646177|449536593|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
124975309|NCT01646177|449536594|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
124975310|NCT01646177|449536595|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
124975311|NCT01646177|449536596|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
124975312|NCT01646177|449536597|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
124975313|NCT01646177|449536598|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
124975314|NCT01646177|449536599|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
124975315|NCT01646177|449536600|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
124975316|NCT01646177|449536589|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124975317|NCT01646177|449536590|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124469746|NCT02435914|447676259|FG001|Overall Study|Ocular Adverse Event|0|||
124469747|NCT02435914|447676260|FG002|Overall Study|Ocular Adverse Event|0|||
124469748|NCT02435914|447676261|FG003|Overall Study|Ocular Adverse Event|0|||
124469749|NCT02435914|447676258|FG000|Overall Study|Withdrawal by Subject|0|||
124469750|NCT02435914|447676259|FG001|Overall Study|Withdrawal by Subject|1|||
124469751|NCT02435914|447676260|FG002|Overall Study|Withdrawal by Subject|0|||
124469752|NCT02435914|447676261|FG003|Overall Study|Withdrawal by Subject|0|||
124469753|NCT02435914|447676258|FG000|Overall Study|Other Miscellaneous Reason|0|||
124469754|NCT02435914|447676259|FG001|Overall Study|Other Miscellaneous Reason|0|||
124469755|NCT02435914|447676260|FG002|Overall Study|Other Miscellaneous Reason|1|||
124469756|NCT02435914|447676261|FG003|Overall Study|Other Miscellaneous Reason|0|||
124469757|NCT01353703|447676262|FG000|Overall Study|Migrated/moved from study area|1|||
124469758|NCT01353703|447676263|FG001|Overall Study|Migrated/moved from study area|0|||
124469759|NCT02286947|447676270|FG000|Overall Study|Withdrawal by Subject|2|||
124469760|NCT02175680|447676271|FG000|Overall Study|non-compliance|1|||
124469761|NCT02175680|447676271|FG000|Overall Study|other non-medical reason|1|||
124469762|NCT03979274|447676272|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124469763|NCT03979274|447676273|FG001|Treatment Period 2|Withdrawal by Subject|1|||
124552284|NCT03022799|447978677|FG006|Overall Study|Adverse Event|0|||
124552285|NCT03022799|447978678|FG007|Overall Study|Adverse Event|0|||
124975318|NCT01646177|449536591|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
124975319|NCT01646177|449536592|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
124975320|NCT01646177|449536593|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124975321|NCT01646177|449536594|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124975322|NCT01646177|449536595|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124975323|NCT01646177|449536596|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124975324|NCT01646177|449536597|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124975325|NCT01646177|449536598|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124975326|NCT01646177|449536599|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124469764|NCT01665144|447676274|FG000|Core Part|Withdrawal by Subject|96|||
124469765|NCT01665144|447676275|FG001|Core Part|Withdrawal by Subject|77|||
124552286|NCT03022799|447978679|FG008|Overall Study|Adverse Event|0|||
124552287|NCT03022799|447978680|FG009|Overall Study|Adverse Event|1|||
124552288|NCT03022799|447978681|FG010|Overall Study|Adverse Event|1|||
124975327|NCT01646177|449536600|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
124975328|NCT01646177|449536589|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
124469766|NCT01665144|447676276|FG002|Core Part|Withdrawal by Subject|0|||
124552289|NCT03022799|447978682|FG011|Overall Study|Adverse Event|0|||
124469767|NCT01665144|447676274|FG000|Core Part|Adverse Event|45|||
124469768|NCT01665144|447676275|FG001|Core Part|Adverse Event|18|||
124469769|NCT01665144|447676276|FG002|Core Part|Adverse Event|0|||
124469770|NCT01665144|447676274|FG000|Core Part|Lack of Efficacy|16|||
124469771|NCT01665144|447676275|FG001|Core Part|Lack of Efficacy|11|||
124469772|NCT01665144|447676276|FG002|Core Part|Lack of Efficacy|0|||
124469773|NCT01665144|447676274|FG000|Core Part|Lost to Follow-up|9|||
124469774|NCT01665144|447676275|FG001|Core Part|Lost to Follow-up|8|||
124469775|NCT01665144|447676276|FG002|Core Part|Lost to Follow-up|0|||
124469776|NCT01665144|447676274|FG000|Core Part|Physician Decision|13|||
124469777|NCT01665144|447676275|FG001|Core Part|Physician Decision|1|||
124469778|NCT01665144|447676276|FG002|Core Part|Physician Decision|0|||
124469779|NCT01665144|447676274|FG000|Core Part|Progressive disease|8|||
124469780|NCT01665144|447676275|FG001|Core Part|Progressive disease|4|||
124469781|NCT01665144|447676276|FG002|Core Part|Progressive disease|0|||
124469782|NCT01665144|447676274|FG000|Core Part|Non-compliance with study treatment|5|||
124469783|NCT01665144|447676275|FG001|Core Part|Non-compliance with study treatment|0|||
124469784|NCT01665144|447676276|FG002|Core Part|Non-compliance with study treatment|0|||
124469785|NCT01665144|447676274|FG000|Core Part|Death|3|||
124469786|NCT01665144|447676275|FG001|Core Part|Death|1|||
124469787|NCT01665144|447676276|FG002|Core Part|Death|0|||
124469788|NCT01665144|447676274|FG000|Core Part|Protocol deviation|3|||
124469789|NCT01665144|447676275|FG001|Core Part|Protocol deviation|1|||
124469790|NCT01665144|447676276|FG002|Core Part|Protocol deviation|0|||
124469791|NCT01665144|447676274|FG000|Core Part|New therapy for study indication|2|||
124469792|NCT01665144|447676275|FG001|Core Part|New therapy for study indication|1|||
124469793|NCT01665144|447676276|FG002|Core Part|New therapy for study indication|0|||
124469794|NCT01665144|447676274|FG000|Core Part|Technical problems|2|||
124469795|NCT01665144|447676275|FG001|Core Part|Technical problems|0|||
124469796|NCT01665144|447676276|FG002|Core Part|Technical problems|0|||
124469797|NCT01665144|447676274|FG000|Extension Part|Patient/guardian decision|180|||
124469798|NCT01665144|447676275|FG001|Extension Part|Patient/guardian decision|0|||
124469799|NCT01665144|447676276|FG002|Extension Part|Patient/guardian decision|98|||
124469800|NCT01665144|447676274|FG000|Extension Part|Adverse Event|104|||
124469801|NCT01665144|447676275|FG001|Extension Part|Adverse Event|0|||
124469802|NCT01665144|447676276|FG002|Extension Part|Adverse Event|59|||
124975329|NCT01646177|449536590|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
124975330|NCT01646177|449536591|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
124975331|NCT01646177|449536592|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975332|NCT01646177|449536593|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975333|NCT01646177|449536594|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975334|NCT01646177|449536595|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975335|NCT01646177|449536596|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975336|NCT01646177|449536597|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975337|NCT01646177|449536598|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975338|NCT01646177|449536599|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975339|NCT01646177|449536600|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
124975340|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
124975341|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
124975342|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
124975343|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
124975344|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
124975345|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
124975346|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
124975347|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
124975348|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
124975349|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
124975350|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
124975351|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
124975352|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
124975353|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
124975354|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
124975355|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
124975356|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
124469803|NCT01665144|447676274|FG000|Extension Part|Study closed early|42|||
124469804|NCT01665144|447676275|FG001|Extension Part|Study closed early|0|||
124469805|NCT01665144|447676276|FG002|Extension Part|Study closed early|19|||
124469806|NCT01665144|447676274|FG000|Extension Part|Progressive disease|36|||
124469807|NCT01665144|447676275|FG001|Extension Part|Progressive disease|0|||
124469808|NCT01665144|447676276|FG002|Extension Part|Progressive disease|14|||
124469809|NCT01665144|447676274|FG000|Extension Part|Lack of Efficacy|37|||
124469810|NCT01665144|447676275|FG001|Extension Part|Lack of Efficacy|0|||
124469811|NCT01665144|447676276|FG002|Extension Part|Lack of Efficacy|12|||
124469812|NCT01665144|447676274|FG000|Extension Part|Physician Decision|29|||
124469813|NCT01665144|447676275|FG001|Extension Part|Physician Decision|0|||
124770481|NCT03224819|448788871|FG011|Overall Study|Death|1|||
124770482|NCT03224819|448788872|FG012|Overall Study|Death|0|||
124975357|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
124975358|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
124975359|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
124975360|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
124975361|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
124975362|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
124975363|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
124975364|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
124975365|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
124975366|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
124975367|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
124975368|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
124975369|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
124975370|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
124975371|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
124975372|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
124975373|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
124975374|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
124975375|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
124975376|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
124975377|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
124975378|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
124975379|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
124975380|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
124975381|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
124975382|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
124975383|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
124975384|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
124975385|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
124975386|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
124975387|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
124975388|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
124975389|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
124975390|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
124975391|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
124975392|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
124975393|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
124975394|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
124975395|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
124975396|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
124975397|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
124975398|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
124975399|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
124975400|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975401|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975402|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975403|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975404|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
124975405|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
124975406|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975407|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
124975408|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975409|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975410|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975411|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
124975412|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
124975413|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
124975414|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
124975415|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
124975416|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
124770483|NCT03224819|448788873|FG013|Overall Study|Death|0|||
124975417|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
124975418|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
124975419|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
124975420|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
124975421|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
124975422|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
124975423|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
124975424|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
124975425|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
124975426|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
124975427|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
124975428|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
124975429|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
124975430|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
124975431|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
124975432|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
124975433|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
124975434|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
124975435|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
124975436|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
124975437|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
124975438|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
124975439|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
124975440|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
124975441|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
124975442|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
124975443|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
124975444|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
124975445|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
124975446|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
124975447|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
124975448|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975449|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975450|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975451|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975452|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975453|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975454|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975455|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
124975456|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975457|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975458|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124469814|NCT01665144|447676276|FG002|Extension Part|Physician Decision|13|||
124469815|NCT01665144|447676274|FG000|Extension Part|Technical problems|20|||
124469816|NCT01665144|447676275|FG001|Extension Part|Technical problems|0|||
124469817|NCT01665144|447676276|FG002|Extension Part|Technical problems|8|||
124469818|NCT01665144|447676274|FG000|Extension Part|Death|20|||
124469819|NCT01665144|447676275|FG001|Extension Part|Death|0|||
124469820|NCT01665144|447676276|FG002|Extension Part|Death|4|||
124469821|NCT01665144|447676274|FG000|Extension Part|Missing|12|||
124469822|NCT01665144|447676275|FG001|Extension Part|Missing|0|||
124469823|NCT01665144|447676276|FG002|Extension Part|Missing|6|||
124469824|NCT01665144|447676274|FG000|Extension Part|Lost to Follow-up|9|||
124469825|NCT01665144|447676275|FG001|Extension Part|Lost to Follow-up|0|||
124469826|NCT01665144|447676276|FG002|Extension Part|Lost to Follow-up|5|||
124469827|NCT01665144|447676274|FG000|Extension Part|New therapy for study indication|3|||
124469828|NCT01665144|447676275|FG001|Extension Part|New therapy for study indication|0|||
124469829|NCT01665144|447676276|FG002|Extension Part|New therapy for study indication|2|||
124469830|NCT01665144|447676274|FG000|Extension Part|Protocol deviation|3|||
124469831|NCT01665144|447676275|FG001|Extension Part|Protocol deviation|0|||
124469832|NCT01665144|447676276|FG002|Extension Part|Protocol deviation|0|||
124469833|NCT01913483|447676283|FG000|Overall Study|Withdrawal by Subject|1|||
124469834|NCT01913483|447676284|FG001|Overall Study|Withdrawal by Subject|2|||
124469835|NCT01913483|447676283|FG000|Overall Study|Lost to Follow-up|6|||
124469836|NCT01913483|447676284|FG001|Overall Study|Lost to Follow-up|3|||
124469837|NCT01913483|447676283|FG000|Overall Study|Death|14|||
124469838|NCT01913483|447676284|FG001|Overall Study|Death|17|||
124469839|NCT02302963|447676285|FG000|Overall Study|Withdrawal by Subject|2|||
124469840|NCT02302963|447676286|FG001|Overall Study|Withdrawal by Subject|1|||
124469841|NCT02302963|447676285|FG000|Overall Study|Steroid injection|0|||
124975459|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
124975460|NCT01646177|449536589|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975461|NCT01646177|449536590|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975462|NCT01646177|449536591|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975463|NCT01646177|449536592|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975464|NCT01646177|449536593|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975465|NCT01646177|449536594|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
124975466|NCT01646177|449536595|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
124975467|NCT01646177|449536596|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
124975468|NCT01646177|449536597|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975469|NCT01646177|449536598|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975470|NCT01646177|449536599|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975471|NCT01646177|449536600|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
124975472|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
124975473|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
124975474|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
124975475|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
124975476|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
124975477|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
124975478|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
124975479|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
124975480|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
124975481|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
124975482|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
124975483|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
124975484|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
124975485|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
124975486|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
124975487|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
124975488|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
124975489|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
124975490|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
124975491|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
124975492|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
124975493|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
124975494|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
124975495|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
124975496|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
124975497|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
124713506|NCT00532844|448576507|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
124713507|NCT03637491|448576508|FG000|Overall Study|Death|9|||
124552290|NCT03022799|447978683|FG012|Overall Study|Adverse Event|0|||
124713508|NCT03637491|448576509|FG001|Overall Study|Death|9|||
124713509|NCT03637491|448576510|FG002|Overall Study|Death|5|||
124552291|NCT03273257|447978687|FG000|Overall Study|Death|0|||
124469842|NCT02302963|447676286|FG001|Overall Study|Steroid injection|1|||
124469843|NCT02302963|447676285|FG000|Overall Study|Physician Decision|1|||
124469844|NCT02302963|447676286|FG001|Overall Study|Physician Decision|0|||
124713510|NCT03637491|448576511|FG003|Overall Study|Death|3|||
124713511|NCT03637491|448576508|FG000|Overall Study|Lost to Follow-up|0|||
124975498|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
124975499|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
124975500|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
124975501|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
124975502|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
124975503|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
124975504|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
124975505|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
124975506|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
124975507|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
124975508|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
124975509|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
124975510|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
124469845|NCT01816243|447676287|FG000|Overall Study|Adverse Event|6|||
124713512|NCT03637491|448576509|FG001|Overall Study|Lost to Follow-up|1|||
124975511|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
124469846|NCT01816243|447676287|FG000|Overall Study|Lost to Follow-up|1|||
124469847|NCT01816243|447676287|FG000|Overall Study|Lack of Efficacy|1|||
124469848|NCT01816243|447676287|FG000|Overall Study|Not eligible for the study|1|||
124469849|NCT01816243|447676287|FG000|Overall Study|Amputation|3|||
124469850|NCT00915343|447676288|FG000|Part B - Open Label Period|Treatment switch|0|||
124469851|NCT00915343|447676289|FG001|Part B - Open Label Period|Treatment switch|0|||
124469852|NCT00915343|447676290|FG002|Part B - Open Label Period|Treatment switch|1|||
124469853|NCT00915343|447676288|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
124469854|NCT00915343|447676289|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
124469855|NCT00915343|447676290|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
124469856|NCT01920711|447676291|FG000|Overall Study|Death|347|||
124469857|NCT01920711|447676292|FG001|Overall Study|Death|356|||
124469858|NCT01920711|447676291|FG000|Overall Study|Lost to Follow-up|13|||
124469859|NCT01920711|447676292|FG001|Overall Study|Lost to Follow-up|14|||
124469860|NCT01920711|447676291|FG000|Overall Study|Withdrawal by Subject|4|||
124469861|NCT01920711|447676292|FG001|Overall Study|Withdrawal by Subject|3|||
124469862|NCT02319044|447676293|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
124469863|NCT02319044|447676294|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
124469864|NCT02319044|447676295|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
124469865|NCT02319044|447676293|FG000|Overall Study|Withdrawal by Subject|3|||
124469866|NCT02319044|447676294|FG001|Overall Study|Withdrawal by Subject|3|||
124469867|NCT02319044|447676295|FG002|Overall Study|Withdrawal by Subject|6|||
124469868|NCT02319044|447676293|FG000|Overall Study|Condition under investigation worsened|100|||
124469869|NCT02319044|447676294|FG001|Overall Study|Condition under investigation worsened|50|||
124469870|NCT02319044|447676295|FG002|Overall Study|Condition under investigation worsened|46|||
124469871|NCT02319044|447676293|FG000|Overall Study|Adverse Event|17|||
124469872|NCT02319044|447676294|FG001|Overall Study|Adverse Event|2|||
124469873|NCT02319044|447676295|FG002|Overall Study|Adverse Event|8|||
124469874|NCT02319044|447676293|FG000|Overall Study|Study specific discontinuation criteria|2|||
124469875|NCT02319044|447676294|FG001|Overall Study|Study specific discontinuation criteria|2|||
124469876|NCT02319044|447676295|FG002|Overall Study|Study specific discontinuation criteria|1|||
124469877|NCT02319044|447676293|FG000|Overall Study|Not treated|0|||
124469878|NCT02319044|447676294|FG001|Overall Study|Not treated|2|||
124469879|NCT02319044|447676295|FG002|Overall Study|Not treated|2|||
124469880|NCT01145066|447676296|FG000|Overall Study|To resume NSAIDs|2|||
124469881|NCT01145066|447676297|FG001|Overall Study|To resume NSAIDs|2|||
124469882|NCT01145066|447676298|FG002|Overall Study|To resume NSAIDs|1|||
124469883|NCT01145066|447676296|FG000|Overall Study|Non-related surgery|0|||
124469884|NCT01145066|447676297|FG001|Overall Study|Non-related surgery|0|||
124469885|NCT01145066|447676298|FG002|Overall Study|Non-related surgery|1|||
124469886|NCT01145066|447676296|FG000|Overall Study|Withdrawal by Subject|0|||
124469887|NCT01145066|447676297|FG001|Overall Study|Withdrawal by Subject|0|||
124469888|NCT01145066|447676298|FG002|Overall Study|Withdrawal by Subject|2|||
124552292|NCT03273257|447978688|FG001|Overall Study|Death|1|||
124552293|NCT03273257|447978687|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
124469889|NCT01145066|447676296|FG000|Overall Study|To start new med|1|||
124469890|NCT01145066|447676297|FG001|Overall Study|To start new med|0|||
124469891|NCT01145066|447676298|FG002|Overall Study|To start new med|0|||
124469892|NCT01145066|447676296|FG000|Overall Study|problems swallowing capsule|1|||
124469893|NCT01145066|447676297|FG001|Overall Study|problems swallowing capsule|0|||
124469894|NCT01145066|447676298|FG002|Overall Study|problems swallowing capsule|0|||
124713513|NCT03637491|448576510|FG002|Overall Study|Lost to Follow-up|0|||
124713514|NCT03637491|448576511|FG003|Overall Study|Lost to Follow-up|1|||
124713515|NCT03637491|448576508|FG000|Overall Study|Study Terminated By Sponsor|0|||
124713516|NCT03637491|448576509|FG001|Overall Study|Study Terminated By Sponsor|2|||
124469895|NCT01145066|447676296|FG000|Overall Study|Abdominal discomfort|0|||
124469896|NCT01145066|447676297|FG001|Overall Study|Abdominal discomfort|1|||
124469897|NCT01145066|447676298|FG002|Overall Study|Abdominal discomfort|0|||
124469898|NCT01145066|447676296|FG000|Overall Study|Low platelet count|0|||
124469899|NCT01145066|447676297|FG001|Overall Study|Low platelet count|1|||
124469900|NCT01145066|447676298|FG002|Overall Study|Low platelet count|0|||
124469901|NCT03687502|447676300|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
124469902|NCT03687502|447676300|FG000|Overall Study|Lumason not available|1|||
124469903|NCT01724528|447676301|FG000|Overall Study|Death|3|||
124469904|NCT01724528|447676302|FG001|Overall Study|Death|0|||
124469905|NCT01724528|447676301|FG000|Overall Study|Withdrawal by Subject|0|||
124469906|NCT01724528|447676302|FG001|Overall Study|Withdrawal by Subject|2|||
124469907|NCT01724528|447676301|FG000|Overall Study|Protocol Violation|0|||
124469908|NCT01724528|447676302|FG001|Overall Study|Protocol Violation|1|||
124469909|NCT01724528|447676301|FG000|Overall Study|Patient refused to attend last visit|1|||
124469910|NCT01724528|447676302|FG001|Overall Study|Patient refused to attend last visit|0|||
124469911|NCT04949841|447676306|FG000|Overall Study|Adverse Event|7|||
124469912|NCT04949841|447676306|FG000|Overall Study|Death|1|||
124469913|NCT04949841|447676306|FG000|Overall Study|Withdrawal by Subject|52|||
124469914|NCT04949841|447676306|FG000|Overall Study|Pregnancy|4|||
124469915|NCT04949841|447676306|FG000|Overall Study|Lost to Follow-up|9|||
124469916|NCT04949841|447676306|FG000|Overall Study|Lack of Efficacy|55|||
124469917|NCT04949841|447676306|FG000|Overall Study|Various reasons|9|||
124469918|NCT01777581|447676307|FG000|Overall Study|Lost to Follow-up|1|||
124469919|NCT01777581|447676308|FG001|Overall Study|Lost to Follow-up|1|||
124469920|NCT01777581|447676307|FG000|Overall Study|Adverse Event|2|||
124770484|NCT03104868|448788874|FG000|6 Week Follow up|Lost to Follow-up|5|||
124469921|NCT01777581|447676308|FG001|Overall Study|Adverse Event|0|||
124469922|NCT01777581|447676307|FG000|Overall Study|Lack of Efficacy|0|||
124469923|NCT01777581|447676308|FG001|Overall Study|Lack of Efficacy|1|||
124469924|NCT01634555|447676311|FG000|Overall Study|Adverse Event|3|||
124469925|NCT01634555|447676311|FG000|Overall Study|Physician Decision|1|||
124469926|NCT06228586|447676313|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
124469927|NCT06228586|447676314|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
124713517|NCT03637491|448576510|FG002|Overall Study|Study Terminated By Sponsor|1|||
124713518|NCT03637491|448576511|FG003|Overall Study|Study Terminated By Sponsor|0|||
124713519|NCT03637491|448576508|FG000|Overall Study|Withdrawal by Subject|1|||
124713520|NCT03637491|448576509|FG001|Overall Study|Withdrawal by Subject|0|||
124713521|NCT03637491|448576510|FG002|Overall Study|Withdrawal by Subject|1|||
124469928|NCT02527707|447677999|FG000|Overall Study|Adverse Event|1|||
124469929|NCT02527707|447677999|FG000|Overall Study|Adverse Event|1|||
124713522|NCT03637491|448576511|FG003|Overall Study|Withdrawal by Subject|2|||
124469930|NCT00930059|447678000|FG000|Overall Study|Death|1|||
124713523|NCT04389866|448576515|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
124713524|NCT04389866|448576516|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
124469931|NCT00930059|447678001|FG001|Overall Study|Death|0|||
124469932|NCT00930059|447678000|FG000|Overall Study|Did not meet entrance criteria|1|||
124469933|NCT00930059|447678001|FG001|Overall Study|Did not meet entrance criteria|1|||
124469934|NCT00930059|447678000|FG000|Overall Study|Withdrawal by Subject|3|||
124469935|NCT00930059|447678001|FG001|Overall Study|Withdrawal by Subject|4|||
124469936|NCT00930059|447678000|FG000|Overall Study|Other|1|||
124469937|NCT00930059|447678001|FG001|Overall Study|Other|0|||
124469938|NCT00930059|447678000|FG000|Overall Study|1 site terminated by sponsor|1|||
124469939|NCT00930059|447678001|FG001|Overall Study|1 site terminated by sponsor|1|||
124469940|NCT00930059|447678000|FG000|Overall Study|Adverse Event|1|||
124469941|NCT00930059|447678001|FG001|Overall Study|Adverse Event|6|||
124469942|NCT01299766|447678005|FG000|Overall Study|Death|5|||
124469943|NCT01299766|447678006|FG001|Overall Study|Death|4|||
124469944|NCT01299766|447678005|FG000|Overall Study|Withdrawal by Subject|29|||
124469945|NCT01299766|447678006|FG001|Overall Study|Withdrawal by Subject|19|||
124469946|NCT03064763|447678009|FG000|Overall Study|Lost to Follow-up|1|||
124469947|NCT03064763|447678009|FG000|Overall Study|Death|8|||
124469948|NCT00403260|447678010|FG000|Overall Study|Adverse Event|5|||
124469949|NCT00403260|447678011|FG001|Overall Study|Adverse Event|4|||
124469950|NCT00403260|447678010|FG000|Overall Study|Withdrawal by Subject|5|||
124469951|NCT00403260|447678011|FG001|Overall Study|Withdrawal by Subject|6|||
124469952|NCT00403260|447678010|FG000|Overall Study|Lost to Follow-up|49|||
124469953|NCT00403260|447678011|FG001|Overall Study|Lost to Follow-up|25|||
124469954|NCT00403260|447678010|FG000|Overall Study|Re-appearance of P. falciparum|34|||
124469955|NCT00403260|447678011|FG001|Overall Study|Re-appearance of P. falciparum|25|||
124469956|NCT00403260|447678010|FG000|Overall Study|P. vivax infection|26|||
124469957|NCT00403260|447678011|FG001|Overall Study|P. vivax infection|4|||
124469958|NCT00403260|447678010|FG000|Overall Study|Mixed infection with P. vivax|2|||
124469959|NCT00403260|447678011|FG001|Overall Study|Mixed infection with P. vivax|0|||
124469960|NCT00403260|447678010|FG000|Overall Study|Mixed infection with P. falciparum|1|||
124469961|NCT00403260|447678011|FG001|Overall Study|Mixed infection with P. falciparum|0|||
124469962|NCT00403260|447678010|FG000|Overall Study|P. vivax infection at screening|1|||
124713525|NCT03465722|448576520|FG000|Overall Study|Withdrawal by Subject|21|||
124713526|NCT03465722|448576521|FG001|Overall Study|Withdrawal by Subject|14|||
124713527|NCT03465722|448576520|FG000|Overall Study|Death|89|||
124713528|NCT03465722|448576521|FG001|Overall Study|Death|87|||
124469963|NCT00403260|447678011|FG001|Overall Study|P. vivax infection at screening|0|||
124713529|NCT03465722|448576520|FG000|Overall Study|Lost to Follow-up|5|||
124713530|NCT03465722|448576521|FG001|Overall Study|Lost to Follow-up|3|||
124469964|NCT00403260|447678010|FG000|Overall Study|P. ovale infection|1|||
124713531|NCT03465722|448576520|FG000|Overall Study|Administrative/Other|33|||
124469965|NCT00403260|447678011|FG001|Overall Study|P. ovale infection|0|||
124469966|NCT00403260|447678010|FG000|Overall Study|Gametocyte re-appearance|1|||
124469967|NCT00403260|447678011|FG001|Overall Study|Gametocyte re-appearance|1|||
124469968|NCT00403260|447678010|FG000|Overall Study|Withdrawn from study accidentally|0|||
124469969|NCT00403260|447678011|FG001|Overall Study|Withdrawn from study accidentally|1|||
124469970|NCT01354028|447678012|FG000|Overall Study|Physician Decision|0|||
124469971|NCT01354028|447678013|FG001|Overall Study|Physician Decision|2|||
124469972|NCT01354028|447678012|FG000|Overall Study|Discharged before study start|2|||
124469973|NCT01354028|447678013|FG001|Overall Study|Discharged before study start|2|||
124469974|NCT01354028|447678012|FG000|Overall Study|No quiet alert state|0|||
124469975|NCT01354028|447678013|FG001|Overall Study|No quiet alert state|1|||
124469976|NCT00935883|447678016|FG000|Treatment Period|Physician Decision|1|||
124469977|NCT00935883|447678017|FG001|Treatment Period|Physician Decision|0|||
124713532|NCT03465722|448576521|FG001|Overall Study|Administrative/Other|32|||
124469978|NCT00935883|447678016|FG000|Treatment Period|Withdrawal by Subject|0|||
124713533|NCT03465722|448576520|FG000|Overall Study|Not treated|1|||
124469979|NCT00935883|447678017|FG001|Treatment Period|Withdrawal by Subject|2|||
124975512|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
124975513|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
124975514|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
124975515|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
124975516|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
124975517|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
124975518|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
124975519|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
124975520|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
124975521|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
124975522|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
124975523|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
124975524|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
124975525|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
124975526|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
124975527|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
124975528|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
124975529|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
124975530|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
124975531|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
124975532|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
124469980|NCT00808444|447678025|FG000|Overall Study|Withdrawal by Subject|1|||
124469981|NCT00808444|447678026|FG001|Overall Study|Withdrawal by Subject|0|||
124469982|NCT00808444|447678025|FG000|Overall Study|Lost to Follow-up|0|||
124469983|NCT00808444|447678026|FG001|Overall Study|Lost to Follow-up|1|||
124469984|NCT02770326|447678036|FG000|Overall Study|Death|3|||
124469985|NCT02770326|447678036|FG000|Overall Study|Lost to Follow-up|1|||
124469986|NCT01622569|447678037|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
124469987|NCT01622569|447678038|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
124469988|NCT01622569|447678039|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
124770485|NCT03104868|448788875|FG001|6 Week Follow up|Lost to Follow-up|8|||
124469989|NCT01622569|447678040|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
124469990|NCT01622569|447678037|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
124552294|NCT03273257|447978688|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
124552295|NCT03273257|447978687|FG000|Overall Study|Study terminated|3|||
124552296|NCT03273257|447978688|FG001|Overall Study|Study terminated|2|||
124552297|NCT04355767|447978690|FG000|Overall Study|Withdrawal by Subject|2|||
124552298|NCT04355767|447978691|FG001|Overall Study|Withdrawal by Subject|2|||
124552299|NCT04355767|447978690|FG000|Overall Study|Death|5|||
124552300|NCT04355767|447978691|FG001|Overall Study|Death|1|||
124552301|NCT01999322|447978692|FG000|Overall Study|Adverse Event|1|||
124552302|NCT01999322|447978693|FG001|Overall Study|Adverse Event|0|||
124552303|NCT02200614|447978694|FG000|Double Blind Treatment|Adverse Event|86|||
124552304|NCT02200614|447978695|FG001|Double Blind Treatment|Adverse Event|48|||
124552305|NCT02200614|447978694|FG000|Double Blind Treatment|Confirmed metastasis|120|||
124552306|NCT02200614|447978695|FG001|Double Blind Treatment|Confirmed metastasis|140|||
124552307|NCT02200614|447978694|FG000|Double Blind Treatment|Judgment of the investigator|59|||
124552308|NCT02200614|447978695|FG001|Double Blind Treatment|Judgment of the investigator|99|||
124552309|NCT02200614|447978694|FG000|Double Blind Treatment|Metastasis by local reading|1|||
124552310|NCT02200614|447978695|FG001|Double Blind Treatment|Metastasis by local reading|3|||
124552311|NCT02200614|447978694|FG000|Double Blind Treatment|Other reason|6|||
124552312|NCT02200614|447978695|FG001|Double Blind Treatment|Other reason|2|||
124552313|NCT02200614|447978694|FG000|Double Blind Treatment|Personal reason|77|||
124552314|NCT02200614|447978695|FG001|Double Blind Treatment|Personal reason|85|||
124552315|NCT02200614|447978694|FG000|Double Blind Treatment|Protocol deviation|14|||
124552316|NCT02200614|447978695|FG001|Double Blind Treatment|Protocol deviation|7|||
124552317|NCT02200614|447978694|FG000|Double Blind Treatment|Not treated|1|||
124552318|NCT02200614|447978695|FG001|Double Blind Treatment|Not treated|0|||
124552319|NCT02200614|447978694|FG000|Open Label|Adverse Event|41|||
124552320|NCT02200614|447978695|FG001|Open Label|Adverse Event|11|||
124552321|NCT02200614|447978694|FG000|Open Label|Confirmed metastasis|1|||
124552322|NCT02200614|447978695|FG001|Open Label|Confirmed metastasis|0|||
124552323|NCT02200614|447978694|FG000|Open Label|Judgment of the investigator|29|||
124552324|NCT02200614|447978695|FG001|Open Label|Judgment of the investigator|2|||
124770486|NCT03104868|448788874|FG000|6 Week Follow up|Death|1|||
124552325|NCT02200614|447978694|FG000|Open Label|Metastasis by local reading|138|||
124770487|NCT03104868|448788875|FG001|6 Week Follow up|Death|1|||
124713534|NCT03465722|448576521|FG001|Overall Study|Not treated|2|||
124713535|NCT03465722|448576520|FG000|Overall Study|Sponsor decision|91|||
124469991|NCT01622569|447678038|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
124469992|NCT01622569|447678039|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
124469993|NCT01622569|447678040|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
124469994|NCT01622569|447678037|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
124469995|NCT01622569|447678038|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
124713536|NCT03465722|448576521|FG001|Overall Study|Sponsor decision|98|||
124469996|NCT01622569|447678039|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
124713537|NCT01490918|448576522|FG000|Overall Study|Lost to Follow-up|2|||
124713538|NCT01490918|448576523|FG001|Overall Study|Lost to Follow-up|1|||
124552326|NCT02200614|447978695|FG001|Open Label|Metastasis by local reading|27|||
124552327|NCT02200614|447978694|FG000|Open Label|Other reason|22|||
124713539|NCT01490918|448576524|FG002|Overall Study|Lost to Follow-up|0|||
124713540|NCT01490918|448576522|FG000|Overall Study|Withdrawal by Subject|7|||
124469997|NCT01622569|447678040|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
124552328|NCT02200614|447978695|FG001|Open Label|Other reason|4|||
124469998|NCT01622569|447678037|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
124552329|NCT02200614|447978694|FG000|Open Label|Personal reason|60|||
124469999|NCT01622569|447678038|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
124470000|NCT01622569|447678039|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
124770488|NCT03104868|448788874|FG000|6 Week Follow up|Withdrawal by Subject|7|||
124713541|NCT01490918|448576523|FG001|Overall Study|Withdrawal by Subject|8|||
124713542|NCT01490918|448576524|FG002|Overall Study|Withdrawal by Subject|3|||
124713543|NCT01490918|448576522|FG000|Overall Study|Adverse Event|0|||
124713544|NCT01490918|448576523|FG001|Overall Study|Adverse Event|0|||
124713545|NCT01490918|448576524|FG002|Overall Study|Adverse Event|1|||
124713546|NCT01490918|448576522|FG000|Overall Study|other cause|4|||
124713547|NCT01490918|448576523|FG001|Overall Study|other cause|5|||
124713548|NCT01490918|448576524|FG002|Overall Study|other cause|8|||
124713549|NCT04940130|448576532|FG000|Overall Study|Travel|1|||
124470001|NCT01622569|447678040|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
124470002|NCT01622569|447678037|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
124470003|NCT01622569|447678038|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
124470004|NCT01622569|447678039|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
124470005|NCT01622569|447678040|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
124470006|NCT01622569|447678037|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
124470007|NCT01622569|447678038|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
124470008|NCT01622569|447678039|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
124470009|NCT01622569|447678040|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
124470010|NCT01622569|447678037|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
124470011|NCT01622569|447678038|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
124470012|NCT01622569|447678039|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
124470013|NCT01622569|447678040|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
124470014|NCT01622569|447678037|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
124470015|NCT01622569|447678038|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
124470016|NCT01622569|447678039|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
124470017|NCT01622569|447678040|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
124470018|NCT01505894|447678041|FG000|Overall Study|Adverse Event|1|||
124552330|NCT02200614|447978695|FG001|Open Label|Personal reason|8|||
124713550|NCT04940130|448576533|FG001|Overall Study|Travel|0|||
124713551|NCT04940130|448576534|FG002|Overall Study|Travel|2|||
124713552|NCT04940130|448576532|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
124713553|NCT04940130|448576533|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
124713554|NCT04940130|448576534|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
124713555|NCT04940130|448576532|FG000|Overall Study|Adverse Event|0|||
124713556|NCT04940130|448576533|FG001|Overall Study|Adverse Event|0|||
124713557|NCT04940130|448576534|FG002|Overall Study|Adverse Event|2|||
124713558|NCT04940130|448576532|FG000|Overall Study|Disease progression/treatment failure|0|||
124713559|NCT04940130|448576533|FG001|Overall Study|Disease progression/treatment failure|0|||
124713560|NCT04940130|448576534|FG002|Overall Study|Disease progression/treatment failure|1|||
124713561|NCT04940130|448576532|FG000|Overall Study|Participant refusal|0|||
124713562|NCT04940130|448576533|FG001|Overall Study|Participant refusal|0|||
124713563|NCT04940130|448576534|FG002|Overall Study|Participant refusal|1|||
124713564|NCT02240121|448576535|FG000|Overall Study|Protocol Violation|1|||
124713565|NCT02240121|448576536|FG001|Overall Study|Protocol Violation|2|||
124713566|NCT02240121|448576535|FG000|Overall Study|Physician Decision|0|||
124713567|NCT02240121|448576536|FG001|Overall Study|Physician Decision|1|||
124713568|NCT02240121|448576535|FG000|Overall Study|Change in protocol interpretation|1|||
124713569|NCT02240121|448576536|FG001|Overall Study|Change in protocol interpretation|0|||
124713570|NCT02240121|448576535|FG000|Overall Study|Lack of Efficacy|2|||
124713571|NCT02240121|448576536|FG001|Overall Study|Lack of Efficacy|3|||
124713572|NCT02240121|448576535|FG000|Overall Study|Site closed|1|||
124713573|NCT02240121|448576536|FG001|Overall Study|Site closed|1|||
124470019|NCT01505894|447678042|FG001|Overall Study|Adverse Event|0|||
124713574|NCT02240121|448576535|FG000|Overall Study|Pregnancy|1|||
124770489|NCT03104868|448788875|FG001|6 Week Follow up|Withdrawal by Subject|6|||
124713575|NCT02240121|448576536|FG001|Overall Study|Pregnancy|0|||
124713576|NCT02240121|448576535|FG000|Overall Study|Adverse Event|2|||
124713577|NCT02240121|448576536|FG001|Overall Study|Adverse Event|4|||
124713578|NCT02240121|448576535|FG000|Overall Study|Withdrawal by Subject|6|||
124470020|NCT01505894|447678043|FG002|Overall Study|Adverse Event|0|||
124770490|NCT03104868|448788874|FG000|6 Week Follow up|Completed Later Timepoint|24|||
124470021|NCT01505894|447678044|FG003|Overall Study|Adverse Event|0|||
124470022|NCT01505894|447678045|FG004|Overall Study|Adverse Event|0|||
124470023|NCT01505894|447678046|FG005|Overall Study|Adverse Event|0|||
124770491|NCT03104868|448788875|FG001|6 Week Follow up|Completed Later Timepoint|22|||
124770492|NCT03104868|448788874|FG000|6 Month Follow up|Lost to Follow-up|2|||
124770493|NCT03104868|448788875|FG001|6 Month Follow up|Lost to Follow-up|2|||
124770494|NCT03104868|448788874|FG000|6 Month Follow up|Death|0|||
124770495|NCT03104868|448788875|FG001|6 Month Follow up|Death|1|||
124770496|NCT03104868|448788874|FG000|6 Month Follow up|Completed Later Timepoint|22|||
124770497|NCT03104868|448788875|FG001|6 Month Follow up|Completed Later Timepoint|32|||
124770498|NCT03104868|448788874|FG000|12 Month Follow up|Lost to Follow-up|1|||
124770499|NCT03104868|448788875|FG001|12 Month Follow up|Lost to Follow-up|2|||
124770500|NCT03104868|448788874|FG000|12 Month Follow up|Death|0|||
124770501|NCT03104868|448788875|FG001|12 Month Follow up|Death|1|||
124770502|NCT03104868|448788874|FG000|12 Month Follow up|Withdrawal by Subject|0|||
124770503|NCT03104868|448788875|FG001|12 Month Follow up|Withdrawal by Subject|3|||
124770504|NCT03104868|448788874|FG000|12 Month Follow up|Completed Later Timepoint|32|||
124770505|NCT03104868|448788875|FG001|12 Month Follow up|Completed Later Timepoint|29|||
124770506|NCT03104868|448788874|FG000|18 Month Follow up|Lost to Follow-up|7|||
124770507|NCT03104868|448788875|FG001|18 Month Follow up|Lost to Follow-up|11|||
124770508|NCT03104868|448788874|FG000|18 Month Follow up|Death|2|||
124770509|NCT03104868|448788875|FG001|18 Month Follow up|Death|1|||
124470024|NCT01505894|447678047|FG006|Overall Study|Adverse Event|0|||
124470025|NCT01505894|447678048|FG007|Overall Study|Adverse Event|0|||
124470026|NCT01505894|447678049|FG008|Overall Study|Adverse Event|0|||
124470027|NCT01505894|447678041|FG000|Overall Study|Other than specified|0|||
124470028|NCT01505894|447678042|FG001|Overall Study|Other than specified|0|||
124470029|NCT01505894|447678043|FG002|Overall Study|Other than specified|0|||
124470030|NCT01505894|447678044|FG003|Overall Study|Other than specified|0|||
124470031|NCT01505894|447678045|FG004|Overall Study|Other than specified|1|||
124470032|NCT01505894|447678046|FG005|Overall Study|Other than specified|0|||
124470033|NCT01505894|447678047|FG006|Overall Study|Other than specified|0|||
124770510|NCT03104868|448788874|FG000|18 Month Follow up|Withdrawal by Subject|1|||
124770511|NCT03104868|448788875|FG001|18 Month Follow up|Withdrawal by Subject|2|||
124770512|NCT03104868|448788874|FG000|18 Month Follow up|Graft Loss|1|||
124770513|NCT03104868|448788875|FG001|18 Month Follow up|Graft Loss|1|||
124470034|NCT01505894|447678048|FG007|Overall Study|Other than specified|0|||
124470035|NCT01505894|447678049|FG008|Overall Study|Other than specified|0|||
124470036|NCT01001702|447678050|FG000|Overall Study|Lost to Follow-up|7|||
124470037|NCT01001702|447678050|FG000|Overall Study|Adverse Event|7|||
124470038|NCT01001702|447678050|FG000|Overall Study|Sponsor Discontinued Study|4|||
124470039|NCT01001702|447678050|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
124713579|NCT02240121|448576536|FG001|Overall Study|Withdrawal by Subject|2|||
124713580|NCT02240121|448576535|FG000|Overall Study|Lost to Follow-up|3|||
124713581|NCT02240121|448576536|FG001|Overall Study|Lost to Follow-up|4|||
124713582|NCT02240121|448576535|FG000|Overall Study|Other than specified|1|||
124713583|NCT02240121|448576536|FG001|Overall Study|Other than specified|3|||
124713584|NCT01925768|448576539|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
124713585|NCT01925768|448576540|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124713586|NCT01925768|448576539|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
124713587|NCT01925768|448576540|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
124713588|NCT01925768|448576539|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
124713589|NCT01925768|448576540|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
124713590|NCT01925768|448576539|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
124713591|NCT01925768|448576540|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
124713592|NCT01925768|448576539|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
124470040|NCT01001702|447678050|FG000|Overall Study|Investigator withdrew Subject|10|||
124470041|NCT01001702|447678050|FG000|Overall Study|Withdrawal by Subject|19|||
124470042|NCT01001702|447678050|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
124470043|NCT01940484|447678054|FG000|Overall Study|Withdrawal by Subject|3|||
124470044|NCT01940484|447678054|FG000|Overall Study|Underwent transplantation|4|||
124470045|NCT01940484|447678054|FG000|Overall Study|Death|2|||
124470046|NCT01940484|447678054|FG000|Overall Study|Adverse Event|1|||
124470047|NCT03106779|447678055|FG000|Overall Study|Lack of Efficacy|33|||
124470048|NCT03106779|447678056|FG001|Overall Study|Lack of Efficacy|24|||
124470049|NCT03106779|447678055|FG000|Overall Study|Adverse Event|8|||
124470050|NCT03106779|447678056|FG001|Overall Study|Adverse Event|16|||
124770514|NCT03104868|448788874|FG000|18 Month Follow up|Completed Later Timepoint|19|||
124470051|NCT03106779|447678055|FG000|Overall Study|Physician Decision|10|||
124470052|NCT03106779|447678056|FG001|Overall Study|Physician Decision|6|||
124470053|NCT03106779|447678055|FG000|Overall Study|Patient/guardian decision|4|||
124470054|NCT03106779|447678056|FG001|Overall Study|Patient/guardian decision|3|||
124470055|NCT03106779|447678055|FG000|Overall Study|Progressive disease|1|||
124470056|NCT03106779|447678056|FG001|Overall Study|Progressive disease|3|||
124470057|NCT03106779|447678055|FG000|Overall Study|Lost to Follow-up|1|||
124470058|NCT03106779|447678056|FG001|Overall Study|Lost to Follow-up|2|||
124470059|NCT03106779|447678055|FG000|Overall Study|Death|1|||
124470060|NCT03106779|447678056|FG001|Overall Study|Death|0|||
124770515|NCT03104868|448788875|FG001|18 Month Follow up|Completed Later Timepoint|20|||
124770516|NCT03104868|448788874|FG000|24 Month Follow up|Lost to Follow-up|15|||
124770517|NCT03104868|448788875|FG001|24 Month Follow up|Lost to Follow-up|16|||
124770518|NCT03104868|448788874|FG000|24 Month Follow up|Death|3|||
124770519|NCT03104868|448788875|FG001|24 Month Follow up|Death|2|||
124770520|NCT03104868|448788874|FG000|24 Month Follow up|Withdrawal by Subject|1|||
124770521|NCT03104868|448788875|FG001|24 Month Follow up|Withdrawal by Subject|0|||
124770522|NCT03104868|448788874|FG000|24 Month Follow up|Graft Loss|2|||
124770523|NCT03104868|448788875|FG001|24 Month Follow up|Graft Loss|0|||
124770524|NCT00005780|448788876|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
124770525|NCT04408989|448788877|FG000|Overall Study|Lost to Follow-up|0|||
124713593|NCT01925768|448576540|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
124713594|NCT01925768|448576539|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
124713595|NCT01925768|448576540|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
124713596|NCT01925768|448576539|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
124713597|NCT01925768|448576540|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
124713598|NCT01925768|448576539|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
124713599|NCT01925768|448576540|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
124713600|NCT01925768|448576539|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
124713601|NCT01925768|448576540|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
124713602|NCT01925768|448576539|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
124470061|NCT03106779|447678055|FG000|Overall Study|Protocol Violation|1|||
124470062|NCT03106779|447678056|FG001|Overall Study|Protocol Violation|0|||
124470063|NCT03106779|447678055|FG000|Overall Study|Not treated|1|||
124470064|NCT03106779|447678056|FG001|Overall Study|Not treated|0|||
124470065|NCT02288247|447678057|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
124470066|NCT02288247|447678058|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
124470067|NCT02288247|447678057|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
124552331|NCT02200614|447978694|FG000|Open Label|Protocol deviation|3|||
124713603|NCT01925768|448576540|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
124770526|NCT04408989|448788878|FG001|Overall Study|Lost to Follow-up|0|||
124770527|NCT04408989|448788879|FG002|Overall Study|Lost to Follow-up|1|||
124770528|NCT04408989|448788877|FG000|Overall Study|Withdrawal by Subject|0|||
124470068|NCT02288247|447678058|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
124470069|NCT02288247|447678057|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
124470070|NCT02288247|447678058|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
124713604|NCT01925768|448576539|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
124713605|NCT01925768|448576540|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
124713606|NCT00251693|448576545|FG000|Overall Study|Adverse Event|17|||
124713607|NCT00251693|448576546|FG001|Overall Study|Adverse Event|9|||
124713608|NCT00251693|448576547|FG002|Overall Study|Adverse Event|9|||
124470071|NCT02288247|447678057|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
124470072|NCT02288247|447678058|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
124470073|NCT02288247|447678057|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
124470074|NCT02288247|447678058|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
124470075|NCT02288247|447678057|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
124470076|NCT02288247|447678058|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
124470077|NCT02288247|447678057|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
124713609|NCT00251693|448576545|FG000|Overall Study|Protocol Violation|2|||
124552332|NCT02200614|447978695|FG001|Open Label|Protocol deviation|2|||
124552333|NCT02200614|447978694|FG000|Open Label|Missing|2|||
124552334|NCT02200614|447978695|FG001|Open Label|Missing|2|||
124552335|NCT00391092|447980320|FG000|Overall Study|Death|78|||
124713610|NCT00251693|448576546|FG001|Overall Study|Protocol Violation|0|||
124713611|NCT00251693|448576547|FG002|Overall Study|Protocol Violation|2|||
124713612|NCT00251693|448576545|FG000|Overall Study|Lost to Follow-up|12|||
124713613|NCT00251693|448576546|FG001|Overall Study|Lost to Follow-up|7|||
124713614|NCT00251693|448576547|FG002|Overall Study|Lost to Follow-up|8|||
124470078|NCT02288247|447678058|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
124470079|NCT02288247|447678057|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
124470080|NCT02288247|447678058|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
124470081|NCT02288247|447678057|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
124470082|NCT02288247|447678058|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
124470083|NCT02288247|447678057|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
124470084|NCT02288247|447678058|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
124470085|NCT02288247|447678057|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
124470086|NCT02288247|447678058|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
124470087|NCT02288247|447678057|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
124470088|NCT02288247|447678058|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
124470089|NCT02288247|447678057|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
124470090|NCT02288247|447678058|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
124470091|NCT02288247|447678057|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
124470092|NCT02288247|447678058|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
124470093|NCT02288247|447678057|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
124470094|NCT02288247|447678058|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
124470095|NCT02288247|447678057|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
124470096|NCT02288247|447678058|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
124470097|NCT04142983|447678059|FG000|Overall Study|Lost to Follow-up|73|||
124470098|NCT04142983|447678059|FG000|Overall Study|Withdrawal by Subject|10|||
124470099|NCT04142983|447678059|FG000|Overall Study|Physician Decision|1|||
124470100|NCT04142983|447678059|FG000|Overall Study|Adverse Event|1|||
124470101|NCT04142983|447678059|FG000|Overall Study|No longer eligible|4|||
124470102|NCT04142983|447678059|FG000|Overall Study|Screen Failure|10|||
124470103|NCT00643994|447678062|FG000|Overall Study|Death|24|||
124470104|NCT00643994|447678062|FG000|Overall Study|Lost to Follow-up|72|||
124470105|NCT00197054|447678063|FG000|Overall Study|Withdrawal by Subject|9|||
124470106|NCT00197054|447678064|FG001|Overall Study|Withdrawal by Subject|3|||
124470107|NCT00197054|447678065|FG002|Overall Study|Withdrawal by Subject|3|||
124470108|NCT00197054|447678063|FG000|Overall Study|Moved from area|7|||
124470109|NCT00197054|447678064|FG001|Overall Study|Moved from area|14|||
124470110|NCT00197054|447678065|FG002|Overall Study|Moved from area|9|||
124470111|NCT00197054|447678063|FG000|Overall Study|Lost to Follow-up|1|||
124470112|NCT00197054|447678064|FG001|Overall Study|Lost to Follow-up|4|||
124470113|NCT00197054|447678065|FG002|Overall Study|Lost to Follow-up|0|||
124470114|NCT04823949|447678067|FG000|Overall Study|Withdrawal by Subject|0|||
124470115|NCT04823949|447678068|FG001|Overall Study|Withdrawal by Subject|4|||
124470116|NCT04823949|447678067|FG000|Overall Study|Physician Decision|0|||
124470117|NCT04823949|447678068|FG001|Overall Study|Physician Decision|1|||
124552336|NCT00391092|447980321|FG001|Overall Study|Death|81|||
124552337|NCT00391092|447980320|FG000|Overall Study|Lost to Follow-up|13|||
124552338|NCT00391092|447980321|FG001|Overall Study|Lost to Follow-up|18|||
124713615|NCT00251693|448576545|FG000|Overall Study|Withdrawal by Subject|11|||
124713616|NCT00251693|448576546|FG001|Overall Study|Withdrawal by Subject|17|||
124552339|NCT00391092|447980320|FG000|Overall Study|Alive on treatment|29|||
124552340|NCT00391092|447980321|FG001|Overall Study|Alive on treatment|33|||
124470118|NCT00797823|447678070|FG000|First Period (Initial Randomization)|Physician Decision|1|||
124470119|NCT00797823|447678071|FG001|First Period (Initial Randomization)|Physician Decision|0|||
124470120|NCT00797823|447678072|FG002|First Period (Initial Randomization)|Physician Decision|0|||
124470121|NCT02568046|447678073|FG000|Overall Study|Adverse Event|0|||
124470122|NCT02568046|447678074|FG001|Overall Study|Adverse Event|1|||
124470123|NCT02568046|447678073|FG000|Overall Study|Death|2|||
124470124|NCT02568046|447678074|FG001|Overall Study|Death|0|||
124470125|NCT02568046|447678073|FG000|Overall Study|Progressive Disease|1|||
124470126|NCT02568046|447678074|FG001|Overall Study|Progressive Disease|0|||
124470127|NCT02568046|447678073|FG000|Overall Study|Withdrawal by Subject|2|||
124470128|NCT02568046|447678074|FG001|Overall Study|Withdrawal by Subject|1|||
124470129|NCT02568046|447678073|FG000|Overall Study|Other Events|0|||
124470130|NCT02568046|447678074|FG001|Overall Study|Other Events|1|||
124470131|NCT00523991|447678075|FG000|Overall Study|Adverse Event|6|||
124470132|NCT00523991|447678076|FG001|Overall Study|Adverse Event|5|||
124470133|NCT00523991|447678075|FG000|Overall Study|Protocol Violation|1|||
124470134|NCT00523991|447678076|FG001|Overall Study|Protocol Violation|4|||
124470135|NCT00523991|447678075|FG000|Overall Study|Lost to Follow-up|4|||
124470136|NCT00523991|447678076|FG001|Overall Study|Lost to Follow-up|1|||
124470137|NCT00523991|447678075|FG000|Overall Study|Withdrawal by Subject|7|||
124470138|NCT00523991|447678076|FG001|Overall Study|Withdrawal by Subject|17|||
124470139|NCT00523991|447678075|FG000|Overall Study|Other reason (not specified)|3|||
124470140|NCT00523991|447678076|FG001|Overall Study|Other reason (not specified)|0|||
124470141|NCT00193063|447678077|FG000|Overall Study|Lack of Efficacy|3|||
124470142|NCT00193063|447678077|FG000|Overall Study|Adverse Event|1|||
124470143|NCT00379795|447678080|FG000|Overall Study|Death|31|||
124470144|NCT00379795|447678081|FG001|Overall Study|Death|8|||
124470145|NCT00379795|447678082|FG002|Overall Study|Death|6|||
124470146|NCT00379795|447678083|FG003|Overall Study|Death|4|||
124470147|NCT00379795|447678084|FG004|Overall Study|Death|7|||
124470148|NCT00379795|447678080|FG000|Overall Study|Adverse Event|17|||
124470149|NCT00379795|447678081|FG001|Overall Study|Adverse Event|3|||
124470150|NCT00379795|447678082|FG002|Overall Study|Adverse Event|3|||
124552341|NCT00391092|447980320|FG000|Overall Study|Alive in follow-up|88|||
124470151|NCT00379795|447678083|FG003|Overall Study|Adverse Event|1|||
124470152|NCT00379795|447678084|FG004|Overall Study|Adverse Event|4|||
124470153|NCT00379795|447678080|FG000|Overall Study|Lost to Follow-up|8|||
124470154|NCT00379795|447678081|FG001|Overall Study|Lost to Follow-up|1|||
124470155|NCT00379795|447678082|FG002|Overall Study|Lost to Follow-up|2|||
124470156|NCT00379795|447678083|FG003|Overall Study|Lost to Follow-up|1|||
124470157|NCT00379795|447678084|FG004|Overall Study|Lost to Follow-up|4|||
124470158|NCT00379795|447678080|FG000|Overall Study|Physician Decision|25|||
124470159|NCT00379795|447678081|FG001|Overall Study|Physician Decision|0|||
124470160|NCT00379795|447678082|FG002|Overall Study|Physician Decision|2|||
124470161|NCT00379795|447678083|FG003|Overall Study|Physician Decision|2|||
124470162|NCT00379795|447678084|FG004|Overall Study|Physician Decision|2|||
124470163|NCT00379795|447678080|FG000|Overall Study|Withdrawal by Subject|94|||
124470164|NCT00379795|447678081|FG001|Overall Study|Withdrawal by Subject|11|||
124470165|NCT00379795|447678082|FG002|Overall Study|Withdrawal by Subject|19|||
124470166|NCT00379795|447678083|FG003|Overall Study|Withdrawal by Subject|7|||
124470167|NCT00379795|447678084|FG004|Overall Study|Withdrawal by Subject|14|||
124470168|NCT00379795|447678080|FG000|Overall Study|Subject non-compliance|7|||
124470169|NCT00379795|447678081|FG001|Overall Study|Subject non-compliance|2|||
124470170|NCT00379795|447678082|FG002|Overall Study|Subject non-compliance|0|||
124470171|NCT00379795|447678083|FG003|Overall Study|Subject non-compliance|0|||
124470172|NCT00379795|447678084|FG004|Overall Study|Subject non-compliance|1|||
124470173|NCT00379795|447678080|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
124470174|NCT00379795|447678081|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
124470175|NCT00379795|447678082|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
124470176|NCT00379795|447678083|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
124470177|NCT00379795|447678084|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
124470178|NCT00379795|447678080|FG000|Overall Study|Subjects condition mandated intervention|34|||
124470179|NCT00379795|447678081|FG001|Overall Study|Subjects condition mandated intervention|9|||
124470180|NCT00379795|447678082|FG002|Overall Study|Subjects condition mandated intervention|7|||
124470181|NCT00379795|447678083|FG003|Overall Study|Subjects condition mandated intervention|5|||
124470182|NCT00379795|447678084|FG004|Overall Study|Subjects condition mandated intervention|7|||
124470183|NCT00379795|447678080|FG000|Overall Study|Sponsor's decision|257|||
124470184|NCT00379795|447678081|FG001|Overall Study|Sponsor's decision|17|||
124470185|NCT00379795|447678082|FG002|Overall Study|Sponsor's decision|54|||
124470186|NCT00379795|447678083|FG003|Overall Study|Sponsor's decision|47|||
124470187|NCT00379795|447678084|FG004|Overall Study|Sponsor's decision|10|||
124470188|NCT02435849|447678085|FG000|Overall Study|Death|23|||
124470189|NCT02435849|447678086|FG001|Overall Study|Death|0|||
124470190|NCT02435849|447678085|FG000|Overall Study|Lack of Efficacy|10|||
124470191|NCT02435849|447678086|FG001|Overall Study|Lack of Efficacy|0|||
124470192|NCT02435849|447678085|FG000|Overall Study|New therapy for study indication|8|||
124470193|NCT02435849|447678086|FG001|Overall Study|New therapy for study indication|0|||
124470194|NCT02435849|447678085|FG000|Overall Study|Subject/guardian decision|5|||
124470195|NCT02435849|447678086|FG001|Overall Study|Subject/guardian decision|1|||
124470196|NCT02435849|447678085|FG000|Overall Study|Lost to Follow-up|1|||
124470197|NCT02435849|447678086|FG001|Overall Study|Lost to Follow-up|0|||
124470198|NCT02435849|447678085|FG000|Overall Study|Physician Decision|1|||
124470199|NCT02435849|447678086|FG001|Overall Study|Physician Decision|0|||
124470200|NCT04849780|447678087|FG000|Period 1|Covid-19 Related|1|||
124770529|NCT04408989|448788878|FG001|Overall Study|Withdrawal by Subject|0|||
124470201|NCT04849780|447678088|FG001|Period 1|Covid-19 Related|0|||
124470202|NCT04849780|447678087|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
124470203|NCT04849780|447678088|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
124470204|NCT04849780|447678087|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
124470205|NCT04849780|447678088|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
124470206|NCT00352105|447678089|FG000|Overall Study|Death|5|||
124552342|NCT00391092|447980321|FG001|Overall Study|Alive in follow-up|84|||
124552343|NCT01901146|447980322|FG000|Neoadjuvant Phase|Death|1|||
124552344|NCT01901146|447980323|FG001|Neoadjuvant Phase|Death|2|||
124552345|NCT01901146|447980324|FG002|Neoadjuvant Phase|Death|0|||
124552346|NCT01901146|447980325|FG003|Neoadjuvant Phase|Death|0|||
124552347|NCT01901146|447980326|FG004|Neoadjuvant Phase|Death|0|||
124552348|NCT01901146|447980322|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
124552349|NCT01901146|447980323|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
124552350|NCT01901146|447980324|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
124552351|NCT01901146|447980325|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
124552352|NCT01901146|447980326|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
124552353|NCT01901146|447980322|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
124552354|NCT01901146|447980323|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
124552355|NCT01901146|447980324|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
124552356|NCT01901146|447980325|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
124552357|NCT01901146|447980326|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
124552358|NCT01901146|447980322|FG000|Neoadjuvant Phase|Physician Decision|1|||
124552359|NCT01901146|447980323|FG001|Neoadjuvant Phase|Physician Decision|2|||
124552360|NCT01901146|447980324|FG002|Neoadjuvant Phase|Physician Decision|0|||
124552361|NCT01901146|447980325|FG003|Neoadjuvant Phase|Physician Decision|0|||
124552362|NCT01901146|447980326|FG004|Neoadjuvant Phase|Physician Decision|0|||
124552363|NCT01901146|447980322|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
124552364|NCT01901146|447980323|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
124552365|NCT01901146|447980324|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
124552366|NCT01901146|447980325|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
124552367|NCT01901146|447980326|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
124552368|NCT01901146|447980322|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
124552369|NCT01901146|447980323|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
124552370|NCT01901146|447980324|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
124552371|NCT01901146|447980325|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
124552372|NCT01901146|447980326|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
124552373|NCT01901146|447980322|FG000|Adjuvant Phase|Other|0|||
124552374|NCT01901146|447980323|FG001|Adjuvant Phase|Other|0|||
124552375|NCT01901146|447980324|FG002|Adjuvant Phase|Other|1|||
124552376|NCT01901146|447980325|FG003|Adjuvant Phase|Other|0|||
124552377|NCT01901146|447980326|FG004|Adjuvant Phase|Other|0|||
124552378|NCT01901146|447980322|FG000|Adjuvant Phase|Death|0|||
124552379|NCT01901146|447980323|FG001|Adjuvant Phase|Death|0|||
124552380|NCT01901146|447980324|FG002|Adjuvant Phase|Death|0|||
124552381|NCT01901146|447980325|FG003|Adjuvant Phase|Death|0|||
124552382|NCT01901146|447980326|FG004|Adjuvant Phase|Death|3|||
124552383|NCT01901146|447980322|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
124552384|NCT01901146|447980323|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
124552385|NCT01901146|447980324|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
124552386|NCT01901146|447980325|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
124552387|NCT01901146|447980326|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
124552388|NCT01901146|447980322|FG000|Adjuvant Phase|Physician Decision|0|||
124552389|NCT01901146|447980323|FG001|Adjuvant Phase|Physician Decision|0|||
124552390|NCT01901146|447980324|FG002|Adjuvant Phase|Physician Decision|9|||
124552391|NCT01901146|447980325|FG003|Adjuvant Phase|Physician Decision|2|||
124552392|NCT01901146|447980326|FG004|Adjuvant Phase|Physician Decision|4|||
124552393|NCT01901146|447980322|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
124552394|NCT01901146|447980323|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
124552395|NCT01901146|447980324|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
124552396|NCT01901146|447980325|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
124552397|NCT01901146|447980326|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
124552398|NCT00297492|447980327|FG000|Set Quit Date|Lost to Follow-up|7|||
124552399|NCT00297492|447980328|FG001|Set Quit Date|Lost to Follow-up|13|||
124552400|NCT00297492|447980329|FG002|Set Quit Date|Lost to Follow-up|5|||
124552401|NCT00297492|447980327|FG000|6 Month Follow-up|Lost to Follow-up|63|||
124552402|NCT00297492|447980328|FG001|6 Month Follow-up|Lost to Follow-up|49|||
124552403|NCT00297492|447980329|FG002|6 Month Follow-up|Lost to Follow-up|27|||
124552404|NCT02414854|447980330|FG000|Overall Study|Adverse Event|9|||
124552405|NCT02414854|447980331|FG001|Overall Study|Adverse Event|7|||
124552406|NCT02414854|447980332|FG002|Overall Study|Adverse Event|1|||
124552407|NCT02414854|447980333|FG003|Overall Study|Adverse Event|12|||
124552408|NCT02414854|447980330|FG000|Overall Study|Poor compliance to protocol|1|||
124552409|NCT02414854|447980331|FG001|Overall Study|Poor compliance to protocol|1|||
124552410|NCT02414854|447980332|FG002|Overall Study|Poor compliance to protocol|2|||
124552411|NCT02414854|447980333|FG003|Overall Study|Poor compliance to protocol|2|||
124552412|NCT02414854|447980330|FG000|Overall Study|Other than specified above|12|||
124552413|NCT02414854|447980331|FG001|Overall Study|Other than specified above|37|||
124552414|NCT02414854|447980332|FG002|Overall Study|Other than specified above|17|||
124552415|NCT02414854|447980333|FG003|Overall Study|Other than specified above|37|||
124552416|NCT00606801|447980334|FG000|Intervention|Protocol Violation|3|||
124552417|NCT00606801|447980335|FG001|Intervention|Protocol Violation|3|||
124552418|NCT00303316|447980338|FG000|Overall Study|Protocol Violation|1|||
124713617|NCT00251693|448576547|FG002|Overall Study|Withdrawal by Subject|14|||
124713618|NCT00251693|448576545|FG000|Overall Study|Lack of Efficacy|0|||
124713619|NCT00251693|448576546|FG001|Overall Study|Lack of Efficacy|1|||
124713620|NCT00251693|448576547|FG002|Overall Study|Lack of Efficacy|0|||
124713621|NCT00251693|448576545|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
124713622|NCT00251693|448576546|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
124713623|NCT00251693|448576547|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
124975533|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
124975534|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
124975535|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
124975536|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
124975537|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
124975538|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
124975539|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
124975540|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
124975541|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
124975542|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
124975543|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
124975544|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
124975545|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
124975546|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
124975547|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
124975548|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
124975549|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
124975550|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
124975551|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
124975552|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
124975553|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
124975554|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
124713624|NCT00251693|448576545|FG000|Overall Study|Noncompliant|0|||
124470207|NCT00352105|447678089|FG000|Overall Study|Withdrawal by Subject|5|||
124470208|NCT00352105|447678089|FG000|Overall Study|Lack of Efficacy|9|||
124470209|NCT00352105|447678089|FG000|Overall Study|Adverse Event|19|||
124470210|NCT00352105|447678089|FG000|Overall Study|Protocol Violation|2|||
124470211|NCT01405053|447678090|FG000|Overall Study|Adverse Event|3|||
124470212|NCT01405053|447678091|FG001|Overall Study|Adverse Event|0|||
124470213|NCT01405053|447678090|FG000|Overall Study|Lost to Follow-up|0|||
124470214|NCT01405053|447678091|FG001|Overall Study|Lost to Follow-up|1|||
124470215|NCT01405053|447678090|FG000|Overall Study|Participant choice|2|||
124470216|NCT01405053|447678091|FG001|Overall Study|Participant choice|1|||
124470217|NCT01405053|447678090|FG000|Overall Study|Inadequate therapeutic effect|2|||
124470218|NCT01405053|447678091|FG001|Overall Study|Inadequate therapeutic effect|1|||
124470219|NCT01405053|447678090|FG000|Overall Study|Withdrawal by Subject|3|||
124470220|NCT01405053|447678091|FG001|Overall Study|Withdrawal by Subject|4|||
124470221|NCT01405053|447678090|FG000|Overall Study|Other|0|||
124470222|NCT01405053|447678091|FG001|Overall Study|Other|1|||
124470223|NCT02551159|447678092|FG000|Overall Study|Death|352|||
124470224|NCT02551159|447678093|FG001|Overall Study|Death|174|||
124470225|NCT02551159|447678094|FG002|Overall Study|Death|161|||
124470226|NCT02551159|447678092|FG000|Overall Study|Withdrawal by Subject|8|||
124470227|NCT02551159|447678093|FG001|Overall Study|Withdrawal by Subject|5|||
124470228|NCT02551159|447678094|FG002|Overall Study|Withdrawal by Subject|16|||
124713625|NCT00251693|448576546|FG001|Overall Study|Noncompliant|0|||
124713626|NCT00251693|448576547|FG002|Overall Study|Noncompliant|2|||
124713627|NCT00251693|448576545|FG000|Overall Study|Possible Barrett's esophagus|3|||
124713628|NCT00251693|448576546|FG001|Overall Study|Possible Barrett's esophagus|5|||
124713629|NCT00251693|448576547|FG002|Overall Study|Possible Barrett's esophagus|2|||
124713630|NCT00251693|448576545|FG000|Overall Study|Subject request/subject unavailable|1|||
124470229|NCT02551159|447678092|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
124470230|NCT02551159|447678093|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
124470231|NCT02551159|447678094|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
124470232|NCT00268242|447678095|FG000|Overall Study|Death|1|||
124470233|NCT00993928|447678096|FG000|Overall Study|Withdrawal by Subject|4|||
124470234|NCT00993928|447678097|FG001|Overall Study|Withdrawal by Subject|7|||
124470235|NCT00993928|447678096|FG000|Overall Study|ineligible|1|||
124470236|NCT00993928|447678097|FG001|Overall Study|ineligible|0|||
124552419|NCT00303316|447980339|FG001|Overall Study|Protocol Violation|0|||
124552420|NCT00303316|447980338|FG000|Overall Study|Lost to Follow-up|0|||
124713631|NCT00251693|448576546|FG001|Overall Study|Subject request/subject unavailable|2|||
124470237|NCT04871711|447678098|FG000|Overall Study|Withdrawal by Subject|11|||
124713632|NCT00251693|448576547|FG002|Overall Study|Subject request/subject unavailable|0|||
124713633|NCT00251693|448576545|FG000|Overall Study|Abnormal laboratory findings|0|||
124470238|NCT04871711|447678099|FG001|Overall Study|Withdrawal by Subject|5|||
124713634|NCT00251693|448576546|FG001|Overall Study|Abnormal laboratory findings|0|||
124470239|NCT04871711|447678098|FG000|Overall Study|Lack of Efficacy|5|||
124470240|NCT04871711|447678099|FG001|Overall Study|Lack of Efficacy|7|||
124470241|NCT04871711|447678098|FG000|Overall Study|Adverse Event|2|||
124470242|NCT04871711|447678099|FG001|Overall Study|Adverse Event|6|||
124470243|NCT04871711|447678098|FG000|Overall Study|Various reasons|2|||
124470244|NCT04871711|447678099|FG001|Overall Study|Various reasons|1|||
124470245|NCT04871711|447678098|FG000|Overall Study|Lost to Follow-up|0|||
124470246|NCT04871711|447678099|FG001|Overall Study|Lost to Follow-up|2|||
124470247|NCT04556617|447678105|FG000|Overall Study|progressive disease|0|||
124470248|NCT04556617|447678106|FG001|Overall Study|progressive disease|2|||
124470249|NCT04556617|447678107|FG002|Overall Study|progressive disease|2|||
124470250|NCT04556617|447678108|FG003|Overall Study|progressive disease|1|||
124470251|NCT04556617|447678109|FG004|Overall Study|progressive disease|1|||
124470252|NCT04556617|447678105|FG000|Overall Study|Physician Decision|0|||
124470253|NCT04556617|447678106|FG001|Overall Study|Physician Decision|0|||
124470254|NCT04556617|447678107|FG002|Overall Study|Physician Decision|2|||
124470255|NCT04556617|447678108|FG003|Overall Study|Physician Decision|0|||
124470256|NCT04556617|447678109|FG004|Overall Study|Physician Decision|0|||
124470257|NCT04556617|447678105|FG000|Overall Study|Adverse Event|0|||
124470258|NCT04556617|447678106|FG001|Overall Study|Adverse Event|0|||
124470259|NCT04556617|447678107|FG002|Overall Study|Adverse Event|2|||
124470260|NCT04556617|447678108|FG003|Overall Study|Adverse Event|3|||
124470261|NCT04556617|447678109|FG004|Overall Study|Adverse Event|0|||
124470262|NCT04556617|447678105|FG000|Overall Study|Withdrawal by Subject|0|||
124470263|NCT04556617|447678106|FG001|Overall Study|Withdrawal by Subject|2|||
124470264|NCT04556617|447678107|FG002|Overall Study|Withdrawal by Subject|1|||
124470265|NCT04556617|447678108|FG003|Overall Study|Withdrawal by Subject|1|||
124470266|NCT04556617|447678109|FG004|Overall Study|Withdrawal by Subject|0|||
124470267|NCT04556617|447678105|FG000|Overall Study|PSA increase|0|||
124470268|NCT04556617|447678106|FG001|Overall Study|PSA increase|1|||
124470269|NCT04556617|447678107|FG002|Overall Study|PSA increase|0|||
124470270|NCT04556617|447678108|FG003|Overall Study|PSA increase|0|||
124470271|NCT04556617|447678109|FG004|Overall Study|PSA increase|0|||
124470272|NCT04556617|447678105|FG000|Overall Study|Sponsor study termination|1|||
124470273|NCT04556617|447678106|FG001|Overall Study|Sponsor study termination|0|||
124470274|NCT04556617|447678107|FG002|Overall Study|Sponsor study termination|0|||
124470275|NCT04556617|447678108|FG003|Overall Study|Sponsor study termination|0|||
124470276|NCT04556617|447678109|FG004|Overall Study|Sponsor study termination|0|||
124470277|NCT03179436|447678110|FG000|Overall Study|Withdrawal by Subject|1|||
124470278|NCT03179436|447678111|FG001|Overall Study|Withdrawal by Subject|0|||
124470279|NCT03179436|447678112|FG002|Overall Study|Withdrawal by Subject|0|||
124470280|NCT03179436|447678113|FG003|Overall Study|Withdrawal by Subject|4|||
124470281|NCT03179436|447678114|FG004|Overall Study|Withdrawal by Subject|2|||
124470282|NCT03179436|447678115|FG005|Overall Study|Withdrawal by Subject|2|||
124470283|NCT03179436|447678116|FG006|Overall Study|Withdrawal by Subject|5|||
124470284|NCT03179436|447678117|FG007|Overall Study|Withdrawal by Subject|0|||
124470285|NCT03179436|447678118|FG008|Overall Study|Withdrawal by Subject|3|||
124470286|NCT03179436|447678119|FG009|Overall Study|Withdrawal by Subject|0|||
124552421|NCT00303316|447980339|FG001|Overall Study|Lost to Follow-up|1|||
124552422|NCT00303316|447980338|FG000|Overall Study|Withdrawal by Subject|1|||
124552423|NCT00303316|447980339|FG001|Overall Study|Withdrawal by Subject|2|||
124552424|NCT02016755|447980342|FG000|Overall Study|Major amputation of index limb|2|||
124552425|NCT02016755|447980342|FG000|Overall Study|Adverse Event|2|||
124552426|NCT02016755|447980342|FG000|Overall Study|Physician Decision|1|||
124552427|NCT02016755|447980342|FG000|Overall Study|Death|2|||
124552428|NCT00337129|447980347|FG000|Overall Study|Adverse Event|4|||
124552429|NCT00337129|447980347|FG000|Overall Study|Withdrawal by Subject|1|||
124552430|NCT00337129|447980347|FG000|Overall Study|Lack of Efficacy|32|||
124552431|NCT00337129|447980347|FG000|Overall Study|Death|2|||
124552432|NCT00337129|447980347|FG000|Overall Study|not protocol specified|1|||
124552433|NCT00306852|447980351|FG000|Overall Study|Death|14|||
124552434|NCT00306852|447980352|FG001|Overall Study|Death|14|||
124552435|NCT00306852|447980351|FG000|Overall Study|Lost to Follow-up|15|||
124552436|NCT00306852|447980352|FG001|Overall Study|Lost to Follow-up|24|||
124552437|NCT01467570|447980353|FG000|Overall Study|Lost to Follow-up|8|||
124552438|NCT01467570|447980354|FG001|Overall Study|Lost to Follow-up|9|||
124552439|NCT01222715|447980357|FG000|Overall Study|Adverse Event|0|||
124552440|NCT01222715|447980358|FG001|Overall Study|Adverse Event|4|||
124552441|NCT01222715|447980357|FG000|Overall Study|Death|0|||
124552442|NCT01222715|447980358|FG001|Overall Study|Death|1|||
124470287|NCT03179436|447678120|FG010|Overall Study|Withdrawal by Subject|0|||
124470288|NCT03179436|447678121|FG011|Overall Study|Withdrawal by Subject|0|||
124470289|NCT03179436|447678110|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124470290|NCT03179436|447678111|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124552443|NCT01222715|447980357|FG000|Overall Study|Lack of Efficacy|22|||
124470291|NCT03179436|447678112|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
124552444|NCT01222715|447980358|FG001|Overall Study|Lack of Efficacy|14|||
124552445|NCT01222715|447980357|FG000|Overall Study|Physician Decision|12|||
124552446|NCT01222715|447980358|FG001|Overall Study|Physician Decision|2|||
124552447|NCT01222715|447980357|FG000|Overall Study|Refusal of further protocol therapy|0|||
124552448|NCT01222715|447980358|FG001|Overall Study|Refusal of further protocol therapy|4|||
124552449|NCT01222715|447980357|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
124470292|NCT03179436|447678113|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
124470293|NCT03179436|447678114|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
124470294|NCT03179436|447678115|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
124470295|NCT03179436|447678116|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
124470296|NCT03179436|447678117|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
124470297|NCT03179436|447678118|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
124470298|NCT03179436|447678119|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
124470299|NCT03179436|447678120|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
124470300|NCT03179436|447678121|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
124470301|NCT03179436|447678110|FG000|Overall Study|Sponsor Decision|0|||
124470302|NCT03179436|447678111|FG001|Overall Study|Sponsor Decision|0|||
124470303|NCT03179436|447678112|FG002|Overall Study|Sponsor Decision|1|||
124470304|NCT03179436|447678113|FG003|Overall Study|Sponsor Decision|3|||
124470305|NCT03179436|447678114|FG004|Overall Study|Sponsor Decision|9|||
124470306|NCT03179436|447678115|FG005|Overall Study|Sponsor Decision|7|||
124470307|NCT03179436|447678116|FG006|Overall Study|Sponsor Decision|2|||
124470308|NCT03179436|447678117|FG007|Overall Study|Sponsor Decision|4|||
124713635|NCT00251693|448576547|FG002|Overall Study|Abnormal laboratory findings|1|||
124713636|NCT02779777|448576548|FG000|Overall Study|Disease Progression|1|||
124713637|NCT02779777|448576549|FG001|Overall Study|Disease Progression|0|||
124713638|NCT02779777|448576550|FG002|Overall Study|Disease Progression|0|||
124713639|NCT02779777|448576548|FG000|Overall Study|Adverse Event|3|||
124713640|NCT02779777|448576549|FG001|Overall Study|Adverse Event|1|||
124713641|NCT02779777|448576550|FG002|Overall Study|Adverse Event|0|||
124470309|NCT03179436|447678118|FG008|Overall Study|Sponsor Decision|23|||
124470310|NCT03179436|447678119|FG009|Overall Study|Sponsor Decision|6|||
124713642|NCT02779777|448576548|FG000|Overall Study|Physician Decision|9|||
124470311|NCT03179436|447678120|FG010|Overall Study|Sponsor Decision|7|||
124713643|NCT02779777|448576549|FG001|Overall Study|Physician Decision|0|||
124713644|NCT02779777|448576550|FG002|Overall Study|Physician Decision|1|||
124470312|NCT03179436|447678121|FG011|Overall Study|Sponsor Decision|5|||
124713645|NCT02779777|448576548|FG000|Overall Study|Withdrawal by Subject|1|||
124713646|NCT02779777|448576549|FG001|Overall Study|Withdrawal by Subject|0|||
124713647|NCT02779777|448576550|FG002|Overall Study|Withdrawal by Subject|0|||
124713648|NCT04571060|448576551|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
124713649|NCT04571060|448576552|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
124713650|NCT04571060|448576551|FG000|Overall Study|Never treated migraine|47|||
124713651|NCT04571060|448576552|FG001|Overall Study|Never treated migraine|36|||
124713652|NCT04571060|448576551|FG000|Overall Study|Protocol Violation|4|||
124713653|NCT04571060|448576552|FG001|Overall Study|Protocol Violation|2|||
124713654|NCT04571060|448576551|FG000|Overall Study|Withdrawal by Subject|6|||
124713655|NCT04571060|448576552|FG001|Overall Study|Withdrawal by Subject|2|||
124713656|NCT04571060|448576551|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
124713657|NCT04571060|448576552|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
124713658|NCT00087698|448576558|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
124713659|NCT00087698|448576558|FG000|Overall Study|Death from Other Causes|3|||
124713660|NCT00087698|448576558|FG000|Overall Study|Adverse Event|4|||
124713661|NCT00087698|448576558|FG000|Overall Study|Withdrawal by Subject|4|||
124713662|NCT00087698|448576558|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
124713663|NCT00087698|448576558|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
124713664|NCT00087698|448576558|FG000|Overall Study|Clinical Relapse|1|||
124713665|NCT00087698|448576558|FG000|Overall Study|Death from Study Disease|2|||
124975555|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
124975556|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975557|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975558|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975559|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975560|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975561|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975562|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975563|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975564|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
124975565|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
124975566|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
124975567|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
124975568|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975569|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975570|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975571|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975572|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975573|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975574|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975575|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975576|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
124975577|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
124975578|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
124975579|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
124975580|NCT01646177|449536589|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975581|NCT01646177|449536590|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975582|NCT01646177|449536591|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975583|NCT01646177|449536592|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975584|NCT01646177|449536593|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975585|NCT01646177|449536594|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975586|NCT01646177|449536595|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975587|NCT01646177|449536596|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975588|NCT01646177|449536597|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975589|NCT01646177|449536598|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
124975590|NCT01646177|449536599|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
124975591|NCT01646177|449536600|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
124975592|NCT01305239|449536604|FG000|Overall Study|Adverse Event|22|||
124975593|NCT01305239|449536604|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
124975594|NCT00402051|449536607|FG000|Overall Study|Progressive Disease|13|||
124975595|NCT00402051|449536608|FG001|Overall Study|Progressive Disease|20|||
124975596|NCT00402051|449536607|FG000|Overall Study|Adverse Event|11|||
124975597|NCT00402051|449536608|FG001|Overall Study|Adverse Event|4|||
124975598|NCT00402051|449536607|FG000|Overall Study|Physician Decision|7|||
124975599|NCT00402051|449536608|FG001|Overall Study|Physician Decision|3|||
124975600|NCT00402051|449536607|FG000|Overall Study|Withdrawal by Subject|3|||
124975601|NCT00402051|449536608|FG001|Overall Study|Withdrawal by Subject|3|||
124470313|NCT03179436|447678110|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
124470314|NCT03179436|447678111|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
124470315|NCT03179436|447678112|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
124470316|NCT03179436|447678113|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
124470317|NCT03179436|447678114|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
124470318|NCT03179436|447678115|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
124470319|NCT03179436|447678116|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
124470320|NCT03179436|447678117|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
124470321|NCT03179436|447678118|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
124470322|NCT03179436|447678119|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
124713666|NCT00087698|448576558|FG000|Overall Study|Death from Study Drug Toxicity|2|||
124713667|NCT00087698|448576558|FG000|Overall Study|Protocol Violation|1|||
124713668|NCT01070979|448576568|FG000|Overall Study|Adverse Event|2|||
124713669|NCT01070979|448576569|FG001|Overall Study|Adverse Event|3|||
124713670|NCT01070979|448576570|FG002|Overall Study|Adverse Event|3|||
124713671|NCT01070979|448576568|FG000|Overall Study|Lost to Follow-up|2|||
124713672|NCT01070979|448576569|FG001|Overall Study|Lost to Follow-up|1|||
124713673|NCT01070979|448576570|FG002|Overall Study|Lost to Follow-up|1|||
124713674|NCT01070979|448576568|FG000|Overall Study|Protocol Violation|0|||
124713675|NCT01070979|448576569|FG001|Overall Study|Protocol Violation|2|||
124713676|NCT01070979|448576570|FG002|Overall Study|Protocol Violation|6|||
124713677|NCT01070979|448576568|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
124713678|NCT01070979|448576569|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
124713679|NCT01070979|448576570|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
124713680|NCT01070979|448576568|FG000|Overall Study|Withdrawal by Subject|3|||
124713681|NCT01070979|448576569|FG001|Overall Study|Withdrawal by Subject|1|||
124713682|NCT01070979|448576570|FG002|Overall Study|Withdrawal by Subject|1|||
124713683|NCT01070979|448576568|FG000|Overall Study|No study drug taken|0|||
124713684|NCT01070979|448576569|FG001|Overall Study|No study drug taken|1|||
124713685|NCT01070979|448576570|FG002|Overall Study|No study drug taken|0|||
124713686|NCT01900665|448576580|FG000|Placebo Controlled Period|Death|9|||
124713687|NCT01900665|448576581|FG001|Placebo Controlled Period|Death|16|||
124713688|NCT01900665|448576580|FG000|Placebo Controlled Period|Adverse Event|48|||
124713689|NCT01900665|448576581|FG001|Placebo Controlled Period|Adverse Event|39|||
124713690|NCT01900665|448576580|FG000|Placebo Controlled Period|Protocol Violation|1|||
124713691|NCT01900665|448576581|FG001|Placebo Controlled Period|Protocol Violation|7|||
124713692|NCT01900665|448576580|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
124713693|NCT01900665|448576581|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
124713694|NCT01900665|448576580|FG000|Placebo Controlled Period|Physician Decision|11|||
124713695|NCT01900665|448576581|FG001|Placebo Controlled Period|Physician Decision|7|||
124713696|NCT01900665|448576580|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
124713697|NCT01900665|448576581|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
124713698|NCT01900665|448576580|FG000|Placebo Controlled Period|Caregiver Decision|33|||
124713699|NCT01900665|448576581|FG001|Placebo Controlled Period|Caregiver Decision|41|||
124713700|NCT01900665|448576580|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
124713701|NCT01900665|448576581|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
124713702|NCT01900665|448576580|FG000|Open Label Period|Adverse Event|16|||
124713703|NCT01900665|448576581|FG001|Open Label Period|Adverse Event|20|||
124713704|NCT01900665|448576580|FG000|Open Label Period|Death|5|||
124713705|NCT01900665|448576581|FG001|Open Label Period|Death|6|||
124713706|NCT01900665|448576580|FG000|Open Label Period|Lost to Follow-up|1|||
124713707|NCT01900665|448576581|FG001|Open Label Period|Lost to Follow-up|1|||
124713708|NCT01900665|448576580|FG000|Open Label Period|Parent/Caregiver Decision|33|||
124713709|NCT01900665|448576581|FG001|Open Label Period|Parent/Caregiver Decision|34|||
124713710|NCT01900665|448576580|FG000|Open Label Period|Physician Decision|4|||
124713711|NCT01900665|448576581|FG001|Open Label Period|Physician Decision|4|||
124713712|NCT01900665|448576580|FG000|Open Label Period|Protocol Violation|0|||
124713713|NCT01900665|448576581|FG001|Open Label Period|Protocol Violation|1|||
124713714|NCT01900665|448576580|FG000|Open Label Period|Sponsor Decision|802|||
124713715|NCT01900665|448576581|FG001|Open Label Period|Sponsor Decision|765|||
124713716|NCT01900665|448576580|FG000|Open Label Period|Withdrawal by Subject|20|||
124975602|NCT00402051|449536607|FG000|Overall Study|Death - Related to Study Drug|1|||
124975603|NCT00402051|449536608|FG001|Overall Study|Death - Related to Study Drug|2|||
124975604|NCT00402051|449536607|FG000|Overall Study|Death Due to Study Disease|2|||
124975605|NCT00402051|449536608|FG001|Overall Study|Death Due to Study Disease|1|||
124975606|NCT00402051|449536607|FG000|Overall Study|Death Due to Adverse Event|0|||
124975607|NCT00402051|449536608|FG001|Overall Study|Death Due to Adverse Event|2|||
124975608|NCT00402051|449536607|FG000|Overall Study|Lost to Follow-up|1|||
124975609|NCT00402051|449536608|FG001|Overall Study|Lost to Follow-up|0|||
124975610|NCT00570908|449536622|FG000|Overall Study|Adverse Event|5|||
124975611|NCT00570908|449536622|FG000|Overall Study|Withdrawal by Subject|2|||
124975612|NCT01213524|449536623|FG000|Baseline|Withdrawal by Subject|5|||
124975613|NCT01213524|449536623|FG000|Baseline|high breath alcohol levels|1|||
124975614|NCT01213524|449536623|FG000|Baseline|Physician Decision|1|||
124975615|NCT01213524|449536623|FG000|Session 2|Withdrawal by Subject|5|||
124975616|NCT01213524|449536623|FG000|Session 3|Withdrawal by Subject|4|||
124975617|NCT01213524|449536623|FG000|Session 4|Physician Decision|1|||
124975618|NCT01213524|449536623|FG000|Session 4|Withdrawal by Subject|2|||
124975619|NCT06152224|449536629|FG000|Overall Study|Withdrawal by Subject|1|||
124975620|NCT06152224|449536630|FG001|Overall Study|Withdrawal by Subject|0|||
124975621|NCT06152224|449536629|FG000|Overall Study|Lost to Follow-up|0|||
124975622|NCT06152224|449536630|FG001|Overall Study|Lost to Follow-up|1|||
124975623|NCT06152224|449536629|FG000|Overall Study|On Follow Up|18|||
124975624|NCT06152224|449536630|FG001|Overall Study|On Follow Up|18|||
124975625|NCT00281320|449536631|FG000|Overall Study|Adverse Event|12|||
124975626|NCT00281320|449536632|FG001|Overall Study|Adverse Event|9|||
124975627|NCT00281320|449536631|FG000|Overall Study|Lack of Efficacy|4|||
124975628|NCT00281320|449536632|FG001|Overall Study|Lack of Efficacy|3|||
124975629|NCT00281320|449536631|FG000|Overall Study|Withdrawal by Subject|5|||
124975630|NCT00281320|449536632|FG001|Overall Study|Withdrawal by Subject|6|||
124975631|NCT00281320|449536631|FG000|Overall Study|Lost to Follow-up|1|||
124975632|NCT00281320|449536632|FG001|Overall Study|Lost to Follow-up|2|||
124975633|NCT00281320|449536631|FG000|Overall Study|Other|3|||
124975634|NCT00281320|449536632|FG001|Overall Study|Other|1|||
124975635|NCT01447576|449536641|FG000|Overall Study|Lost to Follow-up|52|||
124975636|NCT01447576|449536641|FG000|Overall Study|Adverse Event|127|||
124975637|NCT01447576|449536641|FG000|Overall Study|Participant met withdrawal criteria|40|||
124975638|NCT01447576|449536641|FG000|Overall Study|Withdrawal by Subject|100|||
124975639|NCT01447576|449536641|FG000|Overall Study|Protocol deviation|83|||
124975640|NCT01447576|449536641|FG000|Overall Study|Lack of Efficacy|68|||
124975641|NCT01447576|449536641|FG000|Overall Study|Physician Decision|6|||
124975642|NCT00975676|449536642|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
124975643|NCT00975676|449536643|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
124975644|NCT02579772|449536644|FG000|Overall Study|Withdrawal by Subject|0|||
124470323|NCT03179436|447678120|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
124470324|NCT03179436|447678121|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
124470325|NCT03179436|447678110|FG000|Overall Study|Lost to Follow-up|1|||
124713717|NCT01900665|448576581|FG001|Open Label Period|Withdrawal by Subject|28|||
124713718|NCT04749745|448576585|FG000|Overall Study|Withdrawal by Subject|1|||
124713719|NCT04749745|448576586|FG001|Overall Study|Withdrawal by Subject|0|||
124713720|NCT03816176|448576591|FG000|Overall Study|Miscellaneous|5|||
124713721|NCT03816176|448576591|FG000|Overall Study|Lack of Efficacy|4|||
124713722|NCT03816176|448576591|FG000|Overall Study|Adverse Event|3|||
124713723|NCT04472650|448577627|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
124713724|NCT04472650|448577628|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
124713725|NCT00288015|448577633|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
124713726|NCT00288015|448577633|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
124713727|NCT00288015|448577633|FG000|First Response Assessment|Withdrawal by Subject|1|||
124713728|NCT00288015|448577633|FG000|First Response Assessment|Death|1|||
124713729|NCT00288015|448577633|FG000|First Response Assessment|Physician Decision|2|||
124713730|NCT00288015|448577633|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
124713731|NCT00288015|448577633|FG000|Follow up for Survival x 2 Years|Death|13|||
124713732|NCT00288015|448577633|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
124713733|NCT00288015|448577633|FG000|Follow up for Survival x 2 Years|Other|9|||
124713734|NCT01333722|448577634|FG000|Overall Study|Lack of Efficacy|0|||
124713735|NCT01333722|448577635|FG001|Overall Study|Lack of Efficacy|2|||
124713736|NCT01333722|448577634|FG000|Overall Study|Withdrawal by Subject|0|||
124713737|NCT01333722|448577635|FG001|Overall Study|Withdrawal by Subject|1|||
124713738|NCT02477527|448577638|FG000|Overall Study|Lost to Follow-up|2|||
124713739|NCT02477527|448577638|FG000|Overall Study|Withdrawal by Subject|1|||
124713740|NCT02477527|448577638|FG000|Overall Study|Screen Failure|3|||
124713741|NCT03432494|448577648|FG000|Overall Study|Death|1|||
124713742|NCT03432494|448577648|FG000|Overall Study|Noncompliance|1|||
124470326|NCT03179436|447678111|FG001|Overall Study|Lost to Follow-up|0|||
124470327|NCT03179436|447678112|FG002|Overall Study|Lost to Follow-up|0|||
124713743|NCT00856635|448577649|FG000|Overall Study|Lost to Follow-up|2|||
124713744|NCT00856635|448577650|FG001|Overall Study|Lost to Follow-up|5|||
124713745|NCT00856635|448577649|FG000|Overall Study|Pregnancy|1|||
124713746|NCT00856635|448577650|FG001|Overall Study|Pregnancy|0|||
124470328|NCT03179436|447678113|FG003|Overall Study|Lost to Follow-up|1|||
124470329|NCT03179436|447678114|FG004|Overall Study|Lost to Follow-up|0|||
124470330|NCT03179436|447678115|FG005|Overall Study|Lost to Follow-up|1|||
124470331|NCT03179436|447678116|FG006|Overall Study|Lost to Follow-up|0|||
124552450|NCT01222715|447980358|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
124552451|NCT01222715|447980357|FG000|Overall Study|Ineligible|0|||
124552452|NCT01222715|447980358|FG001|Overall Study|Ineligible|1|||
124552453|NCT01222715|447980357|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
124552454|NCT01222715|447980358|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
124552455|NCT03372369|447980359|FG000|Qualification Period|Withdrawal by Subject|16|||
124552456|NCT03372369|447980360|FG001|Qualification Period|Withdrawal by Subject|13|||
124552457|NCT03372369|447980359|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
124552458|NCT03372369|447980360|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
124552459|NCT03372369|447980359|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
124552460|NCT03372369|447980360|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
124552461|NCT02239601|447980361|FG000|Overall Study|Withdrawal by Subject|3|||
124552462|NCT02239601|447980362|FG001|Overall Study|Withdrawal by Subject|4|||
124552463|NCT02239601|447980361|FG000|Overall Study|Protocol Violation|4|||
124552464|NCT02239601|447980362|FG001|Overall Study|Protocol Violation|2|||
124552465|NCT04682639|447980363|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
124552466|NCT04682639|447980364|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
124552467|NCT04682639|447980365|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
124552468|NCT04682639|447980366|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
124552469|NCT04682639|447980367|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
124552470|NCT04682639|447980363|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
124552471|NCT04682639|447980364|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
124552472|NCT04682639|447980365|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
124552473|NCT04682639|447980366|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124552474|NCT04682639|447980367|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124552475|NCT04682639|447980363|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
124552476|NCT04682639|447980364|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
124552477|NCT04682639|447980365|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124552478|NCT04682639|447980366|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124552479|NCT04682639|447980367|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124552480|NCT04682639|447980363|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
124552481|NCT04682639|447980364|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
124552482|NCT04682639|447980365|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
124552483|NCT04682639|447980366|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
124470332|NCT03179436|447678117|FG007|Overall Study|Lost to Follow-up|0|||
124470333|NCT03179436|447678118|FG008|Overall Study|Lost to Follow-up|1|||
124470334|NCT03179436|447678119|FG009|Overall Study|Lost to Follow-up|1|||
124470335|NCT03179436|447678120|FG010|Overall Study|Lost to Follow-up|0|||
124470336|NCT03179436|447678121|FG011|Overall Study|Lost to Follow-up|0|||
124470337|NCT03179436|447678110|FG000|Overall Study|Death|12|||
124470338|NCT03179436|447678111|FG001|Overall Study|Death|17|||
124470339|NCT03179436|447678112|FG002|Overall Study|Death|7|||
124552484|NCT04682639|447980367|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
124552485|NCT04682639|447980363|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
124552486|NCT04682639|447980364|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
124552487|NCT04682639|447980365|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
124552488|NCT04682639|447980366|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
124552489|NCT04682639|447980367|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
124552490|NCT04682639|447980363|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
124552491|NCT04682639|447980364|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
124552492|NCT04682639|447980365|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
124552493|NCT04682639|447980366|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
124552494|NCT04682639|447980367|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
124552495|NCT04682639|447980363|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
124552496|NCT04682639|447980364|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
124552497|NCT04682639|447980365|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
124552498|NCT04682639|447980366|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
124713747|NCT00856635|448577649|FG000|Overall Study|Withdrawal by Subject|3|||
124713748|NCT00856635|448577650|FG001|Overall Study|Withdrawal by Subject|1|||
124713749|NCT00856635|448577649|FG000|Overall Study|Serious Adverse Event|1|||
124713750|NCT00856635|448577650|FG001|Overall Study|Serious Adverse Event|0|||
124713751|NCT00856635|448577649|FG000|Overall Study|Other|1|||
124713752|NCT00856635|448577650|FG001|Overall Study|Other|0|||
124713753|NCT00856635|448577649|FG000|Overall Study|Discontinued at Randomization|2|||
124713754|NCT00856635|448577650|FG001|Overall Study|Discontinued at Randomization|2|||
124713755|NCT01244035|448577652|FG000|Part 1: Period 1|Adverse Event|0|||
124713756|NCT01244035|448577653|FG001|Part 1: Period 1|Adverse Event|0|||
124713757|NCT01244035|448577654|FG002|Part 1: Period 1|Adverse Event|0|||
124713758|NCT01244035|448577655|FG003|Part 1: Period 1|Adverse Event|0|||
124713759|NCT01244035|448577656|FG004|Part 1: Period 1|Adverse Event|0|||
124713760|NCT01244035|448577657|FG005|Part 1: Period 1|Adverse Event|1|||
124713761|NCT01244035|448577652|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
124713762|NCT01244035|448577653|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
124713763|NCT01244035|448577654|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
124713764|NCT01244035|448577655|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
124713765|NCT01244035|448577656|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
124713766|NCT01244035|448577657|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
124552499|NCT04682639|447980367|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
124552500|NCT04682639|447980363|FG000|OLE Period (28 Weeks)|Other|1|||
124713767|NCT01244035|448577652|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
124713768|NCT01244035|448577653|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
124975645|NCT02579772|449536645|FG001|Overall Study|Withdrawal by Subject|1|||
124975646|NCT02579772|449536644|FG000|Overall Study|Usage of additional antioxidants|1|||
124975647|NCT02579772|449536645|FG001|Overall Study|Usage of additional antioxidants|0|||
124975648|NCT02579772|449536644|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
124975649|NCT02579772|449536645|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
124975650|NCT04991753|449538506|FG000|Overall Study|Withdrawal by Subject|0|||
124975651|NCT04991753|449538507|FG001|Overall Study|Withdrawal by Subject|1|||
124975652|NCT03299049|449538510|FG000|Overall Study|On-going|486|||
124975653|NCT03299049|449538511|FG001|Overall Study|On-going|481|||
124975654|NCT03299049|449538510|FG000|Overall Study|Withdrawal by Subject|6|||
124975655|NCT03299049|449538511|FG001|Overall Study|Withdrawal by Subject|21|||
124975656|NCT03299049|449538510|FG000|Overall Study|Physician Decision|5|||
124975657|NCT03299049|449538511|FG001|Overall Study|Physician Decision|1|||
124975658|NCT03299049|449538510|FG000|Overall Study|Lost to Follow-up|2|||
124975659|NCT03299049|449538511|FG001|Overall Study|Lost to Follow-up|0|||
124975660|NCT03299049|449538510|FG000|Overall Study|Pregnancy|1|||
124975661|NCT03299049|449538511|FG001|Overall Study|Pregnancy|3|||
124975662|NCT03299049|449538510|FG000|Overall Study|Protocol Violation|1|||
124975663|NCT03299049|449538511|FG001|Overall Study|Protocol Violation|1|||
124975664|NCT03299049|449538510|FG000|Overall Study|Lack of Efficacy|9|||
124975665|NCT03299049|449538511|FG001|Overall Study|Lack of Efficacy|3|||
124975666|NCT03299049|449538510|FG000|Overall Study|Adverse Event|12|||
124975667|NCT03299049|449538511|FG001|Overall Study|Adverse Event|13|||
124975668|NCT01901419|449538512|FG000|Overall Study|Protocol Violation|2|||
124975669|NCT01901419|449538513|FG001|Overall Study|Protocol Violation|6|||
124975670|NCT01901419|449538512|FG000|Overall Study|unavailable researchers|6|||
124975671|NCT01901419|449538513|FG001|Overall Study|unavailable researchers|3|||
124975672|NCT01667926|449538518|FG000|Overall Study|Withdrawal by Subject|1|||
124470340|NCT03179436|447678113|FG003|Overall Study|Death|32|||
124470341|NCT03179436|447678114|FG004|Overall Study|Death|29|||
124470342|NCT03179436|447678115|FG005|Overall Study|Death|30|||
124470343|NCT03179436|447678116|FG006|Overall Study|Death|33|||
124470344|NCT03179436|447678117|FG007|Overall Study|Death|9|||
124470345|NCT03179436|447678118|FG008|Overall Study|Death|84|||
124470346|NCT03179436|447678119|FG009|Overall Study|Death|33|||
124470347|NCT03179436|447678120|FG010|Overall Study|Death|22|||
124470348|NCT03179436|447678121|FG011|Overall Study|Death|15|||
124470349|NCT01877083|447678125|FG000|Treatment Phase|Disease Progression|10|||
124470350|NCT01877083|447678125|FG000|Treatment Phase|Clinical Progression|1|||
124470351|NCT01877083|447678125|FG000|Treatment Phase|Adverse Event|6|||
124470352|NCT01877083|447678125|FG000|Treatment Phase|Withdrawal by Subject|2|||
124470353|NCT01877083|447678125|FG000|Treatment Phase|Lost to Follow-up|1|||
124470354|NCT01877083|447678125|FG000|Extension Phase|Disease Progression|3|||
124470355|NCT01877083|447678125|FG000|Extension Phase|Adverse Event|2|||
124470356|NCT00429585|447678126|FG000|Overall Study|Death|1|||
124470357|NCT00429585|447678127|FG001|Overall Study|Death|0|||
124470358|NCT00429585|447678126|FG000|Overall Study|Lost to Follow-up|27|||
124470359|NCT00429585|447678127|FG001|Overall Study|Lost to Follow-up|20|||
124470360|NCT00429585|447678126|FG000|Overall Study|Physician Decision|2|||
124470361|NCT00429585|447678127|FG001|Overall Study|Physician Decision|0|||
124470362|NCT01227902|447679871|FG000|Overall Study|Adverse Event|12|||
124470363|NCT01227902|447679872|FG001|Overall Study|Adverse Event|8|||
124470364|NCT01227902|447679873|FG002|Overall Study|Adverse Event|11|||
124470365|NCT01227902|447679874|FG003|Overall Study|Adverse Event|4|||
124470366|NCT01227902|447679871|FG000|Overall Study|Lack of Efficacy|1|||
124470367|NCT01227902|447679872|FG001|Overall Study|Lack of Efficacy|2|||
124470368|NCT01227902|447679873|FG002|Overall Study|Lack of Efficacy|2|||
124470369|NCT01227902|447679874|FG003|Overall Study|Lack of Efficacy|1|||
124470370|NCT01227902|447679871|FG000|Overall Study|Protocol Violation|1|||
124470371|NCT01227902|447679872|FG001|Overall Study|Protocol Violation|0|||
124470372|NCT01227902|447679873|FG002|Overall Study|Protocol Violation|0|||
124470373|NCT01227902|447679874|FG003|Overall Study|Protocol Violation|0|||
124470374|NCT01227902|447679871|FG000|Overall Study|Lost to Follow-up|0|||
124470375|NCT01227902|447679872|FG001|Overall Study|Lost to Follow-up|0|||
124470376|NCT01227902|447679873|FG002|Overall Study|Lost to Follow-up|1|||
124470377|NCT01227902|447679874|FG003|Overall Study|Lost to Follow-up|2|||
124470378|NCT01227902|447679871|FG000|Overall Study|Physician Decision|0|||
124470379|NCT01227902|447679872|FG001|Overall Study|Physician Decision|1|||
124470380|NCT01227902|447679873|FG002|Overall Study|Physician Decision|1|||
124470381|NCT01227902|447679874|FG003|Overall Study|Physician Decision|0|||
124470382|NCT01227902|447679871|FG000|Overall Study|Withdrawal by Subject|4|||
124470383|NCT01227902|447679872|FG001|Overall Study|Withdrawal by Subject|2|||
124470384|NCT01227902|447679873|FG002|Overall Study|Withdrawal by Subject|4|||
124470385|NCT01227902|447679874|FG003|Overall Study|Withdrawal by Subject|3|||
124470386|NCT04002310|447679875|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
124470387|NCT04002310|447679876|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
124470388|NCT04002310|447679877|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
124470389|NCT04002310|447679878|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
124470390|NCT04002310|447679879|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
124470391|NCT00542997|447679880|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
124470392|NCT00542997|447679880|FG000|Wash in / Wash Out Period|Adverse Event|3|||
124470393|NCT00542997|447679880|FG000|Efficacy Period|Adverse Event|3|||
124470394|NCT02949128|447679883|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
124470395|NCT02949128|447679883|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
124552501|NCT04682639|447980364|FG001|OLE Period (28 Weeks)|Other|2|||
124552502|NCT04682639|447980365|FG002|OLE Period (28 Weeks)|Other|0|||
124552503|NCT04682639|447980366|FG003|OLE Period (28 Weeks)|Other|0|||
124713769|NCT01244035|448577654|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
124713770|NCT01244035|448577655|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
124713771|NCT01244035|448577656|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
124713772|NCT01244035|448577657|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
124713773|NCT01244035|448577652|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
124470396|NCT02949128|447679883|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
124470397|NCT02949128|447679883|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
124470398|NCT02949128|447679883|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
124470399|NCT02949128|447679883|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
124470400|NCT02949128|447679883|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
124470401|NCT02949128|447679883|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
124470402|NCT02949128|447679883|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
124470403|NCT02949128|447679883|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
124552504|NCT04682639|447980367|FG004|OLE Period (28 Weeks)|Other|1|||
124470404|NCT03160560|447679889|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
124470405|NCT03160560|447679890|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
124470406|NCT03160560|447679891|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
124470407|NCT03160560|447679892|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
124470408|NCT03160560|447679889|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
124713774|NCT01244035|448577653|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
124470409|NCT03160560|447679890|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
124470410|NCT03160560|447679891|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
124470411|NCT03160560|447679892|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
124470412|NCT02002975|447679897|FG000|Overall Study|Case Report Forms Uncollected|135|||
124470413|NCT02002975|447679897|FG000|Overall Study|Protocol Deviation|437|||
124470414|NCT01430442|447679900|FG000|Overall Study|Subject Withdrew Consent|3|||
124470415|NCT01430442|447679901|FG001|Overall Study|Subject Withdrew Consent|0|||
124470416|NCT01430442|447679902|FG002|Overall Study|Subject Withdrew Consent|1|||
124470417|NCT01430442|447679903|FG003|Overall Study|Subject Withdrew Consent|0|||
124470418|NCT01430442|447679904|FG004|Overall Study|Subject Withdrew Consent|2|||
124470419|NCT01430442|447679905|FG005|Overall Study|Subject Withdrew Consent|1|||
124470420|NCT01430442|447679906|FG006|Overall Study|Subject Withdrew Consent|5|||
124470421|NCT01430442|447679907|FG007|Overall Study|Subject Withdrew Consent|2|||
124470422|NCT01430442|447679900|FG000|Overall Study|Lost to Follow-up|2|||
124470423|NCT01430442|447679901|FG001|Overall Study|Lost to Follow-up|0|||
124470424|NCT01430442|447679902|FG002|Overall Study|Lost to Follow-up|1|||
124470425|NCT01430442|447679903|FG003|Overall Study|Lost to Follow-up|2|||
124470426|NCT01430442|447679904|FG004|Overall Study|Lost to Follow-up|2|||
124470427|NCT01430442|447679905|FG005|Overall Study|Lost to Follow-up|1|||
124470428|NCT01430442|447679906|FG006|Overall Study|Lost to Follow-up|5|||
124470429|NCT01430442|447679907|FG007|Overall Study|Lost to Follow-up|1|||
124470430|NCT01430442|447679900|FG000|Overall Study|Pregnancy|1|||
124470431|NCT01430442|447679901|FG001|Overall Study|Pregnancy|0|||
124470432|NCT01430442|447679902|FG002|Overall Study|Pregnancy|0|||
124470433|NCT01430442|447679903|FG003|Overall Study|Pregnancy|0|||
124470434|NCT01430442|447679904|FG004|Overall Study|Pregnancy|0|||
124470435|NCT01430442|447679905|FG005|Overall Study|Pregnancy|1|||
124470436|NCT01430442|447679906|FG006|Overall Study|Pregnancy|0|||
124470437|NCT01430442|447679907|FG007|Overall Study|Pregnancy|0|||
124470438|NCT01430442|447679900|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
124470439|NCT01430442|447679901|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
124470440|NCT01430442|447679902|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
124470441|NCT01430442|447679903|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
124470442|NCT01430442|447679904|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
124470443|NCT01430442|447679905|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
124470444|NCT01430442|447679906|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
124470445|NCT01430442|447679907|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
124470446|NCT01641939|447679908|FG000|Overall Study|Death|90|||
124470447|NCT01641939|447679909|FG001|Overall Study|Death|187|||
124470448|NCT01641939|447679910|FG002|Overall Study|Death|61|||
124470449|NCT01641939|447679908|FG000|Overall Study|Lost to Follow-up|3|||
124470450|NCT01641939|447679909|FG001|Overall Study|Lost to Follow-up|2|||
124470451|NCT01641939|447679910|FG002|Overall Study|Lost to Follow-up|1|||
124470452|NCT01641939|447679908|FG000|Overall Study|Withdrawal by Subject|14|||
124470453|NCT01641939|447679909|FG001|Overall Study|Withdrawal by Subject|11|||
124470454|NCT01641939|447679910|FG002|Overall Study|Withdrawal by Subject|5|||
124470455|NCT01641939|447679908|FG000|Overall Study|Study Terminated by Sponsor|10|||
124470456|NCT01641939|447679909|FG001|Overall Study|Study Terminated by Sponsor|28|||
124470457|NCT01641939|447679910|FG002|Overall Study|Study Terminated by Sponsor|3|||
124470458|NCT02971202|447679915|FG000|Overall Study|Pregnancy|1|||
124470459|NCT02971202|447679916|FG001|Overall Study|Pregnancy|0|||
124470460|NCT02971202|447679917|FG002|Overall Study|Pregnancy|0|||
124470461|NCT02971202|447679915|FG000|Overall Study|screen fail after consent|1|||
124470462|NCT02971202|447679916|FG001|Overall Study|screen fail after consent|0|||
124470463|NCT02971202|447679917|FG002|Overall Study|screen fail after consent|1|||
124470464|NCT02634580|447679918|FG000|Double-blind Treatment Period|Subject Request|1|||
124470465|NCT02634580|447679919|FG001|Double-blind Treatment Period|Subject Request|0|||
124470466|NCT02634580|447679920|FG002|Double-blind Treatment Period|Subject Request|1|||
124470467|NCT02634580|447679921|FG003|Double-blind Treatment Period|Subject Request|1|||
124470468|NCT02634580|447679918|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
124470469|NCT02634580|447679919|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
124470470|NCT02634580|447679920|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
124470471|NCT02634580|447679921|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
124470472|NCT05425563|447679923|FG000|Overall Study|Withdrawal by Subject|17|||
124470473|NCT04652804|447679927|FG000|Overall Study|Ineligible post randomization|1|||
124470474|NCT04652804|447679928|FG001|Overall Study|Ineligible post randomization|0|||
124470475|NCT04652804|447679929|FG002|Overall Study|Ineligible post randomization|1|||
124470476|NCT04652804|447679930|FG003|Overall Study|Ineligible post randomization|0|||
124470477|NCT04652804|447679931|FG004|Overall Study|Ineligible post randomization|1|||
124470478|NCT04652804|447679932|FG005|Overall Study|Ineligible post randomization|1|||
124470479|NCT04652804|447679927|FG000|Overall Study|Missing SVR lab results|2|||
124470480|NCT04652804|447679928|FG001|Overall Study|Missing SVR lab results|0|||
124470481|NCT04652804|447679929|FG002|Overall Study|Missing SVR lab results|0|||
124470482|NCT04652804|447679930|FG003|Overall Study|Missing SVR lab results|0|||
124470483|NCT04652804|447679931|FG004|Overall Study|Missing SVR lab results|0|||
124470484|NCT04652804|447679932|FG005|Overall Study|Missing SVR lab results|0|||
124470485|NCT00584194|447679933|FG000|Overall Study|Other|135|||
124470486|NCT04093531|447679934|FG000|Overall Study|failed screening|4|||
124470487|NCT02918019|447679935|FG000|Overall Study|Death|0|||
124470488|NCT02918019|447679936|FG001|Overall Study|Death|0|||
124470489|NCT02918019|447679937|FG002|Overall Study|Death|1|||
124470490|NCT02918019|447679938|FG003|Overall Study|Death|0|||
124470491|NCT02918019|447679935|FG000|Overall Study|Lost to Follow-up|1|||
124470492|NCT02918019|447679936|FG001|Overall Study|Lost to Follow-up|1|||
124470493|NCT02918019|447679937|FG002|Overall Study|Lost to Follow-up|0|||
124470494|NCT02918019|447679938|FG003|Overall Study|Lost to Follow-up|1|||
124470495|NCT02918019|447679935|FG000|Overall Study|Principal investigator request|0|||
124470496|NCT02918019|447679936|FG001|Overall Study|Principal investigator request|0|||
124470497|NCT02918019|447679937|FG002|Overall Study|Principal investigator request|0|||
124470498|NCT02918019|447679938|FG003|Overall Study|Principal investigator request|1|||
124470499|NCT02918019|447679935|FG000|Overall Study|Physician Decision|1|||
124470500|NCT02918019|447679936|FG001|Overall Study|Physician Decision|3|||
124470501|NCT02918019|447679937|FG002|Overall Study|Physician Decision|2|||
124470502|NCT02918019|447679938|FG003|Overall Study|Physician Decision|0|||
124470503|NCT02918019|447679935|FG000|Overall Study|Protocol deviation|1|||
124470504|NCT02918019|447679936|FG001|Overall Study|Protocol deviation|1|||
124470505|NCT02918019|447679937|FG002|Overall Study|Protocol deviation|0|||
124470506|NCT02918019|447679938|FG003|Overall Study|Protocol deviation|2|||
124470507|NCT02918019|447679935|FG000|Overall Study|Withdrawal by Subject|3|||
124470508|NCT02918019|447679936|FG001|Overall Study|Withdrawal by Subject|4|||
124470509|NCT02918019|447679937|FG002|Overall Study|Withdrawal by Subject|6|||
124470510|NCT02918019|447679938|FG003|Overall Study|Withdrawal by Subject|4|||
124470511|NCT02918019|447679935|FG000|Overall Study|Adverse Event|0|||
124470512|NCT02918019|447679936|FG001|Overall Study|Adverse Event|1|||
124470513|NCT02918019|447679937|FG002|Overall Study|Adverse Event|0|||
124470514|NCT02918019|447679938|FG003|Overall Study|Adverse Event|1|||
124470515|NCT01212185|447679939|FG000|Overall Study|Protocol Violation|2|||
124470516|NCT01212185|447679940|FG001|Overall Study|Protocol Violation|1|||
124470517|NCT03222349|447679941|FG000|Overall Study|Treatment B not done|5|||
124470518|NCT03222349|447679942|FG001|Overall Study|Treatment B not done|0|||
124470519|NCT03222349|447679941|FG000|Overall Study|Lost to Follow-up|1|||
124470520|NCT03222349|447679942|FG001|Overall Study|Lost to Follow-up|2|||
124552505|NCT04682639|447980363|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
124552506|NCT04682639|447980364|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
124552507|NCT04682639|447980365|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
124552508|NCT04682639|447980366|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
124552509|NCT04682639|447980367|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
124470521|NCT03222349|447679941|FG000|Overall Study|Withdrawal by Subject|1|||
124470522|NCT03222349|447679942|FG001|Overall Study|Withdrawal by Subject|0|||
124470523|NCT03222349|447679941|FG000|Overall Study|Treatment A not done|0|||
124470524|NCT03222349|447679942|FG001|Overall Study|Treatment A not done|5|||
124470525|NCT03222349|447679941|FG000|Overall Study|Study terminated by sponsor|1|||
124470526|NCT03222349|447679942|FG001|Overall Study|Study terminated by sponsor|0|||
124470527|NCT00094757|447679946|FG000|Overall Study|Adverse Event|11|||
124470528|NCT00094757|447679947|FG001|Overall Study|Adverse Event|9|||
124470529|NCT00094757|447679948|FG002|Overall Study|Adverse Event|6|||
124470530|NCT00094757|447679946|FG000|Overall Study|Lack of Efficacy|11|||
124470531|NCT00094757|447679947|FG001|Overall Study|Lack of Efficacy|15|||
124470532|NCT00094757|447679948|FG002|Overall Study|Lack of Efficacy|8|||
124470533|NCT00094757|447679946|FG000|Overall Study|Lost to Follow-up|3|||
124470534|NCT00094757|447679947|FG001|Overall Study|Lost to Follow-up|5|||
124470535|NCT00094757|447679948|FG002|Overall Study|Lost to Follow-up|6|||
124470536|NCT00094757|447679946|FG000|Overall Study|Patient Moved|2|||
124470537|NCT00094757|447679947|FG001|Overall Study|Patient Moved|1|||
124470538|NCT00094757|447679948|FG002|Overall Study|Patient Moved|1|||
124470539|NCT00094757|447679946|FG000|Overall Study|Protocol Violation|8|||
124470540|NCT00094757|447679947|FG001|Overall Study|Protocol Violation|5|||
124470541|NCT00094757|447679948|FG002|Overall Study|Protocol Violation|3|||
124470542|NCT00094757|447679946|FG000|Overall Study|Withdrawal by Subject|14|||
124470543|NCT00094757|447679947|FG001|Overall Study|Withdrawal by Subject|21|||
124470544|NCT00094757|447679948|FG002|Overall Study|Withdrawal by Subject|5|||
124470545|NCT00094757|447679946|FG000|Overall Study|Other|3|||
124470546|NCT00094757|447679947|FG001|Overall Study|Other|3|||
124470547|NCT00094757|447679948|FG002|Overall Study|Other|1|||
124470548|NCT00094757|447679946|FG000|Overall Study|Protocol specified discontinuation|1|||
124470549|NCT00094757|447679947|FG001|Overall Study|Protocol specified discontinuation|3|||
124470550|NCT00094757|447679948|FG002|Overall Study|Protocol specified discontinuation|0|||
124470551|NCT01808612|447679949|FG000|Treatment Period|Adverse Event|8|||
124470552|NCT01808612|447679950|FG001|Treatment Period|Adverse Event|4|||
124470553|NCT01808612|447679951|FG002|Treatment Period|Adverse Event|3|||
124470554|NCT01808612|447679949|FG000|Treatment Period|Lost to Follow-up|2|||
124470555|NCT01808612|447679950|FG001|Treatment Period|Lost to Follow-up|2|||
124470556|NCT01808612|447679951|FG002|Treatment Period|Lost to Follow-up|1|||
124470557|NCT01808612|447679949|FG000|Treatment Period|Protocol Violation|1|||
124470558|NCT01808612|447679950|FG001|Treatment Period|Protocol Violation|0|||
124470559|NCT01808612|447679951|FG002|Treatment Period|Protocol Violation|0|||
124470560|NCT01808612|447679949|FG000|Treatment Period|Withdrawal by Subject|1|||
124470561|NCT01808612|447679950|FG001|Treatment Period|Withdrawal by Subject|0|||
124470562|NCT01808612|447679951|FG002|Treatment Period|Withdrawal by Subject|4|||
124470563|NCT01808612|447679949|FG000|Treatment Period|Physician Decision|1|||
124552510|NCT04682639|447980363|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
124552511|NCT04682639|447980364|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
124470564|NCT01808612|447679950|FG001|Treatment Period|Physician Decision|0|||
124470565|NCT01808612|447679951|FG002|Treatment Period|Physician Decision|4|||
124470566|NCT01808612|447679949|FG000|Treatment Period|Sponsor Decision|1|||
124470567|NCT01808612|447679950|FG001|Treatment Period|Sponsor Decision|0|||
124470568|NCT01808612|447679951|FG002|Treatment Period|Sponsor Decision|0|||
124470569|NCT01808612|447679949|FG000|Treatment Period|Lack of Efficacy|1|||
124470570|NCT01808612|447679950|FG001|Treatment Period|Lack of Efficacy|1|||
124552512|NCT04682639|447980365|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
124552513|NCT04682639|447980366|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
124552514|NCT04682639|447980367|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
124552515|NCT04682639|447980363|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
124552516|NCT04682639|447980364|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
124552517|NCT04682639|447980365|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
124552518|NCT04682639|447980366|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
124713775|NCT01244035|448577654|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
124713776|NCT01244035|448577655|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
124713777|NCT01244035|448577656|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
124552519|NCT04682639|447980367|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
124552520|NCT04682639|447980363|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
124552521|NCT04682639|447980364|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
124552522|NCT04682639|447980365|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
124552523|NCT04682639|447980366|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
124552524|NCT04682639|447980367|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
124552525|NCT01392170|447980368|FG000|Overall Study|Withdrawal by Subject|1|||
124552526|NCT01392170|447980368|FG000|Overall Study|Ineligible|1|||
124552527|NCT02748616|447980386|FG000|Overall Study|Lost to Follow-up|1|||
124552528|NCT02748616|447980386|FG000|Overall Study|Withdrawal by Subject|2|||
124552529|NCT02748616|447980386|FG000|Overall Study|Physician Decision|2|||
124552530|NCT02748616|447980386|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
124552531|NCT00589693|447980387|FG000|Overall Study|randomized in error|12|||
124552532|NCT00589693|447980388|FG001|Overall Study|randomized in error|6|||
124552533|NCT00589693|447980387|FG000|Overall Study|Adverse Event|4|||
124552534|NCT00589693|447980388|FG001|Overall Study|Adverse Event|4|||
124552535|NCT00589693|447980387|FG000|Overall Study|Death|26|||
124552536|NCT00589693|447980388|FG001|Overall Study|Death|16|||
124552537|NCT00589693|447980387|FG000|Overall Study|Lack of Efficacy|0|||
124552538|NCT00589693|447980388|FG001|Overall Study|Lack of Efficacy|1|||
124552539|NCT00589693|447980387|FG000|Overall Study|Lost to Follow-up|1|||
124552540|NCT00589693|447980388|FG001|Overall Study|Lost to Follow-up|0|||
124552541|NCT00589693|447980387|FG000|Overall Study|Physician Decision|0|||
124552542|NCT00589693|447980388|FG001|Overall Study|Physician Decision|1|||
124552543|NCT00589693|447980387|FG000|Overall Study|Protocol Violation|1|||
124552544|NCT00589693|447980388|FG001|Overall Study|Protocol Violation|1|||
124552545|NCT00054275|447980389|FG000|Overall Study|Withdrawal by Subject|4|||
124552546|NCT00054275|447980389|FG000|Overall Study|Adverse Event|5|||
124552547|NCT00054275|447980389|FG000|Overall Study|Progressive disease in cycle 1|1|||
124552548|NCT00054275|447980389|FG000|Overall Study|Physician Decision|1|||
124552549|NCT02030834|447980397|FG000|Overall Study|Death|4|||
124552550|NCT02030834|447980398|FG001|Overall Study|Death|0|||
124552551|NCT02030834|447980399|FG002|Overall Study|Death|0|||
124552552|NCT02030834|447980397|FG000|Overall Study|Manufacturing failure|2|||
124552553|NCT02030834|447980398|FG001|Overall Study|Manufacturing failure|0|||
124552554|NCT02030834|447980399|FG002|Overall Study|Manufacturing failure|1|||
124552555|NCT02030834|447980397|FG000|Overall Study|Disease progression|2|||
124552556|NCT02030834|447980398|FG001|Overall Study|Disease progression|0|||
124552557|NCT02030834|447980399|FG002|Overall Study|Disease progression|2|||
124552558|NCT02030834|447980397|FG000|Overall Study|Lost to Follow-up|1|||
124552559|NCT02030834|447980398|FG001|Overall Study|Lost to Follow-up|0|||
124552560|NCT02030834|447980399|FG002|Overall Study|Lost to Follow-up|0|||
124552561|NCT02030834|447980397|FG000|Overall Study|Withdrawal by Subject|1|||
124552562|NCT02030834|447980398|FG001|Overall Study|Withdrawal by Subject|0|||
124552563|NCT02030834|447980399|FG002|Overall Study|Withdrawal by Subject|0|||
124552564|NCT02030834|447980397|FG000|Overall Study|Lack of funding|1|||
124552565|NCT02030834|447980398|FG001|Overall Study|Lack of funding|0|||
124552566|NCT02030834|447980399|FG002|Overall Study|Lack of funding|0|||
124713778|NCT01244035|448577657|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
124975673|NCT01667926|449538519|FG001|Overall Study|Withdrawal by Subject|2|||
124975674|NCT01667926|449538520|FG002|Overall Study|Withdrawal by Subject|2|||
124975675|NCT01667926|449538518|FG000|Overall Study|Physician Decision|0|||
124975676|NCT01667926|449538519|FG001|Overall Study|Physician Decision|0|||
124975677|NCT01667926|449538520|FG002|Overall Study|Physician Decision|1|||
124975678|NCT01667926|449538518|FG000|Overall Study|Time committment|0|||
124975679|NCT01667926|449538519|FG001|Overall Study|Time committment|0|||
124975680|NCT01667926|449538520|FG002|Overall Study|Time committment|2|||
124975681|NCT01667926|449538518|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
124975682|NCT01667926|449538519|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
124975683|NCT01667926|449538520|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
124975684|NCT01667926|449538518|FG000|Overall Study|Lost to Follow-up|1|||
124975685|NCT01667926|449538519|FG001|Overall Study|Lost to Follow-up|2|||
124975686|NCT01667926|449538520|FG002|Overall Study|Lost to Follow-up|1|||
124975687|NCT01667926|449538518|FG000|Overall Study|Side effects|3|||
124975688|NCT01667926|449538519|FG001|Overall Study|Side effects|0|||
124975689|NCT01667926|449538520|FG002|Overall Study|Side effects|0|||
124975690|NCT01088984|449538525|FG000|Phase 1|Death|2|||
124975691|NCT01088984|449538526|FG001|Phase 1|Death|1|||
124470571|NCT01808612|447679951|FG002|Treatment Period|Lack of Efficacy|2|||
124470572|NCT01808612|447679949|FG000|Discontinuation Period|Adverse Event|1|||
124470573|NCT01808612|447679950|FG001|Discontinuation Period|Adverse Event|0|||
124470574|NCT01808612|447679951|FG002|Discontinuation Period|Adverse Event|0|||
124470575|NCT01808612|447679949|FG000|Discontinuation Period|Physician Decision|1|||
124470576|NCT01808612|447679950|FG001|Discontinuation Period|Physician Decision|0|||
124470577|NCT01808612|447679951|FG002|Discontinuation Period|Physician Decision|0|||
124975692|NCT01088984|449538525|FG000|Phase 1|Disease Progression|2|||
124975693|NCT01088984|449538526|FG001|Phase 1|Disease Progression|4|||
124975694|NCT01088984|449538525|FG000|Phase 1|Other|1|||
124975695|NCT01088984|449538526|FG001|Phase 1|Other|1|||
124975696|NCT01088984|449538525|FG000|Phase 2|Death|0|||
124975697|NCT01088984|449538526|FG001|Phase 2|Death|5|||
124975698|NCT01088984|449538525|FG000|Phase 2|Withdrawal by Subject|0|||
124975699|NCT01088984|449538526|FG001|Phase 2|Withdrawal by Subject|1|||
124975700|NCT01088984|449538525|FG000|Phase 2|DIsease Progression|0|||
124975701|NCT01088984|449538526|FG001|Phase 2|DIsease Progression|25|||
124975702|NCT01088984|449538525|FG000|Phase 2|Other|0|||
124975703|NCT01088984|449538526|FG001|Phase 2|Other|1|||
124975704|NCT04707664|449538527|FG000|Overall Study|Adverse Event|2|||
124975705|NCT04707664|449538528|FG001|Overall Study|Adverse Event|0|||
124975706|NCT04707664|449538527|FG000|Overall Study|Death|1|||
124975707|NCT04707664|449538528|FG001|Overall Study|Death|2|||
124975708|NCT04707664|449538527|FG000|Overall Study|Withdrawal by Subject|13|||
124975709|NCT04707664|449538528|FG001|Overall Study|Withdrawal by Subject|21|||
124975710|NCT04707664|449538527|FG000|Overall Study|Lost to Follow-up|11|||
124975711|NCT04707664|449538528|FG001|Overall Study|Lost to Follow-up|13|||
124975712|NCT04707664|449538527|FG000|Overall Study|Not treated|2|||
124975713|NCT04707664|449538528|FG001|Overall Study|Not treated|0|||
124975714|NCT00699153|449538529|FG000|Overall Study|Lost to Follow-up|1|||
124975715|NCT00699153|449538530|FG001|Overall Study|Lost to Follow-up|0|||
124975716|NCT00699153|449538529|FG000|Overall Study|Adverse Event|0|||
124975717|NCT00699153|449538530|FG001|Overall Study|Adverse Event|2|||
124975718|NCT00699153|449538529|FG000|Overall Study|Protocol Violation|1|||
124975719|NCT00699153|449538530|FG001|Overall Study|Protocol Violation|0|||
124975720|NCT00699153|449538529|FG000|Overall Study|Travel Problem|1|||
124975721|NCT00699153|449538530|FG001|Overall Study|Travel Problem|0|||
124975722|NCT02412735|449538533|FG000|Overall Study|Adverse Event|0|||
124975723|NCT02412735|449538534|FG001|Overall Study|Adverse Event|1|||
124975724|NCT02412735|449538535|FG002|Overall Study|Adverse Event|2|||
124975725|NCT02412735|449538533|FG000|Overall Study|Withdrawal by Subject|23|||
124975726|NCT02412735|449538534|FG001|Overall Study|Withdrawal by Subject|27|||
124975727|NCT02412735|449538535|FG002|Overall Study|Withdrawal by Subject|22|||
124975728|NCT02412735|449538533|FG000|Overall Study|Investigator Decision|3|||
124975729|NCT02412735|449538534|FG001|Overall Study|Investigator Decision|3|||
124975730|NCT02412735|449538535|FG002|Overall Study|Investigator Decision|2|||
124975731|NCT02412735|449538533|FG000|Overall Study|Lost to Follow-up|17|||
124975732|NCT02412735|449538534|FG001|Overall Study|Lost to Follow-up|11|||
124975733|NCT02412735|449538535|FG002|Overall Study|Lost to Follow-up|18|||
124975734|NCT02412735|449538533|FG000|Overall Study|Reason not Specified|3|||
124975735|NCT02412735|449538534|FG001|Overall Study|Reason not Specified|2|||
124975736|NCT02412735|449538535|FG002|Overall Study|Reason not Specified|2|||
124975737|NCT02521363|449538536|FG000|Overall Study|Withdrawal by Subject|1|||
124975738|NCT02521363|449538537|FG001|Overall Study|Withdrawal by Subject|2|||
124975739|NCT03374488|449538538|FG000|Overall Study|Death|13|||
124975740|NCT03374488|449538539|FG001|Overall Study|Death|13|||
124975741|NCT03374488|449538538|FG000|Overall Study|Withdrawal by Subject|3|||
124975742|NCT03374488|449538539|FG001|Overall Study|Withdrawal by Subject|1|||
124975743|NCT03374488|449538538|FG000|Overall Study|Physician Decision|3|||
124975744|NCT03374488|449538539|FG001|Overall Study|Physician Decision|0|||
124975745|NCT01757197|449538540|FG000|Overall Study|Death|2|||
124975746|NCT01077128|449538543|FG000|Overall Study|Adverse Event|8|||
124975747|NCT01077128|449538543|FG000|Overall Study|Lack of Efficacy|1|||
124975748|NCT01077128|449538543|FG000|Overall Study|Disease exacerbation|1|||
124975749|NCT01077128|449538543|FG000|Overall Study|Adverse event and consent withdrawal|1|||
124470578|NCT01808612|447679949|FG000|Discontinuation Period|Lost to Follow-up|0|||
124470579|NCT01808612|447679950|FG001|Discontinuation Period|Lost to Follow-up|1|||
124470580|NCT01808612|447679951|FG002|Discontinuation Period|Lost to Follow-up|0|||
124470581|NCT00756938|447679952|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
124470582|NCT00756938|447679953|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
124470583|NCT00756938|447679954|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
124470584|NCT00756938|447679955|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
124470585|NCT00756938|447679952|FG000|12-week Base Study|Protocol Violation|0|||
124470586|NCT00756938|447679953|FG001|12-week Base Study|Protocol Violation|0|||
124470587|NCT00756938|447679954|FG002|12-week Base Study|Protocol Violation|1|||
124470588|NCT00756938|447679955|FG003|12-week Base Study|Protocol Violation|0|||
124470589|NCT00756938|447679952|FG000|12-week Base Study|Lost to Follow-up|1|||
124470590|NCT00756938|447679953|FG001|12-week Base Study|Lost to Follow-up|0|||
124470591|NCT00756938|447679954|FG002|12-week Base Study|Lost to Follow-up|0|||
124470592|NCT00756938|447679955|FG003|12-week Base Study|Lost to Follow-up|0|||
124470593|NCT00756938|447679952|FG000|Optional Extension|Lack of Efficacy|0|||
124470594|NCT00756938|447679953|FG001|Optional Extension|Lack of Efficacy|0|||
124713779|NCT01244035|448577652|FG000|Part 1: Period 3|Adverse Event|0|||
124713780|NCT01244035|448577653|FG001|Part 1: Period 3|Adverse Event|0|||
124470595|NCT00756938|447679954|FG002|Optional Extension|Lack of Efficacy|0|||
124470596|NCT00756938|447679955|FG003|Optional Extension|Lack of Efficacy|1|||
124713781|NCT01244035|448577654|FG002|Part 1: Period 3|Adverse Event|0|||
124713782|NCT01244035|448577655|FG003|Part 1: Period 3|Adverse Event|0|||
124470597|NCT00756938|447679952|FG000|Optional Extension|End of Study|0|||
124470598|NCT00756938|447679953|FG001|Optional Extension|End of Study|0|||
124470599|NCT00756938|447679954|FG002|Optional Extension|End of Study|0|||
124470600|NCT00756938|447679955|FG003|Optional Extension|End of Study|11|||
124470601|NCT00756938|447679952|FG000|Optional Extension|Protocol-specific criteria met|0|||
124470602|NCT00756938|447679953|FG001|Optional Extension|Protocol-specific criteria met|0|||
124470603|NCT00756938|447679954|FG002|Optional Extension|Protocol-specific criteria met|0|||
124470604|NCT00756938|447679955|FG003|Optional Extension|Protocol-specific criteria met|9|||
124713783|NCT01244035|448577656|FG004|Part 1: Period 3|Adverse Event|0|||
124470605|NCT00756938|447679952|FG000|Optional Extension|Physician Decision|0|||
124470606|NCT00756938|447679953|FG001|Optional Extension|Physician Decision|0|||
124470607|NCT00756938|447679954|FG002|Optional Extension|Physician Decision|0|||
124470608|NCT00756938|447679955|FG003|Optional Extension|Physician Decision|3|||
124470609|NCT00756938|447679952|FG000|Optional Extension|Lost to Follow-up|0|||
124470610|NCT00756938|447679953|FG001|Optional Extension|Lost to Follow-up|0|||
124470611|NCT00756938|447679954|FG002|Optional Extension|Lost to Follow-up|0|||
124470612|NCT00756938|447679955|FG003|Optional Extension|Lost to Follow-up|1|||
124470613|NCT00756938|447679952|FG000|Optional Extension|Protocol Violation|0|||
124470614|NCT00756938|447679953|FG001|Optional Extension|Protocol Violation|0|||
124470615|NCT00756938|447679954|FG002|Optional Extension|Protocol Violation|0|||
124470616|NCT00756938|447679955|FG003|Optional Extension|Protocol Violation|1|||
124470617|NCT00756938|447679952|FG000|Optional Extension|Withdrawal by Subject|0|||
124470618|NCT00756938|447679953|FG001|Optional Extension|Withdrawal by Subject|0|||
124470619|NCT00756938|447679954|FG002|Optional Extension|Withdrawal by Subject|0|||
124470620|NCT00756938|447679955|FG003|Optional Extension|Withdrawal by Subject|10|||
124470621|NCT00756938|447679952|FG000|Optional Extension|Adverse Event|0|||
124470622|NCT00756938|447679953|FG001|Optional Extension|Adverse Event|0|||
124470623|NCT00756938|447679954|FG002|Optional Extension|Adverse Event|0|||
124470624|NCT00756938|447679955|FG003|Optional Extension|Adverse Event|1|||
124470625|NCT01700192|447679956|FG000|Overall Study|Adverse Event|73|||
124470626|NCT01700192|447679957|FG001|Overall Study|Adverse Event|18|||
124470627|NCT01700192|447679956|FG000|Overall Study|Lack of Efficacy|1|||
124470628|NCT01700192|447679957|FG001|Overall Study|Lack of Efficacy|0|||
124470629|NCT01700192|447679956|FG000|Overall Study|Lost to Follow-up|42|||
124770530|NCT04408989|448788879|FG002|Overall Study|Withdrawal by Subject|2|||
124770531|NCT05082857|448788880|FG000|Overall Study|participants relocated and could not continue|2|||
124770532|NCT05082857|448788881|FG001|Overall Study|participants relocated and could not continue|1|||
124470630|NCT01700192|447679957|FG001|Overall Study|Lost to Follow-up|29|||
124470631|NCT01700192|447679956|FG000|Overall Study|Noncompliance with study drug|0|||
124470632|NCT01700192|447679957|FG001|Overall Study|Noncompliance with study drug|5|||
124470633|NCT01700192|447679956|FG000|Overall Study|Physician Decision|2|||
124470634|NCT01700192|447679957|FG001|Overall Study|Physician Decision|3|||
124470635|NCT01700192|447679956|FG000|Overall Study|Pregnancy|1|||
124470636|NCT01700192|447679957|FG001|Overall Study|Pregnancy|4|||
124552567|NCT04333199|447980404|FG000|Evaluated Patients|Lost to Follow-up|0|||
124552568|NCT04333199|447980405|FG001|Evaluated Patients|Lost to Follow-up|1|||
124552569|NCT04333199|447980406|FG002|Evaluated Patients|Lost to Follow-up|2|||
124552570|NCT01155284|447980415|FG000|Overall Study|Withdrawal by Subject|4|||
124552571|NCT01155284|447980416|FG001|Overall Study|Withdrawal by Subject|3|||
124552572|NCT01155284|447980415|FG000|Overall Study|Lost to Follow-up|1|||
124552573|NCT01155284|447980416|FG001|Overall Study|Lost to Follow-up|2|||
124552574|NCT01155284|447980415|FG000|Overall Study|Physician Decision|1|||
124552575|NCT01155284|447980416|FG001|Overall Study|Physician Decision|0|||
124552576|NCT01155284|447980415|FG000|Overall Study|Adverse Event|1|||
124552577|NCT01155284|447980416|FG001|Overall Study|Adverse Event|0|||
124552578|NCT01766310|447980417|FG000|Overall Study|Lost to Follow-up|1|||
124552579|NCT01766310|447980418|FG001|Overall Study|Lost to Follow-up|3|||
124552580|NCT01556490|447980427|FG000|Randomized Patients Summary|Protocol Violation|22|||
124552581|NCT01556490|447980428|FG001|Randomized Patients Summary|Protocol Violation|23|||
124552582|NCT01556490|447980427|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
124552583|NCT01556490|447980428|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
124552584|NCT04529499|447980434|FG000|Overall Study|Withdrawal by Subject|9|||
124552585|NCT04529499|447980435|FG001|Overall Study|Withdrawal by Subject|11|||
124552586|NCT04529499|447980434|FG000|Overall Study|Physician Decision|1|||
124552587|NCT04529499|447980435|FG001|Overall Study|Physician Decision|2|||
124552588|NCT04529499|447980434|FG000|Overall Study|Adverse Event|4|||
124552589|NCT04529499|447980435|FG001|Overall Study|Adverse Event|4|||
124552590|NCT04529499|447980434|FG000|Overall Study|Death|14|||
124552591|NCT04529499|447980435|FG001|Overall Study|Death|11|||
124552592|NCT04529499|447980434|FG000|Overall Study|Lost to Follow-up|1|||
124552593|NCT04529499|447980435|FG001|Overall Study|Lost to Follow-up|1|||
124552594|NCT04529499|447980434|FG000|Overall Study|Others|7|||
124552595|NCT04529499|447980435|FG001|Overall Study|Others|11|||
124552596|NCT00758706|447980436|FG000|Overall Study|Adverse Event|4|||
124552597|NCT00758706|447980437|FG001|Overall Study|Adverse Event|4|||
124552598|NCT01039584|447980438|FG000|Overall Study|Withdrawal by Subject|4|||
124552599|NCT01039584|447980439|FG001|Overall Study|Withdrawal by Subject|2|||
124552600|NCT01039584|447980440|FG002|Overall Study|Withdrawal by Subject|1|||
124552601|NCT01039584|447980438|FG000|Overall Study|Protocol Violation|10|||
124552602|NCT01039584|447980439|FG001|Overall Study|Protocol Violation|4|||
124552603|NCT01039584|447980440|FG002|Overall Study|Protocol Violation|6|||
124552604|NCT01039584|447980438|FG000|Overall Study|Lost to Follow-up|5|||
124552605|NCT01039584|447980439|FG001|Overall Study|Lost to Follow-up|3|||
124552606|NCT01039584|447980440|FG002|Overall Study|Lost to Follow-up|4|||
124552607|NCT01039584|447980438|FG000|Overall Study|Negative Baseline culture for Candida|59|||
124552608|NCT01039584|447980439|FG001|Overall Study|Negative Baseline culture for Candida|59|||
124552609|NCT01039584|447980440|FG002|Overall Study|Negative Baseline culture for Candida|24|||
124552610|NCT01039584|447980438|FG000|Overall Study|Lack of Efficacy|7|||
124552611|NCT01039584|447980439|FG001|Overall Study|Lack of Efficacy|6|||
124552612|NCT01039584|447980440|FG002|Overall Study|Lack of Efficacy|10|||
124552613|NCT01039584|447980438|FG000|Overall Study|other|1|||
124552614|NCT01039584|447980439|FG001|Overall Study|other|3|||
124470637|NCT01700192|447679956|FG000|Overall Study|Progressive disease|1|||
124470638|NCT01700192|447679957|FG001|Overall Study|Progressive disease|0|||
124470639|NCT01700192|447679956|FG000|Overall Study|Protocol Violation|3|||
124470640|NCT01700192|447679957|FG001|Overall Study|Protocol Violation|4|||
124470641|NCT01700192|447679956|FG000|Overall Study|Technical problems|0|||
124470642|NCT01700192|447679957|FG001|Overall Study|Technical problems|1|||
124470643|NCT01700192|447679956|FG000|Overall Study|Withdrawal by Subject|56|||
124470644|NCT01700192|447679957|FG001|Overall Study|Withdrawal by Subject|64|||
124470645|NCT01700192|447679956|FG000|Overall Study|Never received study drug|1|||
124470646|NCT01700192|447679957|FG001|Overall Study|Never received study drug|0|||
124470647|NCT03403192|447679960|FG000|Overall Study|Lost to Follow-up|1|||
124470648|NCT03403192|447679961|FG001|Overall Study|Lost to Follow-up|2|||
124470649|NCT03403192|447679962|FG002|Overall Study|Lost to Follow-up|0|||
124470650|NCT03403192|447679963|FG003|Overall Study|Lost to Follow-up|0|||
124470651|NCT03403192|447679960|FG000|Overall Study|Unable to respond|0|||
124470652|NCT03403192|447679961|FG001|Overall Study|Unable to respond|1|||
124470653|NCT03403192|447679962|FG002|Overall Study|Unable to respond|0|||
124470654|NCT03403192|447679963|FG003|Overall Study|Unable to respond|0|||
124470655|NCT03403192|447679960|FG000|Overall Study|Incomplete|3|||
124470656|NCT03403192|447679961|FG001|Overall Study|Incomplete|1|||
124470657|NCT03403192|447679962|FG002|Overall Study|Incomplete|3|||
124470658|NCT03403192|447679963|FG003|Overall Study|Incomplete|6|||
124470659|NCT01127165|447679964|FG000|Overall Study|Adverse Event|2|||
124470660|NCT01127165|447679965|FG001|Overall Study|Adverse Event|2|||
124470661|NCT01127165|447679964|FG000|Overall Study|Lack of Efficacy|10|||
124713784|NCT01244035|448577657|FG005|Part 1: Period 3|Adverse Event|1|||
124713785|NCT01244035|448577652|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
124713786|NCT01244035|448577653|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
124713787|NCT01244035|448577654|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
124713788|NCT01244035|448577655|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
124713789|NCT01244035|448577656|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
124713790|NCT01244035|448577657|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
124713791|NCT01244035|448577652|FG000|Part 1: Period 3|Protocol Deviation|0|||
124713792|NCT01244035|448577653|FG001|Part 1: Period 3|Protocol Deviation|1|||
124713793|NCT01244035|448577654|FG002|Part 1: Period 3|Protocol Deviation|0|||
124713794|NCT01244035|448577655|FG003|Part 1: Period 3|Protocol Deviation|0|||
124713795|NCT01244035|448577656|FG004|Part 1: Period 3|Protocol Deviation|0|||
124770533|NCT05082857|448788880|FG000|Overall Study|Lost to Follow-up|1|||
124770534|NCT05082857|448788881|FG001|Overall Study|Lost to Follow-up|3|||
124770535|NCT04672239|448788882|FG000|Week 2 Survey|Failed survey check items|1|||
124770536|NCT04672239|448788883|FG001|Week 2 Survey|Failed survey check items|2|||
124713796|NCT01244035|448577657|FG005|Part 1: Period 3|Protocol Deviation|0|||
124770537|NCT04672239|448788884|FG002|Week 2 Survey|Failed survey check items|3|||
124470662|NCT01127165|447679965|FG001|Overall Study|Lack of Efficacy|8|||
124470663|NCT01127165|447679964|FG000|Overall Study|Lost to Follow-up|3|||
124470664|NCT01127165|447679965|FG001|Overall Study|Lost to Follow-up|5|||
124470665|NCT01127165|447679964|FG000|Overall Study|Withdrawal by Subject|1|||
124470666|NCT01127165|447679965|FG001|Overall Study|Withdrawal by Subject|3|||
124470667|NCT01127165|447679964|FG000|Overall Study|Protocol Violation|0|||
124470668|NCT01127165|447679965|FG001|Overall Study|Protocol Violation|1|||
124470669|NCT03175549|447679966|FG000|Overall Study|Lost to Follow-up|2|||
124470670|NCT03175549|447679967|FG001|Overall Study|Lost to Follow-up|2|||
124470671|NCT03175549|447679966|FG000|Overall Study|Medication non-compliance|2|||
124470672|NCT03175549|447679967|FG001|Overall Study|Medication non-compliance|2|||
124470673|NCT00763321|447679968|FG000|Open-label Period|Adverse Event|24|||
124470674|NCT00763321|447679969|FG001|Open-label Period|Adverse Event|0|||
124470675|NCT00763321|447679970|FG002|Open-label Period|Adverse Event|0|||
124470676|NCT00763321|447679968|FG000|Open-label Period|Lost to Follow-up|14|||
124713797|NCT02383862|448577659|FG000|3 Month Follow up|Lost to Follow-up|23|||
124713798|NCT02383862|448577660|FG001|3 Month Follow up|Lost to Follow-up|21|||
124713799|NCT01696773|448577661|FG000|Days 15-27, Washout|Adverse Event|1|||
124470677|NCT00763321|447679969|FG001|Open-label Period|Lost to Follow-up|0|||
124470678|NCT00763321|447679970|FG002|Open-label Period|Lost to Follow-up|0|||
124470679|NCT00763321|447679968|FG000|Open-label Period|Withdrawal by Subject|7|||
124713800|NCT01696773|448577662|FG001|Days 15-27, Washout|Adverse Event|0|||
124713801|NCT01833494|448577663|FG000|Overall Study|Adverse Event|24|||
124470680|NCT00763321|447679969|FG001|Open-label Period|Withdrawal by Subject|0|||
124470681|NCT00763321|447679970|FG002|Open-label Period|Withdrawal by Subject|0|||
124470682|NCT00763321|447679968|FG000|Open-label Period|Subject noncompliant|7|||
124470683|NCT00763321|447679969|FG001|Open-label Period|Subject noncompliant|0|||
124713802|NCT01833494|448577663|FG000|Overall Study|Physician Decision|6|||
124713803|NCT01833494|448577663|FG000|Overall Study|Withdrawal by Subject|6|||
124552615|NCT01039584|447980440|FG002|Overall Study|other|1|||
124552616|NCT01039584|447980438|FG000|Overall Study|Pap smear with significant pathology|10|||
124552617|NCT01039584|447980439|FG001|Overall Study|Pap smear with significant pathology|10|||
124552618|NCT01039584|447980440|FG002|Overall Study|Pap smear with significant pathology|3|||
124552619|NCT01039584|447980438|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
124713804|NCT01833494|448577663|FG000|Overall Study|Decrease in serum phosphorus|4|||
124470684|NCT00763321|447679970|FG002|Open-label Period|Subject noncompliant|0|||
124470685|NCT00763321|447679968|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
124470686|NCT00763321|447679969|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
124470687|NCT00763321|447679970|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
124470688|NCT00763321|447679968|FG000|Open-label Period|Lack of Efficacy|2|||
124470689|NCT00763321|447679969|FG001|Open-label Period|Lack of Efficacy|0|||
124470690|NCT00763321|447679970|FG002|Open-label Period|Lack of Efficacy|0|||
124470691|NCT00763321|447679968|FG000|Open-label Period|Other|4|||
124470692|NCT00763321|447679969|FG001|Open-label Period|Other|0|||
124470693|NCT00763321|447679970|FG002|Open-label Period|Other|0|||
124470694|NCT00763321|447679968|FG000|Double-blind Period|Lack of Efficacy|0|||
124470695|NCT00763321|447679969|FG001|Double-blind Period|Lack of Efficacy|9|||
124470696|NCT00763321|447679970|FG002|Double-blind Period|Lack of Efficacy|17|||
124470697|NCT00763321|447679968|FG000|Double-blind Period|Adverse Event|0|||
124470698|NCT00763321|447679969|FG001|Double-blind Period|Adverse Event|4|||
124470699|NCT00763321|447679970|FG002|Double-blind Period|Adverse Event|4|||
124470700|NCT00763321|447679968|FG000|Double-blind Period|Lost to Follow-up|0|||
124470701|NCT00763321|447679969|FG001|Double-blind Period|Lost to Follow-up|4|||
124470702|NCT00763321|447679970|FG002|Double-blind Period|Lost to Follow-up|2|||
124470703|NCT00763321|447679968|FG000|Double-blind Period|Withdrawal by Subject|0|||
124470704|NCT00763321|447679969|FG001|Double-blind Period|Withdrawal by Subject|2|||
124470705|NCT00763321|447679970|FG002|Double-blind Period|Withdrawal by Subject|3|||
124470706|NCT00763321|447679968|FG000|Double-blind Period|Other|0|||
124470707|NCT00763321|447679969|FG001|Double-blind Period|Other|2|||
124470708|NCT00763321|447679970|FG002|Double-blind Period|Other|3|||
124470709|NCT02486757|447679971|FG000|Overall Study|Lost to Follow-up|1|||
124470710|NCT02793232|447679972|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
124470711|NCT02793232|447679973|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
124470712|NCT02793232|447679974|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
124470713|NCT02793232|447679975|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
124470714|NCT02793232|447679976|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
124470715|NCT02793232|447679977|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
124470716|NCT02793232|447679978|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
124470717|NCT02793232|447679979|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
124470718|NCT02793232|447679980|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
124470719|NCT01298492|447679981|FG000|Overall Study|Death|2|||
124470720|NCT01298492|447679981|FG000|Overall Study|Insufficient Clinical Response|22|||
124470721|NCT01298492|447679981|FG000|Overall Study|Lost to Follow-up|12|||
124470722|NCT01298492|447679981|FG000|Overall Study|Withdrawal by Subject|47|||
124470723|NCT01298492|447679981|FG000|Overall Study|Other (Unspecified)|7|||
124470724|NCT01298492|447679981|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
124470725|NCT01298492|447679981|FG000|Overall Study|Protocol Violation|2|||
124470726|NCT01298492|447679981|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
124470727|NCT01298492|447679981|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
124470728|NCT03543410|447679982|FG000|Overall Study|Adverse Event|10|||
124713805|NCT01833494|448577663|FG000|Overall Study|Decrease in serum calcium|4|||
124470729|NCT03543410|447679983|FG001|Overall Study|Adverse Event|8|||
124470730|NCT03543410|447679984|FG002|Overall Study|Adverse Event|2|||
124470731|NCT03543410|447679982|FG000|Overall Study|Lack of Efficacy|0|||
124470732|NCT03543410|447679983|FG001|Overall Study|Lack of Efficacy|1|||
124470733|NCT03543410|447679984|FG002|Overall Study|Lack of Efficacy|0|||
124470734|NCT03543410|447679982|FG000|Overall Study|Lost to Follow-up|0|||
124470735|NCT03543410|447679983|FG001|Overall Study|Lost to Follow-up|1|||
124470736|NCT03543410|447679984|FG002|Overall Study|Lost to Follow-up|0|||
124470737|NCT03543410|447679982|FG000|Overall Study|Withdrawal by Subject|5|||
124470738|NCT03543410|447679983|FG001|Overall Study|Withdrawal by Subject|2|||
124470739|NCT03543410|447679984|FG002|Overall Study|Withdrawal by Subject|8|||
124470740|NCT03543410|447679982|FG000|Overall Study|Protocol Violation|0|||
124470741|NCT03543410|447679983|FG001|Overall Study|Protocol Violation|1|||
124470742|NCT03543410|447679984|FG002|Overall Study|Protocol Violation|0|||
124470743|NCT03543410|447679982|FG000|Overall Study|Due to COVID-19|4|||
124470744|NCT03543410|447679983|FG001|Overall Study|Due to COVID-19|0|||
124470745|NCT03543410|447679984|FG002|Overall Study|Due to COVID-19|2|||
124470746|NCT03543410|447679982|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
124470747|NCT03543410|447679983|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
124470748|NCT03543410|447679984|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
124470749|NCT03543410|447679982|FG000|Overall Study|Not Due to COVID-19|2|||
124470750|NCT03543410|447679983|FG001|Overall Study|Not Due to COVID-19|0|||
124470751|NCT03543410|447679984|FG002|Overall Study|Not Due to COVID-19|1|||
124470752|NCT02883244|447679985|FG000|Overall Study|Lost to Follow-up|0|||
124470753|NCT02883244|447679986|FG001|Overall Study|Lost to Follow-up|1|||
124470754|NCT00820755|447679987|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
124470755|NCT00820755|447679988|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
124470756|NCT00820755|447679989|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
124470757|NCT00820755|447679987|FG000|Period 1: Combination Therapy Phase|Death|28|||
124470758|NCT00820755|447679988|FG001|Period 1: Combination Therapy Phase|Death|0|||
124470759|NCT00820755|447679989|FG002|Period 1: Combination Therapy Phase|Death|0|||
124470760|NCT00820755|447679987|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
124470761|NCT00820755|447679988|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
124470762|NCT00820755|447679989|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
124470763|NCT00820755|447679987|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
124552620|NCT01039584|447980439|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
124552621|NCT01039584|447980440|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
124552622|NCT01494649|447980441|FG000|Overall Study|Lost to Follow-up|0|||
124713806|NCT01833494|448577663|FG000|Overall Study|Increase in serum ferritin|1|||
124713807|NCT01694433|448577664|FG000|Overall Study|Adverse Event|7|||
124713808|NCT01694433|448577665|FG001|Overall Study|Adverse Event|0|||
124713809|NCT01694433|448577664|FG000|Overall Study|Physician Decision|1|||
124713810|NCT01694433|448577665|FG001|Overall Study|Physician Decision|0|||
124470764|NCT00820755|447679988|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
124470765|NCT00820755|447679989|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
124470766|NCT00820755|447679987|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
124713811|NCT01694433|448577664|FG000|Overall Study|Withdrawal by Subject|3|||
124470767|NCT00820755|447679988|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
124470768|NCT00820755|447679989|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
124470769|NCT00820755|447679987|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
124470770|NCT00820755|447679988|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
124470771|NCT00820755|447679989|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
124470772|NCT00820755|447679987|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
124470773|NCT00820755|447679988|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
124470774|NCT00820755|447679989|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
124470775|NCT00820755|447679987|FG000|Period 1: Combination Therapy Phase|Other|11|||
124470776|NCT00820755|447679988|FG001|Period 1: Combination Therapy Phase|Other|0|||
124470777|NCT00820755|447679989|FG002|Period 1: Combination Therapy Phase|Other|0|||
124470778|NCT00820755|447679987|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
124470779|NCT00820755|447679988|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
124470780|NCT00820755|447679989|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
124470781|NCT03551743|447679995|FG000|Overall Study|Adverse Event|1|||
124470782|NCT03551743|447679996|FG001|Overall Study|Adverse Event|0|||
124470783|NCT03551743|447679997|FG002|Overall Study|Adverse Event|0|||
124470784|NCT03551743|447679998|FG003|Overall Study|Adverse Event|0|||
124470785|NCT03551743|447679995|FG000|Overall Study|Withdrawal by Subject|1|||
124470786|NCT03551743|447679996|FG001|Overall Study|Withdrawal by Subject|0|||
124470787|NCT03551743|447679997|FG002|Overall Study|Withdrawal by Subject|0|||
124470788|NCT03551743|447679998|FG003|Overall Study|Withdrawal by Subject|0|||
124470789|NCT00911989|447679999|FG000|Overall Study|Adverse Event|1|||
124470790|NCT01116544|447680003|FG000|Overall Study|Protocol Violation|1|||
124470791|NCT01116544|447680004|FG001|Overall Study|Protocol Violation|0|||
124470792|NCT01116544|447680003|FG000|Overall Study|Withdrawal by Subject|1|||
124470793|NCT01116544|447680004|FG001|Overall Study|Withdrawal by Subject|1|||
124470794|NCT02183519|447680005|FG000|Overall Study|computer error|3|||
124470795|NCT02183519|447680006|FG001|Overall Study|computer error|0|||
124470796|NCT02183519|447680005|FG000|Overall Study|Did not respond to cough inducter|0|||
124470797|NCT02183519|447680006|FG001|Overall Study|Did not respond to cough inducter|3|||
124470798|NCT02542072|447680007|FG000|First Intervention (1 Month)|Adverse Event|1|||
124470799|NCT02542072|447680008|FG001|First Intervention (1 Month)|Adverse Event|1|||
124470800|NCT02542072|447680007|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
124470801|NCT02542072|447680008|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
124470802|NCT02542072|447680007|FG000|First Intervention (1 Month)|Lens discomfort|1|||
124470803|NCT02542072|447680008|FG001|First Intervention (1 Month)|Lens discomfort|2|||
124470804|NCT02542072|447680007|FG000|First Intervention (1 Month)|Protocol Violation|1|||
124470805|NCT02542072|447680008|FG001|First Intervention (1 Month)|Protocol Violation|0|||
124470806|NCT02542072|447680007|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
124470807|NCT02542072|447680008|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
124470808|NCT02542072|447680007|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
124470809|NCT02542072|447680008|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
124470810|NCT00695565|447680013|FG000|Overall Study|Lost to Follow-up|4|||
124470811|NCT00695565|447680014|FG001|Overall Study|Lost to Follow-up|4|||
124470812|NCT00695565|447680013|FG000|Overall Study|Adverse Event|3|||
124470813|NCT00695565|447680014|FG001|Overall Study|Adverse Event|1|||
124470814|NCT00695565|447680013|FG000|Overall Study|Protocol Violation|3|||
124470815|NCT00695565|447680014|FG001|Overall Study|Protocol Violation|1|||
124470816|NCT00695565|447680013|FG000|Overall Study|Withdrawal by Subject|1|||
124470817|NCT00695565|447680014|FG001|Overall Study|Withdrawal by Subject|1|||
124470818|NCT00695565|447680013|FG000|Overall Study|Lack of Efficacy|1|||
124470819|NCT00695565|447680014|FG001|Overall Study|Lack of Efficacy|1|||
124470820|NCT00695565|447680013|FG000|Overall Study|Subject did not follow instructions|1|||
124470821|NCT00695565|447680014|FG001|Overall Study|Subject did not follow instructions|1|||
124470822|NCT02937350|447680015|FG000|Overall Study|Withdrawal by Subject|0|||
124470823|NCT02937350|447680016|FG001|Overall Study|Withdrawal by Subject|1|||
124470824|NCT02937350|447680017|FG002|Overall Study|Withdrawal by Subject|0|||
124470825|NCT02419508|447680028|FG000|Overall Study|Adverse Event|9|||
124470826|NCT02419508|447680029|FG001|Overall Study|Adverse Event|3|||
124470827|NCT02419508|447680028|FG000|Overall Study|Withdrawal by Subject|1|||
124470828|NCT02419508|447680029|FG001|Overall Study|Withdrawal by Subject|0|||
124470829|NCT02419508|447680028|FG000|Overall Study|Other - Reason not specified|0|||
124470830|NCT02419508|447680029|FG001|Overall Study|Other - Reason not specified|1|||
124470831|NCT03110900|447680030|FG000|Overall Study|Sponsor withdrew|1|||
124470832|NCT03110900|447680031|FG001|Overall Study|Sponsor withdrew|1|||
124470833|NCT02447848|447680032|FG000|Overall Study|Patient discharged|3|||
124470834|NCT02447848|447680032|FG000|Overall Study|Lack of Efficacy|4|||
124470835|NCT02447848|447680032|FG000|Overall Study|Withdrawal by Subject|4|||
124470836|NCT00500682|447680035|FG000|Overall Study|Adverse Event|37|||
124470837|NCT00500682|447680036|FG001|Overall Study|Adverse Event|29|||
124470838|NCT00500682|447680035|FG000|Overall Study|Death|25|||
124470839|NCT00500682|447680036|FG001|Overall Study|Death|16|||
124470840|NCT00500682|447680035|FG000|Overall Study|Lost to Follow-up|11|||
124470841|NCT00500682|447680036|FG001|Overall Study|Lost to Follow-up|11|||
124470842|NCT00500682|447680035|FG000|Overall Study|Physician Decision|6|||
124470843|NCT00500682|447680036|FG001|Overall Study|Physician Decision|10|||
124470844|NCT00500682|447680035|FG000|Overall Study|Pregnancy|2|||
124470845|NCT00500682|447680036|FG001|Overall Study|Pregnancy|0|||
124470846|NCT00500682|447680035|FG000|Overall Study|Protocol Violation|1|||
124713812|NCT01694433|448577665|FG001|Overall Study|Withdrawal by Subject|4|||
124713813|NCT00374595|448577668|FG000|Overall Study|Death|23|||
124470847|NCT00500682|447680036|FG001|Overall Study|Protocol Violation|3|||
124470848|NCT00500682|447680035|FG000|Overall Study|Withdrawal by Subject|80|||
124713814|NCT00374595|448577668|FG000|Overall Study|Withdrawal by Subject|39|||
124713815|NCT00374595|448577668|FG000|Overall Study|Lost to Follow-up|3|||
124713816|NCT00374595|448577668|FG000|Overall Study|too much time commitment|1|||
124713817|NCT00374595|448577668|FG000|Overall Study|transfer care to other clinical site|1|||
124713818|NCT00374595|448577668|FG000|Overall Study|relocation|3|||
124713819|NCT01664247|448577670|FG000|Overall Study|Adverse Event|5|||
124713820|NCT01664247|448577671|FG001|Overall Study|Adverse Event|3|||
124713821|NCT01664247|448577670|FG000|Overall Study|Protocol Violation|3|||
124713822|NCT01664247|448577671|FG001|Overall Study|Protocol Violation|5|||
124713823|NCT01664247|448577670|FG000|Overall Study|Withdrawal Criteria|1|||
124713824|NCT01664247|448577671|FG001|Overall Study|Withdrawal Criteria|4|||
124713825|NCT01664247|448577670|FG000|Overall Study|Unclassified|5|||
124713826|NCT01664247|448577671|FG001|Overall Study|Unclassified|29|||
124713827|NCT01118780|448577679|FG000|Overall Study|Adverse Event|15|||
124713828|NCT01118780|448577680|FG001|Overall Study|Adverse Event|15|||
124713829|NCT01118780|448577679|FG000|Overall Study|Death|1|||
124713830|NCT01118780|448577680|FG001|Overall Study|Death|0|||
124713831|NCT01118780|448577679|FG000|Overall Study|Lack of Efficacy|2|||
124713832|NCT01118780|448577680|FG001|Overall Study|Lack of Efficacy|6|||
124713833|NCT01118780|448577679|FG000|Overall Study|Physician Decision|2|||
124713834|NCT01118780|448577680|FG001|Overall Study|Physician Decision|0|||
124713835|NCT01118780|448577679|FG000|Overall Study|Protocol Violation|3|||
124713836|NCT01118780|448577680|FG001|Overall Study|Protocol Violation|6|||
124713837|NCT01118780|448577679|FG000|Overall Study|Withdrawal by Subject|13|||
124713838|NCT01118780|448577680|FG001|Overall Study|Withdrawal by Subject|8|||
124713839|NCT03962855|448577691|FG000|Overall Study|Death|0|||
124713840|NCT03962855|448577692|FG001|Overall Study|Death|1|||
124713841|NCT03962855|448577691|FG000|Overall Study|Lost to Follow-up|0|||
124713842|NCT03962855|448577692|FG001|Overall Study|Lost to Follow-up|1|||
124713843|NCT03962855|448577691|FG000|Overall Study|Adverse Event|0|||
124713844|NCT03962855|448577692|FG001|Overall Study|Adverse Event|1|||
124713845|NCT03962855|448577691|FG000|Overall Study|Physician Decision|0|||
124713846|NCT03962855|448577692|FG001|Overall Study|Physician Decision|2|||
124713847|NCT04419467|448577695|FG000|Overall Study|Not treated with IP|0|||
124713848|NCT04419467|448577696|FG001|Overall Study|Not treated with IP|0|||
124713849|NCT04419467|448577697|FG002|Overall Study|Not treated with IP|2|||
124713850|NCT04419467|448577695|FG000|Overall Study|Adverse Event|0|||
124713851|NCT04419467|448577696|FG001|Overall Study|Adverse Event|2|||
124713852|NCT04419467|448577697|FG002|Overall Study|Adverse Event|0|||
124713853|NCT04419467|448577695|FG000|Overall Study|Death|1|||
124713854|NCT04419467|448577696|FG001|Overall Study|Death|0|||
124713855|NCT04419467|448577697|FG002|Overall Study|Death|0|||
124713856|NCT04419467|448577695|FG000|Overall Study|Lost to Follow-up|0|||
124713857|NCT04419467|448577696|FG001|Overall Study|Lost to Follow-up|1|||
124713858|NCT04419467|448577697|FG002|Overall Study|Lost to Follow-up|2|||
124713859|NCT04419467|448577695|FG000|Overall Study|Withdrawal by Subject|0|||
124713860|NCT04419467|448577696|FG001|Overall Study|Withdrawal by Subject|0|||
124713861|NCT04419467|448577697|FG002|Overall Study|Withdrawal by Subject|4|||
124713862|NCT04419467|448577695|FG000|Overall Study|Pandemic related|0|||
124713863|NCT04419467|448577696|FG001|Overall Study|Pandemic related|0|||
124713864|NCT04419467|448577697|FG002|Overall Study|Pandemic related|1|||
124713865|NCT04419467|448577695|FG000|Overall Study|Reason not known|1|||
124713866|NCT04419467|448577696|FG001|Overall Study|Reason not known|0|||
124713867|NCT04419467|448577697|FG002|Overall Study|Reason not known|0|||
124713868|NCT00442416|448577698|FG000|Overall Study|Adverse Event|4|||
124713869|NCT00442416|448577699|FG001|Overall Study|Adverse Event|1|||
124713870|NCT00442416|448577698|FG000|Overall Study|Death|1|||
124713871|NCT00442416|448577699|FG001|Overall Study|Death|0|||
124713872|NCT00442416|448577698|FG000|Overall Study|Lack of Efficacy|2|||
124713873|NCT00442416|448577699|FG001|Overall Study|Lack of Efficacy|0|||
124713874|NCT00442416|448577698|FG000|Overall Study|Protocol Violation|2|||
124713875|NCT00442416|448577699|FG001|Overall Study|Protocol Violation|3|||
124713876|NCT00442416|448577698|FG000|Overall Study|Withdrew consent|1|||
124713877|NCT00442416|448577699|FG001|Overall Study|Withdrew consent|2|||
124713878|NCT00442416|448577698|FG000|Overall Study|Administrative/Other|27|||
124713879|NCT00442416|448577699|FG001|Overall Study|Administrative/Other|33|||
124713880|NCT01284959|448577702|FG000|Overall Study|Withdrawal by Subject|1|||
124713881|NCT01284959|448577703|FG001|Overall Study|Withdrawal by Subject|0|||
124713882|NCT01284959|448577704|FG002|Overall Study|Withdrawal by Subject|0|||
124713883|NCT01284959|448577702|FG000|Overall Study|Adverse Event|0|||
124713884|NCT01284959|448577703|FG001|Overall Study|Adverse Event|0|||
124713885|NCT01284959|448577704|FG002|Overall Study|Adverse Event|1|||
124713886|NCT00003869|448577706|FG000|Overall Study|Adverse Event|14|||
124713887|NCT00003869|448577707|FG001|Overall Study|Adverse Event|3|||
124713888|NCT00003869|448577706|FG000|Overall Study|Withdrawal by Subject|21|||
124713889|NCT00003869|448577707|FG001|Overall Study|Withdrawal by Subject|3|||
124713890|NCT00003869|448577706|FG000|Overall Study|Death|1|||
124713891|NCT00003869|448577707|FG001|Overall Study|Death|2|||
124713892|NCT00003869|448577706|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
124713893|NCT00003869|448577707|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
124713894|NCT03364231|448577708|FG000|Overall Study|Adverse Event|1|||
124713895|NCT03364231|448577709|FG001|Overall Study|Adverse Event|4|||
124713896|NCT03364231|448577708|FG000|Overall Study|Death|1|||
124713897|NCT03364231|448577709|FG001|Overall Study|Death|0|||
124713898|NCT03364231|448577708|FG000|Overall Study|Investigator Decision|2|||
124713899|NCT03364231|448577709|FG001|Overall Study|Investigator Decision|2|||
124713900|NCT03364231|448577708|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
124713901|NCT03364231|448577709|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
124552623|NCT01494649|447980442|FG001|Overall Study|Lost to Follow-up|1|||
124713902|NCT03364231|448577708|FG000|Overall Study|Withdrawal of Subject Consent|1|||
124713903|NCT03364231|448577709|FG001|Overall Study|Withdrawal of Subject Consent|0|||
124713904|NCT03364231|448577708|FG000|Overall Study|Reason Not Specified|1|||
124713905|NCT03364231|448577709|FG001|Overall Study|Reason Not Specified|0|||
124713906|NCT03364231|448577708|FG000|Overall Study|Disease Progression|0|||
124713907|NCT03364231|448577709|FG001|Overall Study|Disease Progression|6|||
124713908|NCT04068922|448577710|FG000|Overall Study|Lost to Follow-up|5|||
124713909|NCT04068922|448577710|FG000|Overall Study|Withdrawal by Subject|7|||
124713910|NCT04068922|448577710|FG000|Overall Study|Adverse Event|1|||
124713911|NCT00444106|448577716|FG000|Overall Study|Lost to Follow-up|2|||
124713912|NCT00444106|448577717|FG001|Overall Study|Lost to Follow-up|1|||
124713913|NCT00444106|448577718|FG002|Overall Study|Lost to Follow-up|0|||
124713914|NCT00444106|448577716|FG000|Overall Study|Abnormal Test Procedure Results|0|||
124713915|NCT00444106|448577717|FG001|Overall Study|Abnormal Test Procedure Results|0|||
124713916|NCT00444106|448577718|FG002|Overall Study|Abnormal Test Procedure Results|1|||
124713917|NCT04749914|448577719|FG000|Period 1|Adverse Event|1|||
124713918|NCT04749914|448577720|FG001|Period 1|Adverse Event|0|||
124713919|NCT04749914|448577721|FG002|Period 1|Adverse Event|0|||
124713920|NCT04749914|448577722|FG003|Period 1|Adverse Event|0|||
124713921|NCT04749914|448577719|FG000|Period 1|Withdrawal by Subject|1|||
124713922|NCT04749914|448577720|FG001|Period 1|Withdrawal by Subject|0|||
124713923|NCT04749914|448577721|FG002|Period 1|Withdrawal by Subject|1|||
124713924|NCT04749914|448577722|FG003|Period 1|Withdrawal by Subject|0|||
124713925|NCT01913327|448577725|FG000|Overall Study|Withdrawal by Subject|0|||
124713926|NCT01913327|448577726|FG001|Overall Study|Withdrawal by Subject|1|||
124713927|NCT01074931|448577731|FG000|Overall Study|Economic reasons|1|||
124713928|NCT01074931|448577731|FG000|Overall Study|Death|5|||
124713929|NCT00953706|448577732|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
124713930|NCT00953706|448577733|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
124713931|NCT00953706|448577734|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
124713932|NCT00953706|448577735|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
124713933|NCT00953706|448577732|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
124713934|NCT00953706|448577733|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
124713935|NCT00953706|448577734|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
124713936|NCT00953706|448577735|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
124713937|NCT00953706|448577732|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
124713938|NCT00953706|448577733|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
124713939|NCT00953706|448577734|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
124713940|NCT00953706|448577735|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
124713941|NCT00953706|448577732|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
124713942|NCT00953706|448577733|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
124552624|NCT03467971|447980443|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124552625|NCT03467971|447980444|FG001|Treatment Period 2|Withdrawal by Subject|1|||
124552626|NCT01174368|447980447|FG000|Overall Study|Withdrawal by Subject|1|||
124552627|NCT00000135|447980470|FG000|Overall Study|Death|27|||
124552628|NCT00000135|447980471|FG001|Overall Study|Death|14|||
124552629|NCT01311505|447980472|FG000|First Intervention Period|Protocol Violation|0|||
124552630|NCT01311505|447980473|FG001|First Intervention Period|Protocol Violation|1|||
124552631|NCT00759759|447980474|FG000|Overall Study|didn't return for period 2|1|||
124552632|NCT00759759|447980475|FG001|Overall Study|didn't return for period 2|0|||
124552633|NCT00759759|447980474|FG000|Overall Study|Didn't receive drug in period 2|1|||
124552634|NCT00759759|447980475|FG001|Overall Study|Didn't receive drug in period 2|0|||
124552635|NCT00759759|447980474|FG000|Overall Study|Withdrawal by Subject|2|||
124552636|NCT00759759|447980475|FG001|Overall Study|Withdrawal by Subject|1|||
124552637|NCT04639310|447980485|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
124552638|NCT04639310|447980486|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
124552639|NCT01211613|447981925|FG000|Overall Study|Lost to Follow-up|2|||
124552640|NCT01211613|447981926|FG001|Overall Study|Lost to Follow-up|2|||
124552641|NCT01211613|447981927|FG002|Overall Study|Lost to Follow-up|2|||
124552642|NCT01211613|447981925|FG000|Overall Study|Withdrawal by Subject|1|||
124552643|NCT01211613|447981926|FG001|Overall Study|Withdrawal by Subject|0|||
124552644|NCT01211613|447981927|FG002|Overall Study|Withdrawal by Subject|0|||
124713943|NCT00953706|448577734|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
124713944|NCT00953706|448577735|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
124713945|NCT00953706|448577732|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
124713946|NCT00953706|448577733|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
124713947|NCT00953706|448577734|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
124713948|NCT00953706|448577735|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
124713949|NCT00953706|448577732|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
124713950|NCT00953706|448577733|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
124713951|NCT00953706|448577734|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
124713952|NCT00953706|448577735|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
124770538|NCT04672239|448788882|FG000|Week 2 Survey|Partially completed survey|7|||
124713953|NCT00953706|448577732|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
124713954|NCT00953706|448577733|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
124713955|NCT00953706|448577734|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
124713956|NCT00953706|448577735|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
124713957|NCT00953706|448577732|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
124713958|NCT00953706|448577733|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
124713959|NCT00953706|448577734|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
124713960|NCT00953706|448577735|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
124713961|NCT00953706|448577732|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
124470849|NCT00500682|447680036|FG001|Overall Study|Withdrawal by Subject|74|||
124470850|NCT00500682|447680035|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
124470851|NCT00500682|447680036|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
124470852|NCT01582308|447680039|FG000|Period 1|Withdrawal by Subject|0|||
124470853|NCT01582308|447680040|FG001|Period 1|Withdrawal by Subject|0|||
124470854|NCT01582308|447680041|FG002|Period 1|Withdrawal by Subject|0|||
124470855|NCT01582308|447680042|FG003|Period 1|Withdrawal by Subject|0|||
124470856|NCT01582308|447680043|FG004|Period 1|Withdrawal by Subject|0|||
124470857|NCT01582308|447680044|FG005|Period 1|Withdrawal by Subject|0|||
124470858|NCT01582308|447680045|FG006|Period 1|Withdrawal by Subject|1|||
124470859|NCT01582308|447680046|FG007|Period 1|Withdrawal by Subject|0|||
124470860|NCT01582308|447680047|FG008|Period 1|Withdrawal by Subject|0|||
124470861|NCT01582308|447680048|FG009|Period 1|Withdrawal by Subject|0|||
124470862|NCT01582308|447680039|FG000|10-day Washout Following Period 1|Physician Decision|0|||
124470863|NCT01582308|447680040|FG001|10-day Washout Following Period 1|Physician Decision|0|||
124470864|NCT01582308|447680041|FG002|10-day Washout Following Period 1|Physician Decision|0|||
124470865|NCT01582308|447680042|FG003|10-day Washout Following Period 1|Physician Decision|0|||
124470866|NCT01582308|447680043|FG004|10-day Washout Following Period 1|Physician Decision|1|||
124470867|NCT01582308|447680044|FG005|10-day Washout Following Period 1|Physician Decision|0|||
124470868|NCT01582308|447680045|FG006|10-day Washout Following Period 1|Physician Decision|0|||
124470869|NCT01582308|447680046|FG007|10-day Washout Following Period 1|Physician Decision|0|||
124470870|NCT01582308|447680047|FG008|10-day Washout Following Period 1|Physician Decision|0|||
124470871|NCT01582308|447680048|FG009|10-day Washout Following Period 1|Physician Decision|0|||
124470872|NCT01582308|447680039|FG000|Period 4|Physician Decision|1|||
124470873|NCT01582308|447680040|FG001|Period 4|Physician Decision|0|||
124470874|NCT01582308|447680041|FG002|Period 4|Physician Decision|0|||
124470875|NCT01582308|447680042|FG003|Period 4|Physician Decision|0|||
124470876|NCT01582308|447680043|FG004|Period 4|Physician Decision|0|||
124470877|NCT01582308|447680044|FG005|Period 4|Physician Decision|1|||
124470878|NCT01582308|447680045|FG006|Period 4|Physician Decision|0|||
124470879|NCT01582308|447680046|FG007|Period 4|Physician Decision|0|||
124470880|NCT01582308|447680047|FG008|Period 4|Physician Decision|0|||
124470881|NCT01582308|447680048|FG009|Period 4|Physician Decision|1|||
124470882|NCT02320487|447680049|FG000|Overall Study|Reason not Specified|1|||
124470883|NCT02320487|447680049|FG000|Overall Study|Physician Decision|5|||
124470884|NCT02320487|447680049|FG000|Overall Study|Withdrawal by Subject|1|||
124470885|NCT02320487|447680049|FG000|Overall Study|Death|3|||
124470886|NCT02320487|447680049|FG000|Overall Study|Adverse Event|11|||
124470887|NCT01182428|447680050|FG000|Overall Study|Physician Decision|1|||
124470888|NCT01182428|447680051|FG001|Overall Study|Physician Decision|0|||
124470889|NCT01182428|447680050|FG000|Overall Study|Lost to Follow-up|9|||
124470890|NCT01182428|447680051|FG001|Overall Study|Lost to Follow-up|1|||
124470891|NCT01182428|447680050|FG000|Overall Study|Withdrawal by Subject|1|||
124470892|NCT01182428|447680051|FG001|Overall Study|Withdrawal by Subject|0|||
124470893|NCT05280756|447681993|FG000|Overall Study|Lost to Follow-up|1|||
124470894|NCT05280756|447681994|FG001|Overall Study|Lost to Follow-up|1|||
124470895|NCT01461044|447681999|FG000|Overall Study|Death|58|||
124470896|NCT01461044|447682000|FG001|Overall Study|Death|35|||
124470897|NCT01461044|447681999|FG000|Overall Study|Lost to Follow-up|12|||
124470898|NCT01461044|447682000|FG001|Overall Study|Lost to Follow-up|5|||
124470899|NCT00716976|447682001|FG000|Overall Study|Adverse Event|2|||
124470900|NCT00716976|447682002|FG001|Overall Study|Adverse Event|0|||
124470901|NCT00716976|447682001|FG000|Overall Study|Death|1|||
124470902|NCT00716976|447682002|FG001|Overall Study|Death|0|||
124470903|NCT00716976|447682001|FG000|Overall Study|Physician Decision|2|||
124470904|NCT00716976|447682002|FG001|Overall Study|Physician Decision|2|||
124552645|NCT03853213|447981928|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
124713962|NCT00953706|448577733|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
124713963|NCT00953706|448577734|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
124713964|NCT00953706|448577735|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
124713965|NCT00953706|448577732|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
124713966|NCT00953706|448577733|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
124713967|NCT00953706|448577734|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
124713968|NCT00953706|448577735|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
124713969|NCT00953706|448577732|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
124713970|NCT00953706|448577733|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
124713971|NCT00953706|448577734|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
124713972|NCT00953706|448577735|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
124713973|NCT02137070|448577737|FG000|Overall Study|Adverse Event|12|||
124713974|NCT02137070|448577738|FG001|Overall Study|Adverse Event|3|||
124713975|NCT02137070|448577737|FG000|Overall Study|Death|2|||
124713976|NCT02137070|448577738|FG001|Overall Study|Death|0|||
124713977|NCT02137070|448577737|FG000|Overall Study|Lost to Follow-up|24|||
124713978|NCT02137070|448577738|FG001|Overall Study|Lost to Follow-up|9|||
124713979|NCT02137070|448577737|FG000|Overall Study|Physician Decision|0|||
124713980|NCT02137070|448577738|FG001|Overall Study|Physician Decision|1|||
124713981|NCT02137070|448577737|FG000|Overall Study|Protocol Violation|18|||
124713982|NCT02137070|448577738|FG001|Overall Study|Protocol Violation|4|||
124713983|NCT02137070|448577737|FG000|Overall Study|Withdrawal by Subject|18|||
124713984|NCT02137070|448577738|FG001|Overall Study|Withdrawal by Subject|1|||
124713985|NCT02112656|448577739|FG000|Overall Study|Death|78|||
124713986|NCT02112656|448577740|FG001|Overall Study|Death|82|||
124713987|NCT02112656|448577739|FG000|Overall Study|Withdrawal by Subject|9|||
124713988|NCT02112656|448577740|FG001|Overall Study|Withdrawal by Subject|11|||
124713989|NCT02112656|448577739|FG000|Overall Study|Lost to Follow-up|2|||
124713990|NCT02112656|448577740|FG001|Overall Study|Lost to Follow-up|4|||
124713991|NCT02112656|448577739|FG000|Overall Study|Noncompliance|1|||
124713992|NCT02112656|448577740|FG001|Overall Study|Noncompliance|2|||
124713993|NCT03761056|448577741|FG000|Overall Study|Death|8|||
124713994|NCT03761056|448577741|FG000|Overall Study|Enrolled but never treated|2|||
124713995|NCT03761056|448577741|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
124713996|NCT03761056|448577741|FG000|Overall Study|Investigator decision|1|||
124713997|NCT03965403|448577746|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
124713998|NCT01979614|448579273|FG000|Overall Study|Adverse Event|1|||
124713999|NCT01979614|448579274|FG001|Overall Study|Adverse Event|1|||
124714000|NCT00756275|448579275|FG000|Overall Study|Lost to Follow-up|25|||
124714001|NCT00756275|448579276|FG001|Overall Study|Lost to Follow-up|21|||
124714002|NCT00756275|448579275|FG000|Overall Study|Withdrawal by Subject|4|||
124714003|NCT00756275|448579276|FG001|Overall Study|Withdrawal by Subject|7|||
124714004|NCT00938912|448579279|FG000|Overall Study|Withdrawal by Subject|28|||
124714005|NCT00938912|448579279|FG000|Overall Study|Lost to Follow-up|4|||
124714006|NCT00938912|448579279|FG000|Overall Study|Lack of Efficacy|43|||
124714007|NCT00938912|448579279|FG000|Overall Study|Adverse event, non-fatal|24|||
124714008|NCT00938912|448579279|FG000|Overall Study|Adverse event, fatal|1|||
124714009|NCT00938912|448579279|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
124714010|NCT00938912|448579279|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
124714011|NCT00938912|448579279|FG000|Overall Study|Participant needed prohibit medication|1|||
124714012|NCT00938912|448579279|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
124714013|NCT00938912|448579279|FG000|Overall Study|Did not meet Eligibility criteria|1|||
124714014|NCT00938912|448579279|FG000|Overall Study|Participant relocated not related to AE|1|||
124714015|NCT00938912|448579279|FG000|Overall Study|Participant moved to another city|1|||
124714016|NCT00938912|448579279|FG000|Overall Study|Participant experienced break through seizures|1|||
124714017|NCT00938912|448579279|FG000|Overall Study|No longer wished to participate in the study|1|||
124714018|NCT00938912|448579279|FG000|Overall Study|Protocol Deviation|2|||
124714019|NCT00456755|448579280|FG000|Overall Study|Lost to Follow-up|2|||
124714020|NCT00456755|448579281|FG001|Overall Study|Lost to Follow-up|1|||
124714021|NCT06164691|448579282|FG000|Overall Study|Withdrawal by Subject|2|||
124714022|NCT06164691|448579283|FG001|Overall Study|Withdrawal by Subject|0|||
124714023|NCT06164691|448579284|FG002|Overall Study|Withdrawal by Subject|0|||
124552646|NCT03853213|447981929|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
124552647|NCT03853213|447981928|FG000|Overall Study|Other (e.g., too busy)|0|||
124714024|NCT02370368|448579296|FG000|Overall Study|Adverse Event|1|||
124714025|NCT02370368|448579297|FG001|Overall Study|Adverse Event|2|||
124552648|NCT03853213|447981929|FG001|Overall Study|Other (e.g., too busy)|2|||
124552649|NCT01458132|447981930|FG000|Overall Study|Other|15|||
124714026|NCT02370368|448579296|FG000|Overall Study|Withdrawal by Subject|5|||
124714027|NCT02370368|448579297|FG001|Overall Study|Withdrawal by Subject|4|||
124552650|NCT01458132|447981931|FG001|Overall Study|Other|3|||
124552651|NCT00833976|447981932|FG000|Overall Study|Withdrawal by Subject|5|||
124552652|NCT00833976|447981932|FG000|Overall Study|Lost to Follow-up|4|||
124552653|NCT00833976|447981932|FG000|Overall Study|Did not meet eligibility criteria|41|||
124552654|NCT00833976|447981932|FG000|Overall Study|Physician Decision|1|||
124552655|NCT03911960|447981933|FG000|Overall Study|Lost to Follow-up|5|||
124552656|NCT03911960|447981934|FG001|Overall Study|Lost to Follow-up|3|||
124552657|NCT02239692|447981935|FG000|Overall Study|Incomplete colonoscopy|1|||
124552658|NCT02239692|447981936|FG001|Overall Study|Incomplete colonoscopy|2|||
124714028|NCT00347932|448579300|FG000|Overall Study|Adverse Event|4|||
124714029|NCT00347932|448579301|FG001|Overall Study|Adverse Event|5|||
124714030|NCT00347932|448579300|FG000|Overall Study|Lack of Efficacy|3|||
124714031|NCT00347932|448579301|FG001|Overall Study|Lack of Efficacy|14|||
124714032|NCT00347932|448579300|FG000|Overall Study|Lost to Follow-up|10|||
124714033|NCT00347932|448579301|FG001|Overall Study|Lost to Follow-up|9|||
124714034|NCT00347932|448579300|FG000|Overall Study|Withdrawal by Subject|10|||
124714035|NCT00347932|448579301|FG001|Overall Study|Withdrawal by Subject|16|||
124714036|NCT00347932|448579300|FG000|Overall Study|Did not meet inclusion criteria|4|||
124714037|NCT00347932|448579301|FG001|Overall Study|Did not meet inclusion criteria|8|||
124714038|NCT04512001|448579302|FG000|Week 0 to Week 24|Adverse Event|14|||
124714039|NCT04512001|448579303|FG001|Week 0 to Week 24|Adverse Event|10|||
124714040|NCT04512001|448579304|FG002|Week 0 to Week 24|Adverse Event|0|||
124470905|NCT00716976|447682001|FG000|Overall Study|Withdrawal by Subject|5|||
124470906|NCT00716976|447682002|FG001|Overall Study|Withdrawal by Subject|1|||
124470907|NCT00716976|447682001|FG000|Overall Study|Premature discontinuation cisplatin|5|||
124552659|NCT02239692|447981935|FG000|Overall Study|Adverse Event|0|||
124714041|NCT04512001|448579305|FG003|Week 0 to Week 24|Adverse Event|0|||
124714042|NCT04512001|448579306|FG004|Week 0 to Week 24|Adverse Event|0|||
124470908|NCT00716976|447682002|FG001|Overall Study|Premature discontinuation cisplatin|4|||
124470909|NCT00716976|447682001|FG000|Overall Study|Radiation during protocol|1|||
124470910|NCT00716976|447682002|FG001|Overall Study|Radiation during protocol|0|||
124470911|NCT00716976|447682001|FG000|Overall Study|Ineligibles|4|||
124470912|NCT00716976|447682002|FG001|Overall Study|Ineligibles|2|||
124470913|NCT00122135|447682003|FG000|Overall Study|Withdrawal by Subject|3|||
124470914|NCT00122135|447682004|FG001|Overall Study|Withdrawal by Subject|0|||
124470915|NCT03068325|447682005|FG000|Overall Study|Lost to Follow-up|5|||
124470916|NCT00168831|447682009|FG000|Overall Study|Adverse Event|36|||
124470917|NCT00168831|447682010|FG001|Overall Study|Adverse Event|47|||
124470918|NCT00168831|447682011|FG002|Overall Study|Adverse Event|74|||
124470919|NCT00168831|447682009|FG000|Overall Study|Lost to Follow-up|5|||
124470920|NCT00168831|447682010|FG001|Overall Study|Lost to Follow-up|6|||
124470921|NCT00168831|447682011|FG002|Overall Study|Lost to Follow-up|4|||
124470922|NCT00168831|447682009|FG000|Overall Study|Withdrawal by Subject|7|||
124470923|NCT00168831|447682010|FG001|Overall Study|Withdrawal by Subject|14|||
124470924|NCT00168831|447682011|FG002|Overall Study|Withdrawal by Subject|19|||
124470925|NCT00168831|447682009|FG000|Overall Study|Protocol Violation|6|||
124470926|NCT00168831|447682010|FG001|Overall Study|Protocol Violation|11|||
124470927|NCT00168831|447682011|FG002|Overall Study|Protocol Violation|11|||
124470928|NCT00168831|447682009|FG000|Overall Study|Other|6|||
124470929|NCT00168831|447682010|FG001|Overall Study|Other|3|||
124470930|NCT00168831|447682011|FG002|Overall Study|Other|6|||
124470931|NCT02009878|447682012|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
124470932|NCT02009878|447682013|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
124470933|NCT02009878|447682014|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
124470934|NCT03634800|447682016|FG000|Overall Study|Adverse Event|1|||
124470935|NCT03634800|447682016|FG000|Overall Study|Disease Progression|4|||
124470936|NCT03634800|447682016|FG000|Overall Study|Withdrawal by Subject|1|||
124552660|NCT02239692|447981936|FG001|Overall Study|Adverse Event|1|||
124770539|NCT04672239|448788883|FG001|Week 2 Survey|Partially completed survey|1|||
124770540|NCT04672239|448788884|FG002|Week 2 Survey|Partially completed survey|4|||
124770541|NCT04672239|448788882|FG000|Week 2 Survey|Withdrawal by Subject|0|||
124470937|NCT00927368|447682020|FG000|Overall Study|enrollment in another study|1|||
124470938|NCT00927368|447682021|FG001|Overall Study|enrollment in another study|1|||
124470939|NCT00927368|447682022|FG002|Overall Study|enrollment in another study|2|||
124470940|NCT00927368|447682020|FG000|Overall Study|Lost to Follow-up|4|||
124470941|NCT00927368|447682021|FG001|Overall Study|Lost to Follow-up|0|||
124770542|NCT04672239|448788883|FG001|Week 2 Survey|Withdrawal by Subject|1|||
124470942|NCT00927368|447682022|FG002|Overall Study|Lost to Follow-up|0|||
124470943|NCT00927368|447682020|FG000|Overall Study|equipment failure|1|||
124470944|NCT00927368|447682021|FG001|Overall Study|equipment failure|0|||
124470945|NCT00927368|447682022|FG002|Overall Study|equipment failure|0|||
124470946|NCT00927368|447682020|FG000|Overall Study|ineligible post randomization|0|||
124470947|NCT00927368|447682021|FG001|Overall Study|ineligible post randomization|3|||
124470948|NCT00927368|447682022|FG002|Overall Study|ineligible post randomization|1|||
124470949|NCT00927368|447682020|FG000|Overall Study|cancellation of surgery|0|||
124470950|NCT00927368|447682021|FG001|Overall Study|cancellation of surgery|1|||
124470951|NCT00927368|447682022|FG002|Overall Study|cancellation of surgery|2|||
124470952|NCT00343512|447682028|FG000|Overall Study|Withdrawal by Subject|2|||
124470953|NCT00191451|447682033|FG000|Overall Study|Withdrawal by Subject|2|||
124470954|NCT00191451|447682034|FG001|Overall Study|Withdrawal by Subject|3|||
124470955|NCT00191451|447682035|FG002|Overall Study|Withdrawal by Subject|5|||
124470956|NCT00191451|447682033|FG000|Overall Study|Physician Decision|2|||
124470957|NCT00191451|447682034|FG001|Overall Study|Physician Decision|9|||
124470958|NCT00191451|447682035|FG002|Overall Study|Physician Decision|6|||
124470959|NCT00191451|447682033|FG000|Overall Study|Sponsor Decision|1|||
124470960|NCT00191451|447682034|FG001|Overall Study|Sponsor Decision|0|||
124470961|NCT00191451|447682035|FG002|Overall Study|Sponsor Decision|0|||
124470962|NCT00191451|447682033|FG000|Overall Study|Ineligible|0|||
124470963|NCT00191451|447682034|FG001|Overall Study|Ineligible|1|||
124470964|NCT00191451|447682035|FG002|Overall Study|Ineligible|0|||
124470965|NCT00191451|447682033|FG000|Overall Study|Reason Not Specified|2|||
124470966|NCT00191451|447682034|FG001|Overall Study|Reason Not Specified|1|||
124470967|NCT00191451|447682035|FG002|Overall Study|Reason Not Specified|3|||
124470968|NCT00684515|447682036|FG000|Overall Study|Adverse Event|3|||
124470969|NCT00684515|447682037|FG001|Overall Study|Adverse Event|3|||
124470970|NCT00684515|447682038|FG002|Overall Study|Adverse Event|1|||
124470971|NCT00684515|447682036|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
124470972|NCT00684515|447682037|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
124470973|NCT00684515|447682038|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
124552661|NCT02239692|447981935|FG000|Overall Study|Physician Decision|0|||
124552662|NCT02239692|447981936|FG001|Overall Study|Physician Decision|1|||
124552663|NCT02239692|447981935|FG000|Overall Study|Lost to Follow-up|1|||
124552664|NCT02239692|447981936|FG001|Overall Study|Lost to Follow-up|4|||
124552665|NCT02239692|447981935|FG000|Overall Study|Withdrawal by Subject|3|||
124552666|NCT02239692|447981936|FG001|Overall Study|Withdrawal by Subject|5|||
124552667|NCT02239692|447981935|FG000|Overall Study|Other reason|1|||
124552668|NCT02239692|447981936|FG001|Overall Study|Other reason|0|||
124470974|NCT01114529|447682042|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
124470975|NCT01114529|447682043|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
124470976|NCT01114529|447682044|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
124470977|NCT01114529|447682042|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
124470978|NCT01114529|447682043|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
124470979|NCT01114529|447682044|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
124470980|NCT01114529|447682042|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
124470981|NCT01114529|447682043|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
124470982|NCT01114529|447682044|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
124470983|NCT01114529|447682042|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
124470984|NCT01114529|447682043|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
124470985|NCT01114529|447682044|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
124470986|NCT01114529|447682042|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
124470987|NCT01114529|447682043|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
124470988|NCT01114529|447682044|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
124714043|NCT04512001|448579302|FG000|Week 0 to Week 24|Death|0|||
124714044|NCT04512001|448579303|FG001|Week 0 to Week 24|Death|2|||
124714045|NCT04512001|448579304|FG002|Week 0 to Week 24|Death|0|||
124714046|NCT04512001|448579305|FG003|Week 0 to Week 24|Death|0|||
124770543|NCT04672239|448788884|FG002|Week 2 Survey|Withdrawal by Subject|0|||
124770544|NCT04672239|448788882|FG000|Week 2 Survey|Lost to Follow-up|3|||
124770545|NCT04672239|448788883|FG001|Week 2 Survey|Lost to Follow-up|2|||
124770546|NCT04672239|448788884|FG002|Week 2 Survey|Lost to Follow-up|5|||
124770547|NCT04672239|448788882|FG000|Week 6 Survey|Failed survey check items|2|||
124470989|NCT01114529|447682042|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
124470990|NCT01114529|447682043|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
124470991|NCT01114529|447682044|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
124470992|NCT01114529|447682042|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
124470993|NCT01114529|447682043|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
124470994|NCT01114529|447682044|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
124470995|NCT01114529|447682042|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
124470996|NCT01114529|447682043|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
124470997|NCT01114529|447682044|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
124470998|NCT01114529|447682042|FG000|Completed Study Medication at Month 24|Death|2|||
124470999|NCT01114529|447682043|FG001|Completed Study Medication at Month 24|Death|1|||
124471000|NCT01114529|447682044|FG002|Completed Study Medication at Month 24|Death|2|||
124471001|NCT01114529|447682042|FG000|Completed Study Medication at Month 24|Graft loss|0|||
124471002|NCT01114529|447682043|FG001|Completed Study Medication at Month 24|Graft loss|2|||
124471003|NCT01114529|447682044|FG002|Completed Study Medication at Month 24|Graft loss|0|||
124471004|NCT01114529|447682042|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
124471005|NCT01114529|447682043|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
124471006|NCT01114529|447682044|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
124471007|NCT01114529|447682042|FG000|Completed Study Medication at Month 24|Missing|2|||
124471008|NCT01114529|447682043|FG001|Completed Study Medication at Month 24|Missing|0|||
124471009|NCT01114529|447682044|FG002|Completed Study Medication at Month 24|Missing|0|||
124471010|NCT01114529|447682042|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
124471011|NCT01114529|447682043|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
124471012|NCT01114529|447682044|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
124471013|NCT01114529|447682042|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
124471014|NCT01114529|447682043|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
124471015|NCT01114529|447682044|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
124471016|NCT01114529|447682042|FG000|Completed Study Phase at Month 24|Death|8|||
124471017|NCT01114529|447682043|FG001|Completed Study Phase at Month 24|Death|5|||
124471018|NCT01114529|447682044|FG002|Completed Study Phase at Month 24|Death|4|||
124471019|NCT01114529|447682042|FG000|Completed Study Phase at Month 24|Other|2|||
124471020|NCT01114529|447682043|FG001|Completed Study Phase at Month 24|Other|0|||
124471021|NCT01114529|447682044|FG002|Completed Study Phase at Month 24|Other|0|||
124471022|NCT01114529|447682042|FG000|Completed Study Phase at Month 24|Missing|2|||
124471023|NCT01114529|447682043|FG001|Completed Study Phase at Month 24|Missing|0|||
124471024|NCT01114529|447682044|FG002|Completed Study Phase at Month 24|Missing|0|||
124471025|NCT04428411|447682045|FG000|Overall Study|Lost to Follow-up|114|||
124471026|NCT00331409|447682046|FG000|Overall Study|Lack of Efficacy|4|||
124471027|NCT00272987|447682047|FG000|Overall Study|Adverse Event|1|||
124471028|NCT00272987|447682048|FG001|Overall Study|Adverse Event|0|||
124471029|NCT00272987|447682049|FG002|Overall Study|Adverse Event|0|||
124471030|NCT00272987|447682047|FG000|Overall Study|Lost to Follow-up|3|||
124471031|NCT00272987|447682048|FG001|Overall Study|Lost to Follow-up|1|||
124471032|NCT00272987|447682049|FG002|Overall Study|Lost to Follow-up|1|||
124471033|NCT00272987|447682047|FG000|Overall Study|Withdrawal by Subject|1|||
124471034|NCT00272987|447682048|FG001|Overall Study|Withdrawal by Subject|0|||
124471035|NCT00272987|447682049|FG002|Overall Study|Withdrawal by Subject|3|||
124471036|NCT00272987|447682047|FG000|Overall Study|Sponsor Terminated study|0|||
124471037|NCT00272987|447682048|FG001|Overall Study|Sponsor Terminated study|1|||
124471038|NCT00272987|447682049|FG002|Overall Study|Sponsor Terminated study|1|||
124471039|NCT00272987|447682047|FG000|Overall Study|Disease progression|1|||
124471040|NCT00272987|447682048|FG001|Overall Study|Disease progression|1|||
124471041|NCT00272987|447682049|FG002|Overall Study|Disease progression|2|||
124471042|NCT00272987|447682047|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
124471043|NCT00272987|447682048|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
124471044|NCT00272987|447682049|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
124471045|NCT00272987|447682047|FG000|Overall Study|Death|1|||
124471046|NCT00272987|447682048|FG001|Overall Study|Death|0|||
124471047|NCT00272987|447682049|FG002|Overall Study|Death|0|||
124471048|NCT01163786|447682051|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
124471049|NCT01163786|447682051|FG000|Treatment With Bortezomib|Adverse Event|2|||
124471050|NCT01163786|447682051|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
124471051|NCT00634569|447682052|FG000|Overall Study|Withdrawal by Subject|0|||
124471052|NCT00634569|447682053|FG001|Overall Study|Withdrawal by Subject|4|||
124471053|NCT00634569|447682052|FG000|Overall Study|Physician Decision|0|||
124471054|NCT00634569|447682053|FG001|Overall Study|Physician Decision|1|||
124471055|NCT02167945|447682058|FG000|Overall Study|Adverse Event|16|||
124471056|NCT02167945|447682058|FG000|Overall Study|Withdrew Consent|42|||
124471057|NCT02167945|447682058|FG000|Overall Study|Lost to Follow-up|122|||
124471058|NCT02167945|447682058|FG000|Overall Study|COVID-19 logistical restrictions|6|||
124714047|NCT04512001|448579306|FG004|Week 0 to Week 24|Death|0|||
124714048|NCT04512001|448579302|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
124714049|NCT04512001|448579303|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
124714050|NCT04512001|448579304|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
124552669|NCT01614925|447981938|FG000|Overall Study|Withdrawal by Subject|1|||
124552670|NCT01614925|447981939|FG001|Overall Study|Withdrawal by Subject|0|||
124552671|NCT01614925|447981938|FG000|Overall Study|Protocol Violation|3|||
124552672|NCT01614925|447981939|FG001|Overall Study|Protocol Violation|2|||
124552673|NCT02437890|447981944|FG000|Overall Study|Non-compliance to study drug|0|||
124552674|NCT02437890|447981945|FG001|Overall Study|Non-compliance to study drug|1|||
124552675|NCT02437890|447981946|FG002|Overall Study|Non-compliance to study drug|0|||
124552676|NCT02437890|447981947|FG003|Overall Study|Non-compliance to study drug|0|||
124552677|NCT02437890|447981948|FG004|Overall Study|Non-compliance to study drug|1|||
124552678|NCT02437890|447981944|FG000|Overall Study|Sponsor's decision|1|||
124552679|NCT02437890|447981945|FG001|Overall Study|Sponsor's decision|1|||
124552680|NCT02437890|447981946|FG002|Overall Study|Sponsor's decision|4|||
124552681|NCT02437890|447981947|FG003|Overall Study|Sponsor's decision|0|||
124552682|NCT02437890|447981948|FG004|Overall Study|Sponsor's decision|2|||
124552683|NCT02437890|447981944|FG000|Overall Study|Physician Decision|0|||
124552684|NCT02437890|447981945|FG001|Overall Study|Physician Decision|0|||
124552685|NCT02437890|447981946|FG002|Overall Study|Physician Decision|0|||
124552686|NCT02437890|447981947|FG003|Overall Study|Physician Decision|1|||
124552687|NCT02437890|447981948|FG004|Overall Study|Physician Decision|0|||
124552688|NCT02437890|447981944|FG000|Overall Study|Unable to attend visit(s)|1|||
124714051|NCT04512001|448579305|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
124714052|NCT04512001|448579306|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
124714053|NCT04512001|448579302|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
124552689|NCT02437890|447981945|FG001|Overall Study|Unable to attend visit(s)|0|||
124552690|NCT02437890|447981946|FG002|Overall Study|Unable to attend visit(s)|0|||
124552691|NCT02437890|447981947|FG003|Overall Study|Unable to attend visit(s)|0|||
124552692|NCT02437890|447981948|FG004|Overall Study|Unable to attend visit(s)|0|||
124552693|NCT02437890|447981944|FG000|Overall Study|Lack of Efficacy|1|||
124552694|NCT02437890|447981945|FG001|Overall Study|Lack of Efficacy|3|||
124552695|NCT02437890|447981946|FG002|Overall Study|Lack of Efficacy|0|||
124552696|NCT02437890|447981947|FG003|Overall Study|Lack of Efficacy|3|||
124714054|NCT04512001|448579303|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
124714055|NCT04512001|448579304|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
124552697|NCT02437890|447981948|FG004|Overall Study|Lack of Efficacy|1|||
124714056|NCT04512001|448579305|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
124714057|NCT04512001|448579306|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
124552698|NCT02437890|447981944|FG000|Overall Study|Adverse Event|4|||
124552699|NCT02437890|447981945|FG001|Overall Study|Adverse Event|9|||
124552700|NCT02437890|447981946|FG002|Overall Study|Adverse Event|5|||
124552701|NCT02437890|447981947|FG003|Overall Study|Adverse Event|11|||
124552702|NCT02437890|447981948|FG004|Overall Study|Adverse Event|7|||
124552703|NCT02437890|447981944|FG000|Overall Study|Withdrawal by Subject|1|||
124552704|NCT02437890|447981945|FG001|Overall Study|Withdrawal by Subject|2|||
124552705|NCT02437890|447981946|FG002|Overall Study|Withdrawal by Subject|6|||
124714058|NCT04512001|448579302|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
124714059|NCT04512001|448579303|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
124714060|NCT04512001|448579304|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
124714061|NCT04512001|448579305|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
124714062|NCT04512001|448579306|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
124471059|NCT02167945|447682058|FG000|Overall Study|Other, not specified|63|||
124471060|NCT01192347|447682059|FG000|Overall Study|Death|3|||
124471061|NCT01192347|447682059|FG000|Overall Study|Lost to Follow-up|3|||
124471062|NCT01192347|447682059|FG000|Overall Study|Withdrawal by Subject|1|||
124471063|NCT01192347|447682059|FG000|Overall Study|Adverse Event|1|||
124714063|NCT04512001|448579302|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
124714064|NCT04512001|448579303|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
124471064|NCT01192347|447682059|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
124471065|NCT01192347|447682059|FG000|Overall Study|Patient seen in different hospital|1|||
124471066|NCT01192347|447682059|FG000|Overall Study|Patient not visiting hospital regularly|1|||
124714065|NCT04512001|448579304|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
124714066|NCT04512001|448579305|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
124714067|NCT04512001|448579306|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
124471067|NCT01192347|447682059|FG000|Overall Study|Patient did not show up for visits|1|||
124471068|NCT03433781|447682065|FG000|Overall Study|Progression of Disease|1|||
124471069|NCT03433781|447682066|FG001|Overall Study|Progression of Disease|0|||
124471070|NCT03433781|447682067|FG002|Overall Study|Progression of Disease|0|||
124471071|NCT03433781|447682065|FG000|Overall Study|Physician Decision|0|||
124471072|NCT03433781|447682066|FG001|Overall Study|Physician Decision|1|||
124471073|NCT03433781|447682067|FG002|Overall Study|Physician Decision|0|||
124471074|NCT00408694|447682068|FG000|Overall Study|Ineligible|1|||
124471075|NCT00408694|447682068|FG000|Overall Study|No protocol treatment|1|||
124471076|NCT03261531|447682071|FG000|Overall Study|Withdrawal by Subject|4|||
124471077|NCT00091832|447682086|FG000|Overall Study|Physician Decision|1|||
124471078|NCT00091832|447682087|FG001|Overall Study|Physician Decision|0|||
124471079|NCT00091832|447682088|FG002|Overall Study|Physician Decision|0|||
124471080|NCT00091832|447682089|FG003|Overall Study|Physician Decision|0|||
124471081|NCT00091832|447682090|FG004|Overall Study|Physician Decision|0|||
124471082|NCT00091832|447682091|FG005|Overall Study|Physician Decision|0|||
124471083|NCT00091832|447682086|FG000|Overall Study|Adverse Event|0|||
124471084|NCT00091832|447682087|FG001|Overall Study|Adverse Event|0|||
124471085|NCT00091832|447682088|FG002|Overall Study|Adverse Event|0|||
124471086|NCT00091832|447682089|FG003|Overall Study|Adverse Event|1|||
124471087|NCT00091832|447682090|FG004|Overall Study|Adverse Event|3|||
124471088|NCT00091832|447682091|FG005|Overall Study|Adverse Event|0|||
124471089|NCT00091832|447682086|FG000|Overall Study|Withdrawal by Subject|4|||
124471090|NCT00091832|447682087|FG001|Overall Study|Withdrawal by Subject|5|||
124471091|NCT00091832|447682088|FG002|Overall Study|Withdrawal by Subject|0|||
124471092|NCT00091832|447682089|FG003|Overall Study|Withdrawal by Subject|1|||
124471093|NCT00091832|447682090|FG004|Overall Study|Withdrawal by Subject|3|||
124471094|NCT00091832|447682091|FG005|Overall Study|Withdrawal by Subject|1|||
124471095|NCT00091832|447682086|FG000|Overall Study|Death|6|||
124471096|NCT00091832|447682087|FG001|Overall Study|Death|4|||
124770548|NCT04672239|448788883|FG001|Week 6 Survey|Failed survey check items|2|||
124770549|NCT04672239|448788884|FG002|Week 6 Survey|Failed survey check items|2|||
124770550|NCT04672239|448788882|FG000|Week 6 Survey|Partially completed survey|3|||
124770551|NCT04672239|448788883|FG001|Week 6 Survey|Partially completed survey|3|||
124471097|NCT00091832|447682088|FG002|Overall Study|Death|5|||
124471098|NCT00091832|447682089|FG003|Overall Study|Death|8|||
124471099|NCT00091832|447682090|FG004|Overall Study|Death|5|||
124471100|NCT00091832|447682091|FG005|Overall Study|Death|6|||
124714068|NCT04512001|448579302|FG000|Week 24 to Week 63|Adverse Event|0|||
124471101|NCT00091832|447682086|FG000|Overall Study|Disease Progression|2|||
124471102|NCT00091832|447682087|FG001|Overall Study|Disease Progression|0|||
124471103|NCT00091832|447682088|FG002|Overall Study|Disease Progression|0|||
124471104|NCT00091832|447682089|FG003|Overall Study|Disease Progression|1|||
124471105|NCT00091832|447682090|FG004|Overall Study|Disease Progression|1|||
124471106|NCT00091832|447682091|FG005|Overall Study|Disease Progression|2|||
124471107|NCT00091832|447682086|FG000|Overall Study|Ineligibility Determined|0|||
124552706|NCT02437890|447981947|FG003|Overall Study|Withdrawal by Subject|5|||
124552707|NCT02437890|447981948|FG004|Overall Study|Withdrawal by Subject|5|||
124714069|NCT04512001|448579303|FG001|Week 24 to Week 63|Adverse Event|0|||
124714070|NCT04512001|448579304|FG002|Week 24 to Week 63|Adverse Event|13|||
124714071|NCT04512001|448579305|FG003|Week 24 to Week 63|Adverse Event|8|||
124714072|NCT04512001|448579306|FG004|Week 24 to Week 63|Adverse Event|6|||
124714073|NCT04512001|448579302|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
124714074|NCT04512001|448579303|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
124471108|NCT00091832|447682087|FG001|Overall Study|Ineligibility Determined|0|||
124471109|NCT00091832|447682088|FG002|Overall Study|Ineligibility Determined|1|||
124471110|NCT00091832|447682089|FG003|Overall Study|Ineligibility Determined|0|||
124471111|NCT00091832|447682090|FG004|Overall Study|Ineligibility Determined|1|||
124471112|NCT00091832|447682091|FG005|Overall Study|Ineligibility Determined|0|||
124471113|NCT00091832|447682086|FG000|Overall Study|Lost to Follow-up|1|||
124471114|NCT00091832|447682087|FG001|Overall Study|Lost to Follow-up|0|||
124471115|NCT00091832|447682088|FG002|Overall Study|Lost to Follow-up|3|||
124552708|NCT02437890|447981944|FG000|Overall Study|Death|0|||
124552709|NCT02437890|447981945|FG001|Overall Study|Death|0|||
124552710|NCT02437890|447981946|FG002|Overall Study|Death|0|||
124714075|NCT04512001|448579304|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
124471116|NCT00091832|447682089|FG003|Overall Study|Lost to Follow-up|3|||
124471117|NCT00091832|447682090|FG004|Overall Study|Lost to Follow-up|2|||
124471118|NCT00091832|447682091|FG005|Overall Study|Lost to Follow-up|1|||
124471119|NCT00091832|447682086|FG000|Overall Study|Noncompliance|0|||
124471120|NCT00091832|447682087|FG001|Overall Study|Noncompliance|1|||
124471121|NCT00091832|447682088|FG002|Overall Study|Noncompliance|0|||
124471122|NCT00091832|447682089|FG003|Overall Study|Noncompliance|0|||
124471123|NCT00091832|447682090|FG004|Overall Study|Noncompliance|0|||
124714076|NCT04512001|448579305|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
124714077|NCT04512001|448579306|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
124714078|NCT04512001|448579302|FG000|Week 24 to Week 63|Death|0|||
124714079|NCT04512001|448579303|FG001|Week 24 to Week 63|Death|0|||
124714080|NCT04512001|448579304|FG002|Week 24 to Week 63|Death|0|||
124714081|NCT04512001|448579305|FG003|Week 24 to Week 63|Death|1|||
124714082|NCT04512001|448579306|FG004|Week 24 to Week 63|Death|1|||
124714083|NCT04512001|448579302|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
124714084|NCT04512001|448579303|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
124714085|NCT04512001|448579304|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
124714086|NCT04512001|448579305|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
124770552|NCT04672239|448788884|FG002|Week 6 Survey|Partially completed survey|2|||
124552711|NCT02437890|447981947|FG003|Overall Study|Death|2|||
124714087|NCT04512001|448579306|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
124770553|NCT04672239|448788882|FG000|Week 6 Survey|Withdrawal by Subject|1|||
124714088|NCT04512001|448579302|FG000|Week 24 to Week 63|Miscellaneous|0|||
124770554|NCT04672239|448788883|FG001|Week 6 Survey|Withdrawal by Subject|1|||
124471124|NCT00091832|447682091|FG005|Overall Study|Noncompliance|0|||
124471125|NCT00091832|447682086|FG000|Overall Study|Other|0|||
124471126|NCT00091832|447682087|FG001|Overall Study|Other|1|||
124471127|NCT00091832|447682088|FG002|Overall Study|Other|2|||
124471128|NCT00091832|447682089|FG003|Overall Study|Other|0|||
124471129|NCT00091832|447682090|FG004|Overall Study|Other|0|||
124471130|NCT00091832|447682091|FG005|Overall Study|Other|0|||
124471131|NCT00091832|447682086|FG000|Overall Study|Protocol Violation|0|||
124471132|NCT00091832|447682087|FG001|Overall Study|Protocol Violation|0|||
124714089|NCT04512001|448579303|FG001|Week 24 to Week 63|Miscellaneous|0|||
124714090|NCT04512001|448579304|FG002|Week 24 to Week 63|Miscellaneous|3|||
124714091|NCT04512001|448579305|FG003|Week 24 to Week 63|Miscellaneous|2|||
124770555|NCT04672239|448788884|FG002|Week 6 Survey|Withdrawal by Subject|1|||
124770556|NCT04672239|448788882|FG000|Week 6 Survey|Withdrawn by PI|0|||
124770557|NCT04672239|448788883|FG001|Week 6 Survey|Withdrawn by PI|1|||
124471133|NCT00091832|447682088|FG002|Overall Study|Protocol Violation|1|||
124471134|NCT00091832|447682089|FG003|Overall Study|Protocol Violation|0|||
124471135|NCT00091832|447682090|FG004|Overall Study|Protocol Violation|0|||
124770558|NCT04672239|448788884|FG002|Week 6 Survey|Withdrawn by PI|0|||
124770559|NCT04672239|448788882|FG000|Week 6 Survey|Lost to Follow-up|12|||
124770560|NCT04672239|448788883|FG001|Week 6 Survey|Lost to Follow-up|2|||
124770561|NCT04672239|448788884|FG002|Week 6 Survey|Lost to Follow-up|5|||
124770562|NCT04672239|448788882|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
124770563|NCT04672239|448788883|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
124471136|NCT00091832|447682091|FG005|Overall Study|Protocol Violation|1|||
124471137|NCT00946309|447682092|FG000|Overall Study|Protocol Violation|1|||
124471138|NCT00946309|447682093|FG001|Overall Study|Protocol Violation|0|||
124471139|NCT00946309|447682092|FG000|Overall Study|Lost to Follow-up|0|||
124471140|NCT00946309|447682093|FG001|Overall Study|Lost to Follow-up|1|||
124471141|NCT00946309|447682092|FG000|Overall Study|Procedure cancelled/discontinued|0|||
124471142|NCT00946309|447682093|FG001|Overall Study|Procedure cancelled/discontinued|3|||
124471143|NCT02317562|447682096|FG000|Overall Study|Physician Decision|1|||
124471144|NCT02317562|447682096|FG000|Overall Study|early termination of the study|8|||
124471145|NCT02317562|447682096|FG000|Overall Study|Lack of Efficacy|4|||
124471146|NCT02317562|447682096|FG000|Overall Study|Withdrawal by Subject|1|||
124471147|NCT00626093|447682097|FG000|Overall Study|Lost to Follow-up|5|||
124471148|NCT00626093|447682097|FG000|Overall Study|Death|1|||
124471149|NCT00626093|447682097|FG000|Overall Study|Physician Decision|4|||
124471150|NCT00626093|447682097|FG000|Overall Study|Withdrawal by Subject|6|||
124471151|NCT00626093|447682097|FG000|Overall Study|Protocol Violation|1|||
124471152|NCT00626093|447682097|FG000|Overall Study|One of the required devices not implante|6|||
124471153|NCT00603915|447682098|FG000|Overall Study|Physician Decision|1|||
124471154|NCT03891901|447682099|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
124471155|NCT03891901|447682100|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
124471156|NCT03891901|447682101|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
124471157|NCT03891901|447682102|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
124471158|NCT03891901|447682103|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
124471159|NCT03891901|447682104|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
124471160|NCT03891901|447682105|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
124471161|NCT03891901|447682106|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
124471162|NCT03891901|447682107|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
124471163|NCT03891901|447682099|FG000|Overall Study|Adverse Event|2|||
124471164|NCT03891901|447682100|FG001|Overall Study|Adverse Event|2|||
124471165|NCT03891901|447682101|FG002|Overall Study|Adverse Event|0|||
124471166|NCT03891901|447682102|FG003|Overall Study|Adverse Event|0|||
124975750|NCT01077128|449538543|FG000|Overall Study|Adverse event and disease exacerbation|1|||
124975751|NCT01077128|449538543|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
124975752|NCT01077128|449538543|FG000|Overall Study|Other|54|||
124975753|NCT01706705|449538544|FG000|Overall Study|Death|1|||
124975754|NCT01706705|449538544|FG000|Overall Study|Lack of Efficacy|13|||
124975755|NCT01706705|449538544|FG000|Overall Study|Non-clinical|6|||
124975756|NCT04703192|449538545|FG000|Overall Study|Withdrawal by Subject|2|||
124975757|NCT04703192|449538546|FG001|Overall Study|Withdrawal by Subject|0|||
124975758|NCT04703192|449538545|FG000|Overall Study|Death|3|||
124975759|NCT04703192|449538546|FG001|Overall Study|Death|1|||
124975760|NCT04703192|449538545|FG000|Overall Study|Adverse Event|13|||
124975761|NCT04703192|449538546|FG001|Overall Study|Adverse Event|2|||
124975762|NCT04703192|449538545|FG000|Overall Study|Progressive or Relapsed Disease|46|||
124975763|NCT04703192|449538546|FG001|Overall Study|Progressive or Relapsed Disease|7|||
124975764|NCT04703192|449538545|FG000|Overall Study|Clinical Progression|19|||
124975765|NCT04703192|449538546|FG001|Overall Study|Clinical Progression|8|||
124975766|NCT04703192|449538545|FG000|Overall Study|Lost to Follow-up|1|||
124975767|NCT04703192|449538546|FG001|Overall Study|Lost to Follow-up|0|||
124975768|NCT04703192|449538545|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
124975769|NCT04703192|449538546|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
124975770|NCT04703192|449538545|FG000|Overall Study|Other|5|||
124975771|NCT04703192|449538546|FG001|Overall Study|Other|1|||
124975772|NCT02088957|449538547|FG000|Overall Study|Lack of Efficacy|1|||
124975773|NCT02088957|449538548|FG001|Overall Study|Lack of Efficacy|0|||
124975774|NCT01939353|449538549|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
124975775|NCT01939353|449538549|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
124975776|NCT01939353|449538549|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
124975777|NCT01939353|449538549|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
124975778|NCT01939353|449538549|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
124975779|NCT00874731|449538555|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
124714092|NCT04512001|448579306|FG004|Week 24 to Week 63|Miscellaneous|1|||
124975780|NCT00874731|449538556|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
124552712|NCT02437890|447981948|FG004|Overall Study|Death|0|||
124552713|NCT04723173|447981949|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
124552714|NCT02996448|447981950|FG000|Overall Study|Study terminated due to adverse effects|3|||
124552715|NCT01422720|447981951|FG000|Overall Study|Adverse Event|16|||
124552716|NCT01422720|447981951|FG000|Overall Study|Lack of Efficacy|1|||
124714093|NCT03389308|448579309|FG000|Overall Study|Withdrawal by Subject|5|||
124714094|NCT03389308|448579309|FG000|Overall Study|Lost to Follow-up|3|||
124714095|NCT03389308|448579309|FG000|Overall Study|Adverse Event|2|||
124714096|NCT03389308|448579309|FG000|Overall Study|Sponsor Request|2|||
124714097|NCT03198767|448579310|FG000|Overall Study|Protocol Violation|0|||
124714098|NCT03198767|448579311|FG001|Overall Study|Protocol Violation|0|||
124714099|NCT03198767|448579312|FG002|Overall Study|Protocol Violation|0|||
124714100|NCT03198767|448579313|FG003|Overall Study|Protocol Violation|6|||
124714101|NCT03198767|448579314|FG004|Overall Study|Protocol Violation|0|||
124714102|NCT03198767|448579315|FG005|Overall Study|Protocol Violation|0|||
124714103|NCT03198767|448579316|FG006|Overall Study|Protocol Violation|0|||
124714104|NCT00570323|448579317|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
124714105|NCT00570323|448579318|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
124714106|NCT00570323|448579317|FG000|Started Treatment After Randomization|Protocol Violation|1|||
124714107|NCT00570323|448579318|FG001|Started Treatment After Randomization|Protocol Violation|0|||
124714108|NCT00570323|448579317|FG000|Started Treatment After Randomization|Physician Decision|1|||
124714109|NCT00570323|448579318|FG001|Started Treatment After Randomization|Physician Decision|0|||
124714110|NCT00570323|448579317|FG000|Complete Study After Start|Lost to Follow-up|0|||
124714111|NCT00570323|448579318|FG001|Complete Study After Start|Lost to Follow-up|1|||
124714112|NCT00570323|448579317|FG000|Complete Study After Start|Withdrawal by Subject|2|||
124714113|NCT00570323|448579318|FG001|Complete Study After Start|Withdrawal by Subject|0|||
124714114|NCT00570323|448579317|FG000|Complete Study After Start|Physician Decision|1|||
124714115|NCT00570323|448579318|FG001|Complete Study After Start|Physician Decision|0|||
124714116|NCT04232943|448579319|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
124714117|NCT04232943|448579320|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
124714118|NCT04232943|448579321|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
124714119|NCT04232943|448579319|FG000|Overall Study|Withdrawal by Subject|1|||
124714120|NCT04232943|448579320|FG001|Overall Study|Withdrawal by Subject|1|||
124714121|NCT04232943|448579321|FG002|Overall Study|Withdrawal by Subject|0|||
124714122|NCT02639247|448579322|FG000|Overall Study|Lost to Follow-up|2|||
124714123|NCT02639247|448579323|FG001|Overall Study|Lost to Follow-up|1|||
124714124|NCT02639247|448579322|FG000|Overall Study|Death|2|||
124714125|NCT02639247|448579323|FG001|Overall Study|Death|0|||
124770564|NCT04672239|448788884|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
124714126|NCT02639247|448579322|FG000|Overall Study|Withdrew Consent|0|||
124714127|NCT02639247|448579323|FG001|Overall Study|Withdrew Consent|1|||
124714128|NCT02639247|448579322|FG000|Overall Study|Protocol Violation|1|||
124714129|NCT02639247|448579323|FG001|Overall Study|Protocol Violation|0|||
124714130|NCT02820844|448579324|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
124714131|NCT02820844|448579325|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
124714132|NCT02820844|448579326|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
124714133|NCT02820844|448579327|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
124552717|NCT01422720|447981951|FG000|Overall Study|Withdrawal by Subject|4|||
124552718|NCT01422720|447981951|FG000|Overall Study|Ineligibility|1|||
124975781|NCT00874731|449538557|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
124975782|NCT00874731|449538555|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
124975783|NCT00874731|449538556|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
124975784|NCT00874731|449538557|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
124975785|NCT00874731|449538555|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
124975786|NCT00874731|449538556|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
124975787|NCT00874731|449538557|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
124975788|NCT01132820|449538564|FG000|Overall Study|Ineligible: wrong cell type|1|||
124975789|NCT01132820|449538564|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
124975790|NCT01132820|449538564|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
124975791|NCT01132820|449538564|FG000|Overall Study|Never treated|1|||
124975792|NCT01132820|449538564|FG000|Overall Study|Inadequate data|1|||
124975793|NCT00667394|449538568|FG000|Overall Study|Adverse Event|3|||
124975794|NCT00667394|449538569|FG001|Overall Study|Adverse Event|0|||
124975795|NCT00667394|449538568|FG000|Overall Study|Progressive disease|1|||
124975796|NCT00667394|449538569|FG001|Overall Study|Progressive disease|0|||
124975797|NCT05000216|449538570|FG000|Stage 1|Lost to Follow-up|0|||
124975798|NCT05000216|449538571|FG001|Stage 1|Lost to Follow-up|0|||
124975799|NCT05000216|449538572|FG002|Stage 1|Lost to Follow-up|0|||
124714134|NCT02820844|448579328|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
124714135|NCT02820844|448579329|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
124714136|NCT02820844|448579324|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
124975800|NCT05000216|449538573|FG003|Stage 1|Lost to Follow-up|0|||
124975801|NCT05000216|449538574|FG004|Stage 1|Lost to Follow-up|0|||
124975802|NCT05000216|449538575|FG005|Stage 1|Lost to Follow-up|0|||
124975803|NCT05000216|449538576|FG006|Stage 1|Lost to Follow-up|1|||
124975804|NCT05000216|449538577|FG007|Stage 1|Lost to Follow-up|1|||
124975805|NCT05000216|449538578|FG008|Stage 1|Lost to Follow-up|0|||
124975806|NCT05000216|449538579|FG009|Stage 1|Lost to Follow-up|2|||
124975807|NCT05000216|449538580|FG010|Stage 1|Lost to Follow-up|3|||
124975808|NCT05000216|449538581|FG011|Stage 1|Lost to Follow-up|0|||
124975809|NCT05000216|449538582|FG012|Stage 1|Lost to Follow-up|0|||
124975810|NCT05000216|449538583|FG013|Stage 1|Lost to Follow-up|0|||
124975811|NCT05000216|449538584|FG014|Stage 1|Lost to Follow-up|0|||
124975812|NCT05000216|449538585|FG015|Stage 1|Lost to Follow-up|0|||
124975813|NCT05000216|449538586|FG016|Stage 1|Lost to Follow-up|0|||
124975814|NCT05000216|449538587|FG017|Stage 1|Lost to Follow-up|0|||
124975815|NCT05000216|449538588|FG018|Stage 1|Lost to Follow-up|0|||
124975816|NCT05000216|449538589|FG019|Stage 1|Lost to Follow-up|0|||
124975817|NCT05000216|449538590|FG020|Stage 1|Lost to Follow-up|0|||
124975818|NCT05000216|449538591|FG021|Stage 1|Lost to Follow-up|0|||
124975819|NCT05000216|449538570|FG000|Stage 1|Physician Decision|0|||
124975820|NCT05000216|449538571|FG001|Stage 1|Physician Decision|0|||
124975821|NCT05000216|449538572|FG002|Stage 1|Physician Decision|0|||
124714137|NCT02820844|448579325|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
124714138|NCT02820844|448579326|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
124714139|NCT02820844|448579327|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
124714140|NCT02820844|448579328|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
124714141|NCT02820844|448579329|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
124714142|NCT02820844|448579324|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
124714143|NCT02820844|448579325|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
124975822|NCT05000216|449538573|FG003|Stage 1|Physician Decision|0|||
124975823|NCT05000216|449538574|FG004|Stage 1|Physician Decision|0|||
124975824|NCT05000216|449538575|FG005|Stage 1|Physician Decision|0|||
124975825|NCT05000216|449538576|FG006|Stage 1|Physician Decision|0|||
124975826|NCT05000216|449538577|FG007|Stage 1|Physician Decision|1|||
124975827|NCT05000216|449538578|FG008|Stage 1|Physician Decision|1|||
124975828|NCT05000216|449538579|FG009|Stage 1|Physician Decision|0|||
124975829|NCT05000216|449538580|FG010|Stage 1|Physician Decision|0|||
124975830|NCT05000216|449538581|FG011|Stage 1|Physician Decision|0|||
124975831|NCT05000216|449538582|FG012|Stage 1|Physician Decision|0|||
124975832|NCT05000216|449538583|FG013|Stage 1|Physician Decision|0|||
124975833|NCT05000216|449538584|FG014|Stage 1|Physician Decision|0|||
124975834|NCT05000216|449538585|FG015|Stage 1|Physician Decision|0|||
124975835|NCT05000216|449538586|FG016|Stage 1|Physician Decision|0|||
124975836|NCT05000216|449538587|FG017|Stage 1|Physician Decision|0|||
124975837|NCT05000216|449538588|FG018|Stage 1|Physician Decision|0|||
124975838|NCT05000216|449538589|FG019|Stage 1|Physician Decision|0|||
124975839|NCT05000216|449538590|FG020|Stage 1|Physician Decision|0|||
124975840|NCT05000216|449538591|FG021|Stage 1|Physician Decision|0|||
124975841|NCT05000216|449538570|FG000|Stage 1|Withdrawal by Subject|0|||
124975842|NCT05000216|449538571|FG001|Stage 1|Withdrawal by Subject|1|||
124975843|NCT05000216|449538572|FG002|Stage 1|Withdrawal by Subject|0|||
124975844|NCT05000216|449538573|FG003|Stage 1|Withdrawal by Subject|0|||
124975845|NCT05000216|449538574|FG004|Stage 1|Withdrawal by Subject|0|||
124975846|NCT05000216|449538575|FG005|Stage 1|Withdrawal by Subject|0|||
124975847|NCT05000216|449538576|FG006|Stage 1|Withdrawal by Subject|0|||
124975848|NCT05000216|449538577|FG007|Stage 1|Withdrawal by Subject|0|||
124975849|NCT05000216|449538578|FG008|Stage 1|Withdrawal by Subject|0|||
124975850|NCT05000216|449538579|FG009|Stage 1|Withdrawal by Subject|3|||
124975851|NCT05000216|449538580|FG010|Stage 1|Withdrawal by Subject|10|||
124975852|NCT05000216|449538581|FG011|Stage 1|Withdrawal by Subject|0|||
124975853|NCT05000216|449538582|FG012|Stage 1|Withdrawal by Subject|0|||
124975854|NCT05000216|449538583|FG013|Stage 1|Withdrawal by Subject|0|||
124975855|NCT05000216|449538584|FG014|Stage 1|Withdrawal by Subject|0|||
124975856|NCT05000216|449538585|FG015|Stage 1|Withdrawal by Subject|0|||
124975857|NCT05000216|449538586|FG016|Stage 1|Withdrawal by Subject|0|||
124975858|NCT05000216|449538587|FG017|Stage 1|Withdrawal by Subject|0|||
124975859|NCT05000216|449538588|FG018|Stage 1|Withdrawal by Subject|0|||
124975860|NCT05000216|449538589|FG019|Stage 1|Withdrawal by Subject|0|||
124975861|NCT05000216|449538590|FG020|Stage 1|Withdrawal by Subject|0|||
124975862|NCT05000216|449538591|FG021|Stage 1|Withdrawal by Subject|0|||
124975863|NCT05000216|449538570|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
124975864|NCT05000216|449538571|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
124975865|NCT05000216|449538572|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
124975866|NCT05000216|449538573|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
124975867|NCT05000216|449538574|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
124975868|NCT05000216|449538575|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
124975869|NCT05000216|449538576|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
124975870|NCT05000216|449538577|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
124975871|NCT05000216|449538578|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
124975872|NCT05000216|449538579|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
124975873|NCT05000216|449538580|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
124975874|NCT05000216|449538581|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
124975875|NCT05000216|449538582|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
124975876|NCT05000216|449538583|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
124975877|NCT05000216|449538584|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
124975878|NCT05000216|449538585|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
124975879|NCT05000216|449538586|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
124975880|NCT05000216|449538587|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
124975881|NCT05000216|449538588|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
124975882|NCT05000216|449538589|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
124975883|NCT05000216|449538590|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
124975884|NCT05000216|449538591|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
124975885|NCT05000216|449538570|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975886|NCT05000216|449538571|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975887|NCT05000216|449538572|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975888|NCT05000216|449538573|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975889|NCT05000216|449538574|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975890|NCT05000216|449538575|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975891|NCT05000216|449538576|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975892|NCT05000216|449538577|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975893|NCT05000216|449538578|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
124975894|NCT05000216|449538579|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975895|NCT05000216|449538580|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975896|NCT05000216|449538581|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975897|NCT05000216|449538582|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975898|NCT05000216|449538583|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975899|NCT05000216|449538584|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975900|NCT05000216|449538585|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975901|NCT05000216|449538586|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975902|NCT05000216|449538587|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975903|NCT05000216|449538588|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975904|NCT05000216|449538589|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975905|NCT05000216|449538590|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975906|NCT05000216|449538591|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
124975907|NCT05000216|449538570|FG000|Stage 1|Other|0|||
124975908|NCT05000216|449538571|FG001|Stage 1|Other|0|||
124975909|NCT05000216|449538572|FG002|Stage 1|Other|0|||
124975910|NCT05000216|449538573|FG003|Stage 1|Other|0|||
124975911|NCT05000216|449538574|FG004|Stage 1|Other|1|||
124975912|NCT05000216|449538575|FG005|Stage 1|Other|0|||
124975913|NCT05000216|449538576|FG006|Stage 1|Other|0|||
124975914|NCT05000216|449538577|FG007|Stage 1|Other|2|||
124975915|NCT05000216|449538578|FG008|Stage 1|Other|0|||
124975916|NCT05000216|449538579|FG009|Stage 1|Other|0|||
124975917|NCT05000216|449538580|FG010|Stage 1|Other|1|||
124975918|NCT05000216|449538581|FG011|Stage 1|Other|1|||
124975919|NCT05000216|449538582|FG012|Stage 1|Other|0|||
124975920|NCT05000216|449538583|FG013|Stage 1|Other|0|||
124975921|NCT05000216|449538584|FG014|Stage 1|Other|0|||
124975922|NCT05000216|449538585|FG015|Stage 1|Other|0|||
124975923|NCT05000216|449538586|FG016|Stage 1|Other|0|||
124975924|NCT05000216|449538587|FG017|Stage 1|Other|0|||
124975925|NCT05000216|449538588|FG018|Stage 1|Other|0|||
124975926|NCT05000216|449538589|FG019|Stage 1|Other|0|||
124975927|NCT05000216|449538590|FG020|Stage 1|Other|0|||
124975928|NCT05000216|449538591|FG021|Stage 1|Other|0|||
124975929|NCT05000216|449538570|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
124975930|NCT05000216|449538571|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
124975931|NCT05000216|449538572|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
124975932|NCT05000216|449538573|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
124975933|NCT05000216|449538574|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
124975934|NCT05000216|449538575|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
124975935|NCT05000216|449538576|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
124975936|NCT05000216|449538577|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
124975937|NCT05000216|449538578|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
124975938|NCT05000216|449538579|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
124975939|NCT05000216|449538580|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
124975940|NCT05000216|449538581|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
124975941|NCT05000216|449538582|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
124975942|NCT05000216|449538583|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
124975943|NCT05000216|449538584|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
124975944|NCT05000216|449538585|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
124975945|NCT05000216|449538586|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
124975946|NCT05000216|449538587|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
124975947|NCT05000216|449538588|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
124975948|NCT05000216|449538589|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
124975949|NCT05000216|449538590|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
124975950|NCT05000216|449538591|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
124975951|NCT05000216|449538570|FG000|Stage 2|Lost to Follow-up|0|||
124975952|NCT05000216|449538571|FG001|Stage 2|Lost to Follow-up|0|||
124975953|NCT05000216|449538572|FG002|Stage 2|Lost to Follow-up|0|||
124975954|NCT05000216|449538573|FG003|Stage 2|Lost to Follow-up|0|||
124975955|NCT05000216|449538574|FG004|Stage 2|Lost to Follow-up|0|||
124975956|NCT05000216|449538575|FG005|Stage 2|Lost to Follow-up|0|||
124975957|NCT05000216|449538576|FG006|Stage 2|Lost to Follow-up|0|||
124975958|NCT05000216|449538577|FG007|Stage 2|Lost to Follow-up|0|||
124975959|NCT05000216|449538578|FG008|Stage 2|Lost to Follow-up|0|||
124975960|NCT05000216|449538579|FG009|Stage 2|Lost to Follow-up|0|||
124975961|NCT05000216|449538580|FG010|Stage 2|Lost to Follow-up|0|||
124975962|NCT05000216|449538581|FG011|Stage 2|Lost to Follow-up|0|||
124975963|NCT05000216|449538582|FG012|Stage 2|Lost to Follow-up|0|||
124975964|NCT05000216|449538583|FG013|Stage 2|Lost to Follow-up|0|||
124975965|NCT05000216|449538584|FG014|Stage 2|Lost to Follow-up|0|||
124975966|NCT05000216|449538585|FG015|Stage 2|Lost to Follow-up|0|||
124975967|NCT05000216|449538586|FG016|Stage 2|Lost to Follow-up|4|||
124975968|NCT05000216|449538587|FG017|Stage 2|Lost to Follow-up|0|||
124975969|NCT05000216|449538588|FG018|Stage 2|Lost to Follow-up|0|||
124975970|NCT05000216|449538589|FG019|Stage 2|Lost to Follow-up|0|||
124975971|NCT05000216|449538590|FG020|Stage 2|Lost to Follow-up|0|||
124975972|NCT05000216|449538591|FG021|Stage 2|Lost to Follow-up|0|||
124975973|NCT05000216|449538570|FG000|Stage 2|Physician Decision|0|||
124975974|NCT05000216|449538571|FG001|Stage 2|Physician Decision|0|||
124975975|NCT05000216|449538572|FG002|Stage 2|Physician Decision|0|||
124975976|NCT05000216|449538573|FG003|Stage 2|Physician Decision|0|||
124975977|NCT05000216|449538574|FG004|Stage 2|Physician Decision|0|||
124975978|NCT05000216|449538575|FG005|Stage 2|Physician Decision|0|||
124975979|NCT05000216|449538576|FG006|Stage 2|Physician Decision|0|||
124975980|NCT05000216|449538577|FG007|Stage 2|Physician Decision|0|||
124975981|NCT05000216|449538578|FG008|Stage 2|Physician Decision|0|||
124975982|NCT05000216|449538579|FG009|Stage 2|Physician Decision|0|||
124975983|NCT05000216|449538580|FG010|Stage 2|Physician Decision|0|||
124975984|NCT05000216|449538581|FG011|Stage 2|Physician Decision|0|||
124975985|NCT05000216|449538582|FG012|Stage 2|Physician Decision|1|||
124975986|NCT05000216|449538583|FG013|Stage 2|Physician Decision|0|||
124975987|NCT05000216|449538584|FG014|Stage 2|Physician Decision|0|||
124975988|NCT05000216|449538585|FG015|Stage 2|Physician Decision|0|||
124975989|NCT05000216|449538586|FG016|Stage 2|Physician Decision|0|||
124975990|NCT05000216|449538587|FG017|Stage 2|Physician Decision|0|||
124975991|NCT05000216|449538588|FG018|Stage 2|Physician Decision|0|||
124975992|NCT05000216|449538589|FG019|Stage 2|Physician Decision|0|||
124975993|NCT05000216|449538590|FG020|Stage 2|Physician Decision|0|||
124975994|NCT05000216|449538591|FG021|Stage 2|Physician Decision|0|||
124975995|NCT05000216|449538570|FG000|Stage 2|Withdrawal by Subject|0|||
124975996|NCT05000216|449538571|FG001|Stage 2|Withdrawal by Subject|0|||
124975997|NCT05000216|449538572|FG002|Stage 2|Withdrawal by Subject|0|||
124975998|NCT05000216|449538573|FG003|Stage 2|Withdrawal by Subject|0|||
124975999|NCT05000216|449538574|FG004|Stage 2|Withdrawal by Subject|0|||
124976000|NCT05000216|449538575|FG005|Stage 2|Withdrawal by Subject|0|||
124976001|NCT05000216|449538576|FG006|Stage 2|Withdrawal by Subject|0|||
124976002|NCT05000216|449538577|FG007|Stage 2|Withdrawal by Subject|0|||
124976003|NCT05000216|449538578|FG008|Stage 2|Withdrawal by Subject|0|||
124976004|NCT05000216|449538579|FG009|Stage 2|Withdrawal by Subject|0|||
124976005|NCT05000216|449538580|FG010|Stage 2|Withdrawal by Subject|0|||
124976006|NCT05000216|449538581|FG011|Stage 2|Withdrawal by Subject|0|||
124976007|NCT05000216|449538582|FG012|Stage 2|Withdrawal by Subject|0|||
124976008|NCT05000216|449538583|FG013|Stage 2|Withdrawal by Subject|0|||
124976009|NCT05000216|449538584|FG014|Stage 2|Withdrawal by Subject|2|||
124976010|NCT05000216|449538585|FG015|Stage 2|Withdrawal by Subject|0|||
124976011|NCT05000216|449538586|FG016|Stage 2|Withdrawal by Subject|9|||
124976012|NCT05000216|449538587|FG017|Stage 2|Withdrawal by Subject|0|||
124976013|NCT05000216|449538588|FG018|Stage 2|Withdrawal by Subject|0|||
124976014|NCT05000216|449538589|FG019|Stage 2|Withdrawal by Subject|0|||
124976015|NCT05000216|449538590|FG020|Stage 2|Withdrawal by Subject|0|||
124976016|NCT05000216|449538591|FG021|Stage 2|Withdrawal by Subject|0|||
124976017|NCT05000216|449538570|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
124976018|NCT05000216|449538571|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
124976019|NCT05000216|449538572|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
124976020|NCT05000216|449538573|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
124976021|NCT05000216|449538574|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
124976022|NCT05000216|449538575|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
124976023|NCT05000216|449538576|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
124976024|NCT05000216|449538577|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
124976025|NCT05000216|449538578|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
124976026|NCT05000216|449538579|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
124976027|NCT05000216|449538580|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
124976028|NCT05000216|449538581|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
124976029|NCT05000216|449538582|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
124976030|NCT05000216|449538583|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
124976031|NCT05000216|449538584|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
124976032|NCT05000216|449538585|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
124976033|NCT05000216|449538586|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
124976034|NCT05000216|449538587|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
124976035|NCT05000216|449538588|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
124976036|NCT05000216|449538589|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
124976037|NCT05000216|449538590|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
124976038|NCT05000216|449538591|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
124976039|NCT05000216|449538570|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976040|NCT05000216|449538571|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976041|NCT05000216|449538572|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976042|NCT05000216|449538573|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124770565|NCT04672239|448788882|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
124770566|NCT04672239|448788883|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
124770567|NCT04672239|448788884|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
124770568|NCT04672239|448788882|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
124770569|NCT04672239|448788883|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
124770570|NCT04672239|448788884|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
124770571|NCT04672239|448788882|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
124471167|NCT03891901|447682103|FG004|Overall Study|Adverse Event|0|||
124714144|NCT02820844|448579326|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
124714145|NCT02820844|448579327|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
124714146|NCT02820844|448579328|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
124714147|NCT02820844|448579329|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
124714148|NCT02820844|448579324|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
124714149|NCT02820844|448579325|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
124714150|NCT02820844|448579326|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
124714151|NCT02820844|448579327|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
124714152|NCT02820844|448579328|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
124976043|NCT05000216|449538574|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976044|NCT05000216|449538575|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976045|NCT05000216|449538576|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976046|NCT05000216|449538577|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976047|NCT05000216|449538578|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976048|NCT05000216|449538579|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976049|NCT05000216|449538580|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976050|NCT05000216|449538581|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976051|NCT05000216|449538582|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976052|NCT05000216|449538583|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976053|NCT05000216|449538584|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
124976054|NCT05000216|449538585|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124714153|NCT02820844|448579329|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
124714154|NCT02820844|448579324|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
124714155|NCT02820844|448579325|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
124714156|NCT02820844|448579326|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
124714157|NCT02820844|448579327|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
124714158|NCT02820844|448579328|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
124714159|NCT02820844|448579329|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
124714160|NCT02820844|448579324|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
124714161|NCT02820844|448579325|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
124714162|NCT02820844|448579326|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
124714163|NCT02820844|448579327|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
124714164|NCT02820844|448579328|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
124714165|NCT02820844|448579329|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
124714166|NCT02820844|448579324|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
124714167|NCT02820844|448579325|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
124714168|NCT02820844|448579326|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
124714169|NCT02820844|448579327|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
124714170|NCT02820844|448579328|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
124714171|NCT02820844|448579329|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
124714172|NCT02820844|448579324|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
124714173|NCT02820844|448579325|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
124714174|NCT02820844|448579326|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
124714175|NCT02820844|448579327|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
124714176|NCT02820844|448579328|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
124714177|NCT02820844|448579329|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
124714178|NCT02820844|448579324|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
124714179|NCT02820844|448579325|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
124714180|NCT02820844|448579326|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
124770572|NCT04672239|448788883|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
124770573|NCT04672239|448788884|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
124976055|NCT05000216|449538586|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
124976056|NCT05000216|449538587|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976057|NCT05000216|449538588|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976058|NCT05000216|449538589|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976059|NCT05000216|449538590|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976060|NCT05000216|449538591|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
124976061|NCT05000216|449538570|FG000|Stage 2|Other reason|0|||
124976062|NCT05000216|449538571|FG001|Stage 2|Other reason|0|||
124976063|NCT05000216|449538572|FG002|Stage 2|Other reason|0|||
124976064|NCT05000216|449538573|FG003|Stage 2|Other reason|0|||
124976065|NCT05000216|449538574|FG004|Stage 2|Other reason|0|||
124976066|NCT05000216|449538575|FG005|Stage 2|Other reason|0|||
124976067|NCT05000216|449538576|FG006|Stage 2|Other reason|0|||
124976068|NCT05000216|449538577|FG007|Stage 2|Other reason|0|||
124976069|NCT05000216|449538578|FG008|Stage 2|Other reason|0|||
124976070|NCT05000216|449538579|FG009|Stage 2|Other reason|0|||
124976071|NCT05000216|449538580|FG010|Stage 2|Other reason|0|||
124976072|NCT05000216|449538581|FG011|Stage 2|Other reason|0|||
124976073|NCT05000216|449538582|FG012|Stage 2|Other reason|0|||
124976074|NCT05000216|449538583|FG013|Stage 2|Other reason|0|||
124976075|NCT05000216|449538584|FG014|Stage 2|Other reason|0|||
124976076|NCT05000216|449538585|FG015|Stage 2|Other reason|0|||
124976077|NCT05000216|449538586|FG016|Stage 2|Other reason|1|||
124976078|NCT05000216|449538587|FG017|Stage 2|Other reason|0|||
124976079|NCT05000216|449538588|FG018|Stage 2|Other reason|0|||
124976080|NCT05000216|449538589|FG019|Stage 2|Other reason|0|||
124976081|NCT05000216|449538590|FG020|Stage 2|Other reason|0|||
124976082|NCT05000216|449538591|FG021|Stage 2|Other reason|0|||
124976083|NCT05000216|449538570|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
124976084|NCT05000216|449538571|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
124552719|NCT02082262|447981952|FG000|Overall Study|Withdrawal by Subject|3|||
124552720|NCT02082262|447981952|FG000|Overall Study|Adverse Event|48|||
124552721|NCT01586624|447981953|FG000|Overall Study|Adverse Event|3|||
124552722|NCT01586624|447981954|FG001|Overall Study|Adverse Event|0|||
124552723|NCT01586624|447981955|FG002|Overall Study|Adverse Event|2|||
124552724|NCT01586624|447981956|FG003|Overall Study|Adverse Event|1|||
124552725|NCT01586624|447981957|FG004|Overall Study|Adverse Event|3|||
124552726|NCT01586624|447981958|FG005|Overall Study|Adverse Event|3|||
124976085|NCT05000216|449538572|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
124976086|NCT05000216|449538573|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
124976087|NCT05000216|449538574|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
124976088|NCT05000216|449538575|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
124976089|NCT05000216|449538576|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
124976090|NCT05000216|449538577|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
124976091|NCT05000216|449538578|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
124552727|NCT01586624|447981959|FG006|Overall Study|Adverse Event|2|||
124552728|NCT01586624|447981960|FG007|Overall Study|Adverse Event|3|||
124976092|NCT05000216|449538579|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
124976093|NCT05000216|449538580|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
124552729|NCT01586624|447981953|FG000|Overall Study|Physician Decision|0|||
124976094|NCT05000216|449538581|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
124976095|NCT05000216|449538582|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
124976096|NCT05000216|449538583|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
124552730|NCT01586624|447981954|FG001|Overall Study|Physician Decision|1|||
124976097|NCT05000216|449538584|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
124976098|NCT05000216|449538585|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
124976099|NCT05000216|449538586|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
124976100|NCT05000216|449538587|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
124976101|NCT05000216|449538588|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
124976102|NCT05000216|449538589|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
124976103|NCT05000216|449538590|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
124976104|NCT05000216|449538591|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
124976105|NCT05000216|449538570|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976106|NCT05000216|449538571|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
124770574|NCT04672239|448788882|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
124770575|NCT04672239|448788883|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
124770576|NCT04672239|448788884|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
124770577|NCT04672239|448788882|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
124770578|NCT04672239|448788883|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
124976107|NCT05000216|449538572|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976108|NCT05000216|449538573|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976109|NCT05000216|449538574|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976110|NCT05000216|449538575|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976111|NCT05000216|449538576|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976112|NCT05000216|449538577|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976113|NCT05000216|449538578|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976114|NCT05000216|449538579|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976115|NCT05000216|449538580|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976116|NCT05000216|449538581|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976117|NCT05000216|449538582|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976118|NCT05000216|449538583|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976119|NCT05000216|449538584|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976120|NCT05000216|449538585|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
124976121|NCT05000216|449538586|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976122|NCT05000216|449538587|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976123|NCT05000216|449538588|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976124|NCT05000216|449538589|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976125|NCT05000216|449538590|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976126|NCT05000216|449538591|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
124976127|NCT05000216|449538570|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976128|NCT05000216|449538571|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976129|NCT05000216|449538572|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976130|NCT05000216|449538573|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976131|NCT05000216|449538574|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976132|NCT05000216|449538575|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976133|NCT05000216|449538576|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976134|NCT05000216|449538577|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976135|NCT05000216|449538578|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976136|NCT05000216|449538579|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976137|NCT05000216|449538580|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976138|NCT05000216|449538581|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976139|NCT05000216|449538582|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976140|NCT05000216|449538583|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
124976141|NCT05000216|449538584|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976142|NCT05000216|449538585|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
124976143|NCT05000216|449538586|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976144|NCT05000216|449538587|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976145|NCT05000216|449538588|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
124976146|NCT05000216|449538589|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976147|NCT05000216|449538590|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976148|NCT05000216|449538591|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
124976149|NCT02195479|449538596|FG000|Overall Study|Lost to Follow-up|18|||
124976150|NCT02195479|449538597|FG001|Overall Study|Lost to Follow-up|15|||
124976151|NCT02195479|449538596|FG000|Overall Study|Death|217|||
124976152|NCT02195479|449538597|FG001|Overall Study|Death|171|||
124976153|NCT02195479|449538596|FG000|Overall Study|Physician Decision|1|||
124976154|NCT02195479|449538597|FG001|Overall Study|Physician Decision|0|||
124976155|NCT02195479|449538596|FG000|Overall Study|Withdrawal by Subject|30|||
124976156|NCT02195479|449538597|FG001|Overall Study|Withdrawal by Subject|30|||
124976157|NCT02195479|449538596|FG000|Overall Study|Other|3|||
124976158|NCT02195479|449538597|FG001|Overall Study|Other|4|||
124976159|NCT02195479|449538596|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
124976160|NCT02195479|449538597|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
124976161|NCT03004404|449538600|FG000|Period 2|Adverse Event|0|||
124976162|NCT03004404|449538601|FG001|Period 2|Adverse Event|0|||
124976163|NCT03004404|449538602|FG002|Period 2|Adverse Event|0|||
124976164|NCT03004404|449538603|FG003|Period 2|Adverse Event|0|||
124976165|NCT03004404|449538604|FG004|Period 2|Adverse Event|0|||
124976166|NCT03004404|449538605|FG005|Period 2|Adverse Event|0|||
124471168|NCT03891901|447682104|FG005|Overall Study|Adverse Event|0|||
124471169|NCT03891901|447682105|FG006|Overall Study|Adverse Event|0|||
124471170|NCT03891901|447682106|FG007|Overall Study|Adverse Event|0|||
124471171|NCT03891901|447682107|FG008|Overall Study|Adverse Event|0|||
124471172|NCT03891901|447682099|FG000|Overall Study|Poor venous access|1|||
124471173|NCT03891901|447682100|FG001|Overall Study|Poor venous access|0|||
124976167|NCT03004404|449538606|FG006|Period 2|Adverse Event|0|||
124976168|NCT03004404|449538607|FG007|Period 2|Adverse Event|0|||
124976169|NCT03004404|449538608|FG008|Period 2|Adverse Event|1|||
124976170|NCT03004404|449538609|FG009|Period 2|Adverse Event|0|||
124976171|NCT03004404|449538610|FG010|Period 2|Adverse Event|0|||
124976172|NCT03004404|449538611|FG011|Period 2|Adverse Event|0|||
124976173|NCT03004404|449538612|FG012|Period 2|Adverse Event|0|||
124976174|NCT03004404|449538613|FG013|Period 2|Adverse Event|0|||
124976175|NCT03004404|449538614|FG014|Period 2|Adverse Event|0|||
124976176|NCT03004404|449538615|FG015|Period 2|Adverse Event|1|||
124976177|NCT02522728|449538619|FG000|Overall Study|Withdrawal by Subject|6|||
124976178|NCT02522728|449538620|FG001|Overall Study|Withdrawal by Subject|6|||
124976179|NCT02522728|449538619|FG000|Overall Study|Death|4|||
124976180|NCT02522728|449538620|FG001|Overall Study|Death|3|||
124976181|NCT02522728|449538619|FG000|Overall Study|Adverse Event|2|||
124976182|NCT02522728|449538620|FG001|Overall Study|Adverse Event|1|||
124976183|NCT02522728|449538619|FG000|Overall Study|Did not receive randomized study device|0|||
124976184|NCT02522728|449538620|FG001|Overall Study|Did not receive randomized study device|1|||
124976185|NCT01266161|449538622|FG000|Overall Study|Ineligible|1|||
124976186|NCT01266161|449538623|FG001|Overall Study|Ineligible|0|||
124976187|NCT01266161|449538622|FG000|Overall Study|Lack of Efficacy|0|||
124976188|NCT01266161|449538623|FG001|Overall Study|Lack of Efficacy|1|||
124976189|NCT01266161|449538622|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
124976190|NCT01266161|449538623|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
124976191|NCT01436305|449538624|FG000|Overall Study|Death|1|||
124976192|NCT01436305|449538625|FG001|Overall Study|Death|0|||
124976193|NCT01436305|449538626|FG002|Overall Study|Death|0|||
124976194|NCT01436305|449538624|FG000|Overall Study|Lost to Follow-up|0|||
124976195|NCT01436305|449538625|FG001|Overall Study|Lost to Follow-up|1|||
124976196|NCT01436305|449538626|FG002|Overall Study|Lost to Follow-up|0|||
124976197|NCT01436305|449538624|FG000|Overall Study|Withdrawal by Subject|1|||
124976198|NCT01436305|449538625|FG001|Overall Study|Withdrawal by Subject|3|||
124976199|NCT01436305|449538626|FG002|Overall Study|Withdrawal by Subject|0|||
124976200|NCT05071053|449538629|FG000|Overall Study|Progressive disease|30|||
124976201|NCT05071053|449538629|FG000|Overall Study|Adverse Event|5|||
124976202|NCT01081886|449538630|FG000|Overall Study|Study termination|11|||
124976203|NCT01081886|449538631|FG001|Overall Study|Study termination|13|||
124976204|NCT04148651|449538632|FG000|Overall Study|Lost to Follow-up|2|||
124976205|NCT01602510|449538633|FG000|Open Label Phase|Adverse Event|46|||
124976206|NCT01602510|449538634|FG001|Open Label Phase|Adverse Event|0|||
124976207|NCT01602510|449538635|FG002|Open Label Phase|Adverse Event|0|||
124976208|NCT01602510|449538633|FG000|Open Label Phase|Lack of Efficacy|22|||
124976209|NCT01602510|449538634|FG001|Open Label Phase|Lack of Efficacy|0|||
124714181|NCT02820844|448579327|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
124976210|NCT01602510|449538635|FG002|Open Label Phase|Lack of Efficacy|0|||
124976211|NCT01602510|449538633|FG000|Open Label Phase|Protocol Violation|15|||
124714182|NCT02820844|448579328|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
124714183|NCT02820844|448579329|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
124976212|NCT01602510|449538634|FG001|Open Label Phase|Protocol Violation|0|||
124976213|NCT01602510|449538635|FG002|Open Label Phase|Protocol Violation|0|||
124976214|NCT01602510|449538633|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
124976215|NCT01602510|449538634|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
124976216|NCT01602510|449538635|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
124976217|NCT01602510|449538633|FG000|Open Label Phase|Lost to Follow-up|22|||
124976218|NCT01602510|449538634|FG001|Open Label Phase|Lost to Follow-up|0|||
124976219|NCT01602510|449538635|FG002|Open Label Phase|Lost to Follow-up|0|||
124976220|NCT01602510|449538633|FG000|Open Label Phase|Physician Decision|19|||
124471174|NCT03891901|447682101|FG002|Overall Study|Poor venous access|0|||
124471175|NCT03891901|447682102|FG003|Overall Study|Poor venous access|0|||
124471176|NCT03891901|447682103|FG004|Overall Study|Poor venous access|0|||
124976221|NCT01602510|449538634|FG001|Open Label Phase|Physician Decision|0|||
124976222|NCT01602510|449538635|FG002|Open Label Phase|Physician Decision|0|||
124976223|NCT01602510|449538633|FG000|Open Label Phase|Withdrawal by Subject|57|||
124976224|NCT01602510|449538634|FG001|Open Label Phase|Withdrawal by Subject|0|||
124976225|NCT01602510|449538635|FG002|Open Label Phase|Withdrawal by Subject|0|||
124976226|NCT01602510|449538633|FG000|Randomized Phase|Adverse Event|0|||
124976227|NCT01602510|449538634|FG001|Randomized Phase|Adverse Event|2|||
124976228|NCT01602510|449538635|FG002|Randomized Phase|Adverse Event|6|||
124976229|NCT01602510|449538633|FG000|Randomized Phase|Lack of Efficacy|0|||
124976230|NCT01602510|449538634|FG001|Randomized Phase|Lack of Efficacy|4|||
124976231|NCT01602510|449538635|FG002|Randomized Phase|Lack of Efficacy|4|||
124976232|NCT01602510|449538633|FG000|Randomized Phase|Protocol Violation|0|||
124976233|NCT01602510|449538634|FG001|Randomized Phase|Protocol Violation|3|||
124976234|NCT01602510|449538635|FG002|Randomized Phase|Protocol Violation|3|||
124976235|NCT01602510|449538633|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
124976236|NCT01602510|449538634|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
124976237|NCT01602510|449538635|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
124976238|NCT01602510|449538633|FG000|Randomized Phase|Lost to Follow-up|0|||
124976239|NCT01602510|449538634|FG001|Randomized Phase|Lost to Follow-up|1|||
124976240|NCT01602510|449538635|FG002|Randomized Phase|Lost to Follow-up|3|||
124976241|NCT01602510|449538633|FG000|Randomized Phase|Physician Decision|0|||
124976242|NCT01602510|449538634|FG001|Randomized Phase|Physician Decision|0|||
124976243|NCT01602510|449538635|FG002|Randomized Phase|Physician Decision|2|||
124976244|NCT01602510|449538633|FG000|Randomized Phase|Withdrawal by Subject|0|||
124976245|NCT01602510|449538634|FG001|Randomized Phase|Withdrawal by Subject|6|||
124976246|NCT01602510|449538635|FG002|Randomized Phase|Withdrawal by Subject|7|||
124976247|NCT05262751|449538636|FG000|Washout Period 2|Adverse Event|1|||
124976248|NCT05262751|449538637|FG001|Washout Period 2|Adverse Event|0|||
124976249|NCT05262751|449538638|FG002|Washout Period 2|Adverse Event|0|||
124976250|NCT05262751|449538639|FG003|Washout Period 2|Adverse Event|0|||
124976251|NCT05262751|449538640|FG004|Washout Period 2|Adverse Event|0|||
124976252|NCT05262751|449538641|FG005|Washout Period 2|Adverse Event|0|||
124976253|NCT05262751|449538636|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
124976254|NCT05262751|449538637|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
124976255|NCT05262751|449538638|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
124976256|NCT05262751|449538639|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
124976257|NCT05262751|449538640|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
124976258|NCT05262751|449538641|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
124976259|NCT03519204|449538642|FG000|Overall Study|Lost to Follow-up|3|||
124976260|NCT03519204|449538643|FG001|Overall Study|Lost to Follow-up|8|||
124976261|NCT03519204|449538642|FG000|Overall Study|Withdrawal by Subject|9|||
124976262|NCT03519204|449538643|FG001|Overall Study|Withdrawal by Subject|7|||
124976263|NCT03519204|449538642|FG000|Overall Study|Other Miscellaneous Reasons|1|||
124976264|NCT03519204|449538643|FG001|Overall Study|Other Miscellaneous Reasons|0|||
124976265|NCT01572740|449538645|FG000|Overall Study|Adverse Event|1|||
124976266|NCT01572740|449538646|FG001|Overall Study|Adverse Event|1|||
124976267|NCT01572740|449538645|FG000|Overall Study|Withdrawal by Subject|1|||
124976268|NCT01572740|449538646|FG001|Overall Study|Withdrawal by Subject|1|||
124976269|NCT01572740|449538645|FG000|Overall Study|unclassified|4|||
124976270|NCT01572740|449538646|FG001|Overall Study|unclassified|3|||
124976271|NCT01289210|449538647|FG000|Overall Study|Adverse Event|1|||
124976272|NCT01110408|449538650|FG000|Overall Study|Protocol Violation|1|||
124976273|NCT01110408|449538651|FG001|Overall Study|Protocol Violation|0|||
124976274|NCT02269423|449538652|FG000|Overall Study|Discontinued due to change in residence|0|||
124976275|NCT02269423|449538653|FG001|Overall Study|Discontinued due to change in residence|1|||
124976276|NCT02269423|449538654|FG002|Overall Study|Discontinued due to change in residence|0|||
124976277|NCT02269423|449538655|FG003|Overall Study|Discontinued due to change in residence|1|||
124976278|NCT00839956|449538656|FG000|Overall Study|Adverse Event|2|||
124976279|NCT00839956|449538656|FG000|Overall Study|Lack of Efficacy|6|||
124552731|NCT01586624|447981955|FG002|Overall Study|Physician Decision|1|||
124552732|NCT01586624|447981956|FG003|Overall Study|Physician Decision|0|||
124976280|NCT00839956|449538656|FG000|Overall Study|Physician Decision|1|||
124976281|NCT00839956|449538656|FG000|Overall Study|Withdrawal by Subject|3|||
124976282|NCT01509547|449538657|FG000|Overall Study|Lost to Follow-up|24|||
124552733|NCT01586624|447981957|FG004|Overall Study|Physician Decision|2|||
124552734|NCT01586624|447981958|FG005|Overall Study|Physician Decision|0|||
124552735|NCT01586624|447981959|FG006|Overall Study|Physician Decision|1|||
124552736|NCT01586624|447981960|FG007|Overall Study|Physician Decision|1|||
124552737|NCT01586624|447981953|FG000|Overall Study|Withdrawal by Subject|0|||
124552738|NCT01586624|447981954|FG001|Overall Study|Withdrawal by Subject|0|||
124552739|NCT01586624|447981955|FG002|Overall Study|Withdrawal by Subject|0|||
124552740|NCT01586624|447981956|FG003|Overall Study|Withdrawal by Subject|1|||
124552741|NCT01586624|447981957|FG004|Overall Study|Withdrawal by Subject|0|||
124552742|NCT01586624|447981958|FG005|Overall Study|Withdrawal by Subject|0|||
124552743|NCT01586624|447981959|FG006|Overall Study|Withdrawal by Subject|0|||
124552744|NCT01586624|447981960|FG007|Overall Study|Withdrawal by Subject|0|||
124552745|NCT01586624|447981953|FG000|Overall Study|Evidence of disease progression|1|||
124552746|NCT01586624|447981954|FG001|Overall Study|Evidence of disease progression|3|||
124552747|NCT01586624|447981955|FG002|Overall Study|Evidence of disease progression|2|||
124552748|NCT01586624|447981956|FG003|Overall Study|Evidence of disease progression|5|||
124552749|NCT01586624|447981957|FG004|Overall Study|Evidence of disease progression|3|||
124552750|NCT01586624|447981958|FG005|Overall Study|Evidence of disease progression|5|||
124552751|NCT01586624|447981959|FG006|Overall Study|Evidence of disease progression|4|||
124552752|NCT01586624|447981960|FG007|Overall Study|Evidence of disease progression|6|||
124552753|NCT01586624|447981953|FG000|Overall Study|Screen failure (no treatment received)|0|||
124552754|NCT01586624|447981954|FG001|Overall Study|Screen failure (no treatment received)|0|||
124552755|NCT01586624|447981955|FG002|Overall Study|Screen failure (no treatment received)|0|||
124552756|NCT01586624|447981956|FG003|Overall Study|Screen failure (no treatment received)|0|||
124552757|NCT01586624|447981957|FG004|Overall Study|Screen failure (no treatment received)|0|||
124552758|NCT01586624|447981958|FG005|Overall Study|Screen failure (no treatment received)|0|||
124552759|NCT01586624|447981959|FG006|Overall Study|Screen failure (no treatment received)|1|||
124552760|NCT01586624|447981960|FG007|Overall Study|Screen failure (no treatment received)|0|||
124552761|NCT01074307|447981962|FG000|Overall Study|No primary endpoint evaluation|14|||
124552762|NCT01074307|447981963|FG001|Overall Study|No primary endpoint evaluation|6|||
124552763|NCT01074307|447981962|FG000|Overall Study|Exclusion criterion|0|||
124552764|NCT01074307|447981963|FG001|Overall Study|Exclusion criterion|1|||
124552765|NCT01074307|447981962|FG000|Overall Study|Protocol Violation|8|||
124552766|NCT01074307|447981963|FG001|Overall Study|Protocol Violation|5|||
124552767|NCT02162511|447981968|FG000|Overall Study|Lack of Efficacy|0|||
124552768|NCT02162511|447981969|FG001|Overall Study|Lack of Efficacy|0|||
124552769|NCT02162511|447981970|FG002|Overall Study|Lack of Efficacy|2|||
124552770|NCT01160198|447981971|FG000|Overall Study|Withdrawal by Subject|2|||
124552771|NCT01160198|447981972|FG001|Overall Study|Withdrawal by Subject|1|||
124552772|NCT01160198|447981973|FG002|Overall Study|Withdrawal by Subject|0|||
124552773|NCT01160198|447981971|FG000|Overall Study|Adverse Event|0|||
124552774|NCT01160198|447981972|FG001|Overall Study|Adverse Event|1|||
124552775|NCT01160198|447981973|FG002|Overall Study|Adverse Event|0|||
124552776|NCT01160198|447981971|FG000|Overall Study|Lost to Follow-up|0|||
124552777|NCT01160198|447981972|FG001|Overall Study|Lost to Follow-up|1|||
124552778|NCT01160198|447981973|FG002|Overall Study|Lost to Follow-up|0|||
124552779|NCT01160198|447981971|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
124552780|NCT01160198|447981972|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
124552781|NCT01160198|447981973|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
124552782|NCT02766088|447981975|FG000|Overall Study|Sponsor study termination|498|||
124552783|NCT02766088|447981975|FG000|Overall Study|Migrated/moved from the study area|1|||
124552784|NCT02766088|447981975|FG000|Overall Study|Lost to Follow-up|5|||
124552785|NCT02766088|447981975|FG000|Overall Study|Other|1|||
124552786|NCT02766088|447981975|FG000|Overall Study|Death|1|||
124552787|NCT03555890|447981982|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
124552788|NCT03555890|447981983|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
124552789|NCT03555890|447981984|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
124714184|NCT02820844|448579324|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
124714185|NCT02820844|448579325|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
124714186|NCT02820844|448579326|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
124714187|NCT02820844|448579327|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
124552790|NCT03555890|447981985|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
124552791|NCT01286207|447981988|FG000|Overall Study|Adverse Event|27|||
124552792|NCT01286207|447981989|FG001|Overall Study|Adverse Event|41|||
124552793|NCT01286207|447981990|FG002|Overall Study|Adverse Event|8|||
124552794|NCT01286207|447981988|FG000|Overall Study|Lost to Follow-up|49|||
124552795|NCT01286207|447981989|FG001|Overall Study|Lost to Follow-up|43|||
124552796|NCT01286207|447981990|FG002|Overall Study|Lost to Follow-up|20|||
124552797|NCT01286207|447981988|FG000|Overall Study|Withdrawal by Subject|93|||
124552798|NCT01286207|447981989|FG001|Overall Study|Withdrawal by Subject|79|||
124552799|NCT01286207|447981990|FG002|Overall Study|Withdrawal by Subject|41|||
124552800|NCT01286207|447981988|FG000|Overall Study|Lack of Response|92|||
124552801|NCT01286207|447981989|FG001|Overall Study|Lack of Response|38|||
124552802|NCT01286207|447981990|FG002|Overall Study|Lack of Response|8|||
124552803|NCT01286207|447981988|FG000|Overall Study|Other|37|||
124552804|NCT01286207|447981989|FG001|Overall Study|Other|47|||
124552805|NCT01286207|447981990|FG002|Overall Study|Other|13|||
124552806|NCT01383954|447981991|FG000|Overall Study|Lack of Efficacy|2|||
124552807|NCT01383954|447981991|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
124552808|NCT01383954|447981991|FG000|Overall Study|Adverse Event|1|||
124552809|NCT01383954|447981991|FG000|Overall Study|Reason Not Specified|9|||
124552810|NCT00450177|447981992|FG000|Overall Study|Adverse Event|7|||
124552811|NCT00450177|447981993|FG001|Overall Study|Adverse Event|4|||
124552812|NCT00450177|447981992|FG000|Overall Study|Withdrawal by Subject|1|||
124552813|NCT00450177|447981993|FG001|Overall Study|Withdrawal by Subject|6|||
124552814|NCT00450177|447981992|FG000|Overall Study|Withdrawal by Primary Team|1|||
124552815|NCT00450177|447981993|FG001|Overall Study|Withdrawal by Primary Team|1|||
124552816|NCT00763269|447981995|FG000|Overall Study|Lost to Follow-up|12|||
124552817|NCT00763269|447981996|FG001|Overall Study|Lost to Follow-up|13|||
124552818|NCT03174925|447981997|FG000|Overall Study|Elastographic images not retrievable|2|||
124552819|NCT03174925|447981997|FG000|Overall Study|Elastography image not interpretable|1|||
124552820|NCT04247594|447982000|FG000|Overall Study|Withdrawal by Subject|4|||
124552821|NCT02609178|447982003|FG000|First Crown|Withdrawal by Subject|0|||
124552822|NCT02609178|447982004|FG001|First Crown|Withdrawal by Subject|0|||
124552823|NCT02609178|447982005|FG002|First Crown|Withdrawal by Subject|1|||
124552824|NCT02609178|447982006|FG003|First Crown|Withdrawal by Subject|1|||
124552825|NCT02609178|447982007|FG004|First Crown|Withdrawal by Subject|0|||
124552826|NCT02609178|447982008|FG005|First Crown|Withdrawal by Subject|0|||
124552827|NCT01128153|447982009|FG000|Overall Study|Adverse Event|1|||
124552828|NCT01128153|447982010|FG001|Overall Study|Adverse Event|3|||
124552829|NCT01128153|447982009|FG000|Overall Study|Condition under investigation worsened|8|||
124552830|NCT01128153|447982010|FG001|Overall Study|Condition under investigation worsened|7|||
124714188|NCT02820844|448579328|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
124552831|NCT01128153|447982009|FG000|Overall Study|Withdrawal by Subject|2|||
124552832|NCT01128153|447982010|FG001|Overall Study|Withdrawal by Subject|3|||
124552833|NCT01128153|447982009|FG000|Overall Study|Incorrect enrolment to study|2|||
124552834|NCT01128153|447982010|FG001|Overall Study|Incorrect enrolment to study|1|||
124552835|NCT01128153|447982009|FG000|Overall Study|Protocol Violation|2|||
124552836|NCT01128153|447982010|FG001|Overall Study|Protocol Violation|0|||
124552837|NCT01128153|447982009|FG000|Overall Study|Developed discontinuation criteria|1|||
124552838|NCT01128153|447982010|FG001|Overall Study|Developed discontinuation criteria|1|||
124552839|NCT03451331|447982011|FG000|Overall Study|Withdrawal by Subject|1|||
124552840|NCT03451331|447982012|FG001|Overall Study|Withdrawal by Subject|0|||
124552841|NCT03451331|447982011|FG000|Overall Study|Unable to start treatment.|1|||
124552842|NCT03451331|447982012|FG001|Overall Study|Unable to start treatment.|1|||
124552843|NCT02419469|447982013|FG000|Overall Study|Withdrawal by Subject|1|||
124552844|NCT00755937|447982014|FG000|Recruitment|Unknown if infliximab received|164|||
124552845|NCT00755937|447982014|FG000|Observational Follow-up|Lost to Follow-up|148|||
124552846|NCT00572156|447982015|FG000|Overall Study|Adverse Event|3|||
124552847|NCT00572156|447982016|FG001|Overall Study|Adverse Event|1|||
124552848|NCT00572156|447982017|FG002|Overall Study|Adverse Event|5|||
124552849|NCT00572156|447982018|FG003|Overall Study|Adverse Event|1|||
124552850|NCT00572156|447982015|FG000|Overall Study|Lost to Follow-up|1|||
124552851|NCT00572156|447982016|FG001|Overall Study|Lost to Follow-up|1|||
124552852|NCT00572156|447982017|FG002|Overall Study|Lost to Follow-up|1|||
124552853|NCT00572156|447982018|FG003|Overall Study|Lost to Follow-up|0|||
124552854|NCT00572156|447982015|FG000|Overall Study|Protocol Violation|1|||
124552855|NCT00572156|447982016|FG001|Overall Study|Protocol Violation|2|||
124552856|NCT00572156|447982017|FG002|Overall Study|Protocol Violation|0|||
124552857|NCT00572156|447982018|FG003|Overall Study|Protocol Violation|2|||
124552858|NCT00572156|447982015|FG000|Overall Study|Patient/Parent Decision|1|||
124714189|NCT02820844|448579329|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
124714190|NCT02266147|448579330|FG000|PART 1: Dose Escalation|Physician Decision|0|||
124714191|NCT02266147|448579331|FG001|PART 1: Dose Escalation|Physician Decision|0|||
124552859|NCT00572156|447982016|FG001|Overall Study|Patient/Parent Decision|6|||
124552860|NCT00572156|447982017|FG002|Overall Study|Patient/Parent Decision|4|||
124552861|NCT00572156|447982018|FG003|Overall Study|Patient/Parent Decision|3|||
124552862|NCT00572156|447982015|FG000|Overall Study|Sponsor Decision|20|||
124552863|NCT00572156|447982016|FG001|Overall Study|Sponsor Decision|16|||
124552864|NCT00572156|447982017|FG002|Overall Study|Sponsor Decision|17|||
124552865|NCT00572156|447982018|FG003|Overall Study|Sponsor Decision|19|||
124714192|NCT02266147|448579332|FG002|PART 1: Dose Escalation|Physician Decision|1|||
124552866|NCT02261974|447982019|FG000|Overall Study|Withdrawal by Subject|3|||
124552867|NCT02261974|447982020|FG001|Overall Study|Withdrawal by Subject|2|||
124552868|NCT02261974|447982019|FG000|Overall Study|Pregnancy|0|||
124552869|NCT02261974|447982020|FG001|Overall Study|Pregnancy|1|||
124552870|NCT02261974|447982019|FG000|Overall Study|Missed treatment cut-off date|6|||
124552871|NCT02261974|447982020|FG001|Overall Study|Missed treatment cut-off date|3|||
124552872|NCT02261974|447982019|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
124552873|NCT02261974|447982020|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
124552874|NCT02261974|447982019|FG000|Overall Study|Lost to Follow-up|2|||
124552875|NCT02261974|447982020|FG001|Overall Study|Lost to Follow-up|0|||
124552876|NCT02261974|447982019|FG000|Overall Study|Adverse Event|1|||
124552877|NCT02261974|447982020|FG001|Overall Study|Adverse Event|0|||
124552878|NCT01347879|447982021|FG000|Overall Study|Adverse Event|0|||
124552879|NCT01347879|447982022|FG001|Overall Study|Adverse Event|12|||
124552880|NCT01347879|447982021|FG000|Overall Study|Lost to Follow-up|2|||
124552881|NCT01347879|447982022|FG001|Overall Study|Lost to Follow-up|0|||
124552882|NCT01347879|447982021|FG000|Overall Study|Withdrawal by Subject|3|||
124552883|NCT01347879|447982022|FG001|Overall Study|Withdrawal by Subject|2|||
124552884|NCT01347879|447982021|FG000|Overall Study|Other|2|||
124552885|NCT01347879|447982022|FG001|Overall Study|Other|3|||
124552886|NCT01238822|447982027|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
124552887|NCT00996918|447982028|FG000|Overall Study|Lack of Efficacy|1|||
124552888|NCT00996918|447982029|FG001|Overall Study|Lack of Efficacy|1|||
124552889|NCT00996918|447982030|FG002|Overall Study|Lack of Efficacy|2|||
124552890|NCT00996918|447982031|FG003|Overall Study|Lack of Efficacy|2|||
124552891|NCT00996918|447982032|FG004|Overall Study|Lack of Efficacy|0|||
124552892|NCT00996918|447982028|FG000|Overall Study|Adverse Event|2|||
124552893|NCT00996918|447982029|FG001|Overall Study|Adverse Event|5|||
124552894|NCT00996918|447982030|FG002|Overall Study|Adverse Event|2|||
124552895|NCT00996918|447982031|FG003|Overall Study|Adverse Event|6|||
124552896|NCT00996918|447982032|FG004|Overall Study|Adverse Event|0|||
124552897|NCT00996918|447982028|FG000|Overall Study|Withdrawal by Subject|1|||
124552898|NCT00996918|447982029|FG001|Overall Study|Withdrawal by Subject|4|||
124552899|NCT00996918|447982030|FG002|Overall Study|Withdrawal by Subject|3|||
124552900|NCT00996918|447982031|FG003|Overall Study|Withdrawal by Subject|3|||
124552901|NCT00996918|447982032|FG004|Overall Study|Withdrawal by Subject|2|||
124552902|NCT00996918|447982028|FG000|Overall Study|Physician Decision|1|||
124552903|NCT00996918|447982029|FG001|Overall Study|Physician Decision|0|||
124552904|NCT00996918|447982030|FG002|Overall Study|Physician Decision|0|||
124552905|NCT00996918|447982031|FG003|Overall Study|Physician Decision|0|||
124552906|NCT00996918|447982032|FG004|Overall Study|Physician Decision|0|||
124552907|NCT00996918|447982028|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
124552908|NCT00996918|447982029|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
124552909|NCT00996918|447982030|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
124552910|NCT00996918|447982031|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
124552911|NCT00996918|447982032|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
124552912|NCT00996918|447982028|FG000|Overall Study|Loss of Caregiver|0|||
124552913|NCT00996918|447982029|FG001|Overall Study|Loss of Caregiver|1|||
124552914|NCT00996918|447982030|FG002|Overall Study|Loss of Caregiver|0|||
124714193|NCT02266147|448579333|FG003|PART 1: Dose Escalation|Physician Decision|0|||
124714194|NCT02266147|448579330|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
124714195|NCT02266147|448579331|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
124552915|NCT00996918|447982031|FG003|Overall Study|Loss of Caregiver|0|||
124552916|NCT00996918|447982032|FG004|Overall Study|Loss of Caregiver|0|||
124552917|NCT00996918|447982028|FG000|Overall Study|Other|3|||
124552918|NCT00996918|447982029|FG001|Overall Study|Other|1|||
124552919|NCT00996918|447982030|FG002|Overall Study|Other|0|||
124552920|NCT00996918|447982031|FG003|Overall Study|Other|0|||
124976283|NCT01509547|449538658|FG001|Overall Study|Lost to Follow-up|14|||
124976284|NCT01509547|449538657|FG000|Overall Study|Withdrawal by Subject|11|||
124976285|NCT01509547|449538658|FG001|Overall Study|Withdrawal by Subject|24|||
124976286|NCT01509547|449538657|FG000|Overall Study|Physician Decision|0|||
124976287|NCT01509547|449538658|FG001|Overall Study|Physician Decision|1|||
124976288|NCT00277095|449538659|FG000|Overall Study|Death|2|||
124976289|NCT00277095|449538659|FG000|Overall Study|Explanted|7|||
124976290|NCT00277095|449538659|FG000|Overall Study|Lost to Follow-up|2|||
124976291|NCT00277095|449538659|FG000|Overall Study|Missed Follow-up|9|||
124976292|NCT00277095|449538659|FG000|Overall Study|Physician Decision|1|||
124976293|NCT04147195|449538660|FG000|Overall Study|Adverse Event|0|||
124976294|NCT04147195|449538661|FG001|Overall Study|Adverse Event|3|||
124976295|NCT04147195|449538660|FG000|Overall Study|Study Terminated by Sponsor|4|||
124976296|NCT04147195|449538661|FG001|Overall Study|Study Terminated by Sponsor|2|||
124976297|NCT04147195|449538660|FG000|Overall Study|Withdrawal by Subject|0|||
124976298|NCT04147195|449538661|FG001|Overall Study|Withdrawal by Subject|1|||
124976299|NCT01006980|449539893|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
124976300|NCT01006980|449539894|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
124976301|NCT01006980|449539893|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
124976302|NCT01006980|449539894|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
124976303|NCT01006980|449539893|FG000|Vemurafenib and Dacarbazine|Death|13|||
124976304|NCT01006980|449539894|FG001|Vemurafenib and Dacarbazine|Death|12|||
124976305|NCT01006980|449539893|FG000|Vemurafenib and Dacarbazine|Progression|257|||
124976306|NCT01006980|449539894|FG001|Vemurafenib and Dacarbazine|Progression|218|||
124976307|NCT01006980|449539893|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
124976308|NCT01006980|449539894|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
124976309|NCT01006980|449539893|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
124976310|NCT01006980|449539894|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
124976311|NCT01006980|449539893|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
124976312|NCT01006980|449539894|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
124976313|NCT01006980|449539893|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
124976314|NCT01006980|449539894|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
124976315|NCT01006980|449539893|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
124976316|NCT01006980|449539894|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
124770579|NCT04672239|448788884|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
124976317|NCT01006980|449539893|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
124976318|NCT01006980|449539894|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
124552921|NCT00996918|447982032|FG004|Overall Study|Other|0|||
124976319|NCT01006980|449539893|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
124552922|NCT04440007|447982037|FG000|Overall Study|Adverse Event|0|||
124552923|NCT04440007|447982038|FG001|Overall Study|Adverse Event|1|||
124976320|NCT01006980|449539894|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
124976321|NCT01006980|449539893|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
124976322|NCT01006980|449539894|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
124552924|NCT04440007|447982037|FG000|Overall Study|Lost to Follow-up|1|||
124552925|NCT04440007|447982038|FG001|Overall Study|Lost to Follow-up|3|||
124552926|NCT04440007|447982037|FG000|Overall Study|Death|7|||
124552927|NCT04440007|447982038|FG001|Overall Study|Death|2|||
124552928|NCT04440007|447982037|FG000|Overall Study|Physician Decision|1|||
124976323|NCT01006980|449539893|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
124976324|NCT01006980|449539894|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
124976325|NCT02706405|449539899|FG000|Overall Study|Death|3|||
124976326|NCT02706405|449539900|FG001|Overall Study|Death|2|||
124976327|NCT02706405|449539901|FG002|Overall Study|Death|0|||
124976328|NCT02706405|449539902|FG003|Overall Study|Death|1|||
124976329|NCT02706405|449539903|FG004|Overall Study|Death|0|||
124976330|NCT02706405|449539904|FG005|Overall Study|Death|0|||
124976331|NCT02706405|449539905|FG006|Overall Study|Death|3|||
124976332|NCT02706405|449539906|FG007|Overall Study|Death|4|||
124976333|NCT02706405|449539899|FG000|Overall Study|Disease progression|0|||
124976334|NCT02706405|449539900|FG001|Overall Study|Disease progression|0|||
124976335|NCT02706405|449539901|FG002|Overall Study|Disease progression|0|||
124976336|NCT02706405|449539902|FG003|Overall Study|Disease progression|0|||
124976337|NCT02706405|449539903|FG004|Overall Study|Disease progression|0|||
124976338|NCT02706405|449539904|FG005|Overall Study|Disease progression|0|||
124976339|NCT02706405|449539905|FG006|Overall Study|Disease progression|0|||
124976340|NCT02706405|449539906|FG007|Overall Study|Disease progression|1|||
124976341|NCT02706405|449539899|FG000|Overall Study|Pt moved to new therapy|0|||
124976342|NCT02706405|449539900|FG001|Overall Study|Pt moved to new therapy|0|||
124976343|NCT02706405|449539901|FG002|Overall Study|Pt moved to new therapy|0|||
124976344|NCT02706405|449539902|FG003|Overall Study|Pt moved to new therapy|0|||
124976345|NCT02706405|449539903|FG004|Overall Study|Pt moved to new therapy|0|||
124976346|NCT02706405|449539904|FG005|Overall Study|Pt moved to new therapy|1|||
124976347|NCT02706405|449539905|FG006|Overall Study|Pt moved to new therapy|0|||
124976348|NCT02706405|449539906|FG007|Overall Study|Pt moved to new therapy|1|||
124976349|NCT02706405|449539899|FG000|Overall Study|Physician Decision|1|||
124976350|NCT02706405|449539900|FG001|Overall Study|Physician Decision|0|||
124976351|NCT02706405|449539901|FG002|Overall Study|Physician Decision|0|||
124976352|NCT02706405|449539902|FG003|Overall Study|Physician Decision|0|||
124976353|NCT02706405|449539903|FG004|Overall Study|Physician Decision|0|||
124976354|NCT02706405|449539904|FG005|Overall Study|Physician Decision|0|||
124976355|NCT02706405|449539905|FG006|Overall Study|Physician Decision|0|||
124714196|NCT02266147|448579332|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
124714197|NCT02266147|448579333|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
124976356|NCT02706405|449539906|FG007|Overall Study|Physician Decision|0|||
124976357|NCT01228318|449539907|FG000|Overall Study|Clinic no show to receive intervention|1|||
124976358|NCT01228318|449539908|FG001|Overall Study|Clinic no show to receive intervention|0|||
124976359|NCT01228318|449539907|FG000|Overall Study|Unable to contact|2|||
124976360|NCT01228318|449539908|FG001|Overall Study|Unable to contact|5|||
124976361|NCT01228318|449539907|FG000|Overall Study|Moved|0|||
124552929|NCT04440007|447982038|FG001|Overall Study|Physician Decision|1|||
124976362|NCT01228318|449539908|FG001|Overall Study|Moved|2|||
124976363|NCT01228318|449539907|FG000|Overall Study|Incarcerated|1|||
124976364|NCT01228318|449539908|FG001|Overall Study|Incarcerated|0|||
124552930|NCT04440007|447982037|FG000|Overall Study|Withdrawal by Subject|2|||
124552931|NCT04440007|447982038|FG001|Overall Study|Withdrawal by Subject|1|||
124552932|NCT04440007|447982037|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
124552933|NCT04440007|447982038|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
124552934|NCT04440007|447982037|FG000|Overall Study|Discontinued prior to dosing|0|||
124552935|NCT04440007|447982038|FG001|Overall Study|Discontinued prior to dosing|2|||
124552936|NCT00854607|447982039|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
124552937|NCT03959137|447982040|FG000|Overall Study|Protocol Violation|6|||
124552938|NCT00190684|447982041|FG000|Overall Study|Adverse Event|86|||
124552939|NCT00190684|447982041|FG000|Overall Study|Satisfactory response|80|||
124552940|NCT00190684|447982041|FG000|Overall Study|Lack of efficacy|204|||
124552941|NCT00190684|447982041|FG000|Overall Study|Lost to Follow-up|232|||
124552942|NCT00190684|447982041|FG000|Overall Study|Patient moved|60|||
124552943|NCT00190684|447982041|FG000|Overall Study|Patient Decision|432|||
124552944|NCT00190684|447982041|FG000|Overall Study|Clinical relapse|67|||
124552945|NCT00190684|447982041|FG000|Overall Study|Sponsor's decision|17|||
124552946|NCT00190684|447982041|FG000|Overall Study|Physician Decision|84|||
124552947|NCT00190684|447982041|FG000|Overall Study|Protocol Violation|123|||
124552948|NCT00190684|447982041|FG000|Overall Study|Study Period III Completed|103|||
124552949|NCT00190684|447982041|FG000|Overall Study|Study Period V Completed|1|||
124552950|NCT00829439|447982047|FG000|Overall Study|Adverse Event|0|||
124552951|NCT00829439|447982048|FG001|Overall Study|Adverse Event|0|||
124552952|NCT00829439|447982049|FG002|Overall Study|Adverse Event|1|||
124552953|NCT00829439|447982050|FG003|Overall Study|Adverse Event|0|||
124552954|NCT00123487|447982051|FG000|Randomized|Death prior to starting treatment|0|||
124552955|NCT00123487|447982052|FG001|Randomized|Death prior to starting treatment|1|||
124552956|NCT00123487|447982051|FG000|Randomized|SAE prior to starting treatment|1|||
124552957|NCT00123487|447982052|FG001|Randomized|SAE prior to starting treatment|0|||
124552958|NCT00123487|447982051|FG000|Treated With Study Drug|Adverse Event|23|||
124552959|NCT00123487|447982052|FG001|Treated With Study Drug|Adverse Event|22|||
124552960|NCT00123487|447982051|FG000|Treated With Study Drug|Disease Progression|141|||
124552961|NCT00123487|447982052|FG001|Treated With Study Drug|Disease Progression|122|||
124552962|NCT00123487|447982051|FG000|Treated With Study Drug|Physician Decision|8|||
124552963|NCT00123487|447982052|FG001|Treated With Study Drug|Physician Decision|9|||
124552964|NCT00123487|447982051|FG000|Treated With Study Drug|Other|59|||
124552965|NCT00123487|447982052|FG001|Treated With Study Drug|Other|58|||
124552966|NCT00123487|447982051|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
124552967|NCT00123487|447982052|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
124552968|NCT00123487|447982051|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
124714198|NCT02266147|448579330|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
124714199|NCT02266147|448579331|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
124714200|NCT02266147|448579332|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
124714201|NCT02266147|448579333|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
124714202|NCT02266147|448579330|FG000|PART 1: Dose Escalation|Other|1|||
124714203|NCT02266147|448579331|FG001|PART 1: Dose Escalation|Other|1|||
124714204|NCT02266147|448579332|FG002|PART 1: Dose Escalation|Other|0|||
124552969|NCT00123487|447982052|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
124552970|NCT00123487|447982051|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
124552971|NCT00123487|447982052|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
124552972|NCT00995488|447982053|FG000|Overall Study|Withdrawal by Subject|1|||
124552973|NCT03672396|447982056|FG000|Overall Study|Withdrawal by Subject|4|||
124552974|NCT03672396|447982056|FG000|Overall Study|Physician Decision|1|||
124552975|NCT03672396|447982056|FG000|Overall Study|Adverse Event|1|||
124552976|NCT01408576|447983757|FG000|Overall Study|Lack of Efficacy|17|||
124552977|NCT01408576|447983758|FG001|Overall Study|Lack of Efficacy|30|||
124552978|NCT01408576|447983759|FG002|Overall Study|Lack of Efficacy|48|||
124552979|NCT01408576|447983757|FG000|Overall Study|Protocol Violation|1|||
124552980|NCT01408576|447983758|FG001|Overall Study|Protocol Violation|2|||
124714205|NCT02266147|448579333|FG003|PART 1: Dose Escalation|Other|0|||
124714206|NCT02266147|448579330|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
124714207|NCT02266147|448579331|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
124714208|NCT02266147|448579332|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
124714209|NCT02266147|448579333|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
124976365|NCT01182441|449539913|FG000|Overall Study|Patient Still in Follow-up|152|||
124976366|NCT01182441|449539914|FG001|Overall Study|Patient Still in Follow-up|72|||
124976367|NCT01182441|449539913|FG000|Overall Study|Death|37|||
124976368|NCT01182441|449539914|FG001|Overall Study|Death|25|||
124976369|NCT01182441|449539913|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
124976370|NCT01182441|449539914|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
124976371|NCT01182441|449539913|FG000|Overall Study|Lost to Follow-up|5|||
124976372|NCT01182441|449539914|FG001|Overall Study|Lost to Follow-up|8|||
124976373|NCT01182441|449539913|FG000|Overall Study|Withdrawal by Subject|6|||
124976374|NCT01182441|449539914|FG001|Overall Study|Withdrawal by Subject|13|||
124976375|NCT01182441|449539913|FG000|Overall Study|Implant Not Attempted|4|||
124976376|NCT01182441|449539914|FG001|Overall Study|Implant Not Attempted|0|||
124714210|NCT02266147|448579330|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
124976377|NCT01182441|449539913|FG000|Overall Study|Adverse Event|2|||
124976378|NCT01182441|449539914|FG001|Overall Study|Adverse Event|0|||
124976379|NCT01182441|449539913|FG000|Overall Study|Physician Decision|1|||
124976380|NCT01182441|449539914|FG001|Overall Study|Physician Decision|1|||
124976381|NCT02124811|449539915|FG000|Overall Study|Early termination|2|||
124976382|NCT02124811|449539916|FG001|Overall Study|Early termination|2|||
124976383|NCT02124811|449539915|FG000|Overall Study|Withdrawal by Subject|1|||
124976384|NCT02124811|449539916|FG001|Overall Study|Withdrawal by Subject|0|||
124976385|NCT04043143|449539917|FG000|Overall Study|Lost to Follow-up|5|||
124976386|NCT04043143|449539918|FG001|Overall Study|Lost to Follow-up|5|||
124976387|NCT04043143|449539917|FG000|Overall Study|screen failure|1|||
124976388|NCT04043143|449539918|FG001|Overall Study|screen failure|0|||
124976389|NCT03480932|449539919|FG000|Overall Study|Death|1|||
124976390|NCT03480932|449539920|FG001|Overall Study|Death|1|||
124976391|NCT03480932|449539921|FG002|Overall Study|Death|0|||
124976392|NCT03480932|449539919|FG000|Overall Study|Lost to Follow-up|0|||
124552981|NCT01408576|447983759|FG002|Overall Study|Protocol Violation|2|||
124552982|NCT01408576|447983757|FG000|Overall Study|Lost to Follow-up|10|||
124552983|NCT01408576|447983758|FG001|Overall Study|Lost to Follow-up|9|||
124552984|NCT01408576|447983759|FG002|Overall Study|Lost to Follow-up|17|||
124552985|NCT01408576|447983757|FG000|Overall Study|Withdrawal by Subject|34|||
124552986|NCT01408576|447983758|FG001|Overall Study|Withdrawal by Subject|60|||
124552987|NCT01408576|447983759|FG002|Overall Study|Withdrawal by Subject|66|||
124552988|NCT01408576|447983757|FG000|Overall Study|Sponsor terminated study|89|||
124552989|NCT01408576|447983758|FG001|Overall Study|Sponsor terminated study|333|||
124552990|NCT01408576|447983759|FG002|Overall Study|Sponsor terminated study|330|||
124552991|NCT01408576|447983757|FG000|Overall Study|AE, serious fatal|4|||
124552992|NCT01408576|447983758|FG001|Overall Study|AE, serious fatal|4|||
124552993|NCT01408576|447983759|FG002|Overall Study|AE, serious fatal|1|||
124552994|NCT01408576|447983757|FG000|Overall Study|SAE, non-fatal|11|||
124552995|NCT01408576|447983758|FG001|Overall Study|SAE, non-fatal|23|||
124714211|NCT02266147|448579331|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
124552996|NCT01408576|447983759|FG002|Overall Study|SAE, non-fatal|14|||
124714212|NCT02266147|448579332|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
124714213|NCT02266147|448579333|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
124976393|NCT03480932|449539920|FG001|Overall Study|Lost to Follow-up|2|||
124976394|NCT03480932|449539921|FG002|Overall Study|Lost to Follow-up|3|||
124976395|NCT03480932|449539919|FG000|Overall Study|Incarcerated|2|||
124976396|NCT03480932|449539920|FG001|Overall Study|Incarcerated|2|||
124552997|NCT01408576|447983757|FG000|Overall Study|AE, non-serious non-fatal|12|||
124552998|NCT01408576|447983758|FG001|Overall Study|AE, non-serious non-fatal|19|||
124552999|NCT01408576|447983759|FG002|Overall Study|AE, non-serious non-fatal|11|||
124976397|NCT03480932|449539921|FG002|Overall Study|Incarcerated|2|||
124714214|NCT03896477|448579336|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
124714215|NCT03896477|448579337|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
124976398|NCT02138786|449539924|FG000|Overall Study|Adverse Event|0|||
124976399|NCT02138786|449539925|FG001|Overall Study|Adverse Event|2|||
124976400|NCT02138786|449539926|FG002|Overall Study|Adverse Event|1|||
124976401|NCT02138786|449539924|FG000|Overall Study|Death|1|||
124976402|NCT02138786|449539925|FG001|Overall Study|Death|7|||
124976403|NCT02138786|449539926|FG002|Overall Study|Death|2|||
124976404|NCT02138786|449539924|FG000|Overall Study|Disease Progression|1|||
124976405|NCT02138786|449539925|FG001|Overall Study|Disease Progression|1|||
124976406|NCT02138786|449539926|FG002|Overall Study|Disease Progression|3|||
124976407|NCT02138786|449539924|FG000|Overall Study|Withdrawal by Subject|1|||
124976408|NCT02138786|449539925|FG001|Overall Study|Withdrawal by Subject|2|||
124976409|NCT02138786|449539926|FG002|Overall Study|Withdrawal by Subject|0|||
124976410|NCT02138786|449539924|FG000|Overall Study|Patient's Wish|0|||
124976411|NCT02138786|449539925|FG001|Overall Study|Patient's Wish|2|||
124976412|NCT02138786|449539926|FG002|Overall Study|Patient's Wish|0|||
124976413|NCT02138786|449539924|FG000|Overall Study|Sponsor Terminated Study|0|||
124976414|NCT02138786|449539925|FG001|Overall Study|Sponsor Terminated Study|1|||
124976415|NCT02138786|449539926|FG002|Overall Study|Sponsor Terminated Study|1|||
124976416|NCT02138786|449539924|FG000|Overall Study|Non-Compliance|0|||
124976417|NCT02138786|449539925|FG001|Overall Study|Non-Compliance|0|||
124976418|NCT02138786|449539926|FG002|Overall Study|Non-Compliance|1|||
124976419|NCT01923662|449539927|FG000|Overall Study|Withdrawal by Subject|1|||
124976420|NCT00659880|449539928|FG000|Overall Study|Lost to Follow-up|5|||
124976421|NCT00669877|449539935|FG000|Overall Study|Disease Progression/Death|4|||
124976422|NCT01465763|449539936|FG000|Overall Study|Withdrawal by Subject|4|||
124976423|NCT01465763|449539937|FG001|Overall Study|Withdrawal by Subject|0|||
124976424|NCT01465763|449539938|FG002|Overall Study|Withdrawal by Subject|1|||
124976425|NCT01465763|449539936|FG000|Overall Study|Insufficient Clinical Response|11|||
124976426|NCT01465763|449539937|FG001|Overall Study|Insufficient Clinical Response|0|||
124976427|NCT01465763|449539938|FG002|Overall Study|Insufficient Clinical Response|1|||
124976428|NCT01465763|449539936|FG000|Overall Study|Adverse Event|9|||
124976429|NCT01465763|449539937|FG001|Overall Study|Adverse Event|0|||
124976430|NCT01465763|449539938|FG002|Overall Study|Adverse Event|1|||
124976431|NCT01465763|449539936|FG000|Overall Study|Other|2|||
124976432|NCT01465763|449539937|FG001|Overall Study|Other|0|||
124976433|NCT01465763|449539938|FG002|Overall Study|Other|0|||
124976434|NCT01465763|449539936|FG000|Overall Study|Protocol Violation|4|||
124976435|NCT01465763|449539937|FG001|Overall Study|Protocol Violation|1|||
124976436|NCT01465763|449539938|FG002|Overall Study|Protocol Violation|1|||
124976437|NCT01465763|449539936|FG000|Overall Study|Death|1|||
124976438|NCT01465763|449539937|FG001|Overall Study|Death|0|||
124976439|NCT01465763|449539938|FG002|Overall Study|Death|0|||
124976440|NCT02920970|449539939|FG000|First Intervention|Protocol Violation|0|||
124976441|NCT02920970|449539940|FG001|First Intervention|Protocol Violation|1|||
124976442|NCT02920970|449539939|FG000|First Intervention|Adverse Event|0|||
124976443|NCT02920970|449539940|FG001|First Intervention|Adverse Event|1|||
124976444|NCT02920970|449539939|FG000|Second Intervention|Poor Lens Fit|1|||
124976445|NCT02920970|449539940|FG001|Second Intervention|Poor Lens Fit|0|||
124976446|NCT01711853|449539942|FG000|Overall Study|Not treated|3|||
124976447|NCT02992691|449539947|FG000|Overall Study|Adverse Event|2|||
124976448|NCT02992691|449539947|FG000|Overall Study|Withdrawal by Subject|1|||
124976449|NCT01427725|449539948|FG000|Overall Study|Lost to Follow-up|17|||
124976450|NCT01427725|449539948|FG000|Overall Study|Protocol Violation|1|||
124976451|NCT01427725|449539948|FG000|Overall Study|Drug not administered|1|||
124976452|NCT01427725|449539948|FG000|Overall Study|Failure to visit|7|||
124976453|NCT01427725|449539948|FG000|Overall Study|Adverse Event|46|||
124976454|NCT01427725|449539948|FG000|Overall Study|Failure to visit after administration|40|||
124976455|NCT01427725|449539948|FG000|Overall Study|Patient's rejection|27|||
124976456|NCT01427725|449539948|FG000|Overall Study|Transfer to a different hospital|17|||
124976457|NCT01427725|449539948|FG000|Overall Study|Lack of Efficacy|8|||
124976458|NCT01427725|449539948|FG000|Overall Study|Death|7|||
124976459|NCT01427725|449539948|FG000|Overall Study|Symptom improvement|6|||
124976460|NCT01427725|449539948|FG000|Overall Study|AE and Patient's rejection|5|||
124976461|NCT01427725|449539948|FG000|Overall Study|Physician Decision|5|||
124976462|NCT01427725|449539948|FG000|Overall Study|Exacerbation of underlying disease|5|||
124976463|NCT01427725|449539948|FG000|Overall Study|Oral feeding difficulty|5|||
124976464|NCT01427725|449539948|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
124976465|NCT01427725|449539948|FG000|Overall Study|Forgetting prescription|1|||
124976466|NCT01427725|449539948|FG000|Overall Study|Other|2|||
124976467|NCT04276051|449539950|FG000|Overall Study|Lost to Follow-up|0|||
124976468|NCT04276051|449539951|FG001|Overall Study|Lost to Follow-up|1|||
124976469|NCT04276051|449539950|FG000|Overall Study|Physician Decision|0|||
124976470|NCT04276051|449539951|FG001|Overall Study|Physician Decision|1|||
124976471|NCT04276051|449539950|FG000|Overall Study|Withdrawal by Subject|1|||
124714216|NCT03896477|448579338|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
124714217|NCT03896477|448579336|FG000|Overall Study|Parent Requested Withdrawal|8|||
124714218|NCT03896477|448579337|FG001|Overall Study|Parent Requested Withdrawal|12|||
124714219|NCT03896477|448579338|FG002|Overall Study|Parent Requested Withdrawal|9|||
124714220|NCT03896477|448579336|FG000|Overall Study|Adverse Event|0|||
124714221|NCT03896477|448579337|FG001|Overall Study|Adverse Event|0|||
124714222|NCT03896477|448579338|FG002|Overall Study|Adverse Event|1|||
124976472|NCT04276051|449539951|FG001|Overall Study|Withdrawal by Subject|1|||
124976473|NCT00392925|449539952|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
124976474|NCT00392925|449539953|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
124976475|NCT00392925|449539954|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
124976476|NCT00392925|449539955|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
124976477|NCT00392925|449539952|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
124976478|NCT00392925|449539953|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
124976479|NCT00392925|449539954|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
124976480|NCT00392925|449539955|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
124976481|NCT00392925|449539952|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
124976482|NCT00392925|449539953|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
124976483|NCT00392925|449539954|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
124976484|NCT00392925|449539955|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
124976485|NCT00392925|449539952|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
124976486|NCT00392925|449539953|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
124976487|NCT00392925|449539954|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
124976488|NCT00392925|449539955|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
124976489|NCT00392925|449539952|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
124976490|NCT00392925|449539953|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
124976491|NCT00392925|449539954|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
124976492|NCT00392925|449539955|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
124976493|NCT00392925|449539952|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
124976494|NCT00392925|449539953|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
124976495|NCT00392925|449539954|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
124976496|NCT00392925|449539955|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
124976497|NCT00392925|449539952|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
124976498|NCT00392925|449539953|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
124976499|NCT00392925|449539954|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
124976500|NCT00392925|449539955|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
124976501|NCT00392925|449539952|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
124976502|NCT00392925|449539953|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
124976503|NCT00392925|449539954|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
124976504|NCT00392925|449539955|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
124976505|NCT00392925|449539952|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
124976506|NCT00392925|449539953|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
124976507|NCT00392925|449539954|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
124976508|NCT00392925|449539955|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
124976509|NCT01281839|449539957|FG000|Overall Study|Lost to Follow-up|6|||
124976510|NCT01281839|449539958|FG001|Overall Study|Lost to Follow-up|3|||
124976511|NCT01281839|449539957|FG000|Overall Study|Withdrawal by Subject|4|||
124976512|NCT01281839|449539958|FG001|Overall Study|Withdrawal by Subject|10|||
124976513|NCT01281839|449539957|FG000|Overall Study|Reason not specified|0|||
124976514|NCT01281839|449539958|FG001|Overall Study|Reason not specified|1|||
124976515|NCT01277887|449539959|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
124976516|NCT01277887|449539960|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
124976517|NCT01277887|449539959|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
124976518|NCT01277887|449539960|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
124976519|NCT01277887|449539959|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
124976520|NCT01277887|449539960|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
124976521|NCT00415051|449539961|FG000|Overall Study|Protocol Violation|1|||
124976522|NCT00780559|449539962|FG000|Overall Study|Lost to Follow-up|2|||
124976523|NCT00780559|449539963|FG001|Overall Study|Lost to Follow-up|7|||
124976524|NCT00780559|449539962|FG000|Overall Study|Death|1|||
124976525|NCT00780559|449539963|FG001|Overall Study|Death|0|||
124976526|NCT04462289|449539966|FG000|Overall Study|Lost to Follow-up|4|||
124976527|NCT04462289|449539967|FG001|Overall Study|Lost to Follow-up|5|||
124976528|NCT04462289|449539966|FG000|Overall Study|Death|0|||
124976529|NCT04462289|449539967|FG001|Overall Study|Death|3|||
124976530|NCT04462289|449539966|FG000|Overall Study|Withdrawal by Subject|1|||
124976531|NCT04462289|449539967|FG001|Overall Study|Withdrawal by Subject|3|||
124553000|NCT01408576|447983757|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
124714223|NCT03896477|448579336|FG000|Overall Study|Death|1|||
124553001|NCT01408576|447983758|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
124714224|NCT03896477|448579337|FG001|Overall Study|Death|0|||
124714225|NCT03896477|448579338|FG002|Overall Study|Death|0|||
124976532|NCT01518153|449539968|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
124976533|NCT01518153|449539969|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
124976534|NCT01518153|449539970|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
124553002|NCT01408576|447983759|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
124714226|NCT03896477|448579336|FG000|Overall Study|Other|5|||
124714227|NCT03896477|448579337|FG001|Overall Study|Other|6|||
124714228|NCT03896477|448579338|FG002|Overall Study|Other|7|||
124714229|NCT03896477|448579336|FG000|Overall Study|Lost to Follow-up|2|||
124714230|NCT03896477|448579337|FG001|Overall Study|Lost to Follow-up|1|||
124714231|NCT03896477|448579338|FG002|Overall Study|Lost to Follow-up|1|||
124714232|NCT01791517|448579339|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
124714233|NCT01791517|448579340|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
124471177|NCT03891901|447682104|FG005|Overall Study|Poor venous access|0|||
124471178|NCT03891901|447682105|FG006|Overall Study|Poor venous access|0|||
124471179|NCT03891901|447682106|FG007|Overall Study|Poor venous access|0|||
124471180|NCT03891901|447682107|FG008|Overall Study|Poor venous access|0|||
124471181|NCT03891901|447682099|FG000|Overall Study|Withdrawal by Subject|0|||
124471182|NCT03891901|447682100|FG001|Overall Study|Withdrawal by Subject|2|||
124471183|NCT03891901|447682101|FG002|Overall Study|Withdrawal by Subject|0|||
124471184|NCT03891901|447682102|FG003|Overall Study|Withdrawal by Subject|0|||
124976535|NCT01518153|449539968|FG000|Stem Cell Transplant|Death|2|||
124976536|NCT01518153|449539969|FG001|Stem Cell Transplant|Death|0|||
124976537|NCT01518153|449539970|FG002|Stem Cell Transplant|Death|0|||
124976538|NCT01518153|449539968|FG000|Stem Cell Transplant|Secondary graft failure|1|||
124976539|NCT01518153|449539969|FG001|Stem Cell Transplant|Secondary graft failure|0|||
124976540|NCT01518153|449539970|FG002|Stem Cell Transplant|Secondary graft failure|0|||
124976541|NCT01518153|449539968|FG000|Stem Cell Transplant|Adverse Event|1|||
124976542|NCT01518153|449539969|FG001|Stem Cell Transplant|Adverse Event|0|||
124976543|NCT01518153|449539970|FG002|Stem Cell Transplant|Adverse Event|0|||
124976544|NCT01518153|449539968|FG000|Donor Lymphocyte Infusion|Death|0|||
124976545|NCT01518153|449539969|FG001|Donor Lymphocyte Infusion|Death|2|||
124976546|NCT01518153|449539970|FG002|Donor Lymphocyte Infusion|Death|1|||
124976547|NCT00856245|449539971|FG000|Overall Study|Was not transplanted|5|||
124976548|NCT02514551|449539975|FG000|Overall Study|Lost to Follow-up|0|||
124976549|NCT02514551|449539976|FG001|Overall Study|Lost to Follow-up|1|||
124976550|NCT02514551|449539975|FG000|Overall Study|Participant Never Treated|0|||
124976551|NCT02514551|449539976|FG001|Overall Study|Participant Never Treated|2|||
124976552|NCT02998476|449539999|FG000|Overall Study|Lost to Follow-up|1|||
124976553|NCT02998476|449540000|FG001|Overall Study|Lost to Follow-up|0|||
124976554|NCT02998476|449539999|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
124976555|NCT02998476|449540000|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
124976556|NCT02998476|449539999|FG000|Overall Study|Withdrawal by Subject|1|||
124976557|NCT02998476|449540000|FG001|Overall Study|Withdrawal by Subject|2|||
124976558|NCT02998476|449539999|FG000|Overall Study|Death|45|||
124976559|NCT02998476|449540000|FG001|Overall Study|Death|2|||
124976560|NCT02998476|449539999|FG000|Overall Study|Other|6|||
124976561|NCT02998476|449540000|FG001|Overall Study|Other|1|||
124976562|NCT03832595|449540001|FG000|Overall Study|Death|142|||
124976563|NCT03832595|449540002|FG001|Overall Study|Death|130|||
124714234|NCT01791517|448579341|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
124714235|NCT01791517|448579342|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
124714236|NCT01791517|448579343|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
124714237|NCT01791517|448579344|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
124714238|NCT01791517|448579345|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
124714239|NCT01791517|448579346|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
124714240|NCT01791517|448579347|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
124553003|NCT01408576|447983757|FG000|Overall Study|AE, unknown type|0|||
124553004|NCT01408576|447983758|FG001|Overall Study|AE, unknown type|1|||
124553005|NCT01408576|447983759|FG002|Overall Study|AE, unknown type|0|||
124553006|NCT01408576|447983757|FG000|Overall Study|Other|10|||
124553007|NCT01408576|447983758|FG001|Overall Study|Other|16|||
124714241|NCT01791517|448579348|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
124714242|NCT01791517|448579349|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
124553008|NCT01408576|447983759|FG002|Overall Study|Other|18|||
124553009|NCT00563524|447983767|FG000|Overall Study|Adverse Event|0|||
124553010|NCT00563524|447983768|FG001|Overall Study|Adverse Event|1|||
124553011|NCT00563524|447983769|FG002|Overall Study|Adverse Event|0|||
124553012|NCT00563524|447983770|FG003|Overall Study|Adverse Event|0|||
124553013|NCT00563524|447983771|FG004|Overall Study|Adverse Event|2|||
124553014|NCT00563524|447983772|FG005|Overall Study|Adverse Event|0|||
124553015|NCT00563524|447983767|FG000|Overall Study|Lost to Follow-up|1|||
124553016|NCT00563524|447983768|FG001|Overall Study|Lost to Follow-up|0|||
124553017|NCT00563524|447983769|FG002|Overall Study|Lost to Follow-up|0|||
124553018|NCT00563524|447983770|FG003|Overall Study|Lost to Follow-up|0|||
124553019|NCT00563524|447983771|FG004|Overall Study|Lost to Follow-up|0|||
124553020|NCT00563524|447983772|FG005|Overall Study|Lost to Follow-up|0|||
124553021|NCT00563524|447983767|FG000|Overall Study|Protocol Violation|0|||
124553022|NCT00563524|447983768|FG001|Overall Study|Protocol Violation|1|||
124553023|NCT00563524|447983769|FG002|Overall Study|Protocol Violation|0|||
124553024|NCT00563524|447983770|FG003|Overall Study|Protocol Violation|0|||
124553025|NCT00563524|447983771|FG004|Overall Study|Protocol Violation|0|||
124553026|NCT00563524|447983772|FG005|Overall Study|Protocol Violation|0|||
124553027|NCT00563524|447983767|FG000|Overall Study|Withdrawal by Subject|1|||
124553028|NCT00563524|447983768|FG001|Overall Study|Withdrawal by Subject|1|||
124553029|NCT00563524|447983769|FG002|Overall Study|Withdrawal by Subject|3|||
124553030|NCT00563524|447983770|FG003|Overall Study|Withdrawal by Subject|0|||
124553031|NCT00563524|447983771|FG004|Overall Study|Withdrawal by Subject|0|||
124553032|NCT00563524|447983772|FG005|Overall Study|Withdrawal by Subject|1|||
124553033|NCT00817778|447983776|FG000|Overall Study|Adverse Event|1|||
124553034|NCT00817778|447983777|FG001|Overall Study|Adverse Event|0|||
124553035|NCT00817778|447983776|FG000|Overall Study|Withdrawal by Subject|1|||
124553036|NCT00817778|447983777|FG001|Overall Study|Withdrawal by Subject|1|||
124553037|NCT00817778|447983776|FG000|Overall Study|Protocol Violation|0|||
124553038|NCT00817778|447983777|FG001|Overall Study|Protocol Violation|1|||
124553039|NCT00817778|447983776|FG000|Overall Study|Study-specific discontinuation criteria|0|||
124553040|NCT00817778|447983777|FG001|Overall Study|Study-specific discontinuation criteria|1|||
124553041|NCT00817778|447983776|FG000|Overall Study|Poor venous access|1|||
124553042|NCT00817778|447983777|FG001|Overall Study|Poor venous access|0|||
124553043|NCT02360397|447983779|FG000|Overall Study|Incomplete screening|3|||
124553044|NCT02360397|447983779|FG000|Overall Study|Adverse Event|1|||
124553045|NCT01537549|447983780|FG000|Overall Study|Lost to Follow-up|1|||
124553046|NCT01537549|447983780|FG000|Overall Study|Withdrawal by Subject|2|||
124553047|NCT02923115|447983788|FG000|Overall Study|Lost to Follow-up|0|||
124553048|NCT02923115|447983789|FG001|Overall Study|Lost to Follow-up|0|||
124553049|NCT02923115|447983790|FG002|Overall Study|Lost to Follow-up|0|||
124553050|NCT02923115|447983791|FG003|Overall Study|Lost to Follow-up|1|||
124553051|NCT02923115|447983792|FG004|Overall Study|Lost to Follow-up|0|||
124553052|NCT02923115|447983793|FG005|Overall Study|Lost to Follow-up|0|||
124553053|NCT02923115|447983788|FG000|Overall Study|Withdrawal by Subject|0|||
124553054|NCT02923115|447983789|FG001|Overall Study|Withdrawal by Subject|1|||
124553055|NCT02923115|447983790|FG002|Overall Study|Withdrawal by Subject|0|||
124553056|NCT02923115|447983791|FG003|Overall Study|Withdrawal by Subject|0|||
124553057|NCT02923115|447983792|FG004|Overall Study|Withdrawal by Subject|0|||
124553058|NCT02923115|447983793|FG005|Overall Study|Withdrawal by Subject|0|||
124553059|NCT02923115|447983788|FG000|Overall Study|Randomized, but not dosed|0|||
124553060|NCT02923115|447983789|FG001|Overall Study|Randomized, but not dosed|0|||
124553061|NCT02923115|447983790|FG002|Overall Study|Randomized, but not dosed|3|||
124553062|NCT02923115|447983791|FG003|Overall Study|Randomized, but not dosed|1|||
124553063|NCT02923115|447983792|FG004|Overall Study|Randomized, but not dosed|5|||
124553064|NCT02923115|447983793|FG005|Overall Study|Randomized, but not dosed|0|||
124553065|NCT04056299|447983796|FG000|Overall Study|Sponsor discontinued study|3|||
124553066|NCT04056299|447983797|FG001|Overall Study|Sponsor discontinued study|3|||
124553067|NCT01791127|447983798|FG000|Overall Study|Death|356|||
124553068|NCT01791127|447983798|FG000|Overall Study|Patient has withdrawn from study|293|||
124553069|NCT01791127|447983798|FG000|Overall Study|Lost to Follow-up|42|||
124553070|NCT01791127|447983798|FG000|Overall Study|All Siello leads are explanted|31|||
124553071|NCT01791127|447983798|FG000|Overall Study|Completion of 30 day safety registry|1|||
124553072|NCT01791127|447983798|FG000|Overall Study|Study terminated for EP Passion|749|||
124553073|NCT00068406|447983800|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
124553074|NCT00068406|447983800|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
124553075|NCT03231709|447983801|FG000|Treatment Period 1|Reason not Specified|0|||
124553076|NCT03231709|447983802|FG001|Treatment Period 1|Reason not Specified|1|||
124553077|NCT03231709|447983801|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
124553078|NCT03231709|447983802|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
124553079|NCT01875991|447983803|FG000|Overall Study|Withdrawal by Subject|6|||
124553080|NCT01875991|447983804|FG001|Overall Study|Withdrawal by Subject|6|||
124553081|NCT01875991|447983803|FG000|Overall Study|Sponsor Decision|1|||
124553082|NCT01875991|447983804|FG001|Overall Study|Sponsor Decision|0|||
124553083|NCT02454972|447983805|FG000|Overall Study|Progressive disease|17|||
124553084|NCT02454972|447983806|FG001|Overall Study|Progressive disease|16|||
124553085|NCT02454972|447983807|FG002|Overall Study|Progressive disease|59|||
124553086|NCT02454972|447983808|FG003|Overall Study|Progressive disease|23|||
124553087|NCT02454972|447983809|FG004|Overall Study|Progressive disease|16|||
124553088|NCT02454972|447983810|FG005|Overall Study|Progressive disease|12|||
124553089|NCT02454972|447983811|FG006|Overall Study|Progressive disease|19|||
124553090|NCT02454972|447983812|FG007|Overall Study|Progressive disease|27|||
124714243|NCT01791517|448579350|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
124553091|NCT02454972|447983813|FG008|Overall Study|Progressive disease|0|||
124714244|NCT01791517|448579339|FG000|Phase I: Period 1|Adverse Event|0|||
124553092|NCT02454972|447983805|FG000|Overall Study|Death|0|||
124714245|NCT01791517|448579340|FG001|Phase I: Period 1|Adverse Event|0|||
124553093|NCT02454972|447983806|FG001|Overall Study|Death|0|||
124553094|NCT02454972|447983807|FG002|Overall Study|Death|5|||
124553095|NCT02454972|447983808|FG003|Overall Study|Death|1|||
124714246|NCT01791517|448579341|FG002|Phase I: Period 1|Adverse Event|1|||
124553096|NCT02454972|447983809|FG004|Overall Study|Death|0|||
124553097|NCT02454972|447983810|FG005|Overall Study|Death|0|||
124714247|NCT01791517|448579342|FG003|Phase I: Period 1|Adverse Event|1|||
124553098|NCT02454972|447983811|FG006|Overall Study|Death|0|||
124553099|NCT02454972|447983812|FG007|Overall Study|Death|0|||
124553100|NCT02454972|447983813|FG008|Overall Study|Death|95|||
124714248|NCT01791517|448579343|FG004|Phase I: Period 1|Adverse Event|0|||
124553101|NCT02454972|447983805|FG000|Overall Study|Physician Decision|0|||
124553102|NCT02454972|447983806|FG001|Overall Study|Physician Decision|1|||
124553103|NCT02454972|447983807|FG002|Overall Study|Physician Decision|2|||
124770580|NCT04672239|448788882|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
124770581|NCT04672239|448788883|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
124770582|NCT04672239|448788884|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
124714249|NCT01791517|448579344|FG005|Phase I: Period 1|Adverse Event|0|||
124714250|NCT01791517|448579345|FG006|Phase I: Period 1|Adverse Event|0|||
124714251|NCT01791517|448579346|FG007|Phase I: Period 1|Adverse Event|0|||
124714252|NCT01791517|448579347|FG008|Phase I: Period 1|Adverse Event|0|||
124714253|NCT01791517|448579348|FG009|Phase I: Period 1|Adverse Event|0|||
124714254|NCT01791517|448579349|FG010|Phase I: Period 1|Adverse Event|0|||
124714255|NCT01791517|448579350|FG011|Phase I: Period 1|Adverse Event|0|||
124714256|NCT01791517|448579339|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
124714257|NCT01791517|448579340|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
124714258|NCT01791517|448579341|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
124714259|NCT01791517|448579342|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
124714260|NCT01791517|448579343|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
124714261|NCT01791517|448579344|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
124714262|NCT01791517|448579345|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
124714263|NCT01791517|448579346|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
124714264|NCT01791517|448579347|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
124714265|NCT01791517|448579348|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
124714266|NCT01791517|448579349|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
124714267|NCT01791517|448579350|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
124714268|NCT01791517|448579339|FG000|Phase I: Period 1|Protocol Violation|0|||
124714269|NCT01791517|448579340|FG001|Phase I: Period 1|Protocol Violation|1|||
124770583|NCT05408429|448788890|FG000|Overall Study|Lost to Follow-up|1|||
124770584|NCT05408429|448788891|FG001|Overall Study|Lost to Follow-up|1|||
124770585|NCT05408429|448788892|FG002|Overall Study|Lost to Follow-up|0|||
124770586|NCT05408429|448788890|FG000|Overall Study|Withdrawal by Subject|5|||
124770587|NCT05408429|448788891|FG001|Overall Study|Withdrawal by Subject|0|||
124714270|NCT01791517|448579341|FG002|Phase I: Period 1|Protocol Violation|0|||
124714271|NCT01791517|448579342|FG003|Phase I: Period 1|Protocol Violation|0|||
124714272|NCT01791517|448579343|FG004|Phase I: Period 1|Protocol Violation|0|||
124714273|NCT01791517|448579344|FG005|Phase I: Period 1|Protocol Violation|0|||
124714274|NCT01791517|448579345|FG006|Phase I: Period 1|Protocol Violation|0|||
124714275|NCT01791517|448579346|FG007|Phase I: Period 1|Protocol Violation|0|||
124714276|NCT01791517|448579347|FG008|Phase I: Period 1|Protocol Violation|0|||
124714277|NCT01791517|448579348|FG009|Phase I: Period 1|Protocol Violation|0|||
124714278|NCT01791517|448579349|FG010|Phase I: Period 1|Protocol Violation|0|||
124714279|NCT01791517|448579350|FG011|Phase I: Period 1|Protocol Violation|0|||
124553104|NCT02454972|447983808|FG003|Overall Study|Physician Decision|1|||
124553105|NCT02454972|447983809|FG004|Overall Study|Physician Decision|2|||
124553106|NCT02454972|447983810|FG005|Overall Study|Physician Decision|0|||
124553107|NCT02454972|447983811|FG006|Overall Study|Physician Decision|0|||
124553108|NCT02454972|447983812|FG007|Overall Study|Physician Decision|1|||
124553109|NCT02454972|447983813|FG008|Overall Study|Physician Decision|0|||
124553110|NCT02454972|447983805|FG000|Overall Study|Non treatment-related adverse event|2|||
124553111|NCT02454972|447983806|FG001|Overall Study|Non treatment-related adverse event|0|||
124553112|NCT02454972|447983807|FG002|Overall Study|Non treatment-related adverse event|1|||
124714280|NCT01791517|448579339|FG000|Phase I: Period 1|Lost to Follow-up|0|||
124714281|NCT01791517|448579340|FG001|Phase I: Period 1|Lost to Follow-up|0|||
124714282|NCT01791517|448579341|FG002|Phase I: Period 1|Lost to Follow-up|0|||
124714283|NCT01791517|448579342|FG003|Phase I: Period 1|Lost to Follow-up|1|||
124714284|NCT01791517|448579343|FG004|Phase I: Period 1|Lost to Follow-up|0|||
124714285|NCT01791517|448579344|FG005|Phase I: Period 1|Lost to Follow-up|0|||
124714286|NCT01791517|448579345|FG006|Phase I: Period 1|Lost to Follow-up|1|||
124714287|NCT01791517|448579346|FG007|Phase I: Period 1|Lost to Follow-up|0|||
124714288|NCT01791517|448579347|FG008|Phase I: Period 1|Lost to Follow-up|1|||
124553113|NCT02454972|447983808|FG003|Overall Study|Non treatment-related adverse event|0|||
124714289|NCT01791517|448579348|FG009|Phase I: Period 1|Lost to Follow-up|1|||
124714290|NCT01791517|448579349|FG010|Phase I: Period 1|Lost to Follow-up|0|||
124553114|NCT02454972|447983809|FG004|Overall Study|Non treatment-related adverse event|0|||
124553115|NCT02454972|447983810|FG005|Overall Study|Non treatment-related adverse event|1|||
124553116|NCT02454972|447983811|FG006|Overall Study|Non treatment-related adverse event|0|||
124553117|NCT02454972|447983812|FG007|Overall Study|Non treatment-related adverse event|1|||
124553118|NCT02454972|447983813|FG008|Overall Study|Non treatment-related adverse event|0|||
124553119|NCT02454972|447983805|FG000|Overall Study|Treatment-related adverse events|0|||
124553120|NCT02454972|447983806|FG001|Overall Study|Treatment-related adverse events|1|||
124553121|NCT02454972|447983807|FG002|Overall Study|Treatment-related adverse events|1|||
124714291|NCT01791517|448579350|FG011|Phase I: Period 1|Lost to Follow-up|0|||
124714292|NCT01791517|448579339|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
124714293|NCT01791517|448579340|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
124714294|NCT01791517|448579341|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
124714295|NCT01791517|448579342|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
124714296|NCT01791517|448579343|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
124714297|NCT01791517|448579344|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
124714298|NCT01791517|448579345|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
124714299|NCT01791517|448579346|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
124714300|NCT01791517|448579347|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
124714301|NCT01791517|448579348|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
124714302|NCT01791517|448579349|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
124714303|NCT01791517|448579350|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
124553122|NCT02454972|447983808|FG003|Overall Study|Treatment-related adverse events|0|||
124714304|NCT01791517|448579339|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
124714305|NCT01791517|448579340|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
124714306|NCT01791517|448579341|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
124714307|NCT01791517|448579342|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
124714308|NCT01791517|448579343|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
124714309|NCT01791517|448579344|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
124714310|NCT01791517|448579345|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
124714311|NCT01791517|448579346|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
124714312|NCT01791517|448579347|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
124714313|NCT01791517|448579348|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
124714314|NCT01791517|448579349|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
124714315|NCT01791517|448579350|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
124714316|NCT01791517|448579339|FG000|Phase I: Period 2|Protocol Violation|0|||
124714317|NCT01791517|448579340|FG001|Phase I: Period 2|Protocol Violation|0|||
124714318|NCT01791517|448579341|FG002|Phase I: Period 2|Protocol Violation|0|||
124553123|NCT02454972|447983809|FG004|Overall Study|Treatment-related adverse events|2|||
124553124|NCT02454972|447983810|FG005|Overall Study|Treatment-related adverse events|0|||
124553125|NCT02454972|447983811|FG006|Overall Study|Treatment-related adverse events|0|||
124553126|NCT02454972|447983812|FG007|Overall Study|Treatment-related adverse events|2|||
124553127|NCT02454972|447983813|FG008|Overall Study|Treatment-related adverse events|0|||
124553128|NCT02454972|447983805|FG000|Overall Study|Patient moves to compassionate use|0|||
124553129|NCT02454972|447983806|FG001|Overall Study|Patient moves to compassionate use|0|||
124553130|NCT02454972|447983807|FG002|Overall Study|Patient moves to compassionate use|0|||
124553131|NCT02454972|447983808|FG003|Overall Study|Patient moves to compassionate use|0|||
124553132|NCT02454972|447983809|FG004|Overall Study|Patient moves to compassionate use|0|||
124553133|NCT02454972|447983810|FG005|Overall Study|Patient moves to compassionate use|0|||
124553134|NCT02454972|447983811|FG006|Overall Study|Patient moves to compassionate use|2|||
124553135|NCT02454972|447983812|FG007|Overall Study|Patient moves to compassionate use|0|||
124553136|NCT02454972|447983813|FG008|Overall Study|Patient moves to compassionate use|0|||
124553137|NCT02454972|447983805|FG000|Overall Study|Withdrawal by Subject|0|||
124553138|NCT02454972|447983806|FG001|Overall Study|Withdrawal by Subject|1|||
124553139|NCT02454972|447983807|FG002|Overall Study|Withdrawal by Subject|5|||
124553140|NCT02454972|447983808|FG003|Overall Study|Withdrawal by Subject|2|||
124553141|NCT02454972|447983809|FG004|Overall Study|Withdrawal by Subject|3|||
124553142|NCT02454972|447983810|FG005|Overall Study|Withdrawal by Subject|2|||
124553143|NCT02454972|447983811|FG006|Overall Study|Withdrawal by Subject|0|||
124553144|NCT02454972|447983812|FG007|Overall Study|Withdrawal by Subject|1|||
124553145|NCT02454972|447983813|FG008|Overall Study|Withdrawal by Subject|2|||
124553146|NCT02454972|447983805|FG000|Overall Study|Multiple delay/holds on treatment|0|||
124553147|NCT02454972|447983806|FG001|Overall Study|Multiple delay/holds on treatment|0|||
124553148|NCT02454972|447983807|FG002|Overall Study|Multiple delay/holds on treatment|0|||
124553149|NCT02454972|447983808|FG003|Overall Study|Multiple delay/holds on treatment|1|||
124553150|NCT02454972|447983809|FG004|Overall Study|Multiple delay/holds on treatment|0|||
124714319|NCT01791517|448579342|FG003|Phase I: Period 2|Protocol Violation|1|||
124553151|NCT02454972|447983810|FG005|Overall Study|Multiple delay/holds on treatment|0|||
124553152|NCT02454972|447983811|FG006|Overall Study|Multiple delay/holds on treatment|0|||
124553153|NCT02454972|447983812|FG007|Overall Study|Multiple delay/holds on treatment|0|||
124714320|NCT01791517|448579343|FG004|Phase I: Period 2|Protocol Violation|0|||
124553154|NCT02454972|447983813|FG008|Overall Study|Multiple delay/holds on treatment|0|||
124553155|NCT02454972|447983805|FG000|Overall Study|Never treated|0|||
124553156|NCT02454972|447983806|FG001|Overall Study|Never treated|0|||
124553157|NCT02454972|447983807|FG002|Overall Study|Never treated|3|||
124553158|NCT02454972|447983808|FG003|Overall Study|Never treated|1|||
124553159|NCT02454972|447983809|FG004|Overall Study|Never treated|1|||
124553160|NCT02454972|447983810|FG005|Overall Study|Never treated|0|||
124553161|NCT02454972|447983811|FG006|Overall Study|Never treated|0|||
124553162|NCT02454972|447983812|FG007|Overall Study|Never treated|0|||
124553163|NCT02454972|447983813|FG008|Overall Study|Never treated|5|||
124553164|NCT02454972|447983805|FG000|Overall Study|Lost to Follow-up|0|||
124553165|NCT02454972|447983806|FG001|Overall Study|Lost to Follow-up|0|||
124553166|NCT02454972|447983807|FG002|Overall Study|Lost to Follow-up|0|||
124553167|NCT02454972|447983808|FG003|Overall Study|Lost to Follow-up|0|||
124553168|NCT02454972|447983809|FG004|Overall Study|Lost to Follow-up|0|||
124553169|NCT02454972|447983810|FG005|Overall Study|Lost to Follow-up|0|||
124553170|NCT02454972|447983811|FG006|Overall Study|Lost to Follow-up|0|||
124553171|NCT02454972|447983812|FG007|Overall Study|Lost to Follow-up|0|||
124553172|NCT02454972|447983813|FG008|Overall Study|Lost to Follow-up|2|||
124553173|NCT02454972|447983805|FG000|Overall Study|Study termination|0|||
124553174|NCT02454972|447983806|FG001|Overall Study|Study termination|0|||
124553175|NCT02454972|447983807|FG002|Overall Study|Study termination|0|||
124553176|NCT02454972|447983808|FG003|Overall Study|Study termination|0|||
124553177|NCT02454972|447983809|FG004|Overall Study|Study termination|0|||
124553178|NCT02454972|447983810|FG005|Overall Study|Study termination|0|||
124553179|NCT02454972|447983811|FG006|Overall Study|Study termination|0|||
124553180|NCT02454972|447983812|FG007|Overall Study|Study termination|0|||
124553181|NCT02454972|447983813|FG008|Overall Study|Study termination|6|||
124553182|NCT01377233|447983814|FG000|Open-label|Adverse Event|1|||
124553183|NCT01377233|447983815|FG001|Open-label|Adverse Event|0|||
124553184|NCT01377233|447983816|FG002|Open-label|Adverse Event|0|||
124553185|NCT01377233|447983817|FG003|Open-label|Adverse Event|0|||
124553186|NCT01377233|447983818|FG004|Open-label|Adverse Event|0|||
124553187|NCT01377233|447983814|FG000|Open-label|Withdrawal by Subject|3|||
124553188|NCT01377233|447983815|FG001|Open-label|Withdrawal by Subject|0|||
124553189|NCT01377233|447983816|FG002|Open-label|Withdrawal by Subject|0|||
124553190|NCT01377233|447983817|FG003|Open-label|Withdrawal by Subject|0|||
124553191|NCT01377233|447983818|FG004|Open-label|Withdrawal by Subject|0|||
124553192|NCT01377233|447983814|FG000|Double-blind|Adverse Event|0|||
124553193|NCT01377233|447983815|FG001|Double-blind|Adverse Event|1|||
124553194|NCT01377233|447983816|FG002|Double-blind|Adverse Event|2|||
124553195|NCT01377233|447983817|FG003|Double-blind|Adverse Event|2|||
124553196|NCT01377233|447983818|FG004|Double-blind|Adverse Event|0|||
124553197|NCT01377233|447983814|FG000|Double-blind|Protocol Violation|0|||
124553198|NCT01377233|447983815|FG001|Double-blind|Protocol Violation|0|||
124553199|NCT01377233|447983816|FG002|Double-blind|Protocol Violation|0|||
124553200|NCT01377233|447983817|FG003|Double-blind|Protocol Violation|0|||
124553201|NCT01377233|447983818|FG004|Double-blind|Protocol Violation|1|||
124553202|NCT01377233|447983814|FG000|Double-blind|Withdrawal by Subject|0|||
124553203|NCT01377233|447983815|FG001|Double-blind|Withdrawal by Subject|0|||
124553204|NCT01377233|447983816|FG002|Double-blind|Withdrawal by Subject|0|||
124553205|NCT01377233|447983817|FG003|Double-blind|Withdrawal by Subject|1|||
124553206|NCT01377233|447983818|FG004|Double-blind|Withdrawal by Subject|0|||
124553207|NCT01377233|447983814|FG000|Double-blind|Administrative or other|0|||
124553208|NCT01377233|447983815|FG001|Double-blind|Administrative or other|0|||
124553209|NCT01377233|447983816|FG002|Double-blind|Administrative or other|0|||
124553210|NCT01377233|447983817|FG003|Double-blind|Administrative or other|1|||
124553211|NCT01377233|447983818|FG004|Double-blind|Administrative or other|1|||
124553212|NCT01785875|447983819|FG000|Overall Study|Withdrawal by Subject|41|||
124553213|NCT01785875|447983820|FG001|Overall Study|Withdrawal by Subject|34|||
124553214|NCT01785875|447983821|FG002|Overall Study|Withdrawal by Subject|36|||
124553215|NCT01785875|447983819|FG000|Overall Study|Lost to Follow-up|19|||
124553216|NCT01785875|447983820|FG001|Overall Study|Lost to Follow-up|22|||
124553217|NCT01785875|447983821|FG002|Overall Study|Lost to Follow-up|6|||
124553218|NCT01785875|447983819|FG000|Overall Study|Death|27|||
124553219|NCT01785875|447983820|FG001|Overall Study|Death|16|||
124553220|NCT01785875|447983821|FG002|Overall Study|Death|7|||
124553221|NCT01785875|447983819|FG000|Overall Study|Sponsor Decision|0|||
124553222|NCT01785875|447983820|FG001|Overall Study|Sponsor Decision|2|||
124553223|NCT01785875|447983821|FG002|Overall Study|Sponsor Decision|0|||
124553224|NCT01785875|447983819|FG000|Overall Study|Protocol Specified Criteria|207|||
124553225|NCT01785875|447983820|FG001|Overall Study|Protocol Specified Criteria|214|||
124553226|NCT01785875|447983821|FG002|Overall Study|Protocol Specified Criteria|55|||
124714321|NCT01791517|448579344|FG005|Phase I: Period 2|Protocol Violation|0|||
124553227|NCT01785875|447983819|FG000|Overall Study|Missing|0|||
124553228|NCT01785875|447983820|FG001|Overall Study|Missing|1|||
124553229|NCT01785875|447983821|FG002|Overall Study|Missing|3|||
124553230|NCT00707174|447983824|FG000|Overall Study|Adverse Event|1|||
124553231|NCT00707174|447983825|FG001|Overall Study|Adverse Event|6|||
124714322|NCT01791517|448579345|FG006|Phase I: Period 2|Protocol Violation|0|||
124714323|NCT01791517|448579346|FG007|Phase I: Period 2|Protocol Violation|0|||
124714324|NCT01791517|448579347|FG008|Phase I: Period 2|Protocol Violation|0|||
124714325|NCT01791517|448579348|FG009|Phase I: Period 2|Protocol Violation|0|||
124714326|NCT01791517|448579349|FG010|Phase I: Period 2|Protocol Violation|0|||
124714327|NCT01791517|448579350|FG011|Phase I: Period 2|Protocol Violation|0|||
124714328|NCT01791517|448579339|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
124714329|NCT01791517|448579340|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
124714330|NCT01791517|448579341|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
124714331|NCT01791517|448579342|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
124553232|NCT00707174|447983824|FG000|Overall Study|Withdrawal by Subject|4|||
124553233|NCT00707174|447983825|FG001|Overall Study|Withdrawal by Subject|1|||
124553234|NCT04991311|447983826|FG000|Overall Study|Adverse Event|1|||
124553235|NCT01453374|447983829|FG000|Overall Study|Adverse Event|7|||
124553236|NCT01453374|447983829|FG000|Overall Study|Lack of Efficacy|1|||
124553237|NCT01453374|447983829|FG000|Overall Study|Lost to Follow-up|3|||
124553238|NCT01453374|447983829|FG000|Overall Study|Withdrawal by Subject|5|||
124553239|NCT01453374|447983829|FG000|Overall Study|Incarcerated|2|||
124553240|NCT01440595|447983830|FG000|Overall Study|Lost to Follow-up|0|||
124553241|NCT01440595|447983831|FG001|Overall Study|Lost to Follow-up|1|||
124553242|NCT01440595|447983832|FG002|Overall Study|Lost to Follow-up|0|||
124553243|NCT01440595|447983830|FG000|Overall Study|Study terminated by sponsor.|1|||
124553244|NCT01440595|447983831|FG001|Overall Study|Study terminated by sponsor.|2|||
124553245|NCT01440595|447983832|FG002|Overall Study|Study terminated by sponsor.|1|||
124553246|NCT01223196|447983833|FG000|Overall Study|Lost to Follow-up|2|||
124553247|NCT01223196|447983834|FG001|Overall Study|Lost to Follow-up|0|||
124553248|NCT01223196|447983833|FG000|Overall Study|Physician Decision|1|||
124553249|NCT01223196|447983834|FG001|Overall Study|Physician Decision|0|||
124553250|NCT01223196|447983833|FG000|Overall Study|Withdrawal by Subject|1|||
124553251|NCT01223196|447983834|FG001|Overall Study|Withdrawal by Subject|0|||
124714332|NCT01791517|448579343|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
124553252|NCT05180630|447983838|FG000|First Intervention|Physician Decision|0|||
124553253|NCT05180630|447983839|FG001|First Intervention|Physician Decision|0|||
124553254|NCT05180630|447983840|FG002|First Intervention|Physician Decision|3|||
124553255|NCT00709735|447983843|FG000|Overall Study|Lost to Follow-up|1|||
124714333|NCT01791517|448579344|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
124553256|NCT00709735|447983844|FG001|Overall Study|Lost to Follow-up|1|||
124714334|NCT01791517|448579345|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
124714335|NCT01791517|448579346|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
124714336|NCT01791517|448579347|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
124714337|NCT01791517|448579348|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
124714338|NCT01791517|448579349|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
124714339|NCT01791517|448579350|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
124714340|NCT01791517|448579339|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
124714341|NCT01791517|448579340|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
124714342|NCT01791517|448579341|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
124714343|NCT01791517|448579342|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
124770588|NCT05408429|448788892|FG002|Overall Study|Withdrawal by Subject|1|||
124553257|NCT00709735|447983843|FG000|Overall Study|Relapse into Opioid Abuse|0|||
124553258|NCT00709735|447983844|FG001|Overall Study|Relapse into Opioid Abuse|1|||
124714344|NCT01791517|448579343|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
124714345|NCT01791517|448579344|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
124714346|NCT01791517|448579345|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
124770589|NCT01074970|448788894|FG000|Overall Study|Never Treated|0|||
124714347|NCT01791517|448579346|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
124553259|NCT00709735|447983843|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
124553260|NCT00709735|447983844|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
124553261|NCT01466673|447983845|FG000|Overall Study|Non-compliance with study treatment|2|||
124553262|NCT01466673|447983846|FG001|Overall Study|Non-compliance with study treatment|0|||
124553263|NCT01466673|447983845|FG000|Overall Study|Lost to Follow-up|3|||
124553264|NCT01466673|447983846|FG001|Overall Study|Lost to Follow-up|5|||
124553265|NCT01466673|447983845|FG000|Overall Study|Adverse Event|2|||
124553266|NCT01466673|447983846|FG001|Overall Study|Adverse Event|1|||
124553267|NCT02725671|447983854|FG000|Overall Study|Lost to Follow-up|1|||
124553268|NCT00965263|447983855|FG000|Overall Study|Physician Decision|2|||
124553269|NCT00965263|447983856|FG001|Overall Study|Physician Decision|0|||
124553270|NCT00965263|447983855|FG000|Overall Study|Family emergency|0|||
124553271|NCT00965263|447983856|FG001|Overall Study|Family emergency|1|||
124553272|NCT00965263|447983855|FG000|Overall Study|Protocol Violation|0|||
124553273|NCT00965263|447983856|FG001|Overall Study|Protocol Violation|2|||
124553274|NCT00963599|447983857|FG000|Overall Study|Adverse Event|2|||
124553275|NCT00963599|447983858|FG001|Overall Study|Adverse Event|0|||
124553276|NCT00963599|447983859|FG002|Overall Study|Adverse Event|1|||
124553277|NCT00963599|447983860|FG003|Overall Study|Adverse Event|2|||
124553278|NCT00963599|447983857|FG000|Overall Study|Lack of Efficacy|0|||
124553279|NCT00963599|447983858|FG001|Overall Study|Lack of Efficacy|2|||
124553280|NCT00963599|447983859|FG002|Overall Study|Lack of Efficacy|1|||
124553281|NCT00963599|447983860|FG003|Overall Study|Lack of Efficacy|4|||
124553282|NCT00963599|447983857|FG000|Overall Study|Lost to Follow-up|0|||
124553283|NCT00963599|447983858|FG001|Overall Study|Lost to Follow-up|1|||
124553284|NCT00963599|447983859|FG002|Overall Study|Lost to Follow-up|1|||
124553285|NCT00963599|447983860|FG003|Overall Study|Lost to Follow-up|1|||
124553286|NCT00963599|447983857|FG000|Overall Study|Protocol Violation|2|||
124553287|NCT00963599|447983858|FG001|Overall Study|Protocol Violation|2|||
124553288|NCT00963599|447983859|FG002|Overall Study|Protocol Violation|3|||
124553289|NCT00963599|447983860|FG003|Overall Study|Protocol Violation|4|||
124553290|NCT00963599|447983857|FG000|Overall Study|Withdrawal by Subject|2|||
124553291|NCT00963599|447983858|FG001|Overall Study|Withdrawal by Subject|1|||
124553292|NCT00963599|447983859|FG002|Overall Study|Withdrawal by Subject|3|||
124553293|NCT00963599|447983860|FG003|Overall Study|Withdrawal by Subject|3|||
124553294|NCT03496207|447983863|FG000|Base Study|Adverse Event|0|||
124553295|NCT03496207|447983864|FG001|Base Study|Adverse Event|0|||
124714348|NCT01791517|448579347|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
124714349|NCT01791517|448579348|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
124714350|NCT01791517|448579349|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
124714351|NCT01791517|448579350|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
124714352|NCT01791517|448579339|FG000|Phase I: Period 2|Lens Discomfort|0|||
124714353|NCT01791517|448579340|FG001|Phase I: Period 2|Lens Discomfort|0|||
124553296|NCT03496207|447983865|FG002|Base Study|Adverse Event|1|||
124714354|NCT01791517|448579341|FG002|Phase I: Period 2|Lens Discomfort|0|||
124714355|NCT01791517|448579342|FG003|Phase I: Period 2|Lens Discomfort|0|||
124553297|NCT03496207|447983866|FG003|Base Study|Adverse Event|1|||
124553298|NCT03496207|447983867|FG004|Base Study|Adverse Event|4|||
124553299|NCT03496207|447983863|FG000|Base Study|Death|0|||
124553300|NCT03496207|447983864|FG001|Base Study|Death|0|||
124553301|NCT03496207|447983865|FG002|Base Study|Death|0|||
124553302|NCT03496207|447983866|FG003|Base Study|Death|0|||
124553303|NCT03496207|447983867|FG004|Base Study|Death|1|||
124553304|NCT03496207|447983863|FG000|Base Study|Withdrawal by Subject|0|||
124553305|NCT03496207|447983864|FG001|Base Study|Withdrawal by Subject|0|||
124553306|NCT03496207|447983865|FG002|Base Study|Withdrawal by Subject|1|||
124553307|NCT03496207|447983866|FG003|Base Study|Withdrawal by Subject|0|||
124553308|NCT03496207|447983867|FG004|Base Study|Withdrawal by Subject|1|||
124553309|NCT03496207|447983863|FG000|Extension Period|Adverse Event|0|||
124553310|NCT03496207|447983864|FG001|Extension Period|Adverse Event|0|||
124553311|NCT03496207|447983865|FG002|Extension Period|Adverse Event|0|||
124553312|NCT03496207|447983866|FG003|Extension Period|Adverse Event|1|||
124553313|NCT03496207|447983867|FG004|Extension Period|Adverse Event|1|||
124553314|NCT03496207|447983863|FG000|Extension Period|Death|1|||
124553315|NCT03496207|447983864|FG001|Extension Period|Death|0|||
124553316|NCT03496207|447983865|FG002|Extension Period|Death|0|||
124553317|NCT03496207|447983866|FG003|Extension Period|Death|1|||
124553318|NCT03496207|447983867|FG004|Extension Period|Death|2|||
124553319|NCT03496207|447983863|FG000|Extension Period|Withdrawal by Subject|1|||
124553320|NCT03496207|447983864|FG001|Extension Period|Withdrawal by Subject|0|||
124553321|NCT03496207|447983865|FG002|Extension Period|Withdrawal by Subject|0|||
124553322|NCT03496207|447983866|FG003|Extension Period|Withdrawal by Subject|1|||
124553323|NCT03496207|447983867|FG004|Extension Period|Withdrawal by Subject|1|||
124553324|NCT03496207|447983863|FG000|Extension Period|Elevated hemoglobin levels|0|||
124553325|NCT03496207|447983864|FG001|Extension Period|Elevated hemoglobin levels|0|||
124553326|NCT03496207|447983865|FG002|Extension Period|Elevated hemoglobin levels|0|||
124553327|NCT03496207|447983866|FG003|Extension Period|Elevated hemoglobin levels|0|||
124553328|NCT03496207|447983867|FG004|Extension Period|Elevated hemoglobin levels|1|||
124553329|NCT01255722|447983868|FG000|Overall Study|Adverse Event|0|||
124553330|NCT01255722|447983869|FG001|Overall Study|Adverse Event|1|||
124553331|NCT01255722|447983870|FG002|Overall Study|Adverse Event|1|||
124553332|NCT01255722|447983868|FG000|Overall Study|asymptomatic patient|1|||
124553333|NCT01255722|447983869|FG001|Overall Study|asymptomatic patient|0|||
124553334|NCT01255722|447983870|FG002|Overall Study|asymptomatic patient|0|||
124553335|NCT01255722|447983868|FG000|Overall Study|beta-blocker contraindicated|2|||
124553336|NCT01255722|447983869|FG001|Overall Study|beta-blocker contraindicated|0|||
124553337|NCT01255722|447983870|FG002|Overall Study|beta-blocker contraindicated|0|||
124553338|NCT02164539|447983871|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
124553339|NCT02164539|447983872|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
124553340|NCT02164539|447983873|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
124553341|NCT02164539|447983874|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
124553342|NCT02164539|447983875|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
124553343|NCT02164539|447983876|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
124553344|NCT02164539|447983877|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
124553345|NCT02164539|447983871|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
124553346|NCT02164539|447983872|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
124553347|NCT02164539|447983873|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
124553348|NCT02164539|447983874|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
124553349|NCT02164539|447983875|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
124553350|NCT02164539|447983876|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
124553351|NCT02164539|447983877|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
124553352|NCT02164539|447983871|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
124553353|NCT02164539|447983872|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
124553354|NCT02164539|447983873|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
124553355|NCT02164539|447983874|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
124553356|NCT02164539|447983875|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
124553357|NCT02164539|447983876|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
124553358|NCT02164539|447983877|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
124553359|NCT02164539|447983871|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
124553360|NCT02164539|447983872|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
124553361|NCT02164539|447983873|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
124553362|NCT02164539|447983874|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
124553363|NCT02164539|447983875|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
124553364|NCT02164539|447983876|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
124553365|NCT02164539|447983877|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
124553366|NCT02164539|447983871|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
124553367|NCT02164539|447983872|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
124553368|NCT02164539|447983873|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
124553369|NCT02164539|447983874|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
124553370|NCT02164539|447983875|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
124553371|NCT02164539|447983876|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
124553372|NCT02164539|447983877|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
124553373|NCT02164539|447983871|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
124553374|NCT02164539|447983872|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
124553375|NCT02164539|447983873|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
124553376|NCT02164539|447983874|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
124553377|NCT02164539|447983875|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
124553378|NCT02164539|447983876|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
124553379|NCT02164539|447983877|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
124714356|NCT01791517|448579343|FG004|Phase I: Period 2|Lens Discomfort|0|||
124714357|NCT01791517|448579344|FG005|Phase I: Period 2|Lens Discomfort|1|||
124714358|NCT01791517|448579345|FG006|Phase I: Period 2|Lens Discomfort|0|||
124714359|NCT01791517|448579346|FG007|Phase I: Period 2|Lens Discomfort|0|||
124553380|NCT03835975|447983880|FG000|Overall Study|Lost to Follow-up|1|||
124553381|NCT03835975|447983881|FG001|Overall Study|Lost to Follow-up|1|||
124553382|NCT03835975|447983882|FG002|Overall Study|Lost to Follow-up|0|||
124553383|NCT03835975|447983883|FG003|Overall Study|Lost to Follow-up|0|||
124553384|NCT03835975|447983884|FG004|Overall Study|Lost to Follow-up|0|||
124553385|NCT03835975|447983880|FG000|Overall Study|No longer met eligibility criteria|0|||
124553386|NCT03835975|447983881|FG001|Overall Study|No longer met eligibility criteria|1|||
124553387|NCT03835975|447983882|FG002|Overall Study|No longer met eligibility criteria|0|||
124553388|NCT03835975|447983883|FG003|Overall Study|No longer met eligibility criteria|0|||
124553389|NCT03835975|447983884|FG004|Overall Study|No longer met eligibility criteria|0|||
124553390|NCT03835975|447983880|FG000|Overall Study|Protocol Violation|1|||
124553391|NCT03835975|447983881|FG001|Overall Study|Protocol Violation|1|||
124553392|NCT03835975|447983882|FG002|Overall Study|Protocol Violation|2|||
124714360|NCT01791517|448579347|FG008|Phase I: Period 2|Lens Discomfort|0|||
124553393|NCT03835975|447983883|FG003|Overall Study|Protocol Violation|0|||
124714361|NCT01791517|448579348|FG009|Phase I: Period 2|Lens Discomfort|0|||
124714362|NCT01791517|448579349|FG010|Phase I: Period 2|Lens Discomfort|0|||
124714363|NCT01791517|448579350|FG011|Phase I: Period 2|Lens Discomfort|0|||
124714364|NCT01791517|448579339|FG000|Phase I: Period 2|Lost to Follow-up|0|||
124714365|NCT01791517|448579340|FG001|Phase I: Period 2|Lost to Follow-up|3|||
124714366|NCT01791517|448579341|FG002|Phase I: Period 2|Lost to Follow-up|2|||
124714367|NCT01791517|448579342|FG003|Phase I: Period 2|Lost to Follow-up|0|||
124714368|NCT01791517|448579343|FG004|Phase I: Period 2|Lost to Follow-up|0|||
124553394|NCT03835975|447983884|FG004|Overall Study|Protocol Violation|0|||
124770590|NCT01074970|448788895|FG001|Overall Study|Never Treated|0|||
124714369|NCT01791517|448579344|FG005|Phase I: Period 2|Lost to Follow-up|0|||
124714370|NCT01791517|448579345|FG006|Phase I: Period 2|Lost to Follow-up|0|||
124714371|NCT01791517|448579346|FG007|Phase I: Period 2|Lost to Follow-up|0|||
124714372|NCT01791517|448579347|FG008|Phase I: Period 2|Lost to Follow-up|0|||
124714373|NCT01791517|448579348|FG009|Phase I: Period 2|Lost to Follow-up|0|||
124714374|NCT01791517|448579349|FG010|Phase I: Period 2|Lost to Follow-up|0|||
124714375|NCT01791517|448579350|FG011|Phase I: Period 2|Lost to Follow-up|0|||
124714376|NCT01791517|448579339|FG000|Phase I: Period 3|Lens Discomfort|0|||
124714377|NCT01791517|448579340|FG001|Phase I: Period 3|Lens Discomfort|0|||
124714378|NCT01791517|448579341|FG002|Phase I: Period 3|Lens Discomfort|0|||
124714379|NCT01791517|448579342|FG003|Phase I: Period 3|Lens Discomfort|0|||
124714380|NCT01791517|448579343|FG004|Phase I: Period 3|Lens Discomfort|0|||
124714381|NCT01791517|448579344|FG005|Phase I: Period 3|Lens Discomfort|0|||
124553395|NCT03835975|447983880|FG000|Overall Study|Withdrawal by Subject|1|||
124553396|NCT03835975|447983881|FG001|Overall Study|Withdrawal by Subject|0|||
124714382|NCT01791517|448579345|FG006|Phase I: Period 3|Lens Discomfort|0|||
124553397|NCT03835975|447983882|FG002|Overall Study|Withdrawal by Subject|1|||
124553398|NCT03835975|447983883|FG003|Overall Study|Withdrawal by Subject|1|||
124714383|NCT01791517|448579346|FG007|Phase I: Period 3|Lens Discomfort|0|||
124714384|NCT01791517|448579347|FG008|Phase I: Period 3|Lens Discomfort|0|||
124714385|NCT01791517|448579348|FG009|Phase I: Period 3|Lens Discomfort|0|||
124714386|NCT01791517|448579349|FG010|Phase I: Period 3|Lens Discomfort|0|||
124714387|NCT01791517|448579350|FG011|Phase I: Period 3|Lens Discomfort|1|||
124714388|NCT01791517|448579339|FG000|Phase I: Period 3|Lost to Follow-up|0|||
124714389|NCT01791517|448579340|FG001|Phase I: Period 3|Lost to Follow-up|1|||
124714390|NCT01791517|448579341|FG002|Phase I: Period 3|Lost to Follow-up|0|||
124714391|NCT01791517|448579342|FG003|Phase I: Period 3|Lost to Follow-up|0|||
124714392|NCT01791517|448579343|FG004|Phase I: Period 3|Lost to Follow-up|1|||
124714393|NCT01791517|448579344|FG005|Phase I: Period 3|Lost to Follow-up|0|||
124714394|NCT01791517|448579345|FG006|Phase I: Period 3|Lost to Follow-up|0|||
124714395|NCT01791517|448579346|FG007|Phase I: Period 3|Lost to Follow-up|0|||
124714396|NCT01791517|448579347|FG008|Phase I: Period 3|Lost to Follow-up|0|||
124714397|NCT01791517|448579348|FG009|Phase I: Period 3|Lost to Follow-up|0|||
124714398|NCT01791517|448579349|FG010|Phase I: Period 3|Lost to Follow-up|0|||
124714399|NCT01791517|448579350|FG011|Phase I: Period 3|Lost to Follow-up|0|||
124714400|NCT01791517|448579339|FG000|Phase I: Period 3|Adverse Event|0|||
124714401|NCT01791517|448579340|FG001|Phase I: Period 3|Adverse Event|0|||
124714402|NCT01791517|448579341|FG002|Phase I: Period 3|Adverse Event|0|||
124714403|NCT01791517|448579342|FG003|Phase I: Period 3|Adverse Event|1|||
124714404|NCT01791517|448579343|FG004|Phase I: Period 3|Adverse Event|0|||
124714405|NCT01791517|448579344|FG005|Phase I: Period 3|Adverse Event|0|||
124714406|NCT01791517|448579345|FG006|Phase I: Period 3|Adverse Event|0|||
124714407|NCT01791517|448579346|FG007|Phase I: Period 3|Adverse Event|0|||
124714408|NCT01791517|448579347|FG008|Phase I: Period 3|Adverse Event|0|||
124714409|NCT01791517|448579348|FG009|Phase I: Period 3|Adverse Event|0|||
124714410|NCT01791517|448579349|FG010|Phase I: Period 3|Adverse Event|0|||
124714411|NCT01791517|448579350|FG011|Phase I: Period 3|Adverse Event|0|||
124714412|NCT01791517|448579339|FG000|Phase II|Lost to Follow-up|1|||
124714413|NCT01791517|448579340|FG001|Phase II|Lost to Follow-up|0|||
124714414|NCT01791517|448579341|FG002|Phase II|Lost to Follow-up|1|||
124714415|NCT01791517|448579342|FG003|Phase II|Lost to Follow-up|0|||
124714416|NCT01791517|448579343|FG004|Phase II|Lost to Follow-up|1|||
124714417|NCT01791517|448579344|FG005|Phase II|Lost to Follow-up|2|||
124714418|NCT01791517|448579345|FG006|Phase II|Lost to Follow-up|0|||
124553399|NCT03835975|447983884|FG004|Overall Study|Withdrawal by Subject|0|||
124553400|NCT00061945|447983885|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
124553401|NCT00061945|447983886|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
124553402|NCT00061945|447983885|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
124714419|NCT01791517|448579346|FG007|Phase II|Lost to Follow-up|1|||
124714420|NCT01791517|448579347|FG008|Phase II|Lost to Follow-up|1|||
124770591|NCT01074970|448788896|FG002|Overall Study|Never Treated|8|||
124770592|NCT01074970|448788897|FG003|Overall Study|Never Treated|1|||
124553403|NCT00061945|447983886|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
124553404|NCT00061945|447983885|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
124553405|NCT00061945|447983886|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
124553406|NCT00061945|447983885|FG000|Course IV: Alemtuzumab|Early exits|6|||
124553407|NCT00061945|447983886|FG001|Course IV: Alemtuzumab|Early exits|15|||
124553408|NCT00975884|447983888|FG000|Overall Study|Adverse Event|1|||
124553409|NCT00975884|447983889|FG001|Overall Study|Adverse Event|0|||
124553410|NCT00975884|447983888|FG000|Overall Study|Lost to Follow-up|5|||
124553411|NCT00975884|447983889|FG001|Overall Study|Lost to Follow-up|3|||
124553412|NCT00975884|447983888|FG000|Overall Study|Withdrawal by Subject|9|||
124553413|NCT00975884|447983889|FG001|Overall Study|Withdrawal by Subject|9|||
124553414|NCT00975884|447983888|FG000|Overall Study|Other|1|||
124553415|NCT00975884|447983889|FG001|Overall Study|Other|3|||
124553416|NCT01656967|447983890|FG000|Overall Study|faulty monitor|1|||
124553417|NCT01656967|447983891|FG001|Overall Study|faulty monitor|0|||
124553418|NCT01656967|447983890|FG000|Overall Study|unsuccessful ETT insertion|3|||
124553419|NCT01656967|447983891|FG001|Overall Study|unsuccessful ETT insertion|2|||
124553420|NCT05166512|447983892|FG000|Randomized|Lost to Follow-up|2|||
124553421|NCT05166512|447983893|FG001|Randomized|Lost to Follow-up|0|||
124553422|NCT05166512|447983892|FG000|Randomized|Withdrawal by Subject|1|||
124553423|NCT05166512|447983893|FG001|Randomized|Withdrawal by Subject|0|||
124553424|NCT05166512|447983892|FG000|Baseline Data Collection|Lost to Follow-up|0|||
124553425|NCT05166512|447983893|FG001|Baseline Data Collection|Lost to Follow-up|3|||
124553426|NCT05166512|447983892|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
124553427|NCT05166512|447983893|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
124553428|NCT05166512|447983892|FG000|Baseline Data Collection|Protocol Violation|2|||
124553429|NCT05166512|447983893|FG001|Baseline Data Collection|Protocol Violation|0|||
124553430|NCT05166512|447983892|FG000|4 Month Data Collection|Lost to Follow-up|1|||
124553431|NCT05166512|447983893|FG001|4 Month Data Collection|Lost to Follow-up|0|||
124553432|NCT05166512|447983892|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
124553433|NCT05166512|447983893|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
124553434|NCT05166512|447983892|FG000|12 Month Data Collection|Lost to Follow-up|3|||
124714421|NCT01791517|448579348|FG009|Phase II|Lost to Follow-up|1|||
124714422|NCT01791517|448579349|FG010|Phase II|Lost to Follow-up|0|||
124714423|NCT01791517|448579350|FG011|Phase II|Lost to Follow-up|0|||
124714424|NCT01791517|448579339|FG000|Phase II|Withdrawal by Subject|1|||
124714425|NCT01791517|448579340|FG001|Phase II|Withdrawal by Subject|0|||
124714426|NCT01791517|448579341|FG002|Phase II|Withdrawal by Subject|0|||
124714427|NCT01791517|448579342|FG003|Phase II|Withdrawal by Subject|0|||
124714428|NCT01791517|448579343|FG004|Phase II|Withdrawal by Subject|0|||
124714429|NCT01791517|448579344|FG005|Phase II|Withdrawal by Subject|2|||
124714430|NCT01791517|448579345|FG006|Phase II|Withdrawal by Subject|0|||
124714431|NCT01791517|448579346|FG007|Phase II|Withdrawal by Subject|1|||
124714432|NCT01791517|448579347|FG008|Phase II|Withdrawal by Subject|0|||
124714433|NCT01791517|448579348|FG009|Phase II|Withdrawal by Subject|0|||
124714434|NCT01791517|448579349|FG010|Phase II|Withdrawal by Subject|1|||
124714435|NCT01791517|448579350|FG011|Phase II|Withdrawal by Subject|0|||
124714436|NCT01791517|448579339|FG000|Phase II|Lack of Efficacy|0|||
124714437|NCT01791517|448579340|FG001|Phase II|Lack of Efficacy|0|||
124714438|NCT01791517|448579341|FG002|Phase II|Lack of Efficacy|0|||
124714439|NCT01791517|448579342|FG003|Phase II|Lack of Efficacy|0|||
124714440|NCT01791517|448579343|FG004|Phase II|Lack of Efficacy|1|||
124714441|NCT01791517|448579344|FG005|Phase II|Lack of Efficacy|0|||
124714442|NCT01791517|448579345|FG006|Phase II|Lack of Efficacy|0|||
124714443|NCT01791517|448579346|FG007|Phase II|Lack of Efficacy|0|||
124714444|NCT01791517|448579347|FG008|Phase II|Lack of Efficacy|0|||
124714445|NCT01791517|448579348|FG009|Phase II|Lack of Efficacy|0|||
124714446|NCT01791517|448579349|FG010|Phase II|Lack of Efficacy|0|||
124714447|NCT01791517|448579350|FG011|Phase II|Lack of Efficacy|0|||
124714448|NCT01791517|448579339|FG000|Phase II|Adverse Event|0|||
124714449|NCT01791517|448579340|FG001|Phase II|Adverse Event|0|||
124714450|NCT01791517|448579341|FG002|Phase II|Adverse Event|0|||
124714451|NCT01791517|448579342|FG003|Phase II|Adverse Event|0|||
124714452|NCT01791517|448579343|FG004|Phase II|Adverse Event|0|||
124714453|NCT01791517|448579344|FG005|Phase II|Adverse Event|0|||
124714454|NCT01791517|448579345|FG006|Phase II|Adverse Event|2|||
124714455|NCT01791517|448579346|FG007|Phase II|Adverse Event|1|||
124714456|NCT01791517|448579347|FG008|Phase II|Adverse Event|0|||
124714457|NCT01791517|448579348|FG009|Phase II|Adverse Event|1|||
124714458|NCT01791517|448579349|FG010|Phase II|Adverse Event|0|||
124714459|NCT01791517|448579350|FG011|Phase II|Adverse Event|0|||
124714460|NCT01791517|448579339|FG000|Phase II|Lens Handling Difficulties|0|||
124714461|NCT01791517|448579340|FG001|Phase II|Lens Handling Difficulties|0|||
124714462|NCT01791517|448579341|FG002|Phase II|Lens Handling Difficulties|0|||
124714463|NCT01791517|448579342|FG003|Phase II|Lens Handling Difficulties|0|||
124714464|NCT01791517|448579343|FG004|Phase II|Lens Handling Difficulties|0|||
124714465|NCT01791517|448579344|FG005|Phase II|Lens Handling Difficulties|0|||
124714466|NCT01791517|448579345|FG006|Phase II|Lens Handling Difficulties|0|||
124714467|NCT01791517|448579346|FG007|Phase II|Lens Handling Difficulties|0|||
124714468|NCT01791517|448579347|FG008|Phase II|Lens Handling Difficulties|1|||
124714469|NCT01791517|448579348|FG009|Phase II|Lens Handling Difficulties|0|||
124714470|NCT01791517|448579349|FG010|Phase II|Lens Handling Difficulties|0|||
124714471|NCT01791517|448579350|FG011|Phase II|Lens Handling Difficulties|0|||
124714472|NCT01791517|448579339|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
124714473|NCT01791517|448579340|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
124714474|NCT01791517|448579341|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
124714475|NCT01791517|448579342|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
124714476|NCT01791517|448579343|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
124714477|NCT01791517|448579344|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
124714478|NCT01791517|448579345|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
124714479|NCT01791517|448579346|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
124714480|NCT01791517|448579347|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
124714481|NCT01791517|448579348|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
124714482|NCT01791517|448579349|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
124714483|NCT01791517|448579350|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
124714484|NCT01791517|448579339|FG000|Phase II|Pre-Existing Ocular Issue|0|||
124714485|NCT01791517|448579340|FG001|Phase II|Pre-Existing Ocular Issue|0|||
124714486|NCT01791517|448579341|FG002|Phase II|Pre-Existing Ocular Issue|0|||
124714487|NCT01791517|448579342|FG003|Phase II|Pre-Existing Ocular Issue|0|||
124714488|NCT01791517|448579343|FG004|Phase II|Pre-Existing Ocular Issue|0|||
124714489|NCT01791517|448579344|FG005|Phase II|Pre-Existing Ocular Issue|0|||
124714490|NCT01791517|448579345|FG006|Phase II|Pre-Existing Ocular Issue|0|||
124553435|NCT05166512|447983893|FG001|12 Month Data Collection|Lost to Follow-up|1|||
124553436|NCT05166512|447983892|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
124553437|NCT05166512|447983893|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
124553438|NCT02139306|447983896|FG000|Overall Study|Withdrawal by Subject|4|||
124553439|NCT02139306|447983897|FG001|Overall Study|Withdrawal by Subject|6|||
124553440|NCT02139306|447983896|FG000|Overall Study|Adverse Event|3|||
124553441|NCT02139306|447983897|FG001|Overall Study|Adverse Event|4|||
124553442|NCT02139306|447983896|FG000|Overall Study|Physician Decision|0|||
124553443|NCT02139306|447983897|FG001|Overall Study|Physician Decision|1|||
124553444|NCT02139306|447983896|FG000|Overall Study|Other Unspecified|2|||
124553445|NCT02139306|447983897|FG001|Overall Study|Other Unspecified|3|||
124553446|NCT02139306|447983896|FG000|Overall Study|Protocol Violation|4|||
124553447|NCT02139306|447983897|FG001|Overall Study|Protocol Violation|0|||
124553448|NCT02956005|447983898|FG000|Overall Study|Not eligible|1|||
124553449|NCT02956005|447983898|FG000|Overall Study|Withdrawal by Subject|3|||
124553450|NCT02956005|447983898|FG000|Overall Study|Physician Decision|12|||
124553451|NCT03909971|447983899|FG000|Overall Study|Other Reasons Not Specified|0|||
124553452|NCT03909971|447983900|FG001|Overall Study|Other Reasons Not Specified|1|||
124553453|NCT03909971|447983899|FG000|Overall Study|Global Deterioration of Health Status|2|||
124553454|NCT03909971|447983900|FG001|Overall Study|Global Deterioration of Health Status|1|||
124553455|NCT03909971|447983899|FG000|Overall Study|Progressive Disease|6|||
124553456|NCT03909971|447983900|FG001|Overall Study|Progressive Disease|14|||
124553457|NCT03909971|447983899|FG000|Overall Study|Death|2|||
124553458|NCT03909971|447983900|FG001|Overall Study|Death|6|||
124553459|NCT01185639|447983901|FG000|Overall Study|Progressed and didn't receive therapy|2|||
124553460|NCT01861717|447983906|FG000|Overall Study|Lost to Follow-up|1|||
124553461|NCT01861717|447983906|FG000|Overall Study|Withdrawal by Subject|1|||
124553462|NCT03033069|447983907|FG000|Overall Study|Adverse Event|6|||
124553463|NCT03033069|447983908|FG001|Overall Study|Adverse Event|7|||
124553464|NCT03033069|447983909|FG002|Overall Study|Adverse Event|4|||
124553465|NCT03033069|447983910|FG003|Overall Study|Adverse Event|6|||
124553466|NCT03033069|447983907|FG000|Overall Study|Lack of Efficacy|0|||
124553467|NCT03033069|447983908|FG001|Overall Study|Lack of Efficacy|0|||
124553468|NCT03033069|447983909|FG002|Overall Study|Lack of Efficacy|1|||
124553469|NCT03033069|447983910|FG003|Overall Study|Lack of Efficacy|0|||
124553470|NCT03033069|447983907|FG000|Overall Study|Lost to Follow-up|6|||
124553471|NCT03033069|447983908|FG001|Overall Study|Lost to Follow-up|5|||
124553472|NCT03033069|447983909|FG002|Overall Study|Lost to Follow-up|5|||
124553473|NCT03033069|447983910|FG003|Overall Study|Lost to Follow-up|6|||
124553474|NCT03033069|447983907|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124553475|NCT03033069|447983908|FG001|Overall Study|Non-Compliance With Study Drug|1|||
124553476|NCT03033069|447983909|FG002|Overall Study|Non-Compliance With Study Drug|1|||
124553477|NCT03033069|447983910|FG003|Overall Study|Non-Compliance With Study Drug|0|||
124553478|NCT03033069|447983907|FG000|Overall Study|Protocol Deviation|0|||
124553479|NCT03033069|447983908|FG001|Overall Study|Protocol Deviation|1|||
124553480|NCT03033069|447983909|FG002|Overall Study|Protocol Deviation|0|||
124714491|NCT01791517|448579346|FG007|Phase II|Pre-Existing Ocular Issue|0|||
124714492|NCT01791517|448579347|FG008|Phase II|Pre-Existing Ocular Issue|0|||
124714493|NCT01791517|448579348|FG009|Phase II|Pre-Existing Ocular Issue|0|||
124714494|NCT01791517|448579349|FG010|Phase II|Pre-Existing Ocular Issue|0|||
124714495|NCT01791517|448579350|FG011|Phase II|Pre-Existing Ocular Issue|1|||
124714496|NCT04011735|448579351|FG000|Overall Study|Withdrawal by Subject|1|||
124553481|NCT03033069|447983910|FG003|Overall Study|Protocol Deviation|0|||
124553482|NCT03033069|447983907|FG000|Overall Study|Withdrawal by Subject|10|||
124553483|NCT03033069|447983908|FG001|Overall Study|Withdrawal by Subject|10|||
124553484|NCT03033069|447983909|FG002|Overall Study|Withdrawal by Subject|11|||
124553485|NCT03033069|447983910|FG003|Overall Study|Withdrawal by Subject|6|||
124553486|NCT03033069|447983907|FG000|Overall Study|Withdrawal By Caregiver|1|||
124553487|NCT03033069|447983908|FG001|Overall Study|Withdrawal By Caregiver|0|||
124553488|NCT03033069|447983909|FG002|Overall Study|Withdrawal By Caregiver|0|||
124553489|NCT03033069|447983910|FG003|Overall Study|Withdrawal By Caregiver|0|||
124553490|NCT03033069|447983907|FG000|Overall Study|Reason not Specified|0|||
124553491|NCT03033069|447983908|FG001|Overall Study|Reason not Specified|1|||
124714497|NCT04011735|448579352|FG001|Overall Study|Withdrawal by Subject|0|||
124714498|NCT04011735|448579353|FG002|Overall Study|Withdrawal by Subject|1|||
124714499|NCT04011735|448579351|FG000|Overall Study|Met exclusion criteria after study entry|0|||
124714500|NCT04011735|448579352|FG001|Overall Study|Met exclusion criteria after study entry|1|||
124553492|NCT03033069|447983909|FG002|Overall Study|Reason not Specified|0|||
124553493|NCT03033069|447983910|FG003|Overall Study|Reason not Specified|1|||
124553494|NCT00430638|447983911|FG000|Overall Study|Adverse Event|15|||
124553495|NCT00430638|447983912|FG001|Overall Study|Adverse Event|15|||
124553496|NCT00430638|447983911|FG000|Overall Study|Uncontrolled blood pressure|48|||
124553497|NCT00430638|447983912|FG001|Overall Study|Uncontrolled blood pressure|13|||
124553498|NCT00430638|447983911|FG000|Overall Study|Lost to Follow-up|1|||
124553499|NCT00430638|447983912|FG001|Overall Study|Lost to Follow-up|7|||
124553500|NCT00430638|447983911|FG000|Overall Study|Protocol Violation|6|||
124553501|NCT00430638|447983912|FG001|Overall Study|Protocol Violation|4|||
124553502|NCT00430638|447983911|FG000|Overall Study|Withdrawal by Subject|4|||
124553503|NCT00430638|447983912|FG001|Overall Study|Withdrawal by Subject|6|||
124553504|NCT00430638|447983911|FG000|Overall Study|Non-compliant|2|||
124553505|NCT00430638|447983912|FG001|Overall Study|Non-compliant|1|||
124553506|NCT00430638|447983911|FG000|Overall Study|Other|2|||
124553507|NCT00430638|447983912|FG001|Overall Study|Other|2|||
124553508|NCT05458895|447983914|FG000|Overall Study|Withdrawal by Subject|8|||
124553509|NCT05458895|447983914|FG000|Overall Study|Lost to Follow-up|17|||
124553510|NCT05458895|447983914|FG000|Overall Study|Pregnancy|2|||
124553511|NCT05458895|447983914|FG000|Overall Study|Withdrawal by Study Team|1|||
124553512|NCT00802529|447985396|FG000|Overall Study|Lost to Follow-up|0|||
124553513|NCT00802529|447985397|FG001|Overall Study|Lost to Follow-up|1|||
124553514|NCT03591107|447985398|FG000|Overall Study|Same patient in both arms|1|||
124553515|NCT03591107|447985399|FG001|Overall Study|Same patient in both arms|1|||
124553516|NCT03591107|447985398|FG000|Overall Study|Sought care at other clinics|0|||
124553517|NCT03591107|447985399|FG001|Overall Study|Sought care at other clinics|2|||
124553518|NCT03591107|447985398|FG000|Overall Study|Discharged from clinic|0|||
124553519|NCT03591107|447985399|FG001|Overall Study|Discharged from clinic|1|||
124553520|NCT03591107|447985398|FG000|Overall Study|Withdrawal by Subject|0|||
124553521|NCT03591107|447985399|FG001|Overall Study|Withdrawal by Subject|1|||
124553522|NCT01084603|447985411|FG000|Baseline|Withdrawal by Subject|2|||
124553523|NCT01084603|447985411|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
124553524|NCT01084603|447985411|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
124553525|NCT01084603|447985411|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
124553526|NCT01084603|447985411|FG000|Washout Period 4|Adverse Event|1|||
124553527|NCT03862625|447985413|FG000|Overall Study|Lost to Follow-up|0|||
124553528|NCT03862625|447985414|FG001|Overall Study|Lost to Follow-up|1|||
124714501|NCT04011735|448579353|FG002|Overall Study|Met exclusion criteria after study entry|0|||
124553529|NCT00520494|447985415|FG000|Overall Study|Withdrawal by Subject|1|||
124553530|NCT03471182|447985419|FG000|Overall Study|Withdrawal by Subject|1|||
124553531|NCT03471182|447985420|FG001|Overall Study|Withdrawal by Subject|1|||
124553532|NCT03471182|447985421|FG002|Overall Study|Withdrawal by Subject|0|||
124553533|NCT03471182|447985419|FG000|Overall Study|Technical failure|2|||
124553534|NCT03471182|447985420|FG001|Overall Study|Technical failure|0|||
124553535|NCT03471182|447985421|FG002|Overall Study|Technical failure|0|||
124553536|NCT04440163|447985422|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
124553537|NCT04440163|447985423|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
124553538|NCT04440163|447985424|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
124553539|NCT04440163|447985425|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
124553540|NCT04440163|447985426|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
124553541|NCT04440163|447985427|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
124553542|NCT04440163|447985428|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
124553543|NCT04440163|447985429|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
124553544|NCT04440163|447985422|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
124553545|NCT04440163|447985423|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
124553546|NCT04440163|447985424|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
124553547|NCT04440163|447985425|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
124553548|NCT04440163|447985426|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
124553549|NCT04440163|447985427|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
124553550|NCT04440163|447985428|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
124553551|NCT04440163|447985429|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
124553552|NCT04440163|447985422|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
124553553|NCT04440163|447985423|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
124553554|NCT04440163|447985424|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
124553555|NCT04440163|447985425|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
124553556|NCT04440163|447985426|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
124553557|NCT04440163|447985427|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
124553558|NCT04440163|447985428|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
124553559|NCT04440163|447985429|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
124553560|NCT04440163|447985422|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
124553561|NCT04440163|447985423|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
124553562|NCT04440163|447985424|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
124553563|NCT04440163|447985425|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
124553564|NCT04440163|447985426|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
124553565|NCT04440163|447985427|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
124553566|NCT04440163|447985428|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
124553567|NCT04440163|447985429|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
124553568|NCT04440163|447985422|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
124553569|NCT04440163|447985423|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
124553570|NCT04440163|447985424|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
124714502|NCT02298868|448579354|FG000|Overall Study|Adverse Event|1|||
124714503|NCT02298868|448579354|FG000|Overall Study|Death|1|||
124714504|NCT02298868|448579354|FG000|Overall Study|Patient underwent transplant|1|||
124714505|NCT01000506|448579355|FG000|Overall Study|Adverse Event|6|||
124714506|NCT01000506|448579356|FG001|Overall Study|Adverse Event|5|||
124714507|NCT01000506|448579357|FG002|Overall Study|Adverse Event|8|||
124714508|NCT01000506|448579358|FG003|Overall Study|Adverse Event|9|||
124714509|NCT01000506|448579355|FG000|Overall Study|Lack of Efficacy|8|||
124714510|NCT01000506|448579356|FG001|Overall Study|Lack of Efficacy|6|||
124714511|NCT01000506|448579357|FG002|Overall Study|Lack of Efficacy|4|||
124714512|NCT01000506|448579358|FG003|Overall Study|Lack of Efficacy|4|||
124714513|NCT01000506|448579355|FG000|Overall Study|Protocol Violation|1|||
124714514|NCT01000506|448579356|FG001|Overall Study|Protocol Violation|1|||
124770593|NCT01074970|448788894|FG000|Overall Study|Adverse Event|1|||
124553571|NCT04440163|447985425|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
124553572|NCT04440163|447985426|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
124553573|NCT04440163|447985427|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
124553574|NCT04440163|447985428|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
124553575|NCT04440163|447985429|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
124553576|NCT04440163|447985422|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
124553577|NCT04440163|447985423|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
124553578|NCT04440163|447985424|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
124553579|NCT04440163|447985425|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
124553580|NCT04440163|447985426|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
124553581|NCT04440163|447985427|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
124553582|NCT04440163|447985428|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
124553583|NCT04440163|447985429|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
124553584|NCT04440163|447985422|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
124553585|NCT04440163|447985423|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
124553586|NCT04440163|447985424|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
124714515|NCT01000506|448579357|FG002|Overall Study|Protocol Violation|0|||
124714516|NCT01000506|448579358|FG003|Overall Study|Protocol Violation|0|||
124714517|NCT01000506|448579355|FG000|Overall Study|Lost to Follow-up|1|||
124714518|NCT01000506|448579356|FG001|Overall Study|Lost to Follow-up|1|||
124553587|NCT04440163|447985425|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
124553588|NCT04440163|447985426|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
124553589|NCT04440163|447985427|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
124714519|NCT01000506|448579357|FG002|Overall Study|Lost to Follow-up|4|||
124553590|NCT04440163|447985428|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
124553591|NCT04440163|447985429|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
124714520|NCT01000506|448579358|FG003|Overall Study|Lost to Follow-up|0|||
124714521|NCT01000506|448579355|FG000|Overall Study|Physician Decision|1|||
124714522|NCT01000506|448579356|FG001|Overall Study|Physician Decision|3|||
124714523|NCT01000506|448579357|FG002|Overall Study|Physician Decision|3|||
124714524|NCT01000506|448579358|FG003|Overall Study|Physician Decision|3|||
124770594|NCT01074970|448788895|FG001|Overall Study|Adverse Event|0|||
124770595|NCT01074970|448788896|FG002|Overall Study|Adverse Event|4|||
124770596|NCT01074970|448788897|FG003|Overall Study|Adverse Event|3|||
124770597|NCT01074970|448788894|FG000|Overall Study|Disease progression during treatment|3|||
124770598|NCT01074970|448788895|FG001|Overall Study|Disease progression during treatment|1|||
124770599|NCT01074970|448788896|FG002|Overall Study|Disease progression during treatment|2|||
124770600|NCT01074970|448788897|FG003|Overall Study|Disease progression during treatment|9|||
124770601|NCT01074970|448788894|FG000|Overall Study|Lost to Follow-up|0|||
124770602|NCT01074970|448788895|FG001|Overall Study|Lost to Follow-up|0|||
124770603|NCT01074970|448788896|FG002|Overall Study|Lost to Follow-up|1|||
124770604|NCT01074970|448788897|FG003|Overall Study|Lost to Follow-up|0|||
124770605|NCT01074970|448788894|FG000|Overall Study|Withdrawal by Subject|0|||
124770606|NCT01074970|448788895|FG001|Overall Study|Withdrawal by Subject|0|||
124770607|NCT01074970|448788896|FG002|Overall Study|Withdrawal by Subject|6|||
124770608|NCT01074970|448788897|FG003|Overall Study|Withdrawal by Subject|4|||
124770609|NCT05565742|448788902|FG000|Overall Study|Withdrawal by Subject|0|||
124714525|NCT01000506|448579355|FG000|Overall Study|Withdrawal by Subject|11|||
124714526|NCT01000506|448579356|FG001|Overall Study|Withdrawal by Subject|8|||
124553592|NCT04440163|447985422|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
124553593|NCT04440163|447985423|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
124553594|NCT04440163|447985424|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
124553595|NCT04440163|447985425|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
124553596|NCT04440163|447985426|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
124553597|NCT04440163|447985427|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
124553598|NCT04440163|447985428|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
124553599|NCT04440163|447985429|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
124553600|NCT04440163|447985422|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
124553601|NCT04440163|447985423|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
124553602|NCT04440163|447985424|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
124553603|NCT04440163|447985425|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
124553604|NCT04440163|447985426|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
124553605|NCT04440163|447985427|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
124553606|NCT04440163|447985428|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
124714527|NCT01000506|448579357|FG002|Overall Study|Withdrawal by Subject|2|||
124714528|NCT01000506|448579358|FG003|Overall Study|Withdrawal by Subject|7|||
124714529|NCT00739310|448579359|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
124714530|NCT00739310|448579359|FG000|Overall Study|Withdrawal by Subject|1|||
124714531|NCT00739310|448579359|FG000|Overall Study|Lost to Follow-up|2|||
124714532|NCT01071954|448579360|FG000|Overall Study|Noncompliance|4|||
124714533|NCT01071954|448579360|FG000|Overall Study|Adverse Event|1|||
124714534|NCT01071954|448579360|FG000|Overall Study|Withdrawal by Subject|11|||
124714535|NCT01071954|448579360|FG000|Overall Study|Requirement for Alternative Therapy|5|||
124714536|NCT01071954|448579360|FG000|Overall Study|Administrative Decision|5|||
124714537|NCT01071954|448579360|FG000|Overall Study|Protocol Specified Criteria|1|||
124714538|NCT00590967|448579361|FG000|Overall Study|Withdrawal by Subject|1|||
124714539|NCT00590967|448579362|FG001|Overall Study|Withdrawal by Subject|1|||
124714540|NCT00590967|448579361|FG000|Overall Study|Ineligible|1|||
124714541|NCT00590967|448579362|FG001|Overall Study|Ineligible|0|||
124714542|NCT00590967|448579361|FG000|Overall Study|Poor performance status|0|||
124714543|NCT00590967|448579362|FG001|Overall Study|Poor performance status|1|||
124714544|NCT00590967|448579361|FG000|Overall Study|Non-compliant|0|||
124714545|NCT00590967|448579362|FG001|Overall Study|Non-compliant|2|||
124714546|NCT00590967|448579361|FG000|Overall Study|Did not sign consent form|0|||
124714547|NCT00590967|448579362|FG001|Overall Study|Did not sign consent form|1|||
124714548|NCT00590967|448579361|FG000|Overall Study|Did not receive chemo per protocol|1|||
124714549|NCT00590967|448579362|FG001|Overall Study|Did not receive chemo per protocol|0|||
124714550|NCT01847755|448579363|FG000|Overall Study|Adverse Event|2|||
124714551|NCT01847755|448579363|FG000|Overall Study|Withdrawal by Subject|2|||
124714552|NCT01847755|448579363|FG000|Overall Study|Physician Decision|1|||
124714553|NCT00920556|448579364|FG000|Overall Study|Adverse Event|16|||
124714554|NCT00920556|448579364|FG000|Overall Study|Physician Decision|7|||
124714555|NCT00920556|448579364|FG000|Overall Study|Withdrawal by Subject|1|||
124553607|NCT04440163|447985429|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
124553608|NCT04440163|447985422|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
124714556|NCT04245709|448579365|FG000|Overall Study|Adverse Event|13|||
124714557|NCT04245709|448579365|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
124714558|NCT02185534|448579367|FG000|First Period|Withdrawal by Subject|0|||
124714559|NCT02185534|448579368|FG001|First Period|Withdrawal by Subject|0|||
124714560|NCT02185534|448579369|FG002|First Period|Withdrawal by Subject|0|||
124714561|NCT02185534|448579370|FG003|First Period|Withdrawal by Subject|1|||
124714562|NCT02185534|448579371|FG004|First Period|Withdrawal by Subject|0|||
124714563|NCT02185534|448579372|FG005|First Period|Withdrawal by Subject|0|||
124714564|NCT02185534|448579367|FG000|First Washout Period|Withdrawal by Subject|1|||
124714565|NCT02185534|448579368|FG001|First Washout Period|Withdrawal by Subject|0|||
124714566|NCT02185534|448579369|FG002|First Washout Period|Withdrawal by Subject|0|||
124714567|NCT02185534|448579370|FG003|First Washout Period|Withdrawal by Subject|0|||
124553609|NCT04440163|447985423|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
124553610|NCT04440163|447985424|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
124553611|NCT04440163|447985425|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
124553612|NCT04440163|447985426|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
124553613|NCT04440163|447985427|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
124553614|NCT04440163|447985428|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
124553615|NCT04440163|447985429|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
124553616|NCT04440163|447985422|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
124553617|NCT04440163|447985423|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
124553618|NCT04440163|447985424|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
124553619|NCT04440163|447985425|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
124553620|NCT04440163|447985426|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
124553621|NCT04440163|447985427|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
124553622|NCT04440163|447985428|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
124553623|NCT04440163|447985429|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
124553624|NCT04440163|447985422|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
124553625|NCT04440163|447985423|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
124553626|NCT04440163|447985424|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
124553627|NCT04440163|447985425|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
124553628|NCT04440163|447985426|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
124553629|NCT04440163|447985427|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
124553630|NCT04440163|447985428|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
124553631|NCT04440163|447985429|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
124553632|NCT02018042|447985432|FG000|Overall Study|Withdrawal by Subject|1|||
124553633|NCT01954082|447985433|FG000|Overall Study|Study Suspension|42|||
124553634|NCT01954082|447985434|FG001|Overall Study|Study Suspension|36|||
124553635|NCT01954082|447985433|FG000|Overall Study|Adverse Event|10|||
124553636|NCT01954082|447985434|FG001|Overall Study|Adverse Event|4|||
124553637|NCT01954082|447985433|FG000|Overall Study|Intolerance|0|||
124553638|NCT01954082|447985434|FG001|Overall Study|Intolerance|1|||
124553639|NCT01954082|447985433|FG000|Overall Study|Non-compliance|6|||
124553640|NCT01954082|447985434|FG001|Overall Study|Non-compliance|4|||
124553641|NCT01954082|447985433|FG000|Overall Study|Physician Decision|2|||
124553642|NCT01954082|447985434|FG001|Overall Study|Physician Decision|0|||
124553643|NCT01954082|447985433|FG000|Overall Study|Parent Decision|1|||
124714568|NCT02185534|448579371|FG004|First Washout Period|Withdrawal by Subject|1|||
124714569|NCT02185534|448579372|FG005|First Washout Period|Withdrawal by Subject|0|||
124714570|NCT02185534|448579367|FG000|First Washout Period|Protocol Violation|0|||
124714571|NCT02185534|448579368|FG001|First Washout Period|Protocol Violation|0|||
124714572|NCT02185534|448579369|FG002|First Washout Period|Protocol Violation|0|||
124714573|NCT02185534|448579370|FG003|First Washout Period|Protocol Violation|0|||
124714574|NCT02185534|448579371|FG004|First Washout Period|Protocol Violation|0|||
124714575|NCT02185534|448579372|FG005|First Washout Period|Protocol Violation|1|||
124714576|NCT02041299|448579376|FG000|Overall Study|Adverse Event|9|||
124714577|NCT02041299|448579377|FG001|Overall Study|Adverse Event|3|||
124714578|NCT02041299|448579376|FG000|Overall Study|Lost to Follow-up|4|||
124714579|NCT02041299|448579377|FG001|Overall Study|Lost to Follow-up|1|||
124714580|NCT02041299|448579376|FG000|Overall Study|Physician Decision|1|||
124714581|NCT02041299|448579377|FG001|Overall Study|Physician Decision|1|||
124714582|NCT02041299|448579376|FG000|Overall Study|Withdrawal by Subject|13|||
124714583|NCT02041299|448579377|FG001|Overall Study|Withdrawal by Subject|7|||
124714584|NCT02041299|448579376|FG000|Overall Study|Protocol Violation|11|||
124714585|NCT02041299|448579377|FG001|Overall Study|Protocol Violation|4|||
124553644|NCT01954082|447985434|FG001|Overall Study|Parent Decision|0|||
124553645|NCT01954082|447985433|FG000|Overall Study|Withdrawal by Subject|0|||
124553646|NCT01954082|447985434|FG001|Overall Study|Withdrawal by Subject|1|||
124553647|NCT01954082|447985433|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
124553648|NCT01954082|447985434|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
124714586|NCT02041299|448579376|FG000|Overall Study|Termination of the study|7|||
124714587|NCT02041299|448579377|FG001|Overall Study|Termination of the study|3|||
124770610|NCT05565742|448788903|FG001|Overall Study|Withdrawal by Subject|0|||
124770611|NCT05565742|448788904|FG002|Overall Study|Withdrawal by Subject|2|||
124770612|NCT05565742|448788905|FG003|Overall Study|Withdrawal by Subject|2|||
124770613|NCT05565742|448788906|FG004|Overall Study|Withdrawal by Subject|2|||
124770614|NCT05565742|448788902|FG000|Overall Study|Death|1|||
124770615|NCT05565742|448788903|FG001|Overall Study|Death|0|||
124553649|NCT01954082|447985433|FG000|Overall Study|Redirection of Care|0|||
124553650|NCT01954082|447985434|FG001|Overall Study|Redirection of Care|2|||
124553651|NCT01954082|447985433|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
124553652|NCT01954082|447985434|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
124553653|NCT01954082|447985433|FG000|Overall Study|Comfort Care|0|||
124553654|NCT01954082|447985434|FG001|Overall Study|Comfort Care|1|||
124553655|NCT01954082|447985433|FG000|Overall Study|Infant Moved|0|||
124553656|NCT01954082|447985434|FG001|Overall Study|Infant Moved|1|||
124553657|NCT01954082|447985433|FG000|Overall Study|Randomized not Treated|4|||
124553658|NCT01954082|447985434|FG001|Overall Study|Randomized not Treated|2|||
124553659|NCT00666718|447985442|FG000|Overall Study|Adverse Event|0|||
124553660|NCT00666718|447985443|FG001|Overall Study|Adverse Event|1|||
124553661|NCT00666718|447985442|FG000|Overall Study|Death|1|||
124553662|NCT00666718|447985443|FG001|Overall Study|Death|0|||
124553663|NCT00666718|447985442|FG000|Overall Study|Lost to Follow-up|1|||
124714588|NCT02041299|448579376|FG000|Overall Study|Required bone marrow transplant|0|||
124714589|NCT02041299|448579377|FG001|Overall Study|Required bone marrow transplant|1|||
124714590|NCT02041299|448579376|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
124714591|NCT02041299|448579377|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
124714592|NCT02389465|448579378|FG000|Overall Study|Lost to Follow-up|1|||
124770616|NCT05565742|448788904|FG002|Overall Study|Death|0|||
124714593|NCT02389465|448579379|FG001|Overall Study|Lost to Follow-up|3|||
124714594|NCT02389465|448579380|FG002|Overall Study|Lost to Follow-up|3|||
124714595|NCT02389465|448579381|FG003|Overall Study|Lost to Follow-up|0|||
124714596|NCT02389465|448579378|FG000|Overall Study|Physician Decision|0|||
124714597|NCT02389465|448579379|FG001|Overall Study|Physician Decision|0|||
124714598|NCT02389465|448579380|FG002|Overall Study|Physician Decision|0|||
124714599|NCT02389465|448579381|FG003|Overall Study|Physician Decision|1|||
124714600|NCT02389465|448579378|FG000|Overall Study|Withdrawal by Subject|0|||
124714601|NCT02389465|448579379|FG001|Overall Study|Withdrawal by Subject|1|||
124714602|NCT02389465|448579380|FG002|Overall Study|Withdrawal by Subject|2|||
124714603|NCT02389465|448579381|FG003|Overall Study|Withdrawal by Subject|2|||
124714604|NCT00846846|448579382|FG000|Overall Study|Death|56|||
124714605|NCT00846846|448579382|FG000|Overall Study|Withdrawal by Subject|19|||
124714606|NCT04179305|448579388|FG000|Overall Study|Death|1|||
124714607|NCT04179305|448579389|FG001|Overall Study|Death|1|||
124714608|NCT04179305|448579390|FG002|Overall Study|Death|0|||
124714609|NCT04179305|448579391|FG003|Overall Study|Death|0|||
124714610|NCT04179305|448579388|FG000|Overall Study|Lost to Follow-up|1|||
124714611|NCT04179305|448579389|FG001|Overall Study|Lost to Follow-up|1|||
124714612|NCT04179305|448579390|FG002|Overall Study|Lost to Follow-up|0|||
124714613|NCT04179305|448579391|FG003|Overall Study|Lost to Follow-up|0|||
124714614|NCT04179305|448579388|FG000|Overall Study|Withdrawal by Subject|0|||
124714615|NCT04179305|448579389|FG001|Overall Study|Withdrawal by Subject|1|||
124714616|NCT04179305|448579390|FG002|Overall Study|Withdrawal by Subject|0|||
124714617|NCT04179305|448579391|FG003|Overall Study|Withdrawal by Subject|0|||
124714618|NCT04179305|448579388|FG000|Overall Study|Did not have scan|1|||
124714619|NCT04179305|448579389|FG001|Overall Study|Did not have scan|0|||
124714620|NCT04179305|448579390|FG002|Overall Study|Did not have scan|0|||
124714621|NCT04179305|448579391|FG003|Overall Study|Did not have scan|0|||
124714622|NCT04179305|448579388|FG000|Overall Study|In hospice care|3|||
124714623|NCT04179305|448579389|FG001|Overall Study|In hospice care|0|||
124714624|NCT04179305|448579390|FG002|Overall Study|In hospice care|0|||
124714625|NCT04179305|448579391|FG003|Overall Study|In hospice care|0|||
124714626|NCT00503425|448579394|FG000|Overall Study|Participant files lost|6|||
124770617|NCT05565742|448788905|FG003|Overall Study|Death|0|||
124714627|NCT00503425|448579394|FG000|Overall Study|Adverse Event|5|||
124714628|NCT00503425|448579394|FG000|Overall Study|Lack of Efficacy|25|||
124714629|NCT00503425|448579394|FG000|Overall Study|Withdrawal by Subject|8|||
124714630|NCT00503425|448579394|FG000|Overall Study|Lost to Follow-up|3|||
124714631|NCT00503425|448579394|FG000|Overall Study|Death|3|||
124714632|NCT00503425|448579394|FG000|Overall Study|Missing Data/Unknown|4|||
124714633|NCT00326599|448579395|FG000|Overall Study|Withdrawal by Subject|1|||
124714634|NCT00326599|448579396|FG001|Overall Study|Withdrawal by Subject|0|||
124770618|NCT05565742|448788906|FG004|Overall Study|Death|0|||
124714635|NCT00326599|448579397|FG002|Overall Study|Withdrawal by Subject|5|||
124553664|NCT00666718|447985443|FG001|Overall Study|Lost to Follow-up|0|||
124714636|NCT00326599|448579398|FG003|Overall Study|Withdrawal by Subject|2|||
124553665|NCT00666718|447985442|FG000|Overall Study|Entry Criteria Not Met|2|||
124553666|NCT00666718|447985443|FG001|Overall Study|Entry Criteria Not Met|0|||
124553667|NCT00666718|447985442|FG000|Overall Study|Protocol Violation|1|||
124553668|NCT00666718|447985443|FG001|Overall Study|Protocol Violation|3|||
124553669|NCT00666718|447985442|FG000|Overall Study|Withdrawal by Subject|7|||
124553670|NCT00666718|447985443|FG001|Overall Study|Withdrawal by Subject|12|||
124553671|NCT00666718|447985442|FG000|Overall Study|Physician Decision|0|||
124553672|NCT00666718|447985443|FG001|Overall Study|Physician Decision|2|||
124553673|NCT00810615|447985446|FG000|Overall Study|Withdrawal by Subject|1|||
124553674|NCT00810615|447985447|FG001|Overall Study|Withdrawal by Subject|1|||
124553675|NCT02525562|447985448|FG000|Overall Study|Death|9|||
124553676|NCT02525562|447985449|FG001|Overall Study|Death|0|||
124553677|NCT02525562|447985450|FG002|Overall Study|Death|0|||
124553678|NCT02525562|447985448|FG000|Overall Study|Lost to Follow-up|19|||
124553679|NCT02525562|447985449|FG001|Overall Study|Lost to Follow-up|0|||
124553680|NCT02525562|447985450|FG002|Overall Study|Lost to Follow-up|0|||
124553681|NCT02525562|447985448|FG000|Overall Study|Withdrawal by Subject|37|||
124553682|NCT02525562|447985449|FG001|Overall Study|Withdrawal by Subject|0|||
124553683|NCT02525562|447985450|FG002|Overall Study|Withdrawal by Subject|0|||
124553684|NCT02525562|447985448|FG000|Overall Study|Revision/Removal of Study Device|4|||
124553685|NCT02525562|447985449|FG001|Overall Study|Revision/Removal of Study Device|0|||
124553686|NCT02525562|447985450|FG002|Overall Study|Revision/Removal of Study Device|0|||
124553687|NCT02525562|447985448|FG000|Overall Study|Study Closed by Sponsor|154|||
124553688|NCT02525562|447985449|FG001|Overall Study|Study Closed by Sponsor|0|||
124553689|NCT02525562|447985450|FG002|Overall Study|Study Closed by Sponsor|0|||
124553690|NCT02567266|447985451|FG000|Overall Study|Withdrawal by Subject|10|||
124714637|NCT00326599|448579395|FG000|Overall Study|Adverse Event|1|||
124714638|NCT00326599|448579396|FG001|Overall Study|Adverse Event|0|||
124553691|NCT02567266|447985452|FG001|Overall Study|Withdrawal by Subject|7|||
124553692|NCT02567266|447985453|FG002|Overall Study|Withdrawal by Subject|6|||
124553693|NCT02567266|447985451|FG000|Overall Study|Lost to Follow-up|13|||
124553694|NCT02567266|447985452|FG001|Overall Study|Lost to Follow-up|8|||
124553695|NCT02567266|447985453|FG002|Overall Study|Lost to Follow-up|10|||
124553696|NCT02643966|447985454|FG000|First Screening Round|ineligible|1|||
124553697|NCT02643966|447985454|FG000|First Screening Round|excluded from analysis|2|||
124714639|NCT00326599|448579397|FG002|Overall Study|Adverse Event|32|||
124714640|NCT00326599|448579398|FG003|Overall Study|Adverse Event|3|||
124714641|NCT00326599|448579395|FG000|Overall Study|Disease Progression|3|||
124714642|NCT00326599|448579396|FG001|Overall Study|Disease Progression|1|||
124714643|NCT00326599|448579397|FG002|Overall Study|Disease Progression|13|||
124714644|NCT00326599|448579398|FG003|Overall Study|Disease Progression|11|||
124714645|NCT00326599|448579395|FG000|Overall Study|Alternate Treatment|1|||
124714646|NCT00326599|448579396|FG001|Overall Study|Alternate Treatment|0|||
124714647|NCT00326599|448579397|FG002|Overall Study|Alternate Treatment|0|||
124714648|NCT00326599|448579398|FG003|Overall Study|Alternate Treatment|0|||
124714649|NCT00326599|448579395|FG000|Overall Study|Death|0|||
124714650|NCT00326599|448579396|FG001|Overall Study|Death|0|||
124714651|NCT00326599|448579397|FG002|Overall Study|Death|1|||
124714652|NCT00326599|448579398|FG003|Overall Study|Death|2|||
124714653|NCT00326599|448579395|FG000|Overall Study|Other Unspecified Reason|0|||
124714654|NCT00326599|448579396|FG001|Overall Study|Other Unspecified Reason|0|||
124714655|NCT00326599|448579397|FG002|Overall Study|Other Unspecified Reason|2|||
124714656|NCT00326599|448579398|FG003|Overall Study|Other Unspecified Reason|1|||
124714657|NCT00142792|448579399|FG000|Overall Study|Death|0|||
124714658|NCT00142792|448579400|FG001|Overall Study|Death|0|||
124714659|NCT00142792|448579401|FG002|Overall Study|Death|1|||
124714660|NCT00142792|448579399|FG000|Overall Study|Withdrawal by Subject|3|||
124714661|NCT00142792|448579400|FG001|Overall Study|Withdrawal by Subject|2|||
124714662|NCT00142792|448579401|FG002|Overall Study|Withdrawal by Subject|3|||
124553698|NCT02643966|447985454|FG000|First Screening Round|Lost to Follow-up|56|||
124553699|NCT02643966|447985454|FG000|First Screening Round|Withdrawal by Subject|28|||
124553700|NCT02643966|447985454|FG000|First Screening Round|Death|1|||
124770619|NCT05565742|448788902|FG000|Overall Study|Participant Travelled Abroad|0|||
124553701|NCT02643966|447985454|FG000|Between First and Second Screening|Lost to Follow-up|65|||
124553702|NCT02643966|447985454|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
124553703|NCT02643966|447985454|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
124553704|NCT02643966|447985454|FG000|Second Screening Round|Withdrawal by Subject|20|||
124553705|NCT02643966|447985454|FG000|Second Screening Round|Lost to Follow-up|57|||
124553706|NCT02643966|447985454|FG000|Second Screening Round|Physician Decision|2|||
124553707|NCT02643966|447985454|FG000|Second Screening Round|Death|4|||
124553708|NCT02643966|447985454|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
124553709|NCT02643966|447985454|FG000|Between Second and Third Screening|Death|1|||
124553710|NCT02643966|447985454|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
124553711|NCT02643966|447985454|FG000|Third Screening Round|PI excluded|2|||
124553712|NCT02643966|447985454|FG000|Third Screening Round|Lost to Follow-up|241|||
124553713|NCT03611751|447985459|FG000|Pre-treatment|Randomized but not treated|1|||
124553714|NCT03611751|447985460|FG001|Pre-treatment|Randomized but not treated|1|||
124553715|NCT03611751|447985461|FG002|Pre-treatment|Randomized but not treated|0|||
124553716|NCT03611751|447985459|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
124553717|NCT03611751|447985460|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
124553718|NCT03611751|447985461|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
124553719|NCT03611751|447985459|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
124553720|NCT03611751|447985460|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
124553721|NCT03611751|447985461|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
124553722|NCT03611751|447985459|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
124553723|NCT03611751|447985460|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
124553724|NCT03611751|447985461|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
124553725|NCT03611751|447985459|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
124553726|NCT03611751|447985460|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
124553727|NCT03611751|447985461|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
124553728|NCT03611751|447985459|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
124553729|NCT03611751|447985460|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
124553730|NCT03611751|447985461|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
124553731|NCT03611751|447985459|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
124553732|NCT03611751|447985460|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
124553733|NCT03611751|447985461|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
124553734|NCT03611751|447985459|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
124553735|NCT03611751|447985460|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
124553736|NCT03611751|447985461|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
124553737|NCT03611751|447985459|FG000|Treatment Week 0 - Week 16|Death|0|||
124553738|NCT03611751|447985460|FG001|Treatment Week 0 - Week 16|Death|0|||
124553739|NCT03611751|447985461|FG002|Treatment Week 0 - Week 16|Death|1|||
124553740|NCT03611751|447985459|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
124553741|NCT03611751|447985460|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
124714663|NCT00142792|448579399|FG000|Overall Study|Lost to Follow-up|8|||
124714664|NCT00142792|448579400|FG001|Overall Study|Lost to Follow-up|11|||
124714665|NCT00142792|448579401|FG002|Overall Study|Lost to Follow-up|7|||
124714666|NCT00142792|448579399|FG000|Overall Study|No category|1|||
124714667|NCT00142792|448579400|FG001|Overall Study|No category|2|||
124714668|NCT00142792|448579401|FG002|Overall Study|No category|1|||
124714669|NCT00437268|448579402|FG000|Overall Study|Adverse Event|1|||
124714670|NCT00437268|448579403|FG001|Overall Study|Adverse Event|1|||
124714671|NCT00437268|448579402|FG000|Overall Study|Withdrawal by Subject|2|||
124714672|NCT00437268|448579403|FG001|Overall Study|Withdrawal by Subject|2|||
124714673|NCT00437268|448579402|FG000|Overall Study|Progressive disease|9|||
124714674|NCT00437268|448579403|FG001|Overall Study|Progressive disease|9|||
124714675|NCT00437268|448579402|FG000|Overall Study|Physician Decision|1|||
124714676|NCT00437268|448579403|FG001|Overall Study|Physician Decision|0|||
124714677|NCT00437268|448579402|FG000|Overall Study|Death|0|||
124714678|NCT00437268|448579403|FG001|Overall Study|Death|1|||
124714679|NCT00444925|448579404|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
124714680|NCT00444925|448579405|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
124714681|NCT00444925|448579406|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
124714682|NCT00444925|448579404|FG000|Double-blind Treatment Period|Death|2|||
124714683|NCT00444925|448579405|FG001|Double-blind Treatment Period|Death|0|||
124714684|NCT00444925|448579406|FG002|Double-blind Treatment Period|Death|0|||
124714685|NCT00444925|448579404|FG000|Double-blind Treatment Period|Adverse Event|6|||
124714686|NCT00444925|448579405|FG001|Double-blind Treatment Period|Adverse Event|28|||
124714687|NCT00444925|448579406|FG002|Double-blind Treatment Period|Adverse Event|44|||
124714688|NCT00444925|448579404|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
124714689|NCT00444925|448579405|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
124714690|NCT00444925|448579406|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
124714691|NCT00444925|448579404|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
124714692|NCT00444925|448579405|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
124714693|NCT00444925|448579406|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
124714694|NCT00444925|448579404|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
124714695|NCT00444925|448579405|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
124714696|NCT00444925|448579406|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
124714697|NCT00444925|448579404|FG000|Double-blind Treatment Period|Other|7|||
124714698|NCT00444925|448579405|FG001|Double-blind Treatment Period|Other|7|||
124714699|NCT00444925|448579406|FG002|Double-blind Treatment Period|Other|12|||
124714700|NCT03484429|448579410|FG000|Overall Study|Withdrawal by Subject|1|||
124714701|NCT03484429|448579411|FG001|Overall Study|Withdrawal by Subject|0|||
124714702|NCT03484429|448579410|FG000|Overall Study|Adverse Event|2|||
124714703|NCT03484429|448579411|FG001|Overall Study|Adverse Event|0|||
124714704|NCT00943761|448579412|FG000|Overall Study|Lost to Follow-up|2|||
124714705|NCT00943761|448579413|FG001|Overall Study|Lost to Follow-up|0|||
124714706|NCT00943761|448579412|FG000|Overall Study|Withdrawal by Subject|2|||
124714707|NCT00943761|448579413|FG001|Overall Study|Withdrawal by Subject|1|||
124714708|NCT00714948|448579414|FG000|Overall Study|Adverse Event|2|||
124714709|NCT01342926|448579417|FG000|Overall Study|Adverse Event|5|||
124714710|NCT01342926|448579418|FG001|Overall Study|Adverse Event|8|||
124714711|NCT01342926|448579419|FG002|Overall Study|Adverse Event|10|||
124714712|NCT01342926|448579420|FG003|Overall Study|Adverse Event|7|||
124714713|NCT01342926|448579417|FG000|Overall Study|Lost to Follow-up|0|||
124714714|NCT01342926|448579418|FG001|Overall Study|Lost to Follow-up|1|||
124714715|NCT01342926|448579419|FG002|Overall Study|Lost to Follow-up|1|||
124714716|NCT01342926|448579420|FG003|Overall Study|Lost to Follow-up|0|||
124770620|NCT05565742|448788903|FG001|Overall Study|Participant Travelled Abroad|0|||
124770621|NCT05565742|448788904|FG002|Overall Study|Participant Travelled Abroad|0|||
124770622|NCT05565742|448788905|FG003|Overall Study|Participant Travelled Abroad|0|||
124770623|NCT05565742|448788906|FG004|Overall Study|Participant Travelled Abroad|1|||
124714717|NCT01342926|448579417|FG000|Overall Study|Investigator Discretion|2|||
124714718|NCT01342926|448579418|FG001|Overall Study|Investigator Discretion|2|||
124714719|NCT01342926|448579419|FG002|Overall Study|Investigator Discretion|0|||
124714720|NCT01342926|448579420|FG003|Overall Study|Investigator Discretion|0|||
124714721|NCT01342926|448579417|FG000|Overall Study|Withdrawal by Subject|2|||
124553742|NCT03611751|447985461|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
124553743|NCT03611751|447985459|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
124553744|NCT03611751|447985460|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
124553745|NCT03611751|447985461|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
124553746|NCT03611751|447985459|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
124553747|NCT03611751|447985460|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
124553748|NCT03611751|447985461|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
124553749|NCT03611751|447985459|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
124553750|NCT03611751|447985460|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
124553751|NCT03611751|447985461|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
124553752|NCT03611751|447985459|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
124553753|NCT03611751|447985460|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
124553754|NCT03611751|447985461|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
124553755|NCT03611751|447985459|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
124553756|NCT03611751|447985460|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
124553757|NCT03611751|447985461|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
124553758|NCT03611751|447985459|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
124553759|NCT03611751|447985460|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
124553760|NCT03611751|447985461|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
124553761|NCT03611751|447985459|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
124714722|NCT01342926|448579418|FG001|Overall Study|Withdrawal by Subject|4|||
124714723|NCT01342926|448579419|FG002|Overall Study|Withdrawal by Subject|3|||
124714724|NCT01342926|448579420|FG003|Overall Study|Withdrawal by Subject|5|||
124714725|NCT03382912|448579421|FG000|Overall Study|Physician Decision|0|||
124553762|NCT03611751|447985460|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
124553763|NCT03611751|447985461|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
124553764|NCT03611751|447985459|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
124553765|NCT03611751|447985460|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
124553766|NCT03611751|447985461|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
124553767|NCT03611751|447985459|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
124553768|NCT03611751|447985460|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
124553769|NCT03611751|447985461|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
124553770|NCT03611751|447985459|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
124553771|NCT03611751|447985460|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
124553772|NCT03611751|447985461|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
124553773|NCT03611751|447985459|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
124553774|NCT03611751|447985460|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
124553775|NCT03611751|447985461|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
124553776|NCT03611751|447985459|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
124553777|NCT03611751|447985460|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
124553778|NCT03611751|447985461|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
124553779|NCT03611751|447985459|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
124553780|NCT03611751|447985460|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
124553781|NCT03611751|447985461|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
124553782|NCT02441179|447985462|FG000|Overall Study|Withdrawal by Subject|1|||
124553783|NCT02441179|447985463|FG001|Overall Study|Withdrawal by Subject|1|||
124553784|NCT02702271|447985464|FG000|Overall Study|Death|36|||
124553785|NCT02702271|447985465|FG001|Overall Study|Death|7|||
124553786|NCT02702271|447985464|FG000|Overall Study|Lost to Follow-up|12|||
124553787|NCT02702271|447985465|FG001|Overall Study|Lost to Follow-up|0|||
124553788|NCT02702271|447985464|FG000|Overall Study|Withdrawal by Subject|8|||
124553789|NCT02702271|447985465|FG001|Overall Study|Withdrawal by Subject|1|||
124553790|NCT02702271|447985464|FG000|Overall Study|Physician Decision|2|||
124553791|NCT02702271|447985465|FG001|Overall Study|Physician Decision|0|||
124553792|NCT02702271|447985464|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
124553793|NCT02702271|447985465|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
124553794|NCT03091400|447985466|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
124553795|NCT03091400|447985467|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
124553796|NCT00051636|447985468|FG000|Period 1 - Core|Adverse Event|2|||
124553797|NCT00051636|447985469|FG001|Period 1 - Core|Adverse Event|2|||
124553798|NCT00051636|447985468|FG000|Period 1 - Core|Protocol Violation|1|||
124553799|NCT00051636|447985469|FG001|Period 1 - Core|Protocol Violation|0|||
124553800|NCT00051636|447985468|FG000|Period 1 - Core|Withdrawal by Subject|1|||
124553801|NCT00051636|447985469|FG001|Period 1 - Core|Withdrawal by Subject|2|||
124553802|NCT00051636|447985468|FG000|Period 1 - Core|Lost to Follow-up|0|||
124553803|NCT00051636|447985469|FG001|Period 1 - Core|Lost to Follow-up|2|||
124553804|NCT00051636|447985468|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
124553805|NCT00051636|447985469|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
124553806|NCT00051636|447985468|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
124553807|NCT00051636|447985469|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
124553808|NCT00051636|447985468|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
124553809|NCT00051636|447985469|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
124553810|NCT00051636|447985468|FG000|Period 2- Extended Observation Period|Death|4|||
124553811|NCT00051636|447985469|FG001|Period 2- Extended Observation Period|Death|5|||
124553812|NCT00051636|447985468|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
124553813|NCT00051636|447985469|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
124714726|NCT03382912|448579422|FG001|Overall Study|Physician Decision|1|||
124553814|NCT00479765|447985470|FG000|Overall Study|study terminated|4|||
124553815|NCT03056001|447985471|FG000|Overall Study|Death|24|||
124553816|NCT01364298|447985474|FG000|Overall Study|Adverse Event|3|||
124553817|NCT01364298|447985475|FG001|Overall Study|Adverse Event|4|||
124714727|NCT03382912|448579421|FG000|Overall Study|Sponsor Decision|6|||
124553818|NCT01364298|447985474|FG000|Overall Study|Lack of adherence to treatment|1|||
124553819|NCT01364298|447985475|FG001|Overall Study|Lack of adherence to treatment|3|||
124553820|NCT01364298|447985474|FG000|Overall Study|Lack of Efficacy|1|||
124553821|NCT01364298|447985475|FG001|Overall Study|Lack of Efficacy|0|||
124553822|NCT01364298|447985474|FG000|Overall Study|Lost to Follow-up|5|||
124553823|NCT01364298|447985475|FG001|Overall Study|Lost to Follow-up|10|||
124553824|NCT01364298|447985474|FG000|Overall Study|Withdrawal by Subject|3|||
124553825|NCT01364298|447985475|FG001|Overall Study|Withdrawal by Subject|3|||
124553826|NCT01364298|447985474|FG000|Overall Study|Other|1|||
124553827|NCT01364298|447985475|FG001|Overall Study|Other|3|||
124553828|NCT03707522|447985478|FG000|Overall Study|Lost to Follow-up|24|||
124553829|NCT03707522|447985479|FG001|Overall Study|Lost to Follow-up|27|||
124553830|NCT03707522|447985480|FG002|Overall Study|Lost to Follow-up|41|||
124553831|NCT03707522|447985481|FG003|Overall Study|Lost to Follow-up|36|||
124553832|NCT00420849|447985482|FG000|Overall Study|Lack of Efficacy|154|||
124553833|NCT00420849|447985482|FG000|Overall Study|Adverse Event|107|||
124553834|NCT00420849|447985482|FG000|Overall Study|Withdrawal by Subject|28|||
124553835|NCT00420849|447985482|FG000|Overall Study|Death|18|||
124553836|NCT00420849|447985482|FG000|Overall Study|Other|14|||
124553837|NCT00420849|447985482|FG000|Overall Study|Transplant|8|||
124553838|NCT00420849|447985482|FG000|Overall Study|Protocol Violation|1|||
124553839|NCT00420849|447985482|FG000|Overall Study|Lost to Follow-up|1|||
124553840|NCT00659581|447985483|FG000|Overall Study|Adverse Event|1006|||
124553841|NCT00659581|447985483|FG000|Overall Study|Lack of Efficacy|1183|||
124553842|NCT00659581|447985483|FG000|Overall Study|Other|6393|||
124553843|NCT00944125|447985489|FG000|3 to 6 Months|Withdrawal by Subject|0|||
124553844|NCT00944125|447985490|FG001|3 to 6 Months|Withdrawal by Subject|2|||
124553845|NCT00944125|447985489|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
124553846|NCT00944125|447985490|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
124553847|NCT00446134|447985491|FG000|Overall Study|Adverse Event|7|||
124553848|NCT00446134|447985492|FG001|Overall Study|Adverse Event|17|||
124553849|NCT00446134|447985493|FG002|Overall Study|Adverse Event|13|||
124553850|NCT00446134|447985494|FG003|Overall Study|Adverse Event|18|||
124553851|NCT00446134|447985491|FG000|Overall Study|Lack of Efficacy|19|||
124553852|NCT00446134|447985492|FG001|Overall Study|Lack of Efficacy|19|||
124553853|NCT00446134|447985493|FG002|Overall Study|Lack of Efficacy|24|||
124553854|NCT00446134|447985494|FG003|Overall Study|Lack of Efficacy|19|||
124553855|NCT00446134|447985491|FG000|Overall Study|Protocol Violation|0|||
124471185|NCT03891901|447682103|FG004|Overall Study|Withdrawal by Subject|0|||
124471186|NCT03891901|447682104|FG005|Overall Study|Withdrawal by Subject|0|||
124471187|NCT03891901|447682105|FG006|Overall Study|Withdrawal by Subject|0|||
124471188|NCT03891901|447682106|FG007|Overall Study|Withdrawal by Subject|0|||
124471189|NCT03891901|447682107|FG008|Overall Study|Withdrawal by Subject|0|||
124471190|NCT00573794|447682118|FG000|Overall Study|Adverse Event|81|||
124471191|NCT00573794|447682118|FG000|Overall Study|Withdrew Consent|90|||
124471192|NCT00573794|447682118|FG000|Overall Study|Lost to Follow-up|13|||
124471193|NCT00573794|447682118|FG000|Overall Study|Protocol Violation|6|||
124471194|NCT00573794|447682118|FG000|Overall Study|Lack of Efficacy|94|||
124471195|NCT00573794|447682118|FG000|Overall Study|Other|46|||
124471196|NCT02026063|447682119|FG000|Overall Study|Physician Decision|0|||
124471197|NCT02026063|447682120|FG001|Overall Study|Physician Decision|10|||
124471198|NCT02026063|447682119|FG000|Overall Study|Noncompliance with Study Drug|1|||
124471199|NCT02026063|447682120|FG001|Overall Study|Noncompliance with Study Drug|1|||
124471200|NCT02026063|447682119|FG000|Overall Study|Withdrawal of Consent|1|||
124471201|NCT02026063|447682120|FG001|Overall Study|Withdrawal of Consent|6|||
124471202|NCT02026063|447682119|FG000|Overall Study|Adverse Event|5|||
124471203|NCT02026063|447682120|FG001|Overall Study|Adverse Event|20|||
124471204|NCT02026063|447682119|FG000|Overall Study|Lack of Efficacy|0|||
124471205|NCT02026063|447682120|FG001|Overall Study|Lack of Efficacy|4|||
124553856|NCT00446134|447985492|FG001|Overall Study|Protocol Violation|2|||
124553857|NCT00446134|447985493|FG002|Overall Study|Protocol Violation|1|||
124553858|NCT00446134|447985494|FG003|Overall Study|Protocol Violation|0|||
124553859|NCT00446134|447985491|FG000|Overall Study|Lost to Follow-up|1|||
124471206|NCT02026063|447682119|FG000|Overall Study|Lost to Follow-up|0|||
124471207|NCT02026063|447682120|FG001|Overall Study|Lost to Follow-up|1|||
124553860|NCT00446134|447985492|FG001|Overall Study|Lost to Follow-up|3|||
124553861|NCT00446134|447985493|FG002|Overall Study|Lost to Follow-up|1|||
124553862|NCT00446134|447985494|FG003|Overall Study|Lost to Follow-up|1|||
124553863|NCT00446134|447985491|FG000|Overall Study|Withdrawal by Subject|3|||
124471208|NCT02026063|447682119|FG000|Overall Study|Reason not Specified|2|||
124471209|NCT02026063|447682120|FG001|Overall Study|Reason not Specified|7|||
124471210|NCT02154087|447682121|FG000|Overall Study|Study Termination|1|||
124471211|NCT00486278|447682123|FG000|Overall Study|Adverse Event|5|||
124471212|NCT00486278|447682123|FG000|Overall Study|Withdrawal by Subject|2|||
124553864|NCT00446134|447985492|FG001|Overall Study|Withdrawal by Subject|3|||
124553865|NCT00446134|447985493|FG002|Overall Study|Withdrawal by Subject|1|||
124553866|NCT00446134|447985494|FG003|Overall Study|Withdrawal by Subject|3|||
124553867|NCT00446134|447985491|FG000|Overall Study|Physician Decision|0|||
124553868|NCT00446134|447985492|FG001|Overall Study|Physician Decision|0|||
124471213|NCT00486278|447682123|FG000|Overall Study|Physician Decision|2|||
124471214|NCT05501119|447682124|FG000|Overall Study|Withdrawal by Subject|2|||
124471215|NCT05501119|447682124|FG000|Overall Study|Lost to Follow-up|5|||
124471216|NCT05168267|447682128|FG000|Overall Study|Withdrawal by Subject|2|||
124471217|NCT05168267|447682129|FG001|Overall Study|Withdrawal by Subject|1|||
124471218|NCT05168267|447682128|FG000|Overall Study|Withdrawn by Therapist|1|||
124471219|NCT05168267|447682129|FG001|Overall Study|Withdrawn by Therapist|1|||
124770624|NCT02855125|448788907|FG000|Overall Study|Withdrawal by Subject|2|||
124770625|NCT02855125|448788908|FG001|Overall Study|Withdrawal by Subject|2|||
124770626|NCT02855125|448788907|FG000|Overall Study|Clinical Disease Progression|5|||
124770627|NCT02855125|448788908|FG001|Overall Study|Clinical Disease Progression|4|||
124770628|NCT02855125|448788907|FG000|Overall Study|Radiologic Disease Progression|36|||
124770629|NCT02855125|448788908|FG001|Overall Study|Radiologic Disease Progression|39|||
124770630|NCT02855125|448788907|FG000|Overall Study|Adverse Event|11|||
124770631|NCT02855125|448788908|FG001|Overall Study|Adverse Event|7|||
124770632|NCT02855125|448788907|FG000|Overall Study|Physician Decision|1|||
124770633|NCT02855125|448788908|FG001|Overall Study|Physician Decision|0|||
124770634|NCT02855125|448788907|FG000|Overall Study|On Treatment|9|||
124770635|NCT02855125|448788908|FG001|Overall Study|On Treatment|11|||
124770636|NCT02855125|448788907|FG000|Overall Study|Randomized but not treated|0|||
124770637|NCT02855125|448788908|FG001|Overall Study|Randomized but not treated|1|||
124770638|NCT04467905|448788909|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
124770639|NCT04467905|448788910|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
124471220|NCT05168267|447682128|FG000|Overall Study|Left Facility|1|||
124471221|NCT05168267|447682129|FG001|Overall Study|Left Facility|0|||
124471222|NCT05702736|447682130|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
124471223|NCT05702736|447682131|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
124471224|NCT05702736|447682130|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
124471225|NCT05702736|447682131|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
124471226|NCT01356589|447682132|FG000|Overall Study|Enrolled, but not treated|3|||
124471227|NCT01356589|447682132|FG000|Overall Study|Dose data not recorded|2|||
124471228|NCT01462266|447682133|FG000|Overall Study|Adverse Event|7|||
124471229|NCT01462266|447682134|FG001|Overall Study|Adverse Event|6|||
124471230|NCT01462266|447682133|FG000|Overall Study|Death|2|||
124471231|NCT01462266|447682134|FG001|Overall Study|Death|1|||
124471232|NCT01462266|447682133|FG000|Overall Study|Lack of Efficacy|0|||
124471233|NCT01462266|447682134|FG001|Overall Study|Lack of Efficacy|2|||
124471234|NCT01462266|447682133|FG000|Overall Study|Lost to Follow-up|4|||
124471235|NCT01462266|447682134|FG001|Overall Study|Lost to Follow-up|3|||
124471236|NCT01462266|447682133|FG000|Overall Study|Non-compliance with study drug|3|||
124553869|NCT00446134|447985493|FG002|Overall Study|Physician Decision|0|||
124553870|NCT00446134|447985494|FG003|Overall Study|Physician Decision|2|||
124553871|NCT00446134|447985491|FG000|Overall Study|Adverse Event-Diarrhea|1|||
124714728|NCT03382912|448579422|FG001|Overall Study|Sponsor Decision|6|||
124714729|NCT03382912|448579421|FG000|Overall Study|Withdrawal by Subject|0|||
124714730|NCT03382912|448579422|FG001|Overall Study|Withdrawal by Subject|5|||
124714731|NCT05653700|448579423|FG000|Overall Study|Non Responders|9|||
124714732|NCT05653700|448579424|FG001|Overall Study|Non Responders|0|||
124714733|NCT02573948|448579427|FG000|Longitudinal Cohort|Death|9|||
124714734|NCT02573948|448579427|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
124714735|NCT02573948|448579427|FG000|Longitudinal Cohort|Incarcerated|25|||
124714736|NCT00707993|448579430|FG000|Overall Study|Adverse Event|16|||
124714737|NCT00707993|448579431|FG001|Overall Study|Adverse Event|20|||
124714738|NCT00707993|448579430|FG000|Overall Study|Protocol Violation|4|||
124714739|NCT00707993|448579431|FG001|Overall Study|Protocol Violation|7|||
124770640|NCT04467905|448788911|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
124714740|NCT00707993|448579430|FG000|Overall Study|Lost to Follow-up|0|||
124770641|NCT04467905|448788909|FG000|Overall Study|Conversion to SR|0|||
124714741|NCT00707993|448579431|FG001|Overall Study|Lost to Follow-up|4|||
124714742|NCT00707993|448579430|FG000|Overall Study|Withdrawal by Subject|12|||
124714743|NCT00707993|448579431|FG001|Overall Study|Withdrawal by Subject|16|||
124714744|NCT00707993|448579430|FG000|Overall Study|Hyperglycemic Rescue|55|||
124714745|NCT00707993|448579431|FG001|Overall Study|Hyperglycemic Rescue|47|||
124714746|NCT00707993|448579430|FG000|Overall Study|Other|2|||
124714747|NCT00707993|448579431|FG001|Overall Study|Other|0|||
124714748|NCT05414175|448579434|FG000|Overall Study|Withdrawal by Subject|1|||
124714749|NCT05414175|448579434|FG000|Overall Study|Other Reasons|1|||
124714750|NCT00678288|448581162|FG000|Overall Study|Adverse Event|0|||
124714751|NCT00678288|448581163|FG001|Overall Study|Adverse Event|2|||
124714752|NCT00678288|448581162|FG000|Overall Study|Withdrawal by Subject|1|||
124714753|NCT00678288|448581163|FG001|Overall Study|Withdrawal by Subject|1|||
124714754|NCT00678288|448581162|FG000|Overall Study|Study terminated by the sponsor|2|||
124714755|NCT00678288|448581163|FG001|Overall Study|Study terminated by the sponsor|0|||
124714756|NCT00678288|448581162|FG000|Overall Study|Not compliant with study medication|0|||
124714757|NCT00678288|448581163|FG001|Overall Study|Not compliant with study medication|1|||
124714758|NCT00678288|448581162|FG000|Overall Study|Switch to commercial drug|0|||
124714759|NCT00678288|448581163|FG001|Overall Study|Switch to commercial drug|1|||
124714760|NCT00678288|448581162|FG000|Overall Study|Reason not reported|1|||
124714761|NCT00678288|448581163|FG001|Overall Study|Reason not reported|0|||
124714762|NCT00678288|448581162|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
124714763|NCT00678288|448581163|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
124714764|NCT00552071|448581174|FG000|Overall Study|Adverse Event|1|||
124714765|NCT00552071|448581175|FG001|Overall Study|Adverse Event|0|||
124714766|NCT00552071|448581174|FG000|Overall Study|Lack of Efficacy|1|||
124714767|NCT00552071|448581175|FG001|Overall Study|Lack of Efficacy|0|||
124714768|NCT00552071|448581174|FG000|Overall Study|Physician Decision|1|||
124714769|NCT00552071|448581175|FG001|Overall Study|Physician Decision|0|||
124714770|NCT00552071|448581174|FG000|Overall Study|Pregnancy|1|||
124714771|NCT00552071|448581175|FG001|Overall Study|Pregnancy|0|||
124714772|NCT00552071|448581174|FG000|Overall Study|Death|0|||
124714773|NCT00552071|448581175|FG001|Overall Study|Death|1|||
124714774|NCT00552071|448581174|FG000|Overall Study|Withdrawal by Subject|0|||
124714775|NCT00552071|448581175|FG001|Overall Study|Withdrawal by Subject|1|||
124714776|NCT00532129|448581176|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
124714777|NCT00532129|448581176|FG000|Treatment Period|Physician Decision|15|||
124714778|NCT00532129|448581176|FG000|Treatment Period|Disease progression|3|||
124714779|NCT00532129|448581176|FG000|Treatment Period|Protocol Violation|1|||
124714780|NCT00532129|448581176|FG000|Treatment Period|Other|5|||
124714781|NCT00532129|448581176|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
124714782|NCT00532129|448581176|FG000|Follow-up Period|Disease progression|57|||
124471237|NCT01462266|447682134|FG001|Overall Study|Non-compliance with study drug|0|||
124471238|NCT01462266|447682133|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
124471239|NCT01462266|447682134|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
124471240|NCT01462266|447682133|FG000|Overall Study|Physician Decision|2|||
124471241|NCT01462266|447682134|FG001|Overall Study|Physician Decision|5|||
124471242|NCT01462266|447682133|FG000|Overall Study|Protocol Violation|1|||
124471243|NCT01462266|447682134|FG001|Overall Study|Protocol Violation|3|||
124471244|NCT01462266|447682133|FG000|Overall Study|Withdrawal by Subject|7|||
124471245|NCT01462266|447682134|FG001|Overall Study|Withdrawal by Subject|2|||
124471246|NCT01462266|447682133|FG000|Overall Study|Screen failure|1|||
124471247|NCT01462266|447682134|FG001|Overall Study|Screen failure|1|||
124471248|NCT01106846|447682135|FG000|Overall Study|Change in surgical procedure|0|||
124471249|NCT01106846|447682136|FG001|Overall Study|Change in surgical procedure|1|||
124471250|NCT00803179|447682137|FG000|Overall Study|Lost to Follow-up|3|||
124471251|NCT04811716|447682138|FG000|Overall Study|Withdrawal by Subject|2|||
124471252|NCT04811716|447682139|FG001|Overall Study|Withdrawal by Subject|0|||
124471253|NCT00684957|447682153|FG000|Overall Study|Withdrawal by Subject|1|||
124471254|NCT00684957|447682154|FG001|Overall Study|Withdrawal by Subject|1|||
124471255|NCT00684957|447682153|FG000|Overall Study|Lost to Follow-up|1|||
124714783|NCT00532129|448581176|FG000|Follow-up Period|Lost to Follow-up|1|||
124714784|NCT00532129|448581176|FG000|Follow-up Period|Other|6|||
124471256|NCT00684957|447682154|FG001|Overall Study|Lost to Follow-up|0|||
124471257|NCT04439175|447683843|FG000|Overall Study|Never started treatment|4|||
124714785|NCT00784368|448581179|FG000|Overall Study|Physician Decision|0|||
124714786|NCT00784368|448581180|FG001|Overall Study|Physician Decision|0|||
124714787|NCT00784368|448581181|FG002|Overall Study|Physician Decision|6|||
124714788|NCT00784368|448581179|FG000|Overall Study|Lack of Efficacy|2|||
124714789|NCT00784368|448581180|FG001|Overall Study|Lack of Efficacy|0|||
124714790|NCT00784368|448581181|FG002|Overall Study|Lack of Efficacy|1|||
124714791|NCT00784368|448581179|FG000|Overall Study|Adverse Event|6|||
124714792|NCT00784368|448581180|FG001|Overall Study|Adverse Event|9|||
124714793|NCT00784368|448581181|FG002|Overall Study|Adverse Event|2|||
124714794|NCT00784368|448581179|FG000|Overall Study|Diagnosis of fever|0|||
124714795|NCT00784368|448581180|FG001|Overall Study|Diagnosis of fever|0|||
124714796|NCT00784368|448581181|FG002|Overall Study|Diagnosis of fever|1|||
124714797|NCT00784368|448581179|FG000|Overall Study|Worsening of complications|0|||
124714798|NCT00784368|448581180|FG001|Overall Study|Worsening of complications|0|||
124714799|NCT00784368|448581181|FG002|Overall Study|Worsening of complications|1|||
124714800|NCT00784368|448581179|FG000|Overall Study|Worsening of symptoms|0|||
124714801|NCT00784368|448581180|FG001|Overall Study|Worsening of symptoms|1|||
124714802|NCT00784368|448581181|FG002|Overall Study|Worsening of symptoms|0|||
124714803|NCT00784368|448581179|FG000|Overall Study|Withdrawal of informed consent|0|||
124714804|NCT00784368|448581180|FG001|Overall Study|Withdrawal of informed consent|1|||
124714805|NCT00784368|448581181|FG002|Overall Study|Withdrawal of informed consent|0|||
124714806|NCT02079909|448581182|FG000|Overall Study|Adverse Event|23|||
124714807|NCT02079909|448581183|FG001|Overall Study|Adverse Event|23|||
124714808|NCT02079909|448581184|FG002|Overall Study|Adverse Event|7|||
124714809|NCT02079909|448581182|FG000|Overall Study|Withdrawal by Subject|9|||
124714810|NCT02079909|448581183|FG001|Overall Study|Withdrawal by Subject|17|||
124714811|NCT02079909|448581184|FG002|Overall Study|Withdrawal by Subject|4|||
124714812|NCT02079909|448581182|FG000|Overall Study|Lost to Follow-up|2|||
124714813|NCT02079909|448581183|FG001|Overall Study|Lost to Follow-up|3|||
124714814|NCT02079909|448581184|FG002|Overall Study|Lost to Follow-up|1|||
124714815|NCT02079909|448581182|FG000|Overall Study|Death|2|||
124714816|NCT02079909|448581183|FG001|Overall Study|Death|2|||
124714817|NCT02079909|448581184|FG002|Overall Study|Death|0|||
124714818|NCT02079909|448581182|FG000|Overall Study|Lack of Efficacy|0|||
124714819|NCT02079909|448581183|FG001|Overall Study|Lack of Efficacy|0|||
124714820|NCT02079909|448581184|FG002|Overall Study|Lack of Efficacy|1|||
124714821|NCT02079909|448581182|FG000|Overall Study|Protocol Violation|0|||
124714822|NCT02079909|448581183|FG001|Overall Study|Protocol Violation|1|||
124714823|NCT02079909|448581184|FG002|Overall Study|Protocol Violation|1|||
124714824|NCT02079909|448581182|FG000|Overall Study|Physician Decision|0|||
124714825|NCT02079909|448581183|FG001|Overall Study|Physician Decision|1|||
124714826|NCT02079909|448581184|FG002|Overall Study|Physician Decision|1|||
124714827|NCT02079909|448581182|FG000|Overall Study|Relocation etc.|2|||
124714828|NCT02079909|448581183|FG001|Overall Study|Relocation etc.|2|||
124714829|NCT02079909|448581184|FG002|Overall Study|Relocation etc.|3|||
124714830|NCT00720356|448581189|FG000|Registration to Study|Determined to have methylated MGMT|67|||
124714831|NCT00720356|448581189|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
124714832|NCT00720356|448581189|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
124714833|NCT00720356|448581189|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
124714834|NCT00720356|448581189|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
124714835|NCT00720356|448581189|FG000|Follow up Until Death|Withdrawal by Subject|1|||
124714836|NCT00720356|448581189|FG000|Follow up Until Death|Alive at last data collection|4|||
124714837|NCT02237001|448581192|FG000|Overall Study|Lost to Follow-up|2|||
124714838|NCT02237001|448581192|FG000|Overall Study|Withdrawal by Subject|1|||
124714839|NCT02237001|448581192|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
124714840|NCT02237001|448581192|FG000|Overall Study|Re-operation|4|||
124714841|NCT02237001|448581192|FG000|Overall Study|Incarceration|1|||
124714842|NCT00342628|448581195|FG000|Overall Study|Withdrawal by Subject|19|||
124714843|NCT00342628|448581196|FG001|Overall Study|Withdrawal by Subject|19|||
124714844|NCT00342628|448581197|FG002|Overall Study|Withdrawal by Subject|18|||
124714845|NCT00342628|448581195|FG000|Overall Study|Death|1|||
124714846|NCT00342628|448581196|FG001|Overall Study|Death|1|||
124714847|NCT00342628|448581197|FG002|Overall Study|Death|0|||
124714848|NCT00342628|448581195|FG000|Overall Study|moved residence|0|||
124714849|NCT00342628|448581196|FG001|Overall Study|moved residence|1|||
124714850|NCT00342628|448581197|FG002|Overall Study|moved residence|1|||
124714851|NCT04551898|448581198|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
124714852|NCT04551898|448581199|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
124714853|NCT04551898|448581200|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
124714854|NCT04551898|448581201|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
124714855|NCT04551898|448581198|FG000|Overall Study|Withdrawal by Subject|5|||
124714856|NCT04551898|448581199|FG001|Overall Study|Withdrawal by Subject|1|||
124714857|NCT04551898|448581200|FG002|Overall Study|Withdrawal by Subject|2|||
124714858|NCT04551898|448581201|FG003|Overall Study|Withdrawal by Subject|2|||
124714859|NCT04551898|448581198|FG000|Overall Study|Lost to Follow-up|2|||
124714860|NCT04551898|448581199|FG001|Overall Study|Lost to Follow-up|1|||
124714861|NCT04551898|448581200|FG002|Overall Study|Lost to Follow-up|2|||
124714862|NCT04551898|448581201|FG003|Overall Study|Lost to Follow-up|2|||
124714863|NCT04551898|448581198|FG000|Overall Study|Death|1|||
124714864|NCT04551898|448581199|FG001|Overall Study|Death|0|||
124714865|NCT04551898|448581200|FG002|Overall Study|Death|0|||
124714866|NCT04551898|448581201|FG003|Overall Study|Death|0|||
124714867|NCT04551898|448581198|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
124714868|NCT04551898|448581199|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
124714869|NCT04551898|448581200|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
124714870|NCT04551898|448581201|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
124714871|NCT03427814|448581202|FG000|Overall Study|Withdrawal by Subject|4|||
124714872|NCT03427814|448581203|FG001|Overall Study|Withdrawal by Subject|4|||
124714873|NCT03427814|448581202|FG000|Overall Study|Lost to Follow-up|0|||
124714874|NCT03427814|448581203|FG001|Overall Study|Lost to Follow-up|2|||
124714875|NCT03427814|448581202|FG000|Overall Study|Death|42|||
124714876|NCT03427814|448581203|FG001|Overall Study|Death|31|||
124714877|NCT03427814|448581202|FG000|Overall Study|Sponsor's Decision|1|||
124714878|NCT03427814|448581203|FG001|Overall Study|Sponsor's Decision|0|||
124714879|NCT03427814|448581202|FG000|Overall Study|Investigator's Decision|1|||
124714880|NCT03427814|448581203|FG001|Overall Study|Investigator's Decision|2|||
124714881|NCT03427814|448581202|FG000|Overall Study|Disease progression|1|||
124714882|NCT03427814|448581203|FG001|Overall Study|Disease progression|0|||
124714883|NCT03427814|448581202|FG000|Overall Study|Treatment Completed|0|||
124714884|NCT03427814|448581203|FG001|Overall Study|Treatment Completed|1|||
124714885|NCT03427814|448581202|FG000|Overall Study|Sponsor's Decision to End study|21|||
124714886|NCT03427814|448581203|FG001|Overall Study|Sponsor's Decision to End study|25|||
124714887|NCT03427814|448581202|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
124714888|NCT03427814|448581203|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
124714889|NCT03145064|448581204|FG000|Overall Study|Death|24|||
124714890|NCT03145064|448581204|FG000|Overall Study|Lost to Follow-up|3|||
124714891|NCT03145064|448581204|FG000|Overall Study|Withdrawal by Subject|6|||
124752794|NCT04427072|448716839|FG000|Randomized Treatment Phase|Progressive disease|9|||
124714892|NCT03145064|448581204|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
124714893|NCT03145064|448581204|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
124714894|NCT03846427|448581205|FG000|Overall Study|Death|13|||
124714895|NCT03846427|448581205|FG000|Overall Study|Withdrawal by Subject|3|||
124714896|NCT03846427|448581205|FG000|Overall Study|Physician Decision|1|||
124714897|NCT01693250|448581206|FG000|Overall Study|Lost to Follow-up|2|||
124714898|NCT01693250|448581207|FG001|Overall Study|Lost to Follow-up|2|||
124714899|NCT00628446|448581208|FG000|Overall Study|Lost to Follow-up|3|||
124714900|NCT00628446|448581208|FG000|Overall Study|Withdrawal by Subject|1|||
124714901|NCT00628446|448581208|FG000|Overall Study|Protocol Violation|3|||
124714902|NCT01396187|448581209|FG000|Overall Study|Adverse Event|0|||
124714903|NCT01396187|448581210|FG001|Overall Study|Adverse Event|1|||
124714904|NCT01396187|448581211|FG002|Overall Study|Adverse Event|0|||
124714905|NCT01396187|448581212|FG003|Overall Study|Adverse Event|0|||
124714906|NCT01396187|448581213|FG004|Overall Study|Adverse Event|0|||
124714907|NCT01396187|448581209|FG000|Overall Study|Withdrawal by Subject|0|||
124714908|NCT01396187|448581210|FG001|Overall Study|Withdrawal by Subject|1|||
124714909|NCT01396187|448581211|FG002|Overall Study|Withdrawal by Subject|1|||
124714910|NCT01396187|448581212|FG003|Overall Study|Withdrawal by Subject|0|||
124714911|NCT01396187|448581213|FG004|Overall Study|Withdrawal by Subject|0|||
124714912|NCT01396187|448581209|FG000|Overall Study|Other|1|||
124714913|NCT01396187|448581210|FG001|Overall Study|Other|1|||
124714914|NCT01396187|448581211|FG002|Overall Study|Other|0|||
124714915|NCT01396187|448581212|FG003|Overall Study|Other|0|||
124714916|NCT01396187|448581213|FG004|Overall Study|Other|1|||
124714917|NCT04971967|448581217|FG000|Overall Study|Lost to Follow-up|6|||
124714918|NCT04971967|448581218|FG001|Overall Study|Lost to Follow-up|7|||
124714919|NCT00682929|448581221|FG000|Overall Study|Adverse Event|4|||
124714920|NCT00682929|448581222|FG001|Overall Study|Adverse Event|1|||
124714921|NCT00682929|448581223|FG002|Overall Study|Adverse Event|1|||
124714922|NCT00682929|448581221|FG000|Overall Study|Withdrawal by Subject|1|||
124714923|NCT00682929|448581222|FG001|Overall Study|Withdrawal by Subject|2|||
124714924|NCT00682929|448581223|FG002|Overall Study|Withdrawal by Subject|1|||
124714925|NCT00682929|448581221|FG000|Overall Study|dosing compliance < 80%|0|||
124714926|NCT00682929|448581222|FG001|Overall Study|dosing compliance < 80%|2|||
124714927|NCT00682929|448581223|FG002|Overall Study|dosing compliance < 80%|0|||
124714928|NCT00682929|448581221|FG000|Overall Study|lag in DEA renewal|1|||
124714929|NCT00682929|448581222|FG001|Overall Study|lag in DEA renewal|0|||
124714930|NCT00682929|448581223|FG002|Overall Study|lag in DEA renewal|0|||
124714931|NCT01462929|448581224|FG000|Overall Study|Adverse Event|3|||
124714932|NCT01462929|448581225|FG001|Overall Study|Adverse Event|3|||
124714933|NCT01462929|448581226|FG002|Overall Study|Adverse Event|4|||
124714934|NCT01462929|448581224|FG000|Overall Study|Withdrawal by Subject|2|||
124714935|NCT01462929|448581225|FG001|Overall Study|Withdrawal by Subject|1|||
124714936|NCT01462929|448581226|FG002|Overall Study|Withdrawal by Subject|0|||
124714937|NCT01462929|448581224|FG000|Overall Study|Lack of Efficacy|0|||
124714938|NCT01462929|448581225|FG001|Overall Study|Lack of Efficacy|0|||
124714939|NCT01462929|448581226|FG002|Overall Study|Lack of Efficacy|1|||
124714940|NCT04723355|448581227|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
124714941|NCT04723355|448581227|FG000|Overall Study|Errors in the informed consent form|2|||
124714942|NCT04072835|448581228|FG000|Overall Study|Overall trial ended|603|||
124714943|NCT04072835|448581228|FG000|Overall Study|Ablation|97|||
124714944|NCT04072835|448581228|FG000|Overall Study|Withdrawal of consent|66|||
124714945|NCT04072835|448581228|FG000|Overall Study|Physician Decision|50|||
124714946|NCT04072835|448581228|FG000|Overall Study|Lost to Follow-up|39|||
124714947|NCT04072835|448581228|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
124714948|NCT04072835|448581228|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
124714949|NCT04072835|448581228|FG000|Overall Study|Adverse Event|25|||
124714950|NCT04072835|448581228|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
124714951|NCT04072835|448581228|FG000|Overall Study|Death|11|||
124714952|NCT04072835|448581228|FG000|Overall Study|Participant felt the drug did not work|8|||
124714953|NCT04072835|448581228|FG000|Overall Study|Participant tolerability|5|||
124714954|NCT04072835|448581228|FG000|Overall Study|Missing|5|||
124714955|NCT04072835|448581228|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
124714956|NCT04072835|448581228|FG000|Overall Study|Pregnancy|3|||
124714957|NCT00841776|448581231|FG000|Overall Study|Lack of Efficacy|0|||
124714958|NCT00841776|448581232|FG001|Overall Study|Lack of Efficacy|1|||
124714959|NCT00841776|448581231|FG000|Overall Study|Lost to Follow-up|2|||
124714960|NCT00841776|448581232|FG001|Overall Study|Lost to Follow-up|1|||
124714961|NCT00841776|448581231|FG000|Overall Study|Withdrawal by Subject|0|||
124714962|NCT00841776|448581232|FG001|Overall Study|Withdrawal by Subject|1|||
124714963|NCT01306643|448581234|FG000|Overall Study|Adverse Event|5|||
124714964|NCT01306643|448581234|FG000|Overall Study|Disease Progression|7|||
124714965|NCT01306643|448581234|FG000|Overall Study|Other: Change in Eligibility Status|1|||
124714966|NCT02071771|448581235|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
124714967|NCT02071771|448581236|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
124714968|NCT02071771|448581235|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
124714969|NCT02071771|448581236|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
124714970|NCT02479880|448581240|FG000|Overall Study|Study Terminated by Sponsor|13|||
124714971|NCT02479880|448581241|FG001|Overall Study|Study Terminated by Sponsor|12|||
124714972|NCT02479880|448581240|FG000|Overall Study|Pregnancy|0|||
124714973|NCT02479880|448581241|FG001|Overall Study|Pregnancy|1|||
124714974|NCT00355368|448581242|FG000|Overall Study|Protocol Violation|8|||
124714975|NCT00355368|448581243|FG001|Overall Study|Protocol Violation|7|||
124553872|NCT00446134|447985492|FG001|Overall Study|Adverse Event-Diarrhea|1|||
124553873|NCT00446134|447985493|FG002|Overall Study|Adverse Event-Diarrhea|2|||
124553874|NCT00446134|447985494|FG003|Overall Study|Adverse Event-Diarrhea|0|||
124553875|NCT00446134|447985491|FG000|Overall Study|Reason Not Completed|3|||
124553876|NCT00446134|447985492|FG001|Overall Study|Reason Not Completed|0|||
124553877|NCT00446134|447985493|FG002|Overall Study|Reason Not Completed|1|||
124553878|NCT00446134|447985494|FG003|Overall Study|Reason Not Completed|2|||
124553879|NCT00743119|447985495|FG000|Overall Study|unreliable|3|||
124553880|NCT00743119|447985495|FG000|Overall Study|Withdrawal by Subject|1|||
124553881|NCT04816877|447985496|FG000|Overall Study|Withdrawal by Subject|1|||
124553882|NCT04816877|447985497|FG001|Overall Study|Withdrawal by Subject|0|||
124553883|NCT01309828|447985499|FG000|Overall Study|Adverse Event|10|||
124553884|NCT01309828|447985500|FG001|Overall Study|Adverse Event|11|||
124553885|NCT01309828|447985499|FG000|Overall Study|Voluntary Withdrawal|5|||
124553886|NCT01309828|447985500|FG001|Overall Study|Voluntary Withdrawal|4|||
124553887|NCT01309828|447985499|FG000|Overall Study|Major Protocol Deviation|0|||
124553888|NCT01309828|447985500|FG001|Overall Study|Major Protocol Deviation|1|||
124553889|NCT01309828|447985499|FG000|Overall Study|Other|1|||
124553890|NCT01309828|447985500|FG001|Overall Study|Other|0|||
124553891|NCT00295620|447985501|FG000|Overall Study|Lost to Follow-up|9|||
124553892|NCT00295620|447985502|FG001|Overall Study|Lost to Follow-up|5|||
124553893|NCT00295620|447985501|FG000|Overall Study|Withdrawal by Subject|37|||
124714976|NCT00355368|448581242|FG000|Overall Study|cardiac arrest prior to intubation|2|||
124714977|NCT00355368|448581243|FG001|Overall Study|cardiac arrest prior to intubation|2|||
124714978|NCT01349673|448581244|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
124714979|NCT01349673|448581244|FG000|Overall Study|No Longer Qualified For Study|1|||
124714980|NCT01349673|448581244|FG000|Overall Study|Site Closure|10|||
124714981|NCT01349673|448581244|FG000|Overall Study|Withdrawal by Subject|21|||
124714982|NCT01349673|448581244|FG000|Overall Study|Lost to Follow-up|6|||
124714983|NCT01349673|448581244|FG000|Overall Study|Adverse Event|17|||
124714984|NCT01349673|448581244|FG000|Overall Study|Study Terminated By Sponsor|50|||
124714985|NCT01349673|448581244|FG000|Overall Study|Lack of Efficacy|8|||
124714986|NCT03688919|448581247|FG000|Overall Study|Lost to Follow-up|2|||
124714987|NCT03688919|448581248|FG001|Overall Study|Lost to Follow-up|1|||
124714988|NCT03688919|448581247|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
124714989|NCT03688919|448581248|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
124714990|NCT00506779|448581252|FG000|Overall Study|Withdrawal by Subject|1|||
124714991|NCT00506779|448581253|FG001|Overall Study|Withdrawal by Subject|0|||
124714992|NCT00506779|448581254|FG002|Overall Study|Withdrawal by Subject|1|||
124714993|NCT00506779|448581255|FG003|Overall Study|Withdrawal by Subject|0|||
124714994|NCT00506779|448581252|FG000|Overall Study|Adverse Event|0|||
124714995|NCT00506779|448581253|FG001|Overall Study|Adverse Event|1|||
124714996|NCT00506779|448581254|FG002|Overall Study|Adverse Event|1|||
124714997|NCT00506779|448581255|FG003|Overall Study|Adverse Event|1|||
124714998|NCT03462758|448581256|FG000|Overall Study|Chose no or other method of contraception|20|||
124714999|NCT03462758|448581257|FG001|Overall Study|Chose no or other method of contraception|23|||
124715000|NCT03462758|448581256|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
124715001|NCT03462758|448581257|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
124715002|NCT03462758|448581256|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
124715003|NCT03462758|448581257|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
124715004|NCT03462758|448581256|FG000|Overall Study|Medical contraindication|2|||
124715005|NCT03462758|448581257|FG001|Overall Study|Medical contraindication|2|||
124715006|NCT03462758|448581256|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
124715007|NCT03462758|448581257|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
124715008|NCT00413660|448581260|FG000|Up To Week 12|Adverse Event|1|||
124553894|NCT00295620|447985502|FG001|Overall Study|Withdrawal by Subject|50|||
124715009|NCT00413660|448581261|FG001|Up To Week 12|Adverse Event|3|||
124715010|NCT00413660|448581262|FG002|Up To Week 12|Adverse Event|1|||
124715011|NCT00413660|448581263|FG003|Up To Week 12|Adverse Event|4|||
124553895|NCT00295620|447985501|FG000|Overall Study|Death|206|||
124553896|NCT00295620|447985502|FG001|Overall Study|Death|207|||
124553897|NCT00295620|447985501|FG000|Overall Study|Other reasons|10|||
124553898|NCT00295620|447985502|FG001|Overall Study|Other reasons|9|||
124715012|NCT00413660|448581264|FG004|Up To Week 12|Adverse Event|6|||
124553899|NCT00295620|447985501|FG000|Overall Study|Discontinuation by sponsor|580|||
124553900|NCT00295620|447985502|FG001|Overall Study|Discontinuation by sponsor|593|||
124553901|NCT00295620|447985501|FG000|Overall Study|Protocol Violation|30|||
124715013|NCT00413660|448581265|FG005|Up To Week 12|Adverse Event|4|||
124770642|NCT04467905|448788910|FG001|Overall Study|Conversion to SR|0|||
124770643|NCT04467905|448788911|FG002|Overall Study|Conversion to SR|3|||
124770644|NCT04467905|448788909|FG000|Overall Study|Technical issue with Holter ECG|0|||
124770645|NCT04467905|448788910|FG001|Overall Study|Technical issue with Holter ECG|0|||
124770646|NCT04467905|448788911|FG002|Overall Study|Technical issue with Holter ECG|3|||
124770647|NCT04467905|448788909|FG000|Overall Study|Hemodynamic instability|0|||
124770648|NCT04467905|448788910|FG001|Overall Study|Hemodynamic instability|0|||
124770649|NCT04467905|448788911|FG002|Overall Study|Hemodynamic instability|1|||
124770650|NCT04467905|448788909|FG000|Overall Study|Site misinterpretation of protocol|0|||
124770651|NCT04467905|448788910|FG001|Overall Study|Site misinterpretation of protocol|0|||
124770652|NCT04467905|448788911|FG002|Overall Study|Site misinterpretation of protocol|1|||
124770653|NCT00744497|448789917|FG000|Overall Study|Withdrawal by Subject|21|||
124770654|NCT00744497|448789918|FG001|Overall Study|Withdrawal by Subject|18|||
124770655|NCT00744497|448789917|FG000|Overall Study|Death|11|||
124770656|NCT00744497|448789918|FG001|Overall Study|Death|9|||
124770657|NCT00744497|448789917|FG000|Overall Study|Lost to Follow-up|4|||
124770658|NCT00744497|448789918|FG001|Overall Study|Lost to Follow-up|2|||
124770659|NCT00744497|448789917|FG000|Overall Study|Poor compliance/noncompliance|9|||
124770660|NCT00744497|448789918|FG001|Overall Study|Poor compliance/noncompliance|5|||
124770661|NCT00744497|448789917|FG000|Overall Study|No longer meets study criteria|7|||
124770662|NCT00744497|448789918|FG001|Overall Study|No longer meets study criteria|3|||
124770663|NCT00744497|448789917|FG000|Overall Study|Administrative Reason By Sponsor|25|||
124770664|NCT00744497|448789918|FG001|Overall Study|Administrative Reason By Sponsor|8|||
124471258|NCT04439175|447683843|FG000|Overall Study|Ineligible|5|||
124471259|NCT04439175|447683843|FG000|Overall Study|Adverse Event|6|||
124471260|NCT04439175|447683843|FG000|Overall Study|Death|4|||
124471261|NCT04439175|447683843|FG000|Overall Study|Disease progression|44|||
124471262|NCT04439175|447683843|FG000|Overall Study|Withdrawal by Subject|4|||
124471263|NCT04439175|447683843|FG000|Overall Study|Alternative Therapy|1|||
124471264|NCT04439175|447683843|FG000|Overall Study|Other|2|||
124471265|NCT02363478|447683845|FG000|Overall Study|Lost to Follow-up|4|||
124471266|NCT02363478|447683845|FG000|Overall Study|Adverse Event|4|||
124471267|NCT00768898|447683846|FG000|Overall Study|Unrelated injury|1|||
124770665|NCT00744497|448789917|FG000|Overall Study|Disease progression|312|||
124471268|NCT00768898|447683846|FG000|Overall Study|Headache|1|||
124471269|NCT02554929|447683847|FG000|Overall Study|Lost to Follow-up|4|||
124471270|NCT02554929|447683848|FG001|Overall Study|Lost to Follow-up|4|||
124471271|NCT02554929|447683847|FG000|Overall Study|Withdrawal by Subject|2|||
124471272|NCT02554929|447683848|FG001|Overall Study|Withdrawal by Subject|8|||
124471273|NCT00546364|447683849|FG000|Overall Study|Disease progression|5|||
124471274|NCT00546364|447683850|FG001|Overall Study|Disease progression|11|||
124471275|NCT00546364|447683851|FG002|Overall Study|Disease progression|8|||
124471276|NCT00546364|447683849|FG000|Overall Study|Completed and off treatment|1|||
124471277|NCT00546364|447683850|FG001|Overall Study|Completed and off treatment|0|||
124471278|NCT00546364|447683851|FG002|Overall Study|Completed and off treatment|2|||
124471279|NCT00546364|447683849|FG000|Overall Study|Administrative reason by sponsor|1|||
124471280|NCT00546364|447683850|FG001|Overall Study|Administrative reason by sponsor|0|||
124471281|NCT00546364|447683851|FG002|Overall Study|Administrative reason by sponsor|0|||
124471282|NCT00546364|447683849|FG000|Overall Study|Poor compliance/noncompliance|0|||
124471283|NCT00546364|447683850|FG001|Overall Study|Poor compliance/noncompliance|0|||
124471284|NCT00546364|447683851|FG002|Overall Study|Poor compliance/noncompliance|1|||
124471285|NCT00546364|447683849|FG000|Overall Study|No longer meets study criteria|1|||
124553902|NCT00295620|447985502|FG001|Overall Study|Protocol Violation|32|||
124770666|NCT00744497|448789918|FG001|Overall Study|Disease progression|219|||
124770667|NCT00744497|448789917|FG000|Overall Study|Study drug toxicity|68|||
124770668|NCT00744497|448789918|FG001|Overall Study|Study drug toxicity|141|||
124770669|NCT00744497|448789917|FG000|Overall Study|Adverse event unrelated to study drug|78|||
124471286|NCT00546364|447683850|FG001|Overall Study|No longer meets study criteria|1|||
124471287|NCT00546364|447683851|FG002|Overall Study|No longer meets study criteria|0|||
124471288|NCT00546364|447683849|FG000|Overall Study|Withdrawal by Subject|5|||
124471289|NCT00546364|447683850|FG001|Overall Study|Withdrawal by Subject|6|||
124471290|NCT00546364|447683851|FG002|Overall Study|Withdrawal by Subject|3|||
124471291|NCT00546364|447683849|FG000|Overall Study|Prior taxotere|1|||
124471292|NCT00546364|447683850|FG001|Overall Study|Prior taxotere|0|||
124471293|NCT00546364|447683851|FG002|Overall Study|Prior taxotere|0|||
124770670|NCT00744497|448789918|FG001|Overall Study|Adverse event unrelated to study drug|122|||
124770671|NCT00744497|448789917|FG000|Overall Study|Patient requested to stop study drug|65|||
124770672|NCT00744497|448789918|FG001|Overall Study|Patient requested to stop study drug|80|||
124770673|NCT00744497|448789917|FG000|Overall Study|Maximum clinical benefit|141|||
124770674|NCT00744497|448789918|FG001|Overall Study|Maximum clinical benefit|142|||
124770675|NCT00744497|448789917|FG000|Overall Study|Not defined|19|||
124471294|NCT00546364|447683849|FG000|Overall Study|Mixed response|1|||
124471295|NCT00546364|447683850|FG001|Overall Study|Mixed response|0|||
124471296|NCT00546364|447683851|FG002|Overall Study|Mixed response|0|||
124471297|NCT00546364|447683849|FG000|Overall Study|Palliative treatment|1|||
124471298|NCT00546364|447683850|FG001|Overall Study|Palliative treatment|0|||
124471299|NCT00546364|447683851|FG002|Overall Study|Palliative treatment|1|||
124471300|NCT00546364|447683849|FG000|Overall Study|Target lesions resected|1|||
124471301|NCT00546364|447683850|FG001|Overall Study|Target lesions resected|0|||
124471302|NCT00546364|447683851|FG002|Overall Study|Target lesions resected|0|||
124715014|NCT00413660|448581266|FG006|Up To Week 12|Adverse Event|1|||
124715015|NCT00413660|448581267|FG007|Up To Week 12|Adverse Event|0|||
124715016|NCT00413660|448581268|FG008|Up To Week 12|Adverse Event|0|||
124715017|NCT00413660|448581269|FG009|Up To Week 12|Adverse Event|0|||
124715018|NCT00413660|448581270|FG010|Up To Week 12|Adverse Event|0|||
124715019|NCT00413660|448581260|FG000|Up To Week 12|Lack of Efficacy|2|||
124715020|NCT00413660|448581261|FG001|Up To Week 12|Lack of Efficacy|0|||
124715021|NCT00413660|448581262|FG002|Up To Week 12|Lack of Efficacy|0|||
124715022|NCT00413660|448581263|FG003|Up To Week 12|Lack of Efficacy|0|||
124715023|NCT00413660|448581264|FG004|Up To Week 12|Lack of Efficacy|0|||
124715024|NCT00413660|448581265|FG005|Up To Week 12|Lack of Efficacy|0|||
124715025|NCT00413660|448581266|FG006|Up To Week 12|Lack of Efficacy|5|||
124715026|NCT00413660|448581267|FG007|Up To Week 12|Lack of Efficacy|0|||
124715027|NCT00413660|448581268|FG008|Up To Week 12|Lack of Efficacy|0|||
124715028|NCT00413660|448581269|FG009|Up To Week 12|Lack of Efficacy|0|||
124715029|NCT00413660|448581270|FG010|Up To Week 12|Lack of Efficacy|0|||
124715030|NCT00413660|448581260|FG000|Up To Week 12|Lost to Follow-up|0|||
124715031|NCT00413660|448581261|FG001|Up To Week 12|Lost to Follow-up|1|||
124715032|NCT00413660|448581262|FG002|Up To Week 12|Lost to Follow-up|0|||
124715033|NCT00413660|448581263|FG003|Up To Week 12|Lost to Follow-up|0|||
124715034|NCT00413660|448581264|FG004|Up To Week 12|Lost to Follow-up|1|||
124715035|NCT00413660|448581265|FG005|Up To Week 12|Lost to Follow-up|0|||
124715036|NCT00413660|448581266|FG006|Up To Week 12|Lost to Follow-up|0|||
124715037|NCT00413660|448581267|FG007|Up To Week 12|Lost to Follow-up|0|||
124715038|NCT00413660|448581268|FG008|Up To Week 12|Lost to Follow-up|0|||
124715039|NCT00413660|448581269|FG009|Up To Week 12|Lost to Follow-up|0|||
124715040|NCT00413660|448581270|FG010|Up To Week 12|Lost to Follow-up|0|||
124715041|NCT00413660|448581260|FG000|Up To Week 12|Withdrawal by Subject|0|||
124715042|NCT00413660|448581261|FG001|Up To Week 12|Withdrawal by Subject|2|||
124715043|NCT00413660|448581262|FG002|Up To Week 12|Withdrawal by Subject|0|||
124715044|NCT00413660|448581263|FG003|Up To Week 12|Withdrawal by Subject|2|||
124715045|NCT00413660|448581264|FG004|Up To Week 12|Withdrawal by Subject|0|||
124715046|NCT00413660|448581265|FG005|Up To Week 12|Withdrawal by Subject|2|||
124715047|NCT00413660|448581266|FG006|Up To Week 12|Withdrawal by Subject|2|||
124715048|NCT00413660|448581267|FG007|Up To Week 12|Withdrawal by Subject|0|||
124471303|NCT00546364|447683849|FG000|Overall Study|Physician Decision|0|||
124471304|NCT00546364|447683850|FG001|Overall Study|Physician Decision|0|||
124715049|NCT00413660|448581268|FG008|Up To Week 12|Withdrawal by Subject|0|||
124715050|NCT00413660|448581269|FG009|Up To Week 12|Withdrawal by Subject|0|||
124715051|NCT00413660|448581270|FG010|Up To Week 12|Withdrawal by Subject|0|||
124770676|NCT00744497|448789918|FG001|Overall Study|Not defined|13|||
124553903|NCT02556632|447985505|FG000|Overall Study|Lost to Follow-up|1|||
124553904|NCT02556632|447985506|FG001|Overall Study|Lost to Follow-up|0|||
124553905|NCT02556632|447985507|FG002|Overall Study|Lost to Follow-up|0|||
124553906|NCT02556632|447985505|FG000|Overall Study|Disliked Intervention|1|||
124553907|NCT02556632|447985506|FG001|Overall Study|Disliked Intervention|1|||
124553908|NCT02556632|447985507|FG002|Overall Study|Disliked Intervention|1|||
124553909|NCT02556632|447985505|FG000|Overall Study|No Reason|1|||
124553910|NCT02556632|447985506|FG001|Overall Study|No Reason|0|||
124553911|NCT02556632|447985507|FG002|Overall Study|No Reason|1|||
124553912|NCT02556632|447985505|FG000|Overall Study|Personal Issues|0|||
124553913|NCT02556632|447985506|FG001|Overall Study|Personal Issues|1|||
124553914|NCT02556632|447985507|FG002|Overall Study|Personal Issues|1|||
124553915|NCT02556632|447985505|FG000|Overall Study|Changed Mind|0|||
124553916|NCT02556632|447985506|FG001|Overall Study|Changed Mind|1|||
124553917|NCT02556632|447985507|FG002|Overall Study|Changed Mind|0|||
124553918|NCT02556632|447985505|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
124553919|NCT02556632|447985506|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
124553920|NCT02556632|447985507|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
124553921|NCT02556632|447985505|FG000|Overall Study|Unrelated Adverse Event|1|||
124553922|NCT02556632|447985506|FG001|Overall Study|Unrelated Adverse Event|0|||
124553923|NCT02556632|447985507|FG002|Overall Study|Unrelated Adverse Event|3|||
124553924|NCT02556632|447985505|FG000|Overall Study|Related Adverse Event|0|||
124553925|NCT02556632|447985506|FG001|Overall Study|Related Adverse Event|1|||
124553926|NCT02556632|447985507|FG002|Overall Study|Related Adverse Event|0|||
124553927|NCT02556632|447985505|FG000|Overall Study|Possibly Related Adverse Event|0|||
124553928|NCT02556632|447985506|FG001|Overall Study|Possibly Related Adverse Event|0|||
124553929|NCT02556632|447985507|FG002|Overall Study|Possibly Related Adverse Event|1|||
124471305|NCT00546364|447683851|FG002|Overall Study|Physician Decision|1|||
124471306|NCT00546364|447683849|FG000|Overall Study|Sponsor decision|0|||
124471307|NCT00546364|447683850|FG001|Overall Study|Sponsor decision|0|||
124471308|NCT00546364|447683851|FG002|Overall Study|Sponsor decision|1|||
124471309|NCT00667576|447683852|FG000|Overall Study|Withdrawal by Subject|1|||
124471310|NCT00667576|447683853|FG001|Overall Study|Withdrawal by Subject|0|||
124471311|NCT00667576|447683854|FG002|Overall Study|Withdrawal by Subject|1|||
124471312|NCT00667576|447683855|FG003|Overall Study|Withdrawal by Subject|1|||
124471313|NCT00667576|447683856|FG004|Overall Study|Withdrawal by Subject|1|||
124471314|NCT00667576|447683852|FG000|Overall Study|Adverse Event|1|||
124471315|NCT00667576|447683853|FG001|Overall Study|Adverse Event|1|||
124471316|NCT00667576|447683854|FG002|Overall Study|Adverse Event|0|||
124553930|NCT02556632|447985505|FG000|Overall Study|Did Not Start RT|0|||
124553931|NCT02556632|447985506|FG001|Overall Study|Did Not Start RT|1|||
124553932|NCT02556632|447985507|FG002|Overall Study|Did Not Start RT|0|||
124715052|NCT00413660|448581260|FG000|Up To Week 12|Randomized, Not Treated|1|||
124715053|NCT00413660|448581261|FG001|Up To Week 12|Randomized, Not Treated|0|||
124715054|NCT00413660|448581262|FG002|Up To Week 12|Randomized, Not Treated|0|||
124715055|NCT00413660|448581263|FG003|Up To Week 12|Randomized, Not Treated|1|||
124715056|NCT00413660|448581264|FG004|Up To Week 12|Randomized, Not Treated|0|||
124715057|NCT00413660|448581265|FG005|Up To Week 12|Randomized, Not Treated|0|||
124715058|NCT00413660|448581266|FG006|Up To Week 12|Randomized, Not Treated|0|||
124715059|NCT00413660|448581267|FG007|Up To Week 12|Randomized, Not Treated|0|||
124715060|NCT00413660|448581268|FG008|Up To Week 12|Randomized, Not Treated|0|||
124715061|NCT00413660|448581269|FG009|Up To Week 12|Randomized, Not Treated|0|||
124715062|NCT00413660|448581270|FG010|Up To Week 12|Randomized, Not Treated|0|||
124715063|NCT00413660|448581260|FG000|Up To Week 12|Other|3|||
124715064|NCT00413660|448581261|FG001|Up To Week 12|Other|1|||
124715065|NCT00413660|448581262|FG002|Up To Week 12|Other|6|||
124715066|NCT00413660|448581263|FG003|Up To Week 12|Other|1|||
124715067|NCT00413660|448581264|FG004|Up To Week 12|Other|2|||
124715068|NCT00413660|448581265|FG005|Up To Week 12|Other|4|||
124715069|NCT00413660|448581266|FG006|Up To Week 12|Other|3|||
124715070|NCT00413660|448581267|FG007|Up To Week 12|Other|0|||
124715071|NCT00413660|448581268|FG008|Up To Week 12|Other|0|||
124715072|NCT00413660|448581269|FG009|Up To Week 12|Other|0|||
124715073|NCT00413660|448581270|FG010|Up To Week 12|Other|0|||
124715074|NCT00413660|448581260|FG000|Post Week 12|Adverse Event|2|||
124715075|NCT00413660|448581261|FG001|Post Week 12|Adverse Event|0|||
124715076|NCT00413660|448581262|FG002|Post Week 12|Adverse Event|2|||
124715077|NCT00413660|448581263|FG003|Post Week 12|Adverse Event|1|||
124715078|NCT00413660|448581264|FG004|Post Week 12|Adverse Event|4|||
124715079|NCT00413660|448581265|FG005|Post Week 12|Adverse Event|2|||
124715080|NCT00413660|448581266|FG006|Post Week 12|Adverse Event|2|||
124715081|NCT00413660|448581267|FG007|Post Week 12|Adverse Event|0|||
124715082|NCT00413660|448581268|FG008|Post Week 12|Adverse Event|0|||
124715083|NCT00413660|448581269|FG009|Post Week 12|Adverse Event|0|||
124715084|NCT00413660|448581270|FG010|Post Week 12|Adverse Event|0|||
124715085|NCT00413660|448581260|FG000|Post Week 12|Lack of Efficacy|0|||
124715086|NCT00413660|448581261|FG001|Post Week 12|Lack of Efficacy|0|||
124715087|NCT00413660|448581262|FG002|Post Week 12|Lack of Efficacy|1|||
124715088|NCT00413660|448581263|FG003|Post Week 12|Lack of Efficacy|0|||
124715089|NCT00413660|448581264|FG004|Post Week 12|Lack of Efficacy|0|||
124715090|NCT00413660|448581265|FG005|Post Week 12|Lack of Efficacy|0|||
124715091|NCT00413660|448581266|FG006|Post Week 12|Lack of Efficacy|0|||
124715092|NCT00413660|448581267|FG007|Post Week 12|Lack of Efficacy|0|||
124715093|NCT00413660|448581268|FG008|Post Week 12|Lack of Efficacy|0|||
124715094|NCT00413660|448581269|FG009|Post Week 12|Lack of Efficacy|1|||
124715095|NCT00413660|448581270|FG010|Post Week 12|Lack of Efficacy|0|||
124715096|NCT00413660|448581260|FG000|Post Week 12|Lost to Follow-up|0|||
124715097|NCT00413660|448581261|FG001|Post Week 12|Lost to Follow-up|1|||
124715098|NCT00413660|448581262|FG002|Post Week 12|Lost to Follow-up|1|||
124715099|NCT00413660|448581263|FG003|Post Week 12|Lost to Follow-up|0|||
124715100|NCT00413660|448581264|FG004|Post Week 12|Lost to Follow-up|0|||
124715101|NCT00413660|448581265|FG005|Post Week 12|Lost to Follow-up|0|||
124715102|NCT00413660|448581266|FG006|Post Week 12|Lost to Follow-up|0|||
124715103|NCT00413660|448581267|FG007|Post Week 12|Lost to Follow-up|0|||
124715104|NCT00413660|448581268|FG008|Post Week 12|Lost to Follow-up|0|||
124715105|NCT00413660|448581269|FG009|Post Week 12|Lost to Follow-up|0|||
124715106|NCT00413660|448581270|FG010|Post Week 12|Lost to Follow-up|0|||
124715107|NCT00413660|448581260|FG000|Post Week 12|Withdrawal by Subject|0|||
124471317|NCT00667576|447683855|FG003|Overall Study|Adverse Event|0|||
124471318|NCT00667576|447683856|FG004|Overall Study|Adverse Event|0|||
124471319|NCT00667576|447683852|FG000|Overall Study|Lost to Follow-up|0|||
124471320|NCT00667576|447683853|FG001|Overall Study|Lost to Follow-up|0|||
124715108|NCT00413660|448581261|FG001|Post Week 12|Withdrawal by Subject|1|||
124715109|NCT00413660|448581262|FG002|Post Week 12|Withdrawal by Subject|1|||
124715110|NCT00413660|448581263|FG003|Post Week 12|Withdrawal by Subject|0|||
124715111|NCT00413660|448581264|FG004|Post Week 12|Withdrawal by Subject|1|||
124715112|NCT00413660|448581265|FG005|Post Week 12|Withdrawal by Subject|0|||
124715113|NCT00413660|448581266|FG006|Post Week 12|Withdrawal by Subject|0|||
124715114|NCT00413660|448581267|FG007|Post Week 12|Withdrawal by Subject|0|||
124715115|NCT00413660|448581268|FG008|Post Week 12|Withdrawal by Subject|0|||
124715116|NCT00413660|448581269|FG009|Post Week 12|Withdrawal by Subject|0|||
124715117|NCT00413660|448581270|FG010|Post Week 12|Withdrawal by Subject|1|||
124715118|NCT00413660|448581260|FG000|Post Week 12|Other|1|||
124715119|NCT00413660|448581261|FG001|Post Week 12|Other|2|||
124715120|NCT00413660|448581262|FG002|Post Week 12|Other|3|||
124715121|NCT00413660|448581263|FG003|Post Week 12|Other|0|||
124715122|NCT00413660|448581264|FG004|Post Week 12|Other|1|||
124715123|NCT00413660|448581265|FG005|Post Week 12|Other|1|||
124715124|NCT00413660|448581266|FG006|Post Week 12|Other|1|||
124715125|NCT00413660|448581267|FG007|Post Week 12|Other|0|||
124715126|NCT00413660|448581268|FG008|Post Week 12|Other|0|||
124715127|NCT00413660|448581269|FG009|Post Week 12|Other|0|||
124715128|NCT00413660|448581270|FG010|Post Week 12|Other|0|||
124715129|NCT02831855|448581271|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
124715130|NCT02831855|448581272|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
124715131|NCT02831855|448581273|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
124715132|NCT02831855|448581271|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
124715133|NCT02831855|448581272|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
124715134|NCT02831855|448581273|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
124715135|NCT02831855|448581271|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
124715136|NCT02831855|448581272|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
124715137|NCT02831855|448581273|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
124715138|NCT02831855|448581271|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
124715139|NCT02831855|448581272|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
124715140|NCT02831855|448581273|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
124715141|NCT02831855|448581271|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
124715142|NCT02831855|448581272|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
124715143|NCT02831855|448581273|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
124715144|NCT02831855|448581271|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
124715145|NCT02831855|448581272|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
124715146|NCT02831855|448581273|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
124715147|NCT02831855|448581271|FG000|Open Label Phase (24 Weeks)|Other|4|||
124715148|NCT02831855|448581272|FG001|Open Label Phase (24 Weeks)|Other|0|||
124715149|NCT02831855|448581273|FG002|Open Label Phase (24 Weeks)|Other|0|||
124715150|NCT02831855|448581271|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
124715151|NCT02831855|448581272|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
124715152|NCT02831855|448581273|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
124715153|NCT02831855|448581271|FG000|Double Blind Phase (24 Weeks)|Death|0|||
124715154|NCT02831855|448581272|FG001|Double Blind Phase (24 Weeks)|Death|0|||
124715155|NCT02831855|448581273|FG002|Double Blind Phase (24 Weeks)|Death|2|||
124715156|NCT02831855|448581271|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
124715157|NCT02831855|448581272|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
124715158|NCT02831855|448581273|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
124715159|NCT02831855|448581271|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
124715160|NCT02831855|448581272|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
124715161|NCT02831855|448581273|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
124715162|NCT02831855|448581271|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
124715163|NCT02831855|448581272|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
124715164|NCT02831855|448581273|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
124553933|NCT02556632|447985505|FG000|Overall Study|Ineligible|0|||
124715165|NCT02831855|448581271|FG000|Double Blind Phase (24 Weeks)|Other|0|||
124715166|NCT02831855|448581272|FG001|Double Blind Phase (24 Weeks)|Other|2|||
124715167|NCT02831855|448581273|FG002|Double Blind Phase (24 Weeks)|Other|5|||
124715168|NCT02831855|448581271|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
124715169|NCT02831855|448581272|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
124770677|NCT03819114|448789921|FG000|Overall Study|Protocol Violation|0|||
124553934|NCT02556632|447985506|FG001|Overall Study|Ineligible|1|||
124770678|NCT03819114|448789922|FG001|Overall Study|Protocol Violation|1|||
124770679|NCT03819114|448789923|FG002|Overall Study|Protocol Violation|1|||
124770680|NCT03819114|448789924|FG003|Overall Study|Protocol Violation|0|||
124770681|NCT03819114|448789921|FG000|Overall Study|Lost to Follow-up|0|||
124770682|NCT03819114|448789922|FG001|Overall Study|Lost to Follow-up|0|||
124770683|NCT03819114|448789923|FG002|Overall Study|Lost to Follow-up|1|||
124770684|NCT03819114|448789924|FG003|Overall Study|Lost to Follow-up|0|||
124770685|NCT02379728|448789925|FG000|Overall Study|Lost to Follow-up|1|||
124770686|NCT02379728|448789926|FG001|Overall Study|Lost to Follow-up|0|||
124770687|NCT02379728|448789927|FG002|Overall Study|Lost to Follow-up|3|||
124770688|NCT02379728|448789928|FG003|Overall Study|Lost to Follow-up|0|||
124770689|NCT02379728|448789925|FG000|Overall Study|Withdrawal by Subject|5|||
124770690|NCT02379728|448789926|FG001|Overall Study|Withdrawal by Subject|0|||
124770691|NCT02379728|448789927|FG002|Overall Study|Withdrawal by Subject|5|||
124770692|NCT02379728|448789928|FG003|Overall Study|Withdrawal by Subject|3|||
124770693|NCT02379728|448789925|FG000|Overall Study|Protocol Violation|0|||
124770694|NCT02379728|448789926|FG001|Overall Study|Protocol Violation|0|||
124770695|NCT02379728|448789927|FG002|Overall Study|Protocol Violation|2|||
124770696|NCT02379728|448789928|FG003|Overall Study|Protocol Violation|0|||
124770697|NCT05101122|448789932|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
124770698|NCT05101122|448789932|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
124770699|NCT05101122|448789932|FG000|AD313 80/5|Withdrawal by Subject|1|||
124770700|NCT05101122|448789932|FG000|AD313 80/10|Physician Decision|1|||
124770701|NCT03131219|448789933|FG000|Initial Evaluation Period|Adverse Event|2|||
124770702|NCT03131219|448789934|FG001|Initial Evaluation Period|Adverse Event|0|||
124770703|NCT03131219|448789933|FG000|Initial Evaluation Period|Protocol Violation|1|||
124770704|NCT03131219|448789934|FG001|Initial Evaluation Period|Protocol Violation|0|||
124770705|NCT03131219|448789933|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
124770706|NCT03131219|448789934|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
124770707|NCT03131219|448789933|FG000|Initial Evaluation Period|Physician Decision|1|||
124770708|NCT03131219|448789934|FG001|Initial Evaluation Period|Physician Decision|0|||
124770709|NCT03131219|448789933|FG000|Extension Period|Physician Decision|1|||
124770710|NCT03131219|448789934|FG001|Extension Period|Physician Decision|0|||
124770711|NCT04945733|448789937|FG000|Overall Study|Physician Decision|1|||
124770712|NCT04945733|448789938|FG001|Overall Study|Physician Decision|3|||
124770713|NCT04945733|448789939|FG002|Overall Study|Physician Decision|0|||
124770714|NCT04945733|448789937|FG000|Overall Study|Withdrawal by Subject|3|||
124770715|NCT04945733|448789938|FG001|Overall Study|Withdrawal by Subject|3|||
124770716|NCT04945733|448789939|FG002|Overall Study|Withdrawal by Subject|0|||
124770717|NCT01709721|448789942|FG000|Open Label Phase|Withdrawal by Subject|0|||
124770718|NCT01709721|448789943|FG001|Open Label Phase|Withdrawal by Subject|0|||
124770719|NCT01709721|448789944|FG002|Open Label Phase|Withdrawal by Subject|5|||
124770720|NCT01709721|448789942|FG000|Open Label Phase|Adverse Event|0|||
124770721|NCT01709721|448789943|FG001|Open Label Phase|Adverse Event|0|||
124770722|NCT01709721|448789944|FG002|Open Label Phase|Adverse Event|8|||
124770723|NCT01709721|448789942|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
124770724|NCT01709721|448789943|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
124770725|NCT01709721|448789944|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
124770726|NCT01709721|448789942|FG000|Open Label Phase|Investigator Decision|0|||
124770727|NCT01709721|448789943|FG001|Open Label Phase|Investigator Decision|0|||
124471321|NCT00667576|447683854|FG002|Overall Study|Lost to Follow-up|1|||
124471322|NCT00667576|447683855|FG003|Overall Study|Lost to Follow-up|0|||
124471323|NCT00667576|447683856|FG004|Overall Study|Lost to Follow-up|0|||
124770728|NCT01709721|448789944|FG002|Open Label Phase|Investigator Decision|1|||
124770729|NCT01709721|448789942|FG000|Open Label Phase|Sponsor Decision|0|||
124770730|NCT01709721|448789943|FG001|Open Label Phase|Sponsor Decision|0|||
124770731|NCT01709721|448789944|FG002|Open Label Phase|Sponsor Decision|2|||
124770732|NCT01709721|448789942|FG000|Open Label Phase|Protocol Violation|0|||
124471324|NCT00667576|447683852|FG000|Overall Study|Protocol Violation|0|||
124770733|NCT01709721|448789943|FG001|Open Label Phase|Protocol Violation|0|||
124770734|NCT01709721|448789944|FG002|Open Label Phase|Protocol Violation|1|||
124770735|NCT01709721|448789942|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
124770736|NCT01709721|448789943|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
124770737|NCT01709721|448789944|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
124770738|NCT01709721|448789942|FG000|Open Label Phase|Inadequate Pain Control|0|||
124770739|NCT01709721|448789943|FG001|Open Label Phase|Inadequate Pain Control|0|||
124770740|NCT01709721|448789944|FG002|Open Label Phase|Inadequate Pain Control|37|||
124770741|NCT01709721|448789942|FG000|Open Label Phase|Other, Specify in text field in database|0|||
124770742|NCT01709721|448789943|FG001|Open Label Phase|Other, Specify in text field in database|0|||
124715170|NCT02831855|448581273|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
124715171|NCT02831855|448581271|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
124715172|NCT02831855|448581272|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
124715173|NCT02831855|448581273|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
124715174|NCT02831855|448581271|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
124715175|NCT02831855|448581272|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
124715176|NCT02831855|448581273|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
124715177|NCT01722994|448581274|FG000|Overall Study|Missing data|25|||
124715178|NCT01722994|448581275|FG001|Overall Study|Missing data|17|||
124715179|NCT01803880|448581279|FG000|Overall Study|Adverse Event|1|||
124715180|NCT01803880|448581280|FG001|Overall Study|Adverse Event|0|||
124715181|NCT01803880|448581281|FG002|Overall Study|Adverse Event|0|||
124715182|NCT01803880|448581279|FG000|Overall Study|Withdrawal by Subject|1|||
124715183|NCT01803880|448581280|FG001|Overall Study|Withdrawal by Subject|1|||
124715184|NCT01803880|448581281|FG002|Overall Study|Withdrawal by Subject|4|||
124715185|NCT01803880|448581279|FG000|Overall Study|Physician Decision|0|||
124715186|NCT01803880|448581280|FG001|Overall Study|Physician Decision|0|||
124715187|NCT01803880|448581281|FG002|Overall Study|Physician Decision|1|||
124715188|NCT01803880|448581279|FG000|Overall Study|Unable to return for follow-up visits|0|||
124715189|NCT01803880|448581280|FG001|Overall Study|Unable to return for follow-up visits|1|||
124715190|NCT01803880|448581281|FG002|Overall Study|Unable to return for follow-up visits|2|||
124715191|NCT01803880|448581279|FG000|Overall Study|Lost to Follow-up|1|||
124715192|NCT01803880|448581280|FG001|Overall Study|Lost to Follow-up|2|||
124715193|NCT01803880|448581281|FG002|Overall Study|Lost to Follow-up|3|||
124715194|NCT01803880|448581279|FG000|Overall Study|Protocol Violation|1|||
124715195|NCT01803880|448581280|FG001|Overall Study|Protocol Violation|0|||
124715196|NCT01803880|448581281|FG002|Overall Study|Protocol Violation|0|||
124715197|NCT01803880|448581279|FG000|Overall Study|Early study termination|0|||
124715198|NCT01803880|448581280|FG001|Overall Study|Early study termination|6|||
124715199|NCT01803880|448581281|FG002|Overall Study|Early study termination|5|||
124715200|NCT01803880|448581279|FG000|Overall Study|Incomplete data entry by sites|2|||
124715201|NCT01803880|448581280|FG001|Overall Study|Incomplete data entry by sites|0|||
124715202|NCT01803880|448581281|FG002|Overall Study|Incomplete data entry by sites|0|||
124715203|NCT02954887|448581282|FG000|Overall Study|Withdrawal by Subject|3|||
124715204|NCT02954887|448581282|FG000|Overall Study|Lack of Efficacy|3|||
124715205|NCT02954887|448581282|FG000|Overall Study|Other|1|||
124715206|NCT01459666|448581284|FG000|Overall Study|PI left institution|5|||
124715207|NCT01459666|448581285|FG001|Overall Study|PI left institution|4|||
124715208|NCT01152788|448581287|FG000|Overall Study|Withdrawal by Subject|0|||
124715209|NCT01152788|448581288|FG001|Overall Study|Withdrawal by Subject|3|||
124715210|NCT01152788|448581287|FG000|Overall Study|No treatment|0|||
124715211|NCT01152788|448581288|FG001|Overall Study|No treatment|1|||
124715212|NCT00889707|448581291|FG000|Overall Study|Adverse Event|1|||
124471325|NCT00667576|447683853|FG001|Overall Study|Protocol Violation|0|||
124471326|NCT00667576|447683854|FG002|Overall Study|Protocol Violation|0|||
124471327|NCT00667576|447683855|FG003|Overall Study|Protocol Violation|1|||
124471328|NCT00667576|447683856|FG004|Overall Study|Protocol Violation|0|||
124471329|NCT00667576|447683852|FG000|Overall Study|Physician Decision|0|||
124471330|NCT00667576|447683853|FG001|Overall Study|Physician Decision|0|||
124471331|NCT00667576|447683854|FG002|Overall Study|Physician Decision|0|||
124715213|NCT00889707|448581292|FG001|Overall Study|Adverse Event|0|||
124715214|NCT00889707|448581291|FG000|Overall Study|Withdrawal by Subject|4|||
124715215|NCT00889707|448581292|FG001|Overall Study|Withdrawal by Subject|3|||
124715216|NCT00889707|448581291|FG000|Overall Study|Lost to Follow-up|0|||
124471332|NCT00667576|447683855|FG003|Overall Study|Physician Decision|1|||
124715217|NCT00889707|448581292|FG001|Overall Study|Lost to Follow-up|2|||
124715218|NCT00889707|448581291|FG000|Overall Study|Lack of Efficacy|2|||
124471333|NCT00667576|447683856|FG004|Overall Study|Physician Decision|0|||
124471334|NCT00667576|447683852|FG000|Overall Study|Missed Visit|0|||
124715219|NCT00889707|448581292|FG001|Overall Study|Lack of Efficacy|5|||
124715220|NCT02268383|448581297|FG000|Overall Study|Death|12|||
124471335|NCT00667576|447683853|FG001|Overall Study|Missed Visit|0|||
124471336|NCT00667576|447683854|FG002|Overall Study|Missed Visit|0|||
124471337|NCT00667576|447683855|FG003|Overall Study|Missed Visit|1|||
124471338|NCT00667576|447683856|FG004|Overall Study|Missed Visit|0|||
124471339|NCT03968419|447683857|FG000|Treatment Period|Adverse Event|0|||
124471340|NCT03968419|447683858|FG001|Treatment Period|Adverse Event|0|||
124471341|NCT03968419|447683859|FG002|Treatment Period|Adverse Event|1|||
124471342|NCT03968419|447683857|FG000|Safety Follow-up Period|Death|3|||
124471343|NCT03968419|447683858|FG001|Safety Follow-up Period|Death|2|||
124471344|NCT03968419|447683859|FG002|Safety Follow-up Period|Death|1|||
124471345|NCT03968419|447683857|FG000|Safety Follow-up Period|Subject Decision|2|||
124471346|NCT03968419|447683858|FG001|Safety Follow-up Period|Subject Decision|1|||
124471347|NCT03968419|447683859|FG002|Safety Follow-up Period|Subject Decision|0|||
124471348|NCT01390389|447683860|FG000|Overall Study|Withdrawal by Subject|2|||
124471349|NCT01390389|447683861|FG001|Overall Study|Withdrawal by Subject|0|||
124471350|NCT01390389|447683860|FG000|Overall Study|Screen Fail|2|||
124471351|NCT01390389|447683861|FG001|Overall Study|Screen Fail|1|||
124471352|NCT00772629|447683862|FG000|Overall Study|Subject was not vaccinated|1|||
124471353|NCT00772629|447683863|FG001|Overall Study|Subject was not vaccinated|0|||
124471354|NCT02894840|447683864|FG000|Overall Study|Lost to Follow-up|1|||
124471355|NCT02894840|447683865|FG001|Overall Study|Lost to Follow-up|0|||
124471356|NCT02894840|447683866|FG002|Overall Study|Lost to Follow-up|3|||
124471357|NCT02894840|447683867|FG003|Overall Study|Lost to Follow-up|0|||
124471358|NCT05162066|447683869|FG000|Overall Study|Adverse Event|1|||
124471359|NCT05162066|447683870|FG001|Overall Study|Adverse Event|0|||
124471360|NCT05162066|447683871|FG002|Overall Study|Adverse Event|0|||
124471361|NCT05162066|447683869|FG000|Overall Study|Perceived lack of efficacy|1|||
124471362|NCT05162066|447683870|FG001|Overall Study|Perceived lack of efficacy|0|||
124471363|NCT05162066|447683871|FG002|Overall Study|Perceived lack of efficacy|0|||
124471364|NCT01072344|447683872|FG000|Overall Study|Relasped-reached end point|7|||
124471365|NCT01072344|447683873|FG001|Overall Study|Relasped-reached end point|12|||
124471366|NCT01072344|447683872|FG000|Overall Study|Protocol Violation|1|||
124471367|NCT01072344|447683873|FG001|Overall Study|Protocol Violation|2|||
124471368|NCT01072344|447683872|FG000|Overall Study|Lost to Follow-up|3|||
124471369|NCT01072344|447683873|FG001|Overall Study|Lost to Follow-up|4|||
124471370|NCT05499520|447683877|FG000|Overall Study|Lost to Follow-up|0|||
124471371|NCT05499520|447683878|FG001|Overall Study|Lost to Follow-up|0|||
124471372|NCT05499520|447683879|FG002|Overall Study|Lost to Follow-up|38|||
124471373|NCT05499520|447683880|FG003|Overall Study|Lost to Follow-up|41|||
124471374|NCT05499520|447683881|FG004|Overall Study|Lost to Follow-up|46|||
124715221|NCT02268383|448581297|FG000|Overall Study|Lost to Follow-up|2|||
124471375|NCT05499520|447683882|FG005|Overall Study|Lost to Follow-up|0|||
124471376|NCT05499520|447683883|FG006|Overall Study|Lost to Follow-up|31|||
124471377|NCT05499520|447683884|FG007|Overall Study|Lost to Follow-up|45|||
124471378|NCT05499520|447683885|FG008|Overall Study|Lost to Follow-up|42|||
124553935|NCT02556632|447985507|FG002|Overall Study|Ineligible|0|||
124471379|NCT05499520|447683886|FG009|Overall Study|Lost to Follow-up|0|||
124471380|NCT05499520|447683887|FG010|Overall Study|Lost to Follow-up|0|||
124471381|NCT05499520|447683888|FG011|Overall Study|Lost to Follow-up|37|||
124471382|NCT05499520|447683889|FG012|Overall Study|Lost to Follow-up|53|||
124471383|NCT05499520|447683890|FG013|Overall Study|Lost to Follow-up|49|||
124471384|NCT05499520|447683891|FG014|Overall Study|Lost to Follow-up|0|||
124471385|NCT05499520|447683892|FG015|Overall Study|Lost to Follow-up|36|||
124471386|NCT05499520|447683893|FG016|Overall Study|Lost to Follow-up|58|||
124471387|NCT05499520|447683894|FG017|Overall Study|Lost to Follow-up|53|||
124471388|NCT01613326|447683897|FG000|Overall Study|Adverse Event|7|||
124471389|NCT01613326|447683898|FG001|Overall Study|Adverse Event|5|||
124715222|NCT02268383|448581297|FG000|Overall Study|Withdrawal by Subject|9|||
124715223|NCT02268383|448581297|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
124715224|NCT02268383|448581297|FG000|Overall Study|Protocol deviation|3|||
124715225|NCT02268383|448581297|FG000|Overall Study|Sponsor decision|22|||
124715226|NCT02268383|448581297|FG000|Overall Study|Not reported|12|||
124715227|NCT02708680|448581298|FG000|Overall Study|Withdrawal by Subject|4|||
124715228|NCT02708680|448581299|FG001|Overall Study|Withdrawal by Subject|12|||
124471390|NCT01613326|447683897|FG000|Overall Study|Withdrawal by Subject|3|||
124471391|NCT01613326|447683898|FG001|Overall Study|Withdrawal by Subject|4|||
124471392|NCT01613326|447683897|FG000|Overall Study|Abnormal test procedure result(s)|2|||
124471393|NCT01613326|447683898|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124715229|NCT02708680|448581300|FG002|Overall Study|Withdrawal by Subject|12|||
124715230|NCT02708680|448581298|FG000|Overall Study|Death|4|||
124715231|NCT02708680|448581299|FG001|Overall Study|Death|19|||
124715232|NCT02708680|448581300|FG002|Overall Study|Death|21|||
124715233|NCT02708680|448581298|FG000|Overall Study|Lost to Follow-up|0|||
124715234|NCT02708680|448581299|FG001|Overall Study|Lost to Follow-up|3|||
124715235|NCT02708680|448581300|FG002|Overall Study|Lost to Follow-up|3|||
124715236|NCT02708680|448581298|FG000|Overall Study|Study Terminated By Sponsor|0|||
124715237|NCT02708680|448581299|FG001|Overall Study|Study Terminated By Sponsor|5|||
124715238|NCT02708680|448581300|FG002|Overall Study|Study Terminated By Sponsor|4|||
124715239|NCT02708680|448581298|FG000|Overall Study|Other than Specified|0|||
124715240|NCT02708680|448581299|FG001|Overall Study|Other than Specified|0|||
124715241|NCT02708680|448581300|FG002|Overall Study|Other than Specified|1|||
124715242|NCT02708680|448581298|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
124715243|NCT02708680|448581299|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
124715244|NCT02708680|448581300|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
124715245|NCT04162470|448581301|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
124715246|NCT05588440|448581304|FG000|Overall Study|Sponsor Decision|2|||
124715247|NCT05588440|448581305|FG001|Overall Study|Sponsor Decision|0|||
124715248|NCT05588440|448581306|FG002|Overall Study|Sponsor Decision|1|||
124715249|NCT05588440|448581304|FG000|Overall Study|Death|1|||
124715250|NCT05588440|448581305|FG001|Overall Study|Death|1|||
124715251|NCT05588440|448581306|FG002|Overall Study|Death|1|||
124715252|NCT05588440|448581304|FG000|Overall Study|Screen Fail|0|||
124715253|NCT05588440|448581305|FG001|Overall Study|Screen Fail|1|||
124715254|NCT05588440|448581306|FG002|Overall Study|Screen Fail|1|||
124715255|NCT05588440|448581304|FG000|Overall Study|Withdrawal by Subject|0|||
124715256|NCT05588440|448581305|FG001|Overall Study|Withdrawal by Subject|0|||
124715257|NCT05588440|448581306|FG002|Overall Study|Withdrawal by Subject|1|||
124715258|NCT01544348|448581311|FG000|Overall Study|Lost to Follow-up|1|||
124715259|NCT01544348|448581312|FG001|Overall Study|Lost to Follow-up|0|||
124715260|NCT01544348|448581313|FG002|Overall Study|Lost to Follow-up|0|||
124471394|NCT01613326|447683897|FG000|Overall Study|inability to use device|1|||
124471395|NCT01613326|447683898|FG001|Overall Study|inability to use device|0|||
124471396|NCT01613326|447683897|FG000|Overall Study|Lack of Efficacy|0|||
124471397|NCT01613326|447683898|FG001|Overall Study|Lack of Efficacy|1|||
124471398|NCT01613326|447683897|FG000|Overall Study|Lost to Follow-up|0|||
124471399|NCT01613326|447683898|FG001|Overall Study|Lost to Follow-up|1|||
124715261|NCT01544348|448581314|FG003|Overall Study|Lost to Follow-up|0|||
124715262|NCT01544348|448581315|FG004|Overall Study|Lost to Follow-up|0|||
124715263|NCT01544348|448581316|FG005|Overall Study|Lost to Follow-up|0|||
124471400|NCT01613326|447683897|FG000|Overall Study|Administrative|0|||
124715264|NCT01544348|448581317|FG006|Overall Study|Lost to Follow-up|1|||
124471401|NCT01613326|447683898|FG001|Overall Study|Administrative|2|||
124471402|NCT01613326|447683897|FG000|Overall Study|Protocol Violation|0|||
124471403|NCT01613326|447683898|FG001|Overall Study|Protocol Violation|1|||
124770743|NCT01709721|448789944|FG002|Open Label Phase|Other, Specify in text field in database|14|||
124770744|NCT01709721|448789942|FG000|Randomized Phase|Adverse Event|0|||
124770745|NCT01709721|448789943|FG001|Randomized Phase|Adverse Event|1|||
124770746|NCT01709721|448789944|FG002|Randomized Phase|Adverse Event|0|||
124770747|NCT01709721|448789942|FG000|Randomized Phase|Lost to Follow-up|1|||
124770748|NCT01709721|448789943|FG001|Randomized Phase|Lost to Follow-up|0|||
124770749|NCT01709721|448789944|FG002|Randomized Phase|Lost to Follow-up|0|||
124770750|NCT01709721|448789942|FG000|Randomized Phase|Inadequate Pain Control|1|||
124770751|NCT01709721|448789943|FG001|Randomized Phase|Inadequate Pain Control|2|||
124770752|NCT01709721|448789944|FG002|Randomized Phase|Inadequate Pain Control|0|||
124770753|NCT01709721|448789942|FG000|Randomized Phase|Other, Specify text field in database|1|||
124770754|NCT01709721|448789943|FG001|Randomized Phase|Other, Specify text field in database|3|||
124770755|NCT01709721|448789944|FG002|Randomized Phase|Other, Specify text field in database|0|||
124770756|NCT00763035|448789945|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
124770757|NCT00763035|448789946|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
124770758|NCT00763035|448789945|FG000|First Intervention|Adverse Event|0|||
124770759|NCT00763035|448789946|FG001|First Intervention|Adverse Event|1|||
124770760|NCT00763035|448789945|FG000|Second Intervention|Adverse Event|1|||
124770761|NCT00763035|448789946|FG001|Second Intervention|Adverse Event|0|||
124770762|NCT00763035|448789945|FG000|Second Intervention|Physician Decision|2|||
124770763|NCT00763035|448789946|FG001|Second Intervention|Physician Decision|0|||
124770764|NCT02131259|448789947|FG000|Overall Study|Progressive disease|751|||
124770765|NCT02131259|448789947|FG000|Overall Study|Adverse Event|341|||
124770766|NCT02131259|448789947|FG000|Overall Study|Lost to Follow-up|7|||
124770767|NCT02131259|448789947|FG000|Overall Study|Relocation|32|||
124770768|NCT02131259|448789947|FG000|Overall Study|Other|63|||
124770769|NCT02131259|448789947|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
124770770|NCT02131259|448789947|FG000|Overall Study|Progressive disease/relocation|1|||
124770771|NCT02131259|448789947|FG000|Overall Study|Progressive disease/other|2|||
124770772|NCT02131259|448789947|FG000|Overall Study|AE/lost to follow-up|1|||
124770773|NCT02131259|448789947|FG000|Overall Study|AE/other|1|||
124770774|NCT02131259|448789947|FG000|Overall Study|Progressive disease/AE/other|1|||
124770775|NCT02131259|448789947|FG000|Overall Study|Missing|3|||
124770776|NCT03219723|448789948|FG000|Overall Study|Case Report Forms Uncollected|6|||
124770777|NCT03219723|448789948|FG000|Overall Study|Protocol Deviation|4|||
124770778|NCT03137381|448789949|FG000|Overall Study|Adverse Event|3|||
124770779|NCT03137381|448789950|FG001|Overall Study|Adverse Event|0|||
124770780|NCT03137381|448789951|FG002|Overall Study|Adverse Event|2|||
124770781|NCT03137381|448789952|FG003|Overall Study|Adverse Event|0|||
124770782|NCT03137381|448789949|FG000|Overall Study|Lost to Follow-up|2|||
124770783|NCT03137381|448789950|FG001|Overall Study|Lost to Follow-up|1|||
124770784|NCT03137381|448789951|FG002|Overall Study|Lost to Follow-up|1|||
124770785|NCT03137381|448789952|FG003|Overall Study|Lost to Follow-up|0|||
124770786|NCT03137381|448789949|FG000|Overall Study|Protocol deviation|1|||
124770787|NCT03137381|448789950|FG001|Overall Study|Protocol deviation|1|||
124770788|NCT03137381|448789951|FG002|Overall Study|Protocol deviation|0|||
124770789|NCT03137381|448789952|FG003|Overall Study|Protocol deviation|1|||
124770790|NCT03137381|448789949|FG000|Overall Study|Withdrawal by Investigator|0|||
124770791|NCT03137381|448789950|FG001|Overall Study|Withdrawal by Investigator|1|||
124770792|NCT03137381|448789951|FG002|Overall Study|Withdrawal by Investigator|1|||
124770793|NCT03137381|448789952|FG003|Overall Study|Withdrawal by Investigator|0|||
124770794|NCT03137381|448789949|FG000|Overall Study|Withdrawal by Subject|3|||
124770795|NCT03137381|448789950|FG001|Overall Study|Withdrawal by Subject|4|||
124770796|NCT03137381|448789951|FG002|Overall Study|Withdrawal by Subject|3|||
124770797|NCT03137381|448789952|FG003|Overall Study|Withdrawal by Subject|0|||
124770798|NCT03137381|448789949|FG000|Overall Study|Pregnancy|0|||
124770799|NCT03137381|448789950|FG001|Overall Study|Pregnancy|0|||
124770800|NCT03137381|448789951|FG002|Overall Study|Pregnancy|1|||
124770801|NCT03137381|448789952|FG003|Overall Study|Pregnancy|0|||
124770802|NCT00459316|448789957|FG000|Steps 1 & 2|Other eligibility failure|1|||
124770803|NCT00459316|448789958|FG001|Steps 1 & 2|Other eligibility failure|1|||
124770804|NCT00459316|448789959|FG002|Steps 1 & 2|Other eligibility failure|0|||
124770805|NCT00459316|448789957|FG000|Steps 1 & 2|Death|1|||
124770806|NCT00459316|448789958|FG001|Steps 1 & 2|Death|1|||
124770807|NCT00459316|448789959|FG002|Steps 1 & 2|Death|0|||
124715265|NCT01544348|448581318|FG007|Overall Study|Lost to Follow-up|0|||
124715266|NCT01544348|448581311|FG000|Overall Study|Withdrawal by Subject|1|||
124715267|NCT01544348|448581312|FG001|Overall Study|Withdrawal by Subject|0|||
124715268|NCT01544348|448581313|FG002|Overall Study|Withdrawal by Subject|0|||
124715269|NCT01544348|448581314|FG003|Overall Study|Withdrawal by Subject|0|||
124715270|NCT01544348|448581315|FG004|Overall Study|Withdrawal by Subject|1|||
124715271|NCT01544348|448581316|FG005|Overall Study|Withdrawal by Subject|2|||
124715272|NCT01544348|448581317|FG006|Overall Study|Withdrawal by Subject|1|||
124715273|NCT01544348|448581318|FG007|Overall Study|Withdrawal by Subject|0|||
124715274|NCT01544348|448581311|FG000|Overall Study|Physician Decision|0|||
124715275|NCT01544348|448581312|FG001|Overall Study|Physician Decision|0|||
124715276|NCT01544348|448581313|FG002|Overall Study|Physician Decision|0|||
124715277|NCT01544348|448581314|FG003|Overall Study|Physician Decision|0|||
124715278|NCT01544348|448581315|FG004|Overall Study|Physician Decision|0|||
124715279|NCT01544348|448581316|FG005|Overall Study|Physician Decision|1|||
124715280|NCT01544348|448581317|FG006|Overall Study|Physician Decision|0|||
124715281|NCT01544348|448581318|FG007|Overall Study|Physician Decision|0|||
124715282|NCT01445847|448581319|FG000|Overall Study|Protocol Violation|13|||
124715283|NCT01445847|448581320|FG001|Overall Study|Protocol Violation|14|||
124715284|NCT01445847|448581319|FG000|Overall Study|Missed Data|1|||
124715285|NCT01445847|448581320|FG001|Overall Study|Missed Data|0|||
124715286|NCT04790279|448583382|FG000|Overall Study|Did not meet medication start criteria|27|||
124715287|NCT04790279|448583383|FG001|Overall Study|Did not meet medication start criteria|15|||
124715288|NCT04790279|448583382|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
124715289|NCT04790279|448583383|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
124715290|NCT04790279|448583382|FG000|Overall Study|Protocol Violation|8|||
124715291|NCT04790279|448583383|FG001|Overall Study|Protocol Violation|3|||
124715292|NCT04790279|448583382|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
124715293|NCT04790279|448583383|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
124715294|NCT00810277|448583396|FG000|Overall Study|Adverse Event|1|||
124715295|NCT02549989|448583403|FG000|Overall Study|Adverse Event|4|||
124715296|NCT02549989|448583403|FG000|Overall Study|Death|1|||
124715297|NCT02549989|448583403|FG000|Overall Study|Lack of Efficacy|19|||
124715298|NCT02549989|448583403|FG000|Overall Study|Withdrawal by Subject|3|||
124715299|NCT00972023|448583404|FG000|Overall Study|Withdrawal by Subject|1|||
124715300|NCT02628444|448583405|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
124715301|NCT02628444|448583406|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
124715302|NCT02628444|448583407|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
124715303|NCT02628444|448583408|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
124715304|NCT02628444|448583409|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
124715305|NCT02628444|448583410|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
124715306|NCT02628444|448583411|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
124715307|NCT02628444|448583412|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
124471404|NCT03980938|447683899|FG000|Treatment Period 1|Study Terminated|1|||
124471405|NCT03980938|447683900|FG001|Treatment Period 1|Study Terminated|1|||
124471406|NCT03980938|447683899|FG000|Treatment Period 2|Study Terminated|2|||
124471407|NCT03980938|447683900|FG001|Treatment Period 2|Study Terminated|2|||
124471408|NCT00840827|447683901|FG000|Overall Study|Adverse Event|1|||
124471409|NCT00840827|447683901|FG000|Overall Study|Lack of Efficacy|4|||
124471410|NCT00840827|447683901|FG000|Overall Study|Physician Decision|1|||
124471411|NCT01445535|447683902|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
124471412|NCT01445535|447683903|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
124471413|NCT01445535|447683904|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
124471414|NCT01445535|447683905|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
124553936|NCT02556632|447985505|FG000|Overall Study|Disliked Study Procedures|0|||
124553937|NCT02556632|447985506|FG001|Overall Study|Disliked Study Procedures|0|||
124715308|NCT02628444|448583413|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
124715309|NCT02628444|448583405|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
124715310|NCT02628444|448583406|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
124715311|NCT02628444|448583407|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
124715312|NCT02628444|448583408|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
124715313|NCT02628444|448583409|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
124715314|NCT02628444|448583410|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
124471415|NCT01445535|447683902|FG000|Overall Study|Disease progression|1|||
124471416|NCT01445535|447683903|FG001|Overall Study|Disease progression|0|||
124553938|NCT02556632|447985507|FG002|Overall Study|Disliked Study Procedures|1|||
124715315|NCT02628444|448583411|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
124715316|NCT02628444|448583412|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
124715317|NCT02628444|448583413|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
124471417|NCT01445535|447683904|FG002|Overall Study|Disease progression|1|||
124471418|NCT01445535|447683905|FG003|Overall Study|Disease progression|0|||
124471419|NCT01445535|447683902|FG000|Overall Study|PI discretion|0|||
124553939|NCT02556632|447985505|FG000|Overall Study|Treatment or Change Delay|0|||
124553940|NCT02556632|447985506|FG001|Overall Study|Treatment or Change Delay|0|||
124715318|NCT02628444|448583405|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
124715319|NCT02628444|448583406|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
124715320|NCT02628444|448583407|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
124715321|NCT02628444|448583408|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
124553941|NCT02556632|447985507|FG002|Overall Study|Treatment or Change Delay|1|||
124770808|NCT00459316|448789957|FG000|Steps 1 & 2|Not able to get to clinic|7|||
124770809|NCT00459316|448789958|FG001|Steps 1 & 2|Not able to get to clinic|4|||
124770810|NCT00459316|448789959|FG002|Steps 1 & 2|Not able to get to clinic|0|||
124770811|NCT00459316|448789957|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
124770812|NCT00459316|448789958|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
124770813|NCT00459316|448789959|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
124770814|NCT00459316|448789957|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
124770815|NCT00459316|448789958|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
124770816|NCT00459316|448789959|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
124770817|NCT00459316|448789957|FG000|Steps 1 & 2|Lost to Follow-up|5|||
124770818|NCT00459316|448789958|FG001|Steps 1 & 2|Lost to Follow-up|0|||
124770819|NCT00459316|448789959|FG002|Steps 1 & 2|Lost to Follow-up|2|||
124770820|NCT00459316|448789957|FG000|Step 3|Withdrawal by Subject|3|||
124770821|NCT00459316|448789958|FG001|Step 3|Withdrawal by Subject|0|||
124770822|NCT00459316|448789959|FG002|Step 3|Withdrawal by Subject|1|||
124770823|NCT01980017|448789960|FG000|Overall Study|Lost to Follow-up|30|||
124770824|NCT01980017|448789961|FG001|Overall Study|Lost to Follow-up|21|||
124770825|NCT01980017|448789960|FG000|Overall Study|Death|0|||
124770826|NCT01980017|448789961|FG001|Overall Study|Death|1|||
124770827|NCT03044106|448789962|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
124770828|NCT03044106|448789963|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
124770829|NCT02057250|448789964|FG000|AID Assessment Phase|Adverse Event|3|||
124770830|NCT02057250|448789965|FG001|AID Assessment Phase|Adverse Event|2|||
124770831|NCT02057250|448789966|FG002|AID Assessment Phase|Adverse Event|6|||
124770832|NCT02057250|448789967|FG003|AID Assessment Phase|Adverse Event|1|||
124770833|NCT02057250|448789968|FG004|AID Assessment Phase|Adverse Event|0|||
124770834|NCT02057250|448789964|FG000|AID Assessment Phase|Other than specified above|1|||
124770835|NCT02057250|448789965|FG001|AID Assessment Phase|Other than specified above|1|||
124770836|NCT02057250|448789966|FG002|AID Assessment Phase|Other than specified above|1|||
124770837|NCT02057250|448789967|FG003|AID Assessment Phase|Other than specified above|1|||
124770838|NCT02057250|448789968|FG004|AID Assessment Phase|Other than specified above|0|||
124770839|NCT02057250|448789964|FG000|Extension Phase|Adverse Event|0|||
124770840|NCT02057250|448789965|FG001|Extension Phase|Adverse Event|0|||
124770841|NCT02057250|448789966|FG002|Extension Phase|Adverse Event|0|||
124770842|NCT02057250|448789967|FG003|Extension Phase|Adverse Event|0|||
124770843|NCT02057250|448789968|FG004|Extension Phase|Adverse Event|15|||
124770844|NCT02057250|448789964|FG000|Extension Phase|Lack of Efficacy|0|||
124770845|NCT02057250|448789965|FG001|Extension Phase|Lack of Efficacy|0|||
124770846|NCT02057250|448789966|FG002|Extension Phase|Lack of Efficacy|0|||
124770847|NCT02057250|448789967|FG003|Extension Phase|Lack of Efficacy|0|||
124770848|NCT02057250|448789968|FG004|Extension Phase|Lack of Efficacy|10|||
124770849|NCT02057250|448789964|FG000|Extension Phase|Entered in this period but not treated|0|||
124770850|NCT02057250|448789965|FG001|Extension Phase|Entered in this period but not treated|0|||
124770851|NCT02057250|448789966|FG002|Extension Phase|Entered in this period but not treated|0|||
124770852|NCT02057250|448789967|FG003|Extension Phase|Entered in this period but not treated|0|||
124770853|NCT02057250|448789968|FG004|Extension Phase|Entered in this period but not treated|4|||
124770854|NCT02057250|448789964|FG000|Extension Phase|Other than specified above|0|||
124770855|NCT02057250|448789965|FG001|Extension Phase|Other than specified above|0|||
124770856|NCT02057250|448789966|FG002|Extension Phase|Other than specified above|0|||
124770857|NCT02057250|448789967|FG003|Extension Phase|Other than specified above|0|||
124770858|NCT02057250|448789968|FG004|Extension Phase|Other than specified above|7|||
124770859|NCT00423579|448789972|FG000|Overall Study|Lost to Follow-up|3|||
124770860|NCT00423579|448789973|FG001|Overall Study|Lost to Follow-up|0|||
124770861|NCT00423579|448789972|FG000|Overall Study|Protocol Violation|1|||
124770862|NCT00423579|448789973|FG001|Overall Study|Protocol Violation|3|||
124770863|NCT00423579|448789972|FG000|Overall Study|Diagnosis of diabetes|0|||
124770864|NCT00423579|448789973|FG001|Overall Study|Diagnosis of diabetes|1|||
124770865|NCT02161016|448789976|FG000|Overall Study|withdrawn by IRB|1|||
124471420|NCT01445535|447683903|FG001|Overall Study|PI discretion|0|||
124770866|NCT00003475|448789977|FG000|Overall Study|Not evaluable|13|||
124770867|NCT03675126|448789981|FG000|Overall Study|Study Terminated by Sponsor|9|||
124770868|NCT03675126|448789981|FG000|Overall Study|Death|2|||
124471421|NCT01445535|447683904|FG002|Overall Study|PI discretion|0|||
124715322|NCT02628444|448583409|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
124715323|NCT02628444|448583410|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
124715324|NCT02628444|448583411|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
124715325|NCT02628444|448583412|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
124715326|NCT02628444|448583413|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
124715327|NCT02628444|448583405|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
124715328|NCT02628444|448583406|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
124715329|NCT02628444|448583407|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
124715330|NCT02628444|448583408|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
124715331|NCT02628444|448583409|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
124715332|NCT02628444|448583410|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
124715333|NCT02628444|448583411|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
124715334|NCT02628444|448583412|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
124715335|NCT02628444|448583413|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
124715336|NCT02628444|448583405|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
124715337|NCT02628444|448583406|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
124715338|NCT02628444|448583407|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
124715339|NCT02628444|448583408|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
124715340|NCT02628444|448583409|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
124715341|NCT02628444|448583410|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
124715342|NCT02628444|448583411|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
124715343|NCT02628444|448583412|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
124715344|NCT02628444|448583413|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
124715345|NCT02628444|448583405|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
124715346|NCT02628444|448583406|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
124715347|NCT02628444|448583407|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
124715348|NCT02628444|448583408|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
124715349|NCT02628444|448583409|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
124715350|NCT02628444|448583410|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
124715351|NCT02628444|448583411|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
124715352|NCT02628444|448583412|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
124715353|NCT02628444|448583413|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
124715354|NCT02628444|448583405|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
124715355|NCT02628444|448583406|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
124715356|NCT02628444|448583407|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
124715357|NCT02628444|448583408|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
124715358|NCT02628444|448583409|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
124715359|NCT02628444|448583410|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
124715360|NCT02628444|448583411|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
124715361|NCT02628444|448583412|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
124715362|NCT02628444|448583413|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
124715363|NCT02628444|448583405|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
124715364|NCT02628444|448583406|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
124715365|NCT02628444|448583407|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
124715366|NCT02628444|448583408|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
124715367|NCT02628444|448583409|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
124715368|NCT02628444|448583410|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
124715369|NCT02628444|448583411|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
124715370|NCT02628444|448583412|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
124715371|NCT02628444|448583413|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
124715372|NCT02628444|448583405|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
124715373|NCT02628444|448583406|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
124715374|NCT02628444|448583407|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
124715375|NCT02628444|448583408|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
124715376|NCT02628444|448583409|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
124715377|NCT02628444|448583410|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
124715378|NCT02628444|448583411|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
124715379|NCT02628444|448583412|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
124471422|NCT01445535|447683905|FG003|Overall Study|PI discretion|1|||
124715380|NCT02628444|448583413|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
124715381|NCT02628444|448583405|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
124471423|NCT03569202|447683909|FG000|Part 3|Physician Decision|1|||
124471424|NCT03569202|447683910|FG001|Part 3|Physician Decision|0|||
124471425|NCT03569202|447683909|FG000|Part 3|Other|1|||
124471426|NCT03569202|447683910|FG001|Part 3|Other|1|||
124471427|NCT00420511|447683911|FG000|Overall Study|Adverse Event|1|||
124471428|NCT00420511|447683912|FG001|Overall Study|Adverse Event|1|||
124471429|NCT00420511|447683911|FG000|Overall Study|Lost to Follow-up|1|||
124471430|NCT00420511|447683912|FG001|Overall Study|Lost to Follow-up|0|||
124471431|NCT02415712|447683913|FG000|Overall Study|Protocol Violation|16|||
124471432|NCT01668654|447683914|FG000|Overall Study|Study Closed/Terminated|3|||
124471433|NCT01668654|447683914|FG000|Overall Study|Withdrawal by Subject|1|||
124715382|NCT02628444|448583406|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
124715383|NCT02628444|448583407|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
124715384|NCT02628444|448583408|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
124715385|NCT02628444|448583409|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
124715386|NCT02628444|448583410|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
124715387|NCT02628444|448583411|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
124715388|NCT02628444|448583412|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
124715389|NCT02628444|448583413|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
124715390|NCT01713582|448583414|FG000|Overall Study|Disease progression|3|||
124715391|NCT01713582|448583415|FG001|Overall Study|Disease progression|3|||
124715392|NCT01713582|448583416|FG002|Overall Study|Disease progression|3|||
124715393|NCT01713582|448583417|FG003|Overall Study|Disease progression|2|||
124715394|NCT01713582|448583418|FG004|Overall Study|Disease progression|3|||
124715395|NCT01713582|448583419|FG005|Overall Study|Disease progression|3|||
124715396|NCT01713582|448583420|FG006|Overall Study|Disease progression|3|||
124715397|NCT01713582|448583421|FG007|Overall Study|Disease progression|3|||
124715398|NCT01713582|448583422|FG008|Overall Study|Disease progression|3|||
124715399|NCT01713582|448583423|FG009|Overall Study|Disease progression|11|||
124715400|NCT01713582|448583424|FG010|Overall Study|Disease progression|10|||
124715401|NCT01713582|448583425|FG011|Overall Study|Disease progression|5|||
124715402|NCT01713582|448583426|FG012|Overall Study|Disease progression|3|||
124715403|NCT01713582|448583427|FG013|Overall Study|Disease progression|3|||
124715404|NCT01713582|448583428|FG014|Overall Study|Disease progression|6|||
124715405|NCT01713582|448583429|FG015|Overall Study|Disease progression|6|||
124715406|NCT01713582|448583430|FG016|Overall Study|Disease progression|5|||
124715407|NCT01713582|448583431|FG017|Overall Study|Disease progression|2|||
124715408|NCT01713582|448583432|FG018|Overall Study|Disease progression|3|||
124715409|NCT01713582|448583433|FG019|Overall Study|Disease progression|5|||
124715410|NCT01713582|448583434|FG020|Overall Study|Disease progression|15|||
124715411|NCT01713582|448583414|FG000|Overall Study|Death|0|||
124715412|NCT01713582|448583415|FG001|Overall Study|Death|0|||
124715413|NCT01713582|448583416|FG002|Overall Study|Death|0|||
124715414|NCT01713582|448583417|FG003|Overall Study|Death|1|||
124715415|NCT01713582|448583418|FG004|Overall Study|Death|1|||
124715416|NCT01713582|448583419|FG005|Overall Study|Death|3|||
124715417|NCT01713582|448583420|FG006|Overall Study|Death|3|||
124715418|NCT01713582|448583421|FG007|Overall Study|Death|2|||
124715419|NCT01713582|448583422|FG008|Overall Study|Death|3|||
124715420|NCT01713582|448583423|FG009|Overall Study|Death|4|||
124715421|NCT01713582|448583424|FG010|Overall Study|Death|3|||
124471434|NCT04557384|447683915|FG000|Overall Study|Study Terminated by Sponsor|1|||
124471435|NCT04557384|447683915|FG000|Overall Study|Death|1|||
124471436|NCT00454779|447683916|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
124471437|NCT00454779|447683917|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
124471438|NCT00454779|447683916|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
124471439|NCT00454779|447683917|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
124471440|NCT00454779|447683916|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
124471441|NCT00454779|447683917|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
124471442|NCT00454779|447683916|FG000|First-line Treatment Phase|Protocol Violation|0|||
124471443|NCT00454779|447683917|FG001|First-line Treatment Phase|Protocol Violation|1|||
124715422|NCT01713582|448583425|FG011|Overall Study|Death|0|||
124715423|NCT01713582|448583426|FG012|Overall Study|Death|0|||
124715424|NCT01713582|448583427|FG013|Overall Study|Death|0|||
124715425|NCT01713582|448583428|FG014|Overall Study|Death|0|||
124715426|NCT01713582|448583429|FG015|Overall Study|Death|0|||
124715427|NCT01713582|448583430|FG016|Overall Study|Death|0|||
124715428|NCT01713582|448583431|FG017|Overall Study|Death|0|||
124715429|NCT01713582|448583432|FG018|Overall Study|Death|0|||
124715430|NCT01713582|448583433|FG019|Overall Study|Death|0|||
124715431|NCT01713582|448583434|FG020|Overall Study|Death|0|||
124715432|NCT01713582|448583414|FG000|Overall Study|Adverse event-related|0|||
124715433|NCT01713582|448583415|FG001|Overall Study|Adverse event-related|0|||
124715434|NCT01713582|448583416|FG002|Overall Study|Adverse event-related|0|||
124715435|NCT01713582|448583417|FG003|Overall Study|Adverse event-related|0|||
124715436|NCT01713582|448583418|FG004|Overall Study|Adverse event-related|0|||
124715437|NCT01713582|448583419|FG005|Overall Study|Adverse event-related|0|||
124715438|NCT01713582|448583420|FG006|Overall Study|Adverse event-related|0|||
124715439|NCT01713582|448583421|FG007|Overall Study|Adverse event-related|0|||
124715440|NCT01713582|448583422|FG008|Overall Study|Adverse event-related|0|||
124715441|NCT01713582|448583423|FG009|Overall Study|Adverse event-related|1|||
124715442|NCT01713582|448583424|FG010|Overall Study|Adverse event-related|1|||
124770869|NCT03675126|448789981|FG000|Overall Study|Withdrawal by Subject|4|||
124770870|NCT00001959|448789982|FG000|Overall Study|newly diagnosed colon cancer|1|||
124770871|NCT00001959|448789982|FG000|Overall Study|disabling sedation|1|||
124770872|NCT00001959|448789982|FG000|Overall Study|non-compliance|1|||
124770873|NCT04189952|448789987|FG000|Follow-up Period|Death|1|||
124770874|NCT04189952|448789987|FG000|Follow-up Period|Withdrawal by Subject|1|||
124770875|NCT01052493|448789988|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
124770876|NCT01052493|448789989|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
124770877|NCT01052493|448789990|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
124770878|NCT01498068|448789991|FG000|Overall Study|Withdrawal by Subject|1|||
124770879|NCT01498068|448789992|FG001|Overall Study|Withdrawal by Subject|1|||
124770880|NCT01318915|448789995|FG000|Overall Study|Lost to Follow-up|1|||
124770881|NCT00453206|448789997|FG000|Overall Study|Death|1|||
124770882|NCT05523089|448790001|FG000|Overall Study|Withdrawal by Subject|1|||
124770883|NCT05523089|448790002|FG001|Overall Study|Withdrawal by Subject|0|||
124770884|NCT05523089|448790003|FG002|Overall Study|Withdrawal by Subject|0|||
124770885|NCT05523089|448790001|FG000|Overall Study|Lost to Follow-up|1|||
124770886|NCT05523089|448790002|FG001|Overall Study|Lost to Follow-up|0|||
124770887|NCT05523089|448790003|FG002|Overall Study|Lost to Follow-up|0|||
124770888|NCT02681523|448790004|FG000|Overall Study|Adverse Event|1|||
124770889|NCT02681523|448790004|FG000|Overall Study|Patient Non-compliance|1|||
124770890|NCT01899040|448790005|FG000|Overall Study|Randomized in error|0|||
124770891|NCT01899040|448790006|FG001|Overall Study|Randomized in error|1|||
124770892|NCT01899040|448790007|FG002|Overall Study|Randomized in error|1|||
124770893|NCT01899040|448790005|FG000|Overall Study|Adverse Event|3|||
124770894|NCT01899040|448790006|FG001|Overall Study|Adverse Event|1|||
124471444|NCT00454779|447683916|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
124471445|NCT00454779|447683917|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
124471446|NCT00454779|447683916|FG000|First-line Treatment Phase|Ongoing|1|||
124471447|NCT00454779|447683917|FG001|First-line Treatment Phase|Ongoing|0|||
124471448|NCT00454779|447683916|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
124471449|NCT00454779|447683917|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
124471450|NCT00454779|447683916|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
124471451|NCT00454779|447683917|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
124471452|NCT00454779|447683916|FG000|Second-line Treatment Phase|Ongoing|0|||
124471453|NCT00454779|447683917|FG001|Second-line Treatment Phase|Ongoing|1|||
124471454|NCT02397473|447683918|FG000|Treatment Phase|Adverse Event|1|||
124770895|NCT01899040|448790007|FG002|Overall Study|Adverse Event|2|||
124770896|NCT01899040|448790005|FG000|Overall Study|Unspecified reasons|4|||
124770897|NCT01899040|448790006|FG001|Overall Study|Unspecified reasons|4|||
124770898|NCT01899040|448790007|FG002|Overall Study|Unspecified reasons|0|||
124770899|NCT01899040|448790005|FG000|Overall Study|Compliance issues|1|||
124553942|NCT02574260|447985513|FG000|Overall Study|Disease Progression|1|||
124553943|NCT04523831|447985518|FG000|Overall Study|Lost to Follow-up|15|||
124553944|NCT04523831|447985519|FG001|Overall Study|Lost to Follow-up|17|||
124553945|NCT04523831|447985518|FG000|Overall Study|Death|0|||
124770900|NCT01899040|448790006|FG001|Overall Study|Compliance issues|2|||
124553946|NCT04523831|447985519|FG001|Overall Study|Death|3|||
124553947|NCT04523831|447985518|FG000|Overall Study|Adverse Event|2|||
124553948|NCT04523831|447985519|FG001|Overall Study|Adverse Event|0|||
124715443|NCT01713582|448583425|FG011|Overall Study|Adverse event-related|0|||
124715444|NCT01713582|448583426|FG012|Overall Study|Adverse event-related|0|||
124715445|NCT01713582|448583427|FG013|Overall Study|Adverse event-related|0|||
124715446|NCT01713582|448583428|FG014|Overall Study|Adverse event-related|0|||
124715447|NCT01713582|448583429|FG015|Overall Study|Adverse event-related|0|||
124715448|NCT01713582|448583430|FG016|Overall Study|Adverse event-related|0|||
124715449|NCT01713582|448583431|FG017|Overall Study|Adverse event-related|0|||
124715450|NCT01713582|448583432|FG018|Overall Study|Adverse event-related|1|||
124715451|NCT01713582|448583433|FG019|Overall Study|Adverse event-related|0|||
124715452|NCT01713582|448583434|FG020|Overall Study|Adverse event-related|0|||
124715453|NCT01713582|448583414|FG000|Overall Study|Adverse event-unrelated|0|||
124715454|NCT01713582|448583415|FG001|Overall Study|Adverse event-unrelated|0|||
124715455|NCT01713582|448583416|FG002|Overall Study|Adverse event-unrelated|0|||
124715456|NCT01713582|448583417|FG003|Overall Study|Adverse event-unrelated|0|||
124715457|NCT01713582|448583418|FG004|Overall Study|Adverse event-unrelated|0|||
124715458|NCT01713582|448583419|FG005|Overall Study|Adverse event-unrelated|1|||
124715459|NCT01713582|448583420|FG006|Overall Study|Adverse event-unrelated|1|||
124715460|NCT01713582|448583421|FG007|Overall Study|Adverse event-unrelated|1|||
124715461|NCT01713582|448583422|FG008|Overall Study|Adverse event-unrelated|0|||
124715462|NCT01713582|448583423|FG009|Overall Study|Adverse event-unrelated|0|||
124715463|NCT01713582|448583424|FG010|Overall Study|Adverse event-unrelated|0|||
124715464|NCT01713582|448583425|FG011|Overall Study|Adverse event-unrelated|0|||
124715465|NCT01713582|448583426|FG012|Overall Study|Adverse event-unrelated|0|||
124715466|NCT01713582|448583427|FG013|Overall Study|Adverse event-unrelated|1|||
124715467|NCT01713582|448583428|FG014|Overall Study|Adverse event-unrelated|1|||
124715468|NCT01713582|448583429|FG015|Overall Study|Adverse event-unrelated|0|||
124715469|NCT01713582|448583430|FG016|Overall Study|Adverse event-unrelated|0|||
124715470|NCT01713582|448583431|FG017|Overall Study|Adverse event-unrelated|0|||
124715471|NCT01713582|448583432|FG018|Overall Study|Adverse event-unrelated|0|||
124715472|NCT01713582|448583433|FG019|Overall Study|Adverse event-unrelated|0|||
124715473|NCT01713582|448583434|FG020|Overall Study|Adverse event-unrelated|0|||
124715474|NCT01713582|448583414|FG000|Overall Study|Withdrawal of consent|0|||
124553949|NCT02367781|447985524|FG000|Overall Study|Withdrawal by Subject|20|||
124553950|NCT02367781|447985525|FG001|Overall Study|Withdrawal by Subject|13|||
124553951|NCT02367781|447985524|FG000|Overall Study|Protocol Violation|0|||
124553952|NCT02367781|447985525|FG001|Overall Study|Protocol Violation|1|||
124553953|NCT02367781|447985524|FG000|Overall Study|Physician Decision|7|||
124553954|NCT02367781|447985525|FG001|Overall Study|Physician Decision|0|||
124553955|NCT02367781|447985524|FG000|Overall Study|Randomized in Error|5|||
124553956|NCT02367781|447985525|FG001|Overall Study|Randomized in Error|4|||
124553957|NCT02367781|447985524|FG000|Overall Study|Non-Compliance|1|||
124553958|NCT02367781|447985525|FG001|Overall Study|Non-Compliance|0|||
124553959|NCT02367781|447985524|FG000|Overall Study|Lost to Follow-up|1|||
124553960|NCT02367781|447985525|FG001|Overall Study|Lost to Follow-up|2|||
124553961|NCT02367781|447985524|FG000|Overall Study|Death|330|||
124553962|NCT02367781|447985525|FG001|Overall Study|Death|176|||
124553963|NCT02367781|447985524|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
124553964|NCT02367781|447985525|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
124553965|NCT02367781|447985524|FG000|Overall Study|Prolonged Hospitalization|1|||
124553966|NCT02367781|447985525|FG001|Overall Study|Prolonged Hospitalization|0|||
124553967|NCT02367781|447985524|FG000|Overall Study|Death Prior First Dose|1|||
124553968|NCT02367781|447985525|FG001|Overall Study|Death Prior First Dose|0|||
124553969|NCT02367781|447985524|FG000|Overall Study|Administrative-Change Facility|1|||
124553970|NCT02367781|447985525|FG001|Overall Study|Administrative-Change Facility|0|||
124553971|NCT02367781|447985524|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
124553972|NCT02367781|447985525|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
124553973|NCT02367781|447985524|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
124553974|NCT02367781|447985525|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
124553975|NCT02367781|447985524|FG000|Overall Study|Study Terminated by Sponsor|3|||
124553976|NCT02367781|447985525|FG001|Overall Study|Study Terminated by Sponsor|1|||
124553977|NCT02367781|447985524|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
124553978|NCT02367781|447985525|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
124553979|NCT02367781|447985524|FG000|Overall Study|Sponsor Decision|2|||
124553980|NCT02367781|447985525|FG001|Overall Study|Sponsor Decision|0|||
124553981|NCT02367781|447985524|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
124553982|NCT02367781|447985525|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
124553983|NCT02623426|447985526|FG000|Overall Study|Lost to Follow-up|0|||
124553984|NCT02623426|447985527|FG001|Overall Study|Lost to Follow-up|0|||
124553985|NCT02623426|447985528|FG002|Overall Study|Lost to Follow-up|1|||
124553986|NCT02623426|447985526|FG000|Overall Study|Withdrawal by Subject|1|||
124553987|NCT02623426|447985527|FG001|Overall Study|Withdrawal by Subject|2|||
124553988|NCT02623426|447985528|FG002|Overall Study|Withdrawal by Subject|2|||
124553989|NCT03185949|447985531|FG000|ITT Analysis|Withdrawal by Subject|4|||
124553990|NCT03185949|447985532|FG001|ITT Analysis|Withdrawal by Subject|3|||
124553991|NCT03185949|447985531|FG000|PP Analysis|Protocol Violation|2|||
124553992|NCT03185949|447985532|FG001|PP Analysis|Protocol Violation|2|||
124553993|NCT03185949|447985531|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
124553994|NCT03185949|447985532|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
124553995|NCT03724968|447987297|FG000|Overall Study|Insurance issues|0|||
124553996|NCT03724968|447987298|FG001|Overall Study|Insurance issues|1|||
124553997|NCT03724968|447987297|FG000|Overall Study|Study closed|0|||
124553998|NCT03724968|447987298|FG001|Overall Study|Study closed|1|||
124553999|NCT01142466|447987299|FG000|Overall Study|Adverse Event|2|||
124554000|NCT01142466|447987300|FG001|Overall Study|Adverse Event|1|||
124554001|NCT01142466|447987299|FG000|Overall Study|Withdrawal by Subject|1|||
124554002|NCT01142466|447987300|FG001|Overall Study|Withdrawal by Subject|1|||
124554003|NCT00681824|447987301|FG000|Overall Study|withdrawn by investigator|0|||
124554004|NCT00681824|447987302|FG001|Overall Study|withdrawn by investigator|0|||
124554005|NCT00681824|447987303|FG002|Overall Study|withdrawn by investigator|1|||
124554006|NCT00681824|447987301|FG000|Overall Study|scheduling conflict|1|||
124554007|NCT00681824|447987302|FG001|Overall Study|scheduling conflict|0|||
124554008|NCT00681824|447987303|FG002|Overall Study|scheduling conflict|0|||
124554009|NCT00681824|447987301|FG000|Overall Study|Death|0|||
124554010|NCT00681824|447987302|FG001|Overall Study|Death|1|||
124554011|NCT00681824|447987303|FG002|Overall Study|Death|0|||
124554012|NCT03724916|447987304|FG000|Overall Study|Withdrawal by Subject|0|||
124554013|NCT03724916|447987305|FG001|Overall Study|Withdrawal by Subject|1|||
124715475|NCT01713582|448583415|FG001|Overall Study|Withdrawal of consent|0|||
124715476|NCT01713582|448583416|FG002|Overall Study|Withdrawal of consent|1|||
124554014|NCT03724916|447987306|FG002|Overall Study|Withdrawal by Subject|1|||
124554015|NCT03724916|447987307|FG003|Overall Study|Withdrawal by Subject|2|||
124554016|NCT03724916|447987304|FG000|Overall Study|Randomized but not Treated|1|||
124715477|NCT01713582|448583417|FG003|Overall Study|Withdrawal of consent|0|||
124715478|NCT01713582|448583418|FG004|Overall Study|Withdrawal of consent|0|||
124715479|NCT01713582|448583419|FG005|Overall Study|Withdrawal of consent|1|||
124715480|NCT01713582|448583420|FG006|Overall Study|Withdrawal of consent|0|||
124715481|NCT01713582|448583421|FG007|Overall Study|Withdrawal of consent|0|||
124715482|NCT01713582|448583422|FG008|Overall Study|Withdrawal of consent|0|||
124471455|NCT02397473|447683919|FG001|Treatment Phase|Adverse Event|2|||
124471456|NCT02397473|447683918|FG000|Treatment Phase|Lack of Efficacy|8|||
124471457|NCT02397473|447683919|FG001|Treatment Phase|Lack of Efficacy|1|||
124471458|NCT02397473|447683918|FG000|Treatment Phase|Lost to Follow-up|1|||
124471459|NCT02397473|447683919|FG001|Treatment Phase|Lost to Follow-up|0|||
124471460|NCT02397473|447683918|FG000|Treatment Phase|Withdrawal by Subject|2|||
124471461|NCT02397473|447683919|FG001|Treatment Phase|Withdrawal by Subject|1|||
124471462|NCT02397473|447683918|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
124471463|NCT02397473|447683919|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
124471464|NCT02397473|447683918|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
124471465|NCT02397473|447683919|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
124471466|NCT02397473|447683918|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
124471467|NCT02397473|447683919|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
124471468|NCT02397473|447683918|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
124471469|NCT02397473|447683919|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
124471470|NCT02397473|447683918|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
124471471|NCT02397473|447683919|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
124471472|NCT02624492|447683923|FG000|Overall Study|Adverse Event|2|||
124471473|NCT02624492|447683924|FG001|Overall Study|Adverse Event|2|||
124471474|NCT02624492|447683925|FG002|Overall Study|Adverse Event|2|||
124471475|NCT02624492|447683923|FG000|Overall Study|Progressive disease|0|||
124471476|NCT02624492|447683924|FG001|Overall Study|Progressive disease|2|||
124471477|NCT02624492|447683925|FG002|Overall Study|Progressive disease|3|||
124471478|NCT00364689|447683926|FG000|Overall Study|Lost to Follow-up|1|||
124471479|NCT03555266|447683928|FG000|Overall Study|Protocol Violation|6|||
124471480|NCT03555266|447683929|FG001|Overall Study|Protocol Violation|4|||
124471481|NCT00132730|447683930|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
124471482|NCT00132730|447683931|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
124715483|NCT01713582|448583423|FG009|Overall Study|Withdrawal of consent|1|||
124471483|NCT00132730|447683932|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
124715484|NCT01713582|448583424|FG010|Overall Study|Withdrawal of consent|0|||
124715485|NCT01713582|448583425|FG011|Overall Study|Withdrawal of consent|0|||
124715486|NCT01713582|448583426|FG012|Overall Study|Withdrawal of consent|0|||
124471484|NCT00132730|447683933|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
124471485|NCT00132730|447683934|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
124471486|NCT00132730|447683935|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
124471487|NCT00132730|447683930|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
124471488|NCT00132730|447683931|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
124471489|NCT00132730|447683932|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
124471490|NCT00132730|447683933|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
124471491|NCT00132730|447683934|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
124471492|NCT00132730|447683935|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
124471493|NCT00132730|447683930|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
124471494|NCT00132730|447683931|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
124471495|NCT00132730|447683932|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
124471496|NCT00132730|447683933|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
124471497|NCT00132730|447683934|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
124471498|NCT00132730|447683935|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
124471499|NCT00132730|447683930|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
124715487|NCT01713582|448583427|FG013|Overall Study|Withdrawal of consent|0|||
124471500|NCT00132730|447683931|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
124471501|NCT00132730|447683932|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
124471502|NCT00132730|447683933|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
124715488|NCT01713582|448583428|FG014|Overall Study|Withdrawal of consent|0|||
124715489|NCT01713582|448583429|FG015|Overall Study|Withdrawal of consent|0|||
124715490|NCT01713582|448583430|FG016|Overall Study|Withdrawal of consent|0|||
124471503|NCT00132730|447683934|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
124471504|NCT00132730|447683935|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
124471505|NCT00132730|447683930|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
124471506|NCT00132730|447683931|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
124471507|NCT00132730|447683932|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
124471508|NCT00132730|447683933|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
124471509|NCT00132730|447683934|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
124471510|NCT00132730|447683935|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
124471511|NCT00132730|447683930|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
124471512|NCT00132730|447683931|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
124471513|NCT00132730|447683932|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
124471514|NCT00132730|447683933|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
124471515|NCT00132730|447683934|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
124471516|NCT00132730|447683935|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
124471517|NCT00132730|447683930|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
124471518|NCT00132730|447683931|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
124471519|NCT00132730|447683932|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
124471520|NCT00132730|447683933|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
124471521|NCT00132730|447683934|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
124471522|NCT00132730|447683935|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
124471523|NCT00132730|447683930|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
124554017|NCT03724916|447987305|FG001|Overall Study|Randomized but not Treated|0|||
124554018|NCT03724916|447987306|FG002|Overall Study|Randomized but not Treated|0|||
124554019|NCT03724916|447987307|FG003|Overall Study|Randomized but not Treated|0|||
124715491|NCT01713582|448583431|FG017|Overall Study|Withdrawal of consent|0|||
124471524|NCT00132730|447683931|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
124471525|NCT00132730|447683932|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
124471526|NCT00132730|447683933|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
124471527|NCT00132730|447683934|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
124471528|NCT00132730|447683935|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
124471529|NCT00132730|447683930|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
124471530|NCT00132730|447683931|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
124471531|NCT00132730|447683932|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
124471532|NCT00132730|447683933|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
124471533|NCT00132730|447683934|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
124471534|NCT00132730|447683935|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
124471535|NCT00132730|447683930|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
124471536|NCT00132730|447683931|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
124471537|NCT00132730|447683932|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
124471538|NCT00132730|447683933|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
124471539|NCT00132730|447683934|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
124471540|NCT00132730|447683935|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
124471541|NCT00132730|447683930|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
124471542|NCT00132730|447683931|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
124471543|NCT00132730|447683932|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
124471544|NCT00132730|447683933|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
124554020|NCT03836729|447987311|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
124554021|NCT01270841|447987312|FG000|Overall Study|Adverse Event|0|||
124554022|NCT01270841|447987313|FG001|Overall Study|Adverse Event|1|||
124471545|NCT00132730|447683934|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
124471546|NCT00132730|447683935|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
124471547|NCT00132730|447683930|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
124471548|NCT00132730|447683931|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
124471549|NCT00132730|447683932|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
124471550|NCT00132730|447683933|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
124471551|NCT00132730|447683934|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
124471552|NCT00132730|447683935|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
124471553|NCT01554579|447683936|FG000|Overall Study|Adverse Event|6|||
124471554|NCT01554579|447683937|FG001|Overall Study|Adverse Event|25|||
124471555|NCT01554579|447683936|FG000|Overall Study|Lack of Efficacy|2|||
124471556|NCT01554579|447683937|FG001|Overall Study|Lack of Efficacy|1|||
124471557|NCT01554579|447683936|FG000|Overall Study|Withdrawal by Subject|2|||
124471558|NCT01554579|447683937|FG001|Overall Study|Withdrawal by Subject|1|||
124471559|NCT03683394|447683941|FG000|Overall Study|Withdrawal by Subject|4|||
124471560|NCT03683394|447683942|FG001|Overall Study|Withdrawal by Subject|8|||
124715492|NCT01713582|448583432|FG018|Overall Study|Withdrawal of consent|1|||
124715493|NCT01713582|448583433|FG019|Overall Study|Withdrawal of consent|0|||
124715494|NCT01713582|448583434|FG020|Overall Study|Withdrawal of consent|0|||
124715495|NCT01713582|448583414|FG000|Overall Study|Lack of Efficacy|0|||
124715496|NCT01713582|448583415|FG001|Overall Study|Lack of Efficacy|0|||
124715497|NCT01713582|448583416|FG002|Overall Study|Lack of Efficacy|0|||
124715498|NCT01713582|448583417|FG003|Overall Study|Lack of Efficacy|0|||
124715499|NCT01713582|448583418|FG004|Overall Study|Lack of Efficacy|0|||
124715500|NCT01713582|448583419|FG005|Overall Study|Lack of Efficacy|0|||
124715501|NCT01713582|448583420|FG006|Overall Study|Lack of Efficacy|0|||
124770901|NCT01899040|448790007|FG002|Overall Study|Compliance issues|0|||
124770902|NCT02638220|448790013|FG000|Overall Study|Lost to Follow-up|6|||
124471561|NCT03683394|447683941|FG000|Overall Study|Lost to Follow-up|7|||
124471562|NCT03683394|447683942|FG001|Overall Study|Lost to Follow-up|0|||
124471563|NCT03683394|447683941|FG000|Overall Study|Death|3|||
124471564|NCT03683394|447683942|FG001|Overall Study|Death|1|||
124471565|NCT03072160|447683944|FG000|Overall Study|Adverse Event|3|||
124471566|NCT03072160|447683945|FG001|Overall Study|Adverse Event|1|||
124471567|NCT03072160|447683944|FG000|Overall Study|Refused further treatment|6|||
124471568|NCT03072160|447683945|FG001|Overall Study|Refused further treatment|1|||
124471569|NCT03072160|447683944|FG000|Overall Study|Physician Decision|1|||
124471570|NCT03072160|447683945|FG001|Overall Study|Physician Decision|0|||
124471571|NCT03072160|447683944|FG000|Overall Study|Disease progression on study|1|||
124471572|NCT03072160|447683945|FG001|Overall Study|Disease progression on study|1|||
124471573|NCT03072160|447683944|FG000|Overall Study|No contact|0|||
124770903|NCT02638220|448790013|FG000|Overall Study|Withdrawal by Subject|3|||
124770904|NCT02638220|448790013|FG000|Overall Study|Physician Decision|1|||
124770905|NCT02638220|448790013|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
124770906|NCT03204188|448790014|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
124770907|NCT03204188|448790014|FG000|Immunotherapy Phase (1 Year)|Death|1|||
124770908|NCT03204188|448790014|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
124770909|NCT03204188|448790014|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
124770910|NCT01198795|448791610|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
124770911|NCT01198795|448791610|FG000|Overall Study|Withdrawal by Subject|17|||
124770912|NCT01198795|448791610|FG000|Overall Study|Lost to Follow-up|15|||
124770913|NCT01198795|448791610|FG000|Overall Study|Adverse Event|9|||
124770914|NCT01198795|448791610|FG000|Overall Study|Lack of Efficacy|5|||
124770915|NCT01198795|448791610|FG000|Overall Study|Protocol Violation|2|||
124770916|NCT01198795|448791610|FG000|Overall Study|Other Reason|4|||
124770917|NCT00936715|448791643|FG000|Overall Study|Investigators Discretion|1|||
124770918|NCT00936715|448791643|FG000|Overall Study|Protocol Violation|1|||
124770919|NCT00936715|448791643|FG000|Overall Study|Safety or Tolerability Reasons|4|||
124770920|NCT02492763|448791644|FG000|Overall Study|Withdrawal by Subject|0|||
124770921|NCT02492763|448791645|FG001|Overall Study|Withdrawal by Subject|2|||
124770922|NCT02492763|448791646|FG002|Overall Study|Withdrawal by Subject|1|||
124770923|NCT02492763|448791647|FG003|Overall Study|Withdrawal by Subject|0|||
124471574|NCT03072160|447683945|FG001|Overall Study|No contact|1|||
124471575|NCT01046695|447683946|FG000|Overall Study|Subject had a pacemaker|0|||
124471576|NCT01046695|447683947|FG001|Overall Study|Subject had a pacemaker|1|||
124471577|NCT01046695|447683946|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
124715502|NCT01713582|448583421|FG007|Overall Study|Lack of Efficacy|0|||
124715503|NCT01713582|448583422|FG008|Overall Study|Lack of Efficacy|0|||
124715504|NCT01713582|448583423|FG009|Overall Study|Lack of Efficacy|1|||
124770924|NCT02492763|448791644|FG000|Overall Study|Adverse Event|3|||
124770925|NCT02492763|448791645|FG001|Overall Study|Adverse Event|1|||
124770926|NCT02492763|448791646|FG002|Overall Study|Adverse Event|1|||
124471578|NCT01046695|447683947|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
124471579|NCT02239263|447683948|FG000|Overall Study|Protocol Violation|6|||
124471580|NCT01058096|447683950|FG000|Double-blind Treatment Phase|Adverse Event|11|||
124715505|NCT01713582|448583424|FG010|Overall Study|Lack of Efficacy|2|||
124471581|NCT01058096|447683951|FG001|Double-blind Treatment Phase|Adverse Event|15|||
124471582|NCT01058096|447683950|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
124471583|NCT01058096|447683951|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
124471584|NCT01058096|447683950|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
124471585|NCT01058096|447683951|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
124471586|NCT01058096|447683950|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
124471587|NCT01058096|447683951|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
124471588|NCT01058096|447683950|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
124471589|NCT01058096|447683951|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
124471590|NCT01058096|447683950|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
124471591|NCT01058096|447683951|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
124471592|NCT04276207|447683952|FG000|Period 1|Withdrawal by Subject|0|||
124471593|NCT04276207|447683953|FG001|Period 1|Withdrawal by Subject|1|||
124471594|NCT01463098|447683954|FG000|Part A (11 Days)|Participant Choice|2|||
124471595|NCT01463098|447683955|FG001|Part A (11 Days)|Participant Choice|0|||
124471596|NCT01463098|447683956|FG002|Part A (11 Days)|Participant Choice|0|||
124471597|NCT01463098|447683957|FG003|Part A (11 Days)|Participant Choice|0|||
124471598|NCT01463098|447683958|FG004|Part A (11 Days)|Participant Choice|0|||
124471599|NCT01463098|447683959|FG005|Part A (11 Days)|Participant Choice|0|||
124471600|NCT01463098|447683960|FG006|Part A (11 Days)|Participant Choice|0|||
124715506|NCT01713582|448583425|FG011|Overall Study|Lack of Efficacy|0|||
124471601|NCT01463098|447683961|FG007|Part A (11 Days)|Participant Choice|0|||
124471602|NCT01463098|447683962|FG008|Part A (11 Days)|Participant Choice|1|||
124770927|NCT02492763|448791647|FG003|Overall Study|Adverse Event|2|||
124770928|NCT02492763|448791644|FG000|Overall Study|Death|0|||
124471603|NCT01463098|447683963|FG009|Part A (11 Days)|Participant Choice|0|||
124471604|NCT01463098|447683964|FG010|Part A (11 Days)|Participant Choice|0|||
124471605|NCT01463098|447683965|FG011|Part A (11 Days)|Participant Choice|0|||
124715507|NCT01713582|448583426|FG012|Overall Study|Lack of Efficacy|0|||
124715508|NCT01713582|448583427|FG013|Overall Study|Lack of Efficacy|0|||
124715509|NCT01713582|448583428|FG014|Overall Study|Lack of Efficacy|0|||
124715510|NCT01713582|448583429|FG015|Overall Study|Lack of Efficacy|0|||
124715511|NCT01713582|448583430|FG016|Overall Study|Lack of Efficacy|0|||
124715512|NCT01713582|448583431|FG017|Overall Study|Lack of Efficacy|0|||
124715513|NCT01713582|448583432|FG018|Overall Study|Lack of Efficacy|0|||
124715514|NCT01713582|448583433|FG019|Overall Study|Lack of Efficacy|0|||
124770929|NCT02492763|448791645|FG001|Overall Study|Death|0|||
124715515|NCT01713582|448583434|FG020|Overall Study|Lack of Efficacy|0|||
124471606|NCT01463098|447683966|FG012|Part A (11 Days)|Participant Choice|0|||
124471607|NCT01463098|447683967|FG013|Part A (11 Days)|Participant Choice|0|||
124471608|NCT01463098|447683954|FG000|Part A (11 Days)|Lost to Follow-up|0|||
124471609|NCT01463098|447683955|FG001|Part A (11 Days)|Lost to Follow-up|0|||
124471610|NCT01463098|447683956|FG002|Part A (11 Days)|Lost to Follow-up|0|||
124471611|NCT01463098|447683957|FG003|Part A (11 Days)|Lost to Follow-up|0|||
124471612|NCT01463098|447683958|FG004|Part A (11 Days)|Lost to Follow-up|1|||
124471613|NCT01463098|447683959|FG005|Part A (11 Days)|Lost to Follow-up|0|||
124471614|NCT01463098|447683960|FG006|Part A (11 Days)|Lost to Follow-up|0|||
124471615|NCT01463098|447683961|FG007|Part A (11 Days)|Lost to Follow-up|0|||
124471616|NCT01463098|447683962|FG008|Part A (11 Days)|Lost to Follow-up|0|||
124471617|NCT01463098|447683963|FG009|Part A (11 Days)|Lost to Follow-up|0|||
124471618|NCT01463098|447683964|FG010|Part A (11 Days)|Lost to Follow-up|0|||
124471619|NCT01463098|447683965|FG011|Part A (11 Days)|Lost to Follow-up|0|||
124715516|NCT01713582|448583414|FG000|Overall Study|Withdrawal by Subject|0|||
124715517|NCT01713582|448583415|FG001|Overall Study|Withdrawal by Subject|0|||
124715518|NCT01713582|448583416|FG002|Overall Study|Withdrawal by Subject|0|||
124715519|NCT01713582|448583417|FG003|Overall Study|Withdrawal by Subject|0|||
124715520|NCT01713582|448583418|FG004|Overall Study|Withdrawal by Subject|0|||
124715521|NCT01713582|448583419|FG005|Overall Study|Withdrawal by Subject|0|||
124715522|NCT01713582|448583420|FG006|Overall Study|Withdrawal by Subject|0|||
124715523|NCT01713582|448583421|FG007|Overall Study|Withdrawal by Subject|0|||
124715524|NCT01713582|448583422|FG008|Overall Study|Withdrawal by Subject|0|||
124715525|NCT01713582|448583423|FG009|Overall Study|Withdrawal by Subject|0|||
124471620|NCT01463098|447683966|FG012|Part A (11 Days)|Lost to Follow-up|0|||
124471621|NCT01463098|447683967|FG013|Part A (11 Days)|Lost to Follow-up|0|||
124471622|NCT01463098|447683954|FG000|Part B (11 Days)|Participant Choice|0|||
124471623|NCT01463098|447683955|FG001|Part B (11 Days)|Participant Choice|0|||
124471624|NCT01463098|447683956|FG002|Part B (11 Days)|Participant Choice|0|||
124471625|NCT01463098|447683957|FG003|Part B (11 Days)|Participant Choice|0|||
124471626|NCT01463098|447683958|FG004|Part B (11 Days)|Participant Choice|0|||
124471627|NCT01463098|447683959|FG005|Part B (11 Days)|Participant Choice|0|||
124471628|NCT01463098|447683960|FG006|Part B (11 Days)|Participant Choice|0|||
124471629|NCT01463098|447683961|FG007|Part B (11 Days)|Participant Choice|0|||
124715526|NCT01713582|448583424|FG010|Overall Study|Withdrawal by Subject|0|||
124471630|NCT01463098|447683962|FG008|Part B (11 Days)|Participant Choice|0|||
124471631|NCT01463098|447683963|FG009|Part B (11 Days)|Participant Choice|0|||
124471632|NCT01463098|447683964|FG010|Part B (11 Days)|Participant Choice|0|||
124471633|NCT01463098|447683965|FG011|Part B (11 Days)|Participant Choice|1|||
124471634|NCT01463098|447683966|FG012|Part B (11 Days)|Participant Choice|0|||
124715527|NCT01713582|448583425|FG011|Overall Study|Withdrawal by Subject|0|||
124715528|NCT01713582|448583426|FG012|Overall Study|Withdrawal by Subject|0|||
124715529|NCT01713582|448583427|FG013|Overall Study|Withdrawal by Subject|0|||
124471635|NCT01463098|447683967|FG013|Part B (11 Days)|Participant Choice|0|||
124471636|NCT00939692|447683972|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
124471637|NCT00939692|447683973|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
124471638|NCT00939692|447683972|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
124471639|NCT00939692|447683973|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
124715530|NCT01713582|448583428|FG014|Overall Study|Withdrawal by Subject|0|||
124715531|NCT01713582|448583429|FG015|Overall Study|Withdrawal by Subject|0|||
124715532|NCT01713582|448583430|FG016|Overall Study|Withdrawal by Subject|0|||
124715533|NCT01713582|448583431|FG017|Overall Study|Withdrawal by Subject|1|||
124715534|NCT01713582|448583432|FG018|Overall Study|Withdrawal by Subject|0|||
124715535|NCT01713582|448583433|FG019|Overall Study|Withdrawal by Subject|0|||
124715536|NCT01713582|448583434|FG020|Overall Study|Withdrawal by Subject|0|||
124715537|NCT01713582|448583414|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
124715538|NCT01713582|448583415|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
124770930|NCT02492763|448791646|FG002|Overall Study|Death|1|||
124471640|NCT04451330|447683974|FG000|Overall Study|Adverse Event|1|||
124471641|NCT04451330|447683975|FG001|Overall Study|Adverse Event|2|||
124471642|NCT04451330|447683974|FG000|Overall Study|Lost to Follow-up|5|||
124471643|NCT04451330|447683975|FG001|Overall Study|Lost to Follow-up|0|||
124471644|NCT04451330|447683974|FG000|Overall Study|Withdrawal by Subject|3|||
124471645|NCT04451330|447683975|FG001|Overall Study|Withdrawal by Subject|1|||
124471646|NCT04451330|447683974|FG000|Overall Study|Withdrawal by parent/guardian|1|||
124471647|NCT04451330|447683975|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124471648|NCT04451330|447683974|FG000|Overall Study|Other than specified|0|||
124471649|NCT04451330|447683975|FG001|Overall Study|Other than specified|1|||
124471650|NCT02769624|447683976|FG000|Overall Study|Lost to Follow-up|0|||
124770931|NCT02492763|448791647|FG003|Overall Study|Death|0|||
124770932|NCT02492763|448791644|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
124471651|NCT02769624|447683977|FG001|Overall Study|Lost to Follow-up|1|||
124554023|NCT01270841|447987314|FG002|Overall Study|Adverse Event|0|||
124554024|NCT01270841|447987315|FG003|Overall Study|Adverse Event|3|||
124715539|NCT01713582|448583416|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
124715540|NCT01713582|448583417|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
124715541|NCT01713582|448583418|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
124715542|NCT01713582|448583419|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
124715543|NCT01713582|448583420|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
124770933|NCT02492763|448791645|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
124471652|NCT05099640|447683978|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
124471653|NCT05099640|447683979|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
124471654|NCT05099640|447683980|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
124471655|NCT05099640|447683978|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
124471656|NCT05099640|447683979|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
124471657|NCT05099640|447683980|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
124471658|NCT05099640|447683978|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
124471659|NCT05099640|447683979|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
124471660|NCT05099640|447683980|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
124471661|NCT05099640|447683978|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
124471662|NCT05099640|447683979|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
124471663|NCT05099640|447683980|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
124471664|NCT05099640|447683978|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
124471665|NCT05099640|447683979|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
124471666|NCT05099640|447683980|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
124471667|NCT05099640|447683978|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
124471668|NCT05099640|447683979|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
124471669|NCT05099640|447683980|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
124471670|NCT00179959|447683981|FG000|Overall Study|Lost to Follow-up|3|||
124471671|NCT00179959|447683982|FG001|Overall Study|Lost to Follow-up|1|||
124471672|NCT00179959|447683981|FG000|Overall Study|Withdrawal by Subject|3|||
124471673|NCT00179959|447683982|FG001|Overall Study|Withdrawal by Subject|2|||
124471674|NCT00448708|447683983|FG000|Overall Study|Death|21|||
124471675|NCT00448708|447683984|FG001|Overall Study|Death|17|||
124471676|NCT00448708|447683983|FG000|Overall Study|Withdrawal by Subject|8|||
124471677|NCT00448708|447683984|FG001|Overall Study|Withdrawal by Subject|4|||
124471678|NCT00448708|447683983|FG000|Overall Study|Lost to Follow-up|6|||
124471679|NCT00448708|447683984|FG001|Overall Study|Lost to Follow-up|8|||
124770934|NCT02492763|448791646|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
124471680|NCT00448708|447683983|FG000|Overall Study|not listed|0|||
124471681|NCT00448708|447683984|FG001|Overall Study|not listed|2|||
124471682|NCT00236080|447683986|FG000|Overall Study|Adverse Event|0|||
124471683|NCT00236080|447683987|FG001|Overall Study|Adverse Event|0|||
124471684|NCT00236080|447683988|FG002|Overall Study|Adverse Event|3|||
124471685|NCT00236080|447683989|FG003|Overall Study|Adverse Event|1|||
124471686|NCT00236080|447683990|FG004|Overall Study|Adverse Event|0|||
124471687|NCT00236080|447683986|FG000|Overall Study|Lost to Follow-up|0|||
124471688|NCT00236080|447683987|FG001|Overall Study|Lost to Follow-up|1|||
124471689|NCT00236080|447683988|FG002|Overall Study|Lost to Follow-up|0|||
124715544|NCT01713582|448583421|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
124715545|NCT01713582|448583422|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
124715546|NCT01713582|448583423|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
124715547|NCT01713582|448583424|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
124715548|NCT01713582|448583425|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
124715549|NCT01713582|448583426|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
124471690|NCT00236080|447683989|FG003|Overall Study|Lost to Follow-up|0|||
124471691|NCT00236080|447683990|FG004|Overall Study|Lost to Follow-up|0|||
124471692|NCT00236080|447683986|FG000|Overall Study|Physician Decision|1|||
124471693|NCT00236080|447683987|FG001|Overall Study|Physician Decision|0|||
124471694|NCT00236080|447683988|FG002|Overall Study|Physician Decision|1|||
124471695|NCT00236080|447683989|FG003|Overall Study|Physician Decision|1|||
124471696|NCT00236080|447683990|FG004|Overall Study|Physician Decision|1|||
124715550|NCT01713582|448583427|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
124715551|NCT01713582|448583428|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
124715552|NCT01713582|448583429|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
124554025|NCT01270841|447987312|FG000|Overall Study|Withdrawal by Subject|3|||
124554026|NCT01270841|447987313|FG001|Overall Study|Withdrawal by Subject|2|||
124554027|NCT01270841|447987314|FG002|Overall Study|Withdrawal by Subject|3|||
124554028|NCT01270841|447987315|FG003|Overall Study|Withdrawal by Subject|3|||
124554029|NCT01270841|447987312|FG000|Overall Study|Lost to Follow-up|3|||
124554030|NCT01270841|447987313|FG001|Overall Study|Lost to Follow-up|1|||
124554031|NCT01270841|447987314|FG002|Overall Study|Lost to Follow-up|4|||
124554032|NCT01270841|447987315|FG003|Overall Study|Lost to Follow-up|2|||
124554033|NCT01270841|447987312|FG000|Overall Study|Physician Decision|0|||
124554034|NCT01270841|447987313|FG001|Overall Study|Physician Decision|1|||
124554035|NCT01270841|447987314|FG002|Overall Study|Physician Decision|0|||
124554036|NCT01270841|447987315|FG003|Overall Study|Physician Decision|0|||
124554037|NCT01270841|447987312|FG000|Overall Study|Did not qualify|6|||
124554038|NCT01270841|447987313|FG001|Overall Study|Did not qualify|3|||
124554039|NCT01270841|447987314|FG002|Overall Study|Did not qualify|4|||
124554040|NCT01270841|447987315|FG003|Overall Study|Did not qualify|5|||
124554041|NCT01270841|447987312|FG000|Overall Study|Protocol Violation|1|||
124554042|NCT01270841|447987313|FG001|Overall Study|Protocol Violation|5|||
124554043|NCT01270841|447987314|FG002|Overall Study|Protocol Violation|0|||
124554044|NCT01270841|447987315|FG003|Overall Study|Protocol Violation|0|||
124554045|NCT01270841|447987312|FG000|Overall Study|Enrolled in error|0|||
124554046|NCT01270841|447987313|FG001|Overall Study|Enrolled in error|1|||
124554047|NCT01270841|447987314|FG002|Overall Study|Enrolled in error|0|||
124554048|NCT01270841|447987315|FG003|Overall Study|Enrolled in error|0|||
124554049|NCT04388527|447987316|FG000|Overall Study|Death|14|||
124554050|NCT04388527|447987316|FG000|Overall Study|Withdrawal by Subject|2|||
124554051|NCT04388527|447987316|FG000|Overall Study|Lost to Follow-up|1|||
124554052|NCT00782275|447987317|FG000|Overall Study|Adverse Event|11|||
124554053|NCT00782275|447987317|FG000|Overall Study|Withdrawal by Subject|1|||
124554054|NCT00782275|447987317|FG000|Overall Study|Progressive Disease|21|||
124715553|NCT01713582|448583430|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
124715554|NCT01713582|448583431|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
124554055|NCT00782275|447987317|FG000|Overall Study|Physician Decision|4|||
124554056|NCT00782275|447987317|FG000|Overall Study|Not started treatment|1|||
124554057|NCT00782275|447987317|FG000|Overall Study|Other|3|||
124554058|NCT00787566|447987324|FG000|Overall Study|AE related to chemotherapy|0|||
124715555|NCT01713582|448583432|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
124715556|NCT01713582|448583433|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
124471697|NCT00236080|447683986|FG000|Overall Study|Withdrawal by Subject|1|||
124471698|NCT00236080|447683987|FG001|Overall Study|Withdrawal by Subject|0|||
124471699|NCT00236080|447683988|FG002|Overall Study|Withdrawal by Subject|0|||
124471700|NCT00236080|447683989|FG003|Overall Study|Withdrawal by Subject|0|||
124471701|NCT00236080|447683990|FG004|Overall Study|Withdrawal by Subject|0|||
124471702|NCT00236080|447683986|FG000|Overall Study|Miscellaneous|0|||
124471703|NCT00236080|447683987|FG001|Overall Study|Miscellaneous|0|||
124471704|NCT00236080|447683988|FG002|Overall Study|Miscellaneous|1|||
124471705|NCT00236080|447683989|FG003|Overall Study|Miscellaneous|0|||
124471706|NCT00236080|447683990|FG004|Overall Study|Miscellaneous|0|||
124471707|NCT02400255|447683991|FG000|Overall Study|Relapse|4|||
124471708|NCT02400255|447683992|FG001|Overall Study|Relapse|1|||
124471709|NCT02400255|447683993|FG002|Overall Study|Relapse|1|||
124471710|NCT02400255|447683994|FG003|Overall Study|Relapse|2|||
124471711|NCT02400255|447683991|FG000|Overall Study|Adverse Event|6|||
124471712|NCT02400255|447683992|FG001|Overall Study|Adverse Event|3|||
124471713|NCT02400255|447683993|FG002|Overall Study|Adverse Event|0|||
124471714|NCT02400255|447683994|FG003|Overall Study|Adverse Event|0|||
124471715|NCT02400255|447683991|FG000|Overall Study|Physician Decision|6|||
124471716|NCT02400255|447683992|FG001|Overall Study|Physician Decision|0|||
124471717|NCT02400255|447683993|FG002|Overall Study|Physician Decision|0|||
124471718|NCT02400255|447683994|FG003|Overall Study|Physician Decision|0|||
124471719|NCT02400255|447683991|FG000|Overall Study|Loss of insurance|1|||
124471720|NCT02400255|447683992|FG001|Overall Study|Loss of insurance|0|||
124471721|NCT02400255|447683993|FG002|Overall Study|Loss of insurance|0|||
124715557|NCT01713582|448583434|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
124715558|NCT01713582|448583414|FG000|Overall Study|Disease progression and adverse event|0|||
124715559|NCT01713582|448583415|FG001|Overall Study|Disease progression and adverse event|0|||
124471722|NCT02400255|447683994|FG003|Overall Study|Loss of insurance|0|||
124471723|NCT00480857|447683998|FG000|Overall Study|Lack of Efficacy|2|||
124471724|NCT01725750|447684004|FG000|Overall Study|Adverse Event|1|||
124471725|NCT01725750|447684005|FG001|Overall Study|Adverse Event|0|||
124471726|NCT01725750|447684004|FG000|Overall Study|Lost to Follow-up|1|||
124471727|NCT01725750|447684005|FG001|Overall Study|Lost to Follow-up|1|||
124471728|NCT01725750|447684004|FG000|Overall Study|Withdrawal by Subject|0|||
124471729|NCT01725750|447684005|FG001|Overall Study|Withdrawal by Subject|9|||
124471730|NCT00654498|447684008|FG000|Overall Study|Not Treated|1|||
124471731|NCT00654498|447684009|FG001|Overall Study|Not Treated|0|||
124471732|NCT00654498|447684008|FG000|Overall Study|Adverse Event|6|||
124471733|NCT00654498|447684009|FG001|Overall Study|Adverse Event|1|||
124471734|NCT00654498|447684008|FG000|Overall Study|Protocol Violation|1|||
124471735|NCT00654498|447684009|FG001|Overall Study|Protocol Violation|1|||
124471736|NCT00654498|447684008|FG000|Overall Study|Lost to Follow-up|1|||
124471737|NCT00654498|447684009|FG001|Overall Study|Lost to Follow-up|5|||
124471738|NCT00654498|447684008|FG000|Overall Study|Withdrawal by Subject|1|||
124471739|NCT00654498|447684009|FG001|Overall Study|Withdrawal by Subject|0|||
124471740|NCT00654498|447684008|FG000|Overall Study|Other reason not defined above|4|||
124471741|NCT00654498|447684009|FG001|Overall Study|Other reason not defined above|5|||
124471742|NCT01738971|447684018|FG000|Overall Study|Lost to Follow-up|19|||
124471743|NCT01738971|447684019|FG001|Overall Study|Lost to Follow-up|30|||
124471744|NCT01738971|447684020|FG002|Overall Study|Lost to Follow-up|17|||
124471745|NCT01031446|447684021|FG000|Overall Study|Disease Progression|38|||
124471746|NCT01031446|447684021|FG000|Overall Study|Adverse Event|9|||
124471747|NCT01031446|447684021|FG000|Overall Study|Physician Decision|4|||
124471748|NCT01031446|447684021|FG000|Overall Study|Withdrawal by Subject|3|||
124471749|NCT01031446|447684021|FG000|Overall Study|Still on treatment|1|||
124471750|NCT02531646|447684025|FG000|Overall Study|equip. image processing issue|5|||
124471751|NCT02531646|447684026|FG001|Overall Study|equip. image processing issue|1|||
124471752|NCT02531646|447684027|FG002|Overall Study|equip. image processing issue|0|||
124471753|NCT04484285|447685498|FG000|Overall Study|Unable to operate stimulator|3|||
124471754|NCT04484285|447685499|FG001|Overall Study|Unable to operate stimulator|0|||
124471755|NCT05888103|447685500|FG000|Overall Study|Participant decision|3|||
124715560|NCT01713582|448583416|FG002|Overall Study|Disease progression and adverse event|0|||
124471756|NCT05888103|447685501|FG001|Overall Study|Participant decision|3|||
124471757|NCT00167245|447685505|FG000|Overall Study|Lost to Follow-up|20|||
124471758|NCT00167245|447685506|FG001|Overall Study|Lost to Follow-up|31|||
124471759|NCT00167245|447685505|FG000|Overall Study|Withdrawal by Subject|5|||
124471760|NCT00167245|447685506|FG001|Overall Study|Withdrawal by Subject|8|||
124471761|NCT00167245|447685505|FG000|Overall Study|Incarcerated|3|||
124471762|NCT00167245|447685506|FG001|Overall Study|Incarcerated|2|||
124471763|NCT00167245|447685505|FG000|Overall Study|Drowsy|1|||
124471764|NCT00167245|447685506|FG001|Overall Study|Drowsy|0|||
124471765|NCT01871090|447685507|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
124471766|NCT01871090|447685508|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
124471767|NCT01871090|447685507|FG000|Overall Study|Interrogation not completed correctly|1|||
124471768|NCT01871090|447685508|FG001|Overall Study|Interrogation not completed correctly|0|||
124471769|NCT01871090|447685507|FG000|Overall Study|Subject Non-Compliance|0|||
124471770|NCT01871090|447685508|FG001|Overall Study|Subject Non-Compliance|1|||
124471771|NCT00804687|447685511|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
124471772|NCT00804687|447685512|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
124471773|NCT00804687|447685513|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
124471774|NCT00804687|447685514|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
124471775|NCT00804687|447685515|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
124471776|NCT00804687|447685516|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
124471777|NCT00804687|447685511|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
124471778|NCT00804687|447685512|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
124471779|NCT00804687|447685513|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
124471780|NCT00804687|447685514|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
124471781|NCT00804687|447685515|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
124471782|NCT00804687|447685516|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
124471783|NCT00804687|447685511|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
124471784|NCT00804687|447685512|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
124471785|NCT00804687|447685513|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
124471786|NCT00804687|447685514|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
124471787|NCT00804687|447685515|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
124471788|NCT00804687|447685516|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
124471789|NCT00804687|447685511|FG000|Period 5: Treatment Period|Positive drug test|1|||
124471790|NCT00804687|447685512|FG001|Period 5: Treatment Period|Positive drug test|0|||
124471791|NCT00804687|447685513|FG002|Period 5: Treatment Period|Positive drug test|0|||
124471792|NCT00804687|447685514|FG003|Period 5: Treatment Period|Positive drug test|0|||
124471793|NCT00804687|447685515|FG004|Period 5: Treatment Period|Positive drug test|0|||
124471794|NCT00804687|447685516|FG005|Period 5: Treatment Period|Positive drug test|0|||
124554059|NCT00787566|447987325|FG001|Overall Study|AE related to chemotherapy|1|||
124554060|NCT00787566|447987326|FG002|Overall Study|AE related to chemotherapy|0|||
124554061|NCT00417027|447987327|FG000|Overall Study|Protocol Violation|0|||
124715561|NCT01713582|448583417|FG003|Overall Study|Disease progression and adverse event|0|||
124715562|NCT01713582|448583418|FG004|Overall Study|Disease progression and adverse event|0|||
124471795|NCT00688909|447685519|FG000|Overall Study|Adverse Event|28|||
124471796|NCT00688909|447685519|FG000|Overall Study|Patient withdrew consent|2|||
124471797|NCT00688909|447685519|FG000|Overall Study|Administrative problems|1|||
124471798|NCT00688909|447685519|FG000|Overall Study|Protocol Violation|2|||
124471799|NCT01220414|447685522|FG000|Overall Study|Withdrawal by Subject|1|||
124471800|NCT01220414|447685523|FG001|Overall Study|Withdrawal by Subject|0|||
124471801|NCT01220414|447685524|FG002|Overall Study|Withdrawal by Subject|0|||
124471802|NCT01220414|447685525|FG003|Overall Study|Withdrawal by Subject|1|||
124471803|NCT00860158|447685533|FG000|Overall Study|Study Terminated|1|||
124471804|NCT00669617|447685534|FG000|Period 1|Withdrawal by Subject|0|||
124471805|NCT00669617|447685535|FG001|Period 1|Withdrawal by Subject|0|||
124471806|NCT00669617|447685536|FG002|Period 1|Withdrawal by Subject|1|||
124471807|NCT00669617|447685537|FG003|Period 1|Withdrawal by Subject|0|||
124471808|NCT00669617|447685538|FG004|Period 1|Withdrawal by Subject|0|||
124471809|NCT00669617|447685534|FG000|Period 1|Protocol Deviation|0|||
124471810|NCT00669617|447685535|FG001|Period 1|Protocol Deviation|0|||
124471811|NCT00669617|447685536|FG002|Period 1|Protocol Deviation|0|||
124471812|NCT00669617|447685537|FG003|Period 1|Protocol Deviation|0|||
124715563|NCT01713582|448583419|FG005|Overall Study|Disease progression and adverse event|0|||
124715564|NCT01713582|448583420|FG006|Overall Study|Disease progression and adverse event|0|||
124471813|NCT00669617|447685538|FG004|Period 1|Protocol Deviation|1|||
124471814|NCT00669617|447685534|FG000|Period 3|Lost to Follow-up|1|||
124471815|NCT00669617|447685535|FG001|Period 3|Lost to Follow-up|0|||
124715565|NCT01713582|448583421|FG007|Overall Study|Disease progression and adverse event|0|||
124715566|NCT01713582|448583422|FG008|Overall Study|Disease progression and adverse event|0|||
124715567|NCT01713582|448583423|FG009|Overall Study|Disease progression and adverse event|0|||
124471816|NCT00669617|447685536|FG002|Period 3|Lost to Follow-up|0|||
124471817|NCT00669617|447685537|FG003|Period 3|Lost to Follow-up|0|||
124471818|NCT00669617|447685538|FG004|Period 3|Lost to Follow-up|0|||
124471819|NCT01337973|447685542|FG000|Overall Study|Lost to Follow-up|2|||
124471820|NCT01337973|447685543|FG001|Overall Study|Lost to Follow-up|4|||
124471821|NCT01337973|447685544|FG002|Overall Study|Lost to Follow-up|3|||
124471822|NCT01337973|447685542|FG000|Overall Study|Death|1|||
124471823|NCT01337973|447685543|FG001|Overall Study|Death|2|||
124471824|NCT01337973|447685544|FG002|Overall Study|Death|1|||
124471825|NCT01337973|447685542|FG000|Overall Study|Withdrawal by Subject|10|||
124471826|NCT01337973|447685543|FG001|Overall Study|Withdrawal by Subject|8|||
124471827|NCT01337973|447685544|FG002|Overall Study|Withdrawal by Subject|4|||
124471828|NCT01337973|447685542|FG000|Overall Study|missing data on primary outcome|3|||
124471829|NCT01337973|447685543|FG001|Overall Study|missing data on primary outcome|1|||
124471830|NCT01337973|447685544|FG002|Overall Study|missing data on primary outcome|3|||
124471831|NCT02494596|447685545|FG000|Overall Study|Insufficient Therapeutic Response|3|||
124471832|NCT02494596|447685546|FG001|Overall Study|Insufficient Therapeutic Response|3|||
124471833|NCT02494596|447685547|FG002|Overall Study|Insufficient Therapeutic Response|1|||
124471834|NCT02494596|447685545|FG000|Overall Study|Adverse Event|0|||
124471835|NCT02494596|447685546|FG001|Overall Study|Adverse Event|1|||
124471836|NCT02494596|447685547|FG002|Overall Study|Adverse Event|0|||
124471837|NCT02494596|447685545|FG000|Overall Study|Refused Treatment|0|||
124554062|NCT00417027|447987328|FG001|Overall Study|Protocol Violation|5|||
124554063|NCT00417027|447987329|FG002|Overall Study|Protocol Violation|5|||
124554064|NCT00544557|447987330|FG000|Overall Study|Adverse Event|140|||
124554065|NCT00544557|447987330|FG000|Overall Study|Lack of Efficacy|196|||
124554066|NCT00544557|447987330|FG000|Overall Study|Other|98|||
124554067|NCT01169987|447987336|FG000|Overall Study|Withdrawal by Subject|3|||
124554068|NCT01169987|447987336|FG000|Overall Study|Lost to Follow-up|24|||
124554069|NCT01169987|447987336|FG000|Overall Study|Other|4|||
124554070|NCT00386100|447987337|FG000|Overall Study|Did not receive study medication|6|||
124471838|NCT02494596|447685546|FG001|Overall Study|Refused Treatment|1|||
124471839|NCT02494596|447685547|FG002|Overall Study|Refused Treatment|0|||
124471840|NCT00254566|447685548|FG000|Overall Study|Death|1|||
124471841|NCT00254566|447685549|FG001|Overall Study|Death|0|||
124554071|NCT00386100|447987338|FG001|Overall Study|Did not receive study medication|4|||
124471842|NCT00254566|447685548|FG000|Overall Study|Adverse Event|5|||
124471843|NCT00254566|447685549|FG001|Overall Study|Adverse Event|4|||
124471844|NCT00254566|447685548|FG000|Overall Study|Lack of Efficacy|12|||
124471845|NCT00254566|447685549|FG001|Overall Study|Lack of Efficacy|9|||
124471846|NCT00254566|447685548|FG000|Overall Study|Other|1|||
124471847|NCT00254566|447685549|FG001|Overall Study|Other|5|||
124471848|NCT00254566|447685548|FG000|Overall Study|Withdrawal by Subject|5|||
124471849|NCT00254566|447685549|FG001|Overall Study|Withdrawal by Subject|6|||
124471850|NCT00254566|447685548|FG000|Overall Study|Lost to Follow-up|7|||
124471851|NCT00254566|447685549|FG001|Overall Study|Lost to Follow-up|2|||
124471852|NCT00059202|447685550|FG000|Overall Study|Withdrawal by Subject|5|||
124471853|NCT00059202|447685551|FG001|Overall Study|Withdrawal by Subject|9|||
124471854|NCT00059202|447685550|FG000|Overall Study|Protocol Violation|1|||
124471855|NCT00059202|447685551|FG001|Overall Study|Protocol Violation|3|||
124471856|NCT00059202|447685550|FG000|Overall Study|drug toxicity|0|||
124471857|NCT00059202|447685551|FG001|Overall Study|drug toxicity|3|||
124471858|NCT02658448|447685555|FG000|Overall Study|Lost to Follow-up|1|||
124471859|NCT00648167|447685556|FG000|Overall Study|Adverse Event|6|||
124471860|NCT00648167|447685556|FG000|Overall Study|unable to swallow tablets|1|||
124471861|NCT01688050|447685557|FG000|Overall Study|Death|7|||
124471862|NCT01688050|447685557|FG000|Overall Study|Conversion to open repair|1|||
124471863|NCT01688050|447685557|FG000|Overall Study|Lost to Follow-up|13|||
124471864|NCT01688050|447685557|FG000|Overall Study|Withdrawal by Subject|10|||
124471865|NCT02614079|447685560|FG000|Overall Study|Withdrawal by Subject|1|||
124471866|NCT02623335|447685561|FG000|Overall Study|Death|8|||
124471867|NCT02623335|447685562|FG001|Overall Study|Death|7|||
124471868|NCT02623335|447685561|FG000|Overall Study|Lost to Follow-up|15|||
124471869|NCT02623335|447685562|FG001|Overall Study|Lost to Follow-up|23|||
124471870|NCT02623335|447685561|FG000|Overall Study|Withdrawal by Subject|2|||
124471871|NCT02623335|447685562|FG001|Overall Study|Withdrawal by Subject|5|||
124715568|NCT01713582|448583424|FG010|Overall Study|Disease progression and adverse event|0|||
124471872|NCT02623335|447685561|FG000|Overall Study|Protocol Violation|2|||
124471873|NCT02623335|447685562|FG001|Overall Study|Protocol Violation|1|||
124471874|NCT03739528|447685563|FG000|Overall Study|Not treated|8|||
124471875|NCT03739528|447685564|FG001|Overall Study|Not treated|12|||
124471876|NCT03739528|447685563|FG000|Overall Study|Treatment and study discontinued|6|||
124471877|NCT03739528|447685564|FG001|Overall Study|Treatment and study discontinued|2|||
124471878|NCT03739528|447685563|FG000|Overall Study|Treatment discontinued + study completed|1|||
124715569|NCT01713582|448583425|FG011|Overall Study|Disease progression and adverse event|0|||
124471879|NCT03739528|447685564|FG001|Overall Study|Treatment discontinued + study completed|3|||
124471880|NCT01961544|447685569|FG000|Overall Study|Protocol Violation|1|||
124471881|NCT01961544|447685569|FG000|Overall Study|Withdrawal by Subject|7|||
124471882|NCT01961544|447685569|FG000|Overall Study|Adverse Event|1|||
124471883|NCT01961544|447685569|FG000|Overall Study|Physician Decision|2|||
124471884|NCT01961544|447685569|FG000|Overall Study|Poor Tolerance|1|||
124471885|NCT01961544|447685569|FG000|Overall Study|Aggravation of Steral Pain|1|||
124471886|NCT03665285|447685570|FG000|Overall Study|Started New Anticancer Treatment|1|||
124471887|NCT03665285|447685571|FG001|Overall Study|Started New Anticancer Treatment|1|||
124471888|NCT03665285|447685572|FG002|Overall Study|Started New Anticancer Treatment|2|||
124471889|NCT03665285|447685573|FG003|Overall Study|Started New Anticancer Treatment|4|||
124471890|NCT03665285|447685574|FG004|Overall Study|Started New Anticancer Treatment|1|||
124471891|NCT03665285|447685575|FG005|Overall Study|Started New Anticancer Treatment|1|||
124471892|NCT03665285|447685576|FG006|Overall Study|Started New Anticancer Treatment|2|||
124471893|NCT03665285|447685577|FG007|Overall Study|Started New Anticancer Treatment|15|||
124471894|NCT03665285|447685578|FG008|Overall Study|Started New Anticancer Treatment|1|||
124471895|NCT03665285|447685570|FG000|Overall Study|Disease Progression|0|||
124471896|NCT03665285|447685571|FG001|Overall Study|Disease Progression|0|||
124471897|NCT03665285|447685572|FG002|Overall Study|Disease Progression|3|||
124471898|NCT03665285|447685573|FG003|Overall Study|Disease Progression|1|||
124471899|NCT03665285|447685574|FG004|Overall Study|Disease Progression|0|||
124471900|NCT03665285|447685575|FG005|Overall Study|Disease Progression|0|||
124471901|NCT03665285|447685576|FG006|Overall Study|Disease Progression|0|||
124471902|NCT03665285|447685577|FG007|Overall Study|Disease Progression|7|||
124471903|NCT03665285|447685578|FG008|Overall Study|Disease Progression|1|||
124471904|NCT03665285|447685570|FG000|Overall Study|Hospice|0|||
124471905|NCT03665285|447685571|FG001|Overall Study|Hospice|0|||
124715570|NCT01713582|448583426|FG012|Overall Study|Disease progression and adverse event|0|||
124471906|NCT03665285|447685572|FG002|Overall Study|Hospice|0|||
124471907|NCT03665285|447685573|FG003|Overall Study|Hospice|0|||
124715571|NCT01713582|448583427|FG013|Overall Study|Disease progression and adverse event|0|||
124715572|NCT01713582|448583428|FG014|Overall Study|Disease progression and adverse event|0|||
124715573|NCT01713582|448583429|FG015|Overall Study|Disease progression and adverse event|0|||
124715574|NCT01713582|448583430|FG016|Overall Study|Disease progression and adverse event|1|||
124715575|NCT01713582|448583431|FG017|Overall Study|Disease progression and adverse event|0|||
124715576|NCT01713582|448583432|FG018|Overall Study|Disease progression and adverse event|0|||
124715577|NCT01713582|448583433|FG019|Overall Study|Disease progression and adverse event|0|||
124715578|NCT01713582|448583434|FG020|Overall Study|Disease progression and adverse event|0|||
124715579|NCT01898286|448583437|FG000|Overall Study|Withdrawal by Subject|1|||
124715580|NCT01898286|448583437|FG000|Overall Study|Protocol Violation|1|||
124715581|NCT01898286|448583437|FG000|Overall Study|Lost to Follow-up|1|||
124715582|NCT02257242|448583438|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
124715583|NCT02257242|448583439|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
124715584|NCT02257242|448583440|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
124715585|NCT02257242|448583441|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
124715586|NCT02257242|448583442|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
124715587|NCT02257242|448583443|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
124715588|NCT02257242|448583444|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
124715589|NCT02257242|448583445|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
124770935|NCT02492763|448791647|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
124715590|NCT02257242|448583446|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
124715591|NCT01650831|448583452|FG000|Overall Study|Screen failure|1|||
124715592|NCT01048242|448583456|FG000|Overall Study|See study flow chart|4|||
124715593|NCT01048242|448583457|FG001|Overall Study|See study flow chart|2|||
124715594|NCT02964273|448583458|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
124715595|NCT02964273|448583459|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
124715596|NCT02964273|448583460|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
124715597|NCT02964273|448583461|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
124715598|NCT02964273|448583458|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
124715599|NCT02964273|448583459|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
124715600|NCT02964273|448583460|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
124715601|NCT02964273|448583461|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
124715602|NCT02964273|448583458|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
124715603|NCT02964273|448583459|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
124715604|NCT02964273|448583460|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
124715605|NCT02964273|448583461|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
124715606|NCT02964273|448583458|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
124715607|NCT02964273|448583459|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
124715608|NCT02964273|448583460|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
124715609|NCT02964273|448583461|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
124715610|NCT02964273|448583458|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
124715611|NCT02964273|448583459|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
124715612|NCT02964273|448583460|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
124715613|NCT02964273|448583461|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
124715614|NCT02964273|448583458|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
124715615|NCT02964273|448583459|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
124715616|NCT02964273|448583460|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
124715617|NCT02964273|448583461|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
124715618|NCT03333928|448583463|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
124715619|NCT03333928|448583464|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
124715620|NCT03333928|448583465|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
124715621|NCT03333928|448583463|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
124715622|NCT03333928|448583464|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
124715623|NCT03333928|448583465|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
124715624|NCT03333928|448583463|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
124715625|NCT03333928|448583464|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
124715626|NCT03333928|448583465|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
124715627|NCT03333928|448583463|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
124715628|NCT03333928|448583464|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
124715629|NCT03333928|448583465|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
124715630|NCT03333928|448583463|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
124715631|NCT03333928|448583464|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
124715632|NCT03333928|448583465|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
124715633|NCT03333928|448583463|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
124715634|NCT03333928|448583464|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
124770936|NCT02492763|448791644|FG000|Overall Study|Lost to Follow-up|0|||
124770937|NCT02492763|448791645|FG001|Overall Study|Lost to Follow-up|0|||
124715635|NCT03333928|448583465|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
124715636|NCT03333928|448583463|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
124715637|NCT03333928|448583464|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
124715638|NCT03333928|448583465|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
124715639|NCT03333928|448583463|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
124715640|NCT03333928|448583464|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
124715641|NCT03333928|448583465|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
124715642|NCT01453036|448583466|FG000|Overall Study|Lost to Follow-up|26|||
124715643|NCT01453036|448583467|FG001|Overall Study|Lost to Follow-up|115|||
124715644|NCT01453036|448583468|FG002|Overall Study|Lost to Follow-up|31|||
124715645|NCT00559104|448583469|FG000|Overall Study|Lack of Efficacy|9|||
124715646|NCT00559104|448583470|FG001|Overall Study|Lack of Efficacy|0|||
124715647|NCT01336712|448583471|FG000|Overall Study|Death|2|||
124715648|NCT01336712|448583471|FG000|Overall Study|Lack of Efficacy|1|||
124715649|NCT00620373|448583473|FG000|Overall Study|Unverified cancer status|33|||
124715650|NCT00399568|448583474|FG000|Overall Study|Adverse Event|1|||
124715651|NCT00399568|448583475|FG001|Overall Study|Adverse Event|2|||
124471908|NCT03665285|447685574|FG004|Overall Study|Hospice|0|||
124471909|NCT03665285|447685575|FG005|Overall Study|Hospice|0|||
124471910|NCT03665285|447685576|FG006|Overall Study|Hospice|0|||
124471911|NCT03665285|447685577|FG007|Overall Study|Hospice|2|||
124715652|NCT00399568|448583474|FG000|Overall Study|Withdrawal by Subject|7|||
124715653|NCT00399568|448583475|FG001|Overall Study|Withdrawal by Subject|3|||
124471912|NCT03665285|447685578|FG008|Overall Study|Hospice|0|||
124471913|NCT03665285|447685570|FG000|Overall Study|Withdrawal by Subject|0|||
124471914|NCT03665285|447685571|FG001|Overall Study|Withdrawal by Subject|0|||
124471915|NCT03665285|447685572|FG002|Overall Study|Withdrawal by Subject|0|||
124471916|NCT03665285|447685573|FG003|Overall Study|Withdrawal by Subject|0|||
124471917|NCT03665285|447685574|FG004|Overall Study|Withdrawal by Subject|1|||
124471918|NCT03665285|447685575|FG005|Overall Study|Withdrawal by Subject|0|||
124471919|NCT03665285|447685576|FG006|Overall Study|Withdrawal by Subject|0|||
124471920|NCT03665285|447685577|FG007|Overall Study|Withdrawal by Subject|2|||
124471921|NCT03665285|447685578|FG008|Overall Study|Withdrawal by Subject|0|||
124471922|NCT03665285|447685570|FG000|Overall Study|Physician Decision|0|||
124715654|NCT00399568|448583474|FG000|Overall Study|Protocol non-compliance|2|||
124715655|NCT00399568|448583475|FG001|Overall Study|Protocol non-compliance|2|||
124471923|NCT03665285|447685571|FG001|Overall Study|Physician Decision|0|||
124471924|NCT03665285|447685572|FG002|Overall Study|Physician Decision|0|||
124471925|NCT03665285|447685573|FG003|Overall Study|Physician Decision|0|||
124715656|NCT00399568|448583474|FG000|Overall Study|Lost to Follow-up|2|||
124715657|NCT00399568|448583475|FG001|Overall Study|Lost to Follow-up|2|||
124770938|NCT02492763|448791646|FG002|Overall Study|Lost to Follow-up|1|||
124471926|NCT03665285|447685574|FG004|Overall Study|Physician Decision|0|||
124715658|NCT03073525|448583476|FG000|Overall Study|Withdrawal by Subject|0|||
124715659|NCT03073525|448583477|FG001|Overall Study|Withdrawal by Subject|0|||
124471927|NCT03665285|447685575|FG005|Overall Study|Physician Decision|0|||
124715660|NCT03073525|448583478|FG002|Overall Study|Withdrawal by Subject|3|||
124715661|NCT03692403|448583479|FG000|Overall Study|Withdrawal by Subject|1|||
124471928|NCT03665285|447685576|FG006|Overall Study|Physician Decision|0|||
124471929|NCT03665285|447685577|FG007|Overall Study|Physician Decision|2|||
124471930|NCT03665285|447685578|FG008|Overall Study|Physician Decision|0|||
124471931|NCT03213366|447685583|FG000|Overall Study|Lost to Follow-up|9|||
124715662|NCT03692403|448583480|FG001|Overall Study|Withdrawal by Subject|0|||
124715663|NCT03692403|448583481|FG002|Overall Study|Withdrawal by Subject|1|||
124715664|NCT03692403|448583482|FG003|Overall Study|Withdrawal by Subject|0|||
124715665|NCT03692403|448583479|FG000|Overall Study|Adverse Event|0|||
124715666|NCT03692403|448583480|FG001|Overall Study|Adverse Event|0|||
124715667|NCT03692403|448583481|FG002|Overall Study|Adverse Event|0|||
124471932|NCT03213366|447685584|FG001|Overall Study|Lost to Follow-up|4|||
124471933|NCT02471716|447685589|FG000|Overall Study|Withdrawal by Subject|0|||
124471934|NCT02471716|447685590|FG001|Overall Study|Withdrawal by Subject|1|||
124471935|NCT02471716|447685591|FG002|Overall Study|Withdrawal by Subject|0|||
124471936|NCT02471716|447685592|FG003|Overall Study|Withdrawal by Subject|2|||
124471937|NCT02471716|447685593|FG004|Overall Study|Withdrawal by Subject|5|||
124471938|NCT02471716|447685589|FG000|Overall Study|Study Terminiated by sponsor|0|||
124471939|NCT02471716|447685590|FG001|Overall Study|Study Terminiated by sponsor|0|||
124471940|NCT02471716|447685591|FG002|Overall Study|Study Terminiated by sponsor|0|||
124471941|NCT02471716|447685592|FG003|Overall Study|Study Terminiated by sponsor|1|||
124471942|NCT02471716|447685593|FG004|Overall Study|Study Terminiated by sponsor|0|||
124471943|NCT02471716|447685589|FG000|Overall Study|Lost to Follow-up|0|||
124471944|NCT02471716|447685590|FG001|Overall Study|Lost to Follow-up|0|||
124471945|NCT02471716|447685591|FG002|Overall Study|Lost to Follow-up|0|||
124715668|NCT03692403|448583482|FG003|Overall Study|Adverse Event|1|||
124471946|NCT02471716|447685592|FG003|Overall Study|Lost to Follow-up|3|||
124715669|NCT03692403|448583479|FG000|Overall Study|Pregnancy|0|||
124715670|NCT03692403|448583480|FG001|Overall Study|Pregnancy|1|||
124471947|NCT02471716|447685593|FG004|Overall Study|Lost to Follow-up|2|||
124715671|NCT03692403|448583481|FG002|Overall Study|Pregnancy|0|||
124715672|NCT03692403|448583482|FG003|Overall Study|Pregnancy|0|||
124715673|NCT03692403|448583479|FG000|Overall Study|Other|0|||
124715674|NCT03692403|448583480|FG001|Overall Study|Other|0|||
124715675|NCT03692403|448583481|FG002|Overall Study|Other|1|||
124715676|NCT03692403|448583482|FG003|Overall Study|Other|0|||
124715677|NCT02776683|448583483|FG000|Pre-switch Period|Protocol Violation|1|||
124715678|NCT02776683|448583484|FG001|Pre-switch Period|Protocol Violation|0|||
124715679|NCT02776683|448583483|FG000|Pre-switch Period|Adverse Event|21|||
124715680|NCT02776683|448583484|FG001|Pre-switch Period|Adverse Event|0|||
124471948|NCT02471716|447685589|FG000|Overall Study|Death|0|||
124471949|NCT02471716|447685590|FG001|Overall Study|Death|0|||
124770939|NCT02492763|448791647|FG003|Overall Study|Lost to Follow-up|0|||
124770940|NCT02492763|448791644|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124770941|NCT02492763|448791645|FG001|Overall Study|Non-Compliance With Study Drug|1|||
124770942|NCT02492763|448791646|FG002|Overall Study|Non-Compliance With Study Drug|0|||
124715681|NCT02776683|448583483|FG000|Pre-switch Period|Withdrawal by Subject|9|||
124471950|NCT02471716|447685591|FG002|Overall Study|Death|0|||
124715682|NCT02776683|448583484|FG001|Pre-switch Period|Withdrawal by Subject|0|||
124715683|NCT02776683|448583483|FG000|Pre-switch Period|Physician Decision|7|||
124715684|NCT02776683|448583484|FG001|Pre-switch Period|Physician Decision|0|||
124715685|NCT02776683|448583483|FG000|Pre-switch Period|Progressive disease|39|||
124715686|NCT02776683|448583484|FG001|Pre-switch Period|Progressive disease|0|||
124715687|NCT02776683|448583483|FG000|Pre-switch Period|Other than listed|3|||
124715688|NCT02776683|448583484|FG001|Pre-switch Period|Other than listed|0|||
124715689|NCT02776683|448583483|FG000|Post-switch Period|Adverse Event|0|||
124715690|NCT02776683|448583484|FG001|Post-switch Period|Adverse Event|3|||
124715691|NCT02776683|448583483|FG000|Post-switch Period|Withdrawal by Subject|0|||
124715692|NCT02776683|448583484|FG001|Post-switch Period|Withdrawal by Subject|2|||
124715693|NCT02776683|448583483|FG000|Post-switch Period|Physician Decision|0|||
124715694|NCT02776683|448583484|FG001|Post-switch Period|Physician Decision|3|||
124715695|NCT02776683|448583483|FG000|Post-switch Period|Progressive disease|0|||
124715696|NCT02776683|448583484|FG001|Post-switch Period|Progressive disease|20|||
124715697|NCT02776683|448583483|FG000|Post-switch Period|Other than listed|0|||
124715698|NCT02776683|448583484|FG001|Post-switch Period|Other than listed|15|||
124715699|NCT01891396|448583487|FG000|Overall Study|Withdrawal by Subject|4|||
124715700|NCT01891396|448583488|FG001|Overall Study|Withdrawal by Subject|4|||
124715701|NCT01891396|448583489|FG002|Overall Study|Withdrawal by Subject|3|||
124715702|NCT01891396|448583487|FG000|Overall Study|Lost to Follow-up|0|||
124715703|NCT01891396|448583488|FG001|Overall Study|Lost to Follow-up|1|||
124715704|NCT01891396|448583489|FG002|Overall Study|Lost to Follow-up|0|||
124715705|NCT00540592|448583491|FG000|Overall Study|Adverse Event|0|||
124715706|NCT00540592|448583492|FG001|Overall Study|Adverse Event|1|||
124715707|NCT00540592|448583493|FG002|Overall Study|Adverse Event|0|||
124715708|NCT00540592|448583494|FG003|Overall Study|Adverse Event|0|||
124715709|NCT00540592|448583495|FG004|Overall Study|Adverse Event|1|||
124715710|NCT00540592|448583496|FG005|Overall Study|Adverse Event|0|||
124715711|NCT00540592|448583497|FG006|Overall Study|Adverse Event|0|||
124715712|NCT00540592|448583498|FG007|Overall Study|Adverse Event|1|||
124715713|NCT00540592|448583499|FG008|Overall Study|Adverse Event|1|||
124715714|NCT00540592|448583500|FG009|Overall Study|Adverse Event|2|||
124715715|NCT00540592|448583491|FG000|Overall Study|Lost to Follow-up|2|||
124715716|NCT00540592|448583492|FG001|Overall Study|Lost to Follow-up|0|||
124715717|NCT00540592|448583493|FG002|Overall Study|Lost to Follow-up|0|||
124715718|NCT00540592|448583494|FG003|Overall Study|Lost to Follow-up|0|||
124715719|NCT00540592|448583495|FG004|Overall Study|Lost to Follow-up|0|||
124715720|NCT00540592|448583496|FG005|Overall Study|Lost to Follow-up|0|||
124715721|NCT00540592|448583497|FG006|Overall Study|Lost to Follow-up|0|||
124715722|NCT00540592|448583498|FG007|Overall Study|Lost to Follow-up|0|||
124715723|NCT00540592|448583499|FG008|Overall Study|Lost to Follow-up|0|||
124715724|NCT00540592|448583500|FG009|Overall Study|Lost to Follow-up|0|||
124715725|NCT00540592|448583491|FG000|Overall Study|Withdrawal by Subject|0|||
124715726|NCT00540592|448583492|FG001|Overall Study|Withdrawal by Subject|0|||
124715727|NCT00540592|448583493|FG002|Overall Study|Withdrawal by Subject|1|||
124715728|NCT00540592|448583494|FG003|Overall Study|Withdrawal by Subject|1|||
124715729|NCT00540592|448583495|FG004|Overall Study|Withdrawal by Subject|0|||
124715730|NCT00540592|448583496|FG005|Overall Study|Withdrawal by Subject|0|||
124715731|NCT00540592|448583497|FG006|Overall Study|Withdrawal by Subject|0|||
124715732|NCT00540592|448583498|FG007|Overall Study|Withdrawal by Subject|0|||
124715733|NCT00540592|448583499|FG008|Overall Study|Withdrawal by Subject|0|||
124715734|NCT00540592|448583500|FG009|Overall Study|Withdrawal by Subject|0|||
124715735|NCT01456130|448583501|FG000|Overall Study|Adverse Event|4|||
124715736|NCT01456130|448583501|FG000|Overall Study|Voluntary Withdrawal|1|||
124715737|NCT01456130|448583501|FG000|Overall Study|Lack of Efficacy|4|||
124715738|NCT01456130|448583501|FG000|Overall Study|Other|1|||
124715739|NCT00400517|448583502|FG000|Overall Study|Withdrawal by Subject|1|||
124715740|NCT00400517|448583502|FG000|Overall Study|Physician Decision|1|||
124715741|NCT02688192|448583508|FG000|Overall Study|Lost to Follow-up|11|||
124715742|NCT02688192|448583509|FG001|Overall Study|Lost to Follow-up|5|||
124715743|NCT02688192|448583508|FG000|Overall Study|Physician Decision|1|||
124715744|NCT02688192|448583509|FG001|Overall Study|Physician Decision|0|||
124471951|NCT02471716|447685592|FG003|Overall Study|Death|1|||
124715745|NCT05384834|448583510|FG000|Overall Study|Lost to Follow-up|43|||
124715746|NCT05384834|448583510|FG000|Overall Study|Withdrawal by Subject|5|||
124715747|NCT01881789|448583513|FG000|Overall Study|Withdrawal by Subject|0|||
124715748|NCT01881789|448583514|FG001|Overall Study|Withdrawal by Subject|2|||
124715749|NCT01881789|448583515|FG002|Overall Study|Withdrawal by Subject|1|||
124715750|NCT01881789|448583516|FG003|Overall Study|Withdrawal by Subject|0|||
124715751|NCT01881789|448583517|FG004|Overall Study|Withdrawal by Subject|1|||
124715752|NCT01881789|448583518|FG005|Overall Study|Withdrawal by Subject|1|||
124715753|NCT01881789|448583513|FG000|Overall Study|Study Terminated by Sponsor|0|||
124715754|NCT01881789|448583514|FG001|Overall Study|Study Terminated by Sponsor|0|||
124715755|NCT01881789|448583515|FG002|Overall Study|Study Terminated by Sponsor|0|||
124715756|NCT01881789|448583516|FG003|Overall Study|Study Terminated by Sponsor|0|||
124715757|NCT01881789|448583517|FG004|Overall Study|Study Terminated by Sponsor|0|||
124715758|NCT01881789|448583518|FG005|Overall Study|Study Terminated by Sponsor|1|||
124715759|NCT01881789|448583513|FG000|Overall Study|Other|3|||
124471952|NCT02471716|447685593|FG004|Overall Study|Death|0|||
124471953|NCT02471716|447685589|FG000|Overall Study|Other|0|||
124471954|NCT02471716|447685590|FG001|Overall Study|Other|0|||
124471955|NCT02471716|447685591|FG002|Overall Study|Other|0|||
124471956|NCT02471716|447685592|FG003|Overall Study|Other|8|||
124471957|NCT02471716|447685593|FG004|Overall Study|Other|9|||
124471958|NCT00130286|447685594|FG000|Overall Study|Withdrawal by Subject|0|||
124471959|NCT00130286|447685595|FG001|Overall Study|Withdrawal by Subject|1|||
124471960|NCT00130286|447685596|FG002|Overall Study|Withdrawal by Subject|2|||
124471961|NCT00130286|447685597|FG003|Overall Study|Withdrawal by Subject|2|||
124554072|NCT00386100|447987337|FG000|Overall Study|Adverse Event|15|||
124554073|NCT00386100|447987338|FG001|Overall Study|Adverse Event|25|||
124554074|NCT00386100|447987337|FG000|Overall Study|Death|0|||
124554075|NCT00386100|447987338|FG001|Overall Study|Death|1|||
124554076|NCT00386100|447987337|FG000|Overall Study|Insufficient therapeutic effect|30|||
124554077|NCT00386100|447987338|FG001|Overall Study|Insufficient therapeutic effect|6|||
124554078|NCT00386100|447987337|FG000|Overall Study|Lost to Follow-up|29|||
124554079|NCT00386100|447987338|FG001|Overall Study|Lost to Follow-up|29|||
124554080|NCT00386100|447987337|FG000|Overall Study|Non-compliance|18|||
124554081|NCT00386100|447987338|FG001|Overall Study|Non-compliance|19|||
124554082|NCT00386100|447987337|FG000|Overall Study|Protocol Violation|5|||
124554083|NCT00386100|447987338|FG001|Overall Study|Protocol Violation|3|||
124554084|NCT00386100|447987337|FG000|Overall Study|Withdrawal by Subject|32|||
124554085|NCT00386100|447987338|FG001|Overall Study|Withdrawal by Subject|31|||
124471962|NCT00130286|447685594|FG000|Overall Study|Adverse Event|0|||
124471963|NCT00130286|447685595|FG001|Overall Study|Adverse Event|0|||
124471964|NCT00130286|447685596|FG002|Overall Study|Adverse Event|2|||
124471965|NCT00130286|447685597|FG003|Overall Study|Adverse Event|0|||
124471966|NCT00130286|447685594|FG000|Overall Study|Missing lab specimens|0|||
124471967|NCT00130286|447685595|FG001|Overall Study|Missing lab specimens|2|||
124554086|NCT00386100|447987337|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
124554087|NCT00386100|447987338|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
124554088|NCT00386100|447987337|FG000|Overall Study|BMD <2.5|1|||
124554089|NCT00386100|447987338|FG001|Overall Study|BMD <2.5|0|||
124554090|NCT00386100|447987337|FG000|Overall Study|Consecutive elevated Hba1C|1|||
124554091|NCT00386100|447987338|FG001|Overall Study|Consecutive elevated Hba1C|0|||
124554092|NCT00386100|447987337|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
124554093|NCT00386100|447987338|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
124554094|NCT00386100|447987337|FG000|Overall Study|Laboratory findings|1|||
124554095|NCT00386100|447987338|FG001|Overall Study|Laboratory findings|0|||
124554096|NCT00386100|447987337|FG000|Overall Study|Participant's concern due to CPK levels|1|||
124554097|NCT00386100|447987338|FG001|Overall Study|Participant's concern due to CPK levels|0|||
124554098|NCT00386100|447987337|FG000|Overall Study|Participant moving out of state|2|||
124554099|NCT00386100|447987338|FG001|Overall Study|Participant moving out of state|0|||
124554100|NCT00386100|447987337|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
124554101|NCT00386100|447987338|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
124554102|NCT00386100|447987337|FG000|Overall Study|Didn't meet entry criteria|1|||
124554103|NCT00386100|447987338|FG001|Overall Study|Didn't meet entry criteria|1|||
124554104|NCT00386100|447987337|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
124471968|NCT00130286|447685596|FG002|Overall Study|Missing lab specimens|0|||
124471969|NCT00130286|447685597|FG003|Overall Study|Missing lab specimens|0|||
124554105|NCT00386100|447987338|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
124554106|NCT00386100|447987337|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
124554107|NCT00386100|447987338|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
124471970|NCT03604445|447685600|FG000|Overall Study|Death|0|||
124471971|NCT03604445|447685601|FG001|Overall Study|Death|0|||
124471972|NCT03604445|447685602|FG002|Overall Study|Death|0|||
124471973|NCT03604445|447685603|FG003|Overall Study|Death|0|||
124471974|NCT03604445|447685604|FG004|Overall Study|Death|0|||
124471975|NCT03604445|447685605|FG005|Overall Study|Death|0|||
124471976|NCT03604445|447685606|FG006|Overall Study|Death|0|||
124471977|NCT03604445|447685607|FG007|Overall Study|Death|0|||
124471978|NCT03604445|447685608|FG008|Overall Study|Death|1|||
124471979|NCT03604445|447685600|FG000|Overall Study|Withdrawal by Subject|0|||
124471980|NCT03604445|447685601|FG001|Overall Study|Withdrawal by Subject|0|||
124471981|NCT03604445|447685602|FG002|Overall Study|Withdrawal by Subject|0|||
124471982|NCT03604445|447685603|FG003|Overall Study|Withdrawal by Subject|0|||
124471983|NCT03604445|447685604|FG004|Overall Study|Withdrawal by Subject|0|||
124471984|NCT03604445|447685605|FG005|Overall Study|Withdrawal by Subject|0|||
124471985|NCT03604445|447685606|FG006|Overall Study|Withdrawal by Subject|1|||
124471986|NCT03604445|447685607|FG007|Overall Study|Withdrawal by Subject|0|||
124471987|NCT03604445|447685608|FG008|Overall Study|Withdrawal by Subject|0|||
124471988|NCT03604445|447685600|FG000|Overall Study|Missing visit|0|||
124471989|NCT03604445|447685601|FG001|Overall Study|Missing visit|0|||
124471990|NCT03604445|447685602|FG002|Overall Study|Missing visit|0|||
124471991|NCT03604445|447685603|FG003|Overall Study|Missing visit|0|||
124471992|NCT03604445|447685604|FG004|Overall Study|Missing visit|0|||
124471993|NCT03604445|447685605|FG005|Overall Study|Missing visit|1|||
124471994|NCT03604445|447685606|FG006|Overall Study|Missing visit|0|||
124471995|NCT03604445|447685607|FG007|Overall Study|Missing visit|1|||
124471996|NCT03604445|447685608|FG008|Overall Study|Missing visit|0|||
124471997|NCT03604445|447685600|FG000|Overall Study|Adverse Event|0|||
124471998|NCT03604445|447685601|FG001|Overall Study|Adverse Event|0|||
124471999|NCT03604445|447685602|FG002|Overall Study|Adverse Event|0|||
124554108|NCT00386100|447987337|FG000|Overall Study|Bad metabolic control & patient security|1|||
124554109|NCT00386100|447987338|FG001|Overall Study|Bad metabolic control & patient security|0|||
124554110|NCT00386100|447987337|FG000|Overall Study|Bone loss by DXA bone scan|1|||
124554111|NCT00386100|447987338|FG001|Overall Study|Bone loss by DXA bone scan|0|||
124472000|NCT03604445|447685603|FG003|Overall Study|Adverse Event|1|||
124472001|NCT03604445|447685604|FG004|Overall Study|Adverse Event|0|||
124472002|NCT03604445|447685605|FG005|Overall Study|Adverse Event|0|||
124472003|NCT03604445|447685606|FG006|Overall Study|Adverse Event|0|||
124554112|NCT00386100|447987337|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
124554113|NCT00386100|447987338|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
124554114|NCT00386100|447987337|FG000|Overall Study|7.6% bone loss|1|||
124554115|NCT00386100|447987338|FG001|Overall Study|7.6% bone loss|0|||
124554116|NCT00386100|447987337|FG000|Overall Study|Osteoporosis|0|||
124554117|NCT00386100|447987338|FG001|Overall Study|Osteoporosis|1|||
124554118|NCT00386100|447987337|FG000|Overall Study|Positive pregnancy test|1|||
124554119|NCT00386100|447987338|FG001|Overall Study|Positive pregnancy test|3|||
124554120|NCT00386100|447987337|FG000|Overall Study|Out of country for 5 months|1|||
124554121|NCT00386100|447987338|FG001|Overall Study|Out of country for 5 months|0|||
124554122|NCT00386100|447987337|FG000|Overall Study|Hb1Ac >8%|0|||
124554123|NCT00386100|447987338|FG001|Overall Study|Hb1Ac >8%|1|||
124554124|NCT00386100|447987337|FG000|Overall Study|Participant randomized in error|1|||
124554125|NCT00386100|447987338|FG001|Overall Study|Participant randomized in error|0|||
124472004|NCT03604445|447685607|FG007|Overall Study|Adverse Event|0|||
124472005|NCT03604445|447685608|FG008|Overall Study|Adverse Event|1|||
124472006|NCT00713219|447685620|FG000|Overall Study|Death|1|||
124472007|NCT00713219|447685620|FG000|Overall Study|Protocol Violation|1|||
124472008|NCT00880256|447685621|FG000|Overall Study|Lost to Follow-up|28|||
124472009|NCT01481896|447685624|FG000|Overall Study|Lost to Follow-up|12|||
124472010|NCT03336502|447685625|FG000|Overall Study|Physician Decision|0|||
124472011|NCT03336502|447685626|FG001|Overall Study|Physician Decision|1|||
124554126|NCT00886782|447987342|FG000|Overall Study|Disease progression|3|||
124554127|NCT00886782|447987343|FG001|Overall Study|Disease progression|3|||
124554128|NCT00886782|447987344|FG002|Overall Study|Disease progression|3|||
124554129|NCT00886782|447987342|FG000|Overall Study|Study drug toxicity|0|||
124715760|NCT01881789|448583514|FG001|Overall Study|Other|5|||
124715761|NCT01881789|448583515|FG002|Overall Study|Other|2|||
124715762|NCT01881789|448583516|FG003|Overall Study|Other|3|||
124715763|NCT01881789|448583517|FG004|Overall Study|Other|1|||
124715764|NCT01881789|448583518|FG005|Overall Study|Other|1|||
124715765|NCT01282866|448583523|FG000|Overall Study|Adverse Event|1|||
124715766|NCT01964378|448583526|FG000|Overall Study|Disc. due to death before first dosing|0|||
124715767|NCT01964378|448583527|FG001|Overall Study|Disc. due to death before first dosing|1|||
124715768|NCT01964378|448583526|FG000|Overall Study|Disc. due to AE before first dosing|1|||
124715769|NCT01964378|448583527|FG001|Overall Study|Disc. due to AE before first dosing|0|||
124715770|NCT01964378|448583526|FG000|Overall Study|Death|3|||
124715771|NCT01964378|448583527|FG001|Overall Study|Death|2|||
124715772|NCT01964378|448583526|FG000|Overall Study|Adverse Event|12|||
124715773|NCT01964378|448583527|FG001|Overall Study|Adverse Event|5|||
124715774|NCT01964378|448583526|FG000|Overall Study|Lack of Efficacy|0|||
124715775|NCT01964378|448583527|FG001|Overall Study|Lack of Efficacy|1|||
124715776|NCT01964378|448583526|FG000|Overall Study|Protocol Violation|0|||
124715777|NCT01964378|448583527|FG001|Overall Study|Protocol Violation|1|||
124715778|NCT01964378|448583526|FG000|Overall Study|Lost to Follow-up|0|||
124715779|NCT01964378|448583527|FG001|Overall Study|Lost to Follow-up|1|||
124715780|NCT01964378|448583526|FG000|Overall Study|Withdrawal by Subject|7|||
124715781|NCT01964378|448583527|FG001|Overall Study|Withdrawal by Subject|5|||
124715782|NCT01964378|448583526|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
124715783|NCT01964378|448583527|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
124715784|NCT01964378|448583526|FG000|Overall Study|Other|1|||
124715785|NCT01964378|448583527|FG001|Overall Study|Other|2|||
124715786|NCT03386435|448583528|FG000|Overall Study|Protocol Violation|5|||
124715787|NCT03386435|448583529|FG001|Overall Study|Protocol Violation|7|||
124715788|NCT03542266|448583530|FG000|Treatment Phase|Withdrawal by Subject|1|||
124715789|NCT03542266|448583530|FG000|Treatment Phase|Adverse Event|1|||
124715790|NCT03542266|448583530|FG000|Treatment Phase|PD|1|||
124715791|NCT01162473|448583535|FG000|Overall Study|Adverse Event|2|||
124715792|NCT01162473|448583536|FG001|Overall Study|Adverse Event|1|||
124715793|NCT01162473|448583535|FG000|Overall Study|Withdrawal by Subject|0|||
124715794|NCT01162473|448583536|FG001|Overall Study|Withdrawal by Subject|4|||
124715795|NCT01392573|448583545|FG000|Overall Study|Adverse Event|1|||
124715796|NCT01392573|448583546|FG001|Overall Study|Adverse Event|3|||
124715797|NCT01392573|448583545|FG000|Overall Study|Lack of Efficacy|1|||
124715798|NCT01392573|448583546|FG001|Overall Study|Lack of Efficacy|2|||
124715799|NCT01392573|448583545|FG000|Overall Study|Protocol Violation|0|||
124715800|NCT01392573|448583546|FG001|Overall Study|Protocol Violation|2|||
124715801|NCT01392573|448583545|FG000|Overall Study|Withdrawal Criteria|13|||
124472012|NCT03336502|447685625|FG000|Overall Study|Prohibited Drugs|1|||
124472013|NCT03336502|447685626|FG001|Overall Study|Prohibited Drugs|1|||
124472014|NCT03336502|447685625|FG000|Overall Study|Death|1|||
124472015|NCT03336502|447685626|FG001|Overall Study|Death|2|||
124472016|NCT03336502|447685625|FG000|Overall Study|Adverse Event|2|||
124472017|NCT03336502|447685626|FG001|Overall Study|Adverse Event|5|||
124472018|NCT00565617|447685628|FG000|Overall Study|Withdrawal by Subject|1|||
124472019|NCT01890421|447685629|FG000|Overall Study|Adverse Event|1|||
124472020|NCT01890421|447685629|FG000|Overall Study|Other reason|10|||
124472021|NCT00464178|447685630|FG000|Overall Study|Protocol Violation|1|||
124554130|NCT00886782|447987343|FG001|Overall Study|Study drug toxicity|0|||
124554131|NCT00886782|447987344|FG002|Overall Study|Study drug toxicity|1|||
124554132|NCT00886782|447987342|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
124554133|NCT00886782|447987343|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
124554134|NCT00886782|447987344|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
124554135|NCT01612702|447987345|FG000|Overall Study|Protocol Violation|11|||
124554136|NCT01612702|447987346|FG001|Overall Study|Protocol Violation|11|||
124554137|NCT03636542|447987347|FG000|Overall Study|Lost to Follow-up|1|||
124554138|NCT03636542|447987348|FG001|Overall Study|Lost to Follow-up|1|||
124554139|NCT03636542|447987347|FG000|Overall Study|Physician Decision|0|||
124554140|NCT03636542|447987348|FG001|Overall Study|Physician Decision|1|||
124554141|NCT03636542|447987347|FG000|Overall Study|Withdrawal by Subject|1|||
124554142|NCT03636542|447987348|FG001|Overall Study|Withdrawal by Subject|0|||
124554143|NCT01542736|447987351|FG000|Overall Study|Death|1|||
124554144|NCT03674827|447987352|FG000|Treatment Phase|Adverse Event|0|||
124554145|NCT03674827|447987353|FG001|Treatment Phase|Adverse Event|0|||
124554146|NCT03674827|447987354|FG002|Treatment Phase|Adverse Event|0|||
124554147|NCT03674827|447987355|FG003|Treatment Phase|Adverse Event|0|||
124554148|NCT03674827|447987356|FG004|Treatment Phase|Adverse Event|0|||
124554149|NCT03674827|447987357|FG005|Treatment Phase|Adverse Event|2|||
124554150|NCT03674827|447987352|FG000|Treatment Phase|Death|2|||
124554151|NCT03674827|447987353|FG001|Treatment Phase|Death|0|||
124554152|NCT03674827|447987354|FG002|Treatment Phase|Death|0|||
124554153|NCT03674827|447987355|FG003|Treatment Phase|Death|0|||
124554154|NCT03674827|447987356|FG004|Treatment Phase|Death|1|||
124554155|NCT03674827|447987357|FG005|Treatment Phase|Death|0|||
124554156|NCT03674827|447987352|FG000|Treatment Phase|Progressive Disease|0|||
124554157|NCT03674827|447987353|FG001|Treatment Phase|Progressive Disease|4|||
124554158|NCT03674827|447987354|FG002|Treatment Phase|Progressive Disease|3|||
124554159|NCT03674827|447987355|FG003|Treatment Phase|Progressive Disease|4|||
124554160|NCT03674827|447987356|FG004|Treatment Phase|Progressive Disease|4|||
124554161|NCT03674827|447987357|FG005|Treatment Phase|Progressive Disease|9|||
124554162|NCT03674827|447987352|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
124554163|NCT03674827|447987353|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
124554164|NCT03674827|447987354|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
124554165|NCT03674827|447987355|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
124715802|NCT01392573|448583546|FG001|Overall Study|Withdrawal Criteria|15|||
124715803|NCT01392573|448583545|FG000|Overall Study|Site closure|8|||
124715804|NCT01392573|448583546|FG001|Overall Study|Site closure|7|||
124554166|NCT03674827|447987356|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
124472022|NCT00464178|447685630|FG000|Overall Study|Withdrawal by Subject|1|||
124472023|NCT01557166|447685633|FG000|Overall Study|Adverse Event|20|||
124472024|NCT01557166|447685634|FG001|Overall Study|Adverse Event|6|||
124472025|NCT01557166|447685633|FG000|Overall Study|Lack of Efficacy|2|||
124472026|NCT01557166|447685634|FG001|Overall Study|Lack of Efficacy|1|||
124472027|NCT01557166|447685633|FG000|Overall Study|Protocol Violation|8|||
124472028|NCT01557166|447685634|FG001|Overall Study|Protocol Violation|5|||
124472029|NCT01557166|447685633|FG000|Overall Study|Withdrawn consent|12|||
124472030|NCT01557166|447685634|FG001|Overall Study|Withdrawn consent|20|||
124472031|NCT01557166|447685633|FG000|Overall Study|Target dose not tolerated|1|||
124472032|NCT01557166|447685634|FG001|Overall Study|Target dose not tolerated|0|||
124472033|NCT01557166|447685633|FG000|Overall Study|Psychiatric disorder|1|||
124472034|NCT01557166|447685634|FG001|Overall Study|Psychiatric disorder|0|||
124472035|NCT01557166|447685633|FG000|Overall Study|Unclassified|2|||
124472036|NCT01557166|447685634|FG001|Overall Study|Unclassified|5|||
124472037|NCT01465659|447685638|FG000|Completed 1 Cycle of Treatment|Death|0|||
124472038|NCT01465659|447685639|FG001|Completed 1 Cycle of Treatment|Death|1|||
124472039|NCT01465659|447685640|FG002|Completed 1 Cycle of Treatment|Death|0|||
124472040|NCT01465659|447685641|FG003|Completed 1 Cycle of Treatment|Death|0|||
124472041|NCT01465659|447685638|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
124472042|NCT01465659|447685639|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
124472043|NCT01465659|447685640|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
124472044|NCT01465659|447685641|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
124472045|NCT01465659|447685638|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
124472046|NCT01465659|447685639|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
124472047|NCT01465659|447685640|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
124472048|NCT01465659|447685641|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
124472049|NCT01465659|447685638|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
124472050|NCT01465659|447685639|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
124472051|NCT01465659|447685640|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
124472052|NCT01465659|447685641|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
124472053|NCT01465659|447685638|FG000|Completed Follow for 1 Year|Death|6|||
124472054|NCT01465659|447685639|FG001|Completed Follow for 1 Year|Death|3|||
124472055|NCT01465659|447685640|FG002|Completed Follow for 1 Year|Death|2|||
124472056|NCT01465659|447685641|FG003|Completed Follow for 1 Year|Death|4|||
124472057|NCT02445586|447685644|FG000|Overall Study|Death|14|||
124472058|NCT02445586|447685644|FG000|Overall Study|Withdrawal by Subject|13|||
124472059|NCT02445586|447685644|FG000|Overall Study|Disease Progression|10|||
124472060|NCT02445586|447685644|FG000|Overall Study|Protocol Violation|1|||
124472061|NCT02445586|447685644|FG000|Overall Study|Medical Condition|1|||
124472062|NCT00428597|447685649|FG000|Overall Study|Randomized but not treated|3|||
124472063|NCT00428597|447685650|FG001|Overall Study|Randomized but not treated|3|||
124472064|NCT00428597|447685649|FG000|Overall Study|Objective Progression or Relapse|19|||
124472065|NCT00428597|447685650|FG001|Overall Study|Objective Progression or Relapse|47|||
124472066|NCT00428597|447685649|FG000|Overall Study|Study Terminated by Sponsor|41|||
124472067|NCT00428597|447685650|FG001|Overall Study|Study Terminated by Sponsor|16|||
124472068|NCT00428597|447685649|FG000|Overall Study|Adverse Event|15|||
124472069|NCT00428597|447685650|FG001|Overall Study|Adverse Event|7|||
124472070|NCT00428597|447685649|FG000|Overall Study|Global Deterioration of Health Status|1|||
124472071|NCT00428597|447685650|FG001|Overall Study|Global Deterioration of Health Status|5|||
124472072|NCT00428597|447685649|FG000|Overall Study|Protocol Violation|2|||
124472073|NCT00428597|447685650|FG001|Overall Study|Protocol Violation|1|||
124472074|NCT00428597|447685649|FG000|Overall Study|Withdrawal by Subject|2|||
124472075|NCT00428597|447685650|FG001|Overall Study|Withdrawal by Subject|1|||
124472076|NCT00428597|447685649|FG000|Overall Study|Other|1|||
124472077|NCT00428597|447685650|FG001|Overall Study|Other|1|||
124472078|NCT00428597|447685649|FG000|Overall Study|Lost to Follow-up|0|||
124472079|NCT00428597|447685650|FG001|Overall Study|Lost to Follow-up|1|||
124472080|NCT00428597|447685649|FG000|Overall Study|Pregnancy|1|||
124472081|NCT00428597|447685650|FG001|Overall Study|Pregnancy|0|||
124472082|NCT00428597|447685649|FG000|Overall Study|Death|1|||
124472083|NCT00428597|447685650|FG001|Overall Study|Death|3|||
124472084|NCT01469000|447685651|FG000|Overall Study|Withdrawal by Subject|16|||
124472085|NCT01469000|447685652|FG001|Overall Study|Withdrawal by Subject|3|||
124472086|NCT01469000|447685651|FG000|Overall Study|Sponsor Decision|4|||
124472087|NCT01469000|447685652|FG001|Overall Study|Sponsor Decision|1|||
124472088|NCT00686647|447685654|FG000|Overall Study|Lost to Follow-up|1|||
124472089|NCT00686647|447685654|FG000|Overall Study|Death|1|||
124472090|NCT01990261|447685660|FG000|Overall Study|Death Before Treatment Start|2|||
124472091|NCT01990261|447685660|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
124472092|NCT01990261|447685660|FG000|Overall Study|Death From other Causes|1|||
124554167|NCT03674827|447987357|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
124554168|NCT03674827|447987352|FG000|Treatment Phase|Withdrawal by Subject|0|||
124554169|NCT03674827|447987353|FG001|Treatment Phase|Withdrawal by Subject|0|||
124472093|NCT01990261|447685660|FG000|Overall Study|Disease Progression (PD)|8|||
124472094|NCT01990261|447685660|FG000|Overall Study|PD Before Treatment Start|1|||
124472095|NCT01990261|447685660|FG000|Overall Study|Dossier not Approved|1|||
124472096|NCT01990261|447685660|FG000|Overall Study|Lost to Follow-up|2|||
124472097|NCT00772668|447685671|FG000|Overall Study|Physician Decision|3|||
124472098|NCT03344003|447685672|FG000|Overall Study|Switched to alternative treatment|1|||
124472099|NCT03344003|447685673|FG001|Overall Study|Switched to alternative treatment|0|||
124472100|NCT03344003|447685672|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
124554170|NCT03674827|447987354|FG002|Treatment Phase|Withdrawal by Subject|0|||
124554171|NCT03674827|447987355|FG003|Treatment Phase|Withdrawal by Subject|0|||
124715805|NCT01392573|448583545|FG000|Overall Study|Unclassified|9|||
124715806|NCT01392573|448583546|FG001|Overall Study|Unclassified|6|||
124472101|NCT03344003|447685673|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
124472102|NCT03631706|447685676|FG000|Overall Study|Randomized, not treated|1|||
124472103|NCT03631706|447685677|FG001|Overall Study|Randomized, not treated|0|||
124472104|NCT02152345|447687583|FG000|Overall Study|Case Cancellations|2|||
124472105|NCT02152345|447687584|FG001|Overall Study|Case Cancellations|4|||
124472106|NCT02152345|447687583|FG000|Overall Study|Withdrawal by Subject|2|||
124472107|NCT02152345|447687584|FG001|Overall Study|Withdrawal by Subject|1|||
124472108|NCT01916980|447687585|FG000|Overall Study|Adverse Event|4|||
124472109|NCT01916980|447687586|FG001|Overall Study|Adverse Event|2|||
124472110|NCT01916980|447687585|FG000|Overall Study|Lack of Efficacy|2|||
124472111|NCT01916980|447687586|FG001|Overall Study|Lack of Efficacy|2|||
124472112|NCT01916980|447687585|FG000|Overall Study|Withdrawal by Subject|1|||
124472113|NCT01916980|447687586|FG001|Overall Study|Withdrawal by Subject|0|||
124472114|NCT04439279|447687587|FG000|Overall Study|Adverse Event|7|||
124472115|NCT04439279|447687587|FG000|Overall Study|Death|4|||
124472116|NCT04439279|447687587|FG000|Overall Study|Disease progression|17|||
124472117|NCT04439279|447687587|FG000|Overall Study|Complicating disease|3|||
124472118|NCT04439279|447687587|FG000|Overall Study|Withdrawal by Subject|2|||
124472119|NCT04439279|447687587|FG000|Overall Study|Ineligible|1|||
124472120|NCT04439279|447687587|FG000|Overall Study|Treatment still ongoing|1|||
124472121|NCT02324270|447687588|FG000|Overall Study|Withdrawal by Subject|0|||
124472122|NCT02324270|447687589|FG001|Overall Study|Withdrawal by Subject|1|||
124472123|NCT02324270|447687590|FG002|Overall Study|Withdrawal by Subject|0|||
124472124|NCT02324270|447687588|FG000|Overall Study|Lost to Follow-up|4|||
124472125|NCT02324270|447687589|FG001|Overall Study|Lost to Follow-up|3|||
124472126|NCT02324270|447687590|FG002|Overall Study|Lost to Follow-up|4|||
124472127|NCT02324270|447687588|FG000|Overall Study|Protocol Violation|0|||
124472128|NCT02324270|447687589|FG001|Overall Study|Protocol Violation|1|||
124472129|NCT02324270|447687590|FG002|Overall Study|Protocol Violation|1|||
124472130|NCT02324270|447687588|FG000|Overall Study|Non Compliance with Study Drug|1|||
124472131|NCT02324270|447687589|FG001|Overall Study|Non Compliance with Study Drug|2|||
124472132|NCT02324270|447687590|FG002|Overall Study|Non Compliance with Study Drug|0|||
124472133|NCT03521791|447687591|FG000|Overall Study|Protocol Violation|7|||
124472134|NCT03521791|447687592|FG001|Overall Study|Protocol Violation|17|||
124472135|NCT00680836|447687594|FG000|Overall Study|Withdrawal by Subject|3|||
124472136|NCT00680836|447687595|FG001|Overall Study|Withdrawal by Subject|0|||
124472137|NCT00680836|447687594|FG000|Overall Study|Lost to Follow-up|3|||
124472138|NCT00680836|447687595|FG001|Overall Study|Lost to Follow-up|1|||
124472139|NCT00680836|447687594|FG000|Overall Study|Physician Decision|2|||
124472140|NCT00680836|447687595|FG001|Overall Study|Physician Decision|1|||
124472141|NCT03786432|447687596|FG000|Overall Study|Screen Failure after consent|1|||
124472142|NCT03786432|447687596|FG000|Overall Study|Lost to Follow-up|4|||
124472143|NCT03786432|447687596|FG000|Overall Study|did not complete 12 month CT scan|1|||
124472144|NCT00925600|447687600|FG000|Overall Study|Withdrawal by Subject|16|||
124472145|NCT00925600|447687601|FG001|Overall Study|Withdrawal by Subject|14|||
124472146|NCT00925600|447687600|FG000|Overall Study|Death|4|||
124472147|NCT00925600|447687601|FG001|Overall Study|Death|3|||
124472148|NCT00925600|447687600|FG000|Overall Study|Lost to Follow-up|2|||
124472149|NCT00925600|447687601|FG001|Overall Study|Lost to Follow-up|2|||
124472150|NCT00925600|447687600|FG000|Overall Study|Disease Progression|1|||
124472151|NCT00925600|447687601|FG001|Overall Study|Disease Progression|3|||
124472152|NCT00925600|447687600|FG000|Overall Study|Administrative Decision|1|||
124472153|NCT00925600|447687601|FG001|Overall Study|Administrative Decision|1|||
124472154|NCT00925600|447687600|FG000|Overall Study|Noncompliance|2|||
124472155|NCT00925600|447687601|FG001|Overall Study|Noncompliance|0|||
124472156|NCT00925600|447687600|FG000|Overall Study|Ineligibility Determined|2|||
124472157|NCT00925600|447687601|FG001|Overall Study|Ineligibility Determined|0|||
124472158|NCT00925600|447687600|FG000|Overall Study|Protocol Deviation|0|||
124472159|NCT00925600|447687601|FG001|Overall Study|Protocol Deviation|1|||
124472160|NCT00925600|447687600|FG000|Overall Study|Requirement for Alternative Therapy|0|||
124472161|NCT00925600|447687601|FG001|Overall Study|Requirement for Alternative Therapy|1|||
124472162|NCT00925600|447687600|FG000|Overall Study|Other|3|||
124472163|NCT00925600|447687601|FG001|Overall Study|Other|1|||
124472164|NCT00925600|447687600|FG000|Overall Study|Adverse Event|1|||
124472165|NCT00925600|447687601|FG001|Overall Study|Adverse Event|2|||
124472166|NCT01974817|447687602|FG000|Overall Study|Death|4|||
124472167|NCT01974817|447687602|FG000|Overall Study|Lost to Follow-up|2|||
124472168|NCT01974817|447687602|FG000|Overall Study|Protocol Violation|2|||
124472169|NCT05512949|447687603|FG000|Overall Study|Lost to Follow-up|4|||
124472170|NCT05512949|447687604|FG001|Overall Study|Lost to Follow-up|6|||
124472171|NCT05512949|447687605|FG002|Overall Study|Lost to Follow-up|2|||
124472172|NCT05512949|447687603|FG000|Overall Study|Protocol Violation|0|||
124472173|NCT05512949|447687604|FG001|Overall Study|Protocol Violation|0|||
124472174|NCT05512949|447687605|FG002|Overall Study|Protocol Violation|1|||
124472175|NCT05512949|447687603|FG000|Overall Study|Withdrawal by Subject|1|||
124472176|NCT05512949|447687604|FG001|Overall Study|Withdrawal by Subject|1|||
124472177|NCT05512949|447687605|FG002|Overall Study|Withdrawal by Subject|2|||
124472178|NCT05512949|447687603|FG000|Overall Study|Completion status unknown|1|||
124472179|NCT05512949|447687604|FG001|Overall Study|Completion status unknown|3|||
124472180|NCT05512949|447687605|FG002|Overall Study|Completion status unknown|0|||
124472181|NCT03593915|447687606|FG000|Overall Study|Adverse Event|0|||
124472182|NCT03593915|447687607|FG001|Overall Study|Adverse Event|0|||
124472183|NCT03593915|447687608|FG002|Overall Study|Adverse Event|0|||
124472184|NCT03593915|447687609|FG003|Overall Study|Adverse Event|1|||
124472185|NCT03593915|447687610|FG004|Overall Study|Adverse Event|0|||
124472186|NCT03593915|447687611|FG005|Overall Study|Adverse Event|0|||
124472187|NCT03593915|447687606|FG000|Overall Study|Physician Decision|0|||
124472188|NCT03593915|447687607|FG001|Overall Study|Physician Decision|0|||
124472189|NCT03593915|447687608|FG002|Overall Study|Physician Decision|0|||
124472190|NCT03593915|447687609|FG003|Overall Study|Physician Decision|0|||
124472191|NCT03593915|447687610|FG004|Overall Study|Physician Decision|0|||
124472192|NCT03593915|447687611|FG005|Overall Study|Physician Decision|1|||
124472193|NCT04660643|447687612|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
124472194|NCT04660643|447687613|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
124472195|NCT04660643|447687614|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
124472196|NCT04660643|447687612|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
124472197|NCT04660643|447687613|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
124715807|NCT03008070|448583547|FG000|Overall Study|Adverse Event|3|||
124715808|NCT03008070|448583548|FG001|Overall Study|Adverse Event|3|||
124715809|NCT03008070|448583549|FG002|Overall Study|Adverse Event|3|||
124472198|NCT04660643|447687614|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
124472199|NCT04660643|447687612|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
124472200|NCT04660643|447687613|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
124472201|NCT04660643|447687614|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
124472202|NCT04660643|447687612|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
124472203|NCT04660643|447687613|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
124472204|NCT04660643|447687614|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
124472205|NCT04660643|447687612|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
124472206|NCT04660643|447687613|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
124472207|NCT04660643|447687614|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
124472208|NCT04660643|447687612|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
124472209|NCT04660643|447687613|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
124472210|NCT04660643|447687614|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
124554172|NCT03674827|447987356|FG004|Treatment Phase|Withdrawal by Subject|0|||
124554173|NCT03674827|447987357|FG005|Treatment Phase|Withdrawal by Subject|1|||
124554174|NCT03674827|447987352|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
124554175|NCT03674827|447987353|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
124554176|NCT03674827|447987354|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
124554177|NCT03674827|447987355|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
124554178|NCT03674827|447987356|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
124554179|NCT03674827|447987357|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
124554180|NCT03674827|447987352|FG000|Treatment Phase|Other|0|||
124554181|NCT03674827|447987353|FG001|Treatment Phase|Other|1|||
124554182|NCT03674827|447987354|FG002|Treatment Phase|Other|0|||
124554183|NCT03674827|447987355|FG003|Treatment Phase|Other|0|||
124554184|NCT03674827|447987356|FG004|Treatment Phase|Other|0|||
124554185|NCT03674827|447987357|FG005|Treatment Phase|Other|1|||
124554186|NCT03674827|447987352|FG000|Long-Term Follow-up Phase|Death|2|||
124554187|NCT03674827|447987353|FG001|Long-Term Follow-up Phase|Death|4|||
124554188|NCT03674827|447987354|FG002|Long-Term Follow-up Phase|Death|2|||
124554189|NCT03674827|447987355|FG003|Long-Term Follow-up Phase|Death|3|||
124554190|NCT03674827|447987356|FG004|Long-Term Follow-up Phase|Death|2|||
124554191|NCT03674827|447987357|FG005|Long-Term Follow-up Phase|Death|6|||
124554192|NCT03674827|447987352|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
124554193|NCT03674827|447987353|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
124554194|NCT03674827|447987354|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
124554195|NCT03674827|447987355|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
124554196|NCT03674827|447987356|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
124554197|NCT03674827|447987357|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
124554198|NCT03674827|447987352|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
124715810|NCT03008070|448583547|FG000|Overall Study|Lost to Follow-up|1|||
124715811|NCT03008070|448583548|FG001|Overall Study|Lost to Follow-up|1|||
124715812|NCT03008070|448583549|FG002|Overall Study|Lost to Follow-up|0|||
124715813|NCT03008070|448583547|FG000|Overall Study|Non compliance|0|||
124715814|NCT03008070|448583548|FG001|Overall Study|Non compliance|1|||
124715815|NCT03008070|448583549|FG002|Overall Study|Non compliance|1|||
124472211|NCT04660643|447687612|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
124472212|NCT04660643|447687613|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
124472213|NCT04660643|447687614|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
124554199|NCT03674827|447987353|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
124554200|NCT03674827|447987354|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
124715816|NCT03008070|448583547|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
124715817|NCT03008070|448583548|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
124715818|NCT03008070|448583549|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
124472214|NCT04660643|447687612|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
124554201|NCT03674827|447987355|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
124554202|NCT03674827|447987356|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
124715819|NCT03008070|448583547|FG000|Overall Study|Withdrawal by Subject|2|||
124715820|NCT03008070|448583548|FG001|Overall Study|Withdrawal by Subject|0|||
124554203|NCT03674827|447987357|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
124554204|NCT01783483|447987358|FG000|Overall Study|Death|3|||
124715821|NCT03008070|448583549|FG002|Overall Study|Withdrawal by Subject|1|||
124472215|NCT04660643|447687613|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
124472216|NCT04660643|447687614|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
124472217|NCT04660643|447687612|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
124472218|NCT04660643|447687613|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
124472219|NCT04660643|447687614|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
124472220|NCT04660643|447687612|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
124472221|NCT04660643|447687613|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
124472222|NCT04660643|447687614|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
124472223|NCT04660643|447687612|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
124472224|NCT04660643|447687613|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
124472225|NCT04660643|447687614|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
124472226|NCT04660643|447687612|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
124472227|NCT04660643|447687613|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
124472228|NCT04660643|447687614|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
124472229|NCT04660643|447687612|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
124472230|NCT04660643|447687613|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
124554205|NCT01783483|447987359|FG001|Overall Study|Death|3|||
124472231|NCT04660643|447687614|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
124554206|NCT01783483|447987358|FG000|Overall Study|Lost to Follow-up|14|||
124554207|NCT01783483|447987359|FG001|Overall Study|Lost to Follow-up|10|||
124554208|NCT01783483|447987358|FG000|Overall Study|Withdrawal by Subject|2|||
124554209|NCT01783483|447987359|FG001|Overall Study|Withdrawal by Subject|1|||
124554210|NCT01783483|447987358|FG000|Overall Study|Physician Decision|1|||
124554211|NCT01783483|447987359|FG001|Overall Study|Physician Decision|1|||
124554212|NCT04130919|447987362|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
124554213|NCT04130919|447987363|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
124554214|NCT04130919|447987364|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
124554215|NCT04130919|447987365|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
124472232|NCT04660643|447687612|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
124554216|NCT04130919|447987366|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
124554217|NCT04130919|447987367|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
124554218|NCT04130919|447987362|FG000|Blinded Treatment Phase|Adverse Event|0|||
124554219|NCT04130919|447987363|FG001|Blinded Treatment Phase|Adverse Event|0|||
124554220|NCT04130919|447987364|FG002|Blinded Treatment Phase|Adverse Event|1|||
124554221|NCT04130919|447987365|FG003|Blinded Treatment Phase|Adverse Event|0|||
124554222|NCT04130919|447987366|FG004|Blinded Treatment Phase|Adverse Event|0|||
124554223|NCT04130919|447987367|FG005|Blinded Treatment Phase|Adverse Event|0|||
124554224|NCT04130919|447987362|FG000|Blinded Treatment Phase|Disease worsening|0|||
124554225|NCT04130919|447987363|FG001|Blinded Treatment Phase|Disease worsening|0|||
124554226|NCT04130919|447987364|FG002|Blinded Treatment Phase|Disease worsening|1|||
124554227|NCT04130919|447987365|FG003|Blinded Treatment Phase|Disease worsening|0|||
124554228|NCT04130919|447987366|FG004|Blinded Treatment Phase|Disease worsening|0|||
124554229|NCT04130919|447987367|FG005|Blinded Treatment Phase|Disease worsening|0|||
124554230|NCT04130919|447987362|FG000|Blinded Treatment Phase|Investigator's decision|0|||
124554231|NCT04130919|447987363|FG001|Blinded Treatment Phase|Investigator's decision|1|||
124554232|NCT04130919|447987364|FG002|Blinded Treatment Phase|Investigator's decision|0|||
124554233|NCT04130919|447987365|FG003|Blinded Treatment Phase|Investigator's decision|0|||
124554234|NCT04130919|447987366|FG004|Blinded Treatment Phase|Investigator's decision|0|||
124554235|NCT04130919|447987367|FG005|Blinded Treatment Phase|Investigator's decision|0|||
124554236|NCT04130919|447987362|FG000|Blinded Treatment Phase|Withdrew consent|1|||
124554237|NCT04130919|447987363|FG001|Blinded Treatment Phase|Withdrew consent|0|||
124554238|NCT04130919|447987364|FG002|Blinded Treatment Phase|Withdrew consent|0|||
124554239|NCT04130919|447987365|FG003|Blinded Treatment Phase|Withdrew consent|0|||
124554240|NCT04130919|447987366|FG004|Blinded Treatment Phase|Withdrew consent|0|||
124554241|NCT04130919|447987367|FG005|Blinded Treatment Phase|Withdrew consent|0|||
124554242|NCT04130919|447987362|FG000|Open-label Treatment Phase|Withdrew consent|0|||
124554243|NCT04130919|447987363|FG001|Open-label Treatment Phase|Withdrew consent|0|||
124554244|NCT04130919|447987364|FG002|Open-label Treatment Phase|Withdrew consent|0|||
124554245|NCT04130919|447987365|FG003|Open-label Treatment Phase|Withdrew consent|1|||
124554246|NCT04130919|447987366|FG004|Open-label Treatment Phase|Withdrew consent|1|||
124554247|NCT04130919|447987367|FG005|Open-label Treatment Phase|Withdrew consent|1|||
124554248|NCT04130919|447987362|FG000|Open-label Treatment Phase|Disease worsening|0|||
124554249|NCT04130919|447987363|FG001|Open-label Treatment Phase|Disease worsening|0|||
124554250|NCT04130919|447987364|FG002|Open-label Treatment Phase|Disease worsening|0|||
124554251|NCT04130919|447987365|FG003|Open-label Treatment Phase|Disease worsening|1|||
124554252|NCT04130919|447987366|FG004|Open-label Treatment Phase|Disease worsening|0|||
124554253|NCT04130919|447987367|FG005|Open-label Treatment Phase|Disease worsening|1|||
124554254|NCT04130919|447987362|FG000|Open-label Treatment Phase|Investigator's decision|0|||
124554255|NCT04130919|447987363|FG001|Open-label Treatment Phase|Investigator's decision|0|||
124554256|NCT04130919|447987364|FG002|Open-label Treatment Phase|Investigator's decision|0|||
124554257|NCT04130919|447987365|FG003|Open-label Treatment Phase|Investigator's decision|1|||
124554258|NCT04130919|447987366|FG004|Open-label Treatment Phase|Investigator's decision|0|||
124554259|NCT04130919|447987367|FG005|Open-label Treatment Phase|Investigator's decision|0|||
124554260|NCT04130919|447987362|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
124554261|NCT04130919|447987363|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
124554262|NCT04130919|447987364|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
124554263|NCT04130919|447987365|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
124554264|NCT04130919|447987366|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
124554265|NCT04130919|447987367|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
124554266|NCT04130919|447987362|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
124554267|NCT04130919|447987363|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
124554268|NCT04130919|447987364|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
124554269|NCT04130919|447987365|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
124554270|NCT04130919|447987366|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
124554271|NCT04130919|447987367|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
124554272|NCT02624518|447987368|FG000|Overall Study|Physician Decision|1|||
124554273|NCT00370396|447987369|FG000|Overall Study|Withdrawal by Subject|0|||
124554274|NCT00370396|447987370|FG001|Overall Study|Withdrawal by Subject|0|||
124554275|NCT00370396|447987371|FG002|Overall Study|Withdrawal by Subject|1|||
124554276|NCT00370396|447987369|FG000|Overall Study|Lost to Follow-up|11|||
124554277|NCT00370396|447987370|FG001|Overall Study|Lost to Follow-up|1|||
124554278|NCT00370396|447987371|FG002|Overall Study|Lost to Follow-up|0|||
124554279|NCT01462695|447987372|FG000|Overall Study|Adverse Event|1|||
124554280|NCT01462695|447987373|FG001|Overall Study|Adverse Event|1|||
124770943|NCT02492763|448791647|FG003|Overall Study|Non-Compliance With Study Drug|0|||
124770944|NCT02492763|448791644|FG000|Overall Study|Screen Failure|0|||
124554281|NCT01462695|447987372|FG000|Overall Study|Death|2|||
124554282|NCT01462695|447987373|FG001|Overall Study|Death|0|||
124770945|NCT02492763|448791645|FG001|Overall Study|Screen Failure|0|||
124770946|NCT02492763|448791646|FG002|Overall Study|Screen Failure|0|||
124770947|NCT02492763|448791647|FG003|Overall Study|Screen Failure|1|||
124472233|NCT04660643|447687613|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
124472234|NCT04660643|447687614|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
124472235|NCT04660643|447687612|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
124472236|NCT04660643|447687613|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
124472237|NCT04660643|447687614|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
124472238|NCT04660643|447687612|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
124472239|NCT04660643|447687613|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
124472240|NCT04660643|447687614|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
124715822|NCT03008070|448583547|FG000|Overall Study|Use of prohibited drug|0|||
124715823|NCT03008070|448583548|FG001|Overall Study|Use of prohibited drug|0|||
124715824|NCT03008070|448583549|FG002|Overall Study|Use of prohibited drug|2|||
124715825|NCT04409834|448583552|FG000|Overall Study|Death|55|||
124472241|NCT03988907|447687615|FG000|Overall Study|Unable to complete visit|0|||
124472242|NCT03988907|447687616|FG001|Overall Study|Unable to complete visit|1|||
124715826|NCT04409834|448583553|FG001|Overall Study|Death|62|||
124715827|NCT01365455|448583554|FG000|Induction Period|Adverse Event|5|||
124715828|NCT01365455|448583555|FG001|Induction Period|Adverse Event|3|||
124715829|NCT01365455|448583556|FG002|Induction Period|Adverse Event|4|||
124554283|NCT01462695|447987372|FG000|Overall Study|Lack of Efficacy|6|||
124554284|NCT01462695|447987373|FG001|Overall Study|Lack of Efficacy|12|||
124554285|NCT01462695|447987372|FG000|Overall Study|Physician Decision|5|||
124554286|NCT01462695|447987373|FG001|Overall Study|Physician Decision|0|||
124554287|NCT01462695|447987372|FG000|Overall Study|Withdrawal by Subject|2|||
124554288|NCT01462695|447987373|FG001|Overall Study|Withdrawal by Subject|0|||
124554289|NCT01462695|447987372|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
124554290|NCT01462695|447987373|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
124554291|NCT02400905|447987374|FG000|Overall Study|Death|24|||
124715830|NCT01365455|448583557|FG003|Induction Period|Adverse Event|0|||
124715831|NCT01365455|448583558|FG004|Induction Period|Adverse Event|0|||
124715832|NCT01365455|448583554|FG000|Induction Period|Lack of Efficacy|1|||
124715833|NCT01365455|448583555|FG001|Induction Period|Lack of Efficacy|1|||
124715834|NCT01365455|448583556|FG002|Induction Period|Lack of Efficacy|0|||
124715835|NCT01365455|448583557|FG003|Induction Period|Lack of Efficacy|0|||
124715836|NCT01365455|448583558|FG004|Induction Period|Lack of Efficacy|0|||
124715837|NCT01365455|448583554|FG000|Induction Period|Pregnancy|0|||
124715838|NCT01365455|448583555|FG001|Induction Period|Pregnancy|1|||
124715839|NCT01365455|448583556|FG002|Induction Period|Pregnancy|0|||
124715840|NCT01365455|448583557|FG003|Induction Period|Pregnancy|0|||
124554292|NCT02400905|447987374|FG000|Overall Study|Lost to Follow-up|18|||
124715841|NCT01365455|448583558|FG004|Induction Period|Pregnancy|0|||
124715842|NCT01365455|448583554|FG000|Induction Period|Protocol deviation|0|||
124554293|NCT02400905|447987374|FG000|Overall Study|Withdrawal by Subject|16|||
124554294|NCT02400905|447987374|FG000|Overall Study|Physician Decision|4|||
124554295|NCT02400905|447987374|FG000|Overall Study|Other|1|||
124554296|NCT01749033|447987376|FG000|Overall Study|Did not receive allocated intervention|3|||
124554297|NCT01749033|447987377|FG001|Overall Study|Did not receive allocated intervention|3|||
124554298|NCT01749033|447987378|FG002|Overall Study|Did not receive allocated intervention|0|||
124554299|NCT01749033|447987376|FG000|Overall Study|Lost to Follow-up|0|||
124554300|NCT01749033|447987377|FG001|Overall Study|Lost to Follow-up|2|||
124554301|NCT01749033|447987378|FG002|Overall Study|Lost to Follow-up|1|||
124554302|NCT00068237|447987379|FG000|Overall Study|Ineligible|3|||
124554303|NCT00068237|447987379|FG000|Overall Study|No protocol treatment received|2|||
124554304|NCT01358708|447987381|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
124715843|NCT01365455|448583555|FG001|Induction Period|Protocol deviation|1|||
124715844|NCT01365455|448583556|FG002|Induction Period|Protocol deviation|1|||
124715845|NCT01365455|448583557|FG003|Induction Period|Protocol deviation|0|||
124715846|NCT01365455|448583558|FG004|Induction Period|Protocol deviation|0|||
124715847|NCT01365455|448583554|FG000|Induction Period|Subject/guardian decision|9|||
124715848|NCT01365455|448583555|FG001|Induction Period|Subject/guardian decision|1|||
124715849|NCT01365455|448583556|FG002|Induction Period|Subject/guardian decision|8|||
124715850|NCT01365455|448583557|FG003|Induction Period|Subject/guardian decision|0|||
124715851|NCT01365455|448583558|FG004|Induction Period|Subject/guardian decision|0|||
124715852|NCT01365455|448583554|FG000|Induction Period|Lost to Follow-up|0|||
124715853|NCT01365455|448583555|FG001|Induction Period|Lost to Follow-up|0|||
124715854|NCT01365455|448583556|FG002|Induction Period|Lost to Follow-up|3|||
124715855|NCT01365455|448583557|FG003|Induction Period|Lost to Follow-up|0|||
124715856|NCT01365455|448583558|FG004|Induction Period|Lost to Follow-up|0|||
124715857|NCT01365455|448583554|FG000|Maintenance Period|Adverse Event|12|||
124715858|NCT01365455|448583555|FG001|Maintenance Period|Adverse Event|5|||
124715859|NCT01365455|448583556|FG002|Maintenance Period|Adverse Event|1|||
124715860|NCT01365455|448583557|FG003|Maintenance Period|Adverse Event|2|||
124715861|NCT01365455|448583558|FG004|Maintenance Period|Adverse Event|4|||
124715862|NCT01365455|448583554|FG000|Maintenance Period|Lack of Efficacy|10|||
124715863|NCT01365455|448583555|FG001|Maintenance Period|Lack of Efficacy|2|||
124715864|NCT01365455|448583556|FG002|Maintenance Period|Lack of Efficacy|0|||
124715865|NCT01365455|448583557|FG003|Maintenance Period|Lack of Efficacy|2|||
124715866|NCT01365455|448583558|FG004|Maintenance Period|Lack of Efficacy|2|||
124715867|NCT01365455|448583554|FG000|Maintenance Period|Lost to Follow-up|2|||
124715868|NCT01365455|448583555|FG001|Maintenance Period|Lost to Follow-up|4|||
124715869|NCT01365455|448583556|FG002|Maintenance Period|Lost to Follow-up|0|||
124715870|NCT01365455|448583557|FG003|Maintenance Period|Lost to Follow-up|0|||
124715871|NCT01365455|448583558|FG004|Maintenance Period|Lost to Follow-up|3|||
124715872|NCT01365455|448583554|FG000|Maintenance Period|Non-compliance with study treatment|0|||
124715873|NCT01365455|448583555|FG001|Maintenance Period|Non-compliance with study treatment|0|||
124715874|NCT01365455|448583556|FG002|Maintenance Period|Non-compliance with study treatment|0|||
124715875|NCT01365455|448583557|FG003|Maintenance Period|Non-compliance with study treatment|1|||
124715876|NCT01365455|448583558|FG004|Maintenance Period|Non-compliance with study treatment|0|||
124715877|NCT01365455|448583554|FG000|Maintenance Period|Physician Decision|0|||
124715878|NCT01365455|448583555|FG001|Maintenance Period|Physician Decision|1|||
124715879|NCT01365455|448583556|FG002|Maintenance Period|Physician Decision|0|||
124715880|NCT01365455|448583557|FG003|Maintenance Period|Physician Decision|0|||
124715881|NCT01365455|448583558|FG004|Maintenance Period|Physician Decision|1|||
124715882|NCT01365455|448583554|FG000|Maintenance Period|Pregnancy|0|||
124715883|NCT01365455|448583555|FG001|Maintenance Period|Pregnancy|4|||
124715884|NCT01365455|448583556|FG002|Maintenance Period|Pregnancy|0|||
124715885|NCT01365455|448583557|FG003|Maintenance Period|Pregnancy|0|||
124715886|NCT01365455|448583558|FG004|Maintenance Period|Pregnancy|2|||
124715887|NCT01365455|448583554|FG000|Maintenance Period|Protocol deviation|1|||
124715888|NCT01365455|448583555|FG001|Maintenance Period|Protocol deviation|1|||
124715889|NCT01365455|448583556|FG002|Maintenance Period|Protocol deviation|0|||
124715890|NCT01365455|448583557|FG003|Maintenance Period|Protocol deviation|0|||
124715891|NCT01365455|448583558|FG004|Maintenance Period|Protocol deviation|0|||
124715892|NCT01365455|448583554|FG000|Maintenance Period|Subject/guardian decision|4|||
124715893|NCT01365455|448583555|FG001|Maintenance Period|Subject/guardian decision|6|||
124715894|NCT01365455|448583556|FG002|Maintenance Period|Subject/guardian decision|2|||
124715895|NCT01365455|448583557|FG003|Maintenance Period|Subject/guardian decision|4|||
124715896|NCT01365455|448583558|FG004|Maintenance Period|Subject/guardian decision|1|||
124715897|NCT00928187|448583559|FG000|Overall Study|Death|1|||
124715898|NCT00928187|448583560|FG001|Overall Study|Death|2|||
124715899|NCT00928187|448583561|FG002|Overall Study|Death|3|||
124715900|NCT00928187|448583559|FG000|Overall Study|Lost to Follow-up|1|||
124715901|NCT00928187|448583560|FG001|Overall Study|Lost to Follow-up|2|||
124715902|NCT00928187|448583561|FG002|Overall Study|Lost to Follow-up|1|||
124715903|NCT00928187|448583559|FG000|Overall Study|Withdrawal by Subject|0|||
124715904|NCT00928187|448583560|FG001|Overall Study|Withdrawal by Subject|1|||
124715905|NCT00928187|448583561|FG002|Overall Study|Withdrawal by Subject|1|||
124715906|NCT00928187|448583559|FG000|Overall Study|Protocol Violation|0|||
124715907|NCT00928187|448583560|FG001|Overall Study|Protocol Violation|1|||
124715908|NCT00928187|448583561|FG002|Overall Study|Protocol Violation|0|||
124715909|NCT04245449|448584996|FG000|Overall Study|COVID shutdown|7|||
124715910|NCT01273038|448584997|FG000|Second Intervention (14 Days)|Adverse Event|0|||
124715911|NCT01273038|448584998|FG001|Second Intervention (14 Days)|Adverse Event|1|||
124715912|NCT01273038|448584997|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
124715913|NCT01273038|448584998|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
124715914|NCT01976299|448584999|FG000|Overall Study|Withdrawal by Subject|3|||
124715915|NCT01976299|448585000|FG001|Overall Study|Withdrawal by Subject|1|||
124715916|NCT01976299|448584999|FG000|Overall Study|Death|4|||
124715917|NCT01976299|448585000|FG001|Overall Study|Death|2|||
124770948|NCT02492763|448791644|FG000|Overall Study|Study Terminated by Sponsor|13|||
124770949|NCT02492763|448791645|FG001|Overall Study|Study Terminated by Sponsor|10|||
124770950|NCT02492763|448791646|FG002|Overall Study|Study Terminated by Sponsor|6|||
124770951|NCT02492763|448791647|FG003|Overall Study|Study Terminated by Sponsor|10|||
124770952|NCT01337960|448791648|FG000|Overall Study|Lost to Follow-up|1|||
124770953|NCT01337960|448791649|FG001|Overall Study|Lost to Follow-up|0|||
124770954|NCT01337960|448791650|FG002|Overall Study|Lost to Follow-up|0|||
124770955|NCT01337960|448791648|FG000|Overall Study|Withdrawal by Subject|1|||
124770956|NCT01337960|448791649|FG001|Overall Study|Withdrawal by Subject|0|||
124770957|NCT01337960|448791650|FG002|Overall Study|Withdrawal by Subject|0|||
124770958|NCT01772316|448791651|FG000|Overall Study|Serious adverse event|1|||
124770959|NCT01772316|448791651|FG000|Overall Study|Inform consent withdrawn|1|||
124770960|NCT01772316|448791651|FG000|Overall Study|Withdrawn by sponsor decision|5|||
124770961|NCT01747876|448791653|FG000|Overall Study|Adverse Event|1|||
124770962|NCT01747876|448791654|FG001|Overall Study|Adverse Event|0|||
124770963|NCT01747876|448791655|FG002|Overall Study|Adverse Event|2|||
124770964|NCT01747876|448791653|FG000|Overall Study|Withdrawal by Subject|0|||
124770965|NCT01747876|448791654|FG001|Overall Study|Withdrawal by Subject|1|||
124472243|NCT02810964|447687617|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
124472244|NCT02810964|447687618|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
124770966|NCT01747876|448791655|FG002|Overall Study|Withdrawal by Subject|1|||
124770967|NCT01747876|448791653|FG000|Overall Study|Disease progression|4|||
124770968|NCT01747876|448791654|FG001|Overall Study|Disease progression|13|||
124472245|NCT02810964|447687617|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
124472246|NCT02810964|447687618|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
124472247|NCT02810964|447687617|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
124472248|NCT02810964|447687618|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
124472249|NCT02810964|447687617|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
124472250|NCT02810964|447687618|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
124472251|NCT00568555|447687628|FG000|Overall Study|Withdrawal by Subject|1|||
124472252|NCT00568555|447687629|FG001|Overall Study|Withdrawal by Subject|1|||
124472253|NCT01307033|447687630|FG000|8-week Double-blind Period|Adverse Event|2|||
124472254|NCT01307033|447687631|FG001|8-week Double-blind Period|Adverse Event|0|||
124472255|NCT01307033|447687632|FG002|8-week Double-blind Period|Adverse Event|0|||
124472256|NCT01307033|447687633|FG003|8-week Double-blind Period|Adverse Event|0|||
124472257|NCT01307033|447687630|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
124472258|NCT01307033|447687631|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
124472259|NCT01307033|447687632|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
124472260|NCT01307033|447687633|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
124472261|NCT01307033|447687630|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
124472262|NCT01307033|447687631|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
124472263|NCT01307033|447687632|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
124472264|NCT01307033|447687633|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
124472265|NCT01307033|447687630|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
124472266|NCT01307033|447687631|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
124472267|NCT01307033|447687632|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
124472268|NCT01307033|447687633|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
124472269|NCT01307033|447687630|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
124472270|NCT01307033|447687631|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
124472271|NCT01307033|447687632|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
124472272|NCT01307033|447687633|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
124472273|NCT01307033|447687630|FG000|44-week Open-label Extension|Adverse Event|0|||
124472274|NCT01307033|447687631|FG001|44-week Open-label Extension|Adverse Event|0|||
124472275|NCT01307033|447687632|FG002|44-week Open-label Extension|Adverse Event|2|||
124472276|NCT01307033|447687633|FG003|44-week Open-label Extension|Adverse Event|1|||
124472277|NCT01307033|447687630|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
124472278|NCT01307033|447687631|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
124472279|NCT01307033|447687632|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
124472280|NCT01307033|447687633|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
124472281|NCT01307033|447687630|FG000|44-week Open-label Extension|Physician Decision|0|||
124472282|NCT01307033|447687631|FG001|44-week Open-label Extension|Physician Decision|0|||
124472283|NCT01307033|447687632|FG002|44-week Open-label Extension|Physician Decision|1|||
124472284|NCT01307033|447687633|FG003|44-week Open-label Extension|Physician Decision|0|||
124472285|NCT01307033|447687630|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
124472286|NCT01307033|447687631|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
124472287|NCT01307033|447687632|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
124472288|NCT01307033|447687633|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
124472289|NCT01307033|447687630|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
124472290|NCT01307033|447687631|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
124472291|NCT01307033|447687632|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
124472292|NCT01307033|447687633|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
124472293|NCT01307033|447687630|FG000|44-week Open-label Extension|Death|0|||
124472294|NCT01307033|447687631|FG001|44-week Open-label Extension|Death|0|||
124472295|NCT01307033|447687632|FG002|44-week Open-label Extension|Death|0|||
124472296|NCT01307033|447687633|FG003|44-week Open-label Extension|Death|1|||
124472297|NCT01231555|447687634|FG000|Overall Study|Study terminated|8|||
124472298|NCT01231555|447687635|FG001|Overall Study|Study terminated|5|||
124715918|NCT01976299|448584999|FG000|Overall Study|Lost to Follow-up|7|||
124715919|NCT01976299|448585000|FG001|Overall Study|Lost to Follow-up|1|||
124715920|NCT01976299|448584999|FG000|Overall Study|See clarification above in comments|9|||
124715921|NCT01976299|448585000|FG001|Overall Study|See clarification above in comments|2|||
124472299|NCT01231555|447687636|FG002|Overall Study|Study terminated|8|||
124472300|NCT01231555|447687634|FG000|Overall Study|Withdrawal by Subject|0|||
124472301|NCT01231555|447687635|FG001|Overall Study|Withdrawal by Subject|2|||
124472302|NCT01231555|447687636|FG002|Overall Study|Withdrawal by Subject|0|||
124715922|NCT01299389|448585005|FG000|Double-blind|Adverse Event|45|||
124472303|NCT00947531|447687637|FG000|Overall Study|Withdrawal by Subject|10|||
124472304|NCT00947531|447687638|FG001|Overall Study|Withdrawal by Subject|7|||
124715923|NCT01299389|448585006|FG001|Double-blind|Adverse Event|27|||
124472305|NCT00947531|447687637|FG000|Overall Study|Administrative Reason|0|||
124472306|NCT00947531|447687638|FG001|Overall Study|Administrative Reason|1|||
124472307|NCT00947531|447687637|FG000|Overall Study|Adverse Event|2|||
124554305|NCT01358708|447987382|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
124554306|NCT01358708|447987381|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
124554307|NCT01358708|447987382|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
124554308|NCT04363736|447987385|FG000|Overall Study|Withdrawal by Subject|1|||
124554309|NCT04363736|447987386|FG001|Overall Study|Withdrawal by Subject|0|||
124554310|NCT04363736|447987385|FG000|Overall Study|Lost to Follow-up|10|||
124554311|NCT04363736|447987386|FG001|Overall Study|Lost to Follow-up|7|||
124554312|NCT04363736|447987385|FG000|Overall Study|Death|8|||
124554313|NCT04363736|447987386|FG001|Overall Study|Death|6|||
124554314|NCT03125629|447987388|FG000|Overall Study|Withdrawal by Subject|2|||
124554315|NCT03125629|447987388|FG000|Overall Study|Equipment malfunction|1|||
124554316|NCT02176642|447987391|FG000|Overall Study|Withdrawal by Subject|0|||
124715924|NCT01299389|448585007|FG002|Double-blind|Adverse Event|0|||
124715925|NCT01299389|448585008|FG003|Double-blind|Adverse Event|0|||
124715926|NCT01299389|448585005|FG000|Double-blind|Lack of Efficacy|45|||
124715927|NCT01299389|448585006|FG001|Double-blind|Lack of Efficacy|21|||
124715928|NCT01299389|448585007|FG002|Double-blind|Lack of Efficacy|0|||
124715929|NCT01299389|448585008|FG003|Double-blind|Lack of Efficacy|0|||
124715930|NCT01299389|448585005|FG000|Double-blind|Lost to Follow-up|2|||
124715931|NCT01299389|448585006|FG001|Double-blind|Lost to Follow-up|1|||
124715932|NCT01299389|448585007|FG002|Double-blind|Lost to Follow-up|0|||
124715933|NCT01299389|448585008|FG003|Double-blind|Lost to Follow-up|0|||
124715934|NCT01299389|448585005|FG000|Double-blind|Withdrawal by Subject|16|||
124715935|NCT01299389|448585006|FG001|Double-blind|Withdrawal by Subject|13|||
124715936|NCT01299389|448585007|FG002|Double-blind|Withdrawal by Subject|0|||
124715937|NCT01299389|448585008|FG003|Double-blind|Withdrawal by Subject|0|||
124715938|NCT01299389|448585005|FG000|Double-blind|Other|1|||
124715939|NCT01299389|448585006|FG001|Double-blind|Other|1|||
124715940|NCT01299389|448585007|FG002|Double-blind|Other|0|||
124715941|NCT01299389|448585008|FG003|Double-blind|Other|0|||
124715942|NCT01299389|448585005|FG000|Double-blind|"fail to meet study population criteria"|0|||
124715943|NCT01299389|448585006|FG001|Double-blind|"fail to meet study population criteria"|1|||
124715944|NCT01299389|448585007|FG002|Double-blind|"fail to meet study population criteria"|0|||
124715945|NCT01299389|448585008|FG003|Double-blind|"fail to meet study population criteria"|0|||
124715946|NCT01299389|448585005|FG000|Post-observational|Other|0|||
124715947|NCT01299389|448585006|FG001|Post-observational|Other|0|||
124715948|NCT01299389|448585007|FG002|Post-observational|Other|12|||
124715949|NCT01299389|448585008|FG003|Post-observational|Other|6|||
124715950|NCT01151020|448585009|FG000|Overall Study|Death|25|||
124715951|NCT01151020|448585009|FG000|Overall Study|Conversion to open repair|1|||
124715952|NCT01151020|448585009|FG000|Overall Study|Lost to Follow-up|4|||
124715953|NCT01151020|448585009|FG000|Overall Study|Withdrawal by Subject|22|||
124715954|NCT01151020|448585009|FG000|Overall Study|Patients did not receive the device|2|||
124715955|NCT01635998|448585010|FG000|Overall Study|Death|1|||
124715956|NCT01635998|448585011|FG001|Overall Study|Death|1|||
124715957|NCT01635998|448585010|FG000|Overall Study|Lost to Follow-up|2|||
124715958|NCT01635998|448585011|FG001|Overall Study|Lost to Follow-up|1|||
124715959|NCT01635998|448585010|FG000|Overall Study|Withdrawal by Subject|1|||
124715960|NCT01635998|448585011|FG001|Overall Study|Withdrawal by Subject|5|||
124715961|NCT01220401|448585020|FG000|Overall Study|Withdrawal by Subject|2|||
124715962|NCT01220401|448585020|FG000|Overall Study|Protocol Violation|1|||
124715963|NCT00625586|448585023|FG000|Overall Study|Adverse Event|1|||
124715964|NCT00625586|448585023|FG000|Overall Study|Progressive disease|1|||
124715965|NCT00124072|448585026|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
124715966|NCT00124072|448585027|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
124715967|NCT00124072|448585028|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
124715968|NCT00124072|448585029|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
124715969|NCT00124072|448585026|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
124715970|NCT00124072|448585027|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
124715971|NCT00124072|448585028|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
124715972|NCT00124072|448585029|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
124715973|NCT00124072|448585026|FG000|Overall Study|Death|499|||
124715974|NCT00124072|448585027|FG001|Overall Study|Death|484|||
124715975|NCT00124072|448585028|FG002|Overall Study|Death|471|||
124715976|NCT00124072|448585029|FG003|Overall Study|Death|480|||
124715977|NCT02534883|448585030|FG000|Overall Study|Early Termination|8|||
124554317|NCT02176642|447987392|FG001|Overall Study|Withdrawal by Subject|1|||
124554318|NCT00217971|447987393|FG000|Overall Study|Adverse Event|1|||
124715978|NCT02534883|448585031|FG001|Overall Study|Early Termination|3|||
124715979|NCT03328832|448585032|FG000|Overall Study|Lost to Follow-up|0|||
124715980|NCT03328832|448585033|FG001|Overall Study|Lost to Follow-up|1|||
124715981|NCT00886769|448585034|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
124715982|NCT00886769|448585035|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
124715983|NCT00414076|448585036|FG000|Overall Study|Progression|1|||
124715984|NCT00414076|448585037|FG001|Overall Study|Progression|2|||
124554319|NCT00217971|447987394|FG001|Overall Study|Adverse Event|1|||
124554320|NCT00217971|447987393|FG000|Overall Study|Lost to Follow-up|15|||
124715985|NCT00414076|448585036|FG000|Overall Study|Withdrawal by Subject|1|||
124554321|NCT00217971|447987394|FG001|Overall Study|Lost to Follow-up|19|||
124554322|NCT00217971|447987393|FG000|Overall Study|Physician Decision|0|||
124554323|NCT00217971|447987394|FG001|Overall Study|Physician Decision|1|||
124554324|NCT00217971|447987393|FG000|Overall Study|Withdrawal by Subject|7|||
124554325|NCT00217971|447987394|FG001|Overall Study|Withdrawal by Subject|12|||
124554326|NCT00217971|447987393|FG000|Overall Study|non compliant|1|||
124554327|NCT00217971|447987394|FG001|Overall Study|non compliant|0|||
124554328|NCT02989610|447987395|FG000|Overall Study|Withdrawal by Subject|20|||
124554329|NCT02989610|447987395|FG000|Overall Study|Departure of PI from Site|8|||
124554330|NCT02989610|447987395|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
124554331|NCT02989610|447987395|FG000|Overall Study|Lost to Follow-up|3|||
124554332|NCT02989610|447987395|FG000|Overall Study|Death|3|||
124554333|NCT02989610|447987395|FG000|Overall Study|System Explant|3|||
124554334|NCT02989610|447987395|FG000|Overall Study|Subject Non-Compliance|2|||
124554335|NCT02989610|447987395|FG000|Overall Study|System Revision|2|||
124554336|NCT02989610|447987395|FG000|Overall Study|PI Left, Study Closing|1|||
124554337|NCT02989610|447987395|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
124554338|NCT02989610|447987395|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
124554339|NCT04508621|447987398|FG000|Overall Study|Adverse Event|39|||
124554340|NCT04508621|447987399|FG001|Overall Study|Adverse Event|16|||
124554341|NCT04508621|447987398|FG000|Overall Study|Lack of Efficacy|2|||
124554342|NCT04508621|447987399|FG001|Overall Study|Lack of Efficacy|8|||
124554343|NCT04508621|447987398|FG000|Overall Study|Physician Decision|0|||
124554344|NCT04508621|447987399|FG001|Overall Study|Physician Decision|1|||
124554345|NCT04508621|447987398|FG000|Overall Study|Withdrawal by Subject|10|||
124554346|NCT04508621|447987399|FG001|Overall Study|Withdrawal by Subject|14|||
124554347|NCT04508621|447987398|FG000|Overall Study|Lost to Follow-up|12|||
124554348|NCT04508621|447987399|FG001|Overall Study|Lost to Follow-up|9|||
124554349|NCT04508621|447987398|FG000|Overall Study|COVID-19 related crisis|3|||
124554350|NCT04508621|447987399|FG001|Overall Study|COVID-19 related crisis|0|||
124554351|NCT04508621|447987398|FG000|Overall Study|Subject non-compliance|1|||
124554352|NCT04508621|447987399|FG001|Overall Study|Subject non-compliance|0|||
124554353|NCT00808015|447987400|FG000|Overall Study|Death|1|||
124554354|NCT00808015|447987400|FG000|Overall Study|Lack of Efficacy|58|||
124554355|NCT00808015|447987400|FG000|Overall Study|Lost to Follow-up|76|||
124554356|NCT00808015|447987400|FG000|Overall Study|Participants not willing to participate|158|||
124554357|NCT00808015|447987400|FG000|Overall Study|Adverse Event|22|||
124554358|NCT00808015|447987400|FG000|Overall Study|Other|25|||
124554359|NCT00808015|447987400|FG000|Overall Study|Enrolled but not treated|4|||
124554360|NCT01066039|447987401|FG000|Overall Study|Adverse Event|6|||
124554361|NCT01066039|447987401|FG000|Overall Study|Withdrawal by Subject|17|||
124554362|NCT01066039|447987401|FG000|Overall Study|Protocol Violation|2|||
124554363|NCT01066039|447987401|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
124554364|NCT01066039|447987401|FG000|Overall Study|Investigator's Request|1|||
124554365|NCT01066039|447987401|FG000|Overall Study|Dropout due to Insulin Administration|1|||
124554366|NCT01066039|447987401|FG000|Overall Study|Additional Antihypertensive Required|4|||
124554367|NCT01066039|447987401|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
124554368|NCT01066039|447987401|FG000|Overall Study|Failure to Control Blood Pressure|1|||
124554369|NCT01066039|447987401|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
124554370|NCT00084617|447987414|FG000|Overall Study|Withdrawal by Subject|7|||
124554371|NCT00084617|447987414|FG000|Overall Study|Lack of Efficacy|1|||
124554372|NCT00084617|447987414|FG000|Overall Study|Protocol Violation|1|||
124554373|NCT01625286|447987415|FG000|Overall Study|Adverse Event|0|||
124554374|NCT01625286|447987416|FG001|Overall Study|Adverse Event|0|||
124554375|NCT01625286|447987417|FG002|Overall Study|Adverse Event|0|||
124715986|NCT00414076|448585037|FG001|Overall Study|Withdrawal by Subject|3|||
124715987|NCT00414076|448585036|FG000|Overall Study|Adverse Event|1|||
124715988|NCT00414076|448585037|FG001|Overall Study|Adverse Event|0|||
124715989|NCT00778336|448585038|FG000|Index Procedure-Discharge|Death|6|||
124715990|NCT00778336|448585039|FG001|Index Procedure-Discharge|Death|3|||
124715991|NCT00778336|448585040|FG002|Index Procedure-Discharge|Death|2|||
124715992|NCT00778336|448585041|FG003|Index Procedure-Discharge|Death|0|||
124715993|NCT00778336|448585038|FG000|3 Month Follow Up|Lost to Follow-up|15|||
124715994|NCT00778336|448585039|FG001|3 Month Follow Up|Lost to Follow-up|20|||
124715995|NCT00778336|448585040|FG002|3 Month Follow Up|Lost to Follow-up|3|||
124715996|NCT00778336|448585041|FG003|3 Month Follow Up|Lost to Follow-up|0|||
124715997|NCT00778336|448585038|FG000|3 Month Follow Up|Death|8|||
124715998|NCT00778336|448585039|FG001|3 Month Follow Up|Death|3|||
124715999|NCT00778336|448585040|FG002|3 Month Follow Up|Death|2|||
124716000|NCT00778336|448585041|FG003|3 Month Follow Up|Death|0|||
124716001|NCT00049257|448585044|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
124716002|NCT00049257|448585044|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
124716003|NCT00049257|448585044|FG000|Carboplatin, Paclitaxel|Death|2|||
124716004|NCT00049257|448585044|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
124716005|NCT04721158|448585045|FG000|Overall Study|Lost to Follow-up|4|||
124716006|NCT04721158|448585045|FG000|Overall Study|Device did not connect|1|||
124716007|NCT00132301|448585046|FG000|Overall Study|Death|7|||
124716008|NCT00132301|448585047|FG001|Overall Study|Death|6|||
124716009|NCT00132301|448585046|FG000|Overall Study|Withdrawal by Subject|5|||
124716010|NCT00132301|448585047|FG001|Overall Study|Withdrawal by Subject|2|||
124716011|NCT00132301|448585046|FG000|Overall Study|Physician Decision|1|||
124716012|NCT00132301|448585047|FG001|Overall Study|Physician Decision|1|||
124716013|NCT00132301|448585046|FG000|Overall Study|Lost to Follow-up|5|||
124716014|NCT00132301|448585047|FG001|Overall Study|Lost to Follow-up|3|||
124716015|NCT00132301|448585046|FG000|Overall Study|Other|1|||
124716016|NCT00132301|448585047|FG001|Overall Study|Other|1|||
124716017|NCT00132301|448585046|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
124716018|NCT00132301|448585047|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
124716019|NCT02720523|448585048|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
124716020|NCT02720523|448585049|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
124716021|NCT02720523|448585050|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
124716022|NCT02720523|448585051|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
124716023|NCT02720523|448585052|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
124716024|NCT02720523|448585053|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
124716025|NCT02720523|448585054|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
124716026|NCT02720523|448585048|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
124716027|NCT02720523|448585049|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
124716028|NCT02720523|448585050|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
124716029|NCT02720523|448585051|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
124716030|NCT02720523|448585052|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
124716031|NCT02720523|448585053|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
124716032|NCT02720523|448585054|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
124716033|NCT02720523|448585048|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
124716034|NCT02720523|448585049|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
124716035|NCT02720523|448585050|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
124554376|NCT01625286|447987418|FG003|Overall Study|Adverse Event|0|||
124554377|NCT01625286|447987419|FG004|Overall Study|Adverse Event|1|||
124716036|NCT02720523|448585051|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
124716037|NCT02720523|448585052|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
124716038|NCT02720523|448585053|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
124472308|NCT00947531|447687638|FG001|Overall Study|Adverse Event|2|||
124472309|NCT00947531|447687637|FG000|Overall Study|Lack of Efficacy|1|||
124472310|NCT00947531|447687638|FG001|Overall Study|Lack of Efficacy|0|||
124472311|NCT00947531|447687637|FG000|Overall Study|Other|1|||
124472312|NCT00947531|447687638|FG001|Overall Study|Other|1|||
124472313|NCT01773421|447687640|FG000|Treatment Phase|Other|0|||
124472314|NCT01773421|447687641|FG001|Treatment Phase|Other|0|||
124472315|NCT01773421|447687642|FG002|Treatment Phase|Other|2|||
124472316|NCT01773421|447687643|FG003|Treatment Phase|Other|0|||
124472317|NCT01773421|447687644|FG004|Treatment Phase|Other|0|||
124472318|NCT01773421|447687645|FG005|Treatment Phase|Other|0|||
124472319|NCT01773421|447687646|FG006|Treatment Phase|Other|0|||
124472320|NCT01773421|447687640|FG000|Treatment Phase|Adverse Event|0|||
124472321|NCT01773421|447687641|FG001|Treatment Phase|Adverse Event|0|||
124472322|NCT01773421|447687642|FG002|Treatment Phase|Adverse Event|3|||
124472323|NCT01773421|447687643|FG003|Treatment Phase|Adverse Event|1|||
124472324|NCT01773421|447687644|FG004|Treatment Phase|Adverse Event|0|||
124472325|NCT01773421|447687645|FG005|Treatment Phase|Adverse Event|0|||
124472326|NCT01773421|447687646|FG006|Treatment Phase|Adverse Event|0|||
124472327|NCT01773421|447687640|FG000|Treatment Phase|Withdrawal by Subject|0|||
124472328|NCT01773421|447687641|FG001|Treatment Phase|Withdrawal by Subject|0|||
124472329|NCT01773421|447687642|FG002|Treatment Phase|Withdrawal by Subject|1|||
124472330|NCT01773421|447687643|FG003|Treatment Phase|Withdrawal by Subject|1|||
124472331|NCT01773421|447687644|FG004|Treatment Phase|Withdrawal by Subject|0|||
124472332|NCT01773421|447687645|FG005|Treatment Phase|Withdrawal by Subject|0|||
124472333|NCT01773421|447687646|FG006|Treatment Phase|Withdrawal by Subject|0|||
124716039|NCT02720523|448585054|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
124716040|NCT02720523|448585048|FG000|Period 1: Placebo-controlled Period|Other|0|||
124472334|NCT01773421|447687640|FG000|Extension Phase|Other|0|||
124472335|NCT01773421|447687641|FG001|Extension Phase|Other|0|||
124472336|NCT01773421|447687642|FG002|Extension Phase|Other|0|||
124472337|NCT01773421|447687643|FG003|Extension Phase|Other|0|||
124472338|NCT01773421|447687644|FG004|Extension Phase|Other|1|||
124472339|NCT01773421|447687645|FG005|Extension Phase|Other|2|||
124472340|NCT01773421|447687646|FG006|Extension Phase|Other|0|||
124716041|NCT02720523|448585049|FG001|Period 1: Placebo-controlled Period|Other|0|||
124716042|NCT02720523|448585050|FG002|Period 1: Placebo-controlled Period|Other|1|||
124716043|NCT02720523|448585051|FG003|Period 1: Placebo-controlled Period|Other|1|||
124716044|NCT02720523|448585052|FG004|Period 1: Placebo-controlled Period|Other|0|||
124472341|NCT01773421|447687640|FG000|Extension Phase|Adverse Event|0|||
124472342|NCT01773421|447687641|FG001|Extension Phase|Adverse Event|0|||
124472343|NCT01773421|447687642|FG002|Extension Phase|Adverse Event|0|||
124472344|NCT01773421|447687643|FG003|Extension Phase|Adverse Event|0|||
124472345|NCT01773421|447687644|FG004|Extension Phase|Adverse Event|2|||
124472346|NCT01773421|447687645|FG005|Extension Phase|Adverse Event|0|||
124472347|NCT01773421|447687646|FG006|Extension Phase|Adverse Event|0|||
124472348|NCT02804763|447687647|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
124472349|NCT02804763|447687648|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
124472350|NCT02804763|447687649|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
124472351|NCT02804763|447687650|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
124472352|NCT02804763|447687647|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
124472353|NCT02804763|447687648|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
124716045|NCT02720523|448585053|FG005|Period 1: Placebo-controlled Period|Other|0|||
124716046|NCT02720523|448585054|FG006|Period 1: Placebo-controlled Period|Other|0|||
124472354|NCT02804763|447687649|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
124554378|NCT01625286|447987420|FG005|Overall Study|Adverse Event|2|||
124472355|NCT02804763|447687650|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
124472356|NCT02804763|447687647|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
124472357|NCT02804763|447687648|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
124472358|NCT02804763|447687649|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
124472359|NCT02804763|447687650|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
124472360|NCT02804763|447687647|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
124472361|NCT02804763|447687648|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
124472362|NCT02804763|447687649|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
124472363|NCT02804763|447687650|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
124472364|NCT02804763|447687647|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
124472365|NCT02804763|447687648|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
124472366|NCT02804763|447687649|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
124472367|NCT02804763|447687650|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
124472368|NCT02804763|447687647|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
124472369|NCT02804763|447687648|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
124472370|NCT02804763|447687649|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
124472371|NCT02804763|447687650|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
124554379|NCT01625286|447987421|FG006|Overall Study|Adverse Event|1|||
124472372|NCT00282243|447687653|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
124554380|NCT01625286|447987415|FG000|Overall Study|Death|0|||
124554381|NCT01625286|447987416|FG001|Overall Study|Death|0|||
124554382|NCT01625286|447987417|FG002|Overall Study|Death|1|||
124554383|NCT01625286|447987418|FG003|Overall Study|Death|1|||
124554384|NCT01625286|447987419|FG004|Overall Study|Death|0|||
124554385|NCT01625286|447987420|FG005|Overall Study|Death|11|||
124472373|NCT00282243|447687653|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
124554386|NCT01625286|447987421|FG006|Overall Study|Death|16|||
124554387|NCT01625286|447987415|FG000|Overall Study|Withdrawal by Subject|0|||
124554388|NCT01625286|447987416|FG001|Overall Study|Withdrawal by Subject|1|||
124716047|NCT02720523|448585048|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
124716048|NCT02720523|448585049|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
124716049|NCT02720523|448585050|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
124716050|NCT02720523|448585051|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
124716051|NCT02720523|448585052|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
124716052|NCT02720523|448585053|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
124716053|NCT02720523|448585054|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
124716054|NCT02720523|448585048|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
124716055|NCT02720523|448585049|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
124716056|NCT02720523|448585050|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
124716057|NCT02720523|448585051|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
124716058|NCT02720523|448585052|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
124716059|NCT02720523|448585053|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
124716060|NCT02720523|448585054|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
124716061|NCT02720523|448585048|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
124716062|NCT02720523|448585049|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
124716063|NCT02720523|448585050|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
124716064|NCT02720523|448585051|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
124716065|NCT02720523|448585052|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
124716066|NCT02720523|448585053|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
124716067|NCT02720523|448585054|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
124716068|NCT02720523|448585048|FG000|Period 2: Long-term Extension Period|Other|0|||
124716069|NCT02720523|448585049|FG001|Period 2: Long-term Extension Period|Other|0|||
124716070|NCT02720523|448585050|FG002|Period 2: Long-term Extension Period|Other|0|||
124716071|NCT02720523|448585051|FG003|Period 2: Long-term Extension Period|Other|0|||
124716072|NCT02720523|448585052|FG004|Period 2: Long-term Extension Period|Other|2|||
124716073|NCT02720523|448585053|FG005|Period 2: Long-term Extension Period|Other|0|||
124716074|NCT02720523|448585054|FG006|Period 2: Long-term Extension Period|Other|3|||
124716075|NCT04872569|448585055|FG000|Overall Study|Withdrawal by Subject|2|||
124716076|NCT02382991|448585059|FG000|Overall Study|Adverse Event|1|||
124716077|NCT02382991|448585060|FG001|Overall Study|Adverse Event|2|||
124716078|NCT02382991|448585059|FG000|Overall Study|Lost to Follow-up|1|||
124716079|NCT02382991|448585060|FG001|Overall Study|Lost to Follow-up|0|||
124716080|NCT02382991|448585059|FG000|Overall Study|Withdrawal by Subject|0|||
124716081|NCT02382991|448585060|FG001|Overall Study|Withdrawal by Subject|1|||
124716082|NCT04466384|448585061|FG000|First Phase|Protocol Violation|1|||
124716083|NCT04466384|448585062|FG001|First Phase|Protocol Violation|0|||
124716084|NCT04466384|448585061|FG000|First Phase|Missing data|1|||
124716085|NCT04466384|448585062|FG001|First Phase|Missing data|0|||
124716086|NCT04466384|448585061|FG000|Cross Over Phase|Physician Decision|1|||
124716087|NCT04466384|448585062|FG001|Cross Over Phase|Physician Decision|0|||
124716088|NCT04466384|448585061|FG000|Cross Over Phase|Withdrawal by Subject|0|||
124716089|NCT04466384|448585062|FG001|Cross Over Phase|Withdrawal by Subject|1|||
124716090|NCT03666988|448585063|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
124716091|NCT03666988|448585064|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
124716092|NCT03666988|448585065|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
124716093|NCT03666988|448585066|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
124716094|NCT03666988|448585067|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
124716095|NCT03666988|448585068|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
124716096|NCT03666988|448585063|FG000|Part 1 (Up to 28 Months)|Other|0|||
124716097|NCT03666988|448585064|FG001|Part 1 (Up to 28 Months)|Other|1|||
124716098|NCT03666988|448585065|FG002|Part 1 (Up to 28 Months)|Other|1|||
124716099|NCT03666988|448585066|FG003|Part 1 (Up to 28 Months)|Other|0|||
124716100|NCT03666988|448585067|FG004|Part 1 (Up to 28 Months)|Other|0|||
124716101|NCT03666988|448585068|FG005|Part 1 (Up to 28 Months)|Other|0|||
124716102|NCT03666988|448585063|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
124716103|NCT03666988|448585064|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
124716104|NCT03666988|448585065|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
124716105|NCT03666988|448585066|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
124472374|NCT00282243|447687653|FG000|Extension Treatment Period|Adverse Event|15|||
124472375|NCT00282243|447687653|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
124472376|NCT00282243|447687653|FG000|Extension Treatment Period|Non-compliance|2|||
124472377|NCT00282243|447687653|FG000|Extension Treatment Period|Physician Decision|1|||
124472378|NCT02863848|447687654|FG000|Overall Study|Lost to Follow-up|1|||
124472379|NCT02863848|447687655|FG001|Overall Study|Lost to Follow-up|1|||
124472380|NCT02863848|447687654|FG000|Overall Study|Protocol Violation|1|||
124472381|NCT02863848|447687655|FG001|Overall Study|Protocol Violation|2|||
124472382|NCT00395967|447687656|FG000|Treatment Period|Failed Mobilization|1|||
124472383|NCT00395967|447687656|FG000|Follow-up Period|Death|1|||
124554389|NCT01625286|447987417|FG002|Overall Study|Withdrawal by Subject|0|||
124554390|NCT01625286|447987418|FG003|Overall Study|Withdrawal by Subject|1|||
124716106|NCT03666988|448585067|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
124716107|NCT03666988|448585068|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
124716108|NCT03666988|448585063|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
124716109|NCT03666988|448585064|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
124716110|NCT03666988|448585065|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
124716111|NCT03666988|448585066|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
124716112|NCT03666988|448585067|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
124716113|NCT03666988|448585068|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
124716114|NCT03666988|448585063|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
124716115|NCT03666988|448585064|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
124716116|NCT03666988|448585065|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
124716117|NCT03666988|448585066|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
124716118|NCT03666988|448585067|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
124716119|NCT03666988|448585068|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
124716120|NCT03554018|448585071|FG000|Overall Study|Lost to Follow-up|3|||
124716121|NCT03554018|448585072|FG001|Overall Study|Lost to Follow-up|7|||
124716122|NCT02891226|448585075|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
124716123|NCT02891226|448585076|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
124716124|NCT02891226|448585077|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
124716125|NCT02891226|448585078|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
124716126|NCT02891226|448585079|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
124716127|NCT02891226|448585080|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
124716128|NCT02891226|448585081|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
124716129|NCT02891226|448585082|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
124716130|NCT02891226|448585083|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
124716131|NCT02891226|448585084|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
124716132|NCT02891226|448585085|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
124716133|NCT02891226|448585086|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
124716134|NCT02891226|448585087|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
124716135|NCT02891226|448585088|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
124716136|NCT02891226|448585089|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
124716137|NCT02891226|448585090|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
124716138|NCT02891226|448585075|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
124716139|NCT02891226|448585076|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
124716140|NCT02891226|448585077|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124716141|NCT02891226|448585078|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124716142|NCT02891226|448585079|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124472384|NCT00395967|447687656|FG000|Follow-up Period|Lost to Follow-up|1|||
124716143|NCT02891226|448585080|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124716144|NCT02891226|448585081|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124472385|NCT03118947|447687657|FG000|Overall Study|Adverse Event|7|||
124554391|NCT01625286|447987419|FG004|Overall Study|Withdrawal by Subject|0|||
124554392|NCT01625286|447987420|FG005|Overall Study|Withdrawal by Subject|0|||
124554393|NCT01625286|447987421|FG006|Overall Study|Withdrawal by Subject|1|||
124554394|NCT01625286|447987415|FG000|Overall Study|Any reason not specifically recorded|0|||
124554395|NCT01625286|447987416|FG001|Overall Study|Any reason not specifically recorded|0|||
124554396|NCT01625286|447987417|FG002|Overall Study|Any reason not specifically recorded|0|||
124554397|NCT01625286|447987418|FG003|Overall Study|Any reason not specifically recorded|0|||
124554398|NCT01625286|447987419|FG004|Overall Study|Any reason not specifically recorded|0|||
124554399|NCT01625286|447987420|FG005|Overall Study|Any reason not specifically recorded|1|||
124554400|NCT01625286|447987421|FG006|Overall Study|Any reason not specifically recorded|0|||
124554401|NCT01625286|447987415|FG000|Overall Study|Progressive disease|6|||
124554402|NCT01625286|447987416|FG001|Overall Study|Progressive disease|3|||
124554403|NCT01625286|447987417|FG002|Overall Study|Progressive disease|4|||
124554404|NCT01625286|447987418|FG003|Overall Study|Progressive disease|5|||
124554405|NCT01625286|447987419|FG004|Overall Study|Progressive disease|5|||
124554406|NCT01625286|447987420|FG005|Overall Study|Progressive disease|0|||
124554407|NCT01625286|447987421|FG006|Overall Study|Progressive disease|0|||
124554408|NCT01625286|447987415|FG000|Overall Study|Lost to Follow-up|0|||
124716145|NCT02891226|448585082|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124716146|NCT02891226|448585083|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124716147|NCT02891226|448585084|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124716148|NCT02891226|448585085|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124716149|NCT02891226|448585086|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124716150|NCT02891226|448585087|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124716151|NCT02891226|448585088|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124716152|NCT02891226|448585089|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124716153|NCT02891226|448585090|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
124716154|NCT02891226|448585075|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
124716155|NCT02891226|448585076|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
124716156|NCT02891226|448585077|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
124554409|NCT01625286|447987416|FG001|Overall Study|Lost to Follow-up|0|||
124554410|NCT01625286|447987417|FG002|Overall Study|Lost to Follow-up|0|||
124716157|NCT02891226|448585078|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
124716158|NCT02891226|448585079|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
124716159|NCT02891226|448585080|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
124716160|NCT02891226|448585081|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
124716161|NCT02891226|448585082|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
124716162|NCT02891226|448585083|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
124716163|NCT02891226|448585084|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
124716164|NCT02891226|448585085|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
124716165|NCT02891226|448585086|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
124716166|NCT02891226|448585087|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
124716167|NCT02891226|448585088|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
124554411|NCT01625286|447987418|FG003|Overall Study|Lost to Follow-up|0|||
124554412|NCT01625286|447987419|FG004|Overall Study|Lost to Follow-up|0|||
124554413|NCT01625286|447987420|FG005|Overall Study|Lost to Follow-up|0|||
124554414|NCT01625286|447987421|FG006|Overall Study|Lost to Follow-up|1|||
124472386|NCT03118947|447687657|FG000|Overall Study|Death|3|||
124472387|NCT03118947|447687657|FG000|Overall Study|Lack of Efficacy|4|||
124472388|NCT03118947|447687657|FG000|Overall Study|Non-compliance with study drug|1|||
124472389|NCT03118947|447687657|FG000|Overall Study|Protocol Violation|2|||
124472390|NCT03118947|447687657|FG000|Overall Study|Withdrawal by Subject|3|||
124472391|NCT03118947|447687657|FG000|Overall Study|Withdrawal by caregiver|3|||
124472392|NCT03118947|447687657|FG000|Overall Study|Change in patient's living situation|4|||
124472393|NCT03118947|447687657|FG000|Overall Study|Lost to Follow-up|2|||
124472394|NCT01528787|447687658|FG000|Overall Study|Withdrawal by Subject|0|||
124472395|NCT01528787|447687659|FG001|Overall Study|Withdrawal by Subject|0|||
124472396|NCT01528787|447687660|FG002|Overall Study|Withdrawal by Subject|0|||
124472397|NCT01528787|447687661|FG003|Overall Study|Withdrawal by Subject|1|||
124472398|NCT01528787|447687658|FG000|Overall Study|Family Emergency|0|||
124472399|NCT01528787|447687659|FG001|Overall Study|Family Emergency|0|||
124472400|NCT01528787|447687660|FG002|Overall Study|Family Emergency|1|||
124472401|NCT01528787|447687661|FG003|Overall Study|Family Emergency|0|||
124472402|NCT03882424|447687662|FG000|Overall Study|Lost to Follow-up|3|||
124472403|NCT03882424|447687663|FG001|Overall Study|Lost to Follow-up|0|||
124472404|NCT03882424|447687664|FG002|Overall Study|Lost to Follow-up|0|||
124472405|NCT03882424|447687662|FG000|Overall Study|schedule conflict|1|||
124472406|NCT03882424|447687663|FG001|Overall Study|schedule conflict|0|||
124472407|NCT03882424|447687664|FG002|Overall Study|schedule conflict|0|||
124472408|NCT00666926|447687665|FG000|Overall Study|Adverse Event|0|||
124472409|NCT00666926|447687666|FG001|Overall Study|Adverse Event|0|||
124472410|NCT00666926|447687667|FG002|Overall Study|Adverse Event|0|||
124472411|NCT00666926|447687668|FG003|Overall Study|Adverse Event|0|||
124472412|NCT00666926|447687669|FG004|Overall Study|Adverse Event|0|||
124472413|NCT00666926|447687670|FG005|Overall Study|Adverse Event|0|||
124472414|NCT00666926|447687671|FG006|Overall Study|Adverse Event|0|||
124472415|NCT00666926|447687672|FG007|Overall Study|Adverse Event|0|||
124472416|NCT00666926|447687673|FG008|Overall Study|Adverse Event|0|||
124472417|NCT00666926|447687674|FG009|Overall Study|Adverse Event|2|||
124472418|NCT00666926|447687675|FG010|Overall Study|Adverse Event|2|||
124472419|NCT00666926|447687676|FG011|Overall Study|Adverse Event|2|||
124472420|NCT00666926|447687677|FG012|Overall Study|Adverse Event|0|||
124472421|NCT00666926|447687678|FG013|Overall Study|Adverse Event|1|||
124472422|NCT00666926|447687679|FG014|Overall Study|Adverse Event|0|||
124472423|NCT00666926|447687680|FG015|Overall Study|Adverse Event|0|||
124472424|NCT00666926|447687665|FG000|Overall Study|Laboratory abnormality|0|||
124716168|NCT02891226|448585089|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
124716169|NCT02891226|448585090|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
124716170|NCT02891226|448585075|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
124716171|NCT02891226|448585076|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
124716172|NCT02891226|448585077|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
124716173|NCT02891226|448585078|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
124716174|NCT02891226|448585079|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
124716175|NCT02891226|448585080|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
124770969|NCT01747876|448791655|FG002|Overall Study|Disease progression|8|||
124770970|NCT01747876|448791653|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
124472425|NCT00666926|447687666|FG001|Overall Study|Laboratory abnormality|0|||
124472426|NCT00666926|447687667|FG002|Overall Study|Laboratory abnormality|0|||
124472427|NCT00666926|447687668|FG003|Overall Study|Laboratory abnormality|0|||
124472428|NCT00666926|447687669|FG004|Overall Study|Laboratory abnormality|0|||
124716176|NCT02891226|448585081|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
124716177|NCT02891226|448585082|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
124716178|NCT02891226|448585083|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
124716179|NCT02891226|448585084|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
124716180|NCT02891226|448585085|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
124716181|NCT02891226|448585086|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
124716182|NCT02891226|448585087|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
124716183|NCT02891226|448585088|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
124716184|NCT02891226|448585089|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
124716185|NCT02891226|448585090|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
124716186|NCT02891226|448585075|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
124716187|NCT02891226|448585076|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
124716188|NCT02891226|448585077|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
124716189|NCT02891226|448585078|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
124716190|NCT02891226|448585079|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
124716191|NCT02891226|448585080|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
124716192|NCT02891226|448585081|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
124716193|NCT02891226|448585082|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
124716194|NCT02891226|448585083|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
124716195|NCT02891226|448585084|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
124716196|NCT02891226|448585085|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
124716197|NCT02891226|448585086|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
124716198|NCT02891226|448585087|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
124716199|NCT02891226|448585088|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
124716200|NCT02891226|448585089|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
124716201|NCT02891226|448585090|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
124716202|NCT02891226|448585075|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
124716203|NCT02891226|448585076|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
124716204|NCT02891226|448585077|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
124716205|NCT02891226|448585078|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
124716206|NCT02891226|448585079|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
124716207|NCT02891226|448585080|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
124716208|NCT02891226|448585081|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
124716209|NCT02891226|448585082|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
124716210|NCT02891226|448585083|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
124716211|NCT02891226|448585084|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
124716212|NCT02891226|448585085|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
124716213|NCT02891226|448585086|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
124716214|NCT02891226|448585087|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
124716215|NCT02891226|448585088|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
124716216|NCT02891226|448585089|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
124716217|NCT02891226|448585090|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
124716218|NCT02891226|448585075|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
124716219|NCT02891226|448585076|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
124716220|NCT02891226|448585077|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
124716221|NCT02891226|448585078|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
124716222|NCT02891226|448585079|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
124716223|NCT02891226|448585080|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
124716224|NCT02891226|448585081|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
124716225|NCT02891226|448585082|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
124716226|NCT02891226|448585083|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
124716227|NCT02891226|448585084|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
124716228|NCT02891226|448585085|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
124716229|NCT02891226|448585086|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
124716230|NCT02891226|448585087|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
124716231|NCT02891226|448585088|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
124770971|NCT01747876|448791654|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
124716232|NCT02891226|448585089|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
124716233|NCT02891226|448585090|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
124716234|NCT02891226|448585075|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
124716235|NCT02891226|448585076|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
124716236|NCT02891226|448585077|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
124716237|NCT02891226|448585078|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
124716238|NCT02891226|448585079|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
124716239|NCT02891226|448585080|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
124716240|NCT02891226|448585081|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
124716241|NCT02891226|448585082|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
124716242|NCT02891226|448585083|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
124716243|NCT02891226|448585084|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
124472429|NCT00666926|447687670|FG005|Overall Study|Laboratory abnormality|0|||
124472430|NCT00666926|447687671|FG006|Overall Study|Laboratory abnormality|0|||
124472431|NCT00666926|447687672|FG007|Overall Study|Laboratory abnormality|0|||
124472432|NCT00666926|447687673|FG008|Overall Study|Laboratory abnormality|0|||
124472433|NCT00666926|447687674|FG009|Overall Study|Laboratory abnormality|0|||
124472434|NCT00666926|447687675|FG010|Overall Study|Laboratory abnormality|1|||
124472435|NCT00666926|447687676|FG011|Overall Study|Laboratory abnormality|0|||
124472436|NCT00666926|447687677|FG012|Overall Study|Laboratory abnormality|0|||
124472437|NCT00666926|447687678|FG013|Overall Study|Laboratory abnormality|0|||
124472438|NCT00666926|447687679|FG014|Overall Study|Laboratory abnormality|0|||
124472439|NCT00666926|447687680|FG015|Overall Study|Laboratory abnormality|1|||
124472440|NCT00666926|447687665|FG000|Overall Study|Lack of Efficacy|0|||
124472441|NCT00666926|447687666|FG001|Overall Study|Lack of Efficacy|0|||
124472442|NCT00666926|447687667|FG002|Overall Study|Lack of Efficacy|0|||
124472443|NCT00666926|447687668|FG003|Overall Study|Lack of Efficacy|0|||
124472444|NCT00666926|447687669|FG004|Overall Study|Lack of Efficacy|0|||
124472445|NCT00666926|447687670|FG005|Overall Study|Lack of Efficacy|1|||
124472446|NCT00666926|447687671|FG006|Overall Study|Lack of Efficacy|0|||
124472447|NCT00666926|447687672|FG007|Overall Study|Lack of Efficacy|0|||
124472448|NCT00666926|447687673|FG008|Overall Study|Lack of Efficacy|0|||
124472449|NCT00666926|447687674|FG009|Overall Study|Lack of Efficacy|0|||
124472450|NCT00666926|447687675|FG010|Overall Study|Lack of Efficacy|0|||
124472451|NCT00666926|447687676|FG011|Overall Study|Lack of Efficacy|1|||
124472452|NCT00666926|447687677|FG012|Overall Study|Lack of Efficacy|0|||
124472453|NCT00666926|447687678|FG013|Overall Study|Lack of Efficacy|0|||
124472454|NCT00666926|447687679|FG014|Overall Study|Lack of Efficacy|0|||
124472455|NCT00666926|447687680|FG015|Overall Study|Lack of Efficacy|0|||
124472456|NCT00666926|447687665|FG000|Overall Study|Lost to Follow-up|0|||
124472457|NCT00666926|447687666|FG001|Overall Study|Lost to Follow-up|0|||
124472458|NCT00666926|447687667|FG002|Overall Study|Lost to Follow-up|0|||
124472459|NCT00666926|447687668|FG003|Overall Study|Lost to Follow-up|1|||
124472460|NCT00666926|447687669|FG004|Overall Study|Lost to Follow-up|0|||
124472461|NCT00666926|447687670|FG005|Overall Study|Lost to Follow-up|0|||
124716244|NCT02891226|448585085|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
124472462|NCT00666926|447687671|FG006|Overall Study|Lost to Follow-up|0|||
124472463|NCT00666926|447687672|FG007|Overall Study|Lost to Follow-up|0|||
124472464|NCT00666926|447687673|FG008|Overall Study|Lost to Follow-up|0|||
124472465|NCT00666926|447687674|FG009|Overall Study|Lost to Follow-up|0|||
124472466|NCT00666926|447687675|FG010|Overall Study|Lost to Follow-up|0|||
124716245|NCT02891226|448585086|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
124716246|NCT02891226|448585087|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
124716247|NCT02891226|448585088|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
124716248|NCT02891226|448585089|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
124716249|NCT02891226|448585090|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
124716250|NCT02891226|448585075|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
124716251|NCT02891226|448585076|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
124716252|NCT02891226|448585077|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
124716253|NCT02891226|448585078|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
124472467|NCT00666926|447687676|FG011|Overall Study|Lost to Follow-up|0|||
124472468|NCT00666926|447687677|FG012|Overall Study|Lost to Follow-up|0|||
124472469|NCT00666926|447687678|FG013|Overall Study|Lost to Follow-up|0|||
124472470|NCT00666926|447687679|FG014|Overall Study|Lost to Follow-up|0|||
124472471|NCT00666926|447687680|FG015|Overall Study|Lost to Follow-up|0|||
124554415|NCT00928135|447987422|FG000|Overall Study|Withdrawal by Subject|1|||
124472472|NCT00666926|447687665|FG000|Overall Study|Other|2|||
124554416|NCT00928135|447987423|FG001|Overall Study|Withdrawal by Subject|0|||
124472473|NCT00666926|447687666|FG001|Overall Study|Other|4|||
124472474|NCT00666926|447687667|FG002|Overall Study|Other|3|||
124472475|NCT00666926|447687668|FG003|Overall Study|Other|3|||
124554417|NCT03338673|447987426|FG000|Overall Study|Lost to Follow-up|1|||
124472476|NCT00666926|447687669|FG004|Overall Study|Other|3|||
124716254|NCT02891226|448585079|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
124716255|NCT02891226|448585080|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
124716256|NCT02891226|448585081|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
124716257|NCT02891226|448585082|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
124716258|NCT02891226|448585083|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
124716259|NCT02891226|448585084|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
124716260|NCT02891226|448585085|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
124716261|NCT02891226|448585086|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
124716262|NCT02891226|448585087|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
124716263|NCT02891226|448585088|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
124716264|NCT02891226|448585089|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
124716265|NCT02891226|448585090|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
124716266|NCT02891226|448585075|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
124716267|NCT02891226|448585076|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
124716268|NCT02891226|448585077|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
124716269|NCT02891226|448585078|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
124716270|NCT02891226|448585079|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
124716271|NCT02891226|448585080|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
124716272|NCT02891226|448585081|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
124716273|NCT02891226|448585082|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
124716274|NCT02891226|448585083|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
124716275|NCT02891226|448585084|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
124716276|NCT02891226|448585085|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
124716277|NCT02891226|448585086|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
124716278|NCT02891226|448585087|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
124716279|NCT02891226|448585088|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
124716280|NCT02891226|448585089|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
124716281|NCT02891226|448585090|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
124716282|NCT02891226|448585075|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
124716283|NCT02891226|448585076|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
124716284|NCT02891226|448585077|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
124716285|NCT02891226|448585078|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
124716286|NCT02891226|448585079|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
124716287|NCT02891226|448585080|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
124716288|NCT02891226|448585081|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
124716289|NCT02891226|448585082|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
124716290|NCT02891226|448585083|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
124716291|NCT02891226|448585084|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
124716292|NCT02891226|448585085|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
124716293|NCT02891226|448585086|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
124716294|NCT02891226|448585087|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
124770972|NCT01747876|448791655|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
124770973|NCT00914316|448791658|FG000|Phase 1|Physician Decision|4|||
124770974|NCT00914316|448791659|FG001|Phase 1|Physician Decision|0|||
124770975|NCT00914316|448791660|FG002|Phase 1|Physician Decision|1|||
124472477|NCT00666926|447687670|FG005|Overall Study|Other|3|||
124472478|NCT00666926|447687671|FG006|Overall Study|Other|4|||
124472479|NCT00666926|447687672|FG007|Overall Study|Other|0|||
124716295|NCT02891226|448585088|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
124716296|NCT02891226|448585089|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
124716297|NCT02891226|448585090|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
124716298|NCT02891226|448585075|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
124716299|NCT02891226|448585076|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
124716300|NCT02891226|448585077|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
124716301|NCT02891226|448585078|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
124716302|NCT02891226|448585079|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
124716303|NCT02891226|448585080|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
124716304|NCT02891226|448585081|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
124716305|NCT02891226|448585082|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
124716306|NCT02891226|448585083|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
124716307|NCT02891226|448585084|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
124716308|NCT02891226|448585085|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
124716309|NCT02891226|448585086|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
124716310|NCT02891226|448585087|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
124716311|NCT02891226|448585088|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
124770976|NCT00914316|448791661|FG003|Phase 1|Physician Decision|2|||
124770977|NCT00914316|448791658|FG000|Phase 1|Withdrawal by Subject|0|||
124472480|NCT00666926|447687673|FG008|Overall Study|Other|3|||
124472481|NCT00666926|447687674|FG009|Overall Study|Other|5|||
124472482|NCT00666926|447687675|FG010|Overall Study|Other|3|||
124472483|NCT00666926|447687676|FG011|Overall Study|Other|26|||
124472484|NCT00666926|447687677|FG012|Overall Study|Other|3|||
124472485|NCT00666926|447687678|FG013|Overall Study|Other|2|||
124770978|NCT00914316|448791659|FG001|Phase 1|Withdrawal by Subject|2|||
124472486|NCT00666926|447687679|FG014|Overall Study|Other|4|||
124472487|NCT00666926|447687680|FG015|Overall Study|Other|4|||
124472488|NCT00666926|447687665|FG000|Overall Study|Withdrawal by Subject|0|||
124472489|NCT00666926|447687666|FG001|Overall Study|Withdrawal by Subject|0|||
124472490|NCT00666926|447687667|FG002|Overall Study|Withdrawal by Subject|0|||
124472491|NCT00666926|447687668|FG003|Overall Study|Withdrawal by Subject|0|||
124472492|NCT00666926|447687669|FG004|Overall Study|Withdrawal by Subject|0|||
124472493|NCT00666926|447687670|FG005|Overall Study|Withdrawal by Subject|0|||
124472494|NCT00666926|447687671|FG006|Overall Study|Withdrawal by Subject|0|||
124472495|NCT00666926|447687672|FG007|Overall Study|Withdrawal by Subject|1|||
124472496|NCT00666926|447687673|FG008|Overall Study|Withdrawal by Subject|0|||
124472497|NCT00666926|447687674|FG009|Overall Study|Withdrawal by Subject|3|||
124472498|NCT00666926|447687675|FG010|Overall Study|Withdrawal by Subject|0|||
124472499|NCT00666926|447687676|FG011|Overall Study|Withdrawal by Subject|3|||
124472500|NCT00666926|447687677|FG012|Overall Study|Withdrawal by Subject|0|||
124472501|NCT00666926|447687678|FG013|Overall Study|Withdrawal by Subject|1|||
124472502|NCT00666926|447687679|FG014|Overall Study|Withdrawal by Subject|3|||
124472503|NCT00666926|447687680|FG015|Overall Study|Withdrawal by Subject|3|||
124472504|NCT00666926|447687665|FG000|Overall Study|Death|0|||
124472505|NCT00666926|447687666|FG001|Overall Study|Death|0|||
124472506|NCT00666926|447687667|FG002|Overall Study|Death|0|||
124472507|NCT00666926|447687668|FG003|Overall Study|Death|0|||
124472508|NCT00666926|447687669|FG004|Overall Study|Death|0|||
124472509|NCT00666926|447687670|FG005|Overall Study|Death|0|||
124472510|NCT00666926|447687671|FG006|Overall Study|Death|0|||
124472511|NCT00666926|447687672|FG007|Overall Study|Death|0|||
124472512|NCT00666926|447687673|FG008|Overall Study|Death|0|||
124770979|NCT00914316|448791660|FG002|Phase 1|Withdrawal by Subject|4|||
124770980|NCT00914316|448791661|FG003|Phase 1|Withdrawal by Subject|0|||
124770981|NCT00914316|448791658|FG000|Phase 1|Adverse Event|1|||
124770982|NCT00914316|448791659|FG001|Phase 1|Adverse Event|0|||
124770983|NCT00914316|448791660|FG002|Phase 1|Adverse Event|0|||
124770984|NCT00914316|448791661|FG003|Phase 1|Adverse Event|0|||
124770985|NCT00914316|448791658|FG000|Phase 2|Withdrawal by Subject|1|||
124770986|NCT00914316|448791659|FG001|Phase 2|Withdrawal by Subject|0|||
124770987|NCT00914316|448791660|FG002|Phase 2|Withdrawal by Subject|1|||
124770988|NCT00914316|448791661|FG003|Phase 2|Withdrawal by Subject|0|||
124770989|NCT05660577|448791670|FG000|Overall Study|Discontinued|9|||
124770990|NCT03363841|448791673|FG000|Overall Study|Adverse Event|1|||
124770991|NCT03363841|448791673|FG000|Overall Study|Withdrawal by Subject|1|||
124770992|NCT03363841|448791673|FG000|Overall Study|Death|7|||
124770993|NCT03363841|448791673|FG000|Overall Study|Physician Decision|1|||
124770994|NCT01744977|448791674|FG000|Overall Study|Withdrawal by Subject|1|||
124770995|NCT01744977|448791675|FG001|Overall Study|Withdrawal by Subject|2|||
124770996|NCT01744977|448791674|FG000|Overall Study|Death|2|||
124770997|NCT01744977|448791675|FG001|Overall Study|Death|3|||
124472513|NCT00666926|447687674|FG009|Overall Study|Death|0|||
124472514|NCT00666926|447687675|FG010|Overall Study|Death|0|||
124472515|NCT00666926|447687676|FG011|Overall Study|Death|1|||
124472516|NCT00666926|447687677|FG012|Overall Study|Death|0|||
124472517|NCT00666926|447687678|FG013|Overall Study|Death|0|||
124472518|NCT00666926|447687679|FG014|Overall Study|Death|0|||
124472519|NCT00666926|447687680|FG015|Overall Study|Death|0|||
124472520|NCT01727258|447687681|FG000|Overall Study|Adverse Event|0|||
124472521|NCT01727258|447687682|FG001|Overall Study|Adverse Event|2|||
124472522|NCT01727258|447687683|FG002|Overall Study|Adverse Event|0|||
124472523|NCT01727258|447687681|FG000|Overall Study|Noncompliance with Study Drug|0|||
124472524|NCT01727258|447687682|FG001|Overall Study|Noncompliance with Study Drug|0|||
124472525|NCT01727258|447687683|FG002|Overall Study|Noncompliance with Study Drug|1|||
124472526|NCT01727258|447687681|FG000|Overall Study|Withdrawal by Subject|1|||
124472527|NCT01727258|447687682|FG001|Overall Study|Withdrawal by Subject|1|||
124472528|NCT01727258|447687683|FG002|Overall Study|Withdrawal by Subject|0|||
124770998|NCT01744977|448791674|FG000|Overall Study|Lost to Follow-up|2|||
124770999|NCT01744977|448791675|FG001|Overall Study|Lost to Follow-up|0|||
124771000|NCT01744977|448791674|FG000|Overall Study|No longer meets inclusion|6|||
124771001|NCT01744977|448791675|FG001|Overall Study|No longer meets inclusion|0|||
124771002|NCT03879772|448791684|FG000|Overall Study|Adverse Event|2|||
124472529|NCT01727258|447687681|FG000|Overall Study|Lost to Follow-up|1|||
124472530|NCT01727258|447687682|FG001|Overall Study|Lost to Follow-up|0|||
124472531|NCT01727258|447687683|FG002|Overall Study|Lost to Follow-up|0|||
124472532|NCT01360645|447687684|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
124472533|NCT01360645|447687685|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
124472534|NCT01360645|447687686|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
124472535|NCT01360645|447687687|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
124472536|NCT01360645|447687684|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
124472537|NCT01360645|447687685|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
124472538|NCT01360645|447687686|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
124472539|NCT01360645|447687687|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
124472540|NCT01360645|447687684|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
124554418|NCT03338673|447987427|FG001|Overall Study|Lost to Follow-up|1|||
124472541|NCT01360645|447687685|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
124472542|NCT01360645|447687686|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
124472543|NCT01360645|447687687|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
124472544|NCT01360645|447687684|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
124472545|NCT01360645|447687685|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
124472546|NCT01360645|447687686|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
124472547|NCT01360645|447687687|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
124472548|NCT01360645|447687684|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
124472549|NCT01360645|447687685|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
124472550|NCT01360645|447687686|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
124472551|NCT01360645|447687687|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
124472552|NCT01360645|447687684|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
124472553|NCT01360645|447687685|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
124472554|NCT01360645|447687686|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
124472555|NCT01360645|447687687|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
124472556|NCT01360645|447687684|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
124472557|NCT01360645|447687685|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
124472558|NCT01360645|447687686|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
124472559|NCT01360645|447687687|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
124472560|NCT01360645|447687684|FG000|Phase B (6 Weeks)|Adverse Event|0|||
124472561|NCT01360645|447687685|FG001|Phase B (6 Weeks)|Adverse Event|6|||
124472562|NCT01360645|447687686|FG002|Phase B (6 Weeks)|Adverse Event|0|||
124472563|NCT01360645|447687687|FG003|Phase B (6 Weeks)|Adverse Event|0|||
124472564|NCT01360645|447687684|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
124472565|NCT01360645|447687685|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
124472566|NCT01360645|447687686|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
124472567|NCT01360645|447687687|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
124472568|NCT01360645|447687684|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
124472569|NCT01360645|447687685|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
124472570|NCT01360645|447687686|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
124472571|NCT01360645|447687687|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
124472572|NCT01360645|447687684|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
124472573|NCT01360645|447687685|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
124472574|NCT01360645|447687686|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
124472575|NCT01360645|447687687|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
124472576|NCT01360645|447687684|FG000|Phase A+|Lost to Follow-up|0|||
124472577|NCT01360645|447687685|FG001|Phase A+|Lost to Follow-up|0|||
124472578|NCT01360645|447687686|FG002|Phase A+|Lost to Follow-up|0|||
124472579|NCT01360645|447687687|FG003|Phase A+|Lost to Follow-up|7|||
124472580|NCT01360645|447687684|FG000|Phase A+|Adverse Event|0|||
124472581|NCT01360645|447687685|FG001|Phase A+|Adverse Event|0|||
124472582|NCT01360645|447687686|FG002|Phase A+|Adverse Event|0|||
124472583|NCT01360645|447687687|FG003|Phase A+|Adverse Event|2|||
124472584|NCT01360645|447687684|FG000|Phase A+|Met Withdrawal Criteria|0|||
124472585|NCT01360645|447687685|FG001|Phase A+|Met Withdrawal Criteria|0|||
124472586|NCT01360645|447687686|FG002|Phase A+|Met Withdrawal Criteria|0|||
124472587|NCT01360645|447687687|FG003|Phase A+|Met Withdrawal Criteria|4|||
124472588|NCT01360645|447687684|FG000|Phase A+|Physician Decision|0|||
124472589|NCT01360645|447687685|FG001|Phase A+|Physician Decision|0|||
124472590|NCT01360645|447687686|FG002|Phase A+|Physician Decision|0|||
124472591|NCT01360645|447687687|FG003|Phase A+|Physician Decision|2|||
124472592|NCT01360645|447687684|FG000|Phase A+|Withdrawal by Subject|0|||
124472593|NCT01360645|447687685|FG001|Phase A+|Withdrawal by Subject|0|||
124554419|NCT00434148|447987430|FG000|Overall Study|Adverse Event|18|||
124472594|NCT01360645|447687686|FG002|Phase A+|Withdrawal by Subject|0|||
124472595|NCT01360645|447687687|FG003|Phase A+|Withdrawal by Subject|5|||
124472596|NCT01360645|447687684|FG000|Phase A+|Protocol Deviation|0|||
124472597|NCT01360645|447687685|FG001|Phase A+|Protocol Deviation|0|||
124472598|NCT01360645|447687686|FG002|Phase A+|Protocol Deviation|0|||
124472599|NCT01360645|447687687|FG003|Phase A+|Protocol Deviation|4|||
124554420|NCT00434148|447987431|FG001|Overall Study|Adverse Event|18|||
124554421|NCT00434148|447987430|FG000|Overall Study|Lack of Efficacy|25|||
124554422|NCT00434148|447987431|FG001|Overall Study|Lack of Efficacy|28|||
124554423|NCT00434148|447987430|FG000|Overall Study|Withdrawal by Subject|15|||
124554424|NCT00434148|447987431|FG001|Overall Study|Withdrawal by Subject|15|||
124554425|NCT00434148|447987430|FG000|Overall Study|Protocol Violation|4|||
124554426|NCT00434148|447987431|FG001|Overall Study|Protocol Violation|0|||
124554427|NCT00434148|447987430|FG000|Overall Study|Administrative problems|6|||
124554428|NCT00434148|447987431|FG001|Overall Study|Administrative problems|10|||
124554429|NCT00434148|447987430|FG000|Overall Study|Lost to Follow-up|0|||
124554430|NCT00434148|447987431|FG001|Overall Study|Lost to Follow-up|1|||
124472600|NCT01014585|447687692|FG000|Overall Study|Adverse Event|0|||
124472601|NCT01014585|447687693|FG001|Overall Study|Adverse Event|2|||
124472602|NCT01014585|447687694|FG002|Overall Study|Adverse Event|0|||
124472603|NCT01014585|447687695|FG003|Overall Study|Adverse Event|3|||
124472604|NCT01014585|447687692|FG000|Overall Study|Withdrawal by Subject|2|||
124472605|NCT01014585|447687693|FG001|Overall Study|Withdrawal by Subject|0|||
124472606|NCT01014585|447687694|FG002|Overall Study|Withdrawal by Subject|1|||
124472607|NCT01014585|447687695|FG003|Overall Study|Withdrawal by Subject|3|||
124472608|NCT01014585|447687692|FG000|Overall Study|Lost to Follow-up|0|||
124472609|NCT01014585|447687693|FG001|Overall Study|Lost to Follow-up|0|||
124472610|NCT01014585|447687694|FG002|Overall Study|Lost to Follow-up|0|||
124472611|NCT01014585|447687695|FG003|Overall Study|Lost to Follow-up|2|||
124472612|NCT01014585|447687692|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
124472613|NCT01014585|447687693|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
124472614|NCT01014585|447687694|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
124472615|NCT01014585|447687695|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
124472616|NCT04178772|447687696|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
124472617|NCT04178772|447687696|FG000|Overall Study|study terminated early due to COVID-19|7|||
124472618|NCT00773279|447687697|FG000|Period 1|Adverse Event|2|||
124472619|NCT00773279|447687698|FG001|Period 1|Adverse Event|1|||
124472620|NCT00773279|447687697|FG000|Period 1|Lack of Efficacy|0|||
124472621|NCT00773279|447687698|FG001|Period 1|Lack of Efficacy|2|||
124472622|NCT00773279|447687697|FG000|Period 1|Unclassified|5|||
124472623|NCT00773279|447687698|FG001|Period 1|Unclassified|1|||
124472624|NCT00773279|447687697|FG000|Period 2|Adverse Event|0|||
124472625|NCT00773279|447687698|FG001|Period 2|Adverse Event|1|||
124472626|NCT00773279|447687697|FG000|Period 2|Lack of Efficacy|1|||
124472627|NCT00773279|447687698|FG001|Period 2|Lack of Efficacy|0|||
124554431|NCT00434148|447987430|FG000|Overall Study|Condition no longer requires study drug|1|||
124554432|NCT00434148|447987431|FG001|Overall Study|Condition no longer requires study drug|0|||
124716312|NCT02891226|448585089|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
124472628|NCT00773279|447687697|FG000|Period 2|Protocol Violation|0|||
124472629|NCT00773279|447687698|FG001|Period 2|Protocol Violation|3|||
124472630|NCT00773279|447687697|FG000|Period 2|Unclassified|2|||
124472631|NCT00773279|447687698|FG001|Period 2|Unclassified|2|||
124472632|NCT02817087|447687702|FG000|Overall Study|Withdrawal by Subject|2|||
124472633|NCT02817087|447687703|FG001|Overall Study|Withdrawal by Subject|0|||
124472634|NCT00508391|447687704|FG000|First Treatment|Withdrawal by Subject|6|||
124472635|NCT00508391|447687705|FG001|First Treatment|Withdrawal by Subject|3|||
124472636|NCT00508391|447687704|FG000|Second Treatment|Withdrawal by Subject|2|||
124472637|NCT00508391|447687705|FG001|Second Treatment|Withdrawal by Subject|0|||
124472638|NCT00802360|447687706|FG000|Overall Study|Stimulation failure|4|||
124472639|NCT00802360|447687707|FG001|Overall Study|Stimulation failure|0|||
124472640|NCT00802360|447687708|FG002|Overall Study|Stimulation failure|3|||
124472641|NCT00802360|447687709|FG003|Overall Study|Stimulation failure|3|||
124472642|NCT00802360|447687706|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
124472643|NCT00802360|447687707|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
124472644|NCT00802360|447687708|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
124472645|NCT00802360|447687709|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
124472646|NCT00802360|447687706|FG000|Overall Study|Cycle cancelled|0|||
124472647|NCT00802360|447687707|FG001|Overall Study|Cycle cancelled|1|||
124472648|NCT00802360|447687708|FG002|Overall Study|Cycle cancelled|1|||
124472649|NCT00802360|447687709|FG003|Overall Study|Cycle cancelled|1|||
124472650|NCT00802360|447687706|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
124771003|NCT03879772|448791685|FG001|Overall Study|Adverse Event|2|||
124771004|NCT03879772|448791686|FG002|Overall Study|Adverse Event|3|||
124771005|NCT03879772|448791687|FG003|Overall Study|Adverse Event|4|||
124771006|NCT03879772|448791688|FG004|Overall Study|Adverse Event|3|||
124771007|NCT03879772|448791684|FG000|Overall Study|Treatment Failure|1|||
124771008|NCT03879772|448791685|FG001|Overall Study|Treatment Failure|0|||
124771009|NCT03879772|448791686|FG002|Overall Study|Treatment Failure|0|||
124771010|NCT03879772|448791687|FG003|Overall Study|Treatment Failure|2|||
124771011|NCT03879772|448791688|FG004|Overall Study|Treatment Failure|1|||
124771012|NCT03879772|448791684|FG000|Overall Study|Lost to Follow-up|0|||
124771013|NCT03879772|448791685|FG001|Overall Study|Lost to Follow-up|0|||
124771014|NCT03879772|448791686|FG002|Overall Study|Lost to Follow-up|0|||
124771015|NCT03879772|448791687|FG003|Overall Study|Lost to Follow-up|0|||
124771016|NCT03879772|448791688|FG004|Overall Study|Lost to Follow-up|1|||
124771017|NCT03879772|448791684|FG000|Overall Study|Withdrawal by Subject|0|||
124771018|NCT03879772|448791685|FG001|Overall Study|Withdrawal by Subject|1|||
124771019|NCT03879772|448791686|FG002|Overall Study|Withdrawal by Subject|3|||
124771020|NCT03879772|448791687|FG003|Overall Study|Withdrawal by Subject|1|||
124771021|NCT03879772|448791688|FG004|Overall Study|Withdrawal by Subject|1|||
124771022|NCT03879772|448791684|FG000|Overall Study|Protocol Violation|0|||
124771023|NCT03879772|448791685|FG001|Overall Study|Protocol Violation|0|||
124771024|NCT03879772|448791686|FG002|Overall Study|Protocol Violation|3|||
124771025|NCT03879772|448791687|FG003|Overall Study|Protocol Violation|1|||
124771026|NCT03879772|448791688|FG004|Overall Study|Protocol Violation|2|||
124771027|NCT03879772|448791684|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
124771028|NCT03879772|448791685|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
124771029|NCT03879772|448791686|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
124771030|NCT03879772|448791687|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
124771031|NCT03879772|448791688|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
124771032|NCT00106704|448791691|FG000|Overall Study|Adverse Event|10|||
124771033|NCT00106704|448791692|FG001|Overall Study|Adverse Event|7|||
124771034|NCT00106704|448791691|FG000|Overall Study|Death|2|||
124771035|NCT00106704|448791692|FG001|Overall Study|Death|1|||
124771036|NCT00106704|448791691|FG000|Overall Study|Lack of Efficacy|67|||
124771037|NCT00106704|448791692|FG001|Overall Study|Lack of Efficacy|69|||
124771038|NCT00106704|448791691|FG000|Overall Study|Lost to Follow-up|7|||
124771039|NCT00106704|448791692|FG001|Overall Study|Lost to Follow-up|3|||
124771040|NCT00106704|448791691|FG000|Overall Study|Pregnancy|1|||
124771041|NCT00106704|448791692|FG001|Overall Study|Pregnancy|0|||
124771042|NCT00106704|448791691|FG000|Overall Study|Protocol Violation|4|||
124771043|NCT00106704|448791692|FG001|Overall Study|Protocol Violation|7|||
124771044|NCT00106704|448791691|FG000|Overall Study|Withdrawal by Subject|14|||
124771045|NCT00106704|448791692|FG001|Overall Study|Withdrawal by Subject|21|||
124771046|NCT00106704|448791691|FG000|Overall Study|Patient moved|1|||
124771047|NCT00106704|448791692|FG001|Overall Study|Patient moved|0|||
124771048|NCT00106704|448791691|FG000|Overall Study|Site terminated|0|||
124771049|NCT00106704|448791692|FG001|Overall Study|Site terminated|1|||
124771050|NCT00106704|448791691|FG000|Overall Study|Planned major surgery|1|||
124771051|NCT00106704|448791692|FG001|Overall Study|Planned major surgery|0|||
124771052|NCT00106704|448791691|FG000|Overall Study|Patient Received Glycemic Medication|22|||
124771053|NCT00106704|448791692|FG001|Overall Study|Patient Received Glycemic Medication|41|||
124771054|NCT00106704|448791691|FG000|Overall Study|Unable to re-enter US|1|||
124771055|NCT00106704|448791692|FG001|Overall Study|Unable to re-enter US|0|||
124771056|NCT00106704|448791691|FG000|Overall Study|Laboratory test|1|||
124771057|NCT00106704|448791692|FG001|Overall Study|Laboratory test|1|||
124771058|NCT03818321|448791693|FG000|Overall Study|Withdrawal by Subject|1|||
124771059|NCT03818321|448791694|FG001|Overall Study|Withdrawal by Subject|2|||
124771060|NCT03216226|448791697|FG000|Overall Study|Adverse Event|3|||
124771061|NCT03216226|448791698|FG001|Overall Study|Adverse Event|0|||
124771062|NCT03216226|448791697|FG000|Overall Study|Protocol Violation|1|||
124771063|NCT03216226|448791698|FG001|Overall Study|Protocol Violation|3|||
124716313|NCT02891226|448585090|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
124716314|NCT02891226|448585075|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
124716315|NCT02891226|448585076|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
124716316|NCT02891226|448585077|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
124716317|NCT02891226|448585078|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
124716318|NCT02891226|448585079|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
124716319|NCT02891226|448585080|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
124716320|NCT02891226|448585081|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
124716321|NCT02891226|448585082|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
124716322|NCT02891226|448585083|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
124716323|NCT02891226|448585084|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
124716324|NCT02891226|448585085|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
124716325|NCT02891226|448585086|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
124716326|NCT02891226|448585087|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
124716327|NCT02891226|448585088|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
124716328|NCT02891226|448585089|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
124716329|NCT02891226|448585090|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
124716330|NCT02891226|448585075|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
124716331|NCT02891226|448585076|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
124716332|NCT02891226|448585077|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
124716333|NCT02891226|448585078|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
124716334|NCT02891226|448585079|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
124716335|NCT02891226|448585080|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
124716336|NCT02891226|448585081|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
124716337|NCT02891226|448585082|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
124716338|NCT02891226|448585083|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
124716339|NCT02891226|448585084|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
124716340|NCT02891226|448585085|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
124716341|NCT02891226|448585086|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
124716342|NCT02891226|448585087|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
124716343|NCT02891226|448585088|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
124716344|NCT02891226|448585089|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
124716345|NCT02891226|448585090|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
124716346|NCT02891226|448585075|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
124716347|NCT02891226|448585076|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
124716348|NCT02891226|448585077|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
124716349|NCT02891226|448585078|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
124716350|NCT02891226|448585079|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
124716351|NCT02891226|448585080|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
124716352|NCT02891226|448585081|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
124716353|NCT02891226|448585082|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
124716354|NCT02891226|448585083|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
124771064|NCT03216226|448791697|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
124771065|NCT03216226|448791698|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
124771066|NCT03216226|448791697|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
124771067|NCT03216226|448791698|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
124771068|NCT03216226|448791697|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
124771069|NCT03216226|448791698|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
124771070|NCT00871975|448791701|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
124771071|NCT00871975|448791701|FG000|Overall Study|Catheters could not be inserted|1|||
124771072|NCT00871975|448791701|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
124771073|NCT00871975|448791701|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
124771074|NCT05249582|448791702|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
124472651|NCT00802360|447687707|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
124472652|NCT00802360|447687708|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
124472653|NCT00802360|447687709|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
124472654|NCT00802360|447687706|FG000|Overall Study|No positive serum pregnancy|17|||
124472655|NCT00802360|447687707|FG001|Overall Study|No positive serum pregnancy|20|||
124472656|NCT00802360|447687708|FG002|Overall Study|No positive serum pregnancy|14|||
124472657|NCT00802360|447687709|FG003|Overall Study|No positive serum pregnancy|10|||
124472658|NCT00802360|447687706|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
124472659|NCT00802360|447687707|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
124472660|NCT00802360|447687708|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
124472661|NCT00802360|447687709|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
124472662|NCT00802360|447687706|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
124472663|NCT00802360|447687707|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
124472664|NCT00802360|447687708|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
124472665|NCT00802360|447687709|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
124472666|NCT00802360|447687706|FG000|Overall Study|Other|2|||
124472667|NCT00802360|447687707|FG001|Overall Study|Other|3|||
124472668|NCT00802360|447687708|FG002|Overall Study|Other|6|||
124472669|NCT00802360|447687709|FG003|Overall Study|Other|3|||
124472670|NCT02041962|447687710|FG000|Overall Study|Lost Aetna Coverage|43|||
124472671|NCT02041962|447687711|FG001|Overall Study|Lost Aetna Coverage|40|||
124472672|NCT02041962|447687710|FG000|Overall Study|Death|1|||
124472673|NCT02041962|447687711|FG001|Overall Study|Death|1|||
124472674|NCT02041962|447687710|FG000|Overall Study|Lost to Follow-up|37|||
124472675|NCT02041962|447687711|FG001|Overall Study|Lost to Follow-up|32|||
124472676|NCT02041962|447687710|FG000|Overall Study|Withdrawal by Subject|0|||
124472677|NCT02041962|447687711|FG001|Overall Study|Withdrawal by Subject|11|||
124472678|NCT02908516|447687712|FG000|Overall Study|Study Terminated|3|||
124472679|NCT02908516|447687713|FG001|Overall Study|Study Terminated|3|||
124472680|NCT01225562|447687714|FG000|Overall Study|Withdrawal by Subject|52|||
124472681|NCT01225562|447687715|FG001|Overall Study|Withdrawal by Subject|50|||
124472682|NCT01225562|447687716|FG002|Overall Study|Withdrawal by Subject|52|||
124472683|NCT01225562|447687714|FG000|Overall Study|Lost to Follow-up|3|||
124472684|NCT01225562|447687715|FG001|Overall Study|Lost to Follow-up|6|||
124472685|NCT01225562|447687716|FG002|Overall Study|Lost to Follow-up|1|||
124472686|NCT01818726|447687717|FG000|Overall Study|Administrative reasons|5|||
124472687|NCT01818726|447687718|FG001|Overall Study|Administrative reasons|1|||
124472688|NCT01818726|447687717|FG000|Overall Study|Withdrawal by Subject|0|||
124472689|NCT01818726|447687718|FG001|Overall Study|Withdrawal by Subject|1|||
124472690|NCT01818726|447687717|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
124472691|NCT01818726|447687718|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
124472692|NCT01162421|447687719|FG000|Overall Study|Did not receive study drug|2|||
124472693|NCT01162421|447687720|FG001|Overall Study|Did not receive study drug|1|||
124472694|NCT01162421|447687719|FG000|Overall Study|Adverse Event|2|||
124472695|NCT01162421|447687720|FG001|Overall Study|Adverse Event|5|||
124472696|NCT01162421|447687719|FG000|Overall Study|Lost to Follow-up|0|||
124472697|NCT01162421|447687720|FG001|Overall Study|Lost to Follow-up|2|||
124472698|NCT01162421|447687719|FG000|Overall Study|Lack of Efficacy|2|||
124472699|NCT01162421|447687720|FG001|Overall Study|Lack of Efficacy|2|||
124472700|NCT01162421|447687719|FG000|Overall Study|Other|2|||
124472701|NCT01162421|447687720|FG001|Overall Study|Other|3|||
124554433|NCT00434148|447987430|FG000|Overall Study|Abnormal test procedure result|0|||
124716355|NCT02891226|448585084|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
124716356|NCT02891226|448585085|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
124716357|NCT02891226|448585086|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
124716358|NCT02891226|448585087|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
124472702|NCT00611247|447687721|FG000|Overall Study|Death|1|||
124472703|NCT00611247|447687722|FG001|Overall Study|Death|5|||
124472704|NCT00611247|447687721|FG000|Overall Study|Lack of Efficacy|1|||
124472705|NCT00611247|447687722|FG001|Overall Study|Lack of Efficacy|16|||
124472706|NCT01446419|447687731|FG000|Overall Study|Death|1|||
124472707|NCT01446419|447687732|FG001|Overall Study|Death|0|||
124472708|NCT01446419|447687731|FG000|Overall Study|Withdrawal by Subject|1|||
124472709|NCT01446419|447687732|FG001|Overall Study|Withdrawal by Subject|1|||
124472710|NCT01446419|447687731|FG000|Overall Study|Terminated per protocol|3|||
124472711|NCT01446419|447687732|FG001|Overall Study|Terminated per protocol|0|||
124716359|NCT02891226|448585088|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
124716360|NCT02891226|448585089|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
124716361|NCT02891226|448585090|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
124716362|NCT02891226|448585075|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
124716363|NCT02891226|448585076|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
124716364|NCT02891226|448585077|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
124716365|NCT02891226|448585078|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
124716366|NCT02891226|448585079|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
124716367|NCT02891226|448585080|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
124716368|NCT02891226|448585081|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
124716369|NCT02891226|448585082|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
124716370|NCT02891226|448585083|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
124716371|NCT02891226|448585084|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
124716372|NCT02891226|448585085|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
124716373|NCT02891226|448585086|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
124716374|NCT02891226|448585087|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
124716375|NCT02891226|448585088|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
124716376|NCT02891226|448585089|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
124716377|NCT02891226|448585090|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
124716378|NCT02891226|448585075|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
124716379|NCT02891226|448585076|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
124716380|NCT02891226|448585077|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
124716381|NCT02891226|448585078|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
124716382|NCT02891226|448585079|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
124716383|NCT02891226|448585080|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
124716384|NCT02891226|448585081|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
124554434|NCT00434148|447987431|FG001|Overall Study|Abnormal test procedure result|1|||
124554435|NCT00828516|447987432|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
124554436|NCT00990093|447987433|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
124554437|NCT00990093|447987434|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
124554438|NCT00990093|447987433|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
124554439|NCT00990093|447987434|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
124554440|NCT00990093|447987433|FG000|Test Period 1 (1-14 Days)|Other|1|||
124554441|NCT00990093|447987434|FG001|Test Period 1 (1-14 Days)|Other|0|||
124554442|NCT00990093|447987433|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
124554443|NCT00990093|447987434|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
124554444|NCT00990093|447987433|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
124716385|NCT02891226|448585082|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
124716386|NCT02891226|448585083|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
124716387|NCT02891226|448585084|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
124716388|NCT02891226|448585085|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
124716389|NCT02891226|448585086|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
124716390|NCT02891226|448585087|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
124716391|NCT02891226|448585088|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
124716392|NCT02891226|448585089|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
124472712|NCT02867761|447687735|FG000|Overall Study|Participant withdrawn by investigator|0|||
124472713|NCT02867761|447687736|FG001|Overall Study|Participant withdrawn by investigator|1|||
124472714|NCT02867761|447687735|FG000|Overall Study|Lost to Follow-up|25|||
124472715|NCT02867761|447687736|FG001|Overall Study|Lost to Follow-up|18|||
124472716|NCT02867761|447687735|FG000|Overall Study|Unable to complete protocol|3|||
124472717|NCT02867761|447687736|FG001|Overall Study|Unable to complete protocol|7|||
124472718|NCT04506294|447687737|FG000|Overall Study|Lost to Follow-up|70|||
124472719|NCT04506294|447687738|FG001|Overall Study|Lost to Follow-up|20|||
124472720|NCT04506294|447687737|FG000|Overall Study|Withdrawal by Subject|16|||
124472721|NCT04506294|447687738|FG001|Overall Study|Withdrawal by Subject|2|||
124472722|NCT01931059|447687740|FG000|Day 1|Pregnancy|0|||
124472723|NCT01931059|447687741|FG001|Day 1|Pregnancy|1|||
124716393|NCT02891226|448585090|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
124716394|NCT02891226|448585075|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
124716395|NCT02891226|448585076|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
124472724|NCT01931059|447687740|FG000|Day3|Lost to Follow-up|1|||
124472725|NCT01931059|447687741|FG001|Day3|Lost to Follow-up|0|||
124472726|NCT01445678|447687742|FG000|Overall Study|Adverse Event|12|||
124472727|NCT01445678|447687743|FG001|Overall Study|Adverse Event|8|||
124716396|NCT02891226|448585077|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
124716397|NCT02891226|448585078|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
124716398|NCT02891226|448585079|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
124472728|NCT01445678|447687742|FG000|Overall Study|Lack of Efficacy|0|||
124472729|NCT01445678|447687743|FG001|Overall Study|Lack of Efficacy|2|||
124472730|NCT01445678|447687742|FG000|Overall Study|Lost to Follow-up|8|||
124472731|NCT01445678|447687743|FG001|Overall Study|Lost to Follow-up|5|||
124472732|NCT01445678|447687742|FG000|Overall Study|Protocol Violation|1|||
124472733|NCT01445678|447687743|FG001|Overall Study|Protocol Violation|1|||
124472734|NCT01445678|447687742|FG000|Overall Study|Withdrawal by Subject|9|||
124472735|NCT01445678|447687743|FG001|Overall Study|Withdrawal by Subject|5|||
124472736|NCT02307370|447687744|FG000|Overall Study|Death|5|||
124472737|NCT02307370|447687744|FG000|Overall Study|Lost to Follow-up|1|||
124472738|NCT02307370|447687744|FG000|Overall Study|Withdrawal by Subject|1|||
124472739|NCT02307370|447687744|FG000|Overall Study|Declined Addendum ICF|6|||
124472740|NCT02307370|447687744|FG000|Overall Study|No response during telephone contact|5|||
124716399|NCT02891226|448585080|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
124716400|NCT02891226|448585081|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
124716401|NCT02891226|448585082|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
124716402|NCT02891226|448585083|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
124716403|NCT02891226|448585084|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
124716404|NCT02891226|448585085|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
124716405|NCT02891226|448585086|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
124716406|NCT02891226|448585087|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
124716407|NCT02891226|448585088|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
124716408|NCT02891226|448585089|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
124716409|NCT02891226|448585090|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
124716410|NCT02891226|448585075|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
124716411|NCT02891226|448585076|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
124716412|NCT02891226|448585077|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
124716413|NCT02891226|448585078|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
124716414|NCT02891226|448585079|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
124472741|NCT02307370|447687744|FG000|Overall Study|Protocol Violation|1|||
124554445|NCT00990093|447987434|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
124554446|NCT00990093|447987433|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
124554447|NCT00990093|447987434|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
124554448|NCT00990093|447987433|FG000|Test Period 2 (15-28 Days)|Other|0|||
124554449|NCT00990093|447987434|FG001|Test Period 2 (15-28 Days)|Other|1|||
124554450|NCT04556838|447987437|FG000|Overall Study|Withdrawal by Subject|3|||
124554451|NCT04556838|447987438|FG001|Overall Study|Withdrawal by Subject|1|||
124554452|NCT04556838|447987439|FG002|Overall Study|Withdrawal by Subject|2|||
124554453|NCT04556838|447987437|FG000|Overall Study|Adverse Event|0|||
124554454|NCT04556838|447987438|FG001|Overall Study|Adverse Event|1|||
124554455|NCT04556838|447987439|FG002|Overall Study|Adverse Event|1|||
124554456|NCT04556838|447987437|FG000|Overall Study|Lost to Follow-up|0|||
124554457|NCT04556838|447987438|FG001|Overall Study|Lost to Follow-up|0|||
124554458|NCT04556838|447987439|FG002|Overall Study|Lost to Follow-up|2|||
124554459|NCT04556838|447987437|FG000|Overall Study|Subject travel|0|||
124554460|NCT04556838|447987438|FG001|Overall Study|Subject travel|1|||
124554461|NCT04556838|447987439|FG002|Overall Study|Subject travel|0|||
124554462|NCT04556838|447987437|FG000|Overall Study|Physician Decision|1|||
124554463|NCT04556838|447987438|FG001|Overall Study|Physician Decision|0|||
124554464|NCT04556838|447987439|FG002|Overall Study|Physician Decision|0|||
124554465|NCT00995930|447987440|FG000|Overall Study|Protocol deviation|2|||
124554466|NCT00995930|447987441|FG001|Overall Study|Protocol deviation|5|||
124554467|NCT00995930|447987440|FG000|Overall Study|Death|0|||
124554468|NCT00995930|447987441|FG001|Overall Study|Death|1|||
124554469|NCT00995930|447987440|FG000|Overall Study|Administrative problems|4|||
124554470|NCT00995930|447987441|FG001|Overall Study|Administrative problems|2|||
124554471|NCT00995930|447987440|FG000|Overall Study|Lost to Follow-up|1|||
124554472|NCT00995930|447987441|FG001|Overall Study|Lost to Follow-up|2|||
124554473|NCT00995930|447987440|FG000|Overall Study|Withdrawal by Subject|3|||
124554474|NCT00995930|447987441|FG001|Overall Study|Withdrawal by Subject|4|||
124554475|NCT00995930|447987440|FG000|Overall Study|Adverse Event|11|||
124554476|NCT00995930|447987441|FG001|Overall Study|Adverse Event|14|||
124554477|NCT05003167|447987444|FG000|Overall Study|Withdrawal by Subject|1|||
124554478|NCT02842086|447987445|FG000|Overall Study|Randomized but Never Treated|6|||
124554479|NCT02842086|447987446|FG001|Overall Study|Randomized but Never Treated|6|||
124554480|NCT02842086|447987445|FG000|Overall Study|Still in Double-Blind Phase|7|||
124554481|NCT02842086|447987446|FG001|Overall Study|Still in Double-Blind Phase|3|||
124554482|NCT02842086|447987445|FG000|Overall Study|Adverse Event|18|||
124554483|NCT02842086|447987446|FG001|Overall Study|Adverse Event|20|||
124554484|NCT02842086|447987445|FG000|Overall Study|Death|3|||
124554485|NCT02842086|447987446|FG001|Overall Study|Death|3|||
124554486|NCT02842086|447987445|FG000|Overall Study|Investigator's Discretion|9|||
124716415|NCT02891226|448585080|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
124716416|NCT02891226|448585081|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
124716417|NCT02891226|448585082|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
124716418|NCT02891226|448585083|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
124716419|NCT02891226|448585084|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
124716420|NCT02891226|448585085|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
124716421|NCT02891226|448585086|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
124716422|NCT02891226|448585087|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
124716423|NCT02891226|448585088|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
124716424|NCT02891226|448585089|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
124716425|NCT02891226|448585090|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
124716426|NCT02891226|448585075|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
124716427|NCT02891226|448585076|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
124716428|NCT02891226|448585077|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
124716429|NCT02891226|448585078|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
124716430|NCT02891226|448585079|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
124716431|NCT02891226|448585080|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
124716432|NCT02891226|448585081|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
124716433|NCT02891226|448585082|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
124716434|NCT02891226|448585083|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
124554487|NCT02842086|447987446|FG001|Overall Study|Investigator's Discretion|13|||
124554488|NCT02842086|447987445|FG000|Overall Study|Non-Compliance with Study Drug|9|||
124554489|NCT02842086|447987446|FG001|Overall Study|Non-Compliance with Study Drug|8|||
124716435|NCT02891226|448585084|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
124554490|NCT02842086|447987445|FG000|Overall Study|Protocol Violation|8|||
124771075|NCT05249582|448791703|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
124554491|NCT02842086|447987446|FG001|Overall Study|Protocol Violation|4|||
124771076|NCT05249582|448791702|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
124771077|NCT05249582|448791703|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
124771078|NCT05249582|448791702|FG000|Overall Study|Declined to use virtual reality headset|1|||
124771079|NCT05249582|448791703|FG001|Overall Study|Declined to use virtual reality headset|0|||
124771080|NCT00283296|448791704|FG000|Overall Study|in-home trial not completed|5|||
124771081|NCT02668653|448791705|FG000|Overall Study|Refractory disease|41|||
124771082|NCT02668653|448791706|FG001|Overall Study|Refractory disease|70|||
124771083|NCT02668653|448791705|FG000|Overall Study|Relapse|44|||
124771084|NCT02668653|448791706|FG001|Overall Study|Relapse|65|||
124771085|NCT02668653|448791705|FG000|Overall Study|Adverse Event|58|||
124771086|NCT02668653|448791706|FG001|Overall Study|Adverse Event|23|||
124771087|NCT02668653|448791705|FG000|Overall Study|Subject decision to stop study drug|25|||
124771088|NCT02668653|448791706|FG001|Overall Study|Subject decision to stop study drug|23|||
124771089|NCT02668653|448791705|FG000|Overall Study|Other reasons not specified|16|||
124771090|NCT02668653|448791706|FG001|Overall Study|Other reasons not specified|11|||
124771091|NCT02668653|448791705|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
124771092|NCT02668653|448791706|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
124771093|NCT02668653|448791705|FG000|Overall Study|Investigator decision|10|||
124771094|NCT02668653|448791706|FG001|Overall Study|Investigator decision|7|||
124771095|NCT02668653|448791705|FG000|Overall Study|Failure to meet continuation criteria|5|||
124771096|NCT02668653|448791706|FG001|Overall Study|Failure to meet continuation criteria|12|||
124771097|NCT02668653|448791705|FG000|Overall Study|Lost to Follow-up|1|||
124771098|NCT02668653|448791706|FG001|Overall Study|Lost to Follow-up|0|||
124771099|NCT02668653|448791705|FG000|Overall Study|Pregnancy|0|||
124771100|NCT02668653|448791706|FG001|Overall Study|Pregnancy|1|||
124771101|NCT02668653|448791705|FG000|Overall Study|Death|0|||
124771102|NCT02668653|448791706|FG001|Overall Study|Death|1|||
124771103|NCT02158442|448791709|FG000|Overall Study|Withdrawal by Subject|1|||
124771104|NCT02158442|448791710|FG001|Overall Study|Withdrawal by Subject|0|||
124771105|NCT02158442|448791709|FG000|Overall Study|Perfusion staff not available|1|||
124771106|NCT02158442|448791710|FG001|Overall Study|Perfusion staff not available|0|||
124771107|NCT01294553|448791711|FG000|Overall Study|Duplicated Participants|1|||
124771108|NCT01294553|448791711|FG000|Overall Study|Protocol Violation|268|||
124771109|NCT00926237|448791714|FG000|Overall Study|Withdrawal by Subject|2|||
124771110|NCT00926237|448791715|FG001|Overall Study|Withdrawal by Subject|1|||
124771111|NCT00632229|448791721|FG000|Overall Study|Adverse Event|6|||
124771112|NCT00632229|448791722|FG001|Overall Study|Adverse Event|0|||
124554492|NCT02842086|447987445|FG000|Overall Study|Withdrew Consent|205|||
124554493|NCT02842086|447987446|FG001|Overall Study|Withdrew Consent|194|||
124554494|NCT02842086|447987445|FG000|Overall Study|Lost to Follow-up|274|||
124554495|NCT02842086|447987446|FG001|Overall Study|Lost to Follow-up|236|||
124554496|NCT02842086|447987445|FG000|Overall Study|HIV-1 Infection|5|||
124554497|NCT02842086|447987446|FG001|Overall Study|HIV-1 Infection|6|||
124554498|NCT03751124|447987447|FG000|Overall Study|Adverse Event|4|||
124554499|NCT03751124|447987448|FG001|Overall Study|Adverse Event|3|||
124554500|NCT03751124|447987447|FG000|Overall Study|Protocol Deviation|0|||
124554501|NCT03751124|447987448|FG001|Overall Study|Protocol Deviation|1|||
124554502|NCT03751124|447987447|FG000|Overall Study|Lost to Follow-up|6|||
124554503|NCT03751124|447987448|FG001|Overall Study|Lost to Follow-up|4|||
124554504|NCT03751124|447987447|FG000|Overall Study|Withdrawal by Subject|6|||
124554505|NCT03751124|447987448|FG001|Overall Study|Withdrawal by Subject|8|||
124554506|NCT03751124|447987447|FG000|Overall Study|Lack of Efficacy|1|||
124554507|NCT03751124|447987448|FG001|Overall Study|Lack of Efficacy|1|||
124554508|NCT03751124|447987447|FG000|Overall Study|Pregnancy|0|||
124554509|NCT03751124|447987448|FG001|Overall Study|Pregnancy|1|||
124554510|NCT03751124|447987447|FG000|Overall Study|Other|9|||
124554511|NCT03751124|447987448|FG001|Overall Study|Other|9|||
124554512|NCT03751124|447987447|FG000|Overall Study|Participants who did not receive any study drug|0|||
124554513|NCT03751124|447987448|FG001|Overall Study|Participants who did not receive any study drug|1|||
124554514|NCT00555399|447987459|FG000|Overall Study|Withdrawal by Subject|0|||
124771113|NCT00632229|448791721|FG000|Overall Study|Lost to Follow-up|0|||
124771114|NCT00632229|448791722|FG001|Overall Study|Lost to Follow-up|3|||
124554515|NCT00555399|447987460|FG001|Overall Study|Withdrawal by Subject|0|||
124554516|NCT00555399|447987461|FG002|Overall Study|Withdrawal by Subject|1|||
124554517|NCT00555399|447987462|FG003|Overall Study|Withdrawal by Subject|0|||
124771115|NCT00632229|448791721|FG000|Overall Study|Lack of Efficacy|0|||
124771116|NCT00632229|448791722|FG001|Overall Study|Lack of Efficacy|2|||
124771117|NCT00632229|448791721|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
124771118|NCT00632229|448791722|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
124771119|NCT05386329|448791724|FG000|Overall Study|Lost to Follow-up|3|||
124771120|NCT00577889|448791725|FG000|Overall Study|Withdrawal by Subject|1|||
124771121|NCT00577889|448791726|FG001|Overall Study|Withdrawal by Subject|0|||
124771122|NCT00577889|448791727|FG002|Overall Study|Withdrawal by Subject|0|||
124554518|NCT00555399|447987463|FG004|Overall Study|Withdrawal by Subject|0|||
124554519|NCT00555399|447987464|FG005|Overall Study|Withdrawal by Subject|0|||
124771123|NCT02667119|448791731|FG000|Overall Study|Lost to Follow-up|3|||
124472742|NCT04698629|447687745|FG000|Overall Study|Adverse Event|1|||
124472743|NCT03641560|447687746|FG000|Overall Study|Withdrawal by Subject|6|||
124472744|NCT03641560|447687746|FG000|Overall Study|Progressive disease|40|||
124472745|NCT03641560|447687746|FG000|Overall Study|Death|6|||
124472746|NCT05847686|447690624|FG000|Overall Study|Withdrawal by Subject|3|||
124472747|NCT06272370|447690625|FG000|Overall Study|Lost to Follow-up|0|||
124472748|NCT06272370|447690626|FG001|Overall Study|Lost to Follow-up|3|||
124472749|NCT06272370|447690627|FG002|Overall Study|Lost to Follow-up|1|||
124472750|NCT06272370|447690628|FG003|Overall Study|Lost to Follow-up|1|||
124472751|NCT00352534|447690630|FG000|Initial Staging|Ineligible|8|||
124472752|NCT00352534|447690631|FG001|Initial Staging|Ineligible|9|||
124472753|NCT00352534|447690632|FG002|Initial Staging|Ineligible|0|||
124472754|NCT00352534|447690633|FG003|Initial Staging|Ineligible|0|||
124472755|NCT00352534|447690634|FG004|Initial Staging|Ineligible|0|||
124472756|NCT00352534|447690635|FG005|Initial Staging|Ineligible|0|||
124472757|NCT00352534|447690636|FG006|Initial Staging|Ineligible|0|||
124472758|NCT00352534|447690630|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
124472759|NCT00352534|447690631|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
124472760|NCT00352534|447690632|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
124472761|NCT00352534|447690633|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
124472762|NCT00352534|447690634|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
124472763|NCT00352534|447690635|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
124472764|NCT00352534|447690636|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
124472765|NCT00352534|447690630|FG000|Final Risk Group Assignment|Physician Decision|0|||
124472766|NCT00352534|447690631|FG001|Final Risk Group Assignment|Physician Decision|0|||
124472767|NCT00352534|447690632|FG002|Final Risk Group Assignment|Physician Decision|0|||
124472768|NCT00352534|447690633|FG003|Final Risk Group Assignment|Physician Decision|0|||
124472769|NCT00352534|447690634|FG004|Final Risk Group Assignment|Physician Decision|0|||
124472770|NCT00352534|447690635|FG005|Final Risk Group Assignment|Physician Decision|8|||
124472771|NCT00352534|447690636|FG006|Final Risk Group Assignment|Physician Decision|0|||
124472772|NCT00352534|447690630|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
124472773|NCT00352534|447690631|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
124472774|NCT00352534|447690632|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
124472775|NCT00352534|447690633|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
124472776|NCT00352534|447690634|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
124472777|NCT00352534|447690635|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
124472778|NCT00352534|447690636|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
124472779|NCT00352534|447690630|FG000|Final Risk Group Assignment|Ineligible|0|||
124472780|NCT00352534|447690631|FG001|Final Risk Group Assignment|Ineligible|0|||
124472781|NCT00352534|447690632|FG002|Final Risk Group Assignment|Ineligible|3|||
124472782|NCT00352534|447690633|FG003|Final Risk Group Assignment|Ineligible|1|||
124472783|NCT00352534|447690634|FG004|Final Risk Group Assignment|Ineligible|0|||
124472784|NCT00352534|447690635|FG005|Final Risk Group Assignment|Ineligible|13|||
124472785|NCT00352534|447690636|FG006|Final Risk Group Assignment|Ineligible|0|||
124716436|NCT02891226|448585085|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
124716437|NCT02891226|448585086|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
124716438|NCT02891226|448585087|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
124716439|NCT02891226|448585088|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
124716440|NCT02891226|448585089|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
124716441|NCT02891226|448585090|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
124716442|NCT02891226|448585075|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
124716443|NCT02891226|448585076|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
124716444|NCT02891226|448585077|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
124716445|NCT02891226|448585078|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
124716446|NCT02891226|448585079|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
124716447|NCT02891226|448585080|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
124716448|NCT02891226|448585081|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
124716449|NCT02891226|448585082|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
124716450|NCT02891226|448585083|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
124716451|NCT02891226|448585084|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
124716452|NCT02891226|448585085|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
124716453|NCT02891226|448585086|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
124716454|NCT02891226|448585087|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
124716455|NCT02891226|448585088|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
124472786|NCT00352534|447690630|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
124472787|NCT00352534|447690631|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
124472788|NCT00352534|447690632|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
124771124|NCT02667119|448791732|FG001|Overall Study|Lost to Follow-up|0|||
124771125|NCT03783078|448791733|FG000|Overall Study|Death|31|||
124771126|NCT03783078|448791733|FG000|Overall Study|Sponsor Decision|23|||
124771127|NCT03783078|448791733|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
124771128|NCT02059278|448791735|FG000|Overall Study|Adverse Event|1|||
124771129|NCT02059278|448791736|FG001|Overall Study|Adverse Event|1|||
124771130|NCT02059278|448791735|FG000|Overall Study|Lost to Follow-up|1|||
124771131|NCT02059278|448791736|FG001|Overall Study|Lost to Follow-up|0|||
124771132|NCT02059278|448791735|FG000|Overall Study|Withdrawal by Subject|0|||
124771133|NCT02059278|448791736|FG001|Overall Study|Withdrawal by Subject|3|||
124771134|NCT02059278|448791735|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
124771135|NCT02059278|448791736|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
124771136|NCT00737672|448791739|FG000|Overall Study|Graft Abandonment|48|||
124771137|NCT00737672|448791740|FG001|Overall Study|Graft Abandonment|56|||
124771138|NCT00737672|448791739|FG000|Overall Study|Death|23|||
124771139|NCT00737672|448791740|FG001|Overall Study|Death|22|||
124771140|NCT00737672|448791739|FG000|Overall Study|Withdrawal by Subject|1|||
124771141|NCT00737672|448791740|FG001|Overall Study|Withdrawal by Subject|2|||
124771142|NCT00737672|448791739|FG000|Overall Study|Lost to Follow-up|1|||
124771143|NCT00737672|448791740|FG001|Overall Study|Lost to Follow-up|0|||
124771144|NCT00737672|448791739|FG000|Overall Study|Miscellaneous|7|||
124771145|NCT00737672|448791740|FG001|Overall Study|Miscellaneous|1|||
124771146|NCT00737672|448791739|FG000|Overall Study|Physician Decision|0|||
124771147|NCT00737672|448791740|FG001|Overall Study|Physician Decision|2|||
124472789|NCT00352534|447690633|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
124472790|NCT00352534|447690634|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
124472791|NCT00352534|447690635|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
124472792|NCT00352534|447690636|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
124472793|NCT00352534|447690630|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
124771148|NCT02694185|448791741|FG000|Overall Study|Withdrawal by Subject|45|||
124771149|NCT02694185|448791742|FG001|Overall Study|Withdrawal by Subject|0|||
124771150|NCT05972993|448791754|FG000|Overall Study|Lost to Follow-up|2|||
124771151|NCT05972993|448791755|FG001|Overall Study|Lost to Follow-up|0|||
124771152|NCT05972993|448791756|FG002|Overall Study|Lost to Follow-up|1|||
124771153|NCT05972993|448791757|FG003|Overall Study|Lost to Follow-up|0|||
124771154|NCT05972993|448791758|FG004|Overall Study|Lost to Follow-up|0|||
124771155|NCT05972993|448791759|FG005|Overall Study|Lost to Follow-up|0|||
124771156|NCT05972993|448791760|FG006|Overall Study|Lost to Follow-up|0|||
124771157|NCT05972993|448791761|FG007|Overall Study|Lost to Follow-up|2|||
124771158|NCT05972993|448791762|FG008|Overall Study|Lost to Follow-up|0|||
124771159|NCT03866577|448791765|FG000|Overall Study|Protocol Violation|0|||
124771160|NCT03866577|448791766|FG001|Overall Study|Protocol Violation|0|||
124771161|NCT03866577|448791767|FG002|Overall Study|Protocol Violation|0|||
124771162|NCT03866577|448791768|FG003|Overall Study|Protocol Violation|0|||
124771163|NCT03866577|448791769|FG004|Overall Study|Protocol Violation|0|||
124771164|NCT03866577|448791770|FG005|Overall Study|Protocol Violation|0|||
124771165|NCT03866577|448791771|FG006|Overall Study|Protocol Violation|0|||
124771166|NCT03866577|448791772|FG007|Overall Study|Protocol Violation|0|||
124771167|NCT03866577|448791773|FG008|Overall Study|Protocol Violation|0|||
124771168|NCT03866577|448791774|FG009|Overall Study|Protocol Violation|0|||
124771169|NCT03866577|448791775|FG010|Overall Study|Protocol Violation|0|||
124771170|NCT03866577|448791776|FG011|Overall Study|Protocol Violation|1|||
124771171|NCT03866577|448791777|FG012|Overall Study|Protocol Violation|0|||
124771172|NCT03866577|448791765|FG000|Overall Study|Withdrawal by Subject|0|||
124771173|NCT03866577|448791766|FG001|Overall Study|Withdrawal by Subject|0|||
124771174|NCT03866577|448791767|FG002|Overall Study|Withdrawal by Subject|0|||
124771175|NCT03866577|448791768|FG003|Overall Study|Withdrawal by Subject|0|||
124472794|NCT00352534|447690631|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
124472795|NCT00352534|447690632|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
124771176|NCT03866577|448791769|FG004|Overall Study|Withdrawal by Subject|0|||
124771177|NCT03866577|448791770|FG005|Overall Study|Withdrawal by Subject|0|||
124771178|NCT03866577|448791771|FG006|Overall Study|Withdrawal by Subject|0|||
124771179|NCT03866577|448791772|FG007|Overall Study|Withdrawal by Subject|0|||
124771180|NCT03866577|448791773|FG008|Overall Study|Withdrawal by Subject|1|||
124771181|NCT03866577|448791774|FG009|Overall Study|Withdrawal by Subject|1|||
124771182|NCT03866577|448791775|FG010|Overall Study|Withdrawal by Subject|0|||
124554520|NCT00555399|447987465|FG006|Overall Study|Withdrawal by Subject|0|||
124554521|NCT00555399|447987466|FG007|Overall Study|Withdrawal by Subject|0|||
124554522|NCT00555399|447987467|FG008|Overall Study|Withdrawal by Subject|0|||
124554523|NCT00555399|447987468|FG009|Overall Study|Withdrawal by Subject|0|||
124554524|NCT00555399|447987469|FG010|Overall Study|Withdrawal by Subject|0|||
124554525|NCT00555399|447987470|FG011|Overall Study|Withdrawal by Subject|1|||
124554526|NCT00555399|447987459|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
124554527|NCT00555399|447987460|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
124554528|NCT00555399|447987461|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
124771183|NCT03866577|448791776|FG011|Overall Study|Withdrawal by Subject|0|||
124771184|NCT03866577|448791777|FG012|Overall Study|Withdrawal by Subject|0|||
124771185|NCT03866577|448791765|FG000|Overall Study|Not qualified for IVIg infusion|0|||
124771186|NCT03866577|448791766|FG001|Overall Study|Not qualified for IVIg infusion|0|||
124771187|NCT03866577|448791767|FG002|Overall Study|Not qualified for IVIg infusion|0|||
124771188|NCT03866577|448791768|FG003|Overall Study|Not qualified for IVIg infusion|0|||
124771189|NCT03866577|448791769|FG004|Overall Study|Not qualified for IVIg infusion|0|||
124771190|NCT03866577|448791770|FG005|Overall Study|Not qualified for IVIg infusion|0|||
124771191|NCT03866577|448791771|FG006|Overall Study|Not qualified for IVIg infusion|0|||
124771192|NCT03866577|448791772|FG007|Overall Study|Not qualified for IVIg infusion|0|||
124771193|NCT03866577|448791773|FG008|Overall Study|Not qualified for IVIg infusion|0|||
124771194|NCT03866577|448791774|FG009|Overall Study|Not qualified for IVIg infusion|1|||
124771195|NCT03866577|448791775|FG010|Overall Study|Not qualified for IVIg infusion|0|||
124771196|NCT03866577|448791776|FG011|Overall Study|Not qualified for IVIg infusion|0|||
124771197|NCT03866577|448791777|FG012|Overall Study|Not qualified for IVIg infusion|0|||
124771198|NCT04825678|448791778|FG000|Overall Study|Decision by Sponsor|2|||
124771199|NCT04825678|448791779|FG001|Overall Study|Decision by Sponsor|3|||
124771200|NCT04825678|448791778|FG000|Overall Study|Withdrawal of Consent From Study|7|||
124771201|NCT04825678|448791779|FG001|Overall Study|Withdrawal of Consent From Study|9|||
124771202|NCT04825678|448791778|FG000|Overall Study|Lost to Follow-up|3|||
124771203|NCT04825678|448791779|FG001|Overall Study|Lost to Follow-up|4|||
124771204|NCT04825678|448791778|FG000|Overall Study|Never Received Investigational Product|1|||
124771205|NCT04825678|448791779|FG001|Overall Study|Never Received Investigational Product|1|||
124771206|NCT03818256|448791780|FG000|Overall Study|Withdrawal by Subject|2|||
124771207|NCT03818256|448791781|FG001|Overall Study|Withdrawal by Subject|2|||
124771208|NCT03818256|448791780|FG000|Overall Study|Adverse Event|3|||
124771209|NCT03818256|448791781|FG001|Overall Study|Adverse Event|1|||
124771210|NCT03818256|448791780|FG000|Overall Study|Lost to Follow-up|0|||
124771211|NCT03818256|448791781|FG001|Overall Study|Lost to Follow-up|5|||
124771212|NCT03818256|448791780|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
124771213|NCT03818256|448791781|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
124771214|NCT03818256|448791780|FG000|Overall Study|Not reporting for scheduled visits|1|||
124771215|NCT03818256|448791781|FG001|Overall Study|Not reporting for scheduled visits|0|||
124771216|NCT03818256|448791780|FG000|Overall Study|Non-compliant with investigational product|1|||
124771217|NCT03818256|448791781|FG001|Overall Study|Non-compliant with investigational product|0|||
124771218|NCT00734149|448791784|FG000|Overall Study|Withdrawal by Subject|1|||
124771219|NCT03043794|448791788|FG000|Overall Study|Lost to Follow-up|1|||
124771220|NCT04323124|448791791|FG000|Overall Study|Adverse Event|0|||
124472796|NCT00352534|447690633|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
124472797|NCT00352534|447690634|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
124472798|NCT00352534|447690635|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
124472799|NCT00352534|447690636|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
124472800|NCT00352534|447690630|FG000|Final Risk Group Assignment|Death|0|||
124472801|NCT00352534|447690631|FG001|Final Risk Group Assignment|Death|0|||
124472802|NCT00352534|447690632|FG002|Final Risk Group Assignment|Death|0|||
124472803|NCT00352534|447690633|FG003|Final Risk Group Assignment|Death|0|||
124771221|NCT04323124|448791792|FG001|Overall Study|Adverse Event|0|||
124771222|NCT04323124|448791793|FG002|Overall Study|Adverse Event|0|||
124771223|NCT04323124|448791794|FG003|Overall Study|Adverse Event|0|||
124771224|NCT04323124|448791795|FG004|Overall Study|Adverse Event|0|||
124771225|NCT04323124|448791796|FG005|Overall Study|Adverse Event|1|||
124771226|NCT04323124|448791797|FG006|Overall Study|Adverse Event|0|||
124771227|NCT04323124|448791798|FG007|Overall Study|Adverse Event|1|||
124771228|NCT04323124|448791799|FG008|Overall Study|Adverse Event|1|||
124771229|NCT04323124|448791800|FG009|Overall Study|Adverse Event|0|||
124771230|NCT04323124|448791801|FG010|Overall Study|Adverse Event|0|||
124771231|NCT04323124|448791802|FG011|Overall Study|Adverse Event|0|||
124771232|NCT04323124|448791803|FG012|Overall Study|Adverse Event|0|||
124771233|NCT04323124|448791804|FG013|Overall Study|Adverse Event|0|||
124771234|NCT04323124|448791805|FG014|Overall Study|Adverse Event|0|||
124771235|NCT04323124|448791791|FG000|Overall Study|Other|0|||
124771236|NCT04323124|448791792|FG001|Overall Study|Other|0|||
124771237|NCT04323124|448791793|FG002|Overall Study|Other|0|||
124771238|NCT04323124|448791794|FG003|Overall Study|Other|0|||
124771239|NCT04323124|448791795|FG004|Overall Study|Other|1|||
124771240|NCT04323124|448791796|FG005|Overall Study|Other|0|||
124472804|NCT00352534|447690634|FG004|Final Risk Group Assignment|Death|0|||
124472805|NCT00352534|447690635|FG005|Final Risk Group Assignment|Death|2|||
124472806|NCT00352534|447690636|FG006|Final Risk Group Assignment|Death|0|||
124472807|NCT01602341|447690637|FG000|Overall Study|Adverse Event|0|||
124771241|NCT04323124|448791797|FG006|Overall Study|Other|0|||
124771242|NCT04323124|448791798|FG007|Overall Study|Other|0|||
124771243|NCT04323124|448791799|FG008|Overall Study|Other|1|||
124771244|NCT04323124|448791800|FG009|Overall Study|Other|0|||
124771245|NCT04323124|448791801|FG010|Overall Study|Other|0|||
124771246|NCT04323124|448791802|FG011|Overall Study|Other|0|||
124771247|NCT04323124|448791803|FG012|Overall Study|Other|0|||
124771248|NCT04323124|448791804|FG013|Overall Study|Other|0|||
124472808|NCT01602341|447690638|FG001|Overall Study|Adverse Event|1|||
124771249|NCT04323124|448791805|FG014|Overall Study|Other|0|||
124716456|NCT02891226|448585089|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
124716457|NCT02891226|448585090|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
124716458|NCT02891226|448585075|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
124716459|NCT02891226|448585076|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
124716460|NCT02891226|448585077|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
124716461|NCT02891226|448585078|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
124716462|NCT02891226|448585079|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
124716463|NCT02891226|448585080|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
124716464|NCT02891226|448585081|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
124716465|NCT02891226|448585082|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
124716466|NCT02891226|448585083|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
124716467|NCT02891226|448585084|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
124716468|NCT02891226|448585085|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
124716469|NCT02891226|448585086|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
124716470|NCT02891226|448585087|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
124716471|NCT02891226|448585088|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
124716472|NCT02891226|448585089|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
124716473|NCT02891226|448585090|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
124716474|NCT02891226|448585075|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
124716475|NCT02891226|448585076|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
124716476|NCT02891226|448585077|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
124716477|NCT02891226|448585078|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
124716478|NCT02891226|448585079|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
124716479|NCT02891226|448585080|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
124752795|NCT04427072|448716840|FG001|Randomized Treatment Phase|Progressive disease|4|||
124472809|NCT02090855|447690639|FG000|Overall Study|no evaluable Standard of Truth results|2|||
124472810|NCT00388947|447690640|FG000|Overall Study|Protocol Violation|47|||
124472811|NCT03038308|447690641|FG000|Overall Study|Surgical resection|1|||
124472812|NCT03038308|447690641|FG000|Overall Study|Withdrawal by Subject|2|||
124472813|NCT03038308|447690641|FG000|Overall Study|Lost to Follow-up|1|||
124472814|NCT04187092|447690642|FG000|Overall Study|Lost to Follow-up|1|||
124716480|NCT02891226|448585081|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
124716481|NCT02891226|448585082|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
124716482|NCT02891226|448585083|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
124716483|NCT02891226|448585084|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
124716484|NCT02891226|448585085|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
124716485|NCT02891226|448585086|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
124716486|NCT02891226|448585087|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
124716487|NCT02891226|448585088|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
124716488|NCT02891226|448585089|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
124716489|NCT02891226|448585090|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
124716490|NCT02891226|448585075|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
124716491|NCT02891226|448585076|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
124716492|NCT02891226|448585077|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
124716493|NCT02891226|448585078|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
124716494|NCT02891226|448585079|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
124716495|NCT02891226|448585080|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
124716496|NCT02891226|448585081|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
124716497|NCT02891226|448585082|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
124716498|NCT02891226|448585083|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
124716499|NCT02891226|448585084|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
124716500|NCT02891226|448585085|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
124716501|NCT02891226|448585086|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
124716502|NCT02891226|448585087|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
124716503|NCT02891226|448585088|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
124716504|NCT02891226|448585089|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
124716505|NCT02891226|448585090|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
124716506|NCT02891226|448585075|FG000|Follow-up Period|Withdrawal by Subject|0|||
124716507|NCT02891226|448585076|FG001|Follow-up Period|Withdrawal by Subject|0|||
124716508|NCT02891226|448585077|FG002|Follow-up Period|Withdrawal by Subject|0|||
124716509|NCT02891226|448585078|FG003|Follow-up Period|Withdrawal by Subject|0|||
124716510|NCT02891226|448585079|FG004|Follow-up Period|Withdrawal by Subject|0|||
124716511|NCT02891226|448585080|FG005|Follow-up Period|Withdrawal by Subject|0|||
124716512|NCT02891226|448585081|FG006|Follow-up Period|Withdrawal by Subject|0|||
124716513|NCT02891226|448585082|FG007|Follow-up Period|Withdrawal by Subject|0|||
124716514|NCT02891226|448585083|FG008|Follow-up Period|Withdrawal by Subject|0|||
124716515|NCT02891226|448585084|FG009|Follow-up Period|Withdrawal by Subject|0|||
124716516|NCT02891226|448585085|FG010|Follow-up Period|Withdrawal by Subject|0|||
124716517|NCT02891226|448585086|FG011|Follow-up Period|Withdrawal by Subject|1|||
124716518|NCT02891226|448585087|FG012|Follow-up Period|Withdrawal by Subject|0|||
124716519|NCT02891226|448585088|FG013|Follow-up Period|Withdrawal by Subject|0|||
124716520|NCT02891226|448585089|FG014|Follow-up Period|Withdrawal by Subject|1|||
124716521|NCT02891226|448585090|FG015|Follow-up Period|Withdrawal by Subject|1|||
124716522|NCT01928433|448585091|FG000|Overall Study|Adverse Event|5|||
124716523|NCT01928433|448585092|FG001|Overall Study|Adverse Event|2|||
124716524|NCT01928433|448585093|FG002|Overall Study|Adverse Event|5|||
124716525|NCT01928433|448585091|FG000|Overall Study|Protocol Violation|0|||
124716526|NCT01928433|448585092|FG001|Overall Study|Protocol Violation|0|||
124716527|NCT01928433|448585093|FG002|Overall Study|Protocol Violation|2|||
124716528|NCT01928433|448585091|FG000|Overall Study|Lack of Efficacy|5|||
124716529|NCT01928433|448585092|FG001|Overall Study|Lack of Efficacy|4|||
124716530|NCT01928433|448585093|FG002|Overall Study|Lack of Efficacy|4|||
124716531|NCT01928433|448585091|FG000|Overall Study|Withdrawal by Subject|0|||
124716532|NCT01928433|448585092|FG001|Overall Study|Withdrawal by Subject|4|||
124716533|NCT01928433|448585093|FG002|Overall Study|Withdrawal by Subject|0|||
124716534|NCT01928433|448585091|FG000|Overall Study|Negative screening urine culture|7|||
124716535|NCT01928433|448585092|FG001|Overall Study|Negative screening urine culture|6|||
124716536|NCT01928433|448585093|FG002|Overall Study|Negative screening urine culture|10|||
124716537|NCT01928433|448585091|FG000|Overall Study|Lost to Follow-up|0|||
124716538|NCT01928433|448585092|FG001|Overall Study|Lost to Follow-up|2|||
124716539|NCT01928433|448585093|FG002|Overall Study|Lost to Follow-up|3|||
124716540|NCT01928433|448585091|FG000|Overall Study|Other reasons|3|||
124716541|NCT01928433|448585092|FG001|Overall Study|Other reasons|3|||
124716542|NCT01928433|448585093|FG002|Overall Study|Other reasons|4|||
124716543|NCT00145626|448585094|FG000|Overall Study|Did not have NK infusions|2|||
124716544|NCT00145626|448585094|FG000|Overall Study|Turned 2 years old before treatment|1|||
124716545|NCT00145626|448585094|FG000|Overall Study|Death|1|||
124716546|NCT00145626|448585094|FG000|Overall Study|Withdrawal by Subject|1|||
124716547|NCT00436436|448585095|FG000|Overall Study|Progression|4|||
124716548|NCT00436436|448585095|FG000|Overall Study|Adverse Event|2|||
124716549|NCT00436436|448585095|FG000|Overall Study|Death|6|||
124716550|NCT03654274|448585100|FG000|Overall Study|Adverse Event|19|||
124716551|NCT03654274|448585101|FG001|Overall Study|Adverse Event|23|||
124716552|NCT03654274|448585102|FG002|Overall Study|Adverse Event|24|||
124716553|NCT03654274|448585100|FG000|Overall Study|Protocol Deviation|0|||
124716554|NCT03654274|448585101|FG001|Overall Study|Protocol Deviation|2|||
124716555|NCT03654274|448585102|FG002|Overall Study|Protocol Deviation|0|||
124716556|NCT03654274|448585100|FG000|Overall Study|Lost to Follow-up|8|||
124716557|NCT03654274|448585101|FG001|Overall Study|Lost to Follow-up|6|||
124716558|NCT03654274|448585102|FG002|Overall Study|Lost to Follow-up|5|||
124716559|NCT03654274|448585100|FG000|Overall Study|Withdrawal by Subject|46|||
124716560|NCT03654274|448585101|FG001|Overall Study|Withdrawal by Subject|25|||
124716561|NCT03654274|448585102|FG002|Overall Study|Withdrawal by Subject|33|||
124716562|NCT03654274|448585100|FG000|Overall Study|Lack of Efficacy|4|||
124716563|NCT03654274|448585101|FG001|Overall Study|Lack of Efficacy|5|||
124716564|NCT03654274|448585102|FG002|Overall Study|Lack of Efficacy|7|||
124716565|NCT03654274|448585100|FG000|Overall Study|Pregnancy|2|||
124716566|NCT03654274|448585101|FG001|Overall Study|Pregnancy|2|||
124716567|NCT03654274|448585102|FG002|Overall Study|Pregnancy|1|||
124716568|NCT03654274|448585100|FG000|Overall Study|Other|27|||
124716569|NCT03654274|448585101|FG001|Overall Study|Other|29|||
124716570|NCT03654274|448585102|FG002|Overall Study|Other|32|||
124716571|NCT03654274|448585100|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
124716572|NCT03654274|448585101|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
124716573|NCT03654274|448585102|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
124716574|NCT01837680|448585107|FG000|Overall Study|Lost to Follow-up|2|||
124716575|NCT01837680|448585108|FG001|Overall Study|Lost to Follow-up|2|||
124716576|NCT01837680|448585107|FG000|Overall Study|lack of insurance|0|||
124716577|NCT01837680|448585108|FG001|Overall Study|lack of insurance|2|||
124716578|NCT01837680|448585107|FG000|Overall Study|allergic reaction|6|||
124716579|NCT01837680|448585108|FG001|Overall Study|allergic reaction|0|||
124716580|NCT01837680|448585107|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
124716581|NCT01837680|448585108|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
124716582|NCT05005273|448585109|FG000|Overall Study|Study Terminated|1|||
124716583|NCT05005273|448585110|FG001|Overall Study|Study Terminated|0|||
124716584|NCT02151786|448585111|FG000|Overall Study|Unavailability of Case Report Form|26|||
124472815|NCT04187092|447690643|FG001|Overall Study|Lost to Follow-up|1|||
124472816|NCT04187092|447690642|FG000|Overall Study|Withdrawal by Subject|1|||
124472817|NCT04187092|447690643|FG001|Overall Study|Withdrawal by Subject|1|||
124472818|NCT04187092|447690642|FG000|Overall Study|Adverse Event|0|||
124472819|NCT04187092|447690643|FG001|Overall Study|Adverse Event|1|||
124472820|NCT00544869|447690646|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
124472821|NCT00544869|447690647|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
124472822|NCT00544869|447690648|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
124472823|NCT00544869|447690646|FG000|Overall Study|Adverse Event|6|||
124472824|NCT00544869|447690647|FG001|Overall Study|Adverse Event|1|||
124472825|NCT00544869|447690648|FG002|Overall Study|Adverse Event|0|||
124472826|NCT00544869|447690646|FG000|Overall Study|Lack of Efficacy|1|||
124472827|NCT00544869|447690647|FG001|Overall Study|Lack of Efficacy|1|||
124472828|NCT00544869|447690648|FG002|Overall Study|Lack of Efficacy|0|||
124472829|NCT00544869|447690646|FG000|Overall Study|Physician Decision|2|||
124472830|NCT00544869|447690647|FG001|Overall Study|Physician Decision|0|||
124472831|NCT00544869|447690648|FG002|Overall Study|Physician Decision|0|||
124472832|NCT01777763|447690661|FG000|Overall Study|Adverse Event|2|||
124472833|NCT01777763|447690662|FG001|Overall Study|Adverse Event|32|||
124472834|NCT01777763|447690661|FG000|Overall Study|Protocol Violation|1|||
124472835|NCT01777763|447690662|FG001|Overall Study|Protocol Violation|7|||
124472836|NCT01777763|447690661|FG000|Overall Study|Withdrawal by Subject|0|||
124472837|NCT01777763|447690662|FG001|Overall Study|Withdrawal by Subject|2|||
124472838|NCT01777763|447690661|FG000|Overall Study|Treatment Failure|1|||
124472839|NCT01777763|447690662|FG001|Overall Study|Treatment Failure|6|||
124472840|NCT03969875|447690669|FG000|Overall Study|did not receive allocated intervention|3|||
124472841|NCT03969875|447690670|FG001|Overall Study|did not receive allocated intervention|3|||
124472842|NCT03969875|447690671|FG002|Overall Study|did not receive allocated intervention|4|||
124472843|NCT03969875|447690669|FG000|Overall Study|Protocol Violation|4|||
124472844|NCT03969875|447690670|FG001|Overall Study|Protocol Violation|2|||
124472845|NCT03969875|447690671|FG002|Overall Study|Protocol Violation|2|||
124472846|NCT02327260|447690672|FG000|Overall Study|Lost to Follow-up|2|||
124472847|NCT02327260|447690673|FG001|Overall Study|Lost to Follow-up|3|||
124472848|NCT02327260|447690674|FG002|Overall Study|Lost to Follow-up|2|||
124472849|NCT02327260|447690672|FG000|Overall Study|invalid phone number|1|||
124472850|NCT02327260|447690673|FG001|Overall Study|invalid phone number|1|||
124472851|NCT02327260|447690674|FG002|Overall Study|invalid phone number|0|||
124472852|NCT02327260|447690672|FG000|Overall Study|non-adherence to protocol|2|||
124472853|NCT02327260|447690673|FG001|Overall Study|non-adherence to protocol|0|||
124472854|NCT02327260|447690674|FG002|Overall Study|non-adherence to protocol|0|||
124472855|NCT02327260|447690672|FG000|Overall Study|cognitive concerns|1|||
124472856|NCT02327260|447690673|FG001|Overall Study|cognitive concerns|0|||
124472857|NCT02327260|447690674|FG002|Overall Study|cognitive concerns|0|||
124472858|NCT03502330|447690675|FG000|Overall Study|Adverse Event|2|||
124472859|NCT03502330|447690676|FG001|Overall Study|Adverse Event|1|||
124472860|NCT03502330|447690677|FG002|Overall Study|Adverse Event|0|||
124472861|NCT03502330|447690678|FG003|Overall Study|Adverse Event|0|||
124472862|NCT03502330|447690679|FG004|Overall Study|Adverse Event|1|||
124472863|NCT03502330|447690680|FG005|Overall Study|Adverse Event|0|||
124472864|NCT03502330|447690681|FG006|Overall Study|Adverse Event|1|||
124472865|NCT03502330|447690682|FG007|Overall Study|Adverse Event|1|||
124472866|NCT03502330|447690683|FG008|Overall Study|Adverse Event|0|||
124472867|NCT03502330|447690675|FG000|Overall Study|Lack of Efficacy|1|||
124472868|NCT03502330|447690676|FG001|Overall Study|Lack of Efficacy|5|||
124472869|NCT03502330|447690677|FG002|Overall Study|Lack of Efficacy|3|||
124472870|NCT03502330|447690678|FG003|Overall Study|Lack of Efficacy|5|||
124472871|NCT03502330|447690679|FG004|Overall Study|Lack of Efficacy|1|||
124472872|NCT03502330|447690680|FG005|Overall Study|Lack of Efficacy|5|||
124472873|NCT03502330|447690681|FG006|Overall Study|Lack of Efficacy|5|||
124472874|NCT03502330|447690682|FG007|Overall Study|Lack of Efficacy|6|||
124472875|NCT03502330|447690683|FG008|Overall Study|Lack of Efficacy|0|||
124472876|NCT03502330|447690675|FG000|Overall Study|Physician Decision|0|||
124472877|NCT03502330|447690676|FG001|Overall Study|Physician Decision|0|||
124472878|NCT03502330|447690677|FG002|Overall Study|Physician Decision|0|||
124472879|NCT03502330|447690678|FG003|Overall Study|Physician Decision|0|||
124472880|NCT03502330|447690679|FG004|Overall Study|Physician Decision|1|||
124472881|NCT03502330|447690680|FG005|Overall Study|Physician Decision|0|||
124472882|NCT03502330|447690681|FG006|Overall Study|Physician Decision|0|||
124472883|NCT03502330|447690682|FG007|Overall Study|Physician Decision|0|||
124472884|NCT03502330|447690683|FG008|Overall Study|Physician Decision|0|||
124472885|NCT03502330|447690675|FG000|Overall Study|Withdrawal by Subject|0|||
124472886|NCT03502330|447690676|FG001|Overall Study|Withdrawal by Subject|0|||
124472887|NCT03502330|447690677|FG002|Overall Study|Withdrawal by Subject|0|||
124472888|NCT03502330|447690678|FG003|Overall Study|Withdrawal by Subject|0|||
124472889|NCT03502330|447690679|FG004|Overall Study|Withdrawal by Subject|0|||
124472890|NCT03502330|447690680|FG005|Overall Study|Withdrawal by Subject|1|||
124472891|NCT03502330|447690681|FG006|Overall Study|Withdrawal by Subject|0|||
124472892|NCT03502330|447690682|FG007|Overall Study|Withdrawal by Subject|1|||
124771250|NCT04323124|448791791|FG000|Overall Study|Coming from a red zone (COVID)|0|||
124771251|NCT04323124|448791792|FG001|Overall Study|Coming from a red zone (COVID)|0|||
124771252|NCT04323124|448791793|FG002|Overall Study|Coming from a red zone (COVID)|0|||
124771253|NCT04323124|448791794|FG003|Overall Study|Coming from a red zone (COVID)|0|||
124771254|NCT04323124|448791795|FG004|Overall Study|Coming from a red zone (COVID)|1|||
124771255|NCT04323124|448791796|FG005|Overall Study|Coming from a red zone (COVID)|1|||
124771256|NCT04323124|448791797|FG006|Overall Study|Coming from a red zone (COVID)|0|||
124771257|NCT04323124|448791798|FG007|Overall Study|Coming from a red zone (COVID)|0|||
124771258|NCT04323124|448791799|FG008|Overall Study|Coming from a red zone (COVID)|0|||
124771259|NCT04323124|448791800|FG009|Overall Study|Coming from a red zone (COVID)|0|||
124771260|NCT04323124|448791801|FG010|Overall Study|Coming from a red zone (COVID)|0|||
124771261|NCT04323124|448791802|FG011|Overall Study|Coming from a red zone (COVID)|0|||
124771262|NCT04323124|448791803|FG012|Overall Study|Coming from a red zone (COVID)|0|||
124771263|NCT04323124|448791804|FG013|Overall Study|Coming from a red zone (COVID)|0|||
124771264|NCT04323124|448791805|FG014|Overall Study|Coming from a red zone (COVID)|0|||
124771265|NCT04323124|448791791|FG000|Overall Study|No longer meets eligibility criteria|0|||
124771266|NCT04323124|448791792|FG001|Overall Study|No longer meets eligibility criteria|0|||
124771267|NCT04323124|448791793|FG002|Overall Study|No longer meets eligibility criteria|0|||
124771268|NCT04323124|448791794|FG003|Overall Study|No longer meets eligibility criteria|0|||
124771269|NCT04323124|448791795|FG004|Overall Study|No longer meets eligibility criteria|0|||
124771270|NCT04323124|448791796|FG005|Overall Study|No longer meets eligibility criteria|0|||
124771271|NCT04323124|448791797|FG006|Overall Study|No longer meets eligibility criteria|0|||
124771272|NCT04323124|448791798|FG007|Overall Study|No longer meets eligibility criteria|1|||
124771273|NCT04323124|448791799|FG008|Overall Study|No longer meets eligibility criteria|0|||
124771274|NCT04323124|448791800|FG009|Overall Study|No longer meets eligibility criteria|0|||
124771275|NCT04323124|448791801|FG010|Overall Study|No longer meets eligibility criteria|0|||
124771276|NCT04323124|448791802|FG011|Overall Study|No longer meets eligibility criteria|0|||
124771277|NCT04323124|448791803|FG012|Overall Study|No longer meets eligibility criteria|0|||
124771278|NCT04323124|448791804|FG013|Overall Study|No longer meets eligibility criteria|1|||
124771279|NCT04323124|448791805|FG014|Overall Study|No longer meets eligibility criteria|1|||
124771280|NCT04323124|448791791|FG000|Overall Study|Study terminated by sponsor|0|||
124771281|NCT04323124|448791792|FG001|Overall Study|Study terminated by sponsor|0|||
124771282|NCT04323124|448791793|FG002|Overall Study|Study terminated by sponsor|0|||
124771283|NCT04323124|448791794|FG003|Overall Study|Study terminated by sponsor|0|||
124771284|NCT04323124|448791795|FG004|Overall Study|Study terminated by sponsor|0|||
124771285|NCT04323124|448791796|FG005|Overall Study|Study terminated by sponsor|0|||
124771286|NCT04323124|448791797|FG006|Overall Study|Study terminated by sponsor|0|||
124771287|NCT04323124|448791798|FG007|Overall Study|Study terminated by sponsor|0|||
124771288|NCT04323124|448791799|FG008|Overall Study|Study terminated by sponsor|0|||
124771289|NCT04323124|448791800|FG009|Overall Study|Study terminated by sponsor|0|||
124771290|NCT04323124|448791801|FG010|Overall Study|Study terminated by sponsor|0|||
124771291|NCT04323124|448791802|FG011|Overall Study|Study terminated by sponsor|2|||
124771292|NCT04323124|448791803|FG012|Overall Study|Study terminated by sponsor|1|||
124771293|NCT04323124|448791804|FG013|Overall Study|Study terminated by sponsor|0|||
124771294|NCT04323124|448791805|FG014|Overall Study|Study terminated by sponsor|0|||
124771295|NCT00489307|448791806|FG000|Overall Study|Death|1|||
124554529|NCT00555399|447987462|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
124771296|NCT00489307|448791807|FG001|Overall Study|Death|1|||
124771297|NCT00489307|448791806|FG000|Overall Study|Lost to Follow-up|2|||
124771298|NCT00489307|448791807|FG001|Overall Study|Lost to Follow-up|2|||
124771299|NCT00489307|448791806|FG000|Overall Study|Physician Decision|1|||
124771300|NCT00489307|448791807|FG001|Overall Study|Physician Decision|0|||
124771301|NCT00489307|448791806|FG000|Overall Study|Withdrawal by Subject|2|||
124771302|NCT00489307|448791807|FG001|Overall Study|Withdrawal by Subject|4|||
124472893|NCT03502330|447690683|FG008|Overall Study|Withdrawal by Subject|0|||
124472894|NCT03502330|447690675|FG000|Overall Study|Death|0|||
124472895|NCT03502330|447690676|FG001|Overall Study|Death|0|||
124472896|NCT03502330|447690677|FG002|Overall Study|Death|0|||
124472897|NCT03502330|447690678|FG003|Overall Study|Death|0|||
124472898|NCT03502330|447690679|FG004|Overall Study|Death|0|||
124472899|NCT03502330|447690680|FG005|Overall Study|Death|0|||
124472900|NCT03502330|447690681|FG006|Overall Study|Death|2|||
124472901|NCT03502330|447690682|FG007|Overall Study|Death|0|||
124472902|NCT03502330|447690683|FG008|Overall Study|Death|0|||
124472903|NCT04656990|447690684|FG000|Baseline|pandemic|20|||
124472904|NCT04656990|447690685|FG001|Baseline|pandemic|24|||
124472905|NCT04656990|447690684|FG000|Follow Up Period|Lost to Follow-up|61|||
124472906|NCT04656990|447690685|FG001|Follow Up Period|Lost to Follow-up|73|||
124472907|NCT01070329|447690686|FG000|Overall Study|Adverse Event|13|||
124472908|NCT01070329|447690687|FG001|Overall Study|Adverse Event|10|||
124716585|NCT02151786|448585111|FG000|Overall Study|Outside the Contract Period|1|||
124716586|NCT02151786|448585111|FG000|Overall Study|Randomized, not Treated|1|||
124716587|NCT02151786|448585111|FG000|Overall Study|Unavailability of Information|8|||
124716588|NCT03533660|448585112|FG000|Overall Study|Withdrawal by Subject|2|||
124716589|NCT03533660|448585113|FG001|Overall Study|Withdrawal by Subject|2|||
124716590|NCT03533660|448585112|FG000|Overall Study|Death|2|||
124716591|NCT03533660|448585113|FG001|Overall Study|Death|4|||
124716592|NCT03533660|448585112|FG000|Overall Study|Adverse Event|0|||
124716593|NCT03533660|448585113|FG001|Overall Study|Adverse Event|2|||
124716594|NCT00996658|448585114|FG000|Overall Study|Adverse Event|2|||
124716595|NCT00996658|448585115|FG001|Overall Study|Adverse Event|5|||
124716596|NCT00996658|448585114|FG000|Overall Study|Protocol Violation|0|||
124716597|NCT00996658|448585115|FG001|Overall Study|Protocol Violation|1|||
124716598|NCT00996658|448585114|FG000|Overall Study|Lost to Follow-up|2|||
124716599|NCT00996658|448585115|FG001|Overall Study|Lost to Follow-up|5|||
124716600|NCT00996658|448585114|FG000|Overall Study|Non-compliance issues|3|||
124716601|NCT00996658|448585115|FG001|Overall Study|Non-compliance issues|3|||
124716602|NCT00996658|448585114|FG000|Overall Study|Other|9|||
124716603|NCT00996658|448585115|FG001|Overall Study|Other|7|||
124716604|NCT02685826|448585124|FG000|Overall Study|Adverse Event|2|||
124716605|NCT02685826|448585125|FG001|Overall Study|Adverse Event|0|||
124716606|NCT02685826|448585126|FG002|Overall Study|Adverse Event|1|||
124716607|NCT02685826|448585124|FG000|Overall Study|Progressive Disease|2|||
124716608|NCT02685826|448585125|FG001|Overall Study|Progressive Disease|1|||
124716609|NCT02685826|448585126|FG002|Overall Study|Progressive Disease|0|||
124716610|NCT02685826|448585124|FG000|Overall Study|Withdrawal by Subject|2|||
124716611|NCT02685826|448585125|FG001|Overall Study|Withdrawal by Subject|0|||
124716612|NCT02685826|448585126|FG002|Overall Study|Withdrawal by Subject|0|||
124716613|NCT02685826|448585124|FG000|Overall Study|Full Clinical Hold by FDA|19|||
124716614|NCT02685826|448585125|FG001|Overall Study|Full Clinical Hold by FDA|9|||
124716615|NCT02685826|448585126|FG002|Overall Study|Full Clinical Hold by FDA|20|||
124716616|NCT03154476|448585127|FG000|Overall Study|Lost to Follow-up|4|||
124716617|NCT03154476|448585128|FG001|Overall Study|Lost to Follow-up|4|||
124716618|NCT00200967|448585131|FG000|First Treatment Period|Withdrawal by Subject|5|||
124716619|NCT00200967|448585132|FG001|First Treatment Period|Withdrawal by Subject|1|||
124716620|NCT00200967|448585131|FG000|First Treatment Period|Pregnancy|1|||
124716621|NCT00200967|448585132|FG001|First Treatment Period|Pregnancy|0|||
124716622|NCT00200967|448585131|FG000|Wash-out Period|Lost to Follow-up|0|||
124716623|NCT00200967|448585132|FG001|Wash-out Period|Lost to Follow-up|1|||
124716624|NCT00200967|448585131|FG000|Second Treatment Period|Withdrawal by Subject|1|||
124716625|NCT00200967|448585132|FG001|Second Treatment Period|Withdrawal by Subject|2|||
124716626|NCT00200967|448585131|FG000|Run-out Period|Lost to Follow-up|1|||
124716627|NCT00200967|448585132|FG001|Run-out Period|Lost to Follow-up|0|||
124716628|NCT01444430|448585135|FG000|Overall Study|Withdrawal by Subject|53|||
124716629|NCT01444430|448585136|FG001|Overall Study|Withdrawal by Subject|72|||
124716630|NCT01444430|448585135|FG000|Overall Study|Death|6|||
124472909|NCT01070329|447690686|FG000|Overall Study|Lost to Follow-up|22|||
124472910|NCT01070329|447690687|FG001|Overall Study|Lost to Follow-up|12|||
124472911|NCT01070329|447690686|FG000|Overall Study|Withdrawal by Subject|9|||
124472912|NCT01070329|447690687|FG001|Overall Study|Withdrawal by Subject|11|||
124472913|NCT01070329|447690686|FG000|Overall Study|Protocol Violation|3|||
124472914|NCT01070329|447690687|FG001|Overall Study|Protocol Violation|8|||
124716631|NCT01444430|448585136|FG001|Overall Study|Death|8|||
124716632|NCT01444430|448585135|FG000|Overall Study|Lost to Follow-up|2|||
124716633|NCT01444430|448585136|FG001|Overall Study|Lost to Follow-up|0|||
124716634|NCT01444430|448585135|FG000|Overall Study|CRF termination module not completed.|0|||
124716635|NCT01444430|448585136|FG001|Overall Study|CRF termination module not completed.|1|||
124716636|NCT02297815|448586615|FG000|Overall Study|Lost to Follow-up|236|||
124472915|NCT01070329|447690686|FG000|Overall Study|Lack of Efficacy|2|||
124472916|NCT01070329|447690687|FG001|Overall Study|Lack of Efficacy|6|||
124716637|NCT02297815|448586616|FG001|Overall Study|Lost to Follow-up|140|||
124716638|NCT00662831|448586617|FG000|Overall Study|Death|4|||
124716639|NCT00662831|448586618|FG001|Overall Study|Death|1|||
124716640|NCT00662831|448586617|FG000|Overall Study|Lack of Efficacy|6|||
124472917|NCT01070329|447690686|FG000|Overall Study|Physician Decision|2|||
124472918|NCT01070329|447690687|FG001|Overall Study|Physician Decision|1|||
124472919|NCT01070329|447690686|FG000|Overall Study|Entry Criteria Not Met|1|||
124472920|NCT01070329|447690687|FG001|Overall Study|Entry Criteria Not Met|0|||
124771303|NCT00489307|448791806|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
124771304|NCT00489307|448791807|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
124771305|NCT00489307|448791806|FG000|Overall Study|Surgery after assignment|1|||
124771306|NCT00489307|448791807|FG001|Overall Study|Surgery after assignment|0|||
124771307|NCT00489307|448791806|FG000|Overall Study|Did not fill up the forms|2|||
124771308|NCT00489307|448791807|FG001|Overall Study|Did not fill up the forms|1|||
124771309|NCT00489307|448791806|FG000|Overall Study|Patient or family refusal|5|||
124771310|NCT00489307|448791807|FG001|Overall Study|Patient or family refusal|9|||
124771311|NCT04586205|448791808|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
124771312|NCT04586205|448791809|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
124472921|NCT01070329|447690686|FG000|Overall Study|Sponsor Decision|0|||
124472922|NCT01070329|447690687|FG001|Overall Study|Sponsor Decision|1|||
124472923|NCT00700180|447690691|FG000|Overall Study|Death|99|||
124472924|NCT00700180|447690692|FG001|Overall Study|Death|114|||
124472925|NCT00700180|447690691|FG000|Overall Study|Alive on treatment|5|||
124472926|NCT00700180|447690692|FG001|Overall Study|Alive on treatment|3|||
124472927|NCT00700180|447690691|FG000|Overall Study|Alive in follow-up|46|||
124472928|NCT00700180|447690692|FG001|Overall Study|Alive in follow-up|27|||
124472929|NCT00700180|447690691|FG000|Overall Study|Lost to Follow-up|4|||
124472930|NCT00700180|447690692|FG001|Overall Study|Lost to Follow-up|5|||
124472931|NCT03588741|447690694|FG000|Overall Study|Withdrawal by Subject|1|||
124472932|NCT00793793|447690695|FG000|Overall Study|Adverse Event|0|||
124472933|NCT00793793|447690696|FG001|Overall Study|Adverse Event|0|||
124472934|NCT00793793|447690697|FG002|Overall Study|Adverse Event|1|||
124472935|NCT00793793|447690698|FG003|Overall Study|Adverse Event|1|||
124472936|NCT00793793|447690699|FG004|Overall Study|Adverse Event|0|||
124472937|NCT00793793|447690700|FG005|Overall Study|Adverse Event|1|||
124472938|NCT00793793|447690701|FG006|Overall Study|Adverse Event|2|||
124472939|NCT00793793|447690702|FG007|Overall Study|Adverse Event|0|||
124472940|NCT00793793|447690703|FG008|Overall Study|Adverse Event|0|||
124472941|NCT00793793|447690704|FG009|Overall Study|Adverse Event|0|||
124472942|NCT00793793|447690705|FG010|Overall Study|Adverse Event|0|||
124472943|NCT00793793|447690706|FG011|Overall Study|Adverse Event|2|||
124472944|NCT00793793|447690695|FG000|Overall Study|Protocol Violation|0|||
124472945|NCT00793793|447690696|FG001|Overall Study|Protocol Violation|0|||
124472946|NCT00793793|447690697|FG002|Overall Study|Protocol Violation|0|||
124472947|NCT00793793|447690698|FG003|Overall Study|Protocol Violation|1|||
124472948|NCT00793793|447690699|FG004|Overall Study|Protocol Violation|0|||
124472949|NCT00793793|447690700|FG005|Overall Study|Protocol Violation|0|||
124472950|NCT00793793|447690701|FG006|Overall Study|Protocol Violation|0|||
124472951|NCT00793793|447690702|FG007|Overall Study|Protocol Violation|0|||
124472952|NCT00793793|447690703|FG008|Overall Study|Protocol Violation|0|||
124472953|NCT00793793|447690704|FG009|Overall Study|Protocol Violation|0|||
124472954|NCT00793793|447690705|FG010|Overall Study|Protocol Violation|0|||
124472955|NCT00793793|447690706|FG011|Overall Study|Protocol Violation|0|||
124472956|NCT00793793|447690695|FG000|Overall Study|Lost to Follow-up|0|||
124472957|NCT00793793|447690696|FG001|Overall Study|Lost to Follow-up|0|||
124472958|NCT00793793|447690697|FG002|Overall Study|Lost to Follow-up|1|||
124472959|NCT00793793|447690698|FG003|Overall Study|Lost to Follow-up|0|||
124472960|NCT00793793|447690699|FG004|Overall Study|Lost to Follow-up|0|||
124472961|NCT00793793|447690700|FG005|Overall Study|Lost to Follow-up|0|||
124472962|NCT00793793|447690701|FG006|Overall Study|Lost to Follow-up|0|||
124472963|NCT00793793|447690702|FG007|Overall Study|Lost to Follow-up|0|||
124472964|NCT00793793|447690703|FG008|Overall Study|Lost to Follow-up|1|||
124472965|NCT00793793|447690704|FG009|Overall Study|Lost to Follow-up|3|||
124472966|NCT00793793|447690705|FG010|Overall Study|Lost to Follow-up|1|||
124472967|NCT00793793|447690706|FG011|Overall Study|Lost to Follow-up|0|||
124472968|NCT00793793|447690695|FG000|Overall Study|Withdrawal by Subject|0|||
124472969|NCT00793793|447690696|FG001|Overall Study|Withdrawal by Subject|0|||
124771313|NCT01586364|448794415|FG000|Overall Study|Withdrawal by Subject|40|||
124771314|NCT01586364|448794415|FG000|Overall Study|Adverse Event|37|||
124472970|NCT00793793|447690697|FG002|Overall Study|Withdrawal by Subject|0|||
124472971|NCT00793793|447690698|FG003|Overall Study|Withdrawal by Subject|0|||
124472972|NCT00793793|447690699|FG004|Overall Study|Withdrawal by Subject|1|||
124472973|NCT00793793|447690700|FG005|Overall Study|Withdrawal by Subject|0|||
124472974|NCT00793793|447690701|FG006|Overall Study|Withdrawal by Subject|0|||
124472975|NCT00793793|447690702|FG007|Overall Study|Withdrawal by Subject|0|||
124472976|NCT00793793|447690703|FG008|Overall Study|Withdrawal by Subject|1|||
124472977|NCT00793793|447690704|FG009|Overall Study|Withdrawal by Subject|0|||
124472978|NCT00793793|447690705|FG010|Overall Study|Withdrawal by Subject|0|||
124472979|NCT00793793|447690706|FG011|Overall Study|Withdrawal by Subject|0|||
124472980|NCT00793793|447690695|FG000|Overall Study|reason not specified|0|||
124472981|NCT00793793|447690696|FG001|Overall Study|reason not specified|1|||
124472982|NCT00793793|447690697|FG002|Overall Study|reason not specified|0|||
124716641|NCT00662831|448586618|FG001|Overall Study|Lack of Efficacy|6|||
124716642|NCT00662831|448586617|FG000|Overall Study|Lost to Follow-up|1|||
124716643|NCT00662831|448586618|FG001|Overall Study|Lost to Follow-up|0|||
124716644|NCT00662831|448586617|FG000|Overall Study|Withdrawal by Subject|2|||
124716645|NCT00662831|448586618|FG001|Overall Study|Withdrawal by Subject|1|||
124716646|NCT00662831|448586617|FG000|Overall Study|Other|62|||
124716647|NCT00662831|448586618|FG001|Overall Study|Other|31|||
124716648|NCT00662831|448586617|FG000|Overall Study|Protocol Violation|8|||
124716649|NCT00662831|448586618|FG001|Overall Study|Protocol Violation|4|||
124716650|NCT00662831|448586617|FG000|Overall Study|Adverse Event|23|||
124716651|NCT00662831|448586618|FG001|Overall Study|Adverse Event|16|||
124716652|NCT01061723|448586619|FG000|Overall Study|Adverse Event|0|||
124716653|NCT01061723|448586620|FG001|Overall Study|Adverse Event|2|||
124716654|NCT01061723|448586621|FG002|Overall Study|Adverse Event|5|||
124716655|NCT01061723|448586622|FG003|Overall Study|Adverse Event|5|||
124716656|NCT01061723|448586623|FG004|Overall Study|Adverse Event|2|||
124716657|NCT01061723|448586624|FG005|Overall Study|Adverse Event|6|||
124716658|NCT01061723|448586619|FG000|Overall Study|Lack of Efficacy|2|||
124716659|NCT01061723|448586620|FG001|Overall Study|Lack of Efficacy|3|||
124716660|NCT01061723|448586621|FG002|Overall Study|Lack of Efficacy|4|||
124716661|NCT01061723|448586622|FG003|Overall Study|Lack of Efficacy|2|||
124716662|NCT01061723|448586623|FG004|Overall Study|Lack of Efficacy|1|||
124716663|NCT01061723|448586624|FG005|Overall Study|Lack of Efficacy|1|||
124716664|NCT01061723|448586619|FG000|Overall Study|Randomized but not treated|0|||
124716665|NCT01061723|448586620|FG001|Overall Study|Randomized but not treated|0|||
124716666|NCT01061723|448586621|FG002|Overall Study|Randomized but not treated|0|||
124716667|NCT01061723|448586622|FG003|Overall Study|Randomized but not treated|0|||
124716668|NCT01061723|448586623|FG004|Overall Study|Randomized but not treated|0|||
124716669|NCT01061723|448586624|FG005|Overall Study|Randomized but not treated|1|||
124716670|NCT01061723|448586619|FG000|Overall Study|Other than specified above|2|||
124716671|NCT01061723|448586620|FG001|Overall Study|Other than specified above|1|||
124716672|NCT01061723|448586621|FG002|Overall Study|Other than specified above|1|||
124716673|NCT01061723|448586622|FG003|Overall Study|Other than specified above|1|||
124716674|NCT01061723|448586623|FG004|Overall Study|Other than specified above|0|||
124716675|NCT01061723|448586624|FG005|Overall Study|Other than specified above|1|||
124716676|NCT01147393|448586628|FG000|Dose Level 1|Dose limiting Toxicity|2|||
124716677|NCT01147393|448586628|FG000|Dose Level -1|Dose Limited Toxicity|1|||
124716678|NCT01408277|448586632|FG000|Overall Study|Adverse Event|3|||
124716679|NCT01408277|448586633|FG001|Overall Study|Adverse Event|4|||
124716680|NCT01408277|448586632|FG000|Overall Study|Lost to Follow-up|1|||
124716681|NCT01408277|448586633|FG001|Overall Study|Lost to Follow-up|0|||
124716682|NCT01408277|448586632|FG000|Overall Study|Withdrawal by Subject|2|||
124716683|NCT01408277|448586633|FG001|Overall Study|Withdrawal by Subject|0|||
124716684|NCT01408277|448586632|FG000|Overall Study|Protocol Violation|2|||
124716685|NCT01408277|448586633|FG001|Overall Study|Protocol Violation|0|||
124716686|NCT02840253|448586634|FG000|Overall Study|Unsuccessful block|4|||
124716687|NCT00473889|448586635|FG000|Overall Study|Did not receive study medication|1|||
124716688|NCT00473889|448586636|FG001|Overall Study|Did not receive study medication|4|||
124716689|NCT00473889|448586635|FG000|Overall Study|Adverse Event|30|||
124716690|NCT00473889|448586636|FG001|Overall Study|Adverse Event|17|||
124716691|NCT00473889|448586635|FG000|Overall Study|Protocol Violation|4|||
124716692|NCT00473889|448586636|FG001|Overall Study|Protocol Violation|2|||
124716693|NCT00473889|448586635|FG000|Overall Study|Lack of Efficacy|28|||
124716694|NCT00473889|448586636|FG001|Overall Study|Lack of Efficacy|29|||
124716695|NCT00473889|448586635|FG000|Overall Study|Lost to Follow-up|2|||
124716696|NCT00473889|448586636|FG001|Overall Study|Lost to Follow-up|1|||
124716697|NCT00473889|448586635|FG000|Overall Study|Physician Decision|10|||
124716698|NCT00473889|448586636|FG001|Overall Study|Physician Decision|5|||
124716699|NCT00473889|448586635|FG000|Overall Study|Trial Terminated|3|||
124716700|NCT00473889|448586636|FG001|Overall Study|Trial Terminated|6|||
124716701|NCT00473889|448586635|FG000|Overall Study|Withdrawal by Subject|5|||
124716702|NCT00473889|448586636|FG001|Overall Study|Withdrawal by Subject|0|||
124716703|NCT03801928|448586643|FG000|Overall Study|Adverse Event|1|||
124716704|NCT03801928|448586644|FG001|Overall Study|Adverse Event|0|||
124472983|NCT00793793|447690698|FG003|Overall Study|reason not specified|1|||
124716705|NCT03801928|448586645|FG002|Overall Study|Adverse Event|1|||
124716706|NCT03801928|448586646|FG003|Overall Study|Adverse Event|2|||
124716707|NCT03801928|448586647|FG004|Overall Study|Adverse Event|0|||
124716708|NCT03801928|448586648|FG005|Overall Study|Adverse Event|2|||
124716709|NCT03801928|448586643|FG000|Overall Study|Lack of Efficacy|0|||
124716710|NCT03801928|448586644|FG001|Overall Study|Lack of Efficacy|0|||
124716711|NCT03801928|448586645|FG002|Overall Study|Lack of Efficacy|1|||
124716712|NCT03801928|448586646|FG003|Overall Study|Lack of Efficacy|0|||
124716713|NCT03801928|448586647|FG004|Overall Study|Lack of Efficacy|0|||
124716714|NCT03801928|448586648|FG005|Overall Study|Lack of Efficacy|0|||
124716715|NCT03801928|448586643|FG000|Overall Study|Lost to Follow-up|5|||
124716716|NCT03801928|448586644|FG001|Overall Study|Lost to Follow-up|1|||
124716717|NCT03801928|448586645|FG002|Overall Study|Lost to Follow-up|1|||
124716718|NCT03801928|448586646|FG003|Overall Study|Lost to Follow-up|4|||
124472984|NCT00793793|447690699|FG004|Overall Study|reason not specified|1|||
124472985|NCT00793793|447690700|FG005|Overall Study|reason not specified|1|||
124472986|NCT00793793|447690701|FG006|Overall Study|reason not specified|2|||
124472987|NCT00793793|447690702|FG007|Overall Study|reason not specified|0|||
124472988|NCT00793793|447690703|FG008|Overall Study|reason not specified|7|||
124472989|NCT00793793|447690704|FG009|Overall Study|reason not specified|6|||
124472990|NCT00793793|447690705|FG010|Overall Study|reason not specified|2|||
124472991|NCT00793793|447690706|FG011|Overall Study|reason not specified|4|||
124472992|NCT00950170|447690707|FG000|Overall Study|Parent/Legal Guardian Request|1|||
124472993|NCT00950170|447690707|FG000|Overall Study|Adverse Event|2|||
124472994|NCT00950170|447690707|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
124716719|NCT03801928|448586647|FG004|Overall Study|Lost to Follow-up|4|||
124716720|NCT03801928|448586648|FG005|Overall Study|Lost to Follow-up|2|||
124716721|NCT03801928|448586643|FG000|Overall Study|Withdrawal by Subject|0|||
124716722|NCT03801928|448586644|FG001|Overall Study|Withdrawal by Subject|0|||
124716723|NCT03801928|448586645|FG002|Overall Study|Withdrawal by Subject|2|||
124716724|NCT03801928|448586646|FG003|Overall Study|Withdrawal by Subject|1|||
124716725|NCT03801928|448586647|FG004|Overall Study|Withdrawal by Subject|0|||
124716726|NCT03801928|448586648|FG005|Overall Study|Withdrawal by Subject|0|||
124716727|NCT03801928|448586643|FG000|Overall Study|Other|0|||
124716728|NCT03801928|448586644|FG001|Overall Study|Other|2|||
124716729|NCT03801928|448586645|FG002|Overall Study|Other|0|||
124716730|NCT03801928|448586646|FG003|Overall Study|Other|1|||
124716731|NCT03801928|448586647|FG004|Overall Study|Other|0|||
124716732|NCT03801928|448586648|FG005|Overall Study|Other|1|||
124716733|NCT04263766|448586649|FG000|Overall Study|Withdrawal by Subject|6|||
124716734|NCT04263766|448586650|FG001|Overall Study|Withdrawal by Subject|4|||
124716735|NCT04263766|448586649|FG000|Overall Study|Lack of Efficacy|1|||
124716736|NCT04263766|448586650|FG001|Overall Study|Lack of Efficacy|3|||
124716737|NCT03369665|448586652|FG000|Overall Study|Adverse Event|3|||
124716738|NCT03369665|448586652|FG000|Overall Study|Lost to Follow-up|7|||
124716739|NCT03369665|448586652|FG000|Overall Study|Withdrawal by Subject|15|||
124716740|NCT03369665|448586652|FG000|Overall Study|Progression Disease|2|||
124716741|NCT03369665|448586652|FG000|Overall Study|Not classified|3|||
124716742|NCT02553928|448586653|FG000|Overall Study|Adverse Event|2|||
124716743|NCT02553928|448586654|FG001|Overall Study|Adverse Event|1|||
124716744|NCT02553928|448586653|FG000|Overall Study|Lost to Follow-up|0|||
124716745|NCT02553928|448586654|FG001|Overall Study|Lost to Follow-up|1|||
124716746|NCT02553928|448586653|FG000|Overall Study|Administrative reason(s)|0|||
124716747|NCT02553928|448586654|FG001|Overall Study|Administrative reason(s)|1|||
124716748|NCT03230318|448586655|FG000|Overall Study|Radiographic disease progression|72|||
124716749|NCT03230318|448586656|FG001|Overall Study|Radiographic disease progression|19|||
124716750|NCT03230318|448586655|FG000|Overall Study|Clinical progression|17|||
124716751|NCT03230318|448586656|FG001|Overall Study|Clinical progression|7|||
124716752|NCT03230318|448586655|FG000|Overall Study|Adverse Event|5|||
124716753|NCT03230318|448586656|FG001|Overall Study|Adverse Event|3|||
124716754|NCT03230318|448586655|FG000|Overall Study|Physician Decision|2|||
124716755|NCT03230318|448586656|FG001|Overall Study|Physician Decision|3|||
124716756|NCT03230318|448586655|FG000|Overall Study|Death|3|||
124716757|NCT03230318|448586656|FG001|Overall Study|Death|2|||
124716758|NCT03230318|448586655|FG000|Overall Study|Lost to Follow-up|1|||
124716759|NCT03230318|448586656|FG001|Overall Study|Lost to Follow-up|0|||
124716760|NCT03230318|448586655|FG000|Overall Study|Withdrawal by Subject|1|||
124716761|NCT03230318|448586656|FG001|Overall Study|Withdrawal by Subject|3|||
124716762|NCT03230318|448586655|FG000|Overall Study|Other|3|||
124716763|NCT03230318|448586656|FG001|Overall Study|Other|7|||
124716764|NCT00075764|448586663|FG000|Overall Study|Adverse Event|5|||
124716765|NCT00075764|448586664|FG001|Overall Study|Adverse Event|12|||
124716766|NCT00075764|448586663|FG000|Overall Study|Death|4|||
124716767|NCT00075764|448586664|FG001|Overall Study|Death|8|||
124716768|NCT00075764|448586663|FG000|Overall Study|Withdrawal by Subject|28|||
124716769|NCT00075764|448586664|FG001|Overall Study|Withdrawal by Subject|18|||
124716770|NCT00075764|448586663|FG000|Overall Study|Progression|269|||
124716771|NCT00075764|448586664|FG001|Overall Study|Progression|274|||
124716772|NCT00075764|448586663|FG000|Overall Study|Still on treatment|8|||
124716773|NCT00075764|448586664|FG001|Overall Study|Still on treatment|15|||
124472995|NCT02661594|447690708|FG000|Overall Study|Protocol Violation|1|||
124472996|NCT02661594|447690709|FG001|Overall Study|Protocol Violation|0|||
124716774|NCT00075764|448586663|FG000|Overall Study|Delinquent|4|||
124716775|NCT00075764|448586664|FG001|Overall Study|Delinquent|2|||
124716776|NCT00075764|448586663|FG000|Overall Study|Not protocol specified|27|||
124716777|NCT00075764|448586664|FG001|Overall Study|Not protocol specified|19|||
124716778|NCT00075764|448586663|FG000|Overall Study|Under review|0|||
124716779|NCT00075764|448586664|FG001|Overall Study|Under review|1|||
124716780|NCT02817594|448586665|FG000|Overall Study|Withdrawal by Subject|1|||
124716781|NCT02817594|448586665|FG000|Overall Study|Other|1|||
124716782|NCT02817594|448586665|FG000|Overall Study|Did Not Receive Treatment|1|||
124716783|NCT02010593|448586666|FG000|Overall Study|Lost to Follow-up|1|||
124716784|NCT02010593|448586667|FG001|Overall Study|Lost to Follow-up|0|||
124716785|NCT02010593|448586666|FG000|Overall Study|Physician Decision|1|||
124771315|NCT01586364|448794415|FG000|Overall Study|Lost to Follow-up|17|||
124771316|NCT01586364|448794415|FG000|Overall Study|Protocol Violation|16|||
124771317|NCT01586364|448794415|FG000|Overall Study|Lack of Efficacy|1|||
124771318|NCT01586364|448794415|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
124554530|NCT00555399|447987463|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
124554531|NCT00555399|447987464|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
124554532|NCT00555399|447987465|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
124554533|NCT00555399|447987466|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
124771319|NCT01586364|448794415|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
124771320|NCT01586364|448794415|FG000|Overall Study|Other-Site closure due to PI illness|1|||
124771321|NCT01586364|448794415|FG000|Overall Study|Other-PI discretion, site closing|2|||
124771322|NCT01586364|448794415|FG000|Overall Study|Other-Not specified|1|||
124771323|NCT02121535|448794416|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
124771324|NCT02121535|448794417|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
124771325|NCT02121535|448794416|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
124771326|NCT02121535|448794417|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
124771327|NCT00091949|448794418|FG000|Overall Study|Withdrawal by Subject|117|||
124771328|NCT00091949|448794419|FG001|Overall Study|Withdrawal by Subject|110|||
124771329|NCT00091949|448794418|FG000|Overall Study|Lost to Follow-up|58|||
124771330|NCT00091949|448794419|FG001|Overall Study|Lost to Follow-up|41|||
124771331|NCT01256788|448794420|FG000|Overall Study|Lost to Follow-up|5|||
124771332|NCT01256788|448794421|FG001|Overall Study|Lost to Follow-up|8|||
124554534|NCT00555399|447987467|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
124554535|NCT00555399|447987468|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
124554536|NCT00555399|447987469|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
124554537|NCT00555399|447987470|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
124554538|NCT05166421|447987471|FG000|Overall Study|Other|3|||
124554539|NCT05166421|447987472|FG001|Overall Study|Other|1|||
124554540|NCT05166421|447987473|FG002|Overall Study|Other|1|||
124554541|NCT05166421|447987471|FG000|Overall Study|Withdrawal by Subject|5|||
124554542|NCT05166421|447987472|FG001|Overall Study|Withdrawal by Subject|3|||
124472997|NCT02661594|447690710|FG002|Overall Study|Protocol Violation|1|||
124554543|NCT05166421|447987473|FG002|Overall Study|Withdrawal by Subject|6|||
124554544|NCT05166421|447987471|FG000|Overall Study|Lost to Follow-up|4|||
124554545|NCT05166421|447987472|FG001|Overall Study|Lost to Follow-up|1|||
124554546|NCT05166421|447987473|FG002|Overall Study|Lost to Follow-up|7|||
124554547|NCT01858558|447989054|FG000|Overall Study|Death|1|||
124554548|NCT01858558|447989055|FG001|Overall Study|Death|1|||
124554549|NCT01858558|447989054|FG000|Overall Study|Lost to Follow-up|1|||
124554550|NCT01858558|447989055|FG001|Overall Study|Lost to Follow-up|0|||
124554551|NCT01858558|447989054|FG000|Overall Study|Disease progression|3|||
124554552|NCT01858558|447989055|FG001|Overall Study|Disease progression|1|||
124554553|NCT01858558|447989054|FG000|Overall Study|Product contamination|2|||
124554554|NCT01858558|447989055|FG001|Overall Study|Product contamination|0|||
124472998|NCT02661594|447690711|FG003|Overall Study|Protocol Violation|0|||
124472999|NCT02522767|447690712|FG000|Double-blind|Withdrawal by Subject|8|||
124473000|NCT02522767|447690713|FG001|Double-blind|Withdrawal by Subject|11|||
124473001|NCT02522767|447690712|FG000|Double-blind|Lost to Follow-up|1|||
124473002|NCT02522767|447690713|FG001|Double-blind|Lost to Follow-up|0|||
124473003|NCT02522767|447690712|FG000|Double-blind|Adverse Event|1|||
124473004|NCT02522767|447690713|FG001|Double-blind|Adverse Event|10|||
124473005|NCT02522767|447690712|FG000|Double-blind|Protocol Violation|0|||
124473006|NCT02522767|447690713|FG001|Double-blind|Protocol Violation|1|||
124473007|NCT02522767|447690712|FG000|Double-blind|Lack of Efficacy|0|||
124473008|NCT02522767|447690713|FG001|Double-blind|Lack of Efficacy|2|||
124473009|NCT02522767|447690712|FG000|Double-blind|Protocol Deviation|1|||
124473010|NCT02522767|447690713|FG001|Double-blind|Protocol Deviation|0|||
124473011|NCT02522767|447690712|FG000|Open-label|Withdrawal by Subject|2|||
124473012|NCT02522767|447690713|FG001|Open-label|Withdrawal by Subject|3|||
124473013|NCT02522767|447690712|FG000|Open-label|Lost to Follow-up|0|||
124473014|NCT02522767|447690713|FG001|Open-label|Lost to Follow-up|1|||
124473015|NCT02522767|447690712|FG000|Open-label|Adverse Event|2|||
124473016|NCT02522767|447690713|FG001|Open-label|Adverse Event|1|||
124473017|NCT02522767|447690712|FG000|Open-label|Lack of Efficacy|1|||
124473018|NCT02522767|447690713|FG001|Open-label|Lack of Efficacy|1|||
124473019|NCT02522767|447690712|FG000|Open-label|Protocol Violation|0|||
124473020|NCT02522767|447690713|FG001|Open-label|Protocol Violation|1|||
124473021|NCT01705691|447690714|FG000|Overall Study|Death|1|||
124473022|NCT01705691|447690715|FG001|Overall Study|Death|2|||
124473023|NCT01705691|447690714|FG000|Overall Study|Withdrawal by Subject|1|||
124554555|NCT01858558|447989054|FG000|Overall Study|Failed expansion of cell product|2|||
124554556|NCT01858558|447989055|FG001|Overall Study|Failed expansion of cell product|0|||
124473024|NCT01705691|447690715|FG001|Overall Study|Withdrawal by Subject|2|||
124473025|NCT01705691|447690714|FG000|Overall Study|Lost to Follow-up|1|||
124473026|NCT01705691|447690715|FG001|Overall Study|Lost to Follow-up|1|||
124473027|NCT01705691|447690714|FG000|Overall Study|Other|0|||
124473028|NCT01705691|447690715|FG001|Overall Study|Other|1|||
124473029|NCT00214461|447690716|FG000|Overall Study|Adverse Event|0|||
124473030|NCT00214461|447690717|FG001|Overall Study|Adverse Event|0|||
124473031|NCT00214461|447690718|FG002|Overall Study|Adverse Event|1|||
124554557|NCT00343642|447989056|FG000|Overall Study|Lost to Follow-up|0|||
124554558|NCT00343642|447989057|FG001|Overall Study|Lost to Follow-up|1|||
124473032|NCT00214461|447690719|FG003|Overall Study|Adverse Event|1|||
124473033|NCT00214461|447690716|FG000|Overall Study|Withdrawal by Subject|0|||
124554559|NCT00343642|447989058|FG002|Overall Study|Lost to Follow-up|0|||
124554560|NCT00343642|447989056|FG000|Overall Study|Pregnancy|1|||
124716786|NCT02010593|448586667|FG001|Overall Study|Physician Decision|0|||
124716787|NCT02010593|448586666|FG000|Overall Study|Unable to adhere to visit schedule|0|||
124716788|NCT02010593|448586667|FG001|Overall Study|Unable to adhere to visit schedule|2|||
124716789|NCT01773967|448586668|FG000|Overall Study|Lost to Follow-up|15|||
124716790|NCT01773967|448586669|FG001|Overall Study|Lost to Follow-up|13|||
124716791|NCT01135459|448586670|FG000|Overall Study|Adverse Event|8|||
124716792|NCT01135459|448586671|FG001|Overall Study|Adverse Event|10|||
124716793|NCT01135459|448586670|FG000|Overall Study|Lack of Efficacy|3|||
124716794|NCT01135459|448586671|FG001|Overall Study|Lack of Efficacy|1|||
124716795|NCT01135459|448586670|FG000|Overall Study|Withdrawal by Subject|2|||
124716796|NCT01135459|448586671|FG001|Overall Study|Withdrawal by Subject|3|||
124716797|NCT01135459|448586670|FG000|Overall Study|Protocol Violation|5|||
124716798|NCT01135459|448586671|FG001|Overall Study|Protocol Violation|3|||
124716799|NCT01135459|448586670|FG000|Overall Study|Lost to Follow-up|2|||
124716800|NCT01135459|448586671|FG001|Overall Study|Lost to Follow-up|1|||
124716801|NCT01135459|448586670|FG000|Overall Study|Non-compliance to study procedures|0|||
124716802|NCT01135459|448586671|FG001|Overall Study|Non-compliance to study procedures|1|||
124716803|NCT01135459|448586670|FG000|Overall Study|Other than specified|1|||
124716804|NCT01135459|448586671|FG001|Overall Study|Other than specified|1|||
124716805|NCT01766037|448586672|FG000|Overall Study|Adverse Event|1|||
124716806|NCT01766037|448586673|FG001|Overall Study|Adverse Event|0|||
124716807|NCT01766037|448586672|FG000|Overall Study|Lack of Efficacy|1|||
124716808|NCT01766037|448586673|FG001|Overall Study|Lack of Efficacy|0|||
124716809|NCT01766037|448586672|FG000|Overall Study|Lost to Follow-up|0|||
124716810|NCT01766037|448586673|FG001|Overall Study|Lost to Follow-up|10|||
124716811|NCT01766037|448586672|FG000|Overall Study|Physician Decision|0|||
124716812|NCT01766037|448586673|FG001|Overall Study|Physician Decision|1|||
124716813|NCT01766037|448586672|FG000|Overall Study|Withdrawal by Subject|18|||
124716814|NCT01766037|448586673|FG001|Overall Study|Withdrawal by Subject|16|||
124716815|NCT01766037|448586672|FG000|Overall Study|Moved from area|5|||
124716816|NCT01766037|448586673|FG001|Overall Study|Moved from area|0|||
124554561|NCT00343642|447989057|FG001|Overall Study|Pregnancy|0|||
124554562|NCT00343642|447989058|FG002|Overall Study|Pregnancy|2|||
124716817|NCT01766037|448586672|FG000|Overall Study|medical - unrelated|1|||
124716818|NCT01766037|448586673|FG001|Overall Study|medical - unrelated|2|||
124716819|NCT01766037|448586672|FG000|Overall Study|nausea / discomfort|3|||
124716820|NCT01766037|448586673|FG001|Overall Study|nausea / discomfort|0|||
124716821|NCT02413996|448586674|FG000|Overall Study|not comfortable with the intervention|9|||
124473034|NCT00214461|447690717|FG001|Overall Study|Withdrawal by Subject|0|||
124473035|NCT00214461|447690718|FG002|Overall Study|Withdrawal by Subject|1|||
124473036|NCT00214461|447690719|FG003|Overall Study|Withdrawal by Subject|0|||
124473037|NCT02913313|447690720|FG000|Overall Study|DISEASE PROGRESSION|1|||
124473038|NCT02913313|447690721|FG001|Overall Study|DISEASE PROGRESSION|2|||
124473039|NCT02913313|447690722|FG002|Overall Study|DISEASE PROGRESSION|2|||
124473040|NCT02913313|447690723|FG003|Overall Study|DISEASE PROGRESSION|4|||
124473041|NCT02913313|447690724|FG004|Overall Study|DISEASE PROGRESSION|6|||
124473042|NCT02913313|447690725|FG005|Overall Study|DISEASE PROGRESSION|4|||
124473043|NCT02913313|447690726|FG006|Overall Study|DISEASE PROGRESSION|19|||
124473044|NCT02913313|447690727|FG007|Overall Study|DISEASE PROGRESSION|3|||
124473045|NCT02913313|447690728|FG008|Overall Study|DISEASE PROGRESSION|4|||
124473046|NCT02913313|447690729|FG009|Overall Study|DISEASE PROGRESSION|4|||
124473047|NCT02913313|447690730|FG010|Overall Study|DISEASE PROGRESSION|11|||
124473048|NCT02913313|447690731|FG011|Overall Study|DISEASE PROGRESSION|5|||
124473049|NCT02913313|447690732|FG012|Overall Study|DISEASE PROGRESSION|14|||
124473050|NCT02913313|447690733|FG013|Overall Study|DISEASE PROGRESSION|3|||
124473051|NCT02913313|447690720|FG000|Overall Study|Not Reported|0|||
124473052|NCT02913313|447690721|FG001|Overall Study|Not Reported|0|||
124473053|NCT02913313|447690722|FG002|Overall Study|Not Reported|0|||
124473054|NCT02913313|447690723|FG003|Overall Study|Not Reported|0|||
124473055|NCT02913313|447690724|FG004|Overall Study|Not Reported|1|||
124473056|NCT02913313|447690725|FG005|Overall Study|Not Reported|0|||
124473057|NCT02913313|447690726|FG006|Overall Study|Not Reported|0|||
124473058|NCT02913313|447690727|FG007|Overall Study|Not Reported|0|||
124473059|NCT02913313|447690728|FG008|Overall Study|Not Reported|0|||
124473060|NCT02913313|447690729|FG009|Overall Study|Not Reported|0|||
124473061|NCT02913313|447690730|FG010|Overall Study|Not Reported|4|||
124473062|NCT02913313|447690731|FG011|Overall Study|Not Reported|0|||
124473063|NCT02913313|447690732|FG012|Overall Study|Not Reported|0|||
124473064|NCT02913313|447690733|FG013|Overall Study|Not Reported|0|||
124473065|NCT02913313|447690720|FG000|Overall Study|Other reasons|0|||
124473066|NCT02913313|447690721|FG001|Overall Study|Other reasons|0|||
124473067|NCT02913313|447690722|FG002|Overall Study|Other reasons|0|||
124473068|NCT02913313|447690723|FG003|Overall Study|Other reasons|0|||
124473069|NCT02913313|447690724|FG004|Overall Study|Other reasons|1|||
124473070|NCT02913313|447690725|FG005|Overall Study|Other reasons|0|||
124473071|NCT02913313|447690726|FG006|Overall Study|Other reasons|0|||
124473072|NCT02913313|447690727|FG007|Overall Study|Other reasons|0|||
124473073|NCT02913313|447690728|FG008|Overall Study|Other reasons|0|||
124473074|NCT02913313|447690729|FG009|Overall Study|Other reasons|0|||
124473075|NCT02913313|447690730|FG010|Overall Study|Other reasons|1|||
124473076|NCT02913313|447690731|FG011|Overall Study|Other reasons|0|||
124473077|NCT02913313|447690732|FG012|Overall Study|Other reasons|0|||
124473078|NCT02913313|447690733|FG013|Overall Study|Other reasons|0|||
124473079|NCT02913313|447690720|FG000|Overall Study|Withdrawal by Subject|0|||
124473080|NCT02913313|447690721|FG001|Overall Study|Withdrawal by Subject|0|||
124473081|NCT02913313|447690722|FG002|Overall Study|Withdrawal by Subject|1|||
124473082|NCT02913313|447690723|FG003|Overall Study|Withdrawal by Subject|0|||
124473083|NCT02913313|447690724|FG004|Overall Study|Withdrawal by Subject|0|||
124473084|NCT02913313|447690725|FG005|Overall Study|Withdrawal by Subject|0|||
124473085|NCT02913313|447690726|FG006|Overall Study|Withdrawal by Subject|1|||
124473086|NCT02913313|447690727|FG007|Overall Study|Withdrawal by Subject|1|||
124473087|NCT02913313|447690728|FG008|Overall Study|Withdrawal by Subject|0|||
124473088|NCT02913313|447690729|FG009|Overall Study|Withdrawal by Subject|0|||
124473089|NCT02913313|447690730|FG010|Overall Study|Withdrawal by Subject|1|||
124473090|NCT02913313|447690731|FG011|Overall Study|Withdrawal by Subject|0|||
124473091|NCT02913313|447690732|FG012|Overall Study|Withdrawal by Subject|0|||
124473092|NCT02913313|447690733|FG013|Overall Study|Withdrawal by Subject|0|||
124473093|NCT02913313|447690720|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
124473094|NCT02913313|447690721|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
124473095|NCT02913313|447690722|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
124473096|NCT02913313|447690723|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
124473097|NCT02913313|447690724|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
124473098|NCT02913313|447690725|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
124473099|NCT02913313|447690726|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
124473100|NCT02913313|447690727|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
124473101|NCT02913313|447690728|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
124473102|NCT02913313|447690729|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
124473103|NCT02913313|447690730|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
124473104|NCT02913313|447690731|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
124473105|NCT02913313|447690732|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
124473106|NCT02913313|447690733|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
124473107|NCT02913313|447690720|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
124473108|NCT02913313|447690721|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
124473109|NCT02913313|447690722|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
124473110|NCT02913313|447690723|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
124716822|NCT02413996|448586675|FG001|Overall Study|not comfortable with the intervention|2|||
124716823|NCT02443337|448586676|FG000|Overall Study|Adverse Event|0|||
124716824|NCT02443337|448586677|FG001|Overall Study|Adverse Event|1|||
124716825|NCT02443337|448586676|FG000|Overall Study|Clinical Progressive Disease|3|||
124716826|NCT02443337|448586677|FG001|Overall Study|Clinical Progressive Disease|0|||
124716827|NCT02443337|448586676|FG000|Overall Study|Withdrawal by Subject|2|||
124716828|NCT02443337|448586677|FG001|Overall Study|Withdrawal by Subject|1|||
124716829|NCT00635349|448586679|FG000|Overall Study|Other|8|||
124716830|NCT00635349|448586680|FG001|Overall Study|Other|6|||
124716831|NCT00635349|448586679|FG000|Overall Study|Protocol Violation|18|||
124716832|NCT00635349|448586680|FG001|Overall Study|Protocol Violation|22|||
124716833|NCT00635349|448586679|FG000|Overall Study|Withdrawal by Subject|3|||
124716834|NCT00635349|448586680|FG001|Overall Study|Withdrawal by Subject|8|||
124716835|NCT00635349|448586679|FG000|Overall Study|Lost to Follow-up|4|||
124716836|NCT00635349|448586680|FG001|Overall Study|Lost to Follow-up|3|||
124716837|NCT00635349|448586679|FG000|Overall Study|Adverse Event|11|||
124716838|NCT00635349|448586680|FG001|Overall Study|Adverse Event|9|||
124716839|NCT01672879|448586686|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
124716840|NCT01672879|448586687|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
124716841|NCT01672879|448586688|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
124716842|NCT01672879|448586686|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
124716843|NCT01672879|448586687|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
124716844|NCT01672879|448586688|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
124716845|NCT01672879|448586686|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
124716846|NCT01672879|448586687|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
124716847|NCT01672879|448586688|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
124716848|NCT01672879|448586686|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
124716849|NCT01672879|448586687|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
124716850|NCT01672879|448586688|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
124716851|NCT01672879|448586686|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
124716852|NCT01672879|448586687|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
124716853|NCT01672879|448586688|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
124716854|NCT01672879|448586686|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
124716855|NCT01672879|448586687|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
124716856|NCT01672879|448586688|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
124716857|NCT01672879|448586686|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
124716858|NCT01672879|448586687|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
124716859|NCT01672879|448586688|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
124716860|NCT01672879|448586686|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
124716861|NCT01672879|448586687|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
124716862|NCT01672879|448586688|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
124716863|NCT01672879|448586686|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
124716864|NCT01672879|448586687|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
124716865|NCT01672879|448586688|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
124716866|NCT01672879|448586686|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
124716867|NCT01672879|448586687|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
124716868|NCT01672879|448586688|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
124716869|NCT01672879|448586686|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
124716870|NCT01672879|448586687|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
124716871|NCT01672879|448586688|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
124716872|NCT01672879|448586686|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
124716873|NCT01672879|448586687|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
124473111|NCT02913313|447690724|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
124473112|NCT02913313|447690725|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
124473113|NCT02913313|447690726|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
124473114|NCT02913313|447690727|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
124473115|NCT02913313|447690728|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
124473116|NCT02913313|447690729|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
124473117|NCT02913313|447690730|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
124473118|NCT02913313|447690731|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
124473119|NCT02913313|447690732|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
124473120|NCT02913313|447690733|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
124473121|NCT04233229|447690736|FG000|Overall Study|Withdrawal by Subject|0|||
124473122|NCT04233229|447690737|FG001|Overall Study|Withdrawal by Subject|1|||
124473123|NCT04233229|447690736|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
124473124|NCT04233229|447690737|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
124473125|NCT04233229|447690736|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
124473126|NCT04233229|447690737|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
124473127|NCT00841763|447690738|FG000|Overall Study|Withdrawal by Subject|60|||
124473128|NCT00841763|447690739|FG001|Overall Study|Withdrawal by Subject|17|||
124473129|NCT00841763|447690740|FG002|Overall Study|Withdrawal by Subject|4|||
124473130|NCT00841763|447690741|FG003|Overall Study|Withdrawal by Subject|1|||
124473131|NCT00841763|447690738|FG000|Overall Study|Adverse Event|9|||
124473132|NCT00841763|447690739|FG001|Overall Study|Adverse Event|10|||
124473133|NCT00841763|447690740|FG002|Overall Study|Adverse Event|3|||
124473134|NCT00841763|447690741|FG003|Overall Study|Adverse Event|2|||
124473135|NCT00841763|447690738|FG000|Overall Study|Lost to Follow-up|63|||
124473136|NCT00841763|447690739|FG001|Overall Study|Lost to Follow-up|25|||
124473137|NCT00841763|447690740|FG002|Overall Study|Lost to Follow-up|0|||
124473138|NCT00841763|447690741|FG003|Overall Study|Lost to Follow-up|0|||
124473139|NCT00841763|447690738|FG000|Overall Study|Protocol Violation|20|||
124473140|NCT00841763|447690739|FG001|Overall Study|Protocol Violation|3|||
124473141|NCT00841763|447690740|FG002|Overall Study|Protocol Violation|1|||
124473142|NCT00841763|447690741|FG003|Overall Study|Protocol Violation|0|||
124473143|NCT00841763|447690738|FG000|Overall Study|Administrative Reasons|3|||
124473144|NCT00841763|447690739|FG001|Overall Study|Administrative Reasons|1|||
124473145|NCT00841763|447690740|FG002|Overall Study|Administrative Reasons|0|||
124473146|NCT00841763|447690741|FG003|Overall Study|Administrative Reasons|0|||
124473147|NCT00841763|447690738|FG000|Overall Study|Unable to Classify|7|||
124473148|NCT00841763|447690739|FG001|Overall Study|Unable to Classify|1|||
124473149|NCT00841763|447690740|FG002|Overall Study|Unable to Classify|0|||
124473150|NCT00841763|447690741|FG003|Overall Study|Unable to Classify|0|||
124473151|NCT02631538|447690742|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
124473152|NCT02631538|447690743|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
124473153|NCT02631538|447690744|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
124473154|NCT02631538|447690745|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
124716874|NCT01672879|448586688|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
124716875|NCT01672879|448586686|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
124716876|NCT01672879|448586687|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
124473155|NCT02631538|447690742|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
124473156|NCT02631538|447690743|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
124473157|NCT02631538|447690744|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
124473158|NCT02631538|447690745|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
124473159|NCT02631538|447690742|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
124716877|NCT01672879|448586688|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
124473160|NCT02631538|447690743|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
124473161|NCT02631538|447690744|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
124473162|NCT02631538|447690745|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
124554563|NCT00343642|447989056|FG000|Overall Study|Withdrawal by Subject|2|||
124554564|NCT00343642|447989057|FG001|Overall Study|Withdrawal by Subject|3|||
124554565|NCT00343642|447989058|FG002|Overall Study|Withdrawal by Subject|4|||
124554566|NCT00343642|447989056|FG000|Overall Study|Adverse Event|0|||
124554567|NCT00343642|447989057|FG001|Overall Study|Adverse Event|0|||
124554568|NCT00343642|447989058|FG002|Overall Study|Adverse Event|1|||
124554569|NCT00343642|447989056|FG000|Overall Study|Flare up|6|||
124554570|NCT00343642|447989057|FG001|Overall Study|Flare up|4|||
124554571|NCT00343642|447989058|FG002|Overall Study|Flare up|0|||
124554572|NCT00569231|447989065|FG000|Overall Study|Study unrelated surgery|1|||
124554573|NCT00569231|447989065|FG000|Overall Study|Airfare expense|2|||
124554574|NCT00569231|447989065|FG000|Overall Study|Withdrawal by Subject|1|||
124554575|NCT00569231|447989065|FG000|Overall Study|Car accident injury|1|||
124554576|NCT00569231|447989065|FG000|Overall Study|Non-compliance|2|||
124554577|NCT00700310|447989068|FG000|Overall Study|Adverse Event|6|||
124554578|NCT00700310|447989069|FG001|Overall Study|Adverse Event|10|||
124771333|NCT01256788|448794422|FG002|Overall Study|Lost to Follow-up|3|||
124771334|NCT02083354|448794423|FG000|Overall Study|Withdrawal by Subject|9|||
124771335|NCT02083354|448794423|FG000|Overall Study|Lost to Follow-up|1|||
124771336|NCT02083354|448794423|FG000|Overall Study|Adverse Event|3|||
124771337|NCT02083354|448794423|FG000|Overall Study|Disease progression|46|||
124771338|NCT02083354|448794423|FG000|Overall Study|Study closed/terminated|5|||
124771339|NCT03312634|448794424|FG000|Overall Study|Adverse Event|11|||
124771340|NCT03312634|448794425|FG001|Overall Study|Adverse Event|0|||
124771341|NCT03312634|448794424|FG000|Overall Study|Sponsor request|2|||
124771342|NCT03312634|448794425|FG001|Overall Study|Sponsor request|0|||
124771343|NCT03312634|448794424|FG000|Overall Study|Withdrawal by Subject|31|||
124771344|NCT03312634|448794425|FG001|Overall Study|Withdrawal by Subject|9|||
124771345|NCT03312634|448794424|FG000|Overall Study|Enrolled in an interventional study|0|||
124771346|NCT03312634|448794425|FG001|Overall Study|Enrolled in an interventional study|52|||
124771347|NCT03312634|448794424|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
124554579|NCT00700310|447989070|FG002|Overall Study|Adverse Event|5|||
124554580|NCT00700310|447989071|FG003|Overall Study|Adverse Event|11|||
124771348|NCT03312634|448794425|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
124716878|NCT04860869|448586689|FG000|Overall Study|Withdrawal by Subject|1|||
124716879|NCT04860869|448586690|FG001|Overall Study|Withdrawal by Subject|0|||
124716880|NCT01871545|448586691|FG000|Overall Study|Death|2|||
124716881|NCT01871545|448586692|FG001|Overall Study|Death|0|||
124716882|NCT01871545|448586691|FG000|Overall Study|Lack of Efficacy|11|||
124716883|NCT01871545|448586692|FG001|Overall Study|Lack of Efficacy|2|||
124716884|NCT01871545|448586691|FG000|Overall Study|Physician Decision|4|||
124716885|NCT01871545|448586692|FG001|Overall Study|Physician Decision|0|||
124716886|NCT01871545|448586691|FG000|Overall Study|Withdrawal by Subject|0|||
124716887|NCT01871545|448586692|FG001|Overall Study|Withdrawal by Subject|1|||
124716888|NCT04834726|448586695|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
124716889|NCT04834726|448586696|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
124716890|NCT04834726|448586697|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
124716891|NCT04834726|448586698|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
124716892|NCT04834726|448586699|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
124716893|NCT04834726|448586700|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
124716894|NCT04834726|448586701|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
124716895|NCT04834726|448586702|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
124716896|NCT04834726|448586703|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
124716897|NCT02948582|448586706|FG000|Washout Period 1|Adverse Event|0|||
124716898|NCT02948582|448586707|FG001|Washout Period 1|Adverse Event|2|||
124716899|NCT02948582|448586708|FG002|Washout Period 1|Adverse Event|0|||
124716900|NCT02948582|448586709|FG003|Washout Period 1|Adverse Event|0|||
124716901|NCT02948582|448586710|FG004|Washout Period 1|Adverse Event|0|||
124716902|NCT02948582|448586711|FG005|Washout Period 1|Adverse Event|0|||
124716903|NCT02948582|448586706|FG000|Washout Period 1|Protocol Violation|0|||
124716904|NCT02948582|448586707|FG001|Washout Period 1|Protocol Violation|0|||
124716905|NCT02948582|448586708|FG002|Washout Period 1|Protocol Violation|0|||
124716906|NCT02948582|448586709|FG003|Washout Period 1|Protocol Violation|0|||
124554581|NCT00700310|447989068|FG000|Overall Study|Lost to Follow-up|4|||
124554582|NCT00700310|447989069|FG001|Overall Study|Lost to Follow-up|1|||
124554583|NCT00700310|447989070|FG002|Overall Study|Lost to Follow-up|0|||
124554584|NCT00700310|447989071|FG003|Overall Study|Lost to Follow-up|1|||
124554585|NCT00700310|447989068|FG000|Overall Study|Withdrawal by Subject|8|||
124554586|NCT00700310|447989069|FG001|Overall Study|Withdrawal by Subject|9|||
124554587|NCT00700310|447989070|FG002|Overall Study|Withdrawal by Subject|8|||
124554588|NCT00700310|447989071|FG003|Overall Study|Withdrawal by Subject|8|||
124554589|NCT00700310|447989068|FG000|Overall Study|Lack of Efficacy|0|||
124554590|NCT00700310|447989069|FG001|Overall Study|Lack of Efficacy|3|||
124554591|NCT00700310|447989070|FG002|Overall Study|Lack of Efficacy|0|||
124554592|NCT00700310|447989071|FG003|Overall Study|Lack of Efficacy|1|||
124716907|NCT02948582|448586710|FG004|Washout Period 1|Protocol Violation|0|||
124716908|NCT02948582|448586711|FG005|Washout Period 1|Protocol Violation|1|||
124716909|NCT02948582|448586706|FG000|Washout Period 2|Adverse Event|0|||
124716910|NCT02948582|448586707|FG001|Washout Period 2|Adverse Event|1|||
124716911|NCT02948582|448586708|FG002|Washout Period 2|Adverse Event|0|||
124716912|NCT02948582|448586709|FG003|Washout Period 2|Adverse Event|0|||
124716913|NCT02948582|448586710|FG004|Washout Period 2|Adverse Event|0|||
124716914|NCT02948582|448586711|FG005|Washout Period 2|Adverse Event|0|||
124716915|NCT02948582|448586706|FG000|Washout Period 2|personal reasons|0|||
124716916|NCT02948582|448586707|FG001|Washout Period 2|personal reasons|0|||
124716917|NCT02948582|448586708|FG002|Washout Period 2|personal reasons|0|||
124716918|NCT02948582|448586709|FG003|Washout Period 2|personal reasons|1|||
124716919|NCT02948582|448586710|FG004|Washout Period 2|personal reasons|0|||
124716920|NCT02948582|448586711|FG005|Washout Period 2|personal reasons|0|||
124716921|NCT02948582|448586706|FG000|Washout Period 4|Adverse Event|1|||
124716922|NCT02948582|448586707|FG001|Washout Period 4|Adverse Event|0|||
124716923|NCT02948582|448586708|FG002|Washout Period 4|Adverse Event|1|||
124716924|NCT02948582|448586709|FG003|Washout Period 4|Adverse Event|0|||
124716925|NCT02948582|448586710|FG004|Washout Period 4|Adverse Event|0|||
124716926|NCT02948582|448586711|FG005|Washout Period 4|Adverse Event|0|||
124716927|NCT03810014|448586713|FG000|Overall Study|Pregnancy|2|||
124716928|NCT03810014|448586714|FG001|Overall Study|Pregnancy|2|||
124716929|NCT03810014|448586715|FG002|Overall Study|Pregnancy|0|||
124716930|NCT03810014|448586716|FG003|Overall Study|Pregnancy|2|||
124716931|NCT01853462|448586719|FG000|Overall Study|Withdrawal by Subject|1|||
124716932|NCT01853462|448586720|FG001|Overall Study|Withdrawal by Subject|1|||
124716933|NCT02148263|448586721|FG000|Overall Study|Withdrawal by Subject|3|||
124716934|NCT02148263|448586722|FG001|Overall Study|Withdrawal by Subject|2|||
124554593|NCT00700310|447989068|FG000|Overall Study|Administrative/Other|1|||
124554594|NCT00700310|447989069|FG001|Overall Study|Administrative/Other|3|||
124554595|NCT00700310|447989070|FG002|Overall Study|Administrative/Other|1|||
124554596|NCT00700310|447989071|FG003|Overall Study|Administrative/Other|3|||
124716935|NCT02012218|448586723|FG000|Overall Study|Withdrawal by Subject|1|||
124716936|NCT02012218|448586724|FG001|Overall Study|Withdrawal by Subject|0|||
124716937|NCT02012218|448586725|FG002|Overall Study|Withdrawal by Subject|1|||
124716938|NCT02012218|448586726|FG003|Overall Study|Withdrawal by Subject|1|||
124716939|NCT02012218|448586727|FG004|Overall Study|Withdrawal by Subject|1|||
124716940|NCT02012218|448586723|FG000|Overall Study|Adverse Event|1|||
124716941|NCT02012218|448586724|FG001|Overall Study|Adverse Event|0|||
124716942|NCT02012218|448586725|FG002|Overall Study|Adverse Event|0|||
124716943|NCT02012218|448586726|FG003|Overall Study|Adverse Event|1|||
124716944|NCT02012218|448586727|FG004|Overall Study|Adverse Event|0|||
124716945|NCT02012218|448586723|FG000|Overall Study|Lost to Follow-up|0|||
124716946|NCT02012218|448586724|FG001|Overall Study|Lost to Follow-up|1|||
124716947|NCT02012218|448586725|FG002|Overall Study|Lost to Follow-up|1|||
124716948|NCT02012218|448586726|FG003|Overall Study|Lost to Follow-up|0|||
124716949|NCT02012218|448586727|FG004|Overall Study|Lost to Follow-up|0|||
124716950|NCT02012218|448586723|FG000|Overall Study|Protocol Specified|1|||
124473163|NCT02631538|447690742|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
124473164|NCT02631538|447690743|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
124473165|NCT02631538|447690744|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
124473166|NCT02631538|447690745|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
124473167|NCT02631538|447690742|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
124473168|NCT02631538|447690743|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
124473169|NCT02631538|447690744|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
124473170|NCT02631538|447690745|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
124473171|NCT02631538|447690742|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
124473172|NCT02631538|447690743|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
124473173|NCT02631538|447690744|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
124473174|NCT02631538|447690745|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
124473175|NCT01482910|447690750|FG000|Overall Study|Adverse Event|6|||
124473176|NCT01482910|447690751|FG001|Overall Study|Adverse Event|5|||
124473177|NCT01482910|447690750|FG000|Overall Study|Lost to Follow-up|0|||
124473178|NCT01482910|447690751|FG001|Overall Study|Lost to Follow-up|1|||
124473179|NCT01482910|447690750|FG000|Overall Study|Protocol Violation|1|||
124473180|NCT01482910|447690751|FG001|Overall Study|Protocol Violation|1|||
124473181|NCT01482910|447690750|FG000|Overall Study|Withdrawal by Subject|7|||
124473182|NCT01482910|447690751|FG001|Overall Study|Withdrawal by Subject|2|||
124473183|NCT01482910|447690750|FG000|Overall Study|Death|1|||
124473184|NCT01482910|447690751|FG001|Overall Study|Death|0|||
124473185|NCT00440726|447690753|FG000|Phase 1|Dose-Limiting Toxicity|0|||
124473186|NCT00440726|447690754|FG001|Phase 1|Dose-Limiting Toxicity|1|||
124473187|NCT00440726|447690755|FG002|Phase 1|Dose-Limiting Toxicity|0|||
124716951|NCT02012218|448586724|FG001|Overall Study|Protocol Specified|0|||
124716952|NCT02012218|448586725|FG002|Overall Study|Protocol Specified|0|||
124716953|NCT02012218|448586726|FG003|Overall Study|Protocol Specified|0|||
124716954|NCT02012218|448586727|FG004|Overall Study|Protocol Specified|0|||
124716955|NCT02012218|448586723|FG000|Overall Study|Protocol Deviation|1|||
124716956|NCT02012218|448586724|FG001|Overall Study|Protocol Deviation|0|||
124716957|NCT02012218|448586725|FG002|Overall Study|Protocol Deviation|0|||
124716958|NCT02012218|448586726|FG003|Overall Study|Protocol Deviation|0|||
124716959|NCT02012218|448586727|FG004|Overall Study|Protocol Deviation|0|||
124716960|NCT03929913|448586733|FG000|Overall Study|Death|4|||
124716961|NCT03929913|448586733|FG000|Overall Study|Lost to Follow-up|1|||
124716962|NCT03929913|448586733|FG000|Overall Study|Failed Procedure|2|||
124716963|NCT01154452|448586734|FG000|Phase Ib|Not Treated|1|||
124716964|NCT01154452|448586735|FG001|Phase Ib|Not Treated|0|||
124716965|NCT01154452|448586736|FG002|Phase Ib|Not Treated|0|||
124716966|NCT01154452|448586737|FG003|Phase Ib|Not Treated|0|||
124716967|NCT01154452|448586734|FG000|Phase Ib|Adverse Event|2|||
124716968|NCT01154452|448586735|FG001|Phase Ib|Adverse Event|1|||
124716969|NCT01154452|448586736|FG002|Phase Ib|Adverse Event|0|||
124716970|NCT01154452|448586737|FG003|Phase Ib|Adverse Event|0|||
124716971|NCT01154452|448586734|FG000|Phase II|Withdrawal by Subject|0|||
124716972|NCT01154452|448586735|FG001|Phase II|Withdrawal by Subject|0|||
124716973|NCT01154452|448586736|FG002|Phase II|Withdrawal by Subject|1|||
124473188|NCT00440726|447690753|FG000|Phase 1|Physician Decision|1|||
124473189|NCT00440726|447690754|FG001|Phase 1|Physician Decision|0|||
124473190|NCT00440726|447690755|FG002|Phase 1|Physician Decision|0|||
124473191|NCT00440726|447690753|FG000|Phase 2|Death|0|||
124554597|NCT00700310|447989068|FG000|Overall Study|Randomized, Not Treated|2|||
124716974|NCT01154452|448586737|FG003|Phase II|Withdrawal by Subject|2|||
124716975|NCT01154452|448586734|FG000|Phase II|Adverse Event|0|||
124716976|NCT01154452|448586735|FG001|Phase II|Adverse Event|0|||
124716977|NCT01154452|448586736|FG002|Phase II|Adverse Event|4|||
124716978|NCT01154452|448586737|FG003|Phase II|Adverse Event|4|||
124716979|NCT03381287|448586738|FG000|Overall Study|Withdrawal by Subject|0|||
124716980|NCT03381287|448586739|FG001|Overall Study|Withdrawal by Subject|1|||
124473192|NCT00440726|447690754|FG001|Phase 2|Death|0|||
124716981|NCT03381287|448586740|FG002|Overall Study|Withdrawal by Subject|0|||
124716982|NCT03381287|448586741|FG003|Overall Study|Withdrawal by Subject|0|||
124473193|NCT00440726|447690755|FG002|Phase 2|Death|1|||
124473194|NCT00440726|447690753|FG000|Phase 2|Adverse Event|0|||
124473195|NCT00440726|447690754|FG001|Phase 2|Adverse Event|0|||
124473196|NCT00440726|447690755|FG002|Phase 2|Adverse Event|1|||
124473197|NCT03370770|447690756|FG000|Overall Study|Patient was followed in another hospital center|1|||
124473198|NCT03370770|447690756|FG000|Overall Study|Progressive Disease|98|||
124473199|NCT03370770|447690756|FG000|Overall Study|Adverse Event|2|||
124473200|NCT03370770|447690756|FG000|Overall Study|Death|5|||
124473201|NCT00234039|447690757|FG000|Overall Study|Adverse Event|2|||
124473202|NCT00234039|447690757|FG000|Overall Study|Progression/relapse|34|||
124473203|NCT00234039|447690757|FG000|Overall Study|Other - Not Protocol Specified|3|||
124473204|NCT00234039|447690757|FG000|Overall Study|Ineligible|9|||
124473205|NCT00234039|447690757|FG000|Overall Study|No Protocol Treatment Received|2|||
124473206|NCT00110019|447690760|FG000|Overall Study|Lack of Efficacy|253|||
124473207|NCT00110019|447690761|FG001|Overall Study|Lack of Efficacy|285|||
124473208|NCT00110019|447690760|FG000|Overall Study|Adverse Event|61|||
124473209|NCT00110019|447690761|FG001|Overall Study|Adverse Event|40|||
124473210|NCT00110019|447690760|FG000|Overall Study|Death|13|||
124473211|NCT00110019|447690761|FG001|Overall Study|Death|15|||
124473212|NCT00110019|447690760|FG000|Overall Study|Withdrawal by Subject|21|||
124473213|NCT00110019|447690761|FG001|Overall Study|Withdrawal by Subject|9|||
124473214|NCT00110019|447690760|FG000|Overall Study|alternative therapy|5|||
124473215|NCT00110019|447690761|FG001|Overall Study|alternative therapy|1|||
124473216|NCT00110019|447690760|FG000|Overall Study|complicating disease|1|||
124473217|NCT00110019|447690761|FG001|Overall Study|complicating disease|1|||
124473218|NCT00110019|447690760|FG000|Overall Study|symptom deterioration|13|||
124473219|NCT00110019|447690761|FG001|Overall Study|symptom deterioration|16|||
124473220|NCT00110019|447690760|FG000|Overall Study|Not start protocol therapy|17|||
124473221|NCT00110019|447690761|FG001|Overall Study|Not start protocol therapy|16|||
124473222|NCT00110019|447690760|FG000|Overall Study|other reasons|22|||
124473223|NCT00110019|447690761|FG001|Overall Study|other reasons|30|||
124473224|NCT04426695|447690764|FG000|Overall Study|Death|2|||
124473225|NCT04426695|447690765|FG001|Overall Study|Death|0|||
124473226|NCT04426695|447690766|FG002|Overall Study|Death|1|||
124473227|NCT04426695|447690767|FG003|Overall Study|Death|27|||
124473228|NCT04426695|447690768|FG004|Overall Study|Death|25|||
124473229|NCT04426695|447690769|FG005|Overall Study|Death|21|||
124473230|NCT04426695|447690770|FG006|Overall Study|Death|42|||
124473231|NCT04426695|447690771|FG007|Overall Study|Death|23|||
124473232|NCT04426695|447690772|FG008|Overall Study|Death|37|||
124473233|NCT04426695|447690773|FG009|Overall Study|Death|14|||
124473234|NCT04426695|447690774|FG010|Overall Study|Death|8|||
124473235|NCT04426695|447690775|FG011|Overall Study|Death|7|||
124716983|NCT03381287|448586738|FG000|Overall Study|Adverse Event|0|||
124716984|NCT03381287|448586739|FG001|Overall Study|Adverse Event|0|||
124716985|NCT03381287|448586740|FG002|Overall Study|Adverse Event|0|||
124716986|NCT03381287|448586741|FG003|Overall Study|Adverse Event|1|||
124716987|NCT03381287|448586738|FG000|Overall Study|Physician Decision|0|||
124716988|NCT03381287|448586739|FG001|Overall Study|Physician Decision|0|||
124716989|NCT03381287|448586740|FG002|Overall Study|Physician Decision|0|||
124716990|NCT03381287|448586741|FG003|Overall Study|Physician Decision|1|||
124716991|NCT01265992|448586742|FG000|Overall Study|Lost to Follow-up|1|||
124716992|NCT01265992|448586742|FG000|Overall Study|Withdrawal by Subject|1|||
124716993|NCT01265992|448586742|FG000|Overall Study|Adverse Event|1|||
124716994|NCT01265992|448586742|FG000|Overall Study|Administrative reasons|2|||
124716995|NCT01265992|448586742|FG000|Overall Study|Stopped treatment|3|||
124716996|NCT01265992|448586742|FG000|Overall Study|Did not receive treatment|1|||
124716997|NCT01102491|448586743|FG000|Overall Study|Protocol Violation|11|||
124716998|NCT01102491|448586744|FG001|Overall Study|Protocol Violation|12|||
124716999|NCT00566982|448588121|FG000|Overall Study|Adverse Event|6|||
124717000|NCT00566982|448588122|FG001|Overall Study|Adverse Event|48|||
124717001|NCT00566982|448588121|FG000|Overall Study|Withdrawal by Subject|1|||
124717002|NCT00566982|448588122|FG001|Overall Study|Withdrawal by Subject|14|||
124717003|NCT00566982|448588121|FG000|Overall Study|Protocol Violation|1|||
124717004|NCT00566982|448588122|FG001|Overall Study|Protocol Violation|4|||
124717005|NCT00566982|448588121|FG000|Overall Study|Lost to Follow-up|0|||
124717006|NCT00566982|448588122|FG001|Overall Study|Lost to Follow-up|1|||
124717007|NCT00566982|448588121|FG000|Overall Study|Other-family problems & doctor's request|0|||
124717008|NCT00566982|448588122|FG001|Overall Study|Other-family problems & doctor's request|2|||
124717009|NCT02197572|448588125|FG000|Overall Study|Progressive Disease|28|||
124717010|NCT02197572|448588125|FG000|Overall Study|Withdrawal by Subject|9|||
124717011|NCT02197572|448588125|FG000|Overall Study|Adverse Event|3|||
124473236|NCT04426695|447690776|FG012|Overall Study|Death|13|||
124473237|NCT04426695|447690777|FG013|Overall Study|Death|25|||
124473238|NCT04426695|447690778|FG014|Overall Study|Death|19|||
124473239|NCT04426695|447690779|FG015|Overall Study|Death|7|||
124473240|NCT04426695|447690780|FG016|Overall Study|Death|8|||
124473241|NCT04426695|447690781|FG017|Overall Study|Death|4|||
124473242|NCT04426695|447690764|FG000|Overall Study|Lost to Follow-up|2|||
124473243|NCT04426695|447690765|FG001|Overall Study|Lost to Follow-up|4|||
124717012|NCT02197572|448588125|FG000|Overall Study|Reason Not Specified|4|||
124717013|NCT03783962|448588126|FG000|Overall Study|Lost to Follow-up|3|||
124717014|NCT03783962|448588127|FG001|Overall Study|Lost to Follow-up|6|||
124717015|NCT03783962|448588126|FG000|Overall Study|Protocol Violation|0|||
124771349|NCT03312634|448794424|FG000|Overall Study|Death|0|||
124771350|NCT03312634|448794425|FG001|Overall Study|Death|1|||
124771351|NCT03312634|448794424|FG000|Overall Study|Non-compliance|0|||
124771352|NCT03312634|448794425|FG001|Overall Study|Non-compliance|2|||
124771353|NCT03312634|448794424|FG000|Overall Study|Lost to Follow-up|0|||
124771354|NCT03312634|448794425|FG001|Overall Study|Lost to Follow-up|1|||
124771355|NCT03312634|448794424|FG000|Overall Study|Enrolled into non-interventional study|0|||
124771356|NCT03312634|448794425|FG001|Overall Study|Enrolled into non-interventional study|5|||
124771357|NCT03312634|448794424|FG000|Overall Study|Worsening clinical condition|0|||
124771358|NCT03312634|448794425|FG001|Overall Study|Worsening clinical condition|1|||
124771359|NCT03312634|448794424|FG000|Overall Study|Participant did not want to travel|0|||
124771360|NCT03312634|448794425|FG001|Overall Study|Participant did not want to travel|1|||
124771361|NCT03312634|448794424|FG000|Overall Study|Physician Decision|1|||
124771362|NCT03312634|448794425|FG001|Overall Study|Physician Decision|0|||
124771363|NCT03312634|448794424|FG000|Overall Study|Other|13|||
124771364|NCT03312634|448794425|FG001|Overall Study|Other|0|||
124771365|NCT00906204|448794426|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
124771366|NCT00906204|448794427|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
124771367|NCT00906204|448794426|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
124771368|NCT00906204|448794427|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
124771369|NCT00906204|448794426|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
124554598|NCT00700310|447989069|FG001|Overall Study|Randomized, Not Treated|0|||
124554599|NCT00700310|447989070|FG002|Overall Study|Randomized, Not Treated|2|||
124717016|NCT03783962|448588127|FG001|Overall Study|Protocol Violation|1|||
124717017|NCT03458325|448588128|FG000|Overall Study|Withdrawal by Subject|1|||
124717018|NCT00833469|448588129|FG000|Overall Study|Withdrawal by Subject|1|||
124717019|NCT00833469|448588129|FG000|Overall Study|Lost to Follow-up|1|||
124717020|NCT01665911|448588130|FG000|Overall Study|Protocol Violation|4|||
124717021|NCT01665911|448588130|FG000|Overall Study|Withdrawal by Subject|1|||
124717022|NCT01665911|448588130|FG000|Overall Study|Adverse Event|1|||
124717023|NCT01724216|448588135|FG000|Overall Study|Scan was not completed|1|||
124717024|NCT00175916|448588136|FG000|Overall Study|Death|19|||
124717025|NCT00175916|448588136|FG000|Overall Study|Adverse Event|81|||
124717026|NCT00175916|448588136|FG000|Overall Study|Lack of Efficacy|354|||
124717027|NCT00175916|448588136|FG000|Overall Study|Lost to Follow-up|17|||
124717028|NCT00175916|448588136|FG000|Overall Study|Subject Choice|98|||
124717029|NCT00175916|448588136|FG000|Overall Study|Lack of compliance|8|||
124717030|NCT00175916|448588136|FG000|Overall Study|Patient cannot record seizures|1|||
124717031|NCT00175916|448588136|FG000|Overall Study|Sponsor decision|17|||
124717032|NCT00175916|448588136|FG000|Overall Study|Vigabatrin intake|1|||
124717033|NCT00175916|448588136|FG000|Overall Study|Suicidal behaviour|1|||
124717034|NCT00175916|448588136|FG000|Overall Study|Withdrawal by Subject|1|||
124717035|NCT00175916|448588136|FG000|Overall Study|Seizure - free|4|||
124717036|NCT00175916|448588136|FG000|Overall Study|Administrative reason|1|||
124717037|NCT00175916|448588136|FG000|Overall Study|Pregnancy|1|||
124717038|NCT00175916|448588136|FG000|Overall Study|Patient's request|2|||
124717039|NCT00175916|448588136|FG000|Overall Study|Treating physiciant's choice|1|||
124717040|NCT00175916|448588136|FG000|Overall Study|Moved overseas|1|||
124717041|NCT00175916|448588136|FG000|Overall Study|Loss of job and economic burden|1|||
124717042|NCT00175916|448588136|FG000|Overall Study|Site was closed|9|||
124717043|NCT00175916|448588136|FG000|Overall Study|Patient went to prison|1|||
124717044|NCT03650413|448588137|FG000|Overall Study|Adverse Event|1|||
124717045|NCT03650413|448588137|FG000|Overall Study|Lack of Efficacy|17|||
124717046|NCT03650413|448588137|FG000|Overall Study|Other|9|||
124717047|NCT03650413|448588137|FG000|Overall Study|Physician Decision|2|||
124717048|NCT03650413|448588137|FG000|Overall Study|Study Terminated By Sponsor|16|||
124717049|NCT03650413|448588137|FG000|Overall Study|Withdrawal by Subject|16|||
124717050|NCT00564733|448588138|FG000|Overall Study|Withdrawal by Subject|4|||
124717051|NCT00564733|448588138|FG000|Overall Study|Ineligible|5|||
124717052|NCT01014767|448588139|FG000|Overall Study|PI left institution, data unavailable|12|||
124717053|NCT01014767|448588140|FG001|Overall Study|PI left institution, data unavailable|1|||
124717054|NCT01014767|448588141|FG002|Overall Study|PI left institution, data unavailable|4|||
124717055|NCT01014767|448588142|FG003|Overall Study|PI left institution, data unavailable|1|||
124771370|NCT00906204|448794427|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
124771371|NCT00906204|448794426|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
124771372|NCT00906204|448794427|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
124771373|NCT00906204|448794426|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
124717056|NCT00310375|448588147|FG000|Primary Reporting Phase|Adverse Event|28|||
124717057|NCT00310375|448588148|FG001|Primary Reporting Phase|Adverse Event|22|||
124717058|NCT00310375|448588149|FG002|Primary Reporting Phase|Adverse Event|0|||
124717059|NCT00310375|448588147|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
124717060|NCT00310375|448588148|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
124717061|NCT00310375|448588149|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
124717062|NCT00310375|448588147|FG000|Primary Reporting Phase|Pregnancy|2|||
124717063|NCT00310375|448588148|FG001|Primary Reporting Phase|Pregnancy|2|||
124717064|NCT00310375|448588149|FG002|Primary Reporting Phase|Pregnancy|0|||
124717065|NCT00310375|448588147|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
124717066|NCT00310375|448588148|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
124717067|NCT00310375|448588149|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
124717068|NCT00310375|448588147|FG000|Primary Reporting Phase|Protocol Violation|8|||
124717069|NCT00310375|448588148|FG001|Primary Reporting Phase|Protocol Violation|5|||
124717070|NCT00310375|448588149|FG002|Primary Reporting Phase|Protocol Violation|0|||
124771374|NCT00906204|448794427|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
124771375|NCT04328077|448794428|FG000|Overall Study|Lost to Follow-up|0|||
124771376|NCT04328077|448794429|FG001|Overall Study|Lost to Follow-up|1|||
124771377|NCT04328077|448794430|FG002|Overall Study|Lost to Follow-up|0|||
124771378|NCT04328077|448794431|FG003|Overall Study|Lost to Follow-up|0|||
124771379|NCT04328077|448794428|FG000|Overall Study|Withdrawal by Subject|0|||
124771380|NCT04328077|448794429|FG001|Overall Study|Withdrawal by Subject|1|||
124771381|NCT04328077|448794430|FG002|Overall Study|Withdrawal by Subject|1|||
124771382|NCT04328077|448794431|FG003|Overall Study|Withdrawal by Subject|3|||
124771383|NCT05291520|448794432|FG000|Overall Study|Lost to Follow-up|0|||
124771384|NCT05291520|448794433|FG001|Overall Study|Lost to Follow-up|0|||
124771385|NCT05291520|448794434|FG002|Overall Study|Lost to Follow-up|1|||
124771386|NCT01347112|448794435|FG000|Overall Study|Withdrawal by Subject|1|||
124771387|NCT01347112|448794436|FG001|Overall Study|Withdrawal by Subject|7|||
124771388|NCT01347112|448794435|FG000|Overall Study|Lost to Follow-up|3|||
124771389|NCT01347112|448794436|FG001|Overall Study|Lost to Follow-up|5|||
124771390|NCT00696072|448794441|FG000|Overall Study|continuing active treatment|10|||
124771391|NCT00696072|448794442|FG001|Overall Study|continuing active treatment|13|||
124771392|NCT00696072|448794441|FG000|Overall Study|Adverse Event|10|||
124771393|NCT00696072|448794442|FG001|Overall Study|Adverse Event|6|||
124771394|NCT00696072|448794441|FG000|Overall Study|Patient Request|3|||
124771395|NCT00696072|448794442|FG001|Overall Study|Patient Request|7|||
124771396|NCT00696072|448794441|FG000|Overall Study|Investigator Request|1|||
124771397|NCT00696072|448794442|FG001|Overall Study|Investigator Request|4|||
124771398|NCT00696072|448794441|FG000|Overall Study|Sponsor Request|0|||
124771399|NCT00696072|448794442|FG001|Overall Study|Sponsor Request|1|||
124771400|NCT00696072|448794441|FG000|Overall Study|Disease Progression|32|||
124771401|NCT00696072|448794442|FG001|Overall Study|Disease Progression|30|||
124771402|NCT00696072|448794441|FG000|Overall Study|Non-specified|1|||
124771403|NCT00696072|448794442|FG001|Overall Study|Non-specified|2|||
124771404|NCT01597596|448794443|FG000|Overall Study|Study terminated by sponsor|1|||
124771405|NCT01597596|448794444|FG001|Overall Study|Study terminated by sponsor|0|||
124771406|NCT01597596|448794443|FG000|Overall Study|Physician Decision|0|||
124771407|NCT01597596|448794444|FG001|Overall Study|Physician Decision|1|||
124771408|NCT00313014|448794465|FG000|Overall Study|Withdrawal by Subject|11|||
124771409|NCT00313014|448794466|FG001|Overall Study|Withdrawal by Subject|7|||
124771410|NCT00313014|448794467|FG002|Overall Study|Withdrawal by Subject|5|||
124771411|NCT00313014|448794465|FG000|Overall Study|Adverse Event|14|||
124771412|NCT00313014|448794466|FG001|Overall Study|Adverse Event|29|||
124771413|NCT00313014|448794467|FG002|Overall Study|Adverse Event|16|||
124771414|NCT00313014|448794465|FG000|Overall Study|Lost to Follow-up|7|||
124771415|NCT00313014|448794466|FG001|Overall Study|Lost to Follow-up|6|||
124771416|NCT00313014|448794467|FG002|Overall Study|Lost to Follow-up|10|||
124771417|NCT00313014|448794465|FG000|Overall Study|Administrative|9|||
124771418|NCT00313014|448794466|FG001|Overall Study|Administrative|6|||
124771419|NCT00313014|448794467|FG002|Overall Study|Administrative|14|||
124771420|NCT00313014|448794465|FG000|Overall Study|Lack of Efficacy|52|||
124771421|NCT00313014|448794466|FG001|Overall Study|Lack of Efficacy|25|||
124771422|NCT00313014|448794467|FG002|Overall Study|Lack of Efficacy|16|||
124771423|NCT01054885|448794468|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
124771424|NCT01054885|448794469|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
124771425|NCT01054885|448794470|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
124771426|NCT01054885|448794471|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
124771427|NCT01054885|448794472|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
124771428|NCT01054885|448794473|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
124771429|NCT01054885|448794474|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
124771430|NCT01054885|448794468|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
124771431|NCT01054885|448794469|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
124771432|NCT01054885|448794470|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
124717071|NCT00310375|448588147|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
124717072|NCT00310375|448588148|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
124717073|NCT00310375|448588149|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
124717074|NCT00310375|448588147|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
124717075|NCT00310375|448588148|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
124717076|NCT00310375|448588149|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
124717077|NCT00310375|448588147|FG000|Primary Reporting Phase|Physician Decision|5|||
124717078|NCT00310375|448588148|FG001|Primary Reporting Phase|Physician Decision|3|||
124717079|NCT00310375|448588149|FG002|Primary Reporting Phase|Physician Decision|0|||
124717080|NCT00310375|448588147|FG000|Primary Reporting Phase|Request of the sponsor|2|||
124717081|NCT00310375|448588148|FG001|Primary Reporting Phase|Request of the sponsor|2|||
124717082|NCT00310375|448588149|FG002|Primary Reporting Phase|Request of the sponsor|0|||
124717083|NCT00310375|448588147|FG000|Primary Reporting Phase|Failed to return|1|||
124717084|NCT00310375|448588148|FG001|Primary Reporting Phase|Failed to return|3|||
124717085|NCT00310375|448588149|FG002|Primary Reporting Phase|Failed to return|0|||
124717086|NCT00310375|448588147|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
124717087|NCT00310375|448588148|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
124717088|NCT00310375|448588149|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
124717089|NCT00310375|448588147|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
124717090|NCT00310375|448588148|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
124717091|NCT00310375|448588149|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
124717092|NCT00310375|448588147|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
124717093|NCT00310375|448588148|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
124717094|NCT00310375|448588149|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
124717095|NCT00310375|448588147|FG000|Primary Reporting Phase|Site closure|3|||
124717096|NCT00310375|448588148|FG001|Primary Reporting Phase|Site closure|0|||
124717097|NCT00310375|448588149|FG002|Primary Reporting Phase|Site closure|0|||
124717098|NCT00310375|448588147|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
124717099|NCT00310375|448588148|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
124717100|NCT00310375|448588149|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
124717101|NCT00310375|448588147|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
124717102|NCT00310375|448588148|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
124717103|NCT00310375|448588149|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
124717104|NCT00310375|448588147|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
124717105|NCT00310375|448588148|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
124717106|NCT00310375|448588149|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
124717107|NCT00310375|448588147|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
124717108|NCT00310375|448588148|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
124717109|NCT00310375|448588149|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
124717110|NCT00573391|448588150|FG000|Overall Study|study stopped|2|||
124717111|NCT00573391|448588151|FG001|Overall Study|study stopped|2|||
124717112|NCT00573391|448588150|FG000|Overall Study|Death|1|||
124717113|NCT00573391|448588151|FG001|Overall Study|Death|0|||
124717114|NCT00131352|448588152|FG000|Initial Treatment Period|Adverse Event|1|||
124717115|NCT00131352|448588153|FG001|Initial Treatment Period|Adverse Event|3|||
124717116|NCT00131352|448588152|FG000|Initial Treatment Period|Non-compliant|1|||
124717117|NCT00131352|448588153|FG001|Initial Treatment Period|Non-compliant|2|||
124717118|NCT00131352|448588152|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
124717119|NCT00131352|448588153|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
124717120|NCT00131352|448588152|FG000|Initial Treatment Period|Lack of Efficacy|6|||
124717121|NCT00131352|448588153|FG001|Initial Treatment Period|Lack of Efficacy|4|||
124717122|NCT00131352|448588152|FG000|Initial Treatment Period|Other|0|||
124717123|NCT00131352|448588153|FG001|Initial Treatment Period|Other|2|||
124771433|NCT01054885|448794471|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
124717124|NCT00131352|448588152|FG000|Repeat Treatment Period|Adverse Event|1|||
124717125|NCT00131352|448588153|FG001|Repeat Treatment Period|Adverse Event|0|||
124717126|NCT00131352|448588152|FG000|Repeat Treatment Period|Other|1|||
124554600|NCT00700310|447989071|FG003|Overall Study|Randomized, Not Treated|2|||
124554601|NCT03053622|447989077|FG000|Overall Study|Lost to Follow-up|0|||
124771434|NCT01054885|448794472|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
124771435|NCT01054885|448794473|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
124771436|NCT01054885|448794474|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
124771437|NCT01054885|448794468|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
124771438|NCT01054885|448794469|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
124771439|NCT01054885|448794470|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
124771440|NCT01054885|448794471|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
124771441|NCT01054885|448794472|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
124771442|NCT01054885|448794473|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
124771443|NCT01054885|448794474|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
124771444|NCT01054885|448794468|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
124771445|NCT01054885|448794469|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
124771446|NCT01054885|448794470|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
124771447|NCT01054885|448794471|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
124771448|NCT01054885|448794472|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
124771449|NCT01054885|448794473|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
124771450|NCT01054885|448794474|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
124771451|NCT01054885|448794468|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
124771452|NCT01054885|448794469|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
124771453|NCT01054885|448794470|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
124771454|NCT01054885|448794471|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
124771455|NCT01054885|448794472|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
124771456|NCT01054885|448794473|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
124771457|NCT01054885|448794474|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
124771458|NCT01054885|448794468|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
124771459|NCT01054885|448794469|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
124771460|NCT01054885|448794470|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
124771461|NCT01054885|448794471|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
124771462|NCT01054885|448794472|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
124771463|NCT01054885|448794473|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
124771464|NCT01054885|448794474|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
124771465|NCT01054885|448794468|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
124771466|NCT01054885|448794469|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
124771467|NCT01054885|448794470|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
124771468|NCT01054885|448794471|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
124771469|NCT01054885|448794472|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
124771470|NCT01054885|448794473|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
124771471|NCT01054885|448794474|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
124771472|NCT01054885|448794468|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
124771473|NCT01054885|448794469|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
124771474|NCT01054885|448794470|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
124771475|NCT01054885|448794471|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
124771476|NCT01054885|448794472|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
124473244|NCT04426695|447690766|FG002|Overall Study|Lost to Follow-up|1|||
124473245|NCT04426695|447690767|FG003|Overall Study|Lost to Follow-up|19|||
124473246|NCT04426695|447690768|FG004|Overall Study|Lost to Follow-up|10|||
124473247|NCT04426695|447690769|FG005|Overall Study|Lost to Follow-up|14|||
124473248|NCT04426695|447690770|FG006|Overall Study|Lost to Follow-up|5|||
124473249|NCT04426695|447690771|FG007|Overall Study|Lost to Follow-up|14|||
124473250|NCT04426695|447690772|FG008|Overall Study|Lost to Follow-up|10|||
124473251|NCT04426695|447690773|FG009|Overall Study|Lost to Follow-up|11|||
124473252|NCT04426695|447690774|FG010|Overall Study|Lost to Follow-up|12|||
124473253|NCT04426695|447690775|FG011|Overall Study|Lost to Follow-up|6|||
124473254|NCT04426695|447690776|FG012|Overall Study|Lost to Follow-up|2|||
124473255|NCT04426695|447690777|FG013|Overall Study|Lost to Follow-up|2|||
124473256|NCT04426695|447690778|FG014|Overall Study|Lost to Follow-up|2|||
124473257|NCT04426695|447690779|FG015|Overall Study|Lost to Follow-up|0|||
124554602|NCT03053622|447989078|FG001|Overall Study|Lost to Follow-up|0|||
124473258|NCT04426695|447690780|FG016|Overall Study|Lost to Follow-up|0|||
124473259|NCT04426695|447690781|FG017|Overall Study|Lost to Follow-up|0|||
124473260|NCT04426695|447690764|FG000|Overall Study|Participant Decision|1|||
124473261|NCT04426695|447690765|FG001|Overall Study|Participant Decision|2|||
124473262|NCT04426695|447690766|FG002|Overall Study|Participant Decision|2|||
124473263|NCT04426695|447690767|FG003|Overall Study|Participant Decision|12|||
124717127|NCT00131352|448588153|FG001|Repeat Treatment Period|Other|0|||
124717128|NCT01194219|448588154|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
124717129|NCT01194219|448588155|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
124717130|NCT01194219|448588156|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
124717131|NCT01194219|448588157|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
124717132|NCT01194219|448588158|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
124717133|NCT01194219|448588159|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
124717134|NCT01194219|448588160|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
124717135|NCT01194219|448588161|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
124717136|NCT01194219|448588162|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
124717137|NCT01194219|448588163|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
124717138|NCT01194219|448588154|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
124717139|NCT01194219|448588155|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
124717140|NCT01194219|448588156|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
124717141|NCT01194219|448588157|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
124717142|NCT01194219|448588158|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
124717143|NCT01194219|448588159|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
124717144|NCT01194219|448588160|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
124717145|NCT01194219|448588161|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
124717146|NCT01194219|448588162|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
124717147|NCT01194219|448588163|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
124717148|NCT01194219|448588154|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
124717149|NCT01194219|448588155|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
124717150|NCT01194219|448588156|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
124717151|NCT01194219|448588157|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
124717152|NCT01194219|448588158|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
124717153|NCT01194219|448588159|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
124717154|NCT01194219|448588160|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
124717155|NCT01194219|448588161|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
124717156|NCT01194219|448588162|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
124717157|NCT01194219|448588163|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
124717158|NCT01194219|448588154|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
124717159|NCT01194219|448588155|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
124717160|NCT01194219|448588156|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
124717161|NCT01194219|448588157|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
124717162|NCT01194219|448588158|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
124717163|NCT01194219|448588159|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
124717164|NCT01194219|448588160|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
124717165|NCT01194219|448588161|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
124717166|NCT01194219|448588162|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
124717167|NCT01194219|448588163|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
124717168|NCT01194219|448588154|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
124717169|NCT01194219|448588155|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
124717170|NCT01194219|448588156|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
124717171|NCT01194219|448588157|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
124717172|NCT01194219|448588158|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
124717173|NCT01194219|448588159|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
124717174|NCT01194219|448588160|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
124717175|NCT01194219|448588161|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
124717176|NCT01194219|448588162|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
124717177|NCT01194219|448588163|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
124717178|NCT01194219|448588154|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
124771477|NCT01054885|448794473|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
124771478|NCT01054885|448794474|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
124771479|NCT01054885|448794468|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
124771480|NCT01054885|448794469|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
124771481|NCT01054885|448794470|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
124771482|NCT01054885|448794471|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
124771483|NCT01054885|448794472|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
124771484|NCT01054885|448794473|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
124771485|NCT01054885|448794474|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
124771486|NCT01054885|448794468|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
124771487|NCT01054885|448794469|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
124771488|NCT01054885|448794470|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
124771489|NCT01054885|448794471|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
124771490|NCT01054885|448794472|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
124771491|NCT01054885|448794473|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
124771492|NCT01054885|448794474|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
124771493|NCT01054885|448794468|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
124771494|NCT01054885|448794469|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
124771495|NCT01054885|448794470|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
124771496|NCT01054885|448794471|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
124554603|NCT03053622|447989079|FG002|Overall Study|Lost to Follow-up|0|||
124554604|NCT03053622|447989080|FG003|Overall Study|Lost to Follow-up|1|||
124554605|NCT02598622|447989081|FG000|Overall Study|Withdrawal by Subject|3|||
124554606|NCT02598622|447989082|FG001|Overall Study|Withdrawal by Subject|0|||
124554607|NCT02598622|447989081|FG000|Overall Study|Physician Decision|3|||
124554608|NCT02598622|447989082|FG001|Overall Study|Physician Decision|0|||
124554609|NCT04575038|447989086|FG000|Overall Study|Withdrawal by Subject|1|||
124554610|NCT04575038|447989087|FG001|Overall Study|Withdrawal by Subject|1|||
124554611|NCT01902134|447989089|FG000|Overall Study|Adverse Event|3|||
124554612|NCT01902134|447989090|FG001|Overall Study|Adverse Event|1|||
124554613|NCT01902134|447989091|FG002|Overall Study|Adverse Event|2|||
124554614|NCT01902134|447989092|FG003|Overall Study|Adverse Event|1|||
124554615|NCT01902134|447989093|FG004|Overall Study|Adverse Event|1|||
124554616|NCT01902134|447989094|FG005|Overall Study|Adverse Event|3|||
124554617|NCT01902134|447989089|FG000|Overall Study|Lack of Efficacy|0|||
124554618|NCT01902134|447989090|FG001|Overall Study|Lack of Efficacy|0|||
124554619|NCT01902134|447989091|FG002|Overall Study|Lack of Efficacy|2|||
124554620|NCT01902134|447989092|FG003|Overall Study|Lack of Efficacy|0|||
124554621|NCT01902134|447989093|FG004|Overall Study|Lack of Efficacy|0|||
124554622|NCT01902134|447989094|FG005|Overall Study|Lack of Efficacy|1|||
124554623|NCT01902134|447989089|FG000|Overall Study|Physician Decision|0|||
124717179|NCT01194219|448588155|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
124717180|NCT01194219|448588156|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
124717181|NCT01194219|448588157|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
124554624|NCT01902134|447989090|FG001|Overall Study|Physician Decision|1|||
124717182|NCT01194219|448588158|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
124717183|NCT01194219|448588159|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
124717184|NCT01194219|448588160|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
124717185|NCT01194219|448588161|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
124717186|NCT01194219|448588162|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
124717187|NCT01194219|448588163|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
124717188|NCT01194219|448588154|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
124717189|NCT01194219|448588155|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
124717190|NCT01194219|448588156|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
124717191|NCT01194219|448588157|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
124717192|NCT01194219|448588158|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
124717193|NCT01194219|448588159|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
124717194|NCT01194219|448588160|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
124717195|NCT01194219|448588161|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
124717196|NCT01194219|448588162|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
124819522|NCT00543140|448965739|FG000|Overall Study|Conversion to different procedure|1|||
124554625|NCT01902134|447989091|FG002|Overall Study|Physician Decision|0|||
124554626|NCT01902134|447989092|FG003|Overall Study|Physician Decision|0|||
124554627|NCT01902134|447989093|FG004|Overall Study|Physician Decision|0|||
124717197|NCT01194219|448588163|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
124717198|NCT01194219|448588154|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
124717199|NCT01194219|448588155|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
124717200|NCT01194219|448588156|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
124717201|NCT01194219|448588157|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
124717202|NCT01194219|448588158|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
124717203|NCT01194219|448588159|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
124717204|NCT01194219|448588160|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
124717205|NCT01194219|448588161|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
124717206|NCT01194219|448588162|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
124717207|NCT01194219|448588163|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
124717208|NCT01194219|448588154|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
124717209|NCT01194219|448588155|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
124717210|NCT01194219|448588156|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
124717211|NCT01194219|448588157|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
124819523|NCT03902574|448965742|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
124717212|NCT01194219|448588158|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
124717213|NCT01194219|448588159|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
124717214|NCT01194219|448588160|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
124717215|NCT01194219|448588161|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
124717216|NCT01194219|448588162|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
124717217|NCT01194219|448588163|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
124717218|NCT01194219|448588154|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
124717219|NCT01194219|448588155|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
124717220|NCT01194219|448588156|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
124717221|NCT01194219|448588157|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
124717222|NCT01194219|448588158|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
124717223|NCT01194219|448588159|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
124717224|NCT01194219|448588160|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
124717225|NCT01194219|448588161|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
124717226|NCT01194219|448588162|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
124717227|NCT01194219|448588163|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
124717228|NCT01194219|448588154|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
124717229|NCT01194219|448588155|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
124717230|NCT01194219|448588156|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
124717231|NCT01194219|448588157|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
124717232|NCT01194219|448588158|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
124717233|NCT01194219|448588159|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
124717234|NCT01194219|448588160|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
124717235|NCT01194219|448588161|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
124717236|NCT01194219|448588162|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
124717237|NCT01194219|448588163|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
124717238|NCT01194219|448588154|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
124717239|NCT01194219|448588155|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
124717240|NCT01194219|448588156|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
124717241|NCT01194219|448588157|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
124717242|NCT01194219|448588158|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
124717243|NCT01194219|448588159|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
124473264|NCT04426695|447690768|FG004|Overall Study|Participant Decision|18|||
124473265|NCT04426695|447690769|FG005|Overall Study|Participant Decision|22|||
124473266|NCT04426695|447690770|FG006|Overall Study|Participant Decision|13|||
124473267|NCT04426695|447690771|FG007|Overall Study|Participant Decision|13|||
124473268|NCT04426695|447690772|FG008|Overall Study|Participant Decision|10|||
124717244|NCT01194219|448588160|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
124717245|NCT01194219|448588161|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
124717246|NCT01194219|448588162|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
124717247|NCT01194219|448588163|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
124717248|NCT01194219|448588154|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
124717249|NCT01194219|448588155|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
124717250|NCT01194219|448588156|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
124717251|NCT01194219|448588157|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
124717252|NCT01194219|448588158|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
124717253|NCT01194219|448588159|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
124717254|NCT01194219|448588160|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
124717255|NCT01194219|448588161|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
124717256|NCT01194219|448588162|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
124717257|NCT01194219|448588163|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
124717258|NCT01194219|448588154|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
124717259|NCT01194219|448588155|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
124717260|NCT01194219|448588156|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
124717261|NCT01194219|448588157|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
124717262|NCT01194219|448588158|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
124717263|NCT01194219|448588159|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
124717264|NCT01194219|448588160|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
124717265|NCT01194219|448588161|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
124717266|NCT01194219|448588162|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
124717267|NCT01194219|448588163|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
124717268|NCT01194219|448588154|FG000|Maintenance Phase Weeks16-32|Other|0|||
124717269|NCT01194219|448588155|FG001|Maintenance Phase Weeks16-32|Other|0|||
124717270|NCT01194219|448588156|FG002|Maintenance Phase Weeks16-32|Other|2|||
124717271|NCT01194219|448588157|FG003|Maintenance Phase Weeks16-32|Other|1|||
124717272|NCT01194219|448588158|FG004|Maintenance Phase Weeks16-32|Other|0|||
124717273|NCT01194219|448588159|FG005|Maintenance Phase Weeks16-32|Other|0|||
124717274|NCT01194219|448588160|FG006|Maintenance Phase Weeks16-32|Other|0|||
124717275|NCT01194219|448588161|FG007|Maintenance Phase Weeks16-32|Other|0|||
124717276|NCT01194219|448588162|FG008|Maintenance Phase Weeks16-32|Other|0|||
124717277|NCT01194219|448588163|FG009|Maintenance Phase Weeks16-32|Other|0|||
124717278|NCT01194219|448588154|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
124717279|NCT01194219|448588155|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
124717280|NCT01194219|448588156|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
124717281|NCT01194219|448588157|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
124717282|NCT01194219|448588158|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
124717283|NCT01194219|448588159|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
124717284|NCT01194219|448588160|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
124717285|NCT01194219|448588161|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
124717286|NCT01194219|448588162|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
124717287|NCT01194219|448588163|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
124717288|NCT01194219|448588154|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
124717289|NCT01194219|448588155|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
124717290|NCT01194219|448588156|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
124717291|NCT01194219|448588157|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
124717292|NCT01194219|448588158|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
124717293|NCT01194219|448588159|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
124717294|NCT01194219|448588160|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
124717295|NCT01194219|448588161|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
124717296|NCT01194219|448588162|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
124717297|NCT01194219|448588163|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
124717298|NCT01194219|448588154|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
124717299|NCT01194219|448588155|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
124717300|NCT01194219|448588156|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
124717301|NCT01194219|448588157|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
124717302|NCT01194219|448588158|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
124717303|NCT01194219|448588159|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
124717304|NCT01194219|448588160|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
124771497|NCT01054885|448794472|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
124717305|NCT01194219|448588161|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
124717306|NCT01194219|448588162|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
124771498|NCT01054885|448794473|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
124771499|NCT01054885|448794474|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
124771500|NCT01054885|448794468|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
124771501|NCT01054885|448794469|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
124771502|NCT01054885|448794470|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
124771503|NCT01054885|448794471|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
124771504|NCT01054885|448794472|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
124771505|NCT01054885|448794473|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
124771506|NCT01054885|448794474|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
124771507|NCT01054885|448794468|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
124771508|NCT01054885|448794469|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
124771509|NCT01054885|448794470|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
124771510|NCT01054885|448794471|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
124771511|NCT01054885|448794472|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
124771512|NCT01054885|448794473|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
124771513|NCT01054885|448794474|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
124771514|NCT01054885|448794468|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
124473269|NCT04426695|447690773|FG009|Overall Study|Participant Decision|15|||
124473270|NCT04426695|447690774|FG010|Overall Study|Participant Decision|16|||
124473271|NCT04426695|447690775|FG011|Overall Study|Participant Decision|17|||
124473272|NCT04426695|447690776|FG012|Overall Study|Participant Decision|2|||
124473273|NCT04426695|447690777|FG013|Overall Study|Participant Decision|1|||
124473274|NCT04426695|447690778|FG014|Overall Study|Participant Decision|2|||
124473275|NCT04426695|447690779|FG015|Overall Study|Participant Decision|0|||
124473276|NCT04426695|447690780|FG016|Overall Study|Participant Decision|0|||
124473277|NCT04426695|447690781|FG017|Overall Study|Participant Decision|0|||
124473278|NCT04426695|447690764|FG000|Overall Study|Adverse Event|0|||
124473279|NCT04426695|447690765|FG001|Overall Study|Adverse Event|0|||
124473280|NCT04426695|447690766|FG002|Overall Study|Adverse Event|0|||
124771515|NCT01054885|448794469|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
124473281|NCT04426695|447690767|FG003|Overall Study|Adverse Event|0|||
124473282|NCT04426695|447690768|FG004|Overall Study|Adverse Event|0|||
124473283|NCT04426695|447690769|FG005|Overall Study|Adverse Event|0|||
124717307|NCT01194219|448588163|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
124717308|NCT01194219|448588154|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
124717309|NCT01194219|448588155|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
124717310|NCT01194219|448588156|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
124717311|NCT01194219|448588157|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
124717312|NCT01194219|448588158|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
124717313|NCT01194219|448588159|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
124717314|NCT01194219|448588160|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
124717315|NCT01194219|448588161|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
124717316|NCT01194219|448588162|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
124717317|NCT01194219|448588163|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
124717318|NCT01194219|448588154|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
124717319|NCT01194219|448588155|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
124717320|NCT01194219|448588156|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
124717321|NCT01194219|448588157|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
124717322|NCT01194219|448588158|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
124717323|NCT01194219|448588159|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
124717324|NCT01194219|448588160|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
124717325|NCT01194219|448588161|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
124717326|NCT01194219|448588162|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
124717327|NCT01194219|448588163|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
124717328|NCT01194219|448588154|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
124717329|NCT01194219|448588155|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
124473284|NCT04426695|447690770|FG006|Overall Study|Adverse Event|0|||
124717330|NCT01194219|448588156|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
124473285|NCT04426695|447690771|FG007|Overall Study|Adverse Event|1|||
124473286|NCT04426695|447690772|FG008|Overall Study|Adverse Event|0|||
124717331|NCT01194219|448588157|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
124717332|NCT01194219|448588158|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
124717333|NCT01194219|448588159|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
124717334|NCT01194219|448588160|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
124717335|NCT01194219|448588161|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
124717336|NCT01194219|448588162|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
124473287|NCT04426695|447690773|FG009|Overall Study|Adverse Event|0|||
124473288|NCT04426695|447690774|FG010|Overall Study|Adverse Event|1|||
124473289|NCT04426695|447690775|FG011|Overall Study|Adverse Event|1|||
124473290|NCT04426695|447690776|FG012|Overall Study|Adverse Event|0|||
124473291|NCT04426695|447690777|FG013|Overall Study|Adverse Event|0|||
124473292|NCT04426695|447690778|FG014|Overall Study|Adverse Event|0|||
124473293|NCT04426695|447690779|FG015|Overall Study|Adverse Event|0|||
124473294|NCT04426695|447690780|FG016|Overall Study|Adverse Event|0|||
124473295|NCT04426695|447690781|FG017|Overall Study|Adverse Event|0|||
124473296|NCT04426695|447690764|FG000|Overall Study|Sponsor Request|0|||
124473297|NCT04426695|447690765|FG001|Overall Study|Sponsor Request|0|||
124473298|NCT04426695|447690766|FG002|Overall Study|Sponsor Request|0|||
124473299|NCT04426695|447690767|FG003|Overall Study|Sponsor Request|0|||
124473300|NCT04426695|447690768|FG004|Overall Study|Sponsor Request|0|||
124473301|NCT04426695|447690769|FG005|Overall Study|Sponsor Request|0|||
124473302|NCT04426695|447690770|FG006|Overall Study|Sponsor Request|1|||
124473303|NCT04426695|447690771|FG007|Overall Study|Sponsor Request|0|||
124473304|NCT04426695|447690772|FG008|Overall Study|Sponsor Request|0|||
124473305|NCT04426695|447690773|FG009|Overall Study|Sponsor Request|0|||
124473306|NCT04426695|447690774|FG010|Overall Study|Sponsor Request|0|||
124473307|NCT04426695|447690775|FG011|Overall Study|Sponsor Request|0|||
124473308|NCT04426695|447690776|FG012|Overall Study|Sponsor Request|0|||
124473309|NCT04426695|447690777|FG013|Overall Study|Sponsor Request|0|||
124473310|NCT04426695|447690778|FG014|Overall Study|Sponsor Request|0|||
124473311|NCT04426695|447690779|FG015|Overall Study|Sponsor Request|0|||
124473312|NCT04426695|447690780|FG016|Overall Study|Sponsor Request|0|||
124473313|NCT04426695|447690781|FG017|Overall Study|Sponsor Request|0|||
124473314|NCT04426695|447690764|FG000|Overall Study|Physician Decision|0|||
124473315|NCT04426695|447690765|FG001|Overall Study|Physician Decision|0|||
124473316|NCT04426695|447690766|FG002|Overall Study|Physician Decision|0|||
124473317|NCT04426695|447690767|FG003|Overall Study|Physician Decision|0|||
124473318|NCT04426695|447690768|FG004|Overall Study|Physician Decision|0|||
124473319|NCT04426695|447690769|FG005|Overall Study|Physician Decision|0|||
124473320|NCT04426695|447690770|FG006|Overall Study|Physician Decision|0|||
124473321|NCT04426695|447690771|FG007|Overall Study|Physician Decision|0|||
124473322|NCT04426695|447690772|FG008|Overall Study|Physician Decision|0|||
124473323|NCT04426695|447690773|FG009|Overall Study|Physician Decision|1|||
124473324|NCT04426695|447690774|FG010|Overall Study|Physician Decision|0|||
124473325|NCT04426695|447690775|FG011|Overall Study|Physician Decision|0|||
124473326|NCT04426695|447690776|FG012|Overall Study|Physician Decision|1|||
124473327|NCT04426695|447690777|FG013|Overall Study|Physician Decision|0|||
124473328|NCT04426695|447690778|FG014|Overall Study|Physician Decision|0|||
124473329|NCT04426695|447690779|FG015|Overall Study|Physician Decision|0|||
124473330|NCT04426695|447690780|FG016|Overall Study|Physician Decision|0|||
124473331|NCT04426695|447690781|FG017|Overall Study|Physician Decision|0|||
124473332|NCT04426695|447690764|FG000|Overall Study|Randomized but Never Treated|3|||
124473333|NCT04426695|447690765|FG001|Overall Study|Randomized but Never Treated|1|||
124473334|NCT04426695|447690766|FG002|Overall Study|Randomized but Never Treated|0|||
124473335|NCT04426695|447690767|FG003|Overall Study|Randomized but Never Treated|4|||
124473336|NCT04426695|447690768|FG004|Overall Study|Randomized but Never Treated|5|||
124473337|NCT04426695|447690769|FG005|Overall Study|Randomized but Never Treated|5|||
124473338|NCT04426695|447690770|FG006|Overall Study|Randomized but Never Treated|4|||
124473339|NCT04426695|447690771|FG007|Overall Study|Randomized but Never Treated|6|||
124473340|NCT04426695|447690772|FG008|Overall Study|Randomized but Never Treated|6|||
124473341|NCT04426695|447690773|FG009|Overall Study|Randomized but Never Treated|3|||
124473342|NCT04426695|447690774|FG010|Overall Study|Randomized but Never Treated|3|||
124473343|NCT04426695|447690775|FG011|Overall Study|Randomized but Never Treated|6|||
124473344|NCT04426695|447690776|FG012|Overall Study|Randomized but Never Treated|1|||
124473345|NCT04426695|447690777|FG013|Overall Study|Randomized but Never Treated|2|||
124473346|NCT04426695|447690778|FG014|Overall Study|Randomized but Never Treated|0|||
124473347|NCT04426695|447690779|FG015|Overall Study|Randomized but Never Treated|0|||
124473348|NCT04426695|447690780|FG016|Overall Study|Randomized but Never Treated|0|||
124473349|NCT04426695|447690781|FG017|Overall Study|Randomized but Never Treated|0|||
124473350|NCT04303000|447690782|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
124473351|NCT04303000|447690783|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
124473352|NCT04303000|447690784|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
124473353|NCT00559273|447690785|FG000|Correction Period (20 Weeks)|Death|3|||
124473354|NCT00559273|447690786|FG001|Correction Period (20 Weeks)|Death|4|||
124473355|NCT00559273|447690785|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
124473356|NCT00559273|447690786|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
124473357|NCT00559273|447690785|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
124473358|NCT00559273|447690786|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
124473359|NCT00559273|447690785|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
124473360|NCT00559273|447690786|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
124473361|NCT00559273|447690785|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
124473362|NCT00559273|447690786|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
124473363|NCT00559273|447690785|FG000|Evaluation Period (8 Weeks)|Death|1|||
124473364|NCT00559273|447690786|FG001|Evaluation Period (8 Weeks)|Death|3|||
124473365|NCT00559273|447690785|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
124473366|NCT00559273|447690786|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
124473367|NCT00559273|447690785|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
124473368|NCT00559273|447690786|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
124473369|NCT00559273|447690785|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
124473370|NCT00559273|447690786|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
124473371|NCT03653390|447690791|FG000|Overall Study|Lost to Follow-up|12|||
124473372|NCT03653390|447690792|FG001|Overall Study|Lost to Follow-up|8|||
124473373|NCT03653390|447690793|FG002|Overall Study|Lost to Follow-up|7|||
124473374|NCT03653390|447690791|FG000|Overall Study|Withdrawal by Subject|6|||
124473375|NCT03653390|447690792|FG001|Overall Study|Withdrawal by Subject|1|||
124473376|NCT03653390|447690793|FG002|Overall Study|Withdrawal by Subject|1|||
124473377|NCT03653390|447690791|FG000|Overall Study|Death|1|||
124554628|NCT01902134|447989094|FG005|Overall Study|Physician Decision|0|||
124554629|NCT01902134|447989089|FG000|Overall Study|Protocol Violation|0|||
124554630|NCT01902134|447989090|FG001|Overall Study|Protocol Violation|0|||
124554631|NCT01902134|447989091|FG002|Overall Study|Protocol Violation|0|||
124554632|NCT01902134|447989092|FG003|Overall Study|Protocol Violation|0|||
124554633|NCT01902134|447989093|FG004|Overall Study|Protocol Violation|0|||
124554634|NCT01902134|447989094|FG005|Overall Study|Protocol Violation|1|||
124554635|NCT01902134|447989089|FG000|Overall Study|Withdrawal by Subject|4|||
124554636|NCT01902134|447989090|FG001|Overall Study|Withdrawal by Subject|8|||
124554637|NCT01902134|447989091|FG002|Overall Study|Withdrawal by Subject|9|||
124554638|NCT01902134|447989092|FG003|Overall Study|Withdrawal by Subject|1|||
124554639|NCT01902134|447989093|FG004|Overall Study|Withdrawal by Subject|5|||
124554640|NCT01902134|447989094|FG005|Overall Study|Withdrawal by Subject|4|||
124554641|NCT01902134|447989089|FG000|Overall Study|no compliance|1|||
124554642|NCT01902134|447989090|FG001|Overall Study|no compliance|0|||
124554643|NCT01902134|447989091|FG002|Overall Study|no compliance|0|||
124554644|NCT01902134|447989092|FG003|Overall Study|no compliance|0|||
124554645|NCT01902134|447989093|FG004|Overall Study|no compliance|0|||
124554646|NCT01902134|447989094|FG005|Overall Study|no compliance|0|||
124554647|NCT01902134|447989089|FG000|Overall Study|Other|0|||
124554648|NCT01902134|447989090|FG001|Overall Study|Other|1|||
124554649|NCT01902134|447989091|FG002|Overall Study|Other|2|||
124554650|NCT01902134|447989092|FG003|Overall Study|Other|0|||
124554651|NCT01902134|447989093|FG004|Overall Study|Other|1|||
124554652|NCT01902134|447989094|FG005|Overall Study|Other|0|||
124554653|NCT00305110|447989095|FG000|Overall Study|Missing data|29|||
124554654|NCT00678379|447989096|FG000|Overall Study|Injection performed after tonsillectomy|2|||
124554655|NCT00678379|447989097|FG001|Overall Study|Injection performed after tonsillectomy|0|||
124554656|NCT00678379|447989098|FG002|Overall Study|Injection performed after tonsillectomy|1|||
124554657|NCT00678379|447989096|FG000|Overall Study|Incomplete Data|4|||
124554658|NCT00678379|447989097|FG001|Overall Study|Incomplete Data|3|||
124554659|NCT00678379|447989098|FG002|Overall Study|Incomplete Data|3|||
124554660|NCT01835470|447989099|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
124554661|NCT01835470|447989099|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
124554662|NCT04335110|447989117|FG000|Overall Study|Withdrawal by Subject|1|||
124554663|NCT04335110|447989118|FG001|Overall Study|Withdrawal by Subject|1|||
124554664|NCT04335110|447989117|FG000|Overall Study|Death|0|||
124554665|NCT04335110|447989118|FG001|Overall Study|Death|1|||
124554666|NCT00350519|447989119|FG000|Overall Study|Death|0|||
124554667|NCT00350519|447989120|FG001|Overall Study|Death|1|||
124554668|NCT00350519|447989119|FG000|Overall Study|Physician Decision|0|||
124473378|NCT03653390|447690792|FG001|Overall Study|Death|0|||
124473379|NCT03653390|447690793|FG002|Overall Study|Death|0|||
124473380|NCT03653390|447690791|FG000|Overall Study|Paper Survey Lost|1|||
124473381|NCT03653390|447690792|FG001|Overall Study|Paper Survey Lost|0|||
124473382|NCT03653390|447690793|FG002|Overall Study|Paper Survey Lost|0|||
124717337|NCT01194219|448588163|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
124717338|NCT01194219|448588154|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
124717339|NCT01194219|448588155|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
124717340|NCT01194219|448588156|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
124717341|NCT01194219|448588157|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
124717342|NCT01194219|448588158|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
124717343|NCT01194219|448588159|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
124717344|NCT01194219|448588160|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
124717345|NCT01194219|448588161|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
124717346|NCT01194219|448588162|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
124717347|NCT01194219|448588163|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
124717348|NCT01194219|448588154|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
124717349|NCT01194219|448588155|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
124717350|NCT01194219|448588156|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
124717351|NCT01194219|448588157|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
124717352|NCT01194219|448588158|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
124717353|NCT01194219|448588159|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
124717354|NCT01194219|448588160|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
124717355|NCT01194219|448588161|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
124717356|NCT01194219|448588162|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
124717357|NCT01194219|448588163|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
124717358|NCT01194219|448588154|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
124717359|NCT01194219|448588155|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
124717360|NCT01194219|448588156|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
124717361|NCT01194219|448588157|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
124717362|NCT01194219|448588158|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
124717363|NCT01194219|448588159|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
124717364|NCT01194219|448588160|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
124717365|NCT01194219|448588161|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
124717366|NCT01194219|448588162|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
124717367|NCT01194219|448588163|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
124717368|NCT01194219|448588154|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
124717369|NCT01194219|448588155|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
124717370|NCT01194219|448588156|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
124717371|NCT01194219|448588157|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
124717372|NCT01194219|448588158|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
124717373|NCT01194219|448588159|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
124717374|NCT01194219|448588160|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
124717375|NCT01194219|448588161|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
124717376|NCT01194219|448588162|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
124717377|NCT01194219|448588163|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
124717378|NCT01194219|448588154|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
124717379|NCT01194219|448588155|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
124717380|NCT01194219|448588156|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
124717381|NCT01194219|448588157|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
124717382|NCT01194219|448588158|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
124717383|NCT01194219|448588159|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
124717384|NCT01194219|448588160|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
124717385|NCT01194219|448588161|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
124717386|NCT01194219|448588162|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
124717387|NCT01194219|448588163|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
124717388|NCT01194219|448588154|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
124717389|NCT01194219|448588155|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
124717390|NCT01194219|448588156|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
124717391|NCT01194219|448588157|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
124717392|NCT01194219|448588158|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
124717393|NCT01194219|448588159|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
124717394|NCT01194219|448588160|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
124717395|NCT01194219|448588161|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
124717396|NCT01194219|448588162|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
124717397|NCT01194219|448588163|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
124717398|NCT01194219|448588154|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
124473383|NCT01109940|447690794|FG000|Overall Study|Administrative problems|2|||
124717399|NCT01194219|448588155|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
124473384|NCT01109940|447690795|FG001|Overall Study|Administrative problems|0|||
124473385|NCT01109940|447690796|FG002|Overall Study|Administrative problems|0|||
124717400|NCT01194219|448588156|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
124717401|NCT01194219|448588157|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
124717402|NCT01194219|448588158|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
124717403|NCT01194219|448588159|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
124717404|NCT01194219|448588160|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
124717405|NCT01194219|448588161|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
124717406|NCT01194219|448588162|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
124717407|NCT01194219|448588163|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
124717408|NCT01194219|448588154|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
124717409|NCT01194219|448588155|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
124717410|NCT01194219|448588156|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
124717411|NCT01194219|448588157|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
124717412|NCT01194219|448588158|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
124717413|NCT01194219|448588159|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
124717414|NCT01194219|448588160|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
124717415|NCT01194219|448588161|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
124717416|NCT01194219|448588162|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
124717417|NCT01194219|448588163|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
124717418|NCT01194219|448588154|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
124717419|NCT01194219|448588155|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
124717420|NCT01194219|448588156|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
124717421|NCT01194219|448588157|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
124717422|NCT01194219|448588158|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
124717423|NCT01194219|448588159|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
124717424|NCT01194219|448588160|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
124717425|NCT01194219|448588161|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
124717426|NCT01194219|448588162|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
124717427|NCT01194219|448588163|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
124717428|NCT00292045|448588166|FG000|Core Study (Through Week 13)|Adverse Event|1|||
124717429|NCT00292045|448588166|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
124473386|NCT01109940|447690797|FG003|Overall Study|Administrative problems|0|||
124717430|NCT04474197|448588167|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
124717431|NCT04474197|448588168|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
124717432|NCT04474197|448588169|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
124717433|NCT04474197|448588170|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
124717434|NCT02236572|448588171|FG000|Overall Study|Withdrawal by Subject|1|||
124717435|NCT02236572|448588171|FG000|Overall Study|Protocol Violation|1|||
124717436|NCT02236572|448588171|FG000|Overall Study|Lost to Follow-up|1|||
124717437|NCT01057693|448588172|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
124717438|NCT01057693|448588173|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
124717439|NCT01057693|448588174|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
124717440|NCT01057693|448588172|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
124771516|NCT01054885|448794470|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
124473387|NCT01109940|447690794|FG000|Overall Study|Serious Adverse Event|2|||
124473388|NCT01109940|447690795|FG001|Overall Study|Serious Adverse Event|1|||
124717441|NCT01057693|448588173|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
124717442|NCT01057693|448588174|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
124717443|NCT01057693|448588172|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
124717444|NCT01057693|448588173|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
124473389|NCT01109940|447690796|FG002|Overall Study|Serious Adverse Event|0|||
124473390|NCT01109940|447690797|FG003|Overall Study|Serious Adverse Event|0|||
124473391|NCT01109940|447690794|FG000|Overall Study|Lost to Follow-up|1|||
124554669|NCT00350519|447989120|FG001|Overall Study|Physician Decision|1|||
124554670|NCT00350519|447989119|FG000|Overall Study|Protocol Violation|1|||
124717445|NCT01057693|448588174|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
124717446|NCT01057693|448588172|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
124717447|NCT01057693|448588173|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
124717448|NCT01057693|448588174|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
124717449|NCT01057693|448588172|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
124717450|NCT01057693|448588173|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
124717451|NCT01057693|448588174|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
124473392|NCT01109940|447690795|FG001|Overall Study|Lost to Follow-up|0|||
124473393|NCT01109940|447690796|FG002|Overall Study|Lost to Follow-up|0|||
124473394|NCT01109940|447690797|FG003|Overall Study|Lost to Follow-up|0|||
124473395|NCT01109940|447690794|FG000|Overall Study|Patient withdrew consent|1|||
124717452|NCT01057693|448588172|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
124717453|NCT01057693|448588173|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
124473396|NCT01109940|447690795|FG001|Overall Study|Patient withdrew consent|1|||
124473397|NCT01109940|447690796|FG002|Overall Study|Patient withdrew consent|0|||
124473398|NCT01109940|447690797|FG003|Overall Study|Patient withdrew consent|0|||
124473399|NCT01109940|447690794|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124473400|NCT01109940|447690795|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124473401|NCT01109940|447690796|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
124473402|NCT01109940|447690797|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
124473403|NCT01262976|447690798|FG000|Up to Month 2|Serious Adverse Event|0|||
124473404|NCT01262976|447690799|FG001|Up to Month 2|Serious Adverse Event|0|||
124473405|NCT01262976|447690800|FG002|Up to Month 2|Serious Adverse Event|1|||
124473406|NCT01262976|447690801|FG003|Up to Month 2|Serious Adverse Event|0|||
124473407|NCT01262976|447690802|FG004|Up to Month 2|Serious Adverse Event|0|||
124473408|NCT01262976|447690803|FG005|Up to Month 2|Serious Adverse Event|0|||
124473409|NCT01262976|447690798|FG000|Up to Month 2|Withdrawal by Subject|1|||
124473410|NCT01262976|447690799|FG001|Up to Month 2|Withdrawal by Subject|0|||
124554671|NCT00350519|447989120|FG001|Overall Study|Protocol Violation|2|||
124554672|NCT00350519|447989119|FG000|Overall Study|Withdrawal by Subject|3|||
124554673|NCT00350519|447989120|FG001|Overall Study|Withdrawal by Subject|2|||
124473411|NCT01262976|447690800|FG002|Up to Month 2|Withdrawal by Subject|0|||
124473412|NCT01262976|447690801|FG003|Up to Month 2|Withdrawal by Subject|0|||
124473413|NCT01262976|447690802|FG004|Up to Month 2|Withdrawal by Subject|0|||
124473414|NCT01262976|447690803|FG005|Up to Month 2|Withdrawal by Subject|0|||
124473415|NCT01262976|447690798|FG000|Up to Month 2|Migrated/moved from study area|0|||
124473416|NCT01262976|447690799|FG001|Up to Month 2|Migrated/moved from study area|1|||
124473417|NCT01262976|447690800|FG002|Up to Month 2|Migrated/moved from study area|0|||
124473418|NCT01262976|447690801|FG003|Up to Month 2|Migrated/moved from study area|0|||
124473419|NCT01262976|447690802|FG004|Up to Month 2|Migrated/moved from study area|1|||
124554674|NCT02595528|447989121|FG000|Overall Study|Withdrawal by Subject|1|||
124717454|NCT01057693|448588174|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
124717455|NCT01057693|448588172|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
124473420|NCT01262976|447690803|FG005|Up to Month 2|Migrated/moved from study area|1|||
124473421|NCT01262976|447690798|FG000|Up to Month 2|Lost to Follow-up|1|||
124473422|NCT01262976|447690799|FG001|Up to Month 2|Lost to Follow-up|0|||
124473423|NCT01262976|447690800|FG002|Up to Month 2|Lost to Follow-up|0|||
124473424|NCT01262976|447690801|FG003|Up to Month 2|Lost to Follow-up|1|||
124473425|NCT01262976|447690802|FG004|Up to Month 2|Lost to Follow-up|1|||
124473426|NCT01262976|447690803|FG005|Up to Month 2|Lost to Follow-up|1|||
124473427|NCT01262976|447690798|FG000|Up to Month 2|Other|1|||
124473428|NCT01262976|447690799|FG001|Up to Month 2|Other|0|||
124473429|NCT01262976|447690800|FG002|Up to Month 2|Other|0|||
124473430|NCT01262976|447690801|FG003|Up to Month 2|Other|1|||
124473431|NCT01262976|447690802|FG004|Up to Month 2|Other|0|||
124473432|NCT01262976|447690803|FG005|Up to Month 2|Other|2|||
124473433|NCT01262976|447690798|FG000|Up to Month 7|Serious Adverse Event|0|||
124473434|NCT01262976|447690799|FG001|Up to Month 7|Serious Adverse Event|0|||
124473435|NCT01262976|447690800|FG002|Up to Month 7|Serious Adverse Event|2|||
124473436|NCT01262976|447690801|FG003|Up to Month 7|Serious Adverse Event|0|||
124473437|NCT01262976|447690802|FG004|Up to Month 7|Serious Adverse Event|0|||
124473438|NCT01262976|447690803|FG005|Up to Month 7|Serious Adverse Event|0|||
124473439|NCT01262976|447690798|FG000|Up to Month 7|Withdrawal by Subject|1|||
124473440|NCT01262976|447690799|FG001|Up to Month 7|Withdrawal by Subject|0|||
124473441|NCT01262976|447690800|FG002|Up to Month 7|Withdrawal by Subject|0|||
124473442|NCT01262976|447690801|FG003|Up to Month 7|Withdrawal by Subject|0|||
124473443|NCT01262976|447690802|FG004|Up to Month 7|Withdrawal by Subject|0|||
124473444|NCT01262976|447690803|FG005|Up to Month 7|Withdrawal by Subject|0|||
124473445|NCT01262976|447690798|FG000|Up to Month 7|Migrated/moved from study area|0|||
124717456|NCT01057693|448588173|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
124717457|NCT01057693|448588174|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
124717458|NCT01057693|448588172|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
124473446|NCT01262976|447690799|FG001|Up to Month 7|Migrated/moved from study area|0|||
124473447|NCT01262976|447690800|FG002|Up to Month 7|Migrated/moved from study area|1|||
124473448|NCT01262976|447690801|FG003|Up to Month 7|Migrated/moved from study area|3|||
124473449|NCT01262976|447690802|FG004|Up to Month 7|Migrated/moved from study area|1|||
124473450|NCT01262976|447690803|FG005|Up to Month 7|Migrated/moved from study area|1|||
124473451|NCT01262976|447690798|FG000|Up to Month 7|Lost to Follow-up|1|||
124473452|NCT01262976|447690799|FG001|Up to Month 7|Lost to Follow-up|0|||
124473453|NCT01262976|447690800|FG002|Up to Month 7|Lost to Follow-up|1|||
124473454|NCT01262976|447690801|FG003|Up to Month 7|Lost to Follow-up|3|||
124473455|NCT01262976|447690802|FG004|Up to Month 7|Lost to Follow-up|1|||
124473456|NCT01262976|447690803|FG005|Up to Month 7|Lost to Follow-up|3|||
124473457|NCT01262976|447690798|FG000|Up to Month 7|Other|3|||
124473458|NCT01262976|447690799|FG001|Up to Month 7|Other|0|||
124473459|NCT01262976|447690800|FG002|Up to Month 7|Other|2|||
124473460|NCT01262976|447690801|FG003|Up to Month 7|Other|0|||
124473461|NCT01262976|447690802|FG004|Up to Month 7|Other|0|||
124473462|NCT01262976|447690803|FG005|Up to Month 7|Other|0|||
124473463|NCT01262976|447690798|FG000|Up to Year 1|Serious Adverse Event|0|||
124473464|NCT01262976|447690799|FG001|Up to Year 1|Serious Adverse Event|0|||
124473465|NCT01262976|447690800|FG002|Up to Year 1|Serious Adverse Event|2|||
124473466|NCT01262976|447690801|FG003|Up to Year 1|Serious Adverse Event|0|||
124473467|NCT01262976|447690802|FG004|Up to Year 1|Serious Adverse Event|0|||
124473468|NCT01262976|447690803|FG005|Up to Year 1|Serious Adverse Event|0|||
124473469|NCT01262976|447690798|FG000|Up to Year 1|Withdrawal by Subject|1|||
124473470|NCT01262976|447690799|FG001|Up to Year 1|Withdrawal by Subject|0|||
124473471|NCT01262976|447690800|FG002|Up to Year 1|Withdrawal by Subject|0|||
124473472|NCT01262976|447690801|FG003|Up to Year 1|Withdrawal by Subject|0|||
124473473|NCT01262976|447690802|FG004|Up to Year 1|Withdrawal by Subject|0|||
124473474|NCT01262976|447690803|FG005|Up to Year 1|Withdrawal by Subject|0|||
124473475|NCT01262976|447690798|FG000|Up to Year 1|Migrated/moved from study area|1|||
124473476|NCT01262976|447690799|FG001|Up to Year 1|Migrated/moved from study area|0|||
124473477|NCT01262976|447690800|FG002|Up to Year 1|Migrated/moved from study area|0|||
124473478|NCT01262976|447690801|FG003|Up to Year 1|Migrated/moved from study area|3|||
124473479|NCT01262976|447690802|FG004|Up to Year 1|Migrated/moved from study area|3|||
124473480|NCT01262976|447690803|FG005|Up to Year 1|Migrated/moved from study area|2|||
124473481|NCT01262976|447690798|FG000|Up to Year 1|Lost to Follow-up|4|||
124473482|NCT01262976|447690799|FG001|Up to Year 1|Lost to Follow-up|0|||
124473483|NCT01262976|447690800|FG002|Up to Year 1|Lost to Follow-up|0|||
124473484|NCT01262976|447690801|FG003|Up to Year 1|Lost to Follow-up|1|||
124473485|NCT01262976|447690802|FG004|Up to Year 1|Lost to Follow-up|6|||
124473486|NCT01262976|447690803|FG005|Up to Year 1|Lost to Follow-up|5|||
124473487|NCT01262976|447690798|FG000|Up to Year 1|Other|3|||
124473488|NCT01262976|447690799|FG001|Up to Year 1|Other|1|||
124473489|NCT01262976|447690800|FG002|Up to Year 1|Other|0|||
124473490|NCT01262976|447690801|FG003|Up to Year 1|Other|0|||
124473491|NCT01262976|447690802|FG004|Up to Year 1|Other|2|||
124473492|NCT01262976|447690803|FG005|Up to Year 1|Other|1|||
124473493|NCT01262976|447690798|FG000|Up to Year 1|Subjects with unknown completion status|0|||
124473494|NCT01262976|447690799|FG001|Up to Year 1|Subjects with unknown completion status|0|||
124473495|NCT01262976|447690800|FG002|Up to Year 1|Subjects with unknown completion status|1|||
124473496|NCT01262976|447690801|FG003|Up to Year 1|Subjects with unknown completion status|0|||
124473497|NCT01262976|447690802|FG004|Up to Year 1|Subjects with unknown completion status|0|||
124473498|NCT01262976|447690803|FG005|Up to Year 1|Subjects with unknown completion status|1|||
124473499|NCT01262976|447690798|FG000|Up to Year 2|Serious Adverse Event|0|||
124473500|NCT01262976|447690799|FG001|Up to Year 2|Serious Adverse Event|0|||
124473501|NCT01262976|447690800|FG002|Up to Year 2|Serious Adverse Event|2|||
124473502|NCT01262976|447690801|FG003|Up to Year 2|Serious Adverse Event|0|||
124473503|NCT01262976|447690802|FG004|Up to Year 2|Serious Adverse Event|0|||
124473504|NCT01262976|447690803|FG005|Up to Year 2|Serious Adverse Event|0|||
124473505|NCT01262976|447690798|FG000|Up to Year 2|Withdrawal by Subject|1|||
124473506|NCT01262976|447690799|FG001|Up to Year 2|Withdrawal by Subject|0|||
124473507|NCT01262976|447690800|FG002|Up to Year 2|Withdrawal by Subject|0|||
124473508|NCT01262976|447690801|FG003|Up to Year 2|Withdrawal by Subject|0|||
124473509|NCT01262976|447690802|FG004|Up to Year 2|Withdrawal by Subject|0|||
124473510|NCT01262976|447690803|FG005|Up to Year 2|Withdrawal by Subject|0|||
124473511|NCT01262976|447690798|FG000|Up to Year 2|Migrated/moved from study area|0|||
124473512|NCT01262976|447690799|FG001|Up to Year 2|Migrated/moved from study area|0|||
124473513|NCT01262976|447690800|FG002|Up to Year 2|Migrated/moved from study area|0|||
124473514|NCT01262976|447690801|FG003|Up to Year 2|Migrated/moved from study area|2|||
124473515|NCT01262976|447690802|FG004|Up to Year 2|Migrated/moved from study area|1|||
124473516|NCT01262976|447690803|FG005|Up to Year 2|Migrated/moved from study area|2|||
124473517|NCT01262976|447690798|FG000|Up to Year 2|Lost to Follow-up|1|||
124473518|NCT01262976|447690799|FG001|Up to Year 2|Lost to Follow-up|1|||
124717459|NCT01057693|448588173|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
124473519|NCT01262976|447690800|FG002|Up to Year 2|Lost to Follow-up|2|||
124473520|NCT01262976|447690801|FG003|Up to Year 2|Lost to Follow-up|2|||
124473521|NCT01262976|447690802|FG004|Up to Year 2|Lost to Follow-up|3|||
124473522|NCT01262976|447690803|FG005|Up to Year 2|Lost to Follow-up|3|||
124473523|NCT01262976|447690798|FG000|Up to Year 2|Subjects with unknown completion status|0|||
124554675|NCT02595528|447989122|FG001|Overall Study|Withdrawal by Subject|2|||
124554676|NCT02595528|447989123|FG002|Overall Study|Withdrawal by Subject|1|||
124554677|NCT02595528|447989124|FG003|Overall Study|Withdrawal by Subject|3|||
124554678|NCT02595528|447989121|FG000|Overall Study|Lost to Follow-up|1|||
124554679|NCT02595528|447989122|FG001|Overall Study|Lost to Follow-up|1|||
124554680|NCT02595528|447989123|FG002|Overall Study|Lost to Follow-up|0|||
124554681|NCT02595528|447989124|FG003|Overall Study|Lost to Follow-up|1|||
124554682|NCT00948025|447989125|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
124554683|NCT00948025|447989126|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
124554684|NCT00948025|447989125|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
124554685|NCT00948025|447989126|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
124554686|NCT00948025|447989125|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
124554687|NCT00948025|447989126|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
124554688|NCT01637961|447989127|FG000|Overall Study|Ineligible: wrong primary|1|||
124554689|NCT01637961|447989127|FG000|Overall Study|Ineligible: inadequate pathology|1|||
124554690|NCT03101293|447989131|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
124554691|NCT03101293|447989132|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
124717460|NCT01057693|448588174|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
124717461|NCT01057693|448588172|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
124717462|NCT01057693|448588173|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
124717463|NCT01057693|448588174|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
124717464|NCT01057693|448588172|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
124717465|NCT01057693|448588173|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
124717466|NCT01057693|448588174|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
124717467|NCT01057693|448588172|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
124717468|NCT01057693|448588173|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
124717469|NCT01057693|448588174|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
124717470|NCT01057693|448588172|FG000|Between Single-Blind and Double-Blind|Other|6|||
124717471|NCT01057693|448588173|FG001|Between Single-Blind and Double-Blind|Other|0|||
124554692|NCT03333382|447989138|FG000|Overall Study|Lost to Follow-up|1|||
124554693|NCT03333382|447989139|FG001|Overall Study|Lost to Follow-up|0|||
124554694|NCT00550420|447989140|FG000|Overall Study|Adverse Event|28|||
124554695|NCT00550420|447989140|FG000|Overall Study|Lost to Follow-up|8|||
124554696|NCT00550420|447989140|FG000|Overall Study|Protocol Violation|11|||
124554697|NCT00550420|447989140|FG000|Overall Study|Withdrawal by Subject|30|||
124554698|NCT00550420|447989140|FG000|Overall Study|Still in study at termination|206|||
124554699|NCT00550420|447989140|FG000|Overall Study|Missing|2|||
124554700|NCT00550420|447989140|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
124554701|NCT00550420|447989140|FG000|Overall Study|Investigators opinion|1|||
124554702|NCT00550420|447989140|FG000|Overall Study|Lack of curative effect|1|||
124554703|NCT00550420|447989140|FG000|Overall Study|Unethical stop of enrollment|2|||
124554704|NCT00550420|447989140|FG000|Overall Study|Caregiver's decision to withdraw|1|||
124554705|NCT00550420|447989140|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
124554706|NCT00550420|447989140|FG000|Overall Study|Exclusion criteria|1|||
124554707|NCT00550420|447989140|FG000|Overall Study|Prohibited medicine|1|||
124554708|NCT02773446|447989145|FG000|First Admission|Withdrawal by Subject|0|||
124554709|NCT02773446|447989146|FG001|First Admission|Withdrawal by Subject|0|||
124554710|NCT02773446|447989147|FG002|First Admission|Withdrawal by Subject|0|||
124554711|NCT02773446|447989148|FG003|First Admission|Withdrawal by Subject|1|||
124554712|NCT02773446|447989149|FG004|First Admission|Withdrawal by Subject|0|||
124554713|NCT02773446|447989150|FG005|First Admission|Withdrawal by Subject|0|||
124554714|NCT02773446|447989145|FG000|First Admission|Lost to Follow-up|1|||
124554715|NCT02773446|447989146|FG001|First Admission|Lost to Follow-up|0|||
124554716|NCT02773446|447989147|FG002|First Admission|Lost to Follow-up|0|||
124554717|NCT02773446|447989148|FG003|First Admission|Lost to Follow-up|0|||
124554718|NCT02773446|447989149|FG004|First Admission|Lost to Follow-up|0|||
124554719|NCT02773446|447989150|FG005|First Admission|Lost to Follow-up|0|||
124554720|NCT03237611|447989151|FG000|Overall Study|Withdrawal by Subject|1|||
124554721|NCT03237611|447989151|FG000|Overall Study|Ineligible|1|||
124554722|NCT01613131|447989152|FG000|Overall Study|Withdrawal by Subject|3|||
124473524|NCT01262976|447690799|FG001|Up to Year 2|Subjects with unknown completion status|0|||
124473525|NCT01262976|447690800|FG002|Up to Year 2|Subjects with unknown completion status|1|||
124473526|NCT01262976|447690801|FG003|Up to Year 2|Subjects with unknown completion status|0|||
124473527|NCT01262976|447690802|FG004|Up to Year 2|Subjects with unknown completion status|0|||
124473528|NCT01262976|447690803|FG005|Up to Year 2|Subjects with unknown completion status|0|||
124473529|NCT01262976|447690798|FG000|Up to Year 2|Other|3|||
124473530|NCT01262976|447690799|FG001|Up to Year 2|Other|0|||
124473531|NCT01262976|447690800|FG002|Up to Year 2|Other|0|||
124473532|NCT01262976|447690801|FG003|Up to Year 2|Other|0|||
124473533|NCT01262976|447690802|FG004|Up to Year 2|Other|0|||
124473534|NCT01262976|447690803|FG005|Up to Year 2|Other|0|||
124473535|NCT01262976|447690798|FG000|Up to Year 3|Serious Adverse Event|0|||
124473536|NCT01262976|447690799|FG001|Up to Year 3|Serious Adverse Event|0|||
124473537|NCT01262976|447690800|FG002|Up to Year 3|Serious Adverse Event|2|||
124473538|NCT01262976|447690801|FG003|Up to Year 3|Serious Adverse Event|0|||
124473539|NCT01262976|447690802|FG004|Up to Year 3|Serious Adverse Event|0|||
124473540|NCT01262976|447690803|FG005|Up to Year 3|Serious Adverse Event|0|||
124473541|NCT01262976|447690798|FG000|Up to Year 3|Withdrawal by Subject|1|||
124473542|NCT01262976|447690799|FG001|Up to Year 3|Withdrawal by Subject|0|||
124473543|NCT01262976|447690800|FG002|Up to Year 3|Withdrawal by Subject|0|||
124473544|NCT01262976|447690801|FG003|Up to Year 3|Withdrawal by Subject|0|||
124554723|NCT01613131|447989153|FG001|Overall Study|Withdrawal by Subject|5|||
124554724|NCT01814761|447989156|FG000|Overall Study|Other Reasons|1|||
124554725|NCT01814761|447989157|FG001|Overall Study|Other Reasons|10|||
124554726|NCT01814761|447989156|FG000|Overall Study|Ocular Adverse Event|6|||
124554727|NCT01814761|447989157|FG001|Overall Study|Ocular Adverse Event|15|||
124554728|NCT01814761|447989156|FG000|Overall Study|Lost to Follow-up|1|||
124554729|NCT01814761|447989157|FG001|Overall Study|Lost to Follow-up|5|||
124554730|NCT03137082|447989158|FG000|Overall Study|Withdrawal by Subject|1|||
124554731|NCT03137082|447989159|FG001|Overall Study|Withdrawal by Subject|1|||
124554732|NCT03137082|447989158|FG000|Overall Study|Lost to Follow-up|1|||
124554733|NCT03137082|447989159|FG001|Overall Study|Lost to Follow-up|0|||
124554734|NCT01020305|447989162|FG000|Overall Study|Adverse Event|2|||
124554735|NCT01017029|447989166|FG000|Overall Study|Lost to Follow-up|1|||
124554736|NCT01017029|447989167|FG001|Overall Study|Lost to Follow-up|0|||
124554737|NCT01017029|447989166|FG000|Overall Study|Administrative problem|0|||
124554738|NCT01017029|447989167|FG001|Overall Study|Administrative problem|1|||
124554739|NCT01017029|447989166|FG000|Overall Study|Death|3|||
124554740|NCT01017029|447989167|FG001|Overall Study|Death|1|||
124554741|NCT00618774|447989168|FG000|Overall Study|Adverse Event|5|||
124554742|NCT00618774|447989169|FG001|Overall Study|Adverse Event|3|||
124554743|NCT00618774|447989168|FG000|Overall Study|Withdrawal by Subject|1|||
124554744|NCT00618774|447989169|FG001|Overall Study|Withdrawal by Subject|0|||
124473545|NCT01262976|447690802|FG004|Up to Year 3|Withdrawal by Subject|0|||
124473546|NCT01262976|447690803|FG005|Up to Year 3|Withdrawal by Subject|0|||
124554745|NCT02753400|447989171|FG000|Overall Study|Adverse Event|3|||
124554746|NCT02753400|447989172|FG001|Overall Study|Adverse Event|0|||
124554747|NCT02753400|447989171|FG000|Overall Study|Withdrawal by Subject|2|||
124554748|NCT02753400|447989172|FG001|Overall Study|Withdrawal by Subject|1|||
124554749|NCT01415921|447989173|FG000|Overall Study|Adverse Event|0|||
124717472|NCT01057693|448588174|FG002|Between Single-Blind and Double-Blind|Other|0|||
124717473|NCT01057693|448588172|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
124717474|NCT01057693|448588173|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
124717475|NCT01057693|448588174|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
124717476|NCT01057693|448588172|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
124717477|NCT01057693|448588173|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
124717478|NCT01057693|448588174|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
124717479|NCT01057693|448588172|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
124717480|NCT01057693|448588173|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
124717481|NCT01057693|448588174|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
124717482|NCT01057693|448588172|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
124717483|NCT01057693|448588173|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
124717484|NCT01057693|448588174|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
124717485|NCT01057693|448588172|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
124717486|NCT01057693|448588173|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
124717487|NCT01057693|448588174|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
124717488|NCT01057693|448588172|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
124717489|NCT01057693|448588173|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
124717490|NCT01057693|448588174|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
124717491|NCT01057693|448588172|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
124717492|NCT01057693|448588173|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
124717493|NCT01057693|448588174|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
124717494|NCT00709319|448588175|FG000|Overall Study|Death|4|||
124717495|NCT00709319|448588175|FG000|Overall Study|Withdrawal by Subject|2|||
124717496|NCT03951766|448588176|FG000|Treatment Phase|Lost to Follow-up|1|||
124717497|NCT03951766|448588176|FG000|Follow-up Phase|Lost to Follow-up|10|||
124717498|NCT00363142|448588177|FG000|Overall Study|Adverse Event|2|||
124717499|NCT00363142|448588178|FG001|Overall Study|Adverse Event|0|||
124717500|NCT00363142|448588177|FG000|Overall Study|Lack of Efficacy|0|||
124717501|NCT00363142|448588178|FG001|Overall Study|Lack of Efficacy|1|||
124717502|NCT00363142|448588177|FG000|Overall Study|Lost to Follow-up|1|||
124717503|NCT00363142|448588178|FG001|Overall Study|Lost to Follow-up|0|||
124717504|NCT00363142|448588177|FG000|Overall Study|Non-compliance|1|||
124717505|NCT00363142|448588178|FG001|Overall Study|Non-compliance|1|||
124717506|NCT00363142|448588177|FG000|Overall Study|Withdrawal by Subject|3|||
124717507|NCT00363142|448588178|FG001|Overall Study|Withdrawal by Subject|1|||
124717508|NCT01541865|448588179|FG000|Overall Study|Lost to Follow-up|11|||
124717509|NCT01541865|448588179|FG000|Overall Study|Withdrawal by Subject|9|||
124717510|NCT01541865|448588179|FG000|Overall Study|Adverse Event|1|||
124717511|NCT01541865|448588179|FG000|Overall Study|Protocol Violation|1|||
124717512|NCT03606486|448588182|FG000|Overall Study|Unable to collect sample|5|||
124717513|NCT00049322|448588183|FG000|Overall Study|disease burden|0|||
124717514|NCT00049322|448588184|FG001|Overall Study|disease burden|3|||
124717515|NCT00049322|448588183|FG000|Overall Study|Adverse Event|1|||
124717516|NCT00049322|448588184|FG001|Overall Study|Adverse Event|0|||
124717517|NCT00049322|448588183|FG000|Overall Study|refused angio|0|||
124717518|NCT00049322|448588184|FG001|Overall Study|refused angio|3|||
124717519|NCT03072043|448588186|FG000|Overall Study|Death|0|||
124717520|NCT03072043|448588187|FG001|Overall Study|Death|0|||
124717521|NCT03072043|448588188|FG002|Overall Study|Death|3|||
124717522|NCT03072043|448588186|FG000|Overall Study|Adverse Event|0|||
124717523|NCT03072043|448588187|FG001|Overall Study|Adverse Event|0|||
124717524|NCT03072043|448588188|FG002|Overall Study|Adverse Event|2|||
124717525|NCT03072043|448588186|FG000|Overall Study|Withdrawal by Subject|0|||
124717526|NCT03072043|448588187|FG001|Overall Study|Withdrawal by Subject|0|||
124717527|NCT03072043|448588188|FG002|Overall Study|Withdrawal by Subject|4|||
124717528|NCT01340664|448588189|FG000|Overall Study|Adverse Event|0|||
124717529|NCT01340664|448588190|FG001|Overall Study|Adverse Event|1|||
124717530|NCT01340664|448588191|FG002|Overall Study|Adverse Event|7|||
124717531|NCT01340664|448588189|FG000|Overall Study|Lost to Follow-up|2|||
124717532|NCT01340664|448588190|FG001|Overall Study|Lost to Follow-up|0|||
124717533|NCT01340664|448588191|FG002|Overall Study|Lost to Follow-up|2|||
124717534|NCT01340664|448588189|FG000|Overall Study|Withdrawal by Subject|2|||
124717535|NCT01340664|448588190|FG001|Overall Study|Withdrawal by Subject|4|||
124717536|NCT01340664|448588191|FG002|Overall Study|Withdrawal by Subject|0|||
124717537|NCT01340664|448588189|FG000|Overall Study|Glycemic withdrawal criteria|2|||
124717538|NCT01340664|448588190|FG001|Overall Study|Glycemic withdrawal criteria|0|||
124717539|NCT01340664|448588191|FG002|Overall Study|Glycemic withdrawal criteria|0|||
124717540|NCT01340664|448588189|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
124717541|NCT01340664|448588190|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
124717542|NCT01340664|448588191|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
124717543|NCT01340664|448588189|FG000|Overall Study|Other|1|||
124717544|NCT01340664|448588190|FG001|Overall Study|Other|2|||
124717545|NCT01340664|448588191|FG002|Overall Study|Other|2|||
124717546|NCT02997865|448588195|FG000|Overall Study|Death|2|||
124717547|NCT02997865|448588196|FG001|Overall Study|Death|1|||
124717548|NCT02997865|448588195|FG000|Overall Study|Lost to Follow-up|6|||
124717549|NCT02997865|448588196|FG001|Overall Study|Lost to Follow-up|3|||
124717550|NCT02997865|448588195|FG000|Overall Study|Withdrawal by Subject|5|||
124717551|NCT02997865|448588196|FG001|Overall Study|Withdrawal by Subject|0|||
124717552|NCT01926444|448588197|FG000|Overall Study|Colonoscopy not performed|0|||
124717553|NCT01926444|448588198|FG001|Overall Study|Colonoscopy not performed|0|||
124717554|NCT01926444|448588199|FG002|Overall Study|Colonoscopy not performed|4|||
124717555|NCT01926444|448588200|FG003|Overall Study|Colonoscopy not performed|2|||
124717556|NCT03943290|448588201|FG000|Overall Study|Sponsor Terminated Study|6|||
124717557|NCT03943290|448588202|FG001|Overall Study|Sponsor Terminated Study|1|||
124717558|NCT03943290|448588203|FG002|Overall Study|Sponsor Terminated Study|11|||
124717559|NCT03943290|448588204|FG003|Overall Study|Sponsor Terminated Study|6|||
124717560|NCT03943290|448588205|FG004|Overall Study|Sponsor Terminated Study|7|||
124717561|NCT03943290|448588206|FG005|Overall Study|Sponsor Terminated Study|6|||
124717562|NCT03943290|448588207|FG006|Overall Study|Sponsor Terminated Study|6|||
124717563|NCT03943290|448588208|FG007|Overall Study|Sponsor Terminated Study|7|||
124717564|NCT03943290|448588209|FG008|Overall Study|Sponsor Terminated Study|8|||
124717565|NCT03943290|448588201|FG000|Overall Study|Lost to Follow-up|1|||
124717566|NCT03943290|448588202|FG001|Overall Study|Lost to Follow-up|0|||
124717567|NCT03943290|448588203|FG002|Overall Study|Lost to Follow-up|1|||
124717568|NCT03943290|448588204|FG003|Overall Study|Lost to Follow-up|0|||
124717569|NCT03943290|448588205|FG004|Overall Study|Lost to Follow-up|0|||
124717570|NCT03943290|448588206|FG005|Overall Study|Lost to Follow-up|0|||
124717571|NCT03943290|448588207|FG006|Overall Study|Lost to Follow-up|0|||
124717572|NCT03943290|448588208|FG007|Overall Study|Lost to Follow-up|1|||
124717573|NCT03943290|448588209|FG008|Overall Study|Lost to Follow-up|0|||
124717574|NCT03943290|448588201|FG000|Overall Study|Withdrawal by Subject|0|||
124717575|NCT03943290|448588202|FG001|Overall Study|Withdrawal by Subject|0|||
124717576|NCT03943290|448588203|FG002|Overall Study|Withdrawal by Subject|1|||
124717577|NCT03943290|448588204|FG003|Overall Study|Withdrawal by Subject|0|||
124717578|NCT03943290|448588205|FG004|Overall Study|Withdrawal by Subject|0|||
124717579|NCT03943290|448588206|FG005|Overall Study|Withdrawal by Subject|0|||
124717580|NCT03943290|448588207|FG006|Overall Study|Withdrawal by Subject|0|||
124717581|NCT03943290|448588208|FG007|Overall Study|Withdrawal by Subject|0|||
124717582|NCT03943290|448588209|FG008|Overall Study|Withdrawal by Subject|0|||
124717583|NCT00295646|448588210|FG000|Overall Study|Protocol Violation|18|||
124717584|NCT00295646|448588211|FG001|Overall Study|Protocol Violation|20|||
124717585|NCT00295646|448588212|FG002|Overall Study|Protocol Violation|20|||
124717586|NCT00295646|448588213|FG003|Overall Study|Protocol Violation|18|||
124717587|NCT00295646|448588210|FG000|Overall Study|Withdrawal by Subject|8|||
124717588|NCT00295646|448588211|FG001|Overall Study|Withdrawal by Subject|9|||
124717589|NCT00295646|448588212|FG002|Overall Study|Withdrawal by Subject|11|||
124717590|NCT00295646|448588213|FG003|Overall Study|Withdrawal by Subject|14|||
124717591|NCT00295646|448588210|FG000|Overall Study|Lost to Follow-up|0|||
124717592|NCT00295646|448588211|FG001|Overall Study|Lost to Follow-up|5|||
124717593|NCT00295646|448588212|FG002|Overall Study|Lost to Follow-up|1|||
124554750|NCT01415921|447989174|FG001|Overall Study|Adverse Event|1|||
124771517|NCT01054885|448794471|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
124771518|NCT01054885|448794472|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
124771519|NCT01054885|448794473|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
124771520|NCT01054885|448794474|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
124771521|NCT01054885|448794468|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
124771522|NCT01054885|448794469|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
124771523|NCT01054885|448794470|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
124771524|NCT01054885|448794471|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
124771525|NCT01054885|448794472|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
124771526|NCT01054885|448794473|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
124473547|NCT01262976|447690798|FG000|Up to Year 3|Migrated/moved from study area|0|||
124473548|NCT01262976|447690799|FG001|Up to Year 3|Migrated/moved from study area|0|||
124473549|NCT01262976|447690800|FG002|Up to Year 3|Migrated/moved from study area|0|||
124473550|NCT01262976|447690801|FG003|Up to Year 3|Migrated/moved from study area|2|||
124473551|NCT01262976|447690802|FG004|Up to Year 3|Migrated/moved from study area|1|||
124473552|NCT01262976|447690803|FG005|Up to Year 3|Migrated/moved from study area|1|||
124473553|NCT01262976|447690798|FG000|Up to Year 3|Lost to Follow-up|2|||
124473554|NCT01262976|447690799|FG001|Up to Year 3|Lost to Follow-up|2|||
124473555|NCT01262976|447690800|FG002|Up to Year 3|Lost to Follow-up|4|||
124473556|NCT01262976|447690801|FG003|Up to Year 3|Lost to Follow-up|3|||
124473557|NCT01262976|447690802|FG004|Up to Year 3|Lost to Follow-up|1|||
124473558|NCT01262976|447690803|FG005|Up to Year 3|Lost to Follow-up|3|||
124473559|NCT01262976|447690798|FG000|Up to Year 3|Subjects with unknown completion status|0|||
124473560|NCT01262976|447690799|FG001|Up to Year 3|Subjects with unknown completion status|0|||
124473561|NCT01262976|447690800|FG002|Up to Year 3|Subjects with unknown completion status|1|||
124473562|NCT01262976|447690801|FG003|Up to Year 3|Subjects with unknown completion status|0|||
124473563|NCT01262976|447690802|FG004|Up to Year 3|Subjects with unknown completion status|0|||
124473564|NCT01262976|447690803|FG005|Up to Year 3|Subjects with unknown completion status|0|||
124473565|NCT01262976|447690798|FG000|Up to Year 3|Other|3|||
124473566|NCT01262976|447690799|FG001|Up to Year 3|Other|0|||
124473567|NCT01262976|447690800|FG002|Up to Year 3|Other|0|||
124473568|NCT01262976|447690801|FG003|Up to Year 3|Other|0|||
124473569|NCT01262976|447690802|FG004|Up to Year 3|Other|0|||
124473570|NCT01262976|447690803|FG005|Up to Year 3|Other|0|||
124473571|NCT02690194|447690806|FG000|Overall Study|Withdrawal by Subject|1|||
124473572|NCT02690194|447690807|FG001|Overall Study|Withdrawal by Subject|4|||
124473573|NCT02690194|447690808|FG002|Overall Study|Withdrawal by Subject|0|||
124473574|NCT01552681|447690810|FG000|Overall Study|Withdrawal by Subject|4|||
124771527|NCT01054885|448794474|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
124771528|NCT01421719|448794477|FG000|Overall Study|Withdrawal by Subject|4|||
124771529|NCT01942837|448794478|FG000|Overall Study|Death|1|||
124771530|NCT01942837|448794478|FG000|Overall Study|Symptomatic or radiographic progression|49|||
124771531|NCT01942837|448794478|FG000|Overall Study|Adverse Event|6|||
124771532|NCT01942837|448794478|FG000|Overall Study|Physician Decision|3|||
124771533|NCT01942837|448794478|FG000|Overall Study|Withdrawal by Subject|2|||
124771534|NCT01942837|448794478|FG000|Overall Study|Intercurrent Illness|1|||
124771535|NCT01942837|448794478|FG000|Overall Study|On treatment|3|||
124771536|NCT01942837|448794478|FG000|Overall Study|Never initiate the treatment|2|||
124771537|NCT03250273|448794490|FG000|Overall Study|Disease Progression|2|||
124771538|NCT03250273|448794491|FG001|Overall Study|Disease Progression|11|||
124771539|NCT03250273|448794490|FG000|Overall Study|Death|0|||
124473575|NCT01552681|447690811|FG001|Overall Study|Withdrawal by Subject|0|||
124771540|NCT03250273|448794491|FG001|Overall Study|Death|1|||
124771541|NCT04226742|448794492|FG000|Overall Study|Lost to Follow-up|16|||
124771542|NCT04226742|448794493|FG001|Overall Study|Lost to Follow-up|13|||
124771543|NCT04226742|448794492|FG000|Overall Study|Withdrawal by Subject|5|||
124771544|NCT04226742|448794493|FG001|Overall Study|Withdrawal by Subject|3|||
124473576|NCT01552681|447690810|FG000|Overall Study|Physician Decision|1|||
124473577|NCT01552681|447690811|FG001|Overall Study|Physician Decision|0|||
124771545|NCT01759446|448794495|FG000|Overall Study|Protocol Violation|1|||
124771546|NCT01759446|448794496|FG001|Overall Study|Protocol Violation|0|||
124771547|NCT01759446|448794497|FG002|Overall Study|Protocol Violation|1|||
124771548|NCT01759446|448794498|FG003|Overall Study|Protocol Violation|0|||
124771549|NCT01759446|448794499|FG004|Overall Study|Protocol Violation|0|||
124771550|NCT01759446|448794495|FG000|Overall Study|Withdrawal by Subject|0|||
124771551|NCT01759446|448794496|FG001|Overall Study|Withdrawal by Subject|1|||
124771552|NCT01759446|448794497|FG002|Overall Study|Withdrawal by Subject|0|||
124771553|NCT01759446|448794498|FG003|Overall Study|Withdrawal by Subject|1|||
124771554|NCT01759446|448794499|FG004|Overall Study|Withdrawal by Subject|0|||
124473578|NCT01552681|447690810|FG000|Overall Study|Subject moved away|0|||
124473579|NCT01552681|447690811|FG001|Overall Study|Subject moved away|1|||
124473580|NCT01987908|447690812|FG000|Placebo Lead-in Period|Adverse Event|2|||
124473581|NCT01987908|447690813|FG001|Placebo Lead-in Period|Adverse Event|0|||
124473582|NCT01987908|447690814|FG002|Placebo Lead-in Period|Adverse Event|0|||
124473583|NCT01987908|447690812|FG000|Placebo Lead-in Period|Physician Decision|2|||
124473584|NCT01987908|447690813|FG001|Placebo Lead-in Period|Physician Decision|0|||
124473585|NCT01987908|447690814|FG002|Placebo Lead-in Period|Physician Decision|0|||
124473586|NCT01987908|447690812|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
124473587|NCT01987908|447690813|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
124473588|NCT01987908|447690814|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
124554751|NCT01415921|447989173|FG000|Overall Study|Physician Decision|1|||
124771555|NCT04646044|448794501|FG000|Overall Study|Lost to Follow-up|0|||
124771556|NCT04646044|448794502|FG001|Overall Study|Lost to Follow-up|0|||
124771557|NCT04646044|448794503|FG002|Overall Study|Lost to Follow-up|1|||
124771558|NCT04646044|448794504|FG003|Overall Study|Lost to Follow-up|0|||
124771559|NCT04646044|448794501|FG000|Overall Study|Withdrawal by Subject|0|||
124771560|NCT04646044|448794502|FG001|Overall Study|Withdrawal by Subject|1|||
124771561|NCT04646044|448794503|FG002|Overall Study|Withdrawal by Subject|0|||
124771562|NCT04646044|448794504|FG003|Overall Study|Withdrawal by Subject|0|||
124771563|NCT01391546|448794505|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
124771564|NCT01391546|448794506|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
124771565|NCT02156076|448794508|FG000|Treatment Period|no longer meets study criteria|0|||
124771566|NCT02156076|448794509|FG001|Treatment Period|no longer meets study criteria|0|||
124771567|NCT02156076|448794510|FG002|Treatment Period|no longer meets study criteria|1|||
124771568|NCT02156076|448794511|FG003|Treatment Period|no longer meets study criteria|0|||
124771569|NCT02156076|448794508|FG000|Treatment Period|Poor/non-compliance|0|||
124771570|NCT02156076|448794509|FG001|Treatment Period|Poor/non-compliance|1|||
124771571|NCT02156076|448794510|FG002|Treatment Period|Poor/non-compliance|0|||
124771572|NCT02156076|448794511|FG003|Treatment Period|Poor/non-compliance|0|||
124771573|NCT02156076|448794508|FG000|Treatment Period|Lost to Follow-up|0|||
124771574|NCT02156076|448794509|FG001|Treatment Period|Lost to Follow-up|0|||
124771575|NCT02156076|448794510|FG002|Treatment Period|Lost to Follow-up|0|||
124771576|NCT02156076|448794511|FG003|Treatment Period|Lost to Follow-up|1|||
124771577|NCT02156076|448794508|FG000|Treatment Period|Withdrawal by Subject|0|||
124771578|NCT02156076|448794509|FG001|Treatment Period|Withdrawal by Subject|0|||
124771579|NCT02156076|448794510|FG002|Treatment Period|Withdrawal by Subject|1|||
124771580|NCT02156076|448794511|FG003|Treatment Period|Withdrawal by Subject|0|||
124771581|NCT02156076|448794508|FG000|Treatment Period|Subject request to discontinue treatment|0|||
124771582|NCT02156076|448794509|FG001|Treatment Period|Subject request to discontinue treatment|1|||
124771583|NCT02156076|448794510|FG002|Treatment Period|Subject request to discontinue treatment|0|||
124771584|NCT02156076|448794511|FG003|Treatment Period|Subject request to discontinue treatment|0|||
124771585|NCT02156076|448794508|FG000|Treatment Period|Adverse Event|0|||
124771586|NCT02156076|448794509|FG001|Treatment Period|Adverse Event|0|||
124771587|NCT02156076|448794510|FG002|Treatment Period|Adverse Event|0|||
124771588|NCT02156076|448794511|FG003|Treatment Period|Adverse Event|1|||
124771589|NCT02156076|448794508|FG000|Follow-up Period|Withdrawal by Subject|1|||
124771590|NCT02156076|448794509|FG001|Follow-up Period|Withdrawal by Subject|0|||
124771591|NCT02156076|448794510|FG002|Follow-up Period|Withdrawal by Subject|0|||
124771592|NCT02156076|448794511|FG003|Follow-up Period|Withdrawal by Subject|0|||
124771593|NCT01213472|448794512|FG000|Overall Study|Recurrence/Progressive disease|25|||
124771594|NCT01213472|448794512|FG000|Overall Study|Withdrawal by Subject|1|||
124771595|NCT01213472|448794512|FG000|Overall Study|Physician Decision|1|||
124771596|NCT04225897|448794515|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
124771597|NCT04225897|448794516|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
124771598|NCT04225897|448794517|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
124771599|NCT04225897|448794518|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
124771600|NCT04225897|448794519|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
124771601|NCT04225897|448794520|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
124771602|NCT04225897|448794521|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
124771603|NCT04225897|448794522|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
124771604|NCT04225897|448794523|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
124771605|NCT04225897|448794524|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
124771606|NCT04225897|448794525|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
124771607|NCT04225897|448794526|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
124771608|NCT04225897|448794515|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
124771609|NCT04225897|448794516|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
124771610|NCT04225897|448794517|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
124771611|NCT04225897|448794518|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
124771612|NCT04225897|448794519|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
124771613|NCT04225897|448794520|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
124771614|NCT04225897|448794521|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
124771615|NCT04225897|448794522|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
124771616|NCT04225897|448794523|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
124771617|NCT04225897|448794524|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
124771618|NCT04225897|448794525|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
124771619|NCT04225897|448794526|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
124771620|NCT04225897|448794515|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
124771621|NCT04225897|448794516|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
124771622|NCT04225897|448794517|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
124771623|NCT04225897|448794518|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
124771624|NCT04225897|448794519|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
124771625|NCT04225897|448794520|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
124771626|NCT04225897|448794521|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
124771627|NCT04225897|448794522|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
124771628|NCT04225897|448794523|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
124473589|NCT01987908|447690812|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
124473590|NCT01987908|447690813|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
124473591|NCT01987908|447690814|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
124473592|NCT01987908|447690812|FG000|Treatment Period|Adverse Event|0|||
124473593|NCT01987908|447690813|FG001|Treatment Period|Adverse Event|1|||
124473594|NCT01987908|447690814|FG002|Treatment Period|Adverse Event|1|||
124473595|NCT01987908|447690812|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
124473596|NCT01987908|447690813|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
124473597|NCT01987908|447690814|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
124473598|NCT01987908|447690812|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
124473599|NCT01987908|447690813|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
124473600|NCT01987908|447690814|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
124473601|NCT00354601|447690817|FG000|Overall Study|Protocol Violation|1|||
124473602|NCT00354601|447690817|FG000|Overall Study|progression|1|||
124473603|NCT03603652|447690818|FG000|Overall Study|Death|2|||
124473604|NCT02532855|447690819|FG000|Overall Study|Lost to Follow-up|4|||
124473605|NCT02532855|447690820|FG001|Overall Study|Lost to Follow-up|3|||
124473606|NCT02532855|447690819|FG000|Overall Study|Withdrawal by Subject|4|||
124473607|NCT02532855|447690820|FG001|Overall Study|Withdrawal by Subject|8|||
124473608|NCT01960855|447690821|FG000|Overall Study|Subject noncompliant|1|||
124473609|NCT01960855|447690822|FG001|Overall Study|Subject noncompliant|0|||
124473610|NCT01960855|447690823|FG002|Overall Study|Subject noncompliant|0|||
124473611|NCT01960855|447690824|FG003|Overall Study|Subject noncompliant|0|||
124473612|NCT01960855|447690825|FG004|Overall Study|Subject noncompliant|0|||
124473613|NCT01960855|447690821|FG000|Overall Study|Adverse Event|2|||
124473614|NCT01960855|447690822|FG001|Overall Study|Adverse Event|0|||
124473615|NCT01960855|447690823|FG002|Overall Study|Adverse Event|6|||
124473616|NCT01960855|447690824|FG003|Overall Study|Adverse Event|2|||
124473617|NCT01960855|447690825|FG004|Overall Study|Adverse Event|2|||
124473618|NCT01960855|447690821|FG000|Overall Study|Lack of Efficacy|1|||
124473619|NCT01960855|447690822|FG001|Overall Study|Lack of Efficacy|1|||
124473620|NCT01960855|447690823|FG002|Overall Study|Lack of Efficacy|0|||
124473621|NCT01960855|447690824|FG003|Overall Study|Lack of Efficacy|0|||
124473622|NCT01960855|447690825|FG004|Overall Study|Lack of Efficacy|0|||
124473623|NCT01960855|447690821|FG000|Overall Study|Other|2|||
124473624|NCT01960855|447690822|FG001|Overall Study|Other|1|||
124473625|NCT01960855|447690823|FG002|Overall Study|Other|1|||
124473626|NCT01960855|447690824|FG003|Overall Study|Other|1|||
124473627|NCT01960855|447690825|FG004|Overall Study|Other|0|||
124473628|NCT01960855|447690821|FG000|Overall Study|Consent withdrawn by subject|3|||
124473629|NCT01960855|447690822|FG001|Overall Study|Consent withdrawn by subject|1|||
124473630|NCT01960855|447690823|FG002|Overall Study|Consent withdrawn by subject|2|||
124473631|NCT01960855|447690824|FG003|Overall Study|Consent withdrawn by subject|1|||
124473632|NCT01960855|447690825|FG004|Overall Study|Consent withdrawn by subject|1|||
124473633|NCT01960855|447690821|FG000|Overall Study|Lost to Follow-up|2|||
124473634|NCT01960855|447690822|FG001|Overall Study|Lost to Follow-up|1|||
124473635|NCT01960855|447690823|FG002|Overall Study|Lost to Follow-up|0|||
124473636|NCT01960855|447690824|FG003|Overall Study|Lost to Follow-up|0|||
124473637|NCT01960855|447690825|FG004|Overall Study|Lost to Follow-up|2|||
124473638|NCT02058147|447690826|FG000|Overall Study|Randomized but not treated|0|||
124473639|NCT02058147|447690827|FG001|Overall Study|Randomized but not treated|0|||
124473640|NCT02058147|447690828|FG002|Overall Study|Randomized but not treated|1|||
124473641|NCT02058147|447690826|FG000|Overall Study|Adverse Event|12|||
124771629|NCT04225897|448794524|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
124771630|NCT04225897|448794525|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
124771631|NCT04225897|448794526|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
124771632|NCT04225897|448794515|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
124771633|NCT04225897|448794516|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
124771634|NCT04225897|448794517|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
124771635|NCT04225897|448794518|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
124771636|NCT04225897|448794519|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
124771637|NCT04225897|448794520|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
124771638|NCT04225897|448794521|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
124771639|NCT04225897|448794522|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
124473642|NCT02058147|447690827|FG001|Overall Study|Adverse Event|9|||
124473643|NCT02058147|447690828|FG002|Overall Study|Adverse Event|21|||
124473644|NCT02058147|447690826|FG000|Overall Study|Lack of Efficacy|1|||
124473645|NCT02058147|447690827|FG001|Overall Study|Lack of Efficacy|0|||
124473646|NCT02058147|447690828|FG002|Overall Study|Lack of Efficacy|3|||
124473647|NCT02058147|447690826|FG000|Overall Study|Poor compliance to protocol|8|||
124473648|NCT02058147|447690827|FG001|Overall Study|Poor compliance to protocol|9|||
124473649|NCT02058147|447690828|FG002|Overall Study|Poor compliance to protocol|4|||
124473650|NCT02058147|447690826|FG000|Overall Study|Other than specified|8|||
124473651|NCT02058147|447690827|FG001|Overall Study|Other than specified|9|||
124473652|NCT02058147|447690828|FG002|Overall Study|Other than specified|0|||
124473653|NCT02154425|447690831|FG000|Screening Period|Adverse Event|1|||
124473654|NCT02251912|447690832|FG000|Overall Study|Withdrawal by Subject|2|||
124473655|NCT02251912|447690833|FG001|Overall Study|Withdrawal by Subject|3|||
124473656|NCT02251912|447690832|FG000|Overall Study|Adverse Event|0|||
124473657|NCT02251912|447690833|FG001|Overall Study|Adverse Event|2|||
124473658|NCT01107444|447690834|FG000|Overall Study|Withdrawal by Subject|8|||
124473659|NCT01107444|447690835|FG001|Overall Study|Withdrawal by Subject|12|||
124473660|NCT01107444|447690834|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
124473661|NCT01107444|447690835|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
124473662|NCT02526550|447690838|FG000|Overall Study|Lost to Follow-up|1|||
124473663|NCT03969888|447690841|FG000|Overall Study|Never Received Study Drug|0|||
124473664|NCT03969888|447690842|FG001|Overall Study|Never Received Study Drug|0|||
124473665|NCT03969888|447690843|FG002|Overall Study|Never Received Study Drug|1|||
124473666|NCT03969888|447690844|FG003|Overall Study|Never Received Study Drug|0|||
124473667|NCT03969888|447690845|FG004|Overall Study|Never Received Study Drug|0|||
124473668|NCT03969888|447690846|FG005|Overall Study|Never Received Study Drug|0|||
124473669|NCT03969888|447690847|FG006|Overall Study|Never Received Study Drug|1|||
124473670|NCT03969888|447690848|FG007|Overall Study|Never Received Study Drug|0|||
124473671|NCT03969888|447690841|FG000|Overall Study|Reason Not Specified|0|||
124473672|NCT03969888|447690842|FG001|Overall Study|Reason Not Specified|0|||
124473673|NCT03969888|447690843|FG002|Overall Study|Reason Not Specified|0|||
124473674|NCT03969888|447690844|FG003|Overall Study|Reason Not Specified|0|||
124473675|NCT03969888|447690845|FG004|Overall Study|Reason Not Specified|0|||
124473676|NCT03969888|447690846|FG005|Overall Study|Reason Not Specified|0|||
124473677|NCT03969888|447690847|FG006|Overall Study|Reason Not Specified|0|||
124473678|NCT03969888|447690848|FG007|Overall Study|Reason Not Specified|1|||
124473679|NCT03094195|447690852|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
124473680|NCT03094195|447690853|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
124473681|NCT03094195|447690854|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
124473682|NCT03094195|447690855|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
124473683|NCT03094195|447690856|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
124473684|NCT03094195|447690857|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
124473685|NCT03094195|447690858|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
124473686|NCT03094195|447690859|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
124473687|NCT03094195|447690852|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
124473688|NCT03094195|447690853|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
124473689|NCT03094195|447690854|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
124473690|NCT03094195|447690855|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
124473691|NCT03094195|447690856|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
124473692|NCT03094195|447690857|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
124473693|NCT03094195|447690858|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
124473694|NCT03094195|447690859|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
124473695|NCT03094195|447690852|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
124473696|NCT03094195|447690853|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
124771640|NCT04225897|448794523|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
124771641|NCT04225897|448794524|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
124473697|NCT03094195|447690854|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
124473698|NCT03094195|447690855|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
124554752|NCT01415921|447989174|FG001|Overall Study|Physician Decision|1|||
124554753|NCT01415921|447989173|FG000|Overall Study|Withdrawal by Subject|0|||
124554754|NCT01415921|447989174|FG001|Overall Study|Withdrawal by Subject|1|||
124554755|NCT01415921|447989173|FG000|Overall Study|Other|2|||
124554756|NCT01415921|447989174|FG001|Overall Study|Other|0|||
124554757|NCT01830920|447989179|FG000|Overall Study|Adverse Event|1|||
124554758|NCT01830920|447989180|FG001|Overall Study|Adverse Event|0|||
124554759|NCT01830920|447989181|FG002|Overall Study|Adverse Event|1|||
124554760|NCT01830920|447989182|FG003|Overall Study|Adverse Event|0|||
124554761|NCT01830920|447989183|FG004|Overall Study|Adverse Event|0|||
124554762|NCT01830920|447989179|FG000|Overall Study|Withdrawal by Subject|2|||
124554763|NCT01830920|447989180|FG001|Overall Study|Withdrawal by Subject|2|||
124554764|NCT01830920|447989181|FG002|Overall Study|Withdrawal by Subject|1|||
124554765|NCT01830920|447989182|FG003|Overall Study|Withdrawal by Subject|7|||
124554766|NCT01830920|447989183|FG004|Overall Study|Withdrawal by Subject|1|||
124554767|NCT01830920|447989179|FG000|Overall Study|Death|3|||
124554768|NCT01830920|447989180|FG001|Overall Study|Death|3|||
124554769|NCT01830920|447989181|FG002|Overall Study|Death|5|||
124554770|NCT01830920|447989182|FG003|Overall Study|Death|4|||
124554771|NCT01830920|447989183|FG004|Overall Study|Death|4|||
124554772|NCT01830920|447989179|FG000|Overall Study|Other|15|||
124554773|NCT01830920|447989180|FG001|Overall Study|Other|1|||
124554774|NCT01830920|447989181|FG002|Overall Study|Other|1|||
124554775|NCT01830920|447989182|FG003|Overall Study|Other|5|||
124554776|NCT01830920|447989183|FG004|Overall Study|Other|3|||
124554777|NCT03402126|447989186|FG000|Overall Study|Lost to Follow-up|6|||
124554778|NCT03402126|447989186|FG000|Overall Study|Protocol Violation|10|||
124554779|NCT03402126|447989186|FG000|Overall Study|Sponsor request/Study termination|29|||
124554780|NCT03402126|447989186|FG000|Overall Study|Study product no longer in use|1|||
124554781|NCT03402126|447989186|FG000|Overall Study|Technical problems|1|||
124554782|NCT03402126|447989186|FG000|Overall Study|Withdrawal by Subject|6|||
124554783|NCT03402126|447989186|FG000|Overall Study|Physician Decision|2|||
124554784|NCT03402126|447989186|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
124554785|NCT03402126|447989186|FG000|Overall Study|Death|4|||
124554786|NCT00720304|447989189|FG000|Overall Study|Withdrawal by Subject|14|||
124554787|NCT00720304|447989190|FG001|Overall Study|Withdrawal by Subject|1|||
124554788|NCT00720304|447989189|FG000|Overall Study|Death|1|||
124554789|NCT00720304|447989190|FG001|Overall Study|Death|0|||
124554790|NCT00720304|447989189|FG000|Overall Study|Physician Decision|5|||
124554791|NCT00720304|447989190|FG001|Overall Study|Physician Decision|2|||
124554792|NCT00720304|447989189|FG000|Overall Study|Adverse Event|3|||
124554793|NCT00720304|447989190|FG001|Overall Study|Adverse Event|1|||
124554794|NCT00720304|447989189|FG000|Overall Study|Disease progression|6|||
124554795|NCT00720304|447989190|FG001|Overall Study|Disease progression|1|||
124554796|NCT01333475|447989191|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
124554797|NCT01333475|447989192|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
124554798|NCT01333475|447989191|FG000|Overall Study|Toxicity|1|||
124554799|NCT01333475|447989192|FG001|Overall Study|Toxicity|3|||
124554800|NCT02981602|447989193|FG000|Overall Study|Adverse Event|0|||
124554801|NCT02981602|447989194|FG001|Overall Study|Adverse Event|0|||
124554802|NCT02981602|447989195|FG002|Overall Study|Adverse Event|0|||
124554803|NCT02981602|447989196|FG003|Overall Study|Adverse Event|1|||
124554804|NCT02981602|447989197|FG004|Overall Study|Adverse Event|0|||
124554805|NCT01706770|447989200|FG000|Overall Study|Lost to Follow-up|1|||
124554806|NCT01706770|447989201|FG001|Overall Study|Lost to Follow-up|0|||
124554807|NCT01706770|447989200|FG000|Overall Study|Physician Decision|1|||
124554808|NCT01706770|447989201|FG001|Overall Study|Physician Decision|0|||
124554809|NCT00423488|447989204|FG000|Overall Study|No evidence of study drug intake|2|||
124554810|NCT00423488|447989205|FG001|Overall Study|No evidence of study drug intake|1|||
124554811|NCT00423488|447989204|FG000|Overall Study|No post baseline data|3|||
124554812|NCT00423488|447989205|FG001|Overall Study|No post baseline data|0|||
124554813|NCT00527397|447989206|FG000|Overall Study|Adverse Event|3|||
124554814|NCT00527397|447989206|FG000|Overall Study|Lack of Efficacy|1|||
124554815|NCT00527397|447989206|FG000|Overall Study|Protocol Violation|1|||
124554816|NCT00527397|447989206|FG000|Overall Study|Withdrawal by Subject|6|||
124554817|NCT00527397|447989206|FG000|Overall Study|Study terminated by sponsor|13|||
124554818|NCT00383019|447989207|FG000|Overall Study|Adverse Event|5|||
124554819|NCT00383019|447989208|FG001|Overall Study|Adverse Event|1|||
124554820|NCT00383019|447989207|FG000|Overall Study|Withdrawal by Subject|0|||
124554821|NCT00383019|447989208|FG001|Overall Study|Withdrawal by Subject|1|||
124554822|NCT03797222|447989209|FG000|Overall Study|Withdrawal by Subject|1|||
124554823|NCT00725725|447989211|FG000|Overall Study|Adverse Event|1|||
124554824|NCT00725725|447989212|FG001|Overall Study|Adverse Event|3|||
124554825|NCT00725725|447989213|FG002|Overall Study|Adverse Event|2|||
124554826|NCT00725725|447989211|FG000|Overall Study|Lost to Follow-up|2|||
124554827|NCT00725725|447989212|FG001|Overall Study|Lost to Follow-up|0|||
124554828|NCT00725725|447989213|FG002|Overall Study|Lost to Follow-up|2|||
124717594|NCT00295646|448588213|FG003|Overall Study|Lost to Follow-up|5|||
124717595|NCT00295646|448588210|FG000|Overall Study|Death|9|||
124554829|NCT00725725|447989211|FG000|Overall Study|Withdrawal by Subject|1|||
124554830|NCT00725725|447989212|FG001|Overall Study|Withdrawal by Subject|0|||
124554831|NCT00725725|447989213|FG002|Overall Study|Withdrawal by Subject|1|||
124554832|NCT00725725|447989211|FG000|Overall Study|Protocol Violation|0|||
124554833|NCT00725725|447989212|FG001|Overall Study|Protocol Violation|1|||
124554834|NCT00725725|447989213|FG002|Overall Study|Protocol Violation|0|||
124554835|NCT00378482|447989214|FG000|Overall Study|Lost to Follow-up|1|||
124554836|NCT00378482|447989214|FG000|Overall Study|Lack of Efficacy|8|||
124554837|NCT00378482|447989214|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
124554838|NCT00378482|447989214|FG000|Overall Study|Withdrawal by Subject|4|||
124554839|NCT00378482|447989214|FG000|Overall Study|Adverse Event|9|||
124554840|NCT01355523|447990955|FG000|Overall Study|Withdrawal by Subject|1|||
124554841|NCT01355523|447990956|FG001|Overall Study|Withdrawal by Subject|4|||
124554842|NCT01355523|447990955|FG000|Overall Study|Lost to Follow-up|0|||
124554843|NCT01355523|447990956|FG001|Overall Study|Lost to Follow-up|2|||
124554844|NCT01355523|447990955|FG000|Overall Study|Protocol Violation|0|||
124554845|NCT01355523|447990956|FG001|Overall Study|Protocol Violation|2|||
124554846|NCT01355523|447990955|FG000|Overall Study|Adverse Event|0|||
124554847|NCT01355523|447990956|FG001|Overall Study|Adverse Event|2|||
124554848|NCT01011907|447990957|FG000|Overall Study|Withdrawal by Subject|13|||
124554849|NCT01011907|447990958|FG001|Overall Study|Withdrawal by Subject|11|||
124554850|NCT01011907|447990957|FG000|Overall Study|Adverse Event|1|||
124554851|NCT01011907|447990958|FG001|Overall Study|Adverse Event|4|||
124554852|NCT01272193|447990959|FG000|Overall Study|Adverse Event|1|||
124554853|NCT01272193|447990960|FG001|Overall Study|Adverse Event|1|||
124554854|NCT01272193|447990959|FG000|Overall Study|Lack of Efficacy|0|||
124554855|NCT01272193|447990960|FG001|Overall Study|Lack of Efficacy|3|||
124554856|NCT01272193|447990959|FG000|Overall Study|Withdrawal Criteria|1|||
124554857|NCT01272193|447990960|FG001|Overall Study|Withdrawal Criteria|1|||
124554858|NCT01272193|447990959|FG000|Overall Study|Unclassified|8|||
124554859|NCT01272193|447990960|FG001|Overall Study|Unclassified|7|||
124554860|NCT01440647|447990963|FG000|Overall Study|Death|2|||
124554861|NCT01440647|447990964|FG001|Overall Study|Death|3|||
124554862|NCT01406873|447990965|FG000|Overall Study|Withdrawal by Subject|1|||
124554863|NCT01406873|447990966|FG001|Overall Study|Withdrawal by Subject|1|||
124554864|NCT00736099|447990968|FG000|Overall Study|Adverse Event|61|||
124554865|NCT00736099|447990969|FG001|Overall Study|Adverse Event|18|||
124554866|NCT00736099|447990968|FG000|Overall Study|Protocol Violation|10|||
124554867|NCT00736099|447990969|FG001|Overall Study|Protocol Violation|4|||
124554868|NCT00736099|447990968|FG000|Overall Study|Lost to Follow-up|12|||
124554869|NCT00736099|447990969|FG001|Overall Study|Lost to Follow-up|5|||
124554870|NCT00736099|447990968|FG000|Overall Study|Withdrawal by Subject|42|||
124554871|NCT00736099|447990969|FG001|Overall Study|Withdrawal by Subject|13|||
124554872|NCT00736099|447990968|FG000|Overall Study|Lack of Efficacy|15|||
124554873|NCT00736099|447990969|FG001|Overall Study|Lack of Efficacy|8|||
124554874|NCT00736099|447990968|FG000|Overall Study|Other reason|43|||
124554875|NCT00736099|447990969|FG001|Overall Study|Other reason|10|||
124554876|NCT02290028|447990970|FG000|Overall Study|Death|217|||
124554877|NCT02290028|447990970|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
124554878|NCT02290028|447990970|FG000|Overall Study|No longer under care of study physician|76|||
124554879|NCT02290028|447990970|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
124554880|NCT02290028|447990970|FG000|Overall Study|Withdrawal by Subject|52|||
124554881|NCT02290028|447990970|FG000|Overall Study|Study site closure|44|||
124554882|NCT02290028|447990970|FG000|Overall Study|Lost to Follow-up|34|||
124554883|NCT02290028|447990970|FG000|Overall Study|Miscellaneous|10|||
124554884|NCT02290028|447990970|FG000|Overall Study|Transition to EP PASSION|1295|||
124554885|NCT02290028|447990970|FG000|Overall Study|Planned study completion at 12 months|257|||
124554886|NCT03202511|447990971|FG000|Overall Study|Withdrawal by Subject|1|||
124554887|NCT03202511|447990972|FG001|Overall Study|Withdrawal by Subject|0|||
124554888|NCT00096382|447990975|FG000|Overall Study|Not treated|1|||
124554889|NCT00096382|447990976|FG001|Overall Study|Not treated|0|||
124554890|NCT00096382|447990975|FG000|Overall Study|Death during treatment|1|||
124554891|NCT00096382|447990976|FG001|Overall Study|Death during treatment|0|||
124554892|NCT00289731|447990978|FG000|Overall Study|Adverse Event|1|||
124554893|NCT00289731|447990979|FG001|Overall Study|Adverse Event|2|||
124554894|NCT00289731|447990980|FG002|Overall Study|Adverse Event|2|||
124554895|NCT00289731|447990978|FG000|Overall Study|Other|1|||
124554896|NCT00289731|447990979|FG001|Overall Study|Other|0|||
124554897|NCT00289731|447990980|FG002|Overall Study|Other|0|||
124554898|NCT04378010|447990981|FG000|Overall Study|Adverse Event|8|||
124554899|NCT04378010|447990982|FG001|Overall Study|Adverse Event|14|||
124554900|NCT04378010|447990983|FG002|Overall Study|Adverse Event|4|||
124554901|NCT04378010|447990981|FG000|Overall Study|Withdrawal by Subject|0|||
124554902|NCT04378010|447990982|FG001|Overall Study|Withdrawal by Subject|2|||
124554903|NCT04378010|447990983|FG002|Overall Study|Withdrawal by Subject|1|||
124554904|NCT04378010|447990981|FG000|Overall Study|Protocol Violation|2|||
124554905|NCT04378010|447990982|FG001|Overall Study|Protocol Violation|1|||
124554906|NCT04378010|447990983|FG002|Overall Study|Protocol Violation|4|||
124473699|NCT03094195|447690856|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
124473700|NCT03094195|447690857|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
124473701|NCT03094195|447690858|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
124473702|NCT03094195|447690859|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
124473703|NCT03094195|447690852|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
124473704|NCT03094195|447690853|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
124473705|NCT03094195|447690854|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
124473706|NCT03094195|447690855|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
124473707|NCT03094195|447690856|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
124473708|NCT03094195|447690857|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
124473709|NCT03094195|447690858|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
124473710|NCT03094195|447690859|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
124473711|NCT01961115|447690860|FG000|Overall Study|Disease Progression|1|||
124473712|NCT01961115|447690861|FG001|Overall Study|Disease Progression|0|||
124473713|NCT01961115|447690862|FG002|Overall Study|Disease Progression|3|||
124473714|NCT01961115|447690860|FG000|Overall Study|Adverse Event|1|||
124473715|NCT01961115|447690861|FG001|Overall Study|Adverse Event|0|||
124473716|NCT01961115|447690862|FG002|Overall Study|Adverse Event|1|||
124473717|NCT00578643|447690866|FG000|Overall Study|Death|1|||
124473718|NCT00578643|447690866|FG000|Overall Study|Lost to Follow-up|1|||
124473719|NCT02440581|447690867|FG000|Overall Study|Death|0|||
124473720|NCT02440581|447690868|FG001|Overall Study|Death|0|||
124473721|NCT02440581|447690869|FG002|Overall Study|Death|7|||
124473722|NCT02440581|447690870|FG003|Overall Study|Death|5|||
124473723|NCT02440581|447690867|FG000|Overall Study|Transplanted|1|||
124473724|NCT02440581|447690868|FG001|Overall Study|Transplanted|0|||
124473725|NCT02440581|447690869|FG002|Overall Study|Transplanted|3|||
124473726|NCT02440581|447690870|FG003|Overall Study|Transplanted|2|||
124473727|NCT02440581|447690867|FG000|Overall Study|Withdrawal by Subject|4|||
124473728|NCT02440581|447690868|FG001|Overall Study|Withdrawal by Subject|11|||
124473729|NCT02440581|447690869|FG002|Overall Study|Withdrawal by Subject|3|||
124473730|NCT02440581|447690870|FG003|Overall Study|Withdrawal by Subject|7|||
124473731|NCT02474329|447690871|FG000|Overall Study|Withdraw or did not contribute data.|13|||
124473732|NCT03186989|447690872|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
124473733|NCT03186989|447690873|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
124473734|NCT03186989|447690874|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
124473735|NCT03186989|447690875|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
124473736|NCT03186989|447690876|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
124473737|NCT03186989|447690877|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
124473738|NCT03186989|447690878|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
124473739|NCT03186989|447690879|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
124473740|NCT03186989|447690880|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
124473741|NCT03186989|447690881|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
124473742|NCT03186989|447690882|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
124473743|NCT03186989|447690872|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
124473744|NCT03186989|447690873|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
124473745|NCT03186989|447690874|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
124473746|NCT03186989|447690875|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
124473747|NCT03186989|447690876|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
124473748|NCT03186989|447690877|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
124473749|NCT03186989|447690878|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
124473750|NCT03186989|447690879|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
124473751|NCT03186989|447690880|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
124717596|NCT00295646|448588211|FG001|Overall Study|Death|7|||
124473752|NCT03186989|447690881|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
124473753|NCT03186989|447690882|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
124473754|NCT03186989|447690872|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
124473755|NCT03186989|447690873|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
124473756|NCT03186989|447690874|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
124554907|NCT04378010|447990981|FG000|Overall Study|Study terminated by Sponsor|22|||
124554908|NCT04378010|447990982|FG001|Overall Study|Study terminated by Sponsor|16|||
124717597|NCT00295646|448588212|FG002|Overall Study|Death|18|||
124717598|NCT00295646|448588213|FG003|Overall Study|Death|8|||
124717599|NCT02441101|448588224|FG000|Overall Study|Withdrawal by Subject|1|||
124717600|NCT02441101|448588225|FG001|Overall Study|Withdrawal by Subject|0|||
124717601|NCT02441101|448588224|FG000|Overall Study|Lost to Follow-up|1|||
124717602|NCT02441101|448588225|FG001|Overall Study|Lost to Follow-up|0|||
124473757|NCT03186989|447690875|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
124473758|NCT03186989|447690876|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
124473759|NCT03186989|447690877|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
124554909|NCT04378010|447990983|FG002|Overall Study|Study terminated by Sponsor|22|||
124554910|NCT04378010|447990981|FG000|Overall Study|Subject inability to complete study visit|0|||
124554911|NCT04378010|447990982|FG001|Overall Study|Subject inability to complete study visit|0|||
124554912|NCT04378010|447990983|FG002|Overall Study|Subject inability to complete study visit|1|||
124554913|NCT04378010|447990981|FG000|Overall Study|Subject never dosed|0|||
124554914|NCT04378010|447990982|FG001|Overall Study|Subject never dosed|1|||
124554915|NCT04378010|447990983|FG002|Overall Study|Subject never dosed|0|||
124554916|NCT02019979|447990984|FG000|Overall Study|study terminated|14|||
124554917|NCT02513459|447990985|FG000|Overall Study|Adverse Event|7|||
124554918|NCT02513459|447990985|FG000|Overall Study|Withdrew consent|5|||
124554919|NCT02513459|447990985|FG000|Overall Study|Loss of efficacy|2|||
124554920|NCT02513459|447990985|FG000|Overall Study|Pregnancy|2|||
124554921|NCT02513459|447990985|FG000|Overall Study|Subject decision|2|||
124554922|NCT02513459|447990985|FG000|Overall Study|Lack of response|1|||
124554923|NCT02513459|447990985|FG000|Overall Study|Reproductive plans|1|||
124554924|NCT02513459|447990985|FG000|Overall Study|Surgery planned-- not done|1|||
124554925|NCT04023994|447990989|FG000|Overall Study|Lost to Follow-up|0|||
124554926|NCT04023994|447990990|FG001|Overall Study|Lost to Follow-up|1|||
124554927|NCT04023994|447990991|FG002|Overall Study|Lost to Follow-up|2|||
124554928|NCT04023994|447990992|FG003|Overall Study|Lost to Follow-up|0|||
124554929|NCT04023994|447990993|FG004|Overall Study|Lost to Follow-up|0|||
124554930|NCT04023994|447990994|FG005|Overall Study|Lost to Follow-up|0|||
124554931|NCT04023994|447990989|FG000|Overall Study|Withdrawal by Subject|0|||
124554932|NCT04023994|447990990|FG001|Overall Study|Withdrawal by Subject|0|||
124554933|NCT04023994|447990991|FG002|Overall Study|Withdrawal by Subject|0|||
124554934|NCT04023994|447990992|FG003|Overall Study|Withdrawal by Subject|1|||
124554935|NCT04023994|447990993|FG004|Overall Study|Withdrawal by Subject|0|||
124554936|NCT04023994|447990994|FG005|Overall Study|Withdrawal by Subject|0|||
124554937|NCT00923195|447990995|FG000|Overall Study|Death|0|||
124554938|NCT00923195|447990996|FG001|Overall Study|Death|1|||
124554939|NCT00467818|447990999|FG000|Overall Study|Adverse Event|1|||
124554940|NCT00467818|447991000|FG001|Overall Study|Adverse Event|0|||
124554941|NCT00467818|447990999|FG000|Overall Study|Lost to Follow-up|2|||
124554942|NCT00467818|447991000|FG001|Overall Study|Lost to Follow-up|2|||
124554943|NCT02143947|447991004|FG000|Overall Study|Lost to Follow-up|4|||
124554944|NCT02143947|447991005|FG001|Overall Study|Lost to Follow-up|2|||
124554945|NCT01244815|447991006|FG000|Overall Study|Not Treated|0|||
124554946|NCT01244815|447991007|FG001|Overall Study|Not Treated|1|||
124554947|NCT01244815|447991008|FG002|Overall Study|Not Treated|0|||
124554948|NCT01244815|447991009|FG003|Overall Study|Not Treated|0|||
124554949|NCT01244815|447991006|FG000|Overall Study|Adverse Event|4|||
124554950|NCT01244815|447991007|FG001|Overall Study|Adverse Event|7|||
124554951|NCT01244815|447991008|FG002|Overall Study|Adverse Event|5|||
124554952|NCT01244815|447991009|FG003|Overall Study|Adverse Event|5|||
124554953|NCT01244815|447991006|FG000|Overall Study|Treatment Failure|0|||
124554954|NCT01244815|447991007|FG001|Overall Study|Treatment Failure|0|||
124554955|NCT01244815|447991008|FG002|Overall Study|Treatment Failure|0|||
124554956|NCT01244815|447991009|FG003|Overall Study|Treatment Failure|1|||
124554957|NCT01244815|447991006|FG000|Overall Study|Lost to Follow-up|3|||
124554958|NCT01244815|447991007|FG001|Overall Study|Lost to Follow-up|2|||
124554959|NCT01244815|447991008|FG002|Overall Study|Lost to Follow-up|3|||
124554960|NCT01244815|447991009|FG003|Overall Study|Lost to Follow-up|2|||
124554961|NCT01244815|447991006|FG000|Overall Study|Withdrawal by Subject|0|||
124554962|NCT01244815|447991007|FG001|Overall Study|Withdrawal by Subject|2|||
124554963|NCT01244815|447991008|FG002|Overall Study|Withdrawal by Subject|0|||
124554964|NCT01244815|447991009|FG003|Overall Study|Withdrawal by Subject|3|||
124554965|NCT01244815|447991006|FG000|Overall Study|Protocol Violation|7|||
124554966|NCT01244815|447991007|FG001|Overall Study|Protocol Violation|4|||
124554967|NCT01244815|447991008|FG002|Overall Study|Protocol Violation|3|||
124554968|NCT01244815|447991009|FG003|Overall Study|Protocol Violation|1|||
124554969|NCT01244815|447991006|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
124554970|NCT01244815|447991007|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
124554971|NCT01244815|447991008|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
124554972|NCT01244815|447991009|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
124554973|NCT01313728|447991011|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
124554974|NCT03876873|447991016|FG000|Overall Study|Physician Decision|0|||
124554975|NCT03876873|447991017|FG001|Overall Study|Physician Decision|1|||
124554976|NCT03547531|447991018|FG000|Overall Study|not coming in data collection : sick|2|||
124554977|NCT03547531|447991019|FG001|Overall Study|not coming in data collection : sick|2|||
124554978|NCT03547531|447991018|FG000|Overall Study|having family occasion|0|||
124554979|NCT03547531|447991019|FG001|Overall Study|having family occasion|2|||
124554980|NCT02117479|447991027|FG000|Overall Study|Death|13|||
124554981|NCT02117479|447991028|FG001|Overall Study|Death|8|||
124554982|NCT02117479|447991027|FG000|Overall Study|Adverse Event|8|||
124717603|NCT02441101|448588224|FG000|Overall Study|PI relocated and study terminated|1|||
124717604|NCT02441101|448588225|FG001|Overall Study|PI relocated and study terminated|0|||
124717605|NCT00955474|448588226|FG000|Overall Study|Physician Decision|7|||
124717606|NCT00955474|448588227|FG001|Overall Study|Physician Decision|5|||
124717607|NCT02528942|448588230|FG000|Overall Study|Did not meet imaging criteria|9|||
124717608|NCT02528942|448588230|FG000|Overall Study|Lost to Follow-up|25|||
124717609|NCT01737762|448588231|FG000|Overall Study|Adverse Event|2|||
124717610|NCT01737762|448588232|FG001|Overall Study|Adverse Event|2|||
124717611|NCT01737762|448588231|FG000|Overall Study|Lost to Follow-up|1|||
124717612|NCT01737762|448588232|FG001|Overall Study|Lost to Follow-up|0|||
124717613|NCT01737762|448588231|FG000|Overall Study|Withdrawal by Subject|2|||
124717614|NCT01737762|448588232|FG001|Overall Study|Withdrawal by Subject|2|||
124717615|NCT01737762|448588231|FG000|Overall Study|Progressive disease|1|||
124717616|NCT01737762|448588232|FG001|Overall Study|Progressive disease|2|||
124717617|NCT01737762|448588231|FG000|Overall Study|Physician Decision|1|||
124717618|NCT01737762|448588232|FG001|Overall Study|Physician Decision|1|||
124717619|NCT01737762|448588231|FG000|Overall Study|Moved from area|2|||
124717620|NCT01737762|448588232|FG001|Overall Study|Moved from area|1|||
124717621|NCT01737762|448588231|FG000|Overall Study|Trial termination|11|||
124717622|NCT01737762|448588232|FG001|Overall Study|Trial termination|9|||
124717623|NCT00881530|448588233|FG000|Overall Study|Adverse Event|5|||
124717624|NCT00881530|448588234|FG001|Overall Study|Adverse Event|1|||
124717625|NCT00881530|448588235|FG002|Overall Study|Adverse Event|1|||
124717626|NCT00881530|448588236|FG003|Overall Study|Adverse Event|4|||
124717627|NCT00881530|448588237|FG004|Overall Study|Adverse Event|10|||
124717628|NCT00881530|448588238|FG005|Overall Study|Adverse Event|2|||
124717629|NCT00881530|448588233|FG000|Overall Study|Lack of Efficacy|1|||
124717630|NCT00881530|448588234|FG001|Overall Study|Lack of Efficacy|0|||
124717631|NCT00881530|448588235|FG002|Overall Study|Lack of Efficacy|0|||
124717632|NCT00881530|448588236|FG003|Overall Study|Lack of Efficacy|0|||
124717633|NCT00881530|448588237|FG004|Overall Study|Lack of Efficacy|1|||
124717634|NCT00881530|448588238|FG005|Overall Study|Lack of Efficacy|1|||
124717635|NCT00881530|448588233|FG000|Overall Study|Not compliant with the protocol|0|||
124717636|NCT00881530|448588234|FG001|Overall Study|Not compliant with the protocol|0|||
124717637|NCT00881530|448588235|FG002|Overall Study|Not compliant with the protocol|0|||
124717638|NCT00881530|448588236|FG003|Overall Study|Not compliant with the protocol|0|||
124717639|NCT00881530|448588237|FG004|Overall Study|Not compliant with the protocol|2|||
124717640|NCT00881530|448588238|FG005|Overall Study|Not compliant with the protocol|0|||
124717641|NCT00881530|448588233|FG000|Overall Study|Lost to Follow-up|0|||
124717642|NCT00881530|448588234|FG001|Overall Study|Lost to Follow-up|1|||
124717643|NCT00881530|448588235|FG002|Overall Study|Lost to Follow-up|1|||
124717644|NCT00881530|448588236|FG003|Overall Study|Lost to Follow-up|3|||
124717645|NCT00881530|448588237|FG004|Overall Study|Lost to Follow-up|1|||
124717646|NCT00881530|448588238|FG005|Overall Study|Lost to Follow-up|0|||
124717647|NCT00881530|448588233|FG000|Overall Study|Refused to continue medication|7|||
124717648|NCT00881530|448588234|FG001|Overall Study|Refused to continue medication|2|||
124717649|NCT00881530|448588235|FG002|Overall Study|Refused to continue medication|1|||
124717650|NCT00881530|448588236|FG003|Overall Study|Refused to continue medication|2|||
124717651|NCT00881530|448588237|FG004|Overall Study|Refused to continue medication|0|||
124717652|NCT00881530|448588238|FG005|Overall Study|Refused to continue medication|0|||
124717653|NCT00881530|448588233|FG000|Overall Study|Other reason not defined above|1|||
124717654|NCT00881530|448588234|FG001|Overall Study|Other reason not defined above|1|||
124717655|NCT00881530|448588235|FG002|Overall Study|Other reason not defined above|2|||
124717656|NCT00881530|448588236|FG003|Overall Study|Other reason not defined above|0|||
124717657|NCT00881530|448588237|FG004|Overall Study|Other reason not defined above|0|||
124717658|NCT00881530|448588238|FG005|Overall Study|Other reason not defined above|2|||
124717659|NCT03083665|448588240|FG000|Double-Blind Period|Adverse Event|5|||
124717660|NCT03083665|448588241|FG001|Double-Blind Period|Adverse Event|4|||
124717661|NCT03083665|448588242|FG002|Double-Blind Period|Adverse Event|5|||
124717662|NCT03083665|448588243|FG003|Double-Blind Period|Adverse Event|0|||
124717663|NCT03083665|448588244|FG004|Double-Blind Period|Adverse Event|0|||
124717664|NCT03083665|448588245|FG005|Double-Blind Period|Adverse Event|0|||
124717665|NCT03083665|448588240|FG000|Double-Blind Period|Lack of Efficacy|0|||
124717666|NCT03083665|448588241|FG001|Double-Blind Period|Lack of Efficacy|0|||
124717667|NCT03083665|448588242|FG002|Double-Blind Period|Lack of Efficacy|1|||
124717668|NCT03083665|448588243|FG003|Double-Blind Period|Lack of Efficacy|0|||
124717669|NCT03083665|448588244|FG004|Double-Blind Period|Lack of Efficacy|0|||
124717670|NCT03083665|448588245|FG005|Double-Blind Period|Lack of Efficacy|0|||
124473760|NCT03186989|447690878|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
124473761|NCT03186989|447690879|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
124473762|NCT03186989|447690880|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
124473763|NCT03186989|447690881|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
124473764|NCT03186989|447690882|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
124473765|NCT03186989|447690872|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
124473766|NCT03186989|447690873|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
124473767|NCT03186989|447690874|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
124473768|NCT03186989|447690875|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
124473769|NCT03186989|447690876|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
124473770|NCT03186989|447690877|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
124473771|NCT03186989|447690878|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
124473772|NCT03186989|447690879|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
124473773|NCT03186989|447690880|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
124473774|NCT03186989|447690881|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
124473775|NCT03186989|447690882|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
124473776|NCT05900115|447692576|FG000|Overall Study|Lost to Follow-up|129|||
124473777|NCT05900115|447692577|FG001|Overall Study|Lost to Follow-up|98|||
124473778|NCT00619502|447692578|FG000|Overall Study|Lost to Follow-up|8|||
124473779|NCT00619502|447692579|FG001|Overall Study|Lost to Follow-up|10|||
124473780|NCT00771472|447692580|FG000|Overall Study|Physician Decision|2|||
124473781|NCT00771472|447692581|FG001|Overall Study|Physician Decision|3|||
124473782|NCT00771472|447692580|FG000|Overall Study|Progressive Disease|3|||
124473783|NCT00771472|447692581|FG001|Overall Study|Progressive Disease|1|||
124473784|NCT00771472|447692580|FG000|Overall Study|Protocol Violation|1|||
124473785|NCT00771472|447692581|FG001|Overall Study|Protocol Violation|0|||
124473786|NCT00880750|447692584|FG000|First Intervention|Adverse Event|1|||
124473787|NCT00880750|447692585|FG001|First Intervention|Adverse Event|0|||
124473788|NCT00880750|447692584|FG000|First Intervention|Unable to collect urine|4|||
124473789|NCT00880750|447692585|FG001|First Intervention|Unable to collect urine|0|||
124473790|NCT00880750|447692584|FG000|First Intervention|Non-compliance with meals|0|||
124473791|NCT00880750|447692585|FG001|First Intervention|Non-compliance with meals|1|||
124473792|NCT00880750|447692584|FG000|First Intervention|Withdrawal by Subject|2|||
124473793|NCT00880750|447692585|FG001|First Intervention|Withdrawal by Subject|0|||
124473794|NCT00880750|447692584|FG000|First Intervention|Lost to Follow-up|2|||
124473795|NCT00880750|447692585|FG001|First Intervention|Lost to Follow-up|0|||
124473796|NCT00880750|447692584|FG000|Second Intervention|Withdrawal by Subject|2|||
124473797|NCT00880750|447692585|FG001|Second Intervention|Withdrawal by Subject|2|||
124473798|NCT00880750|447692584|FG000|Second Intervention|Protocol Violation|1|||
124473799|NCT00880750|447692585|FG001|Second Intervention|Protocol Violation|0|||
124473800|NCT00880750|447692584|FG000|Second Intervention|Unable to collect urine|1|||
124473801|NCT00880750|447692585|FG001|Second Intervention|Unable to collect urine|0|||
124473802|NCT00483327|447692586|FG000|Overall Study|Adverse Event|1|||
124473803|NCT00483327|447692586|FG000|Overall Study|Withdrawal by Subject|3|||
124473804|NCT00483327|447692586|FG000|Overall Study|Lost to Follow-up|4|||
124473805|NCT00483327|447692586|FG000|Overall Study|Patient Non Compliance|2|||
124473806|NCT00670007|447692587|FG000|Overall Study|Drug abuse|1|||
124473807|NCT00670007|447692587|FG000|Overall Study|Lung transplant|1|||
124473808|NCT00670007|447692587|FG000|Overall Study|Travel/Vacation|1|||
124473809|NCT00670007|447692587|FG000|Overall Study|Adverse event, serious fatal|1|||
124473810|NCT00670007|447692587|FG000|Overall Study|Adverse Event|1|||
124473811|NCT00670007|447692587|FG000|Overall Study|Withdrawal by Subject|4|||
124473812|NCT00618722|447692588|FG000|Overall Study|Refusal of Treatment|0|||
124473813|NCT00618722|447692589|FG001|Overall Study|Refusal of Treatment|0|||
124473814|NCT00618722|447692590|FG002|Overall Study|Refusal of Treatment|1|||
124473815|NCT00618722|447692591|FG003|Overall Study|Refusal of Treatment|0|||
124473816|NCT00618722|447692588|FG000|Overall Study|Patient Request|1|||
124473817|NCT00618722|447692589|FG001|Overall Study|Patient Request|1|||
124473818|NCT00618722|447692590|FG002|Overall Study|Patient Request|1|||
124473819|NCT00618722|447692591|FG003|Overall Study|Patient Request|1|||
124473820|NCT00618722|447692588|FG000|Overall Study|Inability to Complete Study Procedure|0|||
124473821|NCT00618722|447692589|FG001|Overall Study|Inability to Complete Study Procedure|1|||
124473822|NCT00618722|447692590|FG002|Overall Study|Inability to Complete Study Procedure|0|||
124473823|NCT00618722|447692591|FG003|Overall Study|Inability to Complete Study Procedure|0|||
124473824|NCT00618722|447692588|FG000|Overall Study|Lost to Follow-up|2|||
124473825|NCT00618722|447692589|FG001|Overall Study|Lost to Follow-up|0|||
124473826|NCT00618722|447692590|FG002|Overall Study|Lost to Follow-up|0|||
124473827|NCT00618722|447692591|FG003|Overall Study|Lost to Follow-up|2|||
124473828|NCT00618722|447692588|FG000|Overall Study|Miscellaneous Reasons|0|||
124473829|NCT00618722|447692589|FG001|Overall Study|Miscellaneous Reasons|0|||
124473830|NCT00618722|447692590|FG002|Overall Study|Miscellaneous Reasons|1|||
124473831|NCT00618722|447692591|FG003|Overall Study|Miscellaneous Reasons|1|||
124473832|NCT00200057|447692594|FG000|Overall Study|Lack of Efficacy|3|||
124473833|NCT00200057|447692594|FG000|Overall Study|Exited due to terminal illness of PI|2|||
124473834|NCT00200057|447692594|FG000|Overall Study|Withdrawal by Subject|1|||
124473835|NCT00200057|447692594|FG000|Overall Study|Change in medical condition|1|||
124473836|NCT00200057|447692594|FG000|Overall Study|Infection|1|||
124473837|NCT00200057|447692594|FG000|Overall Study|Death|1|||
124473838|NCT00778830|447692595|FG000|Overall Study|Ongoing at data cut-off|0|||
124473839|NCT00778830|447692596|FG001|Overall Study|Ongoing at data cut-off|1|||
124473840|NCT01891643|447692597|FG000|Overall Study|Adverse event unrelated to study drug|2|||
124473841|NCT01891643|447692598|FG001|Overall Study|Adverse event unrelated to study drug|5|||
124473842|NCT01891643|447692597|FG000|Overall Study|Disease Progression|4|||
124473843|NCT01891643|447692598|FG001|Overall Study|Disease Progression|3|||
124473844|NCT01891643|447692597|FG000|Overall Study|Study Drug Toxicity|3|||
124473845|NCT01891643|447692598|FG001|Overall Study|Study Drug Toxicity|0|||
124473846|NCT01891643|447692597|FG000|Overall Study|Maximum Clinical Benefit|0|||
124473847|NCT01891643|447692598|FG001|Overall Study|Maximum Clinical Benefit|1|||
124473848|NCT01891643|447692597|FG000|Overall Study|Poor/Non-compliance|0|||
124473849|NCT01891643|447692598|FG001|Overall Study|Poor/Non-compliance|1|||
124473850|NCT01891643|447692597|FG000|Overall Study|Participant request to discontinue|1|||
124473851|NCT01891643|447692598|FG001|Overall Study|Participant request to discontinue|0|||
124473852|NCT01097629|447692605|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
124473853|NCT01097629|447692606|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
124473854|NCT01097629|447692607|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
124473855|NCT01097629|447692608|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
124473856|NCT01097629|447692609|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
124473857|NCT01097629|447692610|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
124473858|NCT01097629|447692611|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
124473859|NCT01097629|447692612|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
124473860|NCT01097629|447692605|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
124473861|NCT01097629|447692606|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
124473862|NCT01097629|447692607|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
124473863|NCT01097629|447692608|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
124473864|NCT01097629|447692609|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
124473865|NCT01097629|447692610|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
124473866|NCT01097629|447692611|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
124473867|NCT01097629|447692612|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
124473868|NCT01097629|447692605|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
124473869|NCT01097629|447692606|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
124473870|NCT01097629|447692607|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
124473871|NCT01097629|447692608|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
124473872|NCT01097629|447692609|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
124473873|NCT01097629|447692610|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
124473874|NCT01097629|447692611|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
124473875|NCT01097629|447692612|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
124473876|NCT01097629|447692605|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
124473877|NCT01097629|447692606|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
124473878|NCT01097629|447692607|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
124473879|NCT01097629|447692608|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
124473880|NCT01097629|447692609|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
124473881|NCT01097629|447692610|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
124473882|NCT01097629|447692611|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
124473883|NCT01097629|447692612|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
124473884|NCT01097629|447692605|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
124473885|NCT01097629|447692606|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
124473886|NCT01097629|447692607|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
124473887|NCT01097629|447692608|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
124473888|NCT01097629|447692609|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
124473889|NCT01097629|447692610|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
124473890|NCT01097629|447692611|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
124473891|NCT01097629|447692612|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
124473892|NCT01097629|447692605|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
124473893|NCT01097629|447692606|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
124473894|NCT01097629|447692607|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
124473895|NCT01097629|447692608|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
124473896|NCT01097629|447692609|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
124717671|NCT03083665|448588240|FG000|Double-Blind Period|Protocol Violation|1|||
124554983|NCT02117479|447991028|FG001|Overall Study|Adverse Event|16|||
124554984|NCT02117479|447991027|FG000|Overall Study|Subject decision|8|||
124554985|NCT02117479|447991028|FG001|Overall Study|Subject decision|9|||
124554986|NCT02117479|447991027|FG000|Overall Study|Disease progression|104|||
124554987|NCT02117479|447991028|FG001|Overall Study|Disease progression|108|||
124554988|NCT02117479|447991027|FG000|Overall Study|Noncompliance with study treatment|1|||
124554989|NCT02117479|447991028|FG001|Overall Study|Noncompliance with study treatment|0|||
124554990|NCT02117479|447991027|FG000|Overall Study|Study terminated by the sponsor|4|||
124554991|NCT02117479|447991028|FG001|Overall Study|Study terminated by the sponsor|6|||
124554992|NCT02117479|447991027|FG000|Overall Study|Physician Decision|7|||
124554993|NCT02117479|447991028|FG001|Overall Study|Physician Decision|2|||
124554994|NCT02117479|447991027|FG000|Overall Study|Other unspecified|11|||
124554995|NCT02117479|447991028|FG001|Overall Study|Other unspecified|7|||
124554996|NCT02444182|447991029|FG000|Overall Study|non-compliance|2|||
124554997|NCT02444182|447991030|FG001|Overall Study|non-compliance|1|||
124554998|NCT02444182|447991029|FG000|Overall Study|Lost to Follow-up|0|||
124554999|NCT02444182|447991030|FG001|Overall Study|Lost to Follow-up|4|||
124555000|NCT01959230|447991033|FG000|Overall Study|Failure to follow study procedures|0|||
124555001|NCT01959230|447991034|FG001|Overall Study|Failure to follow study procedures|1|||
124555002|NCT01959230|447991033|FG000|Overall Study|Administrative reasons|2|||
124555003|NCT01959230|447991034|FG001|Overall Study|Administrative reasons|0|||
124555004|NCT01959230|447991033|FG000|Overall Study|Withdrawal by Subject|2|||
124555005|NCT01959230|447991034|FG001|Overall Study|Withdrawal by Subject|0|||
124555006|NCT03216954|447991036|FG000|Overall Study|Adverse Event|0|||
124555007|NCT03216954|447991037|FG001|Overall Study|Adverse Event|0|||
124555008|NCT03216954|447991038|FG002|Overall Study|Adverse Event|1|||
124555009|NCT03216954|447991039|FG003|Overall Study|Adverse Event|0|||
124555010|NCT03216954|447991040|FG004|Overall Study|Adverse Event|1|||
124555011|NCT03216954|447991036|FG000|Overall Study|Withdrawal by Subject|2|||
124555012|NCT03216954|447991037|FG001|Overall Study|Withdrawal by Subject|0|||
124555013|NCT03216954|447991038|FG002|Overall Study|Withdrawal by Subject|0|||
124555014|NCT03216954|447991039|FG003|Overall Study|Withdrawal by Subject|0|||
124555015|NCT03216954|447991040|FG004|Overall Study|Withdrawal by Subject|0|||
124555016|NCT03216954|447991036|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
124555017|NCT03216954|447991037|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
124555018|NCT03216954|447991038|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
124555019|NCT03216954|447991039|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
124555020|NCT03216954|447991040|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
124555021|NCT02487979|447991041|FG000|Overall Study|Physician Decision|2|||
124555022|NCT02487979|447991041|FG000|Overall Study|Withdrawal by Subject|2|||
124555023|NCT02487979|447991041|FG000|Overall Study|Progressive Disease|17|||
124555024|NCT00447694|447991042|FG000|Overall Study|Adverse Event|2|||
124555025|NCT00447694|447991042|FG000|Overall Study|Abnormal laboratory value|1|||
124555026|NCT00447694|447991042|FG000|Overall Study|Abnormal test procedure result|1|||
124555027|NCT00447694|447991042|FG000|Overall Study|Withdrawal by Subject|2|||
124555028|NCT01507831|447991046|FG000|Overall Study|Randomized but not treated|0|||
124555029|NCT01507831|447991047|FG001|Overall Study|Randomized but not treated|3|||
124555030|NCT01507831|447991046|FG000|Overall Study|Adverse Event|48|||
124555031|NCT01507831|447991047|FG001|Overall Study|Adverse Event|113|||
124555032|NCT01507831|447991046|FG000|Overall Study|Death|6|||
124555033|NCT01507831|447991047|FG001|Overall Study|Death|2|||
124555034|NCT01507831|447991046|FG000|Overall Study|Poor compliance to protocol|38|||
124555035|NCT01507831|447991047|FG001|Overall Study|Poor compliance to protocol|60|||
124555036|NCT01507831|447991046|FG000|Overall Study|Physician Decision|0|||
124555037|NCT01507831|447991047|FG001|Overall Study|Physician Decision|4|||
124555038|NCT01507831|447991046|FG000|Overall Study|Participant moved|5|||
124555039|NCT01507831|447991047|FG001|Overall Study|Participant moved|19|||
124555040|NCT01507831|447991046|FG000|Overall Study|Consent withdrawn by participant|34|||
124555041|NCT01507831|447991047|FG001|Overall Study|Consent withdrawn by participant|72|||
124555042|NCT01507831|447991046|FG000|Overall Study|Related to study drug administration|5|||
124555043|NCT01507831|447991047|FG001|Overall Study|Related to study drug administration|14|||
124555044|NCT01507831|447991046|FG000|Overall Study|Last visit outside protocol visit window|51|||
124555045|NCT01507831|447991047|FG001|Overall Study|Last visit outside protocol visit window|143|||
124555046|NCT01507831|447991046|FG000|Overall Study|Selection criteria finally not met|0|||
124555047|NCT01507831|447991047|FG001|Overall Study|Selection criteria finally not met|1|||
124555048|NCT01507831|447991046|FG000|Overall Study|Site closure|0|||
124555049|NCT01507831|447991047|FG001|Overall Study|Site closure|3|||
124555050|NCT01507831|447991046|FG000|Overall Study|Potential lost to follow-up|3|||
124555051|NCT01507831|447991047|FG001|Overall Study|Potential lost to follow-up|0|||
124555052|NCT01507831|447991046|FG000|Overall Study|Other|3|||
124555053|NCT01507831|447991047|FG001|Overall Study|Other|6|||
124555054|NCT00879970|447991048|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
124555055|NCT00879970|447991049|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
124555056|NCT00879970|447991050|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
124555057|NCT00879970|447991051|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
124555058|NCT00879970|447991052|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
124555059|NCT00879970|447991048|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
124555060|NCT00879970|447991049|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
124555061|NCT00879970|447991050|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
124555062|NCT00879970|447991051|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
124555063|NCT00879970|447991052|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
124555064|NCT00879970|447991048|FG000|Period 1 TZD Randomization|Death|2|||
124555065|NCT00879970|447991049|FG001|Period 1 TZD Randomization|Death|1|||
124555066|NCT00879970|447991050|FG002|Period 1 TZD Randomization|Death|0|||
124555067|NCT00879970|447991051|FG003|Period 1 TZD Randomization|Death|0|||
124555068|NCT00879970|447991052|FG004|Period 1 TZD Randomization|Death|0|||
124555069|NCT00879970|447991048|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
124555070|NCT00879970|447991049|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
124555071|NCT00879970|447991050|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
124555072|NCT00879970|447991051|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
124555073|NCT00879970|447991052|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
124555074|NCT00879970|447991048|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
124555075|NCT00879970|447991049|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
124555076|NCT00879970|447991050|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
124555077|NCT00879970|447991051|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
124555078|NCT00879970|447991052|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
124555079|NCT00879970|447991048|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
124555080|NCT00879970|447991049|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
124555081|NCT00879970|447991050|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
124555082|NCT00879970|447991051|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
124555083|NCT00879970|447991052|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
124555084|NCT00879970|447991048|FG000|Period 2 Vitamin D Randomization|Death|0|||
124555085|NCT00879970|447991049|FG001|Period 2 Vitamin D Randomization|Death|0|||
124555086|NCT00879970|447991050|FG002|Period 2 Vitamin D Randomization|Death|0|||
124555087|NCT00879970|447991051|FG003|Period 2 Vitamin D Randomization|Death|2|||
124555088|NCT00879970|447991052|FG004|Period 2 Vitamin D Randomization|Death|0|||
124555089|NCT04380701|447991054|FG000|Overall Study|Pregnancy|0|||
124555090|NCT04380701|447991055|FG001|Overall Study|Pregnancy|0|||
124555091|NCT04380701|447991056|FG002|Overall Study|Pregnancy|0|||
124555092|NCT04380701|447991057|FG003|Overall Study|Pregnancy|0|||
124555093|NCT04380701|447991058|FG004|Overall Study|Pregnancy|0|||
124555094|NCT04380701|447991059|FG005|Overall Study|Pregnancy|0|||
124555095|NCT04380701|447991060|FG006|Overall Study|Pregnancy|0|||
124555096|NCT04380701|447991061|FG007|Overall Study|Pregnancy|0|||
124555097|NCT04380701|447991062|FG008|Overall Study|Pregnancy|0|||
124555098|NCT04380701|447991063|FG009|Overall Study|Pregnancy|0|||
124555099|NCT04380701|447991064|FG010|Overall Study|Pregnancy|0|||
124555100|NCT04380701|447991065|FG011|Overall Study|Pregnancy|0|||
124555101|NCT04380701|447991066|FG012|Overall Study|Pregnancy|0|||
124555102|NCT04380701|447991067|FG013|Overall Study|Pregnancy|0|||
124555103|NCT04380701|447991068|FG014|Overall Study|Pregnancy|0|||
124555104|NCT04380701|447991069|FG015|Overall Study|Pregnancy|0|||
124555105|NCT04380701|447991070|FG016|Overall Study|Pregnancy|0|||
124555106|NCT04380701|447991071|FG017|Overall Study|Pregnancy|0|||
124555107|NCT04380701|447991072|FG018|Overall Study|Pregnancy|0|||
124555108|NCT04380701|447991073|FG019|Overall Study|Pregnancy|0|||
124771642|NCT04225897|448794525|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
124555109|NCT04380701|447991074|FG020|Overall Study|Pregnancy|0|||
124555110|NCT04380701|447991075|FG021|Overall Study|Pregnancy|0|||
124555111|NCT04380701|447991076|FG022|Overall Study|Pregnancy|0|||
124473897|NCT01097629|447692610|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
124555112|NCT04380701|447991077|FG023|Overall Study|Pregnancy|0|||
124473898|NCT01097629|447692611|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
124473899|NCT01097629|447692612|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
124473900|NCT01097629|447692605|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
124555113|NCT04380701|447991078|FG024|Overall Study|Pregnancy|0|||
124555114|NCT04380701|447991079|FG025|Overall Study|Pregnancy|0|||
124555115|NCT04380701|447991080|FG026|Overall Study|Pregnancy|0|||
124555116|NCT04380701|447991081|FG027|Overall Study|Pregnancy|0|||
124555117|NCT04380701|447991082|FG028|Overall Study|Pregnancy|0|||
124555118|NCT04380701|447991083|FG029|Overall Study|Pregnancy|0|||
124555119|NCT04380701|447991084|FG030|Overall Study|Pregnancy|0|||
124555120|NCT04380701|447991085|FG031|Overall Study|Pregnancy|0|||
124555121|NCT04380701|447991086|FG032|Overall Study|Pregnancy|1|||
124555122|NCT04380701|447991087|FG033|Overall Study|Pregnancy|0|||
124555123|NCT04380701|447991054|FG000|Overall Study|Lost to Follow-up|0|||
124555124|NCT04380701|447991055|FG001|Overall Study|Lost to Follow-up|0|||
124555125|NCT04380701|447991056|FG002|Overall Study|Lost to Follow-up|0|||
124555126|NCT04380701|447991057|FG003|Overall Study|Lost to Follow-up|0|||
124555127|NCT04380701|447991058|FG004|Overall Study|Lost to Follow-up|0|||
124555128|NCT04380701|447991059|FG005|Overall Study|Lost to Follow-up|0|||
124555129|NCT04380701|447991060|FG006|Overall Study|Lost to Follow-up|0|||
124555130|NCT04380701|447991061|FG007|Overall Study|Lost to Follow-up|0|||
124555131|NCT04380701|447991062|FG008|Overall Study|Lost to Follow-up|0|||
124555132|NCT04380701|447991063|FG009|Overall Study|Lost to Follow-up|0|||
124555133|NCT04380701|447991064|FG010|Overall Study|Lost to Follow-up|0|||
124555134|NCT04380701|447991065|FG011|Overall Study|Lost to Follow-up|0|||
124555135|NCT04380701|447991066|FG012|Overall Study|Lost to Follow-up|0|||
124555136|NCT04380701|447991067|FG013|Overall Study|Lost to Follow-up|0|||
124555137|NCT04380701|447991068|FG014|Overall Study|Lost to Follow-up|0|||
124473901|NCT01097629|447692606|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
124473902|NCT01097629|447692607|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
124473903|NCT01097629|447692608|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
124473904|NCT01097629|447692609|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
124473905|NCT01097629|447692610|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
124473906|NCT01097629|447692611|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
124473907|NCT01097629|447692612|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
124473908|NCT01097629|447692605|FG000|DB RO Phase|Withdrawal by Subject|0|||
124473909|NCT01097629|447692606|FG001|DB RO Phase|Withdrawal by Subject|0|||
124473910|NCT01097629|447692607|FG002|DB RO Phase|Withdrawal by Subject|0|||
124473911|NCT01097629|447692608|FG003|DB RO Phase|Withdrawal by Subject|0|||
124555138|NCT04380701|447991069|FG015|Overall Study|Lost to Follow-up|0|||
124555139|NCT04380701|447991070|FG016|Overall Study|Lost to Follow-up|0|||
124555140|NCT04380701|447991071|FG017|Overall Study|Lost to Follow-up|0|||
124555141|NCT04380701|447991072|FG018|Overall Study|Lost to Follow-up|0|||
124555142|NCT04380701|447991073|FG019|Overall Study|Lost to Follow-up|0|||
124555143|NCT04380701|447991074|FG020|Overall Study|Lost to Follow-up|1|||
124555144|NCT04380701|447991075|FG021|Overall Study|Lost to Follow-up|0|||
124555145|NCT04380701|447991076|FG022|Overall Study|Lost to Follow-up|0|||
124555146|NCT04380701|447991077|FG023|Overall Study|Lost to Follow-up|1|||
124555147|NCT04380701|447991078|FG024|Overall Study|Lost to Follow-up|0|||
124555148|NCT04380701|447991079|FG025|Overall Study|Lost to Follow-up|0|||
124555149|NCT04380701|447991080|FG026|Overall Study|Lost to Follow-up|0|||
124555150|NCT04380701|447991081|FG027|Overall Study|Lost to Follow-up|0|||
124555151|NCT04380701|447991082|FG028|Overall Study|Lost to Follow-up|0|||
124555152|NCT04380701|447991083|FG029|Overall Study|Lost to Follow-up|1|||
124555153|NCT04380701|447991084|FG030|Overall Study|Lost to Follow-up|0|||
124555154|NCT04380701|447991085|FG031|Overall Study|Lost to Follow-up|0|||
124555155|NCT04380701|447991086|FG032|Overall Study|Lost to Follow-up|0|||
124555156|NCT04380701|447991087|FG033|Overall Study|Lost to Follow-up|1|||
124555157|NCT04380701|447991054|FG000|Overall Study|Private reason(s)|0|||
124555158|NCT04380701|447991055|FG001|Overall Study|Private reason(s)|0|||
124555159|NCT04380701|447991056|FG002|Overall Study|Private reason(s)|0|||
124555160|NCT04380701|447991057|FG003|Overall Study|Private reason(s)|0|||
124555161|NCT04380701|447991058|FG004|Overall Study|Private reason(s)|0|||
124555162|NCT04380701|447991059|FG005|Overall Study|Private reason(s)|0|||
124555163|NCT04380701|447991060|FG006|Overall Study|Private reason(s)|1|||
124555164|NCT04380701|447991061|FG007|Overall Study|Private reason(s)|0|||
124555165|NCT04380701|447991062|FG008|Overall Study|Private reason(s)|1|||
124555166|NCT04380701|447991063|FG009|Overall Study|Private reason(s)|1|||
124555167|NCT04380701|447991064|FG010|Overall Study|Private reason(s)|0|||
124555168|NCT04380701|447991065|FG011|Overall Study|Private reason(s)|0|||
124555169|NCT04380701|447991066|FG012|Overall Study|Private reason(s)|0|||
124555170|NCT04380701|447991067|FG013|Overall Study|Private reason(s)|0|||
124555171|NCT04380701|447991068|FG014|Overall Study|Private reason(s)|0|||
124555172|NCT04380701|447991069|FG015|Overall Study|Private reason(s)|0|||
124555173|NCT04380701|447991070|FG016|Overall Study|Private reason(s)|0|||
124555174|NCT04380701|447991071|FG017|Overall Study|Private reason(s)|0|||
124555175|NCT04380701|447991072|FG018|Overall Study|Private reason(s)|0|||
124555176|NCT04380701|447991073|FG019|Overall Study|Private reason(s)|0|||
124555177|NCT04380701|447991074|FG020|Overall Study|Private reason(s)|0|||
124555178|NCT04380701|447991075|FG021|Overall Study|Private reason(s)|0|||
124555179|NCT04380701|447991076|FG022|Overall Study|Private reason(s)|0|||
124555180|NCT04380701|447991077|FG023|Overall Study|Private reason(s)|1|||
124555181|NCT04380701|447991078|FG024|Overall Study|Private reason(s)|0|||
124555182|NCT04380701|447991079|FG025|Overall Study|Private reason(s)|0|||
124555183|NCT04380701|447991080|FG026|Overall Study|Private reason(s)|0|||
124555184|NCT04380701|447991081|FG027|Overall Study|Private reason(s)|0|||
124555185|NCT04380701|447991082|FG028|Overall Study|Private reason(s)|0|||
124555186|NCT04380701|447991083|FG029|Overall Study|Private reason(s)|1|||
124555187|NCT04380701|447991084|FG030|Overall Study|Private reason(s)|0|||
124555188|NCT04380701|447991085|FG031|Overall Study|Private reason(s)|0|||
124555189|NCT04380701|447991086|FG032|Overall Study|Private reason(s)|0|||
124555190|NCT04380701|447991087|FG033|Overall Study|Private reason(s)|0|||
124555191|NCT04380701|447991054|FG000|Overall Study|Withdrawal by Subject|0|||
124555192|NCT04380701|447991055|FG001|Overall Study|Withdrawal by Subject|0|||
124555193|NCT04380701|447991056|FG002|Overall Study|Withdrawal by Subject|0|||
124555194|NCT04380701|447991057|FG003|Overall Study|Withdrawal by Subject|0|||
124555195|NCT04380701|447991058|FG004|Overall Study|Withdrawal by Subject|0|||
124555196|NCT04380701|447991059|FG005|Overall Study|Withdrawal by Subject|0|||
124555197|NCT04380701|447991060|FG006|Overall Study|Withdrawal by Subject|1|||
124555198|NCT04380701|447991061|FG007|Overall Study|Withdrawal by Subject|1|||
124555199|NCT04380701|447991062|FG008|Overall Study|Withdrawal by Subject|0|||
124555200|NCT04380701|447991063|FG009|Overall Study|Withdrawal by Subject|0|||
124555201|NCT04380701|447991064|FG010|Overall Study|Withdrawal by Subject|0|||
124555202|NCT04380701|447991065|FG011|Overall Study|Withdrawal by Subject|1|||
124555203|NCT04380701|447991066|FG012|Overall Study|Withdrawal by Subject|0|||
124555204|NCT04380701|447991067|FG013|Overall Study|Withdrawal by Subject|1|||
124555205|NCT04380701|447991068|FG014|Overall Study|Withdrawal by Subject|0|||
124555206|NCT04380701|447991069|FG015|Overall Study|Withdrawal by Subject|0|||
124555207|NCT04380701|447991070|FG016|Overall Study|Withdrawal by Subject|1|||
124555208|NCT04380701|447991071|FG017|Overall Study|Withdrawal by Subject|0|||
124555209|NCT04380701|447991072|FG018|Overall Study|Withdrawal by Subject|0|||
124555210|NCT04380701|447991073|FG019|Overall Study|Withdrawal by Subject|0|||
124555211|NCT04380701|447991074|FG020|Overall Study|Withdrawal by Subject|0|||
124555212|NCT04380701|447991075|FG021|Overall Study|Withdrawal by Subject|0|||
124555213|NCT04380701|447991076|FG022|Overall Study|Withdrawal by Subject|2|||
124555214|NCT04380701|447991077|FG023|Overall Study|Withdrawal by Subject|2|||
124555215|NCT04380701|447991078|FG024|Overall Study|Withdrawal by Subject|1|||
124555216|NCT04380701|447991079|FG025|Overall Study|Withdrawal by Subject|1|||
124555217|NCT04380701|447991080|FG026|Overall Study|Withdrawal by Subject|0|||
124555218|NCT04380701|447991081|FG027|Overall Study|Withdrawal by Subject|0|||
124555219|NCT04380701|447991082|FG028|Overall Study|Withdrawal by Subject|0|||
124555220|NCT04380701|447991083|FG029|Overall Study|Withdrawal by Subject|0|||
124717672|NCT03083665|448588241|FG001|Double-Blind Period|Protocol Violation|0|||
124717673|NCT03083665|448588242|FG002|Double-Blind Period|Protocol Violation|1|||
124717674|NCT03083665|448588243|FG003|Double-Blind Period|Protocol Violation|0|||
124717675|NCT03083665|448588244|FG004|Double-Blind Period|Protocol Violation|0|||
124717676|NCT03083665|448588245|FG005|Double-Blind Period|Protocol Violation|0|||
124717677|NCT03083665|448588240|FG000|Double-Blind Period|Lost to Follow-up|1|||
124717678|NCT03083665|448588241|FG001|Double-Blind Period|Lost to Follow-up|0|||
124717679|NCT03083665|448588242|FG002|Double-Blind Period|Lost to Follow-up|1|||
124717680|NCT03083665|448588243|FG003|Double-Blind Period|Lost to Follow-up|0|||
124717681|NCT03083665|448588244|FG004|Double-Blind Period|Lost to Follow-up|0|||
124717682|NCT03083665|448588245|FG005|Double-Blind Period|Lost to Follow-up|0|||
124717683|NCT03083665|448588240|FG000|Double-Blind Period|Withdrawal by Subject|3|||
124717684|NCT03083665|448588241|FG001|Double-Blind Period|Withdrawal by Subject|0|||
124717685|NCT03083665|448588242|FG002|Double-Blind Period|Withdrawal by Subject|0|||
124717686|NCT03083665|448588243|FG003|Double-Blind Period|Withdrawal by Subject|0|||
124717687|NCT03083665|448588244|FG004|Double-Blind Period|Withdrawal by Subject|0|||
124717688|NCT03083665|448588245|FG005|Double-Blind Period|Withdrawal by Subject|0|||
124717689|NCT03083665|448588240|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
124717690|NCT03083665|448588241|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
124717691|NCT03083665|448588242|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
124717692|NCT03083665|448588243|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
124717693|NCT03083665|448588244|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
124717694|NCT03083665|448588245|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
124717695|NCT03083665|448588240|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
124717696|NCT03083665|448588241|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
124717697|NCT03083665|448588242|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
124717698|NCT03083665|448588243|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
124717699|NCT03083665|448588244|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
124717700|NCT03083665|448588245|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
124717701|NCT03083665|448588240|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
124717702|NCT03083665|448588241|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
124717703|NCT03083665|448588242|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
124717704|NCT03083665|448588243|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
124717705|NCT03083665|448588244|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
124717706|NCT03083665|448588245|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
124717707|NCT03083665|448588240|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
124717708|NCT03083665|448588241|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
124717709|NCT03083665|448588242|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
124717710|NCT03083665|448588243|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
124555221|NCT04380701|447991084|FG030|Overall Study|Withdrawal by Subject|0|||
124555222|NCT04380701|447991085|FG031|Overall Study|Withdrawal by Subject|0|||
124717711|NCT03083665|448588244|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
124717712|NCT03083665|448588245|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
124717713|NCT03083665|448588240|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
124717714|NCT03083665|448588241|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
124717715|NCT03083665|448588242|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
124717716|NCT03083665|448588243|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
124555223|NCT04380701|447991086|FG032|Overall Study|Withdrawal by Subject|0|||
124555224|NCT04380701|447991087|FG033|Overall Study|Withdrawal by Subject|0|||
124717717|NCT03083665|448588244|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
124717718|NCT03083665|448588245|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
124717719|NCT03083665|448588240|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
124717720|NCT03083665|448588241|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
124717721|NCT03083665|448588242|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
124717722|NCT03083665|448588243|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
124717723|NCT03083665|448588244|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
124717724|NCT03083665|448588245|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
124717725|NCT03083665|448588240|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
124717726|NCT03083665|448588241|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
124717727|NCT03083665|448588242|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
124717728|NCT03083665|448588243|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
124717729|NCT03083665|448588244|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
124717730|NCT03083665|448588245|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
124717731|NCT03083665|448588240|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
124717732|NCT03083665|448588241|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
124717733|NCT03083665|448588242|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
124717734|NCT03083665|448588243|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
124717735|NCT03083665|448588244|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
124717736|NCT03083665|448588245|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
124717737|NCT03083665|448588240|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
124717738|NCT03083665|448588241|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
124717739|NCT03083665|448588242|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
124717740|NCT03083665|448588243|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
124717741|NCT03083665|448588244|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
124717742|NCT03083665|448588245|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
124717743|NCT01467466|448588246|FG000|Overall Study|Withdrawal by Subject|15|||
124717744|NCT01467466|448588247|FG001|Overall Study|Withdrawal by Subject|18|||
124717745|NCT01467466|448588248|FG002|Overall Study|Withdrawal by Subject|13|||
124717746|NCT01467466|448588249|FG003|Overall Study|Withdrawal by Subject|11|||
124717747|NCT01467466|448588246|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
124717748|NCT01467466|448588247|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
124717749|NCT01467466|448588248|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
124717750|NCT01467466|448588249|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
124717751|NCT01467466|448588246|FG000|Overall Study|Procedure Cancelled|46|||
124717752|NCT01467466|448588247|FG001|Overall Study|Procedure Cancelled|45|||
124717753|NCT01467466|448588248|FG002|Overall Study|Procedure Cancelled|25|||
124717754|NCT01467466|448588249|FG003|Overall Study|Procedure Cancelled|29|||
124717755|NCT01467466|448588246|FG000|Overall Study|No Endpoint Blood Draw|38|||
124717756|NCT01467466|448588247|FG001|Overall Study|No Endpoint Blood Draw|32|||
124717757|NCT01467466|448588248|FG002|Overall Study|No Endpoint Blood Draw|51|||
124717758|NCT01467466|448588249|FG003|Overall Study|No Endpoint Blood Draw|43|||
124717759|NCT01144416|448588256|FG000|Intervention Period|Adverse Event|5|||
124717760|NCT01144416|448588257|FG001|Intervention Period|Adverse Event|6|||
124717761|NCT01144416|448588256|FG000|Intervention Period|Insufficient ovarian response|11|||
124717762|NCT01144416|448588257|FG001|Intervention Period|Insufficient ovarian response|17|||
124717763|NCT01144416|448588256|FG000|Intervention Period|Risk of OHSS|0|||
124717764|NCT01144416|448588257|FG001|Intervention Period|Risk of OHSS|1|||
124717765|NCT01144416|448588256|FG000|Intervention Period|Too high ovarian response|4|||
124717766|NCT01144416|448588257|FG001|Intervention Period|Too high ovarian response|2|||
124717767|NCT01144416|448588256|FG000|Intervention Period|No/too few/bad oocytes|7|||
124717768|NCT01144416|448588257|FG001|Intervention Period|No/too few/bad oocytes|5|||
124717769|NCT01144416|448588256|FG000|Intervention Period|No or abnormal fertilization|25|||
124717770|NCT01144416|448588257|FG001|Intervention Period|No or abnormal fertilization|10|||
124717771|NCT01144416|448588256|FG000|Intervention Period|No/too few/bad quality embryos|3|||
124717772|NCT01144416|448588257|FG001|Intervention Period|No/too few/bad quality embryos|3|||
124717773|NCT01144416|448588256|FG000|Intervention Period|Other|7|||
124717774|NCT01144416|448588257|FG001|Intervention Period|Other|5|||
124717775|NCT02131662|448588262|FG000|Overall Study|Protocol Violation|1|||
124717776|NCT02131662|448588263|FG001|Overall Study|Protocol Violation|0|||
124717777|NCT02131662|448588264|FG002|Overall Study|Protocol Violation|0|||
124717778|NCT02131662|448588265|FG003|Overall Study|Protocol Violation|0|||
124717779|NCT02131662|448588266|FG004|Overall Study|Protocol Violation|0|||
124717780|NCT02131662|448588262|FG000|Overall Study|Other|2|||
124717781|NCT02131662|448588263|FG001|Overall Study|Other|4|||
124717782|NCT02131662|448588264|FG002|Overall Study|Other|3|||
124717783|NCT02131662|448588265|FG003|Overall Study|Other|3|||
124717784|NCT02131662|448588266|FG004|Overall Study|Other|4|||
124473912|NCT01097629|447692609|FG004|DB RO Phase|Withdrawal by Subject|0|||
124473913|NCT01097629|447692610|FG005|DB RO Phase|Withdrawal by Subject|0|||
124473914|NCT01097629|447692611|FG006|DB RO Phase|Withdrawal by Subject|0|||
124473915|NCT01097629|447692612|FG007|DB RO Phase|Withdrawal by Subject|1|||
124473916|NCT01097629|447692605|FG000|DB RO Phase|Protocol Violation|0|||
124473917|NCT01097629|447692606|FG001|DB RO Phase|Protocol Violation|0|||
124473918|NCT01097629|447692607|FG002|DB RO Phase|Protocol Violation|0|||
124473919|NCT01097629|447692608|FG003|DB RO Phase|Protocol Violation|1|||
124473920|NCT01097629|447692609|FG004|DB RO Phase|Protocol Violation|0|||
124473921|NCT01097629|447692610|FG005|DB RO Phase|Protocol Violation|1|||
124473922|NCT01097629|447692611|FG006|DB RO Phase|Protocol Violation|1|||
124473923|NCT01097629|447692612|FG007|DB RO Phase|Protocol Violation|0|||
124473924|NCT01097629|447692605|FG000|DB RO Phase|Lost to Follow-up|0|||
124473925|NCT01097629|447692606|FG001|DB RO Phase|Lost to Follow-up|0|||
124473926|NCT01097629|447692607|FG002|DB RO Phase|Lost to Follow-up|0|||
124473927|NCT01097629|447692608|FG003|DB RO Phase|Lost to Follow-up|0|||
124473928|NCT01097629|447692609|FG004|DB RO Phase|Lost to Follow-up|0|||
124473929|NCT01097629|447692610|FG005|DB RO Phase|Lost to Follow-up|0|||
124473930|NCT01097629|447692611|FG006|DB RO Phase|Lost to Follow-up|2|||
124717785|NCT02131662|448588262|FG000|Overall Study|Adverse Event|0|||
124717786|NCT02131662|448588263|FG001|Overall Study|Adverse Event|1|||
124717787|NCT02131662|448588264|FG002|Overall Study|Adverse Event|1|||
124717788|NCT02131662|448588265|FG003|Overall Study|Adverse Event|1|||
124717789|NCT02131662|448588266|FG004|Overall Study|Adverse Event|3|||
124717790|NCT02131662|448588262|FG000|Overall Study|Pregnancy|0|||
124717791|NCT02131662|448588263|FG001|Overall Study|Pregnancy|1|||
124717792|NCT02131662|448588264|FG002|Overall Study|Pregnancy|0|||
124717793|NCT02131662|448588265|FG003|Overall Study|Pregnancy|1|||
124717794|NCT02131662|448588266|FG004|Overall Study|Pregnancy|0|||
124717795|NCT02131662|448588262|FG000|Overall Study|Wish for pregnancy|0|||
124717796|NCT02131662|448588263|FG001|Overall Study|Wish for pregnancy|0|||
124717797|NCT02131662|448588264|FG002|Overall Study|Wish for pregnancy|0|||
124717798|NCT02131662|448588265|FG003|Overall Study|Wish for pregnancy|0|||
124717799|NCT02131662|448588266|FG004|Overall Study|Wish for pregnancy|1|||
124717800|NCT02131662|448588262|FG000|Overall Study|Lack of Efficacy|1|||
124717801|NCT02131662|448588263|FG001|Overall Study|Lack of Efficacy|0|||
124717802|NCT02131662|448588264|FG002|Overall Study|Lack of Efficacy|0|||
124717803|NCT02131662|448588265|FG003|Overall Study|Lack of Efficacy|0|||
124717804|NCT02131662|448588266|FG004|Overall Study|Lack of Efficacy|1|||
124717805|NCT02131662|448588262|FG000|Overall Study|Withdrawal by Subject|1|||
124717806|NCT02131662|448588263|FG001|Overall Study|Withdrawal by Subject|5|||
124717807|NCT02131662|448588264|FG002|Overall Study|Withdrawal by Subject|1|||
124717808|NCT02131662|448588265|FG003|Overall Study|Withdrawal by Subject|5|||
124717809|NCT02131662|448588266|FG004|Overall Study|Withdrawal by Subject|6|||
124717810|NCT02131662|448588262|FG000|Overall Study|Lost to Follow-up|1|||
124717811|NCT02131662|448588263|FG001|Overall Study|Lost to Follow-up|3|||
124717812|NCT02131662|448588264|FG002|Overall Study|Lost to Follow-up|0|||
124717813|NCT02131662|448588265|FG003|Overall Study|Lost to Follow-up|9|||
124717814|NCT02131662|448588266|FG004|Overall Study|Lost to Follow-up|0|||
124717815|NCT02131662|448588262|FG000|Overall Study|Not treated|2|||
124717816|NCT02131662|448588263|FG001|Overall Study|Not treated|0|||
124473931|NCT01097629|447692612|FG007|DB RO Phase|Lost to Follow-up|0|||
124473932|NCT02720757|447692618|FG000|Overall Study|Other reason|5|||
124473933|NCT02720757|447692618|FG000|Overall Study|Loss of contact|4|||
124473934|NCT02720757|447692618|FG000|Overall Study|Informed consent withdrawal|1|||
124473935|NCT02720757|447692618|FG000|Overall Study|Patients wish to withdraw|2|||
124473936|NCT02720757|447692618|FG000|Overall Study|Missing|3|||
124473937|NCT02720757|447692618|FG000|Overall Study|General exclusion|3|||
124473938|NCT00463476|447692619|FG000|Overall Study|Withdrawal by Subject|1|||
124717817|NCT02131662|448588264|FG002|Overall Study|Not treated|2|||
124717818|NCT02131662|448588265|FG003|Overall Study|Not treated|2|||
124717819|NCT02131662|448588266|FG004|Overall Study|Not treated|3|||
124717820|NCT01402869|448588267|FG000|Overall Study|Required Tooth Extraction|0|||
124717821|NCT01402869|448588268|FG001|Overall Study|Required Tooth Extraction|0|||
124717822|NCT01402869|448588269|FG002|Overall Study|Required Tooth Extraction|1|||
124717823|NCT01740687|448588270|FG000|Overall Study|Lost to Follow-up|11|||
124717824|NCT01740687|448588270|FG000|Overall Study|Withdrawal by Subject|2|||
124717825|NCT01740687|448588270|FG000|Overall Study|other reason|22|||
124555225|NCT04380701|447991054|FG000|Overall Study|Adverse Event|0|||
124555226|NCT04380701|447991055|FG001|Overall Study|Adverse Event|0|||
124555227|NCT04380701|447991056|FG002|Overall Study|Adverse Event|0|||
124555228|NCT04380701|447991057|FG003|Overall Study|Adverse Event|0|||
124555229|NCT04380701|447991058|FG004|Overall Study|Adverse Event|0|||
124555230|NCT04380701|447991059|FG005|Overall Study|Adverse Event|1|||
124555231|NCT04380701|447991060|FG006|Overall Study|Adverse Event|0|||
124555232|NCT04380701|447991061|FG007|Overall Study|Adverse Event|0|||
124555233|NCT04380701|447991062|FG008|Overall Study|Adverse Event|0|||
124555234|NCT04380701|447991063|FG009|Overall Study|Adverse Event|0|||
124555235|NCT04380701|447991064|FG010|Overall Study|Adverse Event|0|||
124555236|NCT04380701|447991065|FG011|Overall Study|Adverse Event|0|||
124555237|NCT04380701|447991066|FG012|Overall Study|Adverse Event|0|||
124555238|NCT04380701|447991067|FG013|Overall Study|Adverse Event|0|||
124555239|NCT04380701|447991068|FG014|Overall Study|Adverse Event|0|||
124555240|NCT04380701|447991069|FG015|Overall Study|Adverse Event|1|||
124555241|NCT04380701|447991070|FG016|Overall Study|Adverse Event|0|||
124555242|NCT04380701|447991071|FG017|Overall Study|Adverse Event|0|||
124555243|NCT04380701|447991072|FG018|Overall Study|Adverse Event|0|||
124555244|NCT04380701|447991073|FG019|Overall Study|Adverse Event|1|||
124555245|NCT04380701|447991074|FG020|Overall Study|Adverse Event|0|||
124555246|NCT04380701|447991075|FG021|Overall Study|Adverse Event|0|||
124555247|NCT04380701|447991076|FG022|Overall Study|Adverse Event|0|||
124555248|NCT04380701|447991077|FG023|Overall Study|Adverse Event|0|||
124555249|NCT04380701|447991078|FG024|Overall Study|Adverse Event|0|||
124555250|NCT04380701|447991079|FG025|Overall Study|Adverse Event|0|||
124555251|NCT04380701|447991080|FG026|Overall Study|Adverse Event|0|||
124555252|NCT04380701|447991081|FG027|Overall Study|Adverse Event|0|||
124555253|NCT04380701|447991082|FG028|Overall Study|Adverse Event|0|||
124555254|NCT04380701|447991083|FG029|Overall Study|Adverse Event|0|||
124555255|NCT04380701|447991084|FG030|Overall Study|Adverse Event|0|||
124555256|NCT04380701|447991085|FG031|Overall Study|Adverse Event|0|||
124555257|NCT04380701|447991086|FG032|Overall Study|Adverse Event|0|||
124555258|NCT04380701|447991087|FG033|Overall Study|Adverse Event|0|||
124555259|NCT04380701|447991054|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
124555260|NCT04380701|447991055|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
124555261|NCT04380701|447991056|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
124555262|NCT04380701|447991057|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
124555263|NCT04380701|447991058|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
124555264|NCT04380701|447991059|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
124555265|NCT04380701|447991060|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
124555266|NCT04380701|447991061|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
124555267|NCT04380701|447991062|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
124555268|NCT04380701|447991063|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
124555269|NCT04380701|447991064|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
124555270|NCT04380701|447991065|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
124555271|NCT04380701|447991066|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
124555272|NCT04380701|447991067|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
124555273|NCT04380701|447991068|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
124555274|NCT04380701|447991069|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
124555275|NCT04380701|447991070|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
124555276|NCT04380701|447991071|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
124555277|NCT04380701|447991072|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
124555278|NCT04380701|447991073|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
124555279|NCT04380701|447991074|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
124555280|NCT04380701|447991075|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
124555281|NCT04380701|447991076|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
124555282|NCT04380701|447991077|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
124555283|NCT04380701|447991078|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
124555284|NCT04380701|447991079|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
124555285|NCT04380701|447991080|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
124555286|NCT04380701|447991081|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
124555287|NCT04380701|447991082|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
124555288|NCT04380701|447991083|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
124555289|NCT04380701|447991084|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
124555290|NCT04380701|447991085|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
124555291|NCT04380701|447991086|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
124555292|NCT04380701|447991087|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
124555293|NCT04380701|447991054|FG000|Overall Study|Physician Decision|0|||
124555294|NCT04380701|447991055|FG001|Overall Study|Physician Decision|0|||
124555295|NCT04380701|447991056|FG002|Overall Study|Physician Decision|0|||
124555296|NCT04380701|447991057|FG003|Overall Study|Physician Decision|0|||
124717826|NCT01740687|448588270|FG000|Overall Study|treatment not received|2|||
124717827|NCT00104728|448588272|FG000|Overall Study|screen failures|19|||
124555297|NCT04380701|447991058|FG004|Overall Study|Physician Decision|0|||
124555298|NCT04380701|447991059|FG005|Overall Study|Physician Decision|0|||
124717828|NCT01963767|448588273|FG000|Overall Study|Withdrawal by Subject|4|||
124717829|NCT01963767|448588274|FG001|Overall Study|Withdrawal by Subject|2|||
124717830|NCT01963767|448588273|FG000|Overall Study|Adverse Event|2|||
124717831|NCT01963767|448588274|FG001|Overall Study|Adverse Event|0|||
124717832|NCT03960684|448588275|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
124717833|NCT03941483|448588279|FG000|Overall Study|Miscellaneous|2|||
124717834|NCT03941483|448588280|FG001|Overall Study|Miscellaneous|3|||
124717835|NCT03941483|448588281|FG002|Overall Study|Miscellaneous|0|||
124717836|NCT03941483|448588279|FG000|Overall Study|Study Terminated by Sponsor|1|||
124717837|NCT03941483|448588280|FG001|Overall Study|Study Terminated by Sponsor|0|||
124717838|NCT03941483|448588281|FG002|Overall Study|Study Terminated by Sponsor|0|||
124717839|NCT03941483|448588279|FG000|Overall Study|Withdrawal by Subject|1|||
124717840|NCT03941483|448588280|FG001|Overall Study|Withdrawal by Subject|4|||
124717841|NCT03941483|448588281|FG002|Overall Study|Withdrawal by Subject|1|||
124717842|NCT03941483|448588279|FG000|Overall Study|Lost to Follow-up|2|||
124717843|NCT03941483|448588280|FG001|Overall Study|Lost to Follow-up|1|||
124717844|NCT03941483|448588281|FG002|Overall Study|Lost to Follow-up|8|||
124717845|NCT03941483|448588279|FG000|Overall Study|Death|3|||
124717846|NCT03941483|448588280|FG001|Overall Study|Death|2|||
124717847|NCT03941483|448588281|FG002|Overall Study|Death|6|||
124717848|NCT01082081|448588282|FG000|Overall Study|Lost to Follow-up|0|||
124717849|NCT01082081|448588283|FG001|Overall Study|Lost to Follow-up|0|||
124717850|NCT01082081|448588284|FG002|Overall Study|Lost to Follow-up|1|||
124717851|NCT01082081|448588282|FG000|Overall Study|Withdrawal by Subject|0|||
124717852|NCT01082081|448588283|FG001|Overall Study|Withdrawal by Subject|0|||
124717853|NCT01082081|448588284|FG002|Overall Study|Withdrawal by Subject|1|||
124717854|NCT01082081|448588282|FG000|Overall Study|Other Reason|0|||
124717855|NCT01082081|448588283|FG001|Overall Study|Other Reason|1|||
124717856|NCT01082081|448588284|FG002|Overall Study|Other Reason|0|||
124717857|NCT00670930|448588287|FG000|Overall Study|Adminstrative Problem|0|||
124717858|NCT00670930|448588288|FG001|Overall Study|Adminstrative Problem|1|||
124717859|NCT00670930|448588287|FG000|Overall Study|Lost to Follow-up|1|||
124717860|NCT00670930|448588288|FG001|Overall Study|Lost to Follow-up|0|||
124717861|NCT03493451|448589544|FG000|Overall Study|Death|11|||
124717862|NCT03493451|448589545|FG001|Overall Study|Death|26|||
124717863|NCT03493451|448589546|FG002|Overall Study|Death|3|||
124717864|NCT03493451|448589544|FG000|Overall Study|Lost to Follow-up|1|||
124717865|NCT03493451|448589545|FG001|Overall Study|Lost to Follow-up|4|||
124717866|NCT03493451|448589546|FG002|Overall Study|Lost to Follow-up|1|||
124717867|NCT03493451|448589544|FG000|Overall Study|Withdrawal by Subject|1|||
124717868|NCT03493451|448589545|FG001|Overall Study|Withdrawal by Subject|1|||
124717869|NCT03493451|448589546|FG002|Overall Study|Withdrawal by Subject|2|||
124717870|NCT03493451|448589544|FG000|Overall Study|Progressive Disease|1|||
124717871|NCT03493451|448589545|FG001|Overall Study|Progressive Disease|0|||
124717872|NCT03493451|448589546|FG002|Overall Study|Progressive Disease|0|||
124717873|NCT03493451|448589544|FG000|Overall Study|Transferred to long term extension study|8|||
124717874|NCT03493451|448589545|FG001|Overall Study|Transferred to long term extension study|13|||
124717875|NCT03493451|448589546|FG002|Overall Study|Transferred to long term extension study|5|||
124717876|NCT00600106|448589552|FG000|Overall Study|Withdrawal by Subject|1|||
124717877|NCT00600106|448589553|FG001|Overall Study|Withdrawal by Subject|1|||
124717878|NCT03015363|448589556|FG000|Overall Study|Physician Decision|14|||
124717879|NCT03015363|448589556|FG000|Overall Study|Withdrawal by Subject|3|||
124717880|NCT01206140|448589559|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
124717881|NCT01206140|448589560|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
124717882|NCT00211172|448589561|FG000|Overall Study|Died or lost health plan eligibility|39|||
124717883|NCT00211172|448589562|FG001|Overall Study|Died or lost health plan eligibility|32|||
124717884|NCT00770562|448589568|FG000|Overall Study|Did not take treatment|1|||
124717885|NCT00770562|448589569|FG001|Overall Study|Did not take treatment|1|||
124717886|NCT01643408|448589570|FG000|Overall Study|Adverse Event|12|||
124717887|NCT01643408|448589570|FG000|Overall Study|Other|2|||
124717888|NCT00579553|448589572|FG000|Overall Study|Lost to Follow-up|16|||
124717889|NCT00579553|448589573|FG001|Overall Study|Lost to Follow-up|13|||
124717890|NCT01509846|448589577|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
124717891|NCT01509846|448589578|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
124717892|NCT01509846|448589579|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
124717893|NCT01509846|448589580|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
124717894|NCT01509846|448589581|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
124717895|NCT01509846|448589577|FG000|Received Vaccination 2|Illness|0|||
124717896|NCT01509846|448589578|FG001|Received Vaccination 2|Illness|0|||
124717897|NCT01509846|448589579|FG002|Received Vaccination 2|Illness|0|||
124717898|NCT01509846|448589580|FG003|Received Vaccination 2|Illness|0|||
124717899|NCT01509846|448589581|FG004|Received Vaccination 2|Illness|1|||
124717900|NCT01509846|448589577|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
124717901|NCT01509846|448589578|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
124717902|NCT01509846|448589579|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
124717903|NCT01509846|448589580|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
124555299|NCT04380701|447991060|FG006|Overall Study|Physician Decision|0|||
124555300|NCT04380701|447991061|FG007|Overall Study|Physician Decision|0|||
124555301|NCT04380701|447991062|FG008|Overall Study|Physician Decision|0|||
124555302|NCT04380701|447991063|FG009|Overall Study|Physician Decision|0|||
124555303|NCT04380701|447991064|FG010|Overall Study|Physician Decision|0|||
124555304|NCT04380701|447991065|FG011|Overall Study|Physician Decision|0|||
124555305|NCT04380701|447991066|FG012|Overall Study|Physician Decision|0|||
124555306|NCT04380701|447991067|FG013|Overall Study|Physician Decision|0|||
124555307|NCT04380701|447991068|FG014|Overall Study|Physician Decision|0|||
124555308|NCT04380701|447991069|FG015|Overall Study|Physician Decision|0|||
124555309|NCT04380701|447991070|FG016|Overall Study|Physician Decision|0|||
124555310|NCT04380701|447991071|FG017|Overall Study|Physician Decision|0|||
124555311|NCT04380701|447991072|FG018|Overall Study|Physician Decision|0|||
124555312|NCT04380701|447991073|FG019|Overall Study|Physician Decision|0|||
124555313|NCT04380701|447991074|FG020|Overall Study|Physician Decision|0|||
124555314|NCT04380701|447991075|FG021|Overall Study|Physician Decision|0|||
124555315|NCT04380701|447991076|FG022|Overall Study|Physician Decision|0|||
124555316|NCT04380701|447991077|FG023|Overall Study|Physician Decision|0|||
124555317|NCT04380701|447991078|FG024|Overall Study|Physician Decision|2|||
124555318|NCT04380701|447991079|FG025|Overall Study|Physician Decision|0|||
124555319|NCT04380701|447991080|FG026|Overall Study|Physician Decision|0|||
124555320|NCT04380701|447991081|FG027|Overall Study|Physician Decision|0|||
124555321|NCT04380701|447991082|FG028|Overall Study|Physician Decision|0|||
124555322|NCT04380701|447991083|FG029|Overall Study|Physician Decision|0|||
124555323|NCT04380701|447991084|FG030|Overall Study|Physician Decision|0|||
124555324|NCT04380701|447991085|FG031|Overall Study|Physician Decision|0|||
124555325|NCT04380701|447991086|FG032|Overall Study|Physician Decision|0|||
124555326|NCT04380701|447991087|FG033|Overall Study|Physician Decision|0|||
124555327|NCT04380701|447991054|FG000|Overall Study|Death|0|||
124717904|NCT01509846|448589581|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
124717905|NCT01509846|448589577|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
124717906|NCT01509846|448589578|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
124717907|NCT01509846|448589579|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
124717908|NCT01509846|448589580|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
124717909|NCT01509846|448589581|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
124717910|NCT01509846|448589577|FG000|Received Vaccination 3|Pregnancy|0|||
124717911|NCT01509846|448589578|FG001|Received Vaccination 3|Pregnancy|0|||
124717912|NCT01509846|448589579|FG002|Received Vaccination 3|Pregnancy|0|||
124717913|NCT01509846|448589580|FG003|Received Vaccination 3|Pregnancy|1|||
124717914|NCT01509846|448589581|FG004|Received Vaccination 3|Pregnancy|0|||
124717915|NCT01509846|448589577|FG000|Received Vaccination 3|Lost to Follow-up|0|||
124717916|NCT01509846|448589578|FG001|Received Vaccination 3|Lost to Follow-up|0|||
124717917|NCT01509846|448589579|FG002|Received Vaccination 3|Lost to Follow-up|1|||
124717918|NCT01509846|448589580|FG003|Received Vaccination 3|Lost to Follow-up|0|||
124717919|NCT01509846|448589581|FG004|Received Vaccination 3|Lost to Follow-up|0|||
124717920|NCT01637584|448589582|FG000|Overall Study|Withdrawal by Subject|1|||
124717921|NCT01637584|448589583|FG001|Overall Study|Withdrawal by Subject|3|||
124717922|NCT02484443|448589584|FG000|Overall Study|Lack of Efficacy|28|||
124717923|NCT02484443|448589584|FG000|Overall Study|Physician Decision|2|||
124717924|NCT02484443|448589584|FG000|Overall Study|Ineligible|2|||
124717925|NCT02969915|448589585|FG000|Overall Study|Death|104|||
124717926|NCT02969915|448589586|FG001|Overall Study|Death|125|||
124717927|NCT02969915|448589585|FG000|Overall Study|Lost to Follow-up|108|||
124717928|NCT02969915|448589586|FG001|Overall Study|Lost to Follow-up|112|||
124717929|NCT02969915|448589585|FG000|Overall Study|Censored due to COVID-19|481|||
124717930|NCT02969915|448589586|FG001|Overall Study|Censored due to COVID-19|471|||
124717931|NCT03799952|448589587|FG000|Overall Study|Program was too easy, discontinued|1|||
124717932|NCT03799952|448589588|FG001|Overall Study|Program was too easy, discontinued|0|||
124717933|NCT03799952|448589587|FG000|Overall Study|Lost to Follow-up|0|||
124555328|NCT04380701|447991055|FG001|Overall Study|Death|0|||
124555329|NCT04380701|447991056|FG002|Overall Study|Death|0|||
124555330|NCT04380701|447991057|FG003|Overall Study|Death|0|||
124555331|NCT04380701|447991058|FG004|Overall Study|Death|0|||
124555332|NCT04380701|447991059|FG005|Overall Study|Death|0|||
124555333|NCT04380701|447991060|FG006|Overall Study|Death|0|||
124555334|NCT04380701|447991061|FG007|Overall Study|Death|0|||
124555335|NCT04380701|447991062|FG008|Overall Study|Death|0|||
124555336|NCT04380701|447991063|FG009|Overall Study|Death|0|||
124555337|NCT04380701|447991064|FG010|Overall Study|Death|0|||
124555338|NCT04380701|447991065|FG011|Overall Study|Death|0|||
124555339|NCT04380701|447991066|FG012|Overall Study|Death|0|||
124555340|NCT04380701|447991067|FG013|Overall Study|Death|0|||
124555341|NCT04380701|447991068|FG014|Overall Study|Death|0|||
124717934|NCT03799952|448589588|FG001|Overall Study|Lost to Follow-up|2|||
124717935|NCT01393899|448589589|FG000|Overall Study|Study terminated by sponsor|1|||
124717936|NCT01393899|448589590|FG001|Overall Study|Study terminated by sponsor|0|||
124717937|NCT01393899|448589591|FG002|Overall Study|Study terminated by sponsor|1|||
124717938|NCT01393899|448589589|FG000|Overall Study|Other|1|||
124717939|NCT01393899|448589590|FG001|Overall Study|Other|0|||
124717940|NCT01393899|448589591|FG002|Overall Study|Other|0|||
124717941|NCT01393899|448589589|FG000|Overall Study|Withdrawal by Subject|2|||
124717942|NCT01393899|448589590|FG001|Overall Study|Withdrawal by Subject|2|||
124717943|NCT01393899|448589591|FG002|Overall Study|Withdrawal by Subject|1|||
124717944|NCT01393899|448589589|FG000|Overall Study|Lost to Follow-up|0|||
124717945|NCT01393899|448589590|FG001|Overall Study|Lost to Follow-up|0|||
124717946|NCT01393899|448589591|FG002|Overall Study|Lost to Follow-up|1|||
124717947|NCT01393899|448589589|FG000|Overall Study|Does not meet entrance criteria|1|||
124717948|NCT01393899|448589590|FG001|Overall Study|Does not meet entrance criteria|0|||
124717949|NCT01393899|448589591|FG002|Overall Study|Does not meet entrance criteria|1|||
124717950|NCT01393899|448589589|FG000|Overall Study|Lack of Efficacy|26|||
124717951|NCT01393899|448589590|FG001|Overall Study|Lack of Efficacy|21|||
124717952|NCT01393899|448589591|FG002|Overall Study|Lack of Efficacy|16|||
124717953|NCT01393899|448589589|FG000|Overall Study|Adverse Event|1|||
124717954|NCT01393899|448589590|FG001|Overall Study|Adverse Event|5|||
124717955|NCT01393899|448589591|FG002|Overall Study|Adverse Event|3|||
124717956|NCT02503085|448589592|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
124717957|NCT02503085|448589593|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
124717958|NCT02503085|448589594|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
124717959|NCT02503085|448589595|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
124717960|NCT02595866|448589596|FG000|Overall Study|Adverse Event|2|||
124717961|NCT02595866|448589597|FG001|Overall Study|Adverse Event|5|||
124717962|NCT02595866|448589596|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
124717963|NCT02595866|448589597|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
124717964|NCT02595866|448589596|FG000|Overall Study|Death|0|||
124717965|NCT02595866|448589597|FG001|Overall Study|Death|1|||
124717966|NCT02595866|448589596|FG000|Overall Study|Incarceration|1|||
124717967|NCT02595866|448589597|FG001|Overall Study|Incarceration|0|||
124717968|NCT02595866|448589596|FG000|Overall Study|Lack of Efficacy|17|||
124717969|NCT02595866|448589597|FG001|Overall Study|Lack of Efficacy|7|||
124717970|NCT02595866|448589596|FG000|Overall Study|Physician Decision|4|||
124717971|NCT02595866|448589597|FG001|Overall Study|Physician Decision|3|||
124717972|NCT02595866|448589596|FG000|Overall Study|Switched to Alternative Treatment|1|||
124717973|NCT02595866|448589597|FG001|Overall Study|Switched to Alternative Treatment|0|||
124717974|NCT02595866|448589596|FG000|Overall Study|Study Terminated|0|||
124717975|NCT02595866|448589597|FG001|Overall Study|Study Terminated|4|||
124717976|NCT02595866|448589596|FG000|Overall Study|Withdrawal by Subject|6|||
124717977|NCT02595866|448589597|FG001|Overall Study|Withdrawal by Subject|1|||
124717978|NCT02520388|448589598|FG000|Overall Study|Physician Decision|1|||
124717979|NCT02520388|448589599|FG001|Overall Study|Physician Decision|0|||
124717980|NCT02520388|448589598|FG000|Overall Study|Subject or parent/guardian request|0|||
124717981|NCT02520388|448589599|FG001|Overall Study|Subject or parent/guardian request|6|||
124717982|NCT02520388|448589598|FG000|Overall Study|Adverse Event|1|||
124717983|NCT02520388|448589599|FG001|Overall Study|Adverse Event|4|||
124717984|NCT02520388|448589598|FG000|Overall Study|Lost to Follow-up|3|||
124717985|NCT02520388|448589599|FG001|Overall Study|Lost to Follow-up|2|||
124555342|NCT04380701|447991069|FG015|Overall Study|Death|0|||
124771643|NCT04225897|448794526|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
124555343|NCT04380701|447991070|FG016|Overall Study|Death|0|||
124771644|NCT02085460|448794527|FG000|Overall Study|Adverse Event|2|||
124555344|NCT04380701|447991071|FG017|Overall Study|Death|0|||
124717986|NCT02520388|448589598|FG000|Overall Study|Other (reason not defined)|4|||
124717987|NCT02520388|448589599|FG001|Overall Study|Other (reason not defined)|4|||
124717988|NCT01232127|448589600|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
124717989|NCT01232127|448589601|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
124717990|NCT01232127|448589602|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
124717991|NCT03035864|448589608|FG000|Treatment Period|Adverse Event|1|||
124717992|NCT03035864|448589609|FG001|Treatment Period|Adverse Event|0|||
124717993|NCT03035864|448589608|FG000|Treatment Period|Other|3|||
124717994|NCT03035864|448589609|FG001|Treatment Period|Other|1|||
124555345|NCT04380701|447991072|FG018|Overall Study|Death|0|||
124555346|NCT04380701|447991073|FG019|Overall Study|Death|0|||
124555347|NCT04380701|447991074|FG020|Overall Study|Death|0|||
124555348|NCT04380701|447991075|FG021|Overall Study|Death|0|||
124555349|NCT04380701|447991076|FG022|Overall Study|Death|0|||
124555350|NCT04380701|447991077|FG023|Overall Study|Death|0|||
124555351|NCT04380701|447991078|FG024|Overall Study|Death|1|||
124555352|NCT04380701|447991079|FG025|Overall Study|Death|0|||
124555353|NCT04380701|447991080|FG026|Overall Study|Death|0|||
124555354|NCT04380701|447991081|FG027|Overall Study|Death|0|||
124555355|NCT04380701|447991082|FG028|Overall Study|Death|0|||
124555356|NCT04380701|447991083|FG029|Overall Study|Death|0|||
124555357|NCT04380701|447991084|FG030|Overall Study|Death|0|||
124555358|NCT04380701|447991085|FG031|Overall Study|Death|0|||
124555359|NCT04380701|447991086|FG032|Overall Study|Death|0|||
124555360|NCT04380701|447991087|FG033|Overall Study|Death|0|||
124555361|NCT04380701|447991054|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555362|NCT04380701|447991055|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555363|NCT04380701|447991056|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555364|NCT04380701|447991057|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555365|NCT04380701|447991058|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555366|NCT04380701|447991059|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555367|NCT04380701|447991060|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555368|NCT04380701|447991061|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555369|NCT04380701|447991062|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555370|NCT04380701|447991063|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555371|NCT04380701|447991064|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555372|NCT04380701|447991065|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124717995|NCT03035864|448589608|FG000|Follow-up Period|Adverse Event|1|||
124555373|NCT04380701|447991066|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555374|NCT04380701|447991067|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555375|NCT04380701|447991068|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555376|NCT04380701|447991069|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555377|NCT04380701|447991070|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124717996|NCT03035864|448589609|FG001|Follow-up Period|Adverse Event|0|||
124717997|NCT03035864|448589608|FG000|Follow-up Period|Lost to Follow-up|6|||
124555378|NCT04380701|447991071|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555379|NCT04380701|447991072|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124717998|NCT03035864|448589609|FG001|Follow-up Period|Lost to Follow-up|2|||
124717999|NCT03035864|448589608|FG000|Follow-up Period|Physician Decision|1|||
124718000|NCT03035864|448589609|FG001|Follow-up Period|Physician Decision|0|||
124718001|NCT03035864|448589608|FG000|Follow-up Period|Other|3|||
124718002|NCT03035864|448589609|FG001|Follow-up Period|Other|2|||
124718003|NCT02375373|448589614|FG000|Overall Study|Withdrawal by Subject|11|||
124718004|NCT01890265|448589615|FG000|Overall Study|Other (Unspecified reason)|0|||
124718005|NCT01890265|448589616|FG001|Overall Study|Other (Unspecified reason)|1|||
124771645|NCT02085460|448794528|FG001|Overall Study|Adverse Event|2|||
124555380|NCT04380701|447991073|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555381|NCT04380701|447991074|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555382|NCT04380701|447991075|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
124555383|NCT04380701|447991076|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
124555384|NCT04380701|447991077|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
124555385|NCT04380701|447991078|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
124555386|NCT04380701|447991079|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124771646|NCT02085460|448794529|FG002|Overall Study|Adverse Event|1|||
124718006|NCT01890265|448589617|FG002|Overall Study|Other (Unspecified reason)|0|||
124718007|NCT01890265|448589618|FG003|Overall Study|Other (Unspecified reason)|0|||
124718008|NCT01890265|448589619|FG004|Overall Study|Other (Unspecified reason)|0|||
124718009|NCT01890265|448589620|FG005|Overall Study|Other (Unspecified reason)|0|||
124718010|NCT01890265|448589615|FG000|Overall Study|Progressive disease|6|||
124718011|NCT01890265|448589616|FG001|Overall Study|Progressive disease|6|||
124718012|NCT01890265|448589617|FG002|Overall Study|Progressive disease|0|||
124718013|NCT01890265|448589618|FG003|Overall Study|Progressive disease|0|||
124718014|NCT01890265|448589619|FG004|Overall Study|Progressive disease|0|||
124718015|NCT01890265|448589620|FG005|Overall Study|Progressive disease|0|||
124718016|NCT01890265|448589615|FG000|Overall Study|Adverse Event|2|||
124718017|NCT01890265|448589616|FG001|Overall Study|Adverse Event|1|||
124718018|NCT01890265|448589617|FG002|Overall Study|Adverse Event|0|||
124718019|NCT01890265|448589618|FG003|Overall Study|Adverse Event|0|||
124718020|NCT01890265|448589619|FG004|Overall Study|Adverse Event|0|||
124718021|NCT01890265|448589620|FG005|Overall Study|Adverse Event|0|||
124718022|NCT01890265|448589615|FG000|Overall Study|Death|2|||
124718023|NCT01890265|448589616|FG001|Overall Study|Death|3|||
124718024|NCT01890265|448589617|FG002|Overall Study|Death|1|||
124718025|NCT01890265|448589618|FG003|Overall Study|Death|0|||
124718026|NCT01890265|448589619|FG004|Overall Study|Death|0|||
124718027|NCT01890265|448589620|FG005|Overall Study|Death|0|||
124718028|NCT01890265|448589615|FG000|Overall Study|Withdrawal by Subject|0|||
124718029|NCT01890265|448589616|FG001|Overall Study|Withdrawal by Subject|2|||
124718030|NCT01890265|448589617|FG002|Overall Study|Withdrawal by Subject|3|||
124718031|NCT01890265|448589618|FG003|Overall Study|Withdrawal by Subject|0|||
124718032|NCT01890265|448589619|FG004|Overall Study|Withdrawal by Subject|2|||
124718033|NCT01890265|448589620|FG005|Overall Study|Withdrawal by Subject|0|||
124718034|NCT01445613|448589621|FG000|30-day Follow-up|Withdrawal by Subject|6|||
124718035|NCT01445613|448589621|FG000|30-day Follow-up|Physician Decision|3|||
124718036|NCT01445613|448589621|FG000|30-day Follow-up|Missed visit|23|||
124718037|NCT01445613|448589621|FG000|30-day Follow-up|Death|3|||
124718038|NCT01445613|448589621|FG000|1-year Follow-up|Withdrawal by Subject|12|||
124473939|NCT00463476|447692620|FG001|Overall Study|Withdrawal by Subject|2|||
124718039|NCT01445613|448589621|FG000|1-year Follow-up|Missed visit|29|||
124718040|NCT01445613|448589621|FG000|1-year Follow-up|Lost to Follow-up|2|||
124718041|NCT01445613|448589621|FG000|1-year Follow-up|Death|30|||
124718042|NCT01445613|448589621|FG000|1-year Follow-up|Physician Decision|2|||
124718043|NCT01445613|448589621|FG000|1-year Follow-up|Received a non-study stent|2|||
124718044|NCT03299244|448589625|FG000|Overall Study|Withdrawal by Subject|34|||
124718045|NCT03299244|448589626|FG001|Overall Study|Withdrawal by Subject|29|||
124718046|NCT03299244|448589625|FG000|Overall Study|Decision by Sponsor|4|||
124718047|NCT03299244|448589626|FG001|Overall Study|Decision by Sponsor|5|||
124718048|NCT03299244|448589625|FG000|Overall Study|Death|9|||
124555387|NCT04380701|447991080|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555388|NCT04380701|447991081|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555389|NCT04380701|447991082|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555390|NCT04380701|447991083|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555391|NCT04380701|447991084|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555392|NCT04380701|447991085|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555393|NCT04380701|447991086|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555394|NCT04380701|447991087|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
124555395|NCT00363129|447991088|FG000|Overall Study|Withdrawal by Subject|11|||
124555396|NCT00363129|447991089|FG001|Overall Study|Withdrawal by Subject|18|||
124555397|NCT00363129|447991088|FG000|Overall Study|Adverse Event|8|||
124555398|NCT00363129|447991089|FG001|Overall Study|Adverse Event|3|||
124555399|NCT00363129|447991088|FG000|Overall Study|Alternate Treatment|2|||
124555400|NCT00363129|447991089|FG001|Overall Study|Alternate Treatment|4|||
124718049|NCT03299244|448589626|FG001|Overall Study|Death|4|||
124555401|NCT00363129|447991088|FG000|Overall Study|Other Medical Problems|2|||
124718050|NCT00809926|448589629|FG000|Overall Study|Adverse Event|18|||
124473940|NCT00463476|447692619|FG000|Overall Study|Lost to Follow-up|1|||
124473941|NCT00463476|447692620|FG001|Overall Study|Lost to Follow-up|1|||
124473942|NCT00988247|447692621|FG000|Overall Study|Adverse Event|17|||
124473943|NCT00988247|447692622|FG001|Overall Study|Adverse Event|3|||
124473944|NCT00988247|447692621|FG000|Overall Study|Withdrawal by Subject|44|||
124473945|NCT00988247|447692622|FG001|Overall Study|Withdrawal by Subject|13|||
124473946|NCT00988247|447692621|FG000|Overall Study|Pregnancy|1|||
124473947|NCT00988247|447692622|FG001|Overall Study|Pregnancy|2|||
124473948|NCT00988247|447692621|FG000|Overall Study|Lost to Follow-up|11|||
124473949|NCT00988247|447692622|FG001|Overall Study|Lost to Follow-up|2|||
124473950|NCT00988247|447692621|FG000|Overall Study|Protocol Violation|4|||
124473951|NCT00988247|447692622|FG001|Overall Study|Protocol Violation|5|||
124473952|NCT00988247|447692621|FG000|Overall Study|Sponsor requested withdrawal|3|||
124473953|NCT00988247|447692622|FG001|Overall Study|Sponsor requested withdrawal|1|||
124473954|NCT00988247|447692621|FG000|Overall Study|Other|3|||
124473955|NCT00988247|447692622|FG001|Overall Study|Other|0|||
124473956|NCT04173741|447692623|FG000|Overall Study|IVC measurement cannot be done|1|||
124473957|NCT04173741|447692624|FG001|Overall Study|IVC measurement cannot be done|1|||
124473958|NCT01169779|447692627|FG000|Overall Study|Adverse Event|3|||
124473959|NCT01169779|447692628|FG001|Overall Study|Adverse Event|11|||
124473960|NCT01169779|447692627|FG000|Overall Study|Lack of Efficacy|1|||
124473961|NCT01169779|447692628|FG001|Overall Study|Lack of Efficacy|0|||
124473962|NCT01169779|447692627|FG000|Overall Study|Protocol Violation|1|||
124473963|NCT01169779|447692628|FG001|Overall Study|Protocol Violation|1|||
124473964|NCT01169779|447692627|FG000|Overall Study|Withdrawal by Subject|3|||
124473965|NCT01169779|447692628|FG001|Overall Study|Withdrawal by Subject|2|||
124473966|NCT01169779|447692627|FG000|Overall Study|Familial and personal reasons|3|||
124473967|NCT01169779|447692628|FG001|Overall Study|Familial and personal reasons|3|||
124473968|NCT00548548|447692629|FG000|Overall Study|Death|345|||
124473969|NCT00548548|447692630|FG001|Overall Study|Death|348|||
124473970|NCT00548548|447692629|FG000|Overall Study|Lost to Follow-up|17|||
124473971|NCT00548548|447692630|FG001|Overall Study|Lost to Follow-up|18|||
124473972|NCT03617705|447692635|FG000|Overall Study|Withdrawal by Subject|2|||
124473973|NCT03617705|447692635|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
124473974|NCT03617705|447692635|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
124473975|NCT03502187|447692636|FG000|Overall Study|Withdrawal by Subject|4|||
124473976|NCT03502187|447692637|FG001|Overall Study|Withdrawal by Subject|3|||
124473977|NCT03502187|447692638|FG002|Overall Study|Withdrawal by Subject|3|||
124473978|NCT03502187|447692636|FG000|Overall Study|Lost to Follow-up|5|||
124473979|NCT03502187|447692637|FG001|Overall Study|Lost to Follow-up|4|||
124473980|NCT03502187|447692638|FG002|Overall Study|Lost to Follow-up|5|||
124473981|NCT01061008|447692639|FG000|Overall Study|Badiocephalic fistula failed|3|||
124473982|NCT01061008|447692640|FG001|Overall Study|Badiocephalic fistula failed|2|||
124473983|NCT01061008|447692639|FG000|Overall Study|Death|1|||
124473984|NCT01061008|447692640|FG001|Overall Study|Death|0|||
124473985|NCT01061008|447692639|FG000|Overall Study|Withdrawal by Subject|1|||
124473986|NCT01061008|447692640|FG001|Overall Study|Withdrawal by Subject|3|||
124473987|NCT01061008|447692639|FG000|Overall Study|Unable to exercise following surgery|1|||
124473988|NCT01061008|447692640|FG001|Overall Study|Unable to exercise following surgery|0|||
124473989|NCT01061008|447692639|FG000|Overall Study|Adverse Event|0|||
124473990|NCT01061008|447692640|FG001|Overall Study|Adverse Event|1|||
124473991|NCT02908100|447692642|FG000|Overall Study|Adverse Event|7|||
124473992|NCT02908100|447692643|FG001|Overall Study|Adverse Event|6|||
124473993|NCT02908100|447692644|FG002|Overall Study|Adverse Event|9|||
124473994|NCT02908100|447692642|FG000|Overall Study|Death|2|||
124473995|NCT02908100|447692643|FG001|Overall Study|Death|0|||
124473996|NCT02908100|447692644|FG002|Overall Study|Death|0|||
124473997|NCT02908100|447692642|FG000|Overall Study|Lack of Efficacy|2|||
124473998|NCT02908100|447692643|FG001|Overall Study|Lack of Efficacy|3|||
124555402|NCT00363129|447991089|FG001|Overall Study|Other Medical Problems|4|||
124555403|NCT00363129|447991088|FG000|Overall Study|Death|0|||
124473999|NCT02908100|447692644|FG002|Overall Study|Lack of Efficacy|3|||
124474000|NCT02908100|447692642|FG000|Overall Study|Lost to Follow-up|0|||
124474001|NCT02908100|447692643|FG001|Overall Study|Lost to Follow-up|1|||
124474002|NCT02908100|447692644|FG002|Overall Study|Lost to Follow-up|2|||
124474003|NCT02908100|447692642|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124474004|NCT02908100|447692643|FG001|Overall Study|Non-Compliance With Study Drug|1|||
124474005|NCT02908100|447692644|FG002|Overall Study|Non-Compliance With Study Drug|2|||
124474006|NCT02908100|447692642|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
124474007|NCT02908100|447692643|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
124474008|NCT02908100|447692644|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
124474009|NCT02908100|447692642|FG000|Overall Study|Physician Decision|0|||
124474010|NCT02908100|447692643|FG001|Overall Study|Physician Decision|1|||
124474011|NCT02908100|447692644|FG002|Overall Study|Physician Decision|0|||
124474012|NCT02908100|447692642|FG000|Overall Study|Pregnancy|1|||
124555404|NCT00363129|447991089|FG001|Overall Study|Death|1|||
124474013|NCT02908100|447692643|FG001|Overall Study|Pregnancy|2|||
124474014|NCT02908100|447692644|FG002|Overall Study|Pregnancy|0|||
124474015|NCT02908100|447692642|FG000|Overall Study|Withdrawal by Subject|8|||
124474016|NCT02908100|447692643|FG001|Overall Study|Withdrawal by Subject|7|||
124474017|NCT02908100|447692644|FG002|Overall Study|Withdrawal by Subject|5|||
124474018|NCT02908100|447692642|FG000|Overall Study|Randomised in Error|1|||
124474019|NCT02908100|447692643|FG001|Overall Study|Randomised in Error|0|||
124474020|NCT02908100|447692644|FG002|Overall Study|Randomised in Error|0|||
124474021|NCT04088409|447692645|FG000|Part A|Withdrawal by Subject|2|||
124474022|NCT04088409|447692646|FG001|Part A|Withdrawal by Subject|1|||
124474023|NCT04088409|447692645|FG000|Part A|Did Not Meet Randomization Criteria|2|||
124474024|NCT04088409|447692646|FG001|Part A|Did Not Meet Randomization Criteria|0|||
124474025|NCT04088409|447692645|FG000|Part A|Lack of Efficacy|9|||
124474026|NCT04088409|447692646|FG001|Part A|Lack of Efficacy|0|||
124474027|NCT04088409|447692645|FG000|Part A|Lost to Follow-up|1|||
124474028|NCT04088409|447692646|FG001|Part A|Lost to Follow-up|0|||
124474029|NCT04088409|447692645|FG000|Part A|Adverse Event|1|||
124474030|NCT04088409|447692646|FG001|Part A|Adverse Event|0|||
124474031|NCT04088409|447692645|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
124474032|NCT04088409|447692646|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
124474033|NCT04088409|447692645|FG000|Part B|Ongoing Treatment|10|||
124474034|NCT04088409|447692646|FG001|Part B|Ongoing Treatment|0|||
124474035|NCT00400400|447692647|FG000|Overall Study|Adverse Event|9|||
124474036|NCT00400400|447692648|FG001|Overall Study|Adverse Event|8|||
124474037|NCT00400400|447692647|FG000|Overall Study|Protocol Violation|2|||
124474038|NCT00400400|447692648|FG001|Overall Study|Protocol Violation|0|||
124474039|NCT00400400|447692647|FG000|Overall Study|Withdrawal by Subject|1|||
124474040|NCT00400400|447692648|FG001|Overall Study|Withdrawal by Subject|3|||
124474041|NCT00400400|447692647|FG000|Overall Study|Administrative Problem|1|||
124474042|NCT00400400|447692648|FG001|Overall Study|Administrative Problem|0|||
124474043|NCT00400400|447692647|FG000|Overall Study|Lost to Follow-up|0|||
124474044|NCT00400400|447692648|FG001|Overall Study|Lost to Follow-up|1|||
124474045|NCT00400400|447692647|FG000|Overall Study|Did not receive study drug|1|||
124474046|NCT00400400|447692648|FG001|Overall Study|Did not receive study drug|3|||
124474047|NCT00189462|447692657|FG000|Overall Study|Lack of Efficacy|5|||
124474048|NCT00189462|447692658|FG001|Overall Study|Lack of Efficacy|1|||
124474049|NCT00189462|447692657|FG000|Overall Study|Lost to Follow-up|18|||
124474050|NCT00189462|447692658|FG001|Overall Study|Lost to Follow-up|20|||
124474051|NCT00849667|447692659|FG000|Overall Study|Withdrawal by Subject|16|||
124474052|NCT00849667|447692660|FG001|Overall Study|Withdrawal by Subject|33|||
124474053|NCT00849667|447692661|FG002|Overall Study|Withdrawal by Subject|35|||
124474054|NCT00849667|447692659|FG000|Overall Study|Lost to Follow-up|8|||
124474055|NCT00849667|447692660|FG001|Overall Study|Lost to Follow-up|8|||
124474056|NCT00849667|447692661|FG002|Overall Study|Lost to Follow-up|8|||
124474057|NCT00849667|447692659|FG000|Overall Study|Adverse Event|1|||
124474058|NCT00849667|447692660|FG001|Overall Study|Adverse Event|2|||
124474059|NCT00849667|447692661|FG002|Overall Study|Adverse Event|0|||
124474060|NCT00849667|447692659|FG000|Overall Study|Other|18|||
124474061|NCT00849667|447692660|FG001|Overall Study|Other|19|||
124474062|NCT00849667|447692661|FG002|Overall Study|Other|18|||
124474063|NCT00849667|447692659|FG000|Overall Study|Progressive disease|119|||
124474064|NCT00849667|447692660|FG001|Overall Study|Progressive disease|100|||
124474065|NCT00849667|447692661|FG002|Overall Study|Progressive disease|112|||
124474066|NCT00849667|447692659|FG000|Overall Study|Sponsor decision|208|||
124474067|NCT00849667|447692660|FG001|Overall Study|Sponsor decision|204|||
124474068|NCT00849667|447692661|FG002|Overall Study|Sponsor decision|190|||
124474069|NCT00849667|447692659|FG000|Overall Study|Investigator discretion|0|||
124474070|NCT00849667|447692660|FG001|Overall Study|Investigator discretion|0|||
124718051|NCT00809926|448589630|FG001|Overall Study|Adverse Event|10|||
124718052|NCT00809926|448589629|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
124718053|NCT00809926|448589630|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
124474071|NCT00849667|447692661|FG002|Overall Study|Investigator discretion|1|||
124474072|NCT01262625|447692667|FG000|Overall Study|Administrative Error|1|||
124474073|NCT01262625|447692668|FG001|Overall Study|Administrative Error|1|||
124474074|NCT01262625|447692667|FG000|Overall Study|Site Closed|1|||
124474075|NCT01262625|447692668|FG001|Overall Study|Site Closed|0|||
124474076|NCT02789657|447692669|FG000|Overall Study|Withdrawal by Subject|2|||
124474077|NCT02789657|447692670|FG001|Overall Study|Withdrawal by Subject|0|||
124474078|NCT02789657|447692671|FG002|Overall Study|Withdrawal by Subject|0|||
124474079|NCT02789657|447692672|FG003|Overall Study|Withdrawal by Subject|0|||
124474080|NCT01214044|447692673|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
124474081|NCT01214044|447692673|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
124474082|NCT01214044|447692673|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
124474083|NCT01214044|447692673|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
124474084|NCT01214044|447692673|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
124474085|NCT01214044|447692673|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
124474086|NCT02772757|447692675|FG000|Overall Study|Withdrawal by Subject|1|||
124474087|NCT02772757|447692676|FG001|Overall Study|Withdrawal by Subject|0|||
124474088|NCT02772757|447692677|FG002|Overall Study|Withdrawal by Subject|1|||
124555405|NCT00363129|447991088|FG000|Overall Study|Other Reasons|6|||
124555406|NCT00363129|447991089|FG001|Overall Study|Other Reasons|3|||
124555407|NCT03296553|447991090|FG000|Overall Study|Withdrawal by Subject|1|||
124555408|NCT03296553|447991091|FG001|Overall Study|Withdrawal by Subject|1|||
124555409|NCT03296553|447991090|FG000|Overall Study|Death|1|||
124555410|NCT03296553|447991091|FG001|Overall Study|Death|0|||
124555411|NCT02713243|447991092|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
124555412|NCT02713243|447991093|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
124555413|NCT02713243|447991092|FG000|Overall Study|Administrative problems|0|||
124555414|NCT02713243|447991093|FG001|Overall Study|Administrative problems|1|||
124555415|NCT02713243|447991092|FG000|Overall Study|Protocol deviation|0|||
124555416|NCT02713243|447991093|FG001|Overall Study|Protocol deviation|1|||
124555417|NCT01619085|447991094|FG000|Overall Study|Adverse Event|231|||
124555418|NCT01619085|447991094|FG000|Overall Study|Protocol Violation|4|||
124555419|NCT01619085|447991094|FG000|Overall Study|Lost to Follow-up|3|||
124555420|NCT01619085|447991094|FG000|Overall Study|Withdrawal by Subject|45|||
124555421|NCT01619085|447991094|FG000|Overall Study|Other than specified|96|||
124555422|NCT01619085|447991094|FG000|Overall Study|Not treated|1|||
124555423|NCT01619085|447991094|FG000|Overall Study|Death|145|||
124555424|NCT03125915|447991095|FG000|1 Month Follow up|Lost to Follow-up|3|||
124555425|NCT03125915|447991096|FG001|1 Month Follow up|Lost to Follow-up|3|||
124555426|NCT03125915|447991097|FG002|1 Month Follow up|Lost to Follow-up|2|||
124555427|NCT03125915|447991098|FG003|1 Month Follow up|Lost to Follow-up|3|||
124555428|NCT03125915|447991095|FG000|3 Month Follow-up|Lost to Follow-up|6|||
124555429|NCT03125915|447991096|FG001|3 Month Follow-up|Lost to Follow-up|4|||
124555430|NCT03125915|447991097|FG002|3 Month Follow-up|Lost to Follow-up|4|||
124718054|NCT00809926|448589629|FG000|Overall Study|Patient withdrew consent|8|||
124718055|NCT00809926|448589630|FG001|Overall Study|Patient withdrew consent|6|||
124718056|NCT00809926|448589629|FG000|Overall Study|Lost to Follow-up|2|||
124718057|NCT00809926|448589630|FG001|Overall Study|Lost to Follow-up|1|||
124718058|NCT00809926|448589629|FG000|Overall Study|Administrative Problems|0|||
124718059|NCT00809926|448589630|FG001|Overall Study|Administrative Problems|1|||
124718060|NCT00809926|448589629|FG000|Overall Study|Protocol deviation|0|||
124718061|NCT00809926|448589630|FG001|Overall Study|Protocol deviation|2|||
124718062|NCT00130039|448589635|FG000|Overall Study|Withdrawal by Subject|15|||
124718063|NCT00130039|448589636|FG001|Overall Study|Withdrawal by Subject|11|||
124718064|NCT00130039|448589635|FG000|Overall Study|Lost to Follow-up|3|||
124718065|NCT00130039|448589636|FG001|Overall Study|Lost to Follow-up|1|||
124718066|NCT00130039|448589635|FG000|Overall Study|Adverse Event|4|||
124718067|NCT00130039|448589636|FG001|Overall Study|Adverse Event|2|||
124718068|NCT00130039|448589635|FG000|Overall Study|Physician Decision|3|||
124474089|NCT02772757|447692675|FG000|Overall Study|Protocol Violation|0|||
124474090|NCT02772757|447692676|FG001|Overall Study|Protocol Violation|0|||
124474091|NCT02772757|447692677|FG002|Overall Study|Protocol Violation|1|||
124474092|NCT02772757|447692675|FG000|Overall Study|Physician Decision|0|||
124474093|NCT02772757|447692676|FG001|Overall Study|Physician Decision|3|||
124474094|NCT02772757|447692677|FG002|Overall Study|Physician Decision|3|||
124474095|NCT04698525|447692682|FG000|Overall Study|Lost to Follow-up|1|||
124474096|NCT04698525|447692683|FG001|Overall Study|Lost to Follow-up|2|||
124474097|NCT04698525|447692682|FG000|Overall Study|Three suffered of Covid-19|2|||
124474098|NCT04698525|447692683|FG001|Overall Study|Three suffered of Covid-19|1|||
124474099|NCT00510276|447692687|FG000|Acute Double-Blind Phase|Adverse Event|21|||
124474100|NCT00510276|447692688|FG001|Acute Double-Blind Phase|Adverse Event|6|||
124474101|NCT00510276|447692687|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
124474102|NCT00510276|447692688|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
124474103|NCT00510276|447692687|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
124474104|NCT00510276|447692688|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
124474105|NCT00510276|447692687|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
124474106|NCT00510276|447692688|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
124474107|NCT00510276|447692687|FG000|Acute Double-Blind Phase|Physician Decision|0|||
124474108|NCT00510276|447692688|FG001|Acute Double-Blind Phase|Physician Decision|3|||
124474109|NCT00510276|447692687|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
124474110|NCT00510276|447692688|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
124474111|NCT00510276|447692687|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
124474112|NCT00510276|447692688|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
124474113|NCT00510276|447692687|FG000|Acute Double-Blind Phase|Subject Decision|26|||
124474114|NCT00510276|447692688|FG001|Acute Double-Blind Phase|Subject Decision|28|||
124474115|NCT00510276|447692687|FG000|Extension Open-Label Phase|Adverse Event|9|||
124474116|NCT00510276|447692688|FG001|Extension Open-Label Phase|Adverse Event|18|||
124474117|NCT00510276|447692687|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
124474118|NCT00510276|447692688|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
124555431|NCT03125915|447991098|FG003|3 Month Follow-up|Lost to Follow-up|2|||
124555432|NCT03125915|447991095|FG000|6 Month Follow-up|Lost to Follow-up|7|||
124718069|NCT00130039|448589636|FG001|Overall Study|Physician Decision|0|||
124718070|NCT00130039|448589635|FG000|Overall Study|clinical events without follow up MRI|5|||
124474119|NCT00510276|447692687|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
124474120|NCT00510276|447692688|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
124474121|NCT00510276|447692687|FG000|Extension Open-Label Phase|Physician Decision|2|||
124474122|NCT00510276|447692688|FG001|Extension Open-Label Phase|Physician Decision|3|||
124474123|NCT00510276|447692687|FG000|Extension Open-Label Phase|Protocol Violation|0|||
124474124|NCT00510276|447692688|FG001|Extension Open-Label Phase|Protocol Violation|1|||
124718071|NCT00130039|448589636|FG001|Overall Study|clinical events without follow up MRI|4|||
124474125|NCT00510276|447692687|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
124474126|NCT00510276|447692688|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
124718072|NCT00642707|448589637|FG000|Overall Study|Adverse Event|0|||
124718073|NCT00642707|448589638|FG001|Overall Study|Adverse Event|0|||
124718074|NCT00642707|448589639|FG002|Overall Study|Adverse Event|0|||
124555433|NCT03125915|447991096|FG001|6 Month Follow-up|Lost to Follow-up|3|||
124555434|NCT03125915|447991097|FG002|6 Month Follow-up|Lost to Follow-up|6|||
124555435|NCT03125915|447991098|FG003|6 Month Follow-up|Lost to Follow-up|3|||
124555436|NCT01458119|447991099|FG000|Overall Study|Physician Decision|4|||
124555437|NCT01458119|447991099|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
124555438|NCT01458119|447991099|FG000|Overall Study|Pregnancy|1|||
124555439|NCT01458119|447991099|FG000|Overall Study|Death|2|||
124555440|NCT01458119|447991099|FG000|Overall Study|Adverse Event|1|||
124555441|NCT01458119|447991099|FG000|Overall Study|Consent Withdrawn by Participant|8|||
124555442|NCT01458119|447991099|FG000|Overall Study|Non-compliance With Study Drug|3|||
124555443|NCT00435825|447991100|FG000|Overall Study|Abnormality of Laboratory Test|0|||
124555444|NCT00435825|447991101|FG001|Overall Study|Abnormality of Laboratory Test|1|||
124555445|NCT00435825|447991102|FG002|Overall Study|Abnormality of Laboratory Test|0|||
124555446|NCT00435825|447991103|FG003|Overall Study|Abnormality of Laboratory Test|0|||
124555447|NCT00435825|447991100|FG000|Overall Study|Insufficient Therapeutic Response|3|||
124555448|NCT00435825|447991101|FG001|Overall Study|Insufficient Therapeutic Response|1|||
124555449|NCT00435825|447991102|FG002|Overall Study|Insufficient Therapeutic Response|0|||
124555450|NCT00435825|447991103|FG003|Overall Study|Insufficient Therapeutic Response|3|||
124555451|NCT00435825|447991100|FG000|Overall Study|Other Protocol Violation|1|||
124555452|NCT00435825|447991101|FG001|Overall Study|Other Protocol Violation|0|||
124555453|NCT00435825|447991102|FG002|Overall Study|Other Protocol Violation|0|||
124555454|NCT00435825|447991103|FG003|Overall Study|Other Protocol Violation|0|||
124555455|NCT00435825|447991100|FG000|Overall Study|Refused treatment|2|||
124555456|NCT00435825|447991101|FG001|Overall Study|Refused treatment|0|||
124555457|NCT00435825|447991102|FG002|Overall Study|Refused treatment|0|||
124555458|NCT00435825|447991103|FG003|Overall Study|Refused treatment|5|||
124555459|NCT00435825|447991100|FG000|Overall Study|Failure to return|5|||
124555460|NCT00435825|447991101|FG001|Overall Study|Failure to return|0|||
124718075|NCT00642707|448589640|FG003|Overall Study|Adverse Event|2|||
124718076|NCT00642707|448589637|FG000|Overall Study|Withdrawal by Subject|1|||
124718077|NCT00642707|448589638|FG001|Overall Study|Withdrawal by Subject|0|||
124718078|NCT00642707|448589639|FG002|Overall Study|Withdrawal by Subject|0|||
124718079|NCT00642707|448589640|FG003|Overall Study|Withdrawal by Subject|0|||
124718080|NCT00100802|448589644|FG000|Overall Study|Adverse Event|9|||
124718081|NCT00100802|448589644|FG000|Overall Study|Death|1|||
124718082|NCT00100802|448589644|FG000|Overall Study|Lack of Efficacy|47|||
124718083|NCT00100802|448589644|FG000|Overall Study|Physician Decision|5|||
124718084|NCT00100802|448589644|FG000|Overall Study|Protocol Violation|1|||
124718085|NCT00100802|448589644|FG000|Overall Study|Withdrawal by Subject|5|||
124718086|NCT00100802|448589644|FG000|Overall Study|Ineligible|12|||
124718087|NCT02709720|448589645|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
124718088|NCT02709720|448589645|FG000|Overall Study|Protocol Violation|1|||
124718089|NCT02709720|448589645|FG000|Overall Study|Not take study medication|1|||
124718090|NCT01198574|448589674|FG000|Overall Study|Resigned from schools|4|||
124718091|NCT01198574|448589675|FG001|Overall Study|Resigned from schools|1|||
124555461|NCT00435825|447991102|FG002|Overall Study|Failure to return|4|||
124555462|NCT00435825|447991103|FG003|Overall Study|Failure to return|0|||
124555463|NCT00435825|447991100|FG000|Overall Study|Did not receive study drug|1|||
124555464|NCT00435825|447991101|FG001|Overall Study|Did not receive study drug|0|||
124718092|NCT01198574|448589676|FG002|Overall Study|Resigned from schools|1|||
124718093|NCT01198574|448589677|FG003|Overall Study|Resigned from schools|4|||
124718094|NCT00325130|448589678|FG000|Overall Study|Lost to Follow-up|6|||
124718095|NCT00325130|448589679|FG001|Overall Study|Lost to Follow-up|14|||
124718096|NCT00325130|448589678|FG000|Overall Study|Withdrawal by Subject|12|||
124474127|NCT00510276|447692687|FG000|Extension Open-Label Phase|Subject Decision|7|||
124474128|NCT00510276|447692688|FG001|Extension Open-Label Phase|Subject Decision|9|||
124474129|NCT03486392|447692693|FG000|Overall Study|Lost to Follow-up|0|||
124474130|NCT03486392|447692694|FG001|Overall Study|Lost to Follow-up|0|||
124474131|NCT03486392|447692695|FG002|Overall Study|Lost to Follow-up|8|||
124474132|NCT03486392|447692696|FG003|Overall Study|Lost to Follow-up|5|||
124474133|NCT03486392|447692697|FG004|Overall Study|Lost to Follow-up|2|||
124474134|NCT03486392|447692693|FG000|Overall Study|Withdrawal by Subject|3|||
124474135|NCT03486392|447692694|FG001|Overall Study|Withdrawal by Subject|0|||
124474136|NCT03486392|447692695|FG002|Overall Study|Withdrawal by Subject|6|||
124474137|NCT03486392|447692696|FG003|Overall Study|Withdrawal by Subject|4|||
124474138|NCT03486392|447692697|FG004|Overall Study|Withdrawal by Subject|1|||
124474139|NCT03486392|447692693|FG000|Overall Study|Death|0|||
124474140|NCT03486392|447692694|FG001|Overall Study|Death|0|||
124474141|NCT03486392|447692695|FG002|Overall Study|Death|0|||
124474142|NCT03486392|447692696|FG003|Overall Study|Death|0|||
124474143|NCT03486392|447692697|FG004|Overall Study|Death|1|||
124474144|NCT01731678|447692700|FG000|Overall Study|Withdrawal by Subject|3|||
124474145|NCT01731678|447692700|FG000|Overall Study|Did not meet inclusion criteria|1|||
124474146|NCT01731678|447692700|FG000|Overall Study|RMT too high, making TMS difficult|3|||
124474147|NCT00888355|447692705|FG000|Overall Study|Adverse Event|10|||
124474148|NCT00888355|447692706|FG001|Overall Study|Adverse Event|0|||
124474149|NCT00888355|447692707|FG002|Overall Study|Adverse Event|3|||
124474150|NCT00888355|447692708|FG003|Overall Study|Adverse Event|3|||
124474151|NCT00888355|447692705|FG000|Overall Study|Lack of Efficacy|9|||
124474152|NCT00888355|447692706|FG001|Overall Study|Lack of Efficacy|2|||
124474153|NCT00888355|447692707|FG002|Overall Study|Lack of Efficacy|5|||
124474154|NCT00888355|447692708|FG003|Overall Study|Lack of Efficacy|2|||
124474155|NCT00888355|447692705|FG000|Overall Study|Lost to Follow-up|0|||
124474156|NCT00888355|447692706|FG001|Overall Study|Lost to Follow-up|2|||
124474157|NCT00888355|447692707|FG002|Overall Study|Lost to Follow-up|2|||
124474158|NCT00888355|447692708|FG003|Overall Study|Lost to Follow-up|0|||
124474159|NCT00888355|447692705|FG000|Overall Study|Protocol Violation|3|||
124474160|NCT00888355|447692706|FG001|Overall Study|Protocol Violation|2|||
124474161|NCT00888355|447692707|FG002|Overall Study|Protocol Violation|1|||
124474162|NCT00888355|447692708|FG003|Overall Study|Protocol Violation|2|||
124474163|NCT00888355|447692705|FG000|Overall Study|Withdrawal by Subject|0|||
124474164|NCT00888355|447692706|FG001|Overall Study|Withdrawal by Subject|3|||
124474165|NCT00888355|447692707|FG002|Overall Study|Withdrawal by Subject|1|||
124474166|NCT00888355|447692708|FG003|Overall Study|Withdrawal by Subject|3|||
124474167|NCT01551693|447692710|FG000|Overall Study|Disease Progression|1|||
124474168|NCT01551693|447692711|FG001|Overall Study|Disease Progression|0|||
124474169|NCT01551693|447692710|FG000|Overall Study|Adverse Event|0|||
124474170|NCT01551693|447692711|FG001|Overall Study|Adverse Event|1|||
124474171|NCT01551693|447692710|FG000|Overall Study|Withdrawal by Subject|0|||
124474172|NCT01551693|447692711|FG001|Overall Study|Withdrawal by Subject|1|||
124474173|NCT04897867|447692713|FG000|Overall Study|Withdrawal of Consent|1|||
124474174|NCT04897867|447692713|FG000|Overall Study|Pregnancy|1|||
124474175|NCT04897867|447692713|FG000|Overall Study|Lost to Follow-up|7|||
124474176|NCT04897867|447692713|FG000|Overall Study|Reason not Specified|2|||
124474177|NCT01948830|447692714|FG000|Overall Study|Physician Decision|1|||
124474178|NCT01948830|447692715|FG001|Overall Study|Physician Decision|3|||
124474179|NCT01948830|447692714|FG000|Overall Study|Protocol deviation|1|||
124474180|NCT01948830|447692715|FG001|Overall Study|Protocol deviation|2|||
124474181|NCT01948830|447692714|FG000|Overall Study|Lost to Follow-up|5|||
124474182|NCT01948830|447692715|FG001|Overall Study|Lost to Follow-up|4|||
124474183|NCT01948830|447692714|FG000|Overall Study|Withdrawal by Subject|14|||
124474184|NCT01948830|447692715|FG001|Overall Study|Withdrawal by Subject|17|||
124474185|NCT01948830|447692714|FG000|Overall Study|Adverse Event|9|||
124474186|NCT01948830|447692715|FG001|Overall Study|Adverse Event|2|||
124474187|NCT01948830|447692714|FG000|Overall Study|Death|3|||
124474188|NCT01948830|447692715|FG001|Overall Study|Death|4|||
124474189|NCT01133171|447692716|FG000|Overall Study|Withdrawal by Subject|1|||
124474190|NCT01133171|447692717|FG001|Overall Study|Withdrawal by Subject|2|||
124474191|NCT01133171|447692718|FG002|Overall Study|Withdrawal by Subject|0|||
124474192|NCT01282229|447692727|FG000|Overall Study|Protocol Violation|2|||
124474193|NCT00769119|447692729|FG000|Overall Study|Voluntary discontinuation|0|||
124474194|NCT00769119|447692730|FG001|Overall Study|Voluntary discontinuation|2|||
124474195|NCT00769119|447692729|FG000|Overall Study|Adverse Event|1|||
124474196|NCT00769119|447692730|FG001|Overall Study|Adverse Event|1|||
124474197|NCT00769119|447692729|FG000|Overall Study|Disallowed medication|1|||
124474198|NCT00769119|447692730|FG001|Overall Study|Disallowed medication|0|||
124474199|NCT03828487|447692738|FG000|Overall Study|Physician Decision|1|||
124474200|NCT03430986|447692739|FG000|24-week Control Period|Adverse Event|1|||
124474201|NCT03430986|447692740|FG001|24-week Control Period|Adverse Event|0|||
124474202|NCT03430986|447692739|FG000|24-week Control Period|Lost to Follow-up|2|||
124474203|NCT03430986|447692740|FG001|24-week Control Period|Lost to Follow-up|2|||
124474204|NCT03430986|447692739|FG000|24-week Control Period|Withdrawal by Participant|5|||
124555465|NCT00435825|447991102|FG002|Overall Study|Did not receive study drug|2|||
124555466|NCT00435825|447991103|FG003|Overall Study|Did not receive study drug|0|||
124474205|NCT03430986|447692740|FG001|24-week Control Period|Withdrawal by Participant|0|||
124474206|NCT03430986|447692739|FG000|24-week Control Period|Protocol Deviation|0|||
124555467|NCT00435825|447991100|FG000|Overall Study|Did not enter follow-up|0|||
124474207|NCT03430986|447692740|FG001|24-week Control Period|Protocol Deviation|2|||
124474208|NCT03430986|447692739|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
124555468|NCT00435825|447991101|FG001|Overall Study|Did not enter follow-up|4|||
124474209|NCT03430986|447692740|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
124718097|NCT00325130|448589679|FG001|Overall Study|Withdrawal by Subject|14|||
124718098|NCT00325130|448589678|FG000|Overall Study|Protocol Deviation|0|||
124718099|NCT00325130|448589679|FG001|Overall Study|Protocol Deviation|1|||
124718100|NCT00325130|448589678|FG000|Overall Study|Moved|0|||
124718101|NCT00325130|448589679|FG001|Overall Study|Moved|1|||
124718102|NCT00325130|448589678|FG000|Overall Study|Patient Discontinued for Other|1|||
124718103|NCT00325130|448589679|FG001|Overall Study|Patient Discontinued for Other|0|||
124718104|NCT00326001|448589680|FG000|Overall Study|Adverse Event|4|||
124718105|NCT00326001|448589681|FG001|Overall Study|Adverse Event|5|||
124718106|NCT00326001|448589680|FG000|Overall Study|Physician Decision|3|||
124718107|NCT00326001|448589681|FG001|Overall Study|Physician Decision|3|||
124718108|NCT01042158|448589682|FG000|Overall Study|Physician Decision|1|||
124555469|NCT00435825|447991102|FG002|Overall Study|Did not enter follow-up|1|||
124555470|NCT00435825|447991103|FG003|Overall Study|Did not enter follow-up|3|||
124555471|NCT00435825|447991100|FG000|Overall Study|Did not complete full follow-up period|6|||
124555472|NCT00435825|447991101|FG001|Overall Study|Did not complete full follow-up period|6|||
124555473|NCT00435825|447991102|FG002|Overall Study|Did not complete full follow-up period|4|||
124555474|NCT00435825|447991103|FG003|Overall Study|Did not complete full follow-up period|5|||
124555475|NCT01123980|447991106|FG000|Overall Study|Adverse Event|1|||
124555476|NCT01123980|447991107|FG001|Overall Study|Adverse Event|1|||
124555477|NCT01123980|447991106|FG000|Overall Study|Lack of Efficacy|1|||
124555478|NCT01123980|447991107|FG001|Overall Study|Lack of Efficacy|0|||
124555479|NCT01123980|447991106|FG000|Overall Study|Physician Decision|0|||
124555480|NCT01123980|447991107|FG001|Overall Study|Physician Decision|1|||
124555481|NCT01123980|447991106|FG000|Overall Study|Lost to Follow-up|0|||
124555482|NCT01123980|447991107|FG001|Overall Study|Lost to Follow-up|6|||
124555483|NCT01123980|447991106|FG000|Overall Study|Protocol Violation|6|||
124555484|NCT01123980|447991107|FG001|Overall Study|Protocol Violation|6|||
124555485|NCT01123980|447991106|FG000|Overall Study|Withdrawal by Subject|5|||
124555486|NCT01123980|447991107|FG001|Overall Study|Withdrawal by Subject|3|||
124555487|NCT01123980|447991106|FG000|Overall Study|Unclassified|6|||
124555488|NCT01123980|447991107|FG001|Overall Study|Unclassified|7|||
124555489|NCT01225991|447991108|FG000|Overall Study|Withdrawal by Subject|6|||
124555490|NCT00789828|447991109|FG000|Core Period (48 Weeks)|Administrative problems|0|||
124555491|NCT00789828|447991110|FG001|Core Period (48 Weeks)|Administrative problems|1|||
124555492|NCT00789828|447991109|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
124771647|NCT02085460|448794527|FG000|Overall Study|Physician Decision|1|||
124555493|NCT00789828|447991110|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
124555494|NCT00789828|447991109|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
124555495|NCT00789828|447991110|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
124555496|NCT00789828|447991109|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
124555497|NCT00789828|447991110|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
124555498|NCT00789828|447991109|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
124555499|NCT00789828|447991110|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
124555500|NCT00789828|447991109|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
124555501|NCT00789828|447991110|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
124555502|NCT00789828|447991109|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
124555503|NCT00789828|447991110|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
124555504|NCT00789828|447991109|FG000|Open-label Extension Period (4 Years)|Death|1|||
124555505|NCT00789828|447991110|FG001|Open-label Extension Period (4 Years)|Death|0|||
124555506|NCT00789828|447991109|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
124555507|NCT00789828|447991110|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
124555508|NCT00789828|447991109|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
124555509|NCT00789828|447991110|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
124555510|NCT02094937|447991111|FG000|8 Weeks in Period 1|Adverse Event|9|||
124555511|NCT02094937|447991112|FG001|8 Weeks in Period 1|Adverse Event|0|||
124555512|NCT02094937|447991113|FG002|8 Weeks in Period 1|Adverse Event|0|||
124555513|NCT02094937|447991114|FG003|8 Weeks in Period 1|Adverse Event|0|||
124555514|NCT02094937|447991111|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
124555515|NCT02094937|447991112|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
124555516|NCT02094937|447991113|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
124555517|NCT02094937|447991114|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
124555518|NCT02094937|447991111|FG000|8 Weeks in Period 1|Protocol Violation|2|||
124555519|NCT02094937|447991112|FG001|8 Weeks in Period 1|Protocol Violation|0|||
124555520|NCT02094937|447991113|FG002|8 Weeks in Period 1|Protocol Violation|0|||
124555521|NCT02094937|447991114|FG003|8 Weeks in Period 1|Protocol Violation|0|||
124555522|NCT02094937|447991111|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
124555523|NCT02094937|447991112|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
124555524|NCT02094937|447991113|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
124555525|NCT02094937|447991114|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
124555526|NCT02094937|447991111|FG000|8 Weeks in Period 1|Physician Decision|1|||
124555527|NCT02094937|447991112|FG001|8 Weeks in Period 1|Physician Decision|0|||
124555528|NCT02094937|447991113|FG002|8 Weeks in Period 1|Physician Decision|0|||
124555529|NCT02094937|447991114|FG003|8 Weeks in Period 1|Physician Decision|0|||
124555530|NCT02094937|447991111|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
124555531|NCT02094937|447991112|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
124555532|NCT02094937|447991113|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
124555533|NCT02094937|447991114|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
124555534|NCT02094937|447991111|FG000|12 Weeks in Period 2|Adverse Event|0|||
124555535|NCT02094937|447991112|FG001|12 Weeks in Period 2|Adverse Event|2|||
124555536|NCT02094937|447991113|FG002|12 Weeks in Period 2|Adverse Event|4|||
124555537|NCT02094937|447991114|FG003|12 Weeks in Period 2|Adverse Event|1|||
124555538|NCT02094937|447991111|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
124555539|NCT02094937|447991112|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
124555540|NCT02094937|447991113|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
124555541|NCT02094937|447991114|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
124555542|NCT02094937|447991111|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
124555543|NCT02094937|447991112|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
124555544|NCT02094937|447991113|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
124555545|NCT02094937|447991114|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
124555546|NCT02094937|447991111|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
124555547|NCT02094937|447991112|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
124555548|NCT02094937|447991113|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
124555549|NCT02094937|447991114|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
124555550|NCT02094937|447991111|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
124555551|NCT02094937|447991112|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
124555552|NCT02094937|447991113|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
124555553|NCT02094937|447991114|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
124555554|NCT01133392|447991115|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
124555555|NCT01133392|447991116|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
124555556|NCT01133392|447991115|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
124555557|NCT01133392|447991116|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
124555558|NCT05788237|447991117|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
124555559|NCT05788237|447991118|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
124555560|NCT05788237|447991119|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
124555561|NCT05788237|447991120|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
124555562|NCT05788237|447991117|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
124555563|NCT05788237|447991118|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
124555564|NCT05788237|447991119|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
124555565|NCT05788237|447991120|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
124555566|NCT05788237|447991117|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
124555567|NCT05788237|447991118|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
124555568|NCT05788237|447991119|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
124555569|NCT05788237|447991120|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
124555570|NCT05788237|447991117|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
124555571|NCT05788237|447991118|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
124555572|NCT05788237|447991119|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
124555573|NCT05788237|447991120|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
124555574|NCT05788237|447991117|FG000|SSA (Approximately 2 Months)|Death|0|||
124555575|NCT05788237|447991118|FG001|SSA (Approximately 2 Months)|Death|1|||
124555576|NCT05788237|447991119|FG002|SSA (Approximately 2 Months)|Death|0|||
124555577|NCT05788237|447991120|FG003|SSA (Approximately 2 Months)|Death|0|||
124555578|NCT05788237|447991117|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
124555579|NCT05788237|447991118|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
124555580|NCT05788237|447991119|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
124555581|NCT05788237|447991120|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
124555582|NCT05788237|447991117|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
124555583|NCT05788237|447991118|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
124555584|NCT05788237|447991119|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
124555585|NCT05788237|447991120|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
124555586|NCT05788237|447991117|FG000|SSB (Approximately 1 Month)|Other|0|||
124555587|NCT05788237|447991118|FG001|SSB (Approximately 1 Month)|Other|0|||
124555588|NCT05788237|447991119|FG002|SSB (Approximately 1 Month)|Other|0|||
124555589|NCT05788237|447991120|FG003|SSB (Approximately 1 Month)|Other|1|||
124555590|NCT00304954|447992246|FG000|Overall Study|Withdrawal by Subject|0|||
124555591|NCT00304954|447992247|FG001|Overall Study|Withdrawal by Subject|0|||
124555592|NCT00304954|447992248|FG002|Overall Study|Withdrawal by Subject|1|||
124555593|NCT00304954|447992249|FG003|Overall Study|Withdrawal by Subject|0|||
124555594|NCT00304954|447992246|FG000|Overall Study|Adverse Event|1|||
124555595|NCT00304954|447992247|FG001|Overall Study|Adverse Event|0|||
124555596|NCT00304954|447992248|FG002|Overall Study|Adverse Event|0|||
124555597|NCT00304954|447992249|FG003|Overall Study|Adverse Event|0|||
124555598|NCT03990389|447992260|FG000|Overall Study|Lost to Follow-up|3|||
124555599|NCT03990389|447992261|FG001|Overall Study|Lost to Follow-up|0|||
124555600|NCT00207714|447992262|FG000|Overall Study|Adverse Event|6|||
124555601|NCT00207714|447992263|FG001|Overall Study|Adverse Event|2|||
124555602|NCT00207714|447992264|FG002|Overall Study|Adverse Event|4|||
124555603|NCT00207714|447992265|FG003|Overall Study|Adverse Event|3|||
124555604|NCT00207714|447992266|FG004|Overall Study|Adverse Event|1|||
124555605|NCT00207714|447992262|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
124555606|NCT00207714|447992263|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
124555607|NCT00207714|447992264|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
124555608|NCT00207714|447992265|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
124555609|NCT00207714|447992266|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
124555610|NCT00207714|447992262|FG000|Overall Study|Other|3|||
124555611|NCT00207714|447992263|FG001|Overall Study|Other|2|||
124555612|NCT00207714|447992264|FG002|Overall Study|Other|5|||
124555613|NCT00207714|447992265|FG003|Overall Study|Other|1|||
124555614|NCT00207714|447992266|FG004|Overall Study|Other|0|||
124555615|NCT03627195|447992267|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
124555616|NCT03627195|447992268|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
124555617|NCT03627195|447992269|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
124555618|NCT03627195|447992270|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
124555619|NCT03627195|447992271|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
124555620|NCT03627195|447992272|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
124555621|NCT00833547|447992277|FG000|Overall Study|Withdrawal by Subject|2|||
124555622|NCT00833547|447992278|FG001|Overall Study|Withdrawal by Subject|2|||
124555623|NCT00686790|447992281|FG000|Overall Study|Adverse Event|2|||
124555624|NCT00686790|447992281|FG000|Overall Study|Withdrawal by Subject|1|||
124555625|NCT00686790|447992281|FG000|Overall Study|Death|1|||
124555626|NCT00686790|447992281|FG000|Overall Study|Lost to Follow-up|12|||
124555627|NCT02082912|447992285|FG000|Overall Study|Physician Decision|0|||
124555628|NCT02082912|447992286|FG001|Overall Study|Physician Decision|1|||
124555629|NCT00697112|447992303|FG000|Overall Study|Adverse Event|8|||
124555630|NCT00697112|447992303|FG000|Overall Study|Lost to Follow-up|1|||
124555631|NCT00697112|447992303|FG000|Overall Study|Did not meet inclusion criteria|1|||
124718109|NCT03640325|448591131|FG000|Overall Study|Withdrawal by Subject|4|||
124718110|NCT03640325|448591132|FG001|Overall Study|Withdrawal by Subject|1|||
124718111|NCT03640325|448591133|FG002|Overall Study|Withdrawal by Subject|0|||
124718112|NCT03640325|448591131|FG000|Overall Study|Lost to Follow-up|4|||
124718113|NCT03640325|448591132|FG001|Overall Study|Lost to Follow-up|5|||
124718114|NCT03640325|448591133|FG002|Overall Study|Lost to Follow-up|21|||
124718115|NCT03640325|448591131|FG000|Overall Study|Death|5|||
124718116|NCT03640325|448591132|FG001|Overall Study|Death|5|||
124718117|NCT03640325|448591133|FG002|Overall Study|Death|0|||
124718118|NCT01133756|448591137|FG000|Overall Study|Adverse Event|1|||
124718119|NCT01133756|448591138|FG001|Overall Study|Adverse Event|2|||
124718120|NCT01133756|448591139|FG002|Overall Study|Adverse Event|1|||
124718121|NCT01133756|448591137|FG000|Overall Study|Investigator Decision|1|||
124718122|NCT01133756|448591138|FG001|Overall Study|Investigator Decision|0|||
124718123|NCT01133756|448591139|FG002|Overall Study|Investigator Decision|0|||
124718124|NCT01133756|448591137|FG000|Overall Study|Withdrawal by Subject|0|||
124718125|NCT01133756|448591138|FG001|Overall Study|Withdrawal by Subject|1|||
124718126|NCT01133756|448591139|FG002|Overall Study|Withdrawal by Subject|0|||
124718127|NCT01133756|448591137|FG000|Overall Study|Progression of Disease|0|||
124718128|NCT01133756|448591138|FG001|Overall Study|Progression of Disease|0|||
124718129|NCT01133756|448591139|FG002|Overall Study|Progression of Disease|1|||
124718130|NCT01566149|448591140|FG000|Overall Study|Adverse Event|0|||
124718131|NCT01566149|448591141|FG001|Overall Study|Adverse Event|1|||
124718132|NCT01566149|448591140|FG000|Overall Study|Non-compliance with study medication|2|||
124474210|NCT03430986|447692739|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
124474211|NCT03430986|447692740|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
124474212|NCT01078805|447692742|FG000|Overall Study|Clinically significant abnormal lab|5|||
124474213|NCT01078805|447692742|FG000|Overall Study|Death|134|||
124474214|NCT01078805|447692742|FG000|Overall Study|Lost to Follow-up|676|||
124474215|NCT01078805|447692742|FG000|Overall Study|Physician Decision|169|||
124474216|NCT01078805|447692742|FG000|Overall Study|Serious adverse event|26|||
124718133|NCT01566149|448591141|FG001|Overall Study|Non-compliance with study medication|0|||
124718134|NCT01566149|448591140|FG000|Overall Study|Protocol Violation|0|||
124474217|NCT01078805|447692742|FG000|Overall Study|Sponsor decision|46|||
124474218|NCT01078805|447692742|FG000|Overall Study|Withdrawal by Subject|739|||
124474219|NCT01078805|447692742|FG000|Overall Study|Other|173|||
124718135|NCT01566149|448591141|FG001|Overall Study|Protocol Violation|1|||
124718136|NCT01566149|448591140|FG000|Overall Study|Withdrawal by Subject|1|||
124718137|NCT01566149|448591141|FG001|Overall Study|Withdrawal by Subject|0|||
124718138|NCT03276728|448591144|FG000|Overall Study|Lost to Follow-up|0|||
124718139|NCT03276728|448591145|FG001|Overall Study|Lost to Follow-up|0|||
124718140|NCT03276728|448591146|FG002|Overall Study|Lost to Follow-up|2|||
124718141|NCT03276728|448591147|FG003|Overall Study|Lost to Follow-up|2|||
124718142|NCT03276728|448591148|FG004|Overall Study|Lost to Follow-up|0|||
124555632|NCT00736333|447992304|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
124555633|NCT00736333|447992304|FG000|Overall Study|Data Missing|2|||
124555634|NCT00736333|447992304|FG000|Overall Study|Tumor Progression|75|||
124555635|NCT00736333|447992304|FG000|Overall Study|Toxicity|6|||
124555636|NCT00736333|447992304|FG000|Overall Study|Withdrawal by Subject|10|||
124555637|NCT00736333|447992304|FG000|Overall Study|Death|7|||
124555638|NCT00736333|447992304|FG000|Overall Study|Other|4|||
124555639|NCT04126733|447992305|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
124555640|NCT04126733|447992305|FG000|Treatment Period|Adverse Event|8|||
124555641|NCT04126733|447992305|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
124555642|NCT04126733|447992305|FG000|Treatment Period|Physician Decision|5|||
124555643|NCT04126733|447992305|FG000|Treatment Period|Death|1|||
124555644|NCT04126733|447992305|FG000|Treatment Period|Other Reasons|2|||
124555645|NCT04126733|447992305|FG000|Active Follow-up Period|Death|13|||
124555646|NCT04126733|447992305|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
124555647|NCT04126733|447992305|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
124555648|NCT04126733|447992305|FG000|Active Follow-up Period|Other Reasons|1|||
124555649|NCT04126733|447992305|FG000|Long-term Follow-up Period|Death|22|||
124555650|NCT04126733|447992305|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
124555651|NCT04126733|447992305|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
124555652|NCT02629133|447992306|FG000|Overall Study|Lost to Follow-up|3|||
124555653|NCT02629133|447992307|FG001|Overall Study|Lost to Follow-up|1|||
124555654|NCT02629133|447992306|FG000|Overall Study|Withdrawal by Subject|1|||
124555655|NCT02629133|447992307|FG001|Overall Study|Withdrawal by Subject|1|||
124555656|NCT02598193|447992308|FG000|Overall Study|Adverse Event|13|||
124555657|NCT02598193|447992308|FG000|Overall Study|Withdrawal by Subject|1|||
124555658|NCT02598193|447992308|FG000|Overall Study|Listed in active lung transplant list|1|||
124555659|NCT02598193|447992308|FG000|Overall Study|Does not want to take Nintedanib|1|||
124555660|NCT02354976|447992314|FG000|Overall Study|Other - reason not specified|1|||
124555661|NCT02354976|447992315|FG001|Overall Study|Other - reason not specified|0|||
124555662|NCT02354976|447992316|FG002|Overall Study|Other - reason not specified|1|||
124555663|NCT02354976|447992314|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
124555664|NCT02354976|447992315|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
124555665|NCT02354976|447992316|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
124555666|NCT02354976|447992314|FG000|Overall Study|Adverse Event|1|||
124555667|NCT02354976|447992315|FG001|Overall Study|Adverse Event|0|||
124555668|NCT02354976|447992316|FG002|Overall Study|Adverse Event|2|||
124555669|NCT03726437|447992317|FG000|Overall Study|Lost to Follow-up|85|||
124555670|NCT03726437|447992318|FG001|Overall Study|Lost to Follow-up|76|||
124555671|NCT01896700|447992319|FG000|Overall Study|Adverse Event|4|||
124555672|NCT01896700|447992320|FG001|Overall Study|Adverse Event|5|||
124555673|NCT01896700|447992319|FG000|Overall Study|Withdrawal by Subject|0|||
124555674|NCT01896700|447992320|FG001|Overall Study|Withdrawal by Subject|1|||
124555675|NCT03118765|447992322|FG000|Overall Study|Withdrawal by Subject|0|||
124555676|NCT03118765|447992323|FG001|Overall Study|Withdrawal by Subject|0|||
124555677|NCT03118765|447992324|FG002|Overall Study|Withdrawal by Subject|1|||
124555678|NCT03118765|447992325|FG003|Overall Study|Withdrawal by Subject|0|||
124555679|NCT03118765|447992326|FG004|Overall Study|Withdrawal by Subject|0|||
124555680|NCT03118765|447992322|FG000|Overall Study|Adverse Event|1|||
124555681|NCT03118765|447992323|FG001|Overall Study|Adverse Event|1|||
124555682|NCT03118765|447992324|FG002|Overall Study|Adverse Event|1|||
124555683|NCT03118765|447992325|FG003|Overall Study|Adverse Event|1|||
124555684|NCT03118765|447992326|FG004|Overall Study|Adverse Event|1|||
124555685|NCT03118765|447992322|FG000|Overall Study|Non compliance with Study Procedures|0|||
124555686|NCT03118765|447992323|FG001|Overall Study|Non compliance with Study Procedures|0|||
124555687|NCT03118765|447992324|FG002|Overall Study|Non compliance with Study Procedures|0|||
124555688|NCT03118765|447992325|FG003|Overall Study|Non compliance with Study Procedures|1|||
124555689|NCT03118765|447992326|FG004|Overall Study|Non compliance with Study Procedures|0|||
124555690|NCT03118765|447992322|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
124555691|NCT03118765|447992323|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
124555692|NCT03118765|447992324|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
124555693|NCT03118765|447992325|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
124555694|NCT03118765|447992326|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
124555695|NCT03118765|447992322|FG000|Overall Study|COPD Exacerbation|1|||
124555696|NCT03118765|447992323|FG001|Overall Study|COPD Exacerbation|0|||
124555697|NCT03118765|447992324|FG002|Overall Study|COPD Exacerbation|0|||
124555698|NCT03118765|447992325|FG003|Overall Study|COPD Exacerbation|1|||
124555699|NCT03118765|447992326|FG004|Overall Study|COPD Exacerbation|0|||
124555700|NCT03118765|447992322|FG000|Overall Study|Lost to Follow-up|1|||
124555701|NCT03118765|447992323|FG001|Overall Study|Lost to Follow-up|0|||
124555702|NCT03118765|447992324|FG002|Overall Study|Lost to Follow-up|1|||
124555703|NCT03118765|447992325|FG003|Overall Study|Lost to Follow-up|0|||
124555704|NCT03118765|447992326|FG004|Overall Study|Lost to Follow-up|0|||
124555705|NCT03118765|447992322|FG000|Overall Study|Sponsor Decision|1|||
124555706|NCT03118765|447992323|FG001|Overall Study|Sponsor Decision|0|||
124555707|NCT03118765|447992324|FG002|Overall Study|Sponsor Decision|1|||
124555708|NCT03118765|447992325|FG003|Overall Study|Sponsor Decision|0|||
124555709|NCT03118765|447992326|FG004|Overall Study|Sponsor Decision|1|||
124555710|NCT00849524|447992327|FG000|Overall Study|Lack of Efficacy|3|||
124555711|NCT01610167|447992333|FG000|Overall Study|Scheduling conflict.|0|||
124555712|NCT01610167|447992334|FG001|Overall Study|Scheduling conflict.|0|||
124555713|NCT01610167|447992335|FG002|Overall Study|Scheduling conflict.|2|||
124555714|NCT01021137|447992337|FG000|Overall Study|Lost to Follow-up|9|||
124555715|NCT01021137|447992338|FG001|Overall Study|Lost to Follow-up|4|||
124555716|NCT01021137|447992339|FG002|Overall Study|Lost to Follow-up|2|||
124555717|NCT01021137|447992340|FG003|Overall Study|Lost to Follow-up|6|||
124555718|NCT01021137|447992337|FG000|Overall Study|Withdrawal by Subject|1|||
124555719|NCT01021137|447992338|FG001|Overall Study|Withdrawal by Subject|0|||
124555720|NCT01021137|447992339|FG002|Overall Study|Withdrawal by Subject|0|||
124555721|NCT01021137|447992340|FG003|Overall Study|Withdrawal by Subject|3|||
124555722|NCT03439293|447992341|FG000|Overall Study|Death|22|||
124555723|NCT03439293|447992341|FG000|Overall Study|Withdrawal by Subject|8|||
124555724|NCT03439293|447992341|FG000|Overall Study|Lost to Follow-up|2|||
124555725|NCT03439293|447992341|FG000|Overall Study|Reason Not Specified|28|||
124555726|NCT03439293|447992341|FG000|Overall Study|Missing|1|||
124555727|NCT02766400|447992347|FG000|Overall Study|Death|1|||
124555728|NCT02766400|447992348|FG001|Overall Study|Death|2|||
124555729|NCT02766400|447992347|FG000|Overall Study|Withdrawal by Subject|1|||
124555730|NCT02766400|447992348|FG001|Overall Study|Withdrawal by Subject|0|||
124555731|NCT03499249|447992355|FG000|Overall Study|Physician Decision|1|||
124555732|NCT01559818|447992362|FG000|Overall Study|Physician Decision|1|||
124555733|NCT01559818|447992362|FG000|Overall Study|Pregnancy|1|||
124555734|NCT01559818|447992362|FG000|Overall Study|Study terminated by Sponsor|4|||
124555735|NCT01559818|447992362|FG000|Overall Study|Withdrawal by Subject|1|||
124555736|NCT04071626|447992363|FG000|Overall Study|Withdrawal by Subject|1|||
124555737|NCT04071626|447992364|FG001|Overall Study|Withdrawal by Subject|1|||
124555738|NCT04071626|447992363|FG000|Overall Study|Protocol Violation|0|||
124555739|NCT04071626|447992364|FG001|Overall Study|Protocol Violation|1|||
124555740|NCT01374906|447992365|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124555741|NCT01374906|447992366|FG001|Overall Study|Abnormal laboratory value(s)|3|||
124555742|NCT01374906|447992365|FG000|Overall Study|Administrative problems|2|||
124555743|NCT01374906|447992366|FG001|Overall Study|Administrative problems|2|||
124555744|NCT01374906|447992365|FG000|Overall Study|Adverse Event|10|||
124555745|NCT01374906|447992366|FG001|Overall Study|Adverse Event|11|||
124555746|NCT01374906|447992365|FG000|Overall Study|Death|0|||
124555747|NCT01374906|447992366|FG001|Overall Study|Death|2|||
124555748|NCT01374906|447992365|FG000|Overall Study|Protocol Violation|2|||
124555749|NCT01374906|447992366|FG001|Overall Study|Protocol Violation|2|||
124555750|NCT01374906|447992365|FG000|Overall Study|Withdrawal by Subject|15|||
124555751|NCT01374906|447992366|FG001|Overall Study|Withdrawal by Subject|9|||
124555752|NCT01374906|447992365|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
124555753|NCT01374906|447992366|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
124555754|NCT02475980|447992369|FG000|Overall Study|Lost to Follow-up|4|||
124555755|NCT02475980|447992369|FG000|Overall Study|Withdrawal by Subject|1|||
124555756|NCT00665626|447992375|FG000|Overall Study|Lack of Efficacy|8|||
124555757|NCT00665626|447992376|FG001|Overall Study|Lack of Efficacy|5|||
124555758|NCT00665626|447992375|FG000|Overall Study|Lost to Follow-up|0|||
124555759|NCT00665626|447992376|FG001|Overall Study|Lost to Follow-up|2|||
124555760|NCT00665626|447992375|FG000|Overall Study|Withdrawal by Subject|0|||
124555761|NCT00665626|447992376|FG001|Overall Study|Withdrawal by Subject|1|||
124555762|NCT00665626|447992375|FG000|Overall Study|Protocol Violation|0|||
124555763|NCT00665626|447992376|FG001|Overall Study|Protocol Violation|2|||
124555764|NCT00665626|447992375|FG000|Overall Study|Adverse Event|1|||
124555765|NCT00665626|447992376|FG001|Overall Study|Adverse Event|9|||
124555766|NCT00665626|447992375|FG000|Overall Study|Due to exclusion criteria|0|||
124555767|NCT00665626|447992376|FG001|Overall Study|Due to exclusion criteria|1|||
124555768|NCT00665626|447992375|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
124555769|NCT00665626|447992376|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
124555770|NCT00665626|447992375|FG000|Overall Study|Unably to comply with dosing regimen|0|||
124555771|NCT00665626|447992376|FG001|Overall Study|Unably to comply with dosing regimen|1|||
124555772|NCT00665626|447992375|FG000|Overall Study|Death|1|||
124555773|NCT00665626|447992376|FG001|Overall Study|Death|0|||
124555774|NCT04147611|447992377|FG000|Overall Study|Physician Decision|0|||
124555775|NCT04147611|447992378|FG001|Overall Study|Physician Decision|1|||
124555776|NCT00530439|447992379|FG000|Overall Study|GDM|9|||
124555777|NCT00530439|447992380|FG001|Overall Study|GDM|3|||
124555778|NCT00530439|447992379|FG000|Overall Study|Withdraw|18|||
124555779|NCT00530439|447992380|FG001|Overall Study|Withdraw|14|||
124555780|NCT00530439|447992379|FG000|Overall Study|Missed abortion|1|||
124555781|NCT00530439|447992380|FG001|Overall Study|Missed abortion|4|||
124555782|NCT00530439|447992379|FG000|Overall Study|Misclassification|2|||
124555783|NCT00530439|447992380|FG001|Overall Study|Misclassification|0|||
124555784|NCT00530439|447992379|FG000|Overall Study|Twin pregnancy|0|||
124555785|NCT00530439|447992380|FG001|Overall Study|Twin pregnancy|2|||
124718143|NCT03276728|448591149|FG005|Overall Study|Lost to Follow-up|0|||
124718144|NCT03276728|448591150|FG006|Overall Study|Lost to Follow-up|0|||
124718145|NCT03276728|448591151|FG007|Overall Study|Lost to Follow-up|0|||
124718146|NCT03276728|448591144|FG000|Overall Study|Withdrawal by Subject|0|||
124718147|NCT03276728|448591145|FG001|Overall Study|Withdrawal by Subject|0|||
124718148|NCT03276728|448591146|FG002|Overall Study|Withdrawal by Subject|0|||
124718149|NCT03276728|448591147|FG003|Overall Study|Withdrawal by Subject|3|||
124718150|NCT03276728|448591148|FG004|Overall Study|Withdrawal by Subject|0|||
124718151|NCT03276728|448591149|FG005|Overall Study|Withdrawal by Subject|0|||
124718152|NCT03276728|448591150|FG006|Overall Study|Withdrawal by Subject|0|||
124718153|NCT03276728|448591151|FG007|Overall Study|Withdrawal by Subject|0|||
124718154|NCT03276728|448591144|FG000|Overall Study|Decision by sponsor|0|||
124718155|NCT03276728|448591145|FG001|Overall Study|Decision by sponsor|0|||
124718156|NCT03276728|448591146|FG002|Overall Study|Decision by sponsor|0|||
124718157|NCT03276728|448591147|FG003|Overall Study|Decision by sponsor|0|||
124718158|NCT03276728|448591148|FG004|Overall Study|Decision by sponsor|1|||
124718159|NCT03276728|448591149|FG005|Overall Study|Decision by sponsor|0|||
124718160|NCT03276728|448591150|FG006|Overall Study|Decision by sponsor|2|||
124718161|NCT03276728|448591151|FG007|Overall Study|Decision by sponsor|1|||
124718162|NCT03941873|448591158|FG000|Overall Study|Death|0|||
124718163|NCT03941873|448591159|FG001|Overall Study|Death|12|||
124718164|NCT03941873|448591160|FG002|Overall Study|Death|2|||
124718165|NCT03941873|448591161|FG003|Overall Study|Death|53|||
124718166|NCT03941873|448591158|FG000|Overall Study|Withdrawal by Subject|1|||
124718167|NCT03941873|448591159|FG001|Overall Study|Withdrawal by Subject|1|||
124718168|NCT03941873|448591160|FG002|Overall Study|Withdrawal by Subject|0|||
124718169|NCT03941873|448591161|FG003|Overall Study|Withdrawal by Subject|5|||
124718170|NCT03941873|448591158|FG000|Overall Study|Lost to Follow-up|1|||
124718171|NCT03941873|448591159|FG001|Overall Study|Lost to Follow-up|2|||
124718172|NCT03941873|448591160|FG002|Overall Study|Lost to Follow-up|0|||
124718173|NCT03941873|448591161|FG003|Overall Study|Lost to Follow-up|0|||
124718174|NCT03941873|448591158|FG000|Overall Study|Sponsor Decision|0|||
124718175|NCT03941873|448591159|FG001|Overall Study|Sponsor Decision|6|||
124718176|NCT03941873|448591160|FG002|Overall Study|Sponsor Decision|0|||
124718177|NCT03941873|448591161|FG003|Overall Study|Sponsor Decision|15|||
124718178|NCT02982772|448591162|FG000|Intervention|Lost to Follow-up|19|||
124718179|NCT02982772|448591163|FG001|Intervention|Lost to Follow-up|13|||
124718180|NCT02982772|448591162|FG000|1M Follow-Up|Lost to Follow-up|21|||
124718181|NCT02982772|448591163|FG001|1M Follow-Up|Lost to Follow-up|18|||
124718182|NCT02982772|448591162|FG000|3M Follow-Up|Lost to Follow-up|17|||
124718183|NCT02982772|448591163|FG001|3M Follow-Up|Lost to Follow-up|11|||
124718184|NCT02982772|448591162|FG000|6M Follow-Up|Lost to Follow-up|11|||
124718185|NCT02982772|448591163|FG001|6M Follow-Up|Lost to Follow-up|9|||
124718186|NCT02982772|448591162|FG000|12M Follow-Up|Lost to Follow-up|11|||
124718187|NCT02982772|448591163|FG001|12M Follow-Up|Lost to Follow-up|5|||
124718188|NCT01234480|448591164|FG000|Overall Study|Pregnancy|88|||
124718189|NCT01234480|448591164|FG000|Overall Study|>36/Normal History|50|||
124718190|NCT01234480|448591164|FG000|Overall Study|Age|3|||
124718191|NCT01234480|448591164|FG000|Overall Study|HPV Vaccine History|28|||
124718192|NCT01234480|448591164|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
124718193|NCT01234480|448591164|FG000|Overall Study|Hysterectomy|2|||
124718194|NCT01234480|448591164|FG000|Overall Study|Hysterectomy post enrollment|1|||
124718195|NCT01234480|448591164|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
124718196|NCT01234480|448591164|FG000|Overall Study|Informed Consent Form Violation|30|||
124718197|NCT01234480|448591164|FG000|Overall Study|Incorrect Visit|3|||
124718198|NCT01234480|448591164|FG000|Overall Study|No Florida Lab License|20|||
124718199|NCT01234480|448591164|FG000|Overall Study|Out of Window|42|||
124718200|NCT01234480|448591164|FG000|Overall Study|Sample Processing/Storage|92|||
124718201|NCT01234480|448591164|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
124718202|NCT01234480|448591164|FG000|Overall Study|Site/Subject non-compliance|44|||
124718203|NCT01234480|448591164|FG000|Overall Study|Missing Sample|9|||
124718204|NCT01238991|448591167|FG000|Overall Study|Adverse Event|1|||
124718205|NCT01238991|448591168|FG001|Overall Study|Adverse Event|0|||
124718206|NCT01238991|448591169|FG002|Overall Study|Adverse Event|3|||
124718207|NCT01238991|448591170|FG003|Overall Study|Adverse Event|1|||
124718208|NCT01238991|448591171|FG004|Overall Study|Adverse Event|1|||
124718209|NCT01238991|448591172|FG005|Overall Study|Adverse Event|0|||
124718210|NCT01238991|448591173|FG006|Overall Study|Adverse Event|1|||
124718211|NCT01238991|448591174|FG007|Overall Study|Adverse Event|1|||
124718212|NCT01238991|448591175|FG008|Overall Study|Adverse Event|0|||
124718213|NCT01238991|448591176|FG009|Overall Study|Adverse Event|0|||
124718214|NCT01238991|448591167|FG000|Overall Study|Death|0|||
124718215|NCT01238991|448591168|FG001|Overall Study|Death|0|||
124718216|NCT01238991|448591169|FG002|Overall Study|Death|0|||
124718217|NCT01238991|448591170|FG003|Overall Study|Death|1|||
124718218|NCT01238991|448591171|FG004|Overall Study|Death|0|||
124718219|NCT01238991|448591172|FG005|Overall Study|Death|0|||
124718220|NCT01238991|448591173|FG006|Overall Study|Death|0|||
124555786|NCT00530439|447992379|FG000|Overall Study|Severe malformation/abortion|0|||
124555787|NCT00530439|447992380|FG001|Overall Study|Severe malformation/abortion|3|||
124555788|NCT01010230|447992381|FG000|Overall Study|Withdrawal by Subject|6|||
124555789|NCT01010230|447992382|FG001|Overall Study|Withdrawal by Subject|5|||
124555790|NCT01010230|447992381|FG000|Overall Study|Lost to Follow-up|4|||
124555791|NCT01010230|447992382|FG001|Overall Study|Lost to Follow-up|2|||
124555792|NCT01629693|447992385|FG000|Overall Study|Lost to Follow-up|2|||
124555793|NCT01629693|447992386|FG001|Overall Study|Lost to Follow-up|4|||
124555794|NCT01629693|447992385|FG000|Overall Study|Withdrawal by Subject|2|||
124555795|NCT01629693|447992386|FG001|Overall Study|Withdrawal by Subject|2|||
124555796|NCT01629693|447992385|FG000|Overall Study|Adverse Event|1|||
124555797|NCT01629693|447992386|FG001|Overall Study|Adverse Event|0|||
124555798|NCT01629693|447992385|FG000|Overall Study|Investigator decision|0|||
124555799|NCT01629693|447992386|FG001|Overall Study|Investigator decision|1|||
124555800|NCT01629693|447992385|FG000|Overall Study|Poor comfort of study lenses|0|||
124555801|NCT01629693|447992386|FG001|Overall Study|Poor comfort of study lenses|2|||
124555802|NCT01629693|447992385|FG000|Overall Study|Subject decision unrelated to AE|0|||
124555803|NCT01629693|447992386|FG001|Overall Study|Subject decision unrelated to AE|1|||
124555804|NCT01529749|447992387|FG000|Overall Study|Lost to Follow-up|0|||
124555805|NCT01529749|447992388|FG001|Overall Study|Lost to Follow-up|1|||
124555806|NCT01529749|447992389|FG002|Overall Study|Lost to Follow-up|1|||
124555807|NCT01529749|447992390|FG003|Overall Study|Lost to Follow-up|0|||
124555808|NCT01529749|447992387|FG000|Overall Study|Physician Decision|0|||
124555809|NCT01529749|447992388|FG001|Overall Study|Physician Decision|0|||
124718221|NCT01238991|448591174|FG007|Overall Study|Death|0|||
124718222|NCT01238991|448591175|FG008|Overall Study|Death|0|||
124718223|NCT01238991|448591176|FG009|Overall Study|Death|0|||
124718224|NCT01238991|448591167|FG000|Overall Study|Lack of Efficacy|0|||
124718225|NCT01238991|448591168|FG001|Overall Study|Lack of Efficacy|0|||
124718226|NCT01238991|448591169|FG002|Overall Study|Lack of Efficacy|1|||
124718227|NCT01238991|448591170|FG003|Overall Study|Lack of Efficacy|0|||
124718228|NCT01238991|448591171|FG004|Overall Study|Lack of Efficacy|0|||
124718229|NCT01238991|448591172|FG005|Overall Study|Lack of Efficacy|0|||
124718230|NCT01238991|448591173|FG006|Overall Study|Lack of Efficacy|0|||
124718231|NCT01238991|448591174|FG007|Overall Study|Lack of Efficacy|0|||
124718232|NCT01238991|448591175|FG008|Overall Study|Lack of Efficacy|1|||
124718233|NCT01238991|448591176|FG009|Overall Study|Lack of Efficacy|0|||
124718234|NCT01238991|448591167|FG000|Overall Study|Withdrawal by Subject|0|||
124718235|NCT01238991|448591168|FG001|Overall Study|Withdrawal by Subject|0|||
124718236|NCT01238991|448591169|FG002|Overall Study|Withdrawal by Subject|1|||
124718237|NCT01238991|448591170|FG003|Overall Study|Withdrawal by Subject|0|||
124718238|NCT01238991|448591171|FG004|Overall Study|Withdrawal by Subject|0|||
124718239|NCT01238991|448591172|FG005|Overall Study|Withdrawal by Subject|0|||
124718240|NCT01238991|448591173|FG006|Overall Study|Withdrawal by Subject|0|||
124718241|NCT01238991|448591174|FG007|Overall Study|Withdrawal by Subject|0|||
124718242|NCT01238991|448591175|FG008|Overall Study|Withdrawal by Subject|0|||
124718243|NCT01238991|448591176|FG009|Overall Study|Withdrawal by Subject|0|||
124718244|NCT01238991|448591167|FG000|Overall Study|Study Terminated by Sponsor|0|||
124718245|NCT01238991|448591168|FG001|Overall Study|Study Terminated by Sponsor|0|||
124718246|NCT01238991|448591169|FG002|Overall Study|Study Terminated by Sponsor|0|||
124718247|NCT01238991|448591170|FG003|Overall Study|Study Terminated by Sponsor|0|||
124718248|NCT01238991|448591171|FG004|Overall Study|Study Terminated by Sponsor|1|||
124718249|NCT01238991|448591172|FG005|Overall Study|Study Terminated by Sponsor|0|||
124718250|NCT01238991|448591173|FG006|Overall Study|Study Terminated by Sponsor|7|||
124718251|NCT01238991|448591174|FG007|Overall Study|Study Terminated by Sponsor|4|||
124718252|NCT01238991|448591175|FG008|Overall Study|Study Terminated by Sponsor|2|||
124718253|NCT01238991|448591176|FG009|Overall Study|Study Terminated by Sponsor|2|||
124718254|NCT01238991|448591167|FG000|Overall Study|Caregiver's request|0|||
124718255|NCT01238991|448591168|FG001|Overall Study|Caregiver's request|0|||
124718256|NCT01238991|448591169|FG002|Overall Study|Caregiver's request|0|||
124718257|NCT01238991|448591170|FG003|Overall Study|Caregiver's request|0|||
124718258|NCT01238991|448591171|FG004|Overall Study|Caregiver's request|0|||
124718259|NCT01238991|448591172|FG005|Overall Study|Caregiver's request|0|||
124718260|NCT01238991|448591173|FG006|Overall Study|Caregiver's request|0|||
124718261|NCT01238991|448591174|FG007|Overall Study|Caregiver's request|0|||
124718262|NCT01238991|448591175|FG008|Overall Study|Caregiver's request|1|||
124718263|NCT01238991|448591176|FG009|Overall Study|Caregiver's request|0|||
124718264|NCT01238991|448591167|FG000|Overall Study|Admission to a nursing home|1|||
124555810|NCT01529749|447992389|FG002|Overall Study|Physician Decision|0|||
124555811|NCT01529749|447992390|FG003|Overall Study|Physician Decision|1|||
124718265|NCT01238991|448591168|FG001|Overall Study|Admission to a nursing home|0|||
124718266|NCT01238991|448591169|FG002|Overall Study|Admission to a nursing home|1|||
124718267|NCT01238991|448591170|FG003|Overall Study|Admission to a nursing home|0|||
124555812|NCT01529749|447992387|FG000|Overall Study|Withdrawal by Subject|0|||
124718268|NCT01238991|448591171|FG004|Overall Study|Admission to a nursing home|0|||
124718269|NCT01238991|448591172|FG005|Overall Study|Admission to a nursing home|0|||
124718270|NCT01238991|448591173|FG006|Overall Study|Admission to a nursing home|0|||
124718271|NCT01238991|448591174|FG007|Overall Study|Admission to a nursing home|0|||
124555813|NCT01529749|447992388|FG001|Overall Study|Withdrawal by Subject|1|||
124555814|NCT01529749|447992389|FG002|Overall Study|Withdrawal by Subject|1|||
124555815|NCT01529749|447992390|FG003|Overall Study|Withdrawal by Subject|0|||
124555816|NCT01529749|447992387|FG000|Overall Study|Protocol Violation|0|||
124555817|NCT01529749|447992388|FG001|Overall Study|Protocol Violation|0|||
124555818|NCT01529749|447992389|FG002|Overall Study|Protocol Violation|0|||
124555819|NCT01529749|447992390|FG003|Overall Study|Protocol Violation|1|||
124555820|NCT04385199|447992391|FG000|Overall Study|Withdrawal by Subject|1|||
124555821|NCT04385199|447992392|FG001|Overall Study|Withdrawal by Subject|0|||
124555822|NCT00860574|447994050|FG000|Overall Study|Death|2|||
124555823|NCT00860574|447994050|FG000|Overall Study|Relapse|1|||
124555824|NCT01246986|447994051|FG000|Overall Study|Lost to Follow-up|0|||
124555825|NCT01246986|447994052|FG001|Overall Study|Lost to Follow-up|1|||
124555826|NCT01246986|447994053|FG002|Overall Study|Lost to Follow-up|3|||
124555827|NCT01246986|447994054|FG003|Overall Study|Lost to Follow-up|0|||
124555828|NCT01246986|447994055|FG004|Overall Study|Lost to Follow-up|0|||
124555829|NCT01246986|447994056|FG005|Overall Study|Lost to Follow-up|1|||
124555830|NCT01246986|447994057|FG006|Overall Study|Lost to Follow-up|0|||
124555831|NCT01246986|447994051|FG000|Overall Study|Withdrawal by Subject|3|||
124555832|NCT01246986|447994052|FG001|Overall Study|Withdrawal by Subject|4|||
124555833|NCT01246986|447994053|FG002|Overall Study|Withdrawal by Subject|3|||
124555834|NCT01246986|447994054|FG003|Overall Study|Withdrawal by Subject|0|||
124555835|NCT01246986|447994055|FG004|Overall Study|Withdrawal by Subject|4|||
124555836|NCT01246986|447994056|FG005|Overall Study|Withdrawal by Subject|0|||
124555837|NCT01246986|447994057|FG006|Overall Study|Withdrawal by Subject|0|||
124555838|NCT01416142|447994061|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
124555839|NCT01416142|447994062|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
124555840|NCT01416142|447994063|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
124555841|NCT01335399|447994064|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
124555842|NCT01335399|447994065|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
124555843|NCT01335399|447994064|FG000|Pre-treatment Period|Participant request to discontinue|0|||
124555844|NCT01335399|447994065|FG001|Pre-treatment Period|Participant request to discontinue|1|||
124555845|NCT01335399|447994064|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
124555846|NCT01335399|447994065|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
124555847|NCT01335399|447994064|FG000|Pre-treatment Period|Consent withdrawal|3|||
124555848|NCT01335399|447994065|FG001|Pre-treatment Period|Consent withdrawal|0|||
124555849|NCT01335399|447994064|FG000|Treatment Period|Disease progression|117|||
124555850|NCT01335399|447994065|FG001|Treatment Period|Disease progression|145|||
124555851|NCT01335399|447994064|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
124718272|NCT01238991|448591175|FG008|Overall Study|Admission to a nursing home|0|||
124718273|NCT01238991|448591176|FG009|Overall Study|Admission to a nursing home|0|||
124718274|NCT03370419|448591177|FG000|Overall Study|Lost to Follow-up|16|||
124718275|NCT01897727|448591182|FG000|Overall Study|Exclusion: central sleep apnea|0|||
124718276|NCT01897727|448591183|FG001|Overall Study|Exclusion: central sleep apnea|1|||
124718277|NCT02013778|448591186|FG000|Overall Study|Death|4|||
124718278|NCT02013778|448591186|FG000|Overall Study|Withdrawal by Subject|1|||
124718279|NCT02013778|448591186|FG000|Overall Study|Physician Decision|1|||
124718280|NCT02013778|448591186|FG000|Overall Study|Adverse Event|1|||
124718281|NCT00293813|448591187|FG000|Overall Study|Physician Decision|0|||
124718282|NCT00293813|448591188|FG001|Overall Study|Physician Decision|1|||
124718283|NCT00293813|448591189|FG002|Overall Study|Physician Decision|0|||
124718284|NCT00293813|448591187|FG000|Overall Study|Adverse Event|3|||
124718285|NCT00293813|448591188|FG001|Overall Study|Adverse Event|1|||
124718286|NCT00293813|448591189|FG002|Overall Study|Adverse Event|1|||
124718287|NCT00293813|448591187|FG000|Overall Study|Withdrawal by Subject|7|||
124718288|NCT00293813|448591188|FG001|Overall Study|Withdrawal by Subject|4|||
124718289|NCT00293813|448591189|FG002|Overall Study|Withdrawal by Subject|4|||
124718290|NCT00293813|448591187|FG000|Overall Study|Lost to Follow-up|3|||
124718291|NCT00293813|448591188|FG001|Overall Study|Lost to Follow-up|2|||
124718292|NCT00293813|448591189|FG002|Overall Study|Lost to Follow-up|3|||
124555852|NCT01335399|447994065|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
124718293|NCT00293813|448591187|FG000|Overall Study|Noncompliance|0|||
124718294|NCT00293813|448591188|FG001|Overall Study|Noncompliance|1|||
124718295|NCT00293813|448591189|FG002|Overall Study|Noncompliance|0|||
124555853|NCT01335399|447994064|FG000|Treatment Period|Study drug toxicity|52|||
124555854|NCT01335399|447994065|FG001|Treatment Period|Study drug toxicity|64|||
124555855|NCT01335399|447994064|FG000|Treatment Period|Participant request to discontinue|30|||
124555856|NCT01335399|447994065|FG001|Treatment Period|Participant request to discontinue|22|||
124718296|NCT01521923|448591192|FG000|Overall Study|AE, serious fatal|1|||
124718297|NCT01521923|448591193|FG001|Overall Study|AE, serious fatal|0|||
124718298|NCT01521923|448591194|FG002|Overall Study|AE, serious fatal|0|||
124718299|NCT01521923|448591195|FG003|Overall Study|AE, serious fatal|0|||
124718300|NCT01521923|448591192|FG000|Overall Study|SAE, non-fatal|0|||
124555857|NCT01335399|447994064|FG000|Treatment Period|Other reasons|30|||
124555858|NCT01335399|447994065|FG001|Treatment Period|Other reasons|30|||
124555859|NCT01335399|447994064|FG000|Treatment Period|Consent withdrawal|10|||
124555860|NCT01335399|447994065|FG001|Treatment Period|Consent withdrawal|7|||
124555861|NCT01335399|447994064|FG000|Treatment Period|Death|7|||
124555862|NCT01335399|447994065|FG001|Treatment Period|Death|6|||
124555863|NCT01335399|447994064|FG000|Treatment Period|Poor/Non-compliance|3|||
124555864|NCT01335399|447994065|FG001|Treatment Period|Poor/Non-compliance|4|||
124555865|NCT01335399|447994064|FG000|Treatment Period|Lost to Follow-up|2|||
124555866|NCT01335399|447994065|FG001|Treatment Period|Lost to Follow-up|2|||
124555867|NCT01335399|447994064|FG000|Treatment Period|Maximum clinical benefit|1|||
124555868|NCT01335399|447994065|FG001|Treatment Period|Maximum clinical benefit|1|||
124555869|NCT01335399|447994064|FG000|Treatment Period|No longer meet study criteria|1|||
124555870|NCT01335399|447994065|FG001|Treatment Period|No longer meet study criteria|1|||
124555871|NCT01335399|447994064|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
124555872|NCT01335399|447994065|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
124555873|NCT02464059|447994066|FG000|Overall Study|Lost to Follow-up|6|||
124555874|NCT01326702|447994067|FG000|Overall Study|Other|1|||
124555875|NCT01326702|447994068|FG001|Overall Study|Other|0|||
124555876|NCT01326702|447994069|FG002|Overall Study|Other|0|||
124555877|NCT01326702|447994070|FG003|Overall Study|Other|0|||
124555878|NCT01326702|447994071|FG004|Overall Study|Other|0|||
124555879|NCT01326702|447994072|FG005|Overall Study|Other|1|||
124555880|NCT01326702|447994073|FG006|Overall Study|Other|0|||
124555881|NCT01326702|447994067|FG000|Overall Study|progressive disease|1|||
124555882|NCT01326702|447994068|FG001|Overall Study|progressive disease|1|||
124555883|NCT01326702|447994069|FG002|Overall Study|progressive disease|3|||
124555884|NCT01326702|447994070|FG003|Overall Study|progressive disease|1|||
124555885|NCT01326702|447994071|FG004|Overall Study|progressive disease|3|||
124555886|NCT01326702|447994072|FG005|Overall Study|progressive disease|2|||
124555887|NCT01326702|447994073|FG006|Overall Study|progressive disease|3|||
124555888|NCT01326702|447994067|FG000|Overall Study|Death|0|||
124555889|NCT01326702|447994068|FG001|Overall Study|Death|1|||
124555890|NCT01326702|447994069|FG002|Overall Study|Death|0|||
124555891|NCT01326702|447994070|FG003|Overall Study|Death|0|||
124555892|NCT01326702|447994071|FG004|Overall Study|Death|0|||
124555893|NCT01326702|447994072|FG005|Overall Study|Death|0|||
124474220|NCT01078805|447692742|FG000|Overall Study|Didn't take study drug|82|||
124474221|NCT01609842|447692743|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
124474222|NCT01609842|447692744|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
124474223|NCT00865020|447692753|FG000|Overall Study|Withdrawal by Subject|22|||
124474224|NCT00865020|447692754|FG001|Overall Study|Withdrawal by Subject|16|||
124474225|NCT00865020|447692753|FG000|Overall Study|Adverse Event|9|||
124474226|NCT00865020|447692754|FG001|Overall Study|Adverse Event|14|||
124474227|NCT00865020|447692753|FG000|Overall Study|Abnormal test procedure result(s)|6|||
124474228|NCT00865020|447692754|FG001|Overall Study|Abnormal test procedure result(s)|8|||
124474229|NCT00865020|447692753|FG000|Overall Study|Lost to Follow-up|6|||
124474230|NCT00865020|447692754|FG001|Overall Study|Lost to Follow-up|4|||
124474231|NCT00865020|447692753|FG000|Overall Study|Protocol deviation|4|||
124474232|NCT00865020|447692754|FG001|Overall Study|Protocol deviation|1|||
124474233|NCT00865020|447692753|FG000|Overall Study|Administrative problems|0|||
124474234|NCT00865020|447692754|FG001|Overall Study|Administrative problems|2|||
124474235|NCT00865020|447692753|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124474236|NCT00865020|447692754|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124474237|NCT00865020|447692753|FG000|Overall Study|Death|0|||
124474238|NCT00865020|447692754|FG001|Overall Study|Death|1|||
124474239|NCT00865020|447692753|FG000|Overall Study|Randomized but discontinued|2|||
124474240|NCT00865020|447692754|FG001|Overall Study|Randomized but discontinued|4|||
124474241|NCT01583179|447694132|FG000|Overall Study|Screen failure|1|||
124474242|NCT01583179|447694133|FG001|Overall Study|Screen failure|2|||
124474243|NCT01246206|447694134|FG000|Overall Study|Patient did not receive study regiments.|1|||
124474244|NCT02965716|447694135|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
124474245|NCT02965716|447694136|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
124474246|NCT02965716|447694135|FG000|Overall Study|Progression/Relapse|8|||
124474247|NCT02965716|447694136|FG001|Overall Study|Progression/Relapse|16|||
124474248|NCT02965716|447694135|FG000|Overall Study|Death|1|||
124474249|NCT02965716|447694136|FG001|Overall Study|Death|0|||
124474250|NCT02965716|447694135|FG000|Overall Study|Not Protocol Specified|1|||
124474251|NCT02965716|447694136|FG001|Overall Study|Not Protocol Specified|3|||
124474252|NCT04047797|447694137|FG000|Overall Study|Progressive Disease|1|||
124474253|NCT03523351|447694138|FG000|Overall Study|Death|13|||
124474254|NCT03523351|447694139|FG001|Overall Study|Death|11|||
124474255|NCT03523351|447694138|FG000|Overall Study|Lost to Follow-up|2|||
124474256|NCT03523351|447694139|FG001|Overall Study|Lost to Follow-up|3|||
124474257|NCT03523351|447694138|FG000|Overall Study|Withdrawal by Subject|4|||
124474258|NCT03523351|447694139|FG001|Overall Study|Withdrawal by Subject|0|||
124474259|NCT03523351|447694138|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
124474260|NCT03523351|447694139|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
124474261|NCT00132041|447694145|FG000|Baseline|Ineligible|6|||
124474262|NCT00132041|447694145|FG000|3 Months Post Ablation|Transplant|1|||
124474263|NCT00132041|447694145|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
124474264|NCT00132041|447694145|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
124474265|NCT00132041|447694145|FG000|6 Months Post Ablation|Death|2|||
124474266|NCT00132041|447694145|FG000|6 Months Post Ablation|Transplant|6|||
124474267|NCT00132041|447694145|FG000|9 Months Post Ablation|Death|1|||
124474268|NCT00132041|447694145|FG000|9 Months Post Ablation|Transplant|1|||
124474269|NCT00132041|447694145|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
124474270|NCT00132041|447694145|FG000|12 Months Post Ablation|Death|1|||
124474271|NCT00132041|447694145|FG000|12 Months Post Ablation|Transplant|1|||
124474272|NCT00132041|447694145|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
124474273|NCT00132041|447694145|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
124474274|NCT00132041|447694145|FG000|15 Months Post Ablation|Death|1|||
124474275|NCT00132041|447694145|FG000|15 Months Post Ablation|Transplant|5|||
124474276|NCT00132041|447694145|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
124474277|NCT00132041|447694145|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
124474278|NCT00132041|447694145|FG000|18 Months Post Ablation|Transplant|1|||
124555894|NCT01326702|447994073|FG006|Overall Study|Death|0|||
124555895|NCT01326702|447994067|FG000|Overall Study|Adverse Event|0|||
124555896|NCT01326702|447994068|FG001|Overall Study|Adverse Event|0|||
124555897|NCT01326702|447994069|FG002|Overall Study|Adverse Event|1|||
124555898|NCT01326702|447994070|FG003|Overall Study|Adverse Event|1|||
124555899|NCT01326702|447994071|FG004|Overall Study|Adverse Event|0|||
124555900|NCT01326702|447994072|FG005|Overall Study|Adverse Event|3|||
124555901|NCT01326702|447994073|FG006|Overall Study|Adverse Event|1|||
124555902|NCT01326702|447994067|FG000|Overall Study|Withdrawal by Subject|0|||
124555903|NCT01326702|447994068|FG001|Overall Study|Withdrawal by Subject|0|||
124555904|NCT01326702|447994069|FG002|Overall Study|Withdrawal by Subject|1|||
124555905|NCT01326702|447994070|FG003|Overall Study|Withdrawal by Subject|0|||
124555906|NCT01326702|447994071|FG004|Overall Study|Withdrawal by Subject|1|||
124555907|NCT01326702|447994072|FG005|Overall Study|Withdrawal by Subject|1|||
124555908|NCT01326702|447994073|FG006|Overall Study|Withdrawal by Subject|3|||
124555909|NCT01326702|447994067|FG000|Overall Study|Not Treated|0|||
124555910|NCT01326702|447994068|FG001|Overall Study|Not Treated|0|||
124555911|NCT01326702|447994069|FG002|Overall Study|Not Treated|0|||
124555912|NCT01326702|447994070|FG003|Overall Study|Not Treated|1|||
124555913|NCT01326702|447994071|FG004|Overall Study|Not Treated|0|||
124555914|NCT01326702|447994072|FG005|Overall Study|Not Treated|1|||
124555915|NCT01326702|447994073|FG006|Overall Study|Not Treated|0|||
124555916|NCT01835132|447994075|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
124555917|NCT00856778|447994076|FG000|Overall Study|Adverse Event|7|||
124555918|NCT00856778|447994076|FG000|Overall Study|Withdrawal by Subject|10|||
124555919|NCT00856778|447994076|FG000|Overall Study|Study deviation|2|||
124555920|NCT00856778|447994076|FG000|Overall Study|Lost to Follow-up|5|||
124555921|NCT03208933|447994077|FG000|Overall Study|Death|3|||
124555922|NCT03208933|447994077|FG000|Overall Study|Withdrawal by Subject|3|||
124555923|NCT03208933|447994077|FG000|Overall Study|Adverse Event|1|||
124555924|NCT03208933|447994077|FG000|Overall Study|Lost to Follow-up|2|||
124555925|NCT03208933|447994077|FG000|Overall Study|Physician Decision|3|||
124555926|NCT03208933|447994077|FG000|Overall Study|Protocol Violation|1|||
124555927|NCT00331773|447994078|FG000|Overall Study|Withdrawal by Subject|6|||
124555928|NCT00331773|447994079|FG001|Overall Study|Withdrawal by Subject|4|||
124555929|NCT00331773|447994078|FG000|Overall Study|Protocol Violation|10|||
124555930|NCT00331773|447994079|FG001|Overall Study|Protocol Violation|3|||
124555931|NCT00379587|447994080|FG000|Overall Study|Lost to Follow-up|2|||
124555932|NCT00534092|447994081|FG000|Overall Study|Lost to Follow-up|1|||
124555933|NCT00534092|447994082|FG001|Overall Study|Lost to Follow-up|0|||
124555934|NCT00534092|447994081|FG000|Overall Study|personal reasons/family concerns|1|||
124555935|NCT00534092|447994082|FG001|Overall Study|personal reasons/family concerns|0|||
124555936|NCT00525031|447994087|FG000|Overall Study|Disease Progression|1|||
124555937|NCT00525031|447994088|FG001|Overall Study|Disease Progression|1|||
124555938|NCT02323295|447994089|FG000|Overall Study|Adverse Event|0|||
124555939|NCT02323295|447994090|FG001|Overall Study|Adverse Event|1|||
124555940|NCT02323295|447994089|FG000|Overall Study|Withdrawal by Subject|0|||
124555941|NCT02323295|447994090|FG001|Overall Study|Withdrawal by Subject|1|||
124555942|NCT02323295|447994089|FG000|Overall Study|Patient did not have surgery as planned.|0|||
124555943|NCT02323295|447994090|FG001|Overall Study|Patient did not have surgery as planned.|1|||
124555944|NCT00830063|447994091|FG000|Overall Study|Adverse Event|7|||
124555945|NCT00830063|447994092|FG001|Overall Study|Adverse Event|13|||
124555946|NCT00830063|447994093|FG002|Overall Study|Adverse Event|16|||
124555947|NCT00830063|447994094|FG003|Overall Study|Adverse Event|13|||
124555948|NCT00830063|447994091|FG000|Overall Study|Death|1|||
124474279|NCT00132041|447694145|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
124474280|NCT00132041|447694145|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
124555949|NCT00830063|447994092|FG001|Overall Study|Death|0|||
124555950|NCT00830063|447994093|FG002|Overall Study|Death|0|||
124555951|NCT00830063|447994094|FG003|Overall Study|Death|0|||
124555952|NCT00830063|447994091|FG000|Overall Study|Lost to Follow-up|0|||
124474281|NCT03609619|447694146|FG000|Overall Study|Adverse Event|1|||
124555953|NCT00830063|447994092|FG001|Overall Study|Lost to Follow-up|0|||
124555954|NCT00830063|447994093|FG002|Overall Study|Lost to Follow-up|3|||
124555955|NCT00830063|447994094|FG003|Overall Study|Lost to Follow-up|1|||
124555956|NCT00830063|447994091|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
124555957|NCT00830063|447994092|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
124474282|NCT03609619|447694147|FG001|Overall Study|Adverse Event|0|||
124474283|NCT03609619|447694146|FG000|Overall Study|Lack of Efficacy|1|||
124555958|NCT00830063|447994093|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
124718301|NCT01521923|448591193|FG001|Overall Study|SAE, non-fatal|2|||
124718302|NCT01521923|448591194|FG002|Overall Study|SAE, non-fatal|2|||
124718303|NCT01521923|448591195|FG003|Overall Study|SAE, non-fatal|0|||
124718304|NCT01521923|448591192|FG000|Overall Study|AE, non-serious, non-fatal|1|||
124718305|NCT01521923|448591193|FG001|Overall Study|AE, non-serious, non-fatal|3|||
124718306|NCT01521923|448591194|FG002|Overall Study|AE, non-serious, non-fatal|6|||
124718307|NCT01521923|448591195|FG003|Overall Study|AE, non-serious, non-fatal|2|||
124718308|NCT01521923|448591192|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
124718309|NCT01521923|448591193|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
124718310|NCT01521923|448591194|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
124718311|NCT01521923|448591195|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
124718312|NCT01521923|448591192|FG000|Overall Study|Lack of Efficacy|1|||
124718313|NCT01521923|448591193|FG001|Overall Study|Lack of Efficacy|1|||
124718314|NCT01521923|448591194|FG002|Overall Study|Lack of Efficacy|0|||
124718315|NCT01521923|448591195|FG003|Overall Study|Lack of Efficacy|0|||
124718316|NCT01521923|448591192|FG000|Overall Study|Protocol Violation|0|||
124718317|NCT01521923|448591193|FG001|Overall Study|Protocol Violation|0|||
124718318|NCT01521923|448591194|FG002|Overall Study|Protocol Violation|1|||
124718319|NCT01521923|448591195|FG003|Overall Study|Protocol Violation|0|||
124718320|NCT01521923|448591192|FG000|Overall Study|Lost to Follow-up|1|||
124718321|NCT01521923|448591193|FG001|Overall Study|Lost to Follow-up|0|||
124718322|NCT01521923|448591194|FG002|Overall Study|Lost to Follow-up|2|||
124718323|NCT01521923|448591195|FG003|Overall Study|Lost to Follow-up|1|||
124718324|NCT01521923|448591192|FG000|Overall Study|Withdrawal by Subject|1|||
124718325|NCT01521923|448591193|FG001|Overall Study|Withdrawal by Subject|1|||
124718326|NCT01521923|448591194|FG002|Overall Study|Withdrawal by Subject|1|||
124718327|NCT01521923|448591195|FG003|Overall Study|Withdrawal by Subject|2|||
124718328|NCT01521923|448591192|FG000|Overall Study|Other|2|||
124718329|NCT01521923|448591193|FG001|Overall Study|Other|1|||
124718330|NCT01521923|448591194|FG002|Overall Study|Other|3|||
124718331|NCT01521923|448591195|FG003|Overall Study|Other|6|||
124718332|NCT01521923|448591192|FG000|Overall Study|AE, captured in Period 1|0|||
124718333|NCT01521923|448591193|FG001|Overall Study|AE, captured in Period 1|1|||
124718334|NCT01521923|448591194|FG002|Overall Study|AE, captured in Period 1|0|||
124555959|NCT00830063|447994094|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
124555960|NCT00830063|447994091|FG000|Overall Study|Lack of Efficacy|51|||
124718335|NCT01521923|448591195|FG003|Overall Study|AE, captured in Period 1|1|||
124718336|NCT01465386|448591199|FG000|Overall Study|Lack of Efficacy|3|||
124718337|NCT01465386|448591199|FG000|Overall Study|Adverse Event|1|||
124718338|NCT01279044|448591200|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
124718339|NCT01279044|448591201|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
124718340|NCT01279044|448591202|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
124718341|NCT01279044|448591200|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
124718342|NCT01279044|448591201|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
124718343|NCT01279044|448591202|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
124718344|NCT01279044|448591200|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
124718345|NCT01279044|448591201|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
124718346|NCT01279044|448591202|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
124718347|NCT01582009|448591203|FG000|Overall Study|Withdrawal by Subject|1|||
124718348|NCT01582009|448591203|FG000|Overall Study|Physician Decision|1|||
124718349|NCT01947283|448591208|FG000|Overall Study|Death|1|||
124718350|NCT01947283|448591209|FG001|Overall Study|Death|1|||
124718351|NCT01947283|448591210|FG002|Overall Study|Death|1|||
124718352|NCT01947283|448591211|FG003|Overall Study|Death|0|||
124718353|NCT01947283|448591212|FG004|Overall Study|Death|0|||
124718354|NCT01947283|448591213|FG005|Overall Study|Death|0|||
124718355|NCT01947283|448591214|FG006|Overall Study|Death|0|||
124718356|NCT01947283|448591208|FG000|Overall Study|Lost to Follow-up|4|||
124718357|NCT01947283|448591209|FG001|Overall Study|Lost to Follow-up|6|||
124555961|NCT00830063|447994092|FG001|Overall Study|Lack of Efficacy|23|||
124555962|NCT00830063|447994093|FG002|Overall Study|Lack of Efficacy|25|||
124718358|NCT01947283|448591210|FG002|Overall Study|Lost to Follow-up|5|||
124718359|NCT01947283|448591211|FG003|Overall Study|Lost to Follow-up|5|||
124718360|NCT01947283|448591212|FG004|Overall Study|Lost to Follow-up|0|||
124718361|NCT01947283|448591213|FG005|Overall Study|Lost to Follow-up|2|||
124718362|NCT01947283|448591214|FG006|Overall Study|Lost to Follow-up|5|||
124718363|NCT01947283|448591208|FG000|Overall Study|Withdrawal by Subject|10|||
124771648|NCT02085460|448794528|FG001|Overall Study|Physician Decision|1|||
124771649|NCT02085460|448794529|FG002|Overall Study|Physician Decision|2|||
124718364|NCT01947283|448591209|FG001|Overall Study|Withdrawal by Subject|8|||
124718365|NCT01947283|448591210|FG002|Overall Study|Withdrawal by Subject|4|||
124718366|NCT01947283|448591211|FG003|Overall Study|Withdrawal by Subject|1|||
124718367|NCT01947283|448591212|FG004|Overall Study|Withdrawal by Subject|0|||
124718368|NCT01947283|448591213|FG005|Overall Study|Withdrawal by Subject|0|||
124474284|NCT03609619|447694147|FG001|Overall Study|Lack of Efficacy|2|||
124474285|NCT03609619|447694146|FG000|Overall Study|Protocol Violation|5|||
124474286|NCT03609619|447694147|FG001|Overall Study|Protocol Violation|0|||
124474287|NCT03609619|447694146|FG000|Overall Study|Withdrawal by Subject|2|||
124718369|NCT01947283|448591214|FG006|Overall Study|Withdrawal by Subject|2|||
124718370|NCT01947283|448591208|FG000|Overall Study|No Clinical Recording|12|||
124718371|NCT01947283|448591209|FG001|Overall Study|No Clinical Recording|6|||
124718372|NCT01947283|448591210|FG002|Overall Study|No Clinical Recording|8|||
124718373|NCT01947283|448591211|FG003|Overall Study|No Clinical Recording|10|||
124718374|NCT01947283|448591212|FG004|Overall Study|No Clinical Recording|0|||
124718375|NCT01947283|448591213|FG005|Overall Study|No Clinical Recording|0|||
124718376|NCT01947283|448591214|FG006|Overall Study|No Clinical Recording|0|||
124718377|NCT01947283|448591208|FG000|Overall Study|Non-coding Clinical Recording language|0|||
124718378|NCT01947283|448591209|FG001|Overall Study|Non-coding Clinical Recording language|0|||
124718379|NCT01947283|448591210|FG002|Overall Study|Non-coding Clinical Recording language|0|||
124718380|NCT01947283|448591211|FG003|Overall Study|Non-coding Clinical Recording language|1|||
124474288|NCT03609619|447694147|FG001|Overall Study|Withdrawal by Subject|3|||
124474289|NCT03609619|447694146|FG000|Overall Study|Lost to Follow-up|1|||
124718381|NCT01947283|448591212|FG004|Overall Study|Non-coding Clinical Recording language|0|||
124474290|NCT03609619|447694147|FG001|Overall Study|Lost to Follow-up|1|||
124555963|NCT00830063|447994094|FG003|Overall Study|Lack of Efficacy|32|||
124555964|NCT00830063|447994091|FG000|Overall Study|Other|5|||
124555965|NCT00830063|447994092|FG001|Overall Study|Other|5|||
124555966|NCT00830063|447994093|FG002|Overall Study|Other|8|||
124555967|NCT00830063|447994094|FG003|Overall Study|Other|6|||
124555968|NCT00830063|447994091|FG000|Overall Study|Withdrawal by Subject|16|||
124555969|NCT00830063|447994092|FG001|Overall Study|Withdrawal by Subject|10|||
124718382|NCT01947283|448591213|FG005|Overall Study|Non-coding Clinical Recording language|0|||
124718383|NCT01947283|448591214|FG006|Overall Study|Non-coding Clinical Recording language|0|||
124718384|NCT01947283|448591208|FG000|Overall Study|Missing Follow-up Assessment|2|||
124718385|NCT01947283|448591209|FG001|Overall Study|Missing Follow-up Assessment|2|||
124718386|NCT01947283|448591210|FG002|Overall Study|Missing Follow-up Assessment|3|||
124718387|NCT01947283|448591211|FG003|Overall Study|Missing Follow-up Assessment|0|||
124718388|NCT01947283|448591212|FG004|Overall Study|Missing Follow-up Assessment|0|||
124718389|NCT01947283|448591213|FG005|Overall Study|Missing Follow-up Assessment|2|||
124718390|NCT01947283|448591214|FG006|Overall Study|Missing Follow-up Assessment|0|||
124718391|NCT01947283|448591208|FG000|Overall Study|No patients were enrolled in study|0|||
124718392|NCT01947283|448591209|FG001|Overall Study|No patients were enrolled in study|0|||
124555970|NCT00830063|447994093|FG002|Overall Study|Withdrawal by Subject|16|||
124555971|NCT00830063|447994094|FG003|Overall Study|Withdrawal by Subject|13|||
124555972|NCT00830063|447994091|FG000|Overall Study|Protocol Violation|1|||
124555973|NCT00830063|447994092|FG001|Overall Study|Protocol Violation|0|||
124555974|NCT00830063|447994093|FG002|Overall Study|Protocol Violation|3|||
124555975|NCT00830063|447994094|FG003|Overall Study|Protocol Violation|2|||
124555976|NCT00830063|447994091|FG000|Overall Study|Randomized But Not Treated|0|||
124555977|NCT00830063|447994092|FG001|Overall Study|Randomized But Not Treated|2|||
124555978|NCT00830063|447994093|FG002|Overall Study|Randomized But Not Treated|0|||
124555979|NCT00830063|447994094|FG003|Overall Study|Randomized But Not Treated|2|||
124555980|NCT02140164|447994095|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
124555981|NCT01872689|447994106|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
124555982|NCT01872689|447994107|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
124555983|NCT01872689|447994108|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
124555984|NCT01872689|447994109|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
124555985|NCT01872689|447994106|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
124555986|NCT01872689|447994107|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
124555987|NCT01872689|447994108|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
124555988|NCT01872689|447994109|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
124555989|NCT01872689|447994106|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
124555990|NCT01872689|447994107|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
124555991|NCT01872689|447994108|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
124555992|NCT01872689|447994109|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
124555993|NCT01872689|447994106|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
124555994|NCT01872689|447994107|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
124555995|NCT01872689|447994108|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
124555996|NCT01872689|447994109|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
124555997|NCT01872689|447994106|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
124555998|NCT01872689|447994107|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
124555999|NCT01872689|447994108|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
124556000|NCT01872689|447994109|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
124556001|NCT01872689|447994106|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
124556002|NCT01872689|447994107|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
124556003|NCT01872689|447994108|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
124556004|NCT01872689|447994109|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
124556005|NCT01872689|447994106|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
124556006|NCT01872689|447994107|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
124556007|NCT01872689|447994108|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
124556008|NCT01872689|447994109|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
124556009|NCT01872689|447994106|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
124556010|NCT01872689|447994107|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
124556011|NCT01872689|447994108|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
124556012|NCT01872689|447994109|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
124556013|NCT01872689|447994106|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
124556014|NCT01872689|447994107|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
124556015|NCT01872689|447994108|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
124556016|NCT01872689|447994109|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
124718393|NCT01947283|448591210|FG002|Overall Study|No patients were enrolled in study|0|||
124556017|NCT01872689|447994106|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
124556018|NCT01872689|447994107|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
124556019|NCT01872689|447994108|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
124556020|NCT01872689|447994109|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
124556021|NCT01872689|447994106|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
124556022|NCT01872689|447994107|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
124556023|NCT01872689|447994108|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
124556024|NCT01872689|447994109|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
124556025|NCT01872689|447994106|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
124556026|NCT01872689|447994107|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
124556027|NCT01872689|447994108|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
124556028|NCT01872689|447994109|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
124556029|NCT01872689|447994106|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
124556030|NCT01872689|447994107|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
124556031|NCT01872689|447994108|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
124556032|NCT01872689|447994109|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
124556033|NCT01872689|447994106|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
124556034|NCT01872689|447994107|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
124556035|NCT01872689|447994108|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
124556036|NCT01872689|447994109|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
124556037|NCT00881959|447994112|FG000|Overall Study|Lost to Follow-up|2|||
124556038|NCT00881959|447994113|FG001|Overall Study|Lost to Follow-up|4|||
124556039|NCT00686374|447994115|FG000|Overall Study|Lack of Efficacy|10|||
124556040|NCT00686374|447994115|FG000|Overall Study|Adverse Event|8|||
124556041|NCT00686374|447994115|FG000|Overall Study|Withdrew consent|5|||
124556042|NCT00686374|447994115|FG000|Overall Study|Lost to Follow-up|1|||
124556043|NCT00686374|447994115|FG000|Overall Study|Missing reason|33|||
124556044|NCT00686374|447994115|FG000|Overall Study|Other, not specified|4|||
124556045|NCT01070966|447994116|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
124556046|NCT01070966|447994116|FG000|Participants for Safety Evaluation|Off-label use|9|||
124556047|NCT01070966|447994116|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
124556048|NCT01070966|447994116|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
124556049|NCT01070966|447994116|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
124556050|NCT01070966|447994116|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
124556051|NCT01070966|447994116|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
124556052|NCT01070966|447994116|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
124556053|NCT01725113|447994117|FG000|Overall Study|Kidney Transplant|1|||
124556054|NCT01725113|447994118|FG001|Overall Study|Kidney Transplant|1|||
124556055|NCT01725113|447994117|FG000|Overall Study|Withdrawal by Subject|0|||
124556056|NCT01725113|447994118|FG001|Overall Study|Withdrawal by Subject|1|||
124556057|NCT01808209|447994119|FG000|Overall Study|Lost to Follow-up|0|||
124556058|NCT01808209|447994120|FG001|Overall Study|Lost to Follow-up|1|||
124556059|NCT03066440|447994121|FG000|Overall Study|Physician Decision|1|||
124556060|NCT03066440|447994122|FG001|Overall Study|Physician Decision|1|||
124556061|NCT03066440|447994121|FG000|Overall Study|Protocol Violation|0|||
124556062|NCT03066440|447994122|FG001|Overall Study|Protocol Violation|2|||
124556063|NCT01106352|447994130|FG000|Overall Study|Subjects untreated|0|||
124556064|NCT01106352|447994131|FG001|Overall Study|Subjects untreated|0|||
124556065|NCT01106352|447994132|FG002|Overall Study|Subjects untreated|0|||
124556066|NCT01106352|447994133|FG003|Overall Study|Subjects untreated|3|||
124556067|NCT01106352|447994134|FG004|Overall Study|Subjects untreated|4|||
124556068|NCT01106352|447994130|FG000|Overall Study|Sponsor Decision|1|||
124556069|NCT01106352|447994131|FG001|Overall Study|Sponsor Decision|0|||
124556070|NCT01106352|447994132|FG002|Overall Study|Sponsor Decision|0|||
124556071|NCT01106352|447994133|FG003|Overall Study|Sponsor Decision|0|||
124556072|NCT01106352|447994134|FG004|Overall Study|Sponsor Decision|0|||
124556073|NCT01106352|447994130|FG000|Overall Study|Too ill to come in for the visit|0|||
124556074|NCT01106352|447994131|FG001|Overall Study|Too ill to come in for the visit|0|||
124556075|NCT01106352|447994132|FG002|Overall Study|Too ill to come in for the visit|1|||
124556076|NCT01106352|447994133|FG003|Overall Study|Too ill to come in for the visit|0|||
124556077|NCT01106352|447994134|FG004|Overall Study|Too ill to come in for the visit|0|||
124556078|NCT01106352|447994130|FG000|Overall Study|Lost to Follow-up|0|||
124556079|NCT01106352|447994131|FG001|Overall Study|Lost to Follow-up|0|||
124556080|NCT01106352|447994132|FG002|Overall Study|Lost to Follow-up|0|||
124556081|NCT01106352|447994133|FG003|Overall Study|Lost to Follow-up|0|||
124556082|NCT01106352|447994134|FG004|Overall Study|Lost to Follow-up|1|||
124556083|NCT01106352|447994130|FG000|Overall Study|Death|0|||
124556084|NCT01106352|447994131|FG001|Overall Study|Death|0|||
124556085|NCT01106352|447994132|FG002|Overall Study|Death|1|||
124556086|NCT01106352|447994133|FG003|Overall Study|Death|3|||
124718394|NCT01947283|448591211|FG003|Overall Study|No patients were enrolled in study|0|||
124718395|NCT01947283|448591212|FG004|Overall Study|No patients were enrolled in study|0|||
124718396|NCT01947283|448591213|FG005|Overall Study|No patients were enrolled in study|3|||
124718397|NCT01947283|448591214|FG006|Overall Study|No patients were enrolled in study|1|||
124718398|NCT00460655|448591215|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
124718399|NCT00460655|448591216|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
124718400|NCT00460655|448591217|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
124718401|NCT00460655|448591218|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
124718402|NCT00460655|448591215|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
124718403|NCT00460655|448591216|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
124718404|NCT00460655|448591217|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
124718405|NCT00460655|448591218|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
124718406|NCT00460655|448591215|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
124718407|NCT00460655|448591216|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
124718408|NCT00460655|448591217|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
124718409|NCT00460655|448591218|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
124718410|NCT00460655|448591215|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
124718411|NCT00460655|448591216|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
124718412|NCT00460655|448591217|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
124718413|NCT00460655|448591218|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
124718414|NCT00460655|448591215|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
124718415|NCT00460655|448591216|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
124718416|NCT00460655|448591217|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
124718417|NCT00460655|448591218|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
124718418|NCT00460655|448591215|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
124718419|NCT00460655|448591216|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
124718420|NCT00460655|448591217|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
124718421|NCT00460655|448591218|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
124718422|NCT03592771|448591219|FG000|Overall Study|Adverse Event|2|||
124718423|NCT03592771|448591220|FG001|Overall Study|Adverse Event|0|||
124718424|NCT03592771|448591221|FG002|Overall Study|Adverse Event|1|||
124718425|NCT03592771|448591219|FG000|Overall Study|Death|0|||
124718426|NCT03592771|448591220|FG001|Overall Study|Death|1|||
124718427|NCT03592771|448591221|FG002|Overall Study|Death|1|||
124718428|NCT03592771|448591219|FG000|Overall Study|Lost to Follow-up|5|||
124718429|NCT03592771|448591220|FG001|Overall Study|Lost to Follow-up|11|||
124718430|NCT03592771|448591221|FG002|Overall Study|Lost to Follow-up|15|||
124718431|NCT03592771|448591219|FG000|Overall Study|Withdrawal by Subject|0|||
124718432|NCT03592771|448591220|FG001|Overall Study|Withdrawal by Subject|2|||
124718433|NCT03592771|448591221|FG002|Overall Study|Withdrawal by Subject|0|||
124718434|NCT00735553|448591222|FG000|Overall Study|Study prematurely terminated|77|||
124718435|NCT03654040|448591225|FG000|Overall Study|Death|1|||
124718436|NCT03654040|448591226|FG001|Overall Study|Death|0|||
124718437|NCT03654040|448591225|FG000|Overall Study|Withdrawal by Subject|1|||
124718438|NCT03654040|448591226|FG001|Overall Study|Withdrawal by Subject|0|||
124718439|NCT03654040|448591225|FG000|Overall Study|Study terminated by sponsor|8|||
124718440|NCT03654040|448591226|FG001|Overall Study|Study terminated by sponsor|2|||
124718441|NCT03654040|448591225|FG000|Overall Study|Failure to initiate study therapy|2|||
124718442|NCT03654040|448591226|FG001|Overall Study|Failure to initiate study therapy|0|||
124718443|NCT03654040|448591225|FG000|Overall Study|Transplanted at another center|2|||
124718444|NCT03654040|448591226|FG001|Overall Study|Transplanted at another center|0|||
124718445|NCT03654040|448591225|FG000|Overall Study|Failure to meet eligibility criteria|14|||
124718446|NCT03654040|448591226|FG001|Overall Study|Failure to meet eligibility criteria|2|||
124718447|NCT03654040|448591225|FG000|Overall Study|No longer transplant candidate|1|||
124718448|NCT03654040|448591226|FG001|Overall Study|No longer transplant candidate|0|||
124718449|NCT03654040|448591225|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
124718450|NCT03654040|448591226|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
124718451|NCT03654040|448591225|FG000|Overall Study|Recipient ineligible|0|||
124718452|NCT03654040|448591226|FG001|Overall Study|Recipient ineligible|2|||
124718453|NCT03654040|448591225|FG000|Overall Study|Received deceased liver|0|||
124718454|NCT03654040|448591226|FG001|Overall Study|Received deceased liver|1|||
124718455|NCT01709110|448591227|FG000|Overall Study|Adverse Event|56|||
124474291|NCT01171820|447694148|FG000|Overall Study|Death|3|||
124474292|NCT01171820|447694149|FG001|Overall Study|Death|3|||
124474293|NCT01171820|447694148|FG000|Overall Study|Lost to Follow-up|0|||
124474294|NCT01171820|447694149|FG001|Overall Study|Lost to Follow-up|1|||
124474295|NCT01171820|447694148|FG000|Overall Study|Withdrawal by Subject|2|||
124474296|NCT01171820|447694149|FG001|Overall Study|Withdrawal by Subject|0|||
124474297|NCT01171820|447694148|FG000|Overall Study|Physician Decision|0|||
124474298|NCT01171820|447694149|FG001|Overall Study|Physician Decision|1|||
124474299|NCT01171820|447694148|FG000|Overall Study|1-Year Missed Visit|1|||
124474300|NCT01171820|447694149|FG001|Overall Study|1-Year Missed Visit|1|||
124474301|NCT00956943|447694150|FG000|Overall Study|Lost to Follow-up|9|||
124474302|NCT00956943|447694151|FG001|Overall Study|Lost to Follow-up|10|||
124474303|NCT02613208|447694152|FG000|Overall Study|Withdrawal by Subject|1|||
124474304|NCT02613208|447694152|FG000|Overall Study|Change of address|2|||
124474305|NCT02613208|447694152|FG000|Overall Study|Physician Decision|2|||
124474306|NCT02613208|447694152|FG000|Overall Study|Lost to Follow-up|5|||
124474307|NCT02613208|447694152|FG000|Overall Study|Death|37|||
124474308|NCT02663895|447694153|FG000|Overall Study|Adverse Event|3|||
124474309|NCT02663895|447694153|FG000|Overall Study|Physician Decision|2|||
124474310|NCT02663895|447694153|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
124474311|NCT02663895|447694153|FG000|Overall Study|Withdrawal by Subject|1|||
124474312|NCT02472847|447694155|FG000|Overall Study|Withdrawal by Subject|1|||
124474313|NCT02472847|447694156|FG001|Overall Study|Withdrawal by Subject|5|||
124474314|NCT00623831|447694158|FG000|Overall Study|Withdrawal by Subject|1|||
124474315|NCT00623831|447694159|FG001|Overall Study|Withdrawal by Subject|0|||
124474316|NCT00623831|447694158|FG000|Overall Study|Progressive Disease|0|||
124474317|NCT00623831|447694159|FG001|Overall Study|Progressive Disease|1|||
124718456|NCT01709110|448591228|FG001|Overall Study|Adverse Event|48|||
124718457|NCT01709110|448591227|FG000|Overall Study|Death|14|||
124718458|NCT01709110|448591228|FG001|Overall Study|Death|6|||
124474318|NCT00270894|447694160|FG000|Overall Study|Adverse Event|1|||
124474319|NCT00270894|447694160|FG000|Overall Study|Withdrawal by Subject|1|||
124474320|NCT01748071|447694161|FG000|Overall Study|Adverse Event|2|||
124474321|NCT01748071|447694162|FG001|Overall Study|Adverse Event|2|||
124474322|NCT01748071|447694163|FG002|Overall Study|Adverse Event|0|||
124474323|NCT00605267|447694164|FG000|Overall Study|Adverse Event|0|||
124474324|NCT00605267|447694165|FG001|Overall Study|Adverse Event|1|||
124474325|NCT00605267|447694164|FG000|Overall Study|Lack of Efficacy|1|||
124474326|NCT00605267|447694165|FG001|Overall Study|Lack of Efficacy|5|||
124474327|NCT00605267|447694164|FG000|Overall Study|Withdrawal by Subject|2|||
124474328|NCT00605267|447694165|FG001|Overall Study|Withdrawal by Subject|3|||
124474329|NCT02939131|447694166|FG000|Overall Study|Unable to get to clinic|6|||
124474330|NCT02939131|447694167|FG001|Overall Study|Unable to get to clinic|4|||
124474331|NCT02939131|447694166|FG000|Overall Study|Lost to Follow-up|2|||
124474332|NCT02939131|447694167|FG001|Overall Study|Lost to Follow-up|4|||
124474333|NCT02939131|447694166|FG000|Overall Study|severe debilitation|1|||
124474334|NCT02939131|447694167|FG001|Overall Study|severe debilitation|0|||
124556087|NCT01106352|447994134|FG004|Overall Study|Death|1|||
124556088|NCT01106352|447994130|FG000|Overall Study|Disease progression|0|||
124556089|NCT01106352|447994131|FG001|Overall Study|Disease progression|0|||
124556090|NCT01106352|447994132|FG002|Overall Study|Disease progression|0|||
124556091|NCT01106352|447994133|FG003|Overall Study|Disease progression|1|||
124556092|NCT01106352|447994134|FG004|Overall Study|Disease progression|0|||
124556093|NCT01106352|447994130|FG000|Overall Study|Withdrawal by Subject|0|||
124556094|NCT01106352|447994131|FG001|Overall Study|Withdrawal by Subject|0|||
124556095|NCT01106352|447994132|FG002|Overall Study|Withdrawal by Subject|0|||
124556096|NCT01106352|447994133|FG003|Overall Study|Withdrawal by Subject|3|||
124556097|NCT01106352|447994134|FG004|Overall Study|Withdrawal by Subject|2|||
124556098|NCT01106352|447994130|FG000|Overall Study|Went on hospice|0|||
124556099|NCT01106352|447994131|FG001|Overall Study|Went on hospice|0|||
124556100|NCT01106352|447994132|FG002|Overall Study|Went on hospice|0|||
124474335|NCT02939131|447694166|FG000|Overall Study|Other|0|||
124474336|NCT02939131|447694167|FG001|Overall Study|Other|1|||
124474337|NCT02939131|447694166|FG000|Overall Study|not willing to adhere to protocol|2|||
124556101|NCT01106352|447994133|FG003|Overall Study|Went on hospice|1|||
124474338|NCT02939131|447694167|FG001|Overall Study|not willing to adhere to protocol|0|||
124474339|NCT00883493|447694168|FG000|Overall Study|Adverse Event|11|||
124474340|NCT00883493|447694169|FG001|Overall Study|Adverse Event|12|||
124556102|NCT01106352|447994134|FG004|Overall Study|Went on hospice|0|||
124556103|NCT01106352|447994130|FG000|Overall Study|Subject entered hospice|0|||
124556104|NCT01106352|447994131|FG001|Overall Study|Subject entered hospice|0|||
124474341|NCT00883493|447694168|FG000|Overall Study|Lack of Efficacy|4|||
124474342|NCT00883493|447694169|FG001|Overall Study|Lack of Efficacy|3|||
124474343|NCT00883493|447694168|FG000|Overall Study|Lost to Follow-up|7|||
124474344|NCT00883493|447694169|FG001|Overall Study|Lost to Follow-up|6|||
124474345|NCT00883493|447694168|FG000|Overall Study|Withdrawal by Subject|11|||
124474346|NCT00883493|447694169|FG001|Overall Study|Withdrawal by Subject|20|||
124474347|NCT00883493|447694168|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
124474348|NCT00883493|447694169|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
124718459|NCT01709110|448591227|FG000|Overall Study|Lost to Follow-up|7|||
124718460|NCT01709110|448591228|FG001|Overall Study|Lost to Follow-up|5|||
124718461|NCT01709110|448591227|FG000|Overall Study|Protocol Violation|4|||
124718462|NCT01709110|448591228|FG001|Overall Study|Protocol Violation|6|||
124718463|NCT01709110|448591227|FG000|Overall Study|Withdrawal by Subject|96|||
124718464|NCT01709110|448591228|FG001|Overall Study|Withdrawal by Subject|89|||
124718465|NCT01709110|448591227|FG000|Overall Study|Physician Decision|4|||
124718466|NCT01709110|448591228|FG001|Overall Study|Physician Decision|10|||
124718467|NCT01709110|448591227|FG000|Overall Study|Sponsor Decision|2|||
124474349|NCT00883493|447694168|FG000|Overall Study|Study specific disc. criteria|2|||
124718468|NCT01709110|448591228|FG001|Overall Study|Sponsor Decision|2|||
124718469|NCT01709110|448591227|FG000|Overall Study|Lack of Efficacy|1|||
124718470|NCT01709110|448591228|FG001|Overall Study|Lack of Efficacy|1|||
124718471|NCT01709110|448591227|FG000|Overall Study|Caregiver Decision|1|||
124718472|NCT01709110|448591228|FG001|Overall Study|Caregiver Decision|1|||
124718473|NCT01484496|448591232|FG000|Period 1|Protocol Violation|3|||
124718474|NCT01484496|448591233|FG001|Period 1|Protocol Violation|4|||
124718475|NCT01484496|448591234|FG002|Period 1|Protocol Violation|0|||
124718476|NCT01484496|448591235|FG003|Period 1|Protocol Violation|0|||
124718477|NCT01484496|448591232|FG000|Period 1|Physician Decision|5|||
124718478|NCT01484496|448591233|FG001|Period 1|Physician Decision|1|||
124718479|NCT01484496|448591234|FG002|Period 1|Physician Decision|0|||
124718480|NCT01484496|448591235|FG003|Period 1|Physician Decision|0|||
124718481|NCT01484496|448591232|FG000|Period 1|Lack of Efficacy|10|||
124718482|NCT01484496|448591233|FG001|Period 1|Lack of Efficacy|15|||
124718483|NCT01484496|448591234|FG002|Period 1|Lack of Efficacy|0|||
124718484|NCT01484496|448591235|FG003|Period 1|Lack of Efficacy|0|||
124718485|NCT01484496|448591232|FG000|Period 1|Adverse Event|25|||
124718486|NCT01484496|448591233|FG001|Period 1|Adverse Event|40|||
124718487|NCT01484496|448591234|FG002|Period 1|Adverse Event|0|||
124718488|NCT01484496|448591235|FG003|Period 1|Adverse Event|0|||
124718489|NCT01484496|448591232|FG000|Period 1|Withdrawal by Subject|15|||
124718490|NCT01484496|448591233|FG001|Period 1|Withdrawal by Subject|12|||
124718491|NCT01484496|448591234|FG002|Period 1|Withdrawal by Subject|0|||
124718492|NCT01484496|448591235|FG003|Period 1|Withdrawal by Subject|0|||
124718493|NCT01484496|448591232|FG000|Period 1|Lost to Follow-up|2|||
124718494|NCT01484496|448591233|FG001|Period 1|Lost to Follow-up|6|||
124718495|NCT01484496|448591234|FG002|Period 1|Lost to Follow-up|0|||
124718496|NCT01484496|448591235|FG003|Period 1|Lost to Follow-up|0|||
124474350|NCT00883493|447694169|FG001|Overall Study|Study specific disc. criteria|0|||
124474351|NCT00883493|447694168|FG000|Overall Study|Other|5|||
124718497|NCT01484496|448591232|FG000|Period 1|Positive Pregnancy|1|||
124718498|NCT01484496|448591233|FG001|Period 1|Positive Pregnancy|6|||
124718499|NCT01484496|448591234|FG002|Period 1|Positive Pregnancy|0|||
124474352|NCT00883493|447694169|FG001|Overall Study|Other|3|||
124718500|NCT01484496|448591235|FG003|Period 1|Positive Pregnancy|0|||
124718501|NCT01484496|448591232|FG000|Period 1|Treatment Failure|3|||
124718502|NCT01484496|448591233|FG001|Period 1|Treatment Failure|6|||
124718503|NCT01484496|448591234|FG002|Period 1|Treatment Failure|0|||
124718504|NCT01484496|448591235|FG003|Period 1|Treatment Failure|0|||
124718505|NCT01484496|448591232|FG000|Period 1|Lack of Compliance|2|||
124718506|NCT01484496|448591233|FG001|Period 1|Lack of Compliance|1|||
124718507|NCT01484496|448591234|FG002|Period 1|Lack of Compliance|0|||
124718508|NCT01484496|448591235|FG003|Period 1|Lack of Compliance|0|||
124556105|NCT01106352|447994132|FG002|Overall Study|Subject entered hospice|0|||
124556106|NCT01106352|447994133|FG003|Overall Study|Subject entered hospice|1|||
124556107|NCT01106352|447994134|FG004|Overall Study|Subject entered hospice|0|||
124556108|NCT01106352|447994130|FG000|Overall Study|Home hospice since July 2013|0|||
124556109|NCT01106352|447994131|FG001|Overall Study|Home hospice since July 2013|0|||
124556110|NCT01106352|447994132|FG002|Overall Study|Home hospice since July 2013|0|||
124556111|NCT01106352|447994133|FG003|Overall Study|Home hospice since July 2013|1|||
124556112|NCT01106352|447994134|FG004|Overall Study|Home hospice since July 2013|0|||
124556113|NCT03944707|447994135|FG000|Overall Study|Adverse Event|0|||
124556114|NCT03944707|447994136|FG001|Overall Study|Adverse Event|2|||
124556115|NCT03944707|447994135|FG000|Overall Study|Study terminated by sponsor|12|||
124556116|NCT03944707|447994136|FG001|Overall Study|Study terminated by sponsor|7|||
124556117|NCT03944707|447994135|FG000|Overall Study|Subject decision|0|||
124556118|NCT03944707|447994136|FG001|Overall Study|Subject decision|1|||
124556119|NCT00751998|447994144|FG000|Overall Study|Lost to Follow-up|7|||
124556120|NCT00751998|447994144|FG000|Overall Study|Death|11|||
124556121|NCT00751998|447994144|FG000|Overall Study|Withdrawal by Subject|2|||
124556122|NCT01965535|447994145|FG000|Overall Study|Lack of Efficacy|2|||
124556123|NCT01965535|447994146|FG001|Overall Study|Lack of Efficacy|1|||
124556124|NCT02983227|447994147|FG000|Overall Study|Adverse Event|21|||
124556125|NCT02983227|447994148|FG001|Overall Study|Adverse Event|3|||
124556126|NCT02983227|447994147|FG000|Overall Study|Death|3|||
124718509|NCT01484496|448591232|FG000|Period 1|Unable to Visit Site|0|||
124718510|NCT01484496|448591233|FG001|Period 1|Unable to Visit Site|2|||
124718511|NCT01484496|448591234|FG002|Period 1|Unable to Visit Site|0|||
124718512|NCT01484496|448591235|FG003|Period 1|Unable to Visit Site|0|||
124718513|NCT01484496|448591232|FG000|Period 2|Lack of Efficacy|0|||
124718514|NCT01484496|448591233|FG001|Period 2|Lack of Efficacy|0|||
124718515|NCT01484496|448591234|FG002|Period 2|Lack of Efficacy|1|||
124718516|NCT01484496|448591235|FG003|Period 2|Lack of Efficacy|3|||
124718517|NCT01484496|448591232|FG000|Period 2|Adverse Event|0|||
124718518|NCT01484496|448591233|FG001|Period 2|Adverse Event|0|||
124718519|NCT01484496|448591234|FG002|Period 2|Adverse Event|5|||
124718520|NCT01484496|448591235|FG003|Period 2|Adverse Event|13|||
124718521|NCT01484496|448591232|FG000|Period 2|Other|0|||
124718522|NCT01484496|448591233|FG001|Period 2|Other|0|||
124718523|NCT01484496|448591234|FG002|Period 2|Other|9|||
124718524|NCT01484496|448591235|FG003|Period 2|Other|6|||
124718525|NCT01645735|448591236|FG000|Overall Study|Physician Decision|2|||
124718526|NCT01645735|448591237|FG001|Overall Study|Physician Decision|0|||
124718527|NCT01645735|448591236|FG000|Overall Study|Withdrawal by Subject|1|||
124718528|NCT01645735|448591237|FG001|Overall Study|Withdrawal by Subject|0|||
124718529|NCT01645735|448591236|FG000|Overall Study|Protocol Violation|1|||
124718530|NCT01645735|448591237|FG001|Overall Study|Protocol Violation|0|||
124718531|NCT01645735|448591236|FG000|Overall Study|Adverse Event|0|||
124718532|NCT01645735|448591237|FG001|Overall Study|Adverse Event|1|||
124718533|NCT04830215|448591238|FG000|Overall Study|Adverse Event|6|||
124718534|NCT04830215|448591238|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
124718535|NCT04830215|448591238|FG000|Overall Study|Withdrawal by Subject|3|||
124718536|NCT04830215|448591238|FG000|Overall Study|Protocol Deviation|1|||
124718537|NCT03782064|448591239|FG000|Overall Study|Lack of Efficacy|2|||
124718538|NCT03782064|448591239|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
124718539|NCT02446769|448591240|FG000|Screening Period|Screen Failure|11|||
124718540|NCT02446769|448591241|FG001|Screening Period|Screen Failure|0|||
124718541|NCT02446769|448591242|FG002|Screening Period|Screen Failure|0|||
124718542|NCT02446769|448591240|FG000|Study Period|Randomized in Error|0|||
124718543|NCT02446769|448591241|FG001|Study Period|Randomized in Error|2|||
124718544|NCT02446769|448591242|FG002|Study Period|Randomized in Error|0|||
124718545|NCT00645840|448591243|FG000|Overall Study|Protocol Violation|3|||
124718546|NCT03994211|448591244|FG000|Core Phase|Adverse Event|0|||
124718547|NCT03994211|448591245|FG001|Core Phase|Adverse Event|1|||
124718548|NCT03994211|448591246|FG002|Core Phase|Adverse Event|0|||
124718549|NCT03994211|448591244|FG000|Extension Phase|Adverse Event|0|||
124718550|NCT03994211|448591245|FG001|Extension Phase|Adverse Event|0|||
124718551|NCT03994211|448591246|FG002|Extension Phase|Adverse Event|1|||
124718552|NCT03994211|448591244|FG000|Extension Phase|Physician Decision|0|||
124718553|NCT03994211|448591245|FG001|Extension Phase|Physician Decision|0|||
124718554|NCT03994211|448591246|FG002|Extension Phase|Physician Decision|1|||
124718555|NCT03994211|448591244|FG000|Extension Phase|Progressive Disease|0|||
124718556|NCT03994211|448591245|FG001|Extension Phase|Progressive Disease|0|||
124718557|NCT03994211|448591246|FG002|Extension Phase|Progressive Disease|20|||
124718558|NCT03994211|448591244|FG000|Extension Phase|Withdrawal by Subject|0|||
124718559|NCT03994211|448591245|FG001|Extension Phase|Withdrawal by Subject|0|||
124718560|NCT03994211|448591246|FG002|Extension Phase|Withdrawal by Subject|2|||
124718561|NCT00997984|448591247|FG000|Overall Study|Adverse Event|1|||
124718562|NCT00997984|448591248|FG001|Overall Study|Adverse Event|8|||
124718563|NCT00997984|448591249|FG002|Overall Study|Adverse Event|8|||
124718564|NCT00997984|448591247|FG000|Overall Study|Protocol Violation|1|||
124718565|NCT00997984|448591248|FG001|Overall Study|Protocol Violation|3|||
124718566|NCT00997984|448591249|FG002|Overall Study|Protocol Violation|0|||
124718567|NCT00997984|448591247|FG000|Overall Study|Withdrawal by Subject|6|||
124718568|NCT00997984|448591248|FG001|Overall Study|Withdrawal by Subject|9|||
124718569|NCT00997984|448591249|FG002|Overall Study|Withdrawal by Subject|5|||
124718570|NCT00997984|448591247|FG000|Overall Study|Lost to Follow-up|8|||
124718571|NCT00997984|448591248|FG001|Overall Study|Lost to Follow-up|5|||
124718572|NCT00997984|448591249|FG002|Overall Study|Lost to Follow-up|4|||
124718573|NCT00997984|448591247|FG000|Overall Study|Lack of Efficacy|20|||
124718574|NCT00997984|448591248|FG001|Overall Study|Lack of Efficacy|6|||
124718575|NCT00997984|448591249|FG002|Overall Study|Lack of Efficacy|3|||
124718576|NCT00997984|448591247|FG000|Overall Study|Met exclusion criteria|1|||
124474353|NCT01084551|447694170|FG000|Overall Study|Adverse Event|2|||
124474354|NCT01084551|447694171|FG001|Overall Study|Adverse Event|9|||
124474355|NCT01084551|447694172|FG002|Overall Study|Adverse Event|4|||
124474356|NCT01084551|447694170|FG000|Overall Study|Lack of Efficacy|2|||
124474357|NCT01084551|447694171|FG001|Overall Study|Lack of Efficacy|0|||
124474358|NCT01084551|447694172|FG002|Overall Study|Lack of Efficacy|1|||
124474359|NCT01084551|447694170|FG000|Overall Study|Withdrawal by Subject|2|||
124474360|NCT01084551|447694171|FG001|Overall Study|Withdrawal by Subject|1|||
124474361|NCT01084551|447694172|FG002|Overall Study|Withdrawal by Subject|0|||
124474362|NCT01084551|447694170|FG000|Overall Study|Protocol Violation|2|||
124474363|NCT01084551|447694171|FG001|Overall Study|Protocol Violation|4|||
124474364|NCT01084551|447694172|FG002|Overall Study|Protocol Violation|0|||
124474365|NCT01084551|447694170|FG000|Overall Study|Lost to Follow-up|0|||
124474366|NCT01084551|447694171|FG001|Overall Study|Lost to Follow-up|0|||
124474367|NCT01084551|447694172|FG002|Overall Study|Lost to Follow-up|3|||
124474368|NCT01084551|447694170|FG000|Overall Study|Physician Decision|1|||
124474369|NCT01084551|447694171|FG001|Overall Study|Physician Decision|0|||
124474370|NCT01084551|447694172|FG002|Overall Study|Physician Decision|0|||
124474371|NCT00289913|447694173|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
124474372|NCT00289913|447694174|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
124474373|NCT00289913|447694175|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
124474374|NCT00289913|447694176|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
124474375|NCT00289913|447694177|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
124474376|NCT00289913|447694173|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
124474377|NCT00289913|447694174|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
124474378|NCT00289913|447694175|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
124474379|NCT00289913|447694176|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
124474380|NCT00289913|447694177|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
124474381|NCT00289913|447694173|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
124474382|NCT00289913|447694174|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
124474383|NCT00289913|447694175|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
124474384|NCT00289913|447694176|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
124474385|NCT00289913|447694177|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
124474386|NCT00289913|447694173|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
124474387|NCT00289913|447694174|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
124474388|NCT00289913|447694175|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
124474389|NCT00289913|447694176|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
124474390|NCT00289913|447694177|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
124474391|NCT00289913|447694173|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
124474392|NCT00289913|447694174|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
124474393|NCT00289913|447694175|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
124474394|NCT00289913|447694176|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
124474395|NCT00289913|447694177|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
124556127|NCT02983227|447994148|FG001|Overall Study|Death|0|||
124556128|NCT02983227|447994147|FG000|Overall Study|Lack of Efficacy|8|||
124474396|NCT00289913|447694173|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
124474397|NCT00289913|447694174|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
124474398|NCT00289913|447694175|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
124474399|NCT00289913|447694176|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
124474400|NCT00289913|447694177|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
124474401|NCT00289913|447694173|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
124474402|NCT00289913|447694174|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
124474403|NCT00289913|447694175|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
124474404|NCT00289913|447694176|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
124474405|NCT00289913|447694177|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
124474406|NCT00289913|447694173|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
124556129|NCT02983227|447994148|FG001|Overall Study|Lack of Efficacy|1|||
124718577|NCT00997984|448591248|FG001|Overall Study|Met exclusion criteria|0|||
124718578|NCT00997984|448591249|FG002|Overall Study|Met exclusion criteria|0|||
124718579|NCT00997984|448591247|FG000|Overall Study|non-compliance|0|||
124718580|NCT00997984|448591248|FG001|Overall Study|non-compliance|2|||
124718581|NCT00997984|448591249|FG002|Overall Study|non-compliance|3|||
124718582|NCT00997984|448591247|FG000|Overall Study|Wrong medication dispensed|0|||
124718583|NCT00997984|448591248|FG001|Overall Study|Wrong medication dispensed|1|||
124718584|NCT00997984|448591249|FG002|Overall Study|Wrong medication dispensed|0|||
124718585|NCT00997984|448591247|FG000|Overall Study|Suicidal ideation|0|||
124718586|NCT00997984|448591248|FG001|Overall Study|Suicidal ideation|0|||
124718587|NCT00997984|448591249|FG002|Overall Study|Suicidal ideation|1|||
124718588|NCT00997984|448591247|FG000|Overall Study|Work schedule|0|||
124718589|NCT00997984|448591248|FG001|Overall Study|Work schedule|0|||
124718590|NCT00997984|448591249|FG002|Overall Study|Work schedule|2|||
124718591|NCT00271856|448591256|FG000|Overall Study|Withdrawal by Subject|1|||
124718592|NCT00271856|448591257|FG001|Overall Study|Withdrawal by Subject|7|||
124771650|NCT02085460|448794527|FG000|Overall Study|Withdrawal by Subject|11|||
124771651|NCT02085460|448794528|FG001|Overall Study|Withdrawal by Subject|5|||
124474407|NCT00289913|447694174|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
124718593|NCT00271856|448591256|FG000|Overall Study|Lost to Follow-up|10|||
124718594|NCT00271856|448591257|FG001|Overall Study|Lost to Follow-up|11|||
124718595|NCT04599803|448591258|FG000|Overall Study|Withdrawal by Subject|5|||
124718596|NCT04599803|448591258|FG000|Overall Study|Lost to Follow-up|26|||
124474408|NCT00289913|447694175|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
124474409|NCT00289913|447694176|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
124474410|NCT00289913|447694177|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
124474411|NCT00289913|447694173|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
124474412|NCT00289913|447694174|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
124474413|NCT00289913|447694175|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
124474414|NCT00289913|447694176|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
124474415|NCT00289913|447694177|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
124474416|NCT00289913|447694173|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
124474417|NCT00289913|447694174|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
124474418|NCT00289913|447694175|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
124474419|NCT00289913|447694176|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
124474420|NCT00289913|447694177|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
124474421|NCT00289913|447694173|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
124718597|NCT04677543|448591259|FG000|Overall Study|Withdrawal by Subject|4|||
124718598|NCT04677543|448591260|FG001|Overall Study|Withdrawal by Subject|1|||
124718599|NCT04677543|448591259|FG000|Overall Study|Physician Decision|0|||
124718600|NCT04677543|448591260|FG001|Overall Study|Physician Decision|1|||
124718601|NCT04677543|448591259|FG000|Overall Study|Adverse Event|0|||
124556130|NCT02983227|447994147|FG000|Overall Study|Lost to Follow-up|3|||
124718602|NCT04677543|448591260|FG001|Overall Study|Adverse Event|1|||
124556131|NCT02983227|447994148|FG001|Overall Study|Lost to Follow-up|0|||
124474422|NCT00289913|447694174|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
124556132|NCT02983227|447994147|FG000|Overall Study|Multiple Reasons|2|||
124718603|NCT00995436|448591265|FG000|Overall Study|Withdrawal by Subject|2|||
124718604|NCT00995436|448591266|FG001|Overall Study|Withdrawal by Subject|5|||
124718605|NCT00995436|448591267|FG002|Overall Study|Withdrawal by Subject|0|||
124718606|NCT01437111|448591269|FG000|Overall Study|Adverse Event|2|||
124718607|NCT01437111|448591269|FG000|Overall Study|Withdrawal by Subject|4|||
124718608|NCT01437111|448591269|FG000|Overall Study|Not reported|5|||
124718609|NCT01437111|448591269|FG000|Overall Study|Physician Decision|1|||
124718610|NCT01437111|448591269|FG000|Overall Study|Lost to Follow-up|5|||
124718611|NCT01437111|448591269|FG000|Overall Study|Protocol Violation|1|||
124718612|NCT00771927|448591270|FG000|Overall Study|Adverse Event|100|||
124718613|NCT00771927|448591271|FG001|Overall Study|Adverse Event|105|||
124718614|NCT00771927|448591270|FG000|Overall Study|Lack of Efficacy|70|||
124718615|NCT00771927|448591271|FG001|Overall Study|Lack of Efficacy|42|||
124718616|NCT00771927|448591270|FG000|Overall Study|Lost to Follow-up|46|||
124718617|NCT00771927|448591271|FG001|Overall Study|Lost to Follow-up|46|||
124718618|NCT00771927|448591270|FG000|Overall Study|Withdrawal by Subject|16|||
124718619|NCT00771927|448591271|FG001|Overall Study|Withdrawal by Subject|17|||
124718620|NCT00771927|448591270|FG000|Overall Study|Other reason|23|||
124718621|NCT00771927|448591271|FG001|Overall Study|Other reason|27|||
124718622|NCT00577707|448591272|FG000|Overall Study|Withdrawal by Subject|3|||
124718623|NCT01603043|448591273|FG000|Overall Study|Study Futility|7|||
124718624|NCT01603043|448591274|FG001|Overall Study|Study Futility|3|||
124718625|NCT02712996|448591290|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
124718626|NCT02712996|448591291|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
124718627|NCT01016132|448591292|FG000|Overall Study|Discomfort|1|||
124718628|NCT01451749|448591293|FG000|Overall Study|Protocol Violation|14|||
124718629|NCT01451749|448591294|FG001|Overall Study|Protocol Violation|7|||
124718630|NCT01451749|448591293|FG000|Overall Study|Lost to Follow-up|15|||
124718631|NCT01451749|448591294|FG001|Overall Study|Lost to Follow-up|5|||
124718632|NCT01451749|448591293|FG000|Overall Study|Meet the exclusion criteria,and|1|||
124718633|NCT01451749|448591294|FG001|Overall Study|Meet the exclusion criteria,and|1|||
124718634|NCT01451749|448591293|FG000|Overall Study|Adverse Event|2|||
124718635|NCT01451749|448591294|FG001|Overall Study|Adverse Event|0|||
124718636|NCT01451749|448591293|FG000|Overall Study|Withdrawal by Subject|0|||
124718637|NCT01451749|448591294|FG001|Overall Study|Withdrawal by Subject|1|||
124718638|NCT02454530|448591303|FG000|Overall Study|Other|8|||
124718639|NCT02454530|448591304|FG001|Overall Study|Other|13|||
124718640|NCT02454530|448591303|FG000|Overall Study|Missing information|56|||
124718641|NCT02454530|448591304|FG001|Overall Study|Missing information|69|||
124556133|NCT02983227|447994148|FG001|Overall Study|Multiple Reasons|1|||
124556134|NCT02983227|447994147|FG000|Overall Study|Physician Decision|3|||
124556135|NCT02983227|447994148|FG001|Overall Study|Physician Decision|1|||
124556136|NCT02983227|447994147|FG000|Overall Study|Withdrawal by Subject|19|||
124556137|NCT02983227|447994148|FG001|Overall Study|Withdrawal by Subject|8|||
124556138|NCT00986154|447994149|FG000|Overall Study|Death|136|||
124556139|NCT00986154|447994150|FG001|Overall Study|Death|127|||
124556140|NCT00986154|447994149|FG000|Overall Study|Lost to Follow-up|7|||
124556141|NCT00986154|447994150|FG001|Overall Study|Lost to Follow-up|4|||
124556142|NCT00986154|447994149|FG000|Overall Study|Withdrawal by Subject|32|||
124556143|NCT00986154|447994150|FG001|Overall Study|Withdrawal by Subject|33|||
124556144|NCT00986154|447994149|FG000|Overall Study|investigator/subject decide not continue|6|||
124556145|NCT00986154|447994150|FG001|Overall Study|investigator/subject decide not continue|3|||
124556146|NCT00986154|447994149|FG000|Overall Study|never received study drug|25|||
124556147|NCT00986154|447994150|FG001|Overall Study|never received study drug|27|||
124556148|NCT00068445|447994153|FG000|Randomization|Cancel|1|||
124556149|NCT00068445|447994154|FG001|Randomization|Cancel|3|||
124556150|NCT00068445|447994153|FG000|Randomization|Ineligible|1|||
124556151|NCT00068445|447994154|FG001|Randomization|Ineligible|1|||
124556152|NCT00068445|447994153|FG000|Treatment|Refused Further Treatment|13|||
124556153|NCT00068445|447994154|FG001|Treatment|Refused Further Treatment|10|||
124556154|NCT00068445|447994153|FG000|Treatment|Adverse Event|7|||
124556155|NCT00068445|447994154|FG001|Treatment|Adverse Event|1|||
124474423|NCT00289913|447694175|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
124474424|NCT00289913|447694176|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
124474425|NCT00289913|447694177|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
124474426|NCT00289913|447694173|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
124474427|NCT00289913|447694174|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
124474428|NCT00289913|447694175|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
124474429|NCT00289913|447694176|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
124556156|NCT00068445|447994153|FG000|Treatment|Other (Specifics not available)|9|||
124556157|NCT00068445|447994154|FG001|Treatment|Other (Specifics not available)|5|||
124556158|NCT01493531|447994155|FG000|Overall Study|Adverse Event|4|||
124474430|NCT00289913|447694177|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
124556159|NCT01493531|447994156|FG001|Overall Study|Adverse Event|12|||
124474431|NCT00289913|447694173|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
124474432|NCT00289913|447694174|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
124474433|NCT00289913|447694175|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
124474434|NCT00289913|447694176|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
124474435|NCT00289913|447694177|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
124556160|NCT01493531|447994157|FG002|Overall Study|Adverse Event|9|||
124556161|NCT01493531|447994155|FG000|Overall Study|Gout flare|3|||
124556162|NCT01493531|447994156|FG001|Overall Study|Gout flare|0|||
124474436|NCT00289913|447694173|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
124474437|NCT00289913|447694174|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
124474438|NCT00289913|447694175|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
124474439|NCT00289913|447694176|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
124474440|NCT00289913|447694177|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
124474441|NCT00289913|447694173|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
124474442|NCT00289913|447694174|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
124474443|NCT00289913|447694175|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
124474444|NCT00289913|447694176|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
124474445|NCT00289913|447694177|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
124474446|NCT00289913|447694173|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
124474447|NCT00289913|447694174|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
124474448|NCT00289913|447694175|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
124474449|NCT00289913|447694176|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
124474450|NCT00289913|447694177|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
124474451|NCT00289913|447694173|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
124474452|NCT00289913|447694174|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
124474453|NCT00289913|447694175|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
124474454|NCT00289913|447694176|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
124474455|NCT00289913|447694177|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
124474456|NCT00289913|447694173|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
124474457|NCT00289913|447694174|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
124556163|NCT01493531|447994157|FG002|Overall Study|Gout flare|2|||
124556164|NCT01493531|447994155|FG000|Overall Study|Protocol Violation|8|||
124556165|NCT01493531|447994156|FG001|Overall Study|Protocol Violation|15|||
124556166|NCT01493531|447994157|FG002|Overall Study|Protocol Violation|12|||
124556167|NCT01493531|447994155|FG000|Overall Study|Sponsor terminated study|5|||
124556168|NCT01493531|447994156|FG001|Overall Study|Sponsor terminated study|2|||
124556169|NCT01493531|447994157|FG002|Overall Study|Sponsor terminated study|3|||
124556170|NCT01493531|447994155|FG000|Overall Study|Lost to Follow-up|5|||
124556171|NCT01493531|447994156|FG001|Overall Study|Lost to Follow-up|7|||
124556172|NCT01493531|447994157|FG002|Overall Study|Lost to Follow-up|11|||
124556173|NCT01493531|447994155|FG000|Overall Study|Withdrawal by Subject|16|||
124474458|NCT00289913|447694175|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
124474459|NCT00289913|447694176|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
124474460|NCT00289913|447694177|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
124474461|NCT00289913|447694173|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
124474462|NCT00289913|447694174|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
124474463|NCT00289913|447694175|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
124474464|NCT00289913|447694176|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
124474465|NCT00289913|447694177|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
124474466|NCT00289913|447694173|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
124474467|NCT00289913|447694174|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
124474468|NCT00289913|447694175|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
124474469|NCT00289913|447694176|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
124474470|NCT00289913|447694177|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
124474471|NCT00289913|447694173|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
124474472|NCT00289913|447694174|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
124474473|NCT00289913|447694175|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
124474474|NCT00289913|447694176|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
124474475|NCT00289913|447694177|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
124474476|NCT00289913|447694173|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
124474477|NCT00289913|447694174|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
124474478|NCT00289913|447694175|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
124474479|NCT00289913|447694176|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
124474480|NCT00289913|447694177|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
124474481|NCT00289913|447694173|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
124474482|NCT00289913|447694174|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
124474483|NCT00289913|447694175|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
124474484|NCT00289913|447694176|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
124474485|NCT00289913|447694177|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
124474486|NCT00289913|447694173|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
124474487|NCT00289913|447694174|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
124474488|NCT00289913|447694175|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
124474489|NCT00289913|447694176|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
124474490|NCT00289913|447694177|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
124474491|NCT00289913|447694173|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
124474492|NCT00289913|447694174|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
124474493|NCT00289913|447694175|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
124474494|NCT00289913|447694176|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
124474495|NCT00289913|447694177|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
124474496|NCT00289913|447694173|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
124474497|NCT00289913|447694174|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
124474498|NCT00289913|447694175|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
124474499|NCT00289913|447694176|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
124474500|NCT00289913|447694177|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
124474501|NCT00289913|447694173|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
124474502|NCT00289913|447694174|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
124474503|NCT00289913|447694175|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
124474504|NCT00289913|447694176|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
124474505|NCT00289913|447694177|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
124474506|NCT00289913|447694173|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
124474507|NCT00289913|447694174|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
124474508|NCT00289913|447694175|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
124474509|NCT00289913|447694176|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
124474510|NCT00289913|447694177|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
124474511|NCT00289913|447694173|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
124474512|NCT00289913|447694174|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
124474513|NCT00289913|447694175|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
124474514|NCT00289913|447694176|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
124474515|NCT00289913|447694177|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
124474516|NCT00289913|447694173|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
124474517|NCT00289913|447694174|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
124556174|NCT01493531|447994156|FG001|Overall Study|Withdrawal by Subject|13|||
124771652|NCT02085460|448794529|FG002|Overall Study|Withdrawal by Subject|7|||
124474518|NCT00289913|447694175|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
124474519|NCT00289913|447694176|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
124474520|NCT00289913|447694177|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
124474521|NCT00289913|447694173|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
124474522|NCT00289913|447694174|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
124474523|NCT00289913|447694175|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
124474524|NCT00289913|447694176|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
124474525|NCT00289913|447694177|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
124474526|NCT02024971|447694178|FG000|Overall Study|Data Not Available|30|||
124474527|NCT02024971|447694178|FG000|Overall Study|Lost to Follow-up|6|||
124474528|NCT00944034|447694181|FG000|Overall Study|Inappropriate enrollment|0|||
124474529|NCT00944034|447694182|FG001|Overall Study|Inappropriate enrollment|1|||
124474530|NCT00944034|447694183|FG002|Overall Study|Inappropriate enrollment|0|||
124474531|NCT00944034|447694184|FG003|Overall Study|Inappropriate enrollment|1|||
124474532|NCT00944034|447694185|FG004|Overall Study|Inappropriate enrollment|2|||
124474533|NCT00944034|447694186|FG005|Overall Study|Inappropriate enrollment|1|||
124474534|NCT00944034|447694187|FG006|Overall Study|Inappropriate enrollment|0|||
124474535|NCT00944034|447694188|FG007|Overall Study|Inappropriate enrollment|0|||
124474536|NCT00944034|447694189|FG008|Overall Study|Inappropriate enrollment|1|||
124474537|NCT00944034|447694190|FG009|Overall Study|Inappropriate enrollment|1|||
124474538|NCT00944034|447694191|FG010|Overall Study|Inappropriate enrollment|0|||
124474539|NCT00944034|447694192|FG011|Overall Study|Inappropriate enrollment|0|||
124474540|NCT00944034|447694181|FG000|Overall Study|Withdrawal by Subject|3|||
124474541|NCT00944034|447694182|FG001|Overall Study|Withdrawal by Subject|2|||
124474542|NCT00944034|447694183|FG002|Overall Study|Withdrawal by Subject|6|||
124474543|NCT00944034|447694184|FG003|Overall Study|Withdrawal by Subject|2|||
124474544|NCT00944034|447694185|FG004|Overall Study|Withdrawal by Subject|5|||
124474545|NCT00944034|447694186|FG005|Overall Study|Withdrawal by Subject|8|||
124474546|NCT00944034|447694187|FG006|Overall Study|Withdrawal by Subject|2|||
124474547|NCT00944034|447694188|FG007|Overall Study|Withdrawal by Subject|2|||
124474548|NCT00944034|447694189|FG008|Overall Study|Withdrawal by Subject|3|||
124474549|NCT00944034|447694190|FG009|Overall Study|Withdrawal by Subject|4|||
124474550|NCT00944034|447694191|FG010|Overall Study|Withdrawal by Subject|0|||
124474551|NCT00944034|447694192|FG011|Overall Study|Withdrawal by Subject|4|||
124474552|NCT00944034|447694181|FG000|Overall Study|Lost to Follow-up|0|||
124474553|NCT00944034|447694182|FG001|Overall Study|Lost to Follow-up|4|||
124474554|NCT00944034|447694183|FG002|Overall Study|Lost to Follow-up|2|||
124474555|NCT00944034|447694184|FG003|Overall Study|Lost to Follow-up|0|||
124474556|NCT00944034|447694185|FG004|Overall Study|Lost to Follow-up|5|||
124474557|NCT00944034|447694186|FG005|Overall Study|Lost to Follow-up|7|||
124474558|NCT00944034|447694187|FG006|Overall Study|Lost to Follow-up|0|||
124474559|NCT00944034|447694188|FG007|Overall Study|Lost to Follow-up|1|||
124474560|NCT00944034|447694189|FG008|Overall Study|Lost to Follow-up|5|||
124474561|NCT00944034|447694190|FG009|Overall Study|Lost to Follow-up|1|||
124474562|NCT00944034|447694191|FG010|Overall Study|Lost to Follow-up|1|||
124474563|NCT00944034|447694192|FG011|Overall Study|Lost to Follow-up|0|||
124474564|NCT00944034|447694181|FG000|Overall Study|Death|0|||
124474565|NCT00944034|447694182|FG001|Overall Study|Death|0|||
124474566|NCT00944034|447694183|FG002|Overall Study|Death|1|||
124718642|NCT02454530|448591303|FG000|Overall Study|Death|2|||
124474567|NCT00944034|447694184|FG003|Overall Study|Death|0|||
124556175|NCT01493531|447994157|FG002|Overall Study|Withdrawal by Subject|11|||
124474568|NCT00944034|447694185|FG004|Overall Study|Death|0|||
124474569|NCT00944034|447694186|FG005|Overall Study|Death|0|||
124474570|NCT00944034|447694187|FG006|Overall Study|Death|0|||
124474571|NCT00944034|447694188|FG007|Overall Study|Death|0|||
124474572|NCT00944034|447694189|FG008|Overall Study|Death|0|||
124474573|NCT00944034|447694190|FG009|Overall Study|Death|0|||
124474574|NCT00944034|447694191|FG010|Overall Study|Death|0|||
124474575|NCT00944034|447694192|FG011|Overall Study|Death|0|||
124474576|NCT00944034|447694181|FG000|Overall Study|Protocol Violation|2|||
124474577|NCT00944034|447694182|FG001|Overall Study|Protocol Violation|0|||
124556176|NCT01493531|447994155|FG000|Overall Study|Death|0|||
124474578|NCT00944034|447694183|FG002|Overall Study|Protocol Violation|0|||
124474579|NCT00944034|447694184|FG003|Overall Study|Protocol Violation|1|||
124474580|NCT00944034|447694185|FG004|Overall Study|Protocol Violation|2|||
124474581|NCT00944034|447694186|FG005|Overall Study|Protocol Violation|3|||
124474582|NCT00944034|447694187|FG006|Overall Study|Protocol Violation|0|||
124474583|NCT00944034|447694188|FG007|Overall Study|Protocol Violation|1|||
124474584|NCT00944034|447694189|FG008|Overall Study|Protocol Violation|1|||
124474585|NCT00944034|447694190|FG009|Overall Study|Protocol Violation|4|||
124474586|NCT00944034|447694191|FG010|Overall Study|Protocol Violation|0|||
124474587|NCT00944034|447694192|FG011|Overall Study|Protocol Violation|0|||
124474588|NCT00944034|447694181|FG000|Overall Study|Unable to classify|0|||
124474589|NCT00944034|447694182|FG001|Overall Study|Unable to classify|0|||
124474590|NCT00944034|447694183|FG002|Overall Study|Unable to classify|0|||
124474591|NCT00944034|447694184|FG003|Overall Study|Unable to classify|0|||
124474592|NCT00944034|447694185|FG004|Overall Study|Unable to classify|0|||
124474593|NCT00944034|447694186|FG005|Overall Study|Unable to classify|1|||
124474594|NCT00944034|447694187|FG006|Overall Study|Unable to classify|1|||
124474595|NCT00944034|447694188|FG007|Overall Study|Unable to classify|1|||
124474596|NCT00944034|447694189|FG008|Overall Study|Unable to classify|0|||
124474597|NCT00944034|447694190|FG009|Overall Study|Unable to classify|0|||
124474598|NCT00944034|447694191|FG010|Overall Study|Unable to classify|0|||
124474599|NCT00944034|447694192|FG011|Overall Study|Unable to classify|0|||
124474600|NCT00944034|447694181|FG000|Overall Study|Administrative reason|0|||
124474601|NCT00944034|447694182|FG001|Overall Study|Administrative reason|0|||
124474602|NCT00944034|447694183|FG002|Overall Study|Administrative reason|0|||
124474603|NCT00944034|447694184|FG003|Overall Study|Administrative reason|0|||
124474604|NCT00944034|447694185|FG004|Overall Study|Administrative reason|0|||
124474605|NCT00944034|447694186|FG005|Overall Study|Administrative reason|0|||
124474606|NCT00944034|447694187|FG006|Overall Study|Administrative reason|1|||
124474607|NCT00944034|447694188|FG007|Overall Study|Administrative reason|0|||
124474608|NCT00944034|447694189|FG008|Overall Study|Administrative reason|0|||
124474609|NCT00944034|447694190|FG009|Overall Study|Administrative reason|0|||
124474610|NCT00944034|447694191|FG010|Overall Study|Administrative reason|0|||
124474611|NCT00944034|447694192|FG011|Overall Study|Administrative reason|0|||
124474612|NCT00531960|447694193|FG000|Overall Study|Adverse Event|5|||
124474613|NCT00531960|447694194|FG001|Overall Study|Adverse Event|4|||
124474614|NCT00531960|447694193|FG000|Overall Study|Death|3|||
124474615|NCT00531960|447694194|FG001|Overall Study|Death|2|||
124474616|NCT00531960|447694193|FG000|Overall Study|Lack of Efficacy|42|||
124474617|NCT00531960|447694194|FG001|Overall Study|Lack of Efficacy|41|||
124474618|NCT00531960|447694193|FG000|Overall Study|Violation of Selection Criteria|2|||
124474619|NCT00531960|447694194|FG001|Overall Study|Violation of Selection Criteria|0|||
124474620|NCT00531960|447694193|FG000|Overall Study|Refused Treatment|5|||
124474621|NCT00531960|447694194|FG001|Overall Study|Refused Treatment|6|||
124474622|NCT00531960|447694193|FG000|Overall Study|Other|4|||
124474623|NCT00531960|447694194|FG001|Overall Study|Other|10|||
124474624|NCT01500057|447694195|FG000|Overall Study|Lost to Follow-up|6|||
124474625|NCT01500057|447694196|FG001|Overall Study|Lost to Follow-up|4|||
124474626|NCT01318122|447694200|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124474627|NCT01318122|447694201|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124474628|NCT01318122|447694202|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
124474629|NCT01318122|447694203|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
124474630|NCT01318122|447694200|FG000|Enrolled - Long-Term Extension Study|Other|1|||
124474631|NCT01318122|447694201|FG001|Enrolled - Long-Term Extension Study|Other|0|||
124474632|NCT01318122|447694202|FG002|Enrolled - Long-Term Extension Study|Other|0|||
124474633|NCT01318122|447694203|FG003|Enrolled - Long-Term Extension Study|Other|0|||
124474634|NCT01318122|447694200|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
124474635|NCT01318122|447694201|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
124474636|NCT01318122|447694202|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
124474637|NCT01318122|447694203|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
124474638|NCT01318122|447694200|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
124474639|NCT01318122|447694201|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124474640|NCT01318122|447694202|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124474641|NCT01318122|447694203|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
124474642|NCT01318122|447694200|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
124474643|NCT01318122|447694201|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
124474644|NCT01318122|447694202|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
124474645|NCT01318122|447694203|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
124474646|NCT01318122|447694200|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
124474647|NCT01318122|447694201|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
124474648|NCT01318122|447694202|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
124474649|NCT01318122|447694203|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
124474650|NCT01486199|447694204|FG000|Two Year Period Between Study Days|Physician Decision|1|||
124474651|NCT01486199|447694205|FG001|Two Year Period Between Study Days|Physician Decision|0|||
124474652|NCT01900002|447694218|FG000|Overall Study|Withdrawal by Subject|2|||
124718643|NCT02454530|448591304|FG001|Overall Study|Death|41|||
124718644|NCT02454530|448591303|FG000|Overall Study|Lost to Follow-up|4|||
124718645|NCT02454530|448591304|FG001|Overall Study|Lost to Follow-up|4|||
124718646|NCT03265145|448591305|FG000|Overall Study|Protocol Violation|2|||
124718647|NCT03265145|448591306|FG001|Overall Study|Protocol Violation|0|||
124718648|NCT03265145|448591305|FG000|Overall Study|Adverse Event|1|||
124718649|NCT03265145|448591306|FG001|Overall Study|Adverse Event|0|||
124718650|NCT03265145|448591305|FG000|Overall Study|Withdrawal by Subject|23|||
124718651|NCT03265145|448591306|FG001|Overall Study|Withdrawal by Subject|19|||
124556177|NCT01493531|447994156|FG001|Overall Study|Death|1|||
124718652|NCT03265145|448591305|FG000|Overall Study|Death|12|||
124718653|NCT03265145|448591306|FG001|Overall Study|Death|12|||
124718654|NCT03265145|448591305|FG000|Overall Study|Lost to Follow-up|13|||
124556178|NCT01493531|447994157|FG002|Overall Study|Death|0|||
124718655|NCT03265145|448591306|FG001|Overall Study|Lost to Follow-up|9|||
124718656|NCT03265145|448591305|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
124718657|NCT03265145|448591306|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
124771653|NCT01285323|448794530|FG000|Overall Study|Adverse Event|9|||
124474653|NCT01900002|447694218|FG000|Overall Study|ineligible for Y-90|4|||
124718658|NCT03265145|448591305|FG000|Overall Study|Switched back to previous medication|1|||
124718659|NCT03265145|448591306|FG001|Overall Study|Switched back to previous medication|0|||
124718660|NCT03265145|448591305|FG000|Overall Study|Did not want to take medication|1|||
124718661|NCT03265145|448591306|FG001|Overall Study|Did not want to take medication|0|||
124718662|NCT03265145|448591305|FG000|Overall Study|Subject could not afford medication|0|||
124718663|NCT03265145|448591306|FG001|Overall Study|Subject could not afford medication|1|||
124718664|NCT03265145|448591305|FG000|Overall Study|Site closed|2|||
124718665|NCT03265145|448591306|FG001|Overall Study|Site closed|3|||
124718666|NCT03265145|448591305|FG000|Overall Study|Incorrectly randomized|16|||
124474654|NCT02601573|447694227|FG000|Overall Study|Lost to Follow-up|0|||
124474655|NCT02601573|447694228|FG001|Overall Study|Lost to Follow-up|3|||
124474656|NCT02601573|447694229|FG002|Overall Study|Lost to Follow-up|1|||
124474657|NCT02601573|447694230|FG003|Overall Study|Lost to Follow-up|0|||
124474658|NCT02601573|447694231|FG004|Overall Study|Lost to Follow-up|2|||
124718667|NCT03265145|448591306|FG001|Overall Study|Incorrectly randomized|6|||
124771654|NCT01285323|448794531|FG001|Overall Study|Adverse Event|8|||
124718668|NCT03265145|448591305|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
124474659|NCT02601573|447694227|FG000|Overall Study|Withdrawal by Subject|0|||
124474660|NCT02601573|447694228|FG001|Overall Study|Withdrawal by Subject|1|||
124474661|NCT02601573|447694229|FG002|Overall Study|Withdrawal by Subject|0|||
124474662|NCT02601573|447694230|FG003|Overall Study|Withdrawal by Subject|1|||
124474663|NCT02601573|447694231|FG004|Overall Study|Withdrawal by Subject|0|||
124474664|NCT02921425|447694232|FG000|Overall Study|Protocol Violation|9|||
124474665|NCT03403400|447694233|FG000|Overall Study|Lost to Follow-up|1|||
124474666|NCT03403400|447694234|FG001|Overall Study|Lost to Follow-up|0|||
124474667|NCT03403400|447694235|FG002|Overall Study|Lost to Follow-up|1|||
124474668|NCT03403400|447694233|FG000|Overall Study|Hospitalization|1|||
124718669|NCT03265145|448591306|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
124718670|NCT03265145|448591305|FG000|Overall Study|Physician Decision|0|||
124718671|NCT03265145|448591306|FG001|Overall Study|Physician Decision|3|||
124718672|NCT03265145|448591305|FG000|Overall Study|Subject transferred to another facility|0|||
124474669|NCT03403400|447694234|FG001|Overall Study|Hospitalization|0|||
124474670|NCT03403400|447694235|FG002|Overall Study|Hospitalization|0|||
124474671|NCT03403400|447694233|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
124474672|NCT03403400|447694234|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
124474673|NCT03403400|447694235|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
124474674|NCT01384292|447694239|FG000|Part B|Severe non-compliance to protocol|1|||
124474675|NCT01384292|447694240|FG001|Part B|Severe non-compliance to protocol|0|||
124474676|NCT01384292|447694241|FG002|Part B|Severe non-compliance to protocol|0|||
124474677|NCT01171612|447694242|FG000|Overall Study|Lost to Follow-up|51|||
124474678|NCT00243659|447694243|FG000|Overall Study|Withdrawal by Subject|1|||
124556179|NCT01946282|447994158|FG000|Year 1|Did not return FIT kit|4186|||
124718673|NCT03265145|448591306|FG001|Overall Study|Subject transferred to another facility|1|||
124718674|NCT03159468|448591307|FG000|Overall Study|Withdrawal by Subject|0|||
124718675|NCT03159468|448591308|FG001|Overall Study|Withdrawal by Subject|0|||
124718676|NCT03159468|448591309|FG002|Overall Study|Withdrawal by Subject|3|||
124718677|NCT03159468|448591310|FG003|Overall Study|Withdrawal by Subject|0|||
124718678|NCT03159468|448591311|FG004|Overall Study|Withdrawal by Subject|0|||
124718679|NCT03159468|448591312|FG005|Overall Study|Withdrawal by Subject|0|||
124474679|NCT00243659|447694244|FG001|Overall Study|Withdrawal by Subject|1|||
124474680|NCT00243659|447694243|FG000|Overall Study|Protocol Violation|1|||
124474681|NCT00243659|447694244|FG001|Overall Study|Protocol Violation|2|||
124474682|NCT03310970|447694245|FG000|Overall Study|Withdrawal by Subject|0|||
124474683|NCT03310970|447694246|FG001|Overall Study|Withdrawal by Subject|1|||
124474684|NCT01273064|447694247|FG000|Overall Study|Adverse Event|5|||
124474685|NCT01273064|447694248|FG001|Overall Study|Adverse Event|1|||
124474686|NCT01273064|447694249|FG002|Overall Study|Adverse Event|3|||
124474687|NCT01273064|447694250|FG003|Overall Study|Adverse Event|2|||
124474688|NCT01273064|447694251|FG004|Overall Study|Adverse Event|1|||
124474689|NCT01273064|447694247|FG000|Overall Study|Withdrawal by Subject|4|||
124474690|NCT01273064|447694248|FG001|Overall Study|Withdrawal by Subject|2|||
124718680|NCT03280303|448592730|FG000|Overall Study|Death|505|||
124718681|NCT03280303|448592730|FG000|Overall Study|Study terminated by sponsor|383|||
124474691|NCT01273064|447694249|FG002|Overall Study|Withdrawal by Subject|2|||
124474692|NCT01273064|447694250|FG003|Overall Study|Withdrawal by Subject|2|||
124718682|NCT03280303|448592730|FG000|Overall Study|Other|148|||
124474693|NCT01273064|447694251|FG004|Overall Study|Withdrawal by Subject|0|||
124474694|NCT01273064|447694247|FG000|Overall Study|Study Termination|13|||
124718683|NCT03280303|448592730|FG000|Overall Study|No longer willing to participate in study|101|||
124474695|NCT01273064|447694248|FG001|Overall Study|Study Termination|27|||
124474696|NCT01273064|447694249|FG002|Overall Study|Study Termination|26|||
124474697|NCT01273064|447694250|FG003|Overall Study|Study Termination|16|||
124474698|NCT01273064|447694251|FG004|Overall Study|Study Termination|8|||
124474699|NCT01273064|447694247|FG000|Overall Study|Lost to Follow-up|1|||
124474700|NCT01273064|447694248|FG001|Overall Study|Lost to Follow-up|0|||
124474701|NCT01273064|447694249|FG002|Overall Study|Lost to Follow-up|0|||
124474702|NCT01273064|447694250|FG003|Overall Study|Lost to Follow-up|0|||
124474703|NCT01273064|447694251|FG004|Overall Study|Lost to Follow-up|0|||
124474704|NCT01273064|447694247|FG000|Overall Study|Physician Decision|0|||
124474705|NCT01273064|447694248|FG001|Overall Study|Physician Decision|0|||
124771655|NCT01285323|448794530|FG000|Overall Study|Lack of Efficacy|4|||
124474706|NCT01273064|447694249|FG002|Overall Study|Physician Decision|0|||
124474707|NCT01273064|447694250|FG003|Overall Study|Physician Decision|0|||
124474708|NCT01273064|447694251|FG004|Overall Study|Physician Decision|1|||
124474709|NCT04062214|447694252|FG000|Week 12|Death|1|||
124771656|NCT01285323|448794531|FG001|Overall Study|Lack of Efficacy|2|||
124474710|NCT04062214|447694253|FG001|Week 12|Death|1|||
124474711|NCT04062214|447694252|FG000|Week 12|Withdrawal by Subject|14|||
124474712|NCT04062214|447694253|FG001|Week 12|Withdrawal by Subject|13|||
124474713|NCT04062214|447694252|FG000|Week 12|Lost to Follow-up|55|||
124474714|NCT04062214|447694253|FG001|Week 12|Lost to Follow-up|68|||
124474715|NCT04062214|447694252|FG000|Week 12|Intermittent missing|31|||
124474716|NCT04062214|447694253|FG001|Week 12|Intermittent missing|29|||
124474717|NCT04062214|447694252|FG000|Week 36|Withdrawal by Subject|4|||
124474718|NCT04062214|447694253|FG001|Week 36|Withdrawal by Subject|5|||
124474719|NCT04062214|447694252|FG000|Week 36|Lost to Follow-up|50|||
124474720|NCT04062214|447694253|FG001|Week 36|Lost to Follow-up|46|||
124474721|NCT04062214|447694252|FG000|Week 36|Death|0|||
124474722|NCT04062214|447694253|FG001|Week 36|Death|1|||
124474723|NCT00291551|447694254|FG000|Overall Study|Death|7|||
124474724|NCT00291551|447694254|FG000|Overall Study|Withdrawal by Subject|6|||
124556180|NCT01946282|447994159|FG001|Year 1|Did not return FIT kit|608|||
124474725|NCT04666038|447694255|FG000|Overall Study|Progressive Disease|2|||
124474726|NCT04666038|447694256|FG001|Overall Study|Progressive Disease|0|||
124474727|NCT04666038|447694255|FG000|Overall Study|Death|38|||
124718684|NCT03280303|448592730|FG000|Overall Study|Lost to follow up|39|||
124718685|NCT03280303|448592730|FG000|Overall Study|Adverse Event|20|||
124718686|NCT02974140|448592737|FG000|Overall Study|Adverse Event|2|||
124718687|NCT02974140|448592737|FG000|Overall Study|Lost to Follow-up|1|||
124718688|NCT02974140|448592737|FG000|Overall Study|Study Terminated by Sponsor|36|||
124718689|NCT00617084|448592738|FG000|Overall Study|Withdrawal by Subject|5|||
124718690|NCT00617084|448592739|FG001|Overall Study|Withdrawal by Subject|7|||
124718691|NCT00617084|448592738|FG000|Overall Study|Missed 12 Months visit|16|||
124718692|NCT00617084|448592739|FG001|Overall Study|Missed 12 Months visit|19|||
124474728|NCT04666038|447694256|FG001|Overall Study|Death|32|||
124474729|NCT04666038|447694255|FG000|Overall Study|Withdrawal by Subject|10|||
124718693|NCT02222688|448592743|FG000|Overall Study|Withdrawal by Subject|0|||
124718694|NCT02222688|448592744|FG001|Overall Study|Withdrawal by Subject|0|||
124474730|NCT04666038|447694256|FG001|Overall Study|Withdrawal by Subject|19|||
124718695|NCT02222688|448592745|FG002|Overall Study|Withdrawal by Subject|0|||
124474731|NCT04666038|447694255|FG000|Overall Study|Lost to Follow-up|0|||
124474732|NCT04666038|447694256|FG001|Overall Study|Lost to Follow-up|2|||
124474733|NCT04666038|447694255|FG000|Overall Study|On Study Treatment|46|||
124474734|NCT04666038|447694256|FG001|Overall Study|On Study Treatment|5|||
124474735|NCT04666038|447694255|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
124474736|NCT04666038|447694256|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
124474737|NCT03887130|447694261|FG000|Overall Study|Progressive disease|23|||
124474738|NCT03887130|447694262|FG001|Overall Study|Progressive disease|14|||
124474739|NCT03887130|447694263|FG002|Overall Study|Progressive disease|7|||
124718696|NCT02222688|448592746|FG003|Overall Study|Withdrawal by Subject|2|||
124718697|NCT02222688|448592747|FG004|Overall Study|Withdrawal by Subject|1|||
124718698|NCT02222688|448592748|FG005|Overall Study|Withdrawal by Subject|0|||
124718699|NCT02222688|448592749|FG006|Overall Study|Withdrawal by Subject|1|||
124718700|NCT02222688|448592743|FG000|Overall Study|Disease progression|1|||
124718701|NCT02222688|448592744|FG001|Overall Study|Disease progression|0|||
124718702|NCT02222688|448592745|FG002|Overall Study|Disease progression|0|||
124718703|NCT02222688|448592746|FG003|Overall Study|Disease progression|0|||
124718704|NCT02222688|448592747|FG004|Overall Study|Disease progression|0|||
124718705|NCT02222688|448592748|FG005|Overall Study|Disease progression|0|||
124771657|NCT01285323|448794530|FG000|Overall Study|Withdrawal by Subject|15|||
124474740|NCT03887130|447694261|FG000|Overall Study|Protocol Violation|3|||
124474741|NCT03887130|447694262|FG001|Overall Study|Protocol Violation|1|||
124474742|NCT03887130|447694263|FG002|Overall Study|Protocol Violation|2|||
124474743|NCT03887130|447694261|FG000|Overall Study|Drug related toxicity|7|||
124474744|NCT03887130|447694262|FG001|Overall Study|Drug related toxicity|7|||
124718706|NCT02222688|448592749|FG006|Overall Study|Disease progression|0|||
124474745|NCT03887130|447694263|FG002|Overall Study|Drug related toxicity|13|||
124718707|NCT02522429|448592758|FG000|Overall Study|Lost to Follow-up|8|||
124718708|NCT02522429|448592758|FG000|Overall Study|Adverse Event|2|||
124556181|NCT01946282|447994160|FG002|Year 1|Did not return FIT kit|654|||
124718709|NCT02522429|448592758|FG000|Overall Study|Death|1|||
124718710|NCT02522429|448592758|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
124718711|NCT00958360|448592762|FG000|Overall Study|Withdrawal by Subject|3|||
124718712|NCT00958360|448592763|FG001|Overall Study|Withdrawal by Subject|1|||
124718713|NCT00958360|448592762|FG000|Overall Study|Death|6|||
124718714|NCT00958360|448592763|FG001|Overall Study|Death|7|||
124718715|NCT00958360|448592762|FG000|Overall Study|Physician Decision|2|||
124718716|NCT00958360|448592763|FG001|Overall Study|Physician Decision|1|||
124718717|NCT00958360|448592762|FG000|Overall Study|Lost to Follow-up|0|||
124718718|NCT00958360|448592763|FG001|Overall Study|Lost to Follow-up|1|||
124718719|NCT00500357|448592764|FG000|Overall Study|Death|1|||
124718720|NCT00078806|448592765|FG000|Part 1A|Adverse Event|2|||
124718721|NCT00078806|448592766|FG001|Part 1A|Adverse Event|0|||
124718722|NCT00078806|448592767|FG002|Part 1A|Adverse Event|0|||
124718723|NCT00078806|448592768|FG003|Part 1A|Adverse Event|0|||
124718724|NCT00078806|448592765|FG000|Part 1A|Lack of Efficacy|7|||
124718725|NCT00078806|448592766|FG001|Part 1A|Lack of Efficacy|0|||
124718726|NCT00078806|448592767|FG002|Part 1A|Lack of Efficacy|0|||
124718727|NCT00078806|448592768|FG003|Part 1A|Lack of Efficacy|0|||
124718728|NCT00078806|448592765|FG000|Part 1A|Other|1|||
124718729|NCT00078806|448592766|FG001|Part 1A|Other|0|||
124718730|NCT00078806|448592767|FG002|Part 1A|Other|0|||
124718731|NCT00078806|448592768|FG003|Part 1A|Other|0|||
124718732|NCT00078806|448592765|FG000|Part 1B|Adverse Event|1|||
124718733|NCT00078806|448592766|FG001|Part 1B|Adverse Event|0|||
124718734|NCT00078806|448592767|FG002|Part 1B|Adverse Event|0|||
124718735|NCT00078806|448592768|FG003|Part 1B|Adverse Event|0|||
124718736|NCT00078806|448592765|FG000|Part 1B|Lack of Efficacy|7|||
124718737|NCT00078806|448592766|FG001|Part 1B|Lack of Efficacy|0|||
124718738|NCT00078806|448592767|FG002|Part 1B|Lack of Efficacy|0|||
124718739|NCT00078806|448592768|FG003|Part 1B|Lack of Efficacy|0|||
124718740|NCT00078806|448592765|FG000|Part 2|Adverse Event|0|||
124718741|NCT00078806|448592766|FG001|Part 2|Adverse Event|1|||
124718742|NCT00078806|448592767|FG002|Part 2|Adverse Event|0|||
124718743|NCT00078806|448592768|FG003|Part 2|Adverse Event|0|||
124718744|NCT01734785|448592769|FG000|Open-Label Period|Adverse Event|0|||
124718745|NCT01734785|448592770|FG001|Open-Label Period|Adverse Event|0|||
124718746|NCT01734785|448592771|FG002|Open-Label Period|Adverse Event|0|||
124718747|NCT01734785|448592772|FG003|Open-Label Period|Adverse Event|9|||
124718748|NCT01734785|448592769|FG000|Open-Label Period|Lack of Efficacy|0|||
124718749|NCT01734785|448592770|FG001|Open-Label Period|Lack of Efficacy|0|||
124718750|NCT01734785|448592771|FG002|Open-Label Period|Lack of Efficacy|0|||
124718751|NCT01734785|448592772|FG003|Open-Label Period|Lack of Efficacy|1|||
124718752|NCT01734785|448592769|FG000|Open-Label Period|Protocol Violation|0|||
124718753|NCT01734785|448592770|FG001|Open-Label Period|Protocol Violation|0|||
124718754|NCT01734785|448592771|FG002|Open-Label Period|Protocol Violation|0|||
124718755|NCT01734785|448592772|FG003|Open-Label Period|Protocol Violation|13|||
124718756|NCT01734785|448592769|FG000|Open-Label Period|Lost to Follow-up|0|||
124474746|NCT03887130|447694261|FG000|Overall Study|Non drug related toxicity|3|||
124474747|NCT03887130|447694262|FG001|Overall Study|Non drug related toxicity|0|||
124474748|NCT03887130|447694263|FG002|Overall Study|Non drug related toxicity|0|||
124474749|NCT03887130|447694261|FG000|Overall Study|Death|2|||
124474750|NCT03887130|447694262|FG001|Overall Study|Death|2|||
124474751|NCT03887130|447694263|FG002|Overall Study|Death|1|||
124474752|NCT03887130|447694261|FG000|Overall Study|Withdrawal by Subject|7|||
124474753|NCT03887130|447694262|FG001|Overall Study|Withdrawal by Subject|6|||
124474754|NCT03887130|447694263|FG002|Overall Study|Withdrawal by Subject|11|||
124556182|NCT01946282|447994158|FG000|Year 2|Did not return FIT kit|803|||
124556183|NCT01946282|447994159|FG001|Year 2|Did not return FIT kit|131|||
124556184|NCT01946282|447994160|FG002|Year 2|Did not return FIT kit|115|||
124556185|NCT01946282|447994158|FG000|Year 3|Did not return FIT kit|288|||
124556186|NCT01946282|447994159|FG001|Year 3|Did not return FIT kit|43|||
124556187|NCT01946282|447994160|FG002|Year 3|Did not return FIT kit|30|||
124556188|NCT03031431|447994163|FG000|Overall Study|Infant removed by maternal request|1|||
124556189|NCT01205529|447994164|FG000|Overall Study|Procedure Cancelled|4|||
124556190|NCT01205529|447994164|FG000|Overall Study|Withdrawal by Subject|2|||
124556191|NCT01205529|447994164|FG000|Overall Study|Physician Decision|4|||
124556192|NCT01205529|447994164|FG000|Overall Study|Unstable post op|15|||
124556193|NCT01205529|447994164|FG000|Overall Study|No longer met criteria|30|||
124556194|NCT01027884|447994168|FG000|Overall Study|Adverse Event|2|||
124556195|NCT01027884|447994169|FG001|Overall Study|Adverse Event|1|||
124556196|NCT01027884|447994168|FG000|Overall Study|Protocol Violation|1|||
124556197|NCT01027884|447994169|FG001|Overall Study|Protocol Violation|0|||
124556198|NCT01027884|447994168|FG000|Overall Study|Non-compliance|1|||
124556199|NCT01027884|447994169|FG001|Overall Study|Non-compliance|1|||
124556200|NCT01027884|447994168|FG000|Overall Study|Withdrawal by Subject|0|||
124556201|NCT01027884|447994169|FG001|Overall Study|Withdrawal by Subject|1|||
124556202|NCT01027884|447994168|FG000|Overall Study|Lost to Follow-up|0|||
124556203|NCT01027884|447994169|FG001|Overall Study|Lost to Follow-up|1|||
124556204|NCT01027884|447994168|FG000|Overall Study|Spinal fixation surgery|0|||
124556205|NCT01027884|447994169|FG001|Overall Study|Spinal fixation surgery|3|||
124556206|NCT03670537|447994171|FG000|Overall Study|Protocol Violation|1|||
124556207|NCT02059187|447994172|FG000|Overall Study|Adverse Event|0|||
124556208|NCT02059187|447994173|FG001|Overall Study|Adverse Event|3|||
124556209|NCT02059187|447994172|FG000|Overall Study|Death|1|||
124556210|NCT02059187|447994173|FG001|Overall Study|Death|1|||
124556211|NCT02059187|447994172|FG000|Overall Study|Lost to Follow-up|9|||
124718757|NCT01734785|448592770|FG001|Open-Label Period|Lost to Follow-up|0|||
124718758|NCT01734785|448592771|FG002|Open-Label Period|Lost to Follow-up|0|||
124718759|NCT01734785|448592772|FG003|Open-Label Period|Lost to Follow-up|14|||
124718760|NCT01734785|448592769|FG000|Open-Label Period|Withdrawal by Subject|0|||
124718761|NCT01734785|448592770|FG001|Open-Label Period|Withdrawal by Subject|0|||
124718762|NCT01734785|448592771|FG002|Open-Label Period|Withdrawal by Subject|0|||
124718763|NCT01734785|448592772|FG003|Open-Label Period|Withdrawal by Subject|12|||
124718764|NCT01734785|448592769|FG000|Open-Label Period|Other Reasons|0|||
124556212|NCT02059187|447994173|FG001|Overall Study|Lost to Follow-up|8|||
124771658|NCT01285323|448794531|FG001|Overall Study|Withdrawal by Subject|11|||
124474755|NCT03887130|447694261|FG000|Overall Study|other reason|6|||
124556213|NCT02059187|447994172|FG000|Overall Study|Non-compliance with study drug|1|||
124556214|NCT02059187|447994173|FG001|Overall Study|Non-compliance with study drug|0|||
124556215|NCT02059187|447994172|FG000|Overall Study|Physician Decision|1|||
124556216|NCT02059187|447994173|FG001|Overall Study|Physician Decision|2|||
124556217|NCT02059187|447994172|FG000|Overall Study|Protocol Violation|1|||
124718765|NCT01734785|448592770|FG001|Open-Label Period|Other Reasons|0|||
124718766|NCT01734785|448592771|FG002|Open-Label Period|Other Reasons|0|||
124718767|NCT01734785|448592772|FG003|Open-Label Period|Other Reasons|224|||
124718768|NCT01734785|448592769|FG000|Double-Blind Period|Adverse Event|0|||
124718769|NCT01734785|448592770|FG001|Double-Blind Period|Adverse Event|3|||
124718770|NCT01734785|448592771|FG002|Double-Blind Period|Adverse Event|2|||
124718771|NCT01734785|448592772|FG003|Double-Blind Period|Adverse Event|0|||
124474756|NCT03887130|447694262|FG001|Overall Study|other reason|20|||
124474757|NCT03887130|447694263|FG002|Overall Study|other reason|17|||
124474758|NCT04082663|447694264|FG000|Overall Study|Adverse Event|6|||
124474759|NCT04082663|447694264|FG000|Overall Study|Lost to Follow-up|1|||
124474760|NCT01752023|447694265|FG000|Overall Study|Physician Decision|2|||
124474761|NCT01752023|447694266|FG001|Overall Study|Physician Decision|1|||
124474762|NCT02899156|447694267|FG000|Overall Study|Death|1|||
124474763|NCT02899156|447694268|FG001|Overall Study|Death|0|||
124474764|NCT02899156|447694267|FG000|Overall Study|Physician Decision|0|||
124474765|NCT02899156|447694268|FG001|Overall Study|Physician Decision|1|||
124474766|NCT00787787|447694272|FG000|Overall Study|Lack of Efficacy|4|||
124474767|NCT00787787|447694272|FG000|Overall Study|Adverse Event|3|||
124474768|NCT01412957|447694273|FG000|Overall Study|Withdrawal by Subject|6|||
124474769|NCT01412957|447694274|FG001|Overall Study|Withdrawal by Subject|22|||
124474770|NCT01412957|447694273|FG000|Overall Study|Lost to Follow-up|7|||
124474771|NCT01412957|447694274|FG001|Overall Study|Lost to Follow-up|2|||
124474772|NCT01412957|447694273|FG000|Overall Study|Death|136|||
124474773|NCT01412957|447694274|FG001|Overall Study|Death|133|||
124474774|NCT04722991|447694275|FG000|Overall Study|Adverse Event|12|||
124474775|NCT04722991|447694276|FG001|Overall Study|Adverse Event|4|||
124474776|NCT04722991|447694275|FG000|Overall Study|Death|2|||
124474777|NCT04722991|447694276|FG001|Overall Study|Death|0|||
124474778|NCT04722991|447694275|FG000|Overall Study|Lost to Follow-up|1|||
124474779|NCT04722991|447694276|FG001|Overall Study|Lost to Follow-up|1|||
124474780|NCT04722991|447694275|FG000|Overall Study|Withdrawal cirterion met|2|||
124474781|NCT04722991|447694276|FG001|Overall Study|Withdrawal cirterion met|2|||
124474782|NCT04722991|447694275|FG000|Overall Study|Other|1|||
124474783|NCT04722991|447694276|FG001|Overall Study|Other|0|||
124474784|NCT04722991|447694275|FG000|Overall Study|Non-compliance|0|||
124474785|NCT04722991|447694276|FG001|Overall Study|Non-compliance|1|||
124474786|NCT04722991|447694275|FG000|Overall Study|Withdrawal by Subject|0|||
124474787|NCT04722991|447694276|FG001|Overall Study|Withdrawal by Subject|1|||
124474788|NCT01400932|447695982|FG000|Overall Study|Adverse Event|10|||
124474789|NCT01400932|447695983|FG001|Overall Study|Adverse Event|5|||
124474790|NCT01400932|447695982|FG000|Overall Study|Lack of Efficacy|0|||
124474791|NCT01400932|447695983|FG001|Overall Study|Lack of Efficacy|3|||
124474792|NCT01400932|447695982|FG000|Overall Study|Withdrawal by Subject|2|||
124718772|NCT01734785|448592769|FG000|Double-Blind Period|Lack of Efficacy|0|||
124718773|NCT01734785|448592770|FG001|Double-Blind Period|Lack of Efficacy|1|||
124718774|NCT01734785|448592771|FG002|Double-Blind Period|Lack of Efficacy|0|||
124718775|NCT01734785|448592772|FG003|Double-Blind Period|Lack of Efficacy|0|||
124771659|NCT01285323|448794530|FG000|Overall Study|Protocol Violation|1|||
124474793|NCT01400932|447695983|FG001|Overall Study|Withdrawal by Subject|6|||
124474794|NCT01400932|447695982|FG000|Overall Study|Lost to Follow-up|1|||
124474795|NCT01400932|447695983|FG001|Overall Study|Lost to Follow-up|0|||
124718776|NCT01734785|448592769|FG000|Double-Blind Period|Protocol Violation|0|||
124474796|NCT01400932|447695982|FG000|Overall Study|Protocol Deviation|0|||
124474797|NCT01400932|447695983|FG001|Overall Study|Protocol Deviation|1|||
124474798|NCT01400932|447695982|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
124474799|NCT01400932|447695983|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
124474800|NCT03244059|447696000|FG000|Specific Aim 1|Physician Decision|1|||
124474801|NCT03244059|447696001|FG001|Specific Aim 1|Physician Decision|0|||
124474802|NCT03244059|447696000|FG000|Specific Aim 2|Physician Decision|1|||
124474803|NCT03244059|447696001|FG001|Specific Aim 2|Physician Decision|0|||
124474804|NCT01276821|447696002|FG000|Overall Study|Protocol Violation|0|||
124474805|NCT01276821|447696003|FG001|Overall Study|Protocol Violation|1|||
124474806|NCT03706365|447696005|FG000|Overall Study|Lost to Follow-up|7|||
124474807|NCT03706365|447696006|FG001|Overall Study|Lost to Follow-up|0|||
124474808|NCT03706365|447696005|FG000|Overall Study|Withdrawal by Subject|17|||
124474809|NCT03706365|447696006|FG001|Overall Study|Withdrawal by Subject|15|||
124474810|NCT03706365|447696005|FG000|Overall Study|On Study Treatment|51|||
124474811|NCT03706365|447696006|FG001|Overall Study|On Study Treatment|51|||
124474812|NCT02162862|447696007|FG000|Overall Study|Lost to Follow-up|0|||
124474813|NCT02162862|447696008|FG001|Overall Study|Lost to Follow-up|11|||
124474814|NCT02162862|447696009|FG002|Overall Study|Lost to Follow-up|0|||
124474815|NCT02162862|447696007|FG000|Overall Study|Subject did not feel the med was needed|0|||
124474816|NCT02162862|447696008|FG001|Overall Study|Subject did not feel the med was needed|0|||
124474817|NCT02162862|447696009|FG002|Overall Study|Subject did not feel the med was needed|4|||
124474818|NCT03116113|447696010|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
124474819|NCT03116113|447696011|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
124474820|NCT03116113|447696012|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
124474821|NCT03116113|447696013|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
124474822|NCT03116113|447696014|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
124474823|NCT03116113|447696015|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
124474824|NCT03116113|447696016|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
124474825|NCT03116113|447696017|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
124474826|NCT03116113|447696018|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
124474827|NCT05195528|447696020|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
124474828|NCT05195528|447696021|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
124474829|NCT05195528|447696022|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
124474830|NCT05195528|447696023|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
124474831|NCT05195528|447696024|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
124771660|NCT01285323|448794531|FG001|Overall Study|Protocol Violation|2|||
124771661|NCT01285323|448794530|FG000|Overall Study|Non-compliance with study procedures|2|||
124718777|NCT01734785|448592770|FG001|Double-Blind Period|Protocol Violation|1|||
124718778|NCT01734785|448592771|FG002|Double-Blind Period|Protocol Violation|1|||
124718779|NCT01734785|448592772|FG003|Double-Blind Period|Protocol Violation|0|||
124718780|NCT01734785|448592769|FG000|Double-Blind Period|Lost to Follow-up|2|||
124718781|NCT01734785|448592770|FG001|Double-Blind Period|Lost to Follow-up|4|||
124718782|NCT01734785|448592771|FG002|Double-Blind Period|Lost to Follow-up|2|||
124718783|NCT01734785|448592772|FG003|Double-Blind Period|Lost to Follow-up|0|||
124718784|NCT01734785|448592769|FG000|Double-Blind Period|Withdrawal by Subject|2|||
124718785|NCT01734785|448592770|FG001|Double-Blind Period|Withdrawal by Subject|0|||
124718786|NCT01734785|448592771|FG002|Double-Blind Period|Withdrawal by Subject|0|||
124718787|NCT01734785|448592772|FG003|Double-Blind Period|Withdrawal by Subject|0|||
124718788|NCT01734785|448592769|FG000|Double-Blind Period|Not treated|1|||
124718789|NCT01734785|448592770|FG001|Double-Blind Period|Not treated|0|||
124718790|NCT01734785|448592771|FG002|Double-Blind Period|Not treated|0|||
124718791|NCT01734785|448592772|FG003|Double-Blind Period|Not treated|0|||
124556218|NCT02059187|447994173|FG001|Overall Study|Protocol Violation|0|||
124474832|NCT05195528|447696020|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
124474833|NCT05195528|447696021|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
124474834|NCT05195528|447696022|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
124474835|NCT05195528|447696023|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
124474836|NCT05195528|447696024|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
124474837|NCT05195528|447696020|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
124474838|NCT05195528|447696021|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
124474839|NCT05195528|447696022|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
124718792|NCT00161616|448592773|FG000|Overall Study|Withdrawal by Subject|6|||
124718793|NCT00161616|448592774|FG001|Overall Study|Withdrawal by Subject|5|||
124474840|NCT05195528|447696023|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
124474841|NCT05195528|447696024|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
124474842|NCT05195528|447696020|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
124474843|NCT05195528|447696021|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
124474844|NCT05195528|447696022|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
124474845|NCT05195528|447696023|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
124474846|NCT05195528|447696024|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
124474847|NCT05195528|447696020|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
124718794|NCT00161616|448592773|FG000|Overall Study|Physician Decision|1|||
124718795|NCT00161616|448592774|FG001|Overall Study|Physician Decision|0|||
124718796|NCT00161616|448592773|FG000|Overall Study|Death|1|||
124474848|NCT05195528|447696021|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
124474849|NCT05195528|447696022|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
124474850|NCT05195528|447696023|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
124474851|NCT05195528|447696024|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
124474852|NCT05195528|447696020|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
124474853|NCT05195528|447696021|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
124718797|NCT00161616|448592774|FG001|Overall Study|Death|1|||
124474854|NCT05195528|447696022|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
124474855|NCT05195528|447696023|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
124474856|NCT05195528|447696024|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
124474857|NCT05195528|447696020|FG000|Placebo-controlled Treatment Period|Other|0|||
124474858|NCT05195528|447696021|FG001|Placebo-controlled Treatment Period|Other|0|||
124474859|NCT05195528|447696022|FG002|Placebo-controlled Treatment Period|Other|1|||
124474860|NCT05195528|447696023|FG003|Placebo-controlled Treatment Period|Other|0|||
124718798|NCT00161616|448592773|FG000|Overall Study|Lost to Follow-up|17|||
124474861|NCT05195528|447696024|FG004|Placebo-controlled Treatment Period|Other|0|||
124474862|NCT05195528|447696020|FG000|Extension Period|PTE or AE or SAE|0|||
124474863|NCT05195528|447696021|FG001|Extension Period|PTE or AE or SAE|4|||
124718799|NCT00161616|448592774|FG001|Overall Study|Lost to Follow-up|13|||
124718800|NCT00161616|448592773|FG000|Overall Study|Protocol deviation|1|||
124718801|NCT00161616|448592774|FG001|Overall Study|Protocol deviation|0|||
124474864|NCT05195528|447696022|FG002|Extension Period|PTE or AE or SAE|5|||
124718802|NCT00854724|448592775|FG000|First Intervention|Withdrawal by Subject|1|||
124718803|NCT00854724|448592776|FG001|First Intervention|Withdrawal by Subject|1|||
124718804|NCT00854724|448592775|FG000|Washout|Protocol Violation|1|||
124474865|NCT05195528|447696023|FG003|Extension Period|PTE or AE or SAE|4|||
124556219|NCT02059187|447994172|FG000|Overall Study|Withdrawal by Subject|12|||
124556220|NCT02059187|447994173|FG001|Overall Study|Withdrawal by Subject|8|||
124771662|NCT01285323|448794531|FG001|Overall Study|Non-compliance with study procedures|3|||
124771663|NCT01285323|448794530|FG000|Overall Study|Lost to Follow-up|1|||
124771664|NCT01285323|448794531|FG001|Overall Study|Lost to Follow-up|1|||
124771665|NCT01285323|448794530|FG000|Overall Study|Other|1|||
124771666|NCT01285323|448794531|FG001|Overall Study|Other|3|||
124771667|NCT02703597|448794532|FG000|Assignment to Baseline|Lost to Follow-up|17|||
124771668|NCT02703597|448794533|FG001|Assignment to Baseline|Lost to Follow-up|16|||
124771669|NCT02703597|448794532|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
124771670|NCT02703597|448794533|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
124771671|NCT02703597|448794532|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
124771672|NCT02703597|448794533|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
124771673|NCT02703597|448794532|FG000|First Post-test to First Follow-up|Site drop out|0|||
124771674|NCT02703597|448794533|FG001|First Post-test to First Follow-up|Site drop out|58|||
124771675|NCT02703597|448794532|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
124771676|NCT02703597|448794533|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
124771677|NCT02703597|448794532|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
124771678|NCT02703597|448794533|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
124771679|NCT02703597|448794532|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
124771680|NCT02703597|448794533|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
124771681|NCT02606643|448794534|FG000|Overall Study|did not meet inclusion criteria|1|||
124771682|NCT02606643|448794535|FG001|Overall Study|did not meet inclusion criteria|3|||
124771683|NCT02796170|448794537|FG000|Overall Study|Lost to Follow-up|3|||
124771684|NCT02796170|448794538|FG001|Overall Study|Lost to Follow-up|0|||
124771685|NCT04313244|448794542|FG000|Overall Study|Withdrawal of Consent|3|||
124771686|NCT04313244|448794543|FG001|Overall Study|Withdrawal of Consent|3|||
124771687|NCT04313244|448794542|FG000|Overall Study|Met Exclusion Criteria|1|||
124771688|NCT04313244|448794543|FG001|Overall Study|Met Exclusion Criteria|0|||
124771689|NCT04313244|448794542|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
124771690|NCT04313244|448794543|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
124771691|NCT01472289|448794546|FG000|Overall Study|Death|2|||
124718805|NCT00854724|448592776|FG001|Washout|Protocol Violation|0|||
124718806|NCT00854724|448592775|FG000|Washout|Withdrawal by Subject|0|||
124556221|NCT03070431|447994174|FG000|Overall Study|Withdrawal by Subject|2|||
124718807|NCT00854724|448592776|FG001|Washout|Withdrawal by Subject|1|||
124718808|NCT00854724|448592775|FG000|Second Intervention|Protocol Violation|1|||
124718809|NCT00854724|448592776|FG001|Second Intervention|Protocol Violation|0|||
124718810|NCT00854724|448592775|FG000|Second Intervention|Physician Decision|0|||
124474866|NCT05195528|447696024|FG004|Extension Period|PTE or AE or SAE|4|||
124474867|NCT05195528|447696020|FG000|Extension Period|Protocol Violation|0|||
124474868|NCT05195528|447696021|FG001|Extension Period|Protocol Violation|2|||
124474869|NCT05195528|447696022|FG002|Extension Period|Protocol Violation|1|||
124474870|NCT05195528|447696023|FG003|Extension Period|Protocol Violation|0|||
124474871|NCT05195528|447696024|FG004|Extension Period|Protocol Violation|1|||
124474872|NCT05195528|447696020|FG000|Extension Period|Lost to Follow-up|0|||
124474873|NCT05195528|447696021|FG001|Extension Period|Lost to Follow-up|6|||
124474874|NCT05195528|447696022|FG002|Extension Period|Lost to Follow-up|13|||
124474875|NCT05195528|447696023|FG003|Extension Period|Lost to Follow-up|3|||
124474876|NCT05195528|447696024|FG004|Extension Period|Lost to Follow-up|7|||
124474877|NCT05195528|447696020|FG000|Extension Period|Withdrawal by Subject|0|||
124474878|NCT05195528|447696021|FG001|Extension Period|Withdrawal by Subject|12|||
124474879|NCT05195528|447696022|FG002|Extension Period|Withdrawal by Subject|9|||
124474880|NCT05195528|447696023|FG003|Extension Period|Withdrawal by Subject|6|||
124474881|NCT05195528|447696024|FG004|Extension Period|Withdrawal by Subject|5|||
124474882|NCT05195528|447696020|FG000|Extension Period|Lack of Efficacy|0|||
124474883|NCT05195528|447696021|FG001|Extension Period|Lack of Efficacy|3|||
124718811|NCT00854724|448592776|FG001|Second Intervention|Physician Decision|1|||
124474884|NCT05195528|447696022|FG002|Extension Period|Lack of Efficacy|0|||
124474885|NCT05195528|447696023|FG003|Extension Period|Lack of Efficacy|0|||
124474886|NCT05195528|447696024|FG004|Extension Period|Lack of Efficacy|2|||
124474887|NCT05195528|447696020|FG000|Extension Period|Not Treated|0|||
124556222|NCT03070431|447994174|FG000|Overall Study|Lost to Follow-up|2|||
124556223|NCT01889862|447994175|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
124556224|NCT01889862|447994176|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
124556225|NCT01889862|447994177|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
124556226|NCT01889862|447994178|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
124556227|NCT01889862|447994179|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
124556228|NCT01889862|447994175|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
124556229|NCT01889862|447994176|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
124556230|NCT01889862|447994177|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
124556231|NCT01889862|447994178|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
124556232|NCT01889862|447994179|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
124556233|NCT01889862|447994175|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
124556234|NCT01889862|447994176|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
124556235|NCT01889862|447994177|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
124556236|NCT01889862|447994178|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
124556237|NCT01889862|447994179|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
124556238|NCT01889862|447994175|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
124556239|NCT01889862|447994176|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
124556240|NCT01889862|447994177|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
124556241|NCT01889862|447994178|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
124556242|NCT01889862|447994179|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
124556243|NCT01889862|447994175|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
124556244|NCT01889862|447994176|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
124556245|NCT01889862|447994177|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
124556246|NCT01889862|447994178|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
124556247|NCT01889862|447994179|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
124556248|NCT01889862|447994175|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
124556249|NCT01889862|447994176|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
124556250|NCT01889862|447994177|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
124556251|NCT01889862|447994178|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
124556252|NCT01889862|447994179|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
124556253|NCT01889862|447994175|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
124556254|NCT01889862|447994176|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
124556255|NCT01889862|447994177|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
124556256|NCT01889862|447994178|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
124556257|NCT01889862|447994179|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
124556258|NCT01889862|447994175|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
124556259|NCT01889862|447994176|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
124474888|NCT05195528|447696021|FG001|Extension Period|Not Treated|0|||
124474889|NCT05195528|447696022|FG002|Extension Period|Not Treated|2|||
124474890|NCT05195528|447696023|FG003|Extension Period|Not Treated|3|||
124474891|NCT05195528|447696024|FG004|Extension Period|Not Treated|0|||
124474892|NCT05195528|447696020|FG000|Extension Period|Other|0|||
124474893|NCT05195528|447696021|FG001|Extension Period|Other|1|||
124474894|NCT05195528|447696022|FG002|Extension Period|Other|1|||
124556260|NCT01889862|447994177|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
124556261|NCT01889862|447994178|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
124556262|NCT01889862|447994179|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
124474895|NCT05195528|447696023|FG003|Extension Period|Other|0|||
124474896|NCT05195528|447696024|FG004|Extension Period|Other|0|||
124474897|NCT01552902|447696025|FG000|Overall Study|Adverse Event|1|||
124474898|NCT01552902|447696026|FG001|Overall Study|Adverse Event|15|||
124556263|NCT01889862|447994175|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
124556264|NCT01889862|447994176|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
124556265|NCT01889862|447994177|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
124718812|NCT00861757|448592778|FG000|Overall Study|Adverse Event|1|||
124718813|NCT00861757|448592779|FG001|Overall Study|Adverse Event|5|||
124718814|NCT00861757|448592780|FG002|Overall Study|Adverse Event|7|||
124718815|NCT00861757|448592781|FG003|Overall Study|Adverse Event|2|||
124718816|NCT00861757|448592778|FG000|Overall Study|Entry Criteria Not Met|1|||
124718817|NCT00861757|448592779|FG001|Overall Study|Entry Criteria Not Met|2|||
124718818|NCT00861757|448592780|FG002|Overall Study|Entry Criteria Not Met|1|||
124718819|NCT00861757|448592781|FG003|Overall Study|Entry Criteria Not Met|1|||
124718820|NCT00861757|448592778|FG000|Overall Study|Lack of Efficacy|3|||
124718821|NCT00861757|448592779|FG001|Overall Study|Lack of Efficacy|1|||
124718822|NCT00861757|448592780|FG002|Overall Study|Lack of Efficacy|0|||
124474899|NCT01552902|447696027|FG002|Overall Study|Adverse Event|14|||
124474900|NCT01552902|447696025|FG000|Overall Study|Protocol Violation|3|||
124474901|NCT01552902|447696026|FG001|Overall Study|Protocol Violation|3|||
124474902|NCT01552902|447696027|FG002|Overall Study|Protocol Violation|3|||
124474903|NCT01552902|447696025|FG000|Overall Study|Lack of Efficacy|4|||
124474904|NCT01552902|447696026|FG001|Overall Study|Lack of Efficacy|3|||
124474905|NCT01552902|447696027|FG002|Overall Study|Lack of Efficacy|1|||
124474906|NCT01552902|447696025|FG000|Overall Study|Withdrawal by Subject|1|||
124474907|NCT01552902|447696026|FG001|Overall Study|Withdrawal by Subject|9|||
124474908|NCT01552902|447696027|FG002|Overall Study|Withdrawal by Subject|6|||
124474909|NCT01552902|447696025|FG000|Overall Study|Lost to Follow-up|1|||
124474910|NCT01552902|447696026|FG001|Overall Study|Lost to Follow-up|3|||
124474911|NCT01552902|447696027|FG002|Overall Study|Lost to Follow-up|6|||
124474912|NCT01552902|447696025|FG000|Overall Study|Other|3|||
124474913|NCT01552902|447696026|FG001|Overall Study|Other|4|||
124474914|NCT01552902|447696027|FG002|Overall Study|Other|3|||
124474915|NCT02487108|447696028|FG000|Overall Study|Adverse Event|1|||
124474916|NCT02487108|447696029|FG001|Overall Study|Adverse Event|6|||
124474917|NCT02487108|447696030|FG002|Overall Study|Adverse Event|12|||
124718823|NCT00861757|448592781|FG003|Overall Study|Lack of Efficacy|1|||
124474918|NCT02487108|447696031|FG003|Overall Study|Adverse Event|6|||
124474919|NCT02487108|447696028|FG000|Overall Study|Withdrawal by Subject|8|||
124474920|NCT02487108|447696029|FG001|Overall Study|Withdrawal by Subject|5|||
124474921|NCT02487108|447696030|FG002|Overall Study|Withdrawal by Subject|5|||
124718824|NCT00861757|448592778|FG000|Overall Study|Lost to Follow-up|1|||
124718825|NCT00861757|448592779|FG001|Overall Study|Lost to Follow-up|0|||
124718826|NCT00861757|448592780|FG002|Overall Study|Lost to Follow-up|1|||
124718827|NCT00861757|448592781|FG003|Overall Study|Lost to Follow-up|1|||
124718828|NCT00861757|448592778|FG000|Overall Study|Physician Decision|0|||
124718829|NCT00861757|448592779|FG001|Overall Study|Physician Decision|0|||
124718830|NCT00861757|448592780|FG002|Overall Study|Physician Decision|0|||
124474922|NCT02487108|447696031|FG003|Overall Study|Withdrawal by Subject|0|||
124474923|NCT02487108|447696028|FG000|Overall Study|Non-compliance to study medication|3|||
124474924|NCT02487108|447696029|FG001|Overall Study|Non-compliance to study medication|2|||
124474925|NCT02487108|447696030|FG002|Overall Study|Non-compliance to study medication|5|||
124474926|NCT02487108|447696031|FG003|Overall Study|Non-compliance to study medication|4|||
124474927|NCT02487108|447696028|FG000|Overall Study|Protocol Violation|1|||
124474928|NCT02487108|447696029|FG001|Overall Study|Protocol Violation|1|||
124474929|NCT02487108|447696030|FG002|Overall Study|Protocol Violation|2|||
124474930|NCT02487108|447696031|FG003|Overall Study|Protocol Violation|0|||
124474931|NCT02487108|447696028|FG000|Overall Study|Non-compliance to study procedures|0|||
124474932|NCT02487108|447696029|FG001|Overall Study|Non-compliance to study procedures|0|||
124718831|NCT00861757|448592781|FG003|Overall Study|Physician Decision|1|||
124718832|NCT00861757|448592778|FG000|Overall Study|Protocol Violation|2|||
124474933|NCT02487108|447696030|FG002|Overall Study|Non-compliance to study procedures|0|||
124474934|NCT02487108|447696031|FG003|Overall Study|Non-compliance to study procedures|1|||
124474935|NCT02487108|447696028|FG000|Overall Study|Other than specified|3|||
124474936|NCT02487108|447696029|FG001|Overall Study|Other than specified|2|||
124718833|NCT00861757|448592779|FG001|Overall Study|Protocol Violation|2|||
124718834|NCT00861757|448592780|FG002|Overall Study|Protocol Violation|4|||
124718835|NCT00861757|448592781|FG003|Overall Study|Protocol Violation|1|||
124718836|NCT00861757|448592778|FG000|Overall Study|Withdrawal by Subject|1|||
124718837|NCT00861757|448592779|FG001|Overall Study|Withdrawal by Subject|5|||
124718838|NCT00861757|448592780|FG002|Overall Study|Withdrawal by Subject|5|||
124718839|NCT00861757|448592781|FG003|Overall Study|Withdrawal by Subject|2|||
124718840|NCT02140970|448592784|FG000|Overall Study|Lost to Follow-up|1|||
124718841|NCT02140970|448592785|FG001|Overall Study|Lost to Follow-up|2|||
124718842|NCT02140970|448592784|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
124718843|NCT02140970|448592785|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
124718844|NCT02140970|448592784|FG000|Overall Study|Did not meet inclusion criteria|0|||
124718845|NCT02140970|448592785|FG001|Overall Study|Did not meet inclusion criteria|1|||
124718846|NCT02705105|448592786|FG000|Treatment|Objective Disease Progression|1|||
124718847|NCT02705105|448592787|FG001|Treatment|Objective Disease Progression|50|||
124718848|NCT02705105|448592786|FG000|Treatment|Withdrawal by Subject|3|||
124718849|NCT02705105|448592787|FG001|Treatment|Withdrawal by Subject|5|||
124718850|NCT02705105|448592786|FG000|Treatment|Adverse Event|0|||
124474937|NCT02487108|447696030|FG002|Overall Study|Other than specified|2|||
124474938|NCT02487108|447696031|FG003|Overall Study|Other than specified|0|||
124474939|NCT01254669|447696032|FG000|Overall Study|Withdrawal by Subject|0|||
124474940|NCT01254669|447696033|FG001|Overall Study|Withdrawal by Subject|1|||
124474941|NCT01254669|447696032|FG000|Overall Study|time constraint|2|||
124474942|NCT01254669|447696033|FG001|Overall Study|time constraint|2|||
124474943|NCT01254669|447696032|FG000|Overall Study|called to clinic during intervention|1|||
124474944|NCT01254669|447696033|FG001|Overall Study|called to clinic during intervention|1|||
124474945|NCT00600171|447696034|FG000|Overall Study|Adverse Event|0|||
124474946|NCT00600171|447696035|FG001|Overall Study|Adverse Event|1|||
124474947|NCT00600171|447696036|FG002|Overall Study|Adverse Event|0|||
124474948|NCT00600171|447696037|FG003|Overall Study|Adverse Event|0|||
124474949|NCT00600171|447696038|FG004|Overall Study|Adverse Event|1|||
124474950|NCT00600171|447696039|FG005|Overall Study|Adverse Event|0|||
124474951|NCT00600171|447696034|FG000|Overall Study|Lack of Efficacy|9|||
124474952|NCT00600171|447696035|FG001|Overall Study|Lack of Efficacy|12|||
124474953|NCT00600171|447696036|FG002|Overall Study|Lack of Efficacy|3|||
124474954|NCT00600171|447696037|FG003|Overall Study|Lack of Efficacy|5|||
124474955|NCT00600171|447696038|FG004|Overall Study|Lack of Efficacy|4|||
124474956|NCT00600171|447696039|FG005|Overall Study|Lack of Efficacy|0|||
124474957|NCT00600171|447696034|FG000|Overall Study|Protocol Violation|1|||
124474958|NCT00600171|447696035|FG001|Overall Study|Protocol Violation|2|||
124474959|NCT00600171|447696036|FG002|Overall Study|Protocol Violation|0|||
124474960|NCT00600171|447696037|FG003|Overall Study|Protocol Violation|1|||
124474961|NCT00600171|447696038|FG004|Overall Study|Protocol Violation|0|||
124474962|NCT00600171|447696039|FG005|Overall Study|Protocol Violation|0|||
124718851|NCT02705105|448592787|FG001|Treatment|Adverse Event|17|||
124718852|NCT02705105|448592786|FG000|Treatment|Clinical Disease Progression|0|||
124718853|NCT02705105|448592787|FG001|Treatment|Clinical Disease Progression|32|||
124718854|NCT02705105|448592786|FG000|Treatment|Physician Decision|0|||
124474963|NCT00600171|447696034|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
124474964|NCT00600171|447696035|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
124474965|NCT00600171|447696036|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
124474966|NCT00600171|447696037|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
124474967|NCT00600171|447696038|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
124474968|NCT00600171|447696039|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
124474969|NCT00600171|447696034|FG000|Overall Study|Withdrawal by Subject|3|||
124474970|NCT00600171|447696035|FG001|Overall Study|Withdrawal by Subject|0|||
124474971|NCT00600171|447696036|FG002|Overall Study|Withdrawal by Subject|0|||
124474972|NCT00600171|447696037|FG003|Overall Study|Withdrawal by Subject|1|||
124474973|NCT00600171|447696038|FG004|Overall Study|Withdrawal by Subject|1|||
124474974|NCT00600171|447696039|FG005|Overall Study|Withdrawal by Subject|1|||
124474975|NCT00600171|447696034|FG000|Overall Study|Physician Decision|0|||
124474976|NCT00600171|447696035|FG001|Overall Study|Physician Decision|1|||
124474977|NCT00600171|447696036|FG002|Overall Study|Physician Decision|0|||
124474978|NCT00600171|447696037|FG003|Overall Study|Physician Decision|1|||
124474979|NCT00600171|447696038|FG004|Overall Study|Physician Decision|0|||
124556266|NCT01889862|447994178|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
124474980|NCT00600171|447696039|FG005|Overall Study|Physician Decision|2|||
124556267|NCT01889862|447994179|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
124474981|NCT00600171|447696034|FG000|Overall Study|Lost to Follow-up|0|||
124474982|NCT00600171|447696035|FG001|Overall Study|Lost to Follow-up|0|||
124474983|NCT00600171|447696036|FG002|Overall Study|Lost to Follow-up|0|||
124718855|NCT02705105|448592787|FG001|Treatment|Physician Decision|3|||
124718856|NCT02705105|448592786|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
124474984|NCT00600171|447696037|FG003|Overall Study|Lost to Follow-up|1|||
124474985|NCT00600171|447696038|FG004|Overall Study|Lost to Follow-up|0|||
124474986|NCT00600171|447696039|FG005|Overall Study|Lost to Follow-up|0|||
124474987|NCT00469612|447696040|FG000|Overall Study|Study terminated before data collected|2|||
124474988|NCT00469612|447696041|FG001|Overall Study|Study terminated before data collected|0|||
124474989|NCT00430755|447696042|FG000|Overall Study|Withdrawal by Subject|53|||
124556268|NCT01889862|447994175|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
124556269|NCT01889862|447994176|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
124556270|NCT01889862|447994177|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
124556271|NCT01889862|447994178|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
124556272|NCT01889862|447994179|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
124556273|NCT00845026|447994180|FG000|Study Period III|Adverse Event|23|||
124556274|NCT00845026|447994181|FG001|Study Period III|Adverse Event|19|||
124556275|NCT00845026|447994180|FG000|Study Period III|Perceived lack of efficacy|27|||
124556276|NCT00845026|447994181|FG001|Study Period III|Perceived lack of efficacy|15|||
124556277|NCT00845026|447994180|FG000|Study Period III|Withdrawal by Subject|19|||
124474990|NCT01279057|447696053|FG000|Overall Study|Adverse Event|1|||
124474991|NCT01279057|447696054|FG001|Overall Study|Adverse Event|0|||
124474992|NCT01279057|447696055|FG002|Overall Study|Adverse Event|1|||
124474993|NCT01279057|447696053|FG000|Overall Study|Insufficient therapeutic response|0|||
124474994|NCT01279057|447696054|FG001|Overall Study|Insufficient therapeutic response|0|||
124474995|NCT01279057|447696055|FG002|Overall Study|Insufficient therapeutic response|1|||
124474996|NCT01279057|447696053|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
124474997|NCT01279057|447696054|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
124474998|NCT01279057|447696055|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
124474999|NCT01279057|447696053|FG000|Overall Study|Withdrew consent|2|||
124475000|NCT01279057|447696054|FG001|Overall Study|Withdrew consent|0|||
124475001|NCT01279057|447696055|FG002|Overall Study|Withdrew consent|1|||
124475002|NCT01279057|447696053|FG000|Overall Study|Pregnancy|0|||
124556278|NCT00845026|447994181|FG001|Study Period III|Withdrawal by Subject|15|||
124718857|NCT02705105|448592787|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
124718858|NCT02705105|448592786|FG000|Follow-Up|Death|3|||
124718859|NCT02705105|448592787|FG001|Follow-Up|Death|68|||
124718860|NCT02705105|448592786|FG000|Follow-Up|Withdrawal by Subject|1|||
124718861|NCT02705105|448592787|FG001|Follow-Up|Withdrawal by Subject|14|||
124718862|NCT02705105|448592786|FG000|Follow-Up|Study Terminated|0|||
124718863|NCT02705105|448592787|FG001|Follow-Up|Study Terminated|26|||
124718864|NCT02705105|448592786|FG000|Follow-Up|Discontinued per Amendment 3|0|||
124718865|NCT02705105|448592787|FG001|Follow-Up|Discontinued per Amendment 3|2|||
124718866|NCT03332173|448592788|FG000|Overall Study|Death|7|||
124718867|NCT03332173|448592788|FG000|Overall Study|Withdrawal by Subject|6|||
124718868|NCT03332173|448592788|FG000|Overall Study|Lost to Follow-up|2|||
124718869|NCT03332173|448592788|FG000|Overall Study|Transferred to long-term extension study|29|||
124718870|NCT02168101|448592789|FG000|Overall Study|Death|2|||
124718871|NCT02168101|448592790|FG001|Overall Study|Death|2|||
124718872|NCT02168101|448592791|FG002|Overall Study|Death|1|||
124718873|NCT00910910|448592792|FG000|Overall Study|Adverse Event|63|||
124718874|NCT00910910|448592793|FG001|Overall Study|Adverse Event|35|||
124718875|NCT00910910|448592792|FG000|Overall Study|PD without histologic change|27|||
124718876|NCT00910910|448592793|FG001|Overall Study|PD without histologic change|23|||
124718877|NCT00910910|448592792|FG000|Overall Study|PD with histologic change|0|||
124718878|NCT00910910|448592793|FG001|Overall Study|PD with histologic change|2|||
124718879|NCT00910910|448592792|FG000|Overall Study|Withdrawal by Subject|7|||
124718880|NCT00910910|448592793|FG001|Overall Study|Withdrawal by Subject|5|||
124718881|NCT00910910|448592792|FG000|Overall Study|Lost to Follow-up|2|||
124718882|NCT00910910|448592793|FG001|Overall Study|Lost to Follow-up|2|||
124475003|NCT01279057|447696054|FG001|Overall Study|Pregnancy|1|||
124475004|NCT01279057|447696055|FG002|Overall Study|Pregnancy|0|||
124475005|NCT01279057|447696053|FG000|Overall Study|Other|3|||
124475006|NCT01279057|447696054|FG001|Overall Study|Other|3|||
124475007|NCT01279057|447696055|FG002|Overall Study|Other|0|||
124475008|NCT01427309|447696057|FG000|Overall Study|Lost to Follow-up|130|||
124475009|NCT01427309|447696058|FG001|Overall Study|Lost to Follow-up|145|||
124475010|NCT01427309|447696059|FG002|Overall Study|Lost to Follow-up|122|||
124475011|NCT01427309|447696060|FG003|Overall Study|Lost to Follow-up|135|||
124475012|NCT01427309|447696057|FG000|Overall Study|Protocol Violation|42|||
124475013|NCT01427309|447696058|FG001|Overall Study|Protocol Violation|69|||
124475014|NCT01427309|447696059|FG002|Overall Study|Protocol Violation|125|||
124475015|NCT01427309|447696060|FG003|Overall Study|Protocol Violation|124|||
124475016|NCT01427309|447696057|FG000|Overall Study|Adverse Event|0|||
124475017|NCT01427309|447696058|FG001|Overall Study|Adverse Event|0|||
124475018|NCT01427309|447696059|FG002|Overall Study|Adverse Event|3|||
124475019|NCT01427309|447696060|FG003|Overall Study|Adverse Event|1|||
124475020|NCT01427309|447696057|FG000|Overall Study|Serious adverse event|52|||
124475021|NCT01427309|447696058|FG001|Overall Study|Serious adverse event|45|||
124475022|NCT01427309|447696059|FG002|Overall Study|Serious adverse event|50|||
124475023|NCT01427309|447696060|FG003|Overall Study|Serious adverse event|61|||
124475024|NCT01427309|447696057|FG000|Overall Study|Withdrawal by Subject|148|||
124475025|NCT01427309|447696058|FG001|Overall Study|Withdrawal by Subject|148|||
124475026|NCT01427309|447696059|FG002|Overall Study|Withdrawal by Subject|61|||
124475027|NCT01427309|447696060|FG003|Overall Study|Withdrawal by Subject|55|||
124475028|NCT00849017|447696061|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
124475029|NCT00849017|447696062|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
124475030|NCT00849017|447696063|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
124475031|NCT00849017|447696061|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
124475032|NCT00849017|447696062|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
124556279|NCT00845026|447994180|FG000|Study Period III|Entry Criteria not met|8|||
124556280|NCT00845026|447994181|FG001|Study Period III|Entry Criteria not met|11|||
124556281|NCT00845026|447994180|FG000|Study Period III|Lost to Follow-up|4|||
124556282|NCT00845026|447994181|FG001|Study Period III|Lost to Follow-up|5|||
124475033|NCT00849017|447696063|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
124475034|NCT00849017|447696061|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
124475035|NCT00849017|447696062|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
124475036|NCT00849017|447696063|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
124475037|NCT00849017|447696061|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
124475038|NCT00849017|447696062|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
124475039|NCT00849017|447696063|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
124475040|NCT00849017|447696061|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
124475041|NCT00849017|447696062|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
124475042|NCT00849017|447696063|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
124475043|NCT00849017|447696061|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
124475044|NCT00849017|447696062|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
124718883|NCT00910910|448592792|FG000|Overall Study|Death|9|||
124475045|NCT00849017|447696063|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
124475046|NCT00849017|447696061|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
124475047|NCT00849017|447696062|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
124475048|NCT00849017|447696063|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
124475049|NCT00849017|447696061|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
124475050|NCT00849017|447696062|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
124475051|NCT00849017|447696063|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
124475052|NCT00849017|447696061|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
124475053|NCT00849017|447696062|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
124475054|NCT00849017|447696063|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
124475055|NCT00849017|447696061|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
124475056|NCT00849017|447696062|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
124475057|NCT00849017|447696063|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
124475058|NCT00849017|447696061|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
124475059|NCT00849017|447696062|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
124475060|NCT00849017|447696063|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
124475061|NCT00849017|447696061|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
124475062|NCT00849017|447696062|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
124475063|NCT00849017|447696063|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
124475064|NCT00849017|447696061|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
124475065|NCT00849017|447696062|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
124475066|NCT00849017|447696063|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
124475067|NCT00849017|447696061|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
124475068|NCT00849017|447696062|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
124475069|NCT00849017|447696063|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
124475070|NCT00849017|447696061|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
124475071|NCT00849017|447696062|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
124475072|NCT00849017|447696063|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
124475073|NCT00849017|447696061|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
124475074|NCT00849017|447696062|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
124475075|NCT00849017|447696063|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
124475076|NCT00849017|447696061|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
124475077|NCT00849017|447696062|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
124475078|NCT00849017|447696063|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
124475079|NCT00849017|447696061|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
124475080|NCT00849017|447696062|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
124475081|NCT00849017|447696063|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
124475082|NCT00849017|447696061|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
124475083|NCT00849017|447696062|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
124475084|NCT00849017|447696063|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
124475085|NCT05254418|447696066|FG000|Overall Study|Adverse Event|2|||
124475086|NCT03624946|447696069|FG000|Overall Study|Lost to Follow-up|0|||
124475087|NCT03624946|447696070|FG001|Overall Study|Lost to Follow-up|1|||
124475088|NCT01869348|447696071|FG000|Overall Study|Withdrawal by Subject|1|||
124475089|NCT01869348|447696072|FG001|Overall Study|Withdrawal by Subject|1|||
124475090|NCT00624520|447696074|FG000|Overall Study|Withdrawal by Subject|12|||
124475091|NCT00624520|447696075|FG001|Overall Study|Withdrawal by Subject|7|||
124475092|NCT00624520|447696074|FG000|Overall Study|Death|0|||
124475093|NCT00624520|447696075|FG001|Overall Study|Death|1|||
124475094|NCT01925209|447696076|FG000|Treatment Epoch|Physician Decision|1|||
124475095|NCT01925209|447696077|FG001|Treatment Epoch|Physician Decision|0|||
124475096|NCT01925209|447696078|FG002|Treatment Epoch|Physician Decision|0|||
124475097|NCT01925209|447696079|FG003|Treatment Epoch|Physician Decision|0|||
124475098|NCT01925209|447696076|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
124475099|NCT01925209|447696077|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
124475100|NCT01925209|447696078|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
124475101|NCT01925209|447696079|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
124475102|NCT01925209|447696076|FG000|Treatment Epoch|Death|1|||
124475103|NCT01925209|447696077|FG001|Treatment Epoch|Death|0|||
124475104|NCT01925209|447696078|FG002|Treatment Epoch|Death|0|||
124475105|NCT01925209|447696079|FG003|Treatment Epoch|Death|0|||
124475106|NCT01925209|447696076|FG000|Treatment Epoch|Protocol deviation|0|||
124475107|NCT01925209|447696077|FG001|Treatment Epoch|Protocol deviation|0|||
124475108|NCT01925209|447696078|FG002|Treatment Epoch|Protocol deviation|1|||
124475109|NCT01925209|447696079|FG003|Treatment Epoch|Protocol deviation|1|||
124475110|NCT01925209|447696076|FG000|Treatment Epoch|Withdrawal by Subject|4|||
124475111|NCT01925209|447696077|FG001|Treatment Epoch|Withdrawal by Subject|3|||
124556283|NCT00845026|447994180|FG000|Study Period III|Protocol Violation|8|||
124556284|NCT00845026|447994181|FG001|Study Period III|Protocol Violation|1|||
124556285|NCT00845026|447994180|FG000|Study Period III|Scheduled conflict|3|||
124475112|NCT01925209|447696078|FG002|Treatment Epoch|Withdrawal by Subject|3|||
124475113|NCT01925209|447696079|FG003|Treatment Epoch|Withdrawal by Subject|2|||
124475114|NCT01925209|447696076|FG000|Treatment Epoch|Adverse Event|3|||
124718884|NCT00910910|448592793|FG001|Overall Study|Death|3|||
124475115|NCT01925209|447696077|FG001|Treatment Epoch|Adverse Event|5|||
124475116|NCT01925209|447696078|FG002|Treatment Epoch|Adverse Event|3|||
124475117|NCT01925209|447696079|FG003|Treatment Epoch|Adverse Event|1|||
124718885|NCT00910910|448592792|FG000|Overall Study|Protocol Violation|2|||
124475118|NCT01925209|447696076|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
124475119|NCT01925209|447696077|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
124475120|NCT01925209|447696078|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
124475121|NCT01925209|447696079|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
124475122|NCT01925209|447696076|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
124475123|NCT01925209|447696077|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
124475124|NCT01925209|447696078|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
124475125|NCT01925209|447696079|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
124718886|NCT00910910|448592793|FG001|Overall Study|Protocol Violation|2|||
124475126|NCT01925209|447696076|FG000|Follow-up|Adverse Event|1|||
124475127|NCT01925209|447696077|FG001|Follow-up|Adverse Event|4|||
124475128|NCT01925209|447696078|FG002|Follow-up|Adverse Event|0|||
124475129|NCT01925209|447696079|FG003|Follow-up|Adverse Event|1|||
124475130|NCT01925209|447696076|FG000|Follow-up|Physician Decision|0|||
124475131|NCT01925209|447696077|FG001|Follow-up|Physician Decision|0|||
124475132|NCT01925209|447696078|FG002|Follow-up|Physician Decision|1|||
124475133|NCT01925209|447696079|FG003|Follow-up|Physician Decision|0|||
124475134|NCT01925209|447696076|FG000|Follow-up|Non-compliance with study treatment|0|||
124475135|NCT01925209|447696077|FG001|Follow-up|Non-compliance with study treatment|0|||
124475136|NCT01925209|447696078|FG002|Follow-up|Non-compliance with study treatment|0|||
124475137|NCT01925209|447696079|FG003|Follow-up|Non-compliance with study treatment|1|||
124475138|NCT01925209|447696076|FG000|Follow-up|Withdrawal by Subject|0|||
124718887|NCT00910910|448592792|FG000|Overall Study|Completed 13 cycles of treatment|0|||
124718888|NCT00910910|448592793|FG001|Overall Study|Completed 13 cycles of treatment|118|||
124475139|NCT01925209|447696077|FG001|Follow-up|Withdrawal by Subject|2|||
124475140|NCT01925209|447696078|FG002|Follow-up|Withdrawal by Subject|0|||
124475141|NCT01925209|447696079|FG003|Follow-up|Withdrawal by Subject|2|||
124475142|NCT03075163|447696080|FG000|Overall Study|not eligible for treatment limb|138|||
124475143|NCT03075163|447696081|FG001|Overall Study|not eligible for treatment limb|138|||
124475144|NCT02796755|447696082|FG000|Overall Study|Adverse Event|2|||
124475145|NCT02796755|447696083|FG001|Overall Study|Adverse Event|0|||
124475146|NCT00110994|447696084|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
124475147|NCT00110994|447696085|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
124475148|NCT00110994|447696084|FG000|Double-blind (DB) Treatment|Death|1|||
124475149|NCT00110994|447696085|FG001|Double-blind (DB) Treatment|Death|0|||
124475150|NCT00110994|447696084|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
124475151|NCT00110994|447696085|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
124475152|NCT00110994|447696084|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
124475153|NCT00110994|447696085|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
124475154|NCT00110994|447696084|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
124475155|NCT00110994|447696085|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
124475156|NCT00110994|447696084|FG000|Double-blind (DB) Treatment|other reasons|2|||
124475157|NCT00110994|447696085|FG001|Double-blind (DB) Treatment|other reasons|3|||
124475158|NCT00110994|447696084|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
124475159|NCT00110994|447696085|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
124475160|NCT00110994|447696084|FG000|Active Follow-up|Other reasons|0|||
124475161|NCT00110994|447696085|FG001|Active Follow-up|Other reasons|2|||
124475162|NCT00110994|447696084|FG000|Long Term Follow-up|Death|19|||
124475163|NCT00110994|447696085|FG001|Long Term Follow-up|Death|17|||
124475164|NCT00675025|447696086|FG000|Overall Study|Study Terminated by Sponsor|38|||
124475165|NCT00675025|447696087|FG001|Overall Study|Study Terminated by Sponsor|42|||
124475166|NCT00675025|447696086|FG000|Overall Study|Adverse Event|6|||
124475167|NCT00675025|447696087|FG001|Overall Study|Adverse Event|11|||
124475168|NCT00675025|447696086|FG000|Overall Study|Lost to Follow-up|6|||
124475169|NCT00675025|447696087|FG001|Overall Study|Lost to Follow-up|4|||
124475170|NCT00675025|447696086|FG000|Overall Study|Withdrawal by Subject|4|||
124718889|NCT00910910|448592792|FG000|Overall Study|Other|114|||
124718890|NCT00910910|448592793|FG001|Overall Study|Other|32|||
124475171|NCT00675025|447696087|FG001|Overall Study|Withdrawal by Subject|6|||
124475172|NCT00556426|447696091|FG000|Overall Study|Withdrawal by Subject|3|||
124475173|NCT00556426|447696091|FG000|Overall Study|Death|6|||
124475174|NCT01299727|447696094|FG000|Overall Study|Withdrawal by Subject|1|||
124718891|NCT00910910|448592792|FG000|Overall Study|Untreated before cycle 1|1|||
124475175|NCT01299727|447696095|FG001|Overall Study|Withdrawal by Subject|0|||
124475176|NCT01299727|447696096|FG002|Overall Study|Withdrawal by Subject|0|||
124475177|NCT01299727|447696094|FG000|Overall Study|Adverse Event|0|||
124475178|NCT01299727|447696095|FG001|Overall Study|Adverse Event|0|||
124475179|NCT01299727|447696096|FG002|Overall Study|Adverse Event|1|||
124475180|NCT01299727|447696094|FG000|Overall Study|Completed the Treatment Period|3|||
124475181|NCT01299727|447696095|FG001|Overall Study|Completed the Treatment Period|4|||
124475182|NCT01299727|447696096|FG002|Overall Study|Completed the Treatment Period|3|||
124475183|NCT00441792|447696098|FG000|Overall Study|Lost to Follow-up|0|||
124475184|NCT00441792|447696099|FG001|Overall Study|Lost to Follow-up|2|||
124475185|NCT01879410|447696109|FG000|Overall Study|Adverse Event|9|||
124475186|NCT01879410|447696110|FG001|Overall Study|Adverse Event|14|||
124475187|NCT01879410|447696109|FG000|Overall Study|Lack of Efficacy|4|||
124475188|NCT01879410|447696110|FG001|Overall Study|Lack of Efficacy|6|||
124475189|NCT01879410|447696109|FG000|Overall Study|Protocol Violation|1|||
124475190|NCT01879410|447696110|FG001|Overall Study|Protocol Violation|7|||
124475191|NCT01879410|447696109|FG000|Overall Study|Lost to Follow-up|2|||
124475192|NCT01879410|447696110|FG001|Overall Study|Lost to Follow-up|1|||
124475193|NCT01879410|447696109|FG000|Overall Study|Withdrawal by Subject|7|||
124475194|NCT01879410|447696110|FG001|Overall Study|Withdrawal by Subject|8|||
124475195|NCT01879410|447696109|FG000|Overall Study|Randomised in Error|1|||
124475196|NCT01879410|447696110|FG001|Overall Study|Randomised in Error|2|||
124475197|NCT02649634|447696111|FG000|Overall Study|Withdrawal by Subject|3|||
124475198|NCT02649634|447696112|FG001|Overall Study|Withdrawal by Subject|5|||
124475199|NCT02649634|447696111|FG000|Overall Study|Lost to Follow-up|0|||
124475200|NCT02649634|447696112|FG001|Overall Study|Lost to Follow-up|1|||
124475201|NCT02211261|447696116|FG000|Overall Study|Withdrawal by Subject|0|||
124475202|NCT02211261|447696117|FG001|Overall Study|Withdrawal by Subject|0|||
124475203|NCT02211261|447696118|FG002|Overall Study|Withdrawal by Subject|1|||
124475204|NCT02211261|447696119|FG003|Overall Study|Withdrawal by Subject|0|||
124475205|NCT02211261|447696120|FG004|Overall Study|Withdrawal by Subject|2|||
124475206|NCT02211261|447696121|FG005|Overall Study|Withdrawal by Subject|0|||
124475207|NCT02211261|447696122|FG006|Overall Study|Withdrawal by Subject|0|||
124475208|NCT02211261|447696123|FG007|Overall Study|Withdrawal by Subject|0|||
124475209|NCT02211261|447696124|FG008|Overall Study|Withdrawal by Subject|0|||
124475210|NCT02211261|447696125|FG009|Overall Study|Withdrawal by Subject|0|||
124475211|NCT02211261|447696126|FG010|Overall Study|Withdrawal by Subject|0|||
124475212|NCT02211261|447696116|FG000|Overall Study|Other|0|||
124475213|NCT02211261|447696117|FG001|Overall Study|Other|0|||
124475214|NCT02211261|447696118|FG002|Overall Study|Other|0|||
124475215|NCT02211261|447696119|FG003|Overall Study|Other|0|||
124475216|NCT02211261|447696120|FG004|Overall Study|Other|0|||
124475217|NCT02211261|447696121|FG005|Overall Study|Other|1|||
124475218|NCT02211261|447696122|FG006|Overall Study|Other|0|||
124475219|NCT02211261|447696123|FG007|Overall Study|Other|0|||
124475220|NCT02211261|447696124|FG008|Overall Study|Other|0|||
124475221|NCT02211261|447696125|FG009|Overall Study|Other|2|||
124475222|NCT02211261|447696126|FG010|Overall Study|Other|0|||
124475223|NCT02211261|447696116|FG000|Overall Study|Lost to Follow-up|0|||
124475224|NCT02211261|447696117|FG001|Overall Study|Lost to Follow-up|0|||
124475225|NCT02211261|447696118|FG002|Overall Study|Lost to Follow-up|0|||
124475226|NCT02211261|447696119|FG003|Overall Study|Lost to Follow-up|0|||
124475227|NCT02211261|447696120|FG004|Overall Study|Lost to Follow-up|0|||
124475228|NCT02211261|447696121|FG005|Overall Study|Lost to Follow-up|0|||
124475229|NCT02211261|447696122|FG006|Overall Study|Lost to Follow-up|0|||
124475230|NCT02211261|447696123|FG007|Overall Study|Lost to Follow-up|1|||
124475231|NCT02211261|447696124|FG008|Overall Study|Lost to Follow-up|0|||
124475232|NCT02211261|447696125|FG009|Overall Study|Lost to Follow-up|0|||
124475233|NCT02211261|447696126|FG010|Overall Study|Lost to Follow-up|0|||
124475234|NCT01737931|447696130|FG000|Overall Study|Withdrawal by Subject|0|||
124475235|NCT01737931|447696131|FG001|Overall Study|Withdrawal by Subject|1|||
124475236|NCT01737931|447696132|FG002|Overall Study|Withdrawal by Subject|1|||
124475237|NCT01737931|447696130|FG000|Overall Study|Physician Decision|0|||
124475238|NCT01737931|447696131|FG001|Overall Study|Physician Decision|1|||
124475239|NCT01737931|447696132|FG002|Overall Study|Physician Decision|0|||
124475240|NCT03183128|447696135|FG000|Overall Study|Adverse Event|1|||
124475241|NCT03183128|447696136|FG001|Overall Study|Adverse Event|2|||
124475242|NCT03183128|447696135|FG000|Overall Study|Withdrawal by Subject|1|||
124475243|NCT03183128|447696136|FG001|Overall Study|Withdrawal by Subject|8|||
124475244|NCT03183128|447696135|FG000|Overall Study|Protocol Violation|2|||
124475245|NCT03183128|447696136|FG001|Overall Study|Protocol Violation|0|||
124475246|NCT03183128|447696135|FG000|Overall Study|Lack of Efficacy|4|||
124475247|NCT03183128|447696136|FG001|Overall Study|Lack of Efficacy|27|||
124475248|NCT03183128|447696135|FG000|Overall Study|Lost to Follow-up|1|||
124475249|NCT03183128|447696136|FG001|Overall Study|Lost to Follow-up|0|||
124475250|NCT03183128|447696135|FG000|Overall Study|Death|2|||
124475251|NCT03183128|447696136|FG001|Overall Study|Death|0|||
124475252|NCT03183128|447696135|FG000|Overall Study|Physician Decision|1|||
124475253|NCT03183128|447696136|FG001|Overall Study|Physician Decision|0|||
124475254|NCT00330187|447696137|FG000|Overall Study|Lost to Follow-up|12|||
124475255|NCT00330187|447696138|FG001|Overall Study|Lost to Follow-up|13|||
124475256|NCT00330187|447696139|FG002|Overall Study|Lost to Follow-up|14|||
124475257|NCT00330187|447696140|FG003|Overall Study|Lost to Follow-up|10|||
124475258|NCT00330187|447696137|FG000|Overall Study|Withdrawal by Subject|8|||
124475259|NCT00330187|447696138|FG001|Overall Study|Withdrawal by Subject|5|||
124718892|NCT00910910|448592793|FG001|Overall Study|Untreated before cycle 1|2|||
124718893|NCT01973231|448592794|FG000|Overall Study|Protocol Violation|1|||
124718894|NCT01973231|448592795|FG001|Overall Study|Protocol Violation|1|||
124718895|NCT01973231|448592794|FG000|Overall Study|Lost to Follow-up|1|||
124718896|NCT01973231|448592795|FG001|Overall Study|Lost to Follow-up|1|||
124718897|NCT01973231|448592794|FG000|Overall Study|unclassified|2|||
124718898|NCT01973231|448592795|FG001|Overall Study|unclassified|1|||
124718899|NCT01973231|448592794|FG000|Overall Study|Withdrawal by Subject|7|||
124718900|NCT01973231|448592795|FG001|Overall Study|Withdrawal by Subject|9|||
124718901|NCT01485796|448592796|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
124718902|NCT01485796|448592796|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
124718903|NCT01485796|448592796|FG000|Period 2: Epoch 2|Adverse Event|3|||
124718904|NCT01485796|448592796|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
124718905|NCT01485796|448592796|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
124475260|NCT00330187|447696139|FG002|Overall Study|Withdrawal by Subject|4|||
124475261|NCT00330187|447696140|FG003|Overall Study|Withdrawal by Subject|4|||
124475262|NCT03258814|447696141|FG000|Overall Study|Early Termination|4|||
124718906|NCT01485796|448592796|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
124718907|NCT01485796|448592796|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
124718908|NCT01485796|448592796|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
124718909|NCT01775553|448592801|FG000|Overall Study|Adverse Event|1|||
124718910|NCT01775553|448592801|FG000|Overall Study|Disease Progression|12|||
124718911|NCT00988052|448592802|FG000|Overall Study|Missing|1|||
124718912|NCT00988052|448592803|FG001|Overall Study|Missing|0|||
124718913|NCT00988052|448592802|FG000|Overall Study|Teva requested subject withdrawal|3|||
124718914|NCT00988052|448592803|FG001|Overall Study|Teva requested subject withdrawal|1|||
124556286|NCT00845026|447994181|FG001|Study Period III|Scheduled conflict|1|||
124556287|NCT00845026|447994180|FG000|Study Period III|Subject is moving or has moved|2|||
124556288|NCT00845026|447994181|FG001|Study Period III|Subject is moving or has moved|4|||
124556289|NCT00845026|447994180|FG000|Study Period III|Transportation issues|1|||
124556290|NCT00845026|447994181|FG001|Study Period III|Transportation issues|1|||
124556291|NCT00845026|447994180|FG000|Study Period IV|Adverse Event|4|||
124556292|NCT00845026|447994181|FG001|Study Period IV|Adverse Event|0|||
124556293|NCT00845026|447994180|FG000|Study Period IV|Perceived lack of efficacy|2|||
124718915|NCT00988052|448592802|FG000|Overall Study|Death|1|||
124718916|NCT00988052|448592803|FG001|Overall Study|Death|3|||
124475263|NCT03258814|447696142|FG001|Overall Study|Early Termination|3|||
124475264|NCT03258814|447696143|FG002|Overall Study|Early Termination|10|||
124475265|NCT01413958|447696144|FG000|Overall Study|Lost to Follow-up|0|||
124475266|NCT01413958|447696145|FG001|Overall Study|Lost to Follow-up|1|||
124475267|NCT00364182|447696148|FG000|First Intervention|Secondary prophylaxis|1|||
124475268|NCT00364182|447696149|FG001|First Intervention|Secondary prophylaxis|0|||
124556294|NCT00845026|447994181|FG001|Study Period IV|Perceived lack of efficacy|1|||
124556295|NCT00845026|447994180|FG000|Study Period IV|Protocol Violation|3|||
124556296|NCT00845026|447994181|FG001|Study Period IV|Protocol Violation|1|||
124556297|NCT00845026|447994180|FG000|Study Period IV|Lost to Follow-up|1|||
124556298|NCT00845026|447994181|FG001|Study Period IV|Lost to Follow-up|0|||
124556299|NCT00845026|447994180|FG000|Study Period IV|Withdrawal by Subject|4|||
124556300|NCT00845026|447994181|FG001|Study Period IV|Withdrawal by Subject|1|||
124556301|NCT00845026|447994180|FG000|Study Period IV|Entry Criteria Not Met|1|||
124556302|NCT00845026|447994181|FG001|Study Period IV|Entry Criteria Not Met|0|||
124556303|NCT00845026|447994180|FG000|Study Period IV|Subject is moving or has moved|0|||
124556304|NCT00845026|447994181|FG001|Study Period IV|Subject is moving or has moved|1|||
124556305|NCT00845026|447994180|FG000|Study Period IV|Scheduling conflict|1|||
124556306|NCT00845026|447994181|FG001|Study Period IV|Scheduling conflict|0|||
124556307|NCT01325532|447994182|FG000|Overall Study|Withdrawal by Subject|2|||
124556308|NCT01325532|447994183|FG001|Overall Study|Withdrawal by Subject|0|||
124556309|NCT03012815|447994184|FG000|Overall Study|Lost to Follow-up|1|||
124556310|NCT03012815|447994185|FG001|Overall Study|Lost to Follow-up|0|||
124556311|NCT03012815|447994184|FG000|Overall Study|Physician Decision|3|||
124556312|NCT03012815|447994185|FG001|Overall Study|Physician Decision|2|||
124556313|NCT03012815|447994184|FG000|Overall Study|Adverse Event|1|||
124556314|NCT03012815|447994185|FG001|Overall Study|Adverse Event|0|||
124556315|NCT01252238|447994186|FG000|Overall Study|Sponsor terminated study|4|||
124556316|NCT01252238|447994187|FG001|Overall Study|Sponsor terminated study|4|||
124556317|NCT01252238|447994188|FG002|Overall Study|Sponsor terminated study|4|||
124556318|NCT06371079|447994193|FG000|Overall Study|Missing data|88|||
124556319|NCT06371079|447994194|FG001|Overall Study|Missing data|247|||
124556320|NCT00411762|447994196|FG000|Overall Study|Withdrawal by Subject|5|||
124556321|NCT03276962|447994197|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
124556322|NCT03276962|447994198|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
124556323|NCT03276962|447994199|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
124556324|NCT03276962|447994200|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
124475269|NCT00364182|447696150|FG002|First Intervention|Secondary prophylaxis|0|||
124475270|NCT00364182|447696148|FG000|First Intervention|Withdrawal by Subject|2|||
124475271|NCT00364182|447696149|FG001|First Intervention|Withdrawal by Subject|0|||
124475272|NCT00364182|447696150|FG002|First Intervention|Withdrawal by Subject|0|||
124475273|NCT00364182|447696148|FG000|Second Intervention|non-compliance|0|||
124475274|NCT00364182|447696149|FG001|Second Intervention|non-compliance|1|||
124475275|NCT00364182|447696150|FG002|Second Intervention|non-compliance|1|||
124475276|NCT00364182|447696148|FG000|Second Intervention|Protocol Violation|0|||
124556325|NCT03276962|447994201|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
124556326|NCT03276962|447994197|FG000|Overall Study|Protocol Deviation|2|||
124556327|NCT03276962|447994198|FG001|Overall Study|Protocol Deviation|0|||
124556328|NCT03276962|447994199|FG002|Overall Study|Protocol Deviation|1|||
124556329|NCT03276962|447994200|FG003|Overall Study|Protocol Deviation|2|||
124475277|NCT00364182|447696149|FG001|Second Intervention|Protocol Violation|1|||
124475278|NCT00364182|447696150|FG002|Second Intervention|Protocol Violation|0|||
124475279|NCT00364182|447696148|FG000|Second Intervention|Adverse Event|0|||
124475280|NCT00364182|447696149|FG001|Second Intervention|Adverse Event|0|||
124475281|NCT00364182|447696150|FG002|Second Intervention|Adverse Event|1|||
124475282|NCT00364182|447696148|FG000|Third Intervention|non-compliance|0|||
124475283|NCT00364182|447696149|FG001|Third Intervention|non-compliance|1|||
124475284|NCT00364182|447696150|FG002|Third Intervention|non-compliance|0|||
124475285|NCT00364182|447696148|FG000|Third Intervention|Lost to Follow-up|0|||
124475286|NCT00364182|447696149|FG001|Third Intervention|Lost to Follow-up|0|||
124475287|NCT00364182|447696150|FG002|Third Intervention|Lost to Follow-up|1|||
124475288|NCT00705263|447696152|FG000|Overall Study|Withdrawal by Subject|2|||
124475289|NCT02246621|447696153|FG000|Overall Study|Withdrawal by Subject|28|||
124475290|NCT02246621|447696154|FG001|Overall Study|Withdrawal by Subject|16|||
124475291|NCT02246621|447696153|FG000|Overall Study|Lost to Follow-up|1|||
124475292|NCT02246621|447696154|FG001|Overall Study|Lost to Follow-up|0|||
124475293|NCT02246621|447696153|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
124475294|NCT02246621|447696154|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
124475295|NCT01583374|447696155|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
124475296|NCT01583374|447696156|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
124475297|NCT01583374|447696157|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
124556330|NCT03276962|447994201|FG004|Overall Study|Protocol Deviation|1|||
124556331|NCT03276962|447994197|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
124556332|NCT03276962|447994198|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
124556333|NCT03276962|447994199|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
124556334|NCT03276962|447994200|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
124556335|NCT03276962|447994201|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
124556336|NCT03276962|447994197|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
124556337|NCT03276962|447994198|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
124556338|NCT03276962|447994199|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
124556339|NCT03276962|447994200|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
124556340|NCT03276962|447994201|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
124556341|NCT03276962|447994197|FG000|Overall Study|Lost to Follow-up|10|||
124556342|NCT03276962|447994198|FG001|Overall Study|Lost to Follow-up|10|||
124556343|NCT03276962|447994199|FG002|Overall Study|Lost to Follow-up|4|||
124556344|NCT03276962|447994200|FG003|Overall Study|Lost to Follow-up|6|||
124556345|NCT03276962|447994201|FG004|Overall Study|Lost to Follow-up|10|||
124556346|NCT03276962|447994197|FG000|Overall Study|Other|0|||
124556347|NCT03276962|447994198|FG001|Overall Study|Other|2|||
124556348|NCT03276962|447994199|FG002|Overall Study|Other|0|||
124556349|NCT03276962|447994200|FG003|Overall Study|Other|2|||
124556350|NCT03276962|447994201|FG004|Overall Study|Other|1|||
124556351|NCT02295280|447994210|FG000|Overall Study|Adverse Event|0|||
124556352|NCT02295280|447994211|FG001|Overall Study|Adverse Event|1|||
124475298|NCT01583374|447696158|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124475299|NCT01583374|447696159|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124475300|NCT01583374|447696160|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124475301|NCT01583374|447696161|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124475302|NCT01583374|447696162|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124475303|NCT01583374|447696163|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124475304|NCT01583374|447696155|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
124475305|NCT01583374|447696156|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
124475306|NCT01583374|447696157|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
124475307|NCT01583374|447696158|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124475308|NCT01583374|447696159|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124475309|NCT01583374|447696160|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124475310|NCT01583374|447696161|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124475311|NCT01583374|447696162|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124475312|NCT01583374|447696163|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124475313|NCT01583374|447696155|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
124475314|NCT01583374|447696156|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
124475315|NCT01583374|447696157|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124475316|NCT01583374|447696158|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124475317|NCT01583374|447696159|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124475318|NCT01583374|447696160|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124475319|NCT01583374|447696161|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124475320|NCT01583374|447696162|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124475321|NCT01583374|447696163|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124475322|NCT01583374|447696155|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
124475323|NCT01583374|447696156|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
124475324|NCT01583374|447696157|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
124475325|NCT01583374|447696158|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124475326|NCT01583374|447696159|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124475327|NCT01583374|447696160|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124475328|NCT01583374|447696161|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124718917|NCT00988052|448592802|FG000|Overall Study|Protocol Violation|6|||
124718918|NCT00988052|448592803|FG001|Overall Study|Protocol Violation|5|||
124718919|NCT00988052|448592802|FG000|Overall Study|Pregnancy|6|||
124475329|NCT01583374|447696162|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124475330|NCT01583374|447696163|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124475331|NCT01583374|447696155|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
124475332|NCT01583374|447696156|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
124475333|NCT01583374|447696157|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
124475334|NCT01583374|447696158|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
124475335|NCT01583374|447696159|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
124475336|NCT01583374|447696160|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
124475337|NCT01583374|447696161|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
124475338|NCT01583374|447696162|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
124475339|NCT01583374|447696163|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
124718920|NCT00988052|448592803|FG001|Overall Study|Pregnancy|6|||
124718921|NCT00988052|448592802|FG000|Overall Study|Lack of Efficacy|8|||
124718922|NCT00988052|448592803|FG001|Overall Study|Lack of Efficacy|7|||
124475340|NCT01583374|447696155|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124475341|NCT01583374|447696156|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124475342|NCT01583374|447696157|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
124475343|NCT01583374|447696158|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124475344|NCT01583374|447696159|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124475345|NCT01583374|447696160|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124475346|NCT01583374|447696161|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124475347|NCT01583374|447696162|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124475348|NCT01583374|447696163|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124475349|NCT01583374|447696155|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
124475350|NCT01583374|447696156|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
124475351|NCT01583374|447696157|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
124475352|NCT01583374|447696158|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
124475353|NCT01583374|447696159|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
124475354|NCT01583374|447696160|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
124475355|NCT01583374|447696161|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
124475356|NCT01583374|447696162|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
124475357|NCT01583374|447696163|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
124475358|NCT01583374|447696155|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
124475359|NCT01583374|447696156|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
124475360|NCT01583374|447696157|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
124475361|NCT01583374|447696158|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
124475362|NCT01583374|447696159|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
124475363|NCT01583374|447696160|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
124475364|NCT01583374|447696161|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
124475365|NCT01583374|447696162|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
124475366|NCT01583374|447696163|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
124475367|NCT01583374|447696155|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
124475368|NCT01583374|447696156|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
124475369|NCT01583374|447696157|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
124475370|NCT01583374|447696158|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
124475371|NCT01583374|447696159|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
124475372|NCT01583374|447696160|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
124475373|NCT01583374|447696161|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
124475374|NCT01583374|447696162|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
124475375|NCT01583374|447696163|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
124475376|NCT01583374|447696155|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
124475377|NCT01583374|447696156|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
124475378|NCT01583374|447696157|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
124556353|NCT00558519|447994212|FG000|Overall Study|Ph+|20|||
124556354|NCT00558519|447994212|FG000|Overall Study|Ineligible|1|||
124556355|NCT00558519|447994212|FG000|Overall Study|Insufficient data|1|||
124556356|NCT00558519|447994212|FG000|Overall Study|Never received treatment|1|||
124475379|NCT01583374|447696158|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
124475380|NCT01583374|447696159|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
124475381|NCT01583374|447696160|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
124475382|NCT01583374|447696161|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
124475383|NCT01583374|447696162|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
124475384|NCT01583374|447696163|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
124475385|NCT01583374|447696155|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
124475386|NCT01583374|447696156|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
124475387|NCT01583374|447696157|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
124475388|NCT01583374|447696158|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
124475389|NCT01583374|447696159|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
124475390|NCT01583374|447696160|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
124475391|NCT01583374|447696161|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
124475392|NCT01583374|447696162|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
124475393|NCT01583374|447696163|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
124475394|NCT01583374|447696155|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
124475395|NCT01583374|447696156|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
124475396|NCT01583374|447696157|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
124475397|NCT01583374|447696158|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
124475398|NCT01583374|447696159|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
124475399|NCT01583374|447696160|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
124475400|NCT01583374|447696161|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
124475401|NCT01583374|447696162|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
124475402|NCT01583374|447696163|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
124475403|NCT01583374|447696155|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
124475404|NCT01583374|447696156|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
124475405|NCT01583374|447696157|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
124556357|NCT03056352|447994213|FG000|Overall Study|Lost to Follow-up|1|||
124475406|NCT01583374|447696158|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
124475407|NCT01583374|447696159|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
124475408|NCT01583374|447696160|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
124475409|NCT01583374|447696161|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
124475410|NCT01583374|447696162|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
124475411|NCT01583374|447696163|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
124475412|NCT01583374|447696155|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
124475413|NCT01583374|447696156|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
124475414|NCT01583374|447696157|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
124475415|NCT01583374|447696158|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
124475416|NCT01583374|447696159|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
124475417|NCT01583374|447696160|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
124475418|NCT01583374|447696161|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
124475419|NCT01583374|447696162|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
124475420|NCT01583374|447696163|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
124475421|NCT01583374|447696155|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
124475422|NCT01583374|447696156|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
124475423|NCT01583374|447696157|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
124475424|NCT01583374|447696158|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
124475425|NCT01583374|447696159|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
124475426|NCT01583374|447696160|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
124475427|NCT01583374|447696161|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
124475428|NCT01583374|447696162|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
124475429|NCT01583374|447696163|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
124475430|NCT01583374|447696155|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
124475431|NCT01583374|447696156|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
124475432|NCT01583374|447696157|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
124475433|NCT01583374|447696158|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
124475434|NCT01583374|447696159|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
124475435|NCT01583374|447696160|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
124475436|NCT01583374|447696161|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
124475437|NCT01583374|447696162|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
124475438|NCT01583374|447696163|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
124475439|NCT01583374|447696155|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
124475440|NCT01583374|447696156|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
124475441|NCT01583374|447696157|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
124475442|NCT01583374|447696158|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
124475443|NCT01583374|447696159|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
124475444|NCT01583374|447696160|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
124556358|NCT02278952|447994214|FG000|Overall Study|Insufficient Sample|6|||
124475445|NCT01583374|447696161|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
124475446|NCT01583374|447696162|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
124475447|NCT01583374|447696163|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
124475448|NCT01583374|447696155|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
124475449|NCT01583374|447696156|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
124475450|NCT01583374|447696157|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
124475451|NCT01583374|447696158|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
124475452|NCT01583374|447696159|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
124475453|NCT01583374|447696160|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
124475454|NCT01583374|447696161|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
124475455|NCT01583374|447696162|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
124475456|NCT01583374|447696163|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
124475457|NCT01583374|447696155|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
124475458|NCT01583374|447696156|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
124475459|NCT01583374|447696157|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
124475460|NCT01583374|447696158|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
124475461|NCT01583374|447696159|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
124475462|NCT01583374|447696160|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
124475463|NCT01583374|447696161|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
124556359|NCT00869089|447994217|FG000|Overall Study|Lost to Follow-up|1|||
124718923|NCT00988052|448592802|FG000|Overall Study|Lost to Follow-up|6|||
124718924|NCT00988052|448592803|FG001|Overall Study|Lost to Follow-up|11|||
124718925|NCT00988052|448592802|FG000|Overall Study|Physician Decision|27|||
124718926|NCT00988052|448592803|FG001|Overall Study|Physician Decision|28|||
124718927|NCT00988052|448592802|FG000|Overall Study|Adverse Event|35|||
124718928|NCT00988052|448592803|FG001|Overall Study|Adverse Event|28|||
124475464|NCT01583374|447696162|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
124475465|NCT01583374|447696163|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
124475466|NCT02591615|447697853|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
124475467|NCT02591615|447697854|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
124718929|NCT00988052|448592802|FG000|Overall Study|Withdrawal by Subject|90|||
124718930|NCT00988052|448592803|FG001|Overall Study|Withdrawal by Subject|91|||
124718931|NCT00988052|448592802|FG000|Overall Study|Study terminated by sponsor|240|||
124718932|NCT00988052|448592803|FG001|Overall Study|Study terminated by sponsor|236|||
124718933|NCT01523743|448592804|FG000|Period 1|Adverse Event|1|||
124718934|NCT01523743|448592805|FG001|Period 1|Adverse Event|0|||
124475468|NCT02591615|447697855|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
124475469|NCT02591615|447697856|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
124475470|NCT02591615|447697853|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
124475471|NCT02591615|447697854|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
124475472|NCT02591615|447697855|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
124475473|NCT02591615|447697856|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
124475474|NCT02591615|447697853|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
124475475|NCT02591615|447697854|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
124475476|NCT02591615|447697855|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
124475477|NCT02591615|447697856|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
124475478|NCT02591615|447697853|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
124475479|NCT02591615|447697854|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
124475480|NCT02591615|447697855|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
124475481|NCT02591615|447697856|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
124475482|NCT02591615|447697853|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
124475483|NCT02591615|447697854|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
124475484|NCT02591615|447697855|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
124475485|NCT02591615|447697856|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
124475486|NCT02591615|447697853|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
124475487|NCT02591615|447697854|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
124475488|NCT02591615|447697855|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
124475489|NCT02591615|447697856|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
124475490|NCT02591615|447697853|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
124475491|NCT02591615|447697854|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
124475492|NCT02591615|447697855|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
124475493|NCT02591615|447697856|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
124475494|NCT02591615|447697853|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
124475495|NCT02591615|447697854|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
124475496|NCT02591615|447697855|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
124475497|NCT02591615|447697856|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
124475498|NCT02591615|447697853|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
124475499|NCT02591615|447697854|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
124475500|NCT02591615|447697855|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
124475501|NCT02591615|447697856|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
124475502|NCT02591615|447697853|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
124475503|NCT02591615|447697854|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
124475504|NCT02591615|447697855|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
124718935|NCT01523743|448592804|FG000|Period 1|Withdrawal by Subject|6|||
124475505|NCT02591615|447697856|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
124475506|NCT02591615|447697853|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
124718936|NCT01523743|448592805|FG001|Period 1|Withdrawal by Subject|2|||
124475507|NCT02591615|447697854|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
124475508|NCT02591615|447697855|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
124475509|NCT02591615|447697856|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
124475510|NCT02591615|447697853|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
124475511|NCT02591615|447697854|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
124475512|NCT02591615|447697855|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
124475513|NCT02591615|447697856|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
124475514|NCT02591615|447697853|FG000|Maintenance MK-3475|Adverse Event|0|||
124475515|NCT02591615|447697854|FG001|Maintenance MK-3475|Adverse Event|3|||
124556360|NCT00869089|447994217|FG000|Overall Study|Withdrawal by Subject|1|||
124556361|NCT00869089|447994217|FG000|Overall Study|Screen Fail|1|||
124556362|NCT01963676|447995763|FG000|Overall Study|Withdrawal by Subject|1|||
124556363|NCT01963676|447995764|FG001|Overall Study|Withdrawal by Subject|0|||
124556364|NCT01246973|447995765|FG000|Overall Study|Other|38|||
124556365|NCT01246973|447995766|FG001|Overall Study|Other|25|||
124556366|NCT01246973|447995765|FG000|Overall Study|Adverse Event|16|||
124556367|NCT01246973|447995766|FG001|Overall Study|Adverse Event|9|||
124556368|NCT01246973|447995765|FG000|Overall Study|Withdrawal by Subject|7|||
124556369|NCT01246973|447995766|FG001|Overall Study|Withdrawal by Subject|13|||
124556370|NCT00766506|447995767|FG000|Overall Study|Use rescue medication after 3 hours|3|||
124556371|NCT00766506|447995768|FG001|Overall Study|Use rescue medication after 3 hours|0|||
124556372|NCT00766506|447995767|FG000|Overall Study|Other|2|||
124556373|NCT00766506|447995768|FG001|Overall Study|Other|2|||
124556374|NCT02496221|447995769|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
124556375|NCT02496221|447995770|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
124556376|NCT02496221|447995769|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
124556377|NCT02496221|447995770|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
124556378|NCT02496221|447995769|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
124556379|NCT02496221|447995770|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
124556380|NCT03262233|447995771|FG000|Overall Study|Withdrawal by Subject|12|||
124556381|NCT03262233|447995772|FG001|Overall Study|Withdrawal by Subject|8|||
124556382|NCT03262233|447995773|FG002|Overall Study|Withdrawal by Subject|21|||
124556383|NCT03262233|447995774|FG003|Overall Study|Withdrawal by Subject|13|||
124556384|NCT03262233|447995771|FG000|Overall Study|Declined due to shock|1|||
124556385|NCT03262233|447995772|FG001|Overall Study|Declined due to shock|2|||
124475516|NCT02591615|447697855|FG002|Maintenance MK-3475|Adverse Event|1|||
124475517|NCT02591615|447697856|FG003|Maintenance MK-3475|Adverse Event|2|||
124556386|NCT03262233|447995773|FG002|Overall Study|Declined due to shock|2|||
124556387|NCT03262233|447995774|FG003|Overall Study|Declined due to shock|3|||
124556388|NCT03262233|447995771|FG000|Overall Study|Protocol Violation|5|||
124556389|NCT03262233|447995772|FG001|Overall Study|Protocol Violation|10|||
124556390|NCT03262233|447995773|FG002|Overall Study|Protocol Violation|2|||
124556391|NCT03262233|447995774|FG003|Overall Study|Protocol Violation|13|||
124556392|NCT03262233|447995771|FG000|Overall Study|data collection artifact|0|||
124556393|NCT03262233|447995772|FG001|Overall Study|data collection artifact|1|||
124556394|NCT03262233|447995773|FG002|Overall Study|data collection artifact|0|||
124556395|NCT03262233|447995774|FG003|Overall Study|data collection artifact|0|||
124556396|NCT01120600|447995777|FG000|Overall Study|Adverse Event|7|||
124556397|NCT01120600|447995778|FG001|Overall Study|Adverse Event|7|||
124556398|NCT01120600|447995777|FG000|Overall Study|Excessive Bone Loss|0|||
124556399|NCT01120600|447995778|FG001|Overall Study|Excessive Bone Loss|4|||
124556400|NCT01120600|447995777|FG000|Overall Study|Lost to Follow-up|1|||
124556401|NCT01120600|447995778|FG001|Overall Study|Lost to Follow-up|3|||
124556402|NCT01120600|447995777|FG000|Overall Study|Physician Decision|1|||
124556403|NCT01120600|447995778|FG001|Overall Study|Physician Decision|3|||
124556404|NCT01120600|447995777|FG000|Overall Study|Protocol Violation|0|||
124556405|NCT01120600|447995778|FG001|Overall Study|Protocol Violation|4|||
124556406|NCT01120600|447995777|FG000|Overall Study|Withdrawal by Subject|10|||
124556407|NCT01120600|447995778|FG001|Overall Study|Withdrawal by Subject|11|||
124556408|NCT01165242|447995779|FG000|Overall Study|Unreachable Subjects|1|||
124556409|NCT01165242|447995780|FG001|Overall Study|Unreachable Subjects|0|||
124556410|NCT01165242|447995781|FG002|Overall Study|Unreachable Subjects|0|||
124556411|NCT01165242|447995779|FG000|Overall Study|Incarcerated Subjects|0|||
124556412|NCT01165242|447995780|FG001|Overall Study|Incarcerated Subjects|1|||
124556413|NCT01165242|447995781|FG002|Overall Study|Incarcerated Subjects|0|||
124718937|NCT01523743|448592804|FG000|Period 1|Lost to Follow-up|1|||
124718938|NCT01523743|448592805|FG001|Period 1|Lost to Follow-up|0|||
124718939|NCT01523743|448592804|FG000|Period 1|Lack of Efficacy|1|||
124718940|NCT01523743|448592805|FG001|Period 1|Lack of Efficacy|0|||
124718941|NCT01523743|448592804|FG000|Period 1|Felt unable to empty bladder|1|||
124718942|NCT01523743|448592805|FG001|Period 1|Felt unable to empty bladder|0|||
124718943|NCT01523743|448592804|FG000|Period 2|Withdrawal by Subject|0|||
124718944|NCT01523743|448592805|FG001|Period 2|Withdrawal by Subject|2|||
124718945|NCT01523743|448592804|FG000|Period 2|Adverse Event|1|||
124718946|NCT01523743|448592805|FG001|Period 2|Adverse Event|0|||
124718947|NCT02569476|448592806|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
124718948|NCT02569476|448592806|FG000|Overall Study|Death|33|||
124718949|NCT02569476|448592806|FG000|Overall Study|Withdrawal by Subject|9|||
124718950|NCT02569476|448592806|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
124718951|NCT02569476|448592806|FG000|Overall Study|Palliative care|1|||
124718952|NCT02569476|448592806|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
124718953|NCT02569476|448592806|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
124718954|NCT01434654|448592807|FG000|Overall Study|Withdrawal by Subject|1|||
124718955|NCT01434654|448592808|FG001|Overall Study|Withdrawal by Subject|0|||
124475518|NCT02591615|447697853|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
124475519|NCT02591615|447697854|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
124475520|NCT02591615|447697855|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
124475521|NCT02591615|447697856|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
124475522|NCT02591615|447697853|FG000|Maintenance MK-3475|Death|0|||
124475523|NCT02591615|447697854|FG001|Maintenance MK-3475|Death|1|||
124475524|NCT02591615|447697855|FG002|Maintenance MK-3475|Death|1|||
124475525|NCT02591615|447697856|FG003|Maintenance MK-3475|Death|0|||
124475526|NCT02591615|447697853|FG000|Maintenance MK-3475|Physician discretion|0|||
124475527|NCT02591615|447697854|FG001|Maintenance MK-3475|Physician discretion|0|||
124475528|NCT02591615|447697855|FG002|Maintenance MK-3475|Physician discretion|1|||
124475529|NCT02591615|447697856|FG003|Maintenance MK-3475|Physician discretion|0|||
124475530|NCT02591615|447697853|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
124475531|NCT02591615|447697854|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
124475532|NCT02591615|447697855|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
124475533|NCT02591615|447697856|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
124475534|NCT02591615|447697853|FG000|Maintenance MK-3475|In active treatment|2|||
124475535|NCT02591615|447697854|FG001|Maintenance MK-3475|In active treatment|0|||
124475536|NCT02591615|447697855|FG002|Maintenance MK-3475|In active treatment|0|||
124475537|NCT02591615|447697856|FG003|Maintenance MK-3475|In active treatment|1|||
124475538|NCT04188197|447697857|FG000|Overall Study|Lost to Follow-up|4|||
124475539|NCT04188197|447697858|FG001|Overall Study|Lost to Follow-up|1|||
124475540|NCT04188197|447697857|FG000|Overall Study|Withdrawal by Subject|1|||
124475541|NCT04188197|447697858|FG001|Overall Study|Withdrawal by Subject|1|||
124475542|NCT04188197|447697857|FG000|Overall Study|Pregnancy|0|||
124475543|NCT04188197|447697858|FG001|Overall Study|Pregnancy|1|||
124475544|NCT02107703|447697859|FG000|Overall Study|Withdrawal by Subject|46|||
124475545|NCT02107703|447697860|FG001|Overall Study|Withdrawal by Subject|21|||
124475546|NCT02107703|447697859|FG000|Overall Study|Lost to Follow-up|20|||
124475547|NCT02107703|447697860|FG001|Overall Study|Lost to Follow-up|9|||
124475548|NCT02107703|447697859|FG000|Overall Study|On study treatment/follow up|48|||
124718956|NCT01434654|448592807|FG000|Overall Study|Lost to Follow-up|1|||
124718957|NCT01434654|448592808|FG001|Overall Study|Lost to Follow-up|0|||
124718958|NCT00703963|448592813|FG000|Overall Study|Withdrawal by Subject|7|||
124718959|NCT00703963|448592814|FG001|Overall Study|Withdrawal by Subject|13|||
124718960|NCT00703963|448592813|FG000|Overall Study|Physician Decision|0|||
124718961|NCT00703963|448592814|FG001|Overall Study|Physician Decision|1|||
124718962|NCT00402324|448592817|FG000|Overall Study|Lost to Follow-up|11|||
124475549|NCT02107703|447697860|FG001|Overall Study|On study treatment/follow up|5|||
124475550|NCT04574999|447697861|FG000|Overall Study|Adverse Event|1|||
124475551|NCT04574999|447697862|FG001|Overall Study|Adverse Event|0|||
124718963|NCT00402324|448592818|FG001|Overall Study|Lost to Follow-up|11|||
124475552|NCT04574999|447697861|FG000|Overall Study|Lack of Efficacy|2|||
124475553|NCT04574999|447697862|FG001|Overall Study|Lack of Efficacy|3|||
124475554|NCT04574999|447697861|FG000|Overall Study|Protocol Violation|1|||
124475555|NCT04574999|447697862|FG001|Overall Study|Protocol Violation|0|||
124475556|NCT04574999|447697861|FG000|Overall Study|Withdrawal by Subject|2|||
124556414|NCT01165242|447995779|FG000|Overall Study|Visit 2 Declined by Subject|0|||
124475557|NCT04574999|447697862|FG001|Overall Study|Withdrawal by Subject|2|||
124718964|NCT00402324|448592817|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
124475558|NCT04574999|447697861|FG000|Overall Study|Lost to Follow-up|1|||
124475559|NCT04574999|447697862|FG001|Overall Study|Lost to Follow-up|0|||
124475560|NCT04574999|447697861|FG000|Overall Study|Personal problems|1|||
124475561|NCT04574999|447697862|FG001|Overall Study|Personal problems|0|||
124475562|NCT04574999|447697861|FG000|Overall Study|Previous planned surgery|1|||
124475563|NCT04574999|447697862|FG001|Overall Study|Previous planned surgery|0|||
124475564|NCT00008385|447697864|FG000|Overall Study|Off treatment reasons not reported|79|||
124475565|NCT00008385|447697865|FG001|Overall Study|Off treatment reasons not reported|70|||
124475566|NCT00008385|447697864|FG000|Overall Study|Progressive disease|52|||
124475567|NCT00008385|447697865|FG001|Overall Study|Progressive disease|117|||
124475568|NCT00008385|447697864|FG000|Overall Study|Adverse Event|8|||
124475569|NCT00008385|447697865|FG001|Overall Study|Adverse Event|20|||
124475570|NCT00008385|447697864|FG000|Overall Study|Death|12|||
124475571|NCT00008385|447697865|FG001|Overall Study|Death|18|||
124475572|NCT00008385|447697864|FG000|Overall Study|Withdrawal by Subject|67|||
124475573|NCT00008385|447697865|FG001|Overall Study|Withdrawal by Subject|157|||
124475574|NCT00008385|447697864|FG000|Overall Study|Start non-protocol therapy|3|||
124475575|NCT00008385|447697865|FG001|Overall Study|Start non-protocol therapy|1|||
124475576|NCT00008385|447697864|FG000|Overall Study|Other complicating disease|17|||
124475577|NCT00008385|447697865|FG001|Overall Study|Other complicating disease|30|||
124475578|NCT00008385|447697864|FG000|Overall Study|Maximum dose reached|0|||
124475579|NCT00008385|447697865|FG001|Overall Study|Maximum dose reached|2|||
124475580|NCT00008385|447697864|FG000|Overall Study|Other|105|||
124475581|NCT00008385|447697865|FG001|Overall Study|Other|212|||
124475582|NCT00008385|447697864|FG000|Overall Study|Not start protocol therapy|44|||
124475583|NCT00008385|447697865|FG001|Overall Study|Not start protocol therapy|175|||
124475584|NCT00398112|447697866|FG000|Overall Study|Adverse Event|4|||
124475585|NCT00398112|447697866|FG000|Overall Study|Disease progression|9|||
124475586|NCT00398112|447697866|FG000|Overall Study|Alternative treatment|1|||
124475587|NCT00398112|447697866|FG000|Overall Study|Withdrawal by Subject|3|||
124475588|NCT00398112|447697866|FG000|Overall Study|Death|1|||
124475589|NCT00365989|447697869|FG000|Overall Study|Withdrawal by Subject|1|||
124475590|NCT00365989|447697869|FG000|Overall Study|Non-compliance|1|||
124475591|NCT02318095|447697870|FG000|Overall Study|Adverse Event|1|||
124475592|NCT00686127|447697871|FG000|Overall Study|Withdrawal by Subject|14|||
124475593|NCT00686127|447697872|FG001|Overall Study|Withdrawal by Subject|6|||
124475594|NCT06441877|447697873|FG000|Overall Study|Withdrawal by Subject|0|||
124475595|NCT06441877|447697874|FG001|Overall Study|Withdrawal by Subject|2|||
124475596|NCT06441877|447697875|FG002|Overall Study|Withdrawal by Subject|0|||
124475597|NCT06441877|447697876|FG003|Overall Study|Withdrawal by Subject|0|||
124475598|NCT00066690|447697877|FG000|Overall Study|Adverse Event|145|||
124475599|NCT00066690|447697878|FG001|Overall Study|Adverse Event|58|||
124475600|NCT00066690|447697879|FG002|Overall Study|Adverse Event|126|||
124475601|NCT00066690|447697877|FG000|Overall Study|Death|3|||
124475602|NCT00066690|447697878|FG001|Overall Study|Death|0|||
124475603|NCT00066690|447697879|FG002|Overall Study|Death|2|||
124475604|NCT00066690|447697877|FG000|Overall Study|Lack of Efficacy|114|||
124475605|NCT00066690|447697878|FG001|Overall Study|Lack of Efficacy|110|||
124475606|NCT00066690|447697879|FG002|Overall Study|Lack of Efficacy|76|||
124475607|NCT00066690|447697877|FG000|Overall Study|Lost to Follow-up|40|||
124475608|NCT00066690|447697878|FG001|Overall Study|Lost to Follow-up|21|||
124475609|NCT00066690|447697879|FG002|Overall Study|Lost to Follow-up|29|||
124475610|NCT00066690|447697877|FG000|Overall Study|Withdrawal by Subject|50|||
124556415|NCT01165242|447995780|FG001|Overall Study|Visit 2 Declined by Subject|0|||
124556416|NCT01165242|447995781|FG002|Overall Study|Visit 2 Declined by Subject|1|||
124556417|NCT01165242|447995779|FG000|Overall Study|Withdrawal by Subject|0|||
124475611|NCT00066690|447697878|FG001|Overall Study|Withdrawal by Subject|55|||
124475612|NCT00066690|447697879|FG002|Overall Study|Withdrawal by Subject|49|||
124475613|NCT00066690|447697877|FG000|Overall Study|Treatment Ongoing|246|||
124556418|NCT01165242|447995780|FG001|Overall Study|Withdrawal by Subject|2|||
124556419|NCT01165242|447995781|FG002|Overall Study|Withdrawal by Subject|2|||
124771692|NCT00907335|448794547|FG000|Overall Study|Withdrawal by Subject|2|||
124475614|NCT00066690|447697878|FG001|Overall Study|Treatment Ongoing|278|||
124475615|NCT00066690|447697879|FG002|Overall Study|Treatment Ongoing|282|||
124718965|NCT00402324|448592818|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
124556420|NCT01165242|447995779|FG000|Overall Study|Extended Holiday|0|||
124556421|NCT01165242|447995780|FG001|Overall Study|Extended Holiday|0|||
124475616|NCT02159807|447697882|FG000|Overall Study|Adverse Event|0|||
124475617|NCT02159807|447697883|FG001|Overall Study|Adverse Event|0|||
124475618|NCT02159807|447697884|FG002|Overall Study|Adverse Event|1|||
124475619|NCT02159807|447697882|FG000|Overall Study|No CSF|1|||
124475620|NCT02159807|447697883|FG001|Overall Study|No CSF|1|||
124475621|NCT02159807|447697884|FG002|Overall Study|No CSF|1|||
124475622|NCT02159807|447697882|FG000|Overall Study|elevated blood pressure|0|||
124475623|NCT02159807|447697883|FG001|Overall Study|elevated blood pressure|0|||
124475624|NCT02159807|447697884|FG002|Overall Study|elevated blood pressure|1|||
124475625|NCT02367521|447697888|FG000|Overall Study|severe headache after intervention|2|||
124475626|NCT02367521|447697889|FG001|Overall Study|severe headache after intervention|0|||
124475627|NCT02367521|447697888|FG000|Overall Study|unable to find transportation|2|||
124475628|NCT02367521|447697889|FG001|Overall Study|unable to find transportation|0|||
124475629|NCT00542191|447697893|FG000|Overall Study|Death|3|||
124475630|NCT00103012|447697896|FG000|Overall Study|Withdrawal by Subject|2|||
124475631|NCT00103012|447697897|FG001|Overall Study|Withdrawal by Subject|1|||
124475632|NCT00103012|447697898|FG002|Overall Study|Withdrawal by Subject|2|||
124475633|NCT00103012|447697896|FG000|Overall Study|Pregnancy|1|||
124475634|NCT00103012|447697897|FG001|Overall Study|Pregnancy|0|||
124475635|NCT00103012|447697898|FG002|Overall Study|Pregnancy|0|||
124475636|NCT00103012|447697896|FG000|Overall Study|Adverse Event|0|||
124475637|NCT00103012|447697897|FG001|Overall Study|Adverse Event|0|||
124475638|NCT00103012|447697898|FG002|Overall Study|Adverse Event|1|||
124475639|NCT00103012|447697896|FG000|Overall Study|Subject non-compliant with medications|0|||
124475640|NCT00103012|447697897|FG001|Overall Study|Subject non-compliant with medications|0|||
124475641|NCT00103012|447697898|FG002|Overall Study|Subject non-compliant with medications|1|||
124475642|NCT04684420|447697902|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124475643|NCT04684420|447697903|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124475644|NCT04684420|447697904|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
124475645|NCT04684420|447697905|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
124475646|NCT04684420|447697902|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
124475647|NCT04684420|447697903|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
124475648|NCT04684420|447697904|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
124475649|NCT04684420|447697905|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
124475650|NCT03480802|447697907|FG000|Overall Study|Lost to Follow-up|5|||
124475651|NCT03480802|447697908|FG001|Overall Study|Lost to Follow-up|1|||
124718966|NCT00402324|448592817|FG000|Overall Study|Protocol Violation|8|||
124718967|NCT00402324|448592818|FG001|Overall Study|Protocol Violation|7|||
124718968|NCT00402324|448592817|FG000|Overall Study|Withdrawal by Subject|5|||
124718969|NCT00402324|448592818|FG001|Overall Study|Withdrawal by Subject|2|||
124718970|NCT00402324|448592817|FG000|Overall Study|Physician Decision|2|||
124718971|NCT00402324|448592818|FG001|Overall Study|Physician Decision|4|||
124718972|NCT00402324|448592817|FG000|Overall Study|Sponsor Decision|4|||
124718973|NCT00402324|448592818|FG001|Overall Study|Sponsor Decision|5|||
124718974|NCT00402324|448592817|FG000|Overall Study|Lack of Efficacy|1|||
124718975|NCT00402324|448592818|FG001|Overall Study|Lack of Efficacy|4|||
124718976|NCT00402324|448592817|FG000|Overall Study|Adverse Event|6|||
124475652|NCT03480802|447697907|FG000|Overall Study|Withdrawal by Subject|2|||
124475653|NCT03480802|447697908|FG001|Overall Study|Withdrawal by Subject|1|||
124475654|NCT03480802|447697907|FG000|Overall Study|Relocated|0|||
124475655|NCT03480802|447697908|FG001|Overall Study|Relocated|1|||
124475656|NCT03822884|447697909|FG000|Overall Study|Withdrawal by Subject|0|||
124475657|NCT03822884|447697910|FG001|Overall Study|Withdrawal by Subject|0|||
124475658|NCT03822884|447697911|FG002|Overall Study|Withdrawal by Subject|0|||
124475659|NCT03822884|447697912|FG003|Overall Study|Withdrawal by Subject|0|||
124475660|NCT03822884|447697913|FG004|Overall Study|Withdrawal by Subject|1|||
124475661|NCT03822884|447697914|FG005|Overall Study|Withdrawal by Subject|0|||
124718977|NCT00402324|448592818|FG001|Overall Study|Adverse Event|4|||
124475662|NCT02411448|447697918|FG000|Overall Study|Withdrawal by Subject|1|||
124718978|NCT00402324|448592817|FG000|Overall Study|Death|1|||
124718979|NCT00402324|448592818|FG001|Overall Study|Death|0|||
124718980|NCT01277822|448592819|FG000|Overall Study|Adverse Event|2|||
124556422|NCT01165242|447995781|FG002|Overall Study|Extended Holiday|1|||
124475663|NCT02411448|447697919|FG001|Overall Study|Withdrawal by Subject|14|||
124475664|NCT02411448|447697920|FG002|Overall Study|Withdrawal by Subject|9|||
124475665|NCT02411448|447697918|FG000|Overall Study|Other|0|||
124475666|NCT02411448|447697919|FG001|Overall Study|Other|2|||
124475667|NCT02411448|447697920|FG002|Overall Study|Other|0|||
124475668|NCT02411448|447697918|FG000|Overall Study|Did not receive study treatment|0|||
124475669|NCT02411448|447697919|FG001|Overall Study|Did not receive study treatment|3|||
124475670|NCT02411448|447697920|FG002|Overall Study|Did not receive study treatment|0|||
124475671|NCT02411448|447697918|FG000|Overall Study|Alive on study treatment|3|||
124475672|NCT02411448|447697919|FG001|Overall Study|Alive on study treatment|64|||
124475673|NCT02411448|447697920|FG002|Overall Study|Alive on study treatment|43|||
124475674|NCT04067518|447697923|FG000|Overall Study|Adverse Event|1|||
124475675|NCT04067518|447697924|FG001|Overall Study|Adverse Event|3|||
124475676|NCT04067518|447697923|FG000|Overall Study|Screen failures|0|||
124475677|NCT04067518|447697924|FG001|Overall Study|Screen failures|1|||
124475678|NCT04067518|447697923|FG000|Overall Study|Enrolled but not treated|0|||
124475679|NCT04067518|447697924|FG001|Overall Study|Enrolled but not treated|1|||
124475680|NCT02771522|447697925|FG000|Overall Study|Lost to Follow-up|3|||
124475681|NCT02771522|447697925|FG000|Overall Study|Withdrawal by Subject|2|||
124475682|NCT02771522|447697925|FG000|Overall Study|No white spot lesions|3|||
124475683|NCT05655377|447697928|FG000|Overall Study|Withdrawal by Subject|2|||
124475684|NCT01256177|447697929|FG000|Overall Study|Withdrawal by Subject|23|||
124475685|NCT01256177|447697930|FG001|Overall Study|Withdrawal by Subject|22|||
124475686|NCT01256177|447697929|FG000|Overall Study|Lost to Follow-up|2|||
124475687|NCT01256177|447697930|FG001|Overall Study|Lost to Follow-up|2|||
124475688|NCT01256177|447697929|FG000|Overall Study|Adverse Event|8|||
124475689|NCT01256177|447697930|FG001|Overall Study|Adverse Event|9|||
124475690|NCT01256177|447697929|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
124475691|NCT01256177|447697930|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
124475692|NCT01256177|447697929|FG000|Overall Study|Condition under Investigation Worsened|1|||
124475693|NCT01256177|447697930|FG001|Overall Study|Condition under Investigation Worsened|0|||
124475694|NCT01256177|447697929|FG000|Overall Study|Lack of Efficacy|11|||
124475695|NCT01256177|447697930|FG001|Overall Study|Lack of Efficacy|2|||
124475696|NCT01256177|447697929|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
124475697|NCT01256177|447697930|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
124475698|NCT01728779|447697932|FG000|Overall Study|Withdrawal by Subject|1|||
124475699|NCT00792298|447697937|FG000|Treatment Period 1|Adverse Event|0|||
124475700|NCT00792298|447697938|FG001|Treatment Period 1|Adverse Event|1|||
124475701|NCT00792298|447697939|FG002|Treatment Period 1|Adverse Event|0|||
124475702|NCT00792298|447697940|FG003|Treatment Period 1|Adverse Event|1|||
124475703|NCT00792298|447697941|FG004|Treatment Period 1|Adverse Event|0|||
124475704|NCT00792298|447697942|FG005|Treatment Period 1|Adverse Event|1|||
124475705|NCT00792298|447697943|FG006|Treatment Period 1|Adverse Event|1|||
124475706|NCT00792298|447697944|FG007|Treatment Period 1|Adverse Event|0|||
124475707|NCT00792298|447697937|FG000|Treatment Period 1|Lack of Efficacy|0|||
124475708|NCT00792298|447697938|FG001|Treatment Period 1|Lack of Efficacy|0|||
124475709|NCT00792298|447697939|FG002|Treatment Period 1|Lack of Efficacy|1|||
124475710|NCT00792298|447697940|FG003|Treatment Period 1|Lack of Efficacy|0|||
124475711|NCT00792298|447697941|FG004|Treatment Period 1|Lack of Efficacy|0|||
124475712|NCT00792298|447697942|FG005|Treatment Period 1|Lack of Efficacy|0|||
124475713|NCT00792298|447697943|FG006|Treatment Period 1|Lack of Efficacy|0|||
124475714|NCT00792298|447697944|FG007|Treatment Period 1|Lack of Efficacy|0|||
124475715|NCT00792298|447697937|FG000|Treatment Period 1|Withdrawal by Subject|1|||
124475716|NCT00792298|447697938|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124475717|NCT00792298|447697939|FG002|Treatment Period 1|Withdrawal by Subject|1|||
124475718|NCT00792298|447697940|FG003|Treatment Period 1|Withdrawal by Subject|2|||
124475719|NCT00792298|447697941|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124475720|NCT00792298|447697942|FG005|Treatment Period 1|Withdrawal by Subject|2|||
124475721|NCT00792298|447697943|FG006|Treatment Period 1|Withdrawal by Subject|1|||
124475722|NCT00792298|447697944|FG007|Treatment Period 1|Withdrawal by Subject|0|||
124475723|NCT00792298|447697937|FG000|Treatment Period 1|Lost to Follow-up|0|||
124475724|NCT00792298|447697938|FG001|Treatment Period 1|Lost to Follow-up|0|||
124475725|NCT00792298|447697939|FG002|Treatment Period 1|Lost to Follow-up|0|||
124475726|NCT00792298|447697940|FG003|Treatment Period 1|Lost to Follow-up|0|||
124475727|NCT00792298|447697941|FG004|Treatment Period 1|Lost to Follow-up|0|||
124475728|NCT00792298|447697942|FG005|Treatment Period 1|Lost to Follow-up|0|||
124475729|NCT00792298|447697943|FG006|Treatment Period 1|Lost to Follow-up|1|||
124475730|NCT00792298|447697944|FG007|Treatment Period 1|Lost to Follow-up|0|||
124475731|NCT00792298|447697937|FG000|Treatment Period 1|Physician Decision|0|||
124475732|NCT00792298|447697938|FG001|Treatment Period 1|Physician Decision|0|||
124475733|NCT00792298|447697939|FG002|Treatment Period 1|Physician Decision|0|||
124475734|NCT00792298|447697940|FG003|Treatment Period 1|Physician Decision|1|||
124475735|NCT00792298|447697941|FG004|Treatment Period 1|Physician Decision|0|||
124475736|NCT00792298|447697942|FG005|Treatment Period 1|Physician Decision|0|||
124475737|NCT00792298|447697943|FG006|Treatment Period 1|Physician Decision|1|||
124475738|NCT00792298|447697944|FG007|Treatment Period 1|Physician Decision|0|||
124475739|NCT00792298|447697937|FG000|Treatment Period 1|Protocol Violation|0|||
124475740|NCT00792298|447697938|FG001|Treatment Period 1|Protocol Violation|0|||
124475741|NCT00792298|447697939|FG002|Treatment Period 1|Protocol Violation|0|||
124475742|NCT00792298|447697940|FG003|Treatment Period 1|Protocol Violation|0|||
124475743|NCT00792298|447697941|FG004|Treatment Period 1|Protocol Violation|0|||
124475744|NCT00792298|447697942|FG005|Treatment Period 1|Protocol Violation|0|||
124475745|NCT00792298|447697943|FG006|Treatment Period 1|Protocol Violation|0|||
124475746|NCT00792298|447697944|FG007|Treatment Period 1|Protocol Violation|1|||
124475747|NCT00792298|447697937|FG000|Washout|Adverse Event|0|||
124475748|NCT00792298|447697938|FG001|Washout|Adverse Event|0|||
124475749|NCT00792298|447697939|FG002|Washout|Adverse Event|0|||
124475750|NCT00792298|447697940|FG003|Washout|Adverse Event|0|||
124475751|NCT00792298|447697941|FG004|Washout|Adverse Event|0|||
124475752|NCT00792298|447697942|FG005|Washout|Adverse Event|1|||
124475753|NCT00792298|447697943|FG006|Washout|Adverse Event|0|||
124475754|NCT00792298|447697944|FG007|Washout|Adverse Event|0|||
124475755|NCT00792298|447697937|FG000|Washout|Withdrawal by Subject|0|||
124475756|NCT00792298|447697938|FG001|Washout|Withdrawal by Subject|0|||
124475757|NCT00792298|447697939|FG002|Washout|Withdrawal by Subject|1|||
124475758|NCT00792298|447697940|FG003|Washout|Withdrawal by Subject|0|||
124475759|NCT00792298|447697941|FG004|Washout|Withdrawal by Subject|0|||
124475760|NCT00792298|447697942|FG005|Washout|Withdrawal by Subject|1|||
124475761|NCT00792298|447697943|FG006|Washout|Withdrawal by Subject|0|||
124475762|NCT00792298|447697944|FG007|Washout|Withdrawal by Subject|0|||
124475763|NCT00792298|447697937|FG000|Treatment Period 2|Lack of Efficacy|0|||
124475764|NCT00792298|447697938|FG001|Treatment Period 2|Lack of Efficacy|0|||
124475765|NCT00792298|447697939|FG002|Treatment Period 2|Lack of Efficacy|0|||
124475766|NCT00792298|447697940|FG003|Treatment Period 2|Lack of Efficacy|0|||
124475767|NCT00792298|447697941|FG004|Treatment Period 2|Lack of Efficacy|1|||
124475768|NCT00792298|447697942|FG005|Treatment Period 2|Lack of Efficacy|0|||
124556423|NCT01165242|447995779|FG000|Overall Study|Lost to Follow-up|9|||
124475769|NCT00792298|447697943|FG006|Treatment Period 2|Lack of Efficacy|0|||
124475770|NCT00792298|447697944|FG007|Treatment Period 2|Lack of Efficacy|0|||
124475771|NCT00792298|447697937|FG000|Treatment Period 2|Physician Decision|0|||
124475772|NCT00792298|447697938|FG001|Treatment Period 2|Physician Decision|0|||
124475773|NCT00792298|447697939|FG002|Treatment Period 2|Physician Decision|0|||
124475774|NCT00792298|447697940|FG003|Treatment Period 2|Physician Decision|0|||
124475775|NCT00792298|447697941|FG004|Treatment Period 2|Physician Decision|0|||
124718981|NCT01277822|448592820|FG001|Overall Study|Adverse Event|1|||
124718982|NCT01277822|448592819|FG000|Overall Study|Withdrawal by Subject|6|||
124475776|NCT00792298|447697942|FG005|Treatment Period 2|Physician Decision|0|||
124475777|NCT00792298|447697943|FG006|Treatment Period 2|Physician Decision|1|||
124475778|NCT00792298|447697944|FG007|Treatment Period 2|Physician Decision|0|||
124475779|NCT00792298|447697937|FG000|Treatment Period 2|Pregnancy|0|||
124475780|NCT00792298|447697938|FG001|Treatment Period 2|Pregnancy|0|||
124475781|NCT00792298|447697939|FG002|Treatment Period 2|Pregnancy|1|||
124475782|NCT00792298|447697940|FG003|Treatment Period 2|Pregnancy|0|||
124475783|NCT00792298|447697941|FG004|Treatment Period 2|Pregnancy|0|||
124475784|NCT00792298|447697942|FG005|Treatment Period 2|Pregnancy|0|||
124475785|NCT00792298|447697943|FG006|Treatment Period 2|Pregnancy|0|||
124718983|NCT01277822|448592820|FG001|Overall Study|Withdrawal by Subject|7|||
124718984|NCT01277822|448592819|FG000|Overall Study|Physician Decision|1|||
124475786|NCT00792298|447697944|FG007|Treatment Period 2|Pregnancy|0|||
124475787|NCT00792298|447697937|FG000|Treatment Period 2|Withdrawal by Subject|1|||
124718985|NCT01277822|448592820|FG001|Overall Study|Physician Decision|1|||
124556424|NCT01165242|447995780|FG001|Overall Study|Lost to Follow-up|7|||
124718986|NCT01277822|448592819|FG000|Overall Study|Protocol Violation|1|||
124718987|NCT01277822|448592820|FG001|Overall Study|Protocol Violation|0|||
124718988|NCT01277822|448592819|FG000|Overall Study|Lost to Follow-up|2|||
124718989|NCT01277822|448592820|FG001|Overall Study|Lost to Follow-up|1|||
124718990|NCT01277822|448592819|FG000|Overall Study|Contraindicated medication used|2|||
124718991|NCT01277822|448592820|FG001|Overall Study|Contraindicated medication used|1|||
124718992|NCT01277822|448592819|FG000|Overall Study|Participant moved|1|||
124718993|NCT01277822|448592820|FG001|Overall Study|Participant moved|0|||
124556425|NCT01165242|447995781|FG002|Overall Study|Lost to Follow-up|10|||
124718994|NCT02625220|448592821|FG000|Overall Study|Adverse Event|2|||
124718995|NCT02625220|448592821|FG000|Overall Study|Lost to Follow-up|2|||
124718996|NCT02625220|448592821|FG000|Overall Study|Protocol Violation|1|||
124718997|NCT02625220|448592821|FG000|Overall Study|Study discontinued at site|2|||
124718998|NCT02923531|448592822|FG000|Overall Study|Adverse Event|4|||
124718999|NCT02923531|448592822|FG000|Overall Study|Clinical Deterioration|1|||
124719000|NCT02923531|448592822|FG000|Overall Study|Disease Progression|3|||
124719001|NCT02923531|448592822|FG000|Overall Study|Study Termination|1|||
124719002|NCT01140867|448592823|FG000|Overall Study|Adverse Event|22|||
124719003|NCT01140867|448592823|FG000|Overall Study|Lack of Efficacy|3|||
124719004|NCT01140867|448592823|FG000|Overall Study|Lost to Follow-up|2|||
124719005|NCT01140867|448592823|FG000|Overall Study|Withdrawal by Subject|1|||
124719006|NCT01140867|448592823|FG000|Overall Study|Protocol Violation|1|||
124719007|NCT01140867|448592823|FG000|Overall Study|Uncooperative patient|2|||
124719008|NCT01140867|448592823|FG000|Overall Study|Medication Noncompliance|2|||
124719009|NCT01119066|448592824|FG000|Overall Study|Withdrawal by Subject|4|||
124719010|NCT01119066|448592825|FG001|Overall Study|Withdrawal by Subject|6|||
124719011|NCT01119066|448592826|FG002|Overall Study|Withdrawal by Subject|0|||
124719012|NCT01119066|448592827|FG003|Overall Study|Withdrawal by Subject|0|||
124719013|NCT01119066|448592824|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
124719014|NCT01119066|448592825|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
124719015|NCT01119066|448592826|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
124719016|NCT01119066|448592827|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
124719017|NCT01119066|448592824|FG000|Overall Study|Relapse identified before transplant|1|||
124719018|NCT01119066|448592825|FG001|Overall Study|Relapse identified before transplant|0|||
124719019|NCT01119066|448592826|FG002|Overall Study|Relapse identified before transplant|0|||
124719020|NCT01119066|448592827|FG003|Overall Study|Relapse identified before transplant|0|||
124719021|NCT01119066|448592824|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
124719022|NCT01119066|448592825|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
124719023|NCT01119066|448592826|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
124719024|NCT01119066|448592827|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
124719025|NCT01119066|448592824|FG000|Overall Study|Relapse identified before transplant|0|||
124719026|NCT01119066|448592825|FG001|Overall Study|Relapse identified before transplant|4|||
124719027|NCT01119066|448592826|FG002|Overall Study|Relapse identified before transplant|0|||
124719028|NCT01119066|448592827|FG003|Overall Study|Relapse identified before transplant|0|||
124719029|NCT04396795|448592828|FG000|Month 1|Lost to Follow-up|2|||
124719030|NCT04396795|448592829|FG001|Month 1|Lost to Follow-up|3|||
124719031|NCT04396795|448592828|FG000|Month 3|Lost to Follow-up|1|||
124719032|NCT04396795|448592829|FG001|Month 3|Lost to Follow-up|3|||
124719033|NCT04396795|448592828|FG000|Month 6|Lost to Follow-up|3|||
124719034|NCT04396795|448592829|FG001|Month 6|Lost to Follow-up|3|||
124719035|NCT02366923|448592830|FG000|Overall Study|Withdrawal by Subject|1|||
124719036|NCT02366923|448592830|FG000|Overall Study|Positive Slit Lamp Findings|2|||
124719037|NCT02366923|448592830|FG000|Overall Study|High Astigmatism|3|||
124719038|NCT03902392|448592834|FG000|Overall Study|Lost to Follow-up|7|||
124719039|NCT03902392|448592835|FG001|Overall Study|Lost to Follow-up|7|||
124719040|NCT00431444|448592836|FG000|Overall Study|Protocol Violation|1|||
124719041|NCT00431444|448592837|FG001|Overall Study|Protocol Violation|4|||
124719042|NCT00431444|448592836|FG000|Overall Study|Adverse Event|2|||
124719043|NCT00431444|448592837|FG001|Overall Study|Adverse Event|1|||
124719044|NCT00431444|448592836|FG000|Overall Study|Withdrawal by Subject|1|||
124719045|NCT00431444|448592837|FG001|Overall Study|Withdrawal by Subject|1|||
124719046|NCT00431444|448592836|FG000|Overall Study|Lost to Follow-up|1|||
124719047|NCT00431444|448592837|FG001|Overall Study|Lost to Follow-up|0|||
124719048|NCT00431444|448592836|FG000|Overall Study|Administrative Problems|0|||
124719049|NCT00431444|448592837|FG001|Overall Study|Administrative Problems|1|||
124719050|NCT00556439|448592852|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
124719051|NCT00556439|448592853|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
124719052|NCT00556439|448592854|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
124719053|NCT00556439|448592855|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
124719054|NCT00556439|448592852|FG000|Study Entry to Week 12|Physician Decision|1|||
124719055|NCT00556439|448592853|FG001|Study Entry to Week 12|Physician Decision|0|||
124719056|NCT00556439|448592854|FG002|Study Entry to Week 12|Physician Decision|0|||
124719057|NCT00556439|448592855|FG003|Study Entry to Week 12|Physician Decision|0|||
124719058|NCT00556439|448592852|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
124475788|NCT00792298|447697938|FG001|Treatment Period 2|Withdrawal by Subject|1|||
124475789|NCT00792298|447697939|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124475790|NCT00792298|447697940|FG003|Treatment Period 2|Withdrawal by Subject|2|||
124475791|NCT00792298|447697941|FG004|Treatment Period 2|Withdrawal by Subject|1|||
124475792|NCT00792298|447697942|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124475793|NCT00792298|447697943|FG006|Treatment Period 2|Withdrawal by Subject|0|||
124475794|NCT00792298|447697944|FG007|Treatment Period 2|Withdrawal by Subject|2|||
124475795|NCT04258579|447697945|FG000|Overall Study|Withdrawal by Subject|7|||
124475796|NCT04258579|447697945|FG000|Overall Study|Lost to Follow-up|3|||
124475797|NCT04258579|447697945|FG000|Overall Study|Protocol Violation|2|||
124475798|NCT04258579|447697945|FG000|Overall Study|Adverse Event|1|||
124475799|NCT02388295|447697946|FG000|Dose Escalation Week 1|Adverse Event|1|||
124475800|NCT02388295|447697947|FG001|Dose Escalation Week 1|Adverse Event|2|||
124475801|NCT02388295|447697948|FG002|Dose Escalation Week 1|Adverse Event|1|||
124475802|NCT02388295|447697946|FG000|Dose Escalation Week 1|Determined not eligible|1|||
124475803|NCT02388295|447697947|FG001|Dose Escalation Week 1|Determined not eligible|1|||
124475804|NCT02388295|447697948|FG002|Dose Escalation Week 1|Determined not eligible|1|||
124475805|NCT02388295|447697946|FG000|Dose Escalation Week 2|Protocol Violation|0|||
124475806|NCT02388295|447697947|FG001|Dose Escalation Week 2|Protocol Violation|1|||
124475807|NCT02388295|447697948|FG002|Dose Escalation Week 2|Protocol Violation|0|||
124475808|NCT02388295|447697946|FG000|Dose Escalation Week 2|Determined not eligible|1|||
124475809|NCT02388295|447697947|FG001|Dose Escalation Week 2|Determined not eligible|1|||
124475810|NCT02388295|447697948|FG002|Dose Escalation Week 2|Determined not eligible|1|||
124475811|NCT02388295|447697946|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
124475812|NCT02388295|447697947|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
124475813|NCT02388295|447697948|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
124475814|NCT02076165|447697949|FG000|Overall Study|Lost to Follow-up|7|||
124475815|NCT02076165|447697950|FG001|Overall Study|Lost to Follow-up|5|||
124475816|NCT02076165|447697949|FG000|Overall Study|Refused follow-up assessment|1|||
124475817|NCT02076165|447697950|FG001|Overall Study|Refused follow-up assessment|1|||
124475818|NCT01756456|447697951|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
124475819|NCT01756456|447697952|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
124475820|NCT01756456|447697953|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
124475821|NCT01756456|447697954|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
124475822|NCT01756456|447697955|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
124475823|NCT01756456|447697956|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
124475824|NCT01756456|447697951|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
124475825|NCT01756456|447697952|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
124475826|NCT01756456|447697953|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
124475827|NCT01756456|447697954|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
124475828|NCT01756456|447697955|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
124475829|NCT01756456|447697956|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
124475830|NCT01756456|447697951|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
124475831|NCT01756456|447697952|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
124475832|NCT01756456|447697953|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
124475833|NCT01756456|447697954|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
124475834|NCT01756456|447697955|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
124475835|NCT01756456|447697956|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
124719059|NCT00556439|448592853|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
124719060|NCT00556439|448592854|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
124719061|NCT00556439|448592855|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
124719062|NCT00556439|448592852|FG000|Study Entry to Week 12|Recurrent infection|1|||
124719063|NCT00556439|448592853|FG001|Study Entry to Week 12|Recurrent infection|0|||
124719064|NCT00556439|448592854|FG002|Study Entry to Week 12|Recurrent infection|0|||
124719065|NCT00556439|448592855|FG003|Study Entry to Week 12|Recurrent infection|0|||
124719066|NCT00556439|448592852|FG000|Study Entry to Week 12|Malignancy|0|||
124556426|NCT03770000|447995782|FG000|Overall Study|Premature discontinuation due to PD|0|||
124556427|NCT03770000|447995783|FG001|Overall Study|Premature discontinuation due to PD|0|||
124556428|NCT03770000|447995784|FG002|Overall Study|Premature discontinuation due to PD|1|||
124556429|NCT03770000|447995785|FG003|Overall Study|Premature discontinuation due to PD|3|||
124556430|NCT03770000|447995786|FG004|Overall Study|Premature discontinuation due to PD|2|||
124556431|NCT03877237|447995787|FG000|Overall Study|Adverse Event|1|||
124556432|NCT03877237|447995788|FG001|Overall Study|Adverse Event|2|||
124556433|NCT03877237|447995787|FG000|Overall Study|Death|3|||
124556434|NCT03877237|447995788|FG001|Overall Study|Death|2|||
124556435|NCT03877237|447995787|FG000|Overall Study|Physician Decision|1|||
124556436|NCT03877237|447995788|FG001|Overall Study|Physician Decision|0|||
124556437|NCT03877237|447995787|FG000|Overall Study|Withdrawal by Subject|0|||
124556438|NCT03877237|447995788|FG001|Overall Study|Withdrawal by Subject|2|||
124556439|NCT00566098|447995790|FG000|Collection of MILs|Withdrawal by Subject|1|||
124556440|NCT00566098|447995790|FG000|Collection of MILs|Relapsed|1|||
124556441|NCT00566098|447995790|FG000|Generation of MILs Product|Relapsed|1|||
124556442|NCT00566098|447995790|FG000|Administration of ASCT+MILs|Death|10|||
124556443|NCT00566098|447995790|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
124556444|NCT02236754|447995791|FG000|Overall Study|Withdrawal by Subject|1|||
124556445|NCT02236754|447995792|FG001|Overall Study|Withdrawal by Subject|0|||
124556446|NCT00382291|447995793|FG000|Overall Study|Adverse Event|1|||
124556447|NCT00382291|447995794|FG001|Overall Study|Adverse Event|2|||
124556448|NCT00382291|447995795|FG002|Overall Study|Adverse Event|2|||
124556449|NCT00382291|447995793|FG000|Overall Study|Protocol Violation|1|||
124556450|NCT00382291|447995794|FG001|Overall Study|Protocol Violation|0|||
124556451|NCT00382291|447995795|FG002|Overall Study|Protocol Violation|0|||
124556452|NCT00382291|447995793|FG000|Overall Study|Temporary study suspension|2|||
124556453|NCT00382291|447995794|FG001|Overall Study|Temporary study suspension|2|||
124556454|NCT00382291|447995795|FG002|Overall Study|Temporary study suspension|5|||
124556455|NCT00382291|447995793|FG000|Overall Study|Withdrawal by Subject|0|||
124556456|NCT00382291|447995794|FG001|Overall Study|Withdrawal by Subject|2|||
124556457|NCT00382291|447995795|FG002|Overall Study|Withdrawal by Subject|0|||
124556458|NCT00382291|447995793|FG000|Overall Study|Physician Decision|0|||
124556459|NCT00382291|447995794|FG001|Overall Study|Physician Decision|1|||
124556460|NCT00382291|447995795|FG002|Overall Study|Physician Decision|0|||
124556461|NCT00382291|447995793|FG000|Overall Study|Lack of Efficacy|0|||
124556462|NCT00382291|447995794|FG001|Overall Study|Lack of Efficacy|0|||
124556463|NCT00382291|447995795|FG002|Overall Study|Lack of Efficacy|1|||
124556464|NCT01681771|447995800|FG000|Overall Study|Lost to Follow-up|4|||
124556465|NCT01681771|447995801|FG001|Overall Study|Lost to Follow-up|2|||
124556466|NCT00265083|447995802|FG000|Overall Study|Adverse Event|5|||
124556467|NCT00265083|447995803|FG001|Overall Study|Adverse Event|13|||
124556468|NCT00265083|447995804|FG002|Overall Study|Adverse Event|15|||
124556469|NCT00265083|447995802|FG000|Overall Study|Lost to Follow-up|3|||
124556470|NCT00265083|447995803|FG001|Overall Study|Lost to Follow-up|4|||
124556471|NCT00265083|447995804|FG002|Overall Study|Lost to Follow-up|4|||
124556472|NCT00265083|447995802|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
124556473|NCT00265083|447995803|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
124556474|NCT00265083|447995804|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
124556475|NCT00265083|447995802|FG000|Overall Study|Other|1|||
124556476|NCT00265083|447995803|FG001|Overall Study|Other|12|||
124556477|NCT00265083|447995804|FG002|Overall Study|Other|9|||
124556478|NCT04242186|447995809|FG000|Overall Study|Death|5|||
124556479|NCT01155063|447995810|FG000|Overall Study|Adverse Event|1|||
124556480|NCT01155063|447995810|FG000|Overall Study|Withdrawal by Subject|1|||
124556481|NCT01155063|447995810|FG000|Overall Study|Study terminated by sponsor|87|||
124556482|NCT01314703|447995811|FG000|Overall Study|screen failure and closed enrollment|8|||
124556483|NCT00597584|447995812|FG000|Overall Study|Adverse Event|4|||
124556484|NCT00597584|447995813|FG001|Overall Study|Adverse Event|2|||
124556485|NCT00597584|447995812|FG000|Overall Study|Death|53|||
124556486|NCT00597584|447995813|FG001|Overall Study|Death|30|||
124556487|NCT00597584|447995812|FG000|Overall Study|Lack of Efficacy|1|||
124556488|NCT00597584|447995813|FG001|Overall Study|Lack of Efficacy|0|||
124556489|NCT00597584|447995812|FG000|Overall Study|Lost to Follow-up|2|||
124719067|NCT00556439|448592853|FG001|Study Entry to Week 12|Malignancy|0|||
124556490|NCT00597584|447995813|FG001|Overall Study|Lost to Follow-up|4|||
124556491|NCT00597584|447995812|FG000|Overall Study|Physician Decision|3|||
124556492|NCT00597584|447995813|FG001|Overall Study|Physician Decision|0|||
124719068|NCT00556439|448592854|FG002|Study Entry to Week 12|Malignancy|1|||
124556493|NCT00597584|447995812|FG000|Overall Study|Pregnancy|2|||
124556494|NCT00597584|447995813|FG001|Overall Study|Pregnancy|0|||
124556495|NCT00597584|447995812|FG000|Overall Study|Withdrawal by Subject|44|||
124556496|NCT00597584|447995813|FG001|Overall Study|Withdrawal by Subject|12|||
124556497|NCT00597584|447995812|FG000|Overall Study|Discontinued Dialysis|0|||
124556498|NCT00597584|447995813|FG001|Overall Study|Discontinued Dialysis|1|||
124719069|NCT00556439|448592855|FG003|Study Entry to Week 12|Malignancy|0|||
124475836|NCT01756456|447697951|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
124475837|NCT01756456|447697952|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
124475838|NCT01756456|447697953|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
124475839|NCT01756456|447697954|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
124475840|NCT01756456|447697955|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
124475841|NCT01756456|447697956|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
124475842|NCT01756456|447697951|FG000|Treatment Period: Phase I/II|Other causes|0|||
124475843|NCT01756456|447697952|FG001|Treatment Period: Phase I/II|Other causes|0|||
124475844|NCT01756456|447697953|FG002|Treatment Period: Phase I/II|Other causes|0|||
124475845|NCT01756456|447697954|FG003|Treatment Period: Phase I/II|Other causes|1|||
124475846|NCT01756456|447697955|FG004|Treatment Period: Phase I/II|Other causes|2|||
124475847|NCT01756456|447697956|FG005|Treatment Period: Phase I/II|Other causes|2|||
124475848|NCT01756456|447697951|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
124475849|NCT01756456|447697952|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
124475850|NCT01756456|447697953|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
124475851|NCT01756456|447697954|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
124475852|NCT01756456|447697955|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
124475853|NCT01756456|447697956|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
124475854|NCT01756456|447697951|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
124475855|NCT01756456|447697952|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
124475856|NCT01756456|447697953|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
124475857|NCT01756456|447697954|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
124475858|NCT01756456|447697955|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
124475859|NCT01756456|447697956|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
124475860|NCT01756456|447697951|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
124475861|NCT01756456|447697952|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
124475862|NCT01756456|447697953|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
124475863|NCT01756456|447697954|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
124475864|NCT01756456|447697955|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
124475865|NCT01756456|447697956|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
124475866|NCT01756456|447697951|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
124475867|NCT01756456|447697952|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
124719070|NCT00556439|448592852|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
124719071|NCT00556439|448592853|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
124556499|NCT00597584|447995812|FG000|Overall Study|Lost ability to consent|1|||
124556500|NCT00597584|447995813|FG001|Overall Study|Lost ability to consent|1|||
124719072|NCT00556439|448592854|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
124556501|NCT00597584|447995812|FG000|Overall Study|Never dosed|1|||
124719073|NCT00556439|448592855|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
124719074|NCT00556439|448592852|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
124719075|NCT00556439|448592853|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
124719076|NCT00556439|448592854|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
124719077|NCT00556439|448592855|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
124719078|NCT00556439|448592852|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
124719079|NCT00556439|448592853|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
124719080|NCT00556439|448592854|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
124719081|NCT00556439|448592855|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
124719082|NCT00556439|448592852|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
124719083|NCT00556439|448592853|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
124719084|NCT00556439|448592854|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
124719085|NCT00556439|448592855|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
124719086|NCT02100423|448592857|FG000|Overall Study|Death|1|||
124719087|NCT02100423|448592857|FG000|Overall Study|Withdrawal by Subject|3|||
124719088|NCT02100423|448592857|FG000|Overall Study|Adverse Event|1|||
124719089|NCT02100423|448592857|FG000|Overall Study|Physician Decision|1|||
124719090|NCT02931838|448592858|FG000|Overall Study|Reason not provided by investigator|1|||
124719091|NCT02931838|448592859|FG001|Overall Study|Reason not provided by investigator|0|||
124719092|NCT02931838|448592860|FG002|Overall Study|Reason not provided by investigator|1|||
124719093|NCT02931838|448592861|FG003|Overall Study|Reason not provided by investigator|0|||
124719094|NCT02931838|448592862|FG004|Overall Study|Reason not provided by investigator|0|||
124719095|NCT02931838|448592863|FG005|Overall Study|Reason not provided by investigator|0|||
124719096|NCT02931838|448592858|FG000|Overall Study|Poor/non-compliance|0|||
124719097|NCT02931838|448592859|FG001|Overall Study|Poor/non-compliance|0|||
124719098|NCT02931838|448592860|FG002|Overall Study|Poor/non-compliance|1|||
124719099|NCT02931838|448592861|FG003|Overall Study|Poor/non-compliance|0|||
124719100|NCT02931838|448592862|FG004|Overall Study|Poor/non-compliance|0|||
124719101|NCT02931838|448592863|FG005|Overall Study|Poor/non-compliance|0|||
124719102|NCT02931838|448592858|FG000|Overall Study|Lack of Efficacy|5|||
124719103|NCT02931838|448592859|FG001|Overall Study|Lack of Efficacy|4|||
124719104|NCT02931838|448592860|FG002|Overall Study|Lack of Efficacy|0|||
124719105|NCT02931838|448592861|FG003|Overall Study|Lack of Efficacy|0|||
124719106|NCT02931838|448592862|FG004|Overall Study|Lack of Efficacy|0|||
124719107|NCT02931838|448592863|FG005|Overall Study|Lack of Efficacy|1|||
124719108|NCT02931838|448592858|FG000|Overall Study|Lost to Follow-up|1|||
124719109|NCT02931838|448592859|FG001|Overall Study|Lost to Follow-up|0|||
124719110|NCT02931838|448592860|FG002|Overall Study|Lost to Follow-up|1|||
124719111|NCT02931838|448592861|FG003|Overall Study|Lost to Follow-up|1|||
124719112|NCT02931838|448592862|FG004|Overall Study|Lost to Follow-up|2|||
124719113|NCT02931838|448592863|FG005|Overall Study|Lost to Follow-up|0|||
124719114|NCT02931838|448592858|FG000|Overall Study|Subject request to discontinue treatment|4|||
124719115|NCT02931838|448592859|FG001|Overall Study|Subject request to discontinue treatment|3|||
124719116|NCT02931838|448592860|FG002|Overall Study|Subject request to discontinue treatment|3|||
124719117|NCT02931838|448592861|FG003|Overall Study|Subject request to discontinue treatment|0|||
124719118|NCT02931838|448592862|FG004|Overall Study|Subject request to discontinue treatment|1|||
124475868|NCT01756456|447697953|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
124475869|NCT01756456|447697954|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
124475870|NCT01756456|447697955|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
124475871|NCT01756456|447697956|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
124475872|NCT01756456|447697951|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
124475873|NCT01756456|447697952|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
124475874|NCT01756456|447697953|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
124475875|NCT01756456|447697954|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
124475876|NCT01756456|447697955|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
124475877|NCT01756456|447697956|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
124475878|NCT01756456|447697951|FG000|Follow Up Period Phase I/II|Other causes|0|||
124475879|NCT01756456|447697952|FG001|Follow Up Period Phase I/II|Other causes|0|||
124475880|NCT01756456|447697953|FG002|Follow Up Period Phase I/II|Other causes|0|||
124475881|NCT01756456|447697954|FG003|Follow Up Period Phase I/II|Other causes|1|||
124475882|NCT01756456|447697955|FG004|Follow Up Period Phase I/II|Other causes|3|||
124475883|NCT01756456|447697956|FG005|Follow Up Period Phase I/II|Other causes|5|||
124475884|NCT00974220|447697958|FG000|Treatment Period 1|Adverse Event|2|||
124475885|NCT00974220|447697959|FG001|Treatment Period 1|Adverse Event|1|||
124475886|NCT00974220|447697958|FG000|Treatment Period 1|noncompliant subjects|0|||
124475887|NCT00974220|447697959|FG001|Treatment Period 1|noncompliant subjects|1|||
124475888|NCT01850615|447697960|FG000|Overall Study|Protocol Violation|4|||
124719119|NCT02931838|448592863|FG005|Overall Study|Subject request to discontinue treatment|0|||
124719120|NCT02931838|448592858|FG000|Overall Study|Withdrawal by Subject|1|||
124719121|NCT02931838|448592859|FG001|Overall Study|Withdrawal by Subject|2|||
124475889|NCT01850615|447697961|FG001|Overall Study|Protocol Violation|1|||
124475890|NCT01850615|447697960|FG000|Overall Study|Adverse Event|2|||
124475891|NCT01850615|447697961|FG001|Overall Study|Adverse Event|1|||
124719122|NCT02931838|448592860|FG002|Overall Study|Withdrawal by Subject|0|||
124719123|NCT02931838|448592861|FG003|Overall Study|Withdrawal by Subject|1|||
124719124|NCT02931838|448592862|FG004|Overall Study|Withdrawal by Subject|0|||
124719125|NCT02931838|448592863|FG005|Overall Study|Withdrawal by Subject|0|||
124719126|NCT02931838|448592858|FG000|Overall Study|Adverse Event|2|||
124719127|NCT02931838|448592859|FG001|Overall Study|Adverse Event|1|||
124719128|NCT02931838|448592860|FG002|Overall Study|Adverse Event|2|||
124719129|NCT02931838|448592861|FG003|Overall Study|Adverse Event|1|||
124719130|NCT02931838|448592862|FG004|Overall Study|Adverse Event|3|||
124719131|NCT02931838|448592863|FG005|Overall Study|Adverse Event|1|||
124719132|NCT02701764|448592864|FG000|Overall Study|Lost to Follow-up|0|||
124719133|NCT02701764|448592865|FG001|Overall Study|Lost to Follow-up|1|||
124719134|NCT02949024|448592868|FG000|Overall Study|Withdrawal by Subject|0|||
124719135|NCT02949024|448592869|FG001|Overall Study|Withdrawal by Subject|1|||
124719136|NCT01027650|448592870|FG000|Overall Study|Personal Reasons|0|||
124719137|NCT01027650|448592871|FG001|Overall Study|Personal Reasons|0|||
124719138|NCT01027650|448592872|FG002|Overall Study|Personal Reasons|0|||
124719139|NCT01027650|448592873|FG003|Overall Study|Personal Reasons|0|||
124719140|NCT01027650|448592874|FG004|Overall Study|Personal Reasons|2|||
124719141|NCT01027650|448592875|FG005|Overall Study|Personal Reasons|1|||
124556502|NCT00597584|447995813|FG001|Overall Study|Never dosed|0|||
124556503|NCT00597584|447995812|FG000|Overall Study|Relocation|8|||
124719142|NCT01027650|448592876|FG006|Overall Study|Personal Reasons|0|||
124719143|NCT01027650|448592877|FG007|Overall Study|Personal Reasons|0|||
124719144|NCT01027650|448592870|FG000|Overall Study|Lost to Follow-up|0|||
124719145|NCT01027650|448592871|FG001|Overall Study|Lost to Follow-up|0|||
124719146|NCT01027650|448592872|FG002|Overall Study|Lost to Follow-up|0|||
124719147|NCT01027650|448592873|FG003|Overall Study|Lost to Follow-up|0|||
124719148|NCT01027650|448592874|FG004|Overall Study|Lost to Follow-up|0|||
124719149|NCT01027650|448592875|FG005|Overall Study|Lost to Follow-up|0|||
124719150|NCT01027650|448592876|FG006|Overall Study|Lost to Follow-up|1|||
124719151|NCT01027650|448592877|FG007|Overall Study|Lost to Follow-up|0|||
124719152|NCT01027650|448592870|FG000|Overall Study|Lack of Efficacy|0|||
124719153|NCT01027650|448592871|FG001|Overall Study|Lack of Efficacy|0|||
124719154|NCT01027650|448592872|FG002|Overall Study|Lack of Efficacy|0|||
124719155|NCT01027650|448592873|FG003|Overall Study|Lack of Efficacy|0|||
124719156|NCT01027650|448592874|FG004|Overall Study|Lack of Efficacy|0|||
124719157|NCT01027650|448592875|FG005|Overall Study|Lack of Efficacy|1|||
124719158|NCT01027650|448592876|FG006|Overall Study|Lack of Efficacy|0|||
124475892|NCT01850615|447697960|FG000|Overall Study|Withdrawal by Subject|3|||
124475893|NCT01850615|447697961|FG001|Overall Study|Withdrawal by Subject|1|||
124475894|NCT01850615|447697960|FG000|Overall Study|Lost to Follow-up|0|||
124475895|NCT01850615|447697961|FG001|Overall Study|Lost to Follow-up|1|||
124475896|NCT01850615|447697960|FG000|Overall Study|Unclassified|0|||
124475897|NCT01850615|447697961|FG001|Overall Study|Unclassified|1|||
124475898|NCT01375764|447697962|FG000|Overall Study|Lost to Follow-up|0|||
124719159|NCT01027650|448592877|FG007|Overall Study|Lack of Efficacy|0|||
124719160|NCT00912782|448592878|FG000|Overall Study|Death|2|||
124719161|NCT00912782|448592879|FG001|Overall Study|Death|1|||
124719162|NCT00912782|448592878|FG000|Overall Study|Lost to Follow-up|0|||
124719163|NCT00912782|448592879|FG001|Overall Study|Lost to Follow-up|1|||
124719164|NCT00912782|448592878|FG000|Overall Study|Did not receive vascular access type|1|||
124719165|NCT00912782|448592879|FG001|Overall Study|Did not receive vascular access type|2|||
124719166|NCT00912782|448592878|FG000|Overall Study|Relocated before study completion|0|||
124719167|NCT00912782|448592879|FG001|Overall Study|Relocated before study completion|1|||
124719168|NCT03419897|448594739|FG000|Overall Study|Death|180|||
124719169|NCT03419897|448594739|FG000|Overall Study|Lost to Follow-up|1|||
124719170|NCT03419897|448594739|FG000|Overall Study|Withdrawal by Subject|6|||
124719171|NCT03419897|448594739|FG000|Overall Study|Sponsor Decision|61|||
124719172|NCT03419897|448594739|FG000|Overall Study|Physician Decision|1|||
124719173|NCT02719691|448594741|FG000|Overall Study|Physician Decision|0|||
124719174|NCT02719691|448594742|FG001|Overall Study|Physician Decision|0|||
124719175|NCT02719691|448594743|FG002|Overall Study|Physician Decision|1|||
124719176|NCT02719691|448594744|FG003|Overall Study|Physician Decision|0|||
124719177|NCT02719691|448594745|FG004|Overall Study|Physician Decision|0|||
124556504|NCT00597584|447995813|FG001|Overall Study|Relocation|6|||
124556505|NCT00597584|447995812|FG000|Overall Study|Renal transplant|9|||
124475899|NCT01375764|447697963|FG001|Overall Study|Lost to Follow-up|1|||
124475900|NCT01375764|447697964|FG002|Overall Study|Lost to Follow-up|0|||
124475901|NCT01375764|447697965|FG003|Overall Study|Lost to Follow-up|0|||
124475902|NCT01375764|447697966|FG004|Overall Study|Lost to Follow-up|0|||
124475903|NCT01375764|447697962|FG000|Overall Study|Withdrawal by Subject|2|||
124475904|NCT01375764|447697963|FG001|Overall Study|Withdrawal by Subject|0|||
124475905|NCT01375764|447697964|FG002|Overall Study|Withdrawal by Subject|0|||
124475906|NCT01375764|447697965|FG003|Overall Study|Withdrawal by Subject|0|||
124475907|NCT01375764|447697966|FG004|Overall Study|Withdrawal by Subject|1|||
124475908|NCT01375764|447697962|FG000|Overall Study|Other|0|||
124475909|NCT01375764|447697963|FG001|Overall Study|Other|0|||
124475910|NCT01375764|447697964|FG002|Overall Study|Other|0|||
124475911|NCT01375764|447697965|FG003|Overall Study|Other|1|||
124475912|NCT01375764|447697966|FG004|Overall Study|Other|0|||
124475913|NCT02658812|447697967|FG000|Overall Study|Disease Progression|7|||
124475914|NCT02658812|447697967|FG000|Overall Study|Unrelated to study treatment|1|||
124475915|NCT02658812|447697967|FG000|Overall Study|Adverse Event|1|||
124475916|NCT01512264|447697968|FG000|Overall Study|Lost to Follow-up|0|||
124475917|NCT01512264|447697969|FG001|Overall Study|Lost to Follow-up|0|||
124475918|NCT01512264|447697970|FG002|Overall Study|Lost to Follow-up|0|||
124719178|NCT02719691|448594746|FG005|Overall Study|Physician Decision|0|||
124719179|NCT02719691|448594747|FG006|Overall Study|Physician Decision|0|||
124719180|NCT02719691|448594741|FG000|Overall Study|Withdrawal by Subject|0|||
124719181|NCT02719691|448594742|FG001|Overall Study|Withdrawal by Subject|0|||
124719182|NCT02719691|448594743|FG002|Overall Study|Withdrawal by Subject|0|||
124719183|NCT02719691|448594744|FG003|Overall Study|Withdrawal by Subject|0|||
124719184|NCT02719691|448594745|FG004|Overall Study|Withdrawal by Subject|0|||
124719185|NCT02719691|448594746|FG005|Overall Study|Withdrawal by Subject|1|||
124475919|NCT01512264|447697971|FG003|Overall Study|Lost to Follow-up|1|||
124475920|NCT01194440|447697972|FG000|Baseline (First Dose)|Reason not specified|4|||
124475921|NCT01194440|447697972|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
124556506|NCT00597584|447995813|FG001|Overall Study|Renal transplant|7|||
124475922|NCT01194440|447697972|FG000|Baseline (First Dose)|Change in therapy|1|||
124475923|NCT01194440|447697972|FG000|Baseline (First Dose)|Adverse Event|1|||
124719186|NCT02719691|448594747|FG006|Overall Study|Withdrawal by Subject|0|||
124719187|NCT00336284|448594748|FG000|Overall Study|Death|52|||
124719188|NCT00336284|448594749|FG001|Overall Study|Death|26|||
124719189|NCT00336284|448594748|FG000|Overall Study|Lost to Follow-up|82|||
124719190|NCT00336284|448594749|FG001|Overall Study|Lost to Follow-up|61|||
124719191|NCT00336284|448594748|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
124475924|NCT01194440|447697972|FG000|6-months (2nd Dose)|Change in therapy|4|||
124475925|NCT02675075|447697973|FG000|Overall Study|Lost to Follow-up|3|||
124719192|NCT00336284|448594749|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
124719193|NCT03308968|448594754|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
124719194|NCT03308968|448594755|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
124475926|NCT02675075|447697974|FG001|Overall Study|Lost to Follow-up|0|||
124556507|NCT02853929|447995820|FG000|Overall Study|Lost to Follow-up|3|||
124556508|NCT02853929|447995821|FG001|Overall Study|Lost to Follow-up|0|||
124556509|NCT02853929|447995820|FG000|Overall Study|Withdrawal by Subject|1|||
124556510|NCT02853929|447995821|FG001|Overall Study|Withdrawal by Subject|0|||
124556511|NCT02853929|447995820|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
124556512|NCT02853929|447995821|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
124556513|NCT02770716|447995822|FG000|Overall Study|Death|101|||
124556514|NCT02770716|447995823|FG001|Overall Study|Death|45|||
124556515|NCT02770716|447995822|FG000|Overall Study|Withdrawal by Subject|4|||
124719195|NCT03308968|448594756|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
124719196|NCT03308968|448594754|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
124719197|NCT03308968|448594755|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
124719198|NCT03308968|448594756|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
124719199|NCT03308968|448594754|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
124556516|NCT02770716|447995823|FG001|Overall Study|Withdrawal by Subject|2|||
124556517|NCT02770716|447995822|FG000|Overall Study|Lost to Follow-up|1|||
124556518|NCT02770716|447995823|FG001|Overall Study|Lost to Follow-up|0|||
124556519|NCT02770716|447995822|FG000|Overall Study|Various reasons|6|||
124556520|NCT02770716|447995823|FG001|Overall Study|Various reasons|2|||
124556521|NCT03989115|447995824|FG000|Overall Study|Withdrawal by Subject|2|||
124556522|NCT03989115|447995825|FG001|Overall Study|Withdrawal by Subject|1|||
124556523|NCT03989115|447995826|FG002|Overall Study|Withdrawal by Subject|3|||
124556524|NCT03989115|447995827|FG003|Overall Study|Withdrawal by Subject|0|||
124556525|NCT03989115|447995828|FG004|Overall Study|Withdrawal by Subject|17|||
124556526|NCT03989115|447995829|FG005|Overall Study|Withdrawal by Subject|1|||
124556527|NCT03989115|447995830|FG006|Overall Study|Withdrawal by Subject|0|||
124556528|NCT03989115|447995831|FG007|Overall Study|Withdrawal by Subject|0|||
124556529|NCT03989115|447995824|FG000|Overall Study|Sponsor decision to terminate the study|1|||
124556530|NCT03989115|447995825|FG001|Overall Study|Sponsor decision to terminate the study|1|||
124556531|NCT03989115|447995826|FG002|Overall Study|Sponsor decision to terminate the study|0|||
124556532|NCT03989115|447995827|FG003|Overall Study|Sponsor decision to terminate the study|1|||
124556533|NCT03989115|447995828|FG004|Overall Study|Sponsor decision to terminate the study|11|||
124556534|NCT03989115|447995829|FG005|Overall Study|Sponsor decision to terminate the study|0|||
124556535|NCT03989115|447995830|FG006|Overall Study|Sponsor decision to terminate the study|2|||
124556536|NCT03989115|447995831|FG007|Overall Study|Sponsor decision to terminate the study|1|||
124556537|NCT03989115|447995824|FG000|Overall Study|Lost to Follow-up|2|||
124556538|NCT03989115|447995825|FG001|Overall Study|Lost to Follow-up|0|||
124556539|NCT03989115|447995826|FG002|Overall Study|Lost to Follow-up|0|||
124556540|NCT03989115|447995827|FG003|Overall Study|Lost to Follow-up|0|||
124556541|NCT03989115|447995828|FG004|Overall Study|Lost to Follow-up|1|||
124556542|NCT03989115|447995829|FG005|Overall Study|Lost to Follow-up|0|||
124556543|NCT03989115|447995830|FG006|Overall Study|Lost to Follow-up|0|||
124556544|NCT03989115|447995831|FG007|Overall Study|Lost to Follow-up|0|||
124556545|NCT03989115|447995824|FG000|Overall Study|Death|2|||
124556546|NCT03989115|447995825|FG001|Overall Study|Death|2|||
124556547|NCT03989115|447995826|FG002|Overall Study|Death|9|||
124556548|NCT03989115|447995827|FG003|Overall Study|Death|6|||
124556549|NCT03989115|447995828|FG004|Overall Study|Death|31|||
124556550|NCT03989115|447995829|FG005|Overall Study|Death|6|||
124556551|NCT03989115|447995830|FG006|Overall Study|Death|2|||
124556552|NCT03989115|447995831|FG007|Overall Study|Death|3|||
124475927|NCT04957290|447697975|FG000|Overall Study|Progressive disease|3|||
124475928|NCT04957290|447697976|FG001|Overall Study|Progressive disease|3|||
124475929|NCT04957290|447697977|FG002|Overall Study|Progressive disease|2|||
124475930|NCT04957290|447697978|FG003|Overall Study|Progressive disease|0|||
124475931|NCT04957290|447697979|FG004|Overall Study|Progressive disease|0|||
124475932|NCT04957290|447697980|FG005|Overall Study|Progressive disease|0|||
124475933|NCT04957290|447697975|FG000|Overall Study|Withdrawal by Subject|1|||
124475934|NCT04957290|447697976|FG001|Overall Study|Withdrawal by Subject|0|||
124475935|NCT04957290|447697977|FG002|Overall Study|Withdrawal by Subject|1|||
124475936|NCT04957290|447697978|FG003|Overall Study|Withdrawal by Subject|0|||
124475937|NCT04957290|447697979|FG004|Overall Study|Withdrawal by Subject|0|||
124475938|NCT04957290|447697980|FG005|Overall Study|Withdrawal by Subject|0|||
124475939|NCT04957290|447697975|FG000|Overall Study|Death|0|||
124475940|NCT04957290|447697976|FG001|Overall Study|Death|2|||
124475941|NCT04957290|447697977|FG002|Overall Study|Death|1|||
124475942|NCT04957290|447697978|FG003|Overall Study|Death|0|||
124475943|NCT04957290|447697979|FG004|Overall Study|Death|0|||
124475944|NCT04957290|447697980|FG005|Overall Study|Death|0|||
124475945|NCT04957290|447697975|FG000|Overall Study|non compliance with study drug|0|||
124475946|NCT04957290|447697976|FG001|Overall Study|non compliance with study drug|1|||
124475947|NCT04957290|447697977|FG002|Overall Study|non compliance with study drug|0|||
124475948|NCT04957290|447697978|FG003|Overall Study|non compliance with study drug|0|||
124475949|NCT04957290|447697979|FG004|Overall Study|non compliance with study drug|0|||
124475950|NCT04957290|447697980|FG005|Overall Study|non compliance with study drug|0|||
124475951|NCT04957290|447697975|FG000|Overall Study|none specified.|0|||
124475952|NCT04957290|447697976|FG001|Overall Study|none specified.|1|||
124475953|NCT04957290|447697977|FG002|Overall Study|none specified.|2|||
124475954|NCT04957290|447697978|FG003|Overall Study|none specified.|0|||
124475955|NCT04957290|447697979|FG004|Overall Study|none specified.|0|||
124475956|NCT04957290|447697980|FG005|Overall Study|none specified.|0|||
124475957|NCT04957290|447697975|FG000|Overall Study|unacceptable toxicity|0|||
124475958|NCT04957290|447697976|FG001|Overall Study|unacceptable toxicity|0|||
124475959|NCT04957290|447697977|FG002|Overall Study|unacceptable toxicity|1|||
124475960|NCT04957290|447697978|FG003|Overall Study|unacceptable toxicity|0|||
124475961|NCT04957290|447697979|FG004|Overall Study|unacceptable toxicity|0|||
124475962|NCT04957290|447697980|FG005|Overall Study|unacceptable toxicity|0|||
124475963|NCT04957290|447697975|FG000|Overall Study|Adverse Event|0|||
124475964|NCT04957290|447697976|FG001|Overall Study|Adverse Event|0|||
124475965|NCT04957290|447697977|FG002|Overall Study|Adverse Event|1|||
124475966|NCT04957290|447697978|FG003|Overall Study|Adverse Event|0|||
124475967|NCT04957290|447697979|FG004|Overall Study|Adverse Event|0|||
124475968|NCT04957290|447697980|FG005|Overall Study|Adverse Event|0|||
124475969|NCT04957290|447697975|FG000|Overall Study|study terminated by sponsor|0|||
124475970|NCT04957290|447697976|FG001|Overall Study|study terminated by sponsor|0|||
124475971|NCT04957290|447697977|FG002|Overall Study|study terminated by sponsor|2|||
124475972|NCT04957290|447697978|FG003|Overall Study|study terminated by sponsor|0|||
124475973|NCT04957290|447697979|FG004|Overall Study|study terminated by sponsor|0|||
124475974|NCT04957290|447697980|FG005|Overall Study|study terminated by sponsor|0|||
124475975|NCT02411747|447697981|FG000|Overall Study|Withdrawal by Subject|1|||
124475976|NCT02411747|447697982|FG001|Overall Study|Withdrawal by Subject|0|||
124475977|NCT02411747|447697981|FG000|Overall Study|Protocol Violation|2|||
124475978|NCT02411747|447697982|FG001|Overall Study|Protocol Violation|4|||
124475979|NCT02149810|447697983|FG000|Overall Study|Physician Decision|1|||
124475980|NCT02149810|447697984|FG001|Overall Study|Physician Decision|2|||
124475981|NCT02149810|447697983|FG000|Overall Study|Lost to Follow-up|2|||
124475982|NCT02149810|447697984|FG001|Overall Study|Lost to Follow-up|1|||
124475983|NCT02149810|447697983|FG000|Overall Study|Withdrawal by Subject|5|||
124475984|NCT02149810|447697984|FG001|Overall Study|Withdrawal by Subject|1|||
124475985|NCT00675597|447697985|FG000|Overall Study|Withdrawal by Subject|3|||
124475986|NCT01176916|447697986|FG000|Overall Study|Adverse Event|61|||
124475987|NCT01176916|447697986|FG000|Overall Study|Death|1|||
124475988|NCT01176916|447697986|FG000|Overall Study|Lost to Follow-up|15|||
124475989|NCT01176916|447697986|FG000|Overall Study|Objective progression or relapse|17|||
124475990|NCT01176916|447697986|FG000|Overall Study|Protocol Violation|24|||
124475991|NCT01176916|447697986|FG000|Overall Study|Withdrawal by Subject|37|||
124475992|NCT01176916|447697986|FG000|Overall Study|Other|6|||
124475993|NCT01176916|447697986|FG000|Overall Study|Withdrawal prior to Treatment|6|||
124475994|NCT03158220|447697989|FG000|Overall Study|Screen Failure|0|||
124475995|NCT03158220|447697990|FG001|Overall Study|Screen Failure|1|||
124475996|NCT03158220|447697989|FG000|Overall Study|Withdrawal by Subject|8|||
124475997|NCT03158220|447697990|FG001|Overall Study|Withdrawal by Subject|9|||
124475998|NCT03158220|447697989|FG000|Overall Study|Status unknown|0|||
124475999|NCT03158220|447697990|FG001|Overall Study|Status unknown|1|||
124476000|NCT03158220|447697989|FG000|Overall Study|Lost to Follow-up|8|||
124476001|NCT03158220|447697990|FG001|Overall Study|Lost to Follow-up|5|||
124476002|NCT03158220|447697989|FG000|Overall Study|Physician Decision|1|||
124476003|NCT03158220|447697990|FG001|Overall Study|Physician Decision|0|||
124476004|NCT01015833|447697991|FG000|Overall Study|Death|1|||
124476005|NCT01015833|447697992|FG001|Overall Study|Death|0|||
124476006|NCT01015833|447697991|FG000|Overall Study|Withdrawal by Subject|3|||
124476007|NCT01015833|447697992|FG001|Overall Study|Withdrawal by Subject|2|||
124476008|NCT01015833|447697991|FG000|Overall Study|Adverse Event|0|||
124476009|NCT01015833|447697992|FG001|Overall Study|Adverse Event|1|||
124476010|NCT01015833|447697991|FG000|Overall Study|Physician Decision|2|||
124476011|NCT01015833|447697992|FG001|Overall Study|Physician Decision|0|||
124476012|NCT01015833|447697991|FG000|Overall Study|Symptomatic deterioration|0|||
124476013|NCT01015833|447697992|FG001|Overall Study|Symptomatic deterioration|1|||
124476014|NCT01015833|447697991|FG000|Overall Study|Other|5|||
124476015|NCT01015833|447697992|FG001|Overall Study|Other|1|||
124476016|NCT01015833|447697991|FG000|Overall Study|Motor Vehicle Accidents|1|||
124476017|NCT01015833|447697992|FG001|Overall Study|Motor Vehicle Accidents|0|||
124476018|NCT01015833|447697991|FG000|Overall Study|Did not start treatment|1|||
124476019|NCT01015833|447697992|FG001|Overall Study|Did not start treatment|0|||
124476020|NCT01671280|447697993|FG000|Overall Study|Withdrawal by Subject|2|||
124476021|NCT00996203|447697994|FG000|Overall Study|Adverse Event|3|||
124476022|NCT00996203|447697994|FG000|Overall Study|Lost to Follow-up|1|||
124476023|NCT00996203|447697994|FG000|Overall Study|Lack of Efficacy|1|||
124476024|NCT00996203|447697994|FG000|Overall Study|Protocol Violation|2|||
124476025|NCT01959165|447697996|FG000|Overall Study|Adverse Event|0|||
124476026|NCT01959165|447697997|FG001|Overall Study|Adverse Event|0|||
124476027|NCT01959165|447697998|FG002|Overall Study|Adverse Event|0|||
124476028|NCT01959165|447697999|FG003|Overall Study|Adverse Event|1|||
124476029|NCT01959165|447697996|FG000|Overall Study|Lack of Efficacy|1|||
124476030|NCT01959165|447697997|FG001|Overall Study|Lack of Efficacy|0|||
124476031|NCT01959165|447697998|FG002|Overall Study|Lack of Efficacy|0|||
124476032|NCT01959165|447697999|FG003|Overall Study|Lack of Efficacy|0|||
124476033|NCT01959165|447697996|FG000|Overall Study|overdose|0|||
124476034|NCT01959165|447697997|FG001|Overall Study|overdose|0|||
124476035|NCT01959165|447697998|FG002|Overall Study|overdose|0|||
124476036|NCT01959165|447697999|FG003|Overall Study|overdose|1|||
124476037|NCT01959165|447697996|FG000|Overall Study|Welfare recipient|0|||
124476038|NCT01959165|447697997|FG001|Overall Study|Welfare recipient|1|||
124476039|NCT01959165|447697998|FG002|Overall Study|Welfare recipient|0|||
124476040|NCT01959165|447697999|FG003|Overall Study|Welfare recipient|0|||
124476041|NCT03686969|447698000|FG000|Overall Study|Study terminated|1|||
124476042|NCT03686969|447698001|FG001|Overall Study|Study terminated|0|||
124476043|NCT00560755|447698002|FG000|Overall Study|Protocol Violation|15|||
124476044|NCT00560755|447698002|FG000|Overall Study|Withdrawal by Subject|26|||
124476045|NCT00560755|447698002|FG000|Overall Study|Lost to Follow-up|9|||
124476046|NCT00560755|447698002|FG000|Overall Study|Adverse Event|8|||
124476047|NCT00560755|447698002|FG000|Overall Study|Physician Decision|2|||
124476048|NCT00848120|447698003|FG000|Overall Study|Adverse Event|1|||
124476049|NCT01988090|447698007|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
124476050|NCT01988090|447698008|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
124476051|NCT01988090|447698007|FG000|Start Treament After Randomization|Protocol Violation|0|||
124476052|NCT01988090|447698008|FG001|Start Treament After Randomization|Protocol Violation|1|||
124476053|NCT01988090|447698007|FG000|Complete Study After Start|Withdrawal by Subject|2|||
124476054|NCT01988090|447698008|FG001|Complete Study After Start|Withdrawal by Subject|0|||
124476055|NCT01988090|447698007|FG000|Complete Study After Start|Protocol Violation|1|||
124476056|NCT01988090|447698008|FG001|Complete Study After Start|Protocol Violation|1|||
124476057|NCT00927563|447698025|FG000|Overall Study|Lost to Follow-up|1|||
124476058|NCT00927563|447698025|FG000|Overall Study|Withdrawal by Subject|1|||
124476059|NCT00413959|447698032|FG000|Overall Study|Pt had only one cycle.|1|||
124476060|NCT04343651|447698034|FG000|Overall Study|Physician Decision|2|||
124476061|NCT04343651|447698035|FG001|Overall Study|Physician Decision|1|||
124476062|NCT04343651|447698034|FG000|Overall Study|Lost to Follow-up|2|||
124476063|NCT04343651|447698035|FG001|Overall Study|Lost to Follow-up|1|||
124476064|NCT04343651|447698034|FG000|Overall Study|Protocol Violation|4|||
124476065|NCT04343651|447698035|FG001|Overall Study|Protocol Violation|6|||
124476066|NCT04343651|447698034|FG000|Overall Study|Missing|3|||
124476067|NCT04343651|447698035|FG001|Overall Study|Missing|9|||
124476068|NCT04343651|447698034|FG000|Overall Study|Withdrawal by Subject|0|||
124476069|NCT04343651|447698035|FG001|Overall Study|Withdrawal by Subject|4|||
124476070|NCT04343651|447698034|FG000|Overall Study|Death|0|||
124476071|NCT04343651|447698035|FG001|Overall Study|Death|1|||
124476072|NCT04343651|447698034|FG000|Overall Study|Did not start treatment|1|||
124476073|NCT04343651|447698035|FG001|Overall Study|Did not start treatment|1|||
124556553|NCT03989115|447995824|FG000|Overall Study|Other|1|||
124476074|NCT04343651|447698034|FG000|Overall Study|Patient did not complete visits 3-6|0|||
124476075|NCT04343651|447698035|FG001|Overall Study|Patient did not complete visits 3-6|1|||
124476076|NCT01292057|447698041|FG000|Overall Study|Protocol Violation|1|||
124476077|NCT01292057|447698042|FG001|Overall Study|Protocol Violation|1|||
124476078|NCT01292057|447698041|FG000|Overall Study|Lost to Follow-up|1|||
124476079|NCT01292057|447698042|FG001|Overall Study|Lost to Follow-up|1|||
124476080|NCT01459614|447698043|FG000|Overall Study|Adverse Event|1|||
124476081|NCT01459614|447698044|FG001|Overall Study|Adverse Event|0|||
124476082|NCT01506882|447698048|FG000|Overall Study|Lack of Efficacy|4|||
124556554|NCT03989115|447995825|FG001|Overall Study|Other|2|||
124476083|NCT01506882|447698049|FG001|Overall Study|Lack of Efficacy|3|||
124476084|NCT01506882|447698048|FG000|Overall Study|Lost to Follow-up|1|||
124556555|NCT03989115|447995826|FG002|Overall Study|Other|0|||
124556556|NCT03989115|447995827|FG003|Overall Study|Other|0|||
124556557|NCT03989115|447995828|FG004|Overall Study|Other|5|||
124556558|NCT03989115|447995829|FG005|Overall Study|Other|0|||
124556559|NCT03989115|447995830|FG006|Overall Study|Other|0|||
124556560|NCT03989115|447995831|FG007|Overall Study|Other|0|||
124556561|NCT02499354|447995832|FG000|Overall Study|Withdrawal by Subject|1|||
124556562|NCT02499354|447995833|FG001|Overall Study|Withdrawal by Subject|0|||
124556563|NCT01759381|447995837|FG000|Overall Study|Death|1|||
124556564|NCT01759381|447995838|FG001|Overall Study|Death|0|||
124556565|NCT00447603|447995840|FG000|Screening|Withdrawal by Subject|1|||
124556566|NCT00447603|447995841|FG001|Screening|Withdrawal by Subject|0|||
124556567|NCT00447603|447995842|FG002|Screening|Withdrawal by Subject|0|||
124556568|NCT00447603|447995840|FG000|Screening|Protocol Violation|1|||
124556569|NCT00447603|447995841|FG001|Screening|Protocol Violation|0|||
124556570|NCT00447603|447995842|FG002|Screening|Protocol Violation|0|||
124556571|NCT00447603|447995840|FG000|Screening|Screen Failure|4|||
124556572|NCT00447603|447995841|FG001|Screening|Screen Failure|0|||
124556573|NCT00447603|447995842|FG002|Screening|Screen Failure|0|||
124556574|NCT00447603|447995840|FG000|Screening|Study Terminated by Sponsor|15|||
124556575|NCT00447603|447995841|FG001|Screening|Study Terminated by Sponsor|0|||
124556576|NCT00447603|447995842|FG002|Screening|Study Terminated by Sponsor|0|||
124556577|NCT00447603|447995840|FG000|Filter Period|Adverse Event|0|||
124556578|NCT00447603|447995841|FG001|Filter Period|Adverse Event|0|||
124556579|NCT00447603|447995842|FG002|Filter Period|Adverse Event|1|||
124556580|NCT00447603|447995840|FG000|Filter Period|Screen Failure|0|||
124556581|NCT00447603|447995841|FG001|Filter Period|Screen Failure|3|||
124556582|NCT00447603|447995842|FG002|Filter Period|Screen Failure|4|||
124556583|NCT00447603|447995840|FG000|Filter Period|Study terminated by Sponsor|0|||
124556584|NCT00447603|447995841|FG001|Filter Period|Study terminated by Sponsor|1|||
124556585|NCT00447603|447995842|FG002|Filter Period|Study terminated by Sponsor|10|||
124556586|NCT02410837|447995847|FG000|Overall Study|Death|387|||
124556587|NCT02410837|447995847|FG000|Overall Study|Lost to Follow-up|50|||
124556588|NCT02410837|447995847|FG000|Overall Study|Withdrawal by Subject|44|||
124556589|NCT02410837|447995847|FG000|Overall Study|Physician Decision|6|||
124556590|NCT02410837|447995847|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
124556591|NCT00106028|447995855|FG000|Overall Study|Adverse Event|3|||
124556592|NCT00106028|447995856|FG001|Overall Study|Adverse Event|2|||
124556593|NCT00106028|447995855|FG000|Overall Study|Protocol Violation|1|||
124556594|NCT00106028|447995856|FG001|Overall Study|Protocol Violation|1|||
124556595|NCT00106028|447995855|FG000|Overall Study|Withdrawal by Subject|2|||
124556596|NCT00106028|447995856|FG001|Overall Study|Withdrawal by Subject|8|||
124556597|NCT00106028|447995855|FG000|Overall Study|Lost to Follow-up|0|||
124556598|NCT00106028|447995856|FG001|Overall Study|Lost to Follow-up|1|||
124556599|NCT01280981|447995857|FG000|Overall Study|Withdrawal by Subject|11|||
124556600|NCT01280981|447995857|FG000|Overall Study|Protocol Violation|2|||
124556601|NCT01280981|447995857|FG000|Overall Study|Lack of Efficacy|13|||
124556602|NCT01280981|447995857|FG000|Overall Study|Lost to Follow-up|3|||
124556603|NCT01280981|447995857|FG000|Overall Study|Adverse Event|6|||
124556604|NCT01280981|447995857|FG000|Overall Study|Irregular or discontinued menses|3|||
124556605|NCT01280981|447995857|FG000|Overall Study|Failed to return|45|||
124556606|NCT01280981|447995857|FG000|Overall Study|Non-compliance with protocol|3|||
124556607|NCT01280981|447995857|FG000|Overall Study|Withdrawal of consent|3|||
124556608|NCT01280981|447995857|FG000|Overall Study|Elective surgery|2|||
124556609|NCT01280981|447995857|FG000|Overall Study|Study site closure|1|||
124556610|NCT01256398|447995859|FG000|Overall Study|Withdrawal by Subject|1|||
124556611|NCT01238211|447995860|FG000|Overall Study|Continues active treatment|31|||
124476085|NCT01506882|447698049|FG001|Overall Study|Lost to Follow-up|0|||
124476086|NCT01506882|447698048|FG000|Overall Study|Withdrawal by Subject|9|||
124476087|NCT01506882|447698049|FG001|Overall Study|Withdrawal by Subject|3|||
124476088|NCT01506882|447698048|FG000|Overall Study|SAE, non-fatal|2|||
124476089|NCT01506882|447698049|FG001|Overall Study|SAE, non-fatal|0|||
124476090|NCT01506882|447698048|FG000|Overall Study|AE, non-serious non-fatal|3|||
124476091|NCT01506882|447698049|FG001|Overall Study|AE, non-serious non-fatal|1|||
124476092|NCT01506882|447698048|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
124476093|NCT01506882|447698049|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
124476094|NCT01506882|447698048|FG000|Overall Study|Other Reason|2|||
124556612|NCT01238211|447995860|FG000|Overall Study|Adverse Event|7|||
124476095|NCT01506882|447698049|FG001|Overall Study|Other Reason|0|||
124556613|NCT01238211|447995860|FG000|Overall Study|Death|4|||
124556614|NCT01238211|447995860|FG000|Overall Study|Relapse/Progression|2|||
124556615|NCT01238211|447995860|FG000|Overall Study|Withdrawal by Subject|7|||
124556616|NCT01238211|447995860|FG000|Overall Study|Non-protocol treatment|4|||
124556617|NCT01238211|447995860|FG000|Overall Study|Investigator/Patient Decision|3|||
124556618|NCT04428502|447995861|FG000|Overall Study|Did not meet entrance criteria|14|||
124556619|NCT03550794|447995864|FG000|Overall Study|No longer met inclusion criteria|1|||
124556620|NCT03550794|447995865|FG001|Overall Study|No longer met inclusion criteria|2|||
124556621|NCT03550794|447995864|FG000|Overall Study|Goals of care changed|1|||
124556622|NCT03550794|447995865|FG001|Overall Study|Goals of care changed|0|||
124556623|NCT03550794|447995864|FG000|Overall Study|Withdrawal by Subject|2|||
124556624|NCT03550794|447995865|FG001|Overall Study|Withdrawal by Subject|0|||
124556625|NCT03550794|447995864|FG000|Overall Study|Death|0|||
124556626|NCT03550794|447995865|FG001|Overall Study|Death|1|||
124556627|NCT00449930|447995866|FG000|Overall Study|Adverse Event|9|||
124556628|NCT00449930|447995867|FG001|Overall Study|Adverse Event|19|||
124556629|NCT00449930|447995866|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
124556630|NCT00449930|447995867|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
124556631|NCT00449930|447995866|FG000|Overall Study|Lack of Efficacy|10|||
124556632|NCT00449930|447995867|FG001|Overall Study|Lack of Efficacy|1|||
124556633|NCT00449930|447995866|FG000|Overall Study|Lost to Follow-up|9|||
124556634|NCT00449930|447995867|FG001|Overall Study|Lost to Follow-up|14|||
124556635|NCT00449930|447995866|FG000|Overall Study|Physician Decision|1|||
124556636|NCT00449930|447995867|FG001|Overall Study|Physician Decision|2|||
124556637|NCT00449930|447995866|FG000|Overall Study|Protocol Violation|14|||
124556638|NCT00449930|447995867|FG001|Overall Study|Protocol Violation|15|||
124556639|NCT00449930|447995866|FG000|Overall Study|Withdrawal by Subject|16|||
124556640|NCT00449930|447995867|FG001|Overall Study|Withdrawal by Subject|23|||
124556641|NCT00449930|447995866|FG000|Overall Study|Glycemic discontinuation criteria|1|||
124556642|NCT00449930|447995867|FG001|Overall Study|Glycemic discontinuation criteria|1|||
124556643|NCT01864525|447995868|FG000|Overall Study|Adverse Event|1|||
124556644|NCT01864525|447995869|FG001|Overall Study|Adverse Event|0|||
124556645|NCT03712228|447995870|FG000|Treatment Period 1|Lack of Efficacy|0|||
124556646|NCT03712228|447995871|FG001|Treatment Period 1|Lack of Efficacy|0|||
124556647|NCT03712228|447995872|FG002|Treatment Period 1|Lack of Efficacy|0|||
124556648|NCT03712228|447995873|FG003|Treatment Period 1|Lack of Efficacy|0|||
124556649|NCT03712228|447995874|FG004|Treatment Period 1|Lack of Efficacy|0|||
124556650|NCT03712228|447995875|FG005|Treatment Period 1|Lack of Efficacy|1|||
124556651|NCT03712228|447995870|FG000|Treatment Period 2|Pregnancy|0|||
124556652|NCT03712228|447995871|FG001|Treatment Period 2|Pregnancy|0|||
124556653|NCT03712228|447995872|FG002|Treatment Period 2|Pregnancy|0|||
124556654|NCT03712228|447995873|FG003|Treatment Period 2|Pregnancy|1|||
124556655|NCT03712228|447995874|FG004|Treatment Period 2|Pregnancy|0|||
124556656|NCT03712228|447995875|FG005|Treatment Period 2|Pregnancy|0|||
124556657|NCT03712228|447995870|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124556658|NCT03712228|447995871|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124556659|NCT03712228|447995872|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124556660|NCT03712228|447995873|FG003|Treatment Period 2|Withdrawal by Subject|1|||
124556661|NCT03712228|447995874|FG004|Treatment Period 2|Withdrawal by Subject|0|||
124556662|NCT03712228|447995875|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124556663|NCT03001011|447995876|FG000|Overall Study|Adverse Event|9|||
124556664|NCT03001011|447995877|FG001|Overall Study|Adverse Event|3|||
124556665|NCT03001011|447995876|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
124556666|NCT03001011|447995877|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
124556667|NCT03001011|447995876|FG000|Overall Study|Other than specified above|3|||
124556668|NCT03001011|447995877|FG001|Overall Study|Other than specified above|8|||
124556669|NCT02875067|447995878|FG000|Overall Study|Withdrawal by Subject|1|||
124556670|NCT02875067|447995878|FG000|Overall Study|Withdrawal by Termination of Study|5|||
124556671|NCT00065065|447995879|FG000|Overall Study|Adverse Event|3|||
124556672|NCT00065065|447995880|FG001|Overall Study|Adverse Event|2|||
124556673|NCT00065065|447995879|FG000|Overall Study|Withdrawal by Subject|1|||
124556674|NCT00065065|447995880|FG001|Overall Study|Withdrawal by Subject|5|||
124556675|NCT00065065|447995879|FG000|Overall Study|Lack of Efficacy|4|||
124556676|NCT00065065|447995880|FG001|Overall Study|Lack of Efficacy|11|||
124556677|NCT00065065|447995879|FG000|Overall Study|Other|2|||
124556678|NCT00065065|447995880|FG001|Overall Study|Other|2|||
124556679|NCT05288673|447995882|FG000|Overall Study|Consent withdrawn by subject|0|||
124556680|NCT05288673|447995883|FG001|Overall Study|Consent withdrawn by subject|0|||
124556681|NCT05288673|447995884|FG002|Overall Study|Consent withdrawn by subject|1|||
124556682|NCT01050673|447995885|FG000|Overall Study|Physician Decision|4|||
124556683|NCT01050673|447995886|FG001|Overall Study|Physician Decision|5|||
124719200|NCT03308968|448594755|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
124719201|NCT03308968|448594756|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
124719202|NCT03308968|448594754|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
124719203|NCT03308968|448594755|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
124719204|NCT03308968|448594756|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
124719205|NCT03308968|448594754|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
124719206|NCT03308968|448594755|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
124719207|NCT03308968|448594756|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
124719208|NCT03308968|448594754|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
124719209|NCT03308968|448594755|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
124719210|NCT03308968|448594756|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
124719211|NCT03308968|448594754|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
124719212|NCT03308968|448594755|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
124719213|NCT03308968|448594756|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
124719214|NCT03308968|448594754|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
124719215|NCT03308968|448594755|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
124719216|NCT03308968|448594756|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
124719217|NCT03308968|448594754|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
124719218|NCT03308968|448594755|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
124719219|NCT03308968|448594756|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
124719220|NCT03308968|448594754|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
124719221|NCT03308968|448594755|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
124719222|NCT03308968|448594756|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
124719223|NCT03308968|448594754|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
124719224|NCT03308968|448594755|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
124719225|NCT03308968|448594756|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
124719226|NCT03308968|448594754|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
124719227|NCT03308968|448594755|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
124719228|NCT03308968|448594756|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
124719229|NCT03308968|448594754|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
124719230|NCT03308968|448594755|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
124719231|NCT03308968|448594756|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
124719232|NCT03308968|448594754|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
124719233|NCT03308968|448594755|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
124719234|NCT03308968|448594756|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
124719235|NCT01961297|448594762|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
124719236|NCT01961297|448594763|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
124719237|NCT02141633|448594764|FG000|Overall Study|Physician Decision|1|||
124719238|NCT02141633|448594765|FG001|Overall Study|Physician Decision|0|||
124719239|NCT02482298|448594766|FG000|Overall Study|Withdrawal by Subject|2|||
124719240|NCT02482298|448594767|FG001|Overall Study|Withdrawal by Subject|1|||
124719241|NCT02482298|448594768|FG002|Overall Study|Withdrawal by Subject|2|||
124719242|NCT02482298|448594766|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
124719243|NCT02482298|448594767|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
124719244|NCT02482298|448594768|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
124719245|NCT02482298|448594766|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
124719246|NCT02482298|448594767|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
124719247|NCT02482298|448594768|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
124719248|NCT02482298|448594766|FG000|Overall Study|Lost to Follow-up|0|||
124719249|NCT02482298|448594767|FG001|Overall Study|Lost to Follow-up|1|||
124719250|NCT02482298|448594768|FG002|Overall Study|Lost to Follow-up|0|||
124719251|NCT01188551|448594773|FG000|Overall Study|Pharmacy issues|1|||
124719252|NCT01188551|448594774|FG001|Overall Study|Pharmacy issues|0|||
124719253|NCT01188551|448594775|FG002|Overall Study|Pharmacy issues|0|||
124719254|NCT01188551|448594776|FG003|Overall Study|Pharmacy issues|0|||
124719255|NCT03782259|448594779|FG000|Overall Study|Lost to Follow-up|1|||
124719256|NCT03782259|448594780|FG001|Overall Study|Lost to Follow-up|1|||
124476096|NCT00821678|447698054|FG000|Overall Study|Withdrawal by Subject|8|||
124476097|NCT00821678|447698055|FG001|Overall Study|Withdrawal by Subject|0|||
124476098|NCT00821678|447698054|FG000|Overall Study|Lost to Follow-up|13|||
124476099|NCT00821678|447698055|FG001|Overall Study|Lost to Follow-up|12|||
124476100|NCT00821678|447698054|FG000|Overall Study|Death|0|||
124476101|NCT00821678|447698055|FG001|Overall Study|Death|2|||
124476102|NCT01059448|447700176|FG000|Overall Study|Adverse Event|1|||
124476103|NCT01059448|447700177|FG001|Overall Study|Adverse Event|3|||
124476104|NCT01059448|447700178|FG002|Overall Study|Adverse Event|0|||
124476105|NCT01059448|447700179|FG003|Overall Study|Adverse Event|1|||
124476106|NCT01059448|447700176|FG000|Overall Study|Withdrawal by Subject|2|||
124476107|NCT01059448|447700177|FG001|Overall Study|Withdrawal by Subject|0|||
124476108|NCT01059448|447700178|FG002|Overall Study|Withdrawal by Subject|2|||
124476109|NCT01059448|447700179|FG003|Overall Study|Withdrawal by Subject|4|||
124476110|NCT01059448|447700176|FG000|Overall Study|Disease Progression|2|||
124719257|NCT03782259|448594779|FG000|Overall Study|Moved out of state|0|||
124719258|NCT03782259|448594780|FG001|Overall Study|Moved out of state|2|||
124719259|NCT03782259|448594779|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
124719260|NCT03782259|448594780|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
124719261|NCT03782259|448594779|FG000|Overall Study|Subject discontinued intervention|1|||
124719262|NCT03782259|448594780|FG001|Overall Study|Subject discontinued intervention|0|||
124719263|NCT00603941|448594781|FG000|Overall Study|Disease progression|6|||
124719264|NCT00603941|448594782|FG001|Overall Study|Disease progression|7|||
124719265|NCT00603941|448594783|FG002|Overall Study|Disease progression|1|||
124719266|NCT00603941|448594781|FG000|Overall Study|Adverse Event|1|||
124719267|NCT00603941|448594782|FG001|Overall Study|Adverse Event|0|||
124719268|NCT00603941|448594783|FG002|Overall Study|Adverse Event|1|||
124719269|NCT00603941|448594781|FG000|Overall Study|Physician Decision|0|||
124719270|NCT00603941|448594782|FG001|Overall Study|Physician Decision|1|||
124719271|NCT00603941|448594783|FG002|Overall Study|Physician Decision|0|||
124719272|NCT00603941|448594781|FG000|Overall Study|Withdrawal by Subject|0|||
124719273|NCT00603941|448594782|FG001|Overall Study|Withdrawal by Subject|2|||
124556684|NCT01254045|447995891|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
124556685|NCT01254045|447995892|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
124556686|NCT01254045|447995893|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
124476111|NCT01059448|447700177|FG001|Overall Study|Disease Progression|1|||
124476112|NCT01059448|447700178|FG002|Overall Study|Disease Progression|4|||
124476113|NCT01059448|447700179|FG003|Overall Study|Disease Progression|2|||
124476114|NCT01059448|447700176|FG000|Overall Study|Administrative Decision|43|||
124476115|NCT01059448|447700177|FG001|Overall Study|Administrative Decision|49|||
124476116|NCT01059448|447700178|FG002|Overall Study|Administrative Decision|45|||
124476117|NCT01059448|447700179|FG003|Overall Study|Administrative Decision|46|||
124476118|NCT01059448|447700176|FG000|Overall Study|Lost to Follow-up|0|||
124476119|NCT01059448|447700177|FG001|Overall Study|Lost to Follow-up|0|||
124476120|NCT01059448|447700178|FG002|Overall Study|Lost to Follow-up|2|||
124476121|NCT01059448|447700179|FG003|Overall Study|Lost to Follow-up|0|||
124556687|NCT01254045|447995894|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
124556688|NCT01254045|447995895|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
124556689|NCT01254045|447995896|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
124556690|NCT02971605|447995897|FG000|Overall Study|Withdrawal by Subject|1|||
124556691|NCT00597207|447995898|FG000|Overall Study|Lost to Follow-up|5|||
124719274|NCT00603941|448594783|FG002|Overall Study|Withdrawal by Subject|0|||
124719275|NCT05069597|448594784|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
124719276|NCT05069597|448594785|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
124719277|NCT03379259|448594786|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
124719278|NCT03379259|448594787|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
124719279|NCT03379259|448594788|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
124719280|NCT03379259|448594789|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
124719281|NCT03379259|448594790|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
124719282|NCT03379259|448594791|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
124719283|NCT03379259|448594786|FG000|Overall Study|Death|0|||
124719284|NCT03379259|448594787|FG001|Overall Study|Death|1|||
124719285|NCT03379259|448594788|FG002|Overall Study|Death|2|||
124719286|NCT03379259|448594789|FG003|Overall Study|Death|1|||
124719287|NCT03379259|448594790|FG004|Overall Study|Death|4|||
124719288|NCT03379259|448594791|FG005|Overall Study|Death|2|||
124719289|NCT03379259|448594786|FG000|Overall Study|Withdrawal by Subject|0|||
124719290|NCT03379259|448594787|FG001|Overall Study|Withdrawal by Subject|0|||
124719291|NCT03379259|448594788|FG002|Overall Study|Withdrawal by Subject|1|||
124719292|NCT03379259|448594789|FG003|Overall Study|Withdrawal by Subject|0|||
124719293|NCT03379259|448594790|FG004|Overall Study|Withdrawal by Subject|2|||
124719294|NCT03379259|448594791|FG005|Overall Study|Withdrawal by Subject|0|||
124476122|NCT01059448|447700176|FG000|Overall Study|Death|0|||
124476123|NCT01059448|447700177|FG001|Overall Study|Death|1|||
124719295|NCT03379259|448594786|FG000|Overall Study|Study terminated by sponsor|0|||
124719296|NCT03379259|448594787|FG001|Overall Study|Study terminated by sponsor|0|||
124476124|NCT01059448|447700178|FG002|Overall Study|Death|0|||
124476125|NCT01059448|447700179|FG003|Overall Study|Death|0|||
124476126|NCT01059448|447700176|FG000|Overall Study|Other|1|||
124476127|NCT01059448|447700177|FG001|Overall Study|Other|1|||
124476128|NCT01059448|447700178|FG002|Overall Study|Other|0|||
124476129|NCT01059448|447700179|FG003|Overall Study|Other|1|||
124476130|NCT00809328|447700180|FG000|Overall Study|Lack of Efficacy|18|||
124476131|NCT00809328|447700180|FG000|Overall Study|Adverse Event|6|||
124476132|NCT00809328|447700180|FG000|Overall Study|Protocol Violation|3|||
124476133|NCT00809328|447700180|FG000|Overall Study|Withdrawal by Subject|2|||
124476134|NCT00832819|447700182|FG000|Overall Study|Adverse Event|0|||
124476135|NCT00832819|447700183|FG001|Overall Study|Adverse Event|1|||
124476136|NCT00832819|447700184|FG002|Overall Study|Adverse Event|0|||
124476137|NCT00832819|447700182|FG000|Overall Study|Protocol Violation|0|||
124476138|NCT00832819|447700183|FG001|Overall Study|Protocol Violation|0|||
124476139|NCT00832819|447700184|FG002|Overall Study|Protocol Violation|1|||
124476140|NCT00851903|447700185|FG000|Overall Study|Withdrawal by Subject|2|||
124476141|NCT05742984|447700186|FG000|Overall Study|Adverse Event|0|||
124476142|NCT05742984|447700187|FG001|Overall Study|Adverse Event|0|||
124476143|NCT05742984|447700188|FG002|Overall Study|Adverse Event|1|||
124556692|NCT00597207|447995899|FG001|Overall Study|Lost to Follow-up|7|||
124556693|NCT00520351|447995900|FG000|First Intervention|Withdrawal by Subject|1|||
124556694|NCT00520351|447995901|FG001|First Intervention|Withdrawal by Subject|1|||
124556695|NCT01298596|447995906|FG000|Overall Study|Withdrawal by Subject|1|||
124476144|NCT05742984|447700189|FG003|Overall Study|Adverse Event|0|||
124476145|NCT05742984|447700190|FG004|Overall Study|Adverse Event|1|||
124476146|NCT05742984|447700191|FG005|Overall Study|Adverse Event|1|||
124476147|NCT05742984|447700186|FG000|Overall Study|Withdrawal by Subject|0|||
124476148|NCT05742984|447700187|FG001|Overall Study|Withdrawal by Subject|1|||
124476149|NCT05742984|447700188|FG002|Overall Study|Withdrawal by Subject|0|||
124476150|NCT05742984|447700189|FG003|Overall Study|Withdrawal by Subject|0|||
124476151|NCT05742984|447700190|FG004|Overall Study|Withdrawal by Subject|0|||
124476152|NCT05742984|447700191|FG005|Overall Study|Withdrawal by Subject|2|||
124476153|NCT00379340|447700192|FG000|Overall Study|Death|0|||
124476154|NCT00379340|447700193|FG001|Overall Study|Death|0|||
124476155|NCT00379340|447700194|FG002|Overall Study|Death|0|||
124476156|NCT00379340|447700195|FG003|Overall Study|Death|2|||
124476157|NCT00379340|447700196|FG004|Overall Study|Death|0|||
124476158|NCT00379340|447700192|FG000|Overall Study|Lack of Efficacy|6|||
124476159|NCT00379340|447700193|FG001|Overall Study|Lack of Efficacy|1|||
124476160|NCT00379340|447700194|FG002|Overall Study|Lack of Efficacy|0|||
124476161|NCT00379340|447700195|FG003|Overall Study|Lack of Efficacy|4|||
124476162|NCT00379340|447700196|FG004|Overall Study|Lack of Efficacy|3|||
124476163|NCT00379340|447700192|FG000|Overall Study|Physician Decision|6|||
124476164|NCT00379340|447700193|FG001|Overall Study|Physician Decision|2|||
124476165|NCT00379340|447700194|FG002|Overall Study|Physician Decision|1|||
124476166|NCT00379340|447700195|FG003|Overall Study|Physician Decision|2|||
124476167|NCT00379340|447700196|FG004|Overall Study|Physician Decision|3|||
124476168|NCT00379340|447700192|FG000|Overall Study|Withdrawal by Subject|0|||
124476169|NCT00379340|447700193|FG001|Overall Study|Withdrawal by Subject|0|||
124476170|NCT00379340|447700194|FG002|Overall Study|Withdrawal by Subject|0|||
124476171|NCT00379340|447700195|FG003|Overall Study|Withdrawal by Subject|1|||
124476172|NCT00379340|447700196|FG004|Overall Study|Withdrawal by Subject|0|||
124476173|NCT00379340|447700192|FG000|Overall Study|Refusal of further protocol therapy|1|||
124719297|NCT03379259|448594788|FG002|Overall Study|Study terminated by sponsor|0|||
124719298|NCT03379259|448594789|FG003|Overall Study|Study terminated by sponsor|1|||
124719299|NCT03379259|448594790|FG004|Overall Study|Study terminated by sponsor|1|||
124719300|NCT03379259|448594791|FG005|Overall Study|Study terminated by sponsor|4|||
124719301|NCT03379259|448594786|FG000|Overall Study|Disease progression|0|||
124719302|NCT03379259|448594787|FG001|Overall Study|Disease progression|0|||
124719303|NCT03379259|448594788|FG002|Overall Study|Disease progression|0|||
124719304|NCT03379259|448594789|FG003|Overall Study|Disease progression|1|||
124719305|NCT03379259|448594790|FG004|Overall Study|Disease progression|0|||
124719306|NCT03379259|448594791|FG005|Overall Study|Disease progression|1|||
124719307|NCT03379259|448594786|FG000|Overall Study|Lost to Follow-up|0|||
124719308|NCT03379259|448594787|FG001|Overall Study|Lost to Follow-up|0|||
124719309|NCT03379259|448594788|FG002|Overall Study|Lost to Follow-up|0|||
124719310|NCT03379259|448594789|FG003|Overall Study|Lost to Follow-up|0|||
124719311|NCT03379259|448594790|FG004|Overall Study|Lost to Follow-up|1|||
124719312|NCT03379259|448594791|FG005|Overall Study|Lost to Follow-up|0|||
124719313|NCT03379259|448594786|FG000|Overall Study|Deteriorating condition|0|||
124719314|NCT03379259|448594787|FG001|Overall Study|Deteriorating condition|0|||
124719315|NCT03379259|448594788|FG002|Overall Study|Deteriorating condition|0|||
124719316|NCT03379259|448594789|FG003|Overall Study|Deteriorating condition|0|||
124719317|NCT03379259|448594790|FG004|Overall Study|Deteriorating condition|1|||
124719318|NCT03379259|448594791|FG005|Overall Study|Deteriorating condition|0|||
124719319|NCT05507567|448594792|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
124719320|NCT05507567|448594793|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
124719321|NCT05507567|448594794|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
124719322|NCT05507567|448594792|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
124719323|NCT05507567|448594793|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
124719324|NCT05507567|448594794|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
124719325|NCT05507567|448594792|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
124719326|NCT05507567|448594793|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
124719327|NCT05507567|448594794|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
124719328|NCT05507567|448594792|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
124719329|NCT05507567|448594793|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
124719330|NCT05507567|448594794|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
124719331|NCT00375427|448594795|FG000|Overall Study|Adverse Event|21|||
124719332|NCT00375427|448594796|FG001|Overall Study|Adverse Event|27|||
124719333|NCT00375427|448594795|FG000|Overall Study|Abnormal test procedure result(s)|0|||
124719334|NCT00375427|448594796|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124719335|NCT00375427|448594795|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124719336|NCT00375427|448594796|FG001|Overall Study|Abnormal laboratory value(s)|2|||
124476174|NCT00379340|447700193|FG001|Overall Study|Refusal of further protocol therapy|0|||
124476175|NCT00379340|447700194|FG002|Overall Study|Refusal of further protocol therapy|1|||
124719337|NCT00375427|448594795|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
124719338|NCT00375427|448594796|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
124719339|NCT00375427|448594795|FG000|Overall Study|Patient no longer requires study drug|3|||
124719340|NCT00375427|448594796|FG001|Overall Study|Patient no longer requires study drug|7|||
124719341|NCT00375427|448594795|FG000|Overall Study|Protocol Violation|10|||
124719342|NCT00375427|448594796|FG001|Overall Study|Protocol Violation|8|||
124771693|NCT00907335|448794548|FG001|Overall Study|Withdrawal by Subject|0|||
124771694|NCT00907335|448794547|FG000|Overall Study|Adverse Event|4|||
124771695|NCT00907335|448794548|FG001|Overall Study|Adverse Event|1|||
124771696|NCT00907335|448794547|FG000|Overall Study|Lost to Follow-up|2|||
124719343|NCT00375427|448594795|FG000|Overall Study|Withdrawal by Subject|9|||
124719344|NCT00375427|448594796|FG001|Overall Study|Withdrawal by Subject|13|||
124719345|NCT00375427|448594795|FG000|Overall Study|Lost to Follow-up|1|||
124719346|NCT00375427|448594796|FG001|Overall Study|Lost to Follow-up|1|||
124719347|NCT00375427|448594795|FG000|Overall Study|Administrative reasons|0|||
124719348|NCT00375427|448594796|FG001|Overall Study|Administrative reasons|1|||
124719349|NCT00375427|448594795|FG000|Overall Study|Death|11|||
124771697|NCT00907335|448794548|FG001|Overall Study|Lost to Follow-up|0|||
124719350|NCT00375427|448594796|FG001|Overall Study|Death|10|||
124719351|NCT00606411|448594808|FG000|Overall Study|Adverse Event|1|||
124771698|NCT03873116|448794549|FG000|Part 1|Study drug discontinuation due to rash|0|||
124476176|NCT00379340|447700195|FG003|Overall Study|Refusal of further protocol therapy|1|||
124476177|NCT00379340|447700196|FG004|Overall Study|Refusal of further protocol therapy|7|||
124476178|NCT00379340|447700192|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
124476179|NCT00379340|447700193|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
124476180|NCT00379340|447700194|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
124476181|NCT00379340|447700195|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
124476182|NCT00379340|447700196|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
124476183|NCT00379340|447700192|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
124476184|NCT00379340|447700193|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
124476185|NCT00379340|447700194|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
124476186|NCT00379340|447700195|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
124476187|NCT00379340|447700196|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
124476188|NCT05019131|447700202|FG000|Overall Study|Lost to Follow-up|0|||
124476189|NCT05019131|447700203|FG001|Overall Study|Lost to Follow-up|3|||
124476190|NCT01703000|447700204|FG000|Overall Study|Death|1|||
124476191|NCT06118385|447700206|FG000|Overall Study|Protocol Violation|0|||
124476192|NCT06118385|447700207|FG001|Overall Study|Protocol Violation|0|||
124476193|NCT06118385|447700208|FG002|Overall Study|Protocol Violation|0|||
124476194|NCT06118385|447700209|FG003|Overall Study|Protocol Violation|0|||
124476195|NCT06118385|447700210|FG004|Overall Study|Protocol Violation|0|||
124476196|NCT06118385|447700211|FG005|Overall Study|Protocol Violation|0|||
124476197|NCT06118385|447700212|FG006|Overall Study|Protocol Violation|0|||
124476198|NCT06118385|447700213|FG007|Overall Study|Protocol Violation|0|||
124476199|NCT06118385|447700214|FG008|Overall Study|Protocol Violation|1|||
124476200|NCT06118385|447700215|FG009|Overall Study|Protocol Violation|0|||
124476201|NCT06118385|447700216|FG010|Overall Study|Protocol Violation|0|||
124476202|NCT06118385|447700217|FG011|Overall Study|Protocol Violation|0|||
124476203|NCT06118385|447700206|FG000|Overall Study|Out-of-range blood tests|0|||
124476204|NCT06118385|447700207|FG001|Overall Study|Out-of-range blood tests|0|||
124476205|NCT06118385|447700208|FG002|Overall Study|Out-of-range blood tests|0|||
124476206|NCT06118385|447700209|FG003|Overall Study|Out-of-range blood tests|0|||
124476207|NCT06118385|447700210|FG004|Overall Study|Out-of-range blood tests|0|||
124476208|NCT06118385|447700211|FG005|Overall Study|Out-of-range blood tests|0|||
124476209|NCT06118385|447700212|FG006|Overall Study|Out-of-range blood tests|0|||
124476210|NCT06118385|447700213|FG007|Overall Study|Out-of-range blood tests|0|||
124476211|NCT06118385|447700214|FG008|Overall Study|Out-of-range blood tests|1|||
124476212|NCT06118385|447700215|FG009|Overall Study|Out-of-range blood tests|0|||
124476213|NCT06118385|447700216|FG010|Overall Study|Out-of-range blood tests|0|||
124476214|NCT06118385|447700217|FG011|Overall Study|Out-of-range blood tests|0|||
124476215|NCT01323478|447700218|FG000|Overall Study|Adverse Event|7|||
124476216|NCT01323478|447700218|FG000|Overall Study|Lack of Efficacy|4|||
124476217|NCT01323478|447700218|FG000|Overall Study|Non-compliance With Study Product|3|||
124476218|NCT01323478|447700218|FG000|Overall Study|Protocol Violation|1|||
124476219|NCT01323478|447700218|FG000|Overall Study|Withdrawal of Consent|1|||
124476220|NCT01323478|447700218|FG000|Overall Study|Administrative or Other Reasons|8|||
124476221|NCT00553462|447700219|FG000|Overall Study|Adverse Event|4|||
124476222|NCT00553462|447700219|FG000|Overall Study|Progression|4|||
124476223|NCT00553462|447700219|FG000|Overall Study|Withdrawal by Subject|5|||
124556696|NCT01298596|447995907|FG001|Overall Study|Withdrawal by Subject|1|||
124556697|NCT01298596|447995906|FG000|Overall Study|Death|5|||
124556698|NCT01298596|447995907|FG001|Overall Study|Death|3|||
124556699|NCT01298596|447995906|FG000|Overall Study|Lost to Follow-up|6|||
124556700|NCT01298596|447995907|FG001|Overall Study|Lost to Follow-up|14|||
124556701|NCT01298596|447995906|FG000|Overall Study|Referred for further management|16|||
124556702|NCT01298596|447995907|FG001|Overall Study|Referred for further management|15|||
124556703|NCT04128696|447995908|FG000|Overall Study|Lost to Follow-up|3|||
124556704|NCT04128696|447995909|FG001|Overall Study|Lost to Follow-up|7|||
124556705|NCT04128696|447995908|FG000|Overall Study|Withdrawal by Subject|12|||
124556706|NCT04128696|447995909|FG001|Overall Study|Withdrawal by Subject|11|||
124556707|NCT04128696|447995908|FG000|Overall Study|Study Closed/Terminated|26|||
124556708|NCT04128696|447995909|FG001|Overall Study|Study Closed/Terminated|38|||
124556709|NCT04128696|447995908|FG000|Overall Study|Physician Decision|2|||
124556710|NCT04128696|447995909|FG001|Overall Study|Physician Decision|3|||
124556711|NCT00585039|447995910|FG000|Overall Study|medication spilled|2|||
124556712|NCT00585039|447995911|FG001|Overall Study|medication spilled|0|||
124556713|NCT02133352|447995920|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
124556714|NCT00579254|447995921|FG000|Overall Study|Lost to Follow-up|39|||
124556715|NCT00579254|447995921|FG000|Overall Study|Discontinued when study terminated|73|||
124556716|NCT02557672|447995922|FG000|Overall Study|Withdrawal by Subject|4|||
124556717|NCT02557672|447995923|FG001|Overall Study|Withdrawal by Subject|2|||
124556718|NCT03705169|447995924|FG000|Overall Study|Lost to Follow-up|0|||
124556719|NCT03705169|447995925|FG001|Overall Study|Lost to Follow-up|0|||
124556720|NCT03705169|447995926|FG002|Overall Study|Lost to Follow-up|0|||
124556721|NCT03705169|447995927|FG003|Overall Study|Lost to Follow-up|2|||
124556722|NCT03705169|447995928|FG004|Overall Study|Lost to Follow-up|0|||
124556723|NCT03705169|447995929|FG005|Overall Study|Lost to Follow-up|2|||
124556724|NCT03705169|447995930|FG006|Overall Study|Lost to Follow-up|1|||
124556725|NCT03705169|447995931|FG007|Overall Study|Lost to Follow-up|0|||
124556726|NCT03705169|447995932|FG008|Overall Study|Lost to Follow-up|0|||
124556727|NCT03705169|447995933|FG009|Overall Study|Lost to Follow-up|1|||
124556728|NCT03705169|447995924|FG000|Overall Study|Adverse Event|0|||
124556729|NCT03705169|447995925|FG001|Overall Study|Adverse Event|0|||
124556730|NCT03705169|447995926|FG002|Overall Study|Adverse Event|0|||
124556731|NCT03705169|447995927|FG003|Overall Study|Adverse Event|1|||
124719352|NCT00606411|448594809|FG001|Overall Study|Adverse Event|2|||
124719353|NCT00606411|448594808|FG000|Overall Study|Lack of Adherence|1|||
124556732|NCT03705169|447995928|FG004|Overall Study|Adverse Event|0|||
124556733|NCT03705169|447995929|FG005|Overall Study|Adverse Event|0|||
124476224|NCT00553462|447700219|FG000|Overall Study|Physician Decision|1|||
124476225|NCT04398732|447700220|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
124476226|NCT01596257|447700222|FG000|Overall Study|Inadequate Collection|23|||
124476227|NCT01596257|447700223|FG001|Overall Study|Inadequate Collection|19|||
124476228|NCT01570244|447700224|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
124476229|NCT00934102|447700227|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
124476230|NCT00934102|447700228|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
124476231|NCT00934102|447700229|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
124476232|NCT02318784|447700230|FG000|Overall Study|Adverse Event|13|||
124476233|NCT02318784|447700230|FG000|Overall Study|Death|2|||
124476234|NCT02318784|447700230|FG000|Overall Study|Progressive Disease|37|||
124476235|NCT02318784|447700230|FG000|Overall Study|Withdrawal by Subject|10|||
124476236|NCT04007159|447700232|FG000|Induction Phase|(missed study visits)|16|||
124476237|NCT04007159|447700232|FG000|Induction Phase|Withdrawal by Subject|4|||
124771699|NCT03873116|448794550|FG001|Part 1|Study drug discontinuation due to rash|0|||
124719354|NCT00606411|448594809|FG001|Overall Study|Lack of Adherence|1|||
124719355|NCT00606411|448594808|FG000|Overall Study|Lack of Efficacy|1|||
124719356|NCT00606411|448594809|FG001|Overall Study|Lack of Efficacy|1|||
124476238|NCT04007159|447700232|FG000|Induction Phase|Adverse Event|2|||
124476239|NCT04007159|447700232|FG000|Challenge Phase|missed study visits|3|||
124719357|NCT00606411|448594808|FG000|Overall Study|Withdrawal by Subject|2|||
124719358|NCT00606411|448594809|FG001|Overall Study|Withdrawal by Subject|0|||
124719359|NCT00606411|448594808|FG000|Overall Study|Lost to Follow-up|1|||
124719360|NCT00606411|448594809|FG001|Overall Study|Lost to Follow-up|2|||
124719361|NCT00606411|448594808|FG000|Overall Study|Move out of state|0|||
124719362|NCT00606411|448594809|FG001|Overall Study|Move out of state|1|||
124476240|NCT04134494|447700238|FG000|Overall Study|Lost to Follow-up|2|||
124476241|NCT01950819|447700239|FG000|Overall Study|Graft Loss|35|||
124476242|NCT01950819|447700240|FG001|Overall Study|Graft Loss|30|||
124719363|NCT03726658|448594810|FG000|Overall Study|Lost to Follow-up|0|||
124719364|NCT03726658|448594811|FG001|Overall Study|Lost to Follow-up|0|||
124719365|NCT03726658|448594812|FG002|Overall Study|Lost to Follow-up|2|||
124476243|NCT01950819|447700239|FG000|Overall Study|Death|29|||
124719366|NCT03726658|448594813|FG003|Overall Study|Lost to Follow-up|0|||
124719367|NCT03726658|448594814|FG004|Overall Study|Lost to Follow-up|0|||
124719368|NCT03726658|448594815|FG005|Overall Study|Lost to Follow-up|1|||
124719369|NCT03726658|448594816|FG006|Overall Study|Lost to Follow-up|1|||
124719370|NCT03726658|448594810|FG000|Overall Study|Withdrawal by Subject|1|||
124719371|NCT03726658|448594811|FG001|Overall Study|Withdrawal by Subject|0|||
124719372|NCT03726658|448594812|FG002|Overall Study|Withdrawal by Subject|0|||
124476244|NCT01950819|447700240|FG001|Overall Study|Death|34|||
124476245|NCT01950819|447700239|FG000|Overall Study|Subject / Gardian decision|54|||
124476246|NCT01950819|447700240|FG001|Overall Study|Subject / Gardian decision|51|||
124476247|NCT01950819|447700239|FG000|Overall Study|technical problems|2|||
124476248|NCT01950819|447700240|FG001|Overall Study|technical problems|0|||
124476249|NCT01950819|447700239|FG000|Overall Study|Pregnancy|0|||
124476250|NCT01950819|447700240|FG001|Overall Study|Pregnancy|2|||
124771700|NCT03873116|448794551|FG002|Part 1|Study drug discontinuation due to rash|0|||
124476251|NCT01950819|447700239|FG000|Overall Study|Lost to Follow-up|9|||
124476252|NCT01950819|447700240|FG001|Overall Study|Lost to Follow-up|17|||
124476253|NCT00781365|447700241|FG000|Overall Study|Withdrawal by Subject|13|||
124476254|NCT00781365|447700242|FG001|Overall Study|Withdrawal by Subject|8|||
124476255|NCT00781365|447700241|FG000|Overall Study|Did Not Attend Visit|20|||
124476256|NCT00781365|447700242|FG001|Overall Study|Did Not Attend Visit|28|||
124476257|NCT00781365|447700241|FG000|Overall Study|Language barrier|1|||
124476258|NCT00781365|447700242|FG001|Overall Study|Language barrier|0|||
124476259|NCT01573910|447700247|FG000|Overall Study|Adverse Event|4|||
124476260|NCT01573910|447700248|FG001|Overall Study|Adverse Event|4|||
124476261|NCT01573910|447700247|FG000|Overall Study|Lost to Follow-up|2|||
124476262|NCT01573910|447700248|FG001|Overall Study|Lost to Follow-up|1|||
124476263|NCT01573910|447700247|FG000|Overall Study|Withdrawal by Subject|0|||
124476264|NCT01573910|447700248|FG001|Overall Study|Withdrawal by Subject|1|||
124476265|NCT01573910|447700247|FG000|Overall Study|Protocol Violation|3|||
124476266|NCT01573910|447700248|FG001|Overall Study|Protocol Violation|0|||
124476267|NCT01573910|447700247|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
124476268|NCT01573910|447700248|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
124476269|NCT01227967|447700254|FG000|Overall Study|Protocol Violation|3|||
124476270|NCT01227967|447700255|FG001|Overall Study|Protocol Violation|1|||
124476271|NCT01227967|447700254|FG000|Overall Study|Death|0|||
124476272|NCT01227967|447700255|FG001|Overall Study|Death|1|||
124476273|NCT01227967|447700254|FG000|Overall Study|Lost to Follow-up|8|||
124476274|NCT01227967|447700255|FG001|Overall Study|Lost to Follow-up|3|||
124476275|NCT01227967|447700254|FG000|Overall Study|Withdrawal by Subject|4|||
124476276|NCT01227967|447700255|FG001|Overall Study|Withdrawal by Subject|3|||
124476277|NCT01227967|447700254|FG000|Overall Study|Physician Decision|0|||
124476278|NCT01227967|447700255|FG001|Overall Study|Physician Decision|1|||
124476279|NCT01227967|447700254|FG000|Overall Study|Never Started Treatment|0|||
124719373|NCT03726658|448594813|FG003|Overall Study|Withdrawal by Subject|0|||
124719374|NCT03726658|448594814|FG004|Overall Study|Withdrawal by Subject|6|||
124719375|NCT03726658|448594815|FG005|Overall Study|Withdrawal by Subject|4|||
124719376|NCT03726658|448594816|FG006|Overall Study|Withdrawal by Subject|2|||
124719377|NCT03726658|448594810|FG000|Overall Study|Pregnancy|0|||
124719378|NCT03726658|448594811|FG001|Overall Study|Pregnancy|0|||
124719379|NCT03726658|448594812|FG002|Overall Study|Pregnancy|0|||
124719380|NCT03726658|448594813|FG003|Overall Study|Pregnancy|0|||
124719381|NCT03726658|448594814|FG004|Overall Study|Pregnancy|0|||
124719382|NCT03726658|448594815|FG005|Overall Study|Pregnancy|0|||
124719383|NCT03726658|448594816|FG006|Overall Study|Pregnancy|1|||
124719384|NCT03726658|448594810|FG000|Overall Study|Not Reported|0|||
124719385|NCT03726658|448594811|FG001|Overall Study|Not Reported|0|||
124719386|NCT03726658|448594812|FG002|Overall Study|Not Reported|0|||
124719387|NCT03726658|448594813|FG003|Overall Study|Not Reported|0|||
124719388|NCT03726658|448594814|FG004|Overall Study|Not Reported|0|||
124719389|NCT03726658|448594815|FG005|Overall Study|Not Reported|0|||
124719390|NCT03726658|448594816|FG006|Overall Study|Not Reported|1|||
124719391|NCT00412958|448594817|FG000|Overall Study|Withdrawal by Subject|3|||
124719392|NCT00412958|448594818|FG001|Overall Study|Withdrawal by Subject|0|||
124719393|NCT00412958|448594819|FG002|Overall Study|Withdrawal by Subject|0|||
124719394|NCT00412958|448594820|FG003|Overall Study|Withdrawal by Subject|1|||
124719395|NCT00412958|448594817|FG000|Overall Study|Adverse Event|0|||
124719396|NCT00412958|448594818|FG001|Overall Study|Adverse Event|1|||
124719397|NCT00412958|448594819|FG002|Overall Study|Adverse Event|0|||
124719398|NCT00412958|448594820|FG003|Overall Study|Adverse Event|0|||
124719399|NCT00412958|448594817|FG000|Overall Study|Lost to Follow-up|0|||
124476280|NCT01227967|447700255|FG001|Overall Study|Never Started Treatment|4|||
124476281|NCT01227967|447700254|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
124476282|NCT01227967|447700255|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
124476283|NCT01763164|447700256|FG000|Treatment Phase|Participant/Guardian decision|26|||
124476284|NCT01763164|447700257|FG001|Treatment Phase|Participant/Guardian decision|14|||
124476285|NCT01763164|447700256|FG000|Treatment Phase|Protocol Violation|1|||
124476286|NCT01763164|447700257|FG001|Treatment Phase|Protocol Violation|1|||
124476287|NCT01763164|447700256|FG000|Treatment Phase|Progressive Disease|142|||
124476288|NCT01763164|447700257|FG001|Treatment Phase|Progressive Disease|76|||
124476289|NCT01763164|447700256|FG000|Treatment Phase|Physician Decision|24|||
124476290|NCT01763164|447700257|FG001|Treatment Phase|Physician Decision|13|||
124476291|NCT01763164|447700256|FG000|Treatment Phase|Death|10|||
124476292|NCT01763164|447700257|FG001|Treatment Phase|Death|1|||
124476293|NCT01763164|447700256|FG000|Treatment Phase|Adverse Event|66|||
124476294|NCT01763164|447700257|FG001|Treatment Phase|Adverse Event|8|||
124476295|NCT01763164|447700256|FG000|Treatment Phase|Randomized but not Treated|0|||
124476296|NCT01763164|447700257|FG001|Treatment Phase|Randomized but not Treated|19|||
124476297|NCT01763164|447700256|FG000|Treatment Phase|Other|0|||
124476298|NCT01763164|447700257|FG001|Treatment Phase|Other|1|||
124476299|NCT01763164|447700256|FG000|Follow up Phase|New therapy for study indication|12|||
124476300|NCT01763164|447700257|FG001|Follow up Phase|New therapy for study indication|3|||
124476301|NCT01763164|447700256|FG000|Follow up Phase|Death|21|||
124476302|NCT01763164|447700257|FG001|Follow up Phase|Death|4|||
124476303|NCT01763164|447700256|FG000|Follow up Phase|Subject/guardian decision|9|||
124476304|NCT01763164|447700257|FG001|Follow up Phase|Subject/guardian decision|2|||
124476305|NCT01763164|447700256|FG000|Follow up Phase|Progressive disease|127|||
124476306|NCT01763164|447700257|FG001|Follow up Phase|Progressive disease|62|||
124476307|NCT01763164|447700256|FG000|Follow up Phase|Physician Decision|10|||
124476308|NCT01763164|447700257|FG001|Follow up Phase|Physician Decision|3|||
124719400|NCT00412958|448594818|FG001|Overall Study|Lost to Follow-up|1|||
124719401|NCT00412958|448594819|FG002|Overall Study|Lost to Follow-up|0|||
124476309|NCT01763164|447700256|FG000|Follow up Phase|Lost to Follow-up|1|||
124476310|NCT01763164|447700257|FG001|Follow up Phase|Lost to Follow-up|0|||
124476311|NCT01763164|447700256|FG000|Follow up Phase|Adverse Event|17|||
124719402|NCT00412958|448594820|FG003|Overall Study|Lost to Follow-up|0|||
124719403|NCT00412958|448594817|FG000|Overall Study|Death|0|||
124719404|NCT00412958|448594818|FG001|Overall Study|Death|1|||
124719405|NCT00412958|448594819|FG002|Overall Study|Death|0|||
124719406|NCT00412958|448594820|FG003|Overall Study|Death|0|||
124719407|NCT00412958|448594817|FG000|Overall Study|Transport issue|0|||
124719408|NCT00412958|448594818|FG001|Overall Study|Transport issue|1|||
124719409|NCT00412958|448594819|FG002|Overall Study|Transport issue|0|||
124476312|NCT01763164|447700257|FG001|Follow up Phase|Adverse Event|1|||
124476313|NCT03595280|447700268|FG000|Overall Study|Lost to Follow-up|6|||
124476314|NCT03595280|447700269|FG001|Overall Study|Lost to Follow-up|9|||
124476315|NCT03595280|447700270|FG002|Overall Study|Lost to Follow-up|15|||
124476316|NCT00584870|447700271|FG000|Overall Study|Adverse Event|4|||
124476317|NCT00584870|447700272|FG001|Overall Study|Adverse Event|3|||
124476318|NCT00584870|447700273|FG002|Overall Study|Adverse Event|2|||
124476319|NCT00584870|447700271|FG000|Overall Study|Lost to Follow-up|4|||
124476320|NCT00584870|447700272|FG001|Overall Study|Lost to Follow-up|1|||
124476321|NCT00584870|447700273|FG002|Overall Study|Lost to Follow-up|1|||
124476322|NCT00584870|447700271|FG000|Overall Study|Lack of Efficacy|7|||
124476323|NCT00584870|447700272|FG001|Overall Study|Lack of Efficacy|14|||
124476324|NCT00584870|447700273|FG002|Overall Study|Lack of Efficacy|8|||
124476325|NCT00584870|447700271|FG000|Overall Study|Withdrawal by Subject|10|||
124476326|NCT00584870|447700272|FG001|Overall Study|Withdrawal by Subject|5|||
124476327|NCT00584870|447700273|FG002|Overall Study|Withdrawal by Subject|3|||
124476328|NCT00584870|447700271|FG000|Overall Study|Protocol Violation|1|||
124476329|NCT00584870|447700272|FG001|Overall Study|Protocol Violation|1|||
124476330|NCT00584870|447700273|FG002|Overall Study|Protocol Violation|2|||
124476331|NCT00584870|447700271|FG000|Overall Study|Did not met entrance criteria|1|||
124476332|NCT00584870|447700272|FG001|Overall Study|Did not met entrance criteria|0|||
124476333|NCT00584870|447700273|FG002|Overall Study|Did not met entrance criteria|0|||
124476334|NCT00584870|447700271|FG000|Overall Study|Other|2|||
124476335|NCT00584870|447700272|FG001|Overall Study|Other|0|||
124476336|NCT00584870|447700273|FG002|Overall Study|Other|0|||
124476337|NCT00584870|447700271|FG000|Overall Study|Randomized but not treated|0|||
124476338|NCT00584870|447700272|FG001|Overall Study|Randomized but not treated|1|||
124476339|NCT00584870|447700273|FG002|Overall Study|Randomized but not treated|2|||
124476340|NCT00854828|447700274|FG000|Overall Study|Death|1|||
124476341|NCT00854828|447700275|FG001|Overall Study|Death|0|||
124476342|NCT00854828|447700276|FG002|Overall Study|Death|0|||
124476343|NCT00854828|447700277|FG003|Overall Study|Death|0|||
124476344|NCT00854828|447700274|FG000|Overall Study|Withdrawal by Subject|1|||
124476345|NCT00854828|447700275|FG001|Overall Study|Withdrawal by Subject|1|||
124476346|NCT00854828|447700276|FG002|Overall Study|Withdrawal by Subject|0|||
124476347|NCT00854828|447700277|FG003|Overall Study|Withdrawal by Subject|9|||
124476348|NCT00854828|447700274|FG000|Overall Study|Missed 24mo visit|1|||
124476349|NCT00854828|447700275|FG001|Overall Study|Missed 24mo visit|1|||
124476350|NCT00854828|447700276|FG002|Overall Study|Missed 24mo visit|8|||
124476351|NCT00854828|447700277|FG003|Overall Study|Missed 24mo visit|8|||
124476352|NCT02292212|447700279|FG000|ViE Phase|Withdrawal by Subject|1|||
124476353|NCT02292212|447700279|FG000|ViE Phase|Protocol Violation|2|||
124476354|NCT00896532|447700280|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476355|NCT00896532|447700281|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476356|NCT00896532|447700282|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476357|NCT00896532|447700283|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
124476358|NCT00896532|447700284|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124556734|NCT03705169|447995930|FG006|Overall Study|Adverse Event|0|||
124476359|NCT00896532|447700285|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
124476360|NCT00896532|447700286|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476361|NCT00896532|447700287|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476362|NCT00896532|447700288|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476363|NCT00896532|447700289|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476364|NCT00896532|447700290|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476365|NCT00896532|447700291|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476366|NCT00896532|447700292|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476367|NCT00896532|447700293|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476368|NCT00896532|447700294|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476369|NCT00896532|447700295|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476370|NCT00896532|447700296|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476371|NCT00896532|447700297|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476372|NCT00896532|447700298|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476373|NCT00896532|447700299|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476374|NCT00896532|447700300|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476375|NCT00896532|447700301|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476376|NCT00896532|447700302|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
124476377|NCT00896532|447700280|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
124476378|NCT00896532|447700281|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
124476379|NCT00896532|447700282|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
124476380|NCT00896532|447700283|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
124476381|NCT00896532|447700284|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
124476382|NCT00896532|447700285|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
124476383|NCT00896532|447700286|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
124476384|NCT00896532|447700287|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
124476385|NCT00896532|447700288|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
124476386|NCT00896532|447700289|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
124476387|NCT00896532|447700290|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
124476388|NCT00896532|447700291|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
124476389|NCT00896532|447700292|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
124476390|NCT00896532|447700293|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
124476391|NCT00896532|447700294|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
124476392|NCT00896532|447700295|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
124476393|NCT00896532|447700296|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
124476394|NCT00896532|447700297|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
124476395|NCT00896532|447700298|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
124476396|NCT00896532|447700299|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
124476397|NCT00896532|447700300|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
124476398|NCT00896532|447700301|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
124476399|NCT00896532|447700302|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
124476400|NCT00896532|447700280|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
124476401|NCT00896532|447700281|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
124476402|NCT00896532|447700282|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
124476403|NCT00896532|447700283|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
124476404|NCT00896532|447700284|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
124476405|NCT00896532|447700285|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
124719410|NCT00412958|448594820|FG003|Overall Study|Transport issue|0|||
124719411|NCT00090779|448594821|FG000|Step 1|Withdrawal by Subject|4|||
124719412|NCT00090779|448594822|FG001|Step 1|Withdrawal by Subject|2|||
124719413|NCT00090779|448594821|FG000|Step 1|Lost to Follow-up|3|||
124719414|NCT00090779|448594822|FG001|Step 1|Lost to Follow-up|2|||
124719415|NCT00090779|448594821|FG000|Step 1|Death|0|||
124719416|NCT00090779|448594822|FG001|Step 1|Death|2|||
124719417|NCT00090779|448594821|FG000|Step 1|Physician Decision|1|||
124719418|NCT00090779|448594822|FG001|Step 1|Physician Decision|0|||
124719419|NCT00090779|448594821|FG000|Step 1|Pregnancy|1|||
124719420|NCT00090779|448594822|FG001|Step 1|Pregnancy|0|||
124719421|NCT00090779|448594821|FG000|Step 1|Non-compliance to study requirements|0|||
124719422|NCT00090779|448594822|FG001|Step 1|Non-compliance to study requirements|1|||
124719423|NCT00090779|448594821|FG000|Step 1|Subject relocated|2|||
124719424|NCT00090779|448594822|FG001|Step 1|Subject relocated|8|||
124719425|NCT00090779|448594821|FG000|Step 2|Off study per study closure|6|||
124719426|NCT00090779|448594822|FG001|Step 2|Off study per study closure|16|||
124719427|NCT00090779|448594821|FG000|Step 2|Subject relocated|0|||
124719428|NCT00090779|448594822|FG001|Step 2|Subject relocated|1|||
124719429|NCT00090779|448594821|FG000|Step 2|Non-compliance to study requirements|0|||
124719430|NCT00090779|448594822|FG001|Step 2|Non-compliance to study requirements|1|||
124719431|NCT00090779|448594821|FG000|Step 3|Initiation of ART and off extended study|3|||
124719432|NCT00090779|448594822|FG001|Step 3|Initiation of ART and off extended study|2|||
124719433|NCT00090779|448594821|FG000|Step 3|Off extended study due to study closure|4|||
124719434|NCT00090779|448594822|FG001|Step 3|Off extended study due to study closure|3|||
124719435|NCT01318135|448594823|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
124719436|NCT01318135|448594824|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124719437|NCT01318135|448594825|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124719438|NCT01318135|448594826|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124719439|NCT01318135|448594827|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124719440|NCT01318135|448594828|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124719441|NCT01318135|448594829|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124719442|NCT01318135|448594830|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
124719443|NCT01318135|448594823|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
124719444|NCT01318135|448594824|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
124719445|NCT01318135|448594825|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
124476406|NCT00896532|447700286|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
124476407|NCT00896532|447700287|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
124476408|NCT00896532|447700288|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
124476409|NCT00896532|447700289|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
124476410|NCT00896532|447700290|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
124476411|NCT00896532|447700291|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
124476412|NCT00896532|447700292|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
124476413|NCT00896532|447700293|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
124476414|NCT00896532|447700294|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
124476415|NCT00896532|447700295|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
124476416|NCT00896532|447700296|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
124476417|NCT00896532|447700297|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
124476418|NCT00896532|447700298|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
124476419|NCT00896532|447700299|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
124719446|NCT01318135|448594826|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
124719447|NCT01318135|448594827|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
124719448|NCT01318135|448594828|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
124719449|NCT01318135|448594829|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
124719450|NCT01318135|448594830|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
124719451|NCT01318135|448594823|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
124476420|NCT00896532|447700300|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
124476421|NCT00896532|447700301|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
124476422|NCT00896532|447700302|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
124476423|NCT00896532|447700280|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476424|NCT00896532|447700281|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476425|NCT00896532|447700282|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
124476426|NCT00896532|447700283|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476427|NCT00896532|447700284|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
124476428|NCT00896532|447700285|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476429|NCT00896532|447700286|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476430|NCT00896532|447700287|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476431|NCT00896532|447700288|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476432|NCT00896532|447700289|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476433|NCT00896532|447700290|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476434|NCT00896532|447700291|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476435|NCT00896532|447700292|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476436|NCT00896532|447700293|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476437|NCT00896532|447700294|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476438|NCT00896532|447700295|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476439|NCT00896532|447700296|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476440|NCT00896532|447700297|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476441|NCT00896532|447700298|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476442|NCT00896532|447700299|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476443|NCT00896532|447700300|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476444|NCT00896532|447700301|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476445|NCT00896532|447700302|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
124476446|NCT00896532|447700280|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
124476447|NCT00896532|447700281|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476448|NCT00896532|447700282|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476449|NCT00896532|447700283|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
124476450|NCT00896532|447700284|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476451|NCT00896532|447700285|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476452|NCT00896532|447700286|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476453|NCT00896532|447700287|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476454|NCT00896532|447700288|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476455|NCT00896532|447700289|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476456|NCT00896532|447700290|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476457|NCT00896532|447700291|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476458|NCT00896532|447700292|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476459|NCT00896532|447700293|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476460|NCT00896532|447700294|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476461|NCT00896532|447700295|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476462|NCT00896532|447700296|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476463|NCT00896532|447700297|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476464|NCT00896532|447700298|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476465|NCT00896532|447700299|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476466|NCT00896532|447700300|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476467|NCT00896532|447700301|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476468|NCT00896532|447700302|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
124476469|NCT00896532|447700280|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476470|NCT00896532|447700281|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476471|NCT00896532|447700282|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
124476472|NCT00896532|447700283|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476473|NCT00896532|447700284|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476474|NCT00896532|447700285|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476475|NCT00896532|447700286|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476476|NCT00896532|447700287|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476477|NCT00896532|447700288|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476478|NCT00896532|447700289|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476479|NCT00896532|447700290|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476480|NCT00896532|447700291|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476481|NCT00896532|447700292|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476482|NCT00896532|447700293|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124719452|NCT01318135|448594824|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
124719453|NCT01318135|448594825|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
124719454|NCT01318135|448594826|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
124476483|NCT00896532|447700294|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476484|NCT00896532|447700295|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476485|NCT00896532|447700296|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476486|NCT00896532|447700297|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476487|NCT00896532|447700298|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476488|NCT00896532|447700299|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476489|NCT00896532|447700300|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476490|NCT00896532|447700301|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476491|NCT00896532|447700302|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
124476492|NCT00896532|447700280|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476493|NCT00896532|447700281|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476494|NCT00896532|447700282|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
124476495|NCT00896532|447700283|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476496|NCT00896532|447700284|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476497|NCT00896532|447700285|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476498|NCT00896532|447700286|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476499|NCT00896532|447700287|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476500|NCT00896532|447700288|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476501|NCT00896532|447700289|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476502|NCT00896532|447700290|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476503|NCT00896532|447700291|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476504|NCT00896532|447700292|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476505|NCT00896532|447700293|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476506|NCT00896532|447700294|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476507|NCT00896532|447700295|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476508|NCT00896532|447700296|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476509|NCT00896532|447700297|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476510|NCT00896532|447700298|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476511|NCT00896532|447700299|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476512|NCT00896532|447700300|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476513|NCT00896532|447700301|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476514|NCT00896532|447700302|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
124476515|NCT00896532|447700280|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476516|NCT00896532|447700281|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476517|NCT00896532|447700282|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476518|NCT00896532|447700283|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
124476519|NCT00896532|447700284|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476520|NCT00896532|447700285|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476521|NCT00896532|447700286|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124719455|NCT01318135|448594827|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
124719456|NCT01318135|448594828|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
124719457|NCT01318135|448594829|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
124476522|NCT00896532|447700287|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476523|NCT00896532|447700288|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476524|NCT00896532|447700289|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476525|NCT00896532|447700290|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476526|NCT00896532|447700291|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476527|NCT00896532|447700292|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476528|NCT00896532|447700293|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476529|NCT00896532|447700294|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476530|NCT00896532|447700295|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476531|NCT00896532|447700296|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476532|NCT00896532|447700297|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124556735|NCT03705169|447995931|FG007|Overall Study|Adverse Event|0|||
124556736|NCT03705169|447995932|FG008|Overall Study|Adverse Event|0|||
124476533|NCT00896532|447700298|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476534|NCT00896532|447700299|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476535|NCT00896532|447700300|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124556737|NCT03705169|447995933|FG009|Overall Study|Adverse Event|0|||
124556738|NCT03705169|447995924|FG000|Overall Study|Site Closure|0|||
124556739|NCT03705169|447995925|FG001|Overall Study|Site Closure|0|||
124556740|NCT03705169|447995926|FG002|Overall Study|Site Closure|0|||
124719458|NCT01318135|448594830|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
124719459|NCT01318135|448594823|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
124719460|NCT01318135|448594824|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
124719461|NCT01318135|448594825|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
124719462|NCT01318135|448594826|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
124719463|NCT01318135|448594827|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
124476536|NCT00896532|447700301|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476537|NCT00896532|447700302|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
124476538|NCT00896532|447700280|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476539|NCT00896532|447700281|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
124476540|NCT00896532|447700282|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476541|NCT00896532|447700283|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
124476542|NCT00896532|447700284|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
124476543|NCT00896532|447700285|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476544|NCT00896532|447700286|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476545|NCT00896532|447700287|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476546|NCT00896532|447700288|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476547|NCT00896532|447700289|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124556741|NCT03705169|447995927|FG003|Overall Study|Site Closure|1|||
124556742|NCT03705169|447995928|FG004|Overall Study|Site Closure|0|||
124556743|NCT03705169|447995929|FG005|Overall Study|Site Closure|0|||
124556744|NCT03705169|447995930|FG006|Overall Study|Site Closure|0|||
124556745|NCT03705169|447995931|FG007|Overall Study|Site Closure|0|||
124556746|NCT03705169|447995932|FG008|Overall Study|Site Closure|0|||
124556747|NCT03705169|447995933|FG009|Overall Study|Site Closure|0|||
124556748|NCT03705169|447995924|FG000|Overall Study|Did not receive study treatment|0|||
124556749|NCT03705169|447995925|FG001|Overall Study|Did not receive study treatment|0|||
124556750|NCT03705169|447995926|FG002|Overall Study|Did not receive study treatment|0|||
124556751|NCT03705169|447995927|FG003|Overall Study|Did not receive study treatment|1|||
124476548|NCT00896532|447700290|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476549|NCT00896532|447700291|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476550|NCT00896532|447700292|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476551|NCT00896532|447700293|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476552|NCT00896532|447700294|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476553|NCT00896532|447700295|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476554|NCT00896532|447700296|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124719464|NCT01318135|448594828|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
124719465|NCT01318135|448594829|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
124719466|NCT01318135|448594830|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
124719467|NCT01318135|448594823|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
124476555|NCT00896532|447700297|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476556|NCT00896532|447700298|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476557|NCT00896532|447700299|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476558|NCT00896532|447700300|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476559|NCT00896532|447700301|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476560|NCT00896532|447700302|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
124476561|NCT00896532|447700280|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476562|NCT00896532|447700281|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476563|NCT00896532|447700282|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476564|NCT00896532|447700283|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476565|NCT00896532|447700284|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476566|NCT00896532|447700285|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476567|NCT00896532|447700286|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476568|NCT00896532|447700287|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476569|NCT00896532|447700288|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
124476570|NCT00896532|447700289|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124719468|NCT01318135|448594824|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
124476571|NCT00896532|447700290|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476572|NCT00896532|447700291|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476573|NCT00896532|447700292|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476574|NCT00896532|447700293|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476575|NCT00896532|447700294|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476576|NCT00896532|447700295|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476577|NCT00896532|447700296|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476578|NCT00896532|447700297|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476579|NCT00896532|447700298|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476580|NCT00896532|447700299|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476581|NCT00896532|447700300|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476582|NCT00896532|447700301|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476583|NCT00896532|447700302|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
124476584|NCT00896532|447700280|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476585|NCT00896532|447700281|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476586|NCT00896532|447700282|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476587|NCT00896532|447700283|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124556752|NCT03705169|447995928|FG004|Overall Study|Did not receive study treatment|0|||
124556753|NCT03705169|447995929|FG005|Overall Study|Did not receive study treatment|0|||
124556754|NCT03705169|447995930|FG006|Overall Study|Did not receive study treatment|0|||
124556755|NCT03705169|447995931|FG007|Overall Study|Did not receive study treatment|0|||
124556756|NCT03705169|447995932|FG008|Overall Study|Did not receive study treatment|0|||
124556757|NCT03705169|447995933|FG009|Overall Study|Did not receive study treatment|0|||
124556758|NCT03705169|447995924|FG000|Overall Study|Concerns about study visit compliance|0|||
124556759|NCT03705169|447995925|FG001|Overall Study|Concerns about study visit compliance|0|||
124556760|NCT03705169|447995926|FG002|Overall Study|Concerns about study visit compliance|0|||
124556761|NCT03705169|447995927|FG003|Overall Study|Concerns about study visit compliance|1|||
124556762|NCT03705169|447995928|FG004|Overall Study|Concerns about study visit compliance|0|||
124556763|NCT03705169|447995929|FG005|Overall Study|Concerns about study visit compliance|0|||
124556764|NCT03705169|447995930|FG006|Overall Study|Concerns about study visit compliance|0|||
124556765|NCT03705169|447995931|FG007|Overall Study|Concerns about study visit compliance|0|||
124556766|NCT03705169|447995932|FG008|Overall Study|Concerns about study visit compliance|0|||
124556767|NCT03705169|447995933|FG009|Overall Study|Concerns about study visit compliance|0|||
124556768|NCT01690520|447997615|FG000|Overall Study|Death|25|||
124556769|NCT01690520|447997616|FG001|Overall Study|Death|21|||
124556770|NCT01690520|447997615|FG000|Overall Study|Lost to Follow-up|2|||
124476588|NCT00896532|447700284|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476589|NCT00896532|447700285|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476590|NCT00896532|447700286|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476591|NCT00896532|447700287|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476592|NCT00896532|447700288|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476593|NCT00896532|447700289|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476594|NCT00896532|447700290|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476595|NCT00896532|447700291|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476596|NCT00896532|447700292|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
124476597|NCT00896532|447700293|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476598|NCT00896532|447700294|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476599|NCT00896532|447700295|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476600|NCT00896532|447700296|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476601|NCT00896532|447700297|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476602|NCT00896532|447700298|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476603|NCT00896532|447700299|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476604|NCT00896532|447700300|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476605|NCT00896532|447700301|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476606|NCT00896532|447700302|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
124476607|NCT00896532|447700280|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476608|NCT00896532|447700281|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476609|NCT00896532|447700282|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476610|NCT00896532|447700283|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476611|NCT00896532|447700284|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476612|NCT00896532|447700285|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476613|NCT00896532|447700286|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476614|NCT00896532|447700287|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476615|NCT00896532|447700288|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476616|NCT00896532|447700289|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476617|NCT00896532|447700290|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
124476618|NCT00896532|447700291|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476619|NCT00896532|447700292|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
124476620|NCT00896532|447700293|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476621|NCT00896532|447700294|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476622|NCT00896532|447700295|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476623|NCT00896532|447700296|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476624|NCT00896532|447700297|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476625|NCT00896532|447700298|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476626|NCT00896532|447700299|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476627|NCT00896532|447700300|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476628|NCT00896532|447700301|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476629|NCT00896532|447700302|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
124476630|NCT00896532|447700280|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124476631|NCT00896532|447700281|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124719469|NCT01318135|448594825|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
124476632|NCT00896532|447700282|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124719470|NCT01318135|448594826|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
124719471|NCT01318135|448594827|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
124719472|NCT01318135|448594828|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
124719473|NCT01318135|448594829|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
124719474|NCT01318135|448594830|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
124719475|NCT01318135|448594823|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
124719476|NCT01318135|448594824|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
124719477|NCT01318135|448594825|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
124719478|NCT01318135|448594826|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
124719479|NCT01318135|448594827|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
124719480|NCT01318135|448594828|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
124719481|NCT01318135|448594829|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
124556771|NCT01690520|447997616|FG001|Overall Study|Lost to Follow-up|3|||
124719482|NCT01318135|448594830|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
124719483|NCT01318135|448594823|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
124719484|NCT01318135|448594824|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
124719485|NCT01318135|448594825|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
124719486|NCT01318135|448594826|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
124719487|NCT01318135|448594827|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
124719488|NCT01318135|448594828|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
124719489|NCT01318135|448594829|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
124476633|NCT00896532|447700283|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124476634|NCT00896532|447700284|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124476635|NCT00896532|447700285|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124476636|NCT00896532|447700286|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124476637|NCT00896532|447700287|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124476638|NCT00896532|447700288|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124476639|NCT00896532|447700289|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124476640|NCT00896532|447700290|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124476641|NCT00896532|447700291|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124556772|NCT01690520|447997615|FG000|Overall Study|Withdrawal by Subject|2|||
124556773|NCT01690520|447997616|FG001|Overall Study|Withdrawal by Subject|0|||
124556774|NCT01690520|447997615|FG000|Overall Study|Relapse|0|||
124556775|NCT01690520|447997616|FG001|Overall Study|Relapse|1|||
124556776|NCT01690520|447997615|FG000|Overall Study|Other|0|||
124556777|NCT01690520|447997616|FG001|Overall Study|Other|1|||
124556778|NCT01690520|447997615|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
124556779|NCT01690520|447997616|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
124556780|NCT04006847|447997617|FG000|Overall Study|Product issue|1|||
124556781|NCT01375010|447997618|FG000|Overall Study|Lost to Follow-up|8|||
124556782|NCT01375010|447997619|FG001|Overall Study|Lost to Follow-up|2|||
124556783|NCT01375010|447997618|FG000|Overall Study|Withdrawal by Subject|4|||
124556784|NCT01375010|447997619|FG001|Overall Study|Withdrawal by Subject|2|||
124556785|NCT02614703|447997620|FG000|Overall Study|Withdrawal by Subject|7|||
124556786|NCT02614703|447997621|FG001|Overall Study|Withdrawal by Subject|1|||
124719490|NCT01318135|448594830|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
124719491|NCT03012828|448594837|FG000|Overall Study|Lost to Follow-up|1|||
124719492|NCT03012828|448594838|FG001|Overall Study|Lost to Follow-up|0|||
124476642|NCT00896532|447700292|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
124476643|NCT00896532|447700293|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
124719493|NCT03012828|448594839|FG002|Overall Study|Lost to Follow-up|1|||
124719494|NCT03012828|448594840|FG003|Overall Study|Lost to Follow-up|0|||
124476644|NCT00896532|447700294|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124719495|NCT03012828|448594841|FG004|Overall Study|Lost to Follow-up|1|||
124476645|NCT00896532|447700295|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124719496|NCT03012828|448594842|FG005|Overall Study|Lost to Follow-up|0|||
124719497|NCT03012828|448594837|FG000|Overall Study|Withdrawal by Subject|0|||
124476646|NCT00896532|447700296|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124476647|NCT00896532|447700297|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124476648|NCT00896532|447700298|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124476649|NCT00896532|447700299|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124719498|NCT03012828|448594838|FG001|Overall Study|Withdrawal by Subject|0|||
124719499|NCT03012828|448594839|FG002|Overall Study|Withdrawal by Subject|1|||
124476650|NCT00896532|447700300|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124476651|NCT00896532|447700301|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124476652|NCT00896532|447700302|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
124476653|NCT00896532|447700280|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
124556787|NCT02402933|447997622|FG000|Overall Study|Withdrawal by Subject|4|||
124556788|NCT02402933|447997622|FG000|Overall Study|Discontinued; Site Termination|10|||
124556789|NCT02919475|447997625|FG000|Overall Study|Adverse Event|3|||
124556790|NCT02919475|447997626|FG001|Overall Study|Adverse Event|3|||
124556791|NCT02919475|447997627|FG002|Overall Study|Adverse Event|3|||
124556792|NCT02919475|447997628|FG003|Overall Study|Adverse Event|9|||
124556793|NCT02919475|447997629|FG004|Overall Study|Adverse Event|2|||
124556794|NCT02919475|447997625|FG000|Overall Study|Death|0|||
124556795|NCT02919475|447997626|FG001|Overall Study|Death|1|||
124556796|NCT02919475|447997627|FG002|Overall Study|Death|0|||
124556797|NCT02919475|447997628|FG003|Overall Study|Death|0|||
124556798|NCT02919475|447997629|FG004|Overall Study|Death|0|||
124556799|NCT02919475|447997625|FG000|Overall Study|Lost to Follow-up|0|||
124556800|NCT02919475|447997626|FG001|Overall Study|Lost to Follow-up|0|||
124556801|NCT02919475|447997627|FG002|Overall Study|Lost to Follow-up|0|||
124556802|NCT02919475|447997628|FG003|Overall Study|Lost to Follow-up|1|||
124556803|NCT02919475|447997629|FG004|Overall Study|Lost to Follow-up|0|||
124556804|NCT02919475|447997625|FG000|Overall Study|Withdrawal by Subject|2|||
124556805|NCT02919475|447997626|FG001|Overall Study|Withdrawal by Subject|3|||
124556806|NCT02919475|447997627|FG002|Overall Study|Withdrawal by Subject|1|||
124556807|NCT02919475|447997628|FG003|Overall Study|Withdrawal by Subject|2|||
124556808|NCT02919475|447997629|FG004|Overall Study|Withdrawal by Subject|2|||
124556809|NCT02919475|447997625|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
124556810|NCT02919475|447997626|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
124556811|NCT02919475|447997627|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
124556812|NCT02919475|447997628|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
124556813|NCT02919475|447997629|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124556814|NCT02370784|447997631|FG000|Overall Study|Patient started prohibited medication|0|||
124556815|NCT02370784|447997632|FG001|Overall Study|Patient started prohibited medication|1|||
124556816|NCT00775983|447997633|FG000|Overall Study|Protocol Violation|1|||
124556817|NCT00775983|447997634|FG001|Overall Study|Protocol Violation|2|||
124556818|NCT02962882|447997635|FG000|Overall Study|Adverse Event|2|||
124556819|NCT02962882|447997635|FG000|Overall Study|Withdrawal by Subject|2|||
124556820|NCT02962882|447997635|FG000|Overall Study|Transfer from ICU|32|||
124556821|NCT01312779|447997636|FG000|Overall Study|Withdrawal by Subject|2|||
124556822|NCT01312779|447997636|FG000|Overall Study|Death|3|||
124556823|NCT01312779|447997636|FG000|Overall Study|Not Implanted with Device|27|||
124556824|NCT01663714|447997637|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
124556825|NCT01663714|447997637|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
124556826|NCT01663714|447997637|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
124556827|NCT01663714|447997637|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
124556828|NCT01663714|447997637|FG000|Long-Term Follow-Up|Death|4|||
124556829|NCT01663714|447997637|FG000|Long-Term Follow-Up|Non-compliance|1|||
124556830|NCT00660790|447997640|FG000|Baseline to 3 Months|Death|1|||
124556831|NCT00660790|447997640|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
124556832|NCT00660790|447997640|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
124556833|NCT02791659|447997641|FG000|Overall Study|Protocol Violation|0|||
124556834|NCT02791659|447997642|FG001|Overall Study|Protocol Violation|1|||
124556835|NCT03840811|447997643|FG000|Overall Study|Lost to Follow-up|0|||
124556836|NCT03840811|447997644|FG001|Overall Study|Lost to Follow-up|0|||
124556837|NCT03840811|447997645|FG002|Overall Study|Lost to Follow-up|1|||
124556838|NCT01904383|447997646|FG000|Overall Study|CRF not collected|117|||
124556839|NCT01904383|447997646|FG000|Overall Study|Reason not listed|147|||
124556840|NCT01904383|447997646|FG000|Overall Study|Lost to Follow-up|674|||
124556841|NCT01904383|447997646|FG000|Overall Study|Lack of Efficacy|370|||
124476654|NCT00896532|447700281|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
124476655|NCT00896532|447700282|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
124476656|NCT00896532|447700283|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
124476657|NCT00896532|447700284|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
124476658|NCT00896532|447700285|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
124476659|NCT00896532|447700286|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
124476660|NCT00896532|447700287|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
124476661|NCT00896532|447700288|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
124476662|NCT00896532|447700289|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
124476663|NCT00896532|447700290|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
124476664|NCT00896532|447700291|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
124476665|NCT00896532|447700292|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
124476666|NCT00896532|447700293|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
124476667|NCT00896532|447700294|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
124476668|NCT00896532|447700295|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
124476669|NCT00896532|447700296|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
124476670|NCT00896532|447700297|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
124476671|NCT00896532|447700298|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
124476672|NCT00896532|447700299|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
124476673|NCT00896532|447700300|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
124476674|NCT00896532|447700301|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
124476675|NCT00896532|447700302|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
124476676|NCT00896532|447700280|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476677|NCT00896532|447700281|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476678|NCT00896532|447700282|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476679|NCT00896532|447700283|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476680|NCT00896532|447700284|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476681|NCT00896532|447700285|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476682|NCT00896532|447700286|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476683|NCT00896532|447700287|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476684|NCT00896532|447700288|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476685|NCT00896532|447700289|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476686|NCT00896532|447700290|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476687|NCT00896532|447700291|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476688|NCT00896532|447700292|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476689|NCT00896532|447700293|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476690|NCT00896532|447700294|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476691|NCT00896532|447700295|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
124476692|NCT00896532|447700296|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
124476693|NCT00896532|447700297|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476694|NCT00896532|447700298|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124556842|NCT01904383|447997646|FG000|Overall Study|Improvement|141|||
124556843|NCT01904383|447997646|FG000|Overall Study|Adverse Event|271|||
124556844|NCT01904383|447997646|FG000|Overall Study|No patient visit after entry|54|||
124556845|NCT01625845|447997647|FG000|Overall Study|Adverse Event|1|||
124556846|NCT01625845|447997648|FG001|Overall Study|Adverse Event|2|||
124556847|NCT01625845|447997647|FG000|Overall Study|Lost to Follow-up|2|||
124556848|NCT01625845|447997648|FG001|Overall Study|Lost to Follow-up|1|||
124556849|NCT01625845|447997647|FG000|Overall Study|Withdrawal by Subject|2|||
124556850|NCT01625845|447997648|FG001|Overall Study|Withdrawal by Subject|0|||
124556851|NCT01294592|447997649|FG000|Overall Study|Adverse Event|28|||
124556852|NCT01294592|447997650|FG001|Overall Study|Adverse Event|13|||
124556853|NCT01294592|447997649|FG000|Overall Study|Lack of Efficacy|7|||
124556854|NCT01294592|447997650|FG001|Overall Study|Lack of Efficacy|5|||
124556855|NCT01294592|447997649|FG000|Overall Study|Protocol Violation|1|||
124556856|NCT01294592|447997650|FG001|Overall Study|Protocol Violation|7|||
124556857|NCT01294592|447997649|FG000|Overall Study|Lost to Follow-up|7|||
124556858|NCT01294592|447997650|FG001|Overall Study|Lost to Follow-up|9|||
124556859|NCT01294592|447997649|FG000|Overall Study|Physician Decision|6|||
124556860|NCT01294592|447997650|FG001|Overall Study|Physician Decision|11|||
124556861|NCT01294592|447997649|FG000|Overall Study|Withdrawal by Subject|28|||
124556862|NCT01294592|447997650|FG001|Overall Study|Withdrawal by Subject|28|||
124556863|NCT02762565|447997651|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
124556864|NCT03549130|447997652|FG000|Overall Study|Adverse Event|0|||
124556865|NCT03549130|447997653|FG001|Overall Study|Adverse Event|1|||
124556866|NCT03549130|447997652|FG000|Overall Study|Lost to Follow-up|0|||
124556867|NCT03549130|447997653|FG001|Overall Study|Lost to Follow-up|1|||
124556868|NCT01113710|447997654|FG000|Overall Study|Adverse Event|64|||
124556869|NCT01113710|447997654|FG000|Overall Study|Lack of Efficacy|41|||
124556870|NCT01113710|447997654|FG000|Overall Study|No Information Available|40|||
124556871|NCT01113710|447997654|FG000|Overall Study|Withdrawal by Subject|28|||
124556872|NCT01113710|447997654|FG000|Overall Study|Lost to Follow-up|20|||
124556873|NCT01113710|447997654|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
124556874|NCT01113710|447997654|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
124556875|NCT01113710|447997654|FG000|Overall Study|Lack of Patient's Compliance|8|||
124556876|NCT01113710|447997654|FG000|Overall Study|Other|7|||
124556877|NCT01113710|447997654|FG000|Overall Study|Adverse Event/Other|5|||
124556878|NCT01113710|447997654|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
124556879|NCT01113710|447997654|FG000|Overall Study|Lack of Efficacy/Other|4|||
124556880|NCT01113710|447997654|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
124556881|NCT01113710|447997654|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
124556882|NCT01113710|447997654|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
124556883|NCT01113710|447997654|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
124556884|NCT01113710|447997654|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
124556885|NCT01113710|447997654|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
124556886|NCT01113710|447997654|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
124556887|NCT01113710|447997654|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
124556888|NCT01113710|447997654|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
124556889|NCT01113710|447997654|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
124556890|NCT01113710|447997654|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
124556891|NCT01113710|447997654|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
124556892|NCT01113710|447997654|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
124556893|NCT01078623|447997655|FG000|Treatment Period 1|Adverse Event|1|||
124556894|NCT01078623|447997656|FG001|Treatment Period 1|Adverse Event|1|||
124556895|NCT01078623|447997657|FG002|Treatment Period 1|Adverse Event|1|||
124556896|NCT01078623|447997658|FG003|Treatment Period 1|Adverse Event|0|||
124556897|NCT01078623|447997659|FG004|Treatment Period 1|Adverse Event|0|||
124476695|NCT00896532|447700299|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476696|NCT00896532|447700300|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476697|NCT00896532|447700301|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476698|NCT00896532|447700302|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
124476699|NCT00896532|447700280|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124719500|NCT03012828|448594840|FG003|Overall Study|Withdrawal by Subject|0|||
124719501|NCT03012828|448594841|FG004|Overall Study|Withdrawal by Subject|0|||
124476700|NCT00896532|447700281|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476701|NCT00896532|447700282|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476702|NCT00896532|447700283|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476703|NCT00896532|447700284|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476704|NCT00896532|447700285|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476705|NCT00896532|447700286|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476706|NCT00896532|447700287|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476707|NCT00896532|447700288|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476708|NCT00896532|447700289|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476709|NCT00896532|447700290|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476710|NCT00896532|447700291|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476711|NCT00896532|447700292|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476712|NCT00896532|447700293|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476713|NCT00896532|447700294|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476714|NCT00896532|447700295|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
124476715|NCT00896532|447700296|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
124476716|NCT00896532|447700297|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
124476717|NCT00896532|447700298|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476718|NCT00896532|447700299|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476719|NCT00896532|447700300|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476720|NCT00896532|447700301|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476721|NCT00896532|447700302|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
124476722|NCT00896532|447700280|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476723|NCT00896532|447700281|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476724|NCT00896532|447700282|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476725|NCT00896532|447700283|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476726|NCT00896532|447700284|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476727|NCT00896532|447700285|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476728|NCT00896532|447700286|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476729|NCT00896532|447700287|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476730|NCT00896532|447700288|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476731|NCT00896532|447700289|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476732|NCT00896532|447700290|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476733|NCT00896532|447700291|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124719502|NCT03012828|448594842|FG005|Overall Study|Withdrawal by Subject|1|||
124476734|NCT00896532|447700292|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476735|NCT00896532|447700293|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476736|NCT00896532|447700294|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476737|NCT00896532|447700295|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476738|NCT00896532|447700296|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
124476739|NCT00896532|447700297|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476740|NCT00896532|447700298|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476741|NCT00896532|447700299|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476742|NCT00896532|447700300|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476743|NCT00896532|447700301|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476744|NCT00896532|447700302|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
124476745|NCT00896532|447700280|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
124476746|NCT00896532|447700281|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
124719503|NCT03012828|448594837|FG000|Overall Study|Non-compliance with protocol|0|||
124556898|NCT01078623|447997660|FG005|Treatment Period 1|Adverse Event|0|||
124556899|NCT01078623|447997661|FG006|Treatment Period 1|Adverse Event|1|||
124476747|NCT00896532|447700282|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
124476748|NCT00896532|447700283|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
124476749|NCT00896532|447700284|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
124476750|NCT00896532|447700285|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
124476751|NCT00896532|447700286|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
124476752|NCT00896532|447700287|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
124476753|NCT00896532|447700288|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
124476754|NCT00896532|447700289|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
124476755|NCT00896532|447700290|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
124476756|NCT00896532|447700291|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
124476757|NCT00896532|447700292|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
124476758|NCT00896532|447700293|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
124476759|NCT00896532|447700294|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
124476760|NCT00896532|447700295|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
124719504|NCT03012828|448594838|FG001|Overall Study|Non-compliance with protocol|0|||
124476761|NCT00896532|447700296|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
124476762|NCT00896532|447700297|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
124476763|NCT00896532|447700298|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
124476764|NCT00896532|447700299|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
124476765|NCT00896532|447700300|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
124476766|NCT00896532|447700301|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
124476767|NCT00896532|447700302|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
124476768|NCT00896532|447700280|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476769|NCT00896532|447700281|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476770|NCT00896532|447700282|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476771|NCT00896532|447700283|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476772|NCT00896532|447700284|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476773|NCT00896532|447700285|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476774|NCT00896532|447700286|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476775|NCT00896532|447700287|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476776|NCT00896532|447700288|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476777|NCT00896532|447700289|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476778|NCT00896532|447700290|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476779|NCT00896532|447700291|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476780|NCT00896532|447700292|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476781|NCT00896532|447700293|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476782|NCT00896532|447700294|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476783|NCT00896532|447700295|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476784|NCT00896532|447700296|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
124476785|NCT00896532|447700297|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476786|NCT00896532|447700298|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476787|NCT00896532|447700299|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476788|NCT00896532|447700300|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476789|NCT00896532|447700301|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476790|NCT00896532|447700302|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
124476791|NCT00896532|447700280|FG000|Months 48-72: Follow-on Phase|Death|0|||
124476792|NCT00896532|447700281|FG001|Months 48-72: Follow-on Phase|Death|0|||
124476793|NCT00896532|447700282|FG002|Months 48-72: Follow-on Phase|Death|0|||
124476794|NCT00896532|447700283|FG003|Months 48-72: Follow-on Phase|Death|0|||
124476795|NCT00896532|447700284|FG004|Months 48-72: Follow-on Phase|Death|0|||
124476796|NCT00896532|447700285|FG005|Months 48-72: Follow-on Phase|Death|0|||
124476797|NCT00896532|447700286|FG006|Months 48-72: Follow-on Phase|Death|0|||
124476798|NCT00896532|447700287|FG007|Months 48-72: Follow-on Phase|Death|0|||
124476799|NCT00896532|447700288|FG008|Months 48-72: Follow-on Phase|Death|0|||
124476800|NCT00896532|447700289|FG009|Months 48-72: Follow-on Phase|Death|0|||
124476801|NCT00896532|447700290|FG010|Months 48-72: Follow-on Phase|Death|0|||
124476802|NCT00896532|447700291|FG011|Months 48-72: Follow-on Phase|Death|0|||
124476803|NCT00896532|447700292|FG012|Months 48-72: Follow-on Phase|Death|0|||
124476804|NCT00896532|447700293|FG013|Months 48-72: Follow-on Phase|Death|0|||
124476805|NCT00896532|447700294|FG014|Months 48-72: Follow-on Phase|Death|0|||
124476806|NCT00896532|447700295|FG015|Months 48-72: Follow-on Phase|Death|0|||
124476807|NCT00896532|447700296|FG016|Months 48-72: Follow-on Phase|Death|0|||
124476808|NCT00896532|447700297|FG017|Months 48-72: Follow-on Phase|Death|0|||
124476809|NCT00896532|447700298|FG018|Months 48-72: Follow-on Phase|Death|1|||
124476810|NCT00896532|447700299|FG019|Months 48-72: Follow-on Phase|Death|0|||
124476811|NCT00896532|447700300|FG020|Months 48-72: Follow-on Phase|Death|0|||
124476812|NCT00896532|447700301|FG021|Months 48-72: Follow-on Phase|Death|0|||
124476813|NCT00896532|447700302|FG022|Months 48-72: Follow-on Phase|Death|0|||
124476814|NCT00896532|447700280|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476815|NCT00896532|447700281|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476816|NCT00896532|447700282|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476817|NCT00896532|447700283|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476818|NCT00896532|447700284|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476819|NCT00896532|447700285|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476820|NCT00896532|447700286|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476821|NCT00896532|447700287|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124556900|NCT01078623|447997662|FG007|Treatment Period 1|Adverse Event|0|||
124556901|NCT01078623|447997663|FG008|Treatment Period 1|Adverse Event|1|||
124556902|NCT01078623|447997664|FG009|Treatment Period 1|Adverse Event|1|||
124556903|NCT01078623|447997665|FG010|Treatment Period 1|Adverse Event|0|||
124556904|NCT01078623|447997666|FG011|Treatment Period 1|Adverse Event|0|||
124556905|NCT01078623|447997667|FG012|Treatment Period 1|Adverse Event|0|||
124556906|NCT01078623|447997668|FG013|Treatment Period 1|Adverse Event|0|||
124476822|NCT00896532|447700288|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476823|NCT00896532|447700289|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476824|NCT00896532|447700290|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476825|NCT00896532|447700291|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476826|NCT00896532|447700292|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476827|NCT00896532|447700293|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476828|NCT00896532|447700294|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476829|NCT00896532|447700295|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476830|NCT00896532|447700296|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476831|NCT00896532|447700297|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476832|NCT00896532|447700298|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476833|NCT00896532|447700299|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476834|NCT00896532|447700300|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476835|NCT00896532|447700301|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
124476836|NCT00896532|447700302|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
124476837|NCT00896532|447700280|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476838|NCT00896532|447700281|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476839|NCT00896532|447700282|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476840|NCT00896532|447700283|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476841|NCT00896532|447700284|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124556907|NCT01078623|447997669|FG014|Treatment Period 1|Adverse Event|0|||
124556908|NCT01078623|447997670|FG015|Treatment Period 1|Adverse Event|0|||
124556909|NCT01078623|447997671|FG016|Treatment Period 1|Adverse Event|0|||
124476842|NCT00896532|447700285|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476843|NCT00896532|447700286|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476844|NCT00896532|447700287|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476845|NCT00896532|447700288|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476846|NCT00896532|447700289|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476847|NCT00896532|447700290|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476848|NCT00896532|447700291|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476849|NCT00896532|447700292|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476850|NCT00896532|447700293|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476851|NCT00896532|447700294|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476852|NCT00896532|447700295|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476853|NCT00896532|447700296|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476854|NCT00896532|447700297|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476855|NCT00896532|447700298|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476856|NCT00896532|447700299|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476857|NCT00896532|447700300|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476858|NCT00896532|447700301|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
124476859|NCT00896532|447700302|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
124476860|NCT00631137|447700303|FG000|Overall Study|Withdrawal by Subject|1|||
124476861|NCT00631137|447700304|FG001|Overall Study|Withdrawal by Subject|0|||
124476862|NCT01791855|447700305|FG000|Overall Study|Adverse Event|0|||
124476863|NCT01791855|447700306|FG001|Overall Study|Adverse Event|0|||
124476864|NCT01791855|447700307|FG002|Overall Study|Adverse Event|0|||
124476865|NCT01791855|447700308|FG003|Overall Study|Adverse Event|1|||
124476866|NCT01791855|447700305|FG000|Overall Study|Randomized, not treated|0|||
124476867|NCT01791855|447700306|FG001|Overall Study|Randomized, not treated|1|||
124476868|NCT01791855|447700307|FG002|Overall Study|Randomized, not treated|0|||
124476869|NCT01791855|447700308|FG003|Overall Study|Randomized, not treated|0|||
124476870|NCT00772447|447700309|FG000|Overall Study|Withdrawal by Subject|9|||
124476871|NCT00772447|447700310|FG001|Overall Study|Withdrawal by Subject|5|||
124476872|NCT00772447|447700309|FG000|Overall Study|Physician Decision|4|||
124556910|NCT01078623|447997672|FG017|Treatment Period 1|Adverse Event|0|||
124556911|NCT01078623|447997673|FG018|Treatment Period 1|Adverse Event|0|||
124556912|NCT01078623|447997674|FG019|Treatment Period 1|Adverse Event|0|||
124556913|NCT01078623|447997655|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124556914|NCT01078623|447997656|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124556915|NCT01078623|447997657|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124476873|NCT00772447|447700310|FG001|Overall Study|Physician Decision|8|||
124476874|NCT00772447|447700309|FG000|Overall Study|Lost to Follow-up|2|||
124476875|NCT00772447|447700310|FG001|Overall Study|Lost to Follow-up|4|||
124476876|NCT00772447|447700309|FG000|Overall Study|incorrect enrolment|3|||
124556916|NCT01078623|447997658|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124556917|NCT01078623|447997659|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124556918|NCT01078623|447997660|FG005|Treatment Period 1|Withdrawal by Subject|0|||
124476877|NCT00772447|447700310|FG001|Overall Study|incorrect enrolment|4|||
124476878|NCT00772447|447700309|FG000|Overall Study|Protocol Violation|0|||
124476879|NCT00772447|447700310|FG001|Overall Study|Protocol Violation|1|||
124476880|NCT00772447|447700309|FG000|Overall Study|all others|2|||
124476881|NCT00772447|447700310|FG001|Overall Study|all others|2|||
124476882|NCT01439945|447700311|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
124476883|NCT01439945|447700312|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
124476884|NCT01439945|447700313|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
124476885|NCT01439945|447700314|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
124476886|NCT01439945|447700311|FG000|Double-Blind Treatment Phase|Ineligible|1|||
124476887|NCT01439945|447700312|FG001|Double-Blind Treatment Phase|Ineligible|2|||
124476888|NCT01439945|447700313|FG002|Double-Blind Treatment Phase|Ineligible|0|||
124476889|NCT01439945|447700314|FG003|Double-Blind Treatment Phase|Ineligible|1|||
124476890|NCT01497262|447700317|FG000|Overall Study|Abnormal Lab Values|4|||
124476891|NCT01497262|447700317|FG000|Overall Study|Abnormal Test Procedure Result|1|||
124476892|NCT01497262|447700317|FG000|Overall Study|Physician Decision|1|||
124476893|NCT01497262|447700317|FG000|Overall Study|Withdrawal by Subject|2|||
124476894|NCT01497262|447700317|FG000|Overall Study|Adverse Event|2|||
124476895|NCT01497262|447700317|FG000|Overall Study|Protocol Violation|1|||
124476896|NCT00054132|447700320|FG000|Overall Study|Not Treated|1|||
124476897|NCT01290887|447700321|FG000|Overall Study|Adverse Event|6|||
124476898|NCT01290887|447700322|FG001|Overall Study|Adverse Event|11|||
124476899|NCT01290887|447700321|FG000|Overall Study|Lack of Efficacy|4|||
124476900|NCT01290887|447700322|FG001|Overall Study|Lack of Efficacy|5|||
124476901|NCT01290887|447700321|FG000|Overall Study|Withdrawal by Subject|26|||
124476902|NCT01290887|447700322|FG001|Overall Study|Withdrawal by Subject|32|||
124476903|NCT01290887|447700321|FG000|Overall Study|Protocol Violation|2|||
124476904|NCT01290887|447700322|FG001|Overall Study|Protocol Violation|1|||
124476905|NCT01290887|447700321|FG000|Overall Study|Lost to Follow-up|4|||
124476906|NCT01290887|447700322|FG001|Overall Study|Lost to Follow-up|4|||
124476907|NCT01290887|447700321|FG000|Overall Study|Non-compliance to study procedures|0|||
124476908|NCT01290887|447700322|FG001|Overall Study|Non-compliance to study procedures|1|||
124476909|NCT01290887|447700321|FG000|Overall Study|Non-compliance to study medications|1|||
124476910|NCT01290887|447700322|FG001|Overall Study|Non-compliance to study medications|0|||
124476911|NCT01290887|447700321|FG000|Overall Study|Sponsor closure of study|420|||
124476912|NCT01290887|447700322|FG001|Overall Study|Sponsor closure of study|476|||
124476913|NCT01290887|447700321|FG000|Overall Study|Other|3|||
124476914|NCT01290887|447700322|FG001|Overall Study|Other|6|||
124476915|NCT01468987|447700323|FG000|Overall Study|Adverse Event|12|||
124476916|NCT01468987|447700324|FG001|Overall Study|Adverse Event|9|||
124476917|NCT01468987|447700323|FG000|Overall Study|Death|4|||
124476918|NCT01468987|447700324|FG001|Overall Study|Death|1|||
124476919|NCT01468987|447700323|FG000|Overall Study|Lost to Follow-up|10|||
124476920|NCT01468987|447700324|FG001|Overall Study|Lost to Follow-up|5|||
124476921|NCT01468987|447700323|FG000|Overall Study|Protocol Violation|8|||
124476922|NCT01468987|447700324|FG001|Overall Study|Protocol Violation|2|||
124476923|NCT01468987|447700323|FG000|Overall Study|Withdrawal by Subject|28|||
124476924|NCT01468987|447700324|FG001|Overall Study|Withdrawal by Subject|28|||
124476925|NCT01468987|447700323|FG000|Overall Study|Physician Decision|8|||
124476926|NCT01468987|447700324|FG001|Overall Study|Physician Decision|15|||
124476927|NCT01468987|447700323|FG000|Overall Study|Sponsor Decision|1|||
124476928|NCT01468987|447700324|FG001|Overall Study|Sponsor Decision|0|||
124476929|NCT01795547|447700325|FG000|Overall Study|Adverse Event|16|||
124476930|NCT01795547|447700326|FG001|Overall Study|Adverse Event|27|||
124476931|NCT01795547|447700325|FG000|Overall Study|Lack of Efficacy|8|||
124476932|NCT01795547|447700326|FG001|Overall Study|Lack of Efficacy|3|||
124476933|NCT01795547|447700325|FG000|Overall Study|Protocol Violation|6|||
124476934|NCT01795547|447700326|FG001|Overall Study|Protocol Violation|4|||
124476935|NCT01795547|447700325|FG000|Overall Study|Lost to Follow-up|2|||
124476936|NCT01795547|447700326|FG001|Overall Study|Lost to Follow-up|5|||
124476937|NCT01795547|447700325|FG000|Overall Study|Withdrawal of consent|7|||
124476938|NCT01795547|447700326|FG001|Overall Study|Withdrawal of consent|12|||
124476939|NCT01795547|447700325|FG000|Overall Study|Not Treated|4|||
124476940|NCT01795547|447700326|FG001|Overall Study|Not Treated|10|||
124476941|NCT01795547|447700325|FG000|Overall Study|Non-compliance with IMP|1|||
124556919|NCT01078623|447997661|FG006|Treatment Period 1|Withdrawal by Subject|0|||
124556920|NCT01078623|447997662|FG007|Treatment Period 1|Withdrawal by Subject|1|||
124476942|NCT01795547|447700326|FG001|Overall Study|Non-compliance with IMP|1|||
124556921|NCT01078623|447997663|FG008|Treatment Period 1|Withdrawal by Subject|0|||
124556922|NCT01078623|447997664|FG009|Treatment Period 1|Withdrawal by Subject|0|||
124476943|NCT01795547|447700325|FG000|Overall Study|Others|4|||
124476944|NCT01795547|447700326|FG001|Overall Study|Others|1|||
124476945|NCT01795547|447700325|FG000|Overall Study|Not stated|0|||
124476946|NCT01795547|447700326|FG001|Overall Study|Not stated|1|||
124476947|NCT05032950|447700328|FG000|Overall Study|Adverse Event|0|||
124476948|NCT05032950|447700329|FG001|Overall Study|Adverse Event|0|||
124476949|NCT05032950|447700330|FG002|Overall Study|Adverse Event|1|||
124476950|NCT05032950|447700331|FG003|Overall Study|Adverse Event|1|||
124476951|NCT05032950|447700332|FG004|Overall Study|Adverse Event|0|||
124476952|NCT05032950|447700333|FG005|Overall Study|Adverse Event|0|||
124476953|NCT00961961|447700337|FG000|Phase I|Withdrawal by Subject|7|||
124476954|NCT00961961|447700338|FG001|Phase I|Withdrawal by Subject|0|||
124476955|NCT00961961|447700339|FG002|Phase I|Withdrawal by Subject|0|||
124476956|NCT00961961|447700340|FG003|Phase I|Withdrawal by Subject|0|||
124476957|NCT00961961|447700337|FG000|Phase I|Lost to Follow-up|10|||
124476958|NCT00961961|447700338|FG001|Phase I|Lost to Follow-up|0|||
124476959|NCT00961961|447700339|FG002|Phase I|Lost to Follow-up|0|||
124476960|NCT00961961|447700340|FG003|Phase I|Lost to Follow-up|0|||
124476961|NCT00961961|447700337|FG000|Phase I|Lack of Efficacy|94|||
124476962|NCT00961961|447700338|FG001|Phase I|Lack of Efficacy|0|||
124476963|NCT00961961|447700339|FG002|Phase I|Lack of Efficacy|0|||
124476964|NCT00961961|447700340|FG003|Phase I|Lack of Efficacy|0|||
124476965|NCT00961961|447700337|FG000|Phase I|Adverse Event|7|||
124476966|NCT00961961|447700338|FG001|Phase I|Adverse Event|0|||
124476967|NCT00961961|447700339|FG002|Phase I|Adverse Event|0|||
124476968|NCT00961961|447700340|FG003|Phase I|Adverse Event|0|||
124476969|NCT00961961|447700337|FG000|Phase I|Physician Decision|8|||
124476970|NCT00961961|447700338|FG001|Phase I|Physician Decision|0|||
124476971|NCT00961961|447700339|FG002|Phase I|Physician Decision|0|||
124476972|NCT00961961|447700340|FG003|Phase I|Physician Decision|0|||
124476973|NCT00961961|447700337|FG000|Phase II|Lost to Follow-up|0|||
124476974|NCT00961961|447700338|FG001|Phase II|Lost to Follow-up|0|||
124476975|NCT00961961|447700339|FG002|Phase II|Lost to Follow-up|10|||
124476976|NCT00961961|447700340|FG003|Phase II|Lost to Follow-up|7|||
124476977|NCT00961961|447700337|FG000|Phase II|Adverse Event|0|||
124476978|NCT00961961|447700338|FG001|Phase II|Adverse Event|0|||
124476979|NCT00961961|447700339|FG002|Phase II|Adverse Event|0|||
124476980|NCT00961961|447700340|FG003|Phase II|Adverse Event|1|||
124476981|NCT00961961|447700337|FG000|Phase II|Physician Decision|0|||
124476982|NCT00961961|447700338|FG001|Phase II|Physician Decision|0|||
124476983|NCT00961961|447700339|FG002|Phase II|Physician Decision|1|||
124476984|NCT00961961|447700340|FG003|Phase II|Physician Decision|0|||
124476985|NCT00961961|447700337|FG000|Phase II|Withdrawal by Subject|0|||
124476986|NCT00961961|447700338|FG001|Phase II|Withdrawal by Subject|0|||
124476987|NCT00961961|447700339|FG002|Phase II|Withdrawal by Subject|1|||
124476988|NCT00961961|447700340|FG003|Phase II|Withdrawal by Subject|0|||
124476989|NCT02764541|447700341|FG000|Overall Study|Withdrawal by Subject|0|||
124476990|NCT02764541|447700342|FG001|Overall Study|Withdrawal by Subject|0|||
124476991|NCT02764541|447700343|FG002|Overall Study|Withdrawal by Subject|0|||
124476992|NCT02764541|447700344|FG003|Overall Study|Withdrawal by Subject|0|||
124476993|NCT02764541|447700345|FG004|Overall Study|Withdrawal by Subject|1|||
124476994|NCT02764541|447700346|FG005|Overall Study|Withdrawal by Subject|1|||
124476995|NCT02764541|447700347|FG006|Overall Study|Withdrawal by Subject|0|||
124476996|NCT02764541|447700348|FG007|Overall Study|Withdrawal by Subject|1|||
124476997|NCT02764541|447700341|FG000|Overall Study|Adverse Event|1|||
124476998|NCT02764541|447700342|FG001|Overall Study|Adverse Event|0|||
124476999|NCT02764541|447700343|FG002|Overall Study|Adverse Event|0|||
124477000|NCT02764541|447700344|FG003|Overall Study|Adverse Event|0|||
124477001|NCT02764541|447700345|FG004|Overall Study|Adverse Event|0|||
124477002|NCT02764541|447700346|FG005|Overall Study|Adverse Event|0|||
124477003|NCT02764541|447700347|FG006|Overall Study|Adverse Event|1|||
124477004|NCT02764541|447700348|FG007|Overall Study|Adverse Event|0|||
124477005|NCT02764541|447700341|FG000|Overall Study|Metastasis|1|||
124477006|NCT02764541|447700342|FG001|Overall Study|Metastasis|0|||
124477007|NCT02764541|447700343|FG002|Overall Study|Metastasis|0|||
124477008|NCT02764541|447700344|FG003|Overall Study|Metastasis|0|||
124477009|NCT02764541|447700345|FG004|Overall Study|Metastasis|0|||
124477010|NCT02764541|447700346|FG005|Overall Study|Metastasis|0|||
124477011|NCT02764541|447700347|FG006|Overall Study|Metastasis|0|||
124477012|NCT02764541|447700348|FG007|Overall Study|Metastasis|0|||
124477013|NCT02764541|447700341|FG000|Overall Study|Disease progression|1|||
124477014|NCT02764541|447700342|FG001|Overall Study|Disease progression|1|||
124477015|NCT02764541|447700343|FG002|Overall Study|Disease progression|0|||
124477016|NCT02764541|447700344|FG003|Overall Study|Disease progression|0|||
124477017|NCT02764541|447700345|FG004|Overall Study|Disease progression|0|||
124477018|NCT02764541|447700346|FG005|Overall Study|Disease progression|0|||
124477019|NCT02764541|447700347|FG006|Overall Study|Disease progression|0|||
124477020|NCT02764541|447700348|FG007|Overall Study|Disease progression|1|||
124477021|NCT02764541|447700341|FG000|Overall Study|Protocol Violation|0|||
124477022|NCT02764541|447700342|FG001|Overall Study|Protocol Violation|0|||
124477023|NCT02764541|447700343|FG002|Overall Study|Protocol Violation|0|||
124477024|NCT02764541|447700344|FG003|Overall Study|Protocol Violation|1|||
124477025|NCT02764541|447700345|FG004|Overall Study|Protocol Violation|0|||
124477026|NCT02764541|447700346|FG005|Overall Study|Protocol Violation|1|||
124477027|NCT02764541|447700347|FG006|Overall Study|Protocol Violation|0|||
124477028|NCT02764541|447700348|FG007|Overall Study|Protocol Violation|0|||
124477029|NCT02764541|447700341|FG000|Overall Study|Physician Decision|0|||
124477030|NCT02764541|447700342|FG001|Overall Study|Physician Decision|0|||
124477031|NCT02764541|447700343|FG002|Overall Study|Physician Decision|0|||
124477032|NCT02764541|447700344|FG003|Overall Study|Physician Decision|1|||
124477033|NCT02764541|447700345|FG004|Overall Study|Physician Decision|0|||
124477034|NCT02764541|447700346|FG005|Overall Study|Physician Decision|0|||
124477035|NCT02764541|447700347|FG006|Overall Study|Physician Decision|0|||
124477036|NCT02764541|447700348|FG007|Overall Study|Physician Decision|1|||
124477037|NCT02764541|447700341|FG000|Overall Study|Three Cycles completed before surgery|0|||
124477038|NCT02764541|447700342|FG001|Overall Study|Three Cycles completed before surgery|0|||
124477039|NCT02764541|447700343|FG002|Overall Study|Three Cycles completed before surgery|0|||
124556923|NCT01078623|447997665|FG010|Treatment Period 1|Withdrawal by Subject|1|||
124556924|NCT01078623|447997666|FG011|Treatment Period 1|Withdrawal by Subject|0|||
124477040|NCT02764541|447700344|FG003|Overall Study|Three Cycles completed before surgery|1|||
124477041|NCT02764541|447700345|FG004|Overall Study|Three Cycles completed before surgery|0|||
124477042|NCT02764541|447700346|FG005|Overall Study|Three Cycles completed before surgery|0|||
124477043|NCT02764541|447700347|FG006|Overall Study|Three Cycles completed before surgery|0|||
124477044|NCT02764541|447700348|FG007|Overall Study|Three Cycles completed before surgery|0|||
124477045|NCT02764541|447700341|FG000|Overall Study|Patient Compliance|0|||
124477046|NCT02764541|447700342|FG001|Overall Study|Patient Compliance|0|||
124477047|NCT02764541|447700343|FG002|Overall Study|Patient Compliance|1|||
124477048|NCT02764541|447700344|FG003|Overall Study|Patient Compliance|0|||
124477049|NCT02764541|447700345|FG004|Overall Study|Patient Compliance|0|||
124477050|NCT02764541|447700346|FG005|Overall Study|Patient Compliance|0|||
124477051|NCT02764541|447700347|FG006|Overall Study|Patient Compliance|0|||
124477052|NCT02764541|447700348|FG007|Overall Study|Patient Compliance|0|||
124477053|NCT02764541|447700341|FG000|Overall Study|Death|0|||
124477054|NCT02764541|447700342|FG001|Overall Study|Death|0|||
124477055|NCT02764541|447700343|FG002|Overall Study|Death|0|||
124477056|NCT02764541|447700344|FG003|Overall Study|Death|0|||
124477057|NCT02764541|447700345|FG004|Overall Study|Death|0|||
124477058|NCT02764541|447700346|FG005|Overall Study|Death|0|||
124771701|NCT03873116|448794552|FG003|Part 1|Study drug discontinuation due to rash|0|||
124477059|NCT02764541|447700347|FG006|Overall Study|Death|1|||
124477060|NCT02764541|447700348|FG007|Overall Study|Death|0|||
124477061|NCT02764541|447700341|FG000|Overall Study|Insurance reasons|0|||
124477062|NCT02764541|447700342|FG001|Overall Study|Insurance reasons|0|||
124477063|NCT02764541|447700343|FG002|Overall Study|Insurance reasons|0|||
124477064|NCT02764541|447700344|FG003|Overall Study|Insurance reasons|0|||
124477065|NCT02764541|447700345|FG004|Overall Study|Insurance reasons|0|||
124477066|NCT02764541|447700346|FG005|Overall Study|Insurance reasons|0|||
124477067|NCT02764541|447700347|FG006|Overall Study|Insurance reasons|1|||
124477068|NCT02764541|447700348|FG007|Overall Study|Insurance reasons|0|||
124477069|NCT00749190|447700349|FG000|Overall Study|Adverse Event|0|||
124477070|NCT00749190|447700350|FG001|Overall Study|Adverse Event|2|||
124477071|NCT00749190|447700351|FG002|Overall Study|Adverse Event|0|||
124477072|NCT00749190|447700352|FG003|Overall Study|Adverse Event|4|||
124477073|NCT00749190|447700353|FG004|Overall Study|Adverse Event|0|||
124477074|NCT00749190|447700354|FG005|Overall Study|Adverse Event|3|||
124477075|NCT00749190|447700355|FG006|Overall Study|Adverse Event|0|||
124477076|NCT00749190|447700349|FG000|Overall Study|Lack of Efficacy|3|||
124477077|NCT00749190|447700350|FG001|Overall Study|Lack of Efficacy|1|||
124719505|NCT03012828|448594839|FG002|Overall Study|Non-compliance with protocol|0|||
124719506|NCT03012828|448594840|FG003|Overall Study|Non-compliance with protocol|0|||
124477078|NCT00749190|447700351|FG002|Overall Study|Lack of Efficacy|1|||
124477079|NCT00749190|447700352|FG003|Overall Study|Lack of Efficacy|0|||
124477080|NCT00749190|447700353|FG004|Overall Study|Lack of Efficacy|0|||
124477081|NCT00749190|447700354|FG005|Overall Study|Lack of Efficacy|1|||
124477082|NCT00749190|447700355|FG006|Overall Study|Lack of Efficacy|0|||
124477083|NCT00749190|447700349|FG000|Overall Study|Withdrawal by Subject|2|||
124477084|NCT00749190|447700350|FG001|Overall Study|Withdrawal by Subject|1|||
124477085|NCT00749190|447700351|FG002|Overall Study|Withdrawal by Subject|0|||
124477086|NCT00749190|447700352|FG003|Overall Study|Withdrawal by Subject|0|||
124477087|NCT00749190|447700353|FG004|Overall Study|Withdrawal by Subject|0|||
124477088|NCT00749190|447700354|FG005|Overall Study|Withdrawal by Subject|1|||
124477089|NCT00749190|447700355|FG006|Overall Study|Withdrawal by Subject|0|||
124477090|NCT00749190|447700349|FG000|Overall Study|Protocol Violation|0|||
124477091|NCT00749190|447700350|FG001|Overall Study|Protocol Violation|1|||
124477092|NCT00749190|447700351|FG002|Overall Study|Protocol Violation|0|||
124477093|NCT00749190|447700352|FG003|Overall Study|Protocol Violation|0|||
124477094|NCT00749190|447700353|FG004|Overall Study|Protocol Violation|0|||
124477095|NCT00749190|447700354|FG005|Overall Study|Protocol Violation|0|||
124477096|NCT00749190|447700355|FG006|Overall Study|Protocol Violation|1|||
124477097|NCT00749190|447700349|FG000|Overall Study|Other reason not defined above|0|||
124477098|NCT00749190|447700350|FG001|Overall Study|Other reason not defined above|0|||
124477099|NCT00749190|447700351|FG002|Overall Study|Other reason not defined above|0|||
124477100|NCT00749190|447700352|FG003|Overall Study|Other reason not defined above|1|||
124477101|NCT00749190|447700353|FG004|Overall Study|Other reason not defined above|0|||
124477102|NCT00749190|447700354|FG005|Overall Study|Other reason not defined above|0|||
124477103|NCT00749190|447700355|FG006|Overall Study|Other reason not defined above|0|||
124477104|NCT01245673|447700356|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
124477105|NCT00355121|447700358|FG000|Overall Study|Did not receive study vaccine|1|||
124477106|NCT00355121|447700359|FG001|Overall Study|Did not receive study vaccine|0|||
124477107|NCT00355121|447700360|FG002|Overall Study|Did not receive study vaccine|1|||
124477108|NCT00355121|447700358|FG000|Overall Study|Adverse Event|0|||
124477109|NCT00355121|447700359|FG001|Overall Study|Adverse Event|1|||
124477110|NCT00355121|447700360|FG002|Overall Study|Adverse Event|0|||
124477111|NCT00355121|447700358|FG000|Overall Study|Protocol Violation|7|||
124477112|NCT00355121|447700359|FG001|Overall Study|Protocol Violation|9|||
124477113|NCT00355121|447700360|FG002|Overall Study|Protocol Violation|1|||
124477114|NCT00355121|447700358|FG000|Overall Study|Lost to Follow-up|4|||
124719507|NCT03012828|448594841|FG004|Overall Study|Non-compliance with protocol|1|||
124719508|NCT03012828|448594842|FG005|Overall Study|Non-compliance with protocol|0|||
124719509|NCT03012828|448594837|FG000|Overall Study|Delay to last visit would delay DBL|0|||
124719510|NCT03012828|448594838|FG001|Overall Study|Delay to last visit would delay DBL|0|||
124719511|NCT03012828|448594839|FG002|Overall Study|Delay to last visit would delay DBL|0|||
124719512|NCT03012828|448594840|FG003|Overall Study|Delay to last visit would delay DBL|0|||
124719513|NCT03012828|448594841|FG004|Overall Study|Delay to last visit would delay DBL|0|||
124477115|NCT00355121|447700359|FG001|Overall Study|Lost to Follow-up|7|||
124477116|NCT00355121|447700360|FG002|Overall Study|Lost to Follow-up|1|||
124477117|NCT00355121|447700358|FG000|Overall Study|Withdrawal by Subject|9|||
124477118|NCT00355121|447700359|FG001|Overall Study|Withdrawal by Subject|10|||
124477119|NCT00355121|447700360|FG002|Overall Study|Withdrawal by Subject|2|||
124477120|NCT00355121|447700358|FG000|Overall Study|Serious adverse events|0|||
124477121|NCT00355121|447700359|FG001|Overall Study|Serious adverse events|2|||
124477122|NCT00355121|447700360|FG002|Overall Study|Serious adverse events|0|||
124477123|NCT00630331|447700361|FG000|Overall Study|Death|2|||
124477124|NCT00630331|447700362|FG001|Overall Study|Death|1|||
124477125|NCT00630331|447700363|FG002|Overall Study|Death|1|||
124477126|NCT00630331|447700361|FG000|Overall Study|Adverse Event|1|||
124477127|NCT00630331|447700362|FG001|Overall Study|Adverse Event|0|||
124477128|NCT00630331|447700363|FG002|Overall Study|Adverse Event|0|||
124477129|NCT00630331|447700361|FG000|Overall Study|Withdrawal by Subject|12|||
124477130|NCT00630331|447700362|FG001|Overall Study|Withdrawal by Subject|7|||
124477131|NCT00630331|447700363|FG002|Overall Study|Withdrawal by Subject|5|||
124477132|NCT00630331|447700361|FG000|Overall Study|Lost to Follow-up|175|||
124477133|NCT00630331|447700362|FG001|Overall Study|Lost to Follow-up|143|||
124477134|NCT00630331|447700363|FG002|Overall Study|Lost to Follow-up|170|||
124477135|NCT00630331|447700361|FG000|Overall Study|Inappropriate enrollment|3|||
124477136|NCT00630331|447700362|FG001|Overall Study|Inappropriate enrollment|6|||
124477137|NCT00630331|447700363|FG002|Overall Study|Inappropriate enrollment|3|||
124477138|NCT00630331|447700361|FG000|Overall Study|Unable to classify|9|||
124477139|NCT00630331|447700362|FG001|Overall Study|Unable to classify|4|||
124477140|NCT00630331|447700363|FG002|Overall Study|Unable to classify|3|||
124477141|NCT00630331|447700361|FG000|Overall Study|Protocol Violation|4|||
124477142|NCT00630331|447700362|FG001|Overall Study|Protocol Violation|5|||
124477143|NCT00630331|447700363|FG002|Overall Study|Protocol Violation|6|||
124477144|NCT04640766|447700365|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
124477145|NCT01565980|447700366|FG000|Overall Study|Death|1|||
124477146|NCT01565980|447700367|FG001|Overall Study|Death|0|||
124477147|NCT01565980|447700366|FG000|Overall Study|Lost to Follow-up|1|||
124477148|NCT01565980|447700367|FG001|Overall Study|Lost to Follow-up|0|||
124477149|NCT01565980|447700366|FG000|Overall Study|health complications|1|||
124477150|NCT01565980|447700367|FG001|Overall Study|health complications|1|||
124477151|NCT01565980|447700366|FG000|Overall Study|stopped medical treatment|1|||
124477152|NCT01565980|447700367|FG001|Overall Study|stopped medical treatment|0|||
124477153|NCT01565980|447700366|FG000|Overall Study|Withdrawal by Subject|0|||
124477154|NCT01565980|447700367|FG001|Overall Study|Withdrawal by Subject|3|||
124477155|NCT02425098|447700376|FG000|Overall Study|Lost to Follow-up|7|||
124477156|NCT02425098|447700377|FG001|Overall Study|Lost to Follow-up|7|||
124477157|NCT02425098|447700376|FG000|Overall Study|Withdrawal by Subject|4|||
124477158|NCT02425098|447700377|FG001|Overall Study|Withdrawal by Subject|8|||
124477159|NCT02425098|447700376|FG000|Overall Study|Pregnancy|2|||
124477160|NCT02425098|447700377|FG001|Overall Study|Pregnancy|0|||
124477161|NCT02425098|447700376|FG000|Overall Study|Reason not Specified|0|||
124477162|NCT02425098|447700377|FG001|Overall Study|Reason not Specified|1|||
124477163|NCT01929135|447700378|FG000|Overall Study|Lost to Follow-up|1|||
124477164|NCT01929135|447700379|FG001|Overall Study|Lost to Follow-up|1|||
124477165|NCT02078219|447700380|FG000|Overall Study|Other|2|||
124477166|NCT02078219|447700381|FG001|Overall Study|Other|2|||
124477167|NCT02078219|447700382|FG002|Overall Study|Other|3|||
124477168|NCT02078219|447700383|FG003|Overall Study|Other|0|||
124477169|NCT02078219|447700384|FG004|Overall Study|Other|1|||
124477170|NCT02078219|447700380|FG000|Overall Study|Withdrawal by Subject|0|||
124477171|NCT02078219|447700381|FG001|Overall Study|Withdrawal by Subject|1|||
124477172|NCT02078219|447700382|FG002|Overall Study|Withdrawal by Subject|0|||
124477173|NCT02078219|447700383|FG003|Overall Study|Withdrawal by Subject|1|||
124477174|NCT02078219|447700384|FG004|Overall Study|Withdrawal by Subject|1|||
124477175|NCT02078219|447700380|FG000|Overall Study|Protocol Violation|0|||
124477176|NCT02078219|447700381|FG001|Overall Study|Protocol Violation|0|||
124477177|NCT02078219|447700382|FG002|Overall Study|Protocol Violation|0|||
124477178|NCT02078219|447700383|FG003|Overall Study|Protocol Violation|1|||
124477179|NCT02078219|447700384|FG004|Overall Study|Protocol Violation|0|||
124477180|NCT02078219|447700380|FG000|Overall Study|Death|0|||
124477181|NCT02078219|447700381|FG001|Overall Study|Death|0|||
124719514|NCT03012828|448594842|FG005|Overall Study|Delay to last visit would delay DBL|1|||
124719515|NCT03472495|448594847|FG000|Overall Study|Treatment no longer indicated|1|||
124477182|NCT02078219|447700382|FG002|Overall Study|Death|0|||
124477183|NCT02078219|447700383|FG003|Overall Study|Death|1|||
124477184|NCT02078219|447700384|FG004|Overall Study|Death|0|||
124477185|NCT02078219|447700380|FG000|Overall Study|Adverse Event|1|||
124477186|NCT02078219|447700381|FG001|Overall Study|Adverse Event|1|||
124477187|NCT02078219|447700382|FG002|Overall Study|Adverse Event|3|||
124477188|NCT02078219|447700383|FG003|Overall Study|Adverse Event|1|||
124477189|NCT02078219|447700384|FG004|Overall Study|Adverse Event|0|||
124477190|NCT03136107|447700391|FG000|Overall Study|Other (Not specified)|1|||
124477191|NCT03283085|447700392|FG000|Overall Study|Adverse Event|18|||
124556925|NCT01078623|447997667|FG012|Treatment Period 1|Withdrawal by Subject|0|||
124556926|NCT01078623|447997668|FG013|Treatment Period 1|Withdrawal by Subject|0|||
124556927|NCT01078623|447997669|FG014|Treatment Period 1|Withdrawal by Subject|0|||
124556928|NCT01078623|447997670|FG015|Treatment Period 1|Withdrawal by Subject|0|||
124556929|NCT01078623|447997671|FG016|Treatment Period 1|Withdrawal by Subject|0|||
124556930|NCT01078623|447997672|FG017|Treatment Period 1|Withdrawal by Subject|0|||
124556931|NCT01078623|447997673|FG018|Treatment Period 1|Withdrawal by Subject|0|||
124477192|NCT03283085|447700393|FG001|Overall Study|Adverse Event|3|||
124477193|NCT03283085|447700394|FG002|Overall Study|Adverse Event|13|||
124719516|NCT03472495|448594848|FG001|Overall Study|Treatment no longer indicated|2|||
124477194|NCT03283085|447700395|FG003|Overall Study|Adverse Event|0|||
124477195|NCT03283085|447700396|FG004|Overall Study|Adverse Event|0|||
124477196|NCT03283085|447700397|FG005|Overall Study|Adverse Event|5|||
124477197|NCT03283085|447700392|FG000|Overall Study|Death|0|||
124477198|NCT03283085|447700393|FG001|Overall Study|Death|0|||
124477199|NCT03283085|447700394|FG002|Overall Study|Death|3|||
124477200|NCT03283085|447700395|FG003|Overall Study|Death|1|||
124477201|NCT03283085|447700396|FG004|Overall Study|Death|0|||
124477202|NCT03283085|447700397|FG005|Overall Study|Death|0|||
124477203|NCT03283085|447700392|FG000|Overall Study|Withdrawal by Subject|42|||
124477204|NCT03283085|447700393|FG001|Overall Study|Withdrawal by Subject|21|||
124477205|NCT03283085|447700394|FG002|Overall Study|Withdrawal by Subject|66|||
124477206|NCT03283085|447700395|FG003|Overall Study|Withdrawal by Subject|3|||
124477207|NCT03283085|447700396|FG004|Overall Study|Withdrawal by Subject|3|||
124477208|NCT03283085|447700397|FG005|Overall Study|Withdrawal by Subject|5|||
124477209|NCT03283085|447700392|FG000|Overall Study|Physician Decision|14|||
124477210|NCT03283085|447700393|FG001|Overall Study|Physician Decision|8|||
124477211|NCT03283085|447700394|FG002|Overall Study|Physician Decision|19|||
124477212|NCT03283085|447700395|FG003|Overall Study|Physician Decision|0|||
124477213|NCT03283085|447700396|FG004|Overall Study|Physician Decision|0|||
124477214|NCT03283085|447700397|FG005|Overall Study|Physician Decision|2|||
124477215|NCT03283085|447700392|FG000|Overall Study|Site Terminated by Sponsor|1|||
124477216|NCT03283085|447700393|FG001|Overall Study|Site Terminated by Sponsor|0|||
124477217|NCT03283085|447700394|FG002|Overall Study|Site Terminated by Sponsor|3|||
124477218|NCT03283085|447700395|FG003|Overall Study|Site Terminated by Sponsor|0|||
124477219|NCT03283085|447700396|FG004|Overall Study|Site Terminated by Sponsor|0|||
124477220|NCT03283085|447700397|FG005|Overall Study|Site Terminated by Sponsor|0|||
124477221|NCT03283085|447700392|FG000|Overall Study|Lost to Follow-up|2|||
124477222|NCT03283085|447700393|FG001|Overall Study|Lost to Follow-up|0|||
124477223|NCT03283085|447700394|FG002|Overall Study|Lost to Follow-up|2|||
124477224|NCT03283085|447700395|FG003|Overall Study|Lost to Follow-up|0|||
124477225|NCT03283085|447700396|FG004|Overall Study|Lost to Follow-up|0|||
124477226|NCT03283085|447700397|FG005|Overall Study|Lost to Follow-up|1|||
124477227|NCT03283085|447700392|FG000|Overall Study|Pregnancy|0|||
124477228|NCT03283085|447700393|FG001|Overall Study|Pregnancy|0|||
124477229|NCT03283085|447700394|FG002|Overall Study|Pregnancy|1|||
124477230|NCT03283085|447700395|FG003|Overall Study|Pregnancy|0|||
124477231|NCT03283085|447700396|FG004|Overall Study|Pregnancy|0|||
124477232|NCT03283085|447700397|FG005|Overall Study|Pregnancy|0|||
124477233|NCT03283085|447700392|FG000|Overall Study|Lack of Efficacy|12|||
124477234|NCT03283085|447700393|FG001|Overall Study|Lack of Efficacy|6|||
124477235|NCT03283085|447700394|FG002|Overall Study|Lack of Efficacy|24|||
124477236|NCT03283085|447700395|FG003|Overall Study|Lack of Efficacy|1|||
124477237|NCT03283085|447700396|FG004|Overall Study|Lack of Efficacy|1|||
124477238|NCT03283085|447700397|FG005|Overall Study|Lack of Efficacy|0|||
124477239|NCT03283085|447700392|FG000|Overall Study|Reason not Specified|0|||
124477240|NCT03283085|447700393|FG001|Overall Study|Reason not Specified|4|||
124477241|NCT03283085|447700394|FG002|Overall Study|Reason not Specified|8|||
124477242|NCT03283085|447700395|FG003|Overall Study|Reason not Specified|0|||
124477243|NCT03283085|447700396|FG004|Overall Study|Reason not Specified|0|||
124477244|NCT03283085|447700397|FG005|Overall Study|Reason not Specified|1|||
124477245|NCT02292771|447700401|FG000|Overall Study|Withdrawal by Subject|2|||
124477246|NCT02292771|447700402|FG001|Overall Study|Withdrawal by Subject|1|||
124477247|NCT02292771|447700401|FG000|Overall Study|Lost to Follow-up|2|||
124477248|NCT02292771|447700402|FG001|Overall Study|Lost to Follow-up|1|||
124556932|NCT01078623|447997674|FG019|Treatment Period 1|Withdrawal by Subject|0|||
124556933|NCT01078623|447997655|FG000|Treatment Period 1|Protocol Violation|0|||
124556934|NCT01078623|447997656|FG001|Treatment Period 1|Protocol Violation|0|||
124556935|NCT01078623|447997657|FG002|Treatment Period 1|Protocol Violation|0|||
124477249|NCT01475734|447702631|FG000|Overall Study|Withdrawal by Subject|1|||
124477250|NCT01475734|447702632|FG001|Overall Study|Withdrawal by Subject|0|||
124477251|NCT01475734|447702631|FG000|Overall Study|Protocol Violation|1|||
124477252|NCT01475734|447702632|FG001|Overall Study|Protocol Violation|0|||
124477253|NCT01475734|447702631|FG000|Overall Study|Physician Decision|0|||
124477254|NCT01475734|447702632|FG001|Overall Study|Physician Decision|1|||
124477255|NCT00376961|447702633|FG000|Initial Registration|Adverse Event|1|||
124477256|NCT00376961|447702634|FG001|Initial Registration|Adverse Event|0|||
124477257|NCT00376961|447702633|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
124477258|NCT00376961|447702634|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
124477259|NCT00376961|447702633|FG000|Initial Registration|Progression/relapse|1|||
124477260|NCT00376961|447702634|FG001|Initial Registration|Progression/relapse|0|||
124477261|NCT00376961|447702633|FG000|Initial Registration|Ineligible|3|||
124477262|NCT00376961|447702634|FG001|Initial Registration|Ineligible|0|||
124477263|NCT00376961|447702633|FG000|Maintenance|Adverse Event|0|||
124477264|NCT00376961|447702634|FG001|Maintenance|Adverse Event|1|||
124477265|NCT00376961|447702633|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
124477266|NCT00376961|447702634|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
124477267|NCT00376961|447702633|FG000|Maintenance|Progression/relapse|0|||
124477268|NCT00376961|447702634|FG001|Maintenance|Progression/relapse|18|||
124477269|NCT00376961|447702633|FG000|Maintenance|Ineligible|0|||
124477270|NCT00376961|447702634|FG001|Maintenance|Ineligible|3|||
124477271|NCT02911688|447702635|FG000|Washout|Lost to Follow-up|1|||
124477272|NCT02911688|447702636|FG001|Washout|Lost to Follow-up|1|||
124477273|NCT02911688|447702635|FG000|Washout|Withdrawal by Subject|0|||
124477274|NCT02911688|447702636|FG001|Washout|Withdrawal by Subject|1|||
124477275|NCT05148884|447702645|FG000|Overall Study|Withdrawal by Subject|3|||
124477276|NCT05148884|447702646|FG001|Overall Study|Withdrawal by Subject|0|||
124477277|NCT05148884|447702645|FG000|Overall Study|Deep brain stimulation operation|0|||
124477278|NCT05148884|447702646|FG001|Overall Study|Deep brain stimulation operation|1|||
124477279|NCT01993888|447702647|FG000|Overall Study|Death|1|||
124477280|NCT01993888|447702648|FG001|Overall Study|Death|1|||
124477281|NCT01993888|447702647|FG000|Overall Study|Lost to Follow-up|1|||
124477282|NCT01993888|447702648|FG001|Overall Study|Lost to Follow-up|1|||
124477283|NCT01993888|447702647|FG000|Overall Study|Withdrawal by Subject|0|||
124477284|NCT01993888|447702648|FG001|Overall Study|Withdrawal by Subject|1|||
124477285|NCT00317044|447702649|FG000|Overall Study|Protocol Violation|28|||
124477286|NCT00317044|447702650|FG001|Overall Study|Protocol Violation|22|||
124477287|NCT00317044|447702651|FG002|Overall Study|Protocol Violation|20|||
124477288|NCT00317044|447702649|FG000|Overall Study|Adverse Event|4|||
124477289|NCT00317044|447702650|FG001|Overall Study|Adverse Event|7|||
124477290|NCT00317044|447702651|FG002|Overall Study|Adverse Event|4|||
124477291|NCT00317044|447702649|FG000|Overall Study|Withdrawal by Subject|10|||
124477292|NCT00317044|447702650|FG001|Overall Study|Withdrawal by Subject|7|||
124477293|NCT00317044|447702651|FG002|Overall Study|Withdrawal by Subject|12|||
124556936|NCT01078623|447997658|FG003|Treatment Period 1|Protocol Violation|0|||
124556937|NCT01078623|447997659|FG004|Treatment Period 1|Protocol Violation|0|||
124556938|NCT01078623|447997660|FG005|Treatment Period 1|Protocol Violation|1|||
124556939|NCT01078623|447997661|FG006|Treatment Period 1|Protocol Violation|0|||
124556940|NCT01078623|447997662|FG007|Treatment Period 1|Protocol Violation|0|||
124556941|NCT01078623|447997663|FG008|Treatment Period 1|Protocol Violation|0|||
124556942|NCT01078623|447997664|FG009|Treatment Period 1|Protocol Violation|0|||
124719517|NCT03472495|448594847|FG000|Overall Study|Physician Decision|0|||
124719518|NCT03472495|448594848|FG001|Overall Study|Physician Decision|2|||
124719519|NCT01107392|448594849|FG000|Overall Study|Adverse Event|2|||
124719520|NCT01107392|448594850|FG001|Overall Study|Adverse Event|0|||
124719521|NCT01107392|448594849|FG000|Overall Study|Personal Reasons|2|||
124719522|NCT01107392|448594850|FG001|Overall Study|Personal Reasons|3|||
124719523|NCT01107392|448594849|FG000|Overall Study|Administrative decision|1|||
124719524|NCT01107392|448594850|FG001|Overall Study|Administrative decision|0|||
124719525|NCT02998671|448594854|FG000|Period 1|Study Terminated By Sponsor|2|||
124719526|NCT02998671|448594855|FG001|Period 1|Study Terminated By Sponsor|1|||
124719527|NCT02998671|448594856|FG002|Period 1|Study Terminated By Sponsor|0|||
124719528|NCT02998671|448594857|FG003|Period 1|Study Terminated By Sponsor|0|||
124719529|NCT02998671|448594858|FG004|Period 1|Study Terminated By Sponsor|1|||
124719530|NCT02998671|448594854|FG000|Period 1|Withdrawal by Subject|1|||
124719531|NCT02998671|448594855|FG001|Period 1|Withdrawal by Subject|2|||
124719532|NCT02998671|448594856|FG002|Period 1|Withdrawal by Subject|0|||
124719533|NCT02998671|448594857|FG003|Period 1|Withdrawal by Subject|0|||
124719534|NCT02998671|448594858|FG004|Period 1|Withdrawal by Subject|2|||
124719535|NCT02998671|448594854|FG000|Period 1|Pregnancy|1|||
124719536|NCT02998671|448594855|FG001|Period 1|Pregnancy|0|||
124477294|NCT00317044|447702649|FG000|Overall Study|Lost to Follow-up|0|||
124477295|NCT00317044|447702650|FG001|Overall Study|Lost to Follow-up|2|||
124477296|NCT00317044|447702651|FG002|Overall Study|Lost to Follow-up|3|||
124477297|NCT00317044|447702649|FG000|Overall Study|Multiple Reasons|6|||
124477298|NCT00317044|447702650|FG001|Overall Study|Multiple Reasons|2|||
124477299|NCT00317044|447702651|FG002|Overall Study|Multiple Reasons|6|||
124477300|NCT02357420|447702652|FG000|Overall Study|Adverse Event|3|||
124477301|NCT02357420|447702653|FG001|Overall Study|Adverse Event|3|||
124477302|NCT02357420|447702654|FG002|Overall Study|Adverse Event|8|||
124477303|NCT02357420|447702655|FG003|Overall Study|Adverse Event|9|||
124477304|NCT02357420|447702652|FG000|Overall Study|Investigator Decision|1|||
124477305|NCT02357420|447702653|FG001|Overall Study|Investigator Decision|0|||
124477306|NCT02357420|447702654|FG002|Overall Study|Investigator Decision|0|||
124477307|NCT02357420|447702655|FG003|Overall Study|Investigator Decision|0|||
124477308|NCT02357420|447702652|FG000|Overall Study|Prohibited Medication|1|||
124556943|NCT01078623|447997665|FG010|Treatment Period 1|Protocol Violation|0|||
124556944|NCT01078623|447997666|FG011|Treatment Period 1|Protocol Violation|0|||
124556945|NCT01078623|447997667|FG012|Treatment Period 1|Protocol Violation|0|||
124556946|NCT01078623|447997668|FG013|Treatment Period 1|Protocol Violation|0|||
124556947|NCT01078623|447997669|FG014|Treatment Period 1|Protocol Violation|0|||
124556948|NCT01078623|447997670|FG015|Treatment Period 1|Protocol Violation|0|||
124556949|NCT01078623|447997671|FG016|Treatment Period 1|Protocol Violation|0|||
124556950|NCT01078623|447997672|FG017|Treatment Period 1|Protocol Violation|0|||
124556951|NCT01078623|447997673|FG018|Treatment Period 1|Protocol Violation|0|||
124477309|NCT02357420|447702653|FG001|Overall Study|Prohibited Medication|1|||
124477310|NCT02357420|447702654|FG002|Overall Study|Prohibited Medication|0|||
124477311|NCT02357420|447702655|FG003|Overall Study|Prohibited Medication|0|||
124477312|NCT02357420|447702652|FG000|Overall Study|Protocol Non-compliance|0|||
124556952|NCT01078623|447997674|FG019|Treatment Period 1|Protocol Violation|0|||
124556953|NCT01078623|447997655|FG000|Treatment Period 2|Adverse Event|0|||
124477313|NCT02357420|447702653|FG001|Overall Study|Protocol Non-compliance|0|||
124477314|NCT02357420|447702654|FG002|Overall Study|Protocol Non-compliance|0|||
124477315|NCT02357420|447702655|FG003|Overall Study|Protocol Non-compliance|1|||
124477316|NCT02357420|447702652|FG000|Overall Study|Withdrawn Consent|4|||
124477317|NCT02357420|447702653|FG001|Overall Study|Withdrawn Consent|8|||
124477318|NCT02357420|447702654|FG002|Overall Study|Withdrawn Consent|6|||
124477319|NCT02357420|447702655|FG003|Overall Study|Withdrawn Consent|6|||
124477320|NCT02357420|447702652|FG000|Overall Study|Lost to Follow-up|3|||
124477321|NCT02357420|447702653|FG001|Overall Study|Lost to Follow-up|0|||
124477322|NCT02357420|447702654|FG002|Overall Study|Lost to Follow-up|2|||
124477323|NCT02357420|447702655|FG003|Overall Study|Lost to Follow-up|3|||
124477324|NCT00928070|447702658|FG000|Overall Study|Lost to Follow-up|1|||
124477325|NCT00928070|447702659|FG001|Overall Study|Lost to Follow-up|2|||
124477326|NCT00928070|447702658|FG000|Overall Study|Withdrawal by Subject|10|||
124477327|NCT00928070|447702659|FG001|Overall Study|Withdrawal by Subject|3|||
124477328|NCT00928070|447702658|FG000|Overall Study|Adverse Event|14|||
124477329|NCT00928070|447702659|FG001|Overall Study|Adverse Event|26|||
124477330|NCT00928070|447702658|FG000|Overall Study|Lack of Efficacy|9|||
124477331|NCT00928070|447702659|FG001|Overall Study|Lack of Efficacy|5|||
124477332|NCT00928070|447702658|FG000|Overall Study|Did not meet entrance criteria|16|||
124477333|NCT00928070|447702659|FG001|Overall Study|Did not meet entrance criteria|9|||
124477334|NCT00928070|447702658|FG000|Overall Study|Protocol Violation|6|||
124477335|NCT00928070|447702659|FG001|Overall Study|Protocol Violation|5|||
124477336|NCT00928070|447702658|FG000|Overall Study|Randomized but not treated|2|||
124477337|NCT00928070|447702659|FG001|Overall Study|Randomized but not treated|2|||
124477338|NCT00928070|447702658|FG000|Overall Study|Other|5|||
124477339|NCT00928070|447702659|FG001|Overall Study|Other|5|||
124477340|NCT02054702|447702663|FG000|Overall Study|Lost to Follow-up|3|||
124477341|NCT02054702|447702664|FG001|Overall Study|Lost to Follow-up|5|||
124477342|NCT02054702|447702663|FG000|Overall Study|Adverse Event|3|||
124477343|NCT02054702|447702664|FG001|Overall Study|Adverse Event|1|||
124477344|NCT02054702|447702663|FG000|Overall Study|Met Withdrawal Criteria|4|||
124477345|NCT02054702|447702664|FG001|Overall Study|Met Withdrawal Criteria|1|||
124477346|NCT02054702|447702663|FG000|Overall Study|Physician Decision|0|||
124477347|NCT02054702|447702664|FG001|Overall Study|Physician Decision|1|||
124477348|NCT02054702|447702663|FG000|Overall Study|Withdrawal by Subject|14|||
124477349|NCT02054702|447702664|FG001|Overall Study|Withdrawal by Subject|4|||
124477350|NCT00501228|447702667|FG000|Overall Study|Withdrawal by Subject|1|||
124477351|NCT02304926|447702668|FG000|Overall Study|Lost to Follow-up|2|||
124477352|NCT02304926|447702669|FG001|Overall Study|Lost to Follow-up|1|||
124477353|NCT03157531|447702671|FG000|Overall Study|Death|2|||
124477354|NCT03157531|447702671|FG000|Overall Study|Lost to Follow-up|4|||
124477355|NCT00331006|447702672|FG000|Screening Phase|Withdrawal by Subject|1|||
124477356|NCT00331006|447702672|FG000|Screening Phase|enrollment halted|1|||
124477357|NCT00331006|447702672|FG000|Screening Phase|Lost to Follow-up|1|||
124477358|NCT00331006|447702672|FG000|Screening Phase|Ineligible for treatment phase|4|||
124477359|NCT00331006|447702672|FG000|Treatment Phase|Withdrawal by Subject|1|||
124556954|NCT01078623|447997656|FG001|Treatment Period 2|Adverse Event|0|||
124556955|NCT01078623|447997657|FG002|Treatment Period 2|Adverse Event|0|||
124556956|NCT01078623|447997658|FG003|Treatment Period 2|Adverse Event|0|||
124556957|NCT01078623|447997659|FG004|Treatment Period 2|Adverse Event|0|||
124556958|NCT01078623|447997660|FG005|Treatment Period 2|Adverse Event|0|||
124556959|NCT01078623|447997661|FG006|Treatment Period 2|Adverse Event|1|||
124719537|NCT02998671|448594856|FG002|Period 1|Pregnancy|0|||
124719538|NCT02998671|448594857|FG003|Period 1|Pregnancy|0|||
124719539|NCT02998671|448594858|FG004|Period 1|Pregnancy|0|||
124719540|NCT02998671|448594854|FG000|Period 1|Adverse Event|0|||
124719541|NCT02998671|448594855|FG001|Period 1|Adverse Event|0|||
124556960|NCT01078623|447997662|FG007|Treatment Period 2|Adverse Event|0|||
124556961|NCT01078623|447997663|FG008|Treatment Period 2|Adverse Event|0|||
124719542|NCT02998671|448594856|FG002|Period 1|Adverse Event|0|||
124477360|NCT00331006|447702672|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
124477361|NCT00331006|447702672|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
124477362|NCT03804684|447702673|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
124477363|NCT03804684|447702674|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
124477364|NCT00238264|447702677|FG000|Overall Study|Death|7|||
124477365|NCT00238264|447702677|FG000|Overall Study|Lost to Follow-up|18|||
124477366|NCT00238264|447702677|FG000|Overall Study|Withdrawal by Subject|4|||
124477367|NCT00238264|447702677|FG000|Overall Study|Ineligible|7|||
124556962|NCT01078623|447997664|FG009|Treatment Period 2|Adverse Event|0|||
124556963|NCT01078623|447997665|FG010|Treatment Period 2|Adverse Event|0|||
124556964|NCT01078623|447997666|FG011|Treatment Period 2|Adverse Event|0|||
124556965|NCT01078623|447997667|FG012|Treatment Period 2|Adverse Event|0|||
124556966|NCT01078623|447997668|FG013|Treatment Period 2|Adverse Event|0|||
124556967|NCT01078623|447997669|FG014|Treatment Period 2|Adverse Event|0|||
124556968|NCT01078623|447997670|FG015|Treatment Period 2|Adverse Event|0|||
124556969|NCT01078623|447997671|FG016|Treatment Period 2|Adverse Event|0|||
124556970|NCT01078623|447997672|FG017|Treatment Period 2|Adverse Event|0|||
124556971|NCT01078623|447997673|FG018|Treatment Period 2|Adverse Event|1|||
124556972|NCT01078623|447997674|FG019|Treatment Period 2|Adverse Event|0|||
124556973|NCT01078623|447997655|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124556974|NCT01078623|447997656|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124556975|NCT01078623|447997657|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124556976|NCT01078623|447997658|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124556977|NCT01078623|447997659|FG004|Treatment Period 2|Withdrawal by Subject|0|||
124556978|NCT01078623|447997660|FG005|Treatment Period 2|Withdrawal by Subject|1|||
124556979|NCT01078623|447997661|FG006|Treatment Period 2|Withdrawal by Subject|0|||
124556980|NCT01078623|447997662|FG007|Treatment Period 2|Withdrawal by Subject|0|||
124556981|NCT01078623|447997663|FG008|Treatment Period 2|Withdrawal by Subject|0|||
124556982|NCT01078623|447997664|FG009|Treatment Period 2|Withdrawal by Subject|0|||
124556983|NCT01078623|447997665|FG010|Treatment Period 2|Withdrawal by Subject|0|||
124556984|NCT01078623|447997666|FG011|Treatment Period 2|Withdrawal by Subject|0|||
124556985|NCT01078623|447997667|FG012|Treatment Period 2|Withdrawal by Subject|0|||
124556986|NCT01078623|447997668|FG013|Treatment Period 2|Withdrawal by Subject|0|||
124556987|NCT01078623|447997669|FG014|Treatment Period 2|Withdrawal by Subject|0|||
124556988|NCT01078623|447997670|FG015|Treatment Period 2|Withdrawal by Subject|0|||
124556989|NCT01078623|447997671|FG016|Treatment Period 2|Withdrawal by Subject|0|||
124477368|NCT02706938|447702678|FG000|First Period, 6 Weeks|Adverse Event|8|||
124477369|NCT02706938|447702679|FG001|First Period, 6 Weeks|Adverse Event|0|||
124477370|NCT02706938|447702678|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
124556990|NCT01078623|447997672|FG017|Treatment Period 2|Withdrawal by Subject|0|||
124719543|NCT02998671|448594857|FG003|Period 1|Adverse Event|0|||
124719544|NCT02998671|448594858|FG004|Period 1|Adverse Event|1|||
124556991|NCT01078623|447997673|FG018|Treatment Period 2|Withdrawal by Subject|0|||
124556992|NCT01078623|447997674|FG019|Treatment Period 2|Withdrawal by Subject|0|||
124556993|NCT01078623|447997655|FG000|Treatment Period 3|Adverse Event|0|||
124556994|NCT01078623|447997656|FG001|Treatment Period 3|Adverse Event|0|||
124556995|NCT01078623|447997657|FG002|Treatment Period 3|Adverse Event|0|||
124556996|NCT01078623|447997658|FG003|Treatment Period 3|Adverse Event|0|||
124556997|NCT01078623|447997659|FG004|Treatment Period 3|Adverse Event|1|||
124477371|NCT02706938|447702679|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
124477372|NCT02706938|447702678|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
124477373|NCT02706938|447702679|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
124477374|NCT02706938|447702678|FG000|Second Period, 6 Weeks|Adverse Event|0|||
124477375|NCT02706938|447702679|FG001|Second Period, 6 Weeks|Adverse Event|7|||
124477376|NCT02706938|447702678|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
124477377|NCT02706938|447702679|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
124477378|NCT01838044|447702680|FG000|Overall Study|Adverse Event|4|||
124477379|NCT01838044|447702681|FG001|Overall Study|Adverse Event|6|||
124477380|NCT01838044|447702680|FG000|Overall Study|Protocol Violation|3|||
124477381|NCT01838044|447702681|FG001|Overall Study|Protocol Violation|3|||
124719545|NCT02998671|448594854|FG000|Period 2|Adverse Event|0|||
124719546|NCT02998671|448594855|FG001|Period 2|Adverse Event|1|||
124719547|NCT02998671|448594856|FG002|Period 2|Adverse Event|0|||
124719548|NCT02998671|448594857|FG003|Period 2|Adverse Event|0|||
124719549|NCT02998671|448594858|FG004|Period 2|Adverse Event|0|||
124719550|NCT02998671|448594854|FG000|Period 2|Study Terminated By Sponsor|3|||
124719551|NCT02998671|448594855|FG001|Period 2|Study Terminated By Sponsor|5|||
124719552|NCT02998671|448594856|FG002|Period 2|Study Terminated By Sponsor|1|||
124477382|NCT01838044|447702680|FG000|Overall Study|Withdrawal by Subject|0|||
124719553|NCT02998671|448594857|FG003|Period 2|Study Terminated By Sponsor|3|||
124719554|NCT02998671|448594858|FG004|Period 2|Study Terminated By Sponsor|0|||
124719555|NCT02998671|448594854|FG000|Period 2|Withdrawal by Subject|0|||
124477383|NCT01838044|447702681|FG001|Overall Study|Withdrawal by Subject|2|||
124477384|NCT01838044|447702680|FG000|Overall Study|Insufficient clinical response|1|||
124477385|NCT01838044|447702681|FG001|Overall Study|Insufficient clinical response|2|||
124477386|NCT01838044|447702680|FG000|Overall Study|Medication error without associated AE|0|||
124477387|NCT01838044|447702681|FG001|Overall Study|Medication error without associated AE|1|||
124477388|NCT01838044|447702680|FG000|Overall Study|Lost to Follow-up|0|||
124477389|NCT01838044|447702681|FG001|Overall Study|Lost to Follow-up|2|||
124477390|NCT00860470|447702685|FG000|Overall Study|Death|6|||
124477391|NCT00860470|447702686|FG001|Overall Study|Death|10|||
124719556|NCT02998671|448594855|FG001|Period 2|Withdrawal by Subject|1|||
124477392|NCT00860470|447702685|FG000|Overall Study|Moved away|8|||
124556998|NCT01078623|447997660|FG005|Treatment Period 3|Adverse Event|0|||
124477393|NCT00860470|447702686|FG001|Overall Study|Moved away|10|||
124477394|NCT00860470|447702685|FG000|Overall Study|Lost to Follow-up|34|||
124477395|NCT00860470|447702686|FG001|Overall Study|Lost to Follow-up|39|||
124477396|NCT01662648|447702688|FG000|Overall Study|Death|1|||
124477397|NCT01662648|447702689|FG001|Overall Study|Death|3|||
124477398|NCT01662648|447702688|FG000|Overall Study|Adverse Event|40|||
124477399|NCT01662648|447702689|FG001|Overall Study|Adverse Event|37|||
124477400|NCT01662648|447702688|FG000|Overall Study|Lack of Efficacy|17|||
124477401|NCT01662648|447702689|FG001|Overall Study|Lack of Efficacy|16|||
124477402|NCT01662648|447702688|FG000|Overall Study|Participant ineligible to continue trial|1|||
124477403|NCT01662648|447702689|FG001|Overall Study|Participant ineligible to continue trial|1|||
124477404|NCT01662648|447702688|FG000|Overall Study|Lost to Follow-up|24|||
124477405|NCT01662648|447702689|FG001|Overall Study|Lost to Follow-up|36|||
124477406|NCT01662648|447702688|FG000|Overall Study|Withdrawal by Subject|36|||
124477407|NCT01662648|447702689|FG001|Overall Study|Withdrawal by Subject|53|||
124477408|NCT01662648|447702688|FG000|Overall Study|Participant non-compliant|16|||
124477409|NCT01662648|447702689|FG001|Overall Study|Participant non-compliant|20|||
124477410|NCT01662648|447702688|FG000|Overall Study|Other|8|||
124556999|NCT01078623|447997661|FG006|Treatment Period 3|Adverse Event|0|||
124557000|NCT01078623|447997662|FG007|Treatment Period 3|Adverse Event|0|||
124719557|NCT02998671|448594856|FG002|Period 2|Withdrawal by Subject|0|||
124719558|NCT02998671|448594857|FG003|Period 2|Withdrawal by Subject|0|||
124477411|NCT01662648|447702689|FG001|Overall Study|Other|11|||
124477412|NCT01662648|447702688|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
124477413|NCT01662648|447702689|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
124477414|NCT01662648|447702688|FG000|Overall Study|LOE and other reason unspecified|1|||
124719559|NCT02998671|448594858|FG004|Period 2|Withdrawal by Subject|0|||
124719560|NCT02998671|448594854|FG000|Period 2|Lost to Follow-up|0|||
124719561|NCT02998671|448594855|FG001|Period 2|Lost to Follow-up|0|||
124719562|NCT02998671|448594856|FG002|Period 2|Lost to Follow-up|0|||
124477415|NCT01662648|447702689|FG001|Overall Study|LOE and other reason unspecified|0|||
124477416|NCT01662648|447702688|FG000|Overall Study|LOE and Participant non-compliant|0|||
124477417|NCT01662648|447702689|FG001|Overall Study|LOE and Participant non-compliant|1|||
124477418|NCT02928952|447702690|FG000|Overall Study|Lost to Follow-up|5|||
124477419|NCT02928952|447702691|FG001|Overall Study|Lost to Follow-up|5|||
124477420|NCT02928952|447702690|FG000|Overall Study|Withdrawal by Subject|5|||
124477421|NCT02928952|447702691|FG001|Overall Study|Withdrawal by Subject|1|||
124477422|NCT02928952|447702690|FG000|Overall Study|Physician Decision|0|||
124477423|NCT02928952|447702691|FG001|Overall Study|Physician Decision|1|||
124477424|NCT00723957|447702692|FG000|Overall Study|Adverse event unrelated to study drug|1|||
124477425|NCT00723957|447702693|FG001|Overall Study|Adverse event unrelated to study drug|4|||
124477426|NCT00723957|447702692|FG000|Overall Study|Death|3|||
124477427|NCT00723957|447702693|FG001|Overall Study|Death|4|||
124477428|NCT00723957|447702692|FG000|Overall Study|Disease progression|27|||
124477429|NCT00723957|447702693|FG001|Overall Study|Disease progression|25|||
124719563|NCT02998671|448594857|FG003|Period 2|Lost to Follow-up|1|||
124477430|NCT00723957|447702692|FG000|Overall Study|Maximum clinical benefit|4|||
124477431|NCT00723957|447702693|FG001|Overall Study|Maximum clinical benefit|5|||
124477432|NCT00723957|447702692|FG000|Overall Study|Investigator decision|1|||
124477433|NCT00723957|447702693|FG001|Overall Study|Investigator decision|1|||
124477434|NCT00723957|447702692|FG000|Overall Study|Study drug toxicity|4|||
124477435|NCT00723957|447702693|FG001|Overall Study|Study drug toxicity|6|||
124477436|NCT00723957|447702692|FG000|Overall Study|Withdrawal by Subject|7|||
124477437|NCT00723957|447702693|FG001|Overall Study|Withdrawal by Subject|5|||
124477438|NCT00723957|447702692|FG000|Overall Study|Reason not analyzed|1|||
124477439|NCT00723957|447702693|FG001|Overall Study|Reason not analyzed|0|||
124477440|NCT00723957|447702692|FG000|Overall Study|Never received treatment|3|||
124477441|NCT00723957|447702693|FG001|Overall Study|Never received treatment|3|||
124477442|NCT03751111|447702694|FG000|Overall Study|Lack of Efficacy|9|||
124477443|NCT03751111|447702695|FG001|Overall Study|Lack of Efficacy|30|||
124477444|NCT03751111|447702694|FG000|Overall Study|Adverse Event|3|||
124477445|NCT03751111|447702695|FG001|Overall Study|Adverse Event|2|||
124477446|NCT00706628|447702697|FG000|Overall Study|Other Adverse Event|16|||
124477447|NCT00706628|447702698|FG001|Overall Study|Other Adverse Event|5|||
124477448|NCT00706628|447702699|FG002|Overall Study|Other Adverse Event|5|||
124719564|NCT02998671|448594858|FG004|Period 2|Lost to Follow-up|0|||
124719565|NCT02038946|448594860|FG000|Overall Study|Death|5|||
124719566|NCT02038946|448594860|FG000|Overall Study|Withdrawal by Subject|3|||
124719567|NCT02038946|448594860|FG000|Overall Study|Lost to Follow-up|2|||
124477449|NCT00706628|447702700|FG003|Overall Study|Other Adverse Event|2|||
124477450|NCT00706628|447702697|FG000|Overall Study|Non compliant with protocol|0|||
124477451|NCT00706628|447702698|FG001|Overall Study|Non compliant with protocol|1|||
124477452|NCT00706628|447702699|FG002|Overall Study|Non compliant with protocol|0|||
124477453|NCT00706628|447702700|FG003|Overall Study|Non compliant with protocol|0|||
124477454|NCT00706628|447702697|FG000|Overall Study|Consent withdrawn|6|||
124477455|NCT00706628|447702698|FG001|Overall Study|Consent withdrawn|1|||
124477456|NCT00706628|447702699|FG002|Overall Study|Consent withdrawn|3|||
124477457|NCT00706628|447702700|FG003|Overall Study|Consent withdrawn|0|||
124477458|NCT00706628|447702697|FG000|Overall Study|Progressive disease|20|||
124477459|NCT00706628|447702698|FG001|Overall Study|Progressive disease|13|||
124477460|NCT00706628|447702699|FG002|Overall Study|Progressive disease|8|||
124477461|NCT00706628|447702700|FG003|Overall Study|Progressive disease|1|||
124477462|NCT00706628|447702697|FG000|Overall Study|Other than those stated above|4|||
124719568|NCT02038946|448594860|FG000|Overall Study|Other reasons|2|||
124719569|NCT02623205|448594861|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
124719570|NCT02623205|448594862|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
124719571|NCT03162796|448594863|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
124719572|NCT03162796|448594864|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
124719573|NCT03162796|448594865|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
124719574|NCT03162796|448594863|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
124477463|NCT00706628|447702698|FG001|Overall Study|Other than those stated above|0|||
124477464|NCT00706628|447702699|FG002|Overall Study|Other than those stated above|0|||
124477465|NCT00706628|447702700|FG003|Overall Study|Other than those stated above|0|||
124477466|NCT00706628|447702697|FG000|Overall Study|Not treated|1|||
124477467|NCT00706628|447702698|FG001|Overall Study|Not treated|1|||
124477468|NCT00706628|447702699|FG002|Overall Study|Not treated|0|||
124477469|NCT00706628|447702700|FG003|Overall Study|Not treated|0|||
124477470|NCT01264939|447702701|FG000|Overall Study|Adverse Event|1|||
124477471|NCT01264939|447702702|FG001|Overall Study|Adverse Event|3|||
124477472|NCT01264939|447702701|FG000|Overall Study|Lost to Follow-up|0|||
124477473|NCT01264939|447702702|FG001|Overall Study|Lost to Follow-up|3|||
124477474|NCT01264939|447702701|FG000|Overall Study|Physician Decision|1|||
124477475|NCT01264939|447702702|FG001|Overall Study|Physician Decision|1|||
124477476|NCT01264939|447702701|FG000|Overall Study|Patient/Guardian Decision|8|||
124477477|NCT01264939|447702702|FG001|Overall Study|Patient/Guardian Decision|10|||
124477478|NCT01264939|447702701|FG000|Overall Study|Disease Progression|8|||
124477479|NCT01264939|447702702|FG001|Overall Study|Disease Progression|11|||
124477480|NCT02266433|447702707|FG000|Overall Study|Lost to Follow-up|54|||
124477481|NCT02266433|447702708|FG001|Overall Study|Lost to Follow-up|46|||
124477482|NCT02266433|447702707|FG000|Overall Study|Withdrawal by Subject|5|||
124477483|NCT02266433|447702708|FG001|Overall Study|Withdrawal by Subject|7|||
124477484|NCT04525703|447702709|FG000|Overall Study|Lost to Follow-up|6|||
124477485|NCT04525703|447702710|FG001|Overall Study|Lost to Follow-up|15|||
124477486|NCT04525703|447702711|FG002|Overall Study|Lost to Follow-up|8|||
124477487|NCT01285349|447702712|FG000|Overall Study|Lost to Follow-up|27|||
124477488|NCT01285349|447702713|FG001|Overall Study|Lost to Follow-up|20|||
124477489|NCT01285349|447702714|FG002|Overall Study|Lost to Follow-up|27|||
124477490|NCT01145560|447702715|FG000|Overall Study|Withdrawal by Subject|2|||
124477491|NCT01145560|447702716|FG001|Overall Study|Withdrawal by Subject|1|||
124477492|NCT01145560|447702717|FG002|Overall Study|Withdrawal by Subject|0|||
124477493|NCT01145560|447702715|FG000|Overall Study|Lost to Follow-up|1|||
124477494|NCT01145560|447702716|FG001|Overall Study|Lost to Follow-up|1|||
124477495|NCT01145560|447702717|FG002|Overall Study|Lost to Follow-up|1|||
124477496|NCT01145560|447702715|FG000|Overall Study|No study drug by 24h after organ failure|1|||
124557001|NCT01078623|447997663|FG008|Treatment Period 3|Adverse Event|0|||
124557002|NCT01078623|447997664|FG009|Treatment Period 3|Adverse Event|0|||
124557003|NCT01078623|447997665|FG010|Treatment Period 3|Adverse Event|0|||
124557004|NCT01078623|447997666|FG011|Treatment Period 3|Adverse Event|0|||
124557005|NCT01078623|447997667|FG012|Treatment Period 3|Adverse Event|0|||
124557006|NCT01078623|447997668|FG013|Treatment Period 3|Adverse Event|1|||
124557007|NCT01078623|447997669|FG014|Treatment Period 3|Adverse Event|0|||
124719575|NCT03162796|448594864|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
124719576|NCT03162796|448594865|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
124719577|NCT03162796|448594863|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
124719578|NCT03162796|448594864|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
124719579|NCT03162796|448594865|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
124719580|NCT03162796|448594863|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
124719581|NCT03162796|448594864|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
124719582|NCT03162796|448594865|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
124719583|NCT03162796|448594863|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
124719584|NCT03162796|448594864|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
124557008|NCT01078623|447997670|FG015|Treatment Period 3|Adverse Event|0|||
124719585|NCT03162796|448594865|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
124477497|NCT01145560|447702716|FG001|Overall Study|No study drug by 24h after organ failure|0|||
124477498|NCT01145560|447702717|FG002|Overall Study|No study drug by 24h after organ failure|0|||
124477499|NCT01145560|447702715|FG000|Overall Study|Accidental unblinding of study treatment|0|||
124477500|NCT01145560|447702716|FG001|Overall Study|Accidental unblinding of study treatment|1|||
124477501|NCT01145560|447702717|FG002|Overall Study|Accidental unblinding of study treatment|0|||
124477502|NCT01145560|447702715|FG000|Overall Study|False insurance information|0|||
124477503|NCT01145560|447702716|FG001|Overall Study|False insurance information|1|||
124477504|NCT01145560|447702717|FG002|Overall Study|False insurance information|0|||
124477505|NCT01145560|447702715|FG000|Overall Study|Withdrawal of therapy|0|||
124477506|NCT01145560|447702716|FG001|Overall Study|Withdrawal of therapy|0|||
124477507|NCT01145560|447702717|FG002|Overall Study|Withdrawal of therapy|1|||
124477508|NCT00712348|447702718|FG000|Overall Study|Withdrawal by Subject|1|||
124477509|NCT02452762|447702720|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
124477510|NCT02452762|447702721|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
124477511|NCT02452762|447702720|FG000|Overall Study|Withdrawal by Subject|1|||
124477512|NCT02452762|447702721|FG001|Overall Study|Withdrawal by Subject|0|||
124477513|NCT03682120|447702722|FG000|Overall Study|Lost to Follow-up|11|||
124477514|NCT03682120|447702723|FG001|Overall Study|Lost to Follow-up|4|||
124477515|NCT03682120|447702724|FG002|Overall Study|Lost to Follow-up|5|||
124477516|NCT03682120|447702725|FG003|Overall Study|Lost to Follow-up|2|||
124477517|NCT03682120|447702722|FG000|Overall Study|Physician Decision|1|||
124477518|NCT03682120|447702723|FG001|Overall Study|Physician Decision|0|||
124477519|NCT03682120|447702724|FG002|Overall Study|Physician Decision|0|||
124477520|NCT03682120|447702725|FG003|Overall Study|Physician Decision|0|||
124477521|NCT03682120|447702722|FG000|Overall Study|Withdrawal by Subject|1|||
124477522|NCT03682120|447702723|FG001|Overall Study|Withdrawal by Subject|2|||
124477523|NCT03682120|447702724|FG002|Overall Study|Withdrawal by Subject|3|||
124477524|NCT03682120|447702725|FG003|Overall Study|Withdrawal by Subject|0|||
124477525|NCT03682120|447702722|FG000|Overall Study|Death|0|||
124477526|NCT03682120|447702723|FG001|Overall Study|Death|1|||
124477527|NCT03682120|447702724|FG002|Overall Study|Death|0|||
124477528|NCT03682120|447702725|FG003|Overall Study|Death|0|||
124477529|NCT03682120|447702722|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
124477530|NCT03682120|447702723|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
124477531|NCT03682120|447702724|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
124477532|NCT03682120|447702725|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
124477533|NCT03308188|447702726|FG000|Overall Study|Withdrawal by Subject|0|||
124477534|NCT03308188|447702727|FG001|Overall Study|Withdrawal by Subject|3|||
124477535|NCT03308188|447702726|FG000|Overall Study|Death|0|||
124477536|NCT03308188|447702727|FG001|Overall Study|Death|1|||
124477537|NCT01957137|447702728|FG000|Randomized Portion|Adverse Event|1|||
124477538|NCT01957137|447702728|FG000|Randomized Portion|Withdrawal by Subject|1|||
124477539|NCT02497001|447702731|FG000|Overall Study|Lost to Follow-up|10|||
124477540|NCT02497001|447702732|FG001|Overall Study|Lost to Follow-up|2|||
124477541|NCT02497001|447702733|FG002|Overall Study|Lost to Follow-up|0|||
124477542|NCT02497001|447702734|FG003|Overall Study|Lost to Follow-up|2|||
124477543|NCT02497001|447702731|FG000|Overall Study|Adverse Event|28|||
124477544|NCT02497001|447702732|FG001|Overall Study|Adverse Event|30|||
124557009|NCT01078623|447997671|FG016|Treatment Period 3|Adverse Event|0|||
124477545|NCT02497001|447702733|FG002|Overall Study|Adverse Event|11|||
124477546|NCT02497001|447702734|FG003|Overall Study|Adverse Event|11|||
124477547|NCT02497001|447702731|FG000|Overall Study|Withdrawal by Subject|14|||
124477548|NCT02497001|447702732|FG001|Overall Study|Withdrawal by Subject|37|||
124477549|NCT02497001|447702733|FG002|Overall Study|Withdrawal by Subject|19|||
124477550|NCT02497001|447702734|FG003|Overall Study|Withdrawal by Subject|15|||
124557010|NCT01078623|447997672|FG017|Treatment Period 3|Adverse Event|0|||
124477551|NCT02497001|447702731|FG000|Overall Study|Physician Decision|5|||
124477552|NCT02497001|447702732|FG001|Overall Study|Physician Decision|11|||
124477553|NCT02497001|447702733|FG002|Overall Study|Physician Decision|5|||
124477554|NCT02497001|447702734|FG003|Overall Study|Physician Decision|1|||
124477555|NCT02497001|447702731|FG000|Overall Study|subjects that were not treated|1|||
124477556|NCT02497001|447702732|FG001|Overall Study|subjects that were not treated|2|||
124477557|NCT02497001|447702733|FG002|Overall Study|subjects that were not treated|2|||
124477558|NCT02497001|447702734|FG003|Overall Study|subjects that were not treated|1|||
124477559|NCT02497001|447702731|FG000|Overall Study|Major Protocol Deviation|3|||
124477560|NCT02497001|447702732|FG001|Overall Study|Major Protocol Deviation|4|||
124477561|NCT02497001|447702733|FG002|Overall Study|Major Protocol Deviation|4|||
124477562|NCT02497001|447702734|FG003|Overall Study|Major Protocol Deviation|4|||
124477563|NCT02497001|447702731|FG000|Overall Study|Lack of Efficacy|10|||
124477564|NCT02497001|447702732|FG001|Overall Study|Lack of Efficacy|16|||
124477565|NCT02497001|447702733|FG002|Overall Study|Lack of Efficacy|6|||
124477566|NCT02497001|447702734|FG003|Overall Study|Lack of Efficacy|6|||
124477567|NCT02497001|447702731|FG000|Overall Study|Protocol Violation|3|||
124477568|NCT02497001|447702732|FG001|Overall Study|Protocol Violation|1|||
124477569|NCT02497001|447702733|FG002|Overall Study|Protocol Violation|3|||
124477570|NCT02497001|447702734|FG003|Overall Study|Protocol Violation|1|||
124477571|NCT03898063|447702735|FG000|Overall Study|Withdrawal by Subject|10|||
124477572|NCT03898063|447702736|FG001|Overall Study|Withdrawal by Subject|8|||
124477573|NCT02949830|447702737|FG000|Overall Study|Adverse Event|1|||
124477574|NCT02949830|447702737|FG000|Overall Study|Withdrawal by Subject|1|||
124477575|NCT02959814|447702738|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
124477576|NCT02959814|447702738|FG000|Overall Study|Excluded based on anatomical criteria|2|||
124477577|NCT02959814|447702738|FG000|Overall Study|Protocol Violation|7|||
124477578|NCT02959814|447702738|FG000|Overall Study|FFR not measured|2|||
124477579|NCT02959814|447702738|FG000|Overall Study|In-procedure QFR not computed|6|||
124477580|NCT02959814|447702738|FG000|Overall Study|Excluded by FFR core-lab|24|||
124477581|NCT02116621|447702739|FG000|Baseline|Withdrawal by Subject|0|||
124477582|NCT02116621|447702740|FG001|Baseline|Withdrawal by Subject|4|||
124477583|NCT02116621|447702739|FG000|Three Month Follow-up|Death|1|||
124477584|NCT02116621|447702740|FG001|Three Month Follow-up|Death|1|||
124477585|NCT02116621|447702739|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
124477586|NCT02116621|447702740|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
124477587|NCT02116621|447702739|FG000|Three Month Follow-up|Lost to Follow-up|0|||
124477588|NCT02116621|447702740|FG001|Three Month Follow-up|Lost to Follow-up|1|||
124477589|NCT02116621|447702739|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
124477590|NCT02116621|447702740|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
124477591|NCT02116621|447702739|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
124477592|NCT02116621|447702740|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
124477593|NCT02116621|447702739|FG000|Six Month Follow-up|Lost to Follow-up|2|||
124477594|NCT02116621|447702740|FG001|Six Month Follow-up|Lost to Follow-up|1|||
124477595|NCT02116621|447702739|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
124477596|NCT02116621|447702740|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
124477597|NCT02116621|447702739|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
124477598|NCT02116621|447702740|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
124477599|NCT02116621|447702739|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
124477600|NCT02116621|447702740|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
124477601|NCT02116621|447702739|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
124477602|NCT02116621|447702740|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
124477603|NCT02116621|447702739|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
124477604|NCT02116621|447702740|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
124477605|NCT03437447|447702741|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124477606|NCT03437447|447702742|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124557011|NCT01078623|447997673|FG018|Treatment Period 3|Adverse Event|0|||
124557012|NCT01078623|447997674|FG019|Treatment Period 3|Adverse Event|0|||
124557013|NCT01078623|447997655|FG000|Treatment Period 4|Adverse Event|0|||
124557014|NCT01078623|447997656|FG001|Treatment Period 4|Adverse Event|0|||
124557015|NCT01078623|447997657|FG002|Treatment Period 4|Adverse Event|1|||
124557016|NCT01078623|447997658|FG003|Treatment Period 4|Adverse Event|0|||
124557017|NCT01078623|447997659|FG004|Treatment Period 4|Adverse Event|0|||
124557018|NCT01078623|447997660|FG005|Treatment Period 4|Adverse Event|0|||
124557019|NCT01078623|447997661|FG006|Treatment Period 4|Adverse Event|0|||
124557020|NCT01078623|447997662|FG007|Treatment Period 4|Adverse Event|0|||
124477607|NCT03437447|447702743|FG002|Treatment Period 1|Withdrawal by Subject|1|||
124477608|NCT02040142|447702745|FG000|Overall Study|Lost to Follow-up|5|||
124477609|NCT02040142|447702745|FG000|Overall Study|Death|17|||
124477610|NCT02040142|447702745|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
124477611|NCT02330419|447702747|FG000|Overall Study|Lost to Follow-up|3|||
124477612|NCT02330419|447702748|FG001|Overall Study|Lost to Follow-up|7|||
124477613|NCT01813890|447702751|FG000|Overall Study|Adverse Event|0|||
124477614|NCT01813890|447702752|FG001|Overall Study|Adverse Event|3|||
124557021|NCT01078623|447997663|FG008|Treatment Period 4|Adverse Event|0|||
124477615|NCT01813890|447702753|FG002|Overall Study|Adverse Event|4|||
124477616|NCT01813890|447702751|FG000|Overall Study|Lack of Efficacy|9|||
124477617|NCT01813890|447702752|FG001|Overall Study|Lack of Efficacy|1|||
124477618|NCT01813890|447702753|FG002|Overall Study|Lack of Efficacy|2|||
124477619|NCT03952559|447702754|FG000|Double Blind Treatment Period|Adverse Event|0|||
124477620|NCT03952559|447702755|FG001|Double Blind Treatment Period|Adverse Event|2|||
124477621|NCT03952559|447702756|FG002|Double Blind Treatment Period|Adverse Event|1|||
124477622|NCT03952559|447702757|FG003|Double Blind Treatment Period|Adverse Event|0|||
124477623|NCT03952559|447702758|FG004|Double Blind Treatment Period|Adverse Event|1|||
124477624|NCT03952559|447702754|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
124477625|NCT03952559|447702755|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
124477626|NCT03952559|447702756|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
124477627|NCT03952559|447702757|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
124477628|NCT03952559|447702758|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
124477629|NCT03952559|447702754|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
124477630|NCT03952559|447702755|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
124477631|NCT03952559|447702756|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
124477632|NCT03952559|447702757|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
124477633|NCT03952559|447702758|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
124477634|NCT03952559|447702754|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
124477635|NCT03952559|447702755|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
124477636|NCT03952559|447702756|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
124477637|NCT03952559|447702757|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
124477638|NCT03952559|447702758|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
124477639|NCT01870739|447702761|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
124477640|NCT01870739|447702762|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
124477641|NCT01870739|447702761|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
124477642|NCT01870739|447702762|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
124477643|NCT01870739|447702761|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
124477644|NCT01870739|447702762|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
124477645|NCT01870739|447702761|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
124477646|NCT01870739|447702762|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
124477647|NCT01870739|447702761|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
124477648|NCT01870739|447702762|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
124477649|NCT01870739|447702761|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
124477650|NCT01870739|447702762|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
124477651|NCT01870739|447702761|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
124477652|NCT01870739|447702762|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
124477653|NCT01986062|447702763|FG000|Overall Study|Lost to Follow-up|1|||
124477654|NCT01986062|447702764|FG001|Overall Study|Lost to Follow-up|0|||
124477655|NCT01986062|447702763|FG000|Overall Study|Withdrawal by Subject|0|||
124477656|NCT01986062|447702764|FG001|Overall Study|Withdrawal by Subject|1|||
124477657|NCT03538743|447702765|FG000|Overall Study|Adverse Event|0|||
124557022|NCT01078623|447997664|FG009|Treatment Period 4|Adverse Event|0|||
124557023|NCT01078623|447997665|FG010|Treatment Period 4|Adverse Event|0|||
124557024|NCT01078623|447997666|FG011|Treatment Period 4|Adverse Event|0|||
124557025|NCT01078623|447997667|FG012|Treatment Period 4|Adverse Event|0|||
124557026|NCT01078623|447997668|FG013|Treatment Period 4|Adverse Event|0|||
124557027|NCT01078623|447997669|FG014|Treatment Period 4|Adverse Event|0|||
124557028|NCT01078623|447997670|FG015|Treatment Period 4|Adverse Event|0|||
124477658|NCT03538743|447702766|FG001|Overall Study|Adverse Event|0|||
124477659|NCT03538743|447702767|FG002|Overall Study|Adverse Event|1|||
124477660|NCT03538743|447702768|FG003|Overall Study|Adverse Event|1|||
124477661|NCT03538743|447702769|FG004|Overall Study|Adverse Event|0|||
124477662|NCT03538743|447702770|FG005|Overall Study|Adverse Event|0|||
124477663|NCT03538743|447702771|FG006|Overall Study|Adverse Event|0|||
124477664|NCT03538743|447702772|FG007|Overall Study|Adverse Event|0|||
124557029|NCT01078623|447997671|FG016|Treatment Period 4|Adverse Event|0|||
124557030|NCT01078623|447997672|FG017|Treatment Period 4|Adverse Event|0|||
124557031|NCT01078623|447997673|FG018|Treatment Period 4|Adverse Event|0|||
124477665|NCT03538743|447702773|FG008|Overall Study|Adverse Event|0|||
124477666|NCT03538743|447702765|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
124477667|NCT03538743|447702766|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
124477668|NCT03538743|447702767|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
124477669|NCT03538743|447702768|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
124557032|NCT01078623|447997674|FG019|Treatment Period 4|Adverse Event|0|||
124557033|NCT01078623|447997655|FG000|Treatment Period 4|Withdrawal by Subject|0|||
124557034|NCT01078623|447997656|FG001|Treatment Period 4|Withdrawal by Subject|0|||
124557035|NCT01078623|447997657|FG002|Treatment Period 4|Withdrawal by Subject|0|||
124477670|NCT03538743|447702769|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
124477671|NCT03538743|447702770|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
124477672|NCT03538743|447702771|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
124557036|NCT01078623|447997658|FG003|Treatment Period 4|Withdrawal by Subject|0|||
124477673|NCT03538743|447702772|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
124477674|NCT03538743|447702773|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
124477675|NCT03538743|447702765|FG000|Overall Study|Withdrawal by Subject|0|||
124477676|NCT03538743|447702766|FG001|Overall Study|Withdrawal by Subject|0|||
124477677|NCT03538743|447702767|FG002|Overall Study|Withdrawal by Subject|0|||
124719586|NCT03162796|448594863|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
124719587|NCT03162796|448594864|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
124719588|NCT03162796|448594865|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
124477678|NCT03538743|447702768|FG003|Overall Study|Withdrawal by Subject|1|||
124477679|NCT03538743|447702769|FG004|Overall Study|Withdrawal by Subject|0|||
124477680|NCT03538743|447702770|FG005|Overall Study|Withdrawal by Subject|0|||
124477681|NCT03538743|447702771|FG006|Overall Study|Withdrawal by Subject|0|||
124477682|NCT03538743|447702772|FG007|Overall Study|Withdrawal by Subject|0|||
124477683|NCT03538743|447702773|FG008|Overall Study|Withdrawal by Subject|0|||
124477684|NCT01827384|447702775|FG000|Overall Study|Switched to alternative treatment|0|||
124477685|NCT01827384|447702776|FG001|Overall Study|Switched to alternative treatment|0|||
124477686|NCT01827384|447702777|FG002|Overall Study|Switched to alternative treatment|0|||
124477687|NCT01827384|447702778|FG003|Overall Study|Switched to alternative treatment|0|||
124477688|NCT01827384|447702779|FG004|Overall Study|Switched to alternative treatment|0|||
124477689|NCT01827384|447702780|FG005|Overall Study|Switched to alternative treatment|0|||
124477690|NCT01827384|447702781|FG006|Overall Study|Switched to alternative treatment|0|||
124477691|NCT01827384|447702782|FG007|Overall Study|Switched to alternative treatment|0|||
124477692|NCT01827384|447702783|FG008|Overall Study|Switched to alternative treatment|0|||
124477693|NCT01827384|447702784|FG009|Overall Study|Switched to alternative treatment|0|||
124477694|NCT01827384|447702785|FG010|Overall Study|Switched to alternative treatment|0|||
124477695|NCT01827384|447702786|FG011|Overall Study|Switched to alternative treatment|0|||
124477696|NCT01827384|447702787|FG012|Overall Study|Switched to alternative treatment|0|||
124557037|NCT01078623|447997659|FG004|Treatment Period 4|Withdrawal by Subject|0|||
124557038|NCT01078623|447997660|FG005|Treatment Period 4|Withdrawal by Subject|0|||
124557039|NCT01078623|447997661|FG006|Treatment Period 4|Withdrawal by Subject|0|||
124477697|NCT01827384|447702788|FG013|Overall Study|Switched to alternative treatment|2|||
124477698|NCT01827384|447702775|FG000|Overall Study|Disease progression before treatment|0|||
124557040|NCT01078623|447997662|FG007|Treatment Period 4|Withdrawal by Subject|0|||
124477699|NCT01827384|447702776|FG001|Overall Study|Disease progression before treatment|0|||
124477700|NCT01827384|447702777|FG002|Overall Study|Disease progression before treatment|0|||
124477701|NCT01827384|447702778|FG003|Overall Study|Disease progression before treatment|0|||
124477702|NCT01827384|447702779|FG004|Overall Study|Disease progression before treatment|0|||
124477703|NCT01827384|447702780|FG005|Overall Study|Disease progression before treatment|0|||
124477704|NCT01827384|447702781|FG006|Overall Study|Disease progression before treatment|0|||
124477705|NCT01827384|447702782|FG007|Overall Study|Disease progression before treatment|0|||
124477706|NCT01827384|447702783|FG008|Overall Study|Disease progression before treatment|0|||
124477707|NCT01827384|447702784|FG009|Overall Study|Disease progression before treatment|0|||
124477708|NCT01827384|447702785|FG010|Overall Study|Disease progression before treatment|0|||
124477709|NCT01827384|447702786|FG011|Overall Study|Disease progression before treatment|0|||
124477710|NCT01827384|447702787|FG012|Overall Study|Disease progression before treatment|0|||
124477711|NCT01827384|447702788|FG013|Overall Study|Disease progression before treatment|4|||
124477712|NCT01827384|447702775|FG000|Overall Study|Ineligible|0|||
124477713|NCT01827384|447702776|FG001|Overall Study|Ineligible|0|||
124477714|NCT01827384|447702777|FG002|Overall Study|Ineligible|0|||
124477715|NCT01827384|447702778|FG003|Overall Study|Ineligible|0|||
124477716|NCT01827384|447702779|FG004|Overall Study|Ineligible|0|||
124477717|NCT01827384|447702780|FG005|Overall Study|Ineligible|0|||
124477718|NCT01827384|447702781|FG006|Overall Study|Ineligible|0|||
124477719|NCT01827384|447702782|FG007|Overall Study|Ineligible|0|||
124477720|NCT01827384|447702783|FG008|Overall Study|Ineligible|0|||
124477721|NCT01827384|447702784|FG009|Overall Study|Ineligible|0|||
124477722|NCT01827384|447702785|FG010|Overall Study|Ineligible|0|||
124477723|NCT01827384|447702786|FG011|Overall Study|Ineligible|0|||
124477724|NCT01827384|447702787|FG012|Overall Study|Ineligible|0|||
124477725|NCT01827384|447702788|FG013|Overall Study|Ineligible|19|||
124477726|NCT01827384|447702775|FG000|Overall Study|Participant died before treatment|0|||
124477727|NCT01827384|447702776|FG001|Overall Study|Participant died before treatment|0|||
124477728|NCT01827384|447702777|FG002|Overall Study|Participant died before treatment|0|||
124477729|NCT01827384|447702778|FG003|Overall Study|Participant died before treatment|0|||
124477730|NCT01827384|447702779|FG004|Overall Study|Participant died before treatment|0|||
124477731|NCT01827384|447702780|FG005|Overall Study|Participant died before treatment|0|||
124477732|NCT01827384|447702781|FG006|Overall Study|Participant died before treatment|0|||
124477733|NCT01827384|447702782|FG007|Overall Study|Participant died before treatment|0|||
124477734|NCT01827384|447702783|FG008|Overall Study|Participant died before treatment|0|||
124477735|NCT01827384|447702784|FG009|Overall Study|Participant died before treatment|0|||
124477736|NCT01827384|447702785|FG010|Overall Study|Participant died before treatment|0|||
124477737|NCT01827384|447702786|FG011|Overall Study|Participant died before treatment|0|||
124477738|NCT01827384|447702787|FG012|Overall Study|Participant died before treatment|0|||
124477739|NCT01827384|447702788|FG013|Overall Study|Participant died before treatment|5|||
124477740|NCT01827384|447702775|FG000|Overall Study|Insufficient tumor cells|0|||
124477741|NCT01827384|447702776|FG001|Overall Study|Insufficient tumor cells|0|||
124477742|NCT01827384|447702777|FG002|Overall Study|Insufficient tumor cells|0|||
124477743|NCT01827384|447702778|FG003|Overall Study|Insufficient tumor cells|0|||
124477744|NCT01827384|447702779|FG004|Overall Study|Insufficient tumor cells|0|||
124477745|NCT01827384|447702780|FG005|Overall Study|Insufficient tumor cells|0|||
124477746|NCT01827384|447702781|FG006|Overall Study|Insufficient tumor cells|0|||
124477747|NCT01827384|447702782|FG007|Overall Study|Insufficient tumor cells|0|||
124477748|NCT01827384|447702783|FG008|Overall Study|Insufficient tumor cells|0|||
124477749|NCT01827384|447702784|FG009|Overall Study|Insufficient tumor cells|0|||
124477750|NCT01827384|447702785|FG010|Overall Study|Insufficient tumor cells|0|||
124477751|NCT01827384|447702786|FG011|Overall Study|Insufficient tumor cells|0|||
124477752|NCT01827384|447702787|FG012|Overall Study|Insufficient tumor cells|0|||
124477753|NCT01827384|447702788|FG013|Overall Study|Insufficient tumor cells|13|||
124477754|NCT01827384|447702775|FG000|Overall Study|No actionable mutation|0|||
124477755|NCT01827384|447702776|FG001|Overall Study|No actionable mutation|0|||
124477756|NCT01827384|447702777|FG002|Overall Study|No actionable mutation|0|||
124477757|NCT01827384|447702778|FG003|Overall Study|No actionable mutation|0|||
124477758|NCT01827384|447702779|FG004|Overall Study|No actionable mutation|0|||
124477759|NCT01827384|447702780|FG005|Overall Study|No actionable mutation|0|||
124477760|NCT01827384|447702781|FG006|Overall Study|No actionable mutation|0|||
124477761|NCT01827384|447702782|FG007|Overall Study|No actionable mutation|0|||
124477762|NCT01827384|447702783|FG008|Overall Study|No actionable mutation|0|||
124477763|NCT01827384|447702784|FG009|Overall Study|No actionable mutation|0|||
124477764|NCT01827384|447702785|FG010|Overall Study|No actionable mutation|0|||
124477765|NCT01827384|447702786|FG011|Overall Study|No actionable mutation|0|||
124477766|NCT01827384|447702787|FG012|Overall Study|No actionable mutation|0|||
124477767|NCT01827384|447702788|FG013|Overall Study|No actionable mutation|73|||
124477768|NCT01827384|447702775|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
124477769|NCT01827384|447702776|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
124477770|NCT01827384|447702777|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
124557041|NCT01078623|447997663|FG008|Treatment Period 4|Withdrawal by Subject|0|||
124477771|NCT01827384|447702778|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
124477772|NCT01827384|447702779|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
124477773|NCT01827384|447702780|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
124477774|NCT01827384|447702781|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
124477775|NCT01827384|447702782|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
124477776|NCT01827384|447702783|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
124477777|NCT01827384|447702784|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
124477778|NCT01827384|447702785|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
124477779|NCT01827384|447702786|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
124477780|NCT01827384|447702787|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
124477781|NCT01827384|447702788|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
124477782|NCT03636906|447702795|FG000|Overall Study|Adverse Event|0|||
124477783|NCT03636906|447702796|FG001|Overall Study|Adverse Event|0|||
124477784|NCT03636906|447702797|FG002|Overall Study|Adverse Event|1|||
124477785|NCT03636906|447702795|FG000|Overall Study|Lost to Follow-up|1|||
124477786|NCT03636906|447702796|FG001|Overall Study|Lost to Follow-up|0|||
124477787|NCT03636906|447702797|FG002|Overall Study|Lost to Follow-up|0|||
124477788|NCT03636906|447702795|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
124477789|NCT03636906|447702796|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
124477790|NCT03636906|447702797|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
124477791|NCT03636906|447702795|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
124477792|NCT03636906|447702796|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
124477793|NCT03636906|447702797|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
124477794|NCT03636906|447702795|FG000|Overall Study|Other|0|||
124477795|NCT03636906|447702796|FG001|Overall Study|Other|0|||
124477796|NCT03636906|447702797|FG002|Overall Study|Other|1|||
124477797|NCT01291017|447702798|FG000|Overall Study|Lost to Follow-up|2|||
124477798|NCT01291017|447702798|FG000|Overall Study|Withdrawal by Subject|3|||
124477799|NCT03690869|447702800|FG000|Overall Study|Adverse Event|0|||
124477800|NCT03690869|447702801|FG001|Overall Study|Adverse Event|0|||
124477801|NCT03690869|447702802|FG002|Overall Study|Adverse Event|0|||
124477802|NCT03690869|447702803|FG003|Overall Study|Adverse Event|1|||
124477803|NCT03690869|447702804|FG004|Overall Study|Adverse Event|0|||
124477804|NCT03690869|447702805|FG005|Overall Study|Adverse Event|0|||
124477805|NCT03690869|447702806|FG006|Overall Study|Adverse Event|0|||
124477806|NCT03690869|447702807|FG007|Overall Study|Adverse Event|1|||
124477807|NCT03690869|447702808|FG008|Overall Study|Adverse Event|0|||
124477808|NCT03690869|447702809|FG009|Overall Study|Adverse Event|1|||
124477809|NCT03690869|447702800|FG000|Overall Study|Death|1|||
124477810|NCT03690869|447702801|FG001|Overall Study|Death|1|||
124477811|NCT03690869|447702802|FG002|Overall Study|Death|1|||
124477812|NCT03690869|447702803|FG003|Overall Study|Death|4|||
124477813|NCT03690869|447702804|FG004|Overall Study|Death|2|||
124477814|NCT03690869|447702805|FG005|Overall Study|Death|5|||
124477815|NCT03690869|447702806|FG006|Overall Study|Death|3|||
124477816|NCT03690869|447702807|FG007|Overall Study|Death|2|||
124477817|NCT03690869|447702808|FG008|Overall Study|Death|0|||
124477818|NCT03690869|447702809|FG009|Overall Study|Death|3|||
124477819|NCT03690869|447702800|FG000|Overall Study|Lost to Follow-up|0|||
124477820|NCT03690869|447702801|FG001|Overall Study|Lost to Follow-up|0|||
124477821|NCT03690869|447702802|FG002|Overall Study|Lost to Follow-up|1|||
124477822|NCT03690869|447702803|FG003|Overall Study|Lost to Follow-up|0|||
124477823|NCT03690869|447702804|FG004|Overall Study|Lost to Follow-up|0|||
124477824|NCT03690869|447702805|FG005|Overall Study|Lost to Follow-up|0|||
124477825|NCT03690869|447702806|FG006|Overall Study|Lost to Follow-up|0|||
124477826|NCT03690869|447702807|FG007|Overall Study|Lost to Follow-up|0|||
124477827|NCT03690869|447702808|FG008|Overall Study|Lost to Follow-up|0|||
124477828|NCT03690869|447702809|FG009|Overall Study|Lost to Follow-up|0|||
124477829|NCT03690869|447702800|FG000|Overall Study|Other Treatment|1|||
124477830|NCT03690869|447702801|FG001|Overall Study|Other Treatment|1|||
124477831|NCT03690869|447702802|FG002|Overall Study|Other Treatment|1|||
124477832|NCT03690869|447702803|FG003|Overall Study|Other Treatment|2|||
124477833|NCT03690869|447702804|FG004|Overall Study|Other Treatment|3|||
124477834|NCT03690869|447702805|FG005|Overall Study|Other Treatment|1|||
124477835|NCT03690869|447702806|FG006|Overall Study|Other Treatment|2|||
124477836|NCT03690869|447702807|FG007|Overall Study|Other Treatment|7|||
124477837|NCT03690869|447702808|FG008|Overall Study|Other Treatment|0|||
124477838|NCT03690869|447702809|FG009|Overall Study|Other Treatment|3|||
124477839|NCT03690869|447702800|FG000|Overall Study|Physician Decision|0|||
124477840|NCT03690869|447702801|FG001|Overall Study|Physician Decision|1|||
124477841|NCT03690869|447702802|FG002|Overall Study|Physician Decision|0|||
124477842|NCT03690869|447702803|FG003|Overall Study|Physician Decision|0|||
124477843|NCT03690869|447702804|FG004|Overall Study|Physician Decision|0|||
124477844|NCT03690869|447702805|FG005|Overall Study|Physician Decision|0|||
124477845|NCT03690869|447702806|FG006|Overall Study|Physician Decision|0|||
124477846|NCT03690869|447702807|FG007|Overall Study|Physician Decision|0|||
124477847|NCT03690869|447702808|FG008|Overall Study|Physician Decision|0|||
124477848|NCT03690869|447702809|FG009|Overall Study|Physician Decision|0|||
124477849|NCT03690869|447702800|FG000|Overall Study|Progressive Disease|1|||
124477850|NCT03690869|447702801|FG001|Overall Study|Progressive Disease|2|||
124477851|NCT03690869|447702802|FG002|Overall Study|Progressive Disease|0|||
124477852|NCT03690869|447702803|FG003|Overall Study|Progressive Disease|1|||
124477853|NCT03690869|447702804|FG004|Overall Study|Progressive Disease|0|||
124477854|NCT03690869|447702805|FG005|Overall Study|Progressive Disease|0|||
124477855|NCT03690869|447702806|FG006|Overall Study|Progressive Disease|0|||
124477856|NCT03690869|447702807|FG007|Overall Study|Progressive Disease|0|||
124477857|NCT03690869|447702808|FG008|Overall Study|Progressive Disease|1|||
124477858|NCT03690869|447702809|FG009|Overall Study|Progressive Disease|1|||
124557042|NCT01078623|447997664|FG009|Treatment Period 4|Withdrawal by Subject|0|||
124557043|NCT01078623|447997665|FG010|Treatment Period 4|Withdrawal by Subject|0|||
124557044|NCT01078623|447997666|FG011|Treatment Period 4|Withdrawal by Subject|0|||
124557045|NCT01078623|447997667|FG012|Treatment Period 4|Withdrawal by Subject|0|||
124557046|NCT01078623|447997668|FG013|Treatment Period 4|Withdrawal by Subject|0|||
124557047|NCT01078623|447997669|FG014|Treatment Period 4|Withdrawal by Subject|0|||
124557048|NCT01078623|447997670|FG015|Treatment Period 4|Withdrawal by Subject|1|||
124557049|NCT01078623|447997671|FG016|Treatment Period 4|Withdrawal by Subject|0|||
124557050|NCT01078623|447997672|FG017|Treatment Period 4|Withdrawal by Subject|0|||
124557051|NCT01078623|447997673|FG018|Treatment Period 4|Withdrawal by Subject|0|||
124557052|NCT01078623|447997674|FG019|Treatment Period 4|Withdrawal by Subject|0|||
124719589|NCT03162796|448594863|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
124477859|NCT03690869|447702800|FG000|Overall Study|Subject Decision|0|||
124477860|NCT03690869|447702801|FG001|Overall Study|Subject Decision|0|||
124719590|NCT03162796|448594864|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
124477861|NCT03690869|447702802|FG002|Overall Study|Subject Decision|0|||
124477862|NCT03690869|447702803|FG003|Overall Study|Subject Decision|1|||
124557053|NCT00623623|447997675|FG000|Overall Study|Previous enrolment into this study|1|||
124557054|NCT00623623|447997676|FG001|Overall Study|Previous enrolment into this study|1|||
124557055|NCT04356573|447997678|FG000|Overall Study|Didn't Qualify|1|||
124477863|NCT03690869|447702804|FG004|Overall Study|Subject Decision|0|||
124477864|NCT03690869|447702805|FG005|Overall Study|Subject Decision|0|||
124477865|NCT03690869|447702806|FG006|Overall Study|Subject Decision|0|||
124477866|NCT03690869|447702807|FG007|Overall Study|Subject Decision|1|||
124477867|NCT03690869|447702808|FG008|Overall Study|Subject Decision|0|||
124477868|NCT03690869|447702809|FG009|Overall Study|Subject Decision|0|||
124557056|NCT04356573|447997679|FG001|Overall Study|Didn't Qualify|0|||
124557057|NCT02424565|447997680|FG000|Period 1 (D0)|Protocol Violation|0|||
124557058|NCT02424565|447997681|FG001|Period 1 (D0)|Protocol Violation|1|||
124557059|NCT03568500|447997682|FG000|Overall Study|Lost to Follow-up|1|||
124557060|NCT03568500|447997683|FG001|Overall Study|Lost to Follow-up|1|||
124557061|NCT03568500|447997684|FG002|Overall Study|Lost to Follow-up|2|||
124557062|NCT03568500|447997682|FG000|Overall Study|Adverse Event|1|||
124557063|NCT03568500|447997683|FG001|Overall Study|Adverse Event|1|||
124557064|NCT03568500|447997684|FG002|Overall Study|Adverse Event|2|||
124557065|NCT03568500|447997682|FG000|Overall Study|Physician Decision|1|||
124557066|NCT03568500|447997683|FG001|Overall Study|Physician Decision|0|||
124557067|NCT03568500|447997684|FG002|Overall Study|Physician Decision|0|||
124557068|NCT03568500|447997682|FG000|Overall Study|Withdrawal by Subject|4|||
124557069|NCT03568500|447997683|FG001|Overall Study|Withdrawal by Subject|2|||
124557070|NCT03568500|447997684|FG002|Overall Study|Withdrawal by Subject|0|||
124557071|NCT03568500|447997682|FG000|Overall Study|Technical Problems|2|||
124557072|NCT03568500|447997683|FG001|Overall Study|Technical Problems|1|||
124557073|NCT03568500|447997684|FG002|Overall Study|Technical Problems|0|||
124557074|NCT03568500|447997682|FG000|Overall Study|Participant Noncompliance|1|||
124557075|NCT03568500|447997683|FG001|Overall Study|Participant Noncompliance|1|||
124557076|NCT03568500|447997684|FG002|Overall Study|Participant Noncompliance|0|||
124557077|NCT03650400|447997685|FG000|Overall Study|Study terminated by sponsor|0|||
124557078|NCT03650400|447997686|FG001|Overall Study|Study terminated by sponsor|5|||
124557079|NCT04132232|447997698|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
124557080|NCT04132232|447997699|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
124557081|NCT04132232|447997698|FG000|Overall Study|Lost to Follow-up|6|||
124557082|NCT04132232|447997699|FG001|Overall Study|Lost to Follow-up|7|||
124557083|NCT00368537|447997700|FG000|Randomization|No study drug dosed|13|||
124557084|NCT00368537|447997701|FG001|Randomization|No study drug dosed|6|||
124557085|NCT00368537|447997700|FG000|Baseline Participants|Lost to Follow-up|16|||
124557086|NCT00368537|447997701|FG001|Baseline Participants|Lost to Follow-up|17|||
124557087|NCT00368537|447997700|FG000|Baseline Participants|Withdrawal by Subject|6|||
124557088|NCT00368537|447997701|FG001|Baseline Participants|Withdrawal by Subject|4|||
124557089|NCT00368537|447997700|FG000|Baseline Participants|Death|1|||
124557090|NCT00368537|447997701|FG001|Baseline Participants|Death|2|||
124557091|NCT00368537|447997700|FG000|Baseline Participants|No susceptibility|1|||
124557092|NCT00368537|447997701|FG001|Baseline Participants|No susceptibility|0|||
124557093|NCT00368537|447997700|FG000|Baseline Participants|Patient uncompliant|0|||
124557094|NCT00368537|447997701|FG001|Baseline Participants|Patient uncompliant|1|||
124557095|NCT01368276|447997713|FG000|Overall Study|Death|1|||
124557096|NCT01368276|447997714|FG001|Overall Study|Death|10|||
124557097|NCT01427920|447997717|FG000|Overall Study|Adverse Event|1|||
124557098|NCT01427920|447997718|FG001|Overall Study|Adverse Event|2|||
124557099|NCT01427920|447997717|FG000|Overall Study|Lack of Efficacy|1|||
124557100|NCT01427920|447997718|FG001|Overall Study|Lack of Efficacy|0|||
124557101|NCT01427920|447997717|FG000|Overall Study|Protocol Violation|1|||
124557102|NCT01427920|447997718|FG001|Overall Study|Protocol Violation|3|||
124557103|NCT01427920|447997717|FG000|Overall Study|Withdrawal Criteria|4|||
124557104|NCT01427920|447997718|FG001|Overall Study|Withdrawal Criteria|4|||
124557105|NCT01427920|447997717|FG000|Overall Study|Unclassified|2|||
124557106|NCT01427920|447997718|FG001|Overall Study|Unclassified|8|||
124719591|NCT03162796|448594865|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
124719592|NCT03162796|448594863|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
124719593|NCT03162796|448594864|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
124719594|NCT03162796|448594865|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
124719595|NCT03162796|448594863|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
124719596|NCT03162796|448594864|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
124557107|NCT04228302|447997719|FG000|Overall Study|Adverse Event|0|||
124557108|NCT04228302|447997720|FG001|Overall Study|Adverse Event|0|||
124557109|NCT04228302|447997721|FG002|Overall Study|Adverse Event|0|||
124557110|NCT04228302|447997722|FG003|Overall Study|Adverse Event|0|||
124557111|NCT04228302|447997723|FG004|Overall Study|Adverse Event|1|||
124719597|NCT03162796|448594865|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
124719598|NCT03162796|448594863|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
124557112|NCT04228302|447997724|FG005|Overall Study|Adverse Event|0|||
124557113|NCT02732561|447997732|FG000|Overall Study|Lost to Follow-up|1|||
124557114|NCT02732561|447997733|FG001|Overall Study|Lost to Follow-up|1|||
124557115|NCT02732561|447997732|FG000|Overall Study|Withdrawal by Subject|1|||
124557116|NCT02732561|447997733|FG001|Overall Study|Withdrawal by Subject|0|||
124719599|NCT03162796|448594864|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
124477869|NCT01524991|447704832|FG000|Overall Study|Adverse Event|12|||
124477870|NCT01524991|447704832|FG000|Overall Study|Death|1|||
124477871|NCT01524991|447704832|FG000|Overall Study|Disease ProgressionDu|17|||
124477872|NCT01524991|447704832|FG000|Overall Study|Other complicating disease|1|||
124477873|NCT01524991|447704832|FG000|Overall Study|Withdrawal by Subject|2|||
124477874|NCT01524991|447704832|FG000|Overall Study|Symptomatic Deterioration|1|||
124477875|NCT01805180|447704835|FG000|Lead-in Donor Phase|screen failure|1|||
124477876|NCT01805180|447704836|FG001|Lead-in Donor Phase|screen failure|0|||
124477877|NCT01805180|447704837|FG002|Lead-in Donor Phase|screen failure|0|||
124477878|NCT00582556|447704839|FG000|Overall Study|Withdrawal by Subject|0|||
124477879|NCT00582556|447704840|FG001|Overall Study|Withdrawal by Subject|1|||
124477880|NCT00582556|447704841|FG002|Overall Study|Withdrawal by Subject|1|||
124477881|NCT00582556|447704839|FG000|Overall Study|Physician Decision|0|||
124477882|NCT00582556|447704840|FG001|Overall Study|Physician Decision|0|||
124477883|NCT00582556|447704841|FG002|Overall Study|Physician Decision|1|||
124477884|NCT03124459|447704842|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
124477885|NCT03124459|447704843|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
124477886|NCT03124459|447704844|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
124477887|NCT03124459|447704845|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
124477888|NCT03124459|447704846|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
124557117|NCT00837577|447997740|FG000|Double-blind Period|Clinical Adverse Event|1|||
124477889|NCT03124459|447704847|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
124477890|NCT03124459|447704842|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
124477891|NCT03124459|447704843|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
124477892|NCT03124459|447704844|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
124557118|NCT00837577|447997741|FG001|Double-blind Period|Clinical Adverse Event|0|||
124719600|NCT03162796|448594865|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
124477893|NCT03124459|447704845|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
124477894|NCT03124459|447704846|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
124477895|NCT03124459|447704847|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
124477896|NCT03124459|447704842|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
124719601|NCT03162796|448594863|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
124719602|NCT03162796|448594864|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
124719603|NCT03162796|448594865|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
124719604|NCT02473471|448594866|FG000|Overall Study|poor oral hygiene|2|||
124719605|NCT02473471|448594866|FG000|Overall Study|Lost to Follow-up|1|||
124719606|NCT02342288|448594869|FG000|Overall Study|no protocol anesthesiologist available|3|||
124719607|NCT02342288|448594870|FG001|Overall Study|no protocol anesthesiologist available|2|||
124719608|NCT02342288|448594869|FG000|Overall Study|anesthesia leak in system|1|||
124557119|NCT00837577|447997740|FG000|Double-blind Period|Withdrawal by Subject|1|||
124557120|NCT00837577|447997741|FG001|Double-blind Period|Withdrawal by Subject|0|||
124557121|NCT00837577|447997740|FG000|Open-label Period|Clinical Adverse Event|2|||
124557122|NCT00837577|447997741|FG001|Open-label Period|Clinical Adverse Event|2|||
124557123|NCT00837577|447997740|FG000|Open-label Period|Laboratory Adverse Event|0|||
124557124|NCT00837577|447997741|FG001|Open-label Period|Laboratory Adverse Event|1|||
124557125|NCT00837577|447997740|FG000|Open-label Period|Lack of Efficacy|4|||
124557126|NCT00837577|447997741|FG001|Open-label Period|Lack of Efficacy|3|||
124557127|NCT00837577|447997740|FG000|Open-label Period|Withdrawal by Subject|1|||
124557128|NCT00837577|447997741|FG001|Open-label Period|Withdrawal by Subject|2|||
124557129|NCT00837577|447997740|FG000|Open-label Period|Other Reason|1|||
124557130|NCT00837577|447997741|FG001|Open-label Period|Other Reason|1|||
124557131|NCT00475852|447997745|FG000|Overall Study|Death|444|||
124557132|NCT00475852|447997746|FG001|Overall Study|Death|456|||
124557133|NCT00475852|447997745|FG000|Overall Study|Withdrawal by Subject|19|||
124719609|NCT02342288|448594870|FG001|Overall Study|anesthesia leak in system|0|||
124719610|NCT02342288|448594869|FG000|Overall Study|Withdrawal by Subject|1|||
124719611|NCT02342288|448594870|FG001|Overall Study|Withdrawal by Subject|0|||
124557134|NCT00475852|447997746|FG001|Overall Study|Withdrawal by Subject|24|||
124557135|NCT00475852|447997745|FG000|Overall Study|Lost to Follow-up|54|||
124719612|NCT02342288|448594869|FG000|Overall Study|coordinator contaminated with blood|0|||
124719613|NCT02342288|448594870|FG001|Overall Study|coordinator contaminated with blood|1|||
124719614|NCT02342288|448594869|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
124719615|NCT02342288|448594870|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
124719616|NCT02342288|448594869|FG000|Overall Study|coordinator not available|0|||
124719617|NCT02342288|448594870|FG001|Overall Study|coordinator not available|2|||
124719618|NCT03082677|448594871|FG000|Overall Study|Not Treated|2|||
124557136|NCT00475852|447997746|FG001|Overall Study|Lost to Follow-up|68|||
124719619|NCT01916824|448594876|FG000|Overall Study|Lost to Follow-up|3|||
124719620|NCT01916824|448594877|FG001|Overall Study|Lost to Follow-up|6|||
124719621|NCT01916824|448594876|FG000|Overall Study|Physician Decision|2|||
124477897|NCT03124459|447704843|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
124477898|NCT03124459|447704844|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
124477899|NCT03124459|447704845|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
124477900|NCT03124459|447704846|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
124477901|NCT03124459|447704847|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
124477902|NCT03124459|447704842|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
124477903|NCT03124459|447704843|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
124477904|NCT03124459|447704844|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
124477905|NCT03124459|447704845|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
124477906|NCT03124459|447704846|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
124477907|NCT03124459|447704847|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
124477908|NCT03124459|447704842|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
124477909|NCT03124459|447704843|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
124477910|NCT03124459|447704844|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
124477911|NCT03124459|447704845|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
124477912|NCT03124459|447704846|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
124477913|NCT03124459|447704847|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
124477914|NCT03124459|447704842|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
124477915|NCT03124459|447704843|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
124477916|NCT03124459|447704844|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
124477917|NCT03124459|447704845|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
124477918|NCT03124459|447704846|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
124477919|NCT03124459|447704847|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
124477920|NCT01717638|447704850|FG000|Overall Study|Lost to Follow-up|0|||
124477921|NCT01717638|447704851|FG001|Overall Study|Lost to Follow-up|0|||
124477922|NCT01717638|447704852|FG002|Overall Study|Lost to Follow-up|0|||
124477923|NCT01717638|447704853|FG003|Overall Study|Lost to Follow-up|0|||
124477924|NCT01717638|447704854|FG004|Overall Study|Lost to Follow-up|0|||
124477925|NCT01717638|447704855|FG005|Overall Study|Lost to Follow-up|1|||
124477926|NCT01717638|447704856|FG006|Overall Study|Lost to Follow-up|0|||
124477927|NCT01717638|447704857|FG007|Overall Study|Lost to Follow-up|0|||
124719622|NCT01916824|448594877|FG001|Overall Study|Physician Decision|0|||
124477928|NCT01717638|447704858|FG008|Overall Study|Lost to Follow-up|0|||
124477929|NCT01717638|447704859|FG009|Overall Study|Lost to Follow-up|0|||
124477930|NCT01717638|447704860|FG010|Overall Study|Lost to Follow-up|0|||
124477931|NCT01717638|447704861|FG011|Overall Study|Lost to Follow-up|0|||
124477932|NCT01717638|447704862|FG012|Overall Study|Lost to Follow-up|0|||
124477933|NCT01717638|447704850|FG000|Overall Study|Father in hospital|0|||
124477934|NCT01717638|447704851|FG001|Overall Study|Father in hospital|0|||
124477935|NCT01717638|447704852|FG002|Overall Study|Father in hospital|0|||
124477936|NCT01717638|447704853|FG003|Overall Study|Father in hospital|0|||
124477937|NCT01717638|447704854|FG004|Overall Study|Father in hospital|0|||
124477938|NCT01717638|447704855|FG005|Overall Study|Father in hospital|0|||
124477939|NCT01717638|447704856|FG006|Overall Study|Father in hospital|0|||
124477940|NCT01717638|447704857|FG007|Overall Study|Father in hospital|0|||
124477941|NCT01717638|447704858|FG008|Overall Study|Father in hospital|0|||
124477942|NCT01717638|447704859|FG009|Overall Study|Father in hospital|0|||
124477943|NCT01717638|447704860|FG010|Overall Study|Father in hospital|0|||
124477944|NCT01717638|447704861|FG011|Overall Study|Father in hospital|0|||
124477945|NCT01717638|447704862|FG012|Overall Study|Father in hospital|1|||
124477946|NCT01717638|447704850|FG000|Overall Study|Withdrawal by Subject|0|||
124477947|NCT01717638|447704851|FG001|Overall Study|Withdrawal by Subject|1|||
124477948|NCT01717638|447704852|FG002|Overall Study|Withdrawal by Subject|1|||
124477949|NCT01717638|447704853|FG003|Overall Study|Withdrawal by Subject|0|||
124477950|NCT01717638|447704854|FG004|Overall Study|Withdrawal by Subject|1|||
124477951|NCT01717638|447704855|FG005|Overall Study|Withdrawal by Subject|0|||
124477952|NCT01717638|447704856|FG006|Overall Study|Withdrawal by Subject|2|||
124477953|NCT01717638|447704857|FG007|Overall Study|Withdrawal by Subject|1|||
124477954|NCT01717638|447704858|FG008|Overall Study|Withdrawal by Subject|2|||
124477955|NCT01717638|447704859|FG009|Overall Study|Withdrawal by Subject|1|||
124477956|NCT01717638|447704860|FG010|Overall Study|Withdrawal by Subject|0|||
124477957|NCT01717638|447704861|FG011|Overall Study|Withdrawal by Subject|0|||
124477958|NCT01717638|447704862|FG012|Overall Study|Withdrawal by Subject|18|||
124477959|NCT02300129|447704868|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
124477960|NCT02300129|447704869|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
124477961|NCT02300129|447704870|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
124477962|NCT02300129|447704871|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
124477963|NCT02300129|447704868|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
124477964|NCT02300129|447704869|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
124477965|NCT02300129|447704870|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
124477966|NCT02300129|447704871|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
124477967|NCT02300129|447704868|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
124477968|NCT02300129|447704869|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
124719623|NCT01916824|448594876|FG000|Overall Study|Withdrawal by Subject|2|||
124719624|NCT01916824|448594877|FG001|Overall Study|Withdrawal by Subject|3|||
124719625|NCT02063984|448594880|FG000|Overall Study|Lost to Follow-up|6|||
124719626|NCT02063984|448594881|FG001|Overall Study|Lost to Follow-up|5|||
124719627|NCT01169701|448594883|FG000|Overall Study|Lost to Follow-up|1|||
124719628|NCT01169701|448594884|FG001|Overall Study|Lost to Follow-up|1|||
124719629|NCT01169701|448594883|FG000|Overall Study|Withdrawal by Subject|1|||
124719630|NCT01169701|448594884|FG001|Overall Study|Withdrawal by Subject|3|||
124477969|NCT02300129|447704870|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
124477970|NCT02300129|447704871|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
124477971|NCT00522392|447704874|FG000|Overall Study|Disease progression|0|||
124477972|NCT00522392|447704875|FG001|Overall Study|Disease progression|3|||
124477973|NCT00522392|447704874|FG000|Overall Study|Adverse Event|7|||
124477974|NCT00522392|447704875|FG001|Overall Study|Adverse Event|7|||
124477975|NCT00522392|447704874|FG000|Overall Study|Withdrawal by Subject|1|||
124477976|NCT00522392|447704875|FG001|Overall Study|Withdrawal by Subject|1|||
124477977|NCT00522392|447704874|FG000|Overall Study|Physician Decision|0|||
124477978|NCT00522392|447704875|FG001|Overall Study|Physician Decision|1|||
124477979|NCT00522392|447704874|FG000|Overall Study|Non-compliance|0|||
124477980|NCT00522392|447704875|FG001|Overall Study|Non-compliance|1|||
124477981|NCT05211336|447704882|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
124477982|NCT05211336|447704883|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
124477983|NCT05211336|447704882|FG000|Overall Study|Progressive disease|0|||
124477984|NCT05211336|447704883|FG001|Overall Study|Progressive disease|4|||
124477985|NCT05211336|447704882|FG000|Overall Study|Death due to myocardial infarction|0|||
124477986|NCT05211336|447704883|FG001|Overall Study|Death due to myocardial infarction|1|||
124477987|NCT05211336|447704882|FG000|Overall Study|Death due to unknown cause|0|||
124477988|NCT05211336|447704883|FG001|Overall Study|Death due to unknown cause|1|||
124477989|NCT05211336|447704882|FG000|Overall Study|Worsening kidney function and quality of response|0|||
124477990|NCT05211336|447704883|FG001|Overall Study|Worsening kidney function and quality of response|1|||
124477991|NCT00332709|447704889|FG000|Overall Study|Adverse Event|11|||
124477992|NCT00332709|447704890|FG001|Overall Study|Adverse Event|14|||
124477993|NCT00332709|447704889|FG000|Overall Study|Withdrawal by Subject|2|||
124477994|NCT00332709|447704890|FG001|Overall Study|Withdrawal by Subject|3|||
124477995|NCT00332709|447704889|FG000|Overall Study|Lost to Follow-up|2|||
124477996|NCT00332709|447704890|FG001|Overall Study|Lost to Follow-up|0|||
124477997|NCT00332709|447704889|FG000|Overall Study|Administrative Problems|0|||
124477998|NCT00332709|447704890|FG001|Overall Study|Administrative Problems|3|||
124477999|NCT00332709|447704889|FG000|Overall Study|Abnormal test procedure result|1|||
124478000|NCT00332709|447704890|FG001|Overall Study|Abnormal test procedure result|0|||
124478001|NCT03575104|447704891|FG000|Overall Study|Adverse Event|4|||
124478002|NCT03575104|447704892|FG001|Overall Study|Adverse Event|3|||
124478003|NCT03575104|447704893|FG002|Overall Study|Adverse Event|4|||
124478004|NCT03575104|447704891|FG000|Overall Study|Withdrawal by Subject|13|||
124478005|NCT03575104|447704892|FG001|Overall Study|Withdrawal by Subject|16|||
124478006|NCT03575104|447704893|FG002|Overall Study|Withdrawal by Subject|11|||
124478007|NCT03575104|447704891|FG000|Overall Study|Other reasons|6|||
124478008|NCT03575104|447704892|FG001|Overall Study|Other reasons|8|||
124478009|NCT03575104|447704893|FG002|Overall Study|Other reasons|6|||
124478010|NCT03575104|447704891|FG000|Overall Study|Lost to Follow-up|1|||
124478011|NCT03575104|447704892|FG001|Overall Study|Lost to Follow-up|2|||
124478012|NCT03575104|447704893|FG002|Overall Study|Lost to Follow-up|1|||
124478013|NCT01409928|447704895|FG000|Overall Study|Physician Decision|12|||
124478014|NCT00432237|447704898|FG000|Overall Study|Adverse Event|0|||
124478015|NCT00432237|447704899|FG001|Overall Study|Adverse Event|0|||
124478016|NCT00432237|447704900|FG002|Overall Study|Adverse Event|0|||
124478017|NCT00432237|447704901|FG003|Overall Study|Adverse Event|1|||
124478018|NCT00432237|447704898|FG000|Overall Study|Lack of Efficacy|0|||
124478019|NCT00432237|447704899|FG001|Overall Study|Lack of Efficacy|0|||
124478020|NCT00432237|447704900|FG002|Overall Study|Lack of Efficacy|0|||
124719631|NCT01169701|448594883|FG000|Overall Study|Adverse Event|1|||
124719632|NCT01169701|448594884|FG001|Overall Study|Adverse Event|2|||
124719633|NCT01169701|448594883|FG000|Overall Study|Exclusion criteria|2|||
124478021|NCT00432237|447704901|FG003|Overall Study|Lack of Efficacy|1|||
124478022|NCT00432237|447704898|FG000|Overall Study|Lost to Follow-up|10|||
124478023|NCT00432237|447704899|FG001|Overall Study|Lost to Follow-up|10|||
124478024|NCT00432237|447704900|FG002|Overall Study|Lost to Follow-up|18|||
124478025|NCT00432237|447704901|FG003|Overall Study|Lost to Follow-up|18|||
124719634|NCT01169701|448594884|FG001|Overall Study|Exclusion criteria|0|||
124478026|NCT00432237|447704898|FG000|Overall Study|Physician Decision|1|||
124478027|NCT00432237|447704899|FG001|Overall Study|Physician Decision|3|||
124478028|NCT00432237|447704900|FG002|Overall Study|Physician Decision|2|||
124478029|NCT00432237|447704901|FG003|Overall Study|Physician Decision|1|||
124478030|NCT00432237|447704898|FG000|Overall Study|Pregnancy|0|||
124478031|NCT00432237|447704899|FG001|Overall Study|Pregnancy|1|||
124478032|NCT00432237|447704900|FG002|Overall Study|Pregnancy|0|||
124478033|NCT00432237|447704901|FG003|Overall Study|Pregnancy|0|||
124478034|NCT00432237|447704898|FG000|Overall Study|Protocol Violation|13|||
124478035|NCT00432237|447704899|FG001|Overall Study|Protocol Violation|10|||
124478036|NCT00432237|447704900|FG002|Overall Study|Protocol Violation|11|||
124478037|NCT00432237|447704901|FG003|Overall Study|Protocol Violation|8|||
124478038|NCT00432237|447704898|FG000|Overall Study|Withdrawal by Subject|5|||
124478039|NCT00432237|447704899|FG001|Overall Study|Withdrawal by Subject|6|||
124478040|NCT00432237|447704900|FG002|Overall Study|Withdrawal by Subject|9|||
124478041|NCT00432237|447704901|FG003|Overall Study|Withdrawal by Subject|11|||
124478042|NCT00432237|447704898|FG000|Overall Study|Lack of Qualifying Event|38|||
124478043|NCT00432237|447704899|FG001|Overall Study|Lack of Qualifying Event|71|||
124478044|NCT00432237|447704900|FG002|Overall Study|Lack of Qualifying Event|69|||
124478045|NCT00432237|447704901|FG003|Overall Study|Lack of Qualifying Event|84|||
124478046|NCT01354132|447704902|FG000|Randomization|Physician Decision|1|||
124478047|NCT01354132|447704903|FG001|Randomization|Physician Decision|0|||
124478048|NCT01354132|447704902|FG000|Randomization|Withdrawal by Subject|0|||
124478049|NCT01354132|447704903|FG001|Randomization|Withdrawal by Subject|1|||
124478050|NCT01354132|447704902|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
124478051|NCT01354132|447704903|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
124478052|NCT01354132|447704902|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
124478053|NCT01354132|447704903|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
124478054|NCT01354132|447704902|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
124478055|NCT01354132|447704903|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
124478056|NCT00603239|447704904|FG000|Overall Study|Adverse Event|4|||
124478057|NCT00603239|447704905|FG001|Overall Study|Adverse Event|1|||
124478058|NCT00603239|447704904|FG000|Overall Study|Entry criteria not met|0|||
124478059|NCT00603239|447704905|FG001|Overall Study|Entry criteria not met|1|||
124557137|NCT00272961|447997747|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
124557138|NCT00272961|447997748|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
124478060|NCT00603239|447704904|FG000|Overall Study|Loss of glucose control|3|||
124557139|NCT00272961|447997749|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
124719635|NCT01169701|448594883|FG000|Overall Study|Death|0|||
124719636|NCT01169701|448594884|FG001|Overall Study|Death|1|||
124478061|NCT00603239|447704905|FG001|Overall Study|Loss of glucose control|0|||
124478062|NCT00603239|447704904|FG000|Overall Study|Lost to Follow-up|2|||
124478063|NCT00603239|447704905|FG001|Overall Study|Lost to Follow-up|1|||
124478064|NCT00603239|447704904|FG000|Overall Study|Physician Decision|2|||
124478065|NCT00603239|447704905|FG001|Overall Study|Physician Decision|0|||
124478066|NCT00603239|447704904|FG000|Overall Study|Protocol Violation|2|||
124478067|NCT00603239|447704905|FG001|Overall Study|Protocol Violation|0|||
124478068|NCT00603239|447704904|FG000|Overall Study|Subject decision|2|||
124719637|NCT01169701|448594883|FG000|Overall Study|Administrative problems|0|||
124557140|NCT00272961|447997750|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
124557141|NCT00272961|447997751|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
124557142|NCT00272961|447997747|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
124557143|NCT00272961|447997748|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
124557144|NCT00272961|447997749|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
124557145|NCT00272961|447997750|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
124557146|NCT00272961|447997751|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
124557147|NCT00272961|447997747|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
124557148|NCT00272961|447997748|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
124557149|NCT00272961|447997749|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
124557150|NCT00272961|447997750|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
124557151|NCT00272961|447997751|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
124557152|NCT00272961|447997747|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
124478069|NCT00603239|447704905|FG001|Overall Study|Subject decision|1|||
124478070|NCT00191854|447704906|FG000|Overall Study|Death|26|||
124478071|NCT00191854|447704907|FG001|Overall Study|Death|23|||
124478072|NCT00191854|447704908|FG002|Overall Study|Death|29|||
124478073|NCT00191854|447704906|FG000|Overall Study|Lost to Follow-up|7|||
124478074|NCT00191854|447704907|FG001|Overall Study|Lost to Follow-up|5|||
124478075|NCT00191854|447704908|FG002|Overall Study|Lost to Follow-up|5|||
124478076|NCT00191854|447704906|FG000|Overall Study|Withdrawal by Subject|4|||
124478077|NCT00191854|447704907|FG001|Overall Study|Withdrawal by Subject|2|||
124478078|NCT00191854|447704908|FG002|Overall Study|Withdrawal by Subject|3|||
124478079|NCT00191854|447704906|FG000|Overall Study|Sponsor Decision|0|||
124478080|NCT00191854|447704907|FG001|Overall Study|Sponsor Decision|0|||
124478081|NCT00191854|447704908|FG002|Overall Study|Sponsor Decision|1|||
124478082|NCT00191854|447704906|FG000|Overall Study|Screen Failure|0|||
124478083|NCT00191854|447704907|FG001|Overall Study|Screen Failure|0|||
124478084|NCT00191854|447704908|FG002|Overall Study|Screen Failure|1|||
124478085|NCT00862251|447704910|FG000|Overall Study|Adverse Event|8|||
124478086|NCT00862251|447704911|FG001|Overall Study|Adverse Event|3|||
124478087|NCT00862251|447704912|FG002|Overall Study|Adverse Event|1|||
124478088|NCT00862251|447704910|FG000|Overall Study|Lost to Follow-up|0|||
124478089|NCT00862251|447704911|FG001|Overall Study|Lost to Follow-up|0|||
124478090|NCT00862251|447704912|FG002|Overall Study|Lost to Follow-up|1|||
124478091|NCT00862251|447704910|FG000|Overall Study|Protocol Violation|2|||
124478092|NCT00862251|447704911|FG001|Overall Study|Protocol Violation|0|||
124478093|NCT00862251|447704912|FG002|Overall Study|Protocol Violation|1|||
124478094|NCT00862251|447704910|FG000|Overall Study|Withdrawal by Subject|9|||
124478095|NCT00862251|447704911|FG001|Overall Study|Withdrawal by Subject|2|||
124478096|NCT00862251|447704912|FG002|Overall Study|Withdrawal by Subject|6|||
124478097|NCT01756274|447704919|FG000|Overall Study|Protocol Violation|2|||
124478098|NCT01756274|447704919|FG000|Overall Study|Laboratory error|1|||
124478099|NCT01147926|447704920|FG000|Overall Study|Subject Withdrew Consent|9|||
124478100|NCT01147926|447704921|FG001|Overall Study|Subject Withdrew Consent|10|||
124478101|NCT01147926|447704920|FG000|Overall Study|Adverse Event|7|||
124478102|NCT01147926|447704921|FG001|Overall Study|Adverse Event|6|||
124478103|NCT01147926|447704920|FG000|Overall Study|Subject Non-Compliant|5|||
124478104|NCT01147926|447704921|FG001|Overall Study|Subject Non-Compliant|4|||
124478105|NCT01147926|447704920|FG000|Overall Study|Principal investigator left hospital|1|||
124478106|NCT01147926|447704921|FG001|Overall Study|Principal investigator left hospital|3|||
124478107|NCT01147926|447704920|FG000|Overall Study|Selection criteria not met|3|||
124478108|NCT01147926|447704921|FG001|Overall Study|Selection criteria not met|1|||
124478109|NCT01147926|447704920|FG000|Overall Study|Lost to Follow-up|0|||
124478110|NCT01147926|447704921|FG001|Overall Study|Lost to Follow-up|2|||
124478111|NCT01147926|447704920|FG000|Overall Study|Sponsor's Decision|0|||
124478112|NCT01147926|447704921|FG001|Overall Study|Sponsor's Decision|1|||
124478113|NCT01147926|447704920|FG000|Overall Study|Lack of Efficacy|1|||
124478114|NCT01147926|447704921|FG001|Overall Study|Lack of Efficacy|0|||
124478115|NCT01147926|447704920|FG000|Overall Study|Too busy, no time for study|1|||
124478116|NCT01147926|447704921|FG001|Overall Study|Too busy, no time for study|0|||
124478117|NCT01147926|447704920|FG000|Overall Study|Went on holiday|0|||
124478118|NCT01147926|447704921|FG001|Overall Study|Went on holiday|1|||
124478119|NCT01147926|447704920|FG000|Overall Study|Colonoscopy result|0|||
124478120|NCT01147926|447704921|FG001|Overall Study|Colonoscopy result|1|||
124478121|NCT03417440|447704922|FG000|Overall Study|Lost to Follow-up|0|||
124478122|NCT03417440|447704923|FG001|Overall Study|Lost to Follow-up|1|||
124478123|NCT03417440|447704924|FG002|Overall Study|Lost to Follow-up|0|||
124478124|NCT03417440|447704925|FG003|Overall Study|Lost to Follow-up|0|||
124478125|NCT03417440|447704926|FG004|Overall Study|Lost to Follow-up|1|||
124478126|NCT03417440|447704927|FG005|Overall Study|Lost to Follow-up|0|||
124478127|NCT03417440|447704928|FG006|Overall Study|Lost to Follow-up|0|||
124478128|NCT03417440|447704929|FG007|Overall Study|Lost to Follow-up|0|||
124478129|NCT03417440|447704922|FG000|Overall Study|Withdrawal by Subject|2|||
124478130|NCT03417440|447704923|FG001|Overall Study|Withdrawal by Subject|0|||
124478131|NCT03417440|447704924|FG002|Overall Study|Withdrawal by Subject|2|||
124478132|NCT03417440|447704925|FG003|Overall Study|Withdrawal by Subject|1|||
124478133|NCT03417440|447704926|FG004|Overall Study|Withdrawal by Subject|1|||
124478134|NCT03417440|447704927|FG005|Overall Study|Withdrawal by Subject|0|||
124478135|NCT03417440|447704928|FG006|Overall Study|Withdrawal by Subject|0|||
124478136|NCT03417440|447704929|FG007|Overall Study|Withdrawal by Subject|1|||
124478137|NCT03304522|447704935|FG000|Overall Study|Adverse Event|0|||
124478138|NCT03304522|447704936|FG001|Overall Study|Adverse Event|4|||
124478139|NCT03304522|447704935|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
124478140|NCT03304522|447704936|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
124478141|NCT03304522|447704935|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
124478142|NCT03304522|447704936|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
124478143|NCT03304522|447704935|FG000|Overall Study|Other|0|||
124478144|NCT03304522|447704936|FG001|Overall Study|Other|1|||
124478145|NCT00486603|447704937|FG000|Overall Study|Withdrawal by Subject|1|||
124478146|NCT00486603|447704938|FG001|Overall Study|Withdrawal by Subject|0|||
124478147|NCT00486603|447704939|FG002|Overall Study|Withdrawal by Subject|0|||
124478148|NCT00486603|447704940|FG003|Overall Study|Withdrawal by Subject|0|||
124478149|NCT00486603|447704941|FG004|Overall Study|Withdrawal by Subject|0|||
124478150|NCT00486603|447704937|FG000|Overall Study|Physician Decision|0|||
124478151|NCT00486603|447704938|FG001|Overall Study|Physician Decision|1|||
124478152|NCT00486603|447704939|FG002|Overall Study|Physician Decision|0|||
124478153|NCT00486603|447704940|FG003|Overall Study|Physician Decision|0|||
124478154|NCT00486603|447704941|FG004|Overall Study|Physician Decision|0|||
124478155|NCT01670994|447704942|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
124478156|NCT01670994|447704943|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
124478157|NCT01670994|447704942|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
124478158|NCT01670994|447704943|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
124478159|NCT01670994|447704942|FG000|Overall Study|Patient experienced DLT|0|||
124478160|NCT01670994|447704943|FG001|Overall Study|Patient experienced DLT|1|||
124478161|NCT02013544|447704944|FG000|Overall Study|Adverse Event|5|||
124478162|NCT02013544|447704945|FG001|Overall Study|Adverse Event|5|||
124478163|NCT02013544|447704944|FG000|Overall Study|Lost to Follow-up|2|||
124478164|NCT02013544|447704945|FG001|Overall Study|Lost to Follow-up|3|||
124478165|NCT02013544|447704944|FG000|Overall Study|Withdrawal by Subject|2|||
124478166|NCT02013544|447704945|FG001|Overall Study|Withdrawal by Subject|8|||
124478167|NCT02013544|447704944|FG000|Overall Study|Physician Decision|0|||
124478168|NCT02013544|447704945|FG001|Overall Study|Physician Decision|1|||
124478169|NCT02013544|447704944|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
124478170|NCT02013544|447704945|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
124478171|NCT01295125|447704946|FG000|Overall Study|Study stopped prematurely|9|||
124478172|NCT00885365|447704949|FG000|4 Weeks ON Treatment|Adverse Event|2|||
124478173|NCT00885365|447704950|FG001|4 Weeks ON Treatment|Adverse Event|4|||
124478174|NCT00885365|447704949|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
124478175|NCT00885365|447704950|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
124478176|NCT00885365|447704949|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
124478177|NCT00885365|447704950|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
124478178|NCT01824979|447704951|FG000|Overall Study|Withdrawal by Subject|5|||
124478179|NCT01824979|447704952|FG001|Overall Study|Withdrawal by Subject|0|||
124478180|NCT01824979|447704951|FG000|Overall Study|Physician Decision|2|||
124478181|NCT01824979|447704952|FG001|Overall Study|Physician Decision|0|||
124478182|NCT01824979|447704951|FG000|Overall Study|Protocol Violation|6|||
124478183|NCT01824979|447704952|FG001|Overall Study|Protocol Violation|13|||
124478184|NCT02507349|447704954|FG000|Overall Study|Death|12|||
124478185|NCT02507349|447704955|FG001|Overall Study|Death|16|||
124478186|NCT02507349|447704954|FG000|Overall Study|Withdrawal by Subject|1|||
124478187|NCT02507349|447704955|FG001|Overall Study|Withdrawal by Subject|1|||
124478188|NCT02507349|447704954|FG000|Overall Study|Lost to Follow-up|174|||
124478189|NCT02507349|447704955|FG001|Overall Study|Lost to Follow-up|144|||
124478190|NCT00888238|447704956|FG000|Washout Period After Period 2|Adverse Event|0|||
124478191|NCT00888238|447704957|FG001|Washout Period After Period 2|Adverse Event|0|||
124478192|NCT00888238|447704958|FG002|Washout Period After Period 2|Adverse Event|1|||
124478193|NCT03371355|447704969|FG000|Overall Study|Investigator judgment|0|||
124478194|NCT03371355|447704970|FG001|Overall Study|Investigator judgment|0|||
124478195|NCT03371355|447704971|FG002|Overall Study|Investigator judgment|1|||
124478196|NCT03371355|447704972|FG003|Overall Study|Investigator judgment|1|||
124478197|NCT03371355|447704969|FG000|Overall Study|Voluntary withdrawal|1|||
124478198|NCT03371355|447704970|FG001|Overall Study|Voluntary withdrawal|0|||
124478199|NCT03371355|447704971|FG002|Overall Study|Voluntary withdrawal|1|||
124478200|NCT03371355|447704972|FG003|Overall Study|Voluntary withdrawal|2|||
124478201|NCT03371355|447704969|FG000|Overall Study|Adverse Event|0|||
124478202|NCT03371355|447704970|FG001|Overall Study|Adverse Event|1|||
124478203|NCT03371355|447704971|FG002|Overall Study|Adverse Event|2|||
124478204|NCT03371355|447704972|FG003|Overall Study|Adverse Event|3|||
124478205|NCT03371355|447704969|FG000|Overall Study|Reason not Specified|0|||
124478206|NCT03371355|447704970|FG001|Overall Study|Reason not Specified|1|||
124478207|NCT03371355|447704971|FG002|Overall Study|Reason not Specified|0|||
124478208|NCT03371355|447704972|FG003|Overall Study|Reason not Specified|1|||
124478209|NCT00977470|447704975|FG000|Overall Study|Lack of Efficacy|32|||
124478210|NCT00977470|447704976|FG001|Overall Study|Lack of Efficacy|30|||
124478211|NCT00977470|447704975|FG000|Overall Study|Physician Decision|2|||
124478212|NCT00977470|447704976|FG001|Overall Study|Physician Decision|0|||
124478213|NCT00977470|447704975|FG000|Overall Study|Adverse Event|1|||
124478214|NCT00977470|447704976|FG001|Overall Study|Adverse Event|2|||
124478215|NCT00977470|447704975|FG000|Overall Study|Protocol Violation|1|||
124478216|NCT00977470|447704976|FG001|Overall Study|Protocol Violation|0|||
124478217|NCT00977470|447704975|FG000|Overall Study|Withdrawal by Subject|0|||
124478218|NCT00977470|447704976|FG001|Overall Study|Withdrawal by Subject|2|||
124478219|NCT00977470|447704975|FG000|Overall Study|Death|0|||
124478220|NCT00977470|447704976|FG001|Overall Study|Death|2|||
124478221|NCT00977470|447704975|FG000|Overall Study|clinical decline|0|||
124478222|NCT00977470|447704976|FG001|Overall Study|clinical decline|1|||
124478223|NCT00977470|447704975|FG000|Overall Study|prolonged recovery post-surgery|0|||
124478224|NCT00977470|447704976|FG001|Overall Study|prolonged recovery post-surgery|1|||
124478225|NCT00977470|447704975|FG000|Overall Study|Still on-study|2|||
124478226|NCT00977470|447704976|FG001|Overall Study|Still on-study|0|||
124478227|NCT01818297|447704985|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
124478228|NCT01818297|447704986|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
124478229|NCT01818297|447704985|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
124557153|NCT00272961|447997748|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
124557154|NCT00272961|447997749|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
124478230|NCT01818297|447704986|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
124557155|NCT00272961|447997750|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
124557156|NCT00272961|447997751|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
124557157|NCT00272961|447997747|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
124557158|NCT00272961|447997748|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
124557159|NCT00272961|447997749|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
124557160|NCT00272961|447997750|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
124557161|NCT00272961|447997751|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
124557162|NCT00272961|447997747|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
124557163|NCT00272961|447997748|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
124557164|NCT00272961|447997749|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
124478231|NCT01818297|447704985|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
124478232|NCT01818297|447704986|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
124478233|NCT03529409|447704990|FG000|Randomized|Lost to Follow-up|0|||
124478234|NCT03529409|447704991|FG001|Randomized|Lost to Follow-up|0|||
124478235|NCT03529409|447704992|FG002|Randomized|Lost to Follow-up|4|||
124478236|NCT03529409|447704990|FG000|Randomized|Excluded|0|||
124478237|NCT03529409|447704991|FG001|Randomized|Excluded|0|||
124478238|NCT03529409|447704992|FG002|Randomized|Excluded|1|||
124478239|NCT03529409|447704990|FG000|Post-treatment Assessment|Death|1|||
124478240|NCT03529409|447704991|FG001|Post-treatment Assessment|Death|0|||
124719638|NCT01169701|448594884|FG001|Overall Study|Administrative problems|1|||
124719639|NCT01169701|448594883|FG000|Overall Study|Serious adverse event|0|||
124478241|NCT03529409|447704992|FG002|Post-treatment Assessment|Death|0|||
124478242|NCT03529409|447704990|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
124478243|NCT03529409|447704991|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
124719640|NCT01169701|448594884|FG001|Overall Study|Serious adverse event|1|||
124478244|NCT03529409|447704992|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
124478245|NCT03529409|447704990|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
124719641|NCT01169701|448594883|FG000|Overall Study|Sponsor decision|0|||
124719642|NCT01169701|448594884|FG001|Overall Study|Sponsor decision|1|||
124719643|NCT02455336|448594887|FG000|Overall Study|Withdrawal by Subject|0|||
124719644|NCT02455336|448594888|FG001|Overall Study|Withdrawal by Subject|2|||
124719645|NCT02455336|448594887|FG000|Overall Study|Adverse Event|3|||
124719646|NCT02455336|448594888|FG001|Overall Study|Adverse Event|0|||
124719647|NCT02455336|448594887|FG000|Overall Study|Non-responder to treatment|2|||
124719648|NCT02455336|448594888|FG001|Overall Study|Non-responder to treatment|0|||
124719649|NCT02467192|448594891|FG000|Overall Study|Death|1|||
124719650|NCT02467192|448594891|FG000|Overall Study|revealed to have pneumonia before|2|||
124719651|NCT01814046|448594893|FG000|Drug Administration|Death due to complications of RSV|1|||
124719652|NCT01814046|448594894|FG001|Drug Administration|Death due to complications of RSV|0|||
124719653|NCT01814046|448594895|FG002|Drug Administration|Death due to complications of RSV|0|||
124719654|NCT03089047|448594896|FG000|Overall Study|Lost to Follow-up|1|||
124719655|NCT03089047|448594897|FG001|Overall Study|Lost to Follow-up|0|||
124719656|NCT02517398|448594898|FG000|Overall Study|Death|2|||
124719657|NCT02517398|448594899|FG001|Overall Study|Death|3|||
124719658|NCT02517398|448594900|FG002|Overall Study|Death|4|||
124557165|NCT00272961|447997750|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
124719659|NCT02517398|448594901|FG003|Overall Study|Death|2|||
124719660|NCT02517398|448594902|FG004|Overall Study|Death|3|||
124719661|NCT02517398|448594903|FG005|Overall Study|Death|8|||
124719662|NCT02517398|448594904|FG006|Overall Study|Death|3|||
124719663|NCT02517398|448594905|FG007|Overall Study|Death|2|||
124557166|NCT00272961|447997751|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
124557167|NCT00272961|447997747|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
124557168|NCT00272961|447997748|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
124557169|NCT00272961|447997749|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
124557170|NCT00272961|447997750|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
124557171|NCT00272961|447997751|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
124557172|NCT00272961|447997747|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
124557173|NCT00272961|447997748|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
124557174|NCT00272961|447997749|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
124557175|NCT00272961|447997750|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
124557176|NCT00272961|447997751|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
124557177|NCT02065791|447997752|FG000|Overall Study|Closed Site|1|||
124557178|NCT02065791|447997753|FG001|Overall Study|Closed Site|1|||
124557179|NCT02065791|447997752|FG000|Overall Study|Withdrawal by Subject|11|||
124557180|NCT02065791|447997753|FG001|Overall Study|Withdrawal by Subject|5|||
124557181|NCT02065791|447997752|FG000|Overall Study|Lost to Follow-up|13|||
124557182|NCT02065791|447997753|FG001|Overall Study|Lost to Follow-up|9|||
124719664|NCT02517398|448594906|FG008|Overall Study|Death|6|||
124719665|NCT02517398|448594907|FG009|Overall Study|Death|24|||
124719666|NCT02517398|448594908|FG010|Overall Study|Death|53|||
124719667|NCT02517398|448594909|FG011|Overall Study|Death|25|||
124719668|NCT02517398|448594910|FG012|Overall Study|Death|73|||
124478246|NCT03529409|447704991|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
124478247|NCT03529409|447704992|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
124478248|NCT03529409|447704990|FG000|Follow-up Assessment|Death|1|||
124478249|NCT03529409|447704991|FG001|Follow-up Assessment|Death|0|||
124478250|NCT03529409|447704992|FG002|Follow-up Assessment|Death|0|||
124478251|NCT03529409|447704990|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
124478252|NCT03529409|447704991|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
124478253|NCT03529409|447704992|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
124478254|NCT01412229|447704993|FG000|Overall Study|Physician Decision|1|||
124478255|NCT01889602|447704994|FG000|First Intervention|Adverse Event|1|||
124478256|NCT01889602|447704995|FG001|First Intervention|Adverse Event|1|||
124478257|NCT01889602|447704996|FG002|First Intervention|Adverse Event|1|||
124478258|NCT01889602|447704994|FG000|First Intervention|Protocol Violation|0|||
124478259|NCT01889602|447704995|FG001|First Intervention|Protocol Violation|1|||
124478260|NCT01889602|447704996|FG002|First Intervention|Protocol Violation|1|||
124478261|NCT01889602|447704994|FG000|First Intervention|Study ending|0|||
124478262|NCT01889602|447704995|FG001|First Intervention|Study ending|1|||
124478263|NCT01889602|447704996|FG002|First Intervention|Study ending|0|||
124478264|NCT01889602|447704994|FG000|Second Intervention|Adverse Event|0|||
124478265|NCT01889602|447704995|FG001|Second Intervention|Adverse Event|0|||
124478266|NCT01889602|447704996|FG002|Second Intervention|Adverse Event|1|||
124478267|NCT01889602|447704994|FG000|Second Intervention|Study ending|1|||
124478268|NCT01889602|447704995|FG001|Second Intervention|Study ending|0|||
124478269|NCT01889602|447704996|FG002|Second Intervention|Study ending|0|||
124478270|NCT01889602|447704994|FG000|Second Intervention|Withdrawal by Subject|0|||
124478271|NCT01889602|447704995|FG001|Second Intervention|Withdrawal by Subject|0|||
124478272|NCT01889602|447704996|FG002|Second Intervention|Withdrawal by Subject|1|||
124478273|NCT01889602|447704994|FG000|Third Intervention|Protocol Violation|1|||
124478274|NCT01889602|447704995|FG001|Third Intervention|Protocol Violation|0|||
124478275|NCT01889602|447704996|FG002|Third Intervention|Protocol Violation|0|||
124478276|NCT01889602|447704994|FG000|Third Intervention|Withdrawal by Subject|2|||
124478277|NCT01889602|447704995|FG001|Third Intervention|Withdrawal by Subject|2|||
124478278|NCT01889602|447704996|FG002|Third Intervention|Withdrawal by Subject|0|||
124478279|NCT00591734|447704999|FG000|Overall Study|Lack of Efficacy|35|||
124478280|NCT00591734|447704999|FG000|Overall Study|Adverse Event|5|||
124478281|NCT00591734|447704999|FG000|Overall Study|Physician Decision|5|||
124478282|NCT00591734|447704999|FG000|Overall Study|Intercurrent Illness|8|||
124478283|NCT04752384|447705000|FG000|Overall Study|Withdrawal by Subject|1|||
124478284|NCT04752384|447705000|FG000|Overall Study|Death|1|||
124478285|NCT01955707|447705002|FG000|Overall Study|Adverse Event|1|||
124478286|NCT01955707|447705003|FG001|Overall Study|Adverse Event|2|||
124478287|NCT01955707|447705002|FG000|Overall Study|Lost to Follow-up|2|||
124478288|NCT01955707|447705003|FG001|Overall Study|Lost to Follow-up|1|||
124478289|NCT01955707|447705002|FG000|Overall Study|Withdrawal by Subject|0|||
124478290|NCT01955707|447705003|FG001|Overall Study|Withdrawal by Subject|3|||
124478291|NCT01955707|447705002|FG000|Overall Study|Death|13|||
124771702|NCT03873116|448794553|FG004|Part 1|Study drug discontinuation due to rash|0|||
124478292|NCT01955707|447705003|FG001|Overall Study|Death|14|||
124478293|NCT01955707|447705002|FG000|Overall Study|Other|4|||
124478294|NCT01955707|447705003|FG001|Overall Study|Other|2|||
124478295|NCT01817790|447705006|FG000|Overall Study|Adverse Event|0|||
124478296|NCT01817790|447705007|FG001|Overall Study|Adverse Event|2|||
124478297|NCT01817790|447705006|FG000|Overall Study|Lost to Follow-up|0|||
124478298|NCT01817790|447705007|FG001|Overall Study|Lost to Follow-up|1|||
124478299|NCT01817790|447705006|FG000|Overall Study|Protocol Violation|2|||
124478300|NCT01817790|447705007|FG001|Overall Study|Protocol Violation|1|||
124719669|NCT02517398|448594911|FG013|Overall Study|Death|29|||
124719670|NCT02517398|448594912|FG014|Overall Study|Death|26|||
124478301|NCT01817790|447705006|FG000|Overall Study|Withdrawal by Subject|1|||
124478302|NCT01817790|447705007|FG001|Overall Study|Withdrawal by Subject|3|||
124478303|NCT01817790|447705006|FG000|Overall Study|Other: Could not attend appointment|1|||
124478304|NCT01817790|447705007|FG001|Overall Study|Other: Could not attend appointment|1|||
124478305|NCT01671345|447705008|FG000|Overall Study|Lost to Follow-up|10|||
124478306|NCT01671345|447705009|FG001|Overall Study|Lost to Follow-up|6|||
124478307|NCT01671345|447705008|FG000|Overall Study|visit with non-participating physician|3|||
124478308|NCT01671345|447705009|FG001|Overall Study|visit with non-participating physician|3|||
124478309|NCT04980391|447705010|FG000|Overall Study|Death|0|||
124478310|NCT04980391|447705011|FG001|Overall Study|Death|0|||
124478311|NCT04980391|447705012|FG002|Overall Study|Death|1|||
124478312|NCT04980391|447705013|FG003|Overall Study|Death|1|||
124478313|NCT04980391|447705010|FG000|Overall Study|Lost to Follow-up|3|||
124478314|NCT04980391|447705011|FG001|Overall Study|Lost to Follow-up|3|||
124478315|NCT04980391|447705012|FG002|Overall Study|Lost to Follow-up|2|||
124478316|NCT04980391|447705013|FG003|Overall Study|Lost to Follow-up|3|||
124478317|NCT04980391|447705010|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
124478318|NCT04980391|447705011|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
124478319|NCT04980391|447705012|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
124478320|NCT04980391|447705013|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
124478321|NCT04980391|447705010|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124478322|NCT04980391|447705011|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124478323|NCT04980391|447705012|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
124478324|NCT04980391|447705013|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124478325|NCT04980391|447705010|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
124478326|NCT04980391|447705011|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
124478327|NCT04980391|447705012|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
124478328|NCT04980391|447705013|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
124719671|NCT02517398|448594913|FG015|Overall Study|Death|23|||
124719672|NCT02517398|448594914|FG016|Overall Study|Death|26|||
124719673|NCT02517398|448594915|FG017|Overall Study|Death|25|||
124719674|NCT02517398|448594916|FG018|Overall Study|Death|22|||
124719675|NCT02517398|448594917|FG019|Overall Study|Death|7|||
124719676|NCT02517398|448594918|FG020|Overall Study|Death|26|||
124719677|NCT02517398|448594919|FG021|Overall Study|Death|30|||
124719678|NCT02517398|448594920|FG022|Overall Study|Death|20|||
124719679|NCT02517398|448594898|FG000|Overall Study|Other|0|||
124719680|NCT02517398|448594899|FG001|Overall Study|Other|0|||
124719681|NCT02517398|448594900|FG002|Overall Study|Other|0|||
124719682|NCT02517398|448594901|FG003|Overall Study|Other|1|||
124719683|NCT02517398|448594902|FG004|Overall Study|Other|0|||
124719684|NCT02517398|448594903|FG005|Overall Study|Other|0|||
124719685|NCT02517398|448594904|FG006|Overall Study|Other|0|||
124719686|NCT02517398|448594905|FG007|Overall Study|Other|0|||
124719687|NCT02517398|448594906|FG008|Overall Study|Other|0|||
124478329|NCT04280081|447705015|FG000|Overall Study|Adverse Event|4|||
124478330|NCT04280081|447705015|FG000|Overall Study|Death|2|||
124478331|NCT04280081|447705015|FG000|Overall Study|Progressive Disease|6|||
124478332|NCT01468311|447705016|FG000|Overall Study|mobilization failure|1|||
124719688|NCT02517398|448594907|FG009|Overall Study|Other|1|||
124719689|NCT02517398|448594908|FG010|Overall Study|Other|0|||
124719690|NCT02517398|448594909|FG011|Overall Study|Other|0|||
124719691|NCT02517398|448594910|FG012|Overall Study|Other|0|||
124719692|NCT02517398|448594911|FG013|Overall Study|Other|1|||
124478333|NCT01468311|447705016|FG000|Overall Study|Withdrawal by Subject|1|||
124478334|NCT03219164|447706653|FG000|Overall Study|Study Terminated by Sponsor|16|||
124478335|NCT03219164|447706654|FG001|Overall Study|Study Terminated by Sponsor|12|||
124478336|NCT03219164|447706653|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
124478337|NCT03219164|447706654|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
124478338|NCT03219164|447706653|FG000|Overall Study|Lost to Follow-up|1|||
124478339|NCT03219164|447706654|FG001|Overall Study|Lost to Follow-up|1|||
124478340|NCT03219164|447706653|FG000|Overall Study|Adverse Event|1|||
124557183|NCT01890785|447997756|FG000|Third Intervention|Withdrawal by Subject|0|||
124557184|NCT01890785|447997757|FG001|Third Intervention|Withdrawal by Subject|1|||
124557185|NCT01890785|447997758|FG002|Third Intervention|Withdrawal by Subject|0|||
124557186|NCT01890785|447997759|FG003|Third Intervention|Withdrawal by Subject|0|||
124557187|NCT01890785|447997760|FG004|Third Intervention|Withdrawal by Subject|0|||
124557188|NCT01890785|447997761|FG005|Third Intervention|Withdrawal by Subject|0|||
124557189|NCT01964105|447997762|FG000|Overall Study|Lost to Follow-up|2|||
124557190|NCT01964105|447997763|FG001|Overall Study|Lost to Follow-up|13|||
124557191|NCT01964105|447997764|FG002|Overall Study|Lost to Follow-up|0|||
124557192|NCT00575328|447997765|FG000|Overall Study|Adverse Event|1|||
124557193|NCT00575328|447997766|FG001|Overall Study|Adverse Event|1|||
124557194|NCT00575328|447997765|FG000|Overall Study|Lost to Follow-up|2|||
124557195|NCT00575328|447997766|FG001|Overall Study|Lost to Follow-up|1|||
124557196|NCT02124746|447997767|FG000|Overall Study|Adverse Event|2|||
124557197|NCT02124746|447997768|FG001|Overall Study|Adverse Event|1|||
124557198|NCT02124746|447997769|FG002|Overall Study|Adverse Event|2|||
124557199|NCT02124746|447997767|FG000|Overall Study|Death|2|||
124557200|NCT02124746|447997768|FG001|Overall Study|Death|1|||
124557201|NCT02124746|447997769|FG002|Overall Study|Death|3|||
124557202|NCT02124746|447997767|FG000|Overall Study|Lack of Efficacy|3|||
124557203|NCT02124746|447997768|FG001|Overall Study|Lack of Efficacy|2|||
124557204|NCT02124746|447997769|FG002|Overall Study|Lack of Efficacy|2|||
124557205|NCT02124746|447997767|FG000|Overall Study|Physician Decision|6|||
124557206|NCT02124746|447997768|FG001|Overall Study|Physician Decision|4|||
124557207|NCT02124746|447997769|FG002|Overall Study|Physician Decision|5|||
124557208|NCT02124746|447997767|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124557209|NCT02124746|447997768|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124557210|NCT02124746|447997769|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124557211|NCT02124746|447997767|FG000|Overall Study|Withdrawal by Subject|3|||
124557212|NCT02124746|447997768|FG001|Overall Study|Withdrawal by Subject|3|||
124719693|NCT02517398|448594912|FG014|Overall Study|Other|0|||
124719694|NCT02517398|448594913|FG015|Overall Study|Other|1|||
124719695|NCT02517398|448594914|FG016|Overall Study|Other|1|||
124719696|NCT02517398|448594915|FG017|Overall Study|Other|0|||
124719697|NCT02517398|448594916|FG018|Overall Study|Other|0|||
124719698|NCT02517398|448594917|FG019|Overall Study|Other|1|||
124478341|NCT03219164|447706654|FG001|Overall Study|Adverse Event|0|||
124478342|NCT03219164|447706653|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124478343|NCT03219164|447706654|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124478344|NCT03219164|447706653|FG000|Overall Study|Protocol Violation|0|||
124478345|NCT03219164|447706654|FG001|Overall Study|Protocol Violation|1|||
124478346|NCT03219164|447706653|FG000|Overall Study|Withdrew Assent|1|||
124478347|NCT03219164|447706654|FG001|Overall Study|Withdrew Assent|0|||
124478348|NCT02689492|447706655|FG000|Overall Study|Lost to Follow-up|61|||
124478349|NCT02689492|447706655|FG000|Overall Study|Withdrawal by Subject|11|||
124478350|NCT02689492|447706655|FG000|Overall Study|Death|9|||
124478351|NCT02689492|447706655|FG000|Overall Study|Physician Decision|2|||
124478352|NCT02689492|447706655|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
124557213|NCT02124746|447997769|FG002|Overall Study|Withdrawal by Subject|0|||
124557214|NCT02124746|447997767|FG000|Overall Study|Study Terminated by Sponsor|0|||
124557215|NCT02124746|447997768|FG001|Overall Study|Study Terminated by Sponsor|0|||
124557216|NCT02124746|447997769|FG002|Overall Study|Study Terminated by Sponsor|6|||
124557217|NCT02124746|447997767|FG000|Overall Study|Disease Progression|3|||
124557218|NCT02124746|447997768|FG001|Overall Study|Disease Progression|6|||
124557219|NCT02124746|447997769|FG002|Overall Study|Disease Progression|4|||
124557220|NCT00124449|447997772|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
124557221|NCT00124449|447997773|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
124719699|NCT02517398|448594918|FG020|Overall Study|Other|0|||
124478353|NCT02689492|447706655|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
124478354|NCT02689492|447706655|FG000|Overall Study|Other than listed|1|||
124478355|NCT02029976|447706656|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
124478356|NCT02029976|447706657|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
124478357|NCT02029976|447706656|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
124478358|NCT02029976|447706657|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
124478359|NCT02029976|447706656|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
124478360|NCT02029976|447706657|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
124478361|NCT02029976|447706656|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
124478362|NCT02029976|447706657|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
124478363|NCT04025632|447706658|FG000|Overall Study|Adverse Event|1|||
124478364|NCT04025632|447706659|FG001|Overall Study|Adverse Event|1|||
124478365|NCT04025632|447706658|FG000|Overall Study|Withdrawal by Subject|1|||
124478366|NCT04025632|447706659|FG001|Overall Study|Withdrawal by Subject|1|||
124478367|NCT04025632|447706658|FG000|Overall Study|Study Terminated by Sponsor|10|||
124478368|NCT04025632|447706659|FG001|Overall Study|Study Terminated by Sponsor|9|||
124478369|NCT04025632|447706658|FG000|Overall Study|Physician Decision|3|||
124478370|NCT04025632|447706659|FG001|Overall Study|Physician Decision|1|||
124478371|NCT01750918|447706660|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
124478372|NCT01750918|447706661|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
124478373|NCT01750918|447706662|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
124478374|NCT01750918|447706663|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
124478375|NCT01750918|447706664|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
124478376|NCT01750918|447706665|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
124478377|NCT01750918|447706666|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
124478378|NCT01750918|447706667|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
124478379|NCT01750918|447706660|FG000|Overall Study|Lost to Follow-up|0|||
124478380|NCT01750918|447706661|FG001|Overall Study|Lost to Follow-up|0|||
124478381|NCT01750918|447706662|FG002|Overall Study|Lost to Follow-up|2|||
124478382|NCT01750918|447706663|FG003|Overall Study|Lost to Follow-up|2|||
124478383|NCT01750918|447706664|FG004|Overall Study|Lost to Follow-up|0|||
124478384|NCT01750918|447706665|FG005|Overall Study|Lost to Follow-up|0|||
124478385|NCT01750918|447706666|FG006|Overall Study|Lost to Follow-up|0|||
124478386|NCT01750918|447706667|FG007|Overall Study|Lost to Follow-up|1|||
124478387|NCT01750918|447706660|FG000|Overall Study|Withdrawal by Subject|0|||
124557222|NCT00124449|447997772|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
124557223|NCT00124449|447997773|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
124719700|NCT02517398|448594919|FG021|Overall Study|Other|0|||
124478388|NCT01750918|447706661|FG001|Overall Study|Withdrawal by Subject|0|||
124478389|NCT01750918|447706662|FG002|Overall Study|Withdrawal by Subject|1|||
124719701|NCT02517398|448594920|FG022|Overall Study|Other|0|||
124719702|NCT02517398|448594898|FG000|Overall Study|Lost to Follow-up|0|||
124719703|NCT02517398|448594899|FG001|Overall Study|Lost to Follow-up|0|||
124478390|NCT01750918|447706663|FG003|Overall Study|Withdrawal by Subject|2|||
124557224|NCT00124449|447997772|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
124719704|NCT02517398|448594900|FG002|Overall Study|Lost to Follow-up|0|||
124478391|NCT01750918|447706664|FG004|Overall Study|Withdrawal by Subject|1|||
124478392|NCT01750918|447706665|FG005|Overall Study|Withdrawal by Subject|1|||
124557225|NCT00124449|447997773|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
124557226|NCT00124449|447997772|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
124478393|NCT01750918|447706666|FG006|Overall Study|Withdrawal by Subject|2|||
124478394|NCT01750918|447706667|FG007|Overall Study|Withdrawal by Subject|2|||
124478395|NCT00127127|447706672|FG000|Overall Study|Adverse Event|0|||
124478396|NCT00127127|447706673|FG001|Overall Study|Adverse Event|2|||
124478397|NCT00127127|447706674|FG002|Overall Study|Adverse Event|0|||
124478398|NCT00127127|447706675|FG003|Overall Study|Adverse Event|1|||
124478399|NCT00127127|447706672|FG000|Overall Study|Lack of Efficacy|1|||
124478400|NCT00127127|447706673|FG001|Overall Study|Lack of Efficacy|3|||
124478401|NCT00127127|447706674|FG002|Overall Study|Lack of Efficacy|0|||
124478402|NCT00127127|447706675|FG003|Overall Study|Lack of Efficacy|2|||
124478403|NCT02338843|447706678|FG000|Overall Study|Adverse Event|2|||
124478404|NCT02338843|447706679|FG001|Overall Study|Adverse Event|1|||
124478405|NCT02338843|447706678|FG000|Overall Study|Death|40|||
124478406|NCT02338843|447706679|FG001|Overall Study|Death|53|||
124478407|NCT02338843|447706678|FG000|Overall Study|Physician Decision|1|||
124478408|NCT02338843|447706679|FG001|Overall Study|Physician Decision|0|||
124478409|NCT02338843|447706678|FG000|Overall Study|Withdrawal by Subject|0|||
124478410|NCT02338843|447706679|FG001|Overall Study|Withdrawal by Subject|2|||
124478411|NCT02338843|447706678|FG000|Overall Study|Subject Recovered|0|||
124478412|NCT02338843|447706679|FG001|Overall Study|Subject Recovered|2|||
124478413|NCT02338843|447706678|FG000|Overall Study|Discontinued prior to randomizat|1|||
124478414|NCT02338843|447706679|FG001|Overall Study|Discontinued prior to randomizat|0|||
124478415|NCT00023322|447706680|FG000|Overall Study|Lost to Follow-up|1|||
124478416|NCT01793792|447706685|FG000|Overall Study|Death|5|||
124478417|NCT01793792|447706685|FG000|Overall Study|Lost to Follow-up|5|||
124478418|NCT01793792|447706685|FG000|Overall Study|Withdrawal by Subject|1|||
124478419|NCT01793792|447706685|FG000|Overall Study|Device Not Implanted|1|||
124478420|NCT02185521|447706688|FG000|Overall Study|Withdrawal by Subject|1|||
124478421|NCT02185521|447706688|FG000|Overall Study|Protocol Violation|1|||
124478422|NCT01341457|447706689|FG000|Overall Study|Adverse Event|2|||
124478423|NCT01341457|447706690|FG001|Overall Study|Adverse Event|0|||
124478424|NCT00496366|447706695|FG000|Overall Study|Death|1|||
124478425|NCT03902080|447706699|FG000|Overall Study|Adverse Event|17|||
124478426|NCT03902080|447706700|FG001|Overall Study|Adverse Event|15|||
124478427|NCT03902080|447706699|FG000|Overall Study|Withdrawal by Subject|28|||
124478428|NCT03902080|447706700|FG001|Overall Study|Withdrawal by Subject|35|||
124478429|NCT03902080|447706699|FG000|Overall Study|Lost to Follow-up|6|||
124478430|NCT03902080|447706700|FG001|Overall Study|Lost to Follow-up|7|||
124478431|NCT03902080|447706699|FG000|Overall Study|Other|3|||
124478432|NCT03902080|447706700|FG001|Overall Study|Other|5|||
124478433|NCT03902080|447706699|FG000|Overall Study|Non compliance|4|||
124478434|NCT03902080|447706700|FG001|Overall Study|Non compliance|3|||
124478435|NCT03902080|447706699|FG000|Overall Study|Physician Decision|5|||
124478436|NCT03902080|447706700|FG001|Overall Study|Physician Decision|1|||
124478437|NCT03902080|447706699|FG000|Overall Study|Protocol Violation|3|||
124478438|NCT03902080|447706700|FG001|Overall Study|Protocol Violation|3|||
124478439|NCT03902080|447706699|FG000|Overall Study|Lack of Efficacy|1|||
124478440|NCT03902080|447706700|FG001|Overall Study|Lack of Efficacy|3|||
124478441|NCT03902080|447706699|FG000|Overall Study|Withdrawn prior to dosing|0|||
124478442|NCT03902080|447706700|FG001|Overall Study|Withdrawn prior to dosing|1|||
124478443|NCT00434967|447706701|FG000|Overall Study|Adverse Event|2|||
124478444|NCT00434967|447706702|FG001|Overall Study|Adverse Event|4|||
124478445|NCT00434967|447706703|FG002|Overall Study|Adverse Event|3|||
124478446|NCT00434967|447706704|FG003|Overall Study|Adverse Event|3|||
124478447|NCT00434967|447706701|FG000|Overall Study|Lost to Follow-up|0|||
124478448|NCT00434967|447706702|FG001|Overall Study|Lost to Follow-up|0|||
124478449|NCT00434967|447706703|FG002|Overall Study|Lost to Follow-up|1|||
124478450|NCT00434967|447706704|FG003|Overall Study|Lost to Follow-up|0|||
124478451|NCT00434967|447706701|FG000|Overall Study|Withdrawal by Subject|2|||
124478452|NCT00434967|447706702|FG001|Overall Study|Withdrawal by Subject|2|||
124478453|NCT00434967|447706703|FG002|Overall Study|Withdrawal by Subject|4|||
124478454|NCT00434967|447706704|FG003|Overall Study|Withdrawal by Subject|6|||
124478455|NCT00434967|447706701|FG000|Overall Study|Randomized in error|0|||
124478456|NCT00434967|447706702|FG001|Overall Study|Randomized in error|0|||
124478457|NCT00434967|447706703|FG002|Overall Study|Randomized in error|0|||
124478458|NCT00434967|447706704|FG003|Overall Study|Randomized in error|1|||
124478459|NCT00434967|447706701|FG000|Overall Study|Protocol Violation|0|||
124719705|NCT02517398|448594901|FG003|Overall Study|Lost to Follow-up|0|||
124478460|NCT00434967|447706702|FG001|Overall Study|Protocol Violation|1|||
124478461|NCT00434967|447706703|FG002|Overall Study|Protocol Violation|0|||
124478462|NCT00434967|447706704|FG003|Overall Study|Protocol Violation|1|||
124478463|NCT00434967|447706701|FG000|Overall Study|Physician Decision|1|||
124478464|NCT00434967|447706702|FG001|Overall Study|Physician Decision|1|||
124478465|NCT00434967|447706703|FG002|Overall Study|Physician Decision|1|||
124478466|NCT00434967|447706704|FG003|Overall Study|Physician Decision|0|||
124478467|NCT00434967|447706701|FG000|Overall Study|Patient Disposition Challenges|2|||
124478468|NCT00434967|447706702|FG001|Overall Study|Patient Disposition Challenges|0|||
124478469|NCT00434967|447706703|FG002|Overall Study|Patient Disposition Challenges|0|||
124478470|NCT00434967|447706704|FG003|Overall Study|Patient Disposition Challenges|3|||
124719706|NCT02517398|448594902|FG004|Overall Study|Lost to Follow-up|0|||
124719707|NCT02517398|448594903|FG005|Overall Study|Lost to Follow-up|0|||
124719708|NCT02517398|448594904|FG006|Overall Study|Lost to Follow-up|0|||
124719709|NCT02517398|448594905|FG007|Overall Study|Lost to Follow-up|0|||
124719710|NCT02517398|448594906|FG008|Overall Study|Lost to Follow-up|0|||
124719711|NCT02517398|448594907|FG009|Overall Study|Lost to Follow-up|1|||
124719712|NCT02517398|448594908|FG010|Overall Study|Lost to Follow-up|0|||
124719713|NCT02517398|448594909|FG011|Overall Study|Lost to Follow-up|2|||
124719714|NCT02517398|448594910|FG012|Overall Study|Lost to Follow-up|2|||
124719715|NCT02517398|448594911|FG013|Overall Study|Lost to Follow-up|0|||
124478471|NCT00408005|447706709|FG000|Induction|Adverse Event|19|||
124478472|NCT00408005|447706710|FG001|Induction|Adverse Event|3|||
124478473|NCT00408005|447706711|FG002|Induction|Adverse Event|0|||
124478474|NCT00408005|447706712|FG003|Induction|Adverse Event|0|||
124478475|NCT00408005|447706713|FG004|Induction|Adverse Event|0|||
124478476|NCT00408005|447706714|FG005|Induction|Adverse Event|0|||
124478477|NCT00408005|447706715|FG006|Induction|Adverse Event|0|||
124478478|NCT00408005|447706716|FG007|Induction|Adverse Event|0|||
124478479|NCT00408005|447706709|FG000|Induction|Death|6|||
124478480|NCT00408005|447706710|FG001|Induction|Death|0|||
124478481|NCT00408005|447706711|FG002|Induction|Death|0|||
124478482|NCT00408005|447706712|FG003|Induction|Death|0|||
124478483|NCT00408005|447706713|FG004|Induction|Death|0|||
124478484|NCT00408005|447706714|FG005|Induction|Death|0|||
124478485|NCT00408005|447706715|FG006|Induction|Death|0|||
124478486|NCT00408005|447706716|FG007|Induction|Death|0|||
124478487|NCT00408005|447706709|FG000|Induction|Physician Decision|83|||
124478488|NCT00408005|447706710|FG001|Induction|Physician Decision|9|||
124478489|NCT00408005|447706711|FG002|Induction|Physician Decision|0|||
124478490|NCT00408005|447706712|FG003|Induction|Physician Decision|0|||
124478491|NCT00408005|447706713|FG004|Induction|Physician Decision|0|||
124478492|NCT00408005|447706714|FG005|Induction|Physician Decision|0|||
124478493|NCT00408005|447706715|FG006|Induction|Physician Decision|0|||
124478494|NCT00408005|447706716|FG007|Induction|Physician Decision|0|||
124478495|NCT00408005|447706709|FG000|Induction|Withdrawal by Subject|2|||
124478496|NCT00408005|447706710|FG001|Induction|Withdrawal by Subject|4|||
124478497|NCT00408005|447706711|FG002|Induction|Withdrawal by Subject|0|||
124478498|NCT00408005|447706712|FG003|Induction|Withdrawal by Subject|0|||
124478499|NCT00408005|447706713|FG004|Induction|Withdrawal by Subject|0|||
124478500|NCT00408005|447706714|FG005|Induction|Withdrawal by Subject|0|||
124478501|NCT00408005|447706715|FG006|Induction|Withdrawal by Subject|0|||
124478502|NCT00408005|447706716|FG007|Induction|Withdrawal by Subject|0|||
124478503|NCT00408005|447706709|FG000|Induction|Ineligible|33|||
124478504|NCT00408005|447706710|FG001|Induction|Ineligible|14|||
124478505|NCT00408005|447706711|FG002|Induction|Ineligible|0|||
124478506|NCT00408005|447706712|FG003|Induction|Ineligible|0|||
124478507|NCT00408005|447706713|FG004|Induction|Ineligible|0|||
124478508|NCT00408005|447706714|FG005|Induction|Ineligible|0|||
124478509|NCT00408005|447706715|FG006|Induction|Ineligible|0|||
124478510|NCT00408005|447706716|FG007|Induction|Ineligible|0|||
124478511|NCT00408005|447706709|FG000|Induction|Refusal of Further Protocol Therapy|225|||
124478512|NCT00408005|447706710|FG001|Induction|Refusal of Further Protocol Therapy|44|||
124478513|NCT00408005|447706711|FG002|Induction|Refusal of Further Protocol Therapy|0|||
124478514|NCT00408005|447706712|FG003|Induction|Refusal of Further Protocol Therapy|0|||
124478515|NCT00408005|447706713|FG004|Induction|Refusal of Further Protocol Therapy|0|||
124478516|NCT00408005|447706714|FG005|Induction|Refusal of Further Protocol Therapy|0|||
124478517|NCT00408005|447706715|FG006|Induction|Refusal of Further Protocol Therapy|0|||
124478518|NCT00408005|447706716|FG007|Induction|Refusal of Further Protocol Therapy|0|||
124478519|NCT00408005|447706709|FG000|Induction|Entered another COG therapeutic protocol|4|||
124557227|NCT00124449|447997773|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
124557228|NCT00124449|447997772|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
124557229|NCT00124449|447997773|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
124478520|NCT00408005|447706710|FG001|Induction|Entered another COG therapeutic protocol|0|||
124478521|NCT00408005|447706711|FG002|Induction|Entered another COG therapeutic protocol|0|||
124478522|NCT00408005|447706712|FG003|Induction|Entered another COG therapeutic protocol|0|||
124478523|NCT00408005|447706713|FG004|Induction|Entered another COG therapeutic protocol|0|||
124478524|NCT00408005|447706714|FG005|Induction|Entered another COG therapeutic protocol|0|||
124478525|NCT00408005|447706715|FG006|Induction|Entered another COG therapeutic protocol|0|||
124478526|NCT00408005|447706716|FG007|Induction|Entered another COG therapeutic protocol|0|||
124478527|NCT00408005|447706709|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
124478528|NCT00408005|447706710|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
124478529|NCT00408005|447706711|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
124478530|NCT00408005|447706712|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
124478531|NCT00408005|447706713|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
124637283|NCT01081769|448290461|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
124478532|NCT00408005|447706714|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
124478533|NCT00408005|447706715|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
124478534|NCT00408005|447706716|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
124478535|NCT00408005|447706709|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
124478536|NCT00408005|447706710|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
124478537|NCT00408005|447706711|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
124478538|NCT00408005|447706712|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
124478539|NCT00408005|447706713|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
124478540|NCT00408005|447706714|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
124478541|NCT00408005|447706715|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
124478542|NCT00408005|447706716|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
124478543|NCT00408005|447706709|FG000|Induction|Progressive Disease|0|||
124478544|NCT00408005|447706710|FG001|Induction|Progressive Disease|1|||
124478545|NCT00408005|447706711|FG002|Induction|Progressive Disease|0|||
124478546|NCT00408005|447706712|FG003|Induction|Progressive Disease|0|||
124478547|NCT00408005|447706713|FG004|Induction|Progressive Disease|0|||
124478548|NCT00408005|447706714|FG005|Induction|Progressive Disease|0|||
124478549|NCT00408005|447706715|FG006|Induction|Progressive Disease|0|||
124478550|NCT00408005|447706716|FG007|Induction|Progressive Disease|0|||
124478551|NCT00408005|447706709|FG000|Induction|Inevaluable|18|||
124478552|NCT00408005|447706710|FG001|Induction|Inevaluable|14|||
124478553|NCT00408005|447706711|FG002|Induction|Inevaluable|0|||
124478554|NCT00408005|447706712|FG003|Induction|Inevaluable|0|||
124478555|NCT00408005|447706713|FG004|Induction|Inevaluable|0|||
124478556|NCT00408005|447706714|FG005|Induction|Inevaluable|0|||
124478557|NCT00408005|447706715|FG006|Induction|Inevaluable|0|||
124478558|NCT00408005|447706716|FG007|Induction|Inevaluable|0|||
124478559|NCT00408005|447706709|FG000|Induction|Failed to Complete Randomization|3|||
124478560|NCT00408005|447706710|FG001|Induction|Failed to Complete Randomization|2|||
124478561|NCT00408005|447706711|FG002|Induction|Failed to Complete Randomization|0|||
124478562|NCT00408005|447706712|FG003|Induction|Failed to Complete Randomization|0|||
124478563|NCT00408005|447706713|FG004|Induction|Failed to Complete Randomization|0|||
124478564|NCT00408005|447706714|FG005|Induction|Failed to Complete Randomization|0|||
124478565|NCT00408005|447706715|FG006|Induction|Failed to Complete Randomization|0|||
124478566|NCT00408005|447706716|FG007|Induction|Failed to Complete Randomization|0|||
124478567|NCT00408005|447706709|FG000|Induction|Protocol Deviation|3|||
124478568|NCT00408005|447706710|FG001|Induction|Protocol Deviation|1|||
124478569|NCT00408005|447706711|FG002|Induction|Protocol Deviation|0|||
124478570|NCT00408005|447706712|FG003|Induction|Protocol Deviation|0|||
124478571|NCT00408005|447706713|FG004|Induction|Protocol Deviation|0|||
124478572|NCT00408005|447706714|FG005|Induction|Protocol Deviation|0|||
124478573|NCT00408005|447706715|FG006|Induction|Protocol Deviation|0|||
124478574|NCT00408005|447706716|FG007|Induction|Protocol Deviation|0|||
124478575|NCT00408005|447706709|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
124478576|NCT00408005|447706710|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
124478577|NCT00408005|447706711|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
124478578|NCT00408005|447706712|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
124478579|NCT00408005|447706713|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
124478580|NCT00408005|447706714|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
124557230|NCT00124449|447997772|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
124557231|NCT00124449|447997773|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
124557232|NCT00124449|447997772|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
124478581|NCT00408005|447706715|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
124478582|NCT00408005|447706716|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
124478583|NCT00408005|447706709|FG000|Induction|Recurrent leukemia|1|||
124478584|NCT00408005|447706710|FG001|Induction|Recurrent leukemia|0|||
124478585|NCT00408005|447706711|FG002|Induction|Recurrent leukemia|0|||
124478586|NCT00408005|447706712|FG003|Induction|Recurrent leukemia|0|||
124478587|NCT00408005|447706713|FG004|Induction|Recurrent leukemia|0|||
124478588|NCT00408005|447706714|FG005|Induction|Recurrent leukemia|0|||
124478589|NCT00408005|447706715|FG006|Induction|Recurrent leukemia|0|||
124478590|NCT00408005|447706716|FG007|Induction|Recurrent leukemia|0|||
124478591|NCT00408005|447706709|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
124478592|NCT00408005|447706710|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
124478593|NCT00408005|447706711|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
124478594|NCT00408005|447706712|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
124478595|NCT00408005|447706713|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
124478596|NCT00408005|447706714|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
124478597|NCT00408005|447706715|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
124478598|NCT00408005|447706716|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
124478599|NCT00408005|447706709|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
124478600|NCT00408005|447706710|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
124478601|NCT00408005|447706711|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
124478602|NCT00408005|447706712|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
124478603|NCT00408005|447706713|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
124478604|NCT00408005|447706714|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
124478605|NCT00408005|447706715|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
124478606|NCT00408005|447706716|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
124478607|NCT00408005|447706709|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
124478608|NCT00408005|447706710|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
124478609|NCT00408005|447706711|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
124478610|NCT00408005|447706712|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
124478611|NCT00408005|447706713|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
124478612|NCT00408005|447706714|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
124478613|NCT00408005|447706715|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
124478614|NCT00408005|447706716|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
124478615|NCT00408005|447706709|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
124478616|NCT00408005|447706710|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
124478617|NCT00408005|447706711|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
124478618|NCT00408005|447706712|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
124478619|NCT00408005|447706713|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
124478620|NCT00408005|447706714|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
124478621|NCT00408005|447706715|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
124478622|NCT00408005|447706716|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
124478623|NCT00408005|447706709|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
124478624|NCT00408005|447706710|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
124478625|NCT00408005|447706711|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
124478626|NCT00408005|447706712|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
124478627|NCT00408005|447706713|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
124478628|NCT00408005|447706714|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
124478629|NCT00408005|447706715|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
124478630|NCT00408005|447706716|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
124478631|NCT00408005|447706709|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
124478632|NCT00408005|447706710|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
124478633|NCT00408005|447706711|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
124478634|NCT00408005|447706712|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
124478635|NCT00408005|447706713|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
124478636|NCT00408005|447706714|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
124478637|NCT00408005|447706715|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
124478638|NCT00408005|447706716|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
124478639|NCT00408005|447706709|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
124478640|NCT00408005|447706710|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
124478641|NCT00408005|447706711|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
124478642|NCT00408005|447706712|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
124478643|NCT00408005|447706713|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
124478644|NCT00408005|447706714|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
124478645|NCT00408005|447706715|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
124478646|NCT00408005|447706716|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
124478647|NCT00408005|447706709|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
124478648|NCT00408005|447706710|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
124478649|NCT00408005|447706711|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
124557233|NCT00124449|447997773|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
124719716|NCT02517398|448594912|FG014|Overall Study|Lost to Follow-up|1|||
124478650|NCT00408005|447706712|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
124478651|NCT00408005|447706713|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
124478652|NCT00408005|447706714|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
124719717|NCT02517398|448594913|FG015|Overall Study|Lost to Follow-up|1|||
124719718|NCT02517398|448594914|FG016|Overall Study|Lost to Follow-up|0|||
124719719|NCT02517398|448594915|FG017|Overall Study|Lost to Follow-up|3|||
124557234|NCT00124449|447997772|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
124719720|NCT02517398|448594916|FG018|Overall Study|Lost to Follow-up|1|||
124719721|NCT02517398|448594917|FG019|Overall Study|Lost to Follow-up|0|||
124478653|NCT00408005|447706715|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
124478654|NCT00408005|447706716|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
124478655|NCT00408005|447706709|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
124478656|NCT00408005|447706710|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
124478657|NCT00408005|447706711|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
124478658|NCT00408005|447706712|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
124478659|NCT00408005|447706713|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
124478660|NCT00408005|447706714|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
124478661|NCT00408005|447706715|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
124478662|NCT00408005|447706716|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
124478663|NCT00408005|447706709|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
124478664|NCT00408005|447706710|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
124478665|NCT00408005|447706711|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
124478666|NCT00408005|447706712|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
124478667|NCT00408005|447706713|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
124478668|NCT00408005|447706714|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
124478669|NCT00408005|447706715|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
124478670|NCT00408005|447706716|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
124478671|NCT00408005|447706709|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
124478672|NCT00408005|447706710|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
124478673|NCT00408005|447706711|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
124478674|NCT00408005|447706712|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
124478675|NCT00408005|447706713|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
124478676|NCT00408005|447706714|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
124478677|NCT00408005|447706715|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
124478678|NCT00408005|447706716|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
124478679|NCT00408005|447706709|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
124478680|NCT00408005|447706710|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
124478681|NCT00408005|447706711|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
124478682|NCT00408005|447706712|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
124478683|NCT00408005|447706713|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
124478684|NCT00408005|447706714|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
124478685|NCT00408005|447706715|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
124478686|NCT00408005|447706716|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
124478687|NCT00408005|447706709|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
124478688|NCT00408005|447706710|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
124478689|NCT00408005|447706711|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
124478690|NCT00408005|447706712|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
124478691|NCT00408005|447706713|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
124478692|NCT00408005|447706714|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
124478693|NCT00408005|447706715|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
124478694|NCT00408005|447706716|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
124478695|NCT00408005|447706709|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
124478696|NCT00408005|447706710|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
124478697|NCT00408005|447706711|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
124478698|NCT00408005|447706712|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
124478699|NCT00408005|447706713|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
124478700|NCT00408005|447706714|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
124478701|NCT00408005|447706715|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
124478702|NCT00408005|447706716|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
124478703|NCT01701258|447706718|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
124478704|NCT01701258|447706719|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
124478705|NCT01701258|447706720|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
124478706|NCT01701258|447706721|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
124478707|NCT01701258|447706722|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
124478708|NCT01701258|447706723|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
124478709|NCT01701258|447706724|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
124478710|NCT01701258|447706725|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
124478711|NCT01701258|447706726|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
124478712|NCT01701258|447706727|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
124478713|NCT01701258|447706728|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
124478714|NCT01701258|447706729|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
124478715|NCT01701258|447706730|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
124478716|NCT01701258|447706718|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
124478717|NCT01701258|447706719|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
124478718|NCT01701258|447706720|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
124478719|NCT01701258|447706721|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
124478720|NCT01701258|447706722|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
124478721|NCT01701258|447706723|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
124478722|NCT01701258|447706724|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
124478723|NCT01701258|447706725|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
124478724|NCT01701258|447706726|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
124478725|NCT01701258|447706727|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
124478726|NCT01701258|447706728|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
124478727|NCT01701258|447706729|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
124478728|NCT01701258|447706730|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
124478729|NCT01701258|447706718|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
124478730|NCT01701258|447706719|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
124478731|NCT01701258|447706720|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
124478732|NCT01701258|447706721|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
124478733|NCT01701258|447706722|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
124478734|NCT01701258|447706723|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
124478735|NCT01701258|447706724|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
124478736|NCT01701258|447706725|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
124478737|NCT01701258|447706726|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
124478738|NCT01701258|447706727|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
124478739|NCT01701258|447706728|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
124478740|NCT01701258|447706729|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
124478741|NCT01701258|447706730|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
124478742|NCT01701258|447706718|FG000|Assessment and Scheduling|Investigator Terminated|2|||
124478743|NCT01701258|447706719|FG001|Assessment and Scheduling|Investigator Terminated|0|||
124478744|NCT01701258|447706720|FG002|Assessment and Scheduling|Investigator Terminated|0|||
124478745|NCT01701258|447706721|FG003|Assessment and Scheduling|Investigator Terminated|0|||
124478746|NCT01701258|447706722|FG004|Assessment and Scheduling|Investigator Terminated|0|||
124478747|NCT01701258|447706723|FG005|Assessment and Scheduling|Investigator Terminated|0|||
124478748|NCT01701258|447706724|FG006|Assessment and Scheduling|Investigator Terminated|0|||
124478749|NCT01701258|447706725|FG007|Assessment and Scheduling|Investigator Terminated|0|||
124478750|NCT01701258|447706726|FG008|Assessment and Scheduling|Investigator Terminated|0|||
124478751|NCT01701258|447706727|FG009|Assessment and Scheduling|Investigator Terminated|0|||
124478752|NCT01701258|447706728|FG010|Assessment and Scheduling|Investigator Terminated|0|||
124478753|NCT01701258|447706729|FG011|Assessment and Scheduling|Investigator Terminated|0|||
124478754|NCT01701258|447706730|FG012|Assessment and Scheduling|Investigator Terminated|0|||
124478755|NCT03155997|447706731|FG000|Overall Study|Withdrawal by Subject|119|||
124478756|NCT03155997|447706732|FG001|Overall Study|Withdrawal by Subject|134|||
124478757|NCT03155997|447706731|FG000|Overall Study|Lost to Follow-up|12|||
124478758|NCT03155997|447706732|FG001|Overall Study|Lost to Follow-up|13|||
124719722|NCT02517398|448594918|FG020|Overall Study|Lost to Follow-up|1|||
124719723|NCT02517398|448594919|FG021|Overall Study|Lost to Follow-up|0|||
124719724|NCT02517398|448594920|FG022|Overall Study|Lost to Follow-up|2|||
124478759|NCT03155997|447706731|FG000|Overall Study|Missing disposition data|0|||
124478760|NCT03155997|447706732|FG001|Overall Study|Missing disposition data|1|||
124478761|NCT03155997|447706731|FG000|Overall Study|On study treatment|2027|||
124478762|NCT03155997|447706732|FG001|Overall Study|On study treatment|2074|||
124478763|NCT01848145|447706733|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
124478764|NCT01848145|447706733|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
124478765|NCT01848145|447706733|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
124478766|NCT01848145|447706733|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
124478767|NCT01848145|447706733|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
124478768|NCT01848145|447706733|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
124478769|NCT01848145|447706733|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
124478770|NCT03093402|447706734|FG000|Overall Study|Lost to Follow-up|1|||
124478771|NCT03093402|447706735|FG001|Overall Study|Lost to Follow-up|0|||
124478772|NCT03093402|447706736|FG002|Overall Study|Lost to Follow-up|0|||
124478773|NCT03093402|447706737|FG003|Overall Study|Lost to Follow-up|0|||
124478774|NCT03093402|447706734|FG000|Overall Study|Withdrawal by Subject|3|||
124478775|NCT03093402|447706735|FG001|Overall Study|Withdrawal by Subject|3|||
124557235|NCT00124449|447997773|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
124557236|NCT00124449|447997772|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
124557237|NCT00124449|447997773|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
124557238|NCT00124449|447997772|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
124557239|NCT00124449|447997773|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
124557240|NCT00124449|447997772|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
124478776|NCT03093402|447706736|FG002|Overall Study|Withdrawal by Subject|0|||
124478777|NCT03093402|447706737|FG003|Overall Study|Withdrawal by Subject|1|||
124478778|NCT03093402|447706734|FG000|Overall Study|Withdrew prior to dosing|2|||
124478779|NCT03093402|447706735|FG001|Overall Study|Withdrew prior to dosing|1|||
124478780|NCT03093402|447706736|FG002|Overall Study|Withdrew prior to dosing|2|||
124478781|NCT03093402|447706737|FG003|Overall Study|Withdrew prior to dosing|3|||
124478782|NCT03093402|447706734|FG000|Overall Study|Ineligible for study|1|||
124478783|NCT03093402|447706735|FG001|Overall Study|Ineligible for study|0|||
124478784|NCT03093402|447706736|FG002|Overall Study|Ineligible for study|0|||
124478785|NCT03093402|447706737|FG003|Overall Study|Ineligible for study|0|||
124478786|NCT03093402|447706734|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
124478787|NCT03093402|447706735|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
124478788|NCT03093402|447706736|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
124478789|NCT03093402|447706737|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
124478790|NCT02886702|447706738|FG000|Overall Study|Other|4|||
124478791|NCT02886702|447706739|FG001|Overall Study|Other|3|||
124478792|NCT02886702|447706740|FG002|Overall Study|Other|9|||
124478793|NCT02886702|447706738|FG000|Overall Study|Withdrawal by Subject|24|||
124478794|NCT02886702|447706739|FG001|Overall Study|Withdrawal by Subject|18|||
124478795|NCT02886702|447706740|FG002|Overall Study|Withdrawal by Subject|22|||
124478796|NCT02886702|447706738|FG000|Overall Study|Significant Worsening of Condition|0|||
124478797|NCT02886702|447706739|FG001|Overall Study|Significant Worsening of Condition|1|||
124478798|NCT02886702|447706740|FG002|Overall Study|Significant Worsening of Condition|0|||
124478799|NCT02886702|447706738|FG000|Overall Study|Protocol Violation|2|||
124478800|NCT02886702|447706739|FG001|Overall Study|Protocol Violation|2|||
124478801|NCT02886702|447706740|FG002|Overall Study|Protocol Violation|1|||
124478802|NCT02886702|447706738|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124478803|NCT02886702|447706739|FG001|Overall Study|Non-Compliance With Study Drug|1|||
124478804|NCT02886702|447706740|FG002|Overall Study|Non-Compliance With Study Drug|4|||
124478805|NCT02886702|447706738|FG000|Overall Study|Lost to Follow-up|11|||
124478806|NCT02886702|447706739|FG001|Overall Study|Lost to Follow-up|13|||
124478807|NCT02886702|447706740|FG002|Overall Study|Lost to Follow-up|8|||
124478808|NCT02886702|447706738|FG000|Overall Study|Lack of Efficacy|3|||
124478809|NCT02886702|447706739|FG001|Overall Study|Lack of Efficacy|4|||
124478810|NCT02886702|447706740|FG002|Overall Study|Lack of Efficacy|5|||
124478811|NCT02886702|447706738|FG000|Overall Study|Adverse Event|4|||
124478812|NCT02886702|447706739|FG001|Overall Study|Adverse Event|9|||
124478813|NCT02886702|447706740|FG002|Overall Study|Adverse Event|3|||
124478814|NCT02886702|447706738|FG000|Overall Study|Administrative Reasons|0|||
124478815|NCT02886702|447706739|FG001|Overall Study|Administrative Reasons|0|||
124478816|NCT02886702|447706740|FG002|Overall Study|Administrative Reasons|1|||
124478817|NCT02347631|447706743|FG000|First Intervention (2 Months)|Adverse Event|1|||
124478818|NCT02347631|447706744|FG001|First Intervention (2 Months)|Adverse Event|1|||
124478819|NCT02347631|447706743|FG000|First Intervention (2 Months)|Pregnancy|1|||
124478820|NCT02347631|447706744|FG001|First Intervention (2 Months)|Pregnancy|0|||
124478821|NCT02347631|447706743|FG000|First Intervention (2 Months)|Moved out of area|0|||
124478822|NCT02347631|447706744|FG001|First Intervention (2 Months)|Moved out of area|2|||
124478823|NCT02347631|447706743|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
124478824|NCT02347631|447706744|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
124478825|NCT02347631|447706743|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
124478826|NCT02347631|447706744|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
124478827|NCT02347631|447706743|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
124478828|NCT02347631|447706744|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
124478829|NCT02347631|447706743|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
124478830|NCT02347631|447706744|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
124478831|NCT02347631|447706743|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
124478832|NCT02347631|447706744|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
124478833|NCT02429856|447706745|FG000|Overall Study|Death|12|||
124478834|NCT02429856|447706746|FG001|Overall Study|Death|13|||
124478835|NCT02429856|447706745|FG000|Overall Study|Lost to Follow-up|6|||
124478836|NCT02429856|447706746|FG001|Overall Study|Lost to Follow-up|5|||
124478837|NCT02429856|447706745|FG000|Overall Study|Withdrawal by Subject|1|||
124478838|NCT02429856|447706746|FG001|Overall Study|Withdrawal by Subject|1|||
124478839|NCT03514914|447706754|FG000|Overall Study|Death|3|||
124478840|NCT03514914|447706755|FG001|Overall Study|Death|3|||
124478841|NCT03514914|447706754|FG000|Overall Study|Lost to Follow-up|117|||
124478842|NCT03514914|447706755|FG001|Overall Study|Lost to Follow-up|89|||
124478843|NCT01355289|447706757|FG000|Core Study|Adverse Event, Non-Fatal|1|||
124478844|NCT01355289|447706758|FG001|Core Study|Adverse Event, Non-Fatal|0|||
124478845|NCT01355289|447706759|FG002|Core Study|Adverse Event, Non-Fatal|0|||
124478846|NCT01355289|447706760|FG003|Core Study|Adverse Event, Non-Fatal|0|||
124478847|NCT01355289|447706761|FG004|Core Study|Adverse Event, Non-Fatal|0|||
124478848|NCT01355289|447706757|FG000|Core Study|Inadequate Therapeutic Effect|0|||
124478849|NCT01355289|447706758|FG001|Core Study|Inadequate Therapeutic Effect|0|||
124478850|NCT01355289|447706759|FG002|Core Study|Inadequate Therapeutic Effect|0|||
124478851|NCT01355289|447706760|FG003|Core Study|Inadequate Therapeutic Effect|1|||
124478852|NCT01355289|447706761|FG004|Core Study|Inadequate Therapeutic Effect|0|||
124478853|NCT01355289|447706757|FG000|Core Study|Other|0|||
124478854|NCT01355289|447706758|FG001|Core Study|Other|0|||
124478855|NCT01355289|447706759|FG002|Core Study|Other|0|||
124478856|NCT01355289|447706760|FG003|Core Study|Other|1|||
124478857|NCT01355289|447706761|FG004|Core Study|Other|0|||
124478858|NCT01355289|447706757|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
124478859|NCT01355289|447706758|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
124478860|NCT01355289|447706759|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
124478861|NCT01355289|447706760|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
124478862|NCT01355289|447706761|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
124557241|NCT00124449|447997773|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
124719725|NCT02517398|448594898|FG000|Overall Study|Withdrew Consent|0|||
124719726|NCT02517398|448594899|FG001|Overall Study|Withdrew Consent|0|||
124719727|NCT02517398|448594900|FG002|Overall Study|Withdrew Consent|0|||
124719728|NCT02517398|448594901|FG003|Overall Study|Withdrew Consent|0|||
124719729|NCT02517398|448594902|FG004|Overall Study|Withdrew Consent|0|||
124719730|NCT02517398|448594903|FG005|Overall Study|Withdrew Consent|0|||
124719731|NCT02517398|448594904|FG006|Overall Study|Withdrew Consent|1|||
124478863|NCT01355289|447706757|FG000|Open Label Extension|Lost to Follow-up|0|||
124478864|NCT01355289|447706758|FG001|Open Label Extension|Lost to Follow-up|0|||
124478865|NCT01355289|447706759|FG002|Open Label Extension|Lost to Follow-up|0|||
124478866|NCT01355289|447706760|FG003|Open Label Extension|Lost to Follow-up|0|||
124478867|NCT01355289|447706761|FG004|Open Label Extension|Lost to Follow-up|1|||
124478868|NCT01355289|447706757|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
124478869|NCT01355289|447706758|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
124478870|NCT01355289|447706759|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
124478871|NCT01355289|447706760|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
124478872|NCT01355289|447706761|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
124478873|NCT01355289|447706757|FG000|Open Label Extension|Other|0|||
124478874|NCT01355289|447706758|FG001|Open Label Extension|Other|0|||
124478875|NCT01355289|447706759|FG002|Open Label Extension|Other|0|||
124478876|NCT01355289|447706760|FG003|Open Label Extension|Other|0|||
124478877|NCT01355289|447706761|FG004|Open Label Extension|Other|3|||
124478878|NCT04336163|447706762|FG000|Overall Study|Lost to Follow-up|55|||
124478879|NCT04336163|447706763|FG001|Overall Study|Lost to Follow-up|0|||
124478880|NCT01085682|447706764|FG000|Overall Study|Withdrawal by Subject|25|||
124478881|NCT01085682|447706765|FG001|Overall Study|Withdrawal by Subject|25|||
124478882|NCT01451645|447706766|FG000|Overall Study|Protocol Violation|1|||
124478883|NCT01451645|447706767|FG001|Overall Study|Protocol Violation|0|||
124478884|NCT01451645|447706766|FG000|Overall Study|Adverse Event|0|||
124478885|NCT01451645|447706767|FG001|Overall Study|Adverse Event|3|||
124478886|NCT01451645|447706766|FG000|Overall Study|Withdrawal by Subject|4|||
124478887|NCT01451645|447706767|FG001|Overall Study|Withdrawal by Subject|2|||
124478888|NCT01451645|447706766|FG000|Overall Study|Lost to Follow-up|4|||
124478889|NCT01451645|447706767|FG001|Overall Study|Lost to Follow-up|3|||
124478890|NCT00813995|447706774|FG000|Overall Study|Clinical adverse event|9|||
124478891|NCT00813995|447706775|FG001|Overall Study|Clinical adverse event|3|||
124478892|NCT00813995|447706774|FG000|Overall Study|Laboratory adverse event|0|||
124478893|NCT00813995|447706775|FG001|Overall Study|Laboratory adverse event|2|||
124478894|NCT00813995|447706774|FG000|Overall Study|Lack of Efficacy|1|||
124478895|NCT00813995|447706775|FG001|Overall Study|Lack of Efficacy|0|||
124478896|NCT00813995|447706774|FG000|Overall Study|Lost to Follow-up|4|||
124478897|NCT00813995|447706775|FG001|Overall Study|Lost to Follow-up|2|||
124478898|NCT00813995|447706774|FG000|Overall Study|Other reason|2|||
124478899|NCT00813995|447706775|FG001|Overall Study|Other reason|2|||
124478900|NCT00813995|447706774|FG000|Overall Study|Protocol Violation|3|||
124478901|NCT00813995|447706775|FG001|Overall Study|Protocol Violation|2|||
124478902|NCT00813995|447706774|FG000|Overall Study|Subject moved|4|||
124478903|NCT00813995|447706775|FG001|Overall Study|Subject moved|0|||
124478904|NCT00813995|447706774|FG000|Overall Study|Withdrawal by Subject|0|||
124478905|NCT00813995|447706775|FG001|Overall Study|Withdrawal by Subject|5|||
124478906|NCT01614964|447706776|FG000|Overall Study|Withdrawal by Subject|2|||
124478907|NCT01614964|447706777|FG001|Overall Study|Withdrawal by Subject|0|||
124478908|NCT01614964|447706776|FG000|Overall Study|Lost to Follow-up|3|||
124478909|NCT01614964|447706777|FG001|Overall Study|Lost to Follow-up|0|||
124478910|NCT02700984|447706788|FG000|Overall Study|Death|2|||
124478911|NCT02700984|447706789|FG001|Overall Study|Death|1|||
124478912|NCT02700984|447706788|FG000|Overall Study|Lost to Follow-up|2|||
124478913|NCT02700984|447706789|FG001|Overall Study|Lost to Follow-up|1|||
124478914|NCT02700984|447706788|FG000|Overall Study|Physician Decision|0|||
124478915|NCT02700984|447706789|FG001|Overall Study|Physician Decision|1|||
124478916|NCT02700984|447706788|FG000|Overall Study|Withdrawal by Subject|8|||
124478917|NCT02700984|447706789|FG001|Overall Study|Withdrawal by Subject|9|||
124478918|NCT02700984|447706788|FG000|Overall Study|Reason not specified|3|||
124478919|NCT02700984|447706789|FG001|Overall Study|Reason not specified|2|||
124478920|NCT00473876|447706791|FG000|Overall Study|Lost to Follow-up|3|||
124478921|NCT00473876|447706792|FG001|Overall Study|Lost to Follow-up|1|||
124478922|NCT00348140|447706793|FG000|Overall Study|Adverse Event|46|||
124478923|NCT00348140|447706794|FG001|Overall Study|Adverse Event|49|||
124478924|NCT00348140|447706795|FG002|Overall Study|Adverse Event|78|||
124478925|NCT00348140|447706793|FG000|Overall Study|Lost to Follow-up|4|||
124478926|NCT00348140|447706794|FG001|Overall Study|Lost to Follow-up|4|||
124478927|NCT00348140|447706795|FG002|Overall Study|Lost to Follow-up|4|||
124478928|NCT00348140|447706793|FG000|Overall Study|Protocol Violation|12|||
124478929|NCT00348140|447706794|FG001|Overall Study|Protocol Violation|13|||
124478930|NCT00348140|447706795|FG002|Overall Study|Protocol Violation|14|||
124478931|NCT00348140|447706793|FG000|Overall Study|Withdrawal by Subject|32|||
124478932|NCT00348140|447706794|FG001|Overall Study|Withdrawal by Subject|40|||
124478933|NCT00348140|447706795|FG002|Overall Study|Withdrawal by Subject|40|||
124478934|NCT00348140|447706793|FG000|Overall Study|Non-compliance|8|||
124478935|NCT00348140|447706794|FG001|Overall Study|Non-compliance|13|||
124478936|NCT00348140|447706795|FG002|Overall Study|Non-compliance|5|||
124478937|NCT00348140|447706793|FG000|Overall Study|Participant at risk due to study drug|2|||
124478938|NCT00348140|447706794|FG001|Overall Study|Participant at risk due to study drug|0|||
124478939|NCT00348140|447706795|FG002|Overall Study|Participant at risk due to study drug|0|||
124478940|NCT00348140|447706793|FG000|Overall Study|Conditional medication increased dose|1|||
124478941|NCT00348140|447706794|FG001|Overall Study|Conditional medication increased dose|0|||
124478942|NCT00348140|447706795|FG002|Overall Study|Conditional medication increased dose|0|||
124478943|NCT00348140|447706793|FG000|Overall Study|Caregiver related|4|||
124478944|NCT00348140|447706794|FG001|Overall Study|Caregiver related|7|||
124478945|NCT00348140|447706795|FG002|Overall Study|Caregiver related|3|||
124478946|NCT00348140|447706793|FG000|Overall Study|Participant hospitalised|3|||
124719732|NCT02517398|448594905|FG007|Overall Study|Withdrew Consent|0|||
124719733|NCT02517398|448594906|FG008|Overall Study|Withdrew Consent|0|||
124719734|NCT02517398|448594907|FG009|Overall Study|Withdrew Consent|2|||
124478947|NCT00348140|447706794|FG001|Overall Study|Participant hospitalised|0|||
124478948|NCT00348140|447706795|FG002|Overall Study|Participant hospitalised|0|||
124478949|NCT00348140|447706793|FG000|Overall Study|Efficacy related|1|||
124478950|NCT00348140|447706794|FG001|Overall Study|Efficacy related|1|||
124478951|NCT00348140|447706795|FG002|Overall Study|Efficacy related|0|||
124478952|NCT00348140|447706793|FG000|Overall Study|Administration related|3|||
124478953|NCT00348140|447706794|FG001|Overall Study|Administration related|1|||
124478954|NCT00348140|447706795|FG002|Overall Study|Administration related|1|||
124478955|NCT00348140|447706793|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
124478956|NCT00348140|447706794|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
124478957|NCT00348140|447706795|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
124478958|NCT00348140|447706793|FG000|Overall Study|Participant unwell|1|||
124478959|NCT00348140|447706794|FG001|Overall Study|Participant unwell|0|||
124478960|NCT00348140|447706795|FG002|Overall Study|Participant unwell|0|||
124478961|NCT00348140|447706793|FG000|Overall Study|Screen failure|1|||
124478962|NCT00348140|447706794|FG001|Overall Study|Screen failure|0|||
124478963|NCT00348140|447706795|FG002|Overall Study|Screen failure|0|||
124478964|NCT00348140|447706793|FG000|Overall Study|Investigator decided to discontinue|4|||
124478965|NCT00348140|447706794|FG001|Overall Study|Investigator decided to discontinue|1|||
124478966|NCT00348140|447706795|FG002|Overall Study|Investigator decided to discontinue|4|||
124478967|NCT00348140|447706793|FG000|Overall Study|Decided to discontinue on their own|1|||
124478968|NCT00348140|447706794|FG001|Overall Study|Decided to discontinue on their own|4|||
124478969|NCT00348140|447706795|FG002|Overall Study|Decided to discontinue on their own|1|||
124478970|NCT00348140|447706793|FG000|Overall Study|Use of prohibited drug|1|||
124478971|NCT00348140|447706794|FG001|Overall Study|Use of prohibited drug|0|||
124478972|NCT00348140|447706795|FG002|Overall Study|Use of prohibited drug|2|||
124478973|NCT00348140|447706793|FG000|Overall Study|Disease progression|1|||
124478974|NCT00348140|447706794|FG001|Overall Study|Disease progression|2|||
124478975|NCT00348140|447706795|FG002|Overall Study|Disease progression|5|||
124478976|NCT00348140|447706793|FG000|Overall Study|Increased risk of cardiac infarction|0|||
124478977|NCT00348140|447706794|FG001|Overall Study|Increased risk of cardiac infarction|1|||
124478978|NCT00348140|447706795|FG002|Overall Study|Increased risk of cardiac infarction|0|||
124478979|NCT00348140|447706793|FG000|Overall Study|Serious adverse event|0|||
124478980|NCT00348140|447706794|FG001|Overall Study|Serious adverse event|1|||
124478981|NCT00348140|447706795|FG002|Overall Study|Serious adverse event|0|||
124478982|NCT00348140|447706793|FG000|Overall Study|Abnormal ECG|0|||
124719735|NCT02517398|448594908|FG010|Overall Study|Withdrew Consent|7|||
124719736|NCT02517398|448594909|FG011|Overall Study|Withdrew Consent|1|||
124478983|NCT00348140|447706794|FG001|Overall Study|Abnormal ECG|1|||
124478984|NCT00348140|447706795|FG002|Overall Study|Abnormal ECG|3|||
124478985|NCT00348140|447706793|FG000|Overall Study|Participant died|0|||
124478986|NCT00348140|447706794|FG001|Overall Study|Participant died|1|||
124478987|NCT00348140|447706795|FG002|Overall Study|Participant died|0|||
124478988|NCT00348140|447706793|FG000|Overall Study|Exclusion criteria met|0|||
124478989|NCT00348140|447706794|FG001|Overall Study|Exclusion criteria met|0|||
124478990|NCT00348140|447706795|FG002|Overall Study|Exclusion criteria met|1|||
124478991|NCT00348140|447706793|FG000|Overall Study|Memory declined|0|||
124478992|NCT00348140|447706794|FG001|Overall Study|Memory declined|0|||
124478993|NCT00348140|447706795|FG002|Overall Study|Memory declined|1|||
124478994|NCT01032629|447706796|FG000|Overall Study|Closed Site|21|||
124478995|NCT01032629|447706797|FG001|Overall Study|Closed Site|18|||
124478996|NCT01032629|447706798|FG002|Overall Study|Closed Site|16|||
124478997|NCT01032629|447706796|FG000|Overall Study|Withdrawal by Subject|50|||
124478998|NCT01032629|447706797|FG001|Overall Study|Withdrawal by Subject|36|||
124478999|NCT01032629|447706798|FG002|Overall Study|Withdrawal by Subject|35|||
124479000|NCT01032629|447706796|FG000|Overall Study|Lost to Follow-up|74|||
124479001|NCT01032629|447706797|FG001|Overall Study|Lost to Follow-up|47|||
124479002|NCT01032629|447706798|FG002|Overall Study|Lost to Follow-up|37|||
124479003|NCT03545282|447706799|FG000|Overall Study|Lost to Follow-up|15|||
124479004|NCT03545282|447706800|FG001|Overall Study|Lost to Follow-up|10|||
124479005|NCT03545282|447706799|FG000|Overall Study|Withdrawal by Subject|2|||
124479006|NCT03545282|447706800|FG001|Overall Study|Withdrawal by Subject|2|||
124479007|NCT00755079|447706801|FG000|Overall Study|Lost to Follow-up|1|||
124479008|NCT00755079|447706802|FG001|Overall Study|Lost to Follow-up|3|||
124479009|NCT00755079|447706801|FG000|Overall Study|Adverse Event|0|||
124479010|NCT00755079|447706802|FG001|Overall Study|Adverse Event|1|||
124479011|NCT00755079|447706801|FG000|Overall Study|Withdrawal by Subject|0|||
124479012|NCT00755079|447706802|FG001|Overall Study|Withdrawal by Subject|2|||
124479013|NCT03377634|447706806|FG000|Study Period|Adverse Event|1|||
124479014|NCT03377634|447706807|FG001|Study Period|Adverse Event|0|||
124479015|NCT03377634|447706806|FG000|Study Period|Withdrawal by Subject|1|||
124479016|NCT03377634|447706807|FG001|Study Period|Withdrawal by Subject|0|||
124479017|NCT00737529|447706808|FG000|Overall Study|Disease Progression|95|||
124479018|NCT00737529|447706808|FG000|Overall Study|Adverse Event|24|||
124479019|NCT00737529|447706808|FG000|Overall Study|Withdrawal by Subject|5|||
124479020|NCT00737529|447706808|FG000|Overall Study|Death|4|||
124479021|NCT00737529|447706808|FG000|Overall Study|Protocol Violation|1|||
124479022|NCT00737529|447706808|FG000|Overall Study|Other|4|||
124479023|NCT00151892|447706816|FG000|Overall Study|Lack of Efficacy|50|||
124479024|NCT00151892|447706817|FG001|Overall Study|Lack of Efficacy|57|||
124479025|NCT00151892|447706816|FG000|Overall Study|Patient request|10|||
124479026|NCT00151892|447706817|FG001|Overall Study|Patient request|7|||
124479027|NCT00151892|447706816|FG000|Overall Study|Lost to Follow-up|5|||
124479028|NCT00151892|447706817|FG001|Overall Study|Lost to Follow-up|10|||
124479029|NCT00151892|447706816|FG000|Overall Study|Adverse Event|6|||
124479030|NCT00151892|447706817|FG001|Overall Study|Adverse Event|3|||
124479031|NCT00151892|447706816|FG000|Overall Study|Protocol Violation|3|||
124479032|NCT00151892|447706817|FG001|Overall Study|Protocol Violation|3|||
124479033|NCT00151892|447706816|FG000|Overall Study|Non-compliance|0|||
124479034|NCT00151892|447706817|FG001|Overall Study|Non-compliance|1|||
124479035|NCT00151892|447706816|FG000|Overall Study|Pregnancy|0|||
124479036|NCT00151892|447706817|FG001|Overall Study|Pregnancy|1|||
124479037|NCT00151892|447706816|FG000|Overall Study|Did not return for a visit|1|||
124479038|NCT00151892|447706817|FG001|Overall Study|Did not return for a visit|0|||
124479039|NCT00151892|447706816|FG000|Overall Study|Used prohibited corticosteroids|1|||
124719737|NCT02517398|448594910|FG012|Overall Study|Withdrew Consent|5|||
124719738|NCT02517398|448594911|FG013|Overall Study|Withdrew Consent|4|||
124479040|NCT00151892|447706817|FG001|Overall Study|Used prohibited corticosteroids|0|||
124479041|NCT00151892|447706816|FG000|Overall Study|Lack of study medication at center|0|||
124479042|NCT00151892|447706817|FG001|Overall Study|Lack of study medication at center|1|||
124479043|NCT02901431|447706818|FG000|PK Part|Adverse Event|0|||
124479044|NCT02901431|447706819|FG001|PK Part|Adverse Event|1|||
124479045|NCT02901431|447706820|FG002|PK Part|Adverse Event|0|||
124479046|NCT02901431|447706821|FG003|PK Part|Adverse Event|0|||
124479047|NCT02901431|447706822|FG004|PK Part|Adverse Event|0|||
124479048|NCT02901431|447706823|FG005|PK Part|Adverse Event|0|||
124479049|NCT02901431|447706824|FG006|PK Part|Adverse Event|0|||
124479050|NCT02901431|447706825|FG007|PK Part|Adverse Event|0|||
124479051|NCT02901431|447706826|FG008|PK Part|Adverse Event|0|||
124479052|NCT02901431|447706827|FG009|PK Part|Adverse Event|0|||
124719739|NCT02517398|448594912|FG014|Overall Study|Withdrew Consent|2|||
124719740|NCT02517398|448594913|FG015|Overall Study|Withdrew Consent|5|||
124479053|NCT02901431|447706828|FG010|PK Part|Adverse Event|0|||
124479054|NCT02901431|447706829|FG011|PK Part|Adverse Event|0|||
124479055|NCT02901431|447706830|FG012|PK Part|Adverse Event|0|||
124479056|NCT02901431|447706818|FG000|PK Part|Lost to Follow-up|0|||
124479057|NCT02901431|447706819|FG001|PK Part|Lost to Follow-up|0|||
124479058|NCT02901431|447706820|FG002|PK Part|Lost to Follow-up|1|||
124479059|NCT02901431|447706821|FG003|PK Part|Lost to Follow-up|0|||
124479060|NCT02901431|447706822|FG004|PK Part|Lost to Follow-up|0|||
124479061|NCT02901431|447706823|FG005|PK Part|Lost to Follow-up|0|||
124479062|NCT02901431|447706824|FG006|PK Part|Lost to Follow-up|0|||
124479063|NCT02901431|447706825|FG007|PK Part|Lost to Follow-up|0|||
124479064|NCT02901431|447706826|FG008|PK Part|Lost to Follow-up|0|||
124479065|NCT02901431|447706827|FG009|PK Part|Lost to Follow-up|0|||
124479066|NCT02901431|447706828|FG010|PK Part|Lost to Follow-up|0|||
124479067|NCT02901431|447706829|FG011|PK Part|Lost to Follow-up|0|||
124479068|NCT02901431|447706830|FG012|PK Part|Lost to Follow-up|0|||
124479069|NCT02901431|447706818|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
124479070|NCT02901431|447706819|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
124719741|NCT02517398|448594914|FG016|Overall Study|Withdrew Consent|4|||
124479071|NCT02901431|447706820|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
124479072|NCT02901431|447706821|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
124479073|NCT02901431|447706822|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
124479074|NCT02901431|447706823|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
124479075|NCT02901431|447706824|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
124479076|NCT02901431|447706825|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
124479077|NCT02901431|447706826|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
124479078|NCT02901431|447706827|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
124479079|NCT02901431|447706828|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
124479080|NCT02901431|447706829|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
124479081|NCT02901431|447706830|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
124479082|NCT02901431|447706818|FG000|PK Part|Pending dose confirmation|0|||
124479083|NCT02901431|447706819|FG001|PK Part|Pending dose confirmation|1|||
124479084|NCT02901431|447706820|FG002|PK Part|Pending dose confirmation|0|||
124479085|NCT02901431|447706821|FG003|PK Part|Pending dose confirmation|0|||
124479086|NCT02901431|447706822|FG004|PK Part|Pending dose confirmation|0|||
124479087|NCT02901431|447706823|FG005|PK Part|Pending dose confirmation|0|||
124479088|NCT02901431|447706824|FG006|PK Part|Pending dose confirmation|0|||
124479089|NCT02901431|447706825|FG007|PK Part|Pending dose confirmation|0|||
124479090|NCT02901431|447706826|FG008|PK Part|Pending dose confirmation|0|||
124479091|NCT02901431|447706827|FG009|PK Part|Pending dose confirmation|0|||
124479092|NCT02901431|447706828|FG010|PK Part|Pending dose confirmation|0|||
124479093|NCT02901431|447706829|FG011|PK Part|Pending dose confirmation|0|||
124479094|NCT02901431|447706830|FG012|PK Part|Pending dose confirmation|0|||
124479095|NCT02901431|447706818|FG000|PK Part|8 weeks of treatment ran out|2|||
124479096|NCT02901431|447706819|FG001|PK Part|8 weeks of treatment ran out|0|||
124479097|NCT02901431|447706820|FG002|PK Part|8 weeks of treatment ran out|0|||
124479098|NCT02901431|447706821|FG003|PK Part|8 weeks of treatment ran out|0|||
124479099|NCT02901431|447706822|FG004|PK Part|8 weeks of treatment ran out|0|||
124479100|NCT02901431|447706823|FG005|PK Part|8 weeks of treatment ran out|0|||
124479101|NCT02901431|447706824|FG006|PK Part|8 weeks of treatment ran out|0|||
124479102|NCT02901431|447706825|FG007|PK Part|8 weeks of treatment ran out|0|||
124479103|NCT02901431|447706826|FG008|PK Part|8 weeks of treatment ran out|0|||
124479104|NCT02901431|447706827|FG009|PK Part|8 weeks of treatment ran out|0|||
124479105|NCT02901431|447706828|FG010|PK Part|8 weeks of treatment ran out|0|||
124479106|NCT02901431|447706829|FG011|PK Part|8 weeks of treatment ran out|0|||
124479107|NCT02901431|447706830|FG012|PK Part|8 weeks of treatment ran out|0|||
124479108|NCT02901431|447706818|FG000|PK Part|Stopped treatment after 8 weeks|1|||
124479109|NCT02901431|447706819|FG001|PK Part|Stopped treatment after 8 weeks|0|||
124479110|NCT02901431|447706820|FG002|PK Part|Stopped treatment after 8 weeks|1|||
124479111|NCT02901431|447706821|FG003|PK Part|Stopped treatment after 8 weeks|0|||
124479112|NCT02901431|447706822|FG004|PK Part|Stopped treatment after 8 weeks|0|||
124479113|NCT02901431|447706823|FG005|PK Part|Stopped treatment after 8 weeks|0|||
124479114|NCT02901431|447706824|FG006|PK Part|Stopped treatment after 8 weeks|0|||
124479115|NCT02901431|447706825|FG007|PK Part|Stopped treatment after 8 weeks|0|||
124479116|NCT02901431|447706826|FG008|PK Part|Stopped treatment after 8 weeks|0|||
124479117|NCT02901431|447706827|FG009|PK Part|Stopped treatment after 8 weeks|0|||
124479118|NCT02901431|447706828|FG010|PK Part|Stopped treatment after 8 weeks|0|||
124479119|NCT02901431|447706829|FG011|PK Part|Stopped treatment after 8 weeks|0|||
124479120|NCT02901431|447706830|FG012|PK Part|Stopped treatment after 8 weeks|0|||
124479121|NCT02901431|447706818|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
124479122|NCT02901431|447706819|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
124479123|NCT02901431|447706820|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
124479124|NCT02901431|447706821|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
124479125|NCT02901431|447706822|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
124479126|NCT02901431|447706823|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
124479127|NCT02901431|447706824|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
124479128|NCT02901431|447706825|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
124479129|NCT02901431|447706826|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
124479130|NCT02901431|447706827|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
124479131|NCT02901431|447706828|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
124479132|NCT02901431|447706829|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
124479133|NCT02901431|447706830|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
124479134|NCT02901431|447706818|FG000|PK Part|Discontinued per Sponsor|0|||
124479135|NCT02901431|447706819|FG001|PK Part|Discontinued per Sponsor|3|||
124479136|NCT02901431|447706820|FG002|PK Part|Discontinued per Sponsor|0|||
124479137|NCT02901431|447706821|FG003|PK Part|Discontinued per Sponsor|0|||
124479138|NCT02901431|447706822|FG004|PK Part|Discontinued per Sponsor|0|||
124479139|NCT02901431|447706823|FG005|PK Part|Discontinued per Sponsor|0|||
124479140|NCT02901431|447706824|FG006|PK Part|Discontinued per Sponsor|0|||
124479141|NCT02901431|447706825|FG007|PK Part|Discontinued per Sponsor|0|||
124479142|NCT02901431|447706826|FG008|PK Part|Discontinued per Sponsor|0|||
124479143|NCT02901431|447706827|FG009|PK Part|Discontinued per Sponsor|0|||
124479144|NCT02901431|447706828|FG010|PK Part|Discontinued per Sponsor|0|||
124479145|NCT02901431|447706829|FG011|PK Part|Discontinued per Sponsor|0|||
124479146|NCT02901431|447706830|FG012|PK Part|Discontinued per Sponsor|0|||
124479147|NCT02901431|447706818|FG000|PK Part|Withdrawal by Subject|1|||
124479148|NCT02901431|447706819|FG001|PK Part|Withdrawal by Subject|1|||
124479149|NCT02901431|447706820|FG002|PK Part|Withdrawal by Subject|3|||
124479150|NCT02901431|447706821|FG003|PK Part|Withdrawal by Subject|0|||
124479151|NCT02901431|447706822|FG004|PK Part|Withdrawal by Subject|0|||
124479152|NCT02901431|447706823|FG005|PK Part|Withdrawal by Subject|0|||
124479153|NCT02901431|447706824|FG006|PK Part|Withdrawal by Subject|0|||
124479154|NCT02901431|447706825|FG007|PK Part|Withdrawal by Subject|0|||
124479155|NCT02901431|447706826|FG008|PK Part|Withdrawal by Subject|0|||
124479156|NCT02901431|447706827|FG009|PK Part|Withdrawal by Subject|0|||
124479157|NCT02901431|447706828|FG010|PK Part|Withdrawal by Subject|0|||
124479158|NCT02901431|447706829|FG011|PK Part|Withdrawal by Subject|0|||
124479159|NCT02901431|447706830|FG012|PK Part|Withdrawal by Subject|0|||
124479160|NCT02901431|447706818|FG000|Main Treatment Part|Adverse Event|0|||
124479161|NCT02901431|447706819|FG001|Main Treatment Part|Adverse Event|0|||
124479162|NCT02901431|447706820|FG002|Main Treatment Part|Adverse Event|0|||
124479163|NCT02901431|447706821|FG003|Main Treatment Part|Adverse Event|3|||
124479164|NCT02901431|447706822|FG004|Main Treatment Part|Adverse Event|3|||
124479165|NCT02901431|447706823|FG005|Main Treatment Part|Adverse Event|4|||
124479166|NCT02901431|447706824|FG006|Main Treatment Part|Adverse Event|1|||
124479167|NCT02901431|447706825|FG007|Main Treatment Part|Adverse Event|0|||
124479168|NCT02901431|447706826|FG008|Main Treatment Part|Adverse Event|0|||
124479169|NCT02901431|447706827|FG009|Main Treatment Part|Adverse Event|0|||
124479170|NCT02901431|447706828|FG010|Main Treatment Part|Adverse Event|0|||
124479171|NCT02901431|447706829|FG011|Main Treatment Part|Adverse Event|0|||
124479172|NCT02901431|447706830|FG012|Main Treatment Part|Adverse Event|0|||
124479173|NCT02901431|447706818|FG000|Main Treatment Part|Lack of Efficacy|0|||
124479174|NCT02901431|447706819|FG001|Main Treatment Part|Lack of Efficacy|0|||
124479175|NCT02901431|447706820|FG002|Main Treatment Part|Lack of Efficacy|0|||
124479176|NCT02901431|447706821|FG003|Main Treatment Part|Lack of Efficacy|1|||
124479177|NCT02901431|447706822|FG004|Main Treatment Part|Lack of Efficacy|0|||
124479178|NCT02901431|447706823|FG005|Main Treatment Part|Lack of Efficacy|0|||
124479179|NCT02901431|447706824|FG006|Main Treatment Part|Lack of Efficacy|0|||
124479180|NCT02901431|447706825|FG007|Main Treatment Part|Lack of Efficacy|0|||
124479181|NCT02901431|447706826|FG008|Main Treatment Part|Lack of Efficacy|0|||
124479182|NCT02901431|447706827|FG009|Main Treatment Part|Lack of Efficacy|0|||
124479183|NCT02901431|447706828|FG010|Main Treatment Part|Lack of Efficacy|0|||
124479184|NCT02901431|447706829|FG011|Main Treatment Part|Lack of Efficacy|0|||
124479185|NCT02901431|447706830|FG012|Main Treatment Part|Lack of Efficacy|0|||
124479186|NCT02901431|447706818|FG000|Main Treatment Part|Lost to Follow-up|0|||
124479187|NCT02901431|447706819|FG001|Main Treatment Part|Lost to Follow-up|0|||
124479188|NCT02901431|447706820|FG002|Main Treatment Part|Lost to Follow-up|0|||
124479189|NCT02901431|447706821|FG003|Main Treatment Part|Lost to Follow-up|3|||
124479190|NCT02901431|447706822|FG004|Main Treatment Part|Lost to Follow-up|1|||
124479191|NCT02901431|447706823|FG005|Main Treatment Part|Lost to Follow-up|2|||
124479192|NCT02901431|447706824|FG006|Main Treatment Part|Lost to Follow-up|3|||
124479193|NCT02901431|447706825|FG007|Main Treatment Part|Lost to Follow-up|0|||
124479194|NCT02901431|447706826|FG008|Main Treatment Part|Lost to Follow-up|0|||
124479195|NCT02901431|447706827|FG009|Main Treatment Part|Lost to Follow-up|0|||
124479196|NCT02901431|447706828|FG010|Main Treatment Part|Lost to Follow-up|0|||
124479197|NCT02901431|447706829|FG011|Main Treatment Part|Lost to Follow-up|0|||
124479198|NCT02901431|447706830|FG012|Main Treatment Part|Lost to Follow-up|0|||
124479199|NCT02901431|447706818|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
124479200|NCT02901431|447706819|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
124479201|NCT02901431|447706820|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
124479202|NCT02901431|447706821|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
124479203|NCT02901431|447706822|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
124479204|NCT02901431|447706823|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
124479205|NCT02901431|447706824|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
124479206|NCT02901431|447706825|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
124479207|NCT02901431|447706826|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
124479208|NCT02901431|447706827|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
124479209|NCT02901431|447706828|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
124479210|NCT02901431|447706829|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
124479211|NCT02901431|447706830|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
124719742|NCT02517398|448594915|FG017|Overall Study|Withdrew Consent|2|||
124479212|NCT02901431|447706818|FG000|Main Treatment Part|Physician Decision|0|||
124479213|NCT02901431|447706819|FG001|Main Treatment Part|Physician Decision|0|||
124479214|NCT02901431|447706820|FG002|Main Treatment Part|Physician Decision|0|||
124479215|NCT02901431|447706821|FG003|Main Treatment Part|Physician Decision|1|||
124479216|NCT02901431|447706822|FG004|Main Treatment Part|Physician Decision|0|||
124479217|NCT02901431|447706823|FG005|Main Treatment Part|Physician Decision|0|||
124479218|NCT02901431|447706824|FG006|Main Treatment Part|Physician Decision|1|||
124479219|NCT02901431|447706825|FG007|Main Treatment Part|Physician Decision|0|||
124479220|NCT02901431|447706826|FG008|Main Treatment Part|Physician Decision|0|||
124479221|NCT02901431|447706827|FG009|Main Treatment Part|Physician Decision|0|||
124479222|NCT02901431|447706828|FG010|Main Treatment Part|Physician Decision|0|||
124479223|NCT02901431|447706829|FG011|Main Treatment Part|Physician Decision|0|||
124479224|NCT02901431|447706830|FG012|Main Treatment Part|Physician Decision|0|||
124479225|NCT02901431|447706818|FG000|Main Treatment Part|Withdrawal by Subject|0|||
124479226|NCT02901431|447706819|FG001|Main Treatment Part|Withdrawal by Subject|0|||
124479227|NCT02901431|447706820|FG002|Main Treatment Part|Withdrawal by Subject|0|||
124479228|NCT02901431|447706821|FG003|Main Treatment Part|Withdrawal by Subject|18|||
124479229|NCT02901431|447706822|FG004|Main Treatment Part|Withdrawal by Subject|3|||
124479230|NCT02901431|447706823|FG005|Main Treatment Part|Withdrawal by Subject|5|||
124479231|NCT02901431|447706824|FG006|Main Treatment Part|Withdrawal by Subject|6|||
124479232|NCT02901431|447706825|FG007|Main Treatment Part|Withdrawal by Subject|0|||
124479233|NCT02901431|447706826|FG008|Main Treatment Part|Withdrawal by Subject|0|||
124479234|NCT02901431|447706827|FG009|Main Treatment Part|Withdrawal by Subject|0|||
124479235|NCT02901431|447706828|FG010|Main Treatment Part|Withdrawal by Subject|0|||
124479236|NCT02901431|447706829|FG011|Main Treatment Part|Withdrawal by Subject|0|||
124479237|NCT02901431|447706830|FG012|Main Treatment Part|Withdrawal by Subject|0|||
124479238|NCT02901431|447706818|FG000|Open Label Part|Adverse Event|0|||
124479239|NCT02901431|447706819|FG001|Open Label Part|Adverse Event|0|||
124479240|NCT02901431|447706820|FG002|Open Label Part|Adverse Event|0|||
124479241|NCT02901431|447706821|FG003|Open Label Part|Adverse Event|0|||
124479242|NCT02901431|447706822|FG004|Open Label Part|Adverse Event|0|||
124479243|NCT02901431|447706823|FG005|Open Label Part|Adverse Event|0|||
124479244|NCT02901431|447706824|FG006|Open Label Part|Adverse Event|0|||
124479245|NCT02901431|447706825|FG007|Open Label Part|Adverse Event|0|||
124479246|NCT02901431|447706826|FG008|Open Label Part|Adverse Event|4|||
124479247|NCT02901431|447706827|FG009|Open Label Part|Adverse Event|4|||
124479248|NCT02901431|447706828|FG010|Open Label Part|Adverse Event|0|||
124479249|NCT02901431|447706829|FG011|Open Label Part|Adverse Event|4|||
124479250|NCT02901431|447706830|FG012|Open Label Part|Adverse Event|1|||
124479251|NCT02901431|447706818|FG000|Open Label Part|Lost to Follow-up|0|||
124479252|NCT02901431|447706819|FG001|Open Label Part|Lost to Follow-up|0|||
124479253|NCT02901431|447706820|FG002|Open Label Part|Lost to Follow-up|0|||
124479254|NCT02901431|447706821|FG003|Open Label Part|Lost to Follow-up|0|||
124479255|NCT02901431|447706822|FG004|Open Label Part|Lost to Follow-up|0|||
124479256|NCT02901431|447706823|FG005|Open Label Part|Lost to Follow-up|0|||
124479257|NCT02901431|447706824|FG006|Open Label Part|Lost to Follow-up|0|||
124479258|NCT02901431|447706825|FG007|Open Label Part|Lost to Follow-up|0|||
124479259|NCT02901431|447706826|FG008|Open Label Part|Lost to Follow-up|2|||
124479260|NCT02901431|447706827|FG009|Open Label Part|Lost to Follow-up|2|||
124479261|NCT02901431|447706828|FG010|Open Label Part|Lost to Follow-up|1|||
124479262|NCT02901431|447706829|FG011|Open Label Part|Lost to Follow-up|1|||
124479263|NCT02901431|447706830|FG012|Open Label Part|Lost to Follow-up|1|||
124479264|NCT02901431|447706818|FG000|Open Label Part|Physician Decision|0|||
124479265|NCT02901431|447706819|FG001|Open Label Part|Physician Decision|0|||
124479266|NCT02901431|447706820|FG002|Open Label Part|Physician Decision|0|||
124479267|NCT02901431|447706821|FG003|Open Label Part|Physician Decision|0|||
124479268|NCT02901431|447706822|FG004|Open Label Part|Physician Decision|0|||
124479269|NCT02901431|447706823|FG005|Open Label Part|Physician Decision|0|||
124479270|NCT02901431|447706824|FG006|Open Label Part|Physician Decision|0|||
124479271|NCT02901431|447706825|FG007|Open Label Part|Physician Decision|0|||
124479272|NCT02901431|447706826|FG008|Open Label Part|Physician Decision|1|||
124479273|NCT02901431|447706827|FG009|Open Label Part|Physician Decision|1|||
124479274|NCT02901431|447706828|FG010|Open Label Part|Physician Decision|0|||
124479275|NCT02901431|447706829|FG011|Open Label Part|Physician Decision|0|||
124479276|NCT02901431|447706830|FG012|Open Label Part|Physician Decision|0|||
124479277|NCT02901431|447706818|FG000|Open Label Part|Study Terminated By Sponsor|0|||
124479278|NCT02901431|447706819|FG001|Open Label Part|Study Terminated By Sponsor|0|||
124479279|NCT02901431|447706820|FG002|Open Label Part|Study Terminated By Sponsor|0|||
124479280|NCT02901431|447706821|FG003|Open Label Part|Study Terminated By Sponsor|0|||
124479281|NCT02901431|447706822|FG004|Open Label Part|Study Terminated By Sponsor|0|||
124479282|NCT02901431|447706823|FG005|Open Label Part|Study Terminated By Sponsor|0|||
124479283|NCT02901431|447706824|FG006|Open Label Part|Study Terminated By Sponsor|0|||
124479284|NCT02901431|447706825|FG007|Open Label Part|Study Terminated By Sponsor|0|||
124479285|NCT02901431|447706826|FG008|Open Label Part|Study Terminated By Sponsor|35|||
124479286|NCT02901431|447706827|FG009|Open Label Part|Study Terminated By Sponsor|12|||
124479287|NCT02901431|447706828|FG010|Open Label Part|Study Terminated By Sponsor|21|||
124479288|NCT02901431|447706829|FG011|Open Label Part|Study Terminated By Sponsor|31|||
124479289|NCT02901431|447706830|FG012|Open Label Part|Study Terminated By Sponsor|0|||
124479290|NCT02901431|447706818|FG000|Open Label Part|Withdrawal by Subject|0|||
124479291|NCT02901431|447706819|FG001|Open Label Part|Withdrawal by Subject|0|||
124479292|NCT02901431|447706820|FG002|Open Label Part|Withdrawal by Subject|0|||
124479293|NCT02901431|447706821|FG003|Open Label Part|Withdrawal by Subject|0|||
124479294|NCT02901431|447706822|FG004|Open Label Part|Withdrawal by Subject|0|||
124479295|NCT02901431|447706823|FG005|Open Label Part|Withdrawal by Subject|0|||
124479296|NCT02901431|447706824|FG006|Open Label Part|Withdrawal by Subject|0|||
124479297|NCT02901431|447706825|FG007|Open Label Part|Withdrawal by Subject|0|||
124479298|NCT02901431|447706826|FG008|Open Label Part|Withdrawal by Subject|6|||
124719743|NCT02517398|448594916|FG018|Overall Study|Withdrew Consent|3|||
124479299|NCT02901431|447706827|FG009|Open Label Part|Withdrawal by Subject|5|||
124479300|NCT02901431|447706828|FG010|Open Label Part|Withdrawal by Subject|7|||
124479301|NCT02901431|447706829|FG011|Open Label Part|Withdrawal by Subject|3|||
124479302|NCT02901431|447706830|FG012|Open Label Part|Withdrawal by Subject|1|||
124479303|NCT00404092|447706831|FG000|Overall Study|Death|1|||
124479304|NCT00404092|447706832|FG001|Overall Study|Death|0|||
124479305|NCT00404092|447706833|FG002|Overall Study|Death|0|||
124479306|NCT00404092|447706834|FG003|Overall Study|Death|0|||
124479307|NCT00404092|447706831|FG000|Overall Study|Adverse Event|0|||
124479308|NCT00404092|447706832|FG001|Overall Study|Adverse Event|0|||
124479309|NCT00404092|447706833|FG002|Overall Study|Adverse Event|1|||
124479310|NCT00404092|447706834|FG003|Overall Study|Adverse Event|0|||
124479311|NCT04223609|447706835|FG000|Overall Study|Adverse Event|0|||
124479312|NCT04223609|447706836|FG001|Overall Study|Adverse Event|1|||
124479313|NCT04223609|447706835|FG000|Overall Study|Missed last visit|0|||
124479314|NCT04223609|447706836|FG001|Overall Study|Missed last visit|1|||
124557242|NCT00124449|447997772|FG000|18-Month Untreated Observation Period|Relocated|1|||
124557243|NCT00124449|447997773|FG001|18-Month Untreated Observation Period|Relocated|0|||
124557244|NCT00571922|447997774|FG000|Overall Study|Completion unknown|36|||
124479315|NCT06119191|447706842|FG000|Overall Study|Adverse Event|0|||
124479316|NCT06119191|447706843|FG001|Overall Study|Adverse Event|1|||
124479317|NCT06119191|447706842|FG000|Overall Study|Protocol Violation|1|||
124479318|NCT06119191|447706843|FG001|Overall Study|Protocol Violation|0|||
124479319|NCT02612909|447709025|FG000|Phase 2|Withdrawal by Subject|2|||
124479320|NCT02612909|447709026|FG001|Phase 2|Withdrawal by Subject|5|||
124479321|NCT02612909|447709027|FG002|Phase 2|Withdrawal by Subject|0|||
124479322|NCT02612909|447709028|FG003|Phase 2|Withdrawal by Subject|0|||
124479323|NCT02612909|447709029|FG004|Phase 2|Withdrawal by Subject|0|||
124479324|NCT02612909|447709025|FG000|Phase 2|Pregnancy|0|||
124479325|NCT02612909|447709026|FG001|Phase 2|Pregnancy|0|||
124479326|NCT02612909|447709027|FG002|Phase 2|Pregnancy|1|||
124479327|NCT02612909|447709028|FG003|Phase 2|Pregnancy|0|||
124479328|NCT02612909|447709029|FG004|Phase 2|Pregnancy|0|||
124479329|NCT02612909|447709025|FG000|Phase 3|Withdrawal by Subject|0|||
124479330|NCT02612909|447709026|FG001|Phase 3|Withdrawal by Subject|0|||
124479331|NCT02612909|447709027|FG002|Phase 3|Withdrawal by Subject|0|||
124479332|NCT02612909|447709028|FG003|Phase 3|Withdrawal by Subject|1|||
124479333|NCT02612909|447709029|FG004|Phase 3|Withdrawal by Subject|0|||
124479334|NCT00450580|447709031|FG000|Overall Study|Adverse Event|5|||
124479335|NCT00450580|447709032|FG001|Overall Study|Adverse Event|7|||
124479336|NCT00450580|447709031|FG000|Overall Study|Lost to Follow-up|4|||
124479337|NCT00450580|447709032|FG001|Overall Study|Lost to Follow-up|5|||
124479338|NCT00450580|447709031|FG000|Overall Study|Withdrawal by Subject|2|||
124479339|NCT00450580|447709032|FG001|Overall Study|Withdrawal by Subject|2|||
124479340|NCT00450580|447709031|FG000|Overall Study|Protocol Violation|1|||
124479341|NCT00450580|447709032|FG001|Overall Study|Protocol Violation|1|||
124479342|NCT00450580|447709031|FG000|Overall Study|Protocol-defined virologic failure|1|||
124479343|NCT00450580|447709032|FG001|Overall Study|Protocol-defined virologic failure|0|||
124479344|NCT00450580|447709031|FG000|Overall Study|Could not comply with scheduled visits|1|||
124479345|NCT00450580|447709032|FG001|Overall Study|Could not comply with scheduled visits|0|||
124479346|NCT00450580|447709031|FG000|Overall Study|Patient went to Brazil|1|||
124479347|NCT00450580|447709032|FG001|Overall Study|Patient went to Brazil|0|||
124479348|NCT00450580|447709031|FG000|Overall Study|Patient could not swallow Norvir|1|||
124479349|NCT00450580|447709032|FG001|Overall Study|Patient could not swallow Norvir|0|||
124479350|NCT00450580|447709031|FG000|Overall Study|Withdrawal due to pregnancy|0|||
124479351|NCT00450580|447709032|FG001|Overall Study|Withdrawal due to pregnancy|1|||
124479352|NCT04938648|447709033|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
124479353|NCT04938648|447709034|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
124479354|NCT04938648|447709033|FG000|Overall Study|Patient too ill|0|||
124479355|NCT04938648|447709034|FG001|Overall Study|Patient too ill|1|||
124479356|NCT04938648|447709033|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
124479357|NCT04938648|447709034|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
124479358|NCT04938648|447709033|FG000|Overall Study|Patient did not have memory problems|1|||
124479359|NCT04938648|447709034|FG001|Overall Study|Patient did not have memory problems|1|||
124479360|NCT04938648|447709033|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
124479361|NCT04938648|447709034|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
124479362|NCT04938648|447709033|FG000|Overall Study|Care partner could not be reached|0|||
124479363|NCT04938648|447709034|FG001|Overall Study|Care partner could not be reached|1|||
124557245|NCT00571922|447997775|FG001|Overall Study|Completion unknown|36|||
124479364|NCT04938648|447709033|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
124479365|NCT04938648|447709034|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
124479366|NCT04938648|447709033|FG000|Overall Study|Withdrawal by Subject|2|||
124479367|NCT04938648|447709034|FG001|Overall Study|Withdrawal by Subject|1|||
124479368|NCT03293654|447709035|FG000|Overall Study|Lost to Follow-up|0|||
124479369|NCT03293654|447709036|FG001|Overall Study|Lost to Follow-up|1|||
124479370|NCT03293654|447709037|FG002|Overall Study|Lost to Follow-up|0|||
124479371|NCT00158184|447709046|FG000|Overall Study|personal issues|3|||
124479372|NCT00158184|447709047|FG001|Overall Study|personal issues|1|||
124479373|NCT00158184|447709046|FG000|Overall Study|failed for follow unit/study rules|2|||
124479374|NCT00158184|447709047|FG001|Overall Study|failed for follow unit/study rules|0|||
124479375|NCT00158184|447709046|FG000|Overall Study|Adverse Event|1|||
124479376|NCT00158184|447709047|FG001|Overall Study|Adverse Event|1|||
124479377|NCT05340504|447709048|FG000|Overall Study|Withdrawal by Subject|1|||
124479378|NCT05340504|447709049|FG001|Overall Study|Withdrawal by Subject|0|||
124479379|NCT00619957|447709053|FG000|Month 24 Double-Blind|Adverse Event|9|||
124479380|NCT00619957|447709054|FG001|Month 24 Double-Blind|Adverse Event|7|||
124479381|NCT00619957|447709053|FG000|Month 24 Double-Blind|Protocol Violation|1|||
124479382|NCT00619957|447709054|FG001|Month 24 Double-Blind|Protocol Violation|0|||
124479383|NCT00619957|447709053|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
124479384|NCT00619957|447709054|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
124479385|NCT00619957|447709053|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
124479386|NCT00619957|447709054|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
124479387|NCT00619957|447709053|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
124479388|NCT00619957|447709054|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
124479389|NCT00619957|447709053|FG000|Month 48 Open-Label|Adverse Event|4|||
124479390|NCT00619957|447709054|FG001|Month 48 Open-Label|Adverse Event|4|||
124479391|NCT00619957|447709053|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
124479392|NCT00619957|447709054|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
124479393|NCT00619957|447709053|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
124479394|NCT00619957|447709054|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
124479395|NCT03401749|447709055|FG000|Overall Study|Lost to Follow-up|20|||
124479396|NCT03401749|447709056|FG001|Overall Study|Lost to Follow-up|16|||
124479397|NCT03401749|447709057|FG002|Overall Study|Lost to Follow-up|26|||
124479398|NCT00190775|447709058|FG000|Overall Study|Adverse Event|57|||
124479399|NCT00190775|447709059|FG001|Overall Study|Adverse Event|22|||
124479400|NCT00190775|447709058|FG000|Overall Study|Satisfactory Response|1|||
124479401|NCT00190775|447709059|FG001|Overall Study|Satisfactory Response|0|||
124479402|NCT00190775|447709058|FG000|Overall Study|Lack of Efficacy|28|||
124479403|NCT00190775|447709059|FG001|Overall Study|Lack of Efficacy|32|||
124479404|NCT00190775|447709058|FG000|Overall Study|Lost to Follow-up|31|||
124479405|NCT00190775|447709059|FG001|Overall Study|Lost to Follow-up|23|||
124479406|NCT00190775|447709058|FG000|Overall Study|Participant Moved|0|||
124479407|NCT00190775|447709059|FG001|Overall Study|Participant Moved|1|||
124479408|NCT00190775|447709058|FG000|Overall Study|Withdrawal by Subject|24|||
124479409|NCT00190775|447709059|FG001|Overall Study|Withdrawal by Subject|13|||
124479410|NCT00190775|447709058|FG000|Overall Study|Sponsor Decision|1|||
124479411|NCT00190775|447709059|FG001|Overall Study|Sponsor Decision|0|||
124479412|NCT00190775|447709058|FG000|Overall Study|Physician Decision|3|||
124479413|NCT00190775|447709059|FG001|Overall Study|Physician Decision|0|||
124479414|NCT00190775|447709058|FG000|Overall Study|Noncompliance|3|||
124479415|NCT00190775|447709059|FG001|Overall Study|Noncompliance|5|||
124479416|NCT00190775|447709058|FG000|Overall Study|Protocol Violation|0|||
124479417|NCT00190775|447709059|FG001|Overall Study|Protocol Violation|1|||
124479418|NCT00190775|447709058|FG000|Overall Study|Exclusion Criteria Met|1|||
124479419|NCT00190775|447709059|FG001|Overall Study|Exclusion Criteria Met|3|||
124479420|NCT01526148|447709060|FG000|Overall Study|Adverse Event|6|||
124479421|NCT01526148|447709061|FG001|Overall Study|Adverse Event|5|||
124479422|NCT01526148|447709060|FG000|Overall Study|Lost to Follow-up|3|||
124479423|NCT01526148|447709061|FG001|Overall Study|Lost to Follow-up|6|||
124479424|NCT01526148|447709060|FG000|Overall Study|Withdrawal by Subject|2|||
124479425|NCT01526148|447709061|FG001|Overall Study|Withdrawal by Subject|0|||
124479426|NCT01526148|447709060|FG000|Overall Study|Unstable Medical Condition|1|||
124479427|NCT01526148|447709061|FG001|Overall Study|Unstable Medical Condition|0|||
124479428|NCT01526148|447709060|FG000|Overall Study|Unable to discontinue concomitant med|1|||
124479429|NCT01526148|447709061|FG001|Overall Study|Unable to discontinue concomitant med|0|||
124479430|NCT01526148|447709060|FG000|Overall Study|Moved out of state|1|||
124479431|NCT01526148|447709061|FG001|Overall Study|Moved out of state|0|||
124479432|NCT01526148|447709060|FG000|Overall Study|Incarcerated|0|||
124557246|NCT02191579|447997781|FG000|Treatment 1|Multiple Reasons Specified|27|||
124719744|NCT02517398|448594917|FG019|Overall Study|Withdrew Consent|2|||
124479433|NCT01526148|447709061|FG001|Overall Study|Incarcerated|2|||
124479434|NCT01173653|447709062|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
124479435|NCT01173653|447709063|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
124479436|NCT00481065|447709064|FG000|Overall Study|Adverse event or death|1|||
124479437|NCT00481065|447709065|FG001|Overall Study|Adverse event or death|1|||
124719745|NCT02517398|448594918|FG020|Overall Study|Withdrew Consent|9|||
124719746|NCT02517398|448594919|FG021|Overall Study|Withdrew Consent|3|||
124719747|NCT02517398|448594920|FG022|Overall Study|Withdrew Consent|1|||
124719748|NCT00005947|448594924|FG000|Overall Study|Death|54|||
124479438|NCT00481065|447709066|FG002|Overall Study|Adverse event or death|3|||
124479439|NCT00481065|447709067|FG003|Overall Study|Adverse event or death|0|||
124479440|NCT00481065|447709068|FG004|Overall Study|Adverse event or death|2|||
124479441|NCT00481065|447709069|FG005|Overall Study|Adverse event or death|0|||
124479442|NCT00481065|447709070|FG006|Overall Study|Adverse event or death|1|||
124479443|NCT00481065|447709071|FG007|Overall Study|Adverse event or death|1|||
124479444|NCT00481065|447709064|FG000|Overall Study|Withdrawal by Subject|11|||
124479445|NCT00481065|447709065|FG001|Overall Study|Withdrawal by Subject|12|||
124479446|NCT00481065|447709066|FG002|Overall Study|Withdrawal by Subject|7|||
124479447|NCT00481065|447709067|FG003|Overall Study|Withdrawal by Subject|11|||
124479448|NCT00481065|447709068|FG004|Overall Study|Withdrawal by Subject|13|||
124479449|NCT00481065|447709069|FG005|Overall Study|Withdrawal by Subject|12|||
124479450|NCT00481065|447709070|FG006|Overall Study|Withdrawal by Subject|9|||
124479451|NCT00481065|447709071|FG007|Overall Study|Withdrawal by Subject|10|||
124719749|NCT00005947|448594925|FG001|Overall Study|Death|40|||
124557247|NCT02191579|447997782|FG001|Treatment 1|Multiple Reasons Specified|58|||
124557248|NCT02191579|447997781|FG000|Treatment 2|Multiple Reasons Specified|0|||
124557249|NCT02191579|447997782|FG001|Treatment 2|Multiple Reasons Specified|25|||
124719750|NCT00005947|448594924|FG000|Overall Study|Patient Refused to Continue|2|||
124719751|NCT00005947|448594925|FG001|Overall Study|Patient Refused to Continue|1|||
124479452|NCT00481065|447709064|FG000|Overall Study|Lost to Follow-up|4|||
124479453|NCT00481065|447709065|FG001|Overall Study|Lost to Follow-up|2|||
124479454|NCT00481065|447709066|FG002|Overall Study|Lost to Follow-up|4|||
124479455|NCT00481065|447709067|FG003|Overall Study|Lost to Follow-up|3|||
124479456|NCT00481065|447709068|FG004|Overall Study|Lost to Follow-up|3|||
124479457|NCT00481065|447709069|FG005|Overall Study|Lost to Follow-up|3|||
124479458|NCT00481065|447709070|FG006|Overall Study|Lost to Follow-up|2|||
124479459|NCT00481065|447709071|FG007|Overall Study|Lost to Follow-up|5|||
124479460|NCT00481065|447709064|FG000|Overall Study|Inappropriate enrollment|4|||
124479461|NCT00481065|447709065|FG001|Overall Study|Inappropriate enrollment|0|||
124479462|NCT00481065|447709066|FG002|Overall Study|Inappropriate enrollment|2|||
124479463|NCT00481065|447709067|FG003|Overall Study|Inappropriate enrollment|0|||
124479464|NCT00481065|447709068|FG004|Overall Study|Inappropriate enrollment|2|||
124479465|NCT00481065|447709069|FG005|Overall Study|Inappropriate enrollment|1|||
124479466|NCT00481065|447709070|FG006|Overall Study|Inappropriate enrollment|0|||
124479467|NCT00481065|447709071|FG007|Overall Study|Inappropriate enrollment|1|||
124479468|NCT00481065|447709064|FG000|Overall Study|Administrative reason|0|||
124479469|NCT00481065|447709065|FG001|Overall Study|Administrative reason|0|||
124479470|NCT00481065|447709066|FG002|Overall Study|Administrative reason|0|||
124479471|NCT00481065|447709067|FG003|Overall Study|Administrative reason|0|||
124479472|NCT00481065|447709068|FG004|Overall Study|Administrative reason|0|||
124479473|NCT00481065|447709069|FG005|Overall Study|Administrative reason|2|||
124479474|NCT00481065|447709070|FG006|Overall Study|Administrative reason|1|||
124479475|NCT00481065|447709071|FG007|Overall Study|Administrative reason|0|||
124479476|NCT00481065|447709064|FG000|Overall Study|Protocol Violation|2|||
124479477|NCT00481065|447709065|FG001|Overall Study|Protocol Violation|1|||
124479478|NCT00481065|447709066|FG002|Overall Study|Protocol Violation|1|||
124479479|NCT00481065|447709067|FG003|Overall Study|Protocol Violation|1|||
124479480|NCT00481065|447709068|FG004|Overall Study|Protocol Violation|2|||
124479481|NCT00481065|447709069|FG005|Overall Study|Protocol Violation|6|||
124479482|NCT00481065|447709070|FG006|Overall Study|Protocol Violation|3|||
124479483|NCT00481065|447709071|FG007|Overall Study|Protocol Violation|2|||
124479484|NCT00481065|447709064|FG000|Overall Study|Unable to classify|0|||
124479485|NCT00481065|447709065|FG001|Overall Study|Unable to classify|1|||
124479486|NCT00481065|447709066|FG002|Overall Study|Unable to classify|2|||
124479487|NCT00481065|447709067|FG003|Overall Study|Unable to classify|0|||
124479488|NCT00481065|447709068|FG004|Overall Study|Unable to classify|1|||
124479489|NCT00481065|447709069|FG005|Overall Study|Unable to classify|0|||
124479490|NCT00481065|447709070|FG006|Overall Study|Unable to classify|0|||
124479491|NCT00481065|447709071|FG007|Overall Study|Unable to classify|0|||
124479492|NCT01709331|447709074|FG000|Overall Study|Adverse Event|1|||
124479493|NCT01651780|447709080|FG000|Overall Study|Physician decision: No 30-day visit|2|||
124479494|NCT01651780|447709081|FG001|Overall Study|Physician decision: No 30-day visit|1|||
124479495|NCT01651780|447709080|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
124479496|NCT01651780|447709081|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
124479497|NCT01651780|447709080|FG000|Overall Study|Withdrawal by Subject|2|||
124479498|NCT01651780|447709081|FG001|Overall Study|Withdrawal by Subject|0|||
124719752|NCT00005947|448594924|FG000|Overall Study|Site Closure|1|||
124719753|NCT00005947|448594925|FG001|Overall Study|Site Closure|0|||
124479499|NCT01651780|447709080|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
124479500|NCT01651780|447709081|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124479501|NCT01651780|447709080|FG000|Overall Study|Lost to Follow-up|1|||
124479502|NCT01651780|447709081|FG001|Overall Study|Lost to Follow-up|2|||
124479503|NCT01651780|447709080|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
124479504|NCT01651780|447709081|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
124479505|NCT01628926|447709082|FG000|Overall Study|Adverse Event|13|||
124479506|NCT01628926|447709083|FG001|Overall Study|Adverse Event|11|||
124479507|NCT01628926|447709084|FG002|Overall Study|Adverse Event|9|||
124479508|NCT01628926|447709082|FG000|Overall Study|Lack of Efficacy|2|||
124479509|NCT01628926|447709083|FG001|Overall Study|Lack of Efficacy|1|||
124479510|NCT01628926|447709084|FG002|Overall Study|Lack of Efficacy|5|||
124479511|NCT01628926|447709082|FG000|Overall Study|Withdrawal by Subject|6|||
124479512|NCT01628926|447709083|FG001|Overall Study|Withdrawal by Subject|4|||
124479513|NCT01628926|447709084|FG002|Overall Study|Withdrawal by Subject|2|||
124479514|NCT01628926|447709082|FG000|Overall Study|Protocol Violation|0|||
124479515|NCT01628926|447709083|FG001|Overall Study|Protocol Violation|1|||
124479516|NCT01628926|447709084|FG002|Overall Study|Protocol Violation|0|||
124479517|NCT01628926|447709082|FG000|Overall Study|Discontinuation criteria|3|||
124479518|NCT01628926|447709083|FG001|Overall Study|Discontinuation criteria|4|||
124479519|NCT01628926|447709084|FG002|Overall Study|Discontinuation criteria|0|||
124479520|NCT01628926|447709082|FG000|Overall Study|Physician Decision|2|||
124719754|NCT00429182|448594926|FG000|Overall Study|Not evaluable, Disease Progression|2|||
124719755|NCT00429182|448594926|FG000|Overall Study|Not eligible|5|||
124719756|NCT02195700|448594934|FG000|Overall Study|Protocol Violation|0|||
124719757|NCT02195700|448594935|FG001|Overall Study|Protocol Violation|2|||
124719758|NCT02195700|448594934|FG000|Overall Study|Noncompliance|1|||
124479521|NCT01628926|447709083|FG001|Overall Study|Physician Decision|2|||
124479522|NCT01628926|447709084|FG002|Overall Study|Physician Decision|1|||
124719759|NCT02195700|448594935|FG001|Overall Study|Noncompliance|0|||
124479523|NCT03029832|447709085|FG000|Overall Study|Safety Follow-Up Completed|2|||
124719760|NCT02195700|448594934|FG000|Overall Study|Adverse Event|1|||
124479524|NCT03029832|447709086|FG001|Overall Study|Safety Follow-Up Completed|0|||
124479525|NCT03029832|447709085|FG000|Overall Study|Death due to Disease Progression|1|||
124479526|NCT03029832|447709086|FG001|Overall Study|Death due to Disease Progression|0|||
124479527|NCT03029832|447709085|FG000|Overall Study|Study Terminated By Sponsor|1|||
124479528|NCT03029832|447709086|FG001|Overall Study|Study Terminated By Sponsor|1|||
124479529|NCT01275222|447709095|FG000|Phase l by Treatment|Adverse Event|1|||
124479530|NCT01275222|447709096|FG001|Phase l by Treatment|Adverse Event|4|||
124479531|NCT01275222|447709097|FG002|Phase l by Treatment|Adverse Event|2|||
124479532|NCT01275222|447709098|FG003|Phase l by Treatment|Adverse Event|3|||
124479533|NCT01275222|447709099|FG004|Phase l by Treatment|Adverse Event|0|||
124479534|NCT01275222|447709100|FG005|Phase l by Treatment|Adverse Event|0|||
124479535|NCT01275222|447709095|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
124479536|NCT01275222|447709096|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
124479537|NCT01275222|447709097|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
124479538|NCT01275222|447709098|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
124479539|NCT01275222|447709099|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
124479540|NCT01275222|447709100|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
124479541|NCT01275222|447709095|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
124479542|NCT01275222|447709096|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
124479543|NCT01275222|447709097|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
124479544|NCT01275222|447709098|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
124479545|NCT01275222|447709099|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
124479546|NCT01275222|447709100|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
124479547|NCT01275222|447709095|FG000|Phase l by Treatment|Disease progression|12|||
124479548|NCT01275222|447709096|FG001|Phase l by Treatment|Disease progression|8|||
124479549|NCT01275222|447709097|FG002|Phase l by Treatment|Disease progression|2|||
124479550|NCT01275222|447709098|FG003|Phase l by Treatment|Disease progression|5|||
124479551|NCT01275222|447709099|FG004|Phase l by Treatment|Disease progression|0|||
124479552|NCT01275222|447709100|FG005|Phase l by Treatment|Disease progression|0|||
124479553|NCT01275222|447709095|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
124557250|NCT03940586|447997792|FG000|Overall Study|Death|3|||
124557251|NCT03940586|447997793|FG001|Overall Study|Death|2|||
124719761|NCT02195700|448594935|FG001|Overall Study|Adverse Event|2|||
124479554|NCT01275222|447709096|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
124479555|NCT01275222|447709097|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
124479556|NCT01275222|447709098|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
124479557|NCT01275222|447709099|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
124479558|NCT01275222|447709100|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
124479559|NCT01275222|447709095|FG000|Phase l by Treatment|Death|0|||
124479560|NCT01275222|447709096|FG001|Phase l by Treatment|Death|1|||
124479561|NCT01275222|447709097|FG002|Phase l by Treatment|Death|0|||
124479562|NCT01275222|447709098|FG003|Phase l by Treatment|Death|1|||
124479563|NCT01275222|447709099|FG004|Phase l by Treatment|Death|0|||
124719762|NCT02195700|448594934|FG000|Overall Study|Withdrawal by Subject|3|||
124719763|NCT02195700|448594935|FG001|Overall Study|Withdrawal by Subject|2|||
124479564|NCT01275222|447709100|FG005|Phase l by Treatment|Death|0|||
124719764|NCT02195700|448594934|FG000|Overall Study|Lost to Follow-up|1|||
124719765|NCT02195700|448594935|FG001|Overall Study|Lost to Follow-up|1|||
124719766|NCT03110029|448594936|FG000|Overall Study|Withdrawal by Subject|1|||
124719767|NCT03110029|448594937|FG001|Overall Study|Withdrawal by Subject|1|||
124719768|NCT02524145|448594939|FG000|Overall Study|Withdrawal by Subject|2|||
124719769|NCT02524145|448594940|FG001|Overall Study|Withdrawal by Subject|2|||
124719770|NCT02524145|448594941|FG002|Overall Study|Withdrawal by Subject|3|||
124479565|NCT01275222|447709095|FG000|Phase ll by Stratum|Adverse Event|0|||
124479566|NCT01275222|447709096|FG001|Phase ll by Stratum|Adverse Event|0|||
124479567|NCT01275222|447709097|FG002|Phase ll by Stratum|Adverse Event|0|||
124719771|NCT00283803|448596733|FG000|Overall Study|Physician Decision|9|||
124719772|NCT00283803|448596733|FG000|Overall Study|Withdrawal by Subject|4|||
124479568|NCT01275222|447709098|FG003|Phase ll by Stratum|Adverse Event|0|||
124719773|NCT01127607|448596734|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
124719774|NCT01127607|448596735|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
124719775|NCT01127607|448596734|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
124719776|NCT01127607|448596735|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
124719777|NCT02220855|448596736|FG000|Overall Study|Adverse Event|8|||
124719778|NCT02220855|448596736|FG000|Overall Study|Disease Progression|5|||
124719779|NCT02220855|448596736|FG000|Overall Study|Withdrawal by Subject|1|||
124719780|NCT03107052|448596751|FG000|Overall Study|Adverse Event|6|||
124719781|NCT03107052|448596752|FG001|Overall Study|Adverse Event|1|||
124719782|NCT03107052|448596753|FG002|Overall Study|Adverse Event|2|||
124719783|NCT03107052|448596751|FG000|Overall Study|Withdrawal by Subject|9|||
124719784|NCT03107052|448596752|FG001|Overall Study|Withdrawal by Subject|5|||
124719785|NCT03107052|448596753|FG002|Overall Study|Withdrawal by Subject|8|||
124719786|NCT03107052|448596751|FG000|Overall Study|Protocol Violation|6|||
124719787|NCT03107052|448596752|FG001|Overall Study|Protocol Violation|0|||
124557252|NCT03940586|447997794|FG002|Overall Study|Death|0|||
124557253|NCT03940586|447997792|FG000|Overall Study|Physician Decision|1|||
124557254|NCT03940586|447997793|FG001|Overall Study|Physician Decision|0|||
124557255|NCT03940586|447997794|FG002|Overall Study|Physician Decision|1|||
124557256|NCT03940586|447997792|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
124557257|NCT03940586|447997793|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
124557258|NCT03940586|447997794|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
124479569|NCT01275222|447709099|FG004|Phase ll by Stratum|Adverse Event|2|||
124479570|NCT01275222|447709100|FG005|Phase ll by Stratum|Adverse Event|10|||
124479571|NCT01275222|447709095|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
124479572|NCT01275222|447709096|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
124479573|NCT01275222|447709097|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
124557259|NCT03940586|447997792|FG000|Overall Study|Not Treated|0|||
124557260|NCT03940586|447997793|FG001|Overall Study|Not Treated|2|||
124557261|NCT03940586|447997794|FG002|Overall Study|Not Treated|0|||
124557262|NCT00964223|447997795|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
124557263|NCT00811070|447997796|FG000|Overall Study|Death|0|||
124557264|NCT00811070|447997797|FG001|Overall Study|Death|0|||
124479574|NCT01275222|447709098|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
124479575|NCT01275222|447709099|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
124479576|NCT01275222|447709100|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
124479577|NCT01275222|447709095|FG000|Phase ll by Stratum|Disease progression|0|||
124557265|NCT00811070|447997798|FG002|Overall Study|Death|0|||
124557266|NCT00811070|447997799|FG003|Overall Study|Death|2|||
124557267|NCT00811070|447997800|FG004|Overall Study|Death|5|||
124557268|NCT00811070|447997801|FG005|Overall Study|Death|0|||
124557269|NCT00811070|447997796|FG000|Overall Study|Other|1|||
124557270|NCT00811070|447997797|FG001|Overall Study|Other|0|||
124557271|NCT00811070|447997798|FG002|Overall Study|Other|0|||
124557272|NCT00811070|447997799|FG003|Overall Study|Other|0|||
124557273|NCT00811070|447997800|FG004|Overall Study|Other|0|||
124557274|NCT00811070|447997801|FG005|Overall Study|Other|0|||
124557275|NCT00811070|447997796|FG000|Overall Study|Withdrawal by Subject|0|||
124557276|NCT00811070|447997797|FG001|Overall Study|Withdrawal by Subject|1|||
124719788|NCT03107052|448596753|FG002|Overall Study|Protocol Violation|3|||
124479578|NCT01275222|447709096|FG001|Phase ll by Stratum|Disease progression|0|||
124479579|NCT01275222|447709097|FG002|Phase ll by Stratum|Disease progression|0|||
124479580|NCT01275222|447709098|FG003|Phase ll by Stratum|Disease progression|0|||
124479581|NCT01275222|447709099|FG004|Phase ll by Stratum|Disease progression|23|||
124479582|NCT01275222|447709100|FG005|Phase ll by Stratum|Disease progression|31|||
124479583|NCT01275222|447709095|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
124557277|NCT00811070|447997798|FG002|Overall Study|Withdrawal by Subject|0|||
124557278|NCT00811070|447997799|FG003|Overall Study|Withdrawal by Subject|0|||
124557279|NCT00811070|447997800|FG004|Overall Study|Withdrawal by Subject|0|||
124557280|NCT00811070|447997801|FG005|Overall Study|Withdrawal by Subject|0|||
124557281|NCT00811070|447997796|FG000|Overall Study|Physician Decision|0|||
124557282|NCT00811070|447997797|FG001|Overall Study|Physician Decision|0|||
124557283|NCT00811070|447997798|FG002|Overall Study|Physician Decision|0|||
124557284|NCT00811070|447997799|FG003|Overall Study|Physician Decision|0|||
124557285|NCT00811070|447997800|FG004|Overall Study|Physician Decision|0|||
124557286|NCT00811070|447997801|FG005|Overall Study|Physician Decision|1|||
124557287|NCT01585831|447997806|FG000|Overall Study|Physician Decision|0|||
124557288|NCT01585831|447997807|FG001|Overall Study|Physician Decision|1|||
124557289|NCT01585831|447997806|FG000|Overall Study|Withdrawal by Subject|2|||
124557290|NCT01585831|447997807|FG001|Overall Study|Withdrawal by Subject|1|||
124557291|NCT02046369|447997808|FG000|Overall Study|Adverse Event|3|||
124557292|NCT02046369|447997809|FG001|Overall Study|Adverse Event|3|||
124557293|NCT02046369|447997808|FG000|Overall Study|Lack of Efficacy|3|||
124557294|NCT02046369|447997809|FG001|Overall Study|Lack of Efficacy|3|||
124557295|NCT02046369|447997808|FG000|Overall Study|Lost to Follow-up|3|||
124557296|NCT02046369|447997809|FG001|Overall Study|Lost to Follow-up|3|||
124557297|NCT02046369|447997808|FG000|Overall Study|Protocol Violation|1|||
124557298|NCT02046369|447997809|FG001|Overall Study|Protocol Violation|2|||
124557299|NCT02046369|447997808|FG000|Overall Study|Withdrawal by Subject|3|||
124557300|NCT02046369|447997809|FG001|Overall Study|Withdrawal by Subject|6|||
124557301|NCT02046369|447997808|FG000|Overall Study|never received study drug|0|||
124557302|NCT02046369|447997809|FG001|Overall Study|never received study drug|1|||
124557303|NCT02046369|447997808|FG000|Overall Study|non compliance|1|||
124557304|NCT02046369|447997809|FG001|Overall Study|non compliance|0|||
124557305|NCT03120520|447997810|FG000|Overall Study|Lost to Follow-up|1|||
124557306|NCT03120520|447997811|FG001|Overall Study|Lost to Follow-up|1|||
124557307|NCT03120520|447997812|FG002|Overall Study|Lost to Follow-up|1|||
124557308|NCT03120520|447997813|FG003|Overall Study|Lost to Follow-up|1|||
124557309|NCT03120520|447997810|FG000|Overall Study|Withdrawal by Subject|3|||
124557310|NCT03120520|447997811|FG001|Overall Study|Withdrawal by Subject|2|||
124557311|NCT03120520|447997812|FG002|Overall Study|Withdrawal by Subject|3|||
124557312|NCT03120520|447997813|FG003|Overall Study|Withdrawal by Subject|2|||
124557313|NCT03120520|447997810|FG000|Overall Study|Other|0|||
124719789|NCT03107052|448596751|FG000|Overall Study|Lost to Follow-up|4|||
124719790|NCT03107052|448596752|FG001|Overall Study|Lost to Follow-up|0|||
124719791|NCT03107052|448596753|FG002|Overall Study|Lost to Follow-up|1|||
124719792|NCT03107052|448596751|FG000|Overall Study|Lack of Efficacy|23|||
124719793|NCT03107052|448596752|FG001|Overall Study|Lack of Efficacy|7|||
124719794|NCT03107052|448596753|FG002|Overall Study|Lack of Efficacy|4|||
124719795|NCT03107052|448596751|FG000|Overall Study|Other than specified|4|||
124557314|NCT03120520|447997811|FG001|Overall Study|Other|1|||
124719796|NCT03107052|448596752|FG001|Overall Study|Other than specified|2|||
124557315|NCT03120520|447997812|FG002|Overall Study|Other|0|||
124557316|NCT03120520|447997813|FG003|Overall Study|Other|0|||
124557317|NCT01759537|447997815|FG000|Overall Study|Death|1|||
124557318|NCT01759537|447997816|FG001|Overall Study|Death|1|||
124557319|NCT01759537|447997815|FG000|Overall Study|Pregnancy|1|||
124557320|NCT01759537|447997816|FG001|Overall Study|Pregnancy|1|||
124719797|NCT03107052|448596753|FG002|Overall Study|Other than specified|0|||
124719798|NCT03107052|448596751|FG000|Overall Study|Study terminated due to futility|67|||
124719799|NCT03107052|448596752|FG001|Overall Study|Study terminated due to futility|31|||
124719800|NCT03107052|448596753|FG002|Overall Study|Study terminated due to futility|23|||
124719801|NCT02263326|448596754|FG000|Overall Study|Lost to Follow-up|1|||
124719802|NCT02263326|448596755|FG001|Overall Study|Lost to Follow-up|1|||
124479584|NCT01275222|447709096|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
124479585|NCT01275222|447709097|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
124479586|NCT01275222|447709098|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
124479587|NCT01275222|447709099|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
124719803|NCT02397915|448596756|FG000|Period 1|Protocol Violation|0|||
124719804|NCT02397915|448596757|FG001|Period 1|Protocol Violation|1|||
124719805|NCT02397915|448596758|FG002|Period 1|Protocol Violation|0|||
124719806|NCT02397915|448596759|FG003|Period 1|Protocol Violation|0|||
124719807|NCT02397915|448596756|FG000|Period 1|Physician Decision|1|||
124557321|NCT01759537|447997815|FG000|Overall Study|Lost to Follow-up|9|||
124719808|NCT02397915|448596757|FG001|Period 1|Physician Decision|0|||
124719809|NCT02397915|448596758|FG002|Period 1|Physician Decision|0|||
124557322|NCT01759537|447997816|FG001|Overall Study|Lost to Follow-up|9|||
124719810|NCT02397915|448596759|FG003|Period 1|Physician Decision|0|||
124719811|NCT00933608|448596760|FG000|Overall Study|Adverse Event|4|||
124719812|NCT00933608|448596761|FG001|Overall Study|Adverse Event|2|||
124719813|NCT00933608|448596760|FG000|Overall Study|Physician Decision|1|||
124719814|NCT00933608|448596761|FG001|Overall Study|Physician Decision|0|||
124719815|NCT00391053|448596764|FG000|Overall Study|Serious Adverse Events|1|||
124719816|NCT00391053|448596765|FG001|Overall Study|Serious Adverse Events|0|||
124719817|NCT00391053|448596766|FG002|Overall Study|Serious Adverse Events|1|||
124719818|NCT00391053|448596767|FG003|Overall Study|Serious Adverse Events|4|||
124479588|NCT01275222|447709100|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
124479589|NCT01275222|447709095|FG000|Phase ll by Stratum|Death|0|||
124719819|NCT00391053|448596764|FG000|Overall Study|Protocol Violation|2|||
124719820|NCT00391053|448596765|FG001|Overall Study|Protocol Violation|0|||
124719821|NCT00391053|448596766|FG002|Overall Study|Protocol Violation|0|||
124719822|NCT00391053|448596767|FG003|Overall Study|Protocol Violation|0|||
124719823|NCT00391053|448596764|FG000|Overall Study|Lost to Follow-up|1|||
124719824|NCT00391053|448596765|FG001|Overall Study|Lost to Follow-up|0|||
124719825|NCT00391053|448596766|FG002|Overall Study|Lost to Follow-up|0|||
124719826|NCT00391053|448596767|FG003|Overall Study|Lost to Follow-up|5|||
124479590|NCT01275222|447709096|FG001|Phase ll by Stratum|Death|0|||
124479591|NCT01275222|447709097|FG002|Phase ll by Stratum|Death|0|||
124479592|NCT01275222|447709098|FG003|Phase ll by Stratum|Death|0|||
124479593|NCT01275222|447709099|FG004|Phase ll by Stratum|Death|1|||
124479594|NCT01275222|447709100|FG005|Phase ll by Stratum|Death|1|||
124479595|NCT03440944|447709101|FG000|Overall Study|Physician Decision|1|||
124479596|NCT03440944|447709102|FG001|Overall Study|Physician Decision|0|||
124479597|NCT03440944|447709101|FG000|Overall Study|No Acceptable Vasculature|0|||
124479598|NCT03440944|447709102|FG001|Overall Study|No Acceptable Vasculature|1|||
124479599|NCT00484315|447709103|FG000|12-Month Clinical Follow-up|Death|6|||
124479600|NCT00484315|447709104|FG001|12-Month Clinical Follow-up|Death|2|||
124479601|NCT00484315|447709103|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
124557323|NCT01759537|447997815|FG000|Overall Study|Accident involving jaw fracture|1|||
124719827|NCT00391053|448596764|FG000|Overall Study|Withdrawal by Subject|5|||
124719828|NCT00391053|448596765|FG001|Overall Study|Withdrawal by Subject|1|||
124719829|NCT00391053|448596766|FG002|Overall Study|Withdrawal by Subject|1|||
124479602|NCT00484315|447709104|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
124479603|NCT00484315|447709103|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
124479604|NCT00484315|447709104|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
124479605|NCT00484315|447709103|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
124719830|NCT00391053|448596767|FG003|Overall Study|Withdrawal by Subject|1|||
124719831|NCT04908384|448596768|FG000|Overall Study|Lost to Follow-up|4|||
124719832|NCT04908384|448596769|FG001|Overall Study|Lost to Follow-up|4|||
124719833|NCT04908384|448596770|FG002|Overall Study|Lost to Follow-up|0|||
124479606|NCT00484315|447709104|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
124479607|NCT00484315|447709103|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
124557324|NCT01759537|447997816|FG001|Overall Study|Accident involving jaw fracture|1|||
124557325|NCT01759537|447997815|FG000|Overall Study|Subcrestal implant too coronal|1|||
124557326|NCT01759537|447997816|FG001|Overall Study|Subcrestal implant too coronal|1|||
124479608|NCT00484315|447709104|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
124479609|NCT00484315|447709103|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
124479610|NCT00484315|447709104|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
124479611|NCT00484315|447709103|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
124719834|NCT04908384|448596771|FG003|Overall Study|Lost to Follow-up|0|||
124719835|NCT05002985|448596772|FG000|Overall Study|Withdrawal by Subject|1|||
124719836|NCT01642901|448596776|FG000|12-month Follow-up|Withdrawal by Subject|1|||
124719837|NCT01642901|448596777|FG001|12-month Follow-up|Withdrawal by Subject|0|||
124719838|NCT02943070|448596779|FG000|Overall Study|Physician Decision|1|||
124719839|NCT02943070|448596779|FG000|Overall Study|Adverse Event|2|||
124719840|NCT02943070|448596779|FG000|Overall Study|Death|2|||
124719841|NCT02943070|448596779|FG000|Overall Study|Withdrawal by Subject|3|||
124719842|NCT02943070|448596779|FG000|Overall Study|Lost to Follow-up|4|||
124719843|NCT02943070|448596779|FG000|Overall Study|Retreatment or TURP|13|||
124719844|NCT02943070|448596779|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
124479612|NCT00484315|447709104|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
124479613|NCT00943683|447709105|FG000|Overall Study|Adverse Event|3|||
124479614|NCT00943683|447709106|FG001|Overall Study|Adverse Event|3|||
124479615|NCT00943683|447709105|FG000|Overall Study|Lost to Follow-up|1|||
124479616|NCT00943683|447709106|FG001|Overall Study|Lost to Follow-up|1|||
124479617|NCT00943683|447709105|FG000|Overall Study|Protocol Violation|1|||
124479618|NCT00943683|447709106|FG001|Overall Study|Protocol Violation|2|||
124479619|NCT00943683|447709105|FG000|Overall Study|Withdrawal by Subject|1|||
124479620|NCT00943683|447709106|FG001|Overall Study|Withdrawal by Subject|0|||
124479621|NCT00943683|447709105|FG000|Overall Study|Patient Moved|1|||
124479622|NCT00943683|447709106|FG001|Overall Study|Patient Moved|0|||
124479623|NCT04672083|447709107|FG000|Overall Study|Lost to Follow-up|1|||
124479624|NCT04672083|447709108|FG001|Overall Study|Lost to Follow-up|0|||
124479625|NCT04672083|447709109|FG002|Overall Study|Lost to Follow-up|0|||
124479626|NCT04672083|447709110|FG003|Overall Study|Lost to Follow-up|0|||
124557327|NCT00420290|447997817|FG000|Overall Study|Adverse Event|3|||
124479627|NCT04672083|447709111|FG004|Overall Study|Lost to Follow-up|0|||
124479628|NCT02500537|447709112|FG000|Overall Study|Death|2|||
124479629|NCT02500537|447709113|FG001|Overall Study|Death|0|||
124479630|NCT02500537|447709112|FG000|Overall Study|Lost to Follow-up|0|||
124479631|NCT02500537|447709113|FG001|Overall Study|Lost to Follow-up|1|||
124479632|NCT02500537|447709112|FG000|Overall Study|Withdrawal by Subject|1|||
124479633|NCT02500537|447709113|FG001|Overall Study|Withdrawal by Subject|0|||
124479634|NCT01551745|447709114|FG000|Overall Study|Withdrawal by Subject|1|||
124479635|NCT01551745|447709114|FG000|Overall Study|Disease Progression|2|||
124479636|NCT01661790|447709115|FG000|Overall Study|Lost to Follow-up|0|||
124479637|NCT01661790|447709116|FG001|Overall Study|Lost to Follow-up|2|||
124557328|NCT00420290|447997818|FG001|Overall Study|Adverse Event|1|||
124557329|NCT00420290|447997817|FG000|Overall Study|Withdrawal by Subject|0|||
124557330|NCT00420290|447997818|FG001|Overall Study|Withdrawal by Subject|2|||
124557331|NCT00420290|447997817|FG000|Overall Study|did not meet inclusion/exclusion|1|||
124557332|NCT00420290|447997818|FG001|Overall Study|did not meet inclusion/exclusion|1|||
124557333|NCT02092961|447999048|FG000|Overall Study|Not reported|1|||
124557334|NCT02092961|447999049|FG001|Overall Study|Not reported|0|||
124557335|NCT02092961|447999050|FG002|Overall Study|Not reported|1|||
124557336|NCT02092961|447999048|FG000|Overall Study|Study stopped|13|||
124557337|NCT02092961|447999049|FG001|Overall Study|Study stopped|9|||
124479638|NCT02048904|447709121|FG000|Overall Study|Withdrawal by Subject|7|||
124479639|NCT02048904|447709121|FG000|Overall Study|Physician Decision|70|||
124557338|NCT02092961|447999050|FG002|Overall Study|Study stopped|12|||
124557339|NCT02092961|447999048|FG000|Overall Study|Lack of therapeutic response|2|||
124479640|NCT00784758|447709129|FG000|Overall Study|Withdrawal by Subject|3|||
124479641|NCT00784758|447709130|FG001|Overall Study|Withdrawal by Subject|0|||
124479642|NCT00784758|447709129|FG000|Overall Study|Adverse Event|1|||
124479643|NCT00784758|447709130|FG001|Overall Study|Adverse Event|0|||
124479644|NCT04439123|447709131|FG000|Overall Study|Adverse Event|11|||
124479645|NCT04439123|447709131|FG000|Overall Study|Death|1|||
124479646|NCT04439123|447709131|FG000|Overall Study|Disease progression|19|||
124479647|NCT04439123|447709131|FG000|Overall Study|Withdrawal by Subject|2|||
124479648|NCT04439123|447709131|FG000|Overall Study|Still on treatment|2|||
124479649|NCT02875223|447709132|FG000|Overall Study|Other reasons|0|||
124479650|NCT02875223|447709133|FG001|Overall Study|Other reasons|0|||
124479651|NCT02875223|447709134|FG002|Overall Study|Other reasons|1|||
124479652|NCT02875223|447709135|FG003|Overall Study|Other reasons|0|||
124479653|NCT02875223|447709136|FG004|Overall Study|Other reasons|1|||
124479654|NCT02875223|447709137|FG005|Overall Study|Other reasons|2|||
124479655|NCT02875223|447709138|FG006|Overall Study|Other reasons|0|||
124479656|NCT02875223|447709139|FG007|Overall Study|Other reasons|2|||
124479657|NCT02875223|447709140|FG008|Overall Study|Other reasons|0|||
124479658|NCT02875223|447709141|FG009|Overall Study|Other reasons|0|||
124479659|NCT02875223|447709142|FG010|Overall Study|Other reasons|0|||
124479660|NCT02875223|447709143|FG011|Overall Study|Other reasons|0|||
124479661|NCT02875223|447709144|FG012|Overall Study|Other reasons|0|||
124479662|NCT02875223|447709132|FG000|Overall Study|Withdrawal by Subject|0|||
124479663|NCT02875223|447709133|FG001|Overall Study|Withdrawal by Subject|0|||
124479664|NCT02875223|447709134|FG002|Overall Study|Withdrawal by Subject|0|||
124479665|NCT02875223|447709135|FG003|Overall Study|Withdrawal by Subject|0|||
124479666|NCT02875223|447709136|FG004|Overall Study|Withdrawal by Subject|1|||
124479667|NCT02875223|447709137|FG005|Overall Study|Withdrawal by Subject|1|||
124479668|NCT02875223|447709138|FG006|Overall Study|Withdrawal by Subject|0|||
124479669|NCT02875223|447709139|FG007|Overall Study|Withdrawal by Subject|0|||
124479670|NCT02875223|447709140|FG008|Overall Study|Withdrawal by Subject|1|||
124479671|NCT02875223|447709141|FG009|Overall Study|Withdrawal by Subject|0|||
124479672|NCT02875223|447709142|FG010|Overall Study|Withdrawal by Subject|0|||
124479673|NCT02875223|447709143|FG011|Overall Study|Withdrawal by Subject|0|||
124479674|NCT02875223|447709144|FG012|Overall Study|Withdrawal by Subject|0|||
124479675|NCT02875223|447709132|FG000|Overall Study|Progressive disease|0|||
124479676|NCT02875223|447709133|FG001|Overall Study|Progressive disease|0|||
124479677|NCT02875223|447709134|FG002|Overall Study|Progressive disease|1|||
124479678|NCT02875223|447709135|FG003|Overall Study|Progressive disease|0|||
124479679|NCT02875223|447709136|FG004|Overall Study|Progressive disease|0|||
124479680|NCT02875223|447709137|FG005|Overall Study|Progressive disease|0|||
124479681|NCT02875223|447709138|FG006|Overall Study|Progressive disease|0|||
124479682|NCT02875223|447709139|FG007|Overall Study|Progressive disease|0|||
124479683|NCT02875223|447709140|FG008|Overall Study|Progressive disease|0|||
124479684|NCT02875223|447709141|FG009|Overall Study|Progressive disease|12|||
124479685|NCT02875223|447709142|FG010|Overall Study|Progressive disease|2|||
124479686|NCT02875223|447709143|FG011|Overall Study|Progressive disease|3|||
124479687|NCT02875223|447709144|FG012|Overall Study|Progressive disease|6|||
124479688|NCT02875223|447709132|FG000|Overall Study|Death|4|||
124479689|NCT02875223|447709133|FG001|Overall Study|Death|4|||
124479690|NCT02875223|447709134|FG002|Overall Study|Death|3|||
124479691|NCT02875223|447709135|FG003|Overall Study|Death|4|||
124479692|NCT02875223|447709136|FG004|Overall Study|Death|2|||
124479693|NCT02875223|447709137|FG005|Overall Study|Death|3|||
124479694|NCT02875223|447709138|FG006|Overall Study|Death|5|||
124479695|NCT02875223|447709139|FG007|Overall Study|Death|7|||
124479696|NCT02875223|447709140|FG008|Overall Study|Death|3|||
124479697|NCT02875223|447709141|FG009|Overall Study|Death|2|||
124479698|NCT02875223|447709142|FG010|Overall Study|Death|0|||
124479699|NCT02875223|447709143|FG011|Overall Study|Death|0|||
124479700|NCT02875223|447709144|FG012|Overall Study|Death|0|||
124479701|NCT02875223|447709132|FG000|Overall Study|Lost to Follow-up|0|||
124479702|NCT02875223|447709133|FG001|Overall Study|Lost to Follow-up|1|||
124479703|NCT02875223|447709134|FG002|Overall Study|Lost to Follow-up|1|||
124479704|NCT02875223|447709135|FG003|Overall Study|Lost to Follow-up|0|||
124479705|NCT02875223|447709136|FG004|Overall Study|Lost to Follow-up|1|||
124479706|NCT02875223|447709137|FG005|Overall Study|Lost to Follow-up|0|||
124479707|NCT02875223|447709138|FG006|Overall Study|Lost to Follow-up|1|||
124479708|NCT02875223|447709139|FG007|Overall Study|Lost to Follow-up|1|||
124479709|NCT02875223|447709140|FG008|Overall Study|Lost to Follow-up|0|||
124479710|NCT02875223|447709141|FG009|Overall Study|Lost to Follow-up|0|||
124479711|NCT02875223|447709142|FG010|Overall Study|Lost to Follow-up|0|||
124479712|NCT02875223|447709143|FG011|Overall Study|Lost to Follow-up|0|||
124479713|NCT02875223|447709144|FG012|Overall Study|Lost to Follow-up|0|||
124479714|NCT02382133|447709150|FG000|Overall Study|Death|22|||
124479715|NCT02382133|447709150|FG000|Overall Study|transfer out of ICU|4|||
124479716|NCT02382133|447709150|FG000|Overall Study|Physician Decision|2|||
124719845|NCT04123093|448596784|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
124479717|NCT02382133|447709150|FG000|Overall Study|arterial catheter loss|4|||
124479718|NCT02382133|447709150|FG000|Overall Study|pressure injury both sites|1|||
124719846|NCT04123093|448596785|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
124719847|NCT04123093|448596784|FG000|Phase 2|Physician Decision|0|||
124719848|NCT04123093|448596785|FG001|Phase 2|Physician Decision|1|||
124719849|NCT04123093|448596784|FG000|Phase 2|Withdrawal by Subject|0|||
124719850|NCT04123093|448596785|FG001|Phase 2|Withdrawal by Subject|1|||
124719851|NCT04556591|448596786|FG000|Overall Study|Lost to Follow-up|1|||
124719852|NCT04556591|448596787|FG001|Overall Study|Lost to Follow-up|0|||
124719853|NCT04556591|448596786|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
124719854|NCT04556591|448596787|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
124479719|NCT00655928|447709151|FG000|Overall Study|Withdrawal by Subject|2|||
124479720|NCT00655928|447709152|FG001|Overall Study|Withdrawal by Subject|1|||
124479721|NCT00655928|447709151|FG000|Overall Study|Physician Decision|1|||
124479722|NCT00655928|447709152|FG001|Overall Study|Physician Decision|1|||
124719855|NCT04551963|448596788|FG000|Overall Study|Physician Decision|1|||
124719856|NCT04551963|448596789|FG001|Overall Study|Physician Decision|1|||
124719857|NCT04551963|448596788|FG000|Overall Study|Death|1|||
124719858|NCT04551963|448596789|FG001|Overall Study|Death|0|||
124719859|NCT00700622|448596791|FG000|Overall Study|Adverse Event|4|||
124719860|NCT00700622|448596792|FG001|Overall Study|Adverse Event|0|||
124719861|NCT00700622|448596791|FG000|Overall Study|Lost to Follow-up|0|||
124479723|NCT04906707|447709153|FG000|Overall Study|Withdrawal by Subject|2|||
124479724|NCT04906707|447709154|FG001|Overall Study|Withdrawal by Subject|0|||
124479725|NCT04906707|447709153|FG000|Overall Study|Withdrawal due to PI decision|1|||
124479726|NCT04906707|447709154|FG001|Overall Study|Withdrawal due to PI decision|0|||
124479727|NCT04906707|447709153|FG000|Overall Study|Lost to Follow-up|0|||
124479728|NCT04906707|447709154|FG001|Overall Study|Lost to Follow-up|1|||
124479729|NCT01707992|447709155|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
124479730|NCT01707992|447709156|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
124479731|NCT01707992|447709157|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
124479732|NCT01707992|447709158|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
124479733|NCT01707992|447709159|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
124479734|NCT01707992|447709160|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
124479735|NCT01707992|447709155|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
124479736|NCT01707992|447709156|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
124479737|NCT01707992|447709157|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
124479738|NCT01707992|447709158|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
124719862|NCT00700622|448596792|FG001|Overall Study|Lost to Follow-up|1|||
124719863|NCT00700622|448596791|FG000|Overall Study|Physician Decision|2|||
124719864|NCT00700622|448596792|FG001|Overall Study|Physician Decision|1|||
124719865|NCT00700622|448596791|FG000|Overall Study|Protocol Violation|0|||
124719866|NCT00700622|448596792|FG001|Overall Study|Protocol Violation|1|||
124479739|NCT01707992|447709159|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
124719867|NCT00700622|448596791|FG000|Overall Study|Withdrawal by Subject|4|||
124719868|NCT00700622|448596792|FG001|Overall Study|Withdrawal by Subject|1|||
124719869|NCT00700622|448596791|FG000|Overall Study|Other|3|||
124719870|NCT00700622|448596792|FG001|Overall Study|Other|1|||
124719871|NCT00070109|448596796|FG000|Overall Study|Death|1|||
124719872|NCT00070109|448596797|FG001|Overall Study|Death|1|||
124719873|NCT00070109|448596798|FG002|Overall Study|Death|0|||
124719874|NCT00070109|448596799|FG003|Overall Study|Death|0|||
124719875|NCT00070109|448596800|FG004|Overall Study|Death|1|||
124719876|NCT00070109|448596796|FG000|Overall Study|Lack of Efficacy|6|||
124719877|NCT00070109|448596797|FG001|Overall Study|Lack of Efficacy|4|||
124719878|NCT00070109|448596798|FG002|Overall Study|Lack of Efficacy|5|||
124719879|NCT00070109|448596799|FG003|Overall Study|Lack of Efficacy|15|||
124719880|NCT00070109|448596800|FG004|Overall Study|Lack of Efficacy|5|||
124719881|NCT00070109|448596796|FG000|Overall Study|Physician Decision|1|||
124719882|NCT00070109|448596797|FG001|Overall Study|Physician Decision|0|||
124719883|NCT00070109|448596798|FG002|Overall Study|Physician Decision|0|||
124719884|NCT00070109|448596799|FG003|Overall Study|Physician Decision|0|||
124719885|NCT00070109|448596800|FG004|Overall Study|Physician Decision|0|||
124719886|NCT00070109|448596796|FG000|Overall Study|Withdrawal by Subject|0|||
124719887|NCT00070109|448596797|FG001|Overall Study|Withdrawal by Subject|1|||
124719888|NCT00070109|448596798|FG002|Overall Study|Withdrawal by Subject|1|||
124719889|NCT00070109|448596799|FG003|Overall Study|Withdrawal by Subject|0|||
124719890|NCT00070109|448596800|FG004|Overall Study|Withdrawal by Subject|0|||
124719891|NCT00070109|448596796|FG000|Overall Study|Adverse Event|0|||
124719892|NCT00070109|448596797|FG001|Overall Study|Adverse Event|0|||
124719893|NCT00070109|448596798|FG002|Overall Study|Adverse Event|2|||
124719894|NCT00070109|448596799|FG003|Overall Study|Adverse Event|4|||
124719895|NCT00070109|448596800|FG004|Overall Study|Adverse Event|2|||
124719896|NCT00070109|448596796|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
124719897|NCT00070109|448596797|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
124719898|NCT00070109|448596798|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
124719899|NCT00070109|448596799|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
124719900|NCT00070109|448596800|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
124719901|NCT02526212|448596801|FG000|Overall Study|Incarceration|1|||
124719902|NCT02526212|448596802|FG001|Overall Study|Incarceration|0|||
124719903|NCT02526212|448596801|FG000|Overall Study|Lost to Follow-up|1|||
124719904|NCT02526212|448596802|FG001|Overall Study|Lost to Follow-up|0|||
124719905|NCT02526212|448596801|FG000|Overall Study|Death|0|||
124719906|NCT02526212|448596802|FG001|Overall Study|Death|1|||
124719907|NCT01390298|448596803|FG000|Overall Study|Death|1|||
124719908|NCT01390298|448596803|FG000|Overall Study|long term ICU admission|1|||
124719909|NCT01390298|448596803|FG000|Overall Study|Withdrawal by Subject|14|||
124719910|NCT01390298|448596803|FG000|Overall Study|Lost to Follow-up|7|||
124719911|NCT01390298|448596803|FG000|Overall Study|Surgery cancelled|1|||
124719912|NCT00040742|448596810|FG000|Overall Study|Death|0|||
124719913|NCT00040742|448596811|FG001|Overall Study|Death|0|||
124719914|NCT00040742|448596812|FG002|Overall Study|Death|1|||
124719915|NCT00040742|448596813|FG003|Overall Study|Death|0|||
124719916|NCT00040742|448596810|FG000|Overall Study|Adverse Event|15|||
124719917|NCT00040742|448596811|FG001|Overall Study|Adverse Event|16|||
124719918|NCT00040742|448596812|FG002|Overall Study|Adverse Event|21|||
124719919|NCT00040742|448596813|FG003|Overall Study|Adverse Event|9|||
124719920|NCT00040742|448596810|FG000|Overall Study|Withdrawal by Subject|7|||
124719921|NCT00040742|448596811|FG001|Overall Study|Withdrawal by Subject|15|||
124719922|NCT00040742|448596812|FG002|Overall Study|Withdrawal by Subject|10|||
124719923|NCT00040742|448596813|FG003|Overall Study|Withdrawal by Subject|13|||
124719924|NCT00040742|448596810|FG000|Overall Study|Chemotoxicity|4|||
124719925|NCT00040742|448596811|FG001|Overall Study|Chemotoxicity|3|||
124719926|NCT00040742|448596812|FG002|Overall Study|Chemotoxicity|5|||
124719927|NCT00040742|448596813|FG003|Overall Study|Chemotoxicity|2|||
124719928|NCT00040742|448596810|FG000|Overall Study|Incomplete Forms|6|||
124719929|NCT00040742|448596811|FG001|Overall Study|Incomplete Forms|10|||
124719930|NCT00040742|448596812|FG002|Overall Study|Incomplete Forms|4|||
124719931|NCT00040742|448596813|FG003|Overall Study|Incomplete Forms|5|||
124719932|NCT00040742|448596810|FG000|Overall Study|Other medical|7|||
124719933|NCT00040742|448596811|FG001|Overall Study|Other medical|5|||
124719934|NCT00040742|448596812|FG002|Overall Study|Other medical|5|||
124557340|NCT02092961|447999049|FG001|Overall Study|Lack of therapeutic response|1|||
124719935|NCT00040742|448596813|FG003|Overall Study|Other medical|5|||
124719936|NCT03520920|448596816|FG000|Overall Study|Death|13|||
124719937|NCT03520920|448596817|FG001|Overall Study|Death|1|||
124719938|NCT03520920|448596818|FG002|Overall Study|Death|0|||
124719939|NCT03520920|448596816|FG000|Overall Study|Withdrawal by Subject|2|||
124719940|NCT03520920|448596817|FG001|Overall Study|Withdrawal by Subject|1|||
124719941|NCT03520920|448596818|FG002|Overall Study|Withdrawal by Subject|0|||
124719942|NCT03520920|448596816|FG000|Overall Study|Study Terminated by the Sponsor|5|||
124719943|NCT03520920|448596817|FG001|Overall Study|Study Terminated by the Sponsor|14|||
124719944|NCT03520920|448596818|FG002|Overall Study|Study Terminated by the Sponsor|5|||
124479740|NCT01707992|447709160|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
124479741|NCT01707992|447709155|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
124479742|NCT01707992|447709156|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
124479743|NCT01707992|447709157|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
124479744|NCT01707992|447709158|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
124479745|NCT01707992|447709159|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
124479746|NCT01707992|447709160|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
124479747|NCT01707992|447709155|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
124479748|NCT01707992|447709156|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
124479749|NCT01707992|447709157|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
124479750|NCT01707992|447709158|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
124479751|NCT01707992|447709159|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
124479752|NCT01707992|447709160|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
124557341|NCT02092961|447999050|FG002|Overall Study|Lack of therapeutic response|3|||
124557342|NCT02092961|447999048|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
124557343|NCT02092961|447999049|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
124557344|NCT02092961|447999050|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
124557345|NCT02092961|447999048|FG000|Overall Study|Adverse Event|2|||
124557346|NCT02092961|447999049|FG001|Overall Study|Adverse Event|4|||
124557347|NCT02092961|447999050|FG002|Overall Study|Adverse Event|0|||
124557348|NCT00854620|447999051|FG000|Overall Study|Adverse Event|1|||
124557349|NCT01623830|447999052|FG000|Overall Study|Withdrawal by Subject|6|||
124557350|NCT01623830|447999053|FG001|Overall Study|Withdrawal by Subject|7|||
124557351|NCT01623830|447999052|FG000|Overall Study|Exclusion from Study|1|||
124557352|NCT01623830|447999053|FG001|Overall Study|Exclusion from Study|2|||
124557353|NCT01792284|447999054|FG000|Lead-in Period|Adverse Event|15|||
124557354|NCT01792284|447999055|FG001|Lead-in Period|Adverse Event|0|||
124557355|NCT01792284|447999056|FG002|Lead-in Period|Adverse Event|0|||
124557356|NCT01792284|447999054|FG000|Lead-in Period|Lost to Follow-up|2|||
124557357|NCT01792284|447999055|FG001|Lead-in Period|Lost to Follow-up|0|||
124557358|NCT01792284|447999056|FG002|Lead-in Period|Lost to Follow-up|0|||
124557359|NCT01792284|447999054|FG000|Lead-in Period|Protocol Violation|1|||
124557360|NCT01792284|447999055|FG001|Lead-in Period|Protocol Violation|0|||
124557361|NCT01792284|447999056|FG002|Lead-in Period|Protocol Violation|0|||
124557362|NCT01792284|447999054|FG000|Lead-in Period|Withdrawal by Subject|10|||
124557363|NCT01792284|447999055|FG001|Lead-in Period|Withdrawal by Subject|0|||
124557364|NCT01792284|447999056|FG002|Lead-in Period|Withdrawal by Subject|0|||
124557365|NCT01792284|447999054|FG000|Lead-in Period|Physician Decision|1|||
124557366|NCT01792284|447999055|FG001|Lead-in Period|Physician Decision|0|||
124557367|NCT01792284|447999056|FG002|Lead-in Period|Physician Decision|0|||
124557368|NCT01792284|447999054|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
124557369|NCT01792284|447999055|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
124557370|NCT01792284|447999056|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
124557371|NCT01792284|447999054|FG000|Randomization Period 1|Withdrawal by Subject|0|||
124557372|NCT01792284|447999055|FG001|Randomization Period 1|Withdrawal by Subject|1|||
124557373|NCT01792284|447999056|FG002|Randomization Period 1|Withdrawal by Subject|1|||
124557374|NCT01792284|447999054|FG000|Randomization Period 1|Physician Decision|0|||
124557375|NCT01792284|447999055|FG001|Randomization Period 1|Physician Decision|1|||
124557376|NCT01792284|447999056|FG002|Randomization Period 1|Physician Decision|1|||
124557377|NCT01792284|447999054|FG000|Randomization Period 1|Adverse Event|0|||
124557378|NCT01792284|447999055|FG001|Randomization Period 1|Adverse Event|0|||
124557379|NCT01792284|447999056|FG002|Randomization Period 1|Adverse Event|2|||
124557380|NCT01792284|447999054|FG000|Randomization Period 1|Lost to Follow-up|0|||
124557381|NCT01792284|447999055|FG001|Randomization Period 1|Lost to Follow-up|0|||
124557382|NCT01792284|447999056|FG002|Randomization Period 1|Lost to Follow-up|1|||
124479753|NCT01707992|447709155|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
124479754|NCT01707992|447709156|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
124479755|NCT01707992|447709157|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
124479756|NCT01707992|447709158|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
124479757|NCT01707992|447709159|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
124479758|NCT01707992|447709160|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
124479759|NCT01707992|447709155|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
124479760|NCT01707992|447709156|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
124479761|NCT01707992|447709157|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
124479762|NCT01707992|447709158|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
124479763|NCT01707992|447709159|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
124479764|NCT01707992|447709160|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
124479765|NCT01707992|447709155|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
124479766|NCT01707992|447709156|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
124479767|NCT01707992|447709157|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
124479768|NCT01707992|447709158|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
124479769|NCT01707992|447709159|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
124479770|NCT01707992|447709160|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
124479771|NCT01707992|447709155|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
124479772|NCT01707992|447709156|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
124479773|NCT01707992|447709157|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
124479774|NCT01707992|447709158|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
124479775|NCT01707992|447709159|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
124479776|NCT01707992|447709160|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
124479777|NCT01707992|447709155|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
124479778|NCT01707992|447709156|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
124479779|NCT01707992|447709157|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
124479780|NCT01707992|447709158|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
124479781|NCT01707992|447709159|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
124479782|NCT01707992|447709160|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
124479783|NCT01707992|447709155|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
124479784|NCT01707992|447709156|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
124479785|NCT01707992|447709157|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
124479786|NCT01707992|447709158|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
124479787|NCT01707992|447709159|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
124479788|NCT01707992|447709160|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
124479789|NCT01707992|447709155|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
124479790|NCT01707992|447709156|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
124479791|NCT01707992|447709157|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
124479792|NCT01707992|447709158|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
124479793|NCT01707992|447709159|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
124479794|NCT01707992|447709160|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
124479795|NCT01707992|447709155|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
124479796|NCT01707992|447709156|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
124479797|NCT01707992|447709157|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
124479798|NCT01707992|447709158|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
124479799|NCT01707992|447709159|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
124479800|NCT01707992|447709160|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
124479801|NCT01707992|447709155|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
124479802|NCT01707992|447709156|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
124479803|NCT01707992|447709157|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
124479804|NCT01707992|447709158|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
124479805|NCT01707992|447709159|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
124479806|NCT01707992|447709160|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
124479807|NCT01707992|447709155|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
124479808|NCT01707992|447709156|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
124479809|NCT01707992|447709157|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
124479810|NCT01707992|447709158|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
124479811|NCT01707992|447709159|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
124479812|NCT01707992|447709160|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
124479813|NCT01707992|447709155|FG000|Active Treatment Phase (24 Months)|Death|0|||
124479814|NCT01707992|447709156|FG001|Active Treatment Phase (24 Months)|Death|0|||
124479815|NCT01707992|447709157|FG002|Active Treatment Phase (24 Months)|Death|0|||
124479816|NCT01707992|447709158|FG003|Active Treatment Phase (24 Months)|Death|2|||
124479817|NCT01707992|447709159|FG004|Active Treatment Phase (24 Months)|Death|0|||
124479818|NCT01707992|447709160|FG005|Active Treatment Phase (24 Months)|Death|0|||
124479819|NCT01707992|447709155|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
124479820|NCT01707992|447709156|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
124479821|NCT01707992|447709157|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
124479822|NCT01707992|447709158|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
124479823|NCT01707992|447709159|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
124719945|NCT00405392|448596819|FG000|Overall Study|Adverse Event|15|||
124719946|NCT00405392|448596820|FG001|Overall Study|Adverse Event|14|||
124719947|NCT00405392|448596819|FG000|Overall Study|Did not meet Eligibility criteria|7|||
124719948|NCT00405392|448596820|FG001|Overall Study|Did not meet Eligibility criteria|2|||
124719949|NCT00405392|448596819|FG000|Overall Study|Withdrawal by Subject|4|||
124719950|NCT00405392|448596820|FG001|Overall Study|Withdrawal by Subject|3|||
124719951|NCT00405392|448596819|FG000|Overall Study|Lost to Follow-up|1|||
124719952|NCT00405392|448596820|FG001|Overall Study|Lost to Follow-up|2|||
124719953|NCT00405392|448596819|FG000|Overall Study|Data missing|2|||
124719954|NCT00405392|448596820|FG001|Overall Study|Data missing|0|||
124719955|NCT00405392|448596819|FG000|Overall Study|Non-compliance|0|||
124719956|NCT00405392|448596820|FG001|Overall Study|Non-compliance|1|||
124719957|NCT00405392|448596819|FG000|Overall Study|Other|1|||
124719958|NCT00405392|448596820|FG001|Overall Study|Other|5|||
124719959|NCT01703091|448596823|FG000|Overall Study|Adverse Event|5|||
124719960|NCT01703091|448596824|FG001|Overall Study|Adverse Event|3|||
124719961|NCT01703091|448596823|FG000|Overall Study|Physician Decision|2|||
124719962|NCT01703091|448596824|FG001|Overall Study|Physician Decision|1|||
124719963|NCT01703091|448596823|FG000|Overall Study|Withdrawal by Subject|1|||
124719964|NCT01703091|448596824|FG001|Overall Study|Withdrawal by Subject|0|||
124719965|NCT01703091|448596823|FG000|Overall Study|Sponsor Decision|1|||
124719966|NCT01703091|448596824|FG001|Overall Study|Sponsor Decision|0|||
124557383|NCT01792284|447999054|FG000|Randomization Period 2|Protocol Violation|0|||
124719967|NCT02550288|448596828|FG000|Overall Study|Adverse Event|0|||
124719968|NCT02550288|448596829|FG001|Overall Study|Adverse Event|1|||
124557384|NCT01792284|447999055|FG001|Randomization Period 2|Protocol Violation|1|||
124719969|NCT02550288|448596830|FG002|Overall Study|Adverse Event|0|||
124719970|NCT02550288|448596831|FG003|Overall Study|Adverse Event|0|||
124719971|NCT02550288|448596832|FG004|Overall Study|Adverse Event|0|||
124719972|NCT02550288|448596828|FG000|Overall Study|Physician Decision|0|||
124719973|NCT02550288|448596829|FG001|Overall Study|Physician Decision|0|||
124719974|NCT02550288|448596830|FG002|Overall Study|Physician Decision|0|||
124479824|NCT01707992|447709160|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
124479825|NCT01707992|447709155|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
124479826|NCT01707992|447709156|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
124479827|NCT01707992|447709157|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
124479828|NCT01707992|447709158|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
124479829|NCT01707992|447709159|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
124479830|NCT01707992|447709160|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
124479831|NCT01707992|447709155|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
124479832|NCT01707992|447709156|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
124479833|NCT01707992|447709157|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
124479834|NCT01707992|447709158|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
124479835|NCT01707992|447709159|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
124479836|NCT01707992|447709160|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
124479837|NCT01707992|447709155|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
124479838|NCT01707992|447709156|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
124719975|NCT02550288|448596831|FG003|Overall Study|Physician Decision|1|||
124719976|NCT02550288|448596832|FG004|Overall Study|Physician Decision|0|||
124719977|NCT02550288|448596828|FG000|Overall Study|Protocol Violation|2|||
124719978|NCT02550288|448596829|FG001|Overall Study|Protocol Violation|2|||
124719979|NCT02550288|448596830|FG002|Overall Study|Protocol Violation|1|||
124719980|NCT02550288|448596831|FG003|Overall Study|Protocol Violation|0|||
124719981|NCT02550288|448596832|FG004|Overall Study|Protocol Violation|3|||
124719982|NCT02550288|448596828|FG000|Overall Study|Participant moved|0|||
124719983|NCT02550288|448596829|FG001|Overall Study|Participant moved|0|||
124719984|NCT02550288|448596830|FG002|Overall Study|Participant moved|0|||
124719985|NCT02550288|448596831|FG003|Overall Study|Participant moved|1|||
124719986|NCT02550288|448596832|FG004|Overall Study|Participant moved|0|||
124719987|NCT02550288|448596828|FG000|Overall Study|Withdrawal by Subject|0|||
124719988|NCT02550288|448596829|FG001|Overall Study|Withdrawal by Subject|0|||
124479839|NCT01707992|447709157|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
124479840|NCT01707992|447709158|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
124479841|NCT01707992|447709159|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
124719989|NCT02550288|448596830|FG002|Overall Study|Withdrawal by Subject|0|||
124719990|NCT02550288|448596831|FG003|Overall Study|Withdrawal by Subject|1|||
124719991|NCT02550288|448596832|FG004|Overall Study|Withdrawal by Subject|0|||
124719992|NCT02819297|448596834|FG000|Overall Study|Withdrawal by Subject|25|||
124719993|NCT02819297|448596835|FG001|Overall Study|Withdrawal by Subject|13|||
124719994|NCT02819297|448596834|FG000|Overall Study|Lost to Follow-up|12|||
124719995|NCT02819297|448596835|FG001|Overall Study|Lost to Follow-up|14|||
124719996|NCT02819297|448596834|FG000|Overall Study|Adverse Event|12|||
124719997|NCT02819297|448596835|FG001|Overall Study|Adverse Event|10|||
124719998|NCT02819297|448596834|FG000|Overall Study|Physician Decision|5|||
124479842|NCT01707992|447709160|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
124479843|NCT01976806|447709161|FG000|Overall Study|Lost to Follow-up|1|||
124479844|NCT01976806|447709162|FG001|Overall Study|Lost to Follow-up|4|||
124479845|NCT01976806|447709161|FG000|Overall Study|Adverse Event|1|||
124479846|NCT01976806|447709162|FG001|Overall Study|Adverse Event|1|||
124479847|NCT01976806|447709161|FG000|Overall Study|Withdrawal by Subject|1|||
124479848|NCT01976806|447709162|FG001|Overall Study|Withdrawal by Subject|1|||
124479849|NCT02654002|447709170|FG000|Overall Study|Adverse Event|0|||
124479850|NCT02654002|447709171|FG001|Overall Study|Adverse Event|0|||
124479851|NCT02654002|447709172|FG002|Overall Study|Adverse Event|0|||
124479852|NCT02654002|447709173|FG003|Overall Study|Adverse Event|0|||
124479853|NCT02654002|447709174|FG004|Overall Study|Adverse Event|0|||
124479854|NCT02654002|447709175|FG005|Overall Study|Adverse Event|0|||
124479855|NCT02654002|447709176|FG006|Overall Study|Adverse Event|1|||
124479856|NCT02654002|447709177|FG007|Overall Study|Adverse Event|0|||
124479857|NCT02654002|447709178|FG008|Overall Study|Adverse Event|0|||
124479858|NCT02654002|447709170|FG000|Overall Study|Withdrew Consent|0|||
124479859|NCT02654002|447709171|FG001|Overall Study|Withdrew Consent|0|||
124557385|NCT01792284|447999056|FG002|Randomization Period 2|Protocol Violation|0|||
124479860|NCT02654002|447709172|FG002|Overall Study|Withdrew Consent|0|||
124479861|NCT02654002|447709173|FG003|Overall Study|Withdrew Consent|0|||
124479862|NCT02654002|447709174|FG004|Overall Study|Withdrew Consent|0|||
124479863|NCT02654002|447709175|FG005|Overall Study|Withdrew Consent|1|||
124479864|NCT02654002|447709176|FG006|Overall Study|Withdrew Consent|0|||
124719999|NCT02819297|448596835|FG001|Overall Study|Physician Decision|5|||
124557386|NCT01792284|447999054|FG000|Randomization Period 2|Withdrawal by Subject|0|||
124557387|NCT01792284|447999055|FG001|Randomization Period 2|Withdrawal by Subject|2|||
124479865|NCT02654002|447709177|FG007|Overall Study|Withdrew Consent|1|||
124479866|NCT02654002|447709178|FG008|Overall Study|Withdrew Consent|0|||
124479867|NCT01523873|447709179|FG000|Overall Study|Protocol Violation|422|||
124479868|NCT00891202|447709180|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
124479869|NCT00891202|447709181|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
124479870|NCT00891202|447709182|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
124479871|NCT00891202|447709183|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
124479872|NCT00891202|447709180|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
124479873|NCT00891202|447709181|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
124479874|NCT00891202|447709182|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
124479875|NCT00891202|447709183|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
124479876|NCT00891202|447709180|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
124479877|NCT00891202|447709181|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
124479878|NCT00891202|447709182|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
124479879|NCT00891202|447709183|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
124479880|NCT00891202|447709180|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
124479881|NCT00891202|447709181|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
124479882|NCT00891202|447709182|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
124479883|NCT00891202|447709183|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
124479884|NCT03313050|447709187|FG000|Stage 2: 12 Months|Adverse Event|0|||
124479885|NCT03313050|447709188|FG001|Stage 2: 12 Months|Adverse Event|0|||
124479886|NCT03313050|447709189|FG002|Stage 2: 12 Months|Adverse Event|0|||
124479887|NCT03313050|447709190|FG003|Stage 2: 12 Months|Adverse Event|1|||
124479888|NCT03313050|447709187|FG000|Stage 2: 12 Months|Death|0|||
124479889|NCT03313050|447709188|FG001|Stage 2: 12 Months|Death|0|||
124479890|NCT03313050|447709189|FG002|Stage 2: 12 Months|Death|3|||
124479891|NCT03313050|447709190|FG003|Stage 2: 12 Months|Death|0|||
124479892|NCT03313050|447709187|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
124479893|NCT03313050|447709188|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
124479894|NCT03313050|447709189|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
124479895|NCT03313050|447709190|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
124479896|NCT03313050|447709187|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
124479897|NCT03313050|447709188|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
124479898|NCT03313050|447709189|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
124479899|NCT03313050|447709190|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
124479900|NCT03313050|447709187|FG000|Stage 2: 12 Months|Protocol deviation|0|||
124479901|NCT03313050|447709188|FG001|Stage 2: 12 Months|Protocol deviation|0|||
124479902|NCT03313050|447709189|FG002|Stage 2: 12 Months|Protocol deviation|7|||
124479903|NCT03313050|447709190|FG003|Stage 2: 12 Months|Protocol deviation|7|||
124479904|NCT03313050|447709187|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
124479905|NCT03313050|447709188|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
124479906|NCT03313050|447709189|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
124479907|NCT03313050|447709190|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
124479908|NCT03313050|447709187|FG000|Stage 2: 12 Months|Other|0|||
124479909|NCT03313050|447709188|FG001|Stage 2: 12 Months|Other|0|||
124479910|NCT03313050|447709189|FG002|Stage 2: 12 Months|Other|0|||
124479911|NCT03313050|447709190|FG003|Stage 2: 12 Months|Other|1|||
124479912|NCT04211337|447709191|FG000|Overall Study|On Treatment|175|||
124479913|NCT04211337|447709192|FG001|Overall Study|On Treatment|40|||
124479914|NCT04211337|447709191|FG000|Overall Study|Withdrawal by Subject|0|||
124479915|NCT04211337|447709192|FG001|Overall Study|Withdrawal by Subject|2|||
124479916|NCT04167345|447709201|FG000|Overall Study|Other|1|||
124479917|NCT04167345|447709202|FG001|Overall Study|Other|1|||
124479918|NCT04167345|447709203|FG002|Overall Study|Other|0|||
124479919|NCT04167345|447709204|FG003|Overall Study|Other|0|||
124479920|NCT04167345|447709205|FG004|Overall Study|Other|0|||
124479921|NCT02732951|447710790|FG000|Overall Study|Other than listed|1|||
124479922|NCT02732951|447710791|FG001|Overall Study|Other than listed|0|||
124479923|NCT02732951|447710790|FG000|Overall Study|Lost to Follow-up|0|||
124479924|NCT02732951|447710791|FG001|Overall Study|Lost to Follow-up|1|||
124479925|NCT02732951|447710790|FG000|Overall Study|Adverse Event|4|||
124479926|NCT02732951|447710791|FG001|Overall Study|Adverse Event|4|||
124479927|NCT02732951|447710790|FG000|Overall Study|Protocol Violation|0|||
124479928|NCT02732951|447710791|FG001|Overall Study|Protocol Violation|1|||
124479929|NCT03263806|447710792|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
124479930|NCT03263806|447710793|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
124479931|NCT03263806|447710792|FG000|Overall Study|Withdrawal by Subject|0|||
124479932|NCT03263806|447710793|FG001|Overall Study|Withdrawal by Subject|1|||
124479933|NCT03263806|447710792|FG000|Overall Study|Study Termination|5|||
124479934|NCT03263806|447710793|FG001|Overall Study|Study Termination|6|||
124479935|NCT01412879|447710794|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
124479936|NCT01412879|447710795|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
124479937|NCT01412879|447710796|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
124479938|NCT01412879|447710794|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
124479939|NCT01412879|447710795|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
124479940|NCT01412879|447710796|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
124479941|NCT01412879|447710794|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
124479942|NCT01412879|447710795|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
124479943|NCT01412879|447710796|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
124479944|NCT01412879|447710794|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
124479945|NCT01412879|447710795|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
124479946|NCT01412879|447710796|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
124557388|NCT01792284|447999056|FG002|Randomization Period 2|Withdrawal by Subject|0|||
124479947|NCT01412879|447710794|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
124479948|NCT01412879|447710795|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
124557389|NCT01169649|447999059|FG000|Overall Study|Patient Not Treated|3|||
124479949|NCT01412879|447710796|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
124479950|NCT04840667|447710797|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
124479951|NCT01445171|447710804|FG000|Overall Study|Lost to Follow-up|11|||
124479952|NCT01445171|447710804|FG000|Overall Study|Withdrawal by Subject|16|||
124479953|NCT01445171|447710804|FG000|Overall Study|Death|51|||
124479954|NCT01445171|447710804|FG000|Overall Study|Subjects declined to return for followup|9|||
124479955|NCT01445171|447710804|FG000|Overall Study|Consented but did not receive device|8|||
124479956|NCT03195894|447710805|FG000|Overall Study|"An example is Started other treatment."|4|||
124479957|NCT03195894|447710806|FG001|Overall Study|"An example is Started other treatment."|5|||
124479958|NCT03195894|447710805|FG000|Overall Study|Withdrawal by Subject|15|||
124479959|NCT03195894|447710806|FG001|Overall Study|Withdrawal by Subject|4|||
124479960|NCT03195894|447710805|FG000|Overall Study|Lost to Follow-up|14|||
124479961|NCT03195894|447710806|FG001|Overall Study|Lost to Follow-up|19|||
124479962|NCT00162773|447710807|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
124479963|NCT01903876|447710811|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
124479964|NCT01903876|447710812|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
124479965|NCT01903876|447710811|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
124479966|NCT01903876|447710812|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
124479967|NCT04317690|447710813|FG000|Overall Study|did not have complete information for primary outcome|0|||
124479968|NCT04317690|447710814|FG001|Overall Study|did not have complete information for primary outcome|4|||
124479969|NCT04317690|447710815|FG002|Overall Study|did not have complete information for primary outcome|0|||
124479970|NCT04317690|447710816|FG003|Overall Study|did not have complete information for primary outcome|2|||
124479971|NCT04317690|447710817|FG004|Overall Study|did not have complete information for primary outcome|0|||
124479972|NCT00393718|447710818|FG000|Overall Study|Adverse Event|20|||
124479973|NCT00393718|447710819|FG001|Overall Study|Adverse Event|8|||
124479974|NCT00393718|447710818|FG000|Overall Study|Protocol Violation|1|||
124479975|NCT00393718|447710819|FG001|Overall Study|Protocol Violation|2|||
124479976|NCT00393718|447710818|FG000|Overall Study|Lack of Efficacy|10|||
124479977|NCT00393718|447710819|FG001|Overall Study|Lack of Efficacy|9|||
124479978|NCT00393718|447710818|FG000|Overall Study|Hypoglycaemia|3|||
124479979|NCT00393718|447710819|FG001|Overall Study|Hypoglycaemia|2|||
124479980|NCT00393718|447710818|FG000|Overall Study|Subject decision|5|||
124479981|NCT00393718|447710819|FG001|Overall Study|Subject decision|0|||
124479982|NCT00393718|447710818|FG000|Overall Study|Withdrawal of consent|2|||
124479983|NCT00393718|447710819|FG001|Overall Study|Withdrawal of consent|1|||
124479984|NCT00393718|447710818|FG000|Overall Study|Missed measurement|1|||
124479985|NCT00393718|447710819|FG001|Overall Study|Missed measurement|0|||
124479986|NCT00393718|447710818|FG000|Overall Study|Move|1|||
124479987|NCT00393718|447710819|FG001|Overall Study|Move|0|||
124479988|NCT00391976|447710821|FG000|Overall Study|Adverse Event|0|||
124479989|NCT00391976|447710822|FG001|Overall Study|Adverse Event|0|||
124479990|NCT00391976|447710823|FG002|Overall Study|Adverse Event|1|||
124479991|NCT00391976|447710821|FG000|Overall Study|Withdrawal of consent|0|||
124479992|NCT00391976|447710822|FG001|Overall Study|Withdrawal of consent|1|||
124479993|NCT00391976|447710823|FG002|Overall Study|Withdrawal of consent|1|||
124479994|NCT00391976|447710821|FG000|Overall Study|Lost to Follow-up|1|||
124479995|NCT00391976|447710822|FG001|Overall Study|Lost to Follow-up|2|||
124479996|NCT00391976|447710823|FG002|Overall Study|Lost to Follow-up|0|||
124479997|NCT00391976|447710821|FG000|Overall Study|Inappropriate enrollment|1|||
124479998|NCT00391976|447710822|FG001|Overall Study|Inappropriate enrollment|1|||
124479999|NCT00391976|447710823|FG002|Overall Study|Inappropriate enrollment|0|||
124480000|NCT00391976|447710821|FG000|Overall Study|Protocol deviation/violation|4|||
124480001|NCT00391976|447710822|FG001|Overall Study|Protocol deviation/violation|2|||
124480002|NCT00391976|447710823|FG002|Overall Study|Protocol deviation/violation|1|||
124480003|NCT00391976|447710821|FG000|Overall Study|Recurrence/no eradication of infection|21|||
124480004|NCT00391976|447710822|FG001|Overall Study|Recurrence/no eradication of infection|19|||
124480005|NCT00391976|447710823|FG002|Overall Study|Recurrence/no eradication of infection|0|||
124480006|NCT00391976|447710821|FG000|Overall Study|Unable to classify|0|||
124480007|NCT00391976|447710822|FG001|Overall Study|Unable to classify|0|||
124480008|NCT00391976|447710823|FG002|Overall Study|Unable to classify|1|||
124480009|NCT00391976|447710821|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
124480010|NCT00391976|447710822|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
124480011|NCT00391976|447710823|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
124480012|NCT01919307|447710824|FG000|Overall Study|Withdrawal by Subject|9|||
124480013|NCT02601950|447710828|FG000|Overall Study|Participant enrolled in rollover study|0|||
124480014|NCT02601950|447710829|FG001|Overall Study|Participant enrolled in rollover study|0|||
124480015|NCT02601950|447710830|FG002|Overall Study|Participant enrolled in rollover study|1|||
124720000|NCT02819297|448596834|FG000|Overall Study|Lack of Efficacy|5|||
124480016|NCT02601950|447710831|FG003|Overall Study|Participant enrolled in rollover study|0|||
124480017|NCT02601950|447710832|FG004|Overall Study|Participant enrolled in rollover study|1|||
124480018|NCT02601950|447710833|FG005|Overall Study|Participant enrolled in rollover study|1|||
124480019|NCT02601950|447710834|FG006|Overall Study|Participant enrolled in rollover study|1|||
124720001|NCT02819297|448596835|FG001|Overall Study|Lack of Efficacy|8|||
124720002|NCT02819297|448596834|FG000|Overall Study|Protocol Violation|1|||
124720003|NCT02819297|448596835|FG001|Overall Study|Protocol Violation|2|||
124720004|NCT01071252|448596837|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
124720005|NCT01071252|448596838|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
124720006|NCT01071252|448596839|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
124720007|NCT01071252|448596840|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
124720008|NCT01071252|448596841|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
124720009|NCT01071252|448596837|FG000|Overall Study|Withdrawal by Subject|8|||
124720010|NCT01071252|448596838|FG001|Overall Study|Withdrawal by Subject|2|||
124480020|NCT02601950|447710835|FG007|Overall Study|Participant enrolled in rollover study|0|||
124480021|NCT02601950|447710828|FG000|Overall Study|Disease progression - radiological|21|||
124480022|NCT02601950|447710829|FG001|Overall Study|Disease progression - radiological|26|||
124480023|NCT02601950|447710830|FG002|Overall Study|Disease progression - radiological|22|||
124480024|NCT02601950|447710831|FG003|Overall Study|Disease progression - radiological|11|||
124480025|NCT02601950|447710832|FG004|Overall Study|Disease progression - radiological|46|||
124480026|NCT02601950|447710833|FG005|Overall Study|Disease progression - radiological|52|||
124480027|NCT02601950|447710834|FG006|Overall Study|Disease progression - radiological|7|||
124480028|NCT02601950|447710835|FG007|Overall Study|Disease progression - radiological|5|||
124480029|NCT02601950|447710828|FG000|Overall Study|Disease progression - clinical|3|||
124480030|NCT02601950|447710829|FG001|Overall Study|Disease progression - clinical|5|||
124480031|NCT02601950|447710830|FG002|Overall Study|Disease progression - clinical|4|||
124480032|NCT02601950|447710831|FG003|Overall Study|Disease progression - clinical|2|||
124480033|NCT02601950|447710832|FG004|Overall Study|Disease progression - clinical|6|||
124480034|NCT02601950|447710833|FG005|Overall Study|Disease progression - clinical|6|||
124480035|NCT02601950|447710834|FG006|Overall Study|Disease progression - clinical|5|||
124480036|NCT02601950|447710835|FG007|Overall Study|Disease progression - clinical|1|||
124480037|NCT02601950|447710828|FG000|Overall Study|Death|6|||
124480038|NCT02601950|447710829|FG001|Overall Study|Death|0|||
124480039|NCT02601950|447710830|FG002|Overall Study|Death|3|||
124480040|NCT02601950|447710831|FG003|Overall Study|Death|1|||
124480041|NCT02601950|447710832|FG004|Overall Study|Death|4|||
124480042|NCT02601950|447710833|FG005|Overall Study|Death|1|||
124480043|NCT02601950|447710834|FG006|Overall Study|Death|0|||
124480044|NCT02601950|447710835|FG007|Overall Study|Death|0|||
124480045|NCT02601950|447710828|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
124480046|NCT02601950|447710829|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
124480047|NCT02601950|447710830|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
124480048|NCT02601950|447710831|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
124480049|NCT02601950|447710832|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
124480050|NCT02601950|447710833|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
124480051|NCT02601950|447710834|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
124480052|NCT02601950|447710835|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
124480053|NCT02601950|447710828|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
124480054|NCT02601950|447710829|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
124480055|NCT02601950|447710830|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
124480056|NCT02601950|447710831|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
124480057|NCT02601950|447710832|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
124480058|NCT02601950|447710833|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
124480059|NCT02601950|447710834|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
124480060|NCT02601950|447710835|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
124480061|NCT02601950|447710828|FG000|Overall Study|Non-compliance|0|||
124480062|NCT02601950|447710829|FG001|Overall Study|Non-compliance|1|||
124480063|NCT02601950|447710830|FG002|Overall Study|Non-compliance|0|||
124557390|NCT01847313|447999065|FG000|Overall Study|Death|0|||
124557391|NCT01847313|447999066|FG001|Overall Study|Death|1|||
124557392|NCT01847313|447999065|FG000|Overall Study|Withdrawal by Subject|0|||
124557393|NCT01847313|447999066|FG001|Overall Study|Withdrawal by Subject|1|||
124557394|NCT00515073|447999070|FG000|Overall Study|Withdrawal by Subject|1|||
124557395|NCT00515073|447999070|FG000|Overall Study|Physician Decision|1|||
124557396|NCT01456052|447999071|FG000|Overall Study|Adverse Event|1|||
124557397|NCT01456052|447999072|FG001|Overall Study|Adverse Event|1|||
124557398|NCT01456052|447999073|FG002|Overall Study|Adverse Event|2|||
124480064|NCT02601950|447710831|FG003|Overall Study|Non-compliance|0|||
124480065|NCT02601950|447710832|FG004|Overall Study|Non-compliance|0|||
124480066|NCT02601950|447710833|FG005|Overall Study|Non-compliance|1|||
124480067|NCT02601950|447710834|FG006|Overall Study|Non-compliance|1|||
124480068|NCT02601950|447710835|FG007|Overall Study|Non-compliance|0|||
124480069|NCT02601950|447710828|FG000|Overall Study|Participant refused further study treatment|0|||
124480070|NCT02601950|447710829|FG001|Overall Study|Participant refused further study treatment|1|||
124480071|NCT02601950|447710830|FG002|Overall Study|Participant refused further study treatment|1|||
124480072|NCT02601950|447710831|FG003|Overall Study|Participant refused further study treatment|0|||
124480073|NCT02601950|447710832|FG004|Overall Study|Participant refused further study treatment|2|||
124480074|NCT02601950|447710833|FG005|Overall Study|Participant refused further study treatment|2|||
124480075|NCT02601950|447710834|FG006|Overall Study|Participant refused further study treatment|2|||
124480076|NCT02601950|447710835|FG007|Overall Study|Participant refused further study treatment|1|||
124480077|NCT02601950|447710828|FG000|Overall Study|Investigator discretion|1|||
124480078|NCT02601950|447710829|FG001|Overall Study|Investigator discretion|0|||
124480079|NCT02601950|447710830|FG002|Overall Study|Investigator discretion|1|||
124480080|NCT02601950|447710831|FG003|Overall Study|Investigator discretion|0|||
124480081|NCT02601950|447710832|FG004|Overall Study|Investigator discretion|1|||
124480082|NCT02601950|447710833|FG005|Overall Study|Investigator discretion|1|||
124480083|NCT02601950|447710834|FG006|Overall Study|Investigator discretion|1|||
124480084|NCT02601950|447710835|FG007|Overall Study|Investigator discretion|0|||
124480085|NCT02601950|447710828|FG000|Overall Study|Other|0|||
124480086|NCT02601950|447710829|FG001|Overall Study|Other|0|||
124480087|NCT02601950|447710830|FG002|Overall Study|Other|0|||
124480088|NCT02601950|447710831|FG003|Overall Study|Other|0|||
124480089|NCT02601950|447710832|FG004|Overall Study|Other|2|||
124720011|NCT01071252|448596839|FG002|Overall Study|Withdrawal by Subject|1|||
124720012|NCT01071252|448596840|FG003|Overall Study|Withdrawal by Subject|2|||
124720013|NCT01071252|448596841|FG004|Overall Study|Withdrawal by Subject|3|||
124480090|NCT02601950|447710833|FG005|Overall Study|Other|2|||
124480091|NCT02601950|447710834|FG006|Overall Study|Other|1|||
124480092|NCT02601950|447710835|FG007|Overall Study|Other|0|||
124480093|NCT02731742|447710838|FG000|Overall Study|Death|1|||
124480094|NCT02731742|447710839|FG001|Overall Study|Death|2|||
124720014|NCT01071252|448596837|FG000|Overall Study|administrative problems|1|||
124480095|NCT02731742|447710840|FG002|Overall Study|Death|5|||
124480096|NCT02731742|447710841|FG003|Overall Study|Death|0|||
124480097|NCT02731742|447710838|FG000|Overall Study|Physician Decision|0|||
124480098|NCT02731742|447710839|FG001|Overall Study|Physician Decision|0|||
124480099|NCT02731742|447710840|FG002|Overall Study|Physician Decision|0|||
124480100|NCT02731742|447710841|FG003|Overall Study|Physician Decision|1|||
124480101|NCT02731742|447710838|FG000|Overall Study|Study Terminated by Sponsor|2|||
124720015|NCT01071252|448596838|FG001|Overall Study|administrative problems|1|||
124720016|NCT01071252|448596839|FG002|Overall Study|administrative problems|0|||
124557399|NCT01456052|447999071|FG000|Overall Study|Consent withdrawn|0|||
124557400|NCT01456052|447999072|FG001|Overall Study|Consent withdrawn|2|||
124557401|NCT01456052|447999073|FG002|Overall Study|Consent withdrawn|1|||
124557402|NCT01456052|447999071|FG000|Overall Study|Protocol Violation|0|||
124557403|NCT01456052|447999072|FG001|Overall Study|Protocol Violation|1|||
124557404|NCT01456052|447999073|FG002|Overall Study|Protocol Violation|0|||
124557405|NCT01456052|447999071|FG000|Overall Study|Physician Decision|1|||
124557406|NCT01456052|447999072|FG001|Overall Study|Physician Decision|0|||
124557407|NCT01456052|447999073|FG002|Overall Study|Physician Decision|1|||
124557408|NCT01456052|447999071|FG000|Overall Study|Treatment Failure|0|||
124557409|NCT01456052|447999072|FG001|Overall Study|Treatment Failure|1|||
124720017|NCT01071252|448596840|FG003|Overall Study|administrative problems|2|||
124557410|NCT01456052|447999073|FG002|Overall Study|Treatment Failure|1|||
124557411|NCT00463866|447999074|FG000|Overall Study|Adverse Event|70|||
124557412|NCT00463866|447999075|FG001|Overall Study|Adverse Event|93|||
124557413|NCT00463866|447999074|FG000|Overall Study|Withdrawal by Subject|81|||
124557414|NCT00463866|447999075|FG001|Overall Study|Withdrawal by Subject|79|||
124557415|NCT00463866|447999074|FG000|Overall Study|Lost to Follow-up|46|||
124480102|NCT02731742|447710839|FG001|Overall Study|Study Terminated by Sponsor|1|||
124480103|NCT02731742|447710840|FG002|Overall Study|Study Terminated by Sponsor|1|||
124480104|NCT02731742|447710841|FG003|Overall Study|Study Terminated by Sponsor|1|||
124480105|NCT02786901|447710842|FG000|Overall Study|Adverse Event|1|||
124480106|NCT02786901|447710843|FG001|Overall Study|Adverse Event|1|||
124480107|NCT02786901|447710844|FG002|Overall Study|Adverse Event|2|||
124480108|NCT02786901|447710842|FG000|Overall Study|Physician Decision|1|||
124480109|NCT02786901|447710843|FG001|Overall Study|Physician Decision|0|||
124480110|NCT02786901|447710844|FG002|Overall Study|Physician Decision|0|||
124480111|NCT02786901|447710842|FG000|Overall Study|Rescue Therapy Use|71|||
124480112|NCT02786901|447710843|FG001|Overall Study|Rescue Therapy Use|49|||
124480113|NCT02786901|447710844|FG002|Overall Study|Rescue Therapy Use|33|||
124557416|NCT00463866|447999075|FG001|Overall Study|Lost to Follow-up|55|||
124720018|NCT01071252|448596841|FG004|Overall Study|administrative problems|1|||
124720019|NCT01071252|448596837|FG000|Overall Study|Lost to Follow-up|1|||
124720020|NCT01071252|448596838|FG001|Overall Study|Lost to Follow-up|0|||
124720021|NCT01071252|448596839|FG002|Overall Study|Lost to Follow-up|1|||
124720022|NCT01071252|448596840|FG003|Overall Study|Lost to Follow-up|2|||
124720023|NCT01071252|448596841|FG004|Overall Study|Lost to Follow-up|0|||
124720024|NCT01071252|448596837|FG000|Overall Study|Adverse Event|1|||
124480114|NCT02786901|447710842|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
124480115|NCT02786901|447710843|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
124480116|NCT02786901|447710844|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
124480117|NCT02786901|447710842|FG000|Overall Study|Disallowed medication|1|||
124480118|NCT02786901|447710843|FG001|Overall Study|Disallowed medication|1|||
124480119|NCT02786901|447710844|FG002|Overall Study|Disallowed medication|0|||
124480120|NCT02786901|447710842|FG000|Overall Study|Randomized in error|2|||
124480121|NCT02786901|447710843|FG001|Overall Study|Randomized in error|0|||
124480122|NCT02786901|447710844|FG002|Overall Study|Randomized in error|1|||
124480123|NCT03367871|447710845|FG000|Overall Study|Lost to Follow-up|1|||
124480124|NCT00763009|447710847|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
124480125|NCT01157117|447710848|FG000|Overall Study|Dosing Symptoms|0|||
124480126|NCT01157117|447710849|FG001|Overall Study|Dosing Symptoms|4|||
124480127|NCT01157117|447710850|FG002|Overall Study|Dosing Symptoms|0|||
124480128|NCT01157117|447710848|FG000|Overall Study|Withdrawal by Subject|4|||
124480129|NCT01157117|447710849|FG001|Overall Study|Withdrawal by Subject|1|||
124480130|NCT01157117|447710850|FG002|Overall Study|Withdrawal by Subject|1|||
124480131|NCT01157117|447710848|FG000|Overall Study|Lack of Efficacy|1|||
124720025|NCT01071252|448596838|FG001|Overall Study|Adverse Event|1|||
124480132|NCT01157117|447710849|FG001|Overall Study|Lack of Efficacy|1|||
124480133|NCT01157117|447710850|FG002|Overall Study|Lack of Efficacy|0|||
124480134|NCT01157117|447710848|FG000|Overall Study|Lost to Follow-up|0|||
124480135|NCT01157117|447710849|FG001|Overall Study|Lost to Follow-up|0|||
124480136|NCT01157117|447710850|FG002|Overall Study|Lost to Follow-up|1|||
124480137|NCT01157117|447710848|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
124480138|NCT01157117|447710849|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
124480139|NCT01157117|447710850|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
124480140|NCT00891735|447710851|FG000|Overall Study|Adverse Event|2|||
124480141|NCT00891735|447710852|FG001|Overall Study|Adverse Event|0|||
124480142|NCT00891735|447710853|FG002|Overall Study|Adverse Event|2|||
124480143|NCT00891735|447710854|FG003|Overall Study|Adverse Event|0|||
124557417|NCT00463866|447999074|FG000|Overall Study|Incorrect Enrolment|64|||
124720026|NCT01071252|448596839|FG002|Overall Study|Adverse Event|0|||
124480144|NCT00891735|447710851|FG000|Overall Study|Death|8|||
124480145|NCT00891735|447710852|FG001|Overall Study|Death|5|||
124480146|NCT00891735|447710853|FG002|Overall Study|Death|4|||
124480147|NCT00891735|447710854|FG003|Overall Study|Death|5|||
124480148|NCT00891735|447710851|FG000|Overall Study|Lost to Follow-up|2|||
124480149|NCT00891735|447710852|FG001|Overall Study|Lost to Follow-up|2|||
124480150|NCT00891735|447710853|FG002|Overall Study|Lost to Follow-up|2|||
124480151|NCT00891735|447710854|FG003|Overall Study|Lost to Follow-up|2|||
124480152|NCT00891735|447710851|FG000|Overall Study|Physician's decision to withdraw patient|1|||
124480153|NCT00891735|447710852|FG001|Overall Study|Physician's decision to withdraw patient|0|||
124480154|NCT00891735|447710853|FG002|Overall Study|Physician's decision to withdraw patient|0|||
124480155|NCT00891735|447710854|FG003|Overall Study|Physician's decision to withdraw patient|0|||
124720027|NCT01071252|448596840|FG003|Overall Study|Adverse Event|1|||
124720028|NCT01071252|448596841|FG004|Overall Study|Adverse Event|0|||
124720029|NCT01071252|448596837|FG000|Overall Study|Death|0|||
124720030|NCT01071252|448596838|FG001|Overall Study|Death|0|||
124720031|NCT01071252|448596839|FG002|Overall Study|Death|0|||
124720032|NCT01071252|448596840|FG003|Overall Study|Death|0|||
124720033|NCT01071252|448596841|FG004|Overall Study|Death|1|||
124720034|NCT01945996|448596842|FG000|Overall Study|Lost to Follow-up|3|||
124720035|NCT01945996|448596843|FG001|Overall Study|Lost to Follow-up|5|||
124720036|NCT03928418|448596844|FG000|Overall Study|Lost to Follow-up|5|||
124720037|NCT03928418|448596845|FG001|Overall Study|Lost to Follow-up|3|||
124720038|NCT03928418|448596846|FG002|Overall Study|Lost to Follow-up|5|||
124720039|NCT03928418|448596844|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
124720040|NCT03928418|448596845|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
124720041|NCT03928418|448596846|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
124720042|NCT00763256|448596847|FG000|Overall Study|Didn't return for appointments|7|||
124720043|NCT00763256|448596848|FG001|Overall Study|Didn't return for appointments|10|||
124480156|NCT00891735|447710851|FG000|Overall Study|Patient's decision to withdraw|4|||
124480157|NCT00891735|447710852|FG001|Overall Study|Patient's decision to withdraw|9|||
124720044|NCT02544750|448596849|FG000|Overall Study|Physician Decision|3|||
124720045|NCT02544750|448596850|FG001|Overall Study|Physician Decision|1|||
124720046|NCT02544750|448596849|FG000|Overall Study|Other reasons|69|||
124720047|NCT02544750|448596850|FG001|Overall Study|Other reasons|39|||
124720048|NCT02544750|448596849|FG000|Overall Study|Met withdrawal criteria|2|||
124720049|NCT02544750|448596850|FG001|Overall Study|Met withdrawal criteria|2|||
124720050|NCT02544750|448596849|FG000|Overall Study|Transition To Commercial Product|1|||
124720051|NCT02544750|448596850|FG001|Overall Study|Transition To Commercial Product|0|||
124720052|NCT02544750|448596849|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
124720053|NCT02544750|448596850|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
124720054|NCT02544750|448596849|FG000|Overall Study|Adverse Event|8|||
124557418|NCT00463866|447999075|FG001|Overall Study|Incorrect Enrolment|66|||
124720055|NCT02544750|448596850|FG001|Overall Study|Adverse Event|10|||
124480158|NCT00891735|447710853|FG002|Overall Study|Patient's decision to withdraw|4|||
124480159|NCT00891735|447710854|FG003|Overall Study|Patient's decision to withdraw|8|||
124480160|NCT03663166|447710859|FG000|Overall Study|Withdrawal by Subject|1|||
124480161|NCT01686568|447710860|FG000|Main Study|Withdrawal by Subject|1|||
124480162|NCT01686568|447710861|FG001|Main Study|Withdrawal by Subject|3|||
124480163|NCT01686568|447710860|FG000|Main Study|Noncompliance with protocol|0|||
124480164|NCT01686568|447710861|FG001|Main Study|Noncompliance with protocol|1|||
124480165|NCT01686568|447710860|FG000|Main Study|Liver enzymes above range of exclusion|1|||
124480166|NCT01686568|447710861|FG001|Main Study|Liver enzymes above range of exclusion|0|||
124480167|NCT01686568|447710860|FG000|Sub-Study|Not consented for sub-study|2|||
124480168|NCT01686568|447710861|FG001|Sub-Study|Not consented for sub-study|2|||
124480169|NCT02978222|447710862|FG000|Overall Study|Withdrawal by Subject|2|||
124480170|NCT02978222|447710863|FG001|Overall Study|Withdrawal by Subject|2|||
124480171|NCT02978222|447710862|FG000|Overall Study|Physician Decision|2|||
124480172|NCT02978222|447710863|FG001|Overall Study|Physician Decision|0|||
124480173|NCT02978222|447710862|FG000|Overall Study|Adverse Event|0|||
124480174|NCT02978222|447710863|FG001|Overall Study|Adverse Event|1|||
124480175|NCT02978222|447710862|FG000|Overall Study|Death|1|||
124480176|NCT02978222|447710863|FG001|Overall Study|Death|0|||
124480177|NCT02978222|447710862|FG000|Overall Study|Disease Progression|32|||
124480178|NCT02978222|447710863|FG001|Overall Study|Disease Progression|32|||
124480179|NCT02978222|447710862|FG000|Overall Study|Early Study Termination|24|||
124480180|NCT02978222|447710863|FG001|Overall Study|Early Study Termination|21|||
124480181|NCT03838484|447710867|FG000|Overall Study|Lost to Follow-up|0|||
124480182|NCT03838484|447710868|FG001|Overall Study|Lost to Follow-up|1|||
124480183|NCT03838484|447710869|FG002|Overall Study|Lost to Follow-up|0|||
124480184|NCT03838484|447710870|FG003|Overall Study|Lost to Follow-up|0|||
124480185|NCT01071070|447710873|FG000|Overall Study|Adverse Event|0|||
124480186|NCT01071070|447710874|FG001|Overall Study|Adverse Event|3|||
124480187|NCT01071070|447710873|FG000|Overall Study|Withdrawal by Subject|1|||
124480188|NCT01071070|447710874|FG001|Overall Study|Withdrawal by Subject|0|||
124480189|NCT01071070|447710873|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
124480190|NCT01071070|447710874|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
124480191|NCT01071070|447710873|FG000|Overall Study|Hypercalcemia|1|||
124480192|NCT01071070|447710874|FG001|Overall Study|Hypercalcemia|0|||
124480193|NCT02207907|447710875|FG000|Overall Study|Lost to Follow-up|3|||
124480194|NCT02207907|447710876|FG001|Overall Study|Lost to Follow-up|1|||
124480195|NCT02207907|447710875|FG000|Overall Study|Withdrawal by Subject|5|||
124480196|NCT02207907|447710876|FG001|Overall Study|Withdrawal by Subject|6|||
124480197|NCT02207907|447710875|FG000|Overall Study|Did not meet study criteria|3|||
124480198|NCT02207907|447710876|FG001|Overall Study|Did not meet study criteria|0|||
124480199|NCT02207907|447710875|FG000|Overall Study|Pregnancy|0|||
124480200|NCT02207907|447710876|FG001|Overall Study|Pregnancy|1|||
124480201|NCT02868892|447710879|FG000|Overall Study|Investigator left site and no follow-up|6|||
124480202|NCT02393209|447710880|FG000|Overall Study|Study Terminated by Sponsor|1|||
124480203|NCT02393209|447710881|FG001|Overall Study|Study Terminated by Sponsor|1|||
124480204|NCT02393209|447710882|FG002|Overall Study|Study Terminated by Sponsor|0|||
124480205|NCT02393209|447710883|FG003|Overall Study|Study Terminated by Sponsor|0|||
124480206|NCT02393209|447710880|FG000|Overall Study|Withdrawal by Patient|1|||
124480207|NCT02393209|447710881|FG001|Overall Study|Withdrawal by Patient|0|||
124480208|NCT02393209|447710882|FG002|Overall Study|Withdrawal by Patient|0|||
124480209|NCT02393209|447710883|FG003|Overall Study|Withdrawal by Patient|0|||
124480210|NCT02393209|447710880|FG000|Overall Study|Death|2|||
124480211|NCT02393209|447710881|FG001|Overall Study|Death|2|||
124480212|NCT02393209|447710882|FG002|Overall Study|Death|0|||
124480213|NCT02393209|447710883|FG003|Overall Study|Death|0|||
124480214|NCT02393209|447710880|FG000|Overall Study|Death due to Disease Progression|2|||
124480215|NCT02393209|447710881|FG001|Overall Study|Death due to Disease Progression|2|||
124480216|NCT02393209|447710882|FG002|Overall Study|Death due to Disease Progression|0|||
124480217|NCT02393209|447710883|FG003|Overall Study|Death due to Disease Progression|0|||
124480218|NCT02393209|447710880|FG000|Overall Study|Death from Legionella Infection|0|||
124480219|NCT02393209|447710881|FG001|Overall Study|Death from Legionella Infection|1|||
124480220|NCT02393209|447710882|FG002|Overall Study|Death from Legionella Infection|0|||
124480221|NCT02393209|447710883|FG003|Overall Study|Death from Legionella Infection|0|||
124480222|NCT02393209|447710880|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
124480223|NCT02393209|447710881|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
124480224|NCT02393209|447710882|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
124480225|NCT02393209|447710883|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
124480226|NCT02393209|447710880|FG000|Overall Study|Lost to Follow-up|0|||
124480227|NCT02393209|447710881|FG001|Overall Study|Lost to Follow-up|1|||
124480228|NCT02393209|447710882|FG002|Overall Study|Lost to Follow-up|0|||
124480229|NCT02393209|447710883|FG003|Overall Study|Lost to Follow-up|0|||
124480230|NCT00868790|447710884|FG000|Period 1|Adverse Event|1|||
124480231|NCT00868790|447710885|FG001|Period 1|Adverse Event|0|||
124480232|NCT00868790|447710886|FG002|Period 1|Adverse Event|0|||
124480233|NCT00868790|447710887|FG003|Period 1|Adverse Event|0|||
124480234|NCT00868790|447710888|FG004|Period 1|Adverse Event|0|||
124480235|NCT00868790|447710889|FG005|Period 1|Adverse Event|0|||
124480236|NCT00868790|447710890|FG006|Period 1|Adverse Event|0|||
124480237|NCT00868790|447710891|FG007|Period 1|Adverse Event|3|||
124480238|NCT00868790|447710892|FG008|Period 1|Adverse Event|1|||
124480239|NCT00868790|447710893|FG009|Period 1|Adverse Event|0|||
124480240|NCT00868790|447710894|FG010|Period 1|Adverse Event|0|||
124480241|NCT00868790|447710895|FG011|Period 1|Adverse Event|0|||
124480242|NCT00868790|447710896|FG012|Period 1|Adverse Event|0|||
124480243|NCT00868790|447710897|FG013|Period 1|Adverse Event|1|||
124480244|NCT00868790|447710884|FG000|Period 1|Protocol Violation|1|||
124480245|NCT00868790|447710885|FG001|Period 1|Protocol Violation|0|||
124480246|NCT00868790|447710886|FG002|Period 1|Protocol Violation|0|||
124480247|NCT00868790|447710887|FG003|Period 1|Protocol Violation|0|||
124480248|NCT00868790|447710888|FG004|Period 1|Protocol Violation|0|||
124480249|NCT00868790|447710889|FG005|Period 1|Protocol Violation|0|||
124480250|NCT00868790|447710890|FG006|Period 1|Protocol Violation|0|||
124480251|NCT00868790|447710891|FG007|Period 1|Protocol Violation|0|||
124480252|NCT00868790|447710892|FG008|Period 1|Protocol Violation|0|||
124480253|NCT00868790|447710893|FG009|Period 1|Protocol Violation|0|||
124480254|NCT00868790|447710894|FG010|Period 1|Protocol Violation|0|||
124480255|NCT00868790|447710895|FG011|Period 1|Protocol Violation|0|||
124480256|NCT00868790|447710896|FG012|Period 1|Protocol Violation|0|||
124480257|NCT00868790|447710897|FG013|Period 1|Protocol Violation|0|||
124480258|NCT00868790|447710884|FG000|Period 1|Withdrawal by Subject|0|||
124480259|NCT00868790|447710885|FG001|Period 1|Withdrawal by Subject|1|||
124557419|NCT00463866|447999074|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
124557420|NCT00463866|447999075|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
124557421|NCT00463866|447999074|FG000|Overall Study|Safety Reason|1|||
124557422|NCT00463866|447999075|FG001|Overall Study|Safety Reason|3|||
124557423|NCT00463866|447999074|FG000|Overall Study|Mis-Randomization of subject|0|||
124480260|NCT00868790|447710886|FG002|Period 1|Withdrawal by Subject|0|||
124480261|NCT00868790|447710887|FG003|Period 1|Withdrawal by Subject|0|||
124480262|NCT00868790|447710888|FG004|Period 1|Withdrawal by Subject|0|||
124480263|NCT00868790|447710889|FG005|Period 1|Withdrawal by Subject|0|||
124480264|NCT00868790|447710890|FG006|Period 1|Withdrawal by Subject|0|||
124480265|NCT00868790|447710891|FG007|Period 1|Withdrawal by Subject|0|||
124480266|NCT00868790|447710892|FG008|Period 1|Withdrawal by Subject|0|||
124480267|NCT00868790|447710893|FG009|Period 1|Withdrawal by Subject|0|||
124480268|NCT00868790|447710894|FG010|Period 1|Withdrawal by Subject|0|||
124480269|NCT00868790|447710895|FG011|Period 1|Withdrawal by Subject|0|||
124480270|NCT00868790|447710896|FG012|Period 1|Withdrawal by Subject|0|||
124480271|NCT00868790|447710897|FG013|Period 1|Withdrawal by Subject|1|||
124480272|NCT00868790|447710884|FG000|Period 1|Abnormal Triglycerides|0|||
124480273|NCT00868790|447710885|FG001|Period 1|Abnormal Triglycerides|0|||
124480274|NCT00868790|447710886|FG002|Period 1|Abnormal Triglycerides|0|||
124480275|NCT00868790|447710887|FG003|Period 1|Abnormal Triglycerides|0|||
124480276|NCT00868790|447710888|FG004|Period 1|Abnormal Triglycerides|1|||
124480277|NCT00868790|447710889|FG005|Period 1|Abnormal Triglycerides|0|||
124480278|NCT00868790|447710890|FG006|Period 1|Abnormal Triglycerides|0|||
124480279|NCT00868790|447710891|FG007|Period 1|Abnormal Triglycerides|0|||
124480280|NCT00868790|447710892|FG008|Period 1|Abnormal Triglycerides|0|||
124480281|NCT00868790|447710893|FG009|Period 1|Abnormal Triglycerides|0|||
124480282|NCT00868790|447710894|FG010|Period 1|Abnormal Triglycerides|0|||
124480283|NCT00868790|447710895|FG011|Period 1|Abnormal Triglycerides|0|||
124480284|NCT00868790|447710896|FG012|Period 1|Abnormal Triglycerides|0|||
124480285|NCT00868790|447710897|FG013|Period 1|Abnormal Triglycerides|0|||
124480286|NCT00868790|447710884|FG000|Period 1|Lost to Follow-up|0|||
124480287|NCT00868790|447710885|FG001|Period 1|Lost to Follow-up|0|||
124480288|NCT00868790|447710886|FG002|Period 1|Lost to Follow-up|0|||
124480289|NCT00868790|447710887|FG003|Period 1|Lost to Follow-up|0|||
124720056|NCT02544750|448596849|FG000|Overall Study|Withdrawal by Subject|10|||
124720057|NCT02544750|448596850|FG001|Overall Study|Withdrawal by Subject|4|||
124720058|NCT02544750|448596849|FG000|Overall Study|Lost to Follow-up|1|||
124720059|NCT02544750|448596850|FG001|Overall Study|Lost to Follow-up|0|||
124720060|NCT00244725|448596851|FG000|Overall Study|Lost to Follow-up|3|||
124720061|NCT00244725|448596852|FG001|Overall Study|Lost to Follow-up|4|||
124720062|NCT00244725|448596853|FG002|Overall Study|Lost to Follow-up|9|||
124720063|NCT00244725|448596854|FG003|Overall Study|Lost to Follow-up|2|||
124720064|NCT00244725|448596851|FG000|Overall Study|Withdrawal by Subject|9|||
124480290|NCT00868790|447710888|FG004|Period 1|Lost to Follow-up|0|||
124480291|NCT00868790|447710889|FG005|Period 1|Lost to Follow-up|1|||
124480292|NCT00868790|447710890|FG006|Period 1|Lost to Follow-up|0|||
124480293|NCT00868790|447710891|FG007|Period 1|Lost to Follow-up|0|||
124480294|NCT00868790|447710892|FG008|Period 1|Lost to Follow-up|0|||
124480295|NCT00868790|447710893|FG009|Period 1|Lost to Follow-up|0|||
124480296|NCT00868790|447710894|FG010|Period 1|Lost to Follow-up|0|||
124480297|NCT00868790|447710895|FG011|Period 1|Lost to Follow-up|0|||
124480298|NCT00868790|447710896|FG012|Period 1|Lost to Follow-up|0|||
124480299|NCT00868790|447710897|FG013|Period 1|Lost to Follow-up|0|||
124480300|NCT00868790|447710884|FG000|Period 2|Adverse Event|0|||
124557424|NCT00463866|447999075|FG001|Overall Study|Mis-Randomization of subject|1|||
124480301|NCT00868790|447710885|FG001|Period 2|Adverse Event|0|||
124557425|NCT00463866|447999074|FG000|Overall Study|Other|22|||
124720065|NCT00244725|448596852|FG001|Overall Study|Withdrawal by Subject|7|||
124720066|NCT00244725|448596853|FG002|Overall Study|Withdrawal by Subject|7|||
124720067|NCT00244725|448596854|FG003|Overall Study|Withdrawal by Subject|8|||
124720068|NCT00244725|448596851|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
124720069|NCT00244725|448596852|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
124480302|NCT00868790|447710886|FG002|Period 2|Adverse Event|0|||
124557426|NCT00463866|447999075|FG001|Overall Study|Other|22|||
124720070|NCT00244725|448596853|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
124720071|NCT00244725|448596854|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
124480303|NCT00868790|447710887|FG003|Period 2|Adverse Event|0|||
124480304|NCT00868790|447710888|FG004|Period 2|Adverse Event|0|||
124480305|NCT00868790|447710889|FG005|Period 2|Adverse Event|0|||
124480306|NCT00868790|447710890|FG006|Period 2|Adverse Event|0|||
124480307|NCT00868790|447710891|FG007|Period 2|Adverse Event|0|||
124480308|NCT00868790|447710892|FG008|Period 2|Adverse Event|1|||
124480309|NCT00868790|447710893|FG009|Period 2|Adverse Event|0|||
124720072|NCT00244725|448596851|FG000|Overall Study|Physician Decision|3|||
124720073|NCT00244725|448596852|FG001|Overall Study|Physician Decision|0|||
124480310|NCT00868790|447710894|FG010|Period 2|Adverse Event|0|||
124480311|NCT00868790|447710895|FG011|Period 2|Adverse Event|0|||
124480312|NCT00868790|447710896|FG012|Period 2|Adverse Event|0|||
124480313|NCT00868790|447710897|FG013|Period 2|Adverse Event|0|||
124480314|NCT00868790|447710884|FG000|Period 2|Lost to Follow-up|0|||
124480315|NCT00868790|447710885|FG001|Period 2|Lost to Follow-up|1|||
124480316|NCT00868790|447710886|FG002|Period 2|Lost to Follow-up|0|||
124720074|NCT00244725|448596853|FG002|Overall Study|Physician Decision|1|||
124720075|NCT00244725|448596854|FG003|Overall Study|Physician Decision|2|||
124720076|NCT00244725|448596851|FG000|Overall Study|Adverse Events|3|||
124720077|NCT00244725|448596852|FG001|Overall Study|Adverse Events|1|||
124480317|NCT00868790|447710887|FG003|Period 2|Lost to Follow-up|0|||
124557427|NCT02265952|447999076|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
124720078|NCT00244725|448596853|FG002|Overall Study|Adverse Events|4|||
124557428|NCT02265952|447999077|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
124480318|NCT00868790|447710888|FG004|Period 2|Lost to Follow-up|0|||
124480319|NCT00868790|447710889|FG005|Period 2|Lost to Follow-up|1|||
124480320|NCT00868790|447710890|FG006|Period 2|Lost to Follow-up|0|||
124720079|NCT00244725|448596854|FG003|Overall Study|Adverse Events|4|||
124720080|NCT00244725|448596851|FG000|Overall Study|Withdrwal by participant|1|||
124720081|NCT00244725|448596852|FG001|Overall Study|Withdrwal by participant|0|||
124720082|NCT00244725|448596853|FG002|Overall Study|Withdrwal by participant|0|||
124720083|NCT00244725|448596854|FG003|Overall Study|Withdrwal by participant|1|||
124720084|NCT00244725|448596851|FG000|Overall Study|Liver function test abnormality|2|||
124720085|NCT00244725|448596852|FG001|Overall Study|Liver function test abnormality|0|||
124720086|NCT00244725|448596853|FG002|Overall Study|Liver function test abnormality|0|||
124720087|NCT00244725|448596854|FG003|Overall Study|Liver function test abnormality|1|||
124720088|NCT00244725|448596851|FG000|Overall Study|Sponsor withdrew the participant|1|||
124720089|NCT00244725|448596852|FG001|Overall Study|Sponsor withdrew the participant|0|||
124720090|NCT00244725|448596853|FG002|Overall Study|Sponsor withdrew the participant|0|||
124720091|NCT00244725|448596854|FG003|Overall Study|Sponsor withdrew the participant|1|||
124720092|NCT00244725|448596851|FG000|Overall Study|Mediciation Error|0|||
124720093|NCT00244725|448596852|FG001|Overall Study|Mediciation Error|1|||
124720094|NCT00244725|448596853|FG002|Overall Study|Mediciation Error|0|||
124480321|NCT00868790|447710891|FG007|Period 2|Lost to Follow-up|0|||
124480322|NCT00868790|447710892|FG008|Period 2|Lost to Follow-up|0|||
124480323|NCT00868790|447710893|FG009|Period 2|Lost to Follow-up|0|||
124480324|NCT00868790|447710894|FG010|Period 2|Lost to Follow-up|0|||
124480325|NCT00868790|447710895|FG011|Period 2|Lost to Follow-up|0|||
124480326|NCT00868790|447710896|FG012|Period 2|Lost to Follow-up|0|||
124480327|NCT00868790|447710897|FG013|Period 2|Lost to Follow-up|0|||
124480328|NCT00868790|447710884|FG000|Period 2|Withdrawal by Subject|0|||
124480329|NCT00868790|447710885|FG001|Period 2|Withdrawal by Subject|0|||
124720095|NCT00244725|448596854|FG003|Overall Study|Mediciation Error|0|||
124720096|NCT00244725|448596851|FG000|Overall Study|Rehab Refused to allow participantion|0|||
124480330|NCT00868790|447710886|FG002|Period 2|Withdrawal by Subject|0|||
124480331|NCT00868790|447710887|FG003|Period 2|Withdrawal by Subject|0|||
124480332|NCT00868790|447710888|FG004|Period 2|Withdrawal by Subject|0|||
124720097|NCT00244725|448596852|FG001|Overall Study|Rehab Refused to allow participantion|1|||
124720098|NCT00244725|448596853|FG002|Overall Study|Rehab Refused to allow participantion|0|||
124720099|NCT00244725|448596854|FG003|Overall Study|Rehab Refused to allow participantion|0|||
124720100|NCT00244725|448596851|FG000|Overall Study|Headache|0|||
124720101|NCT00244725|448596852|FG001|Overall Study|Headache|1|||
124720102|NCT00244725|448596853|FG002|Overall Study|Headache|0|||
124720103|NCT00244725|448596854|FG003|Overall Study|Headache|0|||
124720104|NCT00244725|448596851|FG000|Overall Study|Received prohibited medication|0|||
124720105|NCT00244725|448596852|FG001|Overall Study|Received prohibited medication|1|||
124720106|NCT00244725|448596853|FG002|Overall Study|Received prohibited medication|0|||
124720107|NCT00244725|448596854|FG003|Overall Study|Received prohibited medication|1|||
124720108|NCT00244725|448596851|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
124480333|NCT00868790|447710889|FG005|Period 2|Withdrawal by Subject|0|||
124480334|NCT00868790|447710890|FG006|Period 2|Withdrawal by Subject|0|||
124480335|NCT00868790|447710891|FG007|Period 2|Withdrawal by Subject|0|||
124480336|NCT00868790|447710892|FG008|Period 2|Withdrawal by Subject|1|||
124480337|NCT00868790|447710893|FG009|Period 2|Withdrawal by Subject|0|||
124480338|NCT00868790|447710894|FG010|Period 2|Withdrawal by Subject|0|||
124480339|NCT00868790|447710895|FG011|Period 2|Withdrawal by Subject|0|||
124480340|NCT00868790|447710896|FG012|Period 2|Withdrawal by Subject|0|||
124480341|NCT00868790|447710897|FG013|Period 2|Withdrawal by Subject|1|||
124480342|NCT00868790|447710884|FG000|Period 3|Adverse Event|0|||
124480343|NCT00868790|447710885|FG001|Period 3|Adverse Event|0|||
124480344|NCT00868790|447710886|FG002|Period 3|Adverse Event|0|||
124480345|NCT00868790|447710887|FG003|Period 3|Adverse Event|0|||
124480346|NCT00868790|447710888|FG004|Period 3|Adverse Event|0|||
124480347|NCT00868790|447710889|FG005|Period 3|Adverse Event|0|||
124480348|NCT00868790|447710890|FG006|Period 3|Adverse Event|0|||
124480349|NCT00868790|447710891|FG007|Period 3|Adverse Event|0|||
124480350|NCT00868790|447710892|FG008|Period 3|Adverse Event|0|||
124480351|NCT00868790|447710893|FG009|Period 3|Adverse Event|1|||
124480352|NCT00868790|447710894|FG010|Period 3|Adverse Event|0|||
124480353|NCT00868790|447710895|FG011|Period 3|Adverse Event|0|||
124480354|NCT00868790|447710896|FG012|Period 3|Adverse Event|0|||
124480355|NCT00868790|447710897|FG013|Period 3|Adverse Event|0|||
124480356|NCT00868790|447710884|FG000|Period 3|Protocol Violation|0|||
124480357|NCT00868790|447710885|FG001|Period 3|Protocol Violation|0|||
124480358|NCT00868790|447710886|FG002|Period 3|Protocol Violation|0|||
124480359|NCT00868790|447710887|FG003|Period 3|Protocol Violation|0|||
124480360|NCT00868790|447710888|FG004|Period 3|Protocol Violation|0|||
124480361|NCT00868790|447710889|FG005|Period 3|Protocol Violation|0|||
124480362|NCT00868790|447710890|FG006|Period 3|Protocol Violation|0|||
124480363|NCT00868790|447710891|FG007|Period 3|Protocol Violation|0|||
124480364|NCT00868790|447710892|FG008|Period 3|Protocol Violation|0|||
124480365|NCT00868790|447710893|FG009|Period 3|Protocol Violation|0|||
124480366|NCT00868790|447710894|FG010|Period 3|Protocol Violation|1|||
124480367|NCT00868790|447710895|FG011|Period 3|Protocol Violation|0|||
124480368|NCT00868790|447710896|FG012|Period 3|Protocol Violation|0|||
124480369|NCT00868790|447710897|FG013|Period 3|Protocol Violation|0|||
124480370|NCT00868790|447710884|FG000|Period 3|Study Terminated by Sponsor|0|||
124480371|NCT00868790|447710885|FG001|Period 3|Study Terminated by Sponsor|0|||
124480372|NCT00868790|447710886|FG002|Period 3|Study Terminated by Sponsor|0|||
124480373|NCT00868790|447710887|FG003|Period 3|Study Terminated by Sponsor|1|||
124480374|NCT00868790|447710888|FG004|Period 3|Study Terminated by Sponsor|0|||
124480375|NCT00868790|447710889|FG005|Period 3|Study Terminated by Sponsor|0|||
124480376|NCT00868790|447710890|FG006|Period 3|Study Terminated by Sponsor|0|||
124480377|NCT00868790|447710891|FG007|Period 3|Study Terminated by Sponsor|0|||
124480378|NCT00868790|447710892|FG008|Period 3|Study Terminated by Sponsor|0|||
124480379|NCT00868790|447710893|FG009|Period 3|Study Terminated by Sponsor|0|||
124557429|NCT02265952|447999076|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
124480380|NCT00868790|447710894|FG010|Period 3|Study Terminated by Sponsor|0|||
124480381|NCT00868790|447710895|FG011|Period 3|Study Terminated by Sponsor|0|||
124480382|NCT00868790|447710896|FG012|Period 3|Study Terminated by Sponsor|0|||
124480383|NCT00868790|447710897|FG013|Period 3|Study Terminated by Sponsor|0|||
124480384|NCT00868790|447710884|FG000|Period 4|Adverse Event|0|||
124480385|NCT00868790|447710885|FG001|Period 4|Adverse Event|0|||
124480386|NCT00868790|447710886|FG002|Period 4|Adverse Event|0|||
124480387|NCT00868790|447710887|FG003|Period 4|Adverse Event|0|||
124480388|NCT00868790|447710888|FG004|Period 4|Adverse Event|0|||
124480389|NCT00868790|447710889|FG005|Period 4|Adverse Event|0|||
124480390|NCT00868790|447710890|FG006|Period 4|Adverse Event|0|||
124480391|NCT00868790|447710891|FG007|Period 4|Adverse Event|1|||
124480392|NCT00868790|447710892|FG008|Period 4|Adverse Event|0|||
124480393|NCT00868790|447710893|FG009|Period 4|Adverse Event|0|||
124480394|NCT00868790|447710894|FG010|Period 4|Adverse Event|1|||
124480395|NCT00868790|447710895|FG011|Period 4|Adverse Event|0|||
124480396|NCT00868790|447710896|FG012|Period 4|Adverse Event|1|||
124480397|NCT00868790|447710897|FG013|Period 4|Adverse Event|0|||
124480398|NCT00868790|447710884|FG000|Period 4|Lost to Follow-up|0|||
124480399|NCT00868790|447710885|FG001|Period 4|Lost to Follow-up|0|||
124480400|NCT00868790|447710886|FG002|Period 4|Lost to Follow-up|0|||
124480401|NCT00868790|447710887|FG003|Period 4|Lost to Follow-up|0|||
124720109|NCT00244725|448596852|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
124720110|NCT00244725|448596853|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
124720111|NCT00244725|448596854|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
124720112|NCT00244725|448596851|FG000|Overall Study|Administrative reason|0|||
124720113|NCT00244725|448596852|FG001|Overall Study|Administrative reason|0|||
124720114|NCT00244725|448596853|FG002|Overall Study|Administrative reason|1|||
124480402|NCT00868790|447710888|FG004|Period 4|Lost to Follow-up|0|||
124480403|NCT00868790|447710889|FG005|Period 4|Lost to Follow-up|0|||
124720115|NCT00244725|448596854|FG003|Overall Study|Administrative reason|0|||
124720116|NCT00244725|448596851|FG000|Overall Study|Vomit|0|||
124720117|NCT00244725|448596852|FG001|Overall Study|Vomit|0|||
124720118|NCT00244725|448596853|FG002|Overall Study|Vomit|1|||
124720119|NCT00244725|448596854|FG003|Overall Study|Vomit|0|||
124720120|NCT00244725|448596851|FG000|Overall Study|Failed to follow-up|0|||
124720121|NCT00244725|448596852|FG001|Overall Study|Failed to follow-up|0|||
124720122|NCT00244725|448596853|FG002|Overall Study|Failed to follow-up|1|||
124720123|NCT00244725|448596854|FG003|Overall Study|Failed to follow-up|1|||
124720124|NCT02131311|448596855|FG000|Overall Study|Adverse Event|2|||
124720125|NCT02131311|448596855|FG000|Overall Study|Protocol Violation|1|||
124720126|NCT02131311|448596855|FG000|Overall Study|Lost to Follow-up|1|||
124720127|NCT00255723|448596858|FG000|Overall Study|Adverse Event|1|||
124720128|NCT00255723|448596859|FG001|Overall Study|Adverse Event|1|||
124720129|NCT00255723|448596858|FG000|Overall Study|Death|0|||
124720130|NCT00255723|448596859|FG001|Overall Study|Death|1|||
124720131|NCT00255723|448596858|FG000|Overall Study|Response Data Not Available|1|||
124720132|NCT00255723|448596859|FG001|Overall Study|Response Data Not Available|0|||
124720133|NCT03711370|448596863|FG000|Overall Study|Lost to Follow-up|16|||
124720134|NCT03711370|448596864|FG001|Overall Study|Lost to Follow-up|10|||
124720135|NCT03711370|448596863|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
124720136|NCT03711370|448596864|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
124720137|NCT00407602|448596865|FG000|Overall Study|Death - unrelated to device|1|||
124720138|NCT00407602|448596865|FG000|Overall Study|Device explanted|5|||
124720139|NCT00407602|448596865|FG000|Overall Study|Withdrawal by Subject|1|||
124720140|NCT00553436|448596866|FG000|Overall Study|Conversion to another procedure|1|||
124720141|NCT03146663|448596869|FG000|Overall Study|Did not receive study treatment|1|||
124720142|NCT03146663|448596870|FG001|Overall Study|Did not receive study treatment|1|||
124720143|NCT03599518|448596871|FG000|Overall Study|Clinical progression|0|||
124720144|NCT03599518|448596872|FG001|Overall Study|Clinical progression|0|||
124720145|NCT03599518|448596873|FG002|Overall Study|Clinical progression|0|||
124720146|NCT03599518|448596874|FG003|Overall Study|Clinical progression|0|||
124720147|NCT03599518|448596875|FG004|Overall Study|Clinical progression|1|||
124720148|NCT03599518|448596871|FG000|Overall Study|Adverse Event|0|||
124480404|NCT00868790|447710890|FG006|Period 4|Lost to Follow-up|0|||
124480405|NCT00868790|447710891|FG007|Period 4|Lost to Follow-up|1|||
124720149|NCT03599518|448596872|FG001|Overall Study|Adverse Event|0|||
124480406|NCT00868790|447710892|FG008|Period 4|Lost to Follow-up|0|||
124720150|NCT03599518|448596873|FG002|Overall Study|Adverse Event|0|||
124480407|NCT00868790|447710893|FG009|Period 4|Lost to Follow-up|0|||
124557430|NCT02265952|447999077|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
124557431|NCT01042977|447999079|FG000|Overall Study|Adverse Event|4|||
124557432|NCT01042977|447999080|FG001|Overall Study|Adverse Event|12|||
124720151|NCT03599518|448596874|FG003|Overall Study|Adverse Event|0|||
124720152|NCT03599518|448596875|FG004|Overall Study|Adverse Event|1|||
124720153|NCT03599518|448596871|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
124557433|NCT01042977|447999079|FG000|Overall Study|Death|2|||
124720154|NCT03599518|448596872|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
124720155|NCT03599518|448596873|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
124720156|NCT03599518|448596874|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
124720157|NCT03599518|448596875|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
124720158|NCT03599518|448596871|FG000|Overall Study|Participant withdrawal from study treatment|0|||
124720159|NCT03599518|448596872|FG001|Overall Study|Participant withdrawal from study treatment|0|||
124720160|NCT03599518|448596873|FG002|Overall Study|Participant withdrawal from study treatment|1|||
124720161|NCT03599518|448596874|FG003|Overall Study|Participant withdrawal from study treatment|0|||
124720162|NCT03599518|448596875|FG004|Overall Study|Participant withdrawal from study treatment|0|||
124720163|NCT02470585|448596881|FG000|Overall Study|Death|224|||
124720164|NCT02470585|448596882|FG001|Overall Study|Death|227|||
124720165|NCT02470585|448596883|FG002|Overall Study|Death|199|||
124720166|NCT02470585|448596881|FG000|Overall Study|Withdrew consent|21|||
124720167|NCT02470585|448596882|FG001|Overall Study|Withdrew consent|22|||
124720168|NCT02470585|448596883|FG002|Overall Study|Withdrew consent|31|||
124720169|NCT02470585|448596881|FG000|Overall Study|Lost to Follow-up|8|||
124720170|NCT02470585|448596882|FG001|Overall Study|Lost to Follow-up|15|||
124720171|NCT02470585|448596883|FG002|Overall Study|Lost to Follow-up|13|||
124720172|NCT02470585|448596881|FG000|Overall Study|Sponsor discontinued study|117|||
124720173|NCT02470585|448596882|FG001|Overall Study|Sponsor discontinued study|110|||
124720174|NCT02470585|448596883|FG002|Overall Study|Sponsor discontinued study|122|||
124720175|NCT02470585|448596881|FG000|Overall Study|Other, not specified|5|||
124720176|NCT02470585|448596882|FG001|Overall Study|Other, not specified|7|||
124720177|NCT02470585|448596883|FG002|Overall Study|Other, not specified|14|||
124720178|NCT02470585|448596881|FG000|Overall Study|Missing due to site non-compliance|0|||
124720179|NCT02470585|448596882|FG001|Overall Study|Missing due to site non-compliance|2|||
124720180|NCT02470585|448596883|FG002|Overall Study|Missing due to site non-compliance|3|||
124720181|NCT02311881|448596891|FG000|Overall Study|Did not meet the study criteria|2|||
124720182|NCT02311881|448596892|FG001|Overall Study|Did not meet the study criteria|2|||
124720183|NCT02311881|448596893|FG002|Overall Study|Did not meet the study criteria|0|||
124720184|NCT02311881|448596891|FG000|Overall Study|Adverse Event|7|||
124720185|NCT02311881|448596892|FG001|Overall Study|Adverse Event|15|||
124720186|NCT02311881|448596893|FG002|Overall Study|Adverse Event|8|||
124720187|NCT02311881|448596891|FG000|Overall Study|Lost to Follow-up|3|||
124720188|NCT02311881|448596892|FG001|Overall Study|Lost to Follow-up|3|||
124720189|NCT02311881|448596893|FG002|Overall Study|Lost to Follow-up|2|||
124720190|NCT02311881|448596891|FG000|Overall Study|Protocol Violation|1|||
124720191|NCT02311881|448596892|FG001|Overall Study|Protocol Violation|2|||
124720192|NCT02311881|448596893|FG002|Overall Study|Protocol Violation|3|||
124720193|NCT02311881|448596891|FG000|Overall Study|Withdrawal of consent|14|||
124720194|NCT02311881|448596892|FG001|Overall Study|Withdrawal of consent|16|||
124720195|NCT02311881|448596893|FG002|Overall Study|Withdrawal of consent|17|||
124720196|NCT02311881|448596891|FG000|Overall Study|Other|0|||
124720197|NCT02311881|448596892|FG001|Overall Study|Other|0|||
124720198|NCT02311881|448596893|FG002|Overall Study|Other|1|||
124720199|NCT02311881|448596891|FG000|Overall Study|Lack of Efficacy|1|||
124720200|NCT02311881|448596892|FG001|Overall Study|Lack of Efficacy|2|||
124720201|NCT02311881|448596893|FG002|Overall Study|Lack of Efficacy|0|||
124720202|NCT02311881|448596891|FG000|Overall Study|Subject has border line pregnancy test|1|||
124720203|NCT02311881|448596892|FG001|Overall Study|Subject has border line pregnancy test|0|||
124720204|NCT02311881|448596893|FG002|Overall Study|Subject has border line pregnancy test|0|||
124720205|NCT02311881|448596891|FG000|Overall Study|Withdrawal by Subject|3|||
124720206|NCT02311881|448596892|FG001|Overall Study|Withdrawal by Subject|1|||
124720207|NCT02311881|448596893|FG002|Overall Study|Withdrawal by Subject|4|||
124720208|NCT02311881|448596891|FG000|Overall Study|Sponsor Decision|1|||
124720209|NCT02311881|448596892|FG001|Overall Study|Sponsor Decision|1|||
124720210|NCT02311881|448596893|FG002|Overall Study|Sponsor Decision|1|||
124720211|NCT02311881|448596891|FG000|Overall Study|Protocol Deviation|1|||
124720212|NCT02311881|448596892|FG001|Overall Study|Protocol Deviation|0|||
124720213|NCT02311881|448596893|FG002|Overall Study|Protocol Deviation|0|||
124720214|NCT02311881|448596891|FG000|Overall Study|Non-Compliance|1|||
124480408|NCT00868790|447710894|FG010|Period 4|Lost to Follow-up|0|||
124720215|NCT02311881|448596892|FG001|Overall Study|Non-Compliance|0|||
124480409|NCT00868790|447710895|FG011|Period 4|Lost to Follow-up|0|||
124480410|NCT00868790|447710896|FG012|Period 4|Lost to Follow-up|0|||
124480411|NCT00868790|447710897|FG013|Period 4|Lost to Follow-up|0|||
124480412|NCT00868790|447710884|FG000|Period 4|Study Terminated by Sponsor|2|||
124480413|NCT00868790|447710885|FG001|Period 4|Study Terminated by Sponsor|0|||
124480414|NCT00868790|447710886|FG002|Period 4|Study Terminated by Sponsor|0|||
124480415|NCT00868790|447710887|FG003|Period 4|Study Terminated by Sponsor|0|||
124480416|NCT00868790|447710888|FG004|Period 4|Study Terminated by Sponsor|0|||
124480417|NCT00868790|447710889|FG005|Period 4|Study Terminated by Sponsor|0|||
124480418|NCT00868790|447710890|FG006|Period 4|Study Terminated by Sponsor|0|||
124480419|NCT00868790|447710891|FG007|Period 4|Study Terminated by Sponsor|1|||
124480420|NCT00868790|447710892|FG008|Period 4|Study Terminated by Sponsor|2|||
124480421|NCT00868790|447710893|FG009|Period 4|Study Terminated by Sponsor|0|||
124480422|NCT00868790|447710894|FG010|Period 4|Study Terminated by Sponsor|2|||
124480423|NCT00868790|447710895|FG011|Period 4|Study Terminated by Sponsor|1|||
124480424|NCT00868790|447710896|FG012|Period 4|Study Terminated by Sponsor|0|||
124480425|NCT00868790|447710897|FG013|Period 4|Study Terminated by Sponsor|1|||
124480426|NCT00868790|447710884|FG000|Period 4|Abnormal ALT/AST|0|||
124480427|NCT00868790|447710885|FG001|Period 4|Abnormal ALT/AST|0|||
124480428|NCT00868790|447710886|FG002|Period 4|Abnormal ALT/AST|1|||
124480429|NCT00868790|447710887|FG003|Period 4|Abnormal ALT/AST|0|||
124480430|NCT00868790|447710888|FG004|Period 4|Abnormal ALT/AST|0|||
124480431|NCT00868790|447710889|FG005|Period 4|Abnormal ALT/AST|0|||
124480432|NCT00868790|447710890|FG006|Period 4|Abnormal ALT/AST|0|||
124480433|NCT00868790|447710891|FG007|Period 4|Abnormal ALT/AST|0|||
124480434|NCT00868790|447710892|FG008|Period 4|Abnormal ALT/AST|0|||
124480435|NCT00868790|447710893|FG009|Period 4|Abnormal ALT/AST|0|||
124480436|NCT00868790|447710894|FG010|Period 4|Abnormal ALT/AST|0|||
124480437|NCT00868790|447710895|FG011|Period 4|Abnormal ALT/AST|0|||
124720216|NCT02311881|448596893|FG002|Overall Study|Non-Compliance|2|||
124480438|NCT00868790|447710896|FG012|Period 4|Abnormal ALT/AST|0|||
124480439|NCT00868790|447710897|FG013|Period 4|Abnormal ALT/AST|0|||
124480440|NCT00868790|447710884|FG000|Post-study|Withdrawal by Subject|0|||
124720217|NCT02311881|448596891|FG000|Overall Study|Physician Decision|0|||
124720218|NCT02311881|448596892|FG001|Overall Study|Physician Decision|0|||
124720219|NCT02311881|448596893|FG002|Overall Study|Physician Decision|1|||
124720220|NCT02311881|448596891|FG000|Overall Study|Medical Monitor Discretion|0|||
124720221|NCT02311881|448596892|FG001|Overall Study|Medical Monitor Discretion|0|||
124720222|NCT02311881|448596893|FG002|Overall Study|Medical Monitor Discretion|1|||
124480441|NCT00868790|447710885|FG001|Post-study|Withdrawal by Subject|0|||
124480442|NCT00868790|447710886|FG002|Post-study|Withdrawal by Subject|0|||
124720223|NCT02311881|448596891|FG000|Overall Study|Participant taking another medication|0|||
124720224|NCT02311881|448596892|FG001|Overall Study|Participant taking another medication|0|||
124720225|NCT02311881|448596893|FG002|Overall Study|Participant taking another medication|1|||
124720226|NCT02311881|448596891|FG000|Overall Study|Serious Adverse Event|0|||
124720227|NCT02311881|448596892|FG001|Overall Study|Serious Adverse Event|1|||
124720228|NCT02311881|448596893|FG002|Overall Study|Serious Adverse Event|0|||
124720229|NCT00819156|448596896|FG000|Overall Study|Adverse Event|1|||
124720230|NCT00819156|448596897|FG001|Overall Study|Adverse Event|4|||
124720231|NCT00819156|448596898|FG002|Overall Study|Adverse Event|2|||
124720232|NCT00819156|448596899|FG003|Overall Study|Adverse Event|1|||
124720233|NCT00819156|448596900|FG004|Overall Study|Adverse Event|2|||
124480443|NCT00868790|447710887|FG003|Post-study|Withdrawal by Subject|0|||
124720234|NCT00819156|448596901|FG005|Overall Study|Adverse Event|3|||
124720235|NCT00819156|448596896|FG000|Overall Study|Withdrawal by Subject|0|||
124480444|NCT00868790|447710888|FG004|Post-study|Withdrawal by Subject|1|||
124480445|NCT00868790|447710889|FG005|Post-study|Withdrawal by Subject|0|||
124480446|NCT00868790|447710890|FG006|Post-study|Withdrawal by Subject|0|||
124480447|NCT00868790|447710891|FG007|Post-study|Withdrawal by Subject|0|||
124480448|NCT00868790|447710892|FG008|Post-study|Withdrawal by Subject|0|||
124480449|NCT00868790|447710893|FG009|Post-study|Withdrawal by Subject|0|||
124480450|NCT00868790|447710894|FG010|Post-study|Withdrawal by Subject|0|||
124480451|NCT00868790|447710895|FG011|Post-study|Withdrawal by Subject|0|||
124480452|NCT00868790|447710896|FG012|Post-study|Withdrawal by Subject|0|||
124480453|NCT00868790|447710897|FG013|Post-study|Withdrawal by Subject|0|||
124480454|NCT00868790|447710884|FG000|Post-study|Excluded Medication|0|||
124480455|NCT00868790|447710885|FG001|Post-study|Excluded Medication|0|||
124480456|NCT00868790|447710886|FG002|Post-study|Excluded Medication|0|||
124480457|NCT00868790|447710887|FG003|Post-study|Excluded Medication|0|||
124480458|NCT00868790|447710888|FG004|Post-study|Excluded Medication|0|||
124480459|NCT00868790|447710889|FG005|Post-study|Excluded Medication|0|||
124480460|NCT00868790|447710890|FG006|Post-study|Excluded Medication|0|||
124480461|NCT00868790|447710891|FG007|Post-study|Excluded Medication|2|||
124480462|NCT00868790|447710892|FG008|Post-study|Excluded Medication|0|||
124480463|NCT00868790|447710893|FG009|Post-study|Excluded Medication|1|||
124480464|NCT00868790|447710894|FG010|Post-study|Excluded Medication|0|||
124480465|NCT00868790|447710895|FG011|Post-study|Excluded Medication|0|||
124480466|NCT00868790|447710896|FG012|Post-study|Excluded Medication|0|||
124480467|NCT00868790|447710897|FG013|Post-study|Excluded Medication|0|||
124480468|NCT02582671|447710898|FG000|Overall Study|Failure to return|1|||
124480469|NCT02582671|447710898|FG000|Overall Study|Other, not specified|1|||
124480470|NCT03068715|447710899|FG000|Overall Study|No longer met inclusion criteria|1|||
124480471|NCT03068715|447710900|FG001|Overall Study|No longer met inclusion criteria|0|||
124480472|NCT01276288|447710901|FG000|Overall Study|Adverse Event|1|||
124480473|NCT01276288|447710902|FG001|Overall Study|Adverse Event|1|||
124480474|NCT01276288|447710903|FG002|Overall Study|Adverse Event|0|||
124480475|NCT01276288|447710904|FG003|Overall Study|Adverse Event|0|||
124480476|NCT01276288|447710901|FG000|Overall Study|not treated|1|||
124480477|NCT01276288|447710902|FG001|Overall Study|not treated|0|||
124480478|NCT01276288|447710903|FG002|Overall Study|not treated|0|||
124480479|NCT01276288|447710904|FG003|Overall Study|not treated|0|||
124480480|NCT03168867|447710906|FG000|Overall Study|Withdrawal by Subject|1|||
124720236|NCT00819156|448596897|FG001|Overall Study|Withdrawal by Subject|3|||
124720237|NCT00819156|448596898|FG002|Overall Study|Withdrawal by Subject|2|||
124720238|NCT00819156|448596899|FG003|Overall Study|Withdrawal by Subject|0|||
124720239|NCT00819156|448596900|FG004|Overall Study|Withdrawal by Subject|1|||
124720240|NCT00819156|448596901|FG005|Overall Study|Withdrawal by Subject|0|||
124720241|NCT00819156|448596896|FG000|Overall Study|Protocol Violation|1|||
124720242|NCT00819156|448596897|FG001|Overall Study|Protocol Violation|0|||
124480481|NCT03168867|447710907|FG001|Overall Study|Withdrawal by Subject|5|||
124480482|NCT04348851|447710908|FG000|Post-Test 1|Withdrawal by Subject|0|||
124480483|NCT04348851|447710909|FG001|Post-Test 1|Withdrawal by Subject|1|||
124480484|NCT04348851|447710910|FG002|Post-Test 1|Withdrawal by Subject|0|||
124480485|NCT04348851|447710911|FG003|Post-Test 1|Withdrawal by Subject|0|||
124480486|NCT04348851|447710908|FG000|Post-Test 1|Lost to Follow-up|0|||
124480487|NCT04348851|447710909|FG001|Post-Test 1|Lost to Follow-up|1|||
124480488|NCT04348851|447710910|FG002|Post-Test 1|Lost to Follow-up|0|||
124480489|NCT04348851|447710911|FG003|Post-Test 1|Lost to Follow-up|0|||
124480490|NCT04348851|447710908|FG000|Post-Test 2|Stroke survivor death|0|||
124480491|NCT04348851|447710909|FG001|Post-Test 2|Stroke survivor death|1|||
124480492|NCT04348851|447710910|FG002|Post-Test 2|Stroke survivor death|0|||
124480493|NCT04348851|447710911|FG003|Post-Test 2|Stroke survivor death|1|||
124480494|NCT03040024|447710914|FG000|Overall Study|Adverse Event|0|||
124480495|NCT03040024|447710915|FG001|Overall Study|Adverse Event|1|||
124480496|NCT03040024|447710916|FG002|Overall Study|Adverse Event|0|||
124480497|NCT03040024|447710914|FG000|Overall Study|Death|0|||
124480498|NCT03040024|447710915|FG001|Overall Study|Death|1|||
124480499|NCT03040024|447710916|FG002|Overall Study|Death|0|||
124480500|NCT03040024|447710914|FG000|Overall Study|Physician Decision|0|||
124480501|NCT03040024|447710915|FG001|Overall Study|Physician Decision|0|||
124480502|NCT03040024|447710916|FG002|Overall Study|Physician Decision|1|||
124480503|NCT00519077|447710917|FG000|Overall Study|Death|6|||
124480504|NCT00519077|447710917|FG000|Overall Study|Other|2|||
124480505|NCT01967225|447710918|FG000|Overall Study|Adverse Event|3|||
124480506|NCT01967225|447710919|FG001|Overall Study|Adverse Event|1|||
124480507|NCT01967225|447710918|FG000|Overall Study|Withdrawal by Subject|2|||
124557434|NCT01042977|447999080|FG001|Overall Study|Death|1|||
124720243|NCT00819156|448596898|FG002|Overall Study|Protocol Violation|1|||
124720244|NCT00819156|448596899|FG003|Overall Study|Protocol Violation|0|||
124720245|NCT00819156|448596900|FG004|Overall Study|Protocol Violation|0|||
124720246|NCT00819156|448596901|FG005|Overall Study|Protocol Violation|1|||
124720247|NCT00819156|448596896|FG000|Overall Study|Lost to Follow-up|0|||
124720248|NCT00819156|448596897|FG001|Overall Study|Lost to Follow-up|1|||
124720249|NCT00819156|448596898|FG002|Overall Study|Lost to Follow-up|0|||
124720250|NCT00819156|448596899|FG003|Overall Study|Lost to Follow-up|0|||
124720251|NCT00819156|448596900|FG004|Overall Study|Lost to Follow-up|0|||
124720252|NCT00819156|448596901|FG005|Overall Study|Lost to Follow-up|2|||
124720253|NCT00819156|448596896|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
124720254|NCT00819156|448596897|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
124720255|NCT00819156|448596898|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
124720256|NCT00819156|448596899|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
124720257|NCT00819156|448596900|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
124720258|NCT00819156|448596901|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
124720259|NCT00819156|448596896|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
124720260|NCT00819156|448596897|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
124720261|NCT00819156|448596898|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
124720262|NCT00819156|448596899|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
124720263|NCT00819156|448596900|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
124720264|NCT00819156|448596901|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
124720265|NCT00819156|448596896|FG000|Overall Study|Prostate-specific antigen progression|0|||
124720266|NCT00819156|448596897|FG001|Overall Study|Prostate-specific antigen progression|0|||
124720267|NCT00819156|448596898|FG002|Overall Study|Prostate-specific antigen progression|0|||
124720268|NCT00819156|448596899|FG003|Overall Study|Prostate-specific antigen progression|0|||
124720269|NCT00819156|448596900|FG004|Overall Study|Prostate-specific antigen progression|1|||
124720270|NCT00819156|448596901|FG005|Overall Study|Prostate-specific antigen progression|0|||
124720271|NCT00790582|448596902|FG000|Overall Study|Death|14|||
124720272|NCT00790582|448596903|FG001|Overall Study|Death|32|||
124720273|NCT00790582|448596902|FG000|Overall Study|Physician Decision|7|||
124720274|NCT00790582|448596903|FG001|Overall Study|Physician Decision|1|||
124720275|NCT00790582|448596902|FG000|Overall Study|Lost to Follow-up|3|||
124720276|NCT00790582|448596903|FG001|Overall Study|Lost to Follow-up|3|||
124720277|NCT00790582|448596902|FG000|Overall Study|Withdrawal by Subject|7|||
124720278|NCT00790582|448596903|FG001|Overall Study|Withdrawal by Subject|51|||
124720279|NCT01575808|448596906|FG000|Overall Study|Death|2|||
124720280|NCT01575808|448596907|FG001|Overall Study|Death|0|||
124720281|NCT01575808|448596906|FG000|Overall Study|Withdrawal by Subject|1|||
124720282|NCT01575808|448596907|FG001|Overall Study|Withdrawal by Subject|0|||
124720283|NCT05823974|448599230|FG000|Overall Study|Lost to Follow-up|0|||
124720284|NCT05823974|448599231|FG001|Overall Study|Lost to Follow-up|3|||
124720285|NCT05823974|448599232|FG002|Overall Study|Lost to Follow-up|1|||
124720286|NCT05823974|448599233|FG003|Overall Study|Lost to Follow-up|0|||
124720287|NCT05823974|448599234|FG004|Overall Study|Lost to Follow-up|1|||
124720288|NCT05823974|448599235|FG005|Overall Study|Lost to Follow-up|0|||
124720289|NCT05823974|448599236|FG006|Overall Study|Lost to Follow-up|1|||
124720290|NCT05823974|448599237|FG007|Overall Study|Lost to Follow-up|0|||
124720291|NCT05823974|448599238|FG008|Overall Study|Lost to Follow-up|0|||
124720292|NCT05823974|448599239|FG009|Overall Study|Lost to Follow-up|1|||
124720293|NCT05823974|448599240|FG010|Overall Study|Lost to Follow-up|1|||
124720294|NCT05823974|448599241|FG011|Overall Study|Lost to Follow-up|0|||
124720295|NCT05823974|448599242|FG012|Overall Study|Lost to Follow-up|1|||
124720296|NCT05823974|448599243|FG013|Overall Study|Lost to Follow-up|2|||
124720297|NCT05823974|448599244|FG014|Overall Study|Lost to Follow-up|1|||
124720298|NCT05823974|448599245|FG015|Overall Study|Lost to Follow-up|1|||
124720299|NCT05823974|448599246|FG016|Overall Study|Lost to Follow-up|1|||
124720300|NCT05823974|448599247|FG017|Overall Study|Lost to Follow-up|0|||
124720301|NCT05823974|448599248|FG018|Overall Study|Lost to Follow-up|0|||
124557435|NCT01042977|447999079|FG000|Overall Study|Withdrawal by Subject|8|||
124720302|NCT05823974|448599249|FG019|Overall Study|Lost to Follow-up|2|||
124720303|NCT05823974|448599250|FG020|Overall Study|Lost to Follow-up|0|||
124720304|NCT05823974|448599230|FG000|Overall Study|Physician Decision|0|||
124720305|NCT05823974|448599231|FG001|Overall Study|Physician Decision|0|||
124720306|NCT05823974|448599232|FG002|Overall Study|Physician Decision|0|||
124720307|NCT05823974|448599233|FG003|Overall Study|Physician Decision|0|||
124720308|NCT05823974|448599234|FG004|Overall Study|Physician Decision|0|||
124720309|NCT05823974|448599235|FG005|Overall Study|Physician Decision|0|||
124720310|NCT05823974|448599236|FG006|Overall Study|Physician Decision|0|||
124720311|NCT05823974|448599237|FG007|Overall Study|Physician Decision|0|||
124720312|NCT05823974|448599238|FG008|Overall Study|Physician Decision|0|||
124720313|NCT05823974|448599239|FG009|Overall Study|Physician Decision|0|||
124720314|NCT05823974|448599240|FG010|Overall Study|Physician Decision|0|||
124720315|NCT05823974|448599241|FG011|Overall Study|Physician Decision|0|||
124720316|NCT05823974|448599242|FG012|Overall Study|Physician Decision|0|||
124720317|NCT05823974|448599243|FG013|Overall Study|Physician Decision|0|||
124720318|NCT05823974|448599244|FG014|Overall Study|Physician Decision|0|||
124720319|NCT05823974|448599245|FG015|Overall Study|Physician Decision|1|||
124720320|NCT05823974|448599246|FG016|Overall Study|Physician Decision|0|||
124720321|NCT05823974|448599247|FG017|Overall Study|Physician Decision|1|||
124720322|NCT05823974|448599248|FG018|Overall Study|Physician Decision|1|||
124720323|NCT05823974|448599249|FG019|Overall Study|Physician Decision|0|||
124720324|NCT05823974|448599250|FG020|Overall Study|Physician Decision|0|||
124720325|NCT05823974|448599230|FG000|Overall Study|Withdrawal by Subject|1|||
124720326|NCT05823974|448599231|FG001|Overall Study|Withdrawal by Subject|1|||
124720327|NCT05823974|448599232|FG002|Overall Study|Withdrawal by Subject|2|||
124720328|NCT05823974|448599233|FG003|Overall Study|Withdrawal by Subject|0|||
124720329|NCT05823974|448599234|FG004|Overall Study|Withdrawal by Subject|2|||
124720330|NCT05823974|448599235|FG005|Overall Study|Withdrawal by Subject|3|||
124720331|NCT05823974|448599236|FG006|Overall Study|Withdrawal by Subject|1|||
124720332|NCT05823974|448599237|FG007|Overall Study|Withdrawal by Subject|1|||
124720333|NCT05823974|448599238|FG008|Overall Study|Withdrawal by Subject|2|||
124720334|NCT05823974|448599239|FG009|Overall Study|Withdrawal by Subject|1|||
124720335|NCT05823974|448599240|FG010|Overall Study|Withdrawal by Subject|1|||
124480508|NCT01967225|447710919|FG001|Overall Study|Withdrawal by Subject|1|||
124720336|NCT05823974|448599241|FG011|Overall Study|Withdrawal by Subject|0|||
124557436|NCT01042977|447999080|FG001|Overall Study|Withdrawal by Subject|16|||
124720337|NCT05823974|448599242|FG012|Overall Study|Withdrawal by Subject|0|||
124720338|NCT05823974|448599243|FG013|Overall Study|Withdrawal by Subject|1|||
124720339|NCT05823974|448599244|FG014|Overall Study|Withdrawal by Subject|1|||
124720340|NCT05823974|448599245|FG015|Overall Study|Withdrawal by Subject|3|||
124720341|NCT05823974|448599246|FG016|Overall Study|Withdrawal by Subject|0|||
124720342|NCT05823974|448599247|FG017|Overall Study|Withdrawal by Subject|2|||
124720343|NCT05823974|448599248|FG018|Overall Study|Withdrawal by Subject|2|||
124720344|NCT05823974|448599249|FG019|Overall Study|Withdrawal by Subject|0|||
124720345|NCT05823974|448599250|FG020|Overall Study|Withdrawal by Subject|1|||
124720346|NCT05823974|448599230|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720347|NCT05823974|448599231|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720348|NCT05823974|448599232|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124720349|NCT05823974|448599233|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720350|NCT05823974|448599234|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720351|NCT05823974|448599235|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720352|NCT05823974|448599236|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720353|NCT05823974|448599237|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720354|NCT05823974|448599238|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720355|NCT05823974|448599239|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720356|NCT05823974|448599240|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720357|NCT05823974|448599241|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720358|NCT05823974|448599242|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720359|NCT05823974|448599243|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720360|NCT05823974|448599244|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124720361|NCT05823974|448599245|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720362|NCT05823974|448599246|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720363|NCT05823974|448599247|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720364|NCT05823974|448599248|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720365|NCT05823974|448599249|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720366|NCT05823974|448599250|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124720367|NCT05823974|448599230|FG000|Overall Study|Other|0|||
124720368|NCT05823974|448599231|FG001|Overall Study|Other|1|||
124720369|NCT05823974|448599232|FG002|Overall Study|Other|1|||
124720370|NCT05823974|448599233|FG003|Overall Study|Other|1|||
124720371|NCT05823974|448599234|FG004|Overall Study|Other|0|||
124720372|NCT05823974|448599235|FG005|Overall Study|Other|1|||
124720373|NCT05823974|448599236|FG006|Overall Study|Other|1|||
124720374|NCT05823974|448599237|FG007|Overall Study|Other|1|||
124720375|NCT05823974|448599238|FG008|Overall Study|Other|1|||
124720376|NCT05823974|448599239|FG009|Overall Study|Other|0|||
124557437|NCT01042977|447999079|FG000|Overall Study|Lost to Follow-up|0|||
124557438|NCT01042977|447999080|FG001|Overall Study|Lost to Follow-up|2|||
124557439|NCT01042977|447999079|FG000|Overall Study|Poor/non-compliance|3|||
124557440|NCT01042977|447999080|FG001|Overall Study|Poor/non-compliance|4|||
124480509|NCT01967225|447710918|FG000|Overall Study|Lack of Efficacy|1|||
124480510|NCT01967225|447710919|FG001|Overall Study|Lack of Efficacy|1|||
124480511|NCT01967225|447710918|FG000|Overall Study|Switching to other therapy|2|||
124480512|NCT01967225|447710919|FG001|Overall Study|Switching to other therapy|0|||
124480513|NCT01967225|447710918|FG000|Overall Study|Protocol driven decision point|1|||
124480514|NCT01967225|447710919|FG001|Overall Study|Protocol driven decision point|0|||
124480515|NCT01967225|447710918|FG000|Overall Study|Logistical difficulties|1|||
124480516|NCT01967225|447710919|FG001|Overall Study|Logistical difficulties|0|||
124480517|NCT01967225|447710918|FG000|Overall Study|Protocol Violation|2|||
124480518|NCT01967225|447710919|FG001|Overall Study|Protocol Violation|0|||
124480519|NCT04696861|447710921|FG000|Overall Study|Death|1|||
124480520|NCT04696861|447710922|FG001|Overall Study|Death|0|||
124480521|NCT04696861|447710921|FG000|Overall Study|Lost to Follow-up|3|||
124480522|NCT04696861|447710922|FG001|Overall Study|Lost to Follow-up|0|||
124480523|NCT02848833|447710925|FG000|Overall Study|subject who are duplicated|1|||
124480524|NCT02848833|447710925|FG000|Overall Study|have not taken the study drug|11|||
124480525|NCT02848833|447710925|FG000|Overall Study|follow-up failure|6|||
124480526|NCT02848833|447710925|FG000|Overall Study|Protocol Violation|119|||
124480527|NCT02847598|447710926|FG000|Overall Study|Adverse Event|0|||
124480528|NCT02847598|447710927|FG001|Overall Study|Adverse Event|0|||
124480529|NCT02847598|447710928|FG002|Overall Study|Adverse Event|0|||
124480530|NCT02847598|447710929|FG003|Overall Study|Adverse Event|0|||
124480531|NCT02847598|447710930|FG004|Overall Study|Adverse Event|0|||
124480532|NCT02847598|447710931|FG005|Overall Study|Adverse Event|0|||
124480533|NCT02847598|447710932|FG006|Overall Study|Adverse Event|0|||
124480534|NCT02847598|447710933|FG007|Overall Study|Adverse Event|1|||
124480535|NCT02847598|447710926|FG000|Overall Study|Consent withdrawn|2|||
124480536|NCT02847598|447710927|FG001|Overall Study|Consent withdrawn|0|||
124720377|NCT05823974|448599240|FG010|Overall Study|Other|0|||
124720378|NCT05823974|448599241|FG011|Overall Study|Other|0|||
124720379|NCT05823974|448599242|FG012|Overall Study|Other|2|||
124480537|NCT02847598|447710928|FG002|Overall Study|Consent withdrawn|0|||
124480538|NCT02847598|447710929|FG003|Overall Study|Consent withdrawn|4|||
124480539|NCT02847598|447710930|FG004|Overall Study|Consent withdrawn|3|||
124480540|NCT02847598|447710931|FG005|Overall Study|Consent withdrawn|2|||
124480541|NCT02847598|447710932|FG006|Overall Study|Consent withdrawn|1|||
124480542|NCT02847598|447710933|FG007|Overall Study|Consent withdrawn|3|||
124480543|NCT02847598|447710926|FG000|Overall Study|Death|3|||
124480544|NCT02847598|447710927|FG001|Overall Study|Death|0|||
124480545|NCT02847598|447710928|FG002|Overall Study|Death|0|||
124480546|NCT02847598|447710929|FG003|Overall Study|Death|0|||
124480547|NCT02847598|447710930|FG004|Overall Study|Death|0|||
124720380|NCT05823974|448599243|FG013|Overall Study|Other|1|||
124480548|NCT02847598|447710931|FG005|Overall Study|Death|0|||
124480549|NCT02847598|447710932|FG006|Overall Study|Death|0|||
124480550|NCT02847598|447710933|FG007|Overall Study|Death|0|||
124480551|NCT02847598|447710926|FG000|Overall Study|Lost to Follow-up|0|||
124480552|NCT02847598|447710927|FG001|Overall Study|Lost to Follow-up|0|||
124480553|NCT02847598|447710928|FG002|Overall Study|Lost to Follow-up|0|||
124480554|NCT02847598|447710929|FG003|Overall Study|Lost to Follow-up|0|||
124720381|NCT05823974|448599244|FG014|Overall Study|Other|0|||
124720382|NCT05823974|448599245|FG015|Overall Study|Other|1|||
124720383|NCT05823974|448599246|FG016|Overall Study|Other|0|||
124720384|NCT05823974|448599247|FG017|Overall Study|Other|0|||
124720385|NCT05823974|448599248|FG018|Overall Study|Other|0|||
124720386|NCT05823974|448599249|FG019|Overall Study|Other|0|||
124720387|NCT05823974|448599250|FG020|Overall Study|Other|0|||
124720388|NCT00316706|448599251|FG000|Overall Study|Lost to Follow-up|38|||
124720389|NCT00316706|448599252|FG001|Overall Study|Lost to Follow-up|48|||
124720390|NCT03292874|448599254|FG000|Overall Study|Due to pandemic|5|||
124720391|NCT00485758|448599262|FG000|Overall Study|Adverse Event|102|||
124720392|NCT00485758|448599263|FG001|Overall Study|Adverse Event|31|||
124720393|NCT00485758|448599262|FG000|Overall Study|Death|0|||
124720394|NCT00485758|448599263|FG001|Overall Study|Death|1|||
124720395|NCT00485758|448599262|FG000|Overall Study|Lost to Follow-up|5|||
124720396|NCT00485758|448599263|FG001|Overall Study|Lost to Follow-up|1|||
124480555|NCT02847598|447710930|FG004|Overall Study|Lost to Follow-up|0|||
124480556|NCT02847598|447710931|FG005|Overall Study|Lost to Follow-up|1|||
124480557|NCT02847598|447710932|FG006|Overall Study|Lost to Follow-up|1|||
124720397|NCT00485758|448599262|FG000|Overall Study|Physician Decision|3|||
124480558|NCT02847598|447710933|FG007|Overall Study|Lost to Follow-up|0|||
124720398|NCT00485758|448599263|FG001|Overall Study|Physician Decision|3|||
124720399|NCT00485758|448599262|FG000|Overall Study|Protocol Violation|11|||
124720400|NCT00485758|448599263|FG001|Overall Study|Protocol Violation|2|||
124720401|NCT00485758|448599262|FG000|Overall Study|Withdrawal by Subject|32|||
124720402|NCT00485758|448599263|FG001|Overall Study|Withdrawal by Subject|27|||
124480559|NCT05047523|447713816|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
124480560|NCT05047523|447713817|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
124720403|NCT00485758|448599262|FG000|Overall Study|Study Terminated by Sponsor|3|||
124720404|NCT00485758|448599263|FG001|Overall Study|Study Terminated by Sponsor|0|||
124720405|NCT00654745|448599264|FG000|Overall Study|Adverse Event|12|||
124480561|NCT05047523|447713818|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
124480562|NCT05047523|447713819|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
124480563|NCT05047523|447713820|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
124480564|NCT05047523|447713821|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
124480565|NCT05047523|447713816|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
124480566|NCT05047523|447713817|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
124480567|NCT05047523|447713818|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
124480568|NCT05047523|447713819|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
124480569|NCT05047523|447713820|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
124480570|NCT05047523|447713821|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
124480571|NCT05047523|447713816|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
124480572|NCT05047523|447713817|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
124480573|NCT05047523|447713818|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
124480574|NCT05047523|447713819|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
124480575|NCT05047523|447713820|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
124480576|NCT05047523|447713821|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
124480577|NCT05047523|447713816|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
124480578|NCT05047523|447713817|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
124480579|NCT05047523|447713818|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
124720406|NCT00654745|448599264|FG000|Overall Study|Lost to Follow-up|7|||
124720407|NCT00654745|448599264|FG000|Overall Study|Protocol Violation|11|||
124720408|NCT00654745|448599264|FG000|Overall Study|Withdrawal by Subject|10|||
124720409|NCT00654745|448599264|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
124720410|NCT01995526|448599265|FG000|Overall Study|Physician Decision|1|||
124480580|NCT05047523|447713819|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
124480581|NCT05047523|447713820|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
124480582|NCT05047523|447713821|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
124480583|NCT05047523|447713816|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
124480584|NCT05047523|447713817|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
124480585|NCT05047523|447713818|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
124480586|NCT05047523|447713819|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
124480587|NCT05047523|447713820|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
124480588|NCT05047523|447713821|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
124480589|NCT05047523|447713816|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
124480590|NCT05047523|447713817|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
124480591|NCT05047523|447713818|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
124480592|NCT05047523|447713819|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
124480593|NCT05047523|447713820|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
124480594|NCT05047523|447713821|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
124480595|NCT03658889|447713822|FG000|Overall Study|Protocol Violation|2|||
124480596|NCT03658889|447713823|FG001|Overall Study|Protocol Violation|0|||
124480597|NCT00224016|447713830|FG000|Titration Period|Withdrawal by Subject|0|||
124480598|NCT00224016|447713831|FG001|Titration Period|Withdrawal by Subject|1|||
124480599|NCT00224016|447713830|FG000|Titration Period|Lost to Follow-up|1|||
124480600|NCT00224016|447713831|FG001|Titration Period|Lost to Follow-up|0|||
124480601|NCT00224016|447713830|FG000|Maintenance Period|Withdrawal by Subject|2|||
124480602|NCT00224016|447713831|FG001|Maintenance Period|Withdrawal by Subject|0|||
124480603|NCT00224016|447713830|FG000|Maintenance Period|Lost to Follow-up|0|||
124480604|NCT00224016|447713831|FG001|Maintenance Period|Lost to Follow-up|1|||
124480605|NCT01609933|447713832|FG000|Overall Study|Adverse Event|1|||
124480606|NCT01609933|447713832|FG000|Overall Study|Withdrawal by Subject|3|||
124480607|NCT01252966|447713833|FG000|Overall Study|Lost to Follow-up|16|||
124480608|NCT01252966|447713834|FG001|Overall Study|Lost to Follow-up|10|||
124480609|NCT01252966|447713833|FG000|Overall Study|Withdrawal by Subject|7|||
124480610|NCT01252966|447713834|FG001|Overall Study|Withdrawal by Subject|3|||
124480611|NCT00278629|447713849|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
124480612|NCT03323749|447713850|FG000|Double-blind Period|Lost to Follow-up|4|||
124480613|NCT03323749|447713851|FG001|Double-blind Period|Lost to Follow-up|5|||
124480614|NCT03323749|447713850|FG000|Double-blind Period|Adverse Event|3|||
124480615|NCT03323749|447713851|FG001|Double-blind Period|Adverse Event|1|||
124480616|NCT03323749|447713850|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
124480617|NCT03323749|447713851|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
124480618|NCT03323749|447713850|FG000|Open-Label Period|Adverse Event|3|||
124480619|NCT03323749|447713851|FG001|Open-Label Period|Adverse Event|10|||
124480620|NCT03323749|447713850|FG000|Open-Label Period|Withdrawal by Subject|7|||
124480621|NCT03323749|447713851|FG001|Open-Label Period|Withdrawal by Subject|5|||
124480622|NCT03263091|447713853|FG000|OL Component|Withdrawal by Subject|1|||
124480623|NCT03263091|447713854|FG001|OL Component|Withdrawal by Subject|1|||
124480624|NCT03263091|447713855|FG002|OL Component|Withdrawal by Subject|0|||
124480625|NCT03263091|447713856|FG003|OL Component|Withdrawal by Subject|0|||
124480626|NCT03263091|447713857|FG004|OL Component|Withdrawal by Subject|0|||
124480627|NCT03263091|447713858|FG005|OL Component|Withdrawal by Subject|0|||
124480628|NCT03263091|447713853|FG000|OL Component|Physician Decision|0|||
124480629|NCT03263091|447713854|FG001|OL Component|Physician Decision|1|||
124480630|NCT03263091|447713855|FG002|OL Component|Physician Decision|2|||
124480631|NCT03263091|447713856|FG003|OL Component|Physician Decision|0|||
124480632|NCT03263091|447713857|FG004|OL Component|Physician Decision|0|||
124480633|NCT03263091|447713858|FG005|OL Component|Physician Decision|0|||
124480634|NCT03263091|447713853|FG000|OL Component|Death|1|||
124480635|NCT03263091|447713854|FG001|OL Component|Death|0|||
124480636|NCT03263091|447713855|FG002|OL Component|Death|0|||
124480637|NCT03263091|447713856|FG003|OL Component|Death|0|||
124480638|NCT03263091|447713857|FG004|OL Component|Death|0|||
124480639|NCT03263091|447713858|FG005|OL Component|Death|0|||
124480640|NCT03263091|447713853|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
124480641|NCT03263091|447713854|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
124480642|NCT03263091|447713855|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
124480643|NCT03263091|447713856|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
124480644|NCT03263091|447713857|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
124480645|NCT03263091|447713858|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
124480646|NCT03263091|447713853|FG000|OL High-EPO Component|Physician Decision|0|||
124480647|NCT03263091|447713854|FG001|OL High-EPO Component|Physician Decision|0|||
124480648|NCT03263091|447713855|FG002|OL High-EPO Component|Physician Decision|0|||
124720411|NCT00383331|448599266|FG000|Overall Study|Protocol Violation|0|||
124720412|NCT00383331|448599267|FG001|Overall Study|Protocol Violation|1|||
124720413|NCT02229825|448599274|FG000|Overall Study|Personal Reasons|0|||
124720414|NCT02229825|448599275|FG001|Overall Study|Personal Reasons|1|||
124720415|NCT02229825|448599274|FG000|Overall Study|Refused continuing medication|7|||
124480649|NCT03263091|447713856|FG003|OL High-EPO Component|Physician Decision|1|||
124480650|NCT03263091|447713857|FG004|OL High-EPO Component|Physician Decision|0|||
124480651|NCT03263091|447713858|FG005|OL High-EPO Component|Physician Decision|0|||
124480652|NCT03263091|447713853|FG000|OL High-EPO Component|Death|0|||
124480653|NCT03263091|447713854|FG001|OL High-EPO Component|Death|0|||
124480654|NCT03263091|447713855|FG002|OL High-EPO Component|Death|0|||
124480655|NCT03263091|447713856|FG003|OL High-EPO Component|Death|3|||
124480656|NCT03263091|447713857|FG004|OL High-EPO Component|Death|0|||
124480657|NCT03263091|447713858|FG005|OL High-EPO Component|Death|0|||
124557441|NCT01042977|447999079|FG000|Overall Study|Subject no longer meets study criteria|15|||
124720416|NCT02229825|448599275|FG001|Overall Study|Refused continuing medication|6|||
124720417|NCT02229825|448599274|FG000|Overall Study|Lost to Follow-up|1|||
124480658|NCT03263091|447713853|FG000|DB Component|Withdrawal by Subject|0|||
124480659|NCT03263091|447713854|FG001|DB Component|Withdrawal by Subject|0|||
124480660|NCT03263091|447713855|FG002|DB Component|Withdrawal by Subject|0|||
124480661|NCT03263091|447713856|FG003|DB Component|Withdrawal by Subject|0|||
124480662|NCT03263091|447713857|FG004|DB Component|Withdrawal by Subject|22|||
124720418|NCT02229825|448599275|FG001|Overall Study|Lost to Follow-up|2|||
124720419|NCT02229825|448599274|FG000|Overall Study|Protocol Violation|1|||
124720420|NCT02229825|448599275|FG001|Overall Study|Protocol Violation|1|||
124720421|NCT02229825|448599274|FG000|Overall Study|Lack of Efficacy|4|||
124720422|NCT02229825|448599275|FG001|Overall Study|Lack of Efficacy|10|||
124720423|NCT02229825|448599274|FG000|Overall Study|Adverse Event|11|||
124720424|NCT02229825|448599275|FG001|Overall Study|Adverse Event|9|||
124720425|NCT02229825|448599274|FG000|Overall Study|Not treated|0|||
124720426|NCT02229825|448599275|FG001|Overall Study|Not treated|1|||
124720427|NCT03226249|448599278|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
124720428|NCT03226249|448599278|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
124720429|NCT03226249|448599278|FG000|Survival Follow-up|Patients still in follow-up.|30|||
124720430|NCT01532921|448599279|FG000|Overall Study|Death|3|||
124720431|NCT01532921|448599279|FG000|Overall Study|Withdrawal by Subject|2|||
124720432|NCT01532921|448599279|FG000|Overall Study|Lost to Follow-up|3|||
124720433|NCT01532921|448599279|FG000|Overall Study|Physician Decision|7|||
124720434|NCT01532921|448599279|FG000|Overall Study|Device was explanted during procedure|1|||
124720435|NCT02096952|448599285|FG000|Overall Study|Adverse Event|1|||
124720436|NCT00624468|448599286|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
124720437|NCT00624468|448599287|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
124720438|NCT00624468|448599288|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
124720439|NCT00624468|448599289|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
124720440|NCT00624468|448599286|FG000|Double-blind Period|Withdrew Prematurely|1|||
124720441|NCT00624468|448599287|FG001|Double-blind Period|Withdrew Prematurely|1|||
124720442|NCT00624468|448599288|FG002|Double-blind Period|Withdrew Prematurely|0|||
124720443|NCT00624468|448599289|FG003|Double-blind Period|Withdrew Prematurely|0|||
124720444|NCT00624468|448599286|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
124720445|NCT00624468|448599287|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
124720446|NCT00624468|448599288|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
124720447|NCT00624468|448599289|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
124720448|NCT00624468|448599286|FG000|Safety Follow-up (SFU) Period|Other|0|||
124720449|NCT00624468|448599287|FG001|Safety Follow-up (SFU) Period|Other|0|||
124720450|NCT00624468|448599288|FG002|Safety Follow-up (SFU) Period|Other|1|||
124720451|NCT00624468|448599289|FG003|Safety Follow-up (SFU) Period|Other|1|||
124720452|NCT01524224|448599300|FG000|Overall Study|Progressive Disease|1|||
124720453|NCT01524224|448599301|FG001|Overall Study|Progressive Disease|0|||
124720454|NCT01524224|448599302|FG002|Overall Study|Progressive Disease|2|||
124720455|NCT01524224|448599303|FG003|Overall Study|Progressive Disease|1|||
124720456|NCT01524224|448599304|FG004|Overall Study|Progressive Disease|2|||
124720457|NCT01524224|448599305|FG005|Overall Study|Progressive Disease|1|||
124771703|NCT03873116|448794554|FG005|Part 1|Study drug discontinuation due to rash|1|||
124720458|NCT01524224|448599306|FG006|Overall Study|Progressive Disease|1|||
124720459|NCT01524224|448599307|FG007|Overall Study|Progressive Disease|5|||
124720460|NCT01524224|448599300|FG000|Overall Study|Withdrawal by Subject|2|||
124720461|NCT01524224|448599301|FG001|Overall Study|Withdrawal by Subject|0|||
124480663|NCT03263091|447713858|FG005|DB Component|Withdrawal by Subject|8|||
124480664|NCT03263091|447713853|FG000|DB Component|Physician Decision|0|||
124480665|NCT03263091|447713854|FG001|DB Component|Physician Decision|0|||
124480666|NCT03263091|447713855|FG002|DB Component|Physician Decision|0|||
124480667|NCT03263091|447713856|FG003|DB Component|Physician Decision|0|||
124480668|NCT03263091|447713857|FG004|DB Component|Physician Decision|3|||
124480669|NCT03263091|447713858|FG005|DB Component|Physician Decision|1|||
124480670|NCT03263091|447713853|FG000|DB Component|Adverse Event|0|||
124480671|NCT03263091|447713854|FG001|DB Component|Adverse Event|0|||
124480672|NCT03263091|447713855|FG002|DB Component|Adverse Event|0|||
124480673|NCT03263091|447713856|FG003|DB Component|Adverse Event|0|||
124480674|NCT03263091|447713857|FG004|DB Component|Adverse Event|2|||
124480675|NCT03263091|447713858|FG005|DB Component|Adverse Event|1|||
124480676|NCT03263091|447713853|FG000|DB Component|Lost to Follow-up|0|||
124480677|NCT03263091|447713854|FG001|DB Component|Lost to Follow-up|0|||
124480678|NCT03263091|447713855|FG002|DB Component|Lost to Follow-up|0|||
124480679|NCT03263091|447713856|FG003|DB Component|Lost to Follow-up|0|||
124480680|NCT03263091|447713857|FG004|DB Component|Lost to Follow-up|2|||
124480681|NCT03263091|447713858|FG005|DB Component|Lost to Follow-up|1|||
124480682|NCT03263091|447713853|FG000|DB Component|Death|0|||
124480683|NCT03263091|447713854|FG001|DB Component|Death|0|||
124480684|NCT03263091|447713855|FG002|DB Component|Death|0|||
124480685|NCT03263091|447713856|FG003|DB Component|Death|0|||
124480686|NCT03263091|447713857|FG004|DB Component|Death|7|||
124557442|NCT01042977|447999080|FG001|Overall Study|Subject no longer meets study criteria|13|||
124720462|NCT01524224|448599302|FG002|Overall Study|Withdrawal by Subject|0|||
124720463|NCT01524224|448599303|FG003|Overall Study|Withdrawal by Subject|0|||
124720464|NCT01524224|448599304|FG004|Overall Study|Withdrawal by Subject|0|||
124720465|NCT01524224|448599305|FG005|Overall Study|Withdrawal by Subject|0|||
124720466|NCT01524224|448599306|FG006|Overall Study|Withdrawal by Subject|2|||
124720467|NCT01524224|448599307|FG007|Overall Study|Withdrawal by Subject|0|||
124720468|NCT01524224|448599300|FG000|Overall Study|Adverse Event|0|||
124720469|NCT01524224|448599301|FG001|Overall Study|Adverse Event|1|||
124720470|NCT01524224|448599302|FG002|Overall Study|Adverse Event|0|||
124720471|NCT01524224|448599303|FG003|Overall Study|Adverse Event|0|||
124720472|NCT01524224|448599304|FG004|Overall Study|Adverse Event|0|||
124720473|NCT01524224|448599305|FG005|Overall Study|Adverse Event|1|||
124720474|NCT01524224|448599306|FG006|Overall Study|Adverse Event|0|||
124720475|NCT01524224|448599307|FG007|Overall Study|Adverse Event|0|||
124720476|NCT01524224|448599300|FG000|Overall Study|Physician Decision|0|||
124720477|NCT01524224|448599301|FG001|Overall Study|Physician Decision|0|||
124720478|NCT01524224|448599302|FG002|Overall Study|Physician Decision|0|||
124720479|NCT01524224|448599303|FG003|Overall Study|Physician Decision|1|||
124720480|NCT01524224|448599304|FG004|Overall Study|Physician Decision|1|||
124720481|NCT01524224|448599305|FG005|Overall Study|Physician Decision|0|||
124720482|NCT01524224|448599306|FG006|Overall Study|Physician Decision|0|||
124720483|NCT01524224|448599307|FG007|Overall Study|Physician Decision|1|||
124720484|NCT01524224|448599300|FG000|Overall Study|Sponsor Decision|0|||
124480687|NCT03263091|447713858|FG005|DB Component|Death|4|||
124720485|NCT01524224|448599301|FG001|Overall Study|Sponsor Decision|0|||
124720486|NCT01524224|448599302|FG002|Overall Study|Sponsor Decision|0|||
124480688|NCT03263091|447713853|FG000|DB Component|Other than specified|0|||
124480689|NCT03263091|447713854|FG001|DB Component|Other than specified|0|||
124720487|NCT01524224|448599303|FG003|Overall Study|Sponsor Decision|0|||
124720488|NCT01524224|448599304|FG004|Overall Study|Sponsor Decision|1|||
124480690|NCT03263091|447713855|FG002|DB Component|Other than specified|0|||
124480691|NCT03263091|447713856|FG003|DB Component|Other than specified|0|||
124480692|NCT03263091|447713857|FG004|DB Component|Other than specified|8|||
124480693|NCT03263091|447713858|FG005|DB Component|Other than specified|6|||
124480694|NCT02468193|447713859|FG000|Overall Study|Adverse Event|4|||
124480695|NCT02468193|447713859|FG000|Overall Study|Subject/ Guardian decision|2|||
124480696|NCT00742781|447713860|FG000|Overall Study|Withdrawal by Subject|3|||
124480697|NCT01719757|447713861|FG000|Overall Study|Adverse Event|38|||
124480698|NCT01719757|447713861|FG000|Overall Study|Withdrawal by Subject|15|||
124720489|NCT01524224|448599305|FG005|Overall Study|Sponsor Decision|0|||
124720490|NCT01524224|448599306|FG006|Overall Study|Sponsor Decision|0|||
124720491|NCT01524224|448599307|FG007|Overall Study|Sponsor Decision|0|||
124720492|NCT00803361|448599308|FG000|Overall Study|Adverse Event|13|||
124720493|NCT00803361|448599309|FG001|Overall Study|Adverse Event|3|||
124720494|NCT00803361|448599308|FG000|Overall Study|Lack of Efficacy|4|||
124720495|NCT00803361|448599309|FG001|Overall Study|Lack of Efficacy|13|||
124480699|NCT01719757|447713861|FG000|Overall Study|Lost to Follow-up|20|||
124480700|NCT01719757|447713861|FG000|Overall Study|Protocol Violation|1|||
124480701|NCT01719757|447713861|FG000|Overall Study|well controlled pain|27|||
124480702|NCT02626338|447713862|FG000|Overall Study|Lack of Efficacy|3|||
124480703|NCT02626338|447713863|FG001|Overall Study|Lack of Efficacy|2|||
124480704|NCT02626338|447713864|FG002|Overall Study|Lack of Efficacy|0|||
124480705|NCT00826748|447713865|FG000|Overall Study|Withdrawal by Subject|0|||
124480706|NCT00826748|447713866|FG001|Overall Study|Withdrawal by Subject|0|||
124480707|NCT00826748|447713867|FG002|Overall Study|Withdrawal by Subject|2|||
124480708|NCT00826748|447713865|FG000|Overall Study|Physician Decision|0|||
124480709|NCT00826748|447713866|FG001|Overall Study|Physician Decision|0|||
124480710|NCT00826748|447713867|FG002|Overall Study|Physician Decision|1|||
124480711|NCT00826748|447713865|FG000|Overall Study|Samples Did Not pass QC|0|||
124480712|NCT00826748|447713866|FG001|Overall Study|Samples Did Not pass QC|0|||
124480713|NCT00826748|447713867|FG002|Overall Study|Samples Did Not pass QC|1|||
124480714|NCT03312218|447713870|FG000|Overall Study|Never signed in to access the app|54|||
124480715|NCT03312218|447713871|FG001|Overall Study|Never signed in to access the app|58|||
124480716|NCT01901224|447713872|FG000|Overall Study|study was not funded and terminated|2|||
124480717|NCT04125680|447713874|FG000|Overall Study|Lost to Follow-up|15|||
124480718|NCT01562028|447713875|FG000|Overall Study|Withdrawal by Subject|1|||
124480719|NCT01562028|447713876|FG001|Overall Study|Withdrawal by Subject|1|||
124480720|NCT01562028|447713875|FG000|Overall Study|Lost to Follow-up|2|||
124480721|NCT01562028|447713876|FG001|Overall Study|Lost to Follow-up|1|||
124480722|NCT02360098|447713877|FG000|Overall Study|Physician Decision|7|||
124480723|NCT04439266|447713888|FG000|Overall Study|Ineligible|1|||
124480724|NCT04439266|447713888|FG000|Overall Study|Adverse Event|1|||
124480725|NCT04439266|447713888|FG000|Overall Study|Death|1|||
124480726|NCT04439266|447713888|FG000|Overall Study|Disease progression|1|||
124480727|NCT04439266|447713888|FG000|Overall Study|Still on treatment|1|||
124480728|NCT05040971|447713889|FG000|Overall Study|Withdrawal by Subject|0|||
124480729|NCT05040971|447713890|FG001|Overall Study|Withdrawal by Subject|2|||
124480730|NCT05040971|447713889|FG000|Overall Study|Lost to Follow-up|8|||
124480731|NCT05040971|447713890|FG001|Overall Study|Lost to Follow-up|3|||
124480732|NCT05040971|447713889|FG000|Overall Study|Death|2|||
124480733|NCT05040971|447713890|FG001|Overall Study|Death|0|||
124480734|NCT06161012|447713891|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
124480735|NCT06161012|447713892|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
124480736|NCT05817045|447713897|FG000|Overall Study|Protocol Violation|0|||
124480737|NCT05817045|447713898|FG001|Overall Study|Protocol Violation|3|||
124480738|NCT05817045|447713897|FG000|Overall Study|Withdrawal by Subject|10|||
124480739|NCT05817045|447713898|FG001|Overall Study|Withdrawal by Subject|7|||
124480740|NCT05817045|447713897|FG000|Overall Study|Physician Decision|3|||
124480741|NCT05817045|447713898|FG001|Overall Study|Physician Decision|0|||
124480742|NCT05817045|447713897|FG000|Overall Study|Lost to Follow-up|0|||
124480743|NCT05817045|447713898|FG001|Overall Study|Lost to Follow-up|1|||
124480744|NCT05817045|447713897|FG000|Overall Study|Device Deficiency|1|||
124771704|NCT03873116|448794549|FG000|Part 2|Withdrawal by Subject|0|||
124480745|NCT05817045|447713898|FG001|Overall Study|Device Deficiency|0|||
124480746|NCT05817045|447713897|FG000|Overall Study|System Error|1|||
124480747|NCT05817045|447713898|FG001|Overall Study|System Error|0|||
124557443|NCT01042977|447999079|FG000|Overall Study|Incorrect enrollment|6|||
124480748|NCT04889209|447713899|FG000|All Cohorts Except 15E|Adverse Event|0|||
124480749|NCT04889209|447713900|FG001|All Cohorts Except 15E|Adverse Event|0|||
124720496|NCT00803361|448599308|FG000|Overall Study|Lost to Follow-up|1|||
124720497|NCT00803361|448599309|FG001|Overall Study|Lost to Follow-up|2|||
124720498|NCT00803361|448599308|FG000|Overall Study|Physician Decision|1|||
124720499|NCT00803361|448599309|FG001|Overall Study|Physician Decision|0|||
124720500|NCT00803361|448599308|FG000|Overall Study|Protocol Violation|2|||
124720501|NCT00803361|448599309|FG001|Overall Study|Protocol Violation|4|||
124720502|NCT00803361|448599308|FG000|Overall Study|Withdrawal by Subject|5|||
124720503|NCT00803361|448599309|FG001|Overall Study|Withdrawal by Subject|6|||
124720504|NCT02858440|448599310|FG000|Overall Study|Lost to Follow-up|3|||
124720505|NCT02858440|448599310|FG000|Overall Study|Protocol Violation|2|||
124720506|NCT02858440|448599310|FG000|Overall Study|Consent withdrawal|3|||
124720507|NCT02858440|448599310|FG000|Overall Study|Migrated/moved from study area|4|||
124720508|NCT01670279|448599311|FG000|Overall Study|Adverse Event|0|||
124720509|NCT01670279|448599312|FG001|Overall Study|Adverse Event|1|||
124720510|NCT01670279|448599313|FG002|Overall Study|Adverse Event|0|||
124720511|NCT01670279|448599314|FG003|Overall Study|Adverse Event|0|||
124720512|NCT01670279|448599311|FG000|Overall Study|Physician Decision|0|||
124720513|NCT01670279|448599312|FG001|Overall Study|Physician Decision|1|||
124720514|NCT01670279|448599313|FG002|Overall Study|Physician Decision|0|||
124720515|NCT01670279|448599314|FG003|Overall Study|Physician Decision|0|||
124720516|NCT01670279|448599311|FG000|Overall Study|Participant met withdrawal criteria|0|||
124720517|NCT01670279|448599312|FG001|Overall Study|Participant met withdrawal criteria|0|||
124720518|NCT01670279|448599313|FG002|Overall Study|Participant met withdrawal criteria|0|||
124720519|NCT01670279|448599314|FG003|Overall Study|Participant met withdrawal criteria|1|||
124720520|NCT01901614|448599315|FG000|Overall Study|Adverse Event|0|||
124720521|NCT01901614|448599316|FG001|Overall Study|Adverse Event|1|||
124720522|NCT01901614|448599315|FG000|Overall Study|Lost to Follow-up|1|||
124720523|NCT01901614|448599316|FG001|Overall Study|Lost to Follow-up|0|||
124720524|NCT01901614|448599315|FG000|Overall Study|Screen Fail|1|||
124720525|NCT01901614|448599316|FG001|Overall Study|Screen Fail|0|||
124720526|NCT01823198|448599317|FG000|Overall Study|Physician Decision|0|||
124720527|NCT01823198|448599318|FG001|Overall Study|Physician Decision|1|||
124720528|NCT01823198|448599319|FG002|Overall Study|Physician Decision|0|||
124720529|NCT01823198|448599320|FG003|Overall Study|Physician Decision|0|||
124720530|NCT01823198|448599321|FG004|Overall Study|Physician Decision|0|||
124720531|NCT01823198|448599322|FG005|Overall Study|Physician Decision|3|||
124720532|NCT01823198|448599323|FG006|Overall Study|Physician Decision|3|||
124720533|NCT02674464|448599324|FG000|Overall Study|Death|10|||
124720534|NCT02674464|448599325|FG001|Overall Study|Death|21|||
124720535|NCT02674464|448599324|FG000|Overall Study|Withdrawal by Subject|24|||
124720536|NCT02674464|448599325|FG001|Overall Study|Withdrawal by Subject|44|||
124480750|NCT04889209|447713901|FG002|All Cohorts Except 15E|Adverse Event|0|||
124480751|NCT04889209|447713902|FG003|All Cohorts Except 15E|Adverse Event|0|||
124480752|NCT04889209|447713903|FG004|All Cohorts Except 15E|Adverse Event|0|||
124480753|NCT04889209|447713904|FG005|All Cohorts Except 15E|Adverse Event|0|||
124480754|NCT04889209|447713905|FG006|All Cohorts Except 15E|Adverse Event|1|||
124480755|NCT04889209|447713906|FG007|All Cohorts Except 15E|Adverse Event|0|||
124480756|NCT04889209|447713907|FG008|All Cohorts Except 15E|Adverse Event|0|||
124480757|NCT04889209|447713908|FG009|All Cohorts Except 15E|Adverse Event|0|||
124480758|NCT04889209|447713909|FG010|All Cohorts Except 15E|Adverse Event|0|||
124480759|NCT04889209|447713910|FG011|All Cohorts Except 15E|Adverse Event|0|||
124480760|NCT04889209|447713911|FG012|All Cohorts Except 15E|Adverse Event|0|||
124480761|NCT04889209|447713912|FG013|All Cohorts Except 15E|Adverse Event|0|||
124480762|NCT04889209|447713913|FG014|All Cohorts Except 15E|Adverse Event|0|||
124480763|NCT04889209|447713914|FG015|All Cohorts Except 15E|Adverse Event|0|||
124557444|NCT01042977|447999080|FG001|Overall Study|Incorrect enrollment|4|||
124720537|NCT02674464|448599324|FG000|Overall Study|Lost to Follow-up|97|||
124720538|NCT02674464|448599325|FG001|Overall Study|Lost to Follow-up|92|||
124720539|NCT02674464|448599324|FG000|Overall Study|Outside survey window|6|||
124480764|NCT04889209|447713915|FG016|All Cohorts Except 15E|Adverse Event|0|||
124480765|NCT04889209|447713916|FG017|All Cohorts Except 15E|Adverse Event|0|||
124480766|NCT04889209|447713899|FG000|All Cohorts Except 15E|Death|0|||
124557445|NCT01042977|447999079|FG000|Overall Study|Safety|0|||
124557446|NCT01042977|447999080|FG001|Overall Study|Safety|2|||
124557447|NCT01042977|447999079|FG000|Overall Study|Administrative reason by sponsor|0|||
124720540|NCT02674464|448599325|FG001|Overall Study|Outside survey window|3|||
124720541|NCT00783835|448599326|FG000|Overall Study|Adverse Event|3|||
124720542|NCT00783835|448599326|FG000|Overall Study|Medical Criteria|1|||
124720543|NCT00783835|448599326|FG000|Overall Study|Withdrawal by Subject|2|||
124720544|NCT00783835|448599326|FG000|Overall Study|Lost to Follow-up|1|||
124720545|NCT00783835|448599326|FG000|Overall Study|Participant not Adherent|3|||
124720546|NCT01262638|448599327|FG000|Overall Study|Adverse Event|3|||
124720547|NCT01262638|448599328|FG001|Overall Study|Adverse Event|4|||
124720548|NCT01262638|448599329|FG002|Overall Study|Adverse Event|3|||
124720549|NCT01262638|448599330|FG003|Overall Study|Adverse Event|4|||
124720550|NCT01262638|448599327|FG000|Overall Study|Protocol Violation|1|||
124720551|NCT01262638|448599328|FG001|Overall Study|Protocol Violation|0|||
124720552|NCT01262638|448599329|FG002|Overall Study|Protocol Violation|0|||
124720553|NCT01262638|448599330|FG003|Overall Study|Protocol Violation|1|||
124480767|NCT04889209|447713900|FG001|All Cohorts Except 15E|Death|1|||
124480768|NCT04889209|447713901|FG002|All Cohorts Except 15E|Death|0|||
124480769|NCT04889209|447713902|FG003|All Cohorts Except 15E|Death|0|||
124480770|NCT04889209|447713903|FG004|All Cohorts Except 15E|Death|0|||
124480771|NCT04889209|447713904|FG005|All Cohorts Except 15E|Death|0|||
124480772|NCT04889209|447713905|FG006|All Cohorts Except 15E|Death|0|||
124480773|NCT04889209|447713906|FG007|All Cohorts Except 15E|Death|0|||
124480774|NCT04889209|447713907|FG008|All Cohorts Except 15E|Death|0|||
124480775|NCT04889209|447713908|FG009|All Cohorts Except 15E|Death|0|||
124480776|NCT04889209|447713909|FG010|All Cohorts Except 15E|Death|0|||
124480777|NCT04889209|447713910|FG011|All Cohorts Except 15E|Death|0|||
124480778|NCT04889209|447713911|FG012|All Cohorts Except 15E|Death|0|||
124480779|NCT04889209|447713912|FG013|All Cohorts Except 15E|Death|0|||
124480780|NCT04889209|447713913|FG014|All Cohorts Except 15E|Death|0|||
124480781|NCT04889209|447713914|FG015|All Cohorts Except 15E|Death|0|||
124480782|NCT04889209|447713915|FG016|All Cohorts Except 15E|Death|0|||
124480783|NCT04889209|447713916|FG017|All Cohorts Except 15E|Death|0|||
124480784|NCT04889209|447713899|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
124480785|NCT04889209|447713900|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
124480786|NCT04889209|447713901|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
124480787|NCT04889209|447713902|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
124480788|NCT04889209|447713903|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
124480789|NCT04889209|447713904|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
124480790|NCT04889209|447713905|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
124480791|NCT04889209|447713906|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
124480792|NCT04889209|447713907|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
124480793|NCT04889209|447713908|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
124480794|NCT04889209|447713909|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
124480795|NCT04889209|447713910|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
124480796|NCT04889209|447713911|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
124480797|NCT04889209|447713912|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
124480798|NCT04889209|447713913|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
124480799|NCT04889209|447713914|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
124480800|NCT04889209|447713915|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
124480801|NCT04889209|447713916|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
124480802|NCT04889209|447713899|FG000|All Cohorts Except 15E|Physician Decision|0|||
124480803|NCT04889209|447713900|FG001|All Cohorts Except 15E|Physician Decision|0|||
124480804|NCT04889209|447713901|FG002|All Cohorts Except 15E|Physician Decision|0|||
124480805|NCT04889209|447713902|FG003|All Cohorts Except 15E|Physician Decision|0|||
124480806|NCT04889209|447713903|FG004|All Cohorts Except 15E|Physician Decision|1|||
124480807|NCT04889209|447713904|FG005|All Cohorts Except 15E|Physician Decision|0|||
124480808|NCT04889209|447713905|FG006|All Cohorts Except 15E|Physician Decision|0|||
124480809|NCT04889209|447713906|FG007|All Cohorts Except 15E|Physician Decision|1|||
124480810|NCT04889209|447713907|FG008|All Cohorts Except 15E|Physician Decision|0|||
124480811|NCT04889209|447713908|FG009|All Cohorts Except 15E|Physician Decision|1|||
124480812|NCT04889209|447713909|FG010|All Cohorts Except 15E|Physician Decision|0|||
124480813|NCT04889209|447713910|FG011|All Cohorts Except 15E|Physician Decision|1|||
124480814|NCT04889209|447713911|FG012|All Cohorts Except 15E|Physician Decision|1|||
124480815|NCT04889209|447713912|FG013|All Cohorts Except 15E|Physician Decision|0|||
124480816|NCT04889209|447713913|FG014|All Cohorts Except 15E|Physician Decision|0|||
124480817|NCT04889209|447713914|FG015|All Cohorts Except 15E|Physician Decision|0|||
124480818|NCT04889209|447713915|FG016|All Cohorts Except 15E|Physician Decision|0|||
124480819|NCT04889209|447713916|FG017|All Cohorts Except 15E|Physician Decision|0|||
124480820|NCT04889209|447713899|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
124480821|NCT04889209|447713900|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
124480822|NCT04889209|447713901|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
124480823|NCT04889209|447713902|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
124480824|NCT04889209|447713903|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
124480825|NCT04889209|447713904|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
124480826|NCT04889209|447713905|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
124480827|NCT04889209|447713906|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
124480828|NCT04889209|447713907|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
124480829|NCT04889209|447713908|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
124480830|NCT04889209|447713909|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
124557448|NCT01042977|447999080|FG001|Overall Study|Administrative reason by sponsor|1|||
124480831|NCT04889209|447713910|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
124480832|NCT04889209|447713911|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
124480833|NCT04889209|447713912|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
124480834|NCT04889209|447713913|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
124480835|NCT04889209|447713914|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
124480836|NCT04889209|447713915|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
124480837|NCT04889209|447713916|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
124480838|NCT04889209|447713899|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
124480839|NCT04889209|447713900|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
124720554|NCT01262638|448599327|FG000|Overall Study|Withdrawal by Subject|2|||
124480840|NCT04889209|447713901|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
124557449|NCT01042977|447999079|FG000|Overall Study|Various|3|||
124720555|NCT01262638|448599328|FG001|Overall Study|Withdrawal by Subject|1|||
124480841|NCT04889209|447713902|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
124720556|NCT01262638|448599329|FG002|Overall Study|Withdrawal by Subject|0|||
124480842|NCT04889209|447713903|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
124557450|NCT01042977|447999080|FG001|Overall Study|Various|0|||
124720557|NCT01262638|448599330|FG003|Overall Study|Withdrawal by Subject|1|||
124720558|NCT01262638|448599327|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
124720559|NCT01262638|448599328|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
124720560|NCT01262638|448599329|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
124771705|NCT03873116|448794550|FG001|Part 2|Withdrawal by Subject|0|||
124720561|NCT01262638|448599330|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
124720562|NCT01262638|448599327|FG000|Overall Study|Lost to Follow-up|1|||
124720563|NCT01262638|448599328|FG001|Overall Study|Lost to Follow-up|1|||
124720564|NCT01262638|448599329|FG002|Overall Study|Lost to Follow-up|1|||
124720565|NCT01262638|448599330|FG003|Overall Study|Lost to Follow-up|1|||
124720566|NCT01262638|448599327|FG000|Overall Study|Participant Went Out of Town|0|||
124720567|NCT01262638|448599328|FG001|Overall Study|Participant Went Out of Town|0|||
124720568|NCT01262638|448599329|FG002|Overall Study|Participant Went Out of Town|1|||
124720569|NCT01262638|448599330|FG003|Overall Study|Participant Went Out of Town|0|||
124720570|NCT02243371|448599335|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
124720571|NCT02243371|448599336|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
124720572|NCT02243371|448599335|FG000|Overall Study|Death (unrelated)|2|||
124720573|NCT02243371|448599336|FG001|Overall Study|Death (unrelated)|4|||
124720574|NCT02243371|448599335|FG000|Overall Study|Adverse Event (unrelated)|0|||
124720575|NCT02243371|448599336|FG001|Overall Study|Adverse Event (unrelated)|1|||
124720576|NCT02243371|448599335|FG000|Overall Study|Lack of Clinical Benefit|0|||
124720577|NCT02243371|448599336|FG001|Overall Study|Lack of Clinical Benefit|1|||
124720578|NCT02243371|448599335|FG000|Overall Study|Withdrawal by Subject|0|||
124720579|NCT02243371|448599336|FG001|Overall Study|Withdrawal by Subject|2|||
124720580|NCT01369199|448599337|FG000|Overall Study|Withdrawal by Subject|1|||
124720581|NCT01369199|448599337|FG000|Overall Study|Lost to Follow-up|2|||
124720582|NCT01066104|448599338|FG000|Overall Study|Adverse Event|1|||
124720583|NCT01066104|448599339|FG001|Overall Study|Adverse Event|1|||
124720584|NCT01066104|448599338|FG000|Overall Study|Protocol Violation|1|||
124720585|NCT01066104|448599339|FG001|Overall Study|Protocol Violation|0|||
124720586|NCT02091362|448599347|FG000|Period 1|Protocol Violation|1|||
124720587|NCT02091362|448599348|FG001|Period 1|Protocol Violation|0|||
124720588|NCT02091362|448599347|FG000|Period 1|Withdrawal by Subject|2|||
124720589|NCT02091362|448599348|FG001|Period 1|Withdrawal by Subject|3|||
124720590|NCT02091362|448599347|FG000|Period 1|Lost to Follow-up|0|||
124720591|NCT02091362|448599348|FG001|Period 1|Lost to Follow-up|1|||
124720592|NCT02091362|448599347|FG000|Period 1|Adverse Event|2|||
124720593|NCT02091362|448599348|FG001|Period 1|Adverse Event|0|||
124720594|NCT02091362|448599347|FG000|Wash-out|Lost to Follow-up|1|||
124720595|NCT02091362|448599348|FG001|Wash-out|Lost to Follow-up|1|||
124720596|NCT02091362|448599347|FG000|Wash-out|Withdrawal by Subject|0|||
124720597|NCT02091362|448599348|FG001|Wash-out|Withdrawal by Subject|2|||
124720598|NCT02091362|448599347|FG000|Period 2|Adverse Event|1|||
124480843|NCT04889209|447713904|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
124480844|NCT04889209|447713905|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
124480845|NCT04889209|447713906|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
124480846|NCT04889209|447713907|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
124480847|NCT04889209|447713908|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
124480848|NCT04889209|447713909|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
124480849|NCT04889209|447713910|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
124480850|NCT04889209|447713911|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
124480851|NCT04889209|447713912|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
124480852|NCT04889209|447713913|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
124480853|NCT04889209|447713914|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
124480854|NCT04889209|447713915|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
124480855|NCT04889209|447713916|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
124480856|NCT04889209|447713899|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124480857|NCT04889209|447713900|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124480858|NCT04889209|447713901|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124480859|NCT04889209|447713902|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
124480860|NCT04889209|447713903|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124480861|NCT04889209|447713904|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124480862|NCT04889209|447713905|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124480863|NCT04889209|447713906|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124557451|NCT01886300|447999084|FG000|Overall Study|Trial terminated by sponsor|16|||
124480864|NCT04889209|447713907|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124480865|NCT04889209|447713908|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124480866|NCT04889209|447713909|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124480867|NCT04889209|447713910|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124480868|NCT04889209|447713911|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124480869|NCT04889209|447713912|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124480870|NCT04889209|447713913|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124480871|NCT04889209|447713914|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124480872|NCT04889209|447713915|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124480873|NCT04889209|447713916|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
124480874|NCT04889209|447713899|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
124480875|NCT04889209|447713900|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
124480876|NCT04889209|447713901|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
124480877|NCT04889209|447713902|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
124480878|NCT04889209|447713903|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
124480879|NCT04889209|447713904|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
124480880|NCT04889209|447713905|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
124480881|NCT04889209|447713906|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
124480882|NCT04889209|447713907|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
124480883|NCT04889209|447713908|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
124480884|NCT04889209|447713909|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
124480885|NCT04889209|447713910|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
124480886|NCT04889209|447713911|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
124480887|NCT04889209|447713912|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
124480888|NCT04889209|447713913|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
124480889|NCT04889209|447713914|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
124480890|NCT04889209|447713915|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
124480891|NCT04889209|447713916|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
124480892|NCT04889209|447713899|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
124480893|NCT04889209|447713900|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
124480894|NCT04889209|447713901|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
124480895|NCT04889209|447713902|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
124480896|NCT04889209|447713903|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
124480897|NCT04889209|447713904|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
124480898|NCT04889209|447713905|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
124480899|NCT04889209|447713906|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
124480900|NCT04889209|447713907|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
124480901|NCT04889209|447713908|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
124480902|NCT04889209|447713909|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
124480903|NCT04889209|447713910|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
124480904|NCT04889209|447713911|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
124480905|NCT04889209|447713912|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
124480906|NCT04889209|447713913|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
124480907|NCT04889209|447713914|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
124480908|NCT04889209|447713915|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
124480909|NCT04889209|447713916|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
124480910|NCT04889209|447713899|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
124771706|NCT03873116|448794551|FG002|Part 2|Withdrawal by Subject|1|||
124771707|NCT03873116|448794552|FG003|Part 2|Withdrawal by Subject|0|||
124771708|NCT03873116|448794553|FG004|Part 2|Withdrawal by Subject|0|||
124771709|NCT03873116|448794554|FG005|Part 2|Withdrawal by Subject|0|||
124771710|NCT03873116|448794549|FG000|Part 2|Lab abnormality or AE|0|||
124771711|NCT03873116|448794550|FG001|Part 2|Lab abnormality or AE|0|||
124771712|NCT03873116|448794551|FG002|Part 2|Lab abnormality or AE|0|||
124771713|NCT03873116|448794552|FG003|Part 2|Lab abnormality or AE|0|||
124771714|NCT03873116|448794553|FG004|Part 2|Lab abnormality or AE|1|||
124771715|NCT03873116|448794554|FG005|Part 2|Lab abnormality or AE|0|||
124771716|NCT03873116|448794549|FG000|Part 3|Withdrawal by Subject|0|||
124771717|NCT03873116|448794550|FG001|Part 3|Withdrawal by Subject|0|||
124771718|NCT03873116|448794551|FG002|Part 3|Withdrawal by Subject|0|||
124771719|NCT03873116|448794552|FG003|Part 3|Withdrawal by Subject|0|||
124771720|NCT03873116|448794553|FG004|Part 3|Withdrawal by Subject|1|||
124771721|NCT03873116|448794554|FG005|Part 3|Withdrawal by Subject|0|||
124771722|NCT00912808|448794555|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
124771723|NCT00912808|448794556|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
124771724|NCT00912808|448794555|FG000|Washout|Withdrawal by Subject|0|||
124771725|NCT00912808|448794556|FG001|Washout|Withdrawal by Subject|1|||
124771726|NCT00912808|448794555|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
124771727|NCT00912808|448794556|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
124771728|NCT00912808|448794555|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
124771729|NCT00912808|448794556|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
124771730|NCT00474812|448794565|FG000|Overall Study|Withdrawal by Subject|5|||
124771731|NCT00474812|448794565|FG000|Overall Study|No Initiation of treatment|2|||
124771732|NCT03955146|448794575|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
124771733|NCT03955146|448794576|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
124771734|NCT03955146|448794577|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
124771735|NCT03955146|448794578|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
124771736|NCT03955146|448794575|FG000|DB Period (48 Weeks)|Adverse Event|2|||
124771737|NCT03955146|448794576|FG001|DB Period (48 Weeks)|Adverse Event|5|||
124771738|NCT03955146|448794577|FG002|DB Period (48 Weeks)|Adverse Event|1|||
124771739|NCT03955146|448794578|FG003|DB Period (48 Weeks)|Adverse Event|2|||
124771740|NCT03955146|448794575|FG000|DB Period (48 Weeks)|Death|13|||
124771741|NCT03955146|448794576|FG001|DB Period (48 Weeks)|Death|17|||
124771742|NCT03955146|448794577|FG002|DB Period (48 Weeks)|Death|1|||
124771743|NCT03955146|448794578|FG003|DB Period (48 Weeks)|Death|0|||
124771744|NCT03955146|448794575|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
124771745|NCT03955146|448794576|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
124771746|NCT03955146|448794577|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
124771747|NCT03955146|448794578|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
124771748|NCT03955146|448794575|FG000|DB Period (48 Weeks)|Disease Progression|2|||
124771749|NCT03955146|448794576|FG001|DB Period (48 Weeks)|Disease Progression|0|||
124771750|NCT03955146|448794577|FG002|DB Period (48 Weeks)|Disease Progression|0|||
124771751|NCT03955146|448794578|FG003|DB Period (48 Weeks)|Disease Progression|0|||
124771752|NCT03955146|448794575|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
124771753|NCT03955146|448794576|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
124771754|NCT03955146|448794577|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
124771755|NCT03955146|448794578|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
124771756|NCT03955146|448794575|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
124771757|NCT03955146|448794576|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
124480911|NCT04889209|447713900|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
124480912|NCT04889209|447713901|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
124480913|NCT04889209|447713902|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
124480914|NCT04889209|447713903|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
124480915|NCT04889209|447713904|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
124480916|NCT04889209|447713905|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
124480917|NCT04889209|447713906|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
124771758|NCT03955146|448794577|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
124771759|NCT03955146|448794578|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
124771760|NCT03955146|448794575|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
124771761|NCT03955146|448794576|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
124557452|NCT02008721|447999085|FG000|Overall Study|Withdrawal by Subject|5|||
124480918|NCT04889209|447713907|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
124480919|NCT04889209|447713908|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
124480920|NCT04889209|447713909|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
124480921|NCT04889209|447713910|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
124480922|NCT04889209|447713911|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
124480923|NCT04889209|447713912|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
124480924|NCT04889209|447713913|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
124480925|NCT04889209|447713914|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
124480926|NCT04889209|447713915|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
124480927|NCT04889209|447713916|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
124480928|NCT04889209|447713899|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
124480929|NCT04889209|447713900|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
124480930|NCT04889209|447713901|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
124480931|NCT04889209|447713902|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
124480932|NCT04889209|447713903|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
124480933|NCT04889209|447713904|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
124480934|NCT04889209|447713905|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
124480935|NCT04889209|447713906|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
124480936|NCT04889209|447713907|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
124480937|NCT04889209|447713908|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
124480938|NCT04889209|447713909|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
124480939|NCT04889209|447713910|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
124480940|NCT04889209|447713911|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
124480941|NCT04889209|447713912|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
124480942|NCT04889209|447713913|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
124480943|NCT04889209|447713914|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
124480944|NCT04889209|447713915|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
124480945|NCT04889209|447713916|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
124480946|NCT05113940|447713919|FG000|Part A (18 Days)|Adverse Event|0|||
124480947|NCT05113940|447713920|FG001|Part A (18 Days)|Adverse Event|0|||
124480948|NCT05113940|447713921|FG002|Part A (18 Days)|Adverse Event|1|||
124480949|NCT05113940|447713922|FG003|Part A (18 Days)|Adverse Event|1|||
124480950|NCT05113940|447713923|FG004|Part A (18 Days)|Adverse Event|1|||
124480951|NCT05113940|447713924|FG005|Part A (18 Days)|Adverse Event|0|||
124480952|NCT05113940|447713925|FG006|Part A (18 Days)|Adverse Event|0|||
124480953|NCT05113940|447713926|FG007|Part A (18 Days)|Adverse Event|0|||
124480954|NCT05113940|447713927|FG008|Part A (18 Days)|Adverse Event|0|||
124480955|NCT05113940|447713928|FG009|Part A (18 Days)|Adverse Event|0|||
124557453|NCT02008721|447999086|FG001|Overall Study|Withdrawal by Subject|1|||
124557454|NCT02008721|447999085|FG000|Overall Study|Death|4|||
124480956|NCT05113940|447713929|FG010|Part A (18 Days)|Adverse Event|0|||
124480957|NCT05113940|447713930|FG011|Part A (18 Days)|Adverse Event|2|||
124480958|NCT05113940|447713931|FG012|Part A (18 Days)|Adverse Event|0|||
124480959|NCT05113940|447713932|FG013|Part A (18 Days)|Adverse Event|0|||
124480960|NCT05113940|447713933|FG014|Part A (18 Days)|Adverse Event|0|||
124480961|NCT05113940|447713919|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
124480962|NCT05113940|447713920|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
124480963|NCT05113940|447713921|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
124480964|NCT05113940|447713922|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
124771762|NCT03955146|448794577|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
124771763|NCT03955146|448794578|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
124771764|NCT03955146|448794575|FG000|DB Period (48 Weeks)|Participant Decision|9|||
124771765|NCT03955146|448794576|FG001|DB Period (48 Weeks)|Participant Decision|12|||
124771766|NCT03955146|448794577|FG002|DB Period (48 Weeks)|Participant Decision|1|||
124771767|NCT03955146|448794578|FG003|DB Period (48 Weeks)|Participant Decision|1|||
124771768|NCT03955146|448794575|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
124771769|NCT03955146|448794576|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
124771770|NCT03955146|448794577|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
124771771|NCT03955146|448794578|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
124771772|NCT03955146|448794575|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
124771773|NCT03955146|448794576|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
124771774|NCT03955146|448794577|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
124771775|NCT03955146|448794578|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
124771776|NCT03955146|448794575|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
124771777|NCT03955146|448794576|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
124771778|NCT03955146|448794577|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
124771779|NCT03955146|448794578|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
124771780|NCT03955146|448794575|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
124771781|NCT03955146|448794576|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
124771782|NCT03955146|448794577|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
124771783|NCT03955146|448794578|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
124771784|NCT03955146|448794575|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
124771785|NCT03955146|448794576|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
124771786|NCT03955146|448794577|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
124771787|NCT03955146|448794578|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
124771788|NCT03955146|448794575|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
124771789|NCT03955146|448794576|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
124771790|NCT03955146|448794577|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
124771791|NCT03955146|448794578|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
124771792|NCT03955146|448794575|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
124771793|NCT03955146|448794576|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
124771794|NCT03955146|448794577|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
124771795|NCT03955146|448794578|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
124771796|NCT03955146|448794575|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
124771797|NCT03955146|448794576|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
124771798|NCT03955146|448794577|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
124771799|NCT03955146|448794578|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
124771800|NCT03955146|448794575|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
124771801|NCT03955146|448794576|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
124771802|NCT03955146|448794577|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
124771803|NCT03955146|448794578|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
124771804|NCT03955146|448794575|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
124557455|NCT02008721|447999086|FG001|Overall Study|Death|2|||
124557456|NCT02008721|447999085|FG000|Overall Study|Adverse Event|3|||
124557457|NCT02008721|447999086|FG001|Overall Study|Adverse Event|5|||
124771805|NCT03955146|448794576|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
124771806|NCT03955146|448794577|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
124720599|NCT02091362|448599348|FG001|Period 2|Adverse Event|0|||
124720600|NCT02091362|448599347|FG000|Period 2|Lost to Follow-up|0|||
124720601|NCT02091362|448599348|FG001|Period 2|Lost to Follow-up|1|||
124720602|NCT02091362|448599347|FG000|Period 2|Withdrawal by Subject|1|||
124720603|NCT02091362|448599348|FG001|Period 2|Withdrawal by Subject|1|||
124720604|NCT00470262|448599349|FG000|Overall Study|Withdrawal by Subject|2|||
124720605|NCT00470262|448599350|FG001|Overall Study|Withdrawal by Subject|0|||
124720606|NCT00690430|448599351|FG000|Core Phase|Abnormal Laboratory value|0|||
124720607|NCT00690430|448599352|FG001|Core Phase|Abnormal Laboratory value|1|||
124720608|NCT00690430|448599353|FG002|Core Phase|Abnormal Laboratory value|0|||
124720609|NCT00690430|448599351|FG000|Core Phase|Adverse Event|5|||
124720610|NCT00690430|448599352|FG001|Core Phase|Adverse Event|1|||
124720611|NCT00690430|448599353|FG002|Core Phase|Adverse Event|0|||
124720612|NCT00690430|448599351|FG000|Core Phase|Death|0|||
124720613|NCT00690430|448599352|FG001|Core Phase|Death|2|||
124720614|NCT00690430|448599353|FG002|Core Phase|Death|0|||
124720615|NCT00690430|448599351|FG000|Core Phase|Protocol Violation|1|||
124720616|NCT00690430|448599352|FG001|Core Phase|Protocol Violation|0|||
124720617|NCT00690430|448599353|FG002|Core Phase|Protocol Violation|0|||
124720618|NCT00690430|448599351|FG000|Core Phase|Withdrawal by Subject|3|||
124720619|NCT00690430|448599352|FG001|Core Phase|Withdrawal by Subject|3|||
124720620|NCT00690430|448599353|FG002|Core Phase|Withdrawal by Subject|0|||
124720621|NCT00690430|448599351|FG000|Core Phase|Subject no longer requires study drug|1|||
124720622|NCT00690430|448599352|FG001|Core Phase|Subject no longer requires study drug|0|||
124720623|NCT00690430|448599353|FG002|Core Phase|Subject no longer requires study drug|0|||
124720624|NCT00690430|448599351|FG000|Core Phase|Lack of Efficacy|8|||
124720625|NCT00690430|448599352|FG001|Core Phase|Lack of Efficacy|10|||
124720626|NCT00690430|448599353|FG002|Core Phase|Lack of Efficacy|0|||
124720627|NCT00690430|448599351|FG000|Core Phase|Administrative Problems|0|||
124720628|NCT00690430|448599352|FG001|Core Phase|Administrative Problems|1|||
124720629|NCT00690430|448599353|FG002|Core Phase|Administrative Problems|0|||
124720630|NCT00690430|448599351|FG000|Core Phase|Early Termination|0|||
124720631|NCT00690430|448599352|FG001|Core Phase|Early Termination|5|||
124720632|NCT00690430|448599353|FG002|Core Phase|Early Termination|0|||
124720633|NCT00690430|448599351|FG000|Extension Phase|Lack of Efficacy|3|||
124720634|NCT00690430|448599352|FG001|Extension Phase|Lack of Efficacy|1|||
124720635|NCT00690430|448599353|FG002|Extension Phase|Lack of Efficacy|4|||
124720636|NCT00690430|448599351|FG000|Extension Phase|Abnormal Lab Values|1|||
124720637|NCT00690430|448599352|FG001|Extension Phase|Abnormal Lab Values|0|||
124720638|NCT00690430|448599353|FG002|Extension Phase|Abnormal Lab Values|0|||
124720639|NCT00690430|448599351|FG000|Extension Phase|Abnormal test procedure results|1|||
124720640|NCT00690430|448599352|FG001|Extension Phase|Abnormal test procedure results|0|||
124720641|NCT00690430|448599353|FG002|Extension Phase|Abnormal test procedure results|0|||
124720642|NCT00690430|448599351|FG000|Extension Phase|Administrative Problems|0|||
124720643|NCT00690430|448599352|FG001|Extension Phase|Administrative Problems|1|||
124720644|NCT00690430|448599353|FG002|Extension Phase|Administrative Problems|1|||
124720645|NCT00690430|448599351|FG000|Extension Phase|Adverse Event|2|||
124720646|NCT00690430|448599352|FG001|Extension Phase|Adverse Event|1|||
124720647|NCT00690430|448599353|FG002|Extension Phase|Adverse Event|2|||
124720648|NCT00690430|448599351|FG000|Extension Phase|Death|1|||
124720649|NCT00690430|448599352|FG001|Extension Phase|Death|1|||
124720650|NCT00690430|448599353|FG002|Extension Phase|Death|1|||
124720651|NCT00690430|448599351|FG000|Extension Phase|Withdrawal by Subject|0|||
124720652|NCT00690430|448599352|FG001|Extension Phase|Withdrawal by Subject|0|||
124720653|NCT00690430|448599353|FG002|Extension Phase|Withdrawal by Subject|2|||
124720654|NCT00690430|448599351|FG000|Extension Phase|Early Termination|10|||
124720655|NCT00690430|448599352|FG001|Extension Phase|Early Termination|1|||
124720656|NCT00690430|448599353|FG002|Extension Phase|Early Termination|3|||
124720657|NCT03900728|448599354|FG000|Overall Study|No text responses|0|||
124720658|NCT03900728|448599355|FG001|Overall Study|No text responses|0|||
124720659|NCT03900728|448599356|FG002|Overall Study|No text responses|4|||
124557458|NCT02008721|447999085|FG000|Overall Study|Protocol Violation|3|||
124720660|NCT00335738|448599367|FG000|Overall Study|Physician Decision|6|||
124720661|NCT00335738|448599368|FG001|Overall Study|Physician Decision|0|||
124720662|NCT00335738|448599367|FG000|Overall Study|Withdrawal by Subject|2|||
124720663|NCT00335738|448599368|FG001|Overall Study|Withdrawal by Subject|0|||
124720664|NCT00335738|448599367|FG000|Overall Study|Ineligible|3|||
124720665|NCT00335738|448599368|FG001|Overall Study|Ineligible|4|||
124720666|NCT03248167|448599375|FG000|Overall Study|Withdrawal by Subject|2|||
124720667|NCT03248167|448599376|FG001|Overall Study|Withdrawal by Subject|2|||
124720668|NCT03248167|448599375|FG000|Overall Study|Physician Decision|0|||
124720669|NCT03248167|448599376|FG001|Overall Study|Physician Decision|1|||
124720670|NCT03248167|448599375|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
124720671|NCT03248167|448599376|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
124720672|NCT03248167|448599375|FG000|Overall Study|Lost to Follow-up|1|||
124720673|NCT03248167|448599376|FG001|Overall Study|Lost to Follow-up|0|||
124720674|NCT02122146|448599377|FG000|Part 1: Dose Escalation|Death|0|||
124720675|NCT02122146|448599378|FG001|Part 1: Dose Escalation|Death|1|||
124720676|NCT02122146|448599379|FG002|Part 1: Dose Escalation|Death|1|||
124480965|NCT05113940|447713923|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
124480966|NCT05113940|447713924|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
124480967|NCT05113940|447713925|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
124480968|NCT05113940|447713926|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
124480969|NCT05113940|447713927|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
124480970|NCT05113940|447713928|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
124480971|NCT05113940|447713929|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
124480972|NCT05113940|447713930|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
124480973|NCT05113940|447713931|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
124480974|NCT05113940|447713932|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
124480975|NCT05113940|447713933|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
124480976|NCT02688647|447713936|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
124480977|NCT02688647|447713937|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
124480978|NCT02688647|447713936|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
124480979|NCT02688647|447713937|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
124480980|NCT02688647|447713936|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
124480981|NCT02688647|447713937|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
124480982|NCT02688647|447713936|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
124480983|NCT02688647|447713937|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
124480984|NCT02688647|447713936|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
124480985|NCT02688647|447713937|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
124480986|NCT02688647|447713936|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
124480987|NCT02688647|447713937|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
124480988|NCT02688647|447713936|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
124480989|NCT02688647|447713937|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
124480990|NCT00382967|447713938|FG000|Overall Study|Protocol Violation|1|||
124480991|NCT00382967|447713939|FG001|Overall Study|Protocol Violation|1|||
124480992|NCT03049449|447713943|FG000|Overall Study|Did not receive treatment.|0|||
124480993|NCT03049449|447713944|FG001|Overall Study|Did not receive treatment.|0|||
124480994|NCT03049449|447713945|FG002|Overall Study|Did not receive treatment.|0|||
124480995|NCT03049449|447713946|FG003|Overall Study|Did not receive treatment.|0|||
124480996|NCT03049449|447713947|FG004|Overall Study|Did not receive treatment.|0|||
124480997|NCT03049449|447713948|FG005|Overall Study|Did not receive treatment.|0|||
124480998|NCT03049449|447713949|FG006|Overall Study|Did not receive treatment.|0|||
124480999|NCT03049449|447713950|FG007|Overall Study|Did not receive treatment.|0|||
124481000|NCT03049449|447713951|FG008|Overall Study|Did not receive treatment.|1|||
124481001|NCT03049449|447713952|FG009|Overall Study|Did not receive treatment.|0|||
124481002|NCT03049449|447713943|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
124481003|NCT03049449|447713944|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
124481004|NCT03049449|447713945|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
124481005|NCT03049449|447713946|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
124481006|NCT03049449|447713947|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
124481007|NCT03049449|447713948|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
124481008|NCT03049449|447713949|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
124481009|NCT03049449|447713950|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
124481010|NCT03049449|447713951|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
124481011|NCT03049449|447713952|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
124481012|NCT03049449|447713943|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
124481013|NCT03049449|447713944|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
124481014|NCT03049449|447713945|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
124481015|NCT03049449|447713946|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
124481016|NCT03049449|447713947|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
124481017|NCT03049449|447713948|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
124481018|NCT03049449|447713949|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
124481019|NCT03049449|447713950|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
124481020|NCT03049449|447713951|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
124481021|NCT03049449|447713952|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
124481022|NCT00474240|447713953|FG000|Overall Study|Withdrawal by Subject|1|||
124481023|NCT00474240|447713954|FG001|Overall Study|Withdrawal by Subject|1|||
124481024|NCT00474240|447713955|FG002|Overall Study|Withdrawal by Subject|0|||
124481025|NCT00474240|447713956|FG003|Overall Study|Withdrawal by Subject|2|||
124481026|NCT00474240|447713957|FG004|Overall Study|Withdrawal by Subject|3|||
124481027|NCT00474240|447713958|FG005|Overall Study|Withdrawal by Subject|1|||
124481028|NCT00474240|447713953|FG000|Overall Study|Adverse Event|0|||
124481029|NCT00474240|447713954|FG001|Overall Study|Adverse Event|0|||
124481030|NCT00474240|447713955|FG002|Overall Study|Adverse Event|9|||
124481031|NCT00474240|447713956|FG003|Overall Study|Adverse Event|14|||
124481032|NCT00474240|447713957|FG004|Overall Study|Adverse Event|5|||
124481033|NCT00474240|447713958|FG005|Overall Study|Adverse Event|16|||
124481034|NCT00474240|447713953|FG000|Overall Study|Removed due to lab value|0|||
124481035|NCT00474240|447713954|FG001|Overall Study|Removed due to lab value|0|||
124481036|NCT00474240|447713955|FG002|Overall Study|Removed due to lab value|0|||
124481037|NCT00474240|447713956|FG003|Overall Study|Removed due to lab value|0|||
124557459|NCT02008721|447999086|FG001|Overall Study|Protocol Violation|2|||
124481038|NCT00474240|447713957|FG004|Overall Study|Removed due to lab value|0|||
124481039|NCT00474240|447713958|FG005|Overall Study|Removed due to lab value|1|||
124771807|NCT03955146|448794578|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
124771808|NCT03955146|448794575|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
124771809|NCT03955146|448794576|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
124771810|NCT03955146|448794577|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
124771811|NCT03955146|448794578|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
124771812|NCT04363320|448794581|FG000|Overall Study|Lost to Follow-up|43|||
124771813|NCT04363320|448794582|FG001|Overall Study|Lost to Follow-up|42|||
124771814|NCT04363320|448794583|FG002|Overall Study|Lost to Follow-up|24|||
124771815|NCT04363320|448794584|FG003|Overall Study|Lost to Follow-up|29|||
124771816|NCT04363320|448794581|FG000|Overall Study|Death|0|||
124771817|NCT04363320|448794582|FG001|Overall Study|Death|0|||
124771818|NCT04363320|448794583|FG002|Overall Study|Death|1|||
124771819|NCT04363320|448794584|FG003|Overall Study|Death|0|||
124771820|NCT02002598|448794585|FG000|Dose Level 1|Withdrawal by Subject|1|||
124771821|NCT02002598|448794586|FG001|Dose Level 1|Withdrawal by Subject|0|||
124771822|NCT02002598|448794587|FG002|Dose Level 1|Withdrawal by Subject|0|||
124771823|NCT02002598|448794588|FG003|Dose Level 1|Withdrawal by Subject|0|||
124771824|NCT02002598|448794589|FG004|Dose Level 1|Withdrawal by Subject|0|||
124771825|NCT05632211|448794590|FG000|Overall Study|Withdrawal by Subject|2|||
124771826|NCT05632211|448794591|FG001|Overall Study|Withdrawal by Subject|0|||
124771827|NCT05632211|448794592|FG002|Overall Study|Withdrawal by Subject|2|||
124771828|NCT05632211|448794590|FG000|Overall Study|Other reasons|1|||
124771829|NCT05632211|448794591|FG001|Overall Study|Other reasons|1|||
124771830|NCT05632211|448794592|FG002|Overall Study|Other reasons|1|||
124771831|NCT02628873|448794593|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
124771832|NCT02628873|448794594|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
124771833|NCT02628873|448794593|FG000|Second Test (1 Hour)|Physician Decision|1|||
124771834|NCT02628873|448794594|FG001|Second Test (1 Hour)|Physician Decision|0|||
124771835|NCT00541658|448794595|FG000|Overall Study|Adverse Event|28|||
124771836|NCT00541658|448794596|FG001|Overall Study|Adverse Event|37|||
124771837|NCT00541658|448794597|FG002|Overall Study|Adverse Event|25|||
124771838|NCT00541658|448794595|FG000|Overall Study|Physician Decision|0|||
124771839|NCT00541658|448794596|FG001|Overall Study|Physician Decision|0|||
124771840|NCT00541658|448794597|FG002|Overall Study|Physician Decision|4|||
124771841|NCT00541658|448794595|FG000|Overall Study|Lost to Follow-up|3|||
124771842|NCT00541658|448794596|FG001|Overall Study|Lost to Follow-up|3|||
124771843|NCT00541658|448794597|FG002|Overall Study|Lost to Follow-up|6|||
124771844|NCT00541658|448794595|FG000|Overall Study|Protocol Violation|0|||
124771845|NCT00541658|448794596|FG001|Overall Study|Protocol Violation|1|||
124771846|NCT00541658|448794597|FG002|Overall Study|Protocol Violation|1|||
124771847|NCT00541658|448794595|FG000|Overall Study|Withdrawal by Subject|28|||
124771848|NCT00541658|448794596|FG001|Overall Study|Withdrawal by Subject|32|||
124771849|NCT00541658|448794597|FG002|Overall Study|Withdrawal by Subject|32|||
124771850|NCT00541658|448794595|FG000|Overall Study|Took No Study Drug|1|||
124771851|NCT00541658|448794596|FG001|Overall Study|Took No Study Drug|0|||
124771852|NCT00541658|448794597|FG002|Overall Study|Took No Study Drug|0|||
124771853|NCT04123470|448794598|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
124771854|NCT04123470|448794599|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
124771855|NCT04123470|448794598|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
124771856|NCT04123470|448794599|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
124771857|NCT04123470|448794598|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
124771858|NCT04123470|448794599|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
124771859|NCT04123470|448794598|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
124771860|NCT04123470|448794599|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
124771861|NCT05530252|448794600|FG000|Overall Study|Lost to Follow-up|1|||
124771862|NCT05530252|448794601|FG001|Overall Study|Lost to Follow-up|1|||
124771863|NCT05530252|448794602|FG002|Overall Study|Lost to Follow-up|1|||
124771864|NCT02195518|448794603|FG000|Overall Study|Adverse Event|1|||
124771865|NCT02195518|448794603|FG000|Overall Study|Protocol Violation|4|||
124771866|NCT02195518|448794603|FG000|Overall Study|Pregnancy|2|||
124771867|NCT02195518|448794603|FG000|Overall Study|Withdrawal by Subject|1|||
124771868|NCT02195518|448794603|FG000|Overall Study|Lost to Follow-up|1|||
124771869|NCT00911170|448794608|FG000|Treatment Period|Randomized in error|1|||
124771870|NCT00911170|448794609|FG001|Treatment Period|Randomized in error|1|||
124771871|NCT00911170|448794608|FG000|Treatment Period|Ineligibility determined|1|||
124771872|NCT00911170|448794609|FG001|Treatment Period|Ineligibility determined|3|||
124771873|NCT00911170|448794608|FG000|Treatment Period|Protocol deviation|1|||
124771874|NCT00911170|448794609|FG001|Treatment Period|Protocol deviation|2|||
124771875|NCT00911170|448794608|FG000|Treatment Period|Adverse Event|9|||
124771876|NCT00911170|448794609|FG001|Treatment Period|Adverse Event|10|||
124771877|NCT00911170|448794608|FG000|Treatment Period|Withdrawal by Subject|4|||
124771878|NCT00911170|448794609|FG001|Treatment Period|Withdrawal by Subject|4|||
124771879|NCT00911170|448794608|FG000|Treatment Period|Disease progression|0|||
124771880|NCT00911170|448794609|FG001|Treatment Period|Disease progression|2|||
124771881|NCT00911170|448794608|FG000|Treatment Period|Physician Decision|5|||
124557460|NCT00267007|447999089|FG000|Overall Study|Withdrawal by Subject|6|||
124557461|NCT00267007|447999090|FG001|Overall Study|Withdrawal by Subject|0|||
124557462|NCT00267007|447999089|FG000|Overall Study|Lost to Follow-up|1|||
124557463|NCT00267007|447999090|FG001|Overall Study|Lost to Follow-up|0|||
124481040|NCT01147497|447713964|FG000|Overall Study|failed insertion|2|||
124481041|NCT01147497|447713965|FG001|Overall Study|failed insertion|0|||
124481042|NCT00331760|447713966|FG000|Overall Study|Ineligible / no protocol treatment|15|||
124481043|NCT00331760|447713967|FG001|Overall Study|Ineligible / no protocol treatment|8|||
124481044|NCT03093155|447713969|FG000|Overall Study|Not Eligible|1|||
124481045|NCT03093155|447713970|FG001|Overall Study|Not Eligible|0|||
124481046|NCT03093155|447713969|FG000|Overall Study|Withdrawal by Subject|0|||
124481047|NCT03093155|447713970|FG001|Overall Study|Withdrawal by Subject|1|||
124481048|NCT00619229|447713971|FG000|Overall Study|Withdrawal by Subject|1|||
124481049|NCT00619229|447713972|FG001|Overall Study|Withdrawal by Subject|1|||
124481050|NCT00619229|447713971|FG000|Overall Study|Lost to Follow-up|1|||
124481051|NCT00619229|447713972|FG001|Overall Study|Lost to Follow-up|0|||
124481052|NCT00619229|447713971|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
124481053|NCT00619229|447713972|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
124481054|NCT00619229|447713971|FG000|Overall Study|Investigator planned Cataract Operation|1|||
124481055|NCT00619229|447713972|FG001|Overall Study|Investigator planned Cataract Operation|0|||
124481056|NCT02620020|447713973|FG000|Overall Study|Adverse Event|8|||
124481057|NCT02620020|447713974|FG001|Overall Study|Adverse Event|4|||
124481058|NCT02620020|447713975|FG002|Overall Study|Adverse Event|3|||
124481059|NCT02620020|447713976|FG003|Overall Study|Adverse Event|5|||
124481060|NCT02620020|447713973|FG000|Overall Study|Lost to Follow-up|4|||
124481061|NCT02620020|447713974|FG001|Overall Study|Lost to Follow-up|8|||
124481062|NCT02620020|447713975|FG002|Overall Study|Lost to Follow-up|1|||
124481063|NCT02620020|447713976|FG003|Overall Study|Lost to Follow-up|4|||
124481064|NCT02620020|447713973|FG000|Overall Study|Physician Decision|7|||
124481065|NCT02620020|447713974|FG001|Overall Study|Physician Decision|4|||
124481066|NCT02620020|447713975|FG002|Overall Study|Physician Decision|3|||
124481067|NCT02620020|447713976|FG003|Overall Study|Physician Decision|4|||
124481068|NCT02620020|447713973|FG000|Overall Study|Protocol Violation|5|||
124481069|NCT02620020|447713974|FG001|Overall Study|Protocol Violation|2|||
124481070|NCT02620020|447713975|FG002|Overall Study|Protocol Violation|1|||
124481071|NCT02620020|447713976|FG003|Overall Study|Protocol Violation|1|||
124481072|NCT02620020|447713973|FG000|Overall Study|Withdrawal by Subject|20|||
124481073|NCT02620020|447713974|FG001|Overall Study|Withdrawal by Subject|16|||
124481074|NCT02620020|447713975|FG002|Overall Study|Withdrawal by Subject|17|||
124481075|NCT02620020|447713976|FG003|Overall Study|Withdrawal by Subject|12|||
124481076|NCT02620020|447713973|FG000|Overall Study|Death|0|||
124481077|NCT02620020|447713974|FG001|Overall Study|Death|1|||
124481078|NCT02620020|447713975|FG002|Overall Study|Death|0|||
124481079|NCT02620020|447713976|FG003|Overall Study|Death|0|||
124481080|NCT02209506|447713978|FG000|Overall Study|Withdrawal by Subject|0|||
124481081|NCT02209506|447713979|FG001|Overall Study|Withdrawal by Subject|0|||
124481082|NCT02209506|447713980|FG002|Overall Study|Withdrawal by Subject|0|||
124481083|NCT02209506|447713981|FG003|Overall Study|Withdrawal by Subject|0|||
124481084|NCT02209506|447713982|FG004|Overall Study|Withdrawal by Subject|1|||
124481085|NCT01287104|447713983|FG000|Overall Study|Patient developed progressive disease|1|||
124481086|NCT01287104|447713984|FG001|Overall Study|Patient developed progressive disease|1|||
124481087|NCT01287104|447713985|FG002|Overall Study|Patient developed progressive disease|3|||
124481088|NCT01287104|447713986|FG003|Overall Study|Patient developed progressive disease|2|||
124481089|NCT01287104|447713983|FG000|Overall Study|Donor anaphylaxis|0|||
124481090|NCT01287104|447713984|FG001|Overall Study|Donor anaphylaxis|1|||
124481091|NCT01287104|447713985|FG002|Overall Study|Donor anaphylaxis|0|||
124481092|NCT01287104|447713986|FG003|Overall Study|Donor anaphylaxis|1|||
124481093|NCT01287104|447713983|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
124481094|NCT01287104|447713984|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
124481095|NCT01287104|447713985|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
124481096|NCT01287104|447713986|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
124481097|NCT01287104|447713983|FG000|Overall Study|Low donor chimerism|0|||
124481098|NCT01287104|447713984|FG001|Overall Study|Low donor chimerism|1|||
124481099|NCT01287104|447713985|FG002|Overall Study|Low donor chimerism|0|||
124481100|NCT01287104|447713986|FG003|Overall Study|Low donor chimerism|0|||
124481101|NCT01287104|447713983|FG000|Overall Study|NK cells did not meet release criteria|0|||
124481102|NCT01287104|447713984|FG001|Overall Study|NK cells did not meet release criteria|1|||
124481103|NCT01287104|447713985|FG002|Overall Study|NK cells did not meet release criteria|0|||
124481104|NCT01287104|447713986|FG003|Overall Study|NK cells did not meet release criteria|0|||
124720677|NCT02122146|448599380|FG003|Part 1: Dose Escalation|Death|0|||
124720678|NCT02122146|448599381|FG004|Part 1: Dose Escalation|Death|0|||
124720679|NCT02122146|448599382|FG005|Part 1: Dose Escalation|Death|0|||
124720680|NCT02122146|448599383|FG006|Part 1: Dose Escalation|Death|0|||
124720681|NCT02122146|448599384|FG007|Part 1: Dose Escalation|Death|0|||
124481105|NCT02537678|447713991|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
124481106|NCT02537678|447713992|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
124481107|NCT02537678|447713991|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
124481108|NCT02537678|447713992|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
124481109|NCT02537678|447713991|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
124557464|NCT00267007|447999089|FG000|Overall Study|Non-compliance|0|||
124771882|NCT00911170|448794609|FG001|Treatment Period|Physician Decision|5|||
124771883|NCT00911170|448794608|FG000|Treatment Period|Lost to Follow-up|0|||
124771884|NCT00911170|448794609|FG001|Treatment Period|Lost to Follow-up|1|||
124771885|NCT00911170|448794608|FG000|Treatment Period|Death|6|||
124771886|NCT00911170|448794609|FG001|Treatment Period|Death|9|||
124771887|NCT00911170|448794608|FG000|Long Term Follow-Up|Continuing in study|274|||
124771888|NCT00911170|448794609|FG001|Long Term Follow-Up|Continuing in study|269|||
124771889|NCT00911170|448794608|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
124771890|NCT00911170|448794609|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
124771891|NCT00911170|448794608|FG000|Long Term Follow-Up|Physician Decision|5|||
124771892|NCT00911170|448794609|FG001|Long Term Follow-Up|Physician Decision|4|||
124771893|NCT00911170|448794608|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
124771894|NCT00911170|448794609|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
124771895|NCT00911170|448794608|FG000|Long Term Follow-Up|Death|116|||
124771896|NCT00911170|448794609|FG001|Long Term Follow-Up|Death|121|||
124771897|NCT02594124|448794610|FG000|Overall Study|Adverse Event|0|||
124771898|NCT02594124|448794611|FG001|Overall Study|Adverse Event|5|||
124771899|NCT02594124|448794612|FG002|Overall Study|Adverse Event|8|||
124771900|NCT02594124|448794613|FG003|Overall Study|Adverse Event|1|||
124771901|NCT02594124|448794614|FG004|Overall Study|Adverse Event|0|||
124771902|NCT02594124|448794615|FG005|Overall Study|Adverse Event|0|||
124771903|NCT02594124|448794616|FG006|Overall Study|Adverse Event|2|||
124771904|NCT02594124|448794617|FG007|Overall Study|Adverse Event|2|||
124771905|NCT02594124|448794618|FG008|Overall Study|Adverse Event|0|||
124771906|NCT02594124|448794610|FG000|Overall Study|Withdrawal by Subject|2|||
124771907|NCT02594124|448794611|FG001|Overall Study|Withdrawal by Subject|3|||
124771908|NCT02594124|448794612|FG002|Overall Study|Withdrawal by Subject|5|||
124771909|NCT02594124|448794613|FG003|Overall Study|Withdrawal by Subject|1|||
124771910|NCT02594124|448794614|FG004|Overall Study|Withdrawal by Subject|8|||
124771911|NCT02594124|448794615|FG005|Overall Study|Withdrawal by Subject|4|||
124771912|NCT02594124|448794616|FG006|Overall Study|Withdrawal by Subject|13|||
124771913|NCT02594124|448794617|FG007|Overall Study|Withdrawal by Subject|19|||
124771914|NCT02594124|448794618|FG008|Overall Study|Withdrawal by Subject|0|||
124771915|NCT02594124|448794610|FG000|Overall Study|Physician Decision|0|||
124771916|NCT02594124|448794611|FG001|Overall Study|Physician Decision|2|||
124771917|NCT02594124|448794612|FG002|Overall Study|Physician Decision|0|||
124771918|NCT02594124|448794613|FG003|Overall Study|Physician Decision|0|||
124557465|NCT00267007|447999090|FG001|Overall Study|Non-compliance|1|||
124771919|NCT02594124|448794614|FG004|Overall Study|Physician Decision|0|||
124771920|NCT02594124|448794615|FG005|Overall Study|Physician Decision|0|||
124771921|NCT02594124|448794616|FG006|Overall Study|Physician Decision|0|||
124771922|NCT02594124|448794617|FG007|Overall Study|Physician Decision|1|||
124771923|NCT02594124|448794618|FG008|Overall Study|Physician Decision|0|||
124771924|NCT02594124|448794610|FG000|Overall Study|Commercial drug|0|||
124771925|NCT02594124|448794611|FG001|Overall Study|Commercial drug|1|||
124771926|NCT02594124|448794612|FG002|Overall Study|Commercial drug|6|||
124771927|NCT02594124|448794613|FG003|Overall Study|Commercial drug|3|||
124771928|NCT02594124|448794614|FG004|Overall Study|Commercial drug|0|||
124771929|NCT02594124|448794615|FG005|Overall Study|Commercial drug|0|||
124481110|NCT02537678|447713992|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
124481111|NCT02537678|447713991|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
124481112|NCT02537678|447713992|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
124481113|NCT02537678|447713991|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
124481114|NCT02537678|447713992|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
124481115|NCT02537678|447713991|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
124481116|NCT02537678|447713992|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
124481117|NCT02537678|447713991|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
124481118|NCT02537678|447713992|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
124481119|NCT02965378|447713993|FG000|Overall Study|Progression|16|||
124481120|NCT02965378|447713994|FG001|Overall Study|Progression|4|||
124481121|NCT02965378|447713993|FG000|Overall Study|Adverse Event|5|||
124481122|NCT02965378|447713994|FG001|Overall Study|Adverse Event|2|||
124481123|NCT02965378|447713993|FG000|Overall Study|Death|2|||
124557466|NCT00267007|447999089|FG000|Overall Study|Adverse Event|1|||
124557467|NCT00267007|447999090|FG001|Overall Study|Adverse Event|0|||
124557468|NCT01825876|447999091|FG000|Period 2|Withdrawal by Subject|0|||
124557469|NCT01825876|447999092|FG001|Period 2|Withdrawal by Subject|1|||
124557470|NCT03751020|447999095|FG000|Overall Study|Withdrawal by Subject|2|||
124557471|NCT03751020|447999096|FG001|Overall Study|Withdrawal by Subject|0|||
124557472|NCT03751020|447999097|FG002|Overall Study|Withdrawal by Subject|0|||
124557473|NCT03751020|447999095|FG000|Overall Study|Lost to Follow-up|7|||
124557474|NCT03751020|447999096|FG001|Overall Study|Lost to Follow-up|4|||
124557475|NCT03751020|447999097|FG002|Overall Study|Lost to Follow-up|10|||
124481124|NCT02965378|447713994|FG001|Overall Study|Death|0|||
124481125|NCT02965378|447713993|FG000|Overall Study|Refusal|2|||
124557476|NCT04133519|447999100|FG000|Overall Study|Withdrawal by Subject|5|||
124557477|NCT04133519|447999101|FG001|Overall Study|Withdrawal by Subject|4|||
124481126|NCT02965378|447713994|FG001|Overall Study|Refusal|1|||
124481127|NCT02965378|447713993|FG000|Overall Study|Not protocol specified|0|||
124481128|NCT02965378|447713994|FG001|Overall Study|Not protocol specified|2|||
124481129|NCT00629083|447713999|FG000|Overall Study|Adverse Event|0|||
124481130|NCT00629083|447714000|FG001|Overall Study|Adverse Event|2|||
124481131|NCT00629083|447713999|FG000|Overall Study|Lack of Efficacy|3|||
124481132|NCT00629083|447714000|FG001|Overall Study|Lack of Efficacy|1|||
124481133|NCT00629083|447713999|FG000|Overall Study|Withdrawal by Subject|10|||
124481134|NCT00629083|447714000|FG001|Overall Study|Withdrawal by Subject|2|||
124557478|NCT04133519|447999100|FG000|Overall Study|Protocol Violation|0|||
124481135|NCT00629083|447713999|FG000|Overall Study|Lost to Follow-up|12|||
124481136|NCT00629083|447714000|FG001|Overall Study|Lost to Follow-up|8|||
124720682|NCT02122146|448599377|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
124720683|NCT02122146|448599378|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
124720684|NCT02122146|448599379|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
124720685|NCT02122146|448599380|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
124720686|NCT02122146|448599381|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
124720687|NCT02122146|448599382|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
124720688|NCT02122146|448599383|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
124720689|NCT02122146|448599384|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
124720690|NCT02122146|448599377|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124720691|NCT02122146|448599378|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124720692|NCT02122146|448599379|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124720693|NCT02122146|448599380|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
124720694|NCT02122146|448599381|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124481137|NCT00629083|447713999|FG000|Overall Study|Moved out of country/state|2|||
124481138|NCT00629083|447714000|FG001|Overall Study|Moved out of country/state|1|||
124481139|NCT00629083|447713999|FG000|Overall Study|Refused to return for 12 month visit|1|||
124481140|NCT00629083|447714000|FG001|Overall Study|Refused to return for 12 month visit|0|||
124481141|NCT02909153|447714001|FG000|Overall Study|Withdrawal by Subject|0|||
124481142|NCT02909153|447714002|FG001|Overall Study|Withdrawal by Subject|1|||
124481143|NCT02909153|447714003|FG002|Overall Study|Withdrawal by Subject|0|||
124481144|NCT02909153|447714004|FG003|Overall Study|Withdrawal by Subject|0|||
124481145|NCT02909153|447714005|FG004|Overall Study|Withdrawal by Subject|0|||
124481146|NCT01193686|447714006|FG000|Overall Study|Withdrawal by Subject|4|||
124481147|NCT01193686|447714007|FG001|Overall Study|Withdrawal by Subject|1|||
124481148|NCT01193686|447714006|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
124481149|NCT01193686|447714007|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
124481150|NCT01147809|447714008|FG000|Phase I (168 Days)|Adverse Event|0|||
124481151|NCT01147809|447714009|FG001|Phase I (168 Days)|Adverse Event|0|||
124481152|NCT01147809|447714010|FG002|Phase I (168 Days)|Adverse Event|0|||
124481153|NCT01147809|447714011|FG003|Phase I (168 Days)|Adverse Event|1|||
124481154|NCT01147809|447714012|FG004|Phase I (168 Days)|Adverse Event|0|||
124481155|NCT01147809|447714013|FG005|Phase I (168 Days)|Adverse Event|0|||
124481156|NCT01147809|447714008|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
124481157|NCT01147809|447714009|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
124481158|NCT01147809|447714010|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
124481159|NCT01147809|447714011|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
124481160|NCT01147809|447714012|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
124481161|NCT01147809|447714013|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
124481162|NCT01147809|447714008|FG000|Phase I (168 Days)|Physician Decision|0|||
124481163|NCT01147809|447714009|FG001|Phase I (168 Days)|Physician Decision|1|||
124481164|NCT01147809|447714010|FG002|Phase I (168 Days)|Physician Decision|2|||
124481165|NCT01147809|447714011|FG003|Phase I (168 Days)|Physician Decision|0|||
124481166|NCT01147809|447714012|FG004|Phase I (168 Days)|Physician Decision|0|||
124481167|NCT01147809|447714013|FG005|Phase I (168 Days)|Physician Decision|0|||
124481168|NCT01147809|447714008|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
124481169|NCT01147809|447714009|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
124481170|NCT01147809|447714010|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
124481171|NCT01147809|447714011|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
124481172|NCT01147809|447714012|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
124481173|NCT01147809|447714013|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
124481174|NCT01147809|447714008|FG000|Phase II (168 Days)|Adverse Event|0|||
124481175|NCT01147809|447714009|FG001|Phase II (168 Days)|Adverse Event|0|||
124481176|NCT01147809|447714010|FG002|Phase II (168 Days)|Adverse Event|0|||
124481177|NCT01147809|447714011|FG003|Phase II (168 Days)|Adverse Event|0|||
124481178|NCT01147809|447714012|FG004|Phase II (168 Days)|Adverse Event|3|||
124481179|NCT01147809|447714013|FG005|Phase II (168 Days)|Adverse Event|6|||
124481180|NCT01147809|447714008|FG000|Phase II (168 Days)|Protocol Violation|0|||
124481181|NCT01147809|447714009|FG001|Phase II (168 Days)|Protocol Violation|0|||
124481182|NCT01147809|447714010|FG002|Phase II (168 Days)|Protocol Violation|0|||
124481183|NCT01147809|447714011|FG003|Phase II (168 Days)|Protocol Violation|0|||
124481184|NCT01147809|447714012|FG004|Phase II (168 Days)|Protocol Violation|0|||
124481185|NCT01147809|447714013|FG005|Phase II (168 Days)|Protocol Violation|1|||
124481186|NCT01147809|447714008|FG000|Phase II (168 Days)|Physician Decision|0|||
124481187|NCT01147809|447714009|FG001|Phase II (168 Days)|Physician Decision|0|||
124481188|NCT01147809|447714010|FG002|Phase II (168 Days)|Physician Decision|0|||
124481189|NCT01147809|447714011|FG003|Phase II (168 Days)|Physician Decision|0|||
124481190|NCT01147809|447714012|FG004|Phase II (168 Days)|Physician Decision|5|||
124720695|NCT02122146|448599382|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124481191|NCT01147809|447714013|FG005|Phase II (168 Days)|Physician Decision|11|||
124481192|NCT01147809|447714008|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
124720696|NCT02122146|448599383|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124720697|NCT02122146|448599384|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124720698|NCT02122146|448599377|FG000|Part 1: Dose Escalation|Other|1|||
124481193|NCT01147809|447714009|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
124720699|NCT02122146|448599378|FG001|Part 1: Dose Escalation|Other|0|||
124720700|NCT02122146|448599379|FG002|Part 1: Dose Escalation|Other|0|||
124720701|NCT02122146|448599380|FG003|Part 1: Dose Escalation|Other|0|||
124720702|NCT02122146|448599381|FG004|Part 1: Dose Escalation|Other|0|||
124720703|NCT02122146|448599382|FG005|Part 1: Dose Escalation|Other|1|||
124720704|NCT02122146|448599383|FG006|Part 1: Dose Escalation|Other|1|||
124720705|NCT02122146|448599384|FG007|Part 1: Dose Escalation|Other|2|||
124720706|NCT01970241|448599385|FG000|Overall Study|Withdrawal by Subject|2|||
124720707|NCT01970241|448599386|FG001|Overall Study|Withdrawal by Subject|0|||
124720708|NCT01970241|448599385|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
124720709|NCT01970241|448599386|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
124720710|NCT03835481|448599387|FG000|Double-blind Period|Other not stated below|0|||
124720711|NCT03835481|448599388|FG001|Double-blind Period|Other not stated below|0|||
124720712|NCT03835481|448599389|FG002|Double-blind Period|Other not stated below|0|||
124720713|NCT03835481|448599390|FG003|Double-blind Period|Other not stated below|1|||
124720714|NCT03835481|448599391|FG004|Double-blind Period|Other not stated below|1|||
124720715|NCT03835481|448599387|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
124720716|NCT03835481|448599388|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
124720717|NCT03835481|448599389|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
124720718|NCT03835481|448599390|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
124720719|NCT03835481|448599391|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
124720720|NCT03835481|448599387|FG000|Double-blind Period|Withdrawal by Subject|0|||
124720721|NCT03835481|448599388|FG001|Double-blind Period|Withdrawal by Subject|0|||
124481194|NCT01147809|447714010|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
124481195|NCT01147809|447714011|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
124481196|NCT01147809|447714012|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
124481197|NCT01147809|447714013|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
124481198|NCT01147809|447714008|FG000|Phase II (168 Days)|Ongoing|0|||
124481199|NCT01147809|447714009|FG001|Phase II (168 Days)|Ongoing|0|||
124481200|NCT01147809|447714010|FG002|Phase II (168 Days)|Ongoing|0|||
124481201|NCT01147809|447714011|FG003|Phase II (168 Days)|Ongoing|0|||
124481202|NCT01147809|447714012|FG004|Phase II (168 Days)|Ongoing|1|||
124481203|NCT01147809|447714013|FG005|Phase II (168 Days)|Ongoing|0|||
124481204|NCT01307423|447714014|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
124481205|NCT01307423|447714015|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
124481206|NCT01307423|447714016|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
124481207|NCT01307423|447714017|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124481208|NCT01307423|447714018|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124481209|NCT01307423|447714019|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124481210|NCT01307423|447714020|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124481211|NCT01307423|447714021|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124720722|NCT03835481|448599389|FG002|Double-blind Period|Withdrawal by Subject|1|||
124720723|NCT03835481|448599390|FG003|Double-blind Period|Withdrawal by Subject|0|||
124720724|NCT03835481|448599391|FG004|Double-blind Period|Withdrawal by Subject|5|||
124720725|NCT03835481|448599387|FG000|Double-blind Period|Lost to Follow-up|0|||
124481212|NCT01307423|447714022|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
124481213|NCT01307423|447714014|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
124481214|NCT01307423|447714015|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
124720726|NCT03835481|448599388|FG001|Double-blind Period|Lost to Follow-up|0|||
124481215|NCT01307423|447714016|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
124557479|NCT04133519|447999101|FG001|Overall Study|Protocol Violation|1|||
124481216|NCT01307423|447714017|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124481217|NCT01307423|447714018|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124481218|NCT01307423|447714019|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124481219|NCT01307423|447714020|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124481220|NCT01307423|447714021|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124481221|NCT01307423|447714022|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
124481222|NCT01307423|447714014|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
124481223|NCT01307423|447714015|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
124481224|NCT01307423|447714016|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
124481225|NCT01307423|447714017|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124481226|NCT01307423|447714018|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124481227|NCT01307423|447714019|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124481228|NCT01307423|447714020|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124481229|NCT01307423|447714021|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124481230|NCT01307423|447714022|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
124481231|NCT01307423|447714014|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124481232|NCT01307423|447714015|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124481233|NCT01307423|447714016|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
124481234|NCT01307423|447714017|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124481235|NCT01307423|447714018|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124481236|NCT01307423|447714019|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124481237|NCT01307423|447714020|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124481238|NCT01307423|447714021|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124481239|NCT01307423|447714022|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
124481240|NCT01307423|447714014|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
124481241|NCT01307423|447714015|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
124481242|NCT01307423|447714016|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
124481243|NCT01307423|447714017|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124481244|NCT01307423|447714018|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124481245|NCT01307423|447714019|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124481246|NCT01307423|447714020|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124481247|NCT01307423|447714021|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124481248|NCT01307423|447714022|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
124481249|NCT01307423|447714014|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
124481250|NCT01307423|447714015|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124481251|NCT01307423|447714016|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124481252|NCT01307423|447714017|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124481253|NCT01307423|447714018|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124481254|NCT01307423|447714019|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124481255|NCT01307423|447714020|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124481256|NCT01307423|447714021|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124481257|NCT01307423|447714022|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
124481258|NCT01307423|447714014|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
124481259|NCT01307423|447714015|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
124481260|NCT01307423|447714016|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124481261|NCT01307423|447714017|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124481262|NCT01307423|447714018|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124481263|NCT01307423|447714019|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124481264|NCT01307423|447714020|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124481265|NCT01307423|447714021|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124481266|NCT01307423|447714022|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
124481267|NCT01307423|447714014|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
124481268|NCT01307423|447714015|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
124481269|NCT01307423|447714016|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
124481270|NCT01307423|447714017|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
124481271|NCT01307423|447714018|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
124481272|NCT01307423|447714019|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
124481273|NCT01307423|447714020|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
124481274|NCT01307423|447714021|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
124481275|NCT01307423|447714022|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
124481276|NCT01307423|447714014|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
124481277|NCT01307423|447714015|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
124481278|NCT01307423|447714016|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
124481279|NCT01307423|447714017|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
124720727|NCT03835481|448599389|FG002|Double-blind Period|Lost to Follow-up|0|||
124720728|NCT03835481|448599390|FG003|Double-blind Period|Lost to Follow-up|1|||
124720729|NCT03835481|448599391|FG004|Double-blind Period|Lost to Follow-up|0|||
124720730|NCT03835481|448599387|FG000|Double-blind Period|Protocol Violation|0|||
124720731|NCT03835481|448599388|FG001|Double-blind Period|Protocol Violation|2|||
124720732|NCT03835481|448599389|FG002|Double-blind Period|Protocol Violation|0|||
124720733|NCT03835481|448599390|FG003|Double-blind Period|Protocol Violation|1|||
124720734|NCT03835481|448599391|FG004|Double-blind Period|Protocol Violation|0|||
124720735|NCT03835481|448599387|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
124720736|NCT03835481|448599388|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
124720737|NCT03835481|448599389|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
124720738|NCT03835481|448599390|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
124720739|NCT03835481|448599391|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
124720740|NCT03835481|448599387|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
124720741|NCT03835481|448599388|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
124720742|NCT03835481|448599389|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
124720743|NCT03835481|448599390|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
124720744|NCT03835481|448599391|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
124720745|NCT03835481|448599387|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
124720746|NCT03835481|448599388|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
124720747|NCT03835481|448599389|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
124720748|NCT03835481|448599390|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
124720749|NCT03835481|448599391|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
124720750|NCT03835481|448599387|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
124771930|NCT02594124|448794616|FG006|Overall Study|Commercial drug|7|||
124481280|NCT01307423|447714018|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
124481281|NCT01307423|447714019|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
124481282|NCT01307423|447714020|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
124481283|NCT01307423|447714021|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
124481284|NCT01307423|447714022|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
124481285|NCT01307423|447714014|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
124481286|NCT01307423|447714015|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
124481287|NCT01307423|447714016|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
124481288|NCT01307423|447714017|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
124481289|NCT01307423|447714018|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
124481290|NCT01307423|447714019|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
124481291|NCT01307423|447714020|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
124481292|NCT01307423|447714021|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
124481293|NCT01307423|447714022|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
124481294|NCT01307423|447714014|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
124481295|NCT01307423|447714015|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
124481296|NCT01307423|447714016|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
124481297|NCT01307423|447714017|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
124481298|NCT01307423|447714018|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
124481299|NCT01307423|447714019|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
124481300|NCT01307423|447714020|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
124481301|NCT01307423|447714021|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
124481302|NCT01307423|447714022|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
124557480|NCT04133519|447999100|FG000|Overall Study|Never started treatment|1|||
124557481|NCT04133519|447999101|FG001|Overall Study|Never started treatment|1|||
124557482|NCT00297479|447999102|FG000|Overall Study|Lost to Follow-up|37|||
124557483|NCT00297479|447999103|FG001|Overall Study|Lost to Follow-up|54|||
124557484|NCT00297479|447999104|FG002|Overall Study|Lost to Follow-up|51|||
124557485|NCT01664494|447999105|FG000|Overall Study|Withdrawal by Subject|27|||
124557486|NCT01664494|447999105|FG000|Overall Study|Death|18|||
124557487|NCT01664494|447999105|FG000|Overall Study|Other|49|||
124557488|NCT01664494|447999105|FG000|Overall Study|Lost to Follow-up|99|||
124557489|NCT03196791|447999106|FG000|Overall Study|Protocol Violation|7|||
124557490|NCT03196791|447999107|FG001|Overall Study|Protocol Violation|3|||
124557491|NCT03196791|447999106|FG000|Overall Study|Withdrawal by Subject|3|||
124557492|NCT03196791|447999107|FG001|Overall Study|Withdrawal by Subject|2|||
124557493|NCT00373685|447999112|FG000|Overall Study|Death|2|||
124557494|NCT00373685|447999113|FG001|Overall Study|Death|1|||
124557495|NCT00373685|447999112|FG000|Overall Study|Adverse Event|278|||
124557496|NCT00373685|447999113|FG001|Overall Study|Adverse Event|253|||
124557497|NCT00373685|447999112|FG000|Overall Study|Insufficient clinical response|169|||
124557498|NCT00373685|447999113|FG001|Overall Study|Insufficient clinical response|119|||
124557499|NCT00373685|447999112|FG000|Overall Study|Did not meet entrance criteria|167|||
124557500|NCT00373685|447999113|FG001|Overall Study|Did not meet entrance criteria|184|||
124481303|NCT01307423|447714014|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
124481304|NCT01307423|447714015|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
124481305|NCT01307423|447714016|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
124481306|NCT01307423|447714017|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
124481307|NCT01307423|447714018|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
124481308|NCT01307423|447714019|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
124481309|NCT01307423|447714020|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
124481310|NCT01307423|447714021|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
124481311|NCT01307423|447714022|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
124481312|NCT01307423|447714014|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
124481313|NCT01307423|447714015|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
124481314|NCT01307423|447714016|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
124481315|NCT01307423|447714017|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
124481316|NCT01307423|447714018|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
124481317|NCT01307423|447714019|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
124481318|NCT01307423|447714020|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
124481319|NCT01307423|447714021|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
124481320|NCT01307423|447714022|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
124481321|NCT01307423|447714014|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
124481322|NCT01307423|447714015|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
124481323|NCT01307423|447714016|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
124481324|NCT01307423|447714017|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
124481325|NCT01307423|447714018|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
124481326|NCT01307423|447714019|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
124481327|NCT01307423|447714020|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
124481328|NCT01307423|447714021|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
124481329|NCT01307423|447714022|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
124481330|NCT01307423|447714014|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
124481331|NCT01307423|447714015|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
124481332|NCT01307423|447714016|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
124481333|NCT01307423|447714017|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
124481334|NCT01307423|447714018|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
124481335|NCT01307423|447714019|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
124481336|NCT01307423|447714020|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
124481337|NCT01307423|447714021|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
124481338|NCT01307423|447714022|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
124481339|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
124481340|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
124481341|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
124481342|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
124481343|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
124481344|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
124481345|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
124481346|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
124481347|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
124481348|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
124481349|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
124481350|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
124481351|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
124481352|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
124481353|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
124481354|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
124481355|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
124481356|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
124481357|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
124720751|NCT03835481|448599388|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
124481358|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
124481359|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
124481360|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
124720752|NCT03835481|448599389|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
124720753|NCT03835481|448599390|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
124720754|NCT03835481|448599391|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
124771931|NCT02594124|448794617|FG007|Overall Study|Commercial drug|11|||
124481361|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
124481362|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
124481363|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
124481364|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
124481365|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
124481366|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124481367|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
124481368|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
124481369|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124481370|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124481371|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124481372|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
124481373|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
124481374|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
124481375|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124481376|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
124481377|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124481378|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124481379|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124481380|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124481381|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
124481382|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
124481383|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
124481384|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
124481385|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
124481386|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
124481387|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
124481388|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
124481389|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
124481390|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
124481391|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
124481392|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
124481393|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
124481394|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
124481395|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
124481396|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
124481397|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
124481398|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
124481399|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
124481400|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
124481401|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
124481402|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
124481403|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
124481404|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
124481405|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
124481406|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
124481407|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
124481408|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
124481409|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
124481410|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
124481411|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124481412|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
124481413|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
124481414|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124481415|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124481416|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124481417|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
124481418|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
124481419|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
124481420|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124481421|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
124481422|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
124481423|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124481424|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124481425|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124481426|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
124481427|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
124481428|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
124481429|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
124481430|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
124481431|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
124481432|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
124557501|NCT00373685|447999112|FG000|Overall Study|Lost to follow up|83|||
124481433|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
124481434|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
124481435|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
124481436|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
124481437|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
124481438|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124481439|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
124481440|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124481441|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124481442|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124481443|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124481444|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124481445|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124481446|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
124481447|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124481448|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
124481449|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124481450|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124481451|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124481452|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124481453|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124481454|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
124481455|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
124481456|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124481457|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
124481458|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
124481459|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124481460|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124481461|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124481462|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
124481463|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
124481464|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
124481465|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124481466|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124481467|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
124481468|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124481469|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124481470|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124481471|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124481472|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124481473|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
124481474|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124481475|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124481476|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124481477|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124481478|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124481479|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124481480|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124481481|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
124481482|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
124481483|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124481484|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
124481485|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
124481486|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124481487|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124481488|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124481489|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124481490|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
124481491|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
124481492|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124481493|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
124481494|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
124481495|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124481496|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124557502|NCT00373685|447999113|FG001|Overall Study|Lost to follow up|103|||
124557503|NCT00373685|447999112|FG000|Overall Study|No longer willing to participate|337|||
124557504|NCT00373685|447999113|FG001|Overall Study|No longer willing to participate|352|||
124557505|NCT00373685|447999112|FG000|Overall Study|Other|149|||
124557506|NCT00373685|447999113|FG001|Overall Study|Other|146|||
124557507|NCT00373685|447999112|FG000|Overall Study|Protocol Violation|191|||
124481497|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124481498|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124481499|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124481500|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
124481501|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124481502|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
124481503|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
124481504|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124481505|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124481506|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124481507|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124481508|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
124481509|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
124481510|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
124481511|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
124481512|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
124481513|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
124481514|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
124481515|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
124481516|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
124481517|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
124481518|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
124481519|NCT01307423|447714014|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124481520|NCT01307423|447714015|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124481521|NCT01307423|447714016|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
124481522|NCT01307423|447714017|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124481523|NCT01307423|447714018|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124481524|NCT01307423|447714019|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124481525|NCT01307423|447714020|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
124481526|NCT01307423|447714021|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
124481527|NCT01307423|447714022|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
124481528|NCT03075839|447714023|FG000|Overall Study|Lost to Follow-up|4|||
124481529|NCT01499290|447714024|FG000|Overall Study|Withdrawal by Subject|22|||
124481530|NCT01499290|447714025|FG001|Overall Study|Withdrawal by Subject|15|||
124481531|NCT01499290|447714024|FG000|Overall Study|Not specified in study report|11|||
124481532|NCT01499290|447714025|FG001|Overall Study|Not specified in study report|5|||
124481533|NCT01499290|447714024|FG000|Overall Study|Condition improved/subject recovered|1|||
124481534|NCT01499290|447714025|FG001|Overall Study|Condition improved/subject recovered|0|||
124481535|NCT01499290|447714024|FG000|Overall Study|Lack of Efficacy|7|||
124481536|NCT01499290|447714025|FG001|Overall Study|Lack of Efficacy|8|||
124481537|NCT01499290|447714024|FG000|Overall Study|Adverse Event|14|||
124481538|NCT01499290|447714025|FG001|Overall Study|Adverse Event|7|||
124481539|NCT04052139|447714026|FG000|Overall Study|Lost to Follow-up|2|||
124481540|NCT04052139|447714027|FG001|Overall Study|Lost to Follow-up|0|||
124481541|NCT04052139|447714028|FG002|Overall Study|Lost to Follow-up|0|||
124481542|NCT04052139|447714026|FG000|Overall Study|Withdrawal by Subject|1|||
124481543|NCT04052139|447714027|FG001|Overall Study|Withdrawal by Subject|0|||
124481544|NCT04052139|447714028|FG002|Overall Study|Withdrawal by Subject|0|||
124481545|NCT03896295|447714029|FG000|Overall Study|Adverse Event|0|||
124481546|NCT03896295|447714030|FG001|Overall Study|Adverse Event|1|||
124481547|NCT03896295|447714029|FG000|Overall Study|COVID-19|7|||
124481548|NCT03896295|447714030|FG001|Overall Study|COVID-19|29|||
124481549|NCT00700804|447714031|FG000|Overall Study|Withdrawal by Subject|1|||
124481550|NCT00700804|447714032|FG001|Overall Study|Withdrawal by Subject|2|||
124481551|NCT00700804|447714031|FG000|Overall Study|Protocol Violation|1|||
124481552|NCT00700804|447714032|FG001|Overall Study|Protocol Violation|1|||
124481553|NCT00700804|447714031|FG000|Overall Study|Loose Stools|1|||
124481554|NCT00700804|447714032|FG001|Overall Study|Loose Stools|1|||
124481555|NCT01511445|447714033|FG000|Overall Study|Lost to Follow-up|3|||
124481556|NCT01511445|447714034|FG001|Overall Study|Lost to Follow-up|1|||
124481557|NCT01511445|447714033|FG000|Overall Study|Protocol Violation|1|||
124481558|NCT01511445|447714034|FG001|Overall Study|Protocol Violation|3|||
124481559|NCT01511445|447714033|FG000|Overall Study|Protocol Violation|1|||
124481560|NCT01511445|447714034|FG001|Overall Study|Protocol Violation|0|||
124481561|NCT00998738|447714037|FG000|Overall Study|Uknown|1|||
124481562|NCT03946449|447714038|FG000|Treatment Extension II|Rolled over to another study|0|||
124481563|NCT03946449|447714039|FG001|Treatment Extension II|Rolled over to another study|0|||
124481564|NCT03946449|447714040|FG002|Treatment Extension II|Rolled over to another study|2|||
124481565|NCT03946449|447714038|FG000|Treatment Extension II|Withdrawal by Subject|0|||
124481566|NCT03946449|447714039|FG001|Treatment Extension II|Withdrawal by Subject|0|||
124481567|NCT03946449|447714040|FG002|Treatment Extension II|Withdrawal by Subject|1|||
124481568|NCT04375761|447716360|FG000|Overall Study|Death|1|||
124481569|NCT04375761|447716361|FG001|Overall Study|Death|2|||
124481570|NCT04375761|447716360|FG000|Overall Study|Lost to Follow-up|203|||
124481571|NCT04375761|447716361|FG001|Overall Study|Lost to Follow-up|380|||
124481572|NCT04375761|447716360|FG000|Overall Study|Withdrawal by Subject|47|||
124481573|NCT04375761|447716361|FG001|Overall Study|Withdrawal by Subject|98|||
124481574|NCT04375761|447716360|FG000|Overall Study|Noncompliance with study procedure|121|||
124481575|NCT04375761|447716361|FG001|Overall Study|Noncompliance with study procedure|251|||
124481576|NCT04375761|447716360|FG000|Overall Study|Reimbursement not enough|1|||
124481577|NCT04375761|447716361|FG001|Overall Study|Reimbursement not enough|2|||
124481578|NCT04375761|447716360|FG000|Overall Study|Unforeseen family circumstances|1|||
124481579|NCT04375761|447716361|FG001|Overall Study|Unforeseen family circumstances|3|||
124481580|NCT04375761|447716360|FG000|Overall Study|Test too painful|1|||
124481581|NCT04375761|447716361|FG001|Overall Study|Test too painful|1|||
124481582|NCT04375761|447716360|FG000|Overall Study|Moved|0|||
124481583|NCT04375761|447716361|FG001|Overall Study|Moved|2|||
124481584|NCT04375761|447716360|FG000|Overall Study|Nonresponsive|0|||
124481585|NCT04375761|447716361|FG001|Overall Study|Nonresponsive|5|||
124481586|NCT05630846|447716362|FG000|Overall Study|Death|1|||
124481587|NCT05630846|447716363|FG001|Overall Study|Death|0|||
124481588|NCT05630846|447716364|FG002|Overall Study|Death|0|||
124481589|NCT05630846|447716365|FG003|Overall Study|Death|0|||
124481590|NCT05630846|447716362|FG000|Overall Study|Withdrawal by Subject|3|||
124481591|NCT05630846|447716363|FG001|Overall Study|Withdrawal by Subject|3|||
124481592|NCT05630846|447716364|FG002|Overall Study|Withdrawal by Subject|4|||
124481593|NCT05630846|447716365|FG003|Overall Study|Withdrawal by Subject|1|||
124481594|NCT05630846|447716362|FG000|Overall Study|Lost to Follow-up|6|||
124481595|NCT05630846|447716363|FG001|Overall Study|Lost to Follow-up|5|||
124481596|NCT05630846|447716364|FG002|Overall Study|Lost to Follow-up|2|||
124481597|NCT05630846|447716365|FG003|Overall Study|Lost to Follow-up|5|||
124481598|NCT05630846|447716362|FG000|Overall Study|Other|1|||
124481599|NCT05630846|447716363|FG001|Overall Study|Other|0|||
124481600|NCT05630846|447716364|FG002|Overall Study|Other|0|||
124481601|NCT05630846|447716365|FG003|Overall Study|Other|0|||
124481602|NCT00500266|447716376|FG000|Overall Study|Death|3|||
124481603|NCT00500266|447716376|FG000|Overall Study|Lost to Follow-up|3|||
124481604|NCT00500266|447716376|FG000|Overall Study|Withdrawal by Subject|3|||
124481605|NCT00500266|447716376|FG000|Overall Study|Assigned, not treated|4|||
124481606|NCT01431287|447716377|FG000|Overall Study|not treated|0|||
124481607|NCT01431287|447716378|FG001|Overall Study|not treated|0|||
124481608|NCT01431287|447716379|FG002|Overall Study|not treated|1|||
124481609|NCT01431287|447716380|FG003|Overall Study|not treated|0|||
124481610|NCT01431287|447716381|FG004|Overall Study|not treated|0|||
124481611|NCT01431287|447716377|FG000|Overall Study|Adverse Event|59|||
124481612|NCT01431287|447716378|FG001|Overall Study|Adverse Event|57|||
124481613|NCT01431287|447716379|FG002|Overall Study|Adverse Event|53|||
124481614|NCT01431287|447716380|FG003|Overall Study|Adverse Event|33|||
124481615|NCT01431287|447716381|FG004|Overall Study|Adverse Event|41|||
124481616|NCT01431287|447716377|FG000|Overall Study|Non compliant with protocol|6|||
124481617|NCT01431287|447716378|FG001|Overall Study|Non compliant with protocol|6|||
124481618|NCT01431287|447716379|FG002|Overall Study|Non compliant with protocol|5|||
124481619|NCT01431287|447716380|FG003|Overall Study|Non compliant with protocol|6|||
124481620|NCT01431287|447716381|FG004|Overall Study|Non compliant with protocol|5|||
124481621|NCT01431287|447716377|FG000|Overall Study|Lost to Follow-up|0|||
124481622|NCT01431287|447716378|FG001|Overall Study|Lost to Follow-up|3|||
124481623|NCT01431287|447716379|FG002|Overall Study|Lost to Follow-up|2|||
124481624|NCT01431287|447716380|FG003|Overall Study|Lost to Follow-up|3|||
124481625|NCT01431287|447716381|FG004|Overall Study|Lost to Follow-up|1|||
124481626|NCT01431287|447716377|FG000|Overall Study|Consent withdrawn not due to AE|29|||
124481627|NCT01431287|447716378|FG001|Overall Study|Consent withdrawn not due to AE|30|||
124481628|NCT01431287|447716379|FG002|Overall Study|Consent withdrawn not due to AE|34|||
124481629|NCT01431287|447716380|FG003|Overall Study|Consent withdrawn not due to AE|19|||
124481630|NCT01431287|447716381|FG004|Overall Study|Consent withdrawn not due to AE|29|||
124481631|NCT01431287|447716377|FG000|Overall Study|not stated above|4|||
124481632|NCT01431287|447716378|FG001|Overall Study|not stated above|2|||
124481633|NCT01431287|447716379|FG002|Overall Study|not stated above|2|||
124481634|NCT01431287|447716380|FG003|Overall Study|not stated above|2|||
124481635|NCT01431287|447716381|FG004|Overall Study|not stated above|1|||
124481636|NCT00075881|447716383|FG000|Overall Study|Lack of Efficacy|18|||
124481637|NCT00075881|447716383|FG000|Overall Study|Adverse Event|7|||
124481638|NCT00075881|447716383|FG000|Overall Study|Death|1|||
124481639|NCT00075881|447716383|FG000|Overall Study|Withdrawal by Subject|2|||
124481640|NCT00075881|447716383|FG000|Overall Study|Protocol Violation|4|||
124481641|NCT00075881|447716383|FG000|Overall Study|other complicating disease|3|||
124481642|NCT00075881|447716383|FG000|Overall Study|other|4|||
124481643|NCT00075881|447716383|FG000|Overall Study|missing data|2|||
124481644|NCT00075881|447716383|FG000|Overall Study|Ineligible|1|||
124481645|NCT00075881|447716383|FG000|Overall Study|never start protocol therapy|1|||
124481646|NCT02109029|447716384|FG000|Part B|Adverse Event|0|||
124481647|NCT02109029|447716385|FG001|Part B|Adverse Event|0|||
124481648|NCT02109029|447716386|FG002|Part B|Adverse Event|0|||
124481649|NCT02109029|447716387|FG003|Part B|Adverse Event|0|||
124720755|NCT03835481|448599387|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
124720756|NCT03835481|448599388|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
124720757|NCT03835481|448599389|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
124720758|NCT03835481|448599390|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
124752796|NCT04427072|448716839|FG000|Randomized Treatment Phase|Adverse Event|3|||
124481650|NCT02109029|447716388|FG004|Part B|Adverse Event|1|||
124481651|NCT02109029|447716389|FG005|Part B|Adverse Event|1|||
124481652|NCT00110305|447716390|FG000|Overall Study|Adverse Event|46|||
124481653|NCT00110305|447716391|FG001|Overall Study|Adverse Event|13|||
124481654|NCT00110305|447716390|FG000|Overall Study|Sponsors Decision|1|||
124481655|NCT00110305|447716391|FG001|Overall Study|Sponsors Decision|0|||
124481656|NCT00110305|447716390|FG000|Overall Study|Subject Non-Compliant|9|||
124481657|NCT00110305|447716391|FG001|Overall Study|Subject Non-Compliant|2|||
124481658|NCT00110305|447716390|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
124481659|NCT00110305|447716391|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
124481660|NCT00110305|447716390|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
124481661|NCT00110305|447716391|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
124481662|NCT00110305|447716390|FG000|Overall Study|Protocol Violation|0|||
124481663|NCT00110305|447716391|FG001|Overall Study|Protocol Violation|1|||
124481664|NCT00110305|447716390|FG000|Overall Study|Withdrawal by Subject|7|||
124481665|NCT00110305|447716391|FG001|Overall Study|Withdrawal by Subject|7|||
124481666|NCT00110305|447716390|FG000|Overall Study|Lost to Follow-up|20|||
124481667|NCT00110305|447716391|FG001|Overall Study|Lost to Follow-up|3|||
124481668|NCT00110305|447716390|FG000|Overall Study|Other|8|||
124481669|NCT00110305|447716391|FG001|Overall Study|Other|2|||
124481670|NCT00215150|447716397|FG000|Open Label Phase|Lost to Follow-up|7|||
124481671|NCT00215150|447716397|FG000|Open Label Phase|Withdrawal by Subject|1|||
124481672|NCT00215150|447716397|FG000|Open Label Phase|Did not complete a post base visit|13|||
124481673|NCT00215150|447716397|FG000|Open Label Phase|Did not meet randomization criteria|9|||
124481674|NCT00215150|447716397|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
124481675|NCT00215150|447716397|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
124481676|NCT00215150|447716397|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
124481677|NCT02251743|447716398|FG000|Overall Study|Withdrawal by Subject|1|||
124481678|NCT02251743|447716399|FG001|Overall Study|Withdrawal by Subject|1|||
124481679|NCT00206726|447716405|FG000|Overall Study|Delayed recovery of blood counts|1|||
124481680|NCT00206726|447716405|FG000|Overall Study|Progressive disease or relapsed disease|18|||
124481681|NCT00206726|447716405|FG000|Overall Study|Placed on new protocol|1|||
124481682|NCT00206726|447716405|FG000|Overall Study|Bone marrow transplant|1|||
124481683|NCT00206726|447716405|FG000|Overall Study|Adverse Event|17|||
124481684|NCT00206726|447716405|FG000|Overall Study|Death|4|||
124481685|NCT00206726|447716405|FG000|Overall Study|Protocol Violation|1|||
124481686|NCT00206726|447716405|FG000|Overall Study|Withdrawal by Subject|8|||
124481687|NCT01028352|447716406|FG000|Overall Study|Ineligible due to baseline average pain|5|||
124481688|NCT01028352|447716406|FG000|Overall Study|Withdrawal by Subject|1|||
124481689|NCT02091440|447716408|FG000|Overall Study|Death|2|||
124481690|NCT00768222|447716409|FG000|Overall Study|Lost to Follow-up|1|||
124481691|NCT00768222|447716410|FG001|Overall Study|Lost to Follow-up|1|||
124481692|NCT00768222|447716409|FG000|Overall Study|Withdrawal by Subject|3|||
124481693|NCT00768222|447716410|FG001|Overall Study|Withdrawal by Subject|1|||
124481694|NCT00768222|447716409|FG000|Overall Study|Protocol Violation|0|||
124481695|NCT00768222|447716410|FG001|Overall Study|Protocol Violation|2|||
124481696|NCT01887912|447716411|FG000|Overall Study|Serious adverse event|400|||
124481697|NCT01887912|447716412|FG001|Overall Study|Serious adverse event|198|||
124481698|NCT01887912|447716411|FG000|Overall Study|Other Adverse Event|34|||
124481699|NCT01887912|447716412|FG001|Overall Study|Other Adverse Event|15|||
124481700|NCT01887912|447716411|FG000|Overall Study|Protocol Violation|67|||
124481701|NCT01887912|447716412|FG001|Overall Study|Protocol Violation|37|||
124481702|NCT01887912|447716411|FG000|Overall Study|Lost to Follow-up|163|||
124481703|NCT01887912|447716412|FG001|Overall Study|Lost to Follow-up|74|||
124481704|NCT01887912|447716411|FG000|Overall Study|Withdrawal by Subject|606|||
124481705|NCT01887912|447716412|FG001|Overall Study|Withdrawal by Subject|349|||
124481706|NCT01887912|447716411|FG000|Overall Study|Other|122|||
124481707|NCT01887912|447716412|FG001|Overall Study|Other|58|||
124481708|NCT05067127|447716415|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
124481709|NCT05067127|447716416|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
124481710|NCT05067127|447716417|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
124481711|NCT05067127|447716418|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
124481712|NCT05067127|447716415|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
124481713|NCT05067127|447716416|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
124481714|NCT05067127|447716417|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
124481715|NCT05067127|447716418|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
124481716|NCT05067127|447716415|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
124557508|NCT00373685|447999113|FG001|Overall Study|Protocol Violation|182|||
124481717|NCT05067127|447716416|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
124481718|NCT05067127|447716417|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
124481719|NCT05067127|447716418|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
124481720|NCT05067127|447716415|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
124481721|NCT05067127|447716416|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
124481722|NCT05067127|447716417|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
124481723|NCT05067127|447716418|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
124481724|NCT05067127|447716415|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
124481725|NCT05067127|447716416|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
124481726|NCT05067127|447716417|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
124481727|NCT05067127|447716418|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
124481728|NCT05067127|447716415|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
124481729|NCT05067127|447716416|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
124481730|NCT05067127|447716417|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
124481731|NCT05067127|447716418|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
124481732|NCT05067127|447716415|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
124481733|NCT05067127|447716416|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
124481734|NCT05067127|447716417|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
124481735|NCT05067127|447716418|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
124481736|NCT04462536|447716419|FG000|Overall Study|Withdrawal by Subject|3|||
124481737|NCT04462536|447716420|FG001|Overall Study|Withdrawal by Subject|9|||
124481738|NCT04462536|447716419|FG000|Overall Study|Lost to Follow-up|2|||
124481739|NCT04462536|447716420|FG001|Overall Study|Lost to Follow-up|4|||
124481740|NCT01154101|447716426|FG000|Overall Study|Adverse Event|0|||
124481741|NCT01154101|447716427|FG001|Overall Study|Adverse Event|2|||
124481742|NCT01154101|447716428|FG002|Overall Study|Adverse Event|1|||
124481743|NCT01154101|447716429|FG003|Overall Study|Adverse Event|1|||
124481744|NCT01154101|447716430|FG004|Overall Study|Adverse Event|0|||
124481745|NCT01154101|447716426|FG000|Overall Study|Lost to Follow-up|0|||
124481746|NCT01154101|447716427|FG001|Overall Study|Lost to Follow-up|1|||
124481747|NCT01154101|447716428|FG002|Overall Study|Lost to Follow-up|0|||
124481748|NCT01154101|447716429|FG003|Overall Study|Lost to Follow-up|1|||
124481749|NCT01154101|447716430|FG004|Overall Study|Lost to Follow-up|0|||
124481750|NCT01154101|447716426|FG000|Overall Study|Withdrawal by Subject|0|||
124481751|NCT01154101|447716427|FG001|Overall Study|Withdrawal by Subject|1|||
124481752|NCT01154101|447716428|FG002|Overall Study|Withdrawal by Subject|2|||
124481753|NCT01154101|447716429|FG003|Overall Study|Withdrawal by Subject|0|||
124481754|NCT01154101|447716430|FG004|Overall Study|Withdrawal by Subject|1|||
124720759|NCT03835481|448599391|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
124720760|NCT03835481|448599387|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
124720761|NCT03835481|448599388|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
124720762|NCT03835481|448599389|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
124720763|NCT03835481|448599390|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
124720764|NCT03835481|448599391|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
124720765|NCT00191945|448599393|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
124720766|NCT00191945|448599394|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
124720767|NCT00191945|448599393|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
124720768|NCT00191945|448599394|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
124481765|NCT01725165|447716440|FG000|Overall Study|Death|11|||
124481766|NCT01725165|447716441|FG001|Overall Study|Death|18|||
124481767|NCT03619213|447716444|FG000|Overall Study|Lost to Follow-up|2|||
124481768|NCT03619213|447716445|FG001|Overall Study|Lost to Follow-up|1|||
124481769|NCT03619213|447716444|FG000|Overall Study|Withdrawal by Subject|8|||
124481770|NCT03619213|447716445|FG001|Overall Study|Withdrawal by Subject|10|||
124481771|NCT02542267|447716446|FG000|Overall Study|Withdrawal by Subject|10|||
124481772|NCT02542267|447716446|FG000|Overall Study|Physician Decision|6|||
124720769|NCT00191945|448599393|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
124720770|NCT00191945|448599394|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
124720771|NCT00191945|448599393|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
124481773|NCT02542267|447716446|FG000|Overall Study|Lost to Follow-up|4|||
124481774|NCT02542267|447716446|FG000|Overall Study|Death|13|||
124481775|NCT02542267|447716446|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
124481776|NCT02542267|447716446|FG000|Overall Study|Other|9|||
124481777|NCT01974323|447716449|FG000|Overall Study|Other Reasons|25|||
124481778|NCT01974323|447716450|FG001|Overall Study|Other Reasons|28|||
124481779|NCT01974323|447716449|FG000|Overall Study|Protocol Violation|2|||
124481780|NCT01974323|447716450|FG001|Overall Study|Protocol Violation|2|||
124481781|NCT01974323|447716449|FG000|Overall Study|Personal Reasons|15|||
124481782|NCT01974323|447716450|FG001|Overall Study|Personal Reasons|19|||
124481783|NCT01974323|447716449|FG000|Overall Study|Lost to Follow-up|45|||
124481784|NCT01974323|447716450|FG001|Overall Study|Lost to Follow-up|40|||
124481785|NCT01974323|447716449|FG000|Overall Study|Pregnancy|2|||
124481786|NCT01974323|447716450|FG001|Overall Study|Pregnancy|1|||
124481787|NCT01974323|447716449|FG000|Overall Study|Lack of Efficacy|1|||
124481788|NCT01974323|447716450|FG001|Overall Study|Lack of Efficacy|1|||
124481789|NCT01974323|447716449|FG000|Overall Study|Adverse Event|2|||
124481790|NCT01974323|447716450|FG001|Overall Study|Adverse Event|2|||
124481791|NCT01075178|447716451|FG000|Subject Matching|eligible but not matched|130|||
124481792|NCT01075178|447716452|FG001|Subject Matching|eligible but not matched|403|||
124481793|NCT01075178|447716451|FG000|Subject Chart Review|died before chart review period|0|||
124481794|NCT01075178|447716452|FG001|Subject Chart Review|died before chart review period|2|||
124481795|NCT01075178|447716451|FG000|Subject Chart Review|no data collected due to site closure|3|||
124481796|NCT01075178|447716452|FG001|Subject Chart Review|no data collected due to site closure|4|||
124481797|NCT01075178|447716451|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
124481798|NCT01075178|447716452|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
124481799|NCT02983604|447716453|FG000|Overall Study|Enrolled but not Treated|0|||
124481800|NCT02983604|447716454|FG001|Overall Study|Enrolled but not Treated|0|||
124481801|NCT02983604|447716455|FG002|Overall Study|Enrolled but not Treated|1|||
124481802|NCT02983604|447716456|FG003|Overall Study|Enrolled but not Treated|0|||
124481803|NCT01111604|447716457|FG000|Overall Study|Lost to Follow-up|0|||
124481804|NCT01111604|447716458|FG001|Overall Study|Lost to Follow-up|0|||
124481805|NCT01111604|447716459|FG002|Overall Study|Lost to Follow-up|1|||
124481806|NCT01111604|447716457|FG000|Overall Study|Withdrew Consent|3|||
124481807|NCT01111604|447716458|FG001|Overall Study|Withdrew Consent|0|||
124481808|NCT01111604|447716459|FG002|Overall Study|Withdrew Consent|2|||
124481809|NCT01111604|447716457|FG000|Overall Study|Withdrawal by Subject|2|||
124481810|NCT01111604|447716458|FG001|Overall Study|Withdrawal by Subject|0|||
124481811|NCT01111604|447716459|FG002|Overall Study|Withdrawal by Subject|0|||
124481812|NCT01111604|447716457|FG000|Overall Study|Death|1|||
124481813|NCT01111604|447716458|FG001|Overall Study|Death|0|||
124481814|NCT01111604|447716459|FG002|Overall Study|Death|0|||
124481815|NCT01111604|447716457|FG000|Overall Study|Met Exclusion Criteria|2|||
124481816|NCT01111604|447716458|FG001|Overall Study|Met Exclusion Criteria|0|||
124481817|NCT01111604|447716459|FG002|Overall Study|Met Exclusion Criteria|0|||
124481818|NCT00316264|447716461|FG000|Overall Study|Lost to Follow-up|0|||
124481819|NCT00316264|447716462|FG001|Overall Study|Lost to Follow-up|1|||
124481820|NCT00316264|447716463|FG002|Overall Study|Lost to Follow-up|0|||
124481821|NCT00316264|447716461|FG000|Overall Study|Withdrawal of Consent|3|||
124481822|NCT00316264|447716462|FG001|Overall Study|Withdrawal of Consent|5|||
124481823|NCT00316264|447716463|FG002|Overall Study|Withdrawal of Consent|6|||
124481824|NCT00316264|447716461|FG000|Overall Study|Death|2|||
124481825|NCT00316264|447716462|FG001|Overall Study|Death|0|||
124481826|NCT00316264|447716463|FG002|Overall Study|Death|0|||
124481827|NCT00316264|447716461|FG000|Overall Study|Other|1|||
124481828|NCT00316264|447716462|FG001|Overall Study|Other|1|||
124481829|NCT00316264|447716463|FG002|Overall Study|Other|0|||
124481830|NCT00607048|447716464|FG000|Overall Study|Adverse Event|0|||
124481831|NCT00607048|447716465|FG001|Overall Study|Adverse Event|1|||
124481832|NCT00607048|447716466|FG002|Overall Study|Adverse Event|0|||
124481833|NCT00607048|447716467|FG003|Overall Study|Adverse Event|0|||
124481834|NCT00607048|447716468|FG004|Overall Study|Adverse Event|4|||
124481835|NCT00607048|447716469|FG005|Overall Study|Adverse Event|0|||
124481836|NCT00607048|447716464|FG000|Overall Study|Global deterioration of health|1|||
124481837|NCT00607048|447716465|FG001|Overall Study|Global deterioration of health|0|||
124481838|NCT00607048|447716466|FG002|Overall Study|Global deterioration of health|0|||
124481839|NCT00607048|447716467|FG003|Overall Study|Global deterioration of health|0|||
124481840|NCT00607048|447716468|FG004|Overall Study|Global deterioration of health|0|||
124481841|NCT00607048|447716469|FG005|Overall Study|Global deterioration of health|0|||
124481842|NCT00607048|447716464|FG000|Overall Study|Objective disease progression - relapse|1|||
124481843|NCT00607048|447716465|FG001|Overall Study|Objective disease progression - relapse|2|||
124481844|NCT00607048|447716466|FG002|Overall Study|Objective disease progression - relapse|4|||
124481845|NCT00607048|447716467|FG003|Overall Study|Objective disease progression - relapse|2|||
124481846|NCT00607048|447716468|FG004|Overall Study|Objective disease progression - relapse|2|||
124481847|NCT00607048|447716469|FG005|Overall Study|Objective disease progression - relapse|2|||
124481848|NCT00607048|447716464|FG000|Overall Study|Withdrawal by Subject|0|||
124481849|NCT00607048|447716465|FG001|Overall Study|Withdrawal by Subject|0|||
124481850|NCT00607048|447716466|FG002|Overall Study|Withdrawal by Subject|0|||
124481851|NCT00607048|447716467|FG003|Overall Study|Withdrawal by Subject|1|||
124481852|NCT00607048|447716468|FG004|Overall Study|Withdrawal by Subject|0|||
124481853|NCT00607048|447716469|FG005|Overall Study|Withdrawal by Subject|2|||
124481854|NCT00607048|447716464|FG000|Overall Study|Other|1|||
124481855|NCT00607048|447716465|FG001|Overall Study|Other|1|||
124481856|NCT00607048|447716466|FG002|Overall Study|Other|0|||
124481857|NCT00607048|447716467|FG003|Overall Study|Other|0|||
124481858|NCT00607048|447716468|FG004|Overall Study|Other|0|||
124481859|NCT00607048|447716469|FG005|Overall Study|Other|1|||
124481860|NCT00355264|447716470|FG000|Extension (Variable Duration)|Adverse Event|1|||
124481861|NCT00355264|447716470|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
124481862|NCT00826514|447716471|FG000|Overall Study|Adverse Event|1|||
124481863|NCT00826514|447716472|FG001|Overall Study|Adverse Event|1|||
124481864|NCT00826514|447716471|FG000|Overall Study|Lack of Efficacy|0|||
124481865|NCT00826514|447716472|FG001|Overall Study|Lack of Efficacy|1|||
124481866|NCT00826514|447716471|FG000|Overall Study|Withdrawal by Subject|2|||
124481867|NCT00826514|447716472|FG001|Overall Study|Withdrawal by Subject|3|||
124481868|NCT03926143|447716474|FG000|Overall Study|Physician Decision|3|||
124481869|NCT03926143|447716474|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
124481870|NCT03926143|447716474|FG000|Overall Study|Adverse Event|2|||
124481871|NCT03926143|447716474|FG000|Overall Study|Progressive disease|3|||
124481872|NCT02561156|447716475|FG000|Part 2|Adverse Event|0|||
124481873|NCT02561156|447716476|FG001|Part 2|Adverse Event|0|||
124481874|NCT02561156|447716477|FG002|Part 2|Adverse Event|0|||
124481875|NCT02561156|447716478|FG003|Part 2|Adverse Event|0|||
124481876|NCT02561156|447716479|FG004|Part 2|Adverse Event|0|||
124481877|NCT02561156|447716480|FG005|Part 2|Adverse Event|0|||
124481878|NCT02561156|447716481|FG006|Part 2|Adverse Event|0|||
124481879|NCT02561156|447716482|FG007|Part 2|Adverse Event|0|||
124720772|NCT00191945|448599394|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
124720773|NCT02725476|448599395|FG000|Overall Study|Physician Decision|2|||
124720774|NCT02725476|448599396|FG001|Overall Study|Physician Decision|0|||
124720775|NCT02725476|448599395|FG000|Overall Study|Adverse Event|1|||
124720776|NCT02725476|448599396|FG001|Overall Study|Adverse Event|1|||
124720777|NCT04188834|448599407|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
124720778|NCT01030952|448599408|FG000|Overall Study|Protocol Violation|0|||
124720779|NCT01030952|448599409|FG001|Overall Study|Protocol Violation|1|||
124720780|NCT01030952|448599408|FG000|Overall Study|Informed consent withdrawal|1|||
124720781|NCT01030952|448599409|FG001|Overall Study|Informed consent withdrawal|0|||
124720782|NCT01030952|448599408|FG000|Overall Study|Lost to Follow-up|0|||
124720783|NCT01030952|448599409|FG001|Overall Study|Lost to Follow-up|1|||
124720784|NCT01030952|448599408|FG000|Overall Study|Unexplained|1|||
124720785|NCT01030952|448599409|FG001|Overall Study|Unexplained|1|||
124720786|NCT00391430|448599410|FG000|Overall Study|Withdrawal by Subject|3|||
124720787|NCT00391430|448599411|FG001|Overall Study|Withdrawal by Subject|0|||
124481880|NCT02561156|447716483|FG008|Part 2|Adverse Event|0|||
124481881|NCT02561156|447716484|FG009|Part 2|Adverse Event|0|||
124481882|NCT02561156|447716485|FG010|Part 2|Adverse Event|0|||
124481883|NCT02561156|447716486|FG011|Part 2|Adverse Event|1|||
124481884|NCT02561156|447716487|FG012|Part 2|Adverse Event|0|||
124481885|NCT00098787|447716495|FG000|Overall Study|Never started treatment|3|||
124481886|NCT00098787|447716496|FG001|Overall Study|Never started treatment|2|||
124481887|NCT00098787|447716497|FG002|Overall Study|Never started treatment|1|||
124481888|NCT00098787|447716495|FG000|Overall Study|Ineligible|9|||
124481889|NCT00098787|447716496|FG001|Overall Study|Ineligible|7|||
124481890|NCT00098787|447716497|FG002|Overall Study|Ineligible|3|||
124481891|NCT00098787|447716495|FG000|Overall Study|Disease progression|28|||
124481892|NCT00098787|447716496|FG001|Overall Study|Disease progression|17|||
124481893|NCT00098787|447716497|FG002|Overall Study|Disease progression|23|||
124481894|NCT00098787|447716495|FG000|Overall Study|Adverse Event|8|||
124481895|NCT00098787|447716496|FG001|Overall Study|Adverse Event|17|||
124481896|NCT00098787|447716497|FG002|Overall Study|Adverse Event|8|||
124481897|NCT00098787|447716495|FG000|Overall Study|Death|6|||
124481898|NCT00098787|447716496|FG001|Overall Study|Death|1|||
124481899|NCT00098787|447716497|FG002|Overall Study|Death|0|||
124481900|NCT00098787|447716495|FG000|Overall Study|Withdrawal by Subject|4|||
124481901|NCT00098787|447716496|FG001|Overall Study|Withdrawal by Subject|12|||
124481902|NCT00098787|447716497|FG002|Overall Study|Withdrawal by Subject|6|||
124481903|NCT00098787|447716495|FG000|Overall Study|Alternative therapy|8|||
124481904|NCT00098787|447716496|FG001|Overall Study|Alternative therapy|13|||
124481905|NCT00098787|447716497|FG002|Overall Study|Alternative therapy|13|||
124481906|NCT00098787|447716495|FG000|Overall Study|Other|7|||
124481907|NCT00098787|447716496|FG001|Overall Study|Other|6|||
124720788|NCT00391430|448599412|FG002|Overall Study|Withdrawal by Subject|12|||
124720789|NCT00958347|448599416|FG000|Overall Study|Death|43|||
124720790|NCT00958347|448599416|FG000|Overall Study|Withdrawal by Subject|23|||
124481908|NCT00098787|447716497|FG002|Overall Study|Other|9|||
124481909|NCT02203149|447716500|FG000|Part 1|Adverse Event|0|||
124481910|NCT02203149|447716501|FG001|Part 1|Adverse Event|1|||
124481911|NCT02203149|447716502|FG002|Part 1|Adverse Event|0|||
124481912|NCT02203149|447716503|FG003|Part 1|Adverse Event|0|||
124481913|NCT02203149|447716504|FG004|Part 1|Adverse Event|0|||
124481914|NCT02203149|447716500|FG000|Part 2|Death|0|||
124481915|NCT02203149|447716501|FG001|Part 2|Death|0|||
124481916|NCT02203149|447716502|FG002|Part 2|Death|1|||
124481917|NCT02203149|447716503|FG003|Part 2|Death|1|||
124481918|NCT02203149|447716504|FG004|Part 2|Death|0|||
124481919|NCT02203149|447716500|FG000|Part 2|Withdrawal by Subject|0|||
124481920|NCT02203149|447716501|FG001|Part 2|Withdrawal by Subject|0|||
124481921|NCT02203149|447716502|FG002|Part 2|Withdrawal by Subject|0|||
124481922|NCT02203149|447716503|FG003|Part 2|Withdrawal by Subject|1|||
124481923|NCT02203149|447716504|FG004|Part 2|Withdrawal by Subject|0|||
124481924|NCT02203149|447716500|FG000|Part 2|Adverse Event|0|||
124481925|NCT02203149|447716501|FG001|Part 2|Adverse Event|0|||
124481926|NCT02203149|447716502|FG002|Part 2|Adverse Event|0|||
124481927|NCT02203149|447716503|FG003|Part 2|Adverse Event|1|||
124481928|NCT02203149|447716504|FG004|Part 2|Adverse Event|1|||
124481929|NCT01360996|447716505|FG000|Overall Study|Withdrawal by Subject|4|||
124481930|NCT01360996|447716506|FG001|Overall Study|Withdrawal by Subject|3|||
124481931|NCT01360996|447716507|FG002|Overall Study|Withdrawal by Subject|2|||
124481932|NCT01360996|447716505|FG000|Overall Study|Noncompliant|2|||
124481933|NCT01360996|447716506|FG001|Overall Study|Noncompliant|0|||
124481934|NCT01360996|447716507|FG002|Overall Study|Noncompliant|0|||
124481935|NCT01454076|447716508|FG000|Overall Study|Other|2|||
124481936|NCT01454076|447716509|FG001|Overall Study|Other|0|||
124481937|NCT01454076|447716510|FG002|Overall Study|Other|0|||
124481938|NCT01454076|447716511|FG003|Overall Study|Other|1|||
124481939|NCT01454076|447716512|FG004|Overall Study|Other|2|||
124481940|NCT01454076|447716508|FG000|Overall Study|Withdrawal by Subject|3|||
124481941|NCT01454076|447716509|FG001|Overall Study|Withdrawal by Subject|4|||
124481942|NCT01454076|447716510|FG002|Overall Study|Withdrawal by Subject|2|||
124481943|NCT01454076|447716511|FG003|Overall Study|Withdrawal by Subject|1|||
124481944|NCT01454076|447716512|FG004|Overall Study|Withdrawal by Subject|2|||
124481945|NCT01454076|447716508|FG000|Overall Study|Adverse Event|8|||
124481946|NCT01454076|447716509|FG001|Overall Study|Adverse Event|2|||
124481947|NCT01454076|447716510|FG002|Overall Study|Adverse Event|7|||
124481948|NCT01454076|447716511|FG003|Overall Study|Adverse Event|0|||
124481949|NCT01454076|447716512|FG004|Overall Study|Adverse Event|2|||
124481950|NCT04964258|447716513|FG000|Overall Study|Lost to Follow-up|1|||
124481951|NCT04964258|447716514|FG001|Overall Study|Lost to Follow-up|0|||
124481952|NCT04964258|447716515|FG002|Overall Study|Lost to Follow-up|0|||
124481953|NCT04964258|447716516|FG003|Overall Study|Lost to Follow-up|0|||
124481954|NCT04964258|447716517|FG004|Overall Study|Lost to Follow-up|0|||
124481955|NCT04964258|447716518|FG005|Overall Study|Lost to Follow-up|1|||
124481956|NCT04964258|447716519|FG006|Overall Study|Lost to Follow-up|0|||
124481957|NCT04964258|447716520|FG007|Overall Study|Lost to Follow-up|0|||
124481958|NCT04964258|447716521|FG008|Overall Study|Lost to Follow-up|0|||
124481959|NCT04964258|447716522|FG009|Overall Study|Lost to Follow-up|0|||
124481960|NCT04964258|447716523|FG010|Overall Study|Lost to Follow-up|0|||
124481961|NCT01478958|447716524|FG000|Overall Study|Withdrawal by Subject|1|||
124481962|NCT01478958|447716525|FG001|Overall Study|Withdrawal by Subject|1|||
124481963|NCT01478958|447716526|FG002|Overall Study|Withdrawal by Subject|1|||
124481964|NCT01478958|447716524|FG000|Overall Study|Weight loss|1|||
124481965|NCT01478958|447716525|FG001|Overall Study|Weight loss|0|||
124481966|NCT01478958|447716526|FG002|Overall Study|Weight loss|0|||
124481967|NCT01478958|447716524|FG000|Overall Study|Re-located|0|||
124481968|NCT01478958|447716525|FG001|Overall Study|Re-located|1|||
124481969|NCT01478958|447716526|FG002|Overall Study|Re-located|0|||
124481970|NCT01478958|447716524|FG000|Overall Study|Unable to comply|0|||
124481971|NCT01478958|447716525|FG001|Overall Study|Unable to comply|0|||
124481972|NCT01478958|447716526|FG002|Overall Study|Unable to comply|2|||
124481973|NCT03406962|447716527|FG000|Overall Study|Death|2|||
124481974|NCT03406962|447716527|FG000|Overall Study|Adverse Event|1|||
124481975|NCT00327444|447716528|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
124481976|NCT00327444|447716529|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
124481977|NCT00327444|447716528|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
124481978|NCT00327444|447716529|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
124481979|NCT00327444|447716528|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
124481980|NCT00327444|447716529|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
124481981|NCT00327444|447716528|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
124481982|NCT00327444|447716529|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
124481983|NCT00327444|447716528|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
124481984|NCT00327444|447716529|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
124481985|NCT00327444|447716528|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
124481986|NCT00327444|447716529|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
124481987|NCT00327444|447716528|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
124481988|NCT00327444|447716529|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
124481989|NCT00327444|447716528|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
124481990|NCT00327444|447716529|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
124481991|NCT04439344|447716530|FG000|Overall Study|Never started threapy|3|||
124557509|NCT00373685|447999112|FG000|Overall Study|Final Status Unknown|12|||
124481992|NCT04439344|447716530|FG000|Overall Study|Ineligible|3|||
124481993|NCT04439344|447716530|FG000|Overall Study|Adverse Event|13|||
124481994|NCT04439344|447716530|FG000|Overall Study|Death|2|||
124481995|NCT04439344|447716530|FG000|Overall Study|Disease progression|29|||
124481996|NCT04439344|447716530|FG000|Overall Study|Withdrawal by Subject|2|||
124481997|NCT04439344|447716530|FG000|Overall Study|Alternative therapy|1|||
124481998|NCT00552110|447716531|FG000|Overall Study|Serious or Life-Threatening AE|0|||
124481999|NCT00552110|447716532|FG001|Overall Study|Serious or Life-Threatening AE|0|||
124482000|NCT00552110|447716533|FG002|Overall Study|Serious or Life-Threatening AE|1|||
124482001|NCT00552110|447716534|FG003|Overall Study|Serious or Life-Threatening AE|0|||
124482002|NCT00552110|447716535|FG004|Overall Study|Serious or Life-Threatening AE|0|||
124482003|NCT00552110|447716531|FG000|Overall Study|Lack of Efficacy|1|||
124482004|NCT00552110|447716532|FG001|Overall Study|Lack of Efficacy|0|||
124482005|NCT00552110|447716533|FG002|Overall Study|Lack of Efficacy|0|||
124482006|NCT00552110|447716534|FG003|Overall Study|Lack of Efficacy|1|||
124482007|NCT00552110|447716535|FG004|Overall Study|Lack of Efficacy|4|||
124482008|NCT00552110|447716531|FG000|Overall Study|Withdrawal by Subject|0|||
124482009|NCT00552110|447716532|FG001|Overall Study|Withdrawal by Subject|2|||
124482010|NCT00552110|447716533|FG002|Overall Study|Withdrawal by Subject|0|||
124482011|NCT00552110|447716534|FG003|Overall Study|Withdrawal by Subject|3|||
124720791|NCT00958347|448599416|FG000|Overall Study|Lost to Follow-up|15|||
124720792|NCT00958347|448599416|FG000|Overall Study|revision/removal|10|||
124720793|NCT00958347|448599416|FG000|Overall Study|study termination|135|||
124720794|NCT03497039|448599419|FG000|Overall Study|Withdrawal by Subject|1|||
124720795|NCT03497039|448599420|FG001|Overall Study|Withdrawal by Subject|0|||
124720796|NCT03497039|448599419|FG000|Overall Study|Protocol Violation|0|||
124720797|NCT03497039|448599420|FG001|Overall Study|Protocol Violation|1|||
124720798|NCT00465972|448599423|FG000|Overall Study|Withdrawal by Subject|2|||
124720799|NCT00465972|448599424|FG001|Overall Study|Withdrawal by Subject|1|||
124482012|NCT00552110|447716535|FG004|Overall Study|Withdrawal by Subject|2|||
124482013|NCT00552110|447716531|FG000|Overall Study|Lost to Follow-up|0|||
124482014|NCT00552110|447716532|FG001|Overall Study|Lost to Follow-up|0|||
124482015|NCT00552110|447716533|FG002|Overall Study|Lost to Follow-up|0|||
124482016|NCT00552110|447716534|FG003|Overall Study|Lost to Follow-up|1|||
124482017|NCT00552110|447716535|FG004|Overall Study|Lost to Follow-up|1|||
124482018|NCT00552110|447716531|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
124482019|NCT00552110|447716532|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
124482020|NCT00552110|447716533|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
124482021|NCT00552110|447716534|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
124482022|NCT00552110|447716535|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
124482023|NCT00552110|447716531|FG000|Overall Study|Withdrawn per Sponsor|0|||
124482024|NCT00552110|447716532|FG001|Overall Study|Withdrawn per Sponsor|1|||
124482025|NCT00552110|447716533|FG002|Overall Study|Withdrawn per Sponsor|0|||
124482026|NCT00552110|447716534|FG003|Overall Study|Withdrawn per Sponsor|0|||
124482027|NCT00552110|447716535|FG004|Overall Study|Withdrawn per Sponsor|1|||
124482028|NCT00552110|447716531|FG000|Overall Study|Use of Prohibited Medication|1|||
124482029|NCT00552110|447716532|FG001|Overall Study|Use of Prohibited Medication|1|||
124482030|NCT00552110|447716533|FG002|Overall Study|Use of Prohibited Medication|0|||
124482031|NCT00552110|447716534|FG003|Overall Study|Use of Prohibited Medication|0|||
124482032|NCT00552110|447716535|FG004|Overall Study|Use of Prohibited Medication|0|||
124482033|NCT00552110|447716531|FG000|Overall Study|Delay of Study due to Relabeling|0|||
124720800|NCT03292640|448599425|FG000|Overall Study|Withdrawal by Subject|17|||
124720801|NCT03292640|448599426|FG001|Overall Study|Withdrawal by Subject|16|||
124482034|NCT00552110|447716532|FG001|Overall Study|Delay of Study due to Relabeling|0|||
124482035|NCT00552110|447716533|FG002|Overall Study|Delay of Study due to Relabeling|0|||
124482036|NCT00552110|447716534|FG003|Overall Study|Delay of Study due to Relabeling|1|||
124482037|NCT00552110|447716535|FG004|Overall Study|Delay of Study due to Relabeling|0|||
124482038|NCT00552110|447716531|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
124482039|NCT00552110|447716532|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
124482040|NCT00552110|447716533|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
124482041|NCT00552110|447716534|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
124482042|NCT00552110|447716535|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
124482043|NCT00552110|447716531|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
124482044|NCT00552110|447716532|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
124482045|NCT00552110|447716533|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
124482046|NCT00552110|447716534|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
124482047|NCT00552110|447716535|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
124482048|NCT02305563|447716536|FG000|Treatment Period|Disease progression|0|||
124482049|NCT02305563|447716537|FG001|Treatment Period|Disease progression|0|||
124482050|NCT02305563|447716538|FG002|Treatment Period|Disease progression|15|||
124482051|NCT02305563|447716539|FG003|Treatment Period|Disease progression|6|||
124482052|NCT02305563|447716540|FG004|Treatment Period|Disease progression|6|||
124482053|NCT02305563|447716536|FG000|Treatment Period|Study drug toxicity|0|||
124482054|NCT02305563|447716537|FG001|Treatment Period|Study drug toxicity|0|||
124482055|NCT02305563|447716538|FG002|Treatment Period|Study drug toxicity|0|||
124482056|NCT02305563|447716539|FG003|Treatment Period|Study drug toxicity|1|||
124720802|NCT03292640|448599425|FG000|Overall Study|Adverse Event|20|||
124482057|NCT02305563|447716540|FG004|Treatment Period|Study drug toxicity|2|||
124557510|NCT00373685|447999113|FG001|Overall Study|Final Status Unknown|4|||
124720803|NCT03292640|448599426|FG001|Overall Study|Adverse Event|2|||
124482058|NCT02305563|447716536|FG000|Treatment Period|Death|0|||
124482059|NCT02305563|447716537|FG001|Treatment Period|Death|0|||
124482060|NCT02305563|447716538|FG002|Treatment Period|Death|1|||
124720804|NCT03292640|448599425|FG000|Overall Study|Lost to Follow-up|24|||
124482061|NCT02305563|447716539|FG003|Treatment Period|Death|2|||
124482062|NCT02305563|447716540|FG004|Treatment Period|Death|1|||
124482063|NCT02305563|447716536|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
124482064|NCT02305563|447716537|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
124482065|NCT02305563|447716538|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
124482066|NCT02305563|447716539|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
124482067|NCT02305563|447716540|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
124482068|NCT02305563|447716536|FG000|Treatment Period|Participant request to stop therapy|0|||
124482069|NCT02305563|447716537|FG001|Treatment Period|Participant request to stop therapy|2|||
124482070|NCT02305563|447716538|FG002|Treatment Period|Participant request to stop therapy|0|||
124482071|NCT02305563|447716539|FG003|Treatment Period|Participant request to stop therapy|1|||
124482072|NCT02305563|447716540|FG004|Treatment Period|Participant request to stop therapy|0|||
124482073|NCT02305563|447716536|FG000|Treatment Period|Participant withdrew consent|0|||
124482074|NCT02305563|447716537|FG001|Treatment Period|Participant withdrew consent|0|||
124482075|NCT02305563|447716538|FG002|Treatment Period|Participant withdrew consent|1|||
124482076|NCT02305563|447716539|FG003|Treatment Period|Participant withdrew consent|1|||
124482077|NCT02305563|447716540|FG004|Treatment Period|Participant withdrew consent|1|||
124482078|NCT02305563|447716536|FG000|Treatment Period|Maximum clinical benefit|0|||
124482079|NCT02305563|447716537|FG001|Treatment Period|Maximum clinical benefit|0|||
124482080|NCT02305563|447716538|FG002|Treatment Period|Maximum clinical benefit|0|||
124482081|NCT02305563|447716539|FG003|Treatment Period|Maximum clinical benefit|0|||
124482082|NCT02305563|447716540|FG004|Treatment Period|Maximum clinical benefit|1|||
124482083|NCT02305563|447716536|FG000|Treatment Period|Poor/non-compliance|0|||
124482084|NCT02305563|447716537|FG001|Treatment Period|Poor/non-compliance|0|||
124482085|NCT02305563|447716538|FG002|Treatment Period|Poor/non-compliance|0|||
124482086|NCT02305563|447716539|FG003|Treatment Period|Poor/non-compliance|0|||
124482087|NCT02305563|447716540|FG004|Treatment Period|Poor/non-compliance|1|||
124482088|NCT02305563|447716536|FG000|Treatment Period|Administrative reason by Sponsor|0|||
124482089|NCT02305563|447716537|FG001|Treatment Period|Administrative reason by Sponsor|0|||
124482090|NCT02305563|447716538|FG002|Treatment Period|Administrative reason by Sponsor|0|||
124482091|NCT02305563|447716539|FG003|Treatment Period|Administrative reason by Sponsor|0|||
124482092|NCT02305563|447716540|FG004|Treatment Period|Administrative reason by Sponsor|1|||
124482093|NCT02305563|447716536|FG000|Treatment Period|other reason|2|||
124482094|NCT02305563|447716537|FG001|Treatment Period|other reason|0|||
124482095|NCT02305563|447716538|FG002|Treatment Period|other reason|2|||
124482096|NCT02305563|447716539|FG003|Treatment Period|other reason|2|||
124482097|NCT02305563|447716540|FG004|Treatment Period|other reason|1|||
124482098|NCT02305563|447716536|FG000|Treatment Period|Randomized but not treated|0|||
124482099|NCT02305563|447716537|FG001|Treatment Period|Randomized but not treated|0|||
124482100|NCT02305563|447716538|FG002|Treatment Period|Randomized but not treated|0|||
124482101|NCT02305563|447716539|FG003|Treatment Period|Randomized but not treated|0|||
124482102|NCT02305563|447716540|FG004|Treatment Period|Randomized but not treated|2|||
124482103|NCT02305563|447716536|FG000|Treatment Period|added ULO, then disease progression|0|||
124482104|NCT02305563|447716537|FG001|Treatment Period|added ULO, then disease progression|0|||
124482105|NCT02305563|447716538|FG002|Treatment Period|added ULO, then disease progression|0|||
124482106|NCT02305563|447716539|FG003|Treatment Period|added ULO, then disease progression|0|||
124482107|NCT02305563|447716540|FG004|Treatment Period|added ULO, then disease progression|4|||
124482108|NCT02305563|447716536|FG000|Treatment Period|added ULO; then other reason|0|||
124482109|NCT02305563|447716537|FG001|Treatment Period|added ULO; then other reason|0|||
124482110|NCT02305563|447716538|FG002|Treatment Period|added ULO; then other reason|0|||
124720805|NCT03292640|448599426|FG001|Overall Study|Lost to Follow-up|24|||
124482111|NCT02305563|447716539|FG003|Treatment Period|added ULO; then other reason|0|||
124482112|NCT02305563|447716540|FG004|Treatment Period|added ULO; then other reason|1|||
124482113|NCT02305563|447716536|FG000|Treatment Period|added ULO, then request to stop|0|||
124482114|NCT02305563|447716537|FG001|Treatment Period|added ULO, then request to stop|0|||
124482115|NCT02305563|447716538|FG002|Treatment Period|added ULO, then request to stop|0|||
124482116|NCT02305563|447716539|FG003|Treatment Period|added ULO, then request to stop|0|||
124482117|NCT02305563|447716540|FG004|Treatment Period|added ULO, then request to stop|1|||
124482118|NCT02305563|447716536|FG000|Follow-up Period|Death|0|||
124482119|NCT02305563|447716537|FG001|Follow-up Period|Death|0|||
124482120|NCT02305563|447716538|FG002|Follow-up Period|Death|5|||
124482121|NCT02305563|447716539|FG003|Follow-up Period|Death|4|||
124482122|NCT02305563|447716540|FG004|Follow-up Period|Death|7|||
124482123|NCT02305563|447716536|FG000|Follow-up Period|Participant withdrew consent|0|||
124482124|NCT02305563|447716537|FG001|Follow-up Period|Participant withdrew consent|0|||
124482125|NCT02305563|447716538|FG002|Follow-up Period|Participant withdrew consent|2|||
124482126|NCT02305563|447716539|FG003|Follow-up Period|Participant withdrew consent|1|||
124482127|NCT02305563|447716540|FG004|Follow-up Period|Participant withdrew consent|0|||
124482128|NCT02305563|447716536|FG000|Follow-up Period|other reason|0|||
124482129|NCT02305563|447716537|FG001|Follow-up Period|other reason|0|||
124482130|NCT02305563|447716538|FG002|Follow-up Period|other reason|0|||
124482131|NCT02305563|447716539|FG003|Follow-up Period|other reason|0|||
124720806|NCT02218697|448599427|FG000|Overall Study|Adverse Event|0|||
124482132|NCT02305563|447716540|FG004|Follow-up Period|other reason|1|||
124482133|NCT02305563|447716536|FG000|Follow-up Period|Followup no longer required per protocol|3|||
124482134|NCT02305563|447716537|FG001|Follow-up Period|Followup no longer required per protocol|3|||
124482135|NCT02305563|447716538|FG002|Follow-up Period|Followup no longer required per protocol|4|||
124482136|NCT02305563|447716539|FG003|Follow-up Period|Followup no longer required per protocol|1|||
124482137|NCT02305563|447716540|FG004|Follow-up Period|Followup no longer required per protocol|4|||
124482138|NCT00454207|447716541|FG000|Overall Study|Adverse Event|3|||
124482139|NCT00454207|447716542|FG001|Overall Study|Adverse Event|1|||
124482140|NCT00454207|447716541|FG000|Overall Study|Lack of Efficacy|1|||
124482141|NCT00454207|447716542|FG001|Overall Study|Lack of Efficacy|0|||
124482142|NCT00454207|447716541|FG000|Overall Study|Protocol Violation|0|||
124482143|NCT00454207|447716542|FG001|Overall Study|Protocol Violation|1|||
124482144|NCT02272790|447716545|FG000|Overall Study|Physician Decision|0|||
124482145|NCT02272790|447716546|FG001|Overall Study|Physician Decision|1|||
124482146|NCT02272790|447716547|FG002|Overall Study|Physician Decision|0|||
124482147|NCT02272790|447716548|FG003|Overall Study|Physician Decision|0|||
124482148|NCT02272790|447716549|FG004|Overall Study|Physician Decision|0|||
124482149|NCT02272790|447716550|FG005|Overall Study|Physician Decision|0|||
124482150|NCT00332202|447716551|FG000|Overall Study|Adverse Event|72|||
124482151|NCT00332202|447716552|FG001|Overall Study|Adverse Event|28|||
124482152|NCT00332202|447716551|FG000|Overall Study|Lost to Follow-up|2|||
124482153|NCT00332202|447716552|FG001|Overall Study|Lost to Follow-up|1|||
124482154|NCT00332202|447716551|FG000|Overall Study|Physician Decision|6|||
124482155|NCT00332202|447716552|FG001|Overall Study|Physician Decision|8|||
124482156|NCT00332202|447716551|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
124482157|NCT00332202|447716552|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
124482158|NCT00332202|447716551|FG000|Overall Study|Protocol Violation|7|||
124482159|NCT00332202|447716552|FG001|Overall Study|Protocol Violation|2|||
124482160|NCT00332202|447716551|FG000|Overall Study|Sponsor Decision|1|||
124482161|NCT00332202|447716552|FG001|Overall Study|Sponsor Decision|2|||
124482162|NCT00332202|447716551|FG000|Overall Study|Withdrawal by Subject|36|||
124482163|NCT00332202|447716552|FG001|Overall Study|Withdrawal by Subject|17|||
124482164|NCT00332202|447716551|FG000|Overall Study|Progressive Disease|106|||
124482165|NCT00332202|447716552|FG001|Overall Study|Progressive Disease|60|||
124482166|NCT00332202|447716551|FG000|Overall Study|Death|5|||
124482167|NCT00332202|447716552|FG001|Overall Study|Death|2|||
124482168|NCT00818259|447716556|FG000|Part I|Withdrawal by Subject|1|||
124482169|NCT00818259|447716557|FG001|Part I|Withdrawal by Subject|0|||
124482170|NCT00818259|447716558|FG002|Part I|Withdrawal by Subject|0|||
124482171|NCT00818259|447716559|FG003|Part I|Withdrawal by Subject|0|||
124482172|NCT00818259|447716560|FG004|Part I|Withdrawal by Subject|0|||
124482173|NCT00818259|447716561|FG005|Part I|Withdrawal by Subject|0|||
124482174|NCT00818259|447716562|FG006|Part I|Withdrawal by Subject|0|||
124482175|NCT00818259|447716563|FG007|Part I|Withdrawal by Subject|0|||
124482176|NCT00818259|447716564|FG008|Part I|Withdrawal by Subject|0|||
124482177|NCT00818259|447716556|FG000|Part II|Physician Decision|0|||
124482178|NCT00818259|447716557|FG001|Part II|Physician Decision|0|||
124482179|NCT00818259|447716558|FG002|Part II|Physician Decision|1|||
124482180|NCT00818259|447716559|FG003|Part II|Physician Decision|0|||
124482181|NCT00818259|447716560|FG004|Part II|Physician Decision|0|||
124482182|NCT00818259|447716561|FG005|Part II|Physician Decision|0|||
124482183|NCT00818259|447716562|FG006|Part II|Physician Decision|0|||
124482184|NCT00818259|447716563|FG007|Part II|Physician Decision|0|||
124482185|NCT00818259|447716564|FG008|Part II|Physician Decision|0|||
124482186|NCT00818259|447716556|FG000|Part II|Lack of Efficacy|0|||
124482187|NCT00818259|447716557|FG001|Part II|Lack of Efficacy|0|||
124482188|NCT00818259|447716558|FG002|Part II|Lack of Efficacy|0|||
124482189|NCT00818259|447716559|FG003|Part II|Lack of Efficacy|1|||
124482190|NCT00818259|447716560|FG004|Part II|Lack of Efficacy|0|||
124482191|NCT00818259|447716561|FG005|Part II|Lack of Efficacy|0|||
124482192|NCT00818259|447716562|FG006|Part II|Lack of Efficacy|0|||
124482193|NCT00818259|447716563|FG007|Part II|Lack of Efficacy|0|||
124557511|NCT00373685|447999112|FG000|Overall Study|Randomized, not treated|51|||
124482194|NCT00818259|447716564|FG008|Part II|Lack of Efficacy|0|||
124482195|NCT00818259|447716556|FG000|Part II|Not Treated|0|||
124482196|NCT00818259|447716557|FG001|Part II|Not Treated|0|||
124771932|NCT02594124|448794618|FG008|Overall Study|Commercial drug|2|||
124482197|NCT00818259|447716558|FG002|Part II|Not Treated|0|||
124482198|NCT00818259|447716559|FG003|Part II|Not Treated|1|||
124482199|NCT00818259|447716560|FG004|Part II|Not Treated|0|||
124482200|NCT00818259|447716561|FG005|Part II|Not Treated|0|||
124482201|NCT00818259|447716562|FG006|Part II|Not Treated|0|||
124482202|NCT00818259|447716563|FG007|Part II|Not Treated|0|||
124482203|NCT00818259|447716564|FG008|Part II|Not Treated|0|||
124482204|NCT00818259|447716556|FG000|Part IV|Physician Decision|0|||
124482205|NCT00818259|447716557|FG001|Part IV|Physician Decision|0|||
124482206|NCT00818259|447716558|FG002|Part IV|Physician Decision|0|||
124482207|NCT00818259|447716559|FG003|Part IV|Physician Decision|0|||
124482208|NCT00818259|447716560|FG004|Part IV|Physician Decision|0|||
124482209|NCT00818259|447716561|FG005|Part IV|Physician Decision|1|||
124482210|NCT00818259|447716562|FG006|Part IV|Physician Decision|0|||
124482211|NCT00818259|447716563|FG007|Part IV|Physician Decision|0|||
124482212|NCT00818259|447716564|FG008|Part IV|Physician Decision|0|||
124482213|NCT00818259|447716556|FG000|Part V|Adverse Event|0|||
124482214|NCT00818259|447716557|FG001|Part V|Adverse Event|0|||
124482215|NCT00818259|447716558|FG002|Part V|Adverse Event|0|||
124482216|NCT00818259|447716559|FG003|Part V|Adverse Event|0|||
124482217|NCT00818259|447716560|FG004|Part V|Adverse Event|0|||
124482218|NCT00818259|447716561|FG005|Part V|Adverse Event|0|||
124482219|NCT00818259|447716562|FG006|Part V|Adverse Event|0|||
124482220|NCT00818259|447716563|FG007|Part V|Adverse Event|1|||
124482221|NCT00818259|447716564|FG008|Part V|Adverse Event|0|||
124482222|NCT01926626|447716566|FG000|Overall Study|Withdrawal by Subject|15|||
124482223|NCT01926626|447716566|FG000|Overall Study|Lost to Follow-up|7|||
124482224|NCT01237951|447716569|FG000|Overall Study|Death|1|||
124482225|NCT00924703|447716572|FG000|Overall Study|Withdrawal by Subject|11|||
124482226|NCT00924703|447716572|FG000|Overall Study|Physician Decision|5|||
124482227|NCT00924703|447716572|FG000|Overall Study|Lost to Follow-up|3|||
124482228|NCT00924703|447716572|FG000|Overall Study|Adverse Event|2|||
124482229|NCT00924703|447716572|FG000|Overall Study|Withdrawal by Sponsor|1|||
124482230|NCT00666562|447716573|FG000|Overall Study|Withdrawal by Subject|0|||
124482231|NCT00666562|447716574|FG001|Overall Study|Withdrawal by Subject|1|||
124482232|NCT00666562|447716575|FG002|Overall Study|Withdrawal by Subject|0|||
124482233|NCT00666562|447716573|FG000|Overall Study|Concomitant Medication|0|||
124482234|NCT00666562|447716574|FG001|Overall Study|Concomitant Medication|1|||
124482235|NCT00666562|447716575|FG002|Overall Study|Concomitant Medication|0|||
124482236|NCT04429022|447716578|FG000|Overall Study|Protocol Violation|18|||
124482237|NCT04429022|447716579|FG001|Overall Study|Protocol Violation|1|||
124720807|NCT02218697|448599428|FG001|Overall Study|Adverse Event|2|||
124720808|NCT02218697|448599427|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
124720809|NCT02218697|448599428|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
124720810|NCT02218697|448599427|FG000|Overall Study|Withdrawal by Subject|2|||
124720811|NCT02218697|448599428|FG001|Overall Study|Withdrawal by Subject|3|||
124720812|NCT03306433|448599429|FG000|Overall Study|Lost to Follow-up|3|||
124720813|NCT03306433|448599429|FG000|Overall Study|Patient did not have teeth extracted|1|||
124720814|NCT03306433|448599429|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
124720815|NCT00294671|448601065|FG000|Overall Study|Lack of Efficacy|11|||
124720816|NCT00294671|448601066|FG001|Overall Study|Lack of Efficacy|23|||
124720817|NCT00294671|448601065|FG000|Overall Study|Liver transplant|7|||
124720818|NCT00294671|448601066|FG001|Overall Study|Liver transplant|9|||
124720819|NCT00294671|448601065|FG000|Overall Study|Drug related adverse event (AE)|4|||
124720820|NCT00294671|448601066|FG001|Overall Study|Drug related adverse event (AE)|2|||
124720821|NCT00294671|448601065|FG000|Overall Study|Non-drug related AE|3|||
124720822|NCT00294671|448601066|FG001|Overall Study|Non-drug related AE|2|||
124720823|NCT00294671|448601065|FG000|Overall Study|Lost to Follow-up|1|||
124720824|NCT00294671|448601066|FG001|Overall Study|Lost to Follow-up|3|||
124720825|NCT00294671|448601065|FG000|Overall Study|Non-compliance|1|||
124720826|NCT00294671|448601066|FG001|Overall Study|Non-compliance|0|||
124720827|NCT00294671|448601065|FG000|Overall Study|Death|0|||
124720828|NCT00294671|448601066|FG001|Overall Study|Death|1|||
124720829|NCT01893411|448601070|FG000|Overall Study|Protocol Violation|1|||
124720830|NCT01893411|448601071|FG001|Overall Study|Protocol Violation|0|||
124720831|NCT01893411|448601072|FG002|Overall Study|Protocol Violation|0|||
124720832|NCT01893411|448601070|FG000|Overall Study|Physician Decision|1|||
124720833|NCT01893411|448601071|FG001|Overall Study|Physician Decision|1|||
124720834|NCT01893411|448601072|FG002|Overall Study|Physician Decision|2|||
124482266|NCT03896581|447717912|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
124482267|NCT03896581|447717913|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
124482268|NCT03896581|447717912|FG000|Overall Study|Withdrawal by Subject|4|||
124482269|NCT03896581|447717913|FG001|Overall Study|Withdrawal by Subject|1|||
124482270|NCT03896581|447717912|FG000|Overall Study|Lost to Follow-up|1|||
124482271|NCT03896581|447717913|FG001|Overall Study|Lost to Follow-up|0|||
124482272|NCT03896581|447717912|FG000|Overall Study|Lack of Efficacy|2|||
124482273|NCT03896581|447717913|FG001|Overall Study|Lack of Efficacy|1|||
124482274|NCT03896581|447717912|FG000|Overall Study|Adverse event, non-fatal|0|||
124482275|NCT03896581|447717913|FG001|Overall Study|Adverse event, non-fatal|2|||
124482276|NCT03797001|447717914|FG000|Overall Study|Withdrawn due to COVID19|4|||
124482277|NCT03797001|447717915|FG001|Overall Study|Withdrawn due to COVID19|0|||
124482278|NCT03797001|447717914|FG000|Overall Study|Withdrawal by Subject|7|||
124482279|NCT03797001|447717915|FG001|Overall Study|Withdrawal by Subject|6|||
124482280|NCT03797001|447717914|FG000|Overall Study|Adverse Event|0|||
124482281|NCT03797001|447717915|FG001|Overall Study|Adverse Event|1|||
124557512|NCT00373685|447999113|FG001|Overall Study|Randomized, not treated|77|||
124482282|NCT00960076|447717919|FG000|Overall Study|Adverse Event|1|||
124482283|NCT00960076|447717920|FG001|Overall Study|Adverse Event|7|||
124482284|NCT00960076|447717919|FG000|Overall Study|No longer met study criteria|1|||
124482285|NCT00960076|447717920|FG001|Overall Study|No longer met study criteria|5|||
124482286|NCT00960076|447717919|FG000|Overall Study|Withdrawal by Subject|1|||
124482287|NCT00960076|447717920|FG001|Overall Study|Withdrawal by Subject|2|||
124482288|NCT00960076|447717919|FG000|Overall Study|Lost to Follow-up|3|||
124482289|NCT00960076|447717920|FG001|Overall Study|Lost to Follow-up|3|||
124482290|NCT00960076|447717919|FG000|Overall Study|Severe non-compliance to protocol|1|||
124482291|NCT00960076|447717920|FG001|Overall Study|Severe non-compliance to protocol|2|||
124482292|NCT00960076|447717919|FG000|Overall Study|Hyperglycemia|1|||
124482293|NCT00960076|447717920|FG001|Overall Study|Hyperglycemia|5|||
124482294|NCT00960076|447717919|FG000|Overall Study|Did not attend the termination visit|0|||
124482295|NCT00960076|447717920|FG001|Overall Study|Did not attend the termination visit|1|||
124482296|NCT02224664|447717921|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
124482297|NCT02224664|447717922|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
124482298|NCT02224664|447717923|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
124482299|NCT02224664|447717924|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
124482300|NCT02224664|447717925|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
124482301|NCT02224664|447717921|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
124482302|NCT02224664|447717922|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
124482303|NCT02224664|447717923|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
124482304|NCT02224664|447717924|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
124482305|NCT02224664|447717925|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
124482306|NCT02224664|447717921|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
124482307|NCT02224664|447717922|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
124482308|NCT02224664|447717923|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
124482309|NCT02224664|447717924|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
124482310|NCT02224664|447717925|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
124482311|NCT03019549|447717926|FG000|Washout|DId not meet genotype criteria|11|||
124482312|NCT03019549|447717926|FG000|Period 2|Adverse Event|2|||
124482313|NCT03019549|447717926|FG000|Period 2|Physician Decision|2|||
124482314|NCT03019549|447717926|FG000|Period 2|Withdrawal by Subject|1|||
124482315|NCT00260208|447717929|FG000|Overall Study|Subject withdrew consent|11|||
124482316|NCT00260208|447717930|FG001|Overall Study|Subject withdrew consent|7|||
124482317|NCT00260208|447717929|FG000|Overall Study|Lost to Follow-up|6|||
124482318|NCT00260208|447717930|FG001|Overall Study|Lost to Follow-up|1|||
124482319|NCT00260208|447717929|FG000|Overall Study|Death|12|||
124482320|NCT00260208|447717930|FG001|Overall Study|Death|10|||
124482321|NCT00260208|447717929|FG000|Overall Study|Missing|18|||
124482322|NCT00260208|447717930|FG001|Overall Study|Missing|16|||
124482323|NCT03539432|447717936|FG000|Overall Study|Lost to Follow-up|0|||
124482324|NCT03539432|447717937|FG001|Overall Study|Lost to Follow-up|1|||
124482325|NCT02443402|447717940|FG000|Overall Study|Withdrawal by Subject|3|||
124482326|NCT02443402|447717941|FG001|Overall Study|Withdrawal by Subject|1|||
124482327|NCT02443402|447717940|FG000|Overall Study|Screen Failure|1|||
124482328|NCT02443402|447717941|FG001|Overall Study|Screen Failure|2|||
124482329|NCT00824564|447717949|FG000|Overall Study|Lost to Follow-up|5|||
124482330|NCT00824564|447717950|FG001|Overall Study|Lost to Follow-up|7|||
124482331|NCT00824564|447717949|FG000|Overall Study|Withdrawal by Subject|1|||
124482332|NCT00824564|447717950|FG001|Overall Study|Withdrawal by Subject|1|||
124482333|NCT00824564|447717949|FG000|Overall Study|Other|1|||
124482334|NCT00824564|447717950|FG001|Overall Study|Other|2|||
124482335|NCT00824564|447717949|FG000|Overall Study|Randomized, but not treated|1|||
124482336|NCT00824564|447717950|FG001|Overall Study|Randomized, but not treated|0|||
124482337|NCT01552057|447717959|FG000|Overall Study|Adverse Event|14|||
124482338|NCT01552057|447717960|FG001|Overall Study|Adverse Event|15|||
124482339|NCT01552057|447717959|FG000|Overall Study|Lack of Efficacy|8|||
124482340|NCT01552057|447717960|FG001|Overall Study|Lack of Efficacy|23|||
124482341|NCT01552057|447717959|FG000|Overall Study|Withdrawal by Subject|5|||
124482342|NCT01552057|447717960|FG001|Overall Study|Withdrawal by Subject|8|||
124482343|NCT01552057|447717959|FG000|Overall Study|Entry Criteria Not Met|2|||
124482344|NCT01552057|447717960|FG001|Overall Study|Entry Criteria Not Met|2|||
124482345|NCT01552057|447717959|FG000|Overall Study|Physician Decision|1|||
124482346|NCT01552057|447717960|FG001|Overall Study|Physician Decision|0|||
124482347|NCT01389245|447717961|FG000|Overall Study|Protocol Violation|10|||
124482348|NCT01389245|447717961|FG000|Overall Study|Lost to Follow-up|3|||
124482349|NCT01389245|447717961|FG000|Overall Study|Withdrawal by Subject|2|||
124482350|NCT05127486|447717962|FG000|Overall Study|Adverse Event|2|||
124482351|NCT05127486|447717963|FG001|Overall Study|Adverse Event|4|||
124482352|NCT05127486|447717962|FG000|Overall Study|Lack of Efficacy|1|||
124482353|NCT05127486|447717963|FG001|Overall Study|Lack of Efficacy|0|||
124482354|NCT05127486|447717962|FG000|Overall Study|Pregnancy|0|||
124482355|NCT05127486|447717963|FG001|Overall Study|Pregnancy|1|||
124482356|NCT05127486|447717962|FG000|Overall Study|Physician Decision|4|||
124482357|NCT05127486|447717963|FG001|Overall Study|Physician Decision|1|||
124482358|NCT05127486|447717962|FG000|Overall Study|Withdrawal by Subject|14|||
124482359|NCT05127486|447717963|FG001|Overall Study|Withdrawal by Subject|13|||
124482360|NCT05127486|447717962|FG000|Overall Study|Lost to Follow-up|5|||
124482361|NCT05127486|447717963|FG001|Overall Study|Lost to Follow-up|8|||
124482362|NCT00870688|447717964|FG000|Overall Study|Lost to Follow-up|2|||
124482363|NCT00870688|447717964|FG000|Overall Study|Death, Unrelated|1|||
124482364|NCT00870688|447717964|FG000|Overall Study|Granules in the Stools|1|||
124482365|NCT01287754|447717965|FG000|Overall Study|Death|2|||
124482366|NCT01287754|447717966|FG001|Overall Study|Death|12|||
124482367|NCT01287754|447717965|FG000|Overall Study|Lost to Follow-up|1|||
124482368|NCT01287754|447717966|FG001|Overall Study|Lost to Follow-up|6|||
124482369|NCT01287754|447717965|FG000|Overall Study|Protocol Violation|0|||
124482370|NCT01287754|447717966|FG001|Overall Study|Protocol Violation|3|||
124482371|NCT04971226|447717967|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
124482372|NCT04971226|447717968|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
124482373|NCT04971226|447717969|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
124482374|NCT04971226|447717970|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
124482375|NCT04971226|447717967|FG000|Overall Study|Adverse Event|6|||
124482376|NCT04971226|447717968|FG001|Overall Study|Adverse Event|5|||
124482377|NCT04971226|447717969|FG002|Overall Study|Adverse Event|11|||
124482378|NCT04971226|447717970|FG003|Overall Study|Adverse Event|10|||
124482379|NCT04971226|447717967|FG000|Overall Study|Progressive disease|2|||
124482380|NCT04971226|447717968|FG001|Overall Study|Progressive disease|0|||
124482381|NCT04971226|447717969|FG002|Overall Study|Progressive disease|3|||
124482382|NCT04971226|447717970|FG003|Overall Study|Progressive disease|1|||
124482383|NCT04971226|447717967|FG000|Overall Study|Protocol Deviation|1|||
124482384|NCT04971226|447717968|FG001|Overall Study|Protocol Deviation|0|||
124482385|NCT04971226|447717969|FG002|Overall Study|Protocol Deviation|1|||
124482386|NCT04971226|447717970|FG003|Overall Study|Protocol Deviation|1|||
124482387|NCT04971226|447717967|FG000|Overall Study|Subject Decision|0|||
124482388|NCT04971226|447717968|FG001|Overall Study|Subject Decision|1|||
124482389|NCT04971226|447717969|FG002|Overall Study|Subject Decision|1|||
124482390|NCT04971226|447717970|FG003|Overall Study|Subject Decision|1|||
124482391|NCT04971226|447717967|FG000|Overall Study|Pregnancy|0|||
124482392|NCT04971226|447717968|FG001|Overall Study|Pregnancy|0|||
124482393|NCT04971226|447717969|FG002|Overall Study|Pregnancy|0|||
124482394|NCT04971226|447717970|FG003|Overall Study|Pregnancy|1|||
124482395|NCT04971226|447717967|FG000|Overall Study|Participants not treated|1|||
124482396|NCT04971226|447717968|FG001|Overall Study|Participants not treated|0|||
124482397|NCT04971226|447717969|FG002|Overall Study|Participants not treated|2|||
124482398|NCT04971226|447717970|FG003|Overall Study|Participants not treated|1|||
124482399|NCT00001337|447717978|FG000|Overall Study|Switched to alternate treatment|2|||
124482400|NCT00001337|447717979|FG001|Overall Study|Switched to alternate treatment|2|||
124482401|NCT00001337|447717980|FG002|Overall Study|Switched to alternate treatment|0|||
124482402|NCT00001337|447717978|FG000|Overall Study|Refused further treatment|2|||
124482403|NCT00001337|447717979|FG001|Overall Study|Refused further treatment|1|||
124482404|NCT00001337|447717980|FG002|Overall Study|Refused further treatment|0|||
124482405|NCT00001337|447717978|FG000|Overall Study|Began other Tx|1|||
124482406|NCT00001337|447717979|FG001|Overall Study|Began other Tx|0|||
124482407|NCT00001337|447717980|FG002|Overall Study|Began other Tx|0|||
124482408|NCT00001337|447717978|FG000|Overall Study|Physician Decision|3|||
124482409|NCT00001337|447717979|FG001|Overall Study|Physician Decision|1|||
124482410|NCT00001337|447717980|FG002|Overall Study|Physician Decision|0|||
124482411|NCT00001337|447717978|FG000|Overall Study|Doesn't have NHL|0|||
124482412|NCT00001337|447717979|FG001|Overall Study|Doesn't have NHL|1|||
124482413|NCT00001337|447717980|FG002|Overall Study|Doesn't have NHL|0|||
124482414|NCT00001337|447717978|FG000|Overall Study|Non protocol tx needed|3|||
124482415|NCT00001337|447717979|FG001|Overall Study|Non protocol tx needed|1|||
124482416|NCT00001337|447717980|FG002|Overall Study|Non protocol tx needed|0|||
124482417|NCT00001337|447717978|FG000|Overall Study|Protocol change|1|||
124482418|NCT00001337|447717979|FG001|Overall Study|Protocol change|0|||
124482419|NCT00001337|447717980|FG002|Overall Study|Protocol change|0|||
124482420|NCT00001337|447717978|FG000|Overall Study|2nd primary disease|0|||
124482421|NCT00001337|447717979|FG001|Overall Study|2nd primary disease|0|||
124482422|NCT00001337|447717980|FG002|Overall Study|2nd primary disease|1|||
124482423|NCT00001337|447717978|FG000|Overall Study|Death during follow up period|9|||
124482424|NCT00001337|447717979|FG001|Overall Study|Death during follow up period|4|||
124482425|NCT00001337|447717980|FG002|Overall Study|Death during follow up period|0|||
124482426|NCT00001337|447717978|FG000|Overall Study|Death on study|19|||
124482427|NCT00001337|447717979|FG001|Overall Study|Death on study|9|||
124482428|NCT00001337|447717980|FG002|Overall Study|Death on study|0|||
124482429|NCT00001337|447717978|FG000|Overall Study|Disease progression during follow-up period|3|||
124482430|NCT00001337|447717979|FG001|Overall Study|Disease progression during follow-up period|1|||
124482431|NCT00001337|447717980|FG002|Overall Study|Disease progression during follow-up period|0|||
124557513|NCT01789281|447999114|FG000|Overall Study|Disease progression|15|||
124482432|NCT00001337|447717978|FG000|Overall Study|Disease progression on study|33|||
124482433|NCT00001337|447717979|FG001|Overall Study|Disease progression on study|41|||
124482434|NCT00001337|447717980|FG002|Overall Study|Disease progression on study|0|||
124482435|NCT00001337|447717978|FG000|Overall Study|Lost to further follow-up|10|||
124482436|NCT00001337|447717979|FG001|Overall Study|Lost to further follow-up|6|||
124482437|NCT00001337|447717980|FG002|Overall Study|Lost to further follow-up|0|||
124482438|NCT00001337|447717978|FG000|Overall Study|2nd malignancy|1|||
124482439|NCT00001337|447717979|FG001|Overall Study|2nd malignancy|0|||
124482440|NCT00001337|447717980|FG002|Overall Study|2nd malignancy|0|||
124557514|NCT01789281|447999115|FG001|Overall Study|Disease progression|4|||
124482441|NCT00001337|447717978|FG000|Overall Study|Treatment for second lymphoma|0|||
124482442|NCT00001337|447717979|FG001|Overall Study|Treatment for second lymphoma|1|||
124482443|NCT00001337|447717980|FG002|Overall Study|Treatment for second lymphoma|0|||
124482444|NCT00001337|447717978|FG000|Overall Study|Transfer to transplant|0|||
124482445|NCT00001337|447717979|FG001|Overall Study|Transfer to transplant|1|||
124482446|NCT00001337|447717980|FG002|Overall Study|Transfer to transplant|0|||
124482447|NCT05590377|447717981|FG000|Overall Study|Death|1|||
124482448|NCT05590377|447717982|FG001|Overall Study|Death|1|||
124482449|NCT05590377|447717983|FG002|Overall Study|Death|2|||
124482450|NCT05590377|447717984|FG003|Overall Study|Death|0|||
124482451|NCT05590377|447717985|FG004|Overall Study|Death|0|||
124482452|NCT05590377|447717981|FG000|Overall Study|Study Terminated by Sponsor|1|||
124482453|NCT05590377|447717982|FG001|Overall Study|Study Terminated by Sponsor|5|||
124482454|NCT05590377|447717983|FG002|Overall Study|Study Terminated by Sponsor|4|||
124482455|NCT05590377|447717984|FG003|Overall Study|Study Terminated by Sponsor|0|||
124482456|NCT05590377|447717985|FG004|Overall Study|Study Terminated by Sponsor|0|||
124482457|NCT05590377|447717981|FG000|Overall Study|Withdrawal by Subject|1|||
124482458|NCT05590377|447717982|FG001|Overall Study|Withdrawal by Subject|0|||
124482459|NCT05590377|447717983|FG002|Overall Study|Withdrawal by Subject|0|||
124482460|NCT05590377|447717984|FG003|Overall Study|Withdrawal by Subject|0|||
124482461|NCT05590377|447717985|FG004|Overall Study|Withdrawal by Subject|0|||
124720835|NCT01893411|448601070|FG000|Overall Study|Lack of Efficacy|2|||
124482462|NCT00442598|447717986|FG000|Overall Study|Adverse Event|1|||
124482463|NCT00442598|447717987|FG001|Overall Study|Adverse Event|0|||
124482464|NCT00442598|447717988|FG002|Overall Study|Adverse Event|0|||
124482465|NCT00442598|447717986|FG000|Overall Study|Tumor progression|3|||
124482466|NCT00442598|447717987|FG001|Overall Study|Tumor progression|4|||
124482467|NCT00442598|447717988|FG002|Overall Study|Tumor progression|0|||
124482468|NCT00442598|447717986|FG000|Overall Study|Clinical deterioration|1|||
124482469|NCT00442598|447717987|FG001|Overall Study|Clinical deterioration|2|||
124482470|NCT00442598|447717988|FG002|Overall Study|Clinical deterioration|0|||
124482471|NCT00442598|447717986|FG000|Overall Study|CA125 progression|0|||
124482472|NCT00442598|447717987|FG001|Overall Study|CA125 progression|1|||
124482473|NCT00442598|447717988|FG002|Overall Study|CA125 progression|0|||
124482474|NCT00442598|447717986|FG000|Overall Study|Reduced creatinine clearance|1|||
124482475|NCT00442598|447717987|FG001|Overall Study|Reduced creatinine clearance|0|||
124482476|NCT00442598|447717988|FG002|Overall Study|Reduced creatinine clearance|0|||
124482477|NCT00442598|447717986|FG000|Overall Study|Death|0|||
124482478|NCT00442598|447717987|FG001|Overall Study|Death|1|||
124482479|NCT00442598|447717988|FG002|Overall Study|Death|0|||
124482480|NCT01262898|447717989|FG000|Overall Study|Protocol Violation|1|||
124482481|NCT01262898|447717990|FG001|Overall Study|Protocol Violation|1|||
124482482|NCT01262898|447717991|FG002|Overall Study|Protocol Violation|0|||
124482483|NCT01262898|447717992|FG003|Overall Study|Protocol Violation|0|||
124482484|NCT01262898|447717989|FG000|Overall Study|Lost to Follow-up|1|||
124482485|NCT01262898|447717990|FG001|Overall Study|Lost to Follow-up|0|||
124482486|NCT01262898|447717991|FG002|Overall Study|Lost to Follow-up|0|||
124482487|NCT01262898|447717992|FG003|Overall Study|Lost to Follow-up|0|||
124482488|NCT01262898|447717989|FG000|Overall Study|Withdrawal by Subject|1|||
124482489|NCT01262898|447717990|FG001|Overall Study|Withdrawal by Subject|1|||
124482490|NCT01262898|447717991|FG002|Overall Study|Withdrawal by Subject|0|||
124482491|NCT01262898|447717992|FG003|Overall Study|Withdrawal by Subject|0|||
124482492|NCT04026568|447717993|FG000|Overall Study|study terminated|0|||
124482493|NCT04026568|447717994|FG001|Overall Study|study terminated|1|||
124482494|NCT02197377|447717995|FG000|Overall Study|Insertion Failure|0|||
124482495|NCT02197377|447717996|FG001|Overall Study|Insertion Failure|3|||
124482496|NCT00502840|447717997|FG000|Overall Study|Adverse Event|5|||
124482497|NCT00502840|447717997|FG000|Overall Study|Additional or changed therapy|48|||
124482498|NCT00502840|447717997|FG000|Overall Study|Lack of Efficacy|11|||
124482499|NCT00502840|447717997|FG000|Overall Study|Protocol Violation|4|||
124482500|NCT00502840|447717997|FG000|Overall Study|Withdrawal by Subject|5|||
124482501|NCT00502840|447717997|FG000|Overall Study|Lost to Follow-up|6|||
124482502|NCT00502840|447717997|FG000|Overall Study|Administrative problems|1|||
124482503|NCT00502840|447717997|FG000|Overall Study|Other|20|||
124482504|NCT00461175|447717998|FG000|Overall Study|Protocol Violation|522|||
124720836|NCT01893411|448601071|FG001|Overall Study|Lack of Efficacy|1|||
124482505|NCT00461175|447717999|FG001|Overall Study|Protocol Violation|365|||
124482506|NCT01700829|447718000|FG000|Overall Study|Withdrawal by Subject|1|||
124482507|NCT01700829|447718001|FG001|Overall Study|Withdrawal by Subject|1|||
124482508|NCT01025635|447718005|FG000|Overall Study|Withdrawal by Subject|6|||
124482509|NCT01025635|447718006|FG001|Overall Study|Withdrawal by Subject|7|||
124482510|NCT01025635|447718005|FG000|Overall Study|Protocol Violation|4|||
124482511|NCT01025635|447718006|FG001|Overall Study|Protocol Violation|2|||
124720837|NCT01893411|448601072|FG002|Overall Study|Lack of Efficacy|0|||
124482512|NCT01025635|447718005|FG000|Overall Study|Lack of Efficacy|0|||
124482513|NCT01025635|447718006|FG001|Overall Study|Lack of Efficacy|1|||
124482514|NCT01025635|447718005|FG000|Overall Study|Lost to Follow-up|9|||
124482515|NCT01025635|447718006|FG001|Overall Study|Lost to Follow-up|13|||
124482516|NCT01025635|447718005|FG000|Overall Study|Reason not known|4|||
124482517|NCT01025635|447718006|FG001|Overall Study|Reason not known|2|||
124482518|NCT00727402|447718007|FG000|Overall Study|Physician Decision|116|||
124482519|NCT05292755|447718008|FG000|Overall Study|Lost to Follow-up|5|||
124482520|NCT05292755|447718009|FG001|Overall Study|Lost to Follow-up|9|||
124482521|NCT00432809|447718011|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
124482522|NCT00432809|447718012|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
124482523|NCT00432809|447718013|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
124482524|NCT00432809|447718011|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
124482525|NCT00432809|447718012|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
124482526|NCT00432809|447718013|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
124482527|NCT04433117|447718014|FG000|Overall Study|Withdrawal by Subject|1|||
124482528|NCT04433117|447718015|FG001|Overall Study|Withdrawal by Subject|0|||
124482529|NCT01051739|447718016|FG000|Overall Study|Death|3|||
124482530|NCT01051739|447718017|FG001|Overall Study|Death|3|||
124482531|NCT01051739|447718016|FG000|Overall Study|Withdrawal by Subject|25|||
124482532|NCT01051739|447718017|FG001|Overall Study|Withdrawal by Subject|10|||
124482533|NCT00707577|447718018|FG000|Overall Study|Withdrawal by Subject|3|||
124482534|NCT00707577|447718019|FG001|Overall Study|Withdrawal by Subject|2|||
124482535|NCT00707577|447718018|FG000|Overall Study|Lost to Follow-up|34|||
124482536|NCT00707577|447718019|FG001|Overall Study|Lost to Follow-up|25|||
124482537|NCT00707577|447718018|FG000|Overall Study|Left employment|13|||
124482538|NCT00707577|447718019|FG001|Overall Study|Left employment|10|||
124482539|NCT00707577|447718018|FG000|Overall Study|Pregnancy|4|||
124482540|NCT00707577|447718019|FG001|Overall Study|Pregnancy|1|||
124482541|NCT03853694|447718020|FG000|Overall Study|Protocol Violation|3|||
124482542|NCT03853694|447718021|FG001|Overall Study|Protocol Violation|5|||
124482543|NCT03853694|447718022|FG002|Overall Study|Protocol Violation|3|||
124482544|NCT03853694|447718020|FG000|Overall Study|Delivered early|0|||
124482545|NCT03853694|447718021|FG001|Overall Study|Delivered early|1|||
124482546|NCT03853694|447718022|FG002|Overall Study|Delivered early|0|||
124482547|NCT03853694|447718020|FG000|Overall Study|not suitable to proceed|0|||
124482548|NCT03853694|447718021|FG001|Overall Study|not suitable to proceed|1|||
124482549|NCT03853694|447718022|FG002|Overall Study|not suitable to proceed|0|||
124482550|NCT03853694|447718020|FG000|Overall Study|difficult surgery|0|||
124482551|NCT03853694|447718021|FG001|Overall Study|difficult surgery|0|||
124482552|NCT03853694|447718022|FG002|Overall Study|difficult surgery|1|||
124482553|NCT03853694|447718020|FG000|Overall Study|Lost to Follow-up|0|||
124482554|NCT03853694|447718021|FG001|Overall Study|Lost to Follow-up|1|||
124482555|NCT03853694|447718022|FG002|Overall Study|Lost to Follow-up|0|||
124482556|NCT03853694|447718020|FG000|Overall Study|Withdrawal by Subject|0|||
124720838|NCT01893411|448601070|FG000|Overall Study|Other|3|||
124482557|NCT03853694|447718021|FG001|Overall Study|Withdrawal by Subject|1|||
124482558|NCT03853694|447718022|FG002|Overall Study|Withdrawal by Subject|0|||
124482559|NCT03770403|447718023|FG000|Overall Study|Adverse Event|8|||
124482560|NCT03770403|447718023|FG000|Overall Study|Death|5|||
124482561|NCT03770403|447718023|FG000|Overall Study|Physician Decision|1|||
124482562|NCT03770403|447718023|FG000|Overall Study|Sponsor decision|1|||
124482563|NCT03770403|447718023|FG000|Overall Study|Study terminated by Sponsor|1|||
124482564|NCT03770403|447718023|FG000|Overall Study|Withdrawal by Subject|13|||
124482565|NCT03770403|447718023|FG000|Overall Study|Other|88|||
124482566|NCT00642642|447718028|FG000|Treatment & Follow Up|Adverse Event|2|||
124482567|NCT00642642|447718028|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
124482568|NCT00642642|447718028|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
124482569|NCT02337387|447718029|FG000|Overall Study|Adverse Event|0|||
124482570|NCT02337387|447718030|FG001|Overall Study|Adverse Event|1|||
124482571|NCT02337387|447718031|FG002|Overall Study|Adverse Event|0|||
124482572|NCT02337387|447718032|FG003|Overall Study|Adverse Event|0|||
124482573|NCT02337387|447718029|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
124482574|NCT02337387|447718030|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
124482575|NCT02337387|447718031|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
124482576|NCT02337387|447718032|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
124482577|NCT03871491|447718033|FG000|Overall Study|Withdrawal by Subject|14|||
124482578|NCT03871491|447718034|FG001|Overall Study|Withdrawal by Subject|14|||
124720839|NCT01893411|448601071|FG001|Overall Study|Other|1|||
124720840|NCT01893411|448601072|FG002|Overall Study|Other|3|||
124482579|NCT03871491|447718035|FG002|Overall Study|Withdrawal by Subject|14|||
124482580|NCT03871491|447718036|FG003|Overall Study|Withdrawal by Subject|14|||
124482581|NCT03871491|447718033|FG000|Overall Study|Physician Decision|0|||
124482582|NCT03871491|447718034|FG001|Overall Study|Physician Decision|0|||
124482583|NCT03871491|447718035|FG002|Overall Study|Physician Decision|1|||
124482584|NCT03871491|447718036|FG003|Overall Study|Physician Decision|1|||
124482585|NCT03871491|447718033|FG000|Overall Study|Lost to Follow-up|50|||
124482586|NCT03871491|447718034|FG001|Overall Study|Lost to Follow-up|15|||
124482587|NCT03871491|447718035|FG002|Overall Study|Lost to Follow-up|36|||
124482588|NCT03871491|447718036|FG003|Overall Study|Lost to Follow-up|11|||
124482589|NCT04439331|447718037|FG000|Overall Study|Never Start Protocol Therapy|2|||
124482590|NCT04439331|447718037|FG000|Overall Study|Ineligible|2|||
124482591|NCT04439331|447718037|FG000|Overall Study|Mutation Status Not Confirmed|1|||
124720841|NCT01893411|448601070|FG000|Overall Study|Adverse Event|1|||
124482592|NCT04439331|447718037|FG000|Overall Study|Adverse Event|1|||
124482593|NCT04439331|447718037|FG000|Overall Study|Death|1|||
124482594|NCT04439331|447718037|FG000|Overall Study|Disease Progression|20|||
124482595|NCT04439331|447718037|FG000|Overall Study|Withdrawal by Subject|6|||
124482596|NCT04439331|447718037|FG000|Overall Study|Physician Decision|1|||
124482597|NCT04439331|447718037|FG000|Overall Study|Other Complicating Disease|1|||
124482598|NCT01444300|447718040|FG000|Overall Study|Adverse Event|4|||
124482599|NCT01444300|447718041|FG001|Overall Study|Adverse Event|0|||
124482600|NCT00490542|447718042|FG000|Overall Study|Lost to Follow-up|3|||
124482601|NCT00490542|447718043|FG001|Overall Study|Lost to Follow-up|0|||
124482602|NCT00490542|447718042|FG000|Overall Study|Adverse Event|3|||
124482603|NCT00490542|447718043|FG001|Overall Study|Adverse Event|3|||
124482604|NCT00490542|447718042|FG000|Overall Study|Lack of Efficacy|1|||
124482605|NCT00490542|447718043|FG001|Overall Study|Lack of Efficacy|1|||
124482606|NCT01587989|447718044|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
124482607|NCT01587989|447718045|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
124482608|NCT01587989|447718046|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
124482609|NCT01587989|447718044|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
124482610|NCT01587989|447718045|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
124482611|NCT01587989|447718046|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
124482612|NCT01587989|447718044|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
124482613|NCT01587989|447718045|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
124482614|NCT01587989|447718046|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
124482615|NCT01587989|447718044|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
124482616|NCT01587989|447718045|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
124482617|NCT01587989|447718046|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
124482618|NCT01587989|447718044|FG000|Randomized Study Treatment|Screening failure|0|||
124482619|NCT01587989|447718045|FG001|Randomized Study Treatment|Screening failure|1|||
124482620|NCT01587989|447718046|FG002|Randomized Study Treatment|Screening failure|0|||
124482621|NCT01587989|447718044|FG000|Randomized Study Treatment|Physician Decision|0|||
124482622|NCT01587989|447718045|FG001|Randomized Study Treatment|Physician Decision|0|||
124482623|NCT01587989|447718046|FG002|Randomized Study Treatment|Physician Decision|1|||
124482624|NCT00684177|447718048|FG000|Overall Study|Adverse Event|4|||
124482625|NCT00684177|447718049|FG001|Overall Study|Adverse Event|3|||
124482626|NCT00684177|447718048|FG000|Overall Study|Lack of Efficacy|10|||
124482627|NCT00684177|447718049|FG001|Overall Study|Lack of Efficacy|15|||
124482628|NCT00684177|447718048|FG000|Overall Study|Protocol Violation|1|||
124482629|NCT00684177|447718049|FG001|Overall Study|Protocol Violation|0|||
124482630|NCT00684177|447718048|FG000|Overall Study|Lost to Follow-up|2|||
124482631|NCT00684177|447718049|FG001|Overall Study|Lost to Follow-up|1|||
124482632|NCT00684177|447718048|FG000|Overall Study|Physician Decision|2|||
124482633|NCT00684177|447718049|FG001|Overall Study|Physician Decision|0|||
124482634|NCT00684177|447718048|FG000|Overall Study|Withdrawal by Subject|1|||
124482635|NCT00684177|447718049|FG001|Overall Study|Withdrawal by Subject|2|||
124482636|NCT00684177|447718048|FG000|Overall Study|Other|1|||
124482637|NCT00684177|447718049|FG001|Overall Study|Other|2|||
124482638|NCT02582658|447718051|FG000|Overall Study|Failure to Return|10|||
124482639|NCT02582658|447718051|FG000|Overall Study|Insufficient Virological Response|2|||
124482640|NCT02582658|447718051|FG000|Overall Study|Withdrawn Consent|1|||
124482641|NCT02582658|447718051|FG000|Overall Study|Death|1|||
124482642|NCT02582658|447718051|FG000|Overall Study|Not further specified|11|||
124482643|NCT03274687|447720444|FG000|Overall Study|Protocol Violation|1|||
124482644|NCT03274687|447720445|FG001|Overall Study|Protocol Violation|1|||
124482645|NCT05556616|447720446|FG000|Overall Study|Withdrawal by Subject|1|||
124482646|NCT05556616|447720447|FG001|Overall Study|Withdrawal by Subject|0|||
124482647|NCT05556616|447720448|FG002|Overall Study|Withdrawal by Subject|0|||
124482648|NCT05556616|447720449|FG003|Overall Study|Withdrawal by Subject|0|||
124482649|NCT05556616|447720450|FG004|Overall Study|Withdrawal by Subject|0|||
124482650|NCT05556616|447720451|FG005|Overall Study|Withdrawal by Subject|0|||
124482651|NCT05556616|447720452|FG006|Overall Study|Withdrawal by Subject|0|||
124482652|NCT05556616|447720446|FG000|Overall Study|Death|0|||
124482653|NCT05556616|447720447|FG001|Overall Study|Death|0|||
124482654|NCT05556616|447720448|FG002|Overall Study|Death|2|||
124482655|NCT05556616|447720449|FG003|Overall Study|Death|1|||
124482656|NCT05556616|447720450|FG004|Overall Study|Death|0|||
124482657|NCT05556616|447720451|FG005|Overall Study|Death|0|||
124482658|NCT05556616|447720452|FG006|Overall Study|Death|0|||
124482659|NCT05556616|447720446|FG000|Overall Study|Study Terminated by Sponsor|0|||
124482660|NCT05556616|447720447|FG001|Overall Study|Study Terminated by Sponsor|3|||
124482661|NCT05556616|447720448|FG002|Overall Study|Study Terminated by Sponsor|0|||
124482662|NCT05556616|447720449|FG003|Overall Study|Study Terminated by Sponsor|0|||
124482663|NCT05556616|447720450|FG004|Overall Study|Study Terminated by Sponsor|0|||
124482664|NCT05556616|447720451|FG005|Overall Study|Study Terminated by Sponsor|0|||
124482665|NCT05556616|447720452|FG006|Overall Study|Study Terminated by Sponsor|0|||
124482666|NCT03095703|447720457|FG000|Overall Study|Withdrawal by Subject|1|||
124482667|NCT01381094|447720458|FG000|Overall Study|Adverse Event|1|||
124482668|NCT01381094|447720459|FG001|Overall Study|Adverse Event|2|||
124482669|NCT01381094|447720460|FG002|Overall Study|Adverse Event|0|||
124482670|NCT01381094|447720461|FG003|Overall Study|Adverse Event|1|||
124482671|NCT01381094|447720462|FG004|Overall Study|Adverse Event|0|||
124482672|NCT01381094|447720458|FG000|Overall Study|Lost to Follow-up|0|||
124482673|NCT01381094|447720459|FG001|Overall Study|Lost to Follow-up|0|||
124482674|NCT01381094|447720460|FG002|Overall Study|Lost to Follow-up|0|||
124482675|NCT01381094|447720461|FG003|Overall Study|Lost to Follow-up|0|||
124482676|NCT01381094|447720462|FG004|Overall Study|Lost to Follow-up|1|||
124482677|NCT01381094|447720458|FG000|Overall Study|Withdrawal of informed consent|0|||
124482678|NCT01381094|447720459|FG001|Overall Study|Withdrawal of informed consent|1|||
124482679|NCT01381094|447720460|FG002|Overall Study|Withdrawal of informed consent|0|||
124482680|NCT01381094|447720461|FG003|Overall Study|Withdrawal of informed consent|0|||
124482681|NCT01381094|447720462|FG004|Overall Study|Withdrawal of informed consent|0|||
124482682|NCT01381094|447720458|FG000|Overall Study|Participant given Aranesp injection|1|||
124482683|NCT01381094|447720459|FG001|Overall Study|Participant given Aranesp injection|0|||
124482684|NCT01381094|447720460|FG002|Overall Study|Participant given Aranesp injection|0|||
124482685|NCT01381094|447720461|FG003|Overall Study|Participant given Aranesp injection|0|||
124482686|NCT01381094|447720462|FG004|Overall Study|Participant given Aranesp injection|0|||
124482687|NCT01934504|447720465|FG000|Overall Study|Protocol Deviation|0|||
124482688|NCT01934504|447720466|FG001|Overall Study|Protocol Deviation|0|||
124482689|NCT01934504|447720467|FG002|Overall Study|Protocol Deviation|0|||
124482690|NCT01934504|447720468|FG003|Overall Study|Protocol Deviation|2|||
124482691|NCT01934504|447720465|FG000|Overall Study|Study Terminated by Sponsor|1|||
124482692|NCT01934504|447720466|FG001|Overall Study|Study Terminated by Sponsor|0|||
124482693|NCT01934504|447720467|FG002|Overall Study|Study Terminated by Sponsor|5|||
124482694|NCT01934504|447720468|FG003|Overall Study|Study Terminated by Sponsor|5|||
124482695|NCT02665689|447720469|FG000|Overall Study|Adverse Event|1|||
124482696|NCT02665689|447720470|FG001|Overall Study|Adverse Event|0|||
124482697|NCT02665689|447720469|FG000|Overall Study|Trial termination|1|||
124482698|NCT02665689|447720470|FG001|Overall Study|Trial termination|1|||
124482699|NCT02665689|447720469|FG000|Overall Study|Lost to Follow-up|0|||
124482700|NCT02665689|447720470|FG001|Overall Study|Lost to Follow-up|1|||
124482701|NCT00541307|447720471|FG000|Overall Study|Death|5|||
124482702|NCT00541307|447720471|FG000|Overall Study|Physician Decision|3|||
124482703|NCT00541307|447720471|FG000|Overall Study|Withdrawal by Subject|6|||
124482704|NCT00541307|447720471|FG000|Overall Study|Lost to Follow-up|4|||
124482705|NCT00541307|447720471|FG000|Overall Study|Subject returned early (outside window)|1|||
124482706|NCT00541307|447720471|FG000|Overall Study|Surgical Bypass|5|||
124482707|NCT02455557|447720472|FG000|Overall Study|Withdrawal by Subject|2|||
124482708|NCT03615222|447720473|FG000|Overall Study|Ineligible|26|||
124482709|NCT03615222|447720473|FG000|Overall Study|Withdrawal by Subject|7|||
124482710|NCT03615222|447720473|FG000|Overall Study|Death|1|||
124482711|NCT00476086|447720474|FG000|Overall Study|Alternative therapy|1|||
124482712|NCT00476086|447720474|FG000|Overall Study|Progressive Disease|4|||
124482713|NCT02900092|447720475|FG000|Overall Study|Adverse Event|1|||
124482714|NCT04178590|447720476|FG000|Overall Study|Pregnancy|1|||
124482715|NCT04178590|447720476|FG000|Overall Study|Lost to Follow-up|1|||
124482716|NCT03895203|447720477|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
124482717|NCT03895203|447720478|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
124482718|NCT03895203|447720479|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
124482719|NCT03895203|447720480|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
124482720|NCT03895203|447720481|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
124482721|NCT03895203|447720482|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
124482722|NCT03895203|447720477|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
124482723|NCT03895203|447720478|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
124482724|NCT03895203|447720479|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
124482725|NCT03895203|447720480|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
124482726|NCT03895203|447720481|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
124482727|NCT03895203|447720482|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
124482728|NCT03895203|447720477|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
124482729|NCT03895203|447720478|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
124482730|NCT03895203|447720479|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
124482731|NCT03895203|447720480|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
124482732|NCT03895203|447720481|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
124482733|NCT03895203|447720482|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
124482734|NCT03895203|447720477|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
124482735|NCT03895203|447720478|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
124482736|NCT03895203|447720479|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
124482737|NCT03895203|447720480|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
124482738|NCT03895203|447720481|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
124482739|NCT03895203|447720482|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
124482740|NCT03895203|447720477|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
124557515|NCT01789281|447999114|FG000|Overall Study|Adverse Event|5|||
124482741|NCT03895203|447720478|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
124482742|NCT03895203|447720479|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
124482743|NCT03895203|447720480|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
124482744|NCT03895203|447720481|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
124482745|NCT03895203|447720482|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
124482746|NCT03895203|447720477|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
124482747|NCT03895203|447720478|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
124482748|NCT03895203|447720479|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
124482749|NCT03895203|447720480|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
124482750|NCT03895203|447720481|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
124482751|NCT03895203|447720482|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
124482752|NCT03895203|447720477|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
124482753|NCT03895203|447720478|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
124482754|NCT03895203|447720479|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
124482755|NCT03895203|447720480|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
124482756|NCT03895203|447720481|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
124482757|NCT03895203|447720482|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
124482758|NCT03895203|447720477|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
124482759|NCT03895203|447720478|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
124482760|NCT03895203|447720479|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
124482761|NCT03895203|447720480|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
124482762|NCT03895203|447720481|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
124482763|NCT03895203|447720482|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
124482764|NCT03895203|447720477|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
124482765|NCT03895203|447720478|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
124482766|NCT03895203|447720479|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
124482767|NCT03895203|447720480|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
124482768|NCT03895203|447720481|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
124482769|NCT03895203|447720482|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
124482770|NCT03895203|447720477|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
124482771|NCT03895203|447720478|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
124482772|NCT03895203|447720479|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
124482773|NCT03895203|447720480|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
124482774|NCT03895203|447720481|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
124482775|NCT03895203|447720482|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
124482776|NCT03895203|447720477|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
124482777|NCT03895203|447720478|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
124482778|NCT03895203|447720479|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
124482779|NCT03895203|447720480|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
124482780|NCT03895203|447720481|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
124482781|NCT03895203|447720482|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
124482782|NCT03895203|447720477|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
124482783|NCT03895203|447720478|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
124482784|NCT03895203|447720479|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
124482785|NCT03895203|447720480|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
124482786|NCT03895203|447720481|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
124482787|NCT03895203|447720482|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
124482788|NCT03895203|447720477|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
124482789|NCT03895203|447720478|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
124482790|NCT03895203|447720479|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
124482791|NCT03895203|447720480|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
124482792|NCT03895203|447720481|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
124482793|NCT03895203|447720482|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
124482794|NCT03895203|447720477|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
124482795|NCT03895203|447720478|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
124482796|NCT03895203|447720479|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
124482797|NCT03895203|447720480|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
124482798|NCT03895203|447720481|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
124482799|NCT03895203|447720482|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
124482800|NCT00996840|447720484|FG000|Overall Study|Adverse Event|0|||
124557516|NCT01789281|447999115|FG001|Overall Study|Adverse Event|5|||
124557517|NCT01789281|447999114|FG000|Overall Study|Withdrawal by Subject|1|||
124557518|NCT01789281|447999115|FG001|Overall Study|Withdrawal by Subject|0|||
124482801|NCT00996840|447720485|FG001|Overall Study|Adverse Event|1|||
124482802|NCT00996840|447720486|FG002|Overall Study|Adverse Event|0|||
124482803|NCT00996840|447720487|FG003|Overall Study|Adverse Event|0|||
124482804|NCT00996840|447720488|FG004|Overall Study|Adverse Event|0|||
124482805|NCT00996840|447720484|FG000|Overall Study|Physician Decision|0|||
124482806|NCT00996840|447720485|FG001|Overall Study|Physician Decision|0|||
124482807|NCT00996840|447720486|FG002|Overall Study|Physician Decision|1|||
124482808|NCT00996840|447720487|FG003|Overall Study|Physician Decision|1|||
124482809|NCT00996840|447720488|FG004|Overall Study|Physician Decision|2|||
124482810|NCT00996840|447720484|FG000|Overall Study|Withdrawal by Subject|1|||
124482811|NCT00996840|447720485|FG001|Overall Study|Withdrawal by Subject|1|||
124482812|NCT00996840|447720486|FG002|Overall Study|Withdrawal by Subject|0|||
124482813|NCT00996840|447720487|FG003|Overall Study|Withdrawal by Subject|0|||
124482814|NCT00996840|447720488|FG004|Overall Study|Withdrawal by Subject|0|||
124482815|NCT02292849|447720490|FG000|Overall Study|Lost to Follow-up|0|||
124482816|NCT02292849|447720491|FG001|Overall Study|Lost to Follow-up|2|||
124482817|NCT02292849|447720492|FG002|Overall Study|Lost to Follow-up|2|||
124482818|NCT02292849|447720490|FG000|Overall Study|Physician Decision|4|||
124482819|NCT02292849|447720491|FG001|Overall Study|Physician Decision|0|||
124482820|NCT02292849|447720492|FG002|Overall Study|Physician Decision|0|||
124482821|NCT01485614|447720493|FG000|Randomization|Not Treated|1|||
124482822|NCT01485614|447720494|FG001|Randomization|Not Treated|0|||
124482823|NCT01485614|447720495|FG002|Randomization|Not Treated|0|||
124482824|NCT01485614|447720496|FG003|Randomization|Not Treated|0|||
124482825|NCT01485614|447720493|FG000|Weeks 0-20|Lost to Follow-up|2|||
124482826|NCT01485614|447720494|FG001|Weeks 0-20|Lost to Follow-up|0|||
124482827|NCT01485614|447720495|FG002|Weeks 0-20|Lost to Follow-up|0|||
124482828|NCT01485614|447720496|FG003|Weeks 0-20|Lost to Follow-up|0|||
124482829|NCT01485614|447720493|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
124482830|NCT01485614|447720494|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
124482831|NCT01485614|447720495|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
124482832|NCT01485614|447720496|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
124482833|NCT01485614|447720493|FG000|Weeks 0-20|Withdrawal by Subject|3|||
124482834|NCT01485614|447720494|FG001|Weeks 0-20|Withdrawal by Subject|2|||
124482835|NCT01485614|447720495|FG002|Weeks 0-20|Withdrawal by Subject|1|||
124482836|NCT01485614|447720496|FG003|Weeks 0-20|Withdrawal by Subject|0|||
124482837|NCT01485614|447720493|FG000|Weeks 20-54|Lost to Follow-up|4|||
124482838|NCT01485614|447720494|FG001|Weeks 20-54|Lost to Follow-up|3|||
124482839|NCT01485614|447720495|FG002|Weeks 20-54|Lost to Follow-up|1|||
124482840|NCT01485614|447720496|FG003|Weeks 20-54|Lost to Follow-up|0|||
124482841|NCT01485614|447720493|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
124482842|NCT01485614|447720494|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
124482843|NCT01485614|447720495|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
124482844|NCT01485614|447720496|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
124482845|NCT01485614|447720493|FG000|Weeks 20-54|Withdrawal by Subject|5|||
124482846|NCT01485614|447720494|FG001|Weeks 20-54|Withdrawal by Subject|3|||
124482847|NCT01485614|447720495|FG002|Weeks 20-54|Withdrawal by Subject|0|||
124482848|NCT01485614|447720496|FG003|Weeks 20-54|Withdrawal by Subject|0|||
124482849|NCT02210780|447720497|FG000|Overall Study|Adverse Event|0|||
124482850|NCT02210780|447720498|FG001|Overall Study|Adverse Event|5|||
124482851|NCT02210780|447720497|FG000|Overall Study|Lost to Follow-up|2|||
124482852|NCT02210780|447720498|FG001|Overall Study|Lost to Follow-up|1|||
124482853|NCT02210780|447720497|FG000|Overall Study|Withdrawal by Subject|1|||
124482854|NCT02210780|447720498|FG001|Overall Study|Withdrawal by Subject|1|||
124482855|NCT02210780|447720497|FG000|Overall Study|Physician Decision|1|||
124482856|NCT02210780|447720498|FG001|Overall Study|Physician Decision|0|||
124482857|NCT02210780|447720497|FG000|Overall Study|Protocol Violation|1|||
124482858|NCT02210780|447720498|FG001|Overall Study|Protocol Violation|0|||
124482859|NCT02210780|447720497|FG000|Overall Study|Other than specified above|0|||
124482860|NCT02210780|447720498|FG001|Overall Study|Other than specified above|1|||
124482861|NCT00886938|447720499|FG000|Overall Study|Adverse Event|1|||
124482862|NCT00886938|447720499|FG000|Overall Study|Withdrawal by Subject|1|||
124482863|NCT00364793|447720500|FG000|Overall Study|Adverse Event|2|||
124482864|NCT00364793|447720501|FG001|Overall Study|Adverse Event|0|||
124482865|NCT00364793|447720502|FG002|Overall Study|Adverse Event|0|||
124482866|NCT00364793|447720503|FG003|Overall Study|Adverse Event|0|||
124482867|NCT00364793|447720500|FG000|Overall Study|Death|1|||
124482868|NCT00364793|447720501|FG001|Overall Study|Death|0|||
124482869|NCT00364793|447720502|FG002|Overall Study|Death|1|||
124482870|NCT00364793|447720503|FG003|Overall Study|Death|0|||
124482871|NCT00364793|447720500|FG000|Overall Study|Lack of Efficacy|3|||
124482872|NCT00364793|447720501|FG001|Overall Study|Lack of Efficacy|3|||
124482873|NCT00364793|447720502|FG002|Overall Study|Lack of Efficacy|1|||
124482874|NCT00364793|447720503|FG003|Overall Study|Lack of Efficacy|1|||
124482875|NCT00364793|447720500|FG000|Overall Study|Lost to Follow-up|1|||
124482876|NCT00364793|447720501|FG001|Overall Study|Lost to Follow-up|0|||
124482877|NCT00364793|447720502|FG002|Overall Study|Lost to Follow-up|2|||
124482878|NCT00364793|447720503|FG003|Overall Study|Lost to Follow-up|0|||
124482879|NCT00364793|447720500|FG000|Overall Study|Poor or non-compliance|1|||
124482880|NCT00364793|447720501|FG001|Overall Study|Poor or non-compliance|1|||
124482881|NCT00364793|447720502|FG002|Overall Study|Poor or non-compliance|0|||
124482882|NCT00364793|447720503|FG003|Overall Study|Poor or non-compliance|1|||
124482883|NCT00364793|447720500|FG000|Overall Study|No longer meets criteria|0|||
124482884|NCT00364793|447720501|FG001|Overall Study|No longer meets criteria|0|||
124482885|NCT00364793|447720502|FG002|Overall Study|No longer meets criteria|0|||
124482886|NCT00364793|447720503|FG003|Overall Study|No longer meets criteria|1|||
124482887|NCT00364793|447720500|FG000|Overall Study|Withdrawal by Subject|0|||
124482888|NCT00364793|447720501|FG001|Overall Study|Withdrawal by Subject|1|||
124482889|NCT00364793|447720502|FG002|Overall Study|Withdrawal by Subject|0|||
124482890|NCT00364793|447720503|FG003|Overall Study|Withdrawal by Subject|0|||
124482891|NCT00363415|447720506|FG000|Overall Study|Progressive Disease|196|||
124482892|NCT00363415|447720507|FG001|Overall Study|Progressive Disease|107|||
124482893|NCT00363415|447720506|FG000|Overall Study|Sponsor Decision|67|||
124482894|NCT00363415|447720507|FG001|Overall Study|Sponsor Decision|31|||
124482895|NCT00363415|447720506|FG000|Overall Study|Death|32|||
124482896|NCT00363415|447720507|FG001|Overall Study|Death|29|||
124482897|NCT00363415|447720506|FG000|Overall Study|Adverse Event|24|||
124482898|NCT00363415|447720507|FG001|Overall Study|Adverse Event|15|||
124482899|NCT00363415|447720506|FG000|Overall Study|Physician Decision|18|||
124482900|NCT00363415|447720507|FG001|Overall Study|Physician Decision|35|||
124482901|NCT00363415|447720506|FG000|Overall Study|Entry Criteria Not Met|11|||
124482902|NCT00363415|447720507|FG001|Overall Study|Entry Criteria Not Met|10|||
124482903|NCT00363415|447720506|FG000|Overall Study|Withdrawal by Subject|9|||
124482904|NCT00363415|447720507|FG001|Overall Study|Withdrawal by Subject|15|||
124482905|NCT00363415|447720506|FG000|Overall Study|Lost to Follow-up|3|||
124482906|NCT00363415|447720507|FG001|Overall Study|Lost to Follow-up|3|||
124482907|NCT00363415|447720506|FG000|Overall Study|Protocol Violation|1|||
124482908|NCT00363415|447720507|FG001|Overall Study|Protocol Violation|4|||
124482909|NCT05027802|447720510|FG000|Overall Study|Adverse Event|2|||
124482910|NCT05027802|447720510|FG000|Overall Study|Withdrawal by Subject|18|||
124482911|NCT05027802|447720510|FG000|Overall Study|Death|2|||
124482912|NCT05027802|447720510|FG000|Overall Study|Other|1|||
124482913|NCT03872180|447720513|FG000|Overall Study|Adverse Event|4|||
124482914|NCT03872180|447720513|FG000|Overall Study|Lack of Efficacy|2|||
124482915|NCT01506141|447720514|FG000|Overall Study|Adverse Event|0|||
124482916|NCT01506141|447720515|FG001|Overall Study|Adverse Event|2|||
124482917|NCT01506141|447720514|FG000|Overall Study|Participation Terminated by Investigator|1|||
124482918|NCT01506141|447720515|FG001|Overall Study|Participation Terminated by Investigator|1|||
124482919|NCT01506141|447720514|FG000|Overall Study|Site Terminated by Sponsor|2|||
124482920|NCT01506141|447720515|FG001|Overall Study|Site Terminated by Sponsor|0|||
124482921|NCT01506141|447720514|FG000|Overall Study|Reason Not Specified|4|||
124482922|NCT01506141|447720515|FG001|Overall Study|Reason Not Specified|2|||
124482923|NCT04607408|447720516|FG000|Overall Study|Lost to Follow-up|0|||
124482924|NCT04607408|447720517|FG001|Overall Study|Lost to Follow-up|0|||
124482925|NCT04607408|447720518|FG002|Overall Study|Lost to Follow-up|0|||
124482926|NCT04607408|447720519|FG003|Overall Study|Lost to Follow-up|1|||
124482927|NCT04607408|447720520|FG004|Overall Study|Lost to Follow-up|0|||
124482928|NCT04607408|447720516|FG000|Overall Study|Withdrawal by Subject|0|||
124482929|NCT04607408|447720517|FG001|Overall Study|Withdrawal by Subject|1|||
124482930|NCT04607408|447720518|FG002|Overall Study|Withdrawal by Subject|0|||
124482931|NCT04607408|447720519|FG003|Overall Study|Withdrawal by Subject|1|||
124482932|NCT04607408|447720520|FG004|Overall Study|Withdrawal by Subject|0|||
124482933|NCT02725788|447720525|FG000|Overall Study|Lost to Follow-up|1|||
124482934|NCT02725788|447720526|FG001|Overall Study|Lost to Follow-up|1|||
124482935|NCT02725788|447720525|FG000|Overall Study|Protocol Violation|0|||
124482936|NCT02725788|447720526|FG001|Overall Study|Protocol Violation|1|||
124482937|NCT00828464|447720527|FG000|Overall Study|Withdrawal by Subject|1|||
124482938|NCT00809133|447720528|FG000|Overall Study|Progressive disease|2|||
124482939|NCT00809133|447720529|FG001|Overall Study|Progressive disease|5|||
124482940|NCT00809133|447720530|FG002|Overall Study|Progressive disease|5|||
124482941|NCT00809133|447720531|FG003|Overall Study|Progressive disease|3|||
124482942|NCT00809133|447720532|FG004|Overall Study|Progressive disease|4|||
124482943|NCT00809133|447720533|FG005|Overall Study|Progressive disease|1|||
124482944|NCT00809133|447720534|FG006|Overall Study|Progressive disease|3|||
124482945|NCT00809133|447720535|FG007|Overall Study|Progressive disease|3|||
124482946|NCT00809133|447720536|FG008|Overall Study|Progressive disease|3|||
124482947|NCT00809133|447720537|FG009|Overall Study|Progressive disease|9|||
124482948|NCT00809133|447720538|FG010|Overall Study|Progressive disease|5|||
124482949|NCT00809133|447720539|FG011|Overall Study|Progressive disease|7|||
124482950|NCT00809133|447720540|FG012|Overall Study|Progressive disease|5|||
124482951|NCT00809133|447720541|FG013|Overall Study|Progressive disease|4|||
124482952|NCT00809133|447720528|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124482953|NCT00809133|447720529|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124482954|NCT00809133|447720530|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124482955|NCT00809133|447720531|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124482956|NCT00809133|447720532|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124482957|NCT00809133|447720533|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
124482958|NCT00809133|447720534|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
124482959|NCT00809133|447720535|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
124482960|NCT00809133|447720536|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124482961|NCT00809133|447720537|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124482962|NCT00809133|447720538|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124482963|NCT00809133|447720539|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124482964|NCT00809133|447720540|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124482965|NCT00809133|447720541|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
124482966|NCT00809133|447720528|FG000|Overall Study|Other adverse event|1|||
124482967|NCT00809133|447720529|FG001|Overall Study|Other adverse event|1|||
124482968|NCT00809133|447720530|FG002|Overall Study|Other adverse event|1|||
124482969|NCT00809133|447720531|FG003|Overall Study|Other adverse event|0|||
124482970|NCT00809133|447720532|FG004|Overall Study|Other adverse event|0|||
124482971|NCT00809133|447720533|FG005|Overall Study|Other adverse event|3|||
124482972|NCT00809133|447720534|FG006|Overall Study|Other adverse event|2|||
124482973|NCT00809133|447720535|FG007|Overall Study|Other adverse event|4|||
124482974|NCT00809133|447720536|FG008|Overall Study|Other adverse event|0|||
124482975|NCT00809133|447720537|FG009|Overall Study|Other adverse event|0|||
124482976|NCT00809133|447720538|FG010|Overall Study|Other adverse event|1|||
124482977|NCT00809133|447720539|FG011|Overall Study|Other adverse event|1|||
124482978|NCT00809133|447720540|FG012|Overall Study|Other adverse event|0|||
124482979|NCT00809133|447720541|FG013|Overall Study|Other adverse event|1|||
124482980|NCT00809133|447720528|FG000|Overall Study|Lost to Follow-up|0|||
124482981|NCT00809133|447720529|FG001|Overall Study|Lost to Follow-up|0|||
124482982|NCT00809133|447720530|FG002|Overall Study|Lost to Follow-up|0|||
124482983|NCT00809133|447720531|FG003|Overall Study|Lost to Follow-up|0|||
124482984|NCT00809133|447720532|FG004|Overall Study|Lost to Follow-up|0|||
124482985|NCT00809133|447720533|FG005|Overall Study|Lost to Follow-up|1|||
124482986|NCT00809133|447720534|FG006|Overall Study|Lost to Follow-up|0|||
124482987|NCT00809133|447720535|FG007|Overall Study|Lost to Follow-up|0|||
124557519|NCT01789281|447999114|FG000|Overall Study|Lost to Follow-up|1|||
124557520|NCT01789281|447999115|FG001|Overall Study|Lost to Follow-up|0|||
124557521|NCT01789281|447999114|FG000|Overall Study|Administrative problems|0|||
124557522|NCT01789281|447999115|FG001|Overall Study|Administrative problems|1|||
124557523|NCT02746705|447999116|FG000|Overall Study|Physician Decision|1|||
124557524|NCT02746705|447999117|FG001|Overall Study|Physician Decision|1|||
124557525|NCT02746705|447999116|FG000|Overall Study|Lost to Follow-up|1|||
124557526|NCT02746705|447999117|FG001|Overall Study|Lost to Follow-up|0|||
124557527|NCT02746705|447999116|FG000|Overall Study|outlier scores deemed not valid|0|||
124557528|NCT02746705|447999117|FG001|Overall Study|outlier scores deemed not valid|1|||
124557529|NCT02862535|447999125|FG000|Overall Study|Death|7|||
124557530|NCT02862535|447999126|FG001|Overall Study|Death|3|||
124557531|NCT02862535|447999127|FG002|Overall Study|Death|2|||
124557532|NCT02862535|447999128|FG003|Overall Study|Death|5|||
124557533|NCT02862535|447999125|FG000|Overall Study|Study Terminated by Sponsor|1|||
124557534|NCT02862535|447999126|FG001|Overall Study|Study Terminated by Sponsor|3|||
124557535|NCT02862535|447999127|FG002|Overall Study|Study Terminated by Sponsor|8|||
124557536|NCT02862535|447999128|FG003|Overall Study|Study Terminated by Sponsor|5|||
124557537|NCT02862535|447999125|FG000|Overall Study|Enrolled, not Treated|1|||
124557538|NCT02862535|447999126|FG001|Overall Study|Enrolled, not Treated|0|||
124557539|NCT02862535|447999127|FG002|Overall Study|Enrolled, not Treated|0|||
124557540|NCT02862535|447999128|FG003|Overall Study|Enrolled, not Treated|1|||
124482988|NCT00809133|447720536|FG008|Overall Study|Lost to Follow-up|0|||
124482989|NCT00809133|447720537|FG009|Overall Study|Lost to Follow-up|0|||
124482990|NCT00809133|447720538|FG010|Overall Study|Lost to Follow-up|0|||
124482991|NCT00809133|447720539|FG011|Overall Study|Lost to Follow-up|0|||
124482992|NCT00809133|447720540|FG012|Overall Study|Lost to Follow-up|0|||
124482993|NCT00809133|447720541|FG013|Overall Study|Lost to Follow-up|0|||
124482994|NCT00809133|447720528|FG000|Overall Study|Consent withdrawn|0|||
124482995|NCT00809133|447720529|FG001|Overall Study|Consent withdrawn|0|||
124482996|NCT00809133|447720530|FG002|Overall Study|Consent withdrawn|0|||
124482997|NCT00809133|447720531|FG003|Overall Study|Consent withdrawn|0|||
124482998|NCT00809133|447720532|FG004|Overall Study|Consent withdrawn|1|||
124482999|NCT00809133|447720533|FG005|Overall Study|Consent withdrawn|0|||
124483000|NCT00809133|447720534|FG006|Overall Study|Consent withdrawn|0|||
124483001|NCT00809133|447720535|FG007|Overall Study|Consent withdrawn|0|||
124483002|NCT00809133|447720536|FG008|Overall Study|Consent withdrawn|0|||
124483003|NCT00809133|447720537|FG009|Overall Study|Consent withdrawn|0|||
124483004|NCT00809133|447720538|FG010|Overall Study|Consent withdrawn|0|||
124483005|NCT00809133|447720539|FG011|Overall Study|Consent withdrawn|0|||
124483006|NCT00809133|447720540|FG012|Overall Study|Consent withdrawn|0|||
124483007|NCT00809133|447720541|FG013|Overall Study|Consent withdrawn|0|||
124483008|NCT00809133|447720528|FG000|Overall Study|Other not mentioned above|0|||
124483009|NCT00809133|447720529|FG001|Overall Study|Other not mentioned above|1|||
124557541|NCT04304950|447999131|FG000|Overall Study|Lost to Follow-up|1|||
124557542|NCT04304950|447999132|FG001|Overall Study|Lost to Follow-up|1|||
124557543|NCT03077828|447999133|FG000|Treatment Cycles|Death|1|||
124557544|NCT03077828|447999133|FG000|Treatment Cycles|Withdrawal by Subject|1|||
124557545|NCT03077828|447999133|FG000|Treatment Cycles|Screen Fail|2|||
124557546|NCT03077828|447999133|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
124483010|NCT00809133|447720530|FG002|Overall Study|Other not mentioned above|0|||
124483011|NCT00809133|447720531|FG003|Overall Study|Other not mentioned above|0|||
124483012|NCT00809133|447720532|FG004|Overall Study|Other not mentioned above|0|||
124483013|NCT00809133|447720533|FG005|Overall Study|Other not mentioned above|1|||
124483014|NCT00809133|447720534|FG006|Overall Study|Other not mentioned above|0|||
124483015|NCT00809133|447720535|FG007|Overall Study|Other not mentioned above|0|||
124483016|NCT00809133|447720536|FG008|Overall Study|Other not mentioned above|0|||
124483017|NCT00809133|447720537|FG009|Overall Study|Other not mentioned above|0|||
124483018|NCT00809133|447720538|FG010|Overall Study|Other not mentioned above|0|||
124483019|NCT00809133|447720539|FG011|Overall Study|Other not mentioned above|0|||
124483020|NCT00809133|447720540|FG012|Overall Study|Other not mentioned above|0|||
124483021|NCT00809133|447720541|FG013|Overall Study|Other not mentioned above|0|||
124483022|NCT02499952|447720542|FG000|Overall Study|Lost to Follow-up|1|||
124483023|NCT02499952|447720542|FG000|Overall Study|Death|9|||
124483024|NCT05089708|447720543|FG000|Overall Study|Lost to Follow-up|9|||
124483025|NCT05089708|447720544|FG001|Overall Study|Lost to Follow-up|7|||
124483026|NCT05089708|447720543|FG000|Overall Study|Withdrawal by Subject|3|||
124483027|NCT05089708|447720544|FG001|Overall Study|Withdrawal by Subject|1|||
124483028|NCT05089708|447720543|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
124483029|NCT05089708|447720544|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
124483030|NCT05089708|447720543|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
124483031|NCT05089708|447720544|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
124483032|NCT02209766|447720546|FG000|Overall Study|Withdrawal by Subject|0|||
124483033|NCT02209766|447720547|FG001|Overall Study|Withdrawal by Subject|0|||
124483034|NCT02209766|447720548|FG002|Overall Study|Withdrawal by Subject|0|||
124483035|NCT02209766|447720549|FG003|Overall Study|Withdrawal by Subject|1|||
124483036|NCT02209766|447720550|FG004|Overall Study|Withdrawal by Subject|0|||
124483037|NCT00064701|447720551|FG000|One Year Post-transplant|Did not receive study drug|7|||
124483038|NCT00064701|447720552|FG001|One Year Post-transplant|Did not receive study drug|12|||
124483039|NCT00064701|447720553|FG002|One Year Post-transplant|Did not receive study drug|11|||
124483040|NCT00064701|447720551|FG000|One Year Post-transplant|Adverse Event|23|||
124483041|NCT00064701|447720552|FG001|One Year Post-transplant|Adverse Event|19|||
124483042|NCT00064701|447720553|FG002|One Year Post-transplant|Adverse Event|37|||
124483043|NCT00064701|447720551|FG000|One Year Post-transplant|Rejection|0|||
124483044|NCT00064701|447720552|FG001|One Year Post-transplant|Rejection|1|||
124483045|NCT00064701|447720553|FG002|One Year Post-transplant|Rejection|16|||
124483046|NCT00064701|447720551|FG000|One Year Post-transplant|Non-compliance|4|||
124483047|NCT00064701|447720552|FG001|One Year Post-transplant|Non-compliance|2|||
124483048|NCT00064701|447720553|FG002|One Year Post-transplant|Non-compliance|5|||
124483049|NCT00064701|447720551|FG000|One Year Post-transplant|Graft Failure|3|||
124483050|NCT00064701|447720552|FG001|One Year Post-transplant|Graft Failure|2|||
124483051|NCT00064701|447720553|FG002|One Year Post-transplant|Graft Failure|1|||
124483052|NCT00064701|447720551|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
124483053|NCT00064701|447720552|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
124483054|NCT00064701|447720553|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
124483055|NCT00064701|447720551|FG000|One Year Post-transplant|Lost to Follow-up|1|||
124483056|NCT00064701|447720552|FG001|One Year Post-transplant|Lost to Follow-up|0|||
124483057|NCT00064701|447720553|FG002|One Year Post-transplant|Lost to Follow-up|0|||
124483058|NCT00064701|447720551|FG000|One Year Post-transplant|Converted to rapamycin|1|||
124483059|NCT00064701|447720552|FG001|One Year Post-transplant|Converted to rapamycin|0|||
124483060|NCT00064701|447720553|FG002|One Year Post-transplant|Converted to rapamycin|0|||
124483061|NCT00064701|447720551|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
124557547|NCT03077828|447999133|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
124557548|NCT03077828|447999133|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
124557549|NCT03077828|447999133|FG000|Follow-up|Patients still in follow-up|15|||
124557550|NCT02418910|447999137|FG000|Overall Study|Lost to Follow-up|3|||
124557551|NCT02418910|447999137|FG000|Overall Study|Withdrawal by Subject|4|||
124557552|NCT02472977|447999139|FG000|Overall Study|Disease progression|4|||
124557553|NCT02472977|447999140|FG001|Overall Study|Disease progression|25|||
124557554|NCT02472977|447999141|FG002|Overall Study|Disease progression|6|||
124557555|NCT02472977|447999139|FG000|Overall Study|Withdrawal by Subject|0|||
124557556|NCT02472977|447999140|FG001|Overall Study|Withdrawal by Subject|1|||
124557557|NCT02472977|447999141|FG002|Overall Study|Withdrawal by Subject|0|||
124557558|NCT02472977|447999139|FG000|Overall Study|Study drug toxicity|2|||
124557559|NCT02472977|447999140|FG001|Overall Study|Study drug toxicity|0|||
124557560|NCT02472977|447999141|FG002|Overall Study|Study drug toxicity|2|||
124557561|NCT02472977|447999139|FG000|Overall Study|Subject request to discontinue treatment|0|||
124557562|NCT02472977|447999140|FG001|Overall Study|Subject request to discontinue treatment|1|||
124720842|NCT01893411|448601071|FG001|Overall Study|Adverse Event|0|||
124483062|NCT00064701|447720552|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
124483063|NCT00064701|447720553|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
124483064|NCT00064701|447720551|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
124720843|NCT01893411|448601072|FG002|Overall Study|Adverse Event|0|||
124720844|NCT01893411|448601070|FG000|Overall Study|Withdrawal by Subject|7|||
124483065|NCT00064701|447720552|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
124483066|NCT00064701|447720553|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
124483067|NCT00064701|447720551|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
124483068|NCT00064701|447720552|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
124483069|NCT00064701|447720553|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
124483070|NCT00064701|447720551|FG000|One Year Post-transplant|Poor absorption|0|||
124483071|NCT00064701|447720552|FG001|One Year Post-transplant|Poor absorption|1|||
124483072|NCT00064701|447720553|FG002|One Year Post-transplant|Poor absorption|0|||
124483073|NCT00064701|447720551|FG000|One Year Post-transplant|Pancreas transplant|0|||
124483074|NCT00064701|447720552|FG001|One Year Post-transplant|Pancreas transplant|0|||
124483075|NCT00064701|447720553|FG002|One Year Post-transplant|Pancreas transplant|1|||
124483076|NCT00064701|447720551|FG000|Clinical Continuation Phase|Adverse Event|12|||
124483077|NCT00064701|447720552|FG001|Clinical Continuation Phase|Adverse Event|21|||
124483078|NCT00064701|447720553|FG002|Clinical Continuation Phase|Adverse Event|14|||
124483079|NCT00064701|447720551|FG000|Clinical Continuation Phase|Non-compliance|8|||
124483080|NCT00064701|447720552|FG001|Clinical Continuation Phase|Non-compliance|6|||
124483081|NCT00064701|447720553|FG002|Clinical Continuation Phase|Non-compliance|7|||
124483082|NCT00064701|447720551|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
124483083|NCT00064701|447720552|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
124483084|NCT00064701|447720553|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
124483085|NCT00064701|447720551|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
124483086|NCT00064701|447720552|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
124483087|NCT00064701|447720553|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
124483088|NCT00064701|447720551|FG000|Clinical Continuation Phase|Graft Failure|5|||
124483089|NCT00064701|447720552|FG001|Clinical Continuation Phase|Graft Failure|5|||
124483090|NCT00064701|447720553|FG002|Clinical Continuation Phase|Graft Failure|2|||
124483091|NCT00064701|447720551|FG000|Clinical Continuation Phase|Rejection|1|||
124483092|NCT00064701|447720552|FG001|Clinical Continuation Phase|Rejection|2|||
124483093|NCT00064701|447720553|FG002|Clinical Continuation Phase|Rejection|2|||
124483094|NCT00064701|447720551|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
124483095|NCT00064701|447720552|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
124483096|NCT00064701|447720553|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
124483097|NCT00064701|447720551|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
124483098|NCT00064701|447720552|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
124483099|NCT00064701|447720553|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
124483100|NCT00064701|447720551|FG000|Clinical Continuation Phase|Physician Decision|1|||
124483101|NCT00064701|447720552|FG001|Clinical Continuation Phase|Physician Decision|3|||
124483102|NCT00064701|447720553|FG002|Clinical Continuation Phase|Physician Decision|0|||
124483103|NCT00064701|447720551|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
124483104|NCT00064701|447720552|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
124483105|NCT00064701|447720553|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
124483106|NCT00064701|447720551|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
124483107|NCT00064701|447720552|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
124483108|NCT00064701|447720553|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
124483109|NCT00064701|447720551|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
124483110|NCT00064701|447720552|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
124483111|NCT00064701|447720553|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
124483112|NCT00064701|447720551|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
124483113|NCT00064701|447720552|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
124483114|NCT00064701|447720553|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
124483115|NCT00064701|447720551|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
124483116|NCT00064701|447720552|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
124483117|NCT00064701|447720553|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
124483118|NCT00064701|447720551|FG000|Clinical Continuation Phase|Patient opted out|0|||
124483119|NCT00064701|447720552|FG001|Clinical Continuation Phase|Patient opted out|0|||
124483120|NCT00064701|447720553|FG002|Clinical Continuation Phase|Patient opted out|1|||
124483121|NCT01491945|447720555|FG000|Overall Study|Death|30|||
124483122|NCT01491945|447720555|FG000|Overall Study|Withdrwan/LTF|16|||
124483123|NCT01491945|447720555|FG000|Overall Study|Conversion|4|||
124483124|NCT01491945|447720555|FG000|Overall Study|Missed Visit|1|||
124483125|NCT05681715|447720556|FG000|Training Period (6-weeks)|Adverse Event|3|||
124483126|NCT05681715|447720557|FG001|Training Period (6-weeks)|Adverse Event|0|||
124483127|NCT05681715|447720558|FG002|Training Period (6-weeks)|Adverse Event|0|||
124483128|NCT05681715|447720556|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
124557563|NCT02472977|447999141|FG002|Overall Study|Subject request to discontinue treatment|0|||
124557564|NCT00345683|447999142|FG000|Overall Study|Lost to Follow-up|19|||
124557565|NCT00345683|447999143|FG001|Overall Study|Lost to Follow-up|7|||
124557566|NCT00345683|447999142|FG000|Overall Study|Other|6|||
124557567|NCT00345683|447999143|FG001|Overall Study|Other|2|||
124483129|NCT05681715|447720557|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
124483130|NCT05681715|447720558|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
124483131|NCT05681715|447720556|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
124483132|NCT05681715|447720557|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
124483133|NCT05681715|447720558|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
124483134|NCT05681715|447720556|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
124483135|NCT05681715|447720557|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
124483136|NCT05681715|447720558|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
124483137|NCT05681715|447720556|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
124483138|NCT05681715|447720557|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
124483139|NCT05681715|447720558|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
124483140|NCT05681715|447720556|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
124483141|NCT05681715|447720557|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
124483142|NCT05681715|447720558|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
124483143|NCT05681715|447720556|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
124483144|NCT05681715|447720557|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
124483145|NCT05681715|447720558|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
124483146|NCT05681715|447720556|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
124483147|NCT05681715|447720557|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
124483148|NCT05681715|447720558|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
124483149|NCT02700451|447720565|FG000|Overall Study|Protocol Violation|2|||
124483150|NCT02700451|447720566|FG001|Overall Study|Protocol Violation|2|||
124483151|NCT02700451|447720567|FG002|Overall Study|Protocol Violation|3|||
124483152|NCT02700451|447720565|FG000|Overall Study|Discontinued intervention|14|||
124483153|NCT02700451|447720566|FG001|Overall Study|Discontinued intervention|15|||
124483154|NCT02700451|447720567|FG002|Overall Study|Discontinued intervention|14|||
124483155|NCT04373460|447720568|FG000|Overall Study|Did not receive tranfusion|18|||
124483156|NCT04373460|447720569|FG001|Overall Study|Did not receive tranfusion|26|||
124483157|NCT01672957|447720570|FG000|Overall Study|Protocol Violation|48|||
124483158|NCT01672957|447720570|FG000|Overall Study|Death|2|||
124483159|NCT01672957|447720570|FG000|Overall Study|ICF Signed After Transplantation|5|||
124483160|NCT02115308|447720576|FG000|Overall Study|Safety Screening|2|||
124483161|NCT02115308|447720577|FG001|Overall Study|Safety Screening|2|||
124483162|NCT02344576|447720584|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
124483163|NCT02344576|447720585|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
124483164|NCT02344576|447720586|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
124483165|NCT02344576|447720587|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
124483166|NCT02344576|447720584|FG000|1-Month Follow-Up|Death|13|||
124483167|NCT02344576|447720585|FG001|1-Month Follow-Up|Death|8|||
124483168|NCT02344576|447720586|FG002|1-Month Follow-Up|Death|0|||
124483169|NCT02344576|447720587|FG003|1-Month Follow-Up|Death|0|||
124483170|NCT02344576|447720584|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
124483171|NCT02344576|447720585|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
124483172|NCT02344576|447720586|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
124483173|NCT02344576|447720587|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
124483174|NCT02344576|447720584|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
124483175|NCT02344576|447720585|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
124483176|NCT02344576|447720586|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
124483177|NCT02344576|447720587|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
124483178|NCT02344576|447720584|FG000|6-Month Follow-Up|Death|14|||
124483179|NCT02344576|447720585|FG001|6-Month Follow-Up|Death|14|||
124483180|NCT02344576|447720586|FG002|6-Month Follow-Up|Death|0|||
124483181|NCT02344576|447720587|FG003|6-Month Follow-Up|Death|0|||
124483182|NCT02344576|447720584|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
124483183|NCT02344576|447720585|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
124483184|NCT02344576|447720586|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
124483185|NCT02344576|447720587|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
124483186|NCT02344576|447720584|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
124483187|NCT02344576|447720585|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
124483188|NCT02344576|447720586|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
124557568|NCT04288115|447999144|FG000|Overall Study|Withdrawal by Subject|0|||
124557569|NCT04288115|447999145|FG001|Overall Study|Withdrawal by Subject|1|||
124637284|NCT01081769|448290460|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
124483189|NCT02344576|447720587|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
124637285|NCT01081769|448290461|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
124637286|NCT01081769|448290460|FG000|CORE Intent-To-Treat|Pregnancy|1|||
124637287|NCT01081769|448290461|FG001|CORE Intent-To-Treat|Pregnancy|0|||
124637288|NCT01081769|448290460|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
124637289|NCT01081769|448290461|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
124483190|NCT04325503|447720588|FG000|Overall Study|Withdrawal by Subject|1|||
124483191|NCT04325503|447720588|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
124483192|NCT03832387|447720591|FG000|Overall Study|Protocol Violation|2|||
124483193|NCT03832387|447720592|FG001|Overall Study|Protocol Violation|6|||
124483194|NCT03832387|447720591|FG000|Overall Study|EXCLUSION CRITERIA|3|||
124483195|NCT03832387|447720592|FG001|Overall Study|EXCLUSION CRITERIA|1|||
124483196|NCT05202808|447720593|FG000|Overall Study|Lost to Follow-up|3|||
124483197|NCT05202808|447720594|FG001|Overall Study|Lost to Follow-up|1|||
124483198|NCT02495948|447720595|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
124483199|NCT02495948|447720596|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
124483200|NCT02495948|447720595|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
124483201|NCT02495948|447720596|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
124483202|NCT02747004|447720597|FG000|Overall Study|Withdrawal by Subject|8|||
124483203|NCT02747004|447720598|FG001|Overall Study|Withdrawal by Subject|5|||
124483204|NCT02747004|447720599|FG002|Overall Study|Withdrawal by Subject|4|||
124483205|NCT02747004|447720597|FG000|Overall Study|Lost to Follow-up|1|||
124483206|NCT02747004|447720598|FG001|Overall Study|Lost to Follow-up|2|||
124483207|NCT02747004|447720599|FG002|Overall Study|Lost to Follow-up|2|||
124483208|NCT02747004|447720597|FG000|Overall Study|on study treatment/follow-up|48|||
124483209|NCT02747004|447720598|FG001|Overall Study|on study treatment/follow-up|42|||
124483210|NCT02747004|447720599|FG002|Overall Study|on study treatment/follow-up|41|||
124483211|NCT06218251|447720600|FG000|Overall Study|Lost to Follow-up|4|||
124483212|NCT05087030|447720601|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
124483213|NCT05087030|447720602|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
124483214|NCT05087030|447720603|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
124483215|NCT05087030|447720604|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
124483216|NCT05087030|447720605|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
124483217|NCT05087030|447720601|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
124483218|NCT05087030|447720602|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
124483219|NCT05087030|447720603|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
124483220|NCT05087030|447720604|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
124483221|NCT05087030|447720605|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
124483222|NCT05087030|447720601|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
124483223|NCT05087030|447720602|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
124483224|NCT05087030|447720603|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
124483225|NCT05087030|447720604|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
124483226|NCT05087030|447720605|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
124483227|NCT05087030|447720601|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
124483228|NCT05087030|447720602|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
124483229|NCT05087030|447720603|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
124483230|NCT05087030|447720604|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
124483231|NCT05087030|447720605|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
124483232|NCT05087030|447720601|FG000|Main Period (Week 0 to Week 52)|Death|0|||
124483233|NCT05087030|447720602|FG001|Main Period (Week 0 to Week 52)|Death|1|||
124483234|NCT05087030|447720603|FG002|Main Period (Week 0 to Week 52)|Death|0|||
124483235|NCT05087030|447720604|FG003|Main Period (Week 0 to Week 52)|Death|0|||
124483236|NCT05087030|447720605|FG004|Main Period (Week 0 to Week 52)|Death|0|||
124483237|NCT05087030|447720601|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
124483238|NCT05087030|447720602|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
124483239|NCT05087030|447720603|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
124483240|NCT05087030|447720604|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
124483241|NCT05087030|447720605|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
124483242|NCT05087030|447720601|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
124483243|NCT05087030|447720602|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
124483244|NCT05087030|447720603|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
124483245|NCT05087030|447720604|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
124483246|NCT05087030|447720605|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
124483247|NCT05087030|447720601|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
124483248|NCT05087030|447720602|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
124483249|NCT05087030|447720603|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
124483250|NCT05087030|447720604|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
124483251|NCT05087030|447720605|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
124483252|NCT05087030|447720601|FG000|Main Period (Week 0 to Week 52)|Other|1|||
124483253|NCT05087030|447720602|FG001|Main Period (Week 0 to Week 52)|Other|2|||
124483254|NCT05087030|447720603|FG002|Main Period (Week 0 to Week 52)|Other|0|||
124483255|NCT05087030|447720604|FG003|Main Period (Week 0 to Week 52)|Other|0|||
124483256|NCT05087030|447720605|FG004|Main Period (Week 0 to Week 52)|Other|0|||
124557570|NCT04288115|447999144|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
124483257|NCT05087030|447720601|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
124483258|NCT05087030|447720602|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
124483259|NCT05087030|447720603|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
124483260|NCT05087030|447720604|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
124483261|NCT05087030|447720605|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
124483262|NCT01053429|447720606|FG000|Overall Study|Adverse Event|64|||
124483263|NCT01053429|447720606|FG000|Overall Study|Other|309|||
124483264|NCT00963807|447720607|FG000|Overall Study|Physician Decision|2|||
124483265|NCT00963807|447720607|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
124483266|NCT00963807|447720607|FG000|Overall Study|Disease progression|15|||
124483267|NCT02031679|447723113|FG000|Overall Study|Protocol Violation|0|||
124483268|NCT02031679|447723114|FG001|Overall Study|Protocol Violation|1|||
124483269|NCT02031679|447723113|FG000|Overall Study|Lack of Efficacy|0|||
124483270|NCT02031679|447723114|FG001|Overall Study|Lack of Efficacy|1|||
124483271|NCT04030195|447723115|FG000|Overall Study|Withdrawal by Subject|2|||
124483272|NCT04030195|447723116|FG001|Overall Study|Withdrawal by Subject|0|||
124483273|NCT04030195|447723117|FG002|Overall Study|Withdrawal by Subject|0|||
124483274|NCT01024244|447723118|FG000|Overall Study|Adverse Event|1|||
124483275|NCT01024244|447723119|FG001|Overall Study|Adverse Event|2|||
124483276|NCT01024244|447723120|FG002|Overall Study|Adverse Event|0|||
124483277|NCT01024244|447723121|FG003|Overall Study|Adverse Event|1|||
124483278|NCT01024244|447723122|FG004|Overall Study|Adverse Event|2|||
124483279|NCT01024244|447723118|FG000|Overall Study|Entry Criteria Not Met|0|||
124483280|NCT01024244|447723119|FG001|Overall Study|Entry Criteria Not Met|1|||
124483281|NCT01024244|447723120|FG002|Overall Study|Entry Criteria Not Met|0|||
124483282|NCT01024244|447723121|FG003|Overall Study|Entry Criteria Not Met|0|||
124483283|NCT01024244|447723122|FG004|Overall Study|Entry Criteria Not Met|0|||
124483284|NCT01024244|447723118|FG000|Overall Study|Lack of Efficacy|1|||
124483285|NCT01024244|447723119|FG001|Overall Study|Lack of Efficacy|0|||
124483286|NCT01024244|447723120|FG002|Overall Study|Lack of Efficacy|0|||
124483287|NCT01024244|447723121|FG003|Overall Study|Lack of Efficacy|0|||
124483288|NCT01024244|447723122|FG004|Overall Study|Lack of Efficacy|0|||
124483289|NCT01024244|447723118|FG000|Overall Study|Protocol Violation|1|||
124483290|NCT01024244|447723119|FG001|Overall Study|Protocol Violation|0|||
124483291|NCT01024244|447723120|FG002|Overall Study|Protocol Violation|0|||
124483292|NCT01024244|447723121|FG003|Overall Study|Protocol Violation|0|||
124483293|NCT01024244|447723122|FG004|Overall Study|Protocol Violation|2|||
124483294|NCT01024244|447723118|FG000|Overall Study|Sponsor Decision|14|||
124483295|NCT01024244|447723119|FG001|Overall Study|Sponsor Decision|7|||
124483296|NCT01024244|447723120|FG002|Overall Study|Sponsor Decision|14|||
124483297|NCT01024244|447723121|FG003|Overall Study|Sponsor Decision|12|||
124483298|NCT01024244|447723122|FG004|Overall Study|Sponsor Decision|10|||
124483299|NCT01024244|447723118|FG000|Overall Study|Withdrawal by Subject|0|||
124483300|NCT01024244|447723119|FG001|Overall Study|Withdrawal by Subject|1|||
124483301|NCT01024244|447723120|FG002|Overall Study|Withdrawal by Subject|0|||
124483302|NCT01024244|447723121|FG003|Overall Study|Withdrawal by Subject|0|||
124483303|NCT01024244|447723122|FG004|Overall Study|Withdrawal by Subject|0|||
124483304|NCT02660580|447723128|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
124483305|NCT02660580|447723129|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
124483306|NCT02660580|447723130|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
124483307|NCT02660580|447723131|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
124483308|NCT02660580|447723132|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
124483309|NCT02660580|447723128|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
124483310|NCT02660580|447723129|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
124483311|NCT02660580|447723130|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
124483312|NCT02660580|447723131|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
124483313|NCT02660580|447723132|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
124483314|NCT02660580|447723128|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
124720845|NCT01893411|448601071|FG001|Overall Study|Withdrawal by Subject|4|||
124483315|NCT02660580|447723129|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
124483316|NCT02660580|447723130|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
124720846|NCT01893411|448601072|FG002|Overall Study|Withdrawal by Subject|3|||
124483317|NCT02660580|447723131|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
124483318|NCT02660580|447723132|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
124483319|NCT02660580|447723128|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
124483320|NCT02660580|447723129|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
124483321|NCT02660580|447723130|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
124720847|NCT01893411|448601070|FG000|Overall Study|Lost to Follow-up|2|||
124483322|NCT02660580|447723131|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
124483323|NCT02660580|447723132|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
124483324|NCT02660580|447723128|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
124483325|NCT02660580|447723129|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
124720848|NCT01893411|448601071|FG001|Overall Study|Lost to Follow-up|0|||
124720849|NCT01893411|448601072|FG002|Overall Study|Lost to Follow-up|1|||
124720850|NCT02403817|448601075|FG000|Overall Study|Withdrawal by Subject|5|||
124720851|NCT02403817|448601076|FG001|Overall Study|Withdrawal by Subject|0|||
124720852|NCT03053440|448601077|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
124720853|NCT03053440|448601078|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
124720854|NCT03053440|448601077|FG000|Overall Study|Death|18|||
124483326|NCT02660580|447723130|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
124720855|NCT03053440|448601078|FG001|Overall Study|Death|14|||
124720856|NCT03053440|448601077|FG000|Overall Study|Withdrawal by Subject|9|||
124720857|NCT03053440|448601078|FG001|Overall Study|Withdrawal by Subject|8|||
124720858|NCT03053440|448601077|FG000|Overall Study|Lost to Follow-up|1|||
124720859|NCT03053440|448601078|FG001|Overall Study|Lost to Follow-up|0|||
124720860|NCT03053440|448601077|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
124720861|NCT03053440|448601078|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
124720862|NCT03053440|448601077|FG000|Overall Study|Physician Decision|2|||
124720863|NCT03053440|448601078|FG001|Overall Study|Physician Decision|1|||
124720864|NCT03053440|448601077|FG000|Overall Study|Participant Randomized but died before dosing|1|||
124720865|NCT03053440|448601078|FG001|Overall Study|Participant Randomized but died before dosing|0|||
124720866|NCT00430989|448601079|FG000|Overall Study|Lost to Follow-up|2|||
124720867|NCT00430989|448601080|FG001|Overall Study|Lost to Follow-up|3|||
124720868|NCT00430989|448601079|FG000|Overall Study|Withdrawal by Subject|15|||
124720869|NCT00430989|448601080|FG001|Overall Study|Withdrawal by Subject|14|||
124720870|NCT00430989|448601079|FG000|Overall Study|Protocol Violation|30|||
124720871|NCT00430989|448601080|FG001|Overall Study|Protocol Violation|37|||
124720872|NCT00430989|448601079|FG000|Overall Study|Not eligible|13|||
124720873|NCT00430989|448601080|FG001|Overall Study|Not eligible|6|||
124720874|NCT01701362|448601081|FG000|Overall Study|Adverse events not related to study drug|1|||
124720875|NCT01701362|448601082|FG001|Overall Study|Adverse events not related to study drug|6|||
124720876|NCT01701362|448601081|FG000|Overall Study|Adverse events related to study drug|12|||
124720877|NCT01701362|448601082|FG001|Overall Study|Adverse events related to study drug|10|||
124720878|NCT01701362|448601081|FG000|Overall Study|Protocol Violation|5|||
124720879|NCT01701362|448601082|FG001|Overall Study|Protocol Violation|3|||
124483327|NCT02660580|447723131|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
124483328|NCT02660580|447723132|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
124483329|NCT02660580|447723128|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
124483330|NCT02660580|447723129|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
124483331|NCT02660580|447723130|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
124483332|NCT02660580|447723131|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
124483333|NCT02660580|447723132|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
124483334|NCT02660580|447723128|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
124483335|NCT02660580|447723129|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
124483336|NCT02660580|447723130|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
124483337|NCT02660580|447723131|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
124483338|NCT02660580|447723132|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
124483339|NCT02660580|447723128|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
124483340|NCT02660580|447723129|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
124483341|NCT02660580|447723130|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
124483342|NCT02660580|447723131|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
124483343|NCT02660580|447723132|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
124483344|NCT02660580|447723128|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
124483345|NCT02660580|447723129|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
124483346|NCT02660580|447723130|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
124483347|NCT02660580|447723131|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
124483348|NCT02660580|447723132|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
124483349|NCT02660580|447723128|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
124483350|NCT02660580|447723129|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
124483351|NCT02660580|447723130|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
124483352|NCT02660580|447723131|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
124483353|NCT02660580|447723132|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
124483354|NCT02660580|447723128|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
124483355|NCT02660580|447723129|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
124483356|NCT02660580|447723130|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
124483357|NCT02660580|447723131|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
124483358|NCT02660580|447723132|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
124720880|NCT01701362|448601081|FG000|Overall Study|No longer willing to participate|8|||
124720881|NCT01701362|448601082|FG001|Overall Study|No longer willing to participate|14|||
124720882|NCT01701362|448601081|FG000|Overall Study|Lost to Follow-up|6|||
124720883|NCT01701362|448601082|FG001|Overall Study|Lost to Follow-up|9|||
124720884|NCT01701362|448601081|FG000|Overall Study|Insufficient clinical response|6|||
124483359|NCT02660580|447723128|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
124483360|NCT02660580|447723129|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
124483361|NCT02660580|447723130|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
124483362|NCT02660580|447723131|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
124483363|NCT02660580|447723132|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
124483364|NCT02660580|447723128|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
124483365|NCT02660580|447723129|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
124483366|NCT02660580|447723130|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
124483367|NCT02660580|447723131|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
124483368|NCT02660580|447723132|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
124483369|NCT00377962|447723133|FG000|Core Study: 0-12 Months|Adverse Event|18|||
124483370|NCT00377962|447723134|FG001|Core Study: 0-12 Months|Adverse Event|2|||
124483371|NCT00377962|447723133|FG000|Core Study: 0-12 Months|Death|3|||
124483372|NCT00377962|447723134|FG001|Core Study: 0-12 Months|Death|0|||
124483373|NCT00377962|447723133|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
124483374|NCT00377962|447723134|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
124483375|NCT00377962|447723133|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
124483376|NCT00377962|447723134|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
124483377|NCT00377962|447723133|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
124483378|NCT00377962|447723134|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
124483379|NCT00377962|447723133|FG000|Extension Study: 12-24 Months|Death|1|||
124483380|NCT00377962|447723134|FG001|Extension Study: 12-24 Months|Death|1|||
124483381|NCT00377962|447723133|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
124483382|NCT00377962|447723134|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
124483383|NCT00377962|447723133|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
124483384|NCT00377962|447723134|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
124483385|NCT00377962|447723133|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
124483386|NCT00377962|447723134|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
124483387|NCT04645797|447723137|FG000|Overall Study|Disease Progression|3|||
124483388|NCT04645797|447723138|FG001|Overall Study|Disease Progression|3|||
124483389|NCT04645797|447723139|FG002|Overall Study|Disease Progression|1|||
124483390|NCT04645797|447723140|FG003|Overall Study|Disease Progression|0|||
124483391|NCT04645797|447723141|FG004|Overall Study|Disease Progression|0|||
124483392|NCT04645797|447723142|FG005|Overall Study|Disease Progression|0|||
124483393|NCT04645797|447723143|FG006|Overall Study|Disease Progression|0|||
124483394|NCT04645797|447723137|FG000|Overall Study|Death|3|||
124483395|NCT04645797|447723138|FG001|Overall Study|Death|1|||
124483396|NCT04645797|447723139|FG002|Overall Study|Death|0|||
124483397|NCT04645797|447723140|FG003|Overall Study|Death|0|||
124483398|NCT04645797|447723141|FG004|Overall Study|Death|0|||
124483399|NCT04645797|447723142|FG005|Overall Study|Death|0|||
124483400|NCT04645797|447723143|FG006|Overall Study|Death|0|||
124483401|NCT00049127|447723144|FG000|Overall Study|Withdrawal by Subject|0|||
124483402|NCT00049127|447723145|FG001|Overall Study|Withdrawal by Subject|0|||
124483403|NCT00049127|447723146|FG002|Overall Study|Withdrawal by Subject|1|||
124483404|NCT00049127|447723147|FG003|Overall Study|Withdrawal by Subject|0|||
124483405|NCT00049127|447723148|FG004|Overall Study|Withdrawal by Subject|0|||
124483406|NCT02582515|447723149|FG000|Overall Study|Withdrawal by Subject|0|||
124483407|NCT02582515|447723150|FG001|Overall Study|Withdrawal by Subject|1|||
124483408|NCT00775021|447723151|FG000|First Intervention|Lost to Follow-up|1|||
124483409|NCT00775021|447723152|FG001|First Intervention|Lost to Follow-up|0|||
124483410|NCT00775021|447723151|FG000|Second Intervention|Adverse Event|0|||
124483411|NCT00775021|447723152|FG001|Second Intervention|Adverse Event|1|||
124483412|NCT02599402|447723153|FG000|Overall Study|Disease progression|153|||
124483413|NCT02599402|447723153|FG000|Overall Study|Study drug toxicity|201|||
124483414|NCT02599402|447723153|FG000|Overall Study|Death|26|||
124483415|NCT02599402|447723153|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
124483416|NCT02599402|447723153|FG000|Overall Study|Participant request to discontinue study treatment|13|||
124483417|NCT02599402|447723153|FG000|Overall Study|Participant withdrew consent|5|||
124483418|NCT02599402|447723153|FG000|Overall Study|Lost to Follow-up|1|||
124483419|NCT02599402|447723153|FG000|Overall Study|Maximum Clinical Benefit|7|||
124483420|NCT02599402|447723153|FG000|Overall Study|Poor/non-compliance|1|||
124483421|NCT02599402|447723153|FG000|Overall Study|Pregnancy|1|||
124483422|NCT02599402|447723153|FG000|Overall Study|Participant no longer met study criteria|7|||
124483423|NCT02599402|447723153|FG000|Overall Study|Other Reasons|95|||
124483424|NCT00833092|447723154|FG000|Overall Study|Withdrawal by Subject|2|||
124483425|NCT00833092|447723155|FG001|Overall Study|Withdrawal by Subject|3|||
124483426|NCT00833092|447723154|FG000|Overall Study|Protocol Violation|2|||
124483427|NCT00833092|447723155|FG001|Overall Study|Protocol Violation|1|||
124483428|NCT00833092|447723154|FG000|Overall Study|Diarrhea|0|||
124483429|NCT00833092|447723155|FG001|Overall Study|Diarrhea|2|||
124483430|NCT00833092|447723154|FG000|Overall Study|constipation|0|||
124483431|NCT00833092|447723155|FG001|Overall Study|constipation|1|||
124483432|NCT01773473|447723156|FG000|Overall Study|Adverse Event|3|||
124483433|NCT01773473|447723157|FG001|Overall Study|Adverse Event|2|||
124483434|NCT01773473|447723156|FG000|Overall Study|Protocol Violation|0|||
124483435|NCT01773473|447723157|FG001|Overall Study|Protocol Violation|4|||
124483436|NCT01773473|447723156|FG000|Overall Study|Physician Decision|3|||
124483437|NCT01773473|447723157|FG001|Overall Study|Physician Decision|5|||
124483438|NCT01773473|447723156|FG000|Overall Study|Sponsor Decision|2|||
124483439|NCT01773473|447723157|FG001|Overall Study|Sponsor Decision|0|||
124483440|NCT01773473|447723156|FG000|Overall Study|Lack of Efficacy|0|||
124483441|NCT01773473|447723157|FG001|Overall Study|Lack of Efficacy|1|||
124483442|NCT01773473|447723156|FG000|Overall Study|Non-Compliance with study drug|1|||
124483443|NCT01773473|447723157|FG001|Overall Study|Non-Compliance with study drug|4|||
124483444|NCT01773473|447723156|FG000|Overall Study|Withdrawal by Subject|5|||
124483445|NCT01773473|447723157|FG001|Overall Study|Withdrawal by Subject|3|||
124483446|NCT01773473|447723156|FG000|Overall Study|Lost to Follow-up|2|||
124483447|NCT01773473|447723157|FG001|Overall Study|Lost to Follow-up|0|||
124483448|NCT00929240|447723162|FG000|Initial Treatment Phase|Adverse Event|31|||
124483449|NCT00929240|447723163|FG001|Initial Treatment Phase|Adverse Event|0|||
124483450|NCT00929240|447723164|FG002|Initial Treatment Phase|Adverse Event|0|||
124483451|NCT00929240|447723162|FG000|Initial Treatment Phase|Disease progression|41|||
124483452|NCT00929240|447723163|FG001|Initial Treatment Phase|Disease progression|0|||
124483453|NCT00929240|447723164|FG002|Initial Treatment Phase|Disease progression|0|||
124483454|NCT00929240|447723162|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
124483455|NCT00929240|447723163|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
124483456|NCT00929240|447723164|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
124483457|NCT00929240|447723162|FG000|Initial Treatment Phase|Protocol Violation|5|||
124483458|NCT00929240|447723163|FG001|Initial Treatment Phase|Protocol Violation|0|||
124483459|NCT00929240|447723164|FG002|Initial Treatment Phase|Protocol Violation|0|||
124483460|NCT00929240|447723162|FG000|Initial Treatment Phase|Death|2|||
124483461|NCT00929240|447723163|FG001|Initial Treatment Phase|Death|0|||
124483462|NCT00929240|447723164|FG002|Initial Treatment Phase|Death|0|||
124483463|NCT00929240|447723162|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
124720885|NCT01701362|448601082|FG001|Overall Study|Insufficient clinical response|6|||
124483464|NCT00929240|447723163|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
124483465|NCT00929240|447723164|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
124483466|NCT00929240|447723162|FG000|Initial Treatment Phase|Physician Decision|4|||
124483467|NCT00929240|447723163|FG001|Initial Treatment Phase|Physician Decision|0|||
124483468|NCT00929240|447723164|FG002|Initial Treatment Phase|Physician Decision|0|||
124483469|NCT00929240|447723162|FG000|Maintenance Phase|Disease progression|0|||
124483470|NCT00929240|447723163|FG001|Maintenance Phase|Disease progression|73|||
124483471|NCT00929240|447723164|FG002|Maintenance Phase|Disease progression|60|||
124483472|NCT00929240|447723162|FG000|Maintenance Phase|Adverse Event|0|||
124483473|NCT00929240|447723163|FG001|Maintenance Phase|Adverse Event|9|||
124483474|NCT00929240|447723164|FG002|Maintenance Phase|Adverse Event|12|||
124483475|NCT00929240|447723162|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124483476|NCT00929240|447723163|FG001|Maintenance Phase|Withdrawal by Subject|2|||
124483477|NCT00929240|447723164|FG002|Maintenance Phase|Withdrawal by Subject|6|||
124483478|NCT00929240|447723162|FG000|Maintenance Phase|Protocol Violation|0|||
124483479|NCT00929240|447723163|FG001|Maintenance Phase|Protocol Violation|1|||
124483480|NCT00929240|447723164|FG002|Maintenance Phase|Protocol Violation|0|||
124483481|NCT00929240|447723162|FG000|Maintenance Phase|Health authority/Study termination|0|||
124483482|NCT00929240|447723163|FG001|Maintenance Phase|Health authority/Study termination|1|||
124483483|NCT00929240|447723164|FG002|Maintenance Phase|Health authority/Study termination|2|||
124483484|NCT00929240|447723162|FG000|Maintenance Phase|Physician Decision|0|||
124483485|NCT00929240|447723163|FG001|Maintenance Phase|Physician Decision|2|||
124483486|NCT00929240|447723164|FG002|Maintenance Phase|Physician Decision|1|||
124483487|NCT00929240|447723162|FG000|Maintenance Phase|Change of treatment|0|||
124483488|NCT00929240|447723163|FG001|Maintenance Phase|Change of treatment|4|||
124483489|NCT00929240|447723164|FG002|Maintenance Phase|Change of treatment|0|||
124483490|NCT00929240|447723162|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
124483491|NCT00929240|447723163|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
124483492|NCT00929240|447723164|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
124483493|NCT00929240|447723162|FG000|Maintenance Phase|Participant not treated|0|||
124720886|NCT01701362|448601081|FG000|Overall Study|Death|0|||
124720887|NCT01701362|448601082|FG001|Overall Study|Death|1|||
124720888|NCT01701362|448601081|FG000|Overall Study|Randomized but not treated|1|||
124483494|NCT00929240|447723163|FG001|Maintenance Phase|Participant not treated|2|||
124483495|NCT00929240|447723164|FG002|Maintenance Phase|Participant not treated|0|||
124483496|NCT02371629|447723165|FG000|Overall Study|Patient decision|14|||
124483497|NCT02371629|447723166|FG001|Overall Study|Patient decision|10|||
124483498|NCT02371629|447723165|FG000|Overall Study|Adverse Event|8|||
124483499|NCT02371629|447723166|FG001|Overall Study|Adverse Event|8|||
124483500|NCT02371629|447723165|FG000|Overall Study|Physician Decision|2|||
124483501|NCT02371629|447723166|FG001|Overall Study|Physician Decision|3|||
124483502|NCT02371629|447723165|FG000|Overall Study|Death|1|||
124483503|NCT02371629|447723166|FG001|Overall Study|Death|1|||
124483504|NCT02371629|447723165|FG000|Overall Study|Noncompliance with study treatment|1|||
124483505|NCT02371629|447723166|FG001|Overall Study|Noncompliance with study treatment|0|||
124483506|NCT02371629|447723165|FG000|Overall Study|Lack of Efficacy|0|||
124483507|NCT02371629|447723166|FG001|Overall Study|Lack of Efficacy|2|||
124483508|NCT02371629|447723165|FG000|Overall Study|Protocol deviation|0|||
124483509|NCT02371629|447723166|FG001|Overall Study|Protocol deviation|1|||
124483510|NCT00805207|447723167|FG000|Overall Study|Protocol Violation|0|||
124483511|NCT00805207|447723168|FG001|Overall Study|Protocol Violation|0|||
124483512|NCT00805207|447723169|FG002|Overall Study|Protocol Violation|1|||
124483513|NCT00805207|447723170|FG003|Overall Study|Protocol Violation|0|||
124483514|NCT00805207|447723171|FG004|Overall Study|Protocol Violation|0|||
124483515|NCT00805207|447723172|FG005|Overall Study|Protocol Violation|0|||
124483516|NCT00805207|447723173|FG006|Overall Study|Protocol Violation|0|||
124483517|NCT00805207|447723174|FG007|Overall Study|Protocol Violation|0|||
124483518|NCT00805207|447723175|FG008|Overall Study|Protocol Violation|0|||
124483519|NCT00805207|447723167|FG000|Overall Study|Physician Decision|0|||
124483520|NCT00805207|447723168|FG001|Overall Study|Physician Decision|1|||
124483521|NCT00805207|447723169|FG002|Overall Study|Physician Decision|0|||
124483522|NCT00805207|447723170|FG003|Overall Study|Physician Decision|0|||
124483523|NCT00805207|447723171|FG004|Overall Study|Physician Decision|0|||
124483524|NCT00805207|447723172|FG005|Overall Study|Physician Decision|1|||
124483525|NCT00805207|447723173|FG006|Overall Study|Physician Decision|0|||
124483526|NCT00805207|447723174|FG007|Overall Study|Physician Decision|0|||
124483527|NCT00805207|447723175|FG008|Overall Study|Physician Decision|0|||
124483528|NCT00805207|447723167|FG000|Overall Study|Withdrawal by Subject|0|||
124483529|NCT00805207|447723168|FG001|Overall Study|Withdrawal by Subject|1|||
124483530|NCT00805207|447723169|FG002|Overall Study|Withdrawal by Subject|0|||
124483531|NCT00805207|447723170|FG003|Overall Study|Withdrawal by Subject|0|||
124483532|NCT00805207|447723171|FG004|Overall Study|Withdrawal by Subject|1|||
124483533|NCT00805207|447723172|FG005|Overall Study|Withdrawal by Subject|2|||
124483534|NCT00805207|447723173|FG006|Overall Study|Withdrawal by Subject|0|||
124483535|NCT00805207|447723174|FG007|Overall Study|Withdrawal by Subject|0|||
124483536|NCT00805207|447723175|FG008|Overall Study|Withdrawal by Subject|0|||
124483537|NCT00201851|447723176|FG000|Overall Study|Lost to Follow-up|2|||
124483538|NCT00201851|447723177|FG001|Overall Study|Lost to Follow-up|1|||
124483539|NCT00201851|447723178|FG002|Overall Study|Lost to Follow-up|0|||
124483540|NCT00201851|447723176|FG000|Overall Study|Ineligible post enrollment|6|||
124483541|NCT00201851|447723177|FG001|Overall Study|Ineligible post enrollment|1|||
124483542|NCT00201851|447723178|FG002|Overall Study|Ineligible post enrollment|1|||
124483543|NCT02469246|447723179|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
124483544|NCT02469246|447723180|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
124483545|NCT02469246|447723179|FG000|Double-Blind Phase|Adverse Event|12|||
124483546|NCT02469246|447723180|FG001|Double-Blind Phase|Adverse Event|9|||
124483547|NCT02469246|447723179|FG000|Double-Blind Phase|Death|2|||
124483548|NCT02469246|447723180|FG001|Double-Blind Phase|Death|0|||
124483549|NCT02469246|447723179|FG000|Double-Blind Phase|Lack of Efficacy|2|||
124483550|NCT02469246|447723180|FG001|Double-Blind Phase|Lack of Efficacy|1|||
124483551|NCT02469246|447723179|FG000|Double-Blind Phase|Investigator's Discretion|8|||
124483552|NCT02469246|447723180|FG001|Double-Blind Phase|Investigator's Discretion|8|||
124483553|NCT02469246|447723179|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
124483554|NCT02469246|447723180|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
124483555|NCT02469246|447723179|FG000|Double-Blind Phase|Protocol Violation|1|||
124483556|NCT02469246|447723180|FG001|Double-Blind Phase|Protocol Violation|1|||
124483557|NCT02469246|447723179|FG000|Double-Blind Phase|Withdrew Consent|25|||
124483558|NCT02469246|447723180|FG001|Double-Blind Phase|Withdrew Consent|25|||
124483559|NCT02469246|447723179|FG000|Double-Blind Phase|Lost to Follow-up|9|||
124483560|NCT02469246|447723180|FG001|Double-Blind Phase|Lost to Follow-up|5|||
124483561|NCT05564052|447723184|FG000|Overall Study|Withdrawal by Subject|0|||
124483562|NCT05564052|447723185|FG001|Overall Study|Withdrawal by Subject|0|||
124483563|NCT05564052|447723186|FG002|Overall Study|Withdrawal by Subject|0|||
124483564|NCT05564052|447723187|FG003|Overall Study|Withdrawal by Subject|1|||
124483565|NCT05564052|447723184|FG000|Overall Study|Ongoing|8|||
124483566|NCT05564052|447723185|FG001|Overall Study|Ongoing|5|||
124483567|NCT05564052|447723186|FG002|Overall Study|Ongoing|4|||
124483568|NCT05564052|447723187|FG003|Overall Study|Ongoing|1|||
124483569|NCT01658514|447723196|FG000|Overall Study|Protocol Violation|1|||
124483570|NCT01658514|447723197|FG001|Overall Study|Protocol Violation|0|||
124483571|NCT01658514|447723198|FG002|Overall Study|Protocol Violation|2|||
124483572|NCT01856114|447723215|FG000|Overall Study|Withdrawal by Subject|1|||
124483573|NCT01856114|447723216|FG001|Overall Study|Withdrawal by Subject|0|||
124483574|NCT01856114|447723215|FG000|Overall Study|Adverse Event|1|||
124483575|NCT01856114|447723216|FG001|Overall Study|Adverse Event|0|||
124483576|NCT00144170|447723217|FG000|Overall Study|Adverse Event|84|||
124483577|NCT00144170|447723218|FG001|Overall Study|Adverse Event|41|||
124483578|NCT00144170|447723217|FG000|Overall Study|Protocol Violation|23|||
124483579|NCT00144170|447723218|FG001|Overall Study|Protocol Violation|16|||
124483580|NCT00144170|447723217|FG000|Overall Study|Lost to Follow-up|5|||
124483581|NCT00144170|447723218|FG001|Overall Study|Lost to Follow-up|10|||
124483582|NCT00144170|447723217|FG000|Overall Study|Withdrawal by Subject|29|||
124483583|NCT00144170|447723218|FG001|Overall Study|Withdrawal by Subject|13|||
124483584|NCT00144170|447723217|FG000|Overall Study|Other reason not defined above|211|||
124483585|NCT00144170|447723218|FG001|Overall Study|Other reason not defined above|316|||
124483586|NCT00981526|447723219|FG000|Overall Study|Withdrawal by Subject|0|||
124483587|NCT00981526|447723220|FG001|Overall Study|Withdrawal by Subject|2|||
124483588|NCT00981526|447723219|FG000|Overall Study|Physician Decision|4|||
124483589|NCT00981526|447723220|FG001|Overall Study|Physician Decision|4|||
124483590|NCT01243268|447723221|FG000|Overall Study|Lost to Follow-up|4|||
124483591|NCT01243268|447723221|FG000|Overall Study|Protocol Violation|51|||
124483592|NCT01243268|447723221|FG000|Overall Study|Deviation with contract date|7|||
124483593|NCT01243268|447723221|FG000|Overall Study|Duplicate subject|2|||
124483594|NCT01564784|447723222|FG000|Overall Study|Other|1|||
124483595|NCT01564784|447723223|FG001|Overall Study|Other|0|||
124483596|NCT01564784|447723222|FG000|Overall Study|Subject refused further follow-up|1|||
124483597|NCT01564784|447723223|FG001|Overall Study|Subject refused further follow-up|6|||
124483598|NCT01564784|447723222|FG000|Overall Study|Lost to Follow-up|1|||
124483599|NCT01564784|447723223|FG001|Overall Study|Lost to Follow-up|1|||
124483600|NCT01564784|447723222|FG000|Overall Study|Death|131|||
124483601|NCT01564784|447723223|FG001|Overall Study|Death|126|||
124483602|NCT00957853|447723224|FG000|Overall Study|Withdrawal by Subject|1|||
124483603|NCT00957853|447723225|FG001|Overall Study|Withdrawal by Subject|0|||
124483604|NCT00957853|447723226|FG002|Overall Study|Withdrawal by Subject|0|||
124483605|NCT00702143|447723227|FG000|Overall Study|Lost to Follow-up|0|||
124483606|NCT00702143|447723228|FG001|Overall Study|Lost to Follow-up|0|||
124483607|NCT00702143|447723229|FG002|Overall Study|Lost to Follow-up|1|||
124483608|NCT00741819|447723233|FG000|Overall Study|Adverse Event|3|||
124483609|NCT00741819|447723233|FG000|Overall Study|Withdrawal by Subject|3|||
124483610|NCT00741819|447723233|FG000|Overall Study|Death|1|||
124483611|NCT00741819|447723233|FG000|Overall Study|Disease progression|1|||
124483612|NCT00609622|447723234|FG000|Overall Study|Adverse Event|14|||
124483613|NCT00609622|447723235|FG001|Overall Study|Adverse Event|10|||
124483614|NCT00609622|447723234|FG000|Overall Study|Withdrawal by Subject|4|||
124483615|NCT00609622|447723235|FG001|Overall Study|Withdrawal by Subject|20|||
124483616|NCT00609622|447723234|FG000|Overall Study|Death|1|||
124483617|NCT00609622|447723235|FG001|Overall Study|Death|4|||
124483618|NCT00609622|447723234|FG000|Overall Study|Protocol Violation|1|||
124483619|NCT00609622|447723235|FG001|Overall Study|Protocol Violation|1|||
124483620|NCT00609622|447723234|FG000|Overall Study|Objective progression or relapse|47|||
124483621|NCT00609622|447723235|FG001|Overall Study|Objective progression or relapse|41|||
124483622|NCT00609622|447723234|FG000|Overall Study|Study terminated by sponsor|16|||
124483623|NCT00609622|447723235|FG001|Overall Study|Study terminated by sponsor|3|||
124483624|NCT00609622|447723234|FG000|Overall Study|Other|7|||
124483625|NCT00609622|447723235|FG001|Overall Study|Other|14|||
124483626|NCT00609622|447723234|FG000|Overall Study|Global deterioration of health status|6|||
124483627|NCT00609622|447723235|FG001|Overall Study|Global deterioration of health status|2|||
124483628|NCT00752986|447723239|FG000|Overall Study|Withdrawal by Subject|2|||
124483629|NCT00752986|447723240|FG001|Overall Study|Withdrawal by Subject|1|||
124483630|NCT00752986|447723241|FG002|Overall Study|Withdrawal by Subject|2|||
124483631|NCT00752986|447723239|FG000|Overall Study|Protocol Violation|3|||
124483632|NCT00752986|447723240|FG001|Overall Study|Protocol Violation|0|||
124483633|NCT00752986|447723241|FG002|Overall Study|Protocol Violation|0|||
124483634|NCT02970929|447723245|FG000|Overall Study|Adverse Event|18|||
124483635|NCT02970929|447723245|FG000|Overall Study|Lack of Efficacy|8|||
124483636|NCT02970929|447723245|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
124483637|NCT02970929|447723245|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
124483638|NCT02970929|447723245|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
124483639|NCT02970929|447723245|FG000|Overall Study|LOST TO FOLLOWUP|6|||
124483640|NCT02970929|447723245|FG000|Overall Study|MOVED OUT OF STATE|1|||
124483641|NCT02970929|447723245|FG000|Overall Study|Withdrawal by Subject|16|||
124483642|NCT02370121|447723250|FG000|Overall Study|Lost to Follow-up|1|||
124483643|NCT02370121|447723251|FG001|Overall Study|Lost to Follow-up|1|||
124483644|NCT00275561|447723257|FG000|Overall Study|Withdrawal by Subject|0|||
124483645|NCT00275561|447723258|FG001|Overall Study|Withdrawal by Subject|1|||
124483646|NCT00275561|447723257|FG000|Overall Study|Travel|1|||
124483647|NCT00275561|447723258|FG001|Overall Study|Travel|1|||
124483648|NCT00275561|447723257|FG000|Overall Study|Scheduling|1|||
124483649|NCT00275561|447723258|FG001|Overall Study|Scheduling|2|||
124483650|NCT00275561|447723257|FG000|Overall Study|Family Issues|0|||
124483651|NCT00275561|447723258|FG001|Overall Study|Family Issues|2|||
124483652|NCT01769105|447723259|FG000|First Intervention|Protocol Violation|2|||
124483653|NCT01769105|447723260|FG001|First Intervention|Protocol Violation|2|||
124483654|NCT01769105|447723259|FG000|Cross-over|Lost to Follow-up|5|||
124483655|NCT01769105|447723260|FG001|Cross-over|Lost to Follow-up|0|||
124483656|NCT04321343|447723265|FG000|Overall Study|Adverse Event|0|||
124483657|NCT04321343|447723266|FG001|Overall Study|Adverse Event|0|||
124483658|NCT04321343|447723267|FG002|Overall Study|Adverse Event|1|||
124483659|NCT04321343|447723268|FG003|Overall Study|Adverse Event|0|||
124720889|NCT01701362|448601082|FG001|Overall Study|Randomized but not treated|2|||
124720890|NCT01701362|448601081|FG000|Overall Study|Reasons other than those mentioned above|3|||
124720891|NCT01701362|448601082|FG001|Overall Study|Reasons other than those mentioned above|5|||
124483660|NCT04321343|447723265|FG000|Overall Study|Death|0|||
124483661|NCT04321343|447723266|FG001|Overall Study|Death|0|||
124483662|NCT04321343|447723267|FG002|Overall Study|Death|0|||
124483663|NCT04321343|447723268|FG003|Overall Study|Death|1|||
124483664|NCT04321343|447723265|FG000|Overall Study|Pregnancy|1|||
124483665|NCT04321343|447723266|FG001|Overall Study|Pregnancy|0|||
124483666|NCT04321343|447723267|FG002|Overall Study|Pregnancy|0|||
124483667|NCT04321343|447723268|FG003|Overall Study|Pregnancy|0|||
124483668|NCT04321343|447723265|FG000|Overall Study|Protocol Violation|1|||
124483669|NCT04321343|447723266|FG001|Overall Study|Protocol Violation|1|||
124483670|NCT04321343|447723267|FG002|Overall Study|Protocol Violation|1|||
124483671|NCT04321343|447723268|FG003|Overall Study|Protocol Violation|1|||
124483672|NCT04321343|447723265|FG000|Overall Study|Withdrawal by Subject|0|||
124483673|NCT04321343|447723266|FG001|Overall Study|Withdrawal by Subject|6|||
124483674|NCT04321343|447723267|FG002|Overall Study|Withdrawal by Subject|0|||
124483675|NCT04321343|447723268|FG003|Overall Study|Withdrawal by Subject|2|||
124483676|NCT04321343|447723265|FG000|Overall Study|Lost to Follow-up|2|||
124483677|NCT04321343|447723266|FG001|Overall Study|Lost to Follow-up|2|||
124483678|NCT04321343|447723267|FG002|Overall Study|Lost to Follow-up|1|||
124483679|NCT04321343|447723268|FG003|Overall Study|Lost to Follow-up|3|||
124483680|NCT04194944|447723269|FG000|Overall Study|Lost to Follow-up|3|||
124483681|NCT04194944|447723270|FG001|Overall Study|Lost to Follow-up|0|||
124483682|NCT04194944|447723269|FG000|Overall Study|Withdrawal by Subject|2|||
124483683|NCT04194944|447723270|FG001|Overall Study|Withdrawal by Subject|2|||
124483684|NCT04194944|447723269|FG000|Overall Study|On Treatment|93|||
124483685|NCT04194944|447723270|FG001|Overall Study|On Treatment|30|||
124483686|NCT04238819|447723271|FG000|Overall Study|Ongoing Treatment|0|||
124483687|NCT04238819|447723272|FG001|Overall Study|Ongoing Treatment|0|||
124483688|NCT04238819|447723273|FG002|Overall Study|Ongoing Treatment|0|||
124483689|NCT04238819|447723274|FG003|Overall Study|Ongoing Treatment|0|||
124483690|NCT04238819|447723275|FG004|Overall Study|Ongoing Treatment|1|||
124483691|NCT04238819|447723276|FG005|Overall Study|Ongoing Treatment|4|||
124483692|NCT04238819|447723277|FG006|Overall Study|Ongoing Treatment|0|||
124483693|NCT04238819|447723271|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
124483694|NCT04238819|447723272|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
124483695|NCT04238819|447723273|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
124483696|NCT04238819|447723274|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
124483697|NCT04238819|447723275|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
124483698|NCT04238819|447723276|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
124483699|NCT04238819|447723277|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
124483700|NCT00045032|447723288|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
124483701|NCT00045032|447723289|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
124483702|NCT00045032|447723290|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
124483703|NCT00045032|447723288|FG000|Overall Study|Death|22|||
124483704|NCT00045032|447723289|FG001|Overall Study|Death|24|||
124483705|NCT00045032|447723290|FG002|Overall Study|Death|17|||
124483706|NCT00045032|447723288|FG000|Overall Study|Insufficient Therapeutic Response|542|||
124483707|NCT00045032|447723289|FG001|Overall Study|Insufficient Therapeutic Response|437|||
124483708|NCT00045032|447723290|FG002|Overall Study|Insufficient Therapeutic Response|445|||
124483709|NCT00045032|447723288|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
124483710|NCT00045032|447723289|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
124483711|NCT00045032|447723290|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
124483712|NCT00045032|447723288|FG000|Overall Study|Other Protocol Violation|2|||
124483713|NCT00045032|447723289|FG001|Overall Study|Other Protocol Violation|0|||
124483714|NCT00045032|447723290|FG002|Overall Study|Other Protocol Violation|1|||
124483715|NCT00045032|447723288|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
124483716|NCT00045032|447723289|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
124483717|NCT00045032|447723290|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
124483718|NCT00045032|447723288|FG000|Overall Study|Failure to Return|57|||
124483719|NCT00045032|447723289|FG001|Overall Study|Failure to Return|62|||
124720892|NCT00570778|448601083|FG000|Overall Study|Protocol deviation|2|||
124483720|NCT00045032|447723290|FG002|Overall Study|Failure to Return|61|||
124720893|NCT00570778|448601084|FG001|Overall Study|Protocol deviation|1|||
124483721|NCT00045032|447723288|FG000|Overall Study|Other|93|||
124483722|NCT00045032|447723289|FG001|Overall Study|Other|84|||
124483723|NCT00045032|447723290|FG002|Overall Study|Other|105|||
124483724|NCT02581995|447723298|FG000|Overall Study|Unspecified other|3|||
124483725|NCT02581995|447723298|FG000|Overall Study|Adverse Event|6|||
124483726|NCT02581995|447723298|FG000|Overall Study|Lost to Follow-up|5|||
124483727|NCT02581995|447723298|FG000|Overall Study|Withdrawal by participant|12|||
124483728|NCT02581995|447723298|FG000|Overall Study|Physician Decision|1|||
124483729|NCT02581995|447723298|FG000|Overall Study|Death|4|||
124483730|NCT05224258|447724437|FG000|Overall Study|Withdrawal by Subject|1|||
124483731|NCT05224258|447724438|FG001|Overall Study|Withdrawal by Subject|1|||
124483732|NCT05224258|447724437|FG000|Overall Study|Physician Decision|1|||
124483733|NCT05224258|447724438|FG001|Overall Study|Physician Decision|1|||
124483734|NCT05224258|447724437|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
124483735|NCT05224258|447724438|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124483736|NCT05224258|447724437|FG000|Overall Study|Study Product No Longer in Use|1|||
124483737|NCT05224258|447724438|FG001|Overall Study|Study Product No Longer in Use|0|||
124483738|NCT05224258|447724437|FG000|Overall Study|Adverse Event|0|||
124483739|NCT05224258|447724438|FG001|Overall Study|Adverse Event|1|||
124483740|NCT05224258|447724437|FG000|Overall Study|Protocol Deviation|0|||
124483741|NCT05224258|447724438|FG001|Overall Study|Protocol Deviation|1|||
124483742|NCT00486902|447724439|FG000|Overall Study|Withdrawal by Subject|1|||
124483743|NCT00486902|447724440|FG001|Overall Study|Withdrawal by Subject|2|||
124483744|NCT00486902|447724439|FG000|Overall Study|decision for postpartum tubal ligation|3|||
124483745|NCT00486902|447724440|FG001|Overall Study|decision for postpartum tubal ligation|1|||
124483746|NCT00486902|447724439|FG000|Overall Study|spinal anesthetic protocal violation|1|||
124483747|NCT00486902|447724440|FG001|Overall Study|spinal anesthetic protocal violation|1|||
124483748|NCT00486902|447724439|FG000|Overall Study|Did not meet inclusion criteria|1|||
124483749|NCT00486902|447724440|FG001|Overall Study|Did not meet inclusion criteria|0|||
124483750|NCT00486902|447724439|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
124483751|NCT00486902|447724440|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
124483752|NCT00733902|447724441|FG000|Overall Study|Death|0|||
124483753|NCT00733902|447724442|FG001|Overall Study|Death|0|||
124483754|NCT00733902|447724443|FG002|Overall Study|Death|0|||
124483755|NCT00733902|447724444|FG003|Overall Study|Death|1|||
124483756|NCT00733902|447724441|FG000|Overall Study|Adverse Event|3|||
124483757|NCT00733902|447724442|FG001|Overall Study|Adverse Event|4|||
124483758|NCT00733902|447724443|FG002|Overall Study|Adverse Event|7|||
124483759|NCT00733902|447724444|FG003|Overall Study|Adverse Event|11|||
124483760|NCT00733902|447724441|FG000|Overall Study|Lack of Efficacy|56|||
124483761|NCT00733902|447724442|FG001|Overall Study|Lack of Efficacy|21|||
124483762|NCT00733902|447724443|FG002|Overall Study|Lack of Efficacy|34|||
124483763|NCT00733902|447724444|FG003|Overall Study|Lack of Efficacy|23|||
124483764|NCT00733902|447724441|FG000|Overall Study|Protocol Violation|4|||
124483765|NCT00733902|447724442|FG001|Overall Study|Protocol Violation|6|||
124483766|NCT00733902|447724443|FG002|Overall Study|Protocol Violation|3|||
124483767|NCT00733902|447724444|FG003|Overall Study|Protocol Violation|3|||
124483768|NCT00733902|447724441|FG000|Overall Study|Withdrawal by Subject|10|||
124483769|NCT00733902|447724442|FG001|Overall Study|Withdrawal by Subject|5|||
124483770|NCT00733902|447724443|FG002|Overall Study|Withdrawal by Subject|4|||
124483771|NCT00733902|447724444|FG003|Overall Study|Withdrawal by Subject|16|||
124483772|NCT00733902|447724441|FG000|Overall Study|Entered extension study|89|||
124483773|NCT00733902|447724442|FG001|Overall Study|Entered extension study|124|||
124483774|NCT00733902|447724443|FG002|Overall Study|Entered extension study|111|||
124483775|NCT00733902|447724444|FG003|Overall Study|Entered extension study|109|||
124483776|NCT00733902|447724441|FG000|Overall Study|Randomized but not treated|2|||
124483777|NCT00733902|447724442|FG001|Overall Study|Randomized but not treated|2|||
124483778|NCT00733902|447724443|FG002|Overall Study|Randomized but not treated|2|||
124483779|NCT00733902|447724444|FG003|Overall Study|Randomized but not treated|1|||
124483780|NCT00699192|447724445|FG000|Overall Study|Missing|1|||
124483781|NCT00699192|447724446|FG001|Overall Study|Missing|1|||
124483782|NCT00699192|447724447|FG002|Overall Study|Missing|1|||
124483783|NCT00699192|447724445|FG000|Overall Study|Adverse Event|9|||
124483784|NCT00699192|447724446|FG001|Overall Study|Adverse Event|4|||
124483785|NCT00699192|447724447|FG002|Overall Study|Adverse Event|3|||
124483786|NCT00699192|447724445|FG000|Overall Study|Abnormal test procedure result(s)|0|||
124483787|NCT00699192|447724446|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124483788|NCT00699192|447724447|FG002|Overall Study|Abnormal test procedure result(s)|1|||
124483789|NCT00699192|447724445|FG000|Overall Study|Lack of Efficacy|0|||
124483790|NCT00699192|447724446|FG001|Overall Study|Lack of Efficacy|0|||
124483791|NCT00699192|447724447|FG002|Overall Study|Lack of Efficacy|1|||
124483792|NCT00699192|447724445|FG000|Overall Study|Withdrawal by Subject|3|||
124483793|NCT00699192|447724446|FG001|Overall Study|Withdrawal by Subject|2|||
124483794|NCT00699192|447724447|FG002|Overall Study|Withdrawal by Subject|4|||
124483795|NCT00699192|447724445|FG000|Overall Study|Administrative problems|1|||
124720894|NCT00570778|448601085|FG002|Overall Study|Protocol deviation|2|||
124483796|NCT00699192|447724446|FG001|Overall Study|Administrative problems|3|||
124483797|NCT00699192|447724447|FG002|Overall Study|Administrative problems|1|||
124483798|NCT00699192|447724445|FG000|Overall Study|Protocol Violation|2|||
124483799|NCT00699192|447724446|FG001|Overall Study|Protocol Violation|2|||
124483800|NCT00699192|447724447|FG002|Overall Study|Protocol Violation|0|||
124483801|NCT04927312|447724450|FG000|Overall Study|Adverse Event|1|||
124483802|NCT04927312|447724450|FG000|Overall Study|Death|1|||
124483803|NCT04927312|447724450|FG000|Overall Study|Withdrawal by Subject|1|||
124483804|NCT04927312|447724450|FG000|Overall Study|Other|1|||
124720895|NCT00570778|448601086|FG003|Overall Study|Protocol deviation|2|||
124483805|NCT04919564|447724453|FG000|Overall Study|Lost to Follow-up|1|||
124720896|NCT00570778|448601083|FG000|Overall Study|Adverse Event|0|||
124483806|NCT04919564|447724454|FG001|Overall Study|Lost to Follow-up|0|||
124483807|NCT04919564|447724453|FG000|Overall Study|Physician Decision|1|||
124483808|NCT04919564|447724454|FG001|Overall Study|Physician Decision|1|||
124483809|NCT01241786|447724455|FG000|Overall Study|Lack of Efficacy|5|||
124483810|NCT01122927|447724457|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
124483811|NCT01122927|447724458|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
124483812|NCT01122927|447724457|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
124483813|NCT01122927|447724458|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
124483814|NCT01122927|447724457|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
124483815|NCT01122927|447724458|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
124483816|NCT01122927|447724457|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
124483817|NCT01122927|447724458|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
124483818|NCT01122927|447724457|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
124483819|NCT01122927|447724458|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
124483820|NCT01122927|447724457|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
124483821|NCT01122927|447724458|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
124483822|NCT01122927|447724457|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
124483823|NCT01122927|447724458|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
124483824|NCT01122927|447724457|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
124483825|NCT01122927|447724458|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
124483826|NCT01122927|447724457|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
124483827|NCT01122927|447724458|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
124483828|NCT01122927|447724457|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
124483829|NCT01122927|447724458|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
124483830|NCT01122927|447724457|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
124483831|NCT01122927|447724458|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
124483832|NCT01122927|447724457|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
124483833|NCT01122927|447724458|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
124483834|NCT00768560|447724463|FG000|Intervention Set 1|Adverse Event|0|||
124483835|NCT00768560|447724464|FG001|Intervention Set 1|Adverse Event|1|||
124483836|NCT00768560|447724465|FG002|Intervention Set 1|Adverse Event|0|||
124483837|NCT00768560|447724466|FG003|Intervention Set 1|Adverse Event|0|||
124483838|NCT00768560|447724467|FG004|Intervention Set 1|Adverse Event|0|||
124720897|NCT00570778|448601084|FG001|Overall Study|Adverse Event|1|||
124720898|NCT00570778|448601085|FG002|Overall Study|Adverse Event|4|||
124720899|NCT00570778|448601086|FG003|Overall Study|Adverse Event|1|||
124483839|NCT00768560|447724468|FG005|Intervention Set 1|Adverse Event|0|||
124483840|NCT00195650|447724469|FG000|Overall Study|Adverse Event|194|||
124483841|NCT00195650|447724469|FG000|Overall Study|Lack of Efficacy|99|||
124483842|NCT00195650|447724469|FG000|Overall Study|Withdrawal by Subject|67|||
124483843|NCT00195650|447724469|FG000|Overall Study|Lost to Follow-up|44|||
124483844|NCT00195650|447724469|FG000|Overall Study|Death|23|||
124483845|NCT00195650|447724469|FG000|Overall Study|Protocol Violation|15|||
124483846|NCT00195650|447724469|FG000|Overall Study|Administrative reasons|83|||
124483847|NCT03375320|447724470|FG000|Overall Study|Adverse Event|34|||
124483848|NCT03375320|447724471|FG001|Overall Study|Adverse Event|9|||
124483849|NCT03375320|447724472|FG002|Overall Study|Adverse Event|10|||
124483850|NCT03375320|447724473|FG003|Overall Study|Adverse Event|0|||
124483851|NCT03375320|447724470|FG000|Overall Study|Death|6|||
124483852|NCT03375320|447724471|FG001|Overall Study|Death|3|||
124483853|NCT03375320|447724472|FG002|Overall Study|Death|0|||
124483854|NCT03375320|447724473|FG003|Overall Study|Death|0|||
124483855|NCT03375320|447724470|FG000|Overall Study|Withdrawal by Subject|7|||
124483856|NCT03375320|447724471|FG001|Overall Study|Withdrawal by Subject|4|||
124483857|NCT03375320|447724472|FG002|Overall Study|Withdrawal by Subject|5|||
124483858|NCT03375320|447724473|FG003|Overall Study|Withdrawal by Subject|4|||
124483859|NCT03375320|447724470|FG000|Overall Study|Progressive disease|55|||
124483860|NCT03375320|447724471|FG001|Overall Study|Progressive disease|41|||
124483861|NCT03375320|447724472|FG002|Overall Study|Progressive disease|29|||
124483862|NCT03375320|447724473|FG003|Overall Study|Progressive disease|24|||
124483863|NCT03375320|447724470|FG000|Overall Study|Alternative treatment|6|||
124483864|NCT03375320|447724471|FG001|Overall Study|Alternative treatment|1|||
124483865|NCT03375320|447724472|FG002|Overall Study|Alternative treatment|1|||
124483866|NCT03375320|447724473|FG003|Overall Study|Alternative treatment|0|||
124483867|NCT03375320|447724470|FG000|Overall Study|Other disease|1|||
124483868|NCT03375320|447724471|FG001|Overall Study|Other disease|1|||
124483869|NCT03375320|447724472|FG002|Overall Study|Other disease|3|||
124483870|NCT03375320|447724473|FG003|Overall Study|Other disease|0|||
124483871|NCT03375320|447724470|FG000|Overall Study|Withdrawal prior to initiation|2|||
124483872|NCT03375320|447724471|FG001|Overall Study|Withdrawal prior to initiation|2|||
124483873|NCT03375320|447724472|FG002|Overall Study|Withdrawal prior to initiation|1|||
124483874|NCT03375320|447724473|FG003|Overall Study|Withdrawal prior to initiation|0|||
124483875|NCT03375320|447724470|FG000|Overall Study|Physician Decision|1|||
124483876|NCT03375320|447724471|FG001|Overall Study|Physician Decision|1|||
124483877|NCT03375320|447724472|FG002|Overall Study|Physician Decision|1|||
124483878|NCT03375320|447724473|FG003|Overall Study|Physician Decision|1|||
124483879|NCT03375320|447724470|FG000|Overall Study|Non-compliance|1|||
124483880|NCT03375320|447724471|FG001|Overall Study|Non-compliance|0|||
124483881|NCT03375320|447724472|FG002|Overall Study|Non-compliance|0|||
124483882|NCT03375320|447724473|FG003|Overall Study|Non-compliance|0|||
124483883|NCT01535235|447724474|FG000|Overall Study|Adverse Event|1|||
124483884|NCT01535235|447724475|FG001|Overall Study|Adverse Event|0|||
124483885|NCT00389207|447724476|FG000|Overall Study|Adverse Event|26|||
124483886|NCT00389207|447724477|FG001|Overall Study|Adverse Event|32|||
124483887|NCT00389207|447724478|FG002|Overall Study|Adverse Event|10|||
124483888|NCT00389207|447724476|FG000|Overall Study|Protocol Violation|3|||
124483889|NCT00389207|447724477|FG001|Overall Study|Protocol Violation|1|||
124483890|NCT00389207|447724478|FG002|Overall Study|Protocol Violation|4|||
124483891|NCT00389207|447724476|FG000|Overall Study|Lost to Follow-up|12|||
124483892|NCT00389207|447724477|FG001|Overall Study|Lost to Follow-up|9|||
124483893|NCT00389207|447724478|FG002|Overall Study|Lost to Follow-up|7|||
124483894|NCT00389207|447724476|FG000|Overall Study|Withdrawal by Subject|5|||
124483895|NCT00389207|447724477|FG001|Overall Study|Withdrawal by Subject|7|||
124483896|NCT00389207|447724478|FG002|Overall Study|Withdrawal by Subject|11|||
124483897|NCT00389207|447724476|FG000|Overall Study|Other|17|||
124483898|NCT00389207|447724477|FG001|Overall Study|Other|23|||
124483899|NCT00389207|447724478|FG002|Overall Study|Other|9|||
124483900|NCT01794780|447724479|FG000|Overall Study|Adverse Event|0|||
124483901|NCT01794780|447724480|FG001|Overall Study|Adverse Event|1|||
124483902|NCT01794780|447724481|FG002|Overall Study|Adverse Event|2|||
124483903|NCT01794780|447724482|FG003|Overall Study|Adverse Event|0|||
124483904|NCT01794780|447724483|FG004|Overall Study|Adverse Event|0|||
124483905|NCT01794780|447724484|FG005|Overall Study|Adverse Event|0|||
124483906|NCT01794780|447724485|FG006|Overall Study|Adverse Event|0|||
124483907|NCT01794780|447724486|FG007|Overall Study|Adverse Event|0|||
124483908|NCT01794780|447724479|FG000|Overall Study|Death|0|||
124483909|NCT01794780|447724480|FG001|Overall Study|Death|2|||
124483910|NCT01794780|447724481|FG002|Overall Study|Death|14|||
124483911|NCT01794780|447724482|FG003|Overall Study|Death|1|||
124483912|NCT01794780|447724483|FG004|Overall Study|Death|0|||
124483913|NCT01794780|447724484|FG005|Overall Study|Death|9|||
124483914|NCT01794780|447724485|FG006|Overall Study|Death|4|||
124483915|NCT01794780|447724486|FG007|Overall Study|Death|0|||
124483916|NCT01794780|447724479|FG000|Overall Study|Lost to Follow-up|10|||
124483917|NCT01794780|447724480|FG001|Overall Study|Lost to Follow-up|64|||
124483918|NCT01794780|447724481|FG002|Overall Study|Lost to Follow-up|165|||
124483919|NCT01794780|447724482|FG003|Overall Study|Lost to Follow-up|53|||
124483920|NCT01794780|447724483|FG004|Overall Study|Lost to Follow-up|2|||
124483921|NCT01794780|447724484|FG005|Overall Study|Lost to Follow-up|99|||
124483922|NCT01794780|447724485|FG006|Overall Study|Lost to Follow-up|30|||
124483923|NCT01794780|447724486|FG007|Overall Study|Lost to Follow-up|5|||
124483924|NCT01794780|447724479|FG000|Overall Study|Withdrew informed consent|7|||
124483925|NCT01794780|447724480|FG001|Overall Study|Withdrew informed consent|17|||
124483926|NCT01794780|447724481|FG002|Overall Study|Withdrew informed consent|36|||
124483927|NCT01794780|447724482|FG003|Overall Study|Withdrew informed consent|9|||
124483928|NCT01794780|447724483|FG004|Overall Study|Withdrew informed consent|0|||
124483929|NCT01794780|447724484|FG005|Overall Study|Withdrew informed consent|48|||
124483930|NCT01794780|447724485|FG006|Overall Study|Withdrew informed consent|4|||
124483931|NCT01794780|447724486|FG007|Overall Study|Withdrew informed consent|3|||
124483932|NCT01794780|447724479|FG000|Overall Study|Other|0|||
124483933|NCT01794780|447724480|FG001|Overall Study|Other|12|||
124483934|NCT01794780|447724481|FG002|Overall Study|Other|25|||
124483935|NCT01794780|447724482|FG003|Overall Study|Other|20|||
124483936|NCT01794780|447724483|FG004|Overall Study|Other|1|||
124483937|NCT01794780|447724484|FG005|Overall Study|Other|24|||
124483938|NCT01794780|447724485|FG006|Overall Study|Other|4|||
124483939|NCT01794780|447724486|FG007|Overall Study|Other|1|||
124483940|NCT02286102|447724487|FG000|Overall Study|Screen Failure|1|||
124483941|NCT02286102|447724488|FG001|Overall Study|Screen Failure|1|||
124483942|NCT01440101|447724489|FG000|Overall Study|Adverse Event|2|||
124483943|NCT01440101|447724490|FG001|Overall Study|Adverse Event|0|||
124483944|NCT01440101|447724491|FG002|Overall Study|Adverse Event|0|||
124483945|NCT01440101|447724489|FG000|Overall Study|Withdrawal by Subject|0|||
124483946|NCT01440101|447724490|FG001|Overall Study|Withdrawal by Subject|3|||
124483947|NCT01440101|447724491|FG002|Overall Study|Withdrawal by Subject|1|||
124483948|NCT01440101|447724489|FG000|Overall Study|Other|0|||
124483949|NCT01440101|447724490|FG001|Overall Study|Other|1|||
124483950|NCT01440101|447724491|FG002|Overall Study|Other|0|||
124483951|NCT01985321|447724493|FG000|Overall Study|Protocol Violation|4|||
124483952|NCT01985321|447724494|FG001|Overall Study|Protocol Violation|3|||
124483953|NCT01985321|447724493|FG000|Overall Study|Withdrawal by Subject|1|||
124483954|NCT01985321|447724494|FG001|Overall Study|Withdrawal by Subject|0|||
124483955|NCT01985321|447724493|FG000|Overall Study|Lost to Follow-up|5|||
124483956|NCT01985321|447724494|FG001|Overall Study|Lost to Follow-up|2|||
124483957|NCT01985321|447724493|FG000|Overall Study|Subject treated wrong type of sore|1|||
124483958|NCT01985321|447724494|FG001|Overall Study|Subject treated wrong type of sore|0|||
124483959|NCT00636818|447724495|FG000|Overall Study|Adverse Event|1|||
124483960|NCT00636818|447724495|FG000|Overall Study|Lost to Follow-up|2|||
124483961|NCT00636818|447724495|FG000|Overall Study|Entry Criteria Exclusion|3|||
124483962|NCT00636818|447724495|FG000|Overall Study|Protocol Violation|1|||
124483963|NCT00636818|447724495|FG000|Overall Study|Withdrawal by Subject|4|||
124483964|NCT00074958|447724496|FG000|Overall Study|Adverse Event|1|||
124483965|NCT02690701|447724500|FG000|Treatment Period 1|Adverse Event|2|||
124483966|NCT02690701|447724501|FG001|Treatment Period 1|Adverse Event|2|||
124483967|NCT02690701|447724500|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124483968|NCT02690701|447724501|FG001|Treatment Period 1|Withdrawal by Subject|1|||
124483969|NCT02690701|447724500|FG000|Treatment Period 2|Adverse Event|2|||
124483970|NCT02690701|447724501|FG001|Treatment Period 2|Adverse Event|0|||
124483971|NCT02690701|447724500|FG000|Treatment Period 2|Lack of Efficacy|1|||
124483972|NCT02690701|447724501|FG001|Treatment Period 2|Lack of Efficacy|0|||
124483973|NCT02690701|447724500|FG000|Treatment Period 2|Lost to Follow-up|0|||
124483974|NCT02690701|447724501|FG001|Treatment Period 2|Lost to Follow-up|2|||
124483975|NCT02690701|447724500|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124483976|NCT02690701|447724501|FG001|Treatment Period 2|Withdrawal by Subject|2|||
124483977|NCT02690701|447724500|FG000|Treatment Period 2|Protocol Violation|0|||
124483978|NCT02690701|447724501|FG001|Treatment Period 2|Protocol Violation|1|||
124483979|NCT02853760|447724504|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
124483980|NCT02853760|447724505|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
124483981|NCT02853760|447724506|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
124483982|NCT02853760|447724507|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
124483983|NCT02853760|447724508|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
124483984|NCT02853760|447724509|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
124483985|NCT00004980|447724510|FG000|Overall Study|Withdrawal by Subject|1|||
124483986|NCT00004980|447724511|FG001|Overall Study|Withdrawal by Subject|0|||
124483987|NCT00004980|447724510|FG000|Overall Study|memory difficulties|1|||
124483988|NCT00004980|447724511|FG001|Overall Study|memory difficulties|1|||
124483989|NCT00004980|447724510|FG000|Overall Study|Physician Decision|0|||
124483990|NCT00004980|447724511|FG001|Overall Study|Physician Decision|1|||
124483991|NCT01299025|447724512|FG000|Overall Study|Withdrawal by Subject|2|||
124483992|NCT01299025|447724513|FG001|Overall Study|Withdrawal by Subject|1|||
124483993|NCT01299025|447724512|FG000|Overall Study|Lost to Follow-up|1|||
124483994|NCT01299025|447724513|FG001|Overall Study|Lost to Follow-up|0|||
124483995|NCT03577990|447724514|FG000|Overall Study|Lost to Follow-up|4|||
124483996|NCT03577990|447724515|FG001|Overall Study|Lost to Follow-up|6|||
124483997|NCT03577990|447724514|FG000|Overall Study|Withdrawal by Subject|4|||
124483998|NCT03577990|447724515|FG001|Overall Study|Withdrawal by Subject|7|||
124483999|NCT02793544|447724516|FG000|Overall Study|Death|10|||
124484000|NCT02793544|447724517|FG001|Overall Study|Death|8|||
124484001|NCT02793544|447724516|FG000|Overall Study|Lost to Follow-up|2|||
124484002|NCT02793544|447724517|FG001|Overall Study|Lost to Follow-up|0|||
124484003|NCT02793544|447724516|FG000|Overall Study|Withdrawal by Subject|1|||
124484004|NCT02793544|447724517|FG001|Overall Study|Withdrawal by Subject|0|||
124484005|NCT05369806|447724520|FG000|Overall Study|Lost to Follow-up|1|||
124484006|NCT01097044|447724522|FG000|Overall Study|Withdrawal by Subject|4|||
124484007|NCT01097044|447724523|FG001|Overall Study|Withdrawal by Subject|4|||
124484008|NCT01097044|447724522|FG000|Overall Study|Lost to Follow-up|1|||
124484009|NCT01097044|447724523|FG001|Overall Study|Lost to Follow-up|0|||
124484010|NCT01097044|447724522|FG000|Overall Study|Withdrawal by Sponsor|0|||
124484011|NCT01097044|447724523|FG001|Overall Study|Withdrawal by Sponsor|1|||
124484012|NCT03972488|447724524|FG000|Overall Study|Progressive disease|42|||
124484013|NCT03972488|447724525|FG001|Overall Study|Progressive disease|44|||
124484014|NCT03972488|447724524|FG000|Overall Study|Physician Decision|13|||
124484015|NCT03972488|447724525|FG001|Overall Study|Physician Decision|7|||
124484016|NCT03972488|447724524|FG000|Overall Study|Adverse Event|8|||
124484017|NCT03972488|447724525|FG001|Overall Study|Adverse Event|1|||
124484018|NCT03972488|447724524|FG000|Overall Study|Death|4|||
124484019|NCT03972488|447724525|FG001|Overall Study|Death|4|||
124484020|NCT03972488|447724524|FG000|Overall Study|Withdrawal by Subject|3|||
124484021|NCT03972488|447724525|FG001|Overall Study|Withdrawal by Subject|4|||
124484022|NCT03972488|447724524|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
124484023|NCT03972488|447724525|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
124484024|NCT04865731|447724527|FG000|Overall Study|Physician Decision|2|||
124484025|NCT04865731|447724528|FG001|Overall Study|Physician Decision|1|||
124484026|NCT04865731|447724527|FG000|Overall Study|Adverse Event|1|||
124484027|NCT04865731|447724528|FG001|Overall Study|Adverse Event|0|||
124484028|NCT04865731|447724527|FG000|Overall Study|Withdrawal by Subject|0|||
124557571|NCT04288115|447999145|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
124484029|NCT04865731|447724528|FG001|Overall Study|Withdrawal by Subject|1|||
124484030|NCT03277196|447724529|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
124484031|NCT03277196|447724529|FG000|Overall Study|Lost to Follow-up|3|||
124484032|NCT03277196|447724529|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
124484033|NCT03277196|447724529|FG000|Overall Study|Other|2|||
124484034|NCT02017444|447725809|FG000|Overall Study|Physician Decision|1|||
124484035|NCT02017444|447725810|FG001|Overall Study|Physician Decision|0|||
124484036|NCT02017444|447725809|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
124484037|NCT02017444|447725810|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
124484038|NCT00684814|447725825|FG000|Washout Period of 7 Days|Adverse Event|1|||
124484039|NCT00684814|447725826|FG001|Washout Period of 7 Days|Adverse Event|2|||
124484040|NCT00684814|447725825|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
124484041|NCT00684814|447725826|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
124484042|NCT00684814|447725825|FG000|Second Intervention|Adverse Event|1|||
124484043|NCT00684814|447725826|FG001|Second Intervention|Adverse Event|0|||
124484044|NCT00503399|447725827|FG000|Overall Study|Death|2|||
124484045|NCT00503399|447725828|FG001|Overall Study|Death|1|||
124484046|NCT00503399|447725827|FG000|Overall Study|Protocol Violation|1|||
124484047|NCT00503399|447725828|FG001|Overall Study|Protocol Violation|0|||
124484048|NCT00503399|447725827|FG000|Overall Study|Withdrawal by Subject|4|||
124484049|NCT00503399|447725828|FG001|Overall Study|Withdrawal by Subject|2|||
124484050|NCT00503399|447725827|FG000|Overall Study|Adverse Event|0|||
124484051|NCT00503399|447725828|FG001|Overall Study|Adverse Event|3|||
124484052|NCT00503399|447725827|FG000|Overall Study|Lost to Follow-up|0|||
124484053|NCT00503399|447725828|FG001|Overall Study|Lost to Follow-up|2|||
124484054|NCT01676961|447725829|FG000|Overall Study|Death|3|||
124484055|NCT01676961|447725829|FG000|Overall Study|Lost to Follow-up|1|||
124484056|NCT01676961|447725829|FG000|Overall Study|Withdrawal by Subject|1|||
124484057|NCT00117312|447725830|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
124484058|NCT00117312|447725831|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
124484059|NCT00117312|447725832|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
124484060|NCT00117312|447725833|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
124484061|NCT00117312|447725830|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
124484062|NCT00117312|447725831|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
124484063|NCT00117312|447725832|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
124484064|NCT00117312|447725833|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
124484065|NCT00117312|447725830|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
124484066|NCT00117312|447725831|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
124484067|NCT00117312|447725832|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
124484068|NCT00117312|447725833|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
124484069|NCT00117312|447725830|FG000|Overall Study|Other|0|||
124484070|NCT00117312|447725831|FG001|Overall Study|Other|1|||
124484071|NCT00117312|447725832|FG002|Overall Study|Other|3|||
124484072|NCT00117312|447725833|FG003|Overall Study|Other|1|||
124484073|NCT00117312|447725830|FG000|Overall Study|Patient choice|0|||
124484074|NCT00117312|447725831|FG001|Overall Study|Patient choice|0|||
124484075|NCT00117312|447725832|FG002|Overall Study|Patient choice|2|||
124484076|NCT00117312|447725833|FG003|Overall Study|Patient choice|1|||
124484077|NCT00117312|447725830|FG000|Overall Study|Adverse Event|0|||
124484078|NCT00117312|447725831|FG001|Overall Study|Adverse Event|2|||
124484079|NCT00117312|447725832|FG002|Overall Study|Adverse Event|0|||
124484080|NCT00117312|447725833|FG003|Overall Study|Adverse Event|0|||
124484081|NCT00117312|447725830|FG000|Overall Study|Protocol Violation|0|||
124484082|NCT00117312|447725831|FG001|Overall Study|Protocol Violation|1|||
124484083|NCT00117312|447725832|FG002|Overall Study|Protocol Violation|3|||
124484084|NCT00117312|447725833|FG003|Overall Study|Protocol Violation|0|||
124484085|NCT00117312|447725830|FG000|Overall Study|PSA decrease <=50%|0|||
124484086|NCT00117312|447725831|FG001|Overall Study|PSA decrease <=50%|2|||
124484087|NCT00117312|447725832|FG002|Overall Study|PSA decrease <=50%|2|||
124484088|NCT00117312|447725833|FG003|Overall Study|PSA decrease <=50%|4|||
124484089|NCT00117312|447725830|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
124484090|NCT00117312|447725831|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
124484091|NCT00117312|447725832|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
124484092|NCT00117312|447725833|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
124484093|NCT00117312|447725830|FG000|Overall Study|Hepatic abnormality|0|||
124484094|NCT00117312|447725831|FG001|Overall Study|Hepatic abnormality|1|||
124484095|NCT00117312|447725832|FG002|Overall Study|Hepatic abnormality|0|||
124484096|NCT00117312|447725833|FG003|Overall Study|Hepatic abnormality|1|||
124484097|NCT00117312|447725830|FG000|Overall Study|Withdrawal by Subject|0|||
124484098|NCT00117312|447725831|FG001|Overall Study|Withdrawal by Subject|2|||
124484099|NCT00117312|447725832|FG002|Overall Study|Withdrawal by Subject|0|||
124484100|NCT00117312|447725833|FG003|Overall Study|Withdrawal by Subject|0|||
124484101|NCT01128387|447725834|FG000|Overall Study|Physician Decision|0|||
124484102|NCT01128387|447725835|FG001|Overall Study|Physician Decision|1|||
124484103|NCT02635204|447725836|FG000|Overall Study|Adverse Event|1|||
124484104|NCT02635204|447725837|FG001|Overall Study|Adverse Event|0|||
124484105|NCT02635204|447725836|FG000|Overall Study|Lost to Follow-up|1|||
124484106|NCT02635204|447725837|FG001|Overall Study|Lost to Follow-up|1|||
124484107|NCT00858832|447725838|FG000|Overall Study|became ineligible: delivered vaginally|1|||
124557572|NCT03634488|447999146|FG000|Overall Study|Death|1|||
124484108|NCT00858832|447725839|FG001|Overall Study|became ineligible: delivered vaginally|0|||
124484109|NCT00858832|447725838|FG000|Overall Study|Adverse Event|0|||
124484110|NCT00858832|447725839|FG001|Overall Study|Adverse Event|1|||
124484111|NCT03830281|447725850|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
124484112|NCT03830281|447725851|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
124484113|NCT03830281|447725850|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
124484114|NCT03830281|447725851|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
124484115|NCT03830281|447725850|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
124484116|NCT03830281|447725851|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
124484117|NCT03830281|447725850|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
124484118|NCT03830281|447725851|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
124484119|NCT03830281|447725850|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
124484120|NCT03830281|447725851|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
124484121|NCT03830281|447725850|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
124484122|NCT03830281|447725851|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
124484123|NCT03830281|447725850|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
124484124|NCT03830281|447725851|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
124484125|NCT03830281|447725850|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
124484126|NCT03830281|447725851|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
124484127|NCT03830281|447725850|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
124484128|NCT03830281|447725851|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
124484129|NCT03293680|447725852|FG000|Overall Study|Death|1|||
124484130|NCT03293680|447725852|FG000|Overall Study|Did not meet inclusion criteria|8|||
124484131|NCT02201940|447725853|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
124484132|NCT02201940|447725854|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
124484133|NCT02201940|447725853|FG000|Overall Study|Lack of Efficacy|2|||
124484134|NCT02201940|447725854|FG001|Overall Study|Lack of Efficacy|113|||
124484135|NCT02201940|447725853|FG000|Overall Study|Lost to Follow-up|5|||
124484136|NCT02201940|447725854|FG001|Overall Study|Lost to Follow-up|0|||
124720900|NCT00570778|448601083|FG000|Overall Study|Subject withdrew consent|0|||
124720901|NCT00570778|448601084|FG001|Overall Study|Subject withdrew consent|1|||
124720902|NCT00570778|448601085|FG002|Overall Study|Subject withdrew consent|0|||
124720903|NCT00570778|448601086|FG003|Overall Study|Subject withdrew consent|1|||
124720904|NCT00570778|448601083|FG000|Overall Study|Abnormal test procedure|1|||
124720905|NCT00570778|448601084|FG001|Overall Study|Abnormal test procedure|0|||
124720906|NCT00570778|448601085|FG002|Overall Study|Abnormal test procedure|0|||
124720907|NCT00570778|448601086|FG003|Overall Study|Abnormal test procedure|0|||
124720908|NCT00570778|448601083|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124720909|NCT00570778|448601084|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124720910|NCT00570778|448601085|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
124720911|NCT00570778|448601086|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
124720912|NCT00570778|448601083|FG000|Overall Study|Lost to Follow-up|0|||
124720913|NCT00570778|448601084|FG001|Overall Study|Lost to Follow-up|0|||
124720914|NCT00570778|448601085|FG002|Overall Study|Lost to Follow-up|1|||
124720915|NCT00570778|448601086|FG003|Overall Study|Lost to Follow-up|0|||
124720916|NCT00570778|448601083|FG000|Overall Study|Subject no longer requires study drug|0|||
124720917|NCT00570778|448601084|FG001|Overall Study|Subject no longer requires study drug|1|||
124720918|NCT00570778|448601085|FG002|Overall Study|Subject no longer requires study drug|0|||
124720919|NCT00570778|448601086|FG003|Overall Study|Subject no longer requires study drug|0|||
124720920|NCT02120781|448601091|FG000|Overall Study|Physician Decision|2|||
124720921|NCT02120781|448601092|FG001|Overall Study|Physician Decision|0|||
124484137|NCT02201940|447725853|FG000|Overall Study|Withdrew Consent|2|||
124720922|NCT02120781|448601091|FG000|Overall Study|Completion not documented|2|||
124484138|NCT02201940|447725854|FG001|Overall Study|Withdrew Consent|1|||
124484139|NCT02201940|447725853|FG000|Overall Study|Investigator's Discretion|1|||
124484140|NCT02201940|447725854|FG001|Overall Study|Investigator's Discretion|1|||
124484141|NCT02201940|447725853|FG000|Overall Study|Death|1|||
124484142|NCT02201940|447725854|FG001|Overall Study|Death|0|||
124484143|NCT02201940|447725853|FG000|Overall Study|Adverse Event|0|||
124720923|NCT02120781|448601092|FG001|Overall Study|Completion not documented|1|||
124484144|NCT02201940|447725854|FG001|Overall Study|Adverse Event|1|||
124720924|NCT00984165|448601093|FG000|Overall Study|Death on study|2|||
124720925|NCT00984165|448601094|FG001|Overall Study|Death on study|0|||
124720926|NCT00984165|448601095|FG002|Overall Study|Death on study|0|||
124720927|NCT00984165|448601096|FG003|Overall Study|Death on study|0|||
124720928|NCT00984165|448601093|FG000|Overall Study|Disease progression on study|5|||
124720929|NCT00984165|448601094|FG001|Overall Study|Disease progression on study|1|||
124484145|NCT03192904|447725855|FG000|Overall Study|Physician Decision|3|||
124484146|NCT03192904|447725856|FG001|Overall Study|Physician Decision|1|||
124484147|NCT03192904|447725855|FG000|Overall Study|Lost to Follow-up|0|||
124484148|NCT03192904|447725856|FG001|Overall Study|Lost to Follow-up|1|||
124484149|NCT01442181|447725858|FG000|Overall Study|patient refused surgery|1|||
124484150|NCT01442181|447725859|FG001|Overall Study|patient refused surgery|0|||
124484151|NCT01442181|447725858|FG000|Overall Study|no insurance for surgery|1|||
124484152|NCT01442181|447725859|FG001|Overall Study|no insurance for surgery|0|||
124720930|NCT00984165|448601095|FG002|Overall Study|Disease progression on study|0|||
124720931|NCT00984165|448601096|FG003|Overall Study|Disease progression on study|0|||
124720932|NCT00984165|448601093|FG000|Overall Study|Death of recipient|0|||
124720933|NCT00984165|448601094|FG001|Overall Study|Death of recipient|0|||
124720934|NCT00984165|448601095|FG002|Overall Study|Death of recipient|0|||
124720935|NCT00984165|448601096|FG003|Overall Study|Death of recipient|1|||
124720936|NCT00984165|448601093|FG000|Overall Study|New protocol|0|||
124720937|NCT00984165|448601094|FG001|Overall Study|New protocol|0|||
124720938|NCT00984165|448601095|FG002|Overall Study|New protocol|0|||
124720939|NCT00984165|448601096|FG003|Overall Study|New protocol|1|||
124720940|NCT00984165|448601093|FG000|Overall Study|P+/donor pair removed from protocol|0|||
124720941|NCT00984165|448601094|FG001|Overall Study|P+/donor pair removed from protocol|0|||
124720942|NCT00984165|448601095|FG002|Overall Study|P+/donor pair removed from protocol|0|||
124720943|NCT00984165|448601096|FG003|Overall Study|P+/donor pair removed from protocol|1|||
124720944|NCT00984165|448601093|FG000|Overall Study|removed with a pair recipient|0|||
124720945|NCT00984165|448601094|FG001|Overall Study|removed with a pair recipient|0|||
124720946|NCT00984165|448601095|FG002|Overall Study|removed with a pair recipient|0|||
124484153|NCT01442181|447725858|FG000|Overall Study|low ejection factor|0|||
124484154|NCT01442181|447725859|FG001|Overall Study|low ejection factor|1|||
124484155|NCT01442181|447725858|FG000|Overall Study|Lost to Follow-up|1|||
124484156|NCT01442181|447725859|FG001|Overall Study|Lost to Follow-up|1|||
124484157|NCT01442181|447725858|FG000|Overall Study|patient in an additional study|1|||
124484158|NCT01442181|447725859|FG001|Overall Study|patient in an additional study|0|||
124484159|NCT01442181|447725858|FG000|Overall Study|atrial fibrillation not noted|0|||
124720947|NCT00984165|448601096|FG003|Overall Study|removed with a pair recipient|1|||
124720948|NCT00466947|448601097|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
124720949|NCT00466947|448601098|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
124720950|NCT00466947|448601097|FG000|Study End Analysis Period|Adverse Event|35|||
124720951|NCT00466947|448601098|FG001|Study End Analysis Period|Adverse Event|43|||
124720952|NCT00466947|448601097|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
124720953|NCT00466947|448601098|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
124720954|NCT00466947|448601097|FG000|Study End Analysis Period|Physician Decision|29|||
124720955|NCT00466947|448601098|FG001|Study End Analysis Period|Physician Decision|29|||
124720956|NCT00466947|448601097|FG000|Study End Analysis Period|Protocol Violation|9|||
124720957|NCT00466947|448601098|FG001|Study End Analysis Period|Protocol Violation|17|||
124484160|NCT01442181|447725859|FG001|Overall Study|atrial fibrillation not noted|1|||
124484161|NCT00749203|447725860|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
124484162|NCT00749203|447725861|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
124484163|NCT00749203|447725860|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
124720958|NCT00466947|448601097|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
124720959|NCT00466947|448601098|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
124720960|NCT00466947|448601097|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
124720961|NCT00466947|448601098|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
124720962|NCT00466947|448601097|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
124720963|NCT00466947|448601098|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
124720964|NCT00466947|448601097|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
124720965|NCT00466947|448601098|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
124720966|NCT03850093|448601099|FG000|Overall Study|Withdrawal by Subject|1|||
124720967|NCT03850093|448601100|FG001|Overall Study|Withdrawal by Subject|0|||
124720968|NCT03850093|448601101|FG002|Overall Study|Withdrawal by Subject|2|||
124720969|NCT00066222|448601104|FG000|Overall Study|No protocol treatment received|1|||
124720970|NCT02684617|448601105|FG000|Overall Study|Adverse Event|1|||
124720971|NCT02684617|448601106|FG001|Overall Study|Adverse Event|0|||
124720972|NCT02684617|448601107|FG002|Overall Study|Adverse Event|1|||
124720973|NCT02684617|448601105|FG000|Overall Study|Death|8|||
124720974|NCT02684617|448601106|FG001|Overall Study|Death|16|||
124720975|NCT02684617|448601107|FG002|Overall Study|Death|28|||
124720976|NCT02684617|448601105|FG000|Overall Study|Withdrawal by Subject|2|||
124720977|NCT02684617|448601106|FG001|Overall Study|Withdrawal by Subject|0|||
124720978|NCT02684617|448601107|FG002|Overall Study|Withdrawal by Subject|4|||
124771933|NCT02594124|448794610|FG000|Overall Study|Reason Not Specified|1|||
124771934|NCT02594124|448794611|FG001|Overall Study|Reason Not Specified|3|||
124771935|NCT02594124|448794612|FG002|Overall Study|Reason Not Specified|4|||
124771936|NCT02594124|448794613|FG003|Overall Study|Reason Not Specified|0|||
124557573|NCT03634488|447999147|FG001|Overall Study|Death|0|||
124720979|NCT02684617|448601105|FG000|Overall Study|Screen Failure|1|||
124771937|NCT02594124|448794614|FG004|Overall Study|Reason Not Specified|0|||
124771938|NCT02594124|448794615|FG005|Overall Study|Reason Not Specified|1|||
124771939|NCT02594124|448794616|FG006|Overall Study|Reason Not Specified|1|||
124771940|NCT02594124|448794617|FG007|Overall Study|Reason Not Specified|6|||
124484164|NCT00749203|447725861|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
124484165|NCT00749203|447725860|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
124557574|NCT03634488|447999148|FG002|Overall Study|Death|0|||
124720980|NCT02684617|448601106|FG001|Overall Study|Screen Failure|0|||
124720981|NCT02684617|448601107|FG002|Overall Study|Screen Failure|2|||
124720982|NCT02684617|448601105|FG000|Overall Study|Study Terminated by Sponsor|6|||
124720983|NCT02684617|448601106|FG001|Overall Study|Study Terminated by Sponsor|1|||
124720984|NCT02684617|448601107|FG002|Overall Study|Study Terminated by Sponsor|5|||
124720985|NCT00615719|448601118|FG000|Overall Study|Physician Decision|5|||
124720986|NCT02318368|448601119|FG000|Overall Study|Withdrawal by Subject|2|||
124720987|NCT02318368|448601120|FG001|Overall Study|Withdrawal by Subject|0|||
124720988|NCT02318368|448601119|FG000|Overall Study|Study terminated by the sponsor|5|||
124720989|NCT02318368|448601120|FG001|Overall Study|Study terminated by the sponsor|2|||
124720990|NCT02318368|448601119|FG000|Overall Study|Death|0|||
124720991|NCT02318368|448601120|FG001|Overall Study|Death|1|||
124720992|NCT02201329|448601121|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
124720993|NCT02201329|448601121|FG000|Overall Study|Withdrawal by Subject|2|||
124484166|NCT00749203|447725861|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
124484167|NCT00749203|447725860|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
124484168|NCT00749203|447725861|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
124484169|NCT00749203|447725860|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
124484170|NCT00749203|447725861|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
124484171|NCT00749203|447725860|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
124484172|NCT00749203|447725861|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
124484173|NCT00709202|447725862|FG000|Overall Study|Withdrawal by Subject|6|||
124484174|NCT00709202|447725863|FG001|Overall Study|Withdrawal by Subject|6|||
124484175|NCT01642212|447725867|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
124484176|NCT01642212|447725868|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
124484177|NCT01642212|447725869|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
124484178|NCT01642212|447725870|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
124484179|NCT01642212|447725871|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
124484180|NCT01642212|447725867|FG000|Double-blind Treatment|Other|0|||
124484181|NCT01642212|447725868|FG001|Double-blind Treatment|Other|2|||
124484182|NCT01642212|447725869|FG002|Double-blind Treatment|Other|1|||
124484183|NCT01642212|447725870|FG003|Double-blind Treatment|Other|0|||
124484184|NCT01642212|447725871|FG004|Double-blind Treatment|Other|0|||
124484185|NCT01642212|447725867|FG000|Double-blind Treatment|Non-compliance|0|||
124484186|NCT01642212|447725868|FG001|Double-blind Treatment|Non-compliance|1|||
124484187|NCT01642212|447725869|FG002|Double-blind Treatment|Non-compliance|0|||
124484188|NCT01642212|447725870|FG003|Double-blind Treatment|Non-compliance|0|||
124484189|NCT01642212|447725871|FG004|Double-blind Treatment|Non-compliance|0|||
124484190|NCT01642212|447725867|FG000|Double-blind Treatment|Adverse Event|0|||
124484191|NCT01642212|447725868|FG001|Double-blind Treatment|Adverse Event|0|||
124484192|NCT01642212|447725869|FG002|Double-blind Treatment|Adverse Event|1|||
124484193|NCT01642212|447725870|FG003|Double-blind Treatment|Adverse Event|0|||
124484194|NCT01642212|447725871|FG004|Double-blind Treatment|Adverse Event|0|||
124484195|NCT01642212|447725867|FG000|Open-label Extension|Adverse Event|0|||
124484196|NCT01642212|447725868|FG001|Open-label Extension|Adverse Event|0|||
124484197|NCT01642212|447725869|FG002|Open-label Extension|Adverse Event|0|||
124484198|NCT01642212|447725870|FG003|Open-label Extension|Adverse Event|3|||
124484199|NCT01642212|447725871|FG004|Open-label Extension|Adverse Event|0|||
124484200|NCT01642212|447725867|FG000|Open-label Extension|Sponsor Decision|0|||
124484201|NCT01642212|447725868|FG001|Open-label Extension|Sponsor Decision|0|||
124484202|NCT01642212|447725869|FG002|Open-label Extension|Sponsor Decision|0|||
124484203|NCT01642212|447725870|FG003|Open-label Extension|Sponsor Decision|7|||
124484204|NCT01642212|447725871|FG004|Open-label Extension|Sponsor Decision|4|||
124484205|NCT01642212|447725867|FG000|Open-label Extension|Consent Withdrawn|0|||
124484206|NCT01642212|447725868|FG001|Open-label Extension|Consent Withdrawn|0|||
124484207|NCT01642212|447725869|FG002|Open-label Extension|Consent Withdrawn|0|||
124484208|NCT01642212|447725870|FG003|Open-label Extension|Consent Withdrawn|0|||
124484209|NCT01642212|447725871|FG004|Open-label Extension|Consent Withdrawn|2|||
124484210|NCT01642212|447725867|FG000|Open-label Extension|Lost to Follow-up|0|||
124484211|NCT01642212|447725868|FG001|Open-label Extension|Lost to Follow-up|0|||
124484212|NCT01642212|447725869|FG002|Open-label Extension|Lost to Follow-up|0|||
124484213|NCT01642212|447725870|FG003|Open-label Extension|Lost to Follow-up|0|||
124720994|NCT03629223|448601122|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
124484214|NCT01642212|447725871|FG004|Open-label Extension|Lost to Follow-up|1|||
124484215|NCT01642212|447725867|FG000|Open-label Extension|Other|0|||
124484216|NCT01642212|447725868|FG001|Open-label Extension|Other|0|||
124484217|NCT01642212|447725869|FG002|Open-label Extension|Other|0|||
124484218|NCT01642212|447725870|FG003|Open-label Extension|Other|0|||
124484219|NCT01642212|447725871|FG004|Open-label Extension|Other|1|||
124484220|NCT03934684|447725880|FG000|Overall Study|Participants continuing in study|11|||
124720995|NCT03629223|448601123|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
124720996|NCT03629223|448601124|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
124720997|NCT03629223|448601125|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
124720998|NCT03629223|448601126|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
124484221|NCT03934684|447725881|FG001|Overall Study|Participants continuing in study|4|||
124484222|NCT03934684|447725880|FG000|Overall Study|Discontinuation of carfilzomib|20|||
124484223|NCT03934684|447725881|FG001|Overall Study|Discontinuation of carfilzomib|30|||
124484224|NCT03934684|447725880|FG000|Overall Study|Death|2|||
124484225|NCT03934684|447725881|FG001|Overall Study|Death|2|||
124484226|NCT03934684|447725880|FG000|Overall Study|Lost to Follow-up|2|||
124484227|NCT03934684|447725881|FG001|Overall Study|Lost to Follow-up|5|||
124484228|NCT03934684|447725880|FG000|Overall Study|Withdrawal by Subject|7|||
124484229|NCT03934684|447725881|FG001|Overall Study|Withdrawal by Subject|8|||
124484230|NCT04996797|447725882|FG000|Overall Study|Adverse Event|0|||
124484231|NCT04996797|447725883|FG001|Overall Study|Adverse Event|2|||
124484232|NCT04996797|447725884|FG002|Overall Study|Adverse Event|0|||
124484233|NCT04996797|447725885|FG003|Overall Study|Adverse Event|1|||
124484234|NCT04996797|447725882|FG000|Overall Study|Lack of Efficacy|0|||
124484235|NCT04996797|447725883|FG001|Overall Study|Lack of Efficacy|2|||
124484236|NCT04996797|447725884|FG002|Overall Study|Lack of Efficacy|0|||
124484237|NCT04996797|447725885|FG003|Overall Study|Lack of Efficacy|0|||
124484238|NCT04996797|447725882|FG000|Overall Study|Prohibited Medication|0|||
124484239|NCT04996797|447725883|FG001|Overall Study|Prohibited Medication|1|||
124484240|NCT04996797|447725884|FG002|Overall Study|Prohibited Medication|0|||
124484241|NCT04996797|447725885|FG003|Overall Study|Prohibited Medication|0|||
124484242|NCT04996797|447725882|FG000|Overall Study|Ongoing|68|||
124484243|NCT04996797|447725883|FG001|Overall Study|Ongoing|60|||
124484244|NCT04996797|447725884|FG002|Overall Study|Ongoing|22|||
124484245|NCT04996797|447725885|FG003|Overall Study|Ongoing|20|||
124484246|NCT04996797|447725882|FG000|Overall Study|Withdrawal by Subject|0|||
124484247|NCT04996797|447725883|FG001|Overall Study|Withdrawal by Subject|2|||
124484248|NCT04996797|447725884|FG002|Overall Study|Withdrawal by Subject|0|||
124484249|NCT04996797|447725885|FG003|Overall Study|Withdrawal by Subject|0|||
124484250|NCT04091217|447725886|FG000|Overall Study|Lost to Follow-up|2|||
124484251|NCT05662332|447725887|FG000|Overall Study|Death|3|||
124484252|NCT05662332|447725888|FG001|Overall Study|Death|3|||
124484253|NCT05662332|447725887|FG000|Overall Study|Lost to Follow-up|3|||
124484254|NCT05662332|447725888|FG001|Overall Study|Lost to Follow-up|8|||
124484255|NCT05662332|447725887|FG000|Overall Study|Physician Decision|1|||
124484256|NCT05662332|447725888|FG001|Overall Study|Physician Decision|2|||
124484257|NCT05662332|447725887|FG000|Overall Study|Protocol Deviation|2|||
124484258|NCT05662332|447725888|FG001|Overall Study|Protocol Deviation|1|||
124484259|NCT05662332|447725887|FG000|Overall Study|Withdrawal by Subject|14|||
124484260|NCT05662332|447725888|FG001|Overall Study|Withdrawal by Subject|14|||
124484261|NCT05662332|447725887|FG000|Overall Study|Assigned Treatment by Mistake|5|||
124484262|NCT05662332|447725888|FG001|Overall Study|Assigned Treatment by Mistake|7|||
124484263|NCT05662332|447725887|FG000|Overall Study|Non-compliance with study drug|4|||
124484264|NCT05662332|447725888|FG001|Overall Study|Non-compliance with study drug|1|||
124484265|NCT05662332|447725887|FG000|Overall Study|Due to Bariatric surgery|1|||
124484266|NCT05662332|447725888|FG001|Overall Study|Due to Bariatric surgery|0|||
124484267|NCT05662332|447725887|FG000|Overall Study|Subject Moving out of State|0|||
124484268|NCT05662332|447725888|FG001|Overall Study|Subject Moving out of State|1|||
124484269|NCT05662332|447725887|FG000|Overall Study|Subject Missed the Schedule|1|||
124484270|NCT05662332|447725888|FG001|Overall Study|Subject Missed the Schedule|0|||
124484271|NCT05662332|447725887|FG000|Overall Study|The Patient Moved to Another City|1|||
124484272|NCT05662332|447725888|FG001|Overall Study|The Patient Moved to Another City|0|||
124484273|NCT00100048|447725889|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
124484274|NCT00100048|447725890|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
124484275|NCT00100048|447725891|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
124484276|NCT00100048|447725892|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
124484277|NCT00100048|447725893|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
124484278|NCT00100048|447725894|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
124484279|NCT00100048|447725889|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
124484280|NCT00100048|447725890|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
124484281|NCT00100048|447725891|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
124484282|NCT00100048|447725892|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
124484283|NCT00100048|447725893|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
124484284|NCT00100048|447725894|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
124720999|NCT03629223|448601127|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
124484285|NCT00100048|447725889|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
124484286|NCT00100048|447725890|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
124484287|NCT00100048|447725891|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
124484288|NCT00100048|447725892|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
124484289|NCT00100048|447725893|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
124484290|NCT00100048|447725894|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
124484291|NCT00100048|447725889|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
124484292|NCT00100048|447725890|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
124721000|NCT03629223|448601122|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
124484293|NCT00100048|447725891|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
124484294|NCT00100048|447725892|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
124484295|NCT00100048|447725893|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
124484296|NCT00100048|447725894|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
124484297|NCT00100048|447725889|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
124484298|NCT00100048|447725890|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
124484299|NCT00100048|447725891|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
124484300|NCT00100048|447725892|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
124484301|NCT00100048|447725893|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
124484302|NCT00100048|447725894|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
124484303|NCT00100048|447725889|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
124484304|NCT00100048|447725890|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
124484305|NCT00100048|447725891|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
124484306|NCT00100048|447725892|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
124484307|NCT00100048|447725893|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
124484308|NCT00100048|447725894|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
124484309|NCT00100048|447725889|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
124484310|NCT00100048|447725890|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
124484311|NCT00100048|447725891|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
124484312|NCT00100048|447725892|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
124484313|NCT00100048|447725893|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
124484314|NCT00100048|447725894|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
124484315|NCT00100048|447725889|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
124484316|NCT00100048|447725890|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
124484317|NCT00100048|447725891|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
124484318|NCT00100048|447725892|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
124484319|NCT00100048|447725893|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
124484320|NCT00100048|447725894|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
124484321|NCT01624142|447725896|FG000|Overall Study|Withdrawal by Subject|14|||
124484322|NCT01624142|447725897|FG001|Overall Study|Withdrawal by Subject|4|||
124484323|NCT01624142|447725896|FG000|Overall Study|Death|3|||
124484324|NCT01624142|447725897|FG001|Overall Study|Death|6|||
124484325|NCT01624142|447725896|FG000|Overall Study|Study Closure|12|||
124484326|NCT01624142|447725897|FG001|Overall Study|Study Closure|6|||
124484327|NCT01624142|447725896|FG000|Overall Study|Lost to Follow-up|2|||
124484328|NCT01624142|447725897|FG001|Overall Study|Lost to Follow-up|0|||
124484329|NCT01624142|447725896|FG000|Overall Study|Other|1|||
124484330|NCT01624142|447725897|FG001|Overall Study|Other|0|||
124484331|NCT01822561|447725898|FG000|Overall Study|Withdrawal by Subject|2|||
124484332|NCT04826900|447725901|FG000|Overall Study|Family factor|1|||
124484333|NCT04826900|447725902|FG001|Overall Study|Family factor|1|||
124484334|NCT02597062|447725903|FG000|Overall Study|Ineligible|1|||
124484335|NCT03372941|447725904|FG000|Overall Study|Lost to Follow-up|2|||
124484336|NCT03372941|447725905|FG001|Overall Study|Lost to Follow-up|4|||
124484337|NCT01126580|447725906|FG000|Overall Study|Adverse Event|14|||
124484338|NCT01126580|447725907|FG001|Overall Study|Adverse Event|8|||
124484339|NCT01126580|447725908|FG002|Overall Study|Adverse Event|12|||
124484340|NCT01126580|447725906|FG000|Overall Study|Withdrawal by Subject|11|||
124484341|NCT01126580|447725907|FG001|Overall Study|Withdrawal by Subject|19|||
124484342|NCT01126580|447725908|FG002|Overall Study|Withdrawal by Subject|14|||
124484343|NCT01126580|447725906|FG000|Overall Study|Sponsor Decision|5|||
124484344|NCT01126580|447725907|FG001|Overall Study|Sponsor Decision|4|||
124484345|NCT01126580|447725908|FG002|Overall Study|Sponsor Decision|7|||
124484346|NCT01126580|447725906|FG000|Overall Study|Physician Decision|1|||
124484347|NCT01126580|447725907|FG001|Overall Study|Physician Decision|1|||
124484348|NCT01126580|447725908|FG002|Overall Study|Physician Decision|2|||
124484349|NCT01126580|447725906|FG000|Overall Study|Entry Criteria Not Met|1|||
124484350|NCT01126580|447725907|FG001|Overall Study|Entry Criteria Not Met|1|||
124484351|NCT01126580|447725908|FG002|Overall Study|Entry Criteria Not Met|2|||
124484352|NCT01126580|447725906|FG000|Overall Study|Lack of Efficacy|2|||
124484353|NCT01126580|447725907|FG001|Overall Study|Lack of Efficacy|3|||
124484354|NCT01126580|447725908|FG002|Overall Study|Lack of Efficacy|4|||
124484355|NCT01126580|447725906|FG000|Overall Study|Protocol Violation|0|||
124484356|NCT01126580|447725907|FG001|Overall Study|Protocol Violation|1|||
124484357|NCT01126580|447725908|FG002|Overall Study|Protocol Violation|2|||
124484358|NCT01126580|447725906|FG000|Overall Study|Lost to Follow-up|15|||
124484359|NCT01126580|447725907|FG001|Overall Study|Lost to Follow-up|13|||
124484360|NCT01126580|447725908|FG002|Overall Study|Lost to Follow-up|9|||
124484361|NCT01126580|447725906|FG000|Overall Study|Treatment Non-compliance|0|||
124484362|NCT01126580|447725907|FG001|Overall Study|Treatment Non-compliance|2|||
124484363|NCT01126580|447725908|FG002|Overall Study|Treatment Non-compliance|3|||
124484364|NCT00686543|447725909|FG000|Overall Study|Adverse Event|9|||
124484365|NCT00686543|447725910|FG001|Overall Study|Adverse Event|1|||
124484366|NCT00686543|447725911|FG002|Overall Study|Adverse Event|3|||
124484367|NCT00686543|447725912|FG003|Overall Study|Adverse Event|2|||
124484368|NCT00686543|447725909|FG000|Overall Study|Withdrawal by Subject|2|||
124484369|NCT00686543|447725910|FG001|Overall Study|Withdrawal by Subject|0|||
124484370|NCT00686543|447725911|FG002|Overall Study|Withdrawal by Subject|0|||
124484371|NCT00686543|447725912|FG003|Overall Study|Withdrawal by Subject|0|||
124484372|NCT00686543|447725909|FG000|Overall Study|Protocol Violation|3|||
124484373|NCT00686543|447725910|FG001|Overall Study|Protocol Violation|0|||
124484374|NCT00686543|447725911|FG002|Overall Study|Protocol Violation|2|||
124484375|NCT00686543|447725912|FG003|Overall Study|Protocol Violation|1|||
124484376|NCT01708057|447725915|FG000|Overall Study|Withdrawal due to study termination.|1|||
124484377|NCT01708057|447725916|FG001|Overall Study|Withdrawal due to study termination.|1|||
124484378|NCT01708057|447725917|FG002|Overall Study|Withdrawal due to study termination.|1|||
124484379|NCT00947349|447725918|FG000|Triple Treatment Combination Period|Adverse Event|0|||
124484380|NCT00947349|447725919|FG001|Triple Treatment Combination Period|Adverse Event|1|||
124484381|NCT00947349|447725920|FG002|Triple Treatment Combination Period|Adverse Event|0|||
124484382|NCT00947349|447725921|FG003|Triple Treatment Combination Period|Adverse Event|0|||
124484383|NCT00947349|447725918|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
124484384|NCT00947349|447725919|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
124484385|NCT00947349|447725920|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
124484386|NCT00947349|447725921|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
124484387|NCT00947349|447725918|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
124484388|NCT00947349|447725919|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
124484389|NCT00947349|447725920|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
124484390|NCT00947349|447725921|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
124484391|NCT00947349|447725918|FG000|Overall Study Standard of Care|Other|0|||
124484392|NCT00947349|447725919|FG001|Overall Study Standard of Care|Other|0|||
124484393|NCT00947349|447725920|FG002|Overall Study Standard of Care|Other|0|||
124484394|NCT00947349|447725921|FG003|Overall Study Standard of Care|Other|1|||
124484395|NCT00538681|447725922|FG000|Overall Study|Progressive Disease|7|||
124484396|NCT00538681|447725923|FG001|Overall Study|Progressive Disease|0|||
124484397|NCT00538681|447725924|FG002|Overall Study|Progressive Disease|1|||
124484398|NCT00538681|447725925|FG003|Overall Study|Progressive Disease|0|||
124484399|NCT00538681|447725922|FG000|Overall Study|Sponsor Decision|1|||
124721001|NCT03629223|448601123|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
124721002|NCT03629223|448601124|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
124721003|NCT03629223|448601125|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
124721004|NCT03629223|448601126|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
124721005|NCT03629223|448601127|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
124721006|NCT03629223|448601122|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
124721007|NCT03629223|448601123|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
124721008|NCT03629223|448601124|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
124721009|NCT03629223|448601125|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
124721010|NCT03629223|448601126|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
124721011|NCT03629223|448601127|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
124721012|NCT03629223|448601122|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
124721013|NCT03629223|448601123|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
124721014|NCT03629223|448601124|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
124721015|NCT03629223|448601125|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
124721016|NCT03629223|448601126|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
124721017|NCT03629223|448601127|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
124721018|NCT03629223|448601122|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
124721019|NCT03629223|448601123|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
124721020|NCT03629223|448601124|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
124484400|NCT00538681|447725923|FG001|Overall Study|Sponsor Decision|3|||
124484401|NCT00538681|447725924|FG002|Overall Study|Sponsor Decision|8|||
124484402|NCT00538681|447725925|FG003|Overall Study|Sponsor Decision|9|||
124484403|NCT00538681|447725922|FG000|Overall Study|Adverse Event|1|||
124484404|NCT00538681|447725923|FG001|Overall Study|Adverse Event|1|||
124721021|NCT03629223|448601125|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
124721022|NCT03629223|448601126|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
124721023|NCT03629223|448601127|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
124721024|NCT01534351|448601128|FG000|Overall Study|Study Terminated Early|1|||
124721025|NCT01534351|448601129|FG001|Overall Study|Study Terminated Early|0|||
124721026|NCT01534351|448601130|FG002|Overall Study|Study Terminated Early|0|||
124484405|NCT00538681|447725924|FG002|Overall Study|Adverse Event|1|||
124484406|NCT00538681|447725925|FG003|Overall Study|Adverse Event|0|||
124484407|NCT00538681|447725922|FG000|Overall Study|Death|0|||
124484408|NCT00538681|447725923|FG001|Overall Study|Death|0|||
124557575|NCT03634488|447999146|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
124721027|NCT02702609|448601131|FG000|Overall Study|Lost to Follow-up|8|||
124721028|NCT02702609|448601132|FG001|Overall Study|Lost to Follow-up|4|||
124721029|NCT02702609|448601131|FG000|Overall Study|Physician Decision|1|||
124484409|NCT00538681|447725924|FG002|Overall Study|Death|1|||
124484410|NCT00538681|447725925|FG003|Overall Study|Death|1|||
124484411|NCT00538681|447725922|FG000|Overall Study|Investigator Decision|0|||
124484412|NCT00538681|447725923|FG001|Overall Study|Investigator Decision|0|||
124484413|NCT00538681|447725924|FG002|Overall Study|Investigator Decision|0|||
124484414|NCT00538681|447725925|FG003|Overall Study|Investigator Decision|1|||
124484415|NCT01697345|447725926|FG000|Overall Study|Withdrawal by Subject|1|||
124484416|NCT00140855|447725927|FG000|Overall Study|Progressive disease|2|||
124484417|NCT03929250|447725933|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
124484418|NCT03929250|447725934|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
124484419|NCT05262764|447725935|FG000|Overall Study|Case report form not collected|9|||
124484420|NCT05262764|447725935|FG000|Overall Study|No patient visits after entry|23|||
124484421|NCT05262764|447725935|FG000|Overall Study|Registration rule not followed|2|||
124484422|NCT05262764|447725935|FG000|Overall Study|Patient of non-chronic heart failure|1|||
124484423|NCT01392183|447725936|FG000|First Drug Administration|Adverse Event|3|||
124484424|NCT01392183|447725937|FG001|First Drug Administration|Adverse Event|2|||
124484425|NCT01392183|447725936|FG000|First Drug Administration|Death|1|||
124484426|NCT01392183|447725937|FG001|First Drug Administration|Death|0|||
124484427|NCT01392183|447725936|FG000|First Drug Administration|Withdrawal by Subject|10|||
124484428|NCT01392183|447725937|FG001|First Drug Administration|Withdrawal by Subject|17|||
124484429|NCT03430310|447725938|FG000|Overall Study|Protocol Violation|2|||
124484430|NCT03430310|447725939|FG001|Overall Study|Protocol Violation|0|||
124484431|NCT03430310|447725938|FG000|Overall Study|Withdrawal by Subject|3|||
124484432|NCT03430310|447725939|FG001|Overall Study|Withdrawal by Subject|2|||
124484433|NCT03430310|447725938|FG000|Overall Study|COVID shutdown March 2020|0|||
124484434|NCT03430310|447725939|FG001|Overall Study|COVID shutdown March 2020|1|||
124484435|NCT02770807|447725940|FG000|Overall Study|Adverse Event|3|||
124484436|NCT02770807|447725941|FG001|Overall Study|Adverse Event|3|||
124484437|NCT02770807|447725942|FG002|Overall Study|Adverse Event|1|||
124484438|NCT02770807|447725940|FG000|Overall Study|Withdrawal by Subject|7|||
124484439|NCT02770807|447725941|FG001|Overall Study|Withdrawal by Subject|3|||
124484440|NCT02770807|447725942|FG002|Overall Study|Withdrawal by Subject|4|||
124484441|NCT02770807|447725940|FG000|Overall Study|Other|0|||
124484442|NCT02770807|447725941|FG001|Overall Study|Other|1|||
124484443|NCT02770807|447725942|FG002|Overall Study|Other|0|||
124484444|NCT02770807|447725940|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
124484445|NCT02770807|447725941|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
124484446|NCT02770807|447725942|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
124484447|NCT02770807|447725940|FG000|Overall Study|Physician Decision|0|||
124484448|NCT02770807|447725941|FG001|Overall Study|Physician Decision|0|||
124484449|NCT02770807|447725942|FG002|Overall Study|Physician Decision|1|||
124484450|NCT01826214|447727486|FG000|Overall Study|Adverse Event|7|||
124484451|NCT01826214|447727487|FG001|Overall Study|Adverse Event|6|||
124484452|NCT01826214|447727486|FG000|Overall Study|Death|3|||
124484453|NCT01826214|447727487|FG001|Overall Study|Death|1|||
124484454|NCT01826214|447727486|FG000|Overall Study|Lost to Follow-up|1|||
124484455|NCT01826214|447727487|FG001|Overall Study|Lost to Follow-up|0|||
124484456|NCT01826214|447727486|FG000|Overall Study|Physician Decision|0|||
124484457|NCT01826214|447727487|FG001|Overall Study|Physician Decision|2|||
124484458|NCT01826214|447727486|FG000|Overall Study|Progressive disease|22|||
124484459|NCT01826214|447727487|FG001|Overall Study|Progressive disease|21|||
124484460|NCT01826214|447727486|FG000|Overall Study|Study terminated by Sponsor|0|||
124484461|NCT01826214|447727487|FG001|Overall Study|Study terminated by Sponsor|1|||
124484462|NCT01826214|447727486|FG000|Overall Study|Subject/guardian decision|2|||
124484463|NCT01826214|447727487|FG001|Overall Study|Subject/guardian decision|3|||
124484464|NCT00469079|447727496|FG000|Overall Study|Lack of Efficacy|3|||
124721030|NCT02702609|448601132|FG001|Overall Study|Physician Decision|0|||
124721031|NCT02125838|448601134|FG000|Overall Study|Lost to Follow-up|4|||
124721032|NCT02125838|448601135|FG001|Overall Study|Lost to Follow-up|4|||
124721033|NCT02565147|448601136|FG000|Overall Study|Withdrawal by Subject|5|||
124721034|NCT02565147|448601137|FG001|Overall Study|Withdrawal by Subject|1|||
124484465|NCT00469079|447727497|FG001|Overall Study|Lack of Efficacy|8|||
124484466|NCT00469079|447727498|FG002|Overall Study|Lack of Efficacy|5|||
124484467|NCT00469079|447727496|FG000|Overall Study|Adverse Event|1|||
124484468|NCT00469079|447727497|FG001|Overall Study|Adverse Event|3|||
124484469|NCT00469079|447727498|FG002|Overall Study|Adverse Event|2|||
124484470|NCT00469079|447727496|FG000|Overall Study|Lost to Follow-up|4|||
124484471|NCT00469079|447727497|FG001|Overall Study|Lost to Follow-up|8|||
124484472|NCT00469079|447727498|FG002|Overall Study|Lost to Follow-up|10|||
124484473|NCT00469079|447727496|FG000|Overall Study|Withdrawal by Subject|1|||
124484474|NCT00469079|447727497|FG001|Overall Study|Withdrawal by Subject|2|||
124484475|NCT00469079|447727498|FG002|Overall Study|Withdrawal by Subject|2|||
124484476|NCT00469079|447727496|FG000|Overall Study|Ineligible|0|||
124721035|NCT02565147|448601136|FG000|Overall Study|Lost to Follow-up|0|||
124484477|NCT00469079|447727497|FG001|Overall Study|Ineligible|1|||
124484478|NCT00469079|447727498|FG002|Overall Study|Ineligible|0|||
124484479|NCT00942162|447727499|FG000|Overall Study|Death|45|||
124484480|NCT00942162|447727500|FG001|Overall Study|Death|35|||
124484481|NCT00942162|447727501|FG002|Overall Study|Death|0|||
124484482|NCT00942162|447727499|FG000|Overall Study|Withdrawal by Subject|7|||
124484483|NCT00942162|447727500|FG001|Overall Study|Withdrawal by Subject|2|||
124484484|NCT00942162|447727501|FG002|Overall Study|Withdrawal by Subject|0|||
124484485|NCT00942162|447727499|FG000|Overall Study|Lost to Follow-up|4|||
124484486|NCT00942162|447727500|FG001|Overall Study|Lost to Follow-up|0|||
124484487|NCT00942162|447727501|FG002|Overall Study|Lost to Follow-up|0|||
124484488|NCT00942162|447727499|FG000|Overall Study|Other|14|||
124484489|NCT00942162|447727500|FG001|Overall Study|Other|13|||
124484490|NCT00942162|447727501|FG002|Overall Study|Other|2|||
124484491|NCT03874234|447727505|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
124484492|NCT03874234|447727506|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
124484493|NCT03874234|447727507|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
124484494|NCT03874234|447727508|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
124484495|NCT03874234|447727509|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
124484496|NCT03874234|447727510|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
124484497|NCT03874234|447727511|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
124484498|NCT03874234|447727512|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
124484499|NCT03874234|447727513|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
124484500|NCT03874234|447727514|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
124484501|NCT03874234|447727515|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
124484502|NCT03874234|447727516|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
124484503|NCT03874234|447727517|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
124484504|NCT03874234|447727505|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
124484505|NCT03874234|447727506|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
124484506|NCT03874234|447727507|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
124484507|NCT03874234|447727508|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
124484508|NCT03874234|447727509|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
124484509|NCT03874234|447727510|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
124484510|NCT03874234|447727511|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
124484511|NCT03874234|447727512|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
124484512|NCT03874234|447727513|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
124484513|NCT03874234|447727514|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
124484514|NCT03874234|447727515|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
124484515|NCT03874234|447727516|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
124484516|NCT03874234|447727517|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
124484517|NCT03874234|447727505|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
124484518|NCT03874234|447727506|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
124484519|NCT03874234|447727507|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
124484520|NCT03874234|447727508|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
124484521|NCT03874234|447727509|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
124484522|NCT03874234|447727510|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
124484523|NCT03874234|447727511|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
124484524|NCT03874234|447727512|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
124484525|NCT03874234|447727513|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
124484526|NCT03874234|447727514|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
124484527|NCT03874234|447727515|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
124484528|NCT03874234|447727516|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
124484529|NCT03874234|447727517|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
124484530|NCT03874234|447727505|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
124484531|NCT03874234|447727506|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
124484532|NCT03874234|447727507|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
124484533|NCT03874234|447727508|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
124484534|NCT03874234|447727509|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
124484535|NCT03874234|447727510|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
124484536|NCT03874234|447727511|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
124484537|NCT03874234|447727512|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
124484538|NCT03874234|447727513|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
124484539|NCT03874234|447727514|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
124484540|NCT03874234|447727515|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
124484541|NCT03874234|447727516|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
124484542|NCT03874234|447727517|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
124484543|NCT03874234|447727505|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
124484544|NCT03874234|447727506|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
124484545|NCT03874234|447727507|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
124484546|NCT03874234|447727508|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
124484547|NCT03874234|447727509|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
124484548|NCT03874234|447727510|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
124484549|NCT03874234|447727511|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
124484550|NCT03874234|447727512|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
124484551|NCT03874234|447727513|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
124484552|NCT03874234|447727514|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
124484553|NCT03874234|447727515|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
124484554|NCT03874234|447727516|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
124484555|NCT03874234|447727517|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
124484556|NCT03874234|447727505|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
124484557|NCT03874234|447727506|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
124484558|NCT03874234|447727507|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
124484559|NCT03874234|447727508|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
124484560|NCT03874234|447727509|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
124484561|NCT03874234|447727510|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
124484562|NCT03874234|447727511|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
124484563|NCT03874234|447727512|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
124484564|NCT03874234|447727513|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
124484565|NCT03874234|447727514|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
124484566|NCT03874234|447727515|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
124484567|NCT03874234|447727516|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
124484568|NCT03874234|447727517|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
124484569|NCT03874234|447727505|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
124484570|NCT03874234|447727506|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
124484571|NCT03874234|447727507|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
124484572|NCT03874234|447727508|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
124484573|NCT03874234|447727509|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
124484574|NCT03874234|447727510|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
124484575|NCT03874234|447727511|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
124484576|NCT03874234|447727512|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
124484577|NCT03874234|447727513|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
124484578|NCT03874234|447727514|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
124484579|NCT03874234|447727515|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
124484580|NCT03874234|447727516|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
124484581|NCT03874234|447727517|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
124484582|NCT03874234|447727505|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
124484583|NCT03874234|447727506|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
124484584|NCT03874234|447727507|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
124484585|NCT03874234|447727508|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
124484586|NCT03874234|447727509|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
124484587|NCT03874234|447727510|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
124484588|NCT03874234|447727511|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
124484589|NCT03874234|447727512|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
124484590|NCT03874234|447727513|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
124484591|NCT03874234|447727514|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
124484592|NCT03874234|447727515|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
124484593|NCT03874234|447727516|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
124484594|NCT03874234|447727517|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
124484595|NCT02799381|447727520|FG000|Overall Study|Withdrew consent|3|||
124484596|NCT02799381|447727521|FG001|Overall Study|Withdrew consent|2|||
124484597|NCT02799381|447727520|FG000|Overall Study|Adverse Event|0|||
124484598|NCT02799381|447727521|FG001|Overall Study|Adverse Event|1|||
124484599|NCT02799381|447727520|FG000|Overall Study|Participant did not take any study drug|1|||
124484600|NCT02799381|447727521|FG001|Overall Study|Participant did not take any study drug|0|||
124484601|NCT00783289|447727522|FG000|Overall Study|Protocol Violation|0|||
124484602|NCT00783289|447727523|FG001|Overall Study|Protocol Violation|1|||
124484603|NCT00783289|447727524|FG002|Overall Study|Protocol Violation|0|||
124484604|NCT00783289|447727525|FG003|Overall Study|Protocol Violation|0|||
124484605|NCT03952130|447727526|FG000|Overall Study|Adverse Event|0|||
124484606|NCT03952130|447727527|FG001|Overall Study|Adverse Event|1|||
124484607|NCT03952130|447727526|FG000|Overall Study|Lost to Follow-up|1|||
124484608|NCT03952130|447727527|FG001|Overall Study|Lost to Follow-up|0|||
124771941|NCT02594124|448794618|FG008|Overall Study|Reason Not Specified|1|||
124771942|NCT02514083|448794623|FG000|Overall Study|Adverse Event|1|||
124771943|NCT02141295|448796331|FG000|Overall Study|Adverse Event|1|||
124771944|NCT02141295|448796332|FG001|Overall Study|Adverse Event|18|||
124771945|NCT02141295|448796333|FG002|Overall Study|Adverse Event|11|||
124771946|NCT02141295|448796331|FG000|Overall Study|Physician Decision|2|||
124771947|NCT02141295|448796332|FG001|Overall Study|Physician Decision|19|||
124721036|NCT02565147|448601137|FG001|Overall Study|Lost to Follow-up|1|||
124721037|NCT02565147|448601136|FG000|Overall Study|Death|1|||
124721038|NCT02565147|448601137|FG001|Overall Study|Death|1|||
124721039|NCT00787839|448601138|FG000|Overall Study|Failure to have the OGTT was most common|404|||
124721040|NCT00992056|448601145|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
124721041|NCT00992056|448601146|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
124721042|NCT00992056|448601145|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
124721043|NCT00992056|448601146|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
124721044|NCT01001767|448601147|FG000|Overall Study|no baseline study performed|1|||
124721045|NCT01001767|448601148|FG001|Overall Study|no baseline study performed|0|||
124721046|NCT01001767|448601147|FG000|Overall Study|Protocol Violation|1|||
124721047|NCT01001767|448601148|FG001|Overall Study|Protocol Violation|0|||
124721048|NCT01001767|448601147|FG000|Overall Study|Lost to Follow-up|1|||
124721049|NCT01001767|448601148|FG001|Overall Study|Lost to Follow-up|0|||
124721050|NCT01001767|448601147|FG000|Overall Study|Physician Decision|1|||
124721051|NCT01001767|448601148|FG001|Overall Study|Physician Decision|0|||
124721052|NCT01104545|448601149|FG000|Overall Study|Adverse Event|0|||
124721053|NCT01104545|448601150|FG001|Overall Study|Adverse Event|1|||
124721054|NCT01104545|448601151|FG002|Overall Study|Adverse Event|2|||
124721055|NCT00564902|448601159|FG000|Overall Study|Withdrawal by Subject|0|||
124721056|NCT00564902|448601160|FG001|Overall Study|Withdrawal by Subject|3|||
124484609|NCT03952130|447727526|FG000|Overall Study|Withdrawal by Subject|1|||
124484610|NCT03952130|447727527|FG001|Overall Study|Withdrawal by Subject|5|||
124484611|NCT00506389|447727528|FG000|In-treatment Period|Other|3|||
124484612|NCT00506389|447727529|FG001|In-treatment Period|Other|3|||
124484613|NCT00506389|447727530|FG002|In-treatment Period|Other|4|||
124484614|NCT00506389|447727528|FG000|In-treatment Period|Lost to Follow-up|0|||
124484615|NCT00506389|447727529|FG001|In-treatment Period|Lost to Follow-up|0|||
124484616|NCT00506389|447727530|FG002|In-treatment Period|Lost to Follow-up|1|||
124484617|NCT00506389|447727528|FG000|In-treatment Period|Lack of compliance|1|||
124484618|NCT00506389|447727529|FG001|In-treatment Period|Lack of compliance|0|||
124484619|NCT00506389|447727530|FG002|In-treatment Period|Lack of compliance|0|||
124484620|NCT00506389|447727528|FG000|In-treatment Period|Reasons not related to trial|4|||
124484621|NCT00506389|447727529|FG001|In-treatment Period|Reasons not related to trial|1|||
124484622|NCT00506389|447727530|FG002|In-treatment Period|Reasons not related to trial|0|||
124484623|NCT00506389|447727528|FG000|In-treatment Period|Withdrawal by Subject|3|||
124484624|NCT00506389|447727529|FG001|In-treatment Period|Withdrawal by Subject|3|||
124484625|NCT00506389|447727530|FG002|In-treatment Period|Withdrawal by Subject|4|||
124484626|NCT00506389|447727528|FG000|In-treatment Period|Lack of Efficacy|0|||
124484627|NCT00506389|447727529|FG001|In-treatment Period|Lack of Efficacy|2|||
124484628|NCT00506389|447727530|FG002|In-treatment Period|Lack of Efficacy|0|||
124484629|NCT00506389|447727528|FG000|In-treatment Period|Adverse Event|11|||
124484630|NCT00506389|447727529|FG001|In-treatment Period|Adverse Event|5|||
124484631|NCT00506389|447727530|FG002|In-treatment Period|Adverse Event|2|||
124484632|NCT00506389|447727528|FG000|In-treatment Period|Randomized but not treated|4|||
124484633|NCT00506389|447727529|FG001|In-treatment Period|Randomized but not treated|1|||
124484634|NCT00506389|447727530|FG002|In-treatment Period|Randomized but not treated|1|||
124484635|NCT01503021|447727539|FG000|Overall Study|Adverse Event|7|||
124484636|NCT01503021|447727540|FG001|Overall Study|Adverse Event|6|||
124484637|NCT01503021|447727539|FG000|Overall Study|Death|0|||
124484638|NCT01503021|447727540|FG001|Overall Study|Death|2|||
124484639|NCT01503021|447727539|FG000|Overall Study|Lost to Follow-up|2|||
124484640|NCT01503021|447727540|FG001|Overall Study|Lost to Follow-up|0|||
124484641|NCT01503021|447727539|FG000|Overall Study|Physician Decision|3|||
124484642|NCT01503021|447727540|FG001|Overall Study|Physician Decision|0|||
124484643|NCT01503021|447727539|FG000|Overall Study|Protocol Violation|1|||
124484644|NCT01503021|447727540|FG001|Overall Study|Protocol Violation|3|||
124484645|NCT01503021|447727539|FG000|Overall Study|Withdrawal by Subject|9|||
124484646|NCT01503021|447727540|FG001|Overall Study|Withdrawal by Subject|8|||
124484647|NCT01503021|447727539|FG000|Overall Study|Moved, received transplant, etc.|5|||
124484648|NCT01503021|447727540|FG001|Overall Study|Moved, received transplant, etc.|7|||
124484649|NCT00283387|447727548|FG000|First Intervention|Subject non-compliant|1|||
124484650|NCT00283387|447727549|FG001|First Intervention|Subject non-compliant|1|||
124484651|NCT00283387|447727548|FG000|First Intervention|Withdrawal by Subject|0|||
124484652|NCT00283387|447727549|FG001|First Intervention|Withdrawal by Subject|1|||
124484653|NCT01931865|447727550|FG000|Overall Study|Lost to Follow-up|2|||
124484654|NCT01931865|447727550|FG000|Overall Study|Withdrawal by Subject|2|||
124484655|NCT03584009|447727554|FG000|Overall Study|Death|25|||
124484656|NCT03584009|447727555|FG001|Overall Study|Death|18|||
124557576|NCT03634488|447999147|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
124721057|NCT00564902|448601161|FG002|Overall Study|Withdrawal by Subject|4|||
124721058|NCT00564902|448601159|FG000|Overall Study|Death|1|||
124721059|NCT00564902|448601160|FG001|Overall Study|Death|1|||
124484657|NCT03584009|447727554|FG000|Overall Study|Lost to Follow-up|0|||
124484658|NCT03584009|447727555|FG001|Overall Study|Lost to Follow-up|1|||
124484659|NCT03584009|447727554|FG000|Overall Study|Physician Decision|1|||
124484660|NCT03584009|447727555|FG001|Overall Study|Physician Decision|1|||
124484661|NCT03584009|447727554|FG000|Overall Study|Study Terminated by Sponsor|22|||
124484662|NCT03584009|447727555|FG001|Overall Study|Study Terminated by Sponsor|30|||
124484663|NCT03584009|447727554|FG000|Overall Study|Withdrawal by Subject|3|||
124484664|NCT03584009|447727555|FG001|Overall Study|Withdrawal by Subject|2|||
124484665|NCT00446030|447727556|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
124484666|NCT00446030|447727557|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
124484667|NCT00446030|447727556|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
124484668|NCT00446030|447727557|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
124484669|NCT00446030|447727556|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
124484670|NCT00446030|447727557|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
124721060|NCT00564902|448601161|FG002|Overall Study|Death|0|||
124484671|NCT00446030|447727556|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
124484672|NCT00446030|447727557|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
124484673|NCT00446030|447727556|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
124484674|NCT00446030|447727557|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
124484675|NCT00446030|447727556|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
124484676|NCT00446030|447727557|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
124484677|NCT00446030|447727556|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
124484678|NCT00446030|447727557|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
124484679|NCT00446030|447727556|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
124484680|NCT00446030|447727557|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
124484681|NCT00446030|447727556|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
124484682|NCT00446030|447727557|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
124484683|NCT00446030|447727556|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
124484684|NCT00446030|447727557|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
124484685|NCT00446030|447727556|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
124484686|NCT00446030|447727557|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
124484687|NCT00446030|447727556|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
124484688|NCT00446030|447727557|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
124484689|NCT00446030|447727556|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
124484690|NCT00446030|447727557|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
124484691|NCT00446030|447727556|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
124484692|NCT00446030|447727557|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
124484693|NCT00446030|447727556|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
124484694|NCT00446030|447727557|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
124484695|NCT00446030|447727556|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
124484696|NCT00446030|447727557|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
124484697|NCT00446030|447727556|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
124484698|NCT00446030|447727557|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
124484699|NCT00446030|447727556|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
124484700|NCT00446030|447727557|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
124484701|NCT00446030|447727556|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
124484702|NCT00446030|447727557|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
124484703|NCT02886715|447727558|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124484704|NCT02886715|447727559|FG001|Overall Study|Non-Compliance With Study Drug|2|||
124484705|NCT02886715|447727560|FG002|Overall Study|Non-Compliance With Study Drug|0|||
124484706|NCT02886715|447727558|FG000|Overall Study|Adverse Event|4|||
124484707|NCT02886715|447727559|FG001|Overall Study|Adverse Event|2|||
124484708|NCT02886715|447727560|FG002|Overall Study|Adverse Event|0|||
124484709|NCT02886715|447727558|FG000|Overall Study|Lack of Efficacy|0|||
124484710|NCT02886715|447727559|FG001|Overall Study|Lack of Efficacy|2|||
124484711|NCT02886715|447727560|FG002|Overall Study|Lack of Efficacy|1|||
124484712|NCT02886715|447727558|FG000|Overall Study|Lost to Follow-up|29|||
124721061|NCT03583359|448601164|FG000|Overall Study|Withdrawal by Subject|15|||
124721062|NCT03583359|448601165|FG001|Overall Study|Withdrawal by Subject|6|||
124484713|NCT02886715|447727559|FG001|Overall Study|Lost to Follow-up|26|||
124484714|NCT02886715|447727560|FG002|Overall Study|Lost to Follow-up|10|||
124484715|NCT02886715|447727558|FG000|Overall Study|Pregnancy|1|||
124484716|NCT02886715|447727559|FG001|Overall Study|Pregnancy|1|||
124484717|NCT02886715|447727560|FG002|Overall Study|Pregnancy|1|||
124484718|NCT02886715|447727558|FG000|Overall Study|Protocol Violation|3|||
124721063|NCT03583359|448601164|FG000|Overall Study|Lost to Follow-up|12|||
124721064|NCT03583359|448601165|FG001|Overall Study|Lost to Follow-up|3|||
124484719|NCT02886715|447727559|FG001|Overall Study|Protocol Violation|2|||
124484720|NCT02886715|447727560|FG002|Overall Study|Protocol Violation|1|||
124484721|NCT02886715|447727558|FG000|Overall Study|Withdrawal by Subject|20|||
124484722|NCT02886715|447727559|FG001|Overall Study|Withdrawal by Subject|18|||
124484723|NCT02886715|447727560|FG002|Overall Study|Withdrawal by Subject|5|||
124484724|NCT02886715|447727558|FG000|Overall Study|missing|7|||
124484725|NCT02886715|447727559|FG001|Overall Study|missing|2|||
124484726|NCT02886715|447727560|FG002|Overall Study|missing|2|||
124484727|NCT00222105|447727561|FG000|Overall Study|Removed due to wrong diagnosis|1|||
124721065|NCT03583359|448601164|FG000|Overall Study|Adverse Event|0|||
124721066|NCT03583359|448601165|FG001|Overall Study|Adverse Event|1|||
124721067|NCT03583359|448601164|FG000|Overall Study|Protocol Violation|0|||
124721068|NCT03583359|448601165|FG001|Overall Study|Protocol Violation|1|||
124721069|NCT03583359|448601164|FG000|Overall Study|Other|2|||
124721070|NCT03583359|448601165|FG001|Overall Study|Other|1|||
124721071|NCT00375505|448601166|FG000|Overall Study|Adverse Event|1|||
124721072|NCT00375505|448601167|FG001|Overall Study|Adverse Event|2|||
124721073|NCT02146131|448601170|FG000|Overall Study|Physician Decision|61|||
124721074|NCT02146131|448601171|FG001|Overall Study|Physician Decision|56|||
124721075|NCT02567799|448601172|FG000|Concurrent Chemoradiotherapy|Death|1|||
124721076|NCT02567799|448601173|FG001|Concurrent Chemoradiotherapy|Death|0|||
124721077|NCT02567799|448601174|FG002|Concurrent Chemoradiotherapy|Death|0|||
124721078|NCT02567799|448601172|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
124721079|NCT02567799|448601173|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
124721080|NCT02567799|448601174|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
124721081|NCT02567799|448601172|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
124721082|NCT02567799|448601173|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
124721083|NCT02567799|448601174|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
124721084|NCT02567799|448601172|FG000|Follow-up|Death|1|||
124721085|NCT02567799|448601173|FG001|Follow-up|Death|0|||
124721086|NCT02567799|448601174|FG002|Follow-up|Death|1|||
124721087|NCT02567799|448601172|FG000|Follow-up|Progressive Disease|1|||
124721088|NCT02567799|448601173|FG001|Follow-up|Progressive Disease|1|||
124721089|NCT02567799|448601174|FG002|Follow-up|Progressive Disease|3|||
124721090|NCT00349349|448601176|FG000|Overall Study|Adverse Event|5|||
124721091|NCT00349349|448601177|FG001|Overall Study|Adverse Event|6|||
124484728|NCT00222105|447727561|FG000|Overall Study|Withdrawal by Subject|1|||
124484729|NCT00222105|447727561|FG000|Overall Study|Adverse Event|8|||
124484730|NCT00222105|447727561|FG000|Overall Study|Treatment delays|2|||
124484731|NCT00222105|447727561|FG000|Overall Study|Death|2|||
124484732|NCT03812510|447727564|FG000|Overall Study|Lost to Follow-up|39|||
124484733|NCT03812510|447727564|FG000|Overall Study|Withdrawal by Subject|42|||
124484734|NCT03812510|447727564|FG000|Overall Study|Physician Decision|2|||
124484735|NCT03812510|447727564|FG000|Overall Study|Study Terminated by Sponsor|9|||
124484736|NCT03812510|447727564|FG000|Overall Study|Did Not Start Study Medication|55|||
124484737|NCT03812510|447727564|FG000|Overall Study|Adverse Event|5|||
124484738|NCT01120626|447727567|FG000|Overall Study|Withdrawal by Subject|1|||
124484739|NCT01120626|447727568|FG001|Overall Study|Withdrawal by Subject|0|||
124484740|NCT01073943|447727585|FG000|Overall Study|Withdrawal by Subject|8|||
124484741|NCT01073943|447727586|FG001|Overall Study|Withdrawal by Subject|2|||
124484742|NCT01073943|447727585|FG000|Overall Study|Protocol Violation|2|||
124484743|NCT01073943|447727586|FG001|Overall Study|Protocol Violation|1|||
124484744|NCT01073943|447727585|FG000|Overall Study|Adverse Event|1|||
124484745|NCT01073943|447727586|FG001|Overall Study|Adverse Event|1|||
124484746|NCT01073943|447727585|FG000|Overall Study|Lost to Follow-up|0|||
124484747|NCT01073943|447727586|FG001|Overall Study|Lost to Follow-up|2|||
124484748|NCT01073943|447727585|FG000|Overall Study|Power outage; colonoscopy not done|1|||
124484749|NCT01073943|447727586|FG001|Overall Study|Power outage; colonoscopy not done|0|||
124484750|NCT01073943|447727585|FG000|Overall Study|Subject forgot|0|||
124484751|NCT01073943|447727586|FG001|Overall Study|Subject forgot|1|||
124484752|NCT01073943|447727585|FG000|Overall Study|Unable to return for follow-up|0|||
124484753|NCT01073943|447727586|FG001|Overall Study|Unable to return for follow-up|1|||
124484754|NCT01073943|447727585|FG000|Overall Study|Could not tolerate prep|1|||
124484755|NCT01073943|447727586|FG001|Overall Study|Could not tolerate prep|0|||
124484756|NCT00824421|447727587|FG000|Overall Study|Adverse Event|6|||
124484757|NCT00824421|447727588|FG001|Overall Study|Adverse Event|6|||
124484758|NCT00824421|447727589|FG002|Overall Study|Adverse Event|6|||
124484759|NCT00824421|447727587|FG000|Overall Study|Death|0|||
124484760|NCT00824421|447727588|FG001|Overall Study|Death|1|||
124484761|NCT00824421|447727589|FG002|Overall Study|Death|0|||
124721092|NCT00349349|448601178|FG002|Overall Study|Adverse Event|2|||
124721093|NCT00349349|448601176|FG000|Overall Study|Withdrawal by Subject|5|||
124771948|NCT02141295|448796333|FG002|Overall Study|Physician Decision|14|||
124484762|NCT00824421|447727587|FG000|Overall Study|Lack of Efficacy|5|||
124721094|NCT00349349|448601177|FG001|Overall Study|Withdrawal by Subject|2|||
124721095|NCT00349349|448601178|FG002|Overall Study|Withdrawal by Subject|1|||
124721096|NCT00349349|448601176|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
124721097|NCT00349349|448601177|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
124484763|NCT00824421|447727588|FG001|Overall Study|Lack of Efficacy|7|||
124484764|NCT00824421|447727589|FG002|Overall Study|Lack of Efficacy|4|||
124484765|NCT00824421|447727587|FG000|Overall Study|Lost to Follow-up|2|||
124484766|NCT00824421|447727588|FG001|Overall Study|Lost to Follow-up|3|||
124484767|NCT00824421|447727589|FG002|Overall Study|Lost to Follow-up|0|||
124484768|NCT00824421|447727587|FG000|Overall Study|Pregnancy|1|||
124484769|NCT00824421|447727588|FG001|Overall Study|Pregnancy|0|||
124484770|NCT00824421|447727589|FG002|Overall Study|Pregnancy|1|||
124484771|NCT00824421|447727587|FG000|Overall Study|Withdrawal by Subject|2|||
124721098|NCT00349349|448601178|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
124721099|NCT00349349|448601176|FG000|Overall Study|Death|13|||
124484772|NCT00824421|447727588|FG001|Overall Study|Withdrawal by Subject|3|||
124484773|NCT00824421|447727589|FG002|Overall Study|Withdrawal by Subject|3|||
124484774|NCT00824421|447727587|FG000|Overall Study|Randomized but not Treated|1|||
124484775|NCT00824421|447727588|FG001|Overall Study|Randomized but not Treated|1|||
124484776|NCT00824421|447727589|FG002|Overall Study|Randomized but not Treated|0|||
124484777|NCT00824421|447727587|FG000|Overall Study|Other|0|||
124484778|NCT00824421|447727588|FG001|Overall Study|Other|1|||
124484779|NCT00824421|447727589|FG002|Overall Study|Other|0|||
124484780|NCT03527043|447727590|FG000|Overall Study|Withdrawal by Subject|1|||
124484781|NCT03527043|447727591|FG001|Overall Study|Withdrawal by Subject|0|||
124484782|NCT00927485|447727593|FG000|Overall Study|Adverse Event|4|||
124484783|NCT00927485|447727594|FG001|Overall Study|Adverse Event|2|||
124484784|NCT00927485|447727593|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
124484785|NCT00927485|447727594|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
124484786|NCT01309737|447727595|FG000|Week 0 to 16|Death|1|||
124484787|NCT01309737|447727596|FG001|Week 0 to 16|Death|0|||
124484788|NCT01309737|447727597|FG002|Week 0 to 16|Death|1|||
124484789|NCT01309737|447727598|FG003|Week 0 to 16|Death|0|||
124484790|NCT01309737|447727599|FG004|Week 0 to 16|Death|0|||
124484791|NCT01309737|447727595|FG000|Week 0 to 16|Adverse Event|11|||
124484792|NCT01309737|447727596|FG001|Week 0 to 16|Adverse Event|10|||
124484793|NCT01309737|447727597|FG002|Week 0 to 16|Adverse Event|5|||
124484794|NCT01309737|447727598|FG003|Week 0 to 16|Adverse Event|0|||
124484795|NCT01309737|447727599|FG004|Week 0 to 16|Adverse Event|0|||
124484796|NCT01309737|447727595|FG000|Week 0 to 16|Lack of Efficacy|15|||
124484797|NCT01309737|447727596|FG001|Week 0 to 16|Lack of Efficacy|2|||
124484798|NCT01309737|447727597|FG002|Week 0 to 16|Lack of Efficacy|24|||
124484799|NCT01309737|447727598|FG003|Week 0 to 16|Lack of Efficacy|0|||
124484800|NCT01309737|447727599|FG004|Week 0 to 16|Lack of Efficacy|0|||
124484801|NCT01309737|447727595|FG000|Week 0 to 16|Lost to Follow-up|7|||
124484802|NCT01309737|447727596|FG001|Week 0 to 16|Lost to Follow-up|8|||
124484803|NCT01309737|447727597|FG002|Week 0 to 16|Lost to Follow-up|3|||
124484804|NCT01309737|447727598|FG003|Week 0 to 16|Lost to Follow-up|0|||
124484805|NCT01309737|447727599|FG004|Week 0 to 16|Lost to Follow-up|0|||
124484806|NCT01309737|447727595|FG000|Week 0 to 16|Withdrawal by Subject|7|||
124484807|NCT01309737|447727596|FG001|Week 0 to 16|Withdrawal by Subject|6|||
124484808|NCT01309737|447727597|FG002|Week 0 to 16|Withdrawal by Subject|7|||
124484809|NCT01309737|447727598|FG003|Week 0 to 16|Withdrawal by Subject|0|||
124484810|NCT01309737|447727599|FG004|Week 0 to 16|Withdrawal by Subject|0|||
124484811|NCT01309737|447727595|FG000|Week 0 to 16|Other|10|||
124484812|NCT01309737|447727596|FG001|Week 0 to 16|Other|14|||
124484813|NCT01309737|447727597|FG002|Week 0 to 16|Other|4|||
124484814|NCT01309737|447727598|FG003|Week 0 to 16|Other|0|||
124484815|NCT01309737|447727599|FG004|Week 0 to 16|Other|0|||
124484816|NCT01309737|447727595|FG000|Week 0 to 16|Randomized, but not treated|1|||
124484817|NCT01309737|447727596|FG001|Week 0 to 16|Randomized, but not treated|0|||
124484818|NCT01309737|447727597|FG002|Week 0 to 16|Randomized, but not treated|0|||
124484819|NCT01309737|447727598|FG003|Week 0 to 16|Randomized, but not treated|0|||
124484820|NCT01309737|447727599|FG004|Week 0 to 16|Randomized, but not treated|0|||
124484821|NCT01309737|447727595|FG000|Week 16 to 52|Death|0|||
124484822|NCT01309737|447727596|FG001|Week 16 to 52|Death|0|||
124484823|NCT01309737|447727597|FG002|Week 16 to 52|Death|0|||
124484824|NCT01309737|447727598|FG003|Week 16 to 52|Death|0|||
124484825|NCT01309737|447727599|FG004|Week 16 to 52|Death|1|||
124484826|NCT01309737|447727595|FG000|Week 16 to 52|Adverse Event|7|||
124484827|NCT01309737|447727596|FG001|Week 16 to 52|Adverse Event|7|||
124484828|NCT01309737|447727597|FG002|Week 16 to 52|Adverse Event|0|||
124484829|NCT01309737|447727598|FG003|Week 16 to 52|Adverse Event|6|||
124484830|NCT01309737|447727599|FG004|Week 16 to 52|Adverse Event|5|||
124484831|NCT01309737|447727595|FG000|Week 16 to 52|Lack of Efficacy|107|||
124484832|NCT01309737|447727596|FG001|Week 16 to 52|Lack of Efficacy|76|||
124484833|NCT01309737|447727597|FG002|Week 16 to 52|Lack of Efficacy|0|||
124484834|NCT01309737|447727598|FG003|Week 16 to 52|Lack of Efficacy|25|||
124557577|NCT03634488|447999148|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
124484835|NCT01309737|447727599|FG004|Week 16 to 52|Lack of Efficacy|21|||
124484836|NCT01309737|447727595|FG000|Week 16 to 52|Lost to Follow-up|4|||
124484837|NCT01309737|447727596|FG001|Week 16 to 52|Lost to Follow-up|2|||
124484838|NCT01309737|447727597|FG002|Week 16 to 52|Lost to Follow-up|0|||
124484839|NCT01309737|447727598|FG003|Week 16 to 52|Lost to Follow-up|1|||
124484840|NCT01309737|447727599|FG004|Week 16 to 52|Lost to Follow-up|4|||
124484841|NCT01309737|447727595|FG000|Week 16 to 52|Withdrawal by Subject|5|||
124484842|NCT01309737|447727596|FG001|Week 16 to 52|Withdrawal by Subject|6|||
124484843|NCT01309737|447727597|FG002|Week 16 to 52|Withdrawal by Subject|0|||
124484844|NCT01309737|447727598|FG003|Week 16 to 52|Withdrawal by Subject|0|||
124484845|NCT01309737|447727599|FG004|Week 16 to 52|Withdrawal by Subject|2|||
124484846|NCT01309737|447727595|FG000|Week 16 to 52|Other|10|||
124484847|NCT01309737|447727596|FG001|Week 16 to 52|Other|12|||
124484848|NCT01309737|447727597|FG002|Week 16 to 52|Other|0|||
124484849|NCT01309737|447727598|FG003|Week 16 to 52|Other|2|||
124484850|NCT01309737|447727599|FG004|Week 16 to 52|Other|0|||
124484851|NCT00256295|447727600|FG000|Overall Study|Withdrawal by Subject|3|||
124484852|NCT00256295|447727600|FG000|Overall Study|Death|1|||
124484853|NCT01731002|447727610|FG000|Overall Study|Adverse Event|0|||
124484854|NCT01731002|447727611|FG001|Overall Study|Adverse Event|2|||
124484855|NCT01731002|447727612|FG002|Overall Study|Adverse Event|2|||
124484856|NCT01731002|447727610|FG000|Overall Study|Non-Compliant|0|||
124484857|NCT01731002|447727611|FG001|Overall Study|Non-Compliant|1|||
124484858|NCT01731002|447727612|FG002|Overall Study|Non-Compliant|0|||
124484859|NCT01731002|447727610|FG000|Overall Study|Lost to Follow-up|1|||
124484860|NCT01731002|447727611|FG001|Overall Study|Lost to Follow-up|0|||
124484861|NCT01731002|447727612|FG002|Overall Study|Lost to Follow-up|0|||
124484862|NCT01731002|447727610|FG000|Overall Study|Test Agent Discontinuation|0|||
124484863|NCT01731002|447727611|FG001|Overall Study|Test Agent Discontinuation|1|||
124484864|NCT01731002|447727612|FG002|Overall Study|Test Agent Discontinuation|0|||
124484865|NCT01731002|447727610|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
124484866|NCT01731002|447727611|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
124484867|NCT01731002|447727612|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
124484868|NCT01731002|447727610|FG000|Overall Study|Elevated IOP|1|||
124484869|NCT01731002|447727611|FG001|Overall Study|Elevated IOP|0|||
124484870|NCT01731002|447727612|FG002|Overall Study|Elevated IOP|0|||
124484871|NCT01731002|447727610|FG000|Overall Study|Inappropriate use of study medications|0|||
124484872|NCT01731002|447727611|FG001|Overall Study|Inappropriate use of study medications|0|||
124484873|NCT01731002|447727612|FG002|Overall Study|Inappropriate use of study medications|1|||
124484874|NCT00628355|447727615|FG000|Overall Study|Withdrawal by Subject|1|||
124484875|NCT00628355|447727616|FG001|Overall Study|Withdrawal by Subject|1|||
124484876|NCT03542682|447727617|FG000|Overall Study|COVID-19 Protocol|0|||
124484877|NCT03542682|447727618|FG001|Overall Study|COVID-19 Protocol|1|||
124484878|NCT03476239|447727620|FG000|Overall Study|Withdrawal by Subject|10|||
124484879|NCT03476239|447727620|FG000|Overall Study|Death|80|||
124484880|NCT03476239|447727620|FG000|Overall Study|Lost to Follow-up|8|||
124484881|NCT01446809|447727624|FG000|Overall Study|Adverse Event|0|||
124484882|NCT01446809|447727625|FG001|Overall Study|Adverse Event|0|||
124484883|NCT01446809|447727626|FG002|Overall Study|Adverse Event|1|||
124484884|NCT01446809|447727624|FG000|Overall Study|Failure to complete study procedures|0|||
124484885|NCT01446809|447727625|FG001|Overall Study|Failure to complete study procedures|0|||
124484886|NCT01446809|447727626|FG002|Overall Study|Failure to complete study procedures|1|||
124484887|NCT00785577|447727627|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
124484888|NCT00785577|447727628|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
124484889|NCT00785577|447727629|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
124484890|NCT00785577|447727630|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
124484891|NCT00785577|447727631|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
124484892|NCT00785577|447727627|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
124484893|NCT00785577|447727628|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
124484894|NCT00785577|447727629|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
124484895|NCT00785577|447727630|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
124484896|NCT00785577|447727631|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
124484897|NCT00785577|447727627|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
124484898|NCT00785577|447727628|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
124484899|NCT00785577|447727629|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
124484900|NCT00785577|447727630|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
124484901|NCT00785577|447727631|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
124484902|NCT00785577|447727627|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
124484903|NCT00785577|447727628|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
124484904|NCT00785577|447727629|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
124484905|NCT00785577|447727630|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
124484906|NCT00785577|447727631|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
124484907|NCT00785577|447727627|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
124484908|NCT00785577|447727628|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
124484909|NCT00785577|447727629|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
124484910|NCT00785577|447727630|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
124484911|NCT00785577|447727631|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
124484912|NCT00785577|447727627|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
124484913|NCT00785577|447727628|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
124484914|NCT00785577|447727629|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
124484915|NCT00785577|447727630|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
124484916|NCT00785577|447727631|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
124484917|NCT00785577|447727627|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
124484918|NCT00785577|447727628|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
124484919|NCT00785577|447727629|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
124484920|NCT00785577|447727630|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
124484921|NCT00785577|447727631|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
124484922|NCT00785577|447727627|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
124484923|NCT00785577|447727628|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
124484924|NCT00785577|447727629|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
124484925|NCT00785577|447727630|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
124484926|NCT00785577|447727631|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
124484927|NCT00785577|447727627|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
124484928|NCT00785577|447727628|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
124484929|NCT00785577|447727629|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
124484930|NCT00785577|447727630|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
124484931|NCT00785577|447727631|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
124484932|NCT00785577|447727627|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
124484933|NCT00785577|447727628|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
124484934|NCT00785577|447727629|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
124484935|NCT00785577|447727630|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
124484936|NCT00785577|447727631|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
124484937|NCT01331161|447727632|FG000|Overall Study|Physician Decision|1|||
124484938|NCT01331161|447727633|FG001|Overall Study|Physician Decision|0|||
124484939|NCT01331161|447727632|FG000|Overall Study|Lost to Follow-up|0|||
124484940|NCT01331161|447727633|FG001|Overall Study|Lost to Follow-up|1|||
124484941|NCT01331161|447727632|FG000|Overall Study|Pregnancy|0|||
124484942|NCT01331161|447727633|FG001|Overall Study|Pregnancy|1|||
124484943|NCT01682044|447727637|FG000|Overall Study|Death|1|||
124484944|NCT01682044|447727637|FG000|Overall Study|Progression|3|||
124484945|NCT01659151|447727638|FG000|Overall Study|Inadequate TIL growth|1|||
124484946|NCT01056107|447729004|FG000|Overall Study|Withdrawal by Subject|0|||
124484947|NCT01056107|447729005|FG001|Overall Study|Withdrawal by Subject|1|||
124484948|NCT01056107|447729006|FG002|Overall Study|Withdrawal by Subject|3|||
124484949|NCT01056107|447729007|FG003|Overall Study|Withdrawal by Subject|0|||
124484950|NCT01614457|447729008|FG000|Overall Study|Non-Compliance|1|||
124484951|NCT01614457|447729009|FG001|Overall Study|Non-Compliance|0|||
124484952|NCT01614457|447729008|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
124484953|NCT01614457|447729009|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
124484954|NCT00886821|447729010|FG000|Stage 2|Adverse Event|0|||
124484955|NCT00886821|447729011|FG001|Stage 2|Adverse Event|0|||
124484956|NCT00886821|447729012|FG002|Stage 2|Adverse Event|0|||
124484957|NCT00886821|447729013|FG003|Stage 2|Adverse Event|0|||
124484958|NCT00886821|447729014|FG004|Stage 2|Adverse Event|0|||
124484959|NCT00886821|447729015|FG005|Stage 2|Adverse Event|0|||
124484960|NCT00886821|447729016|FG006|Stage 2|Adverse Event|0|||
124484961|NCT00886821|447729017|FG007|Stage 2|Adverse Event|0|||
124484962|NCT00886821|447729018|FG008|Stage 2|Adverse Event|0|||
124484963|NCT00886821|447729019|FG009|Stage 2|Adverse Event|0|||
124484964|NCT00886821|447729020|FG010|Stage 2|Adverse Event|0|||
124484965|NCT00886821|447729021|FG011|Stage 2|Adverse Event|1|||
124484966|NCT00886821|447729022|FG012|Stage 2|Adverse Event|3|||
124484967|NCT00886821|447729023|FG013|Stage 2|Adverse Event|0|||
124484968|NCT00886821|447729010|FG000|Stage 2|Lost to Follow-up|0|||
124484969|NCT00886821|447729011|FG001|Stage 2|Lost to Follow-up|0|||
124484970|NCT00886821|447729012|FG002|Stage 2|Lost to Follow-up|0|||
124484971|NCT00886821|447729013|FG003|Stage 2|Lost to Follow-up|0|||
124484972|NCT00886821|447729014|FG004|Stage 2|Lost to Follow-up|0|||
124484973|NCT00886821|447729015|FG005|Stage 2|Lost to Follow-up|0|||
124484974|NCT00886821|447729016|FG006|Stage 2|Lost to Follow-up|0|||
124484975|NCT00886821|447729017|FG007|Stage 2|Lost to Follow-up|0|||
124484976|NCT00886821|447729018|FG008|Stage 2|Lost to Follow-up|0|||
124484977|NCT00886821|447729019|FG009|Stage 2|Lost to Follow-up|0|||
124484978|NCT00886821|447729020|FG010|Stage 2|Lost to Follow-up|0|||
124484979|NCT00886821|447729021|FG011|Stage 2|Lost to Follow-up|0|||
124484980|NCT00886821|447729022|FG012|Stage 2|Lost to Follow-up|2|||
124484981|NCT00886821|447729023|FG013|Stage 2|Lost to Follow-up|1|||
124484982|NCT00914628|447729024|FG000|Overall Study|Death|35|||
124484983|NCT00914628|447729025|FG001|Overall Study|Death|17|||
124721100|NCT00349349|448601177|FG001|Overall Study|Death|10|||
124721101|NCT00349349|448601178|FG002|Overall Study|Death|1|||
124721102|NCT00349349|448601176|FG000|Overall Study|Other Treatment Selected|2|||
124721103|NCT00349349|448601177|FG001|Overall Study|Other Treatment Selected|0|||
124484984|NCT00914628|447729024|FG000|Overall Study|Medical decision|4|||
124484985|NCT00914628|447729025|FG001|Overall Study|Medical decision|0|||
124484986|NCT00914628|447729024|FG000|Overall Study|Protocol Violation|1|||
124484987|NCT00914628|447729025|FG001|Overall Study|Protocol Violation|0|||
124484988|NCT00914628|447729024|FG000|Overall Study|Lack of Efficacy|1|||
124484989|NCT00914628|447729025|FG001|Overall Study|Lack of Efficacy|0|||
124484990|NCT00914628|447729024|FG000|Overall Study|non-randomized|1|||
124484991|NCT00914628|447729025|FG001|Overall Study|non-randomized|0|||
124721104|NCT00349349|448601178|FG002|Overall Study|Other Treatment Selected|0|||
124484992|NCT00914628|447729024|FG000|Overall Study|Relapse|1|||
124484993|NCT00914628|447729025|FG001|Overall Study|Relapse|2|||
124484994|NCT00914628|447729024|FG000|Overall Study|Study terminated by Sponsor|14|||
124484995|NCT00914628|447729025|FG001|Overall Study|Study terminated by Sponsor|8|||
124484996|NCT00914628|447729024|FG000|Overall Study|Patients who did not receive a single dose|7|||
124484997|NCT00914628|447729025|FG001|Overall Study|Patients who did not receive a single dose|1|||
124484998|NCT03404960|447729026|FG000|Overall Study|Adverse Event|0|||
124484999|NCT03404960|447729027|FG001|Overall Study|Adverse Event|2|||
124485000|NCT03404960|447729026|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
124485001|NCT03404960|447729027|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
124485002|NCT03404960|447729026|FG000|Overall Study|Bowel obstruction|0|||
124485003|NCT03404960|447729027|FG001|Overall Study|Bowel obstruction|1|||
124485004|NCT03404960|447729026|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
124485005|NCT03404960|447729027|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
124485006|NCT03311126|447729028|FG000|Induction|Death|1|||
124485007|NCT03311126|447729028|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
124485008|NCT00374556|447729029|FG000|Overall Study|Lost to Follow-up|1|||
124485009|NCT00374556|447729030|FG001|Overall Study|Lost to Follow-up|0|||
124485010|NCT00374556|447729029|FG000|Overall Study|Removed at baseline due to medical cond|0|||
124485011|NCT00374556|447729030|FG001|Overall Study|Removed at baseline due to medical cond|1|||
124485012|NCT00473694|447729031|FG000|Overall Study|Adverse Event|0|||
124485013|NCT00473694|447729032|FG001|Overall Study|Adverse Event|1|||
124485014|NCT00473694|447729033|FG002|Overall Study|Adverse Event|0|||
124485015|NCT00473694|447729034|FG003|Overall Study|Adverse Event|0|||
124485016|NCT00473694|447729031|FG000|Overall Study|Participants did not receive treatment|11|||
124485017|NCT00473694|447729032|FG001|Overall Study|Participants did not receive treatment|3|||
124485018|NCT00473694|447729033|FG002|Overall Study|Participants did not receive treatment|5|||
124485019|NCT00473694|447729034|FG003|Overall Study|Participants did not receive treatment|6|||
124485020|NCT00473694|447729031|FG000|Overall Study|Lost to Follow-up|0|||
124485021|NCT00473694|447729032|FG001|Overall Study|Lost to Follow-up|0|||
124485022|NCT00473694|447729033|FG002|Overall Study|Lost to Follow-up|0|||
124485023|NCT00473694|447729034|FG003|Overall Study|Lost to Follow-up|1|||
124485024|NCT01821963|447729050|FG000|Overall Study|Adverse Event|1|||
124485025|NCT03368859|447729051|FG000|Overall Study|Withdrew Consent|5|||
124485026|NCT03368859|447729052|FG001|Overall Study|Withdrew Consent|4|||
124485027|NCT03368859|447729051|FG000|Overall Study|Death|12|||
124485028|NCT03368859|447729052|FG001|Overall Study|Death|6|||
124485029|NCT03368859|447729051|FG000|Overall Study|Study terminated by Sponsor|18|||
124485030|NCT03368859|447729052|FG001|Overall Study|Study terminated by Sponsor|23|||
124485031|NCT03368859|447729051|FG000|Overall Study|Other|1|||
124485032|NCT03368859|447729052|FG001|Overall Study|Other|1|||
124485033|NCT02698410|447729053|FG000|Overall Study|Adverse Event|2|||
124485034|NCT02698410|447729053|FG000|Overall Study|Withdrawal by Subject|1|||
124485035|NCT02698410|447729053|FG000|Overall Study|Other|1|||
124485036|NCT01713348|447729054|FG000|Overall Study|Withdrawal by Subject|3|||
124485037|NCT01713348|447729055|FG001|Overall Study|Withdrawal by Subject|2|||
124485038|NCT01713348|447729056|FG002|Overall Study|Withdrawal by Subject|2|||
124485039|NCT01713348|447729057|FG003|Overall Study|Withdrawal by Subject|0|||
124485040|NCT01713348|447729054|FG000|Overall Study|Lost to Follow-up|1|||
124485041|NCT01713348|447729055|FG001|Overall Study|Lost to Follow-up|0|||
124485042|NCT01713348|447729056|FG002|Overall Study|Lost to Follow-up|0|||
124485043|NCT01713348|447729057|FG003|Overall Study|Lost to Follow-up|0|||
124485044|NCT01896232|447729058|FG000|Overall Study|Death|6|||
124485045|NCT01896232|447729059|FG001|Overall Study|Death|10|||
124485046|NCT01896232|447729058|FG000|Overall Study|Withdrawal by Subject|32|||
124485047|NCT01896232|447729059|FG001|Overall Study|Withdrawal by Subject|31|||
124485048|NCT01896232|447729058|FG000|Overall Study|Sponsor Decision|2|||
124485049|NCT01896232|447729059|FG001|Overall Study|Sponsor Decision|0|||
124485050|NCT01896232|447729058|FG000|Overall Study|Lost to Follow-up|9|||
124485051|NCT01896232|447729059|FG001|Overall Study|Lost to Follow-up|12|||
124485052|NCT00686205|447729068|FG000|Overall Study|Protocol Violation|127|||
124485053|NCT00686205|447729069|FG001|Overall Study|Protocol Violation|0|||
124485054|NCT00686205|447729068|FG000|Overall Study|Withdrawal by Subject|2|||
124485055|NCT00686205|447729069|FG001|Overall Study|Withdrawal by Subject|0|||
124485056|NCT00686205|447729068|FG000|Overall Study|Specimen handling procedure altered|5878|||
124485057|NCT00686205|447729069|FG001|Overall Study|Specimen handling procedure altered|0|||
124485058|NCT00686205|447729068|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
124485059|NCT00686205|447729069|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
124485060|NCT00265941|447729070|FG000|Overall Study|Protocol Violation|22|||
124485061|NCT00265941|447729071|FG001|Overall Study|Protocol Violation|25|||
124485062|NCT00265941|447729070|FG000|Overall Study|Lost to Follow-up|1|||
124485063|NCT00265941|447729071|FG001|Overall Study|Lost to Follow-up|1|||
124485064|NCT03816995|447729074|FG000|Overall Study|Withdrawal by Subject|3|||
124485065|NCT03816995|447729075|FG001|Overall Study|Withdrawal by Subject|1|||
124485066|NCT03816995|447729074|FG000|Overall Study|Cancelled Surgery|8|||
124485067|NCT03816995|447729075|FG001|Overall Study|Cancelled Surgery|12|||
124485068|NCT03816995|447729074|FG000|Overall Study|No wound protector used|11|||
124485069|NCT03816995|447729075|FG001|Overall Study|No wound protector used|17|||
124485070|NCT03816995|447729074|FG000|Overall Study|Protocol Violation|2|||
124485071|NCT03816995|447729075|FG001|Overall Study|Protocol Violation|3|||
124485072|NCT05882890|447729077|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
124485073|NCT00613314|447729080|FG000|Overall Study|Adverse Event|5|||
124485074|NCT00613314|447729080|FG000|Overall Study|Protocol Violation|14|||
124485075|NCT00613314|447729080|FG000|Overall Study|Lost to Follow-up|46|||
124485076|NCT00613314|447729080|FG000|Overall Study|Other reason not defined above|90|||
124485077|NCT00719810|447729081|FG000|Overall Study|Adverse Event|0|||
124485078|NCT00719810|447729082|FG001|Overall Study|Adverse Event|2|||
124485079|NCT00719810|447729083|FG002|Overall Study|Adverse Event|3|||
124485080|NCT00719810|447729081|FG000|Overall Study|Lost to Follow-up|2|||
124485081|NCT00719810|447729082|FG001|Overall Study|Lost to Follow-up|0|||
124485082|NCT00719810|447729083|FG002|Overall Study|Lost to Follow-up|3|||
124485083|NCT00719810|447729081|FG000|Overall Study|Physician Decision|0|||
124485084|NCT00719810|447729082|FG001|Overall Study|Physician Decision|1|||
124485085|NCT00719810|447729083|FG002|Overall Study|Physician Decision|0|||
124485086|NCT00719810|447729081|FG000|Overall Study|Withdrawal by Subject|1|||
124485087|NCT00719810|447729082|FG001|Overall Study|Withdrawal by Subject|1|||
124485088|NCT00719810|447729083|FG002|Overall Study|Withdrawal by Subject|2|||
124485089|NCT03090191|447729084|FG000|Overall Study|Adverse Event|90|||
124485090|NCT03090191|447729085|FG001|Overall Study|Adverse Event|72|||
124485091|NCT03090191|447729084|FG000|Overall Study|Death|365|||
124485092|NCT03090191|447729085|FG001|Overall Study|Death|358|||
124485093|NCT03090191|447729084|FG000|Overall Study|Lost to Follow-up|382|||
124485094|NCT03090191|447729085|FG001|Overall Study|Lost to Follow-up|394|||
124485095|NCT03090191|447729084|FG000|Overall Study|Physician Decision|77|||
124485096|NCT03090191|447729085|FG001|Overall Study|Physician Decision|66|||
124485097|NCT03090191|447729084|FG000|Overall Study|Protocol Violation|43|||
124485098|NCT03090191|447729085|FG001|Overall Study|Protocol Violation|52|||
124485099|NCT03090191|447729084|FG000|Overall Study|Withdrawal by Subject|2160|||
124485100|NCT03090191|447729085|FG001|Overall Study|Withdrawal by Subject|2133|||
124485101|NCT03090191|447729084|FG000|Overall Study|Site terminated|7|||
124485102|NCT03090191|447729085|FG001|Overall Study|Site terminated|8|||
124485103|NCT03090191|447729084|FG000|Overall Study|Other|66|||
124485104|NCT03090191|447729085|FG001|Overall Study|Other|60|||
124485105|NCT03090191|447729084|FG000|Overall Study|Withdrawn before any study vaccination|43|||
124485106|NCT03090191|447729085|FG001|Overall Study|Withdrawn before any study vaccination|52|||
124485107|NCT02432807|447729086|FG000|Overall Study|Adverse Event|0|||
124485108|NCT02432807|447729087|FG001|Overall Study|Adverse Event|2|||
124485109|NCT02432807|447729086|FG000|Overall Study|Lost to Follow-up|1|||
124485110|NCT02432807|447729087|FG001|Overall Study|Lost to Follow-up|0|||
124485111|NCT02432807|447729086|FG000|Overall Study|Withdrawal by Subject|1|||
124485112|NCT02432807|447729087|FG001|Overall Study|Withdrawal by Subject|1|||
124485113|NCT02432807|447729086|FG000|Overall Study|Other|1|||
124485114|NCT02432807|447729087|FG001|Overall Study|Other|1|||
124485115|NCT01845025|447729088|FG000|Overall Study|Adverse Event|6|||
124485116|NCT01845025|447729089|FG001|Overall Study|Adverse Event|3|||
124485117|NCT01845025|447729088|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
124485118|NCT01845025|447729089|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124485119|NCT01845025|447729088|FG000|Overall Study|Withdrawal by Subject|48|||
124485120|NCT01845025|447729089|FG001|Overall Study|Withdrawal by Subject|44|||
124485121|NCT01845025|447729088|FG000|Overall Study|Lost to Follow-up|13|||
124485122|NCT01845025|447729089|FG001|Overall Study|Lost to Follow-up|13|||
124485123|NCT01845025|447729088|FG000|Overall Study|Administrative problems|8|||
124485124|NCT01845025|447729089|FG001|Overall Study|Administrative problems|8|||
124485125|NCT01845025|447729088|FG000|Overall Study|Death|2|||
124485126|NCT01845025|447729089|FG001|Overall Study|Death|0|||
124485127|NCT01845025|447729088|FG000|Overall Study|Protocol deviation|3|||
124485128|NCT01845025|447729089|FG001|Overall Study|Protocol deviation|6|||
124485129|NCT01845025|447729088|FG000|Overall Study|Missing|1|||
124485130|NCT01845025|447729089|FG001|Overall Study|Missing|1|||
124485131|NCT03976401|447729090|FG000|Overall Study|Adverse Event|2|||
124485132|NCT03976401|447729091|FG001|Overall Study|Adverse Event|0|||
124485133|NCT03976401|447729092|FG002|Overall Study|Adverse Event|4|||
124485134|NCT03976401|447729093|FG003|Overall Study|Adverse Event|1|||
124485135|NCT03976401|447729094|FG004|Overall Study|Adverse Event|1|||
124485136|NCT03976401|447729095|FG005|Overall Study|Adverse Event|0|||
124485137|NCT03976401|447729090|FG000|Overall Study|Withdrawal by Subject|0|||
124485138|NCT03976401|447729091|FG001|Overall Study|Withdrawal by Subject|1|||
124485139|NCT03976401|447729092|FG002|Overall Study|Withdrawal by Subject|0|||
124485140|NCT03976401|447729093|FG003|Overall Study|Withdrawal by Subject|0|||
124485141|NCT03976401|447729094|FG004|Overall Study|Withdrawal by Subject|0|||
124485142|NCT03976401|447729095|FG005|Overall Study|Withdrawal by Subject|1|||
124485143|NCT03976401|447729090|FG000|Overall Study|Physician Decision|0|||
124485144|NCT03976401|447729091|FG001|Overall Study|Physician Decision|0|||
124485145|NCT03976401|447729092|FG002|Overall Study|Physician Decision|1|||
124485146|NCT03976401|447729093|FG003|Overall Study|Physician Decision|0|||
124485147|NCT03976401|447729094|FG004|Overall Study|Physician Decision|0|||
124557578|NCT00729365|447999150|FG000|Overall Study|Physician Decision|33|||
124485148|NCT03976401|447729095|FG005|Overall Study|Physician Decision|0|||
124485149|NCT03976401|447729090|FG000|Overall Study|Lost to Follow-up|1|||
124485150|NCT03976401|447729091|FG001|Overall Study|Lost to Follow-up|2|||
124485151|NCT03976401|447729092|FG002|Overall Study|Lost to Follow-up|0|||
124485152|NCT03976401|447729093|FG003|Overall Study|Lost to Follow-up|0|||
124485153|NCT03976401|447729094|FG004|Overall Study|Lost to Follow-up|0|||
124485154|NCT03976401|447729095|FG005|Overall Study|Lost to Follow-up|0|||
124485155|NCT03976401|447729090|FG000|Overall Study|Protocol Violation|0|||
124485156|NCT03976401|447729091|FG001|Overall Study|Protocol Violation|1|||
124485157|NCT03976401|447729092|FG002|Overall Study|Protocol Violation|0|||
124485158|NCT03976401|447729093|FG003|Overall Study|Protocol Violation|0|||
124485159|NCT03976401|447729094|FG004|Overall Study|Protocol Violation|0|||
124485160|NCT03976401|447729095|FG005|Overall Study|Protocol Violation|0|||
124485161|NCT03976401|447729090|FG000|Overall Study|Withdrew Consent|0|||
124485162|NCT03976401|447729091|FG001|Overall Study|Withdrew Consent|0|||
124485163|NCT03976401|447729092|FG002|Overall Study|Withdrew Consent|0|||
124485164|NCT03976401|447729093|FG003|Overall Study|Withdrew Consent|1|||
124485165|NCT03976401|447729094|FG004|Overall Study|Withdrew Consent|0|||
124485166|NCT03976401|447729095|FG005|Overall Study|Withdrew Consent|0|||
124485167|NCT01324830|447729097|FG000|Overall Study|Progressive Disease|3|||
124485168|NCT01324830|447729098|FG001|Overall Study|Progressive Disease|2|||
124485169|NCT01324830|447729099|FG002|Overall Study|Progressive Disease|3|||
124485170|NCT01324830|447729100|FG003|Overall Study|Progressive Disease|3|||
124485171|NCT01324830|447729101|FG004|Overall Study|Progressive Disease|6|||
124485172|NCT01324830|447729102|FG005|Overall Study|Progressive Disease|6|||
124485173|NCT01324830|447729103|FG006|Overall Study|Progressive Disease|3|||
124485174|NCT01324830|447729104|FG007|Overall Study|Progressive Disease|3|||
124485175|NCT01324830|447729105|FG008|Overall Study|Progressive Disease|3|||
124485176|NCT01324830|447729106|FG009|Overall Study|Progressive Disease|6|||
124485177|NCT01324830|447729107|FG010|Overall Study|Progressive Disease|2|||
124485178|NCT01324830|447729108|FG011|Overall Study|Progressive Disease|1|||
124485179|NCT01324830|447729109|FG012|Overall Study|Progressive Disease|1|||
124485180|NCT01324830|447729110|FG013|Overall Study|Progressive Disease|1|||
124485181|NCT01324830|447729111|FG014|Overall Study|Progressive Disease|1|||
124485182|NCT01324830|447729112|FG015|Overall Study|Progressive Disease|3|||
124485183|NCT01324830|447729113|FG016|Overall Study|Progressive Disease|2|||
124485184|NCT01324830|447729114|FG017|Overall Study|Progressive Disease|3|||
124485185|NCT01324830|447729115|FG018|Overall Study|Progressive Disease|4|||
124485186|NCT01324830|447729097|FG000|Overall Study|Dose limiting toxicity|0|||
124485187|NCT01324830|447729098|FG001|Overall Study|Dose limiting toxicity|0|||
124485188|NCT01324830|447729099|FG002|Overall Study|Dose limiting toxicity|0|||
124485189|NCT01324830|447729100|FG003|Overall Study|Dose limiting toxicity|0|||
124485190|NCT01324830|447729101|FG004|Overall Study|Dose limiting toxicity|1|||
124485191|NCT01324830|447729102|FG005|Overall Study|Dose limiting toxicity|0|||
124485192|NCT01324830|447729103|FG006|Overall Study|Dose limiting toxicity|0|||
124485193|NCT01324830|447729104|FG007|Overall Study|Dose limiting toxicity|0|||
124485194|NCT01324830|447729105|FG008|Overall Study|Dose limiting toxicity|0|||
124485195|NCT01324830|447729106|FG009|Overall Study|Dose limiting toxicity|0|||
124485196|NCT01324830|447729107|FG010|Overall Study|Dose limiting toxicity|0|||
124485197|NCT01324830|447729108|FG011|Overall Study|Dose limiting toxicity|0|||
124485198|NCT01324830|447729109|FG012|Overall Study|Dose limiting toxicity|0|||
124485199|NCT01324830|447729110|FG013|Overall Study|Dose limiting toxicity|0|||
124485200|NCT01324830|447729111|FG014|Overall Study|Dose limiting toxicity|0|||
124485201|NCT01324830|447729112|FG015|Overall Study|Dose limiting toxicity|0|||
124485202|NCT01324830|447729113|FG016|Overall Study|Dose limiting toxicity|1|||
124485203|NCT01324830|447729114|FG017|Overall Study|Dose limiting toxicity|1|||
124485204|NCT01324830|447729115|FG018|Overall Study|Dose limiting toxicity|1|||
124485205|NCT01324830|447729097|FG000|Overall Study|Reason not mentioned above|0|||
124485206|NCT01324830|447729098|FG001|Overall Study|Reason not mentioned above|0|||
124485207|NCT01324830|447729099|FG002|Overall Study|Reason not mentioned above|0|||
124485208|NCT01324830|447729100|FG003|Overall Study|Reason not mentioned above|0|||
124485209|NCT01324830|447729101|FG004|Overall Study|Reason not mentioned above|0|||
124485210|NCT01324830|447729102|FG005|Overall Study|Reason not mentioned above|0|||
124485211|NCT01324830|447729103|FG006|Overall Study|Reason not mentioned above|0|||
124485212|NCT01324830|447729104|FG007|Overall Study|Reason not mentioned above|0|||
124485213|NCT01324830|447729105|FG008|Overall Study|Reason not mentioned above|0|||
124485214|NCT01324830|447729106|FG009|Overall Study|Reason not mentioned above|0|||
124485215|NCT01324830|447729107|FG010|Overall Study|Reason not mentioned above|0|||
124485216|NCT01324830|447729108|FG011|Overall Study|Reason not mentioned above|0|||
124485217|NCT01324830|447729109|FG012|Overall Study|Reason not mentioned above|0|||
124485218|NCT01324830|447729110|FG013|Overall Study|Reason not mentioned above|0|||
124485219|NCT01324830|447729111|FG014|Overall Study|Reason not mentioned above|0|||
124485220|NCT01324830|447729112|FG015|Overall Study|Reason not mentioned above|0|||
124485221|NCT01324830|447729113|FG016|Overall Study|Reason not mentioned above|0|||
124485222|NCT01324830|447729114|FG017|Overall Study|Reason not mentioned above|1|||
124485223|NCT01324830|447729115|FG018|Overall Study|Reason not mentioned above|0|||
124557579|NCT00729365|447999151|FG001|Overall Study|Physician Decision|6|||
124485224|NCT01324830|447729097|FG000|Overall Study|Adverse Event, serious fatal|0|||
124485225|NCT01324830|447729098|FG001|Overall Study|Adverse Event, serious fatal|1|||
124485226|NCT01324830|447729099|FG002|Overall Study|Adverse Event, serious fatal|0|||
124557580|NCT00729365|447999152|FG002|Overall Study|Physician Decision|7|||
124721105|NCT00349349|448601176|FG000|Overall Study|Participant Reduced General Condition|0|||
124721106|NCT00349349|448601177|FG001|Overall Study|Participant Reduced General Condition|1|||
124721107|NCT00349349|448601178|FG002|Overall Study|Participant Reduced General Condition|0|||
124721108|NCT00349349|448601176|FG000|Overall Study|Physician Decision|1|||
124485227|NCT01324830|447729100|FG003|Overall Study|Adverse Event, serious fatal|0|||
124485228|NCT01324830|447729101|FG004|Overall Study|Adverse Event, serious fatal|0|||
124485229|NCT01324830|447729102|FG005|Overall Study|Adverse Event, serious fatal|0|||
124485230|NCT01324830|447729103|FG006|Overall Study|Adverse Event, serious fatal|0|||
124485231|NCT01324830|447729104|FG007|Overall Study|Adverse Event, serious fatal|0|||
124485232|NCT01324830|447729105|FG008|Overall Study|Adverse Event, serious fatal|0|||
124485233|NCT01324830|447729106|FG009|Overall Study|Adverse Event, serious fatal|0|||
124485234|NCT01324830|447729107|FG010|Overall Study|Adverse Event, serious fatal|0|||
124485235|NCT01324830|447729108|FG011|Overall Study|Adverse Event, serious fatal|0|||
124485236|NCT01324830|447729109|FG012|Overall Study|Adverse Event, serious fatal|0|||
124485237|NCT01324830|447729110|FG013|Overall Study|Adverse Event, serious fatal|0|||
124485238|NCT01324830|447729111|FG014|Overall Study|Adverse Event, serious fatal|0|||
124485239|NCT01324830|447729112|FG015|Overall Study|Adverse Event, serious fatal|0|||
124485240|NCT01324830|447729113|FG016|Overall Study|Adverse Event, serious fatal|0|||
124485241|NCT01324830|447729114|FG017|Overall Study|Adverse Event, serious fatal|0|||
124485242|NCT01324830|447729115|FG018|Overall Study|Adverse Event, serious fatal|0|||
124485243|NCT01324830|447729097|FG000|Overall Study|Adverse Event, non-fatal|0|||
124485244|NCT01324830|447729098|FG001|Overall Study|Adverse Event, non-fatal|0|||
124485245|NCT01324830|447729099|FG002|Overall Study|Adverse Event, non-fatal|0|||
124485246|NCT01324830|447729100|FG003|Overall Study|Adverse Event, non-fatal|0|||
124485247|NCT01324830|447729101|FG004|Overall Study|Adverse Event, non-fatal|0|||
124721109|NCT00349349|448601177|FG001|Overall Study|Physician Decision|2|||
124721110|NCT00349349|448601178|FG002|Overall Study|Physician Decision|1|||
124721111|NCT00349349|448601176|FG000|Overall Study|No Response|0|||
124721112|NCT00349349|448601177|FG001|Overall Study|No Response|3|||
124721113|NCT00349349|448601178|FG002|Overall Study|No Response|0|||
124721114|NCT00349349|448601176|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
124721115|NCT00349349|448601177|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
124721116|NCT00349349|448601178|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
124721117|NCT00861692|448601180|FG000|Overall Study|Death|6|||
124721118|NCT05111002|448601183|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
124721119|NCT05111002|448601184|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
124721120|NCT05111002|448601183|FG000|Secondary Outcome|Lost to Follow-up|1|||
124721121|NCT05111002|448601184|FG001|Secondary Outcome|Lost to Follow-up|0|||
124721122|NCT04380753|448601185|FG000|Overall Study|Participants continuing study|4|||
124721123|NCT04380753|448601185|FG000|Overall Study|Death|2|||
124721124|NCT00972517|448601188|FG000|Overall Study|Adverse Event|0|||
124721125|NCT00972517|448601189|FG001|Overall Study|Adverse Event|0|||
124721126|NCT00972517|448601190|FG002|Overall Study|Adverse Event|0|||
124721127|NCT00972517|448601191|FG003|Overall Study|Adverse Event|1|||
124721128|NCT00972517|448601192|FG004|Overall Study|Adverse Event|0|||
124721129|NCT00972517|448601193|FG005|Overall Study|Adverse Event|0|||
124721130|NCT00972517|448601188|FG000|Overall Study|Withdrawal by Subject|0|||
124721131|NCT00972517|448601189|FG001|Overall Study|Withdrawal by Subject|1|||
124721132|NCT00972517|448601190|FG002|Overall Study|Withdrawal by Subject|0|||
124721133|NCT00972517|448601191|FG003|Overall Study|Withdrawal by Subject|2|||
124721134|NCT00972517|448601192|FG004|Overall Study|Withdrawal by Subject|1|||
124721135|NCT00972517|448601193|FG005|Overall Study|Withdrawal by Subject|0|||
124721136|NCT00851890|448601194|FG000|Overall Study|Lost to Follow-up|0|||
124721137|NCT00851890|448601195|FG001|Overall Study|Lost to Follow-up|1|||
124721138|NCT00851890|448601196|FG002|Overall Study|Lost to Follow-up|0|||
124721139|NCT00851890|448601197|FG003|Overall Study|Lost to Follow-up|1|||
124721140|NCT03135431|448601198|FG000|Overall Study|Study Surgeon not available|2|||
124721141|NCT03135431|448601199|FG001|Overall Study|Study Surgeon not available|0|||
124721142|NCT02709577|448601200|FG000|Overall Study|non-accommodating anatomy|0|||
124721143|NCT02709577|448601201|FG001|Overall Study|non-accommodating anatomy|1|||
124721144|NCT02709577|448601202|FG002|Overall Study|non-accommodating anatomy|0|||
124721145|NCT02709577|448601203|FG003|Overall Study|non-accommodating anatomy|0|||
124721146|NCT02709577|448601200|FG000|Overall Study|procedural complication|0|||
124721147|NCT02709577|448601201|FG001|Overall Study|procedural complication|1|||
124721148|NCT02709577|448601202|FG002|Overall Study|procedural complication|0|||
124485248|NCT01324830|447729102|FG005|Overall Study|Adverse Event, non-fatal|0|||
124485249|NCT01324830|447729103|FG006|Overall Study|Adverse Event, non-fatal|0|||
124721149|NCT02709577|448601203|FG003|Overall Study|procedural complication|0|||
124721150|NCT02709577|448601200|FG000|Overall Study|Withdrawal by Subject|2|||
124721151|NCT02709577|448601201|FG001|Overall Study|Withdrawal by Subject|3|||
124721152|NCT02709577|448601202|FG002|Overall Study|Withdrawal by Subject|2|||
124721153|NCT02709577|448601203|FG003|Overall Study|Withdrawal by Subject|0|||
124721154|NCT00375674|448601204|FG000|Overall Study|Other|26|||
124721155|NCT00375674|448601205|FG001|Overall Study|Other|18|||
124721156|NCT00375674|448601204|FG000|Overall Study|Death|67|||
124721157|NCT00375674|448601205|FG001|Overall Study|Death|76|||
124721158|NCT00375674|448601204|FG000|Overall Study|Participants refused further follow-up|31|||
124721159|NCT00375674|448601205|FG001|Overall Study|Participants refused further follow-up|30|||
124485250|NCT01324830|447729104|FG007|Overall Study|Adverse Event, non-fatal|0|||
124485251|NCT01324830|447729105|FG008|Overall Study|Adverse Event, non-fatal|2|||
124485252|NCT01324830|447729106|FG009|Overall Study|Adverse Event, non-fatal|0|||
124485253|NCT01324830|447729107|FG010|Overall Study|Adverse Event, non-fatal|1|||
124485254|NCT01324830|447729108|FG011|Overall Study|Adverse Event, non-fatal|0|||
124485255|NCT01324830|447729109|FG012|Overall Study|Adverse Event, non-fatal|0|||
124485256|NCT01324830|447729110|FG013|Overall Study|Adverse Event, non-fatal|0|||
124485257|NCT01324830|447729111|FG014|Overall Study|Adverse Event, non-fatal|0|||
124485258|NCT01324830|447729112|FG015|Overall Study|Adverse Event, non-fatal|0|||
124485259|NCT01324830|447729113|FG016|Overall Study|Adverse Event, non-fatal|0|||
124485260|NCT01324830|447729114|FG017|Overall Study|Adverse Event, non-fatal|1|||
124485261|NCT01324830|447729115|FG018|Overall Study|Adverse Event, non-fatal|0|||
124485262|NCT01324830|447729097|FG000|Overall Study|Withdrawal by Subject|0|||
124485263|NCT01324830|447729098|FG001|Overall Study|Withdrawal by Subject|0|||
124485264|NCT01324830|447729099|FG002|Overall Study|Withdrawal by Subject|0|||
124485265|NCT01324830|447729100|FG003|Overall Study|Withdrawal by Subject|0|||
124485266|NCT01324830|447729101|FG004|Overall Study|Withdrawal by Subject|0|||
124485267|NCT01324830|447729102|FG005|Overall Study|Withdrawal by Subject|1|||
124485268|NCT01324830|447729103|FG006|Overall Study|Withdrawal by Subject|0|||
124485269|NCT01324830|447729104|FG007|Overall Study|Withdrawal by Subject|0|||
124485270|NCT01324830|447729105|FG008|Overall Study|Withdrawal by Subject|0|||
124485271|NCT01324830|447729106|FG009|Overall Study|Withdrawal by Subject|0|||
124485272|NCT01324830|447729107|FG010|Overall Study|Withdrawal by Subject|1|||
124485273|NCT01324830|447729108|FG011|Overall Study|Withdrawal by Subject|0|||
124485274|NCT01324830|447729109|FG012|Overall Study|Withdrawal by Subject|0|||
124485275|NCT01324830|447729110|FG013|Overall Study|Withdrawal by Subject|0|||
124485276|NCT01324830|447729111|FG014|Overall Study|Withdrawal by Subject|0|||
124485277|NCT01324830|447729112|FG015|Overall Study|Withdrawal by Subject|0|||
124485278|NCT01324830|447729113|FG016|Overall Study|Withdrawal by Subject|0|||
124485279|NCT01324830|447729114|FG017|Overall Study|Withdrawal by Subject|0|||
124485280|NCT01324830|447729115|FG018|Overall Study|Withdrawal by Subject|1|||
124485281|NCT00942409|447729116|FG000|Overall Study|Lack of Efficacy|1|||
124485282|NCT00942409|447729116|FG000|Overall Study|study drug unavailable|2|||
124485283|NCT00817414|447729119|FG000|Overall Study|Adverse Event|1|||
124485284|NCT00817414|447729120|FG001|Overall Study|Adverse Event|1|||
124485285|NCT00817414|447729121|FG002|Overall Study|Adverse Event|1|||
124485286|NCT00817414|447729122|FG003|Overall Study|Adverse Event|0|||
124485287|NCT00817414|447729123|FG004|Overall Study|Adverse Event|0|||
124485288|NCT00817414|447729119|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
124485289|NCT00817414|447729120|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
124485290|NCT00817414|447729121|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
124485291|NCT00817414|447729122|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
124485292|NCT00817414|447729123|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
124485293|NCT00817414|447729119|FG000|Overall Study|Withdrawal by Subject|1|||
124485294|NCT00817414|447729120|FG001|Overall Study|Withdrawal by Subject|1|||
124485295|NCT00817414|447729121|FG002|Overall Study|Withdrawal by Subject|0|||
124485296|NCT00817414|447729122|FG003|Overall Study|Withdrawal by Subject|0|||
124485297|NCT00817414|447729123|FG004|Overall Study|Withdrawal by Subject|0|||
124485298|NCT00817414|447729119|FG000|Overall Study|Lost to Follow-up|0|||
124485299|NCT00817414|447729120|FG001|Overall Study|Lost to Follow-up|0|||
124721160|NCT00375674|448601204|FG000|Overall Study|Lost to Follow-up|17|||
124721161|NCT00375674|448601205|FG001|Overall Study|Lost to Follow-up|15|||
124721162|NCT00375674|448601204|FG000|Overall Study|Enrolled but not treated|3|||
124485300|NCT00817414|447729121|FG002|Overall Study|Lost to Follow-up|1|||
124485301|NCT00817414|447729122|FG003|Overall Study|Lost to Follow-up|1|||
124485302|NCT00817414|447729123|FG004|Overall Study|Lost to Follow-up|1|||
124485303|NCT00817414|447729119|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
124485304|NCT00817414|447729120|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
124485305|NCT00817414|447729121|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
124485306|NCT00817414|447729122|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
124485307|NCT00817414|447729123|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
124485308|NCT00817414|447729119|FG000|Overall Study|Protocol Violation|0|||
124485309|NCT00817414|447729120|FG001|Overall Study|Protocol Violation|0|||
124485310|NCT00817414|447729121|FG002|Overall Study|Protocol Violation|0|||
124485311|NCT00817414|447729122|FG003|Overall Study|Protocol Violation|0|||
124485312|NCT00817414|447729123|FG004|Overall Study|Protocol Violation|1|||
124485313|NCT02966314|447729124|FG000|Overall Study|Lost to Follow-up|1|||
124485314|NCT02966314|447729125|FG001|Overall Study|Lost to Follow-up|0|||
124485315|NCT01242111|447729127|FG000|Overall Study|Adverse Event|1|||
124485316|NCT01242111|447729127|FG000|Overall Study|Withdrawal by Subject|1|||
124721163|NCT00375674|448601205|FG001|Overall Study|Enrolled but not treated|2|||
124485317|NCT01242111|447729127|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
124485318|NCT01021007|447729130|FG000|Overall Study|Lost to Follow-up|1|||
124485319|NCT01021007|447729131|FG001|Overall Study|Lost to Follow-up|1|||
124485320|NCT01021007|447729130|FG000|Overall Study|Adverse Event|1|||
124485321|NCT01021007|447729131|FG001|Overall Study|Adverse Event|3|||
124485322|NCT02945657|447729132|FG000|Overall Study|Adverse Event|1|||
124485323|NCT02945657|447729132|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
124485324|NCT00087438|447729133|FG000|Overall Study|Ineligible / No protocol treatment|4|||
124485325|NCT00466505|447729134|FG000|Overall Study|disease progression|13|||
124485326|NCT00466505|447729134|FG000|Overall Study|Adverse Event|4|||
124485327|NCT02120417|447729136|FG000|Overall Study|Death|5|||
124485328|NCT02120417|447729137|FG001|Overall Study|Death|1|||
124485329|NCT02120417|447729136|FG000|Overall Study|Adverse Event|3|||
124485330|NCT02120417|447729137|FG001|Overall Study|Adverse Event|9|||
124485331|NCT02120417|447729136|FG000|Overall Study|Participant decision|4|||
124485332|NCT02120417|447729137|FG001|Overall Study|Participant decision|4|||
124485333|NCT02120417|447729136|FG000|Overall Study|Disease progression|41|||
124485334|NCT02120417|447729137|FG001|Overall Study|Disease progression|45|||
124485335|NCT02120417|447729136|FG000|Overall Study|Noncompliance with study treatment|0|||
124485336|NCT02120417|447729137|FG001|Overall Study|Noncompliance with study treatment|2|||
124485337|NCT02120417|447729136|FG000|Overall Study|Physician Decision|2|||
124485338|NCT02120417|447729137|FG001|Overall Study|Physician Decision|3|||
124485339|NCT02120417|447729136|FG000|Overall Study|Other unspecified|5|||
124485340|NCT02120417|447729137|FG001|Overall Study|Other unspecified|4|||
124485341|NCT02604264|447729138|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
124485342|NCT02604264|447729139|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
124485343|NCT00855439|447729142|FG000|Overall Study|Withdrawal by Subject|2|||
124485344|NCT00855439|447729143|FG001|Overall Study|Withdrawal by Subject|0|||
124557581|NCT01154127|447999153|FG000|Period 1 (21 Days)|Adverse Event|3|||
124557582|NCT01154127|447999154|FG001|Period 1 (21 Days)|Adverse Event|4|||
124557583|NCT01154127|447999153|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
124557584|NCT01154127|447999154|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
124557585|NCT01154127|447999153|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
124557586|NCT01154127|447999154|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
124557587|NCT01154127|447999153|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
124557588|NCT01154127|447999154|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
124557589|NCT01154127|447999153|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
124557590|NCT01154127|447999154|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
124557591|NCT01697449|447999155|FG000|Overall Study|Disease progression|47|||
124557592|NCT01697449|447999155|FG000|Overall Study|Adverse Event|7|||
124557593|NCT01697449|447999155|FG000|Overall Study|Lost to Follow-up|5|||
124557594|NCT01697449|447999155|FG000|Overall Study|Withdrawal by Subject|2|||
124557595|NCT01697449|447999155|FG000|Overall Study|Physician Decision|1|||
124557596|NCT01697449|447999155|FG000|Overall Study|Death|2|||
124557597|NCT01697449|447999155|FG000|Overall Study|Other|1|||
124557598|NCT01697449|447999155|FG000|Overall Study|Missing|25|||
124557599|NCT01169844|447999157|FG000|Overall Study|Adverse Event|0|||
124557600|NCT01169844|447999158|FG001|Overall Study|Adverse Event|1|||
124557601|NCT01169844|447999157|FG000|Overall Study|Patient withdrew consent|4|||
124557602|NCT01169844|447999158|FG001|Overall Study|Patient withdrew consent|0|||
124557603|NCT01169844|447999157|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124557604|NCT01169844|447999158|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124557605|NCT05037409|447999159|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
124557606|NCT05037409|447999160|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
124557607|NCT05037409|447999161|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
124557608|NCT00529568|447999162|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
124557609|NCT00529568|447999163|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
124557610|NCT00529568|447999164|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
124557611|NCT00529568|447999162|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
124557612|NCT00529568|447999163|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
124557613|NCT00529568|447999164|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
124557614|NCT00529568|447999162|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
124557615|NCT00529568|447999163|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
124557616|NCT00529568|447999164|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
124721164|NCT03744910|448603548|FG000|Overall Study|Withdrew Consent|1|||
124721165|NCT03744910|448603549|FG001|Overall Study|Withdrew Consent|8|||
124721166|NCT03744910|448603548|FG000|Overall Study|Physician Decision|5|||
124721167|NCT03744910|448603549|FG001|Overall Study|Physician Decision|4|||
124485345|NCT00855439|447729142|FG000|Overall Study|Pregnancy|1|||
124485346|NCT00855439|447729143|FG001|Overall Study|Pregnancy|0|||
124485347|NCT00613626|447729145|FG000|Overall Study|Ineligible|0|||
124485348|NCT00613626|447729146|FG001|Overall Study|Ineligible|1|||
124485349|NCT00613626|447729147|FG002|Overall Study|Ineligible|0|||
124485350|NCT03212261|447729148|FG000|Overall Study|Became ineligible d/t tech|2|||
124485351|NCT03212261|447729148|FG000|Overall Study|Tech Trouble- No first study visit|1|||
124721168|NCT03744910|448603548|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
124721169|NCT03744910|448603549|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
124721170|NCT03744910|448603548|FG000|Overall Study|Lost to Follow-up|0|||
124721171|NCT03744910|448603549|FG001|Overall Study|Lost to Follow-up|1|||
124721172|NCT03744910|448603548|FG000|Overall Study|Other-unspecified|4|||
124721173|NCT03744910|448603549|FG001|Overall Study|Other-unspecified|1|||
124721174|NCT00064259|448603550|FG000|Overall Study|Adverse Event|1|||
124485352|NCT03212261|447729148|FG000|Overall Study|Lost to Follow-up|7|||
124721175|NCT00064259|448603551|FG001|Overall Study|Adverse Event|0|||
124721176|NCT00064259|448603552|FG002|Overall Study|Adverse Event|0|||
124721177|NCT00064259|448603553|FG003|Overall Study|Adverse Event|1|||
124721178|NCT01132651|448603556|FG000|Overall Study|Lost to Follow-up|1|||
124721179|NCT01132651|448603557|FG001|Overall Study|Lost to Follow-up|1|||
124721180|NCT00948857|448603558|FG000|Overall Study|Lost to Follow-up|1|||
124721181|NCT00948857|448603559|FG001|Overall Study|Lost to Follow-up|0|||
124721182|NCT03430843|448603562|FG000|Overall Study|Death|233|||
124721183|NCT03430843|448603563|FG001|Overall Study|Death|233|||
124721184|NCT03430843|448603562|FG000|Overall Study|Sponsor Decision|17|||
124721185|NCT03430843|448603563|FG001|Overall Study|Sponsor Decision|6|||
124485353|NCT03212261|447729148|FG000|Overall Study|Family Emergency|1|||
124485354|NCT03212261|447729148|FG000|Overall Study|Too busy/ No time|5|||
124485355|NCT01076179|447729149|FG000|Overall Study|Withdrawal by Subject|1|||
124485356|NCT00457639|447729150|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
124485357|NCT00457639|447729151|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
124485358|NCT00457639|447729150|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
124485359|NCT00457639|447729151|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
124485360|NCT00457639|447729150|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
124485361|NCT00457639|447729151|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
124485362|NCT04885257|447729152|FG000|Overall Study|Withdrawal by Subject|1|||
124485363|NCT04885257|447729153|FG001|Overall Study|Withdrawal by Subject|0|||
124485364|NCT00853632|447730441|FG000|Overall Study|Death|88|||
124485365|NCT00853632|447730441|FG000|Overall Study|Withdrawal by Subject|45|||
124485366|NCT00853632|447730441|FG000|Overall Study|Lost to Follow-up|30|||
124485367|NCT00853632|447730441|FG000|Overall Study|Reoperation/Explant|17|||
124485368|NCT00853632|447730441|FG000|Overall Study|Exit with other reason|22|||
124485369|NCT01672892|447730442|FG000|Overall Study|Protocol Violation|7|||
124485370|NCT01672892|447730443|FG001|Overall Study|Protocol Violation|3|||
124485371|NCT02579603|447730450|FG000|Overall Study|Not treated|1|||
124485372|NCT02579603|447730451|FG001|Overall Study|Not treated|0|||
124485373|NCT02579603|447730450|FG000|Overall Study|Adverse Event|2|||
124485374|NCT02579603|447730451|FG001|Overall Study|Adverse Event|2|||
124485375|NCT02579603|447730450|FG000|Overall Study|Other than stated|1|||
124485376|NCT02579603|447730451|FG001|Overall Study|Other than stated|0|||
124485377|NCT01006356|447730452|FG000|Overall Study|Adverse Event|6|||
124485378|NCT01006356|447730452|FG000|Overall Study|Physician Decision|1|||
124485379|NCT01006356|447730452|FG000|Overall Study|Paticipants did not cooperate|6|||
124485380|NCT01006356|447730452|FG000|Overall Study|Withdrawal by Subject|1|||
124485381|NCT01006356|447730452|FG000|Overall Study|Choice by participants|2|||
124485382|NCT01006356|447730452|FG000|Overall Study|Protocol Violation|3|||
124485383|NCT01006356|447730452|FG000|Overall Study|Other|23|||
124485384|NCT02981472|447730455|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
124485385|NCT02981472|447730456|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
124485386|NCT02981472|447730455|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
124485387|NCT02981472|447730456|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124485388|NCT02981472|447730455|FG000|Treatment Period|Adverse Event|6|||
124485389|NCT02981472|447730456|FG001|Treatment Period|Adverse Event|1|||
124485390|NCT02981472|447730455|FG000|Treatment Period|Participant withdrew consent|1|||
124485391|NCT02981472|447730456|FG001|Treatment Period|Participant withdrew consent|0|||
124485392|NCT02981472|447730455|FG000|Treatment Period|Lost to Follow-up|0|||
124485393|NCT02981472|447730456|FG001|Treatment Period|Lost to Follow-up|1|||
124485394|NCT01756157|447730457|FG000|First Intervention Period|Withdrawal by Subject|1|||
124485395|NCT01756157|447730458|FG001|First Intervention Period|Withdrawal by Subject|0|||
124485396|NCT01756157|447730457|FG000|First Intervention Period|Lost to Follow-up|0|||
124485397|NCT01756157|447730458|FG001|First Intervention Period|Lost to Follow-up|2|||
124485398|NCT02559505|447730463|FG000|Overall Study|Lost to Follow-up|23|||
124721186|NCT03430843|448603562|FG000|Overall Study|Withdrawal by Subject|5|||
124721187|NCT03430843|448603563|FG001|Overall Study|Withdrawal by Subject|14|||
124721188|NCT03430843|448603562|FG000|Overall Study|Lost to Follow-up|1|||
124771949|NCT02141295|448796331|FG000|Overall Study|Study terminated by sponsor|0|||
124485399|NCT02559505|447730464|FG001|Overall Study|Lost to Follow-up|20|||
124485400|NCT02559505|447730463|FG000|Overall Study|Withdrawal by Subject|4|||
124485401|NCT02559505|447730464|FG001|Overall Study|Withdrawal by Subject|2|||
124485402|NCT03715465|447730465|FG000|Overall Study|Withdrawal by Subject|1|||
124485403|NCT03715465|447730466|FG001|Overall Study|Withdrawal by Subject|2|||
124485404|NCT01584024|447730471|FG000|Overall Study|Lost to Follow-up|10|||
124485405|NCT01584024|447730471|FG000|Overall Study|Withdrawal by Subject|3|||
124721189|NCT03430843|448603563|FG001|Overall Study|Lost to Follow-up|3|||
124721190|NCT00590122|448603572|FG000|Overall Study|swallowed oral dissolving dose|1|||
124721191|NCT00590122|448603573|FG001|Overall Study|swallowed oral dissolving dose|0|||
124721192|NCT03050450|448603574|FG000|Overall Study|Physician Decision|1|||
124721193|NCT03050450|448603575|FG001|Overall Study|Physician Decision|0|||
124721194|NCT03050450|448603576|FG002|Overall Study|Physician Decision|0|||
124721195|NCT03050450|448603577|FG003|Overall Study|Physician Decision|0|||
124485406|NCT01217606|447730472|FG000|Initial Treatment Phase|Other Reasons|0|||
124485407|NCT01217606|447730473|FG001|Initial Treatment Phase|Other Reasons|2|||
124485408|NCT01217606|447730472|FG000|Initial Treatment Phase|Protocol Violation|3|||
124485409|NCT01217606|447730473|FG001|Initial Treatment Phase|Protocol Violation|2|||
124721196|NCT03050450|448603578|FG004|Overall Study|Physician Decision|0|||
124485410|NCT01217606|447730472|FG000|Initial Treatment Phase|Personal Reasons|0|||
124485411|NCT01217606|447730473|FG001|Initial Treatment Phase|Personal Reasons|2|||
124485412|NCT01217606|447730472|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
124485413|NCT01217606|447730473|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
124485414|NCT01217606|447730472|FG000|Initial Treatment Phase|Adverse Event|10|||
124485415|NCT01217606|447730473|FG001|Initial Treatment Phase|Adverse Event|6|||
124485416|NCT01217606|447730472|FG000|9-Month Masked Extension|Adverse Event|3|||
124485417|NCT01217606|447730473|FG001|9-Month Masked Extension|Adverse Event|6|||
124485418|NCT01217606|447730472|FG000|9-Month Masked Extension|Other Reasons|4|||
124485419|NCT01217606|447730473|FG001|9-Month Masked Extension|Other Reasons|4|||
124485420|NCT01217606|447730472|FG000|9-Month Masked Extension|Personal Reasons|2|||
124485421|NCT01217606|447730473|FG001|9-Month Masked Extension|Personal Reasons|1|||
124485422|NCT01217606|447730472|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
124485423|NCT01217606|447730473|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
124485424|NCT01217606|447730472|FG000|9-Month Masked Extension|Pregnancy|1|||
124485425|NCT01217606|447730473|FG001|9-Month Masked Extension|Pregnancy|0|||
124485426|NCT01217606|447730472|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
124485427|NCT01217606|447730473|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
124485428|NCT00893789|447730483|FG000|Overall Study|Withdrawal by Subject|3|||
124485429|NCT00893789|447730484|FG001|Overall Study|Withdrawal by Subject|1|||
124485430|NCT00893789|447730485|FG002|Overall Study|Withdrawal by Subject|3|||
124485431|NCT00893789|447730486|FG003|Overall Study|Withdrawal by Subject|1|||
124485432|NCT00893789|447730483|FG000|Overall Study|Noncompliance With Study Drug|1|||
124485433|NCT00893789|447730484|FG001|Overall Study|Noncompliance With Study Drug|0|||
124485434|NCT00893789|447730485|FG002|Overall Study|Noncompliance With Study Drug|1|||
124485435|NCT00893789|447730486|FG003|Overall Study|Noncompliance With Study Drug|2|||
124485436|NCT00893789|447730483|FG000|Overall Study|Noncompliance With Study Procedures|1|||
124485437|NCT00893789|447730484|FG001|Overall Study|Noncompliance With Study Procedures|0|||
124485438|NCT00893789|447730485|FG002|Overall Study|Noncompliance With Study Procedures|0|||
124485439|NCT00893789|447730486|FG003|Overall Study|Noncompliance With Study Procedures|0|||
124485440|NCT00893789|447730483|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
124485441|NCT00893789|447730484|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
124485442|NCT00893789|447730485|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
124485443|NCT00893789|447730486|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
124485444|NCT00893789|447730483|FG000|Overall Study|Adverse Event|0|||
124485445|NCT00893789|447730484|FG001|Overall Study|Adverse Event|2|||
124485446|NCT00893789|447730485|FG002|Overall Study|Adverse Event|1|||
124485447|NCT00893789|447730486|FG003|Overall Study|Adverse Event|5|||
124485448|NCT00893789|447730483|FG000|Overall Study|Protocol Violation|0|||
124485449|NCT00893789|447730484|FG001|Overall Study|Protocol Violation|1|||
124485450|NCT00893789|447730485|FG002|Overall Study|Protocol Violation|1|||
124485451|NCT00893789|447730486|FG003|Overall Study|Protocol Violation|4|||
124485452|NCT00893789|447730483|FG000|Overall Study|Lost to Follow-up|0|||
124485453|NCT00893789|447730484|FG001|Overall Study|Lost to Follow-up|0|||
124485454|NCT00893789|447730485|FG002|Overall Study|Lost to Follow-up|0|||
124485455|NCT00893789|447730486|FG003|Overall Study|Lost to Follow-up|1|||
124485456|NCT04723537|447730487|FG000|Overall Study|Withdrawal by Subject|3|||
124485457|NCT04723537|447730488|FG001|Overall Study|Withdrawal by Subject|0|||
124485458|NCT04723537|447730489|FG002|Overall Study|Withdrawal by Subject|0|||
124485459|NCT04723537|447730487|FG000|Overall Study|Physician Decision|0|||
124485460|NCT04723537|447730488|FG001|Overall Study|Physician Decision|0|||
124721197|NCT00711594|448603579|FG000|Overall Study|Progressive disease|2|||
124485461|NCT04723537|447730489|FG002|Overall Study|Physician Decision|1|||
124485462|NCT04723537|447730487|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
124485463|NCT04723537|447730488|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
124485464|NCT04723537|447730489|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
124485465|NCT05408858|447730490|FG000|Overall Study|no longer met eligibility criteria|1|||
124485466|NCT04419506|447730491|FG000|Overall Study|Adverse Event|0|||
124485467|NCT04419506|447730492|FG001|Overall Study|Adverse Event|10|||
124485468|NCT04419506|447730493|FG002|Overall Study|Adverse Event|0|||
124721198|NCT00711594|448603580|FG001|Overall Study|Progressive disease|2|||
124721199|NCT00711594|448603581|FG002|Overall Study|Progressive disease|6|||
124721200|NCT00711594|448603582|FG003|Overall Study|Progressive disease|44|||
124485469|NCT04419506|447730494|FG003|Overall Study|Adverse Event|3|||
124485470|NCT04419506|447730491|FG000|Overall Study|Withdrawal by Subject|0|||
124485471|NCT04419506|447730492|FG001|Overall Study|Withdrawal by Subject|0|||
124485472|NCT04419506|447730493|FG002|Overall Study|Withdrawal by Subject|0|||
124485473|NCT04419506|447730494|FG003|Overall Study|Withdrawal by Subject|1|||
124485474|NCT04419506|447730491|FG000|Overall Study|poor-compliance|0|||
124485475|NCT04419506|447730492|FG001|Overall Study|poor-compliance|0|||
124485476|NCT04419506|447730493|FG002|Overall Study|poor-compliance|0|||
124485477|NCT04419506|447730494|FG003|Overall Study|poor-compliance|1|||
124485478|NCT01973283|447730501|FG000|Overall Study|Lost to Follow-up|4|||
124485479|NCT00097539|447730504|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
124485480|NCT00097539|447730505|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
124485481|NCT00097539|447730506|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
124485482|NCT00097539|447730507|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
124485483|NCT00097539|447730508|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
124485484|NCT00097539|447730509|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
124485485|NCT00097539|447730510|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
124485486|NCT00097539|447730504|FG000|Overall Study|Withdrawal by Subject|925|||
124485487|NCT00097539|447730505|FG001|Overall Study|Withdrawal by Subject|323|||
124485488|NCT00097539|447730506|FG002|Overall Study|Withdrawal by Subject|346|||
124485489|NCT00097539|447730507|FG003|Overall Study|Withdrawal by Subject|217|||
124485490|NCT00097539|447730508|FG004|Overall Study|Withdrawal by Subject|68|||
124485491|NCT00097539|447730509|FG005|Overall Study|Withdrawal by Subject|229|||
124485492|NCT00097539|447730510|FG006|Overall Study|Withdrawal by Subject|3|||
124485493|NCT00097539|447730504|FG000|Overall Study|Participant Non-compliant|2140|||
124485494|NCT00097539|447730505|FG001|Overall Study|Participant Non-compliant|567|||
124485495|NCT00097539|447730506|FG002|Overall Study|Participant Non-compliant|1067|||
124485496|NCT00097539|447730507|FG003|Overall Study|Participant Non-compliant|353|||
124485497|NCT00097539|447730508|FG004|Overall Study|Participant Non-compliant|136|||
124485498|NCT00097539|447730509|FG005|Overall Study|Participant Non-compliant|543|||
124485499|NCT00097539|447730510|FG006|Overall Study|Participant Non-compliant|18|||
124485500|NCT00097539|447730504|FG000|Overall Study|Lack of Efficacy|249|||
124485501|NCT00097539|447730505|FG001|Overall Study|Lack of Efficacy|122|||
124485502|NCT00097539|447730506|FG002|Overall Study|Lack of Efficacy|202|||
124485503|NCT00097539|447730507|FG003|Overall Study|Lack of Efficacy|105|||
124485504|NCT00097539|447730508|FG004|Overall Study|Lack of Efficacy|45|||
124485505|NCT00097539|447730509|FG005|Overall Study|Lack of Efficacy|228|||
124485506|NCT00097539|447730510|FG006|Overall Study|Lack of Efficacy|5|||
124485507|NCT00097539|447730504|FG000|Overall Study|Adverse Event|78|||
124485508|NCT00097539|447730505|FG001|Overall Study|Adverse Event|133|||
124485509|NCT00097539|447730506|FG002|Overall Study|Adverse Event|37|||
124485510|NCT00097539|447730507|FG003|Overall Study|Adverse Event|27|||
124485511|NCT00097539|447730508|FG004|Overall Study|Adverse Event|30|||
124485512|NCT00097539|447730509|FG005|Overall Study|Adverse Event|59|||
124485513|NCT00097539|447730510|FG006|Overall Study|Adverse Event|1|||
124485514|NCT00097539|447730504|FG000|Overall Study|Death|2|||
124485515|NCT00097539|447730505|FG001|Overall Study|Death|7|||
124485516|NCT00097539|447730506|FG002|Overall Study|Death|0|||
124485517|NCT00097539|447730507|FG003|Overall Study|Death|0|||
124485518|NCT00097539|447730508|FG004|Overall Study|Death|1|||
124485519|NCT00097539|447730509|FG005|Overall Study|Death|3|||
124485520|NCT00097539|447730510|FG006|Overall Study|Death|0|||
124485521|NCT00097539|447730504|FG000|Overall Study|Reasons Other Than Above|3602|||
124485522|NCT00097539|447730505|FG001|Overall Study|Reasons Other Than Above|1382|||
124485523|NCT00097539|447730506|FG002|Overall Study|Reasons Other Than Above|1757|||
124485524|NCT00097539|447730507|FG003|Overall Study|Reasons Other Than Above|692|||
124485525|NCT00097539|447730508|FG004|Overall Study|Reasons Other Than Above|361|||
124485526|NCT00097539|447730509|FG005|Overall Study|Reasons Other Than Above|1244|||
124485527|NCT00097539|447730510|FG006|Overall Study|Reasons Other Than Above|34|||
124485528|NCT00097539|447730504|FG000|Overall Study|Reason not Specified|111|||
124485529|NCT00097539|447730505|FG001|Overall Study|Reason not Specified|49|||
124485530|NCT00097539|447730506|FG002|Overall Study|Reason not Specified|53|||
124485531|NCT00097539|447730507|FG003|Overall Study|Reason not Specified|21|||
124485532|NCT00097539|447730508|FG004|Overall Study|Reason not Specified|11|||
124485533|NCT00097539|447730509|FG005|Overall Study|Reason not Specified|40|||
124485534|NCT00097539|447730510|FG006|Overall Study|Reason not Specified|2|||
124485535|NCT03941548|447730513|FG000|Overall Study|Adverse Event|0|||
124485536|NCT03941548|447730514|FG001|Overall Study|Adverse Event|1|||
124485537|NCT03941548|447730513|FG000|Overall Study|Lost to Follow-up|0|||
124485538|NCT03941548|447730514|FG001|Overall Study|Lost to Follow-up|1|||
124485539|NCT03941548|447730513|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
124485540|NCT03941548|447730514|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
124485541|NCT03717922|447730517|FG000|Overall Study|Lost to Follow-up|2|||
124485542|NCT03717922|447730518|FG001|Overall Study|Lost to Follow-up|2|||
124485543|NCT02015819|447730519|FG000|Overall Study|Rickham catheter was misaligned|0|||
124485544|NCT02015819|447730520|FG001|Overall Study|Rickham catheter was misaligned|0|||
124485545|NCT02015819|447730521|FG002|Overall Study|Rickham catheter was misaligned|0|||
124485546|NCT02015819|447730522|FG003|Overall Study|Rickham catheter was misaligned|1|||
124485547|NCT00811252|447730524|FG000|Overall Study|Adverse Event|6|||
124485548|NCT00811252|447730525|FG001|Overall Study|Adverse Event|10|||
124485549|NCT00811252|447730526|FG002|Overall Study|Adverse Event|15|||
124485550|NCT00811252|447730524|FG000|Overall Study|Lack of Efficacy|7|||
124485551|NCT00811252|447730525|FG001|Overall Study|Lack of Efficacy|2|||
124485552|NCT00811252|447730526|FG002|Overall Study|Lack of Efficacy|0|||
124485553|NCT00811252|447730524|FG000|Overall Study|Protocol Violation|3|||
124485554|NCT00811252|447730525|FG001|Overall Study|Protocol Violation|3|||
124485555|NCT00811252|447730526|FG002|Overall Study|Protocol Violation|2|||
124485556|NCT00811252|447730524|FG000|Overall Study|Withdrawal of Consent|1|||
124485557|NCT00811252|447730525|FG001|Overall Study|Withdrawal of Consent|2|||
124485558|NCT00811252|447730526|FG002|Overall Study|Withdrawal of Consent|2|||
124485559|NCT00811252|447730524|FG000|Overall Study|Lost to Follow-up|0|||
124485560|NCT00811252|447730525|FG001|Overall Study|Lost to Follow-up|0|||
124485561|NCT00811252|447730526|FG002|Overall Study|Lost to Follow-up|2|||
124485562|NCT00811252|447730524|FG000|Overall Study|Administrative or Other Reasons|0|||
124485563|NCT00811252|447730525|FG001|Overall Study|Administrative or Other Reasons|3|||
124485564|NCT00811252|447730526|FG002|Overall Study|Administrative or Other Reasons|2|||
124485565|NCT01486264|447730527|FG000|Overall Study|Death|1|||
124485566|NCT01486264|447730528|FG001|Overall Study|Death|1|||
124485567|NCT01486264|447730527|FG000|Overall Study|Adverse Event|3|||
124485568|NCT01486264|447730528|FG001|Overall Study|Adverse Event|3|||
124485569|NCT01486264|447730527|FG000|Overall Study|Lack of Efficacy|6|||
124485570|NCT01486264|447730528|FG001|Overall Study|Lack of Efficacy|10|||
124485571|NCT01486264|447730527|FG000|Overall Study|Withdrawal by Subject|7|||
124485572|NCT01486264|447730528|FG001|Overall Study|Withdrawal by Subject|18|||
124485573|NCT01486264|447730527|FG000|Overall Study|Physician Decision|1|||
124485574|NCT01486264|447730528|FG001|Overall Study|Physician Decision|1|||
124485575|NCT01486264|447730527|FG000|Overall Study|Protocol Violation|3|||
124485576|NCT01486264|447730528|FG001|Overall Study|Protocol Violation|0|||
124485577|NCT01486264|447730527|FG000|Overall Study|Lost to Follow-up|3|||
124485578|NCT01486264|447730528|FG001|Overall Study|Lost to Follow-up|2|||
124485579|NCT01486264|447730527|FG000|Overall Study|Other|5|||
124485580|NCT01486264|447730528|FG001|Overall Study|Other|11|||
124485581|NCT01486264|447730527|FG000|Overall Study|Not treated|0|||
124485582|NCT01486264|447730528|FG001|Overall Study|Not treated|1|||
124485583|NCT00813748|447730529|FG000|Skin Test Substudy|Physician Decision|0|||
124485584|NCT00813748|447730530|FG001|Skin Test Substudy|Physician Decision|1|||
124557617|NCT00529568|447999162|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
124557618|NCT00529568|447999163|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
124557619|NCT00529568|447999164|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
124557620|NCT00529568|447999162|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
124557621|NCT00529568|447999163|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
124485585|NCT00504257|447730531|FG000|Overall Study|Withdrawal by Subject|2|||
124485586|NCT00504257|447730531|FG000|Overall Study|ineligible histology|2|||
124485587|NCT02317510|447730537|FG000|Overall Study|Adverse Event|0|||
124485588|NCT02317510|447730538|FG001|Overall Study|Adverse Event|1|||
124485589|NCT00594399|447730543|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
124485590|NCT00594399|447730544|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
124485591|NCT00594399|447730545|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
124485592|NCT00594399|447730543|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
124485593|NCT00594399|447730544|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
124485594|NCT00594399|447730545|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
124485595|NCT00594399|447730543|FG000|Initial 3 Month Counseling|Personal issues|2|||
124485596|NCT00594399|447730544|FG001|Initial 3 Month Counseling|Personal issues|0|||
124485597|NCT00594399|447730545|FG002|Initial 3 Month Counseling|Personal issues|0|||
124485598|NCT00594399|447730543|FG000|Initial 3 Month Counseling|Too busy|7|||
124485599|NCT00594399|447730544|FG001|Initial 3 Month Counseling|Too busy|1|||
124485600|NCT00594399|447730545|FG002|Initial 3 Month Counseling|Too busy|0|||
124485601|NCT00594399|447730543|FG000|Initial 3 Month Counseling|Pain|2|||
124485602|NCT00594399|447730544|FG001|Initial 3 Month Counseling|Pain|0|||
124485603|NCT00594399|447730545|FG002|Initial 3 Month Counseling|Pain|0|||
124485604|NCT00594399|447730543|FG000|Initial 3 Month Counseling|Moved|1|||
124485605|NCT00594399|447730544|FG001|Initial 3 Month Counseling|Moved|0|||
124485606|NCT00594399|447730545|FG002|Initial 3 Month Counseling|Moved|0|||
124485607|NCT00594399|447730543|FG000|Initial 3 Month Counseling|Family illness|1|||
124485608|NCT00594399|447730544|FG001|Initial 3 Month Counseling|Family illness|0|||
124485609|NCT00594399|447730545|FG002|Initial 3 Month Counseling|Family illness|0|||
124485610|NCT00594399|447730543|FG000|Rerandomization Arm 1 Only|Death|2|||
124485611|NCT00594399|447730544|FG001|Rerandomization Arm 1 Only|Death|1|||
124485612|NCT00594399|447730545|FG002|Rerandomization Arm 1 Only|Death|0|||
124485613|NCT00594399|447730543|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
124485614|NCT00594399|447730544|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
124485615|NCT00594399|447730545|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
124485616|NCT03953118|447730546|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
124485617|NCT03953118|447730547|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
124485618|NCT00424398|447730550|FG000|Overall Study|Withdrawal by Subject|2|||
124485619|NCT00424398|447730551|FG001|Overall Study|Withdrawal by Subject|1|||
124485620|NCT00424398|447730552|FG002|Overall Study|Withdrawal by Subject|0|||
124485621|NCT00424398|447730550|FG000|Overall Study|Subject met exclusion criteria|1|||
124485622|NCT00424398|447730551|FG001|Overall Study|Subject met exclusion criteria|0|||
124485623|NCT00424398|447730552|FG002|Overall Study|Subject met exclusion criteria|0|||
124485624|NCT05480514|447730553|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
124485625|NCT05480514|447730554|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
124485626|NCT05480514|447730553|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
124485627|NCT05480514|447730554|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
124485628|NCT05480514|447730553|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
124485629|NCT05480514|447730554|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
124485630|NCT05480514|447730553|FG000|Period 1|Covid-19 Related|1|||
124485631|NCT05480514|447730554|FG001|Period 1|Covid-19 Related|0|||
124485632|NCT05480514|447730553|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
124485633|NCT05480514|447730554|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
124485634|NCT00986349|447730557|FG000|Overall Study|Unsuccessful implant procedure|3|||
124485635|NCT00986349|447730557|FG000|Overall Study|Adverse Event|2|||
124485636|NCT00986349|447730557|FG000|Overall Study|Physician Decision|1|||
124485637|NCT00986349|447730557|FG000|Overall Study|device migration|1|||
124485638|NCT02299934|447730558|FG000|Overall Study|Termination of study|13|||
124485639|NCT02722044|447730559|FG000|Overall Study|Adverse Event|2|||
124485640|NCT02722044|447730559|FG000|Overall Study|Physician Decision|1|||
124485641|NCT02722044|447730559|FG000|Overall Study|Withdrawal by Subject|1|||
124485642|NCT02722044|447730559|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
124485643|NCT02117687|447730560|FG000|Overall Study|Lost to Follow-up|0|||
124485644|NCT02117687|447730561|FG001|Overall Study|Lost to Follow-up|1|||
124485645|NCT02117687|447730560|FG000|Overall Study|Adverse Event|0|||
124485646|NCT02117687|447730561|FG001|Overall Study|Adverse Event|2|||
124485647|NCT02117687|447730560|FG000|Overall Study|Other Reasons|1|||
124485648|NCT02117687|447730561|FG001|Overall Study|Other Reasons|1|||
124485649|NCT03528681|447732407|FG000|Open-Label Phase|Physician Decision|2|||
124485650|NCT03528681|447732408|FG001|Open-Label Phase|Physician Decision|0|||
124485651|NCT03528681|447732409|FG002|Open-Label Phase|Physician Decision|0|||
124485652|NCT03528681|447732410|FG003|Open-Label Phase|Physician Decision|0|||
124485653|NCT03528681|447732407|FG000|Open-Label Phase|Withdrawal by Subject|8|||
124485654|NCT03528681|447732408|FG001|Open-Label Phase|Withdrawal by Subject|0|||
124485655|NCT03528681|447732409|FG002|Open-Label Phase|Withdrawal by Subject|0|||
124485656|NCT03528681|447732410|FG003|Open-Label Phase|Withdrawal by Subject|0|||
124485657|NCT03528681|447732407|FG000|Open-Label Phase|(Not collected)|4|||
124485658|NCT03528681|447732408|FG001|Open-Label Phase|(Not collected)|0|||
124485659|NCT03528681|447732409|FG002|Open-Label Phase|(Not collected)|0|||
124485660|NCT03528681|447732410|FG003|Open-Label Phase|(Not collected)|0|||
124485661|NCT03528681|447732407|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
124485662|NCT03528681|447732408|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
124485663|NCT03528681|447732409|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
124485664|NCT03528681|447732410|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
124485665|NCT03528681|447732407|FG000|Randomized Treatment Phase|Physician Decision|0|||
124485666|NCT03528681|447732408|FG001|Randomized Treatment Phase|Physician Decision|5|||
124485667|NCT03528681|447732409|FG002|Randomized Treatment Phase|Physician Decision|1|||
124485668|NCT03528681|447732410|FG003|Randomized Treatment Phase|Physician Decision|2|||
124485669|NCT03528681|447732407|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
124485670|NCT03528681|447732408|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
124485671|NCT03528681|447732409|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
124485672|NCT03528681|447732410|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
124485673|NCT03528681|447732407|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
124485674|NCT03528681|447732408|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
124485675|NCT03528681|447732409|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
124485676|NCT03528681|447732410|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
124485677|NCT03528681|447732407|FG000|Randomized Treatment Phase|(Not collected)|0|||
124485678|NCT03528681|447732408|FG001|Randomized Treatment Phase|(Not collected)|4|||
124485679|NCT03528681|447732409|FG002|Randomized Treatment Phase|(Not collected)|6|||
124485680|NCT03528681|447732410|FG003|Randomized Treatment Phase|(Not collected)|5|||
124557622|NCT00529568|447999164|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
124485681|NCT00621023|447732416|FG000|Overall Study|Death|5|||
124485682|NCT00621023|447732416|FG000|Overall Study|Follow up discontinued|1|||
124485683|NCT04430348|447732423|FG000|Overall Study|Death|3|||
124485684|NCT04430348|447732424|FG001|Overall Study|Death|2|||
124485685|NCT04430348|447732425|FG002|Overall Study|Death|2|||
124485686|NCT04430348|447732426|FG003|Overall Study|Death|2|||
124485687|NCT04430348|447732427|FG004|Overall Study|Death|2|||
124485688|NCT04430348|447732428|FG005|Overall Study|Death|3|||
124485689|NCT04430348|447732423|FG000|Overall Study|Lost to Follow-up|0|||
124485690|NCT04430348|447732424|FG001|Overall Study|Lost to Follow-up|0|||
124485691|NCT04430348|447732425|FG002|Overall Study|Lost to Follow-up|0|||
124485692|NCT04430348|447732426|FG003|Overall Study|Lost to Follow-up|1|||
124485693|NCT04430348|447732427|FG004|Overall Study|Lost to Follow-up|0|||
124485694|NCT04430348|447732428|FG005|Overall Study|Lost to Follow-up|0|||
124485695|NCT04430348|447732423|FG000|Overall Study|Adverse Event|0|||
124485696|NCT04430348|447732424|FG001|Overall Study|Adverse Event|0|||
124485697|NCT04430348|447732425|FG002|Overall Study|Adverse Event|0|||
124485698|NCT04430348|447732426|FG003|Overall Study|Adverse Event|0|||
124485699|NCT04430348|447732427|FG004|Overall Study|Adverse Event|0|||
124485700|NCT04430348|447732428|FG005|Overall Study|Adverse Event|1|||
124485701|NCT04430348|447732423|FG000|Overall Study|Withdrawal by Subject|0|||
124485702|NCT04430348|447732424|FG001|Overall Study|Withdrawal by Subject|1|||
124485703|NCT04430348|447732425|FG002|Overall Study|Withdrawal by Subject|0|||
124485704|NCT04430348|447732426|FG003|Overall Study|Withdrawal by Subject|0|||
124485705|NCT04430348|447732427|FG004|Overall Study|Withdrawal by Subject|0|||
124485706|NCT04430348|447732428|FG005|Overall Study|Withdrawal by Subject|1|||
124485707|NCT04430348|447732423|FG000|Overall Study|Study Terminated by Sponsor|0|||
124485708|NCT04430348|447732424|FG001|Overall Study|Study Terminated by Sponsor|0|||
124485709|NCT04430348|447732425|FG002|Overall Study|Study Terminated by Sponsor|2|||
124485710|NCT04430348|447732426|FG003|Overall Study|Study Terminated by Sponsor|0|||
124485711|NCT04430348|447732427|FG004|Overall Study|Study Terminated by Sponsor|1|||
124485712|NCT04430348|447732428|FG005|Overall Study|Study Terminated by Sponsor|1|||
124485713|NCT04331899|447732432|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
124485714|NCT04331899|447732433|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
124485715|NCT02424539|447732436|FG000|Overall Study|Adverse Event|0|||
124485716|NCT02424539|447732437|FG001|Overall Study|Adverse Event|0|||
124485717|NCT02424539|447732438|FG002|Overall Study|Adverse Event|1|||
124485718|NCT02424539|447732436|FG000|Overall Study|Physician Decision|0|||
124485719|NCT02424539|447732437|FG001|Overall Study|Physician Decision|0|||
124485720|NCT02424539|447732438|FG002|Overall Study|Physician Decision|1|||
124485721|NCT02424539|447732436|FG000|Overall Study|Withdrawal by Subject|3|||
124485722|NCT02424539|447732437|FG001|Overall Study|Withdrawal by Subject|1|||
124485723|NCT02424539|447732438|FG002|Overall Study|Withdrawal by Subject|0|||
124485724|NCT02424539|447732436|FG000|Overall Study|Other: Reached stopping criteria|11|||
124485725|NCT02424539|447732437|FG001|Overall Study|Other: Reached stopping criteria|7|||
124485726|NCT02424539|447732438|FG002|Overall Study|Other: Reached stopping criteria|6|||
124485727|NCT01697215|447732448|FG000|Overall Study|Physician Decision|5|||
124485728|NCT01697215|447732448|FG000|Overall Study|Malfunction|9|||
124485729|NCT01697215|447732448|FG000|Overall Study|CXR not available|9|||
124485730|NCT01829048|447732449|FG000|Overall Study|Withdrawal by Subject|0|||
124485731|NCT01829048|447732450|FG001|Overall Study|Withdrawal by Subject|0|||
124485732|NCT01829048|447732451|FG002|Overall Study|Withdrawal by Subject|0|||
124485733|NCT01829048|447732452|FG003|Overall Study|Withdrawal by Subject|2|||
124485734|NCT01829048|447732453|FG004|Overall Study|Withdrawal by Subject|0|||
124485735|NCT00728416|447732462|FG000|Overall Study|Adverse Event|1|||
124485736|NCT00728416|447732463|FG001|Overall Study|Adverse Event|1|||
124485737|NCT00728416|447732462|FG000|Overall Study|Treatment Failure|0|||
124485738|NCT00728416|447732463|FG001|Overall Study|Treatment Failure|1|||
124485739|NCT00728416|447732462|FG000|Overall Study|Withdrawal by Subject|1|||
124485740|NCT00728416|447732463|FG001|Overall Study|Withdrawal by Subject|0|||
124485741|NCT01244737|447732471|FG000|Overall Study|Physician Decision|2|||
124485742|NCT01244737|447732472|FG001|Overall Study|Physician Decision|18|||
124485743|NCT01244737|447732473|FG002|Overall Study|Physician Decision|5|||
124485744|NCT01244737|447732471|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
124485745|NCT01244737|447732472|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
124485746|NCT01244737|447732473|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
124485747|NCT01244737|447732471|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
124485748|NCT01244737|447732472|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
124485749|NCT01244737|447732473|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
124485750|NCT01244737|447732471|FG000|Overall Study|MIB immunopathology results not available|3|||
124485751|NCT01244737|447732472|FG001|Overall Study|MIB immunopathology results not available|2|||
124485752|NCT01244737|447732473|FG002|Overall Study|MIB immunopathology results not available|0|||
124485753|NCT01244737|447732471|FG000|Overall Study|PET data failure|0|||
124485754|NCT01244737|447732472|FG001|Overall Study|PET data failure|1|||
124485755|NCT01244737|447732473|FG002|Overall Study|PET data failure|0|||
124485756|NCT01244737|447732471|FG000|Overall Study|Withdrawal by Subject|0|||
124485757|NCT01244737|447732472|FG001|Overall Study|Withdrawal by Subject|0|||
124485758|NCT01244737|447732473|FG002|Overall Study|Withdrawal by Subject|1|||
124485759|NCT00356915|447732476|FG000|Overall Study|Non compliance|1|||
124485760|NCT00356915|447732477|FG001|Overall Study|Non compliance|2|||
124485761|NCT00356915|447732478|FG002|Overall Study|Non compliance|1|||
124485762|NCT00356915|447732476|FG000|Overall Study|Protocol Violation|2|||
124485763|NCT00356915|447732477|FG001|Overall Study|Protocol Violation|3|||
124485764|NCT00356915|447732478|FG002|Overall Study|Protocol Violation|2|||
124485765|NCT00356915|447732476|FG000|Overall Study|Withdrawal by Subject|14|||
124485766|NCT00356915|447732477|FG001|Overall Study|Withdrawal by Subject|14|||
124485767|NCT00356915|447732478|FG002|Overall Study|Withdrawal by Subject|10|||
124485768|NCT00356915|447732476|FG000|Overall Study|Lack of Efficacy|0|||
124485769|NCT00356915|447732477|FG001|Overall Study|Lack of Efficacy|0|||
124485770|NCT00356915|447732478|FG002|Overall Study|Lack of Efficacy|3|||
124485771|NCT00356915|447732476|FG000|Overall Study|Lost to Follow-up|27|||
124485772|NCT00356915|447732477|FG001|Overall Study|Lost to Follow-up|34|||
124485773|NCT00356915|447732478|FG002|Overall Study|Lost to Follow-up|14|||
124485774|NCT00356915|447732476|FG000|Overall Study|Administrative Decision|0|||
124485775|NCT00356915|447732477|FG001|Overall Study|Administrative Decision|0|||
124485776|NCT00356915|447732478|FG002|Overall Study|Administrative Decision|1|||
124485777|NCT00356915|447732476|FG000|Overall Study|Physician Decision|0|||
124485778|NCT00356915|447732477|FG001|Overall Study|Physician Decision|2|||
124485779|NCT00356915|447732478|FG002|Overall Study|Physician Decision|0|||
124485780|NCT00356915|447732476|FG000|Overall Study|Adverse Event|21|||
124485781|NCT00356915|447732477|FG001|Overall Study|Adverse Event|31|||
124485782|NCT00356915|447732478|FG002|Overall Study|Adverse Event|8|||
124485783|NCT00356915|447732476|FG000|Overall Study|Miscellaneous reasons|11|||
124485784|NCT00356915|447732477|FG001|Overall Study|Miscellaneous reasons|8|||
124485785|NCT00356915|447732478|FG002|Overall Study|Miscellaneous reasons|3|||
124485786|NCT00509106|447732480|FG000|Overall Study|Adverse Event|3|||
124485787|NCT00509106|447732481|FG001|Overall Study|Adverse Event|2|||
124485788|NCT00509106|447732480|FG000|Overall Study|Noncompliance|0|||
124485789|NCT00509106|447732481|FG001|Overall Study|Noncompliance|1|||
124485790|NCT00509106|447732480|FG000|Overall Study|At the request of sponsor/investigator|1|||
124485791|NCT00509106|447732481|FG001|Overall Study|At the request of sponsor/investigator|2|||
124485792|NCT00509106|447732480|FG000|Overall Study|Withdrew consent|4|||
124485793|NCT00509106|447732481|FG001|Overall Study|Withdrew consent|8|||
124485794|NCT00509106|447732480|FG000|Overall Study|Lost to Follow-up|16|||
124485795|NCT00509106|447732481|FG001|Overall Study|Lost to Follow-up|10|||
124485796|NCT00509106|447732480|FG000|Overall Study|Other|1|||
124485797|NCT00509106|447732481|FG001|Overall Study|Other|0|||
124485798|NCT00509106|447732480|FG000|Overall Study|Death|6|||
124485799|NCT00509106|447732481|FG001|Overall Study|Death|6|||
124485800|NCT02318602|447732482|FG000|Overall Study|Adverse Event|0|||
124485801|NCT02318602|447732483|FG001|Overall Study|Adverse Event|1|||
124485802|NCT02318602|447732484|FG002|Overall Study|Adverse Event|1|||
124485803|NCT02318602|447732482|FG000|Overall Study|Withdrawal by Subject|0|||
124485804|NCT02318602|447732483|FG001|Overall Study|Withdrawal by Subject|3|||
124485805|NCT02318602|447732484|FG002|Overall Study|Withdrawal by Subject|0|||
124485806|NCT02318602|447732482|FG000|Overall Study|Death|1|||
124485807|NCT02318602|447732483|FG001|Overall Study|Death|0|||
124485808|NCT02318602|447732484|FG002|Overall Study|Death|0|||
124485809|NCT02318602|447732482|FG000|Overall Study|Guardian decision to withdraw|0|||
124485810|NCT02318602|447732483|FG001|Overall Study|Guardian decision to withdraw|0|||
124485811|NCT02318602|447732484|FG002|Overall Study|Guardian decision to withdraw|1|||
124485812|NCT00693706|447732485|FG000|Overall Study|Protocol Violation|0|||
124485813|NCT00693706|447732486|FG001|Overall Study|Protocol Violation|1|||
124485814|NCT00488631|447732487|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
124485815|NCT00488631|447732488|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
124485816|NCT00488631|447732489|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
124485817|NCT00488631|447732490|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
124485818|NCT00488631|447732491|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
124485819|NCT00488631|447732492|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
124485820|NCT00488631|447732493|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
124485821|NCT00488631|447732494|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
124485822|NCT00488631|447732495|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
124485823|NCT00488631|447732496|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
124485824|NCT00488631|447732487|FG000|Double Blind Period (Week 0-54)|Death|0|||
124485825|NCT00488631|447732488|FG001|Double Blind Period (Week 0-54)|Death|0|||
124485826|NCT00488631|447732489|FG002|Double Blind Period (Week 0-54)|Death|0|||
124485827|NCT00488631|447732490|FG003|Double Blind Period (Week 0-54)|Death|0|||
124485828|NCT00488631|447732491|FG004|Double Blind Period (Week 0-54)|Death|0|||
124485829|NCT00488631|447732492|FG005|Double Blind Period (Week 0-54)|Death|1|||
124485830|NCT00488631|447732493|FG006|Double Blind Period (Week 0-54)|Death|0|||
124485831|NCT00488631|447732494|FG007|Double Blind Period (Week 0-54)|Death|0|||
124485832|NCT00488631|447732495|FG008|Double Blind Period (Week 0-54)|Death|0|||
124485833|NCT00488631|447732496|FG009|Double Blind Period (Week 0-54)|Death|0|||
124485834|NCT00488631|447732487|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
124485835|NCT00488631|447732488|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
124485836|NCT00488631|447732489|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
124485837|NCT00488631|447732490|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
124485838|NCT00488631|447732491|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
124485839|NCT00488631|447732492|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
124485840|NCT00488631|447732493|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
124485841|NCT00488631|447732494|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
124485842|NCT00488631|447732495|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
124485843|NCT00488631|447732496|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
124485844|NCT00488631|447732487|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
124485845|NCT00488631|447732488|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
124485846|NCT00488631|447732489|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
124485847|NCT00488631|447732490|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
124485848|NCT00488631|447732491|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
124485849|NCT00488631|447732492|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
124485850|NCT00488631|447732493|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
124485851|NCT00488631|447732494|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
124485852|NCT00488631|447732495|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
124485853|NCT00488631|447732496|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
124485854|NCT00488631|447732487|FG000|Double Blind Period (Week 0-54)|Other|6|||
124485855|NCT00488631|447732488|FG001|Double Blind Period (Week 0-54)|Other|12|||
124485856|NCT00488631|447732489|FG002|Double Blind Period (Week 0-54)|Other|10|||
124485857|NCT00488631|447732490|FG003|Double Blind Period (Week 0-54)|Other|11|||
124485858|NCT00488631|447732491|FG004|Double Blind Period (Week 0-54)|Other|14|||
124485859|NCT00488631|447732492|FG005|Double Blind Period (Week 0-54)|Other|34|||
124485860|NCT00488631|447732493|FG006|Double Blind Period (Week 0-54)|Other|0|||
124485861|NCT00488631|447732494|FG007|Double Blind Period (Week 0-54)|Other|0|||
124485862|NCT00488631|447732495|FG008|Double Blind Period (Week 0-54)|Other|0|||
124485863|NCT00488631|447732496|FG009|Double Blind Period (Week 0-54)|Other|0|||
124485864|NCT00488631|447732487|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
124485865|NCT00488631|447732488|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
124485866|NCT00488631|447732489|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
124485867|NCT00488631|447732490|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
124485868|NCT00488631|447732491|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
124485869|NCT00488631|447732492|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
124485870|NCT00488631|447732493|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
124485871|NCT00488631|447732494|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
124485872|NCT00488631|447732495|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
124485873|NCT00488631|447732496|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
124485874|NCT00488631|447732487|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
124485875|NCT00488631|447732488|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
124485876|NCT00488631|447732489|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
124485877|NCT00488631|447732490|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
124485878|NCT00488631|447732491|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
124485879|NCT00488631|447732492|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
124485880|NCT00488631|447732493|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
124485881|NCT00488631|447732494|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
124485882|NCT00488631|447732495|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
124485883|NCT00488631|447732496|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
124485884|NCT00488631|447732487|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
124485885|NCT00488631|447732488|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
124485886|NCT00488631|447732489|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
124485887|NCT00488631|447732490|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
124485888|NCT00488631|447732491|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
124485889|NCT00488631|447732492|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
124485890|NCT00488631|447732493|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
124485891|NCT00488631|447732494|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
124485892|NCT00488631|447732495|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
124485893|NCT00488631|447732496|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
124485894|NCT00488631|447732487|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
124721201|NCT00711594|448603579|FG000|Overall Study|Other Adverse Event|1|||
124485895|NCT00488631|447732488|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
124485896|NCT00488631|447732489|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
124485897|NCT00488631|447732490|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
124485898|NCT00488631|447732491|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
124485899|NCT00488631|447732492|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
124485900|NCT00488631|447732493|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
124721202|NCT00711594|448603580|FG001|Overall Study|Other Adverse Event|0|||
124557623|NCT00529568|447999162|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
124485901|NCT00488631|447732494|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
124485902|NCT00488631|447732495|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
124485903|NCT00488631|447732496|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
124485904|NCT00488631|447732487|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
124485905|NCT00488631|447732488|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
124485906|NCT00488631|447732489|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
124485907|NCT00488631|447732490|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
124485908|NCT00488631|447732491|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
124485909|NCT00488631|447732492|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
124485910|NCT00488631|447732493|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
124485911|NCT00488631|447732494|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
124485912|NCT00488631|447732495|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
124485913|NCT00488631|447732496|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
124485914|NCT01873950|447732497|FG000|Period 5|Withdrawal by Subject|0|||
124485915|NCT01873950|447732498|FG001|Period 5|Withdrawal by Subject|0|||
124485916|NCT01873950|447732499|FG002|Period 5|Withdrawal by Subject|0|||
124485917|NCT01873950|447732500|FG003|Period 5|Withdrawal by Subject|1|||
124485918|NCT01873950|447732501|FG004|Period 5|Withdrawal by Subject|0|||
124485919|NCT01193335|447732503|FG000|After Infant Series|Lost to Follow-up|1|||
124485920|NCT01193335|447732504|FG001|After Infant Series|Lost to Follow-up|2|||
124485921|NCT01193335|447732503|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
124485922|NCT01193335|447732504|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
124485923|NCT01193335|447732503|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
124485924|NCT01193335|447732504|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
124485925|NCT01193335|447732503|FG000|1-Year Follow-up|Lost to Follow-up|4|||
124485926|NCT01193335|447732504|FG001|1-Year Follow-up|Lost to Follow-up|0|||
124485927|NCT01193335|447732503|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
124485928|NCT01193335|447732504|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
124485929|NCT01193335|447732503|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
124485930|NCT01193335|447732504|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
124485931|NCT01733329|447732505|FG000|Overall Study|Protocol Violation|1|||
124485932|NCT01733329|447732506|FG001|Overall Study|Protocol Violation|1|||
124485933|NCT01733329|447732505|FG000|Overall Study|Uterine artery injury|1|||
124485934|NCT01733329|447732506|FG001|Overall Study|Uterine artery injury|0|||
124485935|NCT00730236|447732508|FG000|Overall Study|Adverse Event|4|||
124485936|NCT00730236|447732508|FG000|Overall Study|Withdrawal by Subject|1|||
124485937|NCT00730236|447732508|FG000|Overall Study|Non-compliance|1|||
124485938|NCT01772134|447732516|FG000|Overall Study|Adverse Event|6|||
124485939|NCT01772134|447732517|FG001|Overall Study|Adverse Event|5|||
124485940|NCT01772134|447732518|FG002|Overall Study|Adverse Event|10|||
124485941|NCT01772134|447732516|FG000|Overall Study|Withdrew Consent|3|||
124485942|NCT01772134|447732517|FG001|Overall Study|Withdrew Consent|1|||
124485943|NCT01772134|447732518|FG002|Overall Study|Withdrew Consent|5|||
124485944|NCT01772134|447732516|FG000|Overall Study|Lost to Follow-up|2|||
124485945|NCT01772134|447732517|FG001|Overall Study|Lost to Follow-up|0|||
124485946|NCT01772134|447732518|FG002|Overall Study|Lost to Follow-up|0|||
124485947|NCT01772134|447732516|FG000|Overall Study|Protocol Deviation|4|||
124485948|NCT01772134|447732517|FG001|Overall Study|Protocol Deviation|3|||
124485949|NCT01772134|447732518|FG002|Overall Study|Protocol Deviation|3|||
124485950|NCT01772134|447732516|FG000|Overall Study|Lack of Efficacy|11|||
124485951|NCT01772134|447732517|FG001|Overall Study|Lack of Efficacy|5|||
124485952|NCT01772134|447732518|FG002|Overall Study|Lack of Efficacy|3|||
124485953|NCT01772134|447732516|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
124485954|NCT01772134|447732517|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
124485955|NCT01772134|447732518|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
124485956|NCT01772134|447732516|FG000|Overall Study|Randomized Study Medication Not Received|2|||
124485957|NCT01772134|447732517|FG001|Overall Study|Randomized Study Medication Not Received|0|||
124485958|NCT01772134|447732518|FG002|Overall Study|Randomized Study Medication Not Received|1|||
124485959|NCT02500550|447732519|FG000|Overall Study|Death|7|||
124485960|NCT01023789|447732526|FG000|3 - Year Visit|Death|29|||
124485961|NCT01023789|447732526|FG000|3 - Year Visit|Withdrawal of consent|1|||
124485962|NCT01023789|447732526|FG000|3 - Year Visit|Lost to Follow-up|13|||
124485963|NCT02034123|447732530|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
124485964|NCT02034123|447732531|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
124485965|NCT02034123|447732532|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
124485966|NCT02034123|447732533|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
124485967|NCT02034123|447732534|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
124485968|NCT02034123|447732535|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
124485969|NCT02034123|447732536|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
124557624|NCT00529568|447999163|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
124485970|NCT02034123|447732537|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
124485971|NCT02034123|447732538|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
124485972|NCT02034123|447732539|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
124485973|NCT02034123|447732540|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
124485974|NCT02034123|447732541|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
124485975|NCT02034123|447732542|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
124485976|NCT02034123|447732543|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
124485977|NCT02034123|447732544|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
124485978|NCT02034123|447732545|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
124485979|NCT02034123|447732546|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
124485980|NCT02034123|447732547|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
124485981|NCT02034123|447732530|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
124485982|NCT02034123|447732531|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
124485983|NCT02034123|447732532|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
124485984|NCT02034123|447732533|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
124485985|NCT02034123|447732534|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
124485986|NCT02034123|447732535|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
124557625|NCT00529568|447999164|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
124557626|NCT00529568|447999162|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
124557627|NCT00529568|447999163|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
124557628|NCT00529568|447999164|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
124557629|NCT00529568|447999162|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
124557630|NCT00529568|447999163|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
124557631|NCT00529568|447999164|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
124557632|NCT00529568|447999162|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
124557633|NCT00529568|447999163|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
124557634|NCT00529568|447999164|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
124557635|NCT00529568|447999162|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
124557636|NCT00529568|447999163|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
124557637|NCT00529568|447999164|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
124557638|NCT00529568|447999162|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
124557639|NCT00529568|447999163|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
124557640|NCT00529568|447999164|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
124557641|NCT01201356|447999165|FG000|Overall Study|Adverse Event|170|||
124557642|NCT01201356|447999165|FG000|Overall Study|Abnormal laboratory value(s)|51|||
124557643|NCT01201356|447999165|FG000|Overall Study|Abnormal test procedure result(s)|3|||
124557644|NCT01201356|447999165|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
124557645|NCT01201356|447999165|FG000|Overall Study|Condition no longer requires study drug|12|||
124557646|NCT01201356|447999165|FG000|Overall Study|Withdrawal by Subject|144|||
124557647|NCT01201356|447999165|FG000|Overall Study|Lost to Follow-up|50|||
124557648|NCT01201356|447999165|FG000|Overall Study|administrative problems|74|||
124557649|NCT01201356|447999165|FG000|Overall Study|Death|16|||
124557650|NCT01201356|447999165|FG000|Overall Study|Protocol Violation|12|||
124557651|NCT00931385|447999166|FG000|Overall Study|Adverse Event|2|||
124557652|NCT00931385|447999167|FG001|Overall Study|Adverse Event|1|||
124557653|NCT00931385|447999168|FG002|Overall Study|Adverse Event|0|||
124557654|NCT00931385|447999169|FG003|Overall Study|Adverse Event|3|||
124557655|NCT00931385|447999166|FG000|Overall Study|Protocol Violation|0|||
124557656|NCT00931385|447999167|FG001|Overall Study|Protocol Violation|0|||
124557657|NCT00931385|447999168|FG002|Overall Study|Protocol Violation|1|||
124557658|NCT00931385|447999169|FG003|Overall Study|Protocol Violation|0|||
124557659|NCT00931385|447999166|FG000|Overall Study|Withdrawal by Subject|0|||
124557660|NCT00931385|447999167|FG001|Overall Study|Withdrawal by Subject|1|||
124557661|NCT00931385|447999168|FG002|Overall Study|Withdrawal by Subject|0|||
124557662|NCT00931385|447999169|FG003|Overall Study|Withdrawal by Subject|1|||
124557663|NCT00931385|447999166|FG000|Overall Study|Lost to Follow-up|0|||
124557664|NCT00931385|447999167|FG001|Overall Study|Lost to Follow-up|0|||
124557665|NCT00931385|447999168|FG002|Overall Study|Lost to Follow-up|0|||
124557666|NCT00931385|447999169|FG003|Overall Study|Lost to Follow-up|1|||
124557667|NCT00738920|447999171|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
124557668|NCT00738920|447999172|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
124485987|NCT02034123|447732536|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
124557669|NCT00738920|447999173|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
124557670|NCT00738920|447999171|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
124557671|NCT00738920|447999172|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
124485988|NCT02034123|447732537|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
124485989|NCT02034123|447732538|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
124485990|NCT02034123|447732539|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
124557672|NCT00738920|447999173|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
124721203|NCT00711594|448603581|FG002|Overall Study|Other Adverse Event|0|||
124557673|NCT00738920|447999171|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
124557674|NCT00738920|447999172|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
124557675|NCT00738920|447999173|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
124557676|NCT00738920|447999171|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
124557677|NCT00738920|447999172|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
124557678|NCT00738920|447999173|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
124557679|NCT00738920|447999171|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
124557680|NCT00738920|447999172|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
124557681|NCT00738920|447999173|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
124557682|NCT00738920|447999171|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
124557683|NCT00738920|447999172|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
124557684|NCT00738920|447999173|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
124557685|NCT00738920|447999171|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
124557686|NCT00738920|447999172|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
124557687|NCT00738920|447999173|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
124557688|NCT00738920|447999171|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
124557689|NCT00738920|447999172|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
124557690|NCT00738920|447999173|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
124557691|NCT00738920|447999171|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
124557692|NCT00738920|447999172|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
124557693|NCT00738920|447999173|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
124557694|NCT00738920|447999171|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
124557695|NCT00738920|447999172|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
124557696|NCT00738920|447999173|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
124557697|NCT04079842|447999175|FG000|Overall Study|Request of subject|2|||
124557698|NCT04079842|447999175|FG000|Overall Study|Unable to draw Arterial samples|1|||
124557699|NCT02904200|447999176|FG000|Overall Study|Withdrawal by Subject|1|||
124557700|NCT02904200|447999177|FG001|Overall Study|Withdrawal by Subject|0|||
124557701|NCT04444752|447999178|FG000|Overall Study|Adverse Event|1|||
124557702|NCT04444752|447999179|FG001|Overall Study|Adverse Event|0|||
124557703|NCT04444752|447999180|FG002|Overall Study|Adverse Event|0|||
124557704|NCT04444752|447999181|FG003|Overall Study|Adverse Event|2|||
124557705|NCT04444752|447999178|FG000|Overall Study|Lost to Follow-up|2|||
124557706|NCT04444752|447999179|FG001|Overall Study|Lost to Follow-up|6|||
124557707|NCT04444752|447999180|FG002|Overall Study|Lost to Follow-up|2|||
124557708|NCT04444752|447999181|FG003|Overall Study|Lost to Follow-up|5|||
124557709|NCT04444752|447999178|FG000|Overall Study|Physician Decision|0|||
124557710|NCT04444752|447999179|FG001|Overall Study|Physician Decision|0|||
124557711|NCT04444752|447999180|FG002|Overall Study|Physician Decision|0|||
124557712|NCT04444752|447999181|FG003|Overall Study|Physician Decision|2|||
124557713|NCT04444752|447999178|FG000|Overall Study|Pregnancy|0|||
124557714|NCT04444752|447999179|FG001|Overall Study|Pregnancy|0|||
124485991|NCT02034123|447732540|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
124485992|NCT02034123|447732541|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
124485993|NCT02034123|447732542|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
124485994|NCT02034123|447732543|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
124485995|NCT02034123|447732544|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
124485996|NCT02034123|447732545|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
124485997|NCT02034123|447732546|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
124485998|NCT02034123|447732547|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
124485999|NCT02034123|447732530|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
124486000|NCT02034123|447732531|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
124486001|NCT02034123|447732532|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
124486002|NCT02034123|447732533|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
124486003|NCT02034123|447732534|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
124486004|NCT02034123|447732535|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
124486005|NCT02034123|447732536|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
124486006|NCT02034123|447732537|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
124486007|NCT02034123|447732538|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
124486008|NCT02034123|447732539|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
124486009|NCT02034123|447732540|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
124486010|NCT02034123|447732541|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
124486011|NCT02034123|447732542|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
124486012|NCT02034123|447732543|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
124486013|NCT02034123|447732544|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
124486014|NCT02034123|447732545|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
124486015|NCT02034123|447732546|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
124486016|NCT02034123|447732547|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
124486017|NCT02034123|447732530|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
124486018|NCT02034123|447732531|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
124486019|NCT02034123|447732532|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
124486020|NCT02034123|447732533|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
124486021|NCT02034123|447732534|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
124486022|NCT02034123|447732535|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
124486023|NCT02034123|447732536|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
124486024|NCT02034123|447732537|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
124486025|NCT02034123|447732538|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
124486026|NCT02034123|447732539|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
124486027|NCT02034123|447732540|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
124486028|NCT02034123|447732541|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
124486029|NCT02034123|447732542|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
124486030|NCT02034123|447732543|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
124486031|NCT02034123|447732544|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
124486032|NCT02034123|447732545|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
124486033|NCT02034123|447732546|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
124486034|NCT02034123|447732547|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
124486035|NCT00246259|447732548|FG000|Overall Study|Other|3|||
124486036|NCT00246259|447732549|FG001|Overall Study|Other|3|||
124486037|NCT00246259|447732548|FG000|Overall Study|Not stable by Week 18|2|||
124486038|NCT00246259|447732549|FG001|Overall Study|Not stable by Week 18|1|||
124486039|NCT00246259|447732548|FG000|Overall Study|Participant non-compliant|4|||
124486040|NCT00246259|447732549|FG001|Overall Study|Participant non-compliant|9|||
124486041|NCT00246259|447732548|FG000|Overall Study|Lack of Efficacy|2|||
124486042|NCT00246259|447732549|FG001|Overall Study|Lack of Efficacy|2|||
124486043|NCT00246259|447732548|FG000|Overall Study|Investigator withdrew participant|2|||
124486044|NCT00246259|447732549|FG001|Overall Study|Investigator withdrew participant|0|||
124486045|NCT00246259|447732548|FG000|Overall Study|Adverse Event|5|||
124486046|NCT00246259|447732549|FG001|Overall Study|Adverse Event|0|||
124486047|NCT00246259|447732548|FG000|Overall Study|Lost to Follow-up|3|||
124486048|NCT00246259|447732549|FG001|Overall Study|Lost to Follow-up|4|||
124486049|NCT00246259|447732548|FG000|Overall Study|Withdrawal by Subject|5|||
124486050|NCT00246259|447732549|FG001|Overall Study|Withdrawal by Subject|1|||
124486051|NCT00246259|447732548|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
124557715|NCT04444752|447999180|FG002|Overall Study|Pregnancy|0|||
124557716|NCT04444752|447999181|FG003|Overall Study|Pregnancy|1|||
124557717|NCT04444752|447999178|FG000|Overall Study|Withdrawal by Subject|6|||
124557718|NCT04444752|447999179|FG001|Overall Study|Withdrawal by Subject|5|||
124557719|NCT04444752|447999180|FG002|Overall Study|Withdrawal by Subject|3|||
124557720|NCT04444752|447999181|FG003|Overall Study|Withdrawal by Subject|4|||
124557721|NCT04444752|447999178|FG000|Overall Study|Protocol Violation|1|||
124557722|NCT04444752|447999179|FG001|Overall Study|Protocol Violation|1|||
124557723|NCT04444752|447999180|FG002|Overall Study|Protocol Violation|0|||
124557724|NCT04444752|447999181|FG003|Overall Study|Protocol Violation|0|||
124557725|NCT04444752|447999178|FG000|Overall Study|Patient moving out of town|1|||
124557726|NCT04444752|447999179|FG001|Overall Study|Patient moving out of town|0|||
124557727|NCT04444752|447999180|FG002|Overall Study|Patient moving out of town|0|||
124557728|NCT04444752|447999181|FG003|Overall Study|Patient moving out of town|1|||
124557729|NCT04444752|447999178|FG000|Overall Study|Lack of Efficacy|0|||
124557730|NCT04444752|447999179|FG001|Overall Study|Lack of Efficacy|0|||
124557731|NCT04444752|447999180|FG002|Overall Study|Lack of Efficacy|0|||
124557732|NCT04444752|447999181|FG003|Overall Study|Lack of Efficacy|1|||
124557733|NCT04444752|447999178|FG000|Overall Study|Death|0|||
124486052|NCT00246259|447732549|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
124486053|NCT04233424|447732556|FG000|Overall Study|Death|15|||
124486054|NCT04233424|447732557|FG001|Overall Study|Death|16|||
124486055|NCT04233424|447732556|FG000|Overall Study|Withdrawal by Subject|2|||
124486056|NCT04233424|447732557|FG001|Overall Study|Withdrawal by Subject|8|||
124486057|NCT04233424|447732556|FG000|Overall Study|Physician Decision|1|||
124486058|NCT04233424|447732557|FG001|Overall Study|Physician Decision|3|||
124486059|NCT04233424|447732556|FG000|Overall Study|Protocol Violation|3|||
124486060|NCT04233424|447732557|FG001|Overall Study|Protocol Violation|1|||
124486061|NCT04233424|447732556|FG000|Overall Study|Lost to Follow-up|1|||
124486062|NCT04233424|447732557|FG001|Overall Study|Lost to Follow-up|3|||
124486063|NCT04233424|447732556|FG000|Overall Study|subject refuse to visit site|2|||
124486064|NCT04233424|447732557|FG001|Overall Study|subject refuse to visit site|0|||
124486065|NCT03133767|447732558|FG000|Overall Study|Lost to Follow-up|38|||
124486066|NCT03133767|447732559|FG001|Overall Study|Lost to Follow-up|24|||
124486067|NCT03133767|447732558|FG000|Overall Study|Protocol Violation|0|||
124557734|NCT04444752|447999179|FG001|Overall Study|Death|0|||
124486068|NCT03133767|447732559|FG001|Overall Study|Protocol Violation|1|||
124486069|NCT03517436|447732560|FG000|Overall Study|Death|3|||
124486070|NCT03517436|447732560|FG000|Overall Study|Withdrawal by Subject|4|||
124486071|NCT03517436|447732560|FG000|Overall Study|Did not receive study valve.|1|||
124486072|NCT02698189|447732563|FG000|Overall Study|Physician Decision|3|||
124486073|NCT02698189|447732564|FG001|Overall Study|Physician Decision|0|||
124486074|NCT02698189|447732563|FG000|Overall Study|Progressive disease|0|||
124486075|NCT02698189|447732564|FG001|Overall Study|Progressive disease|5|||
124486076|NCT02698189|447732563|FG000|Overall Study|Study terminated by sponsor|0|||
124486077|NCT02698189|447732564|FG001|Overall Study|Study terminated by sponsor|1|||
124486078|NCT02240706|447732565|FG000|Overall Study|Lack of Efficacy|2|||
124486079|NCT02240706|447732566|FG001|Overall Study|Lack of Efficacy|2|||
124486080|NCT02240706|447732567|FG002|Overall Study|Lack of Efficacy|2|||
124486081|NCT02240706|447732568|FG003|Overall Study|Lack of Efficacy|2|||
124486082|NCT02240706|447732569|FG004|Overall Study|Lack of Efficacy|5|||
124486083|NCT02240706|447732570|FG005|Overall Study|Lack of Efficacy|0|||
124486084|NCT02240706|447732571|FG006|Overall Study|Lack of Efficacy|0|||
124486085|NCT02240706|447732565|FG000|Overall Study|Adverse Event|1|||
124486086|NCT02240706|447732566|FG001|Overall Study|Adverse Event|0|||
124486087|NCT02240706|447732567|FG002|Overall Study|Adverse Event|1|||
124486088|NCT02240706|447732568|FG003|Overall Study|Adverse Event|0|||
124486089|NCT02240706|447732569|FG004|Overall Study|Adverse Event|2|||
124486090|NCT02240706|447732570|FG005|Overall Study|Adverse Event|0|||
124486091|NCT02240706|447732571|FG006|Overall Study|Adverse Event|0|||
124486092|NCT02240706|447732565|FG000|Overall Study|Progressive disease|0|||
124486093|NCT02240706|447732566|FG001|Overall Study|Progressive disease|0|||
124486094|NCT02240706|447732567|FG002|Overall Study|Progressive disease|0|||
124486095|NCT02240706|447732568|FG003|Overall Study|Progressive disease|0|||
124486096|NCT02240706|447732569|FG004|Overall Study|Progressive disease|1|||
124486097|NCT02240706|447732570|FG005|Overall Study|Progressive disease|0|||
124486098|NCT02240706|447732571|FG006|Overall Study|Progressive disease|0|||
124486099|NCT02240706|447732565|FG000|Overall Study|Dose limiting toxicity|0|||
124486100|NCT02240706|447732566|FG001|Overall Study|Dose limiting toxicity|0|||
124486101|NCT02240706|447732567|FG002|Overall Study|Dose limiting toxicity|0|||
124486102|NCT02240706|447732568|FG003|Overall Study|Dose limiting toxicity|0|||
124486103|NCT02240706|447732569|FG004|Overall Study|Dose limiting toxicity|1|||
124486104|NCT02240706|447732570|FG005|Overall Study|Dose limiting toxicity|0|||
124486105|NCT02240706|447732571|FG006|Overall Study|Dose limiting toxicity|0|||
124486106|NCT02240706|447732565|FG000|Overall Study|Refused to continue taking medication|0|||
124486107|NCT02240706|447732566|FG001|Overall Study|Refused to continue taking medication|1|||
124486108|NCT02240706|447732567|FG002|Overall Study|Refused to continue taking medication|3|||
124486109|NCT02240706|447732568|FG003|Overall Study|Refused to continue taking medication|1|||
124486110|NCT02240706|447732569|FG004|Overall Study|Refused to continue taking medication|2|||
124486111|NCT02240706|447732570|FG005|Overall Study|Refused to continue taking medication|0|||
124486112|NCT02240706|447732571|FG006|Overall Study|Refused to continue taking medication|0|||
124486113|NCT02240706|447732565|FG000|Overall Study|Insurance billing concerns|0|||
124486114|NCT02240706|447732566|FG001|Overall Study|Insurance billing concerns|0|||
124486115|NCT02240706|447732567|FG002|Overall Study|Insurance billing concerns|0|||
124486116|NCT02240706|447732568|FG003|Overall Study|Insurance billing concerns|1|||
124486117|NCT02240706|447732569|FG004|Overall Study|Insurance billing concerns|0|||
124486118|NCT02240706|447732570|FG005|Overall Study|Insurance billing concerns|0|||
124486119|NCT02240706|447732571|FG006|Overall Study|Insurance billing concerns|0|||
124486120|NCT03301857|447732572|FG000|Overall Study|Death|0|||
124486121|NCT03301857|447732573|FG001|Overall Study|Death|2|||
124486122|NCT03301857|447732572|FG000|Overall Study|Lost to Follow-up|4|||
124486123|NCT03301857|447732573|FG001|Overall Study|Lost to Follow-up|2|||
124486124|NCT03301857|447732572|FG000|Overall Study|Decision by Sponsor|6|||
124486125|NCT03301857|447732573|FG001|Overall Study|Decision by Sponsor|0|||
124486126|NCT03301857|447732572|FG000|Overall Study|Withdrawal by Subject|12|||
124486127|NCT03301857|447732573|FG001|Overall Study|Withdrawal by Subject|4|||
124486128|NCT00816036|447732574|FG000|Overall Study|Death|47|||
124486129|NCT00816036|447732575|FG001|Overall Study|Death|28|||
124486130|NCT00816036|447732574|FG000|Overall Study|Lost to Follow-up|75|||
124486131|NCT00816036|447732575|FG001|Overall Study|Lost to Follow-up|57|||
124486132|NCT00816036|447732574|FG000|Overall Study|Withdrawal by Subject|54|||
124486133|NCT00816036|447732575|FG001|Overall Study|Withdrawal by Subject|23|||
124486134|NCT01901328|447732581|FG000|Overall Study|Lost to Follow-up|1|||
124486135|NCT01901328|447732582|FG001|Overall Study|Lost to Follow-up|0|||
124486136|NCT01901328|447732581|FG000|Overall Study|Physician Decision|0|||
124486137|NCT01901328|447732582|FG001|Overall Study|Physician Decision|1|||
124486138|NCT01901328|447732581|FG000|Overall Study|Protocol Violation|1|||
124486139|NCT01901328|447732582|FG001|Overall Study|Protocol Violation|1|||
124486140|NCT01901328|447732581|FG000|Overall Study|Study Terminated by Sponsor|19|||
124486141|NCT01901328|447732582|FG001|Overall Study|Study Terminated by Sponsor|16|||
124486142|NCT01901328|447732581|FG000|Overall Study|Withdrawal by Subject|1|||
124486143|NCT01901328|447732582|FG001|Overall Study|Withdrawal by Subject|2|||
124486144|NCT01901328|447732581|FG000|Overall Study|Lack of Efficacy|0|||
124486145|NCT01901328|447732582|FG001|Overall Study|Lack of Efficacy|1|||
124721204|NCT00711594|448603582|FG003|Overall Study|Other Adverse Event|16|||
124721205|NCT00711594|448603579|FG000|Overall Study|Withdrawal by Subject|0|||
124721206|NCT00711594|448603580|FG001|Overall Study|Withdrawal by Subject|1|||
124721207|NCT00711594|448603581|FG002|Overall Study|Withdrawal by Subject|0|||
124721208|NCT00711594|448603582|FG003|Overall Study|Withdrawal by Subject|2|||
124721209|NCT00443872|448603583|FG000|Overall Study|Protocol Violation|7|||
124721210|NCT00443872|448603583|FG000|Overall Study|Lost to Follow-up|2|||
124721211|NCT00443872|448603583|FG000|Overall Study|Adverse Event|8|||
124721212|NCT00135330|448603584|FG000|Overall Study|Adverse Event|2|||
124721213|NCT00135330|448603585|FG001|Overall Study|Adverse Event|5|||
124486146|NCT03232073|447732583|FG000|Overall Study|Death|1|||
124721214|NCT00135330|448603586|FG002|Overall Study|Adverse Event|1|||
124721215|NCT00135330|448603584|FG000|Overall Study|Lost to Follow-up|0|||
124721216|NCT00135330|448603585|FG001|Overall Study|Lost to Follow-up|2|||
124721217|NCT00135330|448603586|FG002|Overall Study|Lost to Follow-up|3|||
124721218|NCT00135330|448603584|FG000|Overall Study|Physician Decision|1|||
124721219|NCT00135330|448603585|FG001|Overall Study|Physician Decision|1|||
124721220|NCT00135330|448603586|FG002|Overall Study|Physician Decision|0|||
124721221|NCT00135330|448603584|FG000|Overall Study|Protocol Violation|4|||
124721222|NCT00135330|448603585|FG001|Overall Study|Protocol Violation|3|||
124721223|NCT00135330|448603586|FG002|Overall Study|Protocol Violation|3|||
124721224|NCT00135330|448603584|FG000|Overall Study|Patient Decision|5|||
124721225|NCT00135330|448603585|FG001|Overall Study|Patient Decision|1|||
124721226|NCT00135330|448603586|FG002|Overall Study|Patient Decision|4|||
124721227|NCT00135330|448603584|FG000|Overall Study|Sponsor Decision|0|||
124721228|NCT00135330|448603585|FG001|Overall Study|Sponsor Decision|1|||
124721229|NCT00135330|448603586|FG002|Overall Study|Sponsor Decision|0|||
124721230|NCT02854436|448603590|FG000|Overall Study|Adverse Event|1|||
124721231|NCT02854436|448603590|FG000|Overall Study|Death|208|||
124721232|NCT02854436|448603590|FG000|Overall Study|Lost to Follow-up|5|||
124721233|NCT02854436|448603590|FG000|Overall Study|Withdrawal by Subject|24|||
124721234|NCT02854436|448603590|FG000|Overall Study|Other|45|||
124721235|NCT02854436|448603590|FG000|Overall Study|Physician Decision|6|||
124721236|NCT00104416|448603591|FG000|Double-Blind Phase|Adverse Event|2|||
124721237|NCT00104416|448603592|FG001|Double-Blind Phase|Adverse Event|1|||
124721238|NCT00104416|448603593|FG002|Double-Blind Phase|Adverse Event|0|||
124721239|NCT00104416|448603594|FG003|Double-Blind Phase|Adverse Event|0|||
124721240|NCT00104416|448603595|FG004|Double-Blind Phase|Adverse Event|0|||
124721241|NCT00104416|448603591|FG000|Double-Blind Phase|Lost to Follow-up|0|||
124721242|NCT00104416|448603592|FG001|Double-Blind Phase|Lost to Follow-up|1|||
124721243|NCT00104416|448603593|FG002|Double-Blind Phase|Lost to Follow-up|0|||
124721244|NCT00104416|448603594|FG003|Double-Blind Phase|Lost to Follow-up|0|||
124721245|NCT00104416|448603595|FG004|Double-Blind Phase|Lost to Follow-up|0|||
124721246|NCT00104416|448603591|FG000|Double-Blind Phase|Protocol Violation|0|||
124721247|NCT00104416|448603592|FG001|Double-Blind Phase|Protocol Violation|1|||
124721248|NCT00104416|448603593|FG002|Double-Blind Phase|Protocol Violation|0|||
124721249|NCT00104416|448603594|FG003|Double-Blind Phase|Protocol Violation|0|||
124721250|NCT00104416|448603595|FG004|Double-Blind Phase|Protocol Violation|0|||
124721251|NCT00104416|448603591|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
124721252|NCT00104416|448603592|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
124721253|NCT00104416|448603593|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
124721254|NCT00104416|448603594|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
124721255|NCT00104416|448603595|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
124721256|NCT00104416|448603591|FG000|Double-Blind Phase|Pregnancy|1|||
124721257|NCT00104416|448603592|FG001|Double-Blind Phase|Pregnancy|0|||
124721258|NCT00104416|448603593|FG002|Double-Blind Phase|Pregnancy|0|||
124721259|NCT00104416|448603594|FG003|Double-Blind Phase|Pregnancy|0|||
124721260|NCT00104416|448603595|FG004|Double-Blind Phase|Pregnancy|0|||
124721261|NCT00104416|448603591|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
124721262|NCT00104416|448603592|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
124721263|NCT00104416|448603593|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
124721264|NCT00104416|448603594|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
124771950|NCT02141295|448796332|FG001|Overall Study|Study terminated by sponsor|6|||
124486147|NCT03232073|447732584|FG001|Overall Study|Death|0|||
124721265|NCT00104416|448603595|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
124721266|NCT00104416|448603591|FG000|Continuation Phase|Adverse Event|0|||
124721267|NCT00104416|448603592|FG001|Continuation Phase|Adverse Event|0|||
124486148|NCT03232073|447732583|FG000|Overall Study|Adverse Event|7|||
124721268|NCT00104416|448603593|FG002|Continuation Phase|Adverse Event|2|||
124721269|NCT00104416|448603594|FG003|Continuation Phase|Adverse Event|0|||
124721270|NCT00104416|448603595|FG004|Continuation Phase|Adverse Event|2|||
124721271|NCT00104416|448603591|FG000|Continuation Phase|Lost to Follow-up|0|||
124721272|NCT00104416|448603592|FG001|Continuation Phase|Lost to Follow-up|0|||
124721273|NCT00104416|448603593|FG002|Continuation Phase|Lost to Follow-up|1|||
124721274|NCT00104416|448603594|FG003|Continuation Phase|Lost to Follow-up|0|||
124721275|NCT00104416|448603595|FG004|Continuation Phase|Lost to Follow-up|1|||
124721276|NCT00104416|448603591|FG000|Continuation Phase|Withdrawal by Subject|0|||
124486149|NCT03232073|447732584|FG001|Overall Study|Adverse Event|12|||
124486150|NCT03232073|447732583|FG000|Overall Study|Lost to Follow-up|6|||
124486151|NCT03232073|447732584|FG001|Overall Study|Lost to Follow-up|6|||
124486152|NCT03232073|447732583|FG000|Overall Study|Lack of Efficacy|10|||
124486153|NCT03232073|447732584|FG001|Overall Study|Lack of Efficacy|8|||
124486154|NCT03232073|447732583|FG000|Overall Study|Physician Decision|9|||
124486155|NCT03232073|447732584|FG001|Overall Study|Physician Decision|2|||
124486156|NCT03232073|447732583|FG000|Overall Study|Withdrawal by Subject|54|||
124486157|NCT03232073|447732584|FG001|Overall Study|Withdrawal by Subject|39|||
124486158|NCT00955110|447734454|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
124486159|NCT00955110|447734454|FG000|Treatment Phase|Adverse Event|2|||
124486160|NCT00955110|447734454|FG000|Treatment Phase|Administrative reasons|2|||
124486161|NCT00955110|447734454|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
124486162|NCT00955110|447734454|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
124486163|NCT04893265|447734457|FG000|Overall Study|Withdrawal by Subject|2|||
124486164|NCT04893265|447734458|FG001|Overall Study|Withdrawal by Subject|5|||
124486165|NCT04893265|447734457|FG000|Overall Study|Lost to Follow-up|0|||
124486166|NCT04893265|447734458|FG001|Overall Study|Lost to Follow-up|4|||
124486167|NCT00573131|447734459|FG000|Overall Study|Withdrawal by Subject|10|||
124486168|NCT00573131|447734460|FG001|Overall Study|Withdrawal by Subject|8|||
124486169|NCT02024464|447734462|FG000|Overall Study|Discontinued|5|||
124486170|NCT02024464|447734463|FG001|Overall Study|Discontinued|4|||
124486171|NCT02024464|447734462|FG000|Overall Study|Missed Visits|1|||
124486172|NCT02024464|447734463|FG001|Overall Study|Missed Visits|0|||
124486173|NCT02024464|447734462|FG000|Overall Study|Lost to Follow-up|4|||
124486174|NCT02024464|447734463|FG001|Overall Study|Lost to Follow-up|7|||
124486175|NCT02158533|447734467|FG000|Stage 1|Adverse Event|6|||
124486176|NCT02158533|447734468|FG001|Stage 1|Adverse Event|4|||
124486177|NCT02158533|447734469|FG002|Stage 1|Adverse Event|7|||
124486178|NCT02158533|447734470|FG003|Stage 1|Adverse Event|0|||
124486179|NCT02158533|447734471|FG004|Stage 1|Adverse Event|0|||
124486180|NCT02158533|447734472|FG005|Stage 1|Adverse Event|0|||
124486181|NCT02158533|447734467|FG000|Stage 1|Withdrawal by Subject|3|||
124486182|NCT02158533|447734468|FG001|Stage 1|Withdrawal by Subject|2|||
124486183|NCT02158533|447734469|FG002|Stage 1|Withdrawal by Subject|1|||
124486184|NCT02158533|447734470|FG003|Stage 1|Withdrawal by Subject|0|||
124486185|NCT02158533|447734471|FG004|Stage 1|Withdrawal by Subject|0|||
124486186|NCT02158533|447734472|FG005|Stage 1|Withdrawal by Subject|0|||
124486187|NCT02158533|447734467|FG000|Stage 1|Lack of Efficacy|1|||
124486188|NCT02158533|447734468|FG001|Stage 1|Lack of Efficacy|0|||
124486189|NCT02158533|447734469|FG002|Stage 1|Lack of Efficacy|0|||
124486190|NCT02158533|447734470|FG003|Stage 1|Lack of Efficacy|0|||
124486191|NCT02158533|447734471|FG004|Stage 1|Lack of Efficacy|0|||
124486192|NCT02158533|447734472|FG005|Stage 1|Lack of Efficacy|0|||
124486193|NCT02158533|447734467|FG000|Stage 1|Lost to Follow-up|3|||
124486194|NCT02158533|447734468|FG001|Stage 1|Lost to Follow-up|1|||
124486195|NCT02158533|447734469|FG002|Stage 1|Lost to Follow-up|0|||
124486196|NCT02158533|447734470|FG003|Stage 1|Lost to Follow-up|0|||
124486197|NCT02158533|447734471|FG004|Stage 1|Lost to Follow-up|0|||
124486198|NCT02158533|447734472|FG005|Stage 1|Lost to Follow-up|0|||
124486199|NCT02158533|447734467|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
124486200|NCT02158533|447734468|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
124486201|NCT02158533|447734469|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
124486202|NCT02158533|447734470|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
124486203|NCT02158533|447734471|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
124486204|NCT02158533|447734472|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
124486205|NCT02158533|447734467|FG000|Stage 1|Non-compliance with study visits|1|||
124486206|NCT02158533|447734468|FG001|Stage 1|Non-compliance with study visits|0|||
124486207|NCT02158533|447734469|FG002|Stage 1|Non-compliance with study visits|0|||
124486208|NCT02158533|447734470|FG003|Stage 1|Non-compliance with study visits|0|||
124486209|NCT02158533|447734471|FG004|Stage 1|Non-compliance with study visits|0|||
124486210|NCT02158533|447734472|FG005|Stage 1|Non-compliance with study visits|0|||
124486211|NCT02158533|447734467|FG000|Stage 2|Adverse Event|0|||
124486212|NCT02158533|447734468|FG001|Stage 2|Adverse Event|0|||
124721277|NCT00104416|448603592|FG001|Continuation Phase|Withdrawal by Subject|0|||
124486213|NCT02158533|447734469|FG002|Stage 2|Adverse Event|0|||
124486214|NCT02158533|447734470|FG003|Stage 2|Adverse Event|0|||
124486215|NCT02158533|447734471|FG004|Stage 2|Adverse Event|0|||
124486216|NCT02158533|447734472|FG005|Stage 2|Adverse Event|1|||
124486217|NCT02158533|447734467|FG000|Stage 2|Lack of Efficacy|0|||
124486218|NCT02158533|447734468|FG001|Stage 2|Lack of Efficacy|0|||
124486219|NCT02158533|447734469|FG002|Stage 2|Lack of Efficacy|0|||
124486220|NCT02158533|447734470|FG003|Stage 2|Lack of Efficacy|0|||
124486221|NCT02158533|447734471|FG004|Stage 2|Lack of Efficacy|1|||
124486222|NCT02158533|447734472|FG005|Stage 2|Lack of Efficacy|0|||
124486223|NCT02158533|447734467|FG000|Stage 2|Lost to Follow-up|0|||
124486224|NCT02158533|447734468|FG001|Stage 2|Lost to Follow-up|0|||
124486225|NCT02158533|447734469|FG002|Stage 2|Lost to Follow-up|0|||
124486226|NCT02158533|447734470|FG003|Stage 2|Lost to Follow-up|1|||
124486227|NCT02158533|447734471|FG004|Stage 2|Lost to Follow-up|1|||
124486228|NCT02158533|447734472|FG005|Stage 2|Lost to Follow-up|2|||
124486229|NCT02158533|447734467|FG000|Stage 2|Withdrawal by Subject|0|||
124486230|NCT02158533|447734468|FG001|Stage 2|Withdrawal by Subject|0|||
124486231|NCT02158533|447734469|FG002|Stage 2|Withdrawal by Subject|0|||
124486232|NCT02158533|447734470|FG003|Stage 2|Withdrawal by Subject|0|||
124486233|NCT02158533|447734471|FG004|Stage 2|Withdrawal by Subject|1|||
124486234|NCT02158533|447734472|FG005|Stage 2|Withdrawal by Subject|2|||
124486235|NCT02158533|447734467|FG000|Stage 2|Physician Decision|0|||
124486236|NCT02158533|447734468|FG001|Stage 2|Physician Decision|0|||
124486237|NCT02158533|447734469|FG002|Stage 2|Physician Decision|0|||
124486238|NCT02158533|447734470|FG003|Stage 2|Physician Decision|0|||
124486239|NCT02158533|447734471|FG004|Stage 2|Physician Decision|1|||
124486240|NCT02158533|447734472|FG005|Stage 2|Physician Decision|0|||
124486241|NCT02158533|447734467|FG000|Stage 2|Pregnancy|0|||
124486242|NCT02158533|447734468|FG001|Stage 2|Pregnancy|0|||
124486243|NCT02158533|447734469|FG002|Stage 2|Pregnancy|0|||
124486244|NCT02158533|447734470|FG003|Stage 2|Pregnancy|1|||
124486245|NCT02158533|447734471|FG004|Stage 2|Pregnancy|0|||
124486246|NCT02158533|447734472|FG005|Stage 2|Pregnancy|0|||
124486247|NCT02158533|447734467|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
124486248|NCT02158533|447734468|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
124486249|NCT02158533|447734469|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
124486250|NCT02158533|447734470|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
124486251|NCT02158533|447734471|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
124486252|NCT02158533|447734472|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
124486253|NCT02158533|447734467|FG000|Stage 2|Non-adherence with study visits|0|||
124486254|NCT02158533|447734468|FG001|Stage 2|Non-adherence with study visits|0|||
124486255|NCT02158533|447734469|FG002|Stage 2|Non-adherence with study visits|0|||
124486256|NCT02158533|447734470|FG003|Stage 2|Non-adherence with study visits|0|||
124486257|NCT02158533|447734471|FG004|Stage 2|Non-adherence with study visits|0|||
124486258|NCT02158533|447734472|FG005|Stage 2|Non-adherence with study visits|1|||
124486259|NCT02037919|447734473|FG000|Overall Study|Lost to Follow-up|30|||
124486260|NCT02037919|447734474|FG001|Overall Study|Lost to Follow-up|45|||
124486261|NCT00756002|447734482|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
124486262|NCT00756002|447734483|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
124486263|NCT00756002|447734482|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124486264|NCT00756002|447734483|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
124486265|NCT00756002|447734482|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
124486266|NCT00756002|447734483|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
124486267|NCT00756002|447734482|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
124486268|NCT00756002|447734483|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
124486269|NCT00756002|447734482|FG000|Double-Blind Treatment Period|Other|2|||
124486270|NCT00756002|447734483|FG001|Double-Blind Treatment Period|Other|2|||
124486271|NCT04899271|447734490|FG000|Overall Study|Lost to Follow-up|1|||
124486272|NCT04899271|447734491|FG001|Overall Study|Lost to Follow-up|0|||
124486273|NCT04899271|447734490|FG000|Overall Study|Subject request/consent withdrawal|2|||
124486274|NCT04899271|447734491|FG001|Overall Study|Subject request/consent withdrawal|0|||
124486275|NCT01929083|447734492|FG000|Intervention 1|Lost to Follow-up|2|||
124486276|NCT01929083|447734493|FG001|Intervention 1|Lost to Follow-up|0|||
124486277|NCT01929083|447734492|FG000|Intervention 1|Nonadherent to study medications|1|||
124486278|NCT01929083|447734493|FG001|Intervention 1|Nonadherent to study medications|0|||
124486279|NCT01929083|447734492|FG000|Intervention 2|Adverse Event|0|||
124486280|NCT01929083|447734493|FG001|Intervention 2|Adverse Event|1|||
124486281|NCT02586805|447734500|FG000|Overall Study|Withdrawal by Subject|3|||
124486282|NCT02586805|447734501|FG001|Overall Study|Withdrawal by Subject|1|||
124486283|NCT02586805|447734502|FG002|Overall Study|Withdrawal by Subject|1|||
124486284|NCT02586805|447734503|FG003|Overall Study|Withdrawal by Subject|2|||
124486285|NCT02586805|447734500|FG000|Overall Study|Adverse Event|2|||
124486286|NCT02586805|447734501|FG001|Overall Study|Adverse Event|0|||
124486287|NCT02586805|447734502|FG002|Overall Study|Adverse Event|1|||
124486288|NCT02586805|447734503|FG003|Overall Study|Adverse Event|0|||
124486289|NCT02586805|447734500|FG000|Overall Study|Lost to Follow-up|0|||
124486290|NCT02586805|447734501|FG001|Overall Study|Lost to Follow-up|0|||
124486291|NCT02586805|447734502|FG002|Overall Study|Lost to Follow-up|1|||
124486292|NCT02586805|447734503|FG003|Overall Study|Lost to Follow-up|0|||
124486293|NCT02586805|447734500|FG000|Overall Study|Physician Decision|1|||
124486294|NCT02586805|447734501|FG001|Overall Study|Physician Decision|0|||
124721278|NCT00104416|448603593|FG002|Continuation Phase|Withdrawal by Subject|2|||
124486295|NCT02586805|447734502|FG002|Overall Study|Physician Decision|0|||
124486296|NCT02586805|447734503|FG003|Overall Study|Physician Decision|0|||
124486297|NCT00892437|447734507|FG000|Randomized Phase|Randomized but not treated|6|||
124486298|NCT00892437|447734508|FG001|Randomized Phase|Randomized but not treated|0|||
124486299|NCT00892437|447734507|FG000|Randomized Phase|Adverse Event|2|||
124486300|NCT00892437|447734508|FG001|Randomized Phase|Adverse Event|2|||
124486301|NCT00892437|447734507|FG000|Randomized Phase|Lost to Follow-up|1|||
124486302|NCT00892437|447734508|FG001|Randomized Phase|Lost to Follow-up|3|||
124486303|NCT00892437|447734507|FG000|Randomized Phase|Investigator's Discretion|1|||
124486304|NCT00892437|447734508|FG001|Randomized Phase|Investigator's Discretion|0|||
124486305|NCT00892437|447734507|FG000|Randomized Phase|Withdrew Consent|1|||
124721279|NCT00104416|448603594|FG003|Continuation Phase|Withdrawal by Subject|1|||
124486306|NCT00892437|447734508|FG001|Randomized Phase|Withdrew Consent|0|||
124486307|NCT00892437|447734507|FG000|Open-Label Extension Phase|Adverse Event|4|||
124486308|NCT00892437|447734508|FG001|Open-Label Extension Phase|Adverse Event|2|||
124486309|NCT00892437|447734507|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
124486310|NCT00892437|447734508|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
124486311|NCT00892437|447734507|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
124486312|NCT00892437|447734508|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
124486313|NCT00892437|447734507|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
124486314|NCT00892437|447734508|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
124486315|NCT00892437|447734507|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
124486316|NCT00892437|447734508|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
124486317|NCT02504541|447734510|FG000|Overall Study|Adverse Event|4|||
124486318|NCT02504541|447734510|FG000|Overall Study|Withdrawal by Subject|4|||
124486319|NCT02504541|447734510|FG000|Overall Study|Lost to Follow-up|1|||
124486320|NCT02504541|447734510|FG000|Overall Study|Met Stopping Criteria|1|||
124486321|NCT02504541|447734510|FG000|Overall Study|Protocol Violation|2|||
124486322|NCT02504541|447734510|FG000|Overall Study|Termination by Sponsor|1|||
124486323|NCT02504541|447734510|FG000|Overall Study|Other|2|||
124486324|NCT02504541|447734510|FG000|Overall Study|Multiple|5|||
124486325|NCT01531725|447734514|FG000|Overall Study|Protocol Violation|5|||
124486326|NCT00500071|447734515|FG000|Screening and Washout Phase|Protocol Violation|1|||
124486327|NCT00500071|447734515|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
124486328|NCT00500071|447734515|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
124486329|NCT00500071|447734515|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
124486330|NCT00500071|447734515|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
124486331|NCT00500071|447734515|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
124486332|NCT00500071|447734515|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
124486333|NCT00472303|447734516|FG000|Titration Phase|Adverse Event|22|||
124486334|NCT00472303|447734517|FG001|Titration Phase|Adverse Event|12|||
124486335|NCT00472303|447734518|FG002|Titration Phase|Adverse Event|0|||
124486336|NCT00472303|447734516|FG000|Titration Phase|Death|4|||
124486337|NCT00472303|447734517|FG001|Titration Phase|Death|2|||
124486338|NCT00472303|447734518|FG002|Titration Phase|Death|0|||
124486339|NCT00472303|447734516|FG000|Titration Phase|Lack of Efficacy|10|||
124486340|NCT00472303|447734517|FG001|Titration Phase|Lack of Efficacy|0|||
124486341|NCT00472303|447734518|FG002|Titration Phase|Lack of Efficacy|0|||
124486342|NCT00472303|447734516|FG000|Titration Phase|Withdrawal by Subject|16|||
124486343|NCT00472303|447734517|FG001|Titration Phase|Withdrawal by Subject|13|||
124486344|NCT00472303|447734518|FG002|Titration Phase|Withdrawal by Subject|0|||
124486345|NCT00472303|447734516|FG000|Titration Phase|Trial Medication non-compliant|4|||
124486346|NCT00472303|447734517|FG001|Titration Phase|Trial Medication non-compliant|1|||
124486347|NCT00472303|447734518|FG002|Titration Phase|Trial Medication non-compliant|0|||
124486348|NCT00472303|447734516|FG000|Titration Phase|Other|3|||
124486349|NCT00472303|447734517|FG001|Titration Phase|Other|1|||
124486350|NCT00472303|447734518|FG002|Titration Phase|Other|0|||
124486351|NCT00472303|447734516|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
124486352|NCT00472303|447734517|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
124486353|NCT00472303|447734518|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
124486354|NCT00472303|447734516|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
124486355|NCT00472303|447734517|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
124486356|NCT00472303|447734518|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
124486357|NCT00472303|447734516|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
124486358|NCT00472303|447734517|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
124486359|NCT00472303|447734518|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
124486360|NCT00472303|447734516|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
124486361|NCT00472303|447734517|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
124486362|NCT00472303|447734518|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
124486363|NCT00472303|447734516|FG000|Discontinuations After Titration Phase|Other|5|||
124486364|NCT00472303|447734517|FG001|Discontinuations After Titration Phase|Other|0|||
124486365|NCT00472303|447734518|FG002|Discontinuations After Titration Phase|Other|0|||
124486366|NCT00472303|447734516|FG000|Maintenance Phase|Adverse Event|5|||
124486367|NCT00472303|447734517|FG001|Maintenance Phase|Adverse Event|6|||
124721280|NCT00104416|448603595|FG004|Continuation Phase|Withdrawal by Subject|1|||
124721281|NCT00104416|448603591|FG000|Continuation Phase|Pregnancy|0|||
124721282|NCT00104416|448603592|FG001|Continuation Phase|Pregnancy|0|||
124486368|NCT00472303|447734518|FG002|Maintenance Phase|Adverse Event|6|||
124486369|NCT00472303|447734516|FG000|Maintenance Phase|Death|3|||
124721283|NCT00104416|448603593|FG002|Continuation Phase|Pregnancy|1|||
124486370|NCT00472303|447734517|FG001|Maintenance Phase|Death|0|||
124486371|NCT00472303|447734518|FG002|Maintenance Phase|Death|2|||
124486372|NCT00472303|447734516|FG000|Maintenance Phase|Lack of Efficacy|2|||
124486373|NCT00472303|447734517|FG001|Maintenance Phase|Lack of Efficacy|2|||
124486374|NCT00472303|447734518|FG002|Maintenance Phase|Lack of Efficacy|4|||
124486375|NCT00472303|447734516|FG000|Maintenance Phase|Withdrawal by Subject|6|||
124486376|NCT00472303|447734517|FG001|Maintenance Phase|Withdrawal by Subject|7|||
124486377|NCT00472303|447734518|FG002|Maintenance Phase|Withdrawal by Subject|3|||
124486378|NCT00472303|447734516|FG000|Maintenance Phase|Trial medication non-compliant|0|||
124486379|NCT00472303|447734517|FG001|Maintenance Phase|Trial medication non-compliant|0|||
124486380|NCT00472303|447734518|FG002|Maintenance Phase|Trial medication non-compliant|1|||
124486381|NCT00472303|447734516|FG000|Maintenance Phase|Resolution of pain|0|||
124486382|NCT00472303|447734517|FG001|Maintenance Phase|Resolution of pain|0|||
124486383|NCT00472303|447734518|FG002|Maintenance Phase|Resolution of pain|1|||
124486384|NCT00472303|447734516|FG000|Maintenance Phase|Other|1|||
124486385|NCT00472303|447734517|FG001|Maintenance Phase|Other|1|||
124486386|NCT00472303|447734518|FG002|Maintenance Phase|Other|0|||
124486387|NCT01238120|447734519|FG000|Overall Study|Withdrawal by Subject|4|||
124486388|NCT01238120|447734520|FG001|Overall Study|Withdrawal by Subject|1|||
124486389|NCT01238120|447734521|FG002|Overall Study|Withdrawal by Subject|2|||
124486390|NCT01238120|447734522|FG003|Overall Study|Withdrawal by Subject|5|||
124486391|NCT01238120|447734519|FG000|Overall Study|Lost to Follow-up|2|||
124486392|NCT01238120|447734520|FG001|Overall Study|Lost to Follow-up|0|||
124486393|NCT01238120|447734521|FG002|Overall Study|Lost to Follow-up|1|||
124486394|NCT01238120|447734522|FG003|Overall Study|Lost to Follow-up|1|||
124486395|NCT01238120|447734519|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
124486396|NCT01238120|447734520|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
124486397|NCT01238120|447734521|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
124486398|NCT01238120|447734522|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
124486399|NCT03182738|447734523|FG000|Overall Study|Lost to Follow-up|9|||
124486400|NCT03182738|447734524|FG001|Overall Study|Lost to Follow-up|3|||
124486401|NCT03182738|447734523|FG000|Overall Study|Pregnancy|0|||
124486402|NCT03182738|447734524|FG001|Overall Study|Pregnancy|1|||
124486403|NCT03182738|447734523|FG000|Overall Study|Withdrawal by Subject|0|||
124486404|NCT03182738|447734524|FG001|Overall Study|Withdrawal by Subject|1|||
124486405|NCT03596164|447734529|FG000|Overall Study|Adverse Event|0|||
124486406|NCT03596164|447734530|FG001|Overall Study|Adverse Event|1|||
124486407|NCT03596164|447734529|FG000|Overall Study|Death|1|||
124486408|NCT03596164|447734530|FG001|Overall Study|Death|0|||
124486409|NCT04112914|447734531|FG000|Overall Study|Lost to Follow-up|13|||
124486410|NCT04112914|447734532|FG001|Overall Study|Lost to Follow-up|9|||
124486411|NCT04112914|447734531|FG000|Overall Study|Withdrawal by Subject|1|||
124486412|NCT04112914|447734532|FG001|Overall Study|Withdrawal by Subject|0|||
124486413|NCT03427073|447734533|FG000|Overall Study|Disease Progression|1|||
124486414|NCT03427073|447734534|FG001|Overall Study|Disease Progression|1|||
124486415|NCT03427073|447734535|FG002|Overall Study|Disease Progression|1|||
124486416|NCT03427073|447734536|FG003|Overall Study|Disease Progression|3|||
124486417|NCT03427073|447734537|FG004|Overall Study|Disease Progression|3|||
124486418|NCT03427073|447734538|FG005|Overall Study|Disease Progression|4|||
124486419|NCT03427073|447734539|FG006|Overall Study|Disease Progression|2|||
124486420|NCT03427073|447734540|FG007|Overall Study|Disease Progression|3|||
124486421|NCT03427073|447734533|FG000|Overall Study|Physician Decision|0|||
124486422|NCT03427073|447734534|FG001|Overall Study|Physician Decision|0|||
124486423|NCT03427073|447734535|FG002|Overall Study|Physician Decision|0|||
124486424|NCT03427073|447734536|FG003|Overall Study|Physician Decision|0|||
124486425|NCT03427073|447734537|FG004|Overall Study|Physician Decision|0|||
124486426|NCT03427073|447734538|FG005|Overall Study|Physician Decision|0|||
124486427|NCT03427073|447734539|FG006|Overall Study|Physician Decision|1|||
124486428|NCT03427073|447734540|FG007|Overall Study|Physician Decision|1|||
124486429|NCT01486238|447734542|FG000|Overall Study|Death|0|||
124486430|NCT01486238|447734543|FG001|Overall Study|Death|2|||
124486431|NCT01486238|447734542|FG000|Overall Study|Withdrawal by Subject|2|||
124486432|NCT01486238|447734543|FG001|Overall Study|Withdrawal by Subject|1|||
124486433|NCT01486238|447734542|FG000|Overall Study|Lost to Follow-up|0|||
124486434|NCT01486238|447734543|FG001|Overall Study|Lost to Follow-up|3|||
124486435|NCT02835495|447734545|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
124486436|NCT02835495|447734546|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
124486437|NCT02835495|447734545|FG000|Overall Study|Declined in-person follow-up visit|4|||
124486438|NCT02835495|447734546|FG001|Overall Study|Declined in-person follow-up visit|2|||
124486439|NCT05421754|447734547|FG000|Overall Study|Technical issue with sensor|1|||
124486440|NCT03486314|447734553|FG000|Part A|Adverse Event|1|||
124486441|NCT03486314|447734554|FG001|Part A|Adverse Event|0|||
124486442|NCT03486314|447734555|FG002|Part A|Adverse Event|0|||
124486443|NCT03486314|447734553|FG000|Part A|Symptomatic Deterioration|2|||
124486444|NCT03486314|447734554|FG001|Part A|Symptomatic Deterioration|0|||
124486445|NCT03486314|447734555|FG002|Part A|Symptomatic Deterioration|0|||
124486446|NCT00659438|447734556|FG000|Overall Study|Withdrawal by Subject|2|||
124486447|NCT00659438|447734557|FG001|Overall Study|Withdrawal by Subject|2|||
124771951|NCT02141295|448796333|FG002|Overall Study|Study terminated by sponsor|6|||
124486448|NCT00659438|447734556|FG000|Overall Study|Death|11|||
124486449|NCT00659438|447734557|FG001|Overall Study|Death|6|||
124486450|NCT00659438|447734556|FG000|Overall Study|Lost to Follow-up|1|||
124486451|NCT00659438|447734557|FG001|Overall Study|Lost to Follow-up|0|||
124486452|NCT03826914|447734559|FG000|Overall Study|Withdrawal by Subject|1|||
124486453|NCT03826914|447734560|FG001|Overall Study|Withdrawal by Subject|1|||
124486454|NCT04334148|447734563|FG000|Overall Study|positive nasal swab at baseline|0|||
124486455|NCT04334148|447734564|FG001|Overall Study|positive nasal swab at baseline|1|||
124486456|NCT03228186|447734565|FG000|Overall Study|Patient never started treatment|1|||
124486457|NCT04003610|447734566|FG000|Overall Study|Lost to Follow-up|0|||
124486458|NCT04003610|447734567|FG001|Overall Study|Lost to Follow-up|1|||
124486459|NCT04003610|447734568|FG002|Overall Study|Lost to Follow-up|0|||
124486460|NCT04003610|447734566|FG000|Overall Study|Death|0|||
124486461|NCT04003610|447734567|FG001|Overall Study|Death|0|||
124486462|NCT04003610|447734568|FG002|Overall Study|Death|3|||
124486463|NCT04003610|447734566|FG000|Overall Study|Study Terminated by Sponsor|0|||
124486464|NCT04003610|447734567|FG001|Overall Study|Study Terminated by Sponsor|0|||
124486465|NCT04003610|447734568|FG002|Overall Study|Study Terminated by Sponsor|3|||
124486466|NCT02502864|447734572|FG000|Overall Study|Withdrawal by Subject|1|||
124486467|NCT03772327|447734573|FG000|Overall Study|Lost to Follow-up|3|||
124486468|NCT03772327|447734574|FG001|Overall Study|Lost to Follow-up|4|||
124486469|NCT03772327|447734573|FG000|Overall Study|Withdrawal by Subject|2|||
124486470|NCT03772327|447734574|FG001|Overall Study|Withdrawal by Subject|3|||
124486471|NCT05502289|447734582|FG000|Period 1|Out Of Window|1|||
124486472|NCT05502289|447734583|FG001|Period 1|Out Of Window|0|||
124486473|NCT02333227|447734589|FG000|Overall Study|Lost to Follow-up|137|||
124486474|NCT02333227|447734590|FG001|Overall Study|Lost to Follow-up|106|||
124486475|NCT02333227|447734589|FG000|Overall Study|Pregnancy Interrupted|42|||
124486476|NCT02333227|447734590|FG001|Overall Study|Pregnancy Interrupted|89|||
124486477|NCT02333227|447734589|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
124486478|NCT02333227|447734590|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
124486479|NCT01254344|447734591|FG000|Overall Study|Adverse Event|2|||
124486480|NCT01254344|447734592|FG001|Overall Study|Adverse Event|5|||
124486481|NCT01254344|447734591|FG000|Overall Study|Physician Decision|7|||
124486482|NCT01254344|447734592|FG001|Overall Study|Physician Decision|4|||
124486483|NCT01254344|447734591|FG000|Overall Study|Protocol Violation|1|||
124486484|NCT01254344|447734592|FG001|Overall Study|Protocol Violation|4|||
124486485|NCT01254344|447734591|FG000|Overall Study|Withdrawal by Subject|3|||
124486486|NCT01254344|447734592|FG001|Overall Study|Withdrawal by Subject|6|||
124486487|NCT03022461|447734595|FG000|Overall Study|Death|3|||
124486488|NCT01624194|447734596|FG000|Overall Study|Lost to Follow-up|1|||
124486489|NCT01624194|447734597|FG001|Overall Study|Lost to Follow-up|0|||
124486490|NCT01624194|447734596|FG000|Overall Study|Withdrawal by Subject|1|||
124486491|NCT01624194|447734597|FG001|Overall Study|Withdrawal by Subject|0|||
124486492|NCT03459040|447734598|FG000|Overall Study|Death|8|||
124486493|NCT03459040|447734598|FG000|Overall Study|Withdrawal by Subject|1|||
124486494|NCT00561353|447734599|FG000|Overall Study|Subject reached a virologic endpoint|2|||
124486495|NCT00561353|447734600|FG001|Overall Study|Subject reached a virologic endpoint|1|||
124486496|NCT00561353|447734601|FG002|Overall Study|Subject reached a virologic endpoint|1|||
124486497|NCT00561353|447734602|FG003|Overall Study|Subject reached a virologic endpoint|4|||
124486498|NCT00561353|447734603|FG004|Overall Study|Subject reached a virologic endpoint|1|||
124486499|NCT00561353|447734604|FG005|Overall Study|Subject reached a virologic endpoint|3|||
124486500|NCT00561353|447734605|FG006|Overall Study|Subject reached a virologic endpoint|4|||
124486501|NCT00561353|447734606|FG007|Overall Study|Subject reached a virologic endpoint|4|||
124486502|NCT00561353|447734607|FG008|Overall Study|Subject reached a virologic endpoint|5|||
124486503|NCT00561353|447734608|FG009|Overall Study|Subject reached a virologic endpoint|0|||
124486504|NCT00561353|447734599|FG000|Overall Study|Subject ineligible to continue the trial|0|||
124486505|NCT00561353|447734600|FG001|Overall Study|Subject ineligible to continue the trial|0|||
124486506|NCT00561353|447734601|FG002|Overall Study|Subject ineligible to continue the trial|0|||
124486507|NCT00561353|447734602|FG003|Overall Study|Subject ineligible to continue the trial|0|||
124486508|NCT00561353|447734603|FG004|Overall Study|Subject ineligible to continue the trial|0|||
124486509|NCT00561353|447734604|FG005|Overall Study|Subject ineligible to continue the trial|1|||
124486510|NCT00561353|447734605|FG006|Overall Study|Subject ineligible to continue the trial|1|||
124486511|NCT00561353|447734606|FG007|Overall Study|Subject ineligible to continue the trial|0|||
124486512|NCT00561353|447734607|FG008|Overall Study|Subject ineligible to continue the trial|2|||
124486513|NCT00561353|447734608|FG009|Overall Study|Subject ineligible to continue the trial|1|||
124486514|NCT00561353|447734599|FG000|Overall Study|Other|1|||
124486515|NCT00561353|447734600|FG001|Overall Study|Other|0|||
124486516|NCT00561353|447734601|FG002|Overall Study|Other|1|||
124486517|NCT00561353|447734602|FG003|Overall Study|Other|0|||
124486518|NCT00561353|447734603|FG004|Overall Study|Other|0|||
124486519|NCT00561353|447734604|FG005|Overall Study|Other|2|||
124486520|NCT00561353|447734605|FG006|Overall Study|Other|0|||
124486521|NCT00561353|447734606|FG007|Overall Study|Other|0|||
124486522|NCT00561353|447734607|FG008|Overall Study|Other|0|||
124486523|NCT00561353|447734608|FG009|Overall Study|Other|0|||
124486524|NCT00561353|447734599|FG000|Overall Study|Adverse Event|0|||
124486525|NCT00561353|447734600|FG001|Overall Study|Adverse Event|0|||
124486526|NCT00561353|447734601|FG002|Overall Study|Adverse Event|0|||
124771952|NCT02141295|448796331|FG000|Overall Study|Non-compliance|0|||
124486527|NCT00561353|447734602|FG003|Overall Study|Adverse Event|2|||
124486528|NCT00561353|447734603|FG004|Overall Study|Adverse Event|0|||
124486529|NCT00561353|447734604|FG005|Overall Study|Adverse Event|0|||
124486530|NCT00561353|447734605|FG006|Overall Study|Adverse Event|1|||
124486531|NCT00561353|447734606|FG007|Overall Study|Adverse Event|0|||
124486532|NCT00561353|447734607|FG008|Overall Study|Adverse Event|0|||
124486533|NCT00561353|447734608|FG009|Overall Study|Adverse Event|1|||
124486534|NCT00561353|447734599|FG000|Overall Study|Lost to Follow-up|2|||
124486535|NCT00561353|447734600|FG001|Overall Study|Lost to Follow-up|0|||
124486536|NCT00561353|447734601|FG002|Overall Study|Lost to Follow-up|1|||
124486537|NCT00561353|447734602|FG003|Overall Study|Lost to Follow-up|0|||
124486538|NCT00561353|447734603|FG004|Overall Study|Lost to Follow-up|0|||
124486539|NCT00561353|447734604|FG005|Overall Study|Lost to Follow-up|0|||
124486540|NCT00561353|447734605|FG006|Overall Study|Lost to Follow-up|0|||
124486541|NCT00561353|447734606|FG007|Overall Study|Lost to Follow-up|0|||
124486542|NCT00561353|447734607|FG008|Overall Study|Lost to Follow-up|0|||
124486543|NCT00561353|447734608|FG009|Overall Study|Lost to Follow-up|0|||
124486544|NCT00561353|447734599|FG000|Overall Study|Withdrawal by Subject|0|||
124486545|NCT00561353|447734600|FG001|Overall Study|Withdrawal by Subject|2|||
124486546|NCT00561353|447734601|FG002|Overall Study|Withdrawal by Subject|0|||
124486547|NCT00561353|447734602|FG003|Overall Study|Withdrawal by Subject|0|||
124486548|NCT00561353|447734603|FG004|Overall Study|Withdrawal by Subject|0|||
124486549|NCT00561353|447734604|FG005|Overall Study|Withdrawal by Subject|0|||
124486550|NCT00561353|447734605|FG006|Overall Study|Withdrawal by Subject|0|||
124486551|NCT00561353|447734606|FG007|Overall Study|Withdrawal by Subject|0|||
124486552|NCT00561353|447734607|FG008|Overall Study|Withdrawal by Subject|0|||
124486553|NCT00561353|447734608|FG009|Overall Study|Withdrawal by Subject|0|||
124486554|NCT01273818|447734609|FG000|Overall Study|Physician Decision|13|||
124486555|NCT01273818|447734610|FG001|Overall Study|Physician Decision|2|||
124486556|NCT01273818|447734611|FG002|Overall Study|Physician Decision|9|||
124486557|NCT03815175|447734612|FG000|Overall Study|Subject Lost to Follow-up|6|||
124486558|NCT03815175|447734612|FG000|Overall Study|Subject Withdrew Consent|48|||
124486559|NCT03815175|447734612|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
124486560|NCT03815175|447734612|FG000|Overall Study|Death|86|||
124486561|NCT03815175|447734612|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
124486562|NCT03815175|447734612|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
124486563|NCT03815175|447734612|FG000|Overall Study|Other Status Change Reason|1|||
124486564|NCT03815175|447734612|FG000|Overall Study|Missed Visit|12|||
124486565|NCT02493751|447734613|FG000|Overall Study|Withdrawal by Subject|2|||
124486566|NCT02493751|447734614|FG001|Overall Study|Withdrawal by Subject|8|||
124486567|NCT02493751|447734613|FG000|Overall Study|Death|6|||
124486568|NCT02493751|447734614|FG001|Overall Study|Death|13|||
124486569|NCT02493751|447734613|FG000|Overall Study|Lost to Follow-up|2|||
124486570|NCT02493751|447734614|FG001|Overall Study|Lost to Follow-up|3|||
124486571|NCT02493751|447734613|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
124486572|NCT02493751|447734614|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
124486573|NCT03822468|447734615|FG000|Treatment Period|Progressive disease|98|||
124486574|NCT03822468|447734616|FG001|Treatment Period|Progressive disease|94|||
124486575|NCT03822468|447734615|FG000|Treatment Period|Adverse Event|21|||
124486576|NCT03822468|447734616|FG001|Treatment Period|Adverse Event|24|||
124486577|NCT03822468|447734615|FG000|Treatment Period|Withdrawal by Subject|9|||
124486578|NCT03822468|447734616|FG001|Treatment Period|Withdrawal by Subject|5|||
124486579|NCT03822468|447734615|FG000|Treatment Period|Physician Decision|9|||
124486580|NCT03822468|447734616|FG001|Treatment Period|Physician Decision|7|||
124486581|NCT03822468|447734615|FG000|Treatment Period|Protocol Violation|2|||
124486582|NCT03822468|447734616|FG001|Treatment Period|Protocol Violation|1|||
124486583|NCT03822468|447734615|FG000|Treatment Period|Death|2|||
124486584|NCT03822468|447734616|FG001|Treatment Period|Death|3|||
124486585|NCT03822468|447734615|FG000|Treatment Period|Lost to Follow-up|1|||
124486586|NCT03822468|447734616|FG001|Treatment Period|Lost to Follow-up|1|||
124486587|NCT03822468|447734615|FG000|Treatment Period|Sponsor decision|46|||
124486588|NCT03822468|447734616|FG001|Treatment Period|Sponsor decision|53|||
124486589|NCT03822468|447734615|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
124486590|NCT03822468|447734616|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
124486591|NCT03822468|447734615|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
124486592|NCT03822468|447734616|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
124486593|NCT03822468|447734615|FG000|Post-treatment Efficacy Follow-up|Death|1|||
124486594|NCT03822468|447734616|FG001|Post-treatment Efficacy Follow-up|Death|0|||
124486595|NCT03822468|447734615|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
124486596|NCT03822468|447734616|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
124486597|NCT03822468|447734615|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
124486598|NCT03822468|447734616|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124486599|NCT03822468|447734615|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
124486600|NCT03822468|447734616|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124486601|NCT03822468|447734615|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
124486602|NCT03822468|447734616|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
124486603|NCT01084252|447736356|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
124486604|NCT01084252|447736357|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
124721284|NCT00104416|448603594|FG003|Continuation Phase|Pregnancy|1|||
124721285|NCT00104416|448603595|FG004|Continuation Phase|Pregnancy|0|||
124486605|NCT01084252|447736358|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
124486606|NCT01084252|447736359|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
124486607|NCT01084252|447736360|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
124486608|NCT01084252|447736361|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
124486609|NCT01084252|447736362|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
124486610|NCT01084252|447736363|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
124486611|NCT01084252|447736364|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
124486612|NCT01084252|447736365|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
124486613|NCT01084252|447736366|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
124486614|NCT01084252|447736367|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
124486615|NCT01084252|447736368|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
124486616|NCT01084252|447736369|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
124486617|NCT04909463|447736370|FG000|Overall Study|Withdrawal by Subject|0|||
124486618|NCT04909463|447736371|FG001|Overall Study|Withdrawal by Subject|1|||
124486619|NCT04909463|447736372|FG002|Overall Study|Withdrawal by Subject|0|||
124486620|NCT04909463|447736373|FG003|Overall Study|Withdrawal by Subject|0|||
124486621|NCT04909463|447736370|FG000|Overall Study|Lost to Follow-up|2|||
124486622|NCT04909463|447736371|FG001|Overall Study|Lost to Follow-up|1|||
124486623|NCT04909463|447736372|FG002|Overall Study|Lost to Follow-up|1|||
124486624|NCT04909463|447736373|FG003|Overall Study|Lost to Follow-up|0|||
124486625|NCT05635838|447736374|FG000|16-Week DBVC Period|Adverse Event|2|||
124486626|NCT05635838|447736375|FG001|16-Week DBVC Period|Adverse Event|0|||
124486627|NCT05635838|447736376|FG002|16-Week DBVC Period|Adverse Event|0|||
124486628|NCT05635838|447736377|FG003|16-Week DBVC Period|Adverse Event|0|||
124486629|NCT05635838|447736374|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
124486630|NCT05635838|447736375|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
124486631|NCT05635838|447736376|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
124486632|NCT05635838|447736377|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
124486633|NCT05635838|447736374|FG000|16-Week DBVC Period|Physician Decision|0|||
124486634|NCT05635838|447736375|FG001|16-Week DBVC Period|Physician Decision|1|||
124486635|NCT05635838|447736376|FG002|16-Week DBVC Period|Physician Decision|0|||
124486636|NCT05635838|447736377|FG003|16-Week DBVC Period|Physician Decision|0|||
124486637|NCT05635838|447736374|FG000|16-Week DBVC Period|Protocol Violation|1|||
124486638|NCT05635838|447736375|FG001|16-Week DBVC Period|Protocol Violation|0|||
124486639|NCT05635838|447736376|FG002|16-Week DBVC Period|Protocol Violation|0|||
124486640|NCT05635838|447736377|FG003|16-Week DBVC Period|Protocol Violation|0|||
124486641|NCT05635838|447736374|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
124486642|NCT05635838|447736375|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
124486643|NCT05635838|447736376|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
124486644|NCT05635838|447736377|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
124486645|NCT05635838|447736374|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
124486646|NCT05635838|447736375|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
124486647|NCT05635838|447736376|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
124486648|NCT05635838|447736377|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
124486649|NCT05635838|447736374|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
124486650|NCT05635838|447736375|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
124486651|NCT05635838|447736376|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
124486652|NCT05635838|447736377|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
124486653|NCT05635838|447736374|FG000|16-Week OLE Period|Adverse Event|0|||
124486654|NCT05635838|447736375|FG001|16-Week OLE Period|Adverse Event|0|||
124721286|NCT00104416|448603591|FG000|Continuation Phase|Non-compliance|0|||
124721287|NCT00104416|448603592|FG001|Continuation Phase|Non-compliance|0|||
124721288|NCT00104416|448603593|FG002|Continuation Phase|Non-compliance|0|||
124721289|NCT00104416|448603594|FG003|Continuation Phase|Non-compliance|0|||
124721290|NCT00104416|448603595|FG004|Continuation Phase|Non-compliance|1|||
124721291|NCT01309997|448603596|FG000|Overall Study|Adverse Event|1|||
124721292|NCT01309997|448603597|FG001|Overall Study|Adverse Event|0|||
124771953|NCT02141295|448796332|FG001|Overall Study|Non-compliance|1|||
124486655|NCT05635838|447736376|FG002|16-Week OLE Period|Adverse Event|0|||
124486656|NCT05635838|447736377|FG003|16-Week OLE Period|Adverse Event|2|||
124486657|NCT05635838|447736374|FG000|16-Week OLE Period|Lost to Follow-up|0|||
124486658|NCT05635838|447736375|FG001|16-Week OLE Period|Lost to Follow-up|0|||
124486659|NCT05635838|447736376|FG002|16-Week OLE Period|Lost to Follow-up|1|||
124721293|NCT01309997|448603596|FG000|Overall Study|Death|1|||
124721294|NCT01309997|448603597|FG001|Overall Study|Death|3|||
124721295|NCT01309997|448603596|FG000|Overall Study|Lack of Efficacy|2|||
124721296|NCT01309997|448603597|FG001|Overall Study|Lack of Efficacy|2|||
124771954|NCT02141295|448796333|FG002|Overall Study|Non-compliance|0|||
124486660|NCT05635838|447736377|FG003|16-Week OLE Period|Lost to Follow-up|3|||
124486661|NCT05635838|447736374|FG000|16-Week OLE Period|Physician Decision|0|||
124486662|NCT05635838|447736375|FG001|16-Week OLE Period|Physician Decision|0|||
124486663|NCT05635838|447736376|FG002|16-Week OLE Period|Physician Decision|0|||
124486664|NCT05635838|447736377|FG003|16-Week OLE Period|Physician Decision|1|||
124486665|NCT05635838|447736374|FG000|16-Week OLE Period|Protocol Violation|0|||
124486666|NCT05635838|447736375|FG001|16-Week OLE Period|Protocol Violation|0|||
124486667|NCT05635838|447736376|FG002|16-Week OLE Period|Protocol Violation|1|||
124486668|NCT05635838|447736377|FG003|16-Week OLE Period|Protocol Violation|1|||
124486669|NCT05635838|447736374|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
124486670|NCT05635838|447736375|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
124486671|NCT05635838|447736376|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
124486672|NCT05635838|447736377|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
124486673|NCT05635838|447736374|FG000|16-Week OLE Period|Pregnancy|0|||
124486674|NCT05635838|447736375|FG001|16-Week OLE Period|Pregnancy|0|||
124486675|NCT05635838|447736376|FG002|16-Week OLE Period|Pregnancy|1|||
124486676|NCT05635838|447736377|FG003|16-Week OLE Period|Pregnancy|0|||
124486677|NCT03518840|447736382|FG000|Overall Study|Lost to Follow-up|6|||
124486678|NCT03199911|447736390|FG000|Overall Study|Lost to Follow-up|5|||
124486679|NCT03199911|447736391|FG001|Overall Study|Lost to Follow-up|5|||
124486680|NCT03199911|447736390|FG000|Overall Study|Did not proceed with surgery|2|||
124486681|NCT03199911|447736391|FG001|Overall Study|Did not proceed with surgery|1|||
124486682|NCT00698516|447736392|FG000|Overall Study|Study Termination|2|||
124486683|NCT00698516|447736392|FG000|Overall Study|Withdrawal by Subject|3|||
124486684|NCT02586207|447736397|FG000|Overall Study|Physician Decision|1|||
124486685|NCT02586207|447736397|FG000|Overall Study|Withdrawal by Subject|1|||
124486686|NCT00345605|447736411|FG000|Arm 1|Adverse Event|0|||
124486687|NCT00345605|447736412|FG001|Arm 1|Adverse Event|1|||
124486688|NCT00345605|447736411|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
124486689|NCT00345605|447736412|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
124486690|NCT01335971|447736413|FG000|Overall Study|Withdrawal by Subject|1|||
124486691|NCT01335971|447736414|FG001|Overall Study|Withdrawal by Subject|0|||
124486692|NCT01335971|447736415|FG002|Overall Study|Withdrawal by Subject|0|||
124486693|NCT01335971|447736413|FG000|Overall Study|Did not complete bronchoscopy|1|||
124486694|NCT01335971|447736414|FG001|Overall Study|Did not complete bronchoscopy|1|||
124486695|NCT01335971|447736415|FG002|Overall Study|Did not complete bronchoscopy|1|||
124486696|NCT00384956|447736416|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
124486697|NCT00917384|447736417|FG000|Overall Study|Lost to Follow-up|4|||
124486698|NCT00917384|447736418|FG001|Overall Study|Lost to Follow-up|2|||
124486699|NCT00917384|447736417|FG000|Overall Study|Withdrawal by Subject|10|||
124486700|NCT00917384|447736418|FG001|Overall Study|Withdrawal by Subject|2|||
124486701|NCT00149214|447736419|FG000|Overall Study|Adverse Event|12|||
124486702|NCT00149214|447736420|FG001|Overall Study|Adverse Event|9|||
124486703|NCT00149214|447736419|FG000|Overall Study|Withdrawal by Subject|4|||
124486704|NCT00149214|447736420|FG001|Overall Study|Withdrawal by Subject|1|||
124486705|NCT00149214|447736419|FG000|Overall Study|Physician Decision|3|||
124486706|NCT00149214|447736420|FG001|Overall Study|Physician Decision|3|||
124486707|NCT00149214|447736419|FG000|Overall Study|Sponsor Decision|0|||
124486708|NCT00149214|447736420|FG001|Overall Study|Sponsor Decision|1|||
124486709|NCT00149214|447736419|FG000|Overall Study|Progressive Disease|7|||
124486710|NCT00149214|447736420|FG001|Overall Study|Progressive Disease|3|||
124486711|NCT00900796|447736425|FG000|Phase 1|Lacked sufficient information|4|||
124486712|NCT00900796|447736425|FG000|Phase 1|Missing information at Week 16|7|||
124486713|NCT00900796|447736425|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
124486714|NCT00900796|447736425|FG000|Phase 2|Lost to Follow-up|5|||
124486715|NCT01859403|447736426|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
124486716|NCT01859403|447736427|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
124486717|NCT01859403|447736426|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
124486718|NCT01859403|447736427|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
124486719|NCT01859403|447736426|FG000|Primary Endpoint Measure|Physician Decision|0|||
124486720|NCT01859403|447736427|FG001|Primary Endpoint Measure|Physician Decision|1|||
124486721|NCT01859403|447736426|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
124771955|NCT02141295|448796331|FG000|Overall Study|Progressive disease|3|||
124486722|NCT01859403|447736427|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
124557735|NCT04444752|447999180|FG002|Overall Study|Death|1|||
124557736|NCT04444752|447999181|FG003|Overall Study|Death|0|||
124557737|NCT02270983|448001311|FG000|Overall Study|Adverse Event|3|||
124557738|NCT02270983|448001312|FG001|Overall Study|Adverse Event|2|||
124557739|NCT02270983|448001313|FG002|Overall Study|Adverse Event|6|||
124771956|NCT02141295|448796332|FG001|Overall Study|Progressive disease|32|||
124771957|NCT02141295|448796333|FG002|Overall Study|Progressive disease|50|||
124486723|NCT03185130|447736432|FG000|Overall Study|Withdrawal by Subject|0|||
124486724|NCT03185130|447736433|FG001|Overall Study|Withdrawal by Subject|2|||
124486725|NCT02750410|447736434|FG000|Double-Blind Treatment Period|Adverse Event|2|||
124486726|NCT02750410|447736435|FG001|Double-Blind Treatment Period|Adverse Event|2|||
124486727|NCT02750410|447736434|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124557740|NCT02270983|448001311|FG000|Overall Study|Lack of Efficacy|2|||
124557741|NCT02270983|448001312|FG001|Overall Study|Lack of Efficacy|1|||
124557742|NCT02270983|448001313|FG002|Overall Study|Lack of Efficacy|1|||
124557743|NCT02270983|448001311|FG000|Overall Study|Withdrawal by Subject|1|||
124557744|NCT02270983|448001312|FG001|Overall Study|Withdrawal by Subject|0|||
124486728|NCT02750410|447736435|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
124486729|NCT02750410|447736434|FG000|Open-Label Extension Period|Adverse Event|5|||
124486730|NCT02750410|447736435|FG001|Open-Label Extension Period|Adverse Event|3|||
124486731|NCT02750410|447736434|FG000|Open-Label Extension Period|Protocol Violation|0|||
124486732|NCT02750410|447736435|FG001|Open-Label Extension Period|Protocol Violation|1|||
124486733|NCT02750410|447736434|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
124486734|NCT02750410|447736435|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
124486735|NCT03215277|447736437|FG000|Overall Study|Adverse Event|2|||
124486736|NCT03215277|447736438|FG001|Overall Study|Adverse Event|3|||
124486737|NCT03215277|447736437|FG000|Overall Study|Death|1|||
124486738|NCT03215277|447736438|FG001|Overall Study|Death|0|||
124486739|NCT03215277|447736437|FG000|Overall Study|Lost to Follow-up|0|||
124486740|NCT03215277|447736438|FG001|Overall Study|Lost to Follow-up|1|||
124486741|NCT03215277|447736437|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
124486742|NCT03215277|447736438|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
124486743|NCT02580058|447736439|FG000|Overall Study|Adverse Event|16|||
124486744|NCT02580058|447736440|FG001|Overall Study|Adverse Event|30|||
124486745|NCT02580058|447736441|FG002|Overall Study|Adverse Event|20|||
124486746|NCT02580058|447736439|FG000|Overall Study|Death|4|||
124486747|NCT02580058|447736440|FG001|Overall Study|Death|4|||
124486748|NCT02580058|447736441|FG002|Overall Study|Death|5|||
124486749|NCT02580058|447736439|FG000|Overall Study|Physician Decision|1|||
124486750|NCT02580058|447736440|FG001|Overall Study|Physician Decision|3|||
124486751|NCT02580058|447736441|FG002|Overall Study|Physician Decision|11|||
124486752|NCT02580058|447736439|FG000|Overall Study|Other|5|||
124486753|NCT02580058|447736440|FG001|Overall Study|Other|1|||
124486754|NCT02580058|447736441|FG002|Overall Study|Other|3|||
124486755|NCT02580058|447736439|FG000|Overall Study|Withdrawal by Subject|4|||
124486756|NCT02580058|447736440|FG001|Overall Study|Withdrawal by Subject|7|||
124486757|NCT02580058|447736441|FG002|Overall Study|Withdrawal by Subject|31|||
124486758|NCT02580058|447736439|FG000|Overall Study|Global Deterioration of Health Status|19|||
124486759|NCT02580058|447736440|FG001|Overall Study|Global Deterioration of Health Status|18|||
124486760|NCT02580058|447736441|FG002|Overall Study|Global Deterioration of Health Status|24|||
124486761|NCT02580058|447736439|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
124486762|NCT02580058|447736440|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
124486763|NCT02580058|447736441|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
124486764|NCT02580058|447736439|FG000|Overall Study|Progressive Disease|137|||
124486765|NCT02580058|447736440|FG001|Overall Study|Progressive Disease|125|||
124486766|NCT02580058|447736441|FG002|Overall Study|Progressive Disease|94|||
124486767|NCT02580058|447736439|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124486768|NCT02580058|447736440|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124486769|NCT02580058|447736441|FG002|Overall Study|Non-Compliance With Study Drug|0|||
124486770|NCT02388776|447736443|FG000|Overall Study|Death|1|||
124486771|NCT02388776|447736443|FG000|Overall Study|Lost to Follow-up|1|||
124486772|NCT00542828|447736444|FG000|Overall Study|Physician Decision|1|||
124486773|NCT00542828|447736444|FG000|Overall Study|Need for Prohibited Treatment|3|||
124486774|NCT00542828|447736444|FG000|Overall Study|Study Prematurely Discontinued|7|||
124486775|NCT00542828|447736444|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
124486776|NCT04246047|447736449|FG000|Overall Study|Death|50|||
124486777|NCT04246047|447736450|FG001|Overall Study|Death|77|||
124486778|NCT04246047|447736449|FG000|Overall Study|Lost to Follow-up|1|||
124486779|NCT04246047|447736450|FG001|Overall Study|Lost to Follow-up|3|||
124486780|NCT04246047|447736449|FG000|Overall Study|Physician Decision|4|||
124486781|NCT04246047|447736450|FG001|Overall Study|Physician Decision|10|||
124486782|NCT04246047|447736449|FG000|Overall Study|Withdrawal by Subject|19|||
124486783|NCT04246047|447736450|FG001|Overall Study|Withdrawal by Subject|26|||
124486784|NCT04246047|447736449|FG000|Overall Study|Ongoing|169|||
124486785|NCT04246047|447736450|FG001|Overall Study|Ongoing|135|||
124486786|NCT05139030|447736454|FG000|Overall Study|Withdrawal by Subject|1|||
124486787|NCT05139030|447736455|FG001|Overall Study|Withdrawal by Subject|3|||
124486788|NCT05139030|447736454|FG000|Overall Study|Adverse Event|0|||
124486789|NCT05139030|447736455|FG001|Overall Study|Adverse Event|1|||
124486790|NCT05139030|447736454|FG000|Overall Study|Failure to meet continuation criteria|0|||
124486791|NCT05139030|447736455|FG001|Overall Study|Failure to meet continuation criteria|1|||
124486792|NCT01982630|447736456|FG000|Overall Study|Adverse Event|2|||
124486793|NCT01982630|447736457|FG001|Overall Study|Adverse Event|0|||
124486794|NCT01982630|447736458|FG002|Overall Study|Adverse Event|1|||
124486795|NCT01982630|447736459|FG003|Overall Study|Adverse Event|0|||
124486796|NCT01982630|447736460|FG004|Overall Study|Adverse Event|1|||
124486797|NCT01982630|447736461|FG005|Overall Study|Adverse Event|2|||
124486798|NCT01982630|447736462|FG006|Overall Study|Adverse Event|1|||
124486799|NCT01982630|447736463|FG007|Overall Study|Adverse Event|0|||
124721297|NCT01309997|448603596|FG000|Overall Study|Withdrawal by Subject|1|||
124721298|NCT01309997|448603597|FG001|Overall Study|Withdrawal by Subject|1|||
124721299|NCT03462641|448603598|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
124721300|NCT03462641|448603599|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
124721301|NCT03462641|448603598|FG000|Visit 2|Withdrawal by Subject|0|||
124721302|NCT03462641|448603599|FG001|Visit 2|Withdrawal by Subject|1|||
124721303|NCT00372619|448603600|FG000|Overall Study|Ineligible|0|||
124721304|NCT00372619|448603601|FG001|Overall Study|Ineligible|0|||
124486800|NCT01982630|447736456|FG000|Overall Study|Physician Decision|1|||
124486801|NCT01982630|447736457|FG001|Overall Study|Physician Decision|0|||
124486802|NCT01982630|447736458|FG002|Overall Study|Physician Decision|2|||
124486803|NCT01982630|447736459|FG003|Overall Study|Physician Decision|1|||
124486804|NCT01982630|447736460|FG004|Overall Study|Physician Decision|2|||
124486805|NCT01982630|447736461|FG005|Overall Study|Physician Decision|0|||
124486806|NCT01982630|447736462|FG006|Overall Study|Physician Decision|0|||
124486807|NCT01982630|447736463|FG007|Overall Study|Physician Decision|0|||
124486808|NCT01982630|447736456|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
124486809|NCT01982630|447736457|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
124486810|NCT01982630|447736458|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
124486811|NCT01982630|447736459|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
124486812|NCT01982630|447736460|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
124486813|NCT01982630|447736461|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
124486814|NCT01982630|447736462|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
124486815|NCT01982630|447736463|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
124486816|NCT01982630|447736456|FG000|Overall Study|Withdrawal by Subject|0|||
124486817|NCT01982630|447736457|FG001|Overall Study|Withdrawal by Subject|0|||
124486818|NCT01982630|447736458|FG002|Overall Study|Withdrawal by Subject|0|||
124486819|NCT01982630|447736459|FG003|Overall Study|Withdrawal by Subject|0|||
124486820|NCT01982630|447736460|FG004|Overall Study|Withdrawal by Subject|0|||
124486821|NCT01982630|447736461|FG005|Overall Study|Withdrawal by Subject|1|||
124486822|NCT01982630|447736462|FG006|Overall Study|Withdrawal by Subject|0|||
124486823|NCT01982630|447736463|FG007|Overall Study|Withdrawal by Subject|0|||
124486824|NCT00820040|447736464|FG000|Overall Study|Death|1|||
124486825|NCT00820040|447736464|FG000|Overall Study|Sponsor terminated study|1|||
124486826|NCT00820040|447736464|FG000|Overall Study|Screen failure|1|||
124486827|NCT01259466|447736467|FG000|Overall Study|Withdrawal by Subject|1|||
124486828|NCT01259466|447736468|FG001|Overall Study|Withdrawal by Subject|9|||
124486829|NCT01824602|447736471|FG000|Overall Study|Withdrawal by Subject|0|||
124486830|NCT01824602|447736472|FG001|Overall Study|Withdrawal by Subject|0|||
124486831|NCT01824602|447736473|FG002|Overall Study|Withdrawal by Subject|1|||
124486832|NCT01824602|447736474|FG003|Overall Study|Withdrawal by Subject|2|||
124486833|NCT01824602|447736471|FG000|Overall Study|Patient non-compliance|0|||
124486834|NCT01824602|447736472|FG001|Overall Study|Patient non-compliance|0|||
124721305|NCT00372619|448603602|FG002|Overall Study|Ineligible|0|||
124721306|NCT00372619|448603603|FG003|Overall Study|Ineligible|0|||
124721307|NCT00372619|448603604|FG004|Overall Study|Ineligible|0|||
124486835|NCT01824602|447736473|FG002|Overall Study|Patient non-compliance|1|||
124486836|NCT01824602|447736474|FG003|Overall Study|Patient non-compliance|0|||
124486837|NCT01824602|447736471|FG000|Overall Study|Adverse Event|1|||
124486838|NCT01824602|447736472|FG001|Overall Study|Adverse Event|0|||
124486839|NCT01824602|447736473|FG002|Overall Study|Adverse Event|2|||
124486840|NCT01824602|447736474|FG003|Overall Study|Adverse Event|2|||
124486841|NCT01824602|447736471|FG000|Overall Study|Treatment failure|0|||
124486842|NCT01824602|447736472|FG001|Overall Study|Treatment failure|0|||
124486843|NCT01824602|447736473|FG002|Overall Study|Treatment failure|0|||
124486844|NCT01824602|447736474|FG003|Overall Study|Treatment failure|1|||
124486845|NCT02485717|447736477|FG000|Overall Study|Lost to Follow-up|6|||
124486846|NCT02485717|447736478|FG001|Overall Study|Lost to Follow-up|0|||
124486847|NCT02485717|447736479|FG002|Overall Study|Lost to Follow-up|0|||
124486848|NCT02485717|447736477|FG000|Overall Study|Withdrawal by Subject|0|||
124486849|NCT02485717|447736478|FG001|Overall Study|Withdrawal by Subject|0|||
124486850|NCT02485717|447736479|FG002|Overall Study|Withdrawal by Subject|1|||
124721308|NCT00372619|448603605|FG005|Overall Study|Ineligible|2|||
124721309|NCT00372619|448603606|FG006|Overall Study|Ineligible|0|||
124721310|NCT00372619|448603600|FG000|Overall Study|Inevaluable|0|||
124486851|NCT02485717|447736477|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
124486852|NCT02485717|447736478|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
124721311|NCT00372619|448603601|FG001|Overall Study|Inevaluable|0|||
124721312|NCT00372619|448603602|FG002|Overall Study|Inevaluable|0|||
124721313|NCT00372619|448603603|FG003|Overall Study|Inevaluable|0|||
124721314|NCT00372619|448603604|FG004|Overall Study|Inevaluable|0|||
124721315|NCT00372619|448603605|FG005|Overall Study|Inevaluable|1|||
124486853|NCT02485717|447736479|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
124486854|NCT02485717|447736477|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
124486855|NCT02485717|447736478|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
124486856|NCT02485717|447736479|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
124486857|NCT05300087|447736482|FG000|Overall Study|Withdrawal by Subject|0|||
124721316|NCT00372619|448603606|FG006|Overall Study|Inevaluable|0|||
124486858|NCT05300087|447736483|FG001|Overall Study|Withdrawal by Subject|1|||
124486859|NCT05121103|447736484|FG000|Overall Study|Progressive disease|2|||
124486860|NCT05121103|447736485|FG001|Overall Study|Progressive disease|1|||
124486861|NCT05121103|447736486|FG002|Overall Study|Progressive disease|6|||
124486862|NCT05121103|447736484|FG000|Overall Study|Physician Decision|2|||
124486863|NCT05121103|447736485|FG001|Overall Study|Physician Decision|1|||
124486864|NCT05121103|447736486|FG002|Overall Study|Physician Decision|0|||
124486865|NCT05121103|447736484|FG000|Overall Study|Withdrawal by Subject|0|||
124486866|NCT05121103|447736485|FG001|Overall Study|Withdrawal by Subject|1|||
124486867|NCT05121103|447736486|FG002|Overall Study|Withdrawal by Subject|0|||
124486868|NCT03248128|447736487|FG000|Overall Study|Lost to Follow-up|1|||
124486869|NCT03248128|447736488|FG001|Overall Study|Lost to Follow-up|0|||
124486870|NCT03248128|447736487|FG000|Overall Study|Withdrawal by Subject|16|||
124486871|NCT03248128|447736488|FG001|Overall Study|Withdrawal by Subject|14|||
124486872|NCT03248128|447736487|FG000|Overall Study|Site Closed|4|||
124486873|NCT03248128|447736488|FG001|Overall Study|Site Closed|3|||
124486874|NCT03248128|447736487|FG000|Overall Study|Randomized, but did not receive treatment|1|||
124486875|NCT03248128|447736488|FG001|Overall Study|Randomized, but did not receive treatment|3|||
124486876|NCT01914679|447736489|FG000|Overall Study|Lack of Efficacy|1|||
124486877|NCT01914679|447736489|FG000|Overall Study|Sponsor terminated study|4|||
124486878|NCT03885284|447736491|FG000|Overall Study|Disease Progression|1|||
124486879|NCT03885284|447736492|FG001|Overall Study|Disease Progression|3|||
124486880|NCT03885284|447736491|FG000|Overall Study|Physician Decision|0|||
124486881|NCT03885284|447736492|FG001|Overall Study|Physician Decision|1|||
124486882|NCT00002850|447736495|FG000|Overall Study|Death|4|||
124486883|NCT00002850|447736496|FG001|Overall Study|Death|1|||
124486884|NCT00002850|447736497|FG002|Overall Study|Death|3|||
124721317|NCT00338286|448603607|FG000|Overall Study|Withdrawal by Subject|50|||
124721318|NCT00338286|448603608|FG001|Overall Study|Withdrawal by Subject|54|||
124721319|NCT00338286|448603607|FG000|Overall Study|Lost to Follow-up|80|||
124721320|NCT00338286|448603608|FG001|Overall Study|Lost to Follow-up|66|||
124721321|NCT00338286|448603607|FG000|Overall Study|Other|103|||
124721322|NCT00338286|448603608|FG001|Overall Study|Other|93|||
124721323|NCT03748706|448603613|FG000|Overall Study|Lost to Follow-up|1|||
124721324|NCT03517371|448603616|FG000|Overall Study|Adverse Event|8|||
124721325|NCT03517371|448603617|FG001|Overall Study|Adverse Event|9|||
124721326|NCT03517371|448603616|FG000|Overall Study|Lost to Follow-up|1|||
124721327|NCT03517371|448603617|FG001|Overall Study|Lost to Follow-up|2|||
124721328|NCT03517371|448603616|FG000|Overall Study|Withdrawal by Subject|4|||
124721329|NCT03517371|448603617|FG001|Overall Study|Withdrawal by Subject|4|||
124721330|NCT03517371|448603616|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
124721331|NCT03517371|448603617|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
124721332|NCT03517371|448603616|FG000|Overall Study|COVID restrictions|2|||
124721333|NCT03517371|448603617|FG001|Overall Study|COVID restrictions|0|||
124721334|NCT03517371|448603616|FG000|Overall Study|Receiving DBS Surgery|0|||
124721335|NCT03517371|448603617|FG001|Overall Study|Receiving DBS Surgery|1|||
124721336|NCT05420961|448603618|FG000|Overall Study|Withdrawal by Subject|2|||
124721337|NCT05420961|448603619|FG001|Overall Study|Withdrawal by Subject|1|||
124721338|NCT05420961|448603620|FG002|Overall Study|Withdrawal by Subject|1|||
124721339|NCT05420961|448603621|FG003|Overall Study|Withdrawal by Subject|0|||
124721340|NCT05420961|448603622|FG004|Overall Study|Withdrawal by Subject|0|||
124721341|NCT05420961|448603618|FG000|Overall Study|Lost to Follow-up|0|||
124721342|NCT05420961|448603619|FG001|Overall Study|Lost to Follow-up|0|||
124721343|NCT05420961|448603620|FG002|Overall Study|Lost to Follow-up|1|||
124721344|NCT05420961|448603621|FG003|Overall Study|Lost to Follow-up|0|||
124721345|NCT05420961|448603622|FG004|Overall Study|Lost to Follow-up|0|||
124721346|NCT05420961|448603618|FG000|Overall Study|Randomized by mistake without study treatment|0|||
124486885|NCT00002850|447736495|FG000|Overall Study|Protocol Violation|1|||
124486886|NCT00002850|447736496|FG001|Overall Study|Protocol Violation|0|||
124486887|NCT00002850|447736497|FG002|Overall Study|Protocol Violation|1|||
124486888|NCT00002850|447736495|FG000|Overall Study|Withdrawal by Subject|0|||
124721347|NCT05420961|448603619|FG001|Overall Study|Randomized by mistake without study treatment|0|||
124486889|NCT00002850|447736496|FG001|Overall Study|Withdrawal by Subject|1|||
124486890|NCT00002850|447736497|FG002|Overall Study|Withdrawal by Subject|0|||
124486891|NCT02234622|447736500|FG000|Overall Study|Withdrawal by Subject|16|||
124721348|NCT05420961|448603620|FG002|Overall Study|Randomized by mistake without study treatment|1|||
124721349|NCT05420961|448603621|FG003|Overall Study|Randomized by mistake without study treatment|0|||
124721350|NCT05420961|448603622|FG004|Overall Study|Randomized by mistake without study treatment|1|||
124486892|NCT02234622|447736501|FG001|Overall Study|Withdrawal by Subject|22|||
124721351|NCT04283656|448603623|FG000|Overall Study|Adverse Event|1|||
124486893|NCT02234622|447736500|FG000|Overall Study|Lost to Follow-up|27|||
124486894|NCT02234622|447736501|FG001|Overall Study|Lost to Follow-up|14|||
124486895|NCT04090164|447736505|FG000|Overall Study|incomplete data on file|245|||
124486896|NCT04090164|447736506|FG001|Overall Study|incomplete data on file|0|||
124486897|NCT01650805|447736507|FG000|Overall Study|Withdrawal by Subject|1|||
124486898|NCT01650805|447736508|FG001|Overall Study|Withdrawal by Subject|0|||
124486899|NCT02452359|447736509|FG000|Overall Study|Adverse Event|1|||
124486900|NCT02452359|447736509|FG000|Overall Study|Lost to Follow-up|15|||
124486901|NCT02452359|447736509|FG000|Overall Study|Pregnancy|1|||
124486902|NCT02452359|447736509|FG000|Overall Study|Withdrawal by Subject|4|||
124486903|NCT01877655|447736510|FG000|Overall Study|Death|57|||
124486904|NCT01877655|447736511|FG001|Overall Study|Death|52|||
124486905|NCT01877655|447736510|FG000|Overall Study|Withdrawal by Subject|18|||
124486906|NCT01877655|447736511|FG001|Overall Study|Withdrawal by Subject|26|||
124486907|NCT01877655|447736510|FG000|Overall Study|Physician Decision|11|||
124721352|NCT04283656|448603624|FG001|Overall Study|Adverse Event|0|||
124721353|NCT04283656|448603623|FG000|Overall Study|Lost to Follow-up|0|||
124721354|NCT04283656|448603624|FG001|Overall Study|Lost to Follow-up|1|||
124721355|NCT04482439|448603629|FG000|Overall Study|Lost to Follow-up|1|||
124721356|NCT04482439|448603629|FG000|Overall Study|Unrelated illness|1|||
124721357|NCT01555073|448603630|FG000|Overall Study|Lost to Follow-up|1|||
124721358|NCT01555073|448603631|FG001|Overall Study|Lost to Follow-up|2|||
124721359|NCT01555073|448603632|FG002|Overall Study|Lost to Follow-up|0|||
124721360|NCT01555073|448603633|FG003|Overall Study|Lost to Follow-up|5|||
124721361|NCT04660552|448603634|FG000|Overall Study|Withdrawal by Subject|3|||
124721362|NCT04660552|448603635|FG001|Overall Study|Withdrawal by Subject|1|||
124721363|NCT03490292|448603636|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
124721364|NCT03490292|448603637|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
124721365|NCT03490292|448603636|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
124721366|NCT03490292|448603637|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
124721367|NCT03490292|448603636|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
124721368|NCT03490292|448603637|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
124721369|NCT03490292|448603636|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
124721370|NCT03490292|448603637|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
124486908|NCT01877655|447736511|FG001|Overall Study|Physician Decision|10|||
124486909|NCT01877655|447736510|FG000|Overall Study|Miscellaneous|4|||
124486910|NCT01877655|447736511|FG001|Overall Study|Miscellaneous|4|||
124486911|NCT01877655|447736510|FG000|Overall Study|Randomized but Never Received Drug|8|||
124486912|NCT01877655|447736511|FG001|Overall Study|Randomized but Never Received Drug|5|||
124486913|NCT03439345|447738221|FG000|Overall Study|Lost to Follow-up|0|||
124486914|NCT03439345|447738222|FG001|Overall Study|Lost to Follow-up|1|||
124486915|NCT03439345|447738221|FG000|Overall Study|Consent withdrawn|0|||
124486916|NCT03439345|447738222|FG001|Overall Study|Consent withdrawn|1|||
124486917|NCT02128490|447738226|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
124486918|NCT02128490|447738227|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
124486919|NCT02128490|447738228|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
124486920|NCT02128490|447738229|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
124486921|NCT02128490|447738230|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
124486922|NCT02128490|447738226|FG000|Overall Study|Major Protocol Deviation|1|||
124486923|NCT02128490|447738227|FG001|Overall Study|Major Protocol Deviation|2|||
124486924|NCT02128490|447738228|FG002|Overall Study|Major Protocol Deviation|0|||
124486925|NCT02128490|447738229|FG003|Overall Study|Major Protocol Deviation|2|||
124486926|NCT02128490|447738230|FG004|Overall Study|Major Protocol Deviation|2|||
124486927|NCT02128490|447738226|FG000|Overall Study|Lost to Follow-up|0|||
124486928|NCT02128490|447738227|FG001|Overall Study|Lost to Follow-up|0|||
124486929|NCT02128490|447738228|FG002|Overall Study|Lost to Follow-up|1|||
124486930|NCT02128490|447738229|FG003|Overall Study|Lost to Follow-up|1|||
124486931|NCT02128490|447738230|FG004|Overall Study|Lost to Follow-up|1|||
124486932|NCT02128490|447738226|FG000|Overall Study|Voluntary Withdrawal|3|||
124486933|NCT02128490|447738227|FG001|Overall Study|Voluntary Withdrawal|3|||
124486934|NCT02128490|447738228|FG002|Overall Study|Voluntary Withdrawal|1|||
124486935|NCT02128490|447738229|FG003|Overall Study|Voluntary Withdrawal|1|||
124486936|NCT02128490|447738230|FG004|Overall Study|Voluntary Withdrawal|2|||
124486937|NCT02128490|447738226|FG000|Overall Study|Lack of Efficacy|0|||
124486938|NCT02128490|447738227|FG001|Overall Study|Lack of Efficacy|1|||
124486939|NCT02128490|447738228|FG002|Overall Study|Lack of Efficacy|0|||
124486940|NCT02128490|447738229|FG003|Overall Study|Lack of Efficacy|0|||
124486941|NCT02128490|447738230|FG004|Overall Study|Lack of Efficacy|0|||
124486942|NCT02128490|447738226|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
124486943|NCT02128490|447738227|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
124486944|NCT02128490|447738228|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
124486945|NCT02128490|447738229|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
124486946|NCT02128490|447738230|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
124486947|NCT02128490|447738226|FG000|Overall Study|Other Miscellaneous Reasons|0|||
124486948|NCT02128490|447738227|FG001|Overall Study|Other Miscellaneous Reasons|0|||
124486949|NCT02128490|447738228|FG002|Overall Study|Other Miscellaneous Reasons|2|||
124486950|NCT02128490|447738229|FG003|Overall Study|Other Miscellaneous Reasons|1|||
124486951|NCT02128490|447738230|FG004|Overall Study|Other Miscellaneous Reasons|1|||
124486952|NCT02243176|447738231|FG000|Overall Study|Other reason|1|||
124486953|NCT02243176|447738232|FG001|Overall Study|Other reason|2|||
124721371|NCT03490292|448603636|FG000|1 Year Follow Up Post Last Dose|Death|1|||
124721372|NCT03490292|448603637|FG001|1 Year Follow Up Post Last Dose|Death|1|||
124721373|NCT00286091|448603640|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
124486954|NCT02243176|447738231|FG000|Overall Study|protocol specified withdrawal critera|1|||
124486955|NCT02243176|447738232|FG001|Overall Study|protocol specified withdrawal critera|3|||
124486956|NCT02243176|447738231|FG000|Overall Study|Protocol Violation|2|||
124486957|NCT02243176|447738232|FG001|Overall Study|Protocol Violation|1|||
124486958|NCT02243176|447738231|FG000|Overall Study|Withdrawal by Subject|8|||
124486959|NCT02243176|447738232|FG001|Overall Study|Withdrawal by Subject|7|||
124486960|NCT02243176|447738231|FG000|Overall Study|Adverse Event|2|||
124486961|NCT02243176|447738232|FG001|Overall Study|Adverse Event|2|||
124721374|NCT00286091|448603641|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
124721375|NCT00286091|448603640|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
124721376|NCT00286091|448603641|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
124721377|NCT00286091|448603640|FG000|Double-blind Treatment Phase|Death|58|||
124721378|NCT00286091|448603641|FG001|Double-blind Treatment Phase|Death|65|||
124721379|NCT00286091|448603640|FG000|Double-blind Treatment Phase|Adverse Event|28|||
124721380|NCT00286091|448603641|FG001|Double-blind Treatment Phase|Adverse Event|40|||
124721381|NCT00286091|448603640|FG000|Double-blind Treatment Phase|Disease Progression|22|||
124721382|NCT00286091|448603641|FG001|Double-blind Treatment Phase|Disease Progression|35|||
124721383|NCT00286091|448603640|FG000|Double-blind Treatment Phase|Other|25|||
124721384|NCT00286091|448603641|FG001|Double-blind Treatment Phase|Other|33|||
124486962|NCT00875420|447738234|FG000|Overall Study|Adverse Event|0|||
124486963|NCT00875420|447738235|FG001|Overall Study|Adverse Event|1|||
124486964|NCT00875420|447738236|FG002|Overall Study|Adverse Event|1|||
124486965|NCT00875420|447738237|FG003|Overall Study|Adverse Event|0|||
124486966|NCT00875420|447738238|FG004|Overall Study|Adverse Event|0|||
124486967|NCT00875420|447738234|FG000|Overall Study|Inability to complete study procedures|1|||
124486968|NCT00875420|447738235|FG001|Overall Study|Inability to complete study procedures|0|||
124486969|NCT00875420|447738236|FG002|Overall Study|Inability to complete study procedures|1|||
124721385|NCT00286091|448603640|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
124721386|NCT00286091|448603641|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
124721387|NCT00286091|448603640|FG000|Double-blind Treatment Phase|Noncompliance|8|||
124721388|NCT00286091|448603641|FG001|Double-blind Treatment Phase|Noncompliance|8|||
124721389|NCT00286091|448603640|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
124721390|NCT00286091|448603641|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
124721391|NCT00286091|448603640|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
124721392|NCT00286091|448603641|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
124721393|NCT00286091|448603640|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
124721394|NCT00286091|448603641|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
124721395|NCT00286091|448603640|FG000|Open-label Treatment Phase|Physician Decision|24|||
124721396|NCT00286091|448603641|FG001|Open-label Treatment Phase|Physician Decision|21|||
124721397|NCT00286091|448603640|FG000|Open-label Treatment Phase|Adverse Event|5|||
124721398|NCT00286091|448603641|FG001|Open-label Treatment Phase|Adverse Event|16|||
124721399|NCT00286091|448603640|FG000|Open-label Treatment Phase|Other|11|||
124721400|NCT00286091|448603641|FG001|Open-label Treatment Phase|Other|11|||
124721401|NCT00286091|448603640|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
124721402|NCT00286091|448603641|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
124721403|NCT00286091|448603640|FG000|Open-label Treatment Phase|Death|10|||
124721404|NCT00286091|448603641|FG001|Open-label Treatment Phase|Death|7|||
124721405|NCT00286091|448603640|FG000|Open-label Treatment Phase|Disease Progression|9|||
124721406|NCT00286091|448603641|FG001|Open-label Treatment Phase|Disease Progression|3|||
124721407|NCT00286091|448603640|FG000|Open-label Treatment Phase|Noncompliance|3|||
124721408|NCT00286091|448603641|FG001|Open-label Treatment Phase|Noncompliance|1|||
124721409|NCT00286091|448603640|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
124721410|NCT00286091|448603641|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
124486970|NCT00875420|447738237|FG003|Overall Study|Inability to complete study procedures|1|||
124486971|NCT00875420|447738238|FG004|Overall Study|Inability to complete study procedures|1|||
124486972|NCT00875420|447738234|FG000|Overall Study|Lost to Follow-up|1|||
124486973|NCT00875420|447738235|FG001|Overall Study|Lost to Follow-up|0|||
124486974|NCT00875420|447738236|FG002|Overall Study|Lost to Follow-up|0|||
124486975|NCT00875420|447738237|FG003|Overall Study|Lost to Follow-up|0|||
124486976|NCT00875420|447738238|FG004|Overall Study|Lost to Follow-up|0|||
124486977|NCT00875420|447738234|FG000|Overall Study|Personal reason|0|||
124721411|NCT00286091|448603640|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
124721412|NCT00286091|448603641|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
124721413|NCT00286091|448603640|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
124721414|NCT00286091|448603641|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
124721415|NCT02036580|448603642|FG000|Overall Study|Withdrawal by Subject|0|||
124721416|NCT02036580|448603643|FG001|Overall Study|Withdrawal by Subject|1|||
124721417|NCT02036580|448603644|FG002|Overall Study|Withdrawal by Subject|0|||
124486978|NCT00875420|447738235|FG001|Overall Study|Personal reason|0|||
124486979|NCT00875420|447738236|FG002|Overall Study|Personal reason|0|||
124486980|NCT00875420|447738237|FG003|Overall Study|Personal reason|0|||
124486981|NCT00875420|447738238|FG004|Overall Study|Personal reason|1|||
124486982|NCT00875420|447738234|FG000|Overall Study|Prohibited medication|0|||
124486983|NCT00875420|447738235|FG001|Overall Study|Prohibited medication|0|||
124486984|NCT00875420|447738236|FG002|Overall Study|Prohibited medication|0|||
124486985|NCT00875420|447738237|FG003|Overall Study|Prohibited medication|1|||
124486986|NCT00875420|447738238|FG004|Overall Study|Prohibited medication|0|||
124486987|NCT00875420|447738234|FG000|Overall Study|Sponsor decision|0|||
124486988|NCT00875420|447738235|FG001|Overall Study|Sponsor decision|1|||
124486989|NCT00875420|447738236|FG002|Overall Study|Sponsor decision|0|||
124486990|NCT00875420|447738237|FG003|Overall Study|Sponsor decision|0|||
124486991|NCT00875420|447738238|FG004|Overall Study|Sponsor decision|0|||
124486992|NCT00875420|447738234|FG000|Overall Study|Withdrawal by Subject|0|||
124486993|NCT00875420|447738235|FG001|Overall Study|Withdrawal by Subject|0|||
124486994|NCT00875420|447738236|FG002|Overall Study|Withdrawal by Subject|1|||
124486995|NCT00875420|447738237|FG003|Overall Study|Withdrawal by Subject|0|||
124486996|NCT00875420|447738238|FG004|Overall Study|Withdrawal by Subject|0|||
124486997|NCT00001259|447738239|FG000|Study 2|Adverse Event|0|||
124486998|NCT00001259|447738240|FG001|Study 2|Adverse Event|0|||
124486999|NCT00001259|447738241|FG002|Study 2|Adverse Event|0|||
124487000|NCT00001259|447738242|FG003|Study 2|Adverse Event|0|||
124487001|NCT00001259|447738243|FG004|Study 2|Adverse Event|2|||
124487002|NCT00001259|447738244|FG005|Study 2|Adverse Event|0|||
124487003|NCT00001259|447738245|FG006|Study 2|Adverse Event|0|||
124487004|NCT03705494|447738246|FG000|Overall Study|Lost to Follow-up|2|||
124487005|NCT03705494|447738247|FG001|Overall Study|Lost to Follow-up|1|||
124487006|NCT03705494|447738246|FG000|Overall Study|Withdrawal by Subject|5|||
124487007|NCT03705494|447738247|FG001|Overall Study|Withdrawal by Subject|2|||
124487008|NCT03704051|447738248|FG000|Overall Study|Withdrawal by Subject|4|||
124487009|NCT03704051|447738249|FG001|Overall Study|Withdrawal by Subject|0|||
124487010|NCT02629393|447738250|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
124487011|NCT02629393|447738250|FG000|Overall Study|Physician Decision|1|||
124487012|NCT03716726|447738252|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
124487013|NCT03716726|447738253|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
124487014|NCT03716726|447738252|FG000|12 Months Followup|Lost to Follow-up|10|||
124487015|NCT03716726|447738253|FG001|12 Months Followup|Lost to Follow-up|17|||
124487016|NCT01416181|447738254|FG000|Part 1|Other|10|||
124487017|NCT01416181|447738255|FG001|Part 1|Other|24|||
124487018|NCT01416181|447738254|FG000|Part 1|Death|0|||
124487019|NCT01416181|447738255|FG001|Part 1|Death|1|||
124487020|NCT01416181|447738254|FG000|Part 1|Investigator Decision|7|||
124487021|NCT01416181|447738255|FG001|Part 1|Investigator Decision|6|||
124487022|NCT01416181|447738254|FG000|Part 1|Withdrawal by Subject|74|||
124487023|NCT01416181|447738255|FG001|Part 1|Withdrawal by Subject|48|||
124487024|NCT01416181|447738254|FG000|Part 1|Lack of Efficacy|16|||
124487025|NCT01416181|447738255|FG001|Part 1|Lack of Efficacy|8|||
124487026|NCT01416181|447738254|FG000|Part 1|Lost to Follow-up|1|||
124487027|NCT01416181|447738255|FG001|Part 1|Lost to Follow-up|1|||
124487028|NCT01416181|447738254|FG000|Part 1|Adverse Event|15|||
124487029|NCT01416181|447738255|FG001|Part 1|Adverse Event|18|||
124487030|NCT01416181|447738254|FG000|Part 1|Ongoing in Follow-Up|14|||
124487031|NCT01416181|447738255|FG001|Part 1|Ongoing in Follow-Up|8|||
124487032|NCT01416181|447738254|FG000|Part 2|Adverse Event|11|||
124487033|NCT01416181|447738255|FG001|Part 2|Adverse Event|4|||
124487034|NCT01416181|447738254|FG000|Part 2|Other|234|||
124487035|NCT01416181|447738255|FG001|Part 2|Other|267|||
124487036|NCT01416181|447738254|FG000|Part 2|Investigator Decision|6|||
124487037|NCT01416181|447738255|FG001|Part 2|Investigator Decision|7|||
124487038|NCT01416181|447738254|FG000|Part 2|Withdrawal by Subject|14|||
124487039|NCT01416181|447738255|FG001|Part 2|Withdrawal by Subject|5|||
124487040|NCT01416181|447738254|FG000|Part 2|Lack of Efficacy|4|||
124487041|NCT01416181|447738255|FG001|Part 2|Lack of Efficacy|1|||
124487042|NCT01416181|447738254|FG000|Part 2|Lost to Follow-up|2|||
124487043|NCT01416181|447738255|FG001|Part 2|Lost to Follow-up|2|||
124487044|NCT01981187|447738258|FG000|Overall Study|Participant/guardian decision|2|||
124487045|NCT01981187|447738258|FG000|Overall Study|Physician Decision|1|||
124487046|NCT01981187|447738258|FG000|Overall Study|Disease progression|2|||
124487047|NCT01981187|447738258|FG000|Overall Study|Adverse Event|7|||
124487048|NCT01943539|447738262|FG000|Overall Study|Non-compliance with at-home intervention|4|||
124487049|NCT01943539|447738263|FG001|Overall Study|Non-compliance with at-home intervention|0|||
124487050|NCT02333331|447738264|FG000|Overall Study|Adverse Event|1|||
124487051|NCT02333331|447738265|FG001|Overall Study|Adverse Event|0|||
124487052|NCT02333331|447738266|FG002|Overall Study|Adverse Event|4|||
124487053|NCT02333331|447738267|FG003|Overall Study|Adverse Event|1|||
124487054|NCT02333331|447738264|FG000|Overall Study|Death|0|||
124487055|NCT02333331|447738265|FG001|Overall Study|Death|0|||
124487056|NCT02333331|447738266|FG002|Overall Study|Death|2|||
124487057|NCT02333331|447738267|FG003|Overall Study|Death|0|||
124487058|NCT02333331|447738264|FG000|Overall Study|Lost to Follow-up|0|||
124487059|NCT02333331|447738265|FG001|Overall Study|Lost to Follow-up|0|||
124487060|NCT02333331|447738266|FG002|Overall Study|Lost to Follow-up|1|||
124487061|NCT02333331|447738267|FG003|Overall Study|Lost to Follow-up|0|||
124487062|NCT02333331|447738264|FG000|Overall Study|Physician Decision|0|||
124487063|NCT02333331|447738265|FG001|Overall Study|Physician Decision|1|||
124487064|NCT02333331|447738266|FG002|Overall Study|Physician Decision|0|||
124487065|NCT02333331|447738267|FG003|Overall Study|Physician Decision|0|||
124487066|NCT02333331|447738264|FG000|Overall Study|Protocol Deviation|0|||
124487067|NCT02333331|447738265|FG001|Overall Study|Protocol Deviation|3|||
124487068|NCT02333331|447738266|FG002|Overall Study|Protocol Deviation|2|||
124487069|NCT02333331|447738267|FG003|Overall Study|Protocol Deviation|1|||
124487070|NCT02333331|447738264|FG000|Overall Study|Patient/Guardian Decision|1|||
124487071|NCT02333331|447738265|FG001|Overall Study|Patient/Guardian Decision|2|||
124487072|NCT02333331|447738266|FG002|Overall Study|Patient/Guardian Decision|9|||
124487073|NCT02333331|447738267|FG003|Overall Study|Patient/Guardian Decision|1|||
124487074|NCT05309668|447738268|FG000|Overall Study|Ongoing at data cut-off|14|||
124487075|NCT05309668|447738269|FG001|Overall Study|Ongoing at data cut-off|17|||
124487076|NCT05309668|447738270|FG002|Overall Study|Ongoing at data cut-off|4|||
124487077|NCT03180736|447738275|FG000|Overall Study|Adverse Event|3|||
124487078|NCT03180736|447738276|FG001|Overall Study|Adverse Event|4|||
124487079|NCT03180736|447738275|FG000|Overall Study|Death|10|||
124487080|NCT03180736|447738276|FG001|Overall Study|Death|7|||
124487081|NCT03180736|447738275|FG000|Overall Study|Withdrawal by Subject|5|||
124487082|NCT03180736|447738276|FG001|Overall Study|Withdrawal by Subject|12|||
124487083|NCT03180736|447738275|FG000|Overall Study|Lost to Follow-up|1|||
124487084|NCT03180736|447738276|FG001|Overall Study|Lost to Follow-up|0|||
124487085|NCT03180736|447738275|FG000|Overall Study|Lack of Efficacy|66|||
124487086|NCT03180736|447738276|FG001|Overall Study|Lack of Efficacy|87|||
124487087|NCT03180736|447738275|FG000|Overall Study|Physician Decision|4|||
124487088|NCT03180736|447738276|FG001|Overall Study|Physician Decision|7|||
124487089|NCT03180736|447738275|FG000|Overall Study|randomized but not treated|2|||
124487090|NCT03180736|447738276|FG001|Overall Study|randomized but not treated|3|||
124487091|NCT01451515|447738281|FG000|Overall Study|Death|0|||
124487092|NCT01451515|447738282|FG001|Overall Study|Death|1|||
124487093|NCT01451515|447738283|FG002|Overall Study|Death|0|||
124487094|NCT01451515|447738281|FG000|Overall Study|Withdrawal by Subject|0|||
124487095|NCT01451515|447738282|FG001|Overall Study|Withdrawal by Subject|1|||
124487096|NCT01451515|447738283|FG002|Overall Study|Withdrawal by Subject|0|||
124487097|NCT01451515|447738281|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
124487098|NCT01451515|447738282|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
124487099|NCT01451515|447738283|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
124487100|NCT01451515|447738281|FG000|Overall Study|Relapse (except CNS)|1|||
124487101|NCT01451515|447738282|FG001|Overall Study|Relapse (except CNS)|1|||
124487102|NCT01451515|447738283|FG002|Overall Study|Relapse (except CNS)|0|||
124487103|NCT00174941|447738284|FG000|Overall Study|Adverse Event|1|||
124487104|NCT00174941|447738285|FG001|Overall Study|Adverse Event|10|||
124487105|NCT00174941|447738286|FG002|Overall Study|Adverse Event|2|||
124487106|NCT00174941|447738287|FG003|Overall Study|Adverse Event|13|||
124487107|NCT00174941|447738284|FG000|Overall Study|Protocol Violation|0|||
124487108|NCT00174941|447738285|FG001|Overall Study|Protocol Violation|1|||
124487109|NCT00174941|447738286|FG002|Overall Study|Protocol Violation|0|||
124487110|NCT00174941|447738287|FG003|Overall Study|Protocol Violation|1|||
124487111|NCT00174941|447738284|FG000|Overall Study|Lost to Follow-up|0|||
124487112|NCT00174941|447738285|FG001|Overall Study|Lost to Follow-up|3|||
124487113|NCT00174941|447738286|FG002|Overall Study|Lost to Follow-up|2|||
124487114|NCT00174941|447738287|FG003|Overall Study|Lost to Follow-up|5|||
124487115|NCT00174941|447738284|FG000|Overall Study|Personal Reason(s)|0|||
124487116|NCT00174941|447738285|FG001|Overall Study|Personal Reason(s)|14|||
124487117|NCT00174941|447738286|FG002|Overall Study|Personal Reason(s)|8|||
124487118|NCT00174941|447738287|FG003|Overall Study|Personal Reason(s)|22|||
124487119|NCT00174941|447738284|FG000|Overall Study|Gout Flare|0|||
124487120|NCT00174941|447738285|FG001|Overall Study|Gout Flare|4|||
124487121|NCT00174941|447738286|FG002|Overall Study|Gout Flare|4|||
124487122|NCT00174941|447738287|FG003|Overall Study|Gout Flare|8|||
124487123|NCT00174941|447738284|FG000|Overall Study|Reason Not Specified|1|||
124487124|NCT00174941|447738285|FG001|Overall Study|Reason Not Specified|6|||
124487125|NCT00174941|447738286|FG002|Overall Study|Reason Not Specified|2|||
124487126|NCT00174941|447738287|FG003|Overall Study|Reason Not Specified|9|||
124487127|NCT03126227|447738288|FG000|Overall Study|Adverse Event|43|||
124487128|NCT03126227|447738289|FG001|Overall Study|Adverse Event|4|||
124487129|NCT03126227|447738288|FG000|Overall Study|Death|0|||
124487130|NCT03126227|447738289|FG001|Overall Study|Death|1|||
124487131|NCT03126227|447738288|FG000|Overall Study|Lost to Follow-up|0|||
124487132|NCT03126227|447738289|FG001|Overall Study|Lost to Follow-up|1|||
124487133|NCT03126227|447738288|FG000|Overall Study|Physician Decision|2|||
124487134|NCT03126227|447738289|FG001|Overall Study|Physician Decision|0|||
124487135|NCT03126227|447738288|FG000|Overall Study|Protocol Violation|1|||
124487136|NCT03126227|447738289|FG001|Overall Study|Protocol Violation|0|||
124487137|NCT03126227|447738288|FG000|Overall Study|Withdrawal by Subject|19|||
124487138|NCT03126227|447738289|FG001|Overall Study|Withdrawal by Subject|3|||
124487139|NCT03126227|447738288|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
124487140|NCT03126227|447738289|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
124487141|NCT03126227|447738288|FG000|Overall Study|Lack of dosing compliance|2|||
124487142|NCT03126227|447738289|FG001|Overall Study|Lack of dosing compliance|0|||
124487143|NCT03126227|447738288|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
124487144|NCT03126227|447738289|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
124487145|NCT03126227|447738288|FG000|Overall Study|Scheduling conflict|1|||
124487146|NCT03126227|447738289|FG001|Overall Study|Scheduling conflict|0|||
124487147|NCT01121406|447738294|FG000|Overall Study|Progressive disease RECIST|44|||
124487148|NCT01121406|447738295|FG001|Overall Study|Progressive disease RECIST|28|||
124487149|NCT01121406|447738294|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
124487150|NCT01121406|447738295|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
124487151|NCT01121406|447738294|FG000|Overall Study|Other AE|3|||
124487152|NCT01121406|447738295|FG001|Overall Study|Other AE|10|||
124487153|NCT01121406|447738294|FG000|Overall Study|Non-compliant with protocol|0|||
124487154|NCT01121406|447738295|FG001|Overall Study|Non-compliant with protocol|2|||
124487155|NCT01121406|447738294|FG000|Overall Study|Lost to Follow-up|0|||
124487156|NCT01121406|447738295|FG001|Overall Study|Lost to Follow-up|1|||
124487157|NCT01121406|447738294|FG000|Overall Study|Refused continuation of study med.|1|||
124487158|NCT01121406|447738295|FG001|Overall Study|Refused continuation of study med.|2|||
124487159|NCT01121406|447738294|FG000|Overall Study|Reason other than specified above|2|||
124487160|NCT01121406|447738295|FG001|Overall Study|Reason other than specified above|6|||
124487161|NCT01121406|447738294|FG000|Overall Study|Not treated|1|||
124487162|NCT01121406|447738295|FG001|Overall Study|Not treated|0|||
124487163|NCT01925703|447738296|FG000|Overall Study|Physician Decision|1|||
124487164|NCT01925703|447738296|FG000|Overall Study|Lost to Follow-up|2|||
124487165|NCT01925703|447738296|FG000|Overall Study|Discharge prior to full iron repletion|1|||
124487166|NCT03794986|447738297|FG000|Overall Study|0 Sessions Attended|34|||
124487167|NCT03794986|447738298|FG001|Overall Study|0 Sessions Attended|37|||
124487168|NCT03794986|447738297|FG000|Overall Study|Withdrawal by Subject|4|||
124487169|NCT03794986|447738298|FG001|Overall Study|Withdrawal by Subject|6|||
124487170|NCT03794986|447738297|FG000|Overall Study|Protocol Violation|1|||
124487171|NCT03794986|447738298|FG001|Overall Study|Protocol Violation|0|||
124487172|NCT02498652|447738302|FG000|Overall Study|Protocol Violation|0|||
124487173|NCT02498652|447738303|FG001|Overall Study|Protocol Violation|1|||
124487174|NCT00465569|447738304|FG000|Overall Study|persistent eczema during dose escalation|1|||
124487175|NCT00465569|447738305|FG001|Overall Study|persistent eczema during dose escalation|0|||
124487176|NCT00922935|447738306|FG000|Overall Study|Protocol Violation|0|||
124487177|NCT00922935|447738307|FG001|Overall Study|Protocol Violation|3|||
124487178|NCT00922935|447738308|FG002|Overall Study|Protocol Violation|0|||
124487179|NCT00922935|447738306|FG000|Overall Study|Physician Decision|1|||
124487180|NCT00922935|447738307|FG001|Overall Study|Physician Decision|1|||
124487181|NCT00922935|447738308|FG002|Overall Study|Physician Decision|0|||
124487182|NCT00922935|447738306|FG000|Overall Study|Lost to Follow-up|0|||
124487183|NCT00922935|447738307|FG001|Overall Study|Lost to Follow-up|1|||
124487184|NCT00922935|447738308|FG002|Overall Study|Lost to Follow-up|0|||
124487185|NCT00849212|447738309|FG000|Overall Study|Lack of Efficacy|1|||
124487186|NCT00849212|447738309|FG000|Overall Study|Withdrawal by Subject|3|||
124487187|NCT00849212|447738309|FG000|Overall Study|Adverse Event|2|||
124487188|NCT00849212|447738309|FG000|Overall Study|Miscellaneous|1|||
124487189|NCT00095303|447738310|FG000|Main Study|Lost to Follow-up|91|||
124487190|NCT00095303|447738311|FG001|Main Study|Lost to Follow-up|87|||
124487191|NCT00095303|447738310|FG000|Follow Up Study|Lost to Follow-up|59|||
124487192|NCT00095303|447738311|FG001|Follow Up Study|Lost to Follow-up|58|||
124487193|NCT01499576|447738312|FG000|Overall Study|Physician Decision|12|||
124487194|NCT01499576|447738312|FG000|Overall Study|Withdrawal by Subject|9|||
124487195|NCT04283461|447738313|FG000|Overall Study|Enrolled in separate trial|0|||
124487196|NCT04283461|447738314|FG001|Overall Study|Enrolled in separate trial|0|||
124487197|NCT04283461|447738315|FG002|Overall Study|Enrolled in separate trial|8|||
124487198|NCT04283461|447738316|FG003|Overall Study|Enrolled in separate trial|13|||
124487199|NCT04283461|447738317|FG004|Overall Study|Enrolled in separate trial|12|||
124487200|NCT04283461|447738318|FG005|Overall Study|Enrolled in separate trial|0|||
124771958|NCT02141295|448796331|FG000|Overall Study|Reason not specified|0|||
124487201|NCT04283461|447738319|FG006|Overall Study|Enrolled in separate trial|0|||
124487202|NCT04283461|447738320|FG007|Overall Study|Enrolled in separate trial|8|||
124487203|NCT04283461|447738321|FG008|Overall Study|Enrolled in separate trial|0|||
124487204|NCT04283461|447738322|FG009|Overall Study|Enrolled in separate trial|0|||
124487205|NCT04283461|447738323|FG010|Overall Study|Enrolled in separate trial|0|||
124487206|NCT04283461|447738324|FG011|Overall Study|Enrolled in separate trial|7|||
124487207|NCT04283461|447738325|FG012|Overall Study|Enrolled in separate trial|0|||
124487208|NCT04375878|447738332|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
124487209|NCT04375878|447738333|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
124487210|NCT04375878|447738334|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
124487211|NCT04375878|447738335|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
124487212|NCT04375878|447738336|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
124487213|NCT04375878|447738337|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
124487214|NCT04375878|447738332|FG000|Crossover First and Second Interventions|Adverse Event|0|||
124487215|NCT04375878|447738333|FG001|Crossover First and Second Interventions|Adverse Event|0|||
124487216|NCT04375878|447738334|FG002|Crossover First and Second Interventions|Adverse Event|1|||
124487217|NCT04375878|447738335|FG003|Crossover First and Second Interventions|Adverse Event|0|||
124487218|NCT04375878|447738336|FG004|Crossover First and Second Interventions|Adverse Event|0|||
124487219|NCT04375878|447738337|FG005|Crossover First and Second Interventions|Adverse Event|0|||
124487220|NCT04375878|447738332|FG000|Extension Phase|Withdrawal by Subject|0|||
124487221|NCT04375878|447738333|FG001|Extension Phase|Withdrawal by Subject|0|||
124487222|NCT04375878|447738334|FG002|Extension Phase|Withdrawal by Subject|0|||
124487223|NCT04375878|447738335|FG003|Extension Phase|Withdrawal by Subject|0|||
124487224|NCT04375878|447738336|FG004|Extension Phase|Withdrawal by Subject|1|||
124487225|NCT04375878|447738337|FG005|Extension Phase|Withdrawal by Subject|0|||
124487226|NCT00195351|447738338|FG000|Overall Study|Lost to Follow-up|9|||
124487227|NCT00195351|447738339|FG001|Overall Study|Lost to Follow-up|9|||
124487228|NCT00195351|447738338|FG000|Overall Study|Withdrawal by Subject|6|||
124487229|NCT00195351|447738339|FG001|Overall Study|Withdrawal by Subject|3|||
124487230|NCT00195351|447738338|FG000|Overall Study|Protocol Deviation|3|||
124487231|NCT00195351|447738339|FG001|Overall Study|Protocol Deviation|2|||
124487232|NCT00195351|447738338|FG000|Overall Study|Death|3|||
124487233|NCT00195351|447738339|FG001|Overall Study|Death|1|||
124487234|NCT00195351|447738338|FG000|Overall Study|Lack of Efficacy|0|||
124487235|NCT00195351|447738339|FG001|Overall Study|Lack of Efficacy|1|||
124487236|NCT02111369|447738340|FG000|Overall Study|Lost to Follow-up|2|||
124487237|NCT02111369|447738340|FG000|Overall Study|Withdrawal by Subject|1|||
124487238|NCT00971321|447738341|FG000|Up to Month 7|Withdrawal by Subject|1|||
124487239|NCT00971321|447738342|FG001|Up to Month 7|Withdrawal by Subject|0|||
124487240|NCT00971321|447738341|FG000|Up to Month 7|Migrated/moved from study area|3|||
124487241|NCT00971321|447738342|FG001|Up to Month 7|Migrated/moved from study area|2|||
124487242|NCT00971321|447738341|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
124487243|NCT00971321|447738342|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
124487244|NCT00971321|447738341|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
124487245|NCT00971321|447738342|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
124487246|NCT00971321|447738341|FG000|Up to Month 11-12|Lost to Follow-up|1|||
124487247|NCT00971321|447738342|FG001|Up to Month 11-12|Lost to Follow-up|0|||
124487248|NCT00519623|447738343|FG000|Overall Study|Adverse Event|1|||
124487249|NCT02296840|447738347|FG000|Overall Study|Adverse Event|1|||
124487250|NCT02296840|447738348|FG001|Overall Study|Adverse Event|1|||
124487251|NCT02296840|447738347|FG000|Overall Study|Protocol Violation|2|||
124487252|NCT02296840|447738348|FG001|Overall Study|Protocol Violation|1|||
124487253|NCT02296840|447738347|FG000|Overall Study|Lost to Follow-up|6|||
124487254|NCT02296840|447738348|FG001|Overall Study|Lost to Follow-up|17|||
124487255|NCT00104871|447738351|FG000|Overall Study|Not evaluable|1|||
124487256|NCT00761215|447738352|FG000|Overall Study|Randomized but didn't receive drug|1|||
124487257|NCT00761215|447738353|FG001|Overall Study|Randomized but didn't receive drug|1|||
124487258|NCT00761215|447738354|FG002|Overall Study|Randomized but didn't receive drug|2|||
124487259|NCT00761215|447738352|FG000|Overall Study|Lost to Follow-up|6|||
124487260|NCT00761215|447738353|FG001|Overall Study|Lost to Follow-up|3|||
124487261|NCT00761215|447738354|FG002|Overall Study|Lost to Follow-up|6|||
124487262|NCT00761215|447738352|FG000|Overall Study|Withdrawal by Subject|1|||
124487263|NCT00761215|447738353|FG001|Overall Study|Withdrawal by Subject|0|||
124487264|NCT00761215|447738354|FG002|Overall Study|Withdrawal by Subject|0|||
124487265|NCT00761215|447738352|FG000|Overall Study|Bacteremia|1|||
124487266|NCT00761215|447738353|FG001|Overall Study|Bacteremia|0|||
124487267|NCT00761215|447738354|FG002|Overall Study|Bacteremia|0|||
124487268|NCT00667277|447738355|FG000|Overall Study|Withdrawal by Subject|2|||
124487269|NCT01926886|447738358|FG000|Overall Study|Administrative/other|1|||
124487270|NCT01926886|447738359|FG001|Overall Study|Administrative/other|0|||
124487271|NCT01926886|447738358|FG000|Overall Study|Adverse event/intercurrent illness|4|||
124487272|NCT01926886|447738359|FG001|Overall Study|Adverse event/intercurrent illness|0|||
124487273|NCT01926886|447738358|FG000|Overall Study|Disease progression/recurrence|4|||
124487274|NCT01926886|447738359|FG001|Overall Study|Disease progression/recurrence|0|||
124487275|NCT01926886|447738358|FG000|Overall Study|Withdrawal by Subject|15|||
124487276|NCT01926886|447738359|FG001|Overall Study|Withdrawal by Subject|0|||
124487277|NCT01926886|447738358|FG000|Overall Study|Failure to return|3|||
124487278|NCT01926886|447738359|FG001|Overall Study|Failure to return|0|||
124487279|NCT01926886|447738358|FG000|Overall Study|Recurrence of disease|1|||
124487280|NCT01926886|447738359|FG001|Overall Study|Recurrence of disease|0|||
124487281|NCT01926886|447738358|FG000|Overall Study|Progression of disease|2|||
124487282|NCT01926886|447738359|FG001|Overall Study|Progression of disease|0|||
124487283|NCT01926886|447738358|FG000|Overall Study|Death|1|||
124487284|NCT01926886|447738359|FG001|Overall Study|Death|0|||
124487285|NCT01926886|447738358|FG000|Overall Study|Did not cooperate|1|||
124487286|NCT01926886|447738359|FG001|Overall Study|Did not cooperate|0|||
124487287|NCT01662999|447738371|FG000|Period 3|Withdrawal by Subject|0|||
124487288|NCT01662999|447738372|FG001|Period 3|Withdrawal by Subject|1|||
124487289|NCT01662999|447738373|FG002|Period 3|Withdrawal by Subject|0|||
124487290|NCT01662999|447738374|FG003|Period 3|Withdrawal by Subject|0|||
124487291|NCT01662999|447738375|FG004|Period 3|Withdrawal by Subject|0|||
124487292|NCT01662999|447738376|FG005|Period 3|Withdrawal by Subject|0|||
124487293|NCT02932267|447738382|FG000|Overall Study|Withdrawal by Subject|3|||
124487294|NCT02932267|447738382|FG000|Overall Study|Lost to Follow-up|4|||
124487295|NCT02932267|447738382|FG000|Overall Study|Pregnancy|1|||
124487296|NCT01687673|447738387|FG000|Overall Study|Physician Decision|1|||
124487297|NCT02453841|447738388|FG000|Overall Study|Protocol Violation|1|||
124487298|NCT02453841|447738388|FG000|Overall Study|Unable to obtain blood samples|2|||
124487299|NCT00618956|447738389|FG000|Overall Study|Adverse Event|10|||
124487300|NCT00618956|447738390|FG001|Overall Study|Adverse Event|34|||
124487301|NCT00618956|447738389|FG000|Overall Study|Lack of Efficacy|2|||
124487302|NCT00618956|447738390|FG001|Overall Study|Lack of Efficacy|1|||
124487303|NCT00618956|447738389|FG000|Overall Study|Withdrawal by Subject|5|||
124487304|NCT00618956|447738390|FG001|Overall Study|Withdrawal by Subject|7|||
124487305|NCT00618956|447738389|FG000|Overall Study|Lost to Follow-up|4|||
124487306|NCT00618956|447738390|FG001|Overall Study|Lost to Follow-up|5|||
124487307|NCT00618956|447738389|FG000|Overall Study|Protocol Violation|2|||
124487308|NCT00618956|447738390|FG001|Overall Study|Protocol Violation|2|||
124487309|NCT00618956|447738389|FG000|Overall Study|did not meet criteria, non-compliance|2|||
124487310|NCT00618956|447738390|FG001|Overall Study|did not meet criteria, non-compliance|1|||
124487311|NCT02006576|447738391|FG000|Overall Study|Withdrawal by Subject|4|||
124487312|NCT02006576|447738392|FG001|Overall Study|Withdrawal by Subject|6|||
124487313|NCT02006576|447738393|FG002|Overall Study|Withdrawal by Subject|2|||
124487314|NCT02006576|447738391|FG000|Overall Study|Death|0|||
124487315|NCT02006576|447738392|FG001|Overall Study|Death|0|||
124487316|NCT02006576|447738393|FG002|Overall Study|Death|1|||
124487317|NCT02006576|447738391|FG000|Overall Study|Lost to Follow-up|1|||
124487318|NCT02006576|447738392|FG001|Overall Study|Lost to Follow-up|0|||
124487319|NCT02006576|447738393|FG002|Overall Study|Lost to Follow-up|1|||
124487320|NCT02006576|447738391|FG000|Overall Study|Screen Failure, too sick, other|13|||
124487321|NCT02006576|447738392|FG001|Overall Study|Screen Failure, too sick, other|1|||
124487322|NCT02006576|447738393|FG002|Overall Study|Screen Failure, too sick, other|13|||
124487323|NCT05847881|447738396|FG000|Overall Study|Principal Investigator Decision|8|||
124487324|NCT05847881|447738396|FG000|Overall Study|Withdrawal by Subject|2|||
124487325|NCT04513158|447738399|FG000|Overall Study|Screen Failure|1|||
124487326|NCT04493619|447739999|FG000|Overall Study|Death|4|||
124487327|NCT04493619|447740000|FG001|Overall Study|Death|3|||
124487328|NCT04493619|447740001|FG002|Overall Study|Death|3|||
124487329|NCT04493619|447740002|FG003|Overall Study|Death|4|||
124487330|NCT04493619|447739999|FG000|Overall Study|Study discontinued early|10|||
124487331|NCT04493619|447740000|FG001|Overall Study|Study discontinued early|0|||
124487332|NCT04493619|447740001|FG002|Overall Study|Study discontinued early|4|||
124487333|NCT04493619|447740002|FG003|Overall Study|Study discontinued early|8|||
124487334|NCT04493619|447739999|FG000|Overall Study|Lost to Follow-up|0|||
124487335|NCT04493619|447740000|FG001|Overall Study|Lost to Follow-up|0|||
124487336|NCT04493619|447740001|FG002|Overall Study|Lost to Follow-up|0|||
124487337|NCT04493619|447740002|FG003|Overall Study|Lost to Follow-up|1|||
124487338|NCT02413255|447740006|FG000|Overall Study|Voluntary Withdrawal|0|||
124487339|NCT02413255|447740007|FG001|Overall Study|Voluntary Withdrawal|0|||
124487340|NCT02413255|447740008|FG002|Overall Study|Voluntary Withdrawal|0|||
124487341|NCT02413255|447740009|FG003|Overall Study|Voluntary Withdrawal|0|||
124487342|NCT02413255|447740010|FG004|Overall Study|Voluntary Withdrawal|0|||
124487343|NCT02413255|447740011|FG005|Overall Study|Voluntary Withdrawal|0|||
124487344|NCT02413255|447740012|FG006|Overall Study|Voluntary Withdrawal|0|||
124487345|NCT02413255|447740013|FG007|Overall Study|Voluntary Withdrawal|0|||
124487346|NCT02413255|447740014|FG008|Overall Study|Voluntary Withdrawal|0|||
124487347|NCT02413255|447740015|FG009|Overall Study|Voluntary Withdrawal|0|||
124487348|NCT02413255|447740016|FG010|Overall Study|Voluntary Withdrawal|0|||
124721418|NCT02036580|448603642|FG000|Overall Study|Adverse Event|1|||
124487349|NCT02413255|447740017|FG011|Overall Study|Voluntary Withdrawal|0|||
124721419|NCT02036580|448603643|FG001|Overall Study|Adverse Event|0|||
124487350|NCT02413255|447740018|FG012|Overall Study|Voluntary Withdrawal|0|||
124487351|NCT02413255|447740019|FG013|Overall Study|Voluntary Withdrawal|0|||
124487352|NCT02413255|447740020|FG014|Overall Study|Voluntary Withdrawal|1|||
124487353|NCT02413255|447740021|FG015|Overall Study|Voluntary Withdrawal|0|||
124487354|NCT02413255|447740022|FG016|Overall Study|Voluntary Withdrawal|0|||
124487355|NCT04329949|447740024|FG000|Overall Study|Death|36|||
124721420|NCT02036580|448603644|FG002|Overall Study|Adverse Event|0|||
124487356|NCT04329949|447740024|FG000|Overall Study|Withdrawal by Subject|4|||
124487357|NCT04329949|447740024|FG000|Overall Study|Termination of study by sponsor|3|||
124721421|NCT03098433|448603647|FG000|Overall Study|Withdrawal by Subject|10|||
124487358|NCT03230097|447740030|FG000|Overall Study|Adverse Event|2|||
124487359|NCT03230097|447740031|FG001|Overall Study|Adverse Event|1|||
124487360|NCT03230097|447740030|FG000|Overall Study|non-compliance|0|||
124487361|NCT03230097|447740031|FG001|Overall Study|non-compliance|1|||
124487362|NCT03230097|447740030|FG000|Overall Study|Lost to Follow-up|2|||
124487363|NCT03230097|447740031|FG001|Overall Study|Lost to Follow-up|4|||
124487364|NCT03230097|447740030|FG000|Overall Study|Withdrawal by Subject|7|||
124487365|NCT03230097|447740031|FG001|Overall Study|Withdrawal by Subject|3|||
124487366|NCT03230097|447740030|FG000|Overall Study|Trial termination|4|||
124487367|NCT03230097|447740031|FG001|Overall Study|Trial termination|5|||
124487368|NCT03230097|447740030|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
124487369|NCT03230097|447740031|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
124487370|NCT03230097|447740030|FG000|Overall Study|outcome event|0|||
124487371|NCT03230097|447740031|FG001|Overall Study|outcome event|1|||
124487372|NCT00779038|447740033|FG000|Overall Study|Study Prematurely Terminated|13|||
124487373|NCT04786210|447740034|FG000|Overall Study|Lost to Follow-up|2|||
124487374|NCT04786210|447740034|FG000|Overall Study|Withdrawal by Subject|4|||
124487375|NCT05370157|447740035|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
124487376|NCT05370157|447740036|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
124487377|NCT05370157|447740035|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
124487378|NCT05370157|447740036|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
124487379|NCT03700892|447740037|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
124487380|NCT03700892|447740038|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
124487381|NCT03700892|447740039|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
124487382|NCT01364467|447740049|FG000|Overall Study|Lost to Follow-up|1|||
124487383|NCT01364467|447740050|FG001|Overall Study|Lost to Follow-up|2|||
124487384|NCT01634243|447740051|FG000|Overall Study|Adverse Event|5|||
124487385|NCT01634243|447740052|FG001|Overall Study|Adverse Event|5|||
124487386|NCT01634243|447740051|FG000|Overall Study|Lack of Efficacy|1|||
124487387|NCT01634243|447740052|FG001|Overall Study|Lack of Efficacy|0|||
124487388|NCT00587223|447740065|FG000|Overall Study|Adverse Event|1|||
124487389|NCT03240081|447740069|FG000|Overall Study|Withdrawal by Subject|0|||
124487390|NCT03240081|447740070|FG001|Overall Study|Withdrawal by Subject|2|||
124487391|NCT03240081|447740069|FG000|Overall Study|Lost to Follow-up|0|||
124487392|NCT03240081|447740070|FG001|Overall Study|Lost to Follow-up|1|||
124487393|NCT00883753|447740071|FG000|Overall Study|Adverse Event|37|||
124487394|NCT00883753|447740071|FG000|Overall Study|Death|2|||
124487395|NCT00883753|447740071|FG000|Overall Study|Insufficient therapeutic response|16|||
124487396|NCT00883753|447740071|FG000|Overall Study|Lost to Follow-up|4|||
124487397|NCT00883753|447740071|FG000|Overall Study|Violation of selection criteria at entry|7|||
124487398|NCT00883753|447740071|FG000|Overall Study|Protocol Violation|2|||
124487399|NCT00883753|447740071|FG000|Overall Study|Refused treatment|4|||
124487400|NCT00883753|447740071|FG000|Overall Study|Withdrew consent|10|||
124487401|NCT00883753|447740071|FG000|Overall Study|Investigator's decision|17|||
124487402|NCT00883753|447740071|FG000|Overall Study|Administrative/Other|8|||
124487403|NCT01480180|447740076|FG000|Main Phase|Withdrawal criteria|12|||
124487404|NCT01480180|447740077|FG001|Main Phase|Withdrawal criteria|1|||
124487405|NCT01480180|447740078|FG002|Main Phase|Withdrawal criteria|0|||
124487406|NCT01480180|447740079|FG003|Main Phase|Withdrawal criteria|0|||
124487407|NCT01480180|447740080|FG004|Main Phase|Withdrawal criteria|0|||
124487408|NCT01480180|447740081|FG005|Main Phase|Withdrawal criteria|0|||
124487409|NCT01480180|447740076|FG000|Main Phase|Lack of Efficacy|1|||
124487410|NCT01480180|447740077|FG001|Main Phase|Lack of Efficacy|0|||
124487411|NCT01480180|447740078|FG002|Main Phase|Lack of Efficacy|0|||
124487412|NCT01480180|447740079|FG003|Main Phase|Lack of Efficacy|0|||
124487413|NCT01480180|447740080|FG004|Main Phase|Lack of Efficacy|0|||
124487414|NCT01480180|447740081|FG005|Main Phase|Lack of Efficacy|0|||
124487415|NCT01480180|447740076|FG000|Main Phase|Non-compliance|3|||
124487416|NCT01480180|447740077|FG001|Main Phase|Non-compliance|0|||
124487417|NCT01480180|447740078|FG002|Main Phase|Non-compliance|0|||
124487418|NCT01480180|447740079|FG003|Main Phase|Non-compliance|0|||
124487419|NCT01480180|447740080|FG004|Main Phase|Non-compliance|0|||
124487420|NCT01480180|447740081|FG005|Main Phase|Non-compliance|0|||
124487421|NCT01480180|447740076|FG000|Main Phase|Unclassified|3|||
124487422|NCT01480180|447740077|FG001|Main Phase|Unclassified|0|||
124487423|NCT01480180|447740078|FG002|Main Phase|Unclassified|0|||
124487424|NCT01480180|447740079|FG003|Main Phase|Unclassified|0|||
124487425|NCT01480180|447740080|FG004|Main Phase|Unclassified|0|||
124487426|NCT01480180|447740081|FG005|Main Phase|Unclassified|0|||
124487427|NCT01480180|447740076|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
124487428|NCT01480180|447740077|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
124487429|NCT01480180|447740078|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
124487430|NCT01480180|447740079|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
124487431|NCT01480180|447740080|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
124487432|NCT01480180|447740081|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
124487433|NCT01480180|447740076|FG000|Extension Phase, Part 1|Unclassified|0|||
124487434|NCT01480180|447740077|FG001|Extension Phase, Part 1|Unclassified|0|||
124487435|NCT01480180|447740078|FG002|Extension Phase, Part 1|Unclassified|1|||
124487436|NCT01480180|447740079|FG003|Extension Phase, Part 1|Unclassified|0|||
124487437|NCT01480180|447740080|FG004|Extension Phase, Part 1|Unclassified|0|||
124487438|NCT01480180|447740081|FG005|Extension Phase, Part 1|Unclassified|0|||
124487439|NCT01480180|447740076|FG000|Extension Phase, Part 1|Adverse Event|0|||
124487440|NCT01480180|447740077|FG001|Extension Phase, Part 1|Adverse Event|0|||
124487441|NCT01480180|447740078|FG002|Extension Phase, Part 1|Adverse Event|4|||
124487442|NCT01480180|447740079|FG003|Extension Phase, Part 1|Adverse Event|1|||
124487443|NCT01480180|447740080|FG004|Extension Phase, Part 1|Adverse Event|0|||
124487444|NCT01480180|447740081|FG005|Extension Phase, Part 1|Adverse Event|0|||
124487445|NCT01480180|447740076|FG000|Extension Phase, Part 1|Change of treatment|0|||
124487446|NCT01480180|447740077|FG001|Extension Phase, Part 1|Change of treatment|0|||
124487447|NCT01480180|447740078|FG002|Extension Phase, Part 1|Change of treatment|0|||
124487448|NCT01480180|447740079|FG003|Extension Phase, Part 1|Change of treatment|9|||
124487449|NCT01480180|447740080|FG004|Extension Phase, Part 1|Change of treatment|0|||
124487450|NCT01480180|447740081|FG005|Extension Phase, Part 1|Change of treatment|0|||
124487451|NCT01480180|447740076|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
124487452|NCT01480180|447740077|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
124487453|NCT01480180|447740078|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
124487454|NCT01480180|447740079|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
124487455|NCT01480180|447740080|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
124487456|NCT01480180|447740081|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
124487457|NCT01480180|447740076|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
124487458|NCT01480180|447740077|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
124487459|NCT01480180|447740078|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
124487460|NCT01480180|447740079|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
124487461|NCT01480180|447740080|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
124487462|NCT01480180|447740081|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
124487463|NCT01480180|447740076|FG000|Extension Phase, Part 2|Unclassified|0|||
124487464|NCT01480180|447740077|FG001|Extension Phase, Part 2|Unclassified|0|||
124487465|NCT01480180|447740078|FG002|Extension Phase, Part 2|Unclassified|3|||
124487466|NCT01480180|447740079|FG003|Extension Phase, Part 2|Unclassified|1|||
124487467|NCT01480180|447740080|FG004|Extension Phase, Part 2|Unclassified|1|||
124487468|NCT01480180|447740081|FG005|Extension Phase, Part 2|Unclassified|0|||
124487469|NCT02436239|447740083|FG000|Open-Lable Treatment Period|Adverse Event|12|||
124487470|NCT02436239|447740084|FG001|Open-Lable Treatment Period|Adverse Event|3|||
124487471|NCT02436239|447740085|FG002|Open-Lable Treatment Period|Adverse Event|4|||
124487472|NCT02436239|447740086|FG003|Open-Lable Treatment Period|Adverse Event|2|||
124487473|NCT02436239|447740083|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
124487474|NCT02436239|447740084|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
124487475|NCT02436239|447740085|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
124487476|NCT02436239|447740086|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
124487477|NCT02436239|447740083|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
124487478|NCT02436239|447740084|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
124487479|NCT02436239|447740085|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
124487480|NCT02436239|447740086|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
124487481|NCT02436239|447740083|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
124487482|NCT02436239|447740084|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
124487483|NCT02436239|447740085|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
124487484|NCT02436239|447740086|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
124487485|NCT02436239|447740083|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
124487486|NCT02436239|447740084|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
124487487|NCT02436239|447740085|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
124487488|NCT02436239|447740086|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
124487489|NCT02436239|447740083|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
124487490|NCT02436239|447740084|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
124487491|NCT02436239|447740085|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
124487492|NCT02436239|447740086|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
124487493|NCT02436239|447740083|FG000|Open-Lable Treatment Period|Other Reason|1|||
124487494|NCT02436239|447740084|FG001|Open-Lable Treatment Period|Other Reason|1|||
124487495|NCT02436239|447740085|FG002|Open-Lable Treatment Period|Other Reason|0|||
124487496|NCT02436239|447740086|FG003|Open-Lable Treatment Period|Other Reason|0|||
124487497|NCT02436239|447740083|FG000|Down-Taper Period|Withdrawal by Subject|4|||
124487498|NCT02436239|447740084|FG001|Down-Taper Period|Withdrawal by Subject|4|||
124487499|NCT02436239|447740085|FG002|Down-Taper Period|Withdrawal by Subject|1|||
124487500|NCT02436239|447740086|FG003|Down-Taper Period|Withdrawal by Subject|2|||
124487501|NCT04925570|447740087|FG000|Overall Study|Protocol Violation|24|||
124487502|NCT04925570|447740088|FG001|Overall Study|Protocol Violation|30|||
124487503|NCT04925570|447740087|FG000|Overall Study|Withdrawal by Subject|0|||
124487504|NCT04925570|447740088|FG001|Overall Study|Withdrawal by Subject|2|||
124487505|NCT00828451|447740089|FG000|Overall Study|Death|2|||
124487506|NCT00828451|447740089|FG000|Overall Study|Lack of intravenous line|7|||
124487507|NCT00828451|447740089|FG000|Overall Study|Withdrawal by Subject|1|||
124487508|NCT00828451|447740089|FG000|Overall Study|Deterioration in clinical status|1|||
124487509|NCT00814710|447740093|FG000|Overall Study|Adverse Event|1|||
124487510|NCT00814710|447740094|FG001|Overall Study|Adverse Event|0|||
124487511|NCT00814710|447740093|FG000|Overall Study|Lost to Follow-up|7|||
124487512|NCT00814710|447740094|FG001|Overall Study|Lost to Follow-up|3|||
124487513|NCT01476787|447740100|FG000|Treatment|Progression|64|||
124487514|NCT01476787|447740101|FG001|Treatment|Progression|71|||
124487515|NCT01476787|447740100|FG000|Treatment|Toxicity|44|||
124487516|NCT01476787|447740101|FG001|Treatment|Toxicity|16|||
124487517|NCT01476787|447740100|FG000|Treatment|Death|0|||
124487518|NCT01476787|447740101|FG001|Treatment|Death|1|||
124487519|NCT01476787|447740100|FG000|Treatment|Withdrawal by Subject|3|||
124487520|NCT01476787|447740101|FG001|Treatment|Withdrawal by Subject|14|||
124487521|NCT01476787|447740100|FG000|Treatment|Major protocol violation|1|||
124487522|NCT01476787|447740101|FG001|Treatment|Major protocol violation|6|||
124487523|NCT01476787|447740100|FG000|Treatment|Other reasons|10|||
124487524|NCT01476787|447740101|FG001|Treatment|Other reasons|22|||
124487525|NCT01476787|447740100|FG000|Treatment|Concurrent illness|12|||
124487526|NCT01476787|447740101|FG001|Treatment|Concurrent illness|9|||
124487527|NCT01476787|447740100|FG000|Treatment|Insufficient response|15|||
124487528|NCT01476787|447740101|FG001|Treatment|Insufficient response|3|||
124487529|NCT01476787|447740100|FG000|Treatment|Voluntary treatment discontinuation|8|||
124487530|NCT01476787|447740101|FG001|Treatment|Voluntary treatment discontinuation|4|||
124487531|NCT01591330|447740102|FG000|Period 1|Adverse Event|1|||
124487532|NCT01591330|447740103|FG001|Period 1|Adverse Event|0|||
124487533|NCT01591330|447740104|FG002|Period 1|Adverse Event|0|||
124487534|NCT01591330|447740105|FG003|Period 1|Adverse Event|0|||
124487535|NCT01591330|447740102|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
124487536|NCT01591330|447740103|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
124487537|NCT01591330|447740104|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
124487538|NCT01591330|447740105|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
124487539|NCT01591330|447740102|FG000|Period 2|Adverse Event|1|||
124487540|NCT01591330|447740103|FG001|Period 2|Adverse Event|0|||
124487541|NCT01591330|447740104|FG002|Period 2|Adverse Event|0|||
124487542|NCT01591330|447740105|FG003|Period 2|Adverse Event|0|||
124487543|NCT01450137|447740106|FG000|Up to Week 12|Adverse Event|2|||
124487544|NCT01450137|447740107|FG001|Up to Week 12|Adverse Event|1|||
124487545|NCT01450137|447740106|FG000|Up to Week 12|Withdrawal by Subject|0|||
124487546|NCT01450137|447740107|FG001|Up to Week 12|Withdrawal by Subject|2|||
124487547|NCT01450137|447740106|FG000|Week 12 to Study End|Death|0|||
124487548|NCT01450137|447740107|FG001|Week 12 to Study End|Death|1|||
124487549|NCT01450137|447740106|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
124487550|NCT01450137|447740107|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
124487551|NCT01450540|447740108|FG000|Overall Study|Withdrawal by Subject|19|||
124487552|NCT01450540|447740109|FG001|Overall Study|Withdrawal by Subject|13|||
124487553|NCT01450540|447740108|FG000|Overall Study|protocol deviation|3|||
124487554|NCT01450540|447740109|FG001|Overall Study|protocol deviation|23|||
124487555|NCT03875235|447740113|FG000|Overall Study|Ongoing study treatment|63|||
124721422|NCT01667133|448603648|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
124721423|NCT01667133|448603649|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
124721424|NCT01667133|448603650|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
124721425|NCT01667133|448603651|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
124721426|NCT01667133|448603652|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
124721427|NCT01667133|448603653|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
124487556|NCT03875235|447740114|FG001|Overall Study|Ongoing study treatment|20|||
124487557|NCT03875235|447740113|FG000|Overall Study|Off treatment|77|||
124721428|NCT01667133|448603654|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
124721429|NCT01667133|448603655|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
124721430|NCT01667133|448603656|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
124721431|NCT01667133|448603657|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
124487558|NCT03875235|447740114|FG001|Overall Study|Off treatment|91|||
124487559|NCT03875235|447740113|FG000|Overall Study|Withdrawal by Subject|3|||
124487560|NCT03875235|447740114|FG001|Overall Study|Withdrawal by Subject|10|||
124487561|NCT03875235|447740113|FG000|Overall Study|Death|198|||
124487562|NCT03875235|447740114|FG001|Overall Study|Death|223|||
124487563|NCT03851510|447740117|FG000|Overall Study|Screen Fail|1|||
124721432|NCT01667133|448603658|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
124487564|NCT03851510|447740117|FG000|Overall Study|Adverse Event|1|||
124487565|NCT03851510|447740117|FG000|Overall Study|Withdrawal by Subject|1|||
124487566|NCT01151137|447740118|FG000|Overall Study|Death|15|||
124487567|NCT01151137|447740119|FG001|Overall Study|Death|27|||
124487568|NCT01151137|447740118|FG000|Overall Study|Lost to Follow-up|1|||
124487569|NCT01151137|447740119|FG001|Overall Study|Lost to Follow-up|1|||
124487570|NCT03478683|447740120|FG000|Overall Study|Adverse Event|5|||
124487571|NCT03478683|447740121|FG001|Overall Study|Adverse Event|3|||
124487572|NCT03478683|447740120|FG000|Overall Study|Lost to Follow-up|0|||
124487573|NCT03478683|447740121|FG001|Overall Study|Lost to Follow-up|5|||
124487574|NCT03478683|447740120|FG000|Overall Study|Physician Decision|1|||
124487575|NCT03478683|447740121|FG001|Overall Study|Physician Decision|3|||
124487576|NCT03478683|447740120|FG000|Overall Study|Withdrawal by Subject|7|||
124487577|NCT03478683|447740121|FG001|Overall Study|Withdrawal by Subject|7|||
124487578|NCT01887210|447740122|FG000|Overall Study|Withdrawal by Subject|1|||
124721433|NCT01667133|448603659|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
124721434|NCT01667133|448603648|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
124487579|NCT01887210|447740123|FG001|Overall Study|Withdrawal by Subject|3|||
124487580|NCT01887210|447740122|FG000|Overall Study|Lost to Follow-up|0|||
124487581|NCT01887210|447740123|FG001|Overall Study|Lost to Follow-up|1|||
124487582|NCT01287117|447740132|FG000|Overall Study|Adverse Event|2|||
124487583|NCT01287117|447740133|FG001|Overall Study|Adverse Event|1|||
124487584|NCT01287117|447740134|FG002|Overall Study|Adverse Event|1|||
124487585|NCT01287117|447740135|FG003|Overall Study|Adverse Event|1|||
124487586|NCT01287117|447740132|FG000|Overall Study|Lost to Follow-up|1|||
124487587|NCT01287117|447740133|FG001|Overall Study|Lost to Follow-up|1|||
124487588|NCT01287117|447740134|FG002|Overall Study|Lost to Follow-up|0|||
124487589|NCT01287117|447740135|FG003|Overall Study|Lost to Follow-up|0|||
124487590|NCT01287117|447740132|FG000|Overall Study|Physician Decision|0|||
124487591|NCT01287117|447740133|FG001|Overall Study|Physician Decision|1|||
124487592|NCT01287117|447740134|FG002|Overall Study|Physician Decision|1|||
124487593|NCT01287117|447740135|FG003|Overall Study|Physician Decision|1|||
124487594|NCT01287117|447740132|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
124487595|NCT01287117|447740133|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
124487596|NCT01287117|447740134|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
124487597|NCT01287117|447740135|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
124487598|NCT01287117|447740132|FG000|Overall Study|Disease Progression|10|||
124487599|NCT01287117|447740133|FG001|Overall Study|Disease Progression|5|||
124487600|NCT01287117|447740134|FG002|Overall Study|Disease Progression|6|||
124487601|NCT01287117|447740135|FG003|Overall Study|Disease Progression|5|||
124487602|NCT00630032|447740136|FG000|Overall Study|Death|55|||
124487603|NCT00630032|447740137|FG001|Overall Study|Death|49|||
124487604|NCT00630032|447740136|FG000|Overall Study|Withdrawal by Subject|3|||
124487605|NCT00630032|447740137|FG001|Overall Study|Withdrawal by Subject|2|||
124487606|NCT00630032|447740136|FG000|Overall Study|Lost to Follow-up|18|||
124487607|NCT00630032|447740137|FG001|Overall Study|Lost to Follow-up|31|||
124487608|NCT00630032|447740136|FG000|Overall Study|Protocol Violation|1|||
124487609|NCT00630032|447740137|FG001|Overall Study|Protocol Violation|0|||
124487610|NCT00630032|447740136|FG000|Overall Study|Patient has moved|1|||
124487611|NCT00630032|447740137|FG001|Overall Study|Patient has moved|1|||
124487612|NCT00630032|447740136|FG000|Overall Study|Disease progression|1|||
124487613|NCT00630032|447740137|FG001|Overall Study|Disease progression|1|||
124487614|NCT00630032|447740136|FG000|Overall Study|End of monitoring in US centers|11|||
124487615|NCT00630032|447740137|FG001|Overall Study|End of monitoring in US centers|11|||
124487616|NCT02332915|447740138|FG000|Overall Study|Moved out of region|3|||
124487617|NCT02332915|447740139|FG001|Overall Study|Moved out of region|0|||
124487618|NCT02332915|447740138|FG000|Overall Study|Unrelated illness|1|||
124487619|NCT02332915|447740139|FG001|Overall Study|Unrelated illness|1|||
124487620|NCT02332915|447740138|FG000|Overall Study|Travel distance prohibitive|0|||
124487621|NCT02332915|447740139|FG001|Overall Study|Travel distance prohibitive|1|||
124487622|NCT02332915|447740138|FG000|Overall Study|did not meet inclusion criteria|2|||
124487623|NCT02332915|447740139|FG001|Overall Study|did not meet inclusion criteria|4|||
124487624|NCT02342171|447742298|FG000|Overall Study|Death|4|||
124487625|NCT02342171|447742299|FG001|Overall Study|Death|87|||
124487626|NCT02342171|447742298|FG000|Overall Study|Received favipiravir|10|||
124487627|NCT02342171|447742299|FG001|Overall Study|Received favipiravir|0|||
124487628|NCT02342171|447742298|FG000|Overall Study|Missing cycle treshold value|1|||
124487629|NCT02342171|447742299|FG001|Overall Study|Missing cycle treshold value|0|||
124487630|NCT02342171|447742298|FG000|Overall Study|Unknown outcome|0|||
124487631|NCT02342171|447742299|FG001|Overall Study|Unknown outcome|1|||
124487632|NCT02342171|447742298|FG000|Overall Study|Missing age data|0|||
124487633|NCT02342171|447742299|FG001|Overall Study|Missing age data|1|||
124487634|NCT05165394|447742300|FG000|Overall Study|Withdrawal by Subject|5|||
124487635|NCT05165394|447742301|FG001|Overall Study|Withdrawal by Subject|1|||
124487636|NCT05165394|447742300|FG000|Overall Study|Lost to Follow-up|1|||
124487637|NCT05165394|447742301|FG001|Overall Study|Lost to Follow-up|2|||
124487638|NCT05165394|447742300|FG000|Overall Study|Other Than Specified|0|||
124487639|NCT05165394|447742301|FG001|Overall Study|Other Than Specified|1|||
124487640|NCT02517515|447742307|FG000|Overall Study|Adverse Event|0|||
124487641|NCT02517515|447742308|FG001|Overall Study|Adverse Event|1|||
124487642|NCT02517515|447742307|FG000|Overall Study|Withdrew Consent|0|||
124487643|NCT02517515|447742308|FG001|Overall Study|Withdrew Consent|1|||
124487644|NCT02517515|447742307|FG000|Overall Study|Lost to Follow-up|1|||
124487645|NCT02517515|447742308|FG001|Overall Study|Lost to Follow-up|0|||
124487646|NCT02517515|447742307|FG000|Overall Study|Other|1|||
124487647|NCT02517515|447742308|FG001|Overall Study|Other|0|||
124487648|NCT02786537|447742309|FG000|As Randomized|Adverse Event|0|||
124487649|NCT02786537|447742310|FG001|As Randomized|Adverse Event|11|||
124487650|NCT02786537|447742311|FG002|As Randomized|Adverse Event|0|||
124487651|NCT02786537|447742312|FG003|As Randomized|Adverse Event|4|||
124487652|NCT02786537|447742313|FG004|As Randomized|Adverse Event|6|||
124487653|NCT02786537|447742314|FG005|As Randomized|Adverse Event|2|||
124487654|NCT02786537|447742309|FG000|As Randomized|Lack of Efficacy|0|||
124487655|NCT02786537|447742310|FG001|As Randomized|Lack of Efficacy|0|||
124487656|NCT02786537|447742311|FG002|As Randomized|Lack of Efficacy|0|||
124487657|NCT02786537|447742312|FG003|As Randomized|Lack of Efficacy|1|||
124487658|NCT02786537|447742313|FG004|As Randomized|Lack of Efficacy|0|||
124487659|NCT02786537|447742314|FG005|As Randomized|Lack of Efficacy|0|||
124487660|NCT02786537|447742309|FG000|As Randomized|Withdrawal by Subject|1|||
124487661|NCT02786537|447742310|FG001|As Randomized|Withdrawal by Subject|2|||
124487662|NCT02786537|447742311|FG002|As Randomized|Withdrawal by Subject|0|||
124487663|NCT02786537|447742312|FG003|As Randomized|Withdrawal by Subject|1|||
124487664|NCT02786537|447742313|FG004|As Randomized|Withdrawal by Subject|1|||
124487665|NCT02786537|447742314|FG005|As Randomized|Withdrawal by Subject|0|||
124487666|NCT02786537|447742309|FG000|As Randomized|Death|0|||
124487667|NCT02786537|447742310|FG001|As Randomized|Death|2|||
124487668|NCT02786537|447742311|FG002|As Randomized|Death|0|||
124487669|NCT02786537|447742312|FG003|As Randomized|Death|3|||
124487670|NCT02786537|447742313|FG004|As Randomized|Death|1|||
124487671|NCT02786537|447742314|FG005|As Randomized|Death|0|||
124487672|NCT02786537|447742309|FG000|As Randomized|Non-compliance with study drug|1|||
124487673|NCT02786537|447742310|FG001|As Randomized|Non-compliance with study drug|11|||
124487674|NCT02786537|447742311|FG002|As Randomized|Non-compliance with study drug|0|||
124487675|NCT02786537|447742312|FG003|As Randomized|Non-compliance with study drug|1|||
124487676|NCT02786537|447742313|FG004|As Randomized|Non-compliance with study drug|0|||
124487677|NCT02786537|447742314|FG005|As Randomized|Non-compliance with study drug|1|||
124487678|NCT02786537|447742309|FG000|As Randomized|Lost to treatment follow-up|4|||
124487679|NCT02786537|447742310|FG001|As Randomized|Lost to treatment follow-up|32|||
124487680|NCT02786537|447742311|FG002|As Randomized|Lost to treatment follow-up|0|||
124487681|NCT02786537|447742312|FG003|As Randomized|Lost to treatment follow-up|24|||
124487682|NCT02786537|447742313|FG004|As Randomized|Lost to treatment follow-up|4|||
124487683|NCT02786537|447742314|FG005|As Randomized|Lost to treatment follow-up|4|||
124487684|NCT02786537|447742309|FG000|As Randomized|Incarceration|0|||
124487685|NCT02786537|447742310|FG001|As Randomized|Incarceration|1|||
124487686|NCT02786537|447742311|FG002|As Randomized|Incarceration|0|||
124487687|NCT02786537|447742312|FG003|As Randomized|Incarceration|0|||
124487688|NCT02786537|447742313|FG004|As Randomized|Incarceration|0|||
124487689|NCT02786537|447742314|FG005|As Randomized|Incarceration|0|||
124487690|NCT02786537|447742309|FG000|As Randomized|Opiate Dependency Relapse|0|||
124487691|NCT02786537|447742310|FG001|As Randomized|Opiate Dependency Relapse|1|||
124487692|NCT02786537|447742311|FG002|As Randomized|Opiate Dependency Relapse|0|||
124487693|NCT02786537|447742312|FG003|As Randomized|Opiate Dependency Relapse|0|||
124487694|NCT02786537|447742313|FG004|As Randomized|Opiate Dependency Relapse|0|||
124487695|NCT02786537|447742314|FG005|As Randomized|Opiate Dependency Relapse|0|||
124487696|NCT02786537|447742309|FG000|As Randomized|HCV drugs stolen from pt|0|||
124487697|NCT02786537|447742310|FG001|As Randomized|HCV drugs stolen from pt|1|||
124487698|NCT02786537|447742311|FG002|As Randomized|HCV drugs stolen from pt|0|||
124487699|NCT02786537|447742312|FG003|As Randomized|HCV drugs stolen from pt|0|||
124487700|NCT02786537|447742313|FG004|As Randomized|HCV drugs stolen from pt|0|||
124487701|NCT02786537|447742314|FG005|As Randomized|HCV drugs stolen from pt|0|||
124487702|NCT02786537|447742309|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
124487703|NCT02786537|447742310|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
124487704|NCT02786537|447742311|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
124487705|NCT02786537|447742312|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
124487706|NCT02786537|447742313|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
124487707|NCT02786537|447742314|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
124487708|NCT02786537|447742309|FG000|As Randomized|Subject lost insurance|0|||
124487709|NCT02786537|447742310|FG001|As Randomized|Subject lost insurance|0|||
124487710|NCT02786537|447742311|FG002|As Randomized|Subject lost insurance|0|||
124487711|NCT02786537|447742312|FG003|As Randomized|Subject lost insurance|1|||
124487712|NCT02786537|447742313|FG004|As Randomized|Subject lost insurance|0|||
124487713|NCT02786537|447742314|FG005|As Randomized|Subject lost insurance|0|||
124487714|NCT02786537|447742309|FG000|As Treated|Adverse Event|0|||
124487715|NCT02786537|447742310|FG001|As Treated|Adverse Event|11|||
124487716|NCT02786537|447742311|FG002|As Treated|Adverse Event|0|||
124487717|NCT02786537|447742312|FG003|As Treated|Adverse Event|4|||
124487718|NCT02786537|447742313|FG004|As Treated|Adverse Event|6|||
124487719|NCT02786537|447742314|FG005|As Treated|Adverse Event|2|||
124487720|NCT02786537|447742309|FG000|As Treated|Death|0|||
124487721|NCT02786537|447742310|FG001|As Treated|Death|2|||
124487722|NCT02786537|447742311|FG002|As Treated|Death|0|||
124487723|NCT02786537|447742312|FG003|As Treated|Death|3|||
124487724|NCT02786537|447742313|FG004|As Treated|Death|1|||
124487725|NCT02786537|447742314|FG005|As Treated|Death|0|||
124487726|NCT02786537|447742309|FG000|As Treated|Lack of Efficacy|0|||
124487727|NCT02786537|447742310|FG001|As Treated|Lack of Efficacy|0|||
124487728|NCT02786537|447742311|FG002|As Treated|Lack of Efficacy|0|||
124487729|NCT02786537|447742312|FG003|As Treated|Lack of Efficacy|1|||
124487730|NCT02786537|447742313|FG004|As Treated|Lack of Efficacy|0|||
124487731|NCT02786537|447742314|FG005|As Treated|Lack of Efficacy|0|||
124487732|NCT02786537|447742309|FG000|As Treated|Lost to Follow-up|4|||
124487733|NCT02786537|447742310|FG001|As Treated|Lost to Follow-up|32|||
124487734|NCT02786537|447742311|FG002|As Treated|Lost to Follow-up|0|||
124487735|NCT02786537|447742312|FG003|As Treated|Lost to Follow-up|25|||
124487736|NCT02786537|447742313|FG004|As Treated|Lost to Follow-up|4|||
124487737|NCT02786537|447742314|FG005|As Treated|Lost to Follow-up|4|||
124487738|NCT02786537|447742309|FG000|As Treated|Non-compliance with study drug|1|||
124487739|NCT02786537|447742310|FG001|As Treated|Non-compliance with study drug|11|||
124487740|NCT02786537|447742311|FG002|As Treated|Non-compliance with study drug|0|||
124487741|NCT02786537|447742312|FG003|As Treated|Non-compliance with study drug|1|||
124487742|NCT02786537|447742313|FG004|As Treated|Non-compliance with study drug|0|||
124487743|NCT02786537|447742314|FG005|As Treated|Non-compliance with study drug|1|||
124487744|NCT02786537|447742309|FG000|As Treated|Lost insurance|0|||
124487745|NCT02786537|447742310|FG001|As Treated|Lost insurance|0|||
124487746|NCT02786537|447742311|FG002|As Treated|Lost insurance|0|||
124487747|NCT02786537|447742312|FG003|As Treated|Lost insurance|1|||
124487748|NCT02786537|447742313|FG004|As Treated|Lost insurance|0|||
124487749|NCT02786537|447742314|FG005|As Treated|Lost insurance|0|||
124487750|NCT02786537|447742309|FG000|As Treated|Withdrawal by Subject|1|||
124487751|NCT02786537|447742310|FG001|As Treated|Withdrawal by Subject|2|||
124487752|NCT02786537|447742311|FG002|As Treated|Withdrawal by Subject|0|||
124487753|NCT02786537|447742312|FG003|As Treated|Withdrawal by Subject|0|||
124487754|NCT02786537|447742313|FG004|As Treated|Withdrawal by Subject|1|||
124487755|NCT02786537|447742314|FG005|As Treated|Withdrawal by Subject|0|||
124487756|NCT02786537|447742309|FG000|As Treated|Incarceration|0|||
124487757|NCT02786537|447742310|FG001|As Treated|Incarceration|1|||
124487758|NCT02786537|447742311|FG002|As Treated|Incarceration|0|||
124487759|NCT02786537|447742312|FG003|As Treated|Incarceration|0|||
124487760|NCT02786537|447742313|FG004|As Treated|Incarceration|0|||
124487761|NCT02786537|447742314|FG005|As Treated|Incarceration|0|||
124487762|NCT02786537|447742309|FG000|As Treated|Opiate dependency relapse|0|||
124487763|NCT02786537|447742310|FG001|As Treated|Opiate dependency relapse|1|||
124487764|NCT02786537|447742311|FG002|As Treated|Opiate dependency relapse|0|||
124487765|NCT02786537|447742312|FG003|As Treated|Opiate dependency relapse|0|||
124487766|NCT02786537|447742313|FG004|As Treated|Opiate dependency relapse|0|||
124487767|NCT02786537|447742314|FG005|As Treated|Opiate dependency relapse|0|||
124487768|NCT02786537|447742309|FG000|As Treated|Drugs stolen from patient|0|||
124487769|NCT02786537|447742310|FG001|As Treated|Drugs stolen from patient|1|||
124487770|NCT02786537|447742311|FG002|As Treated|Drugs stolen from patient|0|||
124487771|NCT02786537|447742312|FG003|As Treated|Drugs stolen from patient|0|||
124487772|NCT02786537|447742313|FG004|As Treated|Drugs stolen from patient|0|||
124487773|NCT02786537|447742314|FG005|As Treated|Drugs stolen from patient|0|||
124487774|NCT02786537|447742309|FG000|As Treated|Advised to stop tx after loss of meds|0|||
124487775|NCT02786537|447742310|FG001|As Treated|Advised to stop tx after loss of meds|1|||
124487776|NCT02786537|447742311|FG002|As Treated|Advised to stop tx after loss of meds|0|||
124487777|NCT02786537|447742312|FG003|As Treated|Advised to stop tx after loss of meds|0|||
124487778|NCT02786537|447742313|FG004|As Treated|Advised to stop tx after loss of meds|0|||
124487779|NCT02786537|447742314|FG005|As Treated|Advised to stop tx after loss of meds|0|||
124487780|NCT02638012|447742315|FG000|Overall Study|Lost to Follow-up|1|||
124487781|NCT00443560|447742316|FG000|Overall Study|No intrathecal dose|58|||
124487782|NCT00443560|447742317|FG001|Overall Study|No intrathecal dose|26|||
124487783|NCT00443560|447742316|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
124487784|NCT00443560|447742317|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
124487785|NCT01494038|447742318|FG000|Overall Study|Protocol Violation|1|||
124487786|NCT01494038|447742319|FG001|Overall Study|Protocol Violation|1|||
124487787|NCT01494038|447742318|FG000|Overall Study|Lost to Follow-up|18|||
124487788|NCT01494038|447742319|FG001|Overall Study|Lost to Follow-up|20|||
124487789|NCT01494038|447742318|FG000|Overall Study|Withdrawal by Subject|44|||
124487790|NCT01494038|447742319|FG001|Overall Study|Withdrawal by Subject|34|||
124487791|NCT01494038|447742318|FG000|Overall Study|Not able to get to clinic|21|||
124487792|NCT01494038|447742319|FG001|Overall Study|Not able to get to clinic|15|||
124487793|NCT01494038|447742318|FG000|Overall Study|Not willing to adhere to reqs|2|||
124487794|NCT01494038|447742319|FG001|Overall Study|Not willing to adhere to reqs|9|||
124487795|NCT01494038|447742318|FG000|Overall Study|Death|2|||
124487796|NCT01494038|447742319|FG001|Overall Study|Death|4|||
124487797|NCT05299892|447742320|FG000|Overall Study|Withdrawal by Subject|2|||
124487798|NCT01458340|447742321|FG000|Overall Study|Adverse Event|5|||
124487799|NCT01458340|447742322|FG001|Overall Study|Adverse Event|4|||
124487800|NCT01458340|447742323|FG002|Overall Study|Adverse Event|2|||
124487801|NCT01458340|447742321|FG000|Overall Study|Lost to Follow-up|3|||
124487802|NCT01458340|447742322|FG001|Overall Study|Lost to Follow-up|3|||
124487803|NCT01458340|447742323|FG002|Overall Study|Lost to Follow-up|10|||
124487804|NCT01458340|447742321|FG000|Overall Study|Miscellaneous|0|||
124487805|NCT01458340|447742322|FG001|Overall Study|Miscellaneous|1|||
124487806|NCT01458340|447742323|FG002|Overall Study|Miscellaneous|0|||
124487807|NCT01458340|447742321|FG000|Overall Study|Physician Decision|1|||
124487808|NCT01458340|447742322|FG001|Overall Study|Physician Decision|1|||
124487809|NCT01458340|447742323|FG002|Overall Study|Physician Decision|2|||
124487810|NCT01458340|447742321|FG000|Overall Study|Protocol Violation|6|||
124487811|NCT01458340|447742322|FG001|Overall Study|Protocol Violation|6|||
124487812|NCT01458340|447742323|FG002|Overall Study|Protocol Violation|5|||
124487813|NCT01458340|447742321|FG000|Overall Study|Withdrawal by Subject|12|||
124487814|NCT01458340|447742322|FG001|Overall Study|Withdrawal by Subject|6|||
124721435|NCT01667133|448603649|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
124721436|NCT01667133|448603650|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
124721437|NCT01667133|448603651|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
124487815|NCT01458340|447742323|FG002|Overall Study|Withdrawal by Subject|4|||
124487816|NCT01126619|447742326|FG000|Overall Study|Not eligible for the study|2|||
124487817|NCT01126619|447742326|FG000|Overall Study|Investigator decision|4|||
124487818|NCT01126619|447742326|FG000|Overall Study|Serious adverse event|1|||
124487819|NCT01126619|447742326|FG000|Overall Study|Withdrawal by Subject|9|||
124487820|NCT01126619|447742326|FG000|Overall Study|Non-compliance|1|||
124487821|NCT03351244|447742327|FG000|Overall Study|Adverse Event|7|||
124487822|NCT03351244|447742328|FG001|Overall Study|Adverse Event|11|||
124487823|NCT03351244|447742329|FG002|Overall Study|Adverse Event|12|||
124487824|NCT03351244|447742327|FG000|Overall Study|Investigator's decision|0|||
124487825|NCT03351244|447742328|FG001|Overall Study|Investigator's decision|0|||
124487826|NCT03351244|447742329|FG002|Overall Study|Investigator's decision|2|||
124487827|NCT03351244|447742327|FG000|Overall Study|System error|0|||
124487828|NCT03351244|447742328|FG001|Overall Study|System error|0|||
124487829|NCT03351244|447742329|FG002|Overall Study|System error|2|||
124487830|NCT03351244|447742327|FG000|Overall Study|COVID-19 restrictions|3|||
124487831|NCT03351244|447742328|FG001|Overall Study|COVID-19 restrictions|0|||
124487832|NCT03351244|447742329|FG002|Overall Study|COVID-19 restrictions|1|||
124487833|NCT03351244|447742327|FG000|Overall Study|Non-compliance|2|||
124487834|NCT03351244|447742328|FG001|Overall Study|Non-compliance|5|||
124487835|NCT03351244|447742329|FG002|Overall Study|Non-compliance|0|||
124487836|NCT03351244|447742327|FG000|Overall Study|Withdrawal by Subject|11|||
124487837|NCT03351244|447742328|FG001|Overall Study|Withdrawal by Subject|16|||
124487838|NCT03351244|447742329|FG002|Overall Study|Withdrawal by Subject|13|||
124487839|NCT03351244|447742327|FG000|Overall Study|Lost to Follow-up|2|||
124487840|NCT03351244|447742328|FG001|Overall Study|Lost to Follow-up|6|||
124487841|NCT03351244|447742329|FG002|Overall Study|Lost to Follow-up|4|||
124487842|NCT03351244|447742327|FG000|Overall Study|Protocol Violation|2|||
124487843|NCT03351244|447742328|FG001|Overall Study|Protocol Violation|2|||
124487844|NCT03351244|447742329|FG002|Overall Study|Protocol Violation|0|||
124487845|NCT00091793|447742330|FG000|Overall Study|Adverse Event|1|||
124487846|NCT00091793|447742331|FG001|Overall Study|Adverse Event|2|||
124487847|NCT00091793|447742330|FG000|Overall Study|Withdrawal by Subject|10|||
124487848|NCT00091793|447742331|FG001|Overall Study|Withdrawal by Subject|15|||
124487849|NCT00091793|447742330|FG000|Overall Study|Ineligibility determined|2|||
124487850|NCT00091793|447742331|FG001|Overall Study|Ineligibility determined|0|||
124487851|NCT00091793|447742330|FG000|Overall Study|Lost to Follow-up|7|||
124487852|NCT00091793|447742331|FG001|Overall Study|Lost to Follow-up|5|||
124487853|NCT00091793|447742330|FG000|Overall Study|Noncompliance|2|||
124487854|NCT00091793|447742331|FG001|Overall Study|Noncompliance|0|||
124487855|NCT00091793|447742330|FG000|Overall Study|Other|2|||
124487856|NCT00091793|447742331|FG001|Overall Study|Other|0|||
124487857|NCT05309083|447742333|FG000|Overall Study|Withdrawal by Subject|2|||
124487858|NCT01165229|447742334|FG000|Overall Study|Serious Adverse Event|456|||
124487859|NCT01165229|447742335|FG001|Overall Study|Serious Adverse Event|487|||
124487860|NCT01165229|447742334|FG000|Overall Study|Non-Serious Adverse Event|47|||
124487861|NCT01165229|447742335|FG001|Overall Study|Non-Serious Adverse Event|15|||
124487862|NCT01165229|447742334|FG000|Overall Study|Protocol Violation|6|||
124487863|NCT01165229|447742335|FG001|Overall Study|Protocol Violation|8|||
124487864|NCT01165229|447742334|FG000|Overall Study|Withdrawal by Subject|387|||
124487865|NCT01165229|447742335|FG001|Overall Study|Withdrawal by Subject|396|||
124487866|NCT01165229|447742334|FG000|Overall Study|Migrated/moved from study area|51|||
124487867|NCT01165229|447742335|FG001|Overall Study|Migrated/moved from study area|46|||
124487868|NCT01165229|447742334|FG000|Overall Study|Lost to Follow-up|123|||
124487869|NCT01165229|447742335|FG001|Overall Study|Lost to Follow-up|133|||
124487870|NCT01165229|447742334|FG000|Overall Study|Suspected HZ Episode|2|||
124487871|NCT01165229|447742335|FG001|Overall Study|Suspected HZ Episode|2|||
124487872|NCT01165229|447742334|FG000|Overall Study|No reason from the subject|108|||
124487873|NCT01165229|447742335|FG001|Overall Study|No reason from the subject|102|||
124487874|NCT01165229|447742334|FG000|Overall Study|Unknown completion status|0|||
124487875|NCT01165229|447742335|FG001|Overall Study|Unknown completion status|1|||
124487876|NCT00881205|447742339|FG000|Overall Study|Adverse Event|8|||
124487877|NCT00881205|447742340|FG001|Overall Study|Adverse Event|3|||
124487878|NCT00881205|447742339|FG000|Overall Study|Withdrawal by Subject|1|||
124487879|NCT00881205|447742340|FG001|Overall Study|Withdrawal by Subject|2|||
124487880|NCT00881205|447742339|FG000|Overall Study|Lost to Follow-up|0|||
124487881|NCT00881205|447742340|FG001|Overall Study|Lost to Follow-up|1|||
124487882|NCT00881205|447742339|FG000|Overall Study|Administrative problems|1|||
124721438|NCT01667133|448603652|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
124487883|NCT00881205|447742340|FG001|Overall Study|Administrative problems|1|||
124487884|NCT00881205|447742339|FG000|Overall Study|Condition no longer requires drug|1|||
124487885|NCT00881205|447742340|FG001|Overall Study|Condition no longer requires drug|0|||
124487886|NCT00550238|447742341|FG000|Overall Study|Adverse Event|88|||
124487887|NCT00550238|447742341|FG000|Overall Study|Death|34|||
124487888|NCT00550238|447742341|FG000|Overall Study|Disease progression|46|||
124487889|NCT00550238|447742341|FG000|Overall Study|Withdrawal by Subject|167|||
124557745|NCT02270983|448001313|FG002|Overall Study|Withdrawal by Subject|2|||
124557746|NCT02270983|448001311|FG000|Overall Study|Lost to Follow-up|1|||
124487890|NCT00550238|447742341|FG000|Overall Study|Physician Decision|31|||
124487891|NCT00550238|447742341|FG000|Overall Study|Patient noncompliance|25|||
124487892|NCT00550238|447742341|FG000|Overall Study|Lost to Follow-up|13|||
124487893|NCT00550238|447742341|FG000|Overall Study|Sponsor decision|55|||
124487894|NCT00537745|447742342|FG000|Overall Study|Did not meet eligibility criteria|2|||
124487895|NCT00537745|447742342|FG000|Overall Study|Withdrawal by Subject|2|||
124487896|NCT00537745|447742342|FG000|Overall Study|Subject unable to provide Interlock info|1|||
124487897|NCT00845429|447742347|FG000|Overall Study|Protocol Violation|5|||
124487898|NCT00845429|447742348|FG001|Overall Study|Protocol Violation|4|||
124487899|NCT00845429|447742349|FG002|Overall Study|Protocol Violation|7|||
124487900|NCT00845429|447742347|FG000|Overall Study|Lost to Follow-up|7|||
124487901|NCT00845429|447742348|FG001|Overall Study|Lost to Follow-up|9|||
124487902|NCT00845429|447742349|FG002|Overall Study|Lost to Follow-up|10|||
124487903|NCT00845429|447742347|FG000|Overall Study|Withdrawal by Subject|2|||
124487904|NCT00845429|447742348|FG001|Overall Study|Withdrawal by Subject|2|||
124487905|NCT00845429|447742349|FG002|Overall Study|Withdrawal by Subject|2|||
124487906|NCT00845429|447742347|FG000|Overall Study|Serious adverse event|0|||
124487907|NCT00845429|447742348|FG001|Overall Study|Serious adverse event|0|||
124487908|NCT00845429|447742349|FG002|Overall Study|Serious adverse event|1|||
124487909|NCT01856673|447742350|FG000|Overall Study|Withdrawal by Subject|44|||
124487910|NCT01856673|447742351|FG001|Overall Study|Withdrawal by Subject|50|||
124487911|NCT01856673|447742352|FG002|Overall Study|Withdrawal by Subject|33|||
124487912|NCT01856673|447742350|FG000|Overall Study|Lost to Follow-up|31|||
124487913|NCT01856673|447742351|FG001|Overall Study|Lost to Follow-up|34|||
124487914|NCT01856673|447742352|FG002|Overall Study|Lost to Follow-up|0|||
124487915|NCT01856673|447742350|FG000|Overall Study|Unknown reasons|9|||
124487916|NCT01856673|447742351|FG001|Overall Study|Unknown reasons|0|||
124487917|NCT01856673|447742352|FG002|Overall Study|Unknown reasons|0|||
124487918|NCT01856673|447742350|FG000|Overall Study|Psychologist decision|1|||
124487919|NCT01856673|447742351|FG001|Overall Study|Psychologist decision|0|||
124487920|NCT01856673|447742352|FG002|Overall Study|Psychologist decision|0|||
124487921|NCT01856673|447742350|FG000|Overall Study|Paperwork errors|8|||
124487922|NCT01856673|447742351|FG001|Overall Study|Paperwork errors|0|||
124487923|NCT01856673|447742352|FG002|Overall Study|Paperwork errors|0|||
124487924|NCT01856673|447742350|FG000|Overall Study|Death|1|||
124487925|NCT01856673|447742351|FG001|Overall Study|Death|1|||
124487926|NCT01856673|447742352|FG002|Overall Study|Death|0|||
124487927|NCT01856673|447742350|FG000|Overall Study|Protocol Violation|1|||
124487928|NCT01856673|447742351|FG001|Overall Study|Protocol Violation|0|||
124487929|NCT01856673|447742352|FG002|Overall Study|Protocol Violation|1|||
124487930|NCT04332419|447742353|FG000|Overall Study|Withdrawal by Subject|1|||
124487931|NCT00184054|447742354|FG000|Overall Study|Adverse Event|1|||
124487932|NCT00519532|447742357|FG000|Overall Study|Adverse Event|11|||
124487933|NCT00519532|447742357|FG000|Overall Study|Withdrawal by Subject|5|||
124487934|NCT00519532|447742357|FG000|Overall Study|Lost to Follow-up|2|||
124487935|NCT03138564|447742358|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
124487936|NCT03138564|447742359|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
124487937|NCT03138564|447742358|FG000|Overall Study|Lost to Follow-up|16|||
124487938|NCT03138564|447742359|FG001|Overall Study|Lost to Follow-up|2|||
124487939|NCT03138564|447742358|FG000|Overall Study|Withdrawal by Subject|48|||
124487940|NCT03138564|447742359|FG001|Overall Study|Withdrawal by Subject|4|||
124487941|NCT03138564|447742358|FG000|Overall Study|No longer met eligibility criteria|2|||
124487942|NCT03138564|447742359|FG001|Overall Study|No longer met eligibility criteria|0|||
124487943|NCT03138564|447742358|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
124487944|NCT03138564|447742359|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
124487945|NCT03138564|447742358|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
124487946|NCT03138564|447742359|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
124487947|NCT03138564|447742358|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
124487948|NCT03138564|447742359|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
124487949|NCT03138564|447742358|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
124487950|NCT03138564|447742359|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
124487951|NCT03443024|447742363|FG000|Overall Study|Adverse Event|2|||
124487952|NCT03443024|447742364|FG001|Overall Study|Adverse Event|4|||
124487953|NCT03443024|447742365|FG002|Overall Study|Adverse Event|3|||
124487954|NCT03443024|447742366|FG003|Overall Study|Adverse Event|1|||
124487955|NCT03443024|447742363|FG000|Overall Study|Lost to Follow-up|9|||
124487956|NCT03443024|447742364|FG001|Overall Study|Lost to Follow-up|9|||
124487957|NCT03443024|447742365|FG002|Overall Study|Lost to Follow-up|7|||
124487958|NCT03443024|447742366|FG003|Overall Study|Lost to Follow-up|5|||
124487959|NCT03443024|447742363|FG000|Overall Study|Withdrawal by Subject|8|||
124487960|NCT03443024|447742364|FG001|Overall Study|Withdrawal by Subject|15|||
124721439|NCT01667133|448603653|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
124721440|NCT01667133|448603654|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
124721441|NCT01667133|448603655|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
124721442|NCT01667133|448603656|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
124721443|NCT01667133|448603657|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
124721444|NCT01667133|448603658|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
124721445|NCT01667133|448603659|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
124721446|NCT01667133|448603648|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
124721447|NCT01667133|448603649|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
124721448|NCT01667133|448603650|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
124487961|NCT03443024|447742365|FG002|Overall Study|Withdrawal by Subject|9|||
124487962|NCT03443024|447742366|FG003|Overall Study|Withdrawal by Subject|23|||
124487963|NCT03443024|447742363|FG000|Overall Study|Physician Decision|1|||
124487964|NCT03443024|447742364|FG001|Overall Study|Physician Decision|2|||
124487965|NCT03443024|447742365|FG002|Overall Study|Physician Decision|0|||
124487966|NCT03443024|447742366|FG003|Overall Study|Physician Decision|1|||
124487967|NCT03443024|447742363|FG000|Overall Study|Sponsor Decision|1|||
124487968|NCT03443024|447742364|FG001|Overall Study|Sponsor Decision|1|||
124487969|NCT03443024|447742365|FG002|Overall Study|Sponsor Decision|0|||
124487970|NCT03443024|447742366|FG003|Overall Study|Sponsor Decision|0|||
124487971|NCT03443024|447742363|FG000|Overall Study|Protocol Deviation|0|||
124487972|NCT03443024|447742364|FG001|Overall Study|Protocol Deviation|0|||
124487973|NCT03443024|447742365|FG002|Overall Study|Protocol Deviation|0|||
124487974|NCT03443024|447742366|FG003|Overall Study|Protocol Deviation|2|||
124487975|NCT01548638|447742368|FG000|Overall Study|Protocol Violation|3|||
124487976|NCT01548638|447742368|FG000|Overall Study|Withdrawal by Subject|1|||
124487977|NCT05593432|447742369|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
124487978|NCT05593432|447742370|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
124487979|NCT05593432|447742371|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
124487980|NCT05593432|447742372|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
124487981|NCT05593432|447742369|FG000|16-Week OLE Period|Lack of Efficacy|0|||
124487982|NCT05593432|447742370|FG001|16-Week OLE Period|Lack of Efficacy|0|||
124487983|NCT05593432|447742371|FG002|16-Week OLE Period|Lack of Efficacy|0|||
124487984|NCT05593432|447742372|FG003|16-Week OLE Period|Lack of Efficacy|1|||
124487985|NCT05593432|447742369|FG000|16-Week OLE Period|Lost to Follow-up|0|||
124487986|NCT05593432|447742370|FG001|16-Week OLE Period|Lost to Follow-up|0|||
124487987|NCT05593432|447742371|FG002|16-Week OLE Period|Lost to Follow-up|1|||
124487988|NCT05593432|447742372|FG003|16-Week OLE Period|Lost to Follow-up|2|||
124487989|NCT05593432|447742369|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
124487990|NCT05593432|447742370|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
124487991|NCT05593432|447742371|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
124487992|NCT05593432|447742372|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
124487993|NCT02609399|447742375|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
124487994|NCT02609399|447742376|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
124487995|NCT02609399|447742375|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
124487996|NCT02609399|447742376|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
124487997|NCT02609399|447742375|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
124487998|NCT02609399|447742376|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
124487999|NCT02986373|447742377|FG000|Overall Study|Adverse Event|4|||
124488000|NCT02986373|447742377|FG000|Overall Study|Lost to Follow-up|1|||
124488001|NCT02986373|447742377|FG000|Overall Study|Withdrawal by Subject|10|||
124488002|NCT02986373|447742377|FG000|Overall Study|Other|24|||
124488003|NCT04800315|447742378|FG000|Randomization|Did not receive study treatment|1|||
124488004|NCT04800315|447742379|FG001|Randomization|Did not receive study treatment|0|||
124488005|NCT04800315|447742380|FG002|Randomization|Did not receive study treatment|0|||
124488006|NCT04800315|447742381|FG003|Randomization|Did not receive study treatment|0|||
124488007|NCT04800315|447742378|FG000|Treatment Period|Adverse Event|4|||
124488008|NCT04800315|447742379|FG001|Treatment Period|Adverse Event|2|||
124488009|NCT04800315|447742380|FG002|Treatment Period|Adverse Event|1|||
124488010|NCT04800315|447742381|FG003|Treatment Period|Adverse Event|2|||
124488011|NCT04800315|447742378|FG000|Treatment Period|Lack of Efficacy|1|||
124488012|NCT04800315|447742379|FG001|Treatment Period|Lack of Efficacy|0|||
124488013|NCT04800315|447742380|FG002|Treatment Period|Lack of Efficacy|0|||
124488014|NCT04800315|447742381|FG003|Treatment Period|Lack of Efficacy|3|||
124488015|NCT04800315|447742378|FG000|Treatment Period|Lost to Follow-up|0|||
124488016|NCT04800315|447742379|FG001|Treatment Period|Lost to Follow-up|1|||
124488017|NCT04800315|447742380|FG002|Treatment Period|Lost to Follow-up|2|||
124488018|NCT04800315|447742381|FG003|Treatment Period|Lost to Follow-up|2|||
124721449|NCT01667133|448603651|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
124721450|NCT01667133|448603652|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
124488019|NCT04800315|447742378|FG000|Treatment Period|Withdrawal by participant|0|||
124488020|NCT04800315|447742379|FG001|Treatment Period|Withdrawal by participant|0|||
124488021|NCT04800315|447742380|FG002|Treatment Period|Withdrawal by participant|0|||
124488022|NCT04800315|447742381|FG003|Treatment Period|Withdrawal by participant|4|||
124488023|NCT04800315|447742378|FG000|Treatment Period|Other Reasons|0|||
124488024|NCT04800315|447742379|FG001|Treatment Period|Other Reasons|2|||
124488025|NCT04800315|447742380|FG002|Treatment Period|Other Reasons|0|||
124488026|NCT04800315|447742381|FG003|Treatment Period|Other Reasons|1|||
124488027|NCT00753922|447742382|FG000|Overall Study|Lost to Follow-up|155|||
124488028|NCT00753922|447742383|FG001|Overall Study|Lost to Follow-up|24|||
124488029|NCT00753922|447742384|FG002|Overall Study|Lost to Follow-up|28|||
124488030|NCT00753922|447742385|FG003|Overall Study|Lost to Follow-up|5|||
124488031|NCT00753922|447742382|FG000|Overall Study|Withdrawal by Subject|9|||
124488032|NCT00753922|447742383|FG001|Overall Study|Withdrawal by Subject|11|||
124488033|NCT00753922|447742384|FG002|Overall Study|Withdrawal by Subject|4|||
124488034|NCT00753922|447742385|FG003|Overall Study|Withdrawal by Subject|2|||
124488035|NCT00753922|447742382|FG000|Overall Study|Patient Non-compliance|55|||
124488036|NCT00753922|447742383|FG001|Overall Study|Patient Non-compliance|22|||
124488037|NCT00753922|447742384|FG002|Overall Study|Patient Non-compliance|14|||
124488038|NCT00753922|447742385|FG003|Overall Study|Patient Non-compliance|11|||
124488039|NCT00753922|447742382|FG000|Overall Study|Patients Not Completing Visit|11|||
124488040|NCT00753922|447742383|FG001|Overall Study|Patients Not Completing Visit|0|||
124488041|NCT00753922|447742384|FG002|Overall Study|Patients Not Completing Visit|1|||
124488042|NCT00753922|447742385|FG003|Overall Study|Patients Not Completing Visit|0|||
124488043|NCT00753922|447742382|FG000|Overall Study|Death|2|||
124488044|NCT00753922|447742383|FG001|Overall Study|Death|23|||
124488045|NCT00753922|447742384|FG002|Overall Study|Death|2|||
124488046|NCT00753922|447742385|FG003|Overall Study|Death|1|||
124488047|NCT00753922|447742382|FG000|Overall Study|Discontinuation Due to Explantation|14|||
124488048|NCT00753922|447742383|FG001|Overall Study|Discontinuation Due to Explantation|14|||
124488049|NCT00753922|447742384|FG002|Overall Study|Discontinuation Due to Explantation|14|||
124488050|NCT00753922|447742385|FG003|Overall Study|Discontinuation Due to Explantation|4|||
124488051|NCT03598777|447742386|FG000|Overall Study|Study Terminated by Sponsor|3|||
124488052|NCT03598777|447742387|FG001|Overall Study|Study Terminated by Sponsor|0|||
124488053|NCT03598777|447742388|FG002|Overall Study|Study Terminated by Sponsor|0|||
124488054|NCT03598777|447742389|FG003|Overall Study|Study Terminated by Sponsor|0|||
124488055|NCT03598777|447742390|FG004|Overall Study|Study Terminated by Sponsor|15|||
124488056|NCT03598777|447742386|FG000|Overall Study|Withdrawal by Subject|1|||
124488057|NCT03598777|447742387|FG001|Overall Study|Withdrawal by Subject|1|||
124488058|NCT03598777|447742388|FG002|Overall Study|Withdrawal by Subject|0|||
124488059|NCT03598777|447742389|FG003|Overall Study|Withdrawal by Subject|0|||
124488060|NCT03598777|447742390|FG004|Overall Study|Withdrawal by Subject|0|||
124488061|NCT03598777|447742386|FG000|Overall Study|Adverse Event|1|||
124488062|NCT03598777|447742387|FG001|Overall Study|Adverse Event|0|||
124488063|NCT03598777|447742388|FG002|Overall Study|Adverse Event|0|||
124488064|NCT03598777|447742389|FG003|Overall Study|Adverse Event|0|||
124488065|NCT03598777|447742390|FG004|Overall Study|Adverse Event|0|||
124488066|NCT03598777|447742386|FG000|Overall Study|Lost to Follow-up|1|||
124488067|NCT03598777|447742387|FG001|Overall Study|Lost to Follow-up|0|||
124488068|NCT03598777|447742388|FG002|Overall Study|Lost to Follow-up|0|||
124488069|NCT03598777|447742389|FG003|Overall Study|Lost to Follow-up|0|||
124488070|NCT03598777|447742390|FG004|Overall Study|Lost to Follow-up|0|||
124488071|NCT01919411|447742391|FG000|Overall Study|Lost to Follow-up|2|||
124488072|NCT01919411|447742392|FG001|Overall Study|Lost to Follow-up|4|||
124488073|NCT01919411|447742391|FG000|Overall Study|Physician Decision|1|||
124488074|NCT01919411|447742392|FG001|Overall Study|Physician Decision|0|||
124488075|NCT01919411|447742391|FG000|Overall Study|Protocol Violation|2|||
124488076|NCT01919411|447742392|FG001|Overall Study|Protocol Violation|1|||
124488077|NCT00072189|447742393|FG000|Overall Study|Withdrawal by Subject|1|||
124488078|NCT01933672|447742394|FG000|Metformin Run-in Period|Adverse Event|1|||
124488079|NCT01933672|447742395|FG001|Metformin Run-in Period|Adverse Event|0|||
124488080|NCT01933672|447742396|FG002|Metformin Run-in Period|Adverse Event|0|||
124488081|NCT01933672|447742397|FG003|Metformin Run-in Period|Adverse Event|0|||
124488082|NCT01933672|447742398|FG004|Metformin Run-in Period|Adverse Event|0|||
124488083|NCT01933672|447742399|FG005|Metformin Run-in Period|Adverse Event|0|||
124488084|NCT01933672|447742400|FG006|Metformin Run-in Period|Adverse Event|0|||
124488085|NCT01933672|447742394|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
124488086|NCT01933672|447742395|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
124488087|NCT01933672|447742396|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
124488088|NCT01933672|447742397|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
124488089|NCT01933672|447742398|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
124488090|NCT01933672|447742399|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
124488091|NCT01933672|447742400|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
124488092|NCT01933672|447742394|FG000|Metformin Run-in Period|Other|5|||
124488093|NCT01933672|447742395|FG001|Metformin Run-in Period|Other|0|||
124488094|NCT01933672|447742396|FG002|Metformin Run-in Period|Other|0|||
124488095|NCT01933672|447742397|FG003|Metformin Run-in Period|Other|0|||
124488096|NCT01933672|447742398|FG004|Metformin Run-in Period|Other|0|||
124488097|NCT01933672|447742399|FG005|Metformin Run-in Period|Other|0|||
124488098|NCT01933672|447742400|FG006|Metformin Run-in Period|Other|0|||
124488099|NCT01933672|447742394|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
124721451|NCT01667133|448603653|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
124721452|NCT01667133|448603654|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
124721453|NCT01667133|448603655|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
124721454|NCT01667133|448603656|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
124721455|NCT01667133|448603657|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
124721456|NCT01667133|448603658|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
124488100|NCT01933672|447742395|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
124488101|NCT01933672|447742396|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
124488102|NCT01933672|447742397|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
124488103|NCT01933672|447742398|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
124488104|NCT01933672|447742399|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
124488105|NCT01933672|447742400|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
124488106|NCT01933672|447742394|FG000|First Intervention Period (12-16 Days)|Other|0|||
124488107|NCT01933672|447742395|FG001|First Intervention Period (12-16 Days)|Other|0|||
124488108|NCT01933672|447742396|FG002|First Intervention Period (12-16 Days)|Other|1|||
124488109|NCT01933672|447742397|FG003|First Intervention Period (12-16 Days)|Other|0|||
124488110|NCT01933672|447742398|FG004|First Intervention Period (12-16 Days)|Other|0|||
124488111|NCT01933672|447742399|FG005|First Intervention Period (12-16 Days)|Other|1|||
124488112|NCT01933672|447742400|FG006|First Intervention Period (12-16 Days)|Other|0|||
124488113|NCT01933672|447742394|FG000|Second Intervention Period (12-16 Days)|Other|0|||
124488114|NCT01933672|447742395|FG001|Second Intervention Period (12-16 Days)|Other|1|||
124488115|NCT01933672|447742396|FG002|Second Intervention Period (12-16 Days)|Other|1|||
124488116|NCT01933672|447742397|FG003|Second Intervention Period (12-16 Days)|Other|0|||
124488117|NCT01933672|447742398|FG004|Second Intervention Period (12-16 Days)|Other|0|||
124488118|NCT01933672|447742399|FG005|Second Intervention Period (12-16 Days)|Other|0|||
124488119|NCT01933672|447742400|FG006|Second Intervention Period (12-16 Days)|Other|0|||
124488120|NCT01933672|447742394|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
124488121|NCT01933672|447742395|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
124488122|NCT01933672|447742396|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
124488123|NCT01933672|447742397|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
124488124|NCT01933672|447742398|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
124488125|NCT01933672|447742399|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
124488126|NCT01933672|447742400|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
124488127|NCT01933672|447742394|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
124488128|NCT01933672|447742395|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
124488129|NCT01933672|447742396|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
124488130|NCT01933672|447742397|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
124488131|NCT01933672|447742398|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
124488132|NCT01933672|447742399|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
124488133|NCT01933672|447742400|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
124488134|NCT02426086|447742404|FG000|Overall Study|Death|33|||
124488135|NCT02426086|447742405|FG001|Overall Study|Death|36|||
124488136|NCT02426086|447742404|FG000|Overall Study|Lost to Follow-up|2|||
124488137|NCT02426086|447742405|FG001|Overall Study|Lost to Follow-up|0|||
124488138|NCT02426086|447742404|FG000|Overall Study|Study Terminated by Sponsor|5|||
124488139|NCT02426086|447742405|FG001|Overall Study|Study Terminated by Sponsor|14|||
124488140|NCT02426086|447742404|FG000|Overall Study|Withdrawal by Subject|8|||
124488141|NCT02426086|447742405|FG001|Overall Study|Withdrawal by Subject|9|||
124488142|NCT00524303|447742406|FG000|Overall Study|Lost to Follow-up|6|||
124488143|NCT00524303|447742407|FG001|Overall Study|Lost to Follow-up|0|||
124488144|NCT00524303|447742408|FG002|Overall Study|Lost to Follow-up|3|||
124488145|NCT00524303|447742406|FG000|Overall Study|Protocol Violation|0|||
124488146|NCT00524303|447742407|FG001|Overall Study|Protocol Violation|1|||
124488147|NCT00524303|447742408|FG002|Overall Study|Protocol Violation|1|||
124488148|NCT00524303|447742406|FG000|Overall Study|Withdrawal by Subject|3|||
124488149|NCT00524303|447742407|FG001|Overall Study|Withdrawal by Subject|0|||
124488150|NCT00524303|447742408|FG002|Overall Study|Withdrawal by Subject|4|||
124488151|NCT00524303|447742406|FG000|Overall Study|Death|0|||
124488152|NCT00524303|447742407|FG001|Overall Study|Death|2|||
124488153|NCT00524303|447742408|FG002|Overall Study|Death|3|||
124488154|NCT00524303|447742406|FG000|Overall Study|Adverse Event|1|||
124488155|NCT00524303|447742407|FG001|Overall Study|Adverse Event|2|||
124488156|NCT00524303|447742408|FG002|Overall Study|Adverse Event|3|||
124488157|NCT00524303|447742406|FG000|Overall Study|Did not Complete Study Dosing|1|||
124488158|NCT00524303|447742407|FG001|Overall Study|Did not Complete Study Dosing|0|||
124488159|NCT00524303|447742408|FG002|Overall Study|Did not Complete Study Dosing|0|||
124488160|NCT00524303|447742406|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
124488161|NCT00524303|447742407|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
124488162|NCT00524303|447742408|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
124488163|NCT00524303|447742406|FG000|Overall Study|Disease Progression|0|||
124721457|NCT01667133|448603659|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
124488164|NCT00524303|447742407|FG001|Overall Study|Disease Progression|4|||
124488165|NCT00524303|447742408|FG002|Overall Study|Disease Progression|1|||
124488166|NCT00524303|447742406|FG000|Overall Study|Disease Recurrence|0|||
124488167|NCT00524303|447742407|FG001|Overall Study|Disease Recurrence|1|||
124488168|NCT00524303|447742408|FG002|Overall Study|Disease Recurrence|0|||
124488169|NCT00524303|447742406|FG000|Overall Study|Sponsor Request|0|||
124488170|NCT00524303|447742407|FG001|Overall Study|Sponsor Request|0|||
124488171|NCT00524303|447742408|FG002|Overall Study|Sponsor Request|1|||
124488172|NCT00524303|447742406|FG000|Overall Study|Physician Decision|0|||
124488173|NCT00524303|447742407|FG001|Overall Study|Physician Decision|0|||
124488174|NCT00524303|447742408|FG002|Overall Study|Physician Decision|1|||
124488175|NCT00524303|447742406|FG000|Overall Study|Completed 5 years|0|||
124488176|NCT00524303|447742407|FG001|Overall Study|Completed 5 years|0|||
124488177|NCT00524303|447742408|FG002|Overall Study|Completed 5 years|1|||
124488178|NCT00840463|447742412|FG000|Overall Study|Adverse Event|1|||
124488179|NCT00840463|447742413|FG001|Overall Study|Adverse Event|0|||
124488180|NCT01739595|447742415|FG000|Overall Study|Adverse Event|3|||
124488181|NCT01739595|447742416|FG001|Overall Study|Adverse Event|0|||
124488182|NCT01739595|447742417|FG002|Overall Study|Adverse Event|0|||
124488183|NCT01739595|447742415|FG000|Overall Study|Lost to Follow-up|2|||
124488184|NCT01739595|447742416|FG001|Overall Study|Lost to Follow-up|0|||
124488185|NCT01739595|447742417|FG002|Overall Study|Lost to Follow-up|0|||
124488186|NCT01739595|447742415|FG000|Overall Study|Withdrawal by Subject|2|||
124488187|NCT01739595|447742416|FG001|Overall Study|Withdrawal by Subject|1|||
124488188|NCT01739595|447742417|FG002|Overall Study|Withdrawal by Subject|2|||
124488189|NCT01739595|447742415|FG000|Overall Study|Eligibility issue|3|||
124488190|NCT01739595|447742416|FG001|Overall Study|Eligibility issue|0|||
124488191|NCT01739595|447742417|FG002|Overall Study|Eligibility issue|0|||
124488192|NCT01739595|447742415|FG000|Overall Study|Protocol Violation|1|||
124488193|NCT01739595|447742416|FG001|Overall Study|Protocol Violation|0|||
124488194|NCT01739595|447742417|FG002|Overall Study|Protocol Violation|0|||
124488195|NCT01739595|447742415|FG000|Overall Study|Lab assessment|1|||
124488196|NCT01739595|447742416|FG001|Overall Study|Lab assessment|0|||
124488197|NCT01739595|447742417|FG002|Overall Study|Lab assessment|0|||
124488198|NCT01739595|447742415|FG000|Overall Study|Drug discrepancy|1|||
124488199|NCT01739595|447742416|FG001|Overall Study|Drug discrepancy|0|||
124488200|NCT01739595|447742417|FG002|Overall Study|Drug discrepancy|0|||
124488201|NCT02515669|447742418|FG000|228 Week Open-Label Phase|Other|0|||
124488202|NCT02515669|447742419|FG001|228 Week Open-Label Phase|Other|0|||
124488203|NCT02515669|447742420|FG002|228 Week Open-Label Phase|Other|1|||
124488204|NCT02515669|447742421|FG003|228 Week Open-Label Phase|Other|4|||
124488205|NCT02515669|447742418|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
124488206|NCT02515669|447742419|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
124488207|NCT02515669|447742420|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
124488208|NCT02515669|447742421|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
124488209|NCT02515669|447742418|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
124488210|NCT02515669|447742419|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
124488211|NCT02515669|447742420|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
124488212|NCT02515669|447742421|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
124488213|NCT02515669|447742418|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
124488214|NCT02515669|447742419|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
124488215|NCT02515669|447742420|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
124488216|NCT02515669|447742421|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
124488217|NCT02515669|447742418|FG000|228 Week Open-Label Phase|Missing|0|||
124488218|NCT02515669|447742419|FG001|228 Week Open-Label Phase|Missing|2|||
124488219|NCT02515669|447742420|FG002|228 Week Open-Label Phase|Missing|2|||
124488220|NCT02515669|447742421|FG003|228 Week Open-Label Phase|Missing|2|||
124488221|NCT01676116|447742425|FG000|Overall Study|Withdrawal criteria|2|||
124488222|NCT01676116|447742426|FG001|Overall Study|Withdrawal criteria|14|||
124488223|NCT01676116|447742425|FG000|Overall Study|Adverse Event|1|||
124488224|NCT01676116|447742426|FG001|Overall Study|Adverse Event|2|||
124488225|NCT01676116|447742425|FG000|Overall Study|Unclassified|4|||
124488226|NCT01676116|447742426|FG001|Overall Study|Unclassified|10|||
124488227|NCT01676116|447742425|FG000|Overall Study|Protocol Violation|9|||
124488228|NCT01676116|447742426|FG001|Overall Study|Protocol Violation|3|||
124488229|NCT00778999|447742427|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
124488230|NCT00778999|447742428|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
124488231|NCT00778999|447742427|FG000|Overall Study|Did not receive recFSH|14|||
124771959|NCT02141295|448796332|FG001|Overall Study|Reason not specified|9|||
124488232|NCT00778999|447742428|FG001|Overall Study|Did not receive recFSH|20|||
124488233|NCT02032524|447742429|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
124488234|NCT02032524|447742430|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
124488235|NCT02032524|447742431|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
124488236|NCT02032524|447742432|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
124488237|NCT02032524|447742433|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
124488238|NCT02032524|447742434|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
124488239|NCT02032524|447742429|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
124488240|NCT02032524|447742430|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
124488241|NCT02032524|447742431|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
124488242|NCT02032524|447742432|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
124488243|NCT02032524|447742433|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
124488244|NCT02032524|447742434|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
124488245|NCT02032524|447742429|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
124488246|NCT02032524|447742430|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
124488247|NCT02032524|447742431|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
124488248|NCT02032524|447742432|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
124488249|NCT02032524|447742433|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
124488250|NCT02032524|447742434|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
124488251|NCT02032524|447742429|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
124488252|NCT02032524|447742430|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
124488253|NCT02032524|447742431|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
124488254|NCT02032524|447742432|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
124488255|NCT02032524|447742433|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
124488256|NCT02032524|447742434|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
124488257|NCT02032524|447742429|FG000|Period 2: LTS13769 Study|Other|0|||
124488258|NCT02032524|447742430|FG001|Period 2: LTS13769 Study|Other|0|||
124488259|NCT02032524|447742431|FG002|Period 2: LTS13769 Study|Other|0|||
124488260|NCT02032524|447742432|FG003|Period 2: LTS13769 Study|Other|0|||
124488261|NCT02032524|447742433|FG004|Period 2: LTS13769 Study|Other|0|||
124488262|NCT02032524|447742434|FG005|Period 2: LTS13769 Study|Other|1|||
124488263|NCT02975349|447742437|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124488264|NCT02975349|447742438|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124488265|NCT02975349|447742439|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124488266|NCT02975349|447742440|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
124488267|NCT02975349|447742441|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
124488268|NCT02975349|447742442|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124488269|NCT02975349|447742443|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124488270|NCT02975349|447742437|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
124488271|NCT02975349|447742438|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124488272|NCT02975349|447742439|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124488273|NCT02975349|447742440|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124488274|NCT02975349|447742441|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124488275|NCT02975349|447742442|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124488276|NCT02975349|447742443|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124488277|NCT02975349|447742437|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
124488278|NCT02975349|447742438|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
124488279|NCT02975349|447742439|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
124488280|NCT02975349|447742440|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
124488281|NCT02975349|447742441|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
124488282|NCT02975349|447742442|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
124488283|NCT02975349|447742443|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
124488284|NCT02975349|447742437|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
124488285|NCT02975349|447742438|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
124488286|NCT02975349|447742439|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
124488287|NCT02975349|447742440|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
124488288|NCT02975349|447742441|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
124488289|NCT02975349|447742442|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
124488290|NCT02975349|447742443|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
124488291|NCT02975349|447742437|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
124488292|NCT02975349|447742438|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
124488293|NCT02975349|447742439|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
124488294|NCT02975349|447742440|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
124488295|NCT02975349|447742441|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
124488296|NCT02975349|447742442|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
124488297|NCT02975349|447742443|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
124488298|NCT02975349|447742437|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
124488299|NCT02975349|447742438|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
124488300|NCT02975349|447742439|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
124488301|NCT02975349|447742440|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
124488302|NCT02975349|447742441|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
124488303|NCT02975349|447742442|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
124488304|NCT02975349|447742443|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
124488305|NCT02975349|447742437|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
124488306|NCT02975349|447742438|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
124488307|NCT02975349|447742439|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
124488308|NCT02975349|447742440|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
124488309|NCT02975349|447742441|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
124488310|NCT02975349|447742442|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
124488311|NCT02975349|447742443|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
124488312|NCT02975349|447742437|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
124488313|NCT02975349|447742438|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
124488314|NCT02975349|447742439|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
124488315|NCT02975349|447742440|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
124488316|NCT02975349|447742441|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
124488317|NCT02975349|447742442|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
124488318|NCT02975349|447742443|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
124488319|NCT02975349|447742437|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
124488320|NCT02975349|447742438|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
124488321|NCT02975349|447742439|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
124488322|NCT02975349|447742440|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
124488323|NCT02975349|447742441|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
124488324|NCT02975349|447742442|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
124488325|NCT02975349|447742443|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
124488326|NCT02975349|447742437|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
124488327|NCT02975349|447742438|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
124488328|NCT02975349|447742439|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
124488329|NCT02975349|447742440|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
124488330|NCT02975349|447742441|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
124488331|NCT02975349|447742442|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
124488332|NCT02975349|447742443|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
124488333|NCT02975349|447742437|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
124488334|NCT02975349|447742438|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
124488335|NCT02975349|447742439|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
124488336|NCT02975349|447742440|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
124488337|NCT02975349|447742441|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
124488338|NCT02975349|447742442|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
124488339|NCT02975349|447742443|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
124488340|NCT02975349|447742437|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
124488341|NCT02975349|447742438|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
124488342|NCT02975349|447742439|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
124488343|NCT02975349|447742440|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
124488344|NCT02975349|447742441|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
124488345|NCT02975349|447742442|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
124488346|NCT02975349|447742443|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
124488347|NCT02975349|447742437|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
124488348|NCT02975349|447742438|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
124488349|NCT02975349|447742439|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
124488350|NCT02975349|447742440|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
124488351|NCT02975349|447742441|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
124488352|NCT02975349|447742442|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
124488353|NCT02975349|447742443|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
124488354|NCT02975349|447742437|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
124488355|NCT02975349|447742438|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
124488356|NCT02975349|447742439|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
124488357|NCT02975349|447742440|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
124488358|NCT02975349|447742441|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
124488359|NCT02975349|447742442|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
124721458|NCT01667133|448603648|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
124488360|NCT02975349|447742443|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
124488361|NCT02975349|447742437|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
124488362|NCT02975349|447742438|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
124488363|NCT02975349|447742439|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
124488364|NCT02975349|447742440|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
124488365|NCT02975349|447742441|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
124488366|NCT02975349|447742442|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
124488367|NCT02975349|447742443|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
124488368|NCT03497689|447742449|FG000|Overall Study|Adverse Event|2|||
124488369|NCT03497689|447742449|FG000|Overall Study|Death|1|||
124488370|NCT03497689|447742449|FG000|Overall Study|Physician Decision|1|||
124488371|NCT03497689|447742449|FG000|Overall Study|Withdrawal by Subject|1|||
124488372|NCT03497689|447742449|FG000|Overall Study|Protocol Violation|2|||
124488373|NCT04358458|447742450|FG000|Overall Study|Death|1|||
124488374|NCT04358458|447742451|FG001|Overall Study|Death|1|||
124488375|NCT04358458|447742452|FG002|Overall Study|Death|3|||
124488376|NCT04358458|447742453|FG003|Overall Study|Death|8|||
124488377|NCT04358458|447742454|FG004|Overall Study|Death|1|||
124488378|NCT04358458|447742455|FG005|Overall Study|Death|6|||
124488379|NCT04358458|447742456|FG006|Overall Study|Death|2|||
124488380|NCT04358458|447742457|FG007|Overall Study|Death|3|||
124488381|NCT04358458|447742450|FG000|Overall Study|Lost to Follow-up|0|||
124488382|NCT04358458|447742451|FG001|Overall Study|Lost to Follow-up|0|||
124488383|NCT04358458|447742452|FG002|Overall Study|Lost to Follow-up|0|||
124488384|NCT04358458|447742453|FG003|Overall Study|Lost to Follow-up|0|||
124488385|NCT04358458|447742454|FG004|Overall Study|Lost to Follow-up|0|||
124488386|NCT04358458|447742455|FG005|Overall Study|Lost to Follow-up|0|||
124488387|NCT04358458|447742456|FG006|Overall Study|Lost to Follow-up|0|||
124488388|NCT04358458|447742457|FG007|Overall Study|Lost to Follow-up|1|||
124488389|NCT04358458|447742450|FG000|Overall Study|Site is closing study participation|0|||
124488390|NCT04358458|447742451|FG001|Overall Study|Site is closing study participation|0|||
124488391|NCT04358458|447742452|FG002|Overall Study|Site is closing study participation|0|||
124488392|NCT04358458|447742453|FG003|Overall Study|Site is closing study participation|1|||
124488393|NCT04358458|447742454|FG004|Overall Study|Site is closing study participation|0|||
124488394|NCT04358458|447742455|FG005|Overall Study|Site is closing study participation|0|||
124488395|NCT04358458|447742456|FG006|Overall Study|Site is closing study participation|0|||
124488396|NCT04358458|447742457|FG007|Overall Study|Site is closing study participation|0|||
124488397|NCT04358458|447742450|FG000|Overall Study|Sponsor request|2|||
124488398|NCT04358458|447742451|FG001|Overall Study|Sponsor request|3|||
124488399|NCT04358458|447742452|FG002|Overall Study|Sponsor request|3|||
124488400|NCT04358458|447742453|FG003|Overall Study|Sponsor request|0|||
124488401|NCT04358458|447742454|FG004|Overall Study|Sponsor request|2|||
124488402|NCT04358458|447742455|FG005|Overall Study|Sponsor request|3|||
124488403|NCT04358458|447742456|FG006|Overall Study|Sponsor request|1|||
124488404|NCT04358458|447742457|FG007|Overall Study|Sponsor request|1|||
124488405|NCT04358458|447742450|FG000|Overall Study|Withdrawal by Subject|0|||
124488406|NCT04358458|447742451|FG001|Overall Study|Withdrawal by Subject|0|||
124488407|NCT04358458|447742452|FG002|Overall Study|Withdrawal by Subject|1|||
124488408|NCT04358458|447742453|FG003|Overall Study|Withdrawal by Subject|1|||
124488409|NCT04358458|447742454|FG004|Overall Study|Withdrawal by Subject|0|||
124488410|NCT04358458|447742455|FG005|Overall Study|Withdrawal by Subject|1|||
124488411|NCT04358458|447742456|FG006|Overall Study|Withdrawal by Subject|0|||
124488412|NCT04358458|447742457|FG007|Overall Study|Withdrawal by Subject|1|||
124488413|NCT03191786|447742458|FG000|Overall Study|Death|236|||
124488414|NCT03191786|447742459|FG001|Overall Study|Death|127|||
124488415|NCT03191786|447742458|FG000|Overall Study|Lost to Follow-up|9|||
124488416|NCT03191786|447742459|FG001|Overall Study|Lost to Follow-up|3|||
124488417|NCT03191786|447742458|FG000|Overall Study|Physician Decision|1|||
124488418|NCT03191786|447742459|FG001|Overall Study|Physician Decision|0|||
124488419|NCT03191786|447742458|FG000|Overall Study|Moved to Post Trial Access Program|30|||
124488420|NCT03191786|447742459|FG001|Overall Study|Moved to Post Trial Access Program|5|||
124488421|NCT03191786|447742458|FG000|Overall Study|Withdrawal by Subject|26|||
124488422|NCT03191786|447742459|FG001|Overall Study|Withdrawal by Subject|16|||
124488423|NCT01266148|447743846|FG000|Overall Study|Adverse Event|2|||
124488424|NCT01266148|447743847|FG001|Overall Study|Adverse Event|0|||
124488425|NCT01266148|447743846|FG000|Overall Study|Ongoing rejection|1|||
124488426|NCT01266148|447743847|FG001|Overall Study|Ongoing rejection|0|||
124488427|NCT01266148|447743846|FG000|Overall Study|2 2R rejections|1|||
124488428|NCT01266148|447743847|FG001|Overall Study|2 2R rejections|0|||
124488429|NCT01266148|447743846|FG000|Overall Study|Death|2|||
124488430|NCT01266148|447743847|FG001|Overall Study|Death|3|||
124488431|NCT01266148|447743846|FG000|Overall Study|missing mGFR value + AE|1|||
124488432|NCT01266148|447743847|FG001|Overall Study|missing mGFR value + AE|0|||
124488433|NCT03937986|447743850|FG000|Overall Study|COVID-19 Pandemic|1|||
124488434|NCT01853228|447743853|FG000|Phase 1|Lack of Efficacy|8|||
124488435|NCT01853228|447743854|FG001|Phase 1|Lack of Efficacy|0|||
124488436|NCT01853228|447743853|FG000|Phase 1|Other|1|||
124488437|NCT01853228|447743854|FG001|Phase 1|Other|0|||
124488438|NCT01853228|447743853|FG000|Phase 2|Physician Decision|0|||
124488439|NCT01853228|447743854|FG001|Phase 2|Physician Decision|1|||
124488440|NCT01853228|447743853|FG000|Phase 2|Proceed To Transplant|0|||
124488441|NCT01853228|447743854|FG001|Phase 2|Proceed To Transplant|3|||
124488442|NCT01853228|447743853|FG000|Phase 2|Lack of Efficacy|0|||
124488443|NCT01853228|447743854|FG001|Phase 2|Lack of Efficacy|4|||
124488444|NCT03167619|447743855|FG000|Overall Study|Death|11|||
124488445|NCT03167619|447743856|FG001|Overall Study|Death|8|||
124488446|NCT03167619|447743855|FG000|Overall Study|Withdrawal by Subject|1|||
124488447|NCT03167619|447743856|FG001|Overall Study|Withdrawal by Subject|2|||
124488448|NCT03167619|447743855|FG000|Overall Study|Physician Decision|0|||
124488449|NCT03167619|447743856|FG001|Overall Study|Physician Decision|1|||
124488450|NCT01348919|447743859|FG000|Overall Study|Adverse Event|3|||
124488451|NCT01348919|447743860|FG001|Overall Study|Adverse Event|1|||
124488452|NCT01348919|447743861|FG002|Overall Study|Adverse Event|0|||
124721459|NCT01667133|448603649|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
124721460|NCT01667133|448603650|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
124721461|NCT01667133|448603651|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
124721462|NCT01667133|448603652|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
124721463|NCT01667133|448603653|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
124721464|NCT01667133|448603654|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
124721465|NCT01667133|448603655|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
124721466|NCT01667133|448603656|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
124721467|NCT01667133|448603657|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
124721468|NCT01667133|448603658|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
124721469|NCT01667133|448603659|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
124721470|NCT01667133|448603648|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
124721471|NCT01667133|448603649|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
124721472|NCT01667133|448603650|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
124721473|NCT01667133|448603651|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
124721474|NCT01667133|448603652|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
124721475|NCT01667133|448603653|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
124721476|NCT01667133|448603654|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
124721477|NCT01667133|448603655|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
124721478|NCT01667133|448603656|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
124721479|NCT01667133|448603657|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
124721480|NCT01667133|448603658|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
124721481|NCT01667133|448603659|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
124721482|NCT01667133|448603648|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
124721483|NCT01667133|448603649|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
124721484|NCT01667133|448603650|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
124721485|NCT01667133|448603651|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
124721486|NCT01667133|448603652|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
124721487|NCT01667133|448603653|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
124721488|NCT01667133|448603654|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
124721489|NCT01667133|448603655|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
124721490|NCT01667133|448603656|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
124721491|NCT01667133|448603657|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
124721492|NCT01667133|448603658|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
124721493|NCT01667133|448603659|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
124721494|NCT01667133|448603648|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
124721495|NCT01667133|448603649|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
124721496|NCT01667133|448603650|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
124721497|NCT01667133|448603651|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
124721498|NCT01667133|448603652|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
124721499|NCT01667133|448603653|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
124488453|NCT01348919|447743859|FG000|Overall Study|Withdrawal by Subject|0|||
124488454|NCT01348919|447743860|FG001|Overall Study|Withdrawal by Subject|1|||
124488455|NCT01348919|447743861|FG002|Overall Study|Withdrawal by Subject|0|||
124488456|NCT01348919|447743859|FG000|Overall Study|Disease progression|0|||
124488457|NCT01348919|447743860|FG001|Overall Study|Disease progression|1|||
124488458|NCT01348919|447743861|FG002|Overall Study|Disease progression|1|||
124488459|NCT01518699|447743862|FG000|Period 2|Protocol Violation|1|||
124488460|NCT01518699|447743863|FG001|Period 2|Protocol Violation|1|||
124488461|NCT01518699|447743864|FG002|Period 2|Protocol Violation|0|||
124488462|NCT01518699|447743865|FG003|Period 2|Protocol Violation|0|||
124488463|NCT01518699|447743866|FG004|Period 2|Protocol Violation|0|||
124488464|NCT01518699|447743867|FG005|Period 2|Protocol Violation|0|||
124488465|NCT01518699|447743862|FG000|Period 2|Lost to Follow-up|0|||
124488466|NCT01518699|447743863|FG001|Period 2|Lost to Follow-up|1|||
124488467|NCT01518699|447743864|FG002|Period 2|Lost to Follow-up|0|||
124488468|NCT01518699|447743865|FG003|Period 2|Lost to Follow-up|0|||
124488469|NCT01518699|447743866|FG004|Period 2|Lost to Follow-up|0|||
124488470|NCT01518699|447743867|FG005|Period 2|Lost to Follow-up|0|||
124488471|NCT01518699|447743862|FG000|Period 2|Adverse Event|1|||
124488472|NCT01518699|447743863|FG001|Period 2|Adverse Event|0|||
124488473|NCT01518699|447743864|FG002|Period 2|Adverse Event|0|||
124488474|NCT01518699|447743865|FG003|Period 2|Adverse Event|0|||
124488475|NCT01518699|447743866|FG004|Period 2|Adverse Event|0|||
124488476|NCT01518699|447743867|FG005|Period 2|Adverse Event|0|||
124488477|NCT03846947|447743869|FG000|Overall Study|technical issues with imaging sequence|2|||
124721500|NCT01667133|448603654|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
124721501|NCT01667133|448603655|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
124721502|NCT01667133|448603656|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
124721503|NCT01667133|448603657|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
124721504|NCT01667133|448603658|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
124488478|NCT02082184|447743871|FG000|Overall Study|Adverse Event|1|||
124488479|NCT02082184|447743872|FG001|Overall Study|Adverse Event|0|||
124488480|NCT02082184|447743871|FG000|Overall Study|Medical diagnosis|1|||
124488481|NCT02082184|447743872|FG001|Overall Study|Medical diagnosis|2|||
124557747|NCT02270983|448001312|FG001|Overall Study|Lost to Follow-up|1|||
124721505|NCT01667133|448603659|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
124721506|NCT01667133|448603648|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
124721507|NCT01667133|448603649|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
124721508|NCT01667133|448603650|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
124721509|NCT01667133|448603651|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
124721510|NCT01667133|448603652|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
124721511|NCT01667133|448603653|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
124721512|NCT01667133|448603654|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
124721513|NCT01667133|448603655|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
124721514|NCT01667133|448603656|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
124721515|NCT01667133|448603657|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
124721516|NCT01667133|448603658|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
124721517|NCT01667133|448603659|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
124721518|NCT01667133|448603648|FG000|Phase 2: Dose-expansion|Death|0|||
124721519|NCT01667133|448603649|FG001|Phase 2: Dose-expansion|Death|0|||
124721520|NCT01667133|448603650|FG002|Phase 2: Dose-expansion|Death|0|||
124721521|NCT01667133|448603651|FG003|Phase 2: Dose-expansion|Death|0|||
124721522|NCT01667133|448603652|FG004|Phase 2: Dose-expansion|Death|0|||
124721523|NCT01667133|448603653|FG005|Phase 2: Dose-expansion|Death|0|||
124721524|NCT01667133|448603654|FG006|Phase 2: Dose-expansion|Death|0|||
124721525|NCT01667133|448603655|FG007|Phase 2: Dose-expansion|Death|0|||
124721526|NCT01667133|448603656|FG008|Phase 2: Dose-expansion|Death|0|||
124721527|NCT01667133|448603657|FG009|Phase 2: Dose-expansion|Death|1|||
124721528|NCT01667133|448603658|FG010|Phase 2: Dose-expansion|Death|0|||
124721529|NCT01667133|448603659|FG011|Phase 2: Dose-expansion|Death|0|||
124721530|NCT01667133|448603648|FG000|Phase 2: Dose-expansion|Other|0|||
124721531|NCT01667133|448603649|FG001|Phase 2: Dose-expansion|Other|0|||
124721532|NCT01667133|448603650|FG002|Phase 2: Dose-expansion|Other|0|||
124721533|NCT01667133|448603651|FG003|Phase 2: Dose-expansion|Other|0|||
124721534|NCT01667133|448603652|FG004|Phase 2: Dose-expansion|Other|0|||
124721535|NCT01667133|448603653|FG005|Phase 2: Dose-expansion|Other|0|||
124721536|NCT01667133|448603654|FG006|Phase 2: Dose-expansion|Other|0|||
124721537|NCT01667133|448603655|FG007|Phase 2: Dose-expansion|Other|0|||
124721538|NCT01667133|448603656|FG008|Phase 2: Dose-expansion|Other|0|||
124721539|NCT01667133|448603657|FG009|Phase 2: Dose-expansion|Other|0|||
124721540|NCT01667133|448603658|FG010|Phase 2: Dose-expansion|Other|0|||
124721541|NCT01667133|448603659|FG011|Phase 2: Dose-expansion|Other|1|||
124721542|NCT02676895|448603663|FG000|Overall Study|Administrative reason|1|||
124721543|NCT02676895|448603664|FG001|Overall Study|Administrative reason|0|||
124721544|NCT02676895|448603665|FG002|Overall Study|Administrative reason|0|||
124488482|NCT02082184|447743871|FG000|Overall Study|Device associated symptoms|5|||
124488483|NCT02082184|447743872|FG001|Overall Study|Device associated symptoms|0|||
124488484|NCT02082184|447743871|FG000|Overall Study|Withdrawal by Subject|3|||
124488485|NCT02082184|447743872|FG001|Overall Study|Withdrawal by Subject|2|||
124488486|NCT02082184|447743871|FG000|Overall Study|Protocol Violation|0|||
124488487|NCT02082184|447743872|FG001|Overall Study|Protocol Violation|6|||
124488488|NCT02082184|447743871|FG000|Overall Study|Lost to Follow-up|0|||
124488489|NCT02082184|447743872|FG001|Overall Study|Lost to Follow-up|2|||
124488490|NCT02082184|447743871|FG000|Overall Study|Subject non-compliance|0|||
124488491|NCT02082184|447743872|FG001|Overall Study|Subject non-compliance|1|||
124488492|NCT01362322|447743879|FG000|Overall Study|Withdrawal by Subject|3|||
124488493|NCT01362322|447743880|FG001|Overall Study|Withdrawal by Subject|1|||
124488494|NCT01362322|447743879|FG000|Overall Study|Lost to Follow-up|2|||
124488495|NCT01362322|447743880|FG001|Overall Study|Lost to Follow-up|6|||
124488496|NCT01009463|447743883|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
124488497|NCT01009463|447743884|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
124488498|NCT01009463|447743885|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
124488499|NCT01009463|447743886|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
124488500|NCT01009463|447743887|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
124488501|NCT01009463|447743883|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
124488502|NCT01009463|447743884|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
124488503|NCT01009463|447743885|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
124488504|NCT01009463|447743886|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
124488505|NCT01009463|447743887|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
124488506|NCT01009463|447743883|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
124488507|NCT01009463|447743884|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
124488508|NCT01009463|447743885|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
124488509|NCT01009463|447743886|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
124721545|NCT02676895|448603663|FG000|Overall Study|Protocol Violation|1|||
124721546|NCT02676895|448603664|FG001|Overall Study|Protocol Violation|0|||
124488510|NCT01009463|447743887|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
124488511|NCT01009463|447743883|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
124488512|NCT01009463|447743884|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
124721547|NCT02676895|448603665|FG002|Overall Study|Protocol Violation|0|||
124488513|NCT01009463|447743885|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
124488514|NCT01009463|447743886|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
124488515|NCT01009463|447743887|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
124488516|NCT01009463|447743883|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
124488517|NCT01009463|447743884|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
124488518|NCT01009463|447743885|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
124488519|NCT01009463|447743886|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
124488520|NCT01009463|447743887|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
124488521|NCT01009463|447743883|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
124488522|NCT01009463|447743884|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
124488523|NCT01009463|447743885|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
124488524|NCT01009463|447743886|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
124488525|NCT01009463|447743887|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
124488526|NCT01009463|447743883|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
124488527|NCT01009463|447743884|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
124488528|NCT01009463|447743885|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
124488529|NCT01009463|447743886|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
124488530|NCT01009463|447743887|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
124488531|NCT01009463|447743883|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
124488532|NCT01009463|447743884|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
124488533|NCT01009463|447743885|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
124488534|NCT01009463|447743886|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
124488535|NCT01009463|447743887|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
124488536|NCT01009463|447743883|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
124488537|NCT01009463|447743884|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
124488538|NCT01009463|447743885|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
124488539|NCT01009463|447743886|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
124488540|NCT01009463|447743887|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
124488541|NCT01009463|447743883|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
124488542|NCT01009463|447743884|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
124488543|NCT01009463|447743885|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
124488544|NCT01009463|447743886|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
124488545|NCT01009463|447743887|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
124488546|NCT01009463|447743883|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
124488547|NCT01009463|447743884|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
124488548|NCT01009463|447743885|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
124488549|NCT01009463|447743886|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
124488550|NCT01009463|447743887|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
124488551|NCT01009463|447743883|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
124488552|NCT01009463|447743884|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
124488553|NCT01009463|447743885|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
124488554|NCT01009463|447743886|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
124488555|NCT01009463|447743887|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
124488556|NCT01009463|447743883|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
124488557|NCT01009463|447743884|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
124488558|NCT01009463|447743885|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
124488559|NCT01009463|447743886|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
124488560|NCT01009463|447743887|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
124488561|NCT00634543|447743888|FG000|Overall Study|Other|1|||
124488562|NCT00634543|447743889|FG001|Overall Study|Other|2|||
124488563|NCT00634543|447743888|FG000|Overall Study|Protocol Violation|3|||
124488564|NCT00634543|447743889|FG001|Overall Study|Protocol Violation|3|||
124488565|NCT00634543|447743888|FG000|Overall Study|Adverse Event|11|||
124488566|NCT00634543|447743889|FG001|Overall Study|Adverse Event|11|||
124488567|NCT00634543|447743888|FG000|Overall Study|Withdrawal by Subject|4|||
124488568|NCT00634543|447743889|FG001|Overall Study|Withdrawal by Subject|4|||
124488569|NCT00634543|447743888|FG000|Overall Study|Lost to Follow-up|0|||
124488570|NCT00634543|447743889|FG001|Overall Study|Lost to Follow-up|1|||
124488571|NCT02401256|447743891|FG000|Overall Study|Adverse Event|5|||
124488572|NCT02401256|447743891|FG000|Overall Study|Withdrawal by Subject|12|||
124488573|NCT00430781|447743893|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
124488574|NCT00430781|447743894|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
124488575|NCT00430781|447743895|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
124488576|NCT00430781|447743893|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
124488577|NCT00430781|447743894|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
124488578|NCT00430781|447743895|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
124488579|NCT00430781|447743893|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
124488580|NCT00430781|447743894|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
124488581|NCT00430781|447743895|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
124488582|NCT00430781|447743893|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
124488583|NCT00430781|447743894|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
124488584|NCT00430781|447743895|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
124721548|NCT02676895|448603663|FG000|Overall Study|Adverse Event|0|||
124721549|NCT02676895|448603664|FG001|Overall Study|Adverse Event|3|||
124721550|NCT02676895|448603665|FG002|Overall Study|Adverse Event|1|||
124721551|NCT02676895|448603663|FG000|Overall Study|Lost to Follow-up|0|||
124721552|NCT02676895|448603664|FG001|Overall Study|Lost to Follow-up|0|||
124721553|NCT02676895|448603665|FG002|Overall Study|Lost to Follow-up|1|||
124721554|NCT02676895|448603663|FG000|Overall Study|Withdrawal by Subject|0|||
124721555|NCT02676895|448603664|FG001|Overall Study|Withdrawal by Subject|0|||
124721556|NCT02676895|448603665|FG002|Overall Study|Withdrawal by Subject|1|||
124721557|NCT00289289|448603666|FG000|Overall Study|Withdrawal by Subject|5|||
124721558|NCT00289289|448603667|FG001|Overall Study|Withdrawal by Subject|3|||
124721559|NCT00289289|448603668|FG002|Overall Study|Withdrawal by Subject|15|||
124488585|NCT00430781|447743893|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
124488586|NCT00430781|447743894|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
124488587|NCT00430781|447743895|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
124488588|NCT00430781|447743893|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
124488589|NCT00430781|447743894|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
124488590|NCT00430781|447743895|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
124488591|NCT00430781|447743893|FG000|Interim Analysis; 11 February 2008|Death|0|||
124488592|NCT00430781|447743894|FG001|Interim Analysis; 11 February 2008|Death|1|||
124488593|NCT00430781|447743895|FG002|Interim Analysis; 11 February 2008|Death|0|||
124488594|NCT00430781|447743893|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
124488595|NCT00430781|447743894|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
124488596|NCT00430781|447743895|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
124488597|NCT00430781|447743893|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
124488598|NCT00430781|447743894|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
124488599|NCT00430781|447743895|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
124488600|NCT00430781|447743893|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
124488601|NCT00430781|447743894|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
124488602|NCT00430781|447743895|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
124488603|NCT00430781|447743893|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
124488604|NCT00430781|447743894|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
124488605|NCT00430781|447743895|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
124488606|NCT00430781|447743893|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
124488607|NCT00430781|447743894|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
124488608|NCT00430781|447743895|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
124488609|NCT00430781|447743893|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
124488610|NCT00430781|447743894|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
124488611|NCT00430781|447743895|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
124488612|NCT00430781|447743893|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
124488613|NCT00430781|447743894|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
124488614|NCT00430781|447743895|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
124488615|NCT00430781|447743893|FG000|Final Analysis; 31 July 2008|Other|0|||
124488616|NCT00430781|447743894|FG001|Final Analysis; 31 July 2008|Other|1|||
124488617|NCT00430781|447743895|FG002|Final Analysis; 31 July 2008|Other|0|||
124488618|NCT00430781|447743893|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
124488619|NCT00430781|447743894|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
124488620|NCT00430781|447743895|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
124488621|NCT00430781|447743893|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
124488622|NCT00430781|447743894|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
124488623|NCT00430781|447743895|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
124488624|NCT00430781|447743893|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
124488625|NCT00430781|447743894|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
124721560|NCT00289289|448603666|FG000|Overall Study|Lost to Follow-up|1|||
124721561|NCT00289289|448603667|FG001|Overall Study|Lost to Follow-up|0|||
124771960|NCT02141295|448796333|FG002|Overall Study|Reason not specified|10|||
124488626|NCT00430781|447743895|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
124488627|NCT00430781|447743893|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
124721562|NCT00289289|448603668|FG002|Overall Study|Lost to Follow-up|1|||
124721563|NCT00289289|448603666|FG000|Overall Study|Death|4|||
124771961|NCT02141295|448796331|FG000|Overall Study|Withdrawal by Subject|0|||
124771962|NCT02141295|448796332|FG001|Overall Study|Withdrawal by Subject|9|||
124721564|NCT00289289|448603667|FG001|Overall Study|Death|2|||
124721565|NCT00289289|448603668|FG002|Overall Study|Death|5|||
124771963|NCT02141295|448796333|FG002|Overall Study|Withdrawal by Subject|4|||
124488628|NCT00430781|447743894|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
124488629|NCT00430781|447743895|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
124488630|NCT00430781|447743893|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
124488631|NCT00430781|447743894|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
124488632|NCT00430781|447743895|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
124488633|NCT00430781|447743893|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
124488634|NCT00430781|447743894|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
124488635|NCT00430781|447743895|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
124488636|NCT00430781|447743893|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
124488637|NCT00430781|447743894|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
124488638|NCT00430781|447743895|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
124488639|NCT01059812|447743898|FG000|Overall Study|Adverse Event|9|||
124488640|NCT01059812|447743899|FG001|Overall Study|Adverse Event|5|||
124488641|NCT01059812|447743898|FG000|Overall Study|Lack of Efficacy|2|||
124488642|NCT01059812|447743899|FG001|Overall Study|Lack of Efficacy|2|||
124488643|NCT01059812|447743898|FG000|Overall Study|Protocol Violation|3|||
124488644|NCT01059812|447743899|FG001|Overall Study|Protocol Violation|1|||
124488645|NCT01059812|447743898|FG000|Overall Study|Withdrawal Criteria|9|||
124488646|NCT01059812|447743899|FG001|Overall Study|Withdrawal Criteria|4|||
124488647|NCT01059812|447743898|FG000|Overall Study|Unclassified|14|||
124488648|NCT01059812|447743899|FG001|Overall Study|Unclassified|4|||
124488649|NCT01389128|447743900|FG000|Overall Study|Fetal distress|1|||
124488650|NCT01389128|447743901|FG001|Overall Study|Fetal distress|0|||
124488651|NCT01389128|447743900|FG000|Overall Study|Cervix dilation stop|1|||
124488652|NCT01389128|447743901|FG001|Overall Study|Cervix dilation stop|2|||
124488653|NCT01389128|447743900|FG000|Overall Study|Rapid labor evolution|3|||
124488654|NCT01389128|447743901|FG001|Overall Study|Rapid labor evolution|2|||
124488655|NCT01389128|447743900|FG000|Overall Study|Intolerance to procedure|0|||
124488656|NCT01389128|447743901|FG001|Overall Study|Intolerance to procedure|2|||
124488657|NCT03056287|447743906|FG000|Overall Study|Withdrawal by Subject|0|||
124488658|NCT03056287|447743907|FG001|Overall Study|Withdrawal by Subject|1|||
124488659|NCT03056287|447743908|FG002|Overall Study|Withdrawal by Subject|0|||
124488660|NCT03056287|447743909|FG003|Overall Study|Withdrawal by Subject|0|||
124488661|NCT03056287|447743906|FG000|Overall Study|move out of area|0|||
124488662|NCT03056287|447743907|FG001|Overall Study|move out of area|0|||
124488663|NCT03056287|447743908|FG002|Overall Study|move out of area|1|||
124488664|NCT03056287|447743909|FG003|Overall Study|move out of area|1|||
124488665|NCT00947154|447743913|FG000|Overall Study|Lost to Follow-up|1|||
124488666|NCT01588197|447743916|FG000|Overall Study|Lack of Efficacy|0|||
124488667|NCT01588197|447743917|FG001|Overall Study|Lack of Efficacy|1|||
124488668|NCT01588197|447743916|FG000|Overall Study|No MRI|1|||
124488669|NCT01588197|447743917|FG001|Overall Study|No MRI|0|||
124488670|NCT01844076|447743920|FG000|Overall Study|Adverse Event|1|||
124488671|NCT01844076|447743921|FG001|Overall Study|Adverse Event|0|||
124488672|NCT01844076|447743922|FG002|Overall Study|Adverse Event|0|||
124488673|NCT01844076|447743923|FG003|Overall Study|Adverse Event|0|||
124488674|NCT01844076|447743920|FG000|Overall Study|Withdrawal by Subject|1|||
124488675|NCT01844076|447743921|FG001|Overall Study|Withdrawal by Subject|0|||
124771964|NCT01710501|448796334|FG000|Overall Study|Lost to Follow-up|2|||
124771965|NCT01710501|448796335|FG001|Overall Study|Lost to Follow-up|0|||
124771966|NCT01710501|448796336|FG002|Overall Study|Lost to Follow-up|0|||
124771967|NCT02536976|448796337|FG000|Overall Study|Physician Decision|0|||
124771968|NCT02536976|448796338|FG001|Overall Study|Physician Decision|1|||
124771969|NCT01671319|448796341|FG000|Overall Study|Withdrawal by Subject|1|||
124771970|NCT01709084|448796342|FG000|Overall Study|Lost to Follow-up|4|||
124771971|NCT01709084|448796343|FG001|Overall Study|Lost to Follow-up|7|||
124771972|NCT01709084|448796342|FG000|Overall Study|Withdrawal by Subject|2|||
124771973|NCT01709084|448796343|FG001|Overall Study|Withdrawal by Subject|2|||
124771974|NCT01709084|448796342|FG000|Overall Study|Adverse Event|5|||
124488676|NCT01844076|447743922|FG002|Overall Study|Withdrawal by Subject|0|||
124488677|NCT01844076|447743923|FG003|Overall Study|Withdrawal by Subject|0|||
124488678|NCT02286960|447743933|FG000|Overall Study|Lost to Follow-up|3|||
124488679|NCT02286960|447743934|FG001|Overall Study|Lost to Follow-up|3|||
124771975|NCT01709084|448796343|FG001|Overall Study|Adverse Event|0|||
124771976|NCT01709084|448796342|FG000|Overall Study|Other|5|||
124771977|NCT01709084|448796343|FG001|Overall Study|Other|3|||
124488680|NCT00440401|447743935|FG000|Overall Study|Adverse Event|2|||
124488681|NCT00440401|447743936|FG001|Overall Study|Adverse Event|1|||
124488682|NCT00440401|447743935|FG000|Overall Study|Other|2|||
124488683|NCT00440401|447743936|FG001|Overall Study|Other|5|||
124488684|NCT01937312|447743937|FG000|Overall Study|Adverse Event|10|||
124488685|NCT01937312|447743938|FG001|Overall Study|Adverse Event|1|||
124488686|NCT01937312|447743937|FG000|Overall Study|Lack of Efficacy|0|||
124488687|NCT01937312|447743938|FG001|Overall Study|Lack of Efficacy|1|||
124488688|NCT01937312|447743937|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
124771978|NCT01709084|448796342|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
124771979|NCT01709084|448796343|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
124488689|NCT01937312|447743938|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
124488690|NCT00474253|447743939|FG000|Overall Study|Withdrew consent|2|||
124488691|NCT00474253|447743940|FG001|Overall Study|Withdrew consent|0|||
124488692|NCT00474253|447743939|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
124488693|NCT00474253|447743940|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
124488694|NCT00474253|447743939|FG000|Overall Study|Lost to Follow-up|1|||
124488695|NCT00474253|447743940|FG001|Overall Study|Lost to Follow-up|0|||
124488696|NCT00474253|447743939|FG000|Overall Study|Discharged prior to study completion|0|||
124488697|NCT00474253|447743940|FG001|Overall Study|Discharged prior to study completion|1|||
124488698|NCT00593112|447743951|FG000|Overall Study|Scan Anxiety|3|||
124488699|NCT00593112|447743952|FG001|Overall Study|Scan Anxiety|0|||
124488700|NCT00593112|447743951|FG000|Overall Study|Abnormal Scan|1|||
124488701|NCT00593112|447743952|FG001|Overall Study|Abnormal Scan|0|||
124488702|NCT00593112|447743951|FG000|Overall Study|Unreadable Scan|1|||
124488703|NCT00593112|447743952|FG001|Overall Study|Unreadable Scan|0|||
124488704|NCT00593112|447743951|FG000|Overall Study|Withdrawal by Subject|5|||
124488705|NCT00593112|447743952|FG001|Overall Study|Withdrawal by Subject|0|||
124488706|NCT00482001|447743953|FG000|Overall Study|Protocol Violation|1|||
124488707|NCT00482001|447743954|FG001|Overall Study|Protocol Violation|1|||
124488708|NCT00258154|447743955|FG000|Overall Study|Adverse Event|1|||
124488709|NCT00258154|447743956|FG001|Overall Study|Adverse Event|0|||
124488710|NCT00258154|447743955|FG000|Overall Study|Lost to Follow-up|0|||
124488711|NCT00258154|447743956|FG001|Overall Study|Lost to Follow-up|1|||
124488712|NCT00258154|447743955|FG000|Overall Study|Protocol Violation|2|||
124488713|NCT00258154|447743956|FG001|Overall Study|Protocol Violation|1|||
124488714|NCT00258154|447743955|FG000|Overall Study|Withdrawal by Subject|3|||
124488715|NCT00258154|447743956|FG001|Overall Study|Withdrawal by Subject|4|||
124488716|NCT00258154|447743955|FG000|Overall Study|Patient Moved|3|||
124488717|NCT00258154|447743956|FG001|Overall Study|Patient Moved|1|||
124488718|NCT00754390|447743957|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
124488719|NCT00754390|447743957|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
124488720|NCT00754390|447743957|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
124488721|NCT00754390|447743957|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
124488722|NCT00847613|447743958|FG000|Overall Study|Ongoing at cut-off date|250|||
124488723|NCT00847613|447743959|FG001|Overall Study|Ongoing at cut-off date|265|||
124488724|NCT00847613|447743960|FG002|Overall Study|Ongoing at cut-off date|64|||
124488725|NCT00847613|447743961|FG003|Overall Study|Ongoing at cut-off date|64|||
124488726|NCT00847613|447743958|FG000|Overall Study|Death|1|||
124488727|NCT00847613|447743959|FG001|Overall Study|Death|1|||
124488728|NCT00847613|447743960|FG002|Overall Study|Death|0|||
124488729|NCT00847613|447743961|FG003|Overall Study|Death|0|||
124488730|NCT00847613|447743958|FG000|Overall Study|Adverse Event|36|||
124488731|NCT00847613|447743959|FG001|Overall Study|Adverse Event|26|||
124488732|NCT00847613|447743960|FG002|Overall Study|Adverse Event|5|||
124488733|NCT00847613|447743961|FG003|Overall Study|Adverse Event|6|||
124488734|NCT00847613|447743958|FG000|Overall Study|Lack of Efficacy|7|||
124488735|NCT00847613|447743959|FG001|Overall Study|Lack of Efficacy|3|||
124488736|NCT00847613|447743960|FG002|Overall Study|Lack of Efficacy|3|||
124488737|NCT00847613|447743961|FG003|Overall Study|Lack of Efficacy|1|||
124488738|NCT00847613|447743958|FG000|Overall Study|Study terminated by Sponsor|1|||
124488739|NCT00847613|447743959|FG001|Overall Study|Study terminated by Sponsor|0|||
124488740|NCT00847613|447743960|FG002|Overall Study|Study terminated by Sponsor|2|||
124488741|NCT00847613|447743961|FG003|Overall Study|Study terminated by Sponsor|1|||
124488742|NCT00847613|447743958|FG000|Overall Study|Lost to Follow-up|5|||
124488743|NCT00847613|447743959|FG001|Overall Study|Lost to Follow-up|0|||
124488744|NCT00847613|447743960|FG002|Overall Study|Lost to Follow-up|0|||
124488745|NCT00847613|447743961|FG003|Overall Study|Lost to Follow-up|3|||
124488746|NCT00847613|447743958|FG000|Overall Study|Protocol Violation|6|||
124488747|NCT00847613|447743959|FG001|Overall Study|Protocol Violation|6|||
124488748|NCT00847613|447743960|FG002|Overall Study|Protocol Violation|3|||
124488749|NCT00847613|447743961|FG003|Overall Study|Protocol Violation|1|||
124488750|NCT00847613|447743958|FG000|Overall Study|Pregnancy|1|||
124488751|NCT00847613|447743959|FG001|Overall Study|Pregnancy|1|||
124488752|NCT00847613|447743960|FG002|Overall Study|Pregnancy|0|||
124488753|NCT00847613|447743961|FG003|Overall Study|Pregnancy|0|||
124488754|NCT00847613|447743958|FG000|Overall Study|Site closure|1|||
124488755|NCT00847613|447743959|FG001|Overall Study|Site closure|0|||
124488756|NCT00847613|447743960|FG002|Overall Study|Site closure|0|||
124488757|NCT00847613|447743961|FG003|Overall Study|Site closure|1|||
124488758|NCT00847613|447743958|FG000|Overall Study|Withdrawal by Subject|8|||
124488759|NCT00847613|447743959|FG001|Overall Study|Withdrawal by Subject|11|||
124488760|NCT00847613|447743960|FG002|Overall Study|Withdrawal by Subject|2|||
124488761|NCT00847613|447743961|FG003|Overall Study|Withdrawal by Subject|2|||
124488762|NCT00847613|447743958|FG000|Overall Study|Participant moved|4|||
124488763|NCT00847613|447743959|FG001|Overall Study|Participant moved|1|||
124488764|NCT00847613|447743960|FG002|Overall Study|Participant moved|0|||
124488765|NCT00847613|447743961|FG003|Overall Study|Participant moved|0|||
124488766|NCT00847613|447743958|FG000|Overall Study|Sponsor request|0|||
124488767|NCT00847613|447743959|FG001|Overall Study|Sponsor request|1|||
124488768|NCT00847613|447743960|FG002|Overall Study|Sponsor request|0|||
124488769|NCT00847613|447743961|FG003|Overall Study|Sponsor request|0|||
124488770|NCT00847613|447743958|FG000|Overall Study|Randomized, but not treated|0|||
124488771|NCT00847613|447743959|FG001|Overall Study|Randomized, but not treated|3|||
124488772|NCT00847613|447743960|FG002|Overall Study|Randomized, but not treated|0|||
124488773|NCT00847613|447743961|FG003|Overall Study|Randomized, but not treated|0|||
124488774|NCT00847613|447743958|FG000|Overall Study|Other|1|||
124488775|NCT00847613|447743959|FG001|Overall Study|Other|1|||
124488776|NCT00847613|447743960|FG002|Overall Study|Other|2|||
124488777|NCT00847613|447743961|FG003|Overall Study|Other|0|||
124488778|NCT03633331|447743962|FG000|Overall Study|Withdrawal by Subject|1|||
124488779|NCT01009294|447743963|FG000|Overall Study|Study discontinued by Sponsor|6|||
124488780|NCT00658333|447743964|FG000|Overall Study|Adverse Event|2|||
124488781|NCT00658333|447743965|FG001|Overall Study|Adverse Event|1|||
124488782|NCT00624338|447743968|FG000|Overall Study|Adverse Event|14|||
124488783|NCT00624338|447743969|FG001|Overall Study|Adverse Event|14|||
124488784|NCT00624338|447743970|FG002|Overall Study|Adverse Event|18|||
124488785|NCT00624338|447743968|FG000|Overall Study|Lost to Follow-up|1|||
124488786|NCT00624338|447743969|FG001|Overall Study|Lost to Follow-up|0|||
124488787|NCT00624338|447743970|FG002|Overall Study|Lost to Follow-up|0|||
124488788|NCT00624338|447743968|FG000|Overall Study|Lack of Efficacy|11|||
124488789|NCT00624338|447743969|FG001|Overall Study|Lack of Efficacy|3|||
124488790|NCT00624338|447743970|FG002|Overall Study|Lack of Efficacy|14|||
124488791|NCT00624338|447743968|FG000|Overall Study|Protocol Violation|3|||
124488792|NCT00624338|447743969|FG001|Overall Study|Protocol Violation|3|||
124488793|NCT00624338|447743970|FG002|Overall Study|Protocol Violation|2|||
124488794|NCT00624338|447743968|FG000|Overall Study|Death|0|||
124488795|NCT00624338|447743969|FG001|Overall Study|Death|2|||
124488796|NCT00624338|447743970|FG002|Overall Study|Death|0|||
124488797|NCT00624338|447743968|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
124488798|NCT00624338|447743969|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
124488799|NCT00624338|447743970|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
124488800|NCT00624338|447743968|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
124488801|NCT00624338|447743969|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
124488802|NCT00624338|447743970|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
124488803|NCT00624338|447743968|FG000|Overall Study|Other|15|||
124488804|NCT00624338|447743969|FG001|Overall Study|Other|5|||
124488805|NCT00624338|447743970|FG002|Overall Study|Other|9|||
124488806|NCT00624338|447743968|FG000|Overall Study|Randomized but not treated|2|||
124488807|NCT00624338|447743969|FG001|Overall Study|Randomized but not treated|1|||
124488808|NCT00624338|447743970|FG002|Overall Study|Randomized but not treated|3|||
124488809|NCT00995371|447743980|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
124488810|NCT00995371|447743981|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
124488811|NCT04725682|447743982|FG000|Overall Study|Withdrawal by Subject|7|||
124488812|NCT04725682|447743983|FG001|Overall Study|Withdrawal by Subject|5|||
124488813|NCT04725682|447743982|FG000|Overall Study|Failed to comply with the requirements|2|||
124488814|NCT04725682|447743983|FG001|Overall Study|Failed to comply with the requirements|1|||
124488815|NCT04725682|447743982|FG000|Overall Study|Adverse Event|1|||
124488816|NCT04725682|447743983|FG001|Overall Study|Adverse Event|1|||
124488817|NCT04725682|447743982|FG000|Overall Study|Death|0|||
124488818|NCT04725682|447743983|FG001|Overall Study|Death|1|||
124488819|NCT02190591|447743984|FG000|Overall Study|Withdrawal by Subject|1|||
124488820|NCT02190591|447743985|FG001|Overall Study|Withdrawal by Subject|8|||
124488821|NCT02190591|447743984|FG000|Overall Study|Protocol Violation|1|||
124488822|NCT02190591|447743985|FG001|Overall Study|Protocol Violation|0|||
124488823|NCT02190591|447743984|FG000|Overall Study|did not use peanut ball as instructed|0|||
124488824|NCT02190591|447743985|FG001|Overall Study|did not use peanut ball as instructed|2|||
124488825|NCT02190591|447743984|FG000|Overall Study|face presentation so she was ineligible|0|||
124488826|NCT02190591|447743985|FG001|Overall Study|face presentation so she was ineligible|1|||
124488827|NCT00857246|447743986|FG000|Induction Regimen|Adverse Event|1|||
124488828|NCT00857246|447743986|FG000|Induction Regimen|disease-related complications|1|||
124488829|NCT00857246|447743986|FG000|Induction Regimen|Withdrawal by Subject|1|||
124488830|NCT00857246|447743986|FG000|Surgery (Curative)|disease progression|6|||
124488831|NCT00857246|447743986|FG000|ChemoRT|Withdrawal by Subject|1|||
124488832|NCT00857246|447743986|FG000|ChemoRT|Adverse Event|2|||
124488833|NCT00144300|447743987|FG000|Overall Study|Adverse Event|18|||
124488834|NCT00144300|447743988|FG001|Overall Study|Adverse Event|16|||
124488835|NCT00144300|447743987|FG000|Overall Study|Protocol Violation|1|||
124488836|NCT00144300|447743988|FG001|Overall Study|Protocol Violation|3|||
124488837|NCT00144300|447743987|FG000|Overall Study|Lost to Follow-up|3|||
124488838|NCT00144300|447743988|FG001|Overall Study|Lost to Follow-up|0|||
124488839|NCT00144300|447743987|FG000|Overall Study|Withdrawal by Subject|6|||
124488840|NCT00144300|447743988|FG001|Overall Study|Withdrawal by Subject|6|||
124488841|NCT00144300|447743987|FG000|Overall Study|Other reason (not specified)|1|||
124488842|NCT00144300|447743988|FG001|Overall Study|Other reason (not specified)|3|||
124488843|NCT03750838|447743989|FG000|Overall Study|Lost to Follow-up|10|||
124488844|NCT03750838|447743990|FG001|Overall Study|Lost to Follow-up|6|||
124488845|NCT00538733|447743991|FG000|Overall Study|Adverse Event|8|||
124488846|NCT00538733|447743991|FG000|Overall Study|Death|1|||
124488847|NCT00538733|447743991|FG000|Overall Study|declined to participate|2|||
124488848|NCT00538733|447743991|FG000|Overall Study|still on therapy|1|||
124488849|NCT02032875|447743992|FG000|Treatment Period|Adverse Event|1|||
124488850|NCT02032875|447743993|FG001|Treatment Period|Adverse Event|0|||
124488851|NCT02032875|447743992|FG000|Treatment Period|Liver transplant, No extension needed|0|||
124488852|NCT02032875|447743993|FG001|Treatment Period|Liver transplant, No extension needed|1|||
124488853|NCT02032875|447743992|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
124488854|NCT02032875|447743993|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
124488855|NCT02032875|447743992|FG000|Follow-up Period|Death|0|||
124488856|NCT02032875|447743993|FG001|Follow-up Period|Death|1|||
124488857|NCT02032875|447743992|FG000|Follow-up Period|Virologic Relapse|3|||
124488858|NCT02032875|447743993|FG001|Follow-up Period|Virologic Relapse|10|||
124488859|NCT02031146|447745480|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
124488860|NCT02031146|447745481|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
124488861|NCT02031146|447745482|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
124488862|NCT02031146|447745483|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
124488863|NCT02031146|447745484|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
124488864|NCT02031146|447745485|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
124488865|NCT02031146|447745486|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
124488866|NCT02114203|447745492|FG000|Overall Study|Adverse Event|0|||
124488867|NCT02114203|447745493|FG001|Overall Study|Adverse Event|1|||
124488868|NCT02114203|447745494|FG002|Overall Study|Adverse Event|0|||
124488869|NCT02114203|447745492|FG000|Overall Study|Withdrawal by Subject|0|||
124488870|NCT02114203|447745493|FG001|Overall Study|Withdrawal by Subject|1|||
124488871|NCT02114203|447745494|FG002|Overall Study|Withdrawal by Subject|0|||
124488872|NCT02839746|447745495|FG000|Overall Study|Not met selection criteria|12|||
124488873|NCT00744055|447745496|FG000|Overall Study|Withdrawal by Subject|6|||
124488874|NCT00744055|447745497|FG001|Overall Study|Withdrawal by Subject|9|||
124488875|NCT00744055|447745496|FG000|Overall Study|Lack of Efficacy|0|||
124488876|NCT00744055|447745497|FG001|Overall Study|Lack of Efficacy|1|||
124488877|NCT00744055|447745496|FG000|Overall Study|Physician Decision|0|||
124488878|NCT00744055|447745497|FG001|Overall Study|Physician Decision|2|||
124488879|NCT00744055|447745496|FG000|Overall Study|Protocol Violation|1|||
124488880|NCT00744055|447745497|FG001|Overall Study|Protocol Violation|1|||
124488881|NCT00744055|447745496|FG000|Overall Study|Lost to Follow-up|0|||
124488882|NCT00744055|447745497|FG001|Overall Study|Lost to Follow-up|1|||
124488883|NCT02767570|447745498|FG000|Overall Study|Lost to Follow-up|3|||
124488884|NCT02767570|447745499|FG001|Overall Study|Lost to Follow-up|0|||
124488885|NCT02767570|447745498|FG000|Overall Study|COVID shutdown|2|||
124488886|NCT02767570|447745499|FG001|Overall Study|COVID shutdown|5|||
124488887|NCT02767570|447745498|FG000|Overall Study|Increased pain|2|||
124488888|NCT02767570|447745499|FG001|Overall Study|Increased pain|0|||
124488889|NCT02767570|447745498|FG000|Overall Study|Withdrawal by Subject|1|||
124488890|NCT02767570|447745499|FG001|Overall Study|Withdrawal by Subject|3|||
124488891|NCT02767570|447745498|FG000|Overall Study|Unrelated medical issue|1|||
124488892|NCT02767570|447745499|FG001|Overall Study|Unrelated medical issue|1|||
124488893|NCT02767570|447745498|FG000|Overall Study|Received intra-articular injection|0|||
124488894|NCT02767570|447745499|FG001|Overall Study|Received intra-articular injection|1|||
124488895|NCT00151411|447745500|FG000|Overall Study|Lost to Follow-up|15|||
124488896|NCT00151411|447745501|FG001|Overall Study|Lost to Follow-up|19|||
124488897|NCT00151411|447745500|FG000|Overall Study|Withdrawal by Subject|12|||
124488898|NCT00151411|447745501|FG001|Overall Study|Withdrawal by Subject|20|||
124488899|NCT00151411|447745500|FG000|Overall Study|Adverse Event|6|||
124488900|NCT00151411|447745501|FG001|Overall Study|Adverse Event|0|||
124488901|NCT00151411|447745500|FG000|Overall Study|Pregnancy|0|||
124488902|NCT00151411|447745501|FG001|Overall Study|Pregnancy|4|||
124488903|NCT01712438|447745502|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
124488904|NCT01712438|447745502|FG000|Overall Study|Ongoing ITI treatment|6|||
124488905|NCT01712438|447745502|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
124488906|NCT01712438|447745502|FG000|Overall Study|Prematurely Discontinued|25|||
124488907|NCT01157169|447745505|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
124488908|NCT01157169|447745506|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
124488909|NCT01157169|447745505|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
124488910|NCT01157169|447745506|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
124488911|NCT01123889|447745507|FG000|Overall Study|Lost to Follow-up|3|||
124771980|NCT01709084|448796342|FG000|Overall Study|Not Treated|0|||
124488912|NCT01123889|447745508|FG001|Overall Study|Lost to Follow-up|1|||
124488913|NCT02413398|447745515|FG000|Overall Study|Lost to Follow-up|2|||
124488914|NCT02413398|447745516|FG001|Overall Study|Lost to Follow-up|4|||
124488915|NCT02413398|447745515|FG000|Overall Study|Withdrawal by Subject|1|||
124488916|NCT02413398|447745516|FG001|Overall Study|Withdrawal by Subject|1|||
124557748|NCT02270983|448001313|FG002|Overall Study|Lost to Follow-up|2|||
124771981|NCT01709084|448796343|FG001|Overall Study|Not Treated|2|||
124771982|NCT02144610|448796344|FG000|Overall Study|Physician Decision|1|||
124488917|NCT02413398|447745515|FG000|Overall Study|Other Eligibility criteria|1|||
124488918|NCT02413398|447745516|FG001|Overall Study|Other Eligibility criteria|2|||
124488919|NCT02874794|447745517|FG000|Overall Study|Physician Decision|3|||
124488920|NCT02874794|447745518|FG001|Overall Study|Physician Decision|2|||
124488921|NCT02874794|447745517|FG000|Overall Study|Withdrawal by Subject|2|||
124488922|NCT02874794|447745518|FG001|Overall Study|Withdrawal by Subject|8|||
124488923|NCT02874794|447745517|FG000|Overall Study|Death|2|||
124488924|NCT02874794|447745518|FG001|Overall Study|Death|1|||
124488925|NCT00537940|447745519|FG000|Overall Study|Adverse Event|20|||
124488926|NCT00537940|447745520|FG001|Overall Study|Adverse Event|19|||
124488927|NCT00537940|447745519|FG000|Overall Study|Lack of Efficacy|8|||
124488928|NCT00537940|447745520|FG001|Overall Study|Lack of Efficacy|16|||
124488929|NCT00537940|447745519|FG000|Overall Study|Lost to Follow-up|23|||
124488930|NCT00537940|447745520|FG001|Overall Study|Lost to Follow-up|29|||
124488931|NCT00537940|447745519|FG000|Overall Study|Withdrawal by Subject|113|||
124488932|NCT00537940|447745520|FG001|Overall Study|Withdrawal by Subject|95|||
124488933|NCT00537940|447745519|FG000|Overall Study|Protocol Violation|6|||
124488934|NCT00537940|447745520|FG001|Overall Study|Protocol Violation|4|||
124488935|NCT00537940|447745519|FG000|Overall Study|Pregnancy|1|||
124488936|NCT00537940|447745520|FG001|Overall Study|Pregnancy|1|||
124488937|NCT00537940|447745519|FG000|Overall Study|Study terminated by sponsor|2|||
124488938|NCT00537940|447745520|FG001|Overall Study|Study terminated by sponsor|3|||
124488939|NCT00537940|447745519|FG000|Overall Study|Other|10|||
124488940|NCT00537940|447745520|FG001|Overall Study|Other|12|||
124488941|NCT02465034|447745523|FG000|Overall Study|Withdrawal by Subject|1|||
124488942|NCT02465034|447745524|FG001|Overall Study|Withdrawal by Subject|1|||
124488943|NCT02465034|447745523|FG000|Overall Study|Screen fail|2|||
124488944|NCT02465034|447745524|FG001|Overall Study|Screen fail|0|||
124488945|NCT02465034|447745523|FG000|Overall Study|Could not be scheduled for study visit|0|||
124488946|NCT02465034|447745524|FG001|Overall Study|Could not be scheduled for study visit|5|||
124488947|NCT02397655|447745530|FG000|Overall Study|data not completed|1301|||
124488948|NCT01736683|447745531|FG000|Overall Study|Disease Relapse|0|||
124488949|NCT01736683|447745532|FG001|Overall Study|Disease Relapse|0|||
124488950|NCT01736683|447745533|FG002|Overall Study|Disease Relapse|2|||
124488951|NCT01736683|447745534|FG003|Overall Study|Disease Relapse|1|||
124488952|NCT01736683|447745535|FG004|Overall Study|Disease Relapse|0|||
124488953|NCT01736683|447745531|FG000|Overall Study|Adverse Event|0|||
124488954|NCT01736683|447745532|FG001|Overall Study|Adverse Event|2|||
124488955|NCT01736683|447745533|FG002|Overall Study|Adverse Event|2|||
124488956|NCT01736683|447745534|FG003|Overall Study|Adverse Event|3|||
124488957|NCT01736683|447745535|FG004|Overall Study|Adverse Event|2|||
124488958|NCT01736683|447745531|FG000|Overall Study|Withdrawal by Subject|0|||
124488959|NCT01736683|447745532|FG001|Overall Study|Withdrawal by Subject|0|||
124488960|NCT01736683|447745533|FG002|Overall Study|Withdrawal by Subject|3|||
124488961|NCT01736683|447745534|FG003|Overall Study|Withdrawal by Subject|1|||
124488962|NCT01736683|447745535|FG004|Overall Study|Withdrawal by Subject|1|||
124488963|NCT01736683|447745531|FG000|Overall Study|Lack of Therapeutic Effect|7|||
124488964|NCT01736683|447745532|FG001|Overall Study|Lack of Therapeutic Effect|4|||
124488965|NCT01736683|447745533|FG002|Overall Study|Lack of Therapeutic Effect|13|||
124488966|NCT01736683|447745534|FG003|Overall Study|Lack of Therapeutic Effect|20|||
124488967|NCT01736683|447745535|FG004|Overall Study|Lack of Therapeutic Effect|1|||
124488968|NCT01736683|447745531|FG000|Overall Study|Progressive Disease|0|||
124488969|NCT01736683|447745532|FG001|Overall Study|Progressive Disease|0|||
124488970|NCT01736683|447745533|FG002|Overall Study|Progressive Disease|0|||
124488971|NCT01736683|447745534|FG003|Overall Study|Progressive Disease|1|||
124488972|NCT01736683|447745535|FG004|Overall Study|Progressive Disease|0|||
124488973|NCT01736683|447745531|FG000|Overall Study|Other|0|||
124488974|NCT01736683|447745532|FG001|Overall Study|Other|0|||
124488975|NCT01736683|447745533|FG002|Overall Study|Other|1|||
124488976|NCT01736683|447745534|FG003|Overall Study|Other|9|||
124488977|NCT01736683|447745535|FG004|Overall Study|Other|1|||
124771983|NCT02144610|448796345|FG001|Overall Study|Physician Decision|0|||
124488978|NCT03334214|447745536|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
124488979|NCT03334214|447745537|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
124488980|NCT03334214|447745536|FG000|Overall Study|Withdrawal by Subject|0|||
124488981|NCT03334214|447745537|FG001|Overall Study|Withdrawal by Subject|1|||
124488982|NCT03334214|447745536|FG000|Overall Study|Other|1|||
124488983|NCT03334214|447745537|FG001|Overall Study|Other|0|||
124488984|NCT00308620|447745542|FG000|Overall Study|Death|1|||
124488985|NCT00308620|447745543|FG001|Overall Study|Death|1|||
124488986|NCT00308620|447745544|FG002|Overall Study|Death|0|||
124488987|NCT00308620|447745542|FG000|Overall Study|Lost to Follow-up|0|||
124488988|NCT00308620|447745543|FG001|Overall Study|Lost to Follow-up|0|||
124488989|NCT00308620|447745544|FG002|Overall Study|Lost to Follow-up|1|||
124488990|NCT00546351|447745545|FG000|Overall Study|Adverse Event|76|||
124488991|NCT00546351|447745545|FG000|Overall Study|Lack of Efficacy|15|||
124488992|NCT00546351|447745545|FG000|Overall Study|Withdrawal by Subject|109|||
124771984|NCT02144610|448796344|FG000|Overall Study|Withdrawal by Subject|1|||
124488993|NCT00546351|447745545|FG000|Overall Study|Lost to Follow-up|9|||
124488994|NCT00546351|447745545|FG000|Overall Study|Protocol Deviation|1|||
124488995|NCT00546351|447745545|FG000|Overall Study|Unsatisfactory compliance|9|||
124488996|NCT00546351|447745545|FG000|Overall Study|Other reasons for premature termination|17|||
124488997|NCT00592683|447745546|FG000|Overall Study|Found ineligible|0|||
124488998|NCT00592683|447745547|FG001|Overall Study|Found ineligible|1|||
124488999|NCT00592683|447745546|FG000|Overall Study|Withdrawal by Subject|1|||
124489000|NCT00592683|447745547|FG001|Overall Study|Withdrawal by Subject|0|||
124489001|NCT00592683|447745546|FG000|Overall Study|Adverse Event|0|||
124489002|NCT00592683|447745547|FG001|Overall Study|Adverse Event|2|||
124489003|NCT00592683|447745546|FG000|Overall Study|Protocol Violation|1|||
124489004|NCT00592683|447745547|FG001|Overall Study|Protocol Violation|0|||
124489005|NCT00592683|447745546|FG000|Overall Study|Study drug expired|1|||
124489006|NCT00592683|447745547|FG001|Overall Study|Study drug expired|0|||
124489007|NCT00592683|447745546|FG000|Overall Study|Other|1|||
124489008|NCT00592683|447745547|FG001|Overall Study|Other|0|||
124489009|NCT00592683|447745546|FG000|Overall Study|Lost to Follow-up|0|||
124489010|NCT00592683|447745547|FG001|Overall Study|Lost to Follow-up|1|||
124489011|NCT00479466|447745550|FG000|Overall Study|Adverse Event|5|||
124489012|NCT00479466|447745551|FG001|Overall Study|Adverse Event|1|||
124489013|NCT00479466|447745552|FG002|Overall Study|Adverse Event|0|||
124489014|NCT00479466|447745553|FG003|Overall Study|Adverse Event|1|||
124489015|NCT00479466|447745554|FG004|Overall Study|Adverse Event|2|||
124489016|NCT00479466|447745555|FG005|Overall Study|Adverse Event|0|||
124489017|NCT00479466|447745550|FG000|Overall Study|Hyperglycemia|0|||
124489018|NCT00479466|447745551|FG001|Overall Study|Hyperglycemia|0|||
124489019|NCT00479466|447745552|FG002|Overall Study|Hyperglycemia|0|||
124489020|NCT00479466|447745553|FG003|Overall Study|Hyperglycemia|0|||
124489021|NCT00479466|447745554|FG004|Overall Study|Hyperglycemia|0|||
124489022|NCT00479466|447745555|FG005|Overall Study|Hyperglycemia|1|||
124489023|NCT00479466|447745550|FG000|Overall Study|Lack of Efficacy|2|||
124489024|NCT00479466|447745551|FG001|Overall Study|Lack of Efficacy|0|||
124489025|NCT00479466|447745552|FG002|Overall Study|Lack of Efficacy|1|||
124489026|NCT00479466|447745553|FG003|Overall Study|Lack of Efficacy|0|||
124489027|NCT00479466|447745554|FG004|Overall Study|Lack of Efficacy|0|||
124489028|NCT00479466|447745555|FG005|Overall Study|Lack of Efficacy|0|||
124489029|NCT00479466|447745550|FG000|Overall Study|Lost to Follow-up|0|||
124489030|NCT00479466|447745551|FG001|Overall Study|Lost to Follow-up|1|||
124489031|NCT00479466|447745552|FG002|Overall Study|Lost to Follow-up|1|||
124489032|NCT00479466|447745553|FG003|Overall Study|Lost to Follow-up|0|||
124489033|NCT00479466|447745554|FG004|Overall Study|Lost to Follow-up|2|||
124489034|NCT00479466|447745555|FG005|Overall Study|Lost to Follow-up|2|||
124489035|NCT00479466|447745550|FG000|Overall Study|Physician Decision|2|||
124489036|NCT00479466|447745551|FG001|Overall Study|Physician Decision|1|||
124489037|NCT00479466|447745552|FG002|Overall Study|Physician Decision|1|||
124489038|NCT00479466|447745553|FG003|Overall Study|Physician Decision|0|||
124489039|NCT00479466|447745554|FG004|Overall Study|Physician Decision|0|||
124489040|NCT00479466|447745555|FG005|Overall Study|Physician Decision|0|||
124489041|NCT00479466|447745550|FG000|Overall Study|Pregnancy|0|||
124489042|NCT00479466|447745551|FG001|Overall Study|Pregnancy|0|||
124489043|NCT00479466|447745552|FG002|Overall Study|Pregnancy|0|||
124489044|NCT00479466|447745553|FG003|Overall Study|Pregnancy|0|||
124489045|NCT00479466|447745554|FG004|Overall Study|Pregnancy|1|||
124489046|NCT00479466|447745555|FG005|Overall Study|Pregnancy|0|||
124489047|NCT00479466|447745550|FG000|Overall Study|Protocol Violation|1|||
124489048|NCT00479466|447745551|FG001|Overall Study|Protocol Violation|0|||
124489049|NCT00479466|447745552|FG002|Overall Study|Protocol Violation|0|||
124489050|NCT00479466|447745553|FG003|Overall Study|Protocol Violation|0|||
124771985|NCT02144610|448796345|FG001|Overall Study|Withdrawal by Subject|5|||
124489051|NCT00479466|447745554|FG004|Overall Study|Protocol Violation|0|||
124489052|NCT00479466|447745555|FG005|Overall Study|Protocol Violation|0|||
124489053|NCT00479466|447745550|FG000|Overall Study|Withdrawal by Subject|3|||
124489054|NCT00479466|447745551|FG001|Overall Study|Withdrawal by Subject|5|||
124489055|NCT00479466|447745552|FG002|Overall Study|Withdrawal by Subject|0|||
124489056|NCT00479466|447745553|FG003|Overall Study|Withdrawal by Subject|2|||
124489057|NCT00479466|447745554|FG004|Overall Study|Withdrawal by Subject|3|||
124489058|NCT00479466|447745555|FG005|Overall Study|Withdrawal by Subject|1|||
124489059|NCT01325493|447745556|FG000|Overall Study|Protocol Violation|0|||
124489060|NCT01325493|447745557|FG001|Overall Study|Protocol Violation|1|||
124489061|NCT01325493|447745556|FG000|Overall Study|loss of neuromonitoring signals|0|||
124489062|NCT01325493|447745557|FG001|Overall Study|loss of neuromonitoring signals|2|||
124489063|NCT01325493|447745556|FG000|Overall Study|Allergy|1|||
124489064|NCT01325493|447745557|FG001|Overall Study|Allergy|0|||
124489065|NCT05372315|447745558|FG000|Overall Study|Withdrawal by Subject|1|||
124489066|NCT05372315|447745559|FG001|Overall Study|Withdrawal by Subject|0|||
124489067|NCT00650585|447745562|FG000|Overall Study|Lost to Follow-up|505|||
124489068|NCT00650585|447745563|FG001|Overall Study|Lost to Follow-up|482|||
124489069|NCT00650585|447745562|FG000|Overall Study|No parental consent|935|||
124489070|NCT00650585|447745563|FG001|Overall Study|No parental consent|866|||
124489071|NCT00650585|447745562|FG000|Overall Study|Excluded/ruled ineligible|357|||
124489072|NCT00650585|447745563|FG001|Overall Study|Excluded/ruled ineligible|129|||
124489073|NCT00467649|447745564|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
124489074|NCT00467649|447745565|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
124489075|NCT00467649|447745566|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
124489076|NCT00467649|447745567|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
124489077|NCT00467649|447745568|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
124489078|NCT00467649|447745569|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
124489079|NCT00467649|447745564|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
124489080|NCT00467649|447745565|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
124489081|NCT00467649|447745566|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
124489082|NCT00467649|447745567|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
124489083|NCT00467649|447745568|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
124489084|NCT00467649|447745569|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
124489085|NCT00467649|447745564|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
124489086|NCT00467649|447745565|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
124489087|NCT00467649|447745566|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
124489088|NCT00467649|447745567|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
124489089|NCT00467649|447745568|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
124489090|NCT00467649|447745569|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
124489091|NCT00467649|447745564|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
124489092|NCT00467649|447745565|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
124489093|NCT00467649|447745566|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
124489094|NCT00467649|447745567|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
124489095|NCT00467649|447745568|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
124489096|NCT00467649|447745569|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
124489097|NCT00467649|447745564|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
124489098|NCT00467649|447745565|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
124489099|NCT00467649|447745566|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
124489100|NCT00467649|447745567|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
124489101|NCT00467649|447745568|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
124489102|NCT00467649|447745569|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
124489103|NCT00467649|447745564|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
124489104|NCT00467649|447745565|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
124489105|NCT00467649|447745566|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
124489106|NCT00467649|447745567|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
124489107|NCT00467649|447745568|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
124771986|NCT02144610|448796344|FG000|Overall Study|Death|2|||
124489108|NCT00467649|447745569|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
124489109|NCT00467649|447745564|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
124489110|NCT00467649|447745565|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
124489111|NCT00467649|447745566|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
124489112|NCT00467649|447745567|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
124489113|NCT00467649|447745568|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
124489114|NCT00467649|447745569|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
124489115|NCT03233048|447745572|FG000|Overall Study|Withdrawal by Subject|1|||
124489116|NCT05897853|447745582|FG000|Overall Study|Lost to Follow-up|2|||
124489117|NCT05897853|447745583|FG001|Overall Study|Lost to Follow-up|0|||
124489118|NCT05897853|447745582|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
124489119|NCT05897853|447745583|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
124489120|NCT02782715|447745588|FG000|Overall Study|Withdrawal by Subject|1|||
124489121|NCT04458857|447745589|FG000|Overall Study|Adverse Event|0|||
124489122|NCT04458857|447745590|FG001|Overall Study|Adverse Event|1|||
124489123|NCT04458857|447745591|FG002|Overall Study|Adverse Event|0|||
124489124|NCT04458857|447745589|FG000|Overall Study|Withdrawal by Subject|2|||
124489125|NCT04458857|447745590|FG001|Overall Study|Withdrawal by Subject|0|||
124489126|NCT04458857|447745591|FG002|Overall Study|Withdrawal by Subject|0|||
124489127|NCT04458857|447745589|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124489128|NCT04458857|447745590|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124489129|NCT04458857|447745591|FG002|Overall Study|Withdrawal by parent/guardian|1|||
124489130|NCT04458857|447745589|FG000|Overall Study|Non-compliance with study drug|0|||
124489131|NCT04458857|447745590|FG001|Overall Study|Non-compliance with study drug|1|||
124489132|NCT04458857|447745591|FG002|Overall Study|Non-compliance with study drug|0|||
124489133|NCT04458857|447745589|FG000|Overall Study|Lost to Follow-up|4|||
124489134|NCT04458857|447745590|FG001|Overall Study|Lost to Follow-up|1|||
124489135|NCT04458857|447745591|FG002|Overall Study|Lost to Follow-up|0|||
124489136|NCT03368404|447745594|FG000|Overall Study|Adverse Event|2|||
124489137|NCT03368404|447745595|FG001|Overall Study|Adverse Event|1|||
124489138|NCT03368404|447745594|FG000|Overall Study|Withdrawal by Subject|1|||
124489139|NCT03368404|447745595|FG001|Overall Study|Withdrawal by Subject|1|||
124771987|NCT02144610|448796345|FG001|Overall Study|Death|2|||
124721566|NCT00289289|448603666|FG000|Overall Study|No implant attempted|0|||
124721567|NCT00289289|448603667|FG001|Overall Study|No implant attempted|0|||
124489140|NCT00586690|447745600|FG000|Overall Study|Death|2|||
124489141|NCT00586690|447745601|FG001|Overall Study|Death|0|||
124489142|NCT00586690|447745600|FG000|Overall Study|Disease Progression|10|||
124489143|NCT00586690|447745601|FG001|Overall Study|Disease Progression|0|||
124489144|NCT00586690|447745600|FG000|Overall Study|Adverse Event|1|||
124489145|NCT00586690|447745601|FG001|Overall Study|Adverse Event|0|||
124489146|NCT00586690|447745600|FG000|Overall Study|Lack of Efficacy|2|||
124489147|NCT00586690|447745601|FG001|Overall Study|Lack of Efficacy|0|||
124489148|NCT00586690|447745600|FG000|Overall Study|Lab can't accommodate|1|||
124489149|NCT00586690|447745601|FG001|Overall Study|Lab can't accommodate|0|||
124489150|NCT01607892|447745605|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
124489151|NCT01607892|447745606|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
124489152|NCT01607892|447745607|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
124489153|NCT01607892|447745608|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
124489154|NCT01607892|447745609|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
124489155|NCT01607892|447745605|FG000|Overall Study|Death|4|||
124489156|NCT01607892|447745606|FG001|Overall Study|Death|2|||
124489157|NCT01607892|447745607|FG002|Overall Study|Death|8|||
124489158|NCT01607892|447745608|FG003|Overall Study|Death|10|||
124489159|NCT01607892|447745609|FG004|Overall Study|Death|3|||
124489160|NCT01607892|447745605|FG000|Overall Study|Investigator discretion|2|||
124489161|NCT01607892|447745606|FG001|Overall Study|Investigator discretion|4|||
124489162|NCT01607892|447745607|FG002|Overall Study|Investigator discretion|4|||
124489163|NCT01607892|447745608|FG003|Overall Study|Investigator discretion|8|||
124489164|NCT01607892|447745609|FG004|Overall Study|Investigator discretion|0|||
124489165|NCT01607892|447745605|FG000|Overall Study|Other treatments became available|1|||
124489166|NCT01607892|447745606|FG001|Overall Study|Other treatments became available|1|||
124489167|NCT01607892|447745607|FG002|Overall Study|Other treatments became available|0|||
124489168|NCT01607892|447745608|FG003|Overall Study|Other treatments became available|0|||
124489169|NCT01607892|447745609|FG004|Overall Study|Other treatments became available|2|||
124489170|NCT01607892|447745605|FG000|Overall Study|Intercurrent illness|1|||
124489171|NCT01607892|447745606|FG001|Overall Study|Intercurrent illness|0|||
124489172|NCT01607892|447745607|FG002|Overall Study|Intercurrent illness|0|||
124489173|NCT01607892|447745608|FG003|Overall Study|Intercurrent illness|3|||
124489174|NCT01607892|447745609|FG004|Overall Study|Intercurrent illness|0|||
124489175|NCT01607892|447745605|FG000|Overall Study|Non-Compliance with study procedures|0|||
124489176|NCT01607892|447745606|FG001|Overall Study|Non-Compliance with study procedures|0|||
124489177|NCT01607892|447745607|FG002|Overall Study|Non-Compliance with study procedures|1|||
124489178|NCT01607892|447745608|FG003|Overall Study|Non-Compliance with study procedures|0|||
124489179|NCT01607892|447745609|FG004|Overall Study|Non-Compliance with study procedures|0|||
124489180|NCT01607892|447745605|FG000|Overall Study|Consent withdrawn by participant|9|||
124489181|NCT01607892|447745606|FG001|Overall Study|Consent withdrawn by participant|4|||
124489182|NCT01607892|447745607|FG002|Overall Study|Consent withdrawn by participant|24|||
124489183|NCT01607892|447745608|FG003|Overall Study|Consent withdrawn by participant|14|||
124489184|NCT01607892|447745609|FG004|Overall Study|Consent withdrawn by participant|4|||
124489185|NCT01607892|447745605|FG000|Overall Study|Disease progression|38|||
124489186|NCT01607892|447745606|FG001|Overall Study|Disease progression|13|||
124489187|NCT01607892|447745607|FG002|Overall Study|Disease progression|37|||
124489188|NCT01607892|447745608|FG003|Overall Study|Disease progression|57|||
124489189|NCT01607892|447745609|FG004|Overall Study|Disease progression|9|||
124489190|NCT01607892|447745605|FG000|Overall Study|Incidence or severity of Adverse events|3|||
124489191|NCT01607892|447745606|FG001|Overall Study|Incidence or severity of Adverse events|3|||
124489192|NCT01607892|447745607|FG002|Overall Study|Incidence or severity of Adverse events|7|||
124489193|NCT01607892|447745608|FG003|Overall Study|Incidence or severity of Adverse events|2|||
124489194|NCT01607892|447745609|FG004|Overall Study|Incidence or severity of Adverse events|6|||
124489195|NCT03414359|447745613|FG000|Overall Study|Lack of Efficacy|1|||
124489196|NCT03414359|447745614|FG001|Overall Study|Lack of Efficacy|1|||
124489197|NCT03414359|447745613|FG000|Overall Study|Protocol Violation|0|||
124489198|NCT03414359|447745614|FG001|Overall Study|Protocol Violation|1|||
124489199|NCT02273973|447745615|FG000|Overall Study|Adverse Event|4|||
124489200|NCT02273973|447745616|FG001|Overall Study|Adverse Event|0|||
124489201|NCT02273973|447745615|FG000|Overall Study|Withdrawal by Subject|2|||
124489202|NCT02273973|447745616|FG001|Overall Study|Withdrawal by Subject|3|||
124489203|NCT02273973|447745615|FG000|Overall Study|Death|1|||
124489204|NCT02273973|447745616|FG001|Overall Study|Death|0|||
124489205|NCT02273973|447745615|FG000|Overall Study|Non-compliance|1|||
124489206|NCT02273973|447745616|FG001|Overall Study|Non-compliance|0|||
124721568|NCT00289289|448603668|FG002|Overall Study|No implant attempted|1|||
124489207|NCT02273973|447745615|FG000|Overall Study|Protocol Violation|1|||
124489208|NCT02273973|447745616|FG001|Overall Study|Protocol Violation|0|||
124489209|NCT02273973|447745615|FG000|Overall Study|Progression of disease|0|||
124489210|NCT02273973|447745616|FG001|Overall Study|Progression of disease|2|||
124489211|NCT02273973|447745615|FG000|Overall Study|Lost to Follow-up|0|||
124489212|NCT02273973|447745616|FG001|Overall Study|Lost to Follow-up|1|||
124489213|NCT02273973|447745615|FG000|Overall Study|Physician Decision|0|||
124489214|NCT02273973|447745616|FG001|Overall Study|Physician Decision|1|||
124489215|NCT02273973|447745615|FG000|Overall Study|Reason not specified|0|||
124489216|NCT02273973|447745616|FG001|Overall Study|Reason not specified|1|||
124489217|NCT02403206|447745618|FG000|Overall Study|Lost to Follow-up|4|||
124489218|NCT02403206|447745619|FG001|Overall Study|Lost to Follow-up|3|||
124489219|NCT02403206|447745618|FG000|Overall Study|Physician Decision|2|||
124489220|NCT02403206|447745619|FG001|Overall Study|Physician Decision|0|||
124489221|NCT02403206|447745618|FG000|Overall Study|Withdrawal by Subject|3|||
124489222|NCT02403206|447745619|FG001|Overall Study|Withdrawal by Subject|3|||
124489223|NCT02403206|447745618|FG000|Overall Study|Reason not given|2|||
124489224|NCT02403206|447745619|FG001|Overall Study|Reason not given|4|||
124489225|NCT01769404|447745624|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
124489226|NCT01769404|447745625|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
124489227|NCT01769404|447745624|FG000|Treatment Period 1|Withdrawal by Subject|3|||
124489228|NCT01769404|447745625|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124489229|NCT01769404|447745624|FG000|Treatment Period 1|Sponsor decision|1|||
124489230|NCT01769404|447745625|FG001|Treatment Period 1|Sponsor decision|0|||
124489231|NCT01769404|447745624|FG000|Treatment Period 2|Sponsor decision|7|||
124489232|NCT01769404|447745625|FG001|Treatment Period 2|Sponsor decision|0|||
124489233|NCT00095121|447745630|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
124489234|NCT00095121|447745631|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
124489235|NCT00095121|447745630|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
124489236|NCT00095121|447745631|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
124489237|NCT02209597|447745632|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
124489238|NCT02209597|447745632|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
124489239|NCT02209597|447745632|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
124489240|NCT02209597|447745632|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
124489241|NCT03567187|447745643|FG000|Overall Study|Lost to Follow-up|18|||
124489242|NCT00907738|447745646|FG000|Overall Study|Adverse Event|2|||
124489243|NCT00907738|447745647|FG001|Overall Study|Adverse Event|0|||
124489244|NCT00907738|447745648|FG002|Overall Study|Adverse Event|1|||
124489245|NCT00907738|447745649|FG003|Overall Study|Adverse Event|0|||
124489246|NCT00907738|447745650|FG004|Overall Study|Adverse Event|0|||
124489247|NCT00907738|447745646|FG000|Overall Study|not specified or withdrew consent|3|||
124489248|NCT00907738|447745647|FG001|Overall Study|not specified or withdrew consent|0|||
124489249|NCT00907738|447745648|FG002|Overall Study|not specified or withdrew consent|0|||
124489250|NCT00907738|447745649|FG003|Overall Study|not specified or withdrew consent|0|||
124489251|NCT00907738|447745650|FG004|Overall Study|not specified or withdrew consent|0|||
124489252|NCT00907738|447745646|FG000|Overall Study|Disease progression|8|||
124489253|NCT00907738|447745647|FG001|Overall Study|Disease progression|1|||
124489254|NCT00907738|447745648|FG002|Overall Study|Disease progression|6|||
124489255|NCT00907738|447745649|FG003|Overall Study|Disease progression|4|||
124489256|NCT00907738|447745650|FG004|Overall Study|Disease progression|2|||
124489257|NCT02742649|447747172|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
124489258|NCT02742649|447747173|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
124489259|NCT02742649|447747174|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
124489260|NCT02742649|447747175|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
124489261|NCT02742649|447747176|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
124489262|NCT02742649|447747172|FG000|Double-Blind Treatment Period|Adverse Event|0|||
124489263|NCT02742649|447747173|FG001|Double-Blind Treatment Period|Adverse Event|1|||
124489264|NCT02742649|447747174|FG002|Double-Blind Treatment Period|Adverse Event|0|||
124489265|NCT02742649|447747175|FG003|Double-Blind Treatment Period|Adverse Event|0|||
124489266|NCT02742649|447747176|FG004|Double-Blind Treatment Period|Adverse Event|0|||
124489267|NCT02742649|447747172|FG000|Open-Label Period|Lost to Follow-up|0|||
124489268|NCT02742649|447747173|FG001|Open-Label Period|Lost to Follow-up|0|||
124489269|NCT02742649|447747174|FG002|Open-Label Period|Lost to Follow-up|0|||
124489270|NCT02742649|447747175|FG003|Open-Label Period|Lost to Follow-up|0|||
124489271|NCT02742649|447747176|FG004|Open-Label Period|Lost to Follow-up|1|||
124489272|NCT02089737|447747185|FG000|Overall Study|Survey form not completed|5|||
124489273|NCT02089737|447747185|FG000|Overall Study|Not treated|1|||
124721569|NCT00289289|448603666|FG000|Overall Study|Physician Decision|1|||
124721570|NCT00289289|448603667|FG001|Overall Study|Physician Decision|0|||
124721571|NCT00289289|448603668|FG002|Overall Study|Physician Decision|6|||
124721572|NCT00289289|448603666|FG000|Overall Study|Non-study device implanted|2|||
124721573|NCT00289289|448603667|FG001|Overall Study|Non-study device implanted|1|||
124721574|NCT00289289|448603668|FG002|Overall Study|Non-study device implanted|3|||
124721575|NCT00289289|448603666|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
124721576|NCT00289289|448603667|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
124721577|NCT00289289|448603668|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
124721578|NCT00289289|448603666|FG000|Overall Study|Other Exit Reason|6|||
124721579|NCT00289289|448603667|FG001|Overall Study|Other Exit Reason|4|||
124721580|NCT00289289|448603668|FG002|Overall Study|Other Exit Reason|12|||
124721581|NCT03028129|448603676|FG000|Overall Study|Adverse Event|13|||
124489280|NCT04426630|447747187|FG000|Overall Study|Death|4|||
124489281|NCT04426630|447747187|FG000|Overall Study|Lost to Follow-up|2|||
124489282|NCT00849693|447747194|FG000|Acute Treatment Phase|Adverse Event|12|||
124489283|NCT00849693|447747195|FG001|Acute Treatment Phase|Adverse Event|7|||
124489284|NCT00849693|447747196|FG002|Acute Treatment Phase|Adverse Event|6|||
124489285|NCT00849693|447747197|FG003|Acute Treatment Phase|Adverse Event|4|||
124489286|NCT00849693|447747194|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
124489287|NCT00849693|447747195|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
124489288|NCT00849693|447747196|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
124489289|NCT00849693|447747197|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
124489290|NCT00849693|447747194|FG000|Acute Treatment Phase|Protocol Violation|1|||
124489291|NCT00849693|447747195|FG001|Acute Treatment Phase|Protocol Violation|5|||
124489292|NCT00849693|447747196|FG002|Acute Treatment Phase|Protocol Violation|2|||
124489293|NCT00849693|447747197|FG003|Acute Treatment Phase|Protocol Violation|6|||
124489294|NCT00849693|447747194|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
124489295|NCT00849693|447747195|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
124489296|NCT00849693|447747196|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
124489297|NCT00849693|447747197|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
124489298|NCT00849693|447747194|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
124489299|NCT00849693|447747195|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
124489300|NCT00849693|447747196|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
124489301|NCT00849693|447747197|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
124489302|NCT00849693|447747194|FG000|Acute Treatment Phase|Physician Decision|2|||
124489303|NCT00849693|447747195|FG001|Acute Treatment Phase|Physician Decision|1|||
124489304|NCT00849693|447747196|FG002|Acute Treatment Phase|Physician Decision|2|||
124489305|NCT00849693|447747197|FG003|Acute Treatment Phase|Physician Decision|1|||
124489306|NCT00849693|447747194|FG000|Acute Treatment Phase|Sponsor decision|0|||
124489307|NCT00849693|447747195|FG001|Acute Treatment Phase|Sponsor decision|0|||
124489308|NCT00849693|447747196|FG002|Acute Treatment Phase|Sponsor decision|1|||
124489309|NCT00849693|447747197|FG003|Acute Treatment Phase|Sponsor decision|0|||
124489310|NCT00849693|447747194|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
124489311|NCT00849693|447747195|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
124489312|NCT00849693|447747196|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
124489313|NCT00849693|447747197|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
124489314|NCT00849693|447747194|FG000|Extension Phase|Adverse Event|4|||
124489315|NCT00849693|447747195|FG001|Extension Phase|Adverse Event|6|||
124489316|NCT00849693|447747196|FG002|Extension Phase|Adverse Event|3|||
124489317|NCT00849693|447747197|FG003|Extension Phase|Adverse Event|7|||
124489318|NCT00849693|447747194|FG000|Extension Phase|Lost to Follow-up|7|||
124489319|NCT00849693|447747195|FG001|Extension Phase|Lost to Follow-up|5|||
124489320|NCT00849693|447747196|FG002|Extension Phase|Lost to Follow-up|6|||
124489321|NCT00849693|447747197|FG003|Extension Phase|Lost to Follow-up|6|||
124489322|NCT00849693|447747194|FG000|Extension Phase|Protocol Violation|0|||
124489323|NCT00849693|447747195|FG001|Extension Phase|Protocol Violation|3|||
124489324|NCT00849693|447747196|FG002|Extension Phase|Protocol Violation|2|||
124489325|NCT00849693|447747197|FG003|Extension Phase|Protocol Violation|3|||
124489326|NCT00849693|447747194|FG000|Extension Phase|Withdrawal by Subject|6|||
124489327|NCT00849693|447747195|FG001|Extension Phase|Withdrawal by Subject|9|||
124489328|NCT00849693|447747196|FG002|Extension Phase|Withdrawal by Subject|10|||
124489329|NCT00849693|447747197|FG003|Extension Phase|Withdrawal by Subject|15|||
124489330|NCT00849693|447747194|FG000|Extension Phase|Parent or caregiver decision|9|||
124489331|NCT00849693|447747195|FG001|Extension Phase|Parent or caregiver decision|4|||
124489332|NCT00849693|447747196|FG002|Extension Phase|Parent or caregiver decision|10|||
124489333|NCT00849693|447747197|FG003|Extension Phase|Parent or caregiver decision|5|||
124489334|NCT00849693|447747194|FG000|Extension Phase|Physician Decision|1|||
124489335|NCT00849693|447747195|FG001|Extension Phase|Physician Decision|1|||
124489336|NCT00849693|447747196|FG002|Extension Phase|Physician Decision|2|||
124489337|NCT00849693|447747197|FG003|Extension Phase|Physician Decision|0|||
124489338|NCT00849693|447747194|FG000|Extension Phase|Sponsor decision|1|||
124489339|NCT00849693|447747195|FG001|Extension Phase|Sponsor decision|0|||
124489340|NCT00849693|447747196|FG002|Extension Phase|Sponsor decision|0|||
124489341|NCT00849693|447747197|FG003|Extension Phase|Sponsor decision|1|||
124489342|NCT00849693|447747194|FG000|Extension Phase|Lack of Efficacy|2|||
124489343|NCT00849693|447747195|FG001|Extension Phase|Lack of Efficacy|2|||
124489344|NCT00849693|447747196|FG002|Extension Phase|Lack of Efficacy|2|||
124489345|NCT00849693|447747197|FG003|Extension Phase|Lack of Efficacy|1|||
124489346|NCT01062399|447747198|FG000|Overall Study|Protocol Violation|0|||
124489347|NCT01062399|447747199|FG001|Overall Study|Protocol Violation|1|||
124489348|NCT01062399|447747200|FG002|Overall Study|Protocol Violation|0|||
124489349|NCT01062399|447747201|FG003|Overall Study|Protocol Violation|6|||
124489350|NCT01062399|447747202|FG004|Overall Study|Protocol Violation|4|||
124489351|NCT01260181|447747210|FG000|Overall Study|Decision of Investigator|1|||
124489352|NCT00984659|447747211|FG000|2-week Run-in Period|Adverse Event|8|||
124489353|NCT00984659|447747212|FG001|2-week Run-in Period|Adverse Event|0|||
124489354|NCT00984659|447747213|FG002|2-week Run-in Period|Adverse Event|0|||
124489355|NCT00984659|447747214|FG003|2-week Run-in Period|Adverse Event|0|||
124489356|NCT00984659|447747211|FG000|2-week Run-in Period|Protocol Violation|5|||
124489357|NCT00984659|447747212|FG001|2-week Run-in Period|Protocol Violation|0|||
124489358|NCT00984659|447747213|FG002|2-week Run-in Period|Protocol Violation|0|||
124489359|NCT00984659|447747214|FG003|2-week Run-in Period|Protocol Violation|0|||
124489360|NCT00984659|447747211|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
124489361|NCT00984659|447747212|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
124489362|NCT00984659|447747213|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
124489363|NCT00984659|447747214|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
124489364|NCT00984659|447747211|FG000|2-week Run-in Period|Lost to Follow-up|3|||
124489365|NCT00984659|447747212|FG001|2-week Run-in Period|Lost to Follow-up|0|||
124489366|NCT00984659|447747213|FG002|2-week Run-in Period|Lost to Follow-up|0|||
124489367|NCT00984659|447747214|FG003|2-week Run-in Period|Lost to Follow-up|0|||
124489368|NCT00984659|447747211|FG000|2-week Run-in Period|Physician Decision|10|||
124489369|NCT00984659|447747212|FG001|2-week Run-in Period|Physician Decision|0|||
124489370|NCT00984659|447747213|FG002|2-week Run-in Period|Physician Decision|0|||
124489371|NCT00984659|447747214|FG003|2-week Run-in Period|Physician Decision|0|||
124489372|NCT00984659|447747211|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
124489373|NCT00984659|447747212|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
124489374|NCT00984659|447747213|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
124489375|NCT00984659|447747214|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
124489376|NCT00984659|447747211|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
124489377|NCT00984659|447747212|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
124489378|NCT00984659|447747213|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
124489379|NCT00984659|447747214|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
124489380|NCT00984659|447747211|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
124489381|NCT00984659|447747212|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
124489382|NCT00984659|447747213|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
124489383|NCT00984659|447747214|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
124489384|NCT00984659|447747211|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
124489385|NCT00984659|447747212|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
124489386|NCT00984659|447747213|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
124489387|NCT00984659|447747214|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
124489388|NCT00984659|447747211|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
124489389|NCT00984659|447747212|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
124489390|NCT00984659|447747213|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
124489391|NCT00984659|447747214|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
124489392|NCT00984659|447747211|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
124489393|NCT00984659|447747212|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
124489394|NCT00984659|447747213|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
124489395|NCT00984659|447747214|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
124489396|NCT00984659|447747211|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
124489397|NCT00984659|447747212|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
124489398|NCT00984659|447747213|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
124489399|NCT00984659|447747214|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
124489400|NCT00635102|447747217|FG000|Overall Study|Withdrawal by Subject|7|||
124489401|NCT00635102|447747218|FG001|Overall Study|Withdrawal by Subject|8|||
124489402|NCT01938625|447747219|FG000|Overall Study|Withdrawal by Subject|0|||
124489403|NCT01938625|447747220|FG001|Overall Study|Withdrawal by Subject|1|||
124489404|NCT01938625|447747219|FG000|Overall Study|Adverse Event|0|||
124489405|NCT01938625|447747220|FG001|Overall Study|Adverse Event|1|||
124489406|NCT02088034|447747221|FG000|Overall Study|Lost to Follow-up|1|||
124489407|NCT02088034|447747222|FG001|Overall Study|Lost to Follow-up|1|||
124489408|NCT02088034|447747223|FG002|Overall Study|Lost to Follow-up|0|||
124489409|NCT02088034|447747221|FG000|Overall Study|Pregnancy|2|||
124489410|NCT02088034|447747222|FG001|Overall Study|Pregnancy|1|||
124489411|NCT02088034|447747223|FG002|Overall Study|Pregnancy|2|||
124489412|NCT02424149|447747224|FG000|Overall Study|surgery cancelled|2|||
124489413|NCT02424149|447747225|FG001|Overall Study|surgery cancelled|0|||
124489414|NCT02424149|447747224|FG000|Overall Study|Withdrawal by Subject|0|||
124489415|NCT02424149|447747225|FG001|Overall Study|Withdrawal by Subject|1|||
124489416|NCT01025336|447747228|FG000|Overall Study|Protocol Violation|0|||
124489417|NCT01025336|447747229|FG001|Overall Study|Protocol Violation|0|||
124489418|NCT01025336|447747230|FG002|Overall Study|Protocol Violation|0|||
124489419|NCT01025336|447747231|FG003|Overall Study|Protocol Violation|2|||
124489420|NCT01025336|447747232|FG004|Overall Study|Protocol Violation|0|||
124489421|NCT00545818|447747233|FG000|Overall Study|Protocol Violation|1|||
124489422|NCT00545818|447747234|FG001|Overall Study|Protocol Violation|0|||
124489423|NCT00545818|447747233|FG000|Overall Study|Adverse Event|1|||
124489424|NCT00545818|447747234|FG001|Overall Study|Adverse Event|1|||
124489425|NCT00545818|447747233|FG000|Overall Study|Lost to Follow-up|1|||
124489426|NCT00545818|447747234|FG001|Overall Study|Lost to Follow-up|6|||
124489427|NCT02723630|447747235|FG000|Intervention Period 1|Adverse Event|1|||
124489428|NCT02723630|447747236|FG001|Intervention Period 1|Adverse Event|0|||
124489429|NCT02723630|447747237|FG002|Intervention Period 1|Adverse Event|0|||
124489430|NCT02723630|447747238|FG003|Intervention Period 1|Adverse Event|0|||
124489431|NCT02723630|447747239|FG004|Intervention Period 1|Adverse Event|0|||
124489432|NCT02723630|447747240|FG005|Intervention Period 1|Adverse Event|0|||
124489433|NCT02723630|447747235|FG000|Intervention Period 3|consumption of restricted item|0|||
124721582|NCT03028129|448603677|FG001|Overall Study|Adverse Event|2|||
124721583|NCT03028129|448603676|FG000|Overall Study|Lost to Follow-up|50|||
124721584|NCT03028129|448603677|FG001|Overall Study|Lost to Follow-up|38|||
124721585|NCT03028129|448603676|FG000|Overall Study|Physician Decision|0|||
124721586|NCT03028129|448603677|FG001|Overall Study|Physician Decision|1|||
124489434|NCT02723630|447747236|FG001|Intervention Period 3|consumption of restricted item|1|||
124489435|NCT02723630|447747237|FG002|Intervention Period 3|consumption of restricted item|0|||
124489436|NCT02723630|447747238|FG003|Intervention Period 3|consumption of restricted item|0|||
124489437|NCT02723630|447747239|FG004|Intervention Period 3|consumption of restricted item|0|||
124489438|NCT02723630|447747240|FG005|Intervention Period 3|consumption of restricted item|0|||
124489439|NCT01184989|447747245|FG000|Overall Study|Adverse Event|11|||
124489440|NCT01184989|447747245|FG000|Overall Study|Withdrawal by Subject|1|||
124489441|NCT01570491|447747246|FG000|Overall Study|Lost to Follow-up|3|||
124489442|NCT01570491|447747247|FG001|Overall Study|Lost to Follow-up|1|||
124489443|NCT01570491|447747246|FG000|Overall Study|treatment: not given or discontinued|2|||
124489444|NCT01570491|447747247|FG001|Overall Study|treatment: not given or discontinued|0|||
124489445|NCT03047213|447747248|FG000|Overall Study|Withdrawal by Subject|2|||
124489446|NCT03047213|447747249|FG001|Overall Study|Withdrawal by Subject|0|||
124489447|NCT03047213|447747248|FG000|Overall Study|Adverse Event|2|||
124489448|NCT03047213|447747249|FG001|Overall Study|Adverse Event|0|||
124489449|NCT04407507|447747253|FG000|Overall Study|Withdrawal by Subject|0|||
124489450|NCT04407507|447747254|FG001|Overall Study|Withdrawal by Subject|1|||
124489451|NCT00923091|447747255|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
124489452|NCT00923091|447747256|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
124489453|NCT00923091|447747257|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
124489454|NCT00923091|447747258|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
124489455|NCT00923091|447747259|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
124489456|NCT00923091|447747260|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
124489457|NCT00923091|447747261|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
124489458|NCT00923091|447747262|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
124489459|NCT00923091|447747263|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
124489460|NCT00923091|447747264|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
124489461|NCT00923091|447747265|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
124489462|NCT00923091|447747266|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
124489463|NCT00923091|447747267|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
124489464|NCT00923091|447747255|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
124489465|NCT00923091|447747256|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
124489466|NCT00923091|447747257|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
124489467|NCT00923091|447747258|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
124489468|NCT00923091|447747259|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
124489469|NCT00923091|447747260|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
124489470|NCT00923091|447747261|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
124489471|NCT00923091|447747262|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
124489472|NCT00923091|447747263|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
124489473|NCT00923091|447747264|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
124489474|NCT00923091|447747265|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
124489475|NCT00923091|447747266|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
124489476|NCT00923091|447747267|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
124489477|NCT00923091|447747255|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
124489478|NCT00923091|447747256|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
124489479|NCT00923091|447747257|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
124489480|NCT00923091|447747258|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
124489481|NCT00923091|447747259|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
124489482|NCT00923091|447747260|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
124489483|NCT00923091|447747261|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
124489484|NCT00923091|447747262|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
124721587|NCT03028129|448603676|FG000|Overall Study|Protocol Violation|1|||
124489485|NCT00923091|447747263|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
124489486|NCT00923091|447747264|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
124721588|NCT03028129|448603677|FG001|Overall Study|Protocol Violation|1|||
124721589|NCT03028129|448603676|FG000|Overall Study|Withdrawal by Subject|62|||
124489487|NCT00923091|447747265|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
124489488|NCT00923091|447747266|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
124489489|NCT00923091|447747267|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
124489490|NCT00923091|447747255|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
124489491|NCT00923091|447747256|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
124489492|NCT00923091|447747257|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
124489493|NCT00923091|447747258|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
124489494|NCT00923091|447747259|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
124489495|NCT00923091|447747260|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
124489496|NCT00923091|447747261|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
124489497|NCT00923091|447747262|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
124489498|NCT00923091|447747263|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
124489499|NCT00923091|447747264|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
124489500|NCT00923091|447747265|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
124489501|NCT00923091|447747266|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
124489502|NCT00923091|447747267|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
124489503|NCT00923091|447747255|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
124489504|NCT00923091|447747256|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
124489505|NCT00923091|447747257|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
124489506|NCT00923091|447747258|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
124489507|NCT00923091|447747259|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
124489508|NCT00923091|447747260|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
124489509|NCT00923091|447747261|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
124489510|NCT00923091|447747262|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
124489511|NCT00923091|447747263|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
124489512|NCT00923091|447747264|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
124489513|NCT00923091|447747265|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
124489514|NCT00923091|447747266|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
124489515|NCT00923091|447747267|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
124489516|NCT00923091|447747255|FG000|Period III (Single-Blind)|Adverse Event|5|||
124489517|NCT00923091|447747256|FG001|Period III (Single-Blind)|Adverse Event|0|||
124489518|NCT00923091|447747257|FG002|Period III (Single-Blind)|Adverse Event|0|||
124489519|NCT00923091|447747258|FG003|Period III (Single-Blind)|Adverse Event|0|||
124489520|NCT00923091|447747259|FG004|Period III (Single-Blind)|Adverse Event|0|||
124489521|NCT00923091|447747260|FG005|Period III (Single-Blind)|Adverse Event|0|||
124489522|NCT00923091|447747261|FG006|Period III (Single-Blind)|Adverse Event|0|||
124489523|NCT00923091|447747262|FG007|Period III (Single-Blind)|Adverse Event|0|||
124489524|NCT00923091|447747263|FG008|Period III (Single-Blind)|Adverse Event|0|||
124489525|NCT00923091|447747264|FG009|Period III (Single-Blind)|Adverse Event|0|||
124489526|NCT00923091|447747265|FG010|Period III (Single-Blind)|Adverse Event|0|||
124489527|NCT00923091|447747266|FG011|Period III (Single-Blind)|Adverse Event|0|||
124489528|NCT00923091|447747267|FG012|Period III (Single-Blind)|Adverse Event|0|||
124489529|NCT00923091|447747255|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
124489530|NCT00923091|447747256|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
124489531|NCT00923091|447747257|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
124489532|NCT00923091|447747258|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
124489533|NCT00923091|447747259|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
124489534|NCT00923091|447747260|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
124489535|NCT00923091|447747261|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
124489536|NCT00923091|447747262|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
124489537|NCT00923091|447747263|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
124489538|NCT00923091|447747264|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
124489539|NCT00923091|447747265|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
124489540|NCT00923091|447747266|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
124489541|NCT00923091|447747267|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
124489542|NCT00923091|447747255|FG000|Period III (Single-Blind)|Protocol Violation|3|||
124489543|NCT00923091|447747256|FG001|Period III (Single-Blind)|Protocol Violation|0|||
124489544|NCT00923091|447747257|FG002|Period III (Single-Blind)|Protocol Violation|0|||
124489545|NCT00923091|447747258|FG003|Period III (Single-Blind)|Protocol Violation|0|||
124489546|NCT00923091|447747259|FG004|Period III (Single-Blind)|Protocol Violation|0|||
124489547|NCT00923091|447747260|FG005|Period III (Single-Blind)|Protocol Violation|0|||
124489548|NCT00923091|447747261|FG006|Period III (Single-Blind)|Protocol Violation|0|||
124489549|NCT00923091|447747262|FG007|Period III (Single-Blind)|Protocol Violation|0|||
124489550|NCT00923091|447747263|FG008|Period III (Single-Blind)|Protocol Violation|0|||
124489551|NCT00923091|447747264|FG009|Period III (Single-Blind)|Protocol Violation|0|||
124489552|NCT00923091|447747265|FG010|Period III (Single-Blind)|Protocol Violation|0|||
124771988|NCT02144610|448796344|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
124489553|NCT00923091|447747266|FG011|Period III (Single-Blind)|Protocol Violation|0|||
124771989|NCT02144610|448796345|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
124489554|NCT00923091|447747267|FG012|Period III (Single-Blind)|Protocol Violation|0|||
124489555|NCT00923091|447747255|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
124489556|NCT00923091|447747256|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
124489557|NCT00923091|447747257|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
124489558|NCT00923091|447747258|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
124489559|NCT00923091|447747259|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
124489560|NCT00923091|447747260|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
124489561|NCT00923091|447747261|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
124489562|NCT00923091|447747262|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
124489563|NCT00923091|447747263|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
124489564|NCT00923091|447747264|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
124489565|NCT00923091|447747265|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
124489566|NCT00923091|447747266|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
124489567|NCT00923091|447747267|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
124489568|NCT00923091|447747255|FG000|Period IV (Double-Blind)|Adverse Event|2|||
124489569|NCT00923091|447747256|FG001|Period IV (Double-Blind)|Adverse Event|0|||
124489570|NCT00923091|447747257|FG002|Period IV (Double-Blind)|Adverse Event|0|||
124489571|NCT00923091|447747258|FG003|Period IV (Double-Blind)|Adverse Event|0|||
124489572|NCT00923091|447747259|FG004|Period IV (Double-Blind)|Adverse Event|0|||
124489573|NCT00923091|447747260|FG005|Period IV (Double-Blind)|Adverse Event|0|||
124489574|NCT00923091|447747261|FG006|Period IV (Double-Blind)|Adverse Event|0|||
124489575|NCT00923091|447747262|FG007|Period IV (Double-Blind)|Adverse Event|0|||
124489576|NCT00923091|447747263|FG008|Period IV (Double-Blind)|Adverse Event|0|||
124489577|NCT00923091|447747264|FG009|Period IV (Double-Blind)|Adverse Event|0|||
124489578|NCT00923091|447747265|FG010|Period IV (Double-Blind)|Adverse Event|0|||
124489579|NCT00923091|447747266|FG011|Period IV (Double-Blind)|Adverse Event|0|||
124489580|NCT00923091|447747267|FG012|Period IV (Double-Blind)|Adverse Event|0|||
124489581|NCT00923091|447747255|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
124489582|NCT00923091|447747256|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
124489583|NCT00923091|447747257|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
124489584|NCT00923091|447747258|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
124489585|NCT00923091|447747259|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
124489586|NCT00923091|447747260|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
124489587|NCT00923091|447747261|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
124489588|NCT00923091|447747262|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
124489589|NCT00923091|447747263|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
124489590|NCT00923091|447747264|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
124489591|NCT00923091|447747265|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
124489592|NCT00923091|447747266|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
124489593|NCT00923091|447747267|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
124489594|NCT00923091|447747255|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
124489595|NCT00923091|447747256|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
124489596|NCT00923091|447747257|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
124489597|NCT00923091|447747258|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
124489598|NCT00923091|447747259|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
124489599|NCT00923091|447747260|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
124489600|NCT00923091|447747261|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
124489601|NCT00923091|447747262|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
124489602|NCT00923091|447747263|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
124489603|NCT00923091|447747264|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
124489604|NCT00923091|447747265|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
124489605|NCT00923091|447747266|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
124489606|NCT00923091|447747267|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
124489607|NCT00923091|447747255|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
124489608|NCT00923091|447747256|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
124489609|NCT00923091|447747257|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
124489610|NCT00923091|447747258|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
124489611|NCT00923091|447747259|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
124489612|NCT00923091|447747260|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
124489613|NCT00923091|447747261|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
124489614|NCT00923091|447747262|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
124489615|NCT00923091|447747263|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
124489616|NCT00923091|447747264|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
124489617|NCT00923091|447747265|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
124489618|NCT00923091|447747266|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
124489619|NCT00923091|447747267|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
124489620|NCT00923091|447747255|FG000|Period V (Double -Blind)|Protocol Violation|0|||
124489621|NCT00923091|447747256|FG001|Period V (Double -Blind)|Protocol Violation|0|||
124489622|NCT00923091|447747257|FG002|Period V (Double -Blind)|Protocol Violation|0|||
124489623|NCT00923091|447747258|FG003|Period V (Double -Blind)|Protocol Violation|0|||
124489624|NCT00923091|447747259|FG004|Period V (Double -Blind)|Protocol Violation|0|||
124721590|NCT03028129|448603677|FG001|Overall Study|Withdrawal by Subject|45|||
124721591|NCT01831466|448603684|FG000|Overall Study|Protocol Violation|1|||
124721592|NCT01831466|448603685|FG001|Overall Study|Protocol Violation|1|||
124489625|NCT00923091|447747260|FG005|Period V (Double -Blind)|Protocol Violation|0|||
124489626|NCT00923091|447747261|FG006|Period V (Double -Blind)|Protocol Violation|0|||
124489627|NCT00923091|447747262|FG007|Period V (Double -Blind)|Protocol Violation|0|||
124489628|NCT00923091|447747263|FG008|Period V (Double -Blind)|Protocol Violation|0|||
124489629|NCT00923091|447747264|FG009|Period V (Double -Blind)|Protocol Violation|0|||
124489630|NCT00923091|447747265|FG010|Period V (Double -Blind)|Protocol Violation|0|||
124489631|NCT00923091|447747266|FG011|Period V (Double -Blind)|Protocol Violation|0|||
124489632|NCT00923091|447747267|FG012|Period V (Double -Blind)|Protocol Violation|1|||
124489633|NCT00923091|447747255|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
124489634|NCT00923091|447747256|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
124489635|NCT00923091|447747257|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
124489636|NCT00923091|447747258|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
124489637|NCT00923091|447747259|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
124489638|NCT00923091|447747260|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
124489639|NCT00923091|447747261|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
124489640|NCT00923091|447747262|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
124489641|NCT00923091|447747263|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
124489642|NCT00923091|447747264|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
124489643|NCT00923091|447747265|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
124489644|NCT00923091|447747266|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
124489645|NCT00923091|447747267|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
124489646|NCT00923091|447747255|FG000|Period VI (Open-Label)|Adverse Event|17|||
124489647|NCT00923091|447747256|FG001|Period VI (Open-Label)|Adverse Event|0|||
124489648|NCT00923091|447747257|FG002|Period VI (Open-Label)|Adverse Event|4|||
124489649|NCT00923091|447747258|FG003|Period VI (Open-Label)|Adverse Event|1|||
124489650|NCT00923091|447747259|FG004|Period VI (Open-Label)|Adverse Event|1|||
124489651|NCT00923091|447747260|FG005|Period VI (Open-Label)|Adverse Event|0|||
124489652|NCT00923091|447747261|FG006|Period VI (Open-Label)|Adverse Event|0|||
124489653|NCT00923091|447747262|FG007|Period VI (Open-Label)|Adverse Event|0|||
124489654|NCT00923091|447747263|FG008|Period VI (Open-Label)|Adverse Event|0|||
124489655|NCT00923091|447747264|FG009|Period VI (Open-Label)|Adverse Event|0|||
124489656|NCT00923091|447747265|FG010|Period VI (Open-Label)|Adverse Event|0|||
124489657|NCT00923091|447747266|FG011|Period VI (Open-Label)|Adverse Event|0|||
124489658|NCT00923091|447747267|FG012|Period VI (Open-Label)|Adverse Event|0|||
124489659|NCT00923091|447747255|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
124489660|NCT00923091|447747256|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
124489661|NCT00923091|447747257|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
124489662|NCT00923091|447747258|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
124489663|NCT00923091|447747259|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
124489664|NCT00923091|447747260|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
124489665|NCT00923091|447747261|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
124489666|NCT00923091|447747262|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
124489667|NCT00923091|447747263|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
124489668|NCT00923091|447747264|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
124489669|NCT00923091|447747265|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
124489670|NCT00923091|447747266|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
124489671|NCT00923091|447747267|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
124489672|NCT00923091|447747255|FG000|Period VI (Open-Label)|Protocol Violation|6|||
124489673|NCT00923091|447747256|FG001|Period VI (Open-Label)|Protocol Violation|1|||
124489674|NCT00923091|447747257|FG002|Period VI (Open-Label)|Protocol Violation|3|||
124489675|NCT00923091|447747258|FG003|Period VI (Open-Label)|Protocol Violation|1|||
124489676|NCT00923091|447747259|FG004|Period VI (Open-Label)|Protocol Violation|4|||
124489677|NCT00923091|447747260|FG005|Period VI (Open-Label)|Protocol Violation|0|||
124489678|NCT00923091|447747261|FG006|Period VI (Open-Label)|Protocol Violation|0|||
124489679|NCT00923091|447747262|FG007|Period VI (Open-Label)|Protocol Violation|0|||
124489680|NCT00923091|447747263|FG008|Period VI (Open-Label)|Protocol Violation|0|||
124489681|NCT00923091|447747264|FG009|Period VI (Open-Label)|Protocol Violation|0|||
124489682|NCT00923091|447747265|FG010|Period VI (Open-Label)|Protocol Violation|0|||
124489683|NCT00923091|447747266|FG011|Period VI (Open-Label)|Protocol Violation|0|||
124489684|NCT00923091|447747267|FG012|Period VI (Open-Label)|Protocol Violation|0|||
124489685|NCT00923091|447747255|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
124489686|NCT00923091|447747256|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
124489687|NCT00923091|447747257|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
124489688|NCT00923091|447747258|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
124489689|NCT00923091|447747259|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
124489690|NCT00923091|447747260|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
124489691|NCT00923091|447747261|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
124489692|NCT00923091|447747262|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
124489693|NCT00923091|447747263|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
124721593|NCT01831466|448603686|FG002|Overall Study|Protocol Violation|2|||
124489694|NCT00923091|447747264|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
124489695|NCT00923091|447747265|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
124489696|NCT00923091|447747266|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
124489697|NCT00923091|447747267|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
124489698|NCT00923091|447747255|FG000|Period VI (Open-Label)|Other Reason|0|||
124489699|NCT00923091|447747256|FG001|Period VI (Open-Label)|Other Reason|0|||
124489700|NCT00923091|447747257|FG002|Period VI (Open-Label)|Other Reason|0|||
124489701|NCT00923091|447747258|FG003|Period VI (Open-Label)|Other Reason|1|||
124489702|NCT00923091|447747259|FG004|Period VI (Open-Label)|Other Reason|1|||
124489703|NCT00923091|447747260|FG005|Period VI (Open-Label)|Other Reason|0|||
124489704|NCT00923091|447747261|FG006|Period VI (Open-Label)|Other Reason|0|||
124489705|NCT00923091|447747262|FG007|Period VI (Open-Label)|Other Reason|0|||
124489706|NCT00923091|447747263|FG008|Period VI (Open-Label)|Other Reason|0|||
124489707|NCT00923091|447747264|FG009|Period VI (Open-Label)|Other Reason|0|||
124489708|NCT00923091|447747265|FG010|Period VI (Open-Label)|Other Reason|0|||
124489709|NCT00923091|447747266|FG011|Period VI (Open-Label)|Other Reason|0|||
124489710|NCT00923091|447747267|FG012|Period VI (Open-Label)|Other Reason|0|||
124489711|NCT01633060|447747268|FG000|Randomization Phase|Protocol deviation|1|||
124489712|NCT01633060|447747269|FG001|Randomization Phase|Protocol deviation|2|||
124489713|NCT01633060|447747268|FG000|Randomization Phase|Technical problem|0|||
124489714|NCT01633060|447747269|FG001|Randomization Phase|Technical problem|1|||
124489715|NCT01633060|447747268|FG000|Treatment Phase|Adverse Event|24|||
124489716|NCT01633060|447747269|FG001|Treatment Phase|Adverse Event|3|||
124489717|NCT01633060|447747268|FG000|Treatment Phase|Lost to Follow-up|1|||
124489718|NCT01633060|447747269|FG001|Treatment Phase|Lost to Follow-up|0|||
124489719|NCT01633060|447747268|FG000|Treatment Phase|Physician Decision|16|||
124489720|NCT01633060|447747269|FG001|Treatment Phase|Physician Decision|7|||
124489721|NCT01633060|447747268|FG000|Treatment Phase|Progressive Disease|210|||
124489722|NCT01633060|447747269|FG001|Treatment Phase|Progressive Disease|120|||
124489723|NCT01633060|447747268|FG000|Treatment Phase|Protocol Deviation|1|||
124489724|NCT01633060|447747269|FG001|Treatment Phase|Protocol Deviation|0|||
124489725|NCT01633060|447747268|FG000|Treatment Phase|Study Terminated by sponsor|7|||
124489726|NCT01633060|447747269|FG001|Treatment Phase|Study Terminated by sponsor|3|||
124489727|NCT01633060|447747268|FG000|Treatment Phase|Subject/guardian decision|25|||
124489728|NCT01633060|447747269|FG001|Treatment Phase|Subject/guardian decision|4|||
124489729|NCT01633060|447747268|FG000|Treatment Phase|Death|4|||
124489730|NCT01633060|447747269|FG001|Treatment Phase|Death|3|||
124489731|NCT01633060|447747268|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
124489732|NCT01633060|447747269|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
124489733|NCT01633060|447747268|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
124489734|NCT01633060|447747269|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
124489735|NCT01633060|447747268|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
124489736|NCT01633060|447747269|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
124489737|NCT01633060|447747268|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
124489738|NCT01633060|447747269|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
124489739|NCT01633060|447747268|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
124489740|NCT01633060|447747269|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
124489741|NCT01633060|447747268|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
124489742|NCT01633060|447747269|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
124489743|NCT00949650|447747272|FG000|Overall Study|Progressive disease|188|||
124489744|NCT00949650|447747273|FG001|Overall Study|Progressive disease|19|||
124489745|NCT00949650|447747272|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
124489746|NCT00949650|447747273|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
124489747|NCT00949650|447747272|FG000|Overall Study|Other Adverse Event (AE)|28|||
124489748|NCT00949650|447747273|FG001|Overall Study|Other Adverse Event (AE)|17|||
124489749|NCT00949650|447747272|FG000|Overall Study|Protocol Violation|1|||
124489750|NCT00949650|447747273|FG001|Overall Study|Protocol Violation|4|||
124489751|NCT00949650|447747272|FG000|Overall Study|Refusal to continue medication|7|||
124489752|NCT00949650|447747273|FG001|Overall Study|Refusal to continue medication|11|||
124489753|NCT00949650|447747272|FG000|Overall Study|Not treated|1|||
124489754|NCT00949650|447747273|FG001|Overall Study|Not treated|4|||
124489755|NCT00949650|447747272|FG000|Overall Study|Other not specified above|5|||
124489756|NCT00949650|447747273|FG001|Overall Study|Other not specified above|0|||
124489757|NCT00069121|447747277|FG000|Overall Study|Death|286|||
124489758|NCT00069121|447747278|FG001|Overall Study|Death|242|||
124771990|NCT02144610|448796344|FG000|Overall Study|Other|0|||
124771991|NCT02144610|448796345|FG001|Overall Study|Other|1|||
124489759|NCT00069121|447747277|FG000|Overall Study|Withdrawal by Subject|18|||
124489760|NCT00069121|447747278|FG001|Overall Study|Withdrawal by Subject|20|||
124489761|NCT00069121|447747277|FG000|Overall Study|Lost to Follow-up|63|||
124489762|NCT00069121|447747278|FG001|Overall Study|Lost to Follow-up|63|||
124489763|NCT02983292|447747281|FG000|Overall Study|Participant unwell & cannot travel|2|||
124489764|NCT02983292|447747281|FG000|Overall Study|Lost to Follow-up|3|||
124489765|NCT02983292|447747281|FG000|Overall Study|Participant withdrew consent|2|||
124489766|NCT02983292|447747281|FG000|Overall Study|Revision|7|||
124489767|NCT02983292|447747281|FG000|Overall Study|Death|1|||
124489768|NCT02983292|447747281|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
124489769|NCT02983292|447747281|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
124489770|NCT02983292|447747281|FG000|Overall Study|Participant relocation|1|||
124489771|NCT00964795|447747282|FG000|Overall Study|Withdrawal by Subject|79|||
124489772|NCT00964795|447747282|FG000|Overall Study|Adverse Event|12|||
124489773|NCT00964795|447747282|FG000|Overall Study|Death|14|||
124489774|NCT00964795|447747282|FG000|Overall Study|Lost to Follow-up|7|||
124489775|NCT00964795|447747282|FG000|Overall Study|Termination of Study by Sponsor|169|||
124489776|NCT00964795|447747282|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
124489777|NCT00964795|447747282|FG000|Overall Study|Other|23|||
124489778|NCT00231478|447747286|FG000|Overall Study|Protocol Violation|3|||
124489779|NCT00231478|447747287|FG001|Overall Study|Protocol Violation|2|||
124489780|NCT00231478|447747286|FG000|Overall Study|Refused Treatment|1|||
124489781|NCT00231478|447747287|FG001|Overall Study|Refused Treatment|1|||
124489782|NCT00231478|447747286|FG000|Overall Study|Withdrawal by Subject|1|||
124489783|NCT00231478|447747287|FG001|Overall Study|Withdrawal by Subject|0|||
124489784|NCT00231478|447747286|FG000|Overall Study|Adverse Event|0|||
124489785|NCT00231478|447747287|FG001|Overall Study|Adverse Event|1|||
124489786|NCT00231478|447747286|FG000|Overall Study|Administrative|3|||
124489787|NCT00231478|447747287|FG001|Overall Study|Administrative|2|||
124489788|NCT03022422|447747294|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
124489789|NCT03022422|447747295|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
124489790|NCT03022422|447747296|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
124489791|NCT03022422|447747297|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
124489792|NCT03022422|447747298|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
124489793|NCT03022422|447747299|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
124489794|NCT00393458|447747300|FG000|Overall Study|Adverse Event|35|||
124489795|NCT00393458|447747301|FG001|Overall Study|Adverse Event|24|||
124489796|NCT00393458|447747302|FG002|Overall Study|Adverse Event|40|||
124489797|NCT00393458|447747303|FG003|Overall Study|Adverse Event|35|||
124489798|NCT00393458|447747300|FG000|Overall Study|Subject withdrew consent|27|||
124489799|NCT00393458|447747301|FG001|Overall Study|Subject withdrew consent|40|||
124489800|NCT00393458|447747302|FG002|Overall Study|Subject withdrew consent|33|||
124489801|NCT00393458|447747303|FG003|Overall Study|Subject withdrew consent|50|||
124489802|NCT00393458|447747300|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
124489803|NCT00393458|447747301|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
124489804|NCT00393458|447747302|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
124489805|NCT00393458|447747303|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
124489806|NCT00393458|447747300|FG000|Overall Study|Protocol deviation|11|||
124489807|NCT00393458|447747301|FG001|Overall Study|Protocol deviation|11|||
124489808|NCT00393458|447747302|FG002|Overall Study|Protocol deviation|11|||
124489809|NCT00393458|447747303|FG003|Overall Study|Protocol deviation|10|||
124489810|NCT00393458|447747300|FG000|Overall Study|Administrative problems|7|||
124489811|NCT00393458|447747301|FG001|Overall Study|Administrative problems|8|||
124489812|NCT00393458|447747302|FG002|Overall Study|Administrative problems|5|||
124489813|NCT00393458|447747303|FG003|Overall Study|Administrative problems|2|||
124489814|NCT00393458|447747300|FG000|Overall Study|Lost to Follow-up|5|||
124489815|NCT00393458|447747301|FG001|Overall Study|Lost to Follow-up|6|||
124489816|NCT00393458|447747302|FG002|Overall Study|Lost to Follow-up|5|||
124489817|NCT00393458|447747303|FG003|Overall Study|Lost to Follow-up|3|||
124489818|NCT00393458|447747300|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124489819|NCT00393458|447747301|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124489820|NCT00393458|447747302|FG002|Overall Study|Abnormal laboratory value(s)|0|||
124489821|NCT00393458|447747303|FG003|Overall Study|Abnormal laboratory value(s)|0|||
124489822|NCT00393458|447747300|FG000|Overall Study|Death|1|||
124489823|NCT00393458|447747301|FG001|Overall Study|Death|1|||
124489824|NCT00393458|447747302|FG002|Overall Study|Death|5|||
124489825|NCT00393458|447747303|FG003|Overall Study|Death|5|||
124489826|NCT00393458|447747300|FG000|Overall Study|Abnormal test procedure result(s)|0|||
124489827|NCT00393458|447747301|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124489828|NCT00393458|447747302|FG002|Overall Study|Abnormal test procedure result(s)|1|||
124489829|NCT00393458|447747303|FG003|Overall Study|Abnormal test procedure result(s)|2|||
124489830|NCT00393458|447747300|FG000|Overall Study|Subject no longer requires study drug|0|||
124489831|NCT00393458|447747301|FG001|Overall Study|Subject no longer requires study drug|1|||
124489832|NCT00393458|447747302|FG002|Overall Study|Subject no longer requires study drug|0|||
124489833|NCT00393458|447747303|FG003|Overall Study|Subject no longer requires study drug|0|||
124489834|NCT01282814|447747306|FG000|First Intervention|Emesis During Dosing Interval|0|||
124489835|NCT01282814|447747307|FG001|First Intervention|Emesis During Dosing Interval|3|||
124489836|NCT01282814|447747306|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
124489837|NCT01282814|447747307|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
124489838|NCT00957372|447747314|FG000|PART I|Lost to Follow-up|0|||
124489839|NCT00957372|447747315|FG001|PART I|Lost to Follow-up|0|||
124489840|NCT00957372|447747316|FG002|PART I|Lost to Follow-up|1|||
124557749|NCT02270983|448001311|FG000|Overall Study|Protocol Violation|1|||
124557750|NCT02270983|448001312|FG001|Overall Study|Protocol Violation|1|||
124557751|NCT02270983|448001313|FG002|Overall Study|Protocol Violation|1|||
124557752|NCT02270983|448001311|FG000|Overall Study|family emergency|0|||
124489841|NCT00957372|447747317|FG003|PART I|Lost to Follow-up|0|||
124489842|NCT00957372|447747314|FG000|PART II|Withdrawal by Subject|0|||
124489843|NCT00957372|447747315|FG001|PART II|Withdrawal by Subject|0|||
124489844|NCT00957372|447747316|FG002|PART II|Withdrawal by Subject|0|||
124489845|NCT00957372|447747317|FG003|PART II|Withdrawal by Subject|8|||
124489846|NCT00957372|447747314|FG000|PART II|Physician Decision|0|||
124489847|NCT00957372|447747315|FG001|PART II|Physician Decision|0|||
124489848|NCT00957372|447747316|FG002|PART II|Physician Decision|0|||
124489849|NCT00957372|447747317|FG003|PART II|Physician Decision|1|||
124489850|NCT00957372|447747314|FG000|PART II|Pregnancy|0|||
124489851|NCT00957372|447747315|FG001|PART II|Pregnancy|0|||
124489852|NCT00957372|447747316|FG002|PART II|Pregnancy|0|||
124489853|NCT00957372|447747317|FG003|PART II|Pregnancy|1|||
124489854|NCT00957372|447747314|FG000|PART II|Not Know|0|||
124489855|NCT00957372|447747315|FG001|PART II|Not Know|0|||
124489856|NCT00957372|447747316|FG002|PART II|Not Know|0|||
124489857|NCT00957372|447747317|FG003|PART II|Not Know|20|||
124489858|NCT00957372|447747314|FG000|PART II|Adverse Event|0|||
124489859|NCT00957372|447747315|FG001|PART II|Adverse Event|0|||
124489860|NCT00957372|447747316|FG002|PART II|Adverse Event|0|||
124489861|NCT00957372|447747317|FG003|PART II|Adverse Event|10|||
124489862|NCT00957372|447747314|FG000|PART II|Patient non-compliance|0|||
124489863|NCT00957372|447747315|FG001|PART II|Patient non-compliance|0|||
124489864|NCT00957372|447747316|FG002|PART II|Patient non-compliance|0|||
124489865|NCT00957372|447747317|FG003|PART II|Patient non-compliance|4|||
124489866|NCT01524289|447747318|FG000|Overall Study|Lost to Follow-up|0|||
124489867|NCT01524289|447747319|FG001|Overall Study|Lost to Follow-up|1|||
124489868|NCT01524289|447747318|FG000|Overall Study|Physician Decision|1|||
124489869|NCT01524289|447747319|FG001|Overall Study|Physician Decision|0|||
124489870|NCT01524289|447747318|FG000|Overall Study|Protocol Violation|5|||
124489871|NCT01524289|447747319|FG001|Overall Study|Protocol Violation|1|||
124489872|NCT01524289|447747318|FG000|Overall Study|Withdrawal by Subject|11|||
124489873|NCT01524289|447747319|FG001|Overall Study|Withdrawal by Subject|7|||
124489874|NCT01524289|447747318|FG000|Overall Study|Adverse Event|12|||
124489875|NCT01524289|447747319|FG001|Overall Study|Adverse Event|5|||
124489876|NCT01524289|447747318|FG000|Overall Study|Did not take study medication|1|||
124489877|NCT01524289|447747319|FG001|Overall Study|Did not take study medication|0|||
124489878|NCT02104180|447747320|FG000|Overall Study|Protocol Violation|1|||
124489879|NCT02104180|447747321|FG001|Overall Study|Protocol Violation|0|||
124489880|NCT01444391|447747322|FG000|Overall Study|Death|1|||
124489881|NCT02704429|447747325|FG000|Part A: 24 Weeks|Adverse Event|3|||
124489882|NCT02704429|447747326|FG001|Part A: 24 Weeks|Adverse Event|0|||
124489883|NCT02704429|447747325|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
124489884|NCT02704429|447747326|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
124489885|NCT00104104|447747327|FG000|Overall Study|Adverse Event|8|||
124489886|NCT00104104|447747328|FG001|Overall Study|Adverse Event|8|||
124489887|NCT00104104|447747327|FG000|Overall Study|Abnormal laboratory value(s)|20|||
124489888|NCT00104104|447747328|FG001|Overall Study|Abnormal laboratory value(s)|14|||
124489889|NCT00104104|447747327|FG000|Overall Study|Lack of Efficacy|0|||
124489890|NCT00104104|447747328|FG001|Overall Study|Lack of Efficacy|3|||
124489891|NCT00104104|447747327|FG000|Overall Study|Condition no longer requires study drug|7|||
124489892|NCT00104104|447747328|FG001|Overall Study|Condition no longer requires study drug|4|||
124489893|NCT00104104|447747327|FG000|Overall Study|Protocol Violation|5|||
124489894|NCT00104104|447747328|FG001|Overall Study|Protocol Violation|2|||
124489895|NCT00104104|447747327|FG000|Overall Study|Withdrawal by Subject|11|||
124489896|NCT00104104|447747328|FG001|Overall Study|Withdrawal by Subject|15|||
124489897|NCT00104104|447747327|FG000|Overall Study|Lost to Follow-up|3|||
124489898|NCT00104104|447747328|FG001|Overall Study|Lost to Follow-up|7|||
124489899|NCT00104104|447747327|FG000|Overall Study|Administrative problems|12|||
124489900|NCT00104104|447747328|FG001|Overall Study|Administrative problems|13|||
124489901|NCT00104104|447747327|FG000|Overall Study|Death|9|||
124489902|NCT00104104|447747328|FG001|Overall Study|Death|6|||
124489903|NCT01821677|447747331|FG000|Overall Study|Adverse Event|4|||
124771992|NCT00214201|448796347|FG000|Overall Study|Withdrawal by Subject|2|||
124489904|NCT01821677|447747332|FG001|Overall Study|Adverse Event|6|||
124489905|NCT01821677|447747333|FG002|Overall Study|Adverse Event|5|||
124489906|NCT01821677|447747331|FG000|Overall Study|Physician Decision|1|||
124489907|NCT01821677|447747332|FG001|Overall Study|Physician Decision|4|||
124489908|NCT01821677|447747333|FG002|Overall Study|Physician Decision|1|||
124489909|NCT01821677|447747331|FG000|Overall Study|Non-compliance|0|||
124489910|NCT01821677|447747332|FG001|Overall Study|Non-compliance|1|||
124489911|NCT01821677|447747333|FG002|Overall Study|Non-compliance|2|||
124489912|NCT01821677|447747331|FG000|Overall Study|Lost to Follow-up|2|||
124489913|NCT01821677|447747332|FG001|Overall Study|Lost to Follow-up|1|||
124489914|NCT01821677|447747333|FG002|Overall Study|Lost to Follow-up|3|||
124489915|NCT01821677|447747331|FG000|Overall Study|Protocol Violation|0|||
124489916|NCT01821677|447747332|FG001|Overall Study|Protocol Violation|0|||
124489917|NCT01821677|447747333|FG002|Overall Study|Protocol Violation|2|||
124489918|NCT01821677|447747331|FG000|Overall Study|Withdrawal by Subject|7|||
124489919|NCT01821677|447747332|FG001|Overall Study|Withdrawal by Subject|3|||
124489920|NCT01821677|447747333|FG002|Overall Study|Withdrawal by Subject|2|||
124489921|NCT01821677|447747331|FG000|Overall Study|Other|9|||
124489922|NCT01821677|447747332|FG001|Overall Study|Other|0|||
124489923|NCT01821677|447747333|FG002|Overall Study|Other|0|||
124489924|NCT01855789|447747334|FG000|1) Baseline up to Week 24|Adverse Event|37|||
124489925|NCT01855789|447747335|FG001|1) Baseline up to Week 24|Adverse Event|0|||
124489926|NCT01855789|447747336|FG002|1) Baseline up to Week 24|Adverse Event|0|||
124489927|NCT01855789|447747337|FG003|1) Baseline up to Week 24|Adverse Event|0|||
124489928|NCT01855789|447747334|FG000|1) Baseline up to Week 24|Death|2|||
124489929|NCT01855789|447747335|FG001|1) Baseline up to Week 24|Death|0|||
124489930|NCT01855789|447747336|FG002|1) Baseline up to Week 24|Death|0|||
124489931|NCT01855789|447747337|FG003|1) Baseline up to Week 24|Death|0|||
124489932|NCT01855789|447747334|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
124489933|NCT01855789|447747335|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
124489934|NCT01855789|447747336|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
124489935|NCT01855789|447747337|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
124489936|NCT01855789|447747334|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
124489937|NCT01855789|447747335|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
124489938|NCT01855789|447747336|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
124489939|NCT01855789|447747337|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
124489940|NCT01855789|447747334|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
124489941|NCT01855789|447747335|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
124489942|NCT01855789|447747336|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
124489943|NCT01855789|447747337|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
124489944|NCT01855789|447747334|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
124489945|NCT01855789|447747335|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
124489946|NCT01855789|447747336|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
124489947|NCT01855789|447747337|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
124489948|NCT01855789|447747334|FG000|1) Baseline up to Week 24|Physician Decision|4|||
124489949|NCT01855789|447747335|FG001|1) Baseline up to Week 24|Physician Decision|0|||
124489950|NCT01855789|447747336|FG002|1) Baseline up to Week 24|Physician Decision|0|||
124489951|NCT01855789|447747337|FG003|1) Baseline up to Week 24|Physician Decision|0|||
124489952|NCT01855789|447747334|FG000|1) Baseline up to Week 24|Pregnancy|1|||
124489953|NCT01855789|447747335|FG001|1) Baseline up to Week 24|Pregnancy|0|||
124489954|NCT01855789|447747336|FG002|1) Baseline up to Week 24|Pregnancy|0|||
124489955|NCT01855789|447747337|FG003|1) Baseline up to Week 24|Pregnancy|0|||
124489956|NCT01855789|447747334|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
124489957|NCT01855789|447747335|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
124489958|NCT01855789|447747336|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
124489959|NCT01855789|447747337|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
124489960|NCT01855789|447747334|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
124489961|NCT01855789|447747335|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
124489962|NCT01855789|447747336|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
124489963|NCT01855789|447747337|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
124489964|NCT01855789|447747334|FG000|1) Baseline up to Week 24|Other|4|||
124489965|NCT01855789|447747335|FG001|1) Baseline up to Week 24|Other|0|||
124489966|NCT01855789|447747336|FG002|1) Baseline up to Week 24|Other|0|||
124489967|NCT01855789|447747337|FG003|1) Baseline up to Week 24|Other|0|||
124489968|NCT01855789|447747334|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
124489969|NCT01855789|447747335|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
124489970|NCT01855789|447747336|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
124489971|NCT01855789|447747337|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
124489972|NCT01855789|447747334|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
124489973|NCT01855789|447747335|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
124489974|NCT01855789|447747336|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
124489975|NCT01855789|447747337|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
124489976|NCT01855789|447747334|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
124489977|NCT01855789|447747335|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
124771993|NCT00214201|448796348|FG001|Overall Study|Withdrawal by Subject|0|||
124489978|NCT01855789|447747336|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
124489979|NCT01855789|447747337|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
124489980|NCT01855789|447747334|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
124489981|NCT01855789|447747335|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
124489982|NCT01855789|447747336|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
124489983|NCT01855789|447747337|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
124489984|NCT01855789|447747334|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
124489985|NCT01855789|447747335|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
124489986|NCT01855789|447747336|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
124489987|NCT01855789|447747337|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
124489988|NCT01855789|447747334|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
124489989|NCT01855789|447747335|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
124489990|NCT01855789|447747336|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
124489991|NCT01855789|447747337|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
124771994|NCT00214201|448796347|FG000|Overall Study|Death|0|||
124771995|NCT00214201|448796348|FG001|Overall Study|Death|2|||
124771996|NCT01399372|448796349|FG000|Overall Study|Protocol Violation|3|||
124489992|NCT01855789|447747334|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
124489993|NCT01855789|447747335|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
124489994|NCT01855789|447747336|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
124489995|NCT01855789|447747337|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
124489996|NCT01855789|447747334|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
124489997|NCT01855789|447747335|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
124489998|NCT01855789|447747336|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
124489999|NCT01855789|447747337|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
124490000|NCT01855789|447747334|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
124490001|NCT01855789|447747335|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
124490002|NCT01855789|447747336|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
124490003|NCT01855789|447747337|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
124490004|NCT01855789|447747334|FG000|2) Week 24 up to End of Study|Other|0|||
124490005|NCT01855789|447747335|FG001|2) Week 24 up to End of Study|Other|0|||
124490006|NCT01855789|447747336|FG002|2) Week 24 up to End of Study|Other|0|||
124490007|NCT01855789|447747337|FG003|2) Week 24 up to End of Study|Other|1|||
124490008|NCT03067311|447747338|FG000|Overall Study|Lost to Follow-up|1|||
124490009|NCT03067311|447747339|FG001|Overall Study|Lost to Follow-up|1|||
124490010|NCT03067311|447747338|FG000|Overall Study|Moved away|1|||
124490011|NCT03067311|447747339|FG001|Overall Study|Moved away|1|||
124490012|NCT01089725|447747340|FG000|Overall Study|Adverse Event|1|||
124490013|NCT01089725|447747341|FG001|Overall Study|Adverse Event|1|||
124490014|NCT01089725|447747342|FG002|Overall Study|Adverse Event|0|||
124490015|NCT01089725|447747343|FG003|Overall Study|Adverse Event|0|||
124490016|NCT01089725|447747344|FG004|Overall Study|Adverse Event|2|||
124490017|NCT01089725|447747340|FG000|Overall Study|Lack of Efficacy|4|||
124490018|NCT01089725|447747341|FG001|Overall Study|Lack of Efficacy|3|||
124490019|NCT01089725|447747342|FG002|Overall Study|Lack of Efficacy|1|||
124490020|NCT01089725|447747343|FG003|Overall Study|Lack of Efficacy|0|||
124490021|NCT01089725|447747344|FG004|Overall Study|Lack of Efficacy|4|||
124490022|NCT01089725|447747340|FG000|Overall Study|Lost to Follow-up|2|||
124490023|NCT01089725|447747341|FG001|Overall Study|Lost to Follow-up|2|||
124490024|NCT01089725|447747342|FG002|Overall Study|Lost to Follow-up|0|||
124490025|NCT01089725|447747343|FG003|Overall Study|Lost to Follow-up|3|||
124490026|NCT01089725|447747344|FG004|Overall Study|Lost to Follow-up|0|||
124490027|NCT01089725|447747340|FG000|Overall Study|Protocol Violation|0|||
124490028|NCT01089725|447747341|FG001|Overall Study|Protocol Violation|0|||
124490029|NCT01089725|447747342|FG002|Overall Study|Protocol Violation|1|||
124490030|NCT01089725|447747343|FG003|Overall Study|Protocol Violation|1|||
124490031|NCT01089725|447747344|FG004|Overall Study|Protocol Violation|0|||
124490032|NCT01089725|447747340|FG000|Overall Study|Withdrawal by Subject|5|||
124490033|NCT01089725|447747341|FG001|Overall Study|Withdrawal by Subject|5|||
124490034|NCT01089725|447747342|FG002|Overall Study|Withdrawal by Subject|4|||
124490035|NCT01089725|447747343|FG003|Overall Study|Withdrawal by Subject|5|||
124490036|NCT01089725|447747344|FG004|Overall Study|Withdrawal by Subject|4|||
124490037|NCT01089725|447747340|FG000|Overall Study|Study Terminated by Sponsor|51|||
124490038|NCT01089725|447747341|FG001|Overall Study|Study Terminated by Sponsor|56|||
124490039|NCT01089725|447747342|FG002|Overall Study|Study Terminated by Sponsor|53|||
124490040|NCT01089725|447747343|FG003|Overall Study|Study Terminated by Sponsor|68|||
124490041|NCT01089725|447747344|FG004|Overall Study|Study Terminated by Sponsor|68|||
124490042|NCT01089725|447747340|FG000|Overall Study|Randomized, but not treated|0|||
124490043|NCT01089725|447747341|FG001|Overall Study|Randomized, but not treated|1|||
124490044|NCT01089725|447747342|FG002|Overall Study|Randomized, but not treated|2|||
124490045|NCT01089725|447747343|FG003|Overall Study|Randomized, but not treated|1|||
124490046|NCT01089725|447747344|FG004|Overall Study|Randomized, but not treated|2|||
124490047|NCT01089725|447747340|FG000|Overall Study|Other|3|||
124490048|NCT01089725|447747341|FG001|Overall Study|Other|0|||
124490049|NCT01089725|447747342|FG002|Overall Study|Other|0|||
124490050|NCT01089725|447747343|FG003|Overall Study|Other|1|||
124490051|NCT01089725|447747344|FG004|Overall Study|Other|0|||
124490052|NCT02495077|447748942|FG000|Overall Study|Adverse Event|0|||
124490053|NCT02495077|447748943|FG001|Overall Study|Adverse Event|1|||
124490054|NCT02495077|447748944|FG002|Overall Study|Adverse Event|1|||
124490055|NCT02495077|447748945|FG003|Overall Study|Adverse Event|0|||
124490056|NCT02495077|447748942|FG000|Overall Study|Death|3|||
124490057|NCT02495077|447748943|FG001|Overall Study|Death|5|||
124490058|NCT02495077|447748944|FG002|Overall Study|Death|0|||
124490059|NCT02495077|447748945|FG003|Overall Study|Death|0|||
124490060|NCT02495077|447748942|FG000|Overall Study|Lost to Follow-up|6|||
124490061|NCT02495077|447748943|FG001|Overall Study|Lost to Follow-up|4|||
124490062|NCT02495077|447748944|FG002|Overall Study|Lost to Follow-up|0|||
124490063|NCT02495077|447748945|FG003|Overall Study|Lost to Follow-up|0|||
124490064|NCT02495077|447748942|FG000|Overall Study|Physician Decision|2|||
124490065|NCT02495077|447748943|FG001|Overall Study|Physician Decision|1|||
124490066|NCT02495077|447748944|FG002|Overall Study|Physician Decision|4|||
124490067|NCT02495077|447748945|FG003|Overall Study|Physician Decision|0|||
124490068|NCT02495077|447748942|FG000|Overall Study|Protocol Violation|0|||
124490069|NCT02495077|447748943|FG001|Overall Study|Protocol Violation|1|||
124490070|NCT02495077|447748944|FG002|Overall Study|Protocol Violation|0|||
124490071|NCT02495077|447748945|FG003|Overall Study|Protocol Violation|0|||
124490072|NCT02495077|447748942|FG000|Overall Study|Screen Failure|0|||
124490073|NCT02495077|447748943|FG001|Overall Study|Screen Failure|0|||
124490074|NCT02495077|447748944|FG002|Overall Study|Screen Failure|0|||
124490075|NCT02495077|447748945|FG003|Overall Study|Screen Failure|48|||
124490076|NCT02495077|447748942|FG000|Overall Study|Withdrawal by Subject|7|||
124490077|NCT02495077|447748943|FG001|Overall Study|Withdrawal by Subject|7|||
124490078|NCT02495077|447748944|FG002|Overall Study|Withdrawal by Subject|7|||
124490079|NCT02495077|447748945|FG003|Overall Study|Withdrawal by Subject|0|||
124490080|NCT02495077|447748942|FG000|Overall Study|Covid-19 research restrictions|1|||
124490081|NCT02495077|447748943|FG001|Overall Study|Covid-19 research restrictions|0|||
124490082|NCT02495077|447748944|FG002|Overall Study|Covid-19 research restrictions|0|||
124490083|NCT02495077|447748945|FG003|Overall Study|Covid-19 research restrictions|0|||
124490084|NCT02495077|447748942|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
124490085|NCT02495077|447748943|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
124490086|NCT02495077|447748944|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
124490087|NCT02495077|447748945|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
124490088|NCT02495077|447748942|FG000|Overall Study|Incarcerated|0|||
124490089|NCT02495077|447748943|FG001|Overall Study|Incarcerated|1|||
124490090|NCT02495077|447748944|FG002|Overall Study|Incarcerated|0|||
124490091|NCT02495077|447748945|FG003|Overall Study|Incarcerated|0|||
124490092|NCT02495077|447748942|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
124490093|NCT02495077|447748943|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
124490094|NCT02495077|447748944|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
124490095|NCT02495077|447748945|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
124490096|NCT02495077|447748942|FG000|Overall Study|Timing of transplant and randomization|0|||
124490097|NCT02495077|447748943|FG001|Overall Study|Timing of transplant and randomization|0|||
124490098|NCT02495077|447748944|FG002|Overall Study|Timing of transplant and randomization|5|||
124490099|NCT02495077|447748945|FG003|Overall Study|Timing of transplant and randomization|0|||
124490100|NCT01978912|447748952|FG000|Overall Study|Adverse Event|0|||
124490101|NCT01978912|447748953|FG001|Overall Study|Adverse Event|1|||
124490102|NCT01978912|447748954|FG002|Overall Study|Adverse Event|0|||
124490103|NCT01978912|447748955|FG003|Overall Study|Adverse Event|0|||
124490104|NCT01978912|447748952|FG000|Overall Study|Lost to Follow-up|1|||
124490105|NCT01978912|447748953|FG001|Overall Study|Lost to Follow-up|1|||
124490106|NCT01978912|447748954|FG002|Overall Study|Lost to Follow-up|0|||
124490107|NCT01978912|447748955|FG003|Overall Study|Lost to Follow-up|1|||
124490108|NCT01978912|447748952|FG000|Overall Study|Withdrawal by Subject|1|||
124490109|NCT01978912|447748953|FG001|Overall Study|Withdrawal by Subject|0|||
124490110|NCT01978912|447748954|FG002|Overall Study|Withdrawal by Subject|2|||
124490111|NCT01978912|447748955|FG003|Overall Study|Withdrawal by Subject|2|||
124490112|NCT01978912|447748952|FG000|Overall Study|Lumbar Surgery|1|||
124490113|NCT01978912|447748953|FG001|Overall Study|Lumbar Surgery|0|||
124490114|NCT01978912|447748954|FG002|Overall Study|Lumbar Surgery|1|||
124490115|NCT01978912|447748955|FG003|Overall Study|Lumbar Surgery|0|||
124490116|NCT01978912|447748952|FG000|Overall Study|Intradiscal Steroid Injection|0|||
124490117|NCT01978912|447748953|FG001|Overall Study|Intradiscal Steroid Injection|1|||
124490118|NCT01978912|447748954|FG002|Overall Study|Intradiscal Steroid Injection|0|||
124490119|NCT01978912|447748955|FG003|Overall Study|Intradiscal Steroid Injection|0|||
124490120|NCT04220866|447748956|FG000|Overall Study|Death|4|||
124490121|NCT04220866|447748957|FG001|Overall Study|Death|5|||
124490122|NCT04220866|447748956|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
124490123|NCT04220866|447748957|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
124490124|NCT04220866|447748956|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
124490125|NCT04220866|447748957|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
124490126|NCT04220866|447748956|FG000|Overall Study|Withdrawal by Subject|0|||
124490127|NCT04220866|447748957|FG001|Overall Study|Withdrawal by Subject|1|||
124490128|NCT02138110|447748958|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
124490129|NCT02138110|447748958|FG000|Overall Scaffold Implantation|Death|3|||
124490130|NCT01408537|447748962|FG000|Overall Study|Withdrawal by Subject|2|||
124490131|NCT01408537|447748962|FG000|Overall Study|Protocol Violation|3|||
124490132|NCT01408537|447748962|FG000|Overall Study|Lost to Follow-up|3|||
124490133|NCT03842709|447748967|FG000|Overall Study|Withdrawal by Subject|3|||
124490134|NCT03842709|447748968|FG001|Overall Study|Withdrawal by Subject|3|||
124490135|NCT03842709|447748967|FG000|Overall Study|Lost to Follow-up|1|||
124490136|NCT03842709|447748968|FG001|Overall Study|Lost to Follow-up|0|||
124490137|NCT00791128|447748969|FG000|Overall Study|Adverse Event|4|||
124490138|NCT00791128|447748969|FG000|Overall Study|Device migration|2|||
124490139|NCT00791128|447748969|FG000|Overall Study|non-compliance by subject|2|||
124490140|NCT00791128|447748969|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
124490141|NCT03952650|447748972|FG000|Overall Study|TRAVEL|0|||
124490142|NCT03952650|447748973|FG001|Overall Study|TRAVEL|4|||
124490143|NCT03952650|447748974|FG002|Overall Study|TRAVEL|0|||
124490144|NCT03952650|447748975|FG003|Overall Study|TRAVEL|4|||
124490145|NCT03952650|447748976|FG004|Overall Study|TRAVEL|0|||
124490146|NCT03952650|447748977|FG005|Overall Study|TRAVEL|3|||
124490147|NCT03952650|447748978|FG006|Overall Study|TRAVEL|2|||
124490148|NCT03952650|447748972|FG000|Overall Study|Withdrawal by Subject|0|||
124490149|NCT03952650|447748973|FG001|Overall Study|Withdrawal by Subject|2|||
124490150|NCT03952650|447748974|FG002|Overall Study|Withdrawal by Subject|0|||
124490151|NCT03952650|447748975|FG003|Overall Study|Withdrawal by Subject|3|||
124490152|NCT03952650|447748976|FG004|Overall Study|Withdrawal by Subject|0|||
124490153|NCT03952650|447748977|FG005|Overall Study|Withdrawal by Subject|1|||
124490154|NCT03952650|447748978|FG006|Overall Study|Withdrawal by Subject|1|||
124490155|NCT03952650|447748972|FG000|Overall Study|Lost to Follow-up|0|||
124490156|NCT03952650|447748973|FG001|Overall Study|Lost to Follow-up|1|||
124490157|NCT03952650|447748974|FG002|Overall Study|Lost to Follow-up|0|||
124490158|NCT03952650|447748975|FG003|Overall Study|Lost to Follow-up|0|||
124490159|NCT03952650|447748976|FG004|Overall Study|Lost to Follow-up|0|||
124490160|NCT03952650|447748977|FG005|Overall Study|Lost to Follow-up|1|||
124490161|NCT03952650|447748978|FG006|Overall Study|Lost to Follow-up|1|||
124490162|NCT03952650|447748972|FG000|Overall Study|Received wrong vaccine and travelled|0|||
124490163|NCT03952650|447748973|FG001|Overall Study|Received wrong vaccine and travelled|0|||
124490164|NCT03952650|447748974|FG002|Overall Study|Received wrong vaccine and travelled|0|||
124490165|NCT03952650|447748975|FG003|Overall Study|Received wrong vaccine and travelled|0|||
124490166|NCT03952650|447748976|FG004|Overall Study|Received wrong vaccine and travelled|0|||
124490167|NCT03952650|447748977|FG005|Overall Study|Received wrong vaccine and travelled|1|||
124490168|NCT03952650|447748978|FG006|Overall Study|Received wrong vaccine and travelled|0|||
124490169|NCT03952650|447748972|FG000|Overall Study|Unable to make study visit|0|||
124490170|NCT03952650|447748973|FG001|Overall Study|Unable to make study visit|0|||
124490171|NCT03952650|447748974|FG002|Overall Study|Unable to make study visit|0|||
124490172|NCT03952650|447748975|FG003|Overall Study|Unable to make study visit|0|||
124490173|NCT03952650|447748976|FG004|Overall Study|Unable to make study visit|0|||
124490174|NCT03952650|447748977|FG005|Overall Study|Unable to make study visit|1|||
124490175|NCT03952650|447748978|FG006|Overall Study|Unable to make study visit|0|||
124490176|NCT01357239|447748983|FG000|Stratum: All Patients|Adverse Event|0|||
124490177|NCT01357239|447748984|FG001|Stratum: All Patients|Adverse Event|0|||
124490178|NCT01357239|447748985|FG002|Stratum: All Patients|Adverse Event|1|||
124490179|NCT01357239|447748986|FG003|Stratum: All Patients|Adverse Event|1|||
124490180|NCT01357239|447748983|FG000|Stratum: All Patients|Subject withdrew consent|0|||
124490181|NCT01357239|447748984|FG001|Stratum: All Patients|Subject withdrew consent|0|||
124490182|NCT01357239|447748985|FG002|Stratum: All Patients|Subject withdrew consent|1|||
124490183|NCT01357239|447748986|FG003|Stratum: All Patients|Subject withdrew consent|1|||
124490184|NCT01357239|447748983|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
124490185|NCT01357239|447748984|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
124490186|NCT01357239|447748985|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
124490187|NCT01357239|447748986|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
124490188|NCT01357239|447748983|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
124490189|NCT01357239|447748984|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
124490190|NCT01357239|447748985|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
124490191|NCT01357239|447748986|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
124490192|NCT01357239|447748983|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
124490193|NCT01357239|447748984|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
124490194|NCT01357239|447748985|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
124490195|NCT01357239|447748986|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
124490196|NCT03133481|447748989|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
124490197|NCT03133481|447748990|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
124490198|NCT00609609|447748994|FG000|Overall Study|Withdrawal by Subject|2|||
124490199|NCT00609609|447748995|FG001|Overall Study|Withdrawal by Subject|0|||
124490200|NCT00609609|447748994|FG000|Overall Study|Progression|4|||
124490201|NCT00609609|447748995|FG001|Overall Study|Progression|2|||
124490202|NCT00637728|447748996|FG000|Double-blind Phase|Adverse Event|1|||
124490203|NCT00637728|447748997|FG001|Double-blind Phase|Adverse Event|0|||
124490204|NCT00637728|447748998|FG002|Double-blind Phase|Adverse Event|0|||
124490205|NCT00637728|447748996|FG000|Double-blind Phase|Non-compliance|2|||
124490206|NCT00637728|447748997|FG001|Double-blind Phase|Non-compliance|0|||
124490207|NCT00637728|447748998|FG002|Double-blind Phase|Non-compliance|0|||
124490208|NCT00637728|447748996|FG000|Double-blind Phase|Study Discontinued|1|||
124490209|NCT00637728|447748997|FG001|Double-blind Phase|Study Discontinued|1|||
124490210|NCT00637728|447748998|FG002|Double-blind Phase|Study Discontinued|0|||
124490211|NCT01050062|447749001|FG000|Overall Study|Adverse Event|75|||
124490212|NCT01050062|447749002|FG001|Overall Study|Adverse Event|22|||
124490213|NCT01050062|447749001|FG000|Overall Study|Lost to Follow-up|83|||
124490214|NCT01050062|447749002|FG001|Overall Study|Lost to Follow-up|35|||
124490215|NCT01050062|447749001|FG000|Overall Study|Lack of Efficacy|22|||
124490216|NCT01050062|447749002|FG001|Overall Study|Lack of Efficacy|35|||
124490217|NCT01050062|447749001|FG000|Overall Study|Physician Decision|74|||
124490218|NCT01050062|447749002|FG001|Overall Study|Physician Decision|9|||
124490219|NCT01050062|447749001|FG000|Overall Study|Others|17|||
124490220|NCT01050062|447749002|FG001|Overall Study|Others|11|||
124490221|NCT00670111|447749005|FG000|Enrollment to One Month|Testing Failure|0|||
124490222|NCT00670111|447749006|FG001|Enrollment to One Month|Testing Failure|0|||
124490223|NCT00670111|447749007|FG002|Enrollment to One Month|Testing Failure|13|||
124490224|NCT00670111|447749005|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
124490225|NCT00670111|447749006|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
124490226|NCT00670111|447749007|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
124490227|NCT00670111|447749005|FG000|Enrollment to One Month|Physician Decision|1|||
124490228|NCT00670111|447749006|FG001|Enrollment to One Month|Physician Decision|0|||
124490229|NCT00670111|447749007|FG002|Enrollment to One Month|Physician Decision|0|||
124490230|NCT03988751|447749008|FG000|Overall Study|Withdrawal by Subject|1|||
124490231|NCT03988751|447749009|FG001|Overall Study|Withdrawal by Subject|0|||
124490232|NCT03988751|447749008|FG000|Overall Study|Protocol Violation|0|||
124490233|NCT03988751|447749009|FG001|Overall Study|Protocol Violation|1|||
124490234|NCT02623361|447749010|FG000|Overall Study|Protocol Violation|0|||
124490235|NCT02623361|447749011|FG001|Overall Study|Protocol Violation|1|||
124490236|NCT02623361|447749010|FG000|Overall Study|Withdrawal by Subject|0|||
124490237|NCT02623361|447749011|FG001|Overall Study|Withdrawal by Subject|1|||
124490238|NCT00844883|447749014|FG000|Overall Study|Bridged to liver transplant|3|||
124490239|NCT00844883|447749014|FG000|Overall Study|Bridged to resection|1|||
124490240|NCT03894540|447749015|FG000|Overall Study|Adverse Event|0|||
124490241|NCT03894540|447749016|FG001|Overall Study|Adverse Event|0|||
124490242|NCT03894540|447749017|FG002|Overall Study|Adverse Event|0|||
124490243|NCT03894540|447749018|FG003|Overall Study|Adverse Event|0|||
124490244|NCT03894540|447749019|FG004|Overall Study|Adverse Event|1|||
124490245|NCT03894540|447749020|FG005|Overall Study|Adverse Event|0|||
124490246|NCT03894540|447749015|FG000|Overall Study|Withdrawal by Subject|0|||
124490247|NCT03894540|447749016|FG001|Overall Study|Withdrawal by Subject|0|||
124490248|NCT03894540|447749017|FG002|Overall Study|Withdrawal by Subject|0|||
124490249|NCT03894540|447749018|FG003|Overall Study|Withdrawal by Subject|0|||
124490250|NCT03894540|447749019|FG004|Overall Study|Withdrawal by Subject|1|||
124490251|NCT03894540|447749020|FG005|Overall Study|Withdrawal by Subject|0|||
124490252|NCT03894540|447749015|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
124490253|NCT03894540|447749016|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
124490254|NCT03894540|447749017|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
124490255|NCT03894540|447749018|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
124490256|NCT03894540|447749019|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
124490257|NCT03894540|447749020|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
124490258|NCT03894540|447749015|FG000|Overall Study|Progressive Disease Clinical|1|||
124490259|NCT03894540|447749016|FG001|Overall Study|Progressive Disease Clinical|1|||
124490260|NCT03894540|447749017|FG002|Overall Study|Progressive Disease Clinical|0|||
124490261|NCT03894540|447749018|FG003|Overall Study|Progressive Disease Clinical|1|||
124490262|NCT03894540|447749019|FG004|Overall Study|Progressive Disease Clinical|5|||
124490263|NCT03894540|447749020|FG005|Overall Study|Progressive Disease Clinical|1|||
124490264|NCT03894540|447749015|FG000|Overall Study|Study termination by sponsor|0|||
124490265|NCT03894540|447749016|FG001|Overall Study|Study termination by sponsor|0|||
124490266|NCT03894540|447749017|FG002|Overall Study|Study termination by sponsor|0|||
124490267|NCT03894540|447749018|FG003|Overall Study|Study termination by sponsor|0|||
124490268|NCT03894540|447749019|FG004|Overall Study|Study termination by sponsor|2|||
124490269|NCT03894540|447749020|FG005|Overall Study|Study termination by sponsor|0|||
124490270|NCT03000452|447749023|FG000|Treatment Period|Death|1|||
124490271|NCT03000452|447749023|FG000|Treatment Period|Progressive Disease (PD)|14|||
124490272|NCT03000452|447749023|FG000|Treatment Period|Physician Decision|1|||
124490273|NCT03000452|447749023|FG000|Treatment Period|Miscellaneous|2|||
124490274|NCT03000452|447749023|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
124490275|NCT03000452|447749023|FG000|Follow-Up Period|Death|3|||
124490276|NCT03000452|447749023|FG000|Follow-Up Period|Withdrawal by Subject|3|||
124490277|NCT03043365|447749024|FG000|Weeks 0 to Week 8|Adverse Event|1|||
124490278|NCT03043365|447749025|FG001|Weeks 0 to Week 8|Adverse Event|3|||
124490279|NCT03043365|447749024|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
124490280|NCT03043365|447749025|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
124490281|NCT03043365|447749024|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
124490282|NCT03043365|447749025|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
124490283|NCT03455543|447749026|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
124490284|NCT03455543|447749027|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
124490285|NCT03455543|447749028|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
124490286|NCT03455543|447749026|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
124490287|NCT03455543|447749027|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
124490288|NCT03455543|447749028|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
124490289|NCT03455543|447749026|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
124490290|NCT03455543|447749027|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
124490291|NCT03455543|447749028|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
124490292|NCT03455543|447749026|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
124490293|NCT03455543|447749027|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
124490294|NCT03455543|447749028|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
124490295|NCT03455543|447749026|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
124490296|NCT03455543|447749027|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
124490297|NCT03455543|447749028|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
124490298|NCT03455543|447749026|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
124490299|NCT03455543|447749027|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
124490300|NCT03455543|447749028|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
124490301|NCT03455543|447749026|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
124490302|NCT03455543|447749027|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
124490303|NCT03455543|447749028|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
124490304|NCT03455543|447749026|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
124490305|NCT03455543|447749027|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
124490306|NCT03455543|447749028|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
124490307|NCT03455543|447749026|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
124490308|NCT03455543|447749027|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
124490309|NCT03455543|447749028|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
124490310|NCT02873221|447749029|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
124490311|NCT02873221|447749030|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
124490312|NCT02873221|447749031|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
124490313|NCT02873221|447749029|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
124490314|NCT02873221|447749030|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
124490315|NCT02873221|447749031|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
124490316|NCT02873221|447749029|FG000|Treatment Period|Protocol Violation|2|||
124490317|NCT02873221|447749030|FG001|Treatment Period|Protocol Violation|5|||
124490318|NCT02873221|447749031|FG002|Treatment Period|Protocol Violation|8|||
124490319|NCT02873221|447749029|FG000|Treatment Period|Pregnancy|4|||
124490320|NCT02873221|447749030|FG001|Treatment Period|Pregnancy|6|||
124490321|NCT02873221|447749031|FG002|Treatment Period|Pregnancy|3|||
124490322|NCT02873221|447749029|FG000|Treatment Period|Lack of Qualifying Event|0|||
124490323|NCT02873221|447749030|FG001|Treatment Period|Lack of Qualifying Event|3|||
124490324|NCT02873221|447749031|FG002|Treatment Period|Lack of Qualifying Event|1|||
124490325|NCT02873221|447749029|FG000|Treatment Period|Withdrawal of Consent|52|||
124490326|NCT02873221|447749030|FG001|Treatment Period|Withdrawal of Consent|51|||
124490327|NCT02873221|447749031|FG002|Treatment Period|Withdrawal of Consent|41|||
124490328|NCT02873221|447749029|FG000|Treatment Period|Lack of Efficacy|0|||
124490329|NCT02873221|447749030|FG001|Treatment Period|Lack of Efficacy|17|||
124490330|NCT02873221|447749031|FG002|Treatment Period|Lack of Efficacy|12|||
124490331|NCT02873221|447749029|FG000|Treatment Period|Adverse Event|4|||
124490332|NCT02873221|447749030|FG001|Treatment Period|Adverse Event|9|||
124490333|NCT02873221|447749031|FG002|Treatment Period|Adverse Event|11|||
124490334|NCT02873221|447749029|FG000|Treatment Period|Lost to Follow-up|26|||
124490335|NCT02873221|447749030|FG001|Treatment Period|Lost to Follow-up|30|||
124490336|NCT02873221|447749031|FG002|Treatment Period|Lost to Follow-up|26|||
124490337|NCT02873221|447749029|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
124490338|NCT02873221|447749030|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
124490339|NCT02873221|447749031|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
124490340|NCT02873221|447749029|FG000|Safety Follow-up Period|Protocol Violation|0|||
124490341|NCT02873221|447749030|FG001|Safety Follow-up Period|Protocol Violation|0|||
124490342|NCT02873221|447749031|FG002|Safety Follow-up Period|Protocol Violation|1|||
124490343|NCT02873221|447749029|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
124490344|NCT02873221|447749030|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
124490345|NCT02873221|447749031|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
124490346|NCT02873221|447749029|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
124490347|NCT02873221|447749030|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
124490348|NCT02873221|447749031|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
124490349|NCT01508676|447749032|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
124490350|NCT01508676|447749033|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
124490351|NCT01508676|447749032|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
124490352|NCT01508676|447749033|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
124490353|NCT01508676|447749032|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
124490354|NCT01508676|447749033|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
124490355|NCT01508676|447749032|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
124490356|NCT01508676|447749033|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
124490357|NCT01508676|447749032|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
124490358|NCT01508676|447749033|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
124490359|NCT02532543|447749034|FG000|Overall Study|Lost to Follow-up|0|||
124490360|NCT02532543|447749035|FG001|Overall Study|Lost to Follow-up|0|||
124490361|NCT02532543|447749036|FG002|Overall Study|Lost to Follow-up|1|||
124490362|NCT02532543|447749037|FG003|Overall Study|Lost to Follow-up|0|||
124490363|NCT02614794|447749040|FG000|Overall Study|Death|258|||
124490364|NCT02614794|447749041|FG001|Overall Study|Death|151|||
124490365|NCT02614794|447749040|FG000|Overall Study|Study closure by Sponsor|119|||
124490366|NCT02614794|447749041|FG001|Overall Study|Study closure by Sponsor|45|||
124490367|NCT02614794|447749040|FG000|Overall Study|Withdrawal by Subject|24|||
124490368|NCT02614794|447749041|FG001|Overall Study|Withdrawal by Subject|5|||
124490369|NCT02614794|447749040|FG000|Overall Study|Lost to Follow-up|7|||
124490370|NCT02614794|447749041|FG001|Overall Study|Lost to Follow-up|0|||
124490371|NCT02614794|447749040|FG000|Overall Study|Physician Decision|1|||
124490372|NCT02614794|447749041|FG001|Overall Study|Physician Decision|1|||
124490373|NCT02614794|447749040|FG000|Overall Study|Hospital closure|1|||
124490374|NCT02614794|447749041|FG001|Overall Study|Hospital closure|0|||
124490375|NCT02460822|447749051|FG000|Overall Study|Withdrawal by Subject|1|||
124490376|NCT01396525|447749054|FG000|Overall Study|Withdrawal by Subject|8|||
124490377|NCT01396525|447749054|FG000|Overall Study|Death|14|||
124490378|NCT01396525|447749054|FG000|Overall Study|Lost to Follow-up|4|||
124490379|NCT03114969|447749055|FG000|Overall Study|Lost to Follow-up|0|||
124490380|NCT03114969|447749056|FG001|Overall Study|Lost to Follow-up|0|||
124490381|NCT03114969|447749057|FG002|Overall Study|Lost to Follow-up|3|||
124490382|NCT03114969|447749058|FG003|Overall Study|Lost to Follow-up|2|||
124490383|NCT03114969|447749059|FG004|Overall Study|Lost to Follow-up|0|||
124490384|NCT03114969|447749060|FG005|Overall Study|Lost to Follow-up|0|||
124490385|NCT03114969|447749061|FG006|Overall Study|Lost to Follow-up|0|||
124490386|NCT03114969|447749062|FG007|Overall Study|Lost to Follow-up|0|||
124490387|NCT03114969|447749063|FG008|Overall Study|Lost to Follow-up|0|||
124490388|NCT03114969|447749055|FG000|Overall Study|Adverse Event|0|||
124490389|NCT03114969|447749056|FG001|Overall Study|Adverse Event|0|||
124490390|NCT03114969|447749057|FG002|Overall Study|Adverse Event|1|||
124490391|NCT03114969|447749058|FG003|Overall Study|Adverse Event|0|||
124490392|NCT03114969|447749059|FG004|Overall Study|Adverse Event|0|||
124490393|NCT03114969|447749060|FG005|Overall Study|Adverse Event|1|||
124490394|NCT03114969|447749061|FG006|Overall Study|Adverse Event|1|||
124490395|NCT03114969|447749062|FG007|Overall Study|Adverse Event|0|||
124490396|NCT03114969|447749063|FG008|Overall Study|Adverse Event|2|||
124490397|NCT04601272|447749064|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
124490398|NCT04601272|447749065|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
124490399|NCT04601272|447749066|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
124490400|NCT00414440|447749067|FG000|Core Period|Withdrawal by Subject|70|||
124490401|NCT00414440|447749068|FG001|Core Period|Withdrawal by Subject|32|||
124490402|NCT00414440|447749067|FG000|Extension Period|Lost to Follow-up|44|||
124490403|NCT00414440|447749068|FG001|Extension Period|Lost to Follow-up|52|||
124490404|NCT00414440|447749067|FG000|Extension Period|Did not consent to continue follow up|61|||
124490405|NCT00414440|447749068|FG001|Extension Period|Did not consent to continue follow up|54|||
124490406|NCT00414440|447749067|FG000|Extension Period|Other|1|||
124490407|NCT00414440|447749068|FG001|Extension Period|Other|1|||
124490408|NCT00414440|447749067|FG000|Extension Period|Administrative|16|||
124490409|NCT00414440|447749068|FG001|Extension Period|Administrative|16|||
124490410|NCT00414440|447749067|FG000|Extension Period|Death|1|||
124490411|NCT00414440|447749068|FG001|Extension Period|Death|2|||
124490412|NCT00414440|447749067|FG000|Extension Period|Withdrawal by Subject|9|||
124490413|NCT00414440|447749068|FG001|Extension Period|Withdrawal by Subject|7|||
124490414|NCT00414440|447749067|FG000|Extension Period|Not included in follow up period|18|||
124490415|NCT00414440|447749068|FG001|Extension Period|Not included in follow up period|8|||
124490416|NCT02168946|447749069|FG000|Overall Study|Adverse Event|8|||
124490417|NCT02168946|447749070|FG001|Overall Study|Adverse Event|5|||
124490418|NCT02168946|447749069|FG000|Overall Study|Lost to Follow-up|3|||
124490419|NCT02168946|447749070|FG001|Overall Study|Lost to Follow-up|0|||
124490420|NCT02168946|447749069|FG000|Overall Study|Subject unable to come back for visits|1|||
124490421|NCT02168946|447749070|FG001|Overall Study|Subject unable to come back for visits|0|||
124490422|NCT04222725|447749073|FG000|Overall Study|Adverse Event|0|||
124490423|NCT04222725|447749074|FG001|Overall Study|Adverse Event|1|||
124490424|NCT04222725|447749075|FG002|Overall Study|Adverse Event|0|||
124490425|NCT04222725|447749076|FG003|Overall Study|Adverse Event|0|||
124490426|NCT01743027|447749082|FG000|Overall Study|Adverse Event|2|||
124490427|NCT01743027|447749083|FG001|Overall Study|Adverse Event|0|||
124490428|NCT01743027|447749084|FG002|Overall Study|Adverse Event|0|||
124490429|NCT01743027|447749085|FG003|Overall Study|Adverse Event|0|||
124490430|NCT01743027|447749082|FG000|Overall Study|Lost to Follow-up|0|||
124490431|NCT01743027|447749083|FG001|Overall Study|Lost to Follow-up|0|||
124490432|NCT01743027|447749084|FG002|Overall Study|Lost to Follow-up|2|||
124490433|NCT01743027|447749085|FG003|Overall Study|Lost to Follow-up|0|||
124490434|NCT01743027|447749082|FG000|Overall Study|Progressive Disease|1|||
124490435|NCT01743027|447749083|FG001|Overall Study|Progressive Disease|4|||
124490436|NCT01743027|447749084|FG002|Overall Study|Progressive Disease|3|||
124490437|NCT01743027|447749085|FG003|Overall Study|Progressive Disease|0|||
124490438|NCT01743027|447749082|FG000|Overall Study|Protocol Violation|1|||
124490439|NCT01743027|447749083|FG001|Overall Study|Protocol Violation|1|||
124490440|NCT01743027|447749084|FG002|Overall Study|Protocol Violation|1|||
124721594|NCT01831466|448603687|FG003|Overall Study|Protocol Violation|0|||
124490441|NCT01743027|447749085|FG003|Overall Study|Protocol Violation|0|||
124490442|NCT01743027|447749082|FG000|Overall Study|Withdrawal by Subject|1|||
124490443|NCT01743027|447749083|FG001|Overall Study|Withdrawal by Subject|0|||
124490444|NCT01743027|447749084|FG002|Overall Study|Withdrawal by Subject|3|||
124490445|NCT01743027|447749085|FG003|Overall Study|Withdrawal by Subject|1|||
124490446|NCT02498821|447749086|FG000|Overall Study|Screen failure|3|||
124490447|NCT02498821|447749087|FG001|Overall Study|Screen failure|5|||
124490448|NCT01333189|447749096|FG000|Overall Study|Time constraints|1|||
124490449|NCT01333189|447749097|FG001|Overall Study|Time constraints|0|||
124490450|NCT01333189|447749096|FG000|Overall Study|Adverse Event|1|||
124490451|NCT01333189|447749097|FG001|Overall Study|Adverse Event|0|||
124490452|NCT01333189|447749096|FG000|Overall Study|Transportation difficulties|0|||
124490453|NCT01333189|447749097|FG001|Overall Study|Transportation difficulties|1|||
124490454|NCT01333189|447749096|FG000|Overall Study|Moved from region|0|||
124490455|NCT01333189|447749097|FG001|Overall Study|Moved from region|1|||
124490456|NCT01787591|447749105|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
124490457|NCT01787591|447749106|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
124490458|NCT01787591|447749107|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
124490459|NCT01787591|447749108|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
124490460|NCT02725177|447749111|FG000|Overall Study|Physician Decision|4|||
124490461|NCT02725177|447749111|FG000|Overall Study|Adverse Event|1|||
124490462|NCT00793585|447749112|FG000|Overall Study|Adverse Event|1|||
124490463|NCT00793585|447749113|FG001|Overall Study|Adverse Event|1|||
124490464|NCT00793585|447749112|FG000|Overall Study|Protocol Violation|1|||
124490465|NCT00793585|447749113|FG001|Overall Study|Protocol Violation|2|||
124490466|NCT00377299|447749114|FG000|Overall Study|Lost to Follow-up|14|||
124490467|NCT00377299|447749115|FG001|Overall Study|Lost to Follow-up|19|||
124490468|NCT00377299|447749114|FG000|Overall Study|Adverse Event|0|||
124490469|NCT00377299|447749115|FG001|Overall Study|Adverse Event|1|||
124490470|NCT00377299|447749114|FG000|Overall Study|Withdrawal by Subject|5|||
124490471|NCT00377299|447749115|FG001|Overall Study|Withdrawal by Subject|4|||
124490472|NCT01894516|447750690|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
124490473|NCT01894516|447750691|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
124490474|NCT01894516|447750692|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
124490475|NCT01894516|447750693|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
124490476|NCT01894516|447750690|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
124721595|NCT01831466|448603688|FG004|Overall Study|Protocol Violation|0|||
124721596|NCT01831466|448603689|FG005|Overall Study|Protocol Violation|1|||
124721597|NCT01831466|448603690|FG006|Overall Study|Protocol Violation|0|||
124721598|NCT01831466|448603691|FG007|Overall Study|Protocol Violation|0|||
124721599|NCT01831466|448603692|FG008|Overall Study|Protocol Violation|0|||
124721600|NCT01831466|448603693|FG009|Overall Study|Protocol Violation|0|||
124721601|NCT01831466|448603694|FG010|Overall Study|Protocol Violation|0|||
124721602|NCT01831466|448603695|FG011|Overall Study|Protocol Violation|0|||
124721603|NCT01831466|448603684|FG000|Overall Study|Other|2|||
124721604|NCT01831466|448603685|FG001|Overall Study|Other|3|||
124721605|NCT01831466|448603686|FG002|Overall Study|Other|2|||
124721606|NCT01831466|448603687|FG003|Overall Study|Other|2|||
124721607|NCT01831466|448603688|FG004|Overall Study|Other|2|||
124721608|NCT01831466|448603689|FG005|Overall Study|Other|1|||
124721609|NCT01831466|448603690|FG006|Overall Study|Other|0|||
124721610|NCT01831466|448603691|FG007|Overall Study|Other|0|||
124721611|NCT01831466|448603692|FG008|Overall Study|Other|0|||
124721612|NCT01831466|448603693|FG009|Overall Study|Other|0|||
124721613|NCT01831466|448603694|FG010|Overall Study|Other|0|||
124721614|NCT01831466|448603695|FG011|Overall Study|Other|0|||
124771997|NCT01399372|448796350|FG001|Overall Study|Protocol Violation|1|||
124490477|NCT01894516|447750691|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
124490478|NCT01894516|447750692|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
124490479|NCT01894516|447750693|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
124490480|NCT01894516|447750690|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
124721615|NCT01831466|448603684|FG000|Overall Study|Non-compliance with study treatment|2|||
124721616|NCT01831466|448603685|FG001|Overall Study|Non-compliance with study treatment|1|||
124721617|NCT01831466|448603686|FG002|Overall Study|Non-compliance with study treatment|1|||
124721618|NCT01831466|448603687|FG003|Overall Study|Non-compliance with study treatment|0|||
124771998|NCT01432730|448796351|FG000|Period 1|Adverse Event|2|||
124490481|NCT01894516|447750691|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
124490482|NCT01894516|447750692|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
124490483|NCT01894516|447750693|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
124490484|NCT01894516|447750690|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
124490485|NCT01894516|447750691|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
124490486|NCT01894516|447750692|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
124490487|NCT01894516|447750693|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
124490488|NCT01894516|447750690|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
124490489|NCT01894516|447750691|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
124490490|NCT01894516|447750692|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
124490491|NCT01894516|447750693|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
124490492|NCT01894516|447750690|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
124490493|NCT01894516|447750691|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
124490494|NCT01894516|447750692|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
124490495|NCT01894516|447750693|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
124490496|NCT01894516|447750690|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
124490497|NCT01894516|447750691|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
124490498|NCT01894516|447750692|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
124490499|NCT01894516|447750693|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
124490500|NCT01894516|447750690|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
124490501|NCT01894516|447750691|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
124490502|NCT01894516|447750692|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
124490503|NCT01894516|447750693|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
124490504|NCT01582282|447750694|FG000|Overall Study|Adverse Event|1|||
124490505|NCT01582282|447750695|FG001|Overall Study|Adverse Event|1|||
124490506|NCT01582282|447750696|FG002|Overall Study|Adverse Event|0|||
124490507|NCT01582282|447750694|FG000|Overall Study|Lost to Follow-up|1|||
124490508|NCT01582282|447750695|FG001|Overall Study|Lost to Follow-up|0|||
124490509|NCT01582282|447750696|FG002|Overall Study|Lost to Follow-up|0|||
124490510|NCT01582282|447750694|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
124490511|NCT01582282|447750695|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
124490512|NCT01582282|447750696|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
124490513|NCT01486316|447750697|FG000|Overall Study|Device explanted with/without re-implant|3|||
124490514|NCT01486316|447750698|FG001|Overall Study|Device explanted with/without re-implant|2|||
124490515|NCT01486316|447750699|FG002|Overall Study|Device explanted with/without re-implant|0|||
124490516|NCT01486316|447750700|FG003|Overall Study|Device explanted with/without re-implant|2|||
124490517|NCT01486316|447750697|FG000|Overall Study|Not meeting eligibility criteria|0|||
124490518|NCT01486316|447750698|FG001|Overall Study|Not meeting eligibility criteria|0|||
124490519|NCT01486316|447750699|FG002|Overall Study|Not meeting eligibility criteria|1|||
124490520|NCT01486316|447750700|FG003|Overall Study|Not meeting eligibility criteria|0|||
124490521|NCT01486316|447750697|FG000|Overall Study|Withdrawal by Subject|1|||
124490522|NCT01486316|447750698|FG001|Overall Study|Withdrawal by Subject|0|||
124490523|NCT01486316|447750699|FG002|Overall Study|Withdrawal by Subject|3|||
124490524|NCT01486316|447750700|FG003|Overall Study|Withdrawal by Subject|0|||
124490525|NCT01486316|447750697|FG000|Overall Study|Physician Decision|0|||
124490526|NCT01486316|447750698|FG001|Overall Study|Physician Decision|0|||
124490527|NCT01486316|447750699|FG002|Overall Study|Physician Decision|1|||
124490528|NCT01486316|447750700|FG003|Overall Study|Physician Decision|0|||
124490529|NCT01486316|447750697|FG000|Overall Study|Death|0|||
124490530|NCT01486316|447750698|FG001|Overall Study|Death|1|||
124490531|NCT01486316|447750699|FG002|Overall Study|Death|0|||
124490532|NCT01486316|447750700|FG003|Overall Study|Death|0|||
124490533|NCT03191396|447750708|FG000|Overall Study|Lost to Follow-up|0|||
124490534|NCT03191396|447750709|FG001|Overall Study|Lost to Follow-up|3|||
124490535|NCT03191396|447750708|FG000|Overall Study|Withdrawal by Subject|3|||
124490536|NCT03191396|447750709|FG001|Overall Study|Withdrawal by Subject|2|||
124490537|NCT03635190|447750711|FG000|Overall Study|Lost to Follow-up|4|||
124490538|NCT03635190|447750711|FG000|Overall Study|Death|3|||
124490539|NCT03635190|447750711|FG000|Overall Study|Withdrawal by Subject|1|||
124721619|NCT01831466|448603688|FG004|Overall Study|Non-compliance with study treatment|0|||
124721620|NCT01831466|448603689|FG005|Overall Study|Non-compliance with study treatment|1|||
124721621|NCT01831466|448603690|FG006|Overall Study|Non-compliance with study treatment|0|||
124721622|NCT01831466|448603691|FG007|Overall Study|Non-compliance with study treatment|0|||
124721623|NCT01831466|448603692|FG008|Overall Study|Non-compliance with study treatment|0|||
124490540|NCT03635190|447750711|FG000|Overall Study|Patient moved and did not return for follow up|1|||
124490541|NCT03692910|447750714|FG000|Overall Study|Lost to Follow-up|4|||
124490542|NCT03692910|447750715|FG001|Overall Study|Lost to Follow-up|0|||
124490543|NCT03692910|447750716|FG002|Overall Study|Lost to Follow-up|0|||
124490544|NCT03692910|447750714|FG000|Overall Study|Withdrawal by Subject|2|||
124490545|NCT03692910|447750715|FG001|Overall Study|Withdrawal by Subject|0|||
124490546|NCT03692910|447750716|FG002|Overall Study|Withdrawal by Subject|0|||
124490547|NCT01981122|447750721|FG000|Overall Study|Withdrawal by Subject|0|||
124490548|NCT01981122|447750722|FG001|Overall Study|Withdrawal by Subject|2|||
124490549|NCT01981122|447750721|FG000|Overall Study|Protocol Violation|0|||
124490550|NCT01981122|447750722|FG001|Overall Study|Protocol Violation|1|||
124490551|NCT01981122|447750721|FG000|Overall Study|Lost to Follow-up|0|||
124490552|NCT01981122|447750722|FG001|Overall Study|Lost to Follow-up|1|||
124490553|NCT01981122|447750721|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
124490554|NCT01981122|447750722|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
124490555|NCT01981122|447750721|FG000|Overall Study|Death|14|||
124490556|NCT01981122|447750722|FG001|Overall Study|Death|15|||
124490557|NCT03060577|447750723|FG000|Overall Study|Withdrawal by Subject|25|||
124490558|NCT03060577|447750724|FG001|Overall Study|Withdrawal by Subject|5|||
124490559|NCT03060577|447750723|FG000|Overall Study|Physician Decision|4|||
124490560|NCT03060577|447750724|FG001|Overall Study|Physician Decision|3|||
124490561|NCT03060577|447750723|FG000|Overall Study|Lost to Follow-up|3|||
124490562|NCT03060577|447750724|FG001|Overall Study|Lost to Follow-up|0|||
124490563|NCT03060577|447750723|FG000|Overall Study|Death|7|||
124490564|NCT03060577|447750724|FG001|Overall Study|Death|1|||
124490565|NCT03060577|447750723|FG000|Overall Study|Adverse Event|9|||
124490566|NCT03060577|447750724|FG001|Overall Study|Adverse Event|1|||
124490567|NCT03060577|447750723|FG000|Overall Study|Inclusion/Exclusion|1|||
124490568|NCT03060577|447750724|FG001|Overall Study|Inclusion/Exclusion|0|||
124490569|NCT03060577|447750723|FG000|Overall Study|Other|8|||
124490570|NCT03060577|447750724|FG001|Overall Study|Other|2|||
124490571|NCT00092547|447750729|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
124490572|NCT00092547|447750730|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
124490573|NCT00092547|447750731|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
124490574|NCT00092547|447750729|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
124490575|NCT00092547|447750730|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
124490576|NCT00092547|447750731|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
124490577|NCT00092547|447750729|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
124490578|NCT00092547|447750730|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
124490579|NCT00092547|447750731|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
124490580|NCT00092547|447750729|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
124490581|NCT00092547|447750730|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
124490582|NCT00092547|447750731|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
124490583|NCT00092547|447750729|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
124490584|NCT00092547|447750730|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
124490585|NCT00092547|447750731|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
124490586|NCT00092547|447750729|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
124490587|NCT00092547|447750730|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
124490588|NCT00092547|447750731|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
124490589|NCT00092547|447750729|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
124490590|NCT00092547|447750730|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
124490591|NCT00092547|447750731|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
124490592|NCT00092547|447750729|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
124490593|NCT00092547|447750730|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
124490594|NCT00092547|447750731|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
124490595|NCT00092547|447750729|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
124490596|NCT00092547|447750730|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
124490597|NCT00092547|447750731|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
124490598|NCT00092547|447750729|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
124490599|NCT00092547|447750730|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
124490600|NCT00092547|447750731|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
124490601|NCT00092547|447750729|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
124490602|NCT00092547|447750730|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
124490603|NCT00092547|447750731|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
124490604|NCT00092547|447750729|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
124490605|NCT00092547|447750730|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
124490606|NCT00092547|447750731|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
124490607|NCT00092547|447750729|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
124490608|NCT00092547|447750730|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
124490609|NCT00092547|447750731|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
124490610|NCT00092547|447750729|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
124490611|NCT00092547|447750730|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
124490612|NCT00092547|447750731|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
124490613|NCT00092547|447750729|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
124490614|NCT00092547|447750730|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
124490615|NCT00092547|447750731|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
124490616|NCT00092547|447750729|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
124490617|NCT00092547|447750730|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
124490618|NCT00092547|447750731|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
124490619|NCT00092547|447750729|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
124490620|NCT00092547|447750730|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
124771999|NCT01432730|448796352|FG001|Period 1|Adverse Event|0|||
124772000|NCT01432730|448796351|FG000|Period 2|Adverse Event|0|||
124772001|NCT01432730|448796352|FG001|Period 2|Adverse Event|4|||
124772002|NCT01712399|448796355|FG000|Overall Study|Lost to Follow-up|1|||
124772003|NCT01712399|448796355|FG000|Overall Study|Withdrawal by Subject|39|||
124490621|NCT00092547|447750731|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
124490622|NCT00092547|447750729|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
124490623|NCT00092547|447750730|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
124490624|NCT00092547|447750731|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
124490625|NCT00092547|447750729|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
124490626|NCT00092547|447750730|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
124490627|NCT00092547|447750731|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
124490628|NCT00092547|447750729|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
124490629|NCT00092547|447750730|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
124490630|NCT00092547|447750731|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
124490631|NCT00092547|447750729|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
124490632|NCT00092547|447750730|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
124490633|NCT00092547|447750731|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
124490634|NCT04328623|447750732|FG000|Overall Study|Protocol Violation|0|||
124490635|NCT04328623|447750733|FG001|Overall Study|Protocol Violation|1|||
124490636|NCT01539837|447750734|FG000|Overall Study|reduce neutrophil level|0|||
124490637|NCT01539837|447750735|FG001|Overall Study|reduce neutrophil level|1|||
124490638|NCT01539837|447750736|FG002|Overall Study|reduce neutrophil level|1|||
124490639|NCT01539837|447750734|FG000|Overall Study|bad compliance|0|||
124490640|NCT01539837|447750735|FG001|Overall Study|bad compliance|0|||
124490641|NCT01539837|447750736|FG002|Overall Study|bad compliance|1|||
124490642|NCT00685178|447750738|FG000|Overall Study|Adverse Event|1|||
124490643|NCT00685178|447750739|FG001|Overall Study|Adverse Event|5|||
124490644|NCT00685178|447750740|FG002|Overall Study|Adverse Event|2|||
124490645|NCT00685178|447750741|FG003|Overall Study|Adverse Event|4|||
124490646|NCT00685178|447750738|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
124490647|NCT00685178|447750739|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
124490648|NCT00685178|447750740|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
124490649|NCT00685178|447750741|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
124490650|NCT00685178|447750738|FG000|Overall Study|voluntary study discharge|4|||
124490651|NCT00685178|447750739|FG001|Overall Study|voluntary study discharge|5|||
124490652|NCT00685178|447750740|FG002|Overall Study|voluntary study discharge|1|||
124490653|NCT00685178|447750741|FG003|Overall Study|voluntary study discharge|1|||
124490654|NCT00685178|447750738|FG000|Overall Study|incarcerated|1|||
124490655|NCT00685178|447750739|FG001|Overall Study|incarcerated|3|||
124490656|NCT00685178|447750740|FG002|Overall Study|incarcerated|7|||
124490657|NCT00685178|447750741|FG003|Overall Study|incarcerated|0|||
124490658|NCT00685178|447750738|FG000|Overall Study|administrative (disciplinary) discharge|0|||
124490659|NCT00685178|447750739|FG001|Overall Study|administrative (disciplinary) discharge|1|||
124490660|NCT00685178|447750740|FG002|Overall Study|administrative (disciplinary) discharge|0|||
124490661|NCT00685178|447750741|FG003|Overall Study|administrative (disciplinary) discharge|2|||
124490662|NCT00685178|447750738|FG000|Overall Study|Pregnancy|0|||
124490663|NCT00685178|447750739|FG001|Overall Study|Pregnancy|0|||
124490664|NCT00685178|447750740|FG002|Overall Study|Pregnancy|0|||
124490665|NCT00685178|447750741|FG003|Overall Study|Pregnancy|1|||
124490666|NCT00077623|447750742|FG000|Overall Study|Adverse Event|1|||
124490667|NCT00077623|447750743|FG001|Overall Study|Adverse Event|0|||
124490668|NCT00077623|447750744|FG002|Overall Study|Adverse Event|1|||
124490669|NCT00077623|447750742|FG000|Overall Study|Withdrawal by Subject|2|||
124490670|NCT00077623|447750743|FG001|Overall Study|Withdrawal by Subject|10|||
124490671|NCT00077623|447750744|FG002|Overall Study|Withdrawal by Subject|1|||
124490672|NCT00077623|447750742|FG000|Overall Study|Other-Non safety reason|18|||
124490673|NCT00077623|447750743|FG001|Overall Study|Other-Non safety reason|15|||
124490674|NCT00077623|447750744|FG002|Overall Study|Other-Non safety reason|19|||
124490675|NCT00077623|447750742|FG000|Overall Study|Insufficient therapeutic response|2|||
124490676|NCT00077623|447750743|FG001|Overall Study|Insufficient therapeutic response|0|||
124490677|NCT00077623|447750744|FG002|Overall Study|Insufficient therapeutic response|0|||
124772004|NCT01712399|448796355|FG000|Overall Study|Death|1|||
124772005|NCT01712399|448796355|FG000|Overall Study|Adverse Event|11|||
124490678|NCT00077623|447750742|FG000|Overall Study|Death|12|||
124490679|NCT00077623|447750743|FG001|Overall Study|Death|18|||
124490680|NCT00077623|447750744|FG002|Overall Study|Death|11|||
124490681|NCT00077623|447750742|FG000|Overall Study|Failure to return|1|||
124490682|NCT00077623|447750743|FG001|Overall Study|Failure to return|0|||
124772006|NCT01712399|448796355|FG000|Overall Study|Study closure|345|||
124490683|NCT00077623|447750744|FG002|Overall Study|Failure to return|0|||
124490684|NCT00882713|447750747|FG000|Overall Study|Adverse Event|2|||
124490685|NCT00882713|447750747|FG000|Overall Study|Death|3|||
124490686|NCT00882713|447750747|FG000|Overall Study|Administrative reasons|4|||
124490687|NCT00882713|447750747|FG000|Overall Study|refused treatment/withdrew consent|4|||
124490688|NCT00882713|447750747|FG000|Overall Study|Blood transfusion|2|||
124490689|NCT00882713|447750747|FG000|Overall Study|Insufficient therapeutic response|3|||
124490690|NCT00882713|447750747|FG000|Overall Study|Failure to return|2|||
124490691|NCT00882713|447750747|FG000|Overall Study|Other - Reasons|2|||
124490692|NCT02760602|447750748|FG000|Overall Study|Withdrawal by Subject|1|||
124490693|NCT02760602|447750749|FG001|Overall Study|Withdrawal by Subject|0|||
124490694|NCT02760602|447750748|FG000|Overall Study|Terminated by sponsor|12|||
124490695|NCT02760602|447750749|FG001|Overall Study|Terminated by sponsor|13|||
124490696|NCT00283712|447750758|FG000|Overall Study|Death|0|||
124490697|NCT00283712|447750759|FG001|Overall Study|Death|1|||
124490698|NCT01272180|447750764|FG000|Overall Study|Adverse Event|0|||
124490699|NCT01272180|447750765|FG001|Overall Study|Adverse Event|0|||
124490700|NCT01272180|447750766|FG002|Overall Study|Adverse Event|1|||
124490701|NCT01272180|447750767|FG003|Overall Study|Adverse Event|0|||
124490702|NCT01272180|447750764|FG000|Overall Study|Withdrawal by Subject|2|||
124490703|NCT01272180|447750765|FG001|Overall Study|Withdrawal by Subject|6|||
124490704|NCT01272180|447750766|FG002|Overall Study|Withdrawal by Subject|3|||
124490705|NCT01272180|447750767|FG003|Overall Study|Withdrawal by Subject|2|||
124490706|NCT01272180|447750764|FG000|Overall Study|Lost to Follow-up|15|||
124490707|NCT01272180|447750765|FG001|Overall Study|Lost to Follow-up|14|||
124490708|NCT01272180|447750766|FG002|Overall Study|Lost to Follow-up|8|||
124490709|NCT01272180|447750767|FG003|Overall Study|Lost to Follow-up|10|||
124490710|NCT01272180|447750764|FG000|Overall Study|Inappropriate enrollment|0|||
124490711|NCT01272180|447750765|FG001|Overall Study|Inappropriate enrollment|0|||
124490712|NCT01272180|447750766|FG002|Overall Study|Inappropriate enrollment|1|||
124490713|NCT01272180|447750767|FG003|Overall Study|Inappropriate enrollment|1|||
124490714|NCT01272180|447750764|FG000|Overall Study|Protocol Violation|0|||
124490715|NCT01272180|447750765|FG001|Overall Study|Protocol Violation|1|||
124490716|NCT01272180|447750766|FG002|Overall Study|Protocol Violation|0|||
124490717|NCT01272180|447750767|FG003|Overall Study|Protocol Violation|1|||
124490718|NCT00098345|447750768|FG000|Overall Study|Adverse Event|7|||
124490719|NCT00098345|447750768|FG000|Overall Study|Withdrawal by Subject|2|||
124490720|NCT00098345|447750768|FG000|Overall Study|progression|4|||
124490721|NCT01183858|447750769|FG000|Overall Study|Death not related to Progressive Disease|5|||
124490722|NCT01183858|447750770|FG001|Overall Study|Death not related to Progressive Disease|6|||
124490723|NCT01183858|447750769|FG000|Overall Study|Adverse Event|14|||
124490724|NCT01183858|447750770|FG001|Overall Study|Adverse Event|11|||
124490725|NCT01183858|447750769|FG000|Overall Study|Investigator's Decision|0|||
124490726|NCT01183858|447750770|FG001|Overall Study|Investigator's Decision|3|||
124490727|NCT01183858|447750769|FG000|Overall Study|Insufficient Therapeutic Response|2|||
124490728|NCT01183858|447750770|FG001|Overall Study|Insufficient Therapeutic Response|0|||
124490729|NCT01183858|447750769|FG000|Overall Study|Refused Treatment|1|||
124490730|NCT01183858|447750770|FG001|Overall Study|Refused Treatment|4|||
124490731|NCT01183858|447750769|FG000|Overall Study|Withdrew Consent|4|||
124490732|NCT01183858|447750770|FG001|Overall Study|Withdrew Consent|4|||
124490733|NCT01183858|447750769|FG000|Overall Study|Discontinued Smoking|3|||
124490734|NCT01183858|447750770|FG001|Overall Study|Discontinued Smoking|1|||
124490735|NCT01183858|447750769|FG000|Overall Study|Protocol Violation|1|||
124490736|NCT01183858|447750770|FG001|Overall Study|Protocol Violation|0|||
124490737|NCT01183858|447750769|FG000|Overall Study|Administrative/Other|6|||
124490738|NCT01183858|447750770|FG001|Overall Study|Administrative/Other|6|||
124490739|NCT01183858|447750769|FG000|Overall Study|Progressive Disease|112|||
124490740|NCT01183858|447750770|FG001|Overall Study|Progressive Disease|115|||
124490741|NCT01183858|447750769|FG000|Overall Study|Death related to Progressive Disease|4|||
124490742|NCT01183858|447750770|FG001|Overall Study|Death related to Progressive Disease|5|||
124490743|NCT01183858|447750769|FG000|Overall Study|Lost to Follow-up|1|||
124490744|NCT01183858|447750770|FG001|Overall Study|Lost to Follow-up|1|||
124490745|NCT02747043|447750771|FG000|Overall Study|Other|1|||
124490746|NCT02747043|447750772|FG001|Overall Study|Other|1|||
124490747|NCT02747043|447750771|FG000|Overall Study|Adverse Event|3|||
124490748|NCT02747043|447750772|FG001|Overall Study|Adverse Event|1|||
124490749|NCT02747043|447750771|FG000|Overall Study|Withdrawal by Subject|1|||
124490750|NCT02747043|447750772|FG001|Overall Study|Withdrawal by Subject|1|||
124490751|NCT02747043|447750771|FG000|Overall Study|Physician Decision|1|||
124490752|NCT02747043|447750772|FG001|Overall Study|Physician Decision|1|||
124490753|NCT02747043|447750771|FG000|Overall Study|Protocol Violation|0|||
124490754|NCT02747043|447750772|FG001|Overall Study|Protocol Violation|1|||
124490755|NCT02747043|447750771|FG000|Overall Study|Disease progression|4|||
124490756|NCT02747043|447750772|FG001|Overall Study|Disease progression|0|||
124490757|NCT02046564|447750773|FG000|Overall Study|Adverse Event|6|||
124490758|NCT02046564|447750774|FG001|Overall Study|Adverse Event|3|||
124490759|NCT02046564|447750773|FG000|Overall Study|Physician Decision|0|||
124490760|NCT02046564|447750774|FG001|Overall Study|Physician Decision|1|||
124490761|NCT02046564|447750773|FG000|Overall Study|Protocol Violation|3|||
124490762|NCT02046564|447750774|FG001|Overall Study|Protocol Violation|1|||
124490763|NCT02046564|447750773|FG000|Overall Study|Withdrawal by Subject|4|||
124490764|NCT02046564|447750774|FG001|Overall Study|Withdrawal by Subject|10|||
124490765|NCT02046564|447750773|FG000|Overall Study|Subject met withdrawal criteria|2|||
124490766|NCT02046564|447750774|FG001|Overall Study|Subject met withdrawal criteria|5|||
124490767|NCT01295905|447750777|FG000|Overall Study|Did not meet inclusion criteria|1|||
124490768|NCT01295905|447750778|FG001|Overall Study|Did not meet inclusion criteria|0|||
124490769|NCT01295905|447750777|FG000|Overall Study|Met exclusion criteria|1|||
124490770|NCT01295905|447750778|FG001|Overall Study|Met exclusion criteria|0|||
124490771|NCT03707977|447750781|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
124490772|NCT03707977|447750782|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
124490773|NCT03707977|447750783|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
124490774|NCT03707977|447750781|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
124490775|NCT03707977|447750782|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
124490776|NCT03707977|447750783|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
124490777|NCT02564120|447750784|FG000|Overall Study|Did not return release forms|160|||
124490778|NCT02564120|447750784|FG000|Overall Study|Death|58|||
124490779|NCT02564120|447750784|FG000|Overall Study|Withdrawal by Subject|204|||
124490780|NCT02564120|447750784|FG000|Overall Study|Other medical condition|24|||
124490781|NCT01629667|447750785|FG000|Overall Study|Lost to Follow-up|0|||
124490782|NCT01629667|447750786|FG001|Overall Study|Lost to Follow-up|1|||
124490783|NCT01629667|447750787|FG002|Overall Study|Lost to Follow-up|1|||
124490784|NCT01629667|447750785|FG000|Overall Study|Withdrawal by Subject|31|||
124490785|NCT01629667|447750786|FG001|Overall Study|Withdrawal by Subject|20|||
124490786|NCT01629667|447750787|FG002|Overall Study|Withdrawal by Subject|28|||
124490787|NCT01629667|447750785|FG000|Overall Study|Death|1|||
124490788|NCT01629667|447750786|FG001|Overall Study|Death|5|||
124490789|NCT01629667|447750787|FG002|Overall Study|Death|3|||
124490790|NCT01629667|447750785|FG000|Overall Study|Randomized, not treated|2|||
124490791|NCT01629667|447750786|FG001|Overall Study|Randomized, not treated|1|||
124490792|NCT01629667|447750787|FG002|Overall Study|Randomized, not treated|0|||
124490793|NCT01629667|447750785|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
124490794|NCT01629667|447750786|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
124490795|NCT01629667|447750787|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
124490796|NCT01629667|447750785|FG000|Overall Study|Requiring lung transplant|2|||
124490797|NCT01629667|447750786|FG001|Overall Study|Requiring lung transplant|1|||
124490798|NCT01629667|447750787|FG002|Overall Study|Requiring lung transplant|3|||
124490799|NCT01629667|447750785|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
124490800|NCT01629667|447750786|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
124490801|NCT01629667|447750787|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
124490802|NCT01629667|447750785|FG000|Overall Study|Started other medicine|1|||
124490803|NCT01629667|447750786|FG001|Overall Study|Started other medicine|0|||
124490804|NCT01629667|447750787|FG002|Overall Study|Started other medicine|1|||
124490805|NCT01629667|447750785|FG000|Overall Study|Site error in safety follow-up|0|||
124490806|NCT01629667|447750786|FG001|Overall Study|Site error in safety follow-up|0|||
124490807|NCT01629667|447750787|FG002|Overall Study|Site error in safety follow-up|1|||
124490808|NCT01629667|447750785|FG000|Overall Study|Enrolled in another clinical study|0|||
124490809|NCT01629667|447750786|FG001|Overall Study|Enrolled in another clinical study|1|||
124490810|NCT01629667|447750787|FG002|Overall Study|Enrolled in another clinical study|0|||
124490811|NCT01629667|447750785|FG000|Overall Study|Code break|1|||
124490812|NCT01629667|447750786|FG001|Overall Study|Code break|0|||
124490813|NCT01629667|447750787|FG002|Overall Study|Code break|0|||
124490814|NCT02441803|447750788|FG000|Overall Study|Physician Decision|0|||
124490815|NCT02441803|447750789|FG001|Overall Study|Physician Decision|2|||
124490816|NCT02441803|447750790|FG002|Overall Study|Physician Decision|2|||
124490817|NCT00537823|447750794|FG000|Overall Study|Adverse Event|2|||
124490818|NCT00537823|447750795|FG001|Overall Study|Adverse Event|0|||
124490819|NCT03065530|447750796|FG000|Overall Study|Lack of Efficacy|1|||
124490820|NCT03065530|447750797|FG001|Overall Study|Lack of Efficacy|1|||
124490821|NCT03065530|447750798|FG002|Overall Study|Lack of Efficacy|0|||
124490822|NCT03065530|447750799|FG003|Overall Study|Lack of Efficacy|1|||
124490823|NCT03065530|447750796|FG000|Overall Study|Protocol Violation|1|||
124490824|NCT03065530|447750797|FG001|Overall Study|Protocol Violation|0|||
124490825|NCT03065530|447750798|FG002|Overall Study|Protocol Violation|1|||
124490826|NCT03065530|447750799|FG003|Overall Study|Protocol Violation|1|||
124490827|NCT00852930|447750800|FG000|Overall Study|Withdrawal by Subject|1|||
124490828|NCT00852930|447750801|FG001|Overall Study|Withdrawal by Subject|1|||
124490829|NCT00852930|447750802|FG002|Overall Study|Withdrawal by Subject|1|||
124490830|NCT00852930|447750800|FG000|Overall Study|Physician Decision|0|||
124490831|NCT00852930|447750801|FG001|Overall Study|Physician Decision|0|||
124490832|NCT00852930|447750802|FG002|Overall Study|Physician Decision|1|||
124490833|NCT01512368|447750806|FG000|Overall Study|Protocol Violation|3|||
124490834|NCT02717546|447750811|FG000|Overall Study|Lost to Follow-up|12|||
124490835|NCT03396471|447750818|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
124490836|NCT03396471|447750818|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
124490837|NCT03396471|447750818|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
124490838|NCT03396471|447750818|FG000|Study Treatment - Up to 22 Months|Death|2|||
124490839|NCT03396471|447750818|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
124490840|NCT03396471|447750818|FG000|Follow up - Up to 2 Years|Death|9|||
124490841|NCT03396471|447750818|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
124490842|NCT03396471|447750818|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
124490843|NCT03396471|447750818|FG000|Follow up - Up to 2 Years|study terminated|1|||
124490844|NCT03396471|447750818|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
124490845|NCT03396471|447750818|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
124490846|NCT01716169|447750820|FG000|Overall Study|Adverse Event|1|||
124490847|NCT01716169|447750820|FG000|Overall Study|Lost to Follow-up|1|||
124490848|NCT01716169|447750820|FG000|Overall Study|Withdrawal by Subject|1|||
124490849|NCT01716169|447750820|FG000|Overall Study|inconsistent dressing application|1|||
124490850|NCT01088412|447750821|FG000|Overall Study|Adverse Event|38|||
124490851|NCT01088412|447750822|FG001|Overall Study|Adverse Event|0|||
124490852|NCT01088412|447750823|FG002|Overall Study|Adverse Event|0|||
124490853|NCT01088412|447750821|FG000|Overall Study|Death|42|||
124490854|NCT01088412|447750822|FG001|Overall Study|Death|6|||
124490855|NCT01088412|447750823|FG002|Overall Study|Death|0|||
124490856|NCT01088412|447750821|FG000|Overall Study|Other Reason per Case Report Form|2089|||
124490857|NCT01088412|447750822|FG001|Overall Study|Other Reason per Case Report Form|103|||
124490858|NCT01088412|447750823|FG002|Overall Study|Other Reason per Case Report Form|9|||
124490859|NCT01088412|447750821|FG000|Overall Study|Withdrawal by Subject|1761|||
124490860|NCT01088412|447750822|FG001|Overall Study|Withdrawal by Subject|25|||
124490861|NCT01088412|447750823|FG002|Overall Study|Withdrawal by Subject|1|||
124490862|NCT01088412|447750821|FG000|Overall Study|Received Another GH Product|79|||
124490863|NCT01088412|447750822|FG001|Overall Study|Received Another GH Product|0|||
124490864|NCT01088412|447750823|FG002|Overall Study|Received Another GH Product|0|||
124490865|NCT01088412|447750821|FG000|Overall Study|Participant Moved|601|||
124490866|NCT01088412|447750822|FG001|Overall Study|Participant Moved|21|||
124490867|NCT01088412|447750823|FG002|Overall Study|Participant Moved|2|||
124490868|NCT01088412|447750821|FG000|Overall Study|Physician Decision|1041|||
124490869|NCT01088412|447750822|FG001|Overall Study|Physician Decision|8|||
124490870|NCT01088412|447750823|FG002|Overall Study|Physician Decision|4|||
124490871|NCT01088412|447750821|FG000|Overall Study|Sponsor Decision|4467|||
124490872|NCT01088412|447750822|FG001|Overall Study|Sponsor Decision|79|||
124490873|NCT01088412|447750823|FG002|Overall Study|Sponsor Decision|23|||
124490874|NCT01088412|447750821|FG000|Overall Study|Third Party Required to Change Brand|487|||
124490875|NCT01088412|447750822|FG001|Overall Study|Third Party Required to Change Brand|0|||
124490876|NCT01088412|447750823|FG002|Overall Study|Third Party Required to Change Brand|0|||
124490877|NCT01088412|447750821|FG000|Overall Study|Lost to Follow-up|3052|||
124490878|NCT01088412|447750822|FG001|Overall Study|Lost to Follow-up|130|||
124490879|NCT01088412|447750823|FG002|Overall Study|Lost to Follow-up|11|||
124490880|NCT01088412|447750821|FG000|Overall Study|Study Summary Not Completed|4360|||
124490881|NCT01088412|447750822|FG001|Overall Study|Study Summary Not Completed|64|||
124490882|NCT01088412|447750823|FG002|Overall Study|Study Summary Not Completed|22|||
124490883|NCT02111811|447750824|FG000|Treatment Phase|Lost to Follow-up|22|||
124490884|NCT02111811|447750825|FG001|Treatment Phase|Lost to Follow-up|18|||
124490885|NCT02111811|447750824|FG000|Treatment Phase|Death|2|||
124490886|NCT02111811|447750825|FG001|Treatment Phase|Death|0|||
124490887|NCT02111811|447750824|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
124490888|NCT02111811|447750825|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
124490889|NCT02111811|447750824|FG000|Follow up Period (Aim 2)|Death|2|||
124490890|NCT02111811|447750825|FG001|Follow up Period (Aim 2)|Death|0|||
124490891|NCT05258058|447750838|FG000|Overall Study|Withdrawal by Subject|2|||
124490892|NCT04579393|447750841|FG000|Overall Study|Withdrawal by Subject|2|||
124490893|NCT04579393|447750842|FG001|Overall Study|Withdrawal by Subject|2|||
124490894|NCT04579393|447750841|FG000|Overall Study|Death|1|||
124490895|NCT04579393|447750842|FG001|Overall Study|Death|3|||
124490896|NCT01326962|447750843|FG000|Overall Study|Adverse Event|1|||
124490897|NCT01326962|447750843|FG000|Overall Study|Withdrawal by Subject|1|||
124490898|NCT01326962|447750843|FG000|Overall Study|Lost to Follow-up|3|||
124490899|NCT01326962|447750843|FG000|Overall Study|Other|2|||
124490900|NCT00035815|447750845|FG000|Overall Study|Withdrawal by Subject|17|||
124490901|NCT00035815|447750846|FG001|Overall Study|Withdrawal by Subject|11|||
124490902|NCT05243550|447752603|FG000|Overall Study|Ongoing in the Study|171|||
124490903|NCT05243550|447752603|FG000|Overall Study|Withdrawal by Subject|10|||
124490904|NCT05243550|447752603|FG000|Overall Study|Lost to Follow-up|7|||
124490905|NCT05243550|447752603|FG000|Overall Study|Adverse Event|3|||
124490906|NCT05243550|447752603|FG000|Overall Study|Noncompliance|1|||
124490907|NCT05243550|447752603|FG000|Overall Study|Physician Decision|1|||
124490908|NCT05243550|447752603|FG000|Overall Study|Other Reason|4|||
124490909|NCT00128206|447752612|FG000|Overall Study|Lost to Follow-up|137|||
124490910|NCT00128206|447752613|FG001|Overall Study|Lost to Follow-up|118|||
124490911|NCT00128206|447752612|FG000|Overall Study|Adverse Event|0|||
124490912|NCT00128206|447752613|FG001|Overall Study|Adverse Event|2|||
124490913|NCT03270085|447752614|FG000|Overall Study|Withdrawal by Subject|1|||
124490914|NCT03270085|447752615|FG001|Overall Study|Withdrawal by Subject|0|||
124490915|NCT01300286|447752616|FG000|Overall Study|did not get dosed|1|||
124490916|NCT00417612|447752617|FG000|Overall Study|Errant diagnosis|0|||
124490917|NCT00417612|447752618|FG001|Overall Study|Errant diagnosis|1|||
124490918|NCT00417612|447752617|FG000|Overall Study|Adverse Event|2|||
124490919|NCT00417612|447752618|FG001|Overall Study|Adverse Event|0|||
124490920|NCT00417612|447752617|FG000|Overall Study|Protocol Violation|0|||
124490921|NCT00417612|447752618|FG001|Overall Study|Protocol Violation|2|||
124490922|NCT00417612|447752617|FG000|Overall Study|Lost to Follow-up|1|||
124490923|NCT00417612|447752618|FG001|Overall Study|Lost to Follow-up|0|||
124490924|NCT01330381|447752619|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
124490925|NCT01330381|447752620|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
124490926|NCT01330381|447752621|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
124490927|NCT01330381|447752619|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
124490928|NCT01330381|447752620|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
124490929|NCT01330381|447752621|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
124490930|NCT01330381|447752619|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
124490931|NCT01330381|447752620|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
124490932|NCT01330381|447752621|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
124490933|NCT01330381|447752619|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
124490934|NCT01330381|447752620|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
124490935|NCT01330381|447752621|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
124490936|NCT01330381|447752619|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
124490937|NCT01330381|447752620|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
124490938|NCT01330381|447752621|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
124490939|NCT01330381|447752619|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
124490940|NCT01330381|447752620|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
124490941|NCT01330381|447752621|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
124490942|NCT01330381|447752619|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
124490943|NCT01330381|447752620|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
124490944|NCT01330381|447752621|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
124490945|NCT01330381|447752619|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
124490946|NCT01330381|447752620|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
124490947|NCT01330381|447752621|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
124490948|NCT01330381|447752619|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
124490949|NCT01330381|447752620|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
124490950|NCT01330381|447752621|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
124490951|NCT01330381|447752619|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
124490952|NCT01330381|447752620|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
124490953|NCT01330381|447752621|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
124490954|NCT00663858|447752622|FG000|Overall Study|Adverse Event|9|||
124490955|NCT00663858|447752623|FG001|Overall Study|Adverse Event|1|||
124490956|NCT00663858|447752624|FG002|Overall Study|Adverse Event|6|||
124490957|NCT00663858|447752622|FG000|Overall Study|Lack of Efficacy|5|||
124490958|NCT00663858|447752623|FG001|Overall Study|Lack of Efficacy|1|||
124490959|NCT00663858|447752624|FG002|Overall Study|Lack of Efficacy|3|||
124490960|NCT00663858|447752622|FG000|Overall Study|Withdrawal by Subject|7|||
124490961|NCT00663858|447752623|FG001|Overall Study|Withdrawal by Subject|3|||
124490962|NCT00663858|447752624|FG002|Overall Study|Withdrawal by Subject|3|||
124490963|NCT00663858|447752622|FG000|Overall Study|Protocol Violation|5|||
124490964|NCT00663858|447752623|FG001|Overall Study|Protocol Violation|3|||
124490965|NCT00663858|447752624|FG002|Overall Study|Protocol Violation|4|||
124490966|NCT00663858|447752622|FG000|Overall Study|Other|8|||
124490967|NCT00663858|447752623|FG001|Overall Study|Other|2|||
124490968|NCT00663858|447752624|FG002|Overall Study|Other|4|||
124490969|NCT03216265|447752625|FG000|Overall Study|Adverse Event|2|||
124490970|NCT03216265|447752626|FG001|Overall Study|Adverse Event|0|||
124490971|NCT03216265|447752627|FG002|Overall Study|Adverse Event|2|||
124490972|NCT03216265|447752625|FG000|Overall Study|Lost to Follow-up|0|||
124490973|NCT03216265|447752626|FG001|Overall Study|Lost to Follow-up|1|||
124490974|NCT03216265|447752627|FG002|Overall Study|Lost to Follow-up|0|||
124490975|NCT03216265|447752625|FG000|Overall Study|Withdrawal by Subject|0|||
124490976|NCT03216265|447752626|FG001|Overall Study|Withdrawal by Subject|0|||
124490977|NCT03216265|447752627|FG002|Overall Study|Withdrawal by Subject|1|||
124490978|NCT01277289|447752628|FG000|Overall Study|fragile vein|1|||
124490979|NCT01277289|447752629|FG001|Overall Study|fragile vein|0|||
124490980|NCT01277289|447752628|FG000|Overall Study|Physician Decision|1|||
124490981|NCT01277289|447752629|FG001|Overall Study|Physician Decision|0|||
124490982|NCT01277289|447752628|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
124490983|NCT01277289|447752629|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
124490984|NCT01277289|447752628|FG000|Overall Study|Protocol Violation|1|||
124490985|NCT01277289|447752629|FG001|Overall Study|Protocol Violation|1|||
124721624|NCT01831466|448603693|FG009|Overall Study|Non-compliance with study treatment|0|||
124721625|NCT01831466|448603694|FG010|Overall Study|Non-compliance with study treatment|0|||
124721626|NCT01831466|448603695|FG011|Overall Study|Non-compliance with study treatment|0|||
124721627|NCT01831466|448603684|FG000|Overall Study|Death|0|||
124721628|NCT01831466|448603685|FG001|Overall Study|Death|1|||
124721629|NCT01831466|448603686|FG002|Overall Study|Death|0|||
124721630|NCT01831466|448603687|FG003|Overall Study|Death|0|||
124721631|NCT01831466|448603688|FG004|Overall Study|Death|0|||
124721632|NCT01831466|448603689|FG005|Overall Study|Death|0|||
124721633|NCT01831466|448603690|FG006|Overall Study|Death|0|||
124721634|NCT01831466|448603691|FG007|Overall Study|Death|0|||
124721635|NCT01831466|448603692|FG008|Overall Study|Death|0|||
124721636|NCT01831466|448603693|FG009|Overall Study|Death|0|||
124721637|NCT01831466|448603694|FG010|Overall Study|Death|0|||
124721638|NCT01831466|448603695|FG011|Overall Study|Death|0|||
124721639|NCT01831466|448603684|FG000|Overall Study|Withdrawal by Subject|6|||
124721640|NCT01831466|448603685|FG001|Overall Study|Withdrawal by Subject|3|||
124721641|NCT01831466|448603686|FG002|Overall Study|Withdrawal by Subject|3|||
124721642|NCT01831466|448603687|FG003|Overall Study|Withdrawal by Subject|3|||
124721643|NCT01831466|448603688|FG004|Overall Study|Withdrawal by Subject|3|||
124721644|NCT01831466|448603689|FG005|Overall Study|Withdrawal by Subject|5|||
124721645|NCT01831466|448603690|FG006|Overall Study|Withdrawal by Subject|0|||
124721646|NCT01831466|448603691|FG007|Overall Study|Withdrawal by Subject|0|||
124721647|NCT01831466|448603692|FG008|Overall Study|Withdrawal by Subject|0|||
124721648|NCT01831466|448603693|FG009|Overall Study|Withdrawal by Subject|1|||
124721649|NCT01831466|448603694|FG010|Overall Study|Withdrawal by Subject|0|||
124721650|NCT01831466|448603695|FG011|Overall Study|Withdrawal by Subject|1|||
124721651|NCT01831466|448603684|FG000|Overall Study|Lost to Follow-up|0|||
124721652|NCT01831466|448603685|FG001|Overall Study|Lost to Follow-up|1|||
124721653|NCT01831466|448603686|FG002|Overall Study|Lost to Follow-up|4|||
124721654|NCT01831466|448603687|FG003|Overall Study|Lost to Follow-up|2|||
124721655|NCT01831466|448603688|FG004|Overall Study|Lost to Follow-up|0|||
124490986|NCT01277289|447752628|FG000|Overall Study|Adverse Event|2|||
124490987|NCT01277289|447752629|FG001|Overall Study|Adverse Event|1|||
124490988|NCT01277289|447752628|FG000|Overall Study|consent withdrawn|1|||
124490989|NCT01277289|447752629|FG001|Overall Study|consent withdrawn|1|||
124490990|NCT01277289|447752628|FG000|Overall Study|premature closure of the study|4|||
124490991|NCT01277289|447752629|FG001|Overall Study|premature closure of the study|2|||
124490992|NCT00224107|447752630|FG000|Overall Study|Adverse Event|20|||
124490993|NCT00224107|447752631|FG001|Overall Study|Adverse Event|6|||
124490994|NCT00224107|447752630|FG000|Overall Study|Protocol Violation|2|||
124490995|NCT00224107|447752631|FG001|Overall Study|Protocol Violation|3|||
124490996|NCT00224107|447752630|FG000|Overall Study|Withdrawal by Subject|1|||
124490997|NCT00224107|447752631|FG001|Overall Study|Withdrawal by Subject|4|||
124490998|NCT00224107|447752630|FG000|Overall Study|Lack of Efficacy|2|||
124490999|NCT00224107|447752631|FG001|Overall Study|Lack of Efficacy|0|||
124491000|NCT00224107|447752630|FG000|Overall Study|Lost to Follow-up|4|||
124491001|NCT00224107|447752631|FG001|Overall Study|Lost to Follow-up|0|||
124491002|NCT00224107|447752630|FG000|Overall Study|Physician Decision|1|||
124491003|NCT00224107|447752631|FG001|Overall Study|Physician Decision|0|||
124491004|NCT00224107|447752630|FG000|Overall Study|Other|1|||
124491005|NCT00224107|447752631|FG001|Overall Study|Other|1|||
124491006|NCT00401973|447752632|FG000|Overall Study|Adverse Event|2|||
124491007|NCT00401973|447752633|FG001|Overall Study|Adverse Event|8|||
124721656|NCT01831466|448603689|FG005|Overall Study|Lost to Follow-up|3|||
124721657|NCT01831466|448603690|FG006|Overall Study|Lost to Follow-up|0|||
124721658|NCT01831466|448603691|FG007|Overall Study|Lost to Follow-up|0|||
124491008|NCT00401973|447752634|FG002|Overall Study|Adverse Event|4|||
124491009|NCT00401973|447752632|FG000|Overall Study|Clinical Relapse|0|||
124491010|NCT00401973|447752633|FG001|Overall Study|Clinical Relapse|1|||
124491011|NCT00401973|447752634|FG002|Overall Study|Clinical Relapse|1|||
124721659|NCT01831466|448603692|FG008|Overall Study|Lost to Follow-up|0|||
124721660|NCT01831466|448603693|FG009|Overall Study|Lost to Follow-up|1|||
124491012|NCT00401973|447752632|FG000|Overall Study|Lack of Efficacy|0|||
124491013|NCT00401973|447752633|FG001|Overall Study|Lack of Efficacy|0|||
124491014|NCT00401973|447752634|FG002|Overall Study|Lack of Efficacy|3|||
124491015|NCT00401973|447752632|FG000|Overall Study|Lost to Follow-up|2|||
124721661|NCT01831466|448603694|FG010|Overall Study|Lost to Follow-up|0|||
124721662|NCT01831466|448603695|FG011|Overall Study|Lost to Follow-up|1|||
124721663|NCT01831466|448603684|FG000|Overall Study|Lack of Efficacy|5|||
124491016|NCT00401973|447752633|FG001|Overall Study|Lost to Follow-up|2|||
124721664|NCT01831466|448603685|FG001|Overall Study|Lack of Efficacy|8|||
124491017|NCT00401973|447752634|FG002|Overall Study|Lost to Follow-up|2|||
124491018|NCT00401973|447752632|FG000|Overall Study|Physician Decision|2|||
124491019|NCT00401973|447752633|FG001|Overall Study|Physician Decision|0|||
124491020|NCT00401973|447752634|FG002|Overall Study|Physician Decision|1|||
124721665|NCT01831466|448603686|FG002|Overall Study|Lack of Efficacy|7|||
124491021|NCT00401973|447752632|FG000|Overall Study|Protocol Violation|1|||
124491022|NCT00401973|447752633|FG001|Overall Study|Protocol Violation|2|||
124491023|NCT00401973|447752634|FG002|Overall Study|Protocol Violation|3|||
124491024|NCT00401973|447752632|FG000|Overall Study|Sponsor Decision|0|||
124491025|NCT00401973|447752633|FG001|Overall Study|Sponsor Decision|1|||
124491026|NCT00401973|447752634|FG002|Overall Study|Sponsor Decision|0|||
124491027|NCT00401973|447752632|FG000|Overall Study|Withdrawal by Subject|4|||
124491028|NCT00401973|447752633|FG001|Overall Study|Withdrawal by Subject|12|||
124491029|NCT00401973|447752634|FG002|Overall Study|Withdrawal by Subject|9|||
124491030|NCT05523362|447752635|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
124491031|NCT05523362|447752635|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
124491032|NCT05523362|447752635|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
124491033|NCT05523362|447752635|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
124491034|NCT03515538|447752636|FG000|Overall Study|Lack of Efficacy|2|||
124491035|NCT03515538|447752637|FG001|Overall Study|Lack of Efficacy|0|||
124491036|NCT03515538|447752638|FG002|Overall Study|Lack of Efficacy|2|||
124491037|NCT03515538|447752639|FG003|Overall Study|Lack of Efficacy|0|||
124491038|NCT03515538|447752636|FG000|Overall Study|Death|0|||
124491039|NCT03515538|447752637|FG001|Overall Study|Death|0|||
124491040|NCT03515538|447752638|FG002|Overall Study|Death|1|||
124491041|NCT03515538|447752639|FG003|Overall Study|Death|0|||
124491042|NCT03515538|447752636|FG000|Overall Study|Protocol Violation|0|||
124491043|NCT03515538|447752637|FG001|Overall Study|Protocol Violation|0|||
124491044|NCT03515538|447752638|FG002|Overall Study|Protocol Violation|0|||
124491045|NCT03515538|447752639|FG003|Overall Study|Protocol Violation|1|||
124491046|NCT03515538|447752636|FG000|Overall Study|Screen failure (baseline dropout)|0|||
124491047|NCT03515538|447752637|FG001|Overall Study|Screen failure (baseline dropout)|1|||
124491048|NCT03515538|447752638|FG002|Overall Study|Screen failure (baseline dropout)|0|||
124491049|NCT03515538|447752639|FG003|Overall Study|Screen failure (baseline dropout)|0|||
124491050|NCT03515538|447752636|FG000|Overall Study|Withdrawal by Subject|2|||
124491051|NCT03515538|447752637|FG001|Overall Study|Withdrawal by Subject|2|||
124491052|NCT03515538|447752638|FG002|Overall Study|Withdrawal by Subject|1|||
124491053|NCT03515538|447752639|FG003|Overall Study|Withdrawal by Subject|3|||
124491054|NCT03515538|447752636|FG000|Overall Study|Physician Decision|1|||
124491055|NCT03515538|447752637|FG001|Overall Study|Physician Decision|0|||
124491056|NCT03515538|447752638|FG002|Overall Study|Physician Decision|0|||
124491057|NCT03515538|447752639|FG003|Overall Study|Physician Decision|1|||
124491058|NCT04075604|447752640|FG000|Overall Study|Adverse Event|0|||
124491059|NCT04075604|447752641|FG001|Overall Study|Adverse Event|0|||
124491060|NCT04075604|447752642|FG002|Overall Study|Adverse Event|3|||
124491061|NCT04075604|447752640|FG000|Overall Study|Participant request to discontinue study treatment|0|||
124491062|NCT04075604|447752641|FG001|Overall Study|Participant request to discontinue study treatment|0|||
124491063|NCT04075604|447752642|FG002|Overall Study|Participant request to discontinue study treatment|1|||
124491064|NCT04075604|447752640|FG000|Overall Study|Participant withdrew consent|0|||
124491065|NCT04075604|447752641|FG001|Overall Study|Participant withdrew consent|0|||
124491066|NCT04075604|447752642|FG002|Overall Study|Participant withdrew consent|1|||
124491067|NCT04075604|447752640|FG000|Overall Study|Other reasons|1|||
124491068|NCT04075604|447752641|FG001|Overall Study|Other reasons|0|||
124491069|NCT04075604|447752642|FG002|Overall Study|Other reasons|0|||
124491070|NCT04075604|447752640|FG000|Overall Study|Disease progression|0|||
124491071|NCT04075604|447752641|FG001|Overall Study|Disease progression|1|||
124491072|NCT04075604|447752642|FG002|Overall Study|Disease progression|0|||
124491073|NCT04075604|447752640|FG000|Overall Study|Study drug toxicity|0|||
124491074|NCT04075604|447752641|FG001|Overall Study|Study drug toxicity|5|||
124491075|NCT04075604|447752642|FG002|Overall Study|Study drug toxicity|1|||
124491076|NCT01650779|447752645|FG000|Overall Study|Withdrawal by Subject|1|||
124491077|NCT03666143|447752646|FG000|Overall Study|Death|158|||
124491078|NCT03666143|447752646|FG000|Overall Study|Sponsor Decision|31|||
124491079|NCT03666143|447752646|FG000|Overall Study|Withdrawal by Subject|11|||
124491080|NCT03666143|447752646|FG000|Overall Study|Lost to Follow-up|5|||
124491081|NCT03666143|447752646|FG000|Overall Study|Physician Decision|1|||
124491082|NCT03666143|447752646|FG000|Overall Study|Rolled into extension study|9|||
124491083|NCT03666143|447752646|FG000|Overall Study|Progressive Disease|1|||
124491084|NCT04329923|447752649|FG000|Overall Study|Withdrawal by Subject|1|||
124491085|NCT04329923|447752650|FG001|Overall Study|Withdrawal by Subject|4|||
124491086|NCT04329923|447752651|FG002|Overall Study|Withdrawal by Subject|1|||
124491087|NCT04329923|447752652|FG003|Overall Study|Withdrawal by Subject|1|||
124491088|NCT04329923|447752653|FG004|Overall Study|Withdrawal by Subject|1|||
124491089|NCT04329923|447752654|FG005|Overall Study|Withdrawal by Subject|1|||
124491090|NCT04329923|447752649|FG000|Overall Study|early termination of study|0|||
124491091|NCT04329923|447752650|FG001|Overall Study|early termination of study|0|||
124491092|NCT04329923|447752651|FG002|Overall Study|early termination of study|0|||
124491093|NCT04329923|447752652|FG003|Overall Study|early termination of study|0|||
124491094|NCT04329923|447752653|FG004|Overall Study|early termination of study|1|||
124491095|NCT04329923|447752654|FG005|Overall Study|early termination of study|2|||
124491096|NCT04329923|447752649|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
124557753|NCT02270983|448001312|FG001|Overall Study|family emergency|1|||
124491097|NCT04329923|447752650|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
124491098|NCT04329923|447752651|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
124491099|NCT04329923|447752652|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
124491100|NCT04329923|447752653|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
124491101|NCT04329923|447752654|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
124491102|NCT00641147|447752661|FG000|Completed 4 Months.|Physician Decision|1|||
124491103|NCT00641147|447752662|FG001|Completed 4 Months.|Physician Decision|0|||
124491104|NCT00641147|447752661|FG000|Completed 4 Months.|Adverse Event|1|||
124491105|NCT00641147|447752662|FG001|Completed 4 Months.|Adverse Event|0|||
124491106|NCT00641147|447752661|FG000|Completed 8 Months.|Physician Decision|2|||
124491107|NCT00641147|447752662|FG001|Completed 8 Months.|Physician Decision|1|||
124491108|NCT00641147|447752661|FG000|Completed 8 Months.|non compliance|1|||
124491109|NCT00641147|447752662|FG001|Completed 8 Months.|non compliance|0|||
124491110|NCT00641147|447752661|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
124491111|NCT00641147|447752662|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
124491112|NCT00641147|447752661|FG000|Completed 12 Months.|Physician Decision|1|||
124491113|NCT00641147|447752662|FG001|Completed 12 Months.|Physician Decision|1|||
124491114|NCT00641147|447752661|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
124491115|NCT00641147|447752662|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
124491116|NCT00641147|447752661|FG000|Completed 16 Months.|Physician Decision|1|||
124491117|NCT00641147|447752662|FG001|Completed 16 Months.|Physician Decision|0|||
124491118|NCT00641147|447752661|FG000|Completed 16 Months.|Lost to Follow-up|1|||
124491119|NCT00641147|447752662|FG001|Completed 16 Months.|Lost to Follow-up|0|||
124491120|NCT01966731|447752663|FG000|Overall Study|Death|2|||
124491121|NCT01966731|447752663|FG000|Overall Study|Lost to Follow-up|1|||
124491122|NCT01966731|447752663|FG000|Overall Study|Physician Decision|2|||
124491123|NCT01966731|447752663|FG000|Overall Study|Follow up is not complete|600|||
124491124|NCT01966731|447752663|FG000|Overall Study|Screening Failure|29|||
124491125|NCT01966731|447752663|FG000|Overall Study|Found to be ineligible|1|||
124491126|NCT01380093|447752665|FG000|Naloxone Challenge Phase|Screen failures|21|||
124491127|NCT01380093|447752666|FG001|Naloxone Challenge Phase|Screen failures|0|||
124491128|NCT01380093|447752667|FG002|Naloxone Challenge Phase|Screen failures|0|||
124491129|NCT01380093|447752668|FG003|Naloxone Challenge Phase|Screen failures|0|||
124491130|NCT01380093|447752669|FG004|Naloxone Challenge Phase|Screen failures|0|||
124491131|NCT01380093|447752670|FG005|Naloxone Challenge Phase|Screen failures|0|||
124491132|NCT01380093|447752671|FG006|Naloxone Challenge Phase|Screen failures|0|||
124491133|NCT01380093|447752672|FG007|Naloxone Challenge Phase|Screen failures|0|||
124491134|NCT01380093|447752673|FG008|Naloxone Challenge Phase|Screen failures|0|||
124491135|NCT01380093|447752665|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
124491136|NCT01380093|447752666|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
124491137|NCT01380093|447752667|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
124491138|NCT01380093|447752668|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
124491139|NCT01380093|447752669|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
124491140|NCT01380093|447752670|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
124491141|NCT01380093|447752671|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
124491142|NCT01380093|447752672|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
124491143|NCT01380093|447752673|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
124491144|NCT01380093|447752665|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
124491145|NCT01380093|447752666|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
124491146|NCT01380093|447752667|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
124491147|NCT01380093|447752668|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
124491148|NCT01380093|447752669|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
124491149|NCT01380093|447752670|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
124491150|NCT01380093|447752671|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
124491151|NCT01380093|447752672|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
124491152|NCT01380093|447752673|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
124491153|NCT01380093|447752665|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
124491154|NCT01380093|447752666|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
124491155|NCT01380093|447752667|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
124491156|NCT01380093|447752668|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
124491157|NCT01380093|447752669|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
124491158|NCT01380093|447752670|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
124491159|NCT01380093|447752671|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
124491160|NCT01380093|447752672|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
124491161|NCT01380093|447752673|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
124772007|NCT01298648|448796356|FG000|Overall Study|Withdrawal by Subject|2|||
124772008|NCT01298648|448796356|FG000|Overall Study|Lost to Follow-up|21|||
124491162|NCT01380093|447752665|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
124491163|NCT01380093|447752666|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
124491164|NCT01380093|447752667|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
124491165|NCT01380093|447752668|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
124491166|NCT01380093|447752669|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
124491167|NCT01380093|447752670|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
124491168|NCT01380093|447752671|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
124491169|NCT01380093|447752672|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
124491170|NCT01380093|447752673|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
124491171|NCT01380093|447752665|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
124491172|NCT01380093|447752666|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
124491173|NCT01380093|447752667|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
124491174|NCT01380093|447752668|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
124491175|NCT01380093|447752669|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
124491176|NCT01380093|447752670|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
124491177|NCT01380093|447752671|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
124491178|NCT01380093|447752672|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
124721666|NCT01831466|448603687|FG003|Overall Study|Lack of Efficacy|6|||
124721667|NCT01831466|448603688|FG004|Overall Study|Lack of Efficacy|9|||
124721668|NCT01831466|448603689|FG005|Overall Study|Lack of Efficacy|8|||
124721669|NCT01831466|448603690|FG006|Overall Study|Lack of Efficacy|1|||
124721670|NCT01831466|448603691|FG007|Overall Study|Lack of Efficacy|1|||
124721671|NCT01831466|448603692|FG008|Overall Study|Lack of Efficacy|2|||
124721672|NCT01831466|448603693|FG009|Overall Study|Lack of Efficacy|2|||
124721673|NCT01831466|448603694|FG010|Overall Study|Lack of Efficacy|2|||
124721674|NCT01831466|448603695|FG011|Overall Study|Lack of Efficacy|0|||
124721675|NCT01831466|448603684|FG000|Overall Study|Adverse Event|0|||
124721676|NCT01831466|448603685|FG001|Overall Study|Adverse Event|0|||
124721677|NCT01831466|448603686|FG002|Overall Study|Adverse Event|4|||
124721678|NCT01831466|448603687|FG003|Overall Study|Adverse Event|6|||
124721679|NCT01831466|448603688|FG004|Overall Study|Adverse Event|3|||
124721680|NCT01831466|448603689|FG005|Overall Study|Adverse Event|7|||
124721681|NCT01831466|448603690|FG006|Overall Study|Adverse Event|0|||
124721682|NCT01831466|448603691|FG007|Overall Study|Adverse Event|1|||
124721683|NCT01831466|448603692|FG008|Overall Study|Adverse Event|1|||
124721684|NCT01831466|448603693|FG009|Overall Study|Adverse Event|1|||
124721685|NCT01831466|448603694|FG010|Overall Study|Adverse Event|0|||
124721686|NCT01831466|448603695|FG011|Overall Study|Adverse Event|2|||
124721687|NCT04776720|448603698|FG000|Overall Study|COVID Related|4|||
124721688|NCT04776720|448603699|FG001|Overall Study|COVID Related|2|||
124721689|NCT04776720|448603698|FG000|Overall Study|Adverse Event|2|||
124721690|NCT04776720|448603699|FG001|Overall Study|Adverse Event|0|||
124721691|NCT04776720|448603698|FG000|Overall Study|Serious Adverse Event|0|||
124721692|NCT04776720|448603699|FG001|Overall Study|Serious Adverse Event|1|||
124721693|NCT04776720|448603698|FG000|Overall Study|Too Busy|3|||
124721694|NCT04776720|448603699|FG001|Overall Study|Too Busy|1|||
124721695|NCT04776720|448603698|FG000|Overall Study|Lost to Follow-up|1|||
124721696|NCT04776720|448603699|FG001|Overall Study|Lost to Follow-up|2|||
124721697|NCT04776720|448603698|FG000|Overall Study|Family|2|||
124721698|NCT04776720|448603699|FG001|Overall Study|Family|2|||
124721699|NCT04776720|448603698|FG000|Overall Study|No remote technology access|0|||
124721700|NCT04776720|448603699|FG001|Overall Study|No remote technology access|1|||
124721701|NCT04776720|448603698|FG000|Overall Study|Withdrawal by Subject|1|||
124772009|NCT02038933|448796361|FG000|Overall Study|Disease progression|104|||
124491179|NCT01380093|447752673|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
124491180|NCT01380093|447752665|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
124491181|NCT01380093|447752666|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
124491182|NCT01380093|447752667|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
124491183|NCT01380093|447752668|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
124491184|NCT01380093|447752669|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
124491185|NCT01380093|447752670|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
124491186|NCT01380093|447752671|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
124491187|NCT01380093|447752672|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
124491188|NCT01380093|447752673|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
124721702|NCT04776720|448603699|FG001|Overall Study|Withdrawal by Subject|0|||
124721703|NCT04776720|448603698|FG000|Overall Study|Cannot tolerate intervention|1|||
124721704|NCT04776720|448603699|FG001|Overall Study|Cannot tolerate intervention|0|||
124491189|NCT01380093|447752665|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
124721705|NCT04776720|448603698|FG000|Overall Study|Incomplete outcome data|6|||
124721706|NCT04776720|448603699|FG001|Overall Study|Incomplete outcome data|1|||
124721707|NCT05356910|448603700|FG000|Overall Study|Lost to Follow-up|10|||
124721708|NCT05356910|448603701|FG001|Overall Study|Lost to Follow-up|19|||
124721709|NCT05356910|448603702|FG002|Overall Study|Lost to Follow-up|0|||
124721710|NCT05356910|448603703|FG003|Overall Study|Lost to Follow-up|0|||
124721711|NCT05356910|448603700|FG000|Overall Study|Withdrawal by Subject|4|||
124721712|NCT05356910|448603701|FG001|Overall Study|Withdrawal by Subject|2|||
124721713|NCT05356910|448603702|FG002|Overall Study|Withdrawal by Subject|0|||
124721714|NCT05356910|448603703|FG003|Overall Study|Withdrawal by Subject|0|||
124491190|NCT01380093|447752666|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
124491191|NCT01380093|447752667|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
124491192|NCT01380093|447752668|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
124491193|NCT01380093|447752669|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
124491194|NCT01380093|447752670|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
124491195|NCT01380093|447752671|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
124491196|NCT01380093|447752672|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
124491197|NCT01380093|447752673|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
124491198|NCT01380093|447752665|FG000|Treatment Phase: Second Intervention|Other|0|||
124491199|NCT01380093|447752666|FG001|Treatment Phase: Second Intervention|Other|0|||
124491200|NCT01380093|447752667|FG002|Treatment Phase: Second Intervention|Other|0|||
124491201|NCT01380093|447752668|FG003|Treatment Phase: Second Intervention|Other|1|||
124491202|NCT01380093|447752669|FG004|Treatment Phase: Second Intervention|Other|0|||
124491203|NCT01380093|447752670|FG005|Treatment Phase: Second Intervention|Other|0|||
124491204|NCT01380093|447752671|FG006|Treatment Phase: Second Intervention|Other|0|||
124491205|NCT01380093|447752672|FG007|Treatment Phase: Second Intervention|Other|0|||
124491206|NCT01380093|447752673|FG008|Treatment Phase: Second Intervention|Other|0|||
124491207|NCT01380093|447752665|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
124491208|NCT01380093|447752666|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
124491209|NCT01380093|447752667|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
124491210|NCT01380093|447752668|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
124491211|NCT01380093|447752669|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
124491212|NCT01380093|447752670|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
124491213|NCT01380093|447752671|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
124491214|NCT01380093|447752672|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
124491215|NCT01380093|447752673|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
124491216|NCT01380093|447752665|FG000|Treatment Phase: Third Intervention|Other|0|||
124491217|NCT01380093|447752666|FG001|Treatment Phase: Third Intervention|Other|0|||
124491218|NCT01380093|447752667|FG002|Treatment Phase: Third Intervention|Other|0|||
124491219|NCT01380093|447752668|FG003|Treatment Phase: Third Intervention|Other|0|||
124491220|NCT01380093|447752669|FG004|Treatment Phase: Third Intervention|Other|0|||
124491221|NCT01380093|447752670|FG005|Treatment Phase: Third Intervention|Other|0|||
124491222|NCT01380093|447752671|FG006|Treatment Phase: Third Intervention|Other|0|||
124491223|NCT01380093|447752672|FG007|Treatment Phase: Third Intervention|Other|0|||
124491224|NCT01380093|447752673|FG008|Treatment Phase: Third Intervention|Other|1|||
124491225|NCT04734873|447752674|FG000|Overall Study|Lost to Follow-up|1|||
124491226|NCT04734873|447752675|FG001|Overall Study|Lost to Follow-up|3|||
124491227|NCT04734873|447752676|FG002|Overall Study|Lost to Follow-up|2|||
124491228|NCT04734873|447752674|FG000|Overall Study|Randomized but not dosed|1|||
124491229|NCT04734873|447752675|FG001|Overall Study|Randomized but not dosed|0|||
124491230|NCT04734873|447752676|FG002|Overall Study|Randomized but not dosed|1|||
124491231|NCT00328198|447752680|FG000|Treatment|Adverse Event|21|||
124491232|NCT00328198|447752680|FG000|Treatment|Death|1|||
124491233|NCT00328198|447752680|FG000|Treatment|Physician Decision|5|||
124491234|NCT00328198|447752680|FG000|Treatment|Withdrawal by Subject|5|||
124491235|NCT00328198|447752680|FG000|Treatment|Evidence of disease progression|2|||
124491236|NCT00328198|447752680|FG000|Treatment|Non-compliance|1|||
124491237|NCT00328198|447752680|FG000|Treatment|Confirmed complete response, MRD -|3|||
124491238|NCT00328198|447752680|FG000|Follow-up|Lost to Follow-up|4|||
124491239|NCT00328198|447752680|FG000|Follow-up|Death|31|||
124491240|NCT00718861|447752681|FG000|Overall Study|Withdrawal by Subject|15|||
124491241|NCT00718861|447752682|FG001|Overall Study|Withdrawal by Subject|10|||
124491242|NCT00718861|447752681|FG000|Overall Study|Adverse Event|2|||
124491243|NCT00718861|447752682|FG001|Overall Study|Adverse Event|1|||
124491244|NCT00718861|447752681|FG000|Overall Study|Lost to Follow-up|2|||
124491245|NCT00718861|447752682|FG001|Overall Study|Lost to Follow-up|1|||
124491246|NCT00718861|447752681|FG000|Overall Study|Administrative Problems|1|||
124491247|NCT00718861|447752682|FG001|Overall Study|Administrative Problems|1|||
124491248|NCT00718861|447752681|FG000|Overall Study|Death|1|||
124491249|NCT00718861|447752682|FG001|Overall Study|Death|5|||
124491250|NCT03237845|447752683|FG000|Overall Study|Adverse Event|0|||
124491251|NCT03237845|447752684|FG001|Overall Study|Adverse Event|1|||
124491252|NCT03237845|447752683|FG000|Overall Study|Lost to Follow-up|13|||
124491253|NCT03237845|447752684|FG001|Overall Study|Lost to Follow-up|10|||
124491254|NCT03237845|447752683|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
124491255|NCT03237845|447752684|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
124491256|NCT03237845|447752683|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
124491257|NCT03237845|447752684|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
124491258|NCT03237845|447752683|FG000|Overall Study|Physician Decision|1|||
124491259|NCT03237845|447752684|FG001|Overall Study|Physician Decision|2|||
124491260|NCT03237845|447752683|FG000|Overall Study|Pregnancy|1|||
124491261|NCT03237845|447752684|FG001|Overall Study|Pregnancy|0|||
124491262|NCT03237845|447752683|FG000|Overall Study|Protocol Deviation|0|||
124491263|NCT03237845|447752684|FG001|Overall Study|Protocol Deviation|1|||
124491264|NCT03237845|447752683|FG000|Overall Study|Technical Problems|8|||
124491265|NCT03237845|447752684|FG001|Overall Study|Technical Problems|1|||
124491266|NCT03237845|447752683|FG000|Overall Study|Withdrawal by Subject|3|||
124491267|NCT03237845|447752684|FG001|Overall Study|Withdrawal by Subject|3|||
124491268|NCT03237845|447752683|FG000|Overall Study|Other Reasons|4|||
124491269|NCT03237845|447752684|FG001|Overall Study|Other Reasons|0|||
124491270|NCT03865407|447752688|FG000|Overall Study|Adverse Event|1|||
124491271|NCT03865407|447752689|FG001|Overall Study|Adverse Event|0|||
124491272|NCT03865407|447752688|FG000|Overall Study|Withdrawal by Subject|1|||
124491273|NCT03865407|447752689|FG001|Overall Study|Withdrawal by Subject|0|||
124491274|NCT03865407|447752688|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
124491275|NCT03865407|447752689|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
124491276|NCT02117050|447752690|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
124491277|NCT01645280|447752691|FG000|Overall Study|Death|0|||
124491278|NCT01645280|447752692|FG001|Overall Study|Death|1|||
124491279|NCT01645280|447752693|FG002|Overall Study|Death|0|||
124491280|NCT01645280|447752694|FG003|Overall Study|Death|0|||
124491281|NCT01645280|447752695|FG004|Overall Study|Death|0|||
124491282|NCT01645280|447752691|FG000|Overall Study|Withdrawal by Subject|4|||
124491283|NCT01645280|447752692|FG001|Overall Study|Withdrawal by Subject|0|||
124491284|NCT01645280|447752693|FG002|Overall Study|Withdrawal by Subject|2|||
124491285|NCT01645280|447752694|FG003|Overall Study|Withdrawal by Subject|4|||
124491286|NCT01645280|447752695|FG004|Overall Study|Withdrawal by Subject|5|||
124491287|NCT01645280|447752691|FG000|Overall Study|Lost to Follow-up|0|||
124491288|NCT01645280|447752692|FG001|Overall Study|Lost to Follow-up|0|||
124491289|NCT01645280|447752693|FG002|Overall Study|Lost to Follow-up|0|||
124491290|NCT01645280|447752694|FG003|Overall Study|Lost to Follow-up|2|||
124491291|NCT01645280|447752695|FG004|Overall Study|Lost to Follow-up|1|||
124491292|NCT01645280|447752691|FG000|Overall Study|Other|1|||
124491293|NCT01645280|447752692|FG001|Overall Study|Other|1|||
124491294|NCT01645280|447752693|FG002|Overall Study|Other|2|||
124491295|NCT01645280|447752694|FG003|Overall Study|Other|0|||
124491296|NCT01645280|447752695|FG004|Overall Study|Other|0|||
124491297|NCT01645280|447752691|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
124491298|NCT01645280|447752692|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
124491299|NCT01645280|447752693|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
124491300|NCT01645280|447752694|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
124491301|NCT01645280|447752695|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
124491302|NCT00234104|447752700|FG000|Overall Study|Adverse Event|4|||
124491303|NCT00234104|447752701|FG001|Overall Study|Adverse Event|0|||
124491304|NCT00234104|447752702|FG002|Overall Study|Adverse Event|3|||
124491305|NCT00234104|447752703|FG003|Overall Study|Adverse Event|5|||
124491306|NCT00234104|447752700|FG000|Overall Study|Protocol Violation|0|||
124491307|NCT00234104|447752701|FG001|Overall Study|Protocol Violation|0|||
124491308|NCT00234104|447752702|FG002|Overall Study|Protocol Violation|0|||
124491309|NCT00234104|447752703|FG003|Overall Study|Protocol Violation|1|||
124491310|NCT00234104|447752700|FG000|Overall Study|Physician Decision|0|||
124491311|NCT00234104|447752701|FG001|Overall Study|Physician Decision|1|||
124491312|NCT00234104|447752702|FG002|Overall Study|Physician Decision|2|||
124491313|NCT00234104|447752703|FG003|Overall Study|Physician Decision|2|||
124491314|NCT00546819|447752706|FG000|Overall Study|Adverse Event|2|||
124491315|NCT00546819|447752707|FG001|Overall Study|Adverse Event|3|||
124491316|NCT00546819|447752706|FG000|Overall Study|Lost to Follow-up|2|||
124491317|NCT00546819|447752707|FG001|Overall Study|Lost to Follow-up|1|||
124491318|NCT00546819|447752706|FG000|Overall Study|Withdrawal by Subject|4|||
124491319|NCT00546819|447752707|FG001|Overall Study|Withdrawal by Subject|2|||
124491320|NCT02052960|447752709|FG000|Overall Study|Adverse Event|19|||
124491321|NCT02052960|447752710|FG001|Overall Study|Adverse Event|17|||
124491322|NCT02052960|447752709|FG000|Overall Study|Protocol Violation|4|||
124491323|NCT02052960|447752710|FG001|Overall Study|Protocol Violation|3|||
124491324|NCT02052960|447752709|FG000|Overall Study|Withdrawal by Subject|6|||
124491325|NCT02052960|447752710|FG001|Overall Study|Withdrawal by Subject|11|||
124491326|NCT02052960|447752709|FG000|Overall Study|Other|25|||
124491327|NCT02052960|447752710|FG001|Overall Study|Other|15|||
124491328|NCT03849560|447752711|FG000|Overall Study|Withdrawal by Subject|1|||
124491329|NCT03849560|447752712|FG001|Overall Study|Withdrawal by Subject|0|||
124491330|NCT03849560|447752713|FG002|Overall Study|Withdrawal by Subject|0|||
124491331|NCT04045613|447752714|FG000|Overall Study|Adverse Event|2|||
124491332|NCT04045613|447752715|FG001|Overall Study|Adverse Event|2|||
124491333|NCT04045613|447752716|FG002|Overall Study|Adverse Event|1|||
124491334|NCT04045613|447752717|FG003|Overall Study|Adverse Event|1|||
124491335|NCT04045613|447752718|FG004|Overall Study|Adverse Event|0|||
124491336|NCT04045613|447752719|FG005|Overall Study|Adverse Event|0|||
124491337|NCT04045613|447752720|FG006|Overall Study|Adverse Event|1|||
124491338|NCT04045613|447752714|FG000|Overall Study|Withdrawal by Subject|0|||
124491339|NCT04045613|447752715|FG001|Overall Study|Withdrawal by Subject|5|||
124491340|NCT04045613|447752716|FG002|Overall Study|Withdrawal by Subject|0|||
124491341|NCT04045613|447752717|FG003|Overall Study|Withdrawal by Subject|0|||
124491342|NCT04045613|447752718|FG004|Overall Study|Withdrawal by Subject|0|||
124491343|NCT04045613|447752719|FG005|Overall Study|Withdrawal by Subject|1|||
124491344|NCT04045613|447752720|FG006|Overall Study|Withdrawal by Subject|0|||
124491345|NCT04045613|447752714|FG000|Overall Study|Physician Decision|2|||
124491346|NCT04045613|447752715|FG001|Overall Study|Physician Decision|0|||
124491347|NCT04045613|447752716|FG002|Overall Study|Physician Decision|0|||
124491348|NCT04045613|447752717|FG003|Overall Study|Physician Decision|0|||
124491349|NCT04045613|447752718|FG004|Overall Study|Physician Decision|1|||
124491350|NCT04045613|447752719|FG005|Overall Study|Physician Decision|0|||
124491351|NCT04045613|447752720|FG006|Overall Study|Physician Decision|0|||
124491352|NCT04045613|447752714|FG000|Overall Study|Death|3|||
124491353|NCT04045613|447752715|FG001|Overall Study|Death|0|||
124491354|NCT04045613|447752716|FG002|Overall Study|Death|0|||
124491355|NCT04045613|447752717|FG003|Overall Study|Death|0|||
124491356|NCT04045613|447752718|FG004|Overall Study|Death|0|||
124491357|NCT04045613|447752719|FG005|Overall Study|Death|0|||
124491358|NCT04045613|447752720|FG006|Overall Study|Death|1|||
124491359|NCT04045613|447752714|FG000|Overall Study|Other reasons|0|||
124491360|NCT04045613|447752715|FG001|Overall Study|Other reasons|1|||
124491361|NCT04045613|447752716|FG002|Overall Study|Other reasons|0|||
124491362|NCT04045613|447752717|FG003|Overall Study|Other reasons|0|||
124491363|NCT04045613|447752718|FG004|Overall Study|Other reasons|0|||
124491364|NCT04045613|447752719|FG005|Overall Study|Other reasons|0|||
124491365|NCT04045613|447752720|FG006|Overall Study|Other reasons|1|||
124491366|NCT04045613|447752714|FG000|Overall Study|Progressive disease: Clinical progression|1|||
124491367|NCT04045613|447752715|FG001|Overall Study|Progressive disease: Clinical progression|0|||
124491368|NCT04045613|447752716|FG002|Overall Study|Progressive disease: Clinical progression|3|||
124491369|NCT04045613|447752717|FG003|Overall Study|Progressive disease: Clinical progression|1|||
124491370|NCT04045613|447752718|FG004|Overall Study|Progressive disease: Clinical progression|1|||
124491371|NCT04045613|447752719|FG005|Overall Study|Progressive disease: Clinical progression|3|||
124491372|NCT04045613|447752720|FG006|Overall Study|Progressive disease: Clinical progression|3|||
124557754|NCT02270983|448001313|FG002|Overall Study|family emergency|0|||
124557755|NCT02270983|448001311|FG000|Overall Study|study procedure non-compliance|1|||
124491373|NCT04045613|447752714|FG000|Overall Study|Progressive disease: Radiological progression|24|||
124491374|NCT04045613|447752715|FG001|Overall Study|Progressive disease: Radiological progression|6|||
124491375|NCT04045613|447752716|FG002|Overall Study|Progressive disease: Radiological progression|8|||
124491376|NCT04045613|447752717|FG003|Overall Study|Progressive disease: Radiological progression|0|||
124491377|NCT04045613|447752718|FG004|Overall Study|Progressive disease: Radiological progression|6|||
124491378|NCT04045613|447752719|FG005|Overall Study|Progressive disease: Radiological progression|6|||
124491379|NCT04045613|447752720|FG006|Overall Study|Progressive disease: Radiological progression|11|||
124491380|NCT04983901|447752721|FG000|Overall Study|Death|1|||
124491381|NCT04983901|447752722|FG001|Overall Study|Death|4|||
124491382|NCT04983901|447752721|FG000|Overall Study|Lost to Follow-up|3|||
124491383|NCT04983901|447752722|FG001|Overall Study|Lost to Follow-up|0|||
124491384|NCT04983901|447752721|FG000|Overall Study|Protocol Violation|1|||
124491385|NCT04983901|447752722|FG001|Overall Study|Protocol Violation|0|||
124491386|NCT04983901|447752721|FG000|Overall Study|Withdrawal by Subject|1|||
124491387|NCT04983901|447752722|FG001|Overall Study|Withdrawal by Subject|2|||
124491388|NCT02859415|447752730|FG000|Overall Study|Physician Decision|1|||
124721715|NCT00803595|448603704|FG000|Overall Study|Adverse Event|3|||
124721716|NCT00803595|448603705|FG001|Overall Study|Adverse Event|4|||
124721717|NCT00803595|448603706|FG002|Overall Study|Adverse Event|1|||
124721718|NCT00803595|448603704|FG000|Overall Study|Protocol Violation|7|||
124721719|NCT00803595|448603705|FG001|Overall Study|Protocol Violation|2|||
124721720|NCT00803595|448603706|FG002|Overall Study|Protocol Violation|12|||
124491389|NCT02859415|447752731|FG001|Overall Study|Physician Decision|0|||
124491390|NCT02859415|447752730|FG000|Overall Study|Off treatment due to cardiac event|0|||
124491391|NCT02859415|447752731|FG001|Overall Study|Off treatment due to cardiac event|1|||
124491392|NCT01174784|447752732|FG000|Overall Study|Screen fails|4|||
124491393|NCT00450866|447752737|FG000|Overall Study|Adverse Event|0|||
124491394|NCT00450866|447752738|FG001|Overall Study|Adverse Event|1|||
124772010|NCT02038933|448796361|FG000|Overall Study|Study drug toxicity|6|||
124491395|NCT00450866|447752737|FG000|Overall Study|Withdrawal by Subject|5|||
124491396|NCT00450866|447752738|FG001|Overall Study|Withdrawal by Subject|2|||
124491397|NCT00450866|447752737|FG000|Overall Study|Death|1|||
124491398|NCT00450866|447752738|FG001|Overall Study|Death|0|||
124491399|NCT00450866|447752737|FG000|Overall Study|Physician Decision|1|||
124491400|NCT00450866|447752738|FG001|Overall Study|Physician Decision|0|||
124491401|NCT01478347|447752741|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
124491402|NCT01478347|447752741|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
124491403|NCT01478347|447752741|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
124491404|NCT01863758|447752746|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
124491405|NCT01863758|447752746|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
124491406|NCT02369510|447752747|FG000|Overall Study|Spilled Medication|1|||
124557756|NCT02270983|448001312|FG001|Overall Study|study procedure non-compliance|0|||
124491407|NCT02369510|447752748|FG001|Overall Study|Spilled Medication|2|||
124721721|NCT00803595|448603704|FG000|Overall Study|Withdrawal by Subject|5|||
124491408|NCT02369510|447752749|FG002|Overall Study|Spilled Medication|1|||
124491409|NCT02369510|447752747|FG000|Overall Study|Epidural Activation|1|||
124491410|NCT02369510|447752748|FG001|Overall Study|Epidural Activation|1|||
124491411|NCT02369510|447752749|FG002|Overall Study|Epidural Activation|5|||
124491412|NCT04285723|447752753|FG000|Overall Study|Subject decision|1|||
124491413|NCT04285723|447752754|FG001|Overall Study|Subject decision|2|||
124491414|NCT04285723|447752753|FG000|Overall Study|Physician Decision|1|||
124491415|NCT04285723|447752754|FG001|Overall Study|Physician Decision|0|||
124491416|NCT04285723|447752753|FG000|Overall Study|No efficiency|1|||
124491417|NCT04285723|447752754|FG001|Overall Study|No efficiency|0|||
124721722|NCT00803595|448603705|FG001|Overall Study|Withdrawal by Subject|2|||
124721723|NCT00803595|448603706|FG002|Overall Study|Withdrawal by Subject|3|||
124491418|NCT01507246|447752756|FG000|Overall Study|Required different surgical procedures|2|||
124491419|NCT01507246|447752757|FG001|Overall Study|Required different surgical procedures|1|||
124491420|NCT02903511|447752761|FG000|Overall Study|Withdrawal by Subject|1|||
124491421|NCT02903511|447752762|FG001|Overall Study|Withdrawal by Subject|0|||
124491422|NCT02903511|447752761|FG000|Overall Study|Lost to Follow-up|3|||
124491423|NCT02903511|447752762|FG001|Overall Study|Lost to Follow-up|2|||
124491424|NCT00969618|447752763|FG000|Overall Study|Adverse Event|29|||
124491425|NCT00969618|447752763|FG000|Overall Study|Entry Criteria Not Met|3|||
124491426|NCT00969618|447752763|FG000|Overall Study|Lack of Efficacy|2|||
124491427|NCT00969618|447752763|FG000|Overall Study|Lost to Follow-up|7|||
124491428|NCT00969618|447752763|FG000|Overall Study|Physician Decision|1|||
124491429|NCT00969618|447752763|FG000|Overall Study|Protocol Violation|9|||
124491430|NCT00969618|447752763|FG000|Overall Study|Withdrawal by Subject|27|||
124491431|NCT05363293|447752766|FG000|Overall Study|Withdrawal by Subject|1|||
124491432|NCT05363293|447752767|FG001|Overall Study|Withdrawal by Subject|0|||
124491433|NCT05363293|447752768|FG002|Overall Study|Withdrawal by Subject|0|||
124491434|NCT05363293|447752769|FG003|Overall Study|Withdrawal by Subject|0|||
124491435|NCT05363293|447752770|FG004|Overall Study|Withdrawal by Subject|0|||
124491436|NCT05363293|447752771|FG005|Overall Study|Withdrawal by Subject|0|||
124491437|NCT05363293|447752772|FG006|Overall Study|Withdrawal by Subject|0|||
124491438|NCT05363293|447752773|FG007|Overall Study|Withdrawal by Subject|0|||
124491439|NCT05363293|447752774|FG008|Overall Study|Withdrawal by Subject|0|||
124491440|NCT05363293|447752775|FG009|Overall Study|Withdrawal by Subject|0|||
124491441|NCT01318902|447752776|FG000|Overall Study|Symptomatic Deterioration|0|||
124491442|NCT01318902|447752777|FG001|Overall Study|Symptomatic Deterioration|1|||
124491443|NCT01318902|447752778|FG002|Overall Study|Symptomatic Deterioration|1|||
124491444|NCT01318902|447752779|FG003|Overall Study|Symptomatic Deterioration|2|||
124491445|NCT01318902|447752776|FG000|Overall Study|Withdrawal by Patient|0|||
124491446|NCT01318902|447752777|FG001|Overall Study|Withdrawal by Patient|1|||
124491447|NCT01318902|447752778|FG002|Overall Study|Withdrawal by Patient|0|||
124491448|NCT01318902|447752779|FG003|Overall Study|Withdrawal by Patient|3|||
124491449|NCT01318902|447752776|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
124491450|NCT01318902|447752777|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
124491451|NCT01318902|447752778|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
124491452|NCT01318902|447752779|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
124491453|NCT01318902|447752776|FG000|Overall Study|Adverse Event|0|||
124491454|NCT01318902|447752777|FG001|Overall Study|Adverse Event|1|||
124491455|NCT01318902|447752778|FG002|Overall Study|Adverse Event|0|||
124491456|NCT01318902|447752779|FG003|Overall Study|Adverse Event|0|||
124491457|NCT01318902|447752776|FG000|Overall Study|Terminated by Sponsor|0|||
124491458|NCT01318902|447752777|FG001|Overall Study|Terminated by Sponsor|0|||
124491459|NCT01318902|447752778|FG002|Overall Study|Terminated by Sponsor|1|||
124491460|NCT01318902|447752779|FG003|Overall Study|Terminated by Sponsor|0|||
124491461|NCT00375934|447754747|FG000|Overall Study|Adverse Event|1|||
124491462|NCT00375934|447754748|FG001|Overall Study|Adverse Event|1|||
124491463|NCT00375934|447754747|FG000|Overall Study|Withdrawal by Subject|2|||
124491464|NCT00375934|447754748|FG001|Overall Study|Withdrawal by Subject|2|||
124491465|NCT00375934|447754747|FG000|Overall Study|Lack of Efficacy|0|||
124491466|NCT00375934|447754748|FG001|Overall Study|Lack of Efficacy|2|||
124491467|NCT00375934|447754747|FG000|Overall Study|Physician Decision|0|||
124491468|NCT00375934|447754748|FG001|Overall Study|Physician Decision|1|||
124491469|NCT02452970|447754749|FG000|Overall Study|Adverse Event|1|||
124491470|NCT00893113|447754750|FG000|Overall Study|Lost to Follow-up|4|||
124491471|NCT00893113|447754751|FG001|Overall Study|Lost to Follow-up|8|||
124491472|NCT00893113|447754750|FG000|Overall Study|Early Termination|1|||
124721724|NCT00984594|448603707|FG000|Overall Study|Lost to Follow-up|1|||
124491473|NCT00893113|447754751|FG001|Overall Study|Early Termination|1|||
124491474|NCT00893113|447754750|FG000|Overall Study|Withdrew Consent|8|||
124491475|NCT00893113|447754751|FG001|Overall Study|Withdrew Consent|7|||
124491476|NCT02400346|447754756|FG000|Overall Study|Adverse Event|24|||
124491477|NCT02400346|447754756|FG000|Overall Study|Lack of Efficacy|9|||
124491478|NCT02400346|447754756|FG000|Overall Study|Non-compliance with IMP|1|||
124491479|NCT02400346|447754756|FG000|Overall Study|Withdrawal by Subject|7|||
124491480|NCT02400346|447754756|FG000|Overall Study|Administrative or other reason(s)|2|||
124491481|NCT02400346|447754756|FG000|Overall Study|Lost to Follow-up|1|||
124491482|NCT01269125|447754757|FG000|Overall Study|Adverse Event|3|||
124491483|NCT01269125|447754758|FG001|Overall Study|Adverse Event|5|||
124491484|NCT01269125|447754759|FG002|Overall Study|Adverse Event|0|||
124491485|NCT01269125|447754757|FG000|Overall Study|Lost to Follow-up|4|||
124491486|NCT01269125|447754758|FG001|Overall Study|Lost to Follow-up|0|||
124491487|NCT01269125|447754759|FG002|Overall Study|Lost to Follow-up|0|||
124491488|NCT01283581|447754762|FG000|Overall Study|Lost to Follow-up|8|||
124491489|NCT01283581|447754763|FG001|Overall Study|Lost to Follow-up|6|||
124491490|NCT01283581|447754764|FG002|Overall Study|Lost to Follow-up|8|||
124491491|NCT01283581|447754762|FG000|Overall Study|Withdrawal by Subject|2|||
124491492|NCT01283581|447754763|FG001|Overall Study|Withdrawal by Subject|5|||
124491493|NCT01283581|447754764|FG002|Overall Study|Withdrawal by Subject|2|||
124491494|NCT01283581|447754762|FG000|Overall Study|Adverse Event|1|||
124491495|NCT01283581|447754763|FG001|Overall Study|Adverse Event|1|||
124491496|NCT01283581|447754764|FG002|Overall Study|Adverse Event|4|||
124491497|NCT01283581|447754762|FG000|Overall Study|Physician Decision|0|||
124491498|NCT01283581|447754763|FG001|Overall Study|Physician Decision|1|||
124491499|NCT01283581|447754764|FG002|Overall Study|Physician Decision|2|||
124491500|NCT01283581|447754762|FG000|Overall Study|Protocol Violation|0|||
124491501|NCT01283581|447754763|FG001|Overall Study|Protocol Violation|1|||
124491502|NCT01283581|447754764|FG002|Overall Study|Protocol Violation|2|||
124491503|NCT01283581|447754762|FG000|Overall Study|Noncompliance|1|||
124491504|NCT01283581|447754763|FG001|Overall Study|Noncompliance|0|||
124491505|NCT01283581|447754764|FG002|Overall Study|Noncompliance|0|||
124491506|NCT01283581|447754762|FG000|Overall Study|Investigator unblinded|0|||
124491507|NCT01283581|447754763|FG001|Overall Study|Investigator unblinded|0|||
124491508|NCT01283581|447754764|FG002|Overall Study|Investigator unblinded|1|||
124491509|NCT01283581|447754762|FG000|Overall Study|"Early termination"|0|||
124491510|NCT01283581|447754763|FG001|Overall Study|"Early termination"|0|||
124491511|NCT01283581|447754764|FG002|Overall Study|"Early termination"|1|||
124491512|NCT00486226|447754765|FG000|Overall Study|Death|3|||
124491513|NCT00486226|447754765|FG000|Overall Study|Adverse Event|1|||
124491514|NCT00486226|447754765|FG000|Overall Study|Withdrawal by Subject|1|||
124491515|NCT00486226|447754765|FG000|Overall Study|Lost to Follow-up|8|||
124491516|NCT01259492|447754766|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
124491517|NCT01259492|447754767|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
124491518|NCT01259492|447754768|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
124491519|NCT01259492|447754769|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
124491520|NCT01259492|447754766|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
124491521|NCT01259492|447754767|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
124491522|NCT01259492|447754768|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
124491523|NCT01259492|447754769|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
124491524|NCT01259492|447754766|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
124491525|NCT01259492|447754767|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
124491526|NCT01259492|447754768|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
124491527|NCT01259492|447754769|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
124491528|NCT01259492|447754766|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
124491529|NCT01259492|447754767|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
124491530|NCT01259492|447754768|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
124491531|NCT01259492|447754769|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
124491532|NCT01259492|447754766|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
124491533|NCT01259492|447754767|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
124491534|NCT01259492|447754768|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
124557757|NCT02270983|448001313|FG002|Overall Study|study procedure non-compliance|0|||
124557758|NCT02270983|448001311|FG000|Overall Study|moved away from study site|0|||
124557759|NCT02270983|448001312|FG001|Overall Study|moved away from study site|1|||
124557760|NCT02270983|448001313|FG002|Overall Study|moved away from study site|0|||
124557761|NCT00928252|448001319|FG000|Overall Study|Physician Decision|3|||
124491535|NCT01259492|447754769|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
124491536|NCT01259492|447754766|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
124491537|NCT01259492|447754767|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
124491538|NCT01259492|447754768|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
124557762|NCT01605461|448001320|FG000|Overall Study|Lost to Follow-up|3|||
124557763|NCT01605461|448001320|FG000|Overall Study|Withdrawal by Subject|1|||
124557764|NCT02024698|448001321|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
124557765|NCT02024698|448001322|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
124557766|NCT00331630|448001323|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
124557767|NCT00331630|448001323|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
124557768|NCT00331630|448001323|FG000|Follow up for 5 Years|Death|5|||
124557769|NCT00331630|448001323|FG000|Follow up for 5 Years|Data collection was stopped|24|||
124491539|NCT01259492|447754769|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
124491540|NCT01259492|447754766|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
124491541|NCT01259492|447754767|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
124491542|NCT01259492|447754768|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
124491543|NCT01259492|447754769|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
124491544|NCT01259492|447754766|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
124721725|NCT00984594|448603708|FG001|Overall Study|Lost to Follow-up|0|||
124721726|NCT00984594|448603707|FG000|Overall Study|Withdrawal by Subject|0|||
124721727|NCT00984594|448603708|FG001|Overall Study|Withdrawal by Subject|1|||
124721728|NCT03122145|448603709|FG000|Overall Study|Concurrent respiratory disease|3|||
124721729|NCT03122145|448603710|FG001|Overall Study|Concurrent respiratory disease|0|||
124721730|NCT01597908|448603711|FG000|Randomized Phase|Death|217|||
124721731|NCT01597908|448603712|FG001|Randomized Phase|Death|238|||
124721732|NCT01597908|448603713|FG002|Randomized Phase|Death|0|||
124721733|NCT01597908|448603711|FG000|Randomized Phase|Sponsor Decision|93|||
124721734|NCT01597908|448603712|FG001|Randomized Phase|Sponsor Decision|39|||
124721735|NCT01597908|448603713|FG002|Randomized Phase|Sponsor Decision|0|||
124721736|NCT01597908|448603711|FG000|Randomized Phase|Lost to Follow-up|9|||
124721737|NCT01597908|448603712|FG001|Randomized Phase|Lost to Follow-up|16|||
124721738|NCT01597908|448603713|FG002|Randomized Phase|Lost to Follow-up|0|||
124721739|NCT01597908|448603711|FG000|Randomized Phase|Physician Decision|6|||
124721740|NCT01597908|448603712|FG001|Randomized Phase|Physician Decision|3|||
124721741|NCT01597908|448603713|FG002|Randomized Phase|Physician Decision|0|||
124721742|NCT01597908|448603711|FG000|Randomized Phase|Withdrawal by Subject|26|||
124721743|NCT01597908|448603712|FG001|Randomized Phase|Withdrawal by Subject|22|||
124721744|NCT01597908|448603713|FG002|Randomized Phase|Withdrawal by Subject|0|||
124721745|NCT01597908|448603711|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
124721746|NCT01597908|448603712|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
124721747|NCT01597908|448603713|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
124721748|NCT01597908|448603711|FG000|Crossover Phase|Death|0|||
124721749|NCT01597908|448603712|FG001|Crossover Phase|Death|0|||
124721750|NCT01597908|448603713|FG002|Crossover Phase|Death|11|||
124721751|NCT01597908|448603711|FG000|Crossover Phase|Withdrawal by Subject|0|||
124721752|NCT01597908|448603712|FG001|Crossover Phase|Withdrawal by Subject|0|||
124721753|NCT01597908|448603713|FG002|Crossover Phase|Withdrawal by Subject|3|||
124721754|NCT01597908|448603711|FG000|Crossover Phase|Sponsor Decision|0|||
124721755|NCT01597908|448603712|FG001|Crossover Phase|Sponsor Decision|0|||
124721756|NCT01597908|448603713|FG002|Crossover Phase|Sponsor Decision|20|||
124721757|NCT00837161|448603716|FG000|Overall Study|refused hysterectomy|2|||
124721758|NCT01659996|448603719|FG000|Overall Study|Protocol Violation|3|||
124721759|NCT01659996|448603720|FG001|Overall Study|Protocol Violation|3|||
124721760|NCT01659996|448603721|FG002|Overall Study|Protocol Violation|3|||
124721761|NCT01659996|448603719|FG000|Overall Study|Lost to Follow-up|1|||
124721762|NCT01659996|448603720|FG001|Overall Study|Lost to Follow-up|3|||
124721763|NCT01659996|448603721|FG002|Overall Study|Lost to Follow-up|2|||
124491545|NCT01259492|447754767|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
124491546|NCT01259492|447754768|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
124491547|NCT01259492|447754769|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
124491548|NCT01259492|447754766|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
124491549|NCT01259492|447754767|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
124491550|NCT01259492|447754768|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
124491551|NCT01259492|447754769|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
124491552|NCT01259492|447754766|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
124491553|NCT01259492|447754767|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
124491554|NCT01259492|447754768|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
124491555|NCT01259492|447754769|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
124491556|NCT01259492|447754766|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
124491557|NCT01259492|447754767|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
124491558|NCT01259492|447754768|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
124491559|NCT01259492|447754769|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
124491560|NCT01259492|447754766|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
124491561|NCT01259492|447754767|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
124491562|NCT01259492|447754768|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
124491563|NCT01259492|447754769|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
124491564|NCT01259492|447754766|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
124491565|NCT01259492|447754767|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
124491566|NCT01259492|447754768|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
124491567|NCT01259492|447754769|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
124491568|NCT01259492|447754766|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
124491569|NCT01259492|447754767|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
124491570|NCT01259492|447754768|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
124721764|NCT01659996|448603719|FG000|Overall Study|Adverse Event|0|||
124721765|NCT01659996|448603720|FG001|Overall Study|Adverse Event|0|||
124721766|NCT01659996|448603721|FG002|Overall Study|Adverse Event|1|||
124721767|NCT01659996|448603719|FG000|Overall Study|Withdrawal by Subject|4|||
124721768|NCT01659996|448603720|FG001|Overall Study|Withdrawal by Subject|1|||
124721769|NCT01659996|448603721|FG002|Overall Study|Withdrawal by Subject|5|||
124721770|NCT01059864|448603728|FG000|Open-Label Run-In Phase|Adverse Event|7|||
124721771|NCT01059864|448603729|FG001|Open-Label Run-In Phase|Adverse Event|0|||
124721772|NCT01059864|448603730|FG002|Open-Label Run-In Phase|Adverse Event|0|||
124721773|NCT01059864|448603728|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
124721774|NCT01059864|448603729|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
124721775|NCT01059864|448603730|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
124721776|NCT01059864|448603728|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
124721777|NCT01059864|448603729|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
124721778|NCT01059864|448603730|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
124721779|NCT01059864|448603728|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
124721780|NCT01059864|448603729|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
124721781|NCT01059864|448603730|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
124721782|NCT01059864|448603728|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
124721783|NCT01059864|448603729|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
124721784|NCT01059864|448603730|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
124721785|NCT01059864|448603728|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
124721786|NCT01059864|448603729|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
124721787|NCT01059864|448603730|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
124721788|NCT00451958|448603731|FG000|CS21A (NCT00451958)|Adverse Event|21|||
124721789|NCT00451958|448603732|FG001|CS21A (NCT00451958)|Adverse Event|34|||
124721790|NCT00451958|448603733|FG002|CS21A (NCT00451958)|Adverse Event|14|||
124721791|NCT00451958|448603734|FG003|CS21A (NCT00451958)|Adverse Event|17|||
124721792|NCT00451958|448603735|FG004|CS21A (NCT00451958)|Adverse Event|0|||
124721793|NCT00451958|448603731|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
124491571|NCT01259492|447754769|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
124491572|NCT01259492|447754766|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
124491573|NCT01259492|447754767|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
124491574|NCT01259492|447754768|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
124491575|NCT01259492|447754769|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
124491576|NCT01259492|447754766|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
124491577|NCT01259492|447754767|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
124491578|NCT01259492|447754768|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
124491579|NCT01259492|447754769|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
124491580|NCT01259492|447754766|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
124491581|NCT01259492|447754767|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
124491582|NCT01259492|447754768|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
124491583|NCT01259492|447754769|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
124491584|NCT01259492|447754766|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
124491585|NCT01259492|447754767|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
124491586|NCT01259492|447754768|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
124491587|NCT01259492|447754769|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
124491588|NCT01259492|447754766|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
124491589|NCT01259492|447754767|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
124491590|NCT01259492|447754768|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
124491591|NCT01259492|447754769|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
124491592|NCT01259492|447754766|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
124491593|NCT01259492|447754767|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
124491594|NCT01259492|447754768|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
124491595|NCT01259492|447754769|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
124491596|NCT00641043|447754776|FG000|Overall Study|Adverse Event|6|||
124491597|NCT00641043|447754777|FG001|Overall Study|Adverse Event|4|||
124491598|NCT00641043|447754776|FG000|Overall Study|Protocol Violation|2|||
124491599|NCT00641043|447754777|FG001|Overall Study|Protocol Violation|3|||
124491600|NCT00641043|447754776|FG000|Overall Study|Lost to Follow-up|3|||
124491601|NCT00641043|447754777|FG001|Overall Study|Lost to Follow-up|2|||
124491602|NCT00641043|447754776|FG000|Overall Study|Withdrawal by Subject|4|||
124491603|NCT00641043|447754777|FG001|Overall Study|Withdrawal by Subject|4|||
124491604|NCT00641043|447754776|FG000|Overall Study|Other incl. lack of efficacy|4|||
124491605|NCT00641043|447754777|FG001|Overall Study|Other incl. lack of efficacy|2|||
124491606|NCT03088605|447754778|FG000|Overall Study|Withdrawal by Subject|1|||
124491607|NCT03088605|447754779|FG001|Overall Study|Withdrawal by Subject|0|||
124491608|NCT01936649|447754781|FG000|Overall Study|Withdrawal by Subject|4|||
124491609|NCT01936649|447754781|FG000|Overall Study|Physician Decision|2|||
124491610|NCT01936649|447754781|FG000|Overall Study|Protocol Violation|2|||
124491611|NCT01936649|447754781|FG000|Overall Study|Other than specified above|5|||
124491612|NCT04655586|447754788|FG000|Overall Study|Physician Decision|1|||
124721794|NCT00451958|448603732|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
124721795|NCT00451958|448603733|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
124721796|NCT00451958|448603734|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
124721797|NCT00451958|448603735|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
124721798|NCT00451958|448603731|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
124721799|NCT00451958|448603732|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
124772011|NCT02038933|448796361|FG000|Overall Study|Adverse event unrelated to study drug|6|||
124772012|NCT02038933|448796361|FG000|Overall Study|Participant request to discontinue treatment|2|||
124772013|NCT02038933|448796361|FG000|Overall Study|Lost to Follow-up|1|||
124772014|NCT02038933|448796361|FG000|Overall Study|Other reasons|2|||
124772015|NCT04154904|448796362|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
124772016|NCT04154904|448796363|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
124772017|NCT04154904|448796364|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
124772018|NCT03877510|448796367|FG000|Overall Study|Death|6|||
124772019|NCT03877510|448796367|FG000|Overall Study|Lost to Follow-up|2|||
124772020|NCT03877510|448796367|FG000|Overall Study|Non-compliance with study drug|2|||
124772021|NCT03877510|448796367|FG000|Overall Study|Lack of Efficacy|14|||
124772022|NCT03877510|448796367|FG000|Overall Study|Adverse Event|20|||
124491613|NCT04655586|447754789|FG001|Overall Study|Physician Decision|3|||
124491614|NCT04655586|447754790|FG002|Overall Study|Physician Decision|4|||
124491615|NCT04655586|447754788|FG000|Overall Study|Withdrawal by Subject|1|||
124491616|NCT04655586|447754789|FG001|Overall Study|Withdrawal by Subject|3|||
124491617|NCT04655586|447754790|FG002|Overall Study|Withdrawal by Subject|1|||
124491618|NCT00201201|447754793|FG000|Overall Study|Death|0|||
124491619|NCT00201201|447754794|FG001|Overall Study|Death|2|||
124491620|NCT00201201|447754793|FG000|Overall Study|Withdrawal by Subject|5|||
124491621|NCT00201201|447754794|FG001|Overall Study|Withdrawal by Subject|5|||
124491622|NCT01342640|447754800|FG000|Overall Study|Adverse Event|3|||
124491623|NCT01342640|447754800|FG000|Overall Study|Protocol Violation|16|||
124491624|NCT01342640|447754800|FG000|Overall Study|Lost to Follow-up|21|||
124491625|NCT01342640|447754800|FG000|Overall Study|Other|1|||
124491626|NCT00891657|447754801|FG000|Overall Study|Withdrawal by Subject|1|||
124491627|NCT00891657|447754802|FG001|Overall Study|Withdrawal by Subject|1|||
124491628|NCT02927171|447754806|FG000|Overall Study|Lost to Follow-up|0|||
124491629|NCT02927171|447754807|FG001|Overall Study|Lost to Follow-up|1|||
124491630|NCT04530825|447754810|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
124491631|NCT04530825|447754811|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
124491632|NCT04530825|447754812|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
124491633|NCT04530825|447754813|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
124491634|NCT04530825|447754810|FG000|Overall Study|Did not complete follow-up|3|||
124491635|NCT04530825|447754811|FG001|Overall Study|Did not complete follow-up|0|||
124491636|NCT04530825|447754812|FG002|Overall Study|Did not complete follow-up|0|||
124491637|NCT04530825|447754813|FG003|Overall Study|Did not complete follow-up|0|||
124491638|NCT04101422|447754815|FG000|Overall Study|Ineligible|1|||
124491639|NCT04101422|447754816|FG001|Overall Study|Ineligible|0|||
124491640|NCT04101422|447754817|FG002|Overall Study|Ineligible|9|||
124491641|NCT04101422|447754818|FG003|Overall Study|Ineligible|0|||
124491642|NCT04101422|447754815|FG000|Overall Study|Withdrawal by Subject|0|||
124491643|NCT04101422|447754816|FG001|Overall Study|Withdrawal by Subject|0|||
124491644|NCT04101422|447754817|FG002|Overall Study|Withdrawal by Subject|1|||
124491645|NCT04101422|447754818|FG003|Overall Study|Withdrawal by Subject|0|||
124491646|NCT04101422|447754815|FG000|Overall Study|Not attending to the stimuli|0|||
124491647|NCT04101422|447754816|FG001|Overall Study|Not attending to the stimuli|0|||
124491648|NCT04101422|447754817|FG002|Overall Study|Not attending to the stimuli|4|||
124491649|NCT04101422|447754818|FG003|Overall Study|Not attending to the stimuli|0|||
124491650|NCT04101422|447754815|FG000|Overall Study|Did not download app|0|||
124491651|NCT04101422|447754816|FG001|Overall Study|Did not download app|0|||
124491652|NCT04101422|447754817|FG002|Overall Study|Did not download app|0|||
124491653|NCT04101422|447754818|FG003|Overall Study|Did not download app|17|||
124491654|NCT04101422|447754815|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
124491655|NCT04101422|447754816|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
124491656|NCT04101422|447754817|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
124491657|NCT04101422|447754818|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
124491658|NCT02640612|447754819|FG000|Overall Study|Adverse Event|6|||
124491659|NCT02640612|447754820|FG001|Overall Study|Adverse Event|7|||
124491660|NCT02640612|447754821|FG002|Overall Study|Adverse Event|2|||
124491661|NCT02640612|447754819|FG000|Overall Study|Death|1|||
124491662|NCT02640612|447754820|FG001|Overall Study|Death|0|||
124491663|NCT02640612|447754821|FG002|Overall Study|Death|0|||
124491664|NCT02640612|447754819|FG000|Overall Study|Withdrawal by Subject|10|||
124491665|NCT02640612|447754820|FG001|Overall Study|Withdrawal by Subject|3|||
124772023|NCT03877510|448796367|FG000|Overall Study|Withdrawal by Subject|22|||
124491666|NCT02640612|447754821|FG002|Overall Study|Withdrawal by Subject|3|||
124491667|NCT02640612|447754819|FG000|Overall Study|Lost to Follow-up|4|||
124491668|NCT02640612|447754820|FG001|Overall Study|Lost to Follow-up|1|||
124491669|NCT02640612|447754821|FG002|Overall Study|Lost to Follow-up|1|||
124491670|NCT02640612|447754819|FG000|Overall Study|Protocol Violation|0|||
124491671|NCT02640612|447754820|FG001|Overall Study|Protocol Violation|2|||
124772024|NCT03877510|448796367|FG000|Overall Study|Miscellaneous|1|||
124772025|NCT02113982|448796368|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
124772026|NCT02113982|448796369|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
124491672|NCT02640612|447754821|FG002|Overall Study|Protocol Violation|0|||
124491673|NCT02640612|447754819|FG000|Overall Study|Lack of Efficacy|1|||
124491674|NCT02640612|447754820|FG001|Overall Study|Lack of Efficacy|1|||
124491675|NCT02640612|447754821|FG002|Overall Study|Lack of Efficacy|0|||
124491676|NCT01720667|447754822|FG000|Overall Study|Adverse Event|1|||
124491677|NCT01720667|447754823|FG001|Overall Study|Adverse Event|1|||
124491678|NCT01720667|447754822|FG000|Overall Study|Withdrawal by Subject|3|||
124491679|NCT01720667|447754823|FG001|Overall Study|Withdrawal by Subject|0|||
124491680|NCT03472534|447754824|FG000|Overall Study|Withdrawal by Subject|9|||
124491681|NCT03472534|447754824|FG000|Overall Study|Adverse Event|2|||
124491682|NCT00552305|447754825|FG000|Overall Study|Adverse Event|43|||
124491683|NCT00552305|447754825|FG000|Overall Study|Lack of Efficacy|120|||
124491684|NCT00552305|447754825|FG000|Overall Study|Lost to Follow-up|4|||
124491685|NCT00552305|447754825|FG000|Overall Study|Protocol Violation|3|||
124491686|NCT00552305|447754825|FG000|Overall Study|Withdrawal by Subject|44|||
124491687|NCT00552305|447754825|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
124491688|NCT00552305|447754825|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
124491689|NCT00552305|447754825|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
124491690|NCT00552305|447754825|FG000|Overall Study|Unsatisfactory compliance|11|||
124491691|NCT00552305|447754825|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
124491692|NCT00552305|447754825|FG000|Overall Study|AE/Other: prohibited drug required|1|||
124491693|NCT00552305|447754825|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
124491694|NCT00552305|447754825|FG000|Overall Study|Other: Site closed|4|||
124491695|NCT00552305|447754825|FG000|Overall Study|Other: Personal problems|1|||
124491696|NCT00552305|447754825|FG000|Overall Study|Other: Unable to attend visits|1|||
124557770|NCT02764489|448001324|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
124557771|NCT02764489|448001325|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
124557772|NCT02764489|448001324|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
124557773|NCT02764489|448001325|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
124491697|NCT00552305|447754825|FG000|Overall Study|Other: Subject underwent surgery|4|||
124491698|NCT00552305|447754825|FG000|Overall Study|Other: Subject became pregnant|1|||
124491699|NCT00552305|447754825|FG000|Overall Study|Other: Health problems, not drug related|1|||
124491700|NCT00552305|447754825|FG000|Overall Study|Other: Subject moved from area|2|||
124491701|NCT00552305|447754825|FG000|Overall Study|Other: Subject incarcerated|1|||
124491702|NCT00552305|447754825|FG000|Overall Study|Other: Subject went to rehab|1|||
124491703|NCT01319929|447754826|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
124491704|NCT01319929|447754827|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
124491705|NCT01319929|447754826|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
124491706|NCT01319929|447754827|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
124491707|NCT01319929|447754826|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
124557774|NCT02764489|448001324|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
124491708|NCT01319929|447754827|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
124491709|NCT01319929|447754826|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
124491710|NCT01319929|447754827|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
124491711|NCT01319929|447754826|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
124491712|NCT01319929|447754827|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
124491713|NCT01507545|447754828|FG000|Overall Study|Withdrawal by Subject|6|||
124491714|NCT01507545|447754829|FG001|Overall Study|Withdrawal by Subject|2|||
124491715|NCT01507545|447754828|FG000|Overall Study|Lost to Follow-up|1|||
124491716|NCT01507545|447754829|FG001|Overall Study|Lost to Follow-up|0|||
124491717|NCT01507545|447754828|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
124491718|NCT01507545|447754829|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
124491719|NCT01507545|447754828|FG000|Overall Study|Progressive disease|60|||
124491720|NCT01507545|447754829|FG001|Overall Study|Progressive disease|27|||
124491721|NCT01507545|447754828|FG000|Overall Study|Other|6|||
124491722|NCT01507545|447754829|FG001|Overall Study|Other|4|||
124491723|NCT00553787|447754830|FG000|Overall Study|Adverse Event|34|||
124491724|NCT00553787|447754831|FG001|Overall Study|Adverse Event|21|||
124491725|NCT00553787|447754832|FG002|Overall Study|Adverse Event|67|||
124491726|NCT00553787|447754830|FG000|Overall Study|Lost to Follow-up|132|||
124772027|NCT02113982|448796370|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
124772028|NCT02113982|448796371|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
124772029|NCT02113982|448796372|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
124491727|NCT00553787|447754831|FG001|Overall Study|Lost to Follow-up|44|||
124491728|NCT00553787|447754832|FG002|Overall Study|Lost to Follow-up|78|||
124772030|NCT02113982|448796373|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
124772031|NCT02113982|448796374|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
124772032|NCT02113982|448796375|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
124491729|NCT00553787|447754830|FG000|Overall Study|Withdrawal by Subject|151|||
124491730|NCT00553787|447754831|FG001|Overall Study|Withdrawal by Subject|40|||
124491731|NCT00553787|447754832|FG002|Overall Study|Withdrawal by Subject|83|||
124491732|NCT00553787|447754830|FG000|Overall Study|Lack of Efficacy|31|||
124772033|NCT02113982|448796376|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
124491733|NCT00553787|447754831|FG001|Overall Study|Lack of Efficacy|1|||
124491734|NCT00553787|447754832|FG002|Overall Study|Lack of Efficacy|3|||
124491735|NCT00553787|447754830|FG000|Overall Study|Pregnancy|0|||
124491736|NCT00553787|447754831|FG001|Overall Study|Pregnancy|1|||
124491737|NCT00553787|447754832|FG002|Overall Study|Pregnancy|2|||
124491738|NCT00553787|447754830|FG000|Overall Study|non compliance|4|||
124491739|NCT00553787|447754831|FG001|Overall Study|non compliance|0|||
124491740|NCT00553787|447754832|FG002|Overall Study|non compliance|11|||
124491741|NCT00553787|447754830|FG000|Overall Study|Requirement for restricted medication|8|||
124491742|NCT00553787|447754831|FG001|Overall Study|Requirement for restricted medication|7|||
124491743|NCT00553787|447754832|FG002|Overall Study|Requirement for restricted medication|5|||
124491744|NCT00553787|447754830|FG000|Overall Study|Other|18|||
124491745|NCT00553787|447754831|FG001|Overall Study|Other|10|||
124491746|NCT00553787|447754832|FG002|Overall Study|Other|13|||
124491747|NCT02285010|447754833|FG000|Overall Study|not abdominal hysterectomy|2|||
124491748|NCT02285010|447754834|FG001|Overall Study|not abdominal hysterectomy|0|||
124491749|NCT02285010|447754833|FG000|Overall Study|Not spinal anesthesia|3|||
124491750|NCT02285010|447754834|FG001|Overall Study|Not spinal anesthesia|1|||
124491751|NCT01426386|447754836|FG000|Overall Study|Adverse Event|0|||
124491752|NCT01426386|447754837|FG001|Overall Study|Adverse Event|1|||
124491753|NCT01426386|447754838|FG002|Overall Study|Adverse Event|0|||
124491754|NCT01426386|447754839|FG003|Overall Study|Adverse Event|0|||
124491755|NCT01426386|447754840|FG004|Overall Study|Adverse Event|0|||
124491756|NCT01426386|447754841|FG005|Overall Study|Adverse Event|0|||
124491757|NCT01426386|447754836|FG000|Overall Study|Did not attend scheduled visit|1|||
124491758|NCT01426386|447754837|FG001|Overall Study|Did not attend scheduled visit|4|||
124491759|NCT01426386|447754838|FG002|Overall Study|Did not attend scheduled visit|0|||
124491760|NCT01426386|447754839|FG003|Overall Study|Did not attend scheduled visit|0|||
124491761|NCT01426386|447754840|FG004|Overall Study|Did not attend scheduled visit|2|||
124491762|NCT01426386|447754841|FG005|Overall Study|Did not attend scheduled visit|1|||
124491763|NCT01426386|447754836|FG000|Overall Study|Poor response|2|||
124491764|NCT01426386|447754837|FG001|Overall Study|Poor response|1|||
124491765|NCT01426386|447754838|FG002|Overall Study|Poor response|2|||
124491766|NCT01426386|447754839|FG003|Overall Study|Poor response|0|||
124491767|NCT01426386|447754840|FG004|Overall Study|Poor response|1|||
124491768|NCT01426386|447754841|FG005|Overall Study|Poor response|0|||
124491769|NCT01426386|447754836|FG000|Overall Study|Personal reasons|0|||
124491770|NCT01426386|447754837|FG001|Overall Study|Personal reasons|0|||
124491771|NCT01426386|447754838|FG002|Overall Study|Personal reasons|0|||
124491772|NCT01426386|447754839|FG003|Overall Study|Personal reasons|0|||
124491773|NCT01426386|447754840|FG004|Overall Study|Personal reasons|1|||
124491774|NCT01426386|447754841|FG005|Overall Study|Personal reasons|0|||
124491775|NCT01457339|447754842|FG000|Period 3 (100 mg)|Adverse Event|0|||
124491776|NCT01457339|447754843|FG001|Period 3 (100 mg)|Adverse Event|1|||
124491777|NCT01457339|447754842|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
124491778|NCT01457339|447754843|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
124491779|NCT01457339|447754842|FG000|Period 6 (250 mg)|Family Emergency|1|||
124491780|NCT01457339|447754843|FG001|Period 6 (250 mg)|Family Emergency|0|||
124491781|NCT01457339|447754842|FG000|Period 6 (250 mg)|Personal appointment|0|||
124491782|NCT01457339|447754843|FG001|Period 6 (250 mg)|Personal appointment|1|||
124491783|NCT03694522|447754844|FG000|Overall Study|Withdrawal by Subject|8|||
124491784|NCT03694522|447754845|FG001|Overall Study|Withdrawal by Subject|10|||
124491785|NCT03694522|447754844|FG000|Overall Study|Physician Decision|53|||
124491786|NCT03694522|447754845|FG001|Overall Study|Physician Decision|54|||
124491787|NCT03694522|447754844|FG000|Overall Study|Other|1|||
124491788|NCT03694522|447754845|FG001|Overall Study|Other|1|||
124491789|NCT03694522|447754844|FG000|Overall Study|Lost to Follow-up|0|||
124721800|NCT00451958|448603733|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
124721801|NCT00451958|448603734|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
124491790|NCT03694522|447754845|FG001|Overall Study|Lost to Follow-up|1|||
124491791|NCT00196937|447754846|FG000|Overall Study|Serious Adverse Event|1|||
124491792|NCT00196937|447754847|FG001|Overall Study|Serious Adverse Event|0|||
124491793|NCT00196937|447754848|FG002|Overall Study|Serious Adverse Event|0|||
124491794|NCT00196937|447754846|FG000|Overall Study|Non-serious adverse event|1|||
124491795|NCT00196937|447754847|FG001|Overall Study|Non-serious adverse event|1|||
124491796|NCT00196937|447754848|FG002|Overall Study|Non-serious adverse event|1|||
124721802|NCT00451958|448603735|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
124491797|NCT00196937|447754846|FG000|Overall Study|Withdrawal by Subject|0|||
124491798|NCT00196937|447754847|FG001|Overall Study|Withdrawal by Subject|0|||
124491799|NCT00196937|447754848|FG002|Overall Study|Withdrawal by Subject|2|||
124491800|NCT00196937|447754846|FG000|Overall Study|Lost to Follow-up|4|||
124491801|NCT00196937|447754847|FG001|Overall Study|Lost to Follow-up|3|||
124721803|NCT00451958|448603731|FG000|CS21A (NCT00451958)|Physician Decision|2|||
124491802|NCT00196937|447754848|FG002|Overall Study|Lost to Follow-up|3|||
124491803|NCT00196937|447754846|FG000|Overall Study|Other|3|||
124491804|NCT00196937|447754847|FG001|Overall Study|Other|1|||
124491805|NCT00196937|447754848|FG002|Overall Study|Other|1|||
124491806|NCT01748760|447754849|FG000|Overall Study|Withdrawal by Subject|1|||
124491807|NCT01748760|447754850|FG001|Overall Study|Withdrawal by Subject|1|||
124491808|NCT01748760|447754849|FG000|Overall Study|Lost to Follow-up|5|||
124491809|NCT01748760|447754850|FG001|Overall Study|Lost to Follow-up|1|||
124491810|NCT01164501|447754851|FG000|Overall Study|Not treated|2|||
124491811|NCT01164501|447754852|FG001|Overall Study|Not treated|0|||
124491812|NCT01164501|447754853|FG002|Overall Study|Not treated|1|||
124491813|NCT01164501|447754851|FG000|Overall Study|Adverse Event|18|||
124491814|NCT01164501|447754852|FG001|Overall Study|Adverse Event|4|||
124491815|NCT01164501|447754853|FG002|Overall Study|Adverse Event|21|||
124491816|NCT01164501|447754851|FG000|Overall Study|Lack of Efficacy|0|||
124491817|NCT01164501|447754852|FG001|Overall Study|Lack of Efficacy|0|||
124491818|NCT01164501|447754853|FG002|Overall Study|Lack of Efficacy|1|||
124491819|NCT01164501|447754851|FG000|Overall Study|Non compliant with protocol|1|||
124491820|NCT01164501|447754852|FG001|Overall Study|Non compliant with protocol|1|||
124491821|NCT01164501|447754853|FG002|Overall Study|Non compliant with protocol|4|||
124491822|NCT01164501|447754851|FG000|Overall Study|Lost to Follow-up|3|||
124491823|NCT01164501|447754852|FG001|Overall Study|Lost to Follow-up|0|||
124491824|NCT01164501|447754853|FG002|Overall Study|Lost to Follow-up|3|||
124491825|NCT01164501|447754851|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
124491826|NCT01164501|447754852|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
124491827|NCT01164501|447754853|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
124491828|NCT01164501|447754851|FG000|Overall Study|Other reason not defined above|9|||
124491829|NCT01164501|447754852|FG001|Overall Study|Other reason not defined above|1|||
124491830|NCT01164501|447754853|FG002|Overall Study|Other reason not defined above|4|||
124491831|NCT01096667|447754854|FG000|Overall Study|Lost to Follow-up|1|||
124491832|NCT01096667|447754855|FG001|Overall Study|Lost to Follow-up|1|||
124491833|NCT01096667|447754856|FG002|Overall Study|Lost to Follow-up|1|||
124491834|NCT01096667|447754857|FG003|Overall Study|Lost to Follow-up|0|||
124491835|NCT01096667|447754858|FG004|Overall Study|Lost to Follow-up|0|||
124491836|NCT01096667|447754854|FG000|Overall Study|Withdrawal by Subject|1|||
124491837|NCT01096667|447754855|FG001|Overall Study|Withdrawal by Subject|0|||
124491838|NCT01096667|447754856|FG002|Overall Study|Withdrawal by Subject|0|||
124491839|NCT01096667|447754857|FG003|Overall Study|Withdrawal by Subject|1|||
124491840|NCT01096667|447754858|FG004|Overall Study|Withdrawal by Subject|0|||
124491841|NCT01096667|447754854|FG000|Overall Study|Reason not available|0|||
124491842|NCT01096667|447754855|FG001|Overall Study|Reason not available|1|||
124491843|NCT01096667|447754856|FG002|Overall Study|Reason not available|1|||
124491844|NCT01096667|447754857|FG003|Overall Study|Reason not available|1|||
124491845|NCT01096667|447754858|FG004|Overall Study|Reason not available|0|||
124491846|NCT01096667|447754854|FG000|Overall Study|Protocol Violation|0|||
124491847|NCT01096667|447754855|FG001|Overall Study|Protocol Violation|0|||
124491848|NCT01096667|447754856|FG002|Overall Study|Protocol Violation|0|||
124491849|NCT01096667|447754857|FG003|Overall Study|Protocol Violation|1|||
124491850|NCT01096667|447754858|FG004|Overall Study|Protocol Violation|0|||
124491851|NCT01096667|447754854|FG000|Overall Study|Not treated|1|||
124491852|NCT01096667|447754855|FG001|Overall Study|Not treated|0|||
124491853|NCT01096667|447754856|FG002|Overall Study|Not treated|0|||
124491854|NCT01096667|447754857|FG003|Overall Study|Not treated|0|||
124491855|NCT01096667|447754858|FG004|Overall Study|Not treated|0|||
124491856|NCT02522377|447754859|FG000|Overall Study|Withdrawal by Subject|1|||
124491857|NCT02522377|447754860|FG001|Overall Study|Withdrawal by Subject|0|||
124491858|NCT02522377|447754859|FG000|Overall Study|Remission Achieved|3|||
124491859|NCT02522377|447754860|FG001|Overall Study|Remission Achieved|0|||
124491860|NCT00306891|447754861|FG000|Part A|Withdrawal by Subject|1|||
124491861|NCT00306891|447754862|FG001|Part A|Withdrawal by Subject|1|||
124491862|NCT00306891|447754863|FG002|Part A|Withdrawal by Subject|0|||
124491863|NCT00306891|447754864|FG003|Part A|Withdrawal by Subject|0|||
124491864|NCT00306891|447754861|FG000|Part A|Condition under investigation worsened|2|||
124491865|NCT00306891|447754862|FG001|Part A|Condition under investigation worsened|2|||
124491866|NCT00306891|447754863|FG002|Part A|Condition under investigation worsened|0|||
124491867|NCT00306891|447754864|FG003|Part A|Condition under investigation worsened|0|||
124491868|NCT00306891|447754861|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
124491869|NCT00306891|447754862|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
124491870|NCT00306891|447754863|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
124491871|NCT00306891|447754864|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
124491872|NCT00306891|447754861|FG000|Part A|Partial bowel obstruction|1|||
124491873|NCT00306891|447754862|FG001|Part A|Partial bowel obstruction|0|||
124491874|NCT00306891|447754863|FG002|Part A|Partial bowel obstruction|0|||
124491875|NCT00306891|447754864|FG003|Part A|Partial bowel obstruction|0|||
124491876|NCT00306891|447754861|FG000|Part A|Reaccumul. of ascites following drainage|0|||
124491877|NCT00306891|447754862|FG001|Part A|Reaccumul. of ascites following drainage|1|||
124491878|NCT00306891|447754863|FG002|Part A|Reaccumul. of ascites following drainage|0|||
124491879|NCT00306891|447754864|FG003|Part A|Reaccumul. of ascites following drainage|0|||
124491880|NCT00306891|447754861|FG000|Part A|Suspicion of second malignancy|0|||
124491881|NCT00306891|447754862|FG001|Part A|Suspicion of second malignancy|1|||
124491882|NCT00306891|447754863|FG002|Part A|Suspicion of second malignancy|0|||
124721804|NCT00451958|448603732|FG001|CS21A (NCT00451958)|Physician Decision|4|||
124491883|NCT00306891|447754864|FG003|Part A|Suspicion of second malignancy|0|||
124491884|NCT00306891|447754861|FG000|Part A|QTC interval outwith elig. criteria|1|||
124491885|NCT00306891|447754862|FG001|Part A|QTC interval outwith elig. criteria|0|||
124491886|NCT00306891|447754863|FG002|Part A|QTC interval outwith elig. criteria|0|||
124491887|NCT00306891|447754864|FG003|Part A|QTC interval outwith elig. criteria|0|||
124491888|NCT00306891|447754861|FG000|Part B|Death|0|||
124491889|NCT00306891|447754862|FG001|Part B|Death|0|||
124491890|NCT00306891|447754863|FG002|Part B|Death|1|||
124491891|NCT00306891|447754864|FG003|Part B|Death|2|||
124491892|NCT00306891|447754861|FG000|Part B|Adverse Event|0|||
124491893|NCT00306891|447754862|FG001|Part B|Adverse Event|0|||
124491894|NCT00306891|447754863|FG002|Part B|Adverse Event|5|||
124491895|NCT00306891|447754864|FG003|Part B|Adverse Event|5|||
124491896|NCT00306891|447754861|FG000|Part B|Withdrawal by Subject|0|||
124491897|NCT00306891|447754862|FG001|Part B|Withdrawal by Subject|0|||
124491898|NCT00306891|447754863|FG002|Part B|Withdrawal by Subject|3|||
124491899|NCT00306891|447754864|FG003|Part B|Withdrawal by Subject|1|||
124491900|NCT00306891|447754861|FG000|Part B|Condition under investigation worsened|0|||
124491901|NCT00306891|447754862|FG001|Part B|Condition under investigation worsened|0|||
124491902|NCT00306891|447754863|FG002|Part B|Condition under investigation worsened|2|||
124491903|NCT00306891|447754864|FG003|Part B|Condition under investigation worsened|8|||
124491904|NCT00306891|447754861|FG000|Part B|Development of study specific disc crit.|0|||
124491905|NCT00306891|447754862|FG001|Part B|Development of study specific disc crit.|0|||
124721805|NCT00451958|448603733|FG002|CS21A (NCT00451958)|Physician Decision|4|||
124491906|NCT00306891|447754863|FG002|Part B|Development of study specific disc crit.|0|||
124721806|NCT00451958|448603734|FG003|CS21A (NCT00451958)|Physician Decision|4|||
124721807|NCT00451958|448603735|FG004|CS21A (NCT00451958)|Physician Decision|0|||
124721808|NCT00451958|448603731|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
124721809|NCT00451958|448603732|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
124721810|NCT00451958|448603733|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
124721811|NCT00451958|448603734|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
124721812|NCT00451958|448603735|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
124721813|NCT00451958|448603731|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
124721814|NCT00451958|448603732|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
124721815|NCT00451958|448603733|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
124721816|NCT00451958|448603734|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
124721817|NCT00451958|448603735|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
124721818|NCT03108521|448603739|FG000|Overall Study|Lost to Follow-up|3|||
124491907|NCT00306891|447754864|FG003|Part B|Development of study specific disc crit.|1|||
124491908|NCT02263365|447754865|FG000|Overall Study|Physician Decision|22|||
124491909|NCT02263365|447754866|FG001|Overall Study|Physician Decision|18|||
124491910|NCT00673673|447754867|FG000|Overall Study|Progressive disease|27|||
124721819|NCT03108521|448603740|FG001|Overall Study|Lost to Follow-up|0|||
124721820|NCT03108521|448603739|FG000|Overall Study|Lack of Efficacy|2|||
124721821|NCT03108521|448603740|FG001|Overall Study|Lack of Efficacy|0|||
124491911|NCT00673673|447754867|FG000|Overall Study|Adverse Event|4|||
124491912|NCT00673673|447754867|FG000|Overall Study|Withdrawal by Subject|3|||
124491913|NCT00673673|447754867|FG000|Overall Study|Investigators' discretion|2|||
124491914|NCT01751646|447754871|FG000|Overall Study|Lost to Follow-up|5|||
124491915|NCT01751646|447754872|FG001|Overall Study|Lost to Follow-up|1|||
124491916|NCT01751646|447754871|FG000|Overall Study|Withdrawal by Subject|0|||
124491917|NCT01751646|447754872|FG001|Overall Study|Withdrawal by Subject|4|||
124491918|NCT01751646|447754871|FG000|Overall Study|Starting hormone therapy|1|||
124491919|NCT01751646|447754872|FG001|Overall Study|Starting hormone therapy|0|||
124491920|NCT01751646|447754871|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
124491921|NCT01751646|447754872|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
124491922|NCT01751646|447754871|FG000|Overall Study|Inadvertent enrollment|1|||
124491923|NCT01751646|447754872|FG001|Overall Study|Inadvertent enrollment|1|||
124491924|NCT01751646|447754871|FG000|Overall Study|Moved out of the area|1|||
124721822|NCT03108521|448603739|FG000|Overall Study|Physician Decision|4|||
124491925|NCT01751646|447754872|FG001|Overall Study|Moved out of the area|5|||
124491926|NCT01751646|447754871|FG000|Overall Study|Inability to attend required visits|0|||
124491927|NCT01751646|447754872|FG001|Overall Study|Inability to attend required visits|1|||
124491928|NCT01751646|447754871|FG000|Overall Study|Off study due to multiple obligations|0|||
124491929|NCT01751646|447754872|FG001|Overall Study|Off study due to multiple obligations|1|||
124491930|NCT01751646|447754871|FG000|Overall Study|Fails to comply with study requirements|0|||
124721823|NCT03108521|448603740|FG001|Overall Study|Physician Decision|0|||
124721824|NCT03108521|448603739|FG000|Overall Study|Adverse Event|3|||
124491931|NCT01751646|447754872|FG001|Overall Study|Fails to comply with study requirements|1|||
124491932|NCT01751646|447754871|FG000|Overall Study|Childcare issues|1|||
124491933|NCT01751646|447754872|FG001|Overall Study|Childcare issues|1|||
124721825|NCT03108521|448603740|FG001|Overall Study|Adverse Event|0|||
124491934|NCT00945191|447754873|FG000|Overall Study|Did not achieve a complete response|18|||
124491935|NCT00945191|447754873|FG000|Overall Study|Participant relocated to another state|1|||
124491936|NCT00945191|447754873|FG000|Overall Study|Disease progression|3|||
124721826|NCT06899737|448603745|FG000|Overall Study|Lost to Follow-up|19|||
124721827|NCT06899737|448603746|FG001|Overall Study|Lost to Follow-up|7|||
124721828|NCT03281629|448603748|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
124491937|NCT00945191|447754873|FG000|Overall Study|Serious adverse event or adverse event|1|||
124491938|NCT00945191|447754873|FG000|Overall Study|Investigator's discretion|1|||
124491939|NCT02335450|447754874|FG000|Overall Study|Pregnancy|1|||
124491940|NCT02973815|447754877|FG000|Post Intervention|Death|1|||
124491941|NCT02973815|447754878|FG001|Post Intervention|Death|0|||
124491942|NCT02973815|447754877|FG000|Post Intervention|Lost to Follow-up|7|||
124721829|NCT03281629|448603749|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
124721830|NCT03281629|448603748|FG000|Overall Study|Death|0|||
124721831|NCT03281629|448603749|FG001|Overall Study|Death|1|||
124721832|NCT03281629|448603748|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
124721833|NCT03281629|448603749|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
124721834|NCT02175277|448603751|FG000|Overall Study|Protocol-specified Criteria|1|||
124491943|NCT02973815|447754878|FG001|Post Intervention|Lost to Follow-up|24|||
124491944|NCT02973815|447754877|FG000|Follow-up|Lost to Follow-up|2|||
124491945|NCT02973815|447754878|FG001|Follow-up|Lost to Follow-up|0|||
124491946|NCT02613572|447754879|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
124491947|NCT02613572|447754880|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
124491948|NCT02613572|447754881|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
124491949|NCT02613572|447754879|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
124491950|NCT02613572|447754880|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
124491951|NCT02613572|447754881|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
124491952|NCT04538950|447754886|FG000|Overall Study|Pulmonary Issues|2|||
124491953|NCT04538950|447754886|FG000|Overall Study|illness|2|||
124491954|NCT00853905|447754887|FG000|Overall Study|Lost to Follow-up|1|||
124491955|NCT00853905|447754888|FG001|Overall Study|Lost to Follow-up|3|||
124491956|NCT00853905|447754887|FG000|Overall Study|Withdrawal by Subject|0|||
124491957|NCT00853905|447754888|FG001|Overall Study|Withdrawal by Subject|1|||
124491958|NCT00853905|447754887|FG000|Overall Study|never had surgery|1|||
124491959|NCT00853905|447754888|FG001|Overall Study|never had surgery|0|||
124491960|NCT01004146|447754891|FG000|Overall Study|Withdrawal by Subject|4|||
124491961|NCT01004146|447754892|FG001|Overall Study|Withdrawal by Subject|5|||
124491962|NCT00465738|447754895|FG000|Overall Study|Lost to Follow-up|2|||
124491963|NCT00465738|447754896|FG001|Overall Study|Lost to Follow-up|0|||
124491964|NCT00465738|447754895|FG000|Overall Study|Adverse Event|0|||
124491965|NCT00465738|447754896|FG001|Overall Study|Adverse Event|1|||
124491966|NCT00465738|447754895|FG000|Overall Study|Withdrawal by Subject|2|||
124491967|NCT00465738|447754896|FG001|Overall Study|Withdrawal by Subject|0|||
124491968|NCT00465738|447754895|FG000|Overall Study|Other|2|||
124491969|NCT00465738|447754896|FG001|Overall Study|Other|5|||
124491970|NCT02489630|447754898|FG000|Overall Study|Oversedation|1|||
124491971|NCT02489630|447754899|FG001|Overall Study|Oversedation|1|||
124491972|NCT02489630|447754898|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
124491973|NCT02489630|447754899|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
124491974|NCT01056523|447754900|FG000|Overall Study|Death|1|||
124491975|NCT01056523|447754901|FG001|Overall Study|Death|0|||
124491976|NCT01056523|447754902|FG002|Overall Study|Death|2|||
124491977|NCT01056523|447754903|FG003|Overall Study|Death|3|||
124491978|NCT01056523|447754904|FG004|Overall Study|Death|0|||
124491979|NCT01056523|447754905|FG005|Overall Study|Death|0|||
124491980|NCT01056523|447754906|FG006|Overall Study|Death|1|||
124491981|NCT03429556|447754909|FG000|Overall Study|Lost to Follow-up|0|||
124491982|NCT03429556|447754910|FG001|Overall Study|Lost to Follow-up|1|||
124491983|NCT03429556|447754911|FG002|Overall Study|Lost to Follow-up|0|||
124491984|NCT03429556|447754912|FG003|Overall Study|Lost to Follow-up|0|||
124491985|NCT04952389|447754913|FG000|Overall Study|Withdrawal by Subject|8|||
124491986|NCT04952389|447754914|FG001|Overall Study|Withdrawal by Subject|4|||
124491987|NCT02050048|447754915|FG000|Overall Study|Lost to Follow-up|0|||
124491988|NCT02050048|447754916|FG001|Overall Study|Lost to Follow-up|1|||
124491989|NCT02050048|447754915|FG000|Overall Study|Death|1|||
124491990|NCT02050048|447754916|FG001|Overall Study|Death|0|||
124491991|NCT02050048|447754915|FG000|Overall Study|Ineligible after ERCP|4|||
124491992|NCT02050048|447754916|FG001|Overall Study|Ineligible after ERCP|1|||
124491993|NCT02699515|447756686|FG000|Overall Study|Death|3|||
124491994|NCT02699515|447756687|FG001|Overall Study|Death|3|||
124491995|NCT02699515|447756688|FG002|Overall Study|Death|3|||
124491996|NCT02699515|447756689|FG003|Overall Study|Death|23|||
124491997|NCT02699515|447756690|FG004|Overall Study|Death|22|||
124491998|NCT02699515|447756691|FG005|Overall Study|Death|23|||
124491999|NCT02699515|447756692|FG006|Overall Study|Death|3|||
124492000|NCT02699515|447756693|FG007|Overall Study|Death|5|||
124492001|NCT02699515|447756686|FG000|Overall Study|Withdrawal by Subject|0|||
124492002|NCT02699515|447756687|FG001|Overall Study|Withdrawal by Subject|0|||
124492003|NCT02699515|447756688|FG002|Overall Study|Withdrawal by Subject|3|||
124492004|NCT02699515|447756689|FG003|Overall Study|Withdrawal by Subject|1|||
124492005|NCT02699515|447756690|FG004|Overall Study|Withdrawal by Subject|5|||
124492006|NCT02699515|447756691|FG005|Overall Study|Withdrawal by Subject|3|||
124492007|NCT02699515|447756692|FG006|Overall Study|Withdrawal by Subject|0|||
124492008|NCT02699515|447756693|FG007|Overall Study|Withdrawal by Subject|1|||
124492009|NCT02699515|447756686|FG000|Overall Study|Other|1|||
124492010|NCT02699515|447756687|FG001|Overall Study|Other|0|||
124492011|NCT02699515|447756688|FG002|Overall Study|Other|1|||
124492012|NCT02699515|447756689|FG003|Overall Study|Other|6|||
124492013|NCT02699515|447756690|FG004|Overall Study|Other|4|||
124492014|NCT02699515|447756691|FG005|Overall Study|Other|3|||
124492015|NCT02699515|447756692|FG006|Overall Study|Other|0|||
124492016|NCT02699515|447756693|FG007|Overall Study|Other|0|||
124492017|NCT01166659|447756705|FG000|Overall Study|Subject Decision|8|||
124492018|NCT01166659|447756705|FG000|Overall Study|Investigator Decision|2|||
124492019|NCT01166659|447756705|FG000|Overall Study|Death|1|||
124492020|NCT01166659|447756705|FG000|Overall Study|Lost to Follow-up|1|||
124492021|NCT01166659|447756705|FG000|Overall Study|Study Closed at Site|1|||
124492022|NCT01371838|447756724|FG000|Overall Study|Withdrawal by Subject|27|||
124492023|NCT01371838|447756725|FG001|Overall Study|Withdrawal by Subject|33|||
124492024|NCT01371838|447756724|FG000|Overall Study|Lost to Follow-up|10|||
124492025|NCT01371838|447756725|FG001|Overall Study|Lost to Follow-up|20|||
124492026|NCT01371838|447756724|FG000|Overall Study|Death|3|||
124492027|NCT01371838|447756725|FG001|Overall Study|Death|4|||
124492028|NCT01371838|447756724|FG000|Overall Study|Protocol Violation|3|||
124492029|NCT01371838|447756725|FG001|Overall Study|Protocol Violation|0|||
124492030|NCT01371838|447756724|FG000|Overall Study|Investigator Decision|3|||
124492031|NCT01371838|447756725|FG001|Overall Study|Investigator Decision|8|||
124492032|NCT01371838|447756724|FG000|Overall Study|Last follow-up visit not conducted|2|||
124492033|NCT01371838|447756725|FG001|Overall Study|Last follow-up visit not conducted|0|||
124492034|NCT01371838|447756724|FG000|Overall Study|Lack of therapeutic response|0|||
124492035|NCT01371838|447756725|FG001|Overall Study|Lack of therapeutic response|1|||
124492036|NCT01371838|447756724|FG000|Overall Study|Surgery|1|||
124492037|NCT01371838|447756725|FG001|Overall Study|Surgery|0|||
124492038|NCT01334125|447756726|FG000|Overall Study|Lost to Follow-up|3|||
124492039|NCT01334125|447756727|FG001|Overall Study|Lost to Follow-up|3|||
124492040|NCT02584634|447756734|FG000|Overall Study|Adverse Event|3|||
124492041|NCT02584634|447756735|FG001|Overall Study|Adverse Event|5|||
124492042|NCT02584634|447756734|FG000|Overall Study|Death|0|||
124492043|NCT02584634|447756735|FG001|Overall Study|Death|1|||
124492044|NCT02584634|447756734|FG000|Overall Study|Lost to Follow-up|0|||
124492045|NCT02584634|447756735|FG001|Overall Study|Lost to Follow-up|1|||
124492046|NCT02584634|447756734|FG000|Overall Study|Physician Decision|1|||
124492047|NCT02584634|447756735|FG001|Overall Study|Physician Decision|2|||
124492048|NCT02584634|447756734|FG000|Overall Study|Progressive disease|7|||
124492049|NCT02584634|447756735|FG001|Overall Study|Progressive disease|15|||
124492050|NCT02584634|447756734|FG000|Overall Study|Withdrawal by Subject|1|||
124492051|NCT02584634|447756735|FG001|Overall Study|Withdrawal by Subject|1|||
124492052|NCT02584634|447756734|FG000|Overall Study|Other|0|||
124492053|NCT02584634|447756735|FG001|Overall Study|Other|6|||
124492054|NCT04275310|447756736|FG000|Overall Study|Non-randomized due to running out of funding|4|||
124492055|NCT04275310|447756737|FG001|Overall Study|Non-randomized due to running out of funding|0|||
124492056|NCT02225223|447756738|FG000|Overall Study|Death|10|||
124492057|NCT02225223|447756739|FG001|Overall Study|Death|1|||
124492058|NCT02225223|447756738|FG000|Overall Study|Lost to Follow-up|5|||
124492059|NCT02225223|447756739|FG001|Overall Study|Lost to Follow-up|0|||
124492060|NCT02225223|447756738|FG000|Overall Study|Other|1|||
124492061|NCT02225223|447756739|FG001|Overall Study|Other|2|||
124492062|NCT02225223|447756738|FG000|Overall Study|Physician Decision|1|||
124492063|NCT02225223|447756739|FG001|Overall Study|Physician Decision|0|||
124492064|NCT02225223|447756738|FG000|Overall Study|Withdrawal by Subject|2|||
124492065|NCT02225223|447756739|FG001|Overall Study|Withdrawal by Subject|2|||
124492066|NCT01749735|447756741|FG000|Overall Study|Withdrawal by Subject|1|||
124492067|NCT01749735|447756742|FG001|Overall Study|Withdrawal by Subject|0|||
124492068|NCT01221233|447756743|FG000|Overall Study|Withdrawal by Subject|3|||
124492069|NCT01221233|447756744|FG001|Overall Study|Withdrawal by Subject|1|||
124492070|NCT00611455|447756747|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
124492071|NCT00611455|447756748|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
124492072|NCT00611455|447756749|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
124492073|NCT00611455|447756747|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
124492074|NCT00611455|447756748|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
124492075|NCT00611455|447756749|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
124492076|NCT00611455|447756747|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
124492077|NCT00611455|447756748|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
124492078|NCT00611455|447756749|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
124492079|NCT00611455|447756747|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
124492080|NCT00611455|447756748|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
124492081|NCT00611455|447756749|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124492082|NCT00611455|447756747|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
124492083|NCT00611455|447756748|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
124492084|NCT00611455|447756749|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
124492085|NCT00611455|447756747|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
124721835|NCT01905943|448605493|FG000|Overall Study|Withdrawal of consent|90|||
124721836|NCT01905943|448605493|FG000|Overall Study|Lost to Follow-up|16|||
124721837|NCT01905943|448605493|FG000|Overall Study|Investigator discretion|7|||
124492086|NCT00611455|447756748|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
124492087|NCT00611455|447756749|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
124492088|NCT00611455|447756747|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
124492089|NCT00611455|447756748|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
124492090|NCT00611455|447756749|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
124492091|NCT00611455|447756747|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
124492092|NCT00611455|447756748|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
124492093|NCT00611455|447756749|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
124492094|NCT00611455|447756747|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
124492095|NCT00611455|447756748|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
124492096|NCT00611455|447756749|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
124492097|NCT00611455|447756747|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
124492098|NCT00611455|447756748|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
124492099|NCT00611455|447756749|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
124492100|NCT00611455|447756747|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
124492101|NCT00611455|447756748|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
124492102|NCT00611455|447756749|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
124492103|NCT00611455|447756747|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
124492104|NCT00611455|447756748|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
124492105|NCT00611455|447756749|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
124492106|NCT00611455|447756747|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
124492107|NCT00611455|447756748|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
124492108|NCT00611455|447756749|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
124492109|NCT00611455|447756747|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
124492110|NCT00611455|447756748|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
124492111|NCT00611455|447756749|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
124492112|NCT00611455|447756747|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
124492113|NCT00611455|447756748|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
124492114|NCT00611455|447756749|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
124492115|NCT00611455|447756747|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
124492116|NCT00611455|447756748|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
124492117|NCT00611455|447756749|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
124492118|NCT00611455|447756747|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
124492119|NCT00611455|447756748|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
124492120|NCT00611455|447756749|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
124492121|NCT00611455|447756747|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
124492122|NCT00611455|447756748|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
124492123|NCT00611455|447756749|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
124492124|NCT00611455|447756747|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
124492125|NCT00611455|447756748|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
124492126|NCT00611455|447756749|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
124492127|NCT00611455|447756747|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
124492128|NCT00611455|447756748|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
124492129|NCT00611455|447756749|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
124492130|NCT00611455|447756747|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
124492131|NCT00611455|447756748|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
124492132|NCT00611455|447756749|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
124492133|NCT00858702|447756752|FG000|Overall Study|Lack of Efficacy|1|||
124492134|NCT00858702|447756753|FG001|Overall Study|Lack of Efficacy|0|||
124492135|NCT00858702|447756752|FG000|Overall Study|Protocol Violation|1|||
124492136|NCT00858702|447756753|FG001|Overall Study|Protocol Violation|1|||
124492137|NCT00858702|447756752|FG000|Overall Study|Other|2|||
124492138|NCT00858702|447756753|FG001|Overall Study|Other|1|||
124492139|NCT00858702|447756752|FG000|Overall Study|Withdrawal by Subject|1|||
124492140|NCT00858702|447756753|FG001|Overall Study|Withdrawal by Subject|0|||
124492141|NCT00491530|447756754|FG000|Overall Study|Adverse Event|6|||
124492142|NCT00491530|447756755|FG001|Overall Study|Adverse Event|1|||
124492143|NCT00491530|447756756|FG002|Overall Study|Adverse Event|2|||
124492144|NCT00491530|447756754|FG000|Overall Study|Withdrawal by Subject|3|||
124492145|NCT00491530|447756755|FG001|Overall Study|Withdrawal by Subject|0|||
124492146|NCT00491530|447756756|FG002|Overall Study|Withdrawal by Subject|0|||
124492147|NCT00491530|447756754|FG000|Overall Study|Lost to Follow-up|3|||
124492148|NCT00491530|447756755|FG001|Overall Study|Lost to Follow-up|2|||
124492149|NCT00491530|447756756|FG002|Overall Study|Lost to Follow-up|2|||
124721838|NCT01905943|448605493|FG000|Overall Study|Death|186|||
124492150|NCT00491530|447756754|FG000|Overall Study|Lack of Efficacy|0|||
124492151|NCT00491530|447756755|FG001|Overall Study|Lack of Efficacy|1|||
124492152|NCT00491530|447756756|FG002|Overall Study|Lack of Efficacy|0|||
124492153|NCT00491530|447756754|FG000|Overall Study|Investigator Discretion|0|||
124492154|NCT00491530|447756755|FG001|Overall Study|Investigator Discretion|1|||
124492155|NCT00491530|447756756|FG002|Overall Study|Investigator Discretion|0|||
124492156|NCT00491530|447756754|FG000|Overall Study|Patient Request|0|||
124492157|NCT00491530|447756755|FG001|Overall Study|Patient Request|1|||
124492158|NCT00491530|447756756|FG002|Overall Study|Patient Request|0|||
124492159|NCT00491530|447756754|FG000|Overall Study|Use of Prohibited Medication|0|||
124492160|NCT00491530|447756755|FG001|Overall Study|Use of Prohibited Medication|0|||
124492161|NCT00491530|447756756|FG002|Overall Study|Use of Prohibited Medication|1|||
124492162|NCT03671369|447756759|FG000|Overall Study|Other|1|||
124492163|NCT03671369|447756759|FG000|Overall Study|Withdrawal by Subject|289|||
124492164|NCT03671369|447756759|FG000|Overall Study|Not willing to be vaccinated|1|||
124492165|NCT02732912|447756760|FG000|Overall Study|Discharged before night|2|||
124492166|NCT02732912|447756761|FG001|Overall Study|Discharged before night|6|||
124492167|NCT02732912|447756760|FG000|Overall Study|Incomplete completion of questionnaire|2|||
124492168|NCT02732912|447756761|FG001|Overall Study|Incomplete completion of questionnaire|3|||
124492169|NCT02732912|447756760|FG000|Overall Study|No outcome; discharged or refused|6|||
124492170|NCT02732912|447756761|FG001|Overall Study|No outcome; discharged or refused|9|||
124492171|NCT04382651|447756762|FG000|Overall Study|Death|26|||
124492172|NCT04382651|447756763|FG001|Overall Study|Death|23|||
124492173|NCT04382651|447756762|FG000|Overall Study|Lost to Follow-up|3|||
124492174|NCT04382651|447756763|FG001|Overall Study|Lost to Follow-up|4|||
124492175|NCT04382651|447756762|FG000|Overall Study|Withdrawal by Subject|2|||
124492176|NCT04382651|447756763|FG001|Overall Study|Withdrawal by Subject|0|||
124492177|NCT04382651|447756762|FG000|Overall Study|Physician Decision|0|||
124492178|NCT04382651|447756763|FG001|Overall Study|Physician Decision|1|||
124492179|NCT01873742|447756764|FG000|Overall Study|Lost to Follow-up|68|||
124492180|NCT01873742|447756765|FG001|Overall Study|Lost to Follow-up|76|||
124492181|NCT00790296|447756767|FG000|Overall Study|Did not meet study eligibility criteria|1|||
124492182|NCT00790296|447756768|FG001|Overall Study|Did not meet study eligibility criteria|1|||
124492183|NCT00790296|447756767|FG000|Overall Study|Adverse Event|0|||
124492184|NCT00790296|447756768|FG001|Overall Study|Adverse Event|1|||
124492185|NCT01671488|447756769|FG000|Overall Study|Withdrawal by Subject|1|||
124492186|NCT02612077|447756770|FG000|Overall Study|Adverse Event|3|||
124492187|NCT02612077|447756770|FG000|Overall Study|Withdrawal by Subject|9|||
124492188|NCT02612077|447756770|FG000|Overall Study|Protocol Violation|28|||
124492189|NCT02612077|447756770|FG000|Overall Study|Lost to Follow-up|20|||
124492190|NCT02612077|447756770|FG000|Overall Study|Death|377|||
124492191|NCT02612077|447756770|FG000|Overall Study|Moved or Changed Medical Team|23|||
124492192|NCT02612077|447756770|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
124492193|NCT02612077|447756770|FG000|Overall Study|Disease Progression|3|||
124492194|NCT02612077|447756770|FG000|Overall Study|Unknown reason|2|||
124492195|NCT01022853|447756771|FG000|Overall Study|Progressive disease|2|||
124492196|NCT01022853|447756772|FG001|Overall Study|Progressive disease|3|||
124492197|NCT01022853|447756773|FG002|Overall Study|Progressive disease|11|||
124492198|NCT01022853|447756774|FG003|Overall Study|Progressive disease|7|||
124492199|NCT01022853|447756775|FG004|Overall Study|Progressive disease|1|||
124492200|NCT01022853|447756771|FG000|Overall Study|Dose-limiting toxicity|0|||
124492201|NCT01022853|447756772|FG001|Overall Study|Dose-limiting toxicity|0|||
124492202|NCT01022853|447756773|FG002|Overall Study|Dose-limiting toxicity|0|||
124492203|NCT01022853|447756774|FG003|Overall Study|Dose-limiting toxicity|0|||
124492204|NCT01022853|447756775|FG004|Overall Study|Dose-limiting toxicity|1|||
124492205|NCT01022853|447756771|FG000|Overall Study|Withdrawal by Subject|0|||
124492206|NCT01022853|447756772|FG001|Overall Study|Withdrawal by Subject|1|||
124492207|NCT01022853|447756773|FG002|Overall Study|Withdrawal by Subject|1|||
124492208|NCT01022853|447756774|FG003|Overall Study|Withdrawal by Subject|1|||
124492209|NCT01022853|447756775|FG004|Overall Study|Withdrawal by Subject|0|||
124492210|NCT01022853|447756771|FG000|Overall Study|Other not stated above|1|||
124492211|NCT01022853|447756772|FG001|Overall Study|Other not stated above|0|||
124492212|NCT01022853|447756773|FG002|Overall Study|Other not stated above|1|||
124492213|NCT01022853|447756774|FG003|Overall Study|Other not stated above|0|||
124492214|NCT01022853|447756775|FG004|Overall Study|Other not stated above|0|||
124492215|NCT01753518|447756776|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
124492216|NCT01753518|447756777|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
124492217|NCT01753518|447756776|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
124492218|NCT01753518|447756777|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
124492219|NCT01753518|447756776|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
124492220|NCT01753518|447756777|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
124492221|NCT01753518|447756776|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
124492222|NCT01753518|447756777|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
124492223|NCT01971476|447756778|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
124492224|NCT01971476|447756779|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
124492225|NCT01971476|447756780|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
124492226|NCT01971476|447756778|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
124492227|NCT01971476|447756779|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
124492228|NCT01971476|447756780|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
124492229|NCT01971476|447756778|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
124492230|NCT01971476|447756779|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
124492231|NCT01971476|447756780|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
124492232|NCT02075255|447756783|FG000|Overall Study|Study specific withdrawal criteria|0|||
124492233|NCT02075255|447756784|FG001|Overall Study|Study specific withdrawal criteria|1|||
124492234|NCT02075255|447756785|FG002|Overall Study|Study specific withdrawal criteria|1|||
124492235|NCT02075255|447756783|FG000|Overall Study|Withdrawal by Subject|4|||
124492236|NCT02075255|447756784|FG001|Overall Study|Withdrawal by Subject|1|||
124492237|NCT02075255|447756785|FG002|Overall Study|Withdrawal by Subject|0|||
124492238|NCT02075255|447756783|FG000|Overall Study|Lost to Follow-up|0|||
124492239|NCT02075255|447756784|FG001|Overall Study|Lost to Follow-up|0|||
124492240|NCT02075255|447756785|FG002|Overall Study|Lost to Follow-up|1|||
124492241|NCT02075255|447756783|FG000|Overall Study|Adverse Event|0|||
124492242|NCT02075255|447756784|FG001|Overall Study|Adverse Event|0|||
124492243|NCT02075255|447756785|FG002|Overall Study|Adverse Event|1|||
124492244|NCT02075255|447756783|FG000|Overall Study|Death|0|||
124492245|NCT02075255|447756784|FG001|Overall Study|Death|2|||
124492246|NCT02075255|447756785|FG002|Overall Study|Death|0|||
124492247|NCT03792750|447756786|FG000|Overall Study|Death|3|||
124492248|NCT00138151|447756787|FG000|Overall Study|Withdrawal by Subject|3|||
124492249|NCT00138151|447756787|FG000|Overall Study|Physician Decision|1|||
124492250|NCT03503773|447756788|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
124492251|NCT03503773|447756789|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
124492252|NCT03503773|447756788|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
124492253|NCT03503773|447756789|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
124492254|NCT03503773|447756788|FG000|Overall Study|Not completing the primary ABPM|3|||
124492255|NCT03503773|447756789|FG001|Overall Study|Not completing the primary ABPM|1|||
124492256|NCT03503773|447756788|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
124492257|NCT03503773|447756789|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
124492258|NCT02675517|447756795|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
124492259|NCT02675517|447756795|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
124492260|NCT00425438|447756796|FG000|Overall Study|Termination by Sponsor|25|||
124492261|NCT00425438|447756797|FG001|Overall Study|Termination by Sponsor|27|||
124492262|NCT02619253|447756798|FG000|Overall Study|Adverse Event|0|||
124492263|NCT02619253|447756799|FG001|Overall Study|Adverse Event|0|||
124492264|NCT02619253|447756800|FG002|Overall Study|Adverse Event|1|||
124492265|NCT02619253|447756801|FG003|Overall Study|Adverse Event|1|||
124492266|NCT02619253|447756802|FG004|Overall Study|Adverse Event|3|||
124492267|NCT02619253|447756798|FG000|Overall Study|Alternative Therapy|0|||
124492268|NCT02619253|447756799|FG001|Overall Study|Alternative Therapy|0|||
124492269|NCT02619253|447756800|FG002|Overall Study|Alternative Therapy|1|||
124492270|NCT02619253|447756801|FG003|Overall Study|Alternative Therapy|0|||
124492271|NCT02619253|447756802|FG004|Overall Study|Alternative Therapy|0|||
124492272|NCT02619253|447756798|FG000|Overall Study|Death|0|||
124492273|NCT02619253|447756799|FG001|Overall Study|Death|0|||
124492274|NCT02619253|447756800|FG002|Overall Study|Death|0|||
124492275|NCT02619253|447756801|FG003|Overall Study|Death|1|||
124492276|NCT02619253|447756802|FG004|Overall Study|Death|0|||
124492277|NCT02619253|447756798|FG000|Overall Study|Disease Progression|4|||
124492278|NCT02619253|447756799|FG001|Overall Study|Disease Progression|2|||
124492279|NCT02619253|447756800|FG002|Overall Study|Disease Progression|8|||
124492280|NCT02619253|447756801|FG003|Overall Study|Disease Progression|9|||
124492281|NCT02619253|447756802|FG004|Overall Study|Disease Progression|10|||
124492282|NCT02619253|447756798|FG000|Overall Study|Needed a disqualifying therapy|0|||
124492283|NCT02619253|447756799|FG001|Overall Study|Needed a disqualifying therapy|0|||
124492284|NCT02619253|447756800|FG002|Overall Study|Needed a disqualifying therapy|1|||
124492285|NCT02619253|447756801|FG003|Overall Study|Needed a disqualifying therapy|0|||
124492286|NCT02619253|447756802|FG004|Overall Study|Needed a disqualifying therapy|0|||
124492287|NCT02619253|447756798|FG000|Overall Study|Transferred to hospice|0|||
124492288|NCT02619253|447756799|FG001|Overall Study|Transferred to hospice|0|||
124492289|NCT02619253|447756800|FG002|Overall Study|Transferred to hospice|1|||
124492290|NCT02619253|447756801|FG003|Overall Study|Transferred to hospice|0|||
124492291|NCT02619253|447756802|FG004|Overall Study|Transferred to hospice|0|||
124492292|NCT02619253|447756798|FG000|Overall Study|Physician Decision|0|||
124492293|NCT02619253|447756799|FG001|Overall Study|Physician Decision|1|||
124492294|NCT02619253|447756800|FG002|Overall Study|Physician Decision|2|||
124492295|NCT02619253|447756801|FG003|Overall Study|Physician Decision|3|||
124492296|NCT02619253|447756802|FG004|Overall Study|Physician Decision|0|||
124492297|NCT02619253|447756798|FG000|Overall Study|Withdrawal by Subject|0|||
124492298|NCT02619253|447756799|FG001|Overall Study|Withdrawal by Subject|1|||
124492299|NCT02619253|447756800|FG002|Overall Study|Withdrawal by Subject|0|||
124492300|NCT02619253|447756801|FG003|Overall Study|Withdrawal by Subject|0|||
124492301|NCT02619253|447756802|FG004|Overall Study|Withdrawal by Subject|2|||
124492302|NCT00301067|447756806|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
124492303|NCT00301067|447756807|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
124492304|NCT00301067|447756808|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
124492305|NCT00301067|447756809|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
124492306|NCT00301067|447756806|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
124492307|NCT00301067|447756807|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
124492308|NCT00301067|447756808|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
124492309|NCT00301067|447756809|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
124492310|NCT00301067|447756806|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
124492311|NCT00301067|447756807|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
124492312|NCT00301067|447756808|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
124492313|NCT00301067|447756809|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
124492314|NCT00301067|447756806|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
124492315|NCT00301067|447756807|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
124492316|NCT00301067|447756808|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
124492317|NCT00301067|447756809|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
124492318|NCT00301067|447756806|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
124492319|NCT00301067|447756807|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
124492320|NCT00301067|447756808|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
124492321|NCT00301067|447756809|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
124492322|NCT00301067|447756806|FG000|Follow up Until Death|Alive at last data cut point|1|||
124492323|NCT00301067|447756807|FG001|Follow up Until Death|Alive at last data cut point|0|||
124492324|NCT00301067|447756808|FG002|Follow up Until Death|Alive at last data cut point|0|||
124492325|NCT00301067|447756809|FG003|Follow up Until Death|Alive at last data cut point|1|||
124492326|NCT01359982|447756810|FG000|Overall Study|Adverse Event|2|||
124492327|NCT01359982|447756811|FG001|Overall Study|Adverse Event|0|||
124492328|NCT01359982|447756812|FG002|Overall Study|Adverse Event|0|||
124492329|NCT01359982|447756813|FG003|Overall Study|Adverse Event|1|||
124492330|NCT01359982|447756814|FG004|Overall Study|Adverse Event|0|||
124492331|NCT01359982|447756815|FG005|Overall Study|Adverse Event|0|||
124492332|NCT01359982|447756810|FG000|Overall Study|Death|1|||
124492333|NCT01359982|447756811|FG001|Overall Study|Death|0|||
124492334|NCT01359982|447756812|FG002|Overall Study|Death|0|||
124492335|NCT01359982|447756813|FG003|Overall Study|Death|0|||
124492336|NCT01359982|447756814|FG004|Overall Study|Death|0|||
124492337|NCT01359982|447756815|FG005|Overall Study|Death|0|||
124492338|NCT01208181|447756816|FG000|Part 1|Withdrawal by Subject|11|||
124492339|NCT01208181|447756817|FG001|Part 1|Withdrawal by Subject|10|||
124492340|NCT01208181|447756818|FG002|Part 1|Withdrawal by Subject|0|||
124492341|NCT01208181|447756819|FG003|Part 1|Withdrawal by Subject|0|||
124492342|NCT01208181|447756820|FG004|Part 1|Withdrawal by Subject|0|||
124492343|NCT01208181|447756816|FG000|Part 1|Technical problem|5|||
124492344|NCT01208181|447756817|FG001|Part 1|Technical problem|0|||
124492345|NCT01208181|447756818|FG002|Part 1|Technical problem|0|||
124492346|NCT01208181|447756819|FG003|Part 1|Technical problem|0|||
124492347|NCT01208181|447756820|FG004|Part 1|Technical problem|0|||
124492348|NCT01208181|447756816|FG000|Part 1|Protocol Violation|10|||
124492349|NCT01208181|447756817|FG001|Part 1|Protocol Violation|5|||
124492350|NCT01208181|447756818|FG002|Part 1|Protocol Violation|0|||
124492351|NCT01208181|447756819|FG003|Part 1|Protocol Violation|0|||
124492352|NCT01208181|447756820|FG004|Part 1|Protocol Violation|0|||
124492353|NCT01208181|447756816|FG000|Part 1|Physician Decision|4|||
124492354|NCT01208181|447756817|FG001|Part 1|Physician Decision|0|||
124492355|NCT01208181|447756818|FG002|Part 1|Physician Decision|0|||
124492356|NCT01208181|447756819|FG003|Part 1|Physician Decision|0|||
124492357|NCT01208181|447756820|FG004|Part 1|Physician Decision|0|||
124492358|NCT01208181|447756816|FG000|Part 1|Non-compliance with study drug|1|||
124492359|NCT01208181|447756817|FG001|Part 1|Non-compliance with study drug|1|||
124492360|NCT01208181|447756818|FG002|Part 1|Non-compliance with study drug|0|||
124492361|NCT01208181|447756819|FG003|Part 1|Non-compliance with study drug|0|||
124492362|NCT01208181|447756820|FG004|Part 1|Non-compliance with study drug|0|||
124492363|NCT01208181|447756816|FG000|Part 1|Lost to Follow-up|5|||
124492364|NCT01208181|447756817|FG001|Part 1|Lost to Follow-up|3|||
124492365|NCT01208181|447756818|FG002|Part 1|Lost to Follow-up|0|||
124492366|NCT01208181|447756819|FG003|Part 1|Lost to Follow-up|0|||
124492367|NCT01208181|447756820|FG004|Part 1|Lost to Follow-up|1|||
124492368|NCT01208181|447756816|FG000|Part 1|Lack of Efficacy|37|||
124492369|NCT01208181|447756817|FG001|Part 1|Lack of Efficacy|12|||
124492370|NCT01208181|447756818|FG002|Part 1|Lack of Efficacy|0|||
124492371|NCT01208181|447756819|FG003|Part 1|Lack of Efficacy|0|||
124492372|NCT01208181|447756820|FG004|Part 1|Lack of Efficacy|17|||
124492373|NCT01208181|447756816|FG000|Part 1|Adverse Event|26|||
124492374|NCT01208181|447756817|FG001|Part 1|Adverse Event|24|||
124557775|NCT02764489|448001325|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
124557776|NCT02764489|448001324|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
124492375|NCT01208181|447756818|FG002|Part 1|Adverse Event|0|||
124492376|NCT01208181|447756819|FG003|Part 1|Adverse Event|0|||
124557777|NCT02764489|448001325|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
124557778|NCT02038634|448001326|FG000|Overall Study|Lost to Follow-up|0|||
124557779|NCT02038634|448001327|FG001|Overall Study|Lost to Follow-up|1|||
124557780|NCT00693784|448001328|FG000|Overall Study|Lost to Follow-up|2|||
124557781|NCT00693784|448001328|FG000|Overall Study|Withdrawal by Subject|2|||
124557782|NCT01664052|448001329|FG000|Phase 1|No device placement|6|||
124557783|NCT01664052|448001330|FG001|Phase 1|No device placement|0|||
124557784|NCT01664052|448001329|FG000|Phase 1|No HSG 1 hr post placement|1|||
124557785|NCT01664052|448001330|FG001|Phase 1|No HSG 1 hr post placement|0|||
124557786|NCT01664052|448001329|FG000|Phase 2|No device placement|0|||
124557787|NCT01664052|448001330|FG001|Phase 2|No device placement|4|||
124557788|NCT00326885|448001333|FG000|Overall Study|Adverse Event|1|||
124557789|NCT00326885|448001333|FG000|Overall Study|Withdrawal by Subject|3|||
124557790|NCT00326885|448001333|FG000|Overall Study|Physician Decision|1|||
124557791|NCT00326885|448001333|FG000|Overall Study|Hospice withdrew consent|2|||
124557792|NCT01706198|448001334|FG000|Overall Study|Adverse Event|12|||
124557793|NCT01706198|448001335|FG001|Overall Study|Adverse Event|15|||
124557794|NCT01706198|448001334|FG000|Overall Study|Protocol Violation|7|||
124557795|NCT01706198|448001335|FG001|Overall Study|Protocol Violation|5|||
124557796|NCT01706198|448001334|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
124557797|NCT01706198|448001335|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
124557798|NCT01706198|448001334|FG000|Overall Study|Lost to Follow-up|97|||
124557799|NCT01706198|448001335|FG001|Overall Study|Lost to Follow-up|93|||
124557800|NCT01706198|448001334|FG000|Overall Study|Physician Decision|23|||
124557801|NCT01706198|448001335|FG001|Overall Study|Physician Decision|37|||
124557802|NCT01706198|448001334|FG000|Overall Study|Withdrawal by Subject|23|||
124557803|NCT01706198|448001335|FG001|Overall Study|Withdrawal by Subject|31|||
124557804|NCT04313283|448001337|FG000|Overall Study|did not complete intervention|4|||
124557805|NCT01473758|448001342|FG000|Cycle 1|Adverse Event|10|||
124557806|NCT01473758|448001343|FG001|Cycle 1|Adverse Event|2|||
124557807|NCT01473758|448001344|FG002|Cycle 1|Adverse Event|0|||
124557808|NCT01473758|448001345|FG003|Cycle 1|Adverse Event|0|||
124557809|NCT01473758|448001342|FG000|Cycle 1|Withdrawal by Subject|1|||
124557810|NCT01473758|448001343|FG001|Cycle 1|Withdrawal by Subject|1|||
124557811|NCT01473758|448001344|FG002|Cycle 1|Withdrawal by Subject|0|||
124557812|NCT01473758|448001345|FG003|Cycle 1|Withdrawal by Subject|0|||
124557813|NCT01473758|448001342|FG000|Cycle 2|Adverse Event|0|||
124557814|NCT01473758|448001343|FG001|Cycle 2|Adverse Event|0|||
124557815|NCT01473758|448001344|FG002|Cycle 2|Adverse Event|5|||
124557816|NCT01473758|448001345|FG003|Cycle 2|Adverse Event|0|||
124557817|NCT01677910|448001346|FG000|Double-Blind Treatment Period|Adverse Event|6|||
124557818|NCT01677910|448001347|FG001|Double-Blind Treatment Period|Adverse Event|2|||
124557819|NCT01677910|448001348|FG002|Double-Blind Treatment Period|Adverse Event|3|||
124557820|NCT01677910|448001349|FG003|Double-Blind Treatment Period|Adverse Event|0|||
124557821|NCT01677910|448001346|FG000|Double-Blind Treatment Period|Physician Decision|0|||
124557822|NCT01677910|448001347|FG001|Double-Blind Treatment Period|Physician Decision|0|||
124557823|NCT01677910|448001348|FG002|Double-Blind Treatment Period|Physician Decision|1|||
124557824|NCT01677910|448001349|FG003|Double-Blind Treatment Period|Physician Decision|0|||
124557825|NCT01677910|448001346|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
124557826|NCT01677910|448001347|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
124721839|NCT01905943|448605493|FG000|Overall Study|Adverse Event|3|||
124721840|NCT01905943|448605493|FG000|Overall Study|Other|12|||
124721841|NCT02574078|448605494|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124492377|NCT01208181|447756820|FG004|Part 1|Adverse Event|4|||
124492378|NCT01208181|447756816|FG000|Part 2|Adverse Event|0|||
124721842|NCT02574078|448605495|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124492379|NCT01208181|447756817|FG001|Part 2|Adverse Event|0|||
124492380|NCT01208181|447756818|FG002|Part 2|Adverse Event|6|||
124492381|NCT01208181|447756819|FG003|Part 2|Adverse Event|7|||
124492382|NCT01208181|447756820|FG004|Part 2|Adverse Event|0|||
124492383|NCT01208181|447756816|FG000|Part 2|Withdrawal by Subject|0|||
124492384|NCT01208181|447756817|FG001|Part 2|Withdrawal by Subject|0|||
124492385|NCT01208181|447756818|FG002|Part 2|Withdrawal by Subject|1|||
124492386|NCT01208181|447756819|FG003|Part 2|Withdrawal by Subject|1|||
124492387|NCT01208181|447756820|FG004|Part 2|Withdrawal by Subject|0|||
124492388|NCT01208181|447756816|FG000|Part 2|Protocol Violation|0|||
124492389|NCT01208181|447756817|FG001|Part 2|Protocol Violation|0|||
124492390|NCT01208181|447756818|FG002|Part 2|Protocol Violation|1|||
124492391|NCT01208181|447756819|FG003|Part 2|Protocol Violation|0|||
124492392|NCT01208181|447756820|FG004|Part 2|Protocol Violation|0|||
124492393|NCT01208181|447756816|FG000|Part 2|Physician Decision|0|||
124492394|NCT01208181|447756817|FG001|Part 2|Physician Decision|0|||
124492395|NCT01208181|447756818|FG002|Part 2|Physician Decision|1|||
124492396|NCT01208181|447756819|FG003|Part 2|Physician Decision|2|||
124492397|NCT01208181|447756820|FG004|Part 2|Physician Decision|0|||
124492398|NCT01208181|447756816|FG000|Part 2|Non-compliance with study drug|0|||
124492399|NCT01208181|447756817|FG001|Part 2|Non-compliance with study drug|0|||
124492400|NCT01208181|447756818|FG002|Part 2|Non-compliance with study drug|1|||
124492401|NCT01208181|447756819|FG003|Part 2|Non-compliance with study drug|1|||
124492402|NCT01208181|447756820|FG004|Part 2|Non-compliance with study drug|0|||
124492403|NCT01208181|447756816|FG000|Part 2|Lost to Follow-up|0|||
124721843|NCT02574078|448605496|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124721844|NCT02574078|448605497|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124721845|NCT02574078|448605498|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124492404|NCT01208181|447756817|FG001|Part 2|Lost to Follow-up|0|||
124492405|NCT01208181|447756818|FG002|Part 2|Lost to Follow-up|1|||
124492406|NCT01208181|447756819|FG003|Part 2|Lost to Follow-up|2|||
124492407|NCT01208181|447756820|FG004|Part 2|Lost to Follow-up|0|||
124492408|NCT01208181|447756816|FG000|Part 2|Lack of Efficacy|0|||
124492409|NCT01208181|447756817|FG001|Part 2|Lack of Efficacy|0|||
124492410|NCT01208181|447756818|FG002|Part 2|Lack of Efficacy|5|||
124492411|NCT01208181|447756819|FG003|Part 2|Lack of Efficacy|7|||
124492412|NCT01208181|447756820|FG004|Part 2|Lack of Efficacy|0|||
124492413|NCT00206518|447756826|FG000|Overall Study|Lack of Efficacy|6|||
124492414|NCT00206518|447756827|FG001|Overall Study|Lack of Efficacy|4|||
124492415|NCT00206518|447756826|FG000|Overall Study|Adverse Event|2|||
124492416|NCT00206518|447756827|FG001|Overall Study|Adverse Event|1|||
124492417|NCT00206518|447756826|FG000|Overall Study|Physician Decision|1|||
124492418|NCT00206518|447756827|FG001|Overall Study|Physician Decision|0|||
124492419|NCT00206518|447756826|FG000|Overall Study|Protocol Violation|1|||
124492420|NCT00206518|447756827|FG001|Overall Study|Protocol Violation|1|||
124492421|NCT04542291|447756828|FG000|Overall Study|Adverse Event|1|||
124492422|NCT04542291|447756828|FG000|Overall Study|Physician Decision|2|||
124492423|NCT00970294|447756835|FG000|Overall Study|Physician Decision|4|||
124492424|NCT00970294|447756835|FG000|Overall Study|Withdrawal by Subject|1|||
124492425|NCT00847561|447756836|FG000|Overall Study|Withdrawal by Subject|4|||
124492426|NCT00847561|447756837|FG001|Overall Study|Withdrawal by Subject|3|||
124492427|NCT00847561|447756836|FG000|Overall Study|Unable to schedule|9|||
124492428|NCT00847561|447756837|FG001|Overall Study|Unable to schedule|1|||
124492429|NCT00408681|447756838|FG000|Overall Study|Lack of Efficacy|2|||
124492430|NCT00408681|447756838|FG000|Overall Study|Adverse Event|7|||
124492431|NCT00447421|447756844|FG000|Overall Study|Lack of Efficacy|1|||
124492432|NCT00447421|447756844|FG000|Overall Study|Adverse Event|3|||
124492433|NCT00447421|447756844|FG000|Overall Study|Sponsor Decision|2|||
124492434|NCT01707147|447756845|FG000|Overall Study|Administered Trajenta prior to contract|5|||
124492435|NCT01707147|447756845|FG000|Overall Study|Patients who have not taken Trajenta|1|||
124492436|NCT01707147|447756845|FG000|Overall Study|Follow-up failure|17|||
124492437|NCT01707147|447756845|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
124492438|NCT02792777|447756846|FG000|Overall Study|Withdrawal by Subject|2|||
124492439|NCT02792777|447756847|FG001|Overall Study|Withdrawal by Subject|0|||
124492440|NCT02792777|447756846|FG000|Overall Study|Recording malfunction|2|||
124492441|NCT02792777|447756847|FG001|Overall Study|Recording malfunction|0|||
124492442|NCT02792777|447756846|FG000|Overall Study|Later determined to be ineligible|2|||
124492443|NCT02792777|447756847|FG001|Overall Study|Later determined to be ineligible|0|||
124492444|NCT02792777|447756846|FG000|Overall Study|Participant interviewed twice|1|||
124492445|NCT02792777|447756847|FG001|Overall Study|Participant interviewed twice|0|||
124492446|NCT02053246|447756848|FG000|Overall Study|Withdrawal by Subject|3|||
124492447|NCT02053246|447756848|FG000|Overall Study|Physician Decision|1|||
124492448|NCT02795156|447756850|FG000|Overall Study|Progressive Disease|22|||
124492449|NCT02795156|447756851|FG001|Overall Study|Progressive Disease|7|||
124492450|NCT02795156|447756852|FG002|Overall Study|Progressive Disease|34|||
124492451|NCT02795156|447756853|FG003|Overall Study|Progressive Disease|7|||
124492452|NCT02795156|447756850|FG000|Overall Study|Adverse Event|13|||
124492453|NCT02795156|447756851|FG001|Overall Study|Adverse Event|2|||
124492454|NCT02795156|447756852|FG002|Overall Study|Adverse Event|3|||
124492455|NCT02795156|447756853|FG003|Overall Study|Adverse Event|2|||
124492456|NCT02795156|447756850|FG000|Overall Study|Death|1|||
124492457|NCT02795156|447756851|FG001|Overall Study|Death|1|||
124492458|NCT02795156|447756852|FG002|Overall Study|Death|1|||
124492459|NCT02795156|447756853|FG003|Overall Study|Death|0|||
124492460|NCT02795156|447756850|FG000|Overall Study|Physician Decision|1|||
124492461|NCT02795156|447756851|FG001|Overall Study|Physician Decision|0|||
124492462|NCT02795156|447756852|FG002|Overall Study|Physician Decision|1|||
124492463|NCT02795156|447756853|FG003|Overall Study|Physician Decision|0|||
124492464|NCT02795156|447756850|FG000|Overall Study|Withdrawal by Subject|2|||
124492465|NCT02795156|447756851|FG001|Overall Study|Withdrawal by Subject|0|||
124492466|NCT02795156|447756852|FG002|Overall Study|Withdrawal by Subject|3|||
124492467|NCT02795156|447756853|FG003|Overall Study|Withdrawal by Subject|0|||
124492468|NCT02707757|447756854|FG000|Overall Study|Protocol Violation|3|||
124492469|NCT02707757|447756855|FG001|Overall Study|Protocol Violation|2|||
124492470|NCT02707757|447756854|FG000|Overall Study|Withdrawal by Subject|2|||
124492471|NCT02707757|447756855|FG001|Overall Study|Withdrawal by Subject|0|||
124492472|NCT02707757|447756854|FG000|Overall Study|Death|0|||
124492473|NCT02707757|447756855|FG001|Overall Study|Death|1|||
124492474|NCT02707757|447756854|FG000|Overall Study|Adverse Event|6|||
124492475|NCT02707757|447756855|FG001|Overall Study|Adverse Event|4|||
124492476|NCT02707757|447756854|FG000|Overall Study|Renal transplant/elective operation|1|||
124492477|NCT02707757|447756855|FG001|Overall Study|Renal transplant/elective operation|5|||
124721846|NCT02574078|448605499|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
124721847|NCT02574078|448605500|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
124721848|NCT02574078|448605501|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124721849|NCT02574078|448605502|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
124721850|NCT02574078|448605503|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124721851|NCT02574078|448605504|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124721852|NCT02574078|448605505|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124721853|NCT02574078|448605506|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124721854|NCT02574078|448605494|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
124721855|NCT02574078|448605495|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
124721856|NCT02574078|448605496|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
124721857|NCT02574078|448605497|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
124721858|NCT02574078|448605498|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
124721859|NCT02574078|448605499|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
124721860|NCT02574078|448605500|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
124721861|NCT02574078|448605501|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
124721862|NCT02574078|448605502|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
124721863|NCT02574078|448605503|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
124721864|NCT02574078|448605504|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
124721865|NCT02574078|448605505|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
124721866|NCT02574078|448605506|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
124721867|NCT02574078|448605494|FG000|Pre-Treatment Period|Other reasons|0|||
124721868|NCT02574078|448605495|FG001|Pre-Treatment Period|Other reasons|0|||
124721869|NCT02574078|448605496|FG002|Pre-Treatment Period|Other reasons|0|||
124721870|NCT02574078|448605497|FG003|Pre-Treatment Period|Other reasons|0|||
124721871|NCT02574078|448605498|FG004|Pre-Treatment Period|Other reasons|0|||
124721872|NCT02574078|448605499|FG005|Pre-Treatment Period|Other reasons|0|||
124721873|NCT02574078|448605500|FG006|Pre-Treatment Period|Other reasons|2|||
124721874|NCT02574078|448605501|FG007|Pre-Treatment Period|Other reasons|0|||
124721875|NCT02574078|448605502|FG008|Pre-Treatment Period|Other reasons|0|||
124721876|NCT02574078|448605503|FG009|Pre-Treatment Period|Other reasons|0|||
124721877|NCT02574078|448605504|FG010|Pre-Treatment Period|Other reasons|2|||
124721878|NCT02574078|448605505|FG011|Pre-Treatment Period|Other reasons|0|||
124721879|NCT02574078|448605506|FG012|Pre-Treatment Period|Other reasons|0|||
124721880|NCT02574078|448605494|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
124721881|NCT02574078|448605495|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
124721882|NCT02574078|448605496|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
124721883|NCT02574078|448605497|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
124721884|NCT02574078|448605498|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
124721885|NCT02574078|448605499|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
124721886|NCT02574078|448605500|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
124721887|NCT02574078|448605501|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
124721888|NCT02574078|448605502|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
124721889|NCT02574078|448605503|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
124721890|NCT02574078|448605504|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
124721891|NCT02574078|448605505|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
124721892|NCT02574078|448605506|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
124721893|NCT02574078|448605494|FG000|Treatment Period|Disease progression|6|||
124721894|NCT02574078|448605495|FG001|Treatment Period|Disease progression|4|||
124721895|NCT02574078|448605496|FG002|Treatment Period|Disease progression|7|||
124721896|NCT02574078|448605497|FG003|Treatment Period|Disease progression|18|||
124721897|NCT02574078|448605498|FG004|Treatment Period|Disease progression|16|||
124721898|NCT02574078|448605499|FG005|Treatment Period|Disease progression|26|||
124721899|NCT02574078|448605500|FG006|Treatment Period|Disease progression|5|||
124721900|NCT02574078|448605501|FG007|Treatment Period|Disease progression|9|||
124492478|NCT00638846|447756859|FG000|Overall Study|Adverse Event|0|||
124721901|NCT02574078|448605502|FG008|Treatment Period|Disease progression|8|||
124772034|NCT02113982|448796377|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
124772035|NCT02113982|448796378|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
124492479|NCT00638846|447756860|FG001|Overall Study|Adverse Event|1|||
124492480|NCT00638846|447756859|FG000|Overall Study|Lost to Follow-up|3|||
124492481|NCT00638846|447756860|FG001|Overall Study|Lost to Follow-up|2|||
124492482|NCT00638846|447756859|FG000|Overall Study|lens issue|1|||
124721902|NCT02574078|448605503|FG009|Treatment Period|Disease progression|5|||
124721903|NCT02574078|448605504|FG010|Treatment Period|Disease progression|20|||
124721904|NCT02574078|448605505|FG011|Treatment Period|Disease progression|29|||
124721905|NCT02574078|448605506|FG012|Treatment Period|Disease progression|2|||
124721906|NCT02574078|448605494|FG000|Treatment Period|Study drug toxicity|1|||
124721907|NCT02574078|448605495|FG001|Treatment Period|Study drug toxicity|1|||
124721908|NCT02574078|448605496|FG002|Treatment Period|Study drug toxicity|0|||
124721909|NCT02574078|448605497|FG003|Treatment Period|Study drug toxicity|5|||
124772036|NCT02113982|448796379|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
124492483|NCT00638846|447756860|FG001|Overall Study|lens issue|3|||
124492484|NCT01171521|447756861|FG000|Overall Study|Lost to Follow-up|5|||
124492485|NCT01171521|447756861|FG000|Overall Study|screen failure|1|||
124492486|NCT01589094|447756862|FG000|Overall Study|Did not receive treatment|2|||
124492487|NCT03575468|447756863|FG000|Overall Study|Withdrawal by Subject|3|||
124492488|NCT03575468|447756864|FG001|Overall Study|Withdrawal by Subject|0|||
124492489|NCT03575468|447756863|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
124492490|NCT03575468|447756864|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
124492491|NCT03575468|447756863|FG000|Overall Study|Lost to Follow-up|13|||
124492492|NCT03575468|447756864|FG001|Overall Study|Lost to Follow-up|17|||
124492493|NCT03123939|447756865|FG000|Overall Study|Lack of Efficacy|6|||
124492494|NCT03123939|447756865|FG000|Overall Study|Death|5|||
124492495|NCT03123939|447756865|FG000|Overall Study|Physician Decision|2|||
124492496|NCT03123939|447756865|FG000|Overall Study|Subject/guardian decision|2|||
124492497|NCT03123939|447756865|FG000|Overall Study|Lost to Follow-up|1|||
124492498|NCT03123939|447756865|FG000|Overall Study|New therapy for study indication|1|||
124492499|NCT03123939|447756865|FG000|Overall Study|Protocol deviation|1|||
124492500|NCT03123939|447756865|FG000|Overall Study|Progressive disease|18|||
124492501|NCT03123939|447756865|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
124492502|NCT03123939|447756865|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
124492503|NCT02112448|447756866|FG000|Overall Study|lab values precluding use of ketorolac|2|||
124492504|NCT02112448|447756867|FG001|Overall Study|lab values precluding use of ketorolac|2|||
124492505|NCT02112448|447756866|FG000|Overall Study|Protocol Violation|1|||
124492506|NCT02112448|447756867|FG001|Overall Study|Protocol Violation|2|||
124492507|NCT02112448|447756866|FG000|Overall Study|Physician Decision|4|||
124492508|NCT02112448|447756867|FG001|Overall Study|Physician Decision|6|||
124492509|NCT02112448|447756866|FG000|Overall Study|required heparin so could not use ketoro|1|||
124492510|NCT02112448|447756867|FG001|Overall Study|required heparin so could not use ketoro|0|||
124492511|NCT01040832|447758212|FG000|Overall Study|Adverse Event|4|||
124492512|NCT01040832|447758213|FG001|Overall Study|Adverse Event|5|||
124492513|NCT01040832|447758212|FG000|Overall Study|Death|4|||
124492514|NCT01040832|447758213|FG001|Overall Study|Death|6|||
124492515|NCT01040832|447758212|FG000|Overall Study|Withdrawal by Subject|2|||
124492516|NCT01040832|447758213|FG001|Overall Study|Withdrawal by Subject|3|||
124492517|NCT01040832|447758212|FG000|Overall Study|Progressive disease|32|||
124492518|NCT01040832|447758213|FG001|Overall Study|Progressive disease|17|||
124492519|NCT01040832|447758212|FG000|Overall Study|Symptomatic deterioration|2|||
124492520|NCT01040832|447758213|FG001|Overall Study|Symptomatic deterioration|5|||
124492521|NCT01040832|447758212|FG000|Overall Study|Other|2|||
124492522|NCT01040832|447758213|FG001|Overall Study|Other|1|||
124492523|NCT01058369|447758214|FG000|Overall Study|Adverse Event|1|||
124492524|NCT01058369|447758214|FG000|Overall Study|Early termination study|1|||
124492525|NCT02940886|447758215|FG000|Overall Study|Adverse Event|7|||
124492526|NCT02940886|447758216|FG001|Overall Study|Adverse Event|3|||
124492527|NCT02940886|447758215|FG000|Overall Study|Protocol Violation|0|||
124492528|NCT02940886|447758216|FG001|Overall Study|Protocol Violation|2|||
124492529|NCT02940886|447758215|FG000|Overall Study|Withdrawal by Subject|28|||
124492530|NCT02940886|447758216|FG001|Overall Study|Withdrawal by Subject|20|||
124492531|NCT02940886|447758215|FG000|Overall Study|Death|1|||
124492532|NCT02940886|447758216|FG001|Overall Study|Death|0|||
124492533|NCT02940886|447758215|FG000|Overall Study|Lack of Efficacy|1|||
124492534|NCT02940886|447758216|FG001|Overall Study|Lack of Efficacy|0|||
124492535|NCT02940886|447758215|FG000|Overall Study|Lost to Follow-up|49|||
124492536|NCT02940886|447758216|FG001|Overall Study|Lost to Follow-up|21|||
124492537|NCT02940886|447758215|FG000|Overall Study|Physician Decision|9|||
124492538|NCT02940886|447758216|FG001|Overall Study|Physician Decision|4|||
124492539|NCT02940886|447758215|FG000|Overall Study|Sponsor decision|0|||
124492540|NCT02940886|447758216|FG001|Overall Study|Sponsor decision|1|||
124492541|NCT02940886|447758215|FG000|Overall Study|No treatment|7|||
124492542|NCT02940886|447758216|FG001|Overall Study|No treatment|2|||
124492543|NCT02940886|447758215|FG000|Overall Study|Enrolment error|0|||
124492544|NCT02940886|447758216|FG001|Overall Study|Enrolment error|1|||
124492545|NCT01306058|447758218|FG000|Overall Study|Death|1|||
124492546|NCT01306058|447758218|FG000|Overall Study|Enrolled but did not get treatment|1|||
124492547|NCT01666444|447758219|FG000|Overall Study|Did not initiate treatment|2|||
124492548|NCT01666444|447758220|FG001|Overall Study|Did not initiate treatment|1|||
124492549|NCT00592358|447758223|FG000|Overall Study|Withdrawal by Subject|2|||
124492550|NCT00592358|447758223|FG000|Overall Study|Adverse Event|1|||
124492551|NCT00592358|447758223|FG000|Overall Study|Lack of Efficacy|2|||
124492552|NCT00592358|447758223|FG000|Overall Study|Inability to swallow pills|1|||
124492553|NCT00084682|447758224|FG000|Overall Study|Withdrawal by Subject|1|||
124492554|NCT03238248|447758232|FG000|Overall Study|Death|5|||
124492555|NCT03238248|447758232|FG000|Overall Study|Withdrawal by Subject|7|||
124492556|NCT03238248|447758232|FG000|Overall Study|Participant proceeding to transplant|10|||
124492557|NCT03238248|447758232|FG000|Overall Study|Lack of Efficacy|4|||
124492558|NCT03238248|447758232|FG000|Overall Study|Physician Decision|3|||
124492559|NCT03238248|447758232|FG000|Overall Study|Transitioning to another study|1|||
124492560|NCT03238248|447758232|FG000|Overall Study|No longer benefiting|1|||
124492561|NCT03238248|447758232|FG000|Overall Study|Other complicating disease|1|||
124492562|NCT03238248|447758232|FG000|Overall Study|Adverse Event|5|||
124492563|NCT03238248|447758232|FG000|Overall Study|Disease progression|26|||
124492564|NCT03238248|447758232|FG000|Overall Study|N/A participant is still on treatment|1|||
124492565|NCT03238248|447758232|FG000|Overall Study|Decline in condition|1|||
124492566|NCT03238248|447758232|FG000|Overall Study|Alternative therapy|2|||
124492567|NCT01013883|447758233|FG000|Overall Study|Lost to Follow-up|2|||
124492568|NCT01013883|447758234|FG001|Overall Study|Lost to Follow-up|2|||
124492569|NCT02241512|447758235|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
124492570|NCT02241512|447758236|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
124492571|NCT00474630|447758237|FG000|Overall Study|Adverse Event|98|||
124492572|NCT00474630|447758238|FG001|Overall Study|Adverse Event|26|||
124492573|NCT00474630|447758237|FG000|Overall Study|Lost to Follow-up|22|||
124492574|NCT00474630|447758238|FG001|Overall Study|Lost to Follow-up|15|||
124492575|NCT00474630|447758237|FG000|Overall Study|Withdrawal by Subject|21|||
124492576|NCT00474630|447758238|FG001|Overall Study|Withdrawal by Subject|15|||
124492577|NCT00474630|447758237|FG000|Overall Study|Protocol Violation|3|||
124492578|NCT00474630|447758238|FG001|Overall Study|Protocol Violation|4|||
124492579|NCT00474630|447758237|FG000|Overall Study|Lack of Efficacy|5|||
124492580|NCT00474630|447758238|FG001|Overall Study|Lack of Efficacy|6|||
124492581|NCT00474630|447758237|FG000|Overall Study|Drug noncompliance, other|11|||
124492582|NCT00474630|447758238|FG001|Overall Study|Drug noncompliance, other|4|||
124492583|NCT00958568|447758240|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
124492584|NCT00958568|447758241|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
124492585|NCT00958568|447758242|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
124492586|NCT00958568|447758243|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
124492587|NCT00958568|447758240|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
124492588|NCT00958568|447758241|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
124492589|NCT00958568|447758242|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
124492590|NCT00958568|447758243|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
124492591|NCT00958568|447758240|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
124492592|NCT00958568|447758241|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
124492593|NCT00958568|447758242|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
124492594|NCT00958568|447758243|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
124492595|NCT00958568|447758240|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
124492596|NCT00958568|447758241|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
124492597|NCT00958568|447758242|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
124492598|NCT00958568|447758243|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
124492599|NCT00958568|447758240|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
124492600|NCT00958568|447758241|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
124492601|NCT00958568|447758242|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
124492602|NCT00958568|447758243|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
124492603|NCT00958568|447758240|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
124492604|NCT00958568|447758241|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
124492605|NCT00958568|447758242|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
124492606|NCT00958568|447758243|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
124492607|NCT00958568|447758240|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
124492608|NCT00958568|447758241|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
124492609|NCT00958568|447758242|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
124492610|NCT00958568|447758243|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
124492611|NCT00958568|447758240|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
124492612|NCT00958568|447758241|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
124492613|NCT00958568|447758242|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
124492614|NCT00958568|447758243|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
124492615|NCT00958568|447758240|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
124492616|NCT00958568|447758241|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
124492617|NCT00958568|447758242|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
124492618|NCT00958568|447758243|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
124492619|NCT00958568|447758240|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
124492620|NCT00958568|447758241|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
124492621|NCT00958568|447758242|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
124492622|NCT00958568|447758243|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
124492623|NCT00958568|447758240|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
124492624|NCT00958568|447758241|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
124492625|NCT00958568|447758242|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
124492626|NCT00958568|447758243|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
124492627|NCT00958568|447758240|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
124772037|NCT02113982|448796380|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
124772038|NCT02113982|448796381|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
124772039|NCT02113982|448796368|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
124492628|NCT00958568|447758241|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
124492629|NCT00958568|447758242|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
124492630|NCT00958568|447758243|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
124492631|NCT00958568|447758240|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
124492632|NCT00958568|447758241|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
124492633|NCT00958568|447758242|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
124492634|NCT00958568|447758243|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
124492635|NCT00958568|447758240|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
124492636|NCT00958568|447758241|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
124492637|NCT00958568|447758242|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
124492638|NCT00958568|447758243|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
124492639|NCT00958568|447758240|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
124492640|NCT00958568|447758241|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
124492641|NCT00958568|447758242|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
124492642|NCT00958568|447758243|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
124492643|NCT00958568|447758240|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
124492644|NCT00958568|447758241|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
124492645|NCT00958568|447758242|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
124492646|NCT00958568|447758243|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
124492647|NCT00958568|447758240|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
124492648|NCT00958568|447758241|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
124492649|NCT00958568|447758242|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
124492650|NCT00958568|447758243|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
124492651|NCT00958568|447758240|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
124492652|NCT00958568|447758241|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
124492653|NCT00958568|447758242|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
124492654|NCT00958568|447758243|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
124492655|NCT00958568|447758240|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
124492656|NCT00958568|447758241|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
124492657|NCT00958568|447758242|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
124492658|NCT00958568|447758243|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
124492659|NCT00958568|447758240|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
124492660|NCT00958568|447758241|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
124492661|NCT00958568|447758242|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
124492662|NCT00958568|447758243|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
124492663|NCT00958568|447758240|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
124492664|NCT00958568|447758241|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
124492665|NCT00958568|447758242|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
124492666|NCT00958568|447758243|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
124492667|NCT00958568|447758240|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
124492668|NCT00958568|447758241|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
124492669|NCT00958568|447758242|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
124492670|NCT00958568|447758243|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
124492671|NCT00958568|447758240|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
124492672|NCT00958568|447758241|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
124492673|NCT00958568|447758242|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
124492674|NCT00958568|447758243|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
124492675|NCT00958568|447758240|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
124492676|NCT00958568|447758241|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
124492677|NCT00958568|447758242|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
124492678|NCT00958568|447758243|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
124492679|NCT00958568|447758240|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
124492680|NCT00958568|447758241|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
124492681|NCT00958568|447758242|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
124492682|NCT00958568|447758243|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
124492683|NCT00958568|447758240|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
124492684|NCT00958568|447758241|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
124492685|NCT00958568|447758242|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
124492686|NCT00958568|447758243|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
124492687|NCT00958568|447758240|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
124721910|NCT02574078|448605498|FG004|Treatment Period|Study drug toxicity|3|||
124721911|NCT02574078|448605499|FG005|Treatment Period|Study drug toxicity|1|||
124721912|NCT02574078|448605500|FG006|Treatment Period|Study drug toxicity|2|||
124721913|NCT02574078|448605501|FG007|Treatment Period|Study drug toxicity|0|||
124721914|NCT02574078|448605502|FG008|Treatment Period|Study drug toxicity|2|||
124492688|NCT00958568|447758241|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
124492689|NCT00958568|447758242|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
124492690|NCT00958568|447758243|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
124492691|NCT00958568|447758240|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
124492692|NCT00958568|447758241|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
124492693|NCT00958568|447758242|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
124492694|NCT00958568|447758243|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
124492695|NCT00958568|447758240|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
124492696|NCT00958568|447758241|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
124492697|NCT00958568|447758242|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
124492698|NCT00958568|447758243|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
124492699|NCT03268746|447758254|FG000|Overall Study|Withdrawal by Subject|1|||
124492700|NCT00850499|447758257|FG000|Overall Study|Adverse Event|3|||
124492701|NCT00850499|447758258|FG001|Overall Study|Adverse Event|1|||
124492702|NCT00850499|447758257|FG000|Overall Study|Lack of Efficacy|0|||
124492703|NCT00850499|447758258|FG001|Overall Study|Lack of Efficacy|1|||
124492704|NCT00909090|447758264|FG000|Overall Study|Lost to Follow-up|17|||
124492705|NCT00909090|447758265|FG001|Overall Study|Lost to Follow-up|17|||
124492706|NCT02345434|447758267|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
124492707|NCT02345434|447758268|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
124492708|NCT01214434|447758273|FG000|Overall Study|Withdrawal by Subject|1|||
124492709|NCT01214434|447758274|FG001|Overall Study|Withdrawal by Subject|0|||
124492710|NCT01214434|447758273|FG000|Overall Study|Lost to Follow-up|2|||
124492711|NCT01214434|447758274|FG001|Overall Study|Lost to Follow-up|2|||
124492712|NCT01214434|447758273|FG000|Overall Study|Site error|1|||
124492713|NCT01214434|447758274|FG001|Overall Study|Site error|0|||
124492714|NCT02902809|447758276|FG000|Overall Study|Discontinuation of asthma program|28|||
124492715|NCT00532259|447758277|FG000|Overall Study|Withdrawal by Subject|2|||
124492716|NCT00532259|447758277|FG000|Overall Study|Adverse Event|1|||
124492717|NCT00532259|447758277|FG000|Overall Study|Death|1|||
124492718|NCT00532259|447758277|FG000|Overall Study|Lack of Efficacy|21|||
124492719|NCT00532259|447758277|FG000|Overall Study|Lost to Follow-up|3|||
124492720|NCT00532259|447758277|FG000|Overall Study|Physician Decision|3|||
124492721|NCT00532259|447758277|FG000|Overall Study|Protocol Violation|1|||
124492722|NCT00793104|447758278|FG000|Overall Study|Lost to Follow-up|1|||
124492723|NCT03494725|447758279|FG000|Overall Study|Withdrawal by Subject|0|||
124492724|NCT03494725|447758280|FG001|Overall Study|Withdrawal by Subject|2|||
124492725|NCT03494725|447758279|FG000|Overall Study|Antibiotic use|1|||
124492726|NCT03494725|447758280|FG001|Overall Study|Antibiotic use|0|||
124492727|NCT04983940|447758281|FG000|Overall Study|Lost to Follow-up|14|||
124492728|NCT04983940|447758281|FG000|Overall Study|Lack of Efficacy|2|||
124492729|NCT00514449|447758282|FG000|Overall Study|Withdrawal by Subject|1|||
124492730|NCT00514449|447758283|FG001|Overall Study|Withdrawal by Subject|2|||
124492731|NCT00514449|447758282|FG000|Overall Study|Protocol Violation|1|||
124492732|NCT00514449|447758283|FG001|Overall Study|Protocol Violation|2|||
124492733|NCT00514449|447758282|FG000|Overall Study|Lost to Follow-up|1|||
124492734|NCT00514449|447758283|FG001|Overall Study|Lost to Follow-up|0|||
124492735|NCT00149825|447758284|FG000|Overall Study|Intolerance to medication side effects|1|||
124492736|NCT00149825|447758285|FG001|Overall Study|Intolerance to medication side effects|2|||
124492737|NCT00149825|447758284|FG000|Overall Study|Time commitments|2|||
124492738|NCT00149825|447758285|FG001|Overall Study|Time commitments|1|||
124492739|NCT00149825|447758284|FG000|Overall Study|Not liking insomnia therapy|1|||
124492740|NCT00149825|447758285|FG001|Overall Study|Not liking insomnia therapy|0|||
124492741|NCT00149825|447758284|FG000|Overall Study|Other|1|||
124492742|NCT00149825|447758285|FG001|Overall Study|Other|0|||
124492743|NCT00942708|447758286|FG000|Overall Study|Withdrawal by Subject|1|||
124721915|NCT02574078|448605503|FG009|Treatment Period|Study drug toxicity|1|||
124492744|NCT02760407|447758287|FG000|Overall Study|Death|2|||
124492745|NCT02760407|447758288|FG001|Overall Study|Death|3|||
124492746|NCT02760407|447758289|FG002|Overall Study|Death|1|||
124492747|NCT02760407|447758290|FG003|Overall Study|Death|1|||
124492748|NCT02760407|447758287|FG000|Overall Study|Lost to Follow-up|1|||
124492749|NCT02760407|447758288|FG001|Overall Study|Lost to Follow-up|7|||
124492750|NCT02760407|447758289|FG002|Overall Study|Lost to Follow-up|4|||
124492751|NCT02760407|447758290|FG003|Overall Study|Lost to Follow-up|6|||
124492752|NCT02760407|447758287|FG000|Overall Study|Withdrawal by Subject|25|||
124492753|NCT02760407|447758288|FG001|Overall Study|Withdrawal by Subject|31|||
124492754|NCT02760407|447758289|FG002|Overall Study|Withdrawal by Subject|37|||
124492755|NCT02760407|447758290|FG003|Overall Study|Withdrawal by Subject|25|||
124492756|NCT02760407|447758287|FG000|Overall Study|Violation of Eligibility criteria|0|||
124721916|NCT02574078|448605504|FG010|Treatment Period|Study drug toxicity|16|||
124772040|NCT02113982|448796369|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
124772041|NCT02113982|448796370|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
124772042|NCT02113982|448796371|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
124772043|NCT02113982|448796372|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
124492757|NCT02760407|447758288|FG001|Overall Study|Violation of Eligibility criteria|0|||
124492758|NCT02760407|447758289|FG002|Overall Study|Violation of Eligibility criteria|1|||
124772044|NCT02113982|448796373|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
124492759|NCT02760407|447758290|FG003|Overall Study|Violation of Eligibility criteria|1|||
124492760|NCT02760407|447758287|FG000|Overall Study|Personal reasons|0|||
124492761|NCT02760407|447758288|FG001|Overall Study|Personal reasons|0|||
124492762|NCT02760407|447758289|FG002|Overall Study|Personal reasons|0|||
124492763|NCT02760407|447758290|FG003|Overall Study|Personal reasons|1|||
124492764|NCT02760407|447758287|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
124492765|NCT02760407|447758288|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
124492766|NCT02760407|447758289|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
124492767|NCT02760407|447758290|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
124492768|NCT02760407|447758287|FG000|Overall Study|Use of prohibited Medication|0|||
124492769|NCT02760407|447758288|FG001|Overall Study|Use of prohibited Medication|0|||
124492770|NCT02760407|447758289|FG002|Overall Study|Use of prohibited Medication|1|||
124492771|NCT02760407|447758290|FG003|Overall Study|Use of prohibited Medication|0|||
124492772|NCT02760407|447758287|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
124492773|NCT02760407|447758288|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
124492774|NCT02760407|447758289|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
124492775|NCT02760407|447758290|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
124492776|NCT02760407|447758287|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
124492777|NCT02760407|447758288|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
124492778|NCT02760407|447758289|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
124492779|NCT02760407|447758290|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
124492780|NCT02760407|447758287|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
124492781|NCT02760407|447758288|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
124492782|NCT02760407|447758289|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
124492783|NCT02760407|447758290|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
124492784|NCT02760407|447758287|FG000|Overall Study|Inadequately Enrolled|0|||
124492785|NCT02760407|447758288|FG001|Overall Study|Inadequately Enrolled|0|||
124492786|NCT02760407|447758289|FG002|Overall Study|Inadequately Enrolled|0|||
124492787|NCT02760407|447758290|FG003|Overall Study|Inadequately Enrolled|1|||
124492788|NCT02760407|447758287|FG000|Overall Study|Withdrawal By PI's Decision|0|||
124492789|NCT02760407|447758288|FG001|Overall Study|Withdrawal By PI's Decision|1|||
124492790|NCT02760407|447758289|FG002|Overall Study|Withdrawal By PI's Decision|0|||
124492791|NCT02760407|447758290|FG003|Overall Study|Withdrawal By PI's Decision|0|||
124492792|NCT02760407|447758287|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
124492793|NCT02760407|447758288|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
124492794|NCT02760407|447758289|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
124492795|NCT02760407|447758290|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
124492796|NCT02760407|447758287|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
124492797|NCT02760407|447758288|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
124492798|NCT02760407|447758289|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
124492799|NCT02760407|447758290|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
124492800|NCT02760407|447758287|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
124492801|NCT02760407|447758288|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
124492802|NCT02760407|447758289|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
124492803|NCT02760407|447758290|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
124492804|NCT02760407|447758287|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
124492805|NCT02760407|447758288|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
124492806|NCT02760407|447758289|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
124492807|NCT02760407|447758290|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
124492808|NCT02760407|447758287|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
124492809|NCT02760407|447758288|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
124772045|NCT02113982|448796374|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
124772046|NCT02113982|448796375|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
124492810|NCT02760407|447758289|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
124492811|NCT02760407|447758290|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
124492812|NCT02760407|447758287|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
124492813|NCT02760407|447758288|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
124492814|NCT02760407|447758289|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
124492815|NCT02760407|447758290|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
124492816|NCT02760407|447758287|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
124721917|NCT02574078|448605505|FG011|Treatment Period|Study drug toxicity|2|||
124721918|NCT02574078|448605506|FG012|Treatment Period|Study drug toxicity|4|||
124721919|NCT02574078|448605494|FG000|Treatment Period|Death|2|||
124492817|NCT02760407|447758288|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
124492818|NCT02760407|447758289|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
124492819|NCT02760407|447758290|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
124492820|NCT02760407|447758287|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
124492821|NCT02760407|447758288|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
124492822|NCT02760407|447758289|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
124492823|NCT02760407|447758290|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
124492824|NCT02760407|447758287|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
124492825|NCT02760407|447758288|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
124492826|NCT02760407|447758289|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
124492827|NCT02760407|447758290|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
124492828|NCT01645930|447758291|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
124492829|NCT01645930|447758291|FG000|Overall Study|Progressive Disease|12|||
124492830|NCT01645930|447758291|FG000|Overall Study|Adverse Event|4|||
124492831|NCT01645930|447758291|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
124492832|NCT01645930|447758291|FG000|Overall Study|Withdrawal by Participant|2|||
124492833|NCT01645930|447758291|FG000|Overall Study|Reason not Defined|1|||
124492834|NCT03245814|447758292|FG000|Overall Study|Lost to Follow-up|5|||
124492835|NCT03245814|447758293|FG001|Overall Study|Lost to Follow-up|8|||
124492836|NCT03245814|447758292|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
124492837|NCT03245814|447758293|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
124492838|NCT01158950|447758294|FG000|1st Intervention (1 Day)|Physician Decision|1|||
124492839|NCT01158950|447758295|FG001|1st Intervention (1 Day)|Physician Decision|2|||
124492840|NCT00510692|447758297|FG000|Overall Study|Adverse Event|1|||
124492841|NCT00510692|447758298|FG001|Overall Study|Adverse Event|3|||
124492842|NCT00510692|447758297|FG000|Overall Study|Withdrawal by Subject|1|||
124492843|NCT00510692|447758298|FG001|Overall Study|Withdrawal by Subject|0|||
124492844|NCT01001494|447758304|FG000|Overall Study|Adverse Event|8|||
124492845|NCT01001494|447758305|FG001|Overall Study|Adverse Event|4|||
124492846|NCT01001494|447758306|FG002|Overall Study|Adverse Event|6|||
124492847|NCT01001494|447758304|FG000|Overall Study|Protocol Violation|0|||
124492848|NCT01001494|447758305|FG001|Overall Study|Protocol Violation|1|||
124492849|NCT01001494|447758306|FG002|Overall Study|Protocol Violation|1|||
124492850|NCT01001494|447758304|FG000|Overall Study|Lost to Follow-up|2|||
124492851|NCT01001494|447758305|FG001|Overall Study|Lost to Follow-up|0|||
124492852|NCT01001494|447758306|FG002|Overall Study|Lost to Follow-up|1|||
124492853|NCT01001494|447758304|FG000|Overall Study|Withdrawal by Subject|9|||
124492854|NCT01001494|447758305|FG001|Overall Study|Withdrawal by Subject|7|||
124492855|NCT01001494|447758306|FG002|Overall Study|Withdrawal by Subject|17|||
124492856|NCT01001494|447758304|FG000|Overall Study|COPD exacerbation|3|||
124492857|NCT01001494|447758305|FG001|Overall Study|COPD exacerbation|4|||
124492858|NCT01001494|447758306|FG002|Overall Study|COPD exacerbation|5|||
124492859|NCT01001494|447758304|FG000|Overall Study|Lack of Efficacy|2|||
124492860|NCT01001494|447758305|FG001|Overall Study|Lack of Efficacy|0|||
124492861|NCT01001494|447758306|FG002|Overall Study|Lack of Efficacy|8|||
124492862|NCT01001494|447758304|FG000|Overall Study|Other|0|||
124492863|NCT01001494|447758305|FG001|Overall Study|Other|1|||
124492864|NCT01001494|447758306|FG002|Overall Study|Other|3|||
124492865|NCT02519231|447758310|FG000|Overall Study|Lost to Follow-up|2|||
124492866|NCT02519231|447758311|FG001|Overall Study|Lost to Follow-up|5|||
124492867|NCT02519231|447758310|FG000|Overall Study|Withdrawal by Subject|0|||
124721920|NCT02574078|448605495|FG001|Treatment Period|Death|0|||
124721921|NCT02574078|448605496|FG002|Treatment Period|Death|0|||
124721922|NCT02574078|448605497|FG003|Treatment Period|Death|0|||
124492868|NCT02519231|447758311|FG001|Overall Study|Withdrawal by Subject|1|||
124492869|NCT01797432|447758315|FG000|Overall Study|Lost to Follow-up|1|||
124492870|NCT01797432|447758315|FG000|Overall Study|Adverse Event|1|||
124492871|NCT01797432|447758315|FG000|Overall Study|Withdrawal by Subject|1|||
124492872|NCT01797432|447758315|FG000|Overall Study|lived too far from study site|1|||
124492873|NCT00815308|447758316|FG000|Overall Study|Adverse Event|4|||
124492874|NCT00815308|447758316|FG000|Overall Study|Withdrawal by Subject|0|||
124492875|NCT00815308|447758316|FG000|Overall Study|Protocol Violation|6|||
124721923|NCT02574078|448605498|FG004|Treatment Period|Death|1|||
124721924|NCT02574078|448605499|FG005|Treatment Period|Death|1|||
124721925|NCT02574078|448605500|FG006|Treatment Period|Death|1|||
124721926|NCT02574078|448605501|FG007|Treatment Period|Death|1|||
124721927|NCT02574078|448605502|FG008|Treatment Period|Death|7|||
124721928|NCT02574078|448605503|FG009|Treatment Period|Death|1|||
124721929|NCT02574078|448605504|FG010|Treatment Period|Death|0|||
124721930|NCT02574078|448605505|FG011|Treatment Period|Death|2|||
124721931|NCT02574078|448605506|FG012|Treatment Period|Death|1|||
124721932|NCT02574078|448605494|FG000|Treatment Period|Adverse event unrelated to drug|0|||
124721933|NCT02574078|448605495|FG001|Treatment Period|Adverse event unrelated to drug|0|||
124721934|NCT02574078|448605496|FG002|Treatment Period|Adverse event unrelated to drug|1|||
124772047|NCT02113982|448796376|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
124772048|NCT02113982|448796377|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
124772049|NCT02113982|448796378|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
124772050|NCT02113982|448796379|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
124772051|NCT02113982|448796380|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
124772052|NCT02113982|448796381|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
124772053|NCT02113982|448796368|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
124772054|NCT02113982|448796369|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
124772055|NCT02113982|448796370|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
124772056|NCT02113982|448796371|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
124772057|NCT02113982|448796372|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
124772058|NCT02113982|448796373|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
124772059|NCT02113982|448796374|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
124772060|NCT02113982|448796375|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
124772061|NCT02113982|448796376|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
124772062|NCT02113982|448796377|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
124772063|NCT02113982|448796378|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
124772064|NCT02113982|448796379|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
124772065|NCT02113982|448796380|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
124772066|NCT02113982|448796381|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
124772067|NCT02113982|448796368|FG000|Stage 1: Dose Escalation|Transplant|0|||
124772068|NCT02113982|448796369|FG001|Stage 1: Dose Escalation|Transplant|1|||
124772069|NCT02113982|448796370|FG002|Stage 1: Dose Escalation|Transplant|0|||
124772070|NCT02113982|448796371|FG003|Stage 1: Dose Escalation|Transplant|0|||
124492876|NCT00542815|447758324|FG000|Overall Study|Adverse Event|19|||
124492877|NCT00542815|447758325|FG001|Overall Study|Adverse Event|6|||
124492878|NCT00542815|447758326|FG002|Overall Study|Adverse Event|9|||
124492879|NCT00542815|447758324|FG000|Overall Study|Death|10|||
124492880|NCT00542815|447758325|FG001|Overall Study|Death|7|||
124492881|NCT00542815|447758326|FG002|Overall Study|Death|3|||
124492882|NCT00542815|447758324|FG000|Overall Study|Lack of Efficacy|9|||
124721935|NCT02574078|448605497|FG003|Treatment Period|Adverse event unrelated to drug|0|||
124492883|NCT00542815|447758325|FG001|Overall Study|Lack of Efficacy|2|||
124492884|NCT00542815|447758326|FG002|Overall Study|Lack of Efficacy|0|||
124492885|NCT00542815|447758324|FG000|Overall Study|Physician Decision|2|||
124492886|NCT00542815|447758325|FG001|Overall Study|Physician Decision|1|||
124492887|NCT00542815|447758326|FG002|Overall Study|Physician Decision|0|||
124492888|NCT00542815|447758324|FG000|Overall Study|Protocol Violation|1|||
124492889|NCT00542815|447758325|FG001|Overall Study|Protocol Violation|1|||
124492890|NCT00542815|447758326|FG002|Overall Study|Protocol Violation|2|||
124492891|NCT00542815|447758324|FG000|Overall Study|Withdrawal by Subject|41|||
124492892|NCT00542815|447758325|FG001|Overall Study|Withdrawal by Subject|5|||
124492893|NCT00542815|447758326|FG002|Overall Study|Withdrawal by Subject|8|||
124492894|NCT00542815|447758324|FG000|Overall Study|Other reasons|24|||
124492895|NCT00542815|447758325|FG001|Overall Study|Other reasons|10|||
124492896|NCT00542815|447758326|FG002|Overall Study|Other reasons|10|||
124492897|NCT00734929|447758327|FG000|Overall Study|Lost to Follow-up|1|||
124721936|NCT02574078|448605498|FG004|Treatment Period|Adverse event unrelated to drug|2|||
124721937|NCT02574078|448605499|FG005|Treatment Period|Adverse event unrelated to drug|3|||
124772071|NCT02113982|448796372|FG004|Stage 1: Dose Escalation|Transplant|0|||
124772072|NCT02113982|448796373|FG005|Stage 1: Dose Escalation|Transplant|1|||
124772073|NCT02113982|448796374|FG006|Stage 1: Dose Escalation|Transplant|0|||
124772074|NCT02113982|448796375|FG007|Stage 1: Dose Escalation|Transplant|0|||
124772075|NCT02113982|448796376|FG008|Stage 1: Dose Escalation|Transplant|0|||
124772076|NCT02113982|448796377|FG009|Stage 1: Dose Escalation|Transplant|0|||
124772077|NCT02113982|448796378|FG010|Stage 1: Dose Escalation|Transplant|0|||
124492898|NCT00734929|447758328|FG001|Overall Study|Lost to Follow-up|2|||
124492899|NCT00734929|447758327|FG000|Overall Study|No intervention/ screen fail|5|||
124492900|NCT00734929|447758328|FG001|Overall Study|No intervention/ screen fail|3|||
124772078|NCT02113982|448796379|FG011|Stage 1: Dose Escalation|Transplant|0|||
124492901|NCT01422304|447758329|FG000|Overall Study|Adverse Event|0|||
124492902|NCT01422304|447758330|FG001|Overall Study|Adverse Event|1|||
124492903|NCT01422304|447758329|FG000|Overall Study|Lost to Follow-up|14|||
124492904|NCT01422304|447758330|FG001|Overall Study|Lost to Follow-up|20|||
124492905|NCT01422304|447758329|FG000|Overall Study|Never Entered Follow-up|2|||
124492906|NCT01422304|447758330|FG001|Overall Study|Never Entered Follow-up|1|||
124492907|NCT01422304|447758329|FG000|Overall Study|Protocol Violation|1|||
124492908|NCT01422304|447758330|FG001|Overall Study|Protocol Violation|0|||
124492909|NCT01422304|447758329|FG000|Overall Study|Withdrawal by Subject|4|||
124492910|NCT01422304|447758330|FG001|Overall Study|Withdrawal by Subject|2|||
124492911|NCT01422304|447758329|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
124492912|NCT01422304|447758330|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
124492913|NCT01422304|447758329|FG000|Overall Study|Not Treated|3|||
124492914|NCT01422304|447758330|FG001|Overall Study|Not Treated|11|||
124492915|NCT00866294|447758331|FG000|Overall Study|Adverse Event|12|||
124492916|NCT00866294|447758332|FG001|Overall Study|Adverse Event|13|||
124492917|NCT00866294|447758333|FG002|Overall Study|Adverse Event|9|||
124492918|NCT00866294|447758331|FG000|Overall Study|Lack of Efficacy|7|||
124492919|NCT00866294|447758332|FG001|Overall Study|Lack of Efficacy|1|||
124492920|NCT00866294|447758333|FG002|Overall Study|Lack of Efficacy|0|||
124492921|NCT00866294|447758331|FG000|Overall Study|Protocol Violation|2|||
124492922|NCT00866294|447758332|FG001|Overall Study|Protocol Violation|0|||
124492923|NCT00866294|447758333|FG002|Overall Study|Protocol Violation|0|||
124492924|NCT00866294|447758331|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
124492925|NCT00866294|447758332|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
124492926|NCT00866294|447758333|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
124721938|NCT02574078|448605500|FG006|Treatment Period|Adverse event unrelated to drug|0|||
124721939|NCT02574078|448605501|FG007|Treatment Period|Adverse event unrelated to drug|0|||
124721940|NCT02574078|448605502|FG008|Treatment Period|Adverse event unrelated to drug|1|||
124721941|NCT02574078|448605503|FG009|Treatment Period|Adverse event unrelated to drug|2|||
124721942|NCT02574078|448605504|FG010|Treatment Period|Adverse event unrelated to drug|4|||
124721943|NCT02574078|448605505|FG011|Treatment Period|Adverse event unrelated to drug|1|||
124721944|NCT02574078|448605506|FG012|Treatment Period|Adverse event unrelated to drug|0|||
124721945|NCT02574078|448605494|FG000|Treatment Period|Administrative reason by Sponsor|0|||
124721946|NCT02574078|448605495|FG001|Treatment Period|Administrative reason by Sponsor|1|||
124721947|NCT02574078|448605496|FG002|Treatment Period|Administrative reason by Sponsor|0|||
124721948|NCT02574078|448605497|FG003|Treatment Period|Administrative reason by Sponsor|0|||
124721949|NCT02574078|448605498|FG004|Treatment Period|Administrative reason by Sponsor|0|||
124721950|NCT02574078|448605499|FG005|Treatment Period|Administrative reason by Sponsor|0|||
124721951|NCT02574078|448605500|FG006|Treatment Period|Administrative reason by Sponsor|1|||
124721952|NCT02574078|448605501|FG007|Treatment Period|Administrative reason by Sponsor|0|||
124721953|NCT02574078|448605502|FG008|Treatment Period|Administrative reason by Sponsor|0|||
124721954|NCT02574078|448605503|FG009|Treatment Period|Administrative reason by Sponsor|0|||
124721955|NCT02574078|448605504|FG010|Treatment Period|Administrative reason by Sponsor|0|||
124721956|NCT02574078|448605505|FG011|Treatment Period|Administrative reason by Sponsor|0|||
124721957|NCT02574078|448605506|FG012|Treatment Period|Administrative reason by Sponsor|3|||
124721958|NCT02574078|448605494|FG000|Treatment Period|Other reasons|1|||
124721959|NCT02574078|448605495|FG001|Treatment Period|Other reasons|0|||
124721960|NCT02574078|448605496|FG002|Treatment Period|Other reasons|1|||
124721961|NCT02574078|448605497|FG003|Treatment Period|Other reasons|3|||
124721962|NCT02574078|448605498|FG004|Treatment Period|Other reasons|3|||
124721963|NCT02574078|448605499|FG005|Treatment Period|Other reasons|1|||
124721964|NCT02574078|448605500|FG006|Treatment Period|Other reasons|2|||
124721965|NCT02574078|448605501|FG007|Treatment Period|Other reasons|1|||
124721966|NCT02574078|448605502|FG008|Treatment Period|Other reasons|3|||
124721967|NCT02574078|448605503|FG009|Treatment Period|Other reasons|1|||
124721968|NCT02574078|448605504|FG010|Treatment Period|Other reasons|1|||
124721969|NCT02574078|448605505|FG011|Treatment Period|Other reasons|3|||
124721970|NCT02574078|448605506|FG012|Treatment Period|Other reasons|1|||
124721971|NCT02574078|448605494|FG000|Treatment Period|Participant request to stop drug|0|||
124721972|NCT02574078|448605495|FG001|Treatment Period|Participant request to stop drug|0|||
124721973|NCT02574078|448605496|FG002|Treatment Period|Participant request to stop drug|0|||
124721974|NCT02574078|448605497|FG003|Treatment Period|Participant request to stop drug|2|||
124721975|NCT02574078|448605498|FG004|Treatment Period|Participant request to stop drug|4|||
124721976|NCT02574078|448605499|FG005|Treatment Period|Participant request to stop drug|0|||
124721977|NCT02574078|448605500|FG006|Treatment Period|Participant request to stop drug|1|||
124492927|NCT00866294|447758331|FG000|Overall Study|Lost to Follow-up|1|||
124492928|NCT00866294|447758332|FG001|Overall Study|Lost to Follow-up|3|||
124492929|NCT00866294|447758333|FG002|Overall Study|Lost to Follow-up|0|||
124721978|NCT02574078|448605501|FG007|Treatment Period|Participant request to stop drug|0|||
124721979|NCT02574078|448605502|FG008|Treatment Period|Participant request to stop drug|3|||
124721980|NCT02574078|448605503|FG009|Treatment Period|Participant request to stop drug|2|||
124721981|NCT02574078|448605504|FG010|Treatment Period|Participant request to stop drug|2|||
124721982|NCT02574078|448605505|FG011|Treatment Period|Participant request to stop drug|4|||
124721983|NCT02574078|448605506|FG012|Treatment Period|Participant request to stop drug|1|||
124721984|NCT02574078|448605494|FG000|Treatment Period|Participant withdrew consent|0|||
124492930|NCT00866294|447758331|FG000|Overall Study|Physician Decision|6|||
124492931|NCT00866294|447758332|FG001|Overall Study|Physician Decision|2|||
124492932|NCT00866294|447758333|FG002|Overall Study|Physician Decision|1|||
124492933|NCT04799782|447758334|FG000|Washout|Physician Decision|2|||
124492934|NCT04799782|447758335|FG001|Washout|Physician Decision|0|||
124492935|NCT04799782|447758334|FG000|Washout|Withdrawal by Subject|0|||
124492936|NCT04799782|447758335|FG001|Washout|Withdrawal by Subject|2|||
124492937|NCT04799782|447758334|FG000|Washout|Lost to Follow-up|0|||
124492938|NCT04799782|447758335|FG001|Washout|Lost to Follow-up|1|||
124492939|NCT00515463|447758336|FG000|Overall Study|Physician Decision|4|||
124492940|NCT00515463|447758337|FG001|Overall Study|Physician Decision|2|||
124492941|NCT00515463|447758336|FG000|Overall Study|Adverse Event|1|||
124492942|NCT00515463|447758337|FG001|Overall Study|Adverse Event|2|||
124492943|NCT00515463|447758336|FG000|Overall Study|Withdrawal by Subject|3|||
124492944|NCT00515463|447758337|FG001|Overall Study|Withdrawal by Subject|4|||
124492945|NCT00515463|447758336|FG000|Overall Study|Lost to Follow-up|6|||
124492946|NCT00515463|447758337|FG001|Overall Study|Lost to Follow-up|5|||
124492947|NCT00515463|447758336|FG000|Overall Study|Other|0|||
124492948|NCT00515463|447758337|FG001|Overall Study|Other|1|||
124492949|NCT01558089|447758338|FG000|Overall Study|Adverse Event|1|||
124492950|NCT01558089|447758338|FG000|Overall Study|Lack of Efficacy|1|||
124492951|NCT01558089|447758338|FG000|Overall Study|Lost to Follow-up|5|||
124492952|NCT01558089|447758338|FG000|Overall Study|Withdrawal by Subject|6|||
124492953|NCT02190435|447758339|FG000|Overall Study|First 12 patients were lead-ins|12|||
124492954|NCT02190435|447758340|FG001|Overall Study|First 12 patients were lead-ins|0|||
124492955|NCT02190435|447758339|FG000|Overall Study|3 consented screen fails|3|||
124492956|NCT02190435|447758340|FG001|Overall Study|3 consented screen fails|0|||
124492957|NCT02269319|447758341|FG000|Overall Study|Lost to Follow-up|4|||
124492958|NCT02269319|447758342|FG001|Overall Study|Lost to Follow-up|3|||
124492959|NCT02269319|447758341|FG000|Overall Study|Adverse Event|0|||
124492960|NCT02269319|447758342|FG001|Overall Study|Adverse Event|1|||
124492961|NCT02269319|447758341|FG000|Overall Study|Instructions not followed|1|||
124492962|NCT02269319|447758342|FG001|Overall Study|Instructions not followed|0|||
124492963|NCT05270694|447759546|FG000|Overall Study|Death|1|||
124492964|NCT05270694|447759546|FG000|Overall Study|Medical issues impacted ability to participate|2|||
124492965|NCT05270694|447759546|FG000|Overall Study|Lost to Follow-up|3|||
124492966|NCT05270694|447759546|FG000|Overall Study|Withdrawal by Subject|3|||
124492967|NCT01991977|447759549|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
124492968|NCT01991977|447759549|FG000|Overall Study|Withdrew after start of treatment|5|||
124492969|NCT02531035|447759556|FG000|Overall Study|Death|0|||
124492970|NCT02531035|447759557|FG001|Overall Study|Death|1|||
124492971|NCT02531035|447759556|FG000|Overall Study|Protocol Violation|1|||
124492972|NCT02531035|447759557|FG001|Overall Study|Protocol Violation|1|||
124492973|NCT02531035|447759556|FG000|Overall Study|Noncompliance with study drug|8|||
124492974|NCT02531035|447759557|FG001|Overall Study|Noncompliance with study drug|3|||
124492975|NCT02531035|447759556|FG000|Overall Study|Physician Decision|1|||
124492976|NCT02531035|447759557|FG001|Overall Study|Physician Decision|0|||
124492977|NCT02531035|447759556|FG000|Overall Study|Adverse Event|16|||
124492978|NCT02531035|447759557|FG001|Overall Study|Adverse Event|45|||
124492979|NCT02531035|447759556|FG000|Overall Study|Other|3|||
124492980|NCT02531035|447759557|FG001|Overall Study|Other|2|||
124492981|NCT02531035|447759556|FG000|Overall Study|Withdrawal by Subject|42|||
124492982|NCT02531035|447759557|FG001|Overall Study|Withdrawal by Subject|32|||
124492983|NCT02531035|447759556|FG000|Overall Study|Lost to Follow-up|8|||
124492984|NCT02531035|447759557|FG001|Overall Study|Lost to Follow-up|10|||
124492985|NCT02531035|447759556|FG000|Overall Study|Randomized, not treated|2|||
124492986|NCT02531035|447759557|FG001|Overall Study|Randomized, not treated|1|||
124492987|NCT03032068|447759567|FG000|Overall Study|Adverse Event|1|||
124492988|NCT01597622|447759568|FG000|Overall Study|Adverse Event|7|||
124492989|NCT01597622|447759568|FG000|Overall Study|Lack of Efficacy|3|||
124492990|NCT01597622|447759568|FG000|Overall Study|Protocol Violation|1|||
124492991|NCT01597622|447759568|FG000|Overall Study|Lost to Follow-up|1|||
124492992|NCT01597622|447759568|FG000|Overall Study|Investigator Discretion|5|||
124492993|NCT01597622|447759568|FG000|Overall Study|Withdrawal by Subject|20|||
124492994|NCT01597622|447759568|FG000|Overall Study|Death|1|||
124492995|NCT03042611|447759575|FG000|Core Phase|Withdrawal by Subject|13|||
124492996|NCT03042611|447759576|FG001|Core Phase|Withdrawal by Subject|4|||
124492997|NCT03042611|447759577|FG002|Core Phase|Withdrawal by Subject|0|||
124492998|NCT03042611|447759578|FG003|Core Phase|Withdrawal by Subject|0|||
124492999|NCT03042611|447759575|FG000|Core Phase|Death|232|||
124493000|NCT03042611|447759576|FG001|Core Phase|Death|110|||
124493001|NCT03042611|447759577|FG002|Core Phase|Death|0|||
124493002|NCT03042611|447759578|FG003|Core Phase|Death|0|||
124493003|NCT03042611|447759575|FG000|Core Phase|Lost to Follow-up|4|||
124493004|NCT03042611|447759576|FG001|Core Phase|Lost to Follow-up|7|||
124493005|NCT03042611|447759577|FG002|Core Phase|Lost to Follow-up|0|||
124493006|NCT03042611|447759578|FG003|Core Phase|Lost to Follow-up|0|||
124493007|NCT03042611|447759575|FG000|Core Phase|Physician Decision|7|||
124493008|NCT03042611|447759576|FG001|Core Phase|Physician Decision|2|||
124493009|NCT03042611|447759577|FG002|Core Phase|Physician Decision|0|||
124493010|NCT03042611|447759578|FG003|Core Phase|Physician Decision|0|||
124493011|NCT03042611|447759575|FG000|Core Phase|Study Closed|0|||
124493012|NCT03042611|447759576|FG001|Core Phase|Study Closed|1|||
124493013|NCT03042611|447759577|FG002|Core Phase|Study Closed|0|||
124493014|NCT03042611|447759578|FG003|Core Phase|Study Closed|0|||
124493015|NCT03042611|447759575|FG000|Extension Phase|Death|0|||
124493016|NCT03042611|447759576|FG001|Extension Phase|Death|0|||
124493017|NCT03042611|447759577|FG002|Extension Phase|Death|34|||
124493018|NCT03042611|447759578|FG003|Extension Phase|Death|16|||
124493019|NCT03042611|447759575|FG000|Extension Phase|Lost to Follow-up|0|||
124493020|NCT03042611|447759576|FG001|Extension Phase|Lost to Follow-up|0|||
124493021|NCT03042611|447759577|FG002|Extension Phase|Lost to Follow-up|1|||
124493022|NCT03042611|447759578|FG003|Extension Phase|Lost to Follow-up|1|||
124493023|NCT03042611|447759575|FG000|Extension Phase|Study Closed|0|||
124493024|NCT03042611|447759576|FG001|Extension Phase|Study Closed|0|||
124493025|NCT03042611|447759577|FG002|Extension Phase|Study Closed|17|||
124493026|NCT03042611|447759578|FG003|Extension Phase|Study Closed|11|||
124493027|NCT03567291|447759579|FG000|Period I|Adverse Event|14|||
124493028|NCT03567291|447759580|FG001|Period I|Adverse Event|0|||
124493029|NCT03567291|447759581|FG002|Period I|Adverse Event|0|||
124493030|NCT03567291|447759582|FG003|Period I|Adverse Event|0|||
124493031|NCT03567291|447759579|FG000|Period I|Protocol Violation|1|||
124493032|NCT03567291|447759580|FG001|Period I|Protocol Violation|0|||
124493033|NCT03567291|447759581|FG002|Period I|Protocol Violation|0|||
124493034|NCT03567291|447759582|FG003|Period I|Protocol Violation|0|||
124493035|NCT03567291|447759579|FG000|Period I|Withdrawal by Subject|23|||
124493036|NCT03567291|447759580|FG001|Period I|Withdrawal by Subject|0|||
124493037|NCT03567291|447759581|FG002|Period I|Withdrawal by Subject|0|||
124493038|NCT03567291|447759582|FG003|Period I|Withdrawal by Subject|0|||
124493039|NCT03567291|447759579|FG000|Period I|Lost to Follow-up|2|||
124493040|NCT03567291|447759580|FG001|Period I|Lost to Follow-up|0|||
124493041|NCT03567291|447759581|FG002|Period I|Lost to Follow-up|0|||
124493042|NCT03567291|447759582|FG003|Period I|Lost to Follow-up|0|||
124493043|NCT03567291|447759579|FG000|Period I|Terminated by sponsor|44|||
124493044|NCT03567291|447759580|FG001|Period I|Terminated by sponsor|0|||
124493045|NCT03567291|447759581|FG002|Period I|Terminated by sponsor|0|||
124493046|NCT03567291|447759582|FG003|Period I|Terminated by sponsor|0|||
124493047|NCT03567291|447759579|FG000|Period I|Missing or unknown|7|||
124493048|NCT03567291|447759580|FG001|Period I|Missing or unknown|0|||
124493049|NCT03567291|447759581|FG002|Period I|Missing or unknown|0|||
124493050|NCT03567291|447759582|FG003|Period I|Missing or unknown|0|||
124493051|NCT03567291|447759579|FG000|Period II|Adverse Event|0|||
124493052|NCT03567291|447759580|FG001|Period II|Adverse Event|1|||
124493053|NCT03567291|447759581|FG002|Period II|Adverse Event|0|||
124493054|NCT03567291|447759582|FG003|Period II|Adverse Event|0|||
124493055|NCT03567291|447759579|FG000|Period II|Missing or unknown|0|||
124493056|NCT03567291|447759580|FG001|Period II|Missing or unknown|2|||
124493057|NCT03567291|447759581|FG002|Period II|Missing or unknown|1|||
124493058|NCT03567291|447759582|FG003|Period II|Missing or unknown|0|||
124493059|NCT03567291|447759579|FG000|Period III|Adverse Event|0|||
124493060|NCT03567291|447759580|FG001|Period III|Adverse Event|0|||
124493061|NCT03567291|447759581|FG002|Period III|Adverse Event|0|||
124493062|NCT03567291|447759582|FG003|Period III|Adverse Event|4|||
124493063|NCT03567291|447759579|FG000|Period III|Withdrawal by Subject|0|||
124493064|NCT03567291|447759580|FG001|Period III|Withdrawal by Subject|0|||
124493065|NCT03567291|447759581|FG002|Period III|Withdrawal by Subject|0|||
124493066|NCT03567291|447759582|FG003|Period III|Withdrawal by Subject|4|||
124493067|NCT03567291|447759579|FG000|Period III|Lost to Follow-up|0|||
124493068|NCT03567291|447759580|FG001|Period III|Lost to Follow-up|0|||
124493069|NCT03567291|447759581|FG002|Period III|Lost to Follow-up|0|||
124493070|NCT03567291|447759582|FG003|Period III|Lost to Follow-up|1|||
124493071|NCT03567291|447759579|FG000|Period III|Terminated by sponsor|0|||
124493072|NCT03567291|447759580|FG001|Period III|Terminated by sponsor|0|||
124493073|NCT03567291|447759581|FG002|Period III|Terminated by sponsor|0|||
124493074|NCT03567291|447759582|FG003|Period III|Terminated by sponsor|68|||
124493075|NCT03567291|447759579|FG000|Period III|Missing or unknown|0|||
124493076|NCT03567291|447759580|FG001|Period III|Missing or unknown|0|||
124493077|NCT03567291|447759581|FG002|Period III|Missing or unknown|0|||
124493078|NCT03567291|447759582|FG003|Period III|Missing or unknown|8|||
124493079|NCT01103349|447759583|FG000|Overall Study|Adverse Event|8|||
124493080|NCT01103349|447759584|FG001|Overall Study|Adverse Event|5|||
124493081|NCT01103349|447759585|FG002|Overall Study|Adverse Event|3|||
124493082|NCT01103349|447759583|FG000|Overall Study|Consent withdrawn|1|||
124721985|NCT02574078|448605495|FG001|Treatment Period|Participant withdrew consent|0|||
124721986|NCT02574078|448605496|FG002|Treatment Period|Participant withdrew consent|0|||
124493083|NCT01103349|447759584|FG001|Overall Study|Consent withdrawn|0|||
124493084|NCT01103349|447759585|FG002|Overall Study|Consent withdrawn|0|||
124721987|NCT02574078|448605497|FG003|Treatment Period|Participant withdrew consent|0|||
124493085|NCT01103349|447759583|FG000|Overall Study|Incorrectly included in the trial|1|||
124493086|NCT01103349|447759584|FG001|Overall Study|Incorrectly included in the trial|0|||
124493087|NCT01103349|447759585|FG002|Overall Study|Incorrectly included in the trial|0|||
124493088|NCT01103349|447759583|FG000|Overall Study|Withdrawal by Subject|1|||
124493089|NCT01103349|447759584|FG001|Overall Study|Withdrawal by Subject|1|||
124493090|NCT01103349|447759585|FG002|Overall Study|Withdrawal by Subject|0|||
124493091|NCT01103349|447759583|FG000|Overall Study|did not want to take trial medication|0|||
124493092|NCT01103349|447759584|FG001|Overall Study|did not want to take trial medication|1|||
124493093|NCT01103349|447759585|FG002|Overall Study|did not want to take trial medication|0|||
124493094|NCT01103349|447759583|FG000|Overall Study|forgot to take medication|0|||
124493095|NCT01103349|447759584|FG001|Overall Study|forgot to take medication|0|||
124493096|NCT01103349|447759585|FG002|Overall Study|forgot to take medication|1|||
124493097|NCT00090285|447759586|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
124493098|NCT00090285|447759587|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
124493099|NCT00090285|447759588|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
124493100|NCT00090285|447759589|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
124493101|NCT00090285|447759590|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
124493102|NCT00090285|447759591|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
124493103|NCT00090285|447759586|FG000|Base Study Vaccination Period|Adverse Event|2|||
124493104|NCT00090285|447759587|FG001|Base Study Vaccination Period|Adverse Event|4|||
124493105|NCT00090285|447759588|FG002|Base Study Vaccination Period|Adverse Event|0|||
124493106|NCT00090285|447759589|FG003|Base Study Vaccination Period|Adverse Event|0|||
124493107|NCT00090285|447759590|FG004|Base Study Vaccination Period|Adverse Event|0|||
124493108|NCT00090285|447759591|FG005|Base Study Vaccination Period|Adverse Event|0|||
124493109|NCT00090285|447759586|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
124493110|NCT00090285|447759587|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
124493111|NCT00090285|447759588|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
124493112|NCT00090285|447759589|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
124493113|NCT00090285|447759590|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
124493114|NCT00090285|447759591|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
124493115|NCT00090285|447759586|FG000|Base Study Vaccination Period|Protocol Violation|2|||
124493116|NCT00090285|447759587|FG001|Base Study Vaccination Period|Protocol Violation|3|||
124493117|NCT00090285|447759588|FG002|Base Study Vaccination Period|Protocol Violation|0|||
124493118|NCT00090285|447759589|FG003|Base Study Vaccination Period|Protocol Violation|0|||
124493119|NCT00090285|447759590|FG004|Base Study Vaccination Period|Protocol Violation|0|||
124493120|NCT00090285|447759591|FG005|Base Study Vaccination Period|Protocol Violation|0|||
124493121|NCT00090285|447759586|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
124493122|NCT00090285|447759587|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
124493123|NCT00090285|447759588|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
124493124|NCT00090285|447759589|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
124493125|NCT00090285|447759590|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
124493126|NCT00090285|447759591|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
124493127|NCT00090285|447759586|FG000|Base Study Vaccination Period|Uncooperative|2|||
124493128|NCT00090285|447759587|FG001|Base Study Vaccination Period|Uncooperative|2|||
124493129|NCT00090285|447759588|FG002|Base Study Vaccination Period|Uncooperative|0|||
124493130|NCT00090285|447759589|FG003|Base Study Vaccination Period|Uncooperative|0|||
124493131|NCT00090285|447759590|FG004|Base Study Vaccination Period|Uncooperative|0|||
124493132|NCT00090285|447759591|FG005|Base Study Vaccination Period|Uncooperative|0|||
124493133|NCT00090285|447759586|FG000|Base Study Vaccination Period|Moved|20|||
124493134|NCT00090285|447759587|FG001|Base Study Vaccination Period|Moved|21|||
124493135|NCT00090285|447759588|FG002|Base Study Vaccination Period|Moved|0|||
124493136|NCT00090285|447759589|FG003|Base Study Vaccination Period|Moved|0|||
124493137|NCT00090285|447759590|FG004|Base Study Vaccination Period|Moved|0|||
124493138|NCT00090285|447759591|FG005|Base Study Vaccination Period|Moved|0|||
124493139|NCT00090285|447759586|FG000|Base Study Vaccination Period|Site Terminated|1|||
124493140|NCT00090285|447759587|FG001|Base Study Vaccination Period|Site Terminated|0|||
124493141|NCT00090285|447759588|FG002|Base Study Vaccination Period|Site Terminated|0|||
124493142|NCT00090285|447759589|FG003|Base Study Vaccination Period|Site Terminated|0|||
124493143|NCT00090285|447759590|FG004|Base Study Vaccination Period|Site Terminated|0|||
124493144|NCT00090285|447759591|FG005|Base Study Vaccination Period|Site Terminated|0|||
124493145|NCT00090285|447759586|FG000|Base Study Vaccination Period|Other|2|||
124493146|NCT00090285|447759587|FG001|Base Study Vaccination Period|Other|2|||
124493147|NCT00090285|447759588|FG002|Base Study Vaccination Period|Other|0|||
124493148|NCT00090285|447759589|FG003|Base Study Vaccination Period|Other|0|||
124493149|NCT00090285|447759590|FG004|Base Study Vaccination Period|Other|0|||
124493150|NCT00090285|447759591|FG005|Base Study Vaccination Period|Other|0|||
124721988|NCT02574078|448605498|FG004|Treatment Period|Participant withdrew consent|1|||
124721989|NCT02574078|448605499|FG005|Treatment Period|Participant withdrew consent|1|||
124721990|NCT02574078|448605500|FG006|Treatment Period|Participant withdrew consent|0|||
124721991|NCT02574078|448605501|FG007|Treatment Period|Participant withdrew consent|1|||
124493151|NCT00090285|447759586|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
124493152|NCT00090285|447759587|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
124493153|NCT00090285|447759588|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
124493154|NCT00090285|447759589|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
124493155|NCT00090285|447759590|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
124721992|NCT02574078|448605502|FG008|Treatment Period|Participant withdrew consent|0|||
124721993|NCT02574078|448605503|FG009|Treatment Period|Participant withdrew consent|2|||
124493156|NCT00090285|447759591|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
124493157|NCT00090285|447759586|FG000|Base Study Vaccination Period|HIV positive|1|||
124493158|NCT00090285|447759587|FG001|Base Study Vaccination Period|HIV positive|1|||
124493159|NCT00090285|447759588|FG002|Base Study Vaccination Period|HIV positive|0|||
124493160|NCT00090285|447759589|FG003|Base Study Vaccination Period|HIV positive|0|||
124493161|NCT00090285|447759590|FG004|Base Study Vaccination Period|HIV positive|0|||
124493162|NCT00090285|447759591|FG005|Base Study Vaccination Period|HIV positive|0|||
124493163|NCT00090285|447759586|FG000|Base Study Follow-up Period|Adverse Event|3|||
124493164|NCT00090285|447759587|FG001|Base Study Follow-up Period|Adverse Event|10|||
124493165|NCT00090285|447759588|FG002|Base Study Follow-up Period|Adverse Event|0|||
124772079|NCT02113982|448796380|FG012|Stage 1: Dose Escalation|Transplant|0|||
124772080|NCT02113982|448796381|FG013|Stage 1: Dose Escalation|Transplant|0|||
124772081|NCT02113982|448796368|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
124772082|NCT02113982|448796369|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
124772083|NCT02113982|448796370|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
124772084|NCT02113982|448796371|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
124772085|NCT02113982|448796372|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
124772086|NCT02113982|448796373|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
124772087|NCT02113982|448796374|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
124772088|NCT02113982|448796375|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
124772089|NCT02113982|448796376|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
124772090|NCT02113982|448796377|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
124772091|NCT02113982|448796378|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
124772092|NCT02113982|448796379|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
124772093|NCT02113982|448796380|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
124772094|NCT02113982|448796381|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
124772095|NCT02113982|448796368|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
124772096|NCT02113982|448796369|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
124772097|NCT02113982|448796370|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
124772098|NCT02113982|448796371|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
124772099|NCT02113982|448796372|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
124772100|NCT02113982|448796373|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
124772101|NCT02113982|448796374|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
124772102|NCT02113982|448796375|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
124772103|NCT02113982|448796376|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
124772104|NCT02113982|448796377|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
124772105|NCT02113982|448796378|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
124772106|NCT02113982|448796379|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
124772107|NCT02113982|448796380|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
124772108|NCT02113982|448796381|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
124772109|NCT02113982|448796368|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
124772110|NCT02113982|448796369|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
124772111|NCT02113982|448796370|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
124772112|NCT02113982|448796371|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
124772113|NCT02113982|448796372|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
124772114|NCT02113982|448796373|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
124772115|NCT02113982|448796374|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
124493166|NCT00090285|447759589|FG003|Base Study Follow-up Period|Adverse Event|0|||
124493167|NCT00090285|447759590|FG004|Base Study Follow-up Period|Adverse Event|0|||
124493168|NCT00090285|447759591|FG005|Base Study Follow-up Period|Adverse Event|0|||
124493169|NCT00090285|447759586|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
124493170|NCT00090285|447759587|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
124493171|NCT00090285|447759588|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
124493172|NCT00090285|447759589|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
124493173|NCT00090285|447759590|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
124493174|NCT00090285|447759591|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
124493175|NCT00090285|447759586|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
124493176|NCT00090285|447759587|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
124493177|NCT00090285|447759588|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
124493178|NCT00090285|447759589|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
124493179|NCT00090285|447759590|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
124493180|NCT00090285|447759591|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
124493181|NCT00090285|447759586|FG000|Base Study Follow-up Period|Moved|41|||
124493182|NCT00090285|447759587|FG001|Base Study Follow-up Period|Moved|36|||
124772116|NCT02113982|448796375|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
124772117|NCT02113982|448796376|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
124772118|NCT02113982|448796377|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
124493183|NCT00090285|447759588|FG002|Base Study Follow-up Period|Moved|0|||
124493184|NCT00090285|447759589|FG003|Base Study Follow-up Period|Moved|0|||
124772119|NCT02113982|448796378|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
124772120|NCT02113982|448796379|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
124493185|NCT00090285|447759590|FG004|Base Study Follow-up Period|Moved|0|||
124772121|NCT02113982|448796380|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
124493186|NCT00090285|447759591|FG005|Base Study Follow-up Period|Moved|0|||
124493187|NCT00090285|447759586|FG000|Base Study Follow-up Period|Other|2|||
124493188|NCT00090285|447759587|FG001|Base Study Follow-up Period|Other|0|||
124493189|NCT00090285|447759588|FG002|Base Study Follow-up Period|Other|0|||
124493190|NCT00090285|447759589|FG003|Base Study Follow-up Period|Other|0|||
124493191|NCT00090285|447759590|FG004|Base Study Follow-up Period|Other|0|||
124493192|NCT00090285|447759591|FG005|Base Study Follow-up Period|Other|0|||
124493193|NCT00090285|447759586|FG000|Base Study Follow-up Period|Protocol Violation|1|||
124493194|NCT00090285|447759587|FG001|Base Study Follow-up Period|Protocol Violation|0|||
124493195|NCT00090285|447759588|FG002|Base Study Follow-up Period|Protocol Violation|0|||
124493196|NCT00090285|447759589|FG003|Base Study Follow-up Period|Protocol Violation|0|||
124493197|NCT00090285|447759590|FG004|Base Study Follow-up Period|Protocol Violation|0|||
124493198|NCT00090285|447759591|FG005|Base Study Follow-up Period|Protocol Violation|0|||
124493199|NCT00090285|447759586|FG000|Base Study Follow-up Period|Uncooperative|3|||
124493200|NCT00090285|447759587|FG001|Base Study Follow-up Period|Uncooperative|4|||
124493201|NCT00090285|447759588|FG002|Base Study Follow-up Period|Uncooperative|0|||
124493202|NCT00090285|447759589|FG003|Base Study Follow-up Period|Uncooperative|0|||
124493203|NCT00090285|447759590|FG004|Base Study Follow-up Period|Uncooperative|0|||
124493204|NCT00090285|447759591|FG005|Base Study Follow-up Period|Uncooperative|0|||
124493205|NCT00090285|447759586|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
124493206|NCT00090285|447759587|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
124493207|NCT00090285|447759588|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
124493208|NCT00090285|447759589|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
124493209|NCT00090285|447759590|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
124493210|NCT00090285|447759591|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
124493211|NCT00090285|447759586|FG000|Extension 1|Adverse Event|0|||
124493212|NCT00090285|447759587|FG001|Extension 1|Adverse Event|0|||
124493213|NCT00090285|447759588|FG002|Extension 1|Adverse Event|2|||
124493214|NCT00090285|447759589|FG003|Extension 1|Adverse Event|0|||
124493215|NCT00090285|447759590|FG004|Extension 1|Adverse Event|0|||
124493216|NCT00090285|447759591|FG005|Extension 1|Adverse Event|0|||
124493217|NCT00090285|447759586|FG000|Extension 1|Lost to Follow-up|0|||
124493218|NCT00090285|447759587|FG001|Extension 1|Lost to Follow-up|0|||
124493219|NCT00090285|447759588|FG002|Extension 1|Lost to Follow-up|35|||
124493220|NCT00090285|447759589|FG003|Extension 1|Lost to Follow-up|0|||
124493221|NCT00090285|447759590|FG004|Extension 1|Lost to Follow-up|0|||
124493222|NCT00090285|447759591|FG005|Extension 1|Lost to Follow-up|0|||
124493223|NCT00090285|447759586|FG000|Extension 1|Withdrawal by Subject|0|||
124493224|NCT00090285|447759587|FG001|Extension 1|Withdrawal by Subject|0|||
124493225|NCT00090285|447759588|FG002|Extension 1|Withdrawal by Subject|13|||
124493226|NCT00090285|447759589|FG003|Extension 1|Withdrawal by Subject|1|||
124493227|NCT00090285|447759590|FG004|Extension 1|Withdrawal by Subject|0|||
124493228|NCT00090285|447759591|FG005|Extension 1|Withdrawal by Subject|0|||
124493229|NCT00090285|447759586|FG000|Extension 1|Other|0|||
124493230|NCT00090285|447759587|FG001|Extension 1|Other|0|||
124493231|NCT00090285|447759588|FG002|Extension 1|Other|4|||
124493232|NCT00090285|447759589|FG003|Extension 1|Other|0|||
124493233|NCT00090285|447759590|FG004|Extension 1|Other|0|||
124493234|NCT00090285|447759591|FG005|Extension 1|Other|0|||
124493235|NCT00090285|447759586|FG000|Extension 1|Moved|0|||
124493236|NCT00090285|447759587|FG001|Extension 1|Moved|0|||
124493237|NCT00090285|447759588|FG002|Extension 1|Moved|3|||
124493238|NCT00090285|447759589|FG003|Extension 1|Moved|0|||
124493239|NCT00090285|447759590|FG004|Extension 1|Moved|0|||
124493240|NCT00090285|447759591|FG005|Extension 1|Moved|0|||
124493241|NCT00090285|447759586|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
124493242|NCT00090285|447759587|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
124493243|NCT00090285|447759588|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
124721994|NCT02574078|448605504|FG010|Treatment Period|Participant withdrew consent|1|||
124721995|NCT02574078|448605505|FG011|Treatment Period|Participant withdrew consent|4|||
124721996|NCT02574078|448605506|FG012|Treatment Period|Participant withdrew consent|1|||
124721997|NCT02574078|448605494|FG000|Treatment Period|Participant no longer meets criteria|0|||
124493244|NCT00090285|447759589|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
124493245|NCT00090285|447759590|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
124493246|NCT00090285|447759591|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
124493247|NCT00090285|447759586|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
124493248|NCT00090285|447759587|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
124493249|NCT00090285|447759588|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
124493250|NCT00090285|447759589|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
124493251|NCT00090285|447759590|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
124493252|NCT00090285|447759591|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
124493253|NCT00090285|447759586|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
124493254|NCT00090285|447759587|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
124493255|NCT00090285|447759588|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
124493256|NCT00090285|447759589|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
124493257|NCT00090285|447759590|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
124493258|NCT00090285|447759591|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
124493259|NCT00090285|447759586|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
124493260|NCT00090285|447759587|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
124493261|NCT00090285|447759588|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
124493262|NCT00090285|447759589|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
124493263|NCT00090285|447759590|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
124493264|NCT00090285|447759591|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
124493265|NCT00907478|447759592|FG000|Overall Study|Ineligibility determined|0|||
124493266|NCT00907478|447759593|FG001|Overall Study|Ineligibility determined|0|||
124493267|NCT00907478|447759594|FG002|Overall Study|Ineligibility determined|1|||
124493268|NCT00907478|447759592|FG000|Overall Study|Noncompliance|0|||
124493269|NCT00907478|447759593|FG001|Overall Study|Noncompliance|0|||
124493270|NCT00907478|447759594|FG002|Overall Study|Noncompliance|1|||
124493271|NCT00907478|447759592|FG000|Overall Study|Adverse Event|3|||
124493272|NCT00907478|447759593|FG001|Overall Study|Adverse Event|1|||
124493273|NCT00907478|447759594|FG002|Overall Study|Adverse Event|2|||
124493274|NCT00907478|447759592|FG000|Overall Study|Withdrawal by Subject|8|||
124493275|NCT00907478|447759593|FG001|Overall Study|Withdrawal by Subject|9|||
124493276|NCT00907478|447759594|FG002|Overall Study|Withdrawal by Subject|6|||
124493277|NCT00907478|447759592|FG000|Overall Study|Requirement for alternative therapy|1|||
124493278|NCT00907478|447759593|FG001|Overall Study|Requirement for alternative therapy|2|||
124493279|NCT00907478|447759594|FG002|Overall Study|Requirement for alternative therapy|3|||
124493280|NCT00907478|447759592|FG000|Overall Study|Physician Decision|2|||
124493281|NCT00907478|447759593|FG001|Overall Study|Physician Decision|0|||
124493282|NCT00907478|447759594|FG002|Overall Study|Physician Decision|3|||
124493283|NCT00907478|447759592|FG000|Overall Study|Death|4|||
124493284|NCT00907478|447759593|FG001|Overall Study|Death|2|||
124493285|NCT00907478|447759594|FG002|Overall Study|Death|1|||
124493286|NCT00907478|447759592|FG000|Overall Study|Protocol-specified criteria|5|||
124493287|NCT00907478|447759593|FG001|Overall Study|Protocol-specified criteria|2|||
124493288|NCT00907478|447759594|FG002|Overall Study|Protocol-specified criteria|3|||
124493289|NCT00907478|447759592|FG000|Overall Study|Pregnancy|0|||
124493290|NCT00907478|447759593|FG001|Overall Study|Pregnancy|1|||
124493291|NCT00907478|447759594|FG002|Overall Study|Pregnancy|1|||
124493292|NCT00907478|447759592|FG000|Overall Study|Lost to Follow-up|1|||
124493293|NCT00907478|447759593|FG001|Overall Study|Lost to Follow-up|0|||
124493294|NCT00907478|447759594|FG002|Overall Study|Lost to Follow-up|0|||
124493295|NCT00907478|447759592|FG000|Overall Study|Other|3|||
124493296|NCT00907478|447759593|FG001|Overall Study|Other|0|||
124493297|NCT00907478|447759594|FG002|Overall Study|Other|1|||
124493298|NCT03069690|447759597|FG000|Pregnancy Intervention|Pregnancy loss|9|||
124493299|NCT03069690|447759598|FG001|Pregnancy Intervention|Pregnancy loss|4|||
124493300|NCT03069690|447759599|FG002|Pregnancy Intervention|Pregnancy loss|0|||
124493301|NCT03069690|447759600|FG003|Pregnancy Intervention|Pregnancy loss|0|||
124493302|NCT03069690|447759601|FG004|Pregnancy Intervention|Pregnancy loss|0|||
124493303|NCT03069690|447759602|FG005|Pregnancy Intervention|Pregnancy loss|0|||
124493304|NCT03069690|447759597|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
124493305|NCT03069690|447759598|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
124493306|NCT03069690|447759599|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
124493307|NCT03069690|447759600|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
124493308|NCT03069690|447759601|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
124721998|NCT02574078|448605495|FG001|Treatment Period|Participant no longer meets criteria|0|||
124721999|NCT02574078|448605496|FG002|Treatment Period|Participant no longer meets criteria|0|||
124722000|NCT02574078|448605497|FG003|Treatment Period|Participant no longer meets criteria|0|||
124722001|NCT02574078|448605498|FG004|Treatment Period|Participant no longer meets criteria|1|||
124722002|NCT02574078|448605499|FG005|Treatment Period|Participant no longer meets criteria|0|||
124493309|NCT03069690|447759602|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
124493310|NCT03069690|447759597|FG000|Postpartum Intervention|Lost to Follow-up|0|||
124493311|NCT03069690|447759598|FG001|Postpartum Intervention|Lost to Follow-up|0|||
124493312|NCT03069690|447759599|FG002|Postpartum Intervention|Lost to Follow-up|5|||
124493313|NCT03069690|447759600|FG003|Postpartum Intervention|Lost to Follow-up|5|||
124493314|NCT03069690|447759601|FG004|Postpartum Intervention|Lost to Follow-up|2|||
124493315|NCT03069690|447759602|FG005|Postpartum Intervention|Lost to Follow-up|4|||
124493316|NCT01372878|447759603|FG000|Overall Study|Withdrawal by Subject|63|||
124493317|NCT01372878|447759603|FG000|Overall Study|Protocol Violation|17|||
124493318|NCT01372878|447759603|FG000|Overall Study|incomplete study procedure|104|||
124493319|NCT02240628|447759604|FG000|Overall Study|Physician Decision|6|||
124557827|NCT01677910|448001348|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
124557828|NCT01677910|448001349|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
124557829|NCT01677910|448001346|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
124557830|NCT01677910|448001347|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
124557831|NCT01677910|448001348|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
124557832|NCT01677910|448001349|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
124557833|NCT01677910|448001346|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
124557834|NCT01677910|448001347|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
124557835|NCT01677910|448001348|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
124557836|NCT01677910|448001349|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
124722003|NCT02574078|448605500|FG006|Treatment Period|Participant no longer meets criteria|0|||
124722004|NCT02574078|448605501|FG007|Treatment Period|Participant no longer meets criteria|0|||
124722005|NCT02574078|448605502|FG008|Treatment Period|Participant no longer meets criteria|0|||
124722006|NCT02574078|448605503|FG009|Treatment Period|Participant no longer meets criteria|1|||
124722007|NCT02574078|448605504|FG010|Treatment Period|Participant no longer meets criteria|1|||
124722008|NCT02574078|448605505|FG011|Treatment Period|Participant no longer meets criteria|1|||
124722009|NCT02574078|448605506|FG012|Treatment Period|Participant no longer meets criteria|0|||
124722010|NCT02574078|448605494|FG000|Treatment Period|Lost to Follow-up|0|||
124722011|NCT02574078|448605495|FG001|Treatment Period|Lost to Follow-up|0|||
124722012|NCT02574078|448605496|FG002|Treatment Period|Lost to Follow-up|0|||
124722013|NCT02574078|448605497|FG003|Treatment Period|Lost to Follow-up|0|||
124722014|NCT02574078|448605498|FG004|Treatment Period|Lost to Follow-up|0|||
124722015|NCT02574078|448605499|FG005|Treatment Period|Lost to Follow-up|0|||
124493320|NCT02240628|447759605|FG001|Overall Study|Physician Decision|5|||
124493321|NCT02385123|447759606|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
124493322|NCT04498910|447759607|FG000|Overall Study|Lost to Follow-up|0|||
124557837|NCT01677910|448001346|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
124557838|NCT01677910|448001347|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
124557839|NCT01677910|448001348|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
124557840|NCT01677910|448001349|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
124557841|NCT01677910|448001346|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
124557842|NCT01677910|448001347|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
124557843|NCT01677910|448001348|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
124557844|NCT01677910|448001349|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
124557845|NCT01677910|448001346|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
124557846|NCT01677910|448001347|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
124557847|NCT01677910|448001348|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
124557848|NCT01677910|448001349|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
124557849|NCT01677910|448001346|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
124557850|NCT01677910|448001347|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
124557851|NCT01677910|448001348|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
124557852|NCT01677910|448001349|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
124557853|NCT01677910|448001346|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
124557854|NCT01677910|448001347|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
124557855|NCT01677910|448001348|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
124557856|NCT01677910|448001349|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
124557857|NCT00606684|448001359|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
124557858|NCT00606684|448001360|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
124557859|NCT00606684|448001361|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
124557860|NCT00606684|448001362|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
124557861|NCT00606684|448001363|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
124557862|NCT00606684|448001364|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
124557863|NCT00606684|448001365|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
124557864|NCT00606684|448001359|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
124722016|NCT02574078|448605500|FG006|Treatment Period|Lost to Follow-up|0|||
124722017|NCT02574078|448605501|FG007|Treatment Period|Lost to Follow-up|0|||
124493323|NCT04498910|447759608|FG001|Overall Study|Lost to Follow-up|1|||
124722018|NCT02574078|448605502|FG008|Treatment Period|Lost to Follow-up|0|||
124493324|NCT04498910|447759607|FG000|Overall Study|Withdrawal by Subject|2|||
124493325|NCT04498910|447759608|FG001|Overall Study|Withdrawal by Subject|1|||
124493326|NCT04498910|447759607|FG000|Overall Study|Adverse Event|1|||
124493327|NCT04498910|447759608|FG001|Overall Study|Adverse Event|0|||
124493328|NCT01070303|447759609|FG000|Overall Study|Adverse Event|39|||
124493329|NCT01070303|447759609|FG000|Overall Study|Withdrawal by Subject|20|||
124493330|NCT01070303|447759609|FG000|Overall Study|Lost to Follow-up|9|||
124493331|NCT01070303|447759609|FG000|Overall Study|Protocol Violation|0|||
124493332|NCT01070303|447759609|FG000|Overall Study|Lack of Efficacy|2|||
124493333|NCT01070303|447759609|FG000|Overall Study|Administrative Reason|1|||
124493334|NCT01070303|447759609|FG000|Overall Study|Other|18|||
124493335|NCT01849848|447759610|FG000|Overall Study|Physician Decision|1|||
124493336|NCT01849848|447759610|FG000|Overall Study|Progression of the primary disease|3|||
124493337|NCT02926573|447759612|FG000|Overall Study|Nausea|1|||
124493338|NCT02926573|447759613|FG001|Overall Study|Nausea|0|||
124493339|NCT02926573|447759612|FG000|Overall Study|Remain intubated|2|||
124493340|NCT02926573|447759613|FG001|Overall Study|Remain intubated|2|||
124557865|NCT00606684|448001360|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
124722019|NCT02574078|448605503|FG009|Treatment Period|Lost to Follow-up|1|||
124772122|NCT02113982|448796381|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
124493341|NCT02926573|447759612|FG000|Overall Study|Change in surgery plan|3|||
124493342|NCT02926573|447759613|FG001|Overall Study|Change in surgery plan|1|||
124493343|NCT02926573|447759612|FG000|Overall Study|Change to outpatient status|5|||
124493344|NCT02926573|447759613|FG001|Overall Study|Change to outpatient status|1|||
124493345|NCT02926573|447759612|FG000|Overall Study|Withdrawal by Subject|0|||
124493346|NCT02926573|447759613|FG001|Overall Study|Withdrawal by Subject|2|||
124493347|NCT02926573|447759612|FG000|Overall Study|Return to operating room|0|||
124493348|NCT02926573|447759613|FG001|Overall Study|Return to operating room|2|||
124493349|NCT02926573|447759612|FG000|Overall Study|Delirium|0|||
124493350|NCT02926573|447759613|FG001|Overall Study|Delirium|1|||
124493351|NCT02179398|447759636|FG000|Overall Study|Lack of obligatory data|3|||
124493352|NCT02179398|447759637|FG001|Overall Study|Lack of obligatory data|3|||
124493353|NCT02179398|447759636|FG000|Overall Study|Lost to Follow-up|0|||
124493354|NCT02179398|447759637|FG001|Overall Study|Lost to Follow-up|1|||
124493355|NCT02124798|447759638|FG000|Overall Study|Adverse Event|3|||
124493356|NCT02124798|447759638|FG000|Overall Study|Lost to Follow-up|1|||
124493357|NCT02746679|447759643|FG000|Overall Study|Lost to Follow-up|4|||
124493358|NCT02746679|447759644|FG001|Overall Study|Lost to Follow-up|6|||
124493359|NCT00487279|447759645|FG000|Overall Study|Death|1|||
124493360|NCT00487279|447759646|FG001|Overall Study|Death|0|||
124493361|NCT00487279|447759645|FG000|Overall Study|Withdrawal by Subject|0|||
124493362|NCT00487279|447759646|FG001|Overall Study|Withdrawal by Subject|2|||
124493363|NCT00501852|447759647|FG000|Overall Study|Adverse Event|3|||
124493364|NCT00501852|447759647|FG000|Overall Study|Withdrawal by Subject|2|||
124493365|NCT00642616|447759653|FG000|Overall Study|Adverse Event|2|||
124493366|NCT00642616|447759654|FG001|Overall Study|Adverse Event|0|||
124493367|NCT00642616|447759655|FG002|Overall Study|Adverse Event|1|||
124493368|NCT00642616|447759656|FG003|Overall Study|Adverse Event|0|||
124493369|NCT00642616|447759653|FG000|Overall Study|Study Terminated by Sponsor|7|||
124493370|NCT00642616|447759654|FG001|Overall Study|Study Terminated by Sponsor|6|||
124493371|NCT00642616|447759655|FG002|Overall Study|Study Terminated by Sponsor|4|||
124493372|NCT00642616|447759656|FG003|Overall Study|Study Terminated by Sponsor|5|||
124493373|NCT00642616|447759653|FG000|Overall Study|Withdrawal by Subject|0|||
124493374|NCT00642616|447759654|FG001|Overall Study|Withdrawal by Subject|1|||
124493375|NCT00642616|447759655|FG002|Overall Study|Withdrawal by Subject|1|||
124493376|NCT00642616|447759656|FG003|Overall Study|Withdrawal by Subject|1|||
124493377|NCT00642616|447759653|FG000|Overall Study|Protocol Violation|0|||
124493378|NCT00642616|447759654|FG001|Overall Study|Protocol Violation|0|||
124493379|NCT00642616|447759655|FG002|Overall Study|Protocol Violation|2|||
124493380|NCT00642616|447759656|FG003|Overall Study|Protocol Violation|0|||
124493381|NCT00642616|447759653|FG000|Overall Study|Physician Decision|0|||
124493382|NCT00642616|447759654|FG001|Overall Study|Physician Decision|0|||
124493383|NCT00642616|447759655|FG002|Overall Study|Physician Decision|1|||
124493384|NCT00642616|447759656|FG003|Overall Study|Physician Decision|1|||
124493385|NCT00399802|447759657|FG000|Overall Study|Adverse Event|0|||
124493386|NCT00399802|447759658|FG001|Overall Study|Adverse Event|2|||
124493387|NCT00399802|447759657|FG000|Overall Study|Participant discontinued by mistake|0|||
124493388|NCT00399802|447759658|FG001|Overall Study|Participant discontinued by mistake|1|||
124493389|NCT00492921|447759659|FG000|Overall Study|Death|1|||
124493390|NCT00492921|447759660|FG001|Overall Study|Death|0|||
124493391|NCT00492921|447759661|FG002|Overall Study|Death|1|||
124493392|NCT00652093|447759662|FG000|Overall Study|Withdrawal by Subject|0|||
124493393|NCT00652093|447759663|FG001|Overall Study|Withdrawal by Subject|0|||
124493394|NCT00652093|447759664|FG002|Overall Study|Withdrawal by Subject|1|||
124493395|NCT00652093|447759665|FG003|Overall Study|Withdrawal by Subject|0|||
124493396|NCT00652093|447759666|FG004|Overall Study|Withdrawal by Subject|1|||
124493397|NCT00652093|447759667|FG005|Overall Study|Withdrawal by Subject|0|||
124493398|NCT00652093|447759662|FG000|Overall Study|Physician Decision|0|||
124493399|NCT00652093|447759663|FG001|Overall Study|Physician Decision|0|||
124493400|NCT00652093|447759664|FG002|Overall Study|Physician Decision|0|||
124493401|NCT00652093|447759665|FG003|Overall Study|Physician Decision|0|||
124493402|NCT00652093|447759666|FG004|Overall Study|Physician Decision|1|||
124493403|NCT00652093|447759667|FG005|Overall Study|Physician Decision|0|||
124493404|NCT02955186|447759668|FG000|Overall Study|Withdrawal by Subject|6|||
124493405|NCT02955186|447759669|FG001|Overall Study|Withdrawal by Subject|2|||
124493406|NCT02955186|447759668|FG000|Overall Study|Protocol Violation|1|||
124493407|NCT02955186|447759669|FG001|Overall Study|Protocol Violation|0|||
124493408|NCT01618656|447759672|FG000|Overall Study|Withdrawal by Subject|7|||
124493409|NCT01618656|447759673|FG001|Overall Study|Withdrawal by Subject|3|||
124493410|NCT01618656|447759672|FG000|Overall Study|Physician Decision|1|||
124493411|NCT01618656|447759673|FG001|Overall Study|Physician Decision|1|||
124722020|NCT02574078|448605504|FG010|Treatment Period|Lost to Follow-up|0|||
124722021|NCT02574078|448605505|FG011|Treatment Period|Lost to Follow-up|1|||
124722022|NCT02574078|448605506|FG012|Treatment Period|Lost to Follow-up|0|||
124722023|NCT02574078|448605494|FG000|Treatment Period|Maximum clinical benefit|0|||
124493412|NCT02961764|447759674|FG000|Overall Study|Protocol Violation|0|||
124493413|NCT02961764|447759675|FG001|Overall Study|Protocol Violation|1|||
124493414|NCT02961764|447759674|FG000|Overall Study|Death|2|||
124493415|NCT02961764|447759675|FG001|Overall Study|Death|0|||
124493416|NCT02961764|447759674|FG000|Overall Study|Lost to Follow-up|35|||
124493417|NCT02961764|447759675|FG001|Overall Study|Lost to Follow-up|24|||
124493418|NCT02961764|447759674|FG000|Overall Study|Withdrawal by Subject|2|||
124493419|NCT02961764|447759675|FG001|Overall Study|Withdrawal by Subject|0|||
124493420|NCT00469014|447759676|FG000|Initial Phase Randomization|Disease Progression|0|||
124493421|NCT00469014|447759677|FG001|Initial Phase Randomization|Disease Progression|1|||
124493422|NCT00469014|447759678|FG002|Initial Phase Randomization|Disease Progression|1|||
124493423|NCT00469014|447759679|FG003|Initial Phase Randomization|Disease Progression|0|||
124493424|NCT00469014|447759676|FG000|Initial Phase Randomization|No Response|1|||
124493425|NCT00469014|447759677|FG001|Initial Phase Randomization|No Response|0|||
124493426|NCT00469014|447759678|FG002|Initial Phase Randomization|No Response|0|||
124493427|NCT00469014|447759679|FG003|Initial Phase Randomization|No Response|1|||
124493428|NCT00469014|447759676|FG000|Adaptive Randomization|Not Evaluable|1|||
124493429|NCT00469014|447759677|FG001|Adaptive Randomization|Not Evaluable|0|||
124493430|NCT00469014|447759678|FG002|Adaptive Randomization|Not Evaluable|0|||
124493431|NCT00469014|447759679|FG003|Adaptive Randomization|Not Evaluable|1|||
124493432|NCT00469014|447759676|FG000|Adaptive Randomization|No Response|0|||
124493433|NCT00469014|447759677|FG001|Adaptive Randomization|No Response|1|||
124493434|NCT00469014|447759678|FG002|Adaptive Randomization|No Response|0|||
124493435|NCT00469014|447759679|FG003|Adaptive Randomization|No Response|0|||
124493436|NCT00469014|447759676|FG000|Adaptive Randomization|Death|0|||
124493437|NCT00469014|447759677|FG001|Adaptive Randomization|Death|0|||
124493438|NCT00469014|447759678|FG002|Adaptive Randomization|Death|1|||
124493439|NCT00469014|447759679|FG003|Adaptive Randomization|Death|0|||
124493440|NCT03321929|447759680|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
124493441|NCT01632878|447759681|FG000|Screening|Physician Decision|268|||
124493442|NCT01632878|447759681|FG000|Treatment|Lost to Follow-up|41|||
124493443|NCT01632878|447759681|FG000|Treatment|Withdrawal by Subject|36|||
124493444|NCT01632878|447759681|FG000|Treatment|Physician Decision|34|||
124493445|NCT01632878|447759681|FG000|Treatment|missing information|4|||
124493446|NCT01632878|447759681|FG000|Treatment|no information on study completion|43|||
124493447|NCT02606877|447759682|FG000|Overall Study|Adverse Event|3|||
124493448|NCT02606877|447759683|FG001|Overall Study|Adverse Event|0|||
124493449|NCT02606877|447759682|FG000|Overall Study|Non-compliance with protocol|0|||
124493450|NCT02606877|447759683|FG001|Overall Study|Non-compliance with protocol|1|||
124493451|NCT02606877|447759682|FG000|Overall Study|Other than listed above|1|||
124493452|NCT02606877|447759683|FG001|Overall Study|Other than listed above|0|||
124493453|NCT01903434|447759699|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
124493454|NCT01903434|447759700|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
124493455|NCT01903434|447759699|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
124493456|NCT01903434|447759700|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
124493457|NCT01781026|447759701|FG000|Overall Study|Lack of Efficacy|2|||
124493458|NCT01118143|447759702|FG000|Overall Study|Withdrawal by Subject|2|||
124493459|NCT01118143|447759703|FG001|Overall Study|Withdrawal by Subject|5|||
124493460|NCT05094154|447761387|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
124493461|NCT05094154|447761388|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
124493462|NCT05094154|447761387|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
124493463|NCT05094154|447761388|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
124493464|NCT01937130|447761389|FG000|Overall Study|Withdrawal by Subject|0|||
124493465|NCT01937130|447761390|FG001|Overall Study|Withdrawal by Subject|0|||
124493466|NCT01937130|447761391|FG002|Overall Study|Withdrawal by Subject|0|||
124493467|NCT01937130|447761392|FG003|Overall Study|Withdrawal by Subject|1|||
124493468|NCT01937130|447761389|FG000|Overall Study|Adverse Event|0|||
124493469|NCT01937130|447761390|FG001|Overall Study|Adverse Event|1|||
124493470|NCT01937130|447761391|FG002|Overall Study|Adverse Event|0|||
124493471|NCT01937130|447761392|FG003|Overall Study|Adverse Event|1|||
124493472|NCT01937130|447761389|FG000|Overall Study|Death|1|||
124493473|NCT01937130|447761390|FG001|Overall Study|Death|1|||
124493474|NCT01937130|447761391|FG002|Overall Study|Death|1|||
124493475|NCT01937130|447761392|FG003|Overall Study|Death|0|||
124493476|NCT01937130|447761389|FG000|Overall Study|Lost to Follow-up|2|||
124493477|NCT01937130|447761390|FG001|Overall Study|Lost to Follow-up|0|||
124493478|NCT01937130|447761391|FG002|Overall Study|Lost to Follow-up|2|||
124493479|NCT01937130|447761392|FG003|Overall Study|Lost to Follow-up|0|||
124493480|NCT01937130|447761389|FG000|Overall Study|Physician Decision|0|||
124493481|NCT01937130|447761390|FG001|Overall Study|Physician Decision|1|||
124493482|NCT01937130|447761391|FG002|Overall Study|Physician Decision|0|||
124493483|NCT01937130|447761392|FG003|Overall Study|Physician Decision|0|||
124493484|NCT01937130|447761389|FG000|Overall Study|Patients unable to swallow|0|||
124493485|NCT01937130|447761390|FG001|Overall Study|Patients unable to swallow|1|||
124493486|NCT01937130|447761391|FG002|Overall Study|Patients unable to swallow|0|||
124493487|NCT01937130|447761392|FG003|Overall Study|Patients unable to swallow|0|||
124493488|NCT01937130|447761389|FG000|Overall Study|Patient lost to FU due to death|2|||
124493489|NCT01937130|447761390|FG001|Overall Study|Patient lost to FU due to death|0|||
124493490|NCT01937130|447761391|FG002|Overall Study|Patient lost to FU due to death|0|||
124557866|NCT00606684|448001361|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
124493491|NCT01937130|447761392|FG003|Overall Study|Patient lost to FU due to death|0|||
124493492|NCT01543490|447761397|FG000|Overall Study|Adverse Event|4|||
124493493|NCT01543490|447761398|FG001|Overall Study|Adverse Event|0|||
124493494|NCT01543490|447761397|FG000|Overall Study|Physician Decision|1|||
124493495|NCT01543490|447761398|FG001|Overall Study|Physician Decision|0|||
124493496|NCT01543490|447761397|FG000|Overall Study|Lack of Efficacy|3|||
124493497|NCT01543490|447761398|FG001|Overall Study|Lack of Efficacy|3|||
124493498|NCT01543490|447761397|FG000|Overall Study|Lost to Follow-up|5|||
124493499|NCT01543490|447761398|FG001|Overall Study|Lost to Follow-up|0|||
124493500|NCT01543490|447761397|FG000|Overall Study|Withdrawal by Subject|2|||
124493501|NCT01543490|447761398|FG001|Overall Study|Withdrawal by Subject|0|||
124493502|NCT01543490|447761397|FG000|Overall Study|Other-Various Administrative Reasons|1|||
124493503|NCT01543490|447761398|FG001|Overall Study|Other-Various Administrative Reasons|2|||
124493504|NCT04168645|447761401|FG000|Overall Study|Lost to Follow-up|23|||
124493505|NCT04168645|447761402|FG001|Overall Study|Lost to Follow-up|28|||
124493506|NCT04168645|447761403|FG002|Overall Study|Lost to Follow-up|15|||
124493507|NCT04168645|447761404|FG003|Overall Study|Lost to Follow-up|12|||
124493508|NCT04168645|447761401|FG000|Overall Study|Death|1|||
124493509|NCT04168645|447761402|FG001|Overall Study|Death|1|||
124493510|NCT04168645|447761403|FG002|Overall Study|Death|0|||
124493511|NCT04168645|447761404|FG003|Overall Study|Death|0|||
124493512|NCT04168645|447761401|FG000|Overall Study|Withdrawal by Subject|5|||
124493513|NCT04168645|447761402|FG001|Overall Study|Withdrawal by Subject|2|||
124493514|NCT04168645|447761403|FG002|Overall Study|Withdrawal by Subject|2|||
124493515|NCT04168645|447761404|FG003|Overall Study|Withdrawal by Subject|2|||
124493516|NCT04168645|447761401|FG000|Overall Study|Administrative Withdrawal|3|||
124493517|NCT04168645|447761402|FG001|Overall Study|Administrative Withdrawal|1|||
124493518|NCT04168645|447761403|FG002|Overall Study|Administrative Withdrawal|1|||
124493519|NCT04168645|447761404|FG003|Overall Study|Administrative Withdrawal|3|||
124493520|NCT03918642|447761405|FG000|Overall Study|Lost to Follow-up|12|||
124493521|NCT03918642|447761406|FG001|Overall Study|Lost to Follow-up|10|||
124493522|NCT03825042|447761407|FG000|Overall Study|Adverse Event|1|||
124493523|NCT03825042|447761408|FG001|Overall Study|Adverse Event|0|||
124493524|NCT03825042|447761407|FG000|Overall Study|Withdrawal by Subject|1|||
124493525|NCT03825042|447761408|FG001|Overall Study|Withdrawal by Subject|0|||
124493526|NCT02601001|447761409|FG000|Dosing Period 2|Adverse Event|0|||
124493527|NCT02601001|447761410|FG001|Dosing Period 2|Adverse Event|0|||
124493528|NCT02601001|447761411|FG002|Dosing Period 2|Adverse Event|0|||
124493529|NCT02601001|447761412|FG003|Dosing Period 2|Adverse Event|0|||
124493530|NCT02601001|447761413|FG004|Dosing Period 2|Adverse Event|0|||
124493531|NCT02601001|447761414|FG005|Dosing Period 2|Adverse Event|0|||
124493532|NCT02601001|447761415|FG006|Dosing Period 2|Adverse Event|1|||
124493533|NCT01988012|447761420|FG000|Overall Study|Adverse Event|5|||
124493534|NCT01988012|447761420|FG000|Overall Study|Insufficient Therapeutic Response|3|||
124493535|NCT01988012|447761420|FG000|Overall Study|Patient Withdrawal of Consent|4|||
124493536|NCT01988012|447761420|FG000|Overall Study|Lost to Follow-up|1|||
124493537|NCT01988012|447761420|FG000|Overall Study|Physician Decision|1|||
124493538|NCT01988012|447761420|FG000|Overall Study|Protocol Violation|1|||
124493539|NCT00089843|447761421|FG000|Overall Study|Withdrawal by Subject|1|||
124493540|NCT00089843|447761422|FG001|Overall Study|Withdrawal by Subject|4|||
124493541|NCT00089843|447761423|FG002|Overall Study|Withdrawal by Subject|5|||
124493542|NCT00089843|447761424|FG003|Overall Study|Withdrawal by Subject|6|||
124493543|NCT00089843|447761421|FG000|Overall Study|Physician Decision|1|||
124493544|NCT00089843|447761422|FG001|Overall Study|Physician Decision|0|||
124493545|NCT00089843|447761423|FG002|Overall Study|Physician Decision|0|||
124493546|NCT00089843|447761424|FG003|Overall Study|Physician Decision|1|||
124493547|NCT02115815|447761425|FG000|Overall Study|Withdrawal by Subject|2|||
124557867|NCT00606684|448001362|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
124557868|NCT00606684|448001363|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
124493548|NCT02115815|447761426|FG001|Overall Study|Withdrawal by Subject|0|||
124493549|NCT02115815|447761427|FG002|Overall Study|Withdrawal by Subject|0|||
124493550|NCT02115815|447761428|FG003|Overall Study|Withdrawal by Subject|0|||
124493551|NCT02115815|447761429|FG004|Overall Study|Withdrawal by Subject|0|||
124493552|NCT02115815|447761430|FG005|Overall Study|Withdrawal by Subject|0|||
124493553|NCT02115815|447761431|FG006|Overall Study|Withdrawal by Subject|0|||
124493554|NCT02115815|447761425|FG000|Overall Study|Not enough drug to dose participant|0|||
124493555|NCT02115815|447761426|FG001|Overall Study|Not enough drug to dose participant|0|||
124493556|NCT02115815|447761427|FG002|Overall Study|Not enough drug to dose participant|0|||
124493557|NCT02115815|447761428|FG003|Overall Study|Not enough drug to dose participant|0|||
124493558|NCT02115815|447761429|FG004|Overall Study|Not enough drug to dose participant|0|||
124493559|NCT02115815|447761430|FG005|Overall Study|Not enough drug to dose participant|1|||
124493560|NCT02115815|447761431|FG006|Overall Study|Not enough drug to dose participant|0|||
124493561|NCT02115815|447761425|FG000|Overall Study|Missed appointment, randomized in error|0|||
124493562|NCT02115815|447761426|FG001|Overall Study|Missed appointment, randomized in error|0|||
124493563|NCT02115815|447761427|FG002|Overall Study|Missed appointment, randomized in error|0|||
124493564|NCT02115815|447761428|FG003|Overall Study|Missed appointment, randomized in error|0|||
124557869|NCT00606684|448001364|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
124557870|NCT00606684|448001365|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
124557871|NCT00606684|448001359|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
124557872|NCT00606684|448001360|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
124557873|NCT00606684|448001361|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
124557874|NCT00606684|448001362|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
124557875|NCT00606684|448001363|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
124557876|NCT00606684|448001364|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
124557877|NCT00606684|448001365|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
124772123|NCT02113982|448796368|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
124772124|NCT02113982|448796369|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
124772125|NCT02113982|448796370|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
124493565|NCT02115815|447761429|FG004|Overall Study|Missed appointment, randomized in error|0|||
124493566|NCT02115815|447761430|FG005|Overall Study|Missed appointment, randomized in error|1|||
124493567|NCT02115815|447761431|FG006|Overall Study|Missed appointment, randomized in error|0|||
124493568|NCT01228071|447761432|FG000|Overall Study|Protocol Violation|1|||
124493569|NCT01228071|447761432|FG000|Overall Study|Withdrawal by Subject|1|||
124493570|NCT03314519|447761433|FG000|Overall Study|Protocol Violation|3|||
124493571|NCT03314519|447761434|FG001|Overall Study|Protocol Violation|2|||
124493572|NCT04003155|447761435|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
124493573|NCT04003155|447761436|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
124493574|NCT04003155|447761437|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
124493575|NCT04003155|447761438|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
124493576|NCT04003155|447761439|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
124493577|NCT04003155|447761435|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
124493578|NCT04003155|447761436|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
124493579|NCT04003155|447761437|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
124493580|NCT04003155|447761438|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
124493581|NCT04003155|447761439|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
124493582|NCT04003155|447761435|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
124493583|NCT04003155|447761436|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
124493584|NCT04003155|447761437|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
124493585|NCT04003155|447761438|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
124493586|NCT04003155|447761439|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
124493587|NCT04003155|447761435|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
124493588|NCT04003155|447761436|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
124493589|NCT04003155|447761437|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
124493590|NCT04003155|447761438|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
124493591|NCT04003155|447761439|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
124493592|NCT04003155|447761435|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
124493593|NCT04003155|447761436|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
124493594|NCT04003155|447761437|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
124493595|NCT04003155|447761438|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
124493596|NCT04003155|447761439|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
124493597|NCT04003155|447761435|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
124493598|NCT04003155|447761436|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
124493599|NCT04003155|447761437|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
124493600|NCT04003155|447761438|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
124493601|NCT04003155|447761439|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
124493602|NCT04003155|447761435|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
124493603|NCT04003155|447761436|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
124493604|NCT04003155|447761437|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
124493605|NCT04003155|447761438|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
124493606|NCT04003155|447761439|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
124493607|NCT04003155|447761435|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
124493608|NCT04003155|447761436|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
124493609|NCT04003155|447761437|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
124493610|NCT04003155|447761438|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
124493611|NCT04003155|447761439|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
124493612|NCT04003155|447761435|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
124493613|NCT04003155|447761436|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
124493614|NCT04003155|447761437|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
124493615|NCT04003155|447761438|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
124493616|NCT04003155|447761439|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
124493617|NCT01912872|447761440|FG000|Overall Study|Lost to Follow-up|2|||
124493618|NCT01912872|447761441|FG001|Overall Study|Lost to Follow-up|3|||
124557878|NCT00606684|448001359|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
124493619|NCT01912872|447761442|FG002|Overall Study|Lost to Follow-up|5|||
124493620|NCT01912872|447761443|FG003|Overall Study|Lost to Follow-up|5|||
124493621|NCT01912872|447761440|FG000|Overall Study|Other unspecified|3|||
124493622|NCT01912872|447761441|FG001|Overall Study|Other unspecified|1|||
124493623|NCT01912872|447761442|FG002|Overall Study|Other unspecified|3|||
124493624|NCT01912872|447761443|FG003|Overall Study|Other unspecified|0|||
124493625|NCT01912872|447761440|FG000|Overall Study|Informed consent withdrawn|0|||
124493626|NCT01912872|447761441|FG001|Overall Study|Informed consent withdrawn|0|||
124493627|NCT01912872|447761442|FG002|Overall Study|Informed consent withdrawn|1|||
124493628|NCT01912872|447761443|FG003|Overall Study|Informed consent withdrawn|1|||
124493629|NCT01912872|447761440|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
124493630|NCT01912872|447761441|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
124493631|NCT01912872|447761442|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
124493632|NCT01912872|447761443|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
124493633|NCT01912872|447761440|FG000|Overall Study|Protocol Violation|0|||
124493634|NCT01912872|447761441|FG001|Overall Study|Protocol Violation|0|||
124493635|NCT01912872|447761442|FG002|Overall Study|Protocol Violation|1|||
124493636|NCT01912872|447761443|FG003|Overall Study|Protocol Violation|0|||
124493637|NCT01912872|447761440|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124493638|NCT01912872|447761441|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124493639|NCT01912872|447761442|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
124493640|NCT01912872|447761443|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
124493641|NCT01912872|447761440|FG000|Overall Study|Withdrawal of study medication|0|||
124493642|NCT01912872|447761441|FG001|Overall Study|Withdrawal of study medication|0|||
124493643|NCT01912872|447761442|FG002|Overall Study|Withdrawal of study medication|0|||
124493644|NCT01912872|447761443|FG003|Overall Study|Withdrawal of study medication|2|||
124493645|NCT01912872|447761440|FG000|Overall Study|Missing|0|||
124493646|NCT01912872|447761441|FG001|Overall Study|Missing|0|||
124493647|NCT01912872|447761442|FG002|Overall Study|Missing|0|||
124493648|NCT01912872|447761443|FG003|Overall Study|Missing|1|||
124493649|NCT01713036|447761446|FG000|Overall Study|Death|1|||
124493650|NCT00915005|447761452|FG000|Overall Study|Withdrawal by Subject|4|||
124493651|NCT00915005|447761453|FG001|Overall Study|Withdrawal by Subject|4|||
124493652|NCT00915005|447761452|FG000|Overall Study|Patient preferred protons therapy|6|||
124493653|NCT00915005|447761453|FG001|Overall Study|Patient preferred protons therapy|0|||
124493654|NCT00915005|447761452|FG000|Overall Study|Insurance denial|3|||
124493655|NCT00915005|447761453|FG001|Overall Study|Insurance denial|15|||
124493656|NCT00631488|447761456|FG000|Overall Study|Adverse Event|1|||
124493657|NCT00631488|447761457|FG001|Overall Study|Adverse Event|0|||
124493658|NCT00631488|447761458|FG002|Overall Study|Adverse Event|0|||
124493659|NCT00631488|447761456|FG000|Overall Study|Lost to Follow-up|2|||
124493660|NCT00631488|447761457|FG001|Overall Study|Lost to Follow-up|2|||
124493661|NCT00631488|447761458|FG002|Overall Study|Lost to Follow-up|0|||
124493662|NCT00631488|447761456|FG000|Overall Study|Physician Decision|1|||
124493663|NCT00631488|447761457|FG001|Overall Study|Physician Decision|0|||
124493664|NCT00631488|447761458|FG002|Overall Study|Physician Decision|1|||
124493665|NCT00631488|447761456|FG000|Overall Study|Protocol Violation|0|||
124493666|NCT00631488|447761457|FG001|Overall Study|Protocol Violation|0|||
124493667|NCT00631488|447761458|FG002|Overall Study|Protocol Violation|1|||
124493668|NCT03648476|447761459|FG000|Overall Study|Withdrawal by Subject|2|||
124493669|NCT03648476|447761460|FG001|Overall Study|Withdrawal by Subject|1|||
124493670|NCT02639182|447761461|FG000|Overall Study|Disease Progression|50|||
124493671|NCT02639182|447761462|FG001|Overall Study|Disease Progression|49|||
124493672|NCT02639182|447761461|FG000|Overall Study|Adverse Event|7|||
124493673|NCT02639182|447761462|FG001|Overall Study|Adverse Event|5|||
124493674|NCT02639182|447761461|FG000|Overall Study|Physician Decision|3|||
124493675|NCT02639182|447761462|FG001|Overall Study|Physician Decision|3|||
124493676|NCT02639182|447761461|FG000|Overall Study|Withdrew Consent|5|||
124493677|NCT02639182|447761462|FG001|Overall Study|Withdrew Consent|4|||
124493678|NCT02639182|447761461|FG000|Overall Study|Lost to Follow-up|0|||
124493679|NCT02639182|447761462|FG001|Overall Study|Lost to Follow-up|1|||
124493680|NCT02639182|447761461|FG000|Overall Study|Study Closure|1|||
124493681|NCT02639182|447761462|FG001|Overall Study|Study Closure|2|||
124493682|NCT02639182|447761461|FG000|Overall Study|Sponsor Ended Study|0|||
124493683|NCT02639182|447761462|FG001|Overall Study|Sponsor Ended Study|1|||
124493684|NCT02639182|447761461|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
124493685|NCT02639182|447761462|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
124557879|NCT00606684|448001360|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
124722024|NCT02574078|448605495|FG001|Treatment Period|Maximum clinical benefit|0|||
124493686|NCT02546856|447761465|FG000|4 Months Evaluation|Death|2|||
124493687|NCT02546856|447761466|FG001|4 Months Evaluation|Death|3|||
124493688|NCT02546856|447761465|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
124493689|NCT02546856|447761466|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
124493690|NCT02546856|447761465|FG000|4 Months Evaluation|Lost to Follow-up|3|||
124493691|NCT02546856|447761466|FG001|4 Months Evaluation|Lost to Follow-up|3|||
124493692|NCT02546856|447761465|FG000|4 Months Evaluation|Physician Decision|3|||
124493693|NCT02546856|447761466|FG001|4 Months Evaluation|Physician Decision|0|||
124493694|NCT02546856|447761465|FG000|4 Months Evaluation|Working or living abroad|5|||
124772126|NCT02113982|448796371|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
124772127|NCT02113982|448796372|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
124772128|NCT02113982|448796373|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
124772129|NCT02113982|448796374|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
124772130|NCT02113982|448796375|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
124772131|NCT02113982|448796376|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
124772132|NCT02113982|448796377|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
124772133|NCT02113982|448796378|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
124772134|NCT02113982|448796379|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
124772135|NCT02113982|448796380|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
124772136|NCT02113982|448796381|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
124772137|NCT02113982|448796368|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
124772138|NCT02113982|448796369|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
124772139|NCT02113982|448796370|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
124772140|NCT02113982|448796371|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
124772141|NCT02113982|448796372|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
124772142|NCT02113982|448796373|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
124772143|NCT02113982|448796374|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
124772144|NCT02113982|448796375|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
124772145|NCT02113982|448796376|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
124772146|NCT02113982|448796377|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
124772147|NCT02113982|448796378|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
124772148|NCT02113982|448796379|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
124772149|NCT02113982|448796380|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
124772150|NCT02113982|448796381|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
124772151|NCT02113982|448796368|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
124772152|NCT02113982|448796369|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
124772153|NCT02113982|448796370|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
124772154|NCT02113982|448796371|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
124772155|NCT02113982|448796372|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
124772156|NCT02113982|448796373|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
124772157|NCT02113982|448796374|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
124772158|NCT02113982|448796375|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
124772159|NCT02113982|448796376|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
124772160|NCT02113982|448796377|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
124772161|NCT02113982|448796378|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
124772162|NCT02113982|448796379|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
124772163|NCT02113982|448796380|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
124772164|NCT02113982|448796381|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
124772165|NCT02113982|448796368|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
124772166|NCT02113982|448796369|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
124772167|NCT02113982|448796370|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
124772168|NCT02113982|448796371|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
124772169|NCT02113982|448796372|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
124772170|NCT02113982|448796373|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
124772171|NCT02113982|448796374|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
124772172|NCT02113982|448796375|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
124493695|NCT02546856|447761466|FG001|4 Months Evaluation|Working or living abroad|1|||
124493696|NCT02546856|447761465|FG000|4 Months Evaluation|reasons not due to titration|4|||
124493697|NCT02546856|447761466|FG001|4 Months Evaluation|reasons not due to titration|1|||
124493698|NCT02546856|447761465|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
124493699|NCT02546856|447761466|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
124493700|NCT02546856|447761465|FG000|6 Months Evaluation|Death|1|||
124493701|NCT02546856|447761466|FG001|6 Months Evaluation|Death|1|||
124493702|NCT02546856|447761465|FG000|6 Months Evaluation|Lost to Follow-up|1|||
124493703|NCT02546856|447761466|FG001|6 Months Evaluation|Lost to Follow-up|1|||
124493704|NCT02546856|447761465|FG000|6 Months Evaluation|Working or living abroad|6|||
124493705|NCT02546856|447761466|FG001|6 Months Evaluation|Working or living abroad|4|||
124493706|NCT02546856|447761465|FG000|6 Months Evaluation|reasons not due to titration|0|||
124493707|NCT02546856|447761466|FG001|6 Months Evaluation|reasons not due to titration|1|||
124493708|NCT01097616|447761467|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
124493709|NCT01097616|447761468|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
124493710|NCT01097616|447761469|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
124493711|NCT01097616|447761470|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
124493712|NCT01097616|447761471|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
124493713|NCT01097616|447761472|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
124772173|NCT02113982|448796376|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
124772174|NCT02113982|448796377|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
124772175|NCT02113982|448796378|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
124772176|NCT02113982|448796379|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
124493714|NCT01097616|447761473|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
124493715|NCT01097616|447761474|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
124493716|NCT01097616|447761467|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
124493717|NCT01097616|447761468|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
124493718|NCT01097616|447761469|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
124493719|NCT01097616|447761470|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
124493720|NCT01097616|447761471|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
124493721|NCT01097616|447761472|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
124493722|NCT01097616|447761473|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
124493723|NCT01097616|447761474|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
124493724|NCT01097616|447761467|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
124493725|NCT01097616|447761468|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
124493726|NCT01097616|447761469|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
124493727|NCT01097616|447761470|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
124493728|NCT01097616|447761471|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
124493729|NCT01097616|447761472|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
124493730|NCT01097616|447761473|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
124493731|NCT01097616|447761474|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
124493732|NCT01097616|447761467|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
124493733|NCT01097616|447761468|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
124493734|NCT01097616|447761469|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
124493735|NCT01097616|447761470|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
124493736|NCT01097616|447761471|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
124493737|NCT01097616|447761472|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
124493738|NCT01097616|447761473|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
124493739|NCT01097616|447761474|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
124493740|NCT01097616|447761467|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
124493741|NCT01097616|447761468|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
124493742|NCT01097616|447761469|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
124493743|NCT01097616|447761470|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
124493744|NCT01097616|447761471|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
124493745|NCT01097616|447761472|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
124493746|NCT01097616|447761473|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
124493747|NCT01097616|447761474|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
124493748|NCT01097616|447761467|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
124493749|NCT01097616|447761468|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
124493750|NCT01097616|447761469|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
124493751|NCT01097616|447761470|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
124493752|NCT01097616|447761471|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
124493753|NCT01097616|447761472|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
124493754|NCT01097616|447761473|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
124493755|NCT01097616|447761474|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
124493756|NCT01097616|447761467|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
124493757|NCT01097616|447761468|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
124493758|NCT01097616|447761469|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
124493759|NCT01097616|447761470|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
124493760|NCT01097616|447761471|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
124557880|NCT00606684|448001361|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
124557881|NCT00606684|448001362|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
124557882|NCT00606684|448001363|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
124557883|NCT00606684|448001364|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
124557884|NCT00606684|448001365|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
124557885|NCT00606684|448001359|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
124557886|NCT00606684|448001360|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
124493761|NCT01097616|447761472|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
124493762|NCT01097616|447761473|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
124493763|NCT01097616|447761474|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
124493764|NCT01097616|447761467|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
124493765|NCT01097616|447761468|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
124493766|NCT01097616|447761469|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
124493767|NCT01097616|447761470|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
124493768|NCT01097616|447761471|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
124493769|NCT01097616|447761472|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
124557887|NCT00606684|448001361|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
124772177|NCT02113982|448796380|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
124772178|NCT02113982|448796381|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
124772179|NCT02113982|448796368|FG000|Stage 2: Cohort Expansion|Transplant|0|||
124772180|NCT02113982|448796369|FG001|Stage 2: Cohort Expansion|Transplant|0|||
124772181|NCT02113982|448796370|FG002|Stage 2: Cohort Expansion|Transplant|0|||
124772182|NCT02113982|448796371|FG003|Stage 2: Cohort Expansion|Transplant|0|||
124772183|NCT02113982|448796372|FG004|Stage 2: Cohort Expansion|Transplant|0|||
124772184|NCT02113982|448796373|FG005|Stage 2: Cohort Expansion|Transplant|0|||
124772185|NCT02113982|448796374|FG006|Stage 2: Cohort Expansion|Transplant|0|||
124772186|NCT02113982|448796375|FG007|Stage 2: Cohort Expansion|Transplant|0|||
124772187|NCT02113982|448796376|FG008|Stage 2: Cohort Expansion|Transplant|0|||
124772188|NCT02113982|448796377|FG009|Stage 2: Cohort Expansion|Transplant|4|||
124772189|NCT02113982|448796378|FG010|Stage 2: Cohort Expansion|Transplant|2|||
124772190|NCT02113982|448796379|FG011|Stage 2: Cohort Expansion|Transplant|0|||
124772191|NCT02113982|448796380|FG012|Stage 2: Cohort Expansion|Transplant|0|||
124772192|NCT02113982|448796381|FG013|Stage 2: Cohort Expansion|Transplant|0|||
124772193|NCT02113982|448796368|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
124772194|NCT02113982|448796369|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
124772195|NCT02113982|448796370|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
124772196|NCT02113982|448796371|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
124772197|NCT02113982|448796372|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
124772198|NCT02113982|448796373|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
124772199|NCT02113982|448796374|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
124772200|NCT02113982|448796375|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
124772201|NCT02113982|448796376|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
124772202|NCT02113982|448796377|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
124772203|NCT02113982|448796378|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
124772204|NCT02113982|448796379|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
124772205|NCT02113982|448796380|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
124772206|NCT02113982|448796381|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
124772207|NCT02113982|448796368|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
124772208|NCT02113982|448796369|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
124772209|NCT02113982|448796370|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
124772210|NCT02113982|448796371|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
124493770|NCT01097616|447761473|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
124493771|NCT01097616|447761474|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
124493772|NCT01097616|447761467|FG000|Optional DB EXT Phase|Adverse Event|0|||
124493773|NCT01097616|447761468|FG001|Optional DB EXT Phase|Adverse Event|7|||
124493774|NCT01097616|447761469|FG002|Optional DB EXT Phase|Adverse Event|2|||
124493775|NCT01097616|447761470|FG003|Optional DB EXT Phase|Adverse Event|0|||
124493776|NCT01097616|447761471|FG004|Optional DB EXT Phase|Adverse Event|0|||
124493777|NCT01097616|447761472|FG005|Optional DB EXT Phase|Adverse Event|0|||
124493778|NCT01097616|447761473|FG006|Optional DB EXT Phase|Adverse Event|0|||
124493779|NCT01097616|447761474|FG007|Optional DB EXT Phase|Adverse Event|0|||
124493780|NCT01097616|447761467|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
124493781|NCT01097616|447761468|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
124493782|NCT01097616|447761469|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
124493783|NCT01097616|447761470|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
124493784|NCT01097616|447761471|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
124493785|NCT01097616|447761472|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
124493786|NCT01097616|447761473|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
124493787|NCT01097616|447761474|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
124493788|NCT01097616|447761467|FG000|Optional DB EXT Phase|Protocol Violation|0|||
124493789|NCT01097616|447761468|FG001|Optional DB EXT Phase|Protocol Violation|2|||
124493790|NCT01097616|447761469|FG002|Optional DB EXT Phase|Protocol Violation|3|||
124493791|NCT01097616|447761470|FG003|Optional DB EXT Phase|Protocol Violation|0|||
124493792|NCT01097616|447761471|FG004|Optional DB EXT Phase|Protocol Violation|0|||
124493793|NCT01097616|447761472|FG005|Optional DB EXT Phase|Protocol Violation|0|||
124493794|NCT01097616|447761473|FG006|Optional DB EXT Phase|Protocol Violation|0|||
124493795|NCT01097616|447761474|FG007|Optional DB EXT Phase|Protocol Violation|0|||
124493796|NCT01097616|447761467|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
124493797|NCT01097616|447761468|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
124493798|NCT01097616|447761469|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
124493799|NCT01097616|447761470|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
124493800|NCT01097616|447761471|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
124493801|NCT01097616|447761472|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
124493802|NCT01097616|447761473|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
124493803|NCT01097616|447761474|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
124772211|NCT02113982|448796372|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
124772212|NCT02113982|448796373|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
124772213|NCT02113982|448796374|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
124772214|NCT02113982|448796375|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
124772215|NCT02113982|448796376|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
124493804|NCT01097616|447761467|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
124493805|NCT01097616|447761468|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
124493806|NCT01097616|447761469|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
124493807|NCT01097616|447761470|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
124493808|NCT01097616|447761471|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
124493809|NCT01097616|447761472|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
124493810|NCT01097616|447761473|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
124493811|NCT01097616|447761474|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
124493812|NCT01097616|447761467|FG000|Optional DB EXT Phase|Physician Decision|1|||
124493813|NCT01097616|447761468|FG001|Optional DB EXT Phase|Physician Decision|0|||
124493814|NCT01097616|447761469|FG002|Optional DB EXT Phase|Physician Decision|0|||
124493815|NCT01097616|447761470|FG003|Optional DB EXT Phase|Physician Decision|0|||
124493816|NCT01097616|447761471|FG004|Optional DB EXT Phase|Physician Decision|0|||
124493817|NCT01097616|447761472|FG005|Optional DB EXT Phase|Physician Decision|0|||
124493818|NCT01097616|447761473|FG006|Optional DB EXT Phase|Physician Decision|0|||
124493819|NCT01097616|447761474|FG007|Optional DB EXT Phase|Physician Decision|0|||
124493820|NCT01097616|447761467|FG000|DB RO Phase|Adverse Event|0|||
124493821|NCT01097616|447761468|FG001|DB RO Phase|Adverse Event|0|||
124493822|NCT01097616|447761469|FG002|DB RO Phase|Adverse Event|0|||
124493823|NCT01097616|447761470|FG003|DB RO Phase|Adverse Event|0|||
124493824|NCT01097616|447761471|FG004|DB RO Phase|Adverse Event|0|||
124493825|NCT01097616|447761472|FG005|DB RO Phase|Adverse Event|0|||
124493826|NCT01097616|447761473|FG006|DB RO Phase|Adverse Event|1|||
124493827|NCT01097616|447761474|FG007|DB RO Phase|Adverse Event|0|||
124493828|NCT01097616|447761467|FG000|DB RO Phase|Withdrawal by Subject|0|||
124493829|NCT01097616|447761468|FG001|DB RO Phase|Withdrawal by Subject|0|||
124493830|NCT01097616|447761469|FG002|DB RO Phase|Withdrawal by Subject|0|||
124493831|NCT01097616|447761470|FG003|DB RO Phase|Withdrawal by Subject|0|||
124493832|NCT01097616|447761471|FG004|DB RO Phase|Withdrawal by Subject|0|||
124493833|NCT01097616|447761472|FG005|DB RO Phase|Withdrawal by Subject|1|||
124493834|NCT01097616|447761473|FG006|DB RO Phase|Withdrawal by Subject|0|||
124493835|NCT01097616|447761474|FG007|DB RO Phase|Withdrawal by Subject|0|||
124493836|NCT01097616|447761467|FG000|DB RO Phase|Lost to Follow-up|0|||
124493837|NCT01097616|447761468|FG001|DB RO Phase|Lost to Follow-up|0|||
124493838|NCT01097616|447761469|FG002|DB RO Phase|Lost to Follow-up|0|||
124493839|NCT01097616|447761470|FG003|DB RO Phase|Lost to Follow-up|1|||
124493840|NCT01097616|447761471|FG004|DB RO Phase|Lost to Follow-up|1|||
124493841|NCT01097616|447761472|FG005|DB RO Phase|Lost to Follow-up|0|||
124493842|NCT01097616|447761473|FG006|DB RO Phase|Lost to Follow-up|0|||
124493843|NCT01097616|447761474|FG007|DB RO Phase|Lost to Follow-up|1|||
124493844|NCT01097616|447761467|FG000|DB RO Phase|Not Treated in RO|0|||
124493845|NCT01097616|447761468|FG001|DB RO Phase|Not Treated in RO|0|||
124493846|NCT01097616|447761469|FG002|DB RO Phase|Not Treated in RO|0|||
124493847|NCT01097616|447761470|FG003|DB RO Phase|Not Treated in RO|0|||
124493848|NCT01097616|447761471|FG004|DB RO Phase|Not Treated in RO|0|||
124493849|NCT01097616|447761472|FG005|DB RO Phase|Not Treated in RO|1|||
124493850|NCT01097616|447761473|FG006|DB RO Phase|Not Treated in RO|0|||
124493851|NCT01097616|447761474|FG007|DB RO Phase|Not Treated in RO|0|||
124493852|NCT04504032|447761475|FG000|Overall Study|Adverse Event|1|||
124493853|NCT04504032|447761476|FG001|Overall Study|Adverse Event|2|||
124493854|NCT04504032|447761475|FG000|Overall Study|Lost to Follow-up|6|||
124493855|NCT04504032|447761476|FG001|Overall Study|Lost to Follow-up|9|||
124493856|NCT04504032|447761475|FG000|Overall Study|Protocol Violation|2|||
124493857|NCT04504032|447761476|FG001|Overall Study|Protocol Violation|0|||
124493858|NCT04504032|447761475|FG000|Overall Study|Study terminated by sponsor|1|||
124493859|NCT04504032|447761476|FG001|Overall Study|Study terminated by sponsor|2|||
124493860|NCT04504032|447761475|FG000|Overall Study|Withdrawal by Subject|9|||
124493861|NCT04504032|447761476|FG001|Overall Study|Withdrawal by Subject|11|||
124493862|NCT04504032|447761475|FG000|Overall Study|Disease progression prior to dosing|15|||
124493863|NCT04504032|447761476|FG001|Overall Study|Disease progression prior to dosing|3|||
124493864|NCT04504032|447761475|FG000|Overall Study|Drug supply issues|1|||
124493865|NCT04504032|447761476|FG001|Overall Study|Drug supply issues|1|||
124493866|NCT04504032|447761475|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
124493867|NCT04504032|447761476|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
124493868|NCT00771030|447761477|FG000|Overall Study|Adverse Event|0|||
124493869|NCT00771030|447761478|FG001|Overall Study|Adverse Event|1|||
124493870|NCT00771030|447761479|FG002|Overall Study|Adverse Event|0|||
124493871|NCT00771030|447761480|FG003|Overall Study|Adverse Event|0|||
124493872|NCT00771030|447761481|FG004|Overall Study|Adverse Event|0|||
124493873|NCT00771030|447761482|FG005|Overall Study|Adverse Event|0|||
124493874|NCT00771030|447761483|FG006|Overall Study|Adverse Event|0|||
124493875|NCT01839188|447761484|FG000|Overall Study|Withdrawal by Subject|1|||
124493876|NCT01302769|447761495|FG000|Overall Study|Lost to Follow-up|1|||
124493877|NCT01302769|447761496|FG001|Overall Study|Lost to Follow-up|1|||
124493878|NCT01845077|447761497|FG000|Washout Period|Lost to Follow-up|0|||
124493879|NCT01845077|447761498|FG001|Washout Period|Lost to Follow-up|1|||
124493880|NCT01845077|447761499|FG002|Washout Period|Lost to Follow-up|0|||
124493881|NCT01845077|447761500|FG003|Washout Period|Lost to Follow-up|1|||
124493882|NCT01845077|447761501|FG004|Washout Period|Lost to Follow-up|0|||
124493883|NCT01845077|447761502|FG005|Washout Period|Lost to Follow-up|1|||
124493884|NCT01845077|447761497|FG000|Washout Period|Adverse Event|1|||
124493885|NCT01845077|447761498|FG001|Washout Period|Adverse Event|0|||
124493886|NCT01845077|447761499|FG002|Washout Period|Adverse Event|0|||
124493887|NCT01845077|447761500|FG003|Washout Period|Adverse Event|0|||
124493888|NCT01845077|447761501|FG004|Washout Period|Adverse Event|0|||
124493889|NCT01845077|447761502|FG005|Washout Period|Adverse Event|0|||
124493890|NCT01845077|447761497|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
124493891|NCT01845077|447761498|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
124493892|NCT01845077|447761499|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
124493893|NCT01845077|447761500|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
124493894|NCT01845077|447761501|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
124493895|NCT01845077|447761502|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
124493896|NCT01845077|447761497|FG000|Washout Period|Protocol Violation|0|||
124493897|NCT01845077|447761498|FG001|Washout Period|Protocol Violation|0|||
124493898|NCT01845077|447761499|FG002|Washout Period|Protocol Violation|0|||
124493899|NCT01845077|447761500|FG003|Washout Period|Protocol Violation|1|||
124493900|NCT01845077|447761501|FG004|Washout Period|Protocol Violation|1|||
124493901|NCT01845077|447761502|FG005|Washout Period|Protocol Violation|0|||
124493902|NCT00394914|447761503|FG000|Treatment Period|Adverse Event|0|||
124493903|NCT00394914|447761504|FG001|Treatment Period|Adverse Event|3|||
124493904|NCT00394914|447761505|FG002|Treatment Period|Adverse Event|1|||
124493905|NCT00394914|447761503|FG000|Treatment Period|Lost to Follow-up|0|||
124493906|NCT00394914|447761504|FG001|Treatment Period|Lost to Follow-up|1|||
124493907|NCT00394914|447761505|FG002|Treatment Period|Lost to Follow-up|0|||
124772216|NCT02113982|448796377|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
124772217|NCT02113982|448796378|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
124772218|NCT02113982|448796379|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
124772219|NCT02113982|448796380|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
124772220|NCT02113982|448796381|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
124493908|NCT00394914|447761503|FG000|Treatment Period|Withdrawal by Subject|0|||
124493909|NCT00394914|447761504|FG001|Treatment Period|Withdrawal by Subject|2|||
124493910|NCT00394914|447761505|FG002|Treatment Period|Withdrawal by Subject|2|||
124493911|NCT00394914|447761503|FG000|Treatment Period|Noncompliance with protocol|0|||
124493912|NCT00394914|447761504|FG001|Treatment Period|Noncompliance with protocol|3|||
124493913|NCT00394914|447761505|FG002|Treatment Period|Noncompliance with protocol|2|||
124493914|NCT00394914|447761503|FG000|Treatment Period|Did not meet protocol eligibility|0|||
124493915|NCT00394914|447761504|FG001|Treatment Period|Did not meet protocol eligibility|1|||
124493916|NCT00394914|447761505|FG002|Treatment Period|Did not meet protocol eligibility|1|||
124493917|NCT00312377|447761506|FG000|Overall Study|Death|403|||
124493918|NCT00312377|447761507|FG001|Overall Study|Death|418|||
124493919|NCT00312377|447761506|FG000|Overall Study|Withdrawal by Subject|23|||
124493920|NCT00312377|447761507|FG001|Overall Study|Withdrawal by Subject|30|||
124493921|NCT00312377|447761506|FG000|Overall Study|Lost to Follow-up|9|||
124493922|NCT00312377|447761507|FG001|Overall Study|Lost to Follow-up|12|||
124493923|NCT00312377|447761506|FG000|Overall Study|Non-compliance|0|||
124493924|NCT00312377|447761507|FG001|Overall Study|Non-compliance|2|||
124493925|NCT00312377|447761506|FG000|Overall Study|Randomised but never received treatment|6|||
124557888|NCT00606684|448001362|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
124557889|NCT00606684|448001363|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
124557890|NCT00606684|448001364|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
124557891|NCT00606684|448001365|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
124557892|NCT00606684|448001359|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
124557893|NCT00606684|448001360|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
124557894|NCT00606684|448001361|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
124557895|NCT00606684|448001362|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
124557896|NCT00606684|448001363|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
124557897|NCT00606684|448001364|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
124557898|NCT00606684|448001365|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
124557899|NCT00606684|448001359|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
124557900|NCT00606684|448001360|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
124493926|NCT00312377|447761507|FG001|Overall Study|Randomised but never received treatment|6|||
124557901|NCT00606684|448001361|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
124493927|NCT00312377|447761506|FG000|Overall Study|Discontinue treatment survival follow up|202|||
124493928|NCT00312377|447761507|FG001|Overall Study|Discontinue treatment survival follow up|200|||
124493929|NCT00312377|447761506|FG000|Overall Study|Site ended participation in study|1|||
124493930|NCT00312377|447761507|FG001|Overall Study|Site ended participation in study|0|||
124493931|NCT00872898|447761508|FG000|Part Two - Double Blind|Adverse Event|4|||
124493932|NCT00872898|447761509|FG001|Part Two - Double Blind|Adverse Event|3|||
124557902|NCT00606684|448001362|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
124557903|NCT00606684|448001363|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
124772221|NCT02113982|448796368|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
124493933|NCT00872898|447761508|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
124493934|NCT00872898|447761509|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
124493935|NCT00872898|447761508|FG000|Part Two - Double Blind|Protocol Violation|1|||
124493936|NCT00872898|447761509|FG001|Part Two - Double Blind|Protocol Violation|0|||
124493937|NCT00872898|447761508|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
124493938|NCT00872898|447761509|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
124493939|NCT00872898|447761508|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
124493940|NCT00872898|447761509|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
124493941|NCT00872898|447761508|FG000|Part Two - Double Blind|Other reasons|2|||
124493942|NCT00872898|447761509|FG001|Part Two - Double Blind|Other reasons|0|||
124493943|NCT01137435|447761510|FG000|Overall Study|Lost to Follow-up|24|||
124493944|NCT01137435|447761510|FG000|Overall Study|Off label usage|4|||
124493945|NCT01416610|447761511|FG000|Overall Study|Adverse Event|4|||
124493946|NCT01416610|447761511|FG000|Overall Study|Adverse Event -Patient decision|3|||
124493947|NCT01416610|447761511|FG000|Overall Study|Lack of Efficacy|4|||
124493948|NCT01416610|447761511|FG000|Overall Study|No reason given|5|||
124493949|NCT01416610|447761511|FG000|Overall Study|Withdrawal by Subject|13|||
124493950|NCT01416610|447761511|FG000|Overall Study|Lost to Follow-up|7|||
124493951|NCT01416610|447761511|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
124493952|NCT01927562|447761512|FG000|Overall Study|Lost to Follow-up|30|||
124493953|NCT01927562|447761512|FG000|Overall Study|Withdrawal by Subject|3|||
124493954|NCT01927562|447761512|FG000|Overall Study|Physician Decision|5|||
124493955|NCT03176966|447761513|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
124493956|NCT03176966|447761514|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
124493957|NCT03176966|447761513|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
124493958|NCT03176966|447761514|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
124493959|NCT03176966|447761513|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
124493960|NCT03176966|447761514|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
124493961|NCT03176966|447761513|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
124493962|NCT03176966|447761514|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
124493963|NCT03176966|447761513|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
124493964|NCT03176966|447761514|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
124493965|NCT03176966|447761513|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
124493966|NCT03176966|447761514|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
124493967|NCT03176966|447761513|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
124493968|NCT03176966|447761514|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
124493969|NCT01520922|447761518|FG000|Treatment Phase|Physician Decision|2|||
124493970|NCT01520922|447761519|FG001|Treatment Phase|Physician Decision|1|||
124493971|NCT01520922|447761518|FG000|Treatment Phase|Progression|0|||
124493972|NCT01520922|447761519|FG001|Treatment Phase|Progression|2|||
124493973|NCT01520922|447761518|FG000|Treatment Phase|Adverse Event|3|||
124493974|NCT01520922|447761519|FG001|Treatment Phase|Adverse Event|5|||
124493975|NCT01520922|447761518|FG000|Follow up|Lost to Follow-up|0|||
124493976|NCT01520922|447761519|FG001|Follow up|Lost to Follow-up|1|||
124493977|NCT01520922|447761518|FG000|Survival Follow-up|Withdrawal by Subject|1|||
124493978|NCT01520922|447761519|FG001|Survival Follow-up|Withdrawal by Subject|0|||
124493979|NCT01696877|447761520|FG000|Overall Study|Adverse Event|0|||
124493980|NCT01696877|447761521|FG001|Overall Study|Adverse Event|1|||
124493981|NCT04770155|447761526|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
124493982|NCT04770155|447761527|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
124493983|NCT04770155|447761528|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
124493984|NCT04770155|447761529|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
124493985|NCT04770155|447761530|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
124493986|NCT04770155|447761531|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
124493987|NCT04770155|447761532|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
124493988|NCT04770155|447761533|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
124493989|NCT00336492|447761546|FG000|Overall Study|Adverse Event|4|||
124493990|NCT00336492|447761547|FG001|Overall Study|Adverse Event|3|||
124493991|NCT00336492|447761548|FG002|Overall Study|Adverse Event|6|||
124493992|NCT00336492|447761546|FG000|Overall Study|Lack of Efficacy|6|||
124493993|NCT00336492|447761547|FG001|Overall Study|Lack of Efficacy|1|||
124493994|NCT00336492|447761548|FG002|Overall Study|Lack of Efficacy|4|||
124493995|NCT00336492|447761546|FG000|Overall Study|Other|5|||
124493996|NCT00336492|447761547|FG001|Overall Study|Other|0|||
124493997|NCT00336492|447761548|FG002|Overall Study|Other|1|||
124493998|NCT00227877|447761549|FG000|Pre-visit Assessment|Technical difficulties|7|||
124493999|NCT00227877|447761550|FG001|Pre-visit Assessment|Technical difficulties|3|||
124494000|NCT00227877|447761551|FG002|Pre-visit Assessment|Technical difficulties|0|||
124494001|NCT00227877|447761552|FG003|Pre-visit Assessment|Technical difficulties|0|||
124494002|NCT00227877|447761549|FG000|Post-visit Checklist|Lost to Follow-up|24|||
124494003|NCT00227877|447761550|FG001|Post-visit Checklist|Lost to Follow-up|13|||
124494004|NCT00227877|447761551|FG002|Post-visit Checklist|Lost to Follow-up|1|||
124494005|NCT00227877|447761552|FG003|Post-visit Checklist|Lost to Follow-up|0|||
124494006|NCT00227877|447761549|FG000|3-months Follow-up|Completed late|135|||
124494007|NCT00227877|447761550|FG001|3-months Follow-up|Completed late|128|||
124494008|NCT00227877|447761551|FG002|3-months Follow-up|Completed late|34|||
124494009|NCT00227877|447761552|FG003|3-months Follow-up|Completed late|8|||
124494010|NCT00227877|447761549|FG000|3-months Follow-up|Lost to Follow-up|178|||
124494011|NCT00227877|447761550|FG001|3-months Follow-up|Lost to Follow-up|139|||
124494012|NCT00227877|447761551|FG002|3-months Follow-up|Lost to Follow-up|18|||
124494013|NCT00227877|447761552|FG003|3-months Follow-up|Lost to Follow-up|13|||
124494014|NCT00227877|447761549|FG000|12-months Follow-up|Completed late|78|||
124494015|NCT00227877|447761550|FG001|12-months Follow-up|Completed late|74|||
124494016|NCT00227877|447761551|FG002|12-months Follow-up|Completed late|1|||
124494017|NCT00227877|447761552|FG003|12-months Follow-up|Completed late|0|||
124494018|NCT00227877|447761549|FG000|12-months Follow-up|Lost to Follow-up|232|||
124494019|NCT00227877|447761550|FG001|12-months Follow-up|Lost to Follow-up|189|||
124494020|NCT00227877|447761551|FG002|12-months Follow-up|Lost to Follow-up|30|||
124494021|NCT00227877|447761552|FG003|12-months Follow-up|Lost to Follow-up|26|||
124494022|NCT01240811|447762830|FG000|Overall Study|Physician Decision|0|||
124494023|NCT01240811|447762831|FG001|Overall Study|Physician Decision|1|||
124494024|NCT01240811|447762832|FG002|Overall Study|Physician Decision|0|||
124494025|NCT01240811|447762830|FG000|Overall Study|Withdrawal by Subject|0|||
124494026|NCT01240811|447762831|FG001|Overall Study|Withdrawal by Subject|0|||
124494027|NCT01240811|447762832|FG002|Overall Study|Withdrawal by Subject|1|||
124494028|NCT03132805|447762835|FG000|Overall Study|Lost to Follow-up|142|||
124494029|NCT03132805|447762836|FG001|Overall Study|Lost to Follow-up|141|||
124494030|NCT03132805|447762837|FG002|Overall Study|Lost to Follow-up|113|||
124494031|NCT00500149|447762838|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
124494032|NCT00500149|447762839|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
124494033|NCT00500149|447762838|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
124494034|NCT00500149|447762839|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
124494035|NCT00500149|447762838|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
124494036|NCT00500149|447762839|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
124494037|NCT00500149|447762838|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
124494038|NCT00500149|447762839|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
124494039|NCT00500149|447762838|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
124494040|NCT00500149|447762839|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
124494041|NCT00500149|447762838|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
124494042|NCT00500149|447762839|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
124494043|NCT00500149|447762838|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
124494044|NCT00500149|447762839|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
124494045|NCT03123354|447762840|FG000|Overall Study|Physician Decision|6|||
124494046|NCT02778867|447762841|FG000|Phase 1|Withdrawal by Subject|2|||
124494047|NCT02778867|447762842|FG001|Phase 1|Withdrawal by Subject|3|||
124494048|NCT02778867|447762843|FG002|Phase 1|Withdrawal by Subject|0|||
124494049|NCT02778867|447762844|FG003|Phase 1|Withdrawal by Subject|0|||
124494050|NCT02778867|447762841|FG000|Phase 2|Withdrawal by Subject|0|||
124494051|NCT02778867|447762842|FG001|Phase 2|Withdrawal by Subject|0|||
124494052|NCT02778867|447762843|FG002|Phase 2|Withdrawal by Subject|1|||
124494053|NCT02778867|447762844|FG003|Phase 2|Withdrawal by Subject|0|||
124494054|NCT02778867|447762841|FG000|Phase 2|Physician Decision|0|||
124494055|NCT02778867|447762842|FG001|Phase 2|Physician Decision|0|||
124494056|NCT02778867|447762843|FG002|Phase 2|Physician Decision|0|||
124494057|NCT02778867|447762844|FG003|Phase 2|Physician Decision|1|||
124494058|NCT02778867|447762841|FG000|Phase 2|Adverse Event|0|||
124494059|NCT02778867|447762842|FG001|Phase 2|Adverse Event|0|||
124494060|NCT02778867|447762843|FG002|Phase 2|Adverse Event|0|||
124494061|NCT02778867|447762844|FG003|Phase 2|Adverse Event|1|||
124494062|NCT03504774|447762845|FG000|Overall Study|Adverse Event|2|||
124494063|NCT03504774|447762846|FG001|Overall Study|Adverse Event|0|||
124494064|NCT03504774|447762845|FG000|Overall Study|Lost to Follow-up|0|||
124494065|NCT03504774|447762846|FG001|Overall Study|Lost to Follow-up|1|||
124494066|NCT03504774|447762845|FG000|Overall Study|Protocol Violation|11|||
124494067|NCT03504774|447762846|FG001|Overall Study|Protocol Violation|3|||
124494068|NCT03504774|447762845|FG000|Overall Study|failed wk 52 DBPCFC|1|||
124494069|NCT03504774|447762846|FG001|Overall Study|failed wk 52 DBPCFC|0|||
124494070|NCT00305006|447762851|FG000|Overall Study|Withdrawal by Subject|1|||
124494071|NCT00305006|447762852|FG001|Overall Study|Withdrawal by Subject|0|||
124494072|NCT00305006|447762851|FG000|Overall Study|Failure to complete pretest|0|||
124494073|NCT00305006|447762852|FG001|Overall Study|Failure to complete pretest|1|||
124494074|NCT01703819|447762859|FG000|Overall Study|Adverse Event|0|||
124494075|NCT01703819|447762860|FG001|Overall Study|Adverse Event|1|||
124494076|NCT01703819|447762859|FG000|Overall Study|Withdrawal by Subject|0|||
124494077|NCT01703819|447762860|FG001|Overall Study|Withdrawal by Subject|1|||
124494078|NCT00859898|447762861|FG000|Overall Study|Lack of Efficacy|0|||
124494079|NCT00859898|447762862|FG001|Overall Study|Lack of Efficacy|1|||
124494080|NCT00859898|447762863|FG002|Overall Study|Lack of Efficacy|1|||
124494081|NCT00859898|447762861|FG000|Overall Study|Adverse Event|4|||
124494082|NCT00859898|447762862|FG001|Overall Study|Adverse Event|9|||
124494083|NCT00859898|447762863|FG002|Overall Study|Adverse Event|8|||
124494084|NCT00859898|447762861|FG000|Overall Study|Withdrawal by Subject|11|||
124494085|NCT00859898|447762862|FG001|Overall Study|Withdrawal by Subject|8|||
124494086|NCT00859898|447762863|FG002|Overall Study|Withdrawal by Subject|11|||
124494087|NCT00859898|447762861|FG000|Overall Study|Death|0|||
124494088|NCT00859898|447762862|FG001|Overall Study|Death|0|||
124494089|NCT00859898|447762863|FG002|Overall Study|Death|1|||
124494090|NCT00859898|447762861|FG000|Overall Study|Lost to Follow-up|10|||
124494091|NCT00859898|447762862|FG001|Overall Study|Lost to Follow-up|11|||
124494092|NCT00859898|447762863|FG002|Overall Study|Lost to Follow-up|5|||
124494093|NCT00859898|447762861|FG000|Overall Study|poor/non-compliance|2|||
124494094|NCT00859898|447762862|FG001|Overall Study|poor/non-compliance|0|||
124494095|NCT00859898|447762863|FG002|Overall Study|poor/non-compliance|0|||
124494096|NCT00859898|447762861|FG000|Overall Study|No longer meets criteria|0|||
124494097|NCT00859898|447762862|FG001|Overall Study|No longer meets criteria|1|||
124494098|NCT00859898|447762863|FG002|Overall Study|No longer meets criteria|0|||
124494099|NCT00859898|447762861|FG000|Overall Study|non-specified|1|||
124494100|NCT00859898|447762862|FG001|Overall Study|non-specified|1|||
124494101|NCT00859898|447762863|FG002|Overall Study|non-specified|1|||
124494102|NCT02145156|447762864|FG000|Overall Study|No match to vaccination records|60|||
124494103|NCT02145156|447762865|FG001|Overall Study|No match to vaccination records|52|||
124494104|NCT02145156|447762866|FG002|Overall Study|No match to vaccination records|41|||
124494105|NCT01302041|447762867|FG000|Overall Study|Death|5|||
124494106|NCT01302041|447762867|FG000|Overall Study|Withdrawal by Subject|4|||
124494107|NCT01302041|447762867|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
124494108|NCT01302041|447762867|FG000|Overall Study|Other-Miscellaneous Reason|2|||
124494109|NCT02416908|447762870|FG000|Dose Escalation Phase|Adverse Event|0|||
124494110|NCT02416908|447762871|FG001|Dose Escalation Phase|Adverse Event|0|||
124494111|NCT02416908|447762872|FG002|Dose Escalation Phase|Adverse Event|3|||
124494112|NCT02416908|447762873|FG003|Dose Escalation Phase|Adverse Event|0|||
124494113|NCT02416908|447762870|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
124494114|NCT02416908|447762871|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
124494115|NCT02416908|447762872|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
124494116|NCT02416908|447762873|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
124494117|NCT01797783|447762874|FG000|Overall Study|Adverse Event|1|||
124494118|NCT01797783|447762875|FG001|Overall Study|Adverse Event|1|||
124494119|NCT01797783|447762874|FG000|Overall Study|Withdrawal by Subject|1|||
124494120|NCT01797783|447762875|FG001|Overall Study|Withdrawal by Subject|0|||
124494121|NCT00940342|447762876|FG000|Overall Study|Adverse Event|0|||
124494122|NCT00940342|447762877|FG001|Overall Study|Adverse Event|2|||
124494123|NCT00940342|447762878|FG002|Overall Study|Adverse Event|1|||
124494124|NCT05232097|447762879|FG000|Overall Study|Physician Decision|1|||
124494125|NCT01327339|447762880|FG000|Overall Study|Protocol Violation|8|||
124494126|NCT00700752|447762885|FG000|First Intervention|Withdrawal by Subject|0|||
124494127|NCT00700752|447762886|FG001|First Intervention|Withdrawal by Subject|2|||
124494128|NCT03662334|447762887|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
124494129|NCT03662334|447762888|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
124772222|NCT02113982|448796369|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
124772223|NCT02113982|448796370|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
124772224|NCT02113982|448796371|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
124772225|NCT02113982|448796372|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
124772226|NCT02113982|448796373|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
124772227|NCT02113982|448796374|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
124494130|NCT01097330|447762896|FG000|Overall Study|Study terminated early|7|||
124494131|NCT01097330|447762897|FG001|Overall Study|Study terminated early|5|||
124494132|NCT02853331|447762903|FG000|Overall Study|Death|59|||
124494133|NCT02853331|447762904|FG001|Overall Study|Death|95|||
124494134|NCT02853331|447762903|FG000|Overall Study|Withdrawal by Subject|5|||
124494135|NCT02853331|447762904|FG001|Overall Study|Withdrawal by Subject|9|||
124494136|NCT02853331|447762903|FG000|Overall Study|Ongoing in study|368|||
124494137|NCT02853331|447762904|FG001|Overall Study|Ongoing in study|325|||
124494138|NCT03290300|447762911|FG000|Overall Study|Lost to Follow-up|3|||
124494139|NCT01276847|447762918|FG000|Overall Study|Withdrawal by Subject|1|||
124494140|NCT01276847|447762919|FG001|Overall Study|Withdrawal by Subject|0|||
124772228|NCT02113982|448796375|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
124494141|NCT01276847|447762920|FG002|Overall Study|Withdrawal by Subject|0|||
124494142|NCT01899144|447762921|FG000|Treatment Period 2|Other|1|||
124494143|NCT01899144|447762921|FG000|Treatment Period 3|Other|2|||
124494144|NCT01899144|447762921|FG000|Treatment Period 5|Other|1|||
124494145|NCT00751881|447762924|FG000|Core Treatment Period|Not treated|1|||
124494146|NCT00751881|447762925|FG001|Core Treatment Period|Not treated|1|||
124772229|NCT02113982|448796376|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
124557904|NCT00606684|448001364|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
124722025|NCT02574078|448605496|FG002|Treatment Period|Maximum clinical benefit|0|||
124494147|NCT00751881|447762926|FG002|Core Treatment Period|Not treated|2|||
124494148|NCT00751881|447762924|FG000|Core Treatment Period|Adverse Event|26|||
124494149|NCT00751881|447762925|FG001|Core Treatment Period|Adverse Event|54|||
124494150|NCT00751881|447762926|FG002|Core Treatment Period|Adverse Event|58|||
124494151|NCT00751881|447762924|FG000|Core Treatment Period|Lack of Efficacy|37|||
124494152|NCT00751881|447762925|FG001|Core Treatment Period|Lack of Efficacy|30|||
124494153|NCT00751881|447762926|FG002|Core Treatment Period|Lack of Efficacy|20|||
124494154|NCT00751881|447762924|FG000|Core Treatment Period|Poor compliance to protocol|15|||
124494155|NCT00751881|447762925|FG001|Core Treatment Period|Poor compliance to protocol|3|||
124494156|NCT00751881|447762926|FG002|Core Treatment Period|Poor compliance to protocol|4|||
124494157|NCT00751881|447762924|FG000|Core Treatment Period|Lost to Follow-up|6|||
124494158|NCT00751881|447762925|FG001|Core Treatment Period|Lost to Follow-up|4|||
124494159|NCT00751881|447762926|FG002|Core Treatment Period|Lost to Follow-up|3|||
124494160|NCT00751881|447762924|FG000|Core Treatment Period|Other: protocol deviation|3|||
124494161|NCT00751881|447762925|FG001|Core Treatment Period|Other: protocol deviation|3|||
124494162|NCT00751881|447762926|FG002|Core Treatment Period|Other: protocol deviation|7|||
124494163|NCT00751881|447762924|FG000|Core Treatment Period|Other: wish to parent|5|||
124494164|NCT00751881|447762925|FG001|Core Treatment Period|Other: wish to parent|7|||
124494165|NCT00751881|447762926|FG002|Core Treatment Period|Other: wish to parent|4|||
124494166|NCT00751881|447762924|FG000|Core Treatment Period|Other: personal/family constraints|6|||
124494167|NCT00751881|447762925|FG001|Core Treatment Period|Other: personal/family constraints|7|||
124494168|NCT00751881|447762926|FG002|Core Treatment Period|Other: personal/family constraints|10|||
124494169|NCT00751881|447762924|FG000|Core Treatment Period|Other: MS treatment change|6|||
124494170|NCT00751881|447762925|FG001|Core Treatment Period|Other: MS treatment change|4|||
124494171|NCT00751881|447762926|FG002|Core Treatment Period|Other: MS treatment change|4|||
124494172|NCT00751881|447762924|FG000|Core Treatment Period|Other: tolerability complaints|2|||
124494173|NCT00751881|447762925|FG001|Core Treatment Period|Other: tolerability complaints|0|||
124494174|NCT00751881|447762926|FG002|Core Treatment Period|Other: tolerability complaints|0|||
124494175|NCT00751881|447762924|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
124494176|NCT00751881|447762925|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
124494177|NCT00751881|447762926|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
124494178|NCT00751881|447762924|FG000|Extension Study Period|Adverse Event|18|||
124494179|NCT00751881|447762925|FG001|Extension Study Period|Adverse Event|20|||
124494180|NCT00751881|447762926|FG002|Extension Study Period|Adverse Event|21|||
124494181|NCT00751881|447762924|FG000|Extension Study Period|Lack of Efficacy|14|||
124494182|NCT00751881|447762925|FG001|Extension Study Period|Lack of Efficacy|10|||
124494183|NCT00751881|447762926|FG002|Extension Study Period|Lack of Efficacy|20|||
124494184|NCT00751881|447762924|FG000|Extension Study Period|Lost to Follow-up|4|||
124494185|NCT00751881|447762925|FG001|Extension Study Period|Lost to Follow-up|9|||
124494186|NCT00751881|447762926|FG002|Extension Study Period|Lost to Follow-up|6|||
124494187|NCT00751881|447762924|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
124494188|NCT00751881|447762925|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
124494189|NCT00751881|447762926|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
124494190|NCT00751881|447762924|FG000|Extension Study Period|Other than specified above|26|||
124494191|NCT00751881|447762925|FG001|Extension Study Period|Other than specified above|30|||
124494192|NCT00751881|447762926|FG002|Extension Study Period|Other than specified above|18|||
124494193|NCT00864227|447762927|FG000|Overall Study|Withdrawal by Subject|1|||
124494194|NCT00864227|447762927|FG000|Overall Study|Disease Relapse/Progression|3|||
124494195|NCT03461289|447762929|FG000|Overall Study|Death|1|||
124494196|NCT00081289|447762932|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
124494197|NCT00081289|447762933|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
124494198|NCT00081289|447762932|FG000|Overall Study|Ineligible / no protocol treatment|3|||
124494199|NCT00081289|447762933|FG001|Overall Study|Ineligible / no protocol treatment|4|||
124494200|NCT00916721|447762934|FG000|Overall Study|Lost to Follow-up|0|||
124494201|NCT00916721|447762935|FG001|Overall Study|Lost to Follow-up|1|||
124494202|NCT00916721|447762934|FG000|Overall Study|Adverse Event|6|||
124494203|NCT00916721|447762935|FG001|Overall Study|Adverse Event|3|||
124494204|NCT00916721|447762934|FG000|Overall Study|Withdrawal by Subject|2|||
124494205|NCT00916721|447762935|FG001|Overall Study|Withdrawal by Subject|2|||
124494206|NCT00916721|447762934|FG000|Overall Study|Protocol Violation|2|||
124722026|NCT02574078|448605497|FG003|Treatment Period|Maximum clinical benefit|0|||
124722027|NCT02574078|448605498|FG004|Treatment Period|Maximum clinical benefit|0|||
124722028|NCT02574078|448605499|FG005|Treatment Period|Maximum clinical benefit|0|||
124722029|NCT02574078|448605500|FG006|Treatment Period|Maximum clinical benefit|0|||
124722030|NCT02574078|448605501|FG007|Treatment Period|Maximum clinical benefit|0|||
124722031|NCT02574078|448605502|FG008|Treatment Period|Maximum clinical benefit|0|||
124722032|NCT02574078|448605503|FG009|Treatment Period|Maximum clinical benefit|1|||
124722033|NCT02574078|448605504|FG010|Treatment Period|Maximum clinical benefit|0|||
124722034|NCT02574078|448605505|FG011|Treatment Period|Maximum clinical benefit|0|||
124722035|NCT02574078|448605506|FG012|Treatment Period|Maximum clinical benefit|0|||
124494207|NCT00916721|447762935|FG001|Overall Study|Protocol Violation|4|||
124494208|NCT01469052|447762940|FG000|Overall Study|Adverse Event|2|||
124494209|NCT01469052|447762941|FG001|Overall Study|Adverse Event|3|||
124494210|NCT01469052|447762942|FG002|Overall Study|Adverse Event|0|||
124494211|NCT01469052|447762943|FG003|Overall Study|Adverse Event|2|||
124494212|NCT01469052|447762944|FG004|Overall Study|Adverse Event|0|||
124494213|NCT01469052|447762945|FG005|Overall Study|Adverse Event|1|||
124494214|NCT01469052|447762940|FG000|Overall Study|Progressive disease|3|||
124494215|NCT01469052|447762941|FG001|Overall Study|Progressive disease|0|||
124494216|NCT01469052|447762942|FG002|Overall Study|Progressive disease|5|||
124494217|NCT01469052|447762943|FG003|Overall Study|Progressive disease|3|||
124494218|NCT01469052|447762944|FG004|Overall Study|Progressive disease|7|||
124494219|NCT01469052|447762945|FG005|Overall Study|Progressive disease|2|||
124494220|NCT01469052|447762940|FG000|Overall Study|Lack of Efficacy|0|||
124494221|NCT01469052|447762941|FG001|Overall Study|Lack of Efficacy|0|||
124494222|NCT01469052|447762942|FG002|Overall Study|Lack of Efficacy|0|||
124494223|NCT01469052|447762943|FG003|Overall Study|Lack of Efficacy|0|||
124494224|NCT01469052|447762944|FG004|Overall Study|Lack of Efficacy|0|||
124494225|NCT01469052|447762945|FG005|Overall Study|Lack of Efficacy|2|||
124494226|NCT01469052|447762940|FG000|Overall Study|Moved to rollover protocol|1|||
124494227|NCT01469052|447762941|FG001|Overall Study|Moved to rollover protocol|0|||
124494228|NCT01469052|447762942|FG002|Overall Study|Moved to rollover protocol|1|||
124494229|NCT01469052|447762943|FG003|Overall Study|Moved to rollover protocol|0|||
124494230|NCT01469052|447762944|FG004|Overall Study|Moved to rollover protocol|0|||
124494231|NCT01469052|447762945|FG005|Overall Study|Moved to rollover protocol|1|||
124494232|NCT01469052|447762940|FG000|Overall Study|Other|0|||
124494233|NCT01469052|447762941|FG001|Overall Study|Other|1|||
124494234|NCT01469052|447762942|FG002|Overall Study|Other|0|||
124494235|NCT01469052|447762943|FG003|Overall Study|Other|0|||
124494236|NCT01469052|447762944|FG004|Overall Study|Other|1|||
124494237|NCT01469052|447762945|FG005|Overall Study|Other|0|||
124494238|NCT02749370|447762949|FG000|Overall Study|Withdrawal by Subject|11|||
124494239|NCT02749370|447762949|FG000|Overall Study|Lost to Follow-up|3|||
124494240|NCT01519427|447762953|FG000|Overall Study|disease progression|2|||
124494241|NCT03894904|447762954|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
124494242|NCT03894904|447762955|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
124494243|NCT03894904|447762954|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
124494244|NCT03894904|447762955|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
124494245|NCT03242759|447762956|FG000|Overall Study|Adverse Event|5|||
124494246|NCT03242759|447762957|FG001|Overall Study|Adverse Event|1|||
124494247|NCT03242759|447762956|FG000|Overall Study|Withdrawal by Subject|4|||
124494248|NCT03242759|447762957|FG001|Overall Study|Withdrawal by Subject|3|||
124494249|NCT03242759|447762956|FG000|Overall Study|Lost to Follow-up|3|||
124494250|NCT03242759|447762957|FG001|Overall Study|Lost to Follow-up|1|||
124494251|NCT03242759|447762956|FG000|Overall Study|Administrative problems|1|||
124557905|NCT00606684|448001365|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
124557906|NCT00606684|448001359|FG000|Double-Blind Treatment Period|Adverse Event|0|||
124557907|NCT00606684|448001360|FG001|Double-Blind Treatment Period|Adverse Event|3|||
124557908|NCT00606684|448001361|FG002|Double-Blind Treatment Period|Adverse Event|2|||
124557909|NCT00606684|448001362|FG003|Double-Blind Treatment Period|Adverse Event|4|||
124557910|NCT00606684|448001363|FG004|Double-Blind Treatment Period|Adverse Event|2|||
124557911|NCT00606684|448001364|FG005|Double-Blind Treatment Period|Adverse Event|0|||
124557912|NCT00606684|448001365|FG006|Double-Blind Treatment Period|Adverse Event|1|||
124557913|NCT00606684|448001359|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
124557914|NCT00606684|448001360|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
124557915|NCT00606684|448001361|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
124557916|NCT00606684|448001362|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
124557917|NCT00606684|448001363|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
124494252|NCT03242759|447762957|FG001|Overall Study|Administrative problems|1|||
124494253|NCT03242759|447762956|FG000|Overall Study|Death|22|||
124494254|NCT03242759|447762957|FG001|Overall Study|Death|0|||
124494255|NCT03242759|447762956|FG000|Overall Study|Change visit schedule|0|||
124494256|NCT03242759|447762957|FG001|Overall Study|Change visit schedule|1|||
124722036|NCT00301262|448605510|FG000|Double Blind Phase (DB)|Adverse Event|1|||
124494257|NCT04430582|447762961|FG000|Overall Study|Found to meet exclusionary criteria|1|||
124494258|NCT04430582|447762962|FG001|Overall Study|Found to meet exclusionary criteria|0|||
124557918|NCT00606684|448001364|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
124557919|NCT00606684|448001365|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
124557920|NCT00606684|448001359|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
124494259|NCT04430582|447762961|FG000|Overall Study|Withdrawal by Subject|0|||
124494260|NCT04430582|447762962|FG001|Overall Study|Withdrawal by Subject|1|||
124494261|NCT02522481|447762963|FG000|Overall Study|discontinued|1|||
124494262|NCT02522481|447762963|FG000|Overall Study|Not dosed|2|||
124722037|NCT00301262|448605511|FG001|Double Blind Phase (DB)|Adverse Event|0|||
124494263|NCT00404768|447762966|FG000|Part A and B|Withdrawn due to labor progression|1|||
124772230|NCT02113982|448796377|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
124772231|NCT02113982|448796378|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
124772232|NCT02113982|448796379|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
124772233|NCT02113982|448796380|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
124772234|NCT02113982|448796381|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
124772235|NCT02113982|448796368|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
124772236|NCT02113982|448796369|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
124772237|NCT02113982|448796370|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
124772238|NCT02113982|448796371|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
124772239|NCT02113982|448796372|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
124494264|NCT00404768|447762967|FG001|Part A and B|Withdrawn due to labor progression|0|||
124772240|NCT02113982|448796373|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
124772241|NCT02113982|448796374|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
124772242|NCT02113982|448796375|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
124772243|NCT02113982|448796376|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
124772244|NCT02113982|448796377|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
124772245|NCT02113982|448796378|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
124772246|NCT02113982|448796379|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
124772247|NCT02113982|448796380|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
124772248|NCT02113982|448796381|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
124772249|NCT02113982|448796368|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
124772250|NCT02113982|448796369|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
124772251|NCT02113982|448796370|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
124772252|NCT02113982|448796371|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
124772253|NCT02113982|448796372|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
124772254|NCT02113982|448796373|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
124772255|NCT02113982|448796374|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
124772256|NCT02113982|448796375|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
124772257|NCT02113982|448796376|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
124772258|NCT02113982|448796377|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
124772259|NCT02113982|448796378|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
124772260|NCT02113982|448796379|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
124772261|NCT02113982|448796380|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
124772262|NCT02113982|448796381|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
124772263|NCT02113982|448796368|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
124772264|NCT02113982|448796369|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
124772265|NCT02113982|448796370|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
124494265|NCT00404768|447762968|FG002|Part A and B|Withdrawn due to labor progression|0|||
124494266|NCT00404768|447762969|FG003|Part A and B|Withdrawn due to labor progression|0|||
124494267|NCT00404768|447762966|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
124494268|NCT00404768|447762967|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
124494269|NCT00404768|447762968|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
124494270|NCT00404768|447762969|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
124494271|NCT00404768|447762966|FG000|Part C|Adverse Event|0|||
124494272|NCT00404768|447762967|FG001|Part C|Adverse Event|0|||
124494273|NCT00404768|447762968|FG002|Part C|Adverse Event|0|||
124494274|NCT00404768|447762969|FG003|Part C|Adverse Event|3|||
124494275|NCT00404768|447762966|FG000|Part C|Lost to Follow-up|0|||
124494276|NCT00404768|447762967|FG001|Part C|Lost to Follow-up|0|||
124494277|NCT00404768|447762968|FG002|Part C|Lost to Follow-up|3|||
124494278|NCT00404768|447762969|FG003|Part C|Lost to Follow-up|1|||
124494279|NCT00404768|447762966|FG000|Part C|Withdrawal by Subject|0|||
124494280|NCT00404768|447762967|FG001|Part C|Withdrawal by Subject|0|||
124494281|NCT00404768|447762968|FG002|Part C|Withdrawal by Subject|2|||
124494282|NCT00404768|447762969|FG003|Part C|Withdrawal by Subject|1|||
124494283|NCT00404768|447762966|FG000|Part C|Early withdrawal from study medication|0|||
124494284|NCT00404768|447762967|FG001|Part C|Early withdrawal from study medication|0|||
124494285|NCT00404768|447762968|FG002|Part C|Early withdrawal from study medication|1|||
124494286|NCT00404768|447762969|FG003|Part C|Early withdrawal from study medication|0|||
124494287|NCT00404768|447762966|FG000|Part C|Participant did not respond to therapy|0|||
124494288|NCT00404768|447762967|FG001|Part C|Participant did not respond to therapy|0|||
124494289|NCT00404768|447762968|FG002|Part C|Participant did not respond to therapy|1|||
124494290|NCT00404768|447762969|FG003|Part C|Participant did not respond to therapy|1|||
124494291|NCT00404768|447762966|FG000|Part C|Physician withdrew the study medication|0|||
124557921|NCT00606684|448001360|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
124772266|NCT02113982|448796371|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
124772267|NCT02113982|448796372|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
124772268|NCT02113982|448796373|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
124772269|NCT02113982|448796374|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
124494292|NCT00404768|447762967|FG001|Part C|Physician withdrew the study medication|0|||
124494293|NCT00404768|447762968|FG002|Part C|Physician withdrew the study medication|1|||
124772270|NCT02113982|448796375|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
124772271|NCT02113982|448796376|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
124557922|NCT00606684|448001361|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
124557923|NCT00606684|448001362|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
124557924|NCT00606684|448001363|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
124557925|NCT00606684|448001364|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
124557926|NCT00606684|448001365|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
124557927|NCT00606684|448001359|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
124557928|NCT00606684|448001360|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
124494294|NCT00404768|447762969|FG003|Part C|Physician withdrew the study medication|0|||
124494295|NCT00404768|447762966|FG000|Part C|Participant delivered baby|0|||
124494296|NCT00404768|447762967|FG001|Part C|Participant delivered baby|0|||
124494297|NCT00404768|447762968|FG002|Part C|Participant delivered baby|0|||
124494298|NCT00404768|447762969|FG003|Part C|Participant delivered baby|1|||
124494299|NCT00404768|447762966|FG000|Part C|Unsatisfactory uterine response to IP|0|||
124494300|NCT00404768|447762967|FG001|Part C|Unsatisfactory uterine response to IP|0|||
124494301|NCT00404768|447762968|FG002|Part C|Unsatisfactory uterine response to IP|0|||
124494302|NCT00404768|447762969|FG003|Part C|Unsatisfactory uterine response to IP|1|||
124494303|NCT00404768|447762966|FG000|Part C|Active labor|0|||
124494304|NCT00404768|447762967|FG001|Part C|Active labor|0|||
124494305|NCT00404768|447762968|FG002|Part C|Active labor|0|||
124494306|NCT00404768|447762969|FG003|Part C|Active labor|1|||
124494307|NCT00404768|447762966|FG000|Part C|Lack of Efficacy|0|||
124494308|NCT00404768|447762967|FG001|Part C|Lack of Efficacy|0|||
124494309|NCT00404768|447762968|FG002|Part C|Lack of Efficacy|0|||
124494310|NCT00404768|447762969|FG003|Part C|Lack of Efficacy|2|||
124494311|NCT00404768|447762966|FG000|Part C|Treatment failure|0|||
124494312|NCT00404768|447762967|FG001|Part C|Treatment failure|0|||
124494313|NCT00404768|447762968|FG002|Part C|Treatment failure|0|||
124494314|NCT00404768|447762969|FG003|Part C|Treatment failure|1|||
124494315|NCT00404768|447762966|FG000|Part C|Investigator discretion|0|||
124494316|NCT00404768|447762967|FG001|Part C|Investigator discretion|0|||
124494317|NCT00404768|447762968|FG002|Part C|Investigator discretion|0|||
124494318|NCT00404768|447762969|FG003|Part C|Investigator discretion|1|||
124494319|NCT00404768|447762966|FG000|Part C|Researcher suspended study medication|0|||
124494320|NCT00404768|447762967|FG001|Part C|Researcher suspended study medication|0|||
124494321|NCT00404768|447762968|FG002|Part C|Researcher suspended study medication|0|||
124494322|NCT00404768|447762969|FG003|Part C|Researcher suspended study medication|1|||
124494323|NCT04773041|447762970|FG000|Overall Study|Unable to data match|1|||
124494324|NCT04773041|447762971|FG001|Overall Study|Unable to data match|0|||
124494325|NCT04773041|447762972|FG002|Overall Study|Unable to data match|0|||
124494326|NCT02100657|447764211|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
124494327|NCT02100657|447764212|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
124494328|NCT02100657|447764213|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
124494329|NCT02100657|447764211|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
124494330|NCT02100657|447764212|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
124494331|NCT02100657|447764213|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
124494332|NCT02100657|447764211|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
124494333|NCT02100657|447764212|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
124494334|NCT02100657|447764213|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
124494335|NCT02100657|447764211|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
124494336|NCT02100657|447764212|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
124494337|NCT02100657|447764213|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
124494338|NCT02100657|447764211|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
124494339|NCT02100657|447764212|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
124494340|NCT02100657|447764213|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
124494341|NCT02100657|447764211|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
124494342|NCT02100657|447764212|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
124494343|NCT02100657|447764213|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
124494344|NCT02100657|447764211|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
124494345|NCT02100657|447764212|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
124494346|NCT02100657|447764213|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
124494347|NCT02100657|447764211|FG000|Cohort 3: Dose Level 3|Death|0|||
124494348|NCT02100657|447764212|FG001|Cohort 3: Dose Level 3|Death|0|||
124494349|NCT02100657|447764213|FG002|Cohort 3: Dose Level 3|Death|1|||
124494350|NCT02100657|447764211|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
124494351|NCT02100657|447764212|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
124494352|NCT02100657|447764213|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
124494353|NCT02100657|447764211|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
124494354|NCT02100657|447764212|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
124494355|NCT02100657|447764213|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
124494356|NCT02100657|447764211|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
124722038|NCT00301262|448605510|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
124722039|NCT00301262|448605511|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
124494357|NCT02100657|447764212|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
124494358|NCT02100657|447764213|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
124772272|NCT02113982|448796377|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
124772273|NCT02113982|448796378|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
124772274|NCT02113982|448796379|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
124772275|NCT02113982|448796380|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
124772276|NCT02113982|448796381|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
124772277|NCT02113982|448796368|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
124772278|NCT02113982|448796369|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
124772279|NCT02113982|448796370|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
124772280|NCT02113982|448796371|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
124772281|NCT02113982|448796372|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
124772282|NCT02113982|448796373|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
124772283|NCT02113982|448796374|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
124772284|NCT02113982|448796375|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
124772285|NCT02113982|448796376|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
124772286|NCT02113982|448796377|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
124772287|NCT02113982|448796378|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
124772288|NCT02113982|448796379|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
124772289|NCT02113982|448796380|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
124772290|NCT02113982|448796381|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
124772291|NCT02113982|448796368|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
124772292|NCT02113982|448796369|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
124772293|NCT02113982|448796370|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
124772294|NCT02113982|448796371|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
124772295|NCT02113982|448796372|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
124772296|NCT02113982|448796373|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
124772297|NCT02113982|448796374|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
124772298|NCT02113982|448796375|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
124772299|NCT02113982|448796376|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
124772300|NCT02113982|448796377|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
124772301|NCT02113982|448796378|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
124772302|NCT02113982|448796379|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
124772303|NCT02113982|448796380|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
124772304|NCT02113982|448796381|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
124772305|NCT02113982|448796368|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
124772306|NCT02113982|448796369|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
124772307|NCT02113982|448796370|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
124772308|NCT02113982|448796371|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
124772309|NCT02113982|448796372|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
124772310|NCT02113982|448796373|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
124772311|NCT02113982|448796374|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
124772312|NCT02113982|448796375|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
124772313|NCT02113982|448796376|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
124772314|NCT02113982|448796377|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
124772315|NCT02113982|448796378|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
124772316|NCT02113982|448796379|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
124772317|NCT02113982|448796380|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
124494359|NCT02100657|447764211|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
124494360|NCT02100657|447764212|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
124494361|NCT02100657|447764213|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
124494362|NCT02100657|447764211|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
124494363|NCT02100657|447764212|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
124494364|NCT02100657|447764213|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
124494365|NCT04359823|447764214|FG000|Overall Study|Lost to Follow-up|0|||
124494366|NCT04359823|447764215|FG001|Overall Study|Lost to Follow-up|1|||
124494367|NCT04359823|447764214|FG000|Overall Study|Withdrawal by Subject|0|||
124494368|NCT04359823|447764215|FG001|Overall Study|Withdrawal by Subject|1|||
124494369|NCT01850563|447764216|FG000|Overall Study|Not eligible|3|||
124494370|NCT01850563|447764217|FG001|Overall Study|Not eligible|0|||
124494371|NCT02322892|447764220|FG000|Overall Study|Surgery cancelled|1|||
124494372|NCT02322892|447764221|FG001|Overall Study|Surgery cancelled|2|||
124494373|NCT02322892|447764220|FG000|Overall Study|Met exclusion criteria|0|||
124494374|NCT02322892|447764221|FG001|Overall Study|Met exclusion criteria|1|||
124494375|NCT02322892|447764220|FG000|Overall Study|Protocol Violation|1|||
124494376|NCT02322892|447764221|FG001|Overall Study|Protocol Violation|0|||
124494377|NCT02125331|447764224|FG000|Overall Study|Protocol Violation|1|||
124494378|NCT02125331|447764225|FG001|Overall Study|Protocol Violation|0|||
124494379|NCT02125331|447764224|FG000|Overall Study|technical problem|2|||
124494380|NCT02125331|447764225|FG001|Overall Study|technical problem|0|||
124494381|NCT02125331|447764224|FG000|Overall Study|screen failure|2|||
124494382|NCT02125331|447764225|FG001|Overall Study|screen failure|0|||
124494383|NCT00710034|447764226|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
124494384|NCT00710034|447764227|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
124494385|NCT00710034|447764226|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
124494386|NCT00710034|447764227|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
124494387|NCT00710034|447764226|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
124494388|NCT00710034|447764227|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
124494389|NCT00710034|447764226|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
124494390|NCT00710034|447764227|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
124494391|NCT00710034|447764226|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
124494392|NCT00710034|447764227|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
124494393|NCT00710034|447764226|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
124494394|NCT00710034|447764227|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
124494395|NCT00710034|447764226|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
124494396|NCT00710034|447764227|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
124494397|NCT00710034|447764226|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
124494398|NCT00710034|447764227|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
124494399|NCT00710034|447764226|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
124494400|NCT00710034|447764227|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
124494401|NCT00710034|447764226|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
124494402|NCT00710034|447764227|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
124494403|NCT00710034|447764226|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
124494404|NCT00710034|447764227|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
124494405|NCT01158534|447764228|FG000|Overall Study|Withdrawal by Subject|1|||
124494406|NCT01158534|447764228|FG000|Overall Study|Death|1|||
124494407|NCT01158534|447764228|FG000|Overall Study|Other|1|||
124494408|NCT00521339|447764229|FG000|Treatment Phase|Adverse Event|2|||
124494409|NCT00521339|447764230|FG001|Treatment Phase|Adverse Event|0|||
124494410|NCT00521339|447764231|FG002|Treatment Phase|Adverse Event|0|||
124494411|NCT00521339|447764229|FG000|Treatment Phase|Intolerability to study drug|2|||
124494412|NCT00521339|447764230|FG001|Treatment Phase|Intolerability to study drug|0|||
124494413|NCT00521339|447764231|FG002|Treatment Phase|Intolerability to study drug|0|||
124494414|NCT00521339|447764229|FG000|Treatment Phase|Lack of Efficacy|3|||
124494415|NCT00521339|447764230|FG001|Treatment Phase|Lack of Efficacy|0|||
124494416|NCT00521339|447764231|FG002|Treatment Phase|Lack of Efficacy|0|||
124494417|NCT00521339|447764229|FG000|Treatment Phase|Withdrawal by Subject|3|||
124494418|NCT00521339|447764230|FG001|Treatment Phase|Withdrawal by Subject|0|||
124494419|NCT00521339|447764231|FG002|Treatment Phase|Withdrawal by Subject|0|||
124494420|NCT00521339|447764229|FG000|Treatment Phase|Lost to Follow-up|1|||
124494421|NCT00521339|447764230|FG001|Treatment Phase|Lost to Follow-up|0|||
124494422|NCT00521339|447764231|FG002|Treatment Phase|Lost to Follow-up|0|||
124494423|NCT00521339|447764229|FG000|Treatment Phase|Protocol Violation|1|||
124494424|NCT00521339|447764230|FG001|Treatment Phase|Protocol Violation|0|||
124494425|NCT00521339|447764231|FG002|Treatment Phase|Protocol Violation|0|||
124494426|NCT00521339|447764229|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
124494427|NCT00521339|447764230|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
124494428|NCT00521339|447764231|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
124494429|NCT00521339|447764229|FG000|Treatment Extension Phase|Death|0|||
124494430|NCT00521339|447764230|FG001|Treatment Extension Phase|Death|0|||
124494431|NCT00521339|447764231|FG002|Treatment Extension Phase|Death|1|||
124494432|NCT00950690|447764232|FG000|Overall Study|Death|4|||
124494433|NCT00950690|447764232|FG000|Overall Study|Adverse Event|15|||
124494434|NCT00950690|447764232|FG000|Overall Study|Lack of Efficacy|22|||
124494435|NCT00950690|447764232|FG000|Overall Study|Lost to Follow-up|40|||
124494436|NCT00950690|447764232|FG000|Overall Study|Other|163|||
124494437|NCT01996319|447764236|FG000|Overall Study|Protocol Violation|1|||
124494438|NCT01996319|447764237|FG001|Overall Study|Protocol Violation|0|||
124494439|NCT01996319|447764236|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
124494440|NCT01996319|447764237|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
124494441|NCT01996319|447764236|FG000|Overall Study|Adverse Event|2|||
124494442|NCT01996319|447764237|FG001|Overall Study|Adverse Event|2|||
124494443|NCT00130208|447764240|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
124494444|NCT00130208|447764241|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
124494445|NCT00130208|447764240|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
124494446|NCT00130208|447764241|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
124494447|NCT00130208|447764240|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
124494448|NCT00130208|447764241|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
124494449|NCT00130208|447764240|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
124494450|NCT00130208|447764241|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
124494451|NCT00130208|447764240|FG000|Maintenance Period (26 Weeks)|Other|1|||
124494452|NCT00130208|447764241|FG001|Maintenance Period (26 Weeks)|Other|1|||
124494453|NCT00130208|447764240|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
124494454|NCT00130208|447764241|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
124494455|NCT00130208|447764240|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
124772318|NCT02113982|448796381|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
124772319|NCT02113982|448796368|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
124772320|NCT02113982|448796369|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
124772321|NCT02113982|448796370|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
124772322|NCT02113982|448796371|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
124772323|NCT02113982|448796372|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
124772324|NCT02113982|448796373|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
124772325|NCT02113982|448796374|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
124772326|NCT02113982|448796375|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
124772327|NCT02113982|448796376|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
124772328|NCT02113982|448796377|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
124772329|NCT02113982|448796378|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
124772330|NCT02113982|448796379|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
124772331|NCT02113982|448796380|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
124772332|NCT02113982|448796381|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
124772333|NCT02113982|448796368|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
124772334|NCT02113982|448796369|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
124772335|NCT02113982|448796370|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
124772336|NCT02113982|448796371|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
124772337|NCT02113982|448796372|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
124772338|NCT02113982|448796373|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
124772339|NCT02113982|448796374|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
124772340|NCT02113982|448796375|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
124772341|NCT02113982|448796376|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
124772342|NCT02113982|448796377|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
124772343|NCT02113982|448796378|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
124772344|NCT02113982|448796379|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
124772345|NCT02113982|448796380|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
124772346|NCT02113982|448796381|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
124772347|NCT02113982|448796368|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
124772348|NCT02113982|448796369|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
124772349|NCT02113982|448796370|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
124772350|NCT02113982|448796371|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
124772351|NCT02113982|448796372|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
124772352|NCT02113982|448796373|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
124772353|NCT02113982|448796374|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
124772354|NCT02113982|448796375|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
124772355|NCT02113982|448796376|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
124772356|NCT02113982|448796377|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
124772357|NCT02113982|448796378|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
124772358|NCT02113982|448796379|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
124772359|NCT02113982|448796380|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
124772360|NCT02113982|448796381|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
124772361|NCT02113982|448796368|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
124772362|NCT02113982|448796369|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
124772363|NCT02113982|448796370|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
124772364|NCT02113982|448796371|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
124772365|NCT02113982|448796372|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
124494456|NCT00130208|447764241|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
124494457|NCT00130208|447764240|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
124494458|NCT00130208|447764241|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
124494459|NCT00130208|447764240|FG000|Washout Period (8 Weeks)|Other|1|||
124494460|NCT00130208|447764241|FG001|Washout Period (8 Weeks)|Other|1|||
124494461|NCT00589472|447764243|FG000|Overall Study|Adverse Event|1|||
124494462|NCT00553059|447764244|FG000|Overall Study|Deemed ineligible|1|||
124494463|NCT00553059|447764245|FG001|Overall Study|Deemed ineligible|1|||
124494464|NCT00553059|447764244|FG000|Overall Study|Drug supply not available|0|||
124494465|NCT00553059|447764245|FG001|Overall Study|Drug supply not available|1|||
124494466|NCT00117338|447764246|FG000|Overall Study|Adverse Event|0|||
124494467|NCT00117338|447764247|FG001|Overall Study|Adverse Event|1|||
124494468|NCT00117338|447764246|FG000|Overall Study|Protocol Violation|3|||
124494469|NCT00117338|447764247|FG001|Overall Study|Protocol Violation|2|||
124494470|NCT00117338|447764246|FG000|Overall Study|Withdrawal by Subject|1|||
124494471|NCT00117338|447764247|FG001|Overall Study|Withdrawal by Subject|0|||
124494472|NCT00117338|447764246|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
124494473|NCT00117338|447764247|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
124494474|NCT00117338|447764246|FG000|Overall Study|Lack of Efficacy|0|||
124494475|NCT00117338|447764247|FG001|Overall Study|Lack of Efficacy|1|||
124494476|NCT02805907|447764248|FG000|Overall Study|Lost to Follow-up|3|||
124494477|NCT02805907|447764249|FG001|Overall Study|Lost to Follow-up|3|||
124494478|NCT01264965|447764250|FG000|Overall Study|Withdrawal by Subject|10|||
124494479|NCT02202031|447764251|FG000|Overall Study|Lost to Follow-up|1|||
124494480|NCT02202031|447764252|FG001|Overall Study|Lost to Follow-up|0|||
124494481|NCT02202031|447764251|FG000|Overall Study|Too Busy|1|||
124494482|NCT02202031|447764252|FG001|Overall Study|Too Busy|3|||
124494483|NCT02202031|447764251|FG000|Overall Study|Illness/Medical Reason|0|||
124494484|NCT02202031|447764252|FG001|Overall Study|Illness/Medical Reason|2|||
124494485|NCT02202031|447764251|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
124494486|NCT02202031|447764252|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
124494487|NCT00871858|447764257|FG000|Overall Study|Protocol Violation|3|||
124494488|NCT00871858|447764258|FG001|Overall Study|Protocol Violation|4|||
124494489|NCT00871858|447764257|FG000|Overall Study|Adverse Event|1|||
124494490|NCT00871858|447764258|FG001|Overall Study|Adverse Event|1|||
124494491|NCT00871858|447764257|FG000|Overall Study|Withdrawal by Subject|1|||
124494492|NCT00871858|447764258|FG001|Overall Study|Withdrawal by Subject|1|||
124494493|NCT00871858|447764257|FG000|Overall Study|Lost to Follow-up|0|||
124494494|NCT00871858|447764258|FG001|Overall Study|Lost to Follow-up|1|||
124494495|NCT01188798|447764259|FG000|Overall Study|Death|0|||
124494496|NCT01188798|447764260|FG001|Overall Study|Death|1|||
124494497|NCT01188798|447764259|FG000|Overall Study|Required additional transplant|1|||
124494498|NCT01188798|447764260|FG001|Overall Study|Required additional transplant|1|||
124494499|NCT01188798|447764259|FG000|Overall Study|Protocol closure|1|||
124494500|NCT01188798|447764260|FG001|Overall Study|Protocol closure|1|||
124494501|NCT00611130|447764261|FG000|Overall Study|Lost to Follow-up|25|||
124494502|NCT00611130|447764262|FG001|Overall Study|Lost to Follow-up|29|||
124494503|NCT00611130|447764261|FG000|Overall Study|Protocol noncompliance|7|||
124494504|NCT00611130|447764262|FG001|Overall Study|Protocol noncompliance|6|||
124494505|NCT00611130|447764261|FG000|Overall Study|Withdrawal by Subject|6|||
124494506|NCT00611130|447764262|FG001|Overall Study|Withdrawal by Subject|5|||
124494507|NCT00611130|447764261|FG000|Overall Study|Other|5|||
124494508|NCT00611130|447764262|FG001|Overall Study|Other|4|||
124494509|NCT00611130|447764261|FG000|Overall Study|Incarceration|3|||
124494510|NCT00611130|447764262|FG001|Overall Study|Incarceration|2|||
124494511|NCT00611130|447764261|FG000|Overall Study|Administrative|1|||
124494512|NCT00611130|447764262|FG001|Overall Study|Administrative|1|||
124494513|NCT00611130|447764261|FG000|Overall Study|Adverse Event|1|||
124494514|NCT00611130|447764262|FG001|Overall Study|Adverse Event|0|||
124494515|NCT00611130|447764261|FG000|Overall Study|Death|1|||
124494516|NCT00611130|447764262|FG001|Overall Study|Death|0|||
124494517|NCT03078608|447764263|FG000|Overall Study|Death|1|||
124494518|NCT03078608|447764264|FG001|Overall Study|Death|2|||
124494519|NCT03078608|447764265|FG002|Overall Study|Death|0|||
124494520|NCT03078608|447764266|FG003|Overall Study|Death|0|||
124494521|NCT03078608|447764263|FG000|Overall Study|Withdrawal by Subject|8|||
124494522|NCT03078608|447764264|FG001|Overall Study|Withdrawal by Subject|1|||
124494523|NCT03078608|447764265|FG002|Overall Study|Withdrawal by Subject|0|||
124494524|NCT03078608|447764266|FG003|Overall Study|Withdrawal by Subject|0|||
124494525|NCT03078608|447764263|FG000|Overall Study|Lost to Follow-up|5|||
124494526|NCT03078608|447764264|FG001|Overall Study|Lost to Follow-up|8|||
124494527|NCT03078608|447764265|FG002|Overall Study|Lost to Follow-up|4|||
124494528|NCT03078608|447764266|FG003|Overall Study|Lost to Follow-up|1|||
124494529|NCT00723840|447764267|FG000|Overall Study|Lost to Follow-up|2|||
124494530|NCT00723840|447764267|FG000|Overall Study|Failure to return|18|||
124494531|NCT00723840|447764267|FG000|Overall Study|Withdrawal by Subject|55|||
124494532|NCT00723840|447764267|FG000|Overall Study|Serious Adverse Events|3|||
124494533|NCT00723840|447764267|FG000|Overall Study|Other Medical Event|2|||
124494534|NCT00723840|447764267|FG000|Overall Study|Unspecified reason|2|||
124494535|NCT00844428|447764270|FG000|Screening Period|Screen Failure|3|||
124494536|NCT00844428|447764270|FG000|Extension Treatment Period|Death|1|||
124494537|NCT00844428|447764270|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
124494538|NCT04172831|447764271|FG000|Overall Study|Adverse Event|21|||
124494539|NCT04172831|447764272|FG001|Overall Study|Adverse Event|9|||
124494540|NCT04172831|447764271|FG000|Overall Study|Lack of Efficacy|2|||
124494541|NCT04172831|447764272|FG001|Overall Study|Lack of Efficacy|8|||
124494542|NCT04172831|447764271|FG000|Overall Study|Physician Decision|0|||
124494543|NCT04172831|447764272|FG001|Overall Study|Physician Decision|1|||
124494544|NCT04172831|447764271|FG000|Overall Study|Withdrawal by Subject|12|||
124494545|NCT04172831|447764272|FG001|Overall Study|Withdrawal by Subject|11|||
124494546|NCT04172831|447764271|FG000|Overall Study|Lost to Follow-up|4|||
124494547|NCT04172831|447764272|FG001|Overall Study|Lost to Follow-up|9|||
124494548|NCT04172831|447764271|FG000|Overall Study|COVID-19 related crisis|3|||
124494549|NCT04172831|447764272|FG001|Overall Study|COVID-19 related crisis|3|||
124494550|NCT04172831|447764271|FG000|Overall Study|Subject non-compliance|1|||
124494551|NCT04172831|447764272|FG001|Overall Study|Subject non-compliance|1|||
124494552|NCT04172831|447764271|FG000|Overall Study|Family emergency|1|||
124494553|NCT04172831|447764272|FG001|Overall Study|Family emergency|0|||
124494554|NCT02119104|447764279|FG000|Overall Study|Protocol Violation|16|||
124494555|NCT01765764|447764280|FG000|Treatment Period|Adverse Event|1|||
124494556|NCT01765764|447764281|FG001|Treatment Period|Adverse Event|2|||
124557929|NCT00606684|448001361|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
124557930|NCT00606684|448001362|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
124557931|NCT00606684|448001363|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
124557932|NCT00606684|448001364|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
124557933|NCT00606684|448001365|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
124557934|NCT00606684|448001359|FG000|Double-Blind Treatment Period|Physician Decision|0|||
124557935|NCT00606684|448001360|FG001|Double-Blind Treatment Period|Physician Decision|5|||
124557936|NCT00606684|448001361|FG002|Double-Blind Treatment Period|Physician Decision|1|||
124557937|NCT00606684|448001362|FG003|Double-Blind Treatment Period|Physician Decision|0|||
124557938|NCT00606684|448001363|FG004|Double-Blind Treatment Period|Physician Decision|3|||
124557939|NCT00606684|448001364|FG005|Double-Blind Treatment Period|Physician Decision|1|||
124557940|NCT00606684|448001365|FG006|Double-Blind Treatment Period|Physician Decision|2|||
124557941|NCT00606684|448001359|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124557942|NCT00606684|448001360|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
124557943|NCT00606684|448001361|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
124557944|NCT00606684|448001362|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
124557945|NCT00606684|448001363|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
124557946|NCT00606684|448001364|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
124557947|NCT00606684|448001365|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124557948|NCT02763579|448001366|FG000|Global Period|Death|167|||
124557949|NCT02763579|448001367|FG001|Global Period|Death|151|||
124557950|NCT02763579|448001368|FG002|Global Period|Death|0|||
124557951|NCT02763579|448001369|FG003|Global Period|Death|0|||
124557952|NCT02763579|448001366|FG000|Global Period|Lost to Follow-up|2|||
124557953|NCT02763579|448001367|FG001|Global Period|Lost to Follow-up|4|||
124557954|NCT02763579|448001368|FG002|Global Period|Lost to Follow-up|0|||
124557955|NCT02763579|448001369|FG003|Global Period|Lost to Follow-up|0|||
124557956|NCT02763579|448001366|FG000|Global Period|Physician Decision|0|||
124557957|NCT02763579|448001367|FG001|Global Period|Physician Decision|2|||
124557958|NCT02763579|448001368|FG002|Global Period|Physician Decision|0|||
124557959|NCT02763579|448001369|FG003|Global Period|Physician Decision|0|||
124557960|NCT02763579|448001366|FG000|Global Period|Study Terminated By Sponsor|21|||
124557961|NCT02763579|448001367|FG001|Global Period|Study Terminated By Sponsor|26|||
124557962|NCT02763579|448001368|FG002|Global Period|Study Terminated By Sponsor|0|||
124557963|NCT02763579|448001369|FG003|Global Period|Study Terminated By Sponsor|0|||
124557964|NCT02763579|448001366|FG000|Global Period|Withdrawal by Subject|12|||
124557965|NCT02763579|448001367|FG001|Global Period|Withdrawal by Subject|18|||
124557966|NCT02763579|448001368|FG002|Global Period|Withdrawal by Subject|0|||
124722040|NCT00301262|448605510|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
124494557|NCT01765764|447764282|FG002|Treatment Period|Adverse Event|1|||
124494558|NCT01765764|447764280|FG000|Treatment Period|Lost to Follow-up|0|||
124494559|NCT01765764|447764281|FG001|Treatment Period|Lost to Follow-up|3|||
124494560|NCT01765764|447764282|FG002|Treatment Period|Lost to Follow-up|2|||
124494561|NCT01765764|447764280|FG000|Treatment Period|Personal Reasons|1|||
124494562|NCT01765764|447764281|FG001|Treatment Period|Personal Reasons|2|||
124494563|NCT01765764|447764282|FG002|Treatment Period|Personal Reasons|1|||
124494564|NCT01765764|447764280|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
124494565|NCT01765764|447764281|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
124494566|NCT01765764|447764282|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
124494567|NCT01597193|447764283|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
124494568|NCT01597193|447764284|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
124494569|NCT01597193|447764285|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
124494570|NCT01597193|447764286|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
124494571|NCT01597193|447764287|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
124722041|NCT00301262|448605511|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
124722042|NCT00301262|448605510|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
124722043|NCT00301262|448605511|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
124722044|NCT00301262|448605510|FG000|Double Blind Phase (DB)|Other|1|||
124494572|NCT01597193|447764288|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
124722045|NCT00301262|448605511|FG001|Double Blind Phase (DB)|Other|4|||
124722046|NCT00301262|448605510|FG000|Open Label Phase (OL)|Adverse Event|1|||
124722047|NCT00301262|448605511|FG001|Open Label Phase (OL)|Adverse Event|0|||
124722048|NCT00301262|448605510|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
124722049|NCT00301262|448605511|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
124722050|NCT00301262|448605510|FG000|Open Label Phase (OL)|Other|2|||
124722051|NCT00301262|448605511|FG001|Open Label Phase (OL)|Other|0|||
124494573|NCT01597193|447764289|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
124494574|NCT01597193|447764283|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
124557967|NCT02763579|448001369|FG003|Global Period|Withdrawal by Subject|0|||
124557968|NCT02763579|448001366|FG000|China Period|Death|0|||
124557969|NCT02763579|448001367|FG001|China Period|Death|0|||
124722052|NCT00368745|448605512|FG000|Double-blind Treatment Period|Adverse Event|6|||
124722053|NCT00368745|448605513|FG001|Double-blind Treatment Period|Adverse Event|6|||
124722054|NCT00368745|448605512|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
124722055|NCT00368745|448605513|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
124722056|NCT00368745|448605512|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
124722057|NCT00368745|448605513|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
124722058|NCT00368745|448605512|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
124722059|NCT00368745|448605513|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
124722060|NCT00368745|448605512|FG000|Double-blind Treatment Period|Other|7|||
124722061|NCT00368745|448605513|FG001|Double-blind Treatment Period|Other|6|||
124722062|NCT03037476|448605514|FG000|Overall Study|Lost to Follow-up|63|||
124722063|NCT03037476|448605515|FG001|Overall Study|Lost to Follow-up|46|||
124722064|NCT01498692|448605518|FG000|Overall Study|Death|4|||
124722065|NCT01498692|448605518|FG000|Overall Study|Withdrawal by Subject|1|||
124722066|NCT01498692|448605518|FG000|Overall Study|Missed 12-month visit|3|||
124722067|NCT01208324|448605519|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
124722068|NCT01208324|448605520|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
124722069|NCT01208324|448605521|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
124722070|NCT01208324|448605522|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
124722071|NCT02707965|448605523|FG000|Overall Study|Withdrawal by Subject|0|||
124722072|NCT02707965|448605524|FG001|Overall Study|Withdrawal by Subject|0|||
124722073|NCT02707965|448605525|FG002|Overall Study|Withdrawal by Subject|1|||
124722074|NCT02707965|448605526|FG003|Overall Study|Withdrawal by Subject|0|||
124722075|NCT02707965|448605527|FG004|Overall Study|Withdrawal by Subject|0|||
124722076|NCT02707965|448605528|FG005|Overall Study|Withdrawal by Subject|0|||
124722077|NCT02707965|448605529|FG006|Overall Study|Withdrawal by Subject|0|||
124722078|NCT02707965|448605530|FG007|Overall Study|Withdrawal by Subject|2|||
124722079|NCT02707965|448605531|FG008|Overall Study|Withdrawal by Subject|0|||
124722080|NCT02707965|448605532|FG009|Overall Study|Withdrawal by Subject|0|||
124722081|NCT02707965|448605533|FG010|Overall Study|Withdrawal by Subject|0|||
124722082|NCT02707965|448605534|FG011|Overall Study|Withdrawal by Subject|0|||
124722083|NCT02707965|448605535|FG012|Overall Study|Withdrawal by Subject|0|||
124722084|NCT02707965|448605536|FG013|Overall Study|Withdrawal by Subject|0|||
124722085|NCT02707965|448605537|FG014|Overall Study|Withdrawal by Subject|0|||
124722086|NCT02707965|448605538|FG015|Overall Study|Withdrawal by Subject|0|||
124722087|NCT02707965|448605523|FG000|Overall Study|PI decisions|0|||
124722088|NCT02707965|448605524|FG001|Overall Study|PI decisions|0|||
124722089|NCT02707965|448605525|FG002|Overall Study|PI decisions|0|||
124722090|NCT02707965|448605526|FG003|Overall Study|PI decisions|0|||
124722091|NCT02707965|448605527|FG004|Overall Study|PI decisions|0|||
124722092|NCT02707965|448605528|FG005|Overall Study|PI decisions|0|||
124722093|NCT02707965|448605529|FG006|Overall Study|PI decisions|0|||
124722094|NCT02707965|448605530|FG007|Overall Study|PI decisions|0|||
124722095|NCT02707965|448605531|FG008|Overall Study|PI decisions|0|||
124722096|NCT02707965|448605532|FG009|Overall Study|PI decisions|0|||
124722097|NCT02707965|448605533|FG010|Overall Study|PI decisions|0|||
124722098|NCT02707965|448605534|FG011|Overall Study|PI decisions|0|||
124722099|NCT02707965|448605535|FG012|Overall Study|PI decisions|0|||
124722100|NCT02707965|448605536|FG013|Overall Study|PI decisions|0|||
124722101|NCT02707965|448605537|FG014|Overall Study|PI decisions|2|||
124722102|NCT02707965|448605538|FG015|Overall Study|PI decisions|0|||
124722103|NCT02707965|448605523|FG000|Overall Study|Protocol deviation|1|||
124722104|NCT02707965|448605524|FG001|Overall Study|Protocol deviation|1|||
124722105|NCT02707965|448605525|FG002|Overall Study|Protocol deviation|0|||
124722106|NCT02707965|448605526|FG003|Overall Study|Protocol deviation|0|||
124722107|NCT02707965|448605527|FG004|Overall Study|Protocol deviation|0|||
124722108|NCT02707965|448605528|FG005|Overall Study|Protocol deviation|0|||
124722109|NCT02707965|448605529|FG006|Overall Study|Protocol deviation|0|||
124722110|NCT02707965|448605530|FG007|Overall Study|Protocol deviation|1|||
124722111|NCT02707965|448605531|FG008|Overall Study|Protocol deviation|0|||
124722112|NCT02707965|448605532|FG009|Overall Study|Protocol deviation|0|||
124722113|NCT02707965|448605533|FG010|Overall Study|Protocol deviation|0|||
124722114|NCT02707965|448605534|FG011|Overall Study|Protocol deviation|0|||
124722115|NCT02707965|448605535|FG012|Overall Study|Protocol deviation|0|||
124722116|NCT02707965|448605536|FG013|Overall Study|Protocol deviation|0|||
124722117|NCT02707965|448605537|FG014|Overall Study|Protocol deviation|0|||
124722118|NCT02707965|448605538|FG015|Overall Study|Protocol deviation|0|||
124722119|NCT00249808|448605539|FG000|Overall Study|Other|27|||
124722120|NCT00249808|448605539|FG000|Overall Study|Protocol Violation|3|||
124722121|NCT00249808|448605539|FG000|Overall Study|Lost to Follow-up|8|||
124722122|NCT00249808|448605539|FG000|Overall Study|Adverse Event|81|||
124722123|NCT00249808|448605539|FG000|Overall Study|Lack of Efficacy|52|||
124722124|NCT00249808|448605539|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
124722125|NCT02789345|448605540|FG000|Overall Study|Adverse Event|0|||
124722126|NCT02789345|448605541|FG001|Overall Study|Adverse Event|0|||
124722127|NCT02789345|448605542|FG002|Overall Study|Adverse Event|1|||
124722128|NCT02789345|448605540|FG000|Overall Study|Death|0|||
124722129|NCT02789345|448605541|FG001|Overall Study|Death|0|||
124722130|NCT02789345|448605542|FG002|Overall Study|Death|1|||
124722131|NCT02789345|448605540|FG000|Overall Study|Physician Decision|2|||
124494575|NCT01597193|447764284|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
124494576|NCT01597193|447764285|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
124494577|NCT01597193|447764286|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
124772366|NCT02113982|448796373|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
124772367|NCT02113982|448796374|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
124772368|NCT02113982|448796375|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
124772369|NCT02113982|448796376|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
124772370|NCT02113982|448796377|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
124772371|NCT02113982|448796378|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
124772372|NCT02113982|448796379|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
124772373|NCT02113982|448796380|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
124772374|NCT02113982|448796381|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
124772375|NCT02085161|448796383|FG000|Overall Study|Not Treated|1|||
124772376|NCT02085161|448796384|FG001|Overall Study|Not Treated|0|||
124772377|NCT02085161|448796385|FG002|Overall Study|Not Treated|0|||
124772378|NCT02085161|448796386|FG003|Overall Study|Not Treated|0|||
124772379|NCT02085161|448796383|FG000|Overall Study|Adverse Event|8|||
124772380|NCT02085161|448796384|FG001|Overall Study|Adverse Event|5|||
124772381|NCT02085161|448796385|FG002|Overall Study|Adverse Event|4|||
124772382|NCT02085161|448796386|FG003|Overall Study|Adverse Event|5|||
124772383|NCT02085161|448796383|FG000|Overall Study|Protocol Violation|0|||
124772384|NCT02085161|448796384|FG001|Overall Study|Protocol Violation|1|||
124772385|NCT02085161|448796385|FG002|Overall Study|Protocol Violation|0|||
124772386|NCT02085161|448796386|FG003|Overall Study|Protocol Violation|1|||
124772387|NCT02085161|448796383|FG000|Overall Study|Withdrawal by Subject|2|||
124772388|NCT02085161|448796384|FG001|Overall Study|Withdrawal by Subject|4|||
124772389|NCT02085161|448796385|FG002|Overall Study|Withdrawal by Subject|0|||
124494578|NCT01597193|447764287|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
124494579|NCT01597193|447764288|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
124494580|NCT01597193|447764289|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
124494581|NCT01597193|447764283|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
124494582|NCT01597193|447764284|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
124494583|NCT01597193|447764285|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
124494584|NCT01597193|447764286|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
124722132|NCT02789345|448605541|FG001|Overall Study|Physician Decision|0|||
124722133|NCT02789345|448605542|FG002|Overall Study|Physician Decision|1|||
124722134|NCT02789345|448605540|FG000|Overall Study|Progressive Disease|1|||
124722135|NCT02789345|448605541|FG001|Overall Study|Progressive Disease|3|||
124722136|NCT02789345|448605542|FG002|Overall Study|Progressive Disease|14|||
124722137|NCT00748618|448605544|FG000|Overall Study|Adverse Event|1|||
124722138|NCT00748618|448605545|FG001|Overall Study|Adverse Event|0|||
124722139|NCT01977729|448605546|FG000|Overall Study|Study terminated|1|||
124722140|NCT01268046|448605547|FG000|Overall Study|Withdrawal by Subject|1|||
124722141|NCT01268046|448605548|FG001|Overall Study|Withdrawal by Subject|0|||
124722142|NCT01268046|448605549|FG002|Overall Study|Withdrawal by Subject|0|||
124722143|NCT01268046|448605550|FG003|Overall Study|Withdrawal by Subject|1|||
124722144|NCT01268046|448605547|FG000|Overall Study|Lost to Follow-up|0|||
124722145|NCT01268046|448605548|FG001|Overall Study|Lost to Follow-up|0|||
124722146|NCT01268046|448605549|FG002|Overall Study|Lost to Follow-up|1|||
124722147|NCT01268046|448605550|FG003|Overall Study|Lost to Follow-up|0|||
124722148|NCT00224120|448605551|FG000|Overall Study|Adverse Event|10|||
124722149|NCT00224120|448605552|FG001|Overall Study|Adverse Event|4|||
124722150|NCT00224120|448605551|FG000|Overall Study|Protocol Violation|1|||
124722151|NCT00224120|448605552|FG001|Overall Study|Protocol Violation|0|||
124722152|NCT00224120|448605551|FG000|Overall Study|Withdrawal by Subject|5|||
124722153|NCT00224120|448605552|FG001|Overall Study|Withdrawal by Subject|10|||
124722154|NCT00224120|448605551|FG000|Overall Study|Lack of Efficacy|0|||
124722155|NCT00224120|448605552|FG001|Overall Study|Lack of Efficacy|2|||
124722156|NCT00224120|448605551|FG000|Overall Study|Lost to Follow-up|2|||
124722157|NCT00224120|448605552|FG001|Overall Study|Lost to Follow-up|3|||
124722158|NCT00224120|448605551|FG000|Overall Study|Other|4|||
124722159|NCT00224120|448605552|FG001|Overall Study|Other|5|||
124722160|NCT00282087|448605553|FG000|Overall Study|Death|1|||
124722161|NCT01804049|448605556|FG000|Overall Study|Adverse Event|2|||
124722162|NCT01804049|448605557|FG001|Overall Study|Adverse Event|10|||
124722163|NCT01804049|448605556|FG000|Overall Study|Lost to Follow-up|2|||
124722164|NCT01804049|448605557|FG001|Overall Study|Lost to Follow-up|1|||
124722165|NCT01804049|448605556|FG000|Overall Study|Decreased interest/personal|4|||
124722166|NCT01804049|448605557|FG001|Overall Study|Decreased interest/personal|5|||
124722167|NCT01804049|448605556|FG000|Overall Study|Other health concerns|2|||
124494585|NCT01597193|447764287|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
124722168|NCT01804049|448605557|FG001|Overall Study|Other health concerns|7|||
124722169|NCT01804049|448605556|FG000|Overall Study|Moved out of area|0|||
124772390|NCT02085161|448796386|FG003|Overall Study|Withdrawal by Subject|3|||
124772391|NCT02085161|448796383|FG000|Overall Study|Other Reason|1|||
124772392|NCT02085161|448796384|FG001|Overall Study|Other Reason|0|||
124772393|NCT02085161|448796385|FG002|Overall Study|Other Reason|1|||
124772394|NCT02085161|448796386|FG003|Overall Study|Other Reason|1|||
124772395|NCT01936870|448796391|FG000|Overall Study|No Visit After Treatment|176|||
124772396|NCT01936870|448796391|FG000|Overall Study|Protocol Violation|12|||
124772397|NCT01936870|448796391|FG000|Overall Study|No Drug Administration|1|||
124772398|NCT02399163|448796395|FG000|Overall Study|Adverse Event|2|||
124772399|NCT02399163|448796395|FG000|Overall Study|Protocol Deviation|2|||
124772400|NCT02399163|448796395|FG000|Overall Study|Withdrawal by Participant|5|||
124772401|NCT03910244|448796396|FG000|Overall Study|Adverse Event|14|||
124772402|NCT03910244|448796397|FG001|Overall Study|Adverse Event|0|||
124772403|NCT03910244|448796396|FG000|Overall Study|Death|1|||
124772404|NCT03910244|448796397|FG001|Overall Study|Death|0|||
124772405|NCT03910244|448796396|FG000|Overall Study|Lost to Follow-up|0|||
124494586|NCT01597193|447764288|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
124772406|NCT03910244|448796397|FG001|Overall Study|Lost to Follow-up|2|||
124772407|NCT03910244|448796396|FG000|Overall Study|Joint withdrawal decision|1|||
124772408|NCT03910244|448796397|FG001|Overall Study|Joint withdrawal decision|0|||
124772409|NCT03910244|448796396|FG000|Overall Study|Study Terminated by Sponsor|7|||
124772410|NCT03910244|448796397|FG001|Overall Study|Study Terminated by Sponsor|4|||
124772411|NCT03910244|448796396|FG000|Overall Study|Physician Decision|1|||
124772412|NCT03910244|448796397|FG001|Overall Study|Physician Decision|0|||
124772413|NCT03910244|448796396|FG000|Overall Study|Protocol Violation|1|||
124772414|NCT03910244|448796397|FG001|Overall Study|Protocol Violation|0|||
124772415|NCT03910244|448796396|FG000|Overall Study|Withdrawal by Subject|7|||
124772416|NCT03910244|448796397|FG001|Overall Study|Withdrawal by Subject|2|||
124772417|NCT00803569|448796400|FG000|Overall Study|Progressive Disease|3|||
124772418|NCT00803569|448796400|FG000|Overall Study|Noncompliance|1|||
124772419|NCT03345784|448796401|FG000|Overall Study|Withdrawal by Subject|2|||
124772420|NCT03345784|448796402|FG001|Overall Study|Withdrawal by Subject|1|||
124772421|NCT04798196|448796403|FG000|Overall Study|Lost to Follow-up|3|||
124772422|NCT04798196|448796404|FG001|Overall Study|Lost to Follow-up|1|||
124772423|NCT04798196|448796405|FG002|Overall Study|Lost to Follow-up|3|||
124772424|NCT00728689|448796411|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
124772425|NCT00728689|448796412|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
124772426|NCT00929695|448796413|FG000|Overall Study|Death|2|||
124772427|NCT00929695|448796414|FG001|Overall Study|Death|1|||
124772428|NCT00929695|448796413|FG000|Overall Study|Withdrawal by Subject|0|||
124772429|NCT00929695|448796414|FG001|Overall Study|Withdrawal by Subject|2|||
124772430|NCT00929695|448796413|FG000|Overall Study|discharge home|4|||
124772431|NCT00929695|448796414|FG001|Overall Study|discharge home|3|||
124772432|NCT00929695|448796413|FG000|Overall Study|incorrect stratification|2|||
124772433|NCT00929695|448796414|FG001|Overall Study|incorrect stratification|0|||
124772434|NCT00887809|448796416|FG000|Overall Study|Patient Not Treated|3|||
124772435|NCT00887809|448796417|FG001|Overall Study|Patient Not Treated|0|||
124772436|NCT00887809|448796416|FG000|Overall Study|Death|1|||
124772437|NCT00887809|448796417|FG001|Overall Study|Death|0|||
124772438|NCT01690143|448796422|FG000|Overall Study|Withdrawal by Subject|1|||
124772439|NCT03777982|448796423|FG000|Overall Study|Physician Decision|0|||
124772440|NCT03777982|448796424|FG001|Overall Study|Physician Decision|1|||
124772441|NCT00870740|448796425|FG000|Overall Study|Adverse Event|2|||
124772442|NCT00870740|448796426|FG001|Overall Study|Adverse Event|1|||
124772443|NCT00870740|448796427|FG002|Overall Study|Adverse Event|3|||
124772444|NCT00870740|448796428|FG003|Overall Study|Adverse Event|2|||
124772445|NCT00870740|448796429|FG004|Overall Study|Adverse Event|1|||
124772446|NCT00870740|448796430|FG005|Overall Study|Adverse Event|6|||
124772447|NCT00870740|448796425|FG000|Overall Study|Consent Withdrawn|6|||
124772448|NCT00870740|448796426|FG001|Overall Study|Consent Withdrawn|3|||
124772449|NCT00870740|448796427|FG002|Overall Study|Consent Withdrawn|4|||
124772450|NCT00870740|448796428|FG003|Overall Study|Consent Withdrawn|6|||
124772451|NCT00870740|448796429|FG004|Overall Study|Consent Withdrawn|6|||
124772452|NCT00870740|448796430|FG005|Overall Study|Consent Withdrawn|5|||
124494587|NCT01597193|447764289|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
124557970|NCT02763579|448001368|FG002|China Period|Death|46|||
124772453|NCT00870740|448796425|FG000|Overall Study|Investigator Decision|2|||
124772454|NCT00870740|448796426|FG001|Overall Study|Investigator Decision|0|||
124772455|NCT00870740|448796427|FG002|Overall Study|Investigator Decision|1|||
124772456|NCT00870740|448796428|FG003|Overall Study|Investigator Decision|0|||
124772457|NCT00870740|448796429|FG004|Overall Study|Investigator Decision|0|||
124772458|NCT00870740|448796430|FG005|Overall Study|Investigator Decision|0|||
124772459|NCT00870740|448796425|FG000|Overall Study|Subject Non-compliance|0|||
124772460|NCT00870740|448796426|FG001|Overall Study|Subject Non-compliance|0|||
124772461|NCT00870740|448796427|FG002|Overall Study|Subject Non-compliance|0|||
124772462|NCT00870740|448796428|FG003|Overall Study|Subject Non-compliance|0|||
124772463|NCT00870740|448796429|FG004|Overall Study|Subject Non-compliance|0|||
124772464|NCT00870740|448796430|FG005|Overall Study|Subject Non-compliance|1|||
124772465|NCT00870740|448796425|FG000|Overall Study|Death|0|||
124772466|NCT00870740|448796426|FG001|Overall Study|Death|0|||
124772467|NCT00870740|448796427|FG002|Overall Study|Death|0|||
124772468|NCT00870740|448796428|FG003|Overall Study|Death|0|||
124557971|NCT02763579|448001369|FG003|China Period|Death|48|||
124557972|NCT02763579|448001366|FG000|China Period|Lost to Follow-up|0|||
124557973|NCT02763579|448001367|FG001|China Period|Lost to Follow-up|0|||
124557974|NCT02763579|448001368|FG002|China Period|Lost to Follow-up|1|||
124557975|NCT02763579|448001369|FG003|China Period|Lost to Follow-up|1|||
124557976|NCT02763579|448001366|FG000|China Period|Physician Decision|0|||
124557977|NCT02763579|448001367|FG001|China Period|Physician Decision|0|||
124557978|NCT02763579|448001368|FG002|China Period|Physician Decision|0|||
124557979|NCT02763579|448001369|FG003|China Period|Physician Decision|1|||
124557980|NCT02763579|448001366|FG000|China Period|Study Terminated By Sponsor|0|||
124557981|NCT02763579|448001367|FG001|China Period|Study Terminated By Sponsor|0|||
124557982|NCT02763579|448001368|FG002|China Period|Study Terminated By Sponsor|3|||
124557983|NCT02763579|448001369|FG003|China Period|Study Terminated By Sponsor|4|||
124557984|NCT02763579|448001366|FG000|China Period|Withdrawal by Subject|0|||
124557985|NCT02763579|448001367|FG001|China Period|Withdrawal by Subject|0|||
124557986|NCT02763579|448001368|FG002|China Period|Withdrawal by Subject|3|||
124557987|NCT02763579|448001369|FG003|China Period|Withdrawal by Subject|3|||
124557988|NCT00910858|448001376|FG000|Pharmacokinetic Phase|Adverse Event|1|||
124557989|NCT00910858|448001377|FG001|Pharmacokinetic Phase|Adverse Event|0|||
124557990|NCT00910858|448001378|FG002|Pharmacokinetic Phase|Adverse Event|0|||
124557991|NCT00910858|448001376|FG000|Monotherapy Phase|Adverse Event|3|||
124557992|NCT00910858|448001377|FG001|Monotherapy Phase|Adverse Event|2|||
124557993|NCT00910858|448001378|FG002|Monotherapy Phase|Adverse Event|0|||
124557994|NCT00910858|448001376|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
124557995|NCT00910858|448001377|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
124557996|NCT00910858|448001378|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
124557997|NCT00910858|448001376|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
124557998|NCT00910858|448001377|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
124557999|NCT00910858|448001378|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
124558000|NCT00910858|448001376|FG000|Monotherapy Phase|Protocol Violation|1|||
124558001|NCT00910858|448001377|FG001|Monotherapy Phase|Protocol Violation|0|||
124558002|NCT00910858|448001378|FG002|Monotherapy Phase|Protocol Violation|0|||
124558003|NCT00910858|448001376|FG000|Monotherapy Phase|Other|3|||
124558004|NCT00910858|448001377|FG001|Monotherapy Phase|Other|4|||
124558005|NCT00910858|448001378|FG002|Monotherapy Phase|Other|2|||
124558006|NCT00910858|448001376|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
124558007|NCT00910858|448001377|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
124558008|NCT00910858|448001378|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
124558009|NCT00910858|448001376|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
124558010|NCT00910858|448001377|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
124558011|NCT00910858|448001378|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
124558012|NCT00910858|448001376|FG000|Combined Treatment Phase|Protocol Violation|1|||
124558013|NCT00910858|448001377|FG001|Combined Treatment Phase|Protocol Violation|0|||
124558014|NCT00910858|448001378|FG002|Combined Treatment Phase|Protocol Violation|0|||
124558015|NCT00910858|448001376|FG000|Combined Treatment Phase|Other|0|||
124558016|NCT00910858|448001377|FG001|Combined Treatment Phase|Other|2|||
124558017|NCT00910858|448001378|FG002|Combined Treatment Phase|Other|1|||
124558018|NCT01703741|448001385|FG000|Overall Study|Withdrawal by Subject|6|||
124494588|NCT01597193|447764283|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
124494589|NCT01597193|447764284|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
124494590|NCT01597193|447764285|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
124494591|NCT01597193|447764286|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
124494592|NCT01597193|447764287|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
124494593|NCT01597193|447764288|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
124494594|NCT01597193|447764289|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
124494595|NCT01597193|447764283|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
124494596|NCT01597193|447764284|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
124494597|NCT01597193|447764285|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
124494598|NCT01597193|447764286|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
124494599|NCT01597193|447764287|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
124494600|NCT01597193|447764288|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
124494601|NCT01597193|447764289|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
124494602|NCT02508701|447764290|FG000|Overall Study|Lost to Follow-up|9|||
124494603|NCT02508701|447764291|FG001|Overall Study|Lost to Follow-up|5|||
124494604|NCT02508701|447764292|FG002|Overall Study|Lost to Follow-up|5|||
124494605|NCT02508701|447764293|FG003|Overall Study|Lost to Follow-up|3|||
124494606|NCT03184701|447764294|FG000|Overall Study|Death|3|||
124494607|NCT03184701|447764294|FG000|Overall Study|Physician Decision|3|||
124494608|NCT03184701|447764294|FG000|Overall Study|Withdrawal by Subject|6|||
124558019|NCT01703741|448001385|FG000|Overall Study|Adverse Event|2|||
124558020|NCT01703741|448001385|FG000|Overall Study|Physician Decision|2|||
124494609|NCT03184701|447764294|FG000|Overall Study|Lost to Follow-up|5|||
124558021|NCT01703741|448001385|FG000|Overall Study|Protocol Violation|1|||
124558022|NCT01703741|448001385|FG000|Overall Study|Lost to Follow-up|3|||
124558023|NCT01703741|448001385|FG000|Overall Study|Subject did not want to continue|2|||
124722170|NCT01804049|448605557|FG001|Overall Study|Moved out of area|7|||
124722171|NCT01804049|448605556|FG000|Overall Study|other MD recommended|1|||
124722172|NCT01804049|448605557|FG001|Overall Study|other MD recommended|1|||
124722173|NCT01804049|448605556|FG000|Overall Study|Enrollment in dual studies|0|||
124722174|NCT01804049|448605557|FG001|Overall Study|Enrollment in dual studies|1|||
124722175|NCT01147250|448605562|FG000|Overall Study|Lost to Follow-up|14|||
124722176|NCT01147250|448605563|FG001|Overall Study|Lost to Follow-up|11|||
124722177|NCT01147250|448605562|FG000|Overall Study|Withdrawal by Subject|83|||
124722178|NCT01147250|448605563|FG001|Overall Study|Withdrawal by Subject|88|||
124722179|NCT01147250|448605562|FG000|Overall Study|Site termination by sponsor|13|||
124722180|NCT01147250|448605563|FG001|Overall Study|Site termination by sponsor|5|||
124494610|NCT00530712|447764297|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
124494611|NCT00530712|447764297|FG000|30 Day Follow-up Visit|Missed Visit|5|||
124494612|NCT00530712|447764297|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
124494613|NCT00530712|447764297|FG000|6 Month Follow-up Visit|Missed Visit|3|||
124494614|NCT00530712|447764297|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
124494615|NCT00530712|447764297|FG000|6 Month Follow-up Visit|Death|2|||
124494616|NCT00530712|447764297|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
124494617|NCT00530712|447764297|FG000|12 Month Follow-up Visit|Missed Visit|3|||
124494618|NCT00530712|447764297|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
124494619|NCT00530712|447764297|FG000|12 Month Follow-up Visit|Death|9|||
124494620|NCT03117049|447764305|FG000|Overall Study|Continued the follow-up period|109|||
124494621|NCT03117049|447764306|FG001|Overall Study|Continued the follow-up period|129|||
124494622|NCT03117049|447764305|FG000|Overall Study|Died|82|||
124494623|NCT03117049|447764306|FG001|Overall Study|Died|93|||
124494624|NCT03117049|447764305|FG000|Overall Study|Consent withdrawal|7|||
124494625|NCT03117049|447764306|FG001|Overall Study|Consent withdrawal|6|||
124494626|NCT03117049|447764305|FG000|Overall Study|Missing contact|3|||
124494627|NCT03117049|447764306|FG001|Overall Study|Missing contact|3|||
124494628|NCT00651118|447764307|FG000|Overall Study|Adverse Event|4|||
124494629|NCT00651118|447764308|FG001|Overall Study|Adverse Event|0|||
124494630|NCT00651118|447764309|FG002|Overall Study|Adverse Event|1|||
124494631|NCT00651118|447764310|FG003|Overall Study|Adverse Event|1|||
124494632|NCT00651118|447764307|FG000|Overall Study|Protocol Violation|2|||
124558024|NCT01703741|448001385|FG000|Overall Study|Subject cannot comply with study visits|1|||
124558025|NCT01703741|448001385|FG000|Overall Study|Subject started testosterone injections|1|||
124558026|NCT01170364|448001386|FG000|Overall Study|Protocol Violation|4|||
124558027|NCT01170364|448001387|FG001|Overall Study|Protocol Violation|1|||
124558028|NCT01381900|448001388|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
124558029|NCT01381900|448001389|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
124558030|NCT01381900|448001390|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
124558031|NCT01381900|448001388|FG000|Overall Study|Adverse Event|4|||
124558032|NCT01381900|448001389|FG001|Overall Study|Adverse Event|6|||
124558033|NCT01381900|448001390|FG002|Overall Study|Adverse Event|7|||
124558034|NCT01381900|448001388|FG000|Overall Study|Noncompliance with study drug|0|||
124558035|NCT01381900|448001389|FG001|Overall Study|Noncompliance with study drug|0|||
124558036|NCT01381900|448001390|FG002|Overall Study|Noncompliance with study drug|1|||
124558037|NCT01381900|448001388|FG000|Overall Study|Physician Decision|0|||
124558038|NCT01381900|448001389|FG001|Overall Study|Physician Decision|1|||
124558039|NCT01381900|448001390|FG002|Overall Study|Physician Decision|1|||
124558040|NCT01381900|448001388|FG000|Overall Study|Protocol Violation|0|||
124558041|NCT01381900|448001389|FG001|Overall Study|Protocol Violation|1|||
124558042|NCT01381900|448001390|FG002|Overall Study|Protocol Violation|1|||
124558043|NCT01381900|448001388|FG000|Overall Study|Withdrawal by Subject|0|||
124558044|NCT01381900|448001389|FG001|Overall Study|Withdrawal by Subject|0|||
124558045|NCT01381900|448001390|FG002|Overall Study|Withdrawal by Subject|1|||
124558046|NCT01381900|448001388|FG000|Overall Study|Early withdraw|3|||
124558047|NCT01381900|448001389|FG001|Overall Study|Early withdraw|1|||
124558048|NCT01381900|448001390|FG002|Overall Study|Early withdraw|1|||
124558049|NCT02041494|448001392|FG000|Overall Study|Death|1|||
124558050|NCT02041494|448001393|FG001|Overall Study|Death|3|||
124558051|NCT02041494|448001392|FG000|Overall Study|Lost to Follow-up|2|||
124558052|NCT02041494|448001393|FG001|Overall Study|Lost to Follow-up|6|||
124558053|NCT02041494|448001392|FG000|Overall Study|study terminated|16|||
124558054|NCT02041494|448001393|FG001|Overall Study|study terminated|11|||
124558055|NCT03341273|448001394|FG000|Overall Study|Lost to Follow-up|7|||
124722181|NCT01147250|448605562|FG000|Overall Study|Other than specified|0|||
124722182|NCT01147250|448605563|FG001|Overall Study|Other than specified|1|||
124722183|NCT03985943|448605567|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
124494633|NCT00651118|447764308|FG001|Overall Study|Protocol Violation|2|||
124494634|NCT00651118|447764309|FG002|Overall Study|Protocol Violation|6|||
124494635|NCT00651118|447764310|FG003|Overall Study|Protocol Violation|2|||
124558056|NCT03341273|448001395|FG001|Overall Study|Lost to Follow-up|7|||
124558057|NCT03341273|448001394|FG000|Overall Study|Withdrawal by Subject|4|||
124558058|NCT03341273|448001395|FG001|Overall Study|Withdrawal by Subject|2|||
124722184|NCT03985943|448605568|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
124558059|NCT03341273|448001394|FG000|Overall Study|Physician Decision|1|||
124558060|NCT03341273|448001395|FG001|Overall Study|Physician Decision|0|||
124772469|NCT00870740|448796429|FG004|Overall Study|Death|1|||
124772470|NCT00870740|448796430|FG005|Overall Study|Death|0|||
124772471|NCT00870740|448796425|FG000|Overall Study|Other|2|||
124772472|NCT00870740|448796426|FG001|Overall Study|Other|5|||
124772473|NCT00870740|448796427|FG002|Overall Study|Other|2|||
124772474|NCT00870740|448796428|FG003|Overall Study|Other|4|||
124772475|NCT00870740|448796429|FG004|Overall Study|Other|3|||
124772476|NCT00870740|448796430|FG005|Overall Study|Other|5|||
124772477|NCT03755934|448796431|FG000|Overall Study|Adverse Event|4|||
124772478|NCT03755934|448796432|FG001|Overall Study|Adverse Event|1|||
124772479|NCT03755934|448796433|FG002|Overall Study|Adverse Event|1|||
124772480|NCT03755934|448796434|FG003|Overall Study|Adverse Event|3|||
124772481|NCT03755934|448796431|FG000|Overall Study|Physician Decision|2|||
124772482|NCT03755934|448796432|FG001|Overall Study|Physician Decision|0|||
124772483|NCT03755934|448796433|FG002|Overall Study|Physician Decision|0|||
124772484|NCT03755934|448796434|FG003|Overall Study|Physician Decision|1|||
124772485|NCT03755934|448796431|FG000|Overall Study|Withdrawal by Subject|5|||
124772486|NCT03755934|448796432|FG001|Overall Study|Withdrawal by Subject|0|||
124772487|NCT03755934|448796433|FG002|Overall Study|Withdrawal by Subject|0|||
124772488|NCT03755934|448796434|FG003|Overall Study|Withdrawal by Subject|1|||
124772489|NCT03755934|448796431|FG000|Overall Study|Other|3|||
124772490|NCT03755934|448796432|FG001|Overall Study|Other|1|||
124772491|NCT03755934|448796433|FG002|Overall Study|Other|3|||
124772492|NCT03755934|448796434|FG003|Overall Study|Other|1|||
124772493|NCT00307801|448796437|FG000|Overall Study|Adverse Event|12|||
124772494|NCT00307801|448796438|FG001|Overall Study|Adverse Event|4|||
124772495|NCT00307801|448796437|FG000|Overall Study|Withdrawal by Subject|9|||
124772496|NCT00307801|448796438|FG001|Overall Study|Withdrawal by Subject|4|||
124772497|NCT00307801|448796437|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
124772498|NCT00307801|448796438|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
124772499|NCT00307801|448796437|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
124772500|NCT00307801|448796438|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
124772501|NCT00307801|448796437|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
124772502|NCT00307801|448796438|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
124772503|NCT00307801|448796437|FG000|Overall Study|Wrong Randomization|1|||
124772504|NCT00307801|448796438|FG001|Overall Study|Wrong Randomization|0|||
124772505|NCT00307801|448796437|FG000|Overall Study|Lack of Efficacy|0|||
124772506|NCT00307801|448796438|FG001|Overall Study|Lack of Efficacy|2|||
124772507|NCT00307801|448796437|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
124772508|NCT00307801|448796438|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
124772509|NCT00307801|448796437|FG000|Overall Study|Frustration with e-diary|1|||
124772510|NCT00307801|448796438|FG001|Overall Study|Frustration with e-diary|0|||
124772511|NCT00307801|448796437|FG000|Overall Study|Protocol Violation|3|||
124772512|NCT00307801|448796438|FG001|Overall Study|Protocol Violation|2|||
124772513|NCT00307801|448796437|FG000|Overall Study|No reason specified|2|||
124772514|NCT00307801|448796438|FG001|Overall Study|No reason specified|0|||
124772515|NCT00307801|448796437|FG000|Overall Study|Pregnancy|0|||
124772516|NCT00307801|448796438|FG001|Overall Study|Pregnancy|1|||
124772517|NCT00551642|448796444|FG000|Treatment Period|Protocol Deviation|6|||
124772518|NCT00551642|448796445|FG001|Treatment Period|Protocol Deviation|11|||
124772519|NCT00551642|448796444|FG000|Treatment Period|Delivery device failure|1|||
124772520|NCT00551642|448796445|FG001|Treatment Period|Delivery device failure|3|||
124772521|NCT00551642|448796444|FG000|Treatment Period|Physician Decision|0|||
124772522|NCT00551642|448796445|FG001|Treatment Period|Physician Decision|1|||
124772523|NCT00551642|448796444|FG000|Treatment Period|Death|33|||
124494636|NCT00651118|447764307|FG000|Overall Study|Lost to Follow-up|2|||
124494637|NCT00651118|447764308|FG001|Overall Study|Lost to Follow-up|0|||
124494638|NCT00651118|447764309|FG002|Overall Study|Lost to Follow-up|1|||
124494639|NCT00651118|447764310|FG003|Overall Study|Lost to Follow-up|2|||
124494640|NCT00651118|447764307|FG000|Overall Study|administrative|1|||
124494641|NCT00651118|447764308|FG001|Overall Study|administrative|4|||
124494642|NCT00651118|447764309|FG002|Overall Study|administrative|2|||
124772524|NCT00551642|448796445|FG001|Treatment Period|Death|31|||
124772525|NCT00551642|448796444|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
124772526|NCT00551642|448796445|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
124772527|NCT00551642|448796444|FG000|Treatment Period|Adverse Event|15|||
124772528|NCT00551642|448796445|FG001|Treatment Period|Adverse Event|12|||
124772529|NCT00551642|448796444|FG000|Treatment Period|Withdrawal by Subject|2|||
124772530|NCT00551642|448796445|FG001|Treatment Period|Withdrawal by Subject|1|||
124772531|NCT00361296|448796447|FG000|Overall Study|Physician Decision|1|||
124772532|NCT00361296|448796447|FG000|Overall Study|Lack of Efficacy|2|||
124772533|NCT00198822|448796448|FG000|Overall Study|Lost to Follow-up|14|||
124494643|NCT00651118|447764310|FG003|Overall Study|administrative|1|||
124494644|NCT00651118|447764307|FG000|Overall Study|Withdrawal by Subject|0|||
124494645|NCT00651118|447764308|FG001|Overall Study|Withdrawal by Subject|1|||
124772534|NCT00198822|448796449|FG001|Overall Study|Lost to Follow-up|20|||
124772535|NCT00198822|448796450|FG002|Overall Study|Lost to Follow-up|21|||
124772536|NCT03011099|448796451|FG000|Overall Study|Withdrawal by Subject|0|||
124772537|NCT03011099|448796452|FG001|Overall Study|Withdrawal by Subject|2|||
124722185|NCT03985943|448605569|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
124722186|NCT03985943|448605570|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
124722187|NCT03985943|448605571|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
124494646|NCT00651118|447764309|FG002|Overall Study|Withdrawal by Subject|1|||
124494647|NCT00651118|447764310|FG003|Overall Study|Withdrawal by Subject|1|||
124494648|NCT00839098|447764311|FG000|Overall Study|Withdrawal by Subject|2|||
124494649|NCT00839098|447764312|FG001|Overall Study|Withdrawal by Subject|1|||
124494650|NCT00839098|447764313|FG002|Overall Study|Withdrawal by Subject|7|||
124494651|NCT00365976|447764316|FG000|Overall Study|Withdrawal by Subject|1|||
124494652|NCT00365976|447764317|FG001|Overall Study|Withdrawal by Subject|5|||
124494653|NCT02260193|447764318|FG000|Overall Study|Lack of Efficacy|0|||
124494654|NCT02260193|447764319|FG001|Overall Study|Lack of Efficacy|1|||
124494655|NCT02260193|447764320|FG002|Overall Study|Lack of Efficacy|6|||
124494656|NCT02260193|447764318|FG000|Overall Study|Adverse Event|3|||
124494657|NCT02260193|447764319|FG001|Overall Study|Adverse Event|4|||
124494658|NCT02260193|447764320|FG002|Overall Study|Adverse Event|1|||
124494659|NCT02260193|447764318|FG000|Overall Study|Protocol Violation|0|||
124494660|NCT02260193|447764319|FG001|Overall Study|Protocol Violation|4|||
124494661|NCT02260193|447764320|FG002|Overall Study|Protocol Violation|0|||
124494662|NCT02260193|447764318|FG000|Overall Study|Withdrawal by Subject|3|||
124494663|NCT02260193|447764319|FG001|Overall Study|Withdrawal by Subject|0|||
124494664|NCT02260193|447764320|FG002|Overall Study|Withdrawal by Subject|2|||
124494665|NCT02260193|447764318|FG000|Overall Study|Kidney Transplantation|0|||
124494666|NCT02260193|447764319|FG001|Overall Study|Kidney Transplantation|0|||
124494667|NCT02260193|447764320|FG002|Overall Study|Kidney Transplantation|1|||
124494668|NCT00633139|447764327|FG000|Overall Study|Non compliance|0|||
124494669|NCT00633139|447764328|FG001|Overall Study|Non compliance|0|||
124494670|NCT00633139|447764329|FG002|Overall Study|Non compliance|1|||
124494671|NCT00633139|447764327|FG000|Overall Study|Withdrawal by Subject|0|||
124494672|NCT00633139|447764328|FG001|Overall Study|Withdrawal by Subject|1|||
124494673|NCT00633139|447764329|FG002|Overall Study|Withdrawal by Subject|0|||
124494674|NCT01522651|447764332|FG000|Overall Study|Adverse Event|3|||
124494675|NCT01522651|447764333|FG001|Overall Study|Adverse Event|4|||
124494676|NCT01522651|447764334|FG002|Overall Study|Adverse Event|4|||
124494677|NCT01522651|447764335|FG003|Overall Study|Adverse Event|5|||
124494678|NCT01522651|447764336|FG004|Overall Study|Adverse Event|4|||
124494679|NCT01522651|447764332|FG000|Overall Study|Cardioversion|1|||
124494680|NCT01522651|447764333|FG001|Overall Study|Cardioversion|0|||
124494681|NCT01522651|447764334|FG002|Overall Study|Cardioversion|0|||
124494682|NCT01522651|447764335|FG003|Overall Study|Cardioversion|0|||
124494683|NCT01522651|447764336|FG004|Overall Study|Cardioversion|0|||
124494684|NCT01522651|447764332|FG000|Overall Study|Device Malfunction|0|||
124494685|NCT01522651|447764333|FG001|Overall Study|Device Malfunction|1|||
124494686|NCT01522651|447764334|FG002|Overall Study|Device Malfunction|0|||
124494687|NCT01522651|447764335|FG003|Overall Study|Device Malfunction|0|||
124494688|NCT01522651|447764336|FG004|Overall Study|Device Malfunction|0|||
124494689|NCT01522651|447764332|FG000|Overall Study|Investigator's Discretion|0|||
124494690|NCT01522651|447764333|FG001|Overall Study|Investigator's Discretion|1|||
124494691|NCT01522651|447764334|FG002|Overall Study|Investigator's Discretion|0|||
124494692|NCT01522651|447764335|FG003|Overall Study|Investigator's Discretion|0|||
124494693|NCT01522651|447764336|FG004|Overall Study|Investigator's Discretion|0|||
124494694|NCT01522651|447764332|FG000|Overall Study|Protocol Violation|3|||
124494695|NCT01522651|447764333|FG001|Overall Study|Protocol Violation|0|||
124494696|NCT01522651|447764334|FG002|Overall Study|Protocol Violation|0|||
124494697|NCT01522651|447764335|FG003|Overall Study|Protocol Violation|0|||
124494698|NCT01522651|447764336|FG004|Overall Study|Protocol Violation|0|||
124494699|NCT01522651|447764332|FG000|Overall Study|Reason Not Specified|0|||
124494700|NCT01522651|447764333|FG001|Overall Study|Reason Not Specified|0|||
124494701|NCT01522651|447764334|FG002|Overall Study|Reason Not Specified|0|||
124494702|NCT01522651|447764335|FG003|Overall Study|Reason Not Specified|1|||
124494703|NCT01522651|447764336|FG004|Overall Study|Reason Not Specified|0|||
124494704|NCT01522651|447764332|FG000|Overall Study|Participant Non-Compliance|1|||
124494705|NCT01522651|447764333|FG001|Overall Study|Participant Non-Compliance|0|||
124494706|NCT01522651|447764334|FG002|Overall Study|Participant Non-Compliance|0|||
124494707|NCT01522651|447764335|FG003|Overall Study|Participant Non-Compliance|0|||
124494708|NCT01522651|447764336|FG004|Overall Study|Participant Non-Compliance|0|||
124494709|NCT01522651|447764332|FG000|Overall Study|Withdrew Consent|1|||
124494710|NCT01522651|447764333|FG001|Overall Study|Withdrew Consent|1|||
124722188|NCT03985943|448605572|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
124494711|NCT01522651|447764334|FG002|Overall Study|Withdrew Consent|0|||
124494712|NCT01522651|447764335|FG003|Overall Study|Withdrew Consent|1|||
124494713|NCT01522651|447764336|FG004|Overall Study|Withdrew Consent|1|||
124494714|NCT01522651|447764332|FG000|Overall Study|Randomized but Never Treated|0|||
124494715|NCT01522651|447764333|FG001|Overall Study|Randomized but Never Treated|1|||
124494716|NCT01522651|447764334|FG002|Overall Study|Randomized but Never Treated|0|||
124722189|NCT03985943|448605567|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
124722190|NCT03985943|448605568|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
124494717|NCT01522651|447764335|FG003|Overall Study|Randomized but Never Treated|1|||
124494718|NCT01522651|447764336|FG004|Overall Study|Randomized but Never Treated|1|||
124494719|NCT02658656|447764337|FG000|Screening|Failed eligibility criteria|0|||
124494720|NCT02658656|447764338|FG001|Screening|Failed eligibility criteria|0|||
124494721|NCT02658656|447764339|FG002|Screening|Failed eligibility criteria|263|||
124494722|NCT02658656|447764337|FG000|Randomization|Withdrawal by Subject|8|||
124494723|NCT02658656|447764338|FG001|Randomization|Withdrawal by Subject|7|||
124494724|NCT02658656|447764339|FG002|Randomization|Withdrawal by Subject|0|||
124494725|NCT02658656|447764337|FG000|Randomization|Lost to Follow-up|1|||
124494726|NCT02658656|447764338|FG001|Randomization|Lost to Follow-up|3|||
124494727|NCT02658656|447764339|FG002|Randomization|Lost to Follow-up|0|||
124494728|NCT02658656|447764337|FG000|Randomization|Adverse Event|4|||
124494729|NCT02658656|447764338|FG001|Randomization|Adverse Event|0|||
124494730|NCT02658656|447764339|FG002|Randomization|Adverse Event|0|||
124494731|NCT02658656|447764337|FG000|Randomization|Administrative Termination|3|||
124494732|NCT02658656|447764338|FG001|Randomization|Administrative Termination|1|||
124494733|NCT02658656|447764339|FG002|Randomization|Administrative Termination|0|||
124494734|NCT02658656|447764337|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
124494735|NCT02658656|447764338|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
124494736|NCT02658656|447764339|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
124494737|NCT02658656|447764337|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
124494738|NCT02658656|447764338|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
124494739|NCT02658656|447764339|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
124494740|NCT02658656|447764337|FG000|Randomization|Not eligible for Randomization|1|||
124494741|NCT02658656|447764338|FG001|Randomization|Not eligible for Randomization|0|||
124494742|NCT02658656|447764339|FG002|Randomization|Not eligible for Randomization|0|||
124494743|NCT02658656|447764337|FG000|Randomization|Protocol Violation|1|||
124494744|NCT02658656|447764338|FG001|Randomization|Protocol Violation|0|||
124494745|NCT02658656|447764339|FG002|Randomization|Protocol Violation|0|||
124494746|NCT00408421|447766238|FG000|Treatment Initial Randomization|Adverse Event|5|||
124494747|NCT00408421|447766239|FG001|Treatment Initial Randomization|Adverse Event|9|||
124494748|NCT00408421|447766240|FG002|Treatment Initial Randomization|Adverse Event|0|||
124494749|NCT00408421|447766238|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
124494750|NCT00408421|447766239|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
124494751|NCT00408421|447766240|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
124494752|NCT00408421|447766238|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
124494753|NCT00408421|447766239|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
124494754|NCT00408421|447766240|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
124494755|NCT00408421|447766238|FG000|Treatment Initial Randomization|Physician Decision|1|||
124494756|NCT00408421|447766239|FG001|Treatment Initial Randomization|Physician Decision|0|||
124494757|NCT00408421|447766240|FG002|Treatment Initial Randomization|Physician Decision|0|||
124494758|NCT00408421|447766238|FG000|Treatment Initial Randomization|Protocol Violation|0|||
124494759|NCT00408421|447766239|FG001|Treatment Initial Randomization|Protocol Violation|1|||
124494760|NCT00408421|447766240|FG002|Treatment Initial Randomization|Protocol Violation|0|||
124494761|NCT00408421|447766238|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
124494762|NCT00408421|447766239|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
124494763|NCT00408421|447766240|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
124494764|NCT00408421|447766238|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
124494765|NCT00408421|447766239|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
124494766|NCT00408421|447766240|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
124494767|NCT00408421|447766238|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
124494768|NCT00408421|447766239|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
124494769|NCT00408421|447766240|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
124494770|NCT00408421|447766238|FG000|Treatment Re-Randomization|Adverse Event|2|||
124494771|NCT00408421|447766239|FG001|Treatment Re-Randomization|Adverse Event|2|||
124494772|NCT00408421|447766240|FG002|Treatment Re-Randomization|Adverse Event|4|||
124494773|NCT00408421|447766238|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
124494774|NCT00408421|447766239|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
124494775|NCT00408421|447766240|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
124494776|NCT00408421|447766238|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
124494777|NCT00408421|447766239|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
124494778|NCT00408421|447766240|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
124494779|NCT00408421|447766238|FG000|Treatment Re-Randomization|Physician Decision|1|||
124494780|NCT00408421|447766239|FG001|Treatment Re-Randomization|Physician Decision|3|||
124494781|NCT00408421|447766240|FG002|Treatment Re-Randomization|Physician Decision|0|||
124494782|NCT00408421|447766238|FG000|Treatment Re-Randomization|Protocol Violation|1|||
124494783|NCT00408421|447766239|FG001|Treatment Re-Randomization|Protocol Violation|1|||
124494784|NCT00408421|447766240|FG002|Treatment Re-Randomization|Protocol Violation|0|||
124494785|NCT00408421|447766238|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
124494786|NCT00408421|447766239|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
124722191|NCT03985943|448605569|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
124494787|NCT00408421|447766240|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
124494788|NCT01790438|447766245|FG000|Overall Study|Adverse Event|3|||
124494789|NCT01790438|447766246|FG001|Overall Study|Adverse Event|2|||
124494790|NCT01790438|447766245|FG000|Overall Study|Death|4|||
124494791|NCT01790438|447766246|FG001|Overall Study|Death|0|||
124494792|NCT01790438|447766245|FG000|Overall Study|Lost to Follow-up|5|||
124494793|NCT01790438|447766246|FG001|Overall Study|Lost to Follow-up|2|||
124494794|NCT01790438|447766245|FG000|Overall Study|Withdrawal by Subject|13|||
124494795|NCT01790438|447766246|FG001|Overall Study|Withdrawal by Subject|2|||
124494796|NCT01790438|447766245|FG000|Overall Study|Physician Decision|3|||
124494797|NCT01790438|447766246|FG001|Overall Study|Physician Decision|1|||
124494798|NCT01790438|447766245|FG000|Overall Study|Sponsor Decision|0|||
124494799|NCT01790438|447766246|FG001|Overall Study|Sponsor Decision|3|||
124494800|NCT01790438|447766245|FG000|Overall Study|Protocol Required Discontinuation|7|||
124494801|NCT01790438|447766246|FG001|Overall Study|Protocol Required Discontinuation|1|||
124494802|NCT04760314|447766252|FG000|Induction Period|Withdrawal by Subject|0|||
124494803|NCT04760314|447766253|FG001|Induction Period|Withdrawal by Subject|1|||
124494804|NCT04760314|447766254|FG002|Induction Period|Withdrawal by Subject|1|||
124494805|NCT04760314|447766255|FG003|Induction Period|Withdrawal by Subject|0|||
124494806|NCT04760314|447766256|FG004|Induction Period|Withdrawal by Subject|0|||
124494807|NCT04760314|447766257|FG005|Induction Period|Withdrawal by Subject|0|||
124494808|NCT04760314|447766258|FG006|Induction Period|Withdrawal by Subject|0|||
124494809|NCT04760314|447766259|FG007|Induction Period|Withdrawal by Subject|0|||
124494810|NCT04760314|447766260|FG008|Induction Period|Withdrawal by Subject|0|||
124494811|NCT04760314|447766261|FG009|Induction Period|Withdrawal by Subject|0|||
124494812|NCT04760314|447766262|FG010|Induction Period|Withdrawal by Subject|0|||
124494813|NCT04760314|447766252|FG000|Induction Period|Adverse Event|0|||
124494814|NCT04760314|447766253|FG001|Induction Period|Adverse Event|0|||
124494815|NCT04760314|447766254|FG002|Induction Period|Adverse Event|2|||
124494816|NCT04760314|447766255|FG003|Induction Period|Adverse Event|0|||
124494817|NCT04760314|447766256|FG004|Induction Period|Adverse Event|0|||
124494818|NCT04760314|447766257|FG005|Induction Period|Adverse Event|0|||
124494819|NCT04760314|447766258|FG006|Induction Period|Adverse Event|0|||
124494820|NCT04760314|447766259|FG007|Induction Period|Adverse Event|0|||
124494821|NCT04760314|447766260|FG008|Induction Period|Adverse Event|0|||
124494822|NCT04760314|447766261|FG009|Induction Period|Adverse Event|0|||
124494823|NCT04760314|447766262|FG010|Induction Period|Adverse Event|0|||
124494824|NCT04760314|447766252|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
124494825|NCT04760314|447766253|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
124494826|NCT04760314|447766254|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
124494827|NCT04760314|447766255|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
124494828|NCT04760314|447766256|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
124494829|NCT04760314|447766257|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
124494830|NCT04760314|447766258|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
124494831|NCT04760314|447766259|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
124494832|NCT04760314|447766260|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
124494833|NCT04760314|447766261|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
124494834|NCT04760314|447766262|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
124494835|NCT04760314|447766252|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
124494836|NCT04760314|447766253|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
124494837|NCT04760314|447766254|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
124494838|NCT04760314|447766255|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
124494839|NCT04760314|447766256|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
124494840|NCT04760314|447766257|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
124494841|NCT04760314|447766258|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
124494842|NCT04760314|447766259|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
124494843|NCT04760314|447766260|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
124494844|NCT04760314|447766261|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
124494845|NCT04760314|447766262|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
124494846|NCT04760314|447766252|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
124494847|NCT04760314|447766253|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
124494848|NCT04760314|447766254|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
124494849|NCT04760314|447766255|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
124494850|NCT04760314|447766256|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
124494851|NCT04760314|447766257|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
124494852|NCT04760314|447766258|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
124494853|NCT04760314|447766259|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
124494854|NCT04760314|447766260|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
124494855|NCT04760314|447766261|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
124494856|NCT04760314|447766262|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
124494857|NCT04760314|447766252|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
124558061|NCT03341273|448001394|FG000|Overall Study|Protocol Violation|0|||
124494858|NCT04760314|447766253|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
124494859|NCT04760314|447766254|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
124494860|NCT04760314|447766255|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
124494861|NCT04760314|447766256|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
124494862|NCT04760314|447766257|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
124494863|NCT04760314|447766258|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
124722192|NCT03985943|448605570|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
124722193|NCT03985943|448605571|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
124722194|NCT03985943|448605572|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
124722195|NCT03985943|448605567|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
124494864|NCT04760314|447766259|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
124494865|NCT04760314|447766260|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
124494866|NCT04760314|447766261|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
124494867|NCT04760314|447766262|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
124722196|NCT03985943|448605568|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
124722197|NCT03985943|448605569|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
124722198|NCT03985943|448605570|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
124722199|NCT03985943|448605571|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
124722200|NCT03985943|448605572|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
124722201|NCT03985943|448605567|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
124722202|NCT03985943|448605568|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
124722203|NCT03985943|448605569|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
124722204|NCT03985943|448605570|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
124722205|NCT03985943|448605571|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
124722206|NCT03985943|448605572|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
124722207|NCT03985943|448605567|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
124722208|NCT03985943|448605568|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
124722209|NCT03985943|448605569|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
124722210|NCT03985943|448605570|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
124722211|NCT03985943|448605571|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
124722212|NCT03985943|448605572|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
124722213|NCT03985943|448605567|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
124722214|NCT03985943|448605568|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
124722215|NCT03985943|448605569|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
124722216|NCT03985943|448605570|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
124722217|NCT03985943|448605571|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
124722218|NCT03985943|448605572|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
124722219|NCT03985943|448605567|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
124722220|NCT03985943|448605568|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
124722221|NCT03985943|448605569|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
124722222|NCT03985943|448605570|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
124494868|NCT04760314|447766252|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124494869|NCT04760314|447766253|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124494870|NCT04760314|447766254|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124494871|NCT04760314|447766255|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124494872|NCT04760314|447766256|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124494873|NCT04760314|447766257|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124494874|NCT04760314|447766258|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124494875|NCT04760314|447766259|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
124494876|NCT04760314|447766260|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124494877|NCT04760314|447766261|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
124494878|NCT04760314|447766262|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
124494879|NCT04760314|447766252|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124494880|NCT04760314|447766253|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124494881|NCT04760314|447766254|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124494882|NCT04760314|447766255|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124494883|NCT04760314|447766256|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124494884|NCT04760314|447766257|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124494885|NCT04760314|447766258|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124494886|NCT04760314|447766259|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
124494887|NCT04760314|447766260|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
124494888|NCT04760314|447766261|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
124494889|NCT04760314|447766262|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124494890|NCT04760314|447766252|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124494891|NCT04760314|447766253|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124494892|NCT04760314|447766254|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124494893|NCT04760314|447766255|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124494894|NCT04760314|447766256|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124494895|NCT04760314|447766257|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124494896|NCT04760314|447766258|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124494897|NCT04760314|447766259|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
124494898|NCT04760314|447766260|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124494899|NCT04760314|447766261|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124494900|NCT04760314|447766262|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124494901|NCT04760314|447766252|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
124494902|NCT04760314|447766253|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
124494903|NCT04760314|447766254|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
124494904|NCT04760314|447766255|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
124494905|NCT04760314|447766256|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
124494906|NCT04760314|447766257|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
124494907|NCT04760314|447766258|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
124494908|NCT04760314|447766259|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
124494909|NCT04760314|447766260|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
124494910|NCT04760314|447766261|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
124494911|NCT04760314|447766262|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
124494912|NCT00960440|447766264|FG000|Overall Study|Death|0|||
124494913|NCT00960440|447766265|FG001|Overall Study|Death|0|||
124494914|NCT00960440|447766266|FG002|Overall Study|Death|0|||
124494915|NCT00960440|447766267|FG003|Overall Study|Death|1|||
124494916|NCT00960440|447766264|FG000|Overall Study|Adverse Event|12|||
124494917|NCT00960440|447766265|FG001|Overall Study|Adverse Event|12|||
124494918|NCT00960440|447766266|FG002|Overall Study|Adverse Event|4|||
124494919|NCT00960440|447766267|FG003|Overall Study|Adverse Event|4|||
124494920|NCT00960440|447766264|FG000|Overall Study|Lack of Efficacy|2|||
124494921|NCT00960440|447766265|FG001|Overall Study|Lack of Efficacy|5|||
124494922|NCT00960440|447766266|FG002|Overall Study|Lack of Efficacy|3|||
124494923|NCT00960440|447766267|FG003|Overall Study|Lack of Efficacy|8|||
124494924|NCT00960440|447766264|FG000|Overall Study|Protocol Violation|2|||
124494925|NCT00960440|447766265|FG001|Overall Study|Protocol Violation|8|||
124494926|NCT00960440|447766266|FG002|Overall Study|Protocol Violation|3|||
124494927|NCT00960440|447766267|FG003|Overall Study|Protocol Violation|4|||
124494928|NCT00960440|447766264|FG000|Overall Study|Withdrawal by Subject|9|||
124494929|NCT00960440|447766265|FG001|Overall Study|Withdrawal by Subject|5|||
124494930|NCT00960440|447766266|FG002|Overall Study|Withdrawal by Subject|2|||
124494931|NCT00960440|447766267|FG003|Overall Study|Withdrawal by Subject|1|||
124494932|NCT00960440|447766264|FG000|Overall Study|Other|1|||
124494933|NCT00960440|447766265|FG001|Overall Study|Other|1|||
124494934|NCT00960440|447766266|FG002|Overall Study|Other|1|||
124494935|NCT00960440|447766267|FG003|Overall Study|Other|0|||
124494936|NCT02421120|447766268|FG000|Overall Study|Adverse Event|1|||
124494937|NCT02207530|447766269|FG000|Overall Study|Worsening condition under investigation|78|||
124494938|NCT02207530|447766269|FG000|Overall Study|Patient decision to stop study treatment|5|||
124494939|NCT02207530|447766269|FG000|Overall Study|Adverse Event|8|||
124494940|NCT02345161|447766270|FG000|Overall Study|Withdrawal by Subject|25|||
124494941|NCT02345161|447766271|FG001|Overall Study|Withdrawal by Subject|33|||
124494942|NCT02345161|447766270|FG000|Overall Study|Adverse Event|16|||
124494943|NCT02345161|447766271|FG001|Overall Study|Adverse Event|19|||
124494944|NCT02345161|447766270|FG000|Overall Study|Physician Decision|4|||
124494945|NCT02345161|447766271|FG001|Overall Study|Physician Decision|4|||
124494946|NCT02345161|447766270|FG000|Overall Study|Lost to Follow-up|0|||
124494947|NCT02345161|447766271|FG001|Overall Study|Lost to Follow-up|1|||
124494948|NCT02869867|447766272|FG000|Overall Study|Protocol Violation|1|||
124494949|NCT02869867|447766273|FG001|Overall Study|Protocol Violation|0|||
124494950|NCT02869867|447766272|FG000|Overall Study|Lost to Follow-up|5|||
124494951|NCT02869867|447766273|FG001|Overall Study|Lost to Follow-up|5|||
124494952|NCT03554005|447766274|FG000|Overall Study|Not in participant's best interest|0|||
124494953|NCT03554005|447766275|FG001|Overall Study|Not in participant's best interest|0|||
124494954|NCT03554005|447766276|FG002|Overall Study|Not in participant's best interest|0|||
124494955|NCT03554005|447766277|FG003|Overall Study|Not in participant's best interest|0|||
124494956|NCT03554005|447766278|FG004|Overall Study|Not in participant's best interest|0|||
124494957|NCT03554005|447766279|FG005|Overall Study|Not in participant's best interest|1|||
124494958|NCT03554005|447766274|FG000|Overall Study|Disease Progression|1|||
124558062|NCT03341273|448001395|FG001|Overall Study|Protocol Violation|1|||
124494959|NCT03554005|447766275|FG001|Overall Study|Disease Progression|1|||
124494960|NCT03554005|447766276|FG002|Overall Study|Disease Progression|1|||
124494961|NCT03554005|447766277|FG003|Overall Study|Disease Progression|1|||
124494962|NCT03554005|447766278|FG004|Overall Study|Disease Progression|5|||
124494963|NCT03554005|447766279|FG005|Overall Study|Disease Progression|6|||
124494964|NCT03554005|447766274|FG000|Overall Study|Adverse Event|0|||
124494965|NCT03554005|447766275|FG001|Overall Study|Adverse Event|0|||
124772538|NCT02072668|448796456|FG000|Second Intervention|Lost to Follow-up|1|||
124772539|NCT02072668|448796457|FG001|Second Intervention|Lost to Follow-up|0|||
124772540|NCT04482647|448796458|FG000|Overall Study|Time constraints|2|||
124772541|NCT04482647|448796458|FG000|Overall Study|Health issues|1|||
124772542|NCT04482647|448796458|FG000|Overall Study|Death in the family|1|||
124772543|NCT04482647|448796458|FG000|Overall Study|Disliked the intervention|1|||
124772544|NCT04482647|448796458|FG000|Overall Study|No reasons specified|7|||
124772545|NCT01231906|448796461|FG000|Overall Study|Lack of Efficacy|75|||
124772546|NCT01231906|448796462|FG001|Overall Study|Lack of Efficacy|68|||
124772547|NCT01231906|448796461|FG000|Overall Study|Lost to Follow-up|1|||
124772548|NCT01231906|448796462|FG001|Overall Study|Lost to Follow-up|0|||
124772549|NCT01231906|448796461|FG000|Overall Study|Physician Decision|34|||
124772550|NCT01231906|448796462|FG001|Overall Study|Physician Decision|24|||
124772551|NCT01231906|448796461|FG000|Overall Study|Withdrawal by Subject|0|||
124772552|NCT01231906|448796462|FG001|Overall Study|Withdrawal by Subject|4|||
124772553|NCT01231906|448796461|FG000|Overall Study|Ineligible|10|||
124772554|NCT01231906|448796462|FG001|Overall Study|Ineligible|3|||
124772555|NCT01231906|448796461|FG000|Overall Study|No treatment|1|||
124772556|NCT01231906|448796462|FG001|Overall Study|No treatment|2|||
124772557|NCT04163341|448796463|FG000|Overall Study|Withdrawal by Subject|2|||
124772558|NCT04163341|448796464|FG001|Overall Study|Withdrawal by Subject|0|||
124772559|NCT04163341|448796463|FG000|Overall Study|Lost to Follow-up|3|||
124772560|NCT04163341|448796464|FG001|Overall Study|Lost to Follow-up|4|||
124772561|NCT02484391|448796466|FG000|Overall Study|Lack of Efficacy|15|||
124772562|NCT02484391|448796467|FG001|Overall Study|Lack of Efficacy|14|||
124772563|NCT02484391|448796468|FG002|Overall Study|Lack of Efficacy|3|||
124772564|NCT02484391|448796466|FG000|Overall Study|Lost to Follow-up|0|||
124772565|NCT02484391|448796467|FG001|Overall Study|Lost to Follow-up|0|||
124772566|NCT02484391|448796468|FG002|Overall Study|Lost to Follow-up|2|||
124772567|NCT02484391|448796466|FG000|Overall Study|Physician Decision|1|||
124772568|NCT02484391|448796467|FG001|Overall Study|Physician Decision|3|||
124772569|NCT02484391|448796468|FG002|Overall Study|Physician Decision|0|||
124772570|NCT02484391|448796466|FG000|Overall Study|Went to Transplant|5|||
124772571|NCT02484391|448796467|FG001|Overall Study|Went to Transplant|3|||
124772572|NCT02484391|448796468|FG002|Overall Study|Went to Transplant|2|||
124772573|NCT00905164|448796471|FG000|Period 1|Protocol Violation|0|||
124772574|NCT00905164|448796472|FG001|Period 1|Protocol Violation|1|||
124772575|NCT04730804|448796477|FG000|Overall Study|Physician Decision|0|||
124772576|NCT04730804|448796478|FG001|Overall Study|Physician Decision|0|||
124772577|NCT04730804|448796479|FG002|Overall Study|Physician Decision|0|||
124772578|NCT04730804|448796480|FG003|Overall Study|Physician Decision|0|||
124772579|NCT04730804|448796481|FG004|Overall Study|Physician Decision|0|||
124772580|NCT04730804|448796482|FG005|Overall Study|Physician Decision|1|||
124772581|NCT04730804|448796477|FG000|Overall Study|Withdrawal by Subject|0|||
124772582|NCT04730804|448796478|FG001|Overall Study|Withdrawal by Subject|0|||
124772583|NCT04730804|448796479|FG002|Overall Study|Withdrawal by Subject|0|||
124772584|NCT04730804|448796480|FG003|Overall Study|Withdrawal by Subject|0|||
124772585|NCT04730804|448796481|FG004|Overall Study|Withdrawal by Subject|1|||
124772586|NCT04730804|448796482|FG005|Overall Study|Withdrawal by Subject|2|||
124772587|NCT05366738|448798723|FG000|Overall Study|Adverse Event|0|||
124772588|NCT05366738|448798724|FG001|Overall Study|Adverse Event|1|||
124772589|NCT05366738|448798725|FG002|Overall Study|Adverse Event|0|||
124772590|NCT01389596|448798726|FG000|Overall Study|Protocol Violation|3|||
124772591|NCT01389596|448798727|FG001|Overall Study|Protocol Violation|4|||
124772592|NCT01389596|448798728|FG002|Overall Study|Protocol Violation|3|||
124772593|NCT01389596|448798726|FG000|Overall Study|Withdrawal by Subject|1|||
124772594|NCT01389596|448798727|FG001|Overall Study|Withdrawal by Subject|2|||
124772595|NCT01389596|448798728|FG002|Overall Study|Withdrawal by Subject|2|||
124772596|NCT01389596|448798726|FG000|Overall Study|Insufficient Clinical Response|3|||
124772597|NCT01389596|448798727|FG001|Overall Study|Insufficient Clinical Response|4|||
124772598|NCT01389596|448798728|FG002|Overall Study|Insufficient Clinical Response|5|||
124494966|NCT03554005|447766276|FG002|Overall Study|Adverse Event|0|||
124772599|NCT01389596|448798726|FG000|Overall Study|Adverse Event|1|||
124772600|NCT01389596|448798727|FG001|Overall Study|Adverse Event|4|||
124772601|NCT01389596|448798728|FG002|Overall Study|Adverse Event|0|||
124772602|NCT01389596|448798726|FG000|Overall Study|Death|0|||
124772603|NCT01389596|448798727|FG001|Overall Study|Death|1|||
124772604|NCT01389596|448798728|FG002|Overall Study|Death|0|||
124772605|NCT01389596|448798726|FG000|Overall Study|Other Unspecified|2|||
124772606|NCT01389596|448798727|FG001|Overall Study|Other Unspecified|1|||
124772607|NCT01389596|448798728|FG002|Overall Study|Other Unspecified|0|||
124772608|NCT01124006|448798732|FG000|Overall Study|Withdrawal by Subject|2|||
124772609|NCT01124006|448798733|FG001|Overall Study|Withdrawal by Subject|2|||
124772610|NCT01124006|448798734|FG002|Overall Study|Withdrawal by Subject|0|||
124772611|NCT01124006|448798732|FG000|Overall Study|Lost to Follow-up|1|||
124772612|NCT01124006|448798733|FG001|Overall Study|Lost to Follow-up|0|||
124494967|NCT03554005|447766277|FG003|Overall Study|Adverse Event|0|||
124494968|NCT03554005|447766278|FG004|Overall Study|Adverse Event|0|||
124772613|NCT01124006|448798734|FG002|Overall Study|Lost to Follow-up|1|||
124772614|NCT01124006|448798732|FG000|Overall Study|Other|0|||
124772615|NCT01124006|448798733|FG001|Overall Study|Other|0|||
124772616|NCT01124006|448798734|FG002|Overall Study|Other|1|||
124772617|NCT03841604|448798742|FG000|Overall Study|Withdrawal by Subject|3|||
124772618|NCT03841604|448798743|FG001|Overall Study|Withdrawal by Subject|1|||
124772619|NCT03841604|448798742|FG000|Overall Study|Adverse Event|4|||
124772620|NCT03841604|448798743|FG001|Overall Study|Adverse Event|2|||
124772621|NCT03841604|448798742|FG000|Overall Study|Physician Decision|1|||
124772622|NCT03841604|448798743|FG001|Overall Study|Physician Decision|0|||
124772623|NCT01417377|448798744|FG000|Overall Study|Lost to Follow-up|12|||
124772624|NCT01417377|448798744|FG000|Overall Study|Enrolled, but not treated|1|||
124772625|NCT01774721|448798745|FG000|Overall Study|Death|133|||
124772626|NCT01774721|448798746|FG001|Overall Study|Death|152|||
124772627|NCT01774721|448798745|FG000|Overall Study|Withdrawal by Subject|20|||
124772628|NCT01774721|448798746|FG001|Overall Study|Withdrawal by Subject|14|||
124772629|NCT01774721|448798745|FG000|Overall Study|Lost to Follow-up|6|||
124772630|NCT01774721|448798746|FG001|Overall Study|Lost to Follow-up|7|||
124772631|NCT01774721|448798745|FG000|Overall Study|Did not meet eligibility criteria|0|||
124772632|NCT01774721|448798746|FG001|Overall Study|Did not meet eligibility criteria|3|||
124772633|NCT01774721|448798745|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
124772634|NCT01774721|448798746|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
124772635|NCT01774721|448798745|FG000|Overall Study|Study terminated by sponsor|5|||
124772636|NCT01774721|448798746|FG001|Overall Study|Study terminated by sponsor|0|||
124772637|NCT01774721|448798745|FG000|Overall Study|Disease progression|5|||
124772638|NCT01774721|448798746|FG001|Overall Study|Disease progression|0|||
124772639|NCT03594110|448798747|FG000|Interventional Part|Participant concerned about study treatment|23|||
124772640|NCT03594110|448798748|FG001|Interventional Part|Participant concerned about study treatment|28|||
124772641|NCT03594110|448798747|FG000|Interventional Part|Doctor advice|38|||
124772642|NCT03594110|448798748|FG001|Interventional Part|Doctor advice|40|||
124772643|NCT03594110|448798747|FG000|Interventional Part|Participants' wish|89|||
124772644|NCT03594110|448798748|FG001|Interventional Part|Participants' wish|68|||
124772645|NCT03594110|448798747|FG000|Interventional Part|Adverse event-non-fatal events|119|||
124772646|NCT03594110|448798748|FG001|Interventional Part|Adverse event-non-fatal events|116|||
124772647|NCT03594110|448798747|FG000|Interventional Part|Study drug stopped, reason missing|336|||
124772648|NCT03594110|448798748|FG001|Interventional Part|Study drug stopped, reason missing|294|||
124772649|NCT03594110|448798747|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
124772650|NCT03594110|448798748|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
124772651|NCT03594110|448798747|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
124772652|NCT03594110|448798748|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
124772653|NCT03594110|448798747|FG000|Interventional Part|Contraindicated drug started|32|||
124772654|NCT03594110|448798748|FG001|Interventional Part|Contraindicated drug started|18|||
124772655|NCT03594110|448798747|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
124772656|NCT03594110|448798748|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
124772657|NCT03594110|448798747|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
124772658|NCT03594110|448798748|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
124772659|NCT03594110|448798747|FG000|Non-interventional Part|Withdrawal by Subject|3|||
124772660|NCT03594110|448798748|FG001|Non-interventional Part|Withdrawal by Subject|4|||
124772661|NCT03594110|448798747|FG000|Non-interventional Part|Lost to Follow-up|45|||
124772662|NCT03594110|448798748|FG001|Non-interventional Part|Lost to Follow-up|41|||
124772663|NCT02351817|448798749|FG000|Period 1|Adverse Event|1|||
124772664|NCT02351817|448798750|FG001|Period 1|Adverse Event|2|||
124772665|NCT02351817|448798749|FG000|Period 1|Lack of Efficacy|0|||
124772666|NCT02351817|448798750|FG001|Period 1|Lack of Efficacy|1|||
124772667|NCT02351817|448798749|FG000|Period 2|Adverse Event|0|||
124772668|NCT02351817|448798750|FG001|Period 2|Adverse Event|2|||
124772669|NCT02351817|448798749|FG000|Period 2|Protocol Violation|1|||
124772670|NCT02351817|448798750|FG001|Period 2|Protocol Violation|0|||
124494969|NCT03554005|447766279|FG005|Overall Study|Adverse Event|3|||
124494970|NCT03554005|447766274|FG000|Overall Study|Physician Decision|0|||
124494971|NCT03554005|447766275|FG001|Overall Study|Physician Decision|0|||
124772671|NCT02488915|448798753|FG000|Overall Study|Death|21|||
124772672|NCT02488915|448798753|FG000|Overall Study|Lost to Follow-up|4|||
124772673|NCT02488915|448798753|FG000|Overall Study|Withdrawal by Subject|1|||
124772674|NCT00684021|448798756|FG000|Overall Study|MRI Contraindicated|1|||
124772675|NCT00684021|448798757|FG001|Overall Study|MRI Contraindicated|1|||
124772676|NCT00684021|448798758|FG002|Overall Study|MRI Contraindicated|1|||
124772677|NCT00684021|448798759|FG003|Overall Study|MRI Contraindicated|0|||
124772678|NCT00684021|448798756|FG000|Overall Study|MRI not performed|0|||
124772679|NCT00684021|448798757|FG001|Overall Study|MRI not performed|1|||
124772680|NCT00684021|448798758|FG002|Overall Study|MRI not performed|1|||
124772681|NCT00684021|448798759|FG003|Overall Study|MRI not performed|2|||
124772682|NCT00684021|448798756|FG000|Overall Study|Death|1|||
124772683|NCT00684021|448798757|FG001|Overall Study|Death|0|||
124772684|NCT00684021|448798758|FG002|Overall Study|Death|0|||
124772685|NCT00684021|448798759|FG003|Overall Study|Death|0|||
124772686|NCT00927953|448798760|FG000|Overall Study|Death|2|||
124772687|NCT00927953|448798761|FG001|Overall Study|Death|1|||
124772688|NCT02976038|448798762|FG000|Overall Study|Physician Decision|22|||
124772689|NCT02976038|448798762|FG000|Overall Study|Withdrawal by Subject|3|||
124772690|NCT02976038|448798762|FG000|Overall Study|Lost to Follow-up|2|||
124772691|NCT02976038|448798762|FG000|Overall Study|Adverse Event|1|||
124772692|NCT01046396|448798763|FG000|Overall Study|Withdrawal by Subject|5|||
124772693|NCT01208207|448798764|FG000|Part I|Adverse Event|19|||
124772694|NCT01208207|448798765|FG001|Part I|Adverse Event|2|||
124772695|NCT01208207|448798766|FG002|Part I|Adverse Event|6|||
124772696|NCT01208207|448798767|FG003|Part I|Adverse Event|0|||
124772697|NCT01208207|448798768|FG004|Part I|Adverse Event|0|||
124494972|NCT03554005|447766276|FG002|Overall Study|Physician Decision|0|||
124494973|NCT03554005|447766277|FG003|Overall Study|Physician Decision|0|||
124494974|NCT03554005|447766278|FG004|Overall Study|Physician Decision|1|||
124494975|NCT03554005|447766279|FG005|Overall Study|Physician Decision|0|||
124494976|NCT03554005|447766274|FG000|Overall Study|Other|0|||
124494977|NCT03554005|447766275|FG001|Overall Study|Other|0|||
124494978|NCT03554005|447766276|FG002|Overall Study|Other|0|||
124494979|NCT03554005|447766277|FG003|Overall Study|Other|0|||
124494980|NCT03554005|447766278|FG004|Overall Study|Other|0|||
124494981|NCT03554005|447766279|FG005|Overall Study|Other|1|||
124494982|NCT02606045|447766280|FG000|Overall Study|Study closed before treament could begin|1|||
124494983|NCT02606045|447766281|FG001|Overall Study|Study closed before treament could begin|2|||
124494984|NCT00907881|447766282|FG000|Overall Study|Lost to Follow-up|59|||
124494985|NCT00907881|447766282|FG000|Overall Study|Noncompliance|5|||
124494986|NCT00907881|447766282|FG000|Overall Study|Withdrawal by Subject|5|||
124494987|NCT00907881|447766282|FG000|Overall Study|Protocol Violation|1|||
124494988|NCT00907881|447766282|FG000|Overall Study|Missing discontinuation information|15|||
124494989|NCT01671085|447766283|FG000|Overall Study|Withdrawal by Subject|1|||
124494990|NCT01671085|447766284|FG001|Overall Study|Withdrawal by Subject|0|||
124494991|NCT00637273|447766285|FG000|Overall Study|Adverse Event|11|||
124494992|NCT00637273|447766286|FG001|Overall Study|Adverse Event|5|||
124494993|NCT00637273|447766287|FG002|Overall Study|Adverse Event|7|||
124494994|NCT00637273|447766285|FG000|Overall Study|Lost to Follow-up|8|||
124494995|NCT00637273|447766286|FG001|Overall Study|Lost to Follow-up|9|||
124494996|NCT00637273|447766287|FG002|Overall Study|Lost to Follow-up|13|||
124494997|NCT00637273|447766285|FG000|Overall Study|Protocol Violation|2|||
124494998|NCT00637273|447766286|FG001|Overall Study|Protocol Violation|4|||
124494999|NCT00637273|447766287|FG002|Overall Study|Protocol Violation|1|||
124495000|NCT00637273|447766285|FG000|Overall Study|Withdrawal of Consent|18|||
124495001|NCT00637273|447766286|FG001|Overall Study|Withdrawal of Consent|6|||
124495002|NCT00637273|447766287|FG002|Overall Study|Withdrawal of Consent|18|||
124495003|NCT00637273|447766285|FG000|Overall Study|Investigator Decision|1|||
124495004|NCT00637273|447766286|FG001|Overall Study|Investigator Decision|3|||
124495005|NCT00637273|447766287|FG002|Overall Study|Investigator Decision|1|||
124495006|NCT00637273|447766285|FG000|Overall Study|Administrative|2|||
124495007|NCT00637273|447766286|FG001|Overall Study|Administrative|0|||
124495008|NCT00637273|447766287|FG002|Overall Study|Administrative|0|||
124495009|NCT00637273|447766285|FG000|Overall Study|Loss of Glucose Control|1|||
124558063|NCT03341273|448001394|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
124558064|NCT03341273|448001395|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
124558065|NCT03341273|448001394|FG000|Overall Study|Became ineligible after enrollment|1|||
124558066|NCT03341273|448001395|FG001|Overall Study|Became ineligible after enrollment|0|||
124558067|NCT03341273|448001394|FG000|Overall Study|Not Eligible at Enrollment|0|||
124558068|NCT03341273|448001395|FG001|Overall Study|Not Eligible at Enrollment|1|||
124558069|NCT03341273|448001394|FG000|Overall Study|Participant incarcerated|1|||
124558070|NCT03341273|448001395|FG001|Overall Study|Participant incarcerated|0|||
124558071|NCT00685919|448001396|FG000|Overall Study|Withdrawal by Subject|0|||
124558072|NCT00685919|448001397|FG001|Overall Study|Withdrawal by Subject|0|||
124558073|NCT00685919|448001398|FG002|Overall Study|Withdrawal by Subject|1|||
124558074|NCT00685919|448001399|FG003|Overall Study|Withdrawal by Subject|0|||
124558075|NCT00685919|448001396|FG000|Overall Study|Physician Decision|1|||
124558076|NCT00685919|448001397|FG001|Overall Study|Physician Decision|0|||
124558077|NCT00685919|448001398|FG002|Overall Study|Physician Decision|0|||
124558078|NCT00685919|448001399|FG003|Overall Study|Physician Decision|0|||
124558079|NCT01717456|448001400|FG000|End of Treatment|Physician Decision|0|||
124558080|NCT01717456|448001401|FG001|End of Treatment|Physician Decision|1|||
124772698|NCT01208207|448798769|FG005|Part I|Adverse Event|0|||
124772699|NCT01208207|448798770|FG006|Part I|Adverse Event|0|||
124495010|NCT00637273|447766286|FG001|Overall Study|Loss of Glucose Control|1|||
124495011|NCT00637273|447766287|FG002|Overall Study|Loss of Glucose Control|1|||
124772700|NCT01208207|448798764|FG000|Part I|Lack of Efficacy|21|||
124495012|NCT00986258|447766288|FG000|Observation Period|Not eligible to be dosed|11|||
124495013|NCT00986258|447766288|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
124495014|NCT00986258|447766288|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
124495015|NCT00986258|447766288|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
124558081|NCT01717456|448001400|FG000|End of Treatment|Lost to Follow-up|0|||
124495016|NCT00986258|447766288|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
124495017|NCT00986258|447766288|FG000|Titration and Optimal Dose Period|Other|1|||
124495018|NCT00986258|447766288|FG000|Maintenance Period|Adverse Event|5|||
124495019|NCT00986258|447766288|FG000|Maintenance Period|Lack of Efficacy|2|||
124495020|NCT00986258|447766288|FG000|Maintenance Period|Withdrawal by Subject|2|||
124495021|NCT02616029|447766291|FG000|Overall Study|Adverse Event|1|||
124722223|NCT03985943|448605571|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
124722224|NCT03985943|448605572|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
124722225|NCT03985943|448605567|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
124722226|NCT03985943|448605568|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
124722227|NCT03985943|448605569|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
124722228|NCT03985943|448605570|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
124722229|NCT03985943|448605571|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
124722230|NCT03985943|448605572|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
124722231|NCT03985943|448605567|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
124722232|NCT03985943|448605568|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
124722233|NCT03985943|448605569|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
124722234|NCT03985943|448605570|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
124722235|NCT03985943|448605571|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
124722236|NCT03985943|448605572|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
124722237|NCT03985943|448605567|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
124722238|NCT03985943|448605568|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
124722239|NCT03985943|448605569|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
124722240|NCT03985943|448605570|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
124722241|NCT03985943|448605571|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
124722242|NCT03985943|448605572|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
124722243|NCT03985943|448605567|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
124722244|NCT03985943|448605568|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
124722245|NCT03985943|448605569|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
124722246|NCT03985943|448605570|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
124722247|NCT03985943|448605571|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
124722248|NCT03985943|448605572|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
124722249|NCT03985943|448605567|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
124722250|NCT03985943|448605568|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
124722251|NCT03985943|448605569|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
124722252|NCT03985943|448605570|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
124722253|NCT03985943|448605571|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
124722254|NCT03985943|448605572|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
124722255|NCT03985943|448605567|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
124722256|NCT03985943|448605568|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
124722257|NCT03985943|448605569|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
124722258|NCT03985943|448605570|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
124722259|NCT03985943|448605571|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
124722260|NCT03985943|448605572|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
124722261|NCT03985943|448605567|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
124722262|NCT03985943|448605568|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
124722263|NCT03985943|448605569|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
124722264|NCT03985943|448605570|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
124722265|NCT03985943|448605571|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
124722266|NCT03985943|448605572|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
124722267|NCT03985943|448605567|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
124722268|NCT03985943|448605568|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
124722269|NCT03985943|448605569|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
124722270|NCT03985943|448605570|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
124722271|NCT03985943|448605571|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
124722272|NCT03985943|448605572|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
124722273|NCT00022763|448605576|FG000|Overall Study|Adverse Event|1|||
124722274|NCT00022763|448605577|FG001|Overall Study|Adverse Event|2|||
124722275|NCT00022763|448605576|FG000|Overall Study|Injection Site Reactions|0|||
124722276|NCT00022763|448605577|FG001|Overall Study|Injection Site Reactions|2|||
124722277|NCT00022763|448605576|FG000|Overall Study|Death|0|||
124722278|NCT00022763|448605577|FG001|Overall Study|Death|1|||
124722279|NCT00022763|448605576|FG000|Overall Study|Lost to Follow-up|0|||
124722280|NCT00022763|448605577|FG001|Overall Study|Lost to Follow-up|3|||
124772701|NCT01208207|448798765|FG001|Part I|Lack of Efficacy|3|||
124772702|NCT01208207|448798766|FG002|Part I|Lack of Efficacy|2|||
124495022|NCT02616029|447766292|FG001|Overall Study|Adverse Event|0|||
124495023|NCT02616029|447766291|FG000|Overall Study|Death|0|||
124495024|NCT02616029|447766292|FG001|Overall Study|Death|1|||
124495025|NCT02616029|447766291|FG000|Overall Study|Protocol Violation|1|||
124495026|NCT02616029|447766292|FG001|Overall Study|Protocol Violation|0|||
124495027|NCT02616029|447766291|FG000|Overall Study|Withdrew Consent|1|||
124495028|NCT02616029|447766292|FG001|Overall Study|Withdrew Consent|0|||
124495029|NCT02616029|447766291|FG000|Overall Study|Enrolled and Never Treated|1|||
124495030|NCT02616029|447766292|FG001|Overall Study|Enrolled and Never Treated|1|||
124495031|NCT04230486|447766300|FG000|Overall Study|Screen Failure|1|||
124495032|NCT03215264|447766301|FG000|Dose Level 2|Adverse Event|0|||
124495033|NCT03215264|447766302|FG001|Dose Level 2|Adverse Event|1|||
124495034|NCT03215264|447766303|FG002|Dose Level 2|Adverse Event|0|||
124495035|NCT03215264|447766301|FG000|Dose Level 3|Withdrawal by Subject|0|||
124495036|NCT03215264|447766302|FG001|Dose Level 3|Withdrawal by Subject|0|||
124495037|NCT03215264|447766303|FG002|Dose Level 3|Withdrawal by Subject|1|||
124495038|NCT02234583|447766306|FG000|Overall Study|Adverse Event|172|||
124495039|NCT02234583|447766307|FG001|Overall Study|Adverse Event|156|||
124495040|NCT02234583|447766306|FG000|Overall Study|Withdrawal by Subject|109|||
124495041|NCT02234583|447766307|FG001|Overall Study|Withdrawal by Subject|157|||
124495042|NCT02234583|447766306|FG000|Overall Study|Lost to Follow-up|0|||
124495043|NCT02234583|447766307|FG001|Overall Study|Lost to Follow-up|1|||
124495044|NCT02234583|447766306|FG000|Overall Study|Lack of Efficacy|58|||
124495045|NCT02234583|447766307|FG001|Overall Study|Lack of Efficacy|103|||
124495046|NCT02234583|447766306|FG000|Overall Study|Protocol Violation|35|||
124495047|NCT02234583|447766307|FG001|Overall Study|Protocol Violation|42|||
124495048|NCT02234583|447766306|FG000|Overall Study|Other|39|||
124495049|NCT02234583|447766307|FG001|Overall Study|Other|97|||
124495050|NCT01740440|447766308|FG000|Overall Study|Lost to Follow-up|3|||
124495051|NCT00532883|447766309|FG000|Overall Study|Adverse Event|1|||
124495052|NCT00532883|447766310|FG001|Overall Study|Adverse Event|0|||
124495053|NCT00532883|447766311|FG002|Overall Study|Adverse Event|0|||
124495054|NCT00532883|447766312|FG003|Overall Study|Adverse Event|1|||
124495055|NCT00532883|447766309|FG000|Overall Study|Lost to Follow-up|1|||
124495056|NCT00532883|447766310|FG001|Overall Study|Lost to Follow-up|1|||
124495057|NCT00532883|447766311|FG002|Overall Study|Lost to Follow-up|1|||
124495058|NCT00532883|447766312|FG003|Overall Study|Lost to Follow-up|0|||
124495059|NCT00532883|447766309|FG000|Overall Study|Withdrawal by Subject|0|||
124495060|NCT00532883|447766310|FG001|Overall Study|Withdrawal by Subject|1|||
124495061|NCT00532883|447766311|FG002|Overall Study|Withdrawal by Subject|1|||
124495062|NCT00532883|447766312|FG003|Overall Study|Withdrawal by Subject|0|||
124495063|NCT00532883|447766309|FG000|Overall Study|Subject was Nonadherent|0|||
124495064|NCT00532883|447766310|FG001|Overall Study|Subject was Nonadherent|1|||
124495065|NCT00532883|447766311|FG002|Overall Study|Subject was Nonadherent|1|||
124495066|NCT00532883|447766312|FG003|Overall Study|Subject was Nonadherent|0|||
124495067|NCT00532883|447766309|FG000|Overall Study|Early Study Termination|4|||
124495068|NCT00532883|447766310|FG001|Overall Study|Early Study Termination|4|||
124495069|NCT00532883|447766311|FG002|Overall Study|Early Study Termination|1|||
124495070|NCT00532883|447766312|FG003|Overall Study|Early Study Termination|4|||
124495071|NCT01172288|447766315|FG000|Overall Study|Adverse Event|1|||
124495072|NCT01172288|447766316|FG001|Overall Study|Adverse Event|0|||
124495073|NCT01172288|447766315|FG000|Overall Study|Protocol Violation|0|||
124495074|NCT01172288|447766316|FG001|Overall Study|Protocol Violation|1|||
124495075|NCT02795767|447766319|FG000|Overall Study|Received Commercial Emicizumab|1|||
124495076|NCT02795767|447766320|FG001|Overall Study|Received Commercial Emicizumab|0|||
124495077|NCT02795767|447766321|FG002|Overall Study|Received Commercial Emicizumab|0|||
124495078|NCT04156646|447766331|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
124495079|NCT04156646|447766332|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
124495080|NCT00751101|447766333|FG000|Overall Study|Withdrawal by Subject|1|||
124495081|NCT00751101|447766334|FG001|Overall Study|Withdrawal by Subject|0|||
124495082|NCT00751101|447766333|FG000|Overall Study|No HFS / Never Started Patch/|0|||
124495083|NCT00751101|447766334|FG001|Overall Study|No HFS / Never Started Patch/|4|||
124495084|NCT00751101|447766333|FG000|Overall Study|Never began capecitabine|1|||
124495085|NCT00751101|447766334|FG001|Overall Study|Never began capecitabine|0|||
124495086|NCT00751101|447766333|FG000|Overall Study|Physician Decision|0|||
124495087|NCT00751101|447766334|FG001|Overall Study|Physician Decision|1|||
124495088|NCT00784784|447766335|FG000|Overall Study|Withdrawal by Subject|2|||
124495089|NCT00784784|447766336|FG001|Overall Study|Withdrawal by Subject|2|||
124495090|NCT01905397|447766337|FG000|Overall Study|Death|0|||
124495091|NCT01905397|447766338|FG001|Overall Study|Death|1|||
124495092|NCT01905397|447766337|FG000|Overall Study|Withdrawal by Subject|2|||
124495093|NCT01905397|447766338|FG001|Overall Study|Withdrawal by Subject|0|||
124495094|NCT01905397|447766337|FG000|Overall Study|Surgery canceled/aborted|9|||
124495095|NCT01905397|447766338|FG001|Overall Study|Surgery canceled/aborted|5|||
124495096|NCT01905397|447766337|FG000|Overall Study|Incision < 7 cm|2|||
124495097|NCT01905397|447766338|FG001|Overall Study|Incision < 7 cm|0|||
124495098|NCT01905397|447766337|FG000|Overall Study|Wrong treatment|1|||
124495099|NCT01905397|447766338|FG001|Overall Study|Wrong treatment|1|||
124495100|NCT01905397|447766337|FG000|Overall Study|Device not applied|3|||
124495101|NCT01905397|447766338|FG001|Overall Study|Device not applied|0|||
124495102|NCT01905397|447766337|FG000|Overall Study|Dressing not applied in operating room|1|||
124495103|NCT01905397|447766338|FG001|Overall Study|Dressing not applied in operating room|0|||
124495104|NCT01905397|447766337|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
124495105|NCT01905397|447766338|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
124495106|NCT00863928|447766341|FG000|Overall Study|Protocol Violation|26|||
124495107|NCT00863928|447766342|FG001|Overall Study|Protocol Violation|0|||
124495108|NCT00863928|447766341|FG000|Overall Study|Withdrawal by Subject|3|||
124722281|NCT00022763|448605576|FG000|Overall Study|Withdrawal by Subject|4|||
124722282|NCT00022763|448605577|FG001|Overall Study|Withdrawal by Subject|7|||
124722283|NCT00022763|448605576|FG000|Overall Study|Insufficient Therapy|1|||
124722284|NCT00022763|448605577|FG001|Overall Study|Insufficient Therapy|0|||
124722285|NCT00022763|448605576|FG000|Overall Study|Admin|3|||
124722286|NCT00022763|448605577|FG001|Overall Study|Admin|2|||
124722287|NCT00716482|448605578|FG000|Overall Study|Lost to Follow-up|6|||
124722288|NCT00716482|448605578|FG000|Overall Study|Inadequate acquisition or analysis|50|||
124722289|NCT00716482|448605578|FG000|Overall Study|no pathology obtained|10|||
124722290|NCT00716482|448605578|FG000|Overall Study|technical/machine error|28|||
124722291|NCT00716482|448605578|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
124722292|NCT03248531|448605579|FG000|Overall Study|Adverse Event|0|||
124722293|NCT03248531|448605580|FG001|Overall Study|Adverse Event|0|||
124722294|NCT03248531|448605581|FG002|Overall Study|Adverse Event|1|||
124722295|NCT03248531|448605579|FG000|Overall Study|Lost to Follow-up|1|||
124722296|NCT03248531|448605580|FG001|Overall Study|Lost to Follow-up|0|||
124722297|NCT03248531|448605581|FG002|Overall Study|Lost to Follow-up|5|||
124722298|NCT03248531|448605579|FG000|Overall Study|Withdrawal by Subject|3|||
124722299|NCT03248531|448605580|FG001|Overall Study|Withdrawal by Subject|3|||
124722300|NCT03248531|448605581|FG002|Overall Study|Withdrawal by Subject|2|||
124722301|NCT03248531|448605579|FG000|Overall Study|Sponsor Request|0|||
124722302|NCT03248531|448605580|FG001|Overall Study|Sponsor Request|2|||
124722303|NCT03248531|448605581|FG002|Overall Study|Sponsor Request|0|||
124722304|NCT04075513|448605582|FG000|Overall Study|Withdrawal by Subject|2|||
124722305|NCT04075513|448605583|FG001|Overall Study|Withdrawal by Subject|2|||
124722306|NCT04075513|448605582|FG000|Overall Study|Lack of Efficacy|1|||
124722307|NCT04075513|448605583|FG001|Overall Study|Lack of Efficacy|0|||
124722308|NCT04075513|448605582|FG000|Overall Study|Lost to Follow-up|4|||
124722309|NCT04075513|448605583|FG001|Overall Study|Lost to Follow-up|2|||
124722310|NCT04075513|448605582|FG000|Overall Study|Switch to insulin pump|1|||
124722311|NCT04075513|448605583|FG001|Overall Study|Switch to insulin pump|0|||
124722312|NCT01035463|448605584|FG000|Overall Study|Adverse Event|0|||
124722313|NCT01035463|448605585|FG001|Overall Study|Adverse Event|0|||
124722314|NCT01035463|448605586|FG002|Overall Study|Adverse Event|4|||
124722315|NCT01035463|448605587|FG003|Overall Study|Adverse Event|1|||
124722316|NCT01035463|448605588|FG004|Overall Study|Adverse Event|5|||
124722317|NCT01035463|448605589|FG005|Overall Study|Adverse Event|7|||
124772703|NCT01208207|448798767|FG003|Part I|Lack of Efficacy|0|||
124772704|NCT01208207|448798768|FG004|Part I|Lack of Efficacy|0|||
124772705|NCT01208207|448798769|FG005|Part I|Lack of Efficacy|0|||
124772706|NCT01208207|448798770|FG006|Part I|Lack of Efficacy|0|||
124772707|NCT01208207|448798764|FG000|Part I|Lost to Follow-up|6|||
124772708|NCT01208207|448798765|FG001|Part I|Lost to Follow-up|1|||
124772709|NCT01208207|448798766|FG002|Part I|Lost to Follow-up|0|||
124772710|NCT01208207|448798767|FG003|Part I|Lost to Follow-up|0|||
124772711|NCT01208207|448798768|FG004|Part I|Lost to Follow-up|0|||
124772712|NCT01208207|448798769|FG005|Part I|Lost to Follow-up|0|||
124772713|NCT01208207|448798770|FG006|Part I|Lost to Follow-up|0|||
124772714|NCT01208207|448798764|FG000|Part I|Non-Compliance With Study Drug|1|||
124772715|NCT01208207|448798765|FG001|Part I|Non-Compliance With Study Drug|0|||
124772716|NCT01208207|448798766|FG002|Part I|Non-Compliance With Study Drug|1|||
124772717|NCT01208207|448798767|FG003|Part I|Non-Compliance With Study Drug|0|||
124772718|NCT01208207|448798768|FG004|Part I|Non-Compliance With Study Drug|0|||
124772719|NCT01208207|448798769|FG005|Part I|Non-Compliance With Study Drug|0|||
124495109|NCT00863928|447766342|FG001|Overall Study|Withdrawal by Subject|0|||
124495110|NCT00863928|447766341|FG000|Overall Study|surgery cancellation|4|||
124722318|NCT01035463|448605584|FG000|Overall Study|Withdrawal by Subject|0|||
124495111|NCT00863928|447766342|FG001|Overall Study|surgery cancellation|0|||
124722319|NCT01035463|448605585|FG001|Overall Study|Withdrawal by Subject|2|||
124722320|NCT01035463|448605586|FG002|Overall Study|Withdrawal by Subject|1|||
124722321|NCT01035463|448605587|FG003|Overall Study|Withdrawal by Subject|0|||
124722322|NCT01035463|448605588|FG004|Overall Study|Withdrawal by Subject|1|||
124722323|NCT01035463|448605589|FG005|Overall Study|Withdrawal by Subject|4|||
124722324|NCT01035463|448605584|FG000|Overall Study|Disease progression|0|||
124722325|NCT01035463|448605585|FG001|Overall Study|Disease progression|0|||
124772720|NCT01208207|448798770|FG006|Part I|Non-Compliance With Study Drug|0|||
124772721|NCT01208207|448798764|FG000|Part I|Physician Decision|0|||
124772722|NCT01208207|448798765|FG001|Part I|Physician Decision|1|||
124772723|NCT01208207|448798766|FG002|Part I|Physician Decision|0|||
124772724|NCT01208207|448798767|FG003|Part I|Physician Decision|0|||
124772725|NCT01208207|448798768|FG004|Part I|Physician Decision|0|||
124495112|NCT00863928|447766341|FG000|Overall Study|medication allergy|3|||
124495113|NCT00863928|447766342|FG001|Overall Study|medication allergy|0|||
124495114|NCT00772967|447766343|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
124495115|NCT00772967|447766344|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
124495116|NCT00772967|447766345|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
124495117|NCT00772967|447766346|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
124495118|NCT00772967|447766347|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
124495119|NCT00772967|447766348|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
124495120|NCT00772967|447766343|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
124495121|NCT00772967|447766344|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
124495122|NCT00772967|447766345|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
124722326|NCT01035463|448605586|FG002|Overall Study|Disease progression|0|||
124722327|NCT01035463|448605587|FG003|Overall Study|Disease progression|0|||
124722328|NCT01035463|448605588|FG004|Overall Study|Disease progression|0|||
124722329|NCT01035463|448605589|FG005|Overall Study|Disease progression|3|||
124722330|NCT01035463|448605584|FG000|Overall Study|Other Malignancy|0|||
124722331|NCT01035463|448605585|FG001|Overall Study|Other Malignancy|0|||
124722332|NCT01035463|448605586|FG002|Overall Study|Other Malignancy|0|||
124722333|NCT01035463|448605587|FG003|Overall Study|Other Malignancy|0|||
124722334|NCT01035463|448605588|FG004|Overall Study|Other Malignancy|0|||
124722335|NCT01035463|448605589|FG005|Overall Study|Other Malignancy|2|||
124722336|NCT01035463|448605584|FG000|Overall Study|Other|0|||
124722337|NCT01035463|448605585|FG001|Overall Study|Other|0|||
124722338|NCT01035463|448605586|FG002|Overall Study|Other|0|||
124722339|NCT01035463|448605587|FG003|Overall Study|Other|1|||
124722340|NCT01035463|448605588|FG004|Overall Study|Other|0|||
124722341|NCT01035463|448605589|FG005|Overall Study|Other|2|||
124722342|NCT00935493|448605599|FG000|Overall Study|Lost to Follow-up|1|||
124722343|NCT00935493|448605600|FG001|Overall Study|Lost to Follow-up|1|||
124722344|NCT00935493|448605601|FG002|Overall Study|Lost to Follow-up|1|||
124722345|NCT00935493|448605599|FG000|Overall Study|Treatment Discontinued|0|||
124722346|NCT00935493|448605600|FG001|Overall Study|Treatment Discontinued|1|||
124722347|NCT00935493|448605601|FG002|Overall Study|Treatment Discontinued|0|||
124722348|NCT04153981|448605602|FG000|Overall Study|Death|1|||
124722349|NCT04153981|448605602|FG000|Overall Study|Withdrawal by Subject|24|||
124722350|NCT04153981|448605602|FG000|Overall Study|Lost to Follow-up|1|||
124722351|NCT04153981|448605602|FG000|Overall Study|Physician Decision|1|||
124722352|NCT04153981|448605602|FG000|Overall Study|Due to Unavailable Glucometer|1|||
124722353|NCT04153981|448605602|FG000|Overall Study|Covid 19|52|||
124722354|NCT04153981|448605602|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
124722355|NCT04153981|448605602|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
124722356|NCT01355679|448605603|FG000|Overall Study|benign tumor types found at biopsy|2|||
124722357|NCT00964002|448605606|FG000|Overall Study|Protocol Violation|8|||
124722358|NCT00904670|448605607|FG000|Open Label Phase|Withdrawal by Subject|2|||
124722359|NCT00904670|448605608|FG001|Open Label Phase|Withdrawal by Subject|0|||
124722360|NCT00904670|448605607|FG000|Open Label Phase|Adverse Event|2|||
124722361|NCT00904670|448605608|FG001|Open Label Phase|Adverse Event|0|||
124722362|NCT00904670|448605607|FG000|Open Label Phase|Lack of Efficacy|1|||
124722363|NCT00904670|448605608|FG001|Open Label Phase|Lack of Efficacy|0|||
124722364|NCT00904670|448605607|FG000|Open Label Phase|Lost to Follow-up|1|||
124722365|NCT00904670|448605608|FG001|Open Label Phase|Lost to Follow-up|0|||
124722366|NCT03423238|448605609|FG000|Overall Study|Lost to Follow-up|1|||
124722367|NCT03423238|448605610|FG001|Overall Study|Lost to Follow-up|0|||
124722368|NCT03423238|448605609|FG000|Overall Study|Withdrawal by Subject|1|||
124722369|NCT03423238|448605610|FG001|Overall Study|Withdrawal by Subject|0|||
124722370|NCT02584452|448605611|FG000|Overall Study|Physician Decision|1|||
124722371|NCT02584452|448605612|FG001|Overall Study|Physician Decision|1|||
124722372|NCT02584452|448605611|FG000|Overall Study|Lost to Follow-up|1|||
124495123|NCT00772967|447766346|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
124495124|NCT00772967|447766347|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
124495125|NCT00772967|447766348|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
124495126|NCT00772967|447766343|FG000|Crossover Treatment 3|Adverse Event|0|||
124495127|NCT00772967|447766344|FG001|Crossover Treatment 3|Adverse Event|0|||
124495128|NCT00772967|447766345|FG002|Crossover Treatment 3|Adverse Event|0|||
124495129|NCT00772967|447766346|FG003|Crossover Treatment 3|Adverse Event|0|||
124495130|NCT00772967|447766347|FG004|Crossover Treatment 3|Adverse Event|1|||
124495131|NCT00772967|447766348|FG005|Crossover Treatment 3|Adverse Event|0|||
124495132|NCT01041573|447766350|FG000|Overall Study|Withdrawal by Subject|2|||
124495133|NCT01041573|447766351|FG001|Overall Study|Withdrawal by Subject|5|||
124495134|NCT01041573|447766352|FG002|Overall Study|Withdrawal by Subject|2|||
124495135|NCT01041573|447766353|FG003|Overall Study|Withdrawal by Subject|0|||
124722373|NCT02584452|448605612|FG001|Overall Study|Lost to Follow-up|1|||
124722374|NCT03640507|448605615|FG000|Overall Study|Withdrawal by Subject|0|||
124722375|NCT03640507|448605616|FG001|Overall Study|Withdrawal by Subject|0|||
124722376|NCT03640507|448605617|FG002|Overall Study|Withdrawal by Subject|1|||
124722377|NCT00923351|448605618|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
124722378|NCT00923351|448605619|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
124772726|NCT01208207|448798769|FG005|Part I|Physician Decision|0|||
124772727|NCT01208207|448798770|FG006|Part I|Physician Decision|0|||
124772728|NCT01208207|448798764|FG000|Part I|Progressive Disease|1|||
124772729|NCT01208207|448798765|FG001|Part I|Progressive Disease|0|||
124772730|NCT01208207|448798766|FG002|Part I|Progressive Disease|0|||
124772731|NCT01208207|448798767|FG003|Part I|Progressive Disease|0|||
124772732|NCT01208207|448798768|FG004|Part I|Progressive Disease|0|||
124495136|NCT01041573|447766350|FG000|Overall Study|Death|1|||
124495137|NCT01041573|447766351|FG001|Overall Study|Death|0|||
124495138|NCT01041573|447766352|FG002|Overall Study|Death|0|||
124495139|NCT01041573|447766353|FG003|Overall Study|Death|0|||
124495140|NCT01041573|447766350|FG000|Overall Study|Lost to Follow-up|0|||
124495141|NCT01041573|447766351|FG001|Overall Study|Lost to Follow-up|1|||
124495142|NCT01041573|447766352|FG002|Overall Study|Lost to Follow-up|2|||
124495143|NCT01041573|447766353|FG003|Overall Study|Lost to Follow-up|1|||
124495144|NCT01041573|447766350|FG000|Overall Study|Adverse Event|0|||
124495145|NCT01041573|447766351|FG001|Overall Study|Adverse Event|2|||
124495146|NCT01041573|447766352|FG002|Overall Study|Adverse Event|0|||
124722379|NCT00923351|448605620|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
124722380|NCT01536561|448605621|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
124722381|NCT01536561|448605621|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
124722382|NCT01536561|448605621|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
124722383|NCT01536561|448605621|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
124722384|NCT01536561|448605621|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
124722385|NCT01536561|448605621|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
124722386|NCT04238481|448605622|FG000|Overall Study|Miscellaneous|0|||
124722387|NCT04238481|448605623|FG001|Overall Study|Miscellaneous|1|||
124722388|NCT04238481|448605624|FG002|Overall Study|Miscellaneous|0|||
124722389|NCT04238481|448605625|FG003|Overall Study|Miscellaneous|0|||
124722390|NCT04552288|448605626|FG000|Overall Study|Death|3|||
124722391|NCT04552288|448605626|FG000|Overall Study|Lost to Follow-up|6|||
124722392|NCT04552288|448605626|FG000|Overall Study|Physician Decision|3|||
124722393|NCT04552288|448605626|FG000|Overall Study|Protocol Violation|9|||
124722394|NCT04552288|448605626|FG000|Overall Study|Withdrawal by Subject|6|||
124495147|NCT01041573|447766353|FG003|Overall Study|Adverse Event|0|||
124495148|NCT01041573|447766350|FG000|Overall Study|relocation|1|||
124495149|NCT01041573|447766351|FG001|Overall Study|relocation|4|||
124495150|NCT01041573|447766352|FG002|Overall Study|relocation|3|||
124495151|NCT01041573|447766353|FG003|Overall Study|relocation|1|||
124495152|NCT01041573|447766350|FG000|Overall Study|further blood extraction|0|||
124495153|NCT01041573|447766351|FG001|Overall Study|further blood extraction|1|||
124495154|NCT01041573|447766352|FG002|Overall Study|further blood extraction|0|||
124495155|NCT01041573|447766353|FG003|Overall Study|further blood extraction|0|||
124495156|NCT01041573|447766350|FG000|Overall Study|positive to anti-HCV|1|||
124495157|NCT01041573|447766351|FG001|Overall Study|positive to anti-HCV|0|||
124495158|NCT01041573|447766352|FG002|Overall Study|positive to anti-HCV|0|||
124495159|NCT01041573|447766353|FG003|Overall Study|positive to anti-HCV|0|||
124495160|NCT01052012|447766354|FG000|Overall Study|Not treated|2|||
124495161|NCT01052012|447766355|FG001|Overall Study|Not treated|5|||
124495162|NCT01052012|447766356|FG002|Overall Study|Not treated|0|||
124495163|NCT01052012|447766357|FG003|Overall Study|Not treated|0|||
124495164|NCT01052012|447766358|FG004|Overall Study|Not treated|11|||
124495165|NCT01052012|447766359|FG005|Overall Study|Not treated|8|||
124495166|NCT01052012|447766354|FG000|Overall Study|Adverse Event|1|||
124495167|NCT01052012|447766355|FG001|Overall Study|Adverse Event|0|||
124495168|NCT01052012|447766356|FG002|Overall Study|Adverse Event|0|||
124495169|NCT01052012|447766357|FG003|Overall Study|Adverse Event|1|||
124495170|NCT01052012|447766358|FG004|Overall Study|Adverse Event|0|||
124495171|NCT01052012|447766359|FG005|Overall Study|Adverse Event|0|||
124495172|NCT01052012|447766354|FG000|Overall Study|Lost to Follow-up|0|||
124495173|NCT01052012|447766355|FG001|Overall Study|Lost to Follow-up|0|||
124495174|NCT01052012|447766356|FG002|Overall Study|Lost to Follow-up|0|||
124495175|NCT01052012|447766357|FG003|Overall Study|Lost to Follow-up|0|||
124495176|NCT01052012|447766358|FG004|Overall Study|Lost to Follow-up|1|||
124495177|NCT01052012|447766359|FG005|Overall Study|Lost to Follow-up|0|||
124495178|NCT01052012|447766354|FG000|Overall Study|Withdrawal by Subject|1|||
124495179|NCT01052012|447766355|FG001|Overall Study|Withdrawal by Subject|1|||
124495180|NCT01052012|447766356|FG002|Overall Study|Withdrawal by Subject|0|||
124495181|NCT01052012|447766357|FG003|Overall Study|Withdrawal by Subject|0|||
124495182|NCT01052012|447766358|FG004|Overall Study|Withdrawal by Subject|3|||
124495183|NCT01052012|447766359|FG005|Overall Study|Withdrawal by Subject|1|||
124495184|NCT01052012|447766354|FG000|Overall Study|Physician Decision|0|||
124495185|NCT01052012|447766355|FG001|Overall Study|Physician Decision|0|||
124495186|NCT01052012|447766356|FG002|Overall Study|Physician Decision|0|||
124722395|NCT04552288|448605626|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
124722396|NCT05285644|448605627|FG000|Overall Study|Adverse Event|3|||
124722397|NCT05285644|448605628|FG001|Overall Study|Adverse Event|3|||
124772733|NCT01208207|448798769|FG005|Part I|Progressive Disease|0|||
124772734|NCT01208207|448798770|FG006|Part I|Progressive Disease|0|||
124772735|NCT01208207|448798764|FG000|Part I|Protocol Violation|8|||
124772736|NCT01208207|448798765|FG001|Part I|Protocol Violation|0|||
124772737|NCT01208207|448798766|FG002|Part I|Protocol Violation|2|||
124772738|NCT01208207|448798767|FG003|Part I|Protocol Violation|0|||
124772739|NCT01208207|448798768|FG004|Part I|Protocol Violation|0|||
124772740|NCT01208207|448798769|FG005|Part I|Protocol Violation|0|||
124772741|NCT01208207|448798770|FG006|Part I|Protocol Violation|0|||
124772742|NCT01208207|448798764|FG000|Part I|Withdrawal by Subject|14|||
124772743|NCT01208207|448798765|FG001|Part I|Withdrawal by Subject|4|||
124772744|NCT01208207|448798766|FG002|Part I|Withdrawal by Subject|4|||
124772745|NCT01208207|448798767|FG003|Part I|Withdrawal by Subject|0|||
124772746|NCT01208207|448798768|FG004|Part I|Withdrawal by Subject|0|||
124772747|NCT01208207|448798769|FG005|Part I|Withdrawal by Subject|0|||
124772748|NCT01208207|448798770|FG006|Part I|Withdrawal by Subject|0|||
124772749|NCT01208207|448798764|FG000|Part II|Withdrawal by Subject|0|||
124772750|NCT01208207|448798765|FG001|Part II|Withdrawal by Subject|0|||
124772751|NCT01208207|448798766|FG002|Part II|Withdrawal by Subject|0|||
124772752|NCT01208207|448798767|FG003|Part II|Withdrawal by Subject|10|||
124772753|NCT01208207|448798768|FG004|Part II|Withdrawal by Subject|9|||
124772754|NCT01208207|448798769|FG005|Part II|Withdrawal by Subject|3|||
124772755|NCT01208207|448798770|FG006|Part II|Withdrawal by Subject|5|||
124772756|NCT01208207|448798764|FG000|Part II|Adverse Event|0|||
124772757|NCT01208207|448798765|FG001|Part II|Adverse Event|0|||
124772758|NCT01208207|448798766|FG002|Part II|Adverse Event|0|||
124772759|NCT01208207|448798767|FG003|Part II|Adverse Event|5|||
124772760|NCT01208207|448798768|FG004|Part II|Adverse Event|9|||
124772761|NCT01208207|448798769|FG005|Part II|Adverse Event|4|||
124772762|NCT01208207|448798770|FG006|Part II|Adverse Event|2|||
124772763|NCT01208207|448798764|FG000|Part II|Lack of Efficacy|0|||
124772764|NCT01208207|448798765|FG001|Part II|Lack of Efficacy|0|||
124772765|NCT01208207|448798766|FG002|Part II|Lack of Efficacy|0|||
124772766|NCT01208207|448798767|FG003|Part II|Lack of Efficacy|6|||
124772767|NCT01208207|448798768|FG004|Part II|Lack of Efficacy|4|||
124772768|NCT01208207|448798769|FG005|Part II|Lack of Efficacy|3|||
124772769|NCT01208207|448798770|FG006|Part II|Lack of Efficacy|3|||
124772770|NCT01208207|448798764|FG000|Part II|Lost to Follow-up|0|||
124772771|NCT01208207|448798765|FG001|Part II|Lost to Follow-up|0|||
124772772|NCT01208207|448798766|FG002|Part II|Lost to Follow-up|0|||
124772773|NCT01208207|448798767|FG003|Part II|Lost to Follow-up|4|||
124772774|NCT01208207|448798768|FG004|Part II|Lost to Follow-up|0|||
124772775|NCT01208207|448798769|FG005|Part II|Lost to Follow-up|2|||
124772776|NCT01208207|448798770|FG006|Part II|Lost to Follow-up|1|||
124772777|NCT01208207|448798764|FG000|Part II|Non-Compliance With Study Drug|0|||
124495187|NCT01052012|447766357|FG003|Overall Study|Physician Decision|0|||
124495188|NCT01052012|447766358|FG004|Overall Study|Physician Decision|0|||
124495189|NCT01052012|447766359|FG005|Overall Study|Physician Decision|1|||
124495190|NCT01052012|447766354|FG000|Overall Study|Other|0|||
124495191|NCT01052012|447766355|FG001|Overall Study|Other|0|||
124495192|NCT01052012|447766356|FG002|Overall Study|Other|0|||
124495193|NCT01052012|447766357|FG003|Overall Study|Other|0|||
124495194|NCT01052012|447766358|FG004|Overall Study|Other|1|||
124495195|NCT01052012|447766359|FG005|Overall Study|Other|0|||
124495196|NCT00935220|447766374|FG000|Overall Study|Adverse Event|1|||
124495197|NCT00935220|447766374|FG000|Overall Study|Other reason (not specified)|1|||
124495198|NCT01000064|447766375|FG000|Overall Study|Withdrawal by Subject|1|||
124495199|NCT01000064|447766376|FG001|Overall Study|Withdrawal by Subject|1|||
124495200|NCT01518192|447766377|FG000|Overall Study|Lost to Follow-up|29|||
124495201|NCT01518192|447766378|FG001|Overall Study|Lost to Follow-up|26|||
124495202|NCT01518192|447766379|FG002|Overall Study|Lost to Follow-up|35|||
124495203|NCT00798967|447766380|FG000|Overall Study|Adverse Event|2|||
124495204|NCT00798967|447766381|FG001|Overall Study|Adverse Event|3|||
124495205|NCT00798967|447766380|FG000|Overall Study|Withdrawal by Subject|0|||
124495206|NCT00798967|447766381|FG001|Overall Study|Withdrawal by Subject|1|||
124495207|NCT00798967|447766380|FG000|Overall Study|Physician Decision|1|||
124495208|NCT00798967|447766381|FG001|Overall Study|Physician Decision|0|||
124495209|NCT00798967|447766380|FG000|Overall Study|Randomized in error by site|1|||
124495210|NCT00798967|447766381|FG001|Overall Study|Randomized in error by site|0|||
124495211|NCT01415440|447766382|FG000|Overall Study|Lost to Follow-up|0|||
124495212|NCT01415440|447766383|FG001|Overall Study|Lost to Follow-up|1|||
124495213|NCT01415440|447766384|FG002|Overall Study|Lost to Follow-up|2|||
124772778|NCT01208207|448798765|FG001|Part II|Non-Compliance With Study Drug|0|||
124495214|NCT01415440|447766382|FG000|Overall Study|Physician Decision|3|||
124495215|NCT01415440|447766383|FG001|Overall Study|Physician Decision|0|||
124495216|NCT01415440|447766384|FG002|Overall Study|Physician Decision|0|||
124772779|NCT01208207|448798766|FG002|Part II|Non-Compliance With Study Drug|0|||
124772780|NCT01208207|448798767|FG003|Part II|Non-Compliance With Study Drug|4|||
124772781|NCT01208207|448798768|FG004|Part II|Non-Compliance With Study Drug|1|||
124772782|NCT01208207|448798769|FG005|Part II|Non-Compliance With Study Drug|1|||
124495217|NCT01415440|447766382|FG000|Overall Study|Withdrawal by Subject|1|||
124772783|NCT01208207|448798770|FG006|Part II|Non-Compliance With Study Drug|0|||
124772784|NCT01208207|448798764|FG000|Part II|Physician Decision|0|||
124772785|NCT01208207|448798765|FG001|Part II|Physician Decision|0|||
124772786|NCT01208207|448798766|FG002|Part II|Physician Decision|0|||
124558082|NCT01717456|448001401|FG001|End of Treatment|Lost to Follow-up|1|||
124558083|NCT01717456|448001400|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
124722398|NCT05285644|448605627|FG000|Overall Study|Withdrawal of Consent|2|||
124722399|NCT05285644|448605628|FG001|Overall Study|Withdrawal of Consent|5|||
124722400|NCT05285644|448605627|FG000|Overall Study|Noncompliance|0|||
124722401|NCT05285644|448605628|FG001|Overall Study|Noncompliance|4|||
124722402|NCT05285644|448605627|FG000|Overall Study|Lost to Follow-up|4|||
124722403|NCT05285644|448605628|FG001|Overall Study|Lost to Follow-up|6|||
124722404|NCT05285644|448605627|FG000|Overall Study|Disallowed Concurrent Medication|1|||
124722405|NCT05285644|448605628|FG001|Overall Study|Disallowed Concurrent Medication|1|||
124722406|NCT05285644|448605627|FG000|Overall Study|Investigator Decision|2|||
124722407|NCT05285644|448605628|FG001|Overall Study|Investigator Decision|0|||
124722408|NCT05285644|448605627|FG000|Overall Study|Protocol Deviation|1|||
124722409|NCT05285644|448605628|FG001|Overall Study|Protocol Deviation|0|||
124722410|NCT05285644|448605627|FG000|Overall Study|As specified in the Clinical Study Report|7|||
124722411|NCT05285644|448605628|FG001|Overall Study|As specified in the Clinical Study Report|3|||
124722412|NCT04532294|448605629|FG000|Overall Study|Withdrawal by Subject|0|||
124722413|NCT04532294|448605630|FG001|Overall Study|Withdrawal by Subject|0|||
124722414|NCT04532294|448605631|FG002|Overall Study|Withdrawal by Subject|1|||
124722415|NCT04532294|448605629|FG000|Overall Study|Participants Not Dosed|0|||
124722416|NCT04532294|448605630|FG001|Overall Study|Participants Not Dosed|0|||
124722417|NCT04532294|448605631|FG002|Overall Study|Participants Not Dosed|2|||
124722418|NCT04295759|448605632|FG000|Overall Study|Lack of Efficacy|9|||
124722419|NCT04295759|448605632|FG000|Overall Study|Death|1|||
124722420|NCT04295759|448605632|FG000|Overall Study|Withdrawal by Subject|2|||
124722421|NCT04295759|448605632|FG000|Overall Study|Deemed ineligible|1|||
124722422|NCT01696981|448605633|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
124722423|NCT01696981|448605634|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
124722424|NCT01696981|448605633|FG000|Overall Study|Died Before Randomization|3|||
124722425|NCT01696981|448605634|FG001|Overall Study|Died Before Randomization|8|||
124722426|NCT01696981|448605633|FG000|Overall Study|Died Before ASU (Control)|278|||
124722427|NCT01696981|448605634|FG001|Overall Study|Died Before ASU (Control)|0|||
124722428|NCT01696981|448605633|FG000|Overall Study|Refused ASU (Control)|920|||
124722429|NCT01696981|448605634|FG001|Overall Study|Refused ASU (Control)|0|||
124722430|NCT01696981|448605633|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
124722431|NCT01696981|448605634|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
124722432|NCT02798315|448605635|FG000|Overall Study|Failure to return|1|||
124722433|NCT03335150|448605637|FG000|Overall Study|Withdrawal by Subject|10|||
124722434|NCT03335150|448605638|FG001|Overall Study|Withdrawal by Subject|4|||
124722435|NCT03335150|448605637|FG000|Overall Study|Adverse Event|0|||
124722436|NCT03335150|448605638|FG001|Overall Study|Adverse Event|1|||
124722437|NCT02097719|448605639|FG000|Overall Study|Subject Withdrew Consent|1|||
124722438|NCT02097719|448605640|FG001|Overall Study|Subject Withdrew Consent|0|||
124722439|NCT02097719|448605639|FG000|Overall Study|Lost to Follow-up|0|||
124722440|NCT02097719|448605640|FG001|Overall Study|Lost to Follow-up|1|||
124722441|NCT02097719|448605639|FG000|Overall Study|Adverse Event|2|||
124722442|NCT02097719|448605640|FG001|Overall Study|Adverse Event|0|||
124722443|NCT03028415|448605641|FG000|Overall Study|Lost to Follow-up|6|||
124722444|NCT03028415|448605642|FG001|Overall Study|Lost to Follow-up|3|||
124722445|NCT03028415|448605641|FG000|Overall Study|Withdrawal by Subject|1|||
124722446|NCT03028415|448605642|FG001|Overall Study|Withdrawal by Subject|0|||
124722447|NCT03028415|448605641|FG000|Overall Study|Discontinued due to COVID-19|1|||
124722448|NCT03028415|448605642|FG001|Overall Study|Discontinued due to COVID-19|0|||
124722449|NCT02907216|448605643|FG000|Overall Study|No benefit to be obtained by continuing|0|||
124722450|NCT02907216|448605644|FG001|Overall Study|No benefit to be obtained by continuing|1|||
124722451|NCT02907216|448605643|FG000|Overall Study|Withdrawal by Subject|1|||
124722452|NCT02907216|448605644|FG001|Overall Study|Withdrawal by Subject|0|||
124722453|NCT01854775|448605645|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
124722454|NCT01854775|448605646|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
124722455|NCT01854775|448605647|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
124722456|NCT01854775|448605645|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
124722457|NCT01854775|448605646|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
124722458|NCT01854775|448605647|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
124722459|NCT01854775|448605645|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
124722460|NCT01854775|448605646|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
124722461|NCT01854775|448605647|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
124722462|NCT01854775|448605645|FG000|Extension Phase|Pregnancy|3|||
124722463|NCT01854775|448605646|FG001|Extension Phase|Pregnancy|0|||
124722464|NCT01854775|448605647|FG002|Extension Phase|Pregnancy|0|||
124722465|NCT01854775|448605645|FG000|Extension Phase|Investigator's Discretion|1|||
124722466|NCT01854775|448605646|FG001|Extension Phase|Investigator's Discretion|0|||
124722467|NCT01854775|448605647|FG002|Extension Phase|Investigator's Discretion|0|||
124722468|NCT01854775|448605645|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
124722469|NCT01854775|448605646|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
124558084|NCT01717456|448001401|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
124558085|NCT00033631|448001404|FG000|Overall Study|Protocol Violation|14|||
124495218|NCT01415440|447766383|FG001|Overall Study|Withdrawal by Subject|0|||
124495219|NCT01415440|447766384|FG002|Overall Study|Withdrawal by Subject|0|||
124495220|NCT03141307|447766385|FG000|In-Hospital|Withdrawal by Subject|0|||
124495221|NCT03141307|447766386|FG001|In-Hospital|Withdrawal by Subject|2|||
124495222|NCT03141307|447766385|FG000|In-Hospital|Protocol Violation|4|||
124495223|NCT03141307|447766386|FG001|In-Hospital|Protocol Violation|0|||
124495224|NCT03141307|447766385|FG000|Follow-Up|Lost to Follow-up|97|||
124495225|NCT03141307|447766386|FG001|Follow-Up|Lost to Follow-up|54|||
124495226|NCT03090737|447766387|FG000|Overall Study|Other reasons|1|||
124495227|NCT03090737|447766387|FG000|Overall Study|Completed treatment as per protocol|17|||
124495228|NCT03090737|447766387|FG000|Overall Study|Maximum clinical benefit|2|||
124495229|NCT03090737|447766387|FG000|Overall Study|Adverse event unrelated to study drug|7|||
124495230|NCT03090737|447766387|FG000|Overall Study|Study drug toxicity|4|||
124495231|NCT03090737|447766387|FG000|Overall Study|Disease progression|98|||
124495232|NCT02160977|447766390|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
124495233|NCT02160977|447766391|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
124495234|NCT02160977|447766390|FG000|Three Months After Surgery|Lost to Follow-up|0|||
124495235|NCT02160977|447766391|FG001|Three Months After Surgery|Lost to Follow-up|2|||
124495236|NCT02160977|447766390|FG000|Six Months After Surgery|Lost to Follow-up|2|||
124495237|NCT02160977|447766391|FG001|Six Months After Surgery|Lost to Follow-up|1|||
124495238|NCT01614769|447767803|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
124495239|NCT01614769|447767804|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
124495240|NCT01614769|447767805|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
124495241|NCT01614769|447767806|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
124495242|NCT01614769|447767807|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
124495243|NCT01614769|447767808|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
124495244|NCT01614769|447767803|FG000|Period 1|Protocol Violation|0|||
124495245|NCT01614769|447767804|FG001|Period 1|Protocol Violation|0|||
124495246|NCT01614769|447767805|FG002|Period 1|Protocol Violation|0|||
124495247|NCT01614769|447767806|FG003|Period 1|Protocol Violation|1|||
124495248|NCT01614769|447767807|FG004|Period 1|Protocol Violation|0|||
124495249|NCT01614769|447767808|FG005|Period 1|Protocol Violation|0|||
124495250|NCT01614769|447767803|FG000|Period 1|Withdrawal by Subject|1|||
124495251|NCT01614769|447767804|FG001|Period 1|Withdrawal by Subject|0|||
124495252|NCT01614769|447767805|FG002|Period 1|Withdrawal by Subject|0|||
124495253|NCT01614769|447767806|FG003|Period 1|Withdrawal by Subject|0|||
124495254|NCT01614769|447767807|FG004|Period 1|Withdrawal by Subject|0|||
124495255|NCT01614769|447767808|FG005|Period 1|Withdrawal by Subject|0|||
124495256|NCT01614769|447767803|FG000|Period 3|Withdrawal by Subject|0|||
124495257|NCT01614769|447767804|FG001|Period 3|Withdrawal by Subject|0|||
124495258|NCT01614769|447767805|FG002|Period 3|Withdrawal by Subject|1|||
124495259|NCT01614769|447767806|FG003|Period 3|Withdrawal by Subject|0|||
124495260|NCT01614769|447767807|FG004|Period 3|Withdrawal by Subject|0|||
124495261|NCT01614769|447767808|FG005|Period 3|Withdrawal by Subject|0|||
124495262|NCT02795988|447767815|FG000|Phase 1b|Withdrawal by Subject|0|||
124495263|NCT02795988|447767816|FG001|Phase 1b|Withdrawal by Subject|1|||
124495264|NCT02795988|447767817|FG002|Phase 1b|Withdrawal by Subject|0|||
124495265|NCT02795988|447767818|FG003|Phase 1b|Withdrawal by Subject|0|||
124495266|NCT02795988|447767819|FG004|Phase 1b|Withdrawal by Subject|0|||
124495267|NCT02795988|447767820|FG005|Phase 1b|Withdrawal by Subject|0|||
124495268|NCT02795988|447767821|FG006|Phase 1b|Withdrawal by Subject|0|||
124495269|NCT02795988|447767815|FG000|Phase 1b|Death|1|||
124495270|NCT02795988|447767816|FG001|Phase 1b|Death|2|||
124495271|NCT02795988|447767817|FG002|Phase 1b|Death|1|||
124495272|NCT02795988|447767818|FG003|Phase 1b|Death|0|||
124495273|NCT02795988|447767819|FG004|Phase 1b|Death|0|||
124495274|NCT02795988|447767820|FG005|Phase 1b|Death|0|||
124495275|NCT02795988|447767821|FG006|Phase 1b|Death|0|||
124495276|NCT02795988|447767815|FG000|Phase 1b|Physician Decision|0|||
124495277|NCT02795988|447767816|FG001|Phase 1b|Physician Decision|0|||
124495278|NCT02795988|447767817|FG002|Phase 1b|Physician Decision|1|||
124495279|NCT02795988|447767818|FG003|Phase 1b|Physician Decision|0|||
124495280|NCT02795988|447767819|FG004|Phase 1b|Physician Decision|0|||
124495281|NCT02795988|447767820|FG005|Phase 1b|Physician Decision|0|||
124495282|NCT02795988|447767821|FG006|Phase 1b|Physician Decision|0|||
124495283|NCT02795988|447767815|FG000|Phase 1b|Progressive Disease|2|||
124495284|NCT02795988|447767816|FG001|Phase 1b|Progressive Disease|2|||
124495285|NCT02795988|447767817|FG002|Phase 1b|Progressive Disease|0|||
124495286|NCT02795988|447767818|FG003|Phase 1b|Progressive Disease|0|||
124495287|NCT02795988|447767819|FG004|Phase 1b|Progressive Disease|0|||
124558086|NCT00033631|448001405|FG001|Overall Study|Protocol Violation|11|||
124495288|NCT02795988|447767820|FG005|Phase 1b|Progressive Disease|0|||
124495289|NCT02795988|447767821|FG006|Phase 1b|Progressive Disease|0|||
124495290|NCT02795988|447767815|FG000|Phase 2|Withdrawal by Subject|0|||
124495291|NCT02795988|447767816|FG001|Phase 2|Withdrawal by Subject|0|||
124495292|NCT02795988|447767817|FG002|Phase 2|Withdrawal by Subject|0|||
124495293|NCT02795988|447767818|FG003|Phase 2|Withdrawal by Subject|1|||
124495294|NCT02795988|447767819|FG004|Phase 2|Withdrawal by Subject|0|||
124772787|NCT01208207|448798767|FG003|Part II|Physician Decision|1|||
124772788|NCT01208207|448798768|FG004|Part II|Physician Decision|0|||
124772789|NCT01208207|448798769|FG005|Part II|Physician Decision|2|||
124772790|NCT01208207|448798770|FG006|Part II|Physician Decision|0|||
124772791|NCT01208207|448798764|FG000|Part II|Protocol Violation|0|||
124772792|NCT01208207|448798765|FG001|Part II|Protocol Violation|0|||
124772793|NCT01208207|448798766|FG002|Part II|Protocol Violation|0|||
124772794|NCT01208207|448798767|FG003|Part II|Protocol Violation|1|||
124772795|NCT01208207|448798768|FG004|Part II|Protocol Violation|0|||
124772796|NCT01208207|448798769|FG005|Part II|Protocol Violation|0|||
124772797|NCT01208207|448798770|FG006|Part II|Protocol Violation|0|||
124772798|NCT01208207|448798764|FG000|Part II|Technical Problems|0|||
124772799|NCT01208207|448798765|FG001|Part II|Technical Problems|0|||
124772800|NCT01208207|448798766|FG002|Part II|Technical Problems|0|||
124772801|NCT01208207|448798767|FG003|Part II|Technical Problems|1|||
124772802|NCT01208207|448798768|FG004|Part II|Technical Problems|0|||
124772803|NCT01208207|448798769|FG005|Part II|Technical Problems|1|||
124772804|NCT01208207|448798770|FG006|Part II|Technical Problems|0|||
124772805|NCT04041414|448798771|FG000|Overall Study|Lost to Follow-up|1|||
124772806|NCT04041414|448798772|FG001|Overall Study|Lost to Follow-up|2|||
124772807|NCT04004988|448798773|FG000|Period 1|Physician Decision|2|||
124772808|NCT04004988|448798774|FG001|Period 1|Physician Decision|0|||
124772809|NCT04004988|448798773|FG000|Period 1|Withdrawal by Subject|0|||
124772810|NCT04004988|448798774|FG001|Period 1|Withdrawal by Subject|1|||
124772811|NCT04004988|448798773|FG000|Period 1|Adverse Event|1|||
124772812|NCT04004988|448798774|FG001|Period 1|Adverse Event|2|||
124772813|NCT00930046|448798775|FG000|Overall Study|Wound catheter malfunctioned|1|||
124772814|NCT00930046|448798776|FG001|Overall Study|Wound catheter malfunctioned|2|||
124495295|NCT02795988|447767820|FG005|Phase 2|Withdrawal by Subject|0|||
124495296|NCT02795988|447767821|FG006|Phase 2|Withdrawal by Subject|0|||
124495297|NCT02795988|447767815|FG000|Phase 2|Death|0|||
124495298|NCT02795988|447767816|FG001|Phase 2|Death|0|||
124495299|NCT02795988|447767817|FG002|Phase 2|Death|0|||
124495300|NCT02795988|447767818|FG003|Phase 2|Death|17|||
124495301|NCT02795988|447767819|FG004|Phase 2|Death|17|||
124495302|NCT02795988|447767820|FG005|Phase 2|Death|0|||
124495303|NCT02795988|447767821|FG006|Phase 2|Death|0|||
124495304|NCT02795988|447767815|FG000|Phase 2|Other|0|||
124495305|NCT02795988|447767816|FG001|Phase 2|Other|0|||
124495306|NCT02795988|447767817|FG002|Phase 2|Other|0|||
124495307|NCT02795988|447767818|FG003|Phase 2|Other|1|||
124495308|NCT02795988|447767819|FG004|Phase 2|Other|0|||
124495309|NCT02795988|447767820|FG005|Phase 2|Other|0|||
124495310|NCT02795988|447767821|FG006|Phase 2|Other|0|||
124495311|NCT02795988|447767815|FG000|Phase 2 Extension|Death|0|||
124495312|NCT02795988|447767816|FG001|Phase 2 Extension|Death|0|||
124495313|NCT02795988|447767817|FG002|Phase 2 Extension|Death|0|||
124495314|NCT02795988|447767818|FG003|Phase 2 Extension|Death|0|||
124495315|NCT02795988|447767819|FG004|Phase 2 Extension|Death|0|||
124495316|NCT02795988|447767820|FG005|Phase 2 Extension|Death|5|||
124495317|NCT02795988|447767821|FG006|Phase 2 Extension|Death|6|||
124495318|NCT02795988|447767815|FG000|Phase 2 Extension|Other reasons|0|||
124495319|NCT02795988|447767816|FG001|Phase 2 Extension|Other reasons|0|||
124495320|NCT02795988|447767817|FG002|Phase 2 Extension|Other reasons|0|||
124772815|NCT01598532|448798777|FG000|Overall Study|Lost to Follow-up|3|||
124772816|NCT01598532|448798777|FG000|Overall Study|Did not meet inclusion criteria|8|||
124772817|NCT04682366|448798778|FG000|Overall Study|Lost to Follow-up|1|||
124495321|NCT02795988|447767818|FG003|Phase 2 Extension|Other reasons|0|||
124495322|NCT02795988|447767819|FG004|Phase 2 Extension|Other reasons|0|||
124495323|NCT02795988|447767820|FG005|Phase 2 Extension|Other reasons|2|||
124495324|NCT02795988|447767821|FG006|Phase 2 Extension|Other reasons|1|||
124495325|NCT02341014|447767822|FG000|Overall Study|Adverse Event|0|||
124495326|NCT02341014|447767823|FG001|Overall Study|Adverse Event|1|||
124495327|NCT02341014|447767824|FG002|Overall Study|Adverse Event|0|||
124495328|NCT02341014|447767825|FG003|Overall Study|Adverse Event|0|||
124495329|NCT02341014|447767826|FG004|Overall Study|Adverse Event|2|||
124495330|NCT00390780|447767827|FG000|Overall Study|Not completed|10|||
124495331|NCT00390780|447767828|FG001|Overall Study|Not completed|4|||
124495332|NCT00390780|447767827|FG000|Overall Study|Protocol Violation|6|||
124772818|NCT04682366|448798779|FG001|Overall Study|Lost to Follow-up|1|||
124772819|NCT00702221|448798780|FG000|Overall Study|Adverse Event|4|||
124495333|NCT00390780|447767828|FG001|Overall Study|Protocol Violation|4|||
124495334|NCT00390780|447767827|FG000|Overall Study|Lost to Follow-up|3|||
124495335|NCT00390780|447767828|FG001|Overall Study|Lost to Follow-up|6|||
124495336|NCT00390780|447767827|FG000|Overall Study|Adverse Event|2|||
124772820|NCT00702221|448798781|FG001|Overall Study|Adverse Event|3|||
124772821|NCT01867671|448798785|FG000|Overall Study|Adverse Event|5|||
124772822|NCT01867671|448798786|FG001|Overall Study|Adverse Event|3|||
124772823|NCT01867671|448798785|FG000|Overall Study|Anaphylaxis|0|||
124495337|NCT00390780|447767828|FG001|Overall Study|Adverse Event|3|||
124495338|NCT00390780|447767827|FG000|Overall Study|Death|1|||
124495339|NCT00390780|447767828|FG001|Overall Study|Death|3|||
124495340|NCT00390780|447767827|FG000|Overall Study|Withdrawal by Subject|1|||
124495341|NCT00390780|447767828|FG001|Overall Study|Withdrawal by Subject|2|||
124495342|NCT00390780|447767827|FG000|Overall Study|Inclusion criteria not satisfied|0|||
124722470|NCT01854775|448605647|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
124722471|NCT01854775|448605645|FG000|Extension Phase|Lost to Follow-up|2|||
124722472|NCT01854775|448605646|FG001|Extension Phase|Lost to Follow-up|0|||
124722473|NCT01854775|448605647|FG002|Extension Phase|Lost to Follow-up|0|||
124722474|NCT01854775|448605645|FG000|Extension Phase|Still on Study|32|||
124722475|NCT01854775|448605646|FG001|Extension Phase|Still on Study|47|||
124722476|NCT01854775|448605647|FG002|Extension Phase|Still on Study|18|||
124722477|NCT04601532|448605650|FG000|Overall Study|Lost to Follow-up|1|||
124722478|NCT04601532|448605651|FG001|Overall Study|Lost to Follow-up|2|||
124722479|NCT04601532|448605650|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
124722480|NCT04601532|448605651|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
124722481|NCT02744612|448607457|FG000|Overall Study|Withdrawal by Subject|0|||
124722482|NCT02744612|448607458|FG001|Overall Study|Withdrawal by Subject|2|||
124495343|NCT00390780|447767828|FG001|Overall Study|Inclusion criteria not satisfied|2|||
124495344|NCT00390780|447767827|FG000|Overall Study|Lost to follow up and other reasons|0|||
124495345|NCT00390780|447767828|FG001|Overall Study|Lost to follow up and other reasons|1|||
124495346|NCT00390780|447767827|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
124495347|NCT00390780|447767828|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
124495348|NCT00390780|447767827|FG000|Overall Study|SAE, death|0|||
124495349|NCT00390780|447767828|FG001|Overall Study|SAE, death|1|||
124495350|NCT01585961|447767833|FG000|Overall Study|Death|6|||
124495351|NCT01585961|447767833|FG000|Overall Study|Physician Decision|1|||
124495352|NCT01585961|447767833|FG000|Overall Study|Decision to use non-study catheter|1|||
124495353|NCT01585961|447767833|FG000|Overall Study|Withdrawal by Subject|1|||
124495354|NCT01585961|447767833|FG000|Overall Study|Lost to Follow-up|23|||
124495355|NCT01585961|447767833|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
124495356|NCT00109733|447767834|FG000|Overall Study|Protocol Violation|0|||
124495357|NCT00109733|447767835|FG001|Overall Study|Protocol Violation|1|||
124495358|NCT00109733|447767834|FG000|Overall Study|Stopped taking study drug|1|||
124495359|NCT00109733|447767835|FG001|Overall Study|Stopped taking study drug|1|||
124495360|NCT00109733|447767834|FG000|Overall Study|Non-compliant|0|||
124495361|NCT00109733|447767835|FG001|Overall Study|Non-compliant|1|||
124495362|NCT00109733|447767834|FG000|Overall Study|Could not commit time for study|1|||
124495363|NCT00109733|447767835|FG001|Overall Study|Could not commit time for study|1|||
124495364|NCT02855411|447767845|FG000|Overall Study|Study terminated by sponsor|21|||
124495365|NCT02855411|447767845|FG000|Overall Study|Does not meet entrance criteria|14|||
124495366|NCT01505491|447767846|FG000|Overall Study|Other reason not listed|1|||
124495367|NCT01505491|447767847|FG001|Overall Study|Other reason not listed|0|||
124495368|NCT01505491|447767848|FG002|Overall Study|Other reason not listed|0|||
124495369|NCT01505491|447767846|FG000|Overall Study|Withdrawal by Subject|1|||
124495370|NCT01505491|447767847|FG001|Overall Study|Withdrawal by Subject|1|||
124495371|NCT01505491|447767848|FG002|Overall Study|Withdrawal by Subject|4|||
124495372|NCT01505491|447767846|FG000|Overall Study|Lost to Follow-up|0|||
124495373|NCT01505491|447767847|FG001|Overall Study|Lost to Follow-up|0|||
124495374|NCT01505491|447767848|FG002|Overall Study|Lost to Follow-up|1|||
124495375|NCT01063751|447767857|FG000|Overall Study|Censored from analyses|42|||
124495376|NCT01063751|447767857|FG000|Overall Study|Withdrawal by Subject|34|||
124495377|NCT01063751|447767857|FG000|Overall Study|Lost to Follow-up|30|||
124495378|NCT01063751|447767857|FG000|Overall Study|Death|13|||
124495379|NCT01063751|447767857|FG000|Overall Study|Sponsored Terminated Study|60|||
124495380|NCT01063751|447767857|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
124495381|NCT01063751|447767857|FG000|Overall Study|Investigator site closed|10|||
124495382|NCT01063751|447767857|FG000|Overall Study|Revision|6|||
124495383|NCT01063751|447767857|FG000|Overall Study|Physician Decision|4|||
124495384|NCT03408873|447767863|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
124495385|NCT03408873|447767863|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
124495386|NCT03408873|447767863|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
124495387|NCT03408873|447767863|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
124495388|NCT03408873|447767863|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
124495389|NCT03408873|447767863|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
124495390|NCT01312428|447767867|FG000|Overall Study|Study Termination|3|||
124495391|NCT01312428|447767868|FG001|Overall Study|Study Termination|4|||
124495392|NCT03799718|447767869|FG000|Overall Study|Adverse Event|2|||
124558087|NCT00033631|448001404|FG000|Overall Study|Withdrawal by Subject|4|||
124558088|NCT00033631|448001405|FG001|Overall Study|Withdrawal by Subject|4|||
124722483|NCT01945216|448607459|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
124722484|NCT01945216|448607459|FG000|Overall Study|Protocol Violation|42|||
124722485|NCT01945216|448607459|FG000|Overall Study|CRF not assured by investigators|5|||
124722486|NCT03062280|448607463|FG000|Overall Study|Adverse Event|1|||
124495393|NCT02214186|447767871|FG000|Overall Study|Lost to Follow-up|1|||
124495394|NCT02214186|447767872|FG001|Overall Study|Lost to Follow-up|1|||
124495395|NCT02214186|447767871|FG000|Overall Study|Protocol Violation|1|||
124495396|NCT02214186|447767872|FG001|Overall Study|Protocol Violation|1|||
124722487|NCT03062280|448607463|FG000|Overall Study|Death|1|||
124722488|NCT03062280|448607463|FG000|Overall Study|Fertility Treatment|2|||
124772824|NCT01867671|448798786|FG001|Overall Study|Anaphylaxis|1|||
124772825|NCT01867671|448798785|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
124772826|NCT01867671|448798786|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
124772827|NCT01867671|448798785|FG000|Overall Study|Lost to Follow-up|0|||
124772828|NCT01867671|448798786|FG001|Overall Study|Lost to Follow-up|1|||
124772829|NCT01867671|448798785|FG000|Overall Study|Non-compliance with Study Drug|1|||
124772830|NCT01867671|448798786|FG001|Overall Study|Non-compliance with Study Drug|2|||
124772831|NCT01867671|448798785|FG000|Overall Study|Withdrawal by Subject|21|||
124772832|NCT01867671|448798786|FG001|Overall Study|Withdrawal by Subject|21|||
124772833|NCT01523366|448798787|FG000|Treatment Period 1|Withdrawal by Subject|1|||
124772834|NCT01523366|448798788|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124772835|NCT01523366|448798787|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
124772836|NCT01523366|448798788|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
124772837|NCT04543279|448798789|FG000|Overall Study|Withdrawal by Subject|1|||
124772838|NCT04543279|448798790|FG001|Overall Study|Withdrawal by Subject|0|||
124772839|NCT04543279|448798789|FG000|Overall Study|Adverse Event|1|||
124772840|NCT04543279|448798790|FG001|Overall Study|Adverse Event|0|||
124772841|NCT04543279|448798789|FG000|Overall Study|Physician Decision|1|||
124772842|NCT04543279|448798790|FG001|Overall Study|Physician Decision|0|||
124772843|NCT01352715|448798791|FG000|Overall Study|Death|3|||
124772844|NCT01352715|448798792|FG001|Overall Study|Death|3|||
124772845|NCT01352715|448798791|FG000|Overall Study|Lost to Follow-up|5|||
124772846|NCT01352715|448798792|FG001|Overall Study|Lost to Follow-up|7|||
124772847|NCT01352715|448798791|FG000|Overall Study|Withdrawal by Subject|4|||
124772848|NCT01352715|448798792|FG001|Overall Study|Withdrawal by Subject|8|||
124772849|NCT01352715|448798791|FG000|Overall Study|site closure|16|||
124772850|NCT01352715|448798792|FG001|Overall Study|site closure|15|||
124772851|NCT01352715|448798791|FG000|Overall Study|no final visit in closeout period|15|||
124772852|NCT01352715|448798792|FG001|Overall Study|no final visit in closeout period|12|||
124772853|NCT01352715|448798791|FG000|Overall Study|major ineligibility|2|||
124772854|NCT01352715|448798792|FG001|Overall Study|major ineligibility|1|||
124772855|NCT04596267|448798793|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
124772856|NCT04596267|448798794|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
124772857|NCT04596267|448798793|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
124772858|NCT04596267|448798794|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
124772859|NCT00071058|448798795|FG000|Overall Study|brain tumor-removed from study|1|||
124772860|NCT02000440|448798796|FG000|Overall Study|Adverse Event|3|||
124772861|NCT02000440|448798796|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
124772862|NCT04109547|448798797|FG000|Overall Study|Withdrawal by Subject|3|||
124772863|NCT04109547|448798798|FG001|Overall Study|Withdrawal by Subject|2|||
124772864|NCT04109547|448798799|FG002|Overall Study|Withdrawal by Subject|6|||
124772865|NCT04109547|448798800|FG003|Overall Study|Withdrawal by Subject|6|||
124772866|NCT04109547|448798797|FG000|Overall Study|Lost to Follow-up|0|||
124772867|NCT04109547|448798798|FG001|Overall Study|Lost to Follow-up|0|||
124772868|NCT04109547|448798799|FG002|Overall Study|Lost to Follow-up|0|||
124772869|NCT04109547|448798800|FG003|Overall Study|Lost to Follow-up|1|||
124772870|NCT04109547|448798797|FG000|Overall Study|Physician Decision|1|||
124772871|NCT04109547|448798798|FG001|Overall Study|Physician Decision|2|||
124772872|NCT04109547|448798799|FG002|Overall Study|Physician Decision|0|||
124772873|NCT04109547|448798800|FG003|Overall Study|Physician Decision|0|||
124772874|NCT01550003|448798801|FG000|Overall Study|Adverse Event|0|||
124772875|NCT01550003|448798802|FG001|Overall Study|Adverse Event|9|||
124772876|NCT01550003|448798803|FG002|Overall Study|Adverse Event|15|||
124772877|NCT01550003|448798801|FG000|Overall Study|Lack of Efficacy|4|||
124772878|NCT01550003|448798802|FG001|Overall Study|Lack of Efficacy|11|||
124772879|NCT01550003|448798803|FG002|Overall Study|Lack of Efficacy|15|||
124772880|NCT01550003|448798801|FG000|Overall Study|Protocol Violation|0|||
124772881|NCT01550003|448798802|FG001|Overall Study|Protocol Violation|3|||
124772882|NCT01550003|448798803|FG002|Overall Study|Protocol Violation|2|||
124772883|NCT01550003|448798801|FG000|Overall Study|Lost to Follow-up|1|||
124772884|NCT01550003|448798802|FG001|Overall Study|Lost to Follow-up|4|||
124772885|NCT01550003|448798803|FG002|Overall Study|Lost to Follow-up|8|||
124495397|NCT01651052|447767873|FG000|Overall Study|Death|21|||
124495398|NCT01651052|447767873|FG000|Overall Study|Explant|1|||
124495399|NCT01651052|447767873|FG000|Overall Study|Withdrawal by Subject|1|||
124495400|NCT01651052|447767873|FG000|Overall Study|Lost to Follow-up|3|||
124495401|NCT03964415|447767878|FG000|Overall Study|Sponsor's decision|1563|||
124495402|NCT03964415|447767879|FG001|Overall Study|Sponsor's decision|1528|||
124495403|NCT03964415|447767878|FG000|Overall Study|Lost to Follow-up|139|||
124495404|NCT03964415|447767879|FG001|Overall Study|Lost to Follow-up|146|||
124772886|NCT01550003|448798801|FG000|Overall Study|Consent withdrawn|2|||
124772887|NCT01550003|448798802|FG001|Overall Study|Consent withdrawn|11|||
124772888|NCT01550003|448798803|FG002|Overall Study|Consent withdrawn|23|||
124772889|NCT01550003|448798801|FG000|Overall Study|Missing|1|||
124772890|NCT01550003|448798802|FG001|Overall Study|Missing|0|||
124495405|NCT03964415|447767878|FG000|Overall Study|Withdrawal by Subject|68|||
124495406|NCT03964415|447767879|FG001|Overall Study|Withdrawal by Subject|72|||
124772891|NCT01550003|448798803|FG002|Overall Study|Missing|2|||
124772892|NCT01550003|448798801|FG000|Overall Study|Study closure as announced by sponsor|7|||
124772893|NCT01550003|448798802|FG001|Overall Study|Study closure as announced by sponsor|6|||
124772894|NCT01550003|448798803|FG002|Overall Study|Study closure as announced by sponsor|24|||
124495407|NCT03964415|447767878|FG000|Overall Study|Physician Decision|34|||
124495408|NCT03964415|447767879|FG001|Overall Study|Physician Decision|48|||
124772895|NCT01550003|448798801|FG000|Overall Study|Protocol Noncompliance|1|||
124772896|NCT01550003|448798802|FG001|Overall Study|Protocol Noncompliance|0|||
124772897|NCT01550003|448798803|FG002|Overall Study|Protocol Noncompliance|0|||
124772898|NCT01550003|448798801|FG000|Overall Study|Study closure|0|||
124772899|NCT01550003|448798802|FG001|Overall Study|Study closure|1|||
124772900|NCT01550003|448798803|FG002|Overall Study|Study closure|1|||
124772901|NCT01550003|448798801|FG000|Overall Study|Patient reached adulthood|0|||
124772902|NCT01550003|448798802|FG001|Overall Study|Patient reached adulthood|1|||
124772903|NCT01550003|448798803|FG002|Overall Study|Patient reached adulthood|0|||
124772904|NCT01550003|448798801|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
124772905|NCT01550003|448798802|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
124772906|NCT01550003|448798803|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
124772907|NCT01550003|448798801|FG000|Overall Study|Sponsor's order|0|||
124772908|NCT01550003|448798802|FG001|Overall Study|Sponsor's order|3|||
124772909|NCT01550003|448798803|FG002|Overall Study|Sponsor's order|3|||
124772910|NCT01550003|448798801|FG000|Overall Study|Sponsor's decision|1|||
124772911|NCT01550003|448798802|FG001|Overall Study|Sponsor's decision|5|||
124772912|NCT01550003|448798803|FG002|Overall Study|Sponsor's decision|4|||
124772913|NCT01550003|448798801|FG000|Overall Study|Subject mother passed away|0|||
124772914|NCT01550003|448798802|FG001|Overall Study|Subject mother passed away|1|||
124772915|NCT01550003|448798803|FG002|Overall Study|Subject mother passed away|0|||
124772916|NCT01550003|448798801|FG000|Overall Study|Discontinuation|0|||
124772917|NCT01550003|448798802|FG001|Overall Study|Discontinuation|1|||
124772918|NCT01550003|448798803|FG002|Overall Study|Discontinuation|0|||
124772919|NCT01550003|448798801|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
124772920|NCT01550003|448798802|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
124772921|NCT01550003|448798803|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
124772922|NCT01550003|448798801|FG000|Overall Study|Site closure|0|||
124772923|NCT01550003|448798802|FG001|Overall Study|Site closure|2|||
124772924|NCT01550003|448798803|FG002|Overall Study|Site closure|0|||
124772925|NCT01550003|448798801|FG000|Overall Study|Pregnancy|0|||
124772926|NCT01550003|448798802|FG001|Overall Study|Pregnancy|1|||
124772927|NCT01550003|448798803|FG002|Overall Study|Pregnancy|0|||
124772928|NCT01550003|448798801|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
124772929|NCT01550003|448798802|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
124772930|NCT01550003|448798803|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
124772931|NCT01550003|448798801|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
124772932|NCT01550003|448798802|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
124772933|NCT01550003|448798803|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
124772934|NCT01550003|448798801|FG000|Overall Study|Switching to adult rheumatologist|0|||
124772935|NCT01550003|448798802|FG001|Overall Study|Switching to adult rheumatologist|0|||
124772936|NCT01550003|448798803|FG002|Overall Study|Switching to adult rheumatologist|1|||
124772937|NCT01550003|448798801|FG000|Overall Study|Patient transition to adult care|0|||
124772938|NCT01550003|448798802|FG001|Overall Study|Patient transition to adult care|0|||
124772939|NCT01550003|448798803|FG002|Overall Study|Patient transition to adult care|1|||
124772940|NCT01550003|448798801|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
124772941|NCT01550003|448798802|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
124495409|NCT03964415|447767878|FG000|Overall Study|Adverse Event|3|||
124495410|NCT03964415|447767879|FG001|Overall Study|Adverse Event|0|||
124495411|NCT03964415|447767878|FG000|Overall Study|Death|4|||
124495412|NCT03964415|447767879|FG001|Overall Study|Death|6|||
124495413|NCT03964415|447767878|FG000|Overall Study|Protocol Violation|1|||
124495414|NCT03964415|447767879|FG001|Overall Study|Protocol Violation|4|||
124495415|NCT03964415|447767878|FG000|Overall Study|Other|35|||
124495416|NCT03964415|447767879|FG001|Overall Study|Other|38|||
124495417|NCT03964415|447767878|FG000|Overall Study|Randomized but not treated|6|||
124495418|NCT03964415|447767879|FG001|Overall Study|Randomized but not treated|7|||
124772942|NCT01550003|448798803|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
124772943|NCT01550003|448798801|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
124772944|NCT01550003|448798802|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
124772945|NCT01550003|448798803|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
124772946|NCT01550003|448798801|FG000|Overall Study|Per Sponsor request|1|||
124772947|NCT01550003|448798802|FG001|Overall Study|Per Sponsor request|0|||
124772948|NCT01550003|448798803|FG002|Overall Study|Per Sponsor request|1|||
124772949|NCT01550003|448798801|FG000|Overall Study|Patient not compliance|0|||
124772950|NCT01550003|448798802|FG001|Overall Study|Patient not compliance|0|||
124495419|NCT01734993|447767880|FG000|Overall Study|Adverse Event|1|||
124495420|NCT01734993|447767880|FG000|Overall Study|Lack of Efficacy|1|||
124495421|NCT01024465|447767881|FG000|Overall Study|Adverse Event|2|||
124495422|NCT01024465|447767881|FG000|Overall Study|Physician Decision|1|||
124495423|NCT02062151|447767882|FG000|Overall Study|screen failure|1|||
124495424|NCT02086565|447767885|FG000|Overall Study|Lost to Follow-up|9|||
124495425|NCT02086565|447767886|FG001|Overall Study|Lost to Follow-up|7|||
124495426|NCT02086565|447767885|FG000|Overall Study|Withdrawal by Subject|2|||
124495427|NCT02086565|447767886|FG001|Overall Study|Withdrawal by Subject|1|||
124495428|NCT02086565|447767885|FG000|Overall Study|Death|3|||
124495429|NCT02086565|447767886|FG001|Overall Study|Death|2|||
124495430|NCT02086565|447767885|FG000|Overall Study|withdrawn by research team|2|||
124495431|NCT02086565|447767886|FG001|Overall Study|withdrawn by research team|2|||
124495432|NCT02116972|447767887|FG000|Overall Study|Adverse Event|4|||
124495433|NCT02116972|447767888|FG001|Overall Study|Adverse Event|4|||
124495434|NCT02116972|447767889|FG002|Overall Study|Adverse Event|1|||
124495435|NCT02116972|447767887|FG000|Overall Study|Withdrawal by Subject|1|||
124495436|NCT02116972|447767888|FG001|Overall Study|Withdrawal by Subject|1|||
124495437|NCT02116972|447767889|FG002|Overall Study|Withdrawal by Subject|5|||
124495438|NCT02116972|447767887|FG000|Overall Study|Protocol Violation|1|||
124495439|NCT02116972|447767888|FG001|Overall Study|Protocol Violation|0|||
124495440|NCT02116972|447767889|FG002|Overall Study|Protocol Violation|1|||
124495441|NCT02116972|447767887|FG000|Overall Study|Lost to Follow-up|4|||
124495442|NCT02116972|447767888|FG001|Overall Study|Lost to Follow-up|3|||
124495443|NCT02116972|447767889|FG002|Overall Study|Lost to Follow-up|1|||
124495444|NCT02116972|447767887|FG000|Overall Study|Lack of Efficacy|6|||
124495445|NCT02116972|447767888|FG001|Overall Study|Lack of Efficacy|6|||
124495446|NCT02116972|447767889|FG002|Overall Study|Lack of Efficacy|5|||
124495447|NCT02116972|447767887|FG000|Overall Study|scheduling conflicts and relocation|3|||
124495448|NCT02116972|447767888|FG001|Overall Study|scheduling conflicts and relocation|3|||
124495449|NCT02116972|447767889|FG002|Overall Study|scheduling conflicts and relocation|6|||
124495450|NCT00789477|447767892|FG000|Overall Study|Withdrawal by Subject|2|||
124495451|NCT00789477|447767893|FG001|Overall Study|Withdrawal by Subject|1|||
124495452|NCT00789477|447767894|FG002|Overall Study|Withdrawal by Subject|3|||
124495453|NCT00789477|447767895|FG003|Overall Study|Withdrawal by Subject|2|||
124495454|NCT00789477|447767896|FG004|Overall Study|Withdrawal by Subject|3|||
124495455|NCT00789477|447767892|FG000|Overall Study|Protocol Violation|1|||
124495456|NCT00789477|447767893|FG001|Overall Study|Protocol Violation|0|||
124495457|NCT00789477|447767894|FG002|Overall Study|Protocol Violation|0|||
124495458|NCT00789477|447767895|FG003|Overall Study|Protocol Violation|1|||
124495459|NCT00789477|447767896|FG004|Overall Study|Protocol Violation|0|||
124722489|NCT03062280|448607463|FG000|Overall Study|Physician Decision|2|||
124722490|NCT03062280|448607463|FG000|Overall Study|Pregnancy|5|||
124722491|NCT03062280|448607463|FG000|Overall Study|Withdrawal by Subject|11|||
124722492|NCT04299308|448607464|FG000|Overall Study|Withdrawal by Subject|1|||
124722493|NCT04299308|448607465|FG001|Overall Study|Withdrawal by Subject|0|||
124722494|NCT04299308|448607464|FG000|Overall Study|issue with PET image (1)|1|||
124722495|NCT04299308|448607465|FG001|Overall Study|issue with PET image (1)|0|||
124722496|NCT05258890|448607466|FG000|Overall Study|Patient withdrawal|6|||
124722497|NCT05258890|448607467|FG001|Overall Study|Patient withdrawal|7|||
124722498|NCT05258890|448607466|FG000|Overall Study|Patient lost to follow-up|10|||
124722499|NCT05258890|448607467|FG001|Overall Study|Patient lost to follow-up|3|||
124722500|NCT05258890|448607466|FG000|Overall Study|Social network member withdrawal|1|||
124722501|NCT05258890|448607467|FG001|Overall Study|Social network member withdrawal|0|||
124722502|NCT05258890|448607466|FG000|Overall Study|Social network member lost to follow-up|5|||
124722503|NCT05258890|448607467|FG001|Overall Study|Social network member lost to follow-up|0|||
124722504|NCT04493424|448607468|FG000|Overall Study|Termination of the trial by the sponsor|89|||
124722505|NCT04493424|448607468|FG000|Overall Study|Withdrawal by Subject|9|||
124722506|NCT04493424|448607468|FG000|Overall Study|Lost to Follow-up|2|||
124722507|NCT04493424|448607468|FG000|Overall Study|Lack of Efficacy|3|||
124722508|NCT04493424|448607468|FG000|Overall Study|Adverse Event|5|||
124722509|NCT02482428|448607469|FG000|Overall Study|Lost to Follow-up|4|||
124722510|NCT02482428|448607470|FG001|Overall Study|Lost to Follow-up|9|||
124722511|NCT02482428|448607471|FG002|Overall Study|Lost to Follow-up|1|||
124722512|NCT02482428|448607472|FG003|Overall Study|Lost to Follow-up|2|||
124722513|NCT02482428|448607473|FG004|Overall Study|Lost to Follow-up|4|||
124722514|NCT02482428|448607469|FG000|Overall Study|Physician Decision|0|||
124495460|NCT00789477|447767892|FG000|Overall Study|Adverse Event|3|||
124495461|NCT00789477|447767893|FG001|Overall Study|Adverse Event|3|||
124495462|NCT00789477|447767894|FG002|Overall Study|Adverse Event|1|||
124495463|NCT00789477|447767895|FG003|Overall Study|Adverse Event|0|||
124495464|NCT00789477|447767896|FG004|Overall Study|Adverse Event|0|||
124495465|NCT00789477|447767892|FG000|Overall Study|Death|1|||
124495466|NCT00789477|447767893|FG001|Overall Study|Death|1|||
124495467|NCT00789477|447767894|FG002|Overall Study|Death|2|||
124495468|NCT00789477|447767895|FG003|Overall Study|Death|2|||
124495469|NCT00789477|447767896|FG004|Overall Study|Death|0|||
124495470|NCT00789477|447767892|FG000|Overall Study|Lost to Follow-up|0|||
124495471|NCT00789477|447767893|FG001|Overall Study|Lost to Follow-up|1|||
124495472|NCT00789477|447767894|FG002|Overall Study|Lost to Follow-up|4|||
124495473|NCT00789477|447767895|FG003|Overall Study|Lost to Follow-up|2|||
124558089|NCT00528879|448001406|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
124558090|NCT00528879|448001407|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
124558091|NCT00528879|448001408|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
124558092|NCT00528879|448001409|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
124558093|NCT00528879|448001406|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
124558094|NCT00528879|448001407|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
124722515|NCT02482428|448607470|FG001|Overall Study|Physician Decision|0|||
124722516|NCT02482428|448607471|FG002|Overall Study|Physician Decision|0|||
124722517|NCT02482428|448607472|FG003|Overall Study|Physician Decision|0|||
124722518|NCT02482428|448607473|FG004|Overall Study|Physician Decision|1|||
124722519|NCT02482428|448607469|FG000|Overall Study|protocol deviation|1|||
124722520|NCT02482428|448607470|FG001|Overall Study|protocol deviation|1|||
124722521|NCT02482428|448607471|FG002|Overall Study|protocol deviation|0|||
124722522|NCT02482428|448607472|FG003|Overall Study|protocol deviation|0|||
124722523|NCT02482428|448607473|FG004|Overall Study|protocol deviation|0|||
124722524|NCT02482428|448607469|FG000|Overall Study|subject/guardian decision|4|||
124722525|NCT02482428|448607470|FG001|Overall Study|subject/guardian decision|2|||
124722526|NCT02482428|448607471|FG002|Overall Study|subject/guardian decision|0|||
124722527|NCT02482428|448607472|FG003|Overall Study|subject/guardian decision|0|||
124722528|NCT02482428|448607473|FG004|Overall Study|subject/guardian decision|2|||
124722529|NCT05959447|448607476|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
124722530|NCT05959447|448607477|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
124722531|NCT05959447|448607476|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
124722532|NCT05959447|448607477|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
124722533|NCT05959447|448607476|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
124722534|NCT05959447|448607477|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
124722535|NCT05959447|448607476|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
124722536|NCT05959447|448607477|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
124722537|NCT00576628|448607479|FG000|Overall Study|Adverse Event|11|||
124722538|NCT00576628|448607479|FG000|Overall Study|Death|2|||
124722539|NCT00576628|448607479|FG000|Overall Study|Failure to return|1|||
124722540|NCT00576628|448607479|FG000|Overall Study|Refused Treatment|8|||
124722541|NCT00576628|448607479|FG000|Overall Study|Pregnancy|1|||
124722542|NCT00576628|448607479|FG000|Overall Study|RBC transfusion|1|||
124722543|NCT00576628|448607479|FG000|Overall Study|Progression of Kidney Disease|1|||
124722544|NCT00576628|448607479|FG000|Overall Study|Progression of Renal Failure|1|||
124722545|NCT00576628|448607479|FG000|Overall Study|The patient move into other town|1|||
124722546|NCT00576628|448607479|FG000|Overall Study|Transplantation|1|||
124722547|NCT00576628|448607479|FG000|Overall Study|Dialysis|15|||
124722548|NCT01092780|448607482|FG000|Washout Period 1|Adverse Event|0|||
124722549|NCT01092780|448607483|FG001|Washout Period 1|Adverse Event|1|||
124722550|NCT01092780|448607484|FG002|Washout Period 1|Adverse Event|0|||
124722551|NCT01092780|448607485|FG003|Washout Period 1|Adverse Event|0|||
124722552|NCT01092780|448607482|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
124722553|NCT01092780|448607483|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
124722554|NCT01092780|448607484|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
124722555|NCT01092780|448607485|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
124722556|NCT01092780|448607482|FG000|Washout Period 2|Adverse Event|0|||
124722557|NCT01092780|448607483|FG001|Washout Period 2|Adverse Event|1|||
124722558|NCT01092780|448607484|FG002|Washout Period 2|Adverse Event|1|||
124722559|NCT01092780|448607485|FG003|Washout Period 2|Adverse Event|0|||
124722560|NCT01864148|448607486|FG000|Overall Study|Other|2|||
124722561|NCT01864148|448607487|FG001|Overall Study|Other|1|||
124722562|NCT01864148|448607488|FG002|Overall Study|Other|1|||
124722563|NCT01864148|448607489|FG003|Overall Study|Other|3|||
124722564|NCT01864148|448607490|FG004|Overall Study|Other|1|||
124722565|NCT01864148|448607486|FG000|Overall Study|Death|0|||
124772951|NCT01550003|448798803|FG002|Overall Study|Patient not compliance|1|||
124772952|NCT01550003|448798801|FG000|Overall Study|Non-compliance|0|||
124772953|NCT01550003|448798802|FG001|Overall Study|Non-compliance|0|||
124772954|NCT01550003|448798803|FG002|Overall Study|Non-compliance|1|||
124772955|NCT01550003|448798801|FG000|Overall Study|Study closed|0|||
124772956|NCT01550003|448798802|FG001|Overall Study|Study closed|1|||
124772957|NCT01550003|448798803|FG002|Overall Study|Study closed|0|||
124772958|NCT01550003|448798801|FG000|Overall Study|Transitioned to adult rheumatology|0|||
124772959|NCT01550003|448798802|FG001|Overall Study|Transitioned to adult rheumatology|0|||
124772960|NCT01550003|448798803|FG002|Overall Study|Transitioned to adult rheumatology|1|||
124772961|NCT01656408|448798804|FG000|Overall Study|Adverse Event|0|||
124772962|NCT01656408|448798805|FG001|Overall Study|Adverse Event|0|||
124772963|NCT01656408|448798806|FG002|Overall Study|Adverse Event|1|||
124772964|NCT01656408|448798807|FG003|Overall Study|Adverse Event|0|||
124772965|NCT01656408|448798808|FG004|Overall Study|Adverse Event|0|||
124772966|NCT01656408|448798809|FG005|Overall Study|Adverse Event|1|||
124722566|NCT01864148|448607487|FG001|Overall Study|Death|0|||
124772967|NCT01656408|448798810|FG006|Overall Study|Adverse Event|1|||
124722567|NCT01864148|448607488|FG002|Overall Study|Death|0|||
124772968|NCT01656408|448798811|FG007|Overall Study|Adverse Event|0|||
124772969|NCT01656408|448798812|FG008|Overall Study|Adverse Event|1|||
124772970|NCT01656408|448798813|FG009|Overall Study|Adverse Event|0|||
124772971|NCT01656408|448798804|FG000|Overall Study|Physician Decision|1|||
124772972|NCT01656408|448798805|FG001|Overall Study|Physician Decision|0|||
124772973|NCT01656408|448798806|FG002|Overall Study|Physician Decision|1|||
124772974|NCT01656408|448798807|FG003|Overall Study|Physician Decision|0|||
124772975|NCT01656408|448798808|FG004|Overall Study|Physician Decision|1|||
124772976|NCT01656408|448798809|FG005|Overall Study|Physician Decision|1|||
124772977|NCT01656408|448798810|FG006|Overall Study|Physician Decision|0|||
124772978|NCT01656408|448798811|FG007|Overall Study|Physician Decision|1|||
124772979|NCT01656408|448798812|FG008|Overall Study|Physician Decision|1|||
124772980|NCT01656408|448798813|FG009|Overall Study|Physician Decision|3|||
124772981|NCT03995368|448798814|FG000|Overall Study|Lost to Follow-up|1|||
124772982|NCT03995368|448798815|FG001|Overall Study|Lost to Follow-up|4|||
124772983|NCT03995368|448798816|FG002|Overall Study|Lost to Follow-up|1|||
124772984|NCT03995368|448798814|FG000|Overall Study|Did not meet inclusion criteria|1|||
124772985|NCT03995368|448798815|FG001|Overall Study|Did not meet inclusion criteria|6|||
124772986|NCT03995368|448798816|FG002|Overall Study|Did not meet inclusion criteria|3|||
124772987|NCT03995368|448798814|FG000|Overall Study|Withdrawal by Subject|0|||
124772988|NCT03995368|448798815|FG001|Overall Study|Withdrawal by Subject|1|||
124772989|NCT03995368|448798816|FG002|Overall Study|Withdrawal by Subject|1|||
124772990|NCT03592186|448798817|FG000|Overall Study|Withdrawal by Subject|1|||
124772991|NCT03592186|448798818|FG001|Overall Study|Withdrawal by Subject|0|||
124772992|NCT03592186|448798817|FG000|Overall Study|Lost to Follow-up|16|||
124772993|NCT03592186|448798818|FG001|Overall Study|Lost to Follow-up|11|||
124772994|NCT01409707|448798821|FG000|Overall Study|Withdrawal by Subject|5|||
124772995|NCT01409707|448798822|FG001|Overall Study|Withdrawal by Subject|17|||
124772996|NCT01409707|448798823|FG002|Overall Study|Withdrawal by Subject|16|||
124772997|NCT01658436|448798824|FG000|Overall Study|Adverse Event|6|||
124772998|NCT01658436|448798825|FG001|Overall Study|Adverse Event|5|||
124772999|NCT01658436|448798824|FG000|Overall Study|Physician Decision|1|||
124773000|NCT01658436|448798825|FG001|Overall Study|Physician Decision|0|||
124773001|NCT01658436|448798824|FG000|Overall Study|Progressive disease|12|||
124773002|NCT01658436|448798825|FG001|Overall Study|Progressive disease|4|||
124773003|NCT01658436|448798824|FG000|Overall Study|Study terminated by sponsor|0|||
124773004|NCT01658436|448798825|FG001|Overall Study|Study terminated by sponsor|1|||
124773005|NCT01658436|448798824|FG000|Overall Study|Subject/guardian decision|0|||
124773006|NCT01658436|448798825|FG001|Overall Study|Subject/guardian decision|1|||
124773007|NCT01658436|448798824|FG000|Overall Study|Death|1|||
124773008|NCT01658436|448798825|FG001|Overall Study|Death|0|||
124773009|NCT01217229|448798826|FG000|Overall Study|Adverse Event|1|||
124773010|NCT01217229|448798826|FG000|Overall Study|Disease progression, deterioration|2|||
124773011|NCT01217229|448798826|FG000|Overall Study|Disease progression, Cheson criteria|14|||
124773012|NCT01217229|448798826|FG000|Overall Study|Protocol Violation|1|||
124773013|NCT01217229|448798826|FG000|Overall Study|Disease progression not confirmed|2|||
124773014|NCT03987503|448798827|FG000|Overall Study|Lost to Follow-up|20|||
124773015|NCT03987503|448798827|FG000|Overall Study|Withdrawal by Subject|2|||
124773016|NCT01929317|448798837|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
124773017|NCT01929317|448798838|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
124773018|NCT01929317|448798837|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
124773019|NCT01929317|448798838|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
124773020|NCT01929317|448798837|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
124773021|NCT01929317|448798838|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
124773022|NCT01929317|448798837|FG000|Long-term Phase|Adverse Event|5|||
124773023|NCT01929317|448798838|FG001|Long-term Phase|Adverse Event|1|||
124773024|NCT01929317|448798837|FG000|Long-term Phase|Physician Decision|3|||
124773025|NCT01929317|448798838|FG001|Long-term Phase|Physician Decision|0|||
124773026|NCT01929317|448798837|FG000|Long-term Phase|Withdrawal by Subject|4|||
124773027|NCT01929317|448798838|FG001|Long-term Phase|Withdrawal by Subject|0|||
124773028|NCT01929317|448798837|FG000|Long-term Phase|Protocol Violation|1|||
124773029|NCT01929317|448798838|FG001|Long-term Phase|Protocol Violation|0|||
124773030|NCT01929317|448798837|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
124773031|NCT01929317|448798838|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
124773032|NCT01929317|448798837|FG000|Long-term Phase|Study Closed/Terminated|5|||
124773033|NCT01929317|448798838|FG001|Long-term Phase|Study Closed/Terminated|3|||
124773034|NCT04322526|448798839|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
124773035|NCT04322526|448798840|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
124495474|NCT00789477|447767896|FG004|Overall Study|Lost to Follow-up|4|||
124495475|NCT00789477|447767892|FG000|Overall Study|Lack of Efficacy|2|||
124773036|NCT04322526|448798839|FG000|Washout (1 Week)|Lost to Follow-up|1|||
124773037|NCT04322526|448798840|FG001|Washout (1 Week)|Lost to Follow-up|2|||
124773038|NCT01523756|448798841|FG000|Baseline Period|Adverse Event|0|||
124773039|NCT01523756|448798842|FG001|Baseline Period|Adverse Event|1|||
124773040|NCT01523756|448798841|FG000|Test Period 1|Adverse Event|1|||
124773041|NCT01523756|448798842|FG001|Test Period 1|Adverse Event|0|||
124773042|NCT01523756|448798841|FG000|Test Period 2|Withdrawal by Subject|0|||
124558095|NCT00528879|448001408|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
124558096|NCT00528879|448001409|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
124558097|NCT00528879|448001406|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
124558098|NCT00528879|448001407|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
124558099|NCT00528879|448001408|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
124558100|NCT00528879|448001409|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
124558101|NCT00528879|448001406|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
124558102|NCT00528879|448001407|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
124558103|NCT00528879|448001408|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
124558104|NCT00528879|448001409|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
124558105|NCT00528879|448001406|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
124558106|NCT00528879|448001407|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
124558107|NCT00528879|448001408|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
124558108|NCT00528879|448001409|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
124558109|NCT00528879|448001406|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
124558110|NCT00528879|448001407|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
124558111|NCT00528879|448001408|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
124558112|NCT00528879|448001409|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
124558113|NCT00528879|448001406|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
124558114|NCT00528879|448001407|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
124558115|NCT00528879|448001408|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
124558116|NCT00528879|448001409|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
124558117|NCT00528879|448001406|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
124558118|NCT00528879|448001407|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
124558119|NCT00528879|448001408|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
124558120|NCT00528879|448001409|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
124558121|NCT00528879|448001406|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
124558122|NCT00528879|448001407|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
124558123|NCT00528879|448001408|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
124558124|NCT00528879|448001409|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
124558125|NCT00528879|448001406|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
124558126|NCT00528879|448001407|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
124558127|NCT00528879|448001408|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
124558128|NCT00528879|448001409|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
124558129|NCT00528879|448001406|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
124558130|NCT00528879|448001407|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
124558131|NCT00528879|448001408|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
124558132|NCT00528879|448001409|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
124558133|NCT00528879|448001406|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
124558134|NCT00528879|448001407|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
124558135|NCT00528879|448001408|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
124558136|NCT00528879|448001409|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
124558137|NCT00528879|448001406|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
124558138|NCT00528879|448001407|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
124558139|NCT00528879|448001408|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
124558140|NCT00528879|448001409|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
124558141|NCT00528879|448001406|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
124558142|NCT00528879|448001407|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
124558143|NCT00528879|448001408|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
124558144|NCT00528879|448001409|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
124558145|NCT00528879|448001406|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
124558146|NCT00528879|448001407|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
124558147|NCT00528879|448001408|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
124722568|NCT01864148|448607489|FG003|Overall Study|Death|1|||
124722569|NCT01864148|448607490|FG004|Overall Study|Death|0|||
124722570|NCT01864148|448607486|FG000|Overall Study|Investigator Decision|5|||
124722571|NCT01864148|448607487|FG001|Overall Study|Investigator Decision|0|||
124722572|NCT01864148|448607488|FG002|Overall Study|Investigator Decision|0|||
124722573|NCT01864148|448607489|FG003|Overall Study|Investigator Decision|4|||
124722574|NCT01864148|448607490|FG004|Overall Study|Investigator Decision|6|||
124722575|NCT01864148|448607486|FG000|Overall Study|Withdrawal by Subject|9|||
124722576|NCT01864148|448607487|FG001|Overall Study|Withdrawal by Subject|2|||
124722577|NCT01864148|448607488|FG002|Overall Study|Withdrawal by Subject|6|||
124722578|NCT01864148|448607489|FG003|Overall Study|Withdrawal by Subject|8|||
124722579|NCT01864148|448607490|FG004|Overall Study|Withdrawal by Subject|8|||
124722580|NCT01864148|448607486|FG000|Overall Study|Lost to Follow-up|0|||
124722581|NCT01864148|448607487|FG001|Overall Study|Lost to Follow-up|0|||
124495476|NCT00789477|447767893|FG001|Overall Study|Lack of Efficacy|0|||
124495477|NCT00789477|447767894|FG002|Overall Study|Lack of Efficacy|0|||
124495478|NCT00789477|447767895|FG003|Overall Study|Lack of Efficacy|0|||
124495479|NCT00789477|447767896|FG004|Overall Study|Lack of Efficacy|0|||
124495480|NCT00789477|447767892|FG000|Overall Study|Other|2|||
124495481|NCT00789477|447767893|FG001|Overall Study|Other|0|||
124495482|NCT00789477|447767894|FG002|Overall Study|Other|1|||
124495483|NCT00789477|447767895|FG003|Overall Study|Other|3|||
124495484|NCT00789477|447767896|FG004|Overall Study|Other|0|||
124495485|NCT02092389|447767898|FG000|Overall Study|Adverse Event|1|||
124495486|NCT02092389|447767898|FG000|Overall Study|Other|5|||
124495487|NCT01242020|447767899|FG000|Overall Study|Withdrawal by Subject|2|||
124495488|NCT01242020|447767900|FG001|Overall Study|Withdrawal by Subject|0|||
124495489|NCT01242020|447767899|FG000|Overall Study|Failed screening|1|||
124495490|NCT01242020|447767900|FG001|Overall Study|Failed screening|0|||
124495491|NCT01161524|447767901|FG000|Core Study (23 Weeks)|Adverse Event|3|||
124495492|NCT01161524|447767902|FG001|Core Study (23 Weeks)|Adverse Event|0|||
124495493|NCT01161524|447767903|FG002|Core Study (23 Weeks)|Adverse Event|0|||
124495494|NCT01161524|447767901|FG000|Core Study (23 Weeks)|Other|1|||
124495495|NCT01161524|447767902|FG001|Core Study (23 Weeks)|Other|0|||
124495496|NCT01161524|447767903|FG002|Core Study (23 Weeks)|Other|0|||
124495497|NCT01161524|447767901|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
124495498|NCT01161524|447767902|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
124495499|NCT01161524|447767903|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
124495500|NCT01161524|447767901|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
124495501|NCT01161524|447767902|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
124495502|NCT01161524|447767903|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
124495503|NCT01161524|447767901|FG000|Core Study (23 Weeks)|Subject Choice|3|||
124495504|NCT01161524|447767902|FG001|Core Study (23 Weeks)|Subject Choice|2|||
124495505|NCT01161524|447767903|FG002|Core Study (23 Weeks)|Subject Choice|0|||
124495506|NCT01161524|447767901|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
124495507|NCT01161524|447767902|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
124495508|NCT01161524|447767903|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
124495509|NCT01161524|447767901|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
124495510|NCT01161524|447767902|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
124495511|NCT01161524|447767903|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
124495512|NCT01161524|447767901|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
124495513|NCT01161524|447767902|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
124495514|NCT01161524|447767903|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
124495515|NCT01161524|447767901|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
124495516|NCT01161524|447767902|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
124495517|NCT01161524|447767903|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
124495518|NCT01161524|447767901|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
124495519|NCT01161524|447767902|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
124495520|NCT01161524|447767903|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
124495521|NCT00564629|447767912|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
124495522|NCT00564629|447767913|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
124495523|NCT03634072|447767914|FG000|Overall Study|Early termination of overall study|1|||
124495524|NCT03634072|447767915|FG001|Overall Study|Early termination of overall study|0|||
124495525|NCT01952015|447767919|FG000|Induction|Protocol Violation|1|||
124495526|NCT01952015|447767919|FG000|Maintenance|Adverse Event|2|||
124495527|NCT01952015|447767919|FG000|Treatment Period 3|Physician Decision|9|||
124495528|NCT02239094|447767920|FG000|Overall Study|Withdrawal by Subject|1|||
124722582|NCT01864148|448607488|FG002|Overall Study|Lost to Follow-up|0|||
124722583|NCT01864148|448607489|FG003|Overall Study|Lost to Follow-up|2|||
124722584|NCT01864148|448607490|FG004|Overall Study|Lost to Follow-up|1|||
124722585|NCT01864148|448607486|FG000|Overall Study|Adverse Event|4|||
124722586|NCT01864148|448607487|FG001|Overall Study|Adverse Event|2|||
124722587|NCT01864148|448607488|FG002|Overall Study|Adverse Event|4|||
124722588|NCT01864148|448607489|FG003|Overall Study|Adverse Event|7|||
124722589|NCT01864148|448607490|FG004|Overall Study|Adverse Event|7|||
124722590|NCT01864148|448607486|FG000|Overall Study|Not Dosed|0|||
124495529|NCT02239094|447767920|FG000|Overall Study|Remitted before started|1|||
124495530|NCT00053846|447767921|FG000|Overall Study|Changed mind|8|||
124495531|NCT00053846|447767922|FG001|Overall Study|Changed mind|13|||
124495532|NCT00053846|447767921|FG000|Overall Study|Became too ill|8|||
124495533|NCT00053846|447767922|FG001|Overall Study|Became too ill|7|||
124495534|NCT00053846|447767921|FG000|Overall Study|Expired|5|||
124495535|NCT00053846|447767922|FG001|Overall Study|Expired|0|||
124495536|NCT00053846|447767921|FG000|Overall Study|Became ineligible|3|||
124495537|NCT00053846|447767922|FG001|Overall Study|Became ineligible|1|||
124495538|NCT00053846|447767921|FG000|Overall Study|Did not return data|1|||
124722591|NCT01864148|448607487|FG001|Overall Study|Not Dosed|0|||
124722592|NCT01864148|448607488|FG002|Overall Study|Not Dosed|0|||
124722593|NCT01864148|448607489|FG003|Overall Study|Not Dosed|1|||
124722594|NCT01864148|448607490|FG004|Overall Study|Not Dosed|0|||
124495539|NCT00053846|447767922|FG001|Overall Study|Did not return data|2|||
124495540|NCT00053846|447767921|FG000|Overall Study|Quit due to side effects|1|||
124722595|NCT02936869|448607499|FG000|Overall Study|Lost to Follow-up|1|||
124722596|NCT02936869|448607500|FG001|Overall Study|Lost to Follow-up|3|||
124722597|NCT02936869|448607499|FG000|Overall Study|Death|0|||
124722598|NCT02936869|448607500|FG001|Overall Study|Death|1|||
124722599|NCT02936869|448607499|FG000|Overall Study|Legal Case|0|||
124722600|NCT02936869|448607500|FG001|Overall Study|Legal Case|1|||
124722601|NCT02936869|448607499|FG000|Overall Study|Protocol Violation|1|||
124722602|NCT02936869|448607500|FG001|Overall Study|Protocol Violation|0|||
124722603|NCT00506454|448607501|FG000|Overall Study|Withdrawal by Subject|1|||
124722604|NCT00506454|448607502|FG001|Overall Study|Withdrawal by Subject|1|||
124722605|NCT00851552|448607503|FG000|Overall Study|Death|2|||
124722606|NCT00851552|448607503|FG000|Overall Study|Adverse Event|1|||
124722607|NCT00851552|448607503|FG000|Overall Study|Disease Progression|4|||
124722608|NCT02689206|448607504|FG000|Overall Study|Adverse Event|0|||
124722609|NCT02689206|448607505|FG001|Overall Study|Adverse Event|0|||
124722610|NCT02689206|448607506|FG002|Overall Study|Adverse Event|1|||
124722611|NCT02689206|448607507|FG003|Overall Study|Adverse Event|0|||
124722612|NCT02689206|448607508|FG004|Overall Study|Adverse Event|2|||
124722613|NCT02689206|448607504|FG000|Overall Study|Protocol Violation|1|||
124722614|NCT02689206|448607505|FG001|Overall Study|Protocol Violation|0|||
124722615|NCT02689206|448607506|FG002|Overall Study|Protocol Violation|0|||
124722616|NCT02689206|448607507|FG003|Overall Study|Protocol Violation|1|||
124722617|NCT02689206|448607508|FG004|Overall Study|Protocol Violation|2|||
124722618|NCT02689206|448607504|FG000|Overall Study|Other: Reached stopping criteria|0|||
124722619|NCT02689206|448607505|FG001|Overall Study|Other: Reached stopping criteria|1|||
124722620|NCT02689206|448607506|FG002|Overall Study|Other: Reached stopping criteria|2|||
124722621|NCT02689206|448607507|FG003|Overall Study|Other: Reached stopping criteria|3|||
124722622|NCT02689206|448607508|FG004|Overall Study|Other: Reached stopping criteria|4|||
124722623|NCT02689206|448607504|FG000|Overall Study|Physician Decision|1|||
124722624|NCT02689206|448607505|FG001|Overall Study|Physician Decision|0|||
124722625|NCT02689206|448607506|FG002|Overall Study|Physician Decision|0|||
124722626|NCT02689206|448607507|FG003|Overall Study|Physician Decision|0|||
124722627|NCT02689206|448607508|FG004|Overall Study|Physician Decision|0|||
124722628|NCT02689206|448607504|FG000|Overall Study|Withdrawal by Subject|1|||
124722629|NCT02689206|448607505|FG001|Overall Study|Withdrawal by Subject|0|||
124722630|NCT02689206|448607506|FG002|Overall Study|Withdrawal by Subject|1|||
124722631|NCT02689206|448607507|FG003|Overall Study|Withdrawal by Subject|0|||
124722632|NCT02689206|448607508|FG004|Overall Study|Withdrawal by Subject|0|||
124722633|NCT01558596|448607511|FG000|Overall Study|Withdrawal by Subject|1|||
124722634|NCT01558596|448607512|FG001|Overall Study|Withdrawal by Subject|0|||
124722635|NCT01558596|448607511|FG000|Overall Study|surgery elsewhere or cancelled|1|||
124722636|NCT01558596|448607512|FG001|Overall Study|surgery elsewhere or cancelled|1|||
124722637|NCT01558596|448607511|FG000|Overall Study|Protocol Violation|1|||
124722638|NCT01558596|448607512|FG001|Overall Study|Protocol Violation|0|||
124722639|NCT01479764|448607514|FG000|Randomized|Adverse Event|1|||
124722640|NCT01479764|448607515|FG001|Randomized|Adverse Event|1|||
124722641|NCT01479764|448607514|FG000|Randomized|Withdrawal by Subject|1|||
124722642|NCT01479764|448607515|FG001|Randomized|Withdrawal by Subject|0|||
124722643|NCT01479764|448607514|FG000|Treated|Lost to Follow-up|0|||
124722644|NCT01479764|448607515|FG001|Treated|Lost to Follow-up|2|||
124722645|NCT00260832|448607517|FG000|Overall Study|Adverse Event|26|||
124722646|NCT00260832|448607518|FG001|Overall Study|Adverse Event|19|||
124722647|NCT00260832|448607517|FG000|Overall Study|Progression|116|||
124722648|NCT00260832|448607518|FG001|Overall Study|Progression|96|||
124722649|NCT00260832|448607517|FG000|Overall Study|Withdrawal by Subject|15|||
124722650|NCT00260832|448607518|FG001|Overall Study|Withdrawal by Subject|17|||
124722651|NCT00260832|448607517|FG000|Overall Study|Physician Decision|15|||
124722652|NCT00260832|448607518|FG001|Overall Study|Physician Decision|9|||
124722653|NCT00260832|448607517|FG000|Overall Study|Death|43|||
124722654|NCT00260832|448607518|FG001|Overall Study|Death|62|||
124722655|NCT00260832|448607517|FG000|Overall Study|Other|10|||
124495541|NCT00053846|447767922|FG001|Overall Study|Quit due to side effects|3|||
124722656|NCT00260832|448607518|FG001|Overall Study|Other|7|||
124722657|NCT00260832|448607517|FG000|Overall Study|Protocol Violation|3|||
124722658|NCT00260832|448607518|FG001|Overall Study|Protocol Violation|1|||
124722659|NCT00902850|448607519|FG000|Overall Study|Physician Decision|2|||
124722660|NCT00902850|448607520|FG001|Overall Study|Physician Decision|2|||
124722661|NCT03745638|448607521|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
124722662|NCT03745638|448607522|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
124722663|NCT03745638|448607523|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
124722664|NCT03745638|448607524|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
124722665|NCT03745638|448607525|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
124722666|NCT03745638|448607526|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
124722667|NCT03745638|448607527|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
124722668|NCT03745638|448607521|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
124722669|NCT03745638|448607522|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124495542|NCT00053846|447767921|FG000|Overall Study|Pills too large|0|||
124495543|NCT00053846|447767922|FG001|Overall Study|Pills too large|1|||
124495544|NCT00592501|447767923|FG000|Overall Study|Withdrawal by Subject|1|||
124495545|NCT00592501|447767923|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
124495546|NCT03880227|447767927|FG000|First Visit|Withdrawal by Subject|1|||
124495547|NCT03880227|447767928|FG001|First Visit|Withdrawal by Subject|0|||
124495548|NCT03880227|447767929|FG002|First Visit|Withdrawal by Subject|0|||
124495549|NCT03880227|447767930|FG003|First Visit|Withdrawal by Subject|0|||
124495550|NCT03880227|447767927|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
124495551|NCT03880227|447767928|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
124495552|NCT03880227|447767929|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
124495553|NCT03880227|447767930|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
124495554|NCT03880227|447767927|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
124495555|NCT03880227|447767928|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
124495556|NCT03880227|447767929|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
124495557|NCT03880227|447767930|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
124495558|NCT03880227|447767927|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
124495559|NCT03880227|447767928|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
124495560|NCT03880227|447767929|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
124495561|NCT03880227|447767930|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
124495562|NCT02399475|447767935|FG000|Overall Study|Physician Decision|1|||
124495563|NCT02399475|447767936|FG001|Overall Study|Physician Decision|0|||
124495564|NCT02807454|447767937|FG000|Overall Study|Adverse Event|1|||
124495565|NCT02807454|447767938|FG001|Overall Study|Adverse Event|0|||
124495566|NCT02807454|447767937|FG000|Overall Study|Withdrawal by Subject|0|||
124495567|NCT02807454|447767938|FG001|Overall Study|Withdrawal by Subject|1|||
124495568|NCT02807454|447767937|FG000|Overall Study|Progressive Disease|30|||
124722670|NCT03745638|448607523|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124722671|NCT03745638|448607524|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124722672|NCT03745638|448607525|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124722673|NCT03745638|448607526|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124722674|NCT03745638|448607527|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
124722675|NCT03745638|448607521|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
124722676|NCT03745638|448607522|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
124722677|NCT03745638|448607523|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
124722678|NCT03745638|448607524|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124722679|NCT03745638|448607525|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124722680|NCT03745638|448607526|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124722681|NCT03745638|448607527|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
124722682|NCT03745638|448607521|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
124722683|NCT03745638|448607522|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
124722684|NCT03745638|448607523|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
124722685|NCT03745638|448607524|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
124722686|NCT03745638|448607525|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
124722687|NCT03745638|448607526|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
124722688|NCT03745638|448607527|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
124722689|NCT03745638|448607521|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
124722690|NCT03745638|448607522|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
124722691|NCT03745638|448607523|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
124722692|NCT03745638|448607524|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
124722693|NCT03745638|448607525|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
124722694|NCT03745638|448607526|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
124722695|NCT03745638|448607527|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
124722696|NCT03745638|448607521|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124722697|NCT03745638|448607522|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
124722698|NCT03745638|448607523|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124722699|NCT03745638|448607524|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124722700|NCT03745638|448607525|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124722701|NCT03745638|448607526|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124722702|NCT03745638|448607527|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
124722703|NCT03745638|448607521|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
124722704|NCT03745638|448607522|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
124722705|NCT03745638|448607523|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
124495569|NCT02807454|447767938|FG001|Overall Study|Progressive Disease|3|||
124495570|NCT02807454|447767937|FG000|Overall Study|Other Reasons|1|||
124495571|NCT02807454|447767938|FG001|Overall Study|Other Reasons|1|||
124773043|NCT01523756|448798842|FG001|Test Period 2|Withdrawal by Subject|1|||
124773044|NCT00993967|448798843|FG000|Overall Study|Adverse Event|8|||
124773045|NCT00993967|448798843|FG000|Overall Study|Death|1|||
124773046|NCT00993967|448798843|FG000|Overall Study|Lost to Follow-up|14|||
124773047|NCT00993967|448798843|FG000|Overall Study|Withdrawal by Subject|36|||
124773048|NCT00993967|448798843|FG000|Overall Study|Protocol Violation|2|||
124773049|NCT02760498|448798844|FG000|Overall Study|Adverse Event|3|||
124773050|NCT02760498|448798845|FG001|Overall Study|Adverse Event|3|||
124773051|NCT02760498|448798846|FG002|Overall Study|Adverse Event|1|||
124773052|NCT02760498|448798847|FG003|Overall Study|Adverse Event|1|||
124773053|NCT02760498|448798848|FG004|Overall Study|Adverse Event|0|||
124773054|NCT02760498|448798849|FG005|Overall Study|Adverse Event|6|||
124773055|NCT02760498|448798844|FG000|Overall Study|Death|7|||
124773056|NCT02760498|448798845|FG001|Overall Study|Death|5|||
124773057|NCT02760498|448798846|FG002|Overall Study|Death|5|||
124773058|NCT02760498|448798847|FG003|Overall Study|Death|7|||
124773059|NCT02760498|448798848|FG004|Overall Study|Death|0|||
124773060|NCT02760498|448798849|FG005|Overall Study|Death|23|||
124773061|NCT02760498|448798844|FG000|Overall Study|Lost to Follow-up|0|||
124773062|NCT02760498|448798845|FG001|Overall Study|Lost to Follow-up|0|||
124773063|NCT02760498|448798846|FG002|Overall Study|Lost to Follow-up|0|||
124773064|NCT02760498|448798847|FG003|Overall Study|Lost to Follow-up|0|||
124773065|NCT02760498|448798848|FG004|Overall Study|Lost to Follow-up|0|||
124773066|NCT02760498|448798849|FG005|Overall Study|Lost to Follow-up|3|||
124773067|NCT02760498|448798844|FG000|Overall Study|Non-compliance with study drug|0|||
124773068|NCT02760498|448798845|FG001|Overall Study|Non-compliance with study drug|2|||
124773069|NCT02760498|448798846|FG002|Overall Study|Non-compliance with study drug|0|||
124773070|NCT02760498|448798847|FG003|Overall Study|Non-compliance with study drug|0|||
124773071|NCT02760498|448798848|FG004|Overall Study|Non-compliance with study drug|0|||
124773072|NCT02760498|448798849|FG005|Overall Study|Non-compliance with study drug|0|||
124773073|NCT02760498|448798844|FG000|Overall Study|Participant decision|1|||
124773074|NCT02760498|448798845|FG001|Overall Study|Participant decision|4|||
124773075|NCT02760498|448798846|FG002|Overall Study|Participant decision|2|||
124773076|NCT02760498|448798847|FG003|Overall Study|Participant decision|2|||
124773077|NCT02760498|448798848|FG004|Overall Study|Participant decision|1|||
124773078|NCT02760498|448798849|FG005|Overall Study|Participant decision|6|||
124773079|NCT02760498|448798844|FG000|Overall Study|Sponsor decision|0|||
124773080|NCT02760498|448798845|FG001|Overall Study|Sponsor decision|0|||
124773081|NCT02760498|448798846|FG002|Overall Study|Sponsor decision|0|||
124773082|NCT02760498|448798847|FG003|Overall Study|Sponsor decision|3|||
124558148|NCT00528879|448001409|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
124558149|NCT00528879|448001406|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
124558150|NCT00528879|448001407|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
124558151|NCT00528879|448001408|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
124558152|NCT00528879|448001409|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
124558153|NCT00078819|448001410|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
124558154|NCT00078819|448001411|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
124558155|NCT00078819|448001412|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
124558156|NCT00078819|448001413|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
124558157|NCT00078819|448001410|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
124558158|NCT00078819|448001411|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
124558159|NCT00078819|448001412|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
124558160|NCT00078819|448001413|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
124558161|NCT00078819|448001410|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
124558162|NCT00078819|448001411|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
124558163|NCT00078819|448001412|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
124558164|NCT00078819|448001413|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
124773083|NCT02760498|448798848|FG004|Overall Study|Sponsor decision|0|||
124773084|NCT02760498|448798849|FG005|Overall Study|Sponsor decision|0|||
124773085|NCT02760498|448798844|FG000|Overall Study|Physician Decision|3|||
124773086|NCT02760498|448798845|FG001|Overall Study|Physician Decision|4|||
124773087|NCT02760498|448798846|FG002|Overall Study|Physician Decision|1|||
124773088|NCT02760498|448798847|FG003|Overall Study|Physician Decision|4|||
124558165|NCT00078819|448001410|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
124558166|NCT00078819|448001411|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
124773089|NCT02760498|448798848|FG004|Overall Study|Physician Decision|0|||
124558167|NCT00078819|448001412|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
124773090|NCT02760498|448798849|FG005|Overall Study|Physician Decision|2|||
124773091|NCT02760498|448798844|FG000|Overall Study|Disease progression|21|||
124773092|NCT02760498|448798845|FG001|Overall Study|Disease progression|19|||
124773093|NCT02760498|448798846|FG002|Overall Study|Disease progression|20|||
124773094|NCT02760498|448798847|FG003|Overall Study|Disease progression|18|||
124773095|NCT02760498|448798848|FG004|Overall Study|Disease progression|4|||
124773096|NCT02760498|448798849|FG005|Overall Study|Disease progression|55|||
124722706|NCT03745638|448607524|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124722707|NCT03745638|448607525|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124722708|NCT03745638|448607526|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124722709|NCT03745638|448607527|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
124722710|NCT03745638|448607521|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
124722711|NCT03745638|448607522|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
124722712|NCT03745638|448607523|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
124722713|NCT03745638|448607524|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
124722714|NCT03745638|448607525|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
124722715|NCT03745638|448607526|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
124722716|NCT03745638|448607527|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
124722717|NCT03745638|448607521|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
124722718|NCT03745638|448607522|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
124722719|NCT03745638|448607523|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
124722720|NCT03745638|448607524|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
124722721|NCT03745638|448607525|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
124722722|NCT03745638|448607526|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
124722723|NCT03745638|448607527|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
124722724|NCT03745638|448607521|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124722725|NCT03745638|448607522|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124722726|NCT03745638|448607523|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124722727|NCT03745638|448607524|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
124722728|NCT03745638|448607525|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
124722729|NCT03745638|448607526|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
124722730|NCT03745638|448607527|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
124722731|NCT03745638|448607521|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
124722732|NCT03745638|448607522|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
124722733|NCT03745638|448607523|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
124722734|NCT03745638|448607524|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
124722735|NCT03745638|448607525|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
124722736|NCT03745638|448607526|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
124722737|NCT03745638|448607527|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
124722738|NCT03745638|448607521|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
124722739|NCT03745638|448607522|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
124722740|NCT03745638|448607523|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
124722741|NCT03745638|448607524|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
124722742|NCT03745638|448607525|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
124722743|NCT03745638|448607526|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
124722744|NCT03745638|448607527|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
124722745|NCT03745638|448607521|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124722746|NCT03745638|448607522|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124722747|NCT03745638|448607523|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124722748|NCT03745638|448607524|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124722749|NCT03745638|448607525|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124722750|NCT03745638|448607526|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
124722751|NCT03745638|448607527|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
124722752|NCT03745638|448607521|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
124722753|NCT03745638|448607522|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
124722754|NCT03745638|448607523|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
124722755|NCT03745638|448607524|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
124722756|NCT03745638|448607525|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
124722757|NCT03745638|448607526|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
124722758|NCT03745638|448607527|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
124722759|NCT03745638|448607521|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
124722760|NCT03745638|448607522|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
124722761|NCT03745638|448607523|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
124722762|NCT03745638|448607524|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
124722763|NCT03745638|448607525|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
124722764|NCT03745638|448607526|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
124722765|NCT03745638|448607527|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
124722766|NCT04470050|448607530|FG000|Double-blind Treatment Phase|Adverse Event|0|||
124773097|NCT02760498|448798844|FG000|Overall Study|Withdrawal by Subject|4|||
124773098|NCT02760498|448798845|FG001|Overall Study|Withdrawal by Subject|7|||
124558168|NCT00078819|448001413|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
124558169|NCT00078819|448001410|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
124558170|NCT00078819|448001411|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
124558171|NCT00078819|448001412|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
124558172|NCT00078819|448001413|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
124558173|NCT00078819|448001410|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
124558174|NCT00078819|448001411|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
124558175|NCT00078819|448001412|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
124558176|NCT00078819|448001413|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
124558177|NCT00078819|448001410|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
124558178|NCT00078819|448001411|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
124558179|NCT00078819|448001412|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
124558180|NCT00078819|448001413|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
124558181|NCT00078819|448001410|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
124558182|NCT00078819|448001411|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
124558183|NCT00078819|448001412|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
124558184|NCT00078819|448001413|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
124558185|NCT00323609|448001414|FG000|Overall Study|Death|16|||
124558186|NCT00323609|448001415|FG001|Overall Study|Death|21|||
124558187|NCT00323609|448001416|FG002|Overall Study|Death|0|||
124558188|NCT00323609|448001417|FG003|Overall Study|Death|0|||
124558189|NCT00323609|448001414|FG000|Overall Study|Lost to Follow-up|9|||
124558190|NCT00323609|448001415|FG001|Overall Study|Lost to Follow-up|10|||
124558191|NCT00323609|448001416|FG002|Overall Study|Lost to Follow-up|0|||
124558192|NCT00323609|448001417|FG003|Overall Study|Lost to Follow-up|0|||
124558193|NCT00323609|448001414|FG000|Overall Study|Physician Decision|2|||
124558194|NCT00323609|448001415|FG001|Overall Study|Physician Decision|0|||
124558195|NCT00323609|448001416|FG002|Overall Study|Physician Decision|0|||
124558196|NCT00323609|448001417|FG003|Overall Study|Physician Decision|1|||
124722767|NCT04470050|448607531|FG001|Double-blind Treatment Phase|Adverse Event|0|||
124722768|NCT04470050|448607532|FG002|Double-blind Treatment Phase|Adverse Event|0|||
124722769|NCT04470050|448607533|FG003|Double-blind Treatment Phase|Adverse Event|1|||
124722770|NCT04470050|448607534|FG004|Double-blind Treatment Phase|Adverse Event|0|||
124722771|NCT04470050|448607535|FG005|Double-blind Treatment Phase|Adverse Event|0|||
124722772|NCT04470050|448607536|FG006|Double-blind Treatment Phase|Adverse Event|0|||
124722773|NCT04470050|448607530|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
124722774|NCT04470050|448607531|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
124722775|NCT04470050|448607532|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
124722776|NCT04470050|448607533|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
124722777|NCT04470050|448607534|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
124722778|NCT04470050|448607535|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
124722779|NCT04470050|448607536|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
124722780|NCT04470050|448607530|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
124722781|NCT04470050|448607531|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
124722782|NCT04470050|448607532|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
124722783|NCT04470050|448607533|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
124722784|NCT04470050|448607534|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
124722785|NCT04470050|448607535|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
124722786|NCT04470050|448607536|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
124722787|NCT03585764|448607537|FG000|Overall Study|Death|3|||
124722788|NCT03585764|448607538|FG001|Overall Study|Death|2|||
124722789|NCT03585764|448607539|FG002|Overall Study|Death|3|||
124722790|NCT03585764|448607540|FG003|Overall Study|Death|0|||
124722791|NCT03585764|448607537|FG000|Overall Study|Lost to Follow-up|0|||
124722792|NCT03585764|448607538|FG001|Overall Study|Lost to Follow-up|1|||
124722793|NCT03585764|448607539|FG002|Overall Study|Lost to Follow-up|0|||
124722794|NCT03585764|448607540|FG003|Overall Study|Lost to Follow-up|0|||
124722795|NCT03585764|448607537|FG000|Overall Study|Physician Decision|0|||
124722796|NCT03585764|448607538|FG001|Overall Study|Physician Decision|0|||
124722797|NCT03585764|448607539|FG002|Overall Study|Physician Decision|2|||
124722798|NCT03585764|448607540|FG003|Overall Study|Physician Decision|0|||
124722799|NCT03604172|448607541|FG000|Overall Study|Lost to Follow-up|1|||
124722800|NCT03604172|448607542|FG001|Overall Study|Lost to Follow-up|2|||
124722801|NCT01270880|448607546|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
124773099|NCT02760498|448798846|FG002|Overall Study|Withdrawal by Subject|5|||
124558197|NCT00323609|448001414|FG000|Overall Study|Withdrawal by Subject|11|||
124558198|NCT00323609|448001415|FG001|Overall Study|Withdrawal by Subject|23|||
124558199|NCT00323609|448001416|FG002|Overall Study|Withdrawal by Subject|4|||
124722802|NCT00976716|448607547|FG000|Overall Study|Adverse Event|1|||
124722803|NCT04222699|448607548|FG000|Overall Study|Lost to Follow-up|2|||
124722804|NCT01606176|448607549|FG000|Overall Study|Adverse Event|2|||
124722805|NCT01606176|448607550|FG001|Overall Study|Adverse Event|3|||
124722806|NCT01606176|448607549|FG000|Overall Study|Disease progression|1|||
124773100|NCT02760498|448798847|FG003|Overall Study|Withdrawal by Subject|1|||
124773101|NCT02760498|448798848|FG004|Overall Study|Withdrawal by Subject|0|||
124773102|NCT02760498|448798849|FG005|Overall Study|Withdrawal by Subject|6|||
124773103|NCT02760498|448798844|FG000|Overall Study|Other than specified|1|||
124495572|NCT01165203|447767939|FG000|Active Phase|Serious Adverse Event|1|||
124495573|NCT01165203|447767940|FG001|Active Phase|Serious Adverse Event|0|||
124722807|NCT01606176|448607550|FG001|Overall Study|Disease progression|0|||
124722808|NCT01606176|448607549|FG000|Overall Study|Withdrawal by Subject|1|||
124722809|NCT01606176|448607550|FG001|Overall Study|Withdrawal by Subject|0|||
124722810|NCT01832493|448607551|FG000|Overall Study|Physician Decision|2|||
124722811|NCT01832493|448607551|FG000|Overall Study|Protocol Violation|4|||
124722812|NCT01832493|448607551|FG000|Overall Study|Unable to place LV lead|2|||
124722813|NCT02993822|448607552|FG000|Overall Study|Lack of Efficacy|1|||
124495574|NCT01165203|447767939|FG000|Active Phase|Withdrawal by Subject|2|||
124722814|NCT02993822|448607553|FG001|Overall Study|Lack of Efficacy|1|||
124722815|NCT02993822|448607554|FG002|Overall Study|Lack of Efficacy|0|||
124722816|NCT02993822|448607555|FG003|Overall Study|Lack of Efficacy|0|||
124722817|NCT02993822|448607552|FG000|Overall Study|Protocol Violation|1|||
124722818|NCT02993822|448607553|FG001|Overall Study|Protocol Violation|0|||
124722819|NCT02993822|448607554|FG002|Overall Study|Protocol Violation|0|||
124722820|NCT02993822|448607555|FG003|Overall Study|Protocol Violation|0|||
124722821|NCT02993822|448607552|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
124722822|NCT02993822|448607553|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
124722823|NCT02993822|448607554|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
124722824|NCT02993822|448607555|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
124722825|NCT02993822|448607552|FG000|Overall Study|Adverse Event|3|||
124722826|NCT02993822|448607553|FG001|Overall Study|Adverse Event|1|||
124722827|NCT02993822|448607554|FG002|Overall Study|Adverse Event|7|||
124722828|NCT02993822|448607555|FG003|Overall Study|Adverse Event|0|||
124722829|NCT02993822|448607552|FG000|Overall Study|Withdrawal by Subject|4|||
124722830|NCT02993822|448607553|FG001|Overall Study|Withdrawal by Subject|2|||
124722831|NCT02993822|448607554|FG002|Overall Study|Withdrawal by Subject|2|||
124722832|NCT02993822|448607555|FG003|Overall Study|Withdrawal by Subject|3|||
124722833|NCT02993822|448607552|FG000|Overall Study|Lost to Follow-up|1|||
124722834|NCT02993822|448607553|FG001|Overall Study|Lost to Follow-up|0|||
124722835|NCT02993822|448607554|FG002|Overall Study|Lost to Follow-up|1|||
124722836|NCT02993822|448607555|FG003|Overall Study|Lost to Follow-up|0|||
124722837|NCT01732510|448607556|FG000|Overall Study|Adverse Event|0|||
124722838|NCT01732510|448607557|FG001|Overall Study|Adverse Event|1|||
124722839|NCT01732510|448607558|FG002|Overall Study|Adverse Event|1|||
124722840|NCT01732510|448607559|FG003|Overall Study|Adverse Event|0|||
124722841|NCT01732510|448607560|FG004|Overall Study|Adverse Event|0|||
124722842|NCT01732510|448607561|FG005|Overall Study|Adverse Event|0|||
124722843|NCT01732510|448607562|FG006|Overall Study|Adverse Event|1|||
124722844|NCT01732510|448607556|FG000|Overall Study|Protocol Violation|0|||
124722845|NCT01732510|448607557|FG001|Overall Study|Protocol Violation|0|||
124722846|NCT01732510|448607558|FG002|Overall Study|Protocol Violation|0|||
124722847|NCT01732510|448607559|FG003|Overall Study|Protocol Violation|1|||
124722848|NCT01732510|448607560|FG004|Overall Study|Protocol Violation|0|||
124722849|NCT01732510|448607561|FG005|Overall Study|Protocol Violation|0|||
124722850|NCT01732510|448607562|FG006|Overall Study|Protocol Violation|0|||
124722851|NCT01732510|448607556|FG000|Overall Study|Withdrawal by Subject|1|||
124722852|NCT01732510|448607557|FG001|Overall Study|Withdrawal by Subject|3|||
124722853|NCT01732510|448607558|FG002|Overall Study|Withdrawal by Subject|2|||
124722854|NCT01732510|448607559|FG003|Overall Study|Withdrawal by Subject|1|||
124722855|NCT01732510|448607560|FG004|Overall Study|Withdrawal by Subject|5|||
124722856|NCT01732510|448607561|FG005|Overall Study|Withdrawal by Subject|0|||
124722857|NCT01732510|448607562|FG006|Overall Study|Withdrawal by Subject|1|||
124722858|NCT01732510|448607556|FG000|Overall Study|Lost to Follow-up|0|||
124722859|NCT01732510|448607557|FG001|Overall Study|Lost to Follow-up|0|||
124495575|NCT01165203|447767940|FG001|Active Phase|Withdrawal by Subject|1|||
124495576|NCT01165203|447767939|FG000|Active Phase|Migrated/moved from study area|0|||
124495577|NCT01165203|447767940|FG001|Active Phase|Migrated/moved from study area|1|||
124495578|NCT01165203|447767939|FG000|Active Phase|Lost to Follow-up|2|||
124495579|NCT01165203|447767940|FG001|Active Phase|Lost to Follow-up|0|||
124495580|NCT01165203|447767939|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
124722860|NCT01732510|448607558|FG002|Overall Study|Lost to Follow-up|1|||
124773104|NCT02760498|448798845|FG001|Overall Study|Other than specified|6|||
124495581|NCT01165203|447767940|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
124722861|NCT01732510|448607559|FG003|Overall Study|Lost to Follow-up|1|||
124722862|NCT01732510|448607560|FG004|Overall Study|Lost to Follow-up|0|||
124722863|NCT01732510|448607561|FG005|Overall Study|Lost to Follow-up|1|||
124722864|NCT01732510|448607562|FG006|Overall Study|Lost to Follow-up|0|||
124722865|NCT01732510|448607556|FG000|Overall Study|Physician Decision|0|||
124722866|NCT01732510|448607557|FG001|Overall Study|Physician Decision|1|||
124722867|NCT01732510|448607558|FG002|Overall Study|Physician Decision|0|||
124722868|NCT01732510|448607559|FG003|Overall Study|Physician Decision|0|||
124722869|NCT01732510|448607560|FG004|Overall Study|Physician Decision|0|||
124722870|NCT01732510|448607561|FG005|Overall Study|Physician Decision|0|||
124722871|NCT01732510|448607562|FG006|Overall Study|Physician Decision|0|||
124722872|NCT01732510|448607556|FG000|Overall Study|Pregnancy|0|||
124722873|NCT01732510|448607557|FG001|Overall Study|Pregnancy|0|||
124722874|NCT01732510|448607558|FG002|Overall Study|Pregnancy|0|||
124722875|NCT01732510|448607559|FG003|Overall Study|Pregnancy|1|||
124722876|NCT01732510|448607560|FG004|Overall Study|Pregnancy|0|||
124722877|NCT01732510|448607561|FG005|Overall Study|Pregnancy|0|||
124722878|NCT01732510|448607562|FG006|Overall Study|Pregnancy|0|||
124722879|NCT01732510|448607556|FG000|Overall Study|Study Terminated By Sponsor|0|||
124722880|NCT01732510|448607557|FG001|Overall Study|Study Terminated By Sponsor|0|||
124722881|NCT01732510|448607558|FG002|Overall Study|Study Terminated By Sponsor|0|||
124722882|NCT01732510|448607559|FG003|Overall Study|Study Terminated By Sponsor|1|||
124722883|NCT01732510|448607560|FG004|Overall Study|Study Terminated By Sponsor|0|||
124722884|NCT01732510|448607561|FG005|Overall Study|Study Terminated By Sponsor|12|||
124722885|NCT01732510|448607562|FG006|Overall Study|Study Terminated By Sponsor|6|||
124722886|NCT00313144|448607563|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
124722887|NCT00313144|448607563|FG000|Overall Study|Death|7|||
124722888|NCT00313144|448607563|FG000|Overall Study|Lost to Follow-up|5|||
124722889|NCT00313144|448607563|FG000|Overall Study|Withdrawal by Subject|4|||
124722890|NCT00313144|448607563|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
124722891|NCT00313144|448607563|FG000|Overall Study|Physician Decision|4|||
124722892|NCT00313144|448607563|FG000|Overall Study|Adverse event - transient|5|||
124722893|NCT00313144|448607563|FG000|Overall Study|Liver transplant|1|||
124722894|NCT00313144|448607563|FG000|Overall Study|Insurance (homecare provider) change|1|||
124722895|NCT00313144|448607563|FG000|Overall Study|Change to different product|1|||
124722896|NCT00313144|448607563|FG000|Overall Study|Due to termination of the study|66|||
124722897|NCT01221753|448607564|FG000|Overall Study|Adverse Event|1|||
124722898|NCT01262560|448607570|FG000|Overall Study|Protocol Violation|0|||
124722899|NCT01262560|448607571|FG001|Overall Study|Protocol Violation|1|||
124722900|NCT01262560|448607572|FG002|Overall Study|Protocol Violation|2|||
124722901|NCT03213938|448607573|FG000|Overall Study|Lost to Follow-up|4|||
124722902|NCT03213938|448607574|FG001|Overall Study|Lost to Follow-up|3|||
124722903|NCT03213938|448607573|FG000|Overall Study|Lack of Efficacy|1|||
124722904|NCT03213938|448607574|FG001|Overall Study|Lack of Efficacy|0|||
124722905|NCT03213938|448607573|FG000|Overall Study|Decline to participate|5|||
124722906|NCT03213938|448607574|FG001|Overall Study|Decline to participate|4|||
124722907|NCT03213938|448607573|FG000|Overall Study|Without reason|4|||
124722908|NCT03213938|448607574|FG001|Overall Study|Without reason|5|||
124722909|NCT00673231|448607575|FG000|Overall Study|Withdrawal by Subject|14|||
124722910|NCT00673231|448607576|FG001|Overall Study|Withdrawal by Subject|10|||
124722911|NCT00673231|448607577|FG002|Overall Study|Withdrawal by Subject|8|||
124722912|NCT00673231|448607578|FG003|Overall Study|Withdrawal by Subject|6|||
124722913|NCT00673231|448607575|FG000|Overall Study|Adverse Event|6|||
124722914|NCT00673231|448607576|FG001|Overall Study|Adverse Event|5|||
124722915|NCT00673231|448607577|FG002|Overall Study|Adverse Event|9|||
124722916|NCT00673231|448607578|FG003|Overall Study|Adverse Event|6|||
124722917|NCT00673231|448607575|FG000|Overall Study|Lost to Follow-up|1|||
124722918|NCT00673231|448607576|FG001|Overall Study|Lost to Follow-up|2|||
124722919|NCT00673231|448607577|FG002|Overall Study|Lost to Follow-up|1|||
124722920|NCT00673231|448607578|FG003|Overall Study|Lost to Follow-up|2|||
124722921|NCT00673231|448607575|FG000|Overall Study|Death|0|||
124722922|NCT00673231|448607576|FG001|Overall Study|Death|0|||
124722923|NCT00673231|448607577|FG002|Overall Study|Death|1|||
124722924|NCT00673231|448607578|FG003|Overall Study|Death|0|||
124722925|NCT00673231|448607575|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
124722926|NCT00673231|448607576|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
124722927|NCT00673231|448607577|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
124722928|NCT00673231|448607578|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
124722929|NCT03594747|448607579|FG000|Overall Study|Death|78|||
124722930|NCT03594747|448607580|FG001|Overall Study|Death|86|||
124722931|NCT03594747|448607581|FG002|Overall Study|Death|87|||
124722932|NCT03594747|448607579|FG000|Overall Study|Withdrawal by Subject|5|||
124495582|NCT01165203|447767939|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
124495583|NCT01165203|447767940|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
124495584|NCT01165203|447767939|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
124495585|NCT01165203|447767940|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
124495586|NCT01165203|447767939|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
124495587|NCT01165203|447767940|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
124722933|NCT03594747|448607580|FG001|Overall Study|Withdrawal by Subject|2|||
124722934|NCT03594747|448607581|FG002|Overall Study|Withdrawal by Subject|11|||
124722935|NCT03594747|448607579|FG000|Overall Study|Lost to Follow-up|4|||
124722936|NCT03594747|448607580|FG001|Overall Study|Lost to Follow-up|1|||
124722937|NCT03594747|448607581|FG002|Overall Study|Lost to Follow-up|1|||
124722938|NCT03594747|448607579|FG000|Overall Study|Physician Decision|0|||
124722939|NCT03594747|448607580|FG001|Overall Study|Physician Decision|1|||
124722940|NCT03594747|448607581|FG002|Overall Study|Physician Decision|0|||
124722941|NCT03594747|448607579|FG000|Overall Study|Sponsor decision|23|||
124495588|NCT01165203|447767939|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
124495589|NCT01165203|447767940|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
124495590|NCT01963117|447767941|FG000|Overall Study|Death|1|||
124495591|NCT01070784|447767942|FG000|Overall Study|Withdrawal by Subject|6|||
124495592|NCT01070784|447767943|FG001|Overall Study|Withdrawal by Subject|9|||
124722942|NCT03594747|448607580|FG001|Overall Study|Sponsor decision|17|||
124722943|NCT03594747|448607581|FG002|Overall Study|Sponsor decision|16|||
124722944|NCT03594747|448607579|FG000|Overall Study|Did not meet inclusion criteria|0|||
124722945|NCT03594747|448607580|FG001|Overall Study|Did not meet inclusion criteria|0|||
124722946|NCT03594747|448607581|FG002|Overall Study|Did not meet inclusion criteria|1|||
124722947|NCT03594747|448607579|FG000|Overall Study|Transfer to long term extension study|10|||
124722948|NCT03594747|448607580|FG001|Overall Study|Transfer to long term extension study|12|||
124722949|NCT03594747|448607581|FG002|Overall Study|Transfer to long term extension study|5|||
124722950|NCT01063062|448607590|FG000|Overall Study|Patient withdrew consent|0|||
124722951|NCT01063062|448607591|FG001|Overall Study|Patient withdrew consent|1|||
124722952|NCT01063062|448607590|FG000|Overall Study|Adverse Event|2|||
124722953|NCT01063062|448607591|FG001|Overall Study|Adverse Event|4|||
124722954|NCT01063062|448607590|FG000|Overall Study|Protocol Violation|5|||
124722955|NCT01063062|448607591|FG001|Overall Study|Protocol Violation|4|||
124722956|NCT01063062|448607590|FG000|Overall Study|Investigator's request|1|||
124722957|NCT01063062|448607591|FG001|Overall Study|Investigator's request|0|||
124722958|NCT01063062|448607590|FG000|Overall Study|Lost to Follow-up|0|||
124722959|NCT01063062|448607591|FG001|Overall Study|Lost to Follow-up|2|||
124722960|NCT01063062|448607590|FG000|Overall Study|Miscellaneous reason|0|||
124722961|NCT01063062|448607591|FG001|Overall Study|Miscellaneous reason|1|||
124722962|NCT02015481|448607596|FG000|Overall Study|Death|1|||
124722963|NCT02485639|448607597|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
124722964|NCT02485639|448607597|FG000|Overall Study|Early termination|4|||
124722965|NCT02485639|448607597|FG000|Overall Study|Withdrawal by Subject|4|||
124722966|NCT02597452|448607598|FG000|Overall Study|testing incomplete|30|||
124722967|NCT02566785|448607605|FG000|Overall Study|Lost to Follow-up|0|||
124722968|NCT02566785|448607606|FG001|Overall Study|Lost to Follow-up|2|||
124722969|NCT02566785|448607605|FG000|Overall Study|Worsening condition|1|||
124722970|NCT02566785|448607606|FG001|Overall Study|Worsening condition|1|||
124722971|NCT00281099|448607607|FG000|Overall Study|Death|46|||
124722972|NCT00281099|448607608|FG001|Overall Study|Death|57|||
124722973|NCT00281099|448607607|FG000|Overall Study|Lost to Follow-up|10|||
124722974|NCT00281099|448607608|FG001|Overall Study|Lost to Follow-up|19|||
124722975|NCT00281099|448607607|FG000|Overall Study|Withdrawal by Subject|65|||
124722976|NCT00281099|448607608|FG001|Overall Study|Withdrawal by Subject|70|||
124722977|NCT00281099|448607607|FG000|Overall Study|Physician Decision|79|||
124722978|NCT00281099|448607608|FG001|Overall Study|Physician Decision|72|||
124722979|NCT00281099|448607607|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
124722980|NCT00281099|448607608|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
124722981|NCT04621240|448607609|FG000|Overall Study|Withdrawal by Subject|36|||
124495593|NCT01070784|447767942|FG000|Overall Study|Adverse Event|14|||
124495594|NCT01070784|447767943|FG001|Overall Study|Adverse Event|9|||
124495595|NCT02582749|447767944|FG000|Overall Study|Study terminated by funder|5|||
124495596|NCT02582749|447767945|FG001|Overall Study|Study terminated by funder|10|||
124495597|NCT02582749|447767944|FG000|Overall Study|Withdrawal by Subject|0|||
124495598|NCT02582749|447767945|FG001|Overall Study|Withdrawal by Subject|1|||
124495599|NCT02815397|447767946|FG000|Overall Study|Physician Decision|2|||
124495600|NCT02518620|447767947|FG000|Overall Study|Adverse Event|23|||
124495601|NCT02518620|447767948|FG001|Overall Study|Adverse Event|11|||
124495602|NCT02518620|447767947|FG000|Overall Study|Lack of Efficacy|2|||
124495603|NCT02518620|447767948|FG001|Overall Study|Lack of Efficacy|0|||
124495604|NCT02518620|447767947|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124495605|NCT02518620|447767948|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124495606|NCT02518620|447767947|FG000|Overall Study|Physician Decision|1|||
124495607|NCT02518620|447767948|FG001|Overall Study|Physician Decision|1|||
124495608|NCT02518620|447767947|FG000|Overall Study|Sponsor's Decision|0|||
124495609|NCT02518620|447767948|FG001|Overall Study|Sponsor's Decision|3|||
124495610|NCT02518620|447767947|FG000|Overall Study|Lost to Follow-up|1|||
124495611|NCT02518620|447767948|FG001|Overall Study|Lost to Follow-up|1|||
124495612|NCT02518620|447767947|FG000|Overall Study|Withdrawal by Subject|17|||
124495613|NCT02518620|447767948|FG001|Overall Study|Withdrawal by Subject|9|||
124495614|NCT02518620|447767947|FG000|Overall Study|Death|1|||
124495615|NCT02518620|447767948|FG001|Overall Study|Death|0|||
124495616|NCT02518620|447767947|FG000|Overall Study|Pregnancy Wish|3|||
124722982|NCT02147197|448607610|FG000|Overall Study|Adverse Event|1|||
124722983|NCT02147197|448607611|FG001|Overall Study|Adverse Event|0|||
124722984|NCT02147197|448607612|FG002|Overall Study|Adverse Event|0|||
124722985|NCT02147197|448607610|FG000|Overall Study|Withdrawal of Consent|4|||
124722986|NCT02147197|448607611|FG001|Overall Study|Withdrawal of Consent|3|||
124722987|NCT02147197|448607612|FG002|Overall Study|Withdrawal of Consent|2|||
124495617|NCT02518620|447767948|FG001|Overall Study|Pregnancy Wish|0|||
124495618|NCT02518620|447767947|FG000|Overall Study|Pregnancy|1|||
124722988|NCT02147197|448607610|FG000|Overall Study|Lost to Follow-up|2|||
124722989|NCT02147197|448607611|FG001|Overall Study|Lost to Follow-up|3|||
124722990|NCT02147197|448607612|FG002|Overall Study|Lost to Follow-up|1|||
124722991|NCT02147197|448607610|FG000|Overall Study|Protocol Violation|1|||
124722992|NCT02147197|448607611|FG001|Overall Study|Protocol Violation|0|||
124722993|NCT02147197|448607612|FG002|Overall Study|Protocol Violation|3|||
124722994|NCT02147197|448607610|FG000|Overall Study|Other Miscellaneous Reasons|1|||
124722995|NCT02147197|448607611|FG001|Overall Study|Other Miscellaneous Reasons|0|||
124722996|NCT02147197|448607612|FG002|Overall Study|Other Miscellaneous Reasons|3|||
124722997|NCT02712983|448609677|FG000|Treatment Phase|Adverse Event|3|||
124722998|NCT02712983|448609678|FG001|Treatment Phase|Adverse Event|1|||
124722999|NCT02712983|448609679|FG002|Treatment Phase|Adverse Event|1|||
124723000|NCT02712983|448609680|FG003|Treatment Phase|Adverse Event|4|||
124723001|NCT02712983|448609681|FG004|Treatment Phase|Adverse Event|3|||
124723002|NCT02712983|448609682|FG005|Treatment Phase|Adverse Event|0|||
124723003|NCT02712983|448609683|FG006|Treatment Phase|Adverse Event|6|||
124723004|NCT02712983|448609684|FG007|Treatment Phase|Adverse Event|6|||
124723005|NCT02712983|448609685|FG008|Treatment Phase|Adverse Event|1|||
124723006|NCT02712983|448609677|FG000|Treatment Phase|Protocol Deviation|0|||
124723007|NCT02712983|448609678|FG001|Treatment Phase|Protocol Deviation|0|||
124723008|NCT02712983|448609679|FG002|Treatment Phase|Protocol Deviation|0|||
124723009|NCT02712983|448609680|FG003|Treatment Phase|Protocol Deviation|2|||
124723010|NCT02712983|448609681|FG004|Treatment Phase|Protocol Deviation|0|||
124723011|NCT02712983|448609682|FG005|Treatment Phase|Protocol Deviation|0|||
124723012|NCT02712983|448609683|FG006|Treatment Phase|Protocol Deviation|1|||
124723013|NCT02712983|448609684|FG007|Treatment Phase|Protocol Deviation|0|||
124723014|NCT02712983|448609685|FG008|Treatment Phase|Protocol Deviation|0|||
124723015|NCT02712983|448609677|FG000|Treatment Phase|Technical Problems|0|||
124723016|NCT02712983|448609678|FG001|Treatment Phase|Technical Problems|0|||
124723017|NCT02712983|448609679|FG002|Treatment Phase|Technical Problems|0|||
124723018|NCT02712983|448609680|FG003|Treatment Phase|Technical Problems|0|||
124723019|NCT02712983|448609681|FG004|Treatment Phase|Technical Problems|0|||
124723020|NCT02712983|448609682|FG005|Treatment Phase|Technical Problems|0|||
124495619|NCT02518620|447767948|FG001|Overall Study|Pregnancy|0|||
124495620|NCT02518620|447767947|FG000|Overall Study|Relocation|2|||
124495621|NCT02518620|447767948|FG001|Overall Study|Relocation|1|||
124495622|NCT00085540|447767949|FG000|Overall Study|Withdrawal by Subject|0|||
124495623|NCT00085540|447767950|FG001|Overall Study|Withdrawal by Subject|1|||
124495624|NCT00085540|447767949|FG000|Overall Study|Protocol Violation|0|||
124495625|NCT00085540|447767950|FG001|Overall Study|Protocol Violation|1|||
124495626|NCT01605396|447767951|FG000|Overall Study|Adverse Event|5|||
124495627|NCT01605396|447767952|FG001|Overall Study|Adverse Event|3|||
124495628|NCT01605396|447767951|FG000|Overall Study|Lost to Follow-up|1|||
124495629|NCT01605396|447767952|FG001|Overall Study|Lost to Follow-up|0|||
124495630|NCT01605396|447767951|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124495631|NCT01605396|447767952|FG001|Overall Study|Non-Compliance With Study Drug|1|||
124495632|NCT01605396|447767951|FG000|Overall Study|Physician Decision|2|||
124495633|NCT01605396|447767952|FG001|Overall Study|Physician Decision|2|||
124495634|NCT01605396|447767951|FG000|Overall Study|Progressive Disease|23|||
124495635|NCT01605396|447767952|FG001|Overall Study|Progressive Disease|27|||
124495636|NCT01605396|447767951|FG000|Overall Study|Withdrawal by Subject|4|||
124495637|NCT01605396|447767952|FG001|Overall Study|Withdrawal by Subject|2|||
124495638|NCT01605396|447767951|FG000|Overall Study|Transfer Off Study|4|||
124495639|NCT01605396|447767952|FG001|Overall Study|Transfer Off Study|5|||
124495640|NCT04267562|447769963|FG000|Assessed for Eligibility|Screen Failure|64|||
124495641|NCT04267562|447769963|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
124495642|NCT04267562|447769963|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
124495643|NCT04267562|447769963|FG000|Assessed for Eligibility|Site closure|6|||
124495644|NCT04267562|447769963|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
124495645|NCT04267562|447769963|FG000|Assessed for Eligibility|Physician Decision|1|||
124495646|NCT04267562|447769963|FG000|Month 24|Elective hysterectomy|1|||
124495647|NCT04267562|447769963|FG000|Month 24|Lost to Follow-up|1|||
124495648|NCT04267562|447769963|FG000|Month 36|Elective hysterectomy|2|||
124495649|NCT04267562|447769963|FG000|Month 36|Lost to Follow-up|3|||
124495650|NCT03009539|447769964|FG000|Overall Study|Lost to Follow-up|132|||
124495651|NCT03009539|447769965|FG001|Overall Study|Lost to Follow-up|113|||
124723021|NCT02712983|448609683|FG006|Treatment Phase|Technical Problems|1|||
124723022|NCT02712983|448609684|FG007|Treatment Phase|Technical Problems|0|||
124723023|NCT02712983|448609685|FG008|Treatment Phase|Technical Problems|0|||
124723024|NCT02712983|448609677|FG000|Treatment Phase|Physician Decision|0|||
124773105|NCT02760498|448798846|FG002|Overall Study|Other than specified|0|||
124773106|NCT02760498|448798847|FG003|Overall Study|Other than specified|3|||
124495652|NCT03009539|447769966|FG002|Overall Study|Lost to Follow-up|132|||
124495653|NCT03009539|447769967|FG003|Overall Study|Lost to Follow-up|113|||
124495654|NCT03151148|447769968|FG000|Overall Study|Lost to Follow-up|1|||
124495655|NCT03151148|447769969|FG001|Overall Study|Lost to Follow-up|0|||
124495656|NCT03151148|447769968|FG000|Overall Study|Withdrawal by Subject|1|||
124495657|NCT03151148|447769969|FG001|Overall Study|Withdrawal by Subject|0|||
124558200|NCT00323609|448001417|FG003|Overall Study|Withdrawal by Subject|4|||
124558201|NCT00323609|448001414|FG000|Overall Study|Other non-VCF-related medical condition|3|||
124558202|NCT00323609|448001415|FG001|Overall Study|Other non-VCF-related medical condition|2|||
124558203|NCT00323609|448001416|FG002|Overall Study|Other non-VCF-related medical condition|0|||
124558204|NCT00323609|448001417|FG003|Overall Study|Other non-VCF-related medical condition|0|||
124558205|NCT00323609|448001414|FG000|Overall Study|Sponsor discontinued trial|29|||
124558206|NCT00323609|448001415|FG001|Overall Study|Sponsor discontinued trial|29|||
124558207|NCT00323609|448001416|FG002|Overall Study|Sponsor discontinued trial|0|||
124558208|NCT00323609|448001417|FG003|Overall Study|Sponsor discontinued trial|0|||
124558209|NCT00323609|448001414|FG000|Overall Study|Unrelenting or severe back pain|1|||
124558210|NCT00323609|448001415|FG001|Overall Study|Unrelenting or severe back pain|1|||
124558211|NCT00323609|448001416|FG002|Overall Study|Unrelenting or severe back pain|0|||
124558212|NCT00323609|448001417|FG003|Overall Study|Unrelenting or severe back pain|0|||
124558213|NCT00323609|448001414|FG000|Overall Study|Logistical withdrawal|9|||
124558214|NCT00323609|448001415|FG001|Overall Study|Logistical withdrawal|5|||
124558215|NCT00323609|448001416|FG002|Overall Study|Logistical withdrawal|0|||
124558216|NCT00323609|448001417|FG003|Overall Study|Logistical withdrawal|1|||
124558217|NCT00323609|448001414|FG000|Overall Study|Other reason|11|||
124558218|NCT00323609|448001415|FG001|Overall Study|Other reason|8|||
124558219|NCT00323609|448001416|FG002|Overall Study|Other reason|4|||
124558220|NCT00323609|448001417|FG003|Overall Study|Other reason|9|||
124558221|NCT02217345|448001421|FG000|Overall Study|Lost to Follow-up|2|||
124558222|NCT02217345|448001422|FG001|Overall Study|Lost to Follow-up|1|||
124558223|NCT02217345|448001421|FG000|Overall Study|Withdrawal by Subject|3|||
124558224|NCT02217345|448001422|FG001|Overall Study|Withdrawal by Subject|2|||
124558225|NCT02217345|448001421|FG000|Overall Study|Adverse Event|2|||
124558226|NCT02217345|448001422|FG001|Overall Study|Adverse Event|1|||
124558227|NCT02217345|448001421|FG000|Overall Study|Physician Decision|0|||
124558228|NCT02217345|448001422|FG001|Overall Study|Physician Decision|1|||
124558229|NCT00950599|448001424|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
124558230|NCT00950599|448001425|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
124558231|NCT00950599|448001426|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
124558232|NCT00950599|448001427|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
124558233|NCT00950599|448001428|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
124558234|NCT00950599|448001429|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
124558235|NCT00950599|448001430|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
124558236|NCT00950599|448001431|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
124558237|NCT00950599|448001432|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
124558238|NCT00950599|448001433|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
124558239|NCT00950599|448001424|FG000|Double-Blind Treatment Period|Adverse Event|0|||
124558240|NCT00950599|448001425|FG001|Double-Blind Treatment Period|Adverse Event|1|||
124558241|NCT00950599|448001426|FG002|Double-Blind Treatment Period|Adverse Event|1|||
124558242|NCT00950599|448001427|FG003|Double-Blind Treatment Period|Adverse Event|1|||
124558243|NCT00950599|448001428|FG004|Double-Blind Treatment Period|Adverse Event|1|||
124558244|NCT00950599|448001429|FG005|Double-Blind Treatment Period|Adverse Event|1|||
124558245|NCT00950599|448001430|FG006|Double-Blind Treatment Period|Adverse Event|0|||
124558246|NCT00950599|448001431|FG007|Double-Blind Treatment Period|Adverse Event|0|||
124558247|NCT00950599|448001432|FG008|Double-Blind Treatment Period|Adverse Event|0|||
124558248|NCT00950599|448001433|FG009|Double-Blind Treatment Period|Adverse Event|0|||
124558249|NCT00950599|448001424|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
124558250|NCT00950599|448001425|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
124723025|NCT02712983|448609678|FG001|Treatment Phase|Physician Decision|0|||
124723026|NCT02712983|448609679|FG002|Treatment Phase|Physician Decision|0|||
124723027|NCT02712983|448609680|FG003|Treatment Phase|Physician Decision|0|||
124723028|NCT02712983|448609681|FG004|Treatment Phase|Physician Decision|0|||
124723029|NCT02712983|448609682|FG005|Treatment Phase|Physician Decision|0|||
124723030|NCT02712983|448609683|FG006|Treatment Phase|Physician Decision|0|||
124723031|NCT02712983|448609684|FG007|Treatment Phase|Physician Decision|1|||
124723032|NCT02712983|448609685|FG008|Treatment Phase|Physician Decision|1|||
124723033|NCT02712983|448609677|FG000|Treatment Phase|Subject Decision|2|||
124723034|NCT02712983|448609678|FG001|Treatment Phase|Subject Decision|0|||
124723035|NCT02712983|448609679|FG002|Treatment Phase|Subject Decision|0|||
124723036|NCT02712983|448609680|FG003|Treatment Phase|Subject Decision|2|||
124723037|NCT02712983|448609681|FG004|Treatment Phase|Subject Decision|1|||
124558251|NCT00950599|448001426|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
124558252|NCT00950599|448001427|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
124558253|NCT00950599|448001428|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
124558254|NCT00950599|448001429|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
124558255|NCT00950599|448001430|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
124558256|NCT00950599|448001431|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
124723038|NCT02712983|448609682|FG005|Treatment Phase|Subject Decision|0|||
124723039|NCT02712983|448609683|FG006|Treatment Phase|Subject Decision|1|||
124558257|NCT00950599|448001432|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
124558258|NCT00950599|448001433|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
124558259|NCT00950599|448001424|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124558260|NCT00950599|448001425|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
124558261|NCT00950599|448001426|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
124558262|NCT00950599|448001427|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
124558263|NCT00950599|448001428|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
124558264|NCT00950599|448001429|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
124558265|NCT00950599|448001430|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
124558266|NCT00950599|448001431|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
124558267|NCT00950599|448001432|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
124558268|NCT00950599|448001433|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
124558269|NCT00950599|448001424|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
124558270|NCT00950599|448001425|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
124558271|NCT00950599|448001426|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
124558272|NCT00950599|448001427|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
124558273|NCT00950599|448001428|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
124558274|NCT00950599|448001429|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
124558275|NCT00950599|448001430|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
124558276|NCT00950599|448001431|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
124773107|NCT02760498|448798848|FG004|Overall Study|Other than specified|1|||
124773108|NCT02760498|448798849|FG005|Overall Study|Other than specified|0|||
124558277|NCT00950599|448001432|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
124558278|NCT00950599|448001433|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
124558279|NCT00950599|448001424|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
124558280|NCT00950599|448001425|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
124558281|NCT00950599|448001426|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
124558282|NCT00950599|448001427|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
124558283|NCT00950599|448001428|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
124558284|NCT00950599|448001429|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
124558285|NCT00950599|448001430|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
124558286|NCT00950599|448001431|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
124558287|NCT00950599|448001432|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
124558288|NCT00950599|448001433|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
124558289|NCT00950599|448001424|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
124558290|NCT00950599|448001425|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
124558291|NCT00950599|448001426|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
124558292|NCT00950599|448001427|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
124558293|NCT00950599|448001428|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
124558294|NCT00950599|448001429|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
124773109|NCT02760498|448798844|FG000|Overall Study|Not treated|0|||
124773110|NCT02760498|448798845|FG001|Overall Study|Not treated|0|||
124773111|NCT02760498|448798846|FG002|Overall Study|Not treated|0|||
124773112|NCT02760498|448798847|FG003|Overall Study|Not treated|0|||
124773113|NCT02760498|448798848|FG004|Overall Study|Not treated|0|||
124495658|NCT00494871|447769970|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
124495659|NCT00494871|447769971|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
124495660|NCT00494871|447769970|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
124495661|NCT00494871|447769971|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
124495662|NCT00494871|447769970|FG000|Double-blind (DB) Treatment Period|Death|8|||
124495663|NCT00494871|447769971|FG001|Double-blind (DB) Treatment Period|Death|3|||
124495664|NCT00494871|447769970|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
124495665|NCT00494871|447769971|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
124495666|NCT00494871|447769970|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
124495667|NCT00494871|447769971|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
124495668|NCT00494871|447769970|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
124495669|NCT00494871|447769971|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
124495670|NCT00494871|447769970|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
124495671|NCT00494871|447769971|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
124495672|NCT00494871|447769970|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
124495673|NCT00494871|447769971|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
124495674|NCT00494871|447769970|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
124495675|NCT00494871|447769971|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
124495676|NCT00494871|447769970|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
124495677|NCT00494871|447769971|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
124495678|NCT00494871|447769970|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
124495679|NCT00494871|447769971|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
124773114|NCT02760498|448798849|FG005|Overall Study|Not treated|2|||
124773115|NCT00935584|448798852|FG000|Overall Study|Withdrawal by Subject|9|||
124773116|NCT00935584|448798853|FG001|Overall Study|Withdrawal by Subject|0|||
124773117|NCT00935584|448798852|FG000|Overall Study|Death|3|||
124773118|NCT00935584|448798853|FG001|Overall Study|Death|0|||
124773119|NCT00935584|448798852|FG000|Overall Study|Lost to Follow-up|8|||
124773120|NCT00935584|448798853|FG001|Overall Study|Lost to Follow-up|0|||
124773121|NCT00935584|448798852|FG000|Overall Study|No show|9|||
124773122|NCT00935584|448798853|FG001|Overall Study|No show|0|||
124773123|NCT00935584|448798852|FG000|Overall Study|Relocated|3|||
124773124|NCT00935584|448798853|FG001|Overall Study|Relocated|0|||
124773125|NCT00935584|448798852|FG000|Overall Study|Patient changed provider|3|||
124773126|NCT00935584|448798853|FG001|Overall Study|Patient changed provider|0|||
124773127|NCT00935584|448798852|FG000|Overall Study|Provider dropped out of study|14|||
124773128|NCT00935584|448798853|FG001|Overall Study|Provider dropped out of study|4|||
124773129|NCT00687193|448798854|FG000|Overall Study|Adverse Event|0|||
124773130|NCT00687193|448798855|FG001|Overall Study|Adverse Event|1|||
124773131|NCT00687193|448798856|FG002|Overall Study|Adverse Event|2|||
124773132|NCT00687193|448798857|FG003|Overall Study|Adverse Event|3|||
124773133|NCT00687193|448798858|FG004|Overall Study|Adverse Event|0|||
124773134|NCT00687193|448798859|FG005|Overall Study|Adverse Event|2|||
124773135|NCT00687193|448798854|FG000|Overall Study|Lack of Efficacy|1|||
124773136|NCT00687193|448798855|FG001|Overall Study|Lack of Efficacy|1|||
124773137|NCT00687193|448798856|FG002|Overall Study|Lack of Efficacy|0|||
124773138|NCT00687193|448798857|FG003|Overall Study|Lack of Efficacy|0|||
124773139|NCT00687193|448798858|FG004|Overall Study|Lack of Efficacy|0|||
124773140|NCT00687193|448798859|FG005|Overall Study|Lack of Efficacy|2|||
124773141|NCT00687193|448798854|FG000|Overall Study|Protocol Violation|1|||
124773142|NCT00687193|448798855|FG001|Overall Study|Protocol Violation|2|||
124773143|NCT00687193|448798856|FG002|Overall Study|Protocol Violation|0|||
124773144|NCT00687193|448798857|FG003|Overall Study|Protocol Violation|1|||
124773145|NCT00687193|448798858|FG004|Overall Study|Protocol Violation|2|||
124773146|NCT00687193|448798859|FG005|Overall Study|Protocol Violation|0|||
124773147|NCT03534804|448798860|FG000|Overall Study|Withdrawal by Subject|1|||
124773148|NCT04986904|448798861|FG000|Overall Study|Lost to Follow-up|11|||
124773149|NCT04986904|448798861|FG000|Overall Study|Withdrawal by Subject|1|||
124773150|NCT00174187|448798862|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
124773151|NCT00174187|448798863|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
124773152|NCT00174187|448798864|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
124773153|NCT00174187|448798862|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
124773154|NCT00174187|448798863|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
124773155|NCT00174187|448798864|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
124773156|NCT00174187|448798862|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
124773157|NCT00174187|448798863|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
124773158|NCT00174187|448798864|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
124773159|NCT00174187|448798862|FG000|Period 1 (up to 3 Years)|Other|0|||
124773160|NCT00174187|448798863|FG001|Period 1 (up to 3 Years)|Other|1|||
124773161|NCT00174187|448798864|FG002|Period 1 (up to 3 Years)|Other|0|||
124773162|NCT00174187|448798862|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
124773163|NCT00174187|448798863|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
124773164|NCT00174187|448798864|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
124773165|NCT00174187|448798862|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
124773166|NCT00174187|448798863|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
124773167|NCT00174187|448798864|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
124773168|NCT00174187|448798862|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
124773169|NCT00174187|448798863|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
124773170|NCT00174187|448798864|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
124773171|NCT00174187|448798862|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
124773172|NCT00174187|448798863|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
124773173|NCT00174187|448798864|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
124773174|NCT00174187|448798862|FG000|Period 2 (After 3 Years)|Other|0|||
124495680|NCT00494871|447769970|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
124495681|NCT00494871|447769971|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
124495682|NCT00494871|447769970|FG000|Follow-up (FU) Period|Adverse Event|1|||
124773175|NCT00174187|448798863|FG001|Period 2 (After 3 Years)|Other|0|||
124773176|NCT00174187|448798864|FG002|Period 2 (After 3 Years)|Other|5|||
124773177|NCT03435211|448798865|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
124773178|NCT00759941|448798866|FG000|Overall Study|Use of medication|1|||
124773179|NCT00759941|448798867|FG001|Overall Study|Use of medication|0|||
124773180|NCT00759941|448798866|FG000|Overall Study|Adverse Event|1|||
124495683|NCT00494871|447769971|FG001|Follow-up (FU) Period|Adverse Event|1|||
124495684|NCT00494871|447769970|FG000|Follow-up (FU) Period|Death|13|||
124773181|NCT00759941|448798867|FG001|Overall Study|Adverse Event|0|||
124773182|NCT00759941|448798866|FG000|Overall Study|Exited in error by site|1|||
124773183|NCT00759941|448798867|FG001|Overall Study|Exited in error by site|1|||
124723040|NCT02712983|448609684|FG007|Treatment Phase|Subject Decision|2|||
124723041|NCT02712983|448609685|FG008|Treatment Phase|Subject Decision|0|||
124723042|NCT02712983|448609677|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
124495685|NCT00494871|447769971|FG001|Follow-up (FU) Period|Death|12|||
124495686|NCT00494871|447769970|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
124495687|NCT00494871|447769971|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
124495688|NCT00494871|447769970|FG000|Follow-up (FU) Period|Physician Decision|0|||
124495689|NCT00494871|447769971|FG001|Follow-up (FU) Period|Physician Decision|1|||
124495690|NCT00494871|447769970|FG000|Follow-up (FU) Period|Protocol Violation|1|||
124495691|NCT00494871|447769971|FG001|Follow-up (FU) Period|Protocol Violation|0|||
124495692|NCT00494871|447769970|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
124495693|NCT00494871|447769971|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
124495694|NCT00494871|447769970|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
124495695|NCT00494871|447769971|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
124495696|NCT04543955|447769972|FG000|Overall Study|Company cancelled study|1|||
124495697|NCT04543955|447769973|FG001|Overall Study|Company cancelled study|0|||
124495698|NCT02433210|447769977|FG000|Overall Study|Physician Decision|1|||
124495699|NCT02433210|447769978|FG001|Overall Study|Physician Decision|0|||
124495700|NCT02433210|447769979|FG002|Overall Study|Physician Decision|0|||
124495701|NCT02090114|447769980|FG000|Overall Study|Withdrawal by Subject|3|||
124495702|NCT02090114|447769981|FG001|Overall Study|Withdrawal by Subject|6|||
124495703|NCT02090114|447769982|FG002|Overall Study|Withdrawal by Subject|2|||
124495704|NCT02090114|447769983|FG003|Overall Study|Withdrawal by Subject|1|||
124495705|NCT02090114|447769980|FG000|Overall Study|Physician Decision|5|||
124495706|NCT02090114|447769981|FG001|Overall Study|Physician Decision|0|||
124495707|NCT02090114|447769982|FG002|Overall Study|Physician Decision|1|||
124495708|NCT02090114|447769983|FG003|Overall Study|Physician Decision|1|||
124495709|NCT02090114|447769980|FG000|Overall Study|Adverse Event|1|||
124495710|NCT02090114|447769981|FG001|Overall Study|Adverse Event|2|||
124495711|NCT02090114|447769982|FG002|Overall Study|Adverse Event|2|||
124495712|NCT02090114|447769983|FG003|Overall Study|Adverse Event|0|||
124495713|NCT02090114|447769980|FG000|Overall Study|Progressive Disease|20|||
124495714|NCT02090114|447769981|FG001|Overall Study|Progressive Disease|21|||
124495715|NCT02090114|447769982|FG002|Overall Study|Progressive Disease|23|||
124495716|NCT02090114|447769983|FG003|Overall Study|Progressive Disease|6|||
124495717|NCT02090114|447769980|FG000|Overall Study|Death|1|||
124495718|NCT02090114|447769981|FG001|Overall Study|Death|0|||
124495719|NCT02090114|447769982|FG002|Overall Study|Death|1|||
124495720|NCT02090114|447769983|FG003|Overall Study|Death|0|||
124495721|NCT01989546|447769988|FG000|Overall Study|Clinical Progression|1|||
124495722|NCT01989546|447769988|FG000|Overall Study|Disease progression on study|8|||
124495723|NCT01958671|447769989|FG000|Overall Study|Adverse Event|1|||
124495724|NCT01958671|447769990|FG001|Overall Study|Adverse Event|1|||
124495725|NCT01958671|447769991|FG002|Overall Study|Adverse Event|5|||
124495726|NCT01958671|447769989|FG000|Overall Study|Death|1|||
124495727|NCT01958671|447769990|FG001|Overall Study|Death|0|||
124495728|NCT01958671|447769991|FG002|Overall Study|Death|0|||
124495729|NCT01958671|447769989|FG000|Overall Study|Excluded medication|0|||
124495730|NCT01958671|447769990|FG001|Overall Study|Excluded medication|0|||
124495731|NCT01958671|447769991|FG002|Overall Study|Excluded medication|1|||
124723043|NCT02712983|448609678|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
124723044|NCT02712983|448609679|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
124723045|NCT02712983|448609680|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
124723046|NCT02712983|448609681|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
124723047|NCT02712983|448609682|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
124723048|NCT02712983|448609683|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
124723049|NCT02712983|448609684|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
124723050|NCT02712983|448609685|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
124723051|NCT02712983|448609677|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
124723052|NCT02712983|448609678|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
124723053|NCT02712983|448609679|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
124495732|NCT01958671|447769989|FG000|Overall Study|Hyperglycemia|0|||
124495733|NCT01958671|447769990|FG001|Overall Study|Hyperglycemia|0|||
124495734|NCT01958671|447769991|FG002|Overall Study|Hyperglycemia|2|||
124495735|NCT01958671|447769989|FG000|Overall Study|Lost to Follow-up|7|||
124495736|NCT01958671|447769990|FG001|Overall Study|Lost to Follow-up|11|||
124495737|NCT01958671|447769991|FG002|Overall Study|Lost to Follow-up|7|||
124495738|NCT01958671|447769989|FG000|Overall Study|Non-compliance with study drug|1|||
124495739|NCT01958671|447769990|FG001|Overall Study|Non-compliance with study drug|1|||
124495740|NCT01958671|447769991|FG002|Overall Study|Non-compliance with study drug|1|||
124495741|NCT01958671|447769989|FG000|Overall Study|Pregnancy|0|||
124495742|NCT01958671|447769990|FG001|Overall Study|Pregnancy|0|||
124495743|NCT01958671|447769991|FG002|Overall Study|Pregnancy|1|||
124495744|NCT01958671|447769989|FG000|Overall Study|Protocol Violation|0|||
124495745|NCT01958671|447769990|FG001|Overall Study|Protocol Violation|1|||
124495746|NCT01958671|447769991|FG002|Overall Study|Protocol Violation|0|||
124723054|NCT02712983|448609680|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
124723055|NCT02712983|448609681|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
124723056|NCT02712983|448609682|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
124723057|NCT02712983|448609683|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
124723058|NCT02712983|448609684|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
124723059|NCT02712983|448609685|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
124723060|NCT02712983|448609677|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
124723061|NCT02712983|448609678|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
124723062|NCT02712983|448609679|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
124723063|NCT02712983|448609680|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
124723064|NCT02712983|448609681|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
124723065|NCT02712983|448609682|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
124723066|NCT02712983|448609683|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
124723067|NCT02712983|448609684|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
124723068|NCT02712983|448609685|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
124723069|NCT02954406|448609686|FG000|Overall Study|Adverse Event|0|||
124723070|NCT02954406|448609687|FG001|Overall Study|Adverse Event|1|||
124723071|NCT02954406|448609688|FG002|Overall Study|Adverse Event|0|||
124723072|NCT02954406|448609689|FG003|Overall Study|Adverse Event|0|||
124723073|NCT02954406|448609690|FG004|Overall Study|Adverse Event|1|||
124723074|NCT02954406|448609691|FG005|Overall Study|Adverse Event|0|||
124723075|NCT02954406|448609692|FG006|Overall Study|Adverse Event|0|||
124723076|NCT02954406|448609693|FG007|Overall Study|Adverse Event|0|||
124723077|NCT02954406|448609694|FG008|Overall Study|Adverse Event|1|||
124723078|NCT02954406|448609695|FG009|Overall Study|Adverse Event|1|||
124723079|NCT02954406|448609696|FG010|Overall Study|Adverse Event|0|||
124723080|NCT02954406|448609686|FG000|Overall Study|Progressive Disease|3|||
124723081|NCT02954406|448609687|FG001|Overall Study|Progressive Disease|4|||
124723082|NCT02954406|448609688|FG002|Overall Study|Progressive Disease|3|||
124723083|NCT02954406|448609689|FG003|Overall Study|Progressive Disease|4|||
124723084|NCT02954406|448609690|FG004|Overall Study|Progressive Disease|3|||
124723085|NCT02954406|448609691|FG005|Overall Study|Progressive Disease|3|||
124723086|NCT02954406|448609692|FG006|Overall Study|Progressive Disease|2|||
124723087|NCT02954406|448609693|FG007|Overall Study|Progressive Disease|2|||
124723088|NCT02954406|448609694|FG008|Overall Study|Progressive Disease|1|||
124723089|NCT02954406|448609695|FG009|Overall Study|Progressive Disease|1|||
124723090|NCT02954406|448609696|FG010|Overall Study|Progressive Disease|0|||
124723091|NCT02954406|448609686|FG000|Overall Study|Symptomatic Deterioration|0|||
124723092|NCT02954406|448609687|FG001|Overall Study|Symptomatic Deterioration|1|||
124723093|NCT02954406|448609688|FG002|Overall Study|Symptomatic Deterioration|0|||
124723094|NCT02954406|448609689|FG003|Overall Study|Symptomatic Deterioration|0|||
124723095|NCT02954406|448609690|FG004|Overall Study|Symptomatic Deterioration|0|||
124723096|NCT02954406|448609691|FG005|Overall Study|Symptomatic Deterioration|0|||
124723097|NCT02954406|448609692|FG006|Overall Study|Symptomatic Deterioration|0|||
124723098|NCT02954406|448609693|FG007|Overall Study|Symptomatic Deterioration|0|||
124723099|NCT02954406|448609694|FG008|Overall Study|Symptomatic Deterioration|0|||
124723100|NCT02954406|448609695|FG009|Overall Study|Symptomatic Deterioration|0|||
124723101|NCT02954406|448609696|FG010|Overall Study|Symptomatic Deterioration|0|||
124723102|NCT02954406|448609686|FG000|Overall Study|Death|0|||
124723103|NCT02954406|448609687|FG001|Overall Study|Death|0|||
124723104|NCT02954406|448609688|FG002|Overall Study|Death|0|||
124723105|NCT02954406|448609689|FG003|Overall Study|Death|0|||
124723106|NCT02954406|448609690|FG004|Overall Study|Death|1|||
124723107|NCT02954406|448609691|FG005|Overall Study|Death|0|||
124723108|NCT02954406|448609692|FG006|Overall Study|Death|0|||
124723109|NCT02954406|448609693|FG007|Overall Study|Death|0|||
124723110|NCT02954406|448609694|FG008|Overall Study|Death|1|||
124723111|NCT02954406|448609695|FG009|Overall Study|Death|1|||
124723112|NCT02954406|448609696|FG010|Overall Study|Death|0|||
124723113|NCT02954406|448609686|FG000|Overall Study|Reason Not Specified|0|||
124723114|NCT02954406|448609687|FG001|Overall Study|Reason Not Specified|0|||
124495747|NCT01958671|447769989|FG000|Overall Study|Study site terminated by sponsor|1|||
124495748|NCT01958671|447769990|FG001|Overall Study|Study site terminated by sponsor|0|||
124723115|NCT02954406|448609688|FG002|Overall Study|Reason Not Specified|3|||
124723116|NCT02954406|448609689|FG003|Overall Study|Reason Not Specified|2|||
124723117|NCT02954406|448609690|FG004|Overall Study|Reason Not Specified|2|||
124723118|NCT02954406|448609691|FG005|Overall Study|Reason Not Specified|0|||
124723119|NCT02954406|448609692|FG006|Overall Study|Reason Not Specified|1|||
124723120|NCT02954406|448609693|FG007|Overall Study|Reason Not Specified|0|||
124723121|NCT02954406|448609694|FG008|Overall Study|Reason Not Specified|1|||
124723122|NCT02954406|448609695|FG009|Overall Study|Reason Not Specified|0|||
124723123|NCT02954406|448609696|FG010|Overall Study|Reason Not Specified|0|||
124495749|NCT01958671|447769991|FG002|Overall Study|Study site terminated by sponsor|1|||
124495750|NCT01958671|447769989|FG000|Overall Study|Participant moved|0|||
124723124|NCT05360966|448609697|FG000|Overall Study|Adverse Event|5|||
124723125|NCT05360966|448609698|FG001|Overall Study|Adverse Event|5|||
124723126|NCT05360966|448609697|FG000|Overall Study|Withdrawal of Consent|5|||
124723127|NCT05360966|448609698|FG001|Overall Study|Withdrawal of Consent|3|||
124723128|NCT05360966|448609697|FG000|Overall Study|Noncompliance|2|||
124723129|NCT05360966|448609698|FG001|Overall Study|Noncompliance|1|||
124723130|NCT05360966|448609697|FG000|Overall Study|Lost to Follow-up|2|||
124723131|NCT05360966|448609698|FG001|Overall Study|Lost to Follow-up|3|||
124723132|NCT05360966|448609697|FG000|Overall Study|Protocol Deviation|2|||
124723133|NCT05360966|448609698|FG001|Overall Study|Protocol Deviation|1|||
124723134|NCT05360966|448609697|FG000|Overall Study|As specified in the Clinical Study Report|1|||
124723135|NCT05360966|448609698|FG001|Overall Study|As specified in the Clinical Study Report|3|||
124723136|NCT03522246|448609699|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
124723137|NCT03522246|448609700|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
124723138|NCT03522246|448609701|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
124723139|NCT03522246|448609702|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
124723140|NCT03522246|448609703|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
124723141|NCT04683029|448609704|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
124723142|NCT04683029|448609705|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
124723143|NCT04683029|448609706|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
124723144|NCT04683029|448609707|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
124723145|NCT04683029|448609704|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
124723146|NCT04683029|448609705|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
124723147|NCT04683029|448609706|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
124723148|NCT04683029|448609707|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
124723149|NCT04683029|448609704|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
124723150|NCT04683029|448609705|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
124723151|NCT04683029|448609706|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
124723152|NCT04683029|448609707|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
124723153|NCT00814580|448609709|FG000|Overall Study|Adverse Event|6|||
124723154|NCT00814580|448609710|FG001|Overall Study|Adverse Event|15|||
124723155|NCT00814580|448609709|FG000|Overall Study|Lack of Efficacy|18|||
124723156|NCT00814580|448609710|FG001|Overall Study|Lack of Efficacy|25|||
124723157|NCT00814580|448609709|FG000|Overall Study|Protocol Violation|2|||
124723158|NCT00814580|448609710|FG001|Overall Study|Protocol Violation|0|||
124723159|NCT00814580|448609709|FG000|Overall Study|Withdrawal by Subject|2|||
124723160|NCT00814580|448609710|FG001|Overall Study|Withdrawal by Subject|2|||
124723161|NCT00814580|448609709|FG000|Overall Study|Other|1|||
124723162|NCT00814580|448609710|FG001|Overall Study|Other|3|||
124723163|NCT00814580|448609709|FG000|Overall Study|Did Not Take Drug|2|||
124723164|NCT00814580|448609710|FG001|Overall Study|Did Not Take Drug|2|||
124723165|NCT05924165|448609720|FG000|Overall Study|Physician Decision|2|||
124723166|NCT05924165|448609721|FG001|Overall Study|Physician Decision|3|||
124723167|NCT04075292|448609722|FG000|Overall Study|Withdrawal by Subject|1|||
124723168|NCT04075292|448609723|FG001|Overall Study|Withdrawal by Subject|9|||
124723169|NCT04075292|448609722|FG000|Overall Study|Death|2|||
124723170|NCT04075292|448609723|FG001|Overall Study|Death|5|||
124723171|NCT04075292|448609722|FG000|Overall Study|Remained on study at time of DCO|74|||
124723172|NCT04075292|448609723|FG001|Overall Study|Remained on study at time of DCO|64|||
124723173|NCT04308239|448609724|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
124723174|NCT04308239|448609725|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
124723175|NCT04308239|448609724|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
124723176|NCT04308239|448609725|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
124723177|NCT04308239|448609724|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
124723178|NCT04308239|448609725|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
124723179|NCT04308239|448609724|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
124723180|NCT04308239|448609725|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
124723181|NCT00459875|448609728|FG000|Overall Study|Ineligible participant|1|||
124723182|NCT00459875|448609728|FG000|Overall Study|Adverse Event|2|||
124723183|NCT01436656|448609733|FG000|Dose Escalation|Death|1|||
124723184|NCT01436656|448609734|FG001|Dose Escalation|Death|3|||
124723185|NCT01436656|448609735|FG002|Dose Escalation|Death|1|||
124723186|NCT01436656|448609736|FG003|Dose Escalation|Death|0|||
124723187|NCT01436656|448609737|FG004|Dose Escalation|Death|2|||
124723188|NCT01436656|448609738|FG005|Dose Escalation|Death|1|||
124723189|NCT01436656|448609739|FG006|Dose Escalation|Death|1|||
124723190|NCT01436656|448609740|FG007|Dose Escalation|Death|1|||
124723191|NCT01436656|448609741|FG008|Dose Escalation|Death|1|||
124723192|NCT01436656|448609742|FG009|Dose Escalation|Death|0|||
124723193|NCT01436656|448609743|FG010|Dose Escalation|Death|0|||
124723194|NCT01436656|448609744|FG011|Dose Escalation|Death|0|||
124723195|NCT01436656|448609745|FG012|Dose Escalation|Death|0|||
124773184|NCT03863080|448798868|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
124723196|NCT01436656|448609746|FG013|Dose Escalation|Death|0|||
124723197|NCT01436656|448609747|FG014|Dose Escalation|Death|0|||
124773185|NCT03863080|448798869|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
124723198|NCT01436656|448609748|FG015|Dose Escalation|Death|0|||
124723199|NCT01436656|448609749|FG016|Dose Escalation|Death|0|||
124723200|NCT01436656|448609750|FG017|Dose Escalation|Death|0|||
124723201|NCT01436656|448609733|FG000|Dose Escalation|Protocol Violation|0|||
124723202|NCT01436656|448609734|FG001|Dose Escalation|Protocol Violation|0|||
124723203|NCT01436656|448609735|FG002|Dose Escalation|Protocol Violation|0|||
124723204|NCT01436656|448609736|FG003|Dose Escalation|Protocol Violation|0|||
124723205|NCT01436656|448609737|FG004|Dose Escalation|Protocol Violation|0|||
124723206|NCT01436656|448609738|FG005|Dose Escalation|Protocol Violation|1|||
124723207|NCT01436656|448609739|FG006|Dose Escalation|Protocol Violation|0|||
124723208|NCT01436656|448609740|FG007|Dose Escalation|Protocol Violation|0|||
124723209|NCT01436656|448609741|FG008|Dose Escalation|Protocol Violation|0|||
124723210|NCT01436656|448609742|FG009|Dose Escalation|Protocol Violation|0|||
124723211|NCT01436656|448609743|FG010|Dose Escalation|Protocol Violation|0|||
124723212|NCT01436656|448609744|FG011|Dose Escalation|Protocol Violation|0|||
124723213|NCT01436656|448609745|FG012|Dose Escalation|Protocol Violation|0|||
124723214|NCT01436656|448609746|FG013|Dose Escalation|Protocol Violation|0|||
124723215|NCT01436656|448609747|FG014|Dose Escalation|Protocol Violation|0|||
124723216|NCT01436656|448609748|FG015|Dose Escalation|Protocol Violation|0|||
124723217|NCT01436656|448609749|FG016|Dose Escalation|Protocol Violation|0|||
124723218|NCT01436656|448609750|FG017|Dose Escalation|Protocol Violation|0|||
124723219|NCT01436656|448609733|FG000|Dose Escalation|Withdrawal by Subject|0|||
124723220|NCT01436656|448609734|FG001|Dose Escalation|Withdrawal by Subject|0|||
124723221|NCT01436656|448609735|FG002|Dose Escalation|Withdrawal by Subject|0|||
124723222|NCT01436656|448609736|FG003|Dose Escalation|Withdrawal by Subject|0|||
124723223|NCT01436656|448609737|FG004|Dose Escalation|Withdrawal by Subject|1|||
124723224|NCT01436656|448609738|FG005|Dose Escalation|Withdrawal by Subject|0|||
124723225|NCT01436656|448609739|FG006|Dose Escalation|Withdrawal by Subject|0|||
124723226|NCT01436656|448609740|FG007|Dose Escalation|Withdrawal by Subject|2|||
124723227|NCT01436656|448609741|FG008|Dose Escalation|Withdrawal by Subject|0|||
124723228|NCT01436656|448609742|FG009|Dose Escalation|Withdrawal by Subject|1|||
124723229|NCT01436656|448609743|FG010|Dose Escalation|Withdrawal by Subject|1|||
124723230|NCT01436656|448609744|FG011|Dose Escalation|Withdrawal by Subject|0|||
124723231|NCT01436656|448609745|FG012|Dose Escalation|Withdrawal by Subject|0|||
124723232|NCT01436656|448609746|FG013|Dose Escalation|Withdrawal by Subject|0|||
124723233|NCT01436656|448609747|FG014|Dose Escalation|Withdrawal by Subject|0|||
124723234|NCT01436656|448609748|FG015|Dose Escalation|Withdrawal by Subject|0|||
124723235|NCT01436656|448609749|FG016|Dose Escalation|Withdrawal by Subject|0|||
124723236|NCT01436656|448609750|FG017|Dose Escalation|Withdrawal by Subject|0|||
124723237|NCT01436656|448609733|FG000|Dose Escalation|Administrative problems|0|||
124723238|NCT01436656|448609734|FG001|Dose Escalation|Administrative problems|1|||
124723239|NCT01436656|448609735|FG002|Dose Escalation|Administrative problems|0|||
124723240|NCT01436656|448609736|FG003|Dose Escalation|Administrative problems|0|||
124723241|NCT01436656|448609737|FG004|Dose Escalation|Administrative problems|0|||
124723242|NCT01436656|448609738|FG005|Dose Escalation|Administrative problems|0|||
124723243|NCT01436656|448609739|FG006|Dose Escalation|Administrative problems|0|||
124723244|NCT01436656|448609740|FG007|Dose Escalation|Administrative problems|0|||
124723245|NCT01436656|448609741|FG008|Dose Escalation|Administrative problems|0|||
124723246|NCT01436656|448609742|FG009|Dose Escalation|Administrative problems|0|||
124723247|NCT01436656|448609743|FG010|Dose Escalation|Administrative problems|0|||
124723248|NCT01436656|448609744|FG011|Dose Escalation|Administrative problems|0|||
124723249|NCT01436656|448609745|FG012|Dose Escalation|Administrative problems|0|||
124723250|NCT01436656|448609746|FG013|Dose Escalation|Administrative problems|0|||
124723251|NCT01436656|448609747|FG014|Dose Escalation|Administrative problems|0|||
124723252|NCT01436656|448609748|FG015|Dose Escalation|Administrative problems|0|||
124723253|NCT01436656|448609749|FG016|Dose Escalation|Administrative problems|0|||
124723254|NCT01436656|448609750|FG017|Dose Escalation|Administrative problems|0|||
124723255|NCT01436656|448609733|FG000|Dose Escalation|Lost to Follow-up|1|||
124723256|NCT01436656|448609734|FG001|Dose Escalation|Lost to Follow-up|0|||
124723257|NCT01436656|448609735|FG002|Dose Escalation|Lost to Follow-up|0|||
124723258|NCT01436656|448609736|FG003|Dose Escalation|Lost to Follow-up|0|||
124723259|NCT01436656|448609737|FG004|Dose Escalation|Lost to Follow-up|1|||
124723260|NCT01436656|448609738|FG005|Dose Escalation|Lost to Follow-up|0|||
124723261|NCT01436656|448609739|FG006|Dose Escalation|Lost to Follow-up|0|||
124723262|NCT01436656|448609740|FG007|Dose Escalation|Lost to Follow-up|0|||
124723263|NCT01436656|448609741|FG008|Dose Escalation|Lost to Follow-up|0|||
124723264|NCT01436656|448609742|FG009|Dose Escalation|Lost to Follow-up|0|||
124723265|NCT01436656|448609743|FG010|Dose Escalation|Lost to Follow-up|0|||
124723266|NCT01436656|448609744|FG011|Dose Escalation|Lost to Follow-up|0|||
124723267|NCT01436656|448609745|FG012|Dose Escalation|Lost to Follow-up|0|||
124723268|NCT01436656|448609746|FG013|Dose Escalation|Lost to Follow-up|0|||
124723269|NCT01436656|448609747|FG014|Dose Escalation|Lost to Follow-up|0|||
124723270|NCT01436656|448609748|FG015|Dose Escalation|Lost to Follow-up|0|||
124723271|NCT01436656|448609749|FG016|Dose Escalation|Lost to Follow-up|0|||
124723272|NCT01436656|448609750|FG017|Dose Escalation|Lost to Follow-up|0|||
124723273|NCT01436656|448609733|FG000|Dose Escalation|New anti-cancer therapy|1|||
124723274|NCT01436656|448609734|FG001|Dose Escalation|New anti-cancer therapy|0|||
124773186|NCT03863080|448798870|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
124773187|NCT03863080|448798871|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
124773188|NCT03863080|448798868|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
124773189|NCT03863080|448798869|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
124773190|NCT03863080|448798870|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
124773191|NCT03863080|448798871|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
124773192|NCT03863080|448798868|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
124773193|NCT03863080|448798869|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
124773194|NCT03863080|448798870|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
124773195|NCT03863080|448798871|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
124773196|NCT01342211|448798872|FG000|Overall Study|Lost to Follow-up|0|||
124773197|NCT01342211|448798873|FG001|Overall Study|Lost to Follow-up|0|||
124773198|NCT01342211|448798874|FG002|Overall Study|Lost to Follow-up|0|||
124773199|NCT01342211|448798875|FG003|Overall Study|Lost to Follow-up|1|||
124773200|NCT01342211|448798876|FG004|Overall Study|Lost to Follow-up|0|||
124773201|NCT01342211|448798872|FG000|Overall Study|Adverse Event|0|||
124773202|NCT01342211|448798873|FG001|Overall Study|Adverse Event|0|||
124773203|NCT01342211|448798874|FG002|Overall Study|Adverse Event|0|||
124773204|NCT01342211|448798875|FG003|Overall Study|Adverse Event|0|||
124773205|NCT01342211|448798876|FG004|Overall Study|Adverse Event|1|||
124773206|NCT01342211|448798872|FG000|Overall Study|Withdrawal by Subject|0|||
124773207|NCT01342211|448798873|FG001|Overall Study|Withdrawal by Subject|0|||
124773208|NCT01342211|448798874|FG002|Overall Study|Withdrawal by Subject|0|||
124773209|NCT01342211|448798875|FG003|Overall Study|Withdrawal by Subject|1|||
124773210|NCT01342211|448798876|FG004|Overall Study|Withdrawal by Subject|0|||
124773211|NCT01342211|448798872|FG000|Overall Study|Randomized, but not Treated|0|||
124773212|NCT01342211|448798873|FG001|Overall Study|Randomized, but not Treated|2|||
124773213|NCT01342211|448798874|FG002|Overall Study|Randomized, but not Treated|0|||
124495751|NCT01958671|447769990|FG001|Overall Study|Participant moved|0|||
124495752|NCT01958671|447769991|FG002|Overall Study|Participant moved|1|||
124495753|NCT01958671|447769989|FG000|Overall Study|Withdrawal by Subject|8|||
124495754|NCT01958671|447769990|FG001|Overall Study|Withdrawal by Subject|10|||
124495755|NCT01958671|447769991|FG002|Overall Study|Withdrawal by Subject|13|||
124495756|NCT01993329|447769992|FG000|Period 2|Adverse Event|0|||
124495757|NCT01993329|447769993|FG001|Period 2|Adverse Event|0|||
124495758|NCT01993329|447769994|FG002|Period 2|Adverse Event|0|||
124495759|NCT01993329|447769995|FG003|Period 2|Adverse Event|0|||
124495760|NCT01993329|447769996|FG004|Period 2|Adverse Event|0|||
124495761|NCT01993329|447769997|FG005|Period 2|Adverse Event|1|||
124495762|NCT01993329|447769992|FG000|Wash-out|Personal reasons|0|||
124495763|NCT01993329|447769993|FG001|Wash-out|Personal reasons|1|||
124495764|NCT01993329|447769994|FG002|Wash-out|Personal reasons|0|||
124495765|NCT01993329|447769995|FG003|Wash-out|Personal reasons|0|||
124495766|NCT01993329|447769996|FG004|Wash-out|Personal reasons|0|||
124495767|NCT01993329|447769997|FG005|Wash-out|Personal reasons|0|||
124495768|NCT02948777|447769998|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
124495769|NCT02311478|447769999|FG000|Overall Study|Withdrawal by Subject|1|||
124495770|NCT02311478|447769999|FG000|Overall Study|Lost to Follow-up|5|||
124495771|NCT02311478|447769999|FG000|Overall Study|Failed IUD Insertion|1|||
124495772|NCT03242928|447770000|FG000|Overall Study|Adverse Event|2|||
124495773|NCT03242928|447770001|FG001|Overall Study|Adverse Event|1|||
124495774|NCT03242928|447770000|FG000|Overall Study|Lost to Follow-up|2|||
124495775|NCT03242928|447770001|FG001|Overall Study|Lost to Follow-up|0|||
124495776|NCT03242928|447770000|FG000|Overall Study|Physician Decision|0|||
124495777|NCT03242928|447770001|FG001|Overall Study|Physician Decision|1|||
124773214|NCT01342211|448798875|FG003|Overall Study|Randomized, but not Treated|0|||
124495778|NCT03242928|447770000|FG000|Overall Study|Withdrawal by Subject|5|||
124495779|NCT03242928|447770001|FG001|Overall Study|Withdrawal by Subject|3|||
124495780|NCT02834403|447770002|FG000|Overall Study|Physician Decision|2|||
124495781|NCT02834403|447770003|FG001|Overall Study|Physician Decision|1|||
124495782|NCT02834403|447770004|FG002|Overall Study|Physician Decision|2|||
124495783|NCT02834403|447770005|FG003|Overall Study|Physician Decision|1|||
124495784|NCT02834403|447770006|FG004|Overall Study|Physician Decision|1|||
124495785|NCT02834403|447770007|FG005|Overall Study|Physician Decision|2|||
124495786|NCT02834403|447770008|FG006|Overall Study|Physician Decision|12|||
124495787|NCT02834403|447770002|FG000|Overall Study|Adverse Event|0|||
124495788|NCT02834403|447770003|FG001|Overall Study|Adverse Event|0|||
124495789|NCT02834403|447770004|FG002|Overall Study|Adverse Event|0|||
124495790|NCT02834403|447770005|FG003|Overall Study|Adverse Event|0|||
124495791|NCT02834403|447770006|FG004|Overall Study|Adverse Event|1|||
124495792|NCT02834403|447770007|FG005|Overall Study|Adverse Event|1|||
124495793|NCT02834403|447770008|FG006|Overall Study|Adverse Event|3|||
124495794|NCT02834403|447770002|FG000|Overall Study|Withdrawal by Subject|0|||
124495795|NCT02834403|447770003|FG001|Overall Study|Withdrawal by Subject|1|||
124773215|NCT01342211|448798876|FG004|Overall Study|Randomized, but not Treated|1|||
124773216|NCT01588522|448798888|FG000|Overall Study|Withdrawal by Subject|1|||
124773217|NCT01588522|448798889|FG001|Overall Study|Withdrawal by Subject|5|||
124773218|NCT01588522|448798890|FG002|Overall Study|Withdrawal by Subject|3|||
124773219|NCT01588522|448798891|FG003|Overall Study|Withdrawal by Subject|1|||
124773220|NCT01588522|448798892|FG004|Overall Study|Withdrawal by Subject|2|||
124773221|NCT01588522|448798893|FG005|Overall Study|Withdrawal by Subject|0|||
124773222|NCT01588522|448798888|FG000|Overall Study|Lack of Efficacy|0|||
124558295|NCT00950599|448001430|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
124558296|NCT00950599|448001431|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
124558297|NCT00950599|448001432|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
124558298|NCT00950599|448001433|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
124558299|NCT00950599|448001424|FG000|Follow-Up Period|Adverse Event|0|||
124558300|NCT00950599|448001425|FG001|Follow-Up Period|Adverse Event|0|||
124558301|NCT00950599|448001426|FG002|Follow-Up Period|Adverse Event|0|||
124558302|NCT00950599|448001427|FG003|Follow-Up Period|Adverse Event|0|||
124558303|NCT00950599|448001428|FG004|Follow-Up Period|Adverse Event|0|||
124558304|NCT00950599|448001429|FG005|Follow-Up Period|Adverse Event|0|||
124558305|NCT00950599|448001430|FG006|Follow-Up Period|Adverse Event|0|||
124558306|NCT00950599|448001431|FG007|Follow-Up Period|Adverse Event|0|||
124558307|NCT00950599|448001432|FG008|Follow-Up Period|Adverse Event|1|||
124558308|NCT00950599|448001433|FG009|Follow-Up Period|Adverse Event|0|||
124558309|NCT00950599|448001424|FG000|Follow-Up Period|Lack of Efficacy|0|||
124558310|NCT00950599|448001425|FG001|Follow-Up Period|Lack of Efficacy|0|||
124558311|NCT00950599|448001426|FG002|Follow-Up Period|Lack of Efficacy|0|||
124558312|NCT00950599|448001427|FG003|Follow-Up Period|Lack of Efficacy|0|||
124558313|NCT00950599|448001428|FG004|Follow-Up Period|Lack of Efficacy|0|||
124558314|NCT00950599|448001429|FG005|Follow-Up Period|Lack of Efficacy|0|||
124558315|NCT00950599|448001430|FG006|Follow-Up Period|Lack of Efficacy|0|||
124558316|NCT00950599|448001431|FG007|Follow-Up Period|Lack of Efficacy|0|||
124558317|NCT00950599|448001432|FG008|Follow-Up Period|Lack of Efficacy|3|||
124558318|NCT00950599|448001433|FG009|Follow-Up Period|Lack of Efficacy|0|||
124558319|NCT00950599|448001424|FG000|Follow-Up Period|Lost to Follow-up|0|||
124558320|NCT00950599|448001425|FG001|Follow-Up Period|Lost to Follow-up|0|||
124558321|NCT00950599|448001426|FG002|Follow-Up Period|Lost to Follow-up|0|||
124558322|NCT00950599|448001427|FG003|Follow-Up Period|Lost to Follow-up|0|||
124558323|NCT00950599|448001428|FG004|Follow-Up Period|Lost to Follow-up|0|||
124558324|NCT00950599|448001429|FG005|Follow-Up Period|Lost to Follow-up|0|||
124558325|NCT00950599|448001430|FG006|Follow-Up Period|Lost to Follow-up|0|||
124558326|NCT00950599|448001431|FG007|Follow-Up Period|Lost to Follow-up|0|||
124558327|NCT00950599|448001432|FG008|Follow-Up Period|Lost to Follow-up|5|||
124558328|NCT00950599|448001433|FG009|Follow-Up Period|Lost to Follow-up|1|||
124558329|NCT00950599|448001424|FG000|Follow-Up Period|Physician Decision|0|||
124558330|NCT00950599|448001425|FG001|Follow-Up Period|Physician Decision|0|||
124558331|NCT00950599|448001426|FG002|Follow-Up Period|Physician Decision|0|||
124558332|NCT00950599|448001427|FG003|Follow-Up Period|Physician Decision|0|||
124558333|NCT00950599|448001428|FG004|Follow-Up Period|Physician Decision|0|||
124558334|NCT00950599|448001429|FG005|Follow-Up Period|Physician Decision|0|||
124558335|NCT00950599|448001430|FG006|Follow-Up Period|Physician Decision|0|||
124558336|NCT00950599|448001431|FG007|Follow-Up Period|Physician Decision|0|||
124558337|NCT00950599|448001432|FG008|Follow-Up Period|Physician Decision|1|||
124558338|NCT00950599|448001433|FG009|Follow-Up Period|Physician Decision|0|||
124558339|NCT00950599|448001424|FG000|Follow-Up Period|Poor/Noncompliance|0|||
124558340|NCT00950599|448001425|FG001|Follow-Up Period|Poor/Noncompliance|0|||
124558341|NCT00950599|448001426|FG002|Follow-Up Period|Poor/Noncompliance|0|||
124558342|NCT00950599|448001427|FG003|Follow-Up Period|Poor/Noncompliance|0|||
124558343|NCT00950599|448001428|FG004|Follow-Up Period|Poor/Noncompliance|0|||
124558344|NCT00950599|448001429|FG005|Follow-Up Period|Poor/Noncompliance|0|||
124558345|NCT00950599|448001430|FG006|Follow-Up Period|Poor/Noncompliance|0|||
124558346|NCT00950599|448001431|FG007|Follow-Up Period|Poor/Noncompliance|0|||
124773223|NCT01588522|448798889|FG001|Overall Study|Lack of Efficacy|0|||
124773224|NCT01588522|448798890|FG002|Overall Study|Lack of Efficacy|0|||
124773225|NCT01588522|448798891|FG003|Overall Study|Lack of Efficacy|0|||
124773226|NCT01588522|448798892|FG004|Overall Study|Lack of Efficacy|1|||
124773227|NCT01588522|448798893|FG005|Overall Study|Lack of Efficacy|0|||
124558347|NCT00950599|448001432|FG008|Follow-Up Period|Poor/Noncompliance|1|||
124558348|NCT00950599|448001433|FG009|Follow-Up Period|Poor/Noncompliance|0|||
124558349|NCT00950599|448001424|FG000|Follow-Up Period|Subject withdrew Consent|0|||
124558350|NCT00950599|448001425|FG001|Follow-Up Period|Subject withdrew Consent|0|||
124558351|NCT00950599|448001426|FG002|Follow-Up Period|Subject withdrew Consent|0|||
124558352|NCT00950599|448001427|FG003|Follow-Up Period|Subject withdrew Consent|0|||
124558353|NCT00950599|448001428|FG004|Follow-Up Period|Subject withdrew Consent|0|||
124773228|NCT01588522|448798888|FG000|Overall Study|Adverse Event|0|||
124558354|NCT00950599|448001429|FG005|Follow-Up Period|Subject withdrew Consent|0|||
124558355|NCT00950599|448001430|FG006|Follow-Up Period|Subject withdrew Consent|0|||
124558356|NCT00950599|448001431|FG007|Follow-Up Period|Subject withdrew Consent|0|||
124558357|NCT00950599|448001432|FG008|Follow-Up Period|Subject withdrew Consent|2|||
124558358|NCT00950599|448001433|FG009|Follow-Up Period|Subject withdrew Consent|1|||
124773229|NCT01588522|448798889|FG001|Overall Study|Adverse Event|0|||
124773230|NCT01588522|448798890|FG002|Overall Study|Adverse Event|0|||
124723275|NCT01436656|448609735|FG002|Dose Escalation|New anti-cancer therapy|0|||
124723276|NCT01436656|448609736|FG003|Dose Escalation|New anti-cancer therapy|0|||
124723277|NCT01436656|448609737|FG004|Dose Escalation|New anti-cancer therapy|0|||
124723278|NCT01436656|448609738|FG005|Dose Escalation|New anti-cancer therapy|0|||
124723279|NCT01436656|448609739|FG006|Dose Escalation|New anti-cancer therapy|0|||
124723280|NCT01436656|448609740|FG007|Dose Escalation|New anti-cancer therapy|0|||
124723281|NCT01436656|448609741|FG008|Dose Escalation|New anti-cancer therapy|1|||
124723282|NCT01436656|448609742|FG009|Dose Escalation|New anti-cancer therapy|1|||
124723283|NCT01436656|448609743|FG010|Dose Escalation|New anti-cancer therapy|0|||
124723284|NCT01436656|448609744|FG011|Dose Escalation|New anti-cancer therapy|0|||
124723285|NCT01436656|448609745|FG012|Dose Escalation|New anti-cancer therapy|0|||
124723286|NCT01436656|448609746|FG013|Dose Escalation|New anti-cancer therapy|0|||
124723287|NCT01436656|448609747|FG014|Dose Escalation|New anti-cancer therapy|0|||
124558359|NCT00971204|448001434|FG000|Overall Study|Did not meet all criteria-not treated|14|||
124558360|NCT00971204|448001434|FG000|Overall Study|Lost to Follow-up|10|||
124558361|NCT02436135|448001435|FG000|Overall Study|Progressive Disease|3|||
124558362|NCT02436135|448001436|FG001|Overall Study|Progressive Disease|1|||
124558363|NCT02436135|448001435|FG000|Overall Study|Investigator Discretion|1|||
124558364|NCT02436135|448001436|FG001|Overall Study|Investigator Discretion|2|||
124558365|NCT02436135|448001435|FG000|Overall Study|Adverse Event|1|||
124558366|NCT02436135|448001436|FG001|Overall Study|Adverse Event|0|||
124723288|NCT01436656|448609748|FG015|Dose Escalation|New anti-cancer therapy|0|||
124495796|NCT02834403|447770004|FG002|Overall Study|Withdrawal by Subject|0|||
124495797|NCT02834403|447770005|FG003|Overall Study|Withdrawal by Subject|0|||
124495798|NCT02834403|447770006|FG004|Overall Study|Withdrawal by Subject|1|||
124495799|NCT02834403|447770007|FG005|Overall Study|Withdrawal by Subject|0|||
124495800|NCT02834403|447770008|FG006|Overall Study|Withdrawal by Subject|0|||
124495801|NCT02834403|447770002|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
124495802|NCT02834403|447770003|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
124495803|NCT02834403|447770004|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
124495804|NCT02834403|447770005|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
124495805|NCT02834403|447770006|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
124495806|NCT02834403|447770007|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
124495807|NCT02834403|447770008|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
124495808|NCT00273858|447770018|FG000|Overall Study|Not completed 24 month observation time|334|||
124495809|NCT00273858|447770018|FG000|Overall Study|Lost to Follow-up|101|||
124495810|NCT00273858|447770018|FG000|Overall Study|Withdrawal by Subject|21|||
124495811|NCT00273858|447770018|FG000|Overall Study|Adverse Event|81|||
124495812|NCT02232516|447770019|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
124495813|NCT02232516|447770019|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
124495814|NCT02232516|447770019|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
124495815|NCT02232516|447770019|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
124495816|NCT02232516|447770019|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
124495817|NCT02232516|447770019|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
124495818|NCT02232516|447770019|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
124495819|NCT02232516|447770019|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
124495820|NCT02232516|447770019|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
124495821|NCT02232516|447770019|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
124495822|NCT02232516|447770019|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
124495823|NCT02232516|447770019|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
124558367|NCT02436135|448001435|FG000|Overall Study|Withdrawal by Participant|1|||
124558368|NCT02436135|448001436|FG001|Overall Study|Withdrawal by Participant|0|||
124558369|NCT02436135|448001435|FG000|Overall Study|Study Terminated By Sponsor|0|||
124558370|NCT02436135|448001436|FG001|Overall Study|Study Terminated By Sponsor|1|||
124723289|NCT01436656|448609749|FG016|Dose Escalation|New anti-cancer therapy|0|||
124723290|NCT01436656|448609750|FG017|Dose Escalation|New anti-cancer therapy|0|||
124723291|NCT01436656|448609733|FG000|Dose Expansion|Adverse Event|0|||
124723292|NCT01436656|448609734|FG001|Dose Expansion|Adverse Event|0|||
124723293|NCT01436656|448609735|FG002|Dose Expansion|Adverse Event|0|||
124723294|NCT01436656|448609736|FG003|Dose Expansion|Adverse Event|0|||
124723295|NCT01436656|448609737|FG004|Dose Expansion|Adverse Event|0|||
124723296|NCT01436656|448609738|FG005|Dose Expansion|Adverse Event|0|||
124723297|NCT01436656|448609739|FG006|Dose Expansion|Adverse Event|0|||
124723298|NCT01436656|448609740|FG007|Dose Expansion|Adverse Event|0|||
124723299|NCT01436656|448609741|FG008|Dose Expansion|Adverse Event|0|||
124723300|NCT01436656|448609742|FG009|Dose Expansion|Adverse Event|0|||
124723301|NCT01436656|448609743|FG010|Dose Expansion|Adverse Event|0|||
124723302|NCT01436656|448609744|FG011|Dose Expansion|Adverse Event|1|||
124723303|NCT01436656|448609745|FG012|Dose Expansion|Adverse Event|0|||
124723304|NCT01436656|448609746|FG013|Dose Expansion|Adverse Event|0|||
124723305|NCT01436656|448609747|FG014|Dose Expansion|Adverse Event|0|||
124723306|NCT01436656|448609748|FG015|Dose Expansion|Adverse Event|0|||
124723307|NCT01436656|448609749|FG016|Dose Expansion|Adverse Event|0|||
124723308|NCT01436656|448609750|FG017|Dose Expansion|Adverse Event|0|||
124723309|NCT01436656|448609733|FG000|Dose Expansion|Withdrawal by Subject|0|||
124723310|NCT01436656|448609734|FG001|Dose Expansion|Withdrawal by Subject|0|||
124723311|NCT01436656|448609735|FG002|Dose Expansion|Withdrawal by Subject|0|||
124723312|NCT01436656|448609736|FG003|Dose Expansion|Withdrawal by Subject|0|||
124723313|NCT01436656|448609737|FG004|Dose Expansion|Withdrawal by Subject|0|||
124723314|NCT01436656|448609738|FG005|Dose Expansion|Withdrawal by Subject|0|||
124723315|NCT01436656|448609739|FG006|Dose Expansion|Withdrawal by Subject|0|||
124723316|NCT01436656|448609740|FG007|Dose Expansion|Withdrawal by Subject|0|||
124723317|NCT01436656|448609741|FG008|Dose Expansion|Withdrawal by Subject|0|||
124723318|NCT01436656|448609742|FG009|Dose Expansion|Withdrawal by Subject|0|||
124723319|NCT01436656|448609743|FG010|Dose Expansion|Withdrawal by Subject|0|||
124723320|NCT01436656|448609744|FG011|Dose Expansion|Withdrawal by Subject|1|||
124723321|NCT01436656|448609745|FG012|Dose Expansion|Withdrawal by Subject|3|||
124723322|NCT01436656|448609746|FG013|Dose Expansion|Withdrawal by Subject|1|||
124723323|NCT01436656|448609747|FG014|Dose Expansion|Withdrawal by Subject|2|||
124495824|NCT02232516|447770019|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
124495825|NCT02232516|447770019|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
124495826|NCT02232516|447770019|FG000|Survival Follow-up|Death|15|||
124495827|NCT02232516|447770019|FG000|Survival Follow-up|Withdrawal by Subject|3|||
124495828|NCT02232516|447770019|FG000|Survival Follow-up|Lost to Follow-up|1|||
124495829|NCT02232516|447770019|FG000|Survival Follow-up|Still in follow-up|5|||
124495830|NCT01070550|447770020|FG000|Overall Study|Adverse Event|43|||
124495831|NCT01070550|447770021|FG001|Overall Study|Adverse Event|1|||
124495832|NCT01070550|447770022|FG002|Overall Study|Adverse Event|3|||
124495833|NCT01070550|447770023|FG003|Overall Study|Adverse Event|0|||
124495834|NCT01070550|447770024|FG004|Overall Study|Adverse Event|0|||
124495835|NCT01070550|447770025|FG005|Overall Study|Adverse Event|0|||
124495836|NCT01070550|447770020|FG000|Overall Study|Death|20|||
124495837|NCT01070550|447770021|FG001|Overall Study|Death|4|||
124495838|NCT01070550|447770022|FG002|Overall Study|Death|3|||
124495839|NCT01070550|447770023|FG003|Overall Study|Death|0|||
124495840|NCT01070550|447770024|FG004|Overall Study|Death|0|||
124495841|NCT01070550|447770025|FG005|Overall Study|Death|0|||
124495842|NCT01070550|447770020|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
124495843|NCT01070550|447770021|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
124495844|NCT01070550|447770022|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
124495845|NCT01070550|447770023|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
124495846|NCT01070550|447770024|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
124495847|NCT01070550|447770025|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
124495848|NCT01070550|447770020|FG000|Overall Study|Early termination|3|||
124495849|NCT01070550|447770021|FG001|Overall Study|Early termination|0|||
124495850|NCT01070550|447770022|FG002|Overall Study|Early termination|0|||
124495851|NCT01070550|447770023|FG003|Overall Study|Early termination|0|||
124495852|NCT01070550|447770024|FG004|Overall Study|Early termination|0|||
124495853|NCT01070550|447770025|FG005|Overall Study|Early termination|0|||
124495854|NCT01070550|447770020|FG000|Overall Study|Failed to return|450|||
124495855|NCT01070550|447770021|FG001|Overall Study|Failed to return|33|||
124495856|NCT01070550|447770022|FG002|Overall Study|Failed to return|144|||
124495857|NCT01070550|447770023|FG003|Overall Study|Failed to return|40|||
124495858|NCT01070550|447770024|FG004|Overall Study|Failed to return|1|||
124495859|NCT01070550|447770025|FG005|Overall Study|Failed to return|2|||
124495860|NCT01070550|447770020|FG000|Overall Study|Incomplete treatment|2|||
124495861|NCT01070550|447770021|FG001|Overall Study|Incomplete treatment|0|||
124495862|NCT01070550|447770022|FG002|Overall Study|Incomplete treatment|0|||
124495863|NCT01070550|447770023|FG003|Overall Study|Incomplete treatment|0|||
124495864|NCT01070550|447770024|FG004|Overall Study|Incomplete treatment|0|||
124495865|NCT01070550|447770025|FG005|Overall Study|Incomplete treatment|0|||
124495866|NCT01070550|447770020|FG000|Overall Study|Lab test not done|22|||
124495867|NCT01070550|447770021|FG001|Overall Study|Lab test not done|3|||
124495868|NCT01070550|447770022|FG002|Overall Study|Lab test not done|4|||
124495869|NCT01070550|447770023|FG003|Overall Study|Lab test not done|1|||
124495870|NCT01070550|447770024|FG004|Overall Study|Lab test not done|0|||
124495871|NCT01070550|447770025|FG005|Overall Study|Lab test not done|1|||
124495872|NCT01070550|447770020|FG000|Overall Study|Lack of Efficacy|65|||
124495873|NCT01070550|447770021|FG001|Overall Study|Lack of Efficacy|1|||
124495874|NCT01070550|447770022|FG002|Overall Study|Lack of Efficacy|5|||
124495875|NCT01070550|447770023|FG003|Overall Study|Lack of Efficacy|5|||
124495876|NCT01070550|447770024|FG004|Overall Study|Lack of Efficacy|0|||
124495877|NCT01070550|447770025|FG005|Overall Study|Lack of Efficacy|1|||
124495878|NCT01070550|447770020|FG000|Overall Study|Miscellaneous|12|||
124495879|NCT01070550|447770021|FG001|Overall Study|Miscellaneous|2|||
124495880|NCT01070550|447770022|FG002|Overall Study|Miscellaneous|3|||
124723324|NCT01436656|448609748|FG015|Dose Expansion|Withdrawal by Subject|0|||
124773231|NCT01588522|448798891|FG003|Overall Study|Adverse Event|1|||
124495881|NCT01070550|447770023|FG003|Overall Study|Miscellaneous|1|||
124495882|NCT01070550|447770024|FG004|Overall Study|Miscellaneous|0|||
124495883|NCT01070550|447770025|FG005|Overall Study|Miscellaneous|0|||
124495884|NCT01070550|447770020|FG000|Overall Study|New treatment started|3|||
124773232|NCT01588522|448798892|FG004|Overall Study|Adverse Event|0|||
124773233|NCT01588522|448798893|FG005|Overall Study|Adverse Event|0|||
124773234|NCT01588522|448798888|FG000|Overall Study|Grade 2 alopecia|1|||
124773235|NCT01588522|448798889|FG001|Overall Study|Grade 2 alopecia|0|||
124773236|NCT01588522|448798890|FG002|Overall Study|Grade 2 alopecia|0|||
124773237|NCT01588522|448798891|FG003|Overall Study|Grade 2 alopecia|0|||
124773238|NCT01588522|448798892|FG004|Overall Study|Grade 2 alopecia|0|||
124773239|NCT01588522|448798893|FG005|Overall Study|Grade 2 alopecia|0|||
124773240|NCT01588522|448798888|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
124773241|NCT01588522|448798889|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
124773242|NCT01588522|448798890|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
124773243|NCT01588522|448798891|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
124773244|NCT01588522|448798892|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
124773245|NCT01588522|448798893|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
124773246|NCT01588522|448798888|FG000|Overall Study|Taken off taxane-based regimen|0|||
124773247|NCT01588522|448798889|FG001|Overall Study|Taken off taxane-based regimen|0|||
124773248|NCT01588522|448798890|FG002|Overall Study|Taken off taxane-based regimen|0|||
124773249|NCT01588522|448798891|FG003|Overall Study|Taken off taxane-based regimen|1|||
124558371|NCT02729194|448001437|FG000|Overall Study|Withdrawal by Subject|3|||
124558372|NCT01401478|448001443|FG000|Overall Study|Study drug not available|6|||
124558373|NCT01401478|448001443|FG000|Overall Study|Adverse Event|5|||
124558374|NCT01401478|448001443|FG000|Overall Study|Hyperphosphatemia|5|||
124558375|NCT01401478|448001443|FG000|Overall Study|Lost to Follow-up|5|||
124558376|NCT01401478|448001443|FG000|Overall Study|Kidney transplantation|3|||
124558377|NCT01401478|448001443|FG000|Overall Study|Withdrawal by Subject|3|||
124558378|NCT01401478|448001443|FG000|Overall Study|Blood samples not available|1|||
124558379|NCT01401478|448001443|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
124558380|NCT01401478|448001443|FG000|Overall Study|Low intact parathyroid hormone|1|||
124558381|NCT01401478|448001443|FG000|Overall Study|Serious adverse event|1|||
124558382|NCT01809314|448001444|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
124558383|NCT01809314|448001444|FG000|Overall Study|Adverse Event|6|||
124558384|NCT01809314|448001444|FG000|Overall Study|Insufficient Therapeutic Response|14|||
124558385|NCT01809314|448001444|FG000|Overall Study|Lost to Follow-up|724|||
124558386|NCT01684722|448001445|FG000|Overall Study|Lost to Follow-up|78|||
124558387|NCT01684722|448001446|FG001|Overall Study|Lost to Follow-up|56|||
124558388|NCT01684722|448001447|FG002|Overall Study|Lost to Follow-up|75|||
124558389|NCT01684722|448001448|FG003|Overall Study|Lost to Follow-up|89|||
124558390|NCT01684722|448001445|FG000|Overall Study|Death|19|||
124558391|NCT01684722|448001446|FG001|Overall Study|Death|21|||
124558392|NCT01684722|448001447|FG002|Overall Study|Death|19|||
124558393|NCT01684722|448001448|FG003|Overall Study|Death|21|||
124558394|NCT00863057|448001451|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
124558395|NCT00863057|448001452|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
124558396|NCT00863057|448001453|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
124558397|NCT00863057|448001454|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
124558398|NCT00863057|448001451|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
124558399|NCT00863057|448001452|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
124558400|NCT00863057|448001453|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
124558401|NCT00863057|448001454|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
124558402|NCT00863057|448001451|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
124558403|NCT00863057|448001452|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
124558404|NCT00863057|448001453|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
124558405|NCT00863057|448001454|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
124558406|NCT00863057|448001451|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
124558407|NCT00863057|448001452|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
124558408|NCT00863057|448001453|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
124558409|NCT00863057|448001454|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
124558410|NCT03063632|448001460|FG000|Overall Study|Death|4|||
124558411|NCT03063632|448001461|FG001|Overall Study|Death|6|||
124558412|NCT03063632|448001460|FG000|Overall Study|Lost to Follow-up|0|||
124558413|NCT03063632|448001461|FG001|Overall Study|Lost to Follow-up|1|||
124558414|NCT03063632|448001460|FG000|Overall Study|Withdrawal by Subject|0|||
124773250|NCT01588522|448798892|FG004|Overall Study|Taken off taxane-based regimen|0|||
124773251|NCT01588522|448798893|FG005|Overall Study|Taken off taxane-based regimen|0|||
124773252|NCT01588522|448798888|FG000|Overall Study|Did not initiate chemotherapy|0|||
124558415|NCT03063632|448001461|FG001|Overall Study|Withdrawal by Subject|2|||
124558416|NCT03063632|448001460|FG000|Overall Study|Physician Decision|2|||
124558417|NCT03063632|448001461|FG001|Overall Study|Physician Decision|0|||
124558418|NCT03063632|448001460|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
124558419|NCT03063632|448001461|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
124558420|NCT02741271|448001466|FG000|Overall Study|Lost to Follow-up|2|||
124558421|NCT02741271|448001467|FG001|Overall Study|Lost to Follow-up|0|||
124558422|NCT02741271|448001466|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124558423|NCT02741271|448001467|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
124773253|NCT01588522|448798889|FG001|Overall Study|Did not initiate chemotherapy|0|||
124773254|NCT01588522|448798890|FG002|Overall Study|Did not initiate chemotherapy|0|||
124773255|NCT01588522|448798891|FG003|Overall Study|Did not initiate chemotherapy|0|||
124773256|NCT01588522|448798892|FG004|Overall Study|Did not initiate chemotherapy|1|||
124773257|NCT01588522|448798893|FG005|Overall Study|Did not initiate chemotherapy|0|||
124773258|NCT03205423|448798896|FG000|Overall Study|Personal|1|||
124773259|NCT03205423|448798897|FG001|Overall Study|Personal|1|||
124773260|NCT03205423|448798896|FG000|Overall Study|Physician Decision|0|||
124773261|NCT03205423|448798897|FG001|Overall Study|Physician Decision|2|||
124773262|NCT05786651|448798900|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
124773263|NCT04390763|448798901|FG000|Safety run-in Part|Adverse Event|4|||
124773264|NCT04390763|448798902|FG001|Safety run-in Part|Adverse Event|0|||
124773265|NCT04390763|448798903|FG002|Safety run-in Part|Adverse Event|0|||
124773266|NCT04390763|448798904|FG003|Safety run-in Part|Adverse Event|0|||
124773267|NCT04390763|448798901|FG000|Safety run-in Part|Physician Decision|1|||
124773268|NCT04390763|448798902|FG001|Safety run-in Part|Physician Decision|0|||
124773269|NCT04390763|448798903|FG002|Safety run-in Part|Physician Decision|0|||
124773270|NCT04390763|448798904|FG003|Safety run-in Part|Physician Decision|0|||
124773271|NCT04390763|448798901|FG000|Safety run-in Part|Progressive Disease|6|||
124773272|NCT04390763|448798902|FG001|Safety run-in Part|Progressive Disease|0|||
124773273|NCT04390763|448798903|FG002|Safety run-in Part|Progressive Disease|0|||
124773274|NCT04390763|448798904|FG003|Safety run-in Part|Progressive Disease|0|||
124773275|NCT04390763|448798901|FG000|Randomized Part|Adverse Event|0|||
124773276|NCT04390763|448798902|FG001|Randomized Part|Adverse Event|11|||
124773277|NCT04390763|448798903|FG002|Randomized Part|Adverse Event|5|||
124773278|NCT04390763|448798904|FG003|Randomized Part|Adverse Event|5|||
124773279|NCT04390763|448798901|FG000|Randomized Part|Death|0|||
124773280|NCT04390763|448798902|FG001|Randomized Part|Death|3|||
124773281|NCT04390763|448798903|FG002|Randomized Part|Death|4|||
124773282|NCT04390763|448798904|FG003|Randomized Part|Death|2|||
124773283|NCT04390763|448798901|FG000|Randomized Part|Physician Decision|0|||
124773284|NCT04390763|448798902|FG001|Randomized Part|Physician Decision|2|||
124773285|NCT04390763|448798903|FG002|Randomized Part|Physician Decision|2|||
124773286|NCT04390763|448798904|FG003|Randomized Part|Physician Decision|9|||
124773287|NCT04390763|448798901|FG000|Randomized Part|Progressive Disease|0|||
124773288|NCT04390763|448798902|FG001|Randomized Part|Progressive Disease|24|||
124773289|NCT04390763|448798903|FG002|Randomized Part|Progressive Disease|31|||
124773290|NCT04390763|448798904|FG003|Randomized Part|Progressive Disease|23|||
124773291|NCT04390763|448798901|FG000|Randomized Part|Study terminated by sponsor|0|||
124773292|NCT04390763|448798902|FG001|Randomized Part|Study terminated by sponsor|1|||
124773293|NCT04390763|448798903|FG002|Randomized Part|Study terminated by sponsor|0|||
124773294|NCT04390763|448798904|FG003|Randomized Part|Study terminated by sponsor|0|||
124773295|NCT04390763|448798901|FG000|Randomized Part|Participant Decision|0|||
124773296|NCT04390763|448798902|FG001|Randomized Part|Participant Decision|5|||
124773297|NCT04390763|448798903|FG002|Randomized Part|Participant Decision|7|||
124773298|NCT04390763|448798904|FG003|Randomized Part|Participant Decision|6|||
124773299|NCT04390763|448798901|FG000|Randomized Part|Not treated|0|||
124773300|NCT04390763|448798902|FG001|Randomized Part|Not treated|4|||
124773301|NCT04390763|448798903|FG002|Randomized Part|Not treated|2|||
124773302|NCT04390763|448798904|FG003|Randomized Part|Not treated|7|||
124773303|NCT01803607|448800498|FG000|Overall Study|Adverse Event|5|||
124773304|NCT01803607|448800499|FG001|Overall Study|Adverse Event|3|||
124773305|NCT01803607|448800498|FG000|Overall Study|Lack of Efficacy|0|||
124773306|NCT01803607|448800499|FG001|Overall Study|Lack of Efficacy|1|||
124773307|NCT01803607|448800498|FG000|Overall Study|Protocol Violation|3|||
124773308|NCT01803607|448800499|FG001|Overall Study|Protocol Violation|2|||
124773309|NCT01803607|448800498|FG000|Overall Study|Study terminated by sponsor|54|||
124773310|NCT01803607|448800499|FG001|Overall Study|Study terminated by sponsor|56|||
124773311|NCT01803607|448800498|FG000|Overall Study|Withdrawal by Subject|6|||
124773312|NCT01803607|448800499|FG001|Overall Study|Withdrawal by Subject|5|||
124773313|NCT03077412|448800500|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
124773314|NCT03077412|448800501|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
124773315|NCT03077412|448800502|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
124495885|NCT01070550|447770021|FG001|Overall Study|New treatment started|1|||
124495886|NCT01070550|447770022|FG002|Overall Study|New treatment started|0|||
124495887|NCT01070550|447770023|FG003|Overall Study|New treatment started|2|||
124495888|NCT01070550|447770024|FG004|Overall Study|New treatment started|0|||
124773316|NCT03077412|448800500|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
124773317|NCT03077412|448800501|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
124773318|NCT03077412|448800502|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
124773319|NCT03077412|448800500|FG000|Overall Study|Adverse Event|1|||
124773320|NCT03077412|448800501|FG001|Overall Study|Adverse Event|2|||
124495889|NCT01070550|447770025|FG005|Overall Study|New treatment started|0|||
124773321|NCT03077412|448800502|FG002|Overall Study|Adverse Event|2|||
124495890|NCT01070550|447770020|FG000|Overall Study|Non-responders|493|||
124558424|NCT01612156|448001468|FG000|Overall Study|Protocol Violation|2|||
124558425|NCT01612156|448001469|FG001|Overall Study|Protocol Violation|0|||
124558426|NCT02570165|448001470|FG000|Overall Study|Adverse Event|1|||
124558427|NCT02570165|448001471|FG001|Overall Study|Adverse Event|0|||
124558428|NCT02570165|448001472|FG002|Overall Study|Adverse Event|2|||
124558429|NCT02570165|448001473|FG003|Overall Study|Adverse Event|0|||
124558430|NCT02570165|448001474|FG004|Overall Study|Adverse Event|0|||
124558431|NCT02570165|448001475|FG005|Overall Study|Adverse Event|0|||
124558432|NCT02570165|448001476|FG006|Overall Study|Adverse Event|0|||
124558433|NCT02570165|448001470|FG000|Overall Study|Lack of Efficacy|0|||
124558434|NCT02570165|448001471|FG001|Overall Study|Lack of Efficacy|1|||
124558435|NCT02570165|448001472|FG002|Overall Study|Lack of Efficacy|0|||
124558436|NCT02570165|448001473|FG003|Overall Study|Lack of Efficacy|0|||
124558437|NCT02570165|448001474|FG004|Overall Study|Lack of Efficacy|4|||
124558438|NCT02570165|448001475|FG005|Overall Study|Lack of Efficacy|0|||
124558439|NCT02570165|448001476|FG006|Overall Study|Lack of Efficacy|0|||
124558440|NCT02570165|448001470|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
124558441|NCT02570165|448001471|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
124558442|NCT02570165|448001472|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
124558443|NCT02570165|448001473|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
124558444|NCT02570165|448001474|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
124558445|NCT02570165|448001475|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
124558446|NCT02570165|448001476|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
124558447|NCT02570165|448001470|FG000|Overall Study|Lost to Follow-up|0|||
124558448|NCT02570165|448001471|FG001|Overall Study|Lost to Follow-up|0|||
124558449|NCT02570165|448001472|FG002|Overall Study|Lost to Follow-up|1|||
124558450|NCT02570165|448001473|FG003|Overall Study|Lost to Follow-up|1|||
124558451|NCT02570165|448001474|FG004|Overall Study|Lost to Follow-up|0|||
124558452|NCT02570165|448001475|FG005|Overall Study|Lost to Follow-up|0|||
124558453|NCT02570165|448001476|FG006|Overall Study|Lost to Follow-up|0|||
124558454|NCT02570165|448001470|FG000|Overall Study|Physician Decision|0|||
124558455|NCT02570165|448001471|FG001|Overall Study|Physician Decision|1|||
124558456|NCT02570165|448001472|FG002|Overall Study|Physician Decision|0|||
124558457|NCT02570165|448001473|FG003|Overall Study|Physician Decision|0|||
124558458|NCT02570165|448001474|FG004|Overall Study|Physician Decision|0|||
124558459|NCT02570165|448001475|FG005|Overall Study|Physician Decision|0|||
124558460|NCT02570165|448001476|FG006|Overall Study|Physician Decision|0|||
124558461|NCT02570165|448001470|FG000|Overall Study|Withdrawal by Subject|0|||
124558462|NCT02570165|448001471|FG001|Overall Study|Withdrawal by Subject|0|||
124558463|NCT02570165|448001472|FG002|Overall Study|Withdrawal by Subject|0|||
124558464|NCT02570165|448001473|FG003|Overall Study|Withdrawal by Subject|2|||
124558465|NCT02570165|448001474|FG004|Overall Study|Withdrawal by Subject|1|||
124558466|NCT02570165|448001475|FG005|Overall Study|Withdrawal by Subject|0|||
124558467|NCT02570165|448001476|FG006|Overall Study|Withdrawal by Subject|0|||
124558468|NCT02570165|448001470|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
124558469|NCT02570165|448001471|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
124558470|NCT02570165|448001472|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
124558471|NCT02570165|448001473|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
124558472|NCT02570165|448001474|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
124558473|NCT02570165|448001475|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
124558474|NCT02570165|448001476|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
124558475|NCT02570165|448001470|FG000|Overall Study|Withdrawal Request by GSK|0|||
124558476|NCT02570165|448001471|FG001|Overall Study|Withdrawal Request by GSK|0|||
124558477|NCT02570165|448001472|FG002|Overall Study|Withdrawal Request by GSK|2|||
124558478|NCT02570165|448001473|FG003|Overall Study|Withdrawal Request by GSK|0|||
124558479|NCT02570165|448001474|FG004|Overall Study|Withdrawal Request by GSK|0|||
124558480|NCT02570165|448001475|FG005|Overall Study|Withdrawal Request by GSK|0|||
124558481|NCT02570165|448001476|FG006|Overall Study|Withdrawal Request by GSK|0|||
124558482|NCT01430104|448001477|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
124558483|NCT05478603|448001478|FG000|Overall Study|Withdrawal by Subject|0|||
124558484|NCT05478603|448001479|FG001|Overall Study|Withdrawal by Subject|1|||
124558485|NCT05478603|448001480|FG002|Overall Study|Withdrawal by Subject|0|||
124558486|NCT05478603|448001481|FG003|Overall Study|Withdrawal by Subject|0|||
124558487|NCT03182686|448001482|FG000|Overall Study|Lost to Follow-up|2|||
124558488|NCT03182686|448001483|FG001|Overall Study|Lost to Follow-up|0|||
124558489|NCT03182686|448001482|FG000|Overall Study|Adverse Event|2|||
124558490|NCT03182686|448001483|FG001|Overall Study|Adverse Event|0|||
124558491|NCT03182686|448001482|FG000|Overall Study|Withdrawal by Subject|3|||
124558492|NCT03182686|448001483|FG001|Overall Study|Withdrawal by Subject|0|||
124558493|NCT01025193|448001486|FG000|Overall Study|Protocol Violation|1|||
124558494|NCT01025193|448001486|FG000|Overall Study|Adverse Event|3|||
124558495|NCT02378506|448001487|FG000|Overall Study|Lack of Efficacy|3|||
124558496|NCT02378506|448001487|FG000|Overall Study|Withdrawal by Subject|4|||
124558497|NCT02378506|448001487|FG000|Overall Study|Protocol Violation|2|||
124558498|NCT02378506|448001487|FG000|Overall Study|Death|1|||
124558499|NCT02378506|448001487|FG000|Overall Study|Adverse Event|14|||
124495891|NCT01070550|447770021|FG001|Overall Study|Non-responders|4|||
124495892|NCT01070550|447770022|FG002|Overall Study|Non-responders|21|||
124495893|NCT01070550|447770023|FG003|Overall Study|Non-responders|20|||
124495894|NCT01070550|447770024|FG004|Overall Study|Non-responders|0|||
124495895|NCT01070550|447770025|FG005|Overall Study|Non-responders|2|||
124495896|NCT01070550|447770020|FG000|Overall Study|Not categorized|33|||
124495897|NCT01070550|447770021|FG001|Overall Study|Not categorized|2|||
124495898|NCT01070550|447770022|FG002|Overall Study|Not categorized|6|||
124495899|NCT01070550|447770023|FG003|Overall Study|Not categorized|1|||
124495900|NCT01070550|447770024|FG004|Overall Study|Not categorized|0|||
124495901|NCT01070550|447770025|FG005|Overall Study|Not categorized|1|||
124495902|NCT01070550|447770020|FG000|Overall Study|Protocol Violation|15|||
124495903|NCT01070550|447770021|FG001|Overall Study|Protocol Violation|1|||
124495904|NCT01070550|447770022|FG002|Overall Study|Protocol Violation|1|||
124495905|NCT01070550|447770023|FG003|Overall Study|Protocol Violation|1|||
124495906|NCT01070550|447770024|FG004|Overall Study|Protocol Violation|0|||
124495907|NCT01070550|447770025|FG005|Overall Study|Protocol Violation|0|||
124495908|NCT01070550|447770020|FG000|Overall Study|Relapse|44|||
124495909|NCT01070550|447770021|FG001|Overall Study|Relapse|5|||
124495910|NCT01070550|447770022|FG002|Overall Study|Relapse|14|||
124495911|NCT01070550|447770023|FG003|Overall Study|Relapse|4|||
124495912|NCT01070550|447770024|FG004|Overall Study|Relapse|0|||
124495913|NCT01070550|447770025|FG005|Overall Study|Relapse|0|||
124495914|NCT01070550|447770020|FG000|Overall Study|Result not available|3|||
124495915|NCT01070550|447770021|FG001|Overall Study|Result not available|1|||
124495916|NCT01070550|447770022|FG002|Overall Study|Result not available|3|||
124495917|NCT01070550|447770023|FG003|Overall Study|Result not available|0|||
124495918|NCT01070550|447770024|FG004|Overall Study|Result not available|0|||
124495919|NCT01070550|447770025|FG005|Overall Study|Result not available|0|||
124495920|NCT01070550|447770020|FG000|Overall Study|Screen failure|1|||
124495921|NCT01070550|447770021|FG001|Overall Study|Screen failure|0|||
124495922|NCT01070550|447770022|FG002|Overall Study|Screen failure|0|||
124495923|NCT01070550|447770023|FG003|Overall Study|Screen failure|0|||
124495924|NCT01070550|447770024|FG004|Overall Study|Screen failure|0|||
124495925|NCT01070550|447770025|FG005|Overall Study|Screen failure|0|||
124495926|NCT01070550|447770020|FG000|Overall Study|Sponsor decision|1|||
124495927|NCT01070550|447770021|FG001|Overall Study|Sponsor decision|0|||
124495928|NCT01070550|447770022|FG002|Overall Study|Sponsor decision|0|||
124495929|NCT01070550|447770023|FG003|Overall Study|Sponsor decision|0|||
124495930|NCT01070550|447770024|FG004|Overall Study|Sponsor decision|0|||
124495931|NCT01070550|447770025|FG005|Overall Study|Sponsor decision|0|||
124495932|NCT01070550|447770020|FG000|Overall Study|Treatment duration shortened|1|||
124495933|NCT01070550|447770021|FG001|Overall Study|Treatment duration shortened|0|||
124495934|NCT01070550|447770022|FG002|Overall Study|Treatment duration shortened|0|||
124495935|NCT01070550|447770023|FG003|Overall Study|Treatment duration shortened|0|||
124495936|NCT01070550|447770024|FG004|Overall Study|Treatment duration shortened|0|||
124495937|NCT01070550|447770025|FG005|Overall Study|Treatment duration shortened|0|||
124495938|NCT01070550|447770020|FG000|Overall Study|Treatment interrupted|7|||
124495939|NCT01070550|447770021|FG001|Overall Study|Treatment interrupted|0|||
124495940|NCT01070550|447770022|FG002|Overall Study|Treatment interrupted|1|||
124495941|NCT01070550|447770023|FG003|Overall Study|Treatment interrupted|1|||
124495942|NCT01070550|447770024|FG004|Overall Study|Treatment interrupted|0|||
124495943|NCT01070550|447770025|FG005|Overall Study|Treatment interrupted|0|||
124495944|NCT01070550|447770020|FG000|Overall Study|Treatment not started|14|||
124495945|NCT01070550|447770021|FG001|Overall Study|Treatment not started|2|||
124495946|NCT01070550|447770022|FG002|Overall Study|Treatment not started|4|||
124495947|NCT01070550|447770023|FG003|Overall Study|Treatment not started|0|||
124495948|NCT01070550|447770024|FG004|Overall Study|Treatment not started|0|||
124495949|NCT01070550|447770025|FG005|Overall Study|Treatment not started|0|||
124495950|NCT01070550|447770020|FG000|Overall Study|Treatment restarted|0|||
124495951|NCT01070550|447770021|FG001|Overall Study|Treatment restarted|1|||
124495952|NCT01070550|447770022|FG002|Overall Study|Treatment restarted|0|||
124495953|NCT01070550|447770023|FG003|Overall Study|Treatment restarted|0|||
124495954|NCT01070550|447770024|FG004|Overall Study|Treatment restarted|0|||
124495955|NCT01070550|447770025|FG005|Overall Study|Treatment restarted|0|||
124495956|NCT01070550|447770020|FG000|Overall Study|Treatment stopped|3|||
124495957|NCT01070550|447770021|FG001|Overall Study|Treatment stopped|0|||
124495958|NCT01070550|447770022|FG002|Overall Study|Treatment stopped|0|||
124495959|NCT01070550|447770023|FG003|Overall Study|Treatment stopped|0|||
124495960|NCT01070550|447770024|FG004|Overall Study|Treatment stopped|0|||
124495961|NCT01070550|447770025|FG005|Overall Study|Treatment stopped|0|||
124495962|NCT01070550|447770020|FG000|Overall Study|Treatment unavailable|1|||
124495963|NCT01070550|447770021|FG001|Overall Study|Treatment unavailable|0|||
124495964|NCT01070550|447770022|FG002|Overall Study|Treatment unavailable|0|||
124495965|NCT01070550|447770023|FG003|Overall Study|Treatment unavailable|0|||
124495966|NCT01070550|447770024|FG004|Overall Study|Treatment unavailable|0|||
124495967|NCT01070550|447770025|FG005|Overall Study|Treatment unavailable|0|||
124495968|NCT01070550|447770020|FG000|Overall Study|Treatment was stopped early|7|||
124495969|NCT01070550|447770021|FG001|Overall Study|Treatment was stopped early|0|||
124773322|NCT03077412|448800500|FG000|Overall Study|Investigator's Discretion|0|||
124773323|NCT03077412|448800501|FG001|Overall Study|Investigator's Discretion|1|||
124773324|NCT03077412|448800502|FG002|Overall Study|Investigator's Discretion|1|||
124773325|NCT03077412|448800500|FG000|Overall Study|Withdrew Consent|0|||
124773326|NCT03077412|448800501|FG001|Overall Study|Withdrew Consent|2|||
124773327|NCT03077412|448800502|FG002|Overall Study|Withdrew Consent|0|||
124773328|NCT02266888|448800506|FG000|Overall Study|Death|2|||
124773329|NCT02266888|448800507|FG001|Overall Study|Death|2|||
124773330|NCT02266888|448800508|FG002|Overall Study|Death|4|||
124773331|NCT02266888|448800509|FG003|Overall Study|Death|2|||
124773332|NCT02266888|448800506|FG000|Overall Study|Physician Decision|0|||
124773333|NCT02266888|448800507|FG001|Overall Study|Physician Decision|1|||
124773334|NCT02266888|448800508|FG002|Overall Study|Physician Decision|2|||
124773335|NCT02266888|448800509|FG003|Overall Study|Physician Decision|2|||
124773336|NCT02266888|448800506|FG000|Overall Study|Study Terminated|5|||
124773337|NCT02266888|448800507|FG001|Overall Study|Study Terminated|1|||
124773338|NCT02266888|448800508|FG002|Overall Study|Study Terminated|0|||
124773339|NCT02266888|448800509|FG003|Overall Study|Study Terminated|0|||
124773340|NCT02266888|448800506|FG000|Overall Study|No Longer Eligible|0|||
124773341|NCT02266888|448800507|FG001|Overall Study|No Longer Eligible|0|||
124773342|NCT02266888|448800508|FG002|Overall Study|No Longer Eligible|0|||
124773343|NCT02266888|448800509|FG003|Overall Study|No Longer Eligible|2|||
124773344|NCT02266888|448800506|FG000|Overall Study|Randomization Closed|0|||
124773345|NCT02266888|448800507|FG001|Overall Study|Randomization Closed|0|||
124773346|NCT02266888|448800508|FG002|Overall Study|Randomization Closed|4|||
124773347|NCT02266888|448800509|FG003|Overall Study|Randomization Closed|0|||
124773348|NCT02266888|448800506|FG000|Overall Study|Personnel unavailable at transplant|0|||
124773349|NCT02266888|448800507|FG001|Overall Study|Personnel unavailable at transplant|0|||
124773350|NCT02266888|448800508|FG002|Overall Study|Personnel unavailable at transplant|0|||
124773351|NCT02266888|448800509|FG003|Overall Study|Personnel unavailable at transplant|1|||
124773352|NCT02266888|448800506|FG000|Overall Study|Transfer of care|0|||
124773353|NCT02266888|448800507|FG001|Overall Study|Transfer of care|0|||
124773354|NCT02266888|448800508|FG002|Overall Study|Transfer of care|1|||
124773355|NCT02266888|448800509|FG003|Overall Study|Transfer of care|0|||
124773356|NCT02351856|448800510|FG000|Overall Study|Adverse Event|2|||
124773357|NCT02351856|448800510|FG000|Overall Study|Physician Decision|5|||
124773358|NCT02351856|448800510|FG000|Overall Study|Study terminated by sponsor|1|||
124773359|NCT01281124|448800513|FG000|Overall Study|Death|1|||
124773360|NCT03038100|448800514|FG000|Overall Study|Death|289|||
124773361|NCT03038100|448800515|FG001|Overall Study|Death|272|||
124773362|NCT03038100|448800514|FG000|Overall Study|Lost to Follow-up|9|||
124773363|NCT03038100|448800515|FG001|Overall Study|Lost to Follow-up|10|||
124773364|NCT03038100|448800514|FG000|Overall Study|Protocol Deviation|1|||
124773365|NCT03038100|448800515|FG001|Overall Study|Protocol Deviation|4|||
124773366|NCT03038100|448800514|FG000|Overall Study|Withdrawal by Subject|45|||
124773367|NCT03038100|448800515|FG001|Overall Study|Withdrawal by Subject|51|||
124773368|NCT03038100|448800514|FG000|Overall Study|Study Terminated By Sponsor|305|||
124773369|NCT03038100|448800515|FG001|Overall Study|Study Terminated By Sponsor|311|||
124773370|NCT03038100|448800514|FG000|Overall Study|Physician Decision|1|||
124773371|NCT03038100|448800515|FG001|Overall Study|Physician Decision|3|||
124773372|NCT00918255|448800516|FG000|Overall Study|Adverse Event|1|||
124773373|NCT00918255|448800517|FG001|Overall Study|Adverse Event|0|||
124773374|NCT00918255|448800518|FG002|Overall Study|Adverse Event|0|||
124773375|NCT00918255|448800516|FG000|Overall Study|Withdrawal by Subject|1|||
124773376|NCT00918255|448800517|FG001|Overall Study|Withdrawal by Subject|0|||
124773377|NCT00918255|448800518|FG002|Overall Study|Withdrawal by Subject|2|||
124773378|NCT00918255|448800516|FG000|Overall Study|Lack of Efficacy|1|||
124773379|NCT00918255|448800517|FG001|Overall Study|Lack of Efficacy|0|||
124773380|NCT00918255|448800518|FG002|Overall Study|Lack of Efficacy|0|||
124773381|NCT00918255|448800516|FG000|Overall Study|Lost to Follow-up|1|||
124773382|NCT00918255|448800517|FG001|Overall Study|Lost to Follow-up|0|||
124773383|NCT00918255|448800518|FG002|Overall Study|Lost to Follow-up|2|||
124773384|NCT00918255|448800516|FG000|Overall Study|Exceeded allowed number of interventions|0|||
124773385|NCT00918255|448800517|FG001|Overall Study|Exceeded allowed number of interventions|0|||
124773386|NCT00918255|448800518|FG002|Overall Study|Exceeded allowed number of interventions|1|||
124773387|NCT00918255|448800516|FG000|Overall Study|Non-compliance|1|||
124773388|NCT00918255|448800517|FG001|Overall Study|Non-compliance|0|||
124773389|NCT00918255|448800518|FG002|Overall Study|Non-compliance|0|||
124773390|NCT00918255|448800516|FG000|Overall Study|Investigator discretion|1|||
124773391|NCT00918255|448800517|FG001|Overall Study|Investigator discretion|0|||
124773392|NCT00918255|448800518|FG002|Overall Study|Investigator discretion|0|||
124773393|NCT02392624|448800519|FG000|Overall Study|Withdrawal by Subject|15|||
124773394|NCT02392624|448800520|FG001|Overall Study|Withdrawal by Subject|12|||
124773395|NCT02392624|448800521|FG002|Overall Study|Withdrawal by Subject|9|||
124773396|NCT02392624|448800519|FG000|Overall Study|Adverse Event|4|||
124773397|NCT02392624|448800520|FG001|Overall Study|Adverse Event|1|||
124773398|NCT02392624|448800521|FG002|Overall Study|Adverse Event|2|||
124773399|NCT02392624|448800519|FG000|Overall Study|Pregnancy|1|||
124773400|NCT02392624|448800520|FG001|Overall Study|Pregnancy|0|||
124495970|NCT01070550|447770022|FG002|Overall Study|Treatment was stopped early|0|||
124495971|NCT01070550|447770023|FG003|Overall Study|Treatment was stopped early|0|||
124495972|NCT01070550|447770024|FG004|Overall Study|Treatment was stopped early|0|||
124495973|NCT01070550|447770025|FG005|Overall Study|Treatment was stopped early|0|||
124495974|NCT01070550|447770020|FG000|Overall Study|Other|5|||
124495975|NCT01070550|447770021|FG001|Overall Study|Other|0|||
124495976|NCT01070550|447770022|FG002|Overall Study|Other|0|||
124495977|NCT01070550|447770023|FG003|Overall Study|Other|1|||
124495978|NCT01070550|447770024|FG004|Overall Study|Other|0|||
124495979|NCT01070550|447770025|FG005|Overall Study|Other|0|||
124495980|NCT01070550|447770020|FG000|Overall Study|Withdrawal by Subject|35|||
124495981|NCT01070550|447770021|FG001|Overall Study|Withdrawal by Subject|0|||
124495982|NCT01070550|447770022|FG002|Overall Study|Withdrawal by Subject|3|||
124495983|NCT01070550|447770023|FG003|Overall Study|Withdrawal by Subject|0|||
124495984|NCT01070550|447770024|FG004|Overall Study|Withdrawal by Subject|0|||
124495985|NCT01070550|447770025|FG005|Overall Study|Withdrawal by Subject|0|||
124723325|NCT01436656|448609749|FG016|Dose Expansion|Withdrawal by Subject|1|||
124723326|NCT01436656|448609750|FG017|Dose Expansion|Withdrawal by Subject|1|||
124723327|NCT01436656|448609733|FG000|Dose Expansion|Death|0|||
124723328|NCT01436656|448609734|FG001|Dose Expansion|Death|0|||
124723329|NCT01436656|448609735|FG002|Dose Expansion|Death|0|||
124723330|NCT01436656|448609736|FG003|Dose Expansion|Death|0|||
124723331|NCT01436656|448609737|FG004|Dose Expansion|Death|0|||
124723332|NCT01436656|448609738|FG005|Dose Expansion|Death|0|||
124723333|NCT01436656|448609739|FG006|Dose Expansion|Death|0|||
124723334|NCT01436656|448609740|FG007|Dose Expansion|Death|0|||
124723335|NCT01436656|448609741|FG008|Dose Expansion|Death|0|||
124723336|NCT01436656|448609742|FG009|Dose Expansion|Death|0|||
124723337|NCT01436656|448609743|FG010|Dose Expansion|Death|0|||
124723338|NCT01436656|448609744|FG011|Dose Expansion|Death|0|||
124723339|NCT01436656|448609745|FG012|Dose Expansion|Death|1|||
124723340|NCT01436656|448609746|FG013|Dose Expansion|Death|0|||
124723341|NCT01436656|448609747|FG014|Dose Expansion|Death|3|||
124723342|NCT01436656|448609748|FG015|Dose Expansion|Death|0|||
124723343|NCT01436656|448609749|FG016|Dose Expansion|Death|3|||
124723344|NCT01436656|448609750|FG017|Dose Expansion|Death|3|||
124723345|NCT01436656|448609733|FG000|Dose Expansion|Lost to Follow-up|0|||
124723346|NCT01436656|448609734|FG001|Dose Expansion|Lost to Follow-up|0|||
124723347|NCT01436656|448609735|FG002|Dose Expansion|Lost to Follow-up|0|||
124723348|NCT01436656|448609736|FG003|Dose Expansion|Lost to Follow-up|0|||
124723349|NCT01436656|448609737|FG004|Dose Expansion|Lost to Follow-up|0|||
124723350|NCT01436656|448609738|FG005|Dose Expansion|Lost to Follow-up|0|||
124723351|NCT01436656|448609739|FG006|Dose Expansion|Lost to Follow-up|0|||
124723352|NCT01436656|448609740|FG007|Dose Expansion|Lost to Follow-up|0|||
124723353|NCT01436656|448609741|FG008|Dose Expansion|Lost to Follow-up|0|||
124723354|NCT01436656|448609742|FG009|Dose Expansion|Lost to Follow-up|0|||
124723355|NCT01436656|448609743|FG010|Dose Expansion|Lost to Follow-up|0|||
124723356|NCT01436656|448609744|FG011|Dose Expansion|Lost to Follow-up|0|||
124723357|NCT01436656|448609745|FG012|Dose Expansion|Lost to Follow-up|0|||
124723358|NCT01436656|448609746|FG013|Dose Expansion|Lost to Follow-up|0|||
124723359|NCT01436656|448609747|FG014|Dose Expansion|Lost to Follow-up|0|||
124723360|NCT01436656|448609748|FG015|Dose Expansion|Lost to Follow-up|0|||
124723361|NCT01436656|448609749|FG016|Dose Expansion|Lost to Follow-up|0|||
124723362|NCT01436656|448609750|FG017|Dose Expansion|Lost to Follow-up|3|||
124723363|NCT01436656|448609733|FG000|Dose Expansion|Disease progression|0|||
124723364|NCT01436656|448609734|FG001|Dose Expansion|Disease progression|0|||
124723365|NCT01436656|448609735|FG002|Dose Expansion|Disease progression|0|||
124723366|NCT01436656|448609736|FG003|Dose Expansion|Disease progression|0|||
124723367|NCT01436656|448609737|FG004|Dose Expansion|Disease progression|0|||
124723368|NCT01436656|448609738|FG005|Dose Expansion|Disease progression|0|||
124723369|NCT01436656|448609739|FG006|Dose Expansion|Disease progression|0|||
124723370|NCT01436656|448609740|FG007|Dose Expansion|Disease progression|0|||
124723371|NCT01436656|448609741|FG008|Dose Expansion|Disease progression|0|||
124723372|NCT01436656|448609742|FG009|Dose Expansion|Disease progression|0|||
124723373|NCT01436656|448609743|FG010|Dose Expansion|Disease progression|0|||
124723374|NCT01436656|448609744|FG011|Dose Expansion|Disease progression|3|||
124723375|NCT01436656|448609745|FG012|Dose Expansion|Disease progression|1|||
124723376|NCT01436656|448609746|FG013|Dose Expansion|Disease progression|0|||
124723377|NCT01436656|448609747|FG014|Dose Expansion|Disease progression|1|||
124723378|NCT01436656|448609748|FG015|Dose Expansion|Disease progression|0|||
124723379|NCT01436656|448609749|FG016|Dose Expansion|Disease progression|0|||
124723380|NCT01436656|448609750|FG017|Dose Expansion|Disease progression|1|||
124723381|NCT01436656|448609733|FG000|Dose Expansion|New cancer therapy|0|||
124723382|NCT01436656|448609734|FG001|Dose Expansion|New cancer therapy|0|||
124495986|NCT01258348|447770026|FG000|Overall Study|Adverse Event|1|||
124495987|NCT01258348|447770027|FG001|Overall Study|Adverse Event|1|||
124723383|NCT01436656|448609735|FG002|Dose Expansion|New cancer therapy|0|||
124723384|NCT01436656|448609736|FG003|Dose Expansion|New cancer therapy|0|||
124495988|NCT01258348|447770028|FG002|Overall Study|Adverse Event|3|||
124495989|NCT01258348|447770029|FG003|Overall Study|Adverse Event|2|||
124723385|NCT01436656|448609737|FG004|Dose Expansion|New cancer therapy|0|||
124773401|NCT02392624|448800521|FG002|Overall Study|Pregnancy|0|||
124773402|NCT02392624|448800519|FG000|Overall Study|Protocol Violation|0|||
124773403|NCT02392624|448800520|FG001|Overall Study|Protocol Violation|0|||
124773404|NCT02392624|448800521|FG002|Overall Study|Protocol Violation|1|||
124773405|NCT02392624|448800519|FG000|Overall Study|Sponsor/Investigator Decision|2|||
124773406|NCT02392624|448800520|FG001|Overall Study|Sponsor/Investigator Decision|1|||
124773407|NCT02392624|448800521|FG002|Overall Study|Sponsor/Investigator Decision|0|||
124773408|NCT02392624|448800519|FG000|Overall Study|Other|49|||
124773409|NCT02392624|448800520|FG001|Overall Study|Other|1|||
124773410|NCT02392624|448800521|FG002|Overall Study|Other|1|||
124773411|NCT00706238|448800522|FG000|Overall Study|Disease progression|4|||
124773412|NCT00706238|448800522|FG000|Overall Study|Other|1|||
124495990|NCT01258348|447770030|FG004|Overall Study|Adverse Event|4|||
124495991|NCT01258348|447770026|FG000|Overall Study|Progressive Disease|0|||
124495992|NCT01258348|447770027|FG001|Overall Study|Progressive Disease|3|||
124495993|NCT01258348|447770028|FG002|Overall Study|Progressive Disease|0|||
124495994|NCT01258348|447770029|FG003|Overall Study|Progressive Disease|2|||
124495995|NCT01258348|447770030|FG004|Overall Study|Progressive Disease|2|||
124495996|NCT01258348|447770026|FG000|Overall Study|Physician Decision|0|||
124495997|NCT01258348|447770027|FG001|Overall Study|Physician Decision|0|||
124495998|NCT01258348|447770028|FG002|Overall Study|Physician Decision|0|||
124495999|NCT01258348|447770029|FG003|Overall Study|Physician Decision|2|||
124496000|NCT01258348|447770030|FG004|Overall Study|Physician Decision|0|||
124496001|NCT01258348|447770026|FG000|Overall Study|Withdrawal by Subject|0|||
124496002|NCT01258348|447770027|FG001|Overall Study|Withdrawal by Subject|1|||
124496003|NCT01258348|447770028|FG002|Overall Study|Withdrawal by Subject|0|||
124496004|NCT01258348|447770029|FG003|Overall Study|Withdrawal by Subject|0|||
124496005|NCT01258348|447770030|FG004|Overall Study|Withdrawal by Subject|0|||
124496006|NCT02433288|447770033|FG000|Overall Study|Severe non-compliance to protocol|13|||
124496007|NCT02433288|447770034|FG001|Overall Study|Severe non-compliance to protocol|7|||
124496008|NCT02433288|447770033|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
124496009|NCT02433288|447770034|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
124496010|NCT02433288|447770033|FG000|Overall Study|Withdrawal by Subject|101|||
124496011|NCT02433288|447770034|FG001|Overall Study|Withdrawal by Subject|99|||
124496012|NCT02433288|447770033|FG000|Overall Study|Lost to Follow-up|2|||
124496013|NCT02433288|447770034|FG001|Overall Study|Lost to Follow-up|14|||
124496014|NCT02433288|447770033|FG000|Overall Study|Death|0|||
124496015|NCT02433288|447770034|FG001|Overall Study|Death|3|||
124496016|NCT00367640|447770035|FG000|Overall Study|Adverse Event|3|||
124496017|NCT00367640|447770036|FG001|Overall Study|Adverse Event|6|||
124496018|NCT00367640|447770037|FG002|Overall Study|Adverse Event|8|||
124496019|NCT00367640|447770038|FG003|Overall Study|Adverse Event|0|||
124496020|NCT00367640|447770035|FG000|Overall Study|Withdrawal by Subject|8|||
124496021|NCT00367640|447770036|FG001|Overall Study|Withdrawal by Subject|11|||
124496022|NCT00367640|447770037|FG002|Overall Study|Withdrawal by Subject|8|||
124496023|NCT00367640|447770038|FG003|Overall Study|Withdrawal by Subject|6|||
124496024|NCT00367640|447770035|FG000|Overall Study|Any other reason not above-mentioned|7|||
124496025|NCT00367640|447770036|FG001|Overall Study|Any other reason not above-mentioned|5|||
124496026|NCT00367640|447770037|FG002|Overall Study|Any other reason not above-mentioned|3|||
124496027|NCT00367640|447770038|FG003|Overall Study|Any other reason not above-mentioned|4|||
124496028|NCT00406315|447770040|FG000|Overall Study|Death|1|||
124496029|NCT00406315|447770040|FG000|Overall Study|Adverse Event|39|||
124496030|NCT00406315|447770040|FG000|Overall Study|Laboratory Abnormality|4|||
124496031|NCT00406315|447770040|FG000|Overall Study|Lack of Efficacy|13|||
124496032|NCT00406315|447770040|FG000|Overall Study|Other|33|||
124773413|NCT01193244|448800525|FG000|Overall Study|Withdrawal by Subject|79|||
124773414|NCT01193244|448800526|FG001|Overall Study|Withdrawal by Subject|97|||
124496033|NCT00406315|447770040|FG000|Overall Study|Lost to Follow-up|21|||
124496034|NCT00406315|447770040|FG000|Overall Study|Withdrawal by Subject|30|||
124496035|NCT02142894|447770044|FG000|Overall Study|Protocol Violation|8|||
124496036|NCT01455428|447770051|FG000|Overall Study|Protocol Violation|2|||
124496037|NCT01455428|447770052|FG001|Overall Study|Protocol Violation|1|||
124496038|NCT01455428|447770051|FG000|Overall Study|Adverse Event|6|||
124496039|NCT01455428|447770052|FG001|Overall Study|Adverse Event|2|||
124496040|NCT01455428|447770051|FG000|Overall Study|Lost to Follow-up|1|||
124496041|NCT01455428|447770052|FG001|Overall Study|Lost to Follow-up|1|||
124496042|NCT01455428|447770051|FG000|Overall Study|Withdrawal by Subject|2|||
124773415|NCT01193244|448800525|FG000|Overall Study|Other|303|||
124496043|NCT01455428|447770052|FG001|Overall Study|Withdrawal by Subject|5|||
124496044|NCT01455428|447770051|FG000|Overall Study|Did not meet entrance criteria|0|||
124496045|NCT01455428|447770052|FG001|Overall Study|Did not meet entrance criteria|2|||
124496046|NCT01455428|447770051|FG000|Overall Study|Insufficient clinical response|0|||
124496047|NCT01455428|447770052|FG001|Overall Study|Insufficient clinical response|2|||
124773416|NCT01193244|448800526|FG001|Overall Study|Other|278|||
124773417|NCT01193244|448800525|FG000|Overall Study|Lost to Follow-up|6|||
124773418|NCT01193244|448800526|FG001|Overall Study|Lost to Follow-up|15|||
124496048|NCT01455428|447770051|FG000|Overall Study|Did not receive treatment|1|||
124773419|NCT03763877|448800528|FG000|Overall Study|Withdrawal by Subject|3|||
124496049|NCT01455428|447770052|FG001|Overall Study|Did not receive treatment|1|||
124496050|NCT01455428|447770051|FG000|Overall Study|Other|2|||
124496051|NCT01455428|447770052|FG001|Overall Study|Other|4|||
124496052|NCT03303339|447770053|FG000|Overall Study|Death|2|||
124496053|NCT03303339|447770054|FG001|Overall Study|Death|2|||
124496054|NCT03303339|447770055|FG002|Overall Study|Death|2|||
124496055|NCT03303339|447770056|FG003|Overall Study|Death|1|||
124496056|NCT03303339|447770057|FG004|Overall Study|Death|4|||
124496057|NCT03303339|447770058|FG005|Overall Study|Death|2|||
124496058|NCT03303339|447770059|FG006|Overall Study|Death|2|||
124496059|NCT03303339|447770060|FG007|Overall Study|Death|2|||
124496060|NCT03303339|447770061|FG008|Overall Study|Death|3|||
124496061|NCT03303339|447770062|FG009|Overall Study|Death|3|||
124496062|NCT03303339|447770063|FG010|Overall Study|Death|4|||
124496063|NCT03303339|447770064|FG011|Overall Study|Death|24|||
124496064|NCT03303339|447770053|FG000|Overall Study|Study Terminated by Sponsor|0|||
124496065|NCT03303339|447770054|FG001|Overall Study|Study Terminated by Sponsor|0|||
124496066|NCT03303339|447770055|FG002|Overall Study|Study Terminated by Sponsor|0|||
124496067|NCT03303339|447770056|FG003|Overall Study|Study Terminated by Sponsor|0|||
124496068|NCT03303339|447770057|FG004|Overall Study|Study Terminated by Sponsor|0|||
124496069|NCT03303339|447770058|FG005|Overall Study|Study Terminated by Sponsor|0|||
124496070|NCT03303339|447770059|FG006|Overall Study|Study Terminated by Sponsor|0|||
124496071|NCT03303339|447770060|FG007|Overall Study|Study Terminated by Sponsor|0|||
124496072|NCT03303339|447770061|FG008|Overall Study|Study Terminated by Sponsor|1|||
124496073|NCT03303339|447770062|FG009|Overall Study|Study Terminated by Sponsor|0|||
124496074|NCT03303339|447770063|FG010|Overall Study|Study Terminated by Sponsor|1|||
124496075|NCT03303339|447770064|FG011|Overall Study|Study Terminated by Sponsor|1|||
124496076|NCT03303339|447770053|FG000|Overall Study|Withdrawal by Subject|1|||
124496077|NCT03303339|447770054|FG001|Overall Study|Withdrawal by Subject|0|||
124496078|NCT03303339|447770055|FG002|Overall Study|Withdrawal by Subject|0|||
124496079|NCT03303339|447770056|FG003|Overall Study|Withdrawal by Subject|0|||
124496080|NCT03303339|447770057|FG004|Overall Study|Withdrawal by Subject|0|||
124496081|NCT03303339|447770058|FG005|Overall Study|Withdrawal by Subject|1|||
124496082|NCT03303339|447770059|FG006|Overall Study|Withdrawal by Subject|1|||
124496083|NCT03303339|447770060|FG007|Overall Study|Withdrawal by Subject|0|||
124496084|NCT03303339|447770061|FG008|Overall Study|Withdrawal by Subject|0|||
124496085|NCT03303339|447770062|FG009|Overall Study|Withdrawal by Subject|0|||
124496086|NCT03303339|447770063|FG010|Overall Study|Withdrawal by Subject|0|||
124496087|NCT03303339|447770064|FG011|Overall Study|Withdrawal by Subject|2|||
124496088|NCT03303339|447770053|FG000|Overall Study|Physician Decision|0|||
124496089|NCT03303339|447770054|FG001|Overall Study|Physician Decision|0|||
124496090|NCT03303339|447770055|FG002|Overall Study|Physician Decision|0|||
124496091|NCT03303339|447770056|FG003|Overall Study|Physician Decision|0|||
124496092|NCT03303339|447770057|FG004|Overall Study|Physician Decision|1|||
124496093|NCT03303339|447770058|FG005|Overall Study|Physician Decision|0|||
124496094|NCT03303339|447770059|FG006|Overall Study|Physician Decision|0|||
124496095|NCT03303339|447770060|FG007|Overall Study|Physician Decision|0|||
124496096|NCT03303339|447770061|FG008|Overall Study|Physician Decision|0|||
124496097|NCT03303339|447770062|FG009|Overall Study|Physician Decision|0|||
124496098|NCT03303339|447770063|FG010|Overall Study|Physician Decision|0|||
124496099|NCT03303339|447770064|FG011|Overall Study|Physician Decision|0|||
124496100|NCT03303339|447770053|FG000|Overall Study|Safety/Non-compliance|0|||
124496101|NCT03303339|447770054|FG001|Overall Study|Safety/Non-compliance|0|||
124496102|NCT03303339|447770055|FG002|Overall Study|Safety/Non-compliance|0|||
124496103|NCT03303339|447770056|FG003|Overall Study|Safety/Non-compliance|0|||
124496104|NCT03303339|447770057|FG004|Overall Study|Safety/Non-compliance|0|||
124496105|NCT03303339|447770058|FG005|Overall Study|Safety/Non-compliance|0|||
124496106|NCT03303339|447770059|FG006|Overall Study|Safety/Non-compliance|0|||
124496107|NCT03303339|447770060|FG007|Overall Study|Safety/Non-compliance|0|||
124496108|NCT03303339|447770061|FG008|Overall Study|Safety/Non-compliance|0|||
124496109|NCT03303339|447770062|FG009|Overall Study|Safety/Non-compliance|0|||
124496110|NCT03303339|447770063|FG010|Overall Study|Safety/Non-compliance|0|||
124496111|NCT03303339|447770064|FG011|Overall Study|Safety/Non-compliance|1|||
124496112|NCT00257192|447770067|FG000|Overall Study|Adverse Event|21|||
124496113|NCT00257192|447770068|FG001|Overall Study|Adverse Event|10|||
124496114|NCT00257192|447770067|FG000|Overall Study|Laboratory abnormality|1|||
124496115|NCT00257192|447770068|FG001|Overall Study|Laboratory abnormality|1|||
124496116|NCT00257192|447770067|FG000|Overall Study|Lost to Follow-up|3|||
124496117|NCT00257192|447770068|FG001|Overall Study|Lost to Follow-up|3|||
124496118|NCT00257192|447770067|FG000|Overall Study|Insufficient clinical response|18|||
124496119|NCT00257192|447770068|FG001|Overall Study|Insufficient clinical response|18|||
124496120|NCT00257192|447770067|FG000|Overall Study|Withdrawal by Subject|14|||
124496121|NCT00257192|447770068|FG001|Overall Study|Withdrawal by Subject|2|||
124496122|NCT00257192|447770067|FG000|Overall Study|Randomized but not treated|0|||
124496123|NCT00257192|447770068|FG001|Overall Study|Randomized but not treated|1|||
124496124|NCT00257192|447770067|FG000|Overall Study|Study terminated by sponsor|1|||
124496125|NCT00257192|447770068|FG001|Overall Study|Study terminated by sponsor|0|||
124496126|NCT00257192|447770067|FG000|Overall Study|Miscellaneous|0|||
124773420|NCT03763877|448800529|FG001|Overall Study|Withdrawal by Subject|1|||
124773421|NCT03763877|448800530|FG002|Overall Study|Withdrawal by Subject|3|||
124773422|NCT03763877|448800531|FG003|Overall Study|Withdrawal by Subject|4|||
124773423|NCT03763877|448800528|FG000|Overall Study|Adverse Event|1|||
124773424|NCT03763877|448800529|FG001|Overall Study|Adverse Event|1|||
124773425|NCT03763877|448800530|FG002|Overall Study|Adverse Event|3|||
124773426|NCT03763877|448800531|FG003|Overall Study|Adverse Event|1|||
124773427|NCT03763877|448800528|FG000|Overall Study|Protocol Violation|1|||
124773428|NCT03763877|448800529|FG001|Overall Study|Protocol Violation|1|||
124773429|NCT03763877|448800530|FG002|Overall Study|Protocol Violation|0|||
124773430|NCT03763877|448800531|FG003|Overall Study|Protocol Violation|0|||
124496127|NCT00257192|447770068|FG001|Overall Study|Miscellaneous|4|||
124496128|NCT00570739|447770069|FG000|Overall Study|Adverse Event|8|||
124496129|NCT00570739|447770070|FG001|Overall Study|Adverse Event|6|||
124496130|NCT00570739|447770071|FG002|Overall Study|Adverse Event|2|||
124496131|NCT00570739|447770072|FG003|Overall Study|Adverse Event|2|||
124496132|NCT00570739|447770069|FG000|Overall Study|Lost to Follow-up|4|||
124496133|NCT00570739|447770070|FG001|Overall Study|Lost to Follow-up|5|||
124496134|NCT00570739|447770071|FG002|Overall Study|Lost to Follow-up|4|||
124496135|NCT00570739|447770072|FG003|Overall Study|Lost to Follow-up|1|||
124496136|NCT00570739|447770069|FG000|Overall Study|Physician Decision|1|||
124496137|NCT00570739|447770070|FG001|Overall Study|Physician Decision|1|||
124496138|NCT00570739|447770071|FG002|Overall Study|Physician Decision|0|||
124496139|NCT00570739|447770072|FG003|Overall Study|Physician Decision|0|||
124496140|NCT00570739|447770069|FG000|Overall Study|Withdrawal by Subject|7|||
124496141|NCT00570739|447770070|FG001|Overall Study|Withdrawal by Subject|7|||
124496142|NCT00570739|447770071|FG002|Overall Study|Withdrawal by Subject|3|||
124496143|NCT00570739|447770072|FG003|Overall Study|Withdrawal by Subject|5|||
124496144|NCT00570739|447770069|FG000|Overall Study|Required restricted medication|0|||
124496145|NCT00570739|447770070|FG001|Overall Study|Required restricted medication|0|||
124496146|NCT00570739|447770071|FG002|Overall Study|Required restricted medication|1|||
124496147|NCT00570739|447770072|FG003|Overall Study|Required restricted medication|0|||
124496148|NCT00570739|447770069|FG000|Overall Study|Met discontinuation criteria|1|||
124496149|NCT00570739|447770070|FG001|Overall Study|Met discontinuation criteria|0|||
124496150|NCT00570739|447770071|FG002|Overall Study|Met discontinuation criteria|1|||
124496151|NCT00570739|447770072|FG003|Overall Study|Met discontinuation criteria|1|||
124496152|NCT00570739|447770069|FG000|Overall Study|Other|0|||
124496153|NCT00570739|447770070|FG001|Overall Study|Other|2|||
124496154|NCT00570739|447770071|FG002|Overall Study|Other|5|||
124496155|NCT00570739|447770072|FG003|Overall Study|Other|3|||
124496156|NCT01400971|447770076|FG000|Overall Study|Death|82|||
124496157|NCT01400971|447770076|FG000|Overall Study|Lost to Follow-up|196|||
124496158|NCT01400971|447770076|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
124496159|NCT01400971|447770076|FG000|Overall Study|Physician Decision|57|||
124496160|NCT01400971|447770076|FG000|Overall Study|Withdrawal by Subject|158|||
124496161|NCT01400971|447770076|FG000|Overall Study|Other|422|||
124496162|NCT01921270|447770080|FG000|Overall Study|Withdrawal by Subject|1|||
124496163|NCT00455858|447770081|FG000|Overall Study|Lost to Follow-up|2|||
124496164|NCT00455858|447770081|FG000|Overall Study|Protocol Violation|1|||
124496165|NCT00455858|447770081|FG000|Overall Study|Lack of Efficacy|1|||
124496166|NCT00455858|447770081|FG000|Overall Study|Well controlled FPG without insulin|1|||
124496167|NCT00455858|447770081|FG000|Overall Study|Withdrawal|1|||
124496168|NCT02375698|447770082|FG000|Overall Study|Withdrawal by Subject|0|||
124496169|NCT02375698|447770083|FG001|Overall Study|Withdrawal by Subject|2|||
124496170|NCT02375698|447770082|FG000|Overall Study|Physician Decision|2|||
124496171|NCT02375698|447770083|FG001|Overall Study|Physician Decision|0|||
124496172|NCT01595646|447770086|FG000|Overall Study|Withdrawal by Subject|1|||
124496173|NCT01595646|447770087|FG001|Overall Study|Withdrawal by Subject|0|||
124496174|NCT01595646|447770088|FG002|Overall Study|Withdrawal by Subject|0|||
124496175|NCT00231062|447770090|FG000|Overall Study|Physician Decision|6|||
124496176|NCT00803244|447770091|FG000|Overall Study|Adverse Event|1|||
124496177|NCT00803244|447770092|FG001|Overall Study|Adverse Event|2|||
124496178|NCT00803244|447770091|FG000|Overall Study|Withdrawal by Subject|2|||
124496179|NCT00803244|447770092|FG001|Overall Study|Withdrawal by Subject|3|||
124496180|NCT00803244|447770091|FG000|Overall Study|Any other reason not above-mentioned|4|||
124496181|NCT00803244|447770092|FG001|Overall Study|Any other reason not above-mentioned|10|||
124496182|NCT00616239|447770093|FG000|Overall Study|Withdrawal by Subject|2|||
124496183|NCT02873715|447770094|FG000|Overall Study|Lost to Follow-up|84|||
124496184|NCT02873715|447770095|FG001|Overall Study|Lost to Follow-up|94|||
124496185|NCT02873715|447770094|FG000|Overall Study|Withdrawal by Subject|7|||
124496186|NCT02873715|447770095|FG001|Overall Study|Withdrawal by Subject|26|||
124496187|NCT02021812|447770096|FG000|Overall Study|Death|8|||
124496188|NCT02021812|447770096|FG000|Overall Study|Withdrawal by Subject|3|||
124496189|NCT02021812|447770096|FG000|Overall Study|Lost to Follow-up|2|||
124496190|NCT02021812|447770096|FG000|Overall Study|Refuse to return, COVD 19|2|||
124496191|NCT03241173|447770097|FG000|Overall Study|Death|3|||
124773431|NCT03763877|448800528|FG000|Overall Study|Lost to Follow-up|0|||
124773432|NCT03763877|448800529|FG001|Overall Study|Lost to Follow-up|1|||
124496192|NCT03241173|447770098|FG001|Overall Study|Death|2|||
124496193|NCT03241173|447770099|FG002|Overall Study|Death|4|||
124496194|NCT03241173|447770100|FG003|Overall Study|Death|4|||
124496195|NCT03241173|447770101|FG004|Overall Study|Death|2|||
124496196|NCT03241173|447770102|FG005|Overall Study|Death|2|||
124496197|NCT03241173|447770103|FG006|Overall Study|Death|3|||
124496198|NCT03241173|447770104|FG007|Overall Study|Death|1|||
124496199|NCT03241173|447770105|FG008|Overall Study|Death|0|||
124496200|NCT03241173|447770106|FG009|Overall Study|Death|5|||
124496201|NCT03241173|447770107|FG010|Overall Study|Death|4|||
124558500|NCT02378506|448001487|FG000|Overall Study|Randomized But Not Treated|1|||
124723386|NCT01436656|448609738|FG005|Dose Expansion|New cancer therapy|0|||
124723387|NCT01436656|448609739|FG006|Dose Expansion|New cancer therapy|0|||
124723388|NCT01436656|448609740|FG007|Dose Expansion|New cancer therapy|0|||
124723389|NCT01436656|448609741|FG008|Dose Expansion|New cancer therapy|0|||
124723390|NCT01436656|448609742|FG009|Dose Expansion|New cancer therapy|0|||
124723391|NCT01436656|448609743|FG010|Dose Expansion|New cancer therapy|0|||
124723392|NCT01436656|448609744|FG011|Dose Expansion|New cancer therapy|1|||
124723393|NCT01436656|448609745|FG012|Dose Expansion|New cancer therapy|1|||
124723394|NCT01436656|448609746|FG013|Dose Expansion|New cancer therapy|0|||
124723395|NCT01436656|448609747|FG014|Dose Expansion|New cancer therapy|2|||
124723396|NCT01436656|448609748|FG015|Dose Expansion|New cancer therapy|0|||
124723397|NCT01436656|448609749|FG016|Dose Expansion|New cancer therapy|0|||
124723398|NCT01436656|448609750|FG017|Dose Expansion|New cancer therapy|0|||
124723399|NCT04729972|448609751|FG000|Overall Study|Adverse Event|1|||
124723400|NCT03206970|448609753|FG000|Overall Study|Death|21|||
124723401|NCT03206970|448609753|FG000|Overall Study|Withdrawal by Subject|13|||
124723402|NCT03206970|448609753|FG000|Overall Study|Lost to Follow-up|3|||
124723403|NCT03206970|448609753|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
124723404|NCT02516982|448609754|FG000|Overall Study|Called in to antenatal appointment|32|||
124723405|NCT02516982|448609755|FG001|Overall Study|Called in to antenatal appointment|35|||
124723406|NCT02516982|448609756|FG002|Overall Study|Called in to antenatal appointment|0|||
124723407|NCT02516982|448609757|FG003|Overall Study|Called in to antenatal appointment|0|||
124723408|NCT02516982|448609754|FG000|Overall Study|Withdrawal by Subject|0|||
124723409|NCT02516982|448609755|FG001|Overall Study|Withdrawal by Subject|0|||
124723410|NCT02516982|448609756|FG002|Overall Study|Withdrawal by Subject|1|||
124723411|NCT02516982|448609757|FG003|Overall Study|Withdrawal by Subject|2|||
124723412|NCT02516982|448609754|FG000|Overall Study|Protocol Violation|0|||
124723413|NCT02516982|448609755|FG001|Overall Study|Protocol Violation|0|||
124723414|NCT02516982|448609756|FG002|Overall Study|Protocol Violation|1|||
124723415|NCT02516982|448609757|FG003|Overall Study|Protocol Violation|1|||
124723416|NCT02516982|448609754|FG000|Overall Study|Did not install the app|0|||
124723417|NCT02516982|448609755|FG001|Overall Study|Did not install the app|0|||
124723418|NCT02516982|448609756|FG002|Overall Study|Did not install the app|46|||
124723419|NCT02516982|448609757|FG003|Overall Study|Did not install the app|47|||
124723420|NCT00962741|448609763|FG000|Overall Study|Failed to return|3|||
124723421|NCT00962741|448609763|FG000|Overall Study|Lost to Follow-up|2|||
124723422|NCT00962741|448609763|FG000|Overall Study|Withdrawal by Subject|1|||
124723423|NCT00962741|448609763|FG000|Overall Study|Lack of Efficacy|1|||
124723424|NCT00962741|448609763|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
124723425|NCT01814878|448609764|FG000|Overall Study|Adverse Event|16|||
124723426|NCT01814878|448609765|FG001|Overall Study|Adverse Event|5|||
124723427|NCT01814878|448609764|FG000|Overall Study|Withdrawal by Subject|20|||
124723428|NCT01814878|448609765|FG001|Overall Study|Withdrawal by Subject|16|||
124723429|NCT01814878|448609764|FG000|Overall Study|Protocol Violation|5|||
124723430|NCT01814878|448609765|FG001|Overall Study|Protocol Violation|5|||
124723431|NCT01814878|448609764|FG000|Overall Study|Physician Decision|3|||
124723432|NCT01814878|448609765|FG001|Overall Study|Physician Decision|1|||
124723433|NCT01814878|448609764|FG000|Overall Study|Screening failure (drop-out)|0|||
124723434|NCT01814878|448609765|FG001|Overall Study|Screening failure (drop-out)|3|||
124723435|NCT01814878|448609764|FG000|Overall Study|Other|2|||
124723436|NCT01814878|448609765|FG001|Overall Study|Other|0|||
124723437|NCT03645421|448609766|FG000|Overall Study|Adverse Event|0|||
124723438|NCT03645421|448609767|FG001|Overall Study|Adverse Event|0|||
124723439|NCT03645421|448609768|FG002|Overall Study|Adverse Event|4|||
124723440|NCT03645421|448609769|FG003|Overall Study|Adverse Event|1|||
124723441|NCT03645421|448609766|FG000|Overall Study|Withdrawal by patient|0|||
124723442|NCT03645421|448609767|FG001|Overall Study|Withdrawal by patient|0|||
124723443|NCT03645421|448609768|FG002|Overall Study|Withdrawal by patient|0|||
124723444|NCT03645421|448609769|FG003|Overall Study|Withdrawal by patient|3|||
124723445|NCT03645421|448609766|FG000|Overall Study|Study specific withdrawal criteria|0|||
124723446|NCT03645421|448609767|FG001|Overall Study|Study specific withdrawal criteria|0|||
124496202|NCT03241173|447770108|FG011|Overall Study|Death|3|||
124496203|NCT03241173|447770109|FG012|Overall Study|Death|0|||
124723447|NCT03645421|448609768|FG002|Overall Study|Study specific withdrawal criteria|1|||
124496204|NCT03241173|447770110|FG013|Overall Study|Death|0|||
124773433|NCT03763877|448800530|FG002|Overall Study|Lost to Follow-up|1|||
124496205|NCT03241173|447770111|FG014|Overall Study|Death|0|||
124496206|NCT03241173|447770097|FG000|Overall Study|Withdrawal by Subject|0|||
124773434|NCT03763877|448800531|FG003|Overall Study|Lost to Follow-up|0|||
124773435|NCT03040336|448800532|FG000|Overall Study|Death|1|||
124773436|NCT03040336|448800533|FG001|Overall Study|Death|0|||
124773437|NCT03040336|448800532|FG000|Overall Study|Withdrawal by Subject|2|||
124773438|NCT03040336|448800533|FG001|Overall Study|Withdrawal by Subject|3|||
124773439|NCT00068692|448800538|FG000|Step 1: Registration|Disese progression/relapse|5|||
124773440|NCT00068692|448800539|FG001|Step 1: Registration|Disese progression/relapse|0|||
124773441|NCT00068692|448800540|FG002|Step 1: Registration|Disese progression/relapse|0|||
124773442|NCT00068692|448800541|FG003|Step 1: Registration|Disese progression/relapse|0|||
124773443|NCT00068692|448800542|FG004|Step 1: Registration|Disese progression/relapse|0|||
124773444|NCT00068692|448800543|FG005|Step 1: Registration|Disese progression/relapse|0|||
124773445|NCT00068692|448800544|FG006|Step 1: Registration|Disese progression/relapse|0|||
124773446|NCT00068692|448800545|FG007|Step 1: Registration|Disese progression/relapse|0|||
124773447|NCT00068692|448800538|FG000|Step 1: Registration|Adverse Event|7|||
124773448|NCT00068692|448800539|FG001|Step 1: Registration|Adverse Event|0|||
124496207|NCT03241173|447770098|FG001|Overall Study|Withdrawal by Subject|0|||
124496208|NCT03241173|447770099|FG002|Overall Study|Withdrawal by Subject|1|||
124496209|NCT03241173|447770100|FG003|Overall Study|Withdrawal by Subject|0|||
124496210|NCT03241173|447770101|FG004|Overall Study|Withdrawal by Subject|0|||
124496211|NCT03241173|447770102|FG005|Overall Study|Withdrawal by Subject|1|||
124496212|NCT03241173|447770103|FG006|Overall Study|Withdrawal by Subject|0|||
124496213|NCT03241173|447770104|FG007|Overall Study|Withdrawal by Subject|0|||
124496214|NCT03241173|447770105|FG008|Overall Study|Withdrawal by Subject|0|||
124496215|NCT03241173|447770106|FG009|Overall Study|Withdrawal by Subject|0|||
124496216|NCT03241173|447770107|FG010|Overall Study|Withdrawal by Subject|0|||
124496217|NCT03241173|447770108|FG011|Overall Study|Withdrawal by Subject|0|||
124496218|NCT03241173|447770109|FG012|Overall Study|Withdrawal by Subject|0|||
124496219|NCT03241173|447770110|FG013|Overall Study|Withdrawal by Subject|0|||
124496220|NCT03241173|447770111|FG014|Overall Study|Withdrawal by Subject|0|||
124496221|NCT03241173|447770097|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
124496222|NCT03241173|447770098|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
124496223|NCT03241173|447770099|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
124496224|NCT03241173|447770100|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
124496225|NCT03241173|447770101|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
124496226|NCT03241173|447770102|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
124496227|NCT03241173|447770103|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
124496228|NCT03241173|447770104|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
124496229|NCT03241173|447770105|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
124496230|NCT03241173|447770106|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
124496231|NCT03241173|447770107|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
124496232|NCT03241173|447770108|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
124496233|NCT03241173|447770109|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
124496234|NCT03241173|447770110|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
124496235|NCT03241173|447770111|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
124496236|NCT03241173|447770097|FG000|Overall Study|Lost to Follow-up|0|||
124496237|NCT03241173|447770098|FG001|Overall Study|Lost to Follow-up|0|||
124496238|NCT03241173|447770099|FG002|Overall Study|Lost to Follow-up|0|||
124496239|NCT03241173|447770100|FG003|Overall Study|Lost to Follow-up|0|||
124496240|NCT03241173|447770101|FG004|Overall Study|Lost to Follow-up|1|||
124496241|NCT03241173|447770102|FG005|Overall Study|Lost to Follow-up|0|||
124496242|NCT03241173|447770103|FG006|Overall Study|Lost to Follow-up|0|||
124496243|NCT03241173|447770104|FG007|Overall Study|Lost to Follow-up|0|||
124496244|NCT03241173|447770105|FG008|Overall Study|Lost to Follow-up|0|||
124496245|NCT03241173|447770106|FG009|Overall Study|Lost to Follow-up|1|||
124496246|NCT03241173|447770107|FG010|Overall Study|Lost to Follow-up|0|||
124496247|NCT03241173|447770108|FG011|Overall Study|Lost to Follow-up|0|||
124496248|NCT03241173|447770109|FG012|Overall Study|Lost to Follow-up|0|||
124496249|NCT03241173|447770110|FG013|Overall Study|Lost to Follow-up|0|||
124496250|NCT03241173|447770111|FG014|Overall Study|Lost to Follow-up|0|||
124496251|NCT02698423|447770112|FG000|Overall Study|Lost to Follow-up|19|||
124496252|NCT02698423|447770113|FG001|Overall Study|Lost to Follow-up|24|||
124496253|NCT01651260|447770114|FG000|Overall Study|unable to apply product|3|||
124496254|NCT01259297|447770118|FG000|Double Blind Randomized Period|Death|1|||
124496255|NCT01259297|447770119|FG001|Double Blind Randomized Period|Death|1|||
124496256|NCT01259297|447770120|FG002|Double Blind Randomized Period|Death|1|||
124773449|NCT00068692|448800540|FG002|Step 1: Registration|Adverse Event|0|||
124773450|NCT00068692|448800541|FG003|Step 1: Registration|Adverse Event|0|||
124496257|NCT01259297|447770121|FG003|Double Blind Randomized Period|Death|2|||
124558501|NCT00185211|448001488|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
124773451|NCT00068692|448800542|FG004|Step 1: Registration|Adverse Event|0|||
124773452|NCT00068692|448800543|FG005|Step 1: Registration|Adverse Event|0|||
124496258|NCT01259297|447770122|FG004|Double Blind Randomized Period|Death|1|||
124496259|NCT01259297|447770123|FG005|Double Blind Randomized Period|Death|5|||
124496260|NCT01259297|447770124|FG006|Double Blind Randomized Period|Death|2|||
124496261|NCT01259297|447770125|FG007|Double Blind Randomized Period|Death|1|||
124496262|NCT01259297|447770118|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
124496263|NCT01259297|447770119|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
124496264|NCT01259297|447770120|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
124496265|NCT01259297|447770121|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
124496266|NCT01259297|447770122|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
124496267|NCT01259297|447770123|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
124496268|NCT01259297|447770124|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
124496269|NCT01259297|447770125|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
124496270|NCT01259297|447770118|FG000|Double Blind Randomized Period|Other reasons|0|||
124496271|NCT01259297|447770119|FG001|Double Blind Randomized Period|Other reasons|1|||
124496272|NCT01259297|447770120|FG002|Double Blind Randomized Period|Other reasons|0|||
124496273|NCT01259297|447770121|FG003|Double Blind Randomized Period|Other reasons|0|||
124496274|NCT01259297|447770122|FG004|Double Blind Randomized Period|Other reasons|1|||
124496275|NCT01259297|447770123|FG005|Double Blind Randomized Period|Other reasons|2|||
124496276|NCT01259297|447770124|FG006|Double Blind Randomized Period|Other reasons|3|||
124496277|NCT01259297|447770125|FG007|Double Blind Randomized Period|Other reasons|1|||
124496278|NCT00064662|447770128|FG000|Overall Study|Death|1|||
124496279|NCT00064662|447770129|FG001|Overall Study|Death|1|||
124496280|NCT00064662|447770128|FG000|Overall Study|Lost to Follow-up|57|||
124496281|NCT00064662|447770129|FG001|Overall Study|Lost to Follow-up|44|||
124496282|NCT00064662|447770128|FG000|Overall Study|Withdrawal by Subject|14|||
124496283|NCT00064662|447770129|FG001|Overall Study|Withdrawal by Subject|14|||
124496284|NCT00064662|447770128|FG000|Overall Study|Administratively withdrawn|2|||
124496285|NCT00064662|447770129|FG001|Overall Study|Administratively withdrawn|2|||
124496286|NCT01345786|447770139|FG000|Overall Study|Adverse Event|0|||
124496287|NCT01345786|447770140|FG001|Overall Study|Adverse Event|1|||
124496288|NCT01345786|447770141|FG002|Overall Study|Adverse Event|3|||
124496289|NCT01345786|447770142|FG003|Overall Study|Adverse Event|1|||
124496290|NCT01345786|447770139|FG000|Overall Study|Subject withdrew consent|2|||
124496291|NCT01345786|447770140|FG001|Overall Study|Subject withdrew consent|2|||
124496292|NCT01345786|447770141|FG002|Overall Study|Subject withdrew consent|1|||
124496293|NCT01345786|447770142|FG003|Overall Study|Subject withdrew consent|0|||
124496294|NCT01345786|447770139|FG000|Overall Study|Noncompliance with protocol|1|||
124496295|NCT01345786|447770140|FG001|Overall Study|Noncompliance with protocol|0|||
124496296|NCT01345786|447770141|FG002|Overall Study|Noncompliance with protocol|1|||
124496297|NCT01345786|447770142|FG003|Overall Study|Noncompliance with protocol|0|||
124496298|NCT01345786|447770139|FG000|Overall Study|Administrative|3|||
124496299|NCT01345786|447770140|FG001|Overall Study|Administrative|5|||
124496300|NCT01345786|447770141|FG002|Overall Study|Administrative|0|||
124496301|NCT01345786|447770142|FG003|Overall Study|Administrative|0|||
124496302|NCT01345786|447770139|FG000|Overall Study|Lost to Follow-up|0|||
124496303|NCT01345786|447770140|FG001|Overall Study|Lost to Follow-up|0|||
124496304|NCT01345786|447770141|FG002|Overall Study|Lost to Follow-up|0|||
124496305|NCT01345786|447770142|FG003|Overall Study|Lost to Follow-up|2|||
124496306|NCT01929044|447770143|FG000|Overall Study|Adverse Event|1|||
124496307|NCT01929044|447770144|FG001|Overall Study|Adverse Event|0|||
124496308|NCT01929044|447770143|FG000|Overall Study|Protocol Violation|9|||
124496309|NCT01929044|447770144|FG001|Overall Study|Protocol Violation|14|||
124496310|NCT01929044|447770143|FG000|Overall Study|Not Treated|1|||
124496311|NCT01929044|447770144|FG001|Overall Study|Not Treated|3|||
124496312|NCT01663740|447770145|FG000|Overall Study|Lost to Follow-up|1|||
124496313|NCT01663740|447770146|FG001|Overall Study|Lost to Follow-up|4|||
124496314|NCT01663740|447770145|FG000|Overall Study|Other|9|||
124496315|NCT01663740|447770146|FG001|Overall Study|Other|2|||
124496316|NCT01663740|447770145|FG000|Overall Study|Inclusion/Exclusion not met|1|||
124496317|NCT01663740|447770146|FG001|Overall Study|Inclusion/Exclusion not met|0|||
124496318|NCT01663740|447770145|FG000|Overall Study|Death|0|||
124496319|NCT01663740|447770146|FG001|Overall Study|Death|1|||
124496320|NCT01663740|447770145|FG000|Overall Study|Withdrawal by Subject|2|||
124496321|NCT01663740|447770146|FG001|Overall Study|Withdrawal by Subject|1|||
124496322|NCT01663740|447770145|FG000|Overall Study|No end of study status|3|||
124496323|NCT01663740|447770146|FG001|Overall Study|No end of study status|0|||
124496324|NCT03607682|447770147|FG000|Overall Study|Withdrawal by Subject|1|||
124496325|NCT03607682|447770147|FG000|Overall Study|Disease progression|1|||
124496326|NCT01770353|447770148|FG000|Overall Study|Progressive disease|2|||
124496327|NCT01770353|447770149|FG001|Overall Study|Progressive disease|1|||
124496328|NCT01770353|447770148|FG000|Overall Study|Adverse Event|0|||
124496329|NCT01770353|447770149|FG001|Overall Study|Adverse Event|1|||
124496330|NCT01770353|447770148|FG000|Overall Study|Protocol Violation|1|||
124496331|NCT01770353|447770149|FG001|Overall Study|Protocol Violation|0|||
124496332|NCT01770353|447770148|FG000|Overall Study|Physician Decision|0|||
124496333|NCT01770353|447770149|FG001|Overall Study|Physician Decision|3|||
124773453|NCT00068692|448800544|FG006|Step 1: Registration|Adverse Event|0|||
124773454|NCT00068692|448800545|FG007|Step 1: Registration|Adverse Event|0|||
124773455|NCT00068692|448800538|FG000|Step 1: Registration|Death|1|||
124773456|NCT00068692|448800539|FG001|Step 1: Registration|Death|0|||
124773457|NCT00068692|448800540|FG002|Step 1: Registration|Death|0|||
124773458|NCT00068692|448800541|FG003|Step 1: Registration|Death|0|||
124773459|NCT00068692|448800542|FG004|Step 1: Registration|Death|0|||
124773460|NCT00068692|448800543|FG005|Step 1: Registration|Death|0|||
124773461|NCT00068692|448800544|FG006|Step 1: Registration|Death|0|||
124773462|NCT00068692|448800545|FG007|Step 1: Registration|Death|0|||
124773463|NCT00068692|448800538|FG000|Step 1: Registration|Withdrawal by Subject|11|||
124773464|NCT00068692|448800539|FG001|Step 1: Registration|Withdrawal by Subject|0|||
124496334|NCT01770353|447770148|FG000|Overall Study|Clinical deterioration|3|||
124496335|NCT01770353|447770149|FG001|Overall Study|Clinical deterioration|6|||
124496336|NCT01770353|447770148|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
124496337|NCT01770353|447770149|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
124496338|NCT00376688|447770150|FG000|Overall Study|Adverse Event|3|||
124496339|NCT00376688|447770150|FG000|Overall Study|Death|1|||
124496340|NCT02574312|447770151|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
124496341|NCT02574312|447770152|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
124496342|NCT00696657|447771755|FG000|Overall Study|Protocol Violation|0|||
124496343|NCT00696657|447771756|FG001|Overall Study|Protocol Violation|0|||
124496344|NCT00696657|447771757|FG002|Overall Study|Protocol Violation|0|||
124496345|NCT00696657|447771758|FG003|Overall Study|Protocol Violation|0|||
124496346|NCT00696657|447771759|FG004|Overall Study|Protocol Violation|0|||
124496347|NCT00696657|447771760|FG005|Overall Study|Protocol Violation|1|||
124496348|NCT00696657|447771761|FG006|Overall Study|Protocol Violation|0|||
124496349|NCT00696657|447771762|FG007|Overall Study|Protocol Violation|0|||
124496350|NCT00696657|447771763|FG008|Overall Study|Protocol Violation|1|||
124496351|NCT00696657|447771755|FG000|Overall Study|Lack of Efficacy|0|||
124496352|NCT00696657|447771756|FG001|Overall Study|Lack of Efficacy|1|||
124496353|NCT00696657|447771757|FG002|Overall Study|Lack of Efficacy|0|||
124496354|NCT00696657|447771758|FG003|Overall Study|Lack of Efficacy|0|||
124496355|NCT00696657|447771759|FG004|Overall Study|Lack of Efficacy|0|||
124496356|NCT00696657|447771760|FG005|Overall Study|Lack of Efficacy|0|||
124496357|NCT00696657|447771761|FG006|Overall Study|Lack of Efficacy|0|||
124496358|NCT00696657|447771762|FG007|Overall Study|Lack of Efficacy|0|||
124496359|NCT00696657|447771763|FG008|Overall Study|Lack of Efficacy|0|||
124496360|NCT00696657|447771755|FG000|Overall Study|Withdrawal criteria|1|||
124496361|NCT00696657|447771756|FG001|Overall Study|Withdrawal criteria|3|||
124496362|NCT00696657|447771757|FG002|Overall Study|Withdrawal criteria|2|||
124496363|NCT00696657|447771758|FG003|Overall Study|Withdrawal criteria|2|||
124496364|NCT00696657|447771759|FG004|Overall Study|Withdrawal criteria|0|||
124496365|NCT00696657|447771760|FG005|Overall Study|Withdrawal criteria|0|||
124496366|NCT00696657|447771761|FG006|Overall Study|Withdrawal criteria|1|||
124496367|NCT00696657|447771762|FG007|Overall Study|Withdrawal criteria|1|||
124496368|NCT00696657|447771763|FG008|Overall Study|Withdrawal criteria|2|||
124496369|NCT00696657|447771755|FG000|Overall Study|Unclassified|0|||
124496370|NCT00696657|447771756|FG001|Overall Study|Unclassified|1|||
124496371|NCT00696657|447771757|FG002|Overall Study|Unclassified|3|||
124496372|NCT00696657|447771758|FG003|Overall Study|Unclassified|2|||
124496373|NCT00696657|447771759|FG004|Overall Study|Unclassified|4|||
124496374|NCT00696657|447771760|FG005|Overall Study|Unclassified|2|||
124496375|NCT00696657|447771761|FG006|Overall Study|Unclassified|0|||
124496376|NCT00696657|447771762|FG007|Overall Study|Unclassified|0|||
124496377|NCT00696657|447771763|FG008|Overall Study|Unclassified|1|||
124496378|NCT00696657|447771755|FG000|Overall Study|Adverse Event|0|||
124496379|NCT00696657|447771756|FG001|Overall Study|Adverse Event|0|||
124496380|NCT00696657|447771757|FG002|Overall Study|Adverse Event|3|||
124496381|NCT00696657|447771758|FG003|Overall Study|Adverse Event|7|||
124496382|NCT00696657|447771759|FG004|Overall Study|Adverse Event|6|||
124773465|NCT00068692|448800540|FG002|Step 1: Registration|Withdrawal by Subject|0|||
124496383|NCT00696657|447771760|FG005|Overall Study|Adverse Event|9|||
124496384|NCT00696657|447771761|FG006|Overall Study|Adverse Event|14|||
124496385|NCT00696657|447771762|FG007|Overall Study|Adverse Event|2|||
124496386|NCT00696657|447771763|FG008|Overall Study|Adverse Event|5|||
124496387|NCT03074162|447771764|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
124496388|NCT03074162|447771765|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
124496389|NCT03074162|447771766|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
124496390|NCT03074162|447771767|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
124496391|NCT03074162|447771768|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
124496392|NCT03074162|447771769|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
124496393|NCT03074162|447771764|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
124496394|NCT03074162|447771765|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
124496395|NCT03074162|447771766|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
124496396|NCT03074162|447771767|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
124773466|NCT00068692|448800541|FG003|Step 1: Registration|Withdrawal by Subject|0|||
124558502|NCT00185211|448001489|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
124558503|NCT00185211|448001488|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
124558504|NCT00185211|448001489|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
124558505|NCT00185211|448001488|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
124558506|NCT00185211|448001489|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
124558507|NCT00185211|448001488|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
124558508|NCT00185211|448001489|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
124558509|NCT00185211|448001488|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
124558510|NCT00185211|448001489|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
124558511|NCT00185211|448001488|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
124558512|NCT00185211|448001489|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
124558513|NCT00185211|448001488|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
124558514|NCT00185211|448001489|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
124558515|NCT00185211|448001488|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
124558516|NCT00185211|448001489|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
124558517|NCT00185211|448001488|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
124558518|NCT00185211|448001489|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
124558519|NCT00185211|448001488|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
124558520|NCT00185211|448001489|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
124558521|NCT00185211|448001488|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
124558522|NCT00185211|448001489|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
124558523|NCT00185211|448001488|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
124558524|NCT00185211|448001489|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
124558525|NCT01606137|448001490|FG000|Overall Study|Adverse Event|85|||
124558526|NCT01606137|448001490|FG000|Overall Study|Withdrawal by Subject|74|||
124723448|NCT03645421|448609769|FG003|Overall Study|Study specific withdrawal criteria|0|||
124723449|NCT02253433|448609773|FG000|Overall Study|Unable to Contact|9|||
124723450|NCT02253433|448609774|FG001|Overall Study|Unable to Contact|16|||
124496397|NCT03074162|447771768|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
124496398|NCT03074162|447771769|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
124496399|NCT03074162|447771764|FG000|Period 3|Withdrawal by Subject|1|||
124496400|NCT03074162|447771765|FG001|Period 3|Withdrawal by Subject|0|||
124496401|NCT03074162|447771766|FG002|Period 3|Withdrawal by Subject|0|||
124496402|NCT03074162|447771767|FG003|Period 3|Withdrawal by Subject|0|||
124496403|NCT03074162|447771768|FG004|Period 3|Withdrawal by Subject|1|||
124496404|NCT03074162|447771769|FG005|Period 3|Withdrawal by Subject|0|||
124496405|NCT04964063|447771773|FG000|Overall Study|Adverse Event|4|||
124496406|NCT04964063|447771773|FG000|Overall Study|Lost to Follow-up|47|||
124496407|NCT04964063|447771773|FG000|Overall Study|Withdrawal by Subject|5|||
124496408|NCT04964063|447771773|FG000|Overall Study|Baseline Tasks Expired|41|||
124496409|NCT04964063|447771773|FG000|Overall Study|Participant withdrawn in error|1|||
124496410|NCT01035606|447771774|FG000|Overall Study|change in health, job demands,family|3|||
124496411|NCT01035606|447771775|FG001|Overall Study|change in health, job demands,family|3|||
124496412|NCT01035606|447771776|FG002|Overall Study|change in health, job demands,family|4|||
124496413|NCT03350750|447771777|FG000|Overall Study|Death|1|||
124496414|NCT03350750|447771778|FG001|Overall Study|Death|1|||
124496415|NCT01120093|447771783|FG000|Treatment Period 1|Adverse Event|0|||
124496416|NCT01120093|447771784|FG001|Treatment Period 1|Adverse Event|0|||
124496417|NCT01120093|447771785|FG002|Treatment Period 1|Adverse Event|1|||
124496418|NCT01120093|447771786|FG003|Treatment Period 1|Adverse Event|0|||
124496419|NCT01120093|447771787|FG004|Treatment Period 1|Adverse Event|1|||
124496420|NCT01120093|447771783|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124496421|NCT01120093|447771784|FG001|Treatment Period 1|Withdrawal by Subject|1|||
124496422|NCT01120093|447771785|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124496423|NCT01120093|447771786|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124496424|NCT01120093|447771787|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124496425|NCT01120093|447771783|FG000|Treatment Period 2|Adverse Event|0|||
124496426|NCT01120093|447771784|FG001|Treatment Period 2|Adverse Event|0|||
124496427|NCT01120093|447771785|FG002|Treatment Period 2|Adverse Event|0|||
124496428|NCT01120093|447771786|FG003|Treatment Period 2|Adverse Event|1|||
124496429|NCT01120093|447771787|FG004|Treatment Period 2|Adverse Event|0|||
124496430|NCT01120093|447771783|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124496431|NCT01120093|447771784|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124496432|NCT01120093|447771785|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124496433|NCT01120093|447771786|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124496434|NCT01120093|447771787|FG004|Treatment Period 2|Withdrawal by Subject|1|||
124496435|NCT01120093|447771783|FG000|Treatment Period 3|Lack of Efficacy|0|||
124496436|NCT01120093|447771784|FG001|Treatment Period 3|Lack of Efficacy|0|||
124496437|NCT01120093|447771785|FG002|Treatment Period 3|Lack of Efficacy|0|||
124496438|NCT01120093|447771786|FG003|Treatment Period 3|Lack of Efficacy|1|||
124496439|NCT01120093|447771787|FG004|Treatment Period 3|Lack of Efficacy|0|||
124496440|NCT01120093|447771783|FG000|Treatment Period 3|Adverse Event|0|||
124496441|NCT01120093|447771784|FG001|Treatment Period 3|Adverse Event|0|||
124496442|NCT01120093|447771785|FG002|Treatment Period 3|Adverse Event|0|||
124496443|NCT01120093|447771786|FG003|Treatment Period 3|Adverse Event|0|||
124496444|NCT01120093|447771787|FG004|Treatment Period 3|Adverse Event|1|||
124496445|NCT01120093|447771783|FG000|Treatment Period 3|Withdrawal by Subject|0|||
124496446|NCT01120093|447771784|FG001|Treatment Period 3|Withdrawal by Subject|0|||
124496447|NCT01120093|447771785|FG002|Treatment Period 3|Withdrawal by Subject|1|||
124496448|NCT01120093|447771786|FG003|Treatment Period 3|Withdrawal by Subject|0|||
124496449|NCT01120093|447771787|FG004|Treatment Period 3|Withdrawal by Subject|0|||
124496450|NCT01120093|447771783|FG000|Treatment Period 4|Adverse Event|1|||
124496451|NCT01120093|447771784|FG001|Treatment Period 4|Adverse Event|0|||
124496452|NCT01120093|447771785|FG002|Treatment Period 4|Adverse Event|0|||
124496453|NCT01120093|447771786|FG003|Treatment Period 4|Adverse Event|0|||
124496454|NCT01120093|447771787|FG004|Treatment Period 4|Adverse Event|0|||
124496455|NCT01120093|447771783|FG000|Treatment Period 5|Adverse Event|0|||
124496456|NCT01120093|447771784|FG001|Treatment Period 5|Adverse Event|1|||
124496457|NCT01120093|447771785|FG002|Treatment Period 5|Adverse Event|0|||
124496458|NCT01120093|447771786|FG003|Treatment Period 5|Adverse Event|1|||
124496459|NCT01120093|447771787|FG004|Treatment Period 5|Adverse Event|0|||
124496460|NCT01849250|447771788|FG000|Overall Study|Withdrawal by Subject|1|||
124496461|NCT01849250|447771789|FG001|Overall Study|Withdrawal by Subject|0|||
124496462|NCT01849250|447771788|FG000|Overall Study|Not Evaluable|5|||
124496463|NCT01849250|447771789|FG001|Overall Study|Not Evaluable|3|||
124496464|NCT01849250|447771788|FG000|Overall Study|Screen Failure|1|||
124496465|NCT01849250|447771789|FG001|Overall Study|Screen Failure|0|||
124496466|NCT02389816|447771790|FG000|Overall Study|Randomized but Not Treated|1|||
124496467|NCT02389816|447771791|FG001|Overall Study|Randomized but Not Treated|0|||
124496468|NCT02389816|447771792|FG002|Overall Study|Randomized but Not Treated|0|||
124496469|NCT02389816|447771790|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
124496470|NCT02389816|447771791|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
124723451|NCT02253433|448609773|FG000|Overall Study|Death|1|||
124496471|NCT02389816|447771792|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
124496472|NCT02389816|447771790|FG000|Overall Study|Major Protocol Deviation|1|||
124496473|NCT02389816|447771791|FG001|Overall Study|Major Protocol Deviation|0|||
124496474|NCT02389816|447771792|FG002|Overall Study|Major Protocol Deviation|0|||
124496475|NCT02389816|447771790|FG000|Overall Study|Lost to Follow-up|1|||
124496476|NCT02389816|447771791|FG001|Overall Study|Lost to Follow-up|0|||
124496477|NCT02389816|447771792|FG002|Overall Study|Lost to Follow-up|0|||
124496478|NCT02389816|447771790|FG000|Overall Study|Withdrawal of Consent|6|||
124496479|NCT02389816|447771791|FG001|Overall Study|Withdrawal of Consent|4|||
124496480|NCT02389816|447771792|FG002|Overall Study|Withdrawal of Consent|4|||
124496481|NCT02389816|447771790|FG000|Overall Study|Lack of Efficacy|1|||
124496482|NCT02389816|447771791|FG001|Overall Study|Lack of Efficacy|0|||
124496483|NCT02389816|447771792|FG002|Overall Study|Lack of Efficacy|0|||
124496484|NCT02389816|447771790|FG000|Overall Study|Non Compliance with Study Drug|1|||
124496485|NCT02389816|447771791|FG001|Overall Study|Non Compliance with Study Drug|1|||
124496486|NCT02389816|447771792|FG002|Overall Study|Non Compliance with Study Drug|1|||
124496487|NCT02389816|447771790|FG000|Overall Study|Reason not Specified|0|||
124496488|NCT02389816|447771791|FG001|Overall Study|Reason not Specified|2|||
124496489|NCT02389816|447771792|FG002|Overall Study|Reason not Specified|0|||
124496490|NCT01525849|447771796|FG000|Overall Study|Lost to Follow-up|3|||
124496491|NCT01525849|447771797|FG001|Overall Study|Lost to Follow-up|2|||
124496492|NCT01525849|447771796|FG000|Overall Study|Withdrawal by Subject|1|||
124496493|NCT01525849|447771797|FG001|Overall Study|Withdrawal by Subject|9|||
124496494|NCT01525849|447771796|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
124496495|NCT01525849|447771797|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
124496496|NCT01525849|447771796|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
124496497|NCT01525849|447771797|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
124496498|NCT00339183|447771798|FG000|Overall Study|Adverse Event|5|||
124496499|NCT00339183|447771799|FG001|Overall Study|Adverse Event|3|||
124723452|NCT02253433|448609774|FG001|Overall Study|Death|1|||
124723453|NCT02253433|448609773|FG000|Overall Study|No Longer Interested|3|||
124723454|NCT02253433|448609774|FG001|Overall Study|No Longer Interested|15|||
124723455|NCT02253433|448609773|FG000|Overall Study|Out of Study Area|2|||
124723456|NCT02253433|448609774|FG001|Overall Study|Out of Study Area|7|||
124496500|NCT00339183|447771798|FG000|Overall Study|Withdrawal by Subject|16|||
124496501|NCT00339183|447771799|FG001|Overall Study|Withdrawal by Subject|19|||
124496502|NCT00339183|447771798|FG000|Overall Study|Physician Decision|2|||
124496503|NCT00339183|447771799|FG001|Overall Study|Physician Decision|4|||
124496504|NCT00339183|447771798|FG000|Overall Study|Lost to Follow-up|17|||
124496505|NCT00339183|447771799|FG001|Overall Study|Lost to Follow-up|17|||
124496506|NCT00339183|447771798|FG000|Overall Study|Protocol-specified criteria|12|||
124496507|NCT00339183|447771799|FG001|Overall Study|Protocol-specified criteria|8|||
124496508|NCT00339183|447771798|FG000|Overall Study|Missing reason|3|||
124496509|NCT00339183|447771799|FG001|Overall Study|Missing reason|1|||
124496510|NCT00339183|447771798|FG000|Overall Study|Other|46|||
124496511|NCT00339183|447771799|FG001|Overall Study|Other|40|||
124558527|NCT01606137|448001490|FG000|Overall Study|Lack of Efficacy|56|||
124558528|NCT01606137|448001490|FG000|Overall Study|Lost to Follow-up|15|||
124558529|NCT01606137|448001490|FG000|Overall Study|Protocol Violation|1|||
124558530|NCT01606137|448001490|FG000|Overall Study|Patient non-compliance|9|||
124558531|NCT01606137|448001490|FG000|Overall Study|Death|1|||
124558532|NCT01606137|448001490|FG000|Overall Study|Decreased/no pain|4|||
124558533|NCT01606137|448001490|FG000|Overall Study|Issues with driving|4|||
124558534|NCT01606137|448001490|FG000|Overall Study|multiple sclerosis less stable|1|||
124496512|NCT00339183|447771798|FG000|Overall Study|Ongoing|20|||
124496513|NCT00339183|447771799|FG001|Overall Study|Ongoing|13|||
124496514|NCT00793819|447771800|FG000|Overall Study|Adverse Event|8|||
124496515|NCT00793819|447771801|FG001|Overall Study|Adverse Event|4|||
124558535|NCT01606137|448001490|FG000|Overall Study|Increased bilirubin|1|||
124496516|NCT00793819|447771800|FG000|Overall Study|Lack of Efficacy|1|||
124496517|NCT00793819|447771801|FG001|Overall Study|Lack of Efficacy|1|||
124496518|NCT00793819|447771800|FG000|Overall Study|Withdrawal by Subject|4|||
124496519|NCT00793819|447771801|FG001|Overall Study|Withdrawal by Subject|3|||
124496520|NCT00793819|447771800|FG000|Overall Study|Lost to Follow-up|1|||
124496521|NCT00793819|447771801|FG001|Overall Study|Lost to Follow-up|1|||
124496522|NCT00446446|447771802|FG000|Overall Study|Death|10|||
124496523|NCT00446446|447771802|FG000|Overall Study|Withdrawal by Subject|6|||
124496524|NCT00446446|447771802|FG000|Overall Study|Other|4|||
124496525|NCT00446446|447771802|FG000|Overall Study|Disease Progession|2|||
124496526|NCT00446446|447771802|FG000|Overall Study|Adverse Event|1|||
124496527|NCT00446446|447771802|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
124496528|NCT01757704|447771808|FG000|Overall Study|Protocol Violation|1|||
124496529|NCT01757704|447771809|FG001|Overall Study|Protocol Violation|3|||
124496530|NCT02691247|447771810|FG000|Overall Study|Withdrawal by Subject|1|||
124496531|NCT02691247|447771811|FG001|Overall Study|Withdrawal by Subject|2|||
124496532|NCT02691247|447771812|FG002|Overall Study|Withdrawal by Subject|2|||
124496533|NCT02691247|447771810|FG000|Overall Study|Lost to Follow-up|2|||
124496534|NCT02691247|447771811|FG001|Overall Study|Lost to Follow-up|0|||
124496535|NCT02691247|447771812|FG002|Overall Study|Lost to Follow-up|1|||
124496536|NCT01844700|447771813|FG000|Overall Study|Lack of Efficacy|1|||
124496537|NCT01844700|447771814|FG001|Overall Study|Lack of Efficacy|0|||
124496538|NCT01844700|447771813|FG000|Overall Study|refused medication switch|1|||
124496539|NCT01844700|447771814|FG001|Overall Study|refused medication switch|0|||
124496540|NCT01844700|447771813|FG000|Overall Study|Withdrawal by Subject|1|||
124496541|NCT01844700|447771814|FG001|Overall Study|Withdrawal by Subject|0|||
124496542|NCT01844700|447771813|FG000|Overall Study|stopped taking meds|0|||
124496543|NCT01844700|447771814|FG001|Overall Study|stopped taking meds|1|||
124496544|NCT02680847|447771815|FG000|Overall Study|Other|2|||
124496545|NCT02680847|447771816|FG001|Overall Study|Other|0|||
124496546|NCT02680847|447771817|FG002|Overall Study|Other|0|||
124496547|NCT02680847|447771815|FG000|Overall Study|No longer met eligibility criteria|2|||
124496548|NCT02680847|447771816|FG001|Overall Study|No longer met eligibility criteria|2|||
124496549|NCT02680847|447771817|FG002|Overall Study|No longer met eligibility criteria|0|||
124496550|NCT02680847|447771815|FG000|Overall Study|Unwilling to participate in study|1|||
124496551|NCT02680847|447771816|FG001|Overall Study|Unwilling to participate in study|1|||
124496552|NCT02680847|447771817|FG002|Overall Study|Unwilling to participate in study|0|||
124496553|NCT02680847|447771815|FG000|Overall Study|Lack of Efficacy|0|||
124496554|NCT02680847|447771816|FG001|Overall Study|Lack of Efficacy|0|||
124496555|NCT02680847|447771817|FG002|Overall Study|Lack of Efficacy|2|||
124496556|NCT02680847|447771815|FG000|Overall Study|Adverse Event|0|||
124496557|NCT02680847|447771816|FG001|Overall Study|Adverse Event|0|||
124496558|NCT02680847|447771817|FG002|Overall Study|Adverse Event|1|||
124496559|NCT02144220|447771818|FG000|Overall Study|technology incompatibility|9|||
124496560|NCT02144220|447771818|FG000|Overall Study|Lack of Efficacy|4|||
124496561|NCT02144220|447771818|FG000|Overall Study|Physician Decision|3|||
124558536|NCT01606137|448001490|FG000|Overall Study|Spray causes nausea|1|||
124723457|NCT02253433|448609773|FG000|Overall Study|Uncomfortable with home visitors|0|||
124723458|NCT02253433|448609774|FG001|Overall Study|Uncomfortable with home visitors|3|||
124723459|NCT02253433|448609773|FG000|Overall Study|Unstable Housing/Homeless|0|||
124496562|NCT02144220|447771818|FG000|Overall Study|Withdrawal by Subject|2|||
124496563|NCT02144220|447771818|FG000|Overall Study|Protocol Violation|1|||
124496564|NCT03648996|447771819|FG000|Overall Study|Withdrawal by Subject|0|||
124496565|NCT03648996|447771820|FG001|Overall Study|Withdrawal by Subject|2|||
124496566|NCT03648996|447771821|FG002|Overall Study|Withdrawal by Subject|2|||
124496567|NCT03648996|447771819|FG000|Overall Study|Physician Decision|2|||
124496568|NCT03648996|447771820|FG001|Overall Study|Physician Decision|0|||
124496569|NCT03648996|447771821|FG002|Overall Study|Physician Decision|0|||
124496570|NCT00590681|447771822|FG000|Overall Study|Withdrawal by Subject|7|||
124496571|NCT00590681|447771822|FG000|Overall Study|Adverse Event|8|||
124496572|NCT00590681|447771822|FG000|Overall Study|Death|3|||
124496573|NCT00590681|447771822|FG000|Overall Study|Lost to Follow-up|1|||
124496574|NCT00590681|447771822|FG000|Overall Study|disease progression|1|||
124558537|NCT01606137|448001490|FG000|Overall Study|Not enough improvement|4|||
124558538|NCT01606137|448001490|FG000|Overall Study|Wanted to try another treatment|1|||
124496575|NCT00504166|447771823|FG000|Overall Study|Adverse Event|1|||
124496576|NCT00504166|447771824|FG001|Overall Study|Adverse Event|4|||
124496577|NCT00504166|447771823|FG000|Overall Study|Withdrawal by Subject|3|||
124496578|NCT00504166|447771824|FG001|Overall Study|Withdrawal by Subject|6|||
124496579|NCT00504166|447771823|FG000|Overall Study|Physician Decision|1|||
124496580|NCT00504166|447771824|FG001|Overall Study|Physician Decision|1|||
124496581|NCT00504166|447771823|FG000|Overall Study|Lost to Follow-up|1|||
124496582|NCT00504166|447771824|FG001|Overall Study|Lost to Follow-up|3|||
124496583|NCT02229864|447771825|FG000|Overall Study|Death|2|||
124496584|NCT02229864|447771825|FG000|Overall Study|Lost to Follow-up|1|||
124496585|NCT02650284|447771826|FG000|Overall Study|Lost to Follow-up|3|||
124496586|NCT02650284|447771827|FG001|Overall Study|Lost to Follow-up|3|||
124496587|NCT02650284|447771826|FG000|Overall Study|Consent incorrectly taken|0|||
124496588|NCT02650284|447771827|FG001|Overall Study|Consent incorrectly taken|1|||
124496589|NCT02084134|447771836|FG000|Overall Study|Protocol Violation|4|||
124496590|NCT02084134|447771837|FG001|Overall Study|Protocol Violation|2|||
124496591|NCT02084134|447771836|FG000|Overall Study|Death|0|||
124496592|NCT02084134|447771837|FG001|Overall Study|Death|1|||
124496593|NCT01780389|447771843|FG000|Overall Study|Adverse Event|1|||
124496594|NCT01095250|447771845|FG000|Overall Study|administrative reasons|8|||
124496595|NCT01095250|447771846|FG001|Overall Study|administrative reasons|10|||
124496596|NCT01095250|447771847|FG002|Overall Study|administrative reasons|7|||
124496597|NCT01095250|447771848|FG003|Overall Study|administrative reasons|5|||
124496598|NCT01095250|447771845|FG000|Overall Study|Withdrawal by Subject|0|||
124496599|NCT01095250|447771846|FG001|Overall Study|Withdrawal by Subject|0|||
124496600|NCT01095250|447771847|FG002|Overall Study|Withdrawal by Subject|1|||
124496601|NCT01095250|447771848|FG003|Overall Study|Withdrawal by Subject|0|||
124496602|NCT04598165|447771851|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
124496603|NCT04598165|447771852|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
124496604|NCT04598165|447771851|FG000|Completed 6-week Follow-up|Death|2|||
124496605|NCT04598165|447771852|FG001|Completed 6-week Follow-up|Death|1|||
124496606|NCT04598165|447771851|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
124496607|NCT04598165|447771852|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
124496608|NCT04598165|447771851|FG000|Completed 6-week Follow-up|Ineligible|4|||
124496609|NCT04598165|447771852|FG001|Completed 6-week Follow-up|Ineligible|3|||
124496610|NCT04598165|447771851|FG000|Completed 6-week Follow-up|Partner refusal|0|||
124496611|NCT04598165|447771852|FG001|Completed 6-week Follow-up|Partner refusal|1|||
124496612|NCT04598165|447771851|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
124496613|NCT04598165|447771852|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
124496614|NCT01323673|447771854|FG000|Overall Study|Adverse Event|0|||
124496615|NCT01323673|447771855|FG001|Overall Study|Adverse Event|1|||
124496616|NCT01323673|447771854|FG000|Overall Study|Lost to Follow-up|0|||
124496617|NCT01323673|447771855|FG001|Overall Study|Lost to Follow-up|1|||
124496618|NCT01323673|447771854|FG000|Overall Study|Protocol Violation|1|||
124496619|NCT01323673|447771855|FG001|Overall Study|Protocol Violation|0|||
124496620|NCT01323673|447771854|FG000|Overall Study|Withdrawal by Subject|2|||
124496621|NCT01323673|447771855|FG001|Overall Study|Withdrawal by Subject|3|||
124496622|NCT00426751|447771856|FG000|Overall Study|Adverse Event|8|||
124496623|NCT00426751|447771857|FG001|Overall Study|Adverse Event|1|||
124496624|NCT00426751|447771856|FG000|Overall Study|Lost to Follow-up|7|||
124496625|NCT00426751|447771857|FG001|Overall Study|Lost to Follow-up|6|||
124496626|NCT00426751|447771856|FG000|Overall Study|Consent Withdrawn|0|||
124496627|NCT00426751|447771857|FG001|Overall Study|Consent Withdrawn|1|||
124496628|NCT00426751|447771856|FG000|Overall Study|Other Reasons|7|||
124496629|NCT00426751|447771857|FG001|Overall Study|Other Reasons|12|||
124496630|NCT02504892|447771861|FG000|Overall Study|Adverse event-pneumonitis|2|||
124496631|NCT04229446|447771862|FG000|Overall Study|Death|12|||
124496632|NCT04229446|447771863|FG001|Overall Study|Death|10|||
124496633|NCT04229446|447771862|FG000|Overall Study|Lost to Follow-up|5|||
124496634|NCT04229446|447771863|FG001|Overall Study|Lost to Follow-up|8|||
124496635|NCT02566525|447771864|FG000|Overall Study|Protocol Violation|3|||
124496636|NCT02566525|447771865|FG001|Overall Study|Protocol Violation|5|||
124496637|NCT00337467|447771866|FG000|Overall Study|Adverse Event|3|||
124496638|NCT00337467|447771866|FG000|Overall Study|Subject Withdrew Consent|2|||
124496639|NCT00337467|447771866|FG000|Overall Study|Pregnancy|1|||
124496640|NCT00337467|447771866|FG000|Overall Study|Lost to Follow-up|2|||
124723460|NCT02253433|448609774|FG001|Overall Study|Unstable Housing/Homeless|7|||
124723461|NCT02253433|448609773|FG000|Overall Study|Too Busy|0|||
124723462|NCT02253433|448609774|FG001|Overall Study|Too Busy|4|||
124496641|NCT00337467|447771866|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
124496642|NCT02488759|447771868|FG000|Overall Study|Disease progression|73|||
124496643|NCT02488759|447771869|FG001|Overall Study|Disease progression|111|||
124496644|NCT02488759|447771870|FG002|Overall Study|Disease progression|62|||
124496645|NCT02488759|447771871|FG003|Overall Study|Disease progression|7|||
124496646|NCT02488759|447771872|FG004|Overall Study|Disease progression|4|||
124496647|NCT02488759|447771873|FG005|Overall Study|Disease progression|2|||
124496648|NCT02488759|447771868|FG000|Overall Study|Study drug toxicity|11|||
124496649|NCT02488759|447771869|FG001|Overall Study|Study drug toxicity|33|||
124558539|NCT01606137|448001490|FG000|Overall Study|Patient leaving country|1|||
124558540|NCT01606137|448001490|FG000|Overall Study|Personal reasons|1|||
124558541|NCT01606137|448001490|FG000|Overall Study|Unable to tolerate study med. taste|1|||
124558542|NCT01606137|448001490|FG000|Overall Study|Patient moving|1|||
124558543|NCT01606137|448001490|FG000|Overall Study|Unable to collect consistent data|1|||
124558544|NCT02266706|448003274|FG000|Overall Study|Withdrawal by Subject|0|||
124558545|NCT02266706|448003275|FG001|Overall Study|Withdrawal by Subject|1|||
124558546|NCT02266706|448003276|FG002|Overall Study|Withdrawal by Subject|1|||
124558547|NCT02266706|448003277|FG003|Overall Study|Withdrawal by Subject|0|||
124558548|NCT02266706|448003278|FG004|Overall Study|Withdrawal by Subject|0|||
124558549|NCT02266706|448003279|FG005|Overall Study|Withdrawal by Subject|1|||
124773467|NCT00068692|448800542|FG004|Step 1: Registration|Withdrawal by Subject|0|||
124773468|NCT00068692|448800543|FG005|Step 1: Registration|Withdrawal by Subject|0|||
124773469|NCT00068692|448800544|FG006|Step 1: Registration|Withdrawal by Subject|0|||
124773470|NCT00068692|448800545|FG007|Step 1: Registration|Withdrawal by Subject|0|||
124773471|NCT00068692|448800538|FG000|Step 1: Registration|Alternative therapy|2|||
124773472|NCT00068692|448800539|FG001|Step 1: Registration|Alternative therapy|0|||
124773473|NCT00068692|448800540|FG002|Step 1: Registration|Alternative therapy|0|||
124773474|NCT00068692|448800541|FG003|Step 1: Registration|Alternative therapy|0|||
124773475|NCT00068692|448800542|FG004|Step 1: Registration|Alternative therapy|0|||
124773476|NCT00068692|448800543|FG005|Step 1: Registration|Alternative therapy|0|||
124773477|NCT00068692|448800544|FG006|Step 1: Registration|Alternative therapy|0|||
124773478|NCT00068692|448800545|FG007|Step 1: Registration|Alternative therapy|0|||
124773479|NCT00068692|448800538|FG000|Step 1: Registration|Complicating disease|2|||
124773480|NCT00068692|448800539|FG001|Step 1: Registration|Complicating disease|0|||
124773481|NCT00068692|448800540|FG002|Step 1: Registration|Complicating disease|0|||
124773482|NCT00068692|448800541|FG003|Step 1: Registration|Complicating disease|0|||
124773483|NCT00068692|448800542|FG004|Step 1: Registration|Complicating disease|0|||
124773484|NCT00068692|448800543|FG005|Step 1: Registration|Complicating disease|0|||
124773485|NCT00068692|448800544|FG006|Step 1: Registration|Complicating disease|0|||
124773486|NCT00068692|448800545|FG007|Step 1: Registration|Complicating disease|0|||
124773487|NCT00068692|448800538|FG000|Step 1: Registration|Protocol Violation|1|||
124773488|NCT00068692|448800539|FG001|Step 1: Registration|Protocol Violation|0|||
124773489|NCT00068692|448800540|FG002|Step 1: Registration|Protocol Violation|0|||
124773490|NCT00068692|448800541|FG003|Step 1: Registration|Protocol Violation|0|||
124773491|NCT00068692|448800542|FG004|Step 1: Registration|Protocol Violation|0|||
124773492|NCT00068692|448800543|FG005|Step 1: Registration|Protocol Violation|0|||
124773493|NCT00068692|448800544|FG006|Step 1: Registration|Protocol Violation|0|||
124773494|NCT00068692|448800545|FG007|Step 1: Registration|Protocol Violation|0|||
124773495|NCT00068692|448800538|FG000|Step 1: Registration|Not eligible|6|||
124773496|NCT00068692|448800539|FG001|Step 1: Registration|Not eligible|0|||
124773497|NCT00068692|448800540|FG002|Step 1: Registration|Not eligible|0|||
124773498|NCT00068692|448800541|FG003|Step 1: Registration|Not eligible|0|||
124773499|NCT00068692|448800542|FG004|Step 1: Registration|Not eligible|0|||
124773500|NCT00068692|448800543|FG005|Step 1: Registration|Not eligible|0|||
124773501|NCT00068692|448800544|FG006|Step 1: Registration|Not eligible|0|||
124773502|NCT00068692|448800545|FG007|Step 1: Registration|Not eligible|0|||
124773503|NCT00068692|448800538|FG000|Step 1: Registration|Other|2|||
124773504|NCT00068692|448800539|FG001|Step 1: Registration|Other|0|||
124773505|NCT00068692|448800540|FG002|Step 1: Registration|Other|0|||
124773506|NCT00068692|448800541|FG003|Step 1: Registration|Other|0|||
124773507|NCT00068692|448800542|FG004|Step 1: Registration|Other|0|||
124773508|NCT00068692|448800543|FG005|Step 1: Registration|Other|0|||
124773509|NCT00068692|448800544|FG006|Step 1: Registration|Other|0|||
124773510|NCT00068692|448800545|FG007|Step 1: Registration|Other|0|||
124773511|NCT00068692|448800538|FG000|Step 1: Registration|Not start protocol therapy|3|||
124773512|NCT00068692|448800539|FG001|Step 1: Registration|Not start protocol therapy|0|||
124558550|NCT02266706|448003280|FG006|Overall Study|Withdrawal by Subject|0|||
124558551|NCT02266706|448003281|FG007|Overall Study|Withdrawal by Subject|0|||
124558552|NCT02266706|448003282|FG008|Overall Study|Withdrawal by Subject|0|||
124773513|NCT00068692|448800540|FG002|Step 1: Registration|Not start protocol therapy|0|||
124773514|NCT00068692|448800541|FG003|Step 1: Registration|Not start protocol therapy|0|||
124773515|NCT00068692|448800542|FG004|Step 1: Registration|Not start protocol therapy|0|||
124773516|NCT00068692|448800543|FG005|Step 1: Registration|Not start protocol therapy|0|||
124773517|NCT00068692|448800544|FG006|Step 1: Registration|Not start protocol therapy|0|||
124773518|NCT00068692|448800545|FG007|Step 1: Registration|Not start protocol therapy|0|||
124773519|NCT00068692|448800538|FG000|Step 1: Registration|Registered but not randomized|0|||
124773520|NCT00068692|448800539|FG001|Step 1: Registration|Registered but not randomized|1|||
124773521|NCT00068692|448800540|FG002|Step 1: Registration|Registered but not randomized|0|||
124773522|NCT00068692|448800541|FG003|Step 1: Registration|Registered but not randomized|0|||
124773523|NCT00068692|448800542|FG004|Step 1: Registration|Registered but not randomized|0|||
124773524|NCT00068692|448800543|FG005|Step 1: Registration|Registered but not randomized|0|||
124558553|NCT02266706|448003274|FG000|Overall Study|Screen failure|0|||
124558554|NCT02266706|448003275|FG001|Overall Study|Screen failure|0|||
124558555|NCT02266706|448003276|FG002|Overall Study|Screen failure|0|||
124496650|NCT02488759|447771870|FG002|Overall Study|Study drug toxicity|31|||
124496651|NCT02488759|447771871|FG003|Overall Study|Study drug toxicity|0|||
124496652|NCT02488759|447771872|FG004|Overall Study|Study drug toxicity|0|||
124496653|NCT02488759|447771873|FG005|Overall Study|Study drug toxicity|2|||
124496654|NCT02488759|447771868|FG000|Overall Study|Adverse event unrelated to study drug|9|||
124496655|NCT02488759|447771869|FG001|Overall Study|Adverse event unrelated to study drug|11|||
124496656|NCT02488759|447771870|FG002|Overall Study|Adverse event unrelated to study drug|7|||
124496657|NCT02488759|447771871|FG003|Overall Study|Adverse event unrelated to study drug|0|||
124496658|NCT02488759|447771872|FG004|Overall Study|Adverse event unrelated to study drug|1|||
124496659|NCT02488759|447771873|FG005|Overall Study|Adverse event unrelated to study drug|0|||
124496660|NCT02488759|447771868|FG000|Overall Study|Participant request to discontinue study treatment|6|||
124496661|NCT02488759|447771869|FG001|Overall Study|Participant request to discontinue study treatment|8|||
124496662|NCT02488759|447771870|FG002|Overall Study|Participant request to discontinue study treatment|4|||
124496663|NCT02488759|447771871|FG003|Overall Study|Participant request to discontinue study treatment|0|||
124496664|NCT02488759|447771872|FG004|Overall Study|Participant request to discontinue study treatment|0|||
124496665|NCT02488759|447771873|FG005|Overall Study|Participant request to discontinue study treatment|0|||
124496666|NCT02488759|447771868|FG000|Overall Study|Withdrawal by Subject|4|||
124496667|NCT02488759|447771869|FG001|Overall Study|Withdrawal by Subject|0|||
124496668|NCT02488759|447771870|FG002|Overall Study|Withdrawal by Subject|3|||
124496669|NCT02488759|447771871|FG003|Overall Study|Withdrawal by Subject|0|||
124496670|NCT02488759|447771872|FG004|Overall Study|Withdrawal by Subject|0|||
124496671|NCT02488759|447771873|FG005|Overall Study|Withdrawal by Subject|2|||
124496672|NCT02488759|447771868|FG000|Overall Study|Lost to Follow-up|0|||
124496673|NCT02488759|447771869|FG001|Overall Study|Lost to Follow-up|0|||
124496674|NCT02488759|447771870|FG002|Overall Study|Lost to Follow-up|2|||
124496675|NCT02488759|447771871|FG003|Overall Study|Lost to Follow-up|0|||
124496676|NCT02488759|447771872|FG004|Overall Study|Lost to Follow-up|0|||
124496677|NCT02488759|447771873|FG005|Overall Study|Lost to Follow-up|0|||
124496678|NCT02488759|447771868|FG000|Overall Study|Maximum clinical benefit|3|||
124496679|NCT02488759|447771869|FG001|Overall Study|Maximum clinical benefit|0|||
124496680|NCT02488759|447771870|FG002|Overall Study|Maximum clinical benefit|1|||
124496681|NCT02488759|447771871|FG003|Overall Study|Maximum clinical benefit|0|||
124496682|NCT02488759|447771872|FG004|Overall Study|Maximum clinical benefit|0|||
124496683|NCT02488759|447771873|FG005|Overall Study|Maximum clinical benefit|0|||
124496684|NCT02488759|447771868|FG000|Overall Study|Other reasons|7|||
124496685|NCT02488759|447771869|FG001|Overall Study|Other reasons|32|||
124496686|NCT02488759|447771870|FG002|Overall Study|Other reasons|23|||
124496687|NCT02488759|447771871|FG003|Overall Study|Other reasons|1|||
124496688|NCT02488759|447771872|FG004|Overall Study|Other reasons|1|||
124496689|NCT02488759|447771873|FG005|Overall Study|Other reasons|1|||
124496690|NCT04083222|447771874|FG000|Overall Study|Voluntary Withdrawal|0|||
124496691|NCT04083222|447771875|FG001|Overall Study|Voluntary Withdrawal|1|||
124496692|NCT04083222|447771874|FG000|Overall Study|Reason not Specified|0|||
124496693|NCT04083222|447771875|FG001|Overall Study|Reason not Specified|1|||
124496694|NCT03103750|447771876|FG000|Overall Study|Adverse Event|1|||
124496695|NCT03103750|447771877|FG001|Overall Study|Adverse Event|0|||
124496696|NCT03103750|447771876|FG000|Overall Study|Lost to Follow-up|1|||
124496697|NCT03103750|447771877|FG001|Overall Study|Lost to Follow-up|0|||
124496698|NCT03103750|447771876|FG000|Overall Study|PET Equipment Related|2|||
124496699|NCT03103750|447771877|FG001|Overall Study|PET Equipment Related|2|||
124558556|NCT02266706|448003277|FG003|Overall Study|Screen failure|0|||
124496700|NCT02429427|447771885|FG000|Overall Study|Adverse Event|220|||
124496701|NCT02429427|447771886|FG001|Overall Study|Adverse Event|92|||
124496702|NCT02429427|447771885|FG000|Overall Study|Protocol Violation|10|||
124496703|NCT02429427|447771886|FG001|Overall Study|Protocol Violation|6|||
124496704|NCT02429427|447771885|FG000|Overall Study|Lost to Follow-up|15|||
124558557|NCT02266706|448003278|FG004|Overall Study|Screen failure|0|||
124496705|NCT02429427|447771886|FG001|Overall Study|Lost to Follow-up|6|||
124496706|NCT02429427|447771885|FG000|Overall Study|Withdrawal by Subject|64|||
124496707|NCT02429427|447771886|FG001|Overall Study|Withdrawal by Subject|34|||
124496708|NCT02429427|447771885|FG000|Overall Study|Other|62|||
124496709|NCT02429427|447771886|FG001|Overall Study|Other|41|||
124723463|NCT02253433|448609773|FG000|Overall Study|Medical or Other Concerns|1|||
124496710|NCT02078713|447773667|FG000|Overall Study|Lost to Follow-up|49|||
124723464|NCT02253433|448609774|FG001|Overall Study|Medical or Other Concerns|2|||
124496711|NCT02078713|447773668|FG001|Overall Study|Lost to Follow-up|55|||
124496712|NCT02078713|447773669|FG002|Overall Study|Lost to Follow-up|0|||
124496713|NCT02078713|447773670|FG003|Overall Study|Lost to Follow-up|0|||
124496714|NCT02078713|447773667|FG000|Overall Study|Pregnant at baseline|3|||
124496715|NCT02078713|447773668|FG001|Overall Study|Pregnant at baseline|5|||
124496716|NCT02078713|447773669|FG002|Overall Study|Pregnant at baseline|0|||
124496717|NCT02078713|447773670|FG003|Overall Study|Pregnant at baseline|0|||
124496718|NCT02078713|447773667|FG000|Overall Study|Enrolled twice|0|||
124496719|NCT02078713|447773668|FG001|Overall Study|Enrolled twice|1|||
124496720|NCT02078713|447773669|FG002|Overall Study|Enrolled twice|0|||
124558558|NCT02266706|448003279|FG005|Overall Study|Screen failure|1|||
124558559|NCT02266706|448003280|FG006|Overall Study|Screen failure|1|||
124558560|NCT02266706|448003281|FG007|Overall Study|Screen failure|0|||
124558561|NCT02266706|448003282|FG008|Overall Study|Screen failure|0|||
124558562|NCT02266706|448003274|FG000|Overall Study|Enrollment in another study|0|||
124558563|NCT02266706|448003275|FG001|Overall Study|Enrollment in another study|0|||
124558564|NCT02266706|448003276|FG002|Overall Study|Enrollment in another study|0|||
124558565|NCT02266706|448003277|FG003|Overall Study|Enrollment in another study|1|||
124558566|NCT02266706|448003278|FG004|Overall Study|Enrollment in another study|0|||
124558567|NCT02266706|448003279|FG005|Overall Study|Enrollment in another study|0|||
124558568|NCT02266706|448003280|FG006|Overall Study|Enrollment in another study|0|||
124558569|NCT02266706|448003281|FG007|Overall Study|Enrollment in another study|0|||
124558570|NCT02266706|448003282|FG008|Overall Study|Enrollment in another study|0|||
124558571|NCT02544633|448003283|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
124496721|NCT02078713|447773670|FG003|Overall Study|Enrolled twice|0|||
124496722|NCT00059215|447773677|FG000|Overall Study|Adverse Event|5|||
124496723|NCT00059215|447773678|FG001|Overall Study|Adverse Event|5|||
124496724|NCT00059215|447773679|FG002|Overall Study|Adverse Event|9|||
124496725|NCT00059215|447773680|FG003|Overall Study|Adverse Event|9|||
124496726|NCT00059215|447773677|FG000|Overall Study|Death|0|||
124496727|NCT00059215|447773678|FG001|Overall Study|Death|0|||
124496728|NCT00059215|447773679|FG002|Overall Study|Death|3|||
124496729|NCT00059215|447773680|FG003|Overall Study|Death|0|||
124496730|NCT00059215|447773677|FG000|Overall Study|Lost to Follow-up|1|||
124496731|NCT00059215|447773678|FG001|Overall Study|Lost to Follow-up|2|||
124496732|NCT00059215|447773679|FG002|Overall Study|Lost to Follow-up|0|||
124496733|NCT00059215|447773680|FG003|Overall Study|Lost to Follow-up|0|||
124496734|NCT00059215|447773677|FG000|Overall Study|Withdrawal by Subject|4|||
124496735|NCT00059215|447773678|FG001|Overall Study|Withdrawal by Subject|4|||
124496736|NCT00059215|447773679|FG002|Overall Study|Withdrawal by Subject|1|||
124496737|NCT00059215|447773680|FG003|Overall Study|Withdrawal by Subject|3|||
124558572|NCT02544633|448003284|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
124558573|NCT02544633|448003285|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
124558574|NCT02544633|448003286|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
124723465|NCT00759876|448609782|FG000|Overall Study|Sponsor terminated study early|36|||
124723466|NCT02836717|448609783|FG000|Test Phase|Lack of Efficacy|14|||
124723467|NCT02836717|448609784|FG001|Test Phase|Lack of Efficacy|8|||
124723468|NCT02836717|448609785|FG002|Test Phase|Lack of Efficacy|0|||
124723469|NCT02836717|448609783|FG000|Study Phase|Adverse Event|2|||
124723470|NCT02836717|448609784|FG001|Study Phase|Adverse Event|0|||
124723471|NCT02836717|448609785|FG002|Study Phase|Adverse Event|0|||
124723472|NCT02836717|448609783|FG000|Study Phase|Lack of Efficacy|8|||
124723473|NCT02836717|448609784|FG001|Study Phase|Lack of Efficacy|6|||
124723474|NCT02836717|448609785|FG002|Study Phase|Lack of Efficacy|1|||
124723475|NCT02836717|448609783|FG000|Study Phase|Withdrawal by Subject|1|||
124723476|NCT02836717|448609784|FG001|Study Phase|Withdrawal by Subject|0|||
124723477|NCT02836717|448609785|FG002|Study Phase|Withdrawal by Subject|0|||
124723478|NCT02836717|448609783|FG000|Study Phase|Death|1|||
124723479|NCT02836717|448609784|FG001|Study Phase|Death|0|||
124723480|NCT02836717|448609785|FG002|Study Phase|Death|0|||
124723481|NCT02836717|448609783|FG000|Study Phase|abdominal surgeries|2|||
124723482|NCT02836717|448609784|FG001|Study Phase|abdominal surgeries|1|||
124723483|NCT02836717|448609785|FG002|Study Phase|abdominal surgeries|0|||
124723484|NCT03636893|448609786|FG000|Overall Study|Death|0|||
124723485|NCT03636893|448609787|FG001|Overall Study|Death|1|||
124723486|NCT03636893|448609786|FG000|Overall Study|Protocol Violation|0|||
124723487|NCT03636893|448609787|FG001|Overall Study|Protocol Violation|3|||
124723488|NCT03636893|448609786|FG000|Overall Study|Withdrawal by Subject|1|||
124723489|NCT03636893|448609787|FG001|Overall Study|Withdrawal by Subject|2|||
124723490|NCT03636893|448609786|FG000|Overall Study|Refusal to surgery|4|||
124723491|NCT03636893|448609787|FG001|Overall Study|Refusal to surgery|3|||
124723492|NCT03636893|448609786|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
124723493|NCT03636893|448609787|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
124723494|NCT03636893|448609786|FG000|Overall Study|Adverse Event|1|||
124723495|NCT03636893|448609787|FG001|Overall Study|Adverse Event|1|||
124723496|NCT00438360|448609788|FG000|Overall Study|Adverse Event|6|||
124496738|NCT00059215|447773677|FG000|Overall Study|Protocol Violation|1|||
124496739|NCT00059215|447773678|FG001|Overall Study|Protocol Violation|0|||
124496740|NCT00059215|447773679|FG002|Overall Study|Protocol Violation|1|||
124723497|NCT00438360|448609789|FG001|Overall Study|Adverse Event|1|||
124723498|NCT00438360|448609788|FG000|Overall Study|Lack of Efficacy|42|||
124723499|NCT00438360|448609789|FG001|Overall Study|Lack of Efficacy|27|||
124496741|NCT00059215|447773680|FG003|Overall Study|Protocol Violation|0|||
124496742|NCT00059215|447773677|FG000|Overall Study|Protocol entry criteria not met|1|||
124496743|NCT00059215|447773678|FG001|Overall Study|Protocol entry criteria not met|1|||
124496744|NCT00059215|447773679|FG002|Overall Study|Protocol entry criteria not met|0|||
124558575|NCT02544633|448003283|FG000|Treatment Period|Adverse Event|7|||
124558576|NCT02544633|448003284|FG001|Treatment Period|Adverse Event|4|||
124558577|NCT02544633|448003285|FG002|Treatment Period|Adverse Event|0|||
124723500|NCT00438360|448609788|FG000|Overall Study|Other|24|||
124723501|NCT00438360|448609789|FG001|Overall Study|Other|15|||
124773525|NCT00068692|448800544|FG006|Step 1: Registration|Registered but not randomized|0|||
124773526|NCT00068692|448800545|FG007|Step 1: Registration|Registered but not randomized|0|||
124773527|NCT00068692|448800538|FG000|Step 2: Randomization|Disesae progression/replase|0|||
124773528|NCT00068692|448800539|FG001|Step 2: Randomization|Disesae progression/replase|0|||
124773529|NCT00068692|448800540|FG002|Step 2: Randomization|Disesae progression/replase|1|||
124773530|NCT00068692|448800541|FG003|Step 2: Randomization|Disesae progression/replase|1|||
124773531|NCT00068692|448800542|FG004|Step 2: Randomization|Disesae progression/replase|0|||
124773532|NCT00068692|448800543|FG005|Step 2: Randomization|Disesae progression/replase|0|||
124773533|NCT00068692|448800544|FG006|Step 2: Randomization|Disesae progression/replase|0|||
124773534|NCT00068692|448800545|FG007|Step 2: Randomization|Disesae progression/replase|0|||
124773535|NCT00068692|448800538|FG000|Step 2: Randomization|Adverse Event|0|||
124773536|NCT00068692|448800539|FG001|Step 2: Randomization|Adverse Event|0|||
124773537|NCT00068692|448800540|FG002|Step 2: Randomization|Adverse Event|4|||
124773538|NCT00068692|448800541|FG003|Step 2: Randomization|Adverse Event|2|||
124773539|NCT00068692|448800542|FG004|Step 2: Randomization|Adverse Event|2|||
124773540|NCT00068692|448800543|FG005|Step 2: Randomization|Adverse Event|3|||
124773541|NCT00068692|448800544|FG006|Step 2: Randomization|Adverse Event|4|||
124773542|NCT00068692|448800545|FG007|Step 2: Randomization|Adverse Event|4|||
124773543|NCT00068692|448800538|FG000|Step 2: Randomization|Death|0|||
124773544|NCT00068692|448800539|FG001|Step 2: Randomization|Death|0|||
124773545|NCT00068692|448800540|FG002|Step 2: Randomization|Death|0|||
124773546|NCT00068692|448800541|FG003|Step 2: Randomization|Death|0|||
124773547|NCT00068692|448800542|FG004|Step 2: Randomization|Death|1|||
124773548|NCT00068692|448800543|FG005|Step 2: Randomization|Death|0|||
124773549|NCT00068692|448800544|FG006|Step 2: Randomization|Death|0|||
124773550|NCT00068692|448800545|FG007|Step 2: Randomization|Death|1|||
124773551|NCT00068692|448800538|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
124773552|NCT00068692|448800539|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
124773553|NCT00068692|448800540|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
124773554|NCT00068692|448800541|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
124773555|NCT00068692|448800542|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
124773556|NCT00068692|448800543|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
124773557|NCT00068692|448800544|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
124773558|NCT00068692|448800545|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
124773559|NCT00068692|448800538|FG000|Step 2: Randomization|alternative therapy|0|||
124773560|NCT00068692|448800539|FG001|Step 2: Randomization|alternative therapy|0|||
124773561|NCT00068692|448800540|FG002|Step 2: Randomization|alternative therapy|0|||
124773562|NCT00068692|448800541|FG003|Step 2: Randomization|alternative therapy|1|||
124773563|NCT00068692|448800542|FG004|Step 2: Randomization|alternative therapy|1|||
124773564|NCT00068692|448800543|FG005|Step 2: Randomization|alternative therapy|0|||
124773565|NCT00068692|448800544|FG006|Step 2: Randomization|alternative therapy|0|||
124773566|NCT00068692|448800545|FG007|Step 2: Randomization|alternative therapy|0|||
124773567|NCT00068692|448800538|FG000|Step 2: Randomization|Physician Decision|0|||
124773568|NCT00068692|448800539|FG001|Step 2: Randomization|Physician Decision|0|||
124773569|NCT00068692|448800540|FG002|Step 2: Randomization|Physician Decision|0|||
124773570|NCT00068692|448800541|FG003|Step 2: Randomization|Physician Decision|1|||
124773571|NCT00068692|448800542|FG004|Step 2: Randomization|Physician Decision|1|||
124773572|NCT00068692|448800543|FG005|Step 2: Randomization|Physician Decision|0|||
124773573|NCT00068692|448800544|FG006|Step 2: Randomization|Physician Decision|0|||
124773574|NCT00068692|448800545|FG007|Step 2: Randomization|Physician Decision|0|||
124773575|NCT00068692|448800538|FG000|Step 2: Randomization|Other|0|||
124773576|NCT00068692|448800539|FG001|Step 2: Randomization|Other|0|||
124773577|NCT00068692|448800540|FG002|Step 2: Randomization|Other|0|||
124773578|NCT00068692|448800541|FG003|Step 2: Randomization|Other|1|||
124773579|NCT00068692|448800542|FG004|Step 2: Randomization|Other|0|||
124773580|NCT00068692|448800543|FG005|Step 2: Randomization|Other|1|||
124773581|NCT00068692|448800544|FG006|Step 2: Randomization|Other|0|||
124773582|NCT00068692|448800545|FG007|Step 2: Randomization|Other|0|||
124773583|NCT00068692|448800538|FG000|Step 2: Randomization|never start protocol therapy|0|||
124773584|NCT00068692|448800539|FG001|Step 2: Randomization|never start protocol therapy|0|||
124773585|NCT00068692|448800540|FG002|Step 2: Randomization|never start protocol therapy|1|||
124773586|NCT00068692|448800541|FG003|Step 2: Randomization|never start protocol therapy|0|||
124773587|NCT00068692|448800542|FG004|Step 2: Randomization|never start protocol therapy|1|||
124773588|NCT00068692|448800543|FG005|Step 2: Randomization|never start protocol therapy|0|||
124773589|NCT00068692|448800544|FG006|Step 2: Randomization|never start protocol therapy|0|||
124773590|NCT00068692|448800545|FG007|Step 2: Randomization|never start protocol therapy|0|||
124773591|NCT00248040|448800550|FG000|Overall Study|transplantectomy|2|||
124773592|NCT00248040|448800551|FG001|Overall Study|transplantectomy|1|||
124773593|NCT00248040|448800552|FG002|Overall Study|transplantectomy|3|||
124773594|NCT00248040|448800550|FG000|Overall Study|transplant cancelled post treat start|1|||
124496745|NCT00059215|447773680|FG003|Overall Study|Protocol entry criteria not met|2|||
124496746|NCT00059215|447773677|FG000|Overall Study|Physician Decision|1|||
124773595|NCT00248040|448800551|FG001|Overall Study|transplant cancelled post treat start|0|||
124496747|NCT00059215|447773678|FG001|Overall Study|Physician Decision|2|||
124496748|NCT00059215|447773679|FG002|Overall Study|Physician Decision|1|||
124496749|NCT00059215|447773680|FG003|Overall Study|Physician Decision|1|||
124496750|NCT04439838|447773682|FG000|Overall Study|Withdrawal by Subject|0|||
124496751|NCT04439838|447773683|FG001|Overall Study|Withdrawal by Subject|0|||
124496752|NCT04439838|447773684|FG002|Overall Study|Withdrawal by Subject|0|||
124496753|NCT04439838|447773685|FG003|Overall Study|Withdrawal by Subject|0|||
124496754|NCT04439838|447773686|FG004|Overall Study|Withdrawal by Subject|0|||
124496755|NCT04439838|447773687|FG005|Overall Study|Withdrawal by Subject|0|||
124496756|NCT04439838|447773688|FG006|Overall Study|Withdrawal by Subject|0|||
124496757|NCT04439838|447773689|FG007|Overall Study|Withdrawal by Subject|0|||
124496758|NCT04439838|447773690|FG008|Overall Study|Withdrawal by Subject|1|||
124496759|NCT04494633|447773693|FG000|Overall Study|Lost to Follow-up|5|||
124496760|NCT04494633|447773694|FG001|Overall Study|Lost to Follow-up|3|||
124496761|NCT04494633|447773693|FG000|Overall Study|Protocol Violation|1|||
124496762|NCT04494633|447773694|FG001|Overall Study|Protocol Violation|1|||
124496763|NCT00414310|447773695|FG000|Overall Study|Not treated|1|||
124496764|NCT00414310|447773696|FG001|Overall Study|Not treated|0|||
124496765|NCT01254604|447773697|FG000|Overall Study|Lost to Follow-up|1|||
124496766|NCT01254604|447773698|FG001|Overall Study|Lost to Follow-up|1|||
124496767|NCT01254604|447773697|FG000|Overall Study|Protocol Violation|2|||
124496768|NCT01254604|447773698|FG001|Overall Study|Protocol Violation|2|||
124496769|NCT01254604|447773697|FG000|Overall Study|Withdrawal by Subject|2|||
124496770|NCT01254604|447773698|FG001|Overall Study|Withdrawal by Subject|4|||
124496771|NCT01254604|447773697|FG000|Overall Study|Adverse Event|3|||
124496772|NCT01254604|447773698|FG001|Overall Study|Adverse Event|2|||
124496773|NCT03041116|447773699|FG000|Double-blind|Death|0|||
124496774|NCT03041116|447773700|FG001|Double-blind|Death|2|||
124496775|NCT03041116|447773699|FG000|Double-blind|Withdrawal by Subject|0|||
124496776|NCT03041116|447773700|FG001|Double-blind|Withdrawal by Subject|4|||
124496777|NCT03041116|447773699|FG000|Open-label|Death|1|||
124496778|NCT03041116|447773700|FG001|Open-label|Death|0|||
124496779|NCT03041116|447773699|FG000|Open-label|Termination of the study by Sponsor|39|||
124496780|NCT03041116|447773700|FG001|Open-label|Termination of the study by Sponsor|37|||
124496781|NCT03041116|447773699|FG000|Open-label|Withdrawal by Subject|1|||
124496782|NCT03041116|447773700|FG001|Open-label|Withdrawal by Subject|0|||
124496783|NCT03097328|447773701|FG000|Overall Study|Still on Therapy|2|||
124496784|NCT03097328|447773701|FG000|Overall Study|Progressive Disease|29|||
124496785|NCT03097328|447773701|FG000|Overall Study|Adverse Event|4|||
124496786|NCT03097328|447773701|FG000|Overall Study|Withdrawal by Subject|1|||
124496787|NCT03097328|447773701|FG000|Overall Study|Physician Decision|1|||
124496788|NCT03097328|447773701|FG000|Overall Study|Patient Decision|1|||
124496789|NCT03097328|447773701|FG000|Overall Study|Ineligible for Study Drug|1|||
124496790|NCT02436577|447773702|FG000|Overall Study|Protocol Deviation|0|||
124496791|NCT02436577|447773703|FG001|Overall Study|Protocol Deviation|1|||
124496792|NCT02436577|447773704|FG002|Overall Study|Protocol Deviation|0|||
124496793|NCT02436577|447773705|FG003|Overall Study|Protocol Deviation|0|||
124496794|NCT02436577|447773706|FG004|Overall Study|Protocol Deviation|0|||
124496795|NCT02436577|447773707|FG005|Overall Study|Protocol Deviation|0|||
124496796|NCT01675011|447773708|FG000|Overall Study|Trial terminated by Sponsor|3|||
124496797|NCT01675011|447773709|FG001|Overall Study|Trial terminated by Sponsor|1|||
124496798|NCT00931892|447773713|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
124496799|NCT00931892|447773714|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
124496800|NCT01876732|447773715|FG000|Overall Study|MMA was not over 800mg/dL|75|||
124496801|NCT02531373|447773718|FG000|Overall Study|Lack of Efficacy|0|||
124496802|NCT02531373|447773719|FG001|Overall Study|Lack of Efficacy|0|||
124496803|NCT02531373|447773720|FG002|Overall Study|Lack of Efficacy|0|||
124496804|NCT02531373|447773721|FG003|Overall Study|Lack of Efficacy|0|||
124496805|NCT02531373|447773722|FG004|Overall Study|Lack of Efficacy|3|||
124496806|NCT02531373|447773723|FG005|Overall Study|Lack of Efficacy|2|||
124496807|NCT02531373|447773724|FG006|Overall Study|Lack of Efficacy|4|||
124496808|NCT02531373|447773725|FG007|Overall Study|Lack of Efficacy|8|||
124496809|NCT02531373|447773726|FG008|Overall Study|Lack of Efficacy|5|||
124496810|NCT02531373|447773718|FG000|Overall Study|Lost to Follow-up|0|||
124496811|NCT02531373|447773719|FG001|Overall Study|Lost to Follow-up|0|||
124496812|NCT02531373|447773720|FG002|Overall Study|Lost to Follow-up|0|||
124496813|NCT02531373|447773721|FG003|Overall Study|Lost to Follow-up|0|||
124496814|NCT02531373|447773722|FG004|Overall Study|Lost to Follow-up|0|||
124496815|NCT02531373|447773723|FG005|Overall Study|Lost to Follow-up|2|||
124496816|NCT02531373|447773724|FG006|Overall Study|Lost to Follow-up|2|||
124496817|NCT02531373|447773725|FG007|Overall Study|Lost to Follow-up|0|||
124496818|NCT02531373|447773726|FG008|Overall Study|Lost to Follow-up|0|||
124496819|NCT02531373|447773718|FG000|Overall Study|Physician Decision|0|||
124773596|NCT00248040|448800552|FG002|Overall Study|transplant cancelled post treat start|0|||
124496820|NCT02531373|447773719|FG001|Overall Study|Physician Decision|0|||
124496821|NCT02531373|447773720|FG002|Overall Study|Physician Decision|0|||
124496822|NCT02531373|447773721|FG003|Overall Study|Physician Decision|0|||
124496823|NCT02531373|447773722|FG004|Overall Study|Physician Decision|2|||
124496824|NCT02531373|447773723|FG005|Overall Study|Physician Decision|1|||
124773597|NCT00248040|448800550|FG000|Overall Study|Death|0|||
124773598|NCT00248040|448800551|FG001|Overall Study|Death|0|||
124773599|NCT00248040|448800552|FG002|Overall Study|Death|1|||
124773600|NCT00628108|448800563|FG000|Overall Study|Adverse Event|0|||
124773601|NCT00628108|448800564|FG001|Overall Study|Adverse Event|3|||
124773602|NCT00628108|448800563|FG000|Overall Study|Withdrawal by Subject|1|||
124773603|NCT00628108|448800564|FG001|Overall Study|Withdrawal by Subject|0|||
124773604|NCT03848832|448800565|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
124773605|NCT03848832|448800566|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
124773606|NCT03848832|448800567|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
124773607|NCT03848832|448800565|FG000|Overall Study|Withdrawal by Subject|0|||
124773608|NCT03848832|448800566|FG001|Overall Study|Withdrawal by Subject|0|||
124773609|NCT03848832|448800567|FG002|Overall Study|Withdrawal by Subject|1|||
124773610|NCT03848832|448800565|FG000|Overall Study|Withdrawal (Covid-19)|0|||
124773611|NCT03848832|448800566|FG001|Overall Study|Withdrawal (Covid-19)|2|||
124773612|NCT03848832|448800567|FG002|Overall Study|Withdrawal (Covid-19)|0|||
124773613|NCT03848832|448800565|FG000|Overall Study|Physician Decision|2|||
124496825|NCT02531373|447773724|FG006|Overall Study|Physician Decision|0|||
124496826|NCT02531373|447773725|FG007|Overall Study|Physician Decision|0|||
124496827|NCT02531373|447773726|FG008|Overall Study|Physician Decision|0|||
124496828|NCT02531373|447773718|FG000|Overall Study|Protocol Violation|0|||
124496829|NCT02531373|447773719|FG001|Overall Study|Protocol Violation|0|||
124496830|NCT02531373|447773720|FG002|Overall Study|Protocol Violation|0|||
124496831|NCT02531373|447773721|FG003|Overall Study|Protocol Violation|0|||
124496832|NCT02531373|447773722|FG004|Overall Study|Protocol Violation|0|||
124496833|NCT02531373|447773723|FG005|Overall Study|Protocol Violation|1|||
124496834|NCT02531373|447773724|FG006|Overall Study|Protocol Violation|1|||
124496835|NCT02531373|447773725|FG007|Overall Study|Protocol Violation|0|||
124496836|NCT02531373|447773726|FG008|Overall Study|Protocol Violation|1|||
124496837|NCT02531373|447773718|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124496838|NCT02531373|447773719|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124496839|NCT02531373|447773720|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
124496840|NCT02531373|447773721|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
124496841|NCT02531373|447773722|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
124496842|NCT02531373|447773723|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
124496843|NCT02531373|447773724|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
124496844|NCT02531373|447773725|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
124496845|NCT02531373|447773726|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
124496846|NCT02531373|447773718|FG000|Overall Study|Withdrawal by Subject|0|||
124496847|NCT02531373|447773719|FG001|Overall Study|Withdrawal by Subject|0|||
124496848|NCT02531373|447773720|FG002|Overall Study|Withdrawal by Subject|0|||
124496849|NCT02531373|447773721|FG003|Overall Study|Withdrawal by Subject|0|||
124496850|NCT02531373|447773722|FG004|Overall Study|Withdrawal by Subject|3|||
124496851|NCT02531373|447773723|FG005|Overall Study|Withdrawal by Subject|0|||
124496852|NCT02531373|447773724|FG006|Overall Study|Withdrawal by Subject|0|||
124496853|NCT02531373|447773725|FG007|Overall Study|Withdrawal by Subject|0|||
124496854|NCT02531373|447773726|FG008|Overall Study|Withdrawal by Subject|0|||
124496855|NCT00536731|447773727|FG000|Overall Study|Adverse Event|3|||
124496856|NCT00536731|447773728|FG001|Overall Study|Adverse Event|2|||
124496857|NCT00536731|447773729|FG002|Overall Study|Adverse Event|3|||
124496858|NCT00536731|447773727|FG000|Overall Study|Withdrawal by Subject|0|||
124496859|NCT00536731|447773728|FG001|Overall Study|Withdrawal by Subject|2|||
124496860|NCT00536731|447773729|FG002|Overall Study|Withdrawal by Subject|0|||
124496861|NCT00536731|447773727|FG000|Overall Study|Intake of prohibited conc. medication|0|||
124496862|NCT00536731|447773728|FG001|Overall Study|Intake of prohibited conc. medication|0|||
124496863|NCT00536731|447773729|FG002|Overall Study|Intake of prohibited conc. medication|1|||
124496864|NCT00536731|447773727|FG000|Overall Study|Safety reasons|0|||
124496865|NCT00536731|447773728|FG001|Overall Study|Safety reasons|0|||
124496866|NCT00536731|447773729|FG002|Overall Study|Safety reasons|1|||
124496867|NCT00536731|447773727|FG000|Overall Study|Other|1|||
124496868|NCT00536731|447773728|FG001|Overall Study|Other|1|||
124496869|NCT00536731|447773729|FG002|Overall Study|Other|0|||
124496870|NCT01675531|447773730|FG000|Overall Study|Adverse Event|9|||
124773614|NCT03848832|448800566|FG001|Overall Study|Physician Decision|1|||
124496871|NCT01675531|447773730|FG000|Overall Study|Withdrawal by Subject|7|||
124496872|NCT01675531|447773730|FG000|Overall Study|Lack of Efficacy|1|||
124496873|NCT01675531|447773730|FG000|Overall Study|Protocol Violation|8|||
124496874|NCT00623467|447773731|FG000|Overall Study|Lost to Follow-up|1|||
124496875|NCT00623467|447773731|FG000|Overall Study|Protocol Violation|4|||
124496876|NCT00623467|447773731|FG000|Overall Study|Withdrawal by Subject|2|||
124496877|NCT04705597|447773736|FG000|Overall Study|Death|16|||
124773615|NCT03848832|448800567|FG002|Overall Study|Physician Decision|3|||
124496878|NCT04705597|447773737|FG001|Overall Study|Death|9|||
124496879|NCT04705597|447773736|FG000|Overall Study|Lost to Follow-up|1|||
124496880|NCT04705597|447773737|FG001|Overall Study|Lost to Follow-up|0|||
124773616|NCT03848832|448800565|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
124773617|NCT03848832|448800566|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
124723502|NCT04560816|448609791|FG000|Overall Study|Withdrawal by Subject|1|||
124723503|NCT04560816|448609792|FG001|Overall Study|Withdrawal by Subject|1|||
124723504|NCT04560816|448609793|FG002|Overall Study|Withdrawal by Subject|1|||
124723505|NCT04560816|448609794|FG003|Overall Study|Withdrawal by Subject|0|||
124723506|NCT04560816|448609795|FG004|Overall Study|Withdrawal by Subject|3|||
124723507|NCT04560816|448609796|FG005|Overall Study|Withdrawal by Subject|0|||
124723508|NCT04560816|448609791|FG000|Overall Study|Lost to Follow-up|1|||
124723509|NCT04560816|448609792|FG001|Overall Study|Lost to Follow-up|0|||
124723510|NCT04560816|448609793|FG002|Overall Study|Lost to Follow-up|0|||
124723511|NCT04560816|448609794|FG003|Overall Study|Lost to Follow-up|0|||
124723512|NCT04560816|448609795|FG004|Overall Study|Lost to Follow-up|0|||
124723513|NCT04560816|448609796|FG005|Overall Study|Lost to Follow-up|0|||
124723514|NCT04560816|448609791|FG000|Overall Study|Protocol Violation|1|||
124723515|NCT04560816|448609792|FG001|Overall Study|Protocol Violation|0|||
124723516|NCT04560816|448609793|FG002|Overall Study|Protocol Violation|0|||
124723517|NCT04560816|448609794|FG003|Overall Study|Protocol Violation|0|||
124723518|NCT04560816|448609795|FG004|Overall Study|Protocol Violation|0|||
124723519|NCT04560816|448609796|FG005|Overall Study|Protocol Violation|0|||
124723520|NCT02277691|448609797|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
124723521|NCT02277691|448609797|FG000|Overall Study|Voluntary Withdrawal|7|||
124723522|NCT02277691|448609797|FG000|Overall Study|Lack of Efficacy|5|||
124723523|NCT02277691|448609797|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
124723524|NCT03818607|448609798|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
124723525|NCT03818607|448609799|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
124723526|NCT03818607|448609798|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
124723527|NCT03818607|448609799|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
124723528|NCT03818607|448609798|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
124723529|NCT03818607|448609799|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
124723530|NCT05059301|448609801|FG000|Overall Study|Adverse Event|0|||
124723531|NCT05059301|448609802|FG001|Overall Study|Adverse Event|2|||
124723532|NCT05059301|448609803|FG002|Overall Study|Adverse Event|2|||
124723533|NCT05059301|448609801|FG000|Overall Study|Lost to Follow-up|2|||
124723534|NCT05059301|448609802|FG001|Overall Study|Lost to Follow-up|3|||
124723535|NCT05059301|448609803|FG002|Overall Study|Lost to Follow-up|3|||
124723536|NCT01164891|448609804|FG000|Overall Study|Disease Progression|5|||
124723537|NCT01164891|448609804|FG000|Overall Study|Adverse Event|1|||
124723538|NCT00441142|448609805|FG000|Overall Study|Adverse Event|2|||
124723539|NCT00441142|448609806|FG001|Overall Study|Adverse Event|3|||
124723540|NCT00441142|448609807|FG002|Overall Study|Adverse Event|3|||
124723541|NCT00441142|448609808|FG003|Overall Study|Adverse Event|22|||
124723542|NCT00441142|448609805|FG000|Overall Study|Lack of Efficacy|3|||
124723543|NCT00441142|448609806|FG001|Overall Study|Lack of Efficacy|3|||
124723544|NCT00441142|448609807|FG002|Overall Study|Lack of Efficacy|17|||
124723545|NCT00441142|448609808|FG003|Overall Study|Lack of Efficacy|32|||
124723546|NCT00441142|448609805|FG000|Overall Study|Withdrawal by Subject|0|||
124723547|NCT00441142|448609806|FG001|Overall Study|Withdrawal by Subject|0|||
124723548|NCT00441142|448609807|FG002|Overall Study|Withdrawal by Subject|2|||
124723549|NCT00441142|448609808|FG003|Overall Study|Withdrawal by Subject|10|||
124723550|NCT00441142|448609805|FG000|Overall Study|Patient still receiving active study tx|1|||
124723551|NCT00441142|448609806|FG001|Overall Study|Patient still receiving active study tx|0|||
124723552|NCT00441142|448609807|FG002|Overall Study|Patient still receiving active study tx|0|||
124723553|NCT00441142|448609808|FG003|Overall Study|Patient still receiving active study tx|2|||
124723554|NCT00441142|448609805|FG000|Overall Study|Physician Decision|0|||
124723555|NCT00441142|448609806|FG001|Overall Study|Physician Decision|1|||
124723556|NCT00441142|448609807|FG002|Overall Study|Physician Decision|0|||
124723557|NCT00441142|448609808|FG003|Overall Study|Physician Decision|1|||
124723558|NCT00441142|448609805|FG000|Overall Study|Death|0|||
124723559|NCT00441142|448609806|FG001|Overall Study|Death|0|||
124723560|NCT00441142|448609807|FG002|Overall Study|Death|0|||
124723561|NCT00441142|448609808|FG003|Overall Study|Death|1|||
124723562|NCT04952597|448609809|FG000|Overall Study|Death|12|||
124496881|NCT04705597|447773736|FG000|Overall Study|Withdrawal by Subject|1|||
124496882|NCT04705597|447773737|FG001|Overall Study|Withdrawal by Subject|2|||
124496883|NCT06094296|447773740|FG000|Overall Study|Progressive Disease|1|||
124496884|NCT06094296|447773741|FG001|Overall Study|Progressive Disease|0|||
124496885|NCT06094296|447773742|FG002|Overall Study|Progressive Disease|0|||
124496886|NCT06094296|447773743|FG003|Overall Study|Progressive Disease|0|||
124496887|NCT03332667|447773744|FG000|Overall Study|Adverse Event|0|||
124496888|NCT03332667|447773745|FG001|Overall Study|Adverse Event|0|||
124496889|NCT03332667|447773746|FG002|Overall Study|Adverse Event|2|||
124496890|NCT03332667|447773747|FG003|Overall Study|Adverse Event|1|||
124723563|NCT04952597|448609810|FG001|Overall Study|Death|13|||
124723564|NCT04952597|448609811|FG002|Overall Study|Death|14|||
124723565|NCT04952597|448609809|FG000|Overall Study|Withdrawal by Subject|1|||
124723566|NCT04952597|448609810|FG001|Overall Study|Withdrawal by Subject|0|||
124723567|NCT04952597|448609811|FG002|Overall Study|Withdrawal by Subject|3|||
124723568|NCT04952597|448609809|FG000|Overall Study|Lost to Follow-up|0|||
124496891|NCT03332667|447773744|FG000|Overall Study|Withdrawal by Subject|2|||
124496892|NCT03332667|447773745|FG001|Overall Study|Withdrawal by Subject|1|||
124496893|NCT03332667|447773746|FG002|Overall Study|Withdrawal by Subject|5|||
124496894|NCT03332667|447773747|FG003|Overall Study|Withdrawal by Subject|1|||
124496895|NCT03332667|447773744|FG000|Overall Study|Disease Progression or Relapse|2|||
124496896|NCT03332667|447773745|FG001|Overall Study|Disease Progression or Relapse|1|||
124496897|NCT03332667|447773746|FG002|Overall Study|Disease Progression or Relapse|3|||
124496898|NCT03332667|447773747|FG003|Overall Study|Disease Progression or Relapse|0|||
124496899|NCT03332667|447773744|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
124496900|NCT03332667|447773745|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
124496901|NCT03332667|447773746|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
124496902|NCT03332667|447773747|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
124496903|NCT03332667|447773744|FG000|Overall Study|No Treatment Received|0|||
124496904|NCT03332667|447773745|FG001|Overall Study|No Treatment Received|0|||
124496905|NCT03332667|447773746|FG002|Overall Study|No Treatment Received|1|||
124496906|NCT03332667|447773747|FG003|Overall Study|No Treatment Received|0|||
124496907|NCT01809262|447773748|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
124496908|NCT01809262|447773749|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
124496909|NCT01809262|447773750|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
124496910|NCT01809262|447773751|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
124496911|NCT01809262|447773752|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
124496912|NCT01809262|447773753|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
124496913|NCT01809262|447773754|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
124496914|NCT01809262|447773755|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
124496915|NCT01809262|447773756|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
124496916|NCT01809262|447773757|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
124496917|NCT01809262|447773748|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
124496918|NCT01809262|447773749|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
124496919|NCT01809262|447773750|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
124496920|NCT01809262|447773751|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
124496921|NCT01809262|447773752|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
124496922|NCT01809262|447773753|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
124496923|NCT01809262|447773754|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
124496924|NCT01809262|447773755|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
124496925|NCT01809262|447773756|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
124496926|NCT01809262|447773757|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
124496927|NCT02064439|447773759|FG000|Overall Study|Adverse Event|51|||
124496928|NCT02064439|447773760|FG001|Overall Study|Adverse Event|47|||
124496929|NCT02064439|447773761|FG002|Overall Study|Adverse Event|46|||
124496930|NCT02064439|447773759|FG000|Overall Study|Death|0|||
124496931|NCT02064439|447773760|FG001|Overall Study|Death|2|||
124496932|NCT02064439|447773761|FG002|Overall Study|Death|3|||
124496933|NCT02064439|447773759|FG000|Overall Study|Withdrawal by Subject|29|||
124496934|NCT02064439|447773760|FG001|Overall Study|Withdrawal by Subject|18|||
124496935|NCT02064439|447773761|FG002|Overall Study|Withdrawal by Subject|26|||
124496936|NCT02064439|447773759|FG000|Overall Study|Protocol Violation|3|||
124496937|NCT02064439|447773760|FG001|Overall Study|Protocol Violation|5|||
124496938|NCT02064439|447773761|FG002|Overall Study|Protocol Violation|3|||
124496939|NCT02064439|447773759|FG000|Overall Study|Lost to Follow-up|1|||
124496940|NCT02064439|447773760|FG001|Overall Study|Lost to Follow-up|3|||
124496941|NCT02064439|447773761|FG002|Overall Study|Lost to Follow-up|4|||
124496942|NCT02064439|447773759|FG000|Overall Study|Non-compliance with study medication|21|||
124496943|NCT02064439|447773760|FG001|Overall Study|Non-compliance with study medication|19|||
124496944|NCT02064439|447773761|FG002|Overall Study|Non-compliance with study medication|23|||
124496945|NCT02064439|447773759|FG000|Overall Study|Physician Decision|0|||
124496946|NCT02064439|447773760|FG001|Overall Study|Physician Decision|1|||
124496947|NCT02064439|447773761|FG002|Overall Study|Physician Decision|1|||
124496948|NCT02064439|447773759|FG000|Overall Study|Logistical difficulties|6|||
124496949|NCT02064439|447773760|FG001|Overall Study|Logistical difficulties|5|||
124496950|NCT02064439|447773761|FG002|Overall Study|Logistical difficulties|2|||
124496951|NCT02064439|447773759|FG000|Overall Study|Efficacy outcome reached|18|||
124496952|NCT02064439|447773760|FG001|Overall Study|Efficacy outcome reached|16|||
124496953|NCT02064439|447773761|FG002|Overall Study|Efficacy outcome reached|57|||
124496954|NCT02064439|447773759|FG000|Overall Study|Safety outcome reached|12|||
124496955|NCT02064439|447773760|FG001|Overall Study|Safety outcome reached|20|||
124496956|NCT02064439|447773761|FG002|Overall Study|Safety outcome reached|10|||
124496957|NCT02064439|447773759|FG000|Overall Study|Other|2|||
124496958|NCT02064439|447773760|FG001|Overall Study|Other|2|||
124496959|NCT02064439|447773761|FG002|Overall Study|Other|7|||
124496960|NCT02417233|447773766|FG000|Overall Study|Death|4|||
124496961|NCT02417233|447773767|FG001|Overall Study|Death|10|||
124496962|NCT02417233|447773768|FG002|Overall Study|Death|14|||
124496963|NCT02417233|447773766|FG000|Overall Study|Lost to Follow-up|27|||
124496964|NCT02417233|447773767|FG001|Overall Study|Lost to Follow-up|39|||
124496965|NCT02417233|447773768|FG002|Overall Study|Lost to Follow-up|34|||
124773618|NCT03848832|448800567|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
124773619|NCT03848832|448800565|FG000|Overall Study|Adverse Event|1|||
124773620|NCT03848832|448800566|FG001|Overall Study|Adverse Event|0|||
124773621|NCT03848832|448800567|FG002|Overall Study|Adverse Event|0|||
124773622|NCT01760733|448800568|FG000|Waiting List|Death|18|||
124773623|NCT01760733|448800568|FG000|Waiting List|Removed from waiting list|41|||
124496966|NCT02417233|447773766|FG000|Overall Study|Protocol Violation|2|||
124496967|NCT02417233|447773767|FG001|Overall Study|Protocol Violation|0|||
124496968|NCT02417233|447773768|FG002|Overall Study|Protocol Violation|2|||
124496969|NCT02417233|447773766|FG000|Overall Study|Withdrawal by Subject|2|||
124496970|NCT02417233|447773767|FG001|Overall Study|Withdrawal by Subject|1|||
124496971|NCT02417233|447773768|FG002|Overall Study|Withdrawal by Subject|8|||
124496972|NCT02417233|447773766|FG000|Overall Study|Relocation out of study area|1|||
124496973|NCT02417233|447773767|FG001|Overall Study|Relocation out of study area|0|||
124496974|NCT02417233|447773768|FG002|Overall Study|Relocation out of study area|1|||
124496975|NCT02417233|447773766|FG000|Overall Study|Mentally unstable|0|||
124496976|NCT02417233|447773767|FG001|Overall Study|Mentally unstable|1|||
124496977|NCT02417233|447773768|FG002|Overall Study|Mentally unstable|0|||
124496978|NCT03649321|447773769|FG000|Overall Study|Withdrawal by Subject|1|||
124496979|NCT03649321|447773770|FG001|Overall Study|Withdrawal by Subject|0|||
124496980|NCT03649321|447773769|FG000|Overall Study|Death|1|||
124496981|NCT03649321|447773770|FG001|Overall Study|Death|0|||
124496982|NCT01702363|447773771|FG000|Overall Study|Adverse Event|14|||
124496983|NCT01702363|447773771|FG000|Overall Study|Lack of Efficacy|4|||
124496984|NCT01702363|447773771|FG000|Overall Study|Withdrawal by Subject|2|||
124496985|NCT01293032|447773772|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
124496986|NCT01293032|447773773|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
124496987|NCT01293032|447773774|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
124496988|NCT01293032|447773775|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
124496989|NCT01293032|447773772|FG000|Treatment|Adverse Event|0|||
124496990|NCT01293032|447773773|FG001|Treatment|Adverse Event|0|||
124496991|NCT01293032|447773774|FG002|Treatment|Adverse Event|1|||
124496992|NCT01293032|447773775|FG003|Treatment|Adverse Event|1|||
124496993|NCT01293032|447773772|FG000|Treatment|Withdrawal by Subject|2|||
124496994|NCT01293032|447773773|FG001|Treatment|Withdrawal by Subject|4|||
124496995|NCT01293032|447773774|FG002|Treatment|Withdrawal by Subject|0|||
124496996|NCT01293032|447773775|FG003|Treatment|Withdrawal by Subject|0|||
124496997|NCT01293032|447773772|FG000|Treatment|Disease Progression, relapse|0|||
124496998|NCT01293032|447773773|FG001|Treatment|Disease Progression, relapse|1|||
124496999|NCT01293032|447773774|FG002|Treatment|Disease Progression, relapse|0|||
124497000|NCT01293032|447773775|FG003|Treatment|Disease Progression, relapse|0|||
124497001|NCT02184143|447773782|FG000|Overall Study|Withdrawal by Subject|4|||
124497002|NCT02184143|447773783|FG001|Overall Study|Withdrawal by Subject|4|||
124497003|NCT02184143|447773782|FG000|Overall Study|Lost to Follow-up|5|||
124497004|NCT02184143|447773783|FG001|Overall Study|Lost to Follow-up|3|||
124497005|NCT02184143|447773782|FG000|Overall Study|Death|1|||
124497006|NCT02184143|447773783|FG001|Overall Study|Death|0|||
124497007|NCT00321984|447773784|FG000|Overall Study|Adverse Event|9|||
124497008|NCT00321984|447773785|FG001|Overall Study|Adverse Event|6|||
124497009|NCT00321984|447773786|FG002|Overall Study|Adverse Event|8|||
124497010|NCT00321984|447773784|FG000|Overall Study|Protocol Violation|0|||
124497011|NCT00321984|447773785|FG001|Overall Study|Protocol Violation|1|||
124497012|NCT00321984|447773786|FG002|Overall Study|Protocol Violation|1|||
124497013|NCT00321984|447773784|FG000|Overall Study|Lost to Follow-up|2|||
124497014|NCT00321984|447773785|FG001|Overall Study|Lost to Follow-up|4|||
124497015|NCT00321984|447773786|FG002|Overall Study|Lost to Follow-up|2|||
124497016|NCT00321984|447773784|FG000|Overall Study|Withdrawal by Subject|8|||
124497017|NCT00321984|447773785|FG001|Overall Study|Withdrawal by Subject|6|||
124497018|NCT00321984|447773786|FG002|Overall Study|Withdrawal by Subject|5|||
124497019|NCT00321984|447773784|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
124497020|NCT00321984|447773785|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
124497021|NCT00321984|447773786|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
124773624|NCT01760733|448800568|FG000|Waiting List|Not received a transplant yet|13|||
124773625|NCT01760733|448800568|FG000|Transplanted|Not reached 10 years post transplant|184|||
124773626|NCT01760733|448800568|FG000|Transplanted|Death|26|||
124773627|NCT01760733|448800568|FG000|Transplanted|Graft loss|7|||
124497022|NCT00321984|447773784|FG000|Overall Study|Lack of Efficacy|3|||
124773628|NCT02404025|448800569|FG000|Overall Study|Adverse Event|1|||
124497023|NCT00321984|447773785|FG001|Overall Study|Lack of Efficacy|1|||
124497024|NCT00321984|447773786|FG002|Overall Study|Lack of Efficacy|3|||
124497025|NCT00321984|447773784|FG000|Overall Study|Noncompliant|0|||
124497026|NCT00321984|447773785|FG001|Overall Study|Noncompliant|0|||
124497027|NCT00321984|447773786|FG002|Overall Study|Noncompliant|2|||
124497028|NCT00321984|447773784|FG000|Overall Study|Pregnancy|0|||
124497029|NCT00321984|447773785|FG001|Overall Study|Pregnancy|1|||
124497030|NCT00321984|447773786|FG002|Overall Study|Pregnancy|0|||
124497031|NCT00321984|447773784|FG000|Overall Study|Per Subject Request|1|||
124497032|NCT00321984|447773785|FG001|Overall Study|Per Subject Request|0|||
124558578|NCT02544633|448003286|FG003|Treatment Period|Adverse Event|5|||
124497033|NCT00321984|447773786|FG002|Overall Study|Per Subject Request|0|||
124497034|NCT00321984|447773784|FG000|Overall Study|Per Investigator Request|1|||
124497035|NCT00321984|447773785|FG001|Overall Study|Per Investigator Request|0|||
124497036|NCT00321984|447773786|FG002|Overall Study|Per Investigator Request|0|||
124497037|NCT00321984|447773784|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
124497038|NCT00321984|447773785|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
124497039|NCT00321984|447773786|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
124497040|NCT02985450|447773793|FG000|Overall Study|Lost to Follow-up|7|||
124497041|NCT00431847|447773796|FG000|Overall Study|completion of less than two study visits|6|||
124497042|NCT00431847|447773797|FG001|Overall Study|completion of less than two study visits|3|||
124497043|NCT00431847|447773798|FG002|Overall Study|completion of less than two study visits|4|||
124497044|NCT00431847|447773799|FG003|Overall Study|completion of less than two study visits|14|||
124497045|NCT00431847|447773800|FG004|Overall Study|completion of less than two study visits|0|||
124497046|NCT00431847|447773796|FG000|Overall Study|Protocol Violation|0|||
124497047|NCT00431847|447773797|FG001|Overall Study|Protocol Violation|0|||
124497048|NCT00431847|447773798|FG002|Overall Study|Protocol Violation|0|||
124497049|NCT00431847|447773799|FG003|Overall Study|Protocol Violation|0|||
124497050|NCT00431847|447773800|FG004|Overall Study|Protocol Violation|1|||
124497051|NCT01469013|447773801|FG000|Part A (Treatment Period)|Adverse Event|1|||
124497052|NCT01469013|447773802|FG001|Part A (Treatment Period)|Adverse Event|0|||
124497053|NCT01469013|447773803|FG002|Part A (Treatment Period)|Adverse Event|0|||
124558579|NCT02544633|448003283|FG000|Treatment Period|Lack of Efficacy|17|||
124558580|NCT02544633|448003284|FG001|Treatment Period|Lack of Efficacy|11|||
124558581|NCT02544633|448003285|FG002|Treatment Period|Lack of Efficacy|5|||
124558582|NCT02544633|448003286|FG003|Treatment Period|Lack of Efficacy|5|||
124558583|NCT02544633|448003283|FG000|Treatment Period|Global Deterioration of Health|3|||
124558584|NCT02544633|448003284|FG001|Treatment Period|Global Deterioration of Health|3|||
124558585|NCT02544633|448003285|FG002|Treatment Period|Global Deterioration of Health|0|||
124558586|NCT02544633|448003286|FG003|Treatment Period|Global Deterioration of Health|1|||
124558587|NCT02544633|448003283|FG000|Treatment Period|Withdrawal by Subject|1|||
124558588|NCT02544633|448003284|FG001|Treatment Period|Withdrawal by Subject|0|||
124558589|NCT02544633|448003285|FG002|Treatment Period|Withdrawal by Subject|0|||
124558590|NCT02544633|448003286|FG003|Treatment Period|Withdrawal by Subject|0|||
124558591|NCT02544633|448003283|FG000|Treatment Period|Lost to Follow-up|0|||
124558592|NCT02544633|448003284|FG001|Treatment Period|Lost to Follow-up|1|||
124558593|NCT02544633|448003285|FG002|Treatment Period|Lost to Follow-up|0|||
124558594|NCT02544633|448003286|FG003|Treatment Period|Lost to Follow-up|0|||
124558595|NCT02544633|448003283|FG000|Treatment Period|Death|0|||
124558596|NCT02544633|448003284|FG001|Treatment Period|Death|0|||
124558597|NCT02544633|448003285|FG002|Treatment Period|Death|1|||
124558598|NCT02544633|448003286|FG003|Treatment Period|Death|0|||
124558599|NCT02544633|448003283|FG000|Treatment Period|Non-compliance|0|||
124558600|NCT02544633|448003284|FG001|Treatment Period|Non-compliance|0|||
124558601|NCT02544633|448003285|FG002|Treatment Period|Non-compliance|1|||
124558602|NCT02544633|448003286|FG003|Treatment Period|Non-compliance|0|||
124558603|NCT02544633|448003283|FG000|Treatment Period|Clinical Disease Progression|0|||
124558604|NCT02544633|448003284|FG001|Treatment Period|Clinical Disease Progression|0|||
124558605|NCT02544633|448003285|FG002|Treatment Period|Clinical Disease Progression|0|||
124558606|NCT02544633|448003286|FG003|Treatment Period|Clinical Disease Progression|1|||
124558607|NCT02544633|448003283|FG000|Survival Follow-up Period|Death|12|||
124558608|NCT02544633|448003284|FG001|Survival Follow-up Period|Death|14|||
124558609|NCT02544633|448003285|FG002|Survival Follow-up Period|Death|3|||
124558610|NCT02544633|448003286|FG003|Survival Follow-up Period|Death|9|||
124558611|NCT02544633|448003283|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
124558612|NCT02544633|448003284|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
124558613|NCT02544633|448003285|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
124558614|NCT02544633|448003286|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
124558615|NCT02544633|448003283|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
124558616|NCT02544633|448003284|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
124558617|NCT02544633|448003285|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
124558618|NCT02544633|448003286|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
124558619|NCT02544633|448003283|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
124558620|NCT02544633|448003284|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
124558621|NCT02544633|448003285|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
124558622|NCT02544633|448003286|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
124558623|NCT01977352|448003287|FG000|Overall Study|Lost to Follow-up|1|||
124723569|NCT04952597|448609810|FG001|Overall Study|Lost to Follow-up|1|||
124497054|NCT01469013|447773804|FG003|Part A (Treatment Period)|Adverse Event|0|||
124497055|NCT01469013|447773805|FG004|Part A (Treatment Period)|Adverse Event|1|||
124723570|NCT04952597|448609811|FG002|Overall Study|Lost to Follow-up|1|||
124723571|NCT05730335|448609812|FG000|Overall Study|Lost to Follow-up|8|||
124558624|NCT01977352|448003288|FG001|Overall Study|Lost to Follow-up|2|||
124558625|NCT02257632|448003292|FG000|Overall Study|Withdrawal by Subject|0|||
124558626|NCT02257632|448003293|FG001|Overall Study|Withdrawal by Subject|1|||
124558627|NCT02257632|448003292|FG000|Overall Study|Adverse Event|1|||
124773629|NCT02404025|448800569|FG000|Overall Study|Lack of Efficacy|3|||
124773630|NCT01524796|448800570|FG000|Overall Study|Adverse Event|13|||
124773631|NCT01524796|448800570|FG000|Overall Study|Lack of Efficacy|3|||
124773632|NCT01524796|448800570|FG000|Overall Study|Lost to Follow-up|1|||
124773633|NCT01524796|448800570|FG000|Overall Study|The price|1|||
124773634|NCT01524796|448800570|FG000|Overall Study|Withdrawal by Subject|4|||
124773635|NCT01524796|448800570|FG000|Overall Study|Move|1|||
124773636|NCT01524796|448800570|FG000|Overall Study|Deterioration of pains|1|||
124773637|NCT01524796|448800570|FG000|Overall Study|Gall stone surgery|1|||
124773638|NCT01524796|448800570|FG000|Overall Study|Nervous about confidentiality|1|||
124773639|NCT01524796|448800570|FG000|Overall Study|Switch to carbamazapine|1|||
124773640|NCT01524796|448800570|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
124773641|NCT03938259|448800574|FG000|Overall Study|unable to establish baseline for ventilation|1|||
124773642|NCT03938259|448800575|FG001|Overall Study|unable to establish baseline for ventilation|1|||
124773643|NCT01002339|448800576|FG000|Overall Study|Withdrawal by Subject|0|||
124773644|NCT01002339|448800577|FG001|Overall Study|Withdrawal by Subject|1|||
124773645|NCT01002339|448800578|FG002|Overall Study|Withdrawal by Subject|0|||
124773646|NCT01002339|448800576|FG000|Overall Study|Incorrect treatment assignment|0|||
124773647|NCT01002339|448800577|FG001|Overall Study|Incorrect treatment assignment|0|||
124773648|NCT01002339|448800578|FG002|Overall Study|Incorrect treatment assignment|1|||
124773649|NCT01002339|448800576|FG000|Overall Study|Protocol Violation|0|||
124773650|NCT01002339|448800577|FG001|Overall Study|Protocol Violation|0|||
124773651|NCT01002339|448800578|FG002|Overall Study|Protocol Violation|2|||
124773652|NCT01002339|448800576|FG000|Overall Study|Lung cancer detected before transplant|0|||
124773653|NCT01002339|448800577|FG001|Overall Study|Lung cancer detected before transplant|0|||
124773654|NCT01002339|448800578|FG002|Overall Study|Lung cancer detected before transplant|1|||
124773655|NCT01002339|448800576|FG000|Overall Study|Randomized. Not transplanted|0|||
124497056|NCT01469013|447773806|FG005|Part A (Treatment Period)|Adverse Event|0|||
124497057|NCT01469013|447773807|FG006|Part A (Treatment Period)|Adverse Event|0|||
124497058|NCT01469013|447773808|FG007|Part A (Treatment Period)|Adverse Event|0|||
124497059|NCT01469013|447773809|FG008|Part A (Treatment Period)|Adverse Event|0|||
124497060|NCT01469013|447773810|FG009|Part A (Treatment Period)|Adverse Event|0|||
124497061|NCT01469013|447773811|FG010|Part A (Treatment Period)|Adverse Event|0|||
124497062|NCT01469013|447773812|FG011|Part A (Treatment Period)|Adverse Event|0|||
124497063|NCT01469013|447773813|FG012|Part A (Treatment Period)|Adverse Event|0|||
124497064|NCT01469013|447773801|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
124497065|NCT01469013|447773802|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
124497066|NCT01469013|447773803|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
124497067|NCT01469013|447773804|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
124497068|NCT01469013|447773805|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
124497069|NCT01469013|447773806|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
124497070|NCT01469013|447773807|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
124497071|NCT01469013|447773808|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
124497072|NCT01469013|447773809|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
124497073|NCT01469013|447773810|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
124497074|NCT01469013|447773811|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
124497075|NCT01469013|447773812|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
124497076|NCT01469013|447773813|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
124497077|NCT01469013|447773801|FG000|Part B (Extension Period)|Adverse Event|0|||
124497078|NCT01469013|447773802|FG001|Part B (Extension Period)|Adverse Event|0|||
124497079|NCT01469013|447773803|FG002|Part B (Extension Period)|Adverse Event|0|||
124497080|NCT01469013|447773804|FG003|Part B (Extension Period)|Adverse Event|0|||
124497081|NCT01469013|447773805|FG004|Part B (Extension Period)|Adverse Event|0|||
124497082|NCT01469013|447773806|FG005|Part B (Extension Period)|Adverse Event|2|||
124497083|NCT01469013|447773807|FG006|Part B (Extension Period)|Adverse Event|5|||
124497084|NCT01469013|447773808|FG007|Part B (Extension Period)|Adverse Event|5|||
124497085|NCT01469013|447773809|FG008|Part B (Extension Period)|Adverse Event|3|||
124497086|NCT01469013|447773810|FG009|Part B (Extension Period)|Adverse Event|3|||
124497087|NCT01469013|447773811|FG010|Part B (Extension Period)|Adverse Event|1|||
124497088|NCT01469013|447773812|FG011|Part B (Extension Period)|Adverse Event|6|||
124497089|NCT01469013|447773813|FG012|Part B (Extension Period)|Adverse Event|3|||
124497090|NCT01469013|447773801|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
124497091|NCT01469013|447773802|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
124497092|NCT01469013|447773803|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
124497093|NCT01469013|447773804|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
124497094|NCT01469013|447773805|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
124497095|NCT01469013|447773806|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
124497096|NCT01469013|447773807|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
124497097|NCT01469013|447773808|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
124497098|NCT01469013|447773809|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
124497099|NCT01469013|447773810|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
124773656|NCT01002339|448800577|FG001|Overall Study|Randomized. Not transplanted|0|||
124773657|NCT01002339|448800578|FG002|Overall Study|Randomized. Not transplanted|1|||
124773658|NCT01907854|448800579|FG000|Overall Study|Protocol Violation|1|||
124773659|NCT01907854|448800580|FG001|Overall Study|Protocol Violation|1|||
124773660|NCT01907854|448800579|FG000|Overall Study|Withdrawal by Subject|9|||
124773661|NCT01907854|448800580|FG001|Overall Study|Withdrawal by Subject|7|||
124773662|NCT01907854|448800579|FG000|Overall Study|Lost to Follow-up|2|||
124773663|NCT01907854|448800580|FG001|Overall Study|Lost to Follow-up|2|||
124773664|NCT01907854|448800579|FG000|Overall Study|Unclassified|4|||
124773665|NCT01907854|448800580|FG001|Overall Study|Unclassified|3|||
124773666|NCT02215252|448800583|FG000|Overall Study|Adverse Event|1|||
124773667|NCT02215252|448800584|FG001|Overall Study|Adverse Event|5|||
124773668|NCT02215252|448800585|FG002|Overall Study|Adverse Event|2|||
124773669|NCT02215252|448800583|FG000|Overall Study|Lost to Follow-up|0|||
124773670|NCT02215252|448800584|FG001|Overall Study|Lost to Follow-up|0|||
124773671|NCT02215252|448800585|FG002|Overall Study|Lost to Follow-up|1|||
124773672|NCT02215252|448800583|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
124773673|NCT02215252|448800584|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
124773674|NCT02215252|448800585|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
124773675|NCT02215252|448800583|FG000|Overall Study|Protocol Violation|0|||
124773676|NCT02215252|448800584|FG001|Overall Study|Protocol Violation|1|||
124773677|NCT02215252|448800585|FG002|Overall Study|Protocol Violation|0|||
124773678|NCT02215252|448800583|FG000|Overall Study|Withdrawal by Subject|1|||
124558628|NCT02257632|448003293|FG001|Overall Study|Adverse Event|2|||
124723572|NCT05730335|448609812|FG000|Overall Study|Withdrawal by Subject|6|||
124723573|NCT05286658|448609817|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
124723574|NCT05286658|448609817|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
124723575|NCT05411822|448609818|FG000|Overall Study|Withdrawal by Subject|2|||
124723576|NCT05411822|448609819|FG001|Overall Study|Withdrawal by Subject|1|||
124723577|NCT02027311|448609821|FG000|Overall Study|Protocol Violation|3|||
124723578|NCT02027311|448609822|FG001|Overall Study|Protocol Violation|2|||
124723579|NCT04004221|448609823|FG000|Overall Study|Death|89|||
124723580|NCT04004221|448609823|FG000|Overall Study|Withdrawal by Subject|5|||
124723581|NCT04004221|448609823|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
124723582|NCT04004221|448609823|FG000|Overall Study|Sponsor Decision|9|||
124723583|NCT04004221|448609823|FG000|Overall Study|Participant refused to enter LTE|1|||
124723584|NCT01814397|448609825|FG000|Overall Study|Adverse Event|7|||
124723585|NCT01814397|448609825|FG000|Overall Study|Withdrawal by Subject|7|||
124723586|NCT01939977|448609827|FG000|Overall Study|Adverse Event|4|||
124723587|NCT01939977|448609828|FG001|Overall Study|Adverse Event|3|||
124723588|NCT01939977|448609827|FG000|Overall Study|Lack of Efficacy|3|||
124723589|NCT01939977|448609828|FG001|Overall Study|Lack of Efficacy|0|||
124723590|NCT01939977|448609827|FG000|Overall Study|Physician Decision|1|||
124723591|NCT01939977|448609828|FG001|Overall Study|Physician Decision|1|||
124723592|NCT01939977|448609827|FG000|Overall Study|Withdrawal by Subject|0|||
124723593|NCT01939977|448609828|FG001|Overall Study|Withdrawal by Subject|2|||
124723594|NCT01939977|448609827|FG000|Overall Study|Did not meet inclusion criteria|1|||
124723595|NCT01939977|448609828|FG001|Overall Study|Did not meet inclusion criteria|0|||
124723596|NCT01939977|448609827|FG000|Overall Study|Did not receive study medication|0|||
124723597|NCT01939977|448609828|FG001|Overall Study|Did not receive study medication|1|||
124723598|NCT02952313|448609838|FG000|Primary Endpoint|Lost to Follow-up|4|||
124723599|NCT02952313|448609838|FG000|Primary Endpoint|Withdrawal by Subject|1|||
124723600|NCT02952313|448609838|FG000|Primary Endpoint|Lack of Efficacy|1|||
124723601|NCT02952313|448609838|FG000|Primary Endpoint|Missed visit|1|||
124723602|NCT02952313|448609838|FG000|Long-term Follow-up|Lost to Follow-up|12|||
124723603|NCT02952313|448609838|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
124723604|NCT02952313|448609838|FG000|Long-term Follow-up|Lack of Efficacy|6|||
124723605|NCT02952313|448609838|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
124723606|NCT02952313|448609838|FG000|Long-term Follow-up|Physician Decision|1|||
124723607|NCT02952313|448609838|FG000|Long-term Follow-up|Death|1|||
124723608|NCT02095873|448609839|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
124723609|NCT02095873|448609840|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
124773679|NCT02215252|448800584|FG001|Overall Study|Withdrawal by Subject|0|||
124773680|NCT02215252|448800585|FG002|Overall Study|Withdrawal by Subject|0|||
124773681|NCT02215252|448800583|FG000|Overall Study|Other|0|||
124773682|NCT02215252|448800584|FG001|Overall Study|Other|1|||
124773683|NCT02215252|448800585|FG002|Overall Study|Other|1|||
124773684|NCT03774576|448800586|FG000|Period 2|Adverse Event|1|||
124773685|NCT01716234|448800587|FG000|Overall Study|Protocol Violation|0|||
124773686|NCT01716234|448800588|FG001|Overall Study|Protocol Violation|0|||
124558629|NCT01059071|448003294|FG000|Overall Study|Lack of Efficacy|1|||
124558630|NCT01059071|448003295|FG001|Overall Study|Lack of Efficacy|4|||
124723610|NCT02095873|448609839|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
124723611|NCT02095873|448609840|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
124773687|NCT01716234|448800589|FG002|Overall Study|Protocol Violation|0|||
124773688|NCT01716234|448800590|FG003|Overall Study|Protocol Violation|1|||
124773689|NCT01716234|448800591|FG004|Overall Study|Protocol Violation|1|||
124558631|NCT01059071|448003296|FG002|Overall Study|Lack of Efficacy|2|||
124558632|NCT01059071|448003297|FG003|Overall Study|Lack of Efficacy|3|||
124558633|NCT01059071|448003294|FG000|Overall Study|Withdrawal by Subject|1|||
124558634|NCT01059071|448003295|FG001|Overall Study|Withdrawal by Subject|0|||
124558635|NCT01059071|448003296|FG002|Overall Study|Withdrawal by Subject|0|||
124558636|NCT01059071|448003297|FG003|Overall Study|Withdrawal by Subject|2|||
124558637|NCT01059071|448003294|FG000|Overall Study|Physician Decision|0|||
124558638|NCT01059071|448003295|FG001|Overall Study|Physician Decision|0|||
124558639|NCT01059071|448003296|FG002|Overall Study|Physician Decision|0|||
124558640|NCT01059071|448003297|FG003|Overall Study|Physician Decision|1|||
124558641|NCT03763331|448003298|FG000|Overall Study|Lost to Follow-up|1|||
124558642|NCT03763331|448003299|FG001|Overall Study|Lost to Follow-up|0|||
124558643|NCT03763331|448003298|FG000|Overall Study|Withdrawal by Subject|1|||
124558644|NCT03763331|448003299|FG001|Overall Study|Withdrawal by Subject|0|||
124558645|NCT03763331|448003298|FG000|Overall Study|Non-compliance|0|||
124558646|NCT03763331|448003299|FG001|Overall Study|Non-compliance|3|||
124558647|NCT00936884|448003300|FG000|Double-blind|Withdrawal by Subject|6|||
124558648|NCT00936884|448003301|FG001|Double-blind|Withdrawal by Subject|4|||
124558649|NCT00936884|448003302|FG002|Double-blind|Withdrawal by Subject|0|||
124558650|NCT00936884|448003300|FG000|Double-blind|Death|2|||
124558651|NCT00936884|448003301|FG001|Double-blind|Death|1|||
124558652|NCT00936884|448003302|FG002|Double-blind|Death|0|||
124558653|NCT00936884|448003300|FG000|Double-blind|Lack of Efficacy|1|||
124558654|NCT00936884|448003301|FG001|Double-blind|Lack of Efficacy|1|||
124558655|NCT00936884|448003302|FG002|Double-blind|Lack of Efficacy|0|||
124558656|NCT00936884|448003300|FG000|Double-blind|Adverse Event|1|||
124558657|NCT00936884|448003301|FG001|Double-blind|Adverse Event|0|||
124558658|NCT00936884|448003302|FG002|Double-blind|Adverse Event|0|||
124558659|NCT00936884|448003300|FG000|Double-blind|Physician Decision|1|||
124558660|NCT00936884|448003301|FG001|Double-blind|Physician Decision|0|||
124558661|NCT00936884|448003302|FG002|Double-blind|Physician Decision|0|||
124558662|NCT00936884|448003300|FG000|Double-blind|No post baseline diary entry|1|||
124558663|NCT00936884|448003301|FG001|Double-blind|No post baseline diary entry|0|||
124558664|NCT00936884|448003302|FG002|Double-blind|No post baseline diary entry|0|||
124558665|NCT00936884|448003300|FG000|Double-blind|Did not receive study drug|0|||
124558666|NCT00936884|448003301|FG001|Double-blind|Did not receive study drug|1|||
124558667|NCT00936884|448003302|FG002|Double-blind|Did not receive study drug|0|||
124558668|NCT04741503|448003303|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
124558669|NCT04741503|448003304|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
124558670|NCT04741503|448003305|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
124497100|NCT01469013|447773811|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
124497101|NCT01469013|447773812|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
124497102|NCT01469013|447773813|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
124497103|NCT00002663|447773814|FG000|Overall Study|Death|4|||
124497104|NCT00002663|447773815|FG001|Overall Study|Death|1|||
124497105|NCT00002663|447773816|FG002|Overall Study|Death|1|||
124497106|NCT00002663|447773817|FG003|Overall Study|Death|0|||
124497107|NCT00002663|447773818|FG004|Overall Study|Death|0|||
124497108|NCT00002663|447773819|FG005|Overall Study|Death|13|||
124497109|NCT00002663|447773820|FG006|Overall Study|Death|0|||
124497110|NCT00002663|447773821|FG007|Overall Study|Death|1|||
124497111|NCT00002663|447773822|FG008|Overall Study|Death|1|||
124497112|NCT00002663|447773823|FG009|Overall Study|Death|1|||
124497113|NCT00002663|447773814|FG000|Overall Study|Lost to Follow-up|3|||
124497114|NCT00002663|447773815|FG001|Overall Study|Lost to Follow-up|0|||
124497115|NCT00002663|447773816|FG002|Overall Study|Lost to Follow-up|0|||
124497116|NCT00002663|447773817|FG003|Overall Study|Lost to Follow-up|1|||
124497117|NCT00002663|447773818|FG004|Overall Study|Lost to Follow-up|0|||
124558671|NCT04741503|448003303|FG000|Initial Enrollment|Overquotas removed|0|||
124558672|NCT04741503|448003304|FG001|Initial Enrollment|Overquotas removed|0|||
124558673|NCT04741503|448003305|FG002|Initial Enrollment|Overquotas removed|186|||
124558674|NCT04741503|448003303|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
124558675|NCT04741503|448003304|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
124558676|NCT04741503|448003305|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
124497118|NCT00002663|447773819|FG005|Overall Study|Lost to Follow-up|1|||
124497119|NCT00002663|447773820|FG006|Overall Study|Lost to Follow-up|0|||
124558677|NCT02280421|448003306|FG000|Washout (2 Weeks)|Adverse Event|0|||
124558678|NCT02280421|448003307|FG001|Washout (2 Weeks)|Adverse Event|1|||
124497120|NCT00002663|447773821|FG007|Overall Study|Lost to Follow-up|0|||
124497121|NCT00002663|447773822|FG008|Overall Study|Lost to Follow-up|0|||
124558679|NCT02280421|448003306|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
124558680|NCT02280421|448003307|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
124558681|NCT01859390|448003314|FG000|Overall Study|Insufficient Sputum Collected|1|||
124497122|NCT00002663|447773823|FG009|Overall Study|Lost to Follow-up|0|||
124497123|NCT00002663|447773814|FG000|Overall Study|Other|0|||
124497124|NCT00002663|447773815|FG001|Overall Study|Other|1|||
124558682|NCT01859390|448003315|FG001|Overall Study|Insufficient Sputum Collected|3|||
124558683|NCT01859390|448003314|FG000|Overall Study|Sample Missing Collection Date|0|||
124558684|NCT01859390|448003315|FG001|Overall Study|Sample Missing Collection Date|1|||
124558685|NCT01859390|448003314|FG000|Overall Study|Tube Cracked|0|||
124558686|NCT01859390|448003315|FG001|Overall Study|Tube Cracked|2|||
124558687|NCT01859390|448003314|FG000|Overall Study|Shipment Error|0|||
124773690|NCT01716234|448800592|FG005|Overall Study|Protocol Violation|1|||
124773691|NCT01716234|448800593|FG006|Overall Study|Protocol Violation|0|||
124773692|NCT01716234|448800587|FG000|Overall Study|Lack of Efficacy|0|||
124773693|NCT01716234|448800588|FG001|Overall Study|Lack of Efficacy|0|||
124773694|NCT01716234|448800589|FG002|Overall Study|Lack of Efficacy|0|||
124773695|NCT01716234|448800590|FG003|Overall Study|Lack of Efficacy|1|||
124773696|NCT01716234|448800591|FG004|Overall Study|Lack of Efficacy|0|||
124773697|NCT01716234|448800592|FG005|Overall Study|Lack of Efficacy|0|||
124497125|NCT00002663|447773816|FG002|Overall Study|Other|0|||
124497126|NCT00002663|447773817|FG003|Overall Study|Other|0|||
124497127|NCT00002663|447773818|FG004|Overall Study|Other|0|||
124497128|NCT00002663|447773819|FG005|Overall Study|Other|1|||
124497129|NCT00002663|447773820|FG006|Overall Study|Other|1|||
124497130|NCT00002663|447773821|FG007|Overall Study|Other|0|||
124497131|NCT00002663|447773822|FG008|Overall Study|Other|0|||
124497132|NCT00002663|447773823|FG009|Overall Study|Other|0|||
124497133|NCT00002663|447773814|FG000|Overall Study|Physician Decision|0|||
124497134|NCT00002663|447773815|FG001|Overall Study|Physician Decision|0|||
124497135|NCT00002663|447773816|FG002|Overall Study|Physician Decision|0|||
124497136|NCT00002663|447773817|FG003|Overall Study|Physician Decision|0|||
124497137|NCT00002663|447773818|FG004|Overall Study|Physician Decision|1|||
124497138|NCT00002663|447773819|FG005|Overall Study|Physician Decision|0|||
124497139|NCT00002663|447773820|FG006|Overall Study|Physician Decision|0|||
124497140|NCT00002663|447773821|FG007|Overall Study|Physician Decision|0|||
124497141|NCT00002663|447773822|FG008|Overall Study|Physician Decision|1|||
124497142|NCT00002663|447773823|FG009|Overall Study|Physician Decision|1|||
124497143|NCT00002663|447773814|FG000|Overall Study|Adverse Event|0|||
124497144|NCT00002663|447773815|FG001|Overall Study|Adverse Event|0|||
124497145|NCT00002663|447773816|FG002|Overall Study|Adverse Event|0|||
124497146|NCT00002663|447773817|FG003|Overall Study|Adverse Event|1|||
124497147|NCT00002663|447773818|FG004|Overall Study|Adverse Event|0|||
124497148|NCT00002663|447773819|FG005|Overall Study|Adverse Event|0|||
124497149|NCT00002663|447773820|FG006|Overall Study|Adverse Event|0|||
124497150|NCT00002663|447773821|FG007|Overall Study|Adverse Event|1|||
124497151|NCT00002663|447773822|FG008|Overall Study|Adverse Event|0|||
124497152|NCT00002663|447773823|FG009|Overall Study|Adverse Event|0|||
124497153|NCT01603641|447773827|FG000|Overall Study|Did not Receive Treatment|3|||
124497154|NCT01603641|447773827|FG000|Overall Study|Adverse Event|1|||
124497155|NCT01603641|447773827|FG000|Overall Study|Lack of Efficacy|1|||
124497156|NCT01603641|447773827|FG000|Overall Study|Lost to Follow-up|6|||
124497157|NCT01603641|447773827|FG000|Overall Study|Personal Reasons|18|||
124497158|NCT01603641|447773827|FG000|Overall Study|Other Miscellaneous Reasons|6|||
124497159|NCT03161678|447773828|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
124497160|NCT03161678|447773829|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
124497161|NCT03161678|447773830|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
124497162|NCT03161678|447773831|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
124497163|NCT03161678|447773832|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
124497164|NCT03161678|447773833|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
124497165|NCT03161678|447773828|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
124497166|NCT03161678|447773829|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
124497167|NCT03161678|447773830|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
124497168|NCT03161678|447773831|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
124497169|NCT03161678|447773832|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
124497170|NCT03161678|447773833|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
124497171|NCT03161678|447773828|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
124497172|NCT03161678|447773829|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
124497173|NCT03161678|447773830|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
124497174|NCT03161678|447773831|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
124497175|NCT03161678|447773832|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
124497176|NCT03161678|447773833|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
124497177|NCT03161678|447773828|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
124497178|NCT03161678|447773829|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
124497179|NCT03161678|447773830|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
124497180|NCT03161678|447773831|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
124497181|NCT03161678|447773832|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
124497182|NCT03161678|447773833|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
124558688|NCT01859390|448003315|FG001|Overall Study|Shipment Error|1|||
124773698|NCT01716234|448800593|FG006|Overall Study|Lack of Efficacy|0|||
124497183|NCT00739297|447773834|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
124497184|NCT00739297|447773835|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
124497185|NCT00739297|447773836|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
124773699|NCT01716234|448800587|FG000|Overall Study|Did not meet protocol eligibility|0|||
124497186|NCT00739297|447773837|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
124497187|NCT00739297|447773838|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
124497188|NCT00739297|447773839|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
124497189|NCT00739297|447773840|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
124497190|NCT00739297|447773834|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
124497191|NCT00739297|447773835|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
124497192|NCT00739297|447773836|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
124497193|NCT00739297|447773837|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
124497194|NCT00739297|447773838|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
124497195|NCT00739297|447773839|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
124497196|NCT00739297|447773840|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
124497197|NCT02749721|447773846|FG000|Screening|Withdrawal by Subject|1|||
124497198|NCT02749721|447773846|FG000|Screening|Lost to Follow-up|2|||
124497199|NCT02749721|447773846|FG000|Screening|Protocol Violation|3|||
124497200|NCT02749721|447773846|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
124497201|NCT02749721|447773846|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
124497202|NCT02137772|447773847|FG000|Overall Study|Adverse Event|6|||
124497203|NCT02137772|447773848|FG001|Overall Study|Adverse Event|3|||
124497204|NCT02137772|447773847|FG000|Overall Study|Death|71|||
124497205|NCT02137772|447773848|FG001|Overall Study|Death|44|||
124497206|NCT02137772|447773847|FG000|Overall Study|Lost to Follow-up|8|||
124497207|NCT02137772|447773848|FG001|Overall Study|Lost to Follow-up|4|||
124497208|NCT02137772|447773847|FG000|Overall Study|Physician Decision|15|||
124497209|NCT02137772|447773848|FG001|Overall Study|Physician Decision|5|||
124497210|NCT02137772|447773847|FG000|Overall Study|Withdrawal by Subject|28|||
124497211|NCT02137772|447773848|FG001|Overall Study|Withdrawal by Subject|17|||
124497212|NCT02137772|447773847|FG000|Overall Study|Non-compliance with study drug|1|||
124497213|NCT02137772|447773848|FG001|Overall Study|Non-compliance with study drug|0|||
124497214|NCT02137772|447773847|FG000|Overall Study|Not treated|3|||
124497215|NCT02137772|447773848|FG001|Overall Study|Not treated|2|||
124497216|NCT00443430|447773850|FG000|Overall Study|Lack of Efficacy|3|||
124497217|NCT00443430|447773851|FG001|Overall Study|Lack of Efficacy|3|||
124497218|NCT00443430|447773850|FG000|Overall Study|Adverse Event|1|||
124497219|NCT00443430|447773851|FG001|Overall Study|Adverse Event|1|||
124497220|NCT00933335|447773855|FG000|Overall Study|Lost to Follow-up|1|||
124497221|NCT00933335|447773856|FG001|Overall Study|Lost to Follow-up|3|||
124497222|NCT00933335|447773855|FG000|Overall Study|Withdrawal by Subject|0|||
124497223|NCT00933335|447773856|FG001|Overall Study|Withdrawal by Subject|1|||
124497224|NCT00933335|447773855|FG000|Overall Study|Progressive Disease|0|||
124497225|NCT00933335|447773856|FG001|Overall Study|Progressive Disease|11|||
124497226|NCT00933335|447773855|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
124497227|NCT00933335|447773856|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
124497228|NCT00933335|447773855|FG000|Overall Study|Co-morbid Illness|1|||
124497229|NCT00933335|447773856|FG001|Overall Study|Co-morbid Illness|0|||
124497230|NCT05468086|447773857|FG000|Overall Study|Withdrawal by Subject|3|||
124497231|NCT05468086|447773857|FG000|Overall Study|Subject was found ineligible after consent|1|||
124497232|NCT00374907|447773858|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
124723612|NCT02095873|448609839|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
124723613|NCT02095873|448609840|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
124723614|NCT00792740|448609843|FG000|Overall Study|Disease Worsening|3|||
124723615|NCT00792740|448609844|FG001|Overall Study|Disease Worsening|2|||
124723616|NCT00792740|448609843|FG000|Overall Study|Personal Reason|1|||
124723617|NCT00792740|448609844|FG001|Overall Study|Personal Reason|0|||
124723618|NCT00792740|448609843|FG000|Overall Study|Adverse Event|1|||
124723619|NCT00792740|448609844|FG001|Overall Study|Adverse Event|3|||
124723620|NCT00792740|448609843|FG000|Overall Study|Patient's withdrawal of consent|0|||
124723621|NCT00792740|448609844|FG001|Overall Study|Patient's withdrawal of consent|1|||
124723622|NCT00792740|448609843|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
124723623|NCT00792740|448609844|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
124723624|NCT00792740|448609843|FG000|Overall Study|Other reasons|0|||
124723625|NCT00792740|448609844|FG001|Overall Study|Other reasons|1|||
124723626|NCT03206918|448609847|FG000|Overall Study|Death|11|||
124723627|NCT03206918|448609847|FG000|Overall Study|Withdrawal by Subject|5|||
124723628|NCT03206918|448609847|FG000|Overall Study|Study terminated by sponsor|12|||
124723629|NCT03206918|448609847|FG000|Overall Study|Lost to Follow-up|3|||
124723630|NCT03206918|448609847|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
124723631|NCT03823287|448609848|FG000|Overall Study|Withdrawal by Subject|25|||
124723632|NCT03823287|448609849|FG001|Overall Study|Withdrawal by Subject|17|||
124723633|NCT03823287|448609848|FG000|Overall Study|Death|13|||
124497233|NCT00374907|447773859|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
124497234|NCT00374907|447773858|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
124723634|NCT03823287|448609849|FG001|Overall Study|Death|7|||
124723635|NCT03823287|448609848|FG000|Overall Study|Lost to Follow-up|7|||
124497235|NCT00374907|447773859|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
124497236|NCT00374907|447773858|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
124497237|NCT00374907|447773859|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
124497238|NCT00374907|447773858|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
124497239|NCT00374907|447773859|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
124497240|NCT00374907|447773858|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
124497241|NCT00374907|447773859|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
124497242|NCT00783705|447773860|FG000|Overall Study|Adverse Event|2|||
124497243|NCT00783705|447773861|FG001|Overall Study|Adverse Event|0|||
124497244|NCT00783705|447773860|FG000|Overall Study|Withdrawal by Subject|3|||
124497245|NCT00783705|447773861|FG001|Overall Study|Withdrawal by Subject|2|||
124497246|NCT00783705|447773860|FG000|Overall Study|Lost to Follow-up|1|||
124497247|NCT00783705|447773861|FG001|Overall Study|Lost to Follow-up|3|||
124497248|NCT02379923|447773863|FG000|Overall Study|Death|5|||
124497249|NCT01200511|447773864|FG000|Overall Study|Lost to Follow-up|3|||
124497250|NCT01200511|447773864|FG000|Overall Study|Withdrawal by Subject|1|||
124497251|NCT01200511|447773864|FG000|Overall Study|Adverse Event|1|||
124497252|NCT01617434|447773865|FG000|Overall Study|Adverse Event|12|||
124497253|NCT01617434|447773866|FG001|Overall Study|Adverse Event|3|||
124497254|NCT01617434|447773865|FG000|Overall Study|Protocol Violation|8|||
124497255|NCT01617434|447773866|FG001|Overall Study|Protocol Violation|7|||
124497256|NCT01617434|447773865|FG000|Overall Study|Withdrawal Criteria|12|||
124497257|NCT01617434|447773866|FG001|Overall Study|Withdrawal Criteria|37|||
124497258|NCT01617434|447773865|FG000|Overall Study|Unclassified|3|||
124497259|NCT01617434|447773866|FG001|Overall Study|Unclassified|4|||
124497260|NCT00705224|447773867|FG000|Overall Study|Adverse Event|1|||
124497261|NCT00705224|447773867|FG000|Overall Study|Lack of Efficacy|2|||
124497262|NCT00705224|447773867|FG000|Overall Study|Withdrawal by Subject|3|||
124773700|NCT01716234|448800588|FG001|Overall Study|Did not meet protocol eligibility|0|||
124773701|NCT01716234|448800589|FG002|Overall Study|Did not meet protocol eligibility|1|||
124773702|NCT01716234|448800590|FG003|Overall Study|Did not meet protocol eligibility|0|||
124773703|NCT01716234|448800591|FG004|Overall Study|Did not meet protocol eligibility|0|||
124773704|NCT01716234|448800592|FG005|Overall Study|Did not meet protocol eligibility|4|||
124773705|NCT01716234|448800593|FG006|Overall Study|Did not meet protocol eligibility|0|||
124773706|NCT01716234|448800587|FG000|Overall Study|Adverse Event|7|||
124773707|NCT01716234|448800588|FG001|Overall Study|Adverse Event|10|||
124773708|NCT01716234|448800589|FG002|Overall Study|Adverse Event|2|||
124773709|NCT01716234|448800590|FG003|Overall Study|Adverse Event|8|||
124773710|NCT01716234|448800591|FG004|Overall Study|Adverse Event|3|||
124773711|NCT01716234|448800592|FG005|Overall Study|Adverse Event|6|||
124773712|NCT01716234|448800593|FG006|Overall Study|Adverse Event|0|||
124773713|NCT01716234|448800587|FG000|Overall Study|Withdrawal by Subject|3|||
124773714|NCT01716234|448800588|FG001|Overall Study|Withdrawal by Subject|0|||
124773715|NCT01716234|448800589|FG002|Overall Study|Withdrawal by Subject|2|||
124773716|NCT01716234|448800590|FG003|Overall Study|Withdrawal by Subject|2|||
124773717|NCT01716234|448800591|FG004|Overall Study|Withdrawal by Subject|1|||
124773718|NCT01716234|448800592|FG005|Overall Study|Withdrawal by Subject|3|||
124773719|NCT01716234|448800593|FG006|Overall Study|Withdrawal by Subject|0|||
124773720|NCT00515619|448800595|FG000|Overall Study|Adverse Event|34|||
124773721|NCT00515619|448800595|FG000|Overall Study|Lack of Efficacy|92|||
124773722|NCT00515619|448800595|FG000|Overall Study|Withdrawal by Subject|66|||
124497263|NCT00705224|447773867|FG000|Overall Study|Lost to Follow-up|5|||
124497264|NCT04238663|447773868|FG000|Overall Study|Lost to Follow-up|0|||
124497265|NCT04238663|447773869|FG001|Overall Study|Lost to Follow-up|1|||
124497266|NCT04238663|447773870|FG002|Overall Study|Lost to Follow-up|0|||
124497267|NCT00968253|447773871|FG000|Overall Study|Death|0|||
124497268|NCT00968253|447773872|FG001|Overall Study|Death|0|||
124497269|NCT00968253|447773873|FG002|Overall Study|Death|2|||
124497270|NCT00968253|447773871|FG000|Overall Study|Withdrawal by Subject|0|||
124497271|NCT00968253|447773872|FG001|Overall Study|Withdrawal by Subject|0|||
124497272|NCT00968253|447773873|FG002|Overall Study|Withdrawal by Subject|1|||
124497273|NCT00968253|447773871|FG000|Overall Study|Disease Progression|0|||
124497274|NCT00968253|447773872|FG001|Overall Study|Disease Progression|3|||
124497275|NCT00968253|447773873|FG002|Overall Study|Disease Progression|3|||
124497276|NCT00968253|447773871|FG000|Overall Study|Adverse Event|0|||
124497277|NCT00968253|447773872|FG001|Overall Study|Adverse Event|0|||
124773723|NCT00515619|448800595|FG000|Overall Study|Protocol Violation|3|||
124773724|NCT00515619|448800595|FG000|Overall Study|Lost to Follow-up|4|||
124773725|NCT00515619|448800595|FG000|Overall Study|Unsatisfactory compliance|6|||
124497278|NCT00968253|447773873|FG002|Overall Study|Adverse Event|1|||
124497279|NCT03596177|447773874|FG000|Single Blind Period|Withdrawal by Subject|1|||
124497280|NCT03596177|447773875|FG001|Single Blind Period|Withdrawal by Subject|1|||
124497281|NCT03596177|447773874|FG000|Single Blind Period|Other|1|||
124773726|NCT00515619|448800595|FG000|Overall Study|Other: Site discontinuing trials|2|||
124497282|NCT03596177|447773875|FG001|Single Blind Period|Other|0|||
124497283|NCT03596177|447773874|FG000|Double Blind Period|Withdrawal by Subject|0|||
124773727|NCT00515619|448800595|FG000|Overall Study|Other: Subject cannot attend visits|2|||
124773728|NCT00515619|448800595|FG000|Overall Study|Other: Subject required surgery|1|||
124773729|NCT00515619|448800595|FG000|Overall Study|Other: Subject moved to another country|1|||
124497284|NCT03596177|447773875|FG001|Double Blind Period|Withdrawal by Subject|1|||
124497285|NCT03596177|447773874|FG000|Double Blind Period|Other|0|||
124497286|NCT03596177|447773875|FG001|Double Blind Period|Other|4|||
124497287|NCT03596177|447773874|FG000|Double Blind Period|Death during safety follow-up|0|||
124497288|NCT03596177|447773875|FG001|Double Blind Period|Death during safety follow-up|1|||
124497289|NCT00747617|447775123|FG000|Overall Study|Lost to Follow-up|3|||
124497290|NCT00747617|447775124|FG001|Overall Study|Lost to Follow-up|1|||
124497291|NCT02279524|447775125|FG000|Overall Study|Withdrawal by Subject|3|||
124497292|NCT02279524|447775126|FG001|Overall Study|Withdrawal by Subject|6|||
124497293|NCT02279524|447775127|FG002|Overall Study|Withdrawal by Subject|3|||
124497294|NCT02279524|447775125|FG000|Overall Study|Adverse Event|4|||
124497295|NCT02279524|447775126|FG001|Overall Study|Adverse Event|3|||
124497296|NCT02279524|447775127|FG002|Overall Study|Adverse Event|2|||
124497297|NCT02279524|447775125|FG000|Overall Study|Lost to Follow-up|1|||
124497298|NCT02279524|447775126|FG001|Overall Study|Lost to Follow-up|1|||
124497299|NCT02279524|447775127|FG002|Overall Study|Lost to Follow-up|0|||
124497300|NCT02279524|447775125|FG000|Overall Study|Disallowed medication|1|||
124497301|NCT02279524|447775126|FG001|Overall Study|Disallowed medication|1|||
124497302|NCT02279524|447775127|FG002|Overall Study|Disallowed medication|2|||
124497303|NCT02279524|447775125|FG000|Overall Study|Bariatric surgery|1|||
124497304|NCT02279524|447775126|FG001|Overall Study|Bariatric surgery|0|||
124497305|NCT02279524|447775127|FG002|Overall Study|Bariatric surgery|0|||
124497306|NCT01746732|447775128|FG000|Lead-In Period|Withdrawal by Subject|1|||
124497307|NCT01746732|447775129|FG001|Lead-In Period|Withdrawal by Subject|0|||
124497308|NCT01746732|447775130|FG002|Lead-In Period|Withdrawal by Subject|0|||
124497309|NCT01746732|447775128|FG000|Period 1|Physician Decision|0|||
124497310|NCT01746732|447775129|FG001|Period 1|Physician Decision|1|||
124497311|NCT01746732|447775130|FG002|Period 1|Physician Decision|0|||
124497312|NCT01746732|447775128|FG000|Period 2|Withdrawal by Subject|0|||
124497313|NCT01746732|447775129|FG001|Period 2|Withdrawal by Subject|0|||
124497314|NCT01746732|447775130|FG002|Period 2|Withdrawal by Subject|2|||
124497315|NCT01746732|447775128|FG000|Period 2|Adverse Event|0|||
124497316|NCT01746732|447775129|FG001|Period 2|Adverse Event|0|||
124497317|NCT01746732|447775130|FG002|Period 2|Adverse Event|1|||
124497318|NCT01746732|447775128|FG000|Period 2|Lost to Follow-up|0|||
124497319|NCT01746732|447775129|FG001|Period 2|Lost to Follow-up|0|||
124497320|NCT01746732|447775130|FG002|Period 2|Lost to Follow-up|1|||
124497321|NCT03509207|447775131|FG000|Overall Study|Death|2|||
124497322|NCT02817555|447775132|FG000|Overall Study|Death|1|||
124497323|NCT02817555|447775133|FG001|Overall Study|Death|3|||
124497324|NCT02817555|447775132|FG000|Overall Study|moved away|1|||
124497325|NCT02817555|447775133|FG001|Overall Study|moved away|0|||
124497326|NCT02817555|447775132|FG000|Overall Study|transplant|1|||
124497327|NCT02817555|447775133|FG001|Overall Study|transplant|1|||
124497328|NCT02817555|447775132|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
124497329|NCT02817555|447775133|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
124497330|NCT00137436|447775134|FG000|Overall Study|Adverse Event|13|||
124497331|NCT00137436|447775134|FG000|Overall Study|Death|2|||
124497332|NCT00137436|447775134|FG000|Overall Study|Lack of Efficacy|17|||
124497333|NCT00137436|447775134|FG000|Overall Study|Withdrawal by Subject|6|||
124497334|NCT00137436|447775134|FG000|Overall Study|Other|5|||
124497335|NCT01432262|447775135|FG000|Overall Study|Withdrawal by Subject|2|||
124497336|NCT01432262|447775136|FG001|Overall Study|Withdrawal by Subject|1|||
124773730|NCT00515619|448800595|FG000|Overall Study|Other: Investigator decision|1|||
124773731|NCT00515619|448800595|FG000|Overall Study|Other: Subject became pregnant|1|||
124773732|NCT00515619|448800595|FG000|Overall Study|Other: Request from sponsor|1|||
124773733|NCT00515619|448800595|FG000|Overall Study|Other: Drug available on license|1|||
124773734|NCT00515619|448800595|FG000|Overall Study|Other: Subject interested in other AED|1|||
124773735|NCT03815929|448800596|FG000|Overall Study|Lost to Follow-up|2|||
124773736|NCT03815929|448800597|FG001|Overall Study|Lost to Follow-up|1|||
124773737|NCT03815929|448800598|FG002|Overall Study|Lost to Follow-up|0|||
124773738|NCT03815929|448800596|FG000|Overall Study|Physician Decision|2|||
124497337|NCT00165646|447775137|FG000|Overall Study|Adverse Event|1|||
124497338|NCT00165646|447775138|FG001|Overall Study|Adverse Event|1|||
124497339|NCT00165646|447775139|FG002|Overall Study|Adverse Event|1|||
124497340|NCT00165646|447775137|FG000|Overall Study|Lack of Efficacy|1|||
124497341|NCT00165646|447775138|FG001|Overall Study|Lack of Efficacy|2|||
124497342|NCT00165646|447775139|FG002|Overall Study|Lack of Efficacy|0|||
124497343|NCT00165646|447775137|FG000|Overall Study|Withdrawal by Subject|0|||
124497344|NCT00165646|447775138|FG001|Overall Study|Withdrawal by Subject|2|||
124497345|NCT00165646|447775139|FG002|Overall Study|Withdrawal by Subject|1|||
124497346|NCT00165646|447775137|FG000|Overall Study|Physician Decision|2|||
124497347|NCT00165646|447775138|FG001|Overall Study|Physician Decision|0|||
124773739|NCT03815929|448800597|FG001|Overall Study|Physician Decision|2|||
124497348|NCT00165646|447775139|FG002|Overall Study|Physician Decision|2|||
124497349|NCT00165646|447775137|FG000|Overall Study|Protocol Violation|1|||
124497350|NCT00165646|447775138|FG001|Overall Study|Protocol Violation|0|||
124497351|NCT00165646|447775139|FG002|Overall Study|Protocol Violation|0|||
124497352|NCT04657016|447775140|FG000|Overall Study|Adverse Event|2|||
124497353|NCT04657016|447775141|FG001|Overall Study|Adverse Event|4|||
124497354|NCT04657016|447775140|FG000|Overall Study|Death|1|||
124497355|NCT04657016|447775141|FG001|Overall Study|Death|1|||
124497356|NCT04657016|447775140|FG000|Overall Study|Lost to Follow-up|24|||
124497357|NCT04657016|447775141|FG001|Overall Study|Lost to Follow-up|12|||
124497358|NCT04657016|447775140|FG000|Overall Study|Physician Decision|1|||
124497359|NCT04657016|447775141|FG001|Overall Study|Physician Decision|2|||
124497360|NCT04657016|447775140|FG000|Overall Study|Pregnancy|2|||
124497361|NCT04657016|447775141|FG001|Overall Study|Pregnancy|2|||
124497362|NCT04657016|447775140|FG000|Overall Study|Protocol Deviation|1|||
124497363|NCT04657016|447775141|FG001|Overall Study|Protocol Deviation|0|||
124497364|NCT04657016|447775140|FG000|Overall Study|Withdrawal by Subject|28|||
124497365|NCT04657016|447775141|FG001|Overall Study|Withdrawal by Subject|14|||
124497366|NCT04657016|447775140|FG000|Overall Study|Other - as reported by the investigator|6|||
124497367|NCT04657016|447775141|FG001|Overall Study|Other - as reported by the investigator|0|||
124497368|NCT01755195|447775145|FG000|Overall Study|Participant noncompliance|2|||
124497369|NCT01755195|447775145|FG000|Overall Study|Switched to alternative treatment|4|||
124497370|NCT01755195|447775145|FG000|Overall Study|Withdrawal by Subject|1|||
124497371|NCT01755195|447775145|FG000|Overall Study|Participant refused to start treatment|1|||
124497372|NCT01755195|447775145|FG000|Overall Study|Participant has been consented for another trial|1|||
124497373|NCT01755195|447775145|FG000|Overall Study|Refused further treatment|3|||
124497374|NCT01755195|447775145|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
124497375|NCT00912015|447775146|FG000|Overall Study|Lack of Efficacy|1|||
124497376|NCT00912015|447775147|FG001|Overall Study|Lack of Efficacy|0|||
124497377|NCT00912015|447775148|FG002|Overall Study|Lack of Efficacy|0|||
124497378|NCT00912015|447775149|FG003|Overall Study|Lack of Efficacy|0|||
124497379|NCT00912015|447775146|FG000|Overall Study|Withdrawal by Subject|8|||
124497380|NCT00912015|447775147|FG001|Overall Study|Withdrawal by Subject|8|||
124497381|NCT00912015|447775148|FG002|Overall Study|Withdrawal by Subject|3|||
124497382|NCT00912015|447775149|FG003|Overall Study|Withdrawal by Subject|0|||
124497383|NCT00912015|447775146|FG000|Overall Study|Protocol Violation|1|||
124497384|NCT00912015|447775147|FG001|Overall Study|Protocol Violation|0|||
124723636|NCT03823287|448609849|FG001|Overall Study|Lost to Follow-up|8|||
124723637|NCT03823287|448609848|FG000|Overall Study|Adverse Event|6|||
124723638|NCT03823287|448609849|FG001|Overall Study|Adverse Event|8|||
124723639|NCT03823287|448609848|FG000|Overall Study|Physician Decision|5|||
124723640|NCT03823287|448609849|FG001|Overall Study|Physician Decision|2|||
124723641|NCT03823287|448609848|FG000|Overall Study|Lack of Efficacy|2|||
124723642|NCT03823287|448609849|FG001|Overall Study|Lack of Efficacy|0|||
124723643|NCT03823287|448609848|FG000|Overall Study|Other|2|||
124723644|NCT03823287|448609849|FG001|Overall Study|Other|4|||
124723645|NCT01170273|448609851|FG000|Overall Study|Lost to Follow-up|6|||
124723646|NCT01170273|448609852|FG001|Overall Study|Lost to Follow-up|8|||
124723647|NCT01170273|448609851|FG000|Overall Study|Protocol Violation|1|||
124723648|NCT01170273|448609852|FG001|Overall Study|Protocol Violation|0|||
124723649|NCT01170273|448609851|FG000|Overall Study|Death|1|||
124723650|NCT01170273|448609852|FG001|Overall Study|Death|0|||
124723651|NCT01170273|448609851|FG000|Overall Study|Adverse Event|0|||
124723652|NCT01170273|448609852|FG001|Overall Study|Adverse Event|1|||
124723653|NCT01673854|448609853|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
124723654|NCT01673854|448609853|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
124723655|NCT01673854|448609853|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
124723656|NCT01673854|448609853|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
124723657|NCT01673854|448609853|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
124723658|NCT01673854|448609853|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
124723659|NCT01673854|448609853|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
124723660|NCT01673854|448609853|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
124723661|NCT01673854|448609853|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
124723662|NCT01673854|448609853|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
124723663|NCT01673854|448609853|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
124723664|NCT01673854|448609853|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
124723665|NCT00334737|448609854|FG000|Hospital Phase|Death|1|||
124723666|NCT00334737|448609855|FG001|Hospital Phase|Death|2|||
124723667|NCT00334737|448609856|FG002|Hospital Phase|Death|3|||
124723668|NCT00334737|448609854|FG000|Hospital Phase|Withdrawal by Subject|0|||
124723669|NCT00334737|448609855|FG001|Hospital Phase|Withdrawal by Subject|0|||
124723670|NCT00334737|448609856|FG002|Hospital Phase|Withdrawal by Subject|1|||
124497385|NCT00912015|447775148|FG002|Overall Study|Protocol Violation|0|||
124497386|NCT00912015|447775149|FG003|Overall Study|Protocol Violation|1|||
124497387|NCT00912015|447775146|FG000|Overall Study|Adverse Event|6|||
124497388|NCT00912015|447775147|FG001|Overall Study|Adverse Event|0|||
124497389|NCT00912015|447775148|FG002|Overall Study|Adverse Event|0|||
124723671|NCT00334737|448609854|FG000|Hospital Phase|Did not receive study drug|1|||
124723672|NCT00334737|448609855|FG001|Hospital Phase|Did not receive study drug|0|||
124773740|NCT03815929|448800598|FG002|Overall Study|Physician Decision|0|||
124773741|NCT03815929|448800596|FG000|Overall Study|Withdrawal by Subject|0|||
124773742|NCT03815929|448800597|FG001|Overall Study|Withdrawal by Subject|0|||
124773743|NCT03815929|448800598|FG002|Overall Study|Withdrawal by Subject|1|||
124773744|NCT01467960|448800599|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
124773745|NCT01467960|448800600|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
124773746|NCT01467960|448800601|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
124773747|NCT01467960|448800602|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
124773748|NCT01467960|448800603|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
124773749|NCT01467960|448800604|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
124773750|NCT00771758|448800605|FG000|Overall Study|Adverse Event|2|||
124773751|NCT00771758|448800606|FG001|Overall Study|Adverse Event|8|||
124773752|NCT00771758|448800607|FG002|Overall Study|Adverse Event|1|||
124773753|NCT00771758|448800605|FG000|Overall Study|Lack of Efficacy|0|||
124773754|NCT00771758|448800606|FG001|Overall Study|Lack of Efficacy|2|||
124773755|NCT00771758|448800607|FG002|Overall Study|Lack of Efficacy|1|||
124773756|NCT00771758|448800605|FG000|Overall Study|Lost to Follow-up|1|||
124773757|NCT00771758|448800606|FG001|Overall Study|Lost to Follow-up|0|||
124773758|NCT00771758|448800607|FG002|Overall Study|Lost to Follow-up|0|||
124773759|NCT00771758|448800605|FG000|Overall Study|Protocol Violation|1|||
124773760|NCT00771758|448800606|FG001|Overall Study|Protocol Violation|0|||
124773761|NCT00771758|448800607|FG002|Overall Study|Protocol Violation|0|||
124773762|NCT00771758|448800605|FG000|Overall Study|Withdrawal by Subject|1|||
124773763|NCT00771758|448800606|FG001|Overall Study|Withdrawal by Subject|0|||
124773764|NCT00771758|448800607|FG002|Overall Study|Withdrawal by Subject|0|||
124773765|NCT00771758|448800605|FG000|Overall Study|Other|3|||
124773766|NCT00771758|448800606|FG001|Overall Study|Other|2|||
124773767|NCT00771758|448800607|FG002|Overall Study|Other|0|||
124773768|NCT03067077|448800608|FG000|Overall Study|Did not receive surgery|4|||
124773769|NCT03067077|448800609|FG001|Overall Study|Did not receive surgery|5|||
124773770|NCT03067077|448800608|FG000|Overall Study|Lost to Follow-up|3|||
124773771|NCT03067077|448800609|FG001|Overall Study|Lost to Follow-up|2|||
124773772|NCT01394016|448800611|FG000|Overall Study|Progressive Disease|2|||
124773773|NCT01394016|448800612|FG001|Overall Study|Progressive Disease|0|||
124773774|NCT01394016|448800613|FG002|Overall Study|Progressive Disease|0|||
124773775|NCT01394016|448800614|FG003|Overall Study|Progressive Disease|0|||
124773776|NCT01394016|448800615|FG004|Overall Study|Progressive Disease|0|||
124773777|NCT01394016|448800616|FG005|Overall Study|Progressive Disease|0|||
124773778|NCT01394016|448800617|FG006|Overall Study|Progressive Disease|0|||
124773779|NCT01394016|448800618|FG007|Overall Study|Progressive Disease|0|||
124773780|NCT01394016|448800619|FG008|Overall Study|Progressive Disease|0|||
124773781|NCT01394016|448800620|FG009|Overall Study|Progressive Disease|0|||
124773782|NCT01394016|448800621|FG010|Overall Study|Progressive Disease|0|||
124773783|NCT01394016|448800622|FG011|Overall Study|Progressive Disease|0|||
124773784|NCT01394016|448800623|FG012|Overall Study|Progressive Disease|0|||
124773785|NCT01394016|448800624|FG013|Overall Study|Progressive Disease|0|||
124773786|NCT01394016|448800625|FG014|Overall Study|Progressive Disease|0|||
124773787|NCT01394016|448800626|FG015|Overall Study|Progressive Disease|0|||
124773788|NCT01394016|448800627|FG016|Overall Study|Progressive Disease|0|||
124773789|NCT01394016|448800628|FG017|Overall Study|Progressive Disease|0|||
124773790|NCT01394016|448800629|FG018|Overall Study|Progressive Disease|0|||
124773791|NCT01394016|448800611|FG000|Overall Study|Withdrawal by Subject|0|||
124773792|NCT01394016|448800612|FG001|Overall Study|Withdrawal by Subject|0|||
124773793|NCT01394016|448800613|FG002|Overall Study|Withdrawal by Subject|0|||
124773794|NCT01394016|448800614|FG003|Overall Study|Withdrawal by Subject|0|||
124773795|NCT01394016|448800615|FG004|Overall Study|Withdrawal by Subject|0|||
124773796|NCT01394016|448800616|FG005|Overall Study|Withdrawal by Subject|0|||
124773797|NCT01394016|448800617|FG006|Overall Study|Withdrawal by Subject|0|||
124773798|NCT01394016|448800618|FG007|Overall Study|Withdrawal by Subject|1|||
124773799|NCT01394016|448800619|FG008|Overall Study|Withdrawal by Subject|1|||
124773800|NCT01394016|448800620|FG009|Overall Study|Withdrawal by Subject|1|||
124773801|NCT01394016|448800621|FG010|Overall Study|Withdrawal by Subject|4|||
124773802|NCT01394016|448800622|FG011|Overall Study|Withdrawal by Subject|0|||
124773803|NCT01394016|448800623|FG012|Overall Study|Withdrawal by Subject|0|||
124773804|NCT01394016|448800624|FG013|Overall Study|Withdrawal by Subject|3|||
124773805|NCT01394016|448800625|FG014|Overall Study|Withdrawal by Subject|1|||
124773806|NCT01394016|448800626|FG015|Overall Study|Withdrawal by Subject|3|||
124773807|NCT01394016|448800627|FG016|Overall Study|Withdrawal by Subject|1|||
124773808|NCT01394016|448800628|FG017|Overall Study|Withdrawal by Subject|1|||
124773809|NCT01394016|448800629|FG018|Overall Study|Withdrawal by Subject|2|||
124773810|NCT01394016|448800611|FG000|Overall Study|Adverse Event|0|||
124773811|NCT01394016|448800612|FG001|Overall Study|Adverse Event|0|||
124773812|NCT01394016|448800613|FG002|Overall Study|Adverse Event|0|||
124773813|NCT01394016|448800614|FG003|Overall Study|Adverse Event|0|||
124773814|NCT01394016|448800615|FG004|Overall Study|Adverse Event|0|||
124773815|NCT01394016|448800616|FG005|Overall Study|Adverse Event|0|||
124773816|NCT01394016|448800617|FG006|Overall Study|Adverse Event|0|||
124497390|NCT00912015|447775149|FG003|Overall Study|Adverse Event|1|||
124558689|NCT02965820|448003323|FG000|Period 2, Second 30 Days|Adverse Event|1|||
124497391|NCT01356602|447775150|FG000|Overall Study|Protocol Deviation|0|||
124497392|NCT01356602|447775151|FG001|Overall Study|Protocol Deviation|1|||
124497393|NCT01356602|447775152|FG002|Overall Study|Protocol Deviation|1|||
124497394|NCT01356602|447775150|FG000|Overall Study|Administrative Problems|1|||
124497395|NCT01356602|447775151|FG001|Overall Study|Administrative Problems|4|||
124497396|NCT01356602|447775152|FG002|Overall Study|Administrative Problems|5|||
124497397|NCT01356602|447775150|FG000|Overall Study|Lost to Follow-up|4|||
124497398|NCT01356602|447775151|FG001|Overall Study|Lost to Follow-up|5|||
124497399|NCT01356602|447775152|FG002|Overall Study|Lost to Follow-up|6|||
124497400|NCT01356602|447775150|FG000|Overall Study|Withdrawal by Subject|4|||
124497401|NCT01356602|447775151|FG001|Overall Study|Withdrawal by Subject|3|||
124497402|NCT01356602|447775152|FG002|Overall Study|Withdrawal by Subject|7|||
124497403|NCT01356602|447775150|FG000|Overall Study|Lack of Efficacy|0|||
124497404|NCT01356602|447775151|FG001|Overall Study|Lack of Efficacy|1|||
124497405|NCT01356602|447775152|FG002|Overall Study|Lack of Efficacy|4|||
124497406|NCT01356602|447775150|FG000|Overall Study|Adverse Event|0|||
124497407|NCT01356602|447775151|FG001|Overall Study|Adverse Event|1|||
124497408|NCT01356602|447775152|FG002|Overall Study|Adverse Event|1|||
124497409|NCT01115569|447775153|FG000|Conversion/Titration Phase|Adverse Event|59|||
124497410|NCT01115569|447775154|FG001|Conversion/Titration Phase|Adverse Event|0|||
124497411|NCT01115569|447775153|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
124497412|NCT01115569|447775154|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
124497413|NCT01115569|447775153|FG000|Conversion/Titration Phase|Physician Decision|5|||
124497414|NCT01115569|447775154|FG001|Conversion/Titration Phase|Physician Decision|0|||
124497415|NCT01115569|447775153|FG000|Conversion/Titration Phase|Protocol Violation|68|||
124497416|NCT01115569|447775154|FG001|Conversion/Titration Phase|Protocol Violation|0|||
124497417|NCT01115569|447775153|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
124497418|NCT01115569|447775154|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
124497419|NCT01115569|447775153|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
124497420|NCT01115569|447775154|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
124497421|NCT01115569|447775153|FG000|Maintenance Phase|Adverse Event|0|||
124497422|NCT01115569|447775154|FG001|Maintenance Phase|Adverse Event|43|||
124497423|NCT01115569|447775153|FG000|Maintenance Phase|Lost to Follow-up|0|||
124497424|NCT01115569|447775154|FG001|Maintenance Phase|Lost to Follow-up|8|||
124497425|NCT01115569|447775153|FG000|Maintenance Phase|Physician Decision|0|||
124497426|NCT01115569|447775154|FG001|Maintenance Phase|Physician Decision|3|||
124497427|NCT01115569|447775153|FG000|Maintenance Phase|Protocol Violation|0|||
124497428|NCT01115569|447775154|FG001|Maintenance Phase|Protocol Violation|9|||
124497429|NCT01115569|447775153|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124497430|NCT01115569|447775154|FG001|Maintenance Phase|Withdrawal by Subject|27|||
124497431|NCT01115569|447775153|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
124497432|NCT01115569|447775154|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
124497433|NCT01115569|447775153|FG000|Maintenance Phase|Administrative|0|||
124497434|NCT01115569|447775154|FG001|Maintenance Phase|Administrative|1|||
124497435|NCT01931462|447775155|FG000|Overall Study|Withdrawal by Subject|1|||
124497436|NCT02819310|447775156|FG000|Overall Study|Withdrawal by Subject|37|||
124497437|NCT02819310|447775156|FG000|Overall Study|Lost to Follow-up|16|||
124497438|NCT02819310|447775156|FG000|Overall Study|Adverse Event|13|||
124497439|NCT02819310|447775156|FG000|Overall Study|Lack of Efficacy|5|||
124497440|NCT02819310|447775156|FG000|Overall Study|Physician Decision|8|||
124497441|NCT02819310|447775156|FG000|Overall Study|Protocol Violation|30|||
124497442|NCT00028002|447775161|FG000|Overall Study|Withdrawal by Subject|3|||
124497443|NCT00028002|447775161|FG000|Overall Study|Ineligible|8|||
124497444|NCT01793051|447775162|FG000|Overall Study|Withdrawal by Subject|6|||
124497445|NCT01793051|447775163|FG001|Overall Study|Withdrawal by Subject|4|||
124497446|NCT01793051|447775162|FG000|Overall Study|Adverse Event|0|||
124497447|NCT01793051|447775163|FG001|Overall Study|Adverse Event|2|||
124497448|NCT01793051|447775162|FG000|Overall Study|Too ill to continue|1|||
124497449|NCT01793051|447775163|FG001|Overall Study|Too ill to continue|0|||
124497450|NCT01793051|447775162|FG000|Overall Study|Switched chemo|1|||
124497451|NCT01793051|447775163|FG001|Overall Study|Switched chemo|1|||
124497452|NCT01793051|447775162|FG000|Overall Study|Lack of compliance|1|||
124497453|NCT01793051|447775163|FG001|Overall Study|Lack of compliance|0|||
124497454|NCT01793051|447775162|FG000|Overall Study|Requested to be removed from the study|1|||
124497455|NCT01793051|447775163|FG001|Overall Study|Requested to be removed from the study|1|||
124497456|NCT05070429|447775165|FG000|Overall Study|Death|0|||
124497457|NCT05070429|447775166|FG001|Overall Study|Death|4|||
124497458|NCT05070429|447775165|FG000|Overall Study|Withdrawal by Subject|2|||
124497459|NCT05070429|447775166|FG001|Overall Study|Withdrawal by Subject|1|||
124497460|NCT05070429|447775165|FG000|Overall Study|Other|15|||
124497461|NCT05070429|447775166|FG001|Overall Study|Other|5|||
124497462|NCT00943319|447775167|FG000|Overall Study|Death|1|||
124497463|NCT02043301|447775168|FG000|Overall Study|Discontinued|0|||
124497464|NCT02043301|447775169|FG001|Overall Study|Discontinued|1|||
124497465|NCT02043301|447775170|FG002|Overall Study|Discontinued|0|||
124497466|NCT02653976|447775171|FG000|Overall Study|Withdrawal by Subject|5|||
124497467|NCT02653976|447775171|FG000|Overall Study|Death|4|||
124497468|NCT02023164|447775172|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
124497469|NCT02023164|447775173|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
124497470|NCT00883558|447775174|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
124497471|NCT00883558|447775175|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
124497472|NCT00883558|447775176|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
124497473|NCT00883558|447775174|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
124497474|NCT00883558|447775175|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
124497475|NCT00883558|447775176|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
124497476|NCT00883558|447775174|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
124497477|NCT00883558|447775175|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
124497478|NCT00883558|447775176|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
124497479|NCT00883558|447775174|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
124497480|NCT00883558|447775175|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
124497481|NCT00883558|447775176|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
124497482|NCT00883558|447775174|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
124497483|NCT00883558|447775175|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
124497484|NCT00883558|447775176|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
124497485|NCT03703375|447775177|FG000|Randomization Period|Withdrawal by Subject|0|||
124497486|NCT03703375|447775178|FG001|Randomization Period|Withdrawal by Subject|0|||
124497487|NCT03703375|447775179|FG002|Randomization Period|Withdrawal by Subject|0|||
124497488|NCT03703375|447775180|FG003|Randomization Period|Withdrawal by Subject|1|||
124497489|NCT03703375|447775177|FG000|Randomization Period|Completed safety run-in treatment|7|||
124497490|NCT03703375|447775178|FG001|Randomization Period|Completed safety run-in treatment|0|||
124497491|NCT03703375|447775179|FG002|Randomization Period|Completed safety run-in treatment|0|||
124497492|NCT03703375|447775180|FG003|Randomization Period|Completed safety run-in treatment|0|||
124497493|NCT03703375|447775177|FG000|Treatment Period|Other Reasons|0|||
124497494|NCT03703375|447775178|FG001|Treatment Period|Other Reasons|1|||
124497495|NCT03703375|447775179|FG002|Treatment Period|Other Reasons|0|||
124497496|NCT03703375|447775180|FG003|Treatment Period|Other Reasons|3|||
124723673|NCT00334737|448609856|FG002|Hospital Phase|Did not receive study drug|0|||
124723674|NCT00334737|448609854|FG000|Follow up Phase|Lost to Follow-up|5|||
124723675|NCT00334737|448609855|FG001|Follow up Phase|Lost to Follow-up|3|||
124723676|NCT00334737|448609856|FG002|Follow up Phase|Lost to Follow-up|6|||
124723677|NCT00583752|448609857|FG000|Overall Study|Lost to Follow-up|5|||
124723678|NCT00583752|448609858|FG001|Overall Study|Lost to Follow-up|5|||
124723679|NCT02316353|448609859|FG000|Overall Study|Pregnancy|1|||
124723680|NCT02316353|448609860|FG001|Overall Study|Pregnancy|3|||
124723681|NCT02316353|448609859|FG000|Overall Study|Adverse Event|1|||
124723682|NCT02316353|448609860|FG001|Overall Study|Adverse Event|3|||
124723683|NCT02316353|448609859|FG000|Overall Study|Withdrawal by Subject|6|||
124723684|NCT02316353|448609860|FG001|Overall Study|Withdrawal by Subject|2|||
124723685|NCT05396014|448611645|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
124723686|NCT05396014|448611646|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723687|NCT05396014|448611647|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723688|NCT05396014|448611648|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723689|NCT05396014|448611649|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723690|NCT05396014|448611650|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723691|NCT05396014|448611651|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723692|NCT05396014|448611652|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723693|NCT05396014|448611653|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723694|NCT05396014|448611654|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723695|NCT05396014|448611655|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723696|NCT05396014|448611656|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723697|NCT05396014|448611657|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723698|NCT05396014|448611658|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
124723699|NCT05396014|448611659|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723700|NCT05396014|448611660|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723701|NCT05396014|448611661|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723702|NCT05396014|448611662|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723703|NCT05396014|448611663|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723704|NCT05396014|448611664|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723705|NCT05396014|448611665|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723706|NCT05396014|448611666|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723707|NCT05396014|448611667|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723708|NCT05396014|448611668|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723709|NCT05396014|448611669|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124497497|NCT03703375|447775177|FG000|Treatment Period|Consent Withdrawal|0|||
124497498|NCT03703375|447775178|FG001|Treatment Period|Consent Withdrawal|0|||
124497499|NCT03703375|447775179|FG002|Treatment Period|Consent Withdrawal|0|||
124497500|NCT03703375|447775180|FG003|Treatment Period|Consent Withdrawal|1|||
124497501|NCT03703375|447775177|FG000|Treatment Period|Death|1|||
124497502|NCT03703375|447775178|FG001|Treatment Period|Death|0|||
124497503|NCT03703375|447775179|FG002|Treatment Period|Death|1|||
124497504|NCT03703375|447775180|FG003|Treatment Period|Death|2|||
124773817|NCT01394016|448800618|FG007|Overall Study|Adverse Event|0|||
124773818|NCT01394016|448800619|FG008|Overall Study|Adverse Event|0|||
124773819|NCT01394016|448800620|FG009|Overall Study|Adverse Event|1|||
124773820|NCT01394016|448800621|FG010|Overall Study|Adverse Event|0|||
124773821|NCT01394016|448800622|FG011|Overall Study|Adverse Event|0|||
124773822|NCT01394016|448800623|FG012|Overall Study|Adverse Event|0|||
124773823|NCT01394016|448800624|FG013|Overall Study|Adverse Event|0|||
124773824|NCT01394016|448800625|FG014|Overall Study|Adverse Event|0|||
124497505|NCT03703375|447775177|FG000|Treatment Period|Toxicity of Study Treatment|2|||
124497506|NCT03703375|447775178|FG001|Treatment Period|Toxicity of Study Treatment|0|||
124497507|NCT03703375|447775179|FG002|Treatment Period|Toxicity of Study Treatment|4|||
124497508|NCT03703375|447775180|FG003|Treatment Period|Toxicity of Study Treatment|1|||
124497509|NCT03703375|447775177|FG000|Treatment Period|Progression|32|||
124497510|NCT03703375|447775178|FG001|Treatment Period|Progression|1|||
124497511|NCT03703375|447775179|FG002|Treatment Period|Progression|7|||
124497512|NCT03703375|447775180|FG003|Treatment Period|Progression|11|||
124497513|NCT03703375|447775177|FG000|Treatment Period|Completed treatment|7|||
124497514|NCT03703375|447775178|FG001|Treatment Period|Completed treatment|2|||
124497515|NCT03703375|447775179|FG002|Treatment Period|Completed treatment|0|||
124497516|NCT03703375|447775180|FG003|Treatment Period|Completed treatment|0|||
124497517|NCT01781429|447775182|FG000|Overall Study|Death|0|||
124497518|NCT01781429|447775183|FG001|Overall Study|Death|0|||
124497519|NCT01781429|447775184|FG002|Overall Study|Death|0|||
124558690|NCT02965820|448003324|FG001|Period 2, Second 30 Days|Adverse Event|1|||
124558691|NCT01967888|448003325|FG000|Overall Study|Lost to Follow-up|6|||
124558692|NCT01967888|448003326|FG001|Overall Study|Lost to Follow-up|4|||
124558693|NCT01967888|448003325|FG000|Overall Study|Withdrawal by Subject|1|||
124558694|NCT01967888|448003326|FG001|Overall Study|Withdrawal by Subject|1|||
124558695|NCT01967888|448003325|FG000|Overall Study|Did Not Have Transplant|1|||
124558696|NCT01967888|448003326|FG001|Overall Study|Did Not Have Transplant|0|||
124558697|NCT01967888|448003325|FG000|Overall Study|Research visit not done, data recorded|1|||
124558698|NCT01967888|448003326|FG001|Overall Study|Research visit not done, data recorded|0|||
124558699|NCT01967888|448003325|FG000|Overall Study|Subject excluded after randomization|1|||
124558700|NCT01967888|448003326|FG001|Overall Study|Subject excluded after randomization|0|||
124558701|NCT01967888|448003325|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
124558702|NCT01967888|448003326|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
124558703|NCT01967888|448003325|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
124558704|NCT01967888|448003326|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
124558705|NCT00553540|448003329|FG000|Overall Study|discharged after first visit|2|||
124558706|NCT00553540|448003330|FG001|Overall Study|discharged after first visit|5|||
124558707|NCT02622074|448003331|FG000|Overall Study|Death|4|||
124558708|NCT02622074|448003332|FG001|Overall Study|Death|0|||
124558709|NCT02622074|448003333|FG002|Overall Study|Death|0|||
124558710|NCT02622074|448003334|FG003|Overall Study|Death|1|||
124558711|NCT02622074|448003335|FG004|Overall Study|Death|1|||
124558712|NCT02622074|448003336|FG005|Overall Study|Death|0|||
124558713|NCT02622074|448003331|FG000|Overall Study|Withdrawal by Subject|0|||
124558714|NCT02622074|448003332|FG001|Overall Study|Withdrawal by Subject|1|||
124558715|NCT02622074|448003333|FG002|Overall Study|Withdrawal by Subject|0|||
124558716|NCT02622074|448003334|FG003|Overall Study|Withdrawal by Subject|0|||
124558717|NCT02622074|448003335|FG004|Overall Study|Withdrawal by Subject|0|||
124558718|NCT02622074|448003336|FG005|Overall Study|Withdrawal by Subject|0|||
124558719|NCT02114931|448003337|FG000|Overall Study|Withdrawal by Subject|15|||
124558720|NCT02114931|448003338|FG001|Overall Study|Withdrawal by Subject|18|||
124558721|NCT02114931|448003337|FG000|Overall Study|Adverse Event|4|||
124558722|NCT02114931|448003338|FG001|Overall Study|Adverse Event|6|||
124558723|NCT02114931|448003337|FG000|Overall Study|Lost to Follow-up|3|||
124558724|NCT02114931|448003338|FG001|Overall Study|Lost to Follow-up|3|||
124558725|NCT02114931|448003337|FG000|Overall Study|Physician Decision|1|||
124558726|NCT02114931|448003338|FG001|Overall Study|Physician Decision|2|||
124558727|NCT02114931|448003337|FG000|Overall Study|Other|2|||
124558728|NCT02114931|448003338|FG001|Overall Study|Other|1|||
124558729|NCT03870997|448003340|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
124558730|NCT03870997|448003341|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
124558731|NCT03870997|448003342|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
124497520|NCT01781429|447775185|FG003|Overall Study|Death|0|||
124497521|NCT01781429|447775186|FG004|Overall Study|Death|0|||
124497522|NCT01781429|447775187|FG005|Overall Study|Death|0|||
124558732|NCT03870997|448003343|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
124558733|NCT03870997|448003344|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
124773825|NCT01394016|448800626|FG015|Overall Study|Adverse Event|0|||
124497523|NCT01781429|447775188|FG006|Overall Study|Death|0|||
124497524|NCT01781429|447775189|FG007|Overall Study|Death|0|||
124497525|NCT01781429|447775190|FG008|Overall Study|Death|0|||
124497526|NCT01781429|447775191|FG009|Overall Study|Death|1|||
124497527|NCT01781429|447775192|FG010|Overall Study|Death|0|||
124497528|NCT01781429|447775193|FG011|Overall Study|Death|0|||
124497529|NCT01781429|447775194|FG012|Overall Study|Death|1|||
124497530|NCT01781429|447775195|FG013|Overall Study|Death|0|||
124497531|NCT01781429|447775196|FG014|Overall Study|Death|1|||
124497532|NCT01781429|447775197|FG015|Overall Study|Death|0|||
124497533|NCT01781429|447775182|FG000|Overall Study|Withdrawal by Subject|0|||
124497534|NCT01781429|447775183|FG001|Overall Study|Withdrawal by Subject|0|||
124497535|NCT01781429|447775184|FG002|Overall Study|Withdrawal by Subject|0|||
124497536|NCT01781429|447775185|FG003|Overall Study|Withdrawal by Subject|0|||
124497537|NCT01781429|447775186|FG004|Overall Study|Withdrawal by Subject|0|||
124497538|NCT01781429|447775187|FG005|Overall Study|Withdrawal by Subject|0|||
124497539|NCT01781429|447775188|FG006|Overall Study|Withdrawal by Subject|0|||
124497540|NCT01781429|447775189|FG007|Overall Study|Withdrawal by Subject|0|||
124497541|NCT01781429|447775190|FG008|Overall Study|Withdrawal by Subject|1|||
124497542|NCT01781429|447775191|FG009|Overall Study|Withdrawal by Subject|3|||
124497543|NCT01781429|447775192|FG010|Overall Study|Withdrawal by Subject|1|||
124497544|NCT01781429|447775193|FG011|Overall Study|Withdrawal by Subject|1|||
124497545|NCT01781429|447775194|FG012|Overall Study|Withdrawal by Subject|5|||
124497546|NCT01781429|447775195|FG013|Overall Study|Withdrawal by Subject|2|||
124497547|NCT01781429|447775196|FG014|Overall Study|Withdrawal by Subject|3|||
124497548|NCT01781429|447775197|FG015|Overall Study|Withdrawal by Subject|0|||
124497549|NCT01781429|447775182|FG000|Overall Study|Disease Progression|1|||
124497550|NCT01781429|447775183|FG001|Overall Study|Disease Progression|0|||
124497551|NCT01781429|447775184|FG002|Overall Study|Disease Progression|1|||
124497552|NCT01781429|447775185|FG003|Overall Study|Disease Progression|1|||
124497553|NCT01781429|447775186|FG004|Overall Study|Disease Progression|1|||
124497554|NCT01781429|447775187|FG005|Overall Study|Disease Progression|4|||
124497555|NCT01781429|447775188|FG006|Overall Study|Disease Progression|7|||
124497556|NCT01781429|447775189|FG007|Overall Study|Disease Progression|4|||
124497557|NCT01781429|447775190|FG008|Overall Study|Disease Progression|6|||
124497558|NCT01781429|447775191|FG009|Overall Study|Disease Progression|15|||
124497559|NCT01781429|447775192|FG010|Overall Study|Disease Progression|15|||
124497560|NCT01781429|447775193|FG011|Overall Study|Disease Progression|15|||
124497561|NCT01781429|447775194|FG012|Overall Study|Disease Progression|15|||
124497562|NCT01781429|447775195|FG013|Overall Study|Disease Progression|4|||
124497563|NCT01781429|447775196|FG014|Overall Study|Disease Progression|11|||
124497564|NCT01781429|447775197|FG015|Overall Study|Disease Progression|0|||
124497565|NCT01781429|447775182|FG000|Overall Study|Unacceptable Toxicity|0|||
124497566|NCT01781429|447775183|FG001|Overall Study|Unacceptable Toxicity|0|||
124497567|NCT01781429|447775184|FG002|Overall Study|Unacceptable Toxicity|0|||
124558734|NCT03870997|448003345|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
124723710|NCT05396014|448611670|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723711|NCT05396014|448611671|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
124723712|NCT05396014|448611672|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723713|NCT05396014|448611673|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723714|NCT05396014|448611674|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723715|NCT05396014|448611675|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723716|NCT05396014|448611676|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723717|NCT05396014|448611677|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723718|NCT05396014|448611678|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723719|NCT05396014|448611679|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723720|NCT05396014|448611680|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723721|NCT05396014|448611681|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723722|NCT05396014|448611682|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723723|NCT05396014|448611683|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723724|NCT05396014|448611684|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
124723725|NCT05396014|448611685|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723726|NCT05396014|448611686|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723727|NCT05396014|448611687|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
124723728|NCT05396014|448611645|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
124723729|NCT05396014|448611646|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723730|NCT05396014|448611647|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723731|NCT05396014|448611648|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723732|NCT05396014|448611649|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723733|NCT05396014|448611650|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723734|NCT05396014|448611651|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723735|NCT05396014|448611652|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723736|NCT05396014|448611653|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723737|NCT05396014|448611654|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124497568|NCT01781429|447775185|FG003|Overall Study|Unacceptable Toxicity|0|||
124497569|NCT01781429|447775186|FG004|Overall Study|Unacceptable Toxicity|0|||
124497570|NCT01781429|447775187|FG005|Overall Study|Unacceptable Toxicity|0|||
124497571|NCT01781429|447775188|FG006|Overall Study|Unacceptable Toxicity|0|||
124497572|NCT01781429|447775189|FG007|Overall Study|Unacceptable Toxicity|0|||
124497573|NCT01781429|447775190|FG008|Overall Study|Unacceptable Toxicity|0|||
124497574|NCT01781429|447775191|FG009|Overall Study|Unacceptable Toxicity|0|||
124497575|NCT01781429|447775192|FG010|Overall Study|Unacceptable Toxicity|0|||
124497576|NCT01781429|447775193|FG011|Overall Study|Unacceptable Toxicity|2|||
124497577|NCT01781429|447775194|FG012|Overall Study|Unacceptable Toxicity|0|||
124497578|NCT01781429|447775195|FG013|Overall Study|Unacceptable Toxicity|0|||
124497579|NCT01781429|447775196|FG014|Overall Study|Unacceptable Toxicity|0|||
124497580|NCT01781429|447775197|FG015|Overall Study|Unacceptable Toxicity|0|||
124497581|NCT01781429|447775182|FG000|Overall Study|Patient Condition Changed|0|||
124497582|NCT01781429|447775183|FG001|Overall Study|Patient Condition Changed|0|||
124497583|NCT01781429|447775184|FG002|Overall Study|Patient Condition Changed|0|||
124497584|NCT01781429|447775185|FG003|Overall Study|Patient Condition Changed|0|||
124497585|NCT01781429|447775186|FG004|Overall Study|Patient Condition Changed|0|||
124497586|NCT01781429|447775187|FG005|Overall Study|Patient Condition Changed|0|||
124497587|NCT01781429|447775188|FG006|Overall Study|Patient Condition Changed|0|||
124497588|NCT01781429|447775189|FG007|Overall Study|Patient Condition Changed|0|||
124497589|NCT01781429|447775190|FG008|Overall Study|Patient Condition Changed|0|||
124497590|NCT01781429|447775191|FG009|Overall Study|Patient Condition Changed|4|||
124497591|NCT01781429|447775192|FG010|Overall Study|Patient Condition Changed|0|||
124497592|NCT01781429|447775193|FG011|Overall Study|Patient Condition Changed|1|||
124497593|NCT01781429|447775194|FG012|Overall Study|Patient Condition Changed|0|||
124497594|NCT01781429|447775195|FG013|Overall Study|Patient Condition Changed|1|||
124497595|NCT01781429|447775196|FG014|Overall Study|Patient Condition Changed|0|||
124497596|NCT01781429|447775197|FG015|Overall Study|Patient Condition Changed|0|||
124497597|NCT01781429|447775182|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
124497598|NCT01781429|447775183|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
124497599|NCT01781429|447775184|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
124497600|NCT01781429|447775185|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
124497601|NCT01781429|447775186|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
124497602|NCT01781429|447775187|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
124497603|NCT01781429|447775188|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
124497604|NCT01781429|447775189|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
124497605|NCT01781429|447775190|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
124497606|NCT01781429|447775191|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
124497607|NCT01781429|447775192|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
124497608|NCT01781429|447775193|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
124497609|NCT01781429|447775194|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
124497610|NCT01781429|447775195|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
124497611|NCT01781429|447775196|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
124497612|NCT01781429|447775197|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
124497613|NCT01781429|447775182|FG000|Overall Study|Enrolled, but not treated|0|||
124497614|NCT01781429|447775183|FG001|Overall Study|Enrolled, but not treated|0|||
124497615|NCT01781429|447775184|FG002|Overall Study|Enrolled, but not treated|0|||
124497616|NCT01781429|447775185|FG003|Overall Study|Enrolled, but not treated|0|||
124497617|NCT01781429|447775186|FG004|Overall Study|Enrolled, but not treated|0|||
124497618|NCT01781429|447775187|FG005|Overall Study|Enrolled, but not treated|0|||
124497619|NCT01781429|447775188|FG006|Overall Study|Enrolled, but not treated|0|||
124497620|NCT01781429|447775189|FG007|Overall Study|Enrolled, but not treated|0|||
124497621|NCT01781429|447775190|FG008|Overall Study|Enrolled, but not treated|0|||
124497622|NCT01781429|447775191|FG009|Overall Study|Enrolled, but not treated|0|||
124497623|NCT01781429|447775192|FG010|Overall Study|Enrolled, but not treated|1|||
124497624|NCT01781429|447775193|FG011|Overall Study|Enrolled, but not treated|0|||
124497625|NCT01781429|447775194|FG012|Overall Study|Enrolled, but not treated|0|||
124497626|NCT01781429|447775195|FG013|Overall Study|Enrolled, but not treated|0|||
124497627|NCT01781429|447775196|FG014|Overall Study|Enrolled, but not treated|0|||
124497628|NCT01781429|447775197|FG015|Overall Study|Enrolled, but not treated|0|||
124497629|NCT02678741|447775198|FG000|Overall Study|Death|4|||
124497630|NCT02678741|447775198|FG000|Overall Study|Withdrawal by Subject|1|||
124497631|NCT02678741|447775198|FG000|Overall Study|ineligible|3|||
124497632|NCT02678741|447775198|FG000|Overall Study|Not RECIST Measurable|2|||
124497633|NCT02678741|447775198|FG000|Overall Study|Lack of Efficacy|10|||
124497634|NCT00903032|447775199|FG000|Overall Study|Withdrawal by Subject|5|||
124497635|NCT00903032|447775200|FG001|Overall Study|Withdrawal by Subject|3|||
124497636|NCT00903032|447775199|FG000|Overall Study|Lost to Follow-up|2|||
124497637|NCT00903032|447775200|FG001|Overall Study|Lost to Follow-up|2|||
124497638|NCT01703286|447775213|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
124497639|NCT01703286|447775214|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
124497640|NCT01703286|447775215|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
124497641|NCT01703286|447775216|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
124497642|NCT01703286|447775217|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
124497643|NCT01703286|447775218|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
124723738|NCT05396014|448611655|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723739|NCT05396014|448611656|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723740|NCT05396014|448611657|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723741|NCT05396014|448611658|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
124723742|NCT05396014|448611659|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723743|NCT05396014|448611660|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723744|NCT05396014|448611661|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723745|NCT05396014|448611662|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723746|NCT05396014|448611663|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723747|NCT05396014|448611664|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723748|NCT05396014|448611665|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723749|NCT05396014|448611666|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723750|NCT05396014|448611667|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723751|NCT05396014|448611668|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723752|NCT05396014|448611669|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723753|NCT05396014|448611670|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723754|NCT05396014|448611671|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
124723755|NCT05396014|448611672|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723756|NCT05396014|448611673|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723757|NCT05396014|448611674|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723758|NCT05396014|448611675|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723759|NCT05396014|448611676|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723760|NCT05396014|448611677|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723761|NCT05396014|448611678|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723762|NCT05396014|448611679|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723763|NCT05396014|448611680|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723764|NCT05396014|448611681|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723765|NCT05396014|448611682|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723766|NCT05396014|448611683|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723767|NCT05396014|448611684|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
124723768|NCT05396014|448611685|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723769|NCT05396014|448611686|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723770|NCT05396014|448611687|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
124723771|NCT05396014|448611645|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
124723772|NCT05396014|448611646|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723773|NCT05396014|448611647|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723774|NCT05396014|448611648|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723775|NCT05396014|448611649|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723776|NCT05396014|448611650|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723777|NCT05396014|448611651|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723778|NCT05396014|448611652|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723779|NCT05396014|448611653|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723780|NCT05396014|448611654|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723781|NCT05396014|448611655|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723782|NCT05396014|448611656|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723783|NCT05396014|448611657|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723784|NCT05396014|448611658|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
124723785|NCT05396014|448611659|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723786|NCT05396014|448611660|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723787|NCT05396014|448611661|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723788|NCT05396014|448611662|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723789|NCT05396014|448611663|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723790|NCT05396014|448611664|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723791|NCT05396014|448611665|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723792|NCT05396014|448611666|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723793|NCT05396014|448611667|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723794|NCT05396014|448611668|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723795|NCT05396014|448611669|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723796|NCT05396014|448611670|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723797|NCT05396014|448611671|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
124723798|NCT05396014|448611672|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723799|NCT05396014|448611673|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723800|NCT05396014|448611674|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723801|NCT05396014|448611675|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723802|NCT05396014|448611676|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723803|NCT05396014|448611677|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124773826|NCT01394016|448800627|FG016|Overall Study|Adverse Event|1|||
124773827|NCT01394016|448800628|FG017|Overall Study|Adverse Event|1|||
124773828|NCT01394016|448800629|FG018|Overall Study|Adverse Event|0|||
124773829|NCT01394016|448800611|FG000|Overall Study|Sponsor Decision|0|||
124773830|NCT01394016|448800612|FG001|Overall Study|Sponsor Decision|0|||
124773831|NCT01394016|448800613|FG002|Overall Study|Sponsor Decision|0|||
124773832|NCT01394016|448800614|FG003|Overall Study|Sponsor Decision|0|||
124773833|NCT01394016|448800615|FG004|Overall Study|Sponsor Decision|0|||
124773834|NCT01394016|448800616|FG005|Overall Study|Sponsor Decision|0|||
124773835|NCT01394016|448800617|FG006|Overall Study|Sponsor Decision|0|||
124773836|NCT01394016|448800618|FG007|Overall Study|Sponsor Decision|0|||
124773837|NCT01394016|448800619|FG008|Overall Study|Sponsor Decision|0|||
124773838|NCT01394016|448800620|FG009|Overall Study|Sponsor Decision|0|||
124773839|NCT01394016|448800621|FG010|Overall Study|Sponsor Decision|0|||
124773840|NCT01394016|448800622|FG011|Overall Study|Sponsor Decision|0|||
124773841|NCT01394016|448800623|FG012|Overall Study|Sponsor Decision|1|||
124773842|NCT01394016|448800624|FG013|Overall Study|Sponsor Decision|0|||
124773843|NCT01394016|448800625|FG014|Overall Study|Sponsor Decision|0|||
124773844|NCT01394016|448800626|FG015|Overall Study|Sponsor Decision|0|||
124773845|NCT01394016|448800627|FG016|Overall Study|Sponsor Decision|0|||
124773846|NCT01394016|448800628|FG017|Overall Study|Sponsor Decision|0|||
124773847|NCT01394016|448800629|FG018|Overall Study|Sponsor Decision|0|||
124773848|NCT01394016|448800611|FG000|Overall Study|Lost to Follow-up|0|||
124773849|NCT01394016|448800612|FG001|Overall Study|Lost to Follow-up|0|||
124773850|NCT01394016|448800613|FG002|Overall Study|Lost to Follow-up|0|||
124773851|NCT01394016|448800614|FG003|Overall Study|Lost to Follow-up|0|||
124773852|NCT01394016|448800615|FG004|Overall Study|Lost to Follow-up|0|||
124773853|NCT01394016|448800616|FG005|Overall Study|Lost to Follow-up|0|||
124773854|NCT01394016|448800617|FG006|Overall Study|Lost to Follow-up|0|||
124773855|NCT01394016|448800618|FG007|Overall Study|Lost to Follow-up|0|||
124773856|NCT01394016|448800619|FG008|Overall Study|Lost to Follow-up|0|||
124773857|NCT01394016|448800620|FG009|Overall Study|Lost to Follow-up|0|||
124773858|NCT01394016|448800621|FG010|Overall Study|Lost to Follow-up|0|||
124773859|NCT01394016|448800622|FG011|Overall Study|Lost to Follow-up|0|||
124773860|NCT01394016|448800623|FG012|Overall Study|Lost to Follow-up|0|||
124773861|NCT01394016|448800624|FG013|Overall Study|Lost to Follow-up|0|||
124773862|NCT01394016|448800625|FG014|Overall Study|Lost to Follow-up|0|||
124773863|NCT01394016|448800626|FG015|Overall Study|Lost to Follow-up|0|||
124773864|NCT01394016|448800627|FG016|Overall Study|Lost to Follow-up|0|||
124773865|NCT01394016|448800628|FG017|Overall Study|Lost to Follow-up|0|||
124773866|NCT01394016|448800629|FG018|Overall Study|Lost to Follow-up|1|||
124773867|NCT04949490|448800637|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
124773868|NCT04949490|448800638|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
124773869|NCT04949490|448800639|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
124773870|NCT04949490|448800640|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
124773871|NCT04949490|448800641|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
124773872|NCT04949490|448800642|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
124773873|NCT04949490|448800637|FG000|Group A and Group B|Withdrawal by Subject|0|||
124773874|NCT04949490|448800638|FG001|Group A and Group B|Withdrawal by Subject|0|||
124497644|NCT01703286|447775213|FG000|Period 2 Including Washout|Adverse Event|0|||
124497645|NCT01703286|447775214|FG001|Period 2 Including Washout|Adverse Event|0|||
124497646|NCT01703286|447775215|FG002|Period 2 Including Washout|Adverse Event|0|||
124497647|NCT01703286|447775216|FG003|Period 2 Including Washout|Adverse Event|1|||
124497648|NCT01703286|447775217|FG004|Period 2 Including Washout|Adverse Event|0|||
124497649|NCT01703286|447775218|FG005|Period 2 Including Washout|Adverse Event|0|||
124497650|NCT01984346|447775219|FG000|Overall Study|Physician Decision|4|||
124558735|NCT03565211|448003349|FG000|Overall Study|Withdrawal by Subject|2|||
124723804|NCT05396014|448611678|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723805|NCT05396014|448611679|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723806|NCT05396014|448611680|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723807|NCT05396014|448611681|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723808|NCT05396014|448611682|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723809|NCT05396014|448611683|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723810|NCT05396014|448611684|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
124723811|NCT05396014|448611685|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723812|NCT05396014|448611686|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723813|NCT05396014|448611687|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
124723814|NCT05396014|448611645|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723815|NCT05396014|448611646|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723816|NCT05396014|448611647|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723817|NCT05396014|448611648|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124773875|NCT04949490|448800639|FG002|Group A and Group B|Withdrawal by Subject|1|||
124773876|NCT04949490|448800640|FG003|Group A and Group B|Withdrawal by Subject|0|||
124773877|NCT04949490|448800641|FG004|Group A and Group B|Withdrawal by Subject|0|||
124497651|NCT01984346|447775220|FG001|Overall Study|Physician Decision|2|||
124558736|NCT03565211|448003349|FG000|Overall Study|Lost to Follow-up|1|||
124497652|NCT01984346|447775219|FG000|Overall Study|Withdrawal by Subject|2|||
124497653|NCT01984346|447775220|FG001|Overall Study|Withdrawal by Subject|2|||
124497654|NCT01984346|447775219|FG000|Overall Study|Enrollment Closed|8|||
124497655|NCT01984346|447775220|FG001|Overall Study|Enrollment Closed|1|||
124497656|NCT01984346|447775219|FG000|Overall Study|Insurance Coverage|1|||
124497657|NCT01984346|447775220|FG001|Overall Study|Insurance Coverage|0|||
124497658|NCT01984346|447775219|FG000|Overall Study|Intra-operative Exclusion|2|||
124497659|NCT01984346|447775220|FG001|Overall Study|Intra-operative Exclusion|0|||
124497660|NCT05058664|447775223|FG000|Overall Study|No follow-up data provided|4|||
124497661|NCT05058664|447775224|FG001|Overall Study|No follow-up data provided|0|||
124497662|NCT05058664|447775225|FG002|Overall Study|No follow-up data provided|2|||
124497663|NCT05058664|447775223|FG000|Overall Study|Withdrawal by Subject|0|||
124497664|NCT05058664|447775224|FG001|Overall Study|Withdrawal by Subject|0|||
124497665|NCT05058664|447775225|FG002|Overall Study|Withdrawal by Subject|1|||
124497666|NCT00972244|447775226|FG000|Overall Study|Incorrect Enrolment|1|||
124497667|NCT00972244|447775227|FG001|Overall Study|Incorrect Enrolment|0|||
124497668|NCT00972244|447775228|FG002|Overall Study|Incorrect Enrolment|0|||
124558737|NCT03565211|448003349|FG000|Overall Study|Adverse Event|44|||
124558738|NCT03565211|448003349|FG000|Overall Study|Personal issues|1|||
124558739|NCT01894984|448003350|FG000|Overall Study|Other|314|||
124558740|NCT01894984|448003351|FG001|Overall Study|Other|175|||
124558741|NCT00827359|448003356|FG000|Overall Study|Progressive Diseas|19|||
124558742|NCT00827359|448003356|FG000|Overall Study|Unacceptable Toxicity|5|||
124558743|NCT00827359|448003356|FG000|Overall Study|Ineligible|1|||
124558744|NCT00667719|448003357|FG000|Overall Study|Adverse Event|39|||
124558745|NCT00667719|448003357|FG000|Overall Study|Abnormal Test Procedure|1|||
124558746|NCT00667719|448003357|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
124497669|NCT00972244|447775229|FG003|Overall Study|Incorrect Enrolment|0|||
124497670|NCT00972244|447775230|FG004|Overall Study|Incorrect Enrolment|0|||
124497671|NCT00972244|447775226|FG000|Overall Study|Adverse Event|0|||
124497672|NCT00972244|447775227|FG001|Overall Study|Adverse Event|1|||
124558747|NCT00667719|448003357|FG000|Overall Study|Protocol Violation|3|||
124558748|NCT00667719|448003357|FG000|Overall Study|Withdrawal by Subject|17|||
124497673|NCT00972244|447775228|FG002|Overall Study|Adverse Event|1|||
124497674|NCT00972244|447775229|FG003|Overall Study|Adverse Event|0|||
124497675|NCT00972244|447775230|FG004|Overall Study|Adverse Event|0|||
124497676|NCT00972244|447775226|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
124497677|NCT00972244|447775227|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
124497678|NCT00972244|447775228|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
124497679|NCT00972244|447775229|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
124497680|NCT00972244|447775230|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
124497681|NCT00972244|447775226|FG000|Overall Study|Withdrawal by Subject|1|||
124497682|NCT00972244|447775227|FG001|Overall Study|Withdrawal by Subject|2|||
124497683|NCT00972244|447775228|FG002|Overall Study|Withdrawal by Subject|1|||
124497684|NCT00972244|447775229|FG003|Overall Study|Withdrawal by Subject|0|||
124497685|NCT00972244|447775230|FG004|Overall Study|Withdrawal by Subject|1|||
124497686|NCT00972244|447775226|FG000|Overall Study|Safety|0|||
124497687|NCT00972244|447775227|FG001|Overall Study|Safety|0|||
124497688|NCT00972244|447775228|FG002|Overall Study|Safety|0|||
124497689|NCT00972244|447775229|FG003|Overall Study|Safety|0|||
124497690|NCT00972244|447775230|FG004|Overall Study|Safety|1|||
124497691|NCT00972244|447775226|FG000|Overall Study|Death|1|||
124497692|NCT00972244|447775227|FG001|Overall Study|Death|0|||
124497693|NCT00972244|447775228|FG002|Overall Study|Death|0|||
124497694|NCT00972244|447775229|FG003|Overall Study|Death|0|||
124558749|NCT00667719|448003357|FG000|Overall Study|Lost to Follow-up|8|||
124558750|NCT03840135|448003358|FG000|Overall Study|Protocol Violation|6|||
124558751|NCT03840135|448003359|FG001|Overall Study|Protocol Violation|1|||
124558752|NCT03840135|448003358|FG000|Overall Study|Withdrawal by Subject|1|||
124558753|NCT03840135|448003359|FG001|Overall Study|Withdrawal by Subject|0|||
124558754|NCT01159769|448003360|FG000|Overall Study|Adverse Event|1|||
124558755|NCT02555618|448003361|FG000|Overall Study|Sponsor's Circumstances|1|||
124497695|NCT00972244|447775230|FG004|Overall Study|Death|0|||
124558756|NCT02555618|448003362|FG001|Overall Study|Sponsor's Circumstances|0|||
124497696|NCT00972244|447775226|FG000|Overall Study|Various|0|||
124497697|NCT00972244|447775227|FG001|Overall Study|Various|0|||
124497698|NCT00972244|447775228|FG002|Overall Study|Various|0|||
124497699|NCT00972244|447775229|FG003|Overall Study|Various|0|||
124497700|NCT00972244|447775230|FG004|Overall Study|Various|2|||
124497701|NCT01597557|447775231|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
124497702|NCT01597557|447775232|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
124497703|NCT02561000|447775235|FG000|Overall Study|Withdrawal by Subject|2|||
124497704|NCT02561000|447775236|FG001|Overall Study|Withdrawal by Subject|3|||
124497705|NCT02561000|447775237|FG002|Overall Study|Withdrawal by Subject|0|||
124558757|NCT01827371|448003363|FG000|Overall Study|Adverse Event|0|||
124558758|NCT01827371|448003364|FG001|Overall Study|Adverse Event|0|||
124558759|NCT01827371|448003365|FG002|Overall Study|Adverse Event|4|||
124558760|NCT01827371|448003366|FG003|Overall Study|Adverse Event|2|||
124558761|NCT01827371|448003363|FG000|Overall Study|Lost to Follow-up|0|||
124558762|NCT01827371|448003364|FG001|Overall Study|Lost to Follow-up|2|||
124773878|NCT04949490|448800642|FG005|Group A and Group B|Withdrawal by Subject|0|||
124773879|NCT04949490|448800637|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
124773880|NCT04949490|448800638|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
124773881|NCT04949490|448800639|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
124773882|NCT04949490|448800640|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
124773883|NCT04949490|448800641|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
124773884|NCT04949490|448800642|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
124773885|NCT04949490|448800637|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
124773886|NCT04949490|448800638|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
124773887|NCT04949490|448800639|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
124773888|NCT04949490|448800640|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
124773889|NCT04949490|448800641|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
124773890|NCT04949490|448800642|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
124773891|NCT02017405|448800643|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
124773892|NCT02017405|448800644|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
124773893|NCT02017405|448800645|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
124773894|NCT02017405|448800646|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
124773895|NCT02017405|448800647|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
124773896|NCT02017405|448800648|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
124773897|NCT02017405|448800643|FG000|Open-label Phase|Adverse Event|1|||
124773898|NCT02017405|448800644|FG001|Open-label Phase|Adverse Event|1|||
124773899|NCT02017405|448800645|FG002|Open-label Phase|Adverse Event|0|||
124773900|NCT02017405|448800646|FG003|Open-label Phase|Adverse Event|0|||
124773901|NCT02017405|448800647|FG004|Open-label Phase|Adverse Event|0|||
124773902|NCT02017405|448800648|FG005|Open-label Phase|Adverse Event|0|||
124773903|NCT02864394|448800650|FG000|Overall Study|Death|184|||
124773904|NCT02864394|448800651|FG001|Overall Study|Death|189|||
124773905|NCT02864394|448800650|FG000|Overall Study|Lost to Follow-up|0|||
124773906|NCT02864394|448800651|FG001|Overall Study|Lost to Follow-up|2|||
124773907|NCT02864394|448800650|FG000|Overall Study|Sponsor Decision|26|||
124773908|NCT02864394|448800651|FG001|Overall Study|Sponsor Decision|11|||
124773909|NCT02864394|448800650|FG000|Overall Study|Withdrawal by Subject|3|||
124773910|NCT02864394|448800651|FG001|Overall Study|Withdrawal by Subject|10|||
124773911|NCT04988477|448800652|FG000|Overall Study|Death|1|||
124773912|NCT04988477|448800653|FG001|Overall Study|Death|0|||
124773913|NCT04988477|448800654|FG002|Overall Study|Death|0|||
124773914|NCT04988477|448800652|FG000|Overall Study|Lost to Follow-up|5|||
124773915|NCT04988477|448800653|FG001|Overall Study|Lost to Follow-up|2|||
124773916|NCT04988477|448800654|FG002|Overall Study|Lost to Follow-up|0|||
124773917|NCT04988477|448800652|FG000|Overall Study|Withdrawal by Subject|2|||
124773918|NCT04988477|448800653|FG001|Overall Study|Withdrawal by Subject|0|||
124773919|NCT04988477|448800654|FG002|Overall Study|Withdrawal by Subject|0|||
124773920|NCT00777153|448802761|FG000|Overall Study|Lost to Follow-up|1|||
124773921|NCT00777153|448802762|FG001|Overall Study|Lost to Follow-up|1|||
124773922|NCT00777153|448802763|FG002|Overall Study|Lost to Follow-up|0|||
124773923|NCT00777153|448802761|FG000|Overall Study|Death|85|||
124773924|NCT00777153|448802762|FG001|Overall Study|Death|73|||
124773925|NCT00777153|448802763|FG002|Overall Study|Death|33|||
124773926|NCT00777153|448802761|FG000|Overall Study|Withdrawal by Subject|3|||
124773927|NCT00777153|448802762|FG001|Overall Study|Withdrawal by Subject|4|||
124773928|NCT00777153|448802763|FG002|Overall Study|Withdrawal by Subject|3|||
124773929|NCT00777153|448802761|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
124773930|NCT00777153|448802762|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
124773931|NCT00777153|448802763|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
124497706|NCT02561000|447775235|FG000|Overall Study|Adverse Event|0|||
124497707|NCT02561000|447775236|FG001|Overall Study|Adverse Event|1|||
124497708|NCT02561000|447775237|FG002|Overall Study|Adverse Event|0|||
124497709|NCT01234402|447775238|FG000|Overall Study|Lost to Follow-up|0|||
124497710|NCT01234402|447775239|FG001|Overall Study|Lost to Follow-up|1|||
124497711|NCT01234402|447775240|FG002|Overall Study|Lost to Follow-up|3|||
124497712|NCT01234402|447775238|FG000|Overall Study|Withdrawal by Subject|1|||
124497713|NCT01234402|447775239|FG001|Overall Study|Withdrawal by Subject|3|||
124497714|NCT01234402|447775240|FG002|Overall Study|Withdrawal by Subject|4|||
124497715|NCT01234402|447775238|FG000|Overall Study|Never treated: Death|0|||
124773932|NCT00554216|448802765|FG000|Overall Study|Lost to Follow-up|92|||
124773933|NCT00554216|448802766|FG001|Overall Study|Lost to Follow-up|31|||
124773934|NCT00554216|448802767|FG002|Overall Study|Lost to Follow-up|63|||
124773935|NCT00554216|448802765|FG000|Overall Study|Adverse Event|16|||
124773936|NCT00554216|448802766|FG001|Overall Study|Adverse Event|16|||
124773937|NCT00554216|448802767|FG002|Overall Study|Adverse Event|36|||
124497716|NCT01234402|447775239|FG001|Overall Study|Never treated: Death|0|||
124497717|NCT01234402|447775240|FG002|Overall Study|Never treated: Death|1|||
124558763|NCT01827371|448003365|FG002|Overall Study|Lost to Follow-up|0|||
124497718|NCT01234402|447775238|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
124773938|NCT00554216|448802765|FG000|Overall Study|Withdrawal by Subject|92|||
124773939|NCT00554216|448802766|FG001|Overall Study|Withdrawal by Subject|31|||
124773940|NCT00554216|448802767|FG002|Overall Study|Withdrawal by Subject|43|||
124773941|NCT00554216|448802765|FG000|Overall Study|Non compliance|10|||
124773942|NCT00554216|448802766|FG001|Overall Study|Non compliance|4|||
124773943|NCT00554216|448802767|FG002|Overall Study|Non compliance|5|||
124773944|NCT00554216|448802765|FG000|Overall Study|Pregnancy|2|||
124773945|NCT00554216|448802766|FG001|Overall Study|Pregnancy|1|||
124773946|NCT00554216|448802767|FG002|Overall Study|Pregnancy|14|||
124773947|NCT00554216|448802765|FG000|Overall Study|Restricted med|3|||
124773948|NCT00554216|448802766|FG001|Overall Study|Restricted med|1|||
124773949|NCT00554216|448802767|FG002|Overall Study|Restricted med|1|||
124773950|NCT00554216|448802765|FG000|Overall Study|Other|12|||
124773951|NCT00554216|448802766|FG001|Overall Study|Other|7|||
124773952|NCT00554216|448802767|FG002|Overall Study|Other|10|||
124773953|NCT00554216|448802765|FG000|Overall Study|Lack of Efficacy|15|||
124773954|NCT00554216|448802766|FG001|Overall Study|Lack of Efficacy|3|||
124773955|NCT00554216|448802767|FG002|Overall Study|Lack of Efficacy|0|||
124773956|NCT02079246|448802768|FG000|OLEX|Withdrawal before treatment|1|||
124773957|NCT02079246|448802769|FG001|OLEX|Withdrawal before treatment|0|||
124773958|NCT02079246|448802768|FG000|OLEX|Death|11|||
124773959|NCT02079246|448802769|FG001|OLEX|Death|0|||
124773960|NCT02079246|448802768|FG000|OLEX|Adverse Event|66|||
124773961|NCT02079246|448802769|FG001|OLEX|Adverse Event|0|||
124497719|NCT01234402|447775239|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
124497720|NCT01234402|447775240|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
124497721|NCT01234402|447775238|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
124497722|NCT01234402|447775239|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
124497723|NCT01234402|447775240|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
124497724|NCT05761444|447775242|FG000|Overall Study|Protocol Violation|2|||
124497725|NCT05761444|447775243|FG001|Overall Study|Protocol Violation|1|||
124497726|NCT05761444|447775242|FG000|Overall Study|Adverse Event|2|||
124497727|NCT05761444|447775243|FG001|Overall Study|Adverse Event|2|||
124497728|NCT05761444|447775242|FG000|Overall Study|Withdrawal by Subject|3|||
124497729|NCT05761444|447775243|FG001|Overall Study|Withdrawal by Subject|2|||
124497730|NCT05761444|447775242|FG000|Overall Study|Other|1|||
124497731|NCT05761444|447775243|FG001|Overall Study|Other|0|||
124497732|NCT01005719|447775244|FG000|Period 1|Adverse Event|0|||
124497733|NCT01005719|447775245|FG001|Period 1|Adverse Event|0|||
124497734|NCT01005719|447775246|FG002|Period 1|Adverse Event|0|||
124497735|NCT01005719|447775247|FG003|Period 1|Adverse Event|1|||
124497736|NCT01005719|447775248|FG004|Period 1|Adverse Event|0|||
124497737|NCT01005719|447775249|FG005|Period 1|Adverse Event|0|||
124497738|NCT01005719|447775244|FG000|Period 1|Delay in completing study procedures|0|||
124497739|NCT01005719|447775245|FG001|Period 1|Delay in completing study procedures|0|||
124497740|NCT01005719|447775246|FG002|Period 1|Delay in completing study procedures|0|||
124497741|NCT01005719|447775247|FG003|Period 1|Delay in completing study procedures|0|||
124497742|NCT01005719|447775248|FG004|Period 1|Delay in completing study procedures|0|||
124497743|NCT01005719|447775249|FG005|Period 1|Delay in completing study procedures|1|||
124497744|NCT01005719|447775244|FG000|Period 2|Adverse Event|0|||
124497745|NCT01005719|447775245|FG001|Period 2|Adverse Event|0|||
124497746|NCT01005719|447775246|FG002|Period 2|Adverse Event|0|||
124497747|NCT01005719|447775247|FG003|Period 2|Adverse Event|0|||
124497748|NCT01005719|447775248|FG004|Period 2|Adverse Event|1|||
124497749|NCT01005719|447775249|FG005|Period 2|Adverse Event|1|||
124497750|NCT01594476|447775250|FG000|Overall Study|Protocol Violation|1|||
124497751|NCT01594476|447775251|FG001|Overall Study|Protocol Violation|3|||
124497752|NCT01106534|447775252|FG000|Overall Study|Withdrawal by Subject|18|||
124497753|NCT01106534|447775252|FG000|Overall Study|Lost to Follow-up|2|||
124497754|NCT01106534|447775252|FG000|Overall Study|Death|16|||
124497755|NCT01106534|447775252|FG000|Overall Study|Physician Decision|1|||
124497756|NCT02275026|447775253|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
124773962|NCT02079246|448802768|FG000|OLEX|Withdrawal by Subject|60|||
124773963|NCT02079246|448802769|FG001|OLEX|Withdrawal by Subject|0|||
124773964|NCT02079246|448802768|FG000|OLEX|Lost to Follow-up|6|||
124773965|NCT02079246|448802769|FG001|OLEX|Lost to Follow-up|0|||
124773966|NCT02079246|448802768|FG000|OLEX|Protocol Violation|6|||
124773967|NCT02079246|448802769|FG001|OLEX|Protocol Violation|0|||
124497757|NCT02275026|447775253|FG000|Overall Study|Withdrawal by Subject|4|||
124497758|NCT02275026|447775253|FG000|Overall Study|Ineligible due to medical history|13|||
124497759|NCT02275026|447775253|FG000|Overall Study|MRI malfunction precluded testing|1|||
124497760|NCT02275026|447775253|FG000|Overall Study|Ineligible after MRI findings|1|||
124497761|NCT02275026|447775253|FG000|Overall Study|Lost to Follow-up|2|||
124497762|NCT02275026|447775253|FG000|Overall Study|Scanner failure|1|||
124497763|NCT01108809|447775256|FG000|Overall Study|Adverse Event|3|||
124497764|NCT01108809|447775256|FG000|Overall Study|Lost to Follow-up|1|||
124497765|NCT00001262|447775258|FG000|Overall Study|Death|10|||
124497766|NCT00001262|447775259|FG001|Overall Study|Death|11|||
124773968|NCT02079246|448802768|FG000|OLEX|Lack of Efficacy|3|||
124497767|NCT00001262|447775260|FG002|Overall Study|Death|0|||
124497768|NCT00001262|447775258|FG000|Overall Study|Withdrawal by Subject|0|||
124497769|NCT00001262|447775259|FG001|Overall Study|Withdrawal by Subject|3|||
124497770|NCT00001262|447775260|FG002|Overall Study|Withdrawal by Subject|0|||
124497771|NCT03844633|447775261|FG000|1 Week FU|Lost to Follow-up|0|||
124497772|NCT03844633|447775262|FG001|1 Week FU|Lost to Follow-up|1|||
124497773|NCT03844633|447775263|FG002|1 Week FU|Lost to Follow-up|4|||
124497774|NCT03844633|447775261|FG000|12-month Follow-up|Lost to Follow-up|7|||
124497775|NCT03844633|447775262|FG001|12-month Follow-up|Lost to Follow-up|5|||
124497776|NCT03844633|447775263|FG002|12-month Follow-up|Lost to Follow-up|8|||
124497777|NCT02588248|447775268|FG000|Overall Study|Physician Decision|4|||
124497778|NCT02588248|447775269|FG001|Overall Study|Physician Decision|3|||
124497779|NCT00576693|447775272|FG000|Overall Study|Lost to Follow-up|7|||
124497780|NCT00576693|447775273|FG001|Overall Study|Lost to Follow-up|11|||
124497781|NCT00576693|447775272|FG000|Overall Study|Withdrawal by Subject|3|||
124497782|NCT00576693|447775273|FG001|Overall Study|Withdrawal by Subject|13|||
124497783|NCT00804193|447775274|FG000|Overall Study|Lack of baseline fungus|32|||
124497784|NCT00804193|447775275|FG001|Overall Study|Lack of baseline fungus|31|||
124497785|NCT00804193|447775276|FG002|Overall Study|Lack of baseline fungus|19|||
124497786|NCT00804193|447775274|FG000|Overall Study|Adverse Event|0|||
124497787|NCT00804193|447775275|FG001|Overall Study|Adverse Event|0|||
124497788|NCT00804193|447775276|FG002|Overall Study|Adverse Event|2|||
124497789|NCT00804193|447775274|FG000|Overall Study|Lack of Efficacy|1|||
124497790|NCT00804193|447775275|FG001|Overall Study|Lack of Efficacy|1|||
124497791|NCT00804193|447775276|FG002|Overall Study|Lack of Efficacy|3|||
124497792|NCT00804193|447775274|FG000|Overall Study|Protocol Violation|0|||
124497793|NCT00804193|447775275|FG001|Overall Study|Protocol Violation|8|||
124497794|NCT00804193|447775276|FG002|Overall Study|Protocol Violation|2|||
124497795|NCT00804193|447775274|FG000|Overall Study|Lost to Follow-up|3|||
124497796|NCT00804193|447775275|FG001|Overall Study|Lost to Follow-up|3|||
124497797|NCT00804193|447775276|FG002|Overall Study|Lost to Follow-up|4|||
124497798|NCT00804193|447775274|FG000|Overall Study|Withdrawal by Subject|3|||
124497799|NCT00804193|447775275|FG001|Overall Study|Withdrawal by Subject|1|||
124497800|NCT00804193|447775276|FG002|Overall Study|Withdrawal by Subject|2|||
124497801|NCT01987986|447775277|FG000|Overall Study|Lost to Follow-up|1|||
124497802|NCT01987986|447775278|FG001|Overall Study|Lost to Follow-up|0|||
124497803|NCT01987986|447775279|FG002|Overall Study|Lost to Follow-up|0|||
124497804|NCT01987986|447775280|FG003|Overall Study|Lost to Follow-up|0|||
124497805|NCT01987986|447775277|FG000|Overall Study|Adverse Event|1|||
124497806|NCT01987986|447775278|FG001|Overall Study|Adverse Event|0|||
124497807|NCT01987986|447775279|FG002|Overall Study|Adverse Event|2|||
124497808|NCT01987986|447775280|FG003|Overall Study|Adverse Event|0|||
124497809|NCT03283163|447775281|FG000|Overall Study|Lost to Follow-up|1|||
124497810|NCT03283163|447775281|FG000|Overall Study|other life commitments|6|||
124497811|NCT03283163|447775281|FG000|Overall Study|COVID-19 institution wide halting|1|||
124497812|NCT03283163|447775281|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
124497813|NCT03283163|447775281|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
124497814|NCT00237796|447775282|FG000|Overall Study|Baseline and one other ILSS required|10|||
124497815|NCT00237796|447775283|FG001|Overall Study|Baseline and one other ILSS required|5|||
124497816|NCT04400318|447776851|FG000|Overall Study|Adverse Event|1|||
124497817|NCT04400318|447776852|FG001|Overall Study|Adverse Event|0|||
124497818|NCT04400318|447776851|FG000|Overall Study|Withdrawal by Subject|1|||
124497819|NCT04400318|447776852|FG001|Overall Study|Withdrawal by Subject|1|||
124497820|NCT04400318|447776851|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
124497821|NCT04400318|447776852|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
124497822|NCT01096446|447776853|FG000|Overall Study|Death|1|||
124497823|NCT01096446|447776854|FG001|Overall Study|Death|0|||
124497824|NCT01096446|447776853|FG000|Overall Study|Protocol Violation|2|||
124497825|NCT01096446|447776854|FG001|Overall Study|Protocol Violation|0|||
124497826|NCT01043185|447776855|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
124497827|NCT01043185|447776856|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
124497828|NCT01043185|447776857|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
124497829|NCT01043185|447776858|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
124497830|NCT01043185|447776859|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
124497831|NCT01043185|447776860|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
124497832|NCT01043185|447776861|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
124497833|NCT01043185|447776862|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
124497834|NCT01043185|447776863|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
124497835|NCT01043185|447776864|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
124497836|NCT01104558|447776865|FG000|Overall Study|Protocol Violation|6|||
124497837|NCT01104558|447776865|FG000|Overall Study|Missing of primary efficacy assessment|10|||
124497838|NCT01104558|447776865|FG000|Overall Study|Missing of genetic analysis results|1|||
124497839|NCT03653507|447776868|FG000|Overall Study|Miscellaneous|26|||
124497840|NCT03653507|447776869|FG001|Overall Study|Miscellaneous|16|||
124497841|NCT03653507|447776868|FG000|Overall Study|Withdrawal by Subject|35|||
124773969|NCT02079246|448802769|FG001|OLEX|Lack of Efficacy|0|||
124773970|NCT02079246|448802768|FG000|OLEX|Results of the lead-in studies|58|||
124773971|NCT02079246|448802769|FG001|OLEX|Results of the lead-in studies|0|||
124773972|NCT02079246|448802768|FG000|OLEX|Other: Disallowed medication|8|||
124773973|NCT02079246|448802769|FG001|OLEX|Other: Disallowed medication|0|||
124773974|NCT02079246|448802768|FG000|OLEX|Other: Insufficient compliance|2|||
124773975|NCT02079246|448802769|FG001|OLEX|Other: Insufficient compliance|0|||
124773976|NCT02079246|448802768|FG000|OLEX|Other: Caregiver unavailable|3|||
124773977|NCT02079246|448802769|FG001|OLEX|Other: Caregiver unavailable|0|||
124773978|NCT02079246|448802768|FG000|OLEX|Other: Coordinator decision|1|||
124773979|NCT02079246|448802769|FG001|OLEX|Other: Coordinator decision|0|||
124773980|NCT02079246|448802768|FG000|OLEX|Other: Worsening of condition|1|||
124773981|NCT02079246|448802769|FG001|OLEX|Other: Worsening of condition|0|||
124773982|NCT02079246|448802768|FG000|OLEX|Other: Moved to nursing home|1|||
124773983|NCT02079246|448802769|FG001|OLEX|Other: Moved to nursing home|0|||
124773984|NCT02079246|448802768|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
124773985|NCT02079246|448802769|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
124773986|NCT02079246|448802768|FG000|OLEX-MEM|Adverse Event|0|||
124773987|NCT02079246|448802769|FG001|OLEX-MEM|Adverse Event|6|||
124773988|NCT02079246|448802768|FG000|OLEX-MEM|Withdrawal by Subject|0|||
124773989|NCT02079246|448802769|FG001|OLEX-MEM|Withdrawal by Subject|7|||
124773990|NCT02079246|448802768|FG000|OLEX-MEM|Protocol Violation|0|||
124773991|NCT02079246|448802769|FG001|OLEX-MEM|Protocol Violation|2|||
124773992|NCT02079246|448802768|FG000|OLEX-MEM|Lost to Follow-up|0|||
124773993|NCT02079246|448802769|FG001|OLEX-MEM|Lost to Follow-up|1|||
124773994|NCT02079246|448802768|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
124773995|NCT02079246|448802769|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
124773996|NCT00463567|448802770|FG000|Overall Study|Adverse Event|29|||
124773997|NCT00463567|448802771|FG001|Overall Study|Adverse Event|26|||
124773998|NCT00463567|448802772|FG002|Overall Study|Adverse Event|17|||
124773999|NCT00463567|448802773|FG003|Overall Study|Adverse Event|46|||
124774000|NCT00463567|448802774|FG004|Overall Study|Adverse Event|10|||
124774001|NCT00463567|448802775|FG005|Overall Study|Adverse Event|10|||
124774002|NCT00463567|448802776|FG006|Overall Study|Adverse Event|4|||
124774003|NCT00463567|448802770|FG000|Overall Study|Withdrawal by Subject|29|||
124774004|NCT00463567|448802771|FG001|Overall Study|Withdrawal by Subject|22|||
124774005|NCT00463567|448802772|FG002|Overall Study|Withdrawal by Subject|20|||
124774006|NCT00463567|448802773|FG003|Overall Study|Withdrawal by Subject|37|||
124774007|NCT00463567|448802774|FG004|Overall Study|Withdrawal by Subject|6|||
124774008|NCT00463567|448802775|FG005|Overall Study|Withdrawal by Subject|5|||
124497842|NCT03653507|447776869|FG001|Overall Study|Withdrawal by Subject|23|||
124497843|NCT03653507|447776868|FG000|Overall Study|Protocol Deviation|2|||
124497844|NCT03653507|447776869|FG001|Overall Study|Protocol Deviation|1|||
124497845|NCT03653507|447776868|FG000|Overall Study|Progressive disease|102|||
124497846|NCT03653507|447776869|FG001|Overall Study|Progressive disease|157|||
124497847|NCT03653507|447776868|FG000|Overall Study|Lost to Follow-up|1|||
124497848|NCT03653507|447776869|FG001|Overall Study|Lost to Follow-up|1|||
124497849|NCT03653507|447776868|FG000|Overall Study|Death|24|||
124497850|NCT03653507|447776869|FG001|Overall Study|Death|22|||
124497851|NCT03653507|447776868|FG000|Overall Study|Adverse Event|34|||
124497852|NCT03653507|447776869|FG001|Overall Study|Adverse Event|15|||
124497853|NCT00392171|447776870|FG000|Overall Study|Did not meet inclusion criteria|4|||
124497854|NCT00392171|447776870|FG000|Overall Study|Disease progression|101|||
124497855|NCT01605071|447776871|FG000|Overall Study|Withdrawal by Subject|3|||
124497856|NCT01605071|447776872|FG001|Overall Study|Withdrawal by Subject|2|||
124497857|NCT03470922|447776874|FG000|Overall Study|Death|107|||
124497858|NCT03470922|447776875|FG001|Overall Study|Death|118|||
124497859|NCT03470922|447776874|FG000|Overall Study|Lost to Follow-up|5|||
124497860|NCT03470922|447776875|FG001|Overall Study|Lost to Follow-up|5|||
124497861|NCT03470922|447776874|FG000|Overall Study|Participant Withdrew Consent|4|||
124497862|NCT03470922|447776875|FG001|Overall Study|Participant Withdrew Consent|9|||
124497863|NCT03470922|447776874|FG000|Overall Study|Other reasons|1|||
124497864|NCT03470922|447776875|FG001|Overall Study|Other reasons|0|||
124497865|NCT03470922|447776874|FG000|Overall Study|Not reported|1|||
124497866|NCT03470922|447776875|FG001|Overall Study|Not reported|0|||
124497867|NCT02340819|447776876|FG000|Overall Study|Adverse Event|1|||
124497868|NCT02340819|447776876|FG000|Overall Study|Withdrawal by Subject|2|||
124497869|NCT02340819|447776876|FG000|Overall Study|Discontinued with other reason|1|||
124774009|NCT00463567|448802776|FG006|Overall Study|Withdrawal by Subject|1|||
124497870|NCT02361762|447776877|FG000|Overall Study|Withdrawal by Subject|0|||
124497871|NCT02361762|447776878|FG001|Overall Study|Withdrawal by Subject|1|||
124497872|NCT02361762|447776877|FG000|Overall Study|Lost to Follow-up|0|||
124497873|NCT02361762|447776878|FG001|Overall Study|Lost to Follow-up|1|||
124774010|NCT00463567|448802770|FG000|Overall Study|Protocol Deviation|13|||
124774011|NCT00463567|448802771|FG001|Overall Study|Protocol Deviation|9|||
124774012|NCT00463567|448802772|FG002|Overall Study|Protocol Deviation|14|||
124497874|NCT04907539|447776879|FG000|Overall Study|Consent withdrawn|1|||
124497875|NCT04907539|447776880|FG001|Overall Study|Consent withdrawn|0|||
124774013|NCT00463567|448802773|FG003|Overall Study|Protocol Deviation|11|||
124497876|NCT04907539|447776879|FG000|Overall Study|Death|14|||
124497877|NCT04907539|447776880|FG001|Overall Study|Death|3|||
124497878|NCT01881620|447776881|FG000|Overall Study|Protocol Violation|4|||
124497879|NCT04467164|447776885|FG000|Washout (1 Week)|Lost to Follow-up|2|||
124497880|NCT04467164|447776886|FG001|Washout (1 Week)|Lost to Follow-up|0|||
124497881|NCT01701583|447776889|FG000|Overall Study|Withdrawal by Subject|2|||
124497882|NCT01701583|447776890|FG001|Overall Study|Withdrawal by Subject|0|||
124497883|NCT01441440|447776891|FG000|Overall Study|Death|1|||
124497884|NCT01441440|447776892|FG001|Overall Study|Death|0|||
124497885|NCT01441440|447776893|FG002|Overall Study|Death|1|||
124497886|NCT01441440|447776891|FG000|Overall Study|Adverse Event|2|||
124497887|NCT01441440|447776892|FG001|Overall Study|Adverse Event|9|||
124497888|NCT01441440|447776893|FG002|Overall Study|Adverse Event|9|||
124497889|NCT01441440|447776891|FG000|Overall Study|Lost to Follow-up|0|||
124497890|NCT01441440|447776892|FG001|Overall Study|Lost to Follow-up|2|||
124497891|NCT01441440|447776893|FG002|Overall Study|Lost to Follow-up|1|||
124497892|NCT01441440|447776891|FG000|Overall Study|Withdrawal by Subject|11|||
124497893|NCT01441440|447776892|FG001|Overall Study|Withdrawal by Subject|9|||
124497894|NCT01441440|447776893|FG002|Overall Study|Withdrawal by Subject|9|||
124497895|NCT01441440|447776891|FG000|Overall Study|Pregnancy|1|||
124497896|NCT01441440|447776892|FG001|Overall Study|Pregnancy|0|||
124497897|NCT01441440|447776893|FG002|Overall Study|Pregnancy|0|||
124558764|NCT01827371|448003366|FG003|Overall Study|Lost to Follow-up|4|||
124558765|NCT01827371|448003363|FG000|Overall Study|Protocol Violation|1|||
124558766|NCT01827371|448003364|FG001|Overall Study|Protocol Violation|0|||
124558767|NCT01827371|448003365|FG002|Overall Study|Protocol Violation|0|||
124558768|NCT01827371|448003366|FG003|Overall Study|Protocol Violation|0|||
124558769|NCT01827371|448003363|FG000|Overall Study|Withdrawal by Subject|1|||
124558770|NCT01827371|448003364|FG001|Overall Study|Withdrawal by Subject|2|||
124558771|NCT01827371|448003365|FG002|Overall Study|Withdrawal by Subject|2|||
124558772|NCT01827371|448003366|FG003|Overall Study|Withdrawal by Subject|3|||
124558773|NCT01827371|448003363|FG000|Overall Study|Physician Decision|0|||
124558774|NCT01827371|448003364|FG001|Overall Study|Physician Decision|1|||
124558775|NCT01827371|448003365|FG002|Overall Study|Physician Decision|0|||
124558776|NCT01827371|448003366|FG003|Overall Study|Physician Decision|1|||
124558777|NCT01827371|448003363|FG000|Overall Study|Temporary study halt to vaccinations|11|||
124558778|NCT01827371|448003364|FG001|Overall Study|Temporary study halt to vaccinations|2|||
124558779|NCT01827371|448003365|FG002|Overall Study|Temporary study halt to vaccinations|5|||
124558780|NCT01827371|448003366|FG003|Overall Study|Temporary study halt to vaccinations|13|||
124558781|NCT01361607|448003369|FG000|Overall Study|Adverse Event|38|||
124558782|NCT01361607|448003370|FG001|Overall Study|Adverse Event|29|||
124558783|NCT01361607|448003369|FG000|Overall Study|Withdrawal by Subject|19|||
124558784|NCT01361607|448003370|FG001|Overall Study|Withdrawal by Subject|8|||
124558785|NCT01361607|448003369|FG000|Overall Study|Withdrawal by Investigator|5|||
124558786|NCT01361607|448003370|FG001|Overall Study|Withdrawal by Investigator|3|||
124558787|NCT01361607|448003369|FG000|Overall Study|Lost to Follow-up|1|||
124558788|NCT01361607|448003370|FG001|Overall Study|Lost to Follow-up|0|||
124558789|NCT01361607|448003369|FG000|Overall Study|Met Withdrawal Criteria|1|||
124558790|NCT01361607|448003370|FG001|Overall Study|Met Withdrawal Criteria|1|||
124558791|NCT01814137|448003371|FG000|Overall Study|Adverse Event|0|||
124558792|NCT01814137|448003372|FG001|Overall Study|Adverse Event|1|||
124558793|NCT01814137|448003371|FG000|Overall Study|Withdrawal by Subject|2|||
124558794|NCT01814137|448003372|FG001|Overall Study|Withdrawal by Subject|2|||
124558795|NCT01814137|448003371|FG000|Overall Study|Physician Decision|1|||
124558796|NCT01814137|448003372|FG001|Overall Study|Physician Decision|1|||
124558797|NCT01814137|448003371|FG000|Overall Study|Unclassified|2|||
124558798|NCT01814137|448003372|FG001|Overall Study|Unclassified|1|||
124497898|NCT01441440|447776891|FG000|Overall Study|Lack of Efficacy|1|||
124497899|NCT01441440|447776892|FG001|Overall Study|Lack of Efficacy|0|||
124558799|NCT00219557|448003373|FG000|Phase 1|Lack of Efficacy|3|||
124558800|NCT00219557|448003374|FG001|Phase 1|Lack of Efficacy|0|||
124558801|NCT00219557|448003375|FG002|Phase 1|Lack of Efficacy|0|||
124558802|NCT00219557|448003373|FG000|Phase 1|Adverse Event|2|||
124558803|NCT00219557|448003374|FG001|Phase 1|Adverse Event|0|||
124558804|NCT00219557|448003375|FG002|Phase 1|Adverse Event|0|||
124558805|NCT00219557|448003373|FG000|Phase 1|Withdrawal by Subject|1|||
124558806|NCT00219557|448003374|FG001|Phase 1|Withdrawal by Subject|0|||
124558807|NCT00219557|448003375|FG002|Phase 1|Withdrawal by Subject|0|||
124497900|NCT01441440|447776893|FG002|Overall Study|Lack of Efficacy|1|||
124497901|NCT01441440|447776891|FG000|Overall Study|Moving|0|||
124497902|NCT01441440|447776892|FG001|Overall Study|Moving|1|||
124497903|NCT01441440|447776893|FG002|Overall Study|Moving|1|||
124497904|NCT01441440|447776891|FG000|Overall Study|Work-related matter|0|||
124497905|NCT01441440|447776892|FG001|Overall Study|Work-related matter|1|||
124497906|NCT01441440|447776893|FG002|Overall Study|Work-related matter|0|||
124497907|NCT01441440|447776891|FG000|Overall Study|Difficllty in keeping the schedule|1|||
124497908|NCT01441440|447776892|FG001|Overall Study|Difficllty in keeping the schedule|1|||
124558808|NCT00219557|448003373|FG000|Phase 1|Started chemotherapy at other institute|1|||
124497909|NCT01441440|447776893|FG002|Overall Study|Difficllty in keeping the schedule|0|||
124497910|NCT02750813|447776899|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
124497911|NCT02750813|447776900|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
124497912|NCT02750813|447776899|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
124497913|NCT02750813|447776900|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
124497914|NCT03276936|447776901|FG000|Overall Study|Adverse Event|4|||
124497915|NCT03276936|447776902|FG001|Overall Study|Adverse Event|2|||
124497916|NCT03276936|447776901|FG000|Overall Study|Lost to Follow-up|16|||
124497917|NCT03276936|447776902|FG001|Overall Study|Lost to Follow-up|13|||
124497918|NCT03276936|447776901|FG000|Overall Study|Withdrawal by Subject|30|||
124497919|NCT03276936|447776902|FG001|Overall Study|Withdrawal by Subject|20|||
124497920|NCT03276936|447776901|FG000|Overall Study|Not mentioned|6|||
124497921|NCT03276936|447776902|FG001|Overall Study|Not mentioned|3|||
124497922|NCT01798134|447776903|FG000|Overall Study|Lost to Follow-up|1|||
124497923|NCT01798134|447776903|FG000|Overall Study|Withdrawal by Subject|3|||
124497924|NCT01798134|447776903|FG000|Overall Study|Death|2|||
124497925|NCT01798134|447776903|FG000|Overall Study|Adverse Event|3|||
124497926|NCT01798134|447776903|FG000|Overall Study|Physician Decision|3|||
124497927|NCT01798134|447776903|FG000|Overall Study|Liver transplant/surgery|4|||
124497928|NCT00625365|447776904|FG000|Overall Study|Withdrawal by Subject|1|||
124497929|NCT00625365|447776904|FG000|Overall Study|No IV access|5|||
124497930|NCT00625365|447776904|FG000|Overall Study|VSD|1|||
124497931|NCT02245568|447776905|FG000|Overall Study|Study terminated by Sponsor|346|||
124497932|NCT02245568|447776905|FG000|Overall Study|Adverse Event|144|||
124497933|NCT02245568|447776905|FG000|Overall Study|Lack of Efficacy|98|||
124497934|NCT02245568|447776905|FG000|Overall Study|Withdrawal by Caregiver|85|||
124497935|NCT02245568|447776905|FG000|Overall Study|Withdrawal by Subject|77|||
124497936|NCT02245568|447776905|FG000|Overall Study|Withdrawal by Legal Representative|31|||
124497937|NCT02245568|447776905|FG000|Overall Study|Missing (Site closure)|16|||
124497938|NCT02245568|447776905|FG000|Overall Study|Physician Decision|14|||
124497939|NCT02245568|447776905|FG000|Overall Study|Non-compliance with study drug|11|||
124497940|NCT02245568|447776905|FG000|Overall Study|Death|9|||
124497941|NCT02245568|447776905|FG000|Overall Study|Blue staining|6|||
124497942|NCT02245568|447776905|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
124497943|NCT02245568|447776905|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
124497944|NCT02245568|447776905|FG000|Overall Study|Lost to Follow-up|5|||
124497945|NCT00366548|447776906|FG000|Infant Series|Adverse Event|1|||
124497946|NCT00366548|447776907|FG001|Infant Series|Adverse Event|3|||
124497947|NCT00366548|447776906|FG000|Infant Series|Protocol Violation|0|||
124497948|NCT00366548|447776907|FG001|Infant Series|Protocol Violation|1|||
124558809|NCT00219557|448003374|FG001|Phase 1|Started chemotherapy at other institute|0|||
124558810|NCT00219557|448003375|FG002|Phase 1|Started chemotherapy at other institute|0|||
124558811|NCT00219557|448003373|FG000|Phase 2|Lack of Efficacy|0|||
124558812|NCT00219557|448003374|FG001|Phase 2|Lack of Efficacy|21|||
124558813|NCT00219557|448003375|FG002|Phase 2|Lack of Efficacy|15|||
124558814|NCT00219557|448003373|FG000|Phase 2|Adverse Event|0|||
124558815|NCT00219557|448003374|FG001|Phase 2|Adverse Event|22|||
124558816|NCT00219557|448003375|FG002|Phase 2|Adverse Event|2|||
124558817|NCT00219557|448003373|FG000|Phase 2|Death|0|||
124558818|NCT00219557|448003374|FG001|Phase 2|Death|8|||
124558819|NCT00219557|448003375|FG002|Phase 2|Death|2|||
124558820|NCT00219557|448003373|FG000|Phase 2|Other|0|||
124774014|NCT00463567|448802774|FG004|Overall Study|Protocol Deviation|1|||
124774015|NCT00463567|448802775|FG005|Overall Study|Protocol Deviation|1|||
124774016|NCT00463567|448802776|FG006|Overall Study|Protocol Deviation|2|||
124774017|NCT00463567|448802770|FG000|Overall Study|Lost to Follow-up|12|||
124774018|NCT00463567|448802771|FG001|Overall Study|Lost to Follow-up|6|||
124774019|NCT00463567|448802772|FG002|Overall Study|Lost to Follow-up|13|||
124774020|NCT00463567|448802773|FG003|Overall Study|Lost to Follow-up|8|||
124774021|NCT00463567|448802774|FG004|Overall Study|Lost to Follow-up|1|||
124774022|NCT00463567|448802775|FG005|Overall Study|Lost to Follow-up|1|||
124558821|NCT00219557|448003374|FG001|Phase 2|Other|8|||
124558822|NCT00219557|448003375|FG002|Phase 2|Other|6|||
124558823|NCT00219557|448003373|FG000|Phase 2|Withdrawal by Subject|0|||
124774023|NCT00463567|448802776|FG006|Overall Study|Lost to Follow-up|1|||
124774024|NCT00463567|448802770|FG000|Overall Study|Administrative problems|5|||
124497949|NCT00366548|447776906|FG000|Infant Series|Withdrawal by Subject|3|||
124558824|NCT00219557|448003374|FG001|Phase 2|Withdrawal by Subject|9|||
124497950|NCT00366548|447776907|FG001|Infant Series|Withdrawal by Subject|1|||
124497951|NCT00366548|447776906|FG000|After Infant Series|Withdrawal by Subject|3|||
124558825|NCT00219557|448003375|FG002|Phase 2|Withdrawal by Subject|5|||
124774025|NCT00463567|448802771|FG001|Overall Study|Administrative problems|3|||
124497952|NCT00366548|447776907|FG001|After Infant Series|Withdrawal by Subject|1|||
124497953|NCT00366548|447776906|FG000|After Infant Series|Adverse Event|2|||
124497954|NCT00366548|447776907|FG001|After Infant Series|Adverse Event|0|||
124497955|NCT00366548|447776906|FG000|After Infant Series|Lost to Follow-up|1|||
124497956|NCT00366548|447776907|FG001|After Infant Series|Lost to Follow-up|0|||
124558826|NCT00219557|448003373|FG000|Phase 2|Treatment not received|0|||
124558827|NCT00219557|448003374|FG001|Phase 2|Treatment not received|1|||
124774026|NCT00463567|448802772|FG002|Overall Study|Administrative problems|6|||
124774027|NCT00463567|448802773|FG003|Overall Study|Administrative problems|9|||
124558828|NCT00219557|448003375|FG002|Phase 2|Treatment not received|3|||
124558829|NCT01427803|448003380|FG000|Overall Study|Lost to Follow-up|32|||
124558830|NCT01427803|448003381|FG001|Overall Study|Lost to Follow-up|26|||
124558831|NCT01427803|448003380|FG000|Overall Study|Withdrawal by Subject|20|||
124558832|NCT01427803|448003381|FG001|Overall Study|Withdrawal by Subject|0|||
124558833|NCT01427803|448003380|FG000|Overall Study|Unable to complete full treatment period|6|||
124558834|NCT01427803|448003381|FG001|Overall Study|Unable to complete full treatment period|0|||
124558835|NCT01427803|448003380|FG000|Overall Study|Protocol Violation|1|||
124558836|NCT01427803|448003381|FG001|Overall Study|Protocol Violation|0|||
124558837|NCT01427803|448003380|FG000|Overall Study|Physician Decision|3|||
124558838|NCT01427803|448003381|FG001|Overall Study|Physician Decision|0|||
124558839|NCT01427803|448003380|FG000|Overall Study|did not take product|1|||
124558840|NCT01427803|448003381|FG001|Overall Study|did not take product|0|||
124558841|NCT03412019|448003382|FG000|Overall Study|Withdrawal by Subject|1|||
124558842|NCT03412019|448003383|FG001|Overall Study|Withdrawal by Subject|1|||
124558843|NCT01023269|448003384|FG000|Overall Study|early termination of the study|2|||
124558844|NCT01023269|448003385|FG001|Overall Study|early termination of the study|0|||
124558845|NCT00947011|448003387|FG000|Overall Study|Study was terminated,PI left institution|12|||
124558846|NCT00814658|448003388|FG000|Overall Study|Lost to Follow-up|0|||
124558847|NCT00814658|448003389|FG001|Overall Study|Lost to Follow-up|1|||
124558848|NCT00814658|448003388|FG000|Overall Study|Physician Decision|1|||
124558849|NCT00814658|448003389|FG001|Overall Study|Physician Decision|0|||
124558850|NCT00814658|448003388|FG000|Overall Study|Adverse Event|3|||
124497957|NCT01252134|447776908|FG000|Period 1, 8 Hours|Personal Reasons|0|||
124497958|NCT01252134|447776909|FG001|Period 1, 8 Hours|Personal Reasons|1|||
124497959|NCT01252134|447776910|FG002|Period 1, 8 Hours|Personal Reasons|1|||
124497960|NCT01252134|447776911|FG003|Period 1, 8 Hours|Personal Reasons|0|||
124497961|NCT01252134|447776912|FG004|Period 1, 8 Hours|Personal Reasons|0|||
124497962|NCT01252134|447776913|FG005|Period 1, 8 Hours|Personal Reasons|0|||
124497963|NCT03650452|447776915|FG000|Overall Study|Physician Decision|1|||
124497964|NCT03650452|447776916|FG001|Overall Study|Physician Decision|0|||
124497965|NCT03650452|447776915|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
124497966|NCT03650452|447776916|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
124497967|NCT03650452|447776915|FG000|Overall Study|Adverse Event|3|||
124497968|NCT03650452|447776916|FG001|Overall Study|Adverse Event|4|||
124497969|NCT03650452|447776915|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
124497970|NCT03650452|447776916|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
124497971|NCT02273050|447776917|FG000|Overall Study|Adverse Event|4|||
124497972|NCT02273050|447776918|FG001|Overall Study|Adverse Event|3|||
124497973|NCT02273050|447776919|FG002|Overall Study|Adverse Event|3|||
124558851|NCT00814658|448003389|FG001|Overall Study|Adverse Event|3|||
124558852|NCT05266456|448003390|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
124558853|NCT05266456|448003391|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
124558854|NCT05266456|448003392|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
124558855|NCT05266456|448003393|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
124497974|NCT02273050|447776917|FG000|Overall Study|Death|0|||
124497975|NCT02273050|447776918|FG001|Overall Study|Death|0|||
124497976|NCT02273050|447776919|FG002|Overall Study|Death|1|||
124497977|NCT02273050|447776917|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
124497978|NCT02273050|447776918|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
124558856|NCT05266456|448003390|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
124558857|NCT05266456|448003391|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
124558858|NCT05266456|448003392|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
124558859|NCT05266456|448003393|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
124558860|NCT05266456|448003390|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
124558861|NCT05266456|448003391|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
124558862|NCT05266456|448003392|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
124558863|NCT05266456|448003393|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
124558864|NCT05266456|448003390|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
124558865|NCT05266456|448003391|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
124558866|NCT05266456|448003392|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
124558867|NCT05266456|448003393|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
124723818|NCT05396014|448611649|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723819|NCT05396014|448611650|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723820|NCT05396014|448611651|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723821|NCT05396014|448611652|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723822|NCT05396014|448611653|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124497979|NCT02273050|447776919|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
124497980|NCT02273050|447776917|FG000|Overall Study|Lack of Efficacy|0|||
124497981|NCT02273050|447776918|FG001|Overall Study|Lack of Efficacy|1|||
124497982|NCT02273050|447776919|FG002|Overall Study|Lack of Efficacy|1|||
124497983|NCT02273050|447776917|FG000|Overall Study|Withdrawal by Subject|17|||
124497984|NCT02273050|447776918|FG001|Overall Study|Withdrawal by Subject|14|||
124497985|NCT02273050|447776919|FG002|Overall Study|Withdrawal by Subject|16|||
124497986|NCT02273050|447776917|FG000|Overall Study|Lost to Follow-up|0|||
124497987|NCT02273050|447776918|FG001|Overall Study|Lost to Follow-up|2|||
124497988|NCT02273050|447776919|FG002|Overall Study|Lost to Follow-up|3|||
124497989|NCT02273050|447776917|FG000|Overall Study|Protocol Violation|3|||
124497990|NCT02273050|447776918|FG001|Overall Study|Protocol Violation|1|||
124497991|NCT02273050|447776919|FG002|Overall Study|Protocol Violation|4|||
124497992|NCT02297438|447776920|FG000|Overall Study|Death|79|||
124497993|NCT02297438|447776921|FG001|Overall Study|Death|86|||
124497994|NCT02297438|447776920|FG000|Overall Study|Lost to Follow-up|9|||
124497995|NCT02297438|447776921|FG001|Overall Study|Lost to Follow-up|7|||
124497996|NCT02297438|447776920|FG000|Overall Study|Withdrawal by Subject|7|||
124497997|NCT02297438|447776921|FG001|Overall Study|Withdrawal by Subject|0|||
124497998|NCT02297438|447776920|FG000|Overall Study|Other|9|||
124497999|NCT02297438|447776921|FG001|Overall Study|Other|5|||
124498000|NCT02297438|447776920|FG000|Overall Study|Ongoing|65|||
124498001|NCT02297438|447776921|FG001|Overall Study|Ongoing|73|||
124498002|NCT02042404|447776922|FG000|Overall Study|Death|1|||
124498003|NCT02042404|447776923|FG001|Overall Study|Death|0|||
124498004|NCT02042404|447776922|FG000|Overall Study|Unrelated Adverse Event|3|||
124498005|NCT02042404|447776923|FG001|Overall Study|Unrelated Adverse Event|0|||
124498006|NCT02042404|447776922|FG000|Overall Study|Inability to meet time requirements|1|||
124498007|NCT02042404|447776923|FG001|Overall Study|Inability to meet time requirements|0|||
124498008|NCT03952468|447776927|FG000|Overall Study|Death|0|||
124498009|NCT03952468|447776928|FG001|Overall Study|Death|1|||
124498010|NCT03952468|447776927|FG000|Overall Study|Adverse Event|0|||
124498011|NCT03952468|447776928|FG001|Overall Study|Adverse Event|1|||
124498012|NCT03952468|447776927|FG000|Overall Study|Physician Decision|1|||
124498013|NCT03952468|447776928|FG001|Overall Study|Physician Decision|0|||
124498014|NCT03952468|447776927|FG000|Overall Study|Lost to Follow-up|3|||
124498015|NCT03952468|447776928|FG001|Overall Study|Lost to Follow-up|4|||
124498016|NCT03952468|447776927|FG000|Overall Study|Withdrawal by Subject|2|||
124498017|NCT03952468|447776928|FG001|Overall Study|Withdrawal by Subject|1|||
124498018|NCT04075266|447776929|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
124498019|NCT04075266|447776930|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
124498020|NCT04075266|447776929|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
124498021|NCT04075266|447776930|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
124498022|NCT04742907|447776931|FG000|Overall Study|Adverse Event|1|||
124498023|NCT04742907|447776932|FG001|Overall Study|Adverse Event|0|||
124498024|NCT04742907|447776933|FG002|Overall Study|Adverse Event|1|||
124498025|NCT04742907|447776931|FG000|Overall Study|Lost to Follow-up|3|||
124498026|NCT04742907|447776932|FG001|Overall Study|Lost to Follow-up|3|||
124498027|NCT04742907|447776933|FG002|Overall Study|Lost to Follow-up|2|||
124498028|NCT04742907|447776931|FG000|Overall Study|Physician Decision|0|||
124498029|NCT04742907|447776932|FG001|Overall Study|Physician Decision|1|||
124498030|NCT04742907|447776933|FG002|Overall Study|Physician Decision|0|||
124498031|NCT04742907|447776931|FG000|Overall Study|Protocol Violation|1|||
124498032|NCT04742907|447776932|FG001|Overall Study|Protocol Violation|1|||
124498033|NCT04742907|447776933|FG002|Overall Study|Protocol Violation|1|||
124498034|NCT04742907|447776931|FG000|Overall Study|Withdrawal by Subject|5|||
124498035|NCT04742907|447776932|FG001|Overall Study|Withdrawal by Subject|6|||
124498036|NCT04742907|447776933|FG002|Overall Study|Withdrawal by Subject|4|||
124498037|NCT04742907|447776931|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
124498038|NCT04742907|447776932|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
124498039|NCT04742907|447776933|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
124498040|NCT04742907|447776931|FG000|Overall Study|Did Not Receive the Study Drug|2|||
124498041|NCT04742907|447776932|FG001|Overall Study|Did Not Receive the Study Drug|4|||
124498042|NCT04742907|447776933|FG002|Overall Study|Did Not Receive the Study Drug|4|||
124498043|NCT02280291|447776934|FG000|Overall Study|Lost to Follow-up|2|||
124498044|NCT02280291|447776935|FG001|Overall Study|Lost to Follow-up|1|||
124498045|NCT02280291|447776936|FG002|Overall Study|Lost to Follow-up|3|||
124498046|NCT02280291|447776937|FG003|Overall Study|Lost to Follow-up|8|||
124498047|NCT02280291|447776934|FG000|Overall Study|Protocol Violation|1|||
124498048|NCT02280291|447776935|FG001|Overall Study|Protocol Violation|0|||
124498049|NCT02280291|447776936|FG002|Overall Study|Protocol Violation|0|||
124498050|NCT02280291|447776937|FG003|Overall Study|Protocol Violation|0|||
124498051|NCT02280291|447776934|FG000|Overall Study|Other|1|||
124498052|NCT02280291|447776935|FG001|Overall Study|Other|1|||
124498053|NCT02280291|447776936|FG002|Overall Study|Other|0|||
124498054|NCT02280291|447776937|FG003|Overall Study|Other|0|||
124498055|NCT03508622|447776938|FG000|Overall Study|Protocol Violation|1|||
124498056|NCT03508622|447776939|FG001|Overall Study|Protocol Violation|0|||
124498057|NCT03508622|447776938|FG000|Overall Study|Withdrawal by Subject|1|||
124498058|NCT03508622|447776939|FG001|Overall Study|Withdrawal by Subject|0|||
124498059|NCT03508622|447776938|FG000|Overall Study|Lost to Follow-up|16|||
124498060|NCT03508622|447776939|FG001|Overall Study|Lost to Follow-up|0|||
124498061|NCT03508622|447776938|FG000|Overall Study|Incomplete data|0|||
124498062|NCT03508622|447776939|FG001|Overall Study|Incomplete data|24|||
124774028|NCT00463567|448802774|FG004|Overall Study|Administrative problems|3|||
124774029|NCT00463567|448802775|FG005|Overall Study|Administrative problems|2|||
124774030|NCT00463567|448802776|FG006|Overall Study|Administrative problems|2|||
124774031|NCT00463567|448802770|FG000|Overall Study|Lack of Efficacy|4|||
124774032|NCT00463567|448802771|FG001|Overall Study|Lack of Efficacy|9|||
124774033|NCT00463567|448802772|FG002|Overall Study|Lack of Efficacy|9|||
124774034|NCT00463567|448802773|FG003|Overall Study|Lack of Efficacy|17|||
124774035|NCT00463567|448802774|FG004|Overall Study|Lack of Efficacy|1|||
124774036|NCT00463567|448802775|FG005|Overall Study|Lack of Efficacy|0|||
124774037|NCT00463567|448802776|FG006|Overall Study|Lack of Efficacy|1|||
124774038|NCT00463567|448802770|FG000|Overall Study|Abnormal lab value(s)|1|||
124774039|NCT00463567|448802771|FG001|Overall Study|Abnormal lab value(s)|1|||
124774040|NCT00463567|448802772|FG002|Overall Study|Abnormal lab value(s)|2|||
124774041|NCT00463567|448802773|FG003|Overall Study|Abnormal lab value(s)|1|||
124774042|NCT00463567|448802774|FG004|Overall Study|Abnormal lab value(s)|1|||
124774043|NCT00463567|448802775|FG005|Overall Study|Abnormal lab value(s)|0|||
124774044|NCT00463567|448802776|FG006|Overall Study|Abnormal lab value(s)|0|||
124774045|NCT00463567|448802770|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124774046|NCT00463567|448802771|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124774047|NCT00463567|448802772|FG002|Overall Study|Abnormal test procedure result(s)|6|||
124774048|NCT00463567|448802773|FG003|Overall Study|Abnormal test procedure result(s)|2|||
124498063|NCT00210158|447776941|FG000|Overall Study|Protocol Violation|0|||
124498064|NCT00210158|447776942|FG001|Overall Study|Protocol Violation|2|||
124498065|NCT04716933|447776943|FG000|Overall Study|Sponsor Decision|36|||
124498066|NCT04716933|447776944|FG001|Overall Study|Sponsor Decision|33|||
124498067|NCT04716933|447776943|FG000|Overall Study|Death|65|||
124498068|NCT04716933|447776944|FG001|Overall Study|Death|67|||
124498069|NCT03196505|447776947|FG000|Overall Study|Physician Decision|26|||
124498070|NCT03196505|447776948|FG001|Overall Study|Physician Decision|26|||
124498071|NCT04430738|447776949|FG000|Phase 1: Dose Escalation|Death|1|||
124498072|NCT04430738|447776950|FG001|Phase 1: Dose Escalation|Death|4|||
124498073|NCT04430738|447776951|FG002|Phase 1: Dose Escalation|Death|4|||
124498074|NCT04430738|447776952|FG003|Phase 1: Dose Escalation|Death|1|||
124558868|NCT05266456|448003390|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
124774049|NCT00463567|448802774|FG004|Overall Study|Abnormal test procedure result(s)|0|||
124498075|NCT04430738|447776953|FG004|Phase 1: Dose Escalation|Death|6|||
124498076|NCT04430738|447776954|FG005|Phase 1: Dose Escalation|Death|0|||
124498077|NCT04430738|447776949|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
124498078|NCT04430738|447776950|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
124498079|NCT04430738|447776951|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
124498080|NCT04430738|447776952|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
124498081|NCT04430738|447776953|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
124498082|NCT04430738|447776954|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
124498083|NCT04430738|447776949|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
124498084|NCT04430738|447776950|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
124498085|NCT04430738|447776951|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
124498086|NCT04430738|447776952|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
124498087|NCT04430738|447776953|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
124498088|NCT04430738|447776954|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
124498089|NCT04430738|447776949|FG000|Phase 1: Dose Escalation|Other|1|||
124498090|NCT04430738|447776950|FG001|Phase 1: Dose Escalation|Other|0|||
124498091|NCT04430738|447776951|FG002|Phase 1: Dose Escalation|Other|0|||
124498092|NCT04430738|447776952|FG003|Phase 1: Dose Escalation|Other|0|||
124498093|NCT04430738|447776953|FG004|Phase 1: Dose Escalation|Other|0|||
124498094|NCT04430738|447776954|FG005|Phase 1: Dose Escalation|Other|0|||
124498095|NCT04430738|447776949|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
124498096|NCT04430738|447776950|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
124498097|NCT04430738|447776951|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
124498098|NCT04430738|447776952|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
124498099|NCT04430738|447776953|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
124498100|NCT04430738|447776954|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
124498101|NCT04430738|447776949|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
124498102|NCT04430738|447776950|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
124498103|NCT04430738|447776951|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
124498104|NCT04430738|447776952|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
124498105|NCT04430738|447776953|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
124498106|NCT04430738|447776954|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
124498107|NCT05187013|447776955|FG000|Overall Study|Withdrawal by Subject|1|||
124774050|NCT00463567|448802775|FG005|Overall Study|Abnormal test procedure result(s)|2|||
124774051|NCT00463567|448802776|FG006|Overall Study|Abnormal test procedure result(s)|0|||
124774052|NCT00463567|448802770|FG000|Overall Study|Death|1|||
124774053|NCT00463567|448802771|FG001|Overall Study|Death|0|||
124498108|NCT05187013|447776956|FG001|Overall Study|Withdrawal by Subject|1|||
124498109|NCT05187013|447776957|FG002|Overall Study|Withdrawal by Subject|0|||
124498110|NCT05187013|447776955|FG000|Overall Study|Death|0|||
124498111|NCT05187013|447776956|FG001|Overall Study|Death|1|||
124498112|NCT05187013|447776957|FG002|Overall Study|Death|0|||
124498113|NCT05187013|447776955|FG000|Overall Study|Lost to Follow-up|20|||
124498114|NCT05187013|447776956|FG001|Overall Study|Lost to Follow-up|17|||
124498115|NCT05187013|447776957|FG002|Overall Study|Lost to Follow-up|0|||
124498116|NCT05187013|447776955|FG000|Overall Study|Ongoing Participants|3|||
124498117|NCT05187013|447776956|FG001|Overall Study|Ongoing Participants|5|||
124498118|NCT05187013|447776957|FG002|Overall Study|Ongoing Participants|0|||
124498119|NCT04488822|447776958|FG000|Overall Study|Adverse Event|8|||
124498120|NCT04488822|447776958|FG000|Overall Study|Withdrawal by Subject|1|||
124498121|NCT03838367|447776959|FG000|Overall Study|Early termination of study|3|||
124498122|NCT03838367|447776960|FG001|Overall Study|Early termination of study|4|||
124498123|NCT03838367|447776961|FG002|Overall Study|Early termination of study|3|||
124498124|NCT03838367|447776962|FG003|Overall Study|Early termination of study|0|||
124498125|NCT03406104|447776963|FG000|Overall Study|Lost to Follow-up|2|||
124498126|NCT03406104|447776963|FG000|Overall Study|Withdrawal by Subject|2|||
124498127|NCT03406104|447776963|FG000|Overall Study|due to Covid patient did not want to travel|1|||
124498128|NCT03406104|447776963|FG000|Overall Study|Death|2|||
124498129|NCT02499146|447776977|FG000|Overall Study|Lost to Follow-up|1|||
124498130|NCT02499146|447776977|FG000|Overall Study|Withdrawal by Subject|1|||
124498131|NCT02499146|447776977|FG000|Overall Study|Other|2|||
124498132|NCT02499146|447776977|FG000|Overall Study|Ongoing at date of cut-off|9|||
124498133|NCT02499146|447776977|FG000|Overall Study|Began other treatment/therapy|13|||
124498134|NCT01879618|447776978|FG000|Overall Study|Does not meet entrance criteria|1|||
124498135|NCT01879618|447776978|FG000|Overall Study|Withdrawal by Subject|1|||
124498136|NCT01879618|447776978|FG000|Overall Study|Surgery;changed schedule; not available|8|||
124498137|NCT01879618|447776978|FG000|Overall Study|Protocol Violation|6|||
124498138|NCT01879618|447776978|FG000|Overall Study|Adverse Event|5|||
124498139|NCT02890329|447776979|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
124498140|NCT02890329|447776980|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
124498141|NCT02890329|447776981|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
124498142|NCT02890329|447776982|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
124498143|NCT02890329|447776983|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
124498144|NCT02890329|447776984|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
124498145|NCT02890329|447776979|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
124498146|NCT02890329|447776980|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
124498147|NCT02890329|447776981|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
124498148|NCT02890329|447776982|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
124498149|NCT02890329|447776983|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
124498150|NCT02890329|447776984|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
124498151|NCT02890329|447776979|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
124498152|NCT02890329|447776980|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
124498153|NCT02890329|447776981|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
124498154|NCT02890329|447776982|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
124498155|NCT02890329|447776983|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
124498156|NCT02890329|447776984|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
124498157|NCT02890329|447776979|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
124498158|NCT02890329|447776980|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
124498159|NCT02890329|447776981|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
124498160|NCT02890329|447776982|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
124498161|NCT02890329|447776983|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
124498162|NCT02890329|447776984|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
124498163|NCT00878072|447776985|FG000|Overall Study|Withdrew consent|2|||
124498164|NCT01954121|447776986|FG000|Overall Study|Lack of Efficacy|94|||
124498165|NCT01954121|447776987|FG001|Overall Study|Lack of Efficacy|41|||
124498166|NCT01954121|447776986|FG000|Overall Study|Protocol Violation|0|||
124498167|NCT01954121|447776987|FG001|Overall Study|Protocol Violation|2|||
124498168|NCT01954121|447776986|FG000|Overall Study|Lost to Follow-up|5|||
124498169|NCT01954121|447776987|FG001|Overall Study|Lost to Follow-up|6|||
124498170|NCT01954121|447776986|FG000|Overall Study|Withdrawal by Subject|18|||
124723823|NCT05396014|448611654|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124498171|NCT01954121|447776987|FG001|Overall Study|Withdrawal by Subject|12|||
124498172|NCT01954121|447776986|FG000|Overall Study|Pregnancy|1|||
124498173|NCT01954121|447776987|FG001|Overall Study|Pregnancy|1|||
124498174|NCT01954121|447776986|FG000|Overall Study|AE, serious fatal|1|||
124498175|NCT01954121|447776987|FG001|Overall Study|AE, serious fatal|0|||
124498176|NCT01954121|447776986|FG000|Overall Study|AE, non-serious non-fatal|5|||
124498177|NCT01954121|447776987|FG001|Overall Study|AE, non-serious non-fatal|22|||
124498178|NCT01954121|447776986|FG000|Overall Study|SAE, non-fatal|1|||
124498179|NCT01954121|447776987|FG001|Overall Study|SAE, non-fatal|4|||
124498180|NCT01954121|447776986|FG000|Overall Study|Non-compliant with study procedures|1|||
124498181|NCT01954121|447776987|FG001|Overall Study|Non-compliant with study procedures|0|||
124498182|NCT01954121|447776986|FG000|Overall Study|Non-compliant patient|1|||
124498183|NCT01954121|447776987|FG001|Overall Study|Non-compliant patient|1|||
124498184|NCT01954121|447776986|FG000|Overall Study|Subject did not follow instructions|0|||
124498185|NCT01954121|447776987|FG001|Overall Study|Subject did not follow instructions|2|||
124498186|NCT01413178|447776988|FG000|Overall Study|Toxicity|1|||
124498187|NCT01413178|447776989|FG001|Overall Study|Toxicity|0|||
124498188|NCT01413178|447776988|FG000|Overall Study|Ineligible|0|||
124498189|NCT01413178|447776989|FG001|Overall Study|Ineligible|2|||
124498190|NCT04070378|447776993|FG000|Overall Study|Withdrawal by Subject|2|||
124498191|NCT04070378|447776993|FG000|Overall Study|Screen Failure|6|||
124498192|NCT04070378|447776993|FG000|Overall Study|Physician Decision|1|||
124498193|NCT04070378|447776993|FG000|Overall Study|Adverse Event|1|||
124498194|NCT03259334|447776994|FG000|Overall Study|Adverse Event|3|||
124498195|NCT03259334|447776995|FG001|Overall Study|Adverse Event|8|||
124498196|NCT03259334|447776996|FG002|Overall Study|Adverse Event|5|||
124498197|NCT03259334|447776994|FG000|Overall Study|Withdrawal by Subject|4|||
124498198|NCT03259334|447776995|FG001|Overall Study|Withdrawal by Subject|2|||
124498199|NCT03259334|447776996|FG002|Overall Study|Withdrawal by Subject|4|||
124498200|NCT03259334|447776994|FG000|Overall Study|Physician Decision|1|||
124498201|NCT03259334|447776995|FG001|Overall Study|Physician Decision|0|||
124498202|NCT03259334|447776996|FG002|Overall Study|Physician Decision|0|||
124498203|NCT03259334|447776994|FG000|Overall Study|Lost to Follow-up|0|||
124498204|NCT03259334|447776995|FG001|Overall Study|Lost to Follow-up|2|||
124498205|NCT03259334|447776996|FG002|Overall Study|Lost to Follow-up|1|||
124498206|NCT03259334|447776994|FG000|Overall Study|Protocol Deviation|0|||
124498207|NCT03259334|447776995|FG001|Overall Study|Protocol Deviation|3|||
124498208|NCT03259334|447776996|FG002|Overall Study|Protocol Deviation|2|||
124498209|NCT03259334|447776994|FG000|Overall Study|Lack of Efficacy|2|||
124498210|NCT03259334|447776995|FG001|Overall Study|Lack of Efficacy|0|||
124498211|NCT03259334|447776996|FG002|Overall Study|Lack of Efficacy|1|||
124498212|NCT03259334|447776994|FG000|Overall Study|Randomized but never treated|0|||
124498213|NCT03259334|447776995|FG001|Overall Study|Randomized but never treated|2|||
124498214|NCT03259334|447776996|FG002|Overall Study|Randomized but never treated|0|||
124498215|NCT03860844|447776997|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
124498216|NCT03860844|447776998|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
124498217|NCT03860844|447776999|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
124498218|NCT03860844|447776997|FG000|Overall Study|Progressive disease|5|||
124498219|NCT03860844|447776998|FG001|Overall Study|Progressive disease|3|||
124498220|NCT03860844|447776999|FG002|Overall Study|Progressive disease|4|||
124498221|NCT03860844|447776997|FG000|Overall Study|Other, Not related to COVID-19|0|||
124498222|NCT03860844|447776998|FG001|Overall Study|Other, Not related to COVID-19|1|||
124498223|NCT03860844|447776999|FG002|Overall Study|Other, Not related to COVID-19|0|||
124498224|NCT01678807|447777000|FG000|Overall Study|Adverse Event|4|||
124498225|NCT01678807|447777001|FG001|Overall Study|Adverse Event|4|||
124498226|NCT01678807|447777002|FG002|Overall Study|Adverse Event|0|||
124498227|NCT01678807|447777000|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
124498228|NCT01678807|447777001|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
124498229|NCT01678807|447777002|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
124723824|NCT05396014|448611655|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723825|NCT05396014|448611656|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723826|NCT05396014|448611657|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723827|NCT05396014|448611658|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723828|NCT05396014|448611659|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723829|NCT05396014|448611660|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723830|NCT05396014|448611661|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723831|NCT05396014|448611662|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723832|NCT05396014|448611663|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723833|NCT05396014|448611664|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723834|NCT05396014|448611665|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723835|NCT05396014|448611666|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723836|NCT05396014|448611667|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723837|NCT05396014|448611668|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124774054|NCT00463567|448802772|FG002|Overall Study|Death|2|||
124774055|NCT00463567|448802773|FG003|Overall Study|Death|0|||
124498230|NCT00370149|447777003|FG000|Overall Study|Physician Decision|16|||
124498231|NCT00370149|447777004|FG001|Overall Study|Physician Decision|16|||
124498232|NCT00370149|447777003|FG000|Overall Study|Protocol Violation|1|||
124498233|NCT00370149|447777004|FG001|Overall Study|Protocol Violation|0|||
124498234|NCT00370149|447777003|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
124498235|NCT00370149|447777004|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
124498236|NCT00370149|447777003|FG000|Overall Study|Pre-existing infection|0|||
124498237|NCT00370149|447777004|FG001|Overall Study|Pre-existing infection|1|||
124498238|NCT00370149|447777003|FG000|Overall Study|Antibiotic coated dressing placed|0|||
124498239|NCT00370149|447777004|FG001|Overall Study|Antibiotic coated dressing placed|1|||
124498240|NCT05306873|447778106|FG000|Stage 2|Study stopped|1|||
124498241|NCT05306873|447778107|FG001|Stage 2|Study stopped|1|||
124498242|NCT05306873|447778108|FG002|Stage 2|Study stopped|0|||
124498243|NCT05306873|447778109|FG003|Stage 2|Study stopped|0|||
124498244|NCT05306873|447778106|FG000|Stage 2|Stage 2 Treatment Failure|2|||
124498245|NCT05306873|447778107|FG001|Stage 2|Stage 2 Treatment Failure|3|||
124498246|NCT05306873|447778108|FG002|Stage 2|Stage 2 Treatment Failure|0|||
124498247|NCT05306873|447778109|FG003|Stage 2|Stage 2 Treatment Failure|0|||
124498248|NCT05306873|447778106|FG000|Stage 2|Logistical issues due to participant moving|1|||
124498249|NCT05306873|447778107|FG001|Stage 2|Logistical issues due to participant moving|0|||
124498250|NCT05306873|447778108|FG002|Stage 2|Logistical issues due to participant moving|0|||
124498251|NCT05306873|447778109|FG003|Stage 2|Logistical issues due to participant moving|0|||
124498252|NCT05306873|447778106|FG000|Stage 3|Stage 3 Treatment Failure|0|||
124498253|NCT05306873|447778107|FG001|Stage 3|Stage 3 Treatment Failure|0|||
124498254|NCT05306873|447778108|FG002|Stage 3|Stage 3 Treatment Failure|0|||
124498255|NCT05306873|447778109|FG003|Stage 3|Stage 3 Treatment Failure|1|||
124498256|NCT05306873|447778106|FG000|Stage 3|Study Stopped|0|||
124498257|NCT05306873|447778107|FG001|Stage 3|Study Stopped|0|||
124498258|NCT05306873|447778108|FG002|Stage 3|Study Stopped|1|||
124498259|NCT05306873|447778109|FG003|Stage 3|Study Stopped|0|||
124498260|NCT01286272|447778110|FG000|Overall Study|Ineligible after beginning treatment|1|||
124498261|NCT01286272|447778111|FG001|Overall Study|Ineligible after beginning treatment|3|||
124498262|NCT03625986|447778120|FG000|Randomization Period|Lost to Follow-up|7|||
124498263|NCT03625986|447778121|FG001|Randomization Period|Lost to Follow-up|12|||
124498264|NCT03625986|447778120|FG000|Randomization Period|Withdrawal by Subject|10|||
124498265|NCT03625986|447778121|FG001|Randomization Period|Withdrawal by Subject|6|||
124498266|NCT00620321|447778123|FG000|Overall Study|Adverse Event|1|||
124498267|NCT00620321|447778124|FG001|Overall Study|Adverse Event|1|||
124498268|NCT00620321|447778123|FG000|Overall Study|Death|1|||
124498269|NCT00620321|447778124|FG001|Overall Study|Death|1|||
124498270|NCT00620321|447778123|FG000|Overall Study|Physician Decision|0|||
124498271|NCT00620321|447778124|FG001|Overall Study|Physician Decision|7|||
124498272|NCT00620321|447778123|FG000|Overall Study|Progressive Disease|5|||
124498273|NCT00620321|447778124|FG001|Overall Study|Progressive Disease|5|||
124498274|NCT00620321|447778123|FG000|Overall Study|Sponsor Decision|0|||
124498275|NCT00620321|447778124|FG001|Overall Study|Sponsor Decision|1|||
124498276|NCT00620321|447778123|FG000|Overall Study|Withdrawal by Subject|1|||
124498277|NCT00620321|447778124|FG001|Overall Study|Withdrawal by Subject|1|||
124498278|NCT04191967|447778125|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
124498279|NCT04191967|447778125|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
124498280|NCT01431144|447778126|FG000|Overall Study|Implant mobility and removal|2|||
124498281|NCT01431144|447778127|FG001|Overall Study|Implant mobility and removal|0|||
124498282|NCT02410902|447778133|FG000|Overall Study|Adverse Event|2|||
124498283|NCT02410902|447778134|FG001|Overall Study|Adverse Event|3|||
124498284|NCT02410902|447778133|FG000|Overall Study|Lost to Follow-up|4|||
124498285|NCT02410902|447778134|FG001|Overall Study|Lost to Follow-up|1|||
124498286|NCT02410902|447778133|FG000|Overall Study|Protocol Violation|1|||
124498287|NCT02410902|447778134|FG001|Overall Study|Protocol Violation|4|||
124498288|NCT02410902|447778133|FG000|Overall Study|Withdrawal by Subject|6|||
124498289|NCT02410902|447778134|FG001|Overall Study|Withdrawal by Subject|8|||
124498290|NCT02410902|447778133|FG000|Overall Study|Non-Compliance|8|||
124498291|NCT02410902|447778134|FG001|Overall Study|Non-Compliance|2|||
124498292|NCT00953043|447778135|FG000|Overall Study|Withdrawal by Subject|4|||
124498293|NCT00953043|447778136|FG001|Overall Study|Withdrawal by Subject|0|||
124498294|NCT00953043|447778135|FG000|Overall Study|Physician Decision|0|||
124498295|NCT00953043|447778136|FG001|Overall Study|Physician Decision|2|||
124498296|NCT00701727|447778138|FG000|First Treatment Period|Adverse Event|0|||
124498297|NCT00701727|447778139|FG001|First Treatment Period|Adverse Event|0|||
124498298|NCT00701727|447778138|FG000|First Treatment Period|Withdrawal by Subject|1|||
124498299|NCT00701727|447778139|FG001|First Treatment Period|Withdrawal by Subject|0|||
124498300|NCT00701727|447778138|FG000|First Treatment Period|sponsor decision|0|||
124498301|NCT00701727|447778139|FG001|First Treatment Period|sponsor decision|1|||
124498302|NCT00701727|447778138|FG000|First Treatment Period|Lost to Follow-up|0|||
124498303|NCT00701727|447778139|FG001|First Treatment Period|Lost to Follow-up|1|||
124498304|NCT00701727|447778138|FG000|Second Treatment Period|Withdrawal by Subject|2|||
124498305|NCT00701727|447778139|FG001|Second Treatment Period|Withdrawal by Subject|0|||
124498306|NCT05113953|447778142|FG000|Overall Study|Adverse Event|5|||
124498307|NCT05113953|447778143|FG001|Overall Study|Adverse Event|0|||
124498308|NCT05113953|447778144|FG002|Overall Study|Adverse Event|3|||
124498309|NCT05113953|447778142|FG000|Overall Study|Lost to Follow-up|3|||
124498310|NCT05113953|447778143|FG001|Overall Study|Lost to Follow-up|4|||
124498311|NCT05113953|447778144|FG002|Overall Study|Lost to Follow-up|2|||
124558869|NCT05266456|448003391|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
124723838|NCT05396014|448611669|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723839|NCT05396014|448611670|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723840|NCT05396014|448611671|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
124723841|NCT05396014|448611672|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723842|NCT05396014|448611673|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723843|NCT05396014|448611674|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723844|NCT05396014|448611675|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723845|NCT05396014|448611676|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723846|NCT05396014|448611677|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723847|NCT05396014|448611678|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723848|NCT05396014|448611679|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723849|NCT05396014|448611680|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723850|NCT05396014|448611681|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723851|NCT05396014|448611682|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723852|NCT05396014|448611683|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723853|NCT05396014|448611684|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
124723854|NCT05396014|448611685|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723855|NCT05396014|448611686|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723856|NCT05396014|448611687|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
124723857|NCT05396014|448611645|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723858|NCT05396014|448611646|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723859|NCT05396014|448611647|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723860|NCT05396014|448611648|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723861|NCT05396014|448611649|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723862|NCT05396014|448611650|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723863|NCT05396014|448611651|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723864|NCT05396014|448611652|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723865|NCT05396014|448611653|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723866|NCT05396014|448611654|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723867|NCT05396014|448611655|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723868|NCT05396014|448611656|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723869|NCT05396014|448611657|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723870|NCT05396014|448611658|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723871|NCT05396014|448611659|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723872|NCT05396014|448611660|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723873|NCT05396014|448611661|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723874|NCT05396014|448611662|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723875|NCT05396014|448611663|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723876|NCT05396014|448611664|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723877|NCT05396014|448611665|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723878|NCT05396014|448611666|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723879|NCT05396014|448611667|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723880|NCT05396014|448611668|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723881|NCT05396014|448611669|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723882|NCT05396014|448611670|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124498312|NCT05113953|447778142|FG000|Overall Study|Non-compliance with Study Drug|1|||
124498313|NCT05113953|447778143|FG001|Overall Study|Non-compliance with Study Drug|0|||
124498314|NCT05113953|447778144|FG002|Overall Study|Non-compliance with Study Drug|0|||
124498315|NCT05113953|447778142|FG000|Overall Study|Withdrawal by Subject|2|||
124498316|NCT05113953|447778143|FG001|Overall Study|Withdrawal by Subject|6|||
124498317|NCT05113953|447778144|FG002|Overall Study|Withdrawal by Subject|4|||
124498318|NCT05113953|447778142|FG000|Overall Study|Reason not Specified|2|||
124498319|NCT05113953|447778143|FG001|Overall Study|Reason not Specified|0|||
124498320|NCT05113953|447778144|FG002|Overall Study|Reason not Specified|0|||
124498321|NCT03395197|447778145|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
124498322|NCT03395197|447778146|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
124498323|NCT03395197|447778147|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
124498324|NCT03395197|447778148|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
124498325|NCT03395197|447778149|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
124498326|NCT03395197|447778150|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
124498327|NCT03395197|447778145|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
124558870|NCT05266456|448003392|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
124723883|NCT05396014|448611671|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
124498328|NCT03395197|447778146|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
124498329|NCT03395197|447778147|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
124498330|NCT03395197|447778148|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
124498331|NCT03395197|447778149|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
124498332|NCT03395197|447778150|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
124498333|NCT03395197|447778145|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
124498334|NCT03395197|447778146|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
124498335|NCT03395197|447778147|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
124498336|NCT03395197|447778148|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
124498337|NCT03395197|447778149|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
124498338|NCT03395197|447778150|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
124498339|NCT03395197|447778145|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
124498340|NCT03395197|447778146|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
124498341|NCT03395197|447778147|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
124498342|NCT03395197|447778148|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
124498343|NCT03395197|447778149|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
124498344|NCT03395197|447778150|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
124498345|NCT03395197|447778145|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
124498346|NCT03395197|447778146|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
124498347|NCT03395197|447778147|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
124498348|NCT03395197|447778148|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
124498349|NCT03395197|447778149|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
124498350|NCT03395197|447778150|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
124498351|NCT03395197|447778145|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
124498352|NCT03395197|447778146|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
124498353|NCT03395197|447778147|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
124498354|NCT03395197|447778148|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
124498355|NCT03395197|447778149|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
124498356|NCT03395197|447778150|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
124498357|NCT03395197|447778145|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
124498358|NCT03395197|447778146|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
124498359|NCT03395197|447778147|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
124498360|NCT03395197|447778148|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
124498361|NCT03395197|447778149|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
124498362|NCT03395197|447778150|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
124498363|NCT03395197|447778145|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
124498364|NCT03395197|447778146|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
124498365|NCT03395197|447778147|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
124498366|NCT03395197|447778148|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
124498367|NCT03395197|447778149|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
124498368|NCT03395197|447778150|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
124498369|NCT03395197|447778145|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
124498370|NCT03395197|447778146|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
124498371|NCT03395197|447778147|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
124498372|NCT03395197|447778148|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
124498373|NCT03395197|447778149|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
124498374|NCT03395197|447778150|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
124498375|NCT03395197|447778145|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
124498376|NCT03395197|447778146|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
124498377|NCT03395197|447778147|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
124498378|NCT03395197|447778148|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
124498379|NCT03395197|447778149|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
124498380|NCT03395197|447778150|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
124558871|NCT05266456|448003393|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
124558872|NCT01141283|448003394|FG000|Overall Study|Adverse Event|56|||
124558873|NCT01141283|448003394|FG000|Overall Study|Lost to Follow-up|4|||
124558874|NCT01141283|448003394|FG000|Overall Study|Withdrawal by Subject|14|||
124558875|NCT01141283|448003394|FG000|Overall Study|Administrative|4|||
124558876|NCT01141283|448003394|FG000|Overall Study|Lack of Efficacy|10|||
124558877|NCT00479401|448003398|FG000|Overall Study|Adverse Event|24|||
124558878|NCT00479401|448003399|FG001|Overall Study|Adverse Event|20|||
124558879|NCT00479401|448003400|FG002|Overall Study|Adverse Event|4|||
124558880|NCT00479401|448003398|FG000|Overall Study|Lack of Efficacy|2|||
124558881|NCT00479401|448003399|FG001|Overall Study|Lack of Efficacy|2|||
124774056|NCT00463567|448802774|FG004|Overall Study|Death|0|||
124774057|NCT00463567|448802775|FG005|Overall Study|Death|0|||
124723884|NCT05396014|448611672|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723885|NCT05396014|448611673|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723886|NCT05396014|448611674|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723887|NCT05396014|448611675|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723888|NCT05396014|448611676|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723889|NCT05396014|448611677|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723890|NCT05396014|448611678|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723891|NCT05396014|448611679|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723892|NCT05396014|448611680|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723893|NCT05396014|448611681|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723894|NCT05396014|448611682|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723895|NCT05396014|448611683|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723896|NCT05396014|448611684|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723897|NCT05396014|448611685|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723898|NCT05396014|448611686|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723899|NCT05396014|448611687|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
124723900|NCT05396014|448611645|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723901|NCT05396014|448611646|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723902|NCT05396014|448611647|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723903|NCT05396014|448611648|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723904|NCT05396014|448611649|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723905|NCT05396014|448611650|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723906|NCT05396014|448611651|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723907|NCT05396014|448611652|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723908|NCT05396014|448611653|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723909|NCT05396014|448611654|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723910|NCT05396014|448611655|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723911|NCT05396014|448611656|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723912|NCT05396014|448611657|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723913|NCT05396014|448611658|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
124723914|NCT05396014|448611659|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723915|NCT05396014|448611660|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723916|NCT05396014|448611661|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723917|NCT05396014|448611662|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723918|NCT05396014|448611663|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723919|NCT05396014|448611664|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723920|NCT05396014|448611665|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723921|NCT05396014|448611666|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723922|NCT05396014|448611667|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723923|NCT05396014|448611668|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723924|NCT05396014|448611669|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723925|NCT05396014|448611670|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723926|NCT05396014|448611671|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723927|NCT05396014|448611672|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723928|NCT05396014|448611673|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723929|NCT05396014|448611674|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723930|NCT05396014|448611675|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723931|NCT05396014|448611676|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723932|NCT05396014|448611677|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723933|NCT05396014|448611678|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723934|NCT05396014|448611679|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723935|NCT05396014|448611680|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723936|NCT05396014|448611681|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723937|NCT05396014|448611682|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723938|NCT05396014|448611683|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723939|NCT05396014|448611684|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723940|NCT05396014|448611685|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723941|NCT05396014|448611686|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723942|NCT05396014|448611687|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
124723943|NCT05396014|448611645|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
124723944|NCT05396014|448611646|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723945|NCT05396014|448611647|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723946|NCT05396014|448611648|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124558882|NCT00479401|448003400|FG002|Overall Study|Lack of Efficacy|4|||
124558883|NCT00479401|448003398|FG000|Overall Study|Protocol Violation|2|||
124558884|NCT00479401|448003399|FG001|Overall Study|Protocol Violation|1|||
124558885|NCT00479401|448003400|FG002|Overall Study|Protocol Violation|1|||
124558886|NCT00479401|448003398|FG000|Overall Study|Lost to Follow-up|1|||
124558887|NCT00479401|448003399|FG001|Overall Study|Lost to Follow-up|1|||
124558888|NCT00479401|448003400|FG002|Overall Study|Lost to Follow-up|1|||
124558889|NCT00479401|448003398|FG000|Overall Study|Withdrawal by Subject|16|||
124558890|NCT00479401|448003399|FG001|Overall Study|Withdrawal by Subject|10|||
124558891|NCT00479401|448003400|FG002|Overall Study|Withdrawal by Subject|2|||
124558892|NCT00479401|448003398|FG000|Overall Study|Exclusion criteria, relocation|4|||
124558893|NCT00479401|448003399|FG001|Overall Study|Exclusion criteria, relocation|3|||
124558894|NCT00479401|448003400|FG002|Overall Study|Exclusion criteria, relocation|0|||
124558895|NCT01571635|448003403|FG000|Overall Study|Adverse Event|3|||
124558896|NCT01571635|448003404|FG001|Overall Study|Adverse Event|0|||
124558897|NCT01571635|448003405|FG002|Overall Study|Adverse Event|2|||
124558898|NCT01571635|448003406|FG003|Overall Study|Adverse Event|3|||
124558899|NCT01571635|448003407|FG004|Overall Study|Adverse Event|5|||
124558900|NCT01571635|448003403|FG000|Overall Study|Other reasons|2|||
124558901|NCT01571635|448003404|FG001|Overall Study|Other reasons|1|||
124558902|NCT01571635|448003405|FG002|Overall Study|Other reasons|2|||
124558903|NCT01571635|448003406|FG003|Overall Study|Other reasons|2|||
124558904|NCT01571635|448003407|FG004|Overall Study|Other reasons|1|||
124558905|NCT01571635|448003403|FG000|Overall Study|Study terminated by sponsor|0|||
124558906|NCT01571635|448003404|FG001|Overall Study|Study terminated by sponsor|4|||
124558907|NCT01571635|448003405|FG002|Overall Study|Study terminated by sponsor|1|||
124558908|NCT01571635|448003406|FG003|Overall Study|Study terminated by sponsor|3|||
124558909|NCT01571635|448003407|FG004|Overall Study|Study terminated by sponsor|1|||
124558910|NCT01571635|448003403|FG000|Overall Study|Withdrew consent|1|||
124558911|NCT01571635|448003404|FG001|Overall Study|Withdrew consent|1|||
124558912|NCT01571635|448003405|FG002|Overall Study|Withdrew consent|2|||
124558913|NCT01571635|448003406|FG003|Overall Study|Withdrew consent|3|||
124558914|NCT01571635|448003407|FG004|Overall Study|Withdrew consent|0|||
124558915|NCT01571635|448003403|FG000|Overall Study|Lack of Efficacy|0|||
124558916|NCT01571635|448003404|FG001|Overall Study|Lack of Efficacy|2|||
124558917|NCT01571635|448003405|FG002|Overall Study|Lack of Efficacy|0|||
124558918|NCT01571635|448003406|FG003|Overall Study|Lack of Efficacy|1|||
124558919|NCT01571635|448003407|FG004|Overall Study|Lack of Efficacy|2|||
124558920|NCT02868281|448003408|FG000|Overall Study|Adverse Event|2|||
124558921|NCT02868281|448003409|FG001|Overall Study|Adverse Event|2|||
124558922|NCT02868281|448003408|FG000|Overall Study|Protocol Violation|13|||
124558923|NCT02868281|448003409|FG001|Overall Study|Protocol Violation|10|||
124774058|NCT00463567|448802776|FG006|Overall Study|Death|0|||
124774059|NCT02633306|448802777|FG000|Overall Study|Withdrawal by Subject|3|||
124498381|NCT03395197|447778145|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
124498382|NCT03395197|447778146|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
124498383|NCT03395197|447778147|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
124498384|NCT03395197|447778148|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
124498385|NCT03395197|447778149|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
124498386|NCT03395197|447778150|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
124498387|NCT03395197|447778145|FG000|Analysis for DDR-Deficient Participants|Death|0|||
124498388|NCT03395197|447778146|FG001|Analysis for DDR-Deficient Participants|Death|0|||
124498389|NCT03395197|447778147|FG002|Analysis for DDR-Deficient Participants|Death|0|||
124498390|NCT03395197|447778148|FG003|Analysis for DDR-Deficient Participants|Death|0|||
124498391|NCT03395197|447778149|FG004|Analysis for DDR-Deficient Participants|Death|1|||
124498392|NCT03395197|447778150|FG005|Analysis for DDR-Deficient Participants|Death|4|||
124498393|NCT03395197|447778145|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
124498394|NCT03395197|447778146|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
124498395|NCT03395197|447778147|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
124498396|NCT03395197|447778148|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
124498397|NCT03395197|447778149|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
124498398|NCT03395197|447778150|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
124498399|NCT03395197|447778145|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
124498400|NCT03395197|447778146|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
124498401|NCT03395197|447778147|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
124558924|NCT02868281|448003408|FG000|Overall Study|Lost to Follow-up|3|||
124558925|NCT02868281|448003409|FG001|Overall Study|Lost to Follow-up|6|||
124558926|NCT02868281|448003408|FG000|Overall Study|Withdrawal by Subject|11|||
124558927|NCT02868281|448003409|FG001|Overall Study|Withdrawal by Subject|15|||
124558928|NCT02868281|448003408|FG000|Overall Study|Physician Decision|2|||
124558929|NCT02868281|448003409|FG001|Overall Study|Physician Decision|0|||
124558930|NCT02868281|448003408|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
124558931|NCT02868281|448003409|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
124558932|NCT02868281|448003408|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
124774060|NCT00956007|448802778|FG000|Overall Study|Protocol Violation|27|||
124774061|NCT00956007|448802779|FG001|Overall Study|Protocol Violation|23|||
124774062|NCT01746901|448802780|FG000|Naloxone Challenge Phase|Adverse Event|2|||
124774063|NCT01746901|448802781|FG001|Naloxone Challenge Phase|Adverse Event|0|||
124774064|NCT01746901|448802782|FG002|Naloxone Challenge Phase|Adverse Event|0|||
124774065|NCT01746901|448802783|FG003|Naloxone Challenge Phase|Adverse Event|0|||
124774066|NCT01746901|448802784|FG004|Naloxone Challenge Phase|Adverse Event|0|||
124774067|NCT01746901|448802785|FG005|Naloxone Challenge Phase|Adverse Event|0|||
124774068|NCT01746901|448802786|FG006|Naloxone Challenge Phase|Adverse Event|0|||
124774069|NCT01746901|448802787|FG007|Naloxone Challenge Phase|Adverse Event|0|||
124774070|NCT01746901|448802788|FG008|Naloxone Challenge Phase|Adverse Event|0|||
124774071|NCT01746901|448802780|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
124774072|NCT01746901|448802781|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
124774073|NCT01746901|448802782|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
124774074|NCT01746901|448802783|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
124774075|NCT01746901|448802784|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
124774076|NCT01746901|448802785|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
124774077|NCT01746901|448802786|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
124774078|NCT01746901|448802787|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
124774079|NCT01746901|448802788|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
124774080|NCT01746901|448802780|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
124774081|NCT01746901|448802781|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
124774082|NCT01746901|448802782|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
124774083|NCT01746901|448802783|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
124774084|NCT01746901|448802784|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
124774085|NCT01746901|448802785|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
124774086|NCT01746901|448802786|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
124774087|NCT01746901|448802787|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
124774088|NCT01746901|448802788|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
124774089|NCT01746901|448802780|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
124774090|NCT01746901|448802781|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
124774091|NCT01746901|448802782|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
124774092|NCT01746901|448802783|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
124774093|NCT01746901|448802784|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
124774094|NCT01746901|448802785|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
124774095|NCT01746901|448802786|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
124774096|NCT01746901|448802787|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
124774097|NCT01746901|448802788|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
124774098|NCT01746901|448802780|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
124774099|NCT01746901|448802781|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
124774100|NCT01746901|448802782|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
124774101|NCT01746901|448802783|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
124774102|NCT01746901|448802784|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
124774103|NCT01746901|448802785|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
124774104|NCT01746901|448802786|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
124774105|NCT01746901|448802787|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
124774106|NCT01746901|448802788|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
124774107|NCT01746901|448802780|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
124723947|NCT05396014|448611649|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723948|NCT05396014|448611650|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723949|NCT05396014|448611651|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723950|NCT05396014|448611652|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723951|NCT05396014|448611653|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723952|NCT05396014|448611654|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723953|NCT05396014|448611655|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723954|NCT05396014|448611656|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723955|NCT05396014|448611657|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723956|NCT05396014|448611658|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
124723957|NCT05396014|448611659|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723958|NCT05396014|448611660|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723959|NCT05396014|448611661|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723960|NCT05396014|448611662|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723961|NCT05396014|448611663|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723962|NCT05396014|448611664|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723963|NCT05396014|448611665|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723964|NCT05396014|448611666|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124774108|NCT01746901|448802781|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
124774109|NCT01746901|448802782|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
124498402|NCT03395197|447778148|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
124498403|NCT03395197|447778149|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
124498404|NCT03395197|447778150|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
124498405|NCT03395197|447778145|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
124498406|NCT03395197|447778146|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
124498407|NCT03395197|447778147|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
124498408|NCT03395197|447778148|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
124498409|NCT03395197|447778149|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
124558933|NCT02868281|448003409|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
124558934|NCT02868281|448003408|FG000|Overall Study|Long journey/moving away|1|||
124558935|NCT02868281|448003409|FG001|Overall Study|Long journey/moving away|1|||
124558936|NCT01722266|448003410|FG000|Overall Study|Withdrawal by Subject|1|||
124558937|NCT01722266|448003411|FG001|Overall Study|Withdrawal by Subject|2|||
124558938|NCT01722266|448003412|FG002|Overall Study|Withdrawal by Subject|0|||
124558939|NCT01722266|448003413|FG003|Overall Study|Withdrawal by Subject|0|||
124558940|NCT01722266|448003410|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
124558941|NCT01722266|448003411|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
124558942|NCT01722266|448003412|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
124558943|NCT01722266|448003413|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
124558944|NCT01722266|448003410|FG000|Overall Study|Dropped out due to Nausea|0|||
124558945|NCT01722266|448003411|FG001|Overall Study|Dropped out due to Nausea|0|||
124558946|NCT01722266|448003412|FG002|Overall Study|Dropped out due to Nausea|2|||
124558947|NCT01722266|448003413|FG003|Overall Study|Dropped out due to Nausea|0|||
124558948|NCT03124381|448003419|FG000|Overall Study|Lost to Follow-up|1|||
124558949|NCT03124381|448003420|FG001|Overall Study|Lost to Follow-up|1|||
124558950|NCT03124381|448003419|FG000|Overall Study|Withdrawal by Subject|6|||
124558951|NCT03124381|448003420|FG001|Overall Study|Withdrawal by Subject|3|||
124558952|NCT03124381|448003419|FG000|Overall Study|Protocol Violation|0|||
124558953|NCT03124381|448003420|FG001|Overall Study|Protocol Violation|1|||
124558954|NCT03124381|448003419|FG000|Overall Study|Adverse Event|1|||
124558955|NCT03124381|448003420|FG001|Overall Study|Adverse Event|1|||
124558956|NCT03124381|448003419|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
124558957|NCT03124381|448003420|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
124558958|NCT02533999|448003421|FG000|Overall Study|Lost to Follow-up|3|||
124558959|NCT02533999|448003422|FG001|Overall Study|Lost to Follow-up|5|||
124558960|NCT02533999|448003421|FG000|Overall Study|Protocol Violation|3|||
124558961|NCT02533999|448003422|FG001|Overall Study|Protocol Violation|0|||
124558962|NCT02533999|448003421|FG000|Overall Study|Adverse Event|0|||
124558963|NCT02533999|448003422|FG001|Overall Study|Adverse Event|1|||
124558964|NCT02533999|448003421|FG000|Overall Study|Randomized but intervention not received|0|||
124558965|NCT02533999|448003422|FG001|Overall Study|Randomized but intervention not received|1|||
124558966|NCT00291330|448003423|FG000|Overall Study|Adverse Event|47|||
124558967|NCT00291330|448003424|FG001|Overall Study|Adverse Event|40|||
124558968|NCT00291330|448003423|FG000|Overall Study|Protocol Violation|13|||
124558969|NCT00291330|448003424|FG001|Overall Study|Protocol Violation|20|||
124558970|NCT00291330|448003423|FG000|Overall Study|Lost to Follow-up|16|||
124558971|NCT00291330|448003424|FG001|Overall Study|Lost to Follow-up|11|||
124558972|NCT00291330|448003423|FG000|Overall Study|Withdrawal by Subject|22|||
124558973|NCT00291330|448003424|FG001|Overall Study|Withdrawal by Subject|25|||
124558974|NCT00291330|448003423|FG000|Overall Study|Other|3|||
124558975|NCT00291330|448003424|FG001|Overall Study|Other|1|||
124558976|NCT01829295|448003425|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
124558977|NCT01829295|448003426|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
124558978|NCT01829295|448003427|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
124558979|NCT01829295|448003428|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
124558980|NCT01829295|448003425|FG000|6-12 Months|Adverse Event|0|||
124558981|NCT01829295|448003426|FG001|6-12 Months|Adverse Event|0|||
124558982|NCT01829295|448003427|FG002|6-12 Months|Adverse Event|3|||
124558983|NCT01829295|448003428|FG003|6-12 Months|Adverse Event|2|||
124558984|NCT01829295|448003425|FG000|6-12 Months|Lost to Follow-up|2|||
124558985|NCT01829295|448003426|FG001|6-12 Months|Lost to Follow-up|0|||
124558986|NCT01829295|448003427|FG002|6-12 Months|Lost to Follow-up|0|||
124558987|NCT01829295|448003428|FG003|6-12 Months|Lost to Follow-up|0|||
124723965|NCT05396014|448611667|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723966|NCT05396014|448611668|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124558988|NCT01829295|448003425|FG000|6-12 Months|Withdrawal by Subject|2|||
124558989|NCT01829295|448003426|FG001|6-12 Months|Withdrawal by Subject|2|||
124558990|NCT01829295|448003427|FG002|6-12 Months|Withdrawal by Subject|0|||
124558991|NCT01829295|448003428|FG003|6-12 Months|Withdrawal by Subject|0|||
124558992|NCT02390219|448003435|FG000|Overall Study|Death|1|||
124558993|NCT02390219|448003435|FG000|Overall Study|Physician Decision|1|||
124558994|NCT02390219|448003435|FG000|Overall Study|Adverse Event|6|||
124723967|NCT05396014|448611669|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723968|NCT05396014|448611670|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124558995|NCT02390219|448003435|FG000|Overall Study|Withdrawal by Subject|1|||
124498410|NCT03395197|447778150|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
124558996|NCT02390219|448003435|FG000|Overall Study|Lost to Follow-up|2|||
124558997|NCT02390219|448003435|FG000|Overall Study|Other|2|||
124558998|NCT01360632|448003438|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
124558999|NCT01360632|448003439|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
124559000|NCT01360632|448003440|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
124559001|NCT01360632|448003441|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
124559002|NCT01360632|448003442|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
124559003|NCT01360632|448003438|FG000|Phase A (8 Weeks)|Adverse Event|60|||
124498411|NCT03395197|447778145|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
124498412|NCT03395197|447778146|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
124774110|NCT01746901|448802783|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
124774111|NCT01746901|448802784|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
124498413|NCT03395197|447778147|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
124498414|NCT03395197|447778148|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
124498415|NCT03395197|447778149|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
124498416|NCT03395197|447778150|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
124498417|NCT03395197|447778145|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
124498418|NCT03395197|447778146|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
124498419|NCT03395197|447778147|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
124498420|NCT03395197|447778148|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
124498421|NCT03395197|447778149|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
124498422|NCT03395197|447778150|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
124498423|NCT03395197|447778145|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
124559004|NCT01360632|448003439|FG001|Phase A (8 Weeks)|Adverse Event|0|||
124559005|NCT01360632|448003440|FG002|Phase A (8 Weeks)|Adverse Event|0|||
124774112|NCT01746901|448802785|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
124498424|NCT03395197|447778146|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
124774113|NCT01746901|448802786|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
124774114|NCT01746901|448802787|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
124774115|NCT01746901|448802788|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
124774116|NCT01746901|448802780|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
124774117|NCT01746901|448802781|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
124774118|NCT01746901|448802782|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
124774119|NCT01746901|448802783|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
124774120|NCT01746901|448802784|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
124774121|NCT01746901|448802785|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
124774122|NCT01746901|448802786|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
124774123|NCT01746901|448802787|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
124774124|NCT01746901|448802788|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
124774125|NCT01746901|448802780|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
124774126|NCT01746901|448802781|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
124774127|NCT01746901|448802782|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
124774128|NCT01746901|448802783|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
124774129|NCT01746901|448802784|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
124774130|NCT01746901|448802785|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
124774131|NCT01746901|448802786|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
124774132|NCT01746901|448802787|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
124774133|NCT01746901|448802788|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
124774134|NCT01746901|448802780|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
124774135|NCT01746901|448802781|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
124774136|NCT01746901|448802782|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
124774137|NCT01746901|448802783|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
124774138|NCT01746901|448802784|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
124774139|NCT01746901|448802785|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
124774140|NCT01746901|448802786|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
124774141|NCT01746901|448802787|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
124774142|NCT01746901|448802788|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
124774143|NCT01746901|448802780|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
124774144|NCT01746901|448802781|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
124559006|NCT01360632|448003441|FG003|Phase A (8 Weeks)|Adverse Event|0|||
124559007|NCT01360632|448003442|FG004|Phase A (8 Weeks)|Adverse Event|0|||
124559008|NCT01360632|448003438|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
124559009|NCT01360632|448003439|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
124559010|NCT01360632|448003440|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
124559011|NCT01360632|448003441|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
124774145|NCT01746901|448802782|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
124774146|NCT01746901|448802783|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
124774147|NCT01746901|448802784|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
124774148|NCT01746901|448802785|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
124774149|NCT01746901|448802786|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
124774150|NCT01746901|448802787|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
124774151|NCT01746901|448802788|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
124774152|NCT01746901|448802780|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
124774153|NCT01746901|448802781|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
124774154|NCT01746901|448802782|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
124774155|NCT01746901|448802783|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
124774156|NCT01746901|448802784|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
124774157|NCT01746901|448802785|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
124774158|NCT01746901|448802786|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
124774159|NCT01746901|448802787|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
124774160|NCT01746901|448802788|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
124774161|NCT01746901|448802780|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
124774162|NCT01746901|448802781|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
124774163|NCT01746901|448802782|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
124774164|NCT01746901|448802783|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
124774165|NCT01746901|448802784|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
124774166|NCT01746901|448802785|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
124774167|NCT01746901|448802786|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
124774168|NCT01746901|448802787|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
124774169|NCT01746901|448802788|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
124774170|NCT02968004|448802792|FG000|Main Study Phase|Adverse Event|1|||
124774171|NCT02968004|448802793|FG001|Main Study Phase|Adverse Event|0|||
124774172|NCT02968004|448802792|FG000|Main Study Phase|Withdrawal by Subject|0|||
124774173|NCT02968004|448802793|FG001|Main Study Phase|Withdrawal by Subject|1|||
124774174|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
124774175|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
124774176|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
124774177|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
124774178|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
124774179|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
124774180|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
124774181|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
124774182|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
124774183|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
124774184|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
124774185|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
124774186|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
124774187|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
124774188|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
124774189|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
124774190|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
124774191|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
124774192|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
124774193|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
124774194|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
124774195|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
124774196|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
124774197|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
124774198|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
124498425|NCT03395197|447778147|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
124498426|NCT03395197|447778148|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
124498427|NCT03395197|447778149|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
124498428|NCT03395197|447778150|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
124498429|NCT03395197|447778145|FG000|Analysis for DDR-Deficient Participants|Other|0|||
124498430|NCT03395197|447778146|FG001|Analysis for DDR-Deficient Participants|Other|0|||
124498431|NCT03395197|447778147|FG002|Analysis for DDR-Deficient Participants|Other|0|||
124498432|NCT03395197|447778148|FG003|Analysis for DDR-Deficient Participants|Other|0|||
124498433|NCT03395197|447778149|FG004|Analysis for DDR-Deficient Participants|Other|3|||
124498434|NCT03395197|447778150|FG005|Analysis for DDR-Deficient Participants|Other|3|||
124774199|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
124774200|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
124774201|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
124774202|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
124774203|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
124774204|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
124559012|NCT01360632|448003442|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
124774205|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
124774206|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
124774207|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
124774208|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
124774209|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
124774210|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
124774211|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
124774212|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
124774213|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
124774214|NCT02968004|448802792|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
124774215|NCT02968004|448802793|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
124774216|NCT05029362|448802794|FG000|Overall Study|Lost to Follow-up|9|||
124774217|NCT00419952|448802797|FG000|Overall Study|Adverse Event|8|||
124774218|NCT00419952|448802798|FG001|Overall Study|Adverse Event|10|||
124774219|NCT00419952|448802797|FG000|Overall Study|Withdrawal by Subject|44|||
124774220|NCT00419952|448802798|FG001|Overall Study|Withdrawal by Subject|43|||
124774221|NCT00419952|448802797|FG000|Overall Study|Lost to Follow-up|43|||
124774222|NCT00419952|448802798|FG001|Overall Study|Lost to Follow-up|34|||
124774223|NCT00419952|448802797|FG000|Overall Study|Protocol Violation|32|||
124774224|NCT00419952|448802798|FG001|Overall Study|Protocol Violation|24|||
124774225|NCT00419952|448802797|FG000|Overall Study|Pregnancy|4|||
124774226|NCT00419952|448802798|FG001|Overall Study|Pregnancy|2|||
124774227|NCT00419952|448802797|FG000|Overall Study|Physician Decision|1|||
124774228|NCT00419952|448802798|FG001|Overall Study|Physician Decision|3|||
124774229|NCT00419952|448802797|FG000|Overall Study|Incorrectly enrolled|10|||
124774230|NCT00419952|448802798|FG001|Overall Study|Incorrectly enrolled|3|||
124774231|NCT00419952|448802797|FG000|Overall Study|Intake of prohibited medication|2|||
124774232|NCT00419952|448802798|FG001|Overall Study|Intake of prohibited medication|2|||
124774233|NCT00419952|448802797|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
124774234|NCT00419952|448802798|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
124774235|NCT00419952|448802797|FG000|Overall Study|Diary or medication non-compliance|2|||
124774236|NCT00419952|448802798|FG001|Overall Study|Diary or medication non-compliance|4|||
124774237|NCT00419952|448802797|FG000|Overall Study|Abnormal ECG|1|||
124774238|NCT00419952|448802798|FG001|Overall Study|Abnormal ECG|0|||
124774239|NCT03126591|448802799|FG000|Overall Study|Death|6|||
124774240|NCT03126591|448802800|FG001|Overall Study|Death|3|||
124774241|NCT03126591|448802801|FG002|Overall Study|Death|17|||
124774242|NCT03126591|448802799|FG000|Overall Study|Progressive Disease|0|||
124774243|NCT03126591|448802800|FG001|Overall Study|Progressive Disease|1|||
124774244|NCT03126591|448802801|FG002|Overall Study|Progressive Disease|2|||
124774245|NCT03126591|448802799|FG000|Overall Study|Terminated by Sponsor|0|||
124774246|NCT03126591|448802800|FG001|Overall Study|Terminated by Sponsor|1|||
124774247|NCT03126591|448802801|FG002|Overall Study|Terminated by Sponsor|4|||
124774248|NCT03126591|448802799|FG000|Overall Study|Withdrawal by Subject|1|||
124774249|NCT03126591|448802800|FG001|Overall Study|Withdrawal by Subject|1|||
124774250|NCT03126591|448802801|FG002|Overall Study|Withdrawal by Subject|4|||
124774251|NCT02158546|448802802|FG000|Overall Study|Physician Decision|0|||
124774252|NCT02158546|448802803|FG001|Overall Study|Physician Decision|1|||
124774253|NCT02158546|448802804|FG002|Overall Study|Physician Decision|0|||
124774254|NCT02158546|448802805|FG003|Overall Study|Physician Decision|0|||
124774255|NCT02158546|448802802|FG000|Overall Study|Non-compliance|0|||
124774256|NCT02158546|448802803|FG001|Overall Study|Non-compliance|1|||
124774257|NCT02158546|448802804|FG002|Overall Study|Non-compliance|0|||
124498435|NCT03395197|447778145|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
124498436|NCT03395197|447778146|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
124498437|NCT03395197|447778147|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
124498438|NCT03395197|447778148|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
124498439|NCT03395197|447778149|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
124498440|NCT03395197|447778150|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
124498441|NCT05137041|447778151|FG000|Overall Study|Lost to Follow-up|1|||
124498442|NCT05137041|447778152|FG001|Overall Study|Lost to Follow-up|1|||
124774258|NCT02158546|448802805|FG003|Overall Study|Non-compliance|1|||
124498443|NCT05137041|447778151|FG000|Overall Study|Withdrawal by Subject|0|||
124498444|NCT05137041|447778152|FG001|Overall Study|Withdrawal by Subject|2|||
124774259|NCT02158546|448802802|FG000|Overall Study|Failure to meet eligibility criteria|0|||
124774260|NCT02158546|448802803|FG001|Overall Study|Failure to meet eligibility criteria|1|||
124774261|NCT02158546|448802804|FG002|Overall Study|Failure to meet eligibility criteria|0|||
124774262|NCT02158546|448802805|FG003|Overall Study|Failure to meet eligibility criteria|0|||
124774263|NCT02158546|448802802|FG000|Overall Study|Lack of Efficacy|1|||
124774264|NCT02158546|448802803|FG001|Overall Study|Lack of Efficacy|1|||
124774265|NCT02158546|448802804|FG002|Overall Study|Lack of Efficacy|0|||
124774266|NCT02158546|448802805|FG003|Overall Study|Lack of Efficacy|0|||
124774267|NCT02158546|448802802|FG000|Overall Study|Adverse Event|2|||
124774268|NCT02158546|448802803|FG001|Overall Study|Adverse Event|2|||
124774269|NCT02158546|448802804|FG002|Overall Study|Adverse Event|0|||
124774270|NCT02158546|448802805|FG003|Overall Study|Adverse Event|0|||
124774271|NCT02158546|448802802|FG000|Overall Study|Withdrawal by Subject|6|||
124774272|NCT02158546|448802803|FG001|Overall Study|Withdrawal by Subject|2|||
124774273|NCT02158546|448802804|FG002|Overall Study|Withdrawal by Subject|1|||
124774274|NCT02158546|448802805|FG003|Overall Study|Withdrawal by Subject|0|||
124774275|NCT02158546|448802802|FG000|Overall Study|Lost to Follow-up|5|||
124774276|NCT02158546|448802803|FG001|Overall Study|Lost to Follow-up|4|||
124774277|NCT02158546|448802804|FG002|Overall Study|Lost to Follow-up|0|||
124774278|NCT02158546|448802805|FG003|Overall Study|Lost to Follow-up|1|||
124774279|NCT02158546|448802802|FG000|Overall Study|Site Excluded|5|||
124774280|NCT02158546|448802803|FG001|Overall Study|Site Excluded|5|||
124774281|NCT02158546|448802804|FG002|Overall Study|Site Excluded|3|||
124774282|NCT02158546|448802805|FG003|Overall Study|Site Excluded|4|||
124774283|NCT02900378|448802806|FG000|Randomization (Visit 2)|Adverse Event|14|||
124774284|NCT02900378|448802807|FG001|Randomization (Visit 2)|Adverse Event|11|||
124774285|NCT02900378|448802806|FG000|Randomization (Visit 2)|Death|1|||
124774286|NCT02900378|448802807|FG001|Randomization (Visit 2)|Death|4|||
124774287|NCT02900378|448802806|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
124774288|NCT02900378|448802807|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
124774289|NCT02900378|448802806|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
124774290|NCT02900378|448802807|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
124774291|NCT02900378|448802806|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
124498445|NCT05137041|447778151|FG000|Overall Study|Reason not Specified|0|||
124498446|NCT05137041|447778152|FG001|Overall Study|Reason not Specified|1|||
124498447|NCT01808118|447778158|FG000|Period 1|Adverse Event|15|||
124498448|NCT01808118|447778159|FG001|Period 1|Adverse Event|0|||
124498449|NCT01808118|447778160|FG002|Period 1|Adverse Event|0|||
124498450|NCT01808118|447778158|FG000|Period 1|Withdrew consent|24|||
124498451|NCT01808118|447778159|FG001|Period 1|Withdrew consent|0|||
124498452|NCT01808118|447778160|FG002|Period 1|Withdrew consent|0|||
124498453|NCT01808118|447778158|FG000|Period 1|Lost to Follow-up|9|||
124498454|NCT01808118|447778159|FG001|Period 1|Lost to Follow-up|0|||
124498455|NCT01808118|447778160|FG002|Period 1|Lost to Follow-up|0|||
124498456|NCT01808118|447778158|FG000|Period 1|Did not meet criteria for remission|303|||
124498457|NCT01808118|447778159|FG001|Period 1|Did not meet criteria for remission|0|||
124498458|NCT01808118|447778160|FG002|Period 1|Did not meet criteria for remission|0|||
124498459|NCT01808118|447778158|FG000|Period 1|Enrolled in error|7|||
124498460|NCT01808118|447778159|FG001|Period 1|Enrolled in error|0|||
124498461|NCT01808118|447778160|FG002|Period 1|Enrolled in error|0|||
124498462|NCT01808118|447778158|FG000|Period 1|Did not meet inclusion criteria|3|||
124498463|NCT01808118|447778159|FG001|Period 1|Did not meet inclusion criteria|0|||
124498464|NCT01808118|447778160|FG002|Period 1|Did not meet inclusion criteria|0|||
124498465|NCT01808118|447778158|FG000|Period 1|Non-conformance with inclusion criteria|3|||
124498466|NCT01808118|447778159|FG001|Period 1|Non-conformance with inclusion criteria|0|||
124498467|NCT01808118|447778160|FG002|Period 1|Non-conformance with inclusion criteria|0|||
124498468|NCT01808118|447778158|FG000|Period 1|Investigator decision: site closure|2|||
124498469|NCT01808118|447778159|FG001|Period 1|Investigator decision: site closure|0|||
124498470|NCT01808118|447778160|FG002|Period 1|Investigator decision: site closure|0|||
124498471|NCT01808118|447778158|FG000|Period 1|Non-compliance per sponsor|1|||
124498472|NCT01808118|447778159|FG001|Period 1|Non-compliance per sponsor|0|||
124498473|NCT01808118|447778160|FG002|Period 1|Non-compliance per sponsor|0|||
124498474|NCT01808118|447778158|FG000|Period 1|Lack of Efficacy|1|||
124498475|NCT01808118|447778159|FG001|Period 1|Lack of Efficacy|0|||
124498476|NCT01808118|447778160|FG002|Period 1|Lack of Efficacy|0|||
124498477|NCT01808118|447778158|FG000|Period 2|Adverse Event|0|||
124498478|NCT01808118|447778159|FG001|Period 2|Adverse Event|4|||
124498479|NCT01808118|447778160|FG002|Period 2|Adverse Event|0|||
124498480|NCT01808118|447778158|FG000|Period 2|Withdrew consent|0|||
124774292|NCT02900378|448802807|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
124774293|NCT02900378|448802806|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
124774294|NCT02900378|448802807|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
124498481|NCT01808118|447778159|FG001|Period 2|Withdrew consent|7|||
124498482|NCT01808118|447778160|FG002|Period 2|Withdrew consent|6|||
124498483|NCT01808118|447778158|FG000|Period 2|Lost to Follow-up|0|||
124498484|NCT01808118|447778159|FG001|Period 2|Lost to Follow-up|0|||
124498485|NCT01808118|447778160|FG002|Period 2|Lost to Follow-up|2|||
124498486|NCT01808118|447778158|FG000|Period 2|Investigator no longer conducting trials|0|||
124498487|NCT01808118|447778159|FG001|Period 2|Investigator no longer conducting trials|1|||
124498488|NCT01808118|447778160|FG002|Period 2|Investigator no longer conducting trials|0|||
124498489|NCT01808118|447778158|FG000|Period 2|Switched to other therapy|0|||
124498490|NCT01808118|447778159|FG001|Period 2|Switched to other therapy|1|||
124498491|NCT01808118|447778160|FG002|Period 2|Switched to other therapy|0|||
124498492|NCT00615290|447778161|FG000|Overall Study|Adverse Event|2|||
124498493|NCT00615290|447778161|FG000|Overall Study|Lost to Follow-up|3|||
124498494|NCT00615290|447778161|FG000|Overall Study|Withdrawal by Subject|1|||
124498495|NCT00615290|447778161|FG000|Overall Study|Other|2|||
124498496|NCT02044159|447778162|FG000|Overall Study|Consent declined (deferred consent)|2|||
124498497|NCT02044159|447778163|FG001|Overall Study|Consent declined (deferred consent)|4|||
124498498|NCT02044159|447778162|FG000|Overall Study|No longer eligible, drug not given|1|||
124498499|NCT02044159|447778163|FG001|Overall Study|No longer eligible, drug not given|0|||
124498500|NCT02044159|447778162|FG000|Overall Study|Nurse declined to give study drug|1|||
124723969|NCT05396014|448611671|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723970|NCT05396014|448611672|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723971|NCT05396014|448611673|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723972|NCT05396014|448611674|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723973|NCT05396014|448611675|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723974|NCT05396014|448611676|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723975|NCT05396014|448611677|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723976|NCT05396014|448611678|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723977|NCT05396014|448611679|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723978|NCT05396014|448611680|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723979|NCT05396014|448611681|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723980|NCT05396014|448611682|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723981|NCT05396014|448611683|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723982|NCT05396014|448611684|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
124723983|NCT05396014|448611685|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723984|NCT05396014|448611686|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723985|NCT05396014|448611687|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
124723986|NCT05396014|448611645|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
124723987|NCT05396014|448611646|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124723988|NCT05396014|448611647|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124723989|NCT05396014|448611648|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124723990|NCT05396014|448611649|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124723991|NCT05396014|448611650|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124723992|NCT05396014|448611651|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124723993|NCT05396014|448611652|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124723994|NCT05396014|448611653|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124723995|NCT05396014|448611654|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124723996|NCT05396014|448611655|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124723997|NCT05396014|448611656|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124723998|NCT05396014|448611657|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124723999|NCT05396014|448611658|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724000|NCT05396014|448611659|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724001|NCT05396014|448611660|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724002|NCT05396014|448611661|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724003|NCT05396014|448611662|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724004|NCT05396014|448611663|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724005|NCT05396014|448611664|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724006|NCT05396014|448611665|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724007|NCT05396014|448611666|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724008|NCT05396014|448611667|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724009|NCT05396014|448611668|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724010|NCT05396014|448611669|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724011|NCT05396014|448611670|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724012|NCT05396014|448611671|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
124724013|NCT05396014|448611672|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724014|NCT05396014|448611673|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724015|NCT05396014|448611674|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724016|NCT05396014|448611675|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724017|NCT05396014|448611676|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724018|NCT05396014|448611677|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724019|NCT05396014|448611678|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724020|NCT05396014|448611679|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724021|NCT05396014|448611680|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724022|NCT05396014|448611681|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724023|NCT05396014|448611682|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724024|NCT05396014|448611683|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124774295|NCT02900378|448802806|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
124774296|NCT02900378|448802807|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
124774297|NCT02531802|448802809|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
124774298|NCT02531802|448802810|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
124774299|NCT02531802|448802811|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
124774300|NCT02531802|448802812|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
124774301|NCT02531802|448802813|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
124774302|NCT02531802|448802814|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
124774303|NCT02531802|448802815|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
124774304|NCT02531802|448802816|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
124498501|NCT02044159|447778163|FG001|Overall Study|Nurse declined to give study drug|0|||
124498502|NCT01795898|447778164|FG000|Overall Study|Adverse Event|27|||
124498503|NCT01795898|447778164|FG000|Overall Study|Lost to Follow-up|20|||
124498504|NCT01795898|447778164|FG000|Overall Study|Withdrawal of consent|6|||
124498505|NCT01795898|447778164|FG000|Overall Study|Diagnosed with metastasis|1|||
124498506|NCT01795898|447778164|FG000|Overall Study|No pain|1|||
124498507|NCT01795898|447778164|FG000|Overall Study|Death|1|||
124498508|NCT01795898|447778164|FG000|Overall Study|Withdrew consent & had adverse events|3|||
124498509|NCT01795898|447778164|FG000|Overall Study|Physician Decision|1|||
124774305|NCT02531802|448802817|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
124774306|NCT02531802|448802818|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
124498510|NCT00972478|447778178|FG000|Overall Study|Adverse Event|3|||
124498511|NCT00972478|447778179|FG001|Overall Study|Adverse Event|16|||
124498512|NCT00972478|447778178|FG000|Overall Study|Withdrawal by Subject|1|||
124774307|NCT02531802|448802819|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
124774308|NCT02531802|448802820|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
124774309|NCT02531802|448802821|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
124774310|NCT02531802|448802822|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
124774311|NCT02531802|448802823|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
124774312|NCT02531802|448802824|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
124774313|NCT02531802|448802825|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
124774314|NCT02531802|448802826|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
124774315|NCT02531802|448802827|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
124774316|NCT02531802|448802828|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
124774317|NCT02531802|448802829|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
124774318|NCT02531802|448802809|FG000|Received Vaccination 2|Physician Decision|0|||
124774319|NCT02531802|448802810|FG001|Received Vaccination 2|Physician Decision|0|||
124774320|NCT02531802|448802811|FG002|Received Vaccination 2|Physician Decision|0|||
124774321|NCT02531802|448802812|FG003|Received Vaccination 2|Physician Decision|0|||
124774322|NCT02531802|448802813|FG004|Received Vaccination 2|Physician Decision|0|||
124774323|NCT02531802|448802814|FG005|Received Vaccination 2|Physician Decision|1|||
124774324|NCT02531802|448802815|FG006|Received Vaccination 2|Physician Decision|0|||
124774325|NCT02531802|448802816|FG007|Received Vaccination 2|Physician Decision|0|||
124774326|NCT02531802|448802817|FG008|Received Vaccination 2|Physician Decision|0|||
124774327|NCT02531802|448802818|FG009|Received Vaccination 2|Physician Decision|2|||
124774328|NCT02531802|448802819|FG010|Received Vaccination 2|Physician Decision|0|||
124774329|NCT02531802|448802820|FG011|Received Vaccination 2|Physician Decision|0|||
124774330|NCT02531802|448802821|FG012|Received Vaccination 2|Physician Decision|0|||
124774331|NCT02531802|448802822|FG013|Received Vaccination 2|Physician Decision|1|||
124774332|NCT02531802|448802823|FG014|Received Vaccination 2|Physician Decision|0|||
124498513|NCT00972478|447778179|FG001|Overall Study|Withdrawal by Subject|8|||
124498514|NCT00972478|447778178|FG000|Overall Study|Progression/Relapse|0|||
124498515|NCT00972478|447778179|FG001|Overall Study|Progression/Relapse|2|||
124498516|NCT00972478|447778178|FG000|Overall Study|Death|0|||
124498517|NCT00972478|447778179|FG001|Overall Study|Death|2|||
124498518|NCT00972478|447778178|FG000|Overall Study|Not protocol specified|1|||
124498519|NCT00972478|447778179|FG001|Overall Study|Not protocol specified|1|||
124498520|NCT00972478|447778178|FG000|Overall Study|Ineligible|1|||
124498521|NCT00972478|447778179|FG001|Overall Study|Ineligible|7|||
124498522|NCT00972478|447778178|FG000|Overall Study|Not start protocol treatment|1|||
124498523|NCT00972478|447778179|FG001|Overall Study|Not start protocol treatment|2|||
124498524|NCT01522976|447778180|FG000|Overall Study|Ineligible|4|||
124498525|NCT01522976|447778181|FG001|Overall Study|Ineligible|0|||
124498526|NCT01522976|447778182|FG002|Overall Study|Ineligible|1|||
124498527|NCT01522976|447778180|FG000|Overall Study|Death|7|||
124498528|NCT01522976|447778181|FG001|Overall Study|Death|6|||
124498529|NCT01522976|447778182|FG002|Overall Study|Death|2|||
124774333|NCT02531802|448802824|FG015|Received Vaccination 2|Physician Decision|0|||
124498530|NCT01522976|447778180|FG000|Overall Study|Still on treatment|9|||
124498531|NCT01522976|447778181|FG001|Overall Study|Still on treatment|9|||
124774334|NCT02531802|448802825|FG016|Received Vaccination 2|Physician Decision|0|||
124498532|NCT01522976|447778182|FG002|Overall Study|Still on treatment|6|||
124498533|NCT01522976|447778180|FG000|Overall Study|Disease progression|28|||
124774335|NCT02531802|448802826|FG017|Received Vaccination 2|Physician Decision|1|||
124774336|NCT02531802|448802827|FG018|Received Vaccination 2|Physician Decision|0|||
124774337|NCT02531802|448802828|FG019|Received Vaccination 2|Physician Decision|0|||
124774338|NCT02531802|448802829|FG020|Received Vaccination 2|Physician Decision|0|||
124774339|NCT02531802|448802809|FG000|Received Vaccination 2|Adverse Event|0|||
124774340|NCT02531802|448802810|FG001|Received Vaccination 2|Adverse Event|0|||
124774341|NCT02531802|448802811|FG002|Received Vaccination 2|Adverse Event|0|||
124774342|NCT02531802|448802812|FG003|Received Vaccination 2|Adverse Event|0|||
124774343|NCT02531802|448802813|FG004|Received Vaccination 2|Adverse Event|0|||
124774344|NCT02531802|448802814|FG005|Received Vaccination 2|Adverse Event|2|||
124774345|NCT02531802|448802815|FG006|Received Vaccination 2|Adverse Event|0|||
124774346|NCT02531802|448802816|FG007|Received Vaccination 2|Adverse Event|0|||
124774347|NCT02531802|448802817|FG008|Received Vaccination 2|Adverse Event|0|||
124774348|NCT02531802|448802818|FG009|Received Vaccination 2|Adverse Event|0|||
124774349|NCT02531802|448802819|FG010|Received Vaccination 2|Adverse Event|0|||
124774350|NCT02531802|448802820|FG011|Received Vaccination 2|Adverse Event|0|||
124774351|NCT02531802|448802821|FG012|Received Vaccination 2|Adverse Event|0|||
124774352|NCT02531802|448802822|FG013|Received Vaccination 2|Adverse Event|0|||
124774353|NCT02531802|448802823|FG014|Received Vaccination 2|Adverse Event|0|||
124774354|NCT02531802|448802824|FG015|Received Vaccination 2|Adverse Event|0|||
124774355|NCT02531802|448802825|FG016|Received Vaccination 2|Adverse Event|0|||
124774356|NCT02531802|448802826|FG017|Received Vaccination 2|Adverse Event|2|||
124774357|NCT02531802|448802827|FG018|Received Vaccination 2|Adverse Event|1|||
124774358|NCT02531802|448802828|FG019|Received Vaccination 2|Adverse Event|0|||
124774359|NCT02531802|448802829|FG020|Received Vaccination 2|Adverse Event|1|||
124774360|NCT02531802|448802809|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
124774361|NCT02531802|448802810|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
124774362|NCT02531802|448802811|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
124774363|NCT02531802|448802812|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
124774364|NCT02531802|448802813|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
124774365|NCT02531802|448802814|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
124774366|NCT02531802|448802815|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
124774367|NCT02531802|448802816|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
124774368|NCT02531802|448802817|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
124774369|NCT02531802|448802818|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
124774370|NCT02531802|448802819|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
124559013|NCT01360632|448003438|FG000|Phase A (8 Weeks)|Physician Decision|10|||
124559014|NCT01360632|448003439|FG001|Phase A (8 Weeks)|Physician Decision|0|||
124559015|NCT01360632|448003440|FG002|Phase A (8 Weeks)|Physician Decision|0|||
124559016|NCT01360632|448003441|FG003|Phase A (8 Weeks)|Physician Decision|0|||
124559017|NCT01360632|448003442|FG004|Phase A (8 Weeks)|Physician Decision|0|||
124559018|NCT01360632|448003438|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
124559019|NCT01360632|448003439|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
124559020|NCT01360632|448003440|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
124559021|NCT01360632|448003441|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
124559022|NCT01360632|448003442|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
124559023|NCT01360632|448003438|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
124559024|NCT01360632|448003439|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
124774371|NCT02531802|448802820|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
124774372|NCT02531802|448802821|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
124774373|NCT02531802|448802822|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
124774374|NCT02531802|448802823|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
124498534|NCT01522976|447778181|FG001|Overall Study|Disease progression|30|||
124498535|NCT01522976|447778182|FG002|Overall Study|Disease progression|25|||
124498536|NCT01522976|447778180|FG000|Overall Study|Adverse Event|17|||
124498537|NCT01522976|447778181|FG001|Overall Study|Adverse Event|7|||
124498538|NCT01522976|447778182|FG002|Overall Study|Adverse Event|18|||
124498539|NCT01522976|447778180|FG000|Overall Study|Refusal unrelated to adverse event|10|||
124498540|NCT01522976|447778181|FG001|Overall Study|Refusal unrelated to adverse event|13|||
124498541|NCT01522976|447778182|FG002|Overall Study|Refusal unrelated to adverse event|14|||
124498542|NCT01522976|447778180|FG000|Overall Study|Not protocol specified|22|||
124498543|NCT01522976|447778181|FG001|Overall Study|Not protocol specified|27|||
124498544|NCT01522976|447778182|FG002|Overall Study|Not protocol specified|27|||
124498545|NCT05132569|447778185|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
124774375|NCT02531802|448802824|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
124774376|NCT02531802|448802825|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
124774377|NCT02531802|448802826|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
124559025|NCT01360632|448003440|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
124559026|NCT01360632|448003441|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
124559027|NCT01360632|448003442|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
124559028|NCT01360632|448003438|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
124498546|NCT05132569|447778186|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
124498547|NCT05132569|447778185|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
124559029|NCT01360632|448003439|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
124498548|NCT05132569|447778186|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
124498549|NCT05132569|447778185|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
124498550|NCT05132569|447778186|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
124498551|NCT04102098|447778187|FG000|Main Study Period|Ongoing in study|302|||
124498552|NCT04102098|447778188|FG001|Main Study Period|Ongoing in study|291|||
124498553|NCT04102098|447778187|FG000|Main Study Period|Death|20|||
124498554|NCT04102098|447778188|FG001|Main Study Period|Death|27|||
124498555|NCT04102098|447778187|FG000|Main Study Period|Lost to Follow-up|1|||
124498556|NCT04102098|447778188|FG001|Main Study Period|Lost to Follow-up|1|||
124498557|NCT04102098|447778187|FG000|Main Study Period|Physician Decision|0|||
124498558|NCT04102098|447778188|FG001|Main Study Period|Physician Decision|1|||
124498559|NCT04102098|447778187|FG000|Main Study Period|Withdrawal by Subject|11|||
124498560|NCT04102098|447778188|FG001|Main Study Period|Withdrawal by Subject|14|||
124498561|NCT04102098|447778187|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
124498562|NCT04102098|447778188|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
124498563|NCT04102098|447778187|FG000|Crossover: AS Who Crossed Over|Death|11|||
124498564|NCT04102098|447778188|FG001|Crossover: AS Who Crossed Over|Death|0|||
124498565|NCT04102098|447778187|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
124498566|NCT04102098|447778188|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
124724025|NCT05396014|448611684|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724026|NCT05396014|448611685|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724027|NCT05396014|448611686|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724028|NCT05396014|448611687|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
124724029|NCT05396014|448611645|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724030|NCT05396014|448611646|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724031|NCT05396014|448611647|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724032|NCT05396014|448611648|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724033|NCT05396014|448611649|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724034|NCT05396014|448611650|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724035|NCT05396014|448611651|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724036|NCT05396014|448611652|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724037|NCT05396014|448611653|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724038|NCT05396014|448611654|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724039|NCT05396014|448611655|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724040|NCT05396014|448611656|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724041|NCT05396014|448611657|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724042|NCT05396014|448611658|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
124724043|NCT05396014|448611659|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724044|NCT05396014|448611660|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724045|NCT05396014|448611661|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724046|NCT05396014|448611662|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724047|NCT05396014|448611663|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724048|NCT05396014|448611664|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724049|NCT05396014|448611665|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724050|NCT05396014|448611666|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724051|NCT05396014|448611667|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724052|NCT05396014|448611668|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724053|NCT05396014|448611669|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724054|NCT05396014|448611670|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724055|NCT05396014|448611671|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724056|NCT05396014|448611672|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724057|NCT05396014|448611673|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724058|NCT05396014|448611674|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724059|NCT05396014|448611675|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724060|NCT05396014|448611676|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724061|NCT05396014|448611677|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724062|NCT05396014|448611678|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724063|NCT05396014|448611679|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724064|NCT05396014|448611680|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724065|NCT05396014|448611681|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724066|NCT05396014|448611682|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724067|NCT05396014|448611683|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724068|NCT05396014|448611684|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724069|NCT05396014|448611685|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724070|NCT05396014|448611686|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124498567|NCT05590793|447778191|FG000|Overall Study|Withdrawal by Subject|6|||
124498568|NCT05590793|447778191|FG000|Overall Study|Physician Decision|1|||
124724071|NCT05396014|448611687|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
124724072|NCT05396014|448611645|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724073|NCT05396014|448611646|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724074|NCT05396014|448611647|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724075|NCT05396014|448611648|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
124724076|NCT05396014|448611649|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724077|NCT05396014|448611650|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
124724078|NCT05396014|448611651|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
124724079|NCT05396014|448611652|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724080|NCT05396014|448611653|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
124724081|NCT05396014|448611654|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
124724082|NCT05396014|448611655|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724083|NCT05396014|448611656|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724084|NCT05396014|448611657|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724085|NCT05396014|448611658|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724086|NCT05396014|448611659|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724087|NCT05396014|448611660|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
124724088|NCT05396014|448611661|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724089|NCT05396014|448611662|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724090|NCT05396014|448611663|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724091|NCT05396014|448611664|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724092|NCT05396014|448611665|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724093|NCT05396014|448611666|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724094|NCT05396014|448611667|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
124724095|NCT05396014|448611668|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
124724096|NCT05396014|448611669|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
124724097|NCT05396014|448611670|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
124724098|NCT05396014|448611671|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724099|NCT05396014|448611672|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724100|NCT05396014|448611673|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724101|NCT05396014|448611674|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724102|NCT05396014|448611675|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
124724103|NCT05396014|448611676|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
124724104|NCT05396014|448611677|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724105|NCT05396014|448611678|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724106|NCT05396014|448611679|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
124724107|NCT05396014|448611680|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724108|NCT05396014|448611681|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724109|NCT05396014|448611682|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724110|NCT05396014|448611683|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724111|NCT05396014|448611684|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
124724112|NCT05396014|448611685|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
124724113|NCT05396014|448611686|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
124724114|NCT05396014|448611687|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
124724115|NCT05396014|448611645|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724116|NCT05396014|448611646|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724117|NCT05396014|448611647|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724118|NCT05396014|448611648|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724119|NCT05396014|448611649|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724120|NCT05396014|448611650|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724121|NCT05396014|448611651|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
124724122|NCT05396014|448611652|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724123|NCT05396014|448611653|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
124724124|NCT05396014|448611654|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724125|NCT05396014|448611655|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724126|NCT05396014|448611656|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724127|NCT05396014|448611657|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724128|NCT05396014|448611658|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
124724129|NCT05396014|448611659|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124498569|NCT03015610|447778196|FG000|Overall Study|Lost to Follow-up|1|||
124498570|NCT03015610|447778197|FG001|Overall Study|Lost to Follow-up|5|||
124498571|NCT05692154|447778199|FG000|Overall Study|Adverse Event|0|||
124498572|NCT05692154|447778200|FG001|Overall Study|Adverse Event|1|||
124498573|NCT00938327|447778206|FG000|Overall Study|Adverse Event|2|||
124498574|NCT00938327|447778206|FG000|Overall Study|Protocol Violation|1|||
124724130|NCT05396014|448611660|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724131|NCT05396014|448611661|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
124559030|NCT01360632|448003440|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
124559031|NCT01360632|448003441|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
124559032|NCT01360632|448003442|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
124559033|NCT01360632|448003438|FG000|Phase B (6 Weeks)|Adverse Event|0|||
124559034|NCT01360632|448003439|FG001|Phase B (6 Weeks)|Adverse Event|3|||
124559035|NCT01360632|448003440|FG002|Phase B (6 Weeks)|Adverse Event|9|||
124559036|NCT01360632|448003441|FG003|Phase B (6 Weeks)|Adverse Event|3|||
124559037|NCT01360632|448003442|FG004|Phase B (6 Weeks)|Adverse Event|0|||
124559038|NCT01360632|448003438|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
124559039|NCT01360632|448003439|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
124559040|NCT01360632|448003440|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
124559041|NCT01360632|448003441|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
124559042|NCT01360632|448003442|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
124559043|NCT01360632|448003438|FG000|Phase B (6 Weeks)|Physician Decision|0|||
124559044|NCT01360632|448003439|FG001|Phase B (6 Weeks)|Physician Decision|0|||
124559045|NCT01360632|448003440|FG002|Phase B (6 Weeks)|Physician Decision|0|||
124559046|NCT01360632|448003441|FG003|Phase B (6 Weeks)|Physician Decision|1|||
124559047|NCT01360632|448003442|FG004|Phase B (6 Weeks)|Physician Decision|0|||
124559048|NCT01360632|448003438|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
124559049|NCT01360632|448003439|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
124559050|NCT01360632|448003440|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
124559051|NCT01360632|448003441|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
124559052|NCT01360632|448003442|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
124559053|NCT01360632|448003438|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
124559054|NCT01360632|448003439|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
124559055|NCT01360632|448003440|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
124559056|NCT01360632|448003441|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
124559057|NCT01360632|448003442|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
124559058|NCT01360632|448003438|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
124559059|NCT01360632|448003439|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
124559060|NCT01360632|448003440|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
124559061|NCT01360632|448003441|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
124559062|NCT01360632|448003442|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
124559063|NCT01360632|448003438|FG000|Phase A+|Lost to Follow-up|0|||
124559064|NCT01360632|448003439|FG001|Phase A+|Lost to Follow-up|0|||
124559065|NCT01360632|448003440|FG002|Phase A+|Lost to Follow-up|0|||
124559066|NCT01360632|448003441|FG003|Phase A+|Lost to Follow-up|0|||
124559067|NCT01360632|448003442|FG004|Phase A+|Lost to Follow-up|2|||
124559068|NCT01360632|448003438|FG000|Phase A+|Adverse Event|0|||
124559069|NCT01360632|448003439|FG001|Phase A+|Adverse Event|0|||
124724132|NCT05396014|448611662|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
124498575|NCT00938327|447778206|FG000|Overall Study|Withdrawal by Subject|4|||
124498576|NCT00938327|447778206|FG000|Overall Study|Lost to Follow-up|37|||
124498577|NCT00938327|447778206|FG000|Overall Study|2nd dose received outside of the study|7|||
124498578|NCT00938327|447778206|FG000|Overall Study|Vaccine not received as out of stock|9|||
124498579|NCT01379534|447778207|FG000|Treatment Phase|Withdrawal by Subject|2|||
124498580|NCT01379534|447778208|FG001|Treatment Phase|Withdrawal by Subject|2|||
124498581|NCT01379534|447778207|FG000|Treatment Phase|Progressive disease|13|||
124498582|NCT01379534|447778208|FG001|Treatment Phase|Progressive disease|22|||
124498583|NCT01379534|447778207|FG000|Treatment Phase|Adverse Event|7|||
124498584|NCT01379534|447778208|FG001|Treatment Phase|Adverse Event|7|||
124498585|NCT01379534|447778207|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
124498586|NCT01379534|447778208|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
124498587|NCT01379534|447778207|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
124498588|NCT01379534|447778208|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
124498589|NCT01379534|447778207|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
124498590|NCT01379534|447778208|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
124498591|NCT01379534|447778207|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
124498592|NCT01379534|447778208|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
124498593|NCT02552355|447778209|FG000|Overall Study|Adverse Event|0|||
124498594|NCT02552355|447778210|FG001|Overall Study|Adverse Event|2|||
124498595|NCT02552355|447778211|FG002|Overall Study|Adverse Event|2|||
124498596|NCT02552355|447778212|FG003|Overall Study|Adverse Event|0|||
124498597|NCT02552355|447778209|FG000|Overall Study|Withdrawal by Subject|0|||
124498598|NCT02552355|447778210|FG001|Overall Study|Withdrawal by Subject|0|||
124498599|NCT02552355|447778211|FG002|Overall Study|Withdrawal by Subject|0|||
124498600|NCT02552355|447778212|FG003|Overall Study|Withdrawal by Subject|1|||
124498601|NCT01519245|447778213|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
124498602|NCT01519245|447778214|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
124498603|NCT04072146|447778217|FG000|Overall Study|Adverse Event|0|||
124559070|NCT01360632|448003440|FG002|Phase A+|Adverse Event|0|||
124559071|NCT01360632|448003441|FG003|Phase A+|Adverse Event|0|||
124559072|NCT01360632|448003442|FG004|Phase A+|Adverse Event|2|||
124559073|NCT01360632|448003438|FG000|Phase A+|Met Withdrawal Criteria|0|||
124559074|NCT01360632|448003439|FG001|Phase A+|Met Withdrawal Criteria|0|||
124498604|NCT04072146|447778218|FG001|Overall Study|Adverse Event|1|||
124498605|NCT01193348|447778219|FG000|Screening Period|Screen Failure|5|||
124498606|NCT01193348|447778219|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
124498607|NCT01193348|447778219|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
124498608|NCT01193348|447778219|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
124498609|NCT01193348|447778219|FG000|Extension Treatment Period|Physician Decision|1|||
124498610|NCT01193348|447778219|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
124498611|NCT03141086|447778220|FG000|Overall Study|Study Terminated By Sponsor|1|||
124498612|NCT03141086|447778221|FG001|Overall Study|Study Terminated By Sponsor|1|||
124498613|NCT03141086|447778220|FG000|Overall Study|Withdrawal by Subject|0|||
124498614|NCT03141086|447778221|FG001|Overall Study|Withdrawal by Subject|1|||
124498615|NCT03141086|447778220|FG000|Overall Study|Protocol Violation|0|||
124498616|NCT03141086|447778221|FG001|Overall Study|Protocol Violation|1|||
124498617|NCT03141086|447778220|FG000|Overall Study|Adverse Event|0|||
124498618|NCT03141086|447778221|FG001|Overall Study|Adverse Event|2|||
124498619|NCT01064648|447778222|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
124498620|NCT01064648|447778223|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
124498621|NCT01064648|447778224|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
124498622|NCT01064648|447778225|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
124498623|NCT01064648|447778222|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
124498624|NCT01064648|447778223|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
124498625|NCT01064648|447778224|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
124498626|NCT01064648|447778225|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
124498627|NCT01064648|447778222|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
124498628|NCT01064648|447778223|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
124498629|NCT01064648|447778224|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
124498630|NCT01064648|447778225|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
124498631|NCT01064648|447778222|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
124498632|NCT01064648|447778223|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
124498633|NCT01064648|447778224|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
124498634|NCT01064648|447778225|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
124498635|NCT01064648|447778222|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
124498636|NCT01064648|447778223|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
124498637|NCT01064648|447778224|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
124498638|NCT01064648|447778225|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
124498639|NCT01064648|447778222|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
124498640|NCT01064648|447778223|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
124498641|NCT01064648|447778224|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
124724133|NCT05396014|448611663|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
124724134|NCT05396014|448611664|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724135|NCT05396014|448611665|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724136|NCT05396014|448611666|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
124724137|NCT05396014|448611667|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
124724138|NCT05396014|448611668|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724139|NCT05396014|448611669|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
124724140|NCT05396014|448611670|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
124724141|NCT05396014|448611671|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
124724142|NCT05396014|448611672|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
124724143|NCT05396014|448611673|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724144|NCT05396014|448611674|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124498642|NCT01064648|447778225|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
124498643|NCT01064648|447778222|FG000|Phase II|Adverse Event|0|||
124498644|NCT01064648|447778223|FG001|Phase II|Adverse Event|0|||
124498645|NCT01064648|447778224|FG002|Phase II|Adverse Event|15|||
124498646|NCT01064648|447778225|FG003|Phase II|Adverse Event|8|||
124498647|NCT01064648|447778222|FG000|Phase II|Death|0|||
124498648|NCT01064648|447778223|FG001|Phase II|Death|0|||
124498649|NCT01064648|447778224|FG002|Phase II|Death|4|||
124498650|NCT01064648|447778225|FG003|Phase II|Death|5|||
124498651|NCT01064648|447778222|FG000|Phase II|Withdrawal by Subject|0|||
124498652|NCT01064648|447778223|FG001|Phase II|Withdrawal by Subject|0|||
124498653|NCT01064648|447778224|FG002|Phase II|Withdrawal by Subject|2|||
124498654|NCT01064648|447778225|FG003|Phase II|Withdrawal by Subject|5|||
124498655|NCT01064648|447778222|FG000|Phase II|Progression|0|||
124498656|NCT01064648|447778223|FG001|Phase II|Progression|0|||
124498657|NCT01064648|447778224|FG002|Phase II|Progression|21|||
124498658|NCT01064648|447778225|FG003|Phase II|Progression|27|||
124498659|NCT01064648|447778222|FG000|Phase II|Non-protocol specified|0|||
124559075|NCT01360632|448003440|FG002|Phase A+|Met Withdrawal Criteria|0|||
124559076|NCT01360632|448003441|FG003|Phase A+|Met Withdrawal Criteria|0|||
124724145|NCT05396014|448611675|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724146|NCT05396014|448611676|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
124724147|NCT05396014|448611677|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
124559077|NCT01360632|448003442|FG004|Phase A+|Met Withdrawal Criteria|7|||
124559078|NCT01360632|448003438|FG000|Phase A+|Physician Decision|0|||
124559079|NCT01360632|448003439|FG001|Phase A+|Physician Decision|0|||
124559080|NCT01360632|448003440|FG002|Phase A+|Physician Decision|0|||
124559081|NCT01360632|448003441|FG003|Phase A+|Physician Decision|0|||
124559082|NCT01360632|448003442|FG004|Phase A+|Physician Decision|3|||
124559083|NCT01360632|448003438|FG000|Phase A+|Withdrawal by Subject|0|||
124559084|NCT01360632|448003439|FG001|Phase A+|Withdrawal by Subject|0|||
124559085|NCT01360632|448003440|FG002|Phase A+|Withdrawal by Subject|0|||
124559086|NCT01360632|448003441|FG003|Phase A+|Withdrawal by Subject|0|||
124559087|NCT01360632|448003442|FG004|Phase A+|Withdrawal by Subject|8|||
124559088|NCT01360632|448003438|FG000|Phase A+|Protocol Deviation|0|||
124559089|NCT01360632|448003439|FG001|Phase A+|Protocol Deviation|0|||
124559090|NCT01360632|448003440|FG002|Phase A+|Protocol Deviation|0|||
124559091|NCT01360632|448003441|FG003|Phase A+|Protocol Deviation|0|||
124559092|NCT01360632|448003442|FG004|Phase A+|Protocol Deviation|3|||
124559093|NCT01084005|448005203|FG000|Overall Study|Adverse Event|1|||
124559094|NCT01084005|448005204|FG001|Overall Study|Adverse Event|8|||
124559095|NCT01084005|448005203|FG000|Overall Study|Protocol Violation|3|||
124559096|NCT01084005|448005204|FG001|Overall Study|Protocol Violation|7|||
124498660|NCT01064648|447778223|FG001|Phase II|Non-protocol specified|0|||
124498661|NCT01064648|447778224|FG002|Phase II|Non-protocol specified|5|||
124498662|NCT01064648|447778225|FG003|Phase II|Non-protocol specified|3|||
124498663|NCT01064648|447778222|FG000|Phase II|Under Review|0|||
124498664|NCT01064648|447778223|FG001|Phase II|Under Review|0|||
124498665|NCT01064648|447778224|FG002|Phase II|Under Review|2|||
124498666|NCT01064648|447778225|FG003|Phase II|Under Review|0|||
124498667|NCT00977574|447778226|FG000|Overall Study|Never Treated|4|||
124498668|NCT00977574|447778227|FG001|Overall Study|Never Treated|2|||
124498669|NCT00977574|447778228|FG002|Overall Study|Never Treated|4|||
124498670|NCT00719732|447778229|FG000|Overall Study|Lost to Follow-up|20|||
124498671|NCT00719732|447778229|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
124498672|NCT00719732|447778229|FG000|Overall Study|Illness not associated with device|1|||
124498673|NCT05183867|447779878|FG000|Overall Study|Withdrawal by Subject|3|||
124498674|NCT05183867|447779879|FG001|Overall Study|Withdrawal by Subject|2|||
124498675|NCT05183867|447779880|FG002|Overall Study|Withdrawal by Subject|0|||
124498676|NCT04491877|447779883|FG000|Overall Study|Protocol Deviation|1|||
124498677|NCT04491877|447779884|FG001|Overall Study|Protocol Deviation|0|||
124498678|NCT04491877|447779885|FG002|Overall Study|Protocol Deviation|2|||
124498679|NCT04491877|447779886|FG003|Overall Study|Protocol Deviation|0|||
124498680|NCT04491877|447779887|FG004|Overall Study|Protocol Deviation|0|||
124498681|NCT04491877|447779888|FG005|Overall Study|Protocol Deviation|0|||
124498682|NCT04491877|447779889|FG006|Overall Study|Protocol Deviation|1|||
124498683|NCT04491877|447779890|FG007|Overall Study|Protocol Deviation|1|||
124498684|NCT04491877|447779891|FG008|Overall Study|Protocol Deviation|0|||
124498685|NCT04491877|447779883|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124498686|NCT04491877|447779884|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124498687|NCT04491877|447779885|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
124498688|NCT04491877|447779886|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
124498689|NCT04491877|447779887|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
124498690|NCT04491877|447779888|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
124498691|NCT04491877|447779889|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
124498692|NCT04491877|447779890|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
124498693|NCT04491877|447779891|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
124498694|NCT04491877|447779883|FG000|Overall Study|Lost to Follow-up|0|||
124498695|NCT04491877|447779884|FG001|Overall Study|Lost to Follow-up|2|||
124498696|NCT04491877|447779885|FG002|Overall Study|Lost to Follow-up|0|||
124498697|NCT04491877|447779886|FG003|Overall Study|Lost to Follow-up|0|||
124498698|NCT04491877|447779887|FG004|Overall Study|Lost to Follow-up|0|||
124498699|NCT04491877|447779888|FG005|Overall Study|Lost to Follow-up|0|||
124498700|NCT04491877|447779889|FG006|Overall Study|Lost to Follow-up|2|||
124498701|NCT04491877|447779890|FG007|Overall Study|Lost to Follow-up|1|||
124498702|NCT04491877|447779891|FG008|Overall Study|Lost to Follow-up|1|||
124498703|NCT04920084|447779895|FG000|Overall Study|Adverse Event|1|||
124498704|NCT04920084|447779895|FG000|Overall Study|Lost to Follow-up|2|||
124498705|NCT04920084|447779895|FG000|Overall Study|Withdrawal by Subject|2|||
124498706|NCT01953328|447779901|FG000|Overall Study|Withdrawal by Subject|0|||
124498707|NCT01953328|447779902|FG001|Overall Study|Withdrawal by Subject|0|||
124559097|NCT01084005|448005203|FG000|Overall Study|Withdrawal by Subject|1|||
124498708|NCT01953328|447779903|FG002|Overall Study|Withdrawal by Subject|0|||
124498709|NCT01953328|447779904|FG003|Overall Study|Withdrawal by Subject|0|||
124498710|NCT01953328|447779905|FG004|Overall Study|Withdrawal by Subject|1|||
124498711|NCT01953328|447779906|FG005|Overall Study|Withdrawal by Subject|0|||
124498712|NCT01953328|447779907|FG006|Overall Study|Withdrawal by Subject|0|||
124498713|NCT01953328|447779908|FG007|Overall Study|Withdrawal by Subject|0|||
124559098|NCT01084005|448005204|FG001|Overall Study|Withdrawal by Subject|1|||
124559099|NCT02480010|448005205|FG000|Overall Study|Adverse Event|3|||
124498714|NCT01953328|447779901|FG000|Overall Study|Lost to Follow-up|0|||
124498715|NCT01953328|447779902|FG001|Overall Study|Lost to Follow-up|0|||
124559100|NCT02480010|448005206|FG001|Overall Study|Adverse Event|1|||
124774378|NCT02531802|448802827|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
124774379|NCT02531802|448802828|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
124774380|NCT02531802|448802829|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
124774381|NCT01249261|448802835|FG000|Overall Study|Withdrawal by Subject|1|||
124774382|NCT01249261|448802836|FG001|Overall Study|Withdrawal by Subject|0|||
124774383|NCT02819804|448802837|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
124774384|NCT00482053|448802841|FG000|Inter-treatment Period|Disease progression|1|||
124774385|NCT00346697|448802844|FG000|Overall Study|Lost to Follow-up|0|||
124774386|NCT00346697|448802845|FG001|Overall Study|Lost to Follow-up|1|||
124774387|NCT01055197|448802847|FG000|Overall Study|Protocol Violation|7|||
124774388|NCT01055197|448802848|FG001|Overall Study|Protocol Violation|2|||
124774389|NCT01055197|448802847|FG000|Overall Study|Withdrawal by Subject|2|||
124774390|NCT01055197|448802848|FG001|Overall Study|Withdrawal by Subject|0|||
124774391|NCT03739203|448802849|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
124774392|NCT03739203|448802850|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
124774393|NCT03739203|448802851|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
124774394|NCT03739203|448802849|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
124774395|NCT03739203|448802850|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
124774396|NCT03739203|448802851|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
124774397|NCT03739203|448802849|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
124774398|NCT03739203|448802850|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
124774399|NCT03739203|448802851|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
124774400|NCT03739203|448802849|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
124774401|NCT03739203|448802850|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
124774402|NCT03739203|448802851|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
124774403|NCT03739203|448802849|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
124774404|NCT03739203|448802850|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
124774405|NCT03739203|448802851|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
124774406|NCT03739203|448802849|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
124774407|NCT03739203|448802850|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
124774408|NCT03739203|448802851|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
124774409|NCT03739203|448802849|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
124774410|NCT03739203|448802850|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
124774411|NCT03739203|448802851|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
124498716|NCT01953328|447779903|FG002|Overall Study|Lost to Follow-up|0|||
124498717|NCT01953328|447779904|FG003|Overall Study|Lost to Follow-up|0|||
124498718|NCT01953328|447779905|FG004|Overall Study|Lost to Follow-up|1|||
124498719|NCT01953328|447779906|FG005|Overall Study|Lost to Follow-up|0|||
124498720|NCT01953328|447779907|FG006|Overall Study|Lost to Follow-up|0|||
124498721|NCT01953328|447779908|FG007|Overall Study|Lost to Follow-up|0|||
124498722|NCT00523341|447779909|FG000|Overall Study|Withdrawal by Subject|399|||
124498723|NCT00523341|447779910|FG001|Overall Study|Withdrawal by Subject|427|||
124498724|NCT00523341|447779909|FG000|Overall Study|Other|181|||
124498725|NCT00523341|447779910|FG001|Overall Study|Other|198|||
124498726|NCT00523341|447779909|FG000|Overall Study|Adverse Event|122|||
124498727|NCT00523341|447779910|FG001|Overall Study|Adverse Event|155|||
124498728|NCT00523341|447779909|FG000|Overall Study|Death|101|||
124498729|NCT00523341|447779910|FG001|Overall Study|Death|110|||
124498730|NCT00523341|447779909|FG000|Overall Study|Lost to Follow-up|73|||
124498731|NCT00523341|447779910|FG001|Overall Study|Lost to Follow-up|61|||
124498732|NCT00523341|447779909|FG000|Overall Study|Non-compliance|20|||
124559101|NCT02480010|448005205|FG000|Overall Study|Death|1|||
124774412|NCT03739203|448802849|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
124774413|NCT03739203|448802850|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
124498733|NCT00523341|447779910|FG001|Overall Study|Non-compliance|13|||
124498734|NCT00523341|447779909|FG000|Overall Study|Physician Decision|14|||
124498735|NCT00523341|447779910|FG001|Overall Study|Physician Decision|13|||
124498736|NCT00523341|447779909|FG000|Overall Study|Requirement for Alternative Therapy|4|||
124498737|NCT00523341|447779910|FG001|Overall Study|Requirement for Alternative Therapy|14|||
124498738|NCT00523341|447779909|FG000|Overall Study|Protocol Deviation|6|||
124498739|NCT00523341|447779910|FG001|Overall Study|Protocol Deviation|5|||
124498740|NCT00523341|447779909|FG000|Overall Study|Ineligibility Determined|3|||
124498741|NCT00523341|447779910|FG001|Overall Study|Ineligibility Determined|4|||
124498742|NCT00523341|447779909|FG000|Overall Study|Disease Progression|1|||
124498743|NCT00523341|447779910|FG001|Overall Study|Disease Progression|0|||
124498744|NCT02626819|447779913|FG000|Overall Study|Lost to Follow-up|3|||
124498745|NCT02626819|447779914|FG001|Overall Study|Lost to Follow-up|2|||
124498746|NCT02626819|447779913|FG000|Overall Study|Withdrawal by Subject|1|||
124498747|NCT02626819|447779914|FG001|Overall Study|Withdrawal by Subject|0|||
124498748|NCT02626819|447779913|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
124559102|NCT02480010|448005206|FG001|Overall Study|Death|0|||
124774414|NCT03739203|448802851|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
124774415|NCT03739203|448802849|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
124774416|NCT03739203|448802850|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
124774417|NCT03739203|448802851|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
124774418|NCT03739203|448802849|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
124774419|NCT03739203|448802850|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
124774420|NCT03739203|448802851|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
124774421|NCT03739203|448802849|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
124774422|NCT03739203|448802850|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
124774423|NCT03739203|448802851|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
124774424|NCT03131570|448802852|FG000|Overall Study|Adverse Event|1|||
124774425|NCT03131570|448802853|FG001|Overall Study|Adverse Event|0|||
124774426|NCT01782378|448802854|FG000|First Series|Lost to Follow-up|7|||
124774427|NCT01782378|448802855|FG001|First Series|Lost to Follow-up|8|||
124774428|NCT01782378|448802854|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
124774429|NCT01782378|448802855|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
124774430|NCT01782378|448802854|FG000|Second Series|Lost to Follow-up|8|||
124774431|NCT01782378|448802855|FG001|Second Series|Lost to Follow-up|7|||
124774432|NCT01782378|448802854|FG000|Second Series|Did not choose to complete S2 Optional|18|||
124774433|NCT01782378|448802855|FG001|Second Series|Did not choose to complete S2 Optional|0|||
124774434|NCT00830440|448802856|FG000|Overall Study|Protocol Violation|1|||
124774435|NCT00830440|448802857|FG001|Overall Study|Protocol Violation|0|||
124774436|NCT00830440|448802856|FG000|Overall Study|Withdrawal by Subject|1|||
124774437|NCT00830440|448802857|FG001|Overall Study|Withdrawal by Subject|0|||
124774438|NCT00830440|448802856|FG000|Overall Study|unsuccessful procedure|4|||
124774439|NCT00830440|448802857|FG001|Overall Study|unsuccessful procedure|0|||
124774440|NCT00830440|448802856|FG000|Overall Study|Adverse Event|2|||
124774441|NCT00830440|448802857|FG001|Overall Study|Adverse Event|0|||
124774442|NCT00391586|448802860|FG000|Overall Study|Progressive disease|13|||
124774443|NCT00391586|448802860|FG000|Overall Study|Adverse Event|5|||
124774444|NCT00391586|448802860|FG000|Overall Study|Physician Decision|2|||
124774445|NCT00391586|448802860|FG000|Overall Study|Death|4|||
124498749|NCT02626819|447779914|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
124724148|NCT05396014|448611678|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724149|NCT05396014|448611679|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
124724150|NCT05396014|448611680|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
124724151|NCT05396014|448611681|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724152|NCT05396014|448611682|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724153|NCT05396014|448611683|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724154|NCT05396014|448611684|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
124724155|NCT05396014|448611685|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
124724156|NCT05396014|448611686|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
124724157|NCT05396014|448611687|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
124724158|NCT05396014|448611645|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724159|NCT05396014|448611646|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724160|NCT05396014|448611647|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724161|NCT05396014|448611648|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724162|NCT05396014|448611649|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724163|NCT05396014|448611650|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724164|NCT05396014|448611651|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724165|NCT05396014|448611652|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724166|NCT05396014|448611653|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724167|NCT05396014|448611654|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724168|NCT05396014|448611655|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724169|NCT05396014|448611656|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724170|NCT05396014|448611657|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724171|NCT05396014|448611658|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
124724172|NCT05396014|448611659|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724173|NCT05396014|448611660|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724174|NCT05396014|448611661|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724175|NCT05396014|448611662|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724176|NCT05396014|448611663|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124498750|NCT00502307|447779917|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
124498751|NCT00502307|447779918|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
124498752|NCT00502307|447779919|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
124724177|NCT05396014|448611664|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724178|NCT05396014|448611665|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124774446|NCT00904982|448802861|FG000|Overall Study|Withdrawal by Subject|2|||
124774447|NCT00904982|448802862|FG001|Overall Study|Withdrawal by Subject|0|||
124774448|NCT00904982|448802863|FG002|Overall Study|Withdrawal by Subject|0|||
124498753|NCT00502307|447779917|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
124774449|NCT00904982|448802864|FG003|Overall Study|Withdrawal by Subject|0|||
124774450|NCT02420821|448802869|FG000|Overall Study|Lost to Follow-up|6|||
124774451|NCT02420821|448802870|FG001|Overall Study|Lost to Follow-up|6|||
124774452|NCT02420821|448802869|FG000|Overall Study|Non-compliance|0|||
124774453|NCT02420821|448802870|FG001|Overall Study|Non-compliance|2|||
124774454|NCT02420821|448802869|FG000|Overall Study|Physician Decision|6|||
124774455|NCT02420821|448802870|FG001|Overall Study|Physician Decision|2|||
124774456|NCT02420821|448802869|FG000|Overall Study|Withdrawal by Subject|32|||
124774457|NCT02420821|448802870|FG001|Overall Study|Withdrawal by Subject|25|||
124774458|NCT02420821|448802869|FG000|Overall Study|Death|270|||
124774459|NCT02420821|448802870|FG001|Overall Study|Death|263|||
124774460|NCT02420821|448802869|FG000|Overall Study|Study Terminated By Sponsor|145|||
124774461|NCT02420821|448802870|FG001|Overall Study|Study Terminated By Sponsor|149|||
124774462|NCT02420821|448802869|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
124774463|NCT02420821|448802870|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
124774464|NCT02420821|448802869|FG000|Overall Study|Adverse Event|0|||
124774465|NCT02420821|448802870|FG001|Overall Study|Adverse Event|1|||
124774466|NCT02420821|448802869|FG000|Overall Study|Protinuria|0|||
124774467|NCT02420821|448802870|FG001|Overall Study|Protinuria|1|||
124774468|NCT02420821|448802869|FG000|Overall Study|Progressive Disease|1|||
124774469|NCT02420821|448802870|FG001|Overall Study|Progressive Disease|1|||
124774470|NCT02420821|448802869|FG000|Overall Study|Disease Progression|0|||
124774471|NCT02420821|448802870|FG001|Overall Study|Disease Progression|1|||
124774472|NCT02420821|448802869|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
124774473|NCT02420821|448802870|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
124498754|NCT00502307|447779918|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
124498755|NCT00502307|447779919|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
124498756|NCT00502307|447779917|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
124498757|NCT00502307|447779918|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
124498758|NCT00502307|447779919|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
124498759|NCT00502307|447779917|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
124498760|NCT00502307|447779918|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
124498761|NCT00502307|447779919|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
124498762|NCT00502307|447779917|FG000|Maintenance Period|Progressive disease|80|||
124498763|NCT00502307|447779918|FG001|Maintenance Period|Progressive disease|0|||
124498764|NCT00502307|447779919|FG002|Maintenance Period|Progressive disease|0|||
124498765|NCT00502307|447779917|FG000|Maintenance Period|Discontinued due to other reasons|68|||
124498766|NCT00502307|447779918|FG001|Maintenance Period|Discontinued due to other reasons|0|||
124498767|NCT00502307|447779919|FG002|Maintenance Period|Discontinued due to other reasons|0|||
124498768|NCT00051558|447779920|FG000|Overall Study|Adverse Event|30|||
124498769|NCT00051558|447779921|FG001|Overall Study|Adverse Event|18|||
124498770|NCT00051558|447779920|FG000|Overall Study|Withdrawal by Subject|29|||
124498771|NCT00051558|447779921|FG001|Overall Study|Withdrawal by Subject|42|||
124498772|NCT00051558|447779920|FG000|Overall Study|Death|9|||
124498773|NCT00051558|447779921|FG001|Overall Study|Death|15|||
124498774|NCT00051558|447779920|FG000|Overall Study|Lost to Follow-up|4|||
124498775|NCT00051558|447779921|FG001|Overall Study|Lost to Follow-up|13|||
124498776|NCT00051558|447779920|FG000|Overall Study|Protocol Violation|3|||
124498777|NCT00051558|447779921|FG001|Overall Study|Protocol Violation|4|||
124498778|NCT00051558|447779920|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
124498779|NCT00051558|447779921|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
124498780|NCT00051558|447779920|FG000|Overall Study|Sponsor Decision|6|||
124498781|NCT00051558|447779921|FG001|Overall Study|Sponsor Decision|1|||
124498782|NCT00051558|447779920|FG000|Overall Study|Other|2|||
124498783|NCT00051558|447779921|FG001|Overall Study|Other|1|||
124498784|NCT00051558|447779920|FG000|Overall Study|Significant Lab Value|2|||
124498785|NCT00051558|447779921|FG001|Overall Study|Significant Lab Value|0|||
124559103|NCT02480010|448005205|FG000|Overall Study|Insufficient therapeutic response|31|||
124559104|NCT02480010|448005206|FG001|Overall Study|Insufficient therapeutic response|29|||
124559105|NCT02480010|448005205|FG000|Overall Study|Refused Treatment|0|||
124559106|NCT02480010|448005206|FG001|Overall Study|Refused Treatment|3|||
124559107|NCT01034137|448005210|FG000|Overall Study|Adverse Event|9|||
124559108|NCT01034137|448005211|FG001|Overall Study|Adverse Event|10|||
124559109|NCT01034137|448005212|FG002|Overall Study|Adverse Event|8|||
124774474|NCT00686712|448802871|FG000|Overall Study|Protocol Violation|8|||
124774475|NCT00686712|448802872|FG001|Overall Study|Protocol Violation|8|||
124498786|NCT00051558|447779920|FG000|Overall Study|Physician Decision|5|||
124498787|NCT00051558|447779921|FG001|Overall Study|Physician Decision|0|||
124559110|NCT01034137|448005210|FG000|Overall Study|Withdrawal by Subject|4|||
124774476|NCT00686712|448802873|FG002|Overall Study|Protocol Violation|10|||
124498788|NCT02849990|447779929|FG000|Overall Study|Adverse Event|1|||
124498789|NCT02849990|447779929|FG000|Overall Study|Withdrawal by Subject|1|||
124498790|NCT01051986|447779930|FG000|Overall Study|Death|1|||
124774477|NCT00686712|448802871|FG000|Overall Study|Lost to Follow-up|1|||
124774478|NCT00686712|448802872|FG001|Overall Study|Lost to Follow-up|2|||
124774479|NCT00686712|448802873|FG002|Overall Study|Lost to Follow-up|3|||
124498791|NCT01051986|447779931|FG001|Overall Study|Death|0|||
124498792|NCT01051986|447779930|FG000|Overall Study|Withdrawal by Subject|2|||
124498793|NCT01051986|447779931|FG001|Overall Study|Withdrawal by Subject|1|||
124498794|NCT01051986|447779930|FG000|Overall Study|Protocol Violation|2|||
124498795|NCT01051986|447779931|FG001|Overall Study|Protocol Violation|3|||
124498796|NCT01725152|447779933|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
124498797|NCT01725152|447779934|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
124498798|NCT01725152|447779933|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
124498799|NCT01725152|447779934|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
124498800|NCT01725152|447779933|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
124498801|NCT01725152|447779934|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
124559111|NCT01034137|448005211|FG001|Overall Study|Withdrawal by Subject|3|||
124559112|NCT01034137|448005212|FG002|Overall Study|Withdrawal by Subject|3|||
124559113|NCT01034137|448005210|FG000|Overall Study|Lack of Efficacy|9|||
124559114|NCT01034137|448005211|FG001|Overall Study|Lack of Efficacy|4|||
124724179|NCT05396014|448611666|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724180|NCT05396014|448611667|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724181|NCT05396014|448611668|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724182|NCT05396014|448611669|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724183|NCT05396014|448611670|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724184|NCT05396014|448611671|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
124724185|NCT05396014|448611672|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724186|NCT05396014|448611673|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724187|NCT05396014|448611674|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724188|NCT05396014|448611675|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724189|NCT05396014|448611676|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724190|NCT05396014|448611677|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724191|NCT05396014|448611678|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724192|NCT05396014|448611679|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
124724193|NCT05396014|448611680|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724194|NCT05396014|448611681|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724195|NCT05396014|448611682|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724196|NCT05396014|448611683|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724197|NCT05396014|448611684|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724198|NCT05396014|448611685|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724199|NCT05396014|448611686|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
124724200|NCT05396014|448611687|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
124724201|NCT05396014|448611645|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724202|NCT05396014|448611646|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724203|NCT05396014|448611647|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124498802|NCT01725152|447779933|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
124498803|NCT01725152|447779934|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
124498804|NCT01111539|447779936|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
124498805|NCT01111539|447779937|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
124498806|NCT01111539|447779938|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
124498807|NCT01111539|447779939|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
124498808|NCT01111539|447779940|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
124498809|NCT01111539|447779936|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
124498810|NCT01111539|447779937|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
124498811|NCT01111539|447779938|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
124498812|NCT01111539|447779939|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
124498813|NCT01111539|447779940|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
124498814|NCT01111539|447779936|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
124498815|NCT01111539|447779937|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
124498816|NCT01111539|447779938|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
124498817|NCT01111539|447779939|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
124498818|NCT01111539|447779940|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
124498819|NCT01111539|447779936|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
124498820|NCT01111539|447779937|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
124498821|NCT01111539|447779938|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
124498822|NCT01111539|447779939|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
124498823|NCT01111539|447779940|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
124498824|NCT01111539|447779936|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
124498825|NCT01111539|447779937|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
124498826|NCT01111539|447779938|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
124498827|NCT01111539|447779939|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
124498828|NCT01111539|447779940|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
124498829|NCT01111539|447779936|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
124498830|NCT01111539|447779937|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
124498831|NCT01111539|447779938|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
124498832|NCT01111539|447779939|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
124498833|NCT01111539|447779940|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
124498834|NCT01111539|447779936|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
124498835|NCT01111539|447779937|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
124498836|NCT01111539|447779938|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
124498837|NCT01111539|447779939|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
124498838|NCT01111539|447779940|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
124498839|NCT01111539|447779936|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
124498840|NCT01111539|447779937|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
124498841|NCT01111539|447779938|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
124498842|NCT01111539|447779939|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
124498843|NCT01111539|447779940|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
124498844|NCT01111539|447779936|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
124498845|NCT01111539|447779937|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
124498846|NCT01111539|447779938|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
124498847|NCT01111539|447779939|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
124498848|NCT01111539|447779940|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
124498849|NCT01111539|447779936|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
124498850|NCT01111539|447779937|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
124498851|NCT01111539|447779938|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
124498852|NCT01111539|447779939|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
124498853|NCT01111539|447779940|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
124498854|NCT01111539|447779936|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
124498855|NCT01111539|447779937|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
124498856|NCT01111539|447779938|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
124498857|NCT01111539|447779939|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
124498858|NCT01111539|447779940|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
124498859|NCT01111539|447779936|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
124498860|NCT01111539|447779937|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
124498861|NCT01111539|447779938|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
124498862|NCT01111539|447779939|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
124498863|NCT01111539|447779940|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
124498864|NCT01111539|447779936|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
124498865|NCT01111539|447779937|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
124498866|NCT01111539|447779938|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
124498867|NCT01111539|447779939|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
124498868|NCT01111539|447779940|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
124498869|NCT01111539|447779936|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
124498870|NCT01111539|447779937|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
124498871|NCT01111539|447779938|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
124498872|NCT01111539|447779939|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
124498873|NCT01111539|447779940|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
124498874|NCT03628417|447779941|FG000|Overall Study|Death|1|||
124498875|NCT03628417|447779942|FG001|Overall Study|Death|1|||
124498876|NCT03539458|447779943|FG000|Overall Study|Death|1|||
124498877|NCT00372190|447779944|FG000|Overall Study|Lost to Follow-up|3|||
124498878|NCT00372190|447779945|FG001|Overall Study|Lost to Follow-up|1|||
124498879|NCT00718419|447779946|FG000|Overall Study|Adverse Event|2|||
124498880|NCT00718419|447779947|FG001|Overall Study|Adverse Event|1|||
124498881|NCT00718419|447779946|FG000|Overall Study|Physician Decision|1|||
124498882|NCT00718419|447779947|FG001|Overall Study|Physician Decision|6|||
124498883|NCT00718419|447779946|FG000|Overall Study|Sponsor decision|0|||
124498884|NCT00718419|447779947|FG001|Overall Study|Sponsor decision|1|||
124498885|NCT00718419|447779946|FG000|Overall Study|Withdrawal by Subject|0|||
124498886|NCT00718419|447779947|FG001|Overall Study|Withdrawal by Subject|5|||
124498887|NCT00718419|447779946|FG000|Overall Study|Progressive Disease|7|||
124498888|NCT00718419|447779947|FG001|Overall Study|Progressive Disease|25|||
124498889|NCT00718419|447779946|FG000|Overall Study|Death Due to Progressive Disease|2|||
124498890|NCT00718419|447779947|FG001|Overall Study|Death Due to Progressive Disease|0|||
124498891|NCT00718419|447779946|FG000|Overall Study|Death Due to Study Drug Related|0|||
124498892|NCT00718419|447779947|FG001|Overall Study|Death Due to Study Drug Related|1|||
124498893|NCT00718419|447779946|FG000|Overall Study|Death Due to Adverse Events|1|||
124498894|NCT00718419|447779947|FG001|Overall Study|Death Due to Adverse Events|0|||
124498895|NCT00726323|447779950|FG000|Overall Study|Withdrawal by Subject|3|||
124498896|NCT00726323|447779951|FG001|Overall Study|Withdrawal by Subject|1|||
124498897|NCT00726323|447779950|FG000|Overall Study|Physician Decision|1|||
124498898|NCT00726323|447779951|FG001|Overall Study|Physician Decision|0|||
124774480|NCT00686712|448802871|FG000|Overall Study|Adverse Event|1|||
124774481|NCT00686712|448802872|FG001|Overall Study|Adverse Event|1|||
124774482|NCT00686712|448802873|FG002|Overall Study|Adverse Event|0|||
124774483|NCT03058146|448802874|FG000|Overall Study|Withdrawal by Subject|4|||
124774484|NCT03058146|448802875|FG001|Overall Study|Withdrawal by Subject|1|||
124774485|NCT03058146|448802874|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
124774486|NCT03058146|448802875|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
124774487|NCT01352793|448802878|FG000|Overall Study|Lost to Follow-up|289|||
124498899|NCT00726323|447779950|FG000|Overall Study|Progressive disease|23|||
124498900|NCT00726323|447779951|FG001|Overall Study|Progressive disease|16|||
124498901|NCT00726323|447779950|FG000|Overall Study|Clinical progression|0|||
124498902|NCT00726323|447779951|FG001|Overall Study|Clinical progression|3|||
124498903|NCT00726323|447779950|FG000|Overall Study|Adverse Event|9|||
124498904|NCT00726323|447779951|FG001|Overall Study|Adverse Event|9|||
124498905|NCT00726323|447779950|FG000|Overall Study|Death|1|||
124498906|NCT00726323|447779951|FG001|Overall Study|Death|0|||
124498907|NCT00726323|447779950|FG000|Overall Study|Participant wished to discontinue|0|||
124498908|NCT00726323|447779951|FG001|Overall Study|Participant wished to discontinue|1|||
124498909|NCT00726323|447779950|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
124498910|NCT00726323|447779951|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
124498911|NCT03521154|447779961|FG000|Overall Study|Ongoing study at data cut-off|111|||
124498912|NCT03521154|447779962|FG001|Overall Study|Ongoing study at data cut-off|52|||
124498913|NCT00365716|447779965|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
124498914|NCT00365716|447779966|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
124498915|NCT00365716|447779967|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
124498916|NCT00365716|447779968|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
124498917|NCT00365716|447779969|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
124498918|NCT00365716|447779970|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
124498919|NCT00365716|447779971|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
124498920|NCT00365716|447779965|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
124498921|NCT00365716|447779966|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
124498922|NCT00365716|447779967|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
124498923|NCT00365716|447779968|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
124498924|NCT00365716|447779969|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
124498925|NCT00365716|447779970|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
124498926|NCT00365716|447779971|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
124498927|NCT00365716|447779965|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
124498928|NCT00365716|447779966|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
124498929|NCT00365716|447779967|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
124498930|NCT00365716|447779968|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
124498931|NCT00365716|447779969|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
124498932|NCT00365716|447779970|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
124498933|NCT00365716|447779971|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
124498934|NCT00365716|447779965|FG000|Base Study (Day 1 to Month 7)|Other|0|||
124498935|NCT00365716|447779966|FG001|Base Study (Day 1 to Month 7)|Other|1|||
124498936|NCT00365716|447779967|FG002|Base Study (Day 1 to Month 7)|Other|0|||
124498937|NCT00365716|447779968|FG003|Base Study (Day 1 to Month 7)|Other|0|||
124498938|NCT00365716|447779969|FG004|Base Study (Day 1 to Month 7)|Other|0|||
124498939|NCT00365716|447779970|FG005|Base Study (Day 1 to Month 7)|Other|0|||
124498940|NCT00365716|447779971|FG006|Base Study (Day 1 to Month 7)|Other|0|||
124498941|NCT00365716|447779965|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
124498942|NCT00365716|447779966|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
124498943|NCT00365716|447779967|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
124498944|NCT00365716|447779968|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
124498945|NCT00365716|447779969|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
124498946|NCT00365716|447779970|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
124498947|NCT00365716|447779971|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
124498948|NCT00365716|447779965|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
124498949|NCT00365716|447779966|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
124498950|NCT00365716|447779967|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
124498951|NCT00365716|447779968|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
124498952|NCT00365716|447779969|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
124498953|NCT00365716|447779970|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
124498954|NCT00365716|447779971|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
124498955|NCT00365716|447779965|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
124498956|NCT00365716|447779966|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
124498957|NCT00365716|447779967|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
124498958|NCT00365716|447779968|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
124498959|NCT00365716|447779969|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
124498960|NCT00365716|447779970|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
124774488|NCT01352793|448802879|FG001|Overall Study|Lost to Follow-up|125|||
124774489|NCT01352793|448802878|FG000|Overall Study|Withdrawal by Subject|120|||
124559115|NCT01034137|448005212|FG002|Overall Study|Lack of Efficacy|13|||
124559116|NCT01034137|448005210|FG000|Overall Study|Protocol Violation|2|||
124774490|NCT01352793|448802879|FG001|Overall Study|Withdrawal by Subject|55|||
124774491|NCT01352793|448802878|FG000|Overall Study|Protocol Violation|44|||
124774492|NCT01352793|448802879|FG001|Overall Study|Protocol Violation|23|||
124774493|NCT01352793|448802878|FG000|Overall Study|Adverse Event|44|||
124774494|NCT01352793|448802879|FG001|Overall Study|Adverse Event|10|||
124774495|NCT01352793|448802878|FG000|Overall Study|Physician Decision|1|||
124774496|NCT01352793|448802879|FG001|Overall Study|Physician Decision|0|||
124774497|NCT01352793|448802878|FG000|Overall Study|Pregnancy|26|||
124774498|NCT01352793|448802879|FG001|Overall Study|Pregnancy|8|||
124774499|NCT01352793|448802878|FG000|Overall Study|Other|25|||
124774500|NCT01352793|448802879|FG001|Overall Study|Other|7|||
124774501|NCT01352793|448802878|FG000|Overall Study|Medication error|2|||
124774502|NCT01352793|448802879|FG001|Overall Study|Medication error|2|||
124774503|NCT01352793|448802878|FG000|Overall Study|Death|1|||
124774504|NCT01352793|448802879|FG001|Overall Study|Death|0|||
124774505|NCT01352793|448802878|FG000|Overall Study|Randomized but not vaccinated|8|||
124774506|NCT01352793|448802879|FG001|Overall Study|Randomized but not vaccinated|0|||
124774507|NCT01352793|448802878|FG000|Overall Study|No longer meets eligibility criteria|25|||
124774508|NCT01352793|448802879|FG001|Overall Study|No longer meets eligibility criteria|15|||
124774509|NCT02839200|448802882|FG000|Overall Study|Withdrawal by Subject|2|||
124774510|NCT02839200|448802883|FG001|Overall Study|Withdrawal by Subject|0|||
124774511|NCT02839200|448802884|FG002|Overall Study|Withdrawal by Subject|1|||
124774512|NCT02839200|448802885|FG003|Overall Study|Withdrawal by Subject|0|||
124774513|NCT02839200|448802886|FG004|Overall Study|Withdrawal by Subject|0|||
124774514|NCT02839200|448802887|FG005|Overall Study|Withdrawal by Subject|1|||
124774515|NCT02839200|448802882|FG000|Overall Study|Lost to Follow-up|2|||
124774516|NCT02839200|448802883|FG001|Overall Study|Lost to Follow-up|0|||
124774517|NCT02839200|448802884|FG002|Overall Study|Lost to Follow-up|0|||
124774518|NCT02839200|448802885|FG003|Overall Study|Lost to Follow-up|0|||
124774519|NCT02839200|448802886|FG004|Overall Study|Lost to Follow-up|1|||
124774520|NCT02839200|448802887|FG005|Overall Study|Lost to Follow-up|0|||
124774521|NCT02839200|448802882|FG000|Overall Study|Adverse Event|0|||
124498961|NCT00365716|447779971|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
124498962|NCT00365716|447779965|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
124498963|NCT00365716|447779966|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
124498964|NCT00365716|447779967|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
124559117|NCT01034137|448005211|FG001|Overall Study|Protocol Violation|2|||
124498965|NCT00365716|447779968|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
124498966|NCT00365716|447779969|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
124498967|NCT00365716|447779970|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
124498968|NCT00365716|447779971|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
124498969|NCT00365716|447779965|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
124498970|NCT00365716|447779966|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
124498971|NCT00365716|447779967|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
124498972|NCT00365716|447779968|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
124498973|NCT00365716|447779969|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
124498974|NCT00365716|447779970|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
124498975|NCT00365716|447779971|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
124498976|NCT00365716|447779965|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
124498977|NCT00365716|447779966|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
124498978|NCT00365716|447779967|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
124498979|NCT00365716|447779968|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
124498980|NCT00365716|447779969|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
124498981|NCT00365716|447779970|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
124498982|NCT00365716|447779971|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
124498983|NCT00365716|447779965|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
124498984|NCT00365716|447779966|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
124498985|NCT00365716|447779967|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
124498986|NCT00365716|447779968|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
124498987|NCT00365716|447779969|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
124498988|NCT00365716|447779970|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
124498989|NCT00365716|447779971|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
124498990|NCT00365716|447779965|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
124559118|NCT01034137|448005212|FG002|Overall Study|Protocol Violation|1|||
124774522|NCT02839200|448802883|FG001|Overall Study|Adverse Event|0|||
124774523|NCT02839200|448802884|FG002|Overall Study|Adverse Event|0|||
124774524|NCT02839200|448802885|FG003|Overall Study|Adverse Event|0|||
124774525|NCT02839200|448802886|FG004|Overall Study|Adverse Event|1|||
124774526|NCT02839200|448802887|FG005|Overall Study|Adverse Event|0|||
124774527|NCT02839200|448802882|FG000|Overall Study|Randomized in error|0|||
124774528|NCT02839200|448802883|FG001|Overall Study|Randomized in error|1|||
124559119|NCT01034137|448005210|FG000|Overall Study|Refused treatment or did not cooperate|2|||
124559120|NCT01034137|448005211|FG001|Overall Study|Refused treatment or did not cooperate|0|||
124559121|NCT01034137|448005212|FG002|Overall Study|Refused treatment or did not cooperate|1|||
124559122|NCT01034137|448005210|FG000|Overall Study|Administrative or other|2|||
124559123|NCT01034137|448005211|FG001|Overall Study|Administrative or other|3|||
124559124|NCT01034137|448005212|FG002|Overall Study|Administrative or other|4|||
124559125|NCT01764854|448005213|FG000|Overall Study|Adverse Event|0|||
124559126|NCT01764854|448005214|FG001|Overall Study|Adverse Event|0|||
124559127|NCT01764854|448005215|FG002|Overall Study|Adverse Event|2|||
124559128|NCT01764854|448005216|FG003|Overall Study|Adverse Event|0|||
124559129|NCT01764854|448005213|FG000|Overall Study|Withdrawal by Subject|0|||
124559130|NCT01764854|448005214|FG001|Overall Study|Withdrawal by Subject|0|||
124559131|NCT01764854|448005215|FG002|Overall Study|Withdrawal by Subject|1|||
124559132|NCT01764854|448005216|FG003|Overall Study|Withdrawal by Subject|0|||
124559133|NCT01764854|448005213|FG000|Overall Study|relocation|0|||
124559134|NCT01764854|448005214|FG001|Overall Study|relocation|0|||
124559135|NCT01764854|448005215|FG002|Overall Study|relocation|2|||
124559136|NCT01764854|448005216|FG003|Overall Study|relocation|0|||
124559137|NCT01764854|448005213|FG000|Overall Study|Protocol Violation|0|||
124559138|NCT01764854|448005214|FG001|Overall Study|Protocol Violation|0|||
124559139|NCT01764854|448005215|FG002|Overall Study|Protocol Violation|1|||
124559140|NCT01764854|448005216|FG003|Overall Study|Protocol Violation|2|||
124559141|NCT03377556|448005228|FG000|Overall Study|Adverse Event|5|||
124559142|NCT03377556|448005228|FG000|Overall Study|Refusal unrelated to adverse events|1|||
124559143|NCT03377556|448005228|FG000|Overall Study|Progression/relapse|38|||
124559144|NCT03377556|448005228|FG000|Overall Study|Death|3|||
124559145|NCT02736227|448005237|FG000|Overall Study|Withdrawal by Subject|0|||
124559146|NCT02736227|448005238|FG001|Overall Study|Withdrawal by Subject|0|||
124559147|NCT02736227|448005239|FG002|Overall Study|Withdrawal by Subject|1|||
124559148|NCT02736227|448005237|FG000|Overall Study|Physician Decision|0|||
124559149|NCT02736227|448005238|FG001|Overall Study|Physician Decision|0|||
124559150|NCT02736227|448005239|FG002|Overall Study|Physician Decision|5|||
124559151|NCT02736227|448005237|FG000|Overall Study|Non Compliant|0|||
124559152|NCT02736227|448005238|FG001|Overall Study|Non Compliant|0|||
124498991|NCT00365716|447779966|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
124498992|NCT00365716|447779967|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
124498993|NCT00365716|447779968|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
124498994|NCT00365716|447779969|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
124498995|NCT00365716|447779970|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
124498996|NCT00365716|447779971|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
124498997|NCT00365716|447779965|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
124498998|NCT00365716|447779966|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
124559153|NCT02736227|448005239|FG002|Overall Study|Non Compliant|2|||
124559154|NCT04120194|448005240|FG000|Overall Study|Lost to Follow-up|11|||
124559155|NCT04120194|448005241|FG001|Overall Study|Lost to Follow-up|8|||
124498999|NCT00365716|447779967|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
124499000|NCT00365716|447779968|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
124499001|NCT00365716|447779969|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
124499002|NCT00365716|447779970|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
124499003|NCT00365716|447779971|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
124499004|NCT00365716|447779965|FG000|Extension 1|Lost to Follow-up|0|||
124499005|NCT00365716|447779966|FG001|Extension 1|Lost to Follow-up|0|||
124499006|NCT00365716|447779967|FG002|Extension 1|Lost to Follow-up|0|||
124499007|NCT00365716|447779968|FG003|Extension 1|Lost to Follow-up|0|||
124499008|NCT00365716|447779969|FG004|Extension 1|Lost to Follow-up|0|||
124774529|NCT02839200|448802884|FG002|Overall Study|Randomized in error|0|||
124499009|NCT00365716|447779970|FG005|Extension 1|Lost to Follow-up|1|||
124559156|NCT04120194|448005240|FG000|Overall Study|Adverse Event|4|||
124559157|NCT04120194|448005241|FG001|Overall Study|Adverse Event|5|||
124559158|NCT04120194|448005240|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
124774530|NCT02839200|448802885|FG003|Overall Study|Randomized in error|0|||
124499010|NCT00365716|447779971|FG006|Extension 1|Lost to Follow-up|0|||
124499011|NCT00365716|447779965|FG000|Extension 1|Other|0|||
124499012|NCT00365716|447779966|FG001|Extension 1|Other|0|||
124499013|NCT00365716|447779967|FG002|Extension 1|Other|0|||
124559159|NCT04120194|448005241|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
124559160|NCT04120194|448005240|FG000|Overall Study|Miscellaneous|4|||
124559161|NCT04120194|448005241|FG001|Overall Study|Miscellaneous|5|||
124559162|NCT00619619|448005242|FG000|Overall Study|Physician Decision|0|||
124559163|NCT00619619|448005243|FG001|Overall Study|Physician Decision|0|||
124559164|NCT00619619|448005244|FG002|Overall Study|Physician Decision|1|||
124559165|NCT00619619|448005245|FG003|Overall Study|Physician Decision|0|||
124559166|NCT00619619|448005246|FG004|Overall Study|Physician Decision|0|||
124559167|NCT00619619|448005247|FG005|Overall Study|Physician Decision|0|||
124774531|NCT02839200|448802886|FG004|Overall Study|Randomized in error|0|||
124774532|NCT02839200|448802887|FG005|Overall Study|Randomized in error|0|||
124774533|NCT01094119|448802890|FG000|Overall Study|Lack of Efficacy|2|||
124774534|NCT01094119|448802891|FG001|Overall Study|Lack of Efficacy|4|||
124774535|NCT02205736|448802894|FG000|Overall Study|Lost to Follow-up|106|||
124774536|NCT03326713|448802895|FG000|Overall Study|Death|2|||
124774537|NCT03326713|448802896|FG001|Overall Study|Death|1|||
124774538|NCT03326713|448802897|FG002|Overall Study|Death|0|||
124774539|NCT03326713|448802895|FG000|Overall Study|Lost to Follow-up|20|||
124774540|NCT03326713|448802896|FG001|Overall Study|Lost to Follow-up|21|||
124774541|NCT03326713|448802897|FG002|Overall Study|Lost to Follow-up|33|||
124774542|NCT03326713|448802895|FG000|Overall Study|Withdrawal by Subject|1|||
124774543|NCT03326713|448802896|FG001|Overall Study|Withdrawal by Subject|2|||
124774544|NCT03326713|448802897|FG002|Overall Study|Withdrawal by Subject|11|||
124774545|NCT03326713|448802895|FG000|Overall Study|Found Ineligible|11|||
124774546|NCT03326713|448802896|FG001|Overall Study|Found Ineligible|11|||
124774547|NCT03326713|448802897|FG002|Overall Study|Found Ineligible|8|||
124774548|NCT06078124|448802903|FG000|Overall Study|Lost to Follow-up|14|||
124774549|NCT06078124|448802904|FG001|Overall Study|Lost to Follow-up|14|||
124774550|NCT01198977|448802905|FG000|Overall Study|Lost to Follow-up|1|||
124774551|NCT01198977|448802906|FG001|Overall Study|Lost to Follow-up|0|||
124774552|NCT01285557|448802907|FG000|Overall Study|Death|173|||
124774553|NCT01285557|448802908|FG001|Overall Study|Death|90|||
124774554|NCT01285557|448802907|FG000|Overall Study|Lost to Follow-up|6|||
124499014|NCT00365716|447779968|FG003|Extension 1|Other|0|||
124499015|NCT00365716|447779969|FG004|Extension 1|Other|0|||
124499016|NCT00365716|447779970|FG005|Extension 1|Other|9|||
124499017|NCT00365716|447779971|FG006|Extension 1|Other|0|||
124499018|NCT00365716|447779965|FG000|Extension 1|Moved|0|||
124499019|NCT00365716|447779966|FG001|Extension 1|Moved|0|||
124499020|NCT00365716|447779967|FG002|Extension 1|Moved|0|||
124499021|NCT00365716|447779968|FG003|Extension 1|Moved|0|||
124499022|NCT00365716|447779969|FG004|Extension 1|Moved|0|||
124499023|NCT00365716|447779970|FG005|Extension 1|Moved|4|||
124499024|NCT00365716|447779971|FG006|Extension 1|Moved|0|||
124499025|NCT00365716|447779965|FG000|Extension 1|Withdrawal by Subject|0|||
124499026|NCT00365716|447779966|FG001|Extension 1|Withdrawal by Subject|0|||
124499027|NCT00365716|447779967|FG002|Extension 1|Withdrawal by Subject|0|||
124499028|NCT00365716|447779968|FG003|Extension 1|Withdrawal by Subject|0|||
124499029|NCT00365716|447779969|FG004|Extension 1|Withdrawal by Subject|0|||
124499030|NCT00365716|447779970|FG005|Extension 1|Withdrawal by Subject|3|||
124499031|NCT00365716|447779971|FG006|Extension 1|Withdrawal by Subject|0|||
124499032|NCT00365716|447779965|FG000|Extension 1|Pregnancy|0|||
124499033|NCT00365716|447779966|FG001|Extension 1|Pregnancy|0|||
124499034|NCT00365716|447779967|FG002|Extension 1|Pregnancy|0|||
124499035|NCT00365716|447779968|FG003|Extension 1|Pregnancy|0|||
124499036|NCT00365716|447779969|FG004|Extension 1|Pregnancy|0|||
124499037|NCT00365716|447779970|FG005|Extension 1|Pregnancy|4|||
124499038|NCT00365716|447779971|FG006|Extension 1|Pregnancy|0|||
124499039|NCT00365716|447779965|FG000|Extension 1|Protocol Violation|0|||
124499040|NCT00365716|447779966|FG001|Extension 1|Protocol Violation|0|||
124499041|NCT00365716|447779967|FG002|Extension 1|Protocol Violation|0|||
124499042|NCT00365716|447779968|FG003|Extension 1|Protocol Violation|0|||
124499043|NCT00365716|447779969|FG004|Extension 1|Protocol Violation|0|||
124499044|NCT00365716|447779970|FG005|Extension 1|Protocol Violation|1|||
124499045|NCT00365716|447779971|FG006|Extension 1|Protocol Violation|0|||
124499046|NCT00365716|447779965|FG000|Extension 2|Lost to Follow-up|0|||
124499047|NCT00365716|447779966|FG001|Extension 2|Lost to Follow-up|0|||
124499048|NCT00365716|447779967|FG002|Extension 2|Lost to Follow-up|0|||
124499049|NCT00365716|447779968|FG003|Extension 2|Lost to Follow-up|0|||
124499050|NCT00365716|447779969|FG004|Extension 2|Lost to Follow-up|0|||
124499051|NCT00365716|447779970|FG005|Extension 2|Lost to Follow-up|0|||
124499052|NCT00365716|447779971|FG006|Extension 2|Lost to Follow-up|2|||
124499053|NCT00365716|447779965|FG000|Extension 2|Other|0|||
124499054|NCT00365716|447779966|FG001|Extension 2|Other|0|||
124499055|NCT00365716|447779967|FG002|Extension 2|Other|0|||
124499056|NCT00365716|447779968|FG003|Extension 2|Other|0|||
124499057|NCT00365716|447779969|FG004|Extension 2|Other|0|||
124499058|NCT00365716|447779970|FG005|Extension 2|Other|0|||
124499059|NCT00365716|447779971|FG006|Extension 2|Other|3|||
124499060|NCT00365716|447779965|FG000|Extension 2|Withdrawal by Subject|0|||
124499061|NCT00365716|447779966|FG001|Extension 2|Withdrawal by Subject|0|||
124499062|NCT00365716|447779967|FG002|Extension 2|Withdrawal by Subject|0|||
124499063|NCT00365716|447779968|FG003|Extension 2|Withdrawal by Subject|0|||
124774555|NCT01285557|448802908|FG001|Overall Study|Lost to Follow-up|2|||
124774556|NCT01285557|448802907|FG000|Overall Study|Withdrew Consent|6|||
124774557|NCT01285557|448802908|FG001|Overall Study|Withdrew Consent|1|||
124774558|NCT01285557|448802907|FG000|Overall Study|Sponsor Study Termination|23|||
124774559|NCT01285557|448802908|FG001|Overall Study|Sponsor Study Termination|13|||
124774560|NCT01285557|448802907|FG000|Overall Study|Randomized but not treated|1|||
124774561|NCT01285557|448802908|FG001|Overall Study|Randomized but not treated|1|||
124774562|NCT01285557|448802907|FG000|Overall Study|Study follow-up ongoing|28|||
124499064|NCT00365716|447779969|FG004|Extension 2|Withdrawal by Subject|0|||
124499065|NCT00365716|447779970|FG005|Extension 2|Withdrawal by Subject|0|||
124499066|NCT00365716|447779971|FG006|Extension 2|Withdrawal by Subject|5|||
124774563|NCT01285557|448802908|FG001|Overall Study|Study follow-up ongoing|14|||
124499067|NCT06150573|447779972|FG000|Overall Study|Did not meet study criteria|1|||
124499068|NCT06150573|447779973|FG001|Overall Study|Did not meet study criteria|0|||
124499069|NCT06150573|447779972|FG000|Overall Study|Adverse Event|1|||
124499070|NCT06150573|447779973|FG001|Overall Study|Adverse Event|0|||
124499071|NCT06150573|447779972|FG000|Overall Study|Lost to Follow-up|0|||
124499072|NCT06150573|447779973|FG001|Overall Study|Lost to Follow-up|1|||
124499073|NCT06150573|447779972|FG000|Overall Study|Protocol Violation|0|||
124499074|NCT06150573|447779973|FG001|Overall Study|Protocol Violation|1|||
124559168|NCT00619619|448005248|FG006|Overall Study|Physician Decision|0|||
124559169|NCT00619619|448005249|FG007|Overall Study|Physician Decision|0|||
124559170|NCT00619619|448005242|FG000|Overall Study|Protocol Violation|0|||
124559171|NCT00619619|448005243|FG001|Overall Study|Protocol Violation|0|||
124559172|NCT00619619|448005244|FG002|Overall Study|Protocol Violation|0|||
124559173|NCT00619619|448005245|FG003|Overall Study|Protocol Violation|1|||
124559174|NCT00619619|448005246|FG004|Overall Study|Protocol Violation|0|||
124559175|NCT00619619|448005247|FG005|Overall Study|Protocol Violation|0|||
124559176|NCT00619619|448005248|FG006|Overall Study|Protocol Violation|1|||
124559177|NCT00619619|448005249|FG007|Overall Study|Protocol Violation|1|||
124559178|NCT00619619|448005242|FG000|Overall Study|Adverse Event|0|||
124559179|NCT00619619|448005243|FG001|Overall Study|Adverse Event|0|||
124559180|NCT00619619|448005244|FG002|Overall Study|Adverse Event|0|||
124559181|NCT00619619|448005245|FG003|Overall Study|Adverse Event|0|||
124559182|NCT00619619|448005246|FG004|Overall Study|Adverse Event|2|||
124499075|NCT06150573|447779972|FG000|Overall Study|Withdrawal by Subject|2|||
124499076|NCT06150573|447779973|FG001|Overall Study|Withdrawal by Subject|0|||
124499077|NCT00069095|447779974|FG000|Primary Treatment Phase|Ongoing|0|||
124499078|NCT00069095|447779975|FG001|Primary Treatment Phase|Ongoing|0|||
124499079|NCT00069095|447779976|FG002|Primary Treatment Phase|Ongoing|5|||
124499080|NCT00069095|447779977|FG003|Primary Treatment Phase|Ongoing|7|||
124499081|NCT00069095|447779978|FG004|Primary Treatment Phase|Ongoing|7|||
124499082|NCT00069095|447779979|FG005|Primary Treatment Phase|Ongoing|4|||
124499083|NCT00069095|447779974|FG000|Primary Treatment Phase|Admin/Other|29|||
124499084|NCT00069095|447779975|FG001|Primary Treatment Phase|Admin/Other|38|||
124499085|NCT00069095|447779976|FG002|Primary Treatment Phase|Admin/Other|31|||
124499086|NCT00069095|447779977|FG003|Primary Treatment Phase|Admin/Other|45|||
124499087|NCT00069095|447779978|FG004|Primary Treatment Phase|Admin/Other|48|||
124499088|NCT00069095|447779979|FG005|Primary Treatment Phase|Admin/Other|42|||
124499089|NCT00069095|447779974|FG000|Primary Treatment Phase|Adverse Event|99|||
124499090|NCT00069095|447779975|FG001|Primary Treatment Phase|Adverse Event|92|||
124499091|NCT00069095|447779976|FG002|Primary Treatment Phase|Adverse Event|71|||
124499092|NCT00069095|447779977|FG003|Primary Treatment Phase|Adverse Event|72|||
124499093|NCT00069095|447779978|FG004|Primary Treatment Phase|Adverse Event|109|||
124499094|NCT00069095|447779979|FG005|Primary Treatment Phase|Adverse Event|101|||
124499095|NCT00069095|447779974|FG000|Primary Treatment Phase|Death|14|||
124499096|NCT00069095|447779975|FG001|Primary Treatment Phase|Death|8|||
124499097|NCT00069095|447779976|FG002|Primary Treatment Phase|Death|2|||
124499098|NCT00069095|447779977|FG003|Primary Treatment Phase|Death|5|||
124499099|NCT00069095|447779978|FG004|Primary Treatment Phase|Death|8|||
124499100|NCT00069095|447779979|FG005|Primary Treatment Phase|Death|8|||
124499101|NCT00069095|447779974|FG000|Primary Treatment Phase|Failure to return|5|||
124499102|NCT00069095|447779975|FG001|Primary Treatment Phase|Failure to return|5|||
124499103|NCT00069095|447779976|FG002|Primary Treatment Phase|Failure to return|0|||
124499104|NCT00069095|447779977|FG003|Primary Treatment Phase|Failure to return|0|||
124499105|NCT00069095|447779978|FG004|Primary Treatment Phase|Failure to return|0|||
124499106|NCT00069095|447779979|FG005|Primary Treatment Phase|Failure to return|2|||
124499107|NCT00069095|447779974|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
124499108|NCT00069095|447779975|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
124499109|NCT00069095|447779976|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
124499110|NCT00069095|447779977|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
124499111|NCT00069095|447779978|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
124499112|NCT00069095|447779979|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
124499113|NCT00069095|447779974|FG000|Primary Treatment Phase|Refused treatment|15|||
124499114|NCT00069095|447779975|FG001|Primary Treatment Phase|Refused treatment|26|||
124499115|NCT00069095|447779976|FG002|Primary Treatment Phase|Refused treatment|17|||
124499116|NCT00069095|447779977|FG003|Primary Treatment Phase|Refused treatment|31|||
124499117|NCT00069095|447779978|FG004|Primary Treatment Phase|Refused treatment|24|||
124499118|NCT00069095|447779979|FG005|Primary Treatment Phase|Refused treatment|27|||
124499119|NCT00069095|447779974|FG000|Primary Treatment Phase|Withdrew|2|||
124559183|NCT00619619|448005247|FG005|Overall Study|Adverse Event|0|||
124774564|NCT01285557|448802907|FG000|Overall Study|Sponsor Decision|2|||
124499120|NCT00069095|447779975|FG001|Primary Treatment Phase|Withdrew|3|||
124499121|NCT00069095|447779976|FG002|Primary Treatment Phase|Withdrew|8|||
124499122|NCT00069095|447779977|FG003|Primary Treatment Phase|Withdrew|2|||
124499123|NCT00069095|447779978|FG004|Primary Treatment Phase|Withdrew|4|||
124499124|NCT00069095|447779979|FG005|Primary Treatment Phase|Withdrew|9|||
124499125|NCT00069095|447779974|FG000|Primary Treatment Phase|Other Violation|0|||
124774565|NCT01285557|448802908|FG001|Overall Study|Sponsor Decision|1|||
124774566|NCT05615922|448802910|FG000|Overall Study|Lost to Follow-up|1|||
124774567|NCT03173248|448802914|FG000|Overall Study|Death|28|||
124774568|NCT03173248|448802915|FG001|Overall Study|Death|46|||
124774569|NCT03173248|448802914|FG000|Overall Study|Lost to Follow-up|0|||
124774570|NCT03173248|448802915|FG001|Overall Study|Lost to Follow-up|1|||
124774571|NCT03173248|448802914|FG000|Overall Study|Withdrawal by Subject|6|||
124774572|NCT03173248|448802915|FG001|Overall Study|Withdrawal by Subject|4|||
124774573|NCT03173248|448802914|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
124774574|NCT03173248|448802915|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
124774575|NCT01648751|448802918|FG000|Overall Study|Withdrawal by Subject|2|||
124774576|NCT01648751|448802919|FG001|Overall Study|Withdrawal by Subject|3|||
124774577|NCT02991768|448802923|FG000|Overall Study|Physician Decision|4|||
124774578|NCT03467750|448802924|FG000|Overall Study|Surgery canceled|1|||
124774579|NCT03467750|448802925|FG001|Overall Study|Surgery canceled|0|||
124774580|NCT03467750|448802924|FG000|Overall Study|Protocol Violation|1|||
124774581|NCT03467750|448802925|FG001|Overall Study|Protocol Violation|1|||
124774582|NCT03467750|448802924|FG000|Overall Study|Withdrawal by Subject|0|||
124499126|NCT00069095|447779975|FG001|Primary Treatment Phase|Other Violation|1|||
124499127|NCT00069095|447779976|FG002|Primary Treatment Phase|Other Violation|1|||
124499128|NCT00069095|447779977|FG003|Primary Treatment Phase|Other Violation|1|||
124499129|NCT00069095|447779978|FG004|Primary Treatment Phase|Other Violation|0|||
124499130|NCT00069095|447779979|FG005|Primary Treatment Phase|Other Violation|1|||
124499131|NCT00069095|447779974|FG000|Primary Treatment Phase|Violation criteria|0|||
124499132|NCT00069095|447779975|FG001|Primary Treatment Phase|Violation criteria|2|||
124499133|NCT00069095|447779976|FG002|Primary Treatment Phase|Violation criteria|4|||
124499134|NCT00069095|447779977|FG003|Primary Treatment Phase|Violation criteria|3|||
124499135|NCT00069095|447779978|FG004|Primary Treatment Phase|Violation criteria|1|||
124499136|NCT00069095|447779979|FG005|Primary Treatment Phase|Violation criteria|5|||
124499137|NCT00069095|447779974|FG000|Post-study Treatment Phase|Missing reason|1|||
124499138|NCT00069095|447779975|FG001|Post-study Treatment Phase|Missing reason|3|||
124499139|NCT00069095|447779976|FG002|Post-study Treatment Phase|Missing reason|12|||
124499140|NCT00069095|447779977|FG003|Post-study Treatment Phase|Missing reason|8|||
124499141|NCT00069095|447779978|FG004|Post-study Treatment Phase|Missing reason|18|||
124499142|NCT00069095|447779979|FG005|Post-study Treatment Phase|Missing reason|17|||
124499143|NCT00069095|447779974|FG000|Post-study Treatment Phase|Adverse Event|2|||
124499144|NCT00069095|447779975|FG001|Post-study Treatment Phase|Adverse Event|3|||
124499145|NCT00069095|447779976|FG002|Post-study Treatment Phase|Adverse Event|1|||
124499146|NCT00069095|447779977|FG003|Post-study Treatment Phase|Adverse Event|0|||
124499147|NCT00069095|447779978|FG004|Post-study Treatment Phase|Adverse Event|5|||
124499148|NCT00069095|447779979|FG005|Post-study Treatment Phase|Adverse Event|1|||
124499149|NCT00069095|447779974|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
124499150|NCT00069095|447779975|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
124499151|NCT00069095|447779976|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
124499152|NCT00069095|447779977|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
124499153|NCT00069095|447779978|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
124499154|NCT00069095|447779979|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
124499155|NCT00069095|447779974|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
124499156|NCT00069095|447779975|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
124499157|NCT00069095|447779976|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
124499158|NCT00069095|447779977|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
124499159|NCT00069095|447779978|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
124499160|NCT00069095|447779979|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
124499161|NCT00069095|447779974|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
124499162|NCT00069095|447779975|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
124499163|NCT00069095|447779976|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
124499164|NCT00069095|447779977|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
124499165|NCT00069095|447779978|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
124499166|NCT00069095|447779979|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
124499167|NCT00069095|447779974|FG000|Post-study Treatment Phase|Participant had complete response|1|||
124499168|NCT00069095|447779975|FG001|Post-study Treatment Phase|Participant had complete response|1|||
124499169|NCT00069095|447779976|FG002|Post-study Treatment Phase|Participant had complete response|0|||
124499170|NCT00069095|447779977|FG003|Post-study Treatment Phase|Participant had complete response|0|||
124499171|NCT00069095|447779978|FG004|Post-study Treatment Phase|Participant had complete response|0|||
124499172|NCT00069095|447779979|FG005|Post-study Treatment Phase|Participant had complete response|0|||
124774583|NCT03467750|448802925|FG001|Overall Study|Withdrawal by Subject|1|||
124774584|NCT05673876|448802926|FG000|Overall Study|Death|3|||
124774585|NCT05673876|448802927|FG001|Overall Study|Death|1|||
124774586|NCT05673876|448802926|FG000|Overall Study|Study Terminated by Sponsor|0|||
124774587|NCT05673876|448802927|FG001|Overall Study|Study Terminated by Sponsor|1|||
124774588|NCT05673876|448802926|FG000|Overall Study|Physician Decision|0|||
124774589|NCT05673876|448802927|FG001|Overall Study|Physician Decision|1|||
124499173|NCT00069095|447779974|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
124499174|NCT00069095|447779975|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
124499175|NCT00069095|447779976|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
124559184|NCT00619619|448005248|FG006|Overall Study|Adverse Event|0|||
124559185|NCT00619619|448005249|FG007|Overall Study|Adverse Event|2|||
124559186|NCT02063698|448005250|FG000|Overall Study|did not complete booklet for days 2-8|1|||
124499176|NCT00069095|447779977|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
124499177|NCT00069095|447779978|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
124499178|NCT00069095|447779979|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
124499179|NCT00069095|447779974|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
124499180|NCT00069095|447779975|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
124499181|NCT00069095|447779976|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
124499182|NCT00069095|447779977|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
124499183|NCT00069095|447779978|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
124499184|NCT00069095|447779979|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
124499185|NCT00069095|447779974|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
124499186|NCT00069095|447779975|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
124499187|NCT00069095|447779976|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
124559187|NCT02063698|448005251|FG001|Overall Study|did not complete booklet for days 2-8|2|||
124559188|NCT00410410|448005252|FG000|Induction Period (IP)|Death|1|||
124559189|NCT00410410|448005253|FG001|Induction Period (IP)|Death|0|||
124559190|NCT00410410|448005254|FG002|Induction Period (IP)|Death|0|||
124559191|NCT00410410|448005255|FG003|Induction Period (IP)|Death|0|||
124559192|NCT00410410|448005256|FG004|Induction Period (IP)|Death|0|||
124559193|NCT00410410|448005257|FG005|Induction Period (IP)|Death|0|||
124559194|NCT00410410|448005258|FG006|Induction Period (IP)|Death|0|||
124559195|NCT00410410|448005259|FG007|Induction Period (IP)|Death|0|||
124559196|NCT00410410|448005260|FG008|Induction Period (IP)|Death|0|||
124559197|NCT00410410|448005252|FG000|Induction Period (IP)|Adverse Event|3|||
124559198|NCT00410410|448005253|FG001|Induction Period (IP)|Adverse Event|4|||
124559199|NCT00410410|448005254|FG002|Induction Period (IP)|Adverse Event|2|||
124499188|NCT00069095|447779977|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
124499189|NCT00069095|447779978|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
124499190|NCT00069095|447779979|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
124499191|NCT00069095|447779974|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
124499192|NCT00069095|447779975|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
124499193|NCT00069095|447779976|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
124499194|NCT00069095|447779977|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
124499195|NCT00069095|447779978|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
124499196|NCT00069095|447779979|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
124499197|NCT00069095|447779974|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
124499198|NCT00069095|447779975|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
124499199|NCT00069095|447779976|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
124499200|NCT00069095|447779977|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
124499201|NCT00069095|447779978|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
124499202|NCT00069095|447779979|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
124499203|NCT00069095|447779974|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
124499204|NCT00069095|447779975|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
124499205|NCT00069095|447779976|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
124499206|NCT00069095|447779977|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
124499207|NCT00069095|447779978|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
124499208|NCT00069095|447779979|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
124499209|NCT00069095|447779974|FG000|Post-study Treatment Phase|Surgery|0|||
124499210|NCT00069095|447779975|FG001|Post-study Treatment Phase|Surgery|0|||
124499211|NCT00069095|447779976|FG002|Post-study Treatment Phase|Surgery|0|||
124499212|NCT00069095|447779977|FG003|Post-study Treatment Phase|Surgery|1|||
124499213|NCT00069095|447779978|FG004|Post-study Treatment Phase|Surgery|1|||
124499214|NCT00069095|447779979|FG005|Post-study Treatment Phase|Surgery|0|||
124499215|NCT00069095|447779974|FG000|Post-study Treatment Phase|Death|0|||
124499216|NCT00069095|447779975|FG001|Post-study Treatment Phase|Death|0|||
124499217|NCT00069095|447779976|FG002|Post-study Treatment Phase|Death|0|||
124499218|NCT00069095|447779977|FG003|Post-study Treatment Phase|Death|0|||
124499219|NCT00069095|447779978|FG004|Post-study Treatment Phase|Death|1|||
124499220|NCT00069095|447779979|FG005|Post-study Treatment Phase|Death|0|||
124499221|NCT00069095|447779974|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
124559200|NCT00410410|448005255|FG003|Induction Period (IP)|Adverse Event|4|||
124559201|NCT00410410|448005256|FG004|Induction Period (IP)|Adverse Event|1|||
124774590|NCT04500158|448802930|FG000|Overall Study|Physician Decision|17|||
124774591|NCT04500158|448802931|FG001|Overall Study|Physician Decision|11|||
124774592|NCT02749422|448802936|FG000|Overall Study|Lost to Follow-up|0|||
124774593|NCT02749422|448802937|FG001|Overall Study|Lost to Follow-up|2|||
124774594|NCT02749422|448802936|FG000|Overall Study|Ineligible|0|||
124774595|NCT02749422|448802937|FG001|Overall Study|Ineligible|1|||
124774596|NCT04610281|448804613|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
124774597|NCT04610281|448804614|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
124499222|NCT00069095|447779975|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
124559202|NCT00410410|448005257|FG005|Induction Period (IP)|Adverse Event|0|||
124774598|NCT01458392|448804616|FG000|Overall Study|Death|2|||
124774599|NCT01458392|448804617|FG001|Overall Study|Death|11|||
124774600|NCT01458392|448804618|FG002|Overall Study|Death|22|||
124774601|NCT01458392|448804616|FG000|Overall Study|At the discretion of the sponsor|0|||
124774602|NCT01458392|448804617|FG001|Overall Study|At the discretion of the sponsor|2|||
124774603|NCT01458392|448804618|FG002|Overall Study|At the discretion of the sponsor|7|||
124774604|NCT01458392|448804616|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
124774605|NCT01458392|448804617|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
124774606|NCT01458392|448804618|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
124774607|NCT00753506|448804621|FG000|Overall Study|Withdrawal by Subject|4|||
124774608|NCT00753506|448804622|FG001|Overall Study|Withdrawal by Subject|1|||
124774609|NCT00753506|448804621|FG000|Overall Study|Lost to Follow-up|2|||
124774610|NCT00753506|448804622|FG001|Overall Study|Lost to Follow-up|0|||
124774611|NCT00753506|448804621|FG000|Overall Study|Other reason|1|||
124774612|NCT00753506|448804622|FG001|Overall Study|Other reason|1|||
124774613|NCT03557034|448804631|FG000|Overall Study|Withdrawal by Subject|1|||
124774614|NCT03557034|448804632|FG001|Overall Study|Withdrawal by Subject|0|||
124774615|NCT03809104|448804634|FG000|Overall Study|Withdrawal by Subject|3|||
124774616|NCT00790842|448804635|FG000|Dose Level 1|Adverse Event|1|||
124774617|NCT00790842|448804636|FG001|Dose Level 1|Adverse Event|0|||
124774618|NCT00790842|448804637|FG002|Dose Level 1|Adverse Event|0|||
124774619|NCT00790842|448804638|FG003|Dose Level 1|Adverse Event|2|||
124774620|NCT00790842|448804639|FG004|Dose Level 1|Adverse Event|0|||
124774621|NCT00790842|448804640|FG005|Dose Level 1|Adverse Event|0|||
124774622|NCT00790842|448804641|FG006|Dose Level 1|Adverse Event|0|||
124774623|NCT00790842|448804642|FG007|Dose Level 1|Adverse Event|1|||
124774624|NCT00790842|448804643|FG008|Dose Level 1|Adverse Event|0|||
124774625|NCT00790842|448804644|FG009|Dose Level 1|Adverse Event|0|||
124774626|NCT00790842|448804645|FG010|Dose Level 1|Adverse Event|0|||
124774627|NCT00790842|448804635|FG000|Dose Level 1|Physician Decision|1|||
124774628|NCT00790842|448804636|FG001|Dose Level 1|Physician Decision|0|||
124774629|NCT00790842|448804637|FG002|Dose Level 1|Physician Decision|0|||
124774630|NCT00790842|448804638|FG003|Dose Level 1|Physician Decision|0|||
124774631|NCT00790842|448804639|FG004|Dose Level 1|Physician Decision|0|||
124499223|NCT00069095|447779976|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
124499224|NCT00069095|447779977|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
124499225|NCT00069095|447779978|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
124499226|NCT00069095|447779979|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
124499227|NCT00069095|447779974|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
124499228|NCT00069095|447779975|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
124499229|NCT00069095|447779976|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
124499230|NCT00069095|447779977|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
124499231|NCT00069095|447779978|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
124499232|NCT00069095|447779979|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
124499233|NCT00069095|447779974|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
124499234|NCT00069095|447779975|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
124499235|NCT00069095|447779976|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
124499236|NCT00069095|447779977|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
124499237|NCT00069095|447779978|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
124499238|NCT00069095|447779979|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
124499239|NCT00069095|447779974|FG000|Post-study Treatment Phase|Investigator decision|0|||
124499240|NCT00069095|447779975|FG001|Post-study Treatment Phase|Investigator decision|0|||
124499241|NCT00069095|447779976|FG002|Post-study Treatment Phase|Investigator decision|0|||
124559203|NCT00410410|448005258|FG006|Induction Period (IP)|Adverse Event|0|||
124559204|NCT00410410|448005259|FG007|Induction Period (IP)|Adverse Event|0|||
124774632|NCT00790842|448804640|FG005|Dose Level 1|Physician Decision|0|||
124774633|NCT00790842|448804641|FG006|Dose Level 1|Physician Decision|0|||
124774634|NCT00790842|448804642|FG007|Dose Level 1|Physician Decision|1|||
124774635|NCT00790842|448804643|FG008|Dose Level 1|Physician Decision|0|||
124774636|NCT00790842|448804644|FG009|Dose Level 1|Physician Decision|0|||
124774637|NCT00790842|448804645|FG010|Dose Level 1|Physician Decision|0|||
124774638|NCT00790842|448804635|FG000|Dose Level 1|Withdrawal by Subject|1|||
124774639|NCT00790842|448804636|FG001|Dose Level 1|Withdrawal by Subject|0|||
124499242|NCT00069095|447779977|FG003|Post-study Treatment Phase|Investigator decision|0|||
124499243|NCT00069095|447779978|FG004|Post-study Treatment Phase|Investigator decision|0|||
124499244|NCT00069095|447779979|FG005|Post-study Treatment Phase|Investigator decision|1|||
124499245|NCT00069095|447779974|FG000|Follow-up Phase|Death|174|||
124499246|NCT00069095|447779975|FG001|Follow-up Phase|Death|206|||
124499247|NCT00069095|447779976|FG002|Follow-up Phase|Death|120|||
124499248|NCT00069095|447779977|FG003|Follow-up Phase|Death|112|||
124499249|NCT00069095|447779978|FG004|Follow-up Phase|Death|92|||
124499250|NCT00069095|447779979|FG005|Follow-up Phase|Death|101|||
124499251|NCT05114590|447779985|FG000|Overall Study|Adverse Event|1|||
124499252|NCT05114590|447779985|FG000|Overall Study|Investigator decision|1|||
124499253|NCT05114590|447779985|FG000|Overall Study|Lost to Follow-up|5|||
124499254|NCT05114590|447779985|FG000|Overall Study|Withdrawal by Subject|5|||
124499255|NCT05114590|447779985|FG000|Overall Study|Other|2|||
124499256|NCT00358917|447779988|FG000|Overall Study|Adverse Event|14|||
124499257|NCT00358917|447779989|FG001|Overall Study|Adverse Event|21|||
124499258|NCT00358917|447779988|FG000|Overall Study|Withdrawal by Subject|5|||
124499259|NCT00358917|447779989|FG001|Overall Study|Withdrawal by Subject|7|||
124499260|NCT00358917|447779988|FG000|Overall Study|Lost to Follow-up|20|||
124499261|NCT00358917|447779989|FG001|Overall Study|Lost to Follow-up|17|||
124499262|NCT00358917|447779988|FG000|Overall Study|Noncompliance|12|||
124499263|NCT00358917|447779989|FG001|Overall Study|Noncompliance|11|||
124499264|NCT00358917|447779988|FG000|Overall Study|Death|2|||
124499265|NCT00358917|447779989|FG001|Overall Study|Death|3|||
124499266|NCT00358917|447779988|FG000|Overall Study|Virologic failure|11|||
124499267|NCT00358917|447779989|FG001|Overall Study|Virologic failure|8|||
124499268|NCT00358917|447779988|FG000|Overall Study|Unable to Continue Participation|2|||
124499269|NCT00358917|447779989|FG001|Overall Study|Unable to Continue Participation|2|||
124499270|NCT05372575|447779993|FG000|Overall Study|Protocol Violation|7|||
124499271|NCT05372575|447779994|FG001|Overall Study|Protocol Violation|16|||
124499272|NCT01544595|447779995|FG000|Status at Week 68|Adverse Event|3|||
124499273|NCT01544595|447779996|FG001|Status at Week 68|Adverse Event|2|||
124499274|NCT01544595|447779997|FG002|Status at Week 68|Adverse Event|1|||
124499275|NCT01544595|447779998|FG003|Status at Week 68|Adverse Event|0|||
124499276|NCT01544595|447779999|FG004|Status at Week 68|Adverse Event|0|||
124499277|NCT01544595|447780000|FG005|Status at Week 68|Adverse Event|0|||
124499278|NCT01544595|447779995|FG000|Status at Week 68|Lack of Efficacy|1|||
124499279|NCT01544595|447779996|FG001|Status at Week 68|Lack of Efficacy|0|||
124499280|NCT01544595|447779997|FG002|Status at Week 68|Lack of Efficacy|0|||
124499281|NCT01544595|447779998|FG003|Status at Week 68|Lack of Efficacy|0|||
124499282|NCT01544595|447779999|FG004|Status at Week 68|Lack of Efficacy|0|||
124499283|NCT01544595|447780000|FG005|Status at Week 68|Lack of Efficacy|0|||
124499284|NCT01544595|447779995|FG000|Status at Week 68|Lost to Follow-up|1|||
124499285|NCT01544595|447779996|FG001|Status at Week 68|Lost to Follow-up|1|||
124499286|NCT01544595|447779997|FG002|Status at Week 68|Lost to Follow-up|0|||
124499287|NCT01544595|447779998|FG003|Status at Week 68|Lost to Follow-up|0|||
124499288|NCT01544595|447779999|FG004|Status at Week 68|Lost to Follow-up|0|||
124499289|NCT01544595|447780000|FG005|Status at Week 68|Lost to Follow-up|0|||
124499290|NCT01544595|447779995|FG000|Status at Week 68|Non-compliance with study treatment|1|||
124499291|NCT01544595|447779996|FG001|Status at Week 68|Non-compliance with study treatment|0|||
124499292|NCT01544595|447779997|FG002|Status at Week 68|Non-compliance with study treatment|0|||
124499293|NCT01544595|447779998|FG003|Status at Week 68|Non-compliance with study treatment|1|||
124499294|NCT01544595|447779999|FG004|Status at Week 68|Non-compliance with study treatment|0|||
124499295|NCT01544595|447780000|FG005|Status at Week 68|Non-compliance with study treatment|0|||
124499296|NCT01544595|447779995|FG000|Status at Week 68|Protocol Violation|2|||
124499297|NCT01544595|447779996|FG001|Status at Week 68|Protocol Violation|0|||
124499298|NCT01544595|447779997|FG002|Status at Week 68|Protocol Violation|1|||
124499299|NCT01544595|447779998|FG003|Status at Week 68|Protocol Violation|1|||
124499300|NCT01544595|447779999|FG004|Status at Week 68|Protocol Violation|0|||
124499301|NCT01544595|447780000|FG005|Status at Week 68|Protocol Violation|0|||
124499302|NCT01544595|447779995|FG000|Status at Week 68|Technical problems|1|||
124499303|NCT01544595|447779996|FG001|Status at Week 68|Technical problems|0|||
124499304|NCT01544595|447779997|FG002|Status at Week 68|Technical problems|0|||
124499305|NCT01544595|447779998|FG003|Status at Week 68|Technical problems|1|||
124499306|NCT01544595|447779999|FG004|Status at Week 68|Technical problems|0|||
124499307|NCT01544595|447780000|FG005|Status at Week 68|Technical problems|0|||
124499308|NCT01544595|447779995|FG000|Status at Week 68|Withdrawal by Subject|0|||
124499309|NCT01544595|447779996|FG001|Status at Week 68|Withdrawal by Subject|1|||
124499310|NCT01544595|447779997|FG002|Status at Week 68|Withdrawal by Subject|1|||
124499311|NCT01544595|447779998|FG003|Status at Week 68|Withdrawal by Subject|2|||
124499312|NCT01544595|447779999|FG004|Status at Week 68|Withdrawal by Subject|0|||
124499313|NCT01544595|447780000|FG005|Status at Week 68|Withdrawal by Subject|0|||
124499314|NCT01544595|447779995|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
124499315|NCT01544595|447779996|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
124499316|NCT01544595|447779997|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
124499317|NCT01544595|447779998|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
124774640|NCT00790842|448804637|FG002|Dose Level 1|Withdrawal by Subject|0|||
124774641|NCT00790842|448804638|FG003|Dose Level 1|Withdrawal by Subject|0|||
124774642|NCT00790842|448804639|FG004|Dose Level 1|Withdrawal by Subject|0|||
124774643|NCT00790842|448804640|FG005|Dose Level 1|Withdrawal by Subject|0|||
124774644|NCT00790842|448804641|FG006|Dose Level 1|Withdrawal by Subject|0|||
124774645|NCT00790842|448804642|FG007|Dose Level 1|Withdrawal by Subject|0|||
124774646|NCT00790842|448804643|FG008|Dose Level 1|Withdrawal by Subject|0|||
124774647|NCT00790842|448804644|FG009|Dose Level 1|Withdrawal by Subject|0|||
124774648|NCT00790842|448804645|FG010|Dose Level 1|Withdrawal by Subject|0|||
124774649|NCT00790842|448804635|FG000|Dose Level 2|Death|0|||
124774650|NCT00790842|448804636|FG001|Dose Level 2|Death|1|||
124774651|NCT00790842|448804637|FG002|Dose Level 2|Death|0|||
124774652|NCT00790842|448804638|FG003|Dose Level 2|Death|0|||
124774653|NCT00790842|448804639|FG004|Dose Level 2|Death|1|||
124774654|NCT00790842|448804640|FG005|Dose Level 2|Death|0|||
124774655|NCT00790842|448804641|FG006|Dose Level 2|Death|0|||
124774656|NCT00790842|448804642|FG007|Dose Level 2|Death|0|||
124774657|NCT00790842|448804643|FG008|Dose Level 2|Death|0|||
124774658|NCT00790842|448804644|FG009|Dose Level 2|Death|0|||
124774659|NCT00790842|448804645|FG010|Dose Level 2|Death|0|||
124774660|NCT00790842|448804635|FG000|Dose Level 2|Physician Decision|0|||
124774661|NCT00790842|448804636|FG001|Dose Level 2|Physician Decision|1|||
124774662|NCT00790842|448804637|FG002|Dose Level 2|Physician Decision|0|||
124774663|NCT00790842|448804638|FG003|Dose Level 2|Physician Decision|0|||
124774664|NCT00790842|448804639|FG004|Dose Level 2|Physician Decision|0|||
124774665|NCT00790842|448804640|FG005|Dose Level 2|Physician Decision|0|||
124774666|NCT00790842|448804641|FG006|Dose Level 2|Physician Decision|0|||
124774667|NCT00790842|448804642|FG007|Dose Level 2|Physician Decision|0|||
124774668|NCT00790842|448804643|FG008|Dose Level 2|Physician Decision|0|||
124774669|NCT00790842|448804644|FG009|Dose Level 2|Physician Decision|0|||
124774670|NCT00790842|448804645|FG010|Dose Level 2|Physician Decision|0|||
124774671|NCT00790842|448804635|FG000|Dose Level 2|Withdrawal by Subject|0|||
124774672|NCT00790842|448804636|FG001|Dose Level 2|Withdrawal by Subject|1|||
124774673|NCT00790842|448804637|FG002|Dose Level 2|Withdrawal by Subject|0|||
124774674|NCT00790842|448804638|FG003|Dose Level 2|Withdrawal by Subject|0|||
124774675|NCT00790842|448804639|FG004|Dose Level 2|Withdrawal by Subject|0|||
124774676|NCT00790842|448804640|FG005|Dose Level 2|Withdrawal by Subject|0|||
124774677|NCT00790842|448804641|FG006|Dose Level 2|Withdrawal by Subject|0|||
124774678|NCT00790842|448804642|FG007|Dose Level 2|Withdrawal by Subject|0|||
124774679|NCT00790842|448804643|FG008|Dose Level 2|Withdrawal by Subject|0|||
124774680|NCT00790842|448804644|FG009|Dose Level 2|Withdrawal by Subject|0|||
124774681|NCT00790842|448804645|FG010|Dose Level 2|Withdrawal by Subject|0|||
124774682|NCT00790842|448804635|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
124774683|NCT00790842|448804636|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
124774684|NCT00790842|448804637|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
124774685|NCT00790842|448804638|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
124774686|NCT00790842|448804639|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
124774687|NCT00790842|448804640|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
124774688|NCT00790842|448804641|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
124774689|NCT00790842|448804642|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
124774690|NCT00790842|448804643|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
124774691|NCT00790842|448804644|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
124774692|NCT00790842|448804645|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
124774693|NCT00790842|448804635|FG000|Dose Level 3|Adverse Event|0|||
124774694|NCT00790842|448804636|FG001|Dose Level 3|Adverse Event|0|||
124774695|NCT00790842|448804637|FG002|Dose Level 3|Adverse Event|1|||
124774696|NCT00790842|448804638|FG003|Dose Level 3|Adverse Event|0|||
124774697|NCT00790842|448804639|FG004|Dose Level 3|Adverse Event|0|||
124774698|NCT00790842|448804640|FG005|Dose Level 3|Adverse Event|0|||
124774699|NCT00790842|448804641|FG006|Dose Level 3|Adverse Event|0|||
124774700|NCT00790842|448804642|FG007|Dose Level 3|Adverse Event|0|||
124774701|NCT00790842|448804643|FG008|Dose Level 3|Adverse Event|0|||
124774702|NCT00790842|448804644|FG009|Dose Level 3|Adverse Event|0|||
124774703|NCT00790842|448804645|FG010|Dose Level 3|Adverse Event|0|||
124774704|NCT00790842|448804635|FG000|Dose Level 3|Withdrawal by Subject|0|||
124559205|NCT00410410|448005260|FG008|Induction Period (IP)|Adverse Event|0|||
124559206|NCT00410410|448005252|FG000|Induction Period (IP)|Lack of Efficacy|26|||
124774705|NCT00790842|448804636|FG001|Dose Level 3|Withdrawal by Subject|0|||
124774706|NCT00790842|448804637|FG002|Dose Level 3|Withdrawal by Subject|3|||
124774707|NCT00790842|448804638|FG003|Dose Level 3|Withdrawal by Subject|0|||
124774708|NCT00790842|448804639|FG004|Dose Level 3|Withdrawal by Subject|0|||
124774709|NCT00790842|448804640|FG005|Dose Level 3|Withdrawal by Subject|0|||
124774710|NCT00790842|448804641|FG006|Dose Level 3|Withdrawal by Subject|0|||
124774711|NCT00790842|448804642|FG007|Dose Level 3|Withdrawal by Subject|0|||
124774712|NCT00790842|448804643|FG008|Dose Level 3|Withdrawal by Subject|0|||
124774713|NCT00790842|448804644|FG009|Dose Level 3|Withdrawal by Subject|2|||
124774714|NCT00790842|448804645|FG010|Dose Level 3|Withdrawal by Subject|0|||
124559207|NCT00410410|448005253|FG001|Induction Period (IP)|Lack of Efficacy|24|||
124559208|NCT00410410|448005254|FG002|Induction Period (IP)|Lack of Efficacy|8|||
124559209|NCT00410410|448005255|FG003|Induction Period (IP)|Lack of Efficacy|8|||
124559210|NCT00410410|448005256|FG004|Induction Period (IP)|Lack of Efficacy|7|||
124559211|NCT00410410|448005257|FG005|Induction Period (IP)|Lack of Efficacy|7|||
124559212|NCT00410410|448005258|FG006|Induction Period (IP)|Lack of Efficacy|0|||
124559213|NCT00410410|448005259|FG007|Induction Period (IP)|Lack of Efficacy|0|||
124559214|NCT00410410|448005260|FG008|Induction Period (IP)|Lack of Efficacy|0|||
124559215|NCT00410410|448005252|FG000|Induction Period (IP)|Lost to Follow-up|2|||
124559216|NCT00410410|448005253|FG001|Induction Period (IP)|Lost to Follow-up|2|||
124559217|NCT00410410|448005254|FG002|Induction Period (IP)|Lost to Follow-up|2|||
124559218|NCT00410410|448005255|FG003|Induction Period (IP)|Lost to Follow-up|3|||
124559219|NCT00410410|448005256|FG004|Induction Period (IP)|Lost to Follow-up|0|||
124559220|NCT00410410|448005257|FG005|Induction Period (IP)|Lost to Follow-up|1|||
124559221|NCT00410410|448005258|FG006|Induction Period (IP)|Lost to Follow-up|0|||
124559222|NCT00410410|448005259|FG007|Induction Period (IP)|Lost to Follow-up|0|||
124559223|NCT00410410|448005260|FG008|Induction Period (IP)|Lost to Follow-up|0|||
124559224|NCT00410410|448005252|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
124559225|NCT00410410|448005253|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
124559226|NCT00410410|448005254|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
124559227|NCT00410410|448005255|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
124559228|NCT00410410|448005256|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
124559229|NCT00410410|448005257|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
124559230|NCT00410410|448005258|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
124559231|NCT00410410|448005259|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
124559232|NCT00410410|448005260|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
124559233|NCT00410410|448005252|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
124559234|NCT00410410|448005253|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
124559235|NCT00410410|448005254|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
124559236|NCT00410410|448005255|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
124559237|NCT00410410|448005256|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
124559238|NCT00410410|448005257|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
124559239|NCT00410410|448005258|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
124559240|NCT00410410|448005259|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
124559241|NCT00410410|448005260|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
124559242|NCT00410410|448005252|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
124559243|NCT00410410|448005253|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
124559244|NCT00410410|448005254|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
124559245|NCT00410410|448005255|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
124559246|NCT00410410|448005256|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
124559247|NCT00410410|448005257|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
124559248|NCT00410410|448005258|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
124559249|NCT00410410|448005259|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
124559250|NCT00410410|448005260|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
124559251|NCT00410410|448005252|FG000|Induction Period (IP)|Other|0|||
124559252|NCT00410410|448005253|FG001|Induction Period (IP)|Other|0|||
124559253|NCT00410410|448005254|FG002|Induction Period (IP)|Other|1|||
124559254|NCT00410410|448005255|FG003|Induction Period (IP)|Other|0|||
124559255|NCT00410410|448005256|FG004|Induction Period (IP)|Other|0|||
124559256|NCT00410410|448005257|FG005|Induction Period (IP)|Other|0|||
124559257|NCT00410410|448005258|FG006|Induction Period (IP)|Other|0|||
124559258|NCT00410410|448005259|FG007|Induction Period (IP)|Other|0|||
124559259|NCT00410410|448005260|FG008|Induction Period (IP)|Other|0|||
124559260|NCT00410410|448005252|FG000|Maintenance Period (MP)|Death|0|||
124559261|NCT00410410|448005253|FG001|Maintenance Period (MP)|Death|0|||
124559262|NCT00410410|448005254|FG002|Maintenance Period (MP)|Death|0|||
124559263|NCT00410410|448005255|FG003|Maintenance Period (MP)|Death|0|||
124559264|NCT00410410|448005256|FG004|Maintenance Period (MP)|Death|0|||
124559265|NCT00410410|448005257|FG005|Maintenance Period (MP)|Death|0|||
124559266|NCT00410410|448005258|FG006|Maintenance Period (MP)|Death|1|||
124559267|NCT00410410|448005259|FG007|Maintenance Period (MP)|Death|0|||
124559268|NCT00410410|448005260|FG008|Maintenance Period (MP)|Death|0|||
124559269|NCT00410410|448005252|FG000|Maintenance Period (MP)|Adverse Event|0|||
124559270|NCT00410410|448005253|FG001|Maintenance Period (MP)|Adverse Event|0|||
124559271|NCT00410410|448005254|FG002|Maintenance Period (MP)|Adverse Event|0|||
124559272|NCT00410410|448005255|FG003|Maintenance Period (MP)|Adverse Event|0|||
124559273|NCT00410410|448005256|FG004|Maintenance Period (MP)|Adverse Event|0|||
124559274|NCT00410410|448005257|FG005|Maintenance Period (MP)|Adverse Event|0|||
124559275|NCT00410410|448005258|FG006|Maintenance Period (MP)|Adverse Event|1|||
124559276|NCT00410410|448005259|FG007|Maintenance Period (MP)|Adverse Event|3|||
124559277|NCT00410410|448005260|FG008|Maintenance Period (MP)|Adverse Event|0|||
124559278|NCT00410410|448005252|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
124559279|NCT00410410|448005253|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
124559280|NCT00410410|448005254|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
124559281|NCT00410410|448005255|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
124559282|NCT00410410|448005256|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
124559283|NCT00410410|448005257|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
124559284|NCT00410410|448005258|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
124559285|NCT00410410|448005259|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
124559286|NCT00410410|448005260|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
124559287|NCT00410410|448005252|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
124559288|NCT00410410|448005253|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
124559289|NCT00410410|448005254|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
124559290|NCT00410410|448005255|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
124559291|NCT00410410|448005256|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
124559292|NCT00410410|448005257|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
124559293|NCT00410410|448005258|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
124559294|NCT00410410|448005259|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
124559295|NCT00410410|448005260|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
124559296|NCT00410410|448005252|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
124559297|NCT00410410|448005253|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
124559298|NCT00410410|448005254|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
124559299|NCT00410410|448005255|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
124559300|NCT00410410|448005256|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
124559301|NCT00410410|448005257|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
124559302|NCT00410410|448005258|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
124559303|NCT00410410|448005259|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
124559304|NCT00410410|448005260|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
124559305|NCT00410410|448005252|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
124559306|NCT00410410|448005253|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
124559307|NCT00410410|448005254|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
124559308|NCT00410410|448005255|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
124559309|NCT00410410|448005256|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
124559310|NCT00410410|448005257|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
124559311|NCT00410410|448005258|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
124559312|NCT00410410|448005259|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
124559313|NCT00410410|448005260|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
124559314|NCT00410410|448005252|FG000|Open-Label Period (OL)|Death|0|||
124559315|NCT00410410|448005253|FG001|Open-Label Period (OL)|Death|0|||
124559316|NCT00410410|448005254|FG002|Open-Label Period (OL)|Death|0|||
124559317|NCT00410410|448005255|FG003|Open-Label Period (OL)|Death|0|||
124559318|NCT00410410|448005256|FG004|Open-Label Period (OL)|Death|0|||
124559319|NCT00410410|448005257|FG005|Open-Label Period (OL)|Death|0|||
124559320|NCT00410410|448005258|FG006|Open-Label Period (OL)|Death|0|||
124559321|NCT00410410|448005259|FG007|Open-Label Period (OL)|Death|0|||
124559322|NCT00410410|448005260|FG008|Open-Label Period (OL)|Death|1|||
124559323|NCT00410410|448005252|FG000|Open-Label Period (OL)|Adverse Event|0|||
124559324|NCT00410410|448005253|FG001|Open-Label Period (OL)|Adverse Event|0|||
124559325|NCT00410410|448005254|FG002|Open-Label Period (OL)|Adverse Event|0|||
124559326|NCT00410410|448005255|FG003|Open-Label Period (OL)|Adverse Event|0|||
124499318|NCT01544595|447779999|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
124499319|NCT01544595|447780000|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
124499320|NCT01544595|447779995|FG000|Status at Week 156|Withdrawal by Subject|9|||
124499321|NCT01544595|447779996|FG001|Status at Week 156|Withdrawal by Subject|10|||
124499322|NCT01544595|447779997|FG002|Status at Week 156|Withdrawal by Subject|4|||
124499323|NCT01544595|447779998|FG003|Status at Week 156|Withdrawal by Subject|9|||
124499324|NCT01544595|447779999|FG004|Status at Week 156|Withdrawal by Subject|20|||
124499325|NCT01544595|447780000|FG005|Status at Week 156|Withdrawal by Subject|6|||
124499326|NCT01544595|447779995|FG000|Status at Week 156|Adverse Event|9|||
124499327|NCT01544595|447779996|FG001|Status at Week 156|Adverse Event|11|||
124499328|NCT01544595|447779997|FG002|Status at Week 156|Adverse Event|1|||
124499329|NCT01544595|447779998|FG003|Status at Week 156|Adverse Event|3|||
124499330|NCT01544595|447779999|FG004|Status at Week 156|Adverse Event|4|||
124724204|NCT05396014|448611648|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124499331|NCT01544595|447780000|FG005|Status at Week 156|Adverse Event|2|||
124499332|NCT01544595|447779995|FG000|Status at Week 156|Lost to Follow-up|4|||
124559327|NCT00410410|448005256|FG004|Open-Label Period (OL)|Adverse Event|0|||
124559328|NCT00410410|448005257|FG005|Open-Label Period (OL)|Adverse Event|0|||
124559329|NCT00410410|448005258|FG006|Open-Label Period (OL)|Adverse Event|0|||
124499333|NCT01544595|447779996|FG001|Status at Week 156|Lost to Follow-up|4|||
124499334|NCT01544595|447779997|FG002|Status at Week 156|Lost to Follow-up|0|||
124559330|NCT00410410|448005259|FG007|Open-Label Period (OL)|Adverse Event|0|||
124559331|NCT00410410|448005260|FG008|Open-Label Period (OL)|Adverse Event|10|||
124559332|NCT00410410|448005252|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
124559333|NCT00410410|448005253|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
124559334|NCT00410410|448005254|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
124774715|NCT00790842|448804635|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
124774716|NCT00790842|448804636|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
124774717|NCT00790842|448804637|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
124774718|NCT00790842|448804638|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
124774719|NCT00790842|448804639|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
124774720|NCT00790842|448804640|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
124774721|NCT00790842|448804641|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
124774722|NCT00790842|448804642|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
124774723|NCT00790842|448804643|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
124774724|NCT00790842|448804644|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
124774725|NCT00790842|448804645|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
124774726|NCT00790842|448804635|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
124774727|NCT00790842|448804636|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
124774728|NCT00790842|448804637|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
124774729|NCT00790842|448804638|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
124774730|NCT00790842|448804639|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
124774731|NCT00790842|448804640|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
124774732|NCT00790842|448804641|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
124774733|NCT00790842|448804642|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
124774734|NCT00790842|448804643|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
124774735|NCT00790842|448804644|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
124774736|NCT00790842|448804645|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
124774737|NCT00790842|448804635|FG000|Dose Level 4|Adverse Event|0|||
124774738|NCT00790842|448804636|FG001|Dose Level 4|Adverse Event|0|||
124774739|NCT00790842|448804637|FG002|Dose Level 4|Adverse Event|0|||
124774740|NCT00790842|448804638|FG003|Dose Level 4|Adverse Event|0|||
124774741|NCT00790842|448804639|FG004|Dose Level 4|Adverse Event|0|||
124774742|NCT00790842|448804640|FG005|Dose Level 4|Adverse Event|0|||
124774743|NCT00790842|448804641|FG006|Dose Level 4|Adverse Event|1|||
124774744|NCT00790842|448804642|FG007|Dose Level 4|Adverse Event|0|||
124499335|NCT01544595|447779998|FG003|Status at Week 156|Lost to Follow-up|1|||
124499336|NCT01544595|447779999|FG004|Status at Week 156|Lost to Follow-up|4|||
124499337|NCT01544595|447780000|FG005|Status at Week 156|Lost to Follow-up|1|||
124499338|NCT01544595|447779995|FG000|Status at Week 156|Non-compliance with study treatement|0|||
124499339|NCT01544595|447779996|FG001|Status at Week 156|Non-compliance with study treatement|1|||
124499340|NCT01544595|447779997|FG002|Status at Week 156|Non-compliance with study treatement|0|||
124499341|NCT01544595|447779998|FG003|Status at Week 156|Non-compliance with study treatement|1|||
124499342|NCT01544595|447779999|FG004|Status at Week 156|Non-compliance with study treatement|0|||
124499343|NCT01544595|447780000|FG005|Status at Week 156|Non-compliance with study treatement|1|||
124499344|NCT01544595|447779995|FG000|Status at Week 156|Physician Decision|0|||
124499345|NCT01544595|447779996|FG001|Status at Week 156|Physician Decision|3|||
124499346|NCT01544595|447779997|FG002|Status at Week 156|Physician Decision|1|||
124499347|NCT01544595|447779998|FG003|Status at Week 156|Physician Decision|0|||
124499348|NCT01544595|447779999|FG004|Status at Week 156|Physician Decision|0|||
124499349|NCT01544595|447780000|FG005|Status at Week 156|Physician Decision|0|||
124499350|NCT01544595|447779995|FG000|Status at Week 156|Pregnancy|2|||
124499351|NCT01544595|447779996|FG001|Status at Week 156|Pregnancy|3|||
124499352|NCT01544595|447779997|FG002|Status at Week 156|Pregnancy|0|||
124499353|NCT01544595|447779998|FG003|Status at Week 156|Pregnancy|0|||
124499354|NCT01544595|447779999|FG004|Status at Week 156|Pregnancy|0|||
124499355|NCT01544595|447780000|FG005|Status at Week 156|Pregnancy|0|||
124499356|NCT01544595|447779995|FG000|Status at Week 156|Protocol Violation|3|||
124499357|NCT01544595|447779996|FG001|Status at Week 156|Protocol Violation|1|||
124499358|NCT01544595|447779997|FG002|Status at Week 156|Protocol Violation|2|||
124499359|NCT01544595|447779998|FG003|Status at Week 156|Protocol Violation|2|||
124499360|NCT01544595|447779999|FG004|Status at Week 156|Protocol Violation|0|||
124499361|NCT01544595|447780000|FG005|Status at Week 156|Protocol Violation|0|||
124499362|NCT01544595|447779995|FG000|Status at Week 156|Technical problems|3|||
124499363|NCT01544595|447779996|FG001|Status at Week 156|Technical problems|1|||
124499364|NCT01544595|447779997|FG002|Status at Week 156|Technical problems|0|||
124499365|NCT01544595|447779998|FG003|Status at Week 156|Technical problems|1|||
124499366|NCT01544595|447779999|FG004|Status at Week 156|Technical problems|0|||
124499367|NCT01544595|447780000|FG005|Status at Week 156|Technical problems|0|||
124499368|NCT01544595|447779995|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
124499369|NCT01544595|447779996|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
124499370|NCT01544595|447779997|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
124499371|NCT01544595|447779998|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
124499372|NCT01544595|447779999|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
124774745|NCT00790842|448804643|FG008|Dose Level 4|Adverse Event|0|||
124774746|NCT00790842|448804644|FG009|Dose Level 4|Adverse Event|0|||
124774747|NCT00790842|448804645|FG010|Dose Level 4|Adverse Event|0|||
124774748|NCT00790842|448804635|FG000|Dose Level 4|Physician Decision|0|||
124499373|NCT01544595|447780000|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
124499374|NCT01544595|447779995|FG000|Status at Week 156|Lack of Efficacy|1|||
124499375|NCT01544595|447779996|FG001|Status at Week 156|Lack of Efficacy|0|||
124499376|NCT01544595|447779997|FG002|Status at Week 156|Lack of Efficacy|1|||
124499377|NCT01544595|447779998|FG003|Status at Week 156|Lack of Efficacy|4|||
124499378|NCT01544595|447779999|FG004|Status at Week 156|Lack of Efficacy|10|||
124499379|NCT01544595|447780000|FG005|Status at Week 156|Lack of Efficacy|5|||
124499380|NCT00601523|447780002|FG000|Overall Study|Adverse Event|42|||
124499381|NCT00601523|447780003|FG001|Overall Study|Adverse Event|14|||
124499382|NCT00601523|447780002|FG000|Overall Study|Lack of Efficacy|3|||
124499383|NCT00601523|447780003|FG001|Overall Study|Lack of Efficacy|0|||
124499384|NCT00601523|447780002|FG000|Overall Study|Protocol Violation|5|||
124499385|NCT00601523|447780003|FG001|Overall Study|Protocol Violation|1|||
124499386|NCT00601523|447780002|FG000|Overall Study|Lost to Follow-up|0|||
124499387|NCT00601523|447780003|FG001|Overall Study|Lost to Follow-up|1|||
124499388|NCT00601523|447780002|FG000|Overall Study|Withdrawal by Subject|18|||
124499389|NCT00601523|447780003|FG001|Overall Study|Withdrawal by Subject|9|||
124499390|NCT00601523|447780002|FG000|Overall Study|Other|9|||
124499391|NCT00601523|447780003|FG001|Overall Study|Other|1|||
124499392|NCT03643432|447780004|FG000|Overall Study|Lost to Follow-up|1|||
124499393|NCT03643432|447780005|FG001|Overall Study|Lost to Follow-up|0|||
124499394|NCT05281523|447780016|FG000|Overall Study|Adverse Event|1|||
124499395|NCT05281523|447780017|FG001|Overall Study|Adverse Event|1|||
124499396|NCT05281523|447780016|FG000|Overall Study|Physician Decision|1|||
124499397|NCT05281523|447780017|FG001|Overall Study|Physician Decision|1|||
124499398|NCT05281523|447780016|FG000|Overall Study|Withdrawal by Subject|5|||
124499399|NCT05281523|447780017|FG001|Overall Study|Withdrawal by Subject|15|||
124499400|NCT05281523|447780016|FG000|Overall Study|GCP violations|3|||
124499401|NCT05281523|447780017|FG001|Overall Study|GCP violations|4|||
124499402|NCT05513391|447780018|FG000|Overall Study|Adverse Event|1|||
124499403|NCT05513391|447780019|FG001|Overall Study|Adverse Event|0|||
124499404|NCT05513391|447780018|FG000|Overall Study|Protocol Deviation|0|||
124499405|NCT05513391|447780019|FG001|Overall Study|Protocol Deviation|1|||
124499406|NCT05513391|447780018|FG000|Overall Study|Withdrawal by Subject|3|||
124499407|NCT05513391|447780019|FG001|Overall Study|Withdrawal by Subject|1|||
124499408|NCT05513391|447780018|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
124499409|NCT05513391|447780019|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
124499410|NCT05513391|447780018|FG000|Overall Study|Lost to Follow-up|0|||
124499411|NCT05513391|447780019|FG001|Overall Study|Lost to Follow-up|2|||
124499412|NCT05128162|447780020|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
124499413|NCT05128162|447780020|FG000|Overall Study|Physician Decision|1|||
124499414|NCT04038255|447781850|FG000|Overall Study|Lost to Follow-up|0|||
124499415|NCT04038255|447781851|FG001|Overall Study|Lost to Follow-up|9|||
124499416|NCT04038255|447781852|FG002|Overall Study|Lost to Follow-up|5|||
124499417|NCT04038255|447781850|FG000|Overall Study|Withdrawal by Subject|0|||
124499418|NCT04038255|447781851|FG001|Overall Study|Withdrawal by Subject|0|||
124499419|NCT04038255|447781852|FG002|Overall Study|Withdrawal by Subject|1|||
124499420|NCT00074412|447781855|FG000|Overall Study|Death|30|||
124499421|NCT00074412|447781856|FG001|Overall Study|Death|26|||
124499422|NCT00074412|447781855|FG000|Overall Study|Lost to Follow-up|52|||
124499423|NCT00074412|447781856|FG001|Overall Study|Lost to Follow-up|58|||
124499424|NCT00418834|447781859|FG000|Overall Study|Adverse Event|16|||
124499425|NCT00418834|447781860|FG001|Overall Study|Adverse Event|9|||
124499426|NCT00418834|447781859|FG000|Overall Study|Lost to Follow-up|0|||
124499427|NCT00418834|447781860|FG001|Overall Study|Lost to Follow-up|1|||
124499428|NCT00418834|447781859|FG000|Overall Study|Protocol Violation|4|||
124499429|NCT00418834|447781860|FG001|Overall Study|Protocol Violation|3|||
124499430|NCT00418834|447781859|FG000|Overall Study|Withdrawal by Subject|3|||
124499431|NCT00418834|447781860|FG001|Overall Study|Withdrawal by Subject|7|||
124499432|NCT02364947|447781866|FG000|Overall Study|Withdrawal by Subject|10|||
124499433|NCT02364947|447781867|FG001|Overall Study|Withdrawal by Subject|8|||
124499434|NCT02364947|447781868|FG002|Overall Study|Withdrawal by Subject|9|||
124499435|NCT02364947|447781866|FG000|Overall Study|Adverse Event|45|||
124499436|NCT02364947|447781867|FG001|Overall Study|Adverse Event|33|||
124499437|NCT02364947|447781868|FG002|Overall Study|Adverse Event|11|||
124499438|NCT02364947|447781866|FG000|Overall Study|Protocol Violation|1|||
124499439|NCT02364947|447781867|FG001|Overall Study|Protocol Violation|1|||
124499440|NCT02364947|447781868|FG002|Overall Study|Protocol Violation|1|||
124499441|NCT02364947|447781866|FG000|Overall Study|Physician Decision|3|||
124499442|NCT02364947|447781867|FG001|Overall Study|Physician Decision|2|||
124499443|NCT02364947|447781868|FG002|Overall Study|Physician Decision|5|||
124499444|NCT02364947|447781866|FG000|Overall Study|Death|0|||
124499445|NCT02364947|447781867|FG001|Overall Study|Death|1|||
124499446|NCT02364947|447781868|FG002|Overall Study|Death|0|||
124499447|NCT02163993|447781869|FG000|Treatment Period|Adverse Event|0|||
124499448|NCT02163993|447781870|FG001|Treatment Period|Adverse Event|1|||
124499449|NCT02163993|447781871|FG002|Treatment Period|Adverse Event|0|||
124499450|NCT02163993|447781872|FG003|Treatment Period|Adverse Event|0|||
124499451|NCT02163993|447781873|FG004|Treatment Period|Adverse Event|1|||
124499452|NCT02163993|447781869|FG000|Treatment Period|Lost to Follow-up|2|||
124499453|NCT02163993|447781870|FG001|Treatment Period|Lost to Follow-up|3|||
124499454|NCT02163993|447781871|FG002|Treatment Period|Lost to Follow-up|1|||
124499455|NCT02163993|447781872|FG003|Treatment Period|Lost to Follow-up|3|||
124499456|NCT02163993|447781873|FG004|Treatment Period|Lost to Follow-up|1|||
124499457|NCT02163993|447781869|FG000|Treatment Period|Physician Decision|1|||
124499458|NCT02163993|447781870|FG001|Treatment Period|Physician Decision|0|||
124499459|NCT02163993|447781871|FG002|Treatment Period|Physician Decision|0|||
124499460|NCT02163993|447781872|FG003|Treatment Period|Physician Decision|0|||
124499461|NCT02163993|447781873|FG004|Treatment Period|Physician Decision|0|||
124499462|NCT02163993|447781869|FG000|Treatment Period|Protocol Violation|2|||
124499463|NCT02163993|447781870|FG001|Treatment Period|Protocol Violation|1|||
124499464|NCT02163993|447781871|FG002|Treatment Period|Protocol Violation|0|||
124499465|NCT02163993|447781872|FG003|Treatment Period|Protocol Violation|1|||
124499466|NCT02163993|447781873|FG004|Treatment Period|Protocol Violation|2|||
124499467|NCT02163993|447781869|FG000|Treatment Period|Withdrawal by Subject|6|||
124499468|NCT02163993|447781870|FG001|Treatment Period|Withdrawal by Subject|4|||
124499469|NCT02163993|447781871|FG002|Treatment Period|Withdrawal by Subject|1|||
124499470|NCT02163993|447781872|FG003|Treatment Period|Withdrawal by Subject|4|||
124499471|NCT02163993|447781873|FG004|Treatment Period|Withdrawal by Subject|1|||
124499472|NCT02163993|447781869|FG000|Treatment Period|Not treated|1|||
124499473|NCT02163993|447781870|FG001|Treatment Period|Not treated|0|||
124499474|NCT02163993|447781871|FG002|Treatment Period|Not treated|0|||
124499475|NCT02163993|447781872|FG003|Treatment Period|Not treated|1|||
124499476|NCT02163993|447781873|FG004|Treatment Period|Not treated|2|||
124499477|NCT02163993|447781869|FG000|Post-treatment Period|Adverse Event|0|||
124499478|NCT02163993|447781870|FG001|Post-treatment Period|Adverse Event|0|||
124499479|NCT02163993|447781871|FG002|Post-treatment Period|Adverse Event|1|||
124499480|NCT02163993|447781872|FG003|Post-treatment Period|Adverse Event|0|||
124499481|NCT02163993|447781873|FG004|Post-treatment Period|Adverse Event|0|||
124499482|NCT02163993|447781869|FG000|Post-treatment Period|Lost to Follow-up|2|||
124499483|NCT02163993|447781870|FG001|Post-treatment Period|Lost to Follow-up|2|||
124499484|NCT02163993|447781871|FG002|Post-treatment Period|Lost to Follow-up|3|||
124499485|NCT02163993|447781872|FG003|Post-treatment Period|Lost to Follow-up|1|||
124499486|NCT02163993|447781873|FG004|Post-treatment Period|Lost to Follow-up|0|||
124499487|NCT02163993|447781869|FG000|Post-treatment Period|Protocol Violation|0|||
124499488|NCT02163993|447781870|FG001|Post-treatment Period|Protocol Violation|0|||
124499489|NCT02163993|447781871|FG002|Post-treatment Period|Protocol Violation|0|||
124499490|NCT02163993|447781872|FG003|Post-treatment Period|Protocol Violation|0|||
124499491|NCT02163993|447781873|FG004|Post-treatment Period|Protocol Violation|1|||
124499492|NCT02163993|447781869|FG000|Post-treatment Period|Withdrawal by Subject|2|||
124499493|NCT02163993|447781870|FG001|Post-treatment Period|Withdrawal by Subject|4|||
124499494|NCT02163993|447781871|FG002|Post-treatment Period|Withdrawal by Subject|0|||
124499495|NCT02163993|447781872|FG003|Post-treatment Period|Withdrawal by Subject|1|||
124499496|NCT02163993|447781873|FG004|Post-treatment Period|Withdrawal by Subject|2|||
124499497|NCT00853489|447781874|FG000|Overall Study|Lost to Follow-up|5|||
124499498|NCT00853489|447781875|FG001|Overall Study|Lost to Follow-up|2|||
124499499|NCT05525975|447781876|FG000|Overall Study|Surgery cancellation|4|||
124499500|NCT05525975|447781877|FG001|Overall Study|Surgery cancellation|5|||
124499501|NCT05525975|447781876|FG000|Overall Study|didn't fill prescription|1|||
124499502|NCT05525975|447781877|FG001|Overall Study|didn't fill prescription|0|||
124499503|NCT05525975|447781876|FG000|Overall Study|Withdrawal by Subject|0|||
124499504|NCT05525975|447781877|FG001|Overall Study|Withdrawal by Subject|3|||
124499505|NCT00441441|447781878|FG000|Overall Study|Adverse Event|2|||
124499506|NCT00441441|447781879|FG001|Overall Study|Adverse Event|1|||
124499507|NCT00441441|447781878|FG000|Overall Study|Protocol Violation|4|||
124499508|NCT00441441|447781879|FG001|Overall Study|Protocol Violation|6|||
124499509|NCT00441441|447781878|FG000|Overall Study|Exacerbation of asthma|1|||
124499510|NCT00441441|447781879|FG001|Overall Study|Exacerbation of asthma|2|||
124499511|NCT00441441|447781878|FG000|Overall Study|Withdrawal by Subject|1|||
124499512|NCT00441441|447781879|FG001|Overall Study|Withdrawal by Subject|2|||
124499513|NCT00441441|447781878|FG000|Overall Study|Other|3|||
124774749|NCT00790842|448804636|FG001|Dose Level 4|Physician Decision|0|||
124499514|NCT00441441|447781879|FG001|Overall Study|Other|3|||
124499515|NCT04009096|447781880|FG000|Overall Study|Withdrawal by Subject|0|||
124499516|NCT04009096|447781881|FG001|Overall Study|Withdrawal by Subject|7|||
124774750|NCT00790842|448804637|FG002|Dose Level 4|Physician Decision|0|||
124499517|NCT04009096|447781882|FG002|Overall Study|Withdrawal by Subject|0|||
124559335|NCT00410410|448005255|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
124499518|NCT04009096|447781880|FG000|Overall Study|Physician Decision|0|||
124499519|NCT04009096|447781881|FG001|Overall Study|Physician Decision|1|||
124499520|NCT04009096|447781882|FG002|Overall Study|Physician Decision|0|||
124499521|NCT05151471|447781883|FG000|Overall Study|Adverse Event|21|||
124499522|NCT05151471|447781884|FG001|Overall Study|Adverse Event|16|||
124499523|NCT05151471|447781883|FG000|Overall Study|Death|1|||
124499524|NCT05151471|447781884|FG001|Overall Study|Death|0|||
124499525|NCT05151471|447781883|FG000|Overall Study|Lost to Follow-up|0|||
124774751|NCT00790842|448804638|FG003|Dose Level 4|Physician Decision|0|||
124774752|NCT00790842|448804639|FG004|Dose Level 4|Physician Decision|0|||
124774753|NCT00790842|448804640|FG005|Dose Level 4|Physician Decision|0|||
124774754|NCT00790842|448804641|FG006|Dose Level 4|Physician Decision|1|||
124774755|NCT00790842|448804642|FG007|Dose Level 4|Physician Decision|0|||
124774756|NCT00790842|448804643|FG008|Dose Level 4|Physician Decision|0|||
124774757|NCT00790842|448804644|FG009|Dose Level 4|Physician Decision|0|||
124774758|NCT00790842|448804645|FG010|Dose Level 4|Physician Decision|1|||
124774759|NCT00790842|448804635|FG000|Dose Level 4|Withdrawal by Subject|0|||
124774760|NCT00790842|448804636|FG001|Dose Level 4|Withdrawal by Subject|0|||
124774761|NCT00790842|448804637|FG002|Dose Level 4|Withdrawal by Subject|0|||
124774762|NCT00790842|448804638|FG003|Dose Level 4|Withdrawal by Subject|0|||
124774763|NCT00790842|448804639|FG004|Dose Level 4|Withdrawal by Subject|0|||
124774764|NCT00790842|448804640|FG005|Dose Level 4|Withdrawal by Subject|0|||
124774765|NCT00790842|448804641|FG006|Dose Level 4|Withdrawal by Subject|0|||
124774766|NCT00790842|448804642|FG007|Dose Level 4|Withdrawal by Subject|0|||
124774767|NCT00790842|448804643|FG008|Dose Level 4|Withdrawal by Subject|0|||
124774768|NCT00790842|448804644|FG009|Dose Level 4|Withdrawal by Subject|0|||
124499526|NCT05151471|447781884|FG001|Overall Study|Lost to Follow-up|1|||
124499527|NCT05151471|447781883|FG000|Overall Study|Withdrawal by Subject|7|||
124499528|NCT05151471|447781884|FG001|Overall Study|Withdrawal by Subject|9|||
124499529|NCT05151471|447781883|FG000|Overall Study|Study terminated by sponsor|49|||
124499530|NCT05151471|447781884|FG001|Overall Study|Study terminated by sponsor|47|||
124724205|NCT05396014|448611649|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724206|NCT05396014|448611650|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724207|NCT05396014|448611651|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724208|NCT05396014|448611652|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724209|NCT05396014|448611653|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724210|NCT05396014|448611654|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724211|NCT05396014|448611655|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724212|NCT05396014|448611656|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724213|NCT05396014|448611657|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724214|NCT05396014|448611658|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724215|NCT05396014|448611659|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724216|NCT05396014|448611660|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724217|NCT05396014|448611661|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724218|NCT05396014|448611662|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724219|NCT05396014|448611663|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724220|NCT05396014|448611664|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724221|NCT05396014|448611665|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724222|NCT05396014|448611666|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724223|NCT05396014|448611667|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724224|NCT05396014|448611668|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724225|NCT05396014|448611669|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724226|NCT05396014|448611670|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724227|NCT05396014|448611671|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
124724228|NCT05396014|448611672|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724229|NCT05396014|448611673|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724230|NCT05396014|448611674|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724231|NCT05396014|448611675|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724232|NCT05396014|448611676|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724233|NCT05396014|448611677|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724234|NCT05396014|448611678|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724235|NCT05396014|448611679|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724236|NCT05396014|448611680|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724237|NCT05396014|448611681|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724238|NCT05396014|448611682|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724239|NCT05396014|448611683|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724240|NCT05396014|448611684|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724241|NCT05396014|448611685|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724242|NCT05396014|448611686|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724243|NCT05396014|448611687|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
124724244|NCT00516893|448611695|FG000|Overall Study|Lost to Follow-up|4|||
124724245|NCT00516893|448611695|FG000|Overall Study|Adverse Event|3|||
124724246|NCT00516893|448611695|FG000|Overall Study|Withdrawal by Subject|2|||
124724247|NCT00516893|448611695|FG000|Overall Study|Noncompliance|2|||
124774769|NCT00790842|448804645|FG010|Dose Level 4|Withdrawal by Subject|1|||
124774770|NCT00790842|448804635|FG000|Expansion Cohort|Adverse Event|0|||
124774771|NCT00790842|448804636|FG001|Expansion Cohort|Adverse Event|0|||
124499531|NCT05151471|447781883|FG000|Overall Study|Other|2|||
124559336|NCT00410410|448005256|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
124559337|NCT00410410|448005257|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
124559338|NCT00410410|448005258|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
124559339|NCT00410410|448005259|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
124559340|NCT00410410|448005260|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
124559341|NCT00410410|448005252|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
124559342|NCT00410410|448005253|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
124559343|NCT00410410|448005254|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
124559344|NCT00410410|448005255|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
124559345|NCT00410410|448005256|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
124559346|NCT00410410|448005257|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
124559347|NCT00410410|448005258|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
124559348|NCT00410410|448005259|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
124559349|NCT00410410|448005260|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
124559350|NCT00410410|448005252|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
124559351|NCT00410410|448005253|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
124559352|NCT00410410|448005254|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
124559353|NCT00410410|448005255|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
124559354|NCT00410410|448005256|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
124559355|NCT00410410|448005257|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
124559356|NCT00410410|448005258|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
124559357|NCT00410410|448005259|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
124559358|NCT00410410|448005260|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
124559359|NCT00410410|448005252|FG000|Open-Label Period (OL)|Pregnancy|0|||
124559360|NCT00410410|448005253|FG001|Open-Label Period (OL)|Pregnancy|0|||
124559361|NCT00410410|448005254|FG002|Open-Label Period (OL)|Pregnancy|0|||
124559362|NCT00410410|448005255|FG003|Open-Label Period (OL)|Pregnancy|0|||
124499532|NCT05151471|447781884|FG001|Overall Study|Other|1|||
124499533|NCT03010423|447781885|FG000|Overall Study|Study termination|8|||
124499534|NCT01856595|447781886|FG000|Overall Study|Withdrawal by Subject|0|||
124499535|NCT01856595|447781887|FG001|Overall Study|Withdrawal by Subject|1|||
124499536|NCT01856595|447781888|FG002|Overall Study|Withdrawal by Subject|0|||
124499537|NCT01856595|447781889|FG003|Overall Study|Withdrawal by Subject|0|||
124499538|NCT01856595|447781890|FG004|Overall Study|Withdrawal by Subject|0|||
124499539|NCT01856595|447781891|FG005|Overall Study|Withdrawal by Subject|0|||
124499540|NCT01856595|447781892|FG006|Overall Study|Withdrawal by Subject|1|||
124499541|NCT01856595|447781893|FG007|Overall Study|Withdrawal by Subject|0|||
124499542|NCT01856595|447781894|FG008|Overall Study|Withdrawal by Subject|0|||
124499543|NCT04426825|447781895|FG000|Overall Study|Death|17|||
124499544|NCT04426825|447781895|FG000|Overall Study|Lost to Follow-up|1|||
124499545|NCT04426825|447781895|FG000|Overall Study|Study terminated by sponsor|5|||
124499546|NCT04346628|447781896|FG000|Overall Study|Lost to Follow-up|4|||
124499547|NCT04346628|447781897|FG001|Overall Study|Lost to Follow-up|4|||
124499548|NCT04346628|447781896|FG000|Overall Study|Withdrew (had personal reasons)|2|||
124499549|NCT04346628|447781897|FG001|Overall Study|Withdrew (had personal reasons)|5|||
124499550|NCT04346628|447781896|FG000|Overall Study|Withdrew (medication intolerant)|0|||
124499551|NCT04346628|447781897|FG001|Overall Study|Withdrew (medication intolerant)|3|||
124499552|NCT04346628|447781896|FG000|Overall Study|Withdrew (declined intervention)|0|||
124499553|NCT04346628|447781897|FG001|Overall Study|Withdrew (declined intervention)|1|||
124499554|NCT01028651|447781901|FG000|Overall Study|Death|2|||
124499555|NCT01028651|447781901|FG000|Overall Study|Adverse Event|1|||
124499556|NCT00411788|447781902|FG000|Overall Study|Protocol Violation|1|||
124499557|NCT00411788|447781902|FG000|Overall Study|Adverse Event|1|||
124499558|NCT01554956|447781903|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
124499559|NCT01554956|447781904|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
124499560|NCT01554956|447781905|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
124499561|NCT01554956|447781903|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
124499562|NCT01554956|447781904|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
124499563|NCT01554956|447781905|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
124499564|NCT01554956|447781903|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
124499565|NCT01554956|447781904|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
124499566|NCT01554956|447781905|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
124499567|NCT01428063|447781907|FG000|Overall Study|Lack of Efficacy|8|||
124499568|NCT01428063|447781908|FG001|Overall Study|Lack of Efficacy|4|||
124499569|NCT01428063|447781909|FG002|Overall Study|Lack of Efficacy|1|||
124499570|NCT01428063|447781907|FG000|Overall Study|Adverse Event|2|||
124559363|NCT00410410|448005256|FG004|Open-Label Period (OL)|Pregnancy|0|||
124559364|NCT00410410|448005257|FG005|Open-Label Period (OL)|Pregnancy|0|||
124559365|NCT00410410|448005258|FG006|Open-Label Period (OL)|Pregnancy|0|||
124559366|NCT00410410|448005259|FG007|Open-Label Period (OL)|Pregnancy|0|||
124559367|NCT00410410|448005260|FG008|Open-Label Period (OL)|Pregnancy|1|||
124499571|NCT01428063|447781908|FG001|Overall Study|Adverse Event|3|||
124499572|NCT01428063|447781909|FG002|Overall Study|Adverse Event|0|||
124774772|NCT00790842|448804637|FG002|Expansion Cohort|Adverse Event|0|||
124774773|NCT00790842|448804638|FG003|Expansion Cohort|Adverse Event|0|||
124774774|NCT00790842|448804639|FG004|Expansion Cohort|Adverse Event|0|||
124774775|NCT00790842|448804640|FG005|Expansion Cohort|Adverse Event|0|||
124774776|NCT00790842|448804641|FG006|Expansion Cohort|Adverse Event|1|||
124774777|NCT00790842|448804642|FG007|Expansion Cohort|Adverse Event|0|||
124774778|NCT00790842|448804643|FG008|Expansion Cohort|Adverse Event|0|||
124774779|NCT00790842|448804644|FG009|Expansion Cohort|Adverse Event|0|||
124774780|NCT00790842|448804645|FG010|Expansion Cohort|Adverse Event|0|||
124774781|NCT00790842|448804635|FG000|Expansion Cohort|Death|0|||
124774782|NCT00790842|448804636|FG001|Expansion Cohort|Death|0|||
124774783|NCT00790842|448804637|FG002|Expansion Cohort|Death|2|||
124774784|NCT00790842|448804638|FG003|Expansion Cohort|Death|0|||
124774785|NCT00790842|448804639|FG004|Expansion Cohort|Death|0|||
124774786|NCT00790842|448804640|FG005|Expansion Cohort|Death|0|||
124774787|NCT00790842|448804641|FG006|Expansion Cohort|Death|0|||
124774788|NCT00790842|448804642|FG007|Expansion Cohort|Death|0|||
124774789|NCT00790842|448804643|FG008|Expansion Cohort|Death|0|||
124774790|NCT00790842|448804644|FG009|Expansion Cohort|Death|0|||
124774791|NCT00790842|448804645|FG010|Expansion Cohort|Death|0|||
124774792|NCT00790842|448804635|FG000|Expansion Cohort|Physician Decision|0|||
124774793|NCT00790842|448804636|FG001|Expansion Cohort|Physician Decision|0|||
124774794|NCT00790842|448804637|FG002|Expansion Cohort|Physician Decision|1|||
124774795|NCT00790842|448804638|FG003|Expansion Cohort|Physician Decision|0|||
124774796|NCT00790842|448804639|FG004|Expansion Cohort|Physician Decision|0|||
124774797|NCT00790842|448804640|FG005|Expansion Cohort|Physician Decision|0|||
124774798|NCT00790842|448804641|FG006|Expansion Cohort|Physician Decision|0|||
124774799|NCT00790842|448804642|FG007|Expansion Cohort|Physician Decision|0|||
124774800|NCT00790842|448804643|FG008|Expansion Cohort|Physician Decision|0|||
124774801|NCT00790842|448804644|FG009|Expansion Cohort|Physician Decision|0|||
124774802|NCT00790842|448804645|FG010|Expansion Cohort|Physician Decision|0|||
124774803|NCT00790842|448804635|FG000|Expansion Cohort|Withdrawal by Subject|0|||
124774804|NCT00790842|448804636|FG001|Expansion Cohort|Withdrawal by Subject|0|||
124774805|NCT00790842|448804637|FG002|Expansion Cohort|Withdrawal by Subject|3|||
124774806|NCT00790842|448804638|FG003|Expansion Cohort|Withdrawal by Subject|0|||
124774807|NCT00790842|448804639|FG004|Expansion Cohort|Withdrawal by Subject|0|||
124774808|NCT00790842|448804640|FG005|Expansion Cohort|Withdrawal by Subject|0|||
124774809|NCT00790842|448804641|FG006|Expansion Cohort|Withdrawal by Subject|0|||
124774810|NCT00790842|448804642|FG007|Expansion Cohort|Withdrawal by Subject|0|||
124774811|NCT00790842|448804643|FG008|Expansion Cohort|Withdrawal by Subject|0|||
124774812|NCT00790842|448804644|FG009|Expansion Cohort|Withdrawal by Subject|0|||
124774813|NCT00790842|448804645|FG010|Expansion Cohort|Withdrawal by Subject|0|||
124774814|NCT00790842|448804635|FG000|Expansion Cohort|Study Closure|0|||
124774815|NCT00790842|448804636|FG001|Expansion Cohort|Study Closure|0|||
124774816|NCT00790842|448804637|FG002|Expansion Cohort|Study Closure|1|||
124774817|NCT00790842|448804638|FG003|Expansion Cohort|Study Closure|0|||
124774818|NCT00790842|448804639|FG004|Expansion Cohort|Study Closure|0|||
124774819|NCT00790842|448804640|FG005|Expansion Cohort|Study Closure|0|||
124774820|NCT00790842|448804641|FG006|Expansion Cohort|Study Closure|0|||
124774821|NCT00790842|448804642|FG007|Expansion Cohort|Study Closure|0|||
124774822|NCT00790842|448804643|FG008|Expansion Cohort|Study Closure|0|||
124774823|NCT00790842|448804644|FG009|Expansion Cohort|Study Closure|0|||
124774824|NCT00790842|448804645|FG010|Expansion Cohort|Study Closure|0|||
124774825|NCT00885170|448804656|FG000|Overall Study|Adverse Event|12|||
124774826|NCT00885170|448804657|FG001|Overall Study|Adverse Event|4|||
124774827|NCT00885170|448804656|FG000|Overall Study|Excessive bone loss|6|||
124774828|NCT00885170|448804657|FG001|Overall Study|Excessive bone loss|3|||
124774829|NCT00885170|448804656|FG000|Overall Study|Lost to Follow-up|2|||
124774830|NCT00885170|448804657|FG001|Overall Study|Lost to Follow-up|1|||
124774831|NCT00885170|448804656|FG000|Overall Study|Physician Decision|2|||
124774832|NCT00885170|448804657|FG001|Overall Study|Physician Decision|1|||
124774833|NCT00885170|448804656|FG000|Overall Study|Protocol Violation|3|||
124774834|NCT00885170|448804657|FG001|Overall Study|Protocol Violation|1|||
124774835|NCT00885170|448804656|FG000|Overall Study|Withdrawal by Subject|13|||
124774836|NCT00885170|448804657|FG001|Overall Study|Withdrawal by Subject|13|||
124774837|NCT00561925|448804658|FG000|14 Day Lead-In Period|Adverse Event|38|||
124774838|NCT00561925|448804659|FG001|14 Day Lead-In Period|Adverse Event|0|||
124774839|NCT00561925|448804660|FG002|14 Day Lead-In Period|Adverse Event|0|||
124774840|NCT00561925|448804661|FG003|14 Day Lead-In Period|Adverse Event|0|||
124774841|NCT00561925|448804662|FG004|14 Day Lead-In Period|Adverse Event|0|||
124774842|NCT00561925|448804658|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
124774843|NCT00561925|448804659|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
124774844|NCT00561925|448804660|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
124774845|NCT00561925|448804661|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
124774846|NCT00561925|448804662|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
124774847|NCT00561925|448804658|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
124774848|NCT00561925|448804659|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
124774849|NCT00561925|448804660|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
124774850|NCT00561925|448804661|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
124774851|NCT00561925|448804662|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
124774852|NCT00561925|448804658|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
124774853|NCT00561925|448804659|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
124774854|NCT00561925|448804660|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
124774855|NCT00561925|448804661|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
124774856|NCT00561925|448804662|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
124774857|NCT00561925|448804658|FG000|14 Day Lead-In Period|Other|5|||
124774858|NCT00561925|448804659|FG001|14 Day Lead-In Period|Other|0|||
124774859|NCT00561925|448804660|FG002|14 Day Lead-In Period|Other|0|||
124774860|NCT00561925|448804661|FG003|14 Day Lead-In Period|Other|0|||
124774861|NCT00561925|448804662|FG004|14 Day Lead-In Period|Other|0|||
124774862|NCT00561925|448804658|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
124774863|NCT00561925|448804659|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
124774864|NCT00561925|448804660|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
124499573|NCT01428063|447781907|FG000|Overall Study|Lost to Follow-up|0|||
124499574|NCT01428063|447781908|FG001|Overall Study|Lost to Follow-up|2|||
124499575|NCT01428063|447781909|FG002|Overall Study|Lost to Follow-up|0|||
124499576|NCT01428063|447781907|FG000|Overall Study|No longer meets study criteria|0|||
124499577|NCT01428063|447781908|FG001|Overall Study|No longer meets study criteria|1|||
124499578|NCT01428063|447781909|FG002|Overall Study|No longer meets study criteria|0|||
124499579|NCT00913978|447781910|FG000|Overall Study|Surgeon choice|1|||
124499580|NCT00913978|447781911|FG001|Overall Study|Surgeon choice|3|||
124499581|NCT01327651|447781912|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
124499582|NCT01327651|447781913|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
124499583|NCT01327651|447781914|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
124499584|NCT01327651|447781915|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
124499585|NCT01327651|447781916|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
124499586|NCT01327651|447781917|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
124499587|NCT01327651|447781918|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
124499588|NCT01327651|447781919|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
124499589|NCT01327651|447781920|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
124499590|NCT01327651|447781912|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
124499591|NCT01327651|447781913|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
124499592|NCT01327651|447781914|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
124499593|NCT01327651|447781915|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
124499594|NCT01327651|447781916|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
124499595|NCT01327651|447781917|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
124499596|NCT01327651|447781918|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
124499597|NCT01327651|447781919|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
124499598|NCT01327651|447781920|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
124499599|NCT01327651|447781912|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
124499600|NCT01327651|447781913|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
124499601|NCT01327651|447781914|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
124499602|NCT01327651|447781915|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
124499603|NCT01327651|447781916|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
124499604|NCT01327651|447781917|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
124499605|NCT01327651|447781918|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
124499606|NCT01327651|447781919|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
124499607|NCT01327651|447781920|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
124499608|NCT01327651|447781912|FG000|Post Study Follow-up|Lost to Follow-up|0|||
124499609|NCT01327651|447781913|FG001|Post Study Follow-up|Lost to Follow-up|1|||
124499610|NCT01327651|447781914|FG002|Post Study Follow-up|Lost to Follow-up|1|||
124499611|NCT01327651|447781915|FG003|Post Study Follow-up|Lost to Follow-up|0|||
124499612|NCT01327651|447781916|FG004|Post Study Follow-up|Lost to Follow-up|0|||
124499613|NCT01327651|447781917|FG005|Post Study Follow-up|Lost to Follow-up|0|||
124499614|NCT01327651|447781918|FG006|Post Study Follow-up|Lost to Follow-up|4|||
124499615|NCT01327651|447781919|FG007|Post Study Follow-up|Lost to Follow-up|1|||
124499616|NCT01327651|447781920|FG008|Post Study Follow-up|Lost to Follow-up|2|||
124499617|NCT03249792|447781925|FG000|Arms 1, 2, and 4|Death|1|||
124499618|NCT03249792|447781926|FG001|Arms 1, 2, and 4|Death|1|||
124499619|NCT03249792|447781927|FG002|Arms 1, 2, and 4|Death|0|||
124499620|NCT03249792|447781928|FG003|Arms 1, 2, and 4|Death|2|||
124499621|NCT03249792|447781929|FG004|Arms 1, 2, and 4|Death|3|||
124499622|NCT03249792|447781930|FG005|Arms 1, 2, and 4|Death|2|||
124499623|NCT03249792|447781931|FG006|Arms 1, 2, and 4|Death|2|||
124499624|NCT03249792|447781932|FG007|Arms 1, 2, and 4|Death|4|||
124499625|NCT03249792|447781933|FG008|Arms 1, 2, and 4|Death|2|||
124499626|NCT03249792|447781934|FG009|Arms 1, 2, and 4|Death|1|||
124559368|NCT00410410|448005252|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
124774865|NCT00561925|448804661|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
124499627|NCT03249792|447781935|FG010|Arms 1, 2, and 4|Death|7|||
124499628|NCT03249792|447781936|FG011|Arms 1, 2, and 4|Death|7|||
124499629|NCT03249792|447781937|FG012|Arms 1, 2, and 4|Death|12|||
124499630|NCT03249792|447781938|FG013|Arms 1, 2, and 4|Death|7|||
124499631|NCT03249792|447781939|FG014|Arms 1, 2, and 4|Death|0|||
124499632|NCT03249792|447781940|FG015|Arms 1, 2, and 4|Death|4|||
124499633|NCT03249792|447781941|FG016|Arms 1, 2, and 4|Death|4|||
124499634|NCT03249792|447781942|FG017|Arms 1, 2, and 4|Death|12|||
124499635|NCT03249792|447781943|FG018|Arms 1, 2, and 4|Death|6|||
124499636|NCT03249792|447781944|FG019|Arms 1, 2, and 4|Death|4|||
124499637|NCT03249792|447781945|FG020|Arms 1, 2, and 4|Death|2|||
124499638|NCT03249792|447781946|FG021|Arms 1, 2, and 4|Death|3|||
124499639|NCT03249792|447781947|FG022|Arms 1, 2, and 4|Death|1|||
124499640|NCT03249792|447781948|FG023|Arms 1, 2, and 4|Death|1|||
124499641|NCT03249792|447781949|FG024|Arms 1, 2, and 4|Death|4|||
124499642|NCT03249792|447781950|FG025|Arms 1, 2, and 4|Death|0|||
124499643|NCT03249792|447781951|FG026|Arms 1, 2, and 4|Death|0|||
124499644|NCT03249792|447781952|FG027|Arms 1, 2, and 4|Death|0|||
124499645|NCT03249792|447781953|FG028|Arms 1, 2, and 4|Death|0|||
124499646|NCT03249792|447781954|FG029|Arms 1, 2, and 4|Death|0|||
124499647|NCT03249792|447781955|FG030|Arms 1, 2, and 4|Death|0|||
124499648|NCT03249792|447781956|FG031|Arms 1, 2, and 4|Death|0|||
124499649|NCT03249792|447781957|FG032|Arms 1, 2, and 4|Death|0|||
124724248|NCT00516893|448611695|FG000|Overall Study|Death|1|||
124724249|NCT00516893|448611695|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
124724250|NCT00516893|448611695|FG000|Overall Study|Relocated|1|||
124724251|NCT00516893|448611695|FG000|Overall Study|Pregnancy|1|||
124724252|NCT00516893|448611695|FG000|Overall Study|Received Medication From Another Study|1|||
124724253|NCT05935878|448611698|FG000|Overall Study|Death|1|||
124499650|NCT03249792|447781925|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499651|NCT03249792|447781926|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499652|NCT03249792|447781927|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
124499653|NCT03249792|447781928|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499654|NCT03249792|447781929|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499655|NCT03249792|447781930|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
124499656|NCT03249792|447781931|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
124499657|NCT03249792|447781932|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499658|NCT03249792|447781933|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
124499659|NCT03249792|447781934|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
124499660|NCT03249792|447781935|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
124499661|NCT03249792|447781936|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
124499662|NCT03249792|447781937|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
124499663|NCT03249792|447781938|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
124499664|NCT03249792|447781939|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499665|NCT03249792|447781940|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499666|NCT03249792|447781941|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
124499667|NCT03249792|447781942|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499668|NCT03249792|447781943|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
124499669|NCT03249792|447781944|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499670|NCT03249792|447781945|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499671|NCT03249792|447781946|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499672|NCT03249792|447781947|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
124499673|NCT03249792|447781948|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
124499674|NCT03249792|447781949|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499675|NCT03249792|447781950|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499676|NCT03249792|447781951|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499677|NCT03249792|447781952|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499678|NCT03249792|447781953|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499679|NCT03249792|447781954|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499680|NCT03249792|447781955|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499681|NCT03249792|447781956|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499682|NCT03249792|447781957|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
124499683|NCT03249792|447781925|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
124499684|NCT03249792|447781926|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
124499685|NCT03249792|447781927|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
124499686|NCT03249792|447781928|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
124499687|NCT03249792|447781929|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
124499688|NCT03249792|447781930|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
124499689|NCT03249792|447781931|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
124724254|NCT05935878|448611699|FG001|Overall Study|Death|2|||
124724255|NCT05935878|448611698|FG000|Overall Study|Withdrawal by Subject|5|||
124724256|NCT05935878|448611699|FG001|Overall Study|Withdrawal by Subject|5|||
124724257|NCT05935878|448611698|FG000|Overall Study|Revision of implant|1|||
124724258|NCT05935878|448611699|FG001|Overall Study|Revision of implant|1|||
124724259|NCT05935878|448611698|FG000|Overall Study|Mobile bearing dislocation|0|||
124499690|NCT03249792|447781932|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
124499691|NCT03249792|447781933|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
124499692|NCT03249792|447781934|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
124499693|NCT03249792|447781935|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
124499694|NCT03249792|447781936|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
124499695|NCT03249792|447781937|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
124724260|NCT05935878|448611699|FG001|Overall Study|Mobile bearing dislocation|1|||
124724261|NCT01443364|448611700|FG000|Overall Study|Lack of Efficacy|14|||
124724262|NCT01443364|448611700|FG000|Overall Study|Lost to Follow-up|3|||
124724263|NCT01443364|448611700|FG000|Overall Study|Withdrawal by Subject|5|||
124724264|NCT01443364|448611700|FG000|Overall Study|Other Reason|4|||
124724265|NCT01443364|448611700|FG000|Overall Study|SAE, non-fatal|6|||
124724266|NCT01443364|448611700|FG000|Overall Study|AE, non-serious non-fatal|8|||
124724267|NCT01443364|448611700|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
124724268|NCT00559845|448611701|FG000|Overall Study|Withdrew Consent|1|||
124724269|NCT00559845|448611701|FG000|Overall Study|Disease Progression|1|||
124724270|NCT00559845|448611701|FG000|Overall Study|Adverse Event|3|||
124724271|NCT00559845|448611701|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
124724272|NCT00559845|448611701|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
124724273|NCT01406938|448611704|FG000|Induction Period|Subject/guardian decision|6|||
124724274|NCT01406938|448611705|FG001|Induction Period|Subject/guardian decision|8|||
124724275|NCT01406938|448611706|FG002|Induction Period|Subject/guardian decision|0|||
124724276|NCT01406938|448611707|FG003|Induction Period|Subject/guardian decision|0|||
124724277|NCT01406938|448611708|FG004|Induction Period|Subject/guardian decision|0|||
124774866|NCT00561925|448804662|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
124774867|NCT00561925|448804658|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
124774868|NCT00561925|448804659|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
124774869|NCT00561925|448804660|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
124774870|NCT00561925|448804661|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
124774871|NCT00561925|448804662|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
124774872|NCT00561925|448804658|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
124774873|NCT00561925|448804659|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
124774874|NCT00561925|448804660|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
124499696|NCT03249792|447781938|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
124499697|NCT03249792|447781939|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
124499698|NCT03249792|447781940|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
124499699|NCT03249792|447781941|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
124499700|NCT03249792|447781942|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
124499701|NCT03249792|447781943|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
124499702|NCT03249792|447781944|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
124499703|NCT03249792|447781945|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
124499704|NCT03249792|447781946|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
124499705|NCT03249792|447781947|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
124499706|NCT03249792|447781948|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
124499707|NCT03249792|447781949|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
124499708|NCT03249792|447781950|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
124499709|NCT03249792|447781951|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
124499710|NCT03249792|447781952|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
124499711|NCT03249792|447781953|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
124499712|NCT03249792|447781954|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
124499713|NCT03249792|447781955|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
124499714|NCT03249792|447781956|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
124499715|NCT03249792|447781957|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
124499716|NCT03249792|447781925|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499717|NCT03249792|447781926|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499718|NCT03249792|447781927|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499719|NCT03249792|447781928|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499720|NCT03249792|447781929|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499721|NCT03249792|447781930|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499722|NCT03249792|447781931|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499723|NCT03249792|447781932|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499724|NCT03249792|447781933|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
124499725|NCT03249792|447781934|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499726|NCT03249792|447781935|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499727|NCT03249792|447781936|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499728|NCT03249792|447781937|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499729|NCT03249792|447781938|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499730|NCT03249792|447781939|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499731|NCT03249792|447781940|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499732|NCT03249792|447781941|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
124499733|NCT03249792|447781942|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
124499734|NCT03249792|447781943|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499735|NCT03249792|447781944|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
124499736|NCT03249792|447781945|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499737|NCT03249792|447781946|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499738|NCT03249792|447781947|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499739|NCT03249792|447781948|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499740|NCT03249792|447781949|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499741|NCT03249792|447781950|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499742|NCT03249792|447781951|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499743|NCT03249792|447781952|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
124724278|NCT01406938|448611709|FG005|Induction Period|Subject/guardian decision|0|||
124499744|NCT03249792|447781953|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499745|NCT03249792|447781954|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499746|NCT03249792|447781955|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499747|NCT03249792|447781956|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499748|NCT03249792|447781957|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
124499749|NCT03249792|447781925|FG000|Switch Over Period|Withdrawal by Subject|0|||
124499750|NCT03249792|447781926|FG001|Switch Over Period|Withdrawal by Subject|0|||
124499751|NCT03249792|447781927|FG002|Switch Over Period|Withdrawal by Subject|0|||
124499752|NCT03249792|447781928|FG003|Switch Over Period|Withdrawal by Subject|0|||
124499753|NCT03249792|447781929|FG004|Switch Over Period|Withdrawal by Subject|0|||
124499754|NCT03249792|447781930|FG005|Switch Over Period|Withdrawal by Subject|0|||
124499755|NCT03249792|447781931|FG006|Switch Over Period|Withdrawal by Subject|0|||
124499756|NCT03249792|447781932|FG007|Switch Over Period|Withdrawal by Subject|0|||
124499757|NCT03249792|447781933|FG008|Switch Over Period|Withdrawal by Subject|0|||
124499758|NCT03249792|447781934|FG009|Switch Over Period|Withdrawal by Subject|0|||
124499759|NCT03249792|447781935|FG010|Switch Over Period|Withdrawal by Subject|0|||
124499760|NCT03249792|447781936|FG011|Switch Over Period|Withdrawal by Subject|0|||
124499761|NCT03249792|447781937|FG012|Switch Over Period|Withdrawal by Subject|0|||
124499762|NCT03249792|447781938|FG013|Switch Over Period|Withdrawal by Subject|0|||
124499763|NCT03249792|447781939|FG014|Switch Over Period|Withdrawal by Subject|0|||
124499764|NCT03249792|447781940|FG015|Switch Over Period|Withdrawal by Subject|0|||
124499765|NCT03249792|447781941|FG016|Switch Over Period|Withdrawal by Subject|0|||
124499766|NCT03249792|447781942|FG017|Switch Over Period|Withdrawal by Subject|0|||
124499767|NCT03249792|447781943|FG018|Switch Over Period|Withdrawal by Subject|0|||
124499768|NCT03249792|447781944|FG019|Switch Over Period|Withdrawal by Subject|0|||
124499769|NCT03249792|447781945|FG020|Switch Over Period|Withdrawal by Subject|0|||
124499770|NCT03249792|447781946|FG021|Switch Over Period|Withdrawal by Subject|0|||
124499771|NCT03249792|447781947|FG022|Switch Over Period|Withdrawal by Subject|0|||
124499772|NCT03249792|447781948|FG023|Switch Over Period|Withdrawal by Subject|0|||
124499773|NCT03249792|447781949|FG024|Switch Over Period|Withdrawal by Subject|0|||
124499774|NCT03249792|447781950|FG025|Switch Over Period|Withdrawal by Subject|0|||
124499775|NCT03249792|447781951|FG026|Switch Over Period|Withdrawal by Subject|0|||
124499776|NCT03249792|447781952|FG027|Switch Over Period|Withdrawal by Subject|0|||
124499777|NCT03249792|447781953|FG028|Switch Over Period|Withdrawal by Subject|0|||
124499778|NCT03249792|447781954|FG029|Switch Over Period|Withdrawal by Subject|0|||
124499779|NCT03249792|447781955|FG030|Switch Over Period|Withdrawal by Subject|0|||
124499780|NCT03249792|447781956|FG031|Switch Over Period|Withdrawal by Subject|1|||
124499781|NCT03249792|447781957|FG032|Switch Over Period|Withdrawal by Subject|0|||
124499782|NCT03249792|447781925|FG000|Switch Over Period|Progressive Disease|0|||
124499783|NCT03249792|447781926|FG001|Switch Over Period|Progressive Disease|0|||
124499784|NCT03249792|447781927|FG002|Switch Over Period|Progressive Disease|0|||
124499785|NCT03249792|447781928|FG003|Switch Over Period|Progressive Disease|0|||
124499786|NCT03249792|447781929|FG004|Switch Over Period|Progressive Disease|0|||
124499787|NCT03249792|447781930|FG005|Switch Over Period|Progressive Disease|0|||
124499788|NCT03249792|447781931|FG006|Switch Over Period|Progressive Disease|0|||
124499789|NCT03249792|447781932|FG007|Switch Over Period|Progressive Disease|0|||
124499790|NCT03249792|447781933|FG008|Switch Over Period|Progressive Disease|0|||
124499791|NCT03249792|447781934|FG009|Switch Over Period|Progressive Disease|0|||
124499792|NCT03249792|447781935|FG010|Switch Over Period|Progressive Disease|0|||
124499793|NCT03249792|447781936|FG011|Switch Over Period|Progressive Disease|0|||
124499794|NCT03249792|447781937|FG012|Switch Over Period|Progressive Disease|0|||
124499795|NCT03249792|447781938|FG013|Switch Over Period|Progressive Disease|0|||
124499796|NCT03249792|447781939|FG014|Switch Over Period|Progressive Disease|0|||
124499797|NCT03249792|447781940|FG015|Switch Over Period|Progressive Disease|0|||
124499798|NCT03249792|447781941|FG016|Switch Over Period|Progressive Disease|0|||
124499799|NCT03249792|447781942|FG017|Switch Over Period|Progressive Disease|0|||
124499800|NCT03249792|447781943|FG018|Switch Over Period|Progressive Disease|0|||
124499801|NCT03249792|447781944|FG019|Switch Over Period|Progressive Disease|0|||
124499802|NCT03249792|447781945|FG020|Switch Over Period|Progressive Disease|0|||
124499803|NCT03249792|447781946|FG021|Switch Over Period|Progressive Disease|0|||
124499804|NCT03249792|447781947|FG022|Switch Over Period|Progressive Disease|0|||
124499805|NCT03249792|447781948|FG023|Switch Over Period|Progressive Disease|0|||
124499806|NCT03249792|447781949|FG024|Switch Over Period|Progressive Disease|0|||
124499807|NCT03249792|447781950|FG025|Switch Over Period|Progressive Disease|0|||
124499808|NCT03249792|447781951|FG026|Switch Over Period|Progressive Disease|1|||
124499809|NCT03249792|447781952|FG027|Switch Over Period|Progressive Disease|0|||
124499810|NCT03249792|447781953|FG028|Switch Over Period|Progressive Disease|1|||
124499811|NCT03249792|447781954|FG029|Switch Over Period|Progressive Disease|2|||
124499812|NCT03249792|447781955|FG030|Switch Over Period|Progressive Disease|1|||
124499813|NCT03249792|447781956|FG031|Switch Over Period|Progressive Disease|0|||
124499814|NCT03249792|447781957|FG032|Switch Over Period|Progressive Disease|1|||
124499815|NCT03249792|447781925|FG000|Switch Over Period|Adverse Event|0|||
124499816|NCT03249792|447781926|FG001|Switch Over Period|Adverse Event|0|||
124499817|NCT03249792|447781927|FG002|Switch Over Period|Adverse Event|0|||
124499818|NCT03249792|447781928|FG003|Switch Over Period|Adverse Event|0|||
124499819|NCT03249792|447781929|FG004|Switch Over Period|Adverse Event|0|||
124559369|NCT00410410|448005253|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
124559370|NCT00410410|448005254|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
124559371|NCT00410410|448005255|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
124559372|NCT00410410|448005256|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
124559373|NCT00410410|448005257|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
124559374|NCT00410410|448005258|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
124559375|NCT00410410|448005259|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
124559376|NCT00410410|448005260|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
124559377|NCT00410410|448005252|FG000|Open-Label Period (OL)|Other|0|||
124559378|NCT00410410|448005253|FG001|Open-Label Period (OL)|Other|0|||
124559379|NCT00410410|448005254|FG002|Open-Label Period (OL)|Other|0|||
124559380|NCT00410410|448005255|FG003|Open-Label Period (OL)|Other|0|||
124559381|NCT00410410|448005256|FG004|Open-Label Period (OL)|Other|0|||
124559382|NCT00410410|448005257|FG005|Open-Label Period (OL)|Other|0|||
124559383|NCT00410410|448005258|FG006|Open-Label Period (OL)|Other|0|||
124559384|NCT00410410|448005259|FG007|Open-Label Period (OL)|Other|0|||
124559385|NCT00410410|448005260|FG008|Open-Label Period (OL)|Other|7|||
124559386|NCT01953783|448005261|FG000|Overall Study|Progressive disease|2|||
124559387|NCT00686920|448005262|FG000|Overall Study|Death|45|||
124559388|NCT00686920|448005263|FG001|Overall Study|Death|14|||
124559389|NCT00686920|448005262|FG000|Overall Study|Liver Transplant|23|||
124559390|NCT00686920|448005263|FG001|Overall Study|Liver Transplant|8|||
124559391|NCT00686920|448005262|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
124559392|NCT00686920|448005263|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
124559393|NCT00686920|448005262|FG000|Overall Study|Withdrawal by Subject|23|||
124559394|NCT00686920|448005263|FG001|Overall Study|Withdrawal by Subject|5|||
124559395|NCT00686920|448005262|FG000|Overall Study|Protocol Violation|2|||
124559396|NCT00686920|448005263|FG001|Overall Study|Protocol Violation|1|||
124559397|NCT00686920|448005262|FG000|Overall Study|Adverse Event|10|||
124559398|NCT00686920|448005263|FG001|Overall Study|Adverse Event|2|||
124559399|NCT00686920|448005262|FG000|Overall Study|Personal Reason|0|||
124559400|NCT00686920|448005263|FG001|Overall Study|Personal Reason|1|||
124559401|NCT00686920|448005262|FG000|Overall Study|Lost to Follow-up|15|||
124559402|NCT00686920|448005263|FG001|Overall Study|Lost to Follow-up|3|||
124559403|NCT00686920|448005262|FG000|Overall Study|Moved to Another State|1|||
124559404|NCT00686920|448005263|FG001|Overall Study|Moved to Another State|0|||
124559405|NCT00686920|448005262|FG000|Overall Study|Transferred to Nursing Home|1|||
124559406|NCT00686920|448005263|FG001|Overall Study|Transferred to Nursing Home|0|||
124559407|NCT00686920|448005262|FG000|Overall Study|Noncompliance|9|||
124559408|NCT00686920|448005263|FG001|Overall Study|Noncompliance|0|||
124559409|NCT00686920|448005262|FG000|Overall Study|Principal Investigator Decision|2|||
124559410|NCT00686920|448005263|FG001|Overall Study|Principal Investigator Decision|0|||
124559411|NCT01271933|448005270|FG000|Single-Blind Phase|Lack of Efficacy|37|||
124559412|NCT01271933|448005271|FG001|Single-Blind Phase|Lack of Efficacy|0|||
124559413|NCT01271933|448005272|FG002|Single-Blind Phase|Lack of Efficacy|0|||
124559414|NCT01271933|448005270|FG000|Single-Blind Phase|Lost to Follow-up|10|||
124559415|NCT01271933|448005271|FG001|Single-Blind Phase|Lost to Follow-up|0|||
124559416|NCT01271933|448005272|FG002|Single-Blind Phase|Lost to Follow-up|0|||
124559417|NCT01271933|448005270|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
124559418|NCT01271933|448005271|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
124559419|NCT01271933|448005272|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
124559420|NCT01271933|448005270|FG000|Single-Blind Phase|Protocol Violation|3|||
124559421|NCT01271933|448005271|FG001|Single-Blind Phase|Protocol Violation|0|||
124559422|NCT01271933|448005272|FG002|Single-Blind Phase|Protocol Violation|0|||
124559423|NCT01271933|448005270|FG000|Single-Blind Phase|Adverse Event|52|||
124559424|NCT01271933|448005271|FG001|Single-Blind Phase|Adverse Event|0|||
124559425|NCT01271933|448005272|FG002|Single-Blind Phase|Adverse Event|0|||
124559426|NCT01271933|448005270|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
124774875|NCT00561925|448804661|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
124774876|NCT00561925|448804662|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
124774877|NCT00561925|448804658|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
124559427|NCT01271933|448005271|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
124559428|NCT01271933|448005272|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
124559429|NCT01271933|448005270|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
124559430|NCT01271933|448005271|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
124559431|NCT01271933|448005272|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
124559432|NCT01271933|448005270|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
124559433|NCT01271933|448005271|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
124559434|NCT01271933|448005272|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
124559435|NCT01271933|448005270|FG000|Double-Blind Phase|Randomized but not treated|0|||
124559436|NCT01271933|448005271|FG001|Double-Blind Phase|Randomized but not treated|0|||
124559437|NCT01271933|448005272|FG002|Double-Blind Phase|Randomized but not treated|1|||
124559438|NCT01271933|448005270|FG000|Double-Blind Phase|Lack of Efficacy|0|||
124774878|NCT00561925|448804659|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
124774879|NCT00561925|448804660|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
124774880|NCT00561925|448804661|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
124774881|NCT00561925|448804662|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
124774882|NCT00561925|448804658|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
124774883|NCT00561925|448804659|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
124774884|NCT00561925|448804660|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
124774885|NCT00561925|448804661|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
124774886|NCT00561925|448804662|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
124774887|NCT00561925|448804658|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
124774888|NCT00561925|448804659|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
124774889|NCT00561925|448804660|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
124774890|NCT00561925|448804661|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
124774891|NCT00561925|448804662|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
124774892|NCT00561925|448804658|FG000|144-week Double-blind, Double-dummy|Death|0|||
124774893|NCT00561925|448804659|FG001|144-week Double-blind, Double-dummy|Death|6|||
124774894|NCT00561925|448804660|FG002|144-week Double-blind, Double-dummy|Death|3|||
124774895|NCT00561925|448804661|FG003|144-week Double-blind, Double-dummy|Death|0|||
124774896|NCT00561925|448804662|FG004|144-week Double-blind, Double-dummy|Death|0|||
124774897|NCT00561925|448804658|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
124774898|NCT00561925|448804659|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
124774899|NCT00561925|448804660|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
124559439|NCT01271933|448005271|FG001|Double-Blind Phase|Lack of Efficacy|6|||
124559440|NCT01271933|448005272|FG002|Double-Blind Phase|Lack of Efficacy|9|||
124559441|NCT01271933|448005270|FG000|Double-Blind Phase|Lost to Follow-up|0|||
124559442|NCT01271933|448005271|FG001|Double-Blind Phase|Lost to Follow-up|1|||
124559443|NCT01271933|448005272|FG002|Double-Blind Phase|Lost to Follow-up|1|||
124559444|NCT01271933|448005270|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
124559445|NCT01271933|448005271|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
124559446|NCT01271933|448005272|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
124559447|NCT01271933|448005270|FG000|Double-Blind Phase|Adverse Event|0|||
124559448|NCT01271933|448005271|FG001|Double-Blind Phase|Adverse Event|3|||
124559449|NCT01271933|448005272|FG002|Double-Blind Phase|Adverse Event|0|||
124559450|NCT01271933|448005270|FG000|Double-Blind Phase|Participant request-personal reason|0|||
124559451|NCT01271933|448005271|FG001|Double-Blind Phase|Participant request-personal reason|1|||
124559452|NCT01271933|448005272|FG002|Double-Blind Phase|Participant request-personal reason|0|||
124559453|NCT01138150|448005273|FG000|Overall Study|blood unable to be processed|0|||
124559454|NCT01138150|448005274|FG001|Overall Study|blood unable to be processed|1|||
124559455|NCT01138150|448005273|FG000|Overall Study|Physician Decision|1|||
124559456|NCT01138150|448005274|FG001|Overall Study|Physician Decision|0|||
124559457|NCT05085964|448005275|FG000|Overall Study|Premature termination of study|21|||
124559458|NCT05085964|448005276|FG001|Overall Study|Premature termination of study|0|||
124559459|NCT03156270|448005279|FG000|Overall Study|Failed pre-treatment screening|1|||
124559460|NCT03156270|448005279|FG000|Overall Study|Lost to Follow-up|1|||
124559461|NCT00591253|448005282|FG000|Overall Study|Adverse Event|3|||
124559462|NCT00591253|448005283|FG001|Overall Study|Adverse Event|3|||
124559463|NCT00591253|448005284|FG002|Overall Study|Adverse Event|1|||
124559464|NCT00591253|448005282|FG000|Overall Study|Protocol Violation|2|||
124559465|NCT00591253|448005283|FG001|Overall Study|Protocol Violation|2|||
124559466|NCT00591253|448005284|FG002|Overall Study|Protocol Violation|2|||
124559467|NCT00591253|448005282|FG000|Overall Study|Lost to Follow-up|2|||
124559468|NCT00591253|448005283|FG001|Overall Study|Lost to Follow-up|4|||
124559469|NCT00591253|448005284|FG002|Overall Study|Lost to Follow-up|0|||
124559470|NCT00591253|448005282|FG000|Overall Study|Withdrawal by Subject|1|||
124559471|NCT00591253|448005283|FG001|Overall Study|Withdrawal by Subject|7|||
124559472|NCT00591253|448005284|FG002|Overall Study|Withdrawal by Subject|6|||
124559473|NCT00591253|448005282|FG000|Overall Study|Lack of Efficacy|1|||
124559474|NCT00591253|448005283|FG001|Overall Study|Lack of Efficacy|0|||
124774900|NCT00561925|448804661|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
124774901|NCT00561925|448804662|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
124774902|NCT00561925|448804658|FG000|144-week Double-blind, Double-dummy|Other|0|||
124774903|NCT00561925|448804659|FG001|144-week Double-blind, Double-dummy|Other|8|||
124774904|NCT00561925|448804660|FG002|144-week Double-blind, Double-dummy|Other|11|||
124559475|NCT00591253|448005284|FG002|Overall Study|Lack of Efficacy|3|||
124559476|NCT00591253|448005282|FG000|Overall Study|Other|5|||
124559477|NCT00591253|448005283|FG001|Overall Study|Other|5|||
124559478|NCT00591253|448005284|FG002|Overall Study|Other|3|||
124559479|NCT01841359|448005288|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
124559480|NCT01841359|448005288|FG000|Overall Study|Concommitant medical issues|2|||
124559481|NCT01841359|448005288|FG000|Overall Study|Adverse Event|3|||
124559482|NCT01841359|448005288|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
124559483|NCT02168270|448005289|FG000|Overall Study|Lack of Efficacy|4|||
124559484|NCT01102777|448005292|FG000|Overall Study|Death|2|||
124559485|NCT01102777|448005293|FG001|Overall Study|Death|6|||
124499820|NCT03249792|447781930|FG005|Switch Over Period|Adverse Event|0|||
124499821|NCT03249792|447781931|FG006|Switch Over Period|Adverse Event|0|||
124499822|NCT03249792|447781932|FG007|Switch Over Period|Adverse Event|0|||
124499823|NCT03249792|447781933|FG008|Switch Over Period|Adverse Event|0|||
124499824|NCT03249792|447781934|FG009|Switch Over Period|Adverse Event|0|||
124499825|NCT03249792|447781935|FG010|Switch Over Period|Adverse Event|0|||
124499826|NCT03249792|447781936|FG011|Switch Over Period|Adverse Event|0|||
124499827|NCT03249792|447781937|FG012|Switch Over Period|Adverse Event|0|||
124499828|NCT03249792|447781938|FG013|Switch Over Period|Adverse Event|0|||
124499829|NCT03249792|447781939|FG014|Switch Over Period|Adverse Event|0|||
124499830|NCT03249792|447781940|FG015|Switch Over Period|Adverse Event|0|||
124499831|NCT03249792|447781941|FG016|Switch Over Period|Adverse Event|0|||
124499832|NCT03249792|447781942|FG017|Switch Over Period|Adverse Event|0|||
124499833|NCT03249792|447781943|FG018|Switch Over Period|Adverse Event|0|||
124499834|NCT03249792|447781944|FG019|Switch Over Period|Adverse Event|0|||
124499835|NCT03249792|447781945|FG020|Switch Over Period|Adverse Event|0|||
124499836|NCT03249792|447781946|FG021|Switch Over Period|Adverse Event|0|||
124499837|NCT03249792|447781947|FG022|Switch Over Period|Adverse Event|0|||
124499838|NCT03249792|447781948|FG023|Switch Over Period|Adverse Event|0|||
124499839|NCT03249792|447781949|FG024|Switch Over Period|Adverse Event|0|||
124499840|NCT03249792|447781950|FG025|Switch Over Period|Adverse Event|1|||
124499841|NCT03249792|447781951|FG026|Switch Over Period|Adverse Event|0|||
124499842|NCT03249792|447781952|FG027|Switch Over Period|Adverse Event|1|||
124499843|NCT03249792|447781953|FG028|Switch Over Period|Adverse Event|0|||
124499844|NCT03249792|447781954|FG029|Switch Over Period|Adverse Event|0|||
124499845|NCT03249792|447781955|FG030|Switch Over Period|Adverse Event|0|||
124499846|NCT03249792|447781956|FG031|Switch Over Period|Adverse Event|0|||
124499847|NCT03249792|447781957|FG032|Switch Over Period|Adverse Event|0|||
124499848|NCT02284906|447781958|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
124499849|NCT02284906|447781959|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
124499850|NCT02284906|447781960|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
124499851|NCT02284906|447781958|FG000|Overall Study|Major Protocol Deviation|0|||
124499852|NCT02284906|447781959|FG001|Overall Study|Major Protocol Deviation|1|||
124499853|NCT02284906|447781960|FG002|Overall Study|Major Protocol Deviation|0|||
124499854|NCT02284906|447781958|FG000|Overall Study|Voluntary Withdrawal|2|||
124499855|NCT02284906|447781959|FG001|Overall Study|Voluntary Withdrawal|4|||
124499856|NCT02284906|447781960|FG002|Overall Study|Voluntary Withdrawal|5|||
124499857|NCT02284906|447781958|FG000|Overall Study|Study Termination|0|||
124499858|NCT02284906|447781959|FG001|Overall Study|Study Termination|11|||
124499859|NCT02284906|447781960|FG002|Overall Study|Study Termination|14|||
124499860|NCT02284906|447781958|FG000|Overall Study|Reason not Specified|1|||
124499861|NCT02284906|447781959|FG001|Overall Study|Reason not Specified|1|||
124499862|NCT02284906|447781960|FG002|Overall Study|Reason not Specified|0|||
124499863|NCT00069576|447781962|FG000|Original Trial|Lost to Follow-up|25|||
124499864|NCT00069576|447781963|FG001|Original Trial|Lost to Follow-up|33|||
124499865|NCT00069576|447781962|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
124499866|NCT00069576|447781963|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
124499867|NCT04060667|447781964|FG000|Overall Study|Lost to Follow-up|75|||
124499868|NCT04060667|447781965|FG001|Overall Study|Lost to Follow-up|10|||
124499869|NCT00525148|447781967|FG000|Overall Study|Other Adverse Event|3|||
124499870|NCT00525148|447781968|FG001|Overall Study|Other Adverse Event|5|||
124499871|NCT00525148|447781969|FG002|Overall Study|Other Adverse Event|1|||
124499872|NCT00525148|447781970|FG003|Overall Study|Other Adverse Event|8|||
124499873|NCT00525148|447781967|FG000|Overall Study|Progressive disease|18|||
124499874|NCT00525148|447781968|FG001|Overall Study|Progressive disease|30|||
124499875|NCT00525148|447781969|FG002|Overall Study|Progressive disease|6|||
124499876|NCT00525148|447781970|FG003|Overall Study|Progressive disease|49|||
124499877|NCT00525148|447781967|FG000|Overall Study|Refused continuation of study medication|0|||
124499878|NCT00525148|447781968|FG001|Overall Study|Refused continuation of study medication|2|||
124499879|NCT00525148|447781969|FG002|Overall Study|Refused continuation of study medication|0|||
124499880|NCT00525148|447781970|FG003|Overall Study|Refused continuation of study medication|1|||
124499881|NCT00525148|447781967|FG000|Overall Study|Other than stated|2|||
124499882|NCT00525148|447781968|FG001|Overall Study|Other than stated|1|||
124499883|NCT00525148|447781969|FG002|Overall Study|Other than stated|0|||
124499884|NCT00525148|447781970|FG003|Overall Study|Other than stated|3|||
124499885|NCT05100199|447781972|FG000|Overall Study|Lost to Follow-up|5|||
124499886|NCT05100199|447781973|FG001|Overall Study|Lost to Follow-up|8|||
124499887|NCT05100199|447781974|FG002|Overall Study|Lost to Follow-up|3|||
124499888|NCT05100199|447781975|FG003|Overall Study|Lost to Follow-up|6|||
124499889|NCT05100199|447781972|FG000|Overall Study|Withdrawal by Subject|3|||
124499890|NCT05100199|447781973|FG001|Overall Study|Withdrawal by Subject|3|||
124499891|NCT05100199|447781974|FG002|Overall Study|Withdrawal by Subject|9|||
124724279|NCT01406938|448611704|FG000|Induction Period|Protocol deviation|1|||
124499892|NCT05100199|447781975|FG003|Overall Study|Withdrawal by Subject|7|||
124499893|NCT05100199|447781972|FG000|Overall Study|Other|0|||
124499894|NCT05100199|447781973|FG001|Overall Study|Other|0|||
124499895|NCT05100199|447781974|FG002|Overall Study|Other|1|||
124499896|NCT05100199|447781975|FG003|Overall Study|Other|1|||
124559486|NCT01102777|448005292|FG000|Overall Study|Lost to Follow-up|7|||
124559487|NCT01102777|448005293|FG001|Overall Study|Lost to Follow-up|10|||
124559488|NCT01875445|448005294|FG000|Overall Study|Lost to Follow-up|5|||
124559489|NCT01875445|448005295|FG001|Overall Study|Lost to Follow-up|0|||
124559490|NCT01875445|448005294|FG000|Overall Study|Withdrawal by Subject|2|||
124559491|NCT01875445|448005295|FG001|Overall Study|Withdrawal by Subject|0|||
124559492|NCT00771901|448005296|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
124559493|NCT00771901|448005297|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
124559494|NCT00771901|448005298|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
124559495|NCT01965652|448005301|FG000|Overall Study|Adverse Event|40|||
124559496|NCT01965652|448005302|FG001|Overall Study|Adverse Event|37|||
124559497|NCT01965652|448005301|FG000|Overall Study|Withdrawal by Subject|62|||
124559498|NCT01965652|448005302|FG001|Overall Study|Withdrawal by Subject|69|||
124559499|NCT01965652|448005301|FG000|Overall Study|Lost to Follow-up|53|||
124559500|NCT01965652|448005302|FG001|Overall Study|Lost to Follow-up|40|||
124559501|NCT01965652|448005301|FG000|Overall Study|Protocol Violation|34|||
124559502|NCT01965652|448005302|FG001|Overall Study|Protocol Violation|38|||
124559503|NCT01965652|448005301|FG000|Overall Study|Death|3|||
124559504|NCT01965652|448005302|FG001|Overall Study|Death|4|||
124559505|NCT01965652|448005301|FG000|Overall Study|Other - Miscellaneous|18|||
124559506|NCT01965652|448005302|FG001|Overall Study|Other - Miscellaneous|21|||
124559507|NCT01965652|448005301|FG000|Overall Study|Pregnancy|0|||
124559508|NCT01965652|448005302|FG001|Overall Study|Pregnancy|1|||
124559509|NCT01121900|448005303|FG000|First Intervention Period|Adverse Event|1|||
124559510|NCT01121900|448005304|FG001|First Intervention Period|Adverse Event|1|||
124559511|NCT01121900|448005303|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
124559512|NCT01121900|448005304|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
124559513|NCT01328054|448005305|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
124559514|NCT01328054|448005306|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
124559515|NCT01328054|448005305|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
124559516|NCT01328054|448005306|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
124559517|NCT01328054|448005305|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
124559518|NCT01328054|448005306|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
124559519|NCT03493698|448005307|FG000|Treatment Period C|Adverse Event|1|||
124559520|NCT03493698|448005307|FG000|Treatment Period C|Withdrawal by Subject|1|||
124559521|NCT03760510|448005308|FG000|Overall Study|Not ventilated for 24 hours|105|||
124559522|NCT03760510|448005309|FG001|Overall Study|Not ventilated for 24 hours|97|||
124559523|NCT00566709|448005315|FG000|Overall Study|Protocol Violation|5|||
124559524|NCT00566709|448005316|FG001|Overall Study|Protocol Violation|0|||
124559525|NCT03443869|448005317|FG000|Overall Study|Death|3|||
124559526|NCT03443869|448005318|FG001|Overall Study|Death|3|||
124559527|NCT03443869|448005317|FG000|Overall Study|Withdrawal by Subject|34|||
124559528|NCT03443869|448005318|FG001|Overall Study|Withdrawal by Subject|22|||
124559529|NCT03443869|448005317|FG000|Overall Study|Lost to Follow-up|1|||
124559530|NCT03443869|448005318|FG001|Overall Study|Lost to Follow-up|2|||
124559531|NCT03443869|448005317|FG000|Overall Study|Physician Decision|3|||
124559532|NCT03443869|448005318|FG001|Overall Study|Physician Decision|3|||
124559533|NCT03443869|448005317|FG000|Overall Study|Other|4|||
124559534|NCT03443869|448005318|FG001|Overall Study|Other|4|||
124559535|NCT02330081|448005319|FG000|Overall Study|Adverse Event|1|||
124559536|NCT02330081|448005319|FG000|Overall Study|Donation did not meet criteria|1|||
124559537|NCT02330081|448005319|FG000|Overall Study|Protocol Violation|6|||
124559538|NCT00299728|448005320|FG000|Overall Study|Lost to Follow-up|0|||
124559539|NCT00299728|448005321|FG001|Overall Study|Lost to Follow-up|1|||
124559540|NCT00299728|448005320|FG000|Overall Study|Withdrawal by Subject|0|||
124559541|NCT00299728|448005321|FG001|Overall Study|Withdrawal by Subject|1|||
124559542|NCT00299728|448005320|FG000|Overall Study|Progressive disease|0|||
124559543|NCT00299728|448005321|FG001|Overall Study|Progressive disease|1|||
124559544|NCT02826603|448005322|FG000|Overall Study|Adverse Event|17|||
124559545|NCT02826603|448005323|FG001|Overall Study|Adverse Event|9|||
124559546|NCT02826603|448005322|FG000|Overall Study|Lack of Efficacy|4|||
124559547|NCT02826603|448005323|FG001|Overall Study|Lack of Efficacy|9|||
124559548|NCT02826603|448005322|FG000|Overall Study|Lost to Follow-up|13|||
124559549|NCT02826603|448005323|FG001|Overall Study|Lost to Follow-up|12|||
124559550|NCT02826603|448005322|FG000|Overall Study|Noncompliance with treatment|0|||
124724280|NCT01406938|448611705|FG001|Induction Period|Protocol deviation|0|||
124559551|NCT02826603|448005323|FG001|Overall Study|Noncompliance with treatment|2|||
124559552|NCT02826603|448005322|FG000|Overall Study|Physician Decision|1|||
124559553|NCT02826603|448005323|FG001|Overall Study|Physician Decision|7|||
124559554|NCT02826603|448005322|FG000|Overall Study|Pregnancy|1|||
124559555|NCT02826603|448005323|FG001|Overall Study|Pregnancy|2|||
124559556|NCT02826603|448005322|FG000|Overall Study|Protocol Violation|3|||
124559557|NCT02826603|448005323|FG001|Overall Study|Protocol Violation|3|||
124559558|NCT02826603|448005322|FG000|Overall Study|Withdrawal by Subject|20|||
124559559|NCT02826603|448005323|FG001|Overall Study|Withdrawal by Subject|19|||
124559560|NCT02826603|448005322|FG000|Overall Study|Death|2|||
124559561|NCT02826603|448005323|FG001|Overall Study|Death|0|||
124499897|NCT00830037|447781976|FG000|Overall Study|Withdrawal by Subject|2|||
124499898|NCT00830037|447781977|FG001|Overall Study|Withdrawal by Subject|3|||
124499899|NCT00830037|447781976|FG000|Overall Study|Lost to Follow-up|1|||
124499900|NCT00830037|447781977|FG001|Overall Study|Lost to Follow-up|2|||
124499901|NCT00830037|447781976|FG000|Overall Study|Active when terminated by DSMB|15|||
124499902|NCT00830037|447781977|FG001|Overall Study|Active when terminated by DSMB|14|||
124499903|NCT00752609|447781978|FG000|Overall Study|Adverse Event|2|||
124499904|NCT00752609|447781979|FG001|Overall Study|Adverse Event|2|||
124499905|NCT00752609|447781978|FG000|Overall Study|Withdrawal by Subject|3|||
124499906|NCT00752609|447781979|FG001|Overall Study|Withdrawal by Subject|0|||
124499907|NCT00752609|447781978|FG000|Overall Study|Physician Decision|1|||
124499908|NCT00752609|447781979|FG001|Overall Study|Physician Decision|0|||
124499909|NCT00752609|447781978|FG000|Overall Study|Death|1|||
124499910|NCT00752609|447781979|FG001|Overall Study|Death|0|||
124499911|NCT00752609|447781978|FG000|Overall Study|Met exclusion criteria|1|||
124499912|NCT00752609|447781979|FG001|Overall Study|Met exclusion criteria|0|||
124499913|NCT00752609|447781978|FG000|Overall Study|Received Aranesp in error|1|||
124499914|NCT00752609|447781979|FG001|Overall Study|Received Aranesp in error|0|||
124499915|NCT01096550|447781987|FG000|Overall Study|discontinued site|10|||
124499916|NCT01096550|447781988|FG001|Overall Study|discontinued site|11|||
124499917|NCT01096550|447781987|FG000|Overall Study|non-regular treatment track at clinic|1|||
124499918|NCT01096550|447781988|FG001|Overall Study|non-regular treatment track at clinic|1|||
124499919|NCT01096550|447781987|FG000|Overall Study|clinic readmission|1|||
124499920|NCT01096550|447781988|FG001|Overall Study|clinic readmission|1|||
124499921|NCT01096550|447781987|FG000|Overall Study|Withdrawal by Subject|0|||
124499922|NCT01096550|447781988|FG001|Overall Study|Withdrawal by Subject|1|||
124499923|NCT01096550|447781987|FG000|Overall Study|non-African American participant|13|||
124499924|NCT01096550|447781988|FG001|Overall Study|non-African American participant|6|||
124499925|NCT01096550|447781987|FG000|Overall Study|Lost to Follow-up|12|||
124499926|NCT01096550|447781988|FG001|Overall Study|Lost to Follow-up|9|||
124499927|NCT03196297|447781989|FG000|Main Period|Withdrawal by Subject|4|||
124499928|NCT03196297|447781989|FG000|Extension Period|Withdrawal by Subject|1|||
124499929|NCT03196297|447781989|FG000|Extension Period|Lack of Efficacy|2|||
124499930|NCT00829166|447781992|FG000|Overall Study|Death|305|||
124499931|NCT00829166|447781993|FG001|Overall Study|Death|333|||
124499932|NCT00829166|447781992|FG000|Overall Study|Lost to Follow-up|5|||
124499933|NCT00829166|447781993|FG001|Overall Study|Lost to Follow-up|4|||
124499934|NCT00829166|447781992|FG000|Overall Study|Physician's Decision|4|||
124499935|NCT00829166|447781993|FG001|Overall Study|Physician's Decision|3|||
124499936|NCT00829166|447781992|FG000|Overall Study|Subject's Decision|41|||
124499937|NCT00829166|447781993|FG001|Overall Study|Subject's Decision|55|||
124499938|NCT00829166|447781992|FG000|Overall Study|Sponsor's Decision|137|||
124499939|NCT00829166|447781993|FG001|Overall Study|Sponsor's Decision|98|||
124499940|NCT00829166|447781992|FG000|Overall Study|Reason Not Specified|3|||
124499941|NCT00829166|447781993|FG001|Overall Study|Reason Not Specified|3|||
124499942|NCT00320385|447781994|FG000|Overall Study|Lost to Follow-up|7|||
124499943|NCT00320385|447781995|FG001|Overall Study|Lost to Follow-up|10|||
124499944|NCT00320385|447781994|FG000|Overall Study|Withdrawal by Subject|6|||
124499945|NCT00320385|447781995|FG001|Overall Study|Withdrawal by Subject|7|||
124499946|NCT00320385|447781994|FG000|Overall Study|Sponsor Terminated Study|2|||
124499947|NCT00320385|447781995|FG001|Overall Study|Sponsor Terminated Study|1|||
124499948|NCT00320385|447781994|FG000|Overall Study|Investigator Decision|0|||
124499949|NCT00320385|447781995|FG001|Overall Study|Investigator Decision|1|||
124499950|NCT00320385|447781994|FG000|Overall Study|Death|1|||
124499951|NCT00320385|447781995|FG001|Overall Study|Death|2|||
124499952|NCT00320385|447781994|FG000|Overall Study|Serious Adverse Event|1|||
124499953|NCT00320385|447781995|FG001|Overall Study|Serious Adverse Event|0|||
124499954|NCT00320385|447781994|FG000|Overall Study|Withdrew Consent|1|||
124499955|NCT00320385|447781995|FG001|Overall Study|Withdrew Consent|0|||
124499956|NCT00320385|447781994|FG000|Overall Study|Adverse Event|0|||
124499957|NCT00320385|447781995|FG001|Overall Study|Adverse Event|1|||
124499958|NCT03288779|447782002|FG000|Overall Study|Withdrawal by Subject|3|||
124499959|NCT02426658|447782005|FG000|Overall Study|Withdrawal by Subject|1|||
124499960|NCT02426658|447782005|FG000|Overall Study|Patient expired before treatment|2|||
124499961|NCT02928406|447782008|FG000|Overall Study|Death|780|||
124499962|NCT02928406|447782008|FG000|Overall Study|Progressive disease|3|||
124499963|NCT02928406|447782008|FG000|Overall Study|Lost to Follow-up|49|||
124499964|NCT02928406|447782008|FG000|Overall Study|Non-compliance|2|||
124499965|NCT02928406|447782008|FG000|Overall Study|Withdrawal by Subject|40|||
124499966|NCT02928406|447782008|FG000|Overall Study|Study terminated by sponsor|57|||
124499967|NCT02928406|447782008|FG000|Overall Study|Physician Decision|1|||
124774905|NCT00561925|448804661|FG003|144-week Double-blind, Double-dummy|Other|0|||
124499968|NCT02928406|447782008|FG000|Overall Study|Various reasons|72|||
124499969|NCT02149836|447782009|FG000|Overall Study|Withdrawal by Subject|1|||
124499970|NCT00436215|447782010|FG000|Overall Study|Refused further treatment|3|||
124499971|NCT00436215|447782010|FG000|Overall Study|Small bowel obstruction|1|||
124499972|NCT00309777|447782011|FG000|Overall Study|Adverse Event|13|||
124499973|NCT00309777|447782012|FG001|Overall Study|Adverse Event|2|||
124774906|NCT00561925|448804662|FG004|144-week Double-blind, Double-dummy|Other|0|||
124774907|NCT00561925|448804658|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
124774908|NCT00561925|448804659|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
124774909|NCT00561925|448804660|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
124774910|NCT00561925|448804661|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
124774911|NCT00561925|448804662|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
124774912|NCT00724698|448804663|FG000|Overall Study|Adverse Event|9|||
124774913|NCT00724698|448804663|FG000|Overall Study|Failure of Therapy|4|||
124774914|NCT00724698|448804663|FG000|Overall Study|Poor Compliance|16|||
124774915|NCT00724698|448804663|FG000|Overall Study|Lost to Follow-up|36|||
124774916|NCT00724698|448804663|FG000|Overall Study|No Info|25|||
124774917|NCT05021978|448804664|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
124774918|NCT05021978|448804665|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
124774919|NCT05021978|448804666|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
124774920|NCT05021978|448804667|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
124774921|NCT05021978|448804664|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
124774922|NCT05021978|448804665|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
124774923|NCT05021978|448804666|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
124774924|NCT05021978|448804667|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
124774925|NCT02177032|448804670|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
124774926|NCT02177032|448804671|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
124774927|NCT02177032|448804672|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
124774928|NCT02177032|448804673|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
124774929|NCT02177032|448804670|FG000|Overall Study|Lost to Follow-up|0|||
124774930|NCT02177032|448804671|FG001|Overall Study|Lost to Follow-up|2|||
124774931|NCT02177032|448804672|FG002|Overall Study|Lost to Follow-up|0|||
124774932|NCT02177032|448804673|FG003|Overall Study|Lost to Follow-up|0|||
124774933|NCT02177032|448804670|FG000|Overall Study|OTHER|2|||
124774934|NCT02177032|448804671|FG001|Overall Study|OTHER|0|||
124774935|NCT02177032|448804672|FG002|Overall Study|OTHER|1|||
124774936|NCT02177032|448804673|FG003|Overall Study|OTHER|0|||
124774937|NCT02177032|448804670|FG000|Overall Study|Withdrawal by Subject|1|||
124774938|NCT02177032|448804671|FG001|Overall Study|Withdrawal by Subject|0|||
124774939|NCT02177032|448804672|FG002|Overall Study|Withdrawal by Subject|1|||
124774940|NCT02177032|448804673|FG003|Overall Study|Withdrawal by Subject|0|||
124774941|NCT00665652|448804674|FG000|Overall Study|Adverse Event|4|||
124774942|NCT00665652|448804674|FG000|Overall Study|Death|1|||
124774943|NCT00665652|448804674|FG000|Overall Study|No longer met inclusion criteria.|1|||
124774944|NCT02556177|448804678|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
124774945|NCT02556177|448804679|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
124774946|NCT00734539|448804689|FG000|Main Study|Death|33|||
124774947|NCT00734539|448804690|FG001|Main Study|Death|32|||
124774948|NCT00734539|448804689|FG000|Main Study|Physician Decision|2|||
124499974|NCT00309777|447782013|FG002|Overall Study|Adverse Event|8|||
124499975|NCT00309777|447782014|FG003|Overall Study|Adverse Event|1|||
124499976|NCT00309777|447782011|FG000|Overall Study|Protocol Violation|4|||
124499977|NCT00309777|447782012|FG001|Overall Study|Protocol Violation|1|||
124499978|NCT00309777|447782013|FG002|Overall Study|Protocol Violation|3|||
124499979|NCT00309777|447782014|FG003|Overall Study|Protocol Violation|1|||
124499980|NCT00309777|447782011|FG000|Overall Study|Withdrawal by Subject|6|||
124499981|NCT00309777|447782012|FG001|Overall Study|Withdrawal by Subject|5|||
124499982|NCT00309777|447782013|FG002|Overall Study|Withdrawal by Subject|7|||
124724281|NCT01406938|448611706|FG002|Induction Period|Protocol deviation|0|||
124724282|NCT01406938|448611707|FG003|Induction Period|Protocol deviation|0|||
124724283|NCT01406938|448611708|FG004|Induction Period|Protocol deviation|0|||
124724284|NCT01406938|448611709|FG005|Induction Period|Protocol deviation|0|||
124724285|NCT01406938|448611704|FG000|Induction Period|Adverse Event|8|||
124724286|NCT01406938|448611705|FG001|Induction Period|Adverse Event|9|||
124724287|NCT01406938|448611706|FG002|Induction Period|Adverse Event|0|||
124724288|NCT01406938|448611707|FG003|Induction Period|Adverse Event|0|||
124724289|NCT01406938|448611708|FG004|Induction Period|Adverse Event|0|||
124724290|NCT01406938|448611709|FG005|Induction Period|Adverse Event|0|||
124724291|NCT01406938|448611704|FG000|Induction Period|Lack of Efficacy|1|||
124724292|NCT01406938|448611705|FG001|Induction Period|Lack of Efficacy|0|||
124774949|NCT00734539|448804690|FG001|Main Study|Physician Decision|0|||
124774950|NCT00734539|448804689|FG000|Main Study|Withdrawal by Subject|1|||
124774951|NCT00734539|448804690|FG001|Main Study|Withdrawal by Subject|3|||
124774952|NCT00734539|448804689|FG000|Main Study|Enrolled in error; ineligible|1|||
124774953|NCT00734539|448804690|FG001|Main Study|Enrolled in error; ineligible|0|||
124774954|NCT02504151|448804693|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
124774955|NCT02504151|448804694|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
124724293|NCT01406938|448611706|FG002|Induction Period|Lack of Efficacy|0|||
124724294|NCT01406938|448611707|FG003|Induction Period|Lack of Efficacy|0|||
124724295|NCT01406938|448611708|FG004|Induction Period|Lack of Efficacy|0|||
124774956|NCT02504151|448804693|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
124499983|NCT00309777|447782014|FG003|Overall Study|Withdrawal by Subject|2|||
124559562|NCT02826603|448005322|FG000|Overall Study|New therapy for study indication|0|||
124559563|NCT02826603|448005323|FG001|Overall Study|New therapy for study indication|1|||
124559564|NCT01337050|448005327|FG000|Overall Study|Death|0|||
124559565|NCT01337050|448005328|FG001|Overall Study|Death|0|||
124559566|NCT01337050|448005329|FG002|Overall Study|Death|4|||
124559567|NCT01337050|448005327|FG000|Overall Study|Other|4|||
124559568|NCT01337050|448005328|FG001|Overall Study|Other|6|||
124559569|NCT01337050|448005329|FG002|Overall Study|Other|8|||
124559570|NCT01337050|448005327|FG000|Overall Study|Participants refused further follow-up|0|||
124559571|NCT01337050|448005328|FG001|Overall Study|Participants refused further follow-up|7|||
124559572|NCT01337050|448005329|FG002|Overall Study|Participants refused further follow-up|7|||
124559573|NCT00003102|448005330|FG000|Overall Study|Physician Decision|1|||
124559574|NCT00003102|448005331|FG001|Overall Study|Physician Decision|1|||
124559575|NCT00003102|448005332|FG002|Overall Study|Physician Decision|0|||
124559576|NCT00003102|448005330|FG000|Overall Study|Progressive Disease|0|||
124559577|NCT00003102|448005331|FG001|Overall Study|Progressive Disease|1|||
124559578|NCT00003102|448005332|FG002|Overall Study|Progressive Disease|0|||
124774957|NCT02504151|448804694|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
124774958|NCT02504151|448804693|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
124774959|NCT02504151|448804694|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
124774960|NCT02504151|448804693|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
124774961|NCT02504151|448804694|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
124774962|NCT00389610|448804697|FG000|Overall Study|Disease Progression|0|||
124774963|NCT00389610|448804698|FG001|Overall Study|Disease Progression|19|||
124774964|NCT00389610|448804697|FG000|Overall Study|Death|0|||
124774965|NCT00389610|448804698|FG001|Overall Study|Death|1|||
124774966|NCT00389610|448804697|FG000|Overall Study|Physician Decision|0|||
124774967|NCT00389610|448804698|FG001|Overall Study|Physician Decision|1|||
124774968|NCT00389610|448804697|FG000|Overall Study|Withdrawal by Subject|0|||
124774969|NCT00389610|448804698|FG001|Overall Study|Withdrawal by Subject|1|||
124774970|NCT00538902|448804699|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
124774971|NCT00538902|448804700|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
124774972|NCT00538902|448804701|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
124774973|NCT00538902|448804699|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
124774974|NCT00538902|448804700|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
124774975|NCT00538902|448804701|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
124774976|NCT00538902|448804699|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
124774977|NCT00538902|448804700|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
124774978|NCT00538902|448804701|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
124774979|NCT00538902|448804699|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
124774980|NCT00538902|448804700|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
124774981|NCT00538902|448804701|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
124774982|NCT00538902|448804699|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
124774983|NCT00538902|448804700|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
124774984|NCT00538902|448804701|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
124559579|NCT00003102|448005330|FG000|Overall Study|Adverse Event|0|||
124559580|NCT00003102|448005331|FG001|Overall Study|Adverse Event|1|||
124559581|NCT00003102|448005332|FG002|Overall Study|Adverse Event|1|||
124559582|NCT00003102|448005330|FG000|Overall Study|Death|0|||
124559583|NCT00003102|448005331|FG001|Overall Study|Death|0|||
124559584|NCT00003102|448005332|FG002|Overall Study|Death|1|||
124559585|NCT00583596|448005333|FG000|Overall Study|Lost to Follow-up|110|||
124559586|NCT00583596|448005333|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
124559587|NCT00583596|448005333|FG000|Overall Study|Death|2|||
124559588|NCT00583596|448005333|FG000|Overall Study|Withdrawal by Subject|6|||
124559589|NCT00583596|448005333|FG000|Overall Study|Lost to Follow-up|94|||
124559590|NCT00583596|448005333|FG000|Overall Study|Data not complete|1|||
124559591|NCT00583596|448005333|FG000|Overall Study|Not consented|15|||
124559592|NCT00583596|448005333|FG000|Overall Study|Outside f-up window|26|||
124559593|NCT00656019|448005334|FG000|Overall Study|Not Eligible|10|||
124559594|NCT00656019|448005335|FG001|Overall Study|Not Eligible|0|||
124559595|NCT00656019|448005336|FG002|Overall Study|Not Eligible|0|||
124559596|NCT00656019|448005337|FG003|Overall Study|Not Eligible|0|||
124559597|NCT00656019|448005334|FG000|Overall Study|Withdrawal by Subject|2|||
124559598|NCT00656019|448005335|FG001|Overall Study|Withdrawal by Subject|0|||
124774985|NCT00538902|448804699|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
124774986|NCT00538902|448804700|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
124774987|NCT00538902|448804701|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
124559599|NCT00656019|448005336|FG002|Overall Study|Withdrawal by Subject|0|||
124559600|NCT00656019|448005337|FG003|Overall Study|Withdrawal by Subject|0|||
124559601|NCT00656019|448005334|FG000|Overall Study|Lost to Follow-up|2|||
124559602|NCT00656019|448005335|FG001|Overall Study|Lost to Follow-up|1|||
124559603|NCT00656019|448005336|FG002|Overall Study|Lost to Follow-up|0|||
124559604|NCT00656019|448005337|FG003|Overall Study|Lost to Follow-up|0|||
124559605|NCT00096486|448005338|FG000|Overall Study|Withdrawal by Subject|0|||
124559606|NCT00096486|448005339|FG001|Overall Study|Withdrawal by Subject|0|||
124559607|NCT00096486|448005340|FG002|Overall Study|Withdrawal by Subject|1|||
124559608|NCT00096486|448005341|FG003|Overall Study|Withdrawal by Subject|1|||
124559609|NCT00096486|448005338|FG000|Overall Study|Not Treated|0|||
124559610|NCT00096486|448005339|FG001|Overall Study|Not Treated|0|||
124559611|NCT00096486|448005340|FG002|Overall Study|Not Treated|1|||
124559612|NCT00096486|448005341|FG003|Overall Study|Not Treated|1|||
124559613|NCT03558997|448005342|FG000|Overall Study|Adverse Event|0|||
124559614|NCT03558997|448005343|FG001|Overall Study|Adverse Event|2|||
124559615|NCT03558997|448005344|FG002|Overall Study|Adverse Event|5|||
124559616|NCT03558997|448005345|FG003|Overall Study|Adverse Event|1|||
124559617|NCT03558997|448005342|FG000|Overall Study|Physician Decision|0|||
124559618|NCT03558997|448005343|FG001|Overall Study|Physician Decision|0|||
124559619|NCT03558997|448005344|FG002|Overall Study|Physician Decision|1|||
124559620|NCT03558997|448005345|FG003|Overall Study|Physician Decision|0|||
124559621|NCT03558997|448005342|FG000|Overall Study|Withdrawal by Subject|1|||
124559622|NCT03558997|448005343|FG001|Overall Study|Withdrawal by Subject|0|||
124559623|NCT03558997|448005344|FG002|Overall Study|Withdrawal by Subject|1|||
124559624|NCT03558997|448005345|FG003|Overall Study|Withdrawal by Subject|1|||
124559625|NCT03558997|448005342|FG000|Overall Study|Lost to Follow-up|0|||
124559626|NCT03558997|448005343|FG001|Overall Study|Lost to Follow-up|0|||
124559627|NCT03558997|448005344|FG002|Overall Study|Lost to Follow-up|1|||
124559628|NCT03558997|448005345|FG003|Overall Study|Lost to Follow-up|0|||
124559629|NCT02230085|448005346|FG000|Overall Study|Physician Decision|1|||
124559630|NCT02230085|448005346|FG000|Overall Study|Withdrawal by Subject|3|||
124559631|NCT02173301|448005350|FG000|Overall Study|Adverse Event|7|||
124559632|NCT02173301|448005351|FG001|Overall Study|Adverse Event|8|||
124559633|NCT02173301|448005352|FG002|Overall Study|Adverse Event|13|||
124559634|NCT02173301|448005353|FG003|Overall Study|Adverse Event|5|||
124559635|NCT02173301|448005350|FG000|Overall Study|Withdrawal by Subject|8|||
124559636|NCT02173301|448005351|FG001|Overall Study|Withdrawal by Subject|10|||
124559637|NCT02173301|448005352|FG002|Overall Study|Withdrawal by Subject|4|||
124559638|NCT02173301|448005353|FG003|Overall Study|Withdrawal by Subject|8|||
124559639|NCT02173301|448005350|FG000|Overall Study|Lost to Follow-up|4|||
124559640|NCT02173301|448005351|FG001|Overall Study|Lost to Follow-up|4|||
124559641|NCT02173301|448005352|FG002|Overall Study|Lost to Follow-up|2|||
124559642|NCT02173301|448005353|FG003|Overall Study|Lost to Follow-up|2|||
124559643|NCT02173301|448005350|FG000|Overall Study|Protocol Violation|0|||
124559644|NCT02173301|448005351|FG001|Overall Study|Protocol Violation|1|||
124559645|NCT02173301|448005352|FG002|Overall Study|Protocol Violation|0|||
124559646|NCT02173301|448005353|FG003|Overall Study|Protocol Violation|0|||
124559647|NCT02173301|448005350|FG000|Overall Study|Physician Decision|0|||
124559648|NCT02173301|448005351|FG001|Overall Study|Physician Decision|0|||
124559649|NCT02173301|448005352|FG002|Overall Study|Physician Decision|1|||
124559650|NCT02173301|448005353|FG003|Overall Study|Physician Decision|0|||
124559651|NCT02173301|448005350|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
124559652|NCT02173301|448005351|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
124559653|NCT02173301|448005352|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
124559654|NCT02173301|448005353|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
124559655|NCT03016078|448005355|FG000|Overall Study|Protocol Violation|1|||
124559656|NCT03016078|448005355|FG000|Overall Study|Protocol Violation|1|||
124559657|NCT02123459|448005358|FG000|Washout Period (1 Day)|Adverse Event|1|||
124559658|NCT02123459|448005359|FG001|Washout Period (1 Day)|Adverse Event|0|||
124559659|NCT00254397|448005360|FG000|Overall Study|Disease Progression|4|||
124559660|NCT00254397|448005361|FG001|Overall Study|Disease Progression|1|||
124559661|NCT00254397|448005362|FG002|Overall Study|Disease Progression|16|||
124559662|NCT00254397|448005363|FG003|Overall Study|Disease Progression|23|||
124559663|NCT00254397|448005360|FG000|Overall Study|Non-Compliant|0|||
124559664|NCT00254397|448005361|FG001|Overall Study|Non-Compliant|0|||
124559665|NCT00254397|448005362|FG002|Overall Study|Non-Compliant|0|||
124559666|NCT00254397|448005363|FG003|Overall Study|Non-Compliant|1|||
124559667|NCT00254397|448005360|FG000|Overall Study|Adverse Event|2|||
124559668|NCT00254397|448005361|FG001|Overall Study|Adverse Event|0|||
124559669|NCT00254397|448005362|FG002|Overall Study|Adverse Event|3|||
124559670|NCT00254397|448005363|FG003|Overall Study|Adverse Event|1|||
124559671|NCT00972153|448005376|FG000|Overall Study|Equipment malfunction during case|0|||
124559672|NCT00972153|448005377|FG001|Overall Study|Equipment malfunction during case|1|||
124559673|NCT00972153|448005378|FG002|Overall Study|Equipment malfunction during case|0|||
124559674|NCT04136626|448005379|FG000|Treatment Phase|Withdrawal by Subject|1|||
124559675|NCT04136626|448005380|FG001|Treatment Phase|Withdrawal by Subject|9|||
124559676|NCT04136626|448005379|FG000|Treatment Phase|Adverse Event|1|||
124559677|NCT04136626|448005380|FG001|Treatment Phase|Adverse Event|0|||
124559678|NCT04136626|448005379|FG000|Treatment Phase|Lost to Follow-up|1|||
124559679|NCT04136626|448005380|FG001|Treatment Phase|Lost to Follow-up|5|||
124559680|NCT04136626|448005379|FG000|12-month Follow-up|Lost to Follow-up|8|||
124774988|NCT00538902|448804699|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
124499984|NCT00309777|447782011|FG000|Overall Study|Lost to Follow-up|0|||
124499985|NCT00309777|447782012|FG001|Overall Study|Lost to Follow-up|0|||
124499986|NCT00309777|447782013|FG002|Overall Study|Lost to Follow-up|1|||
124499987|NCT00309777|447782014|FG003|Overall Study|Lost to Follow-up|0|||
124499988|NCT00309777|447782011|FG000|Overall Study|Death|0|||
124499989|NCT00309777|447782012|FG001|Overall Study|Death|1|||
124499990|NCT00309777|447782013|FG002|Overall Study|Death|0|||
124499991|NCT00309777|447782014|FG003|Overall Study|Death|0|||
124499992|NCT05513053|447782015|FG000|Overall Study|Lost to Follow-up|9|||
124499993|NCT05513053|447782016|FG001|Overall Study|Lost to Follow-up|11|||
124499994|NCT05513053|447782015|FG000|Overall Study|Withdrawal by parent/guardian|2|||
124499995|NCT05513053|447782016|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124499996|NCT05513053|447782015|FG000|Overall Study|Withdrawal by Subject|2|||
124499997|NCT05513053|447782016|FG001|Overall Study|Withdrawal by Subject|9|||
124499998|NCT05513053|447782015|FG000|Overall Study|Protocol Violation|6|||
124499999|NCT05513053|447782016|FG001|Overall Study|Protocol Violation|3|||
124500000|NCT05513053|447782015|FG000|Overall Study|Adverse Event|0|||
124500001|NCT05513053|447782016|FG001|Overall Study|Adverse Event|2|||
124500002|NCT01520324|447783969|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
124500003|NCT03488472|447783970|FG000|Overall Study|disease progression additional mets|1|||
124500004|NCT00423085|447783972|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
124500005|NCT00423085|447783973|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
124500006|NCT00423085|447783974|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
124500007|NCT00423085|447783975|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
124500008|NCT00423085|447783972|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
124500009|NCT00423085|447783973|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
124500010|NCT00423085|447783974|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
124500011|NCT00423085|447783975|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
124500012|NCT00423085|447783972|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
124500013|NCT00423085|447783973|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
124500014|NCT00423085|447783974|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
124500015|NCT00423085|447783975|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
124500016|NCT00423085|447783972|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
124500017|NCT00423085|447783973|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
124500018|NCT00423085|447783974|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
124500019|NCT00423085|447783975|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
124500020|NCT00423085|447783972|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
124500021|NCT00423085|447783973|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
124500022|NCT00423085|447783974|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
124500023|NCT00423085|447783975|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
124500024|NCT00423085|447783972|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
124500025|NCT00423085|447783973|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
124500026|NCT00423085|447783974|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
124500027|NCT00423085|447783975|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
124500028|NCT00423085|447783972|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
124500029|NCT00423085|447783973|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
124500030|NCT00423085|447783974|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
124500031|NCT00423085|447783975|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
124500032|NCT00423085|447783972|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
124500033|NCT00423085|447783973|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
124500034|NCT00423085|447783974|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
124500035|NCT00423085|447783975|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
124500036|NCT00423085|447783972|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
124500037|NCT00423085|447783973|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
124500038|NCT00423085|447783974|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
124500039|NCT00423085|447783975|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
124500040|NCT00423085|447783972|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
124500041|NCT00423085|447783973|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
124500042|NCT00423085|447783974|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
124500043|NCT00423085|447783975|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
124500044|NCT00423085|447783972|FG000|52-Week Open-Label Extension Phase|Death|0|||
124500045|NCT00423085|447783973|FG001|52-Week Open-Label Extension Phase|Death|0|||
124500046|NCT00423085|447783974|FG002|52-Week Open-Label Extension Phase|Death|0|||
124500047|NCT00423085|447783975|FG003|52-Week Open-Label Extension Phase|Death|2|||
124500048|NCT00262080|447783980|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
124500049|NCT00262080|447783981|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
124774989|NCT00538902|448804700|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
124774990|NCT00538902|448804701|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
124774991|NCT00538902|448804699|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
124774992|NCT00538902|448804700|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
124774993|NCT00538902|448804701|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
124774994|NCT02557139|448804705|FG000|Overall Study|Significant liver elevation|1|||
124774995|NCT02557139|448804706|FG001|Overall Study|Significant liver elevation|0|||
124774996|NCT02557139|448804707|FG002|Overall Study|Significant liver elevation|1|||
124774997|NCT02557139|448804705|FG000|Overall Study|Withdrawal by Subject|1|||
124774998|NCT02557139|448804706|FG001|Overall Study|Withdrawal by Subject|0|||
124774999|NCT02557139|448804707|FG002|Overall Study|Withdrawal by Subject|0|||
124775000|NCT02557139|448804705|FG000|Overall Study|Illness of prohibited medication|0|||
124775001|NCT02557139|448804706|FG001|Overall Study|Illness of prohibited medication|0|||
124775002|NCT02557139|448804707|FG002|Overall Study|Illness of prohibited medication|1|||
124775003|NCT01454102|448804708|FG000|Overall Study|Continuing in the treatment period|0|||
124775004|NCT01454102|448804709|FG001|Overall Study|Continuing in the treatment period|0|||
124775005|NCT01454102|448804710|FG002|Overall Study|Continuing in the treatment period|0|||
124775006|NCT01454102|448804711|FG003|Overall Study|Continuing in the treatment period|0|||
124775007|NCT01454102|448804712|FG004|Overall Study|Continuing in the treatment period|3|||
124775008|NCT01454102|448804713|FG005|Overall Study|Continuing in the treatment period|3|||
124775009|NCT01454102|448804714|FG006|Overall Study|Continuing in the treatment period|2|||
124775010|NCT01454102|448804715|FG007|Overall Study|Continuing in the treatment period|0|||
124775011|NCT01454102|448804716|FG008|Overall Study|Continuing in the treatment period|1|||
124775012|NCT01454102|448804717|FG009|Overall Study|Continuing in the treatment period|0|||
124775013|NCT01454102|448804718|FG010|Overall Study|Continuing in the treatment period|0|||
124775014|NCT01454102|448804719|FG011|Overall Study|Continuing in the treatment period|4|||
124775015|NCT01454102|448804720|FG012|Overall Study|Continuing in the treatment period|7|||
124775016|NCT01454102|448804721|FG013|Overall Study|Continuing in the treatment period|4|||
124775017|NCT01454102|448804722|FG014|Overall Study|Continuing in the treatment period|3|||
124775018|NCT01454102|448804723|FG015|Overall Study|Continuing in the treatment period|1|||
124775019|NCT02592798|448804729|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
124775020|NCT02592798|448804730|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
124775021|NCT02592798|448804729|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
124775022|NCT02592798|448804730|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
124775023|NCT02592798|448804729|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
124775024|NCT02592798|448804730|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
124775025|NCT02592798|448804729|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
124775026|NCT02592798|448804730|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
124775027|NCT02592798|448804729|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
124775028|NCT02592798|448804730|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
124775029|NCT02592798|448804729|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
124775030|NCT02592798|448804730|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
124775031|NCT02592798|448804729|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
124775032|NCT02592798|448804730|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
124775033|NCT02592798|448804729|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
124775034|NCT02592798|448804730|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
124775035|NCT02592798|448804729|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
124775036|NCT02592798|448804730|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
124775037|NCT02592798|448804729|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
124775038|NCT02592798|448804730|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
124775039|NCT02592798|448804729|FG000|Transition From DB2 to OLE|Other reasons|1|||
124500050|NCT00262080|447783982|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
124500051|NCT00262080|447783980|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
124500052|NCT00262080|447783981|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
124500053|NCT00262080|447783982|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
124500054|NCT00262080|447783980|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
124500055|NCT00262080|447783981|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
124500056|NCT00262080|447783982|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
124500057|NCT00262080|447783980|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
124500058|NCT00262080|447783981|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
124500059|NCT00262080|447783982|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
124500060|NCT00262080|447783980|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
124500061|NCT00262080|447783981|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
124500062|NCT00262080|447783982|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
124500063|NCT00262080|447783980|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
124500064|NCT00262080|447783981|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
124500065|NCT00262080|447783982|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
124500066|NCT02273752|447783983|FG000|Overall Study|Trial was terminated early|2|||
124559681|NCT04136626|448005380|FG001|12-month Follow-up|Lost to Follow-up|7|||
124775040|NCT02592798|448804730|FG001|Transition From DB2 to OLE|Other reasons|0|||
124775041|NCT02592798|448804729|FG000|Open Label Period (OLE)|Other reasons|0|||
124775042|NCT02592798|448804730|FG001|Open Label Period (OLE)|Other reasons|2|||
124775043|NCT02592798|448804729|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
124775044|NCT02592798|448804730|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
124775045|NCT02592798|448804729|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
124775046|NCT02592798|448804730|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
124775047|NCT02592798|448804729|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
124775048|NCT02592798|448804730|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
124775049|NCT02592798|448804729|FG000|Open Label Period (OLE)|Adverse Event|0|||
124775050|NCT02592798|448804730|FG001|Open Label Period (OLE)|Adverse Event|1|||
124775051|NCT00705016|448804731|FG000|Overall Study|Adverse Event|6|||
124775052|NCT00705016|448804732|FG001|Overall Study|Adverse Event|11|||
124775053|NCT00705016|448804733|FG002|Overall Study|Adverse Event|10|||
124775054|NCT00705016|448804731|FG000|Overall Study|Death|5|||
124775055|NCT00705016|448804732|FG001|Overall Study|Death|7|||
124775056|NCT00705016|448804733|FG002|Overall Study|Death|5|||
124775057|NCT00705016|448804731|FG000|Overall Study|Protocol Violation|0|||
124775058|NCT00705016|448804732|FG001|Overall Study|Protocol Violation|1|||
124775059|NCT00705016|448804733|FG002|Overall Study|Protocol Violation|1|||
124775060|NCT00705016|448804731|FG000|Overall Study|Withdrawal by Subject|4|||
124775061|NCT00705016|448804732|FG001|Overall Study|Withdrawal by Subject|3|||
124775062|NCT00705016|448804733|FG002|Overall Study|Withdrawal by Subject|2|||
124775063|NCT00705016|448804731|FG000|Overall Study|Progressive Disease|33|||
124775064|NCT00705016|448804732|FG001|Overall Study|Progressive Disease|29|||
124775065|NCT00705016|448804733|FG002|Overall Study|Progressive Disease|33|||
124775066|NCT00705016|448804731|FG000|Overall Study|Symptomatic Deterioration|3|||
124775067|NCT00705016|448804732|FG001|Overall Study|Symptomatic Deterioration|1|||
124775068|NCT00705016|448804733|FG002|Overall Study|Symptomatic Deterioration|1|||
124775069|NCT00705016|448804731|FG000|Overall Study|Other|9|||
124775070|NCT00705016|448804732|FG001|Overall Study|Other|6|||
124775071|NCT00705016|448804733|FG002|Overall Study|Other|6|||
124775072|NCT01967940|448804741|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
124775073|NCT01967940|448804742|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
124775074|NCT01967940|448804743|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
124775075|NCT01967940|448804744|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
124775076|NCT01967940|448804741|FG000|Part 2|Adverse Event|0|||
124775077|NCT01967940|448804742|FG001|Part 2|Adverse Event|0|||
124775078|NCT01967940|448804743|FG002|Part 2|Adverse Event|0|||
124775079|NCT01967940|448804744|FG003|Part 2|Adverse Event|1|||
124775080|NCT01967940|448804741|FG000|Part 2|Unknown Reason|0|||
124775081|NCT01967940|448804742|FG001|Part 2|Unknown Reason|0|||
124775082|NCT01967940|448804743|FG002|Part 2|Unknown Reason|0|||
124775083|NCT01967940|448804744|FG003|Part 2|Unknown Reason|1|||
124775084|NCT00942604|448804745|FG000|Overall Study|Protocol Violation|1|||
124775085|NCT00942604|448804746|FG001|Overall Study|Protocol Violation|1|||
124775086|NCT00942604|448804745|FG000|Overall Study|Adverse Event|0|||
124775087|NCT00942604|448804746|FG001|Overall Study|Adverse Event|1|||
124775088|NCT00942604|448804745|FG000|Overall Study|Withdrawal by Subject|0|||
124775089|NCT00942604|448804746|FG001|Overall Study|Withdrawal by Subject|1|||
124775090|NCT00942604|448804745|FG000|Overall Study|Patient relocation|1|||
124775091|NCT00942604|448804746|FG001|Overall Study|Patient relocation|1|||
124775092|NCT01188343|448804747|FG000|Overall Study|Not vaccinated|0|||
124775093|NCT01188343|448804748|FG001|Overall Study|Not vaccinated|2|||
124775094|NCT01188343|448804749|FG002|Overall Study|Not vaccinated|1|||
124775095|NCT01188343|448804747|FG000|Overall Study|Withdrawal by Subject|1|||
124775096|NCT01188343|448804748|FG001|Overall Study|Withdrawal by Subject|24|||
124775097|NCT01188343|448804749|FG002|Overall Study|Withdrawal by Subject|0|||
124775098|NCT01143246|448804750|FG000|Overall Study|Adverse Event|24|||
124775099|NCT01143246|448804751|FG001|Overall Study|Adverse Event|28|||
124775100|NCT01143246|448804750|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
124775101|NCT01143246|448804751|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
124775102|NCT01143246|448804750|FG000|Overall Study|Lost to Follow-up|0|||
124775103|NCT01143246|448804751|FG001|Overall Study|Lost to Follow-up|1|||
124775104|NCT01143246|448804750|FG000|Overall Study|Death|16|||
124775105|NCT01143246|448804751|FG001|Overall Study|Death|15|||
124559682|NCT00409188|448007169|FG000|Overall Study|Ongoing at data cut-off|383|||
124775106|NCT01143246|448804750|FG000|Overall Study|Reason not Specified|3|||
124775107|NCT01143246|448804751|FG001|Overall Study|Reason not Specified|5|||
124775108|NCT01663103|448804752|FG000|Overall Study|Withdrawal by Subject|1|||
124775109|NCT01663103|448804753|FG001|Overall Study|Withdrawal by Subject|2|||
124775110|NCT01663103|448804752|FG000|Overall Study|Adverse Event|1|||
124775111|NCT01663103|448804753|FG001|Overall Study|Adverse Event|0|||
124775112|NCT01663103|448804752|FG000|Overall Study|dog bite|1|||
124775113|NCT01663103|448804753|FG001|Overall Study|dog bite|0|||
124775114|NCT05375760|448804754|FG000|Overall Study|Adverse Event|1|||
124775115|NCT05375760|448804755|FG001|Overall Study|Adverse Event|0|||
124775116|NCT05375760|448804754|FG000|Overall Study|Death|0|||
124775117|NCT05375760|448804755|FG001|Overall Study|Death|1|||
124775118|NCT05375760|448804754|FG000|Overall Study|Lost to Follow-up|6|||
124775119|NCT05375760|448804755|FG001|Overall Study|Lost to Follow-up|6|||
124775120|NCT05375760|448804754|FG000|Overall Study|Withdrawal by Subject|17|||
124775121|NCT05375760|448804755|FG001|Overall Study|Withdrawal by Subject|19|||
124775122|NCT05375760|448804754|FG000|Overall Study|Dosing halted by FDA|96|||
124775123|NCT05375760|448804755|FG001|Overall Study|Dosing halted by FDA|100|||
124775124|NCT05375760|448804754|FG000|Overall Study|Not compliant with study visit|2|||
124775125|NCT05375760|448804755|FG001|Overall Study|Not compliant with study visit|0|||
124775126|NCT05375760|448804754|FG000|Overall Study|Physician Decision|1|||
124775127|NCT05375760|448804755|FG001|Overall Study|Physician Decision|0|||
124775128|NCT05375760|448804754|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
124775129|NCT05375760|448804755|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
124775130|NCT05375760|448804754|FG000|Overall Study|Participant moved|1|||
124775131|NCT05375760|448804755|FG001|Overall Study|Participant moved|0|||
124775132|NCT00363480|448804756|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
124775133|NCT00363480|448804756|FG000|Overall Study|Adverse Event|4|||
124775134|NCT00363480|448804756|FG000|Overall Study|Lost to Follow-up|5|||
124775135|NCT00363480|448804756|FG000|Overall Study|Withdrawal by Subject|5|||
124775136|NCT00363480|448804756|FG000|Overall Study|Non-compliance of subject|1|||
124775137|NCT00363480|448804756|FG000|Overall Study|Participant discontinued on its own|1|||
124775138|NCT05567783|448804759|FG000|Overall Study|Death|2|||
124775139|NCT05567783|448804760|FG001|Overall Study|Death|3|||
124775140|NCT05567783|448804761|FG002|Overall Study|Death|0|||
124775141|NCT05567783|448804759|FG000|Overall Study|Lost to Follow-up|25|||
124775142|NCT05567783|448804760|FG001|Overall Study|Lost to Follow-up|19|||
124775143|NCT05567783|448804761|FG002|Overall Study|Lost to Follow-up|17|||
124775144|NCT05567783|448804759|FG000|Overall Study|Physician Decision|10|||
124775145|NCT05567783|448804760|FG001|Overall Study|Physician Decision|7|||
124775146|NCT05567783|448804761|FG002|Overall Study|Physician Decision|9|||
124775147|NCT05567783|448804759|FG000|Overall Study|Study Terminated by Sponsor|924|||
124775148|NCT05567783|448804760|FG001|Overall Study|Study Terminated by Sponsor|937|||
124775149|NCT05567783|448804761|FG002|Overall Study|Study Terminated by Sponsor|941|||
124775150|NCT05567783|448804759|FG000|Overall Study|Withdrawal by Subject|23|||
124775151|NCT05567783|448804760|FG001|Overall Study|Withdrawal by Subject|27|||
124775152|NCT05567783|448804761|FG002|Overall Study|Withdrawal by Subject|24|||
124500067|NCT02808312|447783984|FG000|Overall Study|Enrolled but Never Treated|0|||
124500068|NCT02808312|447783985|FG001|Overall Study|Enrolled but Never Treated|0|||
124500069|NCT02808312|447783986|FG002|Overall Study|Enrolled but Never Treated|1|||
124500070|NCT02808312|447783987|FG003|Overall Study|Enrolled but Never Treated|0|||
124500071|NCT02808312|447783988|FG004|Overall Study|Enrolled but Never Treated|0|||
124500072|NCT03100942|447783992|FG000|Randomized Treatment Period|Withdrew Consent|4|||
124500073|NCT03100942|447783993|FG001|Randomized Treatment Period|Withdrew Consent|5|||
124500074|NCT03100942|447783994|FG002|Randomized Treatment Period|Withdrew Consent|3|||
124500075|NCT03100942|447783995|FG003|Randomized Treatment Period|Withdrew Consent|3|||
124500076|NCT03100942|447783996|FG004|Randomized Treatment Period|Withdrew Consent|0|||
124500077|NCT03100942|447783997|FG005|Randomized Treatment Period|Withdrew Consent|0|||
124500078|NCT03100942|447783998|FG006|Randomized Treatment Period|Withdrew Consent|0|||
124500079|NCT03100942|447783992|FG000|Randomized Treatment Period|Adverse Event|5|||
124500080|NCT03100942|447783993|FG001|Randomized Treatment Period|Adverse Event|2|||
124500081|NCT03100942|447783994|FG002|Randomized Treatment Period|Adverse Event|1|||
124500082|NCT03100942|447783995|FG003|Randomized Treatment Period|Adverse Event|0|||
124500083|NCT03100942|447783996|FG004|Randomized Treatment Period|Adverse Event|0|||
124500084|NCT03100942|447783997|FG005|Randomized Treatment Period|Adverse Event|0|||
124500085|NCT03100942|447783998|FG006|Randomized Treatment Period|Adverse Event|0|||
124500086|NCT03100942|447783992|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
124500087|NCT03100942|447783993|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
124500088|NCT03100942|447783994|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
124500089|NCT03100942|447783995|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
124500090|NCT03100942|447783996|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
124500091|NCT03100942|447783997|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
124500092|NCT03100942|447783998|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
124500093|NCT03100942|447783992|FG000|Randomized Treatment Period|Protocol Violation|0|||
124500094|NCT03100942|447783993|FG001|Randomized Treatment Period|Protocol Violation|1|||
124500095|NCT03100942|447783994|FG002|Randomized Treatment Period|Protocol Violation|1|||
124500096|NCT03100942|447783995|FG003|Randomized Treatment Period|Protocol Violation|1|||
124500097|NCT03100942|447783996|FG004|Randomized Treatment Period|Protocol Violation|0|||
124775153|NCT05567783|448804759|FG000|Overall Study|Incarcerated|1|||
124775154|NCT05567783|448804760|FG001|Overall Study|Incarcerated|0|||
124775155|NCT05567783|448804761|FG002|Overall Study|Incarcerated|0|||
124775156|NCT05567783|448804759|FG000|Overall Study|Participant randomized in error|4|||
124775157|NCT05567783|448804760|FG001|Overall Study|Participant randomized in error|2|||
124775158|NCT05567783|448804761|FG002|Overall Study|Participant randomized in error|2|||
124775159|NCT03113487|448804766|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
124775160|NCT03944577|448804772|FG000|Overall Study|Adverse Event|3|||
124775161|NCT00949702|448804782|FG000|Overall Study|Death|40|||
124775162|NCT00949702|448804782|FG000|Overall Study|Disease progression|7|||
124775163|NCT00949702|448804782|FG000|Overall Study|Withdrawal of consent|1|||
124775164|NCT01654302|448804783|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
124775165|NCT01654302|448804784|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
124775166|NCT04119414|448804785|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
124775167|NCT00630838|448804790|FG000|Overall Study|Death|0|||
124775168|NCT00630838|448804791|FG001|Overall Study|Death|1|||
124775169|NCT00630838|448804790|FG000|Overall Study|Lost to Follow-up|0|||
124775170|NCT00630838|448804791|FG001|Overall Study|Lost to Follow-up|1|||
124775171|NCT00670748|448804792|FG000|Overall Study|Death during treatment|1|||
124775172|NCT00670748|448804793|FG001|Overall Study|Death during treatment|1|||
124775173|NCT00670748|448804794|FG002|Overall Study|Death during treatment|1|||
124775174|NCT00670748|448804795|FG003|Overall Study|Death during treatment|0|||
124775175|NCT00670748|448804792|FG000|Overall Study|Not off study|2|||
124775176|NCT00670748|448804793|FG001|Overall Study|Not off study|1|||
124775177|NCT00670748|448804794|FG002|Overall Study|Not off study|1|||
124775178|NCT00670748|448804795|FG003|Overall Study|Not off study|1|||
124775179|NCT02807402|448804799|FG000|Overall Study|Failure to Return|1|||
124500098|NCT03100942|447783997|FG005|Randomized Treatment Period|Protocol Violation|0|||
124775180|NCT02807402|448804799|FG000|Overall Study|Death|3|||
124775181|NCT02807402|448804799|FG000|Overall Study|Other|2|||
124775182|NCT04922216|448804803|FG000|Overall Study|Withdrawal by Subject|0|||
124775183|NCT04922216|448804804|FG001|Overall Study|Withdrawal by Subject|1|||
124775184|NCT04922216|448804805|FG002|Overall Study|Withdrawal by Subject|0|||
124775185|NCT04922216|448804806|FG003|Overall Study|Withdrawal by Subject|0|||
124775186|NCT04922216|448804807|FG004|Overall Study|Withdrawal by Subject|0|||
124775187|NCT04922216|448804808|FG005|Overall Study|Withdrawal by Subject|0|||
124775188|NCT04922216|448804809|FG006|Overall Study|Withdrawal by Subject|0|||
124775189|NCT04922216|448804810|FG007|Overall Study|Withdrawal by Subject|2|||
124775190|NCT04922216|448804811|FG008|Overall Study|Withdrawal by Subject|0|||
124775191|NCT04922216|448804812|FG009|Overall Study|Withdrawal by Subject|0|||
124775192|NCT04922216|448804813|FG010|Overall Study|Withdrawal by Subject|0|||
124775193|NCT04922216|448804814|FG011|Overall Study|Withdrawal by Subject|0|||
124775194|NCT04922216|448804815|FG012|Overall Study|Withdrawal by Subject|1|||
124775195|NCT04922216|448804816|FG013|Overall Study|Withdrawal by Subject|1|||
124775196|NCT04922216|448804817|FG014|Overall Study|Withdrawal by Subject|1|||
124775197|NCT04922216|448804818|FG015|Overall Study|Withdrawal by Subject|0|||
124775198|NCT04922216|448804819|FG016|Overall Study|Withdrawal by Subject|0|||
124775199|NCT04922216|448804820|FG017|Overall Study|Withdrawal by Subject|1|||
124775200|NCT04922216|448804821|FG018|Overall Study|Withdrawal by Subject|1|||
124775201|NCT04922216|448804822|FG019|Overall Study|Withdrawal by Subject|1|||
124775202|NCT04922216|448804823|FG020|Overall Study|Withdrawal by Subject|1|||
124775203|NCT04922216|448804824|FG021|Overall Study|Withdrawal by Subject|0|||
124775204|NCT04922216|448804825|FG022|Overall Study|Withdrawal by Subject|0|||
124775205|NCT04922216|448804826|FG023|Overall Study|Withdrawal by Subject|2|||
124775206|NCT04922216|448804827|FG024|Overall Study|Withdrawal by Subject|0|||
124775207|NCT04922216|448804828|FG025|Overall Study|Withdrawal by Subject|0|||
124775208|NCT04922216|448804829|FG026|Overall Study|Withdrawal by Subject|1|||
124775209|NCT04922216|448804830|FG027|Overall Study|Withdrawal by Subject|0|||
124775210|NCT04922216|448804831|FG028|Overall Study|Withdrawal by Subject|0|||
124775211|NCT04922216|448804832|FG029|Overall Study|Withdrawal by Subject|0|||
124775212|NCT04922216|448804833|FG030|Overall Study|Withdrawal by Subject|1|||
124775213|NCT04922216|448804834|FG031|Overall Study|Withdrawal by Subject|0|||
124775214|NCT04922216|448804803|FG000|Overall Study|Lost to Follow-up|1|||
124775215|NCT04922216|448804804|FG001|Overall Study|Lost to Follow-up|0|||
124775216|NCT04922216|448804805|FG002|Overall Study|Lost to Follow-up|2|||
124775217|NCT04922216|448804806|FG003|Overall Study|Lost to Follow-up|0|||
124775218|NCT04922216|448804807|FG004|Overall Study|Lost to Follow-up|0|||
124775219|NCT04922216|448804808|FG005|Overall Study|Lost to Follow-up|2|||
124775220|NCT04922216|448804809|FG006|Overall Study|Lost to Follow-up|0|||
124775221|NCT04922216|448804810|FG007|Overall Study|Lost to Follow-up|1|||
124775222|NCT04922216|448804811|FG008|Overall Study|Lost to Follow-up|1|||
124775223|NCT04922216|448804812|FG009|Overall Study|Lost to Follow-up|2|||
124775224|NCT04922216|448804813|FG010|Overall Study|Lost to Follow-up|2|||
124775225|NCT04922216|448804814|FG011|Overall Study|Lost to Follow-up|1|||
124775226|NCT04922216|448804815|FG012|Overall Study|Lost to Follow-up|1|||
124775227|NCT04922216|448804816|FG013|Overall Study|Lost to Follow-up|0|||
124775228|NCT04922216|448804817|FG014|Overall Study|Lost to Follow-up|1|||
124775229|NCT04922216|448804818|FG015|Overall Study|Lost to Follow-up|0|||
124775230|NCT04922216|448804819|FG016|Overall Study|Lost to Follow-up|0|||
124775231|NCT04922216|448804820|FG017|Overall Study|Lost to Follow-up|2|||
124775232|NCT04922216|448804821|FG018|Overall Study|Lost to Follow-up|1|||
124775233|NCT04922216|448804822|FG019|Overall Study|Lost to Follow-up|0|||
124500099|NCT03100942|447783998|FG006|Randomized Treatment Period|Protocol Violation|0|||
124775234|NCT04922216|448804823|FG020|Overall Study|Lost to Follow-up|1|||
124775235|NCT04922216|448804824|FG021|Overall Study|Lost to Follow-up|0|||
124775236|NCT04922216|448804825|FG022|Overall Study|Lost to Follow-up|2|||
124775237|NCT04922216|448804826|FG023|Overall Study|Lost to Follow-up|1|||
124775238|NCT04922216|448804827|FG024|Overall Study|Lost to Follow-up|0|||
124775239|NCT04922216|448804828|FG025|Overall Study|Lost to Follow-up|2|||
124775240|NCT04922216|448804829|FG026|Overall Study|Lost to Follow-up|0|||
124775241|NCT04922216|448804830|FG027|Overall Study|Lost to Follow-up|0|||
124775242|NCT04922216|448804831|FG028|Overall Study|Lost to Follow-up|1|||
124775243|NCT04922216|448804832|FG029|Overall Study|Lost to Follow-up|0|||
124775244|NCT04922216|448804833|FG030|Overall Study|Lost to Follow-up|2|||
124775245|NCT04922216|448804834|FG031|Overall Study|Lost to Follow-up|1|||
124775246|NCT04721977|448804835|FG000|Overall Study|Death|15|||
124775247|NCT04721977|448804835|FG000|Overall Study|Ongoing|51|||
124775248|NCT03278249|448804836|FG000|Overall Study|Withdrawal by Subject|2|||
124775249|NCT03278249|448804836|FG000|Overall Study|Lost to Follow-up|1|||
124775250|NCT00775190|448806463|FG000|Overall Study|Lost to Follow-up|2|||
124775251|NCT00775190|448806464|FG001|Overall Study|Lost to Follow-up|3|||
124775252|NCT00775190|448806463|FG000|Overall Study|Withdrawal by Subject|1|||
124775253|NCT00775190|448806464|FG001|Overall Study|Withdrawal by Subject|2|||
124775254|NCT00775190|448806463|FG000|Overall Study|Protocol Violation|1|||
124775255|NCT00775190|448806464|FG001|Overall Study|Protocol Violation|0|||
124775256|NCT00904033|448806469|FG000|Overall Study|Withdrawal by Subject|1|||
124775257|NCT00904033|448806470|FG001|Overall Study|Withdrawal by Subject|1|||
124775258|NCT00904033|448806471|FG002|Overall Study|Withdrawal by Subject|0|||
124775259|NCT00904033|448806472|FG003|Overall Study|Withdrawal by Subject|0|||
124775260|NCT00904033|448806469|FG000|Overall Study|Physician Decision|0|||
124775261|NCT00904033|448806470|FG001|Overall Study|Physician Decision|0|||
124775262|NCT00904033|448806471|FG002|Overall Study|Physician Decision|1|||
124775263|NCT00904033|448806472|FG003|Overall Study|Physician Decision|0|||
124775264|NCT00904033|448806469|FG000|Overall Study|Unable to obtain final blood draw|0|||
124775265|NCT00904033|448806470|FG001|Overall Study|Unable to obtain final blood draw|0|||
124775266|NCT00904033|448806471|FG002|Overall Study|Unable to obtain final blood draw|0|||
124775267|NCT00904033|448806472|FG003|Overall Study|Unable to obtain final blood draw|2|||
124775268|NCT01357850|448806473|FG000|Overall Study|Lost to Follow-up|1|||
124775269|NCT01357850|448806474|FG001|Overall Study|Lost to Follow-up|0|||
124775270|NCT01357850|448806475|FG002|Overall Study|Lost to Follow-up|0|||
124775271|NCT01357850|448806476|FG003|Overall Study|Lost to Follow-up|0|||
124775272|NCT01600716|448806479|FG000|Overall Study|Other Reasons|3|||
124775273|NCT01600716|448806480|FG001|Overall Study|Other Reasons|1|||
124775274|NCT01600716|448806479|FG000|Overall Study|Personal Reasons|0|||
124775275|NCT01600716|448806480|FG001|Overall Study|Personal Reasons|2|||
124775276|NCT01600716|448806479|FG000|Overall Study|Lost to Follow-up|0|||
124775277|NCT01600716|448806480|FG001|Overall Study|Lost to Follow-up|2|||
124775278|NCT01600716|448806479|FG000|Overall Study|Pregnancy|1|||
124775279|NCT01600716|448806480|FG001|Overall Study|Pregnancy|0|||
124775280|NCT01600716|448806479|FG000|Overall Study|Lack of Efficacy|2|||
124775281|NCT01600716|448806480|FG001|Overall Study|Lack of Efficacy|1|||
124775282|NCT01600716|448806479|FG000|Overall Study|Adverse Event|1|||
124775283|NCT01600716|448806480|FG001|Overall Study|Adverse Event|1|||
124775284|NCT03349034|448806483|FG000|Overall Study|catheters dislodged during transport|2|||
124775285|NCT03349034|448806484|FG001|Overall Study|catheters dislodged during transport|0|||
124775286|NCT03349034|448806483|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
124775287|NCT03349034|448806484|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
124775288|NCT03349034|448806483|FG000|Overall Study|soft tissue flap used|1|||
124775289|NCT03349034|448806484|FG001|Overall Study|soft tissue flap used|0|||
124775290|NCT03349034|448806483|FG000|Overall Study|Other|0|||
124775291|NCT03349034|448806484|FG001|Overall Study|Other|1|||
124775292|NCT01177397|448806485|FG000|Overall Study|Protocol Violation|0|||
124775293|NCT01177397|448806486|FG001|Overall Study|Protocol Violation|0|||
124775294|NCT01177397|448806487|FG002|Overall Study|Protocol Violation|0|||
124775295|NCT01177397|448806488|FG003|Overall Study|Protocol Violation|0|||
124775296|NCT01177397|448806489|FG004|Overall Study|Protocol Violation|0|||
124775297|NCT01177397|448806490|FG005|Overall Study|Protocol Violation|1|||
124775298|NCT01177397|448806491|FG006|Overall Study|Protocol Violation|0|||
124775299|NCT01177397|448806492|FG007|Overall Study|Protocol Violation|0|||
124775300|NCT01177397|448806493|FG008|Overall Study|Protocol Violation|0|||
124775301|NCT01177397|448806494|FG009|Overall Study|Protocol Violation|0|||
124775302|NCT01177397|448806495|FG010|Overall Study|Protocol Violation|0|||
124775303|NCT01177397|448806496|FG011|Overall Study|Protocol Violation|0|||
124775304|NCT01177397|448806485|FG000|Overall Study|Lost to Follow-up|0|||
124500100|NCT03100942|447783992|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
124500101|NCT03100942|447783993|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
124500102|NCT03100942|447783994|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
124775305|NCT01177397|448806486|FG001|Overall Study|Lost to Follow-up|0|||
124775306|NCT01177397|448806487|FG002|Overall Study|Lost to Follow-up|0|||
124775307|NCT01177397|448806488|FG003|Overall Study|Lost to Follow-up|0|||
124775308|NCT01177397|448806489|FG004|Overall Study|Lost to Follow-up|1|||
124775309|NCT01177397|448806490|FG005|Overall Study|Lost to Follow-up|0|||
124775310|NCT01177397|448806491|FG006|Overall Study|Lost to Follow-up|0|||
124775311|NCT01177397|448806492|FG007|Overall Study|Lost to Follow-up|2|||
124775312|NCT01177397|448806493|FG008|Overall Study|Lost to Follow-up|0|||
124775313|NCT01177397|448806494|FG009|Overall Study|Lost to Follow-up|0|||
124775314|NCT01177397|448806495|FG010|Overall Study|Lost to Follow-up|0|||
124775315|NCT01177397|448806496|FG011|Overall Study|Lost to Follow-up|0|||
124775316|NCT01177397|448806485|FG000|Overall Study|Death|0|||
124775317|NCT01177397|448806486|FG001|Overall Study|Death|0|||
124775318|NCT01177397|448806487|FG002|Overall Study|Death|1|||
124775319|NCT01177397|448806488|FG003|Overall Study|Death|1|||
124775320|NCT01177397|448806489|FG004|Overall Study|Death|0|||
124775321|NCT01177397|448806490|FG005|Overall Study|Death|0|||
124775322|NCT01177397|448806491|FG006|Overall Study|Death|0|||
124775323|NCT01177397|448806492|FG007|Overall Study|Death|5|||
124775324|NCT01177397|448806493|FG008|Overall Study|Death|2|||
124775325|NCT01177397|448806494|FG009|Overall Study|Death|1|||
124775326|NCT01177397|448806495|FG010|Overall Study|Death|0|||
124775327|NCT01177397|448806496|FG011|Overall Study|Death|0|||
124775328|NCT01177397|448806485|FG000|Overall Study|Withdrawal by Subject|0|||
124775329|NCT01177397|448806486|FG001|Overall Study|Withdrawal by Subject|0|||
124775330|NCT01177397|448806487|FG002|Overall Study|Withdrawal by Subject|1|||
124775331|NCT01177397|448806488|FG003|Overall Study|Withdrawal by Subject|1|||
124775332|NCT01177397|448806489|FG004|Overall Study|Withdrawal by Subject|1|||
124500103|NCT03100942|447783995|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
124500104|NCT03100942|447783996|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
124500105|NCT03100942|447783997|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
124500106|NCT03100942|447783998|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
124500107|NCT03100942|447783992|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
124500108|NCT03100942|447783993|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
124500109|NCT03100942|447783994|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
124500110|NCT03100942|447783995|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
124500111|NCT03100942|447783996|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
124500112|NCT03100942|447783997|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
124500113|NCT03100942|447783998|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
124500114|NCT03100942|447783992|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
124500115|NCT03100942|447783993|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
124500116|NCT03100942|447783994|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
124500117|NCT03100942|447783995|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
124500118|NCT03100942|447783996|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
124500119|NCT03100942|447783997|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
124500120|NCT03100942|447783998|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
124500121|NCT04263142|447783999|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
124500122|NCT04263142|447784000|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
124500123|NCT04263142|447784001|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
124500124|NCT04263142|447784002|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
124500125|NCT04263142|447784003|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
124500126|NCT04263142|447783999|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
124500127|NCT04263142|447784000|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
124500128|NCT04263142|447784001|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
124500129|NCT04263142|447784002|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
124500130|NCT04263142|447784003|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
124500131|NCT01623531|447784004|FG000|Overall Study|Death|1|||
124500132|NCT01623531|447784005|FG001|Overall Study|Death|0|||
124500133|NCT01623531|447784004|FG000|Overall Study|Protocol Violation|2|||
124500134|NCT01623531|447784005|FG001|Overall Study|Protocol Violation|1|||
124500135|NCT01623531|447784004|FG000|Overall Study|Missing data at primary outcome time poi|1|||
124500136|NCT01623531|447784005|FG001|Overall Study|Missing data at primary outcome time poi|1|||
124500137|NCT01429792|447784006|FG000|Overall Study|Other Reasons|67|||
124500138|NCT01429792|447784006|FG000|Overall Study|Unknown Disposition|94|||
124500139|NCT01429792|447784006|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
124500140|NCT01429792|447784006|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
124500141|NCT01429792|447784006|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
124500142|NCT01429792|447784006|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
124500143|NCT01429792|447784006|FG000|Overall Study|Withdrawal by Subject|70|||
124500144|NCT01429792|447784006|FG000|Overall Study|Lost to Follow-up|88|||
124500145|NCT04184622|447784008|FG000|Primary Treatment Period|Adverse Event|6|||
124500146|NCT04184622|447784009|FG001|Primary Treatment Period|Adverse Event|4|||
124500147|NCT04184622|447784010|FG002|Primary Treatment Period|Adverse Event|8|||
124500148|NCT04184622|447784011|FG003|Primary Treatment Period|Adverse Event|6|||
124500149|NCT04184622|447784008|FG000|Primary Treatment Period|Death|4|||
124500150|NCT04184622|447784009|FG001|Primary Treatment Period|Death|4|||
124775333|NCT01177397|448806490|FG005|Overall Study|Withdrawal by Subject|2|||
124775334|NCT01177397|448806491|FG006|Overall Study|Withdrawal by Subject|0|||
124500151|NCT04184622|447784010|FG002|Primary Treatment Period|Death|2|||
124775335|NCT01177397|448806492|FG007|Overall Study|Withdrawal by Subject|5|||
124775336|NCT01177397|448806493|FG008|Overall Study|Withdrawal by Subject|9|||
124775337|NCT01177397|448806494|FG009|Overall Study|Withdrawal by Subject|1|||
124775338|NCT01177397|448806495|FG010|Overall Study|Withdrawal by Subject|1|||
124775339|NCT01177397|448806496|FG011|Overall Study|Withdrawal by Subject|0|||
124775340|NCT01177397|448806485|FG000|Overall Study|Adverse Event|0|||
124775341|NCT01177397|448806486|FG001|Overall Study|Adverse Event|0|||
124775342|NCT01177397|448806487|FG002|Overall Study|Adverse Event|1|||
124775343|NCT01177397|448806488|FG003|Overall Study|Adverse Event|2|||
124775344|NCT01177397|448806489|FG004|Overall Study|Adverse Event|0|||
124775345|NCT01177397|448806490|FG005|Overall Study|Adverse Event|12|||
124775346|NCT01177397|448806491|FG006|Overall Study|Adverse Event|1|||
124775347|NCT01177397|448806492|FG007|Overall Study|Adverse Event|14|||
124775348|NCT01177397|448806493|FG008|Overall Study|Adverse Event|8|||
124775349|NCT01177397|448806494|FG009|Overall Study|Adverse Event|6|||
124775350|NCT01177397|448806495|FG010|Overall Study|Adverse Event|3|||
124775351|NCT01177397|448806496|FG011|Overall Study|Adverse Event|7|||
124775352|NCT01177397|448806485|FG000|Overall Study|Disease progression|1|||
124775353|NCT01177397|448806486|FG001|Overall Study|Disease progression|2|||
124500152|NCT04184622|447784011|FG003|Primary Treatment Period|Death|1|||
124500153|NCT04184622|447784008|FG000|Primary Treatment Period|Lost to Follow-up|41|||
124724296|NCT01406938|448611709|FG005|Induction Period|Lack of Efficacy|0|||
124724297|NCT01406938|448611704|FG000|Induction Period|Lost to Follow-up|2|||
124724298|NCT01406938|448611705|FG001|Induction Period|Lost to Follow-up|3|||
124724299|NCT01406938|448611706|FG002|Induction Period|Lost to Follow-up|0|||
124724300|NCT01406938|448611707|FG003|Induction Period|Lost to Follow-up|0|||
124724301|NCT01406938|448611708|FG004|Induction Period|Lost to Follow-up|0|||
124724302|NCT01406938|448611709|FG005|Induction Period|Lost to Follow-up|0|||
124724303|NCT01406938|448611704|FG000|Maintenance Period|Adverse Event|0|||
124724304|NCT01406938|448611705|FG001|Maintenance Period|Adverse Event|0|||
124724305|NCT01406938|448611706|FG002|Maintenance Period|Adverse Event|2|||
124724306|NCT01406938|448611707|FG003|Maintenance Period|Adverse Event|8|||
124500154|NCT04184622|447784009|FG001|Primary Treatment Period|Lost to Follow-up|17|||
124500155|NCT04184622|447784010|FG002|Primary Treatment Period|Lost to Follow-up|15|||
124500156|NCT04184622|447784011|FG003|Primary Treatment Period|Lost to Follow-up|13|||
124500157|NCT04184622|447784008|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
124500158|NCT04184622|447784009|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
124500159|NCT04184622|447784010|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
124500160|NCT04184622|447784011|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
124724307|NCT01406938|448611708|FG004|Maintenance Period|Adverse Event|4|||
124724308|NCT01406938|448611709|FG005|Maintenance Period|Adverse Event|2|||
124724309|NCT01406938|448611704|FG000|Maintenance Period|Death|0|||
124724310|NCT01406938|448611705|FG001|Maintenance Period|Death|0|||
124724311|NCT01406938|448611706|FG002|Maintenance Period|Death|0|||
124724312|NCT01406938|448611707|FG003|Maintenance Period|Death|0|||
124724313|NCT01406938|448611708|FG004|Maintenance Period|Death|1|||
124724314|NCT01406938|448611709|FG005|Maintenance Period|Death|0|||
124724315|NCT01406938|448611704|FG000|Maintenance Period|Subject/guardian decision|0|||
124724316|NCT01406938|448611705|FG001|Maintenance Period|Subject/guardian decision|0|||
124724317|NCT01406938|448611706|FG002|Maintenance Period|Subject/guardian decision|11|||
124724318|NCT01406938|448611707|FG003|Maintenance Period|Subject/guardian decision|7|||
124724319|NCT01406938|448611708|FG004|Maintenance Period|Subject/guardian decision|10|||
124724320|NCT01406938|448611709|FG005|Maintenance Period|Subject/guardian decision|7|||
124724321|NCT01406938|448611704|FG000|Maintenance Period|Protocol Violation|0|||
124724322|NCT01406938|448611705|FG001|Maintenance Period|Protocol Violation|0|||
124500161|NCT04184622|447784008|FG000|Primary Treatment Period|Physician Decision|0|||
124500162|NCT04184622|447784009|FG001|Primary Treatment Period|Physician Decision|0|||
124500163|NCT04184622|447784010|FG002|Primary Treatment Period|Physician Decision|3|||
124500164|NCT04184622|447784011|FG003|Primary Treatment Period|Physician Decision|1|||
124500165|NCT04184622|447784008|FG000|Primary Treatment Period|Pregnancy|4|||
124500166|NCT04184622|447784009|FG001|Primary Treatment Period|Pregnancy|3|||
124500167|NCT04184622|447784010|FG002|Primary Treatment Period|Pregnancy|4|||
124500168|NCT04184622|447784011|FG003|Primary Treatment Period|Pregnancy|1|||
124500169|NCT04184622|447784008|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
124724323|NCT01406938|448611706|FG002|Maintenance Period|Protocol Violation|2|||
124724324|NCT01406938|448611707|FG003|Maintenance Period|Protocol Violation|2|||
124724325|NCT01406938|448611708|FG004|Maintenance Period|Protocol Violation|2|||
124724326|NCT01406938|448611709|FG005|Maintenance Period|Protocol Violation|2|||
124724327|NCT01406938|448611704|FG000|Maintenance Period|Pregnancy|0|||
124724328|NCT01406938|448611705|FG001|Maintenance Period|Pregnancy|0|||
124775354|NCT01177397|448806487|FG002|Overall Study|Disease progression|5|||
124775355|NCT01177397|448806488|FG003|Overall Study|Disease progression|5|||
124775356|NCT01177397|448806489|FG004|Overall Study|Disease progression|4|||
124775357|NCT01177397|448806490|FG005|Overall Study|Disease progression|10|||
124500170|NCT04184622|447784009|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
124724329|NCT01406938|448611706|FG002|Maintenance Period|Pregnancy|0|||
124775358|NCT01177397|448806491|FG006|Overall Study|Disease progression|10|||
124775359|NCT01177397|448806492|FG007|Overall Study|Disease progression|21|||
124775360|NCT01177397|448806493|FG008|Overall Study|Disease progression|18|||
124775361|NCT01177397|448806494|FG009|Overall Study|Disease progression|12|||
124775362|NCT01177397|448806495|FG010|Overall Study|Disease progression|10|||
124775363|NCT01177397|448806496|FG011|Overall Study|Disease progression|8|||
124775364|NCT01177397|448806485|FG000|Overall Study|Other reasons|0|||
124775365|NCT01177397|448806486|FG001|Overall Study|Other reasons|0|||
124775366|NCT01177397|448806487|FG002|Overall Study|Other reasons|1|||
124775367|NCT01177397|448806488|FG003|Overall Study|Other reasons|0|||
124775368|NCT01177397|448806489|FG004|Overall Study|Other reasons|1|||
124559683|NCT00409188|448007170|FG001|Overall Study|Ongoing at data cut-off|175|||
124559684|NCT01393990|448007174|FG000|Overall Study|Adverse Event|0|||
124559685|NCT01393990|448007175|FG001|Overall Study|Adverse Event|0|||
124559686|NCT01393990|448007176|FG002|Overall Study|Adverse Event|0|||
124775369|NCT01177397|448806490|FG005|Overall Study|Other reasons|1|||
124775370|NCT01177397|448806491|FG006|Overall Study|Other reasons|2|||
124775371|NCT01177397|448806492|FG007|Overall Study|Other reasons|6|||
124500171|NCT04184622|447784010|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
124500172|NCT04184622|447784011|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
124500173|NCT04184622|447784008|FG000|Additional Treatment Period|Adverse Event|1|||
124500174|NCT04184622|447784009|FG001|Additional Treatment Period|Adverse Event|2|||
124500175|NCT04184622|447784010|FG002|Additional Treatment Period|Adverse Event|1|||
124500176|NCT04184622|447784011|FG003|Additional Treatment Period|Adverse Event|0|||
124500177|NCT04184622|447784008|FG000|Additional Treatment Period|Death|0|||
124500178|NCT04184622|447784009|FG001|Additional Treatment Period|Death|0|||
124500179|NCT04184622|447784010|FG002|Additional Treatment Period|Death|1|||
124500180|NCT04184622|447784011|FG003|Additional Treatment Period|Death|1|||
124500181|NCT04184622|447784008|FG000|Additional Treatment Period|Lost to Follow-up|6|||
124500182|NCT04184622|447784009|FG001|Additional Treatment Period|Lost to Follow-up|4|||
124500183|NCT04184622|447784010|FG002|Additional Treatment Period|Lost to Follow-up|8|||
124500184|NCT04184622|447784011|FG003|Additional Treatment Period|Lost to Follow-up|6|||
124500185|NCT04184622|447784008|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
124500186|NCT04184622|447784009|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
124500187|NCT04184622|447784010|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
124500188|NCT04184622|447784011|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
124500189|NCT04184622|447784008|FG000|Additional Treatment Period|Physician Decision|0|||
124500190|NCT04184622|447784009|FG001|Additional Treatment Period|Physician Decision|0|||
124500191|NCT04184622|447784010|FG002|Additional Treatment Period|Physician Decision|1|||
124500192|NCT04184622|447784011|FG003|Additional Treatment Period|Physician Decision|0|||
124500193|NCT04184622|447784008|FG000|Additional Treatment Period|Pregnancy|0|||
124500194|NCT04184622|447784009|FG001|Additional Treatment Period|Pregnancy|0|||
124500195|NCT04184622|447784010|FG002|Additional Treatment Period|Pregnancy|0|||
124500196|NCT04184622|447784011|FG003|Additional Treatment Period|Pregnancy|1|||
124500197|NCT04184622|447784008|FG000|Additional Treatment Period|Protocol deviation|0|||
124500198|NCT04184622|447784009|FG001|Additional Treatment Period|Protocol deviation|0|||
124500199|NCT04184622|447784010|FG002|Additional Treatment Period|Protocol deviation|1|||
124500200|NCT04184622|447784011|FG003|Additional Treatment Period|Protocol deviation|0|||
124500201|NCT04184622|447784008|FG000|Additional Treatment Period|Site closed|1|||
124500202|NCT04184622|447784009|FG001|Additional Treatment Period|Site closed|0|||
124500203|NCT04184622|447784010|FG002|Additional Treatment Period|Site closed|1|||
124500204|NCT04184622|447784011|FG003|Additional Treatment Period|Site closed|0|||
124500205|NCT04184622|447784008|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
124500206|NCT04184622|447784009|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
124500207|NCT04184622|447784010|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
124500208|NCT04184622|447784011|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
124500209|NCT04184622|447784008|FG000|Safety Follow-up Period|Adverse Event|6|||
124500210|NCT04184622|447784009|FG001|Safety Follow-up Period|Adverse Event|8|||
124500211|NCT04184622|447784010|FG002|Safety Follow-up Period|Adverse Event|9|||
124500212|NCT04184622|447784011|FG003|Safety Follow-up Period|Adverse Event|16|||
124500213|NCT04184622|447784008|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
124500214|NCT04184622|447784009|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
124500215|NCT04184622|447784010|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
124500216|NCT04184622|447784011|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
124500217|NCT04184622|447784008|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
124500218|NCT04184622|447784009|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
124500219|NCT04184622|447784010|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
124500220|NCT04184622|447784011|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
124500221|NCT04184622|447784008|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
124500222|NCT04184622|447784009|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
124500223|NCT04184622|447784010|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
124500224|NCT04184622|447784011|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
124775372|NCT01177397|448806493|FG008|Overall Study|Other reasons|10|||
124775373|NCT01177397|448806494|FG009|Overall Study|Other reasons|8|||
124775374|NCT01177397|448806495|FG010|Overall Study|Other reasons|0|||
124775375|NCT01177397|448806496|FG011|Overall Study|Other reasons|2|||
124775376|NCT00865566|448806497|FG000|Overall Study|Death|1|||
124775377|NCT00865566|448806498|FG001|Overall Study|Death|11|||
124775378|NCT00865566|448806497|FG000|Overall Study|Lost to Follow-up|314|||
124775379|NCT00865566|448806498|FG001|Overall Study|Lost to Follow-up|315|||
124775380|NCT00865566|448806497|FG000|Overall Study|Withdrawal by Subject|45|||
124775381|NCT00865566|448806498|FG001|Overall Study|Withdrawal by Subject|65|||
124775382|NCT00865566|448806497|FG000|Overall Study|Physician Decision|0|||
124775383|NCT00865566|448806498|FG001|Overall Study|Physician Decision|1|||
124775384|NCT00865566|448806497|FG000|Overall Study|Participant relocated|78|||
124775385|NCT00865566|448806498|FG001|Overall Study|Participant relocated|107|||
124775386|NCT00865566|448806497|FG000|Overall Study|Participant unable to adhere|27|||
124775387|NCT00865566|448806498|FG001|Overall Study|Participant unable to adhere|42|||
124775388|NCT00865566|448806497|FG000|Overall Study|Other; N=245 due to early study closure|154|||
124775389|NCT00865566|448806498|FG001|Overall Study|Other; N=245 due to early study closure|139|||
124775390|NCT00865566|448806497|FG000|Overall Study|HIV infection|5|||
124775391|NCT00865566|448806498|FG001|Overall Study|HIV infection|7|||
124775392|NCT00719472|448806501|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
124775393|NCT00719472|448806501|FG000|Enrolled in Study|Subject decision to withdraw|8|||
124775394|NCT00719472|448806501|FG000|Enrolled in Study|Various Reasons|17|||
124775395|NCT00719472|448806501|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
124775396|NCT00719472|448806501|FG000|Received Cycle 1 Treatment|Death|5|||
124775397|NCT00719472|448806501|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
124775398|NCT00719472|448806501|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
124775399|NCT00719472|448806501|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
124775400|NCT00719472|448806501|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
124775401|NCT00719472|448806501|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
124775402|NCT00719472|448806501|FG000|Received Cycle 2 Treatment|Death|6|||
124775403|NCT00719472|448806501|FG000|Received Cycle 2 Treatment|Disease progression|3|||
124775404|NCT00719472|448806501|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
124775405|NCT00719472|448806501|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
124775406|NCT00719472|448806501|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
124775407|NCT00719472|448806501|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
124775408|NCT02395471|448806502|FG000|Overall Study|Lost to Follow-up|2|||
124775409|NCT02395471|448806503|FG001|Overall Study|Lost to Follow-up|0|||
124775410|NCT02395471|448806502|FG000|Overall Study|Withdrawal by Subject|2|||
124775411|NCT02395471|448806503|FG001|Overall Study|Withdrawal by Subject|1|||
124775412|NCT02395471|448806502|FG000|Overall Study|Physician Decision|1|||
124775413|NCT02395471|448806503|FG001|Overall Study|Physician Decision|0|||
124775414|NCT02395471|448806502|FG000|Overall Study|Protocol Violation|0|||
124775415|NCT02395471|448806503|FG001|Overall Study|Protocol Violation|1|||
124775416|NCT02395471|448806502|FG000|Overall Study|Failure to swollow sponge twice|1|||
124775417|NCT02395471|448806503|FG001|Overall Study|Failure to swollow sponge twice|0|||
124775418|NCT02395471|448806502|FG000|Overall Study|Patient did not return for procedure|0|||
124775419|NCT02395471|448806503|FG001|Overall Study|Patient did not return for procedure|1|||
124775420|NCT02395471|448806502|FG000|Overall Study|Subject not eligible|1|||
124775421|NCT02395471|448806503|FG001|Overall Study|Subject not eligible|0|||
124775422|NCT01244893|448806504|FG000|Baseline|Protocol Violation|0|||
124775423|NCT01244893|448806505|FG001|Baseline|Protocol Violation|1|||
124775424|NCT01244893|448806504|FG000|1-Week Follow Up|Lost to Follow-up|1|||
124775425|NCT01244893|448806505|FG001|1-Week Follow Up|Lost to Follow-up|0|||
124775426|NCT00357552|448806506|FG000|Screening|Did not meet eligibility criteria|84|||
124775427|NCT00357552|448806506|FG000|Weeks 0 to 24|Death|1|||
124775428|NCT00357552|448806506|FG000|Weeks 24 to 104|Death|3|||
124775429|NCT00357552|448806506|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
124775430|NCT00711191|448806511|FG000|Overall Study|Adverse Event|1|||
124775431|NCT00711191|448806512|FG001|Overall Study|Adverse Event|1|||
124775432|NCT00711191|448806513|FG002|Overall Study|Adverse Event|2|||
124775433|NCT00711191|448806511|FG000|Overall Study|Objective progression or relapse|2|||
124775434|NCT00711191|448806512|FG001|Overall Study|Objective progression or relapse|3|||
124775435|NCT00711191|448806513|FG002|Overall Study|Objective progression or relapse|7|||
124775436|NCT00711191|448806511|FG000|Overall Study|Withdrawal by Subject|0|||
124775437|NCT00711191|448806512|FG001|Overall Study|Withdrawal by Subject|1|||
124775438|NCT00711191|448806513|FG002|Overall Study|Withdrawal by Subject|3|||
124775439|NCT03584789|448806514|FG000|Overall Study|refused EHR permission|19|||
124775440|NCT03584789|448806515|FG001|Overall Study|refused EHR permission|28|||
124775441|NCT03584789|448806516|FG002|Overall Study|refused EHR permission|23|||
124775442|NCT03584789|448806514|FG000|Overall Study|patients tied to a provider who retired|0|||
124775443|NCT03584789|448806515|FG001|Overall Study|patients tied to a provider who retired|0|||
124775444|NCT03584789|448806516|FG002|Overall Study|patients tied to a provider who retired|3|||
124775445|NCT02035267|448806517|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
124500225|NCT04184622|447784008|FG000|Safety Follow-up Period|Physician Decision|1|||
124500226|NCT04184622|447784009|FG001|Safety Follow-up Period|Physician Decision|0|||
124500227|NCT04184622|447784010|FG002|Safety Follow-up Period|Physician Decision|0|||
124724330|NCT01406938|448611707|FG003|Maintenance Period|Pregnancy|0|||
124724331|NCT01406938|448611708|FG004|Maintenance Period|Pregnancy|1|||
124724332|NCT01406938|448611709|FG005|Maintenance Period|Pregnancy|0|||
124724333|NCT01406938|448611704|FG000|Maintenance Period|Lost to Follow-up|0|||
124724334|NCT01406938|448611705|FG001|Maintenance Period|Lost to Follow-up|0|||
124724335|NCT01406938|448611706|FG002|Maintenance Period|Lost to Follow-up|0|||
124724336|NCT01406938|448611707|FG003|Maintenance Period|Lost to Follow-up|0|||
124724337|NCT01406938|448611708|FG004|Maintenance Period|Lost to Follow-up|4|||
124724338|NCT01406938|448611709|FG005|Maintenance Period|Lost to Follow-up|0|||
124724339|NCT01406938|448611704|FG000|Maintenance Period|Lack of Efficacy|0|||
124724340|NCT01406938|448611705|FG001|Maintenance Period|Lack of Efficacy|0|||
124724341|NCT01406938|448611706|FG002|Maintenance Period|Lack of Efficacy|2|||
124724342|NCT01406938|448611707|FG003|Maintenance Period|Lack of Efficacy|1|||
124724343|NCT01406938|448611708|FG004|Maintenance Period|Lack of Efficacy|3|||
124724344|NCT01406938|448611709|FG005|Maintenance Period|Lack of Efficacy|5|||
124724345|NCT01406938|448611704|FG000|Follow up|Lack of Efficacy|3|||
124724346|NCT01406938|448611705|FG001|Follow up|Lack of Efficacy|2|||
124724347|NCT01406938|448611706|FG002|Follow up|Lack of Efficacy|1|||
124724348|NCT01406938|448611707|FG003|Follow up|Lack of Efficacy|0|||
124724349|NCT01406938|448611708|FG004|Follow up|Lack of Efficacy|0|||
124724350|NCT01406938|448611709|FG005|Follow up|Lack of Efficacy|0|||
124724351|NCT01406938|448611704|FG000|Follow up|Patient/guardian decision|4|||
124724352|NCT01406938|448611705|FG001|Follow up|Patient/guardian decision|2|||
124724353|NCT01406938|448611706|FG002|Follow up|Patient/guardian decision|4|||
124724354|NCT01406938|448611707|FG003|Follow up|Patient/guardian decision|2|||
124724355|NCT01406938|448611708|FG004|Follow up|Patient/guardian decision|4|||
124724356|NCT01406938|448611709|FG005|Follow up|Patient/guardian decision|1|||
124724357|NCT01406938|448611704|FG000|Follow up|Protocol Violation|0|||
124724358|NCT01406938|448611705|FG001|Follow up|Protocol Violation|0|||
124724359|NCT01406938|448611706|FG002|Follow up|Protocol Violation|1|||
124724360|NCT01406938|448611707|FG003|Follow up|Protocol Violation|0|||
124724361|NCT01406938|448611708|FG004|Follow up|Protocol Violation|0|||
124724362|NCT01406938|448611709|FG005|Follow up|Protocol Violation|0|||
124724363|NCT01406938|448611704|FG000|Follow up|Physician Decision|0|||
124724364|NCT01406938|448611705|FG001|Follow up|Physician Decision|0|||
124724365|NCT01406938|448611706|FG002|Follow up|Physician Decision|2|||
124724366|NCT01406938|448611707|FG003|Follow up|Physician Decision|0|||
124724367|NCT01406938|448611708|FG004|Follow up|Physician Decision|3|||
124724368|NCT01406938|448611709|FG005|Follow up|Physician Decision|1|||
124724369|NCT01406938|448611704|FG000|Follow up|Lost to Follow-up|1|||
124724370|NCT01406938|448611705|FG001|Follow up|Lost to Follow-up|1|||
124724371|NCT01406938|448611706|FG002|Follow up|Lost to Follow-up|0|||
124724372|NCT01406938|448611707|FG003|Follow up|Lost to Follow-up|1|||
124724373|NCT01406938|448611708|FG004|Follow up|Lost to Follow-up|2|||
124724374|NCT01406938|448611709|FG005|Follow up|Lost to Follow-up|1|||
124724375|NCT01576146|448611710|FG000|Extension Period 1|Adverse Event|2|||
124724376|NCT01576146|448611710|FG000|Extension Period 1|Death|2|||
124724377|NCT01576146|448611710|FG000|Extension Period 1|Physician Decision|2|||
124724378|NCT01576146|448611710|FG000|Extension Period 1|Withdrawal by Subject|1|||
124724379|NCT01576146|448611710|FG000|Extension Period 1|Lost to Follow-up|1|||
124724380|NCT01576146|448611710|FG000|Extension Period 1|Parathyroidectomy|1|||
124724381|NCT01576146|448611710|FG000|Extension Period 1|Renal Transplant|1|||
124724382|NCT01576146|448611710|FG000|Extension Period 2|Sponsor Decision|13|||
124724383|NCT01576146|448611710|FG000|Extension Period 2|Death|1|||
124724384|NCT01576146|448611710|FG000|Extension Period 2|Adverse Event|1|||
124724385|NCT01576146|448611710|FG000|Extension Period 2|Renal Transplant|1|||
124724386|NCT01576146|448611710|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
124724387|NCT00878254|448611712|FG000|Overall Study|Physician Decision|1|||
124724388|NCT00878254|448611712|FG000|Overall Study|Death|1|||
124724389|NCT00878254|448611712|FG000|Overall Study|Withdrawal by Subject|1|||
124724390|NCT04995419|448611713|FG000|Overall Study|Withdrawal by Subject|3|||
124724391|NCT04995419|448611713|FG000|Overall Study|Progressive Disease|19|||
124724392|NCT04995419|448611713|FG000|Overall Study|Adverse Event|2|||
124724393|NCT04995419|448611713|FG000|Overall Study|Ongoing|16|||
124724394|NCT03367403|448611716|FG000|Overall Study|Adverse Event|20|||
124724395|NCT03367403|448611717|FG001|Overall Study|Adverse Event|6|||
124724396|NCT03367403|448611718|FG002|Overall Study|Adverse Event|2|||
124724397|NCT03367403|448611716|FG000|Overall Study|Withdrawal by Subject|12|||
124724398|NCT03367403|448611717|FG001|Overall Study|Withdrawal by Subject|13|||
124724399|NCT03367403|448611718|FG002|Overall Study|Withdrawal by Subject|1|||
124724400|NCT03367403|448611716|FG000|Overall Study|Death|1|||
124724401|NCT03367403|448611717|FG001|Overall Study|Death|2|||
124724402|NCT03367403|448611718|FG002|Overall Study|Death|0|||
124724403|NCT03367403|448611716|FG000|Overall Study|Physician Decision|0|||
124724404|NCT03367403|448611717|FG001|Overall Study|Physician Decision|1|||
124724405|NCT03367403|448611718|FG002|Overall Study|Physician Decision|0|||
124724406|NCT03367403|448611716|FG000|Overall Study|Protocol Violation|1|||
124724407|NCT03367403|448611717|FG001|Overall Study|Protocol Violation|1|||
124559687|NCT01393990|448007177|FG003|Overall Study|Adverse Event|0|||
124559688|NCT01393990|448007178|FG004|Overall Study|Adverse Event|0|||
124559689|NCT01393990|448007179|FG005|Overall Study|Adverse Event|0|||
124559690|NCT01393990|448007180|FG006|Overall Study|Adverse Event|0|||
124559691|NCT01393990|448007181|FG007|Overall Study|Adverse Event|0|||
124559692|NCT01393990|448007182|FG008|Overall Study|Adverse Event|0|||
124559693|NCT01393990|448007183|FG009|Overall Study|Adverse Event|0|||
124559694|NCT01393990|448007184|FG010|Overall Study|Adverse Event|0|||
124559695|NCT01393990|448007185|FG011|Overall Study|Adverse Event|0|||
124559696|NCT01393990|448007186|FG012|Overall Study|Adverse Event|0|||
124559697|NCT01393990|448007187|FG013|Overall Study|Adverse Event|0|||
124559698|NCT01393990|448007188|FG014|Overall Study|Adverse Event|1|||
124559699|NCT01393990|448007189|FG015|Overall Study|Adverse Event|1|||
124559700|NCT01393990|448007190|FG016|Overall Study|Adverse Event|0|||
124559701|NCT01393990|448007191|FG017|Overall Study|Adverse Event|0|||
124559702|NCT01393990|448007174|FG000|Overall Study|Progressive Disease|1|||
124559703|NCT01393990|448007175|FG001|Overall Study|Progressive Disease|0|||
124559704|NCT01393990|448007176|FG002|Overall Study|Progressive Disease|0|||
124559705|NCT01393990|448007177|FG003|Overall Study|Progressive Disease|1|||
124559706|NCT01393990|448007178|FG004|Overall Study|Progressive Disease|1|||
124559707|NCT01393990|448007179|FG005|Overall Study|Progressive Disease|1|||
124500228|NCT04184622|447784011|FG003|Safety Follow-up Period|Physician Decision|1|||
124500229|NCT04184622|447784008|FG000|Safety Follow-up Period|Pregnancy|1|||
124500230|NCT04184622|447784009|FG001|Safety Follow-up Period|Pregnancy|3|||
124500231|NCT04184622|447784010|FG002|Safety Follow-up Period|Pregnancy|0|||
124500232|NCT04184622|447784011|FG003|Safety Follow-up Period|Pregnancy|6|||
124500233|NCT04184622|447784008|FG000|Safety Follow-up Period|Protocol deviation|1|||
124500234|NCT04184622|447784009|FG001|Safety Follow-up Period|Protocol deviation|0|||
124500235|NCT04184622|447784010|FG002|Safety Follow-up Period|Protocol deviation|0|||
124500236|NCT04184622|447784011|FG003|Safety Follow-up Period|Protocol deviation|0|||
124500237|NCT04184622|447784008|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
124500238|NCT04184622|447784009|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
124500239|NCT04184622|447784010|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
124500240|NCT04184622|447784011|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
124500241|NCT00769704|447784013|FG000|Overall Study|Lost to Follow-up|3|||
124500242|NCT00769704|447784014|FG001|Overall Study|Lost to Follow-up|2|||
124500243|NCT00769704|447784013|FG000|Overall Study|Death|95|||
124500244|NCT00769704|447784014|FG001|Overall Study|Death|190|||
124500245|NCT00769704|447784013|FG000|Overall Study|Withdrawal by Subject|12|||
124500246|NCT00769704|447784014|FG001|Overall Study|Withdrawal by Subject|5|||
124500247|NCT00769704|447784013|FG000|Overall Study|Other|1|||
124500248|NCT00769704|447784014|FG001|Overall Study|Other|2|||
124500249|NCT01617681|447784017|FG000|Period 1 Double Blind|Adverse Event|2|||
124500250|NCT01617681|447784018|FG001|Period 1 Double Blind|Adverse Event|0|||
124500251|NCT01617681|447784019|FG002|Period 1 Double Blind|Adverse Event|0|||
124500252|NCT01617681|447784020|FG003|Period 1 Double Blind|Adverse Event|2|||
124500253|NCT01617681|447784021|FG004|Period 1 Double Blind|Adverse Event|0|||
124500254|NCT01617681|447784017|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
124500255|NCT01617681|447784018|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
124500256|NCT01617681|447784019|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
124500257|NCT01617681|447784020|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
124500258|NCT01617681|447784021|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
124500259|NCT01617681|447784017|FG000|Period 2 Open Label|Adverse Event|0|||
124500260|NCT01617681|447784018|FG001|Period 2 Open Label|Adverse Event|0|||
124500261|NCT01617681|447784019|FG002|Period 2 Open Label|Adverse Event|0|||
124500262|NCT01617681|447784020|FG003|Period 2 Open Label|Adverse Event|0|||
124500263|NCT01617681|447784021|FG004|Period 2 Open Label|Adverse Event|3|||
124500264|NCT01617681|447784017|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
124500265|NCT01617681|447784018|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
124500266|NCT01617681|447784019|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
124500267|NCT01617681|447784020|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
124559708|NCT01393990|448007180|FG006|Overall Study|Progressive Disease|1|||
124559709|NCT01393990|448007181|FG007|Overall Study|Progressive Disease|1|||
124559710|NCT01393990|448007182|FG008|Overall Study|Progressive Disease|3|||
124559711|NCT01393990|448007183|FG009|Overall Study|Progressive Disease|1|||
124500268|NCT01617681|447784021|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
124500269|NCT01763905|447784028|FG000|Overall Study|Withdrawal by Subject|1|||
124500270|NCT01763905|447784029|FG001|Overall Study|Withdrawal by Subject|1|||
124500271|NCT01763905|447784030|FG002|Overall Study|Withdrawal by Subject|0|||
124500272|NCT01763905|447784031|FG003|Overall Study|Withdrawal by Subject|1|||
124500273|NCT01763905|447784028|FG000|Overall Study|Decision by sponsor|5|||
124500274|NCT01763905|447784029|FG001|Overall Study|Decision by sponsor|0|||
124500275|NCT01763905|447784030|FG002|Overall Study|Decision by sponsor|8|||
124500276|NCT01763905|447784031|FG003|Overall Study|Decision by sponsor|0|||
124500277|NCT01763905|447784028|FG000|Overall Study|Lost to Follow-up|0|||
124559712|NCT01393990|448007184|FG010|Overall Study|Progressive Disease|0|||
124559713|NCT01393990|448007185|FG011|Overall Study|Progressive Disease|0|||
124559714|NCT01393990|448007186|FG012|Overall Study|Progressive Disease|0|||
124559715|NCT01393990|448007187|FG013|Overall Study|Progressive Disease|1|||
124559716|NCT01393990|448007188|FG014|Overall Study|Progressive Disease|6|||
124500278|NCT01763905|447784029|FG001|Overall Study|Lost to Follow-up|0|||
124500279|NCT01763905|447784030|FG002|Overall Study|Lost to Follow-up|1|||
124500280|NCT01763905|447784031|FG003|Overall Study|Lost to Follow-up|0|||
124500281|NCT03165721|447784032|FG000|Overall Study|Refused further treatment|3|||
124500282|NCT03165721|447784033|FG001|Overall Study|Refused further treatment|0|||
124500283|NCT03165721|447784034|FG002|Overall Study|Refused further treatment|0|||
124500284|NCT03165721|447784032|FG000|Overall Study|Physician Decision|1|||
124500285|NCT03165721|447784033|FG001|Overall Study|Physician Decision|0|||
124500286|NCT03165721|447784034|FG002|Overall Study|Physician Decision|0|||
124500287|NCT01863849|447784036|FG000|Overall Study|Lost to Follow-up|1|||
124500288|NCT01863849|447784037|FG001|Overall Study|Lost to Follow-up|0|||
124500289|NCT01263691|447784039|FG000|Overall Study|Lost to Follow-up|1|||
124500290|NCT01263691|447784040|FG001|Overall Study|Lost to Follow-up|0|||
124500291|NCT01263691|447784041|FG002|Overall Study|Lost to Follow-up|1|||
124500292|NCT01263691|447784042|FG003|Overall Study|Lost to Follow-up|1|||
124500293|NCT01263691|447784043|FG004|Overall Study|Lost to Follow-up|0|||
124500294|NCT01263691|447784044|FG005|Overall Study|Lost to Follow-up|0|||
124500295|NCT01263691|447784039|FG000|Overall Study|Withdrawal by Subject|1|||
124500296|NCT01263691|447784040|FG001|Overall Study|Withdrawal by Subject|0|||
124500297|NCT01263691|447784041|FG002|Overall Study|Withdrawal by Subject|0|||
124500298|NCT01263691|447784042|FG003|Overall Study|Withdrawal by Subject|0|||
124500299|NCT01263691|447784043|FG004|Overall Study|Withdrawal by Subject|0|||
124500300|NCT01263691|447784044|FG005|Overall Study|Withdrawal by Subject|0|||
124500301|NCT01263691|447784039|FG000|Overall Study|Adverse Event|1|||
124500302|NCT01263691|447784040|FG001|Overall Study|Adverse Event|0|||
124500303|NCT01263691|447784041|FG002|Overall Study|Adverse Event|0|||
124500304|NCT01263691|447784042|FG003|Overall Study|Adverse Event|0|||
124500305|NCT01263691|447784043|FG004|Overall Study|Adverse Event|0|||
124500306|NCT01263691|447784044|FG005|Overall Study|Adverse Event|0|||
124500307|NCT01533935|447784047|FG000|Overall Study|Adverse Event|5|||
124500308|NCT01533935|447784048|FG001|Overall Study|Adverse Event|7|||
124500309|NCT01533935|447784049|FG002|Overall Study|Adverse Event|1|||
124500310|NCT01533935|447784050|FG003|Overall Study|Adverse Event|5|||
124500311|NCT01533935|447784051|FG004|Overall Study|Adverse Event|3|||
124500312|NCT01533935|447784047|FG000|Overall Study|Protocol Violation|0|||
124500313|NCT01533935|447784048|FG001|Overall Study|Protocol Violation|2|||
124500314|NCT01533935|447784049|FG002|Overall Study|Protocol Violation|0|||
124500315|NCT01533935|447784050|FG003|Overall Study|Protocol Violation|0|||
124500316|NCT01533935|447784051|FG004|Overall Study|Protocol Violation|0|||
124500317|NCT01533935|447784047|FG000|Overall Study|Lost to Follow-up|0|||
124500318|NCT01533935|447784048|FG001|Overall Study|Lost to Follow-up|0|||
124500319|NCT01533935|447784049|FG002|Overall Study|Lost to Follow-up|1|||
124500320|NCT01533935|447784050|FG003|Overall Study|Lost to Follow-up|0|||
124500321|NCT01533935|447784051|FG004|Overall Study|Lost to Follow-up|0|||
124500322|NCT01533935|447784047|FG000|Overall Study|Withdrawal by Subject|0|||
124500323|NCT01533935|447784048|FG001|Overall Study|Withdrawal by Subject|4|||
124500324|NCT01533935|447784049|FG002|Overall Study|Withdrawal by Subject|5|||
124500325|NCT01533935|447784050|FG003|Overall Study|Withdrawal by Subject|2|||
124500326|NCT01533935|447784051|FG004|Overall Study|Withdrawal by Subject|4|||
124500327|NCT01533935|447784047|FG000|Overall Study|Other reason not defined above|1|||
124500328|NCT01533935|447784048|FG001|Overall Study|Other reason not defined above|0|||
124500329|NCT01533935|447784049|FG002|Overall Study|Other reason not defined above|1|||
124500330|NCT01533935|447784050|FG003|Overall Study|Other reason not defined above|0|||
124500331|NCT01533935|447784051|FG004|Overall Study|Other reason not defined above|1|||
124500332|NCT00316303|447784052|FG000|Overall Study|Lost to Follow-up|11|||
124500333|NCT00316303|447784053|FG001|Overall Study|Lost to Follow-up|16|||
124500334|NCT00532948|447784054|FG000|Overall Study|Protocol Violation|1|||
124500335|NCT00532948|447784055|FG001|Overall Study|Protocol Violation|0|||
124500336|NCT00532948|447784056|FG002|Overall Study|Protocol Violation|0|||
124500337|NCT00532948|447784054|FG000|Overall Study|Death|3|||
124500338|NCT00532948|447784055|FG001|Overall Study|Death|3|||
124500339|NCT00532948|447784056|FG002|Overall Study|Death|4|||
124500340|NCT00532948|447784054|FG000|Overall Study|Violation of selection criteria at entry|0|||
124500341|NCT00532948|447784055|FG001|Overall Study|Violation of selection criteria at entry|1|||
124559717|NCT01393990|448007189|FG015|Overall Study|Progressive Disease|1|||
124775446|NCT02035267|448806518|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
124559718|NCT01393990|448007190|FG016|Overall Study|Progressive Disease|0|||
124500342|NCT00532948|447784056|FG002|Overall Study|Violation of selection criteria at entry|0|||
124500343|NCT00532948|447784054|FG000|Overall Study|Failure to return|0|||
124500344|NCT00532948|447784055|FG001|Overall Study|Failure to return|1|||
124500345|NCT00532948|447784056|FG002|Overall Study|Failure to return|0|||
124500346|NCT01753076|447784057|FG000|Overall Study|Adverse Event|17|||
124500347|NCT01753076|447784058|FG001|Overall Study|Adverse Event|18|||
124500348|NCT01753076|447784057|FG000|Overall Study|Lack of Efficacy|3|||
124775447|NCT02035267|448806519|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
124500349|NCT01753076|447784058|FG001|Overall Study|Lack of Efficacy|1|||
124724408|NCT03367403|448611718|FG002|Overall Study|Protocol Violation|0|||
124724409|NCT03367403|448611716|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
124724410|NCT03367403|448611717|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
124724411|NCT03367403|448611718|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
124724412|NCT03367403|448611716|FG000|Overall Study|COVID-19|3|||
124724413|NCT03367403|448611717|FG001|Overall Study|COVID-19|6|||
124724414|NCT03367403|448611718|FG002|Overall Study|COVID-19|0|||
124724415|NCT03367403|448611716|FG000|Overall Study|Abuse of Alcohol Intake|0|||
124724416|NCT03367403|448611717|FG001|Overall Study|Abuse of Alcohol Intake|1|||
124724417|NCT03367403|448611718|FG002|Overall Study|Abuse of Alcohol Intake|0|||
124724418|NCT03367403|448611716|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
124724419|NCT03367403|448611717|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
124724420|NCT03367403|448611718|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
124724421|NCT00194077|448611719|FG000|Overall Study|Lack of Efficacy|22|||
124724422|NCT00194077|448611720|FG001|Overall Study|Lack of Efficacy|29|||
124724423|NCT00194077|448611719|FG000|Overall Study|Study nonadherence|1|||
124724424|NCT00194077|448611720|FG001|Overall Study|Study nonadherence|0|||
124724425|NCT00194077|448611719|FG000|Overall Study|Withdrawal by Subject|1|||
124724426|NCT00194077|448611720|FG001|Overall Study|Withdrawal by Subject|1|||
124724427|NCT03470194|448611723|FG000|Overall Study|Lost to Follow-up|11|||
124724428|NCT03470194|448611724|FG001|Overall Study|Lost to Follow-up|17|||
124724429|NCT03286543|448611725|FG000|Consented|Screen failure before randomization|2|||
124724430|NCT03286543|448611726|FG001|Consented|Screen failure before randomization|0|||
124724431|NCT03286543|448611727|FG002|Consented|Screen failure before randomization|0|||
124724432|NCT03286543|448611725|FG000|Consented|Screen failure before enrollment|4|||
124724433|NCT03286543|448611726|FG001|Consented|Screen failure before enrollment|0|||
124724434|NCT03286543|448611727|FG002|Consented|Screen failure before enrollment|0|||
124724435|NCT03286543|448611725|FG000|Consented|TKA cancelled after enrollment|1|||
124724436|NCT03286543|448611726|FG001|Consented|TKA cancelled after enrollment|0|||
124724437|NCT03286543|448611727|FG002|Consented|TKA cancelled after enrollment|0|||
124724438|NCT03286543|448611725|FG000|Consented|Withdrawn from study|12|||
124724439|NCT03286543|448611726|FG001|Consented|Withdrawn from study|0|||
124724440|NCT03286543|448611727|FG002|Consented|Withdrawn from study|0|||
124724441|NCT03286543|448611725|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
124724442|NCT03286543|448611726|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
124724443|NCT03286543|448611727|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
124724444|NCT03286543|448611725|FG000|Study Enrollment|Withdrawn from study|0|||
124724445|NCT03286543|448611726|FG001|Study Enrollment|Withdrawn from study|6|||
124724446|NCT03286543|448611727|FG002|Study Enrollment|Withdrawn from study|6|||
124724447|NCT01822899|448611728|FG000|Overall Study|Adverse Event|6|||
124724448|NCT01822899|448611729|FG001|Overall Study|Adverse Event|5|||
124724449|NCT01822899|448611728|FG000|Overall Study|Lack of Efficacy|6|||
124724450|NCT01822899|448611729|FG001|Overall Study|Lack of Efficacy|3|||
124724451|NCT01822899|448611728|FG000|Overall Study|Protocol Violation|6|||
124724452|NCT01822899|448611729|FG001|Overall Study|Protocol Violation|3|||
124724453|NCT01822899|448611728|FG000|Overall Study|Lost to Follow-up|1|||
124724454|NCT01822899|448611729|FG001|Overall Study|Lost to Follow-up|0|||
124724455|NCT01822899|448611728|FG000|Overall Study|Withdrawal by Subject|5|||
124724456|NCT01822899|448611729|FG001|Overall Study|Withdrawal by Subject|7|||
124724457|NCT05332392|448611730|FG000|Overall Study|Did not meet inclusion criteria|25|||
124724458|NCT05332392|448611730|FG000|Overall Study|Principal Investigator's decision|17|||
124724459|NCT05332392|448611730|FG000|Overall Study|Adverse Event|1|||
124724460|NCT05332392|448611730|FG000|Overall Study|Subject's decision|1|||
124724461|NCT00758069|448611732|FG000|Overall Study|Lack of Efficacy|0|||
124724462|NCT00758069|448611733|FG001|Overall Study|Lack of Efficacy|0|||
124724463|NCT00758069|448611734|FG002|Overall Study|Lack of Efficacy|1|||
124724464|NCT00758069|448611732|FG000|Overall Study|Incorrect Study Drug|1|||
124500350|NCT01753076|447784057|FG000|Overall Study|Lost to Follow-up|2|||
124500351|NCT01753076|447784058|FG001|Overall Study|Lost to Follow-up|1|||
124500352|NCT01753076|447784057|FG000|Overall Study|Physician Decision|4|||
124500353|NCT01753076|447784058|FG001|Overall Study|Physician Decision|2|||
124724465|NCT00758069|448611733|FG001|Overall Study|Incorrect Study Drug|0|||
124724466|NCT00758069|448611734|FG002|Overall Study|Incorrect Study Drug|0|||
124724467|NCT00588237|448611735|FG000|Overall Study|Evaluable for toxicity only|3|||
124724468|NCT00588237|448611735|FG000|Overall Study|Patien not treated|1|||
124724469|NCT04908865|448611739|FG000|Overall Study|Adverse Event|2|||
124724470|NCT04908865|448611739|FG000|Overall Study|Lack of Efficacy|5|||
124724471|NCT04908865|448611739|FG000|Overall Study|Lost to Follow-up|1|||
124724472|NCT02141399|448611742|FG000|Overall Study|Adverse Event|158|||
124724473|NCT02141399|448611742|FG000|Overall Study|Lack of Efficacy|62|||
124724474|NCT02141399|448611742|FG000|Overall Study|Lost to Follow-up|151|||
124724475|NCT02141399|448611742|FG000|Overall Study|Non-compliance with study drug|18|||
124724476|NCT02141399|448611742|FG000|Overall Study|Other|45|||
124724477|NCT02141399|448611742|FG000|Overall Study|Physician Decision|17|||
124724478|NCT02141399|448611742|FG000|Overall Study|Pregnancy|3|||
124724479|NCT02141399|448611742|FG000|Overall Study|Protocol Violation|38|||
124724480|NCT02141399|448611742|FG000|Overall Study|Withdrawal by Subject|238|||
124724481|NCT02141399|448611742|FG000|Overall Study|Failure to meet eligibility criteria|14|||
124724482|NCT01296711|448611743|FG000|Overall Study|Adverse Event|3|||
124724483|NCT01296711|448611744|FG001|Overall Study|Adverse Event|1|||
124500354|NCT01753076|447784057|FG000|Overall Study|Withdrawal by Subject|14|||
124500355|NCT01753076|447784058|FG001|Overall Study|Withdrawal by Subject|24|||
124500356|NCT01753076|447784057|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
124500357|NCT01753076|447784058|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
124500358|NCT02575079|447784059|FG000|Overall Study|Death|3|||
124500359|NCT02575079|447784060|FG001|Overall Study|Death|0|||
124500360|NCT02575079|447784059|FG000|Overall Study|Withdrawal by Subject|3|||
124500361|NCT02575079|447784060|FG001|Overall Study|Withdrawal by Subject|0|||
124500362|NCT02918266|447784061|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
124500363|NCT02918266|447784062|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
124500364|NCT02918266|447784063|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
124500365|NCT02918266|447784064|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
124500366|NCT02918266|447784065|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
124500367|NCT02918266|447784066|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
124500368|NCT02918266|447784067|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
124500369|NCT02918266|447784068|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
124500370|NCT02918266|447784069|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
124500371|NCT02918266|447784070|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
124500372|NCT02918266|447784071|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
124500373|NCT01259856|447784078|FG000|Overall Study|Adverse Event|12|||
124500374|NCT01259856|447784079|FG001|Overall Study|Adverse Event|9|||
124500375|NCT01259856|447784078|FG000|Overall Study|Death|0|||
124500376|NCT01259856|447784079|FG001|Overall Study|Death|1|||
124500377|NCT01259856|447784078|FG000|Overall Study|Lack of Efficacy|3|||
124500378|NCT01259856|447784079|FG001|Overall Study|Lack of Efficacy|1|||
124500379|NCT01259856|447784078|FG000|Overall Study|Lost to Follow-up|1|||
124500380|NCT01259856|447784079|FG001|Overall Study|Lost to Follow-up|1|||
124500381|NCT01259856|447784078|FG000|Overall Study|Physician Decision|2|||
124500382|NCT01259856|447784079|FG001|Overall Study|Physician Decision|1|||
124500383|NCT01259856|447784078|FG000|Overall Study|Withdrawal by Subject|9|||
124500384|NCT01259856|447784079|FG001|Overall Study|Withdrawal by Subject|10|||
124500385|NCT01259856|447784078|FG000|Overall Study|Treatment never started|0|||
124500386|NCT01259856|447784079|FG001|Overall Study|Treatment never started|6|||
124500387|NCT01259856|447784078|FG000|Overall Study|Study closure by sponsor|40|||
124500388|NCT01259856|447784079|FG001|Overall Study|Study closure by sponsor|41|||
124500389|NCT01259856|447784078|FG000|Overall Study|Patient developed other disease|0|||
124500390|NCT01259856|447784079|FG001|Overall Study|Patient developed other disease|1|||
124500391|NCT01259856|447784078|FG000|Overall Study|Transfer to another study|0|||
124500392|NCT01259856|447784079|FG001|Overall Study|Transfer to another study|1|||
124500393|NCT01259856|447784078|FG000|Overall Study|Unknown/missing|2|||
124500394|NCT01259856|447784079|FG001|Overall Study|Unknown/missing|2|||
124500395|NCT00578864|447784080|FG000|Overall Study|Death|1|||
124500396|NCT00578864|447784081|FG001|Overall Study|Death|0|||
124500397|NCT01087528|447784082|FG000|Overall Study|Withdrawal by Subject|1|||
124500398|NCT01087528|447784082|FG000|Overall Study|Incomplete CE procedure|6|||
124500399|NCT02702193|447784087|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
124500400|NCT02702193|447784088|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
124500401|NCT02702193|447784087|FG000|4 Month Follow up|Withdrawal by Subject|1|||
124500402|NCT02702193|447784088|FG001|4 Month Follow up|Withdrawal by Subject|0|||
124500403|NCT02702193|447784087|FG000|4 Month Follow up|Lost to Follow-up|17|||
124500404|NCT02702193|447784088|FG001|4 Month Follow up|Lost to Follow-up|18|||
124500405|NCT02702193|447784087|FG000|8 Month Follow up|Withdrawal by Subject|1|||
124500406|NCT02702193|447784088|FG001|8 Month Follow up|Withdrawal by Subject|0|||
124500407|NCT02702193|447784087|FG000|8 Month Follow up|Lost to Follow-up|14|||
124500408|NCT02702193|447784088|FG001|8 Month Follow up|Lost to Follow-up|18|||
124500409|NCT02702193|447784087|FG000|12 Month Follow up|Withdrawal by Subject|1|||
124500410|NCT02702193|447784088|FG001|12 Month Follow up|Withdrawal by Subject|0|||
124500411|NCT02702193|447784087|FG000|12 Month Follow up|Lost to Follow-up|16|||
124500412|NCT02702193|447784088|FG001|12 Month Follow up|Lost to Follow-up|18|||
124500413|NCT01201798|447784091|FG000|Overall Study|Adverse Event|2|||
124500414|NCT01201798|447784092|FG001|Overall Study|Adverse Event|0|||
124500415|NCT01201798|447784091|FG000|Overall Study|Lost to Follow-up|3|||
124500416|NCT01201798|447784092|FG001|Overall Study|Lost to Follow-up|5|||
124500417|NCT01201798|447784091|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
124500418|NCT01201798|447784092|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
124500419|NCT01201798|447784091|FG000|Overall Study|Noncompliance|1|||
124500420|NCT01201798|447784092|FG001|Overall Study|Noncompliance|0|||
124559719|NCT01393990|448007191|FG017|Overall Study|Progressive Disease|0|||
124559720|NCT01393990|448007174|FG000|Overall Study|Death|0|||
124724484|NCT01296711|448611745|FG002|Overall Study|Adverse Event|4|||
124724485|NCT01296711|448611746|FG003|Overall Study|Adverse Event|3|||
124724486|NCT01296711|448611747|FG004|Overall Study|Adverse Event|1|||
124724487|NCT01296711|448611748|FG005|Overall Study|Adverse Event|6|||
124724488|NCT01296711|448611749|FG006|Overall Study|Adverse Event|11|||
124724489|NCT01296711|448611750|FG007|Overall Study|Adverse Event|3|||
124724490|NCT01296711|448611743|FG000|Overall Study|Lack of Efficacy|1|||
124724491|NCT01296711|448611744|FG001|Overall Study|Lack of Efficacy|4|||
124724492|NCT01296711|448611745|FG002|Overall Study|Lack of Efficacy|1|||
124724493|NCT01296711|448611746|FG003|Overall Study|Lack of Efficacy|1|||
124724494|NCT01296711|448611747|FG004|Overall Study|Lack of Efficacy|1|||
124724495|NCT01296711|448611748|FG005|Overall Study|Lack of Efficacy|0|||
124724496|NCT01296711|448611749|FG006|Overall Study|Lack of Efficacy|2|||
124724497|NCT01296711|448611750|FG007|Overall Study|Lack of Efficacy|3|||
124724498|NCT01296711|448611743|FG000|Overall Study|Lost to Follow-up|0|||
124724499|NCT01296711|448611744|FG001|Overall Study|Lost to Follow-up|0|||
124724500|NCT01296711|448611745|FG002|Overall Study|Lost to Follow-up|1|||
124724501|NCT01296711|448611746|FG003|Overall Study|Lost to Follow-up|1|||
124724502|NCT01296711|448611747|FG004|Overall Study|Lost to Follow-up|2|||
124724503|NCT01296711|448611748|FG005|Overall Study|Lost to Follow-up|0|||
124724504|NCT01296711|448611749|FG006|Overall Study|Lost to Follow-up|4|||
124724505|NCT01296711|448611750|FG007|Overall Study|Lost to Follow-up|2|||
124724506|NCT01296711|448611743|FG000|Overall Study|Protocol Violation|0|||
124724507|NCT01296711|448611744|FG001|Overall Study|Protocol Violation|0|||
124724508|NCT01296711|448611745|FG002|Overall Study|Protocol Violation|0|||
124724509|NCT01296711|448611746|FG003|Overall Study|Protocol Violation|1|||
124724510|NCT01296711|448611747|FG004|Overall Study|Protocol Violation|1|||
124724511|NCT01296711|448611748|FG005|Overall Study|Protocol Violation|0|||
124724512|NCT01296711|448611749|FG006|Overall Study|Protocol Violation|0|||
124724513|NCT01296711|448611750|FG007|Overall Study|Protocol Violation|0|||
124500421|NCT01201798|447784091|FG000|Overall Study|Protocol Violation|1|||
124724514|NCT01296711|448611743|FG000|Overall Study|Withdrawal by Subject|4|||
124500422|NCT01201798|447784092|FG001|Overall Study|Protocol Violation|1|||
124500423|NCT01201798|447784091|FG000|Overall Study|Treatment Failure|1|||
124500424|NCT01201798|447784092|FG001|Overall Study|Treatment Failure|8|||
124500425|NCT03609359|447784093|FG000|Overall Study|Progression of primary disease (PD)|25|||
124500426|NCT03609359|447784093|FG000|Overall Study|Patient's refusal|1|||
124500427|NCT03609359|447784093|FG000|Overall Study|Physician Decision|1|||
124500428|NCT03609359|447784093|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
124500429|NCT01035255|447784094|FG000|Overall Study|Death|724|||
124500430|NCT01035255|447784095|FG001|Overall Study|Death|844|||
124500431|NCT01035255|447784094|FG000|Overall Study|Lost to Follow-up|2|||
124500432|NCT01035255|447784095|FG001|Overall Study|Lost to Follow-up|5|||
124500433|NCT01035255|447784094|FG000|Overall Study|patient's request|15|||
124500434|NCT01035255|447784095|FG001|Overall Study|patient's request|13|||
124500435|NCT03007953|447784096|FG000|Overall Study|Withdrawal by Subject|5|||
124500436|NCT03007953|447784097|FG001|Overall Study|Withdrawal by Subject|2|||
124500437|NCT03007953|447784096|FG000|Overall Study|Death|5|||
124500438|NCT03007953|447784097|FG001|Overall Study|Death|7|||
124500439|NCT03007953|447784096|FG000|Overall Study|Lost to Follow-up|3|||
124500440|NCT03007953|447784097|FG001|Overall Study|Lost to Follow-up|2|||
124500441|NCT03007953|447784096|FG000|Overall Study|Enrolled in Hospice|3|||
124500442|NCT03007953|447784097|FG001|Overall Study|Enrolled in Hospice|2|||
124500443|NCT02203838|447784098|FG000|Overall Study|Lack of Efficacy|7|||
124724515|NCT01296711|448611744|FG001|Overall Study|Withdrawal by Subject|2|||
124724516|NCT01296711|448611745|FG002|Overall Study|Withdrawal by Subject|2|||
124724517|NCT01296711|448611746|FG003|Overall Study|Withdrawal by Subject|1|||
124724518|NCT01296711|448611747|FG004|Overall Study|Withdrawal by Subject|1|||
124724519|NCT01296711|448611748|FG005|Overall Study|Withdrawal by Subject|1|||
124724520|NCT01296711|448611749|FG006|Overall Study|Withdrawal by Subject|2|||
124724521|NCT01296711|448611750|FG007|Overall Study|Withdrawal by Subject|1|||
124724522|NCT01296711|448611743|FG000|Overall Study|Study termination|8|||
124724523|NCT01296711|448611744|FG001|Overall Study|Study termination|1|||
124724524|NCT01296711|448611745|FG002|Overall Study|Study termination|5|||
124724525|NCT01296711|448611746|FG003|Overall Study|Study termination|4|||
124724526|NCT01296711|448611747|FG004|Overall Study|Study termination|4|||
124724527|NCT01296711|448611748|FG005|Overall Study|Study termination|4|||
124724528|NCT01296711|448611749|FG006|Overall Study|Study termination|8|||
124724529|NCT01296711|448611750|FG007|Overall Study|Study termination|10|||
124724530|NCT01296711|448611743|FG000|Overall Study|Continued elevated liver enzymes|0|||
124724531|NCT01296711|448611744|FG001|Overall Study|Continued elevated liver enzymes|0|||
124724532|NCT01296711|448611745|FG002|Overall Study|Continued elevated liver enzymes|0|||
124724533|NCT01296711|448611746|FG003|Overall Study|Continued elevated liver enzymes|1|||
124724534|NCT01296711|448611747|FG004|Overall Study|Continued elevated liver enzymes|0|||
124724535|NCT01296711|448611748|FG005|Overall Study|Continued elevated liver enzymes|0|||
124724536|NCT01296711|448611749|FG006|Overall Study|Continued elevated liver enzymes|0|||
124724537|NCT01296711|448611750|FG007|Overall Study|Continued elevated liver enzymes|0|||
124500444|NCT02203838|447784099|FG001|Overall Study|Lack of Efficacy|0|||
124500445|NCT02203838|447784100|FG002|Overall Study|Lack of Efficacy|1|||
124500446|NCT02203838|447784101|FG003|Overall Study|Lack of Efficacy|1|||
124775448|NCT02035267|448806520|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
124775449|NCT02035267|448806517|FG000|Overall Study|Adverse Event|0|||
124775450|NCT02035267|448806518|FG001|Overall Study|Adverse Event|0|||
124775451|NCT02035267|448806519|FG002|Overall Study|Adverse Event|1|||
124775452|NCT02035267|448806520|FG003|Overall Study|Adverse Event|0|||
124775453|NCT02035267|448806517|FG000|Overall Study|Lost to Follow-up|0|||
124775454|NCT02035267|448806518|FG001|Overall Study|Lost to Follow-up|0|||
124775455|NCT02035267|448806519|FG002|Overall Study|Lost to Follow-up|0|||
124775456|NCT02035267|448806520|FG003|Overall Study|Lost to Follow-up|1|||
124775457|NCT02035267|448806517|FG000|Overall Study|Other unspecified|0|||
124775458|NCT02035267|448806518|FG001|Overall Study|Other unspecified|1|||
124775459|NCT02035267|448806519|FG002|Overall Study|Other unspecified|0|||
124775460|NCT02035267|448806520|FG003|Overall Study|Other unspecified|0|||
124775461|NCT02803580|448806522|FG000|Overall Study|Death|13|||
124775462|NCT02803580|448806522|FG000|Overall Study|Lost to Follow-up|19|||
124775463|NCT02803580|448806522|FG000|Overall Study|Withdrawal by Subject|3|||
124775464|NCT02803580|448806522|FG000|Overall Study|Inclusion in clinical trial|1|||
124775465|NCT00836693|448806528|FG000|Overall Study|Adverse Event|4|||
124775466|NCT00836693|448806529|FG001|Overall Study|Adverse Event|1|||
124775467|NCT00836693|448806528|FG000|Overall Study|Sponsor Decision|0|||
124775468|NCT00836693|448806529|FG001|Overall Study|Sponsor Decision|1|||
124775469|NCT00836693|448806528|FG000|Overall Study|Physician Decision|2|||
124775470|NCT00836693|448806529|FG001|Overall Study|Physician Decision|0|||
124775471|NCT00836693|448806528|FG000|Overall Study|Withdrawal by Subject|9|||
124775472|NCT00836693|448806529|FG001|Overall Study|Withdrawal by Subject|4|||
124775473|NCT00836693|448806528|FG000|Overall Study|Protocol Violation|1|||
124775474|NCT00836693|448806529|FG001|Overall Study|Protocol Violation|0|||
124775475|NCT00836693|448806528|FG000|Overall Study|Lost to Follow-up|1|||
124775476|NCT00836693|448806529|FG001|Overall Study|Lost to Follow-up|0|||
124775477|NCT02612779|448806530|FG000|Overall Study|Administrative reason by sponsor|4|||
124775478|NCT02612779|448806531|FG001|Overall Study|Administrative reason by sponsor|1|||
124775479|NCT02612779|448806530|FG000|Overall Study|No longer meet study criteria|0|||
124775480|NCT02612779|448806531|FG001|Overall Study|No longer meet study criteria|1|||
124775481|NCT02612779|448806530|FG000|Overall Study|Disease progression|29|||
124775482|NCT02612779|448806531|FG001|Overall Study|Disease progression|2|||
124775483|NCT02612779|448806530|FG000|Overall Study|Study drug toxicity|10|||
124775484|NCT02612779|448806531|FG001|Overall Study|Study drug toxicity|1|||
124775485|NCT02612779|448806530|FG000|Overall Study|Death|1|||
124775486|NCT02612779|448806531|FG001|Overall Study|Death|0|||
124775487|NCT02612779|448806530|FG000|Overall Study|Adverse event unrelated to study drug|5|||
124775488|NCT02612779|448806531|FG001|Overall Study|Adverse event unrelated to study drug|0|||
124775489|NCT02612779|448806530|FG000|Overall Study|Participant withdrew consent|4|||
124775490|NCT02612779|448806531|FG001|Overall Study|Participant withdrew consent|0|||
124775491|NCT02612779|448806530|FG000|Overall Study|Lost to Follow-up|1|||
124775492|NCT02612779|448806531|FG001|Overall Study|Lost to Follow-up|0|||
124775493|NCT02612779|448806530|FG000|Overall Study|Maximum clinical benefit|10|||
124775494|NCT02612779|448806531|FG001|Overall Study|Maximum clinical benefit|1|||
124775495|NCT02612779|448806530|FG000|Overall Study|Other reasons|4|||
124775496|NCT02612779|448806531|FG001|Overall Study|Other reasons|0|||
124775497|NCT02118961|448806532|FG000|Overall Study|Withdrawal by Subject|1|||
124775498|NCT02118961|448806533|FG001|Overall Study|Withdrawal by Subject|0|||
124775499|NCT01750229|448806534|FG000|Randomized Crossover Phase|Adverse Event|1|||
124775500|NCT01750229|448806534|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
124775501|NCT01750229|448806534|FG000|Long-term Follow-up Phase|Adverse Event|2|||
124775502|NCT01750229|448806534|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
124559721|NCT01393990|448007175|FG001|Overall Study|Death|0|||
124559722|NCT01393990|448007176|FG002|Overall Study|Death|0|||
124559723|NCT01393990|448007177|FG003|Overall Study|Death|0|||
124559724|NCT01393990|448007178|FG004|Overall Study|Death|1|||
124559725|NCT01393990|448007179|FG005|Overall Study|Death|0|||
124559726|NCT01393990|448007180|FG006|Overall Study|Death|0|||
124559727|NCT01393990|448007181|FG007|Overall Study|Death|0|||
124559728|NCT01393990|448007182|FG008|Overall Study|Death|0|||
124559729|NCT01393990|448007183|FG009|Overall Study|Death|0|||
124559730|NCT01393990|448007184|FG010|Overall Study|Death|0|||
124559731|NCT01393990|448007185|FG011|Overall Study|Death|0|||
124559732|NCT01393990|448007186|FG012|Overall Study|Death|0|||
124775503|NCT03722238|448806535|FG000|Overall Study|Protocol Violation|1|||
124775504|NCT03722238|448806536|FG001|Overall Study|Protocol Violation|0|||
124775505|NCT03722238|448806535|FG000|Overall Study|Physician Decision|1|||
124775506|NCT03722238|448806536|FG001|Overall Study|Physician Decision|0|||
124775507|NCT03722238|448806535|FG000|Overall Study|Death|1|||
124775508|NCT03722238|448806536|FG001|Overall Study|Death|0|||
124775509|NCT03722238|448806535|FG000|Overall Study|Lost to Follow-up|6|||
124775510|NCT03722238|448806536|FG001|Overall Study|Lost to Follow-up|0|||
124775511|NCT03722238|448806535|FG000|Overall Study|Partial missing data|44|||
124775512|NCT03722238|448806536|FG001|Overall Study|Partial missing data|1|||
124775513|NCT03722238|448806535|FG000|Overall Study|Withdrawal by Subject|2|||
124775514|NCT03722238|448806536|FG001|Overall Study|Withdrawal by Subject|0|||
124775515|NCT03722238|448806535|FG000|Overall Study|Other|4|||
124559733|NCT01393990|448007187|FG013|Overall Study|Death|1|||
124559734|NCT01393990|448007188|FG014|Overall Study|Death|1|||
124559735|NCT01393990|448007189|FG015|Overall Study|Death|0|||
124559736|NCT01393990|448007190|FG016|Overall Study|Death|0|||
124559737|NCT01393990|448007191|FG017|Overall Study|Death|0|||
124559738|NCT01393990|448007174|FG000|Overall Study|Withdrawal by Subject|0|||
124559739|NCT01393990|448007175|FG001|Overall Study|Withdrawal by Subject|0|||
124559740|NCT01393990|448007176|FG002|Overall Study|Withdrawal by Subject|0|||
124559741|NCT01393990|448007177|FG003|Overall Study|Withdrawal by Subject|0|||
124559742|NCT01393990|448007178|FG004|Overall Study|Withdrawal by Subject|0|||
124559743|NCT01393990|448007179|FG005|Overall Study|Withdrawal by Subject|0|||
124559744|NCT01393990|448007180|FG006|Overall Study|Withdrawal by Subject|0|||
124559745|NCT01393990|448007181|FG007|Overall Study|Withdrawal by Subject|0|||
124559746|NCT01393990|448007182|FG008|Overall Study|Withdrawal by Subject|0|||
124559747|NCT01393990|448007183|FG009|Overall Study|Withdrawal by Subject|0|||
124559748|NCT01393990|448007184|FG010|Overall Study|Withdrawal by Subject|0|||
124559749|NCT01393990|448007185|FG011|Overall Study|Withdrawal by Subject|0|||
124559750|NCT01393990|448007186|FG012|Overall Study|Withdrawal by Subject|0|||
124559751|NCT01393990|448007187|FG013|Overall Study|Withdrawal by Subject|0|||
124559752|NCT01393990|448007188|FG014|Overall Study|Withdrawal by Subject|1|||
124559753|NCT01393990|448007189|FG015|Overall Study|Withdrawal by Subject|1|||
124559754|NCT01393990|448007190|FG016|Overall Study|Withdrawal by Subject|0|||
124559755|NCT01393990|448007191|FG017|Overall Study|Withdrawal by Subject|0|||
124559756|NCT00275028|448007192|FG000|Overall Study|Withdrew consent before treatment began|1|||
124559757|NCT00275028|448007192|FG000|Overall Study|Withdrawal by Subject|5|||
124559758|NCT00275028|448007192|FG000|Overall Study|Adverse Event|9|||
124559759|NCT00275028|448007192|FG000|Overall Study|Progressive Disease|30|||
124559760|NCT00275028|448007192|FG000|Overall Study|Physician Decision|2|||
124559761|NCT00720798|448007194|FG000|Overall Study|Adverse Event|304|||
124559762|NCT00720798|448007194|FG000|Overall Study|Death|39|||
124559763|NCT00720798|448007194|FG000|Overall Study|Insufficient Therapeutic Response|129|||
124559764|NCT00720798|448007194|FG000|Overall Study|Protocol Violation|4|||
124559765|NCT00720798|448007194|FG000|Overall Study|Refused Treatment|151|||
124559766|NCT00720798|448007194|FG000|Overall Study|Failure to Return|46|||
124559767|NCT00720798|448007194|FG000|Overall Study|Reason not Specified|83|||
124559768|NCT00433381|448007195|FG000|Overall Study|Ineligible / no protocol treatment|3|||
124559769|NCT00433381|448007196|FG001|Overall Study|Ineligible / no protocol treatment|3|||
124559770|NCT00549198|448007201|FG000|Overall Study|Adverse Event|28|||
124559771|NCT00549198|448007202|FG001|Overall Study|Adverse Event|26|||
124559772|NCT00549198|448007201|FG000|Overall Study|Insufficient Viral Load Response|4|||
124559773|NCT00549198|448007202|FG001|Overall Study|Insufficient Viral Load Response|2|||
124559774|NCT00549198|448007201|FG000|Overall Study|Protocol-defined Virological Failure|7|||
124559775|NCT00549198|448007202|FG001|Overall Study|Protocol-defined Virological Failure|0|||
124559776|NCT00549198|448007201|FG000|Overall Study|Non-compliance|2|||
124559777|NCT00549198|448007202|FG001|Overall Study|Non-compliance|4|||
124559778|NCT00549198|448007201|FG000|Overall Study|Lost to Follow-up|7|||
124559779|NCT00549198|448007202|FG001|Overall Study|Lost to Follow-up|8|||
124559780|NCT00549198|448007201|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
124559781|NCT00549198|448007202|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
124559782|NCT00549198|448007201|FG000|Overall Study|Protocol Violation|7|||
124559783|NCT00549198|448007202|FG001|Overall Study|Protocol Violation|2|||
124559784|NCT00549198|448007201|FG000|Overall Study|Investigator Decision|4|||
124559785|NCT00549198|448007202|FG001|Overall Study|Investigator Decision|3|||
124559786|NCT00549198|448007201|FG000|Overall Study|Withdrawal by Subject|7|||
124559787|NCT00549198|448007202|FG001|Overall Study|Withdrawal by Subject|7|||
124559788|NCT00549198|448007201|FG000|Overall Study|Disease Progression|1|||
124559789|NCT00549198|448007202|FG001|Overall Study|Disease Progression|0|||
124559790|NCT00549198|448007201|FG000|Overall Study|Participant Moved|2|||
124559791|NCT00549198|448007202|FG001|Overall Study|Participant Moved|0|||
124559792|NCT00549198|448007201|FG000|Overall Study|Participant not able to perform Week 96|1|||
124559793|NCT00549198|448007202|FG001|Overall Study|Participant not able to perform Week 96|0|||
124559794|NCT00549198|448007201|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
124559795|NCT00549198|448007202|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
124559796|NCT00549198|448007201|FG000|Overall Study|Prohibited Medication|1|||
124559797|NCT00549198|448007202|FG001|Overall Study|Prohibited Medication|2|||
124559798|NCT00549198|448007201|FG000|Overall Study|Participant planning pregnancy|1|||
124559799|NCT00549198|448007202|FG001|Overall Study|Participant planning pregnancy|0|||
124559800|NCT00549198|448007201|FG000|Overall Study|Participant overweight, no scan possible|1|||
124559801|NCT00549198|448007202|FG001|Overall Study|Participant overweight, no scan possible|0|||
124559802|NCT00549198|448007201|FG000|Overall Study|No scan facilities|0|||
124559803|NCT00549198|448007202|FG001|Overall Study|No scan facilities|2|||
124724538|NCT01296711|448611743|FG000|Overall Study|Methotrexate discontinued|0|||
124559804|NCT00549198|448007201|FG000|Overall Study|Pregnancy|0|||
124559805|NCT00549198|448007202|FG001|Overall Study|Pregnancy|3|||
124559806|NCT00549198|448007201|FG000|Overall Study|Not Exposed to Study Drug|3|||
124724539|NCT01296711|448611744|FG001|Overall Study|Methotrexate discontinued|0|||
124559807|NCT00549198|448007202|FG001|Overall Study|Not Exposed to Study Drug|4|||
124559808|NCT00472446|448007203|FG000|Overall Study|Protocol Violation|0|||
124559809|NCT00472446|448007204|FG001|Overall Study|Protocol Violation|0|||
124559810|NCT00472446|448007205|FG002|Overall Study|Protocol Violation|0|||
124559811|NCT00472446|448007206|FG003|Overall Study|Protocol Violation|1|||
124559812|NCT00472446|448007203|FG000|Overall Study|Reintervention|0|||
124559813|NCT00472446|448007204|FG001|Overall Study|Reintervention|0|||
124559814|NCT00472446|448007205|FG002|Overall Study|Reintervention|1|||
124559815|NCT00472446|448007206|FG003|Overall Study|Reintervention|1|||
124559816|NCT00472446|448007203|FG000|Overall Study|Questionnaires not returned|5|||
124559817|NCT00472446|448007204|FG001|Overall Study|Questionnaires not returned|6|||
124559818|NCT00472446|448007205|FG002|Overall Study|Questionnaires not returned|6|||
124559819|NCT00472446|448007206|FG003|Overall Study|Questionnaires not returned|4|||
124559820|NCT01165684|448007207|FG000|Overall Study|Adverse Event|1|||
124559821|NCT01165684|448007208|FG001|Overall Study|Adverse Event|1|||
124559822|NCT01165684|448007207|FG000|Overall Study|Lack of Efficacy|2|||
124559823|NCT01165684|448007208|FG001|Overall Study|Lack of Efficacy|1|||
124559824|NCT01165684|448007207|FG000|Overall Study|Protocol Violation|7|||
124559825|NCT01165684|448007208|FG001|Overall Study|Protocol Violation|15|||
124559826|NCT01165684|448007207|FG000|Overall Study|Withdrawal Criteria|2|||
124559827|NCT01165684|448007208|FG001|Overall Study|Withdrawal Criteria|13|||
124559828|NCT01165684|448007207|FG000|Overall Study|Unclassified|16|||
124559829|NCT01165684|448007208|FG001|Overall Study|Unclassified|22|||
124559830|NCT00671879|448007211|FG000|Overall Study|Withdrawal by Subject|0|||
124559831|NCT00671879|448007212|FG001|Overall Study|Withdrawal by Subject|4|||
124559832|NCT00671879|448007213|FG002|Overall Study|Withdrawal by Subject|6|||
124559833|NCT04633837|448007214|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
124559834|NCT04633837|448007215|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
124559835|NCT00901628|448007216|FG000|Overall Study|disconnection of catheter|4|||
124559836|NCT00901628|448007217|FG001|Overall Study|disconnection of catheter|8|||
124559837|NCT00901628|448007216|FG000|Overall Study|disconnection of drain|0|||
124559838|NCT00901628|448007217|FG001|Overall Study|disconnection of drain|1|||
124559839|NCT00901628|448007216|FG000|Overall Study|peroneal nerve palsy|0|||
124559840|NCT00901628|448007217|FG001|Overall Study|peroneal nerve palsy|1|||
124559841|NCT00608205|448007220|FG000|Overall Study|Adverse Event|3|||
124559842|NCT00608205|448007221|FG001|Overall Study|Adverse Event|2|||
124559843|NCT00608205|448007220|FG000|Overall Study|Patient non-compliant|0|||
124559844|NCT00608205|448007221|FG001|Overall Study|Patient non-compliant|1|||
124559845|NCT01797120|448007222|FG000|Overall Study|Disesae progression|37|||
124559846|NCT01797120|448007223|FG001|Overall Study|Disesae progression|49|||
124559847|NCT01797120|448007222|FG000|Overall Study|Adverse Event|13|||
124559848|NCT01797120|448007223|FG001|Overall Study|Adverse Event|5|||
124559849|NCT01797120|448007222|FG000|Overall Study|Withdrawal by Subject|6|||
124559850|NCT01797120|448007223|FG001|Overall Study|Withdrawal by Subject|6|||
124559851|NCT01797120|448007222|FG000|Overall Study|Symptomatic progression|2|||
124559852|NCT01797120|448007223|FG001|Overall Study|Symptomatic progression|1|||
124559853|NCT01797120|448007222|FG000|Overall Study|Non-compliance|1|||
124559854|NCT01797120|448007223|FG001|Overall Study|Non-compliance|0|||
124559855|NCT01797120|448007222|FG000|Overall Study|Physician Decision|3|||
124559856|NCT01797120|448007223|FG001|Overall Study|Physician Decision|0|||
124559857|NCT01797120|448007222|FG000|Overall Study|still on treatment|2|||
124559858|NCT01797120|448007223|FG001|Overall Study|still on treatment|4|||
124559859|NCT01797120|448007222|FG000|Overall Study|never start protocol therapy|2|||
124559860|NCT01797120|448007223|FG001|Overall Study|never start protocol therapy|0|||
124559861|NCT01909466|448007229|FG000|Overall Study|Lost to Follow-up|5|||
124559862|NCT01909466|448007230|FG001|Overall Study|Lost to Follow-up|7|||
124559863|NCT01909466|448007229|FG000|Overall Study|Adverse Event|3|||
124559864|NCT01909466|448007230|FG001|Overall Study|Adverse Event|4|||
124559865|NCT01909466|448007229|FG000|Overall Study|Met Withdrawal Criteria|0|||
124559866|NCT01909466|448007230|FG001|Overall Study|Met Withdrawal Criteria|3|||
124559867|NCT01909466|448007229|FG000|Overall Study|Physician Decision|2|||
124559868|NCT01909466|448007230|FG001|Overall Study|Physician Decision|0|||
124559869|NCT01909466|448007229|FG000|Overall Study|Withdrawal by Subject|11|||
124559870|NCT01909466|448007230|FG001|Overall Study|Withdrawal by Subject|9|||
124559871|NCT01909466|448007229|FG000|Overall Study|Lack of Efficacy|1|||
124559872|NCT01909466|448007230|FG001|Overall Study|Lack of Efficacy|0|||
124559873|NCT01339910|448007231|FG000|Overall Study|Withdrawal by Subject|1|||
124559874|NCT01339910|448007232|FG001|Overall Study|Withdrawal by Subject|0|||
124559875|NCT01339910|448007231|FG000|Overall Study|Physician Decision|1|||
124559876|NCT01339910|448007232|FG001|Overall Study|Physician Decision|0|||
124559877|NCT01339910|448007231|FG000|Overall Study|Disease relapse|1|||
124559878|NCT01339910|448007232|FG001|Overall Study|Disease relapse|4|||
124559879|NCT01567306|448007234|FG000|Overall Study|Protocol Violation|2|||
124559880|NCT01567306|448007235|FG001|Overall Study|Protocol Violation|2|||
124559881|NCT01567306|448007236|FG002|Overall Study|Protocol Violation|0|||
124559882|NCT01567306|448007237|FG003|Overall Study|Protocol Violation|3|||
124559883|NCT01567306|448007238|FG004|Overall Study|Protocol Violation|1|||
124559884|NCT01567306|448007239|FG005|Overall Study|Protocol Violation|1|||
124559885|NCT01567306|448007234|FG000|Overall Study|Change site living|1|||
124559886|NCT01567306|448007235|FG001|Overall Study|Change site living|0|||
124559887|NCT01567306|448007236|FG002|Overall Study|Change site living|0|||
124559888|NCT01567306|448007237|FG003|Overall Study|Change site living|0|||
124559889|NCT01567306|448007238|FG004|Overall Study|Change site living|0|||
124559890|NCT01567306|448007239|FG005|Overall Study|Change site living|0|||
124559891|NCT01567306|448007234|FG000|Overall Study|Adverse Event|0|||
124559892|NCT01567306|448007235|FG001|Overall Study|Adverse Event|0|||
124559893|NCT01567306|448007236|FG002|Overall Study|Adverse Event|0|||
124559894|NCT01567306|448007237|FG003|Overall Study|Adverse Event|2|||
124559895|NCT01567306|448007238|FG004|Overall Study|Adverse Event|4|||
124559896|NCT01567306|448007239|FG005|Overall Study|Adverse Event|1|||
124559897|NCT01567306|448007234|FG000|Overall Study|Lost to Follow-up|0|||
124559898|NCT01567306|448007235|FG001|Overall Study|Lost to Follow-up|0|||
124559899|NCT01567306|448007236|FG002|Overall Study|Lost to Follow-up|0|||
124559900|NCT01567306|448007237|FG003|Overall Study|Lost to Follow-up|0|||
124559901|NCT01567306|448007238|FG004|Overall Study|Lost to Follow-up|2|||
124559902|NCT01567306|448007239|FG005|Overall Study|Lost to Follow-up|0|||
124559903|NCT01567306|448007234|FG000|Overall Study|Withdrawal by Subject|0|||
124559904|NCT01567306|448007235|FG001|Overall Study|Withdrawal by Subject|0|||
124559905|NCT01567306|448007236|FG002|Overall Study|Withdrawal by Subject|0|||
124559906|NCT01567306|448007237|FG003|Overall Study|Withdrawal by Subject|0|||
124559907|NCT01567306|448007238|FG004|Overall Study|Withdrawal by Subject|0|||
124559908|NCT01567306|448007239|FG005|Overall Study|Withdrawal by Subject|1|||
124559909|NCT00738673|448007240|FG000|Overall Study|Adverse Event|1|||
124559910|NCT00738673|448007241|FG001|Overall Study|Adverse Event|0|||
124559911|NCT00738673|448007240|FG000|Overall Study|Lack of Efficacy|19|||
124559912|NCT00738673|448007241|FG001|Overall Study|Lack of Efficacy|8|||
124559913|NCT00738673|448007240|FG000|Overall Study|Protocol Violation|1|||
124559914|NCT00738673|448007241|FG001|Overall Study|Protocol Violation|2|||
124559915|NCT00738673|448007240|FG000|Overall Study|Withdrawal by Subject|3|||
124559916|NCT00738673|448007241|FG001|Overall Study|Withdrawal by Subject|1|||
124559917|NCT03038113|448007242|FG000|Overall Study|Withdrawal by Subject|0|||
124559918|NCT03038113|448007243|FG001|Overall Study|Withdrawal by Subject|0|||
124559919|NCT03038113|448007244|FG002|Overall Study|Withdrawal by Subject|1|||
124559920|NCT03038113|448007245|FG003|Overall Study|Withdrawal by Subject|0|||
124559921|NCT03038113|448007246|FG004|Overall Study|Withdrawal by Subject|0|||
124559922|NCT03038113|448007247|FG005|Overall Study|Withdrawal by Subject|0|||
124559923|NCT03038113|448007248|FG006|Overall Study|Withdrawal by Subject|0|||
124559924|NCT03038113|448007249|FG007|Overall Study|Withdrawal by Subject|0|||
124559925|NCT03038113|448007250|FG008|Overall Study|Withdrawal by Subject|0|||
124559926|NCT03038113|448007251|FG009|Overall Study|Withdrawal by Subject|0|||
124559927|NCT03038113|448007252|FG010|Overall Study|Withdrawal by Subject|0|||
124559928|NCT03038113|448007253|FG011|Overall Study|Withdrawal by Subject|0|||
124559929|NCT03038113|448007254|FG012|Overall Study|Withdrawal by Subject|0|||
124559930|NCT03038113|448007255|FG013|Overall Study|Withdrawal by Subject|1|||
124559931|NCT03038113|448007242|FG000|Overall Study|Lost to Follow-up|0|||
124559932|NCT03038113|448007243|FG001|Overall Study|Lost to Follow-up|0|||
124559933|NCT03038113|448007244|FG002|Overall Study|Lost to Follow-up|0|||
124559934|NCT03038113|448007245|FG003|Overall Study|Lost to Follow-up|0|||
124559935|NCT03038113|448007246|FG004|Overall Study|Lost to Follow-up|0|||
124559936|NCT03038113|448007247|FG005|Overall Study|Lost to Follow-up|0|||
124559937|NCT03038113|448007248|FG006|Overall Study|Lost to Follow-up|1|||
124559938|NCT03038113|448007249|FG007|Overall Study|Lost to Follow-up|0|||
124559939|NCT03038113|448007250|FG008|Overall Study|Lost to Follow-up|0|||
124559940|NCT03038113|448007251|FG009|Overall Study|Lost to Follow-up|0|||
124559941|NCT03038113|448007252|FG010|Overall Study|Lost to Follow-up|0|||
124559942|NCT03038113|448007253|FG011|Overall Study|Lost to Follow-up|0|||
124559943|NCT03038113|448007254|FG012|Overall Study|Lost to Follow-up|0|||
124559944|NCT03038113|448007255|FG013|Overall Study|Lost to Follow-up|0|||
124559945|NCT01418352|448007258|FG000|Overall Study|Lost to Follow-up|2|||
124559946|NCT01418352|448007259|FG001|Overall Study|Lost to Follow-up|0|||
124559947|NCT01418352|448007260|FG002|Overall Study|Lost to Follow-up|0|||
124559948|NCT01418352|448007261|FG003|Overall Study|Lost to Follow-up|0|||
124559949|NCT01418352|448007258|FG000|Overall Study|Adverse Event|0|||
124559950|NCT01418352|448007259|FG001|Overall Study|Adverse Event|1|||
124559951|NCT01418352|448007260|FG002|Overall Study|Adverse Event|0|||
124724540|NCT01296711|448611745|FG002|Overall Study|Methotrexate discontinued|0|||
124724541|NCT01296711|448611746|FG003|Overall Study|Methotrexate discontinued|1|||
124559952|NCT01418352|448007261|FG003|Overall Study|Adverse Event|0|||
124559953|NCT01418352|448007258|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
124559954|NCT01418352|448007259|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
124559955|NCT01418352|448007260|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
124559956|NCT01418352|448007261|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
124559957|NCT01418352|448007258|FG000|Overall Study|Subject Withdrew Consent|0|||
124559958|NCT01418352|448007259|FG001|Overall Study|Subject Withdrew Consent|1|||
124559959|NCT01418352|448007260|FG002|Overall Study|Subject Withdrew Consent|2|||
124559960|NCT01418352|448007261|FG003|Overall Study|Subject Withdrew Consent|1|||
124559961|NCT01418352|448007258|FG000|Overall Study|Protocol Deviation|0|||
124559962|NCT01418352|448007259|FG001|Overall Study|Protocol Deviation|0|||
124559963|NCT01418352|448007260|FG002|Overall Study|Protocol Deviation|1|||
124559964|NCT01418352|448007261|FG003|Overall Study|Protocol Deviation|0|||
124559965|NCT01418352|448007258|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
124559966|NCT01418352|448007259|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
124559967|NCT01418352|448007260|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
124559968|NCT01418352|448007261|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
124559969|NCT01092702|448007262|FG000|Overall Study|Withdrawal by Subject|7|||
124559970|NCT01092702|448007262|FG000|Overall Study|Lost to Follow-up|2|||
124559971|NCT03263819|448007263|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
124559972|NCT03263819|448007264|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
124559973|NCT03652961|448007267|FG000|Overall Study|Lost to Follow-up|3|||
124559974|NCT03652961|448007267|FG000|Overall Study|Screen Failure|1|||
124559975|NCT01783496|448007268|FG000|Overall Study|Lost to Follow-up|0|||
124559976|NCT01783496|448007269|FG001|Overall Study|Lost to Follow-up|0|||
124559977|NCT01783496|448007270|FG002|Overall Study|Lost to Follow-up|0|||
124559978|NCT01783496|448007271|FG003|Overall Study|Lost to Follow-up|2|||
124559979|NCT01783496|448007272|FG004|Overall Study|Lost to Follow-up|0|||
124559980|NCT01783496|448007273|FG005|Overall Study|Lost to Follow-up|1|||
124559981|NCT01783496|448007268|FG000|Overall Study|Withdrawal by Subject|1|||
124559982|NCT01783496|448007269|FG001|Overall Study|Withdrawal by Subject|0|||
124559983|NCT01783496|448007270|FG002|Overall Study|Withdrawal by Subject|0|||
124559984|NCT01783496|448007271|FG003|Overall Study|Withdrawal by Subject|0|||
124559985|NCT01783496|448007272|FG004|Overall Study|Withdrawal by Subject|0|||
124559986|NCT01783496|448007273|FG005|Overall Study|Withdrawal by Subject|0|||
124559987|NCT01620983|448007279|FG000|Overall Study|Lost to Follow-up|8|||
124559988|NCT01620983|448007280|FG001|Overall Study|Lost to Follow-up|4|||
124559989|NCT01620983|448007281|FG002|Overall Study|Lost to Follow-up|9|||
124559990|NCT01620983|448007279|FG000|Overall Study|Withdrawal by Subject|6|||
124559991|NCT01620983|448007280|FG001|Overall Study|Withdrawal by Subject|8|||
124559992|NCT01620983|448007281|FG002|Overall Study|Withdrawal by Subject|1|||
124559993|NCT01620983|448007279|FG000|Overall Study|Death|2|||
124559994|NCT01620983|448007280|FG001|Overall Study|Death|0|||
124559995|NCT01620983|448007281|FG002|Overall Study|Death|0|||
124559996|NCT01620983|448007279|FG000|Overall Study|Physician Decision|3|||
124559997|NCT01620983|448007280|FG001|Overall Study|Physician Decision|10|||
124559998|NCT01620983|448007281|FG002|Overall Study|Physician Decision|5|||
124559999|NCT00545233|448007283|FG000|Overall Study|Adverse Event|10|||
124560000|NCT00545233|448007284|FG001|Overall Study|Adverse Event|5|||
124560001|NCT00545233|448007283|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
124560002|NCT00545233|448007284|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
124560003|NCT00545233|448007283|FG000|Overall Study|Protocol Violation|2|||
124560004|NCT00545233|448007284|FG001|Overall Study|Protocol Violation|0|||
124560005|NCT00545233|448007283|FG000|Overall Study|Refused Treatment|9|||
124560006|NCT00545233|448007284|FG001|Overall Study|Refused Treatment|7|||
124560007|NCT00545233|448007283|FG000|Overall Study|Failure to Return|4|||
124560008|NCT00545233|448007284|FG001|Overall Study|Failure to Return|6|||
124560009|NCT00545233|448007283|FG000|Overall Study|Insufficient response|14|||
124560010|NCT00545233|448007284|FG001|Overall Study|Insufficient response|15|||
124560011|NCT00545233|448007283|FG000|Overall Study|Physician Decision|2|||
124560012|NCT00545233|448007284|FG001|Overall Study|Physician Decision|1|||
124560013|NCT00446654|448007285|FG000|Overall Study|Withdrawal by Subject|1|||
124560014|NCT00446654|448007286|FG001|Overall Study|Withdrawal by Subject|0|||
124560015|NCT00446654|448007285|FG000|Overall Study|Adverse Event|1|||
124560016|NCT00446654|448007286|FG001|Overall Study|Adverse Event|0|||
124560017|NCT01504867|448007290|FG000|Overall Study|Inclusion criteria not met|2|||
124560018|NCT01504867|448007291|FG001|Overall Study|Inclusion criteria not met|2|||
124560019|NCT01504867|448007290|FG000|Overall Study|Consent revoked|5|||
124560020|NCT01504867|448007291|FG001|Overall Study|Consent revoked|1|||
124560021|NCT01783730|448007292|FG000|Overall Study|Failed to meet inclusion criteria|6|||
124724542|NCT01296711|448611747|FG004|Overall Study|Methotrexate discontinued|0|||
124724543|NCT01296711|448611748|FG005|Overall Study|Methotrexate discontinued|0|||
124724544|NCT01296711|448611749|FG006|Overall Study|Methotrexate discontinued|0|||
124724545|NCT01296711|448611750|FG007|Overall Study|Methotrexate discontinued|0|||
124724546|NCT01296711|448611743|FG000|Overall Study|Investigator discretion|0|||
124724547|NCT01296711|448611744|FG001|Overall Study|Investigator discretion|0|||
124724548|NCT01296711|448611745|FG002|Overall Study|Investigator discretion|0|||
124560022|NCT02151461|448007293|FG000|Overall Study|Adverse Event|5|||
124560023|NCT02151461|448007294|FG001|Overall Study|Adverse Event|1|||
124724549|NCT01296711|448611746|FG003|Overall Study|Investigator discretion|0|||
124560024|NCT02151461|448007295|FG002|Overall Study|Adverse Event|0|||
124560025|NCT02151461|448007296|FG003|Overall Study|Adverse Event|2|||
124560026|NCT02151461|448007293|FG000|Overall Study|Lost to Follow-up|0|||
124560027|NCT02151461|448007294|FG001|Overall Study|Lost to Follow-up|0|||
124560028|NCT02151461|448007295|FG002|Overall Study|Lost to Follow-up|1|||
124560029|NCT02151461|448007296|FG003|Overall Study|Lost to Follow-up|1|||
124560030|NCT02151461|448007293|FG000|Overall Study|Withdrawal by Subject|1|||
124560031|NCT02151461|448007294|FG001|Overall Study|Withdrawal by Subject|0|||
124560032|NCT02151461|448007295|FG002|Overall Study|Withdrawal by Subject|1|||
124560033|NCT02151461|448007296|FG003|Overall Study|Withdrawal by Subject|1|||
124560034|NCT02151461|448007293|FG000|Overall Study|Treatment discontinuation|0|||
124560035|NCT02151461|448007294|FG001|Overall Study|Treatment discontinuation|0|||
124560036|NCT02151461|448007295|FG002|Overall Study|Treatment discontinuation|1|||
124560037|NCT02151461|448007296|FG003|Overall Study|Treatment discontinuation|0|||
124560038|NCT00871169|448007298|FG000|Overall Study|Protocol Violation|1|||
124560039|NCT00871169|448007298|FG000|Overall Study|Patient did not receive study treatment|2|||
124560040|NCT03210259|448007302|FG000|12-Week Run-in Period|Adverse Event|1|||
124560041|NCT03210259|448007303|FG001|12-Week Run-in Period|Adverse Event|0|||
124560042|NCT03210259|448007304|FG002|12-Week Run-in Period|Adverse Event|0|||
124560043|NCT03210259|448007302|FG000|12-Week Run-in Period|Death|1|||
124560044|NCT03210259|448007303|FG001|12-Week Run-in Period|Death|0|||
124560045|NCT03210259|448007304|FG002|12-Week Run-in Period|Death|0|||
124560046|NCT03210259|448007302|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
124560047|NCT03210259|448007303|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
124560048|NCT03210259|448007304|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
124560049|NCT03210259|448007302|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
124560050|NCT03210259|448007303|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
124560051|NCT03210259|448007304|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
124560052|NCT03210259|448007302|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
124560053|NCT03210259|448007303|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
124560054|NCT03210259|448007304|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
124560055|NCT03210259|448007302|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
124560056|NCT03210259|448007303|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
124560057|NCT03210259|448007304|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
124560058|NCT03210259|448007302|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
124560059|NCT03210259|448007303|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
124560060|NCT03210259|448007304|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
124560061|NCT03210259|448007302|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
124560062|NCT03210259|448007303|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
124560063|NCT03210259|448007304|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
124560064|NCT03210259|448007302|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
124560065|NCT03210259|448007303|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
124560066|NCT03210259|448007304|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
124560067|NCT03210259|448007302|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
124560068|NCT03210259|448007303|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
124560069|NCT03210259|448007304|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
124560070|NCT03210259|448007302|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
124560071|NCT03210259|448007303|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
124560072|NCT03210259|448007304|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
124560073|NCT02110706|448007305|FG000|Overall Study|Adverse Event|2|||
124560074|NCT02110706|448007306|FG001|Overall Study|Adverse Event|3|||
124560075|NCT02110706|448007305|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
124560076|NCT02110706|448007306|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
124560077|NCT02087059|448007307|FG000|Overall Study|Disease Progression|1|||
124560078|NCT02087059|448007307|FG000|Overall Study|Adverse Event|5|||
124560079|NCT02087059|448007307|FG000|Overall Study|Lost to Follow-up|1|||
124560080|NCT00252187|448007308|FG000|Overall Study|Adverse Event|3|||
124560081|NCT00252187|448007309|FG001|Overall Study|Adverse Event|1|||
124560082|NCT00252187|448007308|FG000|Overall Study|Withdrawal by Subject|1|||
124560083|NCT00252187|448007309|FG001|Overall Study|Withdrawal by Subject|0|||
124560084|NCT05017493|448007312|FG000|Overall Study|Withdrawal by Subject|26|||
124560085|NCT05017493|448007313|FG001|Overall Study|Withdrawal by Subject|0|||
124560086|NCT05017493|448007312|FG000|Overall Study|Physician Decision|15|||
124775516|NCT03722238|448806536|FG001|Overall Study|Other|0|||
124775517|NCT03722238|448806535|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
124775518|NCT03722238|448806536|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
124560087|NCT05017493|448007313|FG001|Overall Study|Physician Decision|0|||
124560088|NCT05017493|448007312|FG000|Overall Study|Protocol Violation|81|||
124560089|NCT05017493|448007313|FG001|Overall Study|Protocol Violation|0|||
124560090|NCT01261325|448007320|FG000|Overall Study|Lack of Efficacy|1|||
124560091|NCT01261325|448007321|FG001|Overall Study|Lack of Efficacy|1|||
124560092|NCT01261325|448007322|FG002|Overall Study|Lack of Efficacy|0|||
124560093|NCT01261325|448007320|FG000|Overall Study|Withdrawal by Subject|2|||
124560094|NCT01261325|448007321|FG001|Overall Study|Withdrawal by Subject|2|||
124560095|NCT01261325|448007322|FG002|Overall Study|Withdrawal by Subject|4|||
124560096|NCT01261325|448007320|FG000|Overall Study|SAE, non-fatal|1|||
124560097|NCT01261325|448007321|FG001|Overall Study|SAE, non-fatal|5|||
124560098|NCT01261325|448007322|FG002|Overall Study|SAE, non-fatal|1|||
124775519|NCT03722238|448806535|FG000|Overall Study|Did not meet risk classification group criteria|90|||
124775520|NCT03722238|448806536|FG001|Overall Study|Did not meet risk classification group criteria|0|||
124775521|NCT03722238|448806535|FG000|Overall Study|Did not sign consent|17|||
124775522|NCT03722238|448806536|FG001|Overall Study|Did not sign consent|0|||
124775523|NCT03722238|448806535|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
124775524|NCT03722238|448806536|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
124775525|NCT03722238|448806535|FG000|Overall Study|Not willing to purchase study medication|142|||
124775526|NCT03722238|448806536|FG001|Overall Study|Not willing to purchase study medication|0|||
124775527|NCT03722238|448806535|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
124775528|NCT03722238|448806536|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
124775529|NCT03771664|448806537|FG000|Overall Study|Adverse Event|1|||
124775530|NCT03771664|448806538|FG001|Overall Study|Adverse Event|0|||
124775531|NCT03771664|448806537|FG000|Overall Study|Lost to Follow-up|1|||
124775532|NCT03771664|448806538|FG001|Overall Study|Lost to Follow-up|0|||
124775533|NCT03771664|448806537|FG000|Overall Study|Withdrawal by Participant|1|||
124775534|NCT03771664|448806538|FG001|Overall Study|Withdrawal by Participant|4|||
124775535|NCT03771664|448806537|FG000|Overall Study|Randomized but not Treated|0|||
124775536|NCT03771664|448806538|FG001|Overall Study|Randomized but not Treated|1|||
124775537|NCT00891904|448806539|FG000|Overall Study|Death|1|||
124775538|NCT00891904|448806539|FG000|Overall Study|Adverse Event|1|||
124775539|NCT03096288|448806541|FG000|Overall Study|Withdrawal by Subject|0|||
124775540|NCT03096288|448806542|FG001|Overall Study|Withdrawal by Subject|1|||
124775541|NCT03096288|448806543|FG002|Overall Study|Withdrawal by Subject|0|||
124775542|NCT03096288|448806544|FG003|Overall Study|Withdrawal by Subject|1|||
124775543|NCT02004093|448806550|FG000|Overall Study|Death|2|||
124775544|NCT02004093|448806551|FG001|Overall Study|Death|1|||
124775545|NCT02004093|448806550|FG000|Overall Study|Lack of Efficacy|66|||
124775546|NCT02004093|448806551|FG001|Overall Study|Lack of Efficacy|62|||
124775547|NCT02004093|448806550|FG000|Overall Study|Protocol Violation|0|||
124775548|NCT02004093|448806551|FG001|Overall Study|Protocol Violation|1|||
124775549|NCT02004093|448806550|FG000|Overall Study|Lost to Follow-up|0|||
124775550|NCT02004093|448806551|FG001|Overall Study|Lost to Follow-up|1|||
124775551|NCT02004093|448806550|FG000|Overall Study|Withdrawal by Subject|3|||
124775552|NCT02004093|448806551|FG001|Overall Study|Withdrawal by Subject|7|||
124775553|NCT02004093|448806550|FG000|Overall Study|Other|3|||
124775554|NCT02004093|448806551|FG001|Overall Study|Other|1|||
124775555|NCT01411891|448806552|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
124775556|NCT01411891|448806553|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
124775557|NCT04639258|448806554|FG000|Overall Study|Screen failure|5|||
124775558|NCT04639258|448806554|FG000|Overall Study|Physician Decision|2|||
124775559|NCT04639258|448806554|FG000|Overall Study|Early study termination|3|||
124775560|NCT04639258|448806554|FG000|Overall Study|Withdrawal by Subject|1|||
124775561|NCT00414596|448806555|FG000|Overall Study|Protocol Violation|2|||
124775562|NCT02558296|448806557|FG000|Completed the Study Through Week 24|Adverse Event|9|||
124775563|NCT02558296|448806558|FG001|Completed the Study Through Week 24|Adverse Event|3|||
124775564|NCT02558296|448806557|FG000|Completed the Study Through Week 24|Death|7|||
124775565|NCT02558296|448806558|FG001|Completed the Study Through Week 24|Death|7|||
124775566|NCT02558296|448806557|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
124775567|NCT02558296|448806558|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
124775568|NCT02558296|448806557|FG000|Completed the Study Through Week 24|Physician Decision|1|||
124775569|NCT02558296|448806558|FG001|Completed the Study Through Week 24|Physician Decision|0|||
124775570|NCT02558296|448806557|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
124775571|NCT02558296|448806558|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
124775572|NCT02558296|448806557|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
124775573|NCT02558296|448806558|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
124775574|NCT02558296|448806557|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
124775575|NCT02558296|448806558|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
124775576|NCT02558296|448806557|FG000|Completed the Study|Adverse Event|14|||
124775577|NCT02558296|448806558|FG001|Completed the Study|Adverse Event|5|||
124775578|NCT02558296|448806557|FG000|Completed the Study|Death|39|||
124500447|NCT02203838|447784098|FG000|Overall Study|Adverse Event|46|||
124500448|NCT02203838|447784099|FG001|Overall Study|Adverse Event|6|||
124500449|NCT02203838|447784100|FG002|Overall Study|Adverse Event|3|||
124775579|NCT02558296|448806558|FG001|Completed the Study|Death|25|||
124775580|NCT02558296|448806557|FG000|Completed the Study|Lost to Follow-up|31|||
124775581|NCT02558296|448806558|FG001|Completed the Study|Lost to Follow-up|23|||
124775582|NCT02558296|448806557|FG000|Completed the Study|Physician Decision|6|||
124775583|NCT02558296|448806558|FG001|Completed the Study|Physician Decision|0|||
124775584|NCT02558296|448806557|FG000|Completed the Study|Protocol Violation|2|||
124775585|NCT02558296|448806558|FG001|Completed the Study|Protocol Violation|1|||
124775586|NCT02558296|448806557|FG000|Completed the Study|Withdrawal by Subject|53|||
124500450|NCT02203838|447784101|FG003|Overall Study|Adverse Event|2|||
124775587|NCT02558296|448806558|FG001|Completed the Study|Withdrawal by Subject|31|||
124560099|NCT01261325|448007320|FG000|Overall Study|AE, non-serious non-fatal|9|||
124560100|NCT01261325|448007321|FG001|Overall Study|AE, non-serious non-fatal|15|||
124560101|NCT01261325|448007322|FG002|Overall Study|AE, non-serious non-fatal|13|||
124560102|NCT01261325|448007320|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
124560103|NCT01261325|448007321|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
124560104|NCT01261325|448007322|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
124560105|NCT01261325|448007320|FG000|Overall Study|Non Compliance|2|||
124560106|NCT01261325|448007321|FG001|Overall Study|Non Compliance|0|||
124560107|NCT01261325|448007322|FG002|Overall Study|Non Compliance|0|||
124560108|NCT01261325|448007320|FG000|Overall Study|Patient Randomized by Mistake|0|||
124560109|NCT01261325|448007321|FG001|Overall Study|Patient Randomized by Mistake|1|||
124560110|NCT01261325|448007322|FG002|Overall Study|Patient Randomized by Mistake|0|||
124560111|NCT01261325|448007320|FG000|Overall Study|Erroneously Randomized|1|||
124560112|NCT01261325|448007321|FG001|Overall Study|Erroneously Randomized|0|||
124560113|NCT01261325|448007322|FG002|Overall Study|Erroneously Randomized|0|||
124560114|NCT01261325|448007320|FG000|Overall Study|Screen Failure|1|||
124560115|NCT01261325|448007321|FG001|Overall Study|Screen Failure|0|||
124560116|NCT01261325|448007322|FG002|Overall Study|Screen Failure|0|||
124560117|NCT01261325|448007320|FG000|Overall Study|Randomized in Error|0|||
124560118|NCT01261325|448007321|FG001|Overall Study|Randomized in Error|0|||
124560119|NCT01261325|448007322|FG002|Overall Study|Randomized in Error|1|||
124560120|NCT01261325|448007320|FG000|Overall Study|Protocol Violation|0|||
124560121|NCT01261325|448007321|FG001|Overall Study|Protocol Violation|3|||
124560122|NCT01261325|448007322|FG002|Overall Study|Protocol Violation|1|||
124560123|NCT01261325|448007320|FG000|Overall Study|Lost to Follow-up|0|||
124560124|NCT01261325|448007321|FG001|Overall Study|Lost to Follow-up|1|||
124560125|NCT01261325|448007322|FG002|Overall Study|Lost to Follow-up|3|||
124560126|NCT01261325|448007320|FG000|Overall Study|AE, serious fatal|0|||
124560127|NCT01261325|448007321|FG001|Overall Study|AE, serious fatal|0|||
124560128|NCT01261325|448007322|FG002|Overall Study|AE, serious fatal|2|||
124560129|NCT03469271|448007328|FG000|Overall Study|Withdrawal by Subject|2|||
124560130|NCT03469271|448007329|FG001|Overall Study|Withdrawal by Subject|0|||
124560131|NCT03469271|448007330|FG002|Overall Study|Withdrawal by Subject|0|||
124560132|NCT03469271|448007331|FG003|Overall Study|Withdrawal by Subject|1|||
124560133|NCT03404206|448007336|FG000|Overall Study|Withdrawal by Subject|1|||
124560134|NCT03404206|448007337|FG001|Overall Study|Withdrawal by Subject|1|||
124560135|NCT03404206|448007338|FG002|Overall Study|Withdrawal by Subject|0|||
124560136|NCT03404206|448007336|FG000|Overall Study|Lost to Follow-up|3|||
124560137|NCT03404206|448007337|FG001|Overall Study|Lost to Follow-up|1|||
124560138|NCT03404206|448007338|FG002|Overall Study|Lost to Follow-up|0|||
124560139|NCT00616928|448007356|FG000|Overall Study|Adverse Event|6|||
124560140|NCT00616928|448007357|FG001|Overall Study|Adverse Event|3|||
124560141|NCT00616928|448007358|FG002|Overall Study|Adverse Event|2|||
124560142|NCT00616928|448007359|FG003|Overall Study|Adverse Event|2|||
124560143|NCT00616928|448007356|FG000|Overall Study|Other|51|||
124560144|NCT00616928|448007357|FG001|Overall Study|Other|8|||
124560145|NCT00616928|448007358|FG002|Overall Study|Other|15|||
124560146|NCT00616928|448007359|FG003|Overall Study|Other|5|||
124560147|NCT00616928|448007356|FG000|Overall Study|Lost to Follow-up|5|||
124560148|NCT00616928|448007357|FG001|Overall Study|Lost to Follow-up|7|||
124560149|NCT00616928|448007358|FG002|Overall Study|Lost to Follow-up|0|||
124560150|NCT00616928|448007359|FG003|Overall Study|Lost to Follow-up|0|||
124560151|NCT03372083|448009474|FG000|Overall Study|Adverse Event|3|||
124560152|NCT03372083|448009474|FG000|Overall Study|Physician Decision|1|||
124560153|NCT03372083|448009474|FG000|Overall Study|Withdrawal by Subject|1|||
124560154|NCT00598559|448009475|FG000|Overall Study|Adverse Event|11|||
124560155|NCT00598559|448009476|FG001|Overall Study|Adverse Event|7|||
124560156|NCT00598559|448009477|FG002|Overall Study|Adverse Event|0|||
124560157|NCT00598559|448009475|FG000|Overall Study|Withdrawal by Subject|2|||
124560158|NCT00598559|448009476|FG001|Overall Study|Withdrawal by Subject|2|||
124560159|NCT00598559|448009477|FG002|Overall Study|Withdrawal by Subject|0|||
124560160|NCT00598559|448009475|FG000|Overall Study|Protocol Non-compliance|1|||
124560161|NCT00598559|448009476|FG001|Overall Study|Protocol Non-compliance|0|||
124560162|NCT00598559|448009477|FG002|Overall Study|Protocol Non-compliance|0|||
124560163|NCT00598559|448009475|FG000|Overall Study|Early discharge from hospital|9|||
124560164|NCT00598559|448009476|FG001|Overall Study|Early discharge from hospital|12|||
124560165|NCT00598559|448009477|FG002|Overall Study|Early discharge from hospital|3|||
124560166|NCT00598559|448009475|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
124560167|NCT00598559|448009476|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
124560168|NCT00598559|448009477|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
124560169|NCT03381248|448009478|FG000|0-6 Months|Withdrawal by Subject|4|||
124560170|NCT03381248|448009479|FG001|0-6 Months|Withdrawal by Subject|1|||
124560171|NCT03381248|448009478|FG000|0-6 Months|Lost to Follow-up|3|||
124560172|NCT03381248|448009479|FG001|0-6 Months|Lost to Follow-up|2|||
124560173|NCT03381248|448009478|FG000|0-6 Months|Lack of Efficacy|1|||
124560174|NCT03381248|448009479|FG001|0-6 Months|Lack of Efficacy|0|||
124560175|NCT03381248|448009478|FG000|0-6 Months|Adverse Event|1|||
124560176|NCT03381248|448009479|FG001|0-6 Months|Adverse Event|0|||
124500451|NCT02203838|447784098|FG000|Overall Study|Lost to Follow-up|39|||
124500452|NCT02203838|447784099|FG001|Overall Study|Lost to Follow-up|3|||
124500453|NCT02203838|447784100|FG002|Overall Study|Lost to Follow-up|2|||
124500454|NCT02203838|447784101|FG003|Overall Study|Lost to Follow-up|1|||
124500455|NCT02203838|447784098|FG000|Overall Study|Protocol Violation|7|||
124500456|NCT02203838|447784099|FG001|Overall Study|Protocol Violation|3|||
124500457|NCT02203838|447784100|FG002|Overall Study|Protocol Violation|0|||
124500458|NCT02203838|447784101|FG003|Overall Study|Protocol Violation|0|||
124500459|NCT02203838|447784098|FG000|Overall Study|Withdrawal by Subject|83|||
124500460|NCT02203838|447784099|FG001|Overall Study|Withdrawal by Subject|10|||
124500461|NCT02203838|447784100|FG002|Overall Study|Withdrawal by Subject|8|||
124500462|NCT02203838|447784101|FG003|Overall Study|Withdrawal by Subject|11|||
124500463|NCT02203838|447784098|FG000|Overall Study|Physician Decision|27|||
124500464|NCT02203838|447784099|FG001|Overall Study|Physician Decision|0|||
124500465|NCT02203838|447784100|FG002|Overall Study|Physician Decision|2|||
124500466|NCT02203838|447784101|FG003|Overall Study|Physician Decision|3|||
124500467|NCT02203838|447784098|FG000|Overall Study|Other|1|||
124500468|NCT02203838|447784099|FG001|Overall Study|Other|0|||
124500469|NCT02203838|447784100|FG002|Overall Study|Other|0|||
124500470|NCT02203838|447784101|FG003|Overall Study|Other|0|||
124500471|NCT04590937|447784102|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
124500472|NCT01635933|447784103|FG000|Overall Study|Adverse Event|1|||
124500473|NCT01635933|447784104|FG001|Overall Study|Adverse Event|0|||
124500474|NCT01635933|447784103|FG000|Overall Study|Lost to Follow-up|0|||
124500475|NCT01635933|447784104|FG001|Overall Study|Lost to Follow-up|5|||
124500476|NCT01635933|447784103|FG000|Overall Study|Subject decision|1|||
124500477|NCT01635933|447784104|FG001|Overall Study|Subject decision|1|||
124500478|NCT01635933|447784103|FG000|Overall Study|Noncompliance|0|||
124500479|NCT01635933|447784104|FG001|Overall Study|Noncompliance|1|||
124500480|NCT01635933|447784103|FG000|Overall Study|No longer had transportation|0|||
124500481|NCT01635933|447784104|FG001|Overall Study|No longer had transportation|1|||
124500482|NCT04333433|447784111|FG000|Overall Study|Withdrawal by Subject|6|||
124500483|NCT04333433|447784112|FG001|Overall Study|Withdrawal by Subject|3|||
124500484|NCT04333433|447784111|FG000|Overall Study|Death|3|||
124500485|NCT04333433|447784112|FG001|Overall Study|Death|0|||
124500486|NCT04333433|447784111|FG000|Overall Study|Lost to Follow-up|6|||
124500487|NCT04333433|447784112|FG001|Overall Study|Lost to Follow-up|1|||
124500488|NCT04333433|447784111|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
124500489|NCT04333433|447784112|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
124500490|NCT02026271|447784113|FG000|Overall Study|Adverse Event|2|||
124500491|NCT02026271|447784114|FG001|Overall Study|Adverse Event|3|||
124500492|NCT02026271|447784115|FG002|Overall Study|Adverse Event|2|||
124500493|NCT02026271|447784116|FG003|Overall Study|Adverse Event|3|||
124500494|NCT02026271|447784117|FG004|Overall Study|Adverse Event|0|||
124500495|NCT02026271|447784113|FG000|Overall Study|Withdrawal by Subject|0|||
124500496|NCT02026271|447784114|FG001|Overall Study|Withdrawal by Subject|0|||
124500497|NCT02026271|447784115|FG002|Overall Study|Withdrawal by Subject|0|||
124500498|NCT02026271|447784116|FG003|Overall Study|Withdrawal by Subject|0|||
124500499|NCT02026271|447784117|FG004|Overall Study|Withdrawal by Subject|1|||
124500500|NCT04743635|447784118|FG000|Overall Study|Lost to Follow-up|2|||
124500501|NCT04743635|447784119|FG001|Overall Study|Lost to Follow-up|0|||
124500502|NCT03382899|447784125|FG000|Overall Study|Ineligibility Determined|0|||
124500503|NCT03382899|447784126|FG001|Overall Study|Ineligibility Determined|1|||
124500504|NCT03382899|447784125|FG000|Overall Study|Lost to Follow-up|0|||
124500505|NCT03382899|447784126|FG001|Overall Study|Lost to Follow-up|1|||
124500506|NCT03382899|447784125|FG000|Overall Study|Sponsor's decision|31|||
124500507|NCT03382899|447784126|FG001|Overall Study|Sponsor's decision|28|||
124500508|NCT03382899|447784125|FG000|Overall Study|Withdrawal by Subject|0|||
124500509|NCT03382899|447784126|FG001|Overall Study|Withdrawal by Subject|5|||
124500510|NCT01355068|447784127|FG000|First Intervention Period|Adverse Event|0|||
124500511|NCT01355068|447784128|FG001|First Intervention Period|Adverse Event|1|||
124500512|NCT01355068|447784127|FG000|First Intervention Period|Withdrawal by Subject|0|||
124500513|NCT01355068|447784128|FG001|First Intervention Period|Withdrawal by Subject|1|||
124500514|NCT00524745|447784129|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
124500515|NCT00524745|447784130|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
124500516|NCT00524745|447784131|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
124500517|NCT00524745|447784132|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
124500518|NCT00872170|447784133|FG000|Overall Study|Adverse Event|1|||
124500519|NCT00872170|447784134|FG001|Overall Study|Adverse Event|0|||
124500520|NCT00540449|447784135|FG000|Overall Study|Adverse Event|12|||
124500521|NCT00540449|447784136|FG001|Overall Study|Adverse Event|32|||
124500522|NCT00540449|447784135|FG000|Overall Study|Sponsor's Decision|1|||
124500523|NCT00540449|447784136|FG001|Overall Study|Sponsor's Decision|1|||
124500524|NCT00540449|447784135|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
124500525|NCT00540449|447784136|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
124500526|NCT00540449|447784135|FG000|Overall Study|Lost to Follow-up|19|||
124500527|NCT00540449|447784136|FG001|Overall Study|Lost to Follow-up|17|||
124560177|NCT03381248|448009478|FG000|0-6 Months|Protocol Violation|2|||
124560178|NCT03381248|448009479|FG001|0-6 Months|Protocol Violation|1|||
124560179|NCT03381248|448009478|FG000|0-6 Months|Physician Decision|1|||
124560180|NCT03381248|448009479|FG001|0-6 Months|Physician Decision|0|||
124560181|NCT03381248|448009478|FG000|0-6 Months|Planning another procedure|1|||
124560182|NCT03381248|448009479|FG001|0-6 Months|Planning another procedure|2|||
124560183|NCT03381248|448009478|FG000|6-12 Months|Withdrawal by Subject|1|||
124560184|NCT03381248|448009479|FG001|6-12 Months|Withdrawal by Subject|3|||
124560185|NCT03381248|448009478|FG000|6-12 Months|Lost to Follow-up|0|||
124560186|NCT03381248|448009479|FG001|6-12 Months|Lost to Follow-up|2|||
124560187|NCT03381248|448009478|FG000|6-12 Months|Protocol Violation|3|||
124560188|NCT03381248|448009479|FG001|6-12 Months|Protocol Violation|2|||
124560189|NCT03381248|448009478|FG000|6-12 Months|Planning another procedure|6|||
124560190|NCT03381248|448009479|FG001|6-12 Months|Planning another procedure|2|||
124560191|NCT03381248|448009478|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
124560192|NCT03381248|448009479|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
124560193|NCT03381248|448009478|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
124560194|NCT03381248|448009479|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
124560195|NCT03381248|448009478|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
124560196|NCT03381248|448009479|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
124560197|NCT01466686|448009486|FG000|Overall Study|Withdrawal by Subject|1|||
124560198|NCT00827827|448009487|FG000|Overall Study|Lost to Follow-up|3|||
124560199|NCT00827827|448009488|FG001|Overall Study|Lost to Follow-up|0|||
124560200|NCT00827827|448009487|FG000|Overall Study|Fall at home- hospitalization|1|||
124560201|NCT00827827|448009488|FG001|Overall Study|Fall at home- hospitalization|0|||
124560202|NCT00827827|448009487|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
124560203|NCT00827827|448009488|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
124560204|NCT00827827|448009487|FG000|Overall Study|Gout|1|||
124560205|NCT00827827|448009488|FG001|Overall Study|Gout|0|||
124560206|NCT00827827|448009487|FG000|Overall Study|Transportation issues|1|||
124560207|NCT00827827|448009488|FG001|Overall Study|Transportation issues|0|||
124560208|NCT00827827|448009487|FG000|Overall Study|Burned with water at home|1|||
124560209|NCT00827827|448009488|FG001|Overall Study|Burned with water at home|0|||
124560210|NCT02884206|448009505|FG000|Valsartan Run-in Period|Death|1|||
124560211|NCT02884206|448009506|FG001|Valsartan Run-in Period|Death|0|||
124560212|NCT02884206|448009507|FG002|Valsartan Run-in Period|Death|0|||
124560213|NCT02884206|448009505|FG000|Valsartan Run-in Period|Adverse Event|31|||
124560214|NCT02884206|448009506|FG001|Valsartan Run-in Period|Adverse Event|0|||
124560215|NCT02884206|448009507|FG002|Valsartan Run-in Period|Adverse Event|0|||
124560216|NCT02884206|448009505|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
124560217|NCT02884206|448009506|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
124560218|NCT02884206|448009507|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
124560219|NCT02884206|448009505|FG000|Valsartan Run-in Period|Protocol deviation|4|||
124560220|NCT02884206|448009506|FG001|Valsartan Run-in Period|Protocol deviation|0|||
124560221|NCT02884206|448009507|FG002|Valsartan Run-in Period|Protocol deviation|0|||
124560222|NCT02884206|448009505|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
124560223|NCT02884206|448009506|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
124560224|NCT02884206|448009507|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
124560225|NCT02884206|448009505|FG000|Valsartan Run-in Period|Physician Decision|1|||
124560226|NCT02884206|448009506|FG001|Valsartan Run-in Period|Physician Decision|0|||
124560227|NCT02884206|448009507|FG002|Valsartan Run-in Period|Physician Decision|0|||
124560228|NCT02884206|448009505|FG000|LCZ696 Run-in Period|Adverse Event|38|||
124560229|NCT02884206|448009506|FG001|LCZ696 Run-in Period|Adverse Event|0|||
124560230|NCT02884206|448009507|FG002|LCZ696 Run-in Period|Adverse Event|0|||
124560231|NCT02884206|448009505|FG000|LCZ696 Run-in Period|Death|2|||
124560232|NCT02884206|448009506|FG001|LCZ696 Run-in Period|Death|0|||
124560233|NCT02884206|448009507|FG002|LCZ696 Run-in Period|Death|0|||
124560234|NCT02884206|448009505|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
124560235|NCT02884206|448009506|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
124560236|NCT02884206|448009507|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
124560237|NCT02884206|448009505|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
124560238|NCT02884206|448009506|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
124724550|NCT01296711|448611747|FG004|Overall Study|Investigator discretion|0|||
124724551|NCT01296711|448611748|FG005|Overall Study|Investigator discretion|0|||
124560239|NCT02884206|448009507|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
124560240|NCT02884206|448009505|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
124560241|NCT02884206|448009506|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
124560242|NCT02884206|448009507|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
124560243|NCT02884206|448009505|FG000|LCZ696 Run-in Period|Physician Decision|1|||
124560244|NCT02884206|448009506|FG001|LCZ696 Run-in Period|Physician Decision|0|||
124724552|NCT01296711|448611749|FG006|Overall Study|Investigator discretion|1|||
124724553|NCT01296711|448611750|FG007|Overall Study|Investigator discretion|0|||
124724554|NCT01296711|448611743|FG000|Overall Study|Other|0|||
124724555|NCT01296711|448611744|FG001|Overall Study|Other|0|||
124560245|NCT02884206|448009507|FG002|LCZ696 Run-in Period|Physician Decision|0|||
124560246|NCT02884206|448009505|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
124560247|NCT02884206|448009506|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
124560248|NCT02884206|448009507|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
124560249|NCT02884206|448009505|FG000|Double-Blind Period|Death|0|||
124560250|NCT02884206|448009506|FG001|Double-Blind Period|Death|28|||
124560251|NCT02884206|448009507|FG002|Double-Blind Period|Death|39|||
124560252|NCT02884206|448009505|FG000|Double-Blind Period|Patient/guardian decision|0|||
124560253|NCT02884206|448009506|FG001|Double-Blind Period|Patient/guardian decision|10|||
124560254|NCT02884206|448009507|FG002|Double-Blind Period|Patient/guardian decision|13|||
124560255|NCT02884206|448009505|FG000|Double-Blind Period|Lost to Follow-up|0|||
124560256|NCT02884206|448009506|FG001|Double-Blind Period|Lost to Follow-up|4|||
124560257|NCT02884206|448009507|FG002|Double-Blind Period|Lost to Follow-up|4|||
124560258|NCT02884206|448009505|FG000|Double-Blind Period|Physician Decision|0|||
124560259|NCT02884206|448009506|FG001|Double-Blind Period|Physician Decision|2|||
124560260|NCT02884206|448009507|FG002|Double-Blind Period|Physician Decision|0|||
124560261|NCT02884206|448009505|FG000|Double-Blind Period|Adverse Event|0|||
124560262|NCT02884206|448009506|FG001|Double-Blind Period|Adverse Event|0|||
124560263|NCT02884206|448009507|FG002|Double-Blind Period|Adverse Event|3|||
124560264|NCT02884206|448009505|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
124560265|NCT02884206|448009506|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
124560266|NCT02884206|448009507|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
124560267|NCT00112489|448009508|FG000|Overall Study|Refused further treatment|8|||
124560268|NCT00112489|448009508|FG000|Overall Study|Adverse Event|12|||
124560269|NCT00112489|448009508|FG000|Overall Study|Death|2|||
124560270|NCT00112489|448009508|FG000|Overall Study|Other, Not Specified|9|||
124560271|NCT00112489|448009508|FG000|Overall Study|Patient never treated|2|||
124560272|NCT00112489|448009508|FG000|Overall Study|Ineligible|7|||
124560273|NCT05751629|448009509|FG000|Overall Study|Withdrawal by Subject|6|||
124560274|NCT05751629|448009509|FG000|Overall Study|Death|25|||
124560275|NCT05751629|448009509|FG000|Overall Study|Study Site Closed|9|||
124560276|NCT05751629|448009509|FG000|Overall Study|Physician Decision|1|||
124560277|NCT02231710|448009511|FG000|Overall Study|Physician Decision|1|||
124560278|NCT00295854|448009513|FG000|Overall Study|Adverse Event|7|||
124560279|NCT00295854|448009514|FG001|Overall Study|Adverse Event|7|||
124560280|NCT00295854|448009515|FG002|Overall Study|Adverse Event|6|||
124560281|NCT00295854|448009513|FG000|Overall Study|Protocol Violation|1|||
124560282|NCT00295854|448009514|FG001|Overall Study|Protocol Violation|1|||
124560283|NCT00295854|448009515|FG002|Overall Study|Protocol Violation|1|||
124560284|NCT00295854|448009513|FG000|Overall Study|Lost to Follow-up|2|||
124560285|NCT00295854|448009514|FG001|Overall Study|Lost to Follow-up|0|||
124560286|NCT00295854|448009515|FG002|Overall Study|Lost to Follow-up|1|||
124560287|NCT00295854|448009513|FG000|Overall Study|Withdrawal by Subject|3|||
124560288|NCT00295854|448009514|FG001|Overall Study|Withdrawal by Subject|7|||
124560289|NCT00295854|448009515|FG002|Overall Study|Withdrawal by Subject|4|||
124560290|NCT00295854|448009513|FG000|Overall Study|did not continue to meet criteria|1|||
124560291|NCT00295854|448009514|FG001|Overall Study|did not continue to meet criteria|1|||
124560292|NCT00295854|448009515|FG002|Overall Study|did not continue to meet criteria|2|||
124560293|NCT00295854|448009513|FG000|Overall Study|required a prohibited medication|1|||
124560294|NCT00295854|448009514|FG001|Overall Study|required a prohibited medication|0|||
124560295|NCT00295854|448009515|FG002|Overall Study|required a prohibited medication|0|||
124560296|NCT00295854|448009513|FG000|Overall Study|Other|3|||
124560297|NCT00295854|448009514|FG001|Overall Study|Other|5|||
124560298|NCT00295854|448009515|FG002|Overall Study|Other|1|||
124560299|NCT00672620|448009516|FG000|Overall Study|Adverse Event|7|||
124560300|NCT00672620|448009517|FG001|Overall Study|Adverse Event|7|||
124560301|NCT00672620|448009518|FG002|Overall Study|Adverse Event|12|||
124560302|NCT00672620|448009519|FG003|Overall Study|Adverse Event|17|||
124560303|NCT00672620|448009516|FG000|Overall Study|Lack of Efficacy|1|||
124560304|NCT00672620|448009517|FG001|Overall Study|Lack of Efficacy|2|||
124560305|NCT00672620|448009518|FG002|Overall Study|Lack of Efficacy|2|||
124560306|NCT00672620|448009519|FG003|Overall Study|Lack of Efficacy|0|||
124724556|NCT01296711|448611745|FG002|Overall Study|Other|0|||
124560307|NCT00672620|448009516|FG000|Overall Study|Noncompliance with Study Drug|3|||
124560308|NCT00672620|448009517|FG001|Overall Study|Noncompliance with Study Drug|4|||
124560309|NCT00672620|448009518|FG002|Overall Study|Noncompliance with Study Drug|0|||
124560310|NCT00672620|448009519|FG003|Overall Study|Noncompliance with Study Drug|2|||
124560311|NCT00672620|448009516|FG000|Overall Study|Protocol Deviations|5|||
124560312|NCT00672620|448009517|FG001|Overall Study|Protocol Deviations|7|||
124560313|NCT00672620|448009518|FG002|Overall Study|Protocol Deviations|2|||
124560314|NCT00672620|448009519|FG003|Overall Study|Protocol Deviations|5|||
124560315|NCT00672620|448009516|FG000|Overall Study|Withdrawal of Consent|6|||
124560316|NCT00672620|448009517|FG001|Overall Study|Withdrawal of Consent|12|||
124560317|NCT00672620|448009518|FG002|Overall Study|Withdrawal of Consent|5|||
124560318|NCT00672620|448009519|FG003|Overall Study|Withdrawal of Consent|6|||
124724557|NCT01296711|448611746|FG003|Overall Study|Other|0|||
124724558|NCT01296711|448611747|FG004|Overall Study|Other|0|||
124724559|NCT01296711|448611748|FG005|Overall Study|Other|0|||
124560319|NCT00672620|448009516|FG000|Overall Study|Lost to Follow-up|8|||
124560320|NCT00672620|448009517|FG001|Overall Study|Lost to Follow-up|19|||
124560321|NCT00672620|448009518|FG002|Overall Study|Lost to Follow-up|8|||
124560322|NCT00672620|448009519|FG003|Overall Study|Lost to Follow-up|11|||
124560323|NCT00672620|448009516|FG000|Overall Study|Reason not Specified|3|||
124560324|NCT00672620|448009517|FG001|Overall Study|Reason not Specified|3|||
124560325|NCT00672620|448009518|FG002|Overall Study|Reason not Specified|2|||
124560326|NCT00672620|448009519|FG003|Overall Study|Reason not Specified|1|||
124560327|NCT00772577|448009520|FG000|Overall Study|Adverse Event|6|||
124560328|NCT00772577|448009521|FG001|Overall Study|Adverse Event|3|||
124560329|NCT00772577|448009520|FG000|Overall Study|Abnormal laboratory values|0|||
124560330|NCT00772577|448009521|FG001|Overall Study|Abnormal laboratory values|1|||
124560331|NCT00772577|448009520|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124560332|NCT00772577|448009521|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
124560333|NCT00772577|448009520|FG000|Overall Study|Patient withdrew consent|8|||
124560334|NCT00772577|448009521|FG001|Overall Study|Patient withdrew consent|5|||
124560335|NCT00772577|448009520|FG000|Overall Study|Lost to Follow-up|4|||
124560336|NCT00772577|448009521|FG001|Overall Study|Lost to Follow-up|3|||
124560337|NCT00772577|448009520|FG000|Overall Study|Administrative problems|2|||
124560338|NCT00772577|448009521|FG001|Overall Study|Administrative problems|1|||
124560339|NCT00772577|448009520|FG000|Overall Study|Protocol Deviation|3|||
124560340|NCT00772577|448009521|FG001|Overall Study|Protocol Deviation|2|||
124560341|NCT03211156|448009522|FG000|Overall Study|Withdrawal by Subject|0|||
124560342|NCT03211156|448009523|FG001|Overall Study|Withdrawal by Subject|2|||
124560343|NCT03211156|448009522|FG000|Overall Study|Lost to Follow-up|1|||
124560344|NCT03211156|448009523|FG001|Overall Study|Lost to Follow-up|1|||
124560345|NCT03211156|448009522|FG000|Overall Study|Adverse Event|1|||
124560346|NCT03211156|448009523|FG001|Overall Study|Adverse Event|0|||
124560347|NCT03255031|448009524|FG000|Overall Study|Adverse Event|5|||
124560348|NCT03255031|448009525|FG001|Overall Study|Adverse Event|3|||
124560349|NCT03255031|448009524|FG000|Overall Study|Physician Decision|2|||
124560350|NCT03255031|448009525|FG001|Overall Study|Physician Decision|1|||
124560351|NCT03255031|448009524|FG000|Overall Study|Withdrawal by Subject|9|||
124560352|NCT03255031|448009525|FG001|Overall Study|Withdrawal by Subject|3|||
124560353|NCT00415532|448009529|FG000|Treatment Period|Adverse Event|2|||
124560354|NCT00415532|448009530|FG001|Treatment Period|Adverse Event|3|||
124560355|NCT00415532|448009529|FG000|Treatment Period|Death|2|||
124560356|NCT00415532|448009530|FG001|Treatment Period|Death|1|||
124560357|NCT00415532|448009529|FG000|Treatment Period|Lost to Follow-up|1|||
124560358|NCT00415532|448009530|FG001|Treatment Period|Lost to Follow-up|1|||
124560359|NCT00415532|448009529|FG000|Treatment Period|Protocol Violation|1|||
124560360|NCT00415532|448009530|FG001|Treatment Period|Protocol Violation|0|||
124560361|NCT00415532|448009529|FG000|Treatment Period|Withdrawal by Subject|6|||
124560362|NCT00415532|448009530|FG001|Treatment Period|Withdrawal by Subject|6|||
124560363|NCT00415532|448009529|FG000|Treatment Period|Other|2|||
124560364|NCT00415532|448009530|FG001|Treatment Period|Other|2|||
124560365|NCT00415532|448009529|FG000|Treatment Period|Ineligibility determined|1|||
124560366|NCT00415532|448009530|FG001|Treatment Period|Ineligibility determined|1|||
124560367|NCT00415532|448009529|FG000|Treatment Period|Noncompliance|1|||
124560368|NCT00415532|448009530|FG001|Treatment Period|Noncompliance|1|||
124560369|NCT00415532|448009529|FG000|Treatment Period|Requirement for alternative therapy|1|||
124560370|NCT00415532|448009530|FG001|Treatment Period|Requirement for alternative therapy|0|||
124560371|NCT00415532|448009529|FG000|Safety Follow Up Period|Adverse Event|1|||
124560372|NCT00415532|448009530|FG001|Safety Follow Up Period|Adverse Event|3|||
124560373|NCT00415532|448009529|FG000|Safety Follow Up Period|Death|3|||
124560374|NCT00415532|448009530|FG001|Safety Follow Up Period|Death|0|||
124560375|NCT00415532|448009529|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
124560376|NCT00415532|448009530|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
124560377|NCT00415532|448009529|FG000|Safety Follow Up Period|Other|1|||
124560378|NCT00415532|448009530|FG001|Safety Follow Up Period|Other|4|||
124560379|NCT00415532|448009529|FG000|Safety Follow Up Period|Ineligibility determined|1|||
124560380|NCT00415532|448009530|FG001|Safety Follow Up Period|Ineligibility determined|1|||
124560381|NCT00415532|448009529|FG000|Safety Follow Up Period|Noncompliance|1|||
124560382|NCT00415532|448009530|FG001|Safety Follow Up Period|Noncompliance|0|||
124560383|NCT00415532|448009529|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
124560384|NCT00415532|448009530|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
124724560|NCT01296711|448611749|FG006|Overall Study|Other|1|||
124560385|NCT01698320|448009531|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
124560386|NCT01698320|448009532|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
124560387|NCT01698320|448009533|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
124560388|NCT01698320|448009531|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
124560389|NCT01698320|448009532|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
124560390|NCT01698320|448009533|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
124560391|NCT01698320|448009531|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
124560392|NCT01698320|448009532|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
124775588|NCT02558296|448806557|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
124775589|NCT02558296|448806558|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
124775590|NCT00297258|448806559|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
124775591|NCT00297258|448806559|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
124775592|NCT00297258|448806559|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
124775593|NCT00297258|448806559|FG000|Overall Study|Intercurrent Illness|3|||
124775594|NCT00297258|448806559|FG000|Overall Study|Intercurrent Death|2|||
124775595|NCT00297258|448806559|FG000|Overall Study|Deteriorization of General Condition|1|||
124775596|NCT00297258|448806559|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
124775597|NCT00297258|448806559|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
124775598|NCT00297258|448806559|FG000|Overall Study|Switch to Commercial Treatment|1|||
124775599|NCT00297258|448806559|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
124775600|NCT05038982|448806568|FG000|Overall Study|Withdrawal by Subject|0|||
124775601|NCT05038982|448806569|FG001|Overall Study|Withdrawal by Subject|2|||
124775602|NCT03133793|448806570|FG000|Overall Study|Withdrawal by Subject|0|||
124775603|NCT03133793|448806571|FG001|Overall Study|Withdrawal by Subject|4|||
124775604|NCT03133793|448806572|FG002|Overall Study|Withdrawal by Subject|2|||
124775605|NCT03133793|448806573|FG003|Overall Study|Withdrawal by Subject|4|||
124775606|NCT03133793|448806570|FG000|Overall Study|Lost to Follow-up|1|||
124775607|NCT03133793|448806571|FG001|Overall Study|Lost to Follow-up|0|||
124775608|NCT03133793|448806572|FG002|Overall Study|Lost to Follow-up|2|||
124775609|NCT03133793|448806573|FG003|Overall Study|Lost to Follow-up|0|||
124775610|NCT03133793|448806570|FG000|Overall Study|Death|0|||
124775611|NCT03133793|448806571|FG001|Overall Study|Death|0|||
124775612|NCT03133793|448806572|FG002|Overall Study|Death|0|||
124775613|NCT03133793|448806573|FG003|Overall Study|Death|1|||
124775614|NCT04476797|448806574|FG000|Overall Study|Withdrawal by Subject|1|||
124775615|NCT04476797|448806575|FG001|Overall Study|Withdrawal by Subject|0|||
124775616|NCT04476797|448806576|FG002|Overall Study|Withdrawal by Subject|0|||
124775617|NCT04476797|448806574|FG000|Overall Study|Death|0|||
124775618|NCT04476797|448806575|FG001|Overall Study|Death|1|||
124775619|NCT04476797|448806576|FG002|Overall Study|Death|2|||
124775620|NCT04476797|448806574|FG000|Overall Study|Sponsor Terminated Study|0|||
124775621|NCT04476797|448806575|FG001|Overall Study|Sponsor Terminated Study|18|||
124775622|NCT04476797|448806576|FG002|Overall Study|Sponsor Terminated Study|17|||
124775623|NCT03614156|448806577|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
124775624|NCT03614156|448806578|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
124775625|NCT03614156|448806579|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
124775626|NCT03614156|448806580|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
124775627|NCT03614156|448806577|FG000|Open-Label Treatment Period|Adverse Event|7|||
124775628|NCT03614156|448806578|FG001|Open-Label Treatment Period|Adverse Event|0|||
124775629|NCT03614156|448806579|FG002|Open-Label Treatment Period|Adverse Event|0|||
124775630|NCT03614156|448806580|FG003|Open-Label Treatment Period|Adverse Event|0|||
124775631|NCT03614156|448806577|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
124775632|NCT03614156|448806578|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
124775633|NCT03614156|448806579|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
124775634|NCT03614156|448806580|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
124775635|NCT03614156|448806577|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
124775636|NCT03614156|448806578|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
124775637|NCT03614156|448806579|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
124775638|NCT03614156|448806580|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
124775639|NCT03614156|448806577|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
124775640|NCT03614156|448806578|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
124775641|NCT03614156|448806579|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
124775642|NCT03614156|448806580|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
124775643|NCT03614156|448806577|FG000|Open-Label Treatment Period|Protocol Violation|2|||
124775644|NCT03614156|448806578|FG001|Open-Label Treatment Period|Protocol Violation|0|||
124775645|NCT03614156|448806579|FG002|Open-Label Treatment Period|Protocol Violation|0|||
124775646|NCT03614156|448806580|FG003|Open-Label Treatment Period|Protocol Violation|0|||
124775647|NCT03614156|448806577|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
124775648|NCT03614156|448806578|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
124775649|NCT03614156|448806579|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
124775650|NCT03614156|448806580|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
124775651|NCT03614156|448806577|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
124775652|NCT03614156|448806578|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
124775653|NCT03614156|448806579|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
124775654|NCT03614156|448806580|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
124775655|NCT03614156|448806577|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
124775656|NCT03614156|448806578|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
124775657|NCT03614156|448806579|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
124775658|NCT03614156|448806580|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
124724561|NCT01296711|448611750|FG007|Overall Study|Other|0|||
124500528|NCT00540449|447784135|FG000|Overall Study|Subject Non-Compliant|7|||
124500529|NCT00540449|447784136|FG001|Overall Study|Subject Non-Compliant|5|||
124500530|NCT00540449|447784135|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
124500531|NCT00540449|447784136|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
124500532|NCT00540449|447784135|FG000|Overall Study|Withdrawal by Subject|10|||
124500533|NCT00540449|447784136|FG001|Overall Study|Withdrawal by Subject|10|||
124500534|NCT00540449|447784135|FG000|Overall Study|Other|1|||
124500535|NCT00540449|447784136|FG001|Overall Study|Other|4|||
124500536|NCT01721408|447784137|FG000|Overall Study|Adverse Event|6|||
124500537|NCT01721408|447784138|FG001|Overall Study|Adverse Event|1|||
124500538|NCT01721408|447784137|FG000|Overall Study|Death|1|||
124500539|NCT01721408|447784138|FG001|Overall Study|Death|0|||
124500540|NCT01721408|447784137|FG000|Overall Study|Insufficient clinical response|15|||
124500541|NCT01721408|447784138|FG001|Overall Study|Insufficient clinical response|6|||
124500542|NCT01721408|447784137|FG000|Overall Study|No longer willing to participate study|9|||
124500543|NCT01721408|447784138|FG001|Overall Study|No longer willing to participate study|10|||
124500544|NCT01721408|447784137|FG000|Overall Study|Protocol Violation|0|||
124500545|NCT01721408|447784138|FG001|Overall Study|Protocol Violation|2|||
124500546|NCT01721408|447784137|FG000|Overall Study|Other|3|||
124500547|NCT01721408|447784138|FG001|Overall Study|Other|3|||
124500548|NCT01721408|447784137|FG000|Overall Study|Lost to Follow-up|1|||
124500549|NCT01721408|447784138|FG001|Overall Study|Lost to Follow-up|2|||
124500550|NCT01721408|447784137|FG000|Overall Study|Does not meet entrance criteria|1|||
124500551|NCT01721408|447784138|FG001|Overall Study|Does not meet entrance criteria|0|||
124500552|NCT00524316|447784139|FG000|Overall Study|Withdrawal by Subject|2|||
124500553|NCT00524316|447784139|FG000|Overall Study|Adverse Event|7|||
124500554|NCT00524316|447784139|FG000|Overall Study|Disease Progression|7|||
124500555|NCT01199263|447784140|FG000|Overall Study|Ineligible|0|||
124500556|NCT01199263|447784141|FG001|Overall Study|Ineligible|2|||
124500557|NCT01199263|447784140|FG000|Overall Study|Never Treated|6|||
124500558|NCT01199263|447784141|FG001|Overall Study|Never Treated|0|||
124500559|NCT01402284|447784142|FG000|Overall Study|Withdrawal consent|2|||
124500560|NCT01402284|447784142|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
124500561|NCT01402284|447784142|FG000|Overall Study|Physician Decision|1|||
124500562|NCT01402284|447784142|FG000|Overall Study|Disease progression on study|10|||
124500563|NCT04937816|447784143|FG000|Overall Study|Study drug stopped, reason missing|5|||
124500564|NCT04937816|447784144|FG001|Overall Study|Study drug stopped, reason missing|3|||
124500565|NCT04937816|447784145|FG002|Overall Study|Study drug stopped, reason missing|4|||
124500566|NCT04937816|447784146|FG003|Overall Study|Study drug stopped, reason missing|6|||
124500567|NCT04937816|447784147|FG004|Overall Study|Study drug stopped, reason missing|1|||
124500568|NCT04937816|447784148|FG005|Overall Study|Study drug stopped, reason missing|0|||
124500569|NCT04937816|447784149|FG006|Overall Study|Study drug stopped, reason missing|0|||
124500570|NCT04937816|447784143|FG000|Overall Study|Other than stated below|173|||
124500571|NCT04937816|447784144|FG001|Overall Study|Other than stated below|143|||
124500572|NCT04937816|447784145|FG002|Overall Study|Other than stated below|125|||
124500573|NCT04937816|447784146|FG003|Overall Study|Other than stated below|44|||
124500574|NCT04937816|447784147|FG004|Overall Study|Other than stated below|45|||
124500575|NCT04937816|447784148|FG005|Overall Study|Other than stated below|28|||
124500576|NCT04937816|447784149|FG006|Overall Study|Other than stated below|31|||
124500577|NCT04937816|447784143|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
124500578|NCT04937816|447784144|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
124500579|NCT04937816|447784145|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
124500580|NCT04937816|447784146|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
124500581|NCT04937816|447784147|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
124500582|NCT04937816|447784148|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
124500583|NCT04937816|447784149|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
124500584|NCT04937816|447784143|FG000|Overall Study|Lost to Follow-up|15|||
124500585|NCT04937816|447784144|FG001|Overall Study|Lost to Follow-up|9|||
124500586|NCT04937816|447784145|FG002|Overall Study|Lost to Follow-up|6|||
124500587|NCT04937816|447784146|FG003|Overall Study|Lost to Follow-up|6|||
124500588|NCT04937816|447784147|FG004|Overall Study|Lost to Follow-up|16|||
124500589|NCT04937816|447784148|FG005|Overall Study|Lost to Follow-up|11|||
124500590|NCT04937816|447784149|FG006|Overall Study|Lost to Follow-up|17|||
124500591|NCT04937816|447784143|FG000|Overall Study|Protocol Violation|15|||
124500592|NCT04937816|447784144|FG001|Overall Study|Protocol Violation|15|||
124500593|NCT04937816|447784145|FG002|Overall Study|Protocol Violation|12|||
124500594|NCT04937816|447784146|FG003|Overall Study|Protocol Violation|30|||
124500595|NCT04937816|447784147|FG004|Overall Study|Protocol Violation|24|||
124500596|NCT04937816|447784148|FG005|Overall Study|Protocol Violation|5|||
124500597|NCT04937816|447784149|FG006|Overall Study|Protocol Violation|5|||
124500598|NCT04937816|447784143|FG000|Overall Study|Adverse Event|303|||
124500599|NCT04937816|447784144|FG001|Overall Study|Adverse Event|267|||
124500600|NCT04937816|447784145|FG002|Overall Study|Adverse Event|273|||
124500601|NCT04937816|447784146|FG003|Overall Study|Adverse Event|553|||
124500602|NCT04937816|447784147|FG004|Overall Study|Adverse Event|575|||
124500603|NCT04937816|447784148|FG005|Overall Study|Adverse Event|343|||
124500604|NCT04937816|447784149|FG006|Overall Study|Adverse Event|337|||
124500605|NCT04937816|447784143|FG000|Overall Study|Not treated|4|||
124500606|NCT04937816|447784144|FG001|Overall Study|Not treated|2|||
124500607|NCT04937816|447784145|FG002|Overall Study|Not treated|2|||
124500608|NCT04937816|447784146|FG003|Overall Study|Not treated|2|||
124500609|NCT04937816|447784147|FG004|Overall Study|Not treated|1|||
124500610|NCT04937816|447784148|FG005|Overall Study|Not treated|4|||
124500611|NCT04937816|447784149|FG006|Overall Study|Not treated|0|||
124500612|NCT00492856|447785422|FG000|Induction|Adverse Event|2|||
124500613|NCT00492856|447785423|FG001|Induction|Adverse Event|0|||
124500614|NCT00492856|447785424|FG002|Induction|Adverse Event|0|||
124500615|NCT00492856|447785425|FG003|Induction|Adverse Event|0|||
124724562|NCT01296711|448611743|FG000|Overall Study|Required restricted steroid injections|0|||
124724563|NCT01296711|448611744|FG001|Overall Study|Required restricted steroid injections|0|||
124724564|NCT01296711|448611745|FG002|Overall Study|Required restricted steroid injections|0|||
124724565|NCT01296711|448611746|FG003|Overall Study|Required restricted steroid injections|0|||
124724566|NCT01296711|448611747|FG004|Overall Study|Required restricted steroid injections|0|||
124724567|NCT01296711|448611748|FG005|Overall Study|Required restricted steroid injections|0|||
124724568|NCT01296711|448611749|FG006|Overall Study|Required restricted steroid injections|1|||
124724569|NCT01296711|448611750|FG007|Overall Study|Required restricted steroid injections|0|||
124724570|NCT01296711|448611743|FG000|Overall Study|Ongoing missed appointments|0|||
124724571|NCT01296711|448611744|FG001|Overall Study|Ongoing missed appointments|0|||
124724572|NCT01296711|448611745|FG002|Overall Study|Ongoing missed appointments|0|||
124724573|NCT01296711|448611746|FG003|Overall Study|Ongoing missed appointments|0|||
124724574|NCT01296711|448611747|FG004|Overall Study|Ongoing missed appointments|0|||
124724575|NCT01296711|448611748|FG005|Overall Study|Ongoing missed appointments|0|||
124724576|NCT01296711|448611749|FG006|Overall Study|Ongoing missed appointments|1|||
124724577|NCT01296711|448611750|FG007|Overall Study|Ongoing missed appointments|0|||
124724578|NCT01296711|448611743|FG000|Overall Study|Failure to comply with visits|0|||
124724579|NCT01296711|448611744|FG001|Overall Study|Failure to comply with visits|0|||
124724580|NCT01296711|448611745|FG002|Overall Study|Failure to comply with visits|0|||
124724581|NCT01296711|448611746|FG003|Overall Study|Failure to comply with visits|0|||
124724582|NCT01296711|448611747|FG004|Overall Study|Failure to comply with visits|0|||
124724583|NCT01296711|448611748|FG005|Overall Study|Failure to comply with visits|0|||
124724584|NCT01296711|448611749|FG006|Overall Study|Failure to comply with visits|0|||
124724585|NCT01296711|448611750|FG007|Overall Study|Failure to comply with visits|1|||
124724586|NCT01296711|448611743|FG000|Overall Study|Patient decision due to transport|0|||
124724587|NCT01296711|448611744|FG001|Overall Study|Patient decision due to transport|0|||
124724588|NCT01296711|448611745|FG002|Overall Study|Patient decision due to transport|0|||
124724589|NCT01296711|448611746|FG003|Overall Study|Patient decision due to transport|0|||
124724590|NCT01296711|448611747|FG004|Overall Study|Patient decision due to transport|0|||
124724591|NCT01296711|448611748|FG005|Overall Study|Patient decision due to transport|0|||
124724592|NCT01296711|448611749|FG006|Overall Study|Patient decision due to transport|0|||
124724593|NCT01296711|448611750|FG007|Overall Study|Patient decision due to transport|1|||
124724594|NCT03249909|448611753|FG000|Overall Study|Withdrawal by Subject|3|||
124724595|NCT03249909|448611754|FG001|Overall Study|Withdrawal by Subject|0|||
124724596|NCT03249909|448611755|FG002|Overall Study|Withdrawal by Subject|0|||
124724597|NCT03249909|448611753|FG000|Overall Study|Adverse Event|3|||
124724598|NCT03249909|448611754|FG001|Overall Study|Adverse Event|0|||
124724599|NCT03249909|448611755|FG002|Overall Study|Adverse Event|0|||
124724600|NCT03249909|448611753|FG000|Overall Study|Lost to Follow-up|0|||
124724601|NCT03249909|448611754|FG001|Overall Study|Lost to Follow-up|1|||
124724602|NCT03249909|448611755|FG002|Overall Study|Lost to Follow-up|0|||
124724603|NCT00606034|448611756|FG000|Overall Study|incarceration|1|||
124724604|NCT01500252|448611758|FG000|Overall Study|Death|4|||
124724605|NCT01500252|448611759|FG001|Overall Study|Death|2|||
124724606|NCT01500252|448611758|FG000|Overall Study|Lost to Follow-up|5|||
124724607|NCT01500252|448611759|FG001|Overall Study|Lost to Follow-up|4|||
124724608|NCT02466425|448611762|FG000|Overall Study|Adverse Event|3|||
124724609|NCT02466425|448611763|FG001|Overall Study|Adverse Event|11|||
124724610|NCT02466425|448611762|FG000|Overall Study|Lack of Efficacy|4|||
124724611|NCT02466425|448611763|FG001|Overall Study|Lack of Efficacy|1|||
124724612|NCT02466425|448611762|FG000|Overall Study|Lost to Follow-up|3|||
124724613|NCT02466425|448611763|FG001|Overall Study|Lost to Follow-up|0|||
124724614|NCT02466425|448611762|FG000|Overall Study|Protocol Violation|1|||
124724615|NCT02466425|448611763|FG001|Overall Study|Protocol Violation|0|||
124724616|NCT02466425|448611762|FG000|Overall Study|Withdrawal by Subject|0|||
124724617|NCT02466425|448611763|FG001|Overall Study|Withdrawal by Subject|1|||
124724618|NCT02466425|448611762|FG000|Overall Study|Other|1|||
124724619|NCT02466425|448611763|FG001|Overall Study|Other|3|||
124500616|NCT00492856|447785422|FG000|Induction|Withdrawal by Subject|1|||
124500617|NCT00492856|447785423|FG001|Induction|Withdrawal by Subject|0|||
124500618|NCT00492856|447785424|FG002|Induction|Withdrawal by Subject|0|||
124500619|NCT00492856|447785425|FG003|Induction|Withdrawal by Subject|0|||
124724620|NCT02466425|448611762|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
124500620|NCT00492856|447785422|FG000|Induction|Death|3|||
124560393|NCT01698320|448009533|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
124560394|NCT01698320|448009531|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
124560395|NCT01698320|448009532|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
124560396|NCT01698320|448009533|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
124560397|NCT01698320|448009531|FG000|12-Week Double-Blind Period|Adverse Event|0|||
124560398|NCT01698320|448009532|FG001|12-Week Double-Blind Period|Adverse Event|1|||
124560399|NCT01698320|448009533|FG002|12-Week Double-Blind Period|Adverse Event|1|||
124560400|NCT01698320|448009531|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
124560401|NCT01698320|448009532|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
124560402|NCT01698320|448009533|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
124560403|NCT01698320|448009531|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
124560404|NCT01698320|448009532|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
124560405|NCT01698320|448009533|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
124560406|NCT01698320|448009531|FG000|12-Week Double-Blind Period|Pregnancy|0|||
124560407|NCT01698320|448009532|FG001|12-Week Double-Blind Period|Pregnancy|1|||
124560408|NCT01698320|448009533|FG002|12-Week Double-Blind Period|Pregnancy|1|||
124560409|NCT01698320|448009531|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
124560410|NCT01698320|448009532|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
124560411|NCT01698320|448009533|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
124560412|NCT01698320|448009531|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
124560413|NCT01698320|448009532|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
124560414|NCT01698320|448009533|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
124560415|NCT01698320|448009531|FG000|40-Week Open-Label Period|Adverse Event|0|||
124560416|NCT01698320|448009532|FG001|40-Week Open-Label Period|Adverse Event|3|||
124560417|NCT01698320|448009533|FG002|40-Week Open-Label Period|Adverse Event|2|||
124560418|NCT01698320|448009531|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
124560419|NCT01698320|448009532|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
124560420|NCT01698320|448009533|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
124560421|NCT01698320|448009531|FG000|40-Week Open-Label Period|Pregnancy|0|||
124560422|NCT01698320|448009532|FG001|40-Week Open-Label Period|Pregnancy|2|||
124560423|NCT01698320|448009533|FG002|40-Week Open-Label Period|Pregnancy|1|||
124560424|NCT01698320|448009531|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
124560425|NCT01698320|448009532|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
124560426|NCT01698320|448009533|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
124560427|NCT01698320|448009531|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
124560428|NCT01698320|448009532|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
124560429|NCT01698320|448009533|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
124560430|NCT01208402|448009538|FG000|Overall Study|Withdrawal by Subject|1|||
124560431|NCT01208402|448009539|FG001|Overall Study|Withdrawal by Subject|0|||
124560432|NCT01335464|448009540|FG000|Overall Study|Adverse Event|15|||
124560433|NCT01335464|448009541|FG001|Overall Study|Adverse Event|25|||
124560434|NCT01335464|448009540|FG000|Overall Study|Non compliant with protocol|2|||
124560435|NCT01335464|448009541|FG001|Overall Study|Non compliant with protocol|0|||
124560436|NCT01335464|448009540|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
124560437|NCT01335464|448009541|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
124560438|NCT01335464|448009540|FG000|Overall Study|Not treated|2|||
124560439|NCT01335464|448009541|FG001|Overall Study|Not treated|0|||
124560440|NCT01335464|448009540|FG000|Overall Study|Reason other than those stated above|1|||
124560441|NCT01335464|448009541|FG001|Overall Study|Reason other than those stated above|1|||
124560442|NCT03811249|448009542|FG000|Overall Study|Withdrawal by Subject|44|||
124560443|NCT03811249|448009542|FG000|Overall Study|Missed Visit|24|||
124560444|NCT00706706|448009543|FG000|Overall Study|Death|53|||
124560445|NCT00706706|448009543|FG000|Overall Study|Lost to Follow-up|7|||
124560446|NCT00706706|448009543|FG000|Overall Study|Study endpoint had reached|45|||
124560447|NCT02175966|448009548|FG000|Follow-up Period|Lack of Efficacy|10|||
124560448|NCT02175966|448009549|FG001|Follow-up Period|Lack of Efficacy|6|||
124560449|NCT01154153|448009550|FG000|Overall Study|Poor compliance to protocol|2|||
124560450|NCT01154153|448009551|FG001|Overall Study|Poor compliance to protocol|0|||
124560451|NCT01154153|448009550|FG000|Overall Study|Unable to use labs|2|||
124560452|NCT01154153|448009551|FG001|Overall Study|Unable to use labs|3|||
124560453|NCT01154153|448009550|FG000|Overall Study|Withdrew consent|1|||
124560454|NCT01154153|448009551|FG001|Overall Study|Withdrew consent|0|||
124560455|NCT00696709|448009552|FG000|Overall Study|Withdrawal by Subject|1|||
124560456|NCT00696709|448009553|FG001|Overall Study|Withdrawal by Subject|2|||
124560457|NCT00696709|448009554|FG002|Overall Study|Withdrawal by Subject|1|||
124560458|NCT00696709|448009555|FG003|Overall Study|Withdrawal by Subject|4|||
124560459|NCT00696709|448009556|FG004|Overall Study|Withdrawal by Subject|3|||
124560460|NCT00696709|448009552|FG000|Overall Study|Protocol Violation|1|||
124560461|NCT00696709|448009553|FG001|Overall Study|Protocol Violation|0|||
124560462|NCT00696709|448009554|FG002|Overall Study|Protocol Violation|0|||
124560463|NCT00696709|448009555|FG003|Overall Study|Protocol Violation|0|||
124560464|NCT00696709|448009556|FG004|Overall Study|Protocol Violation|0|||
124560465|NCT00696709|448009552|FG000|Overall Study|Lost to Follow-up|1|||
124560466|NCT00696709|448009553|FG001|Overall Study|Lost to Follow-up|1|||
124500621|NCT00492856|447785423|FG001|Induction|Death|0|||
124500622|NCT00492856|447785424|FG002|Induction|Death|0|||
124500623|NCT00492856|447785425|FG003|Induction|Death|0|||
124724621|NCT02466425|448611763|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124724622|NCT01721486|448611768|FG000|Overall Study|Protocol Violation|1|||
124724623|NCT01721486|448611769|FG001|Overall Study|Protocol Violation|0|||
124500624|NCT00492856|447785422|FG000|Consolidation|Adverse Event|6|||
124500625|NCT00492856|447785423|FG001|Consolidation|Adverse Event|0|||
124500626|NCT00492856|447785424|FG002|Consolidation|Adverse Event|0|||
124500627|NCT00492856|447785425|FG003|Consolidation|Adverse Event|0|||
124500628|NCT00492856|447785422|FG000|Consolidation|Not protocol specified|2|||
124500629|NCT00492856|447785423|FG001|Consolidation|Not protocol specified|0|||
124500630|NCT00492856|447785424|FG002|Consolidation|Not protocol specified|0|||
124500631|NCT00492856|447785425|FG003|Consolidation|Not protocol specified|0|||
124500632|NCT00492856|447785422|FG000|Consolidation|Lost to Follow-up|1|||
124500633|NCT00492856|447785423|FG001|Consolidation|Lost to Follow-up|0|||
124724624|NCT01721486|448611768|FG000|Overall Study|Physician Decision|0|||
124724625|NCT01721486|448611769|FG001|Overall Study|Physician Decision|1|||
124724626|NCT00582712|448611770|FG000|Overall Study|Adverse Event|1|||
124724627|NCT00582712|448611770|FG000|Overall Study|Lack of Efficacy|1|||
124724628|NCT00582712|448611770|FG000|Overall Study|Withdrawal by Subject|1|||
124724629|NCT00582712|448611770|FG000|Overall Study|Complicating disease requiring treatment|1|||
124724630|NCT05141175|448611771|FG000|Overall Study|Withdrawal by Subject|1|||
124724631|NCT01901289|448611773|FG000|Overall Study|Death|32|||
124724632|NCT01901289|448611773|FG000|Overall Study|Lost to Follow-up|16|||
124724633|NCT01901289|448611773|FG000|Overall Study|Withdrawal by Subject|35|||
124724634|NCT01901289|448611773|FG000|Overall Study|Other type of endpoint met|2|||
124724635|NCT01813058|448611774|FG000|Overall Study|Withdrawal by Subject|5|||
124724636|NCT01813058|448611775|FG001|Overall Study|Withdrawal by Subject|4|||
124724637|NCT00182078|448611777|FG000|Overall Study|Withdrawal by Subject|1|||
124724638|NCT00182078|448611778|FG001|Overall Study|Withdrawal by Subject|0|||
124724639|NCT00395486|448611779|FG000|Overall Study|Adverse Event|1|||
124724640|NCT00395486|448611780|FG001|Overall Study|Adverse Event|2|||
124724641|NCT00395486|448611779|FG000|Overall Study|Withdrawal by Subject|5|||
124724642|NCT00395486|448611780|FG001|Overall Study|Withdrawal by Subject|2|||
124724643|NCT00395486|448611779|FG000|Overall Study|Lost to Follow-up|0|||
124724644|NCT00395486|448611780|FG001|Overall Study|Lost to Follow-up|1|||
124724645|NCT01076205|448611781|FG000|Overall Study|Adverse Drug Reaction|299|||
124724646|NCT01076205|448611781|FG000|Overall Study|Lack of Effectiveness|1423|||
124724647|NCT01076205|448611781|FG000|Overall Study|Other Reason|1075|||
124724648|NCT01076205|448611781|FG000|Overall Study|Unknown Reason|71|||
124724649|NCT01076205|448611781|FG000|Overall Study|Lost to Follow-up|3151|||
124724650|NCT04731298|448611788|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
124724651|NCT04731298|448611789|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
124724652|NCT02443116|448611795|FG000|Part 1|Adverse Event|2|||
124724653|NCT02443116|448611796|FG001|Part 1|Adverse Event|3|||
124724654|NCT02443116|448611797|FG002|Part 1|Adverse Event|0|||
124724655|NCT02443116|448611798|FG003|Part 1|Adverse Event|0|||
124724656|NCT02443116|448611799|FG004|Part 1|Adverse Event|0|||
124724657|NCT02443116|448611800|FG005|Part 1|Adverse Event|0|||
124724658|NCT02443116|448611801|FG006|Part 1|Adverse Event|0|||
124724659|NCT02443116|448611802|FG007|Part 1|Adverse Event|0|||
124724660|NCT02443116|448611803|FG008|Part 1|Adverse Event|0|||
124724661|NCT02443116|448611795|FG000|Part 1|Withdrew informed consent|0|||
124724662|NCT02443116|448611796|FG001|Part 1|Withdrew informed consent|1|||
124724663|NCT02443116|448611797|FG002|Part 1|Withdrew informed consent|0|||
124724664|NCT02443116|448611798|FG003|Part 1|Withdrew informed consent|0|||
124724665|NCT02443116|448611799|FG004|Part 1|Withdrew informed consent|0|||
124724666|NCT02443116|448611800|FG005|Part 1|Withdrew informed consent|0|||
124724667|NCT02443116|448611801|FG006|Part 1|Withdrew informed consent|0|||
124724668|NCT02443116|448611802|FG007|Part 1|Withdrew informed consent|0|||
124724669|NCT02443116|448611803|FG008|Part 1|Withdrew informed consent|0|||
124724670|NCT02443116|448611795|FG000|Part 1|Lost to Follow-up|0|||
124724671|NCT02443116|448611796|FG001|Part 1|Lost to Follow-up|0|||
124724672|NCT02443116|448611797|FG002|Part 1|Lost to Follow-up|2|||
124724673|NCT02443116|448611798|FG003|Part 1|Lost to Follow-up|0|||
124724674|NCT02443116|448611799|FG004|Part 1|Lost to Follow-up|0|||
124724675|NCT02443116|448611800|FG005|Part 1|Lost to Follow-up|0|||
124724676|NCT02443116|448611801|FG006|Part 1|Lost to Follow-up|0|||
124724677|NCT02443116|448611802|FG007|Part 1|Lost to Follow-up|0|||
124724678|NCT02443116|448611803|FG008|Part 1|Lost to Follow-up|0|||
124724679|NCT02443116|448611795|FG000|Part 1|Participant moved out of state|0|||
124724680|NCT02443116|448611796|FG001|Part 1|Participant moved out of state|0|||
124724681|NCT02443116|448611797|FG002|Part 1|Participant moved out of state|1|||
124500634|NCT00492856|447785424|FG002|Consolidation|Lost to Follow-up|0|||
124500635|NCT00492856|447785425|FG003|Consolidation|Lost to Follow-up|0|||
124500636|NCT00492856|447785422|FG000|Post-consolidation|Adverse Event|0|||
124724682|NCT02443116|448611798|FG003|Part 1|Participant moved out of state|0|||
124500637|NCT00492856|447785423|FG001|Post-consolidation|Adverse Event|4|||
124724683|NCT02443116|448611799|FG004|Part 1|Participant moved out of state|0|||
124724684|NCT02443116|448611800|FG005|Part 1|Participant moved out of state|0|||
124775659|NCT03614156|448806577|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
124500638|NCT00492856|447785424|FG002|Post-consolidation|Adverse Event|0|||
124500639|NCT00492856|447785425|FG003|Post-consolidation|Adverse Event|1|||
124500640|NCT00492856|447785422|FG000|Post-consolidation|Withdrawal by Subject|0|||
124500641|NCT00492856|447785423|FG001|Post-consolidation|Withdrawal by Subject|4|||
124500642|NCT00492856|447785424|FG002|Post-consolidation|Withdrawal by Subject|0|||
124500643|NCT00492856|447785425|FG003|Post-consolidation|Withdrawal by Subject|0|||
124500644|NCT00492856|447785422|FG000|Post-consolidation|Death|0|||
124500645|NCT00492856|447785423|FG001|Post-consolidation|Death|1|||
124500646|NCT00492856|447785424|FG002|Post-consolidation|Death|0|||
124500647|NCT00492856|447785425|FG003|Post-consolidation|Death|0|||
124500648|NCT00492856|447785422|FG000|Post-consolidation|Not protocol specified|0|||
124500649|NCT00492856|447785423|FG001|Post-consolidation|Not protocol specified|1|||
124500650|NCT00492856|447785424|FG002|Post-consolidation|Not protocol specified|0|||
124500651|NCT00492856|447785425|FG003|Post-consolidation|Not protocol specified|0|||
124500652|NCT00492856|447785422|FG000|Post-consolidation|Lost to Follow-up|0|||
124500653|NCT00492856|447785423|FG001|Post-consolidation|Lost to Follow-up|2|||
124500654|NCT00492856|447785424|FG002|Post-consolidation|Lost to Follow-up|0|||
124500655|NCT00492856|447785425|FG003|Post-consolidation|Lost to Follow-up|0|||
124500656|NCT00492856|447785422|FG000|Post-consolidation|Observation Arm|0|||
124500657|NCT00492856|447785423|FG001|Post-consolidation|Observation Arm|0|||
124500658|NCT00492856|447785424|FG002|Post-consolidation|Observation Arm|27|||
124500659|NCT00492856|447785425|FG003|Post-consolidation|Observation Arm|0|||
124500660|NCT01998581|447785426|FG000|Overall Study|Refused repeat treatment|20|||
124500661|NCT01998581|447785427|FG001|Overall Study|Refused repeat treatment|4|||
124500662|NCT01998581|447785426|FG000|Overall Study|Protocol Violation|1|||
124500663|NCT01998581|447785427|FG001|Overall Study|Protocol Violation|0|||
124500664|NCT01998581|447785426|FG000|Overall Study|Withdrawal by Subject|8|||
124500665|NCT01998581|447785427|FG001|Overall Study|Withdrawal by Subject|1|||
124500666|NCT01998581|447785426|FG000|Overall Study|Lost to Follow-up|12|||
124500667|NCT01998581|447785427|FG001|Overall Study|Lost to Follow-up|4|||
124500668|NCT01998581|447785426|FG000|Overall Study|Adverse Event|1|||
124500669|NCT01998581|447785427|FG001|Overall Study|Adverse Event|1|||
124500670|NCT01998581|447785426|FG000|Overall Study|Other reasons|3|||
124500671|NCT01998581|447785427|FG001|Overall Study|Other reasons|2|||
124500672|NCT01998581|447785426|FG000|Overall Study|Randomized but withdrew before treatment|1|||
124500673|NCT01998581|447785427|FG001|Overall Study|Randomized but withdrew before treatment|0|||
124500674|NCT01251276|447785428|FG000|Overall Study|Protocol Violation|1|||
124500675|NCT01251276|447785429|FG001|Overall Study|Protocol Violation|0|||
124500676|NCT01251276|447785428|FG000|Overall Study|Lost to Follow-up|0|||
124500677|NCT01251276|447785429|FG001|Overall Study|Lost to Follow-up|1|||
124500678|NCT01345123|447785430|FG000|Overall Study|participants no longer with health plan|79|||
124500679|NCT01345123|447785431|FG001|Overall Study|participants no longer with health plan|85|||
124500680|NCT01345123|447785432|FG002|Overall Study|participants no longer with health plan|88|||
124500681|NCT01457118|447785439|FG000|Overall Study|Adverse Event|1|||
124500682|NCT01457118|447785440|FG001|Overall Study|Adverse Event|0|||
124500683|NCT01457118|447785441|FG002|Overall Study|Adverse Event|0|||
124500684|NCT01457118|447785442|FG003|Overall Study|Adverse Event|1|||
124500685|NCT01457118|447785439|FG000|Overall Study|Clinical Progression|0|||
124500686|NCT01457118|447785440|FG001|Overall Study|Clinical Progression|1|||
124500687|NCT01457118|447785441|FG002|Overall Study|Clinical Progression|0|||
124500688|NCT01457118|447785442|FG003|Overall Study|Clinical Progression|1|||
124500689|NCT01457118|447785439|FG000|Overall Study|Physician Decision|2|||
124500690|NCT01457118|447785440|FG001|Overall Study|Physician Decision|0|||
124500691|NCT01457118|447785441|FG002|Overall Study|Physician Decision|0|||
124500692|NCT01457118|447785442|FG003|Overall Study|Physician Decision|0|||
124500693|NCT01457118|447785439|FG000|Overall Study|Progressive Disease by RECIST|12|||
124500694|NCT01457118|447785440|FG001|Overall Study|Progressive Disease by RECIST|3|||
124500695|NCT01457118|447785441|FG002|Overall Study|Progressive Disease by RECIST|1|||
124500696|NCT01457118|447785442|FG003|Overall Study|Progressive Disease by RECIST|0|||
124500697|NCT01457118|447785439|FG000|Overall Study|Withdrawal by Subject|5|||
124500698|NCT01457118|447785440|FG001|Overall Study|Withdrawal by Subject|0|||
124500699|NCT01457118|447785441|FG002|Overall Study|Withdrawal by Subject|0|||
124500700|NCT01457118|447785442|FG003|Overall Study|Withdrawal by Subject|0|||
124500701|NCT03456713|447785444|FG000|Overall Study|Lost to Follow-up|1|||
124500702|NCT03456713|447785445|FG001|Overall Study|Lost to Follow-up|0|||
124500703|NCT03456713|447785446|FG002|Overall Study|Lost to Follow-up|0|||
124500704|NCT03456713|447785447|FG003|Overall Study|Lost to Follow-up|0|||
124500705|NCT01202227|447785448|FG000|Overall Study|Adverse Event|16|||
124500706|NCT01202227|447785448|FG000|Overall Study|Withdrawal by Subject|2|||
124500707|NCT01202227|447785448|FG000|Overall Study|Lack of Efficacy|1|||
124500708|NCT04402008|447785451|FG000|Overall Study|Adverse Event|0|||
124500709|NCT04402008|447785452|FG001|Overall Study|Adverse Event|0|||
124500710|NCT04402008|447785453|FG002|Overall Study|Adverse Event|0|||
124560467|NCT00696709|448009554|FG002|Overall Study|Lost to Follow-up|0|||
124560468|NCT00696709|448009555|FG003|Overall Study|Lost to Follow-up|0|||
124560469|NCT00696709|448009556|FG004|Overall Study|Lost to Follow-up|0|||
124560470|NCT00696709|448009552|FG000|Overall Study|Adverse Event|0|||
124560471|NCT00696709|448009553|FG001|Overall Study|Adverse Event|0|||
124560472|NCT00696709|448009554|FG002|Overall Study|Adverse Event|0|||
124560473|NCT00696709|448009555|FG003|Overall Study|Adverse Event|1|||
124560474|NCT00696709|448009556|FG004|Overall Study|Adverse Event|0|||
124560475|NCT01227668|448009557|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
124560476|NCT01227668|448009558|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
124560477|NCT01227668|448009557|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
124560478|NCT01227668|448009558|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
124560479|NCT01227668|448009557|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
124560480|NCT01227668|448009558|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
124560481|NCT01227668|448009557|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
124560482|NCT01227668|448009558|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
124560483|NCT01227668|448009557|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
124560484|NCT01227668|448009558|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
124560485|NCT01227668|448009557|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
124560486|NCT01227668|448009558|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
124560487|NCT01227668|448009557|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
124560488|NCT01227668|448009558|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
124560489|NCT01227668|448009557|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
124560490|NCT01227668|448009558|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
124560491|NCT01227668|448009557|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
124560492|NCT01227668|448009558|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
124560493|NCT01227668|448009557|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
124560494|NCT01227668|448009558|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
124560495|NCT01227668|448009557|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
124560496|NCT01227668|448009558|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
124560497|NCT01227668|448009557|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
124560498|NCT01227668|448009558|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
124560499|NCT00210626|448009559|FG000|Overall Study|Adverse Event|1|||
124560500|NCT00210626|448009560|FG001|Overall Study|Adverse Event|2|||
124560501|NCT00210626|448009559|FG000|Overall Study|Protocol Violation|1|||
124560502|NCT00210626|448009560|FG001|Overall Study|Protocol Violation|5|||
124560503|NCT00210626|448009559|FG000|Overall Study|Lost to Follow-up|11|||
124560504|NCT00210626|448009560|FG001|Overall Study|Lost to Follow-up|11|||
124560505|NCT00210626|448009559|FG000|Overall Study|Death|1|||
124560506|NCT00210626|448009560|FG001|Overall Study|Death|0|||
124560507|NCT00210626|448009559|FG000|Overall Study|Withdrawal by Subject|29|||
124560508|NCT00210626|448009560|FG001|Overall Study|Withdrawal by Subject|20|||
124560509|NCT00210626|448009559|FG000|Overall Study|Physician Decision|0|||
124560510|NCT00210626|448009560|FG001|Overall Study|Physician Decision|2|||
124560511|NCT00210626|448009559|FG000|Overall Study|Sponser Request|1|||
124560512|NCT00210626|448009560|FG001|Overall Study|Sponser Request|0|||
124560513|NCT00210626|448009559|FG000|Overall Study|Other|4|||
124560514|NCT00210626|448009560|FG001|Overall Study|Other|5|||
124560515|NCT02473510|448009561|FG000|Overall Study|Lost to Follow-up|1|||
124560516|NCT02473510|448009562|FG001|Overall Study|Lost to Follow-up|2|||
124560517|NCT01306253|448009563|FG000|Overall Study|Lost to Follow-up|1|||
124560518|NCT01306253|448009564|FG001|Overall Study|Lost to Follow-up|1|||
124724685|NCT02443116|448611801|FG006|Part 1|Participant moved out of state|0|||
124724686|NCT02443116|448611802|FG007|Part 1|Participant moved out of state|0|||
124724687|NCT02443116|448611803|FG008|Part 1|Participant moved out of state|0|||
124724688|NCT02443116|448611795|FG000|Part 1|Participant enrolled in another clinical trial|0|||
124724689|NCT02443116|448611796|FG001|Part 1|Participant enrolled in another clinical trial|0|||
124724690|NCT02443116|448611797|FG002|Part 1|Participant enrolled in another clinical trial|1|||
124724691|NCT02443116|448611798|FG003|Part 1|Participant enrolled in another clinical trial|0|||
124500711|NCT04402008|447785454|FG003|Overall Study|Adverse Event|1|||
124500712|NCT04402008|447785455|FG004|Overall Study|Adverse Event|0|||
124500713|NCT04402008|447785456|FG005|Overall Study|Adverse Event|0|||
124500714|NCT04402008|447785457|FG006|Overall Study|Adverse Event|0|||
124500715|NCT04402008|447785451|FG000|Overall Study|Disease Progression|3|||
124500716|NCT04402008|447785452|FG001|Overall Study|Disease Progression|2|||
124500717|NCT04402008|447785453|FG002|Overall Study|Disease Progression|3|||
124500718|NCT04402008|447785454|FG003|Overall Study|Disease Progression|3|||
124500719|NCT04402008|447785455|FG004|Overall Study|Disease Progression|4|||
124500720|NCT04402008|447785456|FG005|Overall Study|Disease Progression|3|||
124500721|NCT04402008|447785457|FG006|Overall Study|Disease Progression|10|||
124500722|NCT04402008|447785451|FG000|Overall Study|Withdrawal by Subject|0|||
124500723|NCT04402008|447785452|FG001|Overall Study|Withdrawal by Subject|1|||
124560519|NCT02280356|448009565|FG000|Overall Study|Not Treated|2|||
124560520|NCT02280356|448009565|FG000|Overall Study|Withdrawal by Subject|1|||
124500724|NCT04402008|447785453|FG002|Overall Study|Withdrawal by Subject|0|||
124500725|NCT04402008|447785454|FG003|Overall Study|Withdrawal by Subject|0|||
124500726|NCT04402008|447785455|FG004|Overall Study|Withdrawal by Subject|1|||
124500727|NCT04402008|447785456|FG005|Overall Study|Withdrawal by Subject|0|||
124500728|NCT04402008|447785457|FG006|Overall Study|Withdrawal by Subject|0|||
124500729|NCT04402008|447785451|FG000|Overall Study|Sponsor Decision|0|||
124500730|NCT04402008|447785452|FG001|Overall Study|Sponsor Decision|0|||
124500731|NCT04402008|447785453|FG002|Overall Study|Sponsor Decision|0|||
124500732|NCT04402008|447785454|FG003|Overall Study|Sponsor Decision|0|||
124500733|NCT04402008|447785455|FG004|Overall Study|Sponsor Decision|0|||
124500734|NCT04402008|447785456|FG005|Overall Study|Sponsor Decision|0|||
124500735|NCT04402008|447785457|FG006|Overall Study|Sponsor Decision|3|||
124500736|NCT04402008|447785451|FG000|Overall Study|Death|0|||
124500737|NCT04402008|447785452|FG001|Overall Study|Death|0|||
124500738|NCT04402008|447785453|FG002|Overall Study|Death|0|||
124500739|NCT04402008|447785454|FG003|Overall Study|Death|0|||
124500740|NCT04402008|447785455|FG004|Overall Study|Death|1|||
124500741|NCT04402008|447785456|FG005|Overall Study|Death|0|||
124500742|NCT04402008|447785457|FG006|Overall Study|Death|2|||
124500743|NCT04402008|447785451|FG000|Overall Study|Other|0|||
124500744|NCT04402008|447785452|FG001|Overall Study|Other|0|||
124500745|NCT04402008|447785453|FG002|Overall Study|Other|0|||
124500746|NCT04402008|447785454|FG003|Overall Study|Other|0|||
124500747|NCT04402008|447785455|FG004|Overall Study|Other|0|||
124500748|NCT04402008|447785456|FG005|Overall Study|Other|0|||
124500749|NCT04402008|447785457|FG006|Overall Study|Other|5|||
124500750|NCT03430245|447785458|FG000|Overall Study|Withdrawal by Subject|6|||
124500751|NCT03430245|447785458|FG000|Overall Study|Lost to Follow-up|1|||
124500752|NCT00850759|447785459|FG000|Overall Study|Lost to Follow-up|7|||
124500753|NCT00850759|447785460|FG001|Overall Study|Lost to Follow-up|5|||
124500754|NCT00850759|447785461|FG002|Overall Study|Lost to Follow-up|5|||
124500755|NCT00850759|447785462|FG003|Overall Study|Lost to Follow-up|3|||
124500756|NCT00788775|447785463|FG000|Overall Study|Progressive Disease|8|||
124500757|NCT00788775|447785464|FG001|Overall Study|Progressive Disease|6|||
124500758|NCT00788775|447785463|FG000|Overall Study|Withdrawal by Subject|0|||
124500759|NCT00788775|447785464|FG001|Overall Study|Withdrawal by Subject|2|||
124500760|NCT00788775|447785463|FG000|Overall Study|Patient Non-Compliance|1|||
124500761|NCT00788775|447785464|FG001|Overall Study|Patient Non-Compliance|0|||
124500762|NCT00788775|447785463|FG000|Overall Study|Patient's measurable disease resected.|1|||
124500763|NCT00788775|447785464|FG001|Overall Study|Patient's measurable disease resected.|0|||
124500764|NCT01864018|447785472|FG000|Overall Study|Ineligible|3|||
124500765|NCT01864018|447785473|FG001|Overall Study|Ineligible|1|||
124500766|NCT00114972|447785474|FG000|Overall Study|Withdrawal by Subject|40|||
124500767|NCT00114972|447785475|FG001|Overall Study|Withdrawal by Subject|7|||
124500768|NCT00114972|447785474|FG000|Overall Study|Lost to Follow-up|8|||
124500769|NCT00114972|447785475|FG001|Overall Study|Lost to Follow-up|5|||
124500770|NCT01425190|447785477|FG000|Overall Study|Full dose not consumed.|1|||
124500771|NCT01425190|447785478|FG001|Overall Study|Full dose not consumed.|0|||
124500772|NCT01425190|447785479|FG002|Overall Study|Full dose not consumed.|0|||
124500773|NCT01912729|447785480|FG000|Overall Study|Withdrawal by Subject|0|||
124500774|NCT01912729|447785481|FG001|Overall Study|Withdrawal by Subject|1|||
124500775|NCT01952834|447785484|FG000|Overall Study|Adverse Event|1|||
124500776|NCT04285346|447785485|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
124500777|NCT04285346|447785486|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
124500778|NCT04285346|447785485|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
124500779|NCT04285346|447785486|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
124500780|NCT04285346|447785485|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
124500781|NCT04285346|447785486|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
124500782|NCT00610935|447785489|FG000|Overall Study|Lost to Follow-up|0|||
124500783|NCT00610935|447785490|FG001|Overall Study|Lost to Follow-up|1|||
124500784|NCT00610935|447785489|FG000|Overall Study|Withdrawal by Subject|0|||
124500785|NCT00610935|447785490|FG001|Overall Study|Withdrawal by Subject|2|||
124500786|NCT00610935|447785489|FG000|Overall Study|Sponsor Discontinuation|1|||
124500787|NCT00610935|447785490|FG001|Overall Study|Sponsor Discontinuation|0|||
124500788|NCT00740779|447785491|FG000|Overall Study|Adverse Event|4|||
124500789|NCT00740779|447785492|FG001|Overall Study|Adverse Event|6|||
124500790|NCT00740779|447785493|FG002|Overall Study|Adverse Event|3|||
124500791|NCT00740779|447785491|FG000|Overall Study|Protocol Violation|1|||
124500792|NCT00740779|447785492|FG001|Overall Study|Protocol Violation|1|||
124500793|NCT00740779|447785493|FG002|Overall Study|Protocol Violation|1|||
124500794|NCT00740779|447785491|FG000|Overall Study|Lack of Efficacy|0|||
124500795|NCT00740779|447785492|FG001|Overall Study|Lack of Efficacy|0|||
124500796|NCT00740779|447785493|FG002|Overall Study|Lack of Efficacy|2|||
124500797|NCT00740779|447785491|FG000|Overall Study|Withdrawal by Subject|2|||
124500798|NCT00740779|447785492|FG001|Overall Study|Withdrawal by Subject|4|||
124500799|NCT00740779|447785493|FG002|Overall Study|Withdrawal by Subject|2|||
124500800|NCT00740779|447785491|FG000|Overall Study|Lost to Follow-up|2|||
124500801|NCT00740779|447785492|FG001|Overall Study|Lost to Follow-up|3|||
124500802|NCT00740779|447785493|FG002|Overall Study|Lost to Follow-up|5|||
124775660|NCT03614156|448806578|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
124775661|NCT03614156|448806579|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
124775662|NCT03614156|448806580|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
124775663|NCT03614156|448806577|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
124775664|NCT03614156|448806578|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
124775665|NCT03614156|448806579|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
124560521|NCT02280356|448009565|FG000|Overall Study|Not evaluable|2|||
124560522|NCT01086215|448009566|FG000|Overall Study|Death|14|||
124560523|NCT01086215|448009567|FG001|Overall Study|Death|8|||
124560524|NCT01086215|448009568|FG002|Overall Study|Death|8|||
124560525|NCT01086215|448009569|FG003|Overall Study|Death|1|||
124560526|NCT01086215|448009566|FG000|Overall Study|Lost to Follow-up|22|||
124560527|NCT01086215|448009567|FG001|Overall Study|Lost to Follow-up|39|||
124560528|NCT01086215|448009568|FG002|Overall Study|Lost to Follow-up|18|||
124560529|NCT01086215|448009569|FG003|Overall Study|Lost to Follow-up|2|||
124560530|NCT02006147|448009572|FG000|Overall Study|Protocol Violation|1|||
124560531|NCT02006147|448009573|FG001|Overall Study|Protocol Violation|1|||
124560532|NCT02006147|448009574|FG002|Overall Study|Protocol Violation|0|||
124560533|NCT02006147|448009575|FG003|Overall Study|Protocol Violation|0|||
124560534|NCT02006147|448009572|FG000|Overall Study|Withdrawal by Subject|0|||
124560535|NCT02006147|448009573|FG001|Overall Study|Withdrawal by Subject|1|||
124560536|NCT02006147|448009574|FG002|Overall Study|Withdrawal by Subject|0|||
124560537|NCT02006147|448009575|FG003|Overall Study|Withdrawal by Subject|0|||
124560538|NCT02006147|448009572|FG000|Overall Study|Withdrawal by Sponsor|1|||
124560539|NCT02006147|448009573|FG001|Overall Study|Withdrawal by Sponsor|0|||
124560540|NCT02006147|448009574|FG002|Overall Study|Withdrawal by Sponsor|0|||
124560541|NCT02006147|448009575|FG003|Overall Study|Withdrawal by Sponsor|0|||
124560542|NCT03361956|448009576|FG000|Overall Study|Adverse Event|1|||
124560543|NCT03361956|448009577|FG001|Overall Study|Adverse Event|0|||
124560544|NCT03361956|448009578|FG002|Overall Study|Adverse Event|1|||
124560545|NCT03361956|448009579|FG003|Overall Study|Adverse Event|1|||
124560546|NCT03361956|448009580|FG004|Overall Study|Adverse Event|0|||
124560547|NCT03361956|448009576|FG000|Overall Study|Other|0|||
124560548|NCT03361956|448009577|FG001|Overall Study|Other|0|||
124560549|NCT03361956|448009578|FG002|Overall Study|Other|0|||
124560550|NCT03361956|448009579|FG003|Overall Study|Other|1|||
124560551|NCT03361956|448009580|FG004|Overall Study|Other|0|||
124560552|NCT03361956|448009576|FG000|Overall Study|Withdrawal by Subject|2|||
124560553|NCT03361956|448009577|FG001|Overall Study|Withdrawal by Subject|2|||
124560554|NCT03361956|448009578|FG002|Overall Study|Withdrawal by Subject|2|||
124560555|NCT03361956|448009579|FG003|Overall Study|Withdrawal by Subject|0|||
124560556|NCT03361956|448009580|FG004|Overall Study|Withdrawal by Subject|3|||
124560557|NCT03361956|448009576|FG000|Overall Study|Disease Relapse|0|||
124560558|NCT03361956|448009577|FG001|Overall Study|Disease Relapse|0|||
124560559|NCT03361956|448009578|FG002|Overall Study|Disease Relapse|1|||
124560560|NCT03361956|448009579|FG003|Overall Study|Disease Relapse|0|||
124560561|NCT03361956|448009580|FG004|Overall Study|Disease Relapse|0|||
124560562|NCT03361956|448009576|FG000|Overall Study|Physician Decision|0|||
124560563|NCT03361956|448009577|FG001|Overall Study|Physician Decision|2|||
124560564|NCT03361956|448009578|FG002|Overall Study|Physician Decision|0|||
124560565|NCT03361956|448009579|FG003|Overall Study|Physician Decision|1|||
124560566|NCT03361956|448009580|FG004|Overall Study|Physician Decision|0|||
124560567|NCT03361956|448009576|FG000|Overall Study|Lost to Follow-up|0|||
124560568|NCT03361956|448009577|FG001|Overall Study|Lost to Follow-up|0|||
124560569|NCT03361956|448009578|FG002|Overall Study|Lost to Follow-up|1|||
124560570|NCT03361956|448009579|FG003|Overall Study|Lost to Follow-up|1|||
124560571|NCT03361956|448009580|FG004|Overall Study|Lost to Follow-up|2|||
124560572|NCT00408876|448009581|FG000|Overall Study|Adverse Event|9|||
124560573|NCT00408876|448009582|FG001|Overall Study|Adverse Event|17|||
124560574|NCT00408876|448009583|FG002|Overall Study|Adverse Event|27|||
124775666|NCT03614156|448806580|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
124775667|NCT03614156|448806577|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
124775668|NCT03614156|448806578|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
124560575|NCT00408876|448009584|FG003|Overall Study|Adverse Event|10|||
124560576|NCT00408876|448009581|FG000|Overall Study|Withdrawal by Subject|3|||
124560577|NCT00408876|448009582|FG001|Overall Study|Withdrawal by Subject|6|||
124560578|NCT00408876|448009583|FG002|Overall Study|Withdrawal by Subject|6|||
124560579|NCT00408876|448009584|FG003|Overall Study|Withdrawal by Subject|14|||
124560580|NCT00408876|448009581|FG000|Overall Study|Lack of Efficacy|2|||
124560581|NCT00408876|448009582|FG001|Overall Study|Lack of Efficacy|4|||
124560582|NCT00408876|448009583|FG002|Overall Study|Lack of Efficacy|5|||
124560583|NCT00408876|448009584|FG003|Overall Study|Lack of Efficacy|6|||
124560584|NCT00408876|448009581|FG000|Overall Study|Lost to Follow-up|1|||
124560585|NCT00408876|448009582|FG001|Overall Study|Lost to Follow-up|6|||
124560586|NCT00408876|448009583|FG002|Overall Study|Lost to Follow-up|5|||
124560587|NCT00408876|448009584|FG003|Overall Study|Lost to Follow-up|2|||
124560588|NCT00408876|448009581|FG000|Overall Study|Protocol Violation|0|||
124560589|NCT00408876|448009582|FG001|Overall Study|Protocol Violation|3|||
124775669|NCT03614156|448806579|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
124775670|NCT03614156|448806580|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
124775671|NCT03614156|448806577|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
124775672|NCT03614156|448806578|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
124775673|NCT03614156|448806579|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
124775674|NCT03614156|448806580|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
124775675|NCT03614156|448806577|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
124775676|NCT03614156|448806578|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
124775677|NCT03614156|448806579|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
124775678|NCT03614156|448806580|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
124775679|NCT03614156|448806577|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
124775680|NCT03614156|448806578|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
124775681|NCT03614156|448806579|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
124775682|NCT03614156|448806580|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
124775683|NCT03614156|448806577|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
124775684|NCT03614156|448806578|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
124775685|NCT03614156|448806579|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
124775686|NCT03614156|448806580|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
124775687|NCT03614156|448806577|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
124775688|NCT03614156|448806578|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
124775689|NCT03614156|448806579|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
124775690|NCT03614156|448806580|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
124775691|NCT04287517|448806582|FG000|Overall Study|Withdrawal by Subject|1|||
124775692|NCT04287517|448806583|FG001|Overall Study|Withdrawal by Subject|1|||
124775693|NCT03070964|448806584|FG000|Overall Study|Progressive disease|8|||
124775694|NCT03070964|448806584|FG000|Overall Study|Treatment-unrelated adverse event|2|||
124775695|NCT03070964|448806584|FG000|Overall Study|Never treated|1|||
124775696|NCT03070964|448806584|FG000|Overall Study|Physician Decision|1|||
124775697|NCT03070964|448806584|FG000|Overall Study|Withdrawal by Subject|1|||
124775698|NCT03070964|448806584|FG000|Overall Study|Adverse Event|1|||
124775699|NCT00834093|448806587|FG000|Overall Study|Progressive Disease|3|||
124775700|NCT00834093|448806587|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
124775701|NCT02425943|448806588|FG000|Overall Study|Adverse Event|3|||
124775702|NCT02425943|448806589|FG001|Overall Study|Adverse Event|1|||
124775703|NCT02425943|448806588|FG000|Overall Study|Lost to Follow-up|59|||
124775704|NCT02425943|448806589|FG001|Overall Study|Lost to Follow-up|37|||
124775705|NCT02425943|448806588|FG000|Overall Study|Protocol Violation|4|||
124775706|NCT02425943|448806589|FG001|Overall Study|Protocol Violation|1|||
124775707|NCT02425943|448806588|FG000|Overall Study|Withdrawal by Subject|64|||
124775708|NCT02425943|448806589|FG001|Overall Study|Withdrawal by Subject|31|||
124775709|NCT02425943|448806588|FG000|Overall Study|Other|6|||
124500803|NCT00850460|447785494|FG000|Overall Study|Lost to Follow-up|4|||
124500804|NCT00850460|447785495|FG001|Overall Study|Lost to Follow-up|4|||
124500805|NCT02399813|447785498|FG000|Overall Study|Progressive Disease-Radiographic|2|||
124500806|NCT02399813|447785498|FG000|Overall Study|Death|20|||
124500807|NCT02399813|447785498|FG000|Overall Study|Withdrawal by Subject|3|||
124500808|NCT02399813|447785498|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
124500809|NCT02399813|447785498|FG000|Overall Study|Lost to Follow-up|2|||
124500810|NCT02399813|447785498|FG000|Overall Study|Other than specified|5|||
124500811|NCT00988559|447785499|FG000|Overall Study|Withdrawal by Subject|1|||
124500812|NCT00988559|447785500|FG001|Overall Study|Withdrawal by Subject|1|||
124500813|NCT00988559|447785501|FG002|Overall Study|Withdrawal by Subject|0|||
124500814|NCT00988559|447785502|FG003|Overall Study|Withdrawal by Subject|1|||
124500815|NCT00988559|447785499|FG000|Overall Study|Pregnancy|0|||
124500816|NCT00988559|447785500|FG001|Overall Study|Pregnancy|1|||
124500817|NCT00988559|447785501|FG002|Overall Study|Pregnancy|1|||
124500818|NCT00988559|447785502|FG003|Overall Study|Pregnancy|0|||
124500819|NCT00988559|447785499|FG000|Overall Study|Lost to Follow-up|0|||
124500820|NCT00988559|447785500|FG001|Overall Study|Lost to Follow-up|0|||
124500821|NCT00988559|447785501|FG002|Overall Study|Lost to Follow-up|1|||
124500822|NCT00988559|447785502|FG003|Overall Study|Lost to Follow-up|0|||
124500823|NCT02224846|447785503|FG000|Period 1 (Month 3)|Adverse Event|2|||
124500824|NCT02224846|447785504|FG001|Period 1 (Month 3)|Adverse Event|1|||
124500825|NCT02224846|447785503|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
124500826|NCT02224846|447785504|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
124500827|NCT02224846|447785503|FG000|Period 1 (Month 3)|Protocol Violation|4|||
124775710|NCT02425943|448806589|FG001|Overall Study|Other|0|||
124500828|NCT02224846|447785504|FG001|Period 1 (Month 3)|Protocol Violation|8|||
124500829|NCT02224846|447785503|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
124500830|NCT02224846|447785504|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
124500831|NCT02224846|447785503|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
124500832|NCT02224846|447785504|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
124775711|NCT02379091|448806590|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
124775712|NCT02379091|448806591|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
124560590|NCT00408876|448009583|FG002|Overall Study|Protocol Violation|4|||
124560591|NCT00408876|448009584|FG003|Overall Study|Protocol Violation|3|||
124560592|NCT00408876|448009581|FG000|Overall Study|Physician Decision|1|||
124560593|NCT00408876|448009582|FG001|Overall Study|Physician Decision|0|||
124560594|NCT00408876|448009583|FG002|Overall Study|Physician Decision|3|||
124560595|NCT00408876|448009584|FG003|Overall Study|Physician Decision|0|||
124560596|NCT00871728|448009590|FG000|Overall Study|Adverse Event|1|||
124560597|NCT00871728|448009590|FG000|Overall Study|Protocol Violation|7|||
124560598|NCT00871728|448009590|FG000|Overall Study|Lost to Follow-up|2|||
124560599|NCT00871728|448009590|FG000|Overall Study|Failed to Visit Hospital|4|||
124560600|NCT00871728|448009590|FG000|Overall Study|Participant Non-compliance|1|||
124560601|NCT00871728|448009590|FG000|Overall Study|Withdrawal of Informed Consent|5|||
124560602|NCT04147715|448009591|FG000|Overall Study|Adverse Event|0|||
124560603|NCT04147715|448009592|FG001|Overall Study|Adverse Event|0|||
124560604|NCT04147715|448009593|FG002|Overall Study|Adverse Event|0|||
124560605|NCT04147715|448009594|FG003|Overall Study|Adverse Event|0|||
124560606|NCT04147715|448009595|FG004|Overall Study|Adverse Event|0|||
124560607|NCT04147715|448009596|FG005|Overall Study|Adverse Event|0|||
124560608|NCT04147715|448009597|FG006|Overall Study|Adverse Event|0|||
124560609|NCT04147715|448009598|FG007|Overall Study|Adverse Event|2|||
124560610|NCT04147715|448009599|FG008|Overall Study|Adverse Event|1|||
124560611|NCT04147715|448009600|FG009|Overall Study|Adverse Event|0|||
124560612|NCT04147715|448009601|FG010|Overall Study|Adverse Event|0|||
124724692|NCT02443116|448611799|FG004|Part 1|Participant enrolled in another clinical trial|0|||
124724693|NCT02443116|448611800|FG005|Part 1|Participant enrolled in another clinical trial|0|||
124724694|NCT02443116|448611801|FG006|Part 1|Participant enrolled in another clinical trial|0|||
124724695|NCT02443116|448611802|FG007|Part 1|Participant enrolled in another clinical trial|0|||
124724696|NCT02443116|448611803|FG008|Part 1|Participant enrolled in another clinical trial|0|||
124724697|NCT02443116|448611795|FG000|Part 2|Adverse Event|0|||
124724698|NCT02443116|448611796|FG001|Part 2|Adverse Event|0|||
124724699|NCT02443116|448611797|FG002|Part 2|Adverse Event|0|||
124724700|NCT02443116|448611798|FG003|Part 2|Adverse Event|0|||
124724701|NCT02443116|448611799|FG004|Part 2|Adverse Event|1|||
124724702|NCT02443116|448611800|FG005|Part 2|Adverse Event|1|||
124724703|NCT02443116|448611801|FG006|Part 2|Adverse Event|2|||
124724704|NCT02443116|448611802|FG007|Part 2|Adverse Event|0|||
124724705|NCT02443116|448611803|FG008|Part 2|Adverse Event|0|||
124724706|NCT02443116|448611795|FG000|Part 2|Withdrew informed consent|0|||
124724707|NCT02443116|448611796|FG001|Part 2|Withdrew informed consent|0|||
124724708|NCT02443116|448611797|FG002|Part 2|Withdrew informed consent|0|||
124724709|NCT02443116|448611798|FG003|Part 2|Withdrew informed consent|0|||
124724710|NCT02443116|448611799|FG004|Part 2|Withdrew informed consent|0|||
124724711|NCT02443116|448611800|FG005|Part 2|Withdrew informed consent|1|||
124724712|NCT02443116|448611801|FG006|Part 2|Withdrew informed consent|1|||
124724713|NCT02443116|448611802|FG007|Part 2|Withdrew informed consent|0|||
124724714|NCT02443116|448611803|FG008|Part 2|Withdrew informed consent|0|||
124724715|NCT02443116|448611795|FG000|Part 2|Inability to comply with protocol|0|||
124724716|NCT02443116|448611796|FG001|Part 2|Inability to comply with protocol|0|||
124724717|NCT02443116|448611797|FG002|Part 2|Inability to comply with protocol|0|||
124724718|NCT02443116|448611798|FG003|Part 2|Inability to comply with protocol|1|||
124724719|NCT02443116|448611799|FG004|Part 2|Inability to comply with protocol|0|||
124724720|NCT02443116|448611800|FG005|Part 2|Inability to comply with protocol|0|||
124724721|NCT02443116|448611801|FG006|Part 2|Inability to comply with protocol|0|||
124724722|NCT02443116|448611802|FG007|Part 2|Inability to comply with protocol|0|||
124724723|NCT02443116|448611803|FG008|Part 2|Inability to comply with protocol|0|||
124724724|NCT02443116|448611795|FG000|Part 2|Lost to Follow-up|0|||
124724725|NCT02443116|448611796|FG001|Part 2|Lost to Follow-up|0|||
124724726|NCT02443116|448611797|FG002|Part 2|Lost to Follow-up|0|||
124724727|NCT02443116|448611798|FG003|Part 2|Lost to Follow-up|1|||
124724728|NCT02443116|448611799|FG004|Part 2|Lost to Follow-up|0|||
124724729|NCT02443116|448611800|FG005|Part 2|Lost to Follow-up|0|||
124724730|NCT02443116|448611801|FG006|Part 2|Lost to Follow-up|0|||
124724731|NCT02443116|448611802|FG007|Part 2|Lost to Follow-up|0|||
124724732|NCT02443116|448611803|FG008|Part 2|Lost to Follow-up|0|||
124724733|NCT02443116|448611795|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
124724734|NCT02443116|448611796|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
124724735|NCT02443116|448611797|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
124724736|NCT02443116|448611798|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
124724737|NCT02443116|448611799|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
124724738|NCT02443116|448611800|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
124724739|NCT02443116|448611801|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
124724740|NCT02443116|448611802|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
124724741|NCT02443116|448611803|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
124724742|NCT02443116|448611795|FG000|Part 3|Adverse Event|0|||
124560613|NCT04147715|448009602|FG011|Overall Study|Adverse Event|0|||
124775713|NCT02379091|448806592|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
124775714|NCT02379091|448806593|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
124775715|NCT02379091|448806590|FG000|Overall Study|Principal Investigator Discretion|0|||
124775716|NCT02379091|448806591|FG001|Overall Study|Principal Investigator Discretion|1|||
124775717|NCT02379091|448806592|FG002|Overall Study|Principal Investigator Discretion|0|||
124775718|NCT02379091|448806593|FG003|Overall Study|Principal Investigator Discretion|0|||
124775719|NCT02379091|448806590|FG000|Overall Study|Lost to Follow-up|0|||
124775720|NCT02379091|448806591|FG001|Overall Study|Lost to Follow-up|0|||
124775721|NCT02379091|448806592|FG002|Overall Study|Lost to Follow-up|0|||
124775722|NCT02379091|448806593|FG003|Overall Study|Lost to Follow-up|1|||
124775723|NCT02379091|448806590|FG000|Overall Study|Voluntary Withdrawal|2|||
124775724|NCT02379091|448806591|FG001|Overall Study|Voluntary Withdrawal|5|||
124775725|NCT02379091|448806592|FG002|Overall Study|Voluntary Withdrawal|2|||
124775726|NCT02379091|448806593|FG003|Overall Study|Voluntary Withdrawal|4|||
124775727|NCT02379091|448806590|FG000|Overall Study|Study Termination|7|||
124775728|NCT02379091|448806591|FG001|Overall Study|Study Termination|2|||
124775729|NCT02379091|448806592|FG002|Overall Study|Study Termination|5|||
124775730|NCT02379091|448806593|FG003|Overall Study|Study Termination|8|||
124775731|NCT02379091|448806590|FG000|Overall Study|Lack of Efficacy|3|||
124775732|NCT02379091|448806591|FG001|Overall Study|Lack of Efficacy|0|||
124775733|NCT02379091|448806592|FG002|Overall Study|Lack of Efficacy|0|||
124775734|NCT02379091|448806593|FG003|Overall Study|Lack of Efficacy|0|||
124775735|NCT02129699|448806596|FG000|Overall Study|Did not start treatment|3|||
124775736|NCT02129699|448806597|FG001|Overall Study|Did not start treatment|2|||
124775737|NCT01076361|448806601|FG000|Overall Study|22 leads were excluded from analysis|21|||
124775738|NCT04801420|448806607|FG000|Overall Study|Other|1|||
124775739|NCT04801420|448806608|FG001|Overall Study|Other|2|||
124775740|NCT04801420|448806609|FG002|Overall Study|Other|1|||
124775741|NCT04801420|448806607|FG000|Overall Study|Lost to Follow-up|7|||
124775742|NCT04801420|448806608|FG001|Overall Study|Lost to Follow-up|9|||
124775743|NCT04801420|448806609|FG002|Overall Study|Lost to Follow-up|10|||
124775744|NCT04801420|448806607|FG000|Overall Study|Moved from study area|0|||
124775745|NCT04801420|448806608|FG001|Overall Study|Moved from study area|1|||
124775746|NCT04801420|448806609|FG002|Overall Study|Moved from study area|1|||
124775747|NCT04801420|448806607|FG000|Overall Study|Withdrawal by Subject|5|||
124775748|NCT04801420|448806608|FG001|Overall Study|Withdrawal by Subject|1|||
124775749|NCT04801420|448806609|FG002|Overall Study|Withdrawal by Subject|4|||
124775750|NCT04801420|448806607|FG000|Overall Study|Individual stopping criteria reached|0|||
124775751|NCT04801420|448806608|FG001|Overall Study|Individual stopping criteria reached|1|||
124500833|NCT02224846|447785503|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
124500834|NCT02224846|447785504|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
124500835|NCT02224846|447785503|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
124500836|NCT02224846|447785504|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
124500837|NCT02224846|447785503|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
124500838|NCT02224846|447785504|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
124500839|NCT02224846|447785503|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
124500840|NCT02224846|447785504|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
124500841|NCT02224846|447785503|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
124500842|NCT02224846|447785504|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
124500843|NCT02224846|447785503|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
124500844|NCT02224846|447785504|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
124500845|NCT02224846|447785503|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
124500846|NCT02224846|447785504|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
124500847|NCT02224846|447785503|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
124500848|NCT02224846|447785504|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
124560614|NCT01626859|448009603|FG000|Overall Study|Adverse Event|1|||
124560615|NCT01626859|448009604|FG001|Overall Study|Adverse Event|3|||
124560616|NCT01626859|448009605|FG002|Overall Study|Adverse Event|2|||
124560617|NCT01626859|448009603|FG000|Overall Study|Physician Decision|0|||
124560618|NCT01626859|448009604|FG001|Overall Study|Physician Decision|1|||
124500849|NCT02224846|447785503|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
124500850|NCT02224846|447785504|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
124560619|NCT01626859|448009605|FG002|Overall Study|Physician Decision|0|||
124560620|NCT01626859|448009603|FG000|Overall Study|Withdrawal by Subject|1|||
124775752|NCT04801420|448806609|FG002|Overall Study|Individual stopping criteria reached|0|||
124775753|NCT04801420|448806607|FG000|Overall Study|Ongoing in the study|195|||
124775754|NCT04801420|448806608|FG001|Overall Study|Ongoing in the study|195|||
124775755|NCT04801420|448806609|FG002|Overall Study|Ongoing in the study|192|||
124775756|NCT04774094|448806610|FG000|Overall Study|Other|2|||
124775757|NCT04774094|448806610|FG000|Overall Study|Withdrawal by Subject|9|||
124775758|NCT04774094|448806610|FG000|Overall Study|Lost to Follow-up|7|||
124775759|NCT04774094|448806610|FG000|Overall Study|Lack of Efficacy|5|||
124775760|NCT04774094|448806610|FG000|Overall Study|Death|17|||
124775761|NCT04774094|448806610|FG000|Overall Study|Adverse Event|4|||
124775762|NCT00815659|448808401|FG000|Overall Study|Adverse Event|9|||
124500851|NCT02224846|447785503|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
124500852|NCT02224846|447785504|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
124500853|NCT02224846|447785503|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
124500854|NCT02224846|447785504|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
124500855|NCT02224846|447785503|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
124775763|NCT00815659|448808401|FG000|Overall Study|Withdrawal by Subject|9|||
124775764|NCT00815659|448808401|FG000|Overall Study|Lost to Follow-up|4|||
124775765|NCT00815659|448808401|FG000|Overall Study|Protocol Violation|1|||
124775766|NCT03847896|448808402|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
124775767|NCT03847896|448808403|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
124775768|NCT03847896|448808404|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
124560621|NCT01626859|448009604|FG001|Overall Study|Withdrawal by Subject|4|||
124560622|NCT01626859|448009605|FG002|Overall Study|Withdrawal by Subject|2|||
124560623|NCT02629965|448009606|FG000|Period 1|Adverse Event|1|||
124560624|NCT02629965|448009607|FG001|Period 1|Adverse Event|0|||
124560625|NCT02629965|448009606|FG000|Period 1|Unexpected worsening of disease|2|||
124560626|NCT02629965|448009607|FG001|Period 1|Unexpected worsening of disease|0|||
124560627|NCT02629965|448009606|FG000|Period 1|Other than listed above|1|||
124560628|NCT02629965|448009607|FG001|Period 1|Other than listed above|2|||
124560629|NCT02629965|448009606|FG000|Period 2|Adverse Event|1|||
124560630|NCT02629965|448009607|FG001|Period 2|Adverse Event|0|||
124560631|NCT00905489|448009608|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
124560632|NCT00905489|448009608|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
124560633|NCT00905489|448009608|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
124560634|NCT00895583|448009613|FG000|Overall Study|Adverse Event|28|||
124560635|NCT00895583|448009614|FG001|Overall Study|Adverse Event|4|||
124560636|NCT00895583|448009613|FG000|Overall Study|Death|2|||
124560637|NCT00895583|448009614|FG001|Overall Study|Death|1|||
124560638|NCT00895583|448009613|FG000|Overall Study|Physician Decision|3|||
124560639|NCT00895583|448009614|FG001|Overall Study|Physician Decision|1|||
124560640|NCT00895583|448009613|FG000|Overall Study|Lost to Follow-up|1|||
124560641|NCT00895583|448009614|FG001|Overall Study|Lost to Follow-up|3|||
124560642|NCT00895583|448009613|FG000|Overall Study|Protocol Violation|1|||
124560643|NCT00895583|448009614|FG001|Overall Study|Protocol Violation|0|||
124560644|NCT00895583|448009613|FG000|Overall Study|Withdrawal by Subject|4|||
124560645|NCT00895583|448009614|FG001|Overall Study|Withdrawal by Subject|2|||
124560646|NCT00895583|448009613|FG000|Overall Study|Lack of Efficacy|5|||
124560647|NCT00895583|448009614|FG001|Overall Study|Lack of Efficacy|0|||
124560648|NCT00895583|448009613|FG000|Overall Study|Other|0|||
124560649|NCT00895583|448009614|FG001|Overall Study|Other|1|||
124560650|NCT04535583|448009615|FG000|Overall Study|Lost to Follow-up|1|||
124560651|NCT04535583|448009615|FG000|Overall Study|Physician Decision|1|||
124560652|NCT04535583|448009615|FG000|Overall Study|Withdrawal by Subject|1|||
124560653|NCT00526890|448009617|FG000|Overall Study|Adverse Event|2|||
124560654|NCT04049552|448009618|FG000|Overall Study|Lost to Follow-up|1|||
124560655|NCT02196506|448009624|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
124560656|NCT02196506|448009625|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
124560657|NCT02196506|448009626|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
124560658|NCT02196506|448009627|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
124560659|NCT02196506|448009624|FG000|Phase A|Withdrawal by Subject|34|||
124560660|NCT02196506|448009625|FG001|Phase A|Withdrawal by Subject|0|||
124560661|NCT02196506|448009626|FG002|Phase A|Withdrawal by Subject|0|||
124560662|NCT02196506|448009627|FG003|Phase A|Withdrawal by Subject|0|||
124560663|NCT02196506|448009624|FG000|Phase A|Adverse Event|22|||
124560664|NCT02196506|448009625|FG001|Phase A|Adverse Event|0|||
124560665|NCT02196506|448009626|FG002|Phase A|Adverse Event|0|||
124560666|NCT02196506|448009627|FG003|Phase A|Adverse Event|0|||
124560667|NCT02196506|448009624|FG000|Phase A|Lost to Follow-up|9|||
124560668|NCT02196506|448009625|FG001|Phase A|Lost to Follow-up|0|||
124560669|NCT02196506|448009626|FG002|Phase A|Lost to Follow-up|0|||
124560670|NCT02196506|448009627|FG003|Phase A|Lost to Follow-up|0|||
124775769|NCT03847896|448808405|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
124500856|NCT02224846|447785504|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
124500857|NCT02538666|447785509|FG000|Pre-Treatment|Disease progression|1|||
124560671|NCT02196506|448009624|FG000|Phase A|Protocol deviation|12|||
124560672|NCT02196506|448009625|FG001|Phase A|Protocol deviation|0|||
124560673|NCT02196506|448009626|FG002|Phase A|Protocol deviation|0|||
124560674|NCT02196506|448009627|FG003|Phase A|Protocol deviation|0|||
124560675|NCT02196506|448009624|FG000|Phase A|Participant withdrawn by investigator|10|||
124560676|NCT02196506|448009625|FG001|Phase A|Participant withdrawn by investigator|0|||
124560677|NCT02196506|448009626|FG002|Phase A|Participant withdrawn by investigator|0|||
124560678|NCT02196506|448009627|FG003|Phase A|Participant withdrawn by investigator|0|||
124560679|NCT02196506|448009624|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
124560680|NCT02196506|448009625|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
124560681|NCT02196506|448009626|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
124775770|NCT03847896|448808406|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
124500858|NCT02538666|447785510|FG001|Pre-Treatment|Disease progression|0|||
124500859|NCT02538666|447785511|FG002|Pre-Treatment|Disease progression|0|||
124500860|NCT02538666|447785509|FG000|Pre-Treatment|no longer meets study criteria|1|||
124500861|NCT02538666|447785510|FG001|Pre-Treatment|no longer meets study criteria|0|||
124500862|NCT02538666|447785511|FG002|Pre-Treatment|no longer meets study criteria|0|||
124500863|NCT02538666|447785509|FG000|Pre-Treatment|Withdrew Consent|0|||
124500864|NCT02538666|447785510|FG001|Pre-Treatment|Withdrew Consent|1|||
124500865|NCT02538666|447785511|FG002|Pre-Treatment|Withdrew Consent|1|||
124500866|NCT02538666|447785509|FG000|Treatment|Disease progression|270|||
124500867|NCT02538666|447785510|FG001|Treatment|Disease progression|227|||
124500868|NCT02538666|447785511|FG002|Treatment|Disease progression|165|||
124500869|NCT02538666|447785509|FG000|Treatment|Study drug toxicity|1|||
124500870|NCT02538666|447785510|FG001|Treatment|Study drug toxicity|29|||
124500871|NCT02538666|447785511|FG002|Treatment|Study drug toxicity|92|||
124500872|NCT02538666|447785509|FG000|Treatment|Death|0|||
124500873|NCT02538666|447785510|FG001|Treatment|Death|2|||
124500874|NCT02538666|447785511|FG002|Treatment|Death|3|||
124500875|NCT02538666|447785509|FG000|Treatment|Adverse event unrelated to study drug|8|||
124500876|NCT02538666|447785510|FG001|Treatment|Adverse event unrelated to study drug|10|||
124500877|NCT02538666|447785511|FG002|Treatment|Adverse event unrelated to study drug|15|||
124500878|NCT02538666|447785509|FG000|Treatment|Participant request to discontinue study treatment|3|||
124500879|NCT02538666|447785510|FG001|Treatment|Participant request to discontinue study treatment|6|||
124500880|NCT02538666|447785511|FG002|Treatment|Participant request to discontinue study treatment|11|||
124500881|NCT02538666|447785509|FG000|Treatment|Participant withdrew consent|2|||
124500882|NCT02538666|447785510|FG001|Treatment|Participant withdrew consent|5|||
124500883|NCT02538666|447785511|FG002|Treatment|Participant withdrew consent|3|||
124500884|NCT02538666|447785509|FG000|Treatment|Lost to Follow-up|0|||
124500885|NCT02538666|447785510|FG001|Treatment|Lost to Follow-up|1|||
124500886|NCT02538666|447785511|FG002|Treatment|Lost to Follow-up|1|||
124500887|NCT02538666|447785509|FG000|Treatment|Maximum clinical benefit|4|||
124500888|NCT02538666|447785510|FG001|Treatment|Maximum clinical benefit|3|||
124500889|NCT02538666|447785511|FG002|Treatment|Maximum clinical benefit|4|||
124500890|NCT02538666|447785509|FG000|Treatment|Poor/non-compliance|0|||
124500891|NCT02538666|447785510|FG001|Treatment|Poor/non-compliance|1|||
124500892|NCT02538666|447785511|FG002|Treatment|Poor/non-compliance|0|||
124500893|NCT02538666|447785509|FG000|Treatment|Participant no longer meets study criteria|0|||
124500894|NCT02538666|447785510|FG001|Treatment|Participant no longer meets study criteria|2|||
124500895|NCT02538666|447785511|FG002|Treatment|Participant no longer meets study criteria|0|||
124500896|NCT02538666|447785509|FG000|Treatment|Administrative reason by sponsor|0|||
124500897|NCT02538666|447785510|FG001|Treatment|Administrative reason by sponsor|0|||
124500898|NCT02538666|447785511|FG002|Treatment|Administrative reason by sponsor|1|||
124500899|NCT02538666|447785509|FG000|Treatment|Other reasons|8|||
124500900|NCT02538666|447785510|FG001|Treatment|Other reasons|15|||
124500901|NCT02538666|447785511|FG002|Treatment|Other reasons|5|||
124500902|NCT02538666|447785509|FG000|Treatment|Not reported|2|||
124500903|NCT02538666|447785510|FG001|Treatment|Not reported|2|||
124500904|NCT02538666|447785511|FG002|Treatment|Not reported|2|||
124500905|NCT03510663|447785512|FG000|Overall Study|Withdrawal by Subject|0|||
124500906|NCT03510663|447785513|FG001|Overall Study|Withdrawal by Subject|1|||
124500907|NCT03510663|447785514|FG002|Overall Study|Withdrawal by Subject|0|||
124500908|NCT03510663|447785515|FG003|Overall Study|Withdrawal by Subject|0|||
124500909|NCT03510663|447785516|FG004|Overall Study|Withdrawal by Subject|0|||
124500910|NCT03510663|447785517|FG005|Overall Study|Withdrawal by Subject|0|||
124500911|NCT03510663|447785518|FG006|Overall Study|Withdrawal by Subject|0|||
124500912|NCT03510663|447785519|FG007|Overall Study|Withdrawal by Subject|0|||
124500913|NCT01555463|447785522|FG000|Treatment|Adverse Event|6|||
124500914|NCT01555463|447785523|FG001|Treatment|Adverse Event|12|||
124500915|NCT01555463|447785522|FG000|Treatment|Withdrawal by Subject|24|||
124500916|NCT01555463|447785523|FG001|Treatment|Withdrawal by Subject|36|||
124500917|NCT01555463|447785522|FG000|Treatment|Lost to Follow-up|28|||
124500918|NCT01555463|447785523|FG001|Treatment|Lost to Follow-up|23|||
124500919|NCT01555463|447785522|FG000|Treatment|Protocol Violation|4|||
124500920|NCT01555463|447785523|FG001|Treatment|Protocol Violation|5|||
124500921|NCT01555463|447785522|FG000|Treatment|Other reason|2|||
124500922|NCT01555463|447785523|FG001|Treatment|Other reason|3|||
124500923|NCT01555463|447785522|FG000|Follow up|Adverse Event|2|||
124500924|NCT01555463|447785523|FG001|Follow up|Adverse Event|5|||
124500925|NCT01555463|447785522|FG000|Follow up|Death|0|||
124500926|NCT01555463|447785523|FG001|Follow up|Death|1|||
124500927|NCT01555463|447785522|FG000|Follow up|Withdrawal by Subject|22|||
124500928|NCT01555463|447785523|FG001|Follow up|Withdrawal by Subject|22|||
124500929|NCT01555463|447785522|FG000|Follow up|Lost to Follow-up|9|||
124500930|NCT01555463|447785523|FG001|Follow up|Lost to Follow-up|10|||
124500931|NCT01555463|447785522|FG000|Follow up|Protocol Violation|2|||
124500932|NCT01555463|447785523|FG001|Follow up|Protocol Violation|4|||
124500933|NCT01555463|447785522|FG000|Follow up|Other reason|3|||
124500934|NCT01555463|447785523|FG001|Follow up|Other reason|3|||
124500935|NCT03552549|447785531|FG000|Overall Study|Disease progression|25|||
124500936|NCT03552549|447785532|FG001|Overall Study|Disease progression|17|||
124500937|NCT03552549|447785531|FG000|Overall Study|Adverse event in first 12 months|12|||
124500938|NCT03552549|447785532|FG001|Overall Study|Adverse event in first 12 months|8|||
124500939|NCT03552549|447785531|FG000|Overall Study|Withdrawal by Subject|7|||
124500940|NCT03552549|447785532|FG001|Overall Study|Withdrawal by Subject|7|||
124500941|NCT03552549|447785531|FG000|Overall Study|Unknown (no reason provided)|4|||
124500942|NCT03552549|447785532|FG001|Overall Study|Unknown (no reason provided)|2|||
124500943|NCT03552549|447785531|FG000|Overall Study|Not in participant's best interest|2|||
124500944|NCT03552549|447785532|FG001|Overall Study|Not in participant's best interest|1|||
124500945|NCT03552549|447785531|FG000|Overall Study|Did not complete study treatment|2|||
124500946|NCT03552549|447785532|FG001|Overall Study|Did not complete study treatment|3|||
124500947|NCT03552549|447785531|FG000|Overall Study|Did not meet eligibility criteria|1|||
124500948|NCT03552549|447785532|FG001|Overall Study|Did not meet eligibility criteria|0|||
124560682|NCT02196506|448009627|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
124560683|NCT02196506|448009624|FG000|Phase B|Lack of Efficacy|0|||
124560684|NCT02196506|448009625|FG001|Phase B|Lack of Efficacy|1|||
124560685|NCT02196506|448009626|FG002|Phase B|Lack of Efficacy|2|||
124560686|NCT02196506|448009627|FG003|Phase B|Lack of Efficacy|0|||
124560687|NCT02196506|448009624|FG000|Phase B|Withdrawal by Participant|0|||
124560688|NCT02196506|448009625|FG001|Phase B|Withdrawal by Participant|8|||
124560689|NCT02196506|448009626|FG002|Phase B|Withdrawal by Participant|1|||
124560690|NCT02196506|448009627|FG003|Phase B|Withdrawal by Participant|0|||
124560691|NCT02196506|448009624|FG000|Phase B|Adverse Event|0|||
124560692|NCT02196506|448009625|FG001|Phase B|Adverse Event|4|||
124560693|NCT02196506|448009626|FG002|Phase B|Adverse Event|1|||
124560694|NCT02196506|448009627|FG003|Phase B|Adverse Event|0|||
124560695|NCT02196506|448009624|FG000|Phase B|Lost to Follow-up|0|||
124560696|NCT02196506|448009625|FG001|Phase B|Lost to Follow-up|2|||
124560697|NCT02196506|448009626|FG002|Phase B|Lost to Follow-up|1|||
124560698|NCT02196506|448009627|FG003|Phase B|Lost to Follow-up|0|||
124560699|NCT02196506|448009624|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
124560700|NCT02196506|448009625|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
124560701|NCT02196506|448009626|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
124560702|NCT02196506|448009627|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
124560703|NCT02196506|448009624|FG000|Phase A+|Withdrawal by Participant|0|||
124560704|NCT02196506|448009625|FG001|Phase A+|Withdrawal by Participant|0|||
124560705|NCT02196506|448009626|FG002|Phase A+|Withdrawal by Participant|0|||
124560706|NCT02196506|448009627|FG003|Phase A+|Withdrawal by Participant|5|||
124560707|NCT02196506|448009624|FG000|Phase A+|Adverse Event|0|||
124560708|NCT02196506|448009625|FG001|Phase A+|Adverse Event|0|||
124560709|NCT02196506|448009626|FG002|Phase A+|Adverse Event|0|||
124560710|NCT02196506|448009627|FG003|Phase A+|Adverse Event|1|||
124560711|NCT02196506|448009624|FG000|Phase A+|Lost to Follow-up|0|||
124560712|NCT02196506|448009625|FG001|Phase A+|Lost to Follow-up|0|||
124560713|NCT02196506|448009626|FG002|Phase A+|Lost to Follow-up|0|||
124560714|NCT02196506|448009627|FG003|Phase A+|Lost to Follow-up|6|||
124560715|NCT02196506|448009624|FG000|Phase A+|Participant withdrawn by investigator|0|||
124560716|NCT02196506|448009625|FG001|Phase A+|Participant withdrawn by investigator|0|||
124560717|NCT02196506|448009626|FG002|Phase A+|Participant withdrawn by investigator|0|||
124560718|NCT02196506|448009627|FG003|Phase A+|Participant withdrawn by investigator|1|||
124560719|NCT01859702|448009628|FG000|Overall Study|Protocol deviation|3|||
124560720|NCT01859702|448009628|FG000|Overall Study|Adverse Event|2|||
124560721|NCT01715415|448009629|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
124560722|NCT01715415|448009630|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
124560723|NCT01715415|448009629|FG000|Double-blind Treatment|Adverse Event|3|||
124560724|NCT01715415|448009630|FG001|Double-blind Treatment|Adverse Event|0|||
124560725|NCT01715415|448009629|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
124560726|NCT01715415|448009630|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
124560727|NCT01715415|448009629|FG000|Double-blind Treatment|Other|1|||
124560728|NCT01715415|448009630|FG001|Double-blind Treatment|Other|0|||
124560729|NCT01715415|448009629|FG000|Open-label Treatment|Adverse Event|0|||
124560730|NCT01715415|448009630|FG001|Open-label Treatment|Adverse Event|1|||
124560731|NCT01715415|448009629|FG000|Open-label Treatment|Subject Noncompliant|0|||
124560732|NCT01715415|448009630|FG001|Open-label Treatment|Subject Noncompliant|1|||
124560733|NCT01015612|448009631|FG000|Overall Study|Death|113|||
124560734|NCT01015612|448009631|FG000|Overall Study|Withdrawal by Subject|40|||
124560735|NCT00066807|448009632|FG000|Overall Study|Study was terminated early|14|||
124560736|NCT00066807|448009633|FG001|Overall Study|Study was terminated early|15|||
124560737|NCT05028751|448009634|FG000|Overall Study|Study Terminated by Sponsor|3|||
124560738|NCT05028751|448009635|FG001|Overall Study|Study Terminated by Sponsor|0|||
124560739|NCT05028751|448009636|FG002|Overall Study|Study Terminated by Sponsor|0|||
124560740|NCT05028751|448009637|FG003|Overall Study|Study Terminated by Sponsor|0|||
124560741|NCT05028751|448009634|FG000|Overall Study|Death|9|||
124560742|NCT05028751|448009635|FG001|Overall Study|Death|3|||
124500949|NCT03552549|447785531|FG000|Overall Study|Administrative|0|||
124560743|NCT05028751|448009636|FG002|Overall Study|Death|2|||
124500950|NCT03552549|447785532|FG001|Overall Study|Administrative|14|||
124560744|NCT05028751|448009637|FG003|Overall Study|Death|4|||
124560745|NCT05028751|448009634|FG000|Overall Study|Withdrawal by Subject|0|||
124560746|NCT05028751|448009635|FG001|Overall Study|Withdrawal by Subject|0|||
124560747|NCT05028751|448009636|FG002|Overall Study|Withdrawal by Subject|1|||
124560748|NCT05028751|448009637|FG003|Overall Study|Withdrawal by Subject|0|||
124560749|NCT05028751|448009634|FG000|Overall Study|Miscellaneous|2|||
124560750|NCT05028751|448009635|FG001|Overall Study|Miscellaneous|0|||
124560751|NCT05028751|448009636|FG002|Overall Study|Miscellaneous|0|||
124560752|NCT05028751|448009637|FG003|Overall Study|Miscellaneous|0|||
124560753|NCT03586830|448009638|FG000|Overall Study|Site terminated by Sponsor|1|||
124560754|NCT03586830|448009639|FG001|Overall Study|Site terminated by Sponsor|4|||
124560755|NCT03586830|448009640|FG002|Overall Study|Site terminated by Sponsor|3|||
124560756|NCT03586830|448009641|FG003|Overall Study|Site terminated by Sponsor|3|||
124560757|NCT03586830|448009638|FG000|Overall Study|Lost to Follow-up|0|||
124560758|NCT03586830|448009639|FG001|Overall Study|Lost to Follow-up|2|||
124560759|NCT03586830|448009640|FG002|Overall Study|Lost to Follow-up|2|||
124560760|NCT03586830|448009641|FG003|Overall Study|Lost to Follow-up|1|||
124560761|NCT03586830|448009638|FG000|Overall Study|Withdrawal by Subject|1|||
124560762|NCT03586830|448009639|FG001|Overall Study|Withdrawal by Subject|0|||
124560763|NCT03586830|448009640|FG002|Overall Study|Withdrawal by Subject|3|||
124560764|NCT03586830|448009641|FG003|Overall Study|Withdrawal by Subject|1|||
124560765|NCT04578548|448009642|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
124560766|NCT04578548|448009643|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
124560767|NCT04578548|448009642|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
124560768|NCT04578548|448009643|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
124560769|NCT04578548|448009642|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
124560770|NCT04578548|448009643|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
124560771|NCT04578548|448009642|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
124560772|NCT04578548|448009643|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
124560773|NCT04578548|448009642|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
124560774|NCT04578548|448009643|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
124560775|NCT04578548|448009642|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
124560776|NCT04578548|448009643|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
124560777|NCT00395083|448009646|FG000|Overall Study|Withdrawal by Subject|6|||
124560778|NCT00395083|448009647|FG001|Overall Study|Withdrawal by Subject|5|||
124560779|NCT00395083|448009646|FG000|Overall Study|Developed another disease|4|||
124560780|NCT00395083|448009647|FG001|Overall Study|Developed another disease|3|||
124560781|NCT00628745|448009648|FG000|Overall Study|Withdrawal by Subject|63|||
124560782|NCT00628745|448009649|FG001|Overall Study|Withdrawal by Subject|3|||
124560783|NCT00628745|448009650|FG002|Overall Study|Withdrawal by Subject|9|||
124560784|NCT00628745|448009651|FG003|Overall Study|Withdrawal by Subject|2|||
124560785|NCT00628745|448009652|FG004|Overall Study|Withdrawal by Subject|69|||
124560786|NCT00628745|448009648|FG000|Overall Study|Does not meet inclusion criteria|0|||
124560787|NCT00628745|448009649|FG001|Overall Study|Does not meet inclusion criteria|12|||
124560788|NCT00628745|448009650|FG002|Overall Study|Does not meet inclusion criteria|0|||
124560789|NCT00628745|448009651|FG003|Overall Study|Does not meet inclusion criteria|0|||
124560790|NCT00628745|448009652|FG004|Overall Study|Does not meet inclusion criteria|18|||
124560791|NCT00628745|448009648|FG000|Overall Study|Participation in an interventional clinical trial|81|||
124560792|NCT00628745|448009649|FG001|Overall Study|Participation in an interventional clinical trial|4|||
124560793|NCT00628745|448009650|FG002|Overall Study|Participation in an interventional clinical trial|7|||
124560794|NCT00628745|448009651|FG003|Overall Study|Participation in an interventional clinical trial|0|||
124560795|NCT00628745|448009652|FG004|Overall Study|Participation in an interventional clinical trial|63|||
124560796|NCT00628745|448009648|FG000|Overall Study|Physician Decision|8|||
124560797|NCT00628745|448009649|FG001|Overall Study|Physician Decision|4|||
124560798|NCT00628745|448009650|FG002|Overall Study|Physician Decision|3|||
124560799|NCT00628745|448009651|FG003|Overall Study|Physician Decision|0|||
124560800|NCT00628745|448009652|FG004|Overall Study|Physician Decision|30|||
124560801|NCT00628745|448009648|FG000|Overall Study|Lost to Follow-up|109|||
124560802|NCT00628745|448009649|FG001|Overall Study|Lost to Follow-up|7|||
124560803|NCT00628745|448009650|FG002|Overall Study|Lost to Follow-up|7|||
124560804|NCT00628745|448009651|FG003|Overall Study|Lost to Follow-up|0|||
124560805|NCT00628745|448009652|FG004|Overall Study|Lost to Follow-up|498|||
124560806|NCT00628745|448009648|FG000|Overall Study|Death|197|||
124560807|NCT00628745|448009649|FG001|Overall Study|Death|81|||
124560808|NCT00628745|448009650|FG002|Overall Study|Death|12|||
124560809|NCT00628745|448009651|FG003|Overall Study|Death|4|||
124560810|NCT00628745|448009652|FG004|Overall Study|Death|939|||
124560811|NCT00628745|448009648|FG000|Overall Study|Participant transferred to another THAOS site|6|||
124724743|NCT02443116|448611796|FG001|Part 3|Adverse Event|0|||
124724744|NCT02443116|448611797|FG002|Part 3|Adverse Event|0|||
124724745|NCT02443116|448611798|FG003|Part 3|Adverse Event|0|||
124724746|NCT02443116|448611799|FG004|Part 3|Adverse Event|0|||
124724747|NCT02443116|448611800|FG005|Part 3|Adverse Event|0|||
124724748|NCT02443116|448611801|FG006|Part 3|Adverse Event|0|||
124724749|NCT02443116|448611802|FG007|Part 3|Adverse Event|0|||
124724750|NCT02443116|448611803|FG008|Part 3|Adverse Event|1|||
124500951|NCT02739594|447785533|FG000|Overall Study|Undesired Event|3|||
124500952|NCT02739594|447785534|FG001|Overall Study|Undesired Event|4|||
124500953|NCT02739594|447785533|FG000|Overall Study|Violation of Eligibility Criteria|1|||
124500954|NCT02739594|447785534|FG001|Overall Study|Violation of Eligibility Criteria|2|||
124500955|NCT02739594|447785533|FG000|Overall Study|Protocol Violation|5|||
124500956|NCT02739594|447785534|FG001|Overall Study|Protocol Violation|6|||
124500957|NCT02739594|447785533|FG000|Overall Study|Death|4|||
124500958|NCT02739594|447785534|FG001|Overall Study|Death|2|||
124500959|NCT02739594|447785533|FG000|Overall Study|Renal Insufficiency|4|||
124500960|NCT02739594|447785534|FG001|Overall Study|Renal Insufficiency|6|||
124500961|NCT02739594|447785533|FG000|Overall Study|Administrative Reasons|1|||
124500962|NCT02739594|447785534|FG001|Overall Study|Administrative Reasons|3|||
124500963|NCT02739594|447785533|FG000|Overall Study|Withdrawal by Subject|1|||
124500964|NCT02739594|447785534|FG001|Overall Study|Withdrawal by Subject|1|||
124500965|NCT02739594|447785533|FG000|Overall Study|Lost to Follow-up|0|||
124500966|NCT02739594|447785534|FG001|Overall Study|Lost to Follow-up|1|||
124500967|NCT02739594|447785533|FG000|Overall Study|Elevated Serum Creatinine|0|||
124500968|NCT02739594|447785534|FG001|Overall Study|Elevated Serum Creatinine|1|||
124500969|NCT02739594|447785533|FG000|Overall Study|Other|6|||
124500970|NCT02739594|447785534|FG001|Overall Study|Other|2|||
124500971|NCT01465178|447785535|FG000|Overall Study|Withdrawal by Subject|1|||
124500972|NCT01465178|447785536|FG001|Overall Study|Withdrawal by Subject|0|||
124500973|NCT00527111|447785539|FG000|Overall Study|Adverse Event|14|||
124500974|NCT00527111|447785540|FG001|Overall Study|Adverse Event|13|||
124500975|NCT00527111|447785539|FG000|Overall Study|Death|0|||
124500976|NCT00527111|447785540|FG001|Overall Study|Death|1|||
124500977|NCT00527111|447785539|FG000|Overall Study|Investigator Request|2|||
124500978|NCT00527111|447785540|FG001|Overall Study|Investigator Request|1|||
124500979|NCT00527111|447785539|FG000|Overall Study|Patient Request|2|||
124500980|NCT00527111|447785540|FG001|Overall Study|Patient Request|5|||
124500981|NCT00527111|447785539|FG000|Overall Study|Other|2|||
124500982|NCT00527111|447785540|FG001|Overall Study|Other|2|||
124500983|NCT03827473|447785541|FG000|Overall Study|Withdrawal by Subject|1|||
124500984|NCT03827473|447785542|FG001|Overall Study|Withdrawal by Subject|0|||
124500985|NCT01477892|447785543|FG000|Overall Study|Withdrawal by Subject|0|||
124500986|NCT01477892|447785544|FG001|Overall Study|Withdrawal by Subject|2|||
124500987|NCT01921257|447785545|FG000|Overall Study|Adverse Event|1|||
124500988|NCT01921257|447785545|FG000|Overall Study|Protocol Violation|1|||
124500989|NCT01921257|447785545|FG000|Overall Study|Withdrawal by Subject|1|||
124500990|NCT00777491|447785546|FG000|Overall Study|Protocol Violation|0|||
124500991|NCT00777491|447785547|FG001|Overall Study|Protocol Violation|2|||
124500992|NCT00777491|447785546|FG000|Overall Study|Did not receive any protocol treatment|2|||
124500993|NCT00777491|447785547|FG001|Overall Study|Did not receive any protocol treatment|0|||
124500994|NCT03987620|447785550|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
124500995|NCT03987620|447785551|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
124500996|NCT03987620|447785550|FG000|Overall Study|Adverse Event|3|||
124500997|NCT03987620|447785551|FG001|Overall Study|Adverse Event|0|||
124500998|NCT03987620|447785550|FG000|Overall Study|Lost to Follow-up|1|||
124500999|NCT03987620|447785551|FG001|Overall Study|Lost to Follow-up|2|||
124501000|NCT03987620|447785550|FG000|Overall Study|Physician Decision|0|||
124501001|NCT03987620|447785551|FG001|Overall Study|Physician Decision|1|||
124501002|NCT03987620|447785550|FG000|Overall Study|Pregnancy|1|||
124501003|NCT03987620|447785551|FG001|Overall Study|Pregnancy|0|||
124501004|NCT03987620|447785550|FG000|Overall Study|Withdrawal by Subject|7|||
124501005|NCT03987620|447785551|FG001|Overall Study|Withdrawal by Subject|1|||
124501006|NCT03987620|447785550|FG000|Overall Study|Other|2|||
124501007|NCT03987620|447785551|FG001|Overall Study|Other|5|||
124501008|NCT01745393|447785553|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
124501009|NCT01745393|447785554|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
124501010|NCT01745393|447785553|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
124501011|NCT01745393|447785554|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
124501012|NCT01745393|447785553|FG000|12-month Follow-up|Lost to Follow-up|6|||
124501013|NCT01745393|447785554|FG001|12-month Follow-up|Lost to Follow-up|5|||
124501014|NCT00471445|447785555|FG000|Overall Study|Withdrawal by Subject|1|||
124501015|NCT00471445|447785556|FG001|Overall Study|Withdrawal by Subject|1|||
124501016|NCT00471445|447785555|FG000|Overall Study|Ineligible|1|||
124501017|NCT00471445|447785556|FG001|Overall Study|Ineligible|0|||
124501018|NCT00471445|447785555|FG000|Overall Study|Protocol Violation|0|||
124501019|NCT00471445|447785556|FG001|Overall Study|Protocol Violation|1|||
124501020|NCT03591146|447785557|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
124501021|NCT03591146|447785558|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
124501022|NCT03591146|447785559|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
124501023|NCT03591146|447785560|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
124501024|NCT03591146|447785561|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
124724751|NCT02443116|448611795|FG000|Part 3|Withdrew informed consent|0|||
124724752|NCT02443116|448611796|FG001|Part 3|Withdrew informed consent|0|||
124724753|NCT02443116|448611797|FG002|Part 3|Withdrew informed consent|0|||
124560812|NCT00628745|448009649|FG001|Overall Study|Participant transferred to another THAOS site|0|||
124560813|NCT00628745|448009650|FG002|Overall Study|Participant transferred to another THAOS site|0|||
124560814|NCT00628745|448009651|FG003|Overall Study|Participant transferred to another THAOS site|0|||
124560815|NCT00628745|448009652|FG004|Overall Study|Participant transferred to another THAOS site|7|||
124560816|NCT00628745|448009648|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
124560817|NCT00628745|448009649|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
124560818|NCT00628745|448009650|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
124560819|NCT00628745|448009651|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
124560820|NCT00628745|448009652|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
124560821|NCT00628745|448009648|FG000|Overall Study|Site closure|152|||
124560822|NCT00628745|448009649|FG001|Overall Study|Site closure|146|||
124560823|NCT00628745|448009650|FG002|Overall Study|Site closure|6|||
124560824|NCT00628745|448009651|FG003|Overall Study|Site closure|8|||
124560825|NCT00628745|448009652|FG004|Overall Study|Site closure|691|||
124560826|NCT00628745|448009648|FG000|Overall Study|Duplicate participant|0|||
124560827|NCT00628745|448009649|FG001|Overall Study|Duplicate participant|0|||
124560828|NCT00628745|448009650|FG002|Overall Study|Duplicate participant|0|||
124560829|NCT00628745|448009651|FG003|Overall Study|Duplicate participant|0|||
124560830|NCT00628745|448009652|FG004|Overall Study|Duplicate participant|1|||
124560831|NCT00628745|448009648|FG000|Overall Study|Missing|4|||
124560832|NCT00628745|448009649|FG001|Overall Study|Missing|3|||
124560833|NCT00628745|448009650|FG002|Overall Study|Missing|0|||
124560834|NCT00628745|448009651|FG003|Overall Study|Missing|0|||
124560835|NCT00628745|448009652|FG004|Overall Study|Missing|10|||
124560836|NCT00628745|448009648|FG000|Overall Study|Othe reasons|987|||
124560837|NCT00628745|448009649|FG001|Overall Study|Othe reasons|373|||
124560838|NCT00628745|448009650|FG002|Overall Study|Othe reasons|105|||
124560839|NCT00628745|448009651|FG003|Overall Study|Othe reasons|1|||
124560840|NCT00628745|448009652|FG004|Overall Study|Othe reasons|1772|||
124637290|NCT01081769|448290460|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
124637291|NCT01081769|448290461|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
124637292|NCT01081769|448290460|FG000|CORE Intent-To-Treat|Other|0|||
124637293|NCT01081769|448290461|FG001|CORE Intent-To-Treat|Other|1|||
124637294|NCT01081769|448290460|FG000|CORE Intent-To-Treat|Ineligibility|3|||
124637295|NCT01081769|448290461|FG001|CORE Intent-To-Treat|Ineligibility|4|||
124637296|NCT01081769|448290460|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
124637297|NCT01081769|448290461|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
124637298|NCT01081769|448290460|FG000|CORE Intent-To-Treat|Patient Moved|2|||
124637299|NCT01081769|448290461|FG001|CORE Intent-To-Treat|Patient Moved|2|||
124637300|NCT00507455|448290462|FG000|Overall Study|Adverse Event|3|||
124637301|NCT00507455|448290463|FG001|Overall Study|Adverse Event|3|||
124637302|NCT00507455|448290464|FG002|Overall Study|Adverse Event|6|||
124637303|NCT00507455|448290462|FG000|Overall Study|Withdrawal by Subject|2|||
124501025|NCT03591146|447785557|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
124501026|NCT03591146|447785558|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
124501027|NCT03591146|447785559|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
124501028|NCT03591146|447785560|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
124501029|NCT03591146|447785561|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
124501030|NCT03591146|447785557|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
124501031|NCT03591146|447785558|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
124501032|NCT03591146|447785559|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
124501033|NCT03591146|447785560|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
124501034|NCT03591146|447785561|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
124501035|NCT03591146|447785557|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
124501036|NCT03591146|447785558|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
124501037|NCT03591146|447785559|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
124501038|NCT03591146|447785560|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
124501039|NCT03591146|447785561|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
124501040|NCT04737031|447785564|FG000|Overall Study|Patients who did not have a treatment visit|0|||
124501041|NCT04737031|447785565|FG001|Overall Study|Patients who did not have a treatment visit|31|||
124501042|NCT04737031|447785566|FG002|Overall Study|Patients who did not have a treatment visit|93|||
124501043|NCT04737031|447785567|FG003|Overall Study|Patients who did not have a treatment visit|227|||
124501044|NCT01468909|447785568|FG000|Overall Study|Never Treated|2|||
124501045|NCT01468909|447785569|FG001|Overall Study|Never Treated|2|||
124501046|NCT01204658|447785573|FG000|Primary Phase|Adverse Event|0|||
124501047|NCT01204658|447785574|FG001|Primary Phase|Adverse Event|0|||
124501048|NCT01204658|447785575|FG002|Primary Phase|Adverse Event|1|||
124501049|NCT01204658|447785576|FG003|Primary Phase|Adverse Event|0|||
124501050|NCT00905021|447785577|FG000|Overall Study|Adverse Event|2|||
124501051|NCT01511419|447785578|FG000|Dose 2|Physician Decision|1|||
124501052|NCT01511419|447785579|FG001|Dose 2|Physician Decision|0|||
124501053|NCT00786838|447785580|FG000|Overall Study|Physician Decision|4|||
124775771|NCT03847896|448808402|FG000|Overall Study|Withdrawal by Subject|2|||
124775772|NCT03847896|448808403|FG001|Overall Study|Withdrawal by Subject|10|||
124501054|NCT00786838|447785580|FG000|Overall Study|Death|4|||
124501055|NCT00786838|447785580|FG000|Overall Study|Adverse Event|6|||
124501056|NCT00786838|447785580|FG000|Overall Study|Progressive disease|31|||
124501057|NCT00786838|447785580|FG000|Overall Study|Withdrawal by Subject|4|||
124501058|NCT04594239|447785581|FG000|Overall Study|Withdrawal by Subject|3|||
124501059|NCT04594239|447785582|FG001|Overall Study|Withdrawal by Subject|4|||
124501060|NCT04594239|447785583|FG002|Overall Study|Withdrawal by Subject|2|||
124501061|NCT04594239|447785584|FG003|Overall Study|Withdrawal by Subject|4|||
124501062|NCT04594239|447785581|FG000|Overall Study|Lost to Follow-up|8|||
124501063|NCT04594239|447785582|FG001|Overall Study|Lost to Follow-up|5|||
124501064|NCT04594239|447785583|FG002|Overall Study|Lost to Follow-up|4|||
124501065|NCT04594239|447785584|FG003|Overall Study|Lost to Follow-up|6|||
124501066|NCT04594239|447785581|FG000|Overall Study|Subject relocated|0|||
124501067|NCT04594239|447785582|FG001|Overall Study|Subject relocated|0|||
124501068|NCT04594239|447785583|FG002|Overall Study|Subject relocated|0|||
124501069|NCT04594239|447785584|FG003|Overall Study|Subject relocated|1|||
124501070|NCT00091390|447785585|FG000|Overall Study|Protocol Violation|1|||
124560841|NCT03322462|448010996|FG000|Overall Study|Technical difficulties|2|||
124775773|NCT03847896|448808404|FG002|Overall Study|Withdrawal by Subject|5|||
124775774|NCT03847896|448808405|FG003|Overall Study|Withdrawal by Subject|9|||
124775775|NCT03847896|448808406|FG004|Overall Study|Withdrawal by Subject|8|||
124775776|NCT03847896|448808402|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124775777|NCT03847896|448808403|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124560842|NCT03322462|448010996|FG000|Overall Study|Other|1|||
124560843|NCT01133821|448011001|FG000|Overall Study|Lost to Follow-up|8|||
124560844|NCT01133821|448011002|FG001|Overall Study|Lost to Follow-up|11|||
124560845|NCT01133821|448011001|FG000|Overall Study|Withdrawal by Subject|8|||
124560846|NCT01133821|448011002|FG001|Overall Study|Withdrawal by Subject|3|||
124501071|NCT00091390|447785585|FG000|Overall Study|No protocol treatment|3|||
124501072|NCT03229759|447785586|FG000|Overall Study|Screen Failure|30|||
124501073|NCT03484923|447786906|FG000|Overall Study|Adverse Event|3|||
124501074|NCT03484923|447786907|FG001|Overall Study|Adverse Event|3|||
124501075|NCT03484923|447786908|FG002|Overall Study|Adverse Event|5|||
124501076|NCT03484923|447786909|FG003|Overall Study|Adverse Event|11|||
124501077|NCT03484923|447786910|FG004|Overall Study|Adverse Event|1|||
124501078|NCT03484923|447786906|FG000|Overall Study|Death|2|||
124501079|NCT03484923|447786907|FG001|Overall Study|Death|2|||
124501080|NCT03484923|447786908|FG002|Overall Study|Death|3|||
124501081|NCT03484923|447786909|FG003|Overall Study|Death|0|||
124501082|NCT03484923|447786910|FG004|Overall Study|Death|1|||
124501083|NCT03484923|447786906|FG000|Overall Study|Physician Decision|6|||
124724754|NCT02443116|448611798|FG003|Part 3|Withdrew informed consent|0|||
124724755|NCT02443116|448611799|FG004|Part 3|Withdrew informed consent|0|||
124724756|NCT02443116|448611800|FG005|Part 3|Withdrew informed consent|0|||
124724757|NCT02443116|448611801|FG006|Part 3|Withdrew informed consent|0|||
124724758|NCT02443116|448611802|FG007|Part 3|Withdrew informed consent|3|||
124724759|NCT02443116|448611803|FG008|Part 3|Withdrew informed consent|2|||
124724760|NCT02443116|448611795|FG000|Part 3|Lost to Follow-up|0|||
124724761|NCT02443116|448611796|FG001|Part 3|Lost to Follow-up|0|||
124724762|NCT02443116|448611797|FG002|Part 3|Lost to Follow-up|0|||
124724763|NCT02443116|448611798|FG003|Part 3|Lost to Follow-up|0|||
124724764|NCT02443116|448611799|FG004|Part 3|Lost to Follow-up|0|||
124724765|NCT02443116|448611800|FG005|Part 3|Lost to Follow-up|0|||
124724766|NCT02443116|448611801|FG006|Part 3|Lost to Follow-up|0|||
124724767|NCT02443116|448611802|FG007|Part 3|Lost to Follow-up|1|||
124724768|NCT02443116|448611803|FG008|Part 3|Lost to Follow-up|2|||
124724769|NCT01932372|448611804|FG000|Overall Study|Not meeting eligibility criteria|33|||
124724770|NCT01932372|448611805|FG001|Overall Study|Not meeting eligibility criteria|179|||
124724771|NCT01917929|448611806|FG000|Overall Study|Death|8|||
124724772|NCT01917929|448611806|FG000|Overall Study|Lost to Follow-up|19|||
124724773|NCT01917929|448611806|FG000|Overall Study|Withdrawal by Subject|33|||
124724774|NCT01917929|448611806|FG000|Overall Study|Adverse Event|6|||
124724775|NCT01917929|448611806|FG000|Overall Study|Investigative Site Terminated|35|||
124724776|NCT01917929|448611806|FG000|Overall Study|Censored because study device not implanted|6|||
124775778|NCT03847896|448808404|FG002|Overall Study|Withdrawal by parent/guardian|1|||
124501084|NCT03484923|447786907|FG001|Overall Study|Physician Decision|7|||
124501085|NCT03484923|447786908|FG002|Overall Study|Physician Decision|6|||
124501086|NCT03484923|447786909|FG003|Overall Study|Physician Decision|3|||
124501087|NCT03484923|447786910|FG004|Overall Study|Physician Decision|2|||
124724777|NCT01917929|448611806|FG000|Overall Study|Censored because surgery not performed|3|||
124724778|NCT01917929|448611806|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
124501088|NCT03484923|447786906|FG000|Overall Study|Progressive disease|33|||
124724779|NCT01917929|448611806|FG000|Overall Study|Sponsor terminated study|175|||
124501089|NCT03484923|447786907|FG001|Overall Study|Progressive disease|28|||
124501090|NCT03484923|447786908|FG002|Overall Study|Progressive disease|26|||
124501091|NCT03484923|447786909|FG003|Overall Study|Progressive disease|30|||
124560847|NCT01133821|448011001|FG000|Overall Study|preferred other treatment|1|||
124775779|NCT03847896|448808405|FG003|Overall Study|Withdrawal by parent/guardian|0|||
124501092|NCT03484923|447786910|FG004|Overall Study|Progressive disease|16|||
124501093|NCT03484923|447786906|FG000|Overall Study|Subject Decision|1|||
124501094|NCT03484923|447786907|FG001|Overall Study|Subject Decision|3|||
124501095|NCT03484923|447786908|FG002|Overall Study|Subject Decision|3|||
124501096|NCT03484923|447786909|FG003|Overall Study|Subject Decision|0|||
124501097|NCT03484923|447786910|FG004|Overall Study|Subject Decision|1|||
124501098|NCT03439748|447786911|FG000|Overall Study|Withdrawal by Subject|11|||
124501099|NCT03439748|447786912|FG001|Overall Study|Withdrawal by Subject|17|||
124501100|NCT05131451|447786913|FG000|Overall Study|Protocol Violation|1|||
124501101|NCT05131451|447786914|FG001|Overall Study|Protocol Violation|0|||
124501102|NCT00782418|447786915|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
124501103|NCT00782418|447786916|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
124501104|NCT00782418|447786917|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
124501105|NCT00782418|447786918|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
124501106|NCT00782418|447786919|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
124501107|NCT00782418|447786920|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
124501108|NCT00782418|447786921|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
124501109|NCT00782418|447786915|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
124501110|NCT00782418|447786916|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
124501111|NCT00782418|447786917|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
124501112|NCT00782418|447786918|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
124501113|NCT00782418|447786919|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
124501114|NCT00782418|447786920|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
124501115|NCT00782418|447786921|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
124501116|NCT00643487|447786924|FG000|Overall Study|Technical difficulty|3|||
124501117|NCT00390416|447786926|FG000|Overall Study|Withdrawal by Subject|1|||
124501118|NCT00390416|447786926|FG000|Overall Study|Not treated|3|||
124501119|NCT00630812|447786929|FG000|Randomisation to First Dose|Adverse Event|1|||
124501120|NCT00630812|447786930|FG001|Randomisation to First Dose|Adverse Event|1|||
124501121|NCT00630812|447786929|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
124501122|NCT00630812|447786930|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
124501123|NCT00630812|447786929|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
124501124|NCT00630812|447786930|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
124501125|NCT00630812|447786929|FG000|Randomisation to First Dose|Protocol Violation|4|||
124501126|NCT00630812|447786930|FG001|Randomisation to First Dose|Protocol Violation|1|||
124501127|NCT00630812|447786929|FG000|Double Blind Treatment Period|Adverse Event|13|||
124501128|NCT00630812|447786930|FG001|Double Blind Treatment Period|Adverse Event|5|||
124501129|NCT00630812|447786929|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
124501130|NCT00630812|447786930|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
124501131|NCT00630812|447786929|FG000|Double Blind Treatment Period|Physician Decision|2|||
124501132|NCT00630812|447786930|FG001|Double Blind Treatment Period|Physician Decision|1|||
124501133|NCT00630812|447786929|FG000|Double Blind Treatment Period|Protocol Violation|1|||
124501134|NCT00630812|447786930|FG001|Double Blind Treatment Period|Protocol Violation|0|||
124501135|NCT00630812|447786929|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
124501136|NCT00630812|447786930|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
124501137|NCT00630812|447786929|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
124501138|NCT00630812|447786930|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
124501139|NCT00630812|447786929|FG000|Double Blind Treatment Period|Non-compliance|0|||
124501140|NCT00630812|447786930|FG001|Double Blind Treatment Period|Non-compliance|1|||
124501141|NCT01728584|447786931|FG000|Overall Study|Adverse Event|1|||
124501142|NCT01728584|447786932|FG001|Overall Study|Adverse Event|0|||
124501143|NCT01728584|447786933|FG002|Overall Study|Adverse Event|0|||
124501144|NCT01728584|447786934|FG003|Overall Study|Adverse Event|0|||
124501145|NCT01728584|447786931|FG000|Overall Study|Physician Decision|4|||
124501146|NCT01728584|447786932|FG001|Overall Study|Physician Decision|0|||
124501147|NCT01728584|447786933|FG002|Overall Study|Physician Decision|1|||
124501148|NCT01728584|447786934|FG003|Overall Study|Physician Decision|0|||
124501149|NCT01728584|447786931|FG000|Overall Study|Withdrawal by Subject|1|||
124501150|NCT01728584|447786932|FG001|Overall Study|Withdrawal by Subject|0|||
124501151|NCT01728584|447786933|FG002|Overall Study|Withdrawal by Subject|0|||
124501152|NCT01728584|447786934|FG003|Overall Study|Withdrawal by Subject|0|||
124501153|NCT01728584|447786931|FG000|Overall Study|Screen failure|1|||
124501154|NCT01728584|447786932|FG001|Overall Study|Screen failure|0|||
124501155|NCT01728584|447786933|FG002|Overall Study|Screen failure|0|||
124501156|NCT01728584|447786934|FG003|Overall Study|Screen failure|0|||
124501157|NCT01728584|447786931|FG000|Overall Study|Other reason (not specified)|1|||
124501158|NCT01728584|447786932|FG001|Overall Study|Other reason (not specified)|0|||
124501159|NCT01728584|447786933|FG002|Overall Study|Other reason (not specified)|0|||
124501160|NCT01728584|447786934|FG003|Overall Study|Other reason (not specified)|1|||
124501161|NCT05628181|447786935|FG000|Overall Study|Death|2|||
124501162|NCT05628181|447786936|FG001|Overall Study|Death|4|||
124775780|NCT03847896|448808406|FG004|Overall Study|Withdrawal by parent/guardian|0|||
124775781|NCT03847896|448808402|FG000|Overall Study|Adverse Event|2|||
124775782|NCT03847896|448808403|FG001|Overall Study|Adverse Event|1|||
124775783|NCT03847896|448808404|FG002|Overall Study|Adverse Event|3|||
124775784|NCT03847896|448808405|FG003|Overall Study|Adverse Event|2|||
124775785|NCT03847896|448808406|FG004|Overall Study|Adverse Event|4|||
124775786|NCT03847896|448808402|FG000|Overall Study|A severe exacerbation event|0|||
124775787|NCT03847896|448808403|FG001|Overall Study|A severe exacerbation event|0|||
124775788|NCT03847896|448808404|FG002|Overall Study|A severe exacerbation event|0|||
124775789|NCT03847896|448808405|FG003|Overall Study|A severe exacerbation event|0|||
124775790|NCT03847896|448808406|FG004|Overall Study|A severe exacerbation event|3|||
124775791|NCT03847896|448808402|FG000|Overall Study|Protocol Violation|0|||
124775792|NCT03847896|448808403|FG001|Overall Study|Protocol Violation|2|||
124775793|NCT03847896|448808404|FG002|Overall Study|Protocol Violation|1|||
124775794|NCT03847896|448808405|FG003|Overall Study|Protocol Violation|0|||
124775795|NCT03847896|448808406|FG004|Overall Study|Protocol Violation|2|||
124775796|NCT03847896|448808402|FG000|Overall Study|Lost to Follow-up|0|||
124775797|NCT03847896|448808403|FG001|Overall Study|Lost to Follow-up|0|||
124775798|NCT03847896|448808404|FG002|Overall Study|Lost to Follow-up|0|||
124775799|NCT03847896|448808405|FG003|Overall Study|Lost to Follow-up|1|||
124775800|NCT03847896|448808406|FG004|Overall Study|Lost to Follow-up|0|||
124775801|NCT03847896|448808402|FG000|Overall Study|Condition under investigation worsened|0|||
124775802|NCT03847896|448808403|FG001|Overall Study|Condition under investigation worsened|0|||
124775803|NCT03847896|448808404|FG002|Overall Study|Condition under investigation worsened|0|||
124775804|NCT03847896|448808405|FG003|Overall Study|Condition under investigation worsened|1|||
124775805|NCT03847896|448808406|FG004|Overall Study|Condition under investigation worsened|1|||
124775806|NCT03847896|448808402|FG000|Overall Study|Lack of Efficacy|0|||
124775807|NCT03847896|448808403|FG001|Overall Study|Lack of Efficacy|0|||
124775808|NCT03847896|448808404|FG002|Overall Study|Lack of Efficacy|0|||
124775809|NCT03847896|448808405|FG003|Overall Study|Lack of Efficacy|2|||
124775810|NCT03847896|448808406|FG004|Overall Study|Lack of Efficacy|2|||
124775811|NCT03847896|448808402|FG000|Overall Study|Other reasons|3|||
124775812|NCT03847896|448808403|FG001|Overall Study|Other reasons|3|||
124775813|NCT03847896|448808404|FG002|Overall Study|Other reasons|1|||
124775814|NCT03847896|448808405|FG003|Overall Study|Other reasons|2|||
124775815|NCT03847896|448808406|FG004|Overall Study|Other reasons|1|||
124775816|NCT00118417|448808407|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
124775817|NCT00118417|448808408|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
124775818|NCT00118417|448808407|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
124775819|NCT00118417|448808408|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
124775820|NCT00118417|448808407|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
124775821|NCT00118417|448808408|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
124775822|NCT00118417|448808407|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
124775823|NCT00118417|448808408|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
124775824|NCT00118417|448808407|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
124775825|NCT00118417|448808408|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
124775826|NCT02978781|448808409|FG000|Part A|Adverse Event|1|||
124775827|NCT02978781|448808410|FG001|Part A|Adverse Event|1|||
124775828|NCT02978781|448808411|FG002|Part A|Adverse Event|0|||
124775829|NCT02978781|448808412|FG003|Part A|Adverse Event|0|||
124775830|NCT02978781|448808413|FG004|Part A|Adverse Event|0|||
124775831|NCT02978781|448808409|FG000|Part A|Withdrawal by Subject|0|||
124560848|NCT01133821|448011002|FG001|Overall Study|preferred other treatment|1|||
124560849|NCT01133821|448011001|FG000|Overall Study|Protocol Violation|0|||
124560850|NCT01133821|448011002|FG001|Overall Study|Protocol Violation|1|||
124560851|NCT01133821|448011001|FG000|Overall Study|Refused participation|1|||
124560852|NCT01133821|448011002|FG001|Overall Study|Refused participation|3|||
124560853|NCT03572933|448011006|FG000|Overall Study|Adverse Event|4|||
124560854|NCT03572933|448011007|FG001|Overall Study|Adverse Event|1|||
124560855|NCT03572933|448011006|FG000|Overall Study|Withdrawal by Subject|0|||
124560856|NCT03572933|448011007|FG001|Overall Study|Withdrawal by Subject|1|||
124560857|NCT00633152|448011012|FG000|Overall Study|Adverse Event|1|||
124560858|NCT00633152|448011013|FG001|Overall Study|Adverse Event|0|||
124775832|NCT02978781|448808410|FG001|Part A|Withdrawal by Subject|1|||
124775833|NCT02978781|448808411|FG002|Part A|Withdrawal by Subject|0|||
124775834|NCT02978781|448808412|FG003|Part A|Withdrawal by Subject|0|||
124775835|NCT02978781|448808413|FG004|Part A|Withdrawal by Subject|0|||
124775836|NCT02978781|448808409|FG000|Part B|Withdrawal by Subject|0|||
124775837|NCT02978781|448808410|FG001|Part B|Withdrawal by Subject|0|||
124775838|NCT02978781|448808411|FG002|Part B|Withdrawal by Subject|0|||
124775839|NCT02978781|448808412|FG003|Part B|Withdrawal by Subject|1|||
124775840|NCT02978781|448808413|FG004|Part B|Withdrawal by Subject|0|||
124775841|NCT02978781|448808409|FG000|Part C|Adverse Event|0|||
124775842|NCT02978781|448808410|FG001|Part C|Adverse Event|0|||
124775843|NCT02978781|448808411|FG002|Part C|Adverse Event|0|||
124775844|NCT02978781|448808412|FG003|Part C|Adverse Event|0|||
124775845|NCT02978781|448808413|FG004|Part C|Adverse Event|2|||
124775846|NCT02978781|448808409|FG000|Part C|Withdrawal by Subject|0|||
124775847|NCT02978781|448808410|FG001|Part C|Withdrawal by Subject|0|||
124775848|NCT02978781|448808411|FG002|Part C|Withdrawal by Subject|0|||
124775849|NCT02978781|448808412|FG003|Part C|Withdrawal by Subject|0|||
124775850|NCT02978781|448808413|FG004|Part C|Withdrawal by Subject|1|||
124775851|NCT02978781|448808409|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
124775852|NCT02978781|448808410|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
124775853|NCT02978781|448808411|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
124775854|NCT02978781|448808412|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
124775855|NCT02978781|448808413|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
124775856|NCT00785785|448808414|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
124775857|NCT00785785|448808415|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
124775858|NCT00785785|448808414|FG000|Core Phase up to 36 Months|Adverse Event|31|||
124775859|NCT00785785|448808415|FG001|Core Phase up to 36 Months|Adverse Event|21|||
124775860|NCT00785785|448808414|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
124775861|NCT00785785|448808415|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
124775862|NCT00785785|448808414|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
124775863|NCT00785785|448808415|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
124775864|NCT00785785|448808414|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
124775865|NCT00785785|448808415|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
124775866|NCT00785785|448808414|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
124775867|NCT00785785|448808415|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
124775868|NCT00785785|448808414|FG000|Core Phase up to 36 Months|Administrative problems|3|||
124775869|NCT00785785|448808415|FG001|Core Phase up to 36 Months|Administrative problems|3|||
124775870|NCT00785785|448808414|FG000|Core Phase up to 36 Months|Death|5|||
124775871|NCT00785785|448808415|FG001|Core Phase up to 36 Months|Death|8|||
124775872|NCT00785785|448808414|FG000|Core Phase up to 36 Months|Disease progression|139|||
124775873|NCT00785785|448808415|FG001|Core Phase up to 36 Months|Disease progression|119|||
124775874|NCT00785785|448808414|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
124775875|NCT00785785|448808415|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
124775876|NCT00785785|448808414|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
124775877|NCT00785785|448808415|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
124775878|NCT00785785|448808414|FG000|Optional Extension Phase|Adverse Event|4|||
124775879|NCT00785785|448808415|FG001|Optional Extension Phase|Adverse Event|5|||
124775880|NCT00785785|448808414|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
124775881|NCT00785785|448808415|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
124775882|NCT00785785|448808414|FG000|Optional Extension Phase|Lost to Follow-up|1|||
124775883|NCT00785785|448808415|FG001|Optional Extension Phase|Lost to Follow-up|0|||
124775884|NCT00785785|448808414|FG000|Optional Extension Phase|Administrative problems|2|||
124775885|NCT00785785|448808415|FG001|Optional Extension Phase|Administrative problems|0|||
124775886|NCT00785785|448808414|FG000|Optional Extension Phase|Death|1|||
124775887|NCT00785785|448808415|FG001|Optional Extension Phase|Death|5|||
124775888|NCT00785785|448808414|FG000|Optional Extension Phase|Disease progression|22|||
124775889|NCT00785785|448808415|FG001|Optional Extension Phase|Disease progression|70|||
124775890|NCT00785785|448808414|FG000|Optional Extension Phase|Protocol deviation|0|||
124775891|NCT00785785|448808415|FG001|Optional Extension Phase|Protocol deviation|2|||
124775892|NCT00785785|448808414|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
124775893|NCT00785785|448808415|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
124775894|NCT02453321|448808416|FG000|Overall Study|Weakness|1|||
124775895|NCT02453321|448808417|FG001|Overall Study|Weakness|1|||
124775896|NCT02453321|448808418|FG002|Overall Study|Weakness|2|||
124560859|NCT00633152|448011012|FG000|Overall Study|Randomized, did not receive study drug|5|||
124560860|NCT00633152|448011013|FG001|Overall Study|Randomized, did not receive study drug|2|||
124560861|NCT00633152|448011012|FG000|Overall Study|Withdrawal by Subject|1|||
124560862|NCT00633152|448011013|FG001|Overall Study|Withdrawal by Subject|1|||
124560863|NCT00633152|448011012|FG000|Overall Study|Lost to Follow-up|4|||
124560864|NCT00633152|448011013|FG001|Overall Study|Lost to Follow-up|1|||
124560865|NCT00633152|448011012|FG000|Overall Study|Miscellaneous Other|3|||
124560866|NCT00633152|448011013|FG001|Overall Study|Miscellaneous Other|2|||
124560867|NCT01907087|448011014|FG000|Overall Study|Withdrawal by Subject|1|||
124560868|NCT02049359|448011015|FG000|Overall Study|Lost to Follow-up|26|||
124560869|NCT02049359|448011016|FG001|Overall Study|Lost to Follow-up|19|||
124560870|NCT03273387|448011017|FG000|Overall Study|Death|2|||
124560871|NCT03273387|448011018|FG001|Overall Study|Death|2|||
124560872|NCT03273387|448011017|FG000|Overall Study|Withdrawal by Subject|1|||
124775897|NCT02453321|448808416|FG000|Overall Study|Deep Venous Thrombosis|0|||
124775898|NCT02453321|448808417|FG001|Overall Study|Deep Venous Thrombosis|1|||
124775899|NCT02453321|448808418|FG002|Overall Study|Deep Venous Thrombosis|0|||
124775900|NCT00521404|448808419|FG000|Overall Study|Adverse Event|13|||
124775901|NCT00521404|448808419|FG000|Overall Study|Disease Progression|33|||
124560873|NCT03273387|448011018|FG001|Overall Study|Withdrawal by Subject|1|||
124560874|NCT05216978|448011019|FG000|Overall Study|Withdrawal by Subject|3|||
124560875|NCT05216978|448011019|FG000|Overall Study|Lost to Follow-up|5|||
124775902|NCT00521404|448808419|FG000|Overall Study|Investigator decision|5|||
124775903|NCT00521404|448808419|FG000|Overall Study|Withdrawal of consent|3|||
124775904|NCT00521404|448808419|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
124775905|NCT00521404|448808419|FG000|Overall Study|Other|7|||
124775906|NCT02282605|448808421|FG000|Overall Study|negative SA result on Day -1|3|||
124775907|NCT02282605|448808422|FG001|Overall Study|negative SA result on Day -1|0|||
124775908|NCT02282605|448808423|FG002|Overall Study|negative SA result on Day -1|0|||
124775909|NCT04396639|448808426|FG000|Overall Study|Withdrawal by Subject|1|||
124775910|NCT04396639|448808426|FG000|Overall Study|Other|1|||
124775911|NCT01544335|448808429|FG000|Overall Study|Lost to Follow-up|27|||
124775912|NCT01544335|448808429|FG000|Overall Study|Death|4|||
124775913|NCT01544335|448808429|FG000|Overall Study|Disease progression|3|||
124775914|NCT01544335|448808429|FG000|Overall Study|Baseline Measurements not Available|19|||
124775915|NCT01532986|448808432|FG000|Overall Study|Death|9|||
124775916|NCT01532986|448808433|FG001|Overall Study|Death|9|||
124775917|NCT01532986|448808432|FG000|Overall Study|Withdrawal by Subject|7|||
124775918|NCT01532986|448808433|FG001|Overall Study|Withdrawal by Subject|10|||
124775919|NCT01532986|448808432|FG000|Overall Study|Physician Decision|7|||
124775920|NCT01532986|448808433|FG001|Overall Study|Physician Decision|5|||
124775921|NCT04614974|448808434|FG000|Overall Study|Lost to Follow-up|14|||
124775922|NCT04614974|448808435|FG001|Overall Study|Lost to Follow-up|11|||
124775923|NCT01635153|448808436|FG000|Overall Study|Lost to Follow-up|40|||
124775924|NCT01635153|448808437|FG001|Overall Study|Lost to Follow-up|43|||
124775925|NCT00658359|448808438|FG000|Overall Study|Death|3|||
124775926|NCT00658359|448808439|FG001|Overall Study|Death|1|||
124775927|NCT00658359|448808440|FG002|Overall Study|Death|2|||
124775928|NCT00658359|448808438|FG000|Overall Study|Adverse Event|13|||
124775929|NCT00658359|448808439|FG001|Overall Study|Adverse Event|6|||
124775930|NCT00658359|448808440|FG002|Overall Study|Adverse Event|9|||
124775931|NCT00658359|448808438|FG000|Overall Study|Protocol Violation|1|||
124775932|NCT00658359|448808439|FG001|Overall Study|Protocol Violation|0|||
124775933|NCT00658359|448808440|FG002|Overall Study|Protocol Violation|0|||
124775934|NCT00658359|448808438|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
124775935|NCT00658359|448808439|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
124775936|NCT00658359|448808440|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
124775937|NCT00658359|448808438|FG000|Overall Study|Withdrawal by Subject|7|||
124775938|NCT00658359|448808439|FG001|Overall Study|Withdrawal by Subject|4|||
124775939|NCT00658359|448808440|FG002|Overall Study|Withdrawal by Subject|2|||
124775940|NCT00658359|448808438|FG000|Overall Study|Lost to Follow-up|2|||
124775941|NCT00658359|448808439|FG001|Overall Study|Lost to Follow-up|2|||
124775942|NCT00658359|448808440|FG002|Overall Study|Lost to Follow-up|4|||
124775943|NCT00658359|448808438|FG000|Overall Study|Lack of Efficacy|0|||
124775944|NCT00658359|448808439|FG001|Overall Study|Lack of Efficacy|1|||
124775945|NCT00658359|448808440|FG002|Overall Study|Lack of Efficacy|0|||
124775946|NCT02754440|448808441|FG000|Overall Study|Protocol Violation|3|||
124775947|NCT02754440|448808442|FG001|Overall Study|Protocol Violation|2|||
124775948|NCT02754440|448808443|FG002|Overall Study|Protocol Violation|2|||
124501163|NCT05628181|447786937|FG002|Overall Study|Death|0|||
124501164|NCT03656926|447786947|FG000|Overall Study|Adverse Event|5|||
124501165|NCT03656926|447786948|FG001|Overall Study|Adverse Event|4|||
124501166|NCT03656926|447786947|FG000|Overall Study|Withdrawal by Subject|7|||
124501167|NCT03656926|447786948|FG001|Overall Study|Withdrawal by Subject|2|||
124501168|NCT03656926|447786947|FG000|Overall Study|Screen fail after randomization|1|||
124501169|NCT03656926|447786948|FG001|Overall Study|Screen fail after randomization|0|||
124501170|NCT03656926|447786947|FG000|Overall Study|PI decision due to patient condition|1|||
124501171|NCT03656926|447786948|FG001|Overall Study|PI decision due to patient condition|0|||
124501172|NCT03656926|447786947|FG000|Overall Study|Patient unresponsiveness|1|||
124501173|NCT03656926|447786948|FG001|Overall Study|Patient unresponsiveness|0|||
124501174|NCT05610176|447786949|FG000|Overall Study|Death|6|||
124501175|NCT00471536|447786950|FG000|Overall Study|Withdrawal by Subject|1|||
124501176|NCT01253044|447786954|FG000|Overall Study|Lost to Follow-up|38|||
124501177|NCT01253044|447786955|FG001|Overall Study|Lost to Follow-up|29|||
124501178|NCT03116399|447786956|FG000|Overall Study|Death|8|||
124501179|NCT03116399|447786957|FG001|Overall Study|Death|3|||
124501180|NCT03116399|447786956|FG000|Overall Study|Lost to Follow-up|7|||
124501181|NCT03116399|447786957|FG001|Overall Study|Lost to Follow-up|11|||
124501182|NCT03116399|447786956|FG000|Overall Study|Investigator Decision|1|||
124501183|NCT03116399|447786957|FG001|Overall Study|Investigator Decision|1|||
124501184|NCT03116399|447786956|FG000|Overall Study|Withdrawal by Subject|24|||
124501185|NCT03116399|447786957|FG001|Overall Study|Withdrawal by Subject|9|||
124501186|NCT00905307|447786958|FG000|Overall Study|Switched to Open Label Rescue|7|||
124501187|NCT00905307|447786959|FG001|Overall Study|Switched to Open Label Rescue|17|||
124501188|NCT00905307|447786960|FG002|Overall Study|Switched to Open Label Rescue|11|||
124775949|NCT02754440|448808444|FG003|Overall Study|Protocol Violation|6|||
124775950|NCT02754440|448808441|FG000|Overall Study|Adverse Event|3|||
124775951|NCT02754440|448808442|FG001|Overall Study|Adverse Event|1|||
124775952|NCT02754440|448808443|FG002|Overall Study|Adverse Event|0|||
124775953|NCT02754440|448808444|FG003|Overall Study|Adverse Event|9|||
124775954|NCT02754440|448808441|FG000|Overall Study|Withdrawal by Subject|0|||
124775955|NCT02754440|448808442|FG001|Overall Study|Withdrawal by Subject|0|||
124501189|NCT00905307|447786961|FG003|Overall Study|Switched to Open Label Rescue|11|||
124501190|NCT00905307|447786962|FG004|Overall Study|Switched to Open Label Rescue|4|||
124501191|NCT00905307|447786963|FG005|Overall Study|Switched to Open Label Rescue|15|||
124501192|NCT00905307|447786958|FG000|Overall Study|Lost to Follow-up|0|||
124501193|NCT00905307|447786959|FG001|Overall Study|Lost to Follow-up|0|||
124501194|NCT00905307|447786960|FG002|Overall Study|Lost to Follow-up|0|||
124501195|NCT00905307|447786961|FG003|Overall Study|Lost to Follow-up|0|||
124501196|NCT00905307|447786962|FG004|Overall Study|Lost to Follow-up|1|||
124501197|NCT00905307|447786963|FG005|Overall Study|Lost to Follow-up|1|||
124501198|NCT00905307|447786958|FG000|Overall Study|Adverse Event|3|||
124501199|NCT00905307|447786959|FG001|Overall Study|Adverse Event|4|||
124501200|NCT00905307|447786960|FG002|Overall Study|Adverse Event|5|||
124501201|NCT00905307|447786961|FG003|Overall Study|Adverse Event|11|||
124501202|NCT00905307|447786962|FG004|Overall Study|Adverse Event|3|||
124501203|NCT00905307|447786963|FG005|Overall Study|Adverse Event|5|||
124501204|NCT00905307|447786958|FG000|Overall Study|Withdrawal by Subject|5|||
124501205|NCT00905307|447786959|FG001|Overall Study|Withdrawal by Subject|13|||
124501206|NCT00905307|447786960|FG002|Overall Study|Withdrawal by Subject|15|||
124501207|NCT00905307|447786961|FG003|Overall Study|Withdrawal by Subject|11|||
124501208|NCT00905307|447786962|FG004|Overall Study|Withdrawal by Subject|4|||
124501209|NCT00905307|447786963|FG005|Overall Study|Withdrawal by Subject|13|||
124501210|NCT00905307|447786958|FG000|Overall Study|Protocol Violation|1|||
124501211|NCT00905307|447786959|FG001|Overall Study|Protocol Violation|0|||
124501212|NCT00905307|447786960|FG002|Overall Study|Protocol Violation|1|||
124501213|NCT00905307|447786961|FG003|Overall Study|Protocol Violation|0|||
124501214|NCT00905307|447786962|FG004|Overall Study|Protocol Violation|0|||
124501215|NCT00905307|447786963|FG005|Overall Study|Protocol Violation|0|||
124501216|NCT00905307|447786958|FG000|Overall Study|Lack of Efficacy|6|||
124501217|NCT00905307|447786959|FG001|Overall Study|Lack of Efficacy|3|||
124501218|NCT00905307|447786960|FG002|Overall Study|Lack of Efficacy|5|||
124501219|NCT00905307|447786961|FG003|Overall Study|Lack of Efficacy|4|||
124501220|NCT00905307|447786962|FG004|Overall Study|Lack of Efficacy|4|||
124501221|NCT00905307|447786963|FG005|Overall Study|Lack of Efficacy|8|||
124501222|NCT01401010|447786968|FG000|Overall Study|Could not interpret assay results|1|||
124501223|NCT01401010|447786969|FG001|Overall Study|Could not interpret assay results|0|||
124501224|NCT01975272|447786972|FG000|Overall Study|Excluded after protocol amendment|1|||
124724780|NCT02059499|448611814|FG000|Upto Week 20|Lost to Follow-up|2|||
124501225|NCT01975272|447786973|FG001|Overall Study|Excluded after protocol amendment|1|||
124501226|NCT01975272|447786974|FG002|Overall Study|Excluded after protocol amendment|2|||
124501227|NCT03280550|447786975|FG000|Overall Study|Withdrawal by Subject|2|||
124501228|NCT03280550|447786976|FG001|Overall Study|Withdrawal by Subject|2|||
124501229|NCT03280550|447786975|FG000|Overall Study|Physician Decision|0|||
124501230|NCT03280550|447786976|FG001|Overall Study|Physician Decision|1|||
124501231|NCT03345836|447786977|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
124501232|NCT03345836|447786978|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
124501233|NCT03345836|447786979|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
124501234|NCT03345836|447786980|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
124501235|NCT03345836|447786981|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
124501236|NCT03345836|447786982|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
124501237|NCT03345836|447786977|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
124724781|NCT02059499|448611815|FG001|Upto Week 20|Lost to Follow-up|6|||
124724782|NCT02059499|448611816|FG002|Upto Week 20|Lost to Follow-up|0|||
124724783|NCT02059499|448611814|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
124724784|NCT02059499|448611815|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
124724785|NCT02059499|448611816|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
124724786|NCT02059499|448611814|FG000|Upto Week 20|Withdrawal by Subject|1|||
124724787|NCT02059499|448611815|FG001|Upto Week 20|Withdrawal by Subject|1|||
124724788|NCT02059499|448611816|FG002|Upto Week 20|Withdrawal by Subject|0|||
124724789|NCT02059499|448611814|FG000|Upto Week 20|No treatment per protocol criteria|0|||
124724790|NCT02059499|448611815|FG001|Upto Week 20|No treatment per protocol criteria|0|||
124724791|NCT02059499|448611816|FG002|Upto Week 20|No treatment per protocol criteria|5|||
124724792|NCT02059499|448611814|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
124724793|NCT02059499|448611815|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
124724794|NCT02059499|448611816|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
124724795|NCT02059499|448611814|FG000|Post-week 20|Lost to Follow-up|0|||
124724796|NCT02059499|448611815|FG001|Post-week 20|Lost to Follow-up|2|||
124724797|NCT02059499|448611816|FG002|Post-week 20|Lost to Follow-up|0|||
124501238|NCT03345836|447786978|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
124501239|NCT03345836|447786979|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
124501240|NCT03345836|447786980|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
124501241|NCT03345836|447786981|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
124724798|NCT02059499|448611814|FG000|Post-week 20|Withdrawal by Subject|0|||
124724799|NCT02059499|448611815|FG001|Post-week 20|Withdrawal by Subject|1|||
124724800|NCT02059499|448611816|FG002|Post-week 20|Withdrawal by Subject|0|||
124501242|NCT03345836|447786982|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
124501243|NCT03345836|447786977|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
124501244|NCT03345836|447786978|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
124501245|NCT03345836|447786979|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
124501246|NCT03345836|447786980|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
124501247|NCT03345836|447786981|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
124501248|NCT03345836|447786982|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
124501249|NCT03345836|447786977|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
124501250|NCT03345836|447786978|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
124501251|NCT03345836|447786979|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
124501252|NCT03345836|447786980|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
124501253|NCT03345836|447786981|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
124501254|NCT03345836|447786982|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
124501255|NCT03345836|447786977|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
124501256|NCT03345836|447786978|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
124501257|NCT03345836|447786979|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
124501258|NCT03345836|447786980|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
124501259|NCT03345836|447786981|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
124501260|NCT03345836|447786982|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
124501261|NCT03345836|447786977|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
124501262|NCT03345836|447786978|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
124501263|NCT03345836|447786979|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
124501264|NCT03345836|447786980|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
124501265|NCT03345836|447786981|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
124501266|NCT03345836|447786982|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
124501267|NCT03345836|447786977|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
124501268|NCT03345836|447786978|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
124501269|NCT03345836|447786979|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
124501270|NCT03345836|447786980|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
124501271|NCT03345836|447786981|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
124501272|NCT03345836|447786982|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
124501273|NCT03345836|447786977|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
124501274|NCT03345836|447786978|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
124501275|NCT03345836|447786979|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
124501276|NCT03345836|447786980|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
124501277|NCT03345836|447786981|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
124501278|NCT03345836|447786982|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
124501279|NCT03345836|447786977|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
124501280|NCT03345836|447786978|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
124501281|NCT03345836|447786979|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
124501282|NCT03345836|447786980|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
124501283|NCT03345836|447786981|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
124501284|NCT03345836|447786982|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
124501285|NCT03345836|447786977|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
124501286|NCT03345836|447786978|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
124501287|NCT03345836|447786979|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
124501288|NCT03345836|447786980|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
124501289|NCT03345836|447786981|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
124501290|NCT03345836|447786982|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
124501291|NCT03345836|447786977|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
124501292|NCT03345836|447786978|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
124501293|NCT03345836|447786979|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
124501294|NCT03345836|447786980|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
124501295|NCT03345836|447786981|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
124501296|NCT03345836|447786982|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
124501297|NCT04370028|447786983|FG000|Overall Study|Withdrawal by Subject|695|||
124501298|NCT04370028|447786983|FG000|Overall Study|Protocol Violation|9|||
124501299|NCT04370028|447786983|FG000|Overall Study|Adverse Event|3|||
124501300|NCT02213198|447786986|FG000|Baseline|No show for intake|7|||
124501301|NCT02213198|447786987|FG001|Baseline|No show for intake|9|||
124501302|NCT02213198|447786986|FG000|Baseline|Withdrawal by Subject|34|||
124501303|NCT02213198|447786987|FG001|Baseline|Withdrawal by Subject|11|||
124501304|NCT02213198|447786986|FG000|Baseline|transferred out of clinic|7|||
124501305|NCT02213198|447786987|FG001|Baseline|transferred out of clinic|9|||
124501306|NCT02213198|447786986|FG000|Baseline|Lost to Follow-up|40|||
124501307|NCT02213198|447786987|FG001|Baseline|Lost to Follow-up|21|||
124501308|NCT02213198|447786986|FG000|Baseline|incarcerated,violent|0|||
124501309|NCT02213198|447786987|FG001|Baseline|incarcerated,violent|1|||
124501310|NCT02213198|447786986|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
124501311|NCT02213198|447786987|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
124501312|NCT02213198|447786986|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
124501313|NCT02213198|447786987|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
124501314|NCT02213198|447786986|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
124501315|NCT02213198|447786987|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
124501316|NCT02213198|447786986|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
124501317|NCT02213198|447786987|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
124501318|NCT02213198|447786986|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
124501319|NCT02213198|447786987|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
124501320|NCT02213198|447786986|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
124501321|NCT02213198|447786987|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
124501322|NCT05091060|447786988|FG000|Overall Study|Lost to Follow-up|1|||
124501323|NCT01798706|447786989|FG000|Overall Study|Adverse Event|15|||
124501324|NCT01798706|447786990|FG001|Overall Study|Adverse Event|10|||
124501325|NCT01798706|447786989|FG000|Overall Study|Lack of Efficacy|0|||
124501326|NCT01798706|447786990|FG001|Overall Study|Lack of Efficacy|2|||
124501327|NCT01798706|447786989|FG000|Overall Study|Poor compliance to protocol|1|||
124501328|NCT01798706|447786990|FG001|Overall Study|Poor compliance to protocol|0|||
124501329|NCT01798706|447786989|FG000|Overall Study|Other than specified above|5|||
124501330|NCT01798706|447786990|FG001|Overall Study|Other than specified above|9|||
124501331|NCT00496873|447786991|FG000|Overall Study|Ineligible|2|||
124501332|NCT00496873|447786991|FG000|Overall Study|Death|2|||
124501333|NCT00496873|447786991|FG000|Overall Study|Withdrawal by Subject|3|||
124501334|NCT05896761|447786992|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
124501335|NCT05896761|447786993|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
124775956|NCT02754440|448808443|FG002|Overall Study|Withdrawal by Subject|0|||
124501336|NCT05896761|447786992|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
124501337|NCT05896761|447786993|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
124501338|NCT02761993|447787000|FG000|Overall Study|Adverse Event|0|||
124501339|NCT02761993|447787001|FG001|Overall Study|Adverse Event|2|||
124501340|NCT02761993|447787002|FG002|Overall Study|Adverse Event|0|||
124501341|NCT02761993|447787000|FG000|Overall Study|Lost to Follow-up|1|||
124501342|NCT02761993|447787001|FG001|Overall Study|Lost to Follow-up|3|||
124501343|NCT02761993|447787002|FG002|Overall Study|Lost to Follow-up|2|||
124501344|NCT02761993|447787000|FG000|Overall Study|Withdrawal by Subject|1|||
124501345|NCT02761993|447787001|FG001|Overall Study|Withdrawal by Subject|1|||
124501346|NCT02761993|447787002|FG002|Overall Study|Withdrawal by Subject|2|||
124501347|NCT01842620|447787003|FG000|Period 1|Withdrawal by Subject|1|||
124501348|NCT01842620|447787004|FG001|Period 1|Withdrawal by Subject|0|||
124501349|NCT00875017|447787009|FG000|First Intervention|Withdrawal by Subject|1|||
124501350|NCT00875017|447787010|FG001|First Intervention|Withdrawal by Subject|0|||
124501351|NCT00875017|447787011|FG002|First Intervention|Withdrawal by Subject|1|||
124501352|NCT00875017|447787012|FG003|First Intervention|Withdrawal by Subject|0|||
124501353|NCT00875017|447787013|FG004|First Intervention|Withdrawal by Subject|0|||
124501354|NCT00875017|447787014|FG005|First Intervention|Withdrawal by Subject|0|||
124501355|NCT00875017|447787009|FG000|First Intervention|Adverse Event|0|||
124501356|NCT00875017|447787010|FG001|First Intervention|Adverse Event|0|||
124501357|NCT00875017|447787011|FG002|First Intervention|Adverse Event|0|||
124501358|NCT00875017|447787012|FG003|First Intervention|Adverse Event|1|||
124501359|NCT00875017|447787013|FG004|First Intervention|Adverse Event|0|||
124501360|NCT00875017|447787014|FG005|First Intervention|Adverse Event|0|||
124501361|NCT00875017|447787009|FG000|First Intervention|Problems collecting rectal effluent|1|||
124501362|NCT00875017|447787010|FG001|First Intervention|Problems collecting rectal effluent|0|||
124501363|NCT00875017|447787011|FG002|First Intervention|Problems collecting rectal effluent|0|||
124501364|NCT00875017|447787012|FG003|First Intervention|Problems collecting rectal effluent|0|||
124501365|NCT00875017|447787013|FG004|First Intervention|Problems collecting rectal effluent|0|||
124501366|NCT00875017|447787014|FG005|First Intervention|Problems collecting rectal effluent|0|||
124501367|NCT00875017|447787009|FG000|First Intervention|Intolerance to nasogastric tube|0|||
124501368|NCT00875017|447787010|FG001|First Intervention|Intolerance to nasogastric tube|0|||
124501369|NCT00875017|447787011|FG002|First Intervention|Intolerance to nasogastric tube|0|||
124501370|NCT00875017|447787012|FG003|First Intervention|Intolerance to nasogastric tube|0|||
124501371|NCT00875017|447787013|FG004|First Intervention|Intolerance to nasogastric tube|1|||
124501372|NCT00875017|447787014|FG005|First Intervention|Intolerance to nasogastric tube|0|||
124501373|NCT00875017|447787009|FG000|Washout|Problem collecting rectal effluent|0|||
124501374|NCT00875017|447787010|FG001|Washout|Problem collecting rectal effluent|0|||
124560876|NCT02180061|448011020|FG000|Overall Study|Adverse Event|4|||
124775957|NCT02754440|448808444|FG003|Overall Study|Withdrawal by Subject|1|||
124560877|NCT02180061|448011021|FG001|Overall Study|Adverse Event|2|||
124560878|NCT02180061|448011020|FG000|Overall Study|Clinical Progression|5|||
124560879|NCT02180061|448011021|FG001|Overall Study|Clinical Progression|1|||
124560880|NCT02180061|448011020|FG000|Overall Study|Progressive Disease|15|||
124560881|NCT02180061|448011021|FG001|Overall Study|Progressive Disease|5|||
124560882|NCT02180061|448011020|FG000|Overall Study|Physician Decision|1|||
124560883|NCT02180061|448011021|FG001|Overall Study|Physician Decision|0|||
124560884|NCT01405950|448011022|FG000|Overall Study|Withdrawal by Subject|1|||
124560885|NCT01405950|448011023|FG001|Overall Study|Withdrawal by Subject|0|||
124560886|NCT01405950|448011024|FG002|Overall Study|Withdrawal by Subject|0|||
124560887|NCT01405950|448011025|FG003|Overall Study|Withdrawal by Subject|0|||
124560888|NCT02410252|448011026|FG000|Overall Study|Withdrawal by Subject|4|||
124560889|NCT02410252|448011026|FG000|Overall Study|Physician Decision|2|||
124560890|NCT01772368|448011031|FG000|Overall Study|Adverse Event|1|||
124560891|NCT01772368|448011031|FG000|Overall Study|Withdrawal by Subject|3|||
124560892|NCT01772368|448011031|FG000|Overall Study|Protocol Violation|2|||
124560893|NCT01772368|448011031|FG000|Overall Study|Other|1|||
124560894|NCT01452529|448011032|FG000|Run-in Period|Adverse Event|96|||
124560895|NCT01452529|448011033|FG001|Run-in Period|Adverse Event|0|||
124560896|NCT01452529|448011034|FG002|Run-in Period|Adverse Event|0|||
124560897|NCT01452529|448011032|FG000|Run-in Period|Withdrawal by Subject|49|||
124560898|NCT01452529|448011033|FG001|Run-in Period|Withdrawal by Subject|0|||
124560899|NCT01452529|448011034|FG002|Run-in Period|Withdrawal by Subject|0|||
124560900|NCT01452529|448011032|FG000|Run-in Period|Lost to Follow-up|19|||
124560901|NCT01452529|448011033|FG001|Run-in Period|Lost to Follow-up|0|||
124560902|NCT01452529|448011034|FG002|Run-in Period|Lost to Follow-up|0|||
124560903|NCT01452529|448011032|FG000|Run-in Period|Lack of Efficacy|46|||
124560904|NCT01452529|448011033|FG001|Run-in Period|Lack of Efficacy|0|||
124560905|NCT01452529|448011034|FG002|Run-in Period|Lack of Efficacy|0|||
124560906|NCT01452529|448011032|FG000|Run-in Period|Confirmed or suspected diversion|23|||
124560907|NCT01452529|448011033|FG001|Run-in Period|Confirmed or suspected diversion|0|||
124560908|NCT01452529|448011034|FG002|Run-in Period|Confirmed or suspected diversion|0|||
124560909|NCT01452529|448011032|FG000|Run-in Period|Administrative|21|||
124560910|NCT01452529|448011033|FG001|Run-in Period|Administrative|0|||
124560911|NCT01452529|448011034|FG002|Run-in Period|Administrative|0|||
124560912|NCT01452529|448011032|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
124560913|NCT01452529|448011033|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
124560914|NCT01452529|448011034|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
124560915|NCT01452529|448011032|FG000|Double-blind (DB) Period|Adverse Event|0|||
124560916|NCT01452529|448011033|FG001|Double-blind (DB) Period|Adverse Event|18|||
124560917|NCT01452529|448011034|FG002|Double-blind (DB) Period|Adverse Event|11|||
124560918|NCT01452529|448011032|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
124560919|NCT01452529|448011033|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
124560920|NCT01452529|448011034|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
124560921|NCT01452529|448011032|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
124560922|NCT01452529|448011033|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
124560923|NCT01452529|448011034|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
124560924|NCT01452529|448011032|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
124560925|NCT01452529|448011033|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
124560926|NCT01452529|448011034|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
124560927|NCT01452529|448011032|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
124560928|NCT01452529|448011033|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
124560929|NCT01452529|448011034|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
124560930|NCT01452529|448011032|FG000|Double-blind (DB) Period|Administrative|0|||
124560931|NCT01452529|448011033|FG001|Double-blind (DB) Period|Administrative|11|||
124560932|NCT01452529|448011034|FG002|Double-blind (DB) Period|Administrative|7|||
124560933|NCT03551730|448011035|FG000|Overall Study|Adverse Event|1|||
124560934|NCT03551730|448011036|FG001|Overall Study|Adverse Event|0|||
124560935|NCT03551730|448011037|FG002|Overall Study|Adverse Event|0|||
124560936|NCT03551730|448011038|FG003|Overall Study|Adverse Event|0|||
124560937|NCT03347695|448011042|FG000|Overall Study|Death|0|||
124560938|NCT03347695|448011043|FG001|Overall Study|Death|4|||
124560939|NCT03347695|448011042|FG000|Overall Study|Lost to Follow-up|0|||
124560940|NCT03347695|448011043|FG001|Overall Study|Lost to Follow-up|1|||
124560941|NCT01003886|448011048|FG000|Overall Study|Lack of Efficacy|5|||
124560942|NCT01003886|448011048|FG000|Overall Study|Lost to Follow-up|169|||
124560943|NCT01003886|448011048|FG000|Overall Study|Withdrawal by Subject|39|||
124560944|NCT01003886|448011048|FG000|Overall Study|Other|14|||
124560945|NCT01003886|448011048|FG000|Overall Study|Adverse Event|3|||
124560946|NCT03907280|448011049|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
124560947|NCT03907280|448011050|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
124560948|NCT03907280|448011051|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
124560949|NCT00673361|448011056|FG000|Overall Study|Screen Failure|2|||
124560950|NCT00829413|448011057|FG000|Overall Study|No study drug admimnistered|13|||
124775958|NCT02754440|448808441|FG000|Overall Study|Equipment failure|0|||
124501375|NCT00875017|447787011|FG002|Washout|Problem collecting rectal effluent|1|||
124501376|NCT00875017|447787012|FG003|Washout|Problem collecting rectal effluent|0|||
124501377|NCT00875017|447787013|FG004|Washout|Problem collecting rectal effluent|0|||
124501378|NCT00875017|447787014|FG005|Washout|Problem collecting rectal effluent|0|||
124501379|NCT00875017|447787009|FG000|Second Intervention|Adverse Event|0|||
124501380|NCT00875017|447787010|FG001|Second Intervention|Adverse Event|0|||
124501381|NCT00875017|447787011|FG002|Second Intervention|Adverse Event|0|||
124501382|NCT00875017|447787012|FG003|Second Intervention|Adverse Event|1|||
124501383|NCT00875017|447787013|FG004|Second Intervention|Adverse Event|0|||
124501384|NCT00875017|447787014|FG005|Second Intervention|Adverse Event|0|||
124501385|NCT00875017|447787009|FG000|Washout|Problems collecting rectal effluent|0|||
124501386|NCT00875017|447787010|FG001|Washout|Problems collecting rectal effluent|1|||
124501387|NCT00875017|447787011|FG002|Washout|Problems collecting rectal effluent|0|||
124501388|NCT00875017|447787012|FG003|Washout|Problems collecting rectal effluent|0|||
124775959|NCT02754440|448808442|FG001|Overall Study|Equipment failure|5|||
124775960|NCT02754440|448808443|FG002|Overall Study|Equipment failure|5|||
124775961|NCT02754440|448808444|FG003|Overall Study|Equipment failure|7|||
124775962|NCT02754440|448808441|FG000|Overall Study|Subject issues not resulting in AE|0|||
124775963|NCT02754440|448808442|FG001|Overall Study|Subject issues not resulting in AE|0|||
124775964|NCT02754440|448808443|FG002|Overall Study|Subject issues not resulting in AE|0|||
124775965|NCT02754440|448808444|FG003|Overall Study|Subject issues not resulting in AE|12|||
124775966|NCT02560558|448808445|FG000|Overall Study|Adverse Event|1|||
124775967|NCT02560558|448808446|FG001|Overall Study|Adverse Event|0|||
124775968|NCT02560558|448808445|FG000|Overall Study|Death|0|||
124775969|NCT02560558|448808446|FG001|Overall Study|Death|2|||
124775970|NCT02560558|448808445|FG000|Overall Study|Lost to Follow-up|0|||
124775971|NCT02560558|448808446|FG001|Overall Study|Lost to Follow-up|4|||
124775972|NCT02560558|448808445|FG000|Overall Study|Protocol Violation|3|||
124775973|NCT02560558|448808446|FG001|Overall Study|Protocol Violation|0|||
124775974|NCT02560558|448808445|FG000|Overall Study|Withdrawal by Subject|3|||
124775975|NCT02560558|448808446|FG001|Overall Study|Withdrawal by Subject|0|||
124775976|NCT01263197|448808453|FG000|First Intervention (Period 1)|Adverse Event|0|||
124775977|NCT01263197|448808454|FG001|First Intervention (Period 1)|Adverse Event|0|||
124775978|NCT01263197|448808455|FG002|First Intervention (Period 1)|Adverse Event|0|||
124775979|NCT01263197|448808456|FG003|First Intervention (Period 1)|Adverse Event|0|||
124775980|NCT01263197|448808457|FG004|First Intervention (Period 1)|Adverse Event|0|||
124501389|NCT00875017|447787013|FG004|Washout|Problems collecting rectal effluent|0|||
124501390|NCT00875017|447787014|FG005|Washout|Problems collecting rectal effluent|0|||
124501391|NCT00875017|447787009|FG000|Third Intervention|Adverse Event|0|||
124501392|NCT00875017|447787010|FG001|Third Intervention|Adverse Event|1|||
124501393|NCT00875017|447787011|FG002|Third Intervention|Adverse Event|1|||
124501394|NCT00875017|447787012|FG003|Third Intervention|Adverse Event|0|||
124501395|NCT00875017|447787013|FG004|Third Intervention|Adverse Event|0|||
124501396|NCT00875017|447787014|FG005|Third Intervention|Adverse Event|0|||
124501397|NCT00875017|447787009|FG000|Washout|Withdrawal by Subject|0|||
124501398|NCT00875017|447787010|FG001|Washout|Withdrawal by Subject|0|||
124501399|NCT00875017|447787011|FG002|Washout|Withdrawal by Subject|0|||
124501400|NCT00875017|447787012|FG003|Washout|Withdrawal by Subject|0|||
124501401|NCT00875017|447787013|FG004|Washout|Withdrawal by Subject|1|||
124501402|NCT00875017|447787014|FG005|Washout|Withdrawal by Subject|0|||
124501403|NCT00875017|447787009|FG000|Fourth Intervention|Inability to comply with fasting|0|||
124501404|NCT00875017|447787010|FG001|Fourth Intervention|Inability to comply with fasting|0|||
124501405|NCT00875017|447787011|FG002|Fourth Intervention|Inability to comply with fasting|0|||
124501406|NCT00875017|447787012|FG003|Fourth Intervention|Inability to comply with fasting|0|||
124501407|NCT00875017|447787013|FG004|Fourth Intervention|Inability to comply with fasting|0|||
124501408|NCT00875017|447787014|FG005|Fourth Intervention|Inability to comply with fasting|1|||
124501409|NCT02689219|447787015|FG000|Overall Study|Death|1|||
124501410|NCT02689219|447787016|FG001|Overall Study|Death|1|||
124501411|NCT02689219|447787015|FG000|Overall Study|Disease Progression|10|||
124501412|NCT02689219|447787016|FG001|Overall Study|Disease Progression|6|||
124501413|NCT03342469|447787017|FG000|Overall Study|Withdrawal by Subject|0|||
124501414|NCT03342469|447787018|FG001|Overall Study|Withdrawal by Subject|1|||
124501415|NCT03342469|447787019|FG002|Overall Study|Withdrawal by Subject|0|||
124501416|NCT03342469|447787020|FG003|Overall Study|Withdrawal by Subject|0|||
124501417|NCT05515601|447787026|FG000|Overall Study|Withdrawal by Subject|1|||
124501418|NCT05515601|447787027|FG001|Overall Study|Withdrawal by Subject|3|||
124501419|NCT05515601|447787028|FG002|Overall Study|Withdrawal by Subject|2|||
124501420|NCT05515601|447787029|FG003|Overall Study|Withdrawal by Subject|1|||
124501421|NCT05515601|447787030|FG004|Overall Study|Withdrawal by Subject|1|||
124501422|NCT05515601|447787031|FG005|Overall Study|Withdrawal by Subject|1|||
124501423|NCT05515601|447787026|FG000|Overall Study|Lost to Follow-up|0|||
124501424|NCT05515601|447787027|FG001|Overall Study|Lost to Follow-up|0|||
124501425|NCT05515601|447787028|FG002|Overall Study|Lost to Follow-up|0|||
124775981|NCT01263197|448808458|FG005|First Intervention (Period 1)|Adverse Event|1|||
124775982|NCT01263197|448808453|FG000|Washout Period 1|Protocol Violation|0|||
124501426|NCT05515601|447787029|FG003|Overall Study|Lost to Follow-up|0|||
124501427|NCT05515601|447787030|FG004|Overall Study|Lost to Follow-up|1|||
124501428|NCT05515601|447787031|FG005|Overall Study|Lost to Follow-up|0|||
124501429|NCT00364845|447787032|FG000|Overall Study|Adverse Event|1|||
124501430|NCT00364845|447787033|FG001|Overall Study|Adverse Event|0|||
124501431|NCT00364845|447787032|FG000|Overall Study|Withdrawal by Subject|2|||
124501432|NCT00364845|447787033|FG001|Overall Study|Withdrawal by Subject|1|||
124501433|NCT00364845|447787032|FG000|Overall Study|Physician Decision|8|||
124501434|NCT00364845|447787033|FG001|Overall Study|Physician Decision|8|||
124501435|NCT00364845|447787032|FG000|Overall Study|Lost to Follow-up|0|||
124724801|NCT02059499|448611814|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
124724802|NCT02059499|448611815|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
124724803|NCT02059499|448611816|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
124724804|NCT00703846|448611817|FG000|Overall Study|Adverse Event|8|||
124724805|NCT00703846|448611817|FG000|Overall Study|Lost to Follow-up|55|||
124724806|NCT00703846|448611817|FG000|Overall Study|Lack of Efficacy|15|||
124501436|NCT00364845|447787033|FG001|Overall Study|Lost to Follow-up|1|||
124501437|NCT00364845|447787032|FG000|Overall Study|Death|0|||
124501438|NCT00364845|447787033|FG001|Overall Study|Death|1|||
124501439|NCT01912768|447787034|FG000|Overall Study|Adverse Event|2|||
124501440|NCT01912768|447787035|FG001|Overall Study|Adverse Event|0|||
124501441|NCT01912768|447787034|FG000|Overall Study|Lost to Follow-up|2|||
124501442|NCT01912768|447787035|FG001|Overall Study|Lost to Follow-up|1|||
124501443|NCT01912768|447787034|FG000|Overall Study|Withdrawal by Subject|5|||
124501444|NCT01912768|447787035|FG001|Overall Study|Withdrawal by Subject|3|||
124501445|NCT01912768|447787034|FG000|Overall Study|Randomized in error|1|||
124501446|NCT01912768|447787035|FG001|Overall Study|Randomized in error|0|||
124501447|NCT04160468|447787036|FG000|Overall Study|Lost to Follow-up|19|||
124501448|NCT04160468|447787037|FG001|Overall Study|Lost to Follow-up|4|||
124501449|NCT04160468|447787036|FG000|Overall Study|Randomized but not dosed|6|||
124501450|NCT04160468|447787037|FG001|Overall Study|Randomized but not dosed|0|||
124501451|NCT04160468|447787036|FG000|Overall Study|Withdrawal by Subject|4|||
124501452|NCT04160468|447787037|FG001|Overall Study|Withdrawal by Subject|1|||
124501453|NCT04160468|447787036|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
124501454|NCT04160468|447787037|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
124501455|NCT04160468|447787036|FG000|Overall Study|Participant incarcerated|1|||
124501456|NCT04160468|447787037|FG001|Overall Study|Participant incarcerated|0|||
124501457|NCT01187901|447787038|FG000|Overall Study|Protocol Violation|1|||
124501458|NCT01187901|447787039|FG001|Overall Study|Protocol Violation|0|||
124501459|NCT01187901|447787038|FG000|Overall Study|Lost to Follow-up|1|||
124501460|NCT01187901|447787039|FG001|Overall Study|Lost to Follow-up|2|||
124501461|NCT01187901|447787038|FG000|Overall Study|Unrelated Health Reasons|1|||
124501462|NCT01187901|447787039|FG001|Overall Study|Unrelated Health Reasons|2|||
124501463|NCT01187901|447787038|FG000|Overall Study|Suspected Allergic Reaction|1|||
124501464|NCT01187901|447787039|FG001|Overall Study|Suspected Allergic Reaction|1|||
124501465|NCT01187901|447787038|FG000|Overall Study|Adverse Event|3|||
124501466|NCT01187901|447787039|FG001|Overall Study|Adverse Event|0|||
124501467|NCT01187901|447787038|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
124501468|NCT01187901|447787039|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
124501469|NCT01187901|447787038|FG000|Overall Study|Pregnancy|0|||
124501470|NCT01187901|447787039|FG001|Overall Study|Pregnancy|2|||
124501471|NCT00540436|447787040|FG000|First 12-Week Treatment Period|Adverse Event|1|||
124501472|NCT00540436|447787040|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
124501473|NCT00540436|447787040|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
124501474|NCT00540436|447787040|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
124501475|NCT03255291|447787041|FG000|Overall Study|Determined to be ineligible|10|||
124501476|NCT03255291|447787042|FG001|Overall Study|Determined to be ineligible|12|||
124501477|NCT03255291|447787043|FG002|Overall Study|Determined to be ineligible|6|||
124501478|NCT03255291|447787044|FG003|Overall Study|Determined to be ineligible|6|||
124501479|NCT03255291|447787045|FG004|Overall Study|Determined to be ineligible|5|||
124501480|NCT03255291|447787046|FG005|Overall Study|Determined to be ineligible|10|||
124501481|NCT03255291|447787041|FG000|Overall Study|Baseline data collection issues|3|||
124501482|NCT03255291|447787042|FG001|Overall Study|Baseline data collection issues|0|||
124501483|NCT03255291|447787043|FG002|Overall Study|Baseline data collection issues|0|||
124501484|NCT03255291|447787044|FG003|Overall Study|Baseline data collection issues|0|||
124501485|NCT03255291|447787045|FG004|Overall Study|Baseline data collection issues|2|||
124501486|NCT03255291|447787046|FG005|Overall Study|Baseline data collection issues|0|||
124501487|NCT01067508|447787054|FG000|Overall Study|Physician Decision|0|||
124501488|NCT01067508|447787055|FG001|Overall Study|Physician Decision|1|||
124501489|NCT01067508|447787054|FG000|Overall Study|Withdrawal by Subject|0|||
124501490|NCT01067508|447787055|FG001|Overall Study|Withdrawal by Subject|1|||
124501491|NCT00444626|447787056|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
124501492|NCT00444626|447787056|FG000|Initial Treatment Period|Adverse Event|1|||
124501493|NCT00444626|447787056|FG000|Initial Treatment Period|Lost to Follow-up|9|||
124501494|NCT03050359|447788623|FG000|Overall Study|Randomized But Not Treated|2|||
124501495|NCT03050359|447788624|FG001|Overall Study|Randomized But Not Treated|0|||
124775983|NCT01263197|448808454|FG001|Washout Period 1|Protocol Violation|0|||
124775984|NCT01263197|448808455|FG002|Washout Period 1|Protocol Violation|0|||
124775985|NCT01263197|448808456|FG003|Washout Period 1|Protocol Violation|0|||
124775986|NCT01263197|448808457|FG004|Washout Period 1|Protocol Violation|1|||
124775987|NCT01263197|448808458|FG005|Washout Period 1|Protocol Violation|0|||
124775988|NCT01263197|448808453|FG000|Washout Period 2|Physician Decision|0|||
124775989|NCT01263197|448808454|FG001|Washout Period 2|Physician Decision|0|||
124775990|NCT01263197|448808455|FG002|Washout Period 2|Physician Decision|0|||
124775991|NCT01263197|448808456|FG003|Washout Period 2|Physician Decision|0|||
124775992|NCT01263197|448808457|FG004|Washout Period 2|Physician Decision|0|||
124775993|NCT01263197|448808458|FG005|Washout Period 2|Physician Decision|1|||
124775994|NCT01263197|448808453|FG000|Washout Period 2|Protocol Violation|0|||
124775995|NCT01263197|448808454|FG001|Washout Period 2|Protocol Violation|0|||
124775996|NCT01263197|448808455|FG002|Washout Period 2|Protocol Violation|0|||
124775997|NCT01263197|448808456|FG003|Washout Period 2|Protocol Violation|1|||
124775998|NCT01263197|448808457|FG004|Washout Period 2|Protocol Violation|0|||
124775999|NCT01263197|448808458|FG005|Washout Period 2|Protocol Violation|0|||
124776000|NCT01263197|448808453|FG000|Third Intervention (Period 3)|Adverse Event|0|||
124776001|NCT01263197|448808454|FG001|Third Intervention (Period 3)|Adverse Event|1|||
124776002|NCT01263197|448808455|FG002|Third Intervention (Period 3)|Adverse Event|0|||
124776003|NCT01263197|448808456|FG003|Third Intervention (Period 3)|Adverse Event|0|||
124776004|NCT01263197|448808457|FG004|Third Intervention (Period 3)|Adverse Event|0|||
124776005|NCT01263197|448808458|FG005|Third Intervention (Period 3)|Adverse Event|0|||
124776006|NCT01134055|448808459|FG000|Overall Study|Adverse Event|5|||
124776007|NCT01134055|448808460|FG001|Overall Study|Adverse Event|2|||
124776008|NCT01134055|448808461|FG002|Overall Study|Adverse Event|2|||
124776009|NCT01134055|448808462|FG003|Overall Study|Adverse Event|2|||
124776010|NCT01134055|448808463|FG004|Overall Study|Adverse Event|5|||
124776011|NCT01134055|448808464|FG005|Overall Study|Adverse Event|7|||
124776012|NCT01134055|448808465|FG006|Overall Study|Adverse Event|2|||
124776013|NCT01134055|448808459|FG000|Overall Study|Lost to Follow-up|0|||
124776014|NCT01134055|448808460|FG001|Overall Study|Lost to Follow-up|1|||
124776015|NCT01134055|448808461|FG002|Overall Study|Lost to Follow-up|0|||
124776016|NCT01134055|448808462|FG003|Overall Study|Lost to Follow-up|1|||
124776017|NCT01134055|448808463|FG004|Overall Study|Lost to Follow-up|0|||
124776018|NCT01134055|448808464|FG005|Overall Study|Lost to Follow-up|0|||
124776019|NCT01134055|448808465|FG006|Overall Study|Lost to Follow-up|0|||
124776020|NCT01134055|448808459|FG000|Overall Study|Withdrawal by Subject|3|||
124776021|NCT01134055|448808460|FG001|Overall Study|Withdrawal by Subject|3|||
124776022|NCT01134055|448808461|FG002|Overall Study|Withdrawal by Subject|1|||
124776023|NCT01134055|448808462|FG003|Overall Study|Withdrawal by Subject|2|||
124776024|NCT01134055|448808463|FG004|Overall Study|Withdrawal by Subject|0|||
124776025|NCT01134055|448808464|FG005|Overall Study|Withdrawal by Subject|0|||
124776026|NCT01134055|448808465|FG006|Overall Study|Withdrawal by Subject|8|||
124776027|NCT01134055|448808459|FG000|Overall Study|Protocol Violation|0|||
124776028|NCT01134055|448808460|FG001|Overall Study|Protocol Violation|0|||
124776029|NCT01134055|448808461|FG002|Overall Study|Protocol Violation|0|||
124776030|NCT01134055|448808462|FG003|Overall Study|Protocol Violation|1|||
124776031|NCT01134055|448808463|FG004|Overall Study|Protocol Violation|1|||
124776032|NCT01134055|448808464|FG005|Overall Study|Protocol Violation|0|||
124776033|NCT01134055|448808465|FG006|Overall Study|Protocol Violation|0|||
124776034|NCT01134055|448808459|FG000|Overall Study|Physician Decision|0|||
124776035|NCT01134055|448808460|FG001|Overall Study|Physician Decision|0|||
124776036|NCT01134055|448808461|FG002|Overall Study|Physician Decision|0|||
124776037|NCT01134055|448808462|FG003|Overall Study|Physician Decision|0|||
124776038|NCT01134055|448808463|FG004|Overall Study|Physician Decision|0|||
124776039|NCT01134055|448808464|FG005|Overall Study|Physician Decision|0|||
124776040|NCT01134055|448808465|FG006|Overall Study|Physician Decision|1|||
124776041|NCT03023397|448808470|FG000|Run-In|Failed screening allergen challenge|1|||
124776042|NCT03023397|448808471|FG001|Run-In|Failed screening allergen challenge|0|||
124776043|NCT03023397|448808472|FG002|Run-In|Failed screening allergen challenge|0|||
124776044|NCT03023397|448808470|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
124776045|NCT03023397|448808471|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
124776046|NCT03023397|448808472|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
124776047|NCT01146795|448808476|FG000|Overall Study|Withdrawal by Subject|4|||
124776048|NCT01146795|448808476|FG000|Overall Study|Adverse Event|6|||
124501496|NCT03050359|447788623|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
124501497|NCT03050359|447788624|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
124501498|NCT03050359|447788623|FG000|Overall Study|Significant Protocol Deviation|2|||
124501499|NCT03050359|447788624|FG001|Overall Study|Significant Protocol Deviation|3|||
124501500|NCT03050359|447788623|FG000|Overall Study|Lost to Follow-up|2|||
124776049|NCT01146795|448808476|FG000|Overall Study|Still in treatment at study closure|10|||
124776050|NCT03853109|448808477|FG000|Overall Study|Withdrawal by Subject|0|||
124776051|NCT03853109|448808478|FG001|Overall Study|Withdrawal by Subject|0|||
124501501|NCT03050359|447788624|FG001|Overall Study|Lost to Follow-up|1|||
124501502|NCT03050359|447788623|FG000|Overall Study|Voluntary Withdrawal|4|||
124501503|NCT03050359|447788624|FG001|Overall Study|Voluntary Withdrawal|6|||
124501504|NCT03050359|447788623|FG000|Overall Study|Pregnancy|1|||
124501505|NCT03050359|447788624|FG001|Overall Study|Pregnancy|0|||
124501506|NCT03050359|447788623|FG000|Overall Study|Reason Not Specified|1|||
124501507|NCT03050359|447788624|FG001|Overall Study|Reason Not Specified|0|||
124501508|NCT02614287|447788627|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
124501509|NCT02614287|447788628|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
124501510|NCT02614287|447788627|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
124501511|NCT02614287|447788628|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
124501512|NCT02614287|447788627|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
124501513|NCT02614287|447788628|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
124501514|NCT02614287|447788627|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
124501515|NCT02614287|447788628|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
124501516|NCT02614287|447788627|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
124501517|NCT02614287|447788628|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
124501518|NCT02614287|447788627|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
124501519|NCT02614287|447788628|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
124501520|NCT02614287|447788627|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
124501521|NCT02614287|447788628|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
124501522|NCT02614287|447788627|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
124501523|NCT02614287|447788628|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
124501524|NCT00833248|447788632|FG000|Overall Study|Adverse Event|3|||
124501525|NCT00833248|447788633|FG001|Overall Study|Adverse Event|0|||
124501526|NCT00833248|447788632|FG000|Overall Study|Protocol Violation|1|||
124501527|NCT00833248|447788633|FG001|Overall Study|Protocol Violation|2|||
124501528|NCT00833248|447788632|FG000|Overall Study|Withdrawal by Subject|0|||
124501529|NCT00833248|447788633|FG001|Overall Study|Withdrawal by Subject|1|||
124501530|NCT03580382|447788638|FG000|Overall Study|Early Termination of Study|0|||
124501531|NCT03580382|447788639|FG001|Overall Study|Early Termination of Study|3|||
124501532|NCT04281030|447788642|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
124501533|NCT04281030|447788643|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
124501534|NCT04281030|447788642|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
124501535|NCT04281030|447788643|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
124501536|NCT01826422|447788644|FG000|Overall Study|Withdrawal by Subject|1|||
124501537|NCT01826422|447788645|FG001|Overall Study|Withdrawal by Subject|3|||
124501538|NCT05619172|447788649|FG000|Safety Cohort 1|Death|7|||
124501539|NCT05619172|447788650|FG001|Safety Cohort 1|Death|0|||
124501540|NCT05619172|447788649|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
124501541|NCT05619172|447788650|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
124501542|NCT05619172|447788649|FG000|Safety Cohort 2|Death|0|||
124501543|NCT05619172|447788650|FG001|Safety Cohort 2|Death|1|||
124501544|NCT05619172|447788649|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
124501545|NCT05619172|447788650|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
124501546|NCT00450372|447788651|FG000|Overall Study|Physician Decision|1|||
124501547|NCT00520676|447788655|FG000|Overall Study|Death|84|||
124501548|NCT00520676|447788656|FG001|Overall Study|Death|81|||
124501549|NCT00520676|447788655|FG000|Overall Study|Lost to Follow-up|6|||
124501550|NCT00520676|447788656|FG001|Overall Study|Lost to Follow-up|10|||
124501551|NCT00520676|447788655|FG000|Overall Study|Physician Decision|4|||
124501552|NCT00520676|447788656|FG001|Overall Study|Physician Decision|1|||
124501553|NCT00520676|447788655|FG000|Overall Study|Withdrawal by Subject|7|||
124501554|NCT00520676|447788656|FG001|Overall Study|Withdrawal by Subject|11|||
124501555|NCT02179515|447788659|FG000|Overall Study|switched to alternative treatment|0|||
124501556|NCT02179515|447788660|FG001|Overall Study|switched to alternative treatment|1|||
124501557|NCT02179515|447788661|FG002|Overall Study|switched to alternative treatment|1|||
124501558|NCT02179515|447788659|FG000|Overall Study|Death|0|||
124501559|NCT02179515|447788660|FG001|Overall Study|Death|1|||
124501560|NCT02179515|447788661|FG002|Overall Study|Death|1|||
124501561|NCT02179515|447788659|FG000|Overall Study|refused further treatment|0|||
124501562|NCT02179515|447788660|FG001|Overall Study|refused further treatment|3|||
124501563|NCT02179515|447788661|FG002|Overall Study|refused further treatment|4|||
124501564|NCT02179515|447788659|FG000|Overall Study|Disease progression on study|2|||
124501565|NCT02179515|447788660|FG001|Overall Study|Disease progression on study|11|||
124501566|NCT02179515|447788661|FG002|Overall Study|Disease progression on study|8|||
124501567|NCT01718509|447788662|FG000|Overall Study|Lost to Follow-up|18|||
124501568|NCT01718509|447788663|FG001|Overall Study|Lost to Follow-up|15|||
124501569|NCT01718509|447788662|FG000|Overall Study|Withdrawal by Subject|7|||
124501570|NCT01718509|447788663|FG001|Overall Study|Withdrawal by Subject|13|||
124501571|NCT01718509|447788662|FG000|Overall Study|Adverse Event|5|||
124501572|NCT01718509|447788663|FG001|Overall Study|Adverse Event|7|||
124501573|NCT01718509|447788662|FG000|Overall Study|Other|13|||
124501574|NCT01718509|447788663|FG001|Overall Study|Other|11|||
124501575|NCT01718509|447788662|FG000|Overall Study|Protocol Violation|4|||
124501576|NCT01718509|447788663|FG001|Overall Study|Protocol Violation|2|||
124501577|NCT01718509|447788662|FG000|Overall Study|Lack of Efficacy|1|||
124501578|NCT01718509|447788663|FG001|Overall Study|Lack of Efficacy|0|||
124501579|NCT00879814|447788670|FG000|Overall Study|Adverse Event|0|||
124501580|NCT00879814|447788671|FG001|Overall Study|Adverse Event|1|||
124501581|NCT00879814|447788672|FG002|Overall Study|Adverse Event|0|||
124501582|NCT00879814|447788673|FG003|Overall Study|Adverse Event|0|||
124501583|NCT00879814|447788670|FG000|Overall Study|Lost to Follow-up|1|||
124501584|NCT00879814|447788671|FG001|Overall Study|Lost to Follow-up|0|||
124501585|NCT00879814|447788672|FG002|Overall Study|Lost to Follow-up|0|||
124501586|NCT00879814|447788673|FG003|Overall Study|Lost to Follow-up|2|||
124501587|NCT00879814|447788670|FG000|Overall Study|Participant Failed to Return|0|||
124501588|NCT00879814|447788671|FG001|Overall Study|Participant Failed to Return|0|||
124501589|NCT00879814|447788672|FG002|Overall Study|Participant Failed to Return|0|||
124501590|NCT00879814|447788673|FG003|Overall Study|Participant Failed to Return|1|||
124501591|NCT00879814|447788670|FG000|Overall Study|Withdrawal by Subject|3|||
124501592|NCT00879814|447788671|FG001|Overall Study|Withdrawal by Subject|1|||
124501593|NCT00879814|447788672|FG002|Overall Study|Withdrawal by Subject|1|||
124501594|NCT00879814|447788673|FG003|Overall Study|Withdrawal by Subject|2|||
124501595|NCT00879814|447788670|FG000|Overall Study|Physician Decision|0|||
124501596|NCT00879814|447788671|FG001|Overall Study|Physician Decision|0|||
124501597|NCT00879814|447788672|FG002|Overall Study|Physician Decision|1|||
124501598|NCT00879814|447788673|FG003|Overall Study|Physician Decision|0|||
124501599|NCT00879814|447788670|FG000|Overall Study|Other|0|||
124501600|NCT00879814|447788671|FG001|Overall Study|Other|0|||
124501601|NCT00879814|447788672|FG002|Overall Study|Other|1|||
124501602|NCT00879814|447788673|FG003|Overall Study|Other|0|||
124501603|NCT01219959|447788684|FG000|Overall Study|Adverse Event|6|||
124501604|NCT01219959|447788685|FG001|Overall Study|Adverse Event|14|||
124501605|NCT01219959|447788684|FG000|Overall Study|Physician Decision|0|||
124501606|NCT01219959|447788685|FG001|Overall Study|Physician Decision|4|||
124501607|NCT01219959|447788684|FG000|Overall Study|Withdrawal by Subject|0|||
124501608|NCT01219959|447788685|FG001|Overall Study|Withdrawal by Subject|2|||
124501609|NCT01219959|447788684|FG000|Overall Study|Renal Transplantation|0|||
124501610|NCT01219959|447788685|FG001|Overall Study|Renal Transplantation|3|||
124501611|NCT01219959|447788684|FG000|Overall Study|Other|1|||
124501612|NCT01219959|447788685|FG001|Overall Study|Other|0|||
124501613|NCT02935634|447788686|FG000|Randomization|Participant withdrew consent|0|||
124501614|NCT02935634|447788687|FG001|Randomization|Participant withdrew consent|1|||
124501615|NCT02935634|447788688|FG002|Randomization|Participant withdrew consent|0|||
124501616|NCT02935634|447788689|FG003|Randomization|Participant withdrew consent|0|||
124501617|NCT02935634|447788690|FG004|Randomization|Participant withdrew consent|0|||
124501618|NCT02935634|447788691|FG005|Randomization|Participant withdrew consent|0|||
124501619|NCT02935634|447788686|FG000|Randomization|Death|2|||
124501620|NCT02935634|447788687|FG001|Randomization|Death|1|||
124501621|NCT02935634|447788688|FG002|Randomization|Death|1|||
124501622|NCT02935634|447788689|FG003|Randomization|Death|0|||
124501623|NCT02935634|447788690|FG004|Randomization|Death|0|||
124501624|NCT02935634|447788691|FG005|Randomization|Death|0|||
124501625|NCT02935634|447788686|FG000|Randomization|Other reasons|0|||
124501626|NCT02935634|447788687|FG001|Randomization|Other reasons|2|||
124501627|NCT02935634|447788688|FG002|Randomization|Other reasons|2|||
124501628|NCT02935634|447788689|FG003|Randomization|Other reasons|0|||
124501629|NCT02935634|447788690|FG004|Randomization|Other reasons|0|||
124501630|NCT02935634|447788691|FG005|Randomization|Other reasons|0|||
124501631|NCT02935634|447788686|FG000|Treatment: Track 1|Disease progression|15|||
124501632|NCT02935634|447788687|FG001|Treatment: Track 1|Disease progression|17|||
124501633|NCT02935634|447788688|FG002|Treatment: Track 1|Disease progression|28|||
124501634|NCT02935634|447788689|FG003|Treatment: Track 1|Disease progression|4|||
124501635|NCT02935634|447788690|FG004|Treatment: Track 1|Disease progression|6|||
124501636|NCT02935634|447788691|FG005|Treatment: Track 1|Disease progression|2|||
124501637|NCT02935634|447788686|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
124501638|NCT02935634|447788687|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
124501639|NCT02935634|447788688|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
124501640|NCT02935634|447788689|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
124501641|NCT02935634|447788690|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
124501642|NCT02935634|447788691|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
124501643|NCT02935634|447788686|FG000|Treatment: Track 1|Lost to Follow-up|1|||
124501644|NCT02935634|447788687|FG001|Treatment: Track 1|Lost to Follow-up|0|||
124501645|NCT02935634|447788688|FG002|Treatment: Track 1|Lost to Follow-up|0|||
124501646|NCT02935634|447788689|FG003|Treatment: Track 1|Lost to Follow-up|0|||
124501647|NCT02935634|447788690|FG004|Treatment: Track 1|Lost to Follow-up|0|||
124501648|NCT02935634|447788691|FG005|Treatment: Track 1|Lost to Follow-up|0|||
124501649|NCT02935634|447788686|FG000|Treatment: Track 1|Study drug toxicity|2|||
124501650|NCT02935634|447788687|FG001|Treatment: Track 1|Study drug toxicity|1|||
124501651|NCT02935634|447788688|FG002|Treatment: Track 1|Study drug toxicity|3|||
124501652|NCT02935634|447788689|FG003|Treatment: Track 1|Study drug toxicity|0|||
124560951|NCT00829413|448011057|FG000|Overall Study|Training Patients|67|||
124560952|NCT00829413|448011057|FG000|Overall Study|No truth standard procedure available|9|||
124560953|NCT00829413|448011057|FG000|Overall Study|Technically inadequate truth standard|2|||
124560954|NCT00829413|448011057|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
124560955|NCT01464827|448011058|FG000|Overall Study|Adverse Event|0|||
124560956|NCT01464827|448011059|FG001|Overall Study|Adverse Event|0|||
124560957|NCT01464827|448011060|FG002|Overall Study|Adverse Event|0|||
124560958|NCT01464827|448011061|FG003|Overall Study|Adverse Event|0|||
124560959|NCT01464827|448011062|FG004|Overall Study|Adverse Event|0|||
124560960|NCT01464827|448011063|FG005|Overall Study|Adverse Event|0|||
124560961|NCT01464827|448011064|FG006|Overall Study|Adverse Event|0|||
124560962|NCT01464827|448011065|FG007|Overall Study|Adverse Event|0|||
124560963|NCT01464827|448011066|FG008|Overall Study|Adverse Event|0|||
124560964|NCT01464827|448011067|FG009|Overall Study|Adverse Event|0|||
124560965|NCT01464827|448011068|FG010|Overall Study|Adverse Event|0|||
124560966|NCT01464827|448011069|FG011|Overall Study|Adverse Event|0|||
124560967|NCT01464827|448011070|FG012|Overall Study|Adverse Event|1|||
124501653|NCT02935634|447788690|FG004|Treatment: Track 1|Study drug toxicity|0|||
124501654|NCT02935634|447788691|FG005|Treatment: Track 1|Study drug toxicity|1|||
124501655|NCT02935634|447788686|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
124501656|NCT02935634|447788687|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
124501657|NCT02935634|447788688|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
124501658|NCT02935634|447788689|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
124501659|NCT02935634|447788690|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
124501660|NCT02935634|447788691|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
124501661|NCT02935634|447788686|FG000|Treatment: Track 1|Participant withdrew consent|2|||
124501662|NCT02935634|447788687|FG001|Treatment: Track 1|Participant withdrew consent|0|||
124501663|NCT02935634|447788688|FG002|Treatment: Track 1|Participant withdrew consent|1|||
124501664|NCT02935634|447788689|FG003|Treatment: Track 1|Participant withdrew consent|0|||
124501665|NCT02935634|447788690|FG004|Treatment: Track 1|Participant withdrew consent|1|||
124501666|NCT02935634|447788691|FG005|Treatment: Track 1|Participant withdrew consent|0|||
124501667|NCT02935634|447788686|FG000|Treatment: Track 1|Other reasons|0|||
124501668|NCT02935634|447788687|FG001|Treatment: Track 1|Other reasons|0|||
124501669|NCT02935634|447788688|FG002|Treatment: Track 1|Other reasons|2|||
124501670|NCT02935634|447788689|FG003|Treatment: Track 1|Other reasons|0|||
124501671|NCT02935634|447788690|FG004|Treatment: Track 1|Other reasons|0|||
124501672|NCT02935634|447788691|FG005|Treatment: Track 1|Other reasons|0|||
124501673|NCT02935634|447788686|FG000|Treatment: Track 2|Disease progression|13|||
124501674|NCT02935634|447788687|FG001|Treatment: Track 2|Disease progression|26|||
124501675|NCT02935634|447788688|FG002|Treatment: Track 2|Disease progression|20|||
124501676|NCT02935634|447788689|FG003|Treatment: Track 2|Disease progression|5|||
124501677|NCT02935634|447788690|FG004|Treatment: Track 2|Disease progression|1|||
124501678|NCT02935634|447788691|FG005|Treatment: Track 2|Disease progression|4|||
124501679|NCT02935634|447788686|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
124501680|NCT02935634|447788687|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
124501681|NCT02935634|447788688|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
124501682|NCT02935634|447788689|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
124501683|NCT02935634|447788690|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
124501684|NCT02935634|447788691|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
124501685|NCT02935634|447788686|FG000|Treatment: Track 2|Study drug toxicity|7|||
124501686|NCT02935634|447788687|FG001|Treatment: Track 2|Study drug toxicity|3|||
124501687|NCT02935634|447788688|FG002|Treatment: Track 2|Study drug toxicity|0|||
124501688|NCT02935634|447788689|FG003|Treatment: Track 2|Study drug toxicity|0|||
124501689|NCT02935634|447788690|FG004|Treatment: Track 2|Study drug toxicity|0|||
124501690|NCT02935634|447788691|FG005|Treatment: Track 2|Study drug toxicity|0|||
124501691|NCT02935634|447788686|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
124501692|NCT02935634|447788687|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
124501693|NCT02935634|447788688|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
124501694|NCT02935634|447788689|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
124501695|NCT02935634|447788690|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
124501696|NCT02935634|447788691|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
124501697|NCT02935634|447788686|FG000|Treatment: Track 2|Participant withdrew consent|0|||
124501698|NCT02935634|447788687|FG001|Treatment: Track 2|Participant withdrew consent|1|||
124501699|NCT02935634|447788688|FG002|Treatment: Track 2|Participant withdrew consent|1|||
124501700|NCT02935634|447788689|FG003|Treatment: Track 2|Participant withdrew consent|0|||
124501701|NCT02935634|447788690|FG004|Treatment: Track 2|Participant withdrew consent|1|||
124501702|NCT02935634|447788691|FG005|Treatment: Track 2|Participant withdrew consent|0|||
124560968|NCT01464827|448011071|FG013|Overall Study|Adverse Event|0|||
124560969|NCT01464827|448011058|FG000|Overall Study|Withdrawal by Subject|1|||
124560970|NCT01464827|448011059|FG001|Overall Study|Withdrawal by Subject|0|||
124560971|NCT01464827|448011060|FG002|Overall Study|Withdrawal by Subject|0|||
124560972|NCT01464827|448011061|FG003|Overall Study|Withdrawal by Subject|0|||
124501703|NCT05906732|447788692|FG000|Overall Study|Withdrawal by Subject|1|||
124501704|NCT05906732|447788693|FG001|Overall Study|Withdrawal by Subject|0|||
124501705|NCT05906732|447788694|FG002|Overall Study|Withdrawal by Subject|0|||
124501706|NCT05906732|447788695|FG003|Overall Study|Withdrawal by Subject|0|||
124501707|NCT05906732|447788692|FG000|Overall Study|Physician Decision|2|||
124501708|NCT05906732|447788693|FG001|Overall Study|Physician Decision|4|||
124501709|NCT05906732|447788694|FG002|Overall Study|Physician Decision|0|||
124501710|NCT05906732|447788695|FG003|Overall Study|Physician Decision|0|||
124501711|NCT00506077|447788696|FG000|Treatment Period 1|Adverse Event|2|||
124501712|NCT00506077|447788697|FG001|Treatment Period 1|Adverse Event|1|||
124501713|NCT00506077|447788696|FG000|Treatment Period 1|Lost to Follow-up|0|||
124501714|NCT00506077|447788697|FG001|Treatment Period 1|Lost to Follow-up|2|||
124501715|NCT00506077|447788696|FG000|Treatment Period 1|Withdrawal by Subject|2|||
124501716|NCT00506077|447788697|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124501717|NCT00506077|447788696|FG000|Treatment Period 2|Adverse Event|0|||
124501718|NCT00506077|447788697|FG001|Treatment Period 2|Adverse Event|1|||
124501719|NCT00506077|447788696|FG000|Treatment Period 2|Withdrawal by Subject|1|||
124501720|NCT00506077|447788697|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124501721|NCT01727713|447788701|FG000|Overall Study|Lost to Follow-up|5|||
124501722|NCT01727713|447788701|FG000|Overall Study|Adverse Event|10|||
124501723|NCT01727713|447788701|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
124501724|NCT01727713|447788701|FG000|Overall Study|Withdrawal by Subject|13|||
124501725|NCT01727713|447788701|FG000|Overall Study|Protocol Deviation|2|||
124501726|NCT02651194|447788702|FG000|Overall Study|Lost to Follow-up|3|||
124501727|NCT02651194|447788702|FG000|Overall Study|Other|2|||
124501728|NCT03885726|447788705|FG000|Overall Study|Staffing issues/lost interest|1|||
124501729|NCT03885726|447788705|FG000|Overall Study|Early discharge from hospital|3|||
124501730|NCT01217190|447788706|FG000|Second Dosing|Withdrawal by Subject|0|||
124501731|NCT01217190|447788707|FG001|Second Dosing|Withdrawal by Subject|2|||
124501732|NCT02868216|447788708|FG000|Overall Study|Death|0|||
124501733|NCT02868216|447788709|FG001|Overall Study|Death|1|||
124501734|NCT02868216|447788708|FG000|Overall Study|coronary artery bypass|1|||
124501735|NCT02868216|447788709|FG001|Overall Study|coronary artery bypass|0|||
124501736|NCT02868216|447788708|FG000|Overall Study|Withdrawal by Subject|7|||
124501737|NCT02868216|447788709|FG001|Overall Study|Withdrawal by Subject|5|||
124501738|NCT02496585|447788710|FG000|Overall Study|Death|3|||
124501739|NCT02496585|447788711|FG001|Overall Study|Death|0|||
124501740|NCT02496585|447788710|FG000|Overall Study|Lost to Follow-up|2|||
124501741|NCT02496585|447788711|FG001|Overall Study|Lost to Follow-up|0|||
124501742|NCT02496585|447788710|FG000|Overall Study|Withdrawal by Subject|1|||
124501743|NCT02496585|447788711|FG001|Overall Study|Withdrawal by Subject|2|||
124501744|NCT02496585|447788710|FG000|Overall Study|Progression of Malignancy|4|||
124501745|NCT02496585|447788711|FG001|Overall Study|Progression of Malignancy|1|||
124501746|NCT00515008|447788715|FG000|Overall Study|Lost to Follow-up|1|||
124501747|NCT00515008|447788716|FG001|Overall Study|Lost to Follow-up|0|||
124501748|NCT00515008|447788715|FG000|Overall Study|Declined|0|||
124501749|NCT00515008|447788716|FG001|Overall Study|Declined|3|||
124501750|NCT00515008|447788715|FG000|Overall Study|Left the Boston Area|1|||
124501751|NCT00515008|447788716|FG001|Overall Study|Left the Boston Area|1|||
124501752|NCT00515008|447788715|FG000|Overall Study|Scheduling conflict|1|||
124501753|NCT00515008|447788716|FG001|Overall Study|Scheduling conflict|0|||
124501754|NCT01915849|447788717|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
124501755|NCT01915849|447788718|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
124501756|NCT01915849|447788719|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
124501757|NCT01915849|447788720|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
124501758|NCT01915849|447788717|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
124501759|NCT01915849|447788718|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
124501760|NCT01915849|447788719|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
124501761|NCT01915849|447788720|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
124501762|NCT02775864|447788721|FG000|Overall Study|Data ended end of 2010|1764|||
124501763|NCT02775864|447788722|FG001|Overall Study|Data ended end of 2010|2880|||
124501764|NCT02775864|447788723|FG002|Overall Study|Data ended end of 2010|1140|||
124501765|NCT02775864|447788724|FG003|Overall Study|Data ended end of 2010|1194|||
124501766|NCT02775864|447788721|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
124501767|NCT02775864|447788722|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
124501768|NCT02775864|447788723|FG002|Overall Study|Medicaid eligibility discontinued|720|||
124501769|NCT02775864|447788724|FG003|Overall Study|Medicaid eligibility discontinued|890|||
124501770|NCT03238235|447788725|FG000|Overall Study|Adverse Event|2|||
124501771|NCT03238235|447788726|FG001|Overall Study|Adverse Event|0|||
124501772|NCT03238235|447788725|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
124501773|NCT03238235|447788726|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
124501774|NCT02028338|447788727|FG000|Overall Study|Withdrawal by Subject|3|||
124501775|NCT02028338|447788728|FG001|Overall Study|Withdrawal by Subject|1|||
124501776|NCT02028338|447788727|FG000|Overall Study|Unable to contact participant|1|||
124501777|NCT02028338|447788728|FG001|Overall Study|Unable to contact participant|0|||
124501778|NCT02006667|447790333|FG000|Overall Study|Adverse Event|3|||
124776052|NCT03853109|448808479|FG002|Overall Study|Withdrawal by Subject|1|||
124776053|NCT03853109|448808480|FG003|Overall Study|Withdrawal by Subject|2|||
124776054|NCT03853109|448808481|FG004|Overall Study|Withdrawal by Subject|1|||
124776055|NCT03853109|448808482|FG005|Overall Study|Withdrawal by Subject|4|||
124776056|NCT03853109|448808483|FG006|Overall Study|Withdrawal by Subject|5|||
124776057|NCT03853109|448808484|FG007|Overall Study|Withdrawal by Subject|3|||
124776058|NCT03853109|448808477|FG000|Overall Study|Decision by Sponsor|0|||
124776059|NCT03853109|448808478|FG001|Overall Study|Decision by Sponsor|0|||
124776060|NCT03853109|448808479|FG002|Overall Study|Decision by Sponsor|1|||
124776061|NCT03853109|448808480|FG003|Overall Study|Decision by Sponsor|0|||
124776062|NCT03853109|448808481|FG004|Overall Study|Decision by Sponsor|1|||
124776063|NCT03853109|448808482|FG005|Overall Study|Decision by Sponsor|1|||
124776064|NCT03853109|448808483|FG006|Overall Study|Decision by Sponsor|10|||
124776065|NCT03853109|448808484|FG007|Overall Study|Decision by Sponsor|2|||
124776066|NCT03853109|448808477|FG000|Overall Study|Lost to Follow-up|0|||
124776067|NCT03853109|448808478|FG001|Overall Study|Lost to Follow-up|0|||
124776068|NCT03853109|448808479|FG002|Overall Study|Lost to Follow-up|0|||
124776069|NCT03853109|448808480|FG003|Overall Study|Lost to Follow-up|0|||
124776070|NCT03853109|448808481|FG004|Overall Study|Lost to Follow-up|1|||
124776071|NCT03853109|448808482|FG005|Overall Study|Lost to Follow-up|3|||
124776072|NCT03853109|448808483|FG006|Overall Study|Lost to Follow-up|0|||
124776073|NCT03853109|448808484|FG007|Overall Study|Lost to Follow-up|0|||
124776074|NCT03853109|448808477|FG000|Overall Study|Death|2|||
124776075|NCT03853109|448808478|FG001|Overall Study|Death|5|||
124776076|NCT03853109|448808479|FG002|Overall Study|Death|8|||
124776077|NCT03853109|448808480|FG003|Overall Study|Death|10|||
124776078|NCT03853109|448808481|FG004|Overall Study|Death|3|||
124776079|NCT03853109|448808482|FG005|Overall Study|Death|20|||
124776080|NCT03853109|448808483|FG006|Overall Study|Death|10|||
124776081|NCT03853109|448808484|FG007|Overall Study|Death|5|||
124776082|NCT01721044|448808487|FG000|Treatment Period|Adverse Event|7|||
124776083|NCT01721044|448808488|FG001|Treatment Period|Adverse Event|7|||
124776084|NCT01721044|448808489|FG002|Treatment Period|Adverse Event|10|||
124776085|NCT01721044|448808487|FG000|Treatment Period|Death|0|||
124776086|NCT01721044|448808488|FG001|Treatment Period|Death|0|||
124776087|NCT01721044|448808489|FG002|Treatment Period|Death|1|||
124776088|NCT01721044|448808487|FG000|Treatment Period|Lack of Efficacy|16|||
124776089|NCT01721044|448808488|FG001|Treatment Period|Lack of Efficacy|4|||
124776090|NCT01721044|448808489|FG002|Treatment Period|Lack of Efficacy|4|||
124776091|NCT01721044|448808487|FG000|Treatment Period|Lost to Follow-up|0|||
124776092|NCT01721044|448808488|FG001|Treatment Period|Lost to Follow-up|0|||
124776093|NCT01721044|448808489|FG002|Treatment Period|Lost to Follow-up|1|||
124776094|NCT01721044|448808487|FG000|Treatment Period|Physician Decision|1|||
124776095|NCT01721044|448808488|FG001|Treatment Period|Physician Decision|0|||
124776096|NCT01721044|448808489|FG002|Treatment Period|Physician Decision|2|||
124776097|NCT01721044|448808487|FG000|Treatment Period|Protocol Violation|1|||
124776098|NCT01721044|448808488|FG001|Treatment Period|Protocol Violation|0|||
124776099|NCT01721044|448808489|FG002|Treatment Period|Protocol Violation|0|||
124776100|NCT01721044|448808487|FG000|Treatment Period|Withdrawal by Subject|7|||
124776101|NCT01721044|448808488|FG001|Treatment Period|Withdrawal by Subject|6|||
124776102|NCT01721044|448808489|FG002|Treatment Period|Withdrawal by Subject|1|||
124776103|NCT04032093|448808490|FG000|Overall Study|Lost to Follow-up|7|||
124776104|NCT04032093|448808491|FG001|Overall Study|Lost to Follow-up|7|||
124776105|NCT04032093|448808492|FG002|Overall Study|Lost to Follow-up|6|||
124776106|NCT04032093|448808493|FG003|Overall Study|Lost to Follow-up|10|||
124776107|NCT04032093|448808494|FG004|Overall Study|Lost to Follow-up|13|||
124776108|NCT04032093|448808495|FG005|Overall Study|Lost to Follow-up|7|||
124776109|NCT04032093|448808496|FG006|Overall Study|Lost to Follow-up|7|||
124776110|NCT04032093|448808497|FG007|Overall Study|Lost to Follow-up|5|||
124776111|NCT04032093|448808498|FG008|Overall Study|Lost to Follow-up|9|||
124776112|NCT04032093|448808499|FG009|Overall Study|Lost to Follow-up|12|||
124776113|NCT04032093|448808490|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
124776114|NCT04032093|448808491|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
124776115|NCT04032093|448808492|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
124501779|NCT02006667|447790333|FG000|Overall Study|Death|2|||
124776116|NCT04032093|448808493|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
124776117|NCT04032093|448808494|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
124776118|NCT04032093|448808495|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
124776119|NCT04032093|448808496|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
124776120|NCT04032093|448808497|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
124776121|NCT04032093|448808498|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
124776122|NCT04032093|448808499|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
124776123|NCT04032093|448808490|FG000|Overall Study|Other|1|||
124776124|NCT04032093|448808491|FG001|Overall Study|Other|0|||
124776125|NCT04032093|448808492|FG002|Overall Study|Other|0|||
124776126|NCT04032093|448808493|FG003|Overall Study|Other|1|||
124776127|NCT04032093|448808494|FG004|Overall Study|Other|1|||
124776128|NCT04032093|448808495|FG005|Overall Study|Other|0|||
124776129|NCT04032093|448808496|FG006|Overall Study|Other|0|||
124776130|NCT04032093|448808497|FG007|Overall Study|Other|0|||
124776131|NCT04032093|448808498|FG008|Overall Study|Other|0|||
124776132|NCT04032093|448808499|FG009|Overall Study|Other|1|||
124776133|NCT04032093|448808490|FG000|Overall Study|Withdrawal by Subject|1|||
124776134|NCT04032093|448808491|FG001|Overall Study|Withdrawal by Subject|3|||
124776135|NCT04032093|448808492|FG002|Overall Study|Withdrawal by Subject|2|||
124776136|NCT04032093|448808493|FG003|Overall Study|Withdrawal by Subject|2|||
124776137|NCT04032093|448808494|FG004|Overall Study|Withdrawal by Subject|3|||
124776138|NCT04032093|448808495|FG005|Overall Study|Withdrawal by Subject|0|||
124776139|NCT04032093|448808496|FG006|Overall Study|Withdrawal by Subject|0|||
124776140|NCT04032093|448808497|FG007|Overall Study|Withdrawal by Subject|0|||
124776141|NCT04032093|448808498|FG008|Overall Study|Withdrawal by Subject|0|||
124776142|NCT04032093|448808499|FG009|Overall Study|Withdrawal by Subject|0|||
124776143|NCT04032093|448808490|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124560973|NCT01464827|448011062|FG004|Overall Study|Withdrawal by Subject|1|||
124560974|NCT01464827|448011063|FG005|Overall Study|Withdrawal by Subject|0|||
124560975|NCT01464827|448011064|FG006|Overall Study|Withdrawal by Subject|0|||
124560976|NCT01464827|448011065|FG007|Overall Study|Withdrawal by Subject|1|||
124560977|NCT01464827|448011066|FG008|Overall Study|Withdrawal by Subject|0|||
124560978|NCT01464827|448011067|FG009|Overall Study|Withdrawal by Subject|0|||
124560979|NCT01464827|448011068|FG010|Overall Study|Withdrawal by Subject|0|||
124560980|NCT01464827|448011069|FG011|Overall Study|Withdrawal by Subject|0|||
124560981|NCT01464827|448011070|FG012|Overall Study|Withdrawal by Subject|0|||
124560982|NCT01464827|448011071|FG013|Overall Study|Withdrawal by Subject|0|||
124560983|NCT01464827|448011058|FG000|Overall Study|Lost to Follow-up|0|||
124560984|NCT01464827|448011059|FG001|Overall Study|Lost to Follow-up|2|||
124560985|NCT01464827|448011060|FG002|Overall Study|Lost to Follow-up|0|||
124560986|NCT01464827|448011061|FG003|Overall Study|Lost to Follow-up|2|||
124560987|NCT01464827|448011062|FG004|Overall Study|Lost to Follow-up|3|||
124560988|NCT01464827|448011063|FG005|Overall Study|Lost to Follow-up|1|||
124560989|NCT01464827|448011064|FG006|Overall Study|Lost to Follow-up|2|||
124560990|NCT01464827|448011065|FG007|Overall Study|Lost to Follow-up|2|||
124560991|NCT01464827|448011066|FG008|Overall Study|Lost to Follow-up|0|||
124560992|NCT01464827|448011067|FG009|Overall Study|Lost to Follow-up|0|||
124560993|NCT01464827|448011068|FG010|Overall Study|Lost to Follow-up|0|||
124560994|NCT01464827|448011069|FG011|Overall Study|Lost to Follow-up|1|||
124560995|NCT01464827|448011070|FG012|Overall Study|Lost to Follow-up|0|||
124560996|NCT01464827|448011071|FG013|Overall Study|Lost to Follow-up|1|||
124560997|NCT01464827|448011058|FG000|Overall Study|Other|2|||
124560998|NCT01464827|448011059|FG001|Overall Study|Other|3|||
124560999|NCT01464827|448011060|FG002|Overall Study|Other|0|||
124561000|NCT01464827|448011061|FG003|Overall Study|Other|2|||
124561001|NCT01464827|448011062|FG004|Overall Study|Other|3|||
124561002|NCT01464827|448011063|FG005|Overall Study|Other|0|||
124501780|NCT02006667|447790333|FG000|Overall Study|Withdrawal by Subject|1|||
124501781|NCT02939937|447790334|FG000|Overall Study|Adverse Event|5|||
124501782|NCT02939937|447790335|FG001|Overall Study|Adverse Event|0|||
124501783|NCT02939937|447790334|FG000|Overall Study|Lost to Follow-up|1|||
124501784|NCT02939937|447790335|FG001|Overall Study|Lost to Follow-up|3|||
124501785|NCT01361009|447790338|FG000|Overall Study|Protocol Violation|116|||
124501786|NCT00115349|447790339|FG000|Overall Study|Study closed due to low enrollment.|11|||
124501787|NCT00115349|447790340|FG001|Overall Study|Study closed due to low enrollment.|9|||
124501788|NCT02116660|447790341|FG000|Overall Study|Deteriorating renal function|0|||
124501789|NCT02116660|447790342|FG001|Overall Study|Deteriorating renal function|1|||
124501790|NCT02116660|447790341|FG000|Overall Study|Adverse Event|1|||
124501791|NCT02116660|447790342|FG001|Overall Study|Adverse Event|1|||
124501792|NCT02116660|447790341|FG000|Overall Study|Withdrawal by Subject|0|||
124501793|NCT02116660|447790342|FG001|Overall Study|Withdrawal by Subject|2|||
124501794|NCT02116660|447790341|FG000|Overall Study|Organization reason|1|||
124501795|NCT02116660|447790342|FG001|Overall Study|Organization reason|0|||
124501796|NCT02750800|447790343|FG000|Overall Study|Adverse Event|18|||
124561003|NCT01464827|448011064|FG006|Overall Study|Other|1|||
124561004|NCT01464827|448011065|FG007|Overall Study|Other|0|||
124776144|NCT04032093|448808491|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124776145|NCT04032093|448808492|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
124776146|NCT04032093|448808493|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
124776147|NCT04032093|448808494|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
124561005|NCT01464827|448011066|FG008|Overall Study|Other|3|||
124561006|NCT01464827|448011067|FG009|Overall Study|Other|1|||
124561007|NCT01464827|448011068|FG010|Overall Study|Other|2|||
124561008|NCT01464827|448011069|FG011|Overall Study|Other|0|||
124561009|NCT01464827|448011070|FG012|Overall Study|Other|1|||
124561010|NCT01464827|448011071|FG013|Overall Study|Other|0|||
124501797|NCT02750800|447790343|FG000|Overall Study|Lost to Follow-up|12|||
124501798|NCT02750800|447790343|FG000|Overall Study|Investigator decision|53|||
124501799|NCT02750800|447790343|FG000|Overall Study|Patient request|12|||
124561011|NCT01464827|448011058|FG000|Overall Study|Not Treated|0|||
124561012|NCT01464827|448011059|FG001|Overall Study|Not Treated|2|||
124561013|NCT01464827|448011060|FG002|Overall Study|Not Treated|0|||
124561014|NCT01464827|448011061|FG003|Overall Study|Not Treated|0|||
124561015|NCT01464827|448011062|FG004|Overall Study|Not Treated|1|||
124561016|NCT01464827|448011063|FG005|Overall Study|Not Treated|0|||
124561017|NCT01464827|448011064|FG006|Overall Study|Not Treated|1|||
124561018|NCT01464827|448011065|FG007|Overall Study|Not Treated|0|||
124561019|NCT01464827|448011066|FG008|Overall Study|Not Treated|0|||
124561020|NCT01464827|448011067|FG009|Overall Study|Not Treated|2|||
124561021|NCT01464827|448011068|FG010|Overall Study|Not Treated|0|||
124561022|NCT01464827|448011069|FG011|Overall Study|Not Treated|1|||
124561023|NCT01464827|448011070|FG012|Overall Study|Not Treated|0|||
124561024|NCT01464827|448011071|FG013|Overall Study|Not Treated|2|||
124561025|NCT03487796|448011073|FG000|Overall Study|Lost to Follow-up|18|||
124561026|NCT03487796|448011074|FG001|Overall Study|Lost to Follow-up|6|||
124561027|NCT04272775|448011075|FG000|Overall Study|Study Terminated by Sponsor|1|||
124561028|NCT04272775|448011076|FG001|Overall Study|Study Terminated by Sponsor|0|||
124561029|NCT04272775|448011075|FG000|Overall Study|Protocol Violation|0|||
124561030|NCT04272775|448011076|FG001|Overall Study|Protocol Violation|1|||
124561031|NCT04272775|448011075|FG000|Overall Study|Symptomatic Deterioration|1|||
124561032|NCT04272775|448011076|FG001|Overall Study|Symptomatic Deterioration|1|||
124561033|NCT04272775|448011075|FG000|Overall Study|Withdrawal by Subject|1|||
124561034|NCT04272775|448011076|FG001|Overall Study|Withdrawal by Subject|2|||
124561035|NCT04272775|448011075|FG000|Overall Study|Adverse Event|1|||
124561036|NCT04272775|448011076|FG001|Overall Study|Adverse Event|2|||
124561037|NCT04272775|448011075|FG000|Overall Study|Progressive Disease|3|||
124561038|NCT04272775|448011076|FG001|Overall Study|Progressive Disease|1|||
124561039|NCT00124020|448011077|FG000|Overall Study|Death|67|||
124561040|NCT00124020|448011078|FG001|Overall Study|Death|71|||
124561041|NCT00124020|448011077|FG000|Overall Study|Withdrawal by Subject|13|||
124561042|NCT00124020|448011078|FG001|Overall Study|Withdrawal by Subject|11|||
124561043|NCT00124020|448011077|FG000|Overall Study|Lost to Follow-up|5|||
124561044|NCT00124020|448011078|FG001|Overall Study|Lost to Follow-up|8|||
124561045|NCT00124020|448011077|FG000|Overall Study|Other|1|||
124561046|NCT00124020|448011078|FG001|Overall Study|Other|1|||
124561047|NCT00124020|448011077|FG000|Overall Study|Transfer to another hospital|2|||
124561048|NCT00124020|448011078|FG001|Overall Study|Transfer to another hospital|0|||
124561049|NCT02043366|448011079|FG000|Overall Study|Lost to Follow-up|2|||
124561050|NCT02043366|448011080|FG001|Overall Study|Lost to Follow-up|2|||
124561051|NCT02043366|448011081|FG002|Overall Study|Lost to Follow-up|2|||
124561052|NCT02043366|448011082|FG003|Overall Study|Lost to Follow-up|2|||
124561053|NCT02043366|448011083|FG004|Overall Study|Lost to Follow-up|2|||
124561054|NCT02043366|448011084|FG005|Overall Study|Lost to Follow-up|2|||
124561055|NCT01489956|448011087|FG000|Overall Study|Lost to Follow-up|1|||
124561056|NCT01489956|448011088|FG001|Overall Study|Lost to Follow-up|0|||
124561057|NCT01489956|448011089|FG002|Overall Study|Lost to Follow-up|0|||
124561058|NCT01489956|448011087|FG000|Overall Study|Withdrawal by Subject|0|||
124561059|NCT01489956|448011088|FG001|Overall Study|Withdrawal by Subject|0|||
124561060|NCT01489956|448011089|FG002|Overall Study|Withdrawal by Subject|1|||
124561061|NCT00891774|448011090|FG000|Overall Study|Lost to Follow-up|5|||
124561062|NCT00891774|448011090|FG000|Overall Study|Illness (Self/Mother)|3|||
124561063|NCT00891774|448011090|FG000|Overall Study|Withdrawal by Subject|2|||
124561064|NCT00891774|448011090|FG000|Overall Study|Protocol Violation|4|||
124561065|NCT01977092|448011092|FG000|Overall Study|Death|3|||
124561066|NCT01977092|448011093|FG001|Overall Study|Death|4|||
124561067|NCT01977092|448011092|FG000|Overall Study|Lost to Follow-up|23|||
124561068|NCT01977092|448011093|FG001|Overall Study|Lost to Follow-up|14|||
124561069|NCT01977092|448011092|FG000|Overall Study|Withdrawal by Subject|2|||
124561070|NCT01977092|448011093|FG001|Overall Study|Withdrawal by Subject|1|||
124561071|NCT01977092|448011092|FG000|Overall Study|In prison|3|||
124561072|NCT01977092|448011093|FG001|Overall Study|In prison|11|||
124561073|NCT02927847|448011094|FG000|Overall Study|Lost to Follow-up|1|||
124561074|NCT02927847|448011095|FG001|Overall Study|Lost to Follow-up|0|||
124561075|NCT02927847|448011094|FG000|Overall Study|Withdrawal by Subject|4|||
124561076|NCT02927847|448011095|FG001|Overall Study|Withdrawal by Subject|2|||
124561077|NCT02927847|448011094|FG000|Overall Study|PI withdrawn due to missed visits|1|||
124561078|NCT02927847|448011095|FG001|Overall Study|PI withdrawn due to missed visits|1|||
124561079|NCT00723554|448011096|FG000|Overall Study|Adverse Event|12|||
124561080|NCT00723554|448011096|FG000|Overall Study|Investigator's judgement|5|||
124561081|NCT00723554|448011096|FG000|Overall Study|Inhaled medication other than iloprost|4|||
124561082|NCT00723554|448011096|FG000|Overall Study|Withdrawal of consent|3|||
124561083|NCT00723554|448011096|FG000|Overall Study|Other|3|||
124561084|NCT00723554|448011096|FG000|Overall Study|Lost to Follow-up|1|||
124561085|NCT00723554|448011096|FG000|Overall Study|Non-compliance|1|||
124561086|NCT01405820|448011097|FG000|Randomized Treatment Period|Adverse Event|3|||
124561087|NCT01405820|448011098|FG001|Randomized Treatment Period|Adverse Event|3|||
124561088|NCT01405820|448011099|FG002|Randomized Treatment Period|Adverse Event|3|||
124561089|NCT01405820|448011100|FG003|Randomized Treatment Period|Adverse Event|0|||
124561090|NCT01405820|448011101|FG004|Randomized Treatment Period|Adverse Event|2|||
124561091|NCT01405820|448011102|FG005|Randomized Treatment Period|Adverse Event|1|||
124561092|NCT01405820|448011097|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
124561093|NCT01405820|448011098|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
124776148|NCT04032093|448808495|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
124776149|NCT04032093|448808496|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
124776150|NCT04032093|448808497|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
124776151|NCT04032093|448808498|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
124776152|NCT04032093|448808499|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
124776153|NCT04032093|448808490|FG000|Overall Study|Adverse Event|0|||
124776154|NCT04032093|448808491|FG001|Overall Study|Adverse Event|0|||
124776155|NCT04032093|448808492|FG002|Overall Study|Adverse Event|0|||
124776156|NCT04032093|448808493|FG003|Overall Study|Adverse Event|0|||
124776157|NCT04032093|448808494|FG004|Overall Study|Adverse Event|0|||
124776158|NCT04032093|448808495|FG005|Overall Study|Adverse Event|0|||
124776159|NCT04032093|448808496|FG006|Overall Study|Adverse Event|0|||
124776160|NCT04032093|448808497|FG007|Overall Study|Adverse Event|0|||
124776161|NCT04032093|448808498|FG008|Overall Study|Adverse Event|0|||
124776162|NCT04032093|448808499|FG009|Overall Study|Adverse Event|1|||
124776163|NCT04032093|448808490|FG000|Overall Study|Physician Decision|0|||
124776164|NCT04032093|448808491|FG001|Overall Study|Physician Decision|0|||
124776165|NCT04032093|448808492|FG002|Overall Study|Physician Decision|0|||
124776166|NCT04032093|448808493|FG003|Overall Study|Physician Decision|0|||
124776167|NCT04032093|448808494|FG004|Overall Study|Physician Decision|0|||
124776168|NCT04032093|448808495|FG005|Overall Study|Physician Decision|1|||
124776169|NCT04032093|448808496|FG006|Overall Study|Physician Decision|0|||
124776170|NCT04032093|448808497|FG007|Overall Study|Physician Decision|0|||
124776171|NCT04032093|448808498|FG008|Overall Study|Physician Decision|0|||
124776172|NCT04032093|448808499|FG009|Overall Study|Physician Decision|0|||
124776173|NCT01457703|448808504|FG000|Overall Study|Screen Failure|5|||
124776174|NCT01457703|448808505|FG001|Overall Study|Screen Failure|7|||
124776175|NCT01457703|448808504|FG000|Overall Study|Withdrawal by Subject|1|||
124776176|NCT01457703|448808505|FG001|Overall Study|Withdrawal by Subject|4|||
124776177|NCT02952820|448808506|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
124776178|NCT02952820|448808507|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
124776179|NCT02952820|448808508|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
124776180|NCT02952820|448808506|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
124776181|NCT02952820|448808507|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
124776182|NCT02952820|448808508|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
124776183|NCT02952820|448808506|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
124776184|NCT02952820|448808507|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
124776185|NCT02952820|448808508|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
124776186|NCT02952820|448808506|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
124776187|NCT02952820|448808507|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
124776188|NCT02952820|448808508|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
124776189|NCT02952820|448808506|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
124776190|NCT02952820|448808507|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
124776191|NCT02952820|448808508|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
124776192|NCT02952820|448808506|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
124776193|NCT02952820|448808507|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
124776194|NCT02952820|448808508|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
124776195|NCT02952820|448808506|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
124561094|NCT01405820|448011099|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
124561095|NCT01405820|448011100|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
124561096|NCT01405820|448011101|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
124561097|NCT01405820|448011102|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
124561098|NCT01405820|448011097|FG000|Randomized Treatment Period|Other|2|||
124561099|NCT01405820|448011098|FG001|Randomized Treatment Period|Other|2|||
124561100|NCT01405820|448011099|FG002|Randomized Treatment Period|Other|1|||
124561101|NCT01405820|448011100|FG003|Randomized Treatment Period|Other|1|||
124561102|NCT01405820|448011101|FG004|Randomized Treatment Period|Other|0|||
124776196|NCT02952820|448808507|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
124776197|NCT02952820|448808508|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
124776198|NCT02952820|448808506|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
124776199|NCT02952820|448808507|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
124776200|NCT02952820|448808508|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
124776201|NCT02952820|448808506|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
124776202|NCT02952820|448808507|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
124776203|NCT02952820|448808508|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
124561103|NCT01405820|448011102|FG005|Randomized Treatment Period|Other|0|||
124776204|NCT02952820|448808506|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
124776205|NCT02952820|448808507|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
124776206|NCT02952820|448808508|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
124561104|NCT01405820|448011097|FG000|Randomized Treatment Period|Physician Decision|0|||
124561105|NCT01405820|448011098|FG001|Randomized Treatment Period|Physician Decision|2|||
124501800|NCT02750800|447790343|FG000|Overall Study|Other, not specified|3|||
124501801|NCT03298412|447790344|FG000|Run-in Period|Other, Not Specified|1|||
124501802|NCT03298412|447790344|FG000|Run-in Period|Disease Progression|1|||
124501803|NCT03298412|447790344|FG000|Run-in Period|Ineligibility Determined|1|||
124501804|NCT03298412|447790344|FG000|Run-in Period|Decision by Sponsor|6|||
124501805|NCT05631548|447790345|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
124501806|NCT05631548|447790346|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
124501807|NCT00995345|447790351|FG000|Overall Study|Withdrawal by Subject|4|||
124501808|NCT00995345|447790352|FG001|Overall Study|Withdrawal by Subject|2|||
124501809|NCT00995345|447790353|FG002|Overall Study|Withdrawal by Subject|1|||
124501810|NCT00995345|447790354|FG003|Overall Study|Withdrawal by Subject|3|||
124501811|NCT00995345|447790355|FG004|Overall Study|Withdrawal by Subject|1|||
124501812|NCT00995345|447790351|FG000|Overall Study|Adverse Event|3|||
124501813|NCT00995345|447790352|FG001|Overall Study|Adverse Event|1|||
124501814|NCT00995345|447790353|FG002|Overall Study|Adverse Event|2|||
124501815|NCT00995345|447790354|FG003|Overall Study|Adverse Event|0|||
124501816|NCT00995345|447790355|FG004|Overall Study|Adverse Event|1|||
124501817|NCT00995345|447790351|FG000|Overall Study|Lost to Follow-up|2|||
124501818|NCT00995345|447790352|FG001|Overall Study|Lost to Follow-up|2|||
124501819|NCT00995345|447790353|FG002|Overall Study|Lost to Follow-up|2|||
124501820|NCT00995345|447790354|FG003|Overall Study|Lost to Follow-up|1|||
124501821|NCT00995345|447790355|FG004|Overall Study|Lost to Follow-up|0|||
124501822|NCT00995345|447790351|FG000|Overall Study|all other reasons combined|2|||
124501823|NCT00995345|447790352|FG001|Overall Study|all other reasons combined|2|||
124501824|NCT00995345|447790353|FG002|Overall Study|all other reasons combined|2|||
124501825|NCT00995345|447790354|FG003|Overall Study|all other reasons combined|1|||
124501826|NCT00995345|447790355|FG004|Overall Study|all other reasons combined|3|||
124501827|NCT01860534|447790360|FG000|ROP #1|Needed treatment for ROP|0|||
124501828|NCT01860534|447790361|FG001|ROP #1|Needed treatment for ROP|1|||
124501829|NCT01860534|447790360|FG000|ROP #2|discharged prior to ROP #2|1|||
124501830|NCT01860534|447790361|FG001|ROP #2|discharged prior to ROP #2|0|||
124501831|NCT04891770|447790364|FG000|Overall Study|Withdrew consent|1|||
124501832|NCT04891770|447790365|FG001|Overall Study|Withdrew consent|3|||
124501833|NCT04891770|447790366|FG002|Overall Study|Withdrew consent|0|||
124501834|NCT04891770|447790364|FG000|Overall Study|Enrolled but never treated|0|||
124501835|NCT04891770|447790365|FG001|Overall Study|Enrolled but never treated|0|||
124501836|NCT04891770|447790366|FG002|Overall Study|Enrolled but never treated|1|||
124501837|NCT04891770|447790364|FG000|Overall Study|Investigator's discretion|0|||
124501838|NCT04891770|447790365|FG001|Overall Study|Investigator's discretion|1|||
124501839|NCT04891770|447790366|FG002|Overall Study|Investigator's discretion|0|||
124501840|NCT00195260|447790371|FG000|Part 1: Dose Escalation|Adverse Event|0|||
124501841|NCT00195260|447790372|FG001|Part 1: Dose Escalation|Adverse Event|1|||
124501842|NCT00195260|447790373|FG002|Part 1: Dose Escalation|Adverse Event|0|||
124501843|NCT00195260|447790374|FG003|Part 1: Dose Escalation|Adverse Event|1|||
124501844|NCT00195260|447790375|FG004|Part 1: Dose Escalation|Adverse Event|1|||
124501845|NCT00195260|447790376|FG005|Part 1: Dose Escalation|Adverse Event|0|||
124501846|NCT00195260|447790377|FG006|Part 1: Dose Escalation|Adverse Event|3|||
124501847|NCT00195260|447790378|FG007|Part 1: Dose Escalation|Adverse Event|0|||
124501848|NCT00195260|447790379|FG008|Part 1: Dose Escalation|Adverse Event|0|||
124501849|NCT00195260|447790380|FG009|Part 1: Dose Escalation|Adverse Event|0|||
124501850|NCT00195260|447790381|FG010|Part 1: Dose Escalation|Adverse Event|0|||
124501851|NCT00195260|447790371|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124501852|NCT00195260|447790372|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124501853|NCT00195260|447790373|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124501854|NCT00195260|447790374|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124501855|NCT00195260|447790375|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
124501856|NCT00195260|447790376|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124501857|NCT00195260|447790377|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124501858|NCT00195260|447790378|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
124501859|NCT00195260|447790379|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124501860|NCT00195260|447790380|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124501861|NCT00195260|447790381|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
124501862|NCT00195260|447790371|FG000|Part 1: Dose Escalation|Death|0|||
124501863|NCT00195260|447790372|FG001|Part 1: Dose Escalation|Death|0|||
124501864|NCT00195260|447790373|FG002|Part 1: Dose Escalation|Death|0|||
124501865|NCT00195260|447790374|FG003|Part 1: Dose Escalation|Death|0|||
124501866|NCT00195260|447790375|FG004|Part 1: Dose Escalation|Death|0|||
124501867|NCT00195260|447790376|FG005|Part 1: Dose Escalation|Death|0|||
124501868|NCT00195260|447790377|FG006|Part 1: Dose Escalation|Death|0|||
124501869|NCT00195260|447790378|FG007|Part 1: Dose Escalation|Death|1|||
124501870|NCT00195260|447790379|FG008|Part 1: Dose Escalation|Death|0|||
124501871|NCT00195260|447790380|FG009|Part 1: Dose Escalation|Death|0|||
124501872|NCT00195260|447790381|FG010|Part 1: Dose Escalation|Death|0|||
124501873|NCT00195260|447790371|FG000|Part 1: Dose Escalation|Disease Progression|3|||
124501874|NCT00195260|447790372|FG001|Part 1: Dose Escalation|Disease Progression|2|||
124501875|NCT00195260|447790373|FG002|Part 1: Dose Escalation|Disease Progression|5|||
124501876|NCT00195260|447790374|FG003|Part 1: Dose Escalation|Disease Progression|6|||
124501877|NCT00195260|447790375|FG004|Part 1: Dose Escalation|Disease Progression|4|||
124501878|NCT00195260|447790376|FG005|Part 1: Dose Escalation|Disease Progression|6|||
124501879|NCT00195260|447790377|FG006|Part 1: Dose Escalation|Disease Progression|7|||
124501880|NCT00195260|447790378|FG007|Part 1: Dose Escalation|Disease Progression|4|||
124501881|NCT00195260|447790379|FG008|Part 1: Dose Escalation|Disease Progression|0|||
124501882|NCT00195260|447790380|FG009|Part 1: Dose Escalation|Disease Progression|0|||
124501883|NCT00195260|447790381|FG010|Part 1: Dose Escalation|Disease Progression|0|||
124501884|NCT00195260|447790371|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
124501885|NCT00195260|447790372|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
124501886|NCT00195260|447790373|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
124501887|NCT00195260|447790374|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
124501888|NCT00195260|447790375|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
124501889|NCT00195260|447790376|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
124501890|NCT00195260|447790377|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
124501891|NCT00195260|447790378|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
124501892|NCT00195260|447790379|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
124501893|NCT00195260|447790380|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
124501894|NCT00195260|447790381|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
124501895|NCT00195260|447790371|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
124501896|NCT00195260|447790372|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
124501897|NCT00195260|447790373|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
124501898|NCT00195260|447790374|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
124501899|NCT00195260|447790375|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
124501900|NCT00195260|447790376|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
124501901|NCT00195260|447790377|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
124501902|NCT00195260|447790378|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
124501903|NCT00195260|447790379|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
124501904|NCT00195260|447790380|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
124501905|NCT00195260|447790381|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
124501906|NCT00195260|447790371|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
124501907|NCT00195260|447790372|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
124501908|NCT00195260|447790373|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
124501909|NCT00195260|447790374|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
124501910|NCT00195260|447790375|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
124501911|NCT00195260|447790376|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
124501912|NCT00195260|447790377|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
124501913|NCT00195260|447790378|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
124501914|NCT00195260|447790379|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
124501915|NCT00195260|447790380|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
124501916|NCT00195260|447790381|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
124501917|NCT00195260|447790371|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
124501918|NCT00195260|447790372|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
124501919|NCT00195260|447790373|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
124501920|NCT00195260|447790374|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
124501921|NCT00195260|447790375|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
124501922|NCT00195260|447790376|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
124501923|NCT00195260|447790377|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
124501924|NCT00195260|447790378|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
124501925|NCT00195260|447790379|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
124501926|NCT00195260|447790380|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
124501927|NCT00195260|447790381|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
124501928|NCT00195260|447790371|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
124501929|NCT00195260|447790372|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
124501930|NCT00195260|447790373|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
124724807|NCT00703846|448611817|FG000|Overall Study|Noncompliance with Study Treatment|2|||
124724808|NCT00703846|448611817|FG000|Overall Study|Withdrawal by Subject|40|||
124724809|NCT00703846|448611817|FG000|Overall Study|Death|1|||
124724810|NCT00703846|448611817|FG000|Overall Study|Other|14|||
124501931|NCT00195260|447790374|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
124501932|NCT00195260|447790375|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
124501933|NCT00195260|447790376|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
124501934|NCT00195260|447790377|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
124501935|NCT00195260|447790378|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
124501936|NCT00195260|447790379|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
124724811|NCT00703846|448611817|FG000|Overall Study|Did Not Receive Study Drug|2|||
124724812|NCT01700959|448611822|FG000|Overall Study|Adverse Event|0|||
124561106|NCT01405820|448011099|FG002|Randomized Treatment Period|Physician Decision|1|||
124561107|NCT01405820|448011100|FG003|Randomized Treatment Period|Physician Decision|0|||
124561108|NCT01405820|448011101|FG004|Randomized Treatment Period|Physician Decision|0|||
124561109|NCT01405820|448011102|FG005|Randomized Treatment Period|Physician Decision|0|||
124561110|NCT01405820|448011097|FG000|Randomized Treatment Period|Rescue|0|||
124561111|NCT01405820|448011098|FG001|Randomized Treatment Period|Rescue|1|||
124561112|NCT01405820|448011099|FG002|Randomized Treatment Period|Rescue|13|||
124561113|NCT01405820|448011100|FG003|Randomized Treatment Period|Rescue|10|||
124561114|NCT01405820|448011101|FG004|Randomized Treatment Period|Rescue|8|||
124561115|NCT01405820|448011102|FG005|Randomized Treatment Period|Rescue|8|||
124561116|NCT01405820|448011097|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
124561117|NCT01405820|448011098|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
124561118|NCT01405820|448011099|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
124561119|NCT01405820|448011100|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
124561120|NCT01405820|448011101|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
124561121|NCT01405820|448011102|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
124561122|NCT01405820|448011097|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
124561123|NCT01405820|448011098|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
124561124|NCT01405820|448011099|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
124561125|NCT01405820|448011100|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
124561126|NCT01405820|448011101|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
124561127|NCT01405820|448011102|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
124561128|NCT01405820|448011097|FG000|Randomized Treatment Period|Death|0|||
124561129|NCT01405820|448011098|FG001|Randomized Treatment Period|Death|0|||
124561130|NCT01405820|448011099|FG002|Randomized Treatment Period|Death|0|||
124561131|NCT01405820|448011100|FG003|Randomized Treatment Period|Death|1|||
124561132|NCT01405820|448011101|FG004|Randomized Treatment Period|Death|0|||
124561133|NCT01405820|448011102|FG005|Randomized Treatment Period|Death|0|||
124561134|NCT01405820|448011097|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
124561135|NCT01405820|448011098|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
124561136|NCT01405820|448011099|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
124561137|NCT01405820|448011100|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
124561138|NCT01405820|448011101|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
124561139|NCT01405820|448011102|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
124561140|NCT01405820|448011097|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
124561141|NCT01405820|448011098|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
124561142|NCT01405820|448011099|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
124561143|NCT01405820|448011100|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
124561144|NCT01405820|448011101|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
124561145|NCT01405820|448011102|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
124561146|NCT01405820|448011097|FG000|Open-Label Treatment Period|Other|1|||
124561147|NCT01405820|448011098|FG001|Open-Label Treatment Period|Other|1|||
124561148|NCT01405820|448011099|FG002|Open-Label Treatment Period|Other|1|||
124561149|NCT01405820|448011100|FG003|Open-Label Treatment Period|Other|1|||
124561150|NCT01405820|448011101|FG004|Open-Label Treatment Period|Other|1|||
124561151|NCT01405820|448011102|FG005|Open-Label Treatment Period|Other|1|||
124561152|NCT01405820|448011097|FG000|Open-Label Treatment Period|Physician Decision|0|||
124561153|NCT01405820|448011098|FG001|Open-Label Treatment Period|Physician Decision|0|||
124561154|NCT01405820|448011099|FG002|Open-Label Treatment Period|Physician Decision|1|||
124561155|NCT01405820|448011100|FG003|Open-Label Treatment Period|Physician Decision|2|||
124561156|NCT01405820|448011101|FG004|Open-Label Treatment Period|Physician Decision|1|||
124561157|NCT01405820|448011102|FG005|Open-Label Treatment Period|Physician Decision|0|||
124501937|NCT00195260|447790380|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
124501938|NCT00195260|447790381|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
124501939|NCT04360187|447790388|FG000|Double-Blind Treatment|Adverse Event|9|||
124501940|NCT04360187|447790389|FG001|Double-Blind Treatment|Adverse Event|11|||
124501941|NCT04360187|447790388|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
124501942|NCT04360187|447790389|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
124501943|NCT04360187|447790388|FG000|Double-Blind Treatment|Physician Decision|1|||
124501944|NCT04360187|447790389|FG001|Double-Blind Treatment|Physician Decision|0|||
124501945|NCT04360187|447790388|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
124501946|NCT04360187|447790389|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
124501947|NCT04360187|447790388|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
124501948|NCT04360187|447790389|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
124501949|NCT04360187|447790388|FG000|Follow-Up|Lost to Follow-up|1|||
124561158|NCT01405820|448011097|FG000|Open-Label Treatment Period|Adverse Event|0|||
124561159|NCT01405820|448011098|FG001|Open-Label Treatment Period|Adverse Event|0|||
124561160|NCT01405820|448011099|FG002|Open-Label Treatment Period|Adverse Event|0|||
124561161|NCT01405820|448011100|FG003|Open-Label Treatment Period|Adverse Event|1|||
124561162|NCT01405820|448011101|FG004|Open-Label Treatment Period|Adverse Event|0|||
124561163|NCT01405820|448011102|FG005|Open-Label Treatment Period|Adverse Event|0|||
124561164|NCT01689974|448011109|FG000|Overall Study|Termination of Study|5|||
124776207|NCT02952820|448808506|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
124776208|NCT02952820|448808507|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
124776209|NCT02952820|448808508|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
124776210|NCT02952820|448808506|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
124776211|NCT02952820|448808507|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
124776212|NCT02952820|448808508|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
124776213|NCT02952820|448808506|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
124776214|NCT02952820|448808507|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
124501950|NCT04360187|447790389|FG001|Follow-Up|Lost to Follow-up|0|||
124561165|NCT01689974|448011110|FG001|Overall Study|Termination of Study|5|||
124561166|NCT01952574|448011111|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
124561167|NCT01952574|448011112|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
124561168|NCT01952574|448011113|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
124561169|NCT01952574|448011114|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
124561170|NCT01952574|448011115|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124561171|NCT01952574|448011116|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124561172|NCT01952574|448011117|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124561173|NCT01952574|448011111|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
124561174|NCT01952574|448011112|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
124561175|NCT01952574|448011113|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
124561176|NCT01952574|448011114|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
124561177|NCT01952574|448011115|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
124561178|NCT01952574|448011116|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
124561179|NCT01952574|448011117|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
124561180|NCT01952574|448011111|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
124561181|NCT01952574|448011112|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
124561182|NCT01952574|448011113|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
124561183|NCT01952574|448011114|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
124561184|NCT01952574|448011115|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
124561185|NCT01952574|448011116|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
124561186|NCT01952574|448011117|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
124561187|NCT01952574|448011111|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
124561188|NCT01952574|448011112|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
124561189|NCT01952574|448011113|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
124561190|NCT01952574|448011114|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
124561191|NCT01952574|448011115|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
124776215|NCT02952820|448808508|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
124776216|NCT02952820|448808506|FG000|Active Treatment Period (6 Months)|Not treated|0|||
124501951|NCT00222729|447790393|FG000|Overall Study|Adverse Event|3|||
124501952|NCT01318083|447790394|FG000|Overall Study|Adverse Event|4|||
124501953|NCT01318083|447790395|FG001|Overall Study|Adverse Event|1|||
124501954|NCT01318083|447790396|FG002|Overall Study|Adverse Event|2|||
124501955|NCT01318083|447790394|FG000|Overall Study|Withdrawal by Subject|1|||
124501956|NCT01318083|447790395|FG001|Overall Study|Withdrawal by Subject|0|||
124501957|NCT01318083|447790396|FG002|Overall Study|Withdrawal by Subject|2|||
124501958|NCT01318083|447790394|FG000|Overall Study|Lack of Efficacy|0|||
124501959|NCT01318083|447790395|FG001|Overall Study|Lack of Efficacy|0|||
124501960|NCT01318083|447790396|FG002|Overall Study|Lack of Efficacy|1|||
124501961|NCT01318083|447790394|FG000|Overall Study|Treatment Complications|1|||
124501962|NCT01318083|447790395|FG001|Overall Study|Treatment Complications|0|||
124501963|NCT01318083|447790396|FG002|Overall Study|Treatment Complications|0|||
124501964|NCT01318083|447790394|FG000|Overall Study|Lack of Study Medication Compliance|0|||
124501965|NCT01318083|447790395|FG001|Overall Study|Lack of Study Medication Compliance|1|||
124501966|NCT01318083|447790396|FG002|Overall Study|Lack of Study Medication Compliance|0|||
124501967|NCT00256867|447790397|FG000|Overall Study|Adverse Event|0|||
124501968|NCT00256867|447790398|FG001|Overall Study|Adverse Event|1|||
124501969|NCT00256867|447790399|FG002|Overall Study|Adverse Event|1|||
124501970|NCT00256867|447790400|FG003|Overall Study|Adverse Event|1|||
124501971|NCT00256867|447790401|FG004|Overall Study|Adverse Event|2|||
124501972|NCT00256867|447790402|FG005|Overall Study|Adverse Event|2|||
124501973|NCT00256867|447790403|FG006|Overall Study|Adverse Event|1|||
124501974|NCT00256867|447790404|FG007|Overall Study|Adverse Event|4|||
124501975|NCT00256867|447790397|FG000|Overall Study|Lost to Follow-up|2|||
124501976|NCT00256867|447790398|FG001|Overall Study|Lost to Follow-up|2|||
124501977|NCT00256867|447790399|FG002|Overall Study|Lost to Follow-up|2|||
124501978|NCT00256867|447790400|FG003|Overall Study|Lost to Follow-up|3|||
124501979|NCT00256867|447790401|FG004|Overall Study|Lost to Follow-up|2|||
124561192|NCT01952574|448011116|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
124561193|NCT01952574|448011117|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
124561194|NCT01952574|448011111|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
124561195|NCT01952574|448011112|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
124561196|NCT01952574|448011113|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
124776217|NCT02952820|448808507|FG001|Active Treatment Period (6 Months)|Not treated|0|||
124776218|NCT02952820|448808508|FG002|Active Treatment Period (6 Months)|Not treated|1|||
124776219|NCT04139018|448808509|FG000|Overall Study|Screen fail|1|||
124776220|NCT04139018|448808510|FG001|Overall Study|Screen fail|0|||
124776221|NCT04139018|448808509|FG000|Overall Study|Withdrawal by Subject|2|||
124776222|NCT04139018|448808510|FG001|Overall Study|Withdrawal by Subject|0|||
124776223|NCT04139018|448808509|FG000|Overall Study|Lost to Follow-up|0|||
124776224|NCT04139018|448808510|FG001|Overall Study|Lost to Follow-up|1|||
124776225|NCT03486834|448808511|FG000|Overall Study|Withdrawal by Subject|46|||
124776226|NCT03486834|448808512|FG001|Overall Study|Withdrawal by Subject|46|||
124776227|NCT03486834|448808513|FG002|Overall Study|Withdrawal by Subject|52|||
124776228|NCT03486834|448808511|FG000|Overall Study|Adverse Event|8|||
124776229|NCT03486834|448808512|FG001|Overall Study|Adverse Event|7|||
124776230|NCT03486834|448808513|FG002|Overall Study|Adverse Event|0|||
124776231|NCT03486834|448808511|FG000|Overall Study|Lost to Follow-up|41|||
124776232|NCT03486834|448808512|FG001|Overall Study|Lost to Follow-up|24|||
124776233|NCT03486834|448808513|FG002|Overall Study|Lost to Follow-up|39|||
124776234|NCT03486834|448808511|FG000|Overall Study|Non-compliance with Study Drug|2|||
124776235|NCT03486834|448808512|FG001|Overall Study|Non-compliance with Study Drug|2|||
124776236|NCT03486834|448808513|FG002|Overall Study|Non-compliance with Study Drug|0|||
124776237|NCT03486834|448808511|FG000|Overall Study|Physician Decision|5|||
124776238|NCT03486834|448808512|FG001|Overall Study|Physician Decision|2|||
124776239|NCT03486834|448808513|FG002|Overall Study|Physician Decision|3|||
124776240|NCT03486834|448808511|FG000|Overall Study|Pregnancy|10|||
124776241|NCT03486834|448808512|FG001|Overall Study|Pregnancy|12|||
124776242|NCT03486834|448808513|FG002|Overall Study|Pregnancy|12|||
124776243|NCT03486834|448808511|FG000|Overall Study|Protocol Deviation|2|||
124776244|NCT03486834|448808512|FG001|Overall Study|Protocol Deviation|3|||
124776245|NCT03486834|448808513|FG002|Overall Study|Protocol Deviation|3|||
124776246|NCT03486834|448808511|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
124776247|NCT03486834|448808512|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
124776248|NCT03486834|448808513|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
124776249|NCT03486834|448808511|FG000|Overall Study|Randomized but not treated|4|||
124776250|NCT03486834|448808512|FG001|Overall Study|Randomized but not treated|4|||
124776251|NCT03486834|448808513|FG002|Overall Study|Randomized but not treated|1|||
124776252|NCT02745119|448808532|FG000|Overall Study|Adverse Event|1|||
124776253|NCT02745119|448808533|FG001|Overall Study|Adverse Event|0|||
124776254|NCT02745119|448808534|FG002|Overall Study|Adverse Event|1|||
124776255|NCT02745119|448808535|FG003|Overall Study|Adverse Event|3|||
124776256|NCT02745119|448808532|FG000|Overall Study|Death|3|||
124776257|NCT02745119|448808533|FG001|Overall Study|Death|3|||
124776258|NCT02745119|448808534|FG002|Overall Study|Death|0|||
124776259|NCT02745119|448808535|FG003|Overall Study|Death|4|||
124501980|NCT00256867|447790402|FG005|Overall Study|Lost to Follow-up|0|||
124501981|NCT00256867|447790403|FG006|Overall Study|Lost to Follow-up|1|||
124501982|NCT00256867|447790404|FG007|Overall Study|Lost to Follow-up|2|||
124501983|NCT00256867|447790397|FG000|Overall Study|Protocol Violation|0|||
124501984|NCT00256867|447790398|FG001|Overall Study|Protocol Violation|0|||
124501985|NCT00256867|447790399|FG002|Overall Study|Protocol Violation|0|||
124501986|NCT00256867|447790400|FG003|Overall Study|Protocol Violation|1|||
124501987|NCT00256867|447790401|FG004|Overall Study|Protocol Violation|0|||
124501988|NCT00256867|447790402|FG005|Overall Study|Protocol Violation|1|||
124501989|NCT00256867|447790403|FG006|Overall Study|Protocol Violation|0|||
124501990|NCT00256867|447790404|FG007|Overall Study|Protocol Violation|1|||
124501991|NCT00256867|447790397|FG000|Overall Study|Withdrawal by Subject|0|||
124501992|NCT00256867|447790398|FG001|Overall Study|Withdrawal by Subject|0|||
124501993|NCT00256867|447790399|FG002|Overall Study|Withdrawal by Subject|1|||
124501994|NCT00256867|447790400|FG003|Overall Study|Withdrawal by Subject|1|||
124501995|NCT00256867|447790401|FG004|Overall Study|Withdrawal by Subject|2|||
124501996|NCT00256867|447790402|FG005|Overall Study|Withdrawal by Subject|2|||
124501997|NCT00256867|447790403|FG006|Overall Study|Withdrawal by Subject|3|||
124501998|NCT00256867|447790404|FG007|Overall Study|Withdrawal by Subject|2|||
124501999|NCT00256867|447790397|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
124502000|NCT00256867|447790398|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
124502001|NCT00256867|447790399|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
124502002|NCT00256867|447790400|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
124502003|NCT00256867|447790401|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
124502004|NCT00256867|447790402|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
124502005|NCT00256867|447790403|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
124502006|NCT00256867|447790404|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
124502007|NCT00256867|447790397|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
124502008|NCT00256867|447790398|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
124776260|NCT02745119|448808532|FG000|Overall Study|Lost to Follow-up|0|||
124776261|NCT02745119|448808533|FG001|Overall Study|Lost to Follow-up|0|||
124776262|NCT02745119|448808534|FG002|Overall Study|Lost to Follow-up|0|||
124776263|NCT02745119|448808535|FG003|Overall Study|Lost to Follow-up|1|||
124776264|NCT02745119|448808532|FG000|Overall Study|Protocol Deviation|0|||
124776265|NCT02745119|448808533|FG001|Overall Study|Protocol Deviation|0|||
124502009|NCT00256867|447790399|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
124502010|NCT00256867|447790400|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
124502011|NCT00256867|447790401|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
124502012|NCT00256867|447790402|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
124502013|NCT00256867|447790403|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
124502014|NCT00256867|447790404|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
124502015|NCT00256867|447790397|FG000|Overall Study|Investigator's Decision|0|||
124502016|NCT00256867|447790398|FG001|Overall Study|Investigator's Decision|0|||
124502017|NCT00256867|447790399|FG002|Overall Study|Investigator's Decision|0|||
124561197|NCT01952574|448011114|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
124561198|NCT01952574|448011115|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
124561199|NCT01952574|448011116|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
124561200|NCT01952574|448011117|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
124561201|NCT01952574|448011111|FG000|Open-label Treatment Phase|Missing|0|||
124561202|NCT01952574|448011112|FG001|Open-label Treatment Phase|Missing|0|||
124561203|NCT01952574|448011113|FG002|Open-label Treatment Phase|Missing|0|||
124561204|NCT01952574|448011114|FG003|Open-label Treatment Phase|Missing|0|||
124561205|NCT01952574|448011115|FG004|Open-label Treatment Phase|Missing|4|||
124561206|NCT01952574|448011116|FG005|Open-label Treatment Phase|Missing|0|||
124561207|NCT01952574|448011117|FG006|Open-label Treatment Phase|Missing|0|||
124561208|NCT01952574|448011111|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
124561209|NCT01952574|448011112|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
124561210|NCT01952574|448011113|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
124561211|NCT01952574|448011114|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
124561212|NCT01952574|448011115|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
124561213|NCT01952574|448011116|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
124561214|NCT01952574|448011117|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
124561215|NCT01952574|448011111|FG000|Open-label Treatment Phase|Death|0|||
124561216|NCT01952574|448011112|FG001|Open-label Treatment Phase|Death|0|||
124561217|NCT01952574|448011113|FG002|Open-label Treatment Phase|Death|0|||
124561218|NCT01952574|448011114|FG003|Open-label Treatment Phase|Death|0|||
124502018|NCT00256867|447790400|FG003|Overall Study|Investigator's Decision|0|||
124502019|NCT00256867|447790401|FG004|Overall Study|Investigator's Decision|1|||
124502020|NCT00256867|447790402|FG005|Overall Study|Investigator's Decision|0|||
124502021|NCT00256867|447790403|FG006|Overall Study|Investigator's Decision|0|||
124502022|NCT00256867|447790404|FG007|Overall Study|Investigator's Decision|0|||
124502023|NCT00256867|447790397|FG000|Overall Study|Non-compliance with study medication|0|||
124502024|NCT00256867|447790398|FG001|Overall Study|Non-compliance with study medication|0|||
124502025|NCT00256867|447790399|FG002|Overall Study|Non-compliance with study medication|0|||
124502026|NCT00256867|447790400|FG003|Overall Study|Non-compliance with study medication|0|||
124502027|NCT00256867|447790401|FG004|Overall Study|Non-compliance with study medication|0|||
124502028|NCT00256867|447790402|FG005|Overall Study|Non-compliance with study medication|0|||
124502029|NCT00256867|447790403|FG006|Overall Study|Non-compliance with study medication|0|||
124502030|NCT00256867|447790404|FG007|Overall Study|Non-compliance with study medication|1|||
124502031|NCT00256867|447790397|FG000|Overall Study|Participant travelled Overseas|0|||
124502032|NCT00256867|447790398|FG001|Overall Study|Participant travelled Overseas|1|||
124502033|NCT00256867|447790399|FG002|Overall Study|Participant travelled Overseas|0|||
124502034|NCT00256867|447790400|FG003|Overall Study|Participant travelled Overseas|0|||
124502035|NCT00256867|447790401|FG004|Overall Study|Participant travelled Overseas|0|||
124502036|NCT00256867|447790402|FG005|Overall Study|Participant travelled Overseas|0|||
124502037|NCT00256867|447790403|FG006|Overall Study|Participant travelled Overseas|0|||
124502038|NCT00256867|447790404|FG007|Overall Study|Participant travelled Overseas|0|||
124502039|NCT00256867|447790397|FG000|Overall Study|Participant out of assessment window|0|||
124502040|NCT00256867|447790398|FG001|Overall Study|Participant out of assessment window|0|||
124502041|NCT00256867|447790399|FG002|Overall Study|Participant out of assessment window|1|||
124561219|NCT01952574|448011115|FG004|Open-label Treatment Phase|Death|1|||
124502042|NCT00256867|447790400|FG003|Overall Study|Participant out of assessment window|0|||
124502043|NCT00256867|447790401|FG004|Overall Study|Participant out of assessment window|0|||
124502044|NCT00256867|447790402|FG005|Overall Study|Participant out of assessment window|0|||
124502045|NCT00256867|447790403|FG006|Overall Study|Participant out of assessment window|0|||
124502046|NCT00256867|447790404|FG007|Overall Study|Participant out of assessment window|0|||
124502047|NCT00256867|447790397|FG000|Overall Study|Withdrawal by participant|0|||
124502048|NCT00256867|447790398|FG001|Overall Study|Withdrawal by participant|0|||
124502049|NCT00256867|447790399|FG002|Overall Study|Withdrawal by participant|0|||
124724813|NCT01700959|448611823|FG001|Overall Study|Adverse Event|1|||
124502050|NCT00256867|447790400|FG003|Overall Study|Withdrawal by participant|0|||
124502051|NCT00256867|447790401|FG004|Overall Study|Withdrawal by participant|0|||
124561220|NCT01952574|448011116|FG005|Open-label Treatment Phase|Death|0|||
124561221|NCT01952574|448011117|FG006|Open-label Treatment Phase|Death|0|||
124561222|NCT01952574|448011111|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
124561223|NCT01952574|448011112|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
124502052|NCT00256867|447790402|FG005|Overall Study|Withdrawal by participant|1|||
124502053|NCT00256867|447790403|FG006|Overall Study|Withdrawal by participant|0|||
124502054|NCT00256867|447790404|FG007|Overall Study|Withdrawal by participant|0|||
124561224|NCT01952574|448011113|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
124561225|NCT01952574|448011114|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
124561226|NCT01952574|448011115|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
124502055|NCT02993224|447790405|FG000|Core Phase - Period 1|Adverse Event|4|||
124502056|NCT02993224|447790405|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
124502057|NCT02993224|447790405|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
124502058|NCT02993224|447790405|FG000|Core Phase- Period 2|Adverse Event|1|||
124502059|NCT02993224|447790405|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
124561227|NCT01952574|448011116|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
124561228|NCT01952574|448011117|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
124561229|NCT01952574|448011111|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
124561230|NCT01952574|448011112|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
124502060|NCT02993224|447790405|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
124502061|NCT02993224|447790405|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
124502062|NCT02993224|447790405|FG000|Extension Phase|Adverse Event|3|||
124502063|NCT02993224|447790405|FG000|Extension Phase|Withdrawal by Subject|3|||
124502064|NCT02993224|447790405|FG000|Extension Phase|Lost to Follow-up|2|||
124502065|NCT02993224|447790405|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
124502066|NCT01930799|447790407|FG000|Overall Study|Withdrawal by Subject|3|||
124561231|NCT01952574|448011113|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
124561232|NCT01952574|448011114|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
124561233|NCT01952574|448011115|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
124561234|NCT01952574|448011116|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
124561235|NCT01952574|448011117|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
124561236|NCT02974114|448011121|FG000|Overall Study|Other (Not specified)|0|||
124561237|NCT02974114|448011122|FG001|Overall Study|Other (Not specified)|1|||
124561238|NCT02974114|448011123|FG002|Overall Study|Other (Not specified)|2|||
124561239|NCT01580020|448011124|FG000|Overall Study|Lack of Efficacy|0|||
124561240|NCT01580020|448011125|FG001|Overall Study|Lack of Efficacy|5|||
124561241|NCT01580020|448011126|FG002|Overall Study|Lack of Efficacy|0|||
124561242|NCT01580020|448011127|FG003|Overall Study|Lack of Efficacy|1|||
124561243|NCT01580020|448011124|FG000|Overall Study|Withdrawal by Subject|0|||
124561244|NCT01580020|448011125|FG001|Overall Study|Withdrawal by Subject|1|||
124561245|NCT01580020|448011126|FG002|Overall Study|Withdrawal by Subject|1|||
124561246|NCT01580020|448011127|FG003|Overall Study|Withdrawal by Subject|0|||
124561247|NCT01580020|448011124|FG000|Overall Study|Adverse Event|1|||
124561248|NCT01580020|448011125|FG001|Overall Study|Adverse Event|1|||
124724814|NCT01700959|448611824|FG002|Overall Study|Adverse Event|1|||
124724815|NCT01700959|448611825|FG003|Overall Study|Adverse Event|2|||
124724816|NCT01700959|448611826|FG004|Overall Study|Adverse Event|0|||
124724817|NCT01700959|448611827|FG005|Overall Study|Adverse Event|2|||
124724818|NCT01700959|448611822|FG000|Overall Study|Withdrawal by Subject|15|||
124724819|NCT01700959|448611823|FG001|Overall Study|Withdrawal by Subject|9|||
124724820|NCT01700959|448611824|FG002|Overall Study|Withdrawal by Subject|12|||
124724821|NCT01700959|448611825|FG003|Overall Study|Withdrawal by Subject|11|||
124724822|NCT01700959|448611826|FG004|Overall Study|Withdrawal by Subject|8|||
124502067|NCT01930799|447790407|FG000|Overall Study|Lost to Follow-up|5|||
124502068|NCT00952289|447790410|FG000|All Participants|Death|9|||
124502069|NCT00952289|447790411|FG001|All Participants|Death|9|||
124502070|NCT00952289|447790410|FG000|All Participants|Adverse Event|8|||
124502071|NCT00952289|447790411|FG001|All Participants|Adverse Event|8|||
124502072|NCT00952289|447790410|FG000|All Participants|Disease progression|3|||
124502073|NCT00952289|447790411|FG001|All Participants|Disease progression|12|||
124502074|NCT00952289|447790410|FG000|All Participants|Withdrawal by Subject|1|||
124502075|NCT00952289|447790411|FG001|All Participants|Withdrawal by Subject|10|||
124502076|NCT00952289|447790410|FG000|All Participants|Data lost during site relocation|0|||
124502077|NCT00952289|447790411|FG001|All Participants|Data lost during site relocation|1|||
124561249|NCT01580020|448011126|FG002|Overall Study|Adverse Event|1|||
124724823|NCT01700959|448611827|FG005|Overall Study|Withdrawal by Subject|12|||
124724824|NCT01700959|448611822|FG000|Overall Study|Ineligible|2|||
124724825|NCT01700959|448611823|FG001|Overall Study|Ineligible|1|||
124561250|NCT01580020|448011127|FG003|Overall Study|Adverse Event|1|||
124561251|NCT01580020|448011124|FG000|Overall Study|Administrative Problems|0|||
124561252|NCT01580020|448011125|FG001|Overall Study|Administrative Problems|0|||
124561253|NCT01580020|448011126|FG002|Overall Study|Administrative Problems|1|||
124561254|NCT01580020|448011127|FG003|Overall Study|Administrative Problems|0|||
124561255|NCT01580020|448011124|FG000|Overall Study|Lost to Follow-up|0|||
124561256|NCT01580020|448011125|FG001|Overall Study|Lost to Follow-up|0|||
124561257|NCT01580020|448011126|FG002|Overall Study|Lost to Follow-up|1|||
124724826|NCT01700959|448611824|FG002|Overall Study|Ineligible|2|||
124724827|NCT01700959|448611825|FG003|Overall Study|Ineligible|0|||
124724828|NCT01700959|448611826|FG004|Overall Study|Ineligible|0|||
124502078|NCT00952289|447790410|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
124502079|NCT00952289|447790411|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
124502080|NCT00952289|447790410|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
124502081|NCT00952289|447790411|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
124502082|NCT00952289|447790410|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
124502083|NCT00952289|447790411|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
124502084|NCT00952289|447790410|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
124502085|NCT00952289|447790411|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
124502086|NCT00952289|447790410|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
124502087|NCT00952289|447790411|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
124502088|NCT02371759|447790416|FG000|Overall Study|Protocol Violation|3|||
124502089|NCT02371759|447790417|FG001|Overall Study|Protocol Violation|1|||
124502090|NCT02371759|447790418|FG002|Overall Study|Protocol Violation|1|||
124502091|NCT02371759|447790419|FG003|Overall Study|Protocol Violation|0|||
124502092|NCT02371759|447790420|FG004|Overall Study|Protocol Violation|3|||
124502093|NCT02371759|447790421|FG005|Overall Study|Protocol Violation|1|||
124502094|NCT02371759|447790422|FG006|Overall Study|Protocol Violation|0|||
124502095|NCT02371759|447790423|FG007|Overall Study|Protocol Violation|3|||
124502096|NCT02371759|447790416|FG000|Overall Study|Withdrawal by Subject|0|||
124502097|NCT02371759|447790417|FG001|Overall Study|Withdrawal by Subject|0|||
124502098|NCT02371759|447790418|FG002|Overall Study|Withdrawal by Subject|0|||
124502099|NCT02371759|447790419|FG003|Overall Study|Withdrawal by Subject|0|||
124502100|NCT02371759|447790420|FG004|Overall Study|Withdrawal by Subject|0|||
124502101|NCT02371759|447790421|FG005|Overall Study|Withdrawal by Subject|0|||
124502102|NCT02371759|447790422|FG006|Overall Study|Withdrawal by Subject|0|||
124502103|NCT02371759|447790423|FG007|Overall Study|Withdrawal by Subject|1|||
124502104|NCT03136185|447790429|FG000|Overall Study|Adverse Event|0|||
124502105|NCT03136185|447790430|FG001|Overall Study|Adverse Event|1|||
124502106|NCT03136185|447790431|FG002|Overall Study|Adverse Event|3|||
124502107|NCT03136185|447790432|FG003|Overall Study|Adverse Event|1|||
124502108|NCT03136185|447790433|FG004|Overall Study|Adverse Event|2|||
124502109|NCT03136185|447790434|FG005|Overall Study|Adverse Event|2|||
124502110|NCT03136185|447790435|FG006|Overall Study|Adverse Event|5|||
124502111|NCT03136185|447790436|FG007|Overall Study|Adverse Event|1|||
124502112|NCT03136185|447790437|FG008|Overall Study|Adverse Event|1|||
124502113|NCT03136185|447790429|FG000|Overall Study|Death|0|||
124502114|NCT03136185|447790430|FG001|Overall Study|Death|0|||
124502115|NCT03136185|447790431|FG002|Overall Study|Death|0|||
124502116|NCT03136185|447790432|FG003|Overall Study|Death|1|||
124502117|NCT03136185|447790433|FG004|Overall Study|Death|1|||
124502118|NCT03136185|447790434|FG005|Overall Study|Death|0|||
124502119|NCT03136185|447790435|FG006|Overall Study|Death|1|||
124502120|NCT03136185|447790436|FG007|Overall Study|Death|0|||
124502121|NCT03136185|447790437|FG008|Overall Study|Death|0|||
124502122|NCT03136185|447790429|FG000|Overall Study|Physician Decision|3|||
124502123|NCT03136185|447790430|FG001|Overall Study|Physician Decision|1|||
124502124|NCT03136185|447790431|FG002|Overall Study|Physician Decision|1|||
124502125|NCT03136185|447790432|FG003|Overall Study|Physician Decision|2|||
124502126|NCT03136185|447790433|FG004|Overall Study|Physician Decision|1|||
124502127|NCT03136185|447790434|FG005|Overall Study|Physician Decision|2|||
124502128|NCT03136185|447790435|FG006|Overall Study|Physician Decision|1|||
124502129|NCT03136185|447790436|FG007|Overall Study|Physician Decision|0|||
124502130|NCT03136185|447790437|FG008|Overall Study|Physician Decision|1|||
124502131|NCT03136185|447790429|FG000|Overall Study|Protocol Defined Disease Progression|0|||
124502132|NCT03136185|447790430|FG001|Overall Study|Protocol Defined Disease Progression|0|||
124502133|NCT03136185|447790431|FG002|Overall Study|Protocol Defined Disease Progression|1|||
124502134|NCT03136185|447790432|FG003|Overall Study|Protocol Defined Disease Progression|0|||
124502135|NCT03136185|447790433|FG004|Overall Study|Protocol Defined Disease Progression|0|||
124502136|NCT03136185|447790434|FG005|Overall Study|Protocol Defined Disease Progression|1|||
124502137|NCT03136185|447790435|FG006|Overall Study|Protocol Defined Disease Progression|0|||
124502138|NCT03136185|447790436|FG007|Overall Study|Protocol Defined Disease Progression|1|||
124502139|NCT03136185|447790437|FG008|Overall Study|Protocol Defined Disease Progression|1|||
124502140|NCT03136185|447790429|FG000|Overall Study|Withdrawal by Subject|1|||
124502141|NCT03136185|447790430|FG001|Overall Study|Withdrawal by Subject|0|||
124502142|NCT03136185|447790431|FG002|Overall Study|Withdrawal by Subject|1|||
124502143|NCT03136185|447790432|FG003|Overall Study|Withdrawal by Subject|1|||
124502144|NCT03136185|447790433|FG004|Overall Study|Withdrawal by Subject|1|||
124502145|NCT03136185|447790434|FG005|Overall Study|Withdrawal by Subject|1|||
124502146|NCT03136185|447790435|FG006|Overall Study|Withdrawal by Subject|2|||
124502147|NCT03136185|447790436|FG007|Overall Study|Withdrawal by Subject|3|||
124502148|NCT03136185|447790437|FG008|Overall Study|Withdrawal by Subject|3|||
124502149|NCT03136185|447790429|FG000|Overall Study|Not Reported|4|||
124502150|NCT03136185|447790430|FG001|Overall Study|Not Reported|1|||
124502151|NCT03136185|447790431|FG002|Overall Study|Not Reported|0|||
124502152|NCT03136185|447790432|FG003|Overall Study|Not Reported|1|||
124502153|NCT03136185|447790433|FG004|Overall Study|Not Reported|0|||
124502154|NCT03136185|447790434|FG005|Overall Study|Not Reported|2|||
124502155|NCT03136185|447790435|FG006|Overall Study|Not Reported|1|||
124502156|NCT03136185|447790436|FG007|Overall Study|Not Reported|1|||
124502157|NCT03136185|447790437|FG008|Overall Study|Not Reported|0|||
124502158|NCT00488033|447790441|FG000|Overall Study|Withdrawal by Subject|1|||
124502159|NCT00488033|447790442|FG001|Overall Study|Withdrawal by Subject|0|||
124502160|NCT04715230|447790445|FG000|Overall Study|Withdrawal by Subject|1|||
124502161|NCT04715230|447790446|FG001|Overall Study|Withdrawal by Subject|0|||
124502162|NCT04715230|447790447|FG002|Overall Study|Withdrawal by Subject|0|||
124502163|NCT04715230|447790445|FG000|Overall Study|Lost to Follow-up|0|||
124502164|NCT04715230|447790446|FG001|Overall Study|Lost to Follow-up|5|||
124502165|NCT04715230|447790447|FG002|Overall Study|Lost to Follow-up|1|||
124502166|NCT03453151|447790448|FG000|Overall Study|Withdrawal by Subject|1|||
124502167|NCT03453151|447790448|FG000|Overall Study|Physician Decision|3|||
124502168|NCT02065622|447790452|FG000|Induction Study|Adverse Event|13|||
124502169|NCT02065622|447790453|FG001|Induction Study|Adverse Event|19|||
124502170|NCT02065622|447790454|FG002|Induction Study|Adverse Event|0|||
124502171|NCT02065622|447790455|FG003|Induction Study|Adverse Event|0|||
124502172|NCT02065622|447790456|FG004|Induction Study|Adverse Event|0|||
124502173|NCT02065622|447790452|FG000|Induction Study|Withdrawal by Subject|3|||
124502174|NCT02065622|447790453|FG001|Induction Study|Withdrawal by Subject|5|||
124502175|NCT02065622|447790454|FG002|Induction Study|Withdrawal by Subject|0|||
124502176|NCT02065622|447790455|FG003|Induction Study|Withdrawal by Subject|0|||
124502177|NCT02065622|447790456|FG004|Induction Study|Withdrawal by Subject|0|||
124502178|NCT02065622|447790452|FG000|Induction Study|Lost to Follow-up|1|||
124502179|NCT02065622|447790453|FG001|Induction Study|Lost to Follow-up|0|||
124502180|NCT02065622|447790454|FG002|Induction Study|Lost to Follow-up|0|||
124502181|NCT02065622|447790455|FG003|Induction Study|Lost to Follow-up|0|||
124502182|NCT02065622|447790456|FG004|Induction Study|Lost to Follow-up|0|||
124502183|NCT02065622|447790452|FG000|Induction Study|Lack of Efficacy|22|||
124502184|NCT02065622|447790453|FG001|Induction Study|Lack of Efficacy|27|||
124502185|NCT02065622|447790454|FG002|Induction Study|Lack of Efficacy|0|||
124502186|NCT02065622|447790455|FG003|Induction Study|Lack of Efficacy|0|||
124502187|NCT02065622|447790456|FG004|Induction Study|Lack of Efficacy|0|||
124502188|NCT02065622|447790452|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
124502189|NCT02065622|447790453|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
124502190|NCT02065622|447790454|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
124502191|NCT02065622|447790455|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
124502192|NCT02065622|447790456|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
124502193|NCT02065622|447790452|FG000|Induction Study|Subject Noncompliance|1|||
124502194|NCT02065622|447790453|FG001|Induction Study|Subject Noncompliance|1|||
124502195|NCT02065622|447790454|FG002|Induction Study|Subject Noncompliance|0|||
124502196|NCT02065622|447790455|FG003|Induction Study|Subject Noncompliance|0|||
124502197|NCT02065622|447790456|FG004|Induction Study|Subject Noncompliance|0|||
124502198|NCT02065622|447790452|FG000|Induction Study|Other, Not Specified|3|||
124502199|NCT02065622|447790453|FG001|Induction Study|Other, Not Specified|2|||
124502200|NCT02065622|447790454|FG002|Induction Study|Other, Not Specified|0|||
124502201|NCT02065622|447790455|FG003|Induction Study|Other, Not Specified|0|||
124502202|NCT02065622|447790456|FG004|Induction Study|Other, Not Specified|0|||
124502203|NCT02065622|447790452|FG000|Maintenance Study|Adverse Event|0|||
124502204|NCT02065622|447790453|FG001|Maintenance Study|Adverse Event|0|||
124502205|NCT02065622|447790454|FG002|Maintenance Study|Adverse Event|25|||
124502206|NCT02065622|447790455|FG003|Maintenance Study|Adverse Event|22|||
124502207|NCT02065622|447790456|FG004|Maintenance Study|Adverse Event|11|||
124502208|NCT02065622|447790452|FG000|Maintenance Study|Withdrawal by Subject|0|||
124502209|NCT02065622|447790453|FG001|Maintenance Study|Withdrawal by Subject|0|||
124502210|NCT02065622|447790454|FG002|Maintenance Study|Withdrawal by Subject|11|||
124502211|NCT02065622|447790455|FG003|Maintenance Study|Withdrawal by Subject|5|||
124502212|NCT02065622|447790456|FG004|Maintenance Study|Withdrawal by Subject|7|||
124502213|NCT02065622|447790452|FG000|Maintenance Study|Lost to Follow-up|0|||
124502214|NCT02065622|447790453|FG001|Maintenance Study|Lost to Follow-up|0|||
124502215|NCT02065622|447790454|FG002|Maintenance Study|Lost to Follow-up|4|||
124502216|NCT02065622|447790455|FG003|Maintenance Study|Lost to Follow-up|1|||
124502217|NCT02065622|447790456|FG004|Maintenance Study|Lost to Follow-up|1|||
124502218|NCT02065622|447790452|FG000|Maintenance Study|Lack of Efficacy|0|||
124502219|NCT02065622|447790453|FG001|Maintenance Study|Lack of Efficacy|0|||
124502220|NCT02065622|447790454|FG002|Maintenance Study|Lack of Efficacy|70|||
124502221|NCT02065622|447790455|FG003|Maintenance Study|Lack of Efficacy|55|||
124502222|NCT02065622|447790456|FG004|Maintenance Study|Lack of Efficacy|19|||
124502223|NCT02065622|447790452|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
124502224|NCT02065622|447790453|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
124502225|NCT02065622|447790454|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
124502226|NCT02065622|447790455|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
124502227|NCT02065622|447790456|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
124502228|NCT02065622|447790452|FG000|Maintenance Study|Subject Non-Compliance|0|||
124502229|NCT02065622|447790453|FG001|Maintenance Study|Subject Non-Compliance|0|||
124502230|NCT02065622|447790454|FG002|Maintenance Study|Subject Non-Compliance|1|||
124502231|NCT02065622|447790455|FG003|Maintenance Study|Subject Non-Compliance|3|||
124502232|NCT02065622|447790456|FG004|Maintenance Study|Subject Non-Compliance|2|||
124502233|NCT02065622|447790452|FG000|Maintenance Study|Other, Not Specified|0|||
124502234|NCT02065622|447790453|FG001|Maintenance Study|Other, Not Specified|0|||
124502235|NCT02065622|447790454|FG002|Maintenance Study|Other, Not Specified|6|||
124502236|NCT02065622|447790455|FG003|Maintenance Study|Other, Not Specified|14|||
124502237|NCT02065622|447790456|FG004|Maintenance Study|Other, Not Specified|2|||
124502238|NCT02065622|447790452|FG000|Maintenance Study|Unknown Reason|0|||
124502239|NCT02065622|447790453|FG001|Maintenance Study|Unknown Reason|0|||
124502240|NCT02065622|447790454|FG002|Maintenance Study|Unknown Reason|0|||
124502241|NCT02065622|447790455|FG003|Maintenance Study|Unknown Reason|1|||
124502242|NCT02065622|447790456|FG004|Maintenance Study|Unknown Reason|0|||
124502243|NCT04973228|447790457|FG000|Overall Study|Adverse Event|2|||
124502244|NCT04973228|447790458|FG001|Overall Study|Adverse Event|3|||
124502245|NCT04973228|447790457|FG000|Overall Study|Lack of Efficacy|1|||
124502246|NCT04973228|447790458|FG001|Overall Study|Lack of Efficacy|3|||
124502247|NCT04973228|447790457|FG000|Overall Study|Lost to Follow-up|12|||
124502248|NCT04973228|447790458|FG001|Overall Study|Lost to Follow-up|4|||
124502249|NCT04973228|447790457|FG000|Overall Study|Withdrawal by Subject|11|||
124502250|NCT04973228|447790458|FG001|Overall Study|Withdrawal by Subject|4|||
124502251|NCT04973228|447790457|FG000|Overall Study|Did not tolerate application|1|||
124502252|NCT04973228|447790458|FG001|Overall Study|Did not tolerate application|0|||
124502253|NCT04973228|447790457|FG000|Overall Study|Wanted to early terminate and use own product|0|||
124502254|NCT04973228|447790458|FG001|Overall Study|Wanted to early terminate and use own product|1|||
124502255|NCT04973228|447790457|FG000|Overall Study|Missed visits due to new work schedule|1|||
124502256|NCT04973228|447790458|FG001|Overall Study|Missed visits due to new work schedule|0|||
124502257|NCT02678780|447790462|FG000|Overall Study|Adverse Event|11|||
124502258|NCT02678780|447790463|FG001|Overall Study|Adverse Event|14|||
124502259|NCT02678780|447790462|FG000|Overall Study|Withdrawal by Subject|2|||
124502260|NCT02678780|447790463|FG001|Overall Study|Withdrawal by Subject|1|||
124502261|NCT02678780|447790462|FG000|Overall Study|Sponsor discontinuation|7|||
124502262|NCT02678780|447790463|FG001|Overall Study|Sponsor discontinuation|4|||
124502263|NCT02678780|447790462|FG000|Overall Study|Death|1|||
124502264|NCT02678780|447790463|FG001|Overall Study|Death|1|||
124502265|NCT02678780|447790462|FG000|Overall Study|Other|6|||
124502266|NCT02678780|447790463|FG001|Overall Study|Other|8|||
124502267|NCT02349789|447791795|FG000|Overall Study|Withdrawal by Subject|2|||
124502268|NCT00683475|447791798|FG000|Overall Study|Withdrawal by Subject|1|||
124502269|NCT00683475|447791799|FG001|Overall Study|Withdrawal by Subject|0|||
124502270|NCT00683475|447791798|FG000|Overall Study|Never Treated: Adverse Event|2|||
124502271|NCT00683475|447791799|FG001|Overall Study|Never Treated: Adverse Event|3|||
124502272|NCT00683475|447791798|FG000|Overall Study|Never Treated: Progressive Disease|1|||
124502273|NCT00683475|447791799|FG001|Overall Study|Never Treated: Progressive Disease|0|||
124502274|NCT02922634|447791800|FG000|Overall Study|Withdrawal by Subject|5|||
124502275|NCT02922634|447791800|FG000|Overall Study|Did not have their surgery|5|||
124502276|NCT02723604|447791801|FG000|Overall Study|ineligible|1|||
124502277|NCT02723604|447791801|FG000|Overall Study|never received treatment|1|||
124502278|NCT00352755|447791804|FG000|Overall Study|Physician Decision|1|||
124502279|NCT00352755|447791804|FG000|Overall Study|Adverse Event|1|||
124502280|NCT01694420|447791809|FG000|Overall Study|Lost to Follow-up|3|||
124502281|NCT03987919|447791810|FG000|Overall Study|Adverse Event|1|||
124502282|NCT03987919|447791811|FG001|Overall Study|Adverse Event|4|||
124502283|NCT03987919|447791812|FG002|Overall Study|Adverse Event|1|||
124502284|NCT03987919|447791813|FG003|Overall Study|Adverse Event|3|||
124502285|NCT03987919|447791810|FG000|Overall Study|Death|4|||
124502286|NCT03987919|447791811|FG001|Overall Study|Death|4|||
124502287|NCT03987919|447791812|FG002|Overall Study|Death|4|||
124502288|NCT03987919|447791813|FG003|Overall Study|Death|1|||
124502289|NCT03987919|447791810|FG000|Overall Study|Lost to Follow-up|5|||
124502290|NCT03987919|447791811|FG001|Overall Study|Lost to Follow-up|6|||
124502291|NCT03987919|447791812|FG002|Overall Study|Lost to Follow-up|8|||
124502292|NCT03987919|447791813|FG003|Overall Study|Lost to Follow-up|12|||
124502293|NCT03987919|447791810|FG000|Overall Study|Physician Decision|0|||
124502294|NCT03987919|447791811|FG001|Overall Study|Physician Decision|2|||
124502295|NCT03987919|447791812|FG002|Overall Study|Physician Decision|0|||
124502296|NCT03987919|447791813|FG003|Overall Study|Physician Decision|4|||
124502297|NCT03987919|447791810|FG000|Overall Study|Pregnancy|1|||
124502298|NCT03987919|447791811|FG001|Overall Study|Pregnancy|0|||
124502299|NCT03987919|447791812|FG002|Overall Study|Pregnancy|1|||
124502300|NCT03987919|447791813|FG003|Overall Study|Pregnancy|1|||
124502301|NCT03987919|447791810|FG000|Overall Study|Protocol Violation|0|||
124502302|NCT03987919|447791811|FG001|Overall Study|Protocol Violation|1|||
124502303|NCT03987919|447791812|FG002|Overall Study|Protocol Violation|0|||
124502304|NCT03987919|447791813|FG003|Overall Study|Protocol Violation|0|||
124502305|NCT03987919|447791810|FG000|Overall Study|Site terminated by Sponsor|0|||
124502306|NCT03987919|447791811|FG001|Overall Study|Site terminated by Sponsor|0|||
124502307|NCT03987919|447791812|FG002|Overall Study|Site terminated by Sponsor|0|||
124502308|NCT03987919|447791813|FG003|Overall Study|Site terminated by Sponsor|1|||
124502309|NCT03987919|447791810|FG000|Overall Study|Withdrawal by Subject|7|||
124502310|NCT03987919|447791811|FG001|Overall Study|Withdrawal by Subject|7|||
124502311|NCT03987919|447791812|FG002|Overall Study|Withdrawal by Subject|8|||
124502312|NCT03987919|447791813|FG003|Overall Study|Withdrawal by Subject|4|||
124502313|NCT03987919|447791810|FG000|Overall Study|Other - as reported by the investigator|1|||
124502314|NCT03987919|447791811|FG001|Overall Study|Other - as reported by the investigator|3|||
124502315|NCT03987919|447791812|FG002|Overall Study|Other - as reported by the investigator|2|||
124502316|NCT03987919|447791813|FG003|Overall Study|Other - as reported by the investigator|0|||
124502317|NCT01194804|447791814|FG000|Overall Study|Withdrawal by Subject|1|||
124502318|NCT03621943|447791815|FG000|First Randomized Intervention|Lost to Follow-up|51|||
124502319|NCT03621943|447791816|FG001|First Randomized Intervention|Lost to Follow-up|54|||
124502320|NCT03621943|447791815|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
124502321|NCT03621943|447791816|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
124502322|NCT03621943|447791815|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
124502323|NCT03621943|447791816|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
124502324|NCT03621943|447791815|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
124502325|NCT03621943|447791816|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
124502326|NCT00948818|447791818|FG000|Overall Study|Adverse Event|10|||
124502327|NCT00948818|447791819|FG001|Overall Study|Adverse Event|32|||
124502328|NCT00948818|447791818|FG000|Overall Study|Protocol Violation|9|||
124502329|NCT00948818|447791819|FG001|Overall Study|Protocol Violation|10|||
124502330|NCT00948818|447791818|FG000|Overall Study|Withdrawal by Subject|25|||
124502331|NCT00948818|447791819|FG001|Overall Study|Withdrawal by Subject|25|||
124502332|NCT00948818|447791818|FG000|Overall Study|Lost to Follow-up|10|||
124502333|NCT00948818|447791819|FG001|Overall Study|Lost to Follow-up|17|||
124502334|NCT00948818|447791818|FG000|Overall Study|Lack of Efficacy|4|||
124502335|NCT00948818|447791819|FG001|Overall Study|Lack of Efficacy|5|||
124502336|NCT00948818|447791818|FG000|Overall Study|Other Reason|4|||
124502337|NCT00948818|447791819|FG001|Overall Study|Other Reason|5|||
124502338|NCT01716533|447791820|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
124502339|NCT01716533|447791821|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
124502340|NCT01716533|447791822|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
124502341|NCT01716533|447791823|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
124502342|NCT01716533|447791820|FG000|Overall Study|Withdrawal by Subject|0|||
124502343|NCT01716533|447791821|FG001|Overall Study|Withdrawal by Subject|0|||
124502344|NCT01716533|447791822|FG002|Overall Study|Withdrawal by Subject|0|||
124502345|NCT01716533|447791823|FG003|Overall Study|Withdrawal by Subject|5|||
124502346|NCT01716533|447791820|FG000|Overall Study|Death|0|||
124502347|NCT01716533|447791821|FG001|Overall Study|Death|0|||
124776266|NCT02745119|448808534|FG002|Overall Study|Protocol Deviation|0|||
124502348|NCT01716533|447791822|FG002|Overall Study|Death|0|||
124502349|NCT01716533|447791823|FG003|Overall Study|Death|2|||
124502350|NCT01716533|447791820|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
124502351|NCT01716533|447791821|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
124502352|NCT01716533|447791822|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
124502353|NCT01716533|447791823|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
124502354|NCT02330549|447791824|FG000|Overall Study|Adverse Event|1|||
124502355|NCT02330549|447791825|FG001|Overall Study|Adverse Event|0|||
124502356|NCT02330549|447791824|FG000|Overall Study|Subject withdrew consent|2|||
124502357|NCT02330549|447791825|FG001|Overall Study|Subject withdrew consent|1|||
124502358|NCT02330549|447791824|FG000|Overall Study|Failure to meet randomization criteria|1|||
124502359|NCT02330549|447791825|FG001|Overall Study|Failure to meet randomization criteria|0|||
124502360|NCT01575197|447791826|FG000|Overall Study|Migration out of study area|1|||
124502361|NCT01575197|447791827|FG001|Overall Study|Migration out of study area|5|||
124502362|NCT01575197|447791828|FG002|Overall Study|Migration out of study area|4|||
124502363|NCT01575197|447791826|FG000|Overall Study|SAE|0|||
124502364|NCT01575197|447791827|FG001|Overall Study|SAE|1|||
124502365|NCT01575197|447791828|FG002|Overall Study|SAE|0|||
124502366|NCT01575197|447791826|FG000|Overall Study|Lost to Follow-up|0|||
124502367|NCT01575197|447791827|FG001|Overall Study|Lost to Follow-up|1|||
124502368|NCT01575197|447791828|FG002|Overall Study|Lost to Follow-up|0|||
124502369|NCT01575197|447791826|FG000|Overall Study|Withdrawal by Subject|0|||
124502370|NCT01575197|447791827|FG001|Overall Study|Withdrawal by Subject|1|||
124502371|NCT01575197|447791828|FG002|Overall Study|Withdrawal by Subject|1|||
124502372|NCT01575197|447791826|FG000|Overall Study|Protocol Violation|2|||
124502373|NCT01575197|447791827|FG001|Overall Study|Protocol Violation|1|||
124502374|NCT01575197|447791828|FG002|Overall Study|Protocol Violation|1|||
124502375|NCT03303092|447791830|FG000|Overall Study|Adverse Event|1|||
124502376|NCT03303092|447791831|FG001|Overall Study|Adverse Event|0|||
124502377|NCT03303092|447791832|FG002|Overall Study|Adverse Event|1|||
124776267|NCT02745119|448808535|FG003|Overall Study|Protocol Deviation|1|||
124502378|NCT03303092|447791830|FG000|Overall Study|Protocol Violation|1|||
124502379|NCT03303092|447791831|FG001|Overall Study|Protocol Violation|5|||
124776268|NCT02745119|448808532|FG000|Overall Study|Withdrawal by Subject|7|||
124776269|NCT02745119|448808533|FG001|Overall Study|Withdrawal by Subject|15|||
124776270|NCT02745119|448808534|FG002|Overall Study|Withdrawal by Subject|8|||
124776271|NCT02745119|448808535|FG003|Overall Study|Withdrawal by Subject|14|||
124776272|NCT02745119|448808532|FG000|Overall Study|Study Terminated by Sponsor|134|||
124776273|NCT02745119|448808533|FG001|Overall Study|Study Terminated by Sponsor|252|||
124776274|NCT02745119|448808534|FG002|Overall Study|Study Terminated by Sponsor|135|||
124561258|NCT01580020|448011127|FG003|Overall Study|Lost to Follow-up|0|||
124561259|NCT01724359|448011128|FG000|Overall Study|Adverse Event|10|||
124561260|NCT01724359|448011128|FG000|Overall Study|Death|1|||
124561261|NCT01724359|448011128|FG000|Overall Study|Other|20|||
124561262|NCT00593333|448011138|FG000|Overall Study|Lost to Follow-up|10|||
124776275|NCT02745119|448808535|FG003|Overall Study|Study Terminated by Sponsor|251|||
124776276|NCT02745119|448808532|FG000|Overall Study|Physician Decision|0|||
124776277|NCT02745119|448808533|FG001|Overall Study|Physician Decision|2|||
124776278|NCT02745119|448808534|FG002|Overall Study|Physician Decision|2|||
124776279|NCT02745119|448808535|FG003|Overall Study|Physician Decision|2|||
124776280|NCT02745119|448808532|FG000|Overall Study|Reason Not Specified|0|||
124776281|NCT02745119|448808533|FG001|Overall Study|Reason Not Specified|2|||
124776282|NCT02745119|448808534|FG002|Overall Study|Reason Not Specified|0|||
124776283|NCT02745119|448808535|FG003|Overall Study|Reason Not Specified|1|||
124776284|NCT01587924|448808536|FG000|Overall Study|Adverse Event|0|||
124776285|NCT01587924|448808537|FG001|Overall Study|Adverse Event|2|||
124776286|NCT01587924|448808538|FG002|Overall Study|Adverse Event|0|||
124776287|NCT01587924|448808539|FG003|Overall Study|Adverse Event|0|||
124776288|NCT01587924|448808536|FG000|Overall Study|Protocol Violation|2|||
124776289|NCT01587924|448808537|FG001|Overall Study|Protocol Violation|1|||
124776290|NCT01587924|448808538|FG002|Overall Study|Protocol Violation|2|||
124776291|NCT01587924|448808539|FG003|Overall Study|Protocol Violation|1|||
124776292|NCT01587924|448808536|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
124776293|NCT01587924|448808537|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
124776294|NCT01587924|448808538|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
124776295|NCT01587924|448808539|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
124776296|NCT01587924|448808536|FG000|Overall Study|Withdrawal by Subject|0|||
124776297|NCT01587924|448808537|FG001|Overall Study|Withdrawal by Subject|1|||
124776298|NCT01587924|448808538|FG002|Overall Study|Withdrawal by Subject|1|||
124776299|NCT01587924|448808539|FG003|Overall Study|Withdrawal by Subject|0|||
124776300|NCT00432172|448808540|FG000|Overall Study|Physician Decision|0|||
124776301|NCT00432172|448808541|FG001|Overall Study|Physician Decision|0|||
124776302|NCT00432172|448808542|FG002|Overall Study|Physician Decision|2|||
124776303|NCT00432172|448808543|FG003|Overall Study|Physician Decision|0|||
124776304|NCT00432172|448808540|FG000|Overall Study|Adverse Event|4|||
124776305|NCT00432172|448808541|FG001|Overall Study|Adverse Event|2|||
124776306|NCT00432172|448808542|FG002|Overall Study|Adverse Event|4|||
124776307|NCT00432172|448808543|FG003|Overall Study|Adverse Event|3|||
124776308|NCT00432172|448808540|FG000|Overall Study|Disease progression|0|||
124776309|NCT00432172|448808541|FG001|Overall Study|Disease progression|2|||
124776310|NCT00432172|448808542|FG002|Overall Study|Disease progression|5|||
124776311|NCT00432172|448808543|FG003|Overall Study|Disease progression|1|||
124776312|NCT00432172|448808540|FG000|Overall Study|Withdrawal by Subject|0|||
124776313|NCT00432172|448808541|FG001|Overall Study|Withdrawal by Subject|1|||
124776314|NCT00432172|448808542|FG002|Overall Study|Withdrawal by Subject|0|||
124776315|NCT00432172|448808543|FG003|Overall Study|Withdrawal by Subject|2|||
124776316|NCT00432172|448808540|FG000|Overall Study|No treatment received|2|||
124776317|NCT00432172|448808541|FG001|Overall Study|No treatment received|2|||
124561263|NCT00593333|448011139|FG001|Overall Study|Lost to Follow-up|11|||
124561264|NCT01752920|448011140|FG000|Overall Study|Adverse Event|1|||
124561265|NCT01752920|448011141|FG001|Overall Study|Adverse Event|0|||
124561266|NCT01752920|448011142|FG002|Overall Study|Adverse Event|5|||
124561267|NCT01752920|448011143|FG003|Overall Study|Adverse Event|10|||
124776318|NCT00432172|448808542|FG002|Overall Study|No treatment received|0|||
124776319|NCT00432172|448808543|FG003|Overall Study|No treatment received|1|||
124776320|NCT01106248|448808545|FG000|Overall Study|Adverse Event|1|||
124776321|NCT01106248|448808545|FG000|Overall Study|Administrative|2|||
124776322|NCT00357903|448808546|FG000|Overall Study|Adverse Event|87|||
124776323|NCT00357903|448808547|FG001|Overall Study|Adverse Event|4|||
124776324|NCT00357903|448808546|FG000|Overall Study|Death|33|||
124776325|NCT00357903|448808547|FG001|Overall Study|Death|0|||
124776326|NCT00357903|448808546|FG000|Overall Study|Lost to Follow-up|23|||
124776327|NCT00357903|448808547|FG001|Overall Study|Lost to Follow-up|4|||
124776328|NCT00357903|448808546|FG000|Overall Study|Physician Decision|39|||
124776329|NCT00357903|448808547|FG001|Overall Study|Physician Decision|5|||
124776330|NCT00357903|448808546|FG000|Overall Study|Withdrawal by Subject|57|||
124776331|NCT00357903|448808547|FG001|Overall Study|Withdrawal by Subject|7|||
124776332|NCT00357903|448808546|FG000|Overall Study|Completed month 12 only|0|||
124561268|NCT01752920|448011140|FG000|Overall Study|Clinical Disease Progression|6|||
124561269|NCT01752920|448011141|FG001|Overall Study|Clinical Disease Progression|4|||
124776333|NCT00357903|448808547|FG001|Overall Study|Completed month 12 only|1|||
124502380|NCT03303092|447791832|FG002|Overall Study|Protocol Violation|1|||
124502381|NCT03303092|447791830|FG000|Overall Study|Withdrawal by Subject|1|||
124502382|NCT03303092|447791831|FG001|Overall Study|Withdrawal by Subject|1|||
124502383|NCT03303092|447791832|FG002|Overall Study|Withdrawal by Subject|3|||
124502384|NCT01995136|447791836|FG000|Overall Study|Change in residence|1|||
124502385|NCT01830543|447791839|FG000|Overall Study|Subject Decision|19|||
124502386|NCT01830543|447791840|FG001|Overall Study|Subject Decision|21|||
124502387|NCT01830543|447791841|FG002|Overall Study|Subject Decision|57|||
124502388|NCT01830543|447791839|FG000|Overall Study|Adverse Event|91|||
124502389|NCT01830543|447791840|FG001|Overall Study|Adverse Event|77|||
124502390|NCT01830543|447791841|FG002|Overall Study|Adverse Event|76|||
124502391|NCT01830543|447791839|FG000|Overall Study|Death|20|||
124502392|NCT01830543|447791840|FG001|Overall Study|Death|22|||
124502393|NCT01830543|447791841|FG002|Overall Study|Death|22|||
124502394|NCT01830543|447791839|FG000|Overall Study|Protocol Violation|3|||
124502395|NCT01830543|447791840|FG001|Overall Study|Protocol Violation|7|||
124502396|NCT01830543|447791841|FG002|Overall Study|Protocol Violation|7|||
124502397|NCT01830543|447791839|FG000|Overall Study|Physician Decision|11|||
124502398|NCT01830543|447791840|FG001|Overall Study|Physician Decision|5|||
124502399|NCT01830543|447791841|FG002|Overall Study|Physician Decision|12|||
124502400|NCT01830543|447791839|FG000|Overall Study|Withdrawal by consent|3|||
124502401|NCT01830543|447791840|FG001|Overall Study|Withdrawal by consent|3|||
124502402|NCT01830543|447791841|FG002|Overall Study|Withdrawal by consent|3|||
124502403|NCT01830543|447791839|FG000|Overall Study|Other|12|||
124502404|NCT01830543|447791840|FG001|Overall Study|Other|17|||
124502405|NCT01830543|447791841|FG002|Overall Study|Other|37|||
124502406|NCT03583372|447791842|FG000|Overall Study|Withdrawal by Subject|6|||
124502407|NCT03583372|447791843|FG001|Overall Study|Withdrawal by Subject|11|||
124502408|NCT03583372|447791844|FG002|Overall Study|Withdrawal by Subject|7|||
124502409|NCT03583372|447791845|FG003|Overall Study|Withdrawal by Subject|8|||
124502410|NCT03583372|447791842|FG000|Overall Study|Lost to Follow-up|4|||
124502411|NCT03583372|447791843|FG001|Overall Study|Lost to Follow-up|6|||
124502412|NCT03583372|447791844|FG002|Overall Study|Lost to Follow-up|3|||
124502413|NCT03583372|447791845|FG003|Overall Study|Lost to Follow-up|2|||
124502414|NCT03583372|447791842|FG000|Overall Study|Adverse Event|1|||
124502415|NCT03583372|447791843|FG001|Overall Study|Adverse Event|3|||
124502416|NCT03583372|447791844|FG002|Overall Study|Adverse Event|4|||
124502417|NCT03583372|447791845|FG003|Overall Study|Adverse Event|4|||
124502418|NCT03583372|447791842|FG000|Overall Study|Physician Decision|0|||
124502419|NCT03583372|447791843|FG001|Overall Study|Physician Decision|1|||
124502420|NCT03583372|447791844|FG002|Overall Study|Physician Decision|1|||
124502421|NCT03583372|447791845|FG003|Overall Study|Physician Decision|1|||
124502422|NCT03583372|447791842|FG000|Overall Study|Lack of Efficacy|0|||
124502423|NCT03583372|447791843|FG001|Overall Study|Lack of Efficacy|1|||
124502424|NCT03583372|447791844|FG002|Overall Study|Lack of Efficacy|0|||
124502425|NCT03583372|447791845|FG003|Overall Study|Lack of Efficacy|1|||
124502426|NCT03583372|447791842|FG000|Overall Study|Death|1|||
124502427|NCT03583372|447791843|FG001|Overall Study|Death|0|||
124502428|NCT03583372|447791844|FG002|Overall Study|Death|0|||
124502429|NCT03583372|447791845|FG003|Overall Study|Death|0|||
124502430|NCT03583372|447791842|FG000|Overall Study|Protocol Violation|0|||
124502431|NCT03583372|447791843|FG001|Overall Study|Protocol Violation|1|||
124502432|NCT03583372|447791844|FG002|Overall Study|Protocol Violation|0|||
124502433|NCT03583372|447791845|FG003|Overall Study|Protocol Violation|0|||
124502434|NCT03583372|447791842|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
124502435|NCT03583372|447791843|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
124502436|NCT03583372|447791844|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
124502437|NCT03583372|447791845|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
124502438|NCT03583372|447791842|FG000|Overall Study|Did Not Receive Study Drug|0|||
124502439|NCT03583372|447791843|FG001|Overall Study|Did Not Receive Study Drug|1|||
124502440|NCT03583372|447791844|FG002|Overall Study|Did Not Receive Study Drug|0|||
124502441|NCT03583372|447791845|FG003|Overall Study|Did Not Receive Study Drug|0|||
124502442|NCT03583372|447791842|FG000|Overall Study|Captured as Other in the Database|1|||
124502443|NCT03583372|447791843|FG001|Overall Study|Captured as Other in the Database|2|||
124502444|NCT03583372|447791844|FG002|Overall Study|Captured as Other in the Database|4|||
124502445|NCT03583372|447791845|FG003|Overall Study|Captured as Other in the Database|1|||
124502446|NCT02324842|447791846|FG000|Overall Study|Lost to Follow-up|1|||
124502447|NCT02324842|447791847|FG001|Overall Study|Lost to Follow-up|1|||
124502448|NCT02324842|447791848|FG002|Overall Study|Lost to Follow-up|2|||
124502449|NCT05142332|447791849|FG000|Overall Study|Withdrawal by Subject|0|||
124502450|NCT05142332|447791850|FG001|Overall Study|Withdrawal by Subject|1|||
124502451|NCT05142332|447791851|FG002|Overall Study|Withdrawal by Subject|2|||
124502452|NCT05142332|447791852|FG003|Overall Study|Withdrawal by Subject|0|||
124502453|NCT05142332|447791853|FG004|Overall Study|Withdrawal by Subject|0|||
124502454|NCT05142332|447791854|FG005|Overall Study|Withdrawal by Subject|2|||
124502455|NCT05142332|447791855|FG006|Overall Study|Withdrawal by Subject|6|||
124502456|NCT05142332|447791849|FG000|Overall Study|Left ED|3|||
124502457|NCT05142332|447791850|FG001|Overall Study|Left ED|0|||
124502458|NCT05142332|447791851|FG002|Overall Study|Left ED|4|||
124561270|NCT01752920|448011142|FG002|Overall Study|Clinical Disease Progression|1|||
124561271|NCT01752920|448011143|FG003|Overall Study|Clinical Disease Progression|13|||
124561272|NCT01752920|448011140|FG000|Overall Study|Physician Decision|1|||
124561273|NCT01752920|448011141|FG001|Overall Study|Physician Decision|0|||
124561274|NCT01752920|448011142|FG002|Overall Study|Physician Decision|0|||
124561275|NCT01752920|448011143|FG003|Overall Study|Physician Decision|3|||
124561276|NCT01752920|448011140|FG000|Overall Study|Radiographic Disease Progression|20|||
124561277|NCT01752920|448011141|FG001|Overall Study|Radiographic Disease Progression|7|||
124561278|NCT01752920|448011142|FG002|Overall Study|Radiographic Disease Progression|12|||
124561279|NCT01752920|448011143|FG003|Overall Study|Radiographic Disease Progression|29|||
124561280|NCT01752920|448011140|FG000|Overall Study|Study Terminated by Sponsor|0|||
124561281|NCT01752920|448011141|FG001|Overall Study|Study Terminated by Sponsor|0|||
124561282|NCT01752920|448011142|FG002|Overall Study|Study Terminated by Sponsor|0|||
124561283|NCT01752920|448011143|FG003|Overall Study|Study Terminated by Sponsor|1|||
124561284|NCT01752920|448011140|FG000|Overall Study|Withdrawal by Subject|0|||
124561285|NCT01752920|448011141|FG001|Overall Study|Withdrawal by Subject|1|||
124561286|NCT01752920|448011142|FG002|Overall Study|Withdrawal by Subject|0|||
124561287|NCT01752920|448011143|FG003|Overall Study|Withdrawal by Subject|1|||
124561288|NCT01752920|448011140|FG000|Overall Study|Lack of clinical benefit|1|||
124561289|NCT01752920|448011141|FG001|Overall Study|Lack of clinical benefit|1|||
124561290|NCT01752920|448011142|FG002|Overall Study|Lack of clinical benefit|1|||
124561291|NCT01752920|448011143|FG003|Overall Study|Lack of clinical benefit|1|||
124561292|NCT01738581|448011144|FG000|Overall Study|Lost to Follow-up|1|||
124561293|NCT01738581|448011145|FG001|Overall Study|Lost to Follow-up|0|||
124561294|NCT01186978|448011146|FG000|Overall Study|Withdrawal by Subject|1|||
124561295|NCT01709383|448011152|FG000|Overall Study|Lost to Follow-up|1|||
124561296|NCT01709383|448011153|FG001|Overall Study|Lost to Follow-up|0|||
124561297|NCT03264066|448011154|FG000|Overall Study|Adverse Event|1|||
124561298|NCT03264066|448011155|FG001|Overall Study|Adverse Event|1|||
124561299|NCT03264066|448011156|FG002|Overall Study|Adverse Event|0|||
124561300|NCT03264066|448011157|FG003|Overall Study|Adverse Event|0|||
124561301|NCT03264066|448011158|FG004|Overall Study|Adverse Event|0|||
124561302|NCT03264066|448011159|FG005|Overall Study|Adverse Event|0|||
124561303|NCT03264066|448011154|FG000|Overall Study|Death|12|||
124561304|NCT03264066|448011155|FG001|Overall Study|Death|12|||
124561305|NCT03264066|448011156|FG002|Overall Study|Death|8|||
124561306|NCT03264066|448011157|FG003|Overall Study|Death|10|||
124561307|NCT03264066|448011158|FG004|Overall Study|Death|6|||
124561308|NCT03264066|448011159|FG005|Overall Study|Death|1|||
124561309|NCT03264066|448011154|FG000|Overall Study|Lost to Follow-up|1|||
124561310|NCT03264066|448011155|FG001|Overall Study|Lost to Follow-up|0|||
124561311|NCT03264066|448011156|FG002|Overall Study|Lost to Follow-up|0|||
124561312|NCT03264066|448011157|FG003|Overall Study|Lost to Follow-up|0|||
124561313|NCT03264066|448011158|FG004|Overall Study|Lost to Follow-up|0|||
124561314|NCT03264066|448011159|FG005|Overall Study|Lost to Follow-up|0|||
124561315|NCT03264066|448011154|FG000|Overall Study|Progressive Disease|0|||
124561316|NCT03264066|448011155|FG001|Overall Study|Progressive Disease|2|||
124561317|NCT03264066|448011156|FG002|Overall Study|Progressive Disease|1|||
124561318|NCT03264066|448011157|FG003|Overall Study|Progressive Disease|0|||
124561319|NCT03264066|448011158|FG004|Overall Study|Progressive Disease|0|||
124561320|NCT03264066|448011159|FG005|Overall Study|Progressive Disease|0|||
124561321|NCT03264066|448011154|FG000|Overall Study|Study Terminated by Sponsor|5|||
124561322|NCT03264066|448011155|FG001|Overall Study|Study Terminated by Sponsor|5|||
124561323|NCT03264066|448011156|FG002|Overall Study|Study Terminated by Sponsor|8|||
124561324|NCT03264066|448011157|FG003|Overall Study|Study Terminated by Sponsor|5|||
124561325|NCT03264066|448011158|FG004|Overall Study|Study Terminated by Sponsor|1|||
124561326|NCT03264066|448011159|FG005|Overall Study|Study Terminated by Sponsor|2|||
124561327|NCT03264066|448011154|FG000|Overall Study|Withdrawal by Subject|1|||
124561328|NCT03264066|448011155|FG001|Overall Study|Withdrawal by Subject|0|||
124561329|NCT03264066|448011156|FG002|Overall Study|Withdrawal by Subject|0|||
124561330|NCT03264066|448011157|FG003|Overall Study|Withdrawal by Subject|5|||
124561331|NCT03264066|448011158|FG004|Overall Study|Withdrawal by Subject|0|||
124561332|NCT03264066|448011159|FG005|Overall Study|Withdrawal by Subject|0|||
124561333|NCT00926289|448011160|FG000|Overall Study|Adverse Event|9|||
124776334|NCT00357903|448808546|FG000|Overall Study|Protocol issues|14|||
124561334|NCT00926289|448011161|FG001|Overall Study|Adverse Event|11|||
124561335|NCT00926289|448011160|FG000|Overall Study|Protocol Violation|8|||
124561336|NCT00926289|448011161|FG001|Overall Study|Protocol Violation|12|||
124776335|NCT00357903|448808547|FG001|Overall Study|Protocol issues|3|||
124776336|NCT00357903|448808546|FG000|Overall Study|Response status|61|||
124561337|NCT00926289|448011160|FG000|Overall Study|Lost to Follow-up|3|||
124776337|NCT00357903|448808547|FG001|Overall Study|Response status|9|||
124561338|NCT00926289|448011161|FG001|Overall Study|Lost to Follow-up|6|||
124561339|NCT00926289|448011160|FG000|Overall Study|Withdrawal by Subject|4|||
124561340|NCT00926289|448011161|FG001|Overall Study|Withdrawal by Subject|4|||
124561341|NCT00926289|448011160|FG000|Overall Study|Other|1|||
124561342|NCT00926289|448011161|FG001|Overall Study|Other|3|||
124561343|NCT02115256|448011165|FG000|Overall Study|Withdrawal by Subject|0|||
124776338|NCT00357903|448808546|FG000|Overall Study|Other|49|||
124561344|NCT02115256|448011166|FG001|Overall Study|Withdrawal by Subject|1|||
124561345|NCT02668302|448011168|FG000|Overall Study|Withdrawal by Subject|1|||
124561346|NCT02668302|448011169|FG001|Overall Study|Withdrawal by Subject|0|||
124561347|NCT01078090|448011170|FG000|Overall Study|Lost to Follow-up|2363|||
124561348|NCT01078090|448011170|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
124561349|NCT01078090|448011170|FG000|Overall Study|Lack of Efficacy|1193|||
124561350|NCT01078090|448011170|FG000|Overall Study|ADR and lack of efficacy|61|||
124561351|NCT01078090|448011170|FG000|Overall Study|Other|523|||
124561352|NCT03529955|448011171|FG000|Overall Study|Adverse Event|1|||
124561353|NCT03529955|448011171|FG000|Overall Study|Lack of Efficacy|1|||
124561354|NCT00580983|448011172|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
124561355|NCT03740100|448011173|FG000|Overall Study|Adverse Event|1|||
124561356|NCT03740100|448011173|FG000|Overall Study|Death|1|||
124561357|NCT03387059|448011175|FG000|Overall Study|Study termination|5|||
124561358|NCT03387059|448011176|FG001|Overall Study|Study termination|4|||
124561359|NCT02468557|448012799|FG000|Overall Study|Adverse Event|1|||
124561360|NCT02468557|448012799|FG000|Overall Study|Death|1|||
124561361|NCT02468557|448012799|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
124561362|NCT02468557|448012799|FG000|Overall Study|All Enrolled but Never Dosed|4|||
124561363|NCT00982410|448012800|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
124561364|NCT00982410|448012801|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
124561365|NCT00982410|448012800|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
124561366|NCT00982410|448012801|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
124561367|NCT00982410|448012800|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
124561368|NCT00982410|448012801|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
124561369|NCT00982410|448012800|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
124561370|NCT00982410|448012801|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
124561371|NCT00982410|448012800|FG000|6-month Follow-up Assessment|participant no transportation|1|||
124561372|NCT00982410|448012801|FG001|6-month Follow-up Assessment|participant no transportation|0|||
124561373|NCT00982410|448012800|FG000|6-month Follow-up Assessment|incarceration|0|||
124561374|NCT00982410|448012801|FG001|6-month Follow-up Assessment|incarceration|2|||
124561375|NCT00982410|448012800|FG000|6-month Follow-up Assessment|patent surgery|0|||
124561376|NCT00982410|448012801|FG001|6-month Follow-up Assessment|patent surgery|1|||
124561377|NCT00982410|448012800|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
124561378|NCT00982410|448012801|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
124561379|NCT00982410|448012800|FG000|12-month Follow-up Assessment|Death|0|||
124561380|NCT00982410|448012801|FG001|12-month Follow-up Assessment|Death|2|||
124561381|NCT00982410|448012800|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
124561382|NCT00982410|448012801|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
124561383|NCT00982410|448012800|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
124561384|NCT00982410|448012801|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
124561385|NCT00982410|448012800|FG000|12-month Follow-up Assessment|incarceration|2|||
124561386|NCT00982410|448012801|FG001|12-month Follow-up Assessment|incarceration|1|||
124561387|NCT00982410|448012800|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
124561388|NCT00982410|448012801|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
124561389|NCT04014959|448012805|FG000|Baseline MRI and Assessments|Physician Decision|2|||
124561390|NCT04014959|448012805|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
124561391|NCT04014959|448012805|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
124561392|NCT02034799|448012809|FG000|Overall Study|Withdrawal by Subject|0|||
124561393|NCT02034799|448012810|FG001|Overall Study|Withdrawal by Subject|2|||
124561394|NCT02034799|448012809|FG000|Overall Study|Lost to Follow-up|0|||
124561395|NCT02034799|448012810|FG001|Overall Study|Lost to Follow-up|1|||
124561396|NCT02034799|448012809|FG000|Overall Study|Death|2|||
124561397|NCT02034799|448012810|FG001|Overall Study|Death|1|||
124561398|NCT02806232|448012819|FG000|Overall Study|Lost to Follow-up|1|||
124561399|NCT02806232|448012820|FG001|Overall Study|Lost to Follow-up|2|||
124561400|NCT02806232|448012821|FG002|Overall Study|Lost to Follow-up|1|||
124561401|NCT02806232|448012822|FG003|Overall Study|Lost to Follow-up|0|||
124561402|NCT02806232|448012823|FG004|Overall Study|Lost to Follow-up|0|||
124561403|NCT02806232|448012824|FG005|Overall Study|Lost to Follow-up|1|||
124561404|NCT02806232|448012825|FG006|Overall Study|Lost to Follow-up|0|||
124561405|NCT02806232|448012826|FG007|Overall Study|Lost to Follow-up|0|||
124561406|NCT02806232|448012827|FG008|Overall Study|Lost to Follow-up|0|||
124561407|NCT02806232|448012819|FG000|Overall Study|Withdrawal by Subject|0|||
124561408|NCT02806232|448012820|FG001|Overall Study|Withdrawal by Subject|2|||
124561409|NCT02806232|448012821|FG002|Overall Study|Withdrawal by Subject|0|||
124561410|NCT02806232|448012822|FG003|Overall Study|Withdrawal by Subject|0|||
124561411|NCT02806232|448012823|FG004|Overall Study|Withdrawal by Subject|2|||
124561412|NCT02806232|448012824|FG005|Overall Study|Withdrawal by Subject|1|||
124561413|NCT02806232|448012825|FG006|Overall Study|Withdrawal by Subject|0|||
124561414|NCT02806232|448012826|FG007|Overall Study|Withdrawal by Subject|0|||
124561415|NCT02806232|448012827|FG008|Overall Study|Withdrawal by Subject|0|||
124561416|NCT00434161|448012828|FG000|Overall Study|Adverse Event|5|||
124561417|NCT00434161|448012829|FG001|Overall Study|Adverse Event|1|||
124502459|NCT05142332|447791852|FG003|Overall Study|Left ED|6|||
124502460|NCT05142332|447791853|FG004|Overall Study|Left ED|1|||
124502461|NCT05142332|447791854|FG005|Overall Study|Left ED|2|||
124502462|NCT05142332|447791855|FG006|Overall Study|Left ED|6|||
124502463|NCT05142332|447791849|FG000|Overall Study|Physician Decision|0|||
124502464|NCT05142332|447791850|FG001|Overall Study|Physician Decision|0|||
124502465|NCT05142332|447791851|FG002|Overall Study|Physician Decision|2|||
124502466|NCT05142332|447791852|FG003|Overall Study|Physician Decision|1|||
124502467|NCT05142332|447791853|FG004|Overall Study|Physician Decision|0|||
124502468|NCT05142332|447791854|FG005|Overall Study|Physician Decision|0|||
124502469|NCT05142332|447791855|FG006|Overall Study|Physician Decision|3|||
124502470|NCT05142332|447791849|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
124502471|NCT05142332|447791850|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
124502472|NCT05142332|447791851|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
124502473|NCT05142332|447791852|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
124502474|NCT05142332|447791853|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
124502475|NCT05142332|447791854|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
124502476|NCT05142332|447791855|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
124502477|NCT01409031|447791856|FG000|Overall Study|transferred to other hosp|1|||
124502478|NCT01409031|447791857|FG001|Overall Study|transferred to other hosp|0|||
124502479|NCT05122650|447791858|FG000|Overall Study|Adverse Event|4|||
124502480|NCT05122650|447791859|FG001|Overall Study|Adverse Event|16|||
124502481|NCT05122650|447791860|FG002|Overall Study|Adverse Event|11|||
124502482|NCT05122650|447791861|FG003|Overall Study|Adverse Event|12|||
124502483|NCT05122650|447791858|FG000|Overall Study|Lack of Efficacy|0|||
124502484|NCT05122650|447791859|FG001|Overall Study|Lack of Efficacy|1|||
124502485|NCT05122650|447791860|FG002|Overall Study|Lack of Efficacy|1|||
124502486|NCT05122650|447791861|FG003|Overall Study|Lack of Efficacy|2|||
124502487|NCT05122650|447791858|FG000|Overall Study|Lost to Follow-up|1|||
124502488|NCT05122650|447791859|FG001|Overall Study|Lost to Follow-up|1|||
124502489|NCT05122650|447791860|FG002|Overall Study|Lost to Follow-up|3|||
124502490|NCT05122650|447791861|FG003|Overall Study|Lost to Follow-up|0|||
124502491|NCT05122650|447791858|FG000|Overall Study|Non-compliance with study intervention|0|||
124502492|NCT05122650|447791859|FG001|Overall Study|Non-compliance with study intervention|0|||
124502493|NCT05122650|447791860|FG002|Overall Study|Non-compliance with study intervention|0|||
124502494|NCT05122650|447791861|FG003|Overall Study|Non-compliance with study intervention|2|||
124502495|NCT05122650|447791858|FG000|Overall Study|Protocol Violation|0|||
124502496|NCT05122650|447791859|FG001|Overall Study|Protocol Violation|1|||
124502497|NCT05122650|447791860|FG002|Overall Study|Protocol Violation|0|||
124502498|NCT05122650|447791861|FG003|Overall Study|Protocol Violation|1|||
124502499|NCT05122650|447791858|FG000|Overall Study|Randomized by mistake|0|||
124502500|NCT05122650|447791859|FG001|Overall Study|Randomized by mistake|0|||
124502501|NCT05122650|447791860|FG002|Overall Study|Randomized by mistake|3|||
124502502|NCT05122650|447791861|FG003|Overall Study|Randomized by mistake|2|||
124502503|NCT05122650|447791858|FG000|Overall Study|Sponsor request|0|||
124502504|NCT05122650|447791859|FG001|Overall Study|Sponsor request|1|||
124502505|NCT05122650|447791860|FG002|Overall Study|Sponsor request|1|||
124502506|NCT05122650|447791861|FG003|Overall Study|Sponsor request|2|||
124502507|NCT05122650|447791858|FG000|Overall Study|Withdrawal by Subject|3|||
124502508|NCT05122650|447791859|FG001|Overall Study|Withdrawal by Subject|7|||
124502509|NCT05122650|447791860|FG002|Overall Study|Withdrawal by Subject|4|||
124502510|NCT05122650|447791861|FG003|Overall Study|Withdrawal by Subject|8|||
124502511|NCT05122650|447791858|FG000|Overall Study|Other|5|||
124502512|NCT05122650|447791859|FG001|Overall Study|Other|0|||
124502513|NCT05122650|447791860|FG002|Overall Study|Other|0|||
124502514|NCT05122650|447791861|FG003|Overall Study|Other|0|||
124502515|NCT01689207|447791866|FG000|Overall Study|Adverse Event|0|||
124502516|NCT01689207|447791867|FG001|Overall Study|Adverse Event|1|||
124502517|NCT01689207|447791868|FG002|Overall Study|Adverse Event|0|||
124502518|NCT01689207|447791869|FG003|Overall Study|Adverse Event|0|||
124502519|NCT01689207|447791870|FG004|Overall Study|Adverse Event|2|||
124502520|NCT01689207|447791871|FG005|Overall Study|Adverse Event|1|||
124502521|NCT01689207|447791872|FG006|Overall Study|Adverse Event|0|||
124502522|NCT01689207|447791873|FG007|Overall Study|Adverse Event|0|||
124502523|NCT01689207|447791874|FG008|Overall Study|Adverse Event|1|||
124502524|NCT01689207|447791875|FG009|Overall Study|Adverse Event|0|||
124502525|NCT01689207|447791876|FG010|Overall Study|Adverse Event|0|||
124502526|NCT01423617|447791880|FG000|Overall Study|Lost to Follow-up|0|||
124502527|NCT01423617|447791881|FG001|Overall Study|Lost to Follow-up|1|||
124502528|NCT01515306|447791882|FG000|Overall Study|Adverse Event|3|||
124502529|NCT01515306|447791883|FG001|Overall Study|Adverse Event|2|||
124502530|NCT01515306|447791882|FG000|Overall Study|Progressive Disease|19|||
124502531|NCT01515306|447791883|FG001|Overall Study|Progressive Disease|9|||
124502532|NCT01515306|447791882|FG000|Overall Study|Withdrawal by Subject|1|||
124502533|NCT01515306|447791883|FG001|Overall Study|Withdrawal by Subject|2|||
124502534|NCT01515306|447791882|FG000|Overall Study|Physician Decision|1|||
124502535|NCT01515306|447791883|FG001|Overall Study|Physician Decision|1|||
124561418|NCT00434161|448012830|FG002|Overall Study|Adverse Event|4|||
124561419|NCT00434161|448012828|FG000|Overall Study|Lost to Follow-up|0|||
124561420|NCT00434161|448012829|FG001|Overall Study|Lost to Follow-up|1|||
124561421|NCT00434161|448012830|FG002|Overall Study|Lost to Follow-up|0|||
124561422|NCT00434161|448012828|FG000|Overall Study|Death|1|||
124561423|NCT00434161|448012829|FG001|Overall Study|Death|0|||
124561424|NCT00434161|448012830|FG002|Overall Study|Death|1|||
124561425|NCT00434161|448012828|FG000|Overall Study|Non-Compliance|1|||
124561426|NCT00434161|448012829|FG001|Overall Study|Non-Compliance|1|||
124561427|NCT00434161|448012830|FG002|Overall Study|Non-Compliance|0|||
124561428|NCT00434161|448012828|FG000|Overall Study|Withdrawal by Subject|2|||
124561429|NCT00434161|448012829|FG001|Overall Study|Withdrawal by Subject|0|||
124561430|NCT00434161|448012830|FG002|Overall Study|Withdrawal by Subject|3|||
124561431|NCT00434161|448012828|FG000|Overall Study|Logistical error study assessments|1|||
124561432|NCT00434161|448012829|FG001|Overall Study|Logistical error study assessments|0|||
124561433|NCT00434161|448012830|FG002|Overall Study|Logistical error study assessments|3|||
124561434|NCT01387282|448012831|FG000|Overall Study|Death|47|||
124561435|NCT01387282|448012832|FG001|Overall Study|Death|16|||
124561436|NCT01387282|448012831|FG000|Overall Study|Other|5|||
124561437|NCT01387282|448012832|FG001|Overall Study|Other|1|||
124561438|NCT01387282|448012831|FG000|Overall Study|Unrelated AE|6|||
124561439|NCT01387282|448012832|FG001|Overall Study|Unrelated AE|4|||
124561440|NCT01387282|448012831|FG000|Overall Study|Withdrawal by patient|33|||
124561441|NCT01387282|448012832|FG001|Overall Study|Withdrawal by patient|23|||
124561442|NCT01387282|448012831|FG000|Overall Study|Study drug-related AE|2|||
124561443|NCT01387282|448012832|FG001|Overall Study|Study drug-related AE|2|||
124561444|NCT01387282|448012831|FG000|Overall Study|Lost to Follow-up|4|||
124561445|NCT01387282|448012832|FG001|Overall Study|Lost to Follow-up|1|||
124561446|NCT01267266|448012833|FG000|Enrollment Phase|Withdrawal by Subject|2|||
124561447|NCT01267266|448012834|FG001|Enrollment Phase|Withdrawal by Subject|0|||
124561448|NCT01267266|448012833|FG000|Lead-in Phase|Lack of Efficacy|20|||
124561449|NCT01267266|448012834|FG001|Lead-in Phase|Lack of Efficacy|0|||
124561450|NCT01267266|448012833|FG000|Lead-in Phase|Adverse Event|2|||
124561451|NCT01267266|448012834|FG001|Lead-in Phase|Adverse Event|0|||
124561452|NCT01267266|448012833|FG000|Lead-in Phase|Withdrawal by Subject|1|||
124561453|NCT01267266|448012834|FG001|Lead-in Phase|Withdrawal by Subject|0|||
124561454|NCT02497391|448012835|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
124561455|NCT02497391|448012836|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
124561456|NCT02497391|448012837|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
124561457|NCT02497391|448012838|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
124561458|NCT02497391|448012839|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
124561459|NCT02497391|448012840|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
124561460|NCT02497391|448012835|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
124561461|NCT02497391|448012836|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
124561462|NCT02497391|448012837|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
124561463|NCT02497391|448012838|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
124561464|NCT02497391|448012839|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
124561465|NCT02497391|448012840|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
124561466|NCT02497391|448012835|FG000|Period 3 (14 Days)|Adverse Event|0|||
124561467|NCT02497391|448012836|FG001|Period 3 (14 Days)|Adverse Event|1|||
124561468|NCT02497391|448012837|FG002|Period 3 (14 Days)|Adverse Event|0|||
124561469|NCT02497391|448012838|FG003|Period 3 (14 Days)|Adverse Event|0|||
124561470|NCT02497391|448012839|FG004|Period 3 (14 Days)|Adverse Event|0|||
124561471|NCT02497391|448012840|FG005|Period 3 (14 Days)|Adverse Event|0|||
124561472|NCT02497391|448012835|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
124561473|NCT02497391|448012836|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
124561474|NCT02497391|448012837|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
124561475|NCT02497391|448012838|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
124502536|NCT00634244|447791887|FG000|Overall Study|Never started treatment|0|||
124502537|NCT00634244|447791888|FG001|Overall Study|Never started treatment|1|||
124502538|NCT00634244|447791889|FG002|Overall Study|Never started treatment|0|||
124502539|NCT00634244|447791887|FG000|Overall Study|Death|1|||
124502540|NCT00634244|447791888|FG001|Overall Study|Death|6|||
124502541|NCT00634244|447791889|FG002|Overall Study|Death|0|||
124502542|NCT00634244|447791887|FG000|Overall Study|Adverse Event|0|||
124502543|NCT00634244|447791888|FG001|Overall Study|Adverse Event|2|||
124502544|NCT00634244|447791889|FG002|Overall Study|Adverse Event|0|||
124502545|NCT00634244|447791887|FG000|Overall Study|Withdrawal by Subject|0|||
124776339|NCT00357903|448808547|FG001|Overall Study|Other|10|||
124561476|NCT02497391|448012839|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
124561477|NCT02497391|448012840|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
124561478|NCT02497391|448012835|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
124561479|NCT02497391|448012836|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
124561480|NCT02497391|448012837|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
124561481|NCT02497391|448012838|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
124561482|NCT02497391|448012839|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
124561483|NCT02497391|448012840|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
124561484|NCT00658320|448012850|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
124724829|NCT01700959|448611827|FG005|Overall Study|Ineligible|1|||
124502546|NCT00634244|447791888|FG001|Overall Study|Withdrawal by Subject|1|||
124502547|NCT00634244|447791889|FG002|Overall Study|Withdrawal by Subject|0|||
124502548|NCT00634244|447791887|FG000|Overall Study|Physician Decision|0|||
124502549|NCT00634244|447791888|FG001|Overall Study|Physician Decision|1|||
124502550|NCT00634244|447791889|FG002|Overall Study|Physician Decision|0|||
124502551|NCT00634244|447791887|FG000|Overall Study|Disease progression/relapse|0|||
124502552|NCT00634244|447791888|FG001|Overall Study|Disease progression/relapse|1|||
124502553|NCT00634244|447791889|FG002|Overall Study|Disease progression/relapse|0|||
124502554|NCT00634244|447791887|FG000|Overall Study|Other complicating disease|0|||
124502555|NCT00634244|447791888|FG001|Overall Study|Other complicating disease|1|||
124502556|NCT00634244|447791889|FG002|Overall Study|Other complicating disease|0|||
124502557|NCT03201198|447791890|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
124502558|NCT03201198|447791891|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
124502559|NCT03201198|447791890|FG000|Overall Study|Withdrawal by Subject|2|||
124502560|NCT03201198|447791891|FG001|Overall Study|Withdrawal by Subject|3|||
124502561|NCT03855137|447791892|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
124502562|NCT03855137|447791893|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
124502563|NCT03855137|447791894|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
124502564|NCT03855137|447791892|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
124502565|NCT03855137|447791893|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
124502566|NCT03855137|447791894|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
124502567|NCT03855137|447791892|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
124502568|NCT03855137|447791893|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
124502569|NCT03855137|447791894|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
124502570|NCT03855137|447791892|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
124502571|NCT03855137|447791893|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
124502572|NCT03855137|447791894|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
124502573|NCT03855137|447791892|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
124502574|NCT03855137|447791893|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
124502575|NCT03855137|447791894|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
124502576|NCT03855137|447791892|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
124502577|NCT03855137|447791893|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
124502578|NCT03855137|447791894|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
124502579|NCT03855137|447791892|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
124502580|NCT03855137|447791893|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
124502581|NCT03855137|447791894|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
124502582|NCT03855137|447791892|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
124502583|NCT03855137|447791893|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
124502584|NCT03855137|447791894|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
124502585|NCT03855137|447791892|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
124502586|NCT03855137|447791893|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
124502587|NCT03855137|447791894|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
124502588|NCT03855137|447791892|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
124502589|NCT03855137|447791893|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
124502590|NCT03855137|447791894|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
124502591|NCT02427477|447791897|FG000|Period 1|Adverse Event|1|||
124502592|NCT02427477|447791898|FG001|Period 1|Adverse Event|0|||
124502593|NCT04369430|447791903|FG000|Overall Study|Adverse Event|2|||
124502594|NCT04369430|447791904|FG001|Overall Study|Adverse Event|3|||
124502595|NCT04369430|447791903|FG000|Overall Study|Death|1|||
124502596|NCT04369430|447791904|FG001|Overall Study|Death|0|||
124502597|NCT04369430|447791903|FG000|Overall Study|Withdrawal by Subject|4|||
124502598|NCT04369430|447791904|FG001|Overall Study|Withdrawal by Subject|3|||
124502599|NCT04369430|447791903|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
124502600|NCT04369430|447791904|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
124502601|NCT04369430|447791903|FG000|Overall Study|Lost to Follow-up|0|||
124502602|NCT04369430|447791904|FG001|Overall Study|Lost to Follow-up|1|||
124502603|NCT02435277|447791905|FG000|Overall Study|Adverse Event|1|||
124502604|NCT02435277|447791906|FG001|Overall Study|Adverse Event|1|||
124502605|NCT02435277|447791907|FG002|Overall Study|Adverse Event|0|||
124502606|NCT02435277|447791908|FG003|Overall Study|Adverse Event|0|||
124502607|NCT02435277|447791905|FG000|Overall Study|Withdrawal by Subject|1|||
124502608|NCT02435277|447791906|FG001|Overall Study|Withdrawal by Subject|0|||
124502609|NCT02435277|447791907|FG002|Overall Study|Withdrawal by Subject|0|||
124502610|NCT02435277|447791908|FG003|Overall Study|Withdrawal by Subject|0|||
124502611|NCT02635737|447791915|FG000|Overall Study|Protocol Violation|1|||
124502612|NCT00937768|447791916|FG000|Overall Study|Refused Further Treatment|3|||
124502613|NCT00937768|447791917|FG001|Overall Study|Refused Further Treatment|2|||
124561485|NCT00658320|448012851|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
124724830|NCT01700959|448611822|FG000|Overall Study|Noncompliant|9|||
124776340|NCT00606593|448808548|FG000|Overall Study|Adverse Event|0|||
124776341|NCT00606593|448808549|FG001|Overall Study|Adverse Event|0|||
124776342|NCT00606593|448808550|FG002|Overall Study|Adverse Event|0|||
124776343|NCT00606593|448808551|FG003|Overall Study|Adverse Event|1|||
124776344|NCT00606593|448808552|FG004|Overall Study|Adverse Event|1|||
124776345|NCT00606593|448808553|FG005|Overall Study|Adverse Event|0|||
124776346|NCT00606593|448808554|FG006|Overall Study|Adverse Event|1|||
124776347|NCT00606593|448808555|FG007|Overall Study|Adverse Event|2|||
124776348|NCT00606593|448808556|FG008|Overall Study|Adverse Event|1|||
124776349|NCT00606593|448808557|FG009|Overall Study|Adverse Event|0|||
124776350|NCT00606593|448808548|FG000|Overall Study|Withdrawal of consent|1|||
124776351|NCT00606593|448808549|FG001|Overall Study|Withdrawal of consent|0|||
124776352|NCT00606593|448808550|FG002|Overall Study|Withdrawal of consent|1|||
124776353|NCT00606593|448808551|FG003|Overall Study|Withdrawal of consent|0|||
124776354|NCT00606593|448808552|FG004|Overall Study|Withdrawal of consent|0|||
124776355|NCT00606593|448808553|FG005|Overall Study|Withdrawal of consent|0|||
124776356|NCT00606593|448808554|FG006|Overall Study|Withdrawal of consent|0|||
124776357|NCT00606593|448808555|FG007|Overall Study|Withdrawal of consent|0|||
124776358|NCT00606593|448808556|FG008|Overall Study|Withdrawal of consent|0|||
124776359|NCT00606593|448808557|FG009|Overall Study|Withdrawal of consent|0|||
124776360|NCT00606593|448808548|FG000|Overall Study|Administrative/Other|0|||
124776361|NCT00606593|448808549|FG001|Overall Study|Administrative/Other|0|||
124776362|NCT00606593|448808550|FG002|Overall Study|Administrative/Other|1|||
124776363|NCT00606593|448808551|FG003|Overall Study|Administrative/Other|0|||
124776364|NCT00606593|448808552|FG004|Overall Study|Administrative/Other|0|||
124776365|NCT00606593|448808553|FG005|Overall Study|Administrative/Other|0|||
124776366|NCT00606593|448808554|FG006|Overall Study|Administrative/Other|0|||
124776367|NCT00606593|448808555|FG007|Overall Study|Administrative/Other|0|||
124776368|NCT00606593|448808556|FG008|Overall Study|Administrative/Other|0|||
124776369|NCT00606593|448808557|FG009|Overall Study|Administrative/Other|0|||
124776370|NCT03181529|448808560|FG000|Overall Study|Withdrawal by Subject|1|||
124776371|NCT03181529|448808561|FG001|Overall Study|Withdrawal by Subject|1|||
124776372|NCT03181529|448808560|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
124776373|NCT03181529|448808561|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
124776374|NCT06042855|448808568|FG000|Overall Study|No Receipt of Study Drug|48|||
124776375|NCT06042855|448808569|FG001|Overall Study|No Receipt of Study Drug|57|||
124776376|NCT06042855|448808568|FG000|Overall Study|Administratively Withdrawn|59|||
124776377|NCT06042855|448808569|FG001|Overall Study|Administratively Withdrawn|59|||
124776378|NCT03313037|448808570|FG000|Overall Study|Protocol Violation|4|||
124776379|NCT03313037|448808571|FG001|Overall Study|Protocol Violation|1|||
124776380|NCT03313037|448808570|FG000|Overall Study|Other|1|||
124776381|NCT03313037|448808571|FG001|Overall Study|Other|1|||
124776382|NCT03313037|448808570|FG000|Overall Study|Withdrawal by Subject|4|||
124776383|NCT03313037|448808571|FG001|Overall Study|Withdrawal by Subject|3|||
124776384|NCT03313037|448808570|FG000|Overall Study|No longer meets eligibility criteria|1|||
124776385|NCT03313037|448808571|FG001|Overall Study|No longer meets eligibility criteria|7|||
124776386|NCT03313037|448808570|FG000|Overall Study|Lost to Follow-up|9|||
124776387|NCT03313037|448808571|FG001|Overall Study|Lost to Follow-up|8|||
124776388|NCT03313037|448808570|FG000|Overall Study|Randomized but not treated|1|||
124776389|NCT03313037|448808571|FG001|Overall Study|Randomized but not treated|0|||
124776390|NCT00525161|448808578|FG000|Overall Study|Adverse Event|1|||
124776391|NCT02447003|448808579|FG000|Overall Study|Other|0|||
124776392|NCT02447003|448808580|FG001|Overall Study|Other|4|||
124776393|NCT02447003|448808579|FG000|Overall Study|Site discontinued|0|||
124776394|NCT02447003|448808580|FG001|Overall Study|Site discontinued|2|||
124776395|NCT02447003|448808579|FG000|Overall Study|Physician Decision|0|||
124776396|NCT02447003|448808580|FG001|Overall Study|Physician Decision|1|||
124776397|NCT02447003|448808579|FG000|Overall Study|Withdrawal by Subject|4|||
124776398|NCT02447003|448808580|FG001|Overall Study|Withdrawal by Subject|3|||
124776399|NCT02447003|448808579|FG000|Overall Study|Sponsor Decision|6|||
124776400|NCT02447003|448808580|FG001|Overall Study|Sponsor Decision|11|||
124776401|NCT02447003|448808579|FG000|Overall Study|Progressive Disease|1|||
124776402|NCT02447003|448808580|FG001|Overall Study|Progressive Disease|0|||
124776403|NCT02447003|448808579|FG000|Overall Study|Lost to Follow-up|5|||
124776404|NCT02447003|448808580|FG001|Overall Study|Lost to Follow-up|0|||
124776405|NCT02447003|448808579|FG000|Overall Study|Death|154|||
124776406|NCT02447003|448808580|FG001|Overall Study|Death|63|||
124776407|NCT03848728|448808581|FG000|Overall Study|Death|16|||
124776408|NCT03848728|448808582|FG001|Overall Study|Death|13|||
124776409|NCT03848728|448808581|FG000|Overall Study|Outmigrated to non-study community|98|||
124776410|NCT03848728|448808582|FG001|Overall Study|Outmigrated to non-study community|106|||
124776411|NCT03848728|448808581|FG000|Overall Study|Transfered to non-study clinic|32|||
124776412|NCT03848728|448808582|FG001|Overall Study|Transfered to non-study clinic|48|||
124776413|NCT03848728|448808581|FG000|Overall Study|Withdrawal by Subject|1|||
124776414|NCT03848728|448808582|FG001|Overall Study|Withdrawal by Subject|0|||
124776415|NCT04161157|448808583|FG000|Overall Study|Lost to Follow-up|4|||
124561486|NCT00658320|448012850|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
124776416|NCT04161157|448808583|FG000|Overall Study|Death|3|||
124776417|NCT04161157|448808583|FG000|Overall Study|Ineligible|2|||
124776418|NCT04161157|448808583|FG000|Overall Study|Withdrawal by Subject|4|||
124776419|NCT01108185|448808584|FG000|Overall Study|Non-compliance|15|||
124776420|NCT01108185|448808584|FG000|Overall Study|Lost to Follow-up|12|||
124776421|NCT02581410|448808585|FG000|Vaccination Phase|Adverse Event|2|||
124776422|NCT02581410|448808586|FG001|Vaccination Phase|Adverse Event|1|||
124776423|NCT02581410|448808585|FG000|Vaccination Phase|Withdrawal by Subject|0|||
124776424|NCT02581410|448808586|FG001|Vaccination Phase|Withdrawal by Subject|1|||
124776425|NCT02581410|448808585|FG000|Vaccination Phase|Migrated/moved from study area|0|||
124776426|NCT02581410|448808586|FG001|Vaccination Phase|Migrated/moved from study area|1|||
124776427|NCT02581410|448808585|FG000|End of Study Phase|Adverse Event|4|||
124776428|NCT02581410|448808586|FG001|End of Study Phase|Adverse Event|3|||
124776429|NCT02581410|448808585|FG000|End of Study Phase|Withdrawal by Subject|1|||
124776430|NCT02581410|448808586|FG001|End of Study Phase|Withdrawal by Subject|2|||
124776431|NCT02581410|448808585|FG000|End of Study Phase|Migrated/moved from study area|0|||
124776432|NCT02581410|448808586|FG001|End of Study Phase|Migrated/moved from study area|3|||
124776433|NCT02581410|448808585|FG000|End of Study Phase|Lost to Follow-up|0|||
124776434|NCT02581410|448808586|FG001|End of Study Phase|Lost to Follow-up|2|||
124776435|NCT02581410|448808585|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
124776436|NCT02581410|448808586|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
124776437|NCT06083506|448808592|FG000|Overall Study|Physician Decision|2|||
124776438|NCT06083506|448808592|FG000|Overall Study|Lack of Efficacy|1|||
124776439|NCT02000115|448808593|FG000|Overall Study|Death|56|||
124776440|NCT02000115|448808594|FG001|Overall Study|Death|45|||
124776441|NCT02000115|448808595|FG002|Overall Study|Death|0|||
124776442|NCT02000115|448808596|FG003|Overall Study|Death|0|||
124776443|NCT02000115|448808593|FG000|Overall Study|Missed Visit|6|||
124776444|NCT02000115|448808594|FG001|Overall Study|Missed Visit|8|||
124776445|NCT02000115|448808595|FG002|Overall Study|Missed Visit|1|||
124502614|NCT00937768|447791916|FG000|Overall Study|Disease Progression|1|||
124502615|NCT00937768|447791917|FG001|Overall Study|Disease Progression|1|||
124502616|NCT00937768|447791916|FG000|Overall Study|Alternate Treatment|0|||
124502617|NCT00937768|447791917|FG001|Overall Study|Alternate Treatment|1|||
124502618|NCT00937768|447791916|FG000|Overall Study|No Further Funding|4|||
124502619|NCT00937768|447791917|FG001|Overall Study|No Further Funding|4|||
124502620|NCT01687413|447791918|FG000|Overall Study|Withdrawal by Subject|0|||
124502621|NCT01687413|447791919|FG001|Overall Study|Withdrawal by Subject|2|||
124502622|NCT01687413|447791918|FG000|Overall Study|Not eligible|0|||
124502623|NCT01687413|447791919|FG001|Overall Study|Not eligible|2|||
124502624|NCT01687413|447791918|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
124502625|NCT01687413|447791919|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
124502626|NCT01767194|447791920|FG000|Overall Study|Adverse Event|1|||
124502627|NCT01767194|447791921|FG001|Overall Study|Adverse Event|1|||
124502628|NCT01767194|447791920|FG000|Overall Study|Death|0|||
124502629|NCT01767194|447791921|FG001|Overall Study|Death|1|||
124502630|NCT01767194|447791920|FG000|Overall Study|Lack of Efficacy|12|||
124502631|NCT01767194|447791921|FG001|Overall Study|Lack of Efficacy|11|||
124502632|NCT01767194|447791920|FG000|Overall Study|Physician Decision|2|||
124502633|NCT01767194|447791921|FG001|Overall Study|Physician Decision|23|||
124502634|NCT01767194|447791920|FG000|Overall Study|Withdrawal by Subject|0|||
124502635|NCT01767194|447791921|FG001|Overall Study|Withdrawal by Subject|1|||
124502636|NCT01767194|447791920|FG000|Overall Study|Ineligible|1|||
124502637|NCT01767194|447791921|FG001|Overall Study|Ineligible|1|||
124502638|NCT01767194|447791920|FG000|Overall Study|Refusal by patient/parent|2|||
124502639|NCT01767194|447791921|FG001|Overall Study|Refusal by patient/parent|4|||
124502640|NCT01767194|447791920|FG000|Overall Study|Criteria not met on time for next cycle|0|||
124502641|NCT01767194|447791921|FG001|Overall Study|Criteria not met on time for next cycle|1|||
124502642|NCT01454401|447791924|FG000|Overall Study|Death|1|||
124502643|NCT01454401|447791924|FG000|Overall Study|hospitalised|1|||
124561487|NCT00658320|448012851|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
124637304|NCT00507455|448290463|FG001|Overall Study|Withdrawal by Subject|1|||
124776446|NCT02000115|448808596|FG003|Overall Study|Missed Visit|0|||
124776447|NCT02000115|448808593|FG000|Overall Study|Protocol Violation|2|||
124776448|NCT02000115|448808594|FG001|Overall Study|Protocol Violation|1|||
124776449|NCT02000115|448808595|FG002|Overall Study|Protocol Violation|0|||
124776450|NCT02000115|448808596|FG003|Overall Study|Protocol Violation|0|||
124776451|NCT02000115|448808593|FG000|Overall Study|Physician Decision|2|||
124776452|NCT02000115|448808594|FG001|Overall Study|Physician Decision|0|||
124776453|NCT02000115|448808595|FG002|Overall Study|Physician Decision|0|||
124502644|NCT01454401|447791924|FG000|Overall Study|osteomyelitis|2|||
124502645|NCT01454401|447791924|FG000|Overall Study|non-adherence|1|||
124502646|NCT00488618|447791930|FG000|Overall Study|Adverse Event|13|||
124502647|NCT00488618|447791931|FG001|Overall Study|Adverse Event|17|||
124502648|NCT00488618|447791930|FG000|Overall Study|Insufficient Therapeutic Response|18|||
124502649|NCT00488618|447791931|FG001|Overall Study|Insufficient Therapeutic Response|11|||
124502650|NCT00488618|447791930|FG000|Overall Study|Protocol Violation|0|||
124502651|NCT00488618|447791931|FG001|Overall Study|Protocol Violation|2|||
124502652|NCT00488618|447791930|FG000|Overall Study|Withdrawal of Consent|15|||
124502653|NCT00488618|447791931|FG001|Overall Study|Withdrawal of Consent|13|||
124502654|NCT00488618|447791930|FG000|Overall Study|Lost to Follow-up|1|||
124502655|NCT00488618|447791931|FG001|Overall Study|Lost to Follow-up|0|||
124502656|NCT00992446|447791932|FG000|Overall Study|Disease Progression|1|||
124502657|NCT00992446|447791932|FG000|Overall Study|Withdrawal by Subject|2|||
124502658|NCT00992446|447791932|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
124502659|NCT03675737|447791933|FG000|Overall Study|Death|593|||
124502660|NCT03675737|447791934|FG001|Overall Study|Death|660|||
124502661|NCT03675737|447791933|FG000|Overall Study|Lost to Follow-up|1|||
124502662|NCT03675737|447791934|FG001|Overall Study|Lost to Follow-up|5|||
124502663|NCT03675737|447791933|FG000|Overall Study|Physician Decision|1|||
124502664|NCT03675737|447791934|FG001|Overall Study|Physician Decision|0|||
124502665|NCT03675737|447791933|FG000|Overall Study|Withdrawal by Subject|14|||
124502666|NCT03675737|447791934|FG001|Overall Study|Withdrawal by Subject|12|||
124502667|NCT03675737|447791933|FG000|Overall Study|Ongoing in Study|181|||
124502668|NCT03675737|447791934|FG001|Overall Study|Ongoing in Study|112|||
124502669|NCT02669862|447793376|FG000|Overall Study|Lost to Follow-up|0|||
124502670|NCT02669862|447793377|FG001|Overall Study|Lost to Follow-up|2|||
124502671|NCT02669862|447793378|FG002|Overall Study|Lost to Follow-up|1|||
124502672|NCT02669862|447793376|FG000|Overall Study|Withdrawal by Subject|2|||
124502673|NCT02669862|447793377|FG001|Overall Study|Withdrawal by Subject|2|||
124502674|NCT02669862|447793378|FG002|Overall Study|Withdrawal by Subject|3|||
124502675|NCT02669862|447793376|FG000|Overall Study|moved|0|||
124502676|NCT02669862|447793377|FG001|Overall Study|moved|1|||
124502677|NCT02669862|447793378|FG002|Overall Study|moved|0|||
124502678|NCT02669862|447793376|FG000|Overall Study|Protocol Violation|0|||
124502679|NCT02669862|447793377|FG001|Overall Study|Protocol Violation|0|||
124502680|NCT02669862|447793378|FG002|Overall Study|Protocol Violation|1|||
124502681|NCT00311181|447793379|FG000|Overall Study|Final DFTs were not obtained|96|||
124502682|NCT02294318|447793380|FG000|Overall Study|Worsening of drinking|3|||
124502683|NCT02294318|447793381|FG001|Overall Study|Worsening of drinking|0|||
124502684|NCT02294318|447793380|FG000|Overall Study|Not exposed to intervention|0|||
124502685|NCT02294318|447793381|FG001|Overall Study|Not exposed to intervention|2|||
124502686|NCT02397694|447793382|FG000|Double-Blinded Phase|Adverse Event|1|||
124502687|NCT02397694|447793383|FG001|Double-Blinded Phase|Adverse Event|0|||
124502688|NCT02397694|447793382|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
124502689|NCT02397694|447793383|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
124502690|NCT02397694|447793382|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
124502691|NCT02397694|447793383|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
124502692|NCT02397694|447793382|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
124502693|NCT02397694|447793383|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
124502694|NCT02397694|447793382|FG000|Open Label Extension Phase|Protocol Violation|1|||
124502695|NCT02397694|447793383|FG001|Open Label Extension Phase|Protocol Violation|0|||
124502696|NCT02397694|447793382|FG000|Open Label Extension Phase|Withdrew Consent|3|||
124502697|NCT02397694|447793383|FG001|Open Label Extension Phase|Withdrew Consent|1|||
124502698|NCT02397694|447793382|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
124502699|NCT02397694|447793383|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
124502700|NCT03725202|447793384|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
124502701|NCT03725202|447793385|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
124502702|NCT03725202|447793386|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
124502703|NCT03725202|447793387|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
124502704|NCT03725202|447793388|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
124724831|NCT01700959|448611823|FG001|Overall Study|Noncompliant|9|||
124724832|NCT01700959|448611824|FG002|Overall Study|Noncompliant|17|||
124724833|NCT01700959|448611825|FG003|Overall Study|Noncompliant|18|||
124724834|NCT01700959|448611826|FG004|Overall Study|Noncompliant|15|||
124724835|NCT01700959|448611827|FG005|Overall Study|Noncompliant|9|||
124724836|NCT01700959|448611822|FG000|Overall Study|Side effects|1|||
124724837|NCT01700959|448611823|FG001|Overall Study|Side effects|4|||
124724838|NCT01700959|448611824|FG002|Overall Study|Side effects|8|||
124724839|NCT01700959|448611825|FG003|Overall Study|Side effects|4|||
124724840|NCT01700959|448611826|FG004|Overall Study|Side effects|4|||
124724841|NCT01700959|448611827|FG005|Overall Study|Side effects|1|||
124724842|NCT00830375|448611828|FG000|Overall Study|Lost to Follow-up|1|||
124724843|NCT00782171|448613324|FG000|Overall Study|Lost to Follow-up|2|||
124724844|NCT00782171|448613325|FG001|Overall Study|Lost to Follow-up|2|||
124724845|NCT00782171|448613324|FG000|Overall Study|Withdrawal by Subject|2|||
124724846|NCT00782171|448613325|FG001|Overall Study|Withdrawal by Subject|1|||
124502705|NCT03725202|447793389|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
124502706|NCT03725202|447793390|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
124724847|NCT00782171|448613324|FG000|Overall Study|complications|3|||
124724848|NCT00782171|448613325|FG001|Overall Study|complications|1|||
124724849|NCT00782171|448613324|FG000|Overall Study|others|7|||
124724850|NCT00782171|448613325|FG001|Overall Study|others|9|||
124724851|NCT00782171|448613324|FG000|Overall Study|not eligible|8|||
124561488|NCT00658320|448012850|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
124561489|NCT00658320|448012851|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
124561490|NCT00658320|448012850|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
124561491|NCT00658320|448012851|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
124561492|NCT00387712|448012867|FG000|Overall Study|Physician Decision|6|||
124502707|NCT03725202|447793391|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
124561493|NCT00387712|448012868|FG001|Overall Study|Physician Decision|4|||
124502708|NCT03725202|447793384|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
124502709|NCT03725202|447793385|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
124502710|NCT03725202|447793386|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
124502711|NCT03725202|447793387|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
124502712|NCT03725202|447793388|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
124502713|NCT03725202|447793389|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
124502714|NCT03725202|447793390|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
124502715|NCT03725202|447793391|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
124502716|NCT03725202|447793384|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
124502717|NCT03725202|447793385|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
124502718|NCT03725202|447793386|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
124502719|NCT03725202|447793387|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
124502720|NCT03725202|447793388|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
124502721|NCT03725202|447793389|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
124502722|NCT03725202|447793390|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
124502723|NCT03725202|447793391|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
124502724|NCT03725202|447793384|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
124502725|NCT03725202|447793385|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
124502726|NCT03725202|447793386|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
124502727|NCT03725202|447793387|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
124502728|NCT03725202|447793388|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
124502729|NCT03725202|447793389|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
124502730|NCT03725202|447793390|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
124502731|NCT03725202|447793391|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
124502732|NCT03725202|447793384|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
124502733|NCT03725202|447793385|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
124502734|NCT03725202|447793386|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
124502735|NCT03725202|447793387|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
124502736|NCT03725202|447793388|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
124502737|NCT03725202|447793389|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
124502738|NCT03725202|447793390|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
124502739|NCT03725202|447793391|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
124502740|NCT03725202|447793384|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
124502741|NCT03725202|447793385|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
124502742|NCT03725202|447793386|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
124502743|NCT03725202|447793387|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
124502744|NCT03725202|447793388|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
124502745|NCT03725202|447793389|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
124502746|NCT03725202|447793390|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
124502747|NCT03725202|447793391|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
124502748|NCT03725202|447793384|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
124502749|NCT03725202|447793385|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
124502750|NCT03725202|447793386|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
124502751|NCT03725202|447793387|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
124502752|NCT03725202|447793388|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
124502753|NCT03725202|447793389|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
124502754|NCT03725202|447793390|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
124502755|NCT03725202|447793391|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
124502756|NCT03725202|447793384|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
124502757|NCT03725202|447793385|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
124502758|NCT03725202|447793386|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
124502759|NCT03725202|447793387|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
124502760|NCT03725202|447793388|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
124502761|NCT03725202|447793389|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
124502762|NCT03725202|447793390|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
124502763|NCT03725202|447793391|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
124502764|NCT03725202|447793384|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
124561494|NCT00387712|448012867|FG000|Overall Study|Lost to Follow-up|17|||
124776454|NCT02000115|448808596|FG003|Overall Study|Physician Decision|0|||
124776455|NCT02000115|448808593|FG000|Overall Study|Withdrawal by Subject|11|||
124776456|NCT02000115|448808594|FG001|Overall Study|Withdrawal by Subject|11|||
124776457|NCT02000115|448808595|FG002|Overall Study|Withdrawal by Subject|0|||
124776458|NCT02000115|448808596|FG003|Overall Study|Withdrawal by Subject|0|||
124776459|NCT02000115|448808593|FG000|Overall Study|Lost to Follow-up|0|||
124776460|NCT02000115|448808594|FG001|Overall Study|Lost to Follow-up|1|||
124776461|NCT02000115|448808595|FG002|Overall Study|Lost to Follow-up|0|||
124776462|NCT02000115|448808596|FG003|Overall Study|Lost to Follow-up|0|||
124776463|NCT02000115|448808593|FG000|Overall Study|Non-compliance|2|||
124776464|NCT02000115|448808594|FG001|Overall Study|Non-compliance|1|||
124776465|NCT02000115|448808595|FG002|Overall Study|Non-compliance|0|||
124776466|NCT02000115|448808596|FG003|Overall Study|Non-compliance|0|||
124776467|NCT02000115|448808593|FG000|Overall Study|Withdrawn on day of randomization|0|||
124776468|NCT02000115|448808594|FG001|Overall Study|Withdrawn on day of randomization|1|||
124776469|NCT02000115|448808595|FG002|Overall Study|Withdrawn on day of randomization|0|||
124776470|NCT02000115|448808596|FG003|Overall Study|Withdrawn on day of randomization|0|||
124776471|NCT02000115|448808593|FG000|Overall Study|Still on Study|0|||
124776472|NCT02000115|448808594|FG001|Overall Study|Still on Study|0|||
124776473|NCT02000115|448808595|FG002|Overall Study|Still on Study|0|||
124776474|NCT02000115|448808596|FG003|Overall Study|Still on Study|53|||
124776475|NCT03493464|448808601|FG000|Overall Study|Surgery not performed|1|||
124776476|NCT02374450|448808602|FG000|Overall Study|Protocol Violation|0|||
124776477|NCT02374450|448808603|FG001|Overall Study|Protocol Violation|1|||
124776478|NCT02374450|448808604|FG002|Overall Study|Protocol Violation|0|||
124776479|NCT02374450|448808602|FG000|Overall Study|Withdrawal by Subject|91|||
124776480|NCT02374450|448808603|FG001|Overall Study|Withdrawal by Subject|110|||
124776481|NCT02374450|448808604|FG002|Overall Study|Withdrawal by Subject|4|||
124776482|NCT02374450|448808602|FG000|Overall Study|Lost to Follow-up|168|||
124776483|NCT02374450|448808603|FG001|Overall Study|Lost to Follow-up|194|||
124776484|NCT02374450|448808604|FG002|Overall Study|Lost to Follow-up|138|||
124776485|NCT02374450|448808602|FG000|Overall Study|Death|173|||
124776486|NCT02374450|448808603|FG001|Overall Study|Death|185|||
124561495|NCT00387712|448012868|FG001|Overall Study|Lost to Follow-up|20|||
124776487|NCT02374450|448808604|FG002|Overall Study|Death|81|||
124776488|NCT02374450|448808602|FG000|Overall Study|Migrated from the study area|538|||
124776489|NCT02374450|448808603|FG001|Overall Study|Migrated from the study area|648|||
124502765|NCT03725202|447793385|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
124502766|NCT03725202|447793386|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
124502767|NCT03725202|447793387|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
124502768|NCT03725202|447793388|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
124502769|NCT03725202|447793389|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
124502770|NCT03725202|447793390|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
124502771|NCT03725202|447793391|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
124502772|NCT03725202|447793384|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
124502773|NCT03725202|447793385|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
124502774|NCT03725202|447793386|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
124502775|NCT03725202|447793387|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
124502776|NCT03725202|447793388|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
124502777|NCT03725202|447793389|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
124502778|NCT03725202|447793390|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
124502779|NCT03725202|447793391|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
124502780|NCT03725202|447793384|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
124502781|NCT03725202|447793385|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
124502782|NCT03725202|447793386|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
124502783|NCT03725202|447793387|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
124502784|NCT03725202|447793388|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
124502785|NCT03725202|447793389|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
124502786|NCT03725202|447793390|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
124502787|NCT03725202|447793391|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
124502788|NCT03725202|447793384|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
124502789|NCT03725202|447793385|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
124502790|NCT03725202|447793386|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
124502791|NCT03725202|447793387|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
124502792|NCT03725202|447793388|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
124502793|NCT03725202|447793389|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
124561496|NCT00387712|448012867|FG000|Overall Study|Withdrawal by Subject|6|||
124776490|NCT02374450|448808604|FG002|Overall Study|Migrated from the study area|181|||
124776491|NCT02374450|448808602|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
124776492|NCT02374450|448808603|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
124776493|NCT02374450|448808604|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
124776494|NCT02374450|448808602|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
124561497|NCT00387712|448012868|FG001|Overall Study|Withdrawal by Subject|12|||
124561498|NCT01907737|448012873|FG000|Overall Study|Withdrawal by Subject|1|||
124561499|NCT02668783|448012878|FG000|Overall Study|Pregnancy|0|||
124561500|NCT02668783|448012879|FG001|Overall Study|Pregnancy|1|||
124561501|NCT02668783|448012878|FG000|Overall Study|Protocol Violation|2|||
124561502|NCT02668783|448012879|FG001|Overall Study|Protocol Violation|1|||
124561503|NCT02668783|448012878|FG000|Overall Study|Study terminated by sponsor|9|||
124561504|NCT02668783|448012879|FG001|Overall Study|Study terminated by sponsor|10|||
124561505|NCT02668783|448012878|FG000|Overall Study|Subject moved|1|||
124561506|NCT02668783|448012879|FG001|Overall Study|Subject moved|0|||
124561507|NCT02668783|448012878|FG000|Overall Study|Withdrawal by Subject|1|||
124561508|NCT02668783|448012879|FG001|Overall Study|Withdrawal by Subject|0|||
124561509|NCT04467697|448012882|FG000|Overall Study|Adverse Event|2|||
124561510|NCT04467697|448012882|FG000|Overall Study|Lost to Follow-up|6|||
124561511|NCT04467697|448012882|FG000|Overall Study|Withdrawal by Subject|9|||
124561512|NCT04467697|448012882|FG000|Overall Study|Protocol Violation|3|||
124561513|NCT00909727|448012885|FG000|Overall Study|Adverse Event|1|||
124561514|NCT00909727|448012886|FG001|Overall Study|Adverse Event|0|||
124561515|NCT00909727|448012885|FG000|Overall Study|Wrong Genotype|1|||
124561516|NCT00909727|448012886|FG001|Overall Study|Wrong Genotype|0|||
124561517|NCT00909727|448012885|FG000|Overall Study|Withdrawal of Consent|1|||
124561518|NCT00909727|448012886|FG001|Overall Study|Withdrawal of Consent|0|||
124561519|NCT00909727|448012885|FG000|Overall Study|Prohibited Medication|1|||
124561520|NCT00909727|448012886|FG001|Overall Study|Prohibited Medication|0|||
124561521|NCT01399723|448012887|FG000|Overall Study|Lost to Follow-up|0|||
124561522|NCT01399723|448012888|FG001|Overall Study|Lost to Follow-up|1|||
124561523|NCT04081337|448012889|FG000|Overall Study|Adverse Event|0|||
124561524|NCT04081337|448012890|FG001|Overall Study|Adverse Event|1|||
124561525|NCT04081337|448012889|FG000|Overall Study|Withdrawal by Subject|2|||
124561526|NCT04081337|448012890|FG001|Overall Study|Withdrawal by Subject|0|||
124561527|NCT04081337|448012889|FG000|Overall Study|Physician Decision|1|||
124561528|NCT04081337|448012890|FG001|Overall Study|Physician Decision|2|||
124561529|NCT04081337|448012889|FG000|Overall Study|Lost to Follow-up|1|||
124561530|NCT04081337|448012890|FG001|Overall Study|Lost to Follow-up|0|||
124561531|NCT01799590|448012895|FG000|Overall Study|Adverse Event|13|||
124561532|NCT01799590|448012896|FG001|Overall Study|Adverse Event|7|||
124561533|NCT01799590|448012897|FG002|Overall Study|Adverse Event|5|||
124561534|NCT01799590|448012895|FG000|Overall Study|Pregnancy|2|||
124561535|NCT01799590|448012896|FG001|Overall Study|Pregnancy|0|||
124561536|NCT01799590|448012897|FG002|Overall Study|Pregnancy|0|||
124561537|NCT01799590|448012895|FG000|Overall Study|Lack of Efficacy|3|||
124561538|NCT01799590|448012896|FG001|Overall Study|Lack of Efficacy|1|||
124561539|NCT01799590|448012897|FG002|Overall Study|Lack of Efficacy|3|||
124561540|NCT01799590|448012895|FG000|Overall Study|Participants convenience|4|||
124561541|NCT01799590|448012896|FG001|Overall Study|Participants convenience|4|||
124561542|NCT01799590|448012897|FG002|Overall Study|Participants convenience|2|||
124561543|NCT01799590|448012895|FG000|Overall Study|Aggravation of complications|0|||
124561544|NCT01799590|448012896|FG001|Overall Study|Aggravation of complications|1|||
124561545|NCT01799590|448012897|FG002|Overall Study|Aggravation of complications|1|||
124561546|NCT01799590|448012895|FG000|Overall Study|Using drugs with restricted days of use|0|||
124561547|NCT01799590|448012896|FG001|Overall Study|Using drugs with restricted days of use|3|||
124561548|NCT01799590|448012897|FG002|Overall Study|Using drugs with restricted days of use|2|||
124561549|NCT01799590|448012895|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
124561550|NCT01799590|448012896|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
124561551|NCT01799590|448012897|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
124561552|NCT01799590|448012895|FG000|Overall Study|Other|3|||
124561553|NCT01799590|448012896|FG001|Overall Study|Other|0|||
124561554|NCT01799590|448012897|FG002|Overall Study|Other|1|||
124561555|NCT03175120|448012900|FG000|Overall Study|Adverse Event|2|||
124561556|NCT03175120|448012901|FG001|Overall Study|Adverse Event|2|||
124561557|NCT03175120|448012900|FG000|Overall Study|Protocol Violation|5|||
124561558|NCT03175120|448012901|FG001|Overall Study|Protocol Violation|2|||
124561559|NCT03175120|448012900|FG000|Overall Study|Lost to Follow-up|1|||
124561560|NCT03175120|448012901|FG001|Overall Study|Lost to Follow-up|0|||
124561561|NCT03175120|448012900|FG000|Overall Study|Withdrawal by Subject|2|||
124561562|NCT03175120|448012901|FG001|Overall Study|Withdrawal by Subject|5|||
124561563|NCT03175120|448012900|FG000|Overall Study|Other|2|||
124561564|NCT03175120|448012901|FG001|Overall Study|Other|3|||
124561565|NCT00678392|448012902|FG000|Overall Study|Adverse Event|0|||
124561566|NCT00678392|448012903|FG001|Overall Study|Adverse Event|6|||
124561567|NCT00678392|448012902|FG000|Overall Study|Death|280|||
124561568|NCT00678392|448012903|FG001|Overall Study|Death|269|||
124561569|NCT00678392|448012902|FG000|Overall Study|Lost to Follow-up|15|||
124561570|NCT00678392|448012903|FG001|Overall Study|Lost to Follow-up|13|||
124561571|NCT00678392|448012902|FG000|Overall Study|Objective Progression or Relapse|3|||
124561572|NCT00678392|448012903|FG001|Overall Study|Objective Progression or Relapse|8|||
124561573|NCT00678392|448012902|FG000|Overall Study|Sponsor's Decision|1|||
124561574|NCT00678392|448012903|FG001|Overall Study|Sponsor's Decision|2|||
124561575|NCT00678392|448012902|FG000|Overall Study|Withdrawal by Subject|4|||
124776495|NCT02374450|448808603|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
124776496|NCT02374450|448808604|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
124776497|NCT02374450|448808602|FG000|Overall Study|Other|0|||
124776498|NCT02374450|448808603|FG001|Overall Study|Other|21|||
124776499|NCT02374450|448808604|FG002|Overall Study|Other|79|||
124776500|NCT04145349|448809895|FG000|Overall Study|Withdrawal by Subject|3|||
124776501|NCT04145349|448809896|FG001|Overall Study|Withdrawal by Subject|0|||
124776502|NCT04145349|448809895|FG000|Overall Study|Lost to Follow-up|0|||
124776503|NCT04145349|448809896|FG001|Overall Study|Lost to Follow-up|1|||
124776504|NCT04145349|448809895|FG000|Overall Study|On study treatment (Ongoing)|0|||
124776505|NCT04145349|448809896|FG001|Overall Study|On study treatment (Ongoing)|1|||
124561576|NCT00678392|448012903|FG001|Overall Study|Withdrawal by Subject|4|||
124561577|NCT00678392|448012902|FG000|Overall Study|Randomized But Not Treated|2|||
124561578|NCT00678392|448012903|FG001|Overall Study|Randomized But Not Treated|7|||
124561579|NCT00678392|448012902|FG000|Overall Study|Other|56|||
124561580|NCT00678392|448012903|FG001|Overall Study|Other|53|||
124561581|NCT03341507|448012904|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
124561582|NCT03882047|448012906|FG000|Overall Study|Adverse Event|0|||
124561583|NCT03882047|448012907|FG001|Overall Study|Adverse Event|2|||
124561584|NCT03882047|448012908|FG002|Overall Study|Adverse Event|2|||
124561585|NCT03882047|448012906|FG000|Overall Study|Treatment Failure|3|||
124561586|NCT03882047|448012907|FG001|Overall Study|Treatment Failure|3|||
124561587|NCT03882047|448012908|FG002|Overall Study|Treatment Failure|12|||
124561588|NCT03882047|448012906|FG000|Overall Study|Lost to Follow-up|0|||
124561589|NCT03882047|448012907|FG001|Overall Study|Lost to Follow-up|1|||
124561590|NCT03882047|448012908|FG002|Overall Study|Lost to Follow-up|0|||
124561591|NCT03882047|448012906|FG000|Overall Study|Did Not Wish to Continue|1|||
124561592|NCT03882047|448012907|FG001|Overall Study|Did Not Wish to Continue|4|||
124561593|NCT03882047|448012908|FG002|Overall Study|Did Not Wish to Continue|1|||
124561594|NCT03882047|448012906|FG000|Overall Study|Noncompliance With Protocol|2|||
124561595|NCT03882047|448012907|FG001|Overall Study|Noncompliance With Protocol|0|||
124561596|NCT03882047|448012908|FG002|Overall Study|Noncompliance With Protocol|0|||
124561597|NCT03882047|448012906|FG000|Overall Study|Did Not Meet Eligibility|0|||
124561598|NCT03882047|448012907|FG001|Overall Study|Did Not Meet Eligibility|0|||
124561599|NCT03882047|448012908|FG002|Overall Study|Did Not Meet Eligibility|1|||
124561600|NCT00441584|448012911|FG000|Overall Study|Lack of Efficacy|79|||
124561601|NCT00441584|448012911|FG000|Overall Study|Withdrawal by Subject|8|||
124561602|NCT00441584|448012911|FG000|Overall Study|Adverse Event|6|||
124776506|NCT01148979|448809897|FG000|Overall Study|Lost to Follow-up|0|||
124776507|NCT01148979|448809898|FG001|Overall Study|Lost to Follow-up|1|||
124776508|NCT01376804|448809899|FG000|Treatment Period|Withdrawal by Subject|1|||
124502794|NCT03725202|447793390|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
124502795|NCT03725202|447793391|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
124502796|NCT01328249|447793394|FG000|Overall Study|Adverse Event|3|||
124502797|NCT01328249|447793395|FG001|Overall Study|Adverse Event|0|||
124502798|NCT01328249|447793394|FG000|Overall Study|Disease progression|1|||
124502799|NCT01328249|447793395|FG001|Overall Study|Disease progression|0|||
124502800|NCT01328249|447793394|FG000|Overall Study|Withdrawal by Subject|1|||
124502801|NCT01328249|447793395|FG001|Overall Study|Withdrawal by Subject|1|||
124502802|NCT01328249|447793394|FG000|Overall Study|Moved before end of treatment visit|1|||
124502803|NCT01328249|447793395|FG001|Overall Study|Moved before end of treatment visit|0|||
124502804|NCT01328249|447793394|FG000|Overall Study|Subject choice|1|||
124502805|NCT01328249|447793395|FG001|Overall Study|Subject choice|1|||
124502806|NCT01328249|447793394|FG000|Overall Study|Protocol Violation|0|||
124502807|NCT01328249|447793395|FG001|Overall Study|Protocol Violation|1|||
124502808|NCT01215734|447793396|FG000|Overall Study|Death|0|||
124502809|NCT01215734|447793397|FG001|Overall Study|Death|1|||
124502810|NCT00315705|447793398|FG000|Phase 1|Refused further treatment|1|||
124502811|NCT00315705|447793398|FG000|Phase 1|Failure to achieve response|8|||
124502812|NCT00315705|447793398|FG000|Phase 1|Disease relapse|4|||
124502813|NCT00315705|447793398|FG000|Phase 1|Scheduled for transplant|9|||
124502814|NCT00315705|447793398|FG000|Phase 1|Death|3|||
124502815|NCT00315705|447793398|FG000|Phase 2|Physician Decision|4|||
124502816|NCT00315705|447793398|FG000|Phase 2|Adverse Event|1|||
124502817|NCT00315705|447793398|FG000|Phase 2|Failure to achieve response|3|||
124561603|NCT00441584|448012911|FG000|Overall Study|Protocol Violation|5|||
124561604|NCT00441584|448012911|FG000|Overall Study|Lost to Follow-up|4|||
124561605|NCT00441584|448012911|FG000|Overall Study|Failure to meet eligibility criteria|3|||
124561606|NCT00770991|448012916|FG000|Overall Study|Physician Decision|2|||
124561607|NCT00770991|448012917|FG001|Overall Study|Physician Decision|0|||
124776509|NCT01376804|448809899|FG000|Treatment Period|Adverse Event|6|||
124502818|NCT00315705|447793398|FG000|Phase 2|Disease relapse|1|||
124561608|NCT00770991|448012916|FG000|Overall Study|Withdrawal by Subject|1|||
124776510|NCT01376804|448809899|FG000|Treatment Period|Patient did not receive study drug|1|||
124776511|NCT00882557|448809900|FG000|Overall Study|Withdrawal by Subject|1|||
124502819|NCT00315705|447793398|FG000|Phase 2|Scheduled for transplant|8|||
124502820|NCT00315705|447793398|FG000|Phase 2|Other|1|||
124502821|NCT00315705|447793398|FG000|Phase 2|Death|7|||
124502822|NCT00748553|447793399|FG000|Overall Study|Adverse Event|0|||
124502823|NCT00748553|447793400|FG001|Overall Study|Adverse Event|1|||
124502824|NCT00748553|447793399|FG000|Overall Study|disease progression|2|||
124502825|NCT00748553|447793400|FG001|Overall Study|disease progression|0|||
124502826|NCT00748553|447793399|FG000|Overall Study|noncompliance|1|||
124502827|NCT00748553|447793400|FG001|Overall Study|noncompliance|0|||
124502828|NCT00495495|447793406|FG000|Overall Study|Protocol Violation|99|||
124502829|NCT00745368|447793407|FG000|Overall Study|Unable to provide sample|3|||
124502830|NCT03331666|447793411|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
124502831|NCT03331666|447793412|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
124502832|NCT02326467|447793413|FG000|Overall Study|Withdrawal by Subject|1|||
124502833|NCT00434512|447793414|FG000|Overall Study|Migrated/moved from study area|0|||
124502834|NCT00434512|447793415|FG001|Overall Study|Migrated/moved from study area|0|||
124502835|NCT00434512|447793416|FG002|Overall Study|Migrated/moved from study area|0|||
124502836|NCT00434512|447793417|FG003|Overall Study|Migrated/moved from study area|1|||
124502837|NCT00434512|447793418|FG004|Overall Study|Migrated/moved from study area|1|||
124502838|NCT00434512|447793419|FG005|Overall Study|Migrated/moved from study area|1|||
124502839|NCT00434512|447793414|FG000|Overall Study|Other|0|||
124502840|NCT00434512|447793415|FG001|Overall Study|Other|1|||
124502841|NCT00434512|447793416|FG002|Overall Study|Other|0|||
124502842|NCT00434512|447793417|FG003|Overall Study|Other|0|||
124502843|NCT00434512|447793418|FG004|Overall Study|Other|0|||
124502844|NCT00434512|447793419|FG005|Overall Study|Other|0|||
124502845|NCT03137121|447793424|FG000|Overall Study|Withdrawal by Subject|0|||
124502846|NCT03137121|447793425|FG001|Overall Study|Withdrawal by Subject|1|||
124502847|NCT00111475|447793429|FG000|Overall Study|Lost to Follow-up|0|||
124502848|NCT00111475|447793430|FG001|Overall Study|Lost to Follow-up|0|||
124502849|NCT00111475|447793431|FG002|Overall Study|Lost to Follow-up|0|||
124502850|NCT00111475|447793432|FG003|Overall Study|Lost to Follow-up|0|||
124502851|NCT00111475|447793433|FG004|Overall Study|Lost to Follow-up|0|||
124502852|NCT00111475|447793434|FG005|Overall Study|Lost to Follow-up|1|||
124502853|NCT00111475|447793435|FG006|Overall Study|Lost to Follow-up|0|||
124502854|NCT00111475|447793436|FG007|Overall Study|Lost to Follow-up|0|||
124502855|NCT00111475|447793437|FG008|Overall Study|Lost to Follow-up|0|||
124502856|NCT00111475|447793438|FG009|Overall Study|Lost to Follow-up|0|||
124502857|NCT01026389|447793441|FG000|Overall Study|Withdrawal by Subject|1|||
124502858|NCT01026389|447793442|FG001|Overall Study|Withdrawal by Subject|3|||
124502859|NCT01026389|447793441|FG000|Overall Study|change of treatment, patient moved|4|||
124502860|NCT01026389|447793442|FG001|Overall Study|change of treatment, patient moved|2|||
124502861|NCT00836277|447793443|FG000|Overall Study|Not evaluable for response|6|||
124502862|NCT04410198|447793444|FG000|Overall Study|Death|10|||
124502863|NCT04410198|447793444|FG000|Overall Study|Withdrawal by Subject|7|||
124502864|NCT04410198|447793444|FG000|Overall Study|Transferred/Relocation|4|||
124502865|NCT04410198|447793444|FG000|Overall Study|Kidney Transplant|9|||
124502866|NCT04410198|447793444|FG000|Overall Study|Adverse Event|4|||
124502867|NCT04410198|447793444|FG000|Overall Study|Physician Decision|2|||
124502868|NCT04410198|447793444|FG000|Overall Study|Other than specified|1|||
124561609|NCT00770991|448012917|FG001|Overall Study|Withdrawal by Subject|0|||
124502869|NCT00568958|447793452|FG000|Allocation|Withdrawal by Subject|7|||
124502870|NCT00568958|447793453|FG001|Allocation|Withdrawal by Subject|3|||
124502871|NCT00568958|447793452|FG000|Allocation|Physician Decision|2|||
124502872|NCT00568958|447793453|FG001|Allocation|Physician Decision|0|||
124502873|NCT00568958|447793452|FG000|Follow-Up|Withdrawal by Subject|6|||
124502874|NCT00568958|447793453|FG001|Follow-Up|Withdrawal by Subject|6|||
124502875|NCT00568958|447793452|FG000|Follow-Up|Physician Decision|1|||
124502876|NCT00568958|447793453|FG001|Follow-Up|Physician Decision|1|||
124502877|NCT00568958|447793452|FG000|Follow-Up|Family Emergency|1|||
124502878|NCT00568958|447793453|FG001|Follow-Up|Family Emergency|0|||
124502879|NCT00568958|447793452|FG000|Follow-Up|Adverse Event|1|||
124502880|NCT00568958|447793453|FG001|Follow-Up|Adverse Event|0|||
124502881|NCT01354353|447793455|FG000|Overall Study|Adverse Event|1|||
124502882|NCT01354353|447793456|FG001|Overall Study|Adverse Event|0|||
124502883|NCT01354353|447793457|FG002|Overall Study|Adverse Event|0|||
124502884|NCT01354353|447793458|FG003|Overall Study|Adverse Event|4|||
124502885|NCT01354353|447793459|FG004|Overall Study|Adverse Event|0|||
124502886|NCT01354353|447793460|FG005|Overall Study|Adverse Event|5|||
124502887|NCT01354353|447793455|FG000|Overall Study|Entry Criteria Not Met|0|||
124502888|NCT01354353|447793456|FG001|Overall Study|Entry Criteria Not Met|0|||
124502889|NCT01354353|447793457|FG002|Overall Study|Entry Criteria Not Met|0|||
124502890|NCT01354353|447793458|FG003|Overall Study|Entry Criteria Not Met|1|||
124502891|NCT01354353|447793459|FG004|Overall Study|Entry Criteria Not Met|1|||
124502892|NCT01354353|447793460|FG005|Overall Study|Entry Criteria Not Met|0|||
124502893|NCT01354353|447793455|FG000|Overall Study|Physician Decision|0|||
124502894|NCT01354353|447793456|FG001|Overall Study|Physician Decision|1|||
124502895|NCT01354353|447793457|FG002|Overall Study|Physician Decision|1|||
124502896|NCT01354353|447793458|FG003|Overall Study|Physician Decision|0|||
124502897|NCT01354353|447793459|FG004|Overall Study|Physician Decision|0|||
124502898|NCT01354353|447793460|FG005|Overall Study|Physician Decision|0|||
124502899|NCT01354353|447793455|FG000|Overall Study|Withdrawal by Subject|2|||
124502900|NCT01354353|447793456|FG001|Overall Study|Withdrawal by Subject|0|||
124502901|NCT01354353|447793457|FG002|Overall Study|Withdrawal by Subject|1|||
124502902|NCT01354353|447793458|FG003|Overall Study|Withdrawal by Subject|0|||
124502903|NCT01354353|447793459|FG004|Overall Study|Withdrawal by Subject|0|||
124502904|NCT01354353|447793460|FG005|Overall Study|Withdrawal by Subject|1|||
124502905|NCT03446651|447793468|FG000|Overall Study|Lost to Follow-up|4|||
124502906|NCT03446651|447793469|FG001|Overall Study|Lost to Follow-up|0|||
124502907|NCT03446651|447793468|FG000|Overall Study|Open Label Participants|5|||
124502908|NCT03446651|447793469|FG001|Overall Study|Open Label Participants|0|||
124502909|NCT02420223|447793470|FG000|Overall Study|Adverse Event|1|||
124502910|NCT02420223|447793471|FG001|Overall Study|Adverse Event|0|||
124502911|NCT02420223|447793470|FG000|Overall Study|Physician Decision|0|||
124502912|NCT02420223|447793471|FG001|Overall Study|Physician Decision|2|||
124502913|NCT01894477|447793478|FG000|Overall Study|Protocol Violation|0|||
124502914|NCT01894477|447793479|FG001|Overall Study|Protocol Violation|1|||
124502915|NCT01894477|447793478|FG000|Overall Study|protocol changed due SC changed to cord|0|||
124502916|NCT01894477|447793479|FG001|Overall Study|protocol changed due SC changed to cord|1|||
124502917|NCT02052778|447793480|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
124502918|NCT02052778|447793481|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
124502919|NCT02052778|447793482|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
124502920|NCT02052778|447793483|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
124502921|NCT02052778|447793484|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
124502922|NCT02052778|447793485|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
124502923|NCT02052778|447793486|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
124502924|NCT02052778|447793487|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
124502925|NCT02052778|447793488|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
124502926|NCT02052778|447793489|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
124502927|NCT02052778|447793490|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
124502928|NCT02052778|447793491|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
124502929|NCT02052778|447793492|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
124502930|NCT02052778|447793493|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
124502931|NCT02052778|447793494|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
124502932|NCT02052778|447793495|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
124502933|NCT02052778|447793496|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
124502934|NCT02052778|447793497|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
124502935|NCT02052778|447793498|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
124502936|NCT02052778|447793499|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
124502937|NCT02052778|447793500|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
124502938|NCT02052778|447793501|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
124502939|NCT02052778|447793502|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
124502940|NCT02052778|447793480|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
124502941|NCT02052778|447793481|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
124502942|NCT02052778|447793482|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
124502943|NCT02052778|447793483|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
124502944|NCT02052778|447793484|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
124502945|NCT02052778|447793485|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
124502946|NCT02052778|447793486|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
124502947|NCT02052778|447793487|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
124502948|NCT02052778|447793488|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
124502949|NCT02052778|447793489|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
124502950|NCT02052778|447793490|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
124502951|NCT02052778|447793491|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
124502952|NCT02052778|447793492|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
124502953|NCT02052778|447793493|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
124502954|NCT02052778|447793494|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
124502955|NCT02052778|447793495|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
124502956|NCT02052778|447793496|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
124502957|NCT02052778|447793497|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
124502958|NCT02052778|447793498|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
124502959|NCT02052778|447793499|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
124502960|NCT02052778|447793500|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
124502961|NCT02052778|447793501|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
124502962|NCT02052778|447793502|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
124776512|NCT00882557|448809901|FG001|Overall Study|Withdrawal by Subject|0|||
124776513|NCT00882557|448809900|FG000|Overall Study|Trouble with Vein Access|1|||
124776514|NCT00882557|448809901|FG001|Overall Study|Trouble with Vein Access|0|||
124776515|NCT00882557|448809900|FG000|Overall Study|Randomized Not Treated|0|||
124776516|NCT00882557|448809901|FG001|Overall Study|Randomized Not Treated|1|||
124776517|NCT01383356|448809906|FG000|Period 1|Adverse Event|5|||
124776518|NCT01383356|448809907|FG001|Period 1|Adverse Event|3|||
124776519|NCT01383356|448809906|FG000|Period 1|Non-compliance|3|||
124776520|NCT01383356|448809907|FG001|Period 1|Non-compliance|0|||
124776521|NCT01383356|448809906|FG000|Period 1|Out of Range Mid-study-Test|0|||
124776522|NCT01383356|448809907|FG001|Period 1|Out of Range Mid-study-Test|1|||
124776523|NCT01383356|448809906|FG000|Period 1|Personal|0|||
124776524|NCT01383356|448809907|FG001|Period 1|Personal|2|||
124776525|NCT03038880|448809913|FG000|Overall Study|Death|1|||
124776526|NCT03038880|448809914|FG001|Overall Study|Death|2|||
124776527|NCT03038880|448809915|FG002|Overall Study|Death|0|||
124776528|NCT03038880|448809913|FG000|Overall Study|Physician Decision|2|||
124776529|NCT03038880|448809914|FG001|Overall Study|Physician Decision|1|||
124776530|NCT03038880|448809915|FG002|Overall Study|Physician Decision|0|||
124776531|NCT00602472|448809916|FG000|Overall Study|Adverse Event|5|||
124776532|NCT00602472|448809917|FG001|Overall Study|Adverse Event|23|||
124776533|NCT00602472|448809916|FG000|Overall Study|Protocol Violation|4|||
124776534|NCT00602472|448809917|FG001|Overall Study|Protocol Violation|19|||
124776535|NCT00602472|448809916|FG000|Overall Study|Withdrawal by Subject|8|||
124776536|NCT00602472|448809917|FG001|Overall Study|Withdrawal by Subject|14|||
124776537|NCT00602472|448809916|FG000|Overall Study|Other incl. lack of efficacy|4|||
124776538|NCT00602472|448809917|FG001|Overall Study|Other incl. lack of efficacy|2|||
124776539|NCT02054104|448809924|FG000|Overall Study|Did not want to continue due to college classes|1|||
124776540|NCT02054104|448809925|FG001|Overall Study|Did not want to continue due to college classes|0|||
124776541|NCT02054104|448809924|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
124776542|NCT02054104|448809925|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
124776543|NCT02054104|448809924|FG000|Overall Study|No evidence of immunologic response|2|||
124776544|NCT02054104|448809925|FG001|Overall Study|No evidence of immunologic response|2|||
124776545|NCT02054104|448809924|FG000|Overall Study|Disease Progression On Study|4|||
124776546|NCT02054104|448809925|FG001|Overall Study|Disease Progression On Study|5|||
124776547|NCT02054104|448809924|FG000|Overall Study|Diagnosis of lymphoma|0|||
124776548|NCT02054104|448809925|FG001|Overall Study|Diagnosis of lymphoma|1|||
124776549|NCT02054104|448809924|FG000|Overall Study|Inconclusive response|0|||
124776550|NCT02054104|448809925|FG001|Overall Study|Inconclusive response|1|||
124776551|NCT00823615|448809926|FG000|Period 2|Lost to Follow-up|2|||
124776552|NCT00823615|448809927|FG001|Period 2|Lost to Follow-up|0|||
124776553|NCT00823615|448809926|FG000|Period 2|Time/Job Conflict|1|||
124776554|NCT00823615|448809927|FG001|Period 2|Time/Job Conflict|2|||
124502963|NCT02052778|447793480|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502964|NCT02052778|447793481|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502965|NCT02052778|447793482|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502966|NCT02052778|447793483|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502967|NCT02052778|447793484|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502968|NCT02052778|447793485|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502969|NCT02052778|447793486|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502970|NCT02052778|447793487|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502971|NCT02052778|447793488|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502972|NCT02052778|447793489|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502973|NCT02052778|447793490|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124561610|NCT00770991|448012916|FG000|Overall Study|Adverse Event|1|||
124561611|NCT00770991|448012917|FG001|Overall Study|Adverse Event|5|||
124776555|NCT03926611|448809928|FG000|Overall Study|Adverse Event|0|||
124776556|NCT03926611|448809929|FG001|Overall Study|Adverse Event|0|||
124776557|NCT03926611|448809930|FG002|Overall Study|Adverse Event|0|||
124561612|NCT00770991|448012916|FG000|Overall Study|Pregnancy|1|||
124561613|NCT00770991|448012917|FG001|Overall Study|Pregnancy|0|||
124561614|NCT03465891|448012918|FG000|Overall Study|Withdrawal by Subject|0|||
124776558|NCT03926611|448809931|FG003|Overall Study|Adverse Event|3|||
124776559|NCT03926611|448809932|FG004|Overall Study|Adverse Event|1|||
124776560|NCT03926611|448809933|FG005|Overall Study|Adverse Event|3|||
124776561|NCT03926611|448809934|FG006|Overall Study|Adverse Event|0|||
124776562|NCT03926611|448809928|FG000|Overall Study|Lack of Efficacy|1|||
124776563|NCT03926611|448809929|FG001|Overall Study|Lack of Efficacy|2|||
124502974|NCT02052778|447793491|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124561615|NCT03465891|448012919|FG001|Overall Study|Withdrawal by Subject|1|||
124776564|NCT03926611|448809930|FG002|Overall Study|Lack of Efficacy|0|||
124776565|NCT03926611|448809931|FG003|Overall Study|Lack of Efficacy|0|||
124776566|NCT03926611|448809932|FG004|Overall Study|Lack of Efficacy|1|||
124776567|NCT03926611|448809933|FG005|Overall Study|Lack of Efficacy|0|||
124776568|NCT03926611|448809934|FG006|Overall Study|Lack of Efficacy|1|||
124776569|NCT03926611|448809928|FG000|Overall Study|Physician Decision|0|||
124502975|NCT02052778|447793492|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502976|NCT02052778|447793493|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
124502977|NCT02052778|447793494|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502978|NCT02052778|447793495|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502979|NCT02052778|447793496|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502980|NCT02052778|447793497|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502981|NCT02052778|447793498|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502982|NCT02052778|447793499|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502983|NCT02052778|447793500|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502984|NCT02052778|447793501|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502985|NCT02052778|447793502|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
124502986|NCT02052778|447793480|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
124502987|NCT02052778|447793481|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
124502988|NCT02052778|447793482|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
124502989|NCT02052778|447793483|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
124502990|NCT02052778|447793484|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
124502991|NCT02052778|447793485|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
124502992|NCT02052778|447793486|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
124502993|NCT02052778|447793487|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
124502994|NCT02052778|447793488|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
124502995|NCT02052778|447793489|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
124502996|NCT02052778|447793490|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
124502997|NCT02052778|447793491|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
124502998|NCT02052778|447793492|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
124502999|NCT02052778|447793493|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
124503000|NCT02052778|447793494|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
124503001|NCT02052778|447793495|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
124503002|NCT02052778|447793496|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
124503003|NCT02052778|447793497|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
124503004|NCT02052778|447793498|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
124503005|NCT02052778|447793499|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
124503006|NCT02052778|447793500|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
124503007|NCT02052778|447793501|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
124503008|NCT02052778|447793502|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
124503009|NCT02052778|447793480|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503010|NCT02052778|447793481|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503011|NCT02052778|447793482|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503012|NCT02052778|447793483|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503013|NCT02052778|447793484|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503014|NCT02052778|447793485|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503015|NCT02052778|447793486|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503016|NCT02052778|447793487|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503017|NCT02052778|447793488|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
124503018|NCT02052778|447793489|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503019|NCT02052778|447793490|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503020|NCT02052778|447793491|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503021|NCT02052778|447793492|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503022|NCT02052778|447793493|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
124503023|NCT02052778|447793494|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503024|NCT02052778|447793495|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503025|NCT02052778|447793496|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503026|NCT02052778|447793497|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503027|NCT02052778|447793498|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503028|NCT02052778|447793499|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503029|NCT02052778|447793500|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503030|NCT02052778|447793501|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503031|NCT02052778|447793502|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
124503032|NCT02052778|447793480|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503033|NCT02052778|447793481|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124724852|NCT00782171|448613325|FG001|Overall Study|not eligible|6|||
124724853|NCT02582814|448613332|FG000|Overall Study|Study-specific withdrawal criteria|1|||
124724854|NCT02582814|448613333|FG001|Overall Study|Study-specific withdrawal criteria|0|||
124724855|NCT02582814|448613332|FG000|Overall Study|Withdrawal by Subject|4|||
124724856|NCT02582814|448613333|FG001|Overall Study|Withdrawal by Subject|3|||
124724857|NCT02582814|448613332|FG000|Overall Study|Adverse Event|4|||
124776570|NCT03926611|448809929|FG001|Overall Study|Physician Decision|0|||
124776571|NCT03926611|448809930|FG002|Overall Study|Physician Decision|0|||
124776572|NCT03926611|448809931|FG003|Overall Study|Physician Decision|0|||
124776573|NCT03926611|448809932|FG004|Overall Study|Physician Decision|0|||
124776574|NCT03926611|448809933|FG005|Overall Study|Physician Decision|1|||
124776575|NCT03926611|448809934|FG006|Overall Study|Physician Decision|0|||
124776576|NCT03926611|448809928|FG000|Overall Study|Protocol Violation|1|||
124776577|NCT03926611|448809929|FG001|Overall Study|Protocol Violation|0|||
124776578|NCT03926611|448809930|FG002|Overall Study|Protocol Violation|0|||
124776579|NCT03926611|448809931|FG003|Overall Study|Protocol Violation|1|||
124776580|NCT03926611|448809932|FG004|Overall Study|Protocol Violation|1|||
124776581|NCT03926611|448809933|FG005|Overall Study|Protocol Violation|1|||
124776582|NCT03926611|448809934|FG006|Overall Study|Protocol Violation|1|||
124776583|NCT03926611|448809928|FG000|Overall Study|Technical problems|0|||
124776584|NCT03926611|448809929|FG001|Overall Study|Technical problems|0|||
124776585|NCT03926611|448809930|FG002|Overall Study|Technical problems|0|||
124776586|NCT03926611|448809931|FG003|Overall Study|Technical problems|0|||
124776587|NCT03926611|448809932|FG004|Overall Study|Technical problems|0|||
124776588|NCT03926611|448809933|FG005|Overall Study|Technical problems|1|||
124776589|NCT03926611|448809934|FG006|Overall Study|Technical problems|0|||
124776590|NCT03926611|448809928|FG000|Overall Study|Withdrawal by Subject|1|||
124776591|NCT03926611|448809929|FG001|Overall Study|Withdrawal by Subject|1|||
124776592|NCT03926611|448809930|FG002|Overall Study|Withdrawal by Subject|1|||
124776593|NCT03926611|448809931|FG003|Overall Study|Withdrawal by Subject|0|||
124776594|NCT03926611|448809932|FG004|Overall Study|Withdrawal by Subject|0|||
124776595|NCT03926611|448809933|FG005|Overall Study|Withdrawal by Subject|1|||
124776596|NCT03926611|448809934|FG006|Overall Study|Withdrawal by Subject|3|||
124776597|NCT03926611|448809928|FG000|Overall Study|Covid-19 pandemic|0|||
124776598|NCT03926611|448809929|FG001|Overall Study|Covid-19 pandemic|0|||
124776599|NCT03926611|448809930|FG002|Overall Study|Covid-19 pandemic|1|||
124776600|NCT03926611|448809931|FG003|Overall Study|Covid-19 pandemic|0|||
124776601|NCT03926611|448809932|FG004|Overall Study|Covid-19 pandemic|1|||
124776602|NCT03926611|448809933|FG005|Overall Study|Covid-19 pandemic|2|||
124776603|NCT03926611|448809934|FG006|Overall Study|Covid-19 pandemic|0|||
124776604|NCT00084136|448809935|FG000|PI Comparison|Death|10|||
124776605|NCT00084136|448809936|FG001|PI Comparison|Death|9|||
124776606|NCT00084136|448809937|FG002|PI Comparison|Death|0|||
124776607|NCT00084136|448809935|FG000|PI Comparison|Lost to Follow-up|11|||
124776608|NCT00084136|448809936|FG001|PI Comparison|Lost to Follow-up|8|||
124776609|NCT00084136|448809937|FG002|PI Comparison|Lost to Follow-up|0|||
124776610|NCT00084136|448809935|FG000|PI Comparison|Withdrawal by Subject|33|||
124776611|NCT00084136|448809936|FG001|PI Comparison|Withdrawal by Subject|30|||
124776612|NCT00084136|448809937|FG002|PI Comparison|Withdrawal by Subject|0|||
124776613|NCT00084136|448809935|FG000|PI Comparison|Clinic site closed|1|||
124776614|NCT00084136|448809936|FG001|PI Comparison|Clinic site closed|0|||
124776615|NCT00084136|448809937|FG002|PI Comparison|Clinic site closed|0|||
124776616|NCT00084136|448809935|FG000|NRTI Comparison|Death|20|||
124776617|NCT00084136|448809936|FG001|NRTI Comparison|Death|0|||
124776618|NCT00084136|448809937|FG002|NRTI Comparison|Death|18|||
124776619|NCT00084136|448809935|FG000|NRTI Comparison|Lost to Follow-up|14|||
124776620|NCT00084136|448809936|FG001|NRTI Comparison|Lost to Follow-up|0|||
124776621|NCT00084136|448809937|FG002|NRTI Comparison|Lost to Follow-up|12|||
124776622|NCT00084136|448809935|FG000|NRTI Comparison|Withdrawal by Subject|54|||
124776623|NCT00084136|448809936|FG001|NRTI Comparison|Withdrawal by Subject|0|||
124776624|NCT00084136|448809937|FG002|NRTI Comparison|Withdrawal by Subject|38|||
124776625|NCT00084136|448809935|FG000|NRTI Comparison|Clinic site closed|12|||
124776626|NCT00084136|448809936|FG001|NRTI Comparison|Clinic site closed|0|||
124503034|NCT02052778|447793482|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503035|NCT02052778|447793483|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503036|NCT02052778|447793484|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503037|NCT02052778|447793485|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
124503038|NCT02052778|447793486|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503039|NCT02052778|447793487|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503040|NCT02052778|447793488|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503041|NCT02052778|447793489|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503042|NCT02052778|447793490|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124776627|NCT00084136|448809937|FG002|NRTI Comparison|Clinic site closed|14|||
124776628|NCT00084136|448809935|FG000|NRTI Comparison|Not reason above|1|||
124776629|NCT00084136|448809936|FG001|NRTI Comparison|Not reason above|0|||
124776630|NCT00084136|448809937|FG002|NRTI Comparison|Not reason above|0|||
124776631|NCT02230670|448809938|FG000|Overall Study|Adverse Event|1|||
124776632|NCT02230670|448809939|FG001|Overall Study|Adverse Event|2|||
124776633|NCT02230670|448809938|FG000|Overall Study|Withdrawal by Subject|2|||
124776634|NCT02230670|448809939|FG001|Overall Study|Withdrawal by Subject|2|||
124776635|NCT02230670|448809938|FG000|Overall Study|Physician Decision|0|||
124776636|NCT02230670|448809939|FG001|Overall Study|Physician Decision|1|||
124776637|NCT02230670|448809938|FG000|Overall Study|Protocol Violation|0|||
124561616|NCT03465891|448012918|FG000|Overall Study|Disease progression|1|||
124561617|NCT03465891|448012919|FG001|Overall Study|Disease progression|0|||
124776638|NCT02230670|448809939|FG001|Overall Study|Protocol Violation|1|||
124503043|NCT02052778|447793491|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503044|NCT02052778|447793492|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
124503045|NCT02052778|447793493|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503046|NCT02052778|447793494|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503047|NCT02052778|447793495|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503048|NCT02052778|447793496|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503049|NCT02052778|447793497|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503050|NCT02052778|447793498|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503051|NCT02052778|447793499|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503052|NCT02052778|447793500|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503053|NCT02052778|447793501|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503054|NCT02052778|447793502|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
124503055|NCT02052778|447793480|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
124503056|NCT02052778|447793481|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
124503057|NCT02052778|447793482|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
124503058|NCT02052778|447793483|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
124503059|NCT02052778|447793484|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
124503060|NCT02052778|447793485|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
124503061|NCT02052778|447793486|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
124503062|NCT02052778|447793487|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
124503063|NCT02052778|447793488|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
124503064|NCT02052778|447793489|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
124503065|NCT02052778|447793490|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
124503066|NCT02052778|447793491|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
124503067|NCT02052778|447793492|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
124503068|NCT02052778|447793493|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
124503069|NCT02052778|447793494|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
124503070|NCT02052778|447793495|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
124503071|NCT02052778|447793496|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
124503072|NCT02052778|447793497|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
124503073|NCT02052778|447793498|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
124503074|NCT02052778|447793499|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
124503075|NCT02052778|447793500|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
124503076|NCT02052778|447793501|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
124503077|NCT02052778|447793502|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
124503078|NCT02052778|447793480|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
124503079|NCT02052778|447793481|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
124503080|NCT02052778|447793482|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
124503081|NCT02052778|447793483|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
124503082|NCT02052778|447793484|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
124503083|NCT02052778|447793485|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
124503084|NCT02052778|447793486|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
124503085|NCT02052778|447793487|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
124503086|NCT02052778|447793488|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
124503087|NCT02052778|447793489|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
124503088|NCT02052778|447793490|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
124503089|NCT02052778|447793491|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
124503090|NCT02052778|447793492|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
124503091|NCT02052778|447793493|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
124503092|NCT02052778|447793494|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
124503093|NCT02052778|447793495|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
124503094|NCT02052778|447793496|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
124503095|NCT02052778|447793497|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
124503096|NCT02052778|447793498|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
124503097|NCT02052778|447793499|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
124503098|NCT02052778|447793500|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
124561618|NCT01001169|448012920|FG000|Overall Study|Withdrawal by Subject|2|||
124561619|NCT01001169|448012921|FG001|Overall Study|Withdrawal by Subject|1|||
124776639|NCT02230670|448809938|FG000|Overall Study|Progression to Child-Pugh C|1|||
124776640|NCT02230670|448809939|FG001|Overall Study|Progression to Child-Pugh C|2|||
124776641|NCT00892099|448809941|FG000|Overall Study|Death|1|||
124776642|NCT00892099|448809942|FG001|Overall Study|Death|0|||
124776643|NCT00892099|448809943|FG002|Overall Study|Death|1|||
124776644|NCT00892099|448809941|FG000|Overall Study|Adverse Event|1|||
124503099|NCT02052778|447793501|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
124503100|NCT02052778|447793502|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
124503101|NCT02052778|447793480|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503102|NCT02052778|447793481|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503103|NCT02052778|447793482|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503104|NCT02052778|447793483|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503105|NCT02052778|447793484|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503106|NCT02052778|447793485|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503107|NCT02052778|447793486|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503108|NCT02052778|447793487|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503109|NCT02052778|447793488|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503110|NCT02052778|447793489|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503111|NCT02052778|447793490|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503112|NCT02052778|447793491|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503113|NCT02052778|447793492|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503114|NCT02052778|447793493|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503115|NCT02052778|447793494|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
124503116|NCT02052778|447793495|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
124503117|NCT02052778|447793496|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
124503118|NCT02052778|447793497|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503119|NCT02052778|447793498|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
124503120|NCT02052778|447793499|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
124503121|NCT02052778|447793500|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503122|NCT02052778|447793501|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503123|NCT02052778|447793502|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
124503124|NCT02052778|447793480|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503125|NCT02052778|447793481|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503126|NCT02052778|447793482|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503127|NCT02052778|447793483|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503128|NCT02052778|447793484|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503129|NCT02052778|447793485|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503130|NCT02052778|447793486|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503131|NCT02052778|447793487|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503132|NCT02052778|447793488|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503133|NCT02052778|447793489|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503134|NCT02052778|447793490|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503135|NCT02052778|447793491|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503136|NCT02052778|447793492|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503137|NCT02052778|447793493|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503138|NCT02052778|447793494|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
124503139|NCT02052778|447793495|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
124503140|NCT02052778|447793496|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503141|NCT02052778|447793497|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503142|NCT02052778|447793498|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503143|NCT02052778|447793499|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503144|NCT02052778|447793500|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503145|NCT02052778|447793501|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503146|NCT02052778|447793502|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
124503147|NCT02052778|447793480|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503148|NCT02052778|447793481|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503149|NCT02052778|447793482|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503150|NCT02052778|447793483|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503151|NCT02052778|447793484|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503152|NCT02052778|447793485|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503153|NCT02052778|447793486|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503154|NCT02052778|447793487|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124561620|NCT02040766|448012924|FG000|Overall Study|Adverse Event|1|||
124776645|NCT00892099|448809942|FG001|Overall Study|Adverse Event|0|||
124776646|NCT00892099|448809943|FG002|Overall Study|Adverse Event|0|||
124503155|NCT02052778|447793488|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503156|NCT02052778|447793489|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503157|NCT02052778|447793490|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503158|NCT02052778|447793491|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503159|NCT02052778|447793492|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503160|NCT02052778|447793493|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503161|NCT02052778|447793494|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
124503162|NCT02052778|447793495|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
124503163|NCT02052778|447793496|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503164|NCT02052778|447793497|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503165|NCT02052778|447793498|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503166|NCT02052778|447793499|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
124503167|NCT02052778|447793500|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503168|NCT02052778|447793501|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503169|NCT02052778|447793502|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
124503170|NCT02052778|447793480|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
124503171|NCT02052778|447793481|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
124503172|NCT02052778|447793482|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
124503173|NCT02052778|447793483|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
124503174|NCT02052778|447793484|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
124503175|NCT02052778|447793485|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
124503176|NCT02052778|447793486|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
124503177|NCT02052778|447793487|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
124503178|NCT02052778|447793488|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
124503179|NCT02052778|447793489|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
124503180|NCT02052778|447793490|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
124503181|NCT02052778|447793491|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
124503182|NCT02052778|447793492|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
124503183|NCT02052778|447793493|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
124503184|NCT02052778|447793494|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
124503185|NCT02052778|447793495|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
124503186|NCT02052778|447793496|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
124503187|NCT02052778|447793497|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
124503188|NCT02052778|447793498|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
124503189|NCT02052778|447793499|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
124503190|NCT02052778|447793500|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
124503191|NCT02052778|447793501|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
124503192|NCT02052778|447793502|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
124503193|NCT02052778|447793480|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503194|NCT02052778|447793481|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503195|NCT02052778|447793482|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503196|NCT02052778|447793483|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503197|NCT02052778|447793484|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503198|NCT02052778|447793485|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503199|NCT02052778|447793486|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503200|NCT02052778|447793487|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503201|NCT02052778|447793488|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503202|NCT02052778|447793489|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503203|NCT02052778|447793490|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503204|NCT02052778|447793491|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503205|NCT02052778|447793492|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503206|NCT02052778|447793493|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503207|NCT02052778|447793494|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
124503208|NCT02052778|447793495|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
124503209|NCT02052778|447793496|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
124503210|NCT02052778|447793497|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503211|NCT02052778|447793498|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
124503212|NCT02052778|447793499|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503213|NCT02052778|447793500|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503214|NCT02052778|447793501|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124503215|NCT02052778|447793502|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
124561621|NCT02040766|448012925|FG001|Overall Study|Adverse Event|1|||
124503216|NCT02052778|447793480|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503217|NCT02052778|447793481|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503218|NCT02052778|447793482|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503219|NCT02052778|447793483|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124561622|NCT02040766|448012926|FG002|Overall Study|Adverse Event|1|||
124561623|NCT02040766|448012927|FG003|Overall Study|Adverse Event|0|||
124561624|NCT02040766|448012928|FG004|Overall Study|Adverse Event|2|||
124561625|NCT02040766|448012924|FG000|Overall Study|Withdrawal by Subject|4|||
124561626|NCT02040766|448012925|FG001|Overall Study|Withdrawal by Subject|3|||
124561627|NCT02040766|448012926|FG002|Overall Study|Withdrawal by Subject|2|||
124561628|NCT02040766|448012927|FG003|Overall Study|Withdrawal by Subject|3|||
124561629|NCT02040766|448012928|FG004|Overall Study|Withdrawal by Subject|2|||
124561630|NCT02040766|448012924|FG000|Overall Study|Non-compliance|0|||
124561631|NCT02040766|448012925|FG001|Overall Study|Non-compliance|1|||
124561632|NCT02040766|448012926|FG002|Overall Study|Non-compliance|0|||
124561633|NCT02040766|448012927|FG003|Overall Study|Non-compliance|0|||
124561634|NCT02040766|448012928|FG004|Overall Study|Non-compliance|0|||
124561635|NCT02040766|448012924|FG000|Overall Study|Protocol Violation|2|||
124561636|NCT02040766|448012925|FG001|Overall Study|Protocol Violation|1|||
124561637|NCT02040766|448012926|FG002|Overall Study|Protocol Violation|2|||
124561638|NCT02040766|448012927|FG003|Overall Study|Protocol Violation|3|||
124561639|NCT02040766|448012928|FG004|Overall Study|Protocol Violation|0|||
124561640|NCT02040766|448012924|FG000|Overall Study|Lost to Follow-up|4|||
124561641|NCT02040766|448012925|FG001|Overall Study|Lost to Follow-up|1|||
124561642|NCT02040766|448012926|FG002|Overall Study|Lost to Follow-up|3|||
124503220|NCT02052778|447793484|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503221|NCT02052778|447793485|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503222|NCT02052778|447793486|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503223|NCT02052778|447793487|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503224|NCT02052778|447793488|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503225|NCT02052778|447793489|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503226|NCT02052778|447793490|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503227|NCT02052778|447793491|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503228|NCT02052778|447793492|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503229|NCT02052778|447793493|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503230|NCT02052778|447793494|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503231|NCT02052778|447793495|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503232|NCT02052778|447793496|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503233|NCT02052778|447793497|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503234|NCT02052778|447793498|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503235|NCT02052778|447793499|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503236|NCT02052778|447793500|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503237|NCT02052778|447793501|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
124503238|NCT02052778|447793502|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
124503239|NCT02052778|447793480|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503240|NCT02052778|447793481|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503241|NCT02052778|447793482|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503242|NCT02052778|447793483|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503243|NCT02052778|447793484|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503244|NCT02052778|447793485|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503245|NCT02052778|447793486|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503246|NCT02052778|447793487|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503247|NCT02052778|447793488|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503248|NCT02052778|447793489|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503249|NCT02052778|447793490|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503250|NCT02052778|447793491|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503251|NCT02052778|447793492|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503252|NCT02052778|447793493|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503253|NCT02052778|447793494|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503254|NCT02052778|447793495|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503255|NCT02052778|447793496|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503256|NCT02052778|447793497|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503257|NCT02052778|447793498|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503258|NCT02052778|447793499|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503259|NCT02052778|447793500|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503260|NCT02052778|447793501|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
124503261|NCT02052778|447793502|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
124503262|NCT02052778|447793480|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503263|NCT02052778|447793481|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503264|NCT02052778|447793482|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503265|NCT02052778|447793483|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503266|NCT02052778|447793484|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503267|NCT02052778|447793485|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503268|NCT02052778|447793486|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503269|NCT02052778|447793487|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124561643|NCT02040766|448012927|FG003|Overall Study|Lost to Follow-up|1|||
124561644|NCT02040766|448012928|FG004|Overall Study|Lost to Follow-up|4|||
124561645|NCT02040766|448012924|FG000|Overall Study|Not reported|1|||
124561646|NCT02040766|448012925|FG001|Overall Study|Not reported|0|||
124503270|NCT02052778|447793488|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503271|NCT02052778|447793489|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503272|NCT02052778|447793490|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503273|NCT02052778|447793491|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124561647|NCT02040766|448012926|FG002|Overall Study|Not reported|0|||
124561648|NCT02040766|448012927|FG003|Overall Study|Not reported|0|||
124561649|NCT02040766|448012928|FG004|Overall Study|Not reported|0|||
124561650|NCT02040766|448012924|FG000|Overall Study|Lack of Efficacy|6|||
124561651|NCT02040766|448012925|FG001|Overall Study|Lack of Efficacy|3|||
124561652|NCT02040766|448012926|FG002|Overall Study|Lack of Efficacy|4|||
124561653|NCT02040766|448012927|FG003|Overall Study|Lack of Efficacy|6|||
124561654|NCT02040766|448012928|FG004|Overall Study|Lack of Efficacy|5|||
124561655|NCT00481247|448012938|FG000|Overall Study|Death|0|||
124561656|NCT00481247|448012939|FG001|Overall Study|Death|1|||
124561657|NCT00481247|448012938|FG000|Overall Study|Disease progression|18|||
124561658|NCT00481247|448012939|FG001|Overall Study|Disease progression|22|||
124561659|NCT00481247|448012938|FG000|Overall Study|Intolerance|42|||
124561660|NCT00481247|448012939|FG001|Overall Study|Intolerance|17|||
124561661|NCT00481247|448012938|FG000|Overall Study|Treatment failure|10|||
124561662|NCT00481247|448012939|FG001|Overall Study|Treatment failure|14|||
124561663|NCT00481247|448012938|FG000|Overall Study|AE unrelated to study drug|13|||
124561664|NCT00481247|448012939|FG001|Overall Study|AE unrelated to study drug|4|||
124561665|NCT00481247|448012938|FG000|Overall Study|Withdrawal by Subject|8|||
124561666|NCT00481247|448012939|FG001|Overall Study|Withdrawal by Subject|13|||
124561667|NCT00481247|448012938|FG000|Overall Study|Pregnancy|2|||
124561668|NCT00481247|448012939|FG001|Overall Study|Pregnancy|1|||
124561669|NCT00481247|448012938|FG000|Overall Study|Lost to Follow-up|1|||
124561670|NCT00481247|448012939|FG001|Overall Study|Lost to Follow-up|2|||
124561671|NCT00481247|448012938|FG000|Overall Study|Poor compliance/noncompliance|1|||
124561672|NCT00481247|448012939|FG001|Overall Study|Poor compliance/noncompliance|7|||
124561673|NCT00481247|448012938|FG000|Overall Study|Administrative reason by sponsor|157|||
124561674|NCT00481247|448012939|FG001|Overall Study|Administrative reason by sponsor|162|||
124561675|NCT00481247|448012938|FG000|Overall Study|Varied|6|||
124561676|NCT00481247|448012939|FG001|Overall Study|Varied|15|||
124561677|NCT00481247|448012938|FG000|Overall Study|Did not receive treatment|1|||
124561678|NCT00481247|448012939|FG001|Overall Study|Did not receive treatment|2|||
124503274|NCT02052778|447793492|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503275|NCT02052778|447793493|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503276|NCT02052778|447793494|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503277|NCT02052778|447793495|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503278|NCT02052778|447793496|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503279|NCT02052778|447793497|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503280|NCT02052778|447793498|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503281|NCT02052778|447793499|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503282|NCT02052778|447793500|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503283|NCT02052778|447793501|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
124503284|NCT02052778|447793502|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
124503285|NCT02052778|447793480|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503286|NCT02052778|447793481|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503287|NCT02052778|447793482|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503288|NCT02052778|447793483|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503289|NCT02052778|447793484|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503290|NCT02052778|447793485|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124561679|NCT02535000|448012940|FG000|Overall Study|Cancellation of surgery.|1|||
124561680|NCT02535000|448012941|FG001|Overall Study|Cancellation of surgery.|2|||
124561681|NCT04317781|448012942|FG000|Overall Study|Adverse Event|1|||
124561682|NCT04317781|448012942|FG000|Overall Study|Disease relapse|1|||
124561683|NCT04317781|448012942|FG000|Overall Study|Withdrawal by Subject|1|||
124561684|NCT01620489|448012943|FG000|Overall Study|Adverse Event|17|||
124561685|NCT01620489|448012944|FG001|Overall Study|Adverse Event|4|||
124561686|NCT01620489|448012943|FG000|Overall Study|Protocol Violation|0|||
124561687|NCT01620489|448012944|FG001|Overall Study|Protocol Violation|3|||
124561688|NCT01620489|448012943|FG000|Overall Study|Withdrawal Criteria|17|||
124561689|NCT01620489|448012944|FG001|Overall Study|Withdrawal Criteria|25|||
124561690|NCT01620489|448012943|FG000|Overall Study|Unclassified|1|||
124561691|NCT01620489|448012944|FG001|Overall Study|Unclassified|2|||
124561692|NCT00947856|448012945|FG000|Treatment Period|Progressive Disease|33|||
124561693|NCT00947856|448012946|FG001|Treatment Period|Progressive Disease|12|||
124561694|NCT00947856|448012945|FG000|Treatment Period|Adverse Event|15|||
124561695|NCT00947856|448012946|FG001|Treatment Period|Adverse Event|9|||
124561696|NCT00947856|448012945|FG000|Treatment Period|Physician Decision|14|||
124561697|NCT00947856|448012946|FG001|Treatment Period|Physician Decision|6|||
124561698|NCT00947856|448012945|FG000|Treatment Period|Study Stopped by Sponsor|4|||
124561699|NCT00947856|448012946|FG001|Treatment Period|Study Stopped by Sponsor|4|||
124561700|NCT00947856|448012945|FG000|Treatment Period|Withdrawal by Subject|12|||
124561701|NCT00947856|448012946|FG001|Treatment Period|Withdrawal by Subject|1|||
124561702|NCT00947856|448012945|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
124561703|NCT00947856|448012946|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
124561704|NCT00947856|448012945|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
124561705|NCT00947856|448012946|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
124561706|NCT00947856|448012945|FG000|Follow-up Period|Lost to Follow-up|7|||
124561707|NCT00947856|448012946|FG001|Follow-up Period|Lost to Follow-up|0|||
124561708|NCT00947856|448012945|FG000|Follow-up Period|Patient unavailable for site visits|1|||
124561709|NCT00947856|448012946|FG001|Follow-up Period|Patient unavailable for site visits|0|||
124561710|NCT00947856|448012945|FG000|Follow-up Period|Withdrawal by Subject|1|||
124503291|NCT02052778|447793486|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503292|NCT02052778|447793487|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503293|NCT02052778|447793488|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503294|NCT02052778|447793489|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503295|NCT02052778|447793490|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503296|NCT02052778|447793491|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503297|NCT02052778|447793492|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503298|NCT02052778|447793493|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503299|NCT02052778|447793494|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503300|NCT02052778|447793495|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503301|NCT02052778|447793496|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503302|NCT02052778|447793497|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503303|NCT02052778|447793498|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503304|NCT02052778|447793499|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503305|NCT02052778|447793500|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503306|NCT02052778|447793501|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
124503307|NCT02052778|447793502|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
124503308|NCT02052778|447793480|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503309|NCT02052778|447793481|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503310|NCT02052778|447793482|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503311|NCT02052778|447793483|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503312|NCT02052778|447793484|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503313|NCT02052778|447793485|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503314|NCT02052778|447793486|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503315|NCT02052778|447793487|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503316|NCT02052778|447793488|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503317|NCT02052778|447793489|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503318|NCT02052778|447793490|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503319|NCT02052778|447793491|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503320|NCT02052778|447793492|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503321|NCT02052778|447793493|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503322|NCT02052778|447793494|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503323|NCT02052778|447793495|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503324|NCT02052778|447793496|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503325|NCT02052778|447793497|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503326|NCT02052778|447793498|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503327|NCT02052778|447793499|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503328|NCT02052778|447793500|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503329|NCT02052778|447793501|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
124503330|NCT02052778|447793502|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
124503331|NCT02052778|447793480|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
124503332|NCT02052778|447793481|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
124503333|NCT02052778|447793482|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
124503334|NCT02052778|447793483|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
124503335|NCT02052778|447793484|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
124503336|NCT02052778|447793485|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
124503337|NCT02052778|447793486|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
124503338|NCT02052778|447793487|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
124561711|NCT00947856|448012946|FG001|Follow-up Period|Withdrawal by Subject|0|||
124503339|NCT02052778|447793488|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
124561712|NCT01193517|448012951|FG000|Overall Study|Early Progression|1|||
124561713|NCT01193517|448012952|FG001|Overall Study|Early Progression|0|||
124561714|NCT01193517|448012953|FG002|Overall Study|Early Progression|0|||
124503340|NCT02052778|447793489|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
124503341|NCT02052778|447793490|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
124503342|NCT02052778|447793491|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
124503343|NCT02052778|447793492|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
124503344|NCT02052778|447793493|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
124503345|NCT02052778|447793494|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
124503346|NCT02052778|447793495|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
124503347|NCT02052778|447793496|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
124503348|NCT02052778|447793497|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
124503349|NCT02052778|447793498|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
124503350|NCT02052778|447793499|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
124503351|NCT02052778|447793500|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
124503352|NCT02052778|447793501|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
124503353|NCT02052778|447793502|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
124503354|NCT02052778|447793480|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503355|NCT02052778|447793481|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503356|NCT02052778|447793482|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503357|NCT02052778|447793483|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503358|NCT02052778|447793484|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503359|NCT02052778|447793485|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503360|NCT02052778|447793486|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503361|NCT02052778|447793487|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503362|NCT02052778|447793488|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503363|NCT02052778|447793489|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503364|NCT02052778|447793490|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503365|NCT02052778|447793491|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503366|NCT02052778|447793492|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503367|NCT02052778|447793493|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503368|NCT02052778|447793494|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503369|NCT02052778|447793495|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503370|NCT02052778|447793496|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503371|NCT02052778|447793497|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503372|NCT02052778|447793498|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503373|NCT02052778|447793499|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503374|NCT02052778|447793500|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503375|NCT02052778|447793501|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
124503376|NCT02052778|447793502|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
124503377|NCT01094730|447793509|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
124503378|NCT01094730|447793510|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
124503379|NCT01094730|447793509|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
124503380|NCT01094730|447793510|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
124503381|NCT01094730|447793509|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
124503382|NCT01094730|447793510|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
124503383|NCT01094730|447793509|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
124503384|NCT01094730|447793510|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
124503385|NCT01094730|447793509|FG000|Period 2 (14 Days)|Protocol Violation|2|||
124503386|NCT01094730|447793510|FG001|Period 2 (14 Days)|Protocol Violation|0|||
124503387|NCT01094730|447793509|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
124503388|NCT01094730|447793510|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
124503389|NCT01094730|447793509|FG000|Period 2 (14 Days)|Adverse Event|0|||
124503390|NCT01094730|447793510|FG001|Period 2 (14 Days)|Adverse Event|1|||
124503391|NCT01094730|447793509|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
124503392|NCT01094730|447793510|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
124503393|NCT04171037|447793511|FG000|Overall Study|Lost to Follow-up|1|||
124503394|NCT04171037|447793512|FG001|Overall Study|Lost to Follow-up|0|||
124503395|NCT04171037|447793511|FG000|Overall Study|Physician Decision|3|||
124503396|NCT04171037|447793512|FG001|Overall Study|Physician Decision|3|||
124503397|NCT00987623|447793513|FG000|Overall Study|Lost to Follow-up|2|||
124503398|NCT00987623|447793514|FG001|Overall Study|Lost to Follow-up|1|||
124503399|NCT00987623|447793513|FG000|Overall Study|Time/job conflict|2|||
124503400|NCT00987623|447793514|FG001|Overall Study|Time/job conflict|0|||
124503401|NCT00987623|447793513|FG000|Overall Study|Discomfort|1|||
124503402|NCT00987623|447793514|FG001|Overall Study|Discomfort|0|||
124503403|NCT00987623|447793513|FG000|Overall Study|Biomicroscopy|0|||
124503404|NCT00987623|447793514|FG001|Overall Study|Biomicroscopy|1|||
124503405|NCT00987623|447793513|FG000|Overall Study|Influenza|0|||
124503406|NCT00987623|447793514|FG001|Overall Study|Influenza|1|||
124503407|NCT03135028|447793518|FG000|Overall Study|Death|6|||
124503408|NCT03135028|447793518|FG000|Overall Study|Study Terminated by Sponsor|2|||
124503409|NCT03135028|447793518|FG000|Overall Study|Withdrew Consent|1|||
124503410|NCT00748540|447793519|FG000|Overall Study|Physician Decision|1|||
124503411|NCT02065869|447793520|FG000|Overall Study|Death|7|||
124503412|NCT02065869|447793520|FG000|Overall Study|Disease relapse|16|||
124503413|NCT02065869|447793520|FG000|Overall Study|Lost to Follow-up|4|||
124561715|NCT01512979|448012962|FG000|Overall Study|Adverse Event|2|||
124503414|NCT02065869|447793520|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
124503415|NCT02065869|447793520|FG000|Overall Study|Withdrawal by Subject|1|||
124503416|NCT01814800|447793521|FG000|Overall Study|Adverse Event|2|||
124503417|NCT01814800|447793521|FG000|Overall Study|Pregnancy|1|||
124503418|NCT01814800|447793521|FG000|Overall Study|Sponsor decision|1|||
124503419|NCT01814800|447793521|FG000|Overall Study|Subject relocation|1|||
124503420|NCT04436822|447793522|FG000|Overall Study|Physician Decision|2|||
124503421|NCT04436822|447793523|FG001|Overall Study|Physician Decision|0|||
124503422|NCT04436822|447793522|FG000|Overall Study|Sponsor request|1|||
124503423|NCT04436822|447793523|FG001|Overall Study|Sponsor request|0|||
124503424|NCT04436822|447793522|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124503425|NCT04436822|447793523|FG001|Overall Study|Withdrawal by parent/guardian|3|||
124503426|NCT04436822|447793522|FG000|Overall Study|Unsuccessful procedure|0|||
124503427|NCT04436822|447793523|FG001|Overall Study|Unsuccessful procedure|1|||
124503428|NCT04436822|447793522|FG000|Overall Study|Withdrawal due to Covid-19|8|||
124503429|NCT04436822|447793523|FG001|Overall Study|Withdrawal due to Covid-19|1|||
124503430|NCT04436822|447793522|FG000|Overall Study|Withdrawal by Subject|1|||
124503431|NCT04436822|447793523|FG001|Overall Study|Withdrawal by Subject|0|||
124503432|NCT04436822|447793522|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
124503433|NCT04436822|447793523|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
124503434|NCT03375112|447793526|FG000|Overall Study|Withdrawal by Subject|3|||
124503435|NCT03375112|447793527|FG001|Overall Study|Withdrawal by Subject|0|||
124503436|NCT00243230|447793528|FG000|Double-Blind Period|Adverse Event|0|||
124503437|NCT00243230|447793529|FG001|Double-Blind Period|Adverse Event|2|||
124503438|NCT00243230|447793530|FG002|Double-Blind Period|Adverse Event|2|||
124503439|NCT00243230|447793531|FG003|Double-Blind Period|Adverse Event|0|||
124503440|NCT00243230|447793528|FG000|Double-Blind Period|Withdrawal by Subject|1|||
124503441|NCT00243230|447793529|FG001|Double-Blind Period|Withdrawal by Subject|0|||
124503442|NCT00243230|447793530|FG002|Double-Blind Period|Withdrawal by Subject|0|||
124503443|NCT00243230|447793531|FG003|Double-Blind Period|Withdrawal by Subject|0|||
124503444|NCT00243230|447793528|FG000|Double-Blind Period|Protocol Violation|0|||
124503445|NCT00243230|447793529|FG001|Double-Blind Period|Protocol Violation|0|||
124503446|NCT00243230|447793530|FG002|Double-Blind Period|Protocol Violation|1|||
124503447|NCT00243230|447793531|FG003|Double-Blind Period|Protocol Violation|0|||
124503448|NCT00243230|447793528|FG000|Double-Blind Period|Randomized but Not Treated|0|||
124503449|NCT00243230|447793529|FG001|Double-Blind Period|Randomized but Not Treated|0|||
124503450|NCT00243230|447793530|FG002|Double-Blind Period|Randomized but Not Treated|2|||
124503451|NCT00243230|447793531|FG003|Double-Blind Period|Randomized but Not Treated|0|||
124503452|NCT00243230|447793528|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
124503453|NCT00243230|447793529|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
124503454|NCT00243230|447793530|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
124503455|NCT00243230|447793531|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
124503456|NCT00243230|447793528|FG000|Open Label Period|Adverse Event|0|||
124503457|NCT00243230|447793529|FG001|Open Label Period|Adverse Event|0|||
124503458|NCT00243230|447793530|FG002|Open Label Period|Adverse Event|0|||
124503459|NCT00243230|447793531|FG003|Open Label Period|Adverse Event|2|||
124503460|NCT00243230|447793528|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
124503461|NCT00243230|447793529|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
124503462|NCT00243230|447793530|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
124503463|NCT00243230|447793531|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
124503464|NCT00243230|447793528|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
124503465|NCT00243230|447793529|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
124503466|NCT00243230|447793530|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
124503467|NCT00243230|447793531|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
124503468|NCT00243230|447793528|FG000|Open Label Period|Lost to Follow-up|0|||
124503469|NCT00243230|447793529|FG001|Open Label Period|Lost to Follow-up|0|||
124503470|NCT00243230|447793530|FG002|Open Label Period|Lost to Follow-up|0|||
124503471|NCT00243230|447793531|FG003|Open Label Period|Lost to Follow-up|2|||
124503472|NCT00243230|447793528|FG000|Open Label Period|Withdrawal by Subject|0|||
124503473|NCT00243230|447793529|FG001|Open Label Period|Withdrawal by Subject|0|||
124503474|NCT00243230|447793530|FG002|Open Label Period|Withdrawal by Subject|0|||
124503475|NCT00243230|447793531|FG003|Open Label Period|Withdrawal by Subject|2|||
124503476|NCT00243230|447793528|FG000|Open Label Period|Protocol Violation|0|||
124503477|NCT00243230|447793529|FG001|Open Label Period|Protocol Violation|0|||
124503478|NCT00243230|447793530|FG002|Open Label Period|Protocol Violation|0|||
124503479|NCT00243230|447793531|FG003|Open Label Period|Protocol Violation|2|||
124503480|NCT00243230|447793528|FG000|Open Label Period|Administrative Reason|0|||
124503481|NCT00243230|447793529|FG001|Open Label Period|Administrative Reason|0|||
124503482|NCT00243230|447793530|FG002|Open Label Period|Administrative Reason|0|||
124503483|NCT00243230|447793531|FG003|Open Label Period|Administrative Reason|63|||
124503484|NCT05118386|447793532|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
124503485|NCT05118386|447793533|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
124503486|NCT05118386|447793534|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
124503487|NCT05118386|447793535|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
124503488|NCT05118386|447793536|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
124503489|NCT05118386|447793537|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
124503490|NCT05118386|447793532|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
124503491|NCT05118386|447793533|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
124503492|NCT05118386|447793534|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
124503493|NCT05118386|447793535|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
124503494|NCT05118386|447793536|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
124503495|NCT05118386|447793537|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
124503496|NCT00303108|447793540|FG000|Overall Study|Adverse Event|5|||
124503497|NCT00303108|447793541|FG001|Overall Study|Adverse Event|6|||
124503498|NCT00303108|447793542|FG002|Overall Study|Adverse Event|7|||
124503499|NCT00303108|447793540|FG000|Overall Study|Patient Request|4|||
124503500|NCT00303108|447793541|FG001|Overall Study|Patient Request|2|||
124503501|NCT00303108|447793542|FG002|Overall Study|Patient Request|8|||
124503502|NCT00303108|447793540|FG000|Overall Study|Failed Entry|1|||
124503503|NCT00303108|447793541|FG001|Overall Study|Failed Entry|0|||
124503504|NCT00303108|447793542|FG002|Overall Study|Failed Entry|1|||
124503505|NCT00303108|447793540|FG000|Overall Study|ineligible|2|||
124503506|NCT00303108|447793541|FG001|Overall Study|ineligible|1|||
124503507|NCT00303108|447793542|FG002|Overall Study|ineligible|0|||
124503508|NCT00894413|447793545|FG000|Overall Study|Physician Decision|0|||
124503509|NCT00894413|447793546|FG001|Overall Study|Physician Decision|2|||
124503510|NCT00894413|447793545|FG000|Overall Study|Adverse Event|0|||
124503511|NCT00894413|447793546|FG001|Overall Study|Adverse Event|2|||
124503512|NCT00894413|447793545|FG000|Overall Study|Withdrawal by Subject|0|||
124503513|NCT00894413|447793546|FG001|Overall Study|Withdrawal by Subject|4|||
124503514|NCT00008138|447793547|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
124503515|NCT00008138|447793547|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
124503516|NCT00008138|447793547|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
124503517|NCT00008138|447793547|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
124503518|NCT00008138|447793547|FG000|Interval Debulking|Withdrawal by Subject|2|||
124503519|NCT00008138|447793547|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
124503520|NCT00008138|447793547|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
124503521|NCT00008138|447793547|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
124503522|NCT00142519|447793548|FG000|Overall Study|Not Treated|7|||
124503523|NCT00142519|447793549|FG001|Overall Study|Not Treated|9|||
124503524|NCT00142519|447793548|FG000|Overall Study|Protocol Violation|1|||
124503525|NCT00142519|447793549|FG001|Overall Study|Protocol Violation|0|||
124503526|NCT00142519|447793548|FG000|Overall Study|Withdrawal by Subject|10|||
124503527|NCT00142519|447793549|FG001|Overall Study|Withdrawal by Subject|7|||
124503528|NCT00755846|447795209|FG000|Overall Study|Adverse Event|0|||
124503529|NCT00755846|447795210|FG001|Overall Study|Adverse Event|0|||
124503530|NCT00755846|447795211|FG002|Overall Study|Adverse Event|0|||
124503531|NCT00755846|447795212|FG003|Overall Study|Adverse Event|1|||
124503532|NCT00755846|447795213|FG004|Overall Study|Adverse Event|3|||
124503533|NCT00755846|447795214|FG005|Overall Study|Adverse Event|2|||
124503534|NCT00755846|447795209|FG000|Overall Study|Protocol Violation|1|||
124503535|NCT00755846|447795210|FG001|Overall Study|Protocol Violation|1|||
124503536|NCT00755846|447795211|FG002|Overall Study|Protocol Violation|1|||
124503537|NCT00755846|447795212|FG003|Overall Study|Protocol Violation|1|||
124503538|NCT00755846|447795213|FG004|Overall Study|Protocol Violation|1|||
124503539|NCT00755846|447795214|FG005|Overall Study|Protocol Violation|1|||
124503540|NCT00755846|447795209|FG000|Overall Study|Lost to Follow-up|0|||
124503541|NCT00755846|447795210|FG001|Overall Study|Lost to Follow-up|2|||
124503542|NCT00755846|447795211|FG002|Overall Study|Lost to Follow-up|1|||
124503543|NCT00755846|447795212|FG003|Overall Study|Lost to Follow-up|0|||
124503544|NCT00755846|447795213|FG004|Overall Study|Lost to Follow-up|4|||
124503545|NCT00755846|447795214|FG005|Overall Study|Lost to Follow-up|2|||
124503546|NCT00755846|447795209|FG000|Overall Study|Withdrawal by Subject|2|||
124503547|NCT00755846|447795210|FG001|Overall Study|Withdrawal by Subject|3|||
124503548|NCT00755846|447795211|FG002|Overall Study|Withdrawal by Subject|5|||
124503549|NCT00755846|447795212|FG003|Overall Study|Withdrawal by Subject|2|||
124503550|NCT00755846|447795213|FG004|Overall Study|Withdrawal by Subject|0|||
124503551|NCT00755846|447795214|FG005|Overall Study|Withdrawal by Subject|1|||
124503552|NCT00755846|447795209|FG000|Overall Study|Hyperglycemic Rescue|21|||
124503553|NCT00755846|447795210|FG001|Overall Study|Hyperglycemic Rescue|7|||
124503554|NCT00755846|447795211|FG002|Overall Study|Hyperglycemic Rescue|5|||
124503555|NCT00755846|447795212|FG003|Overall Study|Hyperglycemic Rescue|8|||
124503556|NCT00755846|447795213|FG004|Overall Study|Hyperglycemic Rescue|8|||
124503557|NCT00755846|447795214|FG005|Overall Study|Hyperglycemic Rescue|7|||
124503558|NCT00755846|447795209|FG000|Overall Study|Physician Decision|1|||
124503559|NCT00755846|447795210|FG001|Overall Study|Physician Decision|3|||
124503560|NCT00755846|447795211|FG002|Overall Study|Physician Decision|0|||
124503561|NCT00755846|447795212|FG003|Overall Study|Physician Decision|1|||
124503562|NCT00755846|447795213|FG004|Overall Study|Physician Decision|0|||
124503563|NCT00755846|447795214|FG005|Overall Study|Physician Decision|1|||
124503564|NCT00755846|447795209|FG000|Overall Study|Administrative Error|0|||
124503565|NCT00755846|447795210|FG001|Overall Study|Administrative Error|1|||
124503566|NCT00755846|447795211|FG002|Overall Study|Administrative Error|0|||
124503567|NCT00755846|447795212|FG003|Overall Study|Administrative Error|0|||
124503568|NCT00755846|447795213|FG004|Overall Study|Administrative Error|0|||
124503569|NCT00755846|447795214|FG005|Overall Study|Administrative Error|0|||
124503570|NCT00755846|447795209|FG000|Overall Study|Participant Non-compliance|0|||
124503571|NCT00755846|447795210|FG001|Overall Study|Participant Non-compliance|0|||
124503572|NCT00755846|447795211|FG002|Overall Study|Participant Non-compliance|0|||
124503573|NCT00755846|447795212|FG003|Overall Study|Participant Non-compliance|0|||
124503574|NCT00755846|447795213|FG004|Overall Study|Participant Non-compliance|1|||
124503575|NCT00755846|447795214|FG005|Overall Study|Participant Non-compliance|0|||
124503576|NCT00786032|447795215|FG000|Overall Study|Death|4|||
124503577|NCT00786032|447795215|FG000|Overall Study|Withdrawal by Subject|14|||
124503578|NCT00786032|447795215|FG000|Overall Study|Did not complete in the timeframe|6|||
124503579|NCT02429258|447795216|FG000|Overall Study|Withdrawal by Subject|2|||
124503580|NCT02429258|447795217|FG001|Overall Study|Withdrawal by Subject|0|||
124503581|NCT02429258|447795216|FG000|Overall Study|Protocol Violation|0|||
124503582|NCT02429258|447795217|FG001|Overall Study|Protocol Violation|1|||
124503583|NCT02616185|447795219|FG000|Overall Study|Death|0|||
124503584|NCT02616185|447795220|FG001|Overall Study|Death|0|||
124503585|NCT02616185|447795221|FG002|Overall Study|Death|0|||
124503586|NCT02616185|447795222|FG003|Overall Study|Death|1|||
124503587|NCT02616185|447795223|FG004|Overall Study|Death|2|||
124503588|NCT02616185|447795224|FG005|Overall Study|Death|0|||
124503589|NCT02616185|447795225|FG006|Overall Study|Death|0|||
124503590|NCT02616185|447795226|FG007|Overall Study|Death|2|||
124503591|NCT02616185|447795227|FG008|Overall Study|Death|1|||
124503592|NCT02616185|447795219|FG000|Overall Study|Study terminated by sponsor|0|||
124503593|NCT02616185|447795220|FG001|Overall Study|Study terminated by sponsor|0|||
124503594|NCT02616185|447795221|FG002|Overall Study|Study terminated by sponsor|1|||
124503595|NCT02616185|447795222|FG003|Overall Study|Study terminated by sponsor|0|||
124503596|NCT02616185|447795223|FG004|Overall Study|Study terminated by sponsor|0|||
124503597|NCT02616185|447795224|FG005|Overall Study|Study terminated by sponsor|0|||
124503598|NCT02616185|447795225|FG006|Overall Study|Study terminated by sponsor|5|||
124503599|NCT02616185|447795226|FG007|Overall Study|Study terminated by sponsor|2|||
124503600|NCT02616185|447795227|FG008|Overall Study|Study terminated by sponsor|0|||
124503601|NCT02616185|447795219|FG000|Overall Study|Participant refused further follow-up|1|||
124503602|NCT02616185|447795220|FG001|Overall Study|Participant refused further follow-up|1|||
124503603|NCT02616185|447795221|FG002|Overall Study|Participant refused further follow-up|2|||
124503604|NCT02616185|447795222|FG003|Overall Study|Participant refused further follow-up|3|||
124503605|NCT02616185|447795223|FG004|Overall Study|Participant refused further follow-up|4|||
124503606|NCT02616185|447795224|FG005|Overall Study|Participant refused further follow-up|0|||
124503607|NCT02616185|447795225|FG006|Overall Study|Participant refused further follow-up|3|||
124503608|NCT02616185|447795226|FG007|Overall Study|Participant refused further follow-up|4|||
124503609|NCT02616185|447795227|FG008|Overall Study|Participant refused further follow-up|3|||
124503610|NCT02616185|447795219|FG000|Overall Study|Not reported|0|||
124503611|NCT02616185|447795220|FG001|Overall Study|Not reported|0|||
124503612|NCT02616185|447795221|FG002|Overall Study|Not reported|0|||
124503613|NCT02616185|447795222|FG003|Overall Study|Not reported|1|||
124503614|NCT02616185|447795223|FG004|Overall Study|Not reported|3|||
124503615|NCT02616185|447795224|FG005|Overall Study|Not reported|1|||
124503616|NCT02616185|447795225|FG006|Overall Study|Not reported|0|||
124503617|NCT02616185|447795226|FG007|Overall Study|Not reported|5|||
124503618|NCT02616185|447795227|FG008|Overall Study|Not reported|2|||
124503619|NCT01303380|447795228|FG000|Overall Study|Lack of compliance to study procedures|1|||
124503620|NCT01346371|447795229|FG000|Overall Study|Lost to Follow-up|2|||
124503621|NCT01346371|447795230|FG001|Overall Study|Lost to Follow-up|0|||
124503622|NCT00789958|447795232|FG000|Overall Study|Adverse Event|3|||
124503623|NCT00789958|447795232|FG000|Overall Study|Withdrawal by Subject|4|||
124503624|NCT00789958|447795232|FG000|Overall Study|Progression|3|||
124503625|NCT00789958|447795232|FG000|Overall Study|not protocol specified|1|||
124503626|NCT00789958|447795232|FG000|Overall Study|Not eligible/not analyzable|26|||
124503627|NCT01000727|447795235|FG000|Overall Study|Lost to Follow-up|41|||
124503628|NCT01000727|447795236|FG001|Overall Study|Lost to Follow-up|43|||
124503629|NCT01000727|447795235|FG000|Overall Study|Withdrawal by Subject|111|||
124503630|NCT01000727|447795236|FG001|Overall Study|Withdrawal by Subject|109|||
124503631|NCT01000727|447795235|FG000|Overall Study|Study closed/terminated|23|||
124503632|NCT01000727|447795236|FG001|Overall Study|Study closed/terminated|24|||
124503633|NCT03544268|447795239|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
124503634|NCT03544268|447795240|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
124503635|NCT00377611|447795247|FG000|Overall Study|Adverse Event|2|||
124503636|NCT00377611|447795248|FG001|Overall Study|Adverse Event|9|||
124503637|NCT00377611|447795247|FG000|Overall Study|Protocol Violation|2|||
124503638|NCT00377611|447795248|FG001|Overall Study|Protocol Violation|0|||
124503639|NCT00377611|447795247|FG000|Overall Study|Withdrawal by Subject|0|||
124503640|NCT00377611|447795248|FG001|Overall Study|Withdrawal by Subject|5|||
124503641|NCT00377611|447795247|FG000|Overall Study|Lost to Follow-up|18|||
124503642|NCT00377611|447795248|FG001|Overall Study|Lost to Follow-up|16|||
124503643|NCT00377611|447795247|FG000|Overall Study|Other|0|||
124503644|NCT00377611|447795248|FG001|Overall Study|Other|3|||
124503645|NCT04831515|447795249|FG000|First Intervention|Adverse Event|0|||
124503646|NCT04831515|447795250|FG001|First Intervention|Adverse Event|1|||
124503647|NCT01640925|447795253|FG000|Overall Study|Withdrawal by Subject|1|||
124503648|NCT01640925|447795254|FG001|Overall Study|Withdrawal by Subject|0|||
124503649|NCT01640925|447795253|FG000|Overall Study|Previously enrolled in this trial|13|||
124503650|NCT01640925|447795254|FG001|Overall Study|Previously enrolled in this trial|11|||
124503651|NCT01030458|447795267|FG000|Overall Study|Lost to Follow-up|9|||
124503652|NCT01030458|447795268|FG001|Overall Study|Lost to Follow-up|10|||
124503653|NCT01030458|447795267|FG000|Overall Study|Withdrawal by Subject|2|||
124503654|NCT01030458|447795268|FG001|Overall Study|Withdrawal by Subject|3|||
124503655|NCT01030458|447795267|FG000|Overall Study|Logistical reasons|9|||
124503656|NCT01030458|447795268|FG001|Overall Study|Logistical reasons|5|||
124503657|NCT01030458|447795267|FG000|Overall Study|Moved or changed job|6|||
124503658|NCT01030458|447795268|FG001|Overall Study|Moved or changed job|13|||
124503659|NCT01030458|447795267|FG000|Overall Study|Side effect of medication|1|||
124503660|NCT01030458|447795268|FG001|Overall Study|Side effect of medication|1|||
124503661|NCT01332019|447795269|FG000|Overall Study|Was Not Dosed|1|||
124503662|NCT01332019|447795270|FG001|Overall Study|Was Not Dosed|0|||
124503663|NCT01332019|447795269|FG000|Overall Study|Other|16|||
124503664|NCT01332019|447795270|FG001|Overall Study|Other|18|||
124503665|NCT01332019|447795269|FG000|Overall Study|Death|2|||
124503666|NCT01332019|447795270|FG001|Overall Study|Death|1|||
124503667|NCT01332019|447795269|FG000|Overall Study|Physician Decision|4|||
124503668|NCT01332019|447795270|FG001|Overall Study|Physician Decision|3|||
124503669|NCT01332019|447795269|FG000|Overall Study|Withdrawal by Subject|73|||
124503670|NCT01332019|447795270|FG001|Overall Study|Withdrawal by Subject|71|||
124503671|NCT01332019|447795269|FG000|Overall Study|Lost to Follow-up|4|||
124503672|NCT01332019|447795270|FG001|Overall Study|Lost to Follow-up|7|||
124503673|NCT01332019|447795269|FG000|Overall Study|Adverse Event|13|||
124503674|NCT01332019|447795270|FG001|Overall Study|Adverse Event|22|||
124503675|NCT01395368|447795273|FG000|Overall Study|Physician Decision|14|||
124503676|NCT01395368|447795273|FG000|Overall Study|Withdrawal by Subject|2|||
124503677|NCT00288860|447795277|FG000|Overall Study|Did not complete intake|4|||
124503678|NCT00288860|447795278|FG001|Overall Study|Did not complete intake|8|||
124503679|NCT00288860|447795277|FG000|Overall Study|Death|4|||
124503680|NCT00288860|447795278|FG001|Overall Study|Death|3|||
124503681|NCT00288860|447795277|FG000|Overall Study|Withdrawal by Subject|20|||
124503682|NCT00288860|447795278|FG001|Overall Study|Withdrawal by Subject|15|||
124503683|NCT00288860|447795277|FG000|Overall Study|Lost to Follow-up|74|||
124503684|NCT00288860|447795278|FG001|Overall Study|Lost to Follow-up|71|||
124503685|NCT02586233|447795292|FG000|Overall Study|Randomized but did not receive treatment|0|||
124503686|NCT02586233|447795293|FG001|Overall Study|Randomized but did not receive treatment|1|||
124503687|NCT02586233|447795294|FG002|Overall Study|Randomized but did not receive treatment|0|||
124503688|NCT02586233|447795295|FG003|Overall Study|Randomized but did not receive treatment|0|||
124503689|NCT02586233|447795296|FG004|Overall Study|Randomized but did not receive treatment|0|||
124503690|NCT02586233|447795297|FG005|Overall Study|Randomized but did not receive treatment|2|||
124503691|NCT02586233|447795298|FG006|Overall Study|Randomized but did not receive treatment|2|||
124503692|NCT02586233|447795292|FG000|Overall Study|Death|0|||
124503693|NCT02586233|447795293|FG001|Overall Study|Death|1|||
124503694|NCT02586233|447795294|FG002|Overall Study|Death|0|||
124503695|NCT02586233|447795295|FG003|Overall Study|Death|0|||
124503696|NCT02586233|447795296|FG004|Overall Study|Death|2|||
124503697|NCT02586233|447795297|FG005|Overall Study|Death|0|||
124503698|NCT02586233|447795298|FG006|Overall Study|Death|0|||
124503699|NCT01757405|447795299|FG000|Overall Study|Lost to Follow-up|1|||
124503700|NCT01757405|447795300|FG001|Overall Study|Lost to Follow-up|1|||
124503701|NCT01757405|447795299|FG000|Overall Study|Withdrawal by Subject|0|||
124503702|NCT01757405|447795300|FG001|Overall Study|Withdrawal by Subject|1|||
124503703|NCT01592409|447795301|FG000|Overall Study|Withdrawal by Subject|0|||
124503704|NCT01592409|447795302|FG001|Overall Study|Withdrawal by Subject|1|||
124503705|NCT02345252|447795307|FG000|Double-Blind Phase|Adverse Event|2|||
124503706|NCT02345252|447795308|FG001|Double-Blind Phase|Adverse Event|3|||
124503707|NCT02345252|447795307|FG000|Double-Blind Phase|Death|1|||
124561716|NCT01512979|448012963|FG001|Overall Study|Adverse Event|2|||
124503708|NCT02345252|447795308|FG001|Double-Blind Phase|Death|2|||
124503709|NCT02345252|447795307|FG000|Double-Blind Phase|Lack of Efficacy|1|||
124561717|NCT01512979|448012962|FG000|Overall Study|Protocol Violation|1|||
124503710|NCT02345252|447795308|FG001|Double-Blind Phase|Lack of Efficacy|0|||
124503711|NCT02345252|447795307|FG000|Double-Blind Phase|Investigator's Discretion|4|||
124503712|NCT02345252|447795308|FG001|Double-Blind Phase|Investigator's Discretion|6|||
124503713|NCT02345252|447795307|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
124503714|NCT02345252|447795308|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
124503715|NCT02345252|447795307|FG000|Double-Blind Phase|Protocol Violation|2|||
124503716|NCT02345252|447795308|FG001|Double-Blind Phase|Protocol Violation|1|||
124503717|NCT02345252|447795307|FG000|Double-Blind Phase|Withdrew Consent|21|||
124503718|NCT02345252|447795308|FG001|Double-Blind Phase|Withdrew Consent|23|||
124503719|NCT02345252|447795307|FG000|Double-Blind Phase|Lost to Follow-up|8|||
124503720|NCT02345252|447795308|FG001|Double-Blind Phase|Lost to Follow-up|10|||
124503721|NCT02345252|447795307|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
124503722|NCT02345252|447795308|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
124503723|NCT00779324|447795309|FG000|Overall Study|Lost to Follow-up|2|||
124503724|NCT00779324|447795310|FG001|Overall Study|Lost to Follow-up|1|||
124503725|NCT00779324|447795309|FG000|Overall Study|Withdrawal by Subject|4|||
124503726|NCT00779324|447795310|FG001|Overall Study|Withdrawal by Subject|2|||
124503727|NCT00779324|447795309|FG000|Overall Study|Missed visit|1|||
124503728|NCT00779324|447795310|FG001|Overall Study|Missed visit|1|||
124503729|NCT00617409|447795311|FG000|Overall Study|Withdrawal by Subject|4|||
124503730|NCT00617409|447795312|FG001|Overall Study|Withdrawal by Subject|1|||
124503731|NCT00617409|447795313|FG002|Overall Study|Withdrawal by Subject|2|||
124503732|NCT00617409|447795311|FG000|Overall Study|Adverse Event|0|||
124503733|NCT00617409|447795312|FG001|Overall Study|Adverse Event|2|||
124503734|NCT00617409|447795313|FG002|Overall Study|Adverse Event|3|||
124503735|NCT00617409|447795311|FG000|Overall Study|Disease Progression|8|||
124503736|NCT00617409|447795312|FG001|Overall Study|Disease Progression|8|||
124503737|NCT00617409|447795313|FG002|Overall Study|Disease Progression|18|||
124503738|NCT00617409|447795311|FG000|Overall Study|Death|3|||
124503739|NCT00617409|447795312|FG001|Overall Study|Death|5|||
124503740|NCT00617409|447795313|FG002|Overall Study|Death|4|||
124503741|NCT00617409|447795311|FG000|Overall Study|Alternative Therapy|1|||
124503742|NCT00617409|447795312|FG001|Overall Study|Alternative Therapy|2|||
124503743|NCT00617409|447795313|FG002|Overall Study|Alternative Therapy|0|||
124503744|NCT01496430|447795318|FG000|Overall Study|Adverse Event|0|||
124503745|NCT01496430|447795319|FG001|Overall Study|Adverse Event|0|||
124503746|NCT01496430|447795320|FG002|Overall Study|Adverse Event|1|||
124503747|NCT01496430|447795318|FG000|Overall Study|Major Protocol Deviation|0|||
124503748|NCT01496430|447795319|FG001|Overall Study|Major Protocol Deviation|0|||
124503749|NCT01496430|447795320|FG002|Overall Study|Major Protocol Deviation|1|||
124503750|NCT01496430|447795318|FG000|Overall Study|Lost to Follow-up|2|||
124503751|NCT01496430|447795319|FG001|Overall Study|Lost to Follow-up|3|||
124503752|NCT01496430|447795320|FG002|Overall Study|Lost to Follow-up|1|||
124503753|NCT01496430|447795318|FG000|Overall Study|Voluntary Withdrawal|2|||
124503754|NCT01496430|447795319|FG001|Overall Study|Voluntary Withdrawal|1|||
124503755|NCT01496430|447795320|FG002|Overall Study|Voluntary Withdrawal|6|||
124503756|NCT01496430|447795318|FG000|Overall Study|Principal Investigator Discretion|0|||
124503757|NCT01496430|447795319|FG001|Overall Study|Principal Investigator Discretion|1|||
124503758|NCT01496430|447795320|FG002|Overall Study|Principal Investigator Discretion|1|||
124503759|NCT01496430|447795318|FG000|Overall Study|Other|2|||
124561718|NCT01512979|448012963|FG001|Overall Study|Protocol Violation|4|||
124561719|NCT01512979|448012962|FG000|Overall Study|Lost to Follow-up|2|||
124561720|NCT01512979|448012963|FG001|Overall Study|Lost to Follow-up|5|||
124561721|NCT01512979|448012962|FG000|Overall Study|Withdrawal by Subject|1|||
124561722|NCT01512979|448012963|FG001|Overall Study|Withdrawal by Subject|2|||
124561723|NCT01512979|448012962|FG000|Overall Study|Reason other than stated above|13|||
124561724|NCT01512979|448012963|FG001|Overall Study|Reason other than stated above|9|||
124503760|NCT01496430|447795319|FG001|Overall Study|Other|0|||
124503761|NCT01496430|447795320|FG002|Overall Study|Other|0|||
124503762|NCT01100307|447795321|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
124503763|NCT01100307|447795322|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
124503764|NCT01100307|447795321|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
124503765|NCT01100307|447795322|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
124503766|NCT01100307|447795321|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
124503767|NCT01100307|447795322|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
124503768|NCT01100307|447795321|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
124503769|NCT01100307|447795322|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
124503770|NCT01100307|447795321|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
124503771|NCT01100307|447795322|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
124503772|NCT01100307|447795321|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
124503773|NCT01100307|447795322|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
124503774|NCT02509598|447795323|FG000|Overall Study|Withdrawal by Subject|1|||
124503775|NCT02196038|447795324|FG000|Overall Study|Death|16|||
124503776|NCT02196038|447795325|FG001|Overall Study|Death|21|||
124503777|NCT02196038|447795324|FG000|Overall Study|Withdrawal by Subject|0|||
124503778|NCT02196038|447795325|FG001|Overall Study|Withdrawal by Subject|1|||
124503779|NCT02196038|447795324|FG000|Overall Study|Lost to Follow-up|1|||
124503780|NCT02196038|447795325|FG001|Overall Study|Lost to Follow-up|0|||
124561725|NCT00874757|448012970|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
124561726|NCT00759148|448014559|FG000|Overall Study|Adverse Event|1|||
124561727|NCT00759148|448014560|FG001|Overall Study|Adverse Event|6|||
124561728|NCT00759148|448014559|FG000|Overall Study|Withdrawal by Subject|3|||
124561729|NCT00759148|448014560|FG001|Overall Study|Withdrawal by Subject|7|||
124561730|NCT00759148|448014559|FG000|Overall Study|Lost to Follow-up|3|||
124561731|NCT00759148|448014560|FG001|Overall Study|Lost to Follow-up|9|||
124561732|NCT00759148|448014559|FG000|Overall Study|Treatment Failure|6|||
124561733|NCT00759148|448014560|FG001|Overall Study|Treatment Failure|10|||
124561734|NCT00759148|448014559|FG000|Overall Study|Reason not given|1|||
124561735|NCT00759148|448014560|FG001|Overall Study|Reason not given|0|||
124561736|NCT03433001|448014572|FG000|Overall Study|Lack of Efficacy|109|||
124561737|NCT03433001|448014572|FG000|Overall Study|Adverse Event|69|||
124561738|NCT03433001|448014572|FG000|Overall Study|Withdrawal by Subject|10|||
124561739|NCT03433001|448014572|FG000|Overall Study|Death|12|||
124561740|NCT03433001|448014572|FG000|Overall Study|Lost to Follow-up|4|||
124561741|NCT03433001|448014572|FG000|Overall Study|Other|25|||
124561742|NCT02040428|448014576|FG000|Overall Study|Death|4|||
124561743|NCT02040428|448014577|FG001|Overall Study|Death|3|||
124561744|NCT02040428|448014576|FG000|Overall Study|Withdrawal by Subject|1|||
124561745|NCT02040428|448014577|FG001|Overall Study|Withdrawal by Subject|1|||
124561746|NCT01165996|448014591|FG000|Overall Study|Death|1|||
124561747|NCT01165996|448014591|FG000|Overall Study|Physician Decision|1|||
124561748|NCT00268346|448014595|FG000|Overall Study|Adverse Event|0|||
124561749|NCT00268346|448014596|FG001|Overall Study|Adverse Event|1|||
124561750|NCT00268346|448014595|FG000|Overall Study|Death|0|||
124561751|NCT00268346|448014596|FG001|Overall Study|Death|1|||
124561752|NCT00268346|448014595|FG000|Overall Study|Withdrawal by Subject|0|||
124561753|NCT00268346|448014596|FG001|Overall Study|Withdrawal by Subject|1|||
124561754|NCT05487456|448014597|FG000|Overall Study|Withdrawal by Subject|0|||
124561755|NCT05487456|448014598|FG001|Overall Study|Withdrawal by Subject|0|||
124561756|NCT05487456|448014599|FG002|Overall Study|Withdrawal by Subject|1|||
124561757|NCT05487456|448014600|FG003|Overall Study|Withdrawal by Subject|0|||
124561758|NCT00294723|448014603|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
124561759|NCT00294723|448014604|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
124561760|NCT00294723|448014605|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
124561761|NCT00294723|448014603|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
124561762|NCT00294723|448014604|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
124561763|NCT00294723|448014605|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
124561764|NCT00294723|448014603|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
124561765|NCT00294723|448014604|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
124776647|NCT00892099|448809941|FG000|Overall Study|replocated|1|||
124776648|NCT00892099|448809942|FG001|Overall Study|replocated|0|||
124503781|NCT04056455|447795326|FG000|Overall Study|Adverse Event|1|||
124503782|NCT04056455|447795327|FG001|Overall Study|Adverse Event|0|||
124503783|NCT00369668|447795333|FG000|Overall Study|Lack of Efficacy|4|||
124503784|NCT00369668|447795334|FG001|Overall Study|Lack of Efficacy|5|||
124503785|NCT00369668|447795335|FG002|Overall Study|Lack of Efficacy|7|||
124503786|NCT03352414|447795343|FG000|Overall Study|Ineligible by operative criteria|12|||
124503787|NCT03352414|447795344|FG001|Overall Study|Ineligible by operative criteria|10|||
124503788|NCT03213626|447795345|FG000|Overall Study|Adverse Event|1|||
124503789|NCT03213626|447795345|FG000|Overall Study|Progressive Disease|6|||
124503790|NCT01079962|447795358|FG000|Overall Study|Adverse Event|2|||
124503791|NCT01079962|447795359|FG001|Overall Study|Adverse Event|2|||
124503792|NCT01079962|447795358|FG000|Overall Study|Withdrawal by Subject|5|||
124503793|NCT01079962|447795359|FG001|Overall Study|Withdrawal by Subject|7|||
124503794|NCT01079962|447795358|FG000|Overall Study|Protocol Violation|2|||
124503795|NCT01079962|447795359|FG001|Overall Study|Protocol Violation|2|||
124503796|NCT01079962|447795358|FG000|Overall Study|No blood pressure (BP) control|3|||
124503797|NCT01079962|447795359|FG001|Overall Study|No blood pressure (BP) control|0|||
124503798|NCT01079962|447795358|FG000|Overall Study|Inclusion/exclusion criteria|1|||
124503799|NCT01079962|447795359|FG001|Overall Study|Inclusion/exclusion criteria|3|||
124503800|NCT01079962|447795358|FG000|Overall Study|Participant not returning for next visit|1|||
124503801|NCT01079962|447795359|FG001|Overall Study|Participant not returning for next visit|0|||
124503802|NCT01079962|447795358|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
124503803|NCT01079962|447795359|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
124503804|NCT01331239|447795360|FG000|Part II: Core Study|Adverse Event|0|||
124503805|NCT01331239|447795361|FG001|Part II: Core Study|Adverse Event|3|||
124503806|NCT01331239|447795362|FG002|Part II: Core Study|Adverse Event|0|||
124503807|NCT01331239|447795360|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
124503808|NCT01331239|447795361|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
124561766|NCT00294723|448014605|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
124561767|NCT00294723|448014603|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
124776649|NCT00892099|448809943|FG002|Overall Study|replocated|2|||
124561768|NCT00294723|448014604|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
124561769|NCT00294723|448014605|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
124561770|NCT00294723|448014603|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
124561771|NCT00294723|448014604|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
124503809|NCT01331239|447795362|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
124503810|NCT01331239|447795360|FG000|Part II: Core Study|Withdrawal by Subject|0|||
124503811|NCT01331239|447795361|FG001|Part II: Core Study|Withdrawal by Subject|2|||
124503812|NCT01331239|447795362|FG002|Part II: Core Study|Withdrawal by Subject|0|||
124503813|NCT01331239|447795360|FG000|Part II: Core Study|Administrative problems|0|||
124503814|NCT01331239|447795361|FG001|Part II: Core Study|Administrative problems|1|||
124503815|NCT01331239|447795362|FG002|Part II: Core Study|Administrative problems|0|||
124503816|NCT00946530|447795365|FG000|Overall Study|Withdrawal by Subject|0|||
124503817|NCT00946530|447795366|FG001|Overall Study|Withdrawal by Subject|3|||
124503818|NCT00946530|447795367|FG002|Overall Study|Withdrawal by Subject|0|||
124503819|NCT00946530|447795368|FG003|Overall Study|Withdrawal by Subject|3|||
124503820|NCT00946530|447795365|FG000|Overall Study|Physician Decision|1|||
124503821|NCT00946530|447795366|FG001|Overall Study|Physician Decision|1|||
124503822|NCT00946530|447795367|FG002|Overall Study|Physician Decision|1|||
124503823|NCT00946530|447795368|FG003|Overall Study|Physician Decision|1|||
124503824|NCT01008995|447795369|FG000|Controlled Period|Adverse Event|1|||
124503825|NCT01008995|447795370|FG001|Controlled Period|Adverse Event|2|||
124503826|NCT01008995|447795371|FG002|Controlled Period|Adverse Event|0|||
124503827|NCT01008995|447795372|FG003|Controlled Period|Adverse Event|0|||
124503828|NCT01008995|447795369|FG000|Controlled Period|Other|2|||
124503829|NCT01008995|447795370|FG001|Controlled Period|Other|1|||
124503830|NCT01008995|447795371|FG002|Controlled Period|Other|0|||
124503831|NCT01008995|447795372|FG003|Controlled Period|Other|0|||
124503832|NCT01008995|447795369|FG000|After Controlled Period|Adverse Event|0|||
124503833|NCT01008995|447795370|FG001|After Controlled Period|Adverse Event|0|||
124503834|NCT01008995|447795371|FG002|After Controlled Period|Adverse Event|1|||
124503835|NCT01008995|447795372|FG003|After Controlled Period|Adverse Event|1|||
124503836|NCT01008995|447795369|FG000|After Controlled Period|Other|0|||
124503837|NCT01008995|447795370|FG001|After Controlled Period|Other|0|||
124503838|NCT01008995|447795371|FG002|After Controlled Period|Other|1|||
124503839|NCT01008995|447795372|FG003|After Controlled Period|Other|0|||
124503840|NCT00406640|447795373|FG000|Acute Phase|Adverse Event|18|||
124503841|NCT00406640|447795374|FG001|Acute Phase|Adverse Event|13|||
124503842|NCT00406640|447795373|FG000|Acute Phase|Failed to Return|5|||
124503843|NCT00406640|447795374|FG001|Acute Phase|Failed to Return|1|||
124503844|NCT00406640|447795373|FG000|Acute Phase|Physician Decision|0|||
124503845|NCT00406640|447795374|FG001|Acute Phase|Physician Decision|1|||
124503846|NCT00406640|447795373|FG000|Acute Phase|Lost to Follow-up|7|||
124503847|NCT00406640|447795374|FG001|Acute Phase|Lost to Follow-up|4|||
124503848|NCT00406640|447795373|FG000|Acute Phase|Protocol deviation|4|||
124503849|NCT00406640|447795374|FG001|Acute Phase|Protocol deviation|10|||
124503850|NCT00406640|447795373|FG000|Acute Phase|Protocol Violation|3|||
124503851|NCT00406640|447795374|FG001|Acute Phase|Protocol Violation|2|||
124503852|NCT00406640|447795373|FG000|Acute Phase|Withdrawal by Subject|11|||
124503853|NCT00406640|447795374|FG001|Acute Phase|Withdrawal by Subject|9|||
124503854|NCT00406640|447795373|FG000|Acute Phase|Lack of Efficacy|3|||
124503855|NCT00406640|447795374|FG001|Acute Phase|Lack of Efficacy|3|||
124503856|NCT00406640|447795373|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
124503857|NCT00406640|447795374|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
124503858|NCT00406640|447795373|FG000|DB Continuation Phase for Responders|Death|1|||
124503859|NCT00406640|447795374|FG001|DB Continuation Phase for Responders|Death|0|||
124503860|NCT00406640|447795373|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
124503861|NCT00406640|447795374|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
124503862|NCT00406640|447795373|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
124503863|NCT00406640|447795374|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
124503864|NCT00406640|447795373|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
124503865|NCT00406640|447795374|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
124503866|NCT00406640|447795373|FG000|DB Continuation Phase for Responders|non-compliance|7|||
124503867|NCT00406640|447795374|FG001|DB Continuation Phase for Responders|non-compliance|5|||
124503868|NCT00406640|447795373|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
124503869|NCT00406640|447795374|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
124503870|NCT00406640|447795373|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
124503871|NCT00406640|447795374|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
124503872|NCT00406640|447795373|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
124503873|NCT00406640|447795374|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
124503874|NCT00406640|447795373|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
124503875|NCT00406640|447795374|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
124503876|NCT00406640|447795373|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
124503877|NCT00406640|447795374|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
124503878|NCT00406640|447795373|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
124503879|NCT00406640|447795374|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
124503880|NCT00406640|447795373|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
124503881|NCT00406640|447795374|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
124503882|NCT00406640|447795373|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
124561772|NCT00294723|448014605|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
124561773|NCT00294723|448014603|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
124561774|NCT00294723|448014604|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
124561775|NCT00294723|448014605|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
124561776|NCT00294723|448014603|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
124561777|NCT00294723|448014604|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
124561778|NCT00294723|448014605|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
124561779|NCT00294723|448014603|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
124561780|NCT00294723|448014604|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
124561781|NCT00294723|448014605|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
124561782|NCT00294723|448014603|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
124561783|NCT00294723|448014604|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
124561784|NCT00294723|448014605|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
124561785|NCT00294723|448014603|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
124561786|NCT00294723|448014604|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
124561787|NCT00294723|448014605|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
124561788|NCT00294723|448014603|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
124561789|NCT00294723|448014604|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
124561790|NCT00294723|448014605|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
124561791|NCT00294723|448014603|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
124561792|NCT00294723|448014604|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
124561793|NCT00294723|448014605|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
124561794|NCT00752791|448014606|FG000|Overall Study|Adverse Event|7|||
124561795|NCT00752791|448014606|FG000|Overall Study|Withdrawal by Subject|1|||
124561796|NCT00752791|448014606|FG000|Overall Study|Physician Decision|1|||
124561797|NCT00752791|448014606|FG000|Overall Study|Death|1|||
124561798|NCT00752791|448014606|FG000|Overall Study|Renal transplant|3|||
124561799|NCT00752791|448014606|FG000|Overall Study|Switched to hemodialysis|2|||
124561800|NCT00752791|448014606|FG000|Overall Study|Protocol deviation|1|||
124561801|NCT01958281|448014607|FG000|Overall Study|Lack of Efficacy|5|||
124561802|NCT01958281|448014608|FG001|Overall Study|Lack of Efficacy|2|||
124561803|NCT01958281|448014609|FG002|Overall Study|Lack of Efficacy|0|||
124561804|NCT01958281|448014607|FG000|Overall Study|Adverse Event|0|||
124561805|NCT01958281|448014608|FG001|Overall Study|Adverse Event|2|||
124561806|NCT01958281|448014609|FG002|Overall Study|Adverse Event|0|||
124561807|NCT01958281|448014607|FG000|Overall Study|Withdrew Consent|1|||
124561808|NCT01958281|448014608|FG001|Overall Study|Withdrew Consent|0|||
124561809|NCT01958281|448014609|FG002|Overall Study|Withdrew Consent|0|||
124561810|NCT02784106|448014610|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
124561811|NCT02784106|448014611|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
124561812|NCT02784106|448014612|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
124561813|NCT02784106|448014613|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
124561814|NCT02784106|448014610|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
124561815|NCT02784106|448014611|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
124561816|NCT02784106|448014612|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
124561817|NCT02784106|448014613|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
124561818|NCT02784106|448014610|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
124561819|NCT02784106|448014611|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
124561820|NCT02784106|448014612|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
124561821|NCT02784106|448014613|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
124561822|NCT02784106|448014610|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
124561823|NCT02784106|448014611|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
124561824|NCT02784106|448014612|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
124561825|NCT02784106|448014613|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
124561826|NCT02784106|448014610|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
124561827|NCT02784106|448014611|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
124561828|NCT02784106|448014612|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
124561829|NCT02784106|448014613|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
124561830|NCT02784106|448014610|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
124561831|NCT02784106|448014611|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
124561832|NCT02784106|448014612|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
124561833|NCT02784106|448014613|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
124561834|NCT03222141|448014614|FG000|Overall Study|Death|15|||
124561835|NCT03222141|448014614|FG000|Overall Study|Lost to Follow-up|3|||
124561836|NCT02536378|448014615|FG000|Overall Study|Physician Decision|0|||
124561837|NCT02536378|448014616|FG001|Overall Study|Physician Decision|2|||
124561838|NCT02536378|448014615|FG000|Overall Study|Withdrawal by Subject|0|||
124561839|NCT02536378|448014616|FG001|Overall Study|Withdrawal by Subject|1|||
124561840|NCT02536378|448014615|FG000|Overall Study|Death|1|||
124561841|NCT02536378|448014616|FG001|Overall Study|Death|2|||
124503883|NCT00406640|447795374|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
124503884|NCT00406640|447795373|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
124503885|NCT00406640|447795374|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
124503886|NCT00406640|447795373|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
124503887|NCT00406640|447795374|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
124503888|NCT02457182|447796753|FG000|Overall Study|Lost to Follow-up|1|||
124503889|NCT02457182|447796754|FG001|Overall Study|Lost to Follow-up|0|||
124503890|NCT00506948|447796757|FG000|Overall Study|Death|4|||
124503891|NCT00506948|447796757|FG000|Overall Study|Adverse Event|5|||
124503892|NCT00506948|447796757|FG000|Overall Study|Physician Decision|1|||
124503893|NCT00762372|447796758|FG000|Overall Study|Adverse Event|1|||
124503894|NCT00762372|447796759|FG001|Overall Study|Adverse Event|0|||
124503895|NCT00762372|447796760|FG002|Overall Study|Adverse Event|0|||
124503896|NCT02174861|447796761|FG000|Overall Study|Decision by sponsor|8|||
124503897|NCT02174861|447796761|FG000|Overall Study|Withdrawal by Subject|124|||
124503898|NCT02174861|447796761|FG000|Overall Study|Lost to Follow-up|26|||
124503899|NCT01670656|447796762|FG000|Overall Study|Non-compliance with study drug|0|||
124503900|NCT01670656|447796763|FG001|Overall Study|Non-compliance with study drug|0|||
124561842|NCT02536378|448014615|FG000|Overall Study|Patient refused further follow up|6|||
124561843|NCT02536378|448014616|FG001|Overall Study|Patient refused further follow up|2|||
124561844|NCT00798889|448014617|FG000|Overall Study|Adverse Event|53|||
124561845|NCT00798889|448014617|FG000|Overall Study|Protocol Violation|2|||
124561846|NCT00798889|448014617|FG000|Overall Study|Withdrawal by Subject|31|||
124561847|NCT00798889|448014617|FG000|Overall Study|Lost to Follow-up|1|||
124561848|NCT00798889|448014617|FG000|Overall Study|Lack of Efficacy|213|||
124561849|NCT00798889|448014617|FG000|Overall Study|Decision of Sponsor|11|||
124561850|NCT00798889|448014617|FG000|Overall Study|Enrolled, Not treated|3|||
124561851|NCT00617461|448014618|FG000|First Treatment Intervention Period|Adverse Event|2|||
124561852|NCT00617461|448014619|FG001|First Treatment Intervention Period|Adverse Event|0|||
124561853|NCT00617461|448014618|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
124561854|NCT00617461|448014619|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
124561855|NCT00617461|448014618|FG000|First Treatment Intervention Period|Protocol Violation|2|||
124561856|NCT00617461|448014619|FG001|First Treatment Intervention Period|Protocol Violation|1|||
124561857|NCT00617461|448014618|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
124561858|NCT00617461|448014619|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
124561859|NCT00617461|448014618|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
124561860|NCT00617461|448014619|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
124561861|NCT00617461|448014618|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
124561862|NCT00617461|448014619|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
124561863|NCT00617461|448014618|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
124561864|NCT00617461|448014619|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
124561865|NCT00617461|448014618|FG000|Second Treatment Intervention Period|Adverse Event|0|||
124561866|NCT00617461|448014619|FG001|Second Treatment Intervention Period|Adverse Event|1|||
124561867|NCT00617461|448014618|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
124561868|NCT00617461|448014619|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
124561869|NCT00617461|448014618|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
124561870|NCT00617461|448014619|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
124561871|NCT00617461|448014618|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
124561872|NCT00617461|448014619|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
124561873|NCT00358826|448014620|FG000|Core Study|Adverse Event|1|||
124561874|NCT00358826|448014621|FG001|Core Study|Adverse Event|3|||
124561875|NCT00358826|448014622|FG002|Core Study|Adverse Event|1|||
124561876|NCT00358826|448014623|FG003|Core Study|Adverse Event|1|||
124561877|NCT00358826|448014624|FG004|Core Study|Adverse Event|0|||
124561878|NCT00358826|448014625|FG005|Core Study|Adverse Event|0|||
124561879|NCT00358826|448014626|FG006|Core Study|Adverse Event|0|||
124561880|NCT00358826|448014627|FG007|Core Study|Adverse Event|0|||
124561881|NCT00358826|448014620|FG000|Core Study|Withdrawal by Subject|2|||
124561882|NCT00358826|448014621|FG001|Core Study|Withdrawal by Subject|2|||
124561883|NCT00358826|448014622|FG002|Core Study|Withdrawal by Subject|0|||
124561884|NCT00358826|448014623|FG003|Core Study|Withdrawal by Subject|0|||
124561885|NCT00358826|448014624|FG004|Core Study|Withdrawal by Subject|0|||
124503901|NCT01670656|447796764|FG002|Overall Study|Non-compliance with study drug|3|||
124561886|NCT00358826|448014625|FG005|Core Study|Withdrawal by Subject|0|||
124561887|NCT00358826|448014626|FG006|Core Study|Withdrawal by Subject|0|||
124561888|NCT00358826|448014627|FG007|Core Study|Withdrawal by Subject|0|||
124561889|NCT00358826|448014620|FG000|Core Study|Lost to Follow-up|0|||
124561890|NCT00358826|448014621|FG001|Core Study|Lost to Follow-up|0|||
124561891|NCT00358826|448014622|FG002|Core Study|Lost to Follow-up|0|||
124561892|NCT00358826|448014623|FG003|Core Study|Lost to Follow-up|1|||
124561893|NCT00358826|448014624|FG004|Core Study|Lost to Follow-up|0|||
124561894|NCT00358826|448014625|FG005|Core Study|Lost to Follow-up|0|||
124503902|NCT01670656|447796765|FG003|Overall Study|Non-compliance with study drug|0|||
124503903|NCT01670656|447796766|FG004|Overall Study|Non-compliance with study drug|1|||
124561895|NCT00358826|448014626|FG006|Core Study|Lost to Follow-up|0|||
124503904|NCT01670656|447796762|FG000|Overall Study|Pregnancy|0|||
124503905|NCT01670656|447796763|FG001|Overall Study|Pregnancy|0|||
124503906|NCT01670656|447796764|FG002|Overall Study|Pregnancy|0|||
124503907|NCT01670656|447796765|FG003|Overall Study|Pregnancy|0|||
124503908|NCT01670656|447796766|FG004|Overall Study|Pregnancy|1|||
124503909|NCT01670656|447796762|FG000|Overall Study|Withdrawal by Subject|1|||
124503910|NCT01670656|447796763|FG001|Overall Study|Withdrawal by Subject|1|||
124503911|NCT01670656|447796764|FG002|Overall Study|Withdrawal by Subject|0|||
124503912|NCT01670656|447796765|FG003|Overall Study|Withdrawal by Subject|0|||
124503913|NCT01670656|447796766|FG004|Overall Study|Withdrawal by Subject|0|||
124503914|NCT01670656|447796762|FG000|Overall Study|Non-compliance with protocol|0|||
124503915|NCT01670656|447796763|FG001|Overall Study|Non-compliance with protocol|3|||
124503916|NCT01670656|447796764|FG002|Overall Study|Non-compliance with protocol|1|||
124503917|NCT01670656|447796765|FG003|Overall Study|Non-compliance with protocol|1|||
124503918|NCT01670656|447796766|FG004|Overall Study|Non-compliance with protocol|2|||
124503919|NCT01670656|447796762|FG000|Overall Study|Adverse Event|2|||
124503920|NCT01670656|447796763|FG001|Overall Study|Adverse Event|2|||
124503921|NCT01670656|447796764|FG002|Overall Study|Adverse Event|2|||
124503922|NCT01670656|447796765|FG003|Overall Study|Adverse Event|3|||
124503923|NCT01670656|447796766|FG004|Overall Study|Adverse Event|3|||
124503924|NCT01670656|447796762|FG000|Overall Study|Subject withdrew consent|0|||
124503925|NCT01670656|447796763|FG001|Overall Study|Subject withdrew consent|1|||
124503926|NCT01670656|447796764|FG002|Overall Study|Subject withdrew consent|2|||
124503927|NCT01670656|447796765|FG003|Overall Study|Subject withdrew consent|1|||
124503928|NCT01670656|447796766|FG004|Overall Study|Subject withdrew consent|1|||
124503929|NCT01670656|447796762|FG000|Overall Study|Lost to Follow-up|0|||
124503930|NCT01670656|447796763|FG001|Overall Study|Lost to Follow-up|0|||
124503931|NCT01670656|447796764|FG002|Overall Study|Lost to Follow-up|0|||
124503932|NCT01670656|447796765|FG003|Overall Study|Lost to Follow-up|0|||
124503933|NCT01670656|447796766|FG004|Overall Study|Lost to Follow-up|3|||
124503934|NCT01670656|447796762|FG000|Overall Study|Subject moved|0|||
124503935|NCT01670656|447796763|FG001|Overall Study|Subject moved|0|||
124503936|NCT01670656|447796764|FG002|Overall Study|Subject moved|0|||
124503937|NCT01670656|447796765|FG003|Overall Study|Subject moved|1|||
124503938|NCT01670656|447796766|FG004|Overall Study|Subject moved|0|||
124503939|NCT03196193|447796774|FG000|Overall Study|Adverse Event|1|||
124503940|NCT03196193|447796775|FG001|Overall Study|Adverse Event|0|||
124503941|NCT03196193|447796774|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
124503942|NCT03196193|447796775|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
124503943|NCT02709083|447796776|FG000|Overall Study|Original PI left institution|7|||
124503944|NCT01697267|447796777|FG000|Overall Study|Death|3|||
124503945|NCT01697267|447796778|FG001|Overall Study|Death|1|||
124503946|NCT01697267|447796777|FG000|Overall Study|Withdrawal by Subject|5|||
124503947|NCT01697267|447796778|FG001|Overall Study|Withdrawal by Subject|5|||
124503948|NCT01697267|447796777|FG000|Overall Study|Adverse Event|2|||
124503949|NCT01697267|447796778|FG001|Overall Study|Adverse Event|1|||
124503950|NCT01697267|447796777|FG000|Overall Study|Lost to Follow-up|2|||
124503951|NCT01697267|447796778|FG001|Overall Study|Lost to Follow-up|4|||
124503952|NCT01697267|447796777|FG000|Overall Study|Physician Decision|2|||
124503953|NCT01697267|447796778|FG001|Overall Study|Physician Decision|4|||
124503954|NCT00333619|447796779|FG000|Overall Study|Death|12|||
124503955|NCT00333619|447796780|FG001|Overall Study|Death|6|||
124503956|NCT00333619|447796779|FG000|Overall Study|Withdrawal by Subject|6|||
124503957|NCT00333619|447796780|FG001|Overall Study|Withdrawal by Subject|1|||
124503958|NCT00333619|447796779|FG000|Overall Study|Lost to Follow-up|3|||
124503959|NCT00333619|447796780|FG001|Overall Study|Lost to Follow-up|3|||
124503960|NCT02681055|447796781|FG000|Weeks 5-12|Adverse Event|1|||
124503961|NCT02695524|447796782|FG000|Overall Study|Lost to Follow-up|3|||
124503962|NCT02695524|447796783|FG001|Overall Study|Lost to Follow-up|2|||
124503963|NCT02695524|447796782|FG000|Overall Study|Death|0|||
124503964|NCT02695524|447796783|FG001|Overall Study|Death|1|||
124561896|NCT00358826|448014627|FG007|Core Study|Lost to Follow-up|0|||
124561897|NCT00358826|448014620|FG000|Core Study|Physician Decision|0|||
124561898|NCT00358826|448014621|FG001|Core Study|Physician Decision|0|||
124561899|NCT00358826|448014622|FG002|Core Study|Physician Decision|1|||
124561900|NCT00358826|448014623|FG003|Core Study|Physician Decision|0|||
124503965|NCT00831441|447796784|FG000|Randomized|Death|82|||
124561901|NCT00358826|448014624|FG004|Core Study|Physician Decision|0|||
124503966|NCT00831441|447796785|FG001|Randomized|Death|81|||
124503967|NCT00831441|447796784|FG000|Randomized|Adverse Event|248|||
124503968|NCT00831441|447796785|FG001|Randomized|Adverse Event|321|||
124503969|NCT00831441|447796784|FG000|Randomized|Emergency procedure|2|||
124503970|NCT00831441|447796785|FG001|Randomized|Emergency procedure|2|||
124503971|NCT00831441|447796784|FG000|Randomized|Elective procedure|26|||
124503972|NCT00831441|447796785|FG001|Randomized|Elective procedure|25|||
124503973|NCT00831441|447796784|FG000|Randomized|Physician Decision|26|||
124503974|NCT00831441|447796785|FG001|Randomized|Physician Decision|35|||
124503975|NCT00831441|447796784|FG000|Randomized|No longer met criteria|13|||
124503976|NCT00831441|447796785|FG001|Randomized|No longer met criteria|19|||
124503977|NCT00831441|447796784|FG000|Randomized|Withdrawal by Subject|178|||
124503978|NCT00831441|447796785|FG001|Randomized|Withdrawal by Subject|212|||
124503979|NCT00831441|447796784|FG000|Randomized|Lost to Follow-up|26|||
124503980|NCT00831441|447796785|FG001|Randomized|Lost to Follow-up|35|||
124503981|NCT00831441|447796784|FG000|Randomized|Administrative reason by sponsor|2780|||
124503982|NCT00831441|447796785|FG001|Randomized|Administrative reason by sponsor|2671|||
124503983|NCT00831441|447796784|FG000|Randomized|poor/non-compliance|30|||
124503984|NCT00831441|447796785|FG001|Randomized|poor/non-compliance|38|||
124503985|NCT00831441|447796784|FG000|Randomized|non-specified|276|||
124503986|NCT00831441|447796785|FG001|Randomized|non-specified|266|||
124503987|NCT00831441|447796784|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
124503988|NCT00831441|447796785|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
124503989|NCT00831441|447796784|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
124503990|NCT00831441|447796785|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
124503991|NCT00831441|447796784|FG000|Follow Up (30 Days)|Death|63|||
124503992|NCT00831441|447796785|FG001|Follow Up (30 Days)|Death|86|||
124503993|NCT00831441|447796784|FG000|Follow Up (30 Days)|non-specified|16|||
124503994|NCT00831441|447796785|FG001|Follow Up (30 Days)|non-specified|26|||
124503995|NCT00831441|447796784|FG000|Follow Up (30 Days)|missing end of study status|0|||
124503996|NCT00831441|447796785|FG001|Follow Up (30 Days)|missing end of study status|1|||
124503997|NCT00111917|447796786|FG000|Overall Study|Withdrawal by Subject|1|||
124503998|NCT00111917|447796787|FG001|Overall Study|Withdrawal by Subject|1|||
124503999|NCT02338492|447796797|FG000|Overall Study|Death|32|||
124504000|NCT02338492|447796797|FG000|Overall Study|Adverse Event|3|||
124504001|NCT02338492|447796797|FG000|Overall Study|Lost to Follow-up|4|||
124504002|NCT02338492|447796797|FG000|Overall Study|Reason not captured above|6|||
124504003|NCT00871377|447796798|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
124504004|NCT00871377|447796799|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
124504005|NCT00871377|447796800|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
124504006|NCT00871377|447796801|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
124504007|NCT00871377|447796802|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
124504008|NCT00871377|447796803|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
124504009|NCT00871377|447796798|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
124504010|NCT00871377|447796799|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
124504011|NCT00871377|447796800|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
124504012|NCT00871377|447796801|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
124504013|NCT00871377|447796802|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
124504014|NCT00871377|447796803|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
124504015|NCT00871377|447796798|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
124504016|NCT00871377|447796799|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
124504017|NCT00871377|447796800|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
124504018|NCT00871377|447796801|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
124504019|NCT00871377|447796802|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
124504020|NCT00871377|447796803|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
124504021|NCT00871377|447796798|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
124504022|NCT00871377|447796799|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
124504023|NCT00871377|447796800|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
124504024|NCT00871377|447796801|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
124504025|NCT00871377|447796802|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
124504026|NCT00871377|447796803|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
124504027|NCT00871377|447796798|FG000|Third Intervention (10 Weeks)|Death|0|||
124504028|NCT00871377|447796799|FG001|Third Intervention (10 Weeks)|Death|0|||
124504029|NCT00871377|447796800|FG002|Third Intervention (10 Weeks)|Death|0|||
124504030|NCT00871377|447796801|FG003|Third Intervention (10 Weeks)|Death|1|||
124504031|NCT00871377|447796802|FG004|Third Intervention (10 Weeks)|Death|0|||
124504032|NCT00871377|447796803|FG005|Third Intervention (10 Weeks)|Death|0|||
124504033|NCT03072719|447796806|FG000|Overall Study|Adverse Event|1|||
124504034|NCT03072719|447796807|FG001|Overall Study|Adverse Event|1|||
124504035|NCT00882999|447796808|FG000|Overall Study|Adverse Event|0|||
124504036|NCT00882999|447796809|FG001|Overall Study|Adverse Event|0|||
124504037|NCT00882999|447796810|FG002|Overall Study|Adverse Event|0|||
124504038|NCT00882999|447796811|FG003|Overall Study|Adverse Event|0|||
124504039|NCT00882999|447796812|FG004|Overall Study|Adverse Event|1|||
124504040|NCT00882999|447796813|FG005|Overall Study|Adverse Event|0|||
124504041|NCT00882999|447796814|FG006|Overall Study|Adverse Event|0|||
124504042|NCT00882999|447796808|FG000|Overall Study|Death|0|||
124504043|NCT00882999|447796809|FG001|Overall Study|Death|1|||
124504044|NCT00882999|447796810|FG002|Overall Study|Death|0|||
124504045|NCT00882999|447796811|FG003|Overall Study|Death|0|||
124504046|NCT00882999|447796812|FG004|Overall Study|Death|0|||
124504047|NCT00882999|447796813|FG005|Overall Study|Death|0|||
124504048|NCT00882999|447796814|FG006|Overall Study|Death|0|||
124504049|NCT00882999|447796808|FG000|Overall Study|Withdrawal by Subject|7|||
124504050|NCT00882999|447796809|FG001|Overall Study|Withdrawal by Subject|6|||
124504051|NCT00882999|447796810|FG002|Overall Study|Withdrawal by Subject|3|||
124504052|NCT00882999|447796811|FG003|Overall Study|Withdrawal by Subject|3|||
124504053|NCT00882999|447796812|FG004|Overall Study|Withdrawal by Subject|6|||
124561902|NCT00358826|448014625|FG005|Core Study|Physician Decision|0|||
124561903|NCT00358826|448014626|FG006|Core Study|Physician Decision|0|||
124561904|NCT00358826|448014627|FG007|Core Study|Physician Decision|0|||
124561905|NCT00358826|448014620|FG000|MDCT Substudy|Adverse Event|0|||
124561906|NCT00358826|448014621|FG001|MDCT Substudy|Adverse Event|0|||
124561907|NCT00358826|448014622|FG002|MDCT Substudy|Adverse Event|0|||
124561908|NCT00358826|448014623|FG003|MDCT Substudy|Adverse Event|0|||
124561909|NCT00358826|448014624|FG004|MDCT Substudy|Adverse Event|1|||
124561910|NCT00358826|448014625|FG005|MDCT Substudy|Adverse Event|0|||
124561911|NCT00358826|448014626|FG006|MDCT Substudy|Adverse Event|0|||
124561912|NCT00358826|448014627|FG007|MDCT Substudy|Adverse Event|0|||
124561913|NCT00358826|448014620|FG000|MDCT Substudy|Lost to Follow-up|0|||
124561914|NCT00358826|448014621|FG001|MDCT Substudy|Lost to Follow-up|0|||
124561915|NCT00358826|448014622|FG002|MDCT Substudy|Lost to Follow-up|0|||
124561916|NCT00358826|448014623|FG003|MDCT Substudy|Lost to Follow-up|0|||
124561917|NCT00358826|448014624|FG004|MDCT Substudy|Lost to Follow-up|0|||
124561918|NCT00358826|448014625|FG005|MDCT Substudy|Lost to Follow-up|1|||
124561919|NCT00358826|448014626|FG006|MDCT Substudy|Lost to Follow-up|0|||
124561920|NCT00358826|448014627|FG007|MDCT Substudy|Lost to Follow-up|0|||
124561921|NCT00358826|448014620|FG000|MDCT Substudy|Withdrawal by Subject|0|||
124561922|NCT00358826|448014621|FG001|MDCT Substudy|Withdrawal by Subject|0|||
124561923|NCT00358826|448014622|FG002|MDCT Substudy|Withdrawal by Subject|0|||
124561924|NCT00358826|448014623|FG003|MDCT Substudy|Withdrawal by Subject|0|||
124561925|NCT00358826|448014624|FG004|MDCT Substudy|Withdrawal by Subject|0|||
124561926|NCT00358826|448014625|FG005|MDCT Substudy|Withdrawal by Subject|1|||
124561927|NCT00358826|448014626|FG006|MDCT Substudy|Withdrawal by Subject|0|||
124561928|NCT00358826|448014627|FG007|MDCT Substudy|Withdrawal by Subject|0|||
124561929|NCT00903383|448014628|FG000|Overall Study|Adverse Event|1|||
124561930|NCT00903383|448014629|FG001|Overall Study|Adverse Event|2|||
124561931|NCT00903383|448014630|FG002|Overall Study|Adverse Event|3|||
124561932|NCT00903383|448014631|FG003|Overall Study|Adverse Event|1|||
124561933|NCT00903383|448014628|FG000|Overall Study|Physician Decision|1|||
124561934|NCT00903383|448014629|FG001|Overall Study|Physician Decision|2|||
124561935|NCT00903383|448014630|FG002|Overall Study|Physician Decision|0|||
124561936|NCT00903383|448014631|FG003|Overall Study|Physician Decision|0|||
124561937|NCT00903383|448014628|FG000|Overall Study|Lost to Follow-up|0|||
124561938|NCT00903383|448014629|FG001|Overall Study|Lost to Follow-up|0|||
124561939|NCT00903383|448014630|FG002|Overall Study|Lost to Follow-up|0|||
124561940|NCT00903383|448014631|FG003|Overall Study|Lost to Follow-up|1|||
124561941|NCT00903383|448014628|FG000|Overall Study|Decision of Sponsor|1|||
124561942|NCT00903383|448014629|FG001|Overall Study|Decision of Sponsor|0|||
124561943|NCT00903383|448014630|FG002|Overall Study|Decision of Sponsor|0|||
124561944|NCT00903383|448014631|FG003|Overall Study|Decision of Sponsor|0|||
124561945|NCT00903383|448014628|FG000|Overall Study|Withdrawal by Subject|4|||
124561946|NCT00903383|448014629|FG001|Overall Study|Withdrawal by Subject|1|||
124561947|NCT00903383|448014630|FG002|Overall Study|Withdrawal by Subject|0|||
124561948|NCT00903383|448014631|FG003|Overall Study|Withdrawal by Subject|2|||
124561949|NCT00903383|448014628|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
124561950|NCT00903383|448014629|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
124561951|NCT00903383|448014630|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
124561952|NCT00903383|448014631|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
124561953|NCT00903383|448014628|FG000|Overall Study|Patient Decision|0|||
124561954|NCT00903383|448014629|FG001|Overall Study|Patient Decision|0|||
124561955|NCT00903383|448014630|FG002|Overall Study|Patient Decision|0|||
124561956|NCT00903383|448014631|FG003|Overall Study|Patient Decision|1|||
124561957|NCT01821625|448014634|FG000|Overall Study|Withdrawal by Subject|2|||
124561958|NCT01821625|448014634|FG000|Overall Study|Lack of Efficacy|2|||
124561959|NCT01821625|448014634|FG000|Overall Study|Adverse Event|1|||
124561960|NCT01821625|448014634|FG000|Overall Study|Medical contraindication|1|||
124561961|NCT00320593|448014637|FG000|Overall Study|Lost to Follow-up|3|||
124561962|NCT00320593|448014638|FG001|Overall Study|Lost to Follow-up|0|||
124561963|NCT00320593|448014637|FG000|Overall Study|Moved to another state|1|||
124561964|NCT00320593|448014638|FG001|Overall Study|Moved to another state|0|||
124561965|NCT00320593|448014637|FG000|Overall Study|Withdrawal by Subject|2|||
124561966|NCT00320593|448014638|FG001|Overall Study|Withdrawal by Subject|1|||
124561967|NCT00320593|448014637|FG000|Overall Study|Withdrawal by clinical center|1|||
124561968|NCT00320593|448014638|FG001|Overall Study|Withdrawal by clinical center|0|||
124561969|NCT00457665|448014639|FG000|12 Months|Drug allergy|1|||
124561970|NCT00457665|448014640|FG001|12 Months|Drug allergy|1|||
124561971|NCT00457665|448014639|FG000|12 Months|High HIV viral load|5|||
124561972|NCT00457665|448014640|FG001|12 Months|High HIV viral load|1|||
124561973|NCT00457665|448014639|FG000|12 Months|Lipodystrophy|2|||
124561974|NCT00457665|448014640|FG001|12 Months|Lipodystrophy|0|||
124561975|NCT00457665|448014639|FG000|12 Months|Withdrawal by Subject|0|||
124561976|NCT00457665|448014640|FG001|12 Months|Withdrawal by Subject|2|||
124561977|NCT00457665|448014639|FG000|12 Months|Abnormal Liver function tests|0|||
124561978|NCT00457665|448014640|FG001|12 Months|Abnormal Liver function tests|5|||
124561979|NCT00457665|448014639|FG000|24 Months|Withdrawal by Subject|3|||
124561980|NCT00457665|448014640|FG001|24 Months|Withdrawal by Subject|2|||
124504054|NCT00882999|447796813|FG005|Overall Study|Withdrawal by Subject|5|||
124504055|NCT00882999|447796814|FG006|Overall Study|Withdrawal by Subject|5|||
124504056|NCT00882999|447796808|FG000|Overall Study|Lost to Follow-up|0|||
124504057|NCT00882999|447796809|FG001|Overall Study|Lost to Follow-up|1|||
124504058|NCT00882999|447796810|FG002|Overall Study|Lost to Follow-up|1|||
124504059|NCT00882999|447796811|FG003|Overall Study|Lost to Follow-up|2|||
124504060|NCT00882999|447796812|FG004|Overall Study|Lost to Follow-up|1|||
124504061|NCT00882999|447796813|FG005|Overall Study|Lost to Follow-up|1|||
124504062|NCT00882999|447796814|FG006|Overall Study|Lost to Follow-up|2|||
124504063|NCT00882999|447796808|FG000|Overall Study|Physician Decision|1|||
124504064|NCT00882999|447796809|FG001|Overall Study|Physician Decision|0|||
124504065|NCT00882999|447796810|FG002|Overall Study|Physician Decision|0|||
124504066|NCT00882999|447796811|FG003|Overall Study|Physician Decision|0|||
124504067|NCT00882999|447796812|FG004|Overall Study|Physician Decision|0|||
124504068|NCT00882999|447796813|FG005|Overall Study|Physician Decision|1|||
124504069|NCT00882999|447796814|FG006|Overall Study|Physician Decision|1|||
124504070|NCT01104584|447796815|FG000|Overall Study|Study drug never administered|21|||
124504071|NCT01104584|447796815|FG000|Overall Study|Study prematurely discontinued|2|||
124504072|NCT04017442|447796816|FG000|Overall Study|Withdrawal by Subject|0|||
124561981|NCT00457665|448014639|FG000|24 Months|Lipodystrophy|1|||
124504073|NCT04017442|447796817|FG001|Overall Study|Withdrawal by Subject|3|||
124504074|NCT04017442|447796816|FG000|Overall Study|Lost to Follow-up|21|||
124504075|NCT04017442|447796817|FG001|Overall Study|Lost to Follow-up|19|||
124504076|NCT00082758|447796820|FG000|Overall Study|Adverse Event|0|||
124504077|NCT00082758|447796821|FG001|Overall Study|Adverse Event|2|||
124504078|NCT00082758|447796822|FG002|Overall Study|Adverse Event|0|||
124504079|NCT00082758|447796820|FG000|Overall Study|Lack of Efficacy|12|||
124504080|NCT00082758|447796821|FG001|Overall Study|Lack of Efficacy|13|||
124504081|NCT00082758|447796822|FG002|Overall Study|Lack of Efficacy|0|||
124504082|NCT00082758|447796820|FG000|Overall Study|Physician Decision|0|||
124504083|NCT00082758|447796821|FG001|Overall Study|Physician Decision|1|||
124504084|NCT00082758|447796822|FG002|Overall Study|Physician Decision|0|||
124504085|NCT00082758|447796820|FG000|Overall Study|Withdrawal by Subject|3|||
124504086|NCT00082758|447796821|FG001|Overall Study|Withdrawal by Subject|0|||
124504087|NCT00082758|447796822|FG002|Overall Study|Withdrawal by Subject|0|||
124561982|NCT00457665|448014640|FG001|24 Months|Lipodystrophy|1|||
124561983|NCT00457665|448014639|FG000|24 Months|Abnormal liver function tests|1|||
124561984|NCT00457665|448014640|FG001|24 Months|Abnormal liver function tests|5|||
124561985|NCT01716754|448014641|FG000|Overall Study|Death|0|||
124561986|NCT01716754|448014642|FG001|Overall Study|Death|0|||
124561987|NCT01716754|448014643|FG002|Overall Study|Death|0|||
124561988|NCT01716754|448014644|FG003|Overall Study|Death|1|||
124561989|NCT01716754|448014641|FG000|Overall Study|Protocol deviation|0|||
124561990|NCT01716754|448014642|FG001|Overall Study|Protocol deviation|2|||
124504088|NCT00082758|447796820|FG000|Overall Study|Protocol Violation|0|||
124504089|NCT00082758|447796821|FG001|Overall Study|Protocol Violation|1|||
124504090|NCT00082758|447796822|FG002|Overall Study|Protocol Violation|0|||
124504091|NCT00238303|447796823|FG000|Overall Study|Withdrawal by Subject|11|||
124504092|NCT00238303|447796824|FG001|Overall Study|Withdrawal by Subject|1|||
124504093|NCT00238303|447796825|FG002|Overall Study|Withdrawal by Subject|2|||
124504094|NCT00238303|447796823|FG000|Overall Study|Death|1|||
124504095|NCT00238303|447796824|FG001|Overall Study|Death|0|||
124504096|NCT00238303|447796825|FG002|Overall Study|Death|1|||
124504097|NCT00238303|447796823|FG000|Overall Study|Other Medical Problems|2|||
124504098|NCT00238303|447796824|FG001|Overall Study|Other Medical Problems|0|||
124504099|NCT00238303|447796825|FG002|Overall Study|Other Medical Problems|2|||
124504100|NCT00238303|447796823|FG000|Overall Study|Poor tolerance of study treatment|1|||
124504101|NCT00238303|447796824|FG001|Overall Study|Poor tolerance of study treatment|0|||
124504102|NCT00238303|447796825|FG002|Overall Study|Poor tolerance of study treatment|1|||
124504103|NCT00238303|447796823|FG000|Overall Study|Adverse Event|0|||
124504104|NCT00238303|447796824|FG001|Overall Study|Adverse Event|1|||
124504105|NCT00238303|447796825|FG002|Overall Study|Adverse Event|3|||
124504106|NCT02561299|447796829|FG000|Overall Study|Death|2|||
124504107|NCT02561299|447796830|FG001|Overall Study|Death|4|||
124504108|NCT02561299|447796829|FG000|Overall Study|Lost to Follow-up|1|||
124561991|NCT01716754|448014643|FG002|Overall Study|Protocol deviation|7|||
124561992|NCT01716754|448014644|FG003|Overall Study|Protocol deviation|2|||
124561993|NCT01716754|448014641|FG000|Overall Study|Non-compliance with study treatment|0|||
124561994|NCT01716754|448014642|FG001|Overall Study|Non-compliance with study treatment|0|||
124504109|NCT02561299|447796830|FG001|Overall Study|Lost to Follow-up|0|||
124504110|NCT02561299|447796829|FG000|Overall Study|Withdrawal by Subject|2|||
124504111|NCT02561299|447796830|FG001|Overall Study|Withdrawal by Subject|2|||
124504112|NCT01358877|447796831|FG000|Overall Study|Death|80|||
124504113|NCT01358877|447796832|FG001|Overall Study|Death|89|||
124504114|NCT01358877|447796831|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
124504115|NCT01358877|447796832|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
124504116|NCT01358877|447796831|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
124504117|NCT01358877|447796832|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
124561995|NCT01716754|448014643|FG002|Overall Study|Non-compliance with study treatment|1|||
124504118|NCT01358877|447796831|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
124504119|NCT01358877|447796832|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
124504120|NCT01358877|447796831|FG000|Overall Study|Other|142|||
124504121|NCT01358877|447796832|FG001|Overall Study|Other|129|||
124504122|NCT01911845|447796837|FG000|Overall Study|Adverse Event|2|||
124504123|NCT01911845|447796837|FG000|Overall Study|Lost to Follow-up|1|||
124504124|NCT01911845|447796837|FG000|Overall Study|Other (not specified)|3|||
124504125|NCT01994226|447796838|FG000|Overall Study|Protocol Violation|13|||
124504126|NCT01994226|447796839|FG001|Overall Study|Protocol Violation|10|||
124504127|NCT01994226|447796838|FG000|Overall Study|Early Cessation of treatment|6|||
124504128|NCT01994226|447796839|FG001|Overall Study|Early Cessation of treatment|11|||
124504129|NCT00501046|447796844|FG000|Overall Study|Adverse Event|21|||
124504130|NCT00501046|447796845|FG001|Overall Study|Adverse Event|25|||
124504131|NCT00501046|447796844|FG000|Overall Study|Death|23|||
124504132|NCT00501046|447796845|FG001|Overall Study|Death|30|||
124504133|NCT00501046|447796844|FG000|Overall Study|Lost to Follow-up|14|||
124504134|NCT00501046|447796845|FG001|Overall Study|Lost to Follow-up|13|||
124504135|NCT00501046|447796844|FG000|Overall Study|Physician Decision|7|||
124504136|NCT00501046|447796845|FG001|Overall Study|Physician Decision|2|||
124504137|NCT00501046|447796844|FG000|Overall Study|Pregnancy|0|||
124504138|NCT00501046|447796845|FG001|Overall Study|Pregnancy|3|||
124504139|NCT00501046|447796844|FG000|Overall Study|Protocol Violation|2|||
124504140|NCT00501046|447796845|FG001|Overall Study|Protocol Violation|1|||
124504141|NCT00501046|447796844|FG000|Overall Study|Withdrawal by Subject|84|||
124504142|NCT00501046|447796845|FG001|Overall Study|Withdrawal by Subject|83|||
124504143|NCT00501046|447796844|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
124504144|NCT00501046|447796845|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
124504145|NCT00436566|447796846|FG000|Overall Study|Withdrawal by Subject|2|||
124504146|NCT00436566|447796846|FG000|Overall Study|Protocol Violation|1|||
124504147|NCT01980706|447796847|FG000|Overall Study|Withdrawal by Subject|9|||
124504148|NCT01980706|447796848|FG001|Overall Study|Withdrawal by Subject|6|||
124504149|NCT01980706|447796849|FG002|Overall Study|Withdrawal by Subject|2|||
124504150|NCT01980706|447796847|FG000|Overall Study|Adverse Event|1|||
124504151|NCT01980706|447796848|FG001|Overall Study|Adverse Event|2|||
124504152|NCT01980706|447796849|FG002|Overall Study|Adverse Event|5|||
124504153|NCT01980706|447796847|FG000|Overall Study|Lost to Follow-up|3|||
124504154|NCT01980706|447796848|FG001|Overall Study|Lost to Follow-up|4|||
124504155|NCT01980706|447796849|FG002|Overall Study|Lost to Follow-up|3|||
124504156|NCT01980706|447796847|FG000|Overall Study|miscellaneous|4|||
124504157|NCT01980706|447796848|FG001|Overall Study|miscellaneous|5|||
124504158|NCT01980706|447796849|FG002|Overall Study|miscellaneous|3|||
124504159|NCT01934894|447796854|FG000|Overall Study|Adverse Event|1|||
124504160|NCT01934894|447796855|FG001|Overall Study|Adverse Event|2|||
124504161|NCT01934894|447796854|FG000|Overall Study|Death|2|||
124504162|NCT01934894|447796855|FG001|Overall Study|Death|0|||
124504163|NCT01934894|447796854|FG000|Overall Study|Withdrawal by Subject|0|||
124504164|NCT01934894|447796855|FG001|Overall Study|Withdrawal by Subject|1|||
124504165|NCT01934894|447796854|FG000|Overall Study|Progressive Disease|3|||
124504166|NCT01934894|447796855|FG001|Overall Study|Progressive Disease|2|||
124504167|NCT01842308|447796856|FG000|Overall Study|Withdrawal by Subject|0|||
124504168|NCT01842308|447796857|FG001|Overall Study|Withdrawal by Subject|0|||
124504169|NCT01842308|447796858|FG002|Overall Study|Withdrawal by Subject|0|||
124504170|NCT01842308|447796859|FG003|Overall Study|Withdrawal by Subject|0|||
124504171|NCT01842308|447796860|FG004|Overall Study|Withdrawal by Subject|1|||
124504172|NCT01106625|447796863|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
124504173|NCT01106625|447796864|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
124504174|NCT01106625|447796865|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
124504175|NCT01106625|447796863|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
124504176|NCT01106625|447796864|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
124504177|NCT01106625|447796865|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
124504178|NCT01106625|447796863|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
124504179|NCT01106625|447796864|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
124504180|NCT01106625|447796865|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
124504181|NCT01106625|447796863|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
124504182|NCT01106625|447796864|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
124504183|NCT01106625|447796865|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
124504184|NCT01106625|447796863|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
124504185|NCT01106625|447796864|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
124504186|NCT01106625|447796865|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
124504187|NCT01106625|447796863|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
124504188|NCT01106625|447796864|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
124504189|NCT01106625|447796865|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
124504190|NCT01106625|447796863|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
124504191|NCT01106625|447796864|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
124504192|NCT01106625|447796865|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
124504193|NCT01106625|447796863|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
124504194|NCT01106625|447796864|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
124504195|NCT01106625|447796865|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
124504196|NCT01106625|447796863|FG000|Core Period: Baseline to Week 26|Other|8|||
124504197|NCT01106625|447796864|FG001|Core Period: Baseline to Week 26|Other|7|||
124504198|NCT01106625|447796865|FG002|Core Period: Baseline to Week 26|Other|4|||
124504199|NCT01106625|447796863|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
124504200|NCT01106625|447796864|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
124504201|NCT01106625|447796865|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
124504202|NCT01106625|447796863|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
124504203|NCT01106625|447796864|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
124504204|NCT01106625|447796865|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
124504205|NCT01106625|447796863|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
124504206|NCT01106625|447796864|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
124504207|NCT01106625|447796865|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
124504208|NCT01106625|447796863|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
124504209|NCT01106625|447796864|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
124504210|NCT01106625|447796865|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
124504211|NCT01106625|447796863|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
124504212|NCT01106625|447796864|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
124504213|NCT01106625|447796865|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
124504214|NCT01106625|447796863|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
124504215|NCT01106625|447796864|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
124504216|NCT01106625|447796865|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
124504217|NCT01106625|447796863|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
124504218|NCT01106625|447796864|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
124504219|NCT01106625|447796865|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
124504220|NCT01106625|447796863|FG000|Extension Period: Week 26 to Week 52|Other|5|||
124504221|NCT01106625|447796864|FG001|Extension Period: Week 26 to Week 52|Other|5|||
124504222|NCT01106625|447796865|FG002|Extension Period: Week 26 to Week 52|Other|4|||
124504223|NCT01088438|447796874|FG000|Overall Study|Withdrawal by Subject|11|||
124504224|NCT01088438|447796875|FG001|Overall Study|Withdrawal by Subject|6|||
124504225|NCT01088438|447796874|FG000|Overall Study|Lost to Follow-up|18|||
124504226|NCT01088438|447796875|FG001|Overall Study|Lost to Follow-up|30|||
124504227|NCT00511342|447796876|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
124504228|NCT00511342|447796877|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
124504229|NCT00511342|447796876|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
124504230|NCT00511342|447796877|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
124504231|NCT00511342|447796876|FG000|Overall Study|Pregnancy|0|||
124504232|NCT00511342|447796877|FG001|Overall Study|Pregnancy|1|||
124504233|NCT00511342|447796876|FG000|Overall Study|Pregnancy wish|0|||
124504234|NCT00511342|447796877|FG001|Overall Study|Pregnancy wish|1|||
124504235|NCT00511342|447796876|FG000|Overall Study|Lost to Follow-up|1|||
124504236|NCT00511342|447796877|FG001|Overall Study|Lost to Follow-up|5|||
124504237|NCT00511342|447796876|FG000|Overall Study|Other Reason|2|||
124504238|NCT00511342|447796877|FG001|Overall Study|Other Reason|2|||
124504239|NCT00997321|447796878|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
124504240|NCT00997321|447796879|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
124504241|NCT01153763|447796888|FG000|Overall Study|Study Closed|16|||
124504242|NCT01153763|447796888|FG000|Overall Study|Lost to Follow-up|1|||
124504243|NCT01153763|447796888|FG000|Overall Study|Physician Decision|2|||
124504244|NCT01153763|447796888|FG000|Overall Study|Withdrawal by Subject|2|||
124504245|NCT02402218|447796889|FG000|Overall Study|Did not pickup study medication|12|||
124504246|NCT02402218|447796890|FG001|Overall Study|Did not pickup study medication|9|||
124504247|NCT02402218|447796891|FG002|Overall Study|Did not pickup study medication|13|||
124504248|NCT02402218|447796889|FG000|Overall Study|Lack of Efficacy|0|||
124504249|NCT02402218|447796890|FG001|Overall Study|Lack of Efficacy|1|||
124504250|NCT02402218|447796891|FG002|Overall Study|Lack of Efficacy|1|||
124504251|NCT02402218|447796889|FG000|Overall Study|Death|1|||
124504252|NCT02402218|447796890|FG001|Overall Study|Death|0|||
124504253|NCT02402218|447796891|FG002|Overall Study|Death|0|||
124504254|NCT02402218|447796889|FG000|Overall Study|Reinfection|0|||
124504255|NCT02402218|447796890|FG001|Overall Study|Reinfection|0|||
124504256|NCT02402218|447796891|FG002|Overall Study|Reinfection|1|||
124504257|NCT02402218|447796889|FG000|Overall Study|Adverse Event|0|||
124504258|NCT02402218|447796890|FG001|Overall Study|Adverse Event|2|||
124504259|NCT02402218|447796891|FG002|Overall Study|Adverse Event|1|||
124504260|NCT02402218|447796889|FG000|Overall Study|Withdrawal by Subject|1|||
124504261|NCT02402218|447796890|FG001|Overall Study|Withdrawal by Subject|1|||
124504262|NCT02402218|447796891|FG002|Overall Study|Withdrawal by Subject|1|||
124504263|NCT00789191|447798920|FG000|Overall Study|Adverse Event|2|||
124504264|NCT00789191|447798921|FG001|Overall Study|Adverse Event|4|||
124504265|NCT00789191|447798920|FG000|Overall Study|Lack of Efficacy|0|||
124504266|NCT00789191|447798921|FG001|Overall Study|Lack of Efficacy|5|||
124504267|NCT00789191|447798920|FG000|Overall Study|Protocol Violation|5|||
124504268|NCT00789191|447798921|FG001|Overall Study|Protocol Violation|3|||
124504269|NCT00789191|447798920|FG000|Overall Study|Withdrawal Criteria|2|||
124561996|NCT01716754|448014644|FG003|Overall Study|Non-compliance with study treatment|0|||
124561997|NCT01716754|448014641|FG000|Overall Study|Physician Decision|1|||
124561998|NCT01716754|448014642|FG001|Overall Study|Physician Decision|0|||
124561999|NCT01716754|448014643|FG002|Overall Study|Physician Decision|0|||
124504270|NCT00789191|447798921|FG001|Overall Study|Withdrawal Criteria|4|||
124504271|NCT00789191|447798920|FG000|Overall Study|Unclassified|5|||
124504272|NCT00789191|447798921|FG001|Overall Study|Unclassified|3|||
124504273|NCT03497429|447798922|FG000|Overall Study|Progressive disease|3|||
124504274|NCT03497429|447798923|FG001|Overall Study|Progressive disease|4|||
124504275|NCT03497429|447798922|FG000|Overall Study|Adverse Event|0|||
124504276|NCT03497429|447798923|FG001|Overall Study|Adverse Event|2|||
124504277|NCT01009983|447798924|FG000|Overall Study|necessary scans not completed|1|||
124504278|NCT03364335|447798926|FG000|Overall Study|Adverse Event|3|||
124504279|NCT03364335|447798927|FG001|Overall Study|Adverse Event|4|||
124504280|NCT03364335|447798928|FG002|Overall Study|Adverse Event|1|||
124504281|NCT03364335|447798929|FG003|Overall Study|Adverse Event|2|||
124504282|NCT03364335|447798930|FG004|Overall Study|Adverse Event|0|||
124504283|NCT03364335|447798926|FG000|Overall Study|Lost to Follow-up|7|||
124504284|NCT03364335|447798927|FG001|Overall Study|Lost to Follow-up|7|||
124504285|NCT03364335|447798928|FG002|Overall Study|Lost to Follow-up|10|||
124504286|NCT03364335|447798929|FG003|Overall Study|Lost to Follow-up|11|||
124504287|NCT03364335|447798930|FG004|Overall Study|Lost to Follow-up|11|||
124504288|NCT02670915|447798931|FG000|Overall Study|Withdrawal by Subject|0|||
124504289|NCT02670915|447798932|FG001|Overall Study|Withdrawal by Subject|1|||
124504290|NCT02670915|447798933|FG002|Overall Study|Withdrawal by Subject|4|||
124504291|NCT02670915|447798931|FG000|Overall Study|Withdrawal by parent/guardian|4|||
124504292|NCT02670915|447798932|FG001|Overall Study|Withdrawal by parent/guardian|4|||
124504293|NCT02670915|447798933|FG002|Overall Study|Withdrawal by parent/guardian|1|||
124504294|NCT02670915|447798931|FG000|Overall Study|Unclassified|0|||
124504295|NCT02670915|447798932|FG001|Overall Study|Unclassified|3|||
124504296|NCT02670915|447798933|FG002|Overall Study|Unclassified|0|||
124504297|NCT00818207|447798937|FG000|Overall Study|Adverse Event|6|||
124504298|NCT00818207|447798938|FG001|Overall Study|Adverse Event|0|||
124504299|NCT00818207|447798937|FG000|Overall Study|Lost to Follow-up|160|||
124504300|NCT00818207|447798938|FG001|Overall Study|Lost to Follow-up|146|||
124504301|NCT00818207|447798937|FG000|Overall Study|Multiple reasons|11|||
124504302|NCT00818207|447798938|FG001|Overall Study|Multiple reasons|12|||
124504303|NCT00818207|447798937|FG000|Overall Study|Withdrawal by Subject|42|||
124504304|NCT00818207|447798938|FG001|Overall Study|Withdrawal by Subject|104|||
124504305|NCT00818207|447798937|FG000|Overall Study|Death|3|||
124504306|NCT00818207|447798938|FG001|Overall Study|Death|5|||
124504307|NCT02494778|447798939|FG000|Overall Study|Death|3|||
124562000|NCT01716754|448014644|FG003|Overall Study|Physician Decision|0|||
124562001|NCT01716754|448014641|FG000|Overall Study|Lost to Follow-up|1|||
124562002|NCT01716754|448014642|FG001|Overall Study|Lost to Follow-up|0|||
124562003|NCT01716754|448014643|FG002|Overall Study|Lost to Follow-up|0|||
124562004|NCT01716754|448014644|FG003|Overall Study|Lost to Follow-up|1|||
124562005|NCT01716754|448014641|FG000|Overall Study|Adverse Event|4|||
124562006|NCT01716754|448014642|FG001|Overall Study|Adverse Event|2|||
124562007|NCT01716754|448014643|FG002|Overall Study|Adverse Event|2|||
124562008|NCT01716754|448014644|FG003|Overall Study|Adverse Event|1|||
124562009|NCT01716754|448014641|FG000|Overall Study|Withdrawal by Subject|5|||
124504308|NCT02494778|447798939|FG000|Overall Study|Other|173|||
124504309|NCT02494778|447798939|FG000|Overall Study|Lack of Efficacy|4|||
124504310|NCT02494778|447798939|FG000|Overall Study|Adverse Event|18|||
124504311|NCT02494778|447798939|FG000|Overall Study|Withdrawal by Subject|20|||
124504312|NCT02494778|447798939|FG000|Overall Study|Lost to Follow-up|2|||
124562010|NCT01716754|448014642|FG001|Overall Study|Withdrawal by Subject|0|||
124562011|NCT01716754|448014643|FG002|Overall Study|Withdrawal by Subject|4|||
124562012|NCT01716754|448014644|FG003|Overall Study|Withdrawal by Subject|3|||
124504313|NCT02494778|447798939|FG000|Overall Study|Noncompliant with study drug admin.|1|||
124504314|NCT00967226|447798940|FG000|Overall Study|Adverse Event|0|||
124504315|NCT00967226|447798941|FG001|Overall Study|Adverse Event|5|||
124504316|NCT00967226|447798940|FG000|Overall Study|Protocol Violation|2|||
124504317|NCT00967226|447798941|FG001|Overall Study|Protocol Violation|0|||
124504318|NCT00967226|447798940|FG000|Overall Study|Physician Decision|0|||
124504319|NCT00967226|447798941|FG001|Overall Study|Physician Decision|1|||
124504320|NCT02702518|447798951|FG000|Overall Study|Lost to Follow-up|3|||
124504321|NCT02702518|447798952|FG001|Overall Study|Lost to Follow-up|4|||
124504322|NCT02796391|447798955|FG000|Overall Study|Lost to Follow-up|2|||
124504323|NCT02796391|447798956|FG001|Overall Study|Lost to Follow-up|2|||
124562013|NCT00638157|448014666|FG000|Overall Study|Adverse Event|0|||
124562014|NCT00638157|448014667|FG001|Overall Study|Adverse Event|1|||
124504324|NCT02796391|447798957|FG002|Overall Study|Lost to Follow-up|13|||
124504325|NCT02796391|447798958|FG003|Overall Study|Lost to Follow-up|8|||
124504326|NCT02796391|447798959|FG004|Overall Study|Lost to Follow-up|14|||
124504327|NCT02796391|447798960|FG005|Overall Study|Lost to Follow-up|13|||
124504328|NCT02796391|447798955|FG000|Overall Study|COVID|0|||
124504329|NCT02796391|447798956|FG001|Overall Study|COVID|0|||
124504330|NCT02796391|447798957|FG002|Overall Study|COVID|5|||
124504331|NCT02796391|447798958|FG003|Overall Study|COVID|5|||
124504332|NCT02796391|447798959|FG004|Overall Study|COVID|2|||
124504333|NCT02796391|447798960|FG005|Overall Study|COVID|4|||
124504334|NCT02796391|447798955|FG000|Overall Study|Participant did not like study cigarettes|0|||
124504335|NCT02796391|447798956|FG001|Overall Study|Participant did not like study cigarettes|0|||
124504336|NCT02796391|447798957|FG002|Overall Study|Participant did not like study cigarettes|3|||
124504337|NCT02796391|447798958|FG003|Overall Study|Participant did not like study cigarettes|0|||
124504338|NCT02796391|447798959|FG004|Overall Study|Participant did not like study cigarettes|0|||
124504339|NCT02796391|447798960|FG005|Overall Study|Participant did not like study cigarettes|0|||
124504340|NCT02796391|447798955|FG000|Overall Study|Withdrawal by Subject|1|||
124504341|NCT02796391|447798956|FG001|Overall Study|Withdrawal by Subject|1|||
124504342|NCT02796391|447798957|FG002|Overall Study|Withdrawal by Subject|4|||
124504343|NCT02796391|447798958|FG003|Overall Study|Withdrawal by Subject|3|||
124504344|NCT02796391|447798959|FG004|Overall Study|Withdrawal by Subject|4|||
124504345|NCT02796391|447798960|FG005|Overall Study|Withdrawal by Subject|3|||
124504346|NCT02796391|447798955|FG000|Overall Study|Adverse Event|0|||
124504347|NCT02796391|447798956|FG001|Overall Study|Adverse Event|0|||
124504348|NCT02796391|447798957|FG002|Overall Study|Adverse Event|0|||
124504349|NCT02796391|447798958|FG003|Overall Study|Adverse Event|1|||
124504350|NCT02796391|447798959|FG004|Overall Study|Adverse Event|0|||
124504351|NCT02796391|447798960|FG005|Overall Study|Adverse Event|0|||
124504352|NCT02796391|447798955|FG000|Overall Study|Protocol Violation|0|||
124504353|NCT02796391|447798956|FG001|Overall Study|Protocol Violation|0|||
124504354|NCT02796391|447798957|FG002|Overall Study|Protocol Violation|0|||
124504355|NCT02796391|447798958|FG003|Overall Study|Protocol Violation|1|||
124504356|NCT02796391|447798959|FG004|Overall Study|Protocol Violation|0|||
124504357|NCT02796391|447798960|FG005|Overall Study|Protocol Violation|0|||
124504358|NCT02156492|447798961|FG000|Period 1|No Reason Given|0|||
124504359|NCT02156492|447798962|FG001|Period 1|No Reason Given|1|||
124504360|NCT02156492|447798963|FG002|Period 1|No Reason Given|0|||
124504361|NCT02156492|447798961|FG000|Period 3|Adverse Event|0|||
124504362|NCT02156492|447798962|FG001|Period 3|Adverse Event|1|||
124504363|NCT02156492|447798963|FG002|Period 3|Adverse Event|0|||
124504364|NCT05254613|447798964|FG000|Overall Study|Lost to Follow-up|0|||
124504365|NCT05254613|447798965|FG001|Overall Study|Lost to Follow-up|0|||
124504366|NCT05254613|447798966|FG002|Overall Study|Lost to Follow-up|1|||
124504367|NCT02106455|447798970|FG000|Overall Study|Case Report Form Uncollected|6|||
124504368|NCT02106455|447798970|FG000|Overall Study|Protocol Deviation|2|||
124504369|NCT00229203|447798971|FG000|Overall Study|Progressive disease|18|||
124504370|NCT00229203|447798972|FG001|Overall Study|Progressive disease|9|||
124504371|NCT00229203|447798971|FG000|Overall Study|Toxicity|6|||
124504372|NCT00229203|447798972|FG001|Overall Study|Toxicity|1|||
124504373|NCT00229203|447798971|FG000|Overall Study|Death|4|||
124504374|NCT00229203|447798972|FG001|Overall Study|Death|2|||
124504375|NCT00229203|447798971|FG000|Overall Study|Other|3|||
124504376|NCT00229203|447798972|FG001|Overall Study|Other|3|||
124504377|NCT00229203|447798971|FG000|Overall Study|Withdrawal by Subject|1|||
124504378|NCT00229203|447798972|FG001|Overall Study|Withdrawal by Subject|4|||
124504379|NCT03607838|447798973|FG000|Overall Study|Lack of Efficacy|14|||
124504380|NCT03607838|447798974|FG001|Overall Study|Lack of Efficacy|20|||
124504381|NCT03607838|447798973|FG000|Overall Study|Withdrawal by Subject|13|||
124504382|NCT03607838|447798974|FG001|Overall Study|Withdrawal by Subject|8|||
124504383|NCT03607838|447798973|FG000|Overall Study|Lost to Follow-up|6|||
124504384|NCT03607838|447798974|FG001|Overall Study|Lost to Follow-up|11|||
124504385|NCT03607838|447798973|FG000|Overall Study|Adverse Event|2|||
124504386|NCT03607838|447798974|FG001|Overall Study|Adverse Event|2|||
124504387|NCT03607838|447798973|FG000|Overall Study|Physician Decision|2|||
124504388|NCT03607838|447798974|FG001|Overall Study|Physician Decision|0|||
124504389|NCT03607838|447798973|FG000|Overall Study|Failure to meet randomization criteria|1|||
124504390|NCT03607838|447798974|FG001|Overall Study|Failure to meet randomization criteria|2|||
124504391|NCT03607838|447798973|FG000|Overall Study|Pregnancy|1|||
124504392|NCT03607838|447798974|FG001|Overall Study|Pregnancy|0|||
124504393|NCT03607838|447798973|FG000|Overall Study|Protocol Violation|1|||
124724858|NCT02582814|448613333|FG001|Overall Study|Adverse Event|4|||
124504394|NCT03607838|447798974|FG001|Overall Study|Protocol Violation|0|||
124504395|NCT03607838|447798973|FG000|Overall Study|Due to work|1|||
124504396|NCT03607838|447798974|FG001|Overall Study|Due to work|0|||
124504397|NCT03607838|447798973|FG000|Overall Study|Litigation|0|||
124504398|NCT03607838|447798974|FG001|Overall Study|Litigation|1|||
124504399|NCT03607838|447798973|FG000|Overall Study|Temperature excursion for study drug|0|||
124504400|NCT03607838|447798974|FG001|Overall Study|Temperature excursion for study drug|1|||
124504401|NCT03607838|447798973|FG000|Overall Study|Change of mind|0|||
124504402|NCT03607838|447798974|FG001|Overall Study|Change of mind|1|||
124562015|NCT00638157|448014666|FG000|Overall Study|Clinical (symptomatic) failure|1|||
124562016|NCT00638157|448014667|FG001|Overall Study|Clinical (symptomatic) failure|1|||
124562017|NCT00638157|448014666|FG000|Overall Study|Microbiological failure|1|||
124562018|NCT00638157|448014667|FG001|Overall Study|Microbiological failure|0|||
124562019|NCT00638157|448014666|FG000|Overall Study|Lost to Follow-up|1|||
124562020|NCT00638157|448014667|FG001|Overall Study|Lost to Follow-up|0|||
124562021|NCT00638157|448014666|FG000|Overall Study|Physician Decision|1|||
124562022|NCT00638157|448014667|FG001|Overall Study|Physician Decision|0|||
124562023|NCT00638157|448014666|FG000|Overall Study|Other|1|||
124562024|NCT00638157|448014667|FG001|Overall Study|Other|2|||
124562025|NCT00638157|448014666|FG000|Overall Study|Randomized, not treated|2|||
124562026|NCT00638157|448014667|FG001|Overall Study|Randomized, not treated|0|||
124562027|NCT01851590|448014671|FG000|Overall Study|Withdrawal by Subject|0|||
124562028|NCT01851590|448014672|FG001|Overall Study|Withdrawal by Subject|0|||
124562029|NCT01851590|448014673|FG002|Overall Study|Withdrawal by Subject|1|||
124562030|NCT01851590|448014671|FG000|Overall Study|Adverse Event|0|||
124562031|NCT01851590|448014672|FG001|Overall Study|Adverse Event|0|||
124562032|NCT01851590|448014673|FG002|Overall Study|Adverse Event|2|||
124562033|NCT01851590|448014671|FG000|Overall Study|Lack of Efficacy|0|||
124562034|NCT01851590|448014672|FG001|Overall Study|Lack of Efficacy|1|||
124562035|NCT01851590|448014673|FG002|Overall Study|Lack of Efficacy|0|||
124562036|NCT02611752|448014676|FG000|Overall Study|Adverse Event|0|||
124562037|NCT02611752|448014677|FG001|Overall Study|Adverse Event|1|||
124562038|NCT00310856|448014678|FG000|Overall Study|Withdrawal by Subject|2|||
124562039|NCT00310856|448014679|FG001|Overall Study|Withdrawal by Subject|2|||
124562040|NCT00310856|448014680|FG002|Overall Study|Withdrawal by Subject|2|||
124562041|NCT00310856|448014678|FG000|Overall Study|Lost to Follow-up|1|||
124562042|NCT00310856|448014679|FG001|Overall Study|Lost to Follow-up|2|||
124562043|NCT00310856|448014680|FG002|Overall Study|Lost to Follow-up|6|||
124562044|NCT00310856|448014678|FG000|Overall Study|Inappropriate enrollment|1|||
124562045|NCT00310856|448014679|FG001|Overall Study|Inappropriate enrollment|1|||
124562046|NCT00310856|448014680|FG002|Overall Study|Inappropriate enrollment|0|||
124562047|NCT00310856|448014678|FG000|Overall Study|Unable to classify|1|||
124562048|NCT00310856|448014679|FG001|Overall Study|Unable to classify|0|||
124562049|NCT00310856|448014680|FG002|Overall Study|Unable to classify|0|||
124562050|NCT00321711|448014684|FG000|Part A|Adverse Event|3|||
124562051|NCT00321711|448014685|FG001|Part A|Adverse Event|3|||
124562052|NCT00321711|448014686|FG002|Part A|Adverse Event|2|||
124562053|NCT00321711|448014687|FG003|Part A|Adverse Event|0|||
124562054|NCT00321711|448014688|FG004|Part A|Adverse Event|0|||
124562055|NCT00321711|448014684|FG000|Part A|Withdrawal by Subject|1|||
124562056|NCT00321711|448014685|FG001|Part A|Withdrawal by Subject|1|||
124562057|NCT00321711|448014686|FG002|Part A|Withdrawal by Subject|1|||
124562058|NCT00321711|448014687|FG003|Part A|Withdrawal by Subject|0|||
124562059|NCT00321711|448014688|FG004|Part A|Withdrawal by Subject|0|||
124562060|NCT00321711|448014684|FG000|Part A|Disease progression|0|||
124562061|NCT00321711|448014685|FG001|Part A|Disease progression|1|||
124562062|NCT00321711|448014686|FG002|Part A|Disease progression|0|||
124562063|NCT00321711|448014687|FG003|Part A|Disease progression|0|||
124562064|NCT00321711|448014688|FG004|Part A|Disease progression|0|||
124562065|NCT00321711|448014684|FG000|Part A|Requirement for alternative therapy|0|||
124562066|NCT00321711|448014685|FG001|Part A|Requirement for alternative therapy|2|||
124562067|NCT00321711|448014686|FG002|Part A|Requirement for alternative therapy|1|||
124562068|NCT00321711|448014687|FG003|Part A|Requirement for alternative therapy|0|||
124562069|NCT00321711|448014688|FG004|Part A|Requirement for alternative therapy|0|||
124562070|NCT00321711|448014684|FG000|Part A|Physician Decision|0|||
124562071|NCT00321711|448014685|FG001|Part A|Physician Decision|1|||
124562072|NCT00321711|448014686|FG002|Part A|Physician Decision|3|||
124562073|NCT00321711|448014687|FG003|Part A|Physician Decision|0|||
124562074|NCT00321711|448014688|FG004|Part A|Physician Decision|0|||
124562075|NCT00321711|448014684|FG000|Part A|Other|1|||
124562076|NCT00321711|448014685|FG001|Part A|Other|2|||
124562077|NCT00321711|448014686|FG002|Part A|Other|3|||
124562078|NCT00321711|448014687|FG003|Part A|Other|0|||
124562079|NCT00321711|448014688|FG004|Part A|Other|0|||
124562080|NCT00321711|448014684|FG000|Part A|Protocol deviation|0|||
124562081|NCT00321711|448014685|FG001|Part A|Protocol deviation|0|||
124562082|NCT00321711|448014686|FG002|Part A|Protocol deviation|1|||
124562083|NCT00321711|448014687|FG003|Part A|Protocol deviation|0|||
124562084|NCT00321711|448014688|FG004|Part A|Protocol deviation|0|||
124562085|NCT00321711|448014684|FG000|Part B|Noncompliance|0|||
124562086|NCT00321711|448014685|FG001|Part B|Noncompliance|0|||
124562087|NCT00321711|448014686|FG002|Part B|Noncompliance|0|||
124562088|NCT00321711|448014687|FG003|Part B|Noncompliance|0|||
124562089|NCT00321711|448014688|FG004|Part B|Noncompliance|1|||
124562090|NCT00321711|448014684|FG000|Part B|Adverse Event|0|||
124562091|NCT00321711|448014685|FG001|Part B|Adverse Event|0|||
124562092|NCT00321711|448014686|FG002|Part B|Adverse Event|0|||
124562093|NCT00321711|448014687|FG003|Part B|Adverse Event|2|||
124562094|NCT00321711|448014688|FG004|Part B|Adverse Event|1|||
124562095|NCT00321711|448014684|FG000|Part B|Disease progression|0|||
124562096|NCT00321711|448014685|FG001|Part B|Disease progression|0|||
124562097|NCT00321711|448014686|FG002|Part B|Disease progression|0|||
124562098|NCT00321711|448014687|FG003|Part B|Disease progression|1|||
124562099|NCT00321711|448014688|FG004|Part B|Disease progression|0|||
124562100|NCT00321711|448014684|FG000|Part B|Physician Decision|0|||
124562101|NCT00321711|448014685|FG001|Part B|Physician Decision|0|||
124562102|NCT00321711|448014686|FG002|Part B|Physician Decision|0|||
124562103|NCT00321711|448014687|FG003|Part B|Physician Decision|1|||
124562104|NCT00321711|448014688|FG004|Part B|Physician Decision|2|||
124562105|NCT00321711|448014684|FG000|Part B|Death|0|||
124562106|NCT00321711|448014685|FG001|Part B|Death|0|||
124562107|NCT00321711|448014686|FG002|Part B|Death|0|||
124562108|NCT00321711|448014687|FG003|Part B|Death|2|||
124562109|NCT00321711|448014688|FG004|Part B|Death|1|||
124562110|NCT02843074|448014689|FG000|Overall Study|Withdrawal by Subject|5|||
124562111|NCT02843074|448014689|FG000|Overall Study|Progressive disease|1|||
124562112|NCT02843074|448014689|FG000|Overall Study|Physician Decision|1|||
124562113|NCT02843074|448014689|FG000|Overall Study|Lost to Follow-up|1|||
124562114|NCT02843074|448014689|FG000|Overall Study|Death|9|||
124562115|NCT01211769|448014692|FG000|Overall Study|Lost to Follow-up|7|||
124562116|NCT01211769|448014693|FG001|Overall Study|Lost to Follow-up|9|||
124562117|NCT01211769|448014694|FG002|Overall Study|Lost to Follow-up|5|||
124562118|NCT01211769|448014695|FG003|Overall Study|Lost to Follow-up|9|||
124562119|NCT01211769|448014692|FG000|Overall Study|Physician Decision|2|||
124562120|NCT01211769|448014693|FG001|Overall Study|Physician Decision|0|||
124562121|NCT01211769|448014694|FG002|Overall Study|Physician Decision|2|||
124562122|NCT01211769|448014695|FG003|Overall Study|Physician Decision|1|||
124562123|NCT01211769|448014692|FG000|Overall Study|Adverse Event|0|||
124562124|NCT01211769|448014693|FG001|Overall Study|Adverse Event|1|||
124562125|NCT01211769|448014694|FG002|Overall Study|Adverse Event|1|||
124562126|NCT01211769|448014695|FG003|Overall Study|Adverse Event|1|||
124562127|NCT01214330|448014696|FG000|Overall Study|Withdrawal by Subject|2|||
124562128|NCT01214330|448014696|FG000|Overall Study|Withdrawal by Subject|2|||
124562129|NCT01348542|448014697|FG000|Overall Study|Withdrawal by Subject|3|||
124562130|NCT01348542|448014698|FG001|Overall Study|Withdrawal by Subject|0|||
124562131|NCT03402893|448014699|FG000|Overall Study|Withdrawal by Subject|1|||
124562132|NCT01484028|448014700|FG000|Period 1|Lost to Follow-up|0|||
124562133|NCT01484028|448014701|FG001|Period 1|Lost to Follow-up|1|||
124562134|NCT01484028|448014702|FG002|Period 1|Lost to Follow-up|0|||
124562135|NCT01484028|448014703|FG003|Period 1|Lost to Follow-up|0|||
124562136|NCT01484028|448014700|FG000|Period 1|Non-Compliance to Protocol|0|||
124562137|NCT01484028|448014701|FG001|Period 1|Non-Compliance to Protocol|1|||
124562138|NCT01484028|448014702|FG002|Period 1|Non-Compliance to Protocol|0|||
124562139|NCT01484028|448014703|FG003|Period 1|Non-Compliance to Protocol|1|||
124562140|NCT01484028|448014700|FG000|Period 1|Lens Discomfort|0|||
124562141|NCT01484028|448014701|FG001|Period 1|Lens Discomfort|1|||
124562142|NCT01484028|448014702|FG002|Period 1|Lens Discomfort|0|||
124562143|NCT01484028|448014703|FG003|Period 1|Lens Discomfort|0|||
124562144|NCT01199601|448014707|FG000|Overall Study|Lost to Follow-up|47|||
124562145|NCT01199601|448014708|FG001|Overall Study|Lost to Follow-up|66|||
124562146|NCT01199601|448014707|FG000|Overall Study|Withdrawal by Subject|15|||
124562147|NCT01199601|448014708|FG001|Overall Study|Withdrawal by Subject|3|||
124562148|NCT01199601|448014707|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
124562149|NCT01199601|448014708|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
124562150|NCT00146770|448014709|FG000|Overall Study|Adverse Event|2|||
124562151|NCT00146770|448014710|FG001|Overall Study|Adverse Event|0|||
124562152|NCT00146770|448014709|FG000|Overall Study|Pregnancy|1|||
124562153|NCT00146770|448014710|FG001|Overall Study|Pregnancy|0|||
124562154|NCT00146770|448014709|FG000|Overall Study|Withdrawal by Subject|2|||
124562155|NCT00146770|448014710|FG001|Overall Study|Withdrawal by Subject|0|||
124562156|NCT03775681|448014715|FG000|Overall Study|Physician Decision|3|||
124562157|NCT01855126|448014716|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
124562158|NCT01855126|448014717|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
124562159|NCT01855126|448014716|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
124562160|NCT01855126|448014717|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
124562161|NCT01748890|448014727|FG000|Overall Study|Insufficient recruitment for analysis|4|||
124562162|NCT02669264|448014728|FG000|Overall Study|Death|5|||
124562163|NCT02669264|448014729|FG001|Overall Study|Death|5|||
124562164|NCT02669264|448014730|FG002|Overall Study|Death|3|||
124562165|NCT02669264|448014731|FG003|Overall Study|Death|3|||
124562166|NCT02669264|448014732|FG004|Overall Study|Death|3|||
124562167|NCT02669264|448014733|FG005|Overall Study|Death|6|||
124562168|NCT02669264|448014734|FG006|Overall Study|Death|3|||
124562169|NCT02669264|448014728|FG000|Overall Study|Withdrawal by Subject|0|||
124562170|NCT02669264|448014729|FG001|Overall Study|Withdrawal by Subject|1|||
124562171|NCT02669264|448014730|FG002|Overall Study|Withdrawal by Subject|0|||
124562172|NCT02669264|448014731|FG003|Overall Study|Withdrawal by Subject|0|||
124562173|NCT02669264|448014732|FG004|Overall Study|Withdrawal by Subject|1|||
124562174|NCT02669264|448014733|FG005|Overall Study|Withdrawal by Subject|0|||
124562175|NCT02669264|448014734|FG006|Overall Study|Withdrawal by Subject|0|||
124562176|NCT02669264|448014728|FG000|Overall Study|Lost to Follow-up|0|||
124562177|NCT02669264|448014729|FG001|Overall Study|Lost to Follow-up|0|||
124562178|NCT02669264|448014730|FG002|Overall Study|Lost to Follow-up|0|||
124562179|NCT02669264|448014731|FG003|Overall Study|Lost to Follow-up|0|||
124562180|NCT02669264|448014732|FG004|Overall Study|Lost to Follow-up|1|||
124562181|NCT02669264|448014733|FG005|Overall Study|Lost to Follow-up|0|||
124562182|NCT02669264|448014734|FG006|Overall Study|Lost to Follow-up|0|||
124562183|NCT02669264|448014728|FG000|Overall Study|Miscellaneous|0|||
124562184|NCT02669264|448014729|FG001|Overall Study|Miscellaneous|0|||
124562185|NCT02669264|448014730|FG002|Overall Study|Miscellaneous|0|||
124562186|NCT02669264|448014731|FG003|Overall Study|Miscellaneous|0|||
124562187|NCT02669264|448014732|FG004|Overall Study|Miscellaneous|0|||
124562188|NCT02669264|448014733|FG005|Overall Study|Miscellaneous|0|||
124562189|NCT02669264|448014734|FG006|Overall Study|Miscellaneous|2|||
124562190|NCT01688037|448014735|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
124562191|NCT01688037|448014736|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
124562192|NCT01688037|448014737|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
124562193|NCT01688037|448014735|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
124562194|NCT01688037|448014736|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
124562195|NCT01688037|448014737|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
124562196|NCT01688037|448014735|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
124562197|NCT01688037|448014736|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
124562198|NCT01688037|448014737|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
124562199|NCT01688037|448014735|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
124562200|NCT01688037|448014736|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
124562201|NCT01688037|448014737|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
124562202|NCT01688037|448014735|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
124562203|NCT01688037|448014736|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
124562204|NCT01688037|448014737|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
124562205|NCT01688037|448014735|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
124562206|NCT01688037|448014736|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
124562207|NCT01688037|448014737|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
124562208|NCT01688037|448014735|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
124562209|NCT01688037|448014736|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
124562210|NCT01688037|448014737|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
124562211|NCT01688037|448014735|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
124562212|NCT01688037|448014736|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
124562213|NCT01688037|448014737|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
124562214|NCT01688037|448014735|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
124562215|NCT01688037|448014736|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
124562216|NCT01688037|448014737|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
124562217|NCT01688037|448014735|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
124562218|NCT01688037|448014736|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
124562219|NCT01688037|448014737|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
124562220|NCT03280537|448014740|FG000|Overall Study|Withdrawal by Subject|2|||
124562221|NCT03280537|448014741|FG001|Overall Study|Withdrawal by Subject|4|||
124562222|NCT03083132|448014742|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
124562223|NCT03083132|448014743|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
124562224|NCT03083132|448014742|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
124562225|NCT03083132|448014743|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
124562226|NCT03083132|448014742|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
124562227|NCT03083132|448014743|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
124562228|NCT01588106|448014744|FG000|Overall Study|Withdrawal by Subject|5|||
124562229|NCT01588106|448014745|FG001|Overall Study|Withdrawal by Subject|4|||
124562230|NCT02995837|448014746|FG000|Overall Study|Lost to Follow-up|9|||
124562231|NCT02995837|448014747|FG001|Overall Study|Lost to Follow-up|8|||
124562232|NCT02004847|448016467|FG000|Overall Study|Protocol Violation|1|||
124562233|NCT02004847|448016468|FG001|Overall Study|Protocol Violation|1|||
124562234|NCT03342898|448016469|FG000|Overall Study|Adverse Event|3|||
124562235|NCT03342898|448016470|FG001|Overall Study|Adverse Event|1|||
124562236|NCT03342898|448016471|FG002|Overall Study|Adverse Event|0|||
124562237|NCT03342898|448016469|FG000|Overall Study|Lost to Follow-up|44|||
124562238|NCT03342898|448016470|FG001|Overall Study|Lost to Follow-up|40|||
124562239|NCT03342898|448016471|FG002|Overall Study|Lost to Follow-up|42|||
124562240|NCT03342898|448016469|FG000|Overall Study|Withdrawal of Consent|5|||
124562241|NCT03342898|448016470|FG001|Overall Study|Withdrawal of Consent|9|||
124562242|NCT03342898|448016471|FG002|Overall Study|Withdrawal of Consent|11|||
124562243|NCT03342898|448016469|FG000|Overall Study|Death|0|||
124562244|NCT03342898|448016470|FG001|Overall Study|Death|1|||
124562245|NCT03342898|448016471|FG002|Overall Study|Death|1|||
124562246|NCT03342898|448016469|FG000|Overall Study|Reason not Specified|2|||
124562247|NCT03342898|448016470|FG001|Overall Study|Reason not Specified|2|||
124562248|NCT03342898|448016471|FG002|Overall Study|Reason not Specified|0|||
124562249|NCT03997448|448016472|FG000|Study Treatment|Disease Progression|1|||
124504403|NCT01576016|447798975|FG000|Lead Safety|Death|132|||
124504404|NCT01576016|447798976|FG001|Lead Safety|Death|0|||
124504405|NCT01576016|447798975|FG000|Lead Safety|Withdrawal by Subject|81|||
124504406|NCT01576016|447798976|FG001|Lead Safety|Withdrawal by Subject|0|||
124504407|NCT01576016|447798975|FG000|Lead Safety|System Explanted without Replacement|24|||
124504408|NCT01576016|447798976|FG001|Lead Safety|System Explanted without Replacement|0|||
124504409|NCT01576016|447798975|FG000|Lead Safety|Physician Decision|14|||
124504410|NCT01576016|447798976|FG001|Lead Safety|Physician Decision|0|||
124504411|NCT01576016|447798975|FG000|Lead Safety|Lost to Follow-up|13|||
124504412|NCT01576016|447798976|FG001|Lead Safety|Lost to Follow-up|0|||
124504413|NCT01576016|447798975|FG000|Lead Safety|Unsuccessful implant|2|||
124504414|NCT01576016|447798976|FG001|Lead Safety|Unsuccessful implant|0|||
124504415|NCT01576016|447798975|FG000|Lead Safety|Sponsor request|1|||
124504416|NCT01576016|447798976|FG001|Lead Safety|Sponsor request|0|||
124504417|NCT01576016|447798975|FG000|Lead Safety|Device replaced with CRT-D|1|||
124504418|NCT01576016|447798976|FG001|Lead Safety|Device replaced with CRT-D|0|||
124504419|NCT01576016|447798975|FG000|Lead Safety|Patient on Palliative Care|1|||
124504420|NCT01576016|447798976|FG001|Lead Safety|Patient on Palliative Care|0|||
124504421|NCT01576016|447798975|FG000|Lead Safety|Patient noncompliance|1|||
124504422|NCT01576016|447798976|FG001|Lead Safety|Patient noncompliance|0|||
124504423|NCT01576016|447798975|FG000|Lead Safety|Too far from study site|1|||
124504424|NCT01576016|447798976|FG001|Lead Safety|Too far from study site|0|||
124504425|NCT01576016|447798975|FG000|Lead Safety|System deactivated|1|||
124504426|NCT01576016|447798976|FG001|Lead Safety|System deactivated|0|||
124504427|NCT01576016|447798975|FG000|Lead Safety|Patient no longer followed by study PI|1|||
124504428|NCT01576016|447798976|FG001|Lead Safety|Patient no longer followed by study PI|0|||
124504429|NCT01576016|447798975|FG000|MRI Safety|Withdrawal by Subject|0|||
124504430|NCT01576016|447798976|FG001|MRI Safety|Withdrawal by Subject|10|||
124504431|NCT01576016|447798975|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
124504432|NCT01576016|447798976|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
124504433|NCT01576016|447798975|FG000|MRI Safety|Has not yet completed MRI scan|0|||
124504434|NCT01576016|447798976|FG001|MRI Safety|Has not yet completed MRI scan|56|||
124504435|NCT01576016|447798975|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
124504436|NCT01576016|447798976|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
124504437|NCT02488551|447798979|FG000|Overall Study|Lost to Follow-up|4|||
124504438|NCT02488551|447798980|FG001|Overall Study|Lost to Follow-up|7|||
124504439|NCT02488551|447798981|FG002|Overall Study|Lost to Follow-up|0|||
124504440|NCT02488551|447798982|FG003|Overall Study|Lost to Follow-up|0|||
124504441|NCT02488551|447798979|FG000|Overall Study|Military Deployment|1|||
124504442|NCT02488551|447798980|FG001|Overall Study|Military Deployment|1|||
124504443|NCT02488551|447798981|FG002|Overall Study|Military Deployment|0|||
124504444|NCT02488551|447798982|FG003|Overall Study|Military Deployment|0|||
124504445|NCT04507867|447798985|FG000|Overall Study|Death|7|||
124504446|NCT04507867|447798986|FG001|Overall Study|Death|1|||
124504447|NCT04096326|447798987|FG000|Overall Study|Withdrawal by Subject|0|||
124504448|NCT04096326|447798988|FG001|Overall Study|Withdrawal by Subject|0|||
124504449|NCT04096326|447798989|FG002|Overall Study|Withdrawal by Subject|0|||
124504450|NCT04096326|447798990|FG003|Overall Study|Withdrawal by Subject|0|||
124504451|NCT04096326|447798991|FG004|Overall Study|Withdrawal by Subject|0|||
124504452|NCT04096326|447798992|FG005|Overall Study|Withdrawal by Subject|0|||
124504453|NCT04096326|447798993|FG006|Overall Study|Withdrawal by Subject|1|||
124504454|NCT04096326|447798994|FG007|Overall Study|Withdrawal by Subject|0|||
124504455|NCT04096326|447798995|FG008|Overall Study|Withdrawal by Subject|0|||
124504456|NCT04096326|447798996|FG009|Overall Study|Withdrawal by Subject|0|||
124504457|NCT04096326|447798987|FG000|Overall Study|Lost to Follow-up|0|||
124504458|NCT04096326|447798988|FG001|Overall Study|Lost to Follow-up|1|||
124504459|NCT04096326|447798989|FG002|Overall Study|Lost to Follow-up|0|||
124504460|NCT04096326|447798990|FG003|Overall Study|Lost to Follow-up|0|||
124504461|NCT04096326|447798991|FG004|Overall Study|Lost to Follow-up|0|||
124504462|NCT04096326|447798992|FG005|Overall Study|Lost to Follow-up|0|||
124504463|NCT04096326|447798993|FG006|Overall Study|Lost to Follow-up|0|||
124504464|NCT04096326|447798994|FG007|Overall Study|Lost to Follow-up|0|||
124504465|NCT04096326|447798995|FG008|Overall Study|Lost to Follow-up|0|||
124504466|NCT04096326|447798996|FG009|Overall Study|Lost to Follow-up|0|||
124504467|NCT04096326|447798987|FG000|Overall Study|COVID-19-related reasons|0|||
124504468|NCT04096326|447798988|FG001|Overall Study|COVID-19-related reasons|0|||
124504469|NCT04096326|447798989|FG002|Overall Study|COVID-19-related reasons|0|||
124504470|NCT04096326|447798990|FG003|Overall Study|COVID-19-related reasons|0|||
124504471|NCT04096326|447798991|FG004|Overall Study|COVID-19-related reasons|1|||
124504472|NCT04096326|447798992|FG005|Overall Study|COVID-19-related reasons|5|||
124504473|NCT04096326|447798993|FG006|Overall Study|COVID-19-related reasons|0|||
124504474|NCT04096326|447798994|FG007|Overall Study|COVID-19-related reasons|0|||
124504475|NCT04096326|447798995|FG008|Overall Study|COVID-19-related reasons|0|||
124504476|NCT04096326|447798996|FG009|Overall Study|COVID-19-related reasons|0|||
124504477|NCT02512068|447799007|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
124504478|NCT02512068|447799008|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
124504479|NCT02512068|447799007|FG000|Overall Study|Major Protocol Deviation|1|||
124562250|NCT03997448|448016472|FG000|Study Treatment|Symptomatic Deterioration|1|||
124562251|NCT03997448|448016472|FG000|Follow up|Death|2|||
124562252|NCT03997448|448016472|FG000|Follow up|study terminated|1|||
124562253|NCT02482805|448016479|FG000|Overall Study|Lost to Follow-up|4|||
124562254|NCT02482805|448016480|FG001|Overall Study|Lost to Follow-up|4|||
124562255|NCT02482805|448016481|FG002|Overall Study|Lost to Follow-up|0|||
124562256|NCT01144663|448016484|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
124562257|NCT01144663|448016485|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
124562258|NCT01144663|448016486|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
124562259|NCT01144663|448016487|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
124562260|NCT01144663|448016484|FG000|Primary Vaccination Phase|Adverse Event|1|||
124562261|NCT01144663|448016485|FG001|Primary Vaccination Phase|Adverse Event|0|||
124562262|NCT01144663|448016486|FG002|Primary Vaccination Phase|Adverse Event|0|||
124562263|NCT01144663|448016487|FG003|Primary Vaccination Phase|Adverse Event|1|||
124562264|NCT01144663|448016484|FG000|Primary Vaccination Phase|Protocol Violation|2|||
124562265|NCT01144663|448016485|FG001|Primary Vaccination Phase|Protocol Violation|0|||
124562266|NCT01144663|448016486|FG002|Primary Vaccination Phase|Protocol Violation|1|||
124562267|NCT01144663|448016487|FG003|Primary Vaccination Phase|Protocol Violation|0|||
124562268|NCT01144663|448016484|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
124562269|NCT01144663|448016485|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
124562270|NCT01144663|448016486|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
124562271|NCT01144663|448016487|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
124562272|NCT01144663|448016484|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
124562273|NCT01144663|448016485|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
124562274|NCT01144663|448016486|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
124562275|NCT01144663|448016487|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
124562276|NCT01144663|448016484|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
124562277|NCT01144663|448016485|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
124562278|NCT01144663|448016486|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
124562279|NCT01144663|448016487|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
124562280|NCT01144663|448016484|FG000|Primary Vaccination Phase|Other|0|||
124562281|NCT01144663|448016485|FG001|Primary Vaccination Phase|Other|1|||
124562282|NCT01144663|448016486|FG002|Primary Vaccination Phase|Other|0|||
124562283|NCT01144663|448016487|FG003|Primary Vaccination Phase|Other|2|||
124562284|NCT01144663|448016484|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
124562285|NCT01144663|448016485|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
124562286|NCT01144663|448016486|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
124562287|NCT01144663|448016487|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
124562288|NCT01144663|448016484|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
124562289|NCT01144663|448016485|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
124562290|NCT01144663|448016486|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
124562291|NCT01144663|448016487|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
124562292|NCT01144663|448016484|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
124562293|NCT01144663|448016485|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
124562294|NCT01144663|448016486|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
124562295|NCT01144663|448016487|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
124562296|NCT01144663|448016484|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
124562297|NCT01144663|448016485|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
124562298|NCT01144663|448016486|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
124562299|NCT01144663|448016487|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
124562300|NCT01144663|448016484|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
124562301|NCT01144663|448016485|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
124562302|NCT01144663|448016486|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
124562303|NCT01144663|448016487|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
124562304|NCT01144663|448016484|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
124562305|NCT01144663|448016485|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
124562306|NCT01144663|448016486|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
124562307|NCT01144663|448016487|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
124562308|NCT01335477|448016489|FG000|Overall Study|Adverse Event|30|||
124562309|NCT01335477|448016490|FG001|Overall Study|Adverse Event|42|||
124562310|NCT01335477|448016489|FG000|Overall Study|Non compliant with protocol|0|||
124562311|NCT01335477|448016490|FG001|Overall Study|Non compliant with protocol|2|||
124562312|NCT01335477|448016489|FG000|Overall Study|Lost to Follow-up|1|||
124562313|NCT01335477|448016490|FG001|Overall Study|Lost to Follow-up|2|||
124562314|NCT01335477|448016489|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
124562315|NCT01335477|448016490|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
124562316|NCT01335477|448016489|FG000|Overall Study|Not treated|1|||
124562317|NCT01335477|448016490|FG001|Overall Study|Not treated|2|||
124562318|NCT01335477|448016489|FG000|Overall Study|Reason other than those stated above|2|||
124562319|NCT01335477|448016490|FG001|Overall Study|Reason other than those stated above|2|||
124562320|NCT01007916|448016491|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
124562321|NCT01007916|448016492|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
124562322|NCT01007916|448016491|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
124562323|NCT01007916|448016492|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
124562324|NCT01927757|448016512|FG000|Overall Study|Withdrawal by Subject|14|||
124562325|NCT01927757|448016512|FG000|Overall Study|Lost to Follow-up|2|||
124562326|NCT01927757|448016512|FG000|Overall Study|Decision by Sponsor|2|||
124562327|NCT01927757|448016512|FG000|Overall Study|Other|1|||
124562328|NCT01927757|448016512|FG000|Overall Study|Ethical Reasons|4|||
124562329|NCT00449072|448016514|FG000|Overall Study|Adverse Event|3|||
124562330|NCT00449072|448016515|FG001|Overall Study|Adverse Event|1|||
124562331|NCT00449072|448016514|FG000|Overall Study|Protocol Violation|14|||
124562332|NCT00449072|448016515|FG001|Overall Study|Protocol Violation|12|||
124562333|NCT00449072|448016514|FG000|Overall Study|Lost to Follow-up|5|||
124562334|NCT00449072|448016515|FG001|Overall Study|Lost to Follow-up|7|||
124562335|NCT00449072|448016514|FG000|Overall Study|Withdrawal by Subject|11|||
124562336|NCT00449072|448016515|FG001|Overall Study|Withdrawal by Subject|8|||
124562337|NCT00449072|448016514|FG000|Overall Study|Lack of Efficacy|1|||
124562338|NCT00449072|448016515|FG001|Overall Study|Lack of Efficacy|1|||
124562339|NCT00449072|448016514|FG000|Overall Study|Physician Decision|1|||
124562340|NCT00449072|448016515|FG001|Overall Study|Physician Decision|0|||
124562341|NCT00449072|448016514|FG000|Overall Study|Not treated|0|||
124562342|NCT00449072|448016515|FG001|Overall Study|Not treated|1|||
124562343|NCT00449072|448016514|FG000|Overall Study|Excluded medication|0|||
124562344|NCT00449072|448016515|FG001|Overall Study|Excluded medication|2|||
124562345|NCT00449072|448016514|FG000|Overall Study|Non-compliance|2|||
124562346|NCT00449072|448016515|FG001|Overall Study|Non-compliance|5|||
124504480|NCT02512068|447799008|FG001|Overall Study|Major Protocol Deviation|0|||
124504481|NCT02512068|447799007|FG000|Overall Study|Voluntary Withdrawal|0|||
124504482|NCT02512068|447799008|FG001|Overall Study|Voluntary Withdrawal|1|||
124504483|NCT02512068|447799007|FG000|Overall Study|Lack of Efficacy|0|||
124504484|NCT02512068|447799008|FG001|Overall Study|Lack of Efficacy|1|||
124504485|NCT02512068|447799007|FG000|Overall Study|Reason Not Specified|3|||
124504486|NCT02512068|447799008|FG001|Overall Study|Reason Not Specified|5|||
124504487|NCT03521687|447799011|FG000|Overall Study|Adverse Event|4|||
124504488|NCT03521687|447799011|FG000|Overall Study|Physician Decision|1|||
124504489|NCT01151579|447799017|FG000|Overall Study|Physician Decision|3|||
124504490|NCT01151579|447799018|FG001|Overall Study|Physician Decision|1|||
124504491|NCT01151579|447799017|FG000|Overall Study|Withdrawal by Subject|3|||
124504492|NCT01151579|447799018|FG001|Overall Study|Withdrawal by Subject|2|||
124504493|NCT01151579|447799017|FG000|Overall Study|Not meet inclusion criteria|6|||
124504494|NCT01151579|447799018|FG001|Overall Study|Not meet inclusion criteria|4|||
124504495|NCT01276457|447799019|FG000|Core Study|Adverse Event|6|||
124504496|NCT01276457|447799020|FG001|Core Study|Adverse Event|3|||
124504497|NCT01276457|447799019|FG000|Core Study|Lost to Follow-up|1|||
124504498|NCT01276457|447799020|FG001|Core Study|Lost to Follow-up|2|||
124504499|NCT01276457|447799019|FG000|Core Study|Administrative problems|1|||
124504500|NCT01276457|447799020|FG001|Core Study|Administrative problems|1|||
124504501|NCT01276457|447799019|FG000|Core Study|Death|2|||
124504502|NCT01276457|447799020|FG001|Core Study|Death|2|||
124504503|NCT01276457|447799019|FG000|Core Study|Lack of Efficacy|3|||
124504504|NCT01276457|447799020|FG001|Core Study|Lack of Efficacy|12|||
124504505|NCT01276457|447799019|FG000|Extension Study|Lost to Follow-up|3|||
124504506|NCT01276457|447799020|FG001|Extension Study|Lost to Follow-up|0|||
124504507|NCT01276457|447799019|FG000|Extension Study|Death|0|||
124504508|NCT01276457|447799020|FG001|Extension Study|Death|1|||
124504509|NCT01276457|447799019|FG000|Extension Study|Lack of Efficacy|3|||
124504510|NCT01276457|447799020|FG001|Extension Study|Lack of Efficacy|1|||
124504511|NCT01098461|447799025|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
124504512|NCT01098461|447799026|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
124504513|NCT01098461|447799027|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
124504514|NCT01098461|447799028|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
124504515|NCT01098461|447799025|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
124504516|NCT01098461|447799026|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
124562347|NCT00449072|448016514|FG000|Overall Study|Sponsor decision|1|||
124562348|NCT00449072|448016515|FG001|Overall Study|Sponsor decision|3|||
124562349|NCT00449072|448016514|FG000|Overall Study|Relocation|3|||
124562350|NCT00449072|448016515|FG001|Overall Study|Relocation|2|||
124562351|NCT01992107|448016518|FG000|Overall Study|Administrative reasons|2|||
124504517|NCT01098461|447799027|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
124504518|NCT01098461|447799028|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
124504519|NCT01098461|447799025|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
124504520|NCT01098461|447799026|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
124504521|NCT01098461|447799027|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
124504522|NCT01098461|447799028|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
124504523|NCT01098461|447799025|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
124504524|NCT01098461|447799026|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
124562352|NCT01992107|448016519|FG001|Overall Study|Administrative reasons|0|||
124562353|NCT01992107|448016520|FG002|Overall Study|Administrative reasons|0|||
124562354|NCT01992107|448016518|FG000|Overall Study|Adverse Event|0|||
124562355|NCT01992107|448016519|FG001|Overall Study|Adverse Event|1|||
124562356|NCT01992107|448016520|FG002|Overall Study|Adverse Event|0|||
124562357|NCT01992107|448016518|FG000|Overall Study|Lost to Follow-up|46|||
124562358|NCT01992107|448016519|FG001|Overall Study|Lost to Follow-up|22|||
124562359|NCT01992107|448016520|FG002|Overall Study|Lost to Follow-up|26|||
124562360|NCT01992107|448016518|FG000|Overall Study|noncompliance and were unavailable|7|||
124562361|NCT01992107|448016519|FG001|Overall Study|noncompliance and were unavailable|3|||
124562362|NCT01992107|448016520|FG002|Overall Study|noncompliance and were unavailable|2|||
124562363|NCT01992107|448016518|FG000|Overall Study|Withdrawal by Subject|13|||
124562364|NCT01992107|448016519|FG001|Overall Study|Withdrawal by Subject|7|||
124562365|NCT01992107|448016520|FG002|Overall Study|Withdrawal by Subject|8|||
124504525|NCT01098461|447799027|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
124504526|NCT01098461|447799028|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
124504527|NCT01098461|447799025|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
124504528|NCT01098461|447799026|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
124504529|NCT01098461|447799027|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
124504530|NCT01098461|447799028|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
124504531|NCT01098461|447799025|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
124504532|NCT01098461|447799026|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
124504533|NCT01098461|447799027|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
124504534|NCT01098461|447799028|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
124504535|NCT01098461|447799025|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
124504536|NCT01098461|447799026|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
124504537|NCT01098461|447799027|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
124504538|NCT01098461|447799028|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
124504539|NCT01474746|447799029|FG000|Overall Study|Lost to Follow-up|1|||
124504540|NCT01474746|447799030|FG001|Overall Study|Lost to Follow-up|1|||
124504541|NCT01474746|447799029|FG000|Overall Study|Withdrawal by Subject|2|||
124504542|NCT01474746|447799030|FG001|Overall Study|Withdrawal by Subject|1|||
124504543|NCT01766336|447799032|FG000|Overall Study|Adverse Event|11|||
124504544|NCT01766336|447799033|FG001|Overall Study|Adverse Event|8|||
124504545|NCT01766336|447799032|FG000|Overall Study|Death|4|||
124504546|NCT01766336|447799033|FG001|Overall Study|Death|3|||
124504547|NCT01766336|447799032|FG000|Overall Study|Lost to Follow-up|1|||
124504548|NCT01766336|447799033|FG001|Overall Study|Lost to Follow-up|3|||
124504549|NCT01766336|447799032|FG000|Overall Study|Physician Decision|4|||
124504550|NCT01766336|447799033|FG001|Overall Study|Physician Decision|2|||
124504551|NCT01766336|447799032|FG000|Overall Study|Protocol Violation|0|||
124504552|NCT01766336|447799033|FG001|Overall Study|Protocol Violation|1|||
124504553|NCT01766336|447799032|FG000|Overall Study|Sponsor Decision|52|||
124504554|NCT01766336|447799033|FG001|Overall Study|Sponsor Decision|43|||
124504555|NCT01766336|447799032|FG000|Overall Study|Withdrawal by Subject|18|||
124504556|NCT01766336|447799033|FG001|Overall Study|Withdrawal by Subject|15|||
124504557|NCT02605447|447799034|FG000|Overall Study|Death|66|||
124504558|NCT02605447|447799034|FG000|Overall Study|Physician Decision|1|||
124504559|NCT02605447|447799034|FG000|Overall Study|Lost to Follow-up|24|||
124504560|NCT02605447|447799034|FG000|Overall Study|Withdrawal by Subject|10|||
124504561|NCT02605447|447799034|FG000|Overall Study|Not disclosed|1|||
124504562|NCT04544709|447799038|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
124504563|NCT03628508|447799039|FG000|Overall Study|Lost to Follow-up|1|||
124504564|NCT02045212|447799040|FG000|Overall Study|Adverse Event|0|||
124504565|NCT02045212|447799041|FG001|Overall Study|Adverse Event|1|||
124504566|NCT02045212|447799040|FG000|Overall Study|Withdrawal by Subject|1|||
124504567|NCT02045212|447799041|FG001|Overall Study|Withdrawal by Subject|0|||
124504568|NCT02045212|447799040|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
124504569|NCT02045212|447799041|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
124504570|NCT03807739|447799045|FG000|Overall Study|Adverse Event|1|||
124504571|NCT03807739|447799046|FG001|Overall Study|Adverse Event|0|||
124504572|NCT03807739|447799047|FG002|Overall Study|Adverse Event|0|||
124504573|NCT03807739|447799048|FG003|Overall Study|Adverse Event|0|||
124504574|NCT03807739|447799045|FG000|Overall Study|Withdrawal by Subject|1|||
124504575|NCT03807739|447799046|FG001|Overall Study|Withdrawal by Subject|0|||
124504576|NCT03807739|447799047|FG002|Overall Study|Withdrawal by Subject|0|||
124504577|NCT03807739|447799048|FG003|Overall Study|Withdrawal by Subject|0|||
124504578|NCT03126539|447799053|FG000|Overall Study|Lost to Follow-up|1|||
124504579|NCT03126539|447799054|FG001|Overall Study|Lost to Follow-up|1|||
124504580|NCT03126539|447799055|FG002|Overall Study|Lost to Follow-up|1|||
124504581|NCT03126539|447799056|FG003|Overall Study|Lost to Follow-up|0|||
124504582|NCT03126539|447799057|FG004|Overall Study|Lost to Follow-up|0|||
124504583|NCT02632110|447799058|FG000|Overall Study|Withdrawal by Subject|1|||
124504584|NCT02632110|447799059|FG001|Overall Study|Withdrawal by Subject|1|||
124562366|NCT02022007|448016521|FG000|Overall Study|Withdrawal by Subject|1|||
124562367|NCT02022007|448016522|FG001|Overall Study|Withdrawal by Subject|1|||
124562368|NCT02022007|448016523|FG002|Overall Study|Withdrawal by Subject|1|||
124562369|NCT02022007|448016521|FG000|Overall Study|Noncompliant|0|||
124562370|NCT02022007|448016522|FG001|Overall Study|Noncompliant|0|||
124562371|NCT02022007|448016523|FG002|Overall Study|Noncompliant|1|||
124562372|NCT02087046|448016524|FG000|Overall Study|Adverse Event|4|||
124562373|NCT02087046|448016524|FG000|Overall Study|Death|1|||
124562374|NCT02087046|448016524|FG000|Overall Study|Lost to Follow-up|3|||
124562375|NCT02087046|448016524|FG000|Overall Study|Withdrawal by Subject|2|||
124562376|NCT02087046|448016524|FG000|Overall Study|Physician Decision|1|||
124562377|NCT01107535|448016525|FG000|Overall Study|Death|5|||
124562378|NCT01507896|448016526|FG000|Overall Study|Withdrawal by Subject|1|||
124562379|NCT01507896|448016526|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
124562380|NCT00886483|448016534|FG000|Overall Study|Lost to Follow-up|0|||
124562381|NCT00886483|448016535|FG001|Overall Study|Lost to Follow-up|1|||
124562382|NCT00886483|448016534|FG000|Overall Study|Pursue medications|1|||
124562383|NCT00886483|448016535|FG001|Overall Study|Pursue medications|2|||
124562384|NCT00886483|448016534|FG000|Overall Study|Distance to center, poor grades|1|||
124562385|NCT00886483|448016535|FG001|Overall Study|Distance to center, poor grades|0|||
124562386|NCT00192296|448016536|FG000|Overall Study|Withdrawal by Subject|0|||
124562387|NCT00192296|448016537|FG001|Overall Study|Withdrawal by Subject|1|||
124562388|NCT00192296|448016538|FG002|Overall Study|Withdrawal by Subject|0|||
124562389|NCT00192296|448016539|FG003|Overall Study|Withdrawal by Subject|0|||
124562390|NCT00818623|448016540|FG000|Overall Study|Adverse Event|1|||
124562391|NCT00818623|448016541|FG001|Overall Study|Adverse Event|0|||
124562392|NCT00818623|448016542|FG002|Overall Study|Adverse Event|1|||
124562393|NCT00818623|448016543|FG003|Overall Study|Adverse Event|0|||
124562394|NCT00818623|448016544|FG004|Overall Study|Adverse Event|0|||
124562395|NCT00818623|448016545|FG005|Overall Study|Adverse Event|1|||
124562396|NCT00818623|448016546|FG006|Overall Study|Adverse Event|0|||
124562397|NCT00818623|448016547|FG007|Overall Study|Adverse Event|0|||
124562398|NCT00818623|448016540|FG000|Overall Study|Bad prostate specific antigen response|0|||
124562399|NCT00818623|448016541|FG001|Overall Study|Bad prostate specific antigen response|3|||
124562400|NCT00818623|448016542|FG002|Overall Study|Bad prostate specific antigen response|2|||
124562401|NCT00818623|448016543|FG003|Overall Study|Bad prostate specific antigen response|5|||
124562402|NCT00818623|448016544|FG004|Overall Study|Bad prostate specific antigen response|0|||
124562403|NCT00818623|448016545|FG005|Overall Study|Bad prostate specific antigen response|1|||
124562404|NCT00818623|448016546|FG006|Overall Study|Bad prostate specific antigen response|0|||
124562405|NCT00818623|448016547|FG007|Overall Study|Bad prostate specific antigen response|0|||
124562406|NCT00818623|448016540|FG000|Overall Study|Withdrawal by Subject|0|||
124562407|NCT00818623|448016541|FG001|Overall Study|Withdrawal by Subject|1|||
124562408|NCT00818623|448016542|FG002|Overall Study|Withdrawal by Subject|1|||
124562409|NCT00818623|448016543|FG003|Overall Study|Withdrawal by Subject|0|||
124562410|NCT00818623|448016544|FG004|Overall Study|Withdrawal by Subject|0|||
124562411|NCT00818623|448016545|FG005|Overall Study|Withdrawal by Subject|1|||
124562412|NCT00818623|448016546|FG006|Overall Study|Withdrawal by Subject|1|||
124562413|NCT00818623|448016547|FG007|Overall Study|Withdrawal by Subject|1|||
124562414|NCT00818623|448016540|FG000|Overall Study|Protocol Violation|1|||
124562415|NCT00818623|448016541|FG001|Overall Study|Protocol Violation|0|||
124562416|NCT00818623|448016542|FG002|Overall Study|Protocol Violation|0|||
124562417|NCT00818623|448016543|FG003|Overall Study|Protocol Violation|0|||
124562418|NCT00818623|448016544|FG004|Overall Study|Protocol Violation|1|||
124562419|NCT00818623|448016545|FG005|Overall Study|Protocol Violation|0|||
124562420|NCT00818623|448016546|FG006|Overall Study|Protocol Violation|1|||
124562421|NCT00818623|448016547|FG007|Overall Study|Protocol Violation|0|||
124562422|NCT00818623|448016540|FG000|Overall Study|Need of additional treatment|0|||
124562423|NCT00818623|448016541|FG001|Overall Study|Need of additional treatment|0|||
124562424|NCT00818623|448016542|FG002|Overall Study|Need of additional treatment|0|||
124562425|NCT00818623|448016543|FG003|Overall Study|Need of additional treatment|0|||
124562426|NCT00818623|448016544|FG004|Overall Study|Need of additional treatment|1|||
124562427|NCT00818623|448016545|FG005|Overall Study|Need of additional treatment|0|||
124562428|NCT00818623|448016546|FG006|Overall Study|Need of additional treatment|0|||
124562429|NCT00818623|448016547|FG007|Overall Study|Need of additional treatment|0|||
124562430|NCT00818623|448016540|FG000|Overall Study|Lack of trial drug at site|0|||
124562431|NCT00818623|448016541|FG001|Overall Study|Lack of trial drug at site|0|||
124562432|NCT00818623|448016542|FG002|Overall Study|Lack of trial drug at site|0|||
124562433|NCT00818623|448016543|FG003|Overall Study|Lack of trial drug at site|0|||
124562434|NCT00818623|448016544|FG004|Overall Study|Lack of trial drug at site|2|||
124562435|NCT00818623|448016545|FG005|Overall Study|Lack of trial drug at site|0|||
124562436|NCT00818623|448016546|FG006|Overall Study|Lack of trial drug at site|1|||
124562437|NCT00818623|448016547|FG007|Overall Study|Lack of trial drug at site|0|||
124562438|NCT00818623|448016540|FG000|Overall Study|Disease progression|0|||
124562439|NCT00818623|448016541|FG001|Overall Study|Disease progression|0|||
124562440|NCT00818623|448016542|FG002|Overall Study|Disease progression|0|||
124562441|NCT00818623|448016543|FG003|Overall Study|Disease progression|0|||
124562442|NCT00818623|448016544|FG004|Overall Study|Disease progression|0|||
124562443|NCT00818623|448016545|FG005|Overall Study|Disease progression|0|||
124562444|NCT00818623|448016546|FG006|Overall Study|Disease progression|1|||
124562445|NCT00818623|448016547|FG007|Overall Study|Disease progression|0|||
124562446|NCT02649231|448016551|FG000|Overall Study|Adverse Event|0|||
124562447|NCT02649231|448016552|FG001|Overall Study|Adverse Event|0|||
124504585|NCT02632110|447799060|FG002|Overall Study|Withdrawal by Subject|0|||
124504586|NCT02632110|447799061|FG003|Overall Study|Withdrawal by Subject|0|||
124504587|NCT02632110|447799062|FG004|Overall Study|Withdrawal by Subject|1|||
124504588|NCT02632110|447799063|FG005|Overall Study|Withdrawal by Subject|1|||
124504589|NCT02632110|447799064|FG006|Overall Study|Withdrawal by Subject|3|||
124504590|NCT02632110|447799065|FG007|Overall Study|Withdrawal by Subject|3|||
124504591|NCT02632110|447799066|FG008|Overall Study|Withdrawal by Subject|1|||
124504592|NCT02632110|447799067|FG009|Overall Study|Withdrawal by Subject|1|||
124504593|NCT00516269|447799070|FG000|Overall Study|Adverse Event|2|||
124504594|NCT00516269|447799071|FG001|Overall Study|Adverse Event|1|||
124504595|NCT00516269|447799070|FG000|Overall Study|Lost to Follow-up|0|||
124504596|NCT00516269|447799071|FG001|Overall Study|Lost to Follow-up|1|||
124504597|NCT00516269|447799070|FG000|Overall Study|Protocol Violation|0|||
124504598|NCT00516269|447799071|FG001|Overall Study|Protocol Violation|1|||
124504599|NCT01005732|447799072|FG000|Overall Study|Lost to Follow-up|10|||
124504600|NCT01005732|447799072|FG000|Overall Study|Death|1|||
124504601|NCT02596711|447799073|FG000|Overall Study|Lost to Follow-up|1|||
124504602|NCT02596711|447799074|FG001|Overall Study|Lost to Follow-up|2|||
124504603|NCT02596711|447799075|FG002|Overall Study|Lost to Follow-up|3|||
124504604|NCT01552928|447799076|FG000|Period 3|Adverse Event|0|||
124504605|NCT01552928|447799077|FG001|Period 3|Adverse Event|0|||
124504606|NCT01552928|447799078|FG002|Period 3|Adverse Event|1|||
124504607|NCT01552928|447799079|FG003|Period 3|Adverse Event|0|||
124504608|NCT04570657|447799081|FG000|Overall Study|Adverse Event|0|||
124504609|NCT04570657|447799082|FG001|Overall Study|Adverse Event|0|||
124504610|NCT04570657|447799083|FG002|Overall Study|Adverse Event|1|||
124504611|NCT04570657|447799081|FG000|Overall Study|Lost to Follow-up|0|||
124504612|NCT04570657|447799082|FG001|Overall Study|Lost to Follow-up|0|||
124504613|NCT04570657|447799083|FG002|Overall Study|Lost to Follow-up|1|||
124504614|NCT04570657|447799081|FG000|Overall Study|Physician Decision|0|||
124504615|NCT04570657|447799082|FG001|Overall Study|Physician Decision|1|||
124504616|NCT04570657|447799083|FG002|Overall Study|Physician Decision|0|||
124504617|NCT04570657|447799081|FG000|Overall Study|Withdrawal by Subject|1|||
124504618|NCT04570657|447799082|FG001|Overall Study|Withdrawal by Subject|2|||
124504619|NCT04570657|447799083|FG002|Overall Study|Withdrawal by Subject|2|||
124504620|NCT01072539|447799084|FG000|Overall Study|Treated prior to the Site Initiation|1|||
124504621|NCT01072539|447799084|FG000|Overall Study|Protocol Violation|2|||
124504622|NCT00115804|447799087|FG000|Overall Study|Adverse Event|2|||
124504623|NCT01752842|447799088|FG000|Overall Study|Adverse Event|3|||
124504624|NCT01752842|447799089|FG001|Overall Study|Adverse Event|0|||
124504625|NCT01752842|447799088|FG000|Overall Study|Withdrawal by Subject|0|||
124504626|NCT01752842|447799089|FG001|Overall Study|Withdrawal by Subject|2|||
124504627|NCT01683071|447799090|FG000|Part 1|Lack of Efficacy|1|||
124504628|NCT01683071|447799091|FG001|Part 1|Lack of Efficacy|0|||
124504629|NCT01683071|447799092|FG002|Part 1|Lack of Efficacy|0|||
124504630|NCT01683071|447799093|FG003|Part 1|Lack of Efficacy|3|||
124504631|NCT01683071|447799094|FG004|Part 1|Lack of Efficacy|0|||
124504632|NCT01683071|447799095|FG005|Part 1|Lack of Efficacy|0|||
124504633|NCT01683071|447799090|FG000|Part 1|Withdrawal by Subject|1|||
124504634|NCT01683071|447799091|FG001|Part 1|Withdrawal by Subject|2|||
124504635|NCT01683071|447799092|FG002|Part 1|Withdrawal by Subject|2|||
124504636|NCT01683071|447799093|FG003|Part 1|Withdrawal by Subject|1|||
124504637|NCT01683071|447799094|FG004|Part 1|Withdrawal by Subject|0|||
124504638|NCT01683071|447799095|FG005|Part 1|Withdrawal by Subject|0|||
124504639|NCT01683071|447799090|FG000|Part 1|Surgery Cancelled|1|||
124504640|NCT01683071|447799091|FG001|Part 1|Surgery Cancelled|0|||
124504641|NCT01683071|447799092|FG002|Part 1|Surgery Cancelled|0|||
124504642|NCT01683071|447799093|FG003|Part 1|Surgery Cancelled|0|||
124562448|NCT02649231|448016553|FG002|Overall Study|Adverse Event|0|||
124562449|NCT02649231|448016554|FG003|Overall Study|Adverse Event|1|||
124562450|NCT02649231|448016551|FG000|Overall Study|Lost to Follow-up|2|||
124562451|NCT02649231|448016552|FG001|Overall Study|Lost to Follow-up|1|||
124562452|NCT02649231|448016553|FG002|Overall Study|Lost to Follow-up|1|||
124504643|NCT01683071|447799094|FG004|Part 1|Surgery Cancelled|0|||
124504644|NCT01683071|447799095|FG005|Part 1|Surgery Cancelled|0|||
124504645|NCT01683071|447799090|FG000|Part 1|Did not receive study drug|1|||
124504646|NCT01683071|447799091|FG001|Part 1|Did not receive study drug|0|||
124504647|NCT01683071|447799092|FG002|Part 1|Did not receive study drug|0|||
124504648|NCT01683071|447799093|FG003|Part 1|Did not receive study drug|1|||
124504649|NCT01683071|447799094|FG004|Part 1|Did not receive study drug|0|||
124504650|NCT01683071|447799095|FG005|Part 1|Did not receive study drug|0|||
124504651|NCT01683071|447799090|FG000|Part 1|Early termination; met exclusion criteria|0|||
124504652|NCT01683071|447799091|FG001|Part 1|Early termination; met exclusion criteria|2|||
124562453|NCT02649231|448016554|FG003|Overall Study|Lost to Follow-up|0|||
124562454|NCT02649231|448016551|FG000|Overall Study|Withdrawal by Subject|0|||
124562455|NCT02649231|448016552|FG001|Overall Study|Withdrawal by Subject|1|||
124504653|NCT01683071|447799092|FG002|Part 1|Early termination; met exclusion criteria|1|||
124504654|NCT01683071|447799093|FG003|Part 1|Early termination; met exclusion criteria|0|||
124504655|NCT01683071|447799094|FG004|Part 1|Early termination; met exclusion criteria|0|||
124504656|NCT01683071|447799095|FG005|Part 1|Early termination; met exclusion criteria|0|||
124504657|NCT01683071|447799090|FG000|Part 2|Lack of Efficacy|0|||
124504658|NCT01683071|447799091|FG001|Part 2|Lack of Efficacy|0|||
124504659|NCT01683071|447799092|FG002|Part 2|Lack of Efficacy|0|||
124504660|NCT01683071|447799093|FG003|Part 2|Lack of Efficacy|0|||
124504661|NCT01683071|447799094|FG004|Part 2|Lack of Efficacy|3|||
124504662|NCT01683071|447799095|FG005|Part 2|Lack of Efficacy|4|||
124504663|NCT01683071|447799090|FG000|Part 2|Lost to Follow-up|0|||
124504664|NCT01683071|447799091|FG001|Part 2|Lost to Follow-up|0|||
124504665|NCT01683071|447799092|FG002|Part 2|Lost to Follow-up|0|||
124504666|NCT01683071|447799093|FG003|Part 2|Lost to Follow-up|0|||
124504667|NCT01683071|447799094|FG004|Part 2|Lost to Follow-up|2|||
124504668|NCT01683071|447799095|FG005|Part 2|Lost to Follow-up|0|||
124504669|NCT01683071|447799090|FG000|Part 2|Withdrawal by Subject|0|||
124504670|NCT01683071|447799091|FG001|Part 2|Withdrawal by Subject|0|||
124504671|NCT01683071|447799092|FG002|Part 2|Withdrawal by Subject|0|||
124504672|NCT01683071|447799093|FG003|Part 2|Withdrawal by Subject|0|||
124504673|NCT01683071|447799094|FG004|Part 2|Withdrawal by Subject|3|||
124504674|NCT01683071|447799095|FG005|Part 2|Withdrawal by Subject|3|||
124504675|NCT01683071|447799090|FG000|Part 2|Surgery cancelled|0|||
124504676|NCT01683071|447799091|FG001|Part 2|Surgery cancelled|0|||
124504677|NCT01683071|447799092|FG002|Part 2|Surgery cancelled|0|||
124504678|NCT01683071|447799093|FG003|Part 2|Surgery cancelled|0|||
124504679|NCT01683071|447799094|FG004|Part 2|Surgery cancelled|4|||
124504680|NCT01683071|447799095|FG005|Part 2|Surgery cancelled|2|||
124504681|NCT01683071|447799090|FG000|Part 2|Did not receive study drug|0|||
124504682|NCT01683071|447799091|FG001|Part 2|Did not receive study drug|0|||
124504683|NCT01683071|447799092|FG002|Part 2|Did not receive study drug|0|||
124504684|NCT01683071|447799093|FG003|Part 2|Did not receive study drug|0|||
124504685|NCT01683071|447799094|FG004|Part 2|Did not receive study drug|2|||
124504686|NCT01683071|447799095|FG005|Part 2|Did not receive study drug|1|||
124504687|NCT01683071|447799090|FG000|Part 2|Met exclusion criterion|0|||
124504688|NCT01683071|447799091|FG001|Part 2|Met exclusion criterion|0|||
124504689|NCT01683071|447799092|FG002|Part 2|Met exclusion criterion|0|||
124504690|NCT01683071|447799093|FG003|Part 2|Met exclusion criterion|0|||
124504691|NCT01683071|447799094|FG004|Part 2|Met exclusion criterion|1|||
124504692|NCT01683071|447799095|FG005|Part 2|Met exclusion criterion|1|||
124504693|NCT01683071|447799090|FG000|Part 2|Protocol deviation|0|||
124504694|NCT01683071|447799091|FG001|Part 2|Protocol deviation|0|||
124504695|NCT01683071|447799092|FG002|Part 2|Protocol deviation|0|||
124504696|NCT01683071|447799093|FG003|Part 2|Protocol deviation|0|||
124504697|NCT01683071|447799094|FG004|Part 2|Protocol deviation|1|||
124504698|NCT01683071|447799095|FG005|Part 2|Protocol deviation|2|||
124504699|NCT01683071|447799090|FG000|Part 2|Withdrawal by investigator decision|0|||
124504700|NCT01683071|447799091|FG001|Part 2|Withdrawal by investigator decision|0|||
124504701|NCT01683071|447799092|FG002|Part 2|Withdrawal by investigator decision|0|||
124504702|NCT01683071|447799093|FG003|Part 2|Withdrawal by investigator decision|0|||
124504703|NCT01683071|447799094|FG004|Part 2|Withdrawal by investigator decision|1|||
124504704|NCT01683071|447799095|FG005|Part 2|Withdrawal by investigator decision|2|||
124504705|NCT01968187|447799098|FG000|Overall Study|Adverse Event|0|||
124504706|NCT01968187|447799099|FG001|Overall Study|Adverse Event|1|||
124504707|NCT01968187|447799098|FG000|Overall Study|Randomized but not treated|1|||
124504708|NCT01968187|447799099|FG001|Overall Study|Randomized but not treated|0|||
124504709|NCT02020031|447801087|FG000|Overall Study|Physician Decision|1|||
124504710|NCT02020031|447801088|FG001|Overall Study|Physician Decision|1|||
124504711|NCT02625324|447801095|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
124504712|NCT02625324|447801095|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
124504713|NCT02625324|447801095|FG000|6-Month Follow-up Subject Accountability|Death|5|||
124562456|NCT02649231|448016553|FG002|Overall Study|Withdrawal by Subject|0|||
124562457|NCT02649231|448016554|FG003|Overall Study|Withdrawal by Subject|1|||
124504714|NCT02625324|447801095|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
124504715|NCT02625324|447801095|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
124504716|NCT02625324|447801095|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
124504717|NCT02625324|447801095|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
124504718|NCT02625324|447801095|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
124504719|NCT02625324|447801095|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
124504720|NCT02625324|447801095|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
124504721|NCT02625324|447801095|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
124504722|NCT02625324|447801095|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
124504723|NCT02625324|447801095|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
124504724|NCT02625324|447801095|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
124504725|NCT02625324|447801095|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
124504726|NCT02625324|447801095|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
124504727|NCT02625324|447801095|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
124504728|NCT01116687|447801096|FG000|Overall Study|Withdrawal by Subject|4|||
124504729|NCT00424528|447801097|FG000|Overall Study|Adverse Event|2|||
124504730|NCT00424528|447801098|FG001|Overall Study|Adverse Event|1|||
124504731|NCT00424528|447801099|FG002|Overall Study|Adverse Event|2|||
124504732|NCT00424528|447801097|FG000|Overall Study|Protocol Violation|1|||
124504733|NCT00424528|447801098|FG001|Overall Study|Protocol Violation|1|||
124504734|NCT00424528|447801099|FG002|Overall Study|Protocol Violation|0|||
124504735|NCT00424528|447801097|FG000|Overall Study|Lost to Follow-up|0|||
124504736|NCT00424528|447801098|FG001|Overall Study|Lost to Follow-up|1|||
124504737|NCT00424528|447801099|FG002|Overall Study|Lost to Follow-up|0|||
124504738|NCT00424528|447801097|FG000|Overall Study|noncompliance with study requirements|2|||
124504739|NCT00424528|447801098|FG001|Overall Study|noncompliance with study requirements|1|||
124504740|NCT00424528|447801099|FG002|Overall Study|noncompliance with study requirements|2|||
124504741|NCT02395653|447801100|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
124504742|NCT02395653|447801100|FG000|Overall Study|Consent Withdrawn at Screening|1|||
124504743|NCT02395653|447801100|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
124504744|NCT02395653|447801100|FG000|Overall Study|Investigator Decision at Screening|1|||
124504745|NCT02395653|447801100|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
124504746|NCT02395653|447801100|FG000|Overall Study|Withdrawal by Subject|1|||
124504747|NCT02395653|447801100|FG000|Overall Study|Lost to Follow-up|1|||
124504748|NCT00605722|447801101|FG000|Overall Study|Adverse Event|6|||
124504749|NCT00605722|447801101|FG000|Overall Study|Insufficient therapeutic response|44|||
124504750|NCT00605722|447801101|FG000|Overall Study|Failure to return|1|||
124504751|NCT00165841|447801104|FG000|Overall Study|Adverse Event|2|||
124504752|NCT00165841|447801105|FG001|Overall Study|Adverse Event|3|||
124504753|NCT00165841|447801104|FG000|Overall Study|Lack of Efficacy|6|||
124504754|NCT00165841|447801105|FG001|Overall Study|Lack of Efficacy|33|||
124504755|NCT00165841|447801104|FG000|Overall Study|Lost to Follow-up|4|||
124504756|NCT00165841|447801105|FG001|Overall Study|Lost to Follow-up|4|||
124504757|NCT00165841|447801104|FG000|Overall Study|Withdrawal by Subject|7|||
124504758|NCT00165841|447801105|FG001|Overall Study|Withdrawal by Subject|8|||
124504759|NCT00165841|447801104|FG000|Overall Study|Physician Decision|1|||
124504760|NCT00165841|447801105|FG001|Overall Study|Physician Decision|0|||
124504761|NCT00165841|447801104|FG000|Overall Study|Protocol Violation|6|||
124504762|NCT00165841|447801105|FG001|Overall Study|Protocol Violation|8|||
124504763|NCT00165841|447801104|FG000|Overall Study|Other|3|||
124504764|NCT00165841|447801105|FG001|Overall Study|Other|5|||
124504765|NCT00165841|447801104|FG000|Overall Study|Medication Noncompliance|1|||
124504766|NCT00165841|447801105|FG001|Overall Study|Medication Noncompliance|1|||
124504767|NCT00487084|447801106|FG000|Overall Study|Did not receive intervention|4|||
124504768|NCT00487084|447801107|FG001|Overall Study|Did not receive intervention|3|||
124504769|NCT00487084|447801108|FG002|Overall Study|Did not receive intervention|5|||
124504770|NCT00254293|447801109|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
124504771|NCT00254293|447801110|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
124504772|NCT00254293|447801111|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
124504773|NCT00254293|447801112|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
124504774|NCT00254293|447801113|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
124504775|NCT00254293|447801114|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
124504776|NCT00254293|447801115|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
124504777|NCT00254293|447801109|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
124504778|NCT00254293|447801110|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
124504779|NCT00254293|447801111|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
124504780|NCT00254293|447801112|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
124504781|NCT00254293|447801113|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
124504782|NCT00254293|447801114|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
124504783|NCT00254293|447801115|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
124504784|NCT00254293|447801109|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
124504785|NCT00254293|447801110|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
124504786|NCT00254293|447801111|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
124504787|NCT00254293|447801112|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
124504788|NCT00254293|447801113|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
124504789|NCT00254293|447801114|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
124504790|NCT00254293|447801115|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
124504791|NCT00254293|447801109|FG000|LTE Open Label Variable SC Dosing|Death|0|||
124504792|NCT00254293|447801110|FG001|LTE Open Label Variable SC Dosing|Death|0|||
124504793|NCT00254293|447801111|FG002|LTE Open Label Variable SC Dosing|Death|1|||
124504794|NCT00254293|447801112|FG003|LTE Open Label Variable SC Dosing|Death|0|||
124504795|NCT00254293|447801113|FG004|LTE Open Label Variable SC Dosing|Death|0|||
124504796|NCT00254293|447801114|FG005|LTE Open Label Variable SC Dosing|Death|0|||
124504797|NCT00254293|447801115|FG006|LTE Open Label Variable SC Dosing|Death|0|||
124504798|NCT00254293|447801109|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
124504799|NCT00254293|447801110|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
124562458|NCT02649231|448016551|FG000|Overall Study|Protocol Violation|2|||
124562459|NCT02649231|448016552|FG001|Overall Study|Protocol Violation|1|||
124562460|NCT02649231|448016553|FG002|Overall Study|Protocol Violation|1|||
124562461|NCT02649231|448016554|FG003|Overall Study|Protocol Violation|0|||
124562462|NCT00543439|448016556|FG000|Period 1|Adverse Event|0|||
124562463|NCT00543439|448016557|FG001|Period 1|Adverse Event|2|||
124562464|NCT00543439|448016558|FG002|Period 1|Adverse Event|1|||
124562465|NCT00543439|448016556|FG000|Period 1|Withdrawal by Subject|1|||
124562466|NCT00543439|448016557|FG001|Period 1|Withdrawal by Subject|1|||
124562467|NCT00543439|448016558|FG002|Period 1|Withdrawal by Subject|0|||
124562468|NCT00543439|448016556|FG000|Period 1|Physician Decision|0|||
124562469|NCT00543439|448016557|FG001|Period 1|Physician Decision|0|||
124562470|NCT00543439|448016558|FG002|Period 1|Physician Decision|1|||
124562471|NCT00543439|448016556|FG000|Period 2|Protocol Violation|1|||
124562472|NCT00543439|448016557|FG001|Period 2|Protocol Violation|0|||
124562473|NCT00543439|448016558|FG002|Period 2|Protocol Violation|1|||
124562474|NCT00543439|448016556|FG000|Period 2|Adverse Event|0|||
124562475|NCT00543439|448016557|FG001|Period 2|Adverse Event|1|||
124562476|NCT00543439|448016558|FG002|Period 2|Adverse Event|1|||
124562477|NCT00686036|448016560|FG000|Overall Study|Adverse Event|3|||
124562478|NCT00686036|448016561|FG001|Overall Study|Adverse Event|0|||
124562479|NCT00686036|448016560|FG000|Overall Study|Withdrawal by Subject|3|||
124562480|NCT00686036|448016561|FG001|Overall Study|Withdrawal by Subject|1|||
124562481|NCT00686036|448016560|FG000|Overall Study|Study terminated by AstraZeneca|2|||
124562482|NCT00686036|448016561|FG001|Overall Study|Study terminated by AstraZeneca|1|||
124562483|NCT00686036|448016560|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
124562484|NCT00686036|448016561|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
124562485|NCT00686036|448016560|FG000|Overall Study|Other reasons not identified|0|||
124504800|NCT00254293|447801111|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
124504801|NCT00254293|447801112|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
124504802|NCT00254293|447801113|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
124504803|NCT00254293|447801114|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
124504804|NCT00254293|447801115|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
124504805|NCT00254293|447801109|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
124504806|NCT00254293|447801110|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
124504807|NCT00254293|447801111|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
124504808|NCT00254293|447801112|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
124504809|NCT00254293|447801113|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
124504810|NCT00254293|447801114|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
124504811|NCT00254293|447801115|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
124504812|NCT00254293|447801109|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
124504813|NCT00254293|447801110|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
124504814|NCT00254293|447801111|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
124504815|NCT00254293|447801112|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
124504816|NCT00254293|447801113|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
124504817|NCT00254293|447801114|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
124504818|NCT00254293|447801115|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
124504819|NCT00254293|447801109|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
124504820|NCT00254293|447801110|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
124504821|NCT00254293|447801111|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
124504822|NCT00254293|447801112|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
124504823|NCT00254293|447801113|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
124504824|NCT00254293|447801114|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
124504825|NCT00254293|447801115|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
124504826|NCT00254293|447801109|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
124504827|NCT00254293|447801110|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
124504828|NCT00254293|447801111|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
124504829|NCT00254293|447801112|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
124504830|NCT00254293|447801113|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
124504831|NCT00254293|447801114|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
124504832|NCT00254293|447801115|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
124504833|NCT00254293|447801109|FG000|LTE Open Label Variable SC Dosing|Other|0|||
124504834|NCT00254293|447801110|FG001|LTE Open Label Variable SC Dosing|Other|0|||
124504835|NCT00254293|447801111|FG002|LTE Open Label Variable SC Dosing|Other|2|||
124504836|NCT00254293|447801112|FG003|LTE Open Label Variable SC Dosing|Other|0|||
124504837|NCT00254293|447801113|FG004|LTE Open Label Variable SC Dosing|Other|0|||
124504838|NCT00254293|447801114|FG005|LTE Open Label Variable SC Dosing|Other|0|||
124562486|NCT00686036|448016561|FG001|Overall Study|Other reasons not identified|4|||
124562487|NCT01185288|448016564|FG000|Overall Study|Adverse Event|7|||
124562488|NCT01185288|448016565|FG001|Overall Study|Adverse Event|6|||
124562489|NCT01185288|448016564|FG000|Overall Study|Withdrawal by Subject|6|||
124562490|NCT01185288|448016565|FG001|Overall Study|Withdrawal by Subject|4|||
124562491|NCT01185288|448016564|FG000|Overall Study|Lost to Follow-up|2|||
124504839|NCT00254293|447801115|FG006|LTE Open Label Variable SC Dosing|Other|0|||
124504840|NCT00254293|447801109|FG000|LTE Open Label Fixed Dosing|Death|0|||
124504841|NCT00254293|447801110|FG001|LTE Open Label Fixed Dosing|Death|0|||
124504842|NCT00254293|447801111|FG002|LTE Open Label Fixed Dosing|Death|0|||
124504843|NCT00254293|447801112|FG003|LTE Open Label Fixed Dosing|Death|0|||
124504844|NCT00254293|447801113|FG004|LTE Open Label Fixed Dosing|Death|0|||
124504845|NCT00254293|447801114|FG005|LTE Open Label Fixed Dosing|Death|0|||
124504846|NCT00254293|447801115|FG006|LTE Open Label Fixed Dosing|Death|3|||
124504847|NCT00254293|447801109|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
124504848|NCT00254293|447801110|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
124504849|NCT00254293|447801111|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
124504850|NCT00254293|447801112|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
124504851|NCT00254293|447801113|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
124504852|NCT00254293|447801114|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
124504853|NCT00254293|447801115|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
124504854|NCT00254293|447801109|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
124504855|NCT00254293|447801110|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
124504856|NCT00254293|447801111|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
124504857|NCT00254293|447801112|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
124504858|NCT00254293|447801113|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
124504859|NCT00254293|447801114|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
124504860|NCT00254293|447801115|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
124504861|NCT00254293|447801109|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
124504862|NCT00254293|447801110|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
124504863|NCT00254293|447801111|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
124504864|NCT00254293|447801112|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
124504865|NCT00254293|447801113|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
124504866|NCT00254293|447801114|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
124504867|NCT00254293|447801115|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
124504868|NCT00254293|447801109|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
124504869|NCT00254293|447801110|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
124504870|NCT00254293|447801111|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
124504871|NCT00254293|447801112|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
124504872|NCT00254293|447801113|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
124504873|NCT00254293|447801114|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
124504874|NCT00254293|447801115|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
124504875|NCT00254293|447801109|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
124504876|NCT00254293|447801110|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
124504877|NCT00254293|447801111|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
124504878|NCT00254293|447801112|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
124504879|NCT00254293|447801113|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
124504880|NCT00254293|447801114|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
124504881|NCT00254293|447801115|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
124504882|NCT00254293|447801109|FG000|LTE Open Label Fixed Dosing|Other|0|||
124504883|NCT00254293|447801110|FG001|LTE Open Label Fixed Dosing|Other|0|||
124504884|NCT00254293|447801111|FG002|LTE Open Label Fixed Dosing|Other|0|||
124504885|NCT00254293|447801112|FG003|LTE Open Label Fixed Dosing|Other|0|||
124504886|NCT00254293|447801113|FG004|LTE Open Label Fixed Dosing|Other|0|||
124504887|NCT00254293|447801114|FG005|LTE Open Label Fixed Dosing|Other|0|||
124504888|NCT00254293|447801115|FG006|LTE Open Label Fixed Dosing|Other|1|||
124504889|NCT04031404|447801117|FG000|Baseline|Lost to Follow-up|0|||
124504890|NCT04031404|447801118|FG001|Baseline|Lost to Follow-up|1|||
124504891|NCT04031404|447801117|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
124504892|NCT04031404|447801118|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
124504893|NCT04031404|447801117|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
124504894|NCT04031404|447801118|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
124504895|NCT04031404|447801117|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
124504896|NCT04031404|447801118|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
124504897|NCT04031404|447801117|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
124504898|NCT04031404|447801118|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
124504899|NCT01626352|447801119|FG000|Overall Study|Disease Progression|3|||
124504900|NCT01626352|447801119|FG000|Overall Study|Intercurrent Illness|2|||
124504901|NCT01626352|447801119|FG000|Overall Study|Death|2|||
124504902|NCT01626352|447801119|FG000|Overall Study|Withdrawal by Subject|1|||
124504903|NCT01626352|447801119|FG000|Overall Study|Non-Compliance|1|||
124504904|NCT01626352|447801119|FG000|Overall Study|Never Treated|1|||
124504905|NCT05674344|447801120|FG000|Overall Study|Screen Fail|21|||
124504906|NCT05674344|447801120|FG000|Overall Study|Incomplete study procedures|3|||
124504907|NCT00798655|447801121|FG000|Overall Study|Did not receive at least one dose of pan|2|||
124504908|NCT00960934|447801122|FG000|Overall Study|Adverse Event|2|||
124504909|NCT00960934|447801123|FG001|Overall Study|Adverse Event|3|||
124504910|NCT00960934|447801124|FG002|Overall Study|Adverse Event|3|||
124504911|NCT00960934|447801125|FG003|Overall Study|Adverse Event|2|||
124504912|NCT00960934|447801126|FG004|Overall Study|Adverse Event|4|||
124504913|NCT00960934|447801127|FG005|Overall Study|Adverse Event|3|||
124504914|NCT00960934|447801122|FG000|Overall Study|Lack of Efficacy|1|||
124504915|NCT00960934|447801123|FG001|Overall Study|Lack of Efficacy|0|||
124504916|NCT00960934|447801124|FG002|Overall Study|Lack of Efficacy|0|||
124504917|NCT00960934|447801125|FG003|Overall Study|Lack of Efficacy|0|||
124504918|NCT00960934|447801126|FG004|Overall Study|Lack of Efficacy|0|||
124504919|NCT00960934|447801127|FG005|Overall Study|Lack of Efficacy|0|||
124504920|NCT00960934|447801122|FG000|Overall Study|Lost to Follow-up|0|||
124504921|NCT00960934|447801123|FG001|Overall Study|Lost to Follow-up|1|||
124504922|NCT00960934|447801124|FG002|Overall Study|Lost to Follow-up|0|||
124504923|NCT00960934|447801125|FG003|Overall Study|Lost to Follow-up|0|||
124504924|NCT00960934|447801126|FG004|Overall Study|Lost to Follow-up|0|||
124504925|NCT00960934|447801127|FG005|Overall Study|Lost to Follow-up|0|||
124504926|NCT00960934|447801122|FG000|Overall Study|Other|2|||
124504927|NCT00960934|447801123|FG001|Overall Study|Other|1|||
124504928|NCT00960934|447801124|FG002|Overall Study|Other|5|||
124504929|NCT00960934|447801125|FG003|Overall Study|Other|4|||
124504930|NCT00960934|447801126|FG004|Overall Study|Other|2|||
124504931|NCT00960934|447801127|FG005|Overall Study|Other|2|||
124504932|NCT00960934|447801122|FG000|Overall Study|Physician Decision|0|||
124504933|NCT00960934|447801123|FG001|Overall Study|Physician Decision|1|||
124504934|NCT00960934|447801124|FG002|Overall Study|Physician Decision|0|||
124504935|NCT00960934|447801125|FG003|Overall Study|Physician Decision|0|||
124504936|NCT00960934|447801126|FG004|Overall Study|Physician Decision|0|||
124504937|NCT00960934|447801127|FG005|Overall Study|Physician Decision|0|||
124504938|NCT00960934|447801122|FG000|Overall Study|Progressive Disease|1|||
124504939|NCT00960934|447801123|FG001|Overall Study|Progressive Disease|1|||
124504940|NCT00960934|447801124|FG002|Overall Study|Progressive Disease|0|||
124504941|NCT00960934|447801125|FG003|Overall Study|Progressive Disease|0|||
124504942|NCT00960934|447801126|FG004|Overall Study|Progressive Disease|1|||
124504943|NCT00960934|447801127|FG005|Overall Study|Progressive Disease|1|||
124504944|NCT00960934|447801122|FG000|Overall Study|Protocol Violation|3|||
124504945|NCT00960934|447801123|FG001|Overall Study|Protocol Violation|4|||
124504946|NCT00960934|447801124|FG002|Overall Study|Protocol Violation|0|||
124504947|NCT00960934|447801125|FG003|Overall Study|Protocol Violation|3|||
124504948|NCT00960934|447801126|FG004|Overall Study|Protocol Violation|3|||
124504949|NCT00960934|447801127|FG005|Overall Study|Protocol Violation|2|||
124504950|NCT00960934|447801122|FG000|Overall Study|Withdrawal by Subject|5|||
124504951|NCT00960934|447801123|FG001|Overall Study|Withdrawal by Subject|6|||
124504952|NCT00960934|447801124|FG002|Overall Study|Withdrawal by Subject|4|||
124504953|NCT00960934|447801125|FG003|Overall Study|Withdrawal by Subject|5|||
124504954|NCT00960934|447801126|FG004|Overall Study|Withdrawal by Subject|5|||
124504955|NCT00960934|447801127|FG005|Overall Study|Withdrawal by Subject|7|||
124504956|NCT00960934|447801122|FG000|Overall Study|Study Terminated by Sponsor|50|||
124504957|NCT00960934|447801123|FG001|Overall Study|Study Terminated by Sponsor|46|||
124504958|NCT00960934|447801124|FG002|Overall Study|Study Terminated by Sponsor|52|||
124504959|NCT00960934|447801125|FG003|Overall Study|Study Terminated by Sponsor|50|||
124504960|NCT00960934|447801126|FG004|Overall Study|Study Terminated by Sponsor|49|||
124504961|NCT00960934|447801127|FG005|Overall Study|Study Terminated by Sponsor|49|||
124504962|NCT02387372|447801128|FG000|Overall Study|Not Treated|1|||
124504963|NCT02387372|447801129|FG001|Overall Study|Not Treated|0|||
124504964|NCT00848549|447801130|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
124504965|NCT00848549|447801131|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
124504966|NCT00848549|447801130|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
124504967|NCT00848549|447801131|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
124504968|NCT00848549|447801130|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
124504969|NCT00848549|447801131|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
124562492|NCT01185288|448016565|FG001|Overall Study|Lost to Follow-up|5|||
124562493|NCT01185288|448016564|FG000|Overall Study|Lack of Efficacy|2|||
124562494|NCT01185288|448016565|FG001|Overall Study|Lack of Efficacy|0|||
124562495|NCT01185288|448016564|FG000|Overall Study|Investigator discretion|1|||
124504970|NCT00848549|447801130|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
124504971|NCT00848549|447801131|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
124504972|NCT00848549|447801130|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
124504973|NCT00848549|447801131|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
124504974|NCT00848549|447801130|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
124504975|NCT00848549|447801131|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
124504976|NCT00848549|447801130|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
124504977|NCT00848549|447801131|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
124504978|NCT00848549|447801130|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
124504979|NCT00848549|447801131|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
124504980|NCT00848549|447801130|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
124504981|NCT00848549|447801131|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
124504982|NCT00848549|447801130|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
124562496|NCT01185288|448016565|FG001|Overall Study|Investigator discretion|0|||
124504983|NCT00848549|447801131|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
124504984|NCT00848549|447801130|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
124504985|NCT00848549|447801131|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
124504986|NCT00848549|447801130|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
124504987|NCT00848549|447801131|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
124504988|NCT00848549|447801130|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
124504989|NCT00848549|447801131|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
124504990|NCT00848549|447801130|FG000|E2090-E044-314 (Extension Study)|Other|5|||
124504991|NCT00848549|447801131|FG001|E2090-E044-314 (Extension Study)|Other|6|||
124504992|NCT01248130|447801134|FG000|Overall Study|Protocol Violation|1|||
124504993|NCT01248130|447801135|FG001|Overall Study|Protocol Violation|0|||
124504994|NCT01248130|447801134|FG000|Overall Study|Ineligible|1|||
124504995|NCT01248130|447801135|FG001|Overall Study|Ineligible|0|||
124504996|NCT01163253|447801143|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
124504997|NCT01163253|447801144|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
124504998|NCT01163253|447801143|FG000|Overall Study|Study Terminated by Sponsor|978|||
124504999|NCT01163253|447801144|FG001|Overall Study|Study Terminated by Sponsor|349|||
124505000|NCT01163253|447801143|FG000|Overall Study|Protocol Violation|43|||
124505001|NCT01163253|447801144|FG001|Overall Study|Protocol Violation|12|||
124505002|NCT01163253|447801143|FG000|Overall Study|Withdrawal by Subject|199|||
124505003|NCT01163253|447801144|FG001|Overall Study|Withdrawal by Subject|50|||
124505004|NCT01163253|447801143|FG000|Overall Study|Medication Error|1|||
124505005|NCT01163253|447801144|FG001|Overall Study|Medication Error|0|||
124505006|NCT01163253|447801143|FG000|Overall Study|Lost to Follow-up|125|||
124505007|NCT01163253|447801144|FG001|Overall Study|Lost to Follow-up|23|||
124505008|NCT01163253|447801143|FG000|Overall Study|Insufficient Clinical Response|423|||
124505009|NCT01163253|447801144|FG001|Overall Study|Insufficient Clinical Response|29|||
124505010|NCT01163253|447801143|FG000|Overall Study|Adverse Event|300|||
124505011|NCT01163253|447801144|FG001|Overall Study|Adverse Event|78|||
124505012|NCT01163253|447801143|FG000|Overall Study|Death|17|||
124505013|NCT01163253|447801144|FG001|Overall Study|Death|5|||
124505014|NCT01163253|447801143|FG000|Overall Study|Ongoing|13|||
124505015|NCT01163253|447801144|FG001|Overall Study|Ongoing|4|||
124505016|NCT01163253|447801143|FG000|Overall Study|Other Unspecified|170|||
124505017|NCT01163253|447801144|FG001|Overall Study|Other Unspecified|34|||
124505018|NCT01188564|447801145|FG000|Double-blind Phase|randomized not treated|1|||
124562497|NCT01185288|448016564|FG000|Overall Study|Did not meet inclusion criteria|1|||
124562498|NCT01185288|448016565|FG001|Overall Study|Did not meet inclusion criteria|0|||
124505019|NCT01188564|447801146|FG001|Double-blind Phase|randomized not treated|0|||
124505020|NCT02492997|447801147|FG000|Overall Study|Withdrawal by Subject|1|||
124505021|NCT02492997|447801148|FG001|Overall Study|Withdrawal by Subject|0|||
124562499|NCT01185288|448016564|FG000|Overall Study|Noncompliance|0|||
124562500|NCT01185288|448016565|FG001|Overall Study|Noncompliance|1|||
124562501|NCT01200394|448016566|FG000|Overall Study|Adverse Event|0|||
124562502|NCT01200394|448016567|FG001|Overall Study|Adverse Event|14|||
124562503|NCT01200394|448016566|FG000|Overall Study|Death|1|||
124562504|NCT01200394|448016567|FG001|Overall Study|Death|0|||
124562505|NCT01200394|448016566|FG000|Overall Study|Lost to Follow-up|0|||
124562506|NCT01200394|448016567|FG001|Overall Study|Lost to Follow-up|1|||
124562507|NCT01200394|448016566|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
124562508|NCT01200394|448016567|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
124505022|NCT02492997|447801147|FG000|Overall Study|Gained Weight|1|||
124505023|NCT02492997|447801148|FG001|Overall Study|Gained Weight|0|||
124505024|NCT02492997|447801147|FG000|Overall Study|Lost to Follow-up|0|||
124505025|NCT02492997|447801148|FG001|Overall Study|Lost to Follow-up|1|||
124505026|NCT00579501|447801149|FG000|Overall Study|Death|1|||
124505027|NCT00579501|447801149|FG000|Overall Study|End of neoadjuvant therapy|25|||
124505028|NCT00579501|447801149|FG000|Overall Study|toxicity|1|||
124505029|NCT00579501|447801149|FG000|Overall Study|Secondary lesion|1|||
124505030|NCT00579501|447801149|FG000|Overall Study|Radiation therapy before surgery|1|||
124505031|NCT03025217|447801150|FG000|Overall Study|Pregnancy|1|||
124505032|NCT03025217|447801150|FG000|Overall Study|Lost to Follow-up|1|||
124505033|NCT03025217|447801150|FG000|Overall Study|Not eligible, poor English|2|||
124505034|NCT04069156|447801151|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
124562509|NCT01200394|448016566|FG000|Overall Study|Protocol Violation|0|||
124505035|NCT04069156|447801152|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
124505036|NCT04069156|447801151|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
124505037|NCT04069156|447801152|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
124505038|NCT04069156|447801151|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
124505039|NCT04069156|447801152|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
124505040|NCT04069156|447801151|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
124505041|NCT04069156|447801152|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
124505042|NCT02208024|447801153|FG000|Overall Study|Withdrawal by Subject|1|||
124562510|NCT01200394|448016567|FG001|Overall Study|Protocol Violation|3|||
124562511|NCT01200394|448016566|FG000|Overall Study|Withdrawal by Subject|0|||
124562512|NCT01200394|448016567|FG001|Overall Study|Withdrawal by Subject|5|||
124562513|NCT01200394|448016566|FG000|Overall Study|Other|0|||
124562514|NCT01200394|448016567|FG001|Overall Study|Other|1|||
124562515|NCT02666430|448016568|FG000|Period 1|Lost to Follow-up|1|||
124562516|NCT02666430|448016569|FG001|Period 1|Lost to Follow-up|0|||
124562517|NCT02666430|448016568|FG000|Period 1|Adverse Event|0|||
124562518|NCT02666430|448016569|FG001|Period 1|Adverse Event|1|||
124562519|NCT02666430|448016568|FG000|Period 2|Withdrawal by Subject|1|||
124562520|NCT02666430|448016569|FG001|Period 2|Withdrawal by Subject|4|||
124562521|NCT02666430|448016568|FG000|Period 3|Lost to Follow-up|1|||
124562522|NCT02666430|448016569|FG001|Period 3|Lost to Follow-up|0|||
124562523|NCT03828461|448016570|FG000|Overall Study|Lost to Follow-up|1|||
124562524|NCT03828461|448016570|FG000|Overall Study|Withdrawal by Subject|3|||
124562525|NCT00576199|448016571|FG000|Overall Study|Adverse Event|12|||
124562526|NCT00576199|448016571|FG000|Overall Study|Insufficient Therapeutic Response|14|||
124562527|NCT00576199|448016571|FG000|Overall Study|Refused Treatment|2|||
124562528|NCT00576199|448016571|FG000|Overall Study|Reason Unspecified|2|||
124562529|NCT03035227|448016572|FG000|Overall Study|study stopped due to PI leaving institut|1|||
124562530|NCT03035227|448016573|FG001|Overall Study|study stopped due to PI leaving institut|1|||
124562531|NCT02100956|448016574|FG000|At Least One Week Between Injections|Adverse Event|0|||
124562532|NCT02100956|448016575|FG001|At Least One Week Between Injections|Adverse Event|1|||
124562533|NCT00859469|448016577|FG000|Overall Study|Adverse Event|2|||
124562534|NCT00859469|448016577|FG000|Overall Study|Lack of Efficacy|9|||
124562535|NCT00859469|448016577|FG000|Overall Study|Withdrawal by Subject|1|||
124562536|NCT00859469|448016577|FG000|Overall Study|Death|16|||
124562537|NCT02220907|448016578|FG000|Overall Study|Adverse Event|7|||
124562538|NCT02220907|448016578|FG000|Overall Study|Physician Decision|1|||
124562539|NCT02220907|448016578|FG000|Overall Study|Withdrawal by Subject|2|||
124562540|NCT02220907|448016578|FG000|Overall Study|Conflict with the stopping criteria|1|||
124562541|NCT03111147|448016579|FG000|Overall Study|Lost to Follow-up|2|||
124562542|NCT03111147|448016580|FG001|Overall Study|Lost to Follow-up|5|||
124562543|NCT03111147|448016579|FG000|Overall Study|Withdrawal by Subject|4|||
124562544|NCT03111147|448016580|FG001|Overall Study|Withdrawal by Subject|3|||
124562545|NCT03111147|448016579|FG000|Overall Study|Protocol Violation|2|||
124562546|NCT03111147|448016580|FG001|Overall Study|Protocol Violation|1|||
124562547|NCT03111147|448016579|FG000|Overall Study|Death|1|||
124562548|NCT03111147|448016580|FG001|Overall Study|Death|1|||
124562549|NCT00095199|448016583|FG000|Overall Study|Adverse Event|40|||
124562550|NCT00095199|448016584|FG001|Overall Study|Adverse Event|22|||
124562551|NCT00095199|448016585|FG002|Overall Study|Adverse Event|26|||
124562552|NCT00095199|448016586|FG003|Overall Study|Adverse Event|11|||
124562553|NCT00095199|448016583|FG000|Overall Study|Progressive disease|213|||
124562554|NCT00095199|448016584|FG001|Overall Study|Progressive disease|179|||
124562555|NCT00095199|448016585|FG002|Overall Study|Progressive disease|105|||
124562556|NCT00095199|448016586|FG003|Overall Study|Progressive disease|98|||
124562557|NCT00095199|448016583|FG000|Overall Study|Death|10|||
124562558|NCT00095199|448016584|FG001|Overall Study|Death|6|||
124562559|NCT00095199|448016585|FG002|Overall Study|Death|11|||
124562560|NCT00095199|448016586|FG003|Overall Study|Death|9|||
124562561|NCT00095199|448016583|FG000|Overall Study|Withdrawal by Subject|21|||
124562562|NCT00095199|448016584|FG001|Overall Study|Withdrawal by Subject|16|||
124562563|NCT00095199|448016585|FG002|Overall Study|Withdrawal by Subject|13|||
124505043|NCT02207556|447801154|FG000|Overall Study|Physician Decision|1|||
124505044|NCT02207556|447801155|FG001|Overall Study|Physician Decision|0|||
124505045|NCT02207556|447801154|FG000|Overall Study|Withdrawal by Subject|1|||
124505046|NCT02207556|447801155|FG001|Overall Study|Withdrawal by Subject|0|||
124505047|NCT02207556|447801154|FG000|Overall Study|Death|0|||
124505048|NCT02207556|447801155|FG001|Overall Study|Death|5|||
124505049|NCT03558555|447801156|FG000|Overall Study|Lost to Follow-up|2|||
124505050|NCT03558555|447801157|FG001|Overall Study|Lost to Follow-up|1|||
124505051|NCT01958125|447801158|FG000|Overall Study|Missing diary data|2|||
124505052|NCT01958125|447801159|FG001|Overall Study|Missing diary data|6|||
124505053|NCT01958125|447801158|FG000|Overall Study|No headache attacks|0|||
124505054|NCT01958125|447801159|FG001|Overall Study|No headache attacks|2|||
124505055|NCT00194025|447801160|FG000|Overall Study|Adverse Event|1|||
124505056|NCT00194025|447801160|FG000|Overall Study|non-adherence with study medication|4|||
124562564|NCT00095199|448016586|FG003|Overall Study|Withdrawal by Subject|22|||
124505057|NCT04804033|447801162|FG000|Period 1: DBT Phase|Adverse Event|1|||
124505058|NCT04804033|447801163|FG001|Period 1: DBT Phase|Adverse Event|5|||
124505059|NCT04804033|447801164|FG002|Period 1: DBT Phase|Adverse Event|3|||
124562565|NCT00095199|448016583|FG000|Overall Study|Protocol Violation|4|||
124562566|NCT00095199|448016584|FG001|Overall Study|Protocol Violation|4|||
124562567|NCT00095199|448016585|FG002|Overall Study|Protocol Violation|2|||
124562568|NCT00095199|448016586|FG003|Overall Study|Protocol Violation|0|||
124562569|NCT00095199|448016583|FG000|Overall Study|Liver function test results elevated|0|||
124562570|NCT00095199|448016584|FG001|Overall Study|Liver function test results elevated|0|||
124562571|NCT00095199|448016585|FG002|Overall Study|Liver function test results elevated|1|||
124562572|NCT00095199|448016586|FG003|Overall Study|Liver function test results elevated|1|||
124562573|NCT00095199|448016583|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
124505060|NCT04804033|447801165|FG003|Period 1: DBT Phase|Adverse Event|4|||
124562574|NCT00095199|448016584|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
124562575|NCT00095199|448016585|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
124562576|NCT00095199|448016586|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
124562577|NCT00095199|448016583|FG000|Overall Study|Physician Decision|5|||
124562578|NCT00095199|448016584|FG001|Overall Study|Physician Decision|6|||
124562579|NCT00095199|448016585|FG002|Overall Study|Physician Decision|1|||
124562580|NCT00095199|448016586|FG003|Overall Study|Physician Decision|1|||
124562581|NCT00095199|448016583|FG000|Overall Study|Not eligible|1|||
124562582|NCT00095199|448016584|FG001|Overall Study|Not eligible|7|||
124562583|NCT00095199|448016585|FG002|Overall Study|Not eligible|0|||
124562584|NCT00095199|448016586|FG003|Overall Study|Not eligible|1|||
124562585|NCT00095199|448016583|FG000|Overall Study|Started Palliative Radiotherapy|1|||
124562586|NCT00095199|448016584|FG001|Overall Study|Started Palliative Radiotherapy|0|||
124562587|NCT00095199|448016585|FG002|Overall Study|Started Palliative Radiotherapy|0|||
124562588|NCT00095199|448016586|FG003|Overall Study|Started Palliative Radiotherapy|0|||
124562589|NCT00095199|448016583|FG000|Overall Study|Started radiotherapy regimen|0|||
124562590|NCT00095199|448016584|FG001|Overall Study|Started radiotherapy regimen|1|||
124562591|NCT00095199|448016585|FG002|Overall Study|Started radiotherapy regimen|0|||
124562592|NCT00095199|448016586|FG003|Overall Study|Started radiotherapy regimen|0|||
124562593|NCT00095199|448016583|FG000|Overall Study|Primary tumor removed in other surgery|0|||
124776650|NCT00892099|448809941|FG000|Overall Study|Prolonged hospitalization|1|||
124776651|NCT00892099|448809942|FG001|Overall Study|Prolonged hospitalization|0|||
124776652|NCT00892099|448809943|FG002|Overall Study|Prolonged hospitalization|1|||
124776653|NCT00892099|448809941|FG000|Overall Study|no further details|1|||
124776654|NCT00892099|448809942|FG001|Overall Study|no further details|0|||
124776655|NCT00892099|448809943|FG002|Overall Study|no further details|1|||
124776656|NCT00892099|448809941|FG000|Overall Study|kidney function recovered|0|||
124505061|NCT04804033|447801162|FG000|Period 1: DBT Phase|Death|1|||
124562594|NCT00095199|448016584|FG001|Overall Study|Primary tumor removed in other surgery|1|||
124562595|NCT00095199|448016585|FG002|Overall Study|Primary tumor removed in other surgery|0|||
124562596|NCT00095199|448016586|FG003|Overall Study|Primary tumor removed in other surgery|0|||
124562597|NCT00095199|448016583|FG000|Overall Study|Data inadvertently lost by site|1|||
124562598|NCT00095199|448016584|FG001|Overall Study|Data inadvertently lost by site|0|||
124562599|NCT00095199|448016585|FG002|Overall Study|Data inadvertently lost by site|0|||
124562600|NCT00095199|448016586|FG003|Overall Study|Data inadvertently lost by site|0|||
124562601|NCT01896297|448016587|FG000|Overall Study|Died in post treatment phase|1|||
124562602|NCT01098240|448016588|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
124562603|NCT01098240|448016589|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
124562604|NCT01098240|448016590|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
124562605|NCT01098240|448016588|FG000|Open-Label Phase|Protocol Violation|4|||
124562606|NCT01098240|448016589|FG001|Open-Label Phase|Protocol Violation|0|||
124562607|NCT01098240|448016590|FG002|Open-Label Phase|Protocol Violation|0|||
124505062|NCT04804033|447801163|FG001|Period 1: DBT Phase|Death|0|||
124505063|NCT04804033|447801164|FG002|Period 1: DBT Phase|Death|0|||
124505064|NCT04804033|447801165|FG003|Period 1: DBT Phase|Death|0|||
124505065|NCT04804033|447801162|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
124505066|NCT04804033|447801163|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
124505067|NCT04804033|447801164|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
124505068|NCT04804033|447801165|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
124505069|NCT04804033|447801162|FG000|Period 1: DBT Phase|Non-compliance|1|||
124505070|NCT04804033|447801163|FG001|Period 1: DBT Phase|Non-compliance|0|||
124505071|NCT04804033|447801164|FG002|Period 1: DBT Phase|Non-compliance|1|||
124505072|NCT04804033|447801165|FG003|Period 1: DBT Phase|Non-compliance|2|||
124505073|NCT04804033|447801162|FG000|Period 1: DBT Phase|Other|0|||
124505074|NCT04804033|447801163|FG001|Period 1: DBT Phase|Other|1|||
124505075|NCT04804033|447801164|FG002|Period 1: DBT Phase|Other|0|||
124505076|NCT04804033|447801165|FG003|Period 1: DBT Phase|Other|0|||
124505077|NCT04804033|447801162|FG000|Period 1: DBT Phase|Pregnancy|2|||
124505078|NCT04804033|447801163|FG001|Period 1: DBT Phase|Pregnancy|0|||
124505079|NCT04804033|447801164|FG002|Period 1: DBT Phase|Pregnancy|0|||
124505080|NCT04804033|447801165|FG003|Period 1: DBT Phase|Pregnancy|0|||
124562608|NCT01098240|448016588|FG000|Open-Label Phase|Lost to Follow-up|13|||
124562609|NCT01098240|448016589|FG001|Open-Label Phase|Lost to Follow-up|0|||
124505081|NCT04804033|447801162|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
124505082|NCT04804033|447801163|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
124562610|NCT01098240|448016590|FG002|Open-Label Phase|Lost to Follow-up|0|||
124505083|NCT04804033|447801164|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
124505084|NCT04804033|447801165|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
124505085|NCT04804033|447801162|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
124505086|NCT04804033|447801163|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
124505087|NCT04804033|447801164|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
124562611|NCT01098240|448016588|FG000|Open-Label Phase|Other|19|||
124562612|NCT01098240|448016589|FG001|Open-Label Phase|Other|0|||
124562613|NCT01098240|448016590|FG002|Open-Label Phase|Other|0|||
124505088|NCT04804033|447801165|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
124505089|NCT04804033|447801162|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
124505090|NCT04804033|447801163|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
124505091|NCT04804033|447801164|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
124505092|NCT04804033|447801165|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
124505093|NCT04804033|447801162|FG000|Period 2: OLE Phase|Adverse Event|3|||
124505094|NCT04804033|447801163|FG001|Period 2: OLE Phase|Adverse Event|4|||
124505095|NCT04804033|447801164|FG002|Period 2: OLE Phase|Adverse Event|2|||
124505096|NCT04804033|447801165|FG003|Period 2: OLE Phase|Adverse Event|0|||
124505097|NCT04804033|447801162|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
124505098|NCT04804033|447801163|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
124505099|NCT04804033|447801164|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
124505100|NCT04804033|447801165|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
124505101|NCT04804033|447801162|FG000|Period 2: OLE Phase|Non-compliance|2|||
124505102|NCT04804033|447801163|FG001|Period 2: OLE Phase|Non-compliance|2|||
124505103|NCT04804033|447801164|FG002|Period 2: OLE Phase|Non-compliance|0|||
124505104|NCT04804033|447801165|FG003|Period 2: OLE Phase|Non-compliance|1|||
124505105|NCT04804033|447801162|FG000|Period 2: OLE Phase|Other|0|||
124505106|NCT04804033|447801163|FG001|Period 2: OLE Phase|Other|2|||
124505107|NCT04804033|447801164|FG002|Period 2: OLE Phase|Other|0|||
124505108|NCT04804033|447801165|FG003|Period 2: OLE Phase|Other|0|||
124505109|NCT04804033|447801162|FG000|Period 2: OLE Phase|Physician Decision|1|||
124505110|NCT04804033|447801163|FG001|Period 2: OLE Phase|Physician Decision|1|||
124505111|NCT04804033|447801164|FG002|Period 2: OLE Phase|Physician Decision|0|||
124505112|NCT04804033|447801165|FG003|Period 2: OLE Phase|Physician Decision|0|||
124505113|NCT04804033|447801162|FG000|Period 2: OLE Phase|Pregnancy|0|||
124505114|NCT04804033|447801163|FG001|Period 2: OLE Phase|Pregnancy|0|||
124505115|NCT04804033|447801164|FG002|Period 2: OLE Phase|Pregnancy|2|||
124505116|NCT04804033|447801165|FG003|Period 2: OLE Phase|Pregnancy|0|||
124505117|NCT04804033|447801162|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
124505118|NCT04804033|447801163|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
124505119|NCT04804033|447801164|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
124505120|NCT04804033|447801165|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
124505121|NCT04804033|447801162|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
124505122|NCT04804033|447801163|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
124505123|NCT04804033|447801164|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
124505124|NCT04804033|447801165|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
124505125|NCT04804033|447801162|FG000|Period 2: OLE Phase|Not reported|0|||
124505126|NCT04804033|447801163|FG001|Period 2: OLE Phase|Not reported|2|||
124505127|NCT04804033|447801164|FG002|Period 2: OLE Phase|Not reported|0|||
124505128|NCT04804033|447801165|FG003|Period 2: OLE Phase|Not reported|0|||
124505129|NCT04804033|447801162|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
124505130|NCT04804033|447801163|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
124505131|NCT04804033|447801164|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
124505132|NCT04804033|447801165|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
124505133|NCT04804033|447801162|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
124505134|NCT04804033|447801163|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
124505135|NCT04804033|447801164|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
124505136|NCT04804033|447801165|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
124505137|NCT04804033|447801162|FG000|Period 3: Follow-up Phase|Other|0|||
124505138|NCT04804033|447801163|FG001|Period 3: Follow-up Phase|Other|1|||
124505139|NCT04804033|447801164|FG002|Period 3: Follow-up Phase|Other|2|||
124505140|NCT04804033|447801165|FG003|Period 3: Follow-up Phase|Other|1|||
124505141|NCT04804033|447801162|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
124505142|NCT04804033|447801163|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
124505143|NCT04804033|447801164|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
124505144|NCT04804033|447801165|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
124505145|NCT04804033|447801162|FG000|Period 3: Follow-up Phase|Not reported|18|||
124505146|NCT04804033|447801163|FG001|Period 3: Follow-up Phase|Not reported|15|||
124505147|NCT04804033|447801164|FG002|Period 3: Follow-up Phase|Not reported|1|||
124505148|NCT04804033|447801165|FG003|Period 3: Follow-up Phase|Not reported|4|||
124505149|NCT02130427|447801166|FG000|Overall Study|Imaging results not interpretable|30|||
124505150|NCT00543569|447801171|FG000|Overall Study|Death|2|||
124505151|NCT00543569|447801172|FG001|Overall Study|Death|2|||
124505152|NCT00543569|447801173|FG002|Overall Study|Death|3|||
124505153|NCT00543569|447801174|FG003|Overall Study|Death|1|||
124505154|NCT00543569|447801171|FG000|Overall Study|Lost to Follow-up|0|||
124505155|NCT00543569|447801172|FG001|Overall Study|Lost to Follow-up|0|||
124505156|NCT00543569|447801173|FG002|Overall Study|Lost to Follow-up|1|||
124505157|NCT00543569|447801174|FG003|Overall Study|Lost to Follow-up|1|||
124505158|NCT00543569|447801171|FG000|Overall Study|Miscellaneous Reasons|7|||
124505159|NCT00543569|447801172|FG001|Overall Study|Miscellaneous Reasons|3|||
124505160|NCT00543569|447801173|FG002|Overall Study|Miscellaneous Reasons|11|||
124505161|NCT00543569|447801174|FG003|Overall Study|Miscellaneous Reasons|4|||
124505162|NCT00543569|447801171|FG000|Overall Study|Randomized but never received study drug|3|||
124505163|NCT00543569|447801172|FG001|Overall Study|Randomized but never received study drug|3|||
124505164|NCT00543569|447801173|FG002|Overall Study|Randomized but never received study drug|5|||
124505165|NCT00543569|447801174|FG003|Overall Study|Randomized but never received study drug|3|||
124505166|NCT00781599|447801179|FG000|Overall Study|Lost to Follow-up|7|||
124505167|NCT00781599|447801180|FG001|Overall Study|Lost to Follow-up|4|||
124505168|NCT00089479|447801186|FG000|Overall Study|Death|108|||
124505169|NCT00089479|447801187|FG001|Overall Study|Death|75|||
124505170|NCT00089479|447801186|FG000|Overall Study|Withdrawal by Subject|86|||
124505171|NCT00089479|447801187|FG001|Overall Study|Withdrawal by Subject|107|||
124505172|NCT00089479|447801186|FG000|Overall Study|Lost to Follow-up|137|||
124505173|NCT00089479|447801187|FG001|Overall Study|Lost to Follow-up|107|||
124505174|NCT01124448|447801190|FG000|Overall Study|Lost to Follow-up|0|||
124505175|NCT01124448|447801191|FG001|Overall Study|Lost to Follow-up|3|||
124505176|NCT01124448|447801190|FG000|Overall Study|Protocol Violation|2|||
124505177|NCT01124448|447801191|FG001|Overall Study|Protocol Violation|0|||
124505178|NCT03198754|447801192|FG000|Overall Study|Withdrawal by Subject|5|||
124505179|NCT03198754|447801193|FG001|Overall Study|Withdrawal by Subject|4|||
124505180|NCT03198754|447801192|FG000|Overall Study|Lost to Follow-up|4|||
124505181|NCT03198754|447801193|FG001|Overall Study|Lost to Follow-up|3|||
124505182|NCT03198754|447801192|FG000|Overall Study|Ineligible|2|||
124505183|NCT03198754|447801193|FG001|Overall Study|Ineligible|1|||
124505184|NCT00668200|447801201|FG000|Overall Study|Withdrawal by Subject|2|||
124505185|NCT00668200|447801201|FG000|Overall Study|Lost to Follow-up|1|||
124562614|NCT01098240|448016588|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
124505186|NCT02108951|447801202|FG000|Overall Study|Lost to Follow-up|1|||
124505187|NCT02108951|447801202|FG000|Overall Study|Patient's/guardian's decision|1|||
124505188|NCT02108951|447801202|FG000|Overall Study|Study Terminated by Sponsor|14|||
124505189|NCT00421343|447801205|FG000|Overall Study|Death|1|||
124505190|NCT00421343|447801205|FG000|Overall Study|Withdrawal by Subject|2|||
124505191|NCT00421343|447801205|FG000|Overall Study|Lost to Follow-up|3|||
124505192|NCT03471767|447801209|FG000|Overall Study|Withdrawal by Subject|3|||
124505193|NCT03471767|447801210|FG001|Overall Study|Withdrawal by Subject|1|||
124505194|NCT03471767|447801209|FG000|Overall Study|Adverse Event|1|||
124505195|NCT03471767|447801210|FG001|Overall Study|Adverse Event|0|||
124505196|NCT03471767|447801209|FG000|Overall Study|Lost to Follow-up|1|||
124505197|NCT03471767|447801210|FG001|Overall Study|Lost to Follow-up|0|||
124505198|NCT03471767|447801209|FG000|Overall Study|PI Withdrawal|1|||
124505199|NCT03471767|447801210|FG001|Overall Study|PI Withdrawal|3|||
124505200|NCT00678587|447801213|FG000|Overall Study|Adverse Event|3|||
124505201|NCT00678587|447801214|FG001|Overall Study|Adverse Event|3|||
124505202|NCT00678587|447801213|FG000|Overall Study|Lack of Efficacy|1|||
124505203|NCT00678587|447801214|FG001|Overall Study|Lack of Efficacy|0|||
124505204|NCT00678587|447801213|FG000|Overall Study|Protocol Violation|2|||
124505205|NCT00678587|447801214|FG001|Overall Study|Protocol Violation|1|||
124505206|NCT00678587|447801213|FG000|Overall Study|Study Closed/Terminated|1|||
124562615|NCT01098240|448016589|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
124562616|NCT01098240|448016590|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
124562617|NCT01098240|448016588|FG000|Open-Label Phase|Pregnancy|1|||
124562618|NCT01098240|448016589|FG001|Open-Label Phase|Pregnancy|0|||
124562619|NCT01098240|448016590|FG002|Open-Label Phase|Pregnancy|0|||
124562620|NCT01098240|448016588|FG000|Open-Label Phase|Withdrawal by Subject|9|||
124562621|NCT01098240|448016589|FG001|Open-Label Phase|Withdrawal by Subject|0|||
124562622|NCT01098240|448016590|FG002|Open-Label Phase|Withdrawal by Subject|0|||
124562623|NCT01098240|448016588|FG000|Open-Label Phase|Adverse Event|12|||
124562624|NCT01098240|448016589|FG001|Open-Label Phase|Adverse Event|0|||
124562625|NCT01098240|448016590|FG002|Open-Label Phase|Adverse Event|0|||
124562626|NCT01098240|448016588|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
124562627|NCT01098240|448016589|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
124562628|NCT01098240|448016590|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
124562629|NCT01098240|448016588|FG000|Double-Blind Phase|Protocol Violation|0|||
124505207|NCT00678587|447801214|FG001|Overall Study|Study Closed/Terminated|0|||
124505208|NCT00678587|447801213|FG000|Overall Study|Lost to Follow-up|3|||
124562630|NCT01098240|448016589|FG001|Double-Blind Phase|Protocol Violation|2|||
124505209|NCT00678587|447801214|FG001|Overall Study|Lost to Follow-up|5|||
124505210|NCT00678587|447801213|FG000|Overall Study|Investigator Discretion|2|||
124505211|NCT00678587|447801214|FG001|Overall Study|Investigator Discretion|6|||
124562631|NCT01098240|448016590|FG002|Double-Blind Phase|Protocol Violation|4|||
124562632|NCT01098240|448016588|FG000|Double-Blind Phase|Lost to Follow-up|0|||
124562633|NCT01098240|448016589|FG001|Double-Blind Phase|Lost to Follow-up|2|||
124562634|NCT01098240|448016590|FG002|Double-Blind Phase|Lost to Follow-up|0|||
124505212|NCT00678587|447801213|FG000|Overall Study|Withdrew Consent|8|||
124505213|NCT00678587|447801214|FG001|Overall Study|Withdrew Consent|3|||
124505214|NCT00305253|447801217|FG000|Overall Study|Withdrawal by Subject|0|||
124505215|NCT00305253|447801218|FG001|Overall Study|Withdrawal by Subject|1|||
124505216|NCT03599141|447801220|FG000|Overall Study|Lost to Follow-up|3|||
124505217|NCT03599141|447801221|FG001|Overall Study|Lost to Follow-up|1|||
124505218|NCT00807846|447801222|FG000|Overall Study|Adverse Event|5|||
124505219|NCT00807846|447801223|FG001|Overall Study|Adverse Event|0|||
124562635|NCT01098240|448016588|FG000|Double-Blind Phase|Other|0|||
124562636|NCT01098240|448016589|FG001|Double-Blind Phase|Other|2|||
124562637|NCT01098240|448016590|FG002|Double-Blind Phase|Other|2|||
124562638|NCT01098240|448016588|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
124562639|NCT01098240|448016589|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
124562640|NCT01098240|448016590|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
124562641|NCT01098240|448016588|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
124505220|NCT00807846|447801222|FG000|Overall Study|Lack of Efficacy|2|||
124505221|NCT00807846|447801223|FG001|Overall Study|Lack of Efficacy|0|||
124505222|NCT00807846|447801222|FG000|Overall Study|Protocol Violation|2|||
124505223|NCT00807846|447801223|FG001|Overall Study|Protocol Violation|1|||
124505224|NCT00807846|447801222|FG000|Overall Study|Withdrawal by Subject|2|||
124505225|NCT00807846|447801223|FG001|Overall Study|Withdrawal by Subject|1|||
124505226|NCT00807846|447801222|FG000|Overall Study|Other|1|||
124505227|NCT00807846|447801223|FG001|Overall Study|Other|2|||
124505228|NCT01081873|447801224|FG000|Overall Study|Death|86|||
124505229|NCT01081873|447801224|FG000|Overall Study|Withdrawal by Subject|10|||
124505230|NCT01081873|447801224|FG000|Overall Study|Lost to Follow-up|142|||
124505231|NCT01081873|447801224|FG000|Overall Study|Progression of prostate cancer|13|||
124505232|NCT01081873|447801224|FG000|Overall Study|Other|47|||
124505233|NCT02491073|447801226|FG000|Overall Study|screen failure|1|||
124505234|NCT02491073|447801227|FG001|Overall Study|screen failure|0|||
124505235|NCT01165021|447801228|FG000|Overall Study|Death|1|||
124505236|NCT01419665|447801229|FG000|Combination Treatment|Adverse Event|7|||
124505237|NCT01419665|447801230|FG001|Combination Treatment|Adverse Event|10|||
124505238|NCT01419665|447801229|FG000|Combination Treatment|Physician Decision|5|||
124505239|NCT01419665|447801230|FG001|Combination Treatment|Physician Decision|8|||
124505240|NCT01419665|447801229|FG000|Combination Treatment|Protocol Violation|6|||
124505241|NCT01419665|447801230|FG001|Combination Treatment|Protocol Violation|2|||
124505242|NCT01419665|447801229|FG000|Combination Treatment|disease progression|10|||
124505243|NCT01419665|447801230|FG001|Combination Treatment|disease progression|9|||
124505244|NCT01419665|447801229|FG000|Combination Treatment|Death|5|||
124505245|NCT01419665|447801230|FG001|Combination Treatment|Death|7|||
124505246|NCT01419665|447801229|FG000|Combination Treatment|administrative problems|0|||
124505247|NCT01419665|447801230|FG001|Combination Treatment|administrative problems|1|||
124505248|NCT01419665|447801229|FG000|Combination Treatment|Withdrawal by Subject|5|||
124562642|NCT01098240|448016589|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
124562643|NCT01098240|448016590|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
124562644|NCT01098240|448016588|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
124562645|NCT01098240|448016589|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
124562646|NCT01098240|448016590|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
124562647|NCT01098240|448016588|FG000|Double-Blind Phase|Adverse Event|0|||
124562648|NCT01098240|448016589|FG001|Double-Blind Phase|Adverse Event|3|||
124562649|NCT01098240|448016590|FG002|Double-Blind Phase|Adverse Event|3|||
124562650|NCT01070394|448016591|FG000|Overall Study|Adverse Event|6|||
124562651|NCT01070394|448016591|FG000|Overall Study|Withdrawal by Subject|1|||
124562652|NCT03118739|448016593|FG000|Overall Study|Physician Decision|0|||
124562653|NCT03118739|448016594|FG001|Overall Study|Physician Decision|1|||
124562654|NCT03118739|448016593|FG000|Overall Study|Withdrawal by Subject|5|||
124562655|NCT03118739|448016594|FG001|Overall Study|Withdrawal by Subject|3|||
124562656|NCT03118739|448016593|FG000|Overall Study|Lost to Follow-up|2|||
124562657|NCT03118739|448016594|FG001|Overall Study|Lost to Follow-up|0|||
124562658|NCT00669955|448016595|FG000|Overall Study|Adverse Event|3|||
124562659|NCT00669955|448016596|FG001|Overall Study|Adverse Event|5|||
124562660|NCT00669955|448016595|FG000|Overall Study|Death|0|||
124562661|NCT00669955|448016596|FG001|Overall Study|Death|1|||
124562662|NCT00669955|448016595|FG000|Overall Study|Withdrawal by Subject|2|||
124562663|NCT00669955|448016596|FG001|Overall Study|Withdrawal by Subject|3|||
124562664|NCT00669955|448016595|FG000|Overall Study|Lost to Follow-up|5|||
124562665|NCT00669955|448016596|FG001|Overall Study|Lost to Follow-up|7|||
124562666|NCT00669955|448016595|FG000|Overall Study|Protocol Violation|2|||
124562667|NCT00669955|448016596|FG001|Overall Study|Protocol Violation|7|||
124562668|NCT00669955|448016595|FG000|Overall Study|Investigator Sponsor Judgement|0|||
124505249|NCT01419665|447801230|FG001|Combination Treatment|Withdrawal by Subject|4|||
124505250|NCT01419665|447801229|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
124562669|NCT00669955|448016596|FG001|Overall Study|Investigator Sponsor Judgement|1|||
124562670|NCT00669955|448016595|FG000|Overall Study|not compliant with study drug/visit|2|||
124562671|NCT00669955|448016596|FG001|Overall Study|not compliant with study drug/visit|3|||
124562672|NCT04317053|448016601|FG000|Overall Study|Withdrawn (screen failure)|4|||
124562673|NCT04317053|448016602|FG001|Overall Study|Withdrawn (screen failure)|2|||
124562674|NCT01077713|448016603|FG000|Overall Study|Withdrawal by Subject|1|||
124505251|NCT01419665|447801230|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
124505252|NCT01419665|447801229|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
124505253|NCT01419665|447801230|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
124505254|NCT01419665|447801229|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
124562675|NCT01077713|448016604|FG001|Overall Study|Withdrawal by Subject|2|||
124562676|NCT01077713|448016603|FG000|Overall Study|Progressive Disease (PD)|0|||
124562677|NCT01077713|448016604|FG001|Overall Study|Progressive Disease (PD)|1|||
124562678|NCT01077713|448016603|FG000|Overall Study|Death|28|||
124562679|NCT01077713|448016604|FG001|Overall Study|Death|29|||
124562680|NCT01077713|448016603|FG000|Overall Study|Lost to Follow-up|1|||
124562681|NCT01077713|448016604|FG001|Overall Study|Lost to Follow-up|1|||
124505255|NCT01419665|447801230|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
124505256|NCT01419665|447801229|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
124505257|NCT01419665|447801230|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
124505258|NCT01419665|447801229|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
124505259|NCT01419665|447801230|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
124505260|NCT01419665|447801229|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
124505261|NCT01419665|447801230|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
124505262|NCT01419665|447801229|FG000|Maintenance Treatment and/or Follow up|Death|1|||
124505263|NCT01419665|447801230|FG001|Maintenance Treatment and/or Follow up|Death|2|||
124505264|NCT01419665|447801229|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
124505265|NCT01419665|447801230|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
124505266|NCT01419665|447801229|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
124505267|NCT01419665|447801230|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
124505268|NCT01419665|447801229|FG000|Open Label Phase|Death|1|||
124505269|NCT01419665|447801230|FG001|Open Label Phase|Death|0|||
124505270|NCT01419665|447801229|FG000|Open Label Phase|disease progression|0|||
124505271|NCT01419665|447801230|FG001|Open Label Phase|disease progression|1|||
124505272|NCT01655823|447801231|FG000|Overall Study|Lost to Follow-up|0|||
124505273|NCT01655823|447801232|FG001|Overall Study|Lost to Follow-up|1|||
124505274|NCT01655823|447801233|FG002|Overall Study|Lost to Follow-up|0|||
124505275|NCT01655823|447801234|FG003|Overall Study|Lost to Follow-up|0|||
124505276|NCT01655823|447801235|FG004|Overall Study|Lost to Follow-up|1|||
124505277|NCT01655823|447801231|FG000|Overall Study|Withdrawal by Subject|0|||
124505278|NCT01655823|447801232|FG001|Overall Study|Withdrawal by Subject|1|||
124505279|NCT01655823|447801233|FG002|Overall Study|Withdrawal by Subject|0|||
124505280|NCT01655823|447801234|FG003|Overall Study|Withdrawal by Subject|1|||
124505281|NCT01655823|447801235|FG004|Overall Study|Withdrawal by Subject|0|||
124505282|NCT02998554|447801236|FG000|Overall Study|Adverse Event|8|||
124562682|NCT01077713|448016603|FG000|Overall Study|Adverse Event|2|||
124562683|NCT01077713|448016604|FG001|Overall Study|Adverse Event|1|||
124562684|NCT01077713|448016603|FG000|Overall Study|Other|4|||
124562685|NCT01077713|448016604|FG001|Overall Study|Other|2|||
124562686|NCT03507439|448016605|FG000|Overall Study|Other|2|||
124562687|NCT03507439|448016606|FG001|Overall Study|Other|1|||
124562688|NCT03507439|448016605|FG000|Overall Study|Withdrawal by Subject|1|||
124562689|NCT03507439|448016606|FG001|Overall Study|Withdrawal by Subject|0|||
124562690|NCT03507439|448016605|FG000|Overall Study|Death|1|||
124562691|NCT03507439|448016606|FG001|Overall Study|Death|1|||
124562692|NCT00289458|448016607|FG000|Overall Study|Death|1|||
124562693|NCT00289458|448016608|FG001|Overall Study|Death|0|||
124562694|NCT00289458|448016609|FG002|Overall Study|Death|0|||
124562695|NCT00289458|448016607|FG000|Overall Study|Physician Decision|3|||
124562696|NCT00289458|448016608|FG001|Overall Study|Physician Decision|4|||
124562697|NCT00289458|448016609|FG002|Overall Study|Physician Decision|2|||
124562698|NCT00289458|448016607|FG000|Overall Study|Withdrawal by Subject|2|||
124562699|NCT00289458|448016608|FG001|Overall Study|Withdrawal by Subject|2|||
124562700|NCT00289458|448016609|FG002|Overall Study|Withdrawal by Subject|4|||
124562701|NCT04274192|448016610|FG000|Overall Study|Protocol Violation|1|||
124562702|NCT04274192|448016611|FG001|Overall Study|Protocol Violation|0|||
124562703|NCT01621490|448018228|FG000|Overall Study|Subject no longer meets study criteria|0|||
124562704|NCT01621490|448018229|FG001|Overall Study|Subject no longer meets study criteria|0|||
124562705|NCT01621490|448018230|FG002|Overall Study|Subject no longer meets study criteria|0|||
124562706|NCT01621490|448018231|FG003|Overall Study|Subject no longer meets study criteria|0|||
124562707|NCT01621490|448018232|FG004|Overall Study|Subject no longer meets study criteria|1|||
124562708|NCT01621490|448018233|FG005|Overall Study|Subject no longer meets study criteria|0|||
124562709|NCT01621490|448018234|FG006|Overall Study|Subject no longer meets study criteria|0|||
124562710|NCT01621490|448018235|FG007|Overall Study|Subject no longer meets study criteria|0|||
124562711|NCT01621490|448018236|FG008|Overall Study|Subject no longer meets study criteria|0|||
124562712|NCT01621490|448018237|FG009|Overall Study|Subject no longer meets study criteria|0|||
124562713|NCT01621490|448018238|FG010|Overall Study|Subject no longer meets study criteria|0|||
124562714|NCT01621490|448018228|FG000|Overall Study|Maximum clinical benefit|3|||
124562715|NCT01621490|448018229|FG001|Overall Study|Maximum clinical benefit|2|||
124562716|NCT01621490|448018230|FG002|Overall Study|Maximum clinical benefit|0|||
124562717|NCT01621490|448018231|FG003|Overall Study|Maximum clinical benefit|0|||
124562718|NCT01621490|448018232|FG004|Overall Study|Maximum clinical benefit|0|||
124505283|NCT02998554|447801237|FG001|Overall Study|Adverse Event|3|||
124562719|NCT01621490|448018233|FG005|Overall Study|Maximum clinical benefit|0|||
124505284|NCT02998554|447801236|FG000|Overall Study|Protocol deviation|1|||
124505285|NCT02998554|447801237|FG001|Overall Study|Protocol deviation|0|||
124562720|NCT01621490|448018234|FG006|Overall Study|Maximum clinical benefit|1|||
124562721|NCT01621490|448018235|FG007|Overall Study|Maximum clinical benefit|2|||
124562722|NCT01621490|448018236|FG008|Overall Study|Maximum clinical benefit|2|||
124562723|NCT01621490|448018237|FG009|Overall Study|Maximum clinical benefit|0|||
124562724|NCT01621490|448018238|FG010|Overall Study|Maximum clinical benefit|0|||
124562725|NCT01621490|448018228|FG000|Overall Study|Withdrawal by Subject|1|||
124562726|NCT01621490|448018229|FG001|Overall Study|Withdrawal by Subject|0|||
124562727|NCT01621490|448018230|FG002|Overall Study|Withdrawal by Subject|0|||
124562728|NCT01621490|448018231|FG003|Overall Study|Withdrawal by Subject|0|||
124562729|NCT01621490|448018232|FG004|Overall Study|Withdrawal by Subject|0|||
124562730|NCT01621490|448018233|FG005|Overall Study|Withdrawal by Subject|1|||
124562731|NCT01621490|448018234|FG006|Overall Study|Withdrawal by Subject|0|||
124562732|NCT01621490|448018235|FG007|Overall Study|Withdrawal by Subject|0|||
124562733|NCT01621490|448018236|FG008|Overall Study|Withdrawal by Subject|0|||
124562734|NCT01621490|448018237|FG009|Overall Study|Withdrawal by Subject|0|||
124562735|NCT01621490|448018238|FG010|Overall Study|Withdrawal by Subject|0|||
124562736|NCT01621490|448018228|FG000|Overall Study|Subject request to discontinue study|1|||
124562737|NCT01621490|448018229|FG001|Overall Study|Subject request to discontinue study|3|||
124562738|NCT01621490|448018230|FG002|Overall Study|Subject request to discontinue study|1|||
124562739|NCT01621490|448018231|FG003|Overall Study|Subject request to discontinue study|1|||
124562740|NCT01621490|448018232|FG004|Overall Study|Subject request to discontinue study|0|||
124562741|NCT01621490|448018233|FG005|Overall Study|Subject request to discontinue study|2|||
124562742|NCT01621490|448018234|FG006|Overall Study|Subject request to discontinue study|1|||
124562743|NCT01621490|448018235|FG007|Overall Study|Subject request to discontinue study|0|||
124562744|NCT01621490|448018236|FG008|Overall Study|Subject request to discontinue study|1|||
124562745|NCT01621490|448018237|FG009|Overall Study|Subject request to discontinue study|0|||
124562746|NCT01621490|448018238|FG010|Overall Study|Subject request to discontinue study|0|||
124562747|NCT01621490|448018228|FG000|Overall Study|Adverse event unrelated to study drug|1|||
124562748|NCT01621490|448018229|FG001|Overall Study|Adverse event unrelated to study drug|1|||
124562749|NCT01621490|448018230|FG002|Overall Study|Adverse event unrelated to study drug|0|||
124562750|NCT01621490|448018231|FG003|Overall Study|Adverse event unrelated to study drug|0|||
124562751|NCT01621490|448018232|FG004|Overall Study|Adverse event unrelated to study drug|0|||
124562752|NCT01621490|448018233|FG005|Overall Study|Adverse event unrelated to study drug|0|||
124562753|NCT01621490|448018234|FG006|Overall Study|Adverse event unrelated to study drug|0|||
124562754|NCT01621490|448018235|FG007|Overall Study|Adverse event unrelated to study drug|2|||
124562755|NCT01621490|448018236|FG008|Overall Study|Adverse event unrelated to study drug|0|||
124562756|NCT01621490|448018237|FG009|Overall Study|Adverse event unrelated to study drug|0|||
124562757|NCT01621490|448018238|FG010|Overall Study|Adverse event unrelated to study drug|0|||
124562758|NCT01621490|448018228|FG000|Overall Study|Disease progression|27|||
124562759|NCT01621490|448018229|FG001|Overall Study|Disease progression|28|||
124562760|NCT01621490|448018230|FG002|Overall Study|Disease progression|1|||
124562761|NCT01621490|448018231|FG003|Overall Study|Disease progression|5|||
124562762|NCT01621490|448018232|FG004|Overall Study|Disease progression|3|||
124562763|NCT01621490|448018233|FG005|Overall Study|Disease progression|8|||
124562764|NCT01621490|448018234|FG006|Overall Study|Disease progression|7|||
124562765|NCT01621490|448018235|FG007|Overall Study|Disease progression|1|||
124562766|NCT01621490|448018236|FG008|Overall Study|Disease progression|4|||
124562767|NCT01621490|448018237|FG009|Overall Study|Disease progression|1|||
124562768|NCT01621490|448018238|FG010|Overall Study|Disease progression|1|||
124562769|NCT01621490|448018228|FG000|Overall Study|Study drug toxicity|1|||
124562770|NCT01621490|448018229|FG001|Overall Study|Study drug toxicity|4|||
124562771|NCT01621490|448018230|FG002|Overall Study|Study drug toxicity|5|||
124562772|NCT01621490|448018231|FG003|Overall Study|Study drug toxicity|3|||
124562773|NCT01621490|448018232|FG004|Overall Study|Study drug toxicity|1|||
124562774|NCT01621490|448018233|FG005|Overall Study|Study drug toxicity|10|||
124562775|NCT01621490|448018234|FG006|Overall Study|Study drug toxicity|1|||
124562776|NCT01621490|448018235|FG007|Overall Study|Study drug toxicity|4|||
124562777|NCT01621490|448018236|FG008|Overall Study|Study drug toxicity|1|||
124562778|NCT01621490|448018237|FG009|Overall Study|Study drug toxicity|0|||
124562779|NCT01621490|448018238|FG010|Overall Study|Study drug toxicity|0|||
124562780|NCT01621490|448018228|FG000|Overall Study|Death|0|||
124562781|NCT01621490|448018229|FG001|Overall Study|Death|0|||
124562782|NCT01621490|448018230|FG002|Overall Study|Death|0|||
124562783|NCT01621490|448018231|FG003|Overall Study|Death|0|||
124562784|NCT01621490|448018232|FG004|Overall Study|Death|0|||
124562785|NCT01621490|448018233|FG005|Overall Study|Death|0|||
124562786|NCT01621490|448018234|FG006|Overall Study|Death|0|||
124562787|NCT01621490|448018235|FG007|Overall Study|Death|0|||
124562788|NCT01621490|448018236|FG008|Overall Study|Death|1|||
124562789|NCT01621490|448018237|FG009|Overall Study|Death|0|||
124562790|NCT01621490|448018238|FG010|Overall Study|Death|0|||
124562791|NCT01621490|448018228|FG000|Overall Study|Other reasons|7|||
124562792|NCT01621490|448018229|FG001|Overall Study|Other reasons|6|||
124562793|NCT01621490|448018230|FG002|Overall Study|Other reasons|4|||
124562794|NCT01621490|448018231|FG003|Overall Study|Other reasons|1|||
124562795|NCT01621490|448018232|FG004|Overall Study|Other reasons|1|||
124562796|NCT01621490|448018233|FG005|Overall Study|Other reasons|3|||
124505286|NCT02998554|447801236|FG000|Overall Study|Withdrawal by Subject|2|||
124505287|NCT02998554|447801237|FG001|Overall Study|Withdrawal by Subject|6|||
124505288|NCT02998554|447801236|FG000|Overall Study|Lost to Follow-up|0|||
124505289|NCT02998554|447801237|FG001|Overall Study|Lost to Follow-up|1|||
124505290|NCT02998554|447801236|FG000|Overall Study|Lack of Efficacy|0|||
124505291|NCT02998554|447801237|FG001|Overall Study|Lack of Efficacy|1|||
124505292|NCT02357849|447801238|FG000|Overall Study|Withdrawal by Subject|2|||
124505293|NCT02357849|447801239|FG001|Overall Study|Withdrawal by Subject|3|||
124505294|NCT01536119|447801240|FG000|Overall Study|Lost to Follow-up|17|||
124505295|NCT01536119|447801241|FG001|Overall Study|Lost to Follow-up|14|||
124505296|NCT04095286|447801242|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
124505297|NCT04095286|447801243|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
124505298|NCT04095286|447801244|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
124505299|NCT04095286|447801245|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
124505300|NCT04095286|447801246|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
124505301|NCT04095286|447801247|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
124505302|NCT04095286|447801242|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
124505303|NCT04095286|447801243|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
124505304|NCT04095286|447801244|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
124505305|NCT04095286|447801245|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
124505306|NCT04095286|447801246|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
124505307|NCT04095286|447801247|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
124505308|NCT04095286|447801242|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
124505309|NCT04095286|447801243|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
124505310|NCT04095286|447801244|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
124505311|NCT04095286|447801245|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
124505312|NCT04095286|447801246|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
124505313|NCT04095286|447801247|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
124505314|NCT04095286|447801242|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
124505315|NCT04095286|447801243|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
124505316|NCT04095286|447801244|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
124505317|NCT04095286|447801245|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
124505318|NCT04095286|447801246|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
124505319|NCT04095286|447801247|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
124505320|NCT04095286|447801242|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
124505321|NCT04095286|447801243|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
124505322|NCT04095286|447801244|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
124505323|NCT04095286|447801245|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
124505324|NCT04095286|447801246|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
124505325|NCT04095286|447801247|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
124562797|NCT01621490|448018234|FG006|Overall Study|Other reasons|1|||
124562798|NCT01621490|448018235|FG007|Overall Study|Other reasons|1|||
124562799|NCT01621490|448018236|FG008|Overall Study|Other reasons|1|||
124562800|NCT01621490|448018237|FG009|Overall Study|Other reasons|0|||
124562801|NCT01621490|448018238|FG010|Overall Study|Other reasons|0|||
124562802|NCT00461500|448018239|FG000|Overall Study|Adverse Event|1|||
124562803|NCT00461500|448018240|FG001|Overall Study|Adverse Event|0|||
124562804|NCT00461500|448018239|FG000|Overall Study|Lack of Efficacy|0|||
124562805|NCT00461500|448018240|FG001|Overall Study|Lack of Efficacy|1|||
124562806|NCT00461500|448018239|FG000|Overall Study|Expired Drug Treatment|1|||
124562807|NCT00461500|448018240|FG001|Overall Study|Expired Drug Treatment|1|||
124562808|NCT00461500|448018239|FG000|Overall Study|Study Stopped|1|||
124562809|NCT00461500|448018240|FG001|Overall Study|Study Stopped|2|||
124562810|NCT00461500|448018239|FG000|Overall Study|Drug Treatment Misuse|1|||
124562811|NCT00461500|448018240|FG001|Overall Study|Drug Treatment Misuse|0|||
124562812|NCT00461500|448018239|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
124562813|NCT00461500|448018240|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
124562814|NCT00461500|448018239|FG000|Overall Study|Lost to Follow-up|2|||
124562815|NCT00461500|448018240|FG001|Overall Study|Lost to Follow-up|2|||
124562816|NCT01806597|448018241|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
124562817|NCT01806597|448018242|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
124562818|NCT01806597|448018243|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
124562819|NCT01806597|448018244|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
124562820|NCT01806597|448018245|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
124562821|NCT01806597|448018246|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
124562822|NCT01806597|448018241|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
124562823|NCT01806597|448018242|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
124562824|NCT01806597|448018243|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
124562825|NCT01806597|448018244|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
124562826|NCT01806597|448018245|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
124562827|NCT01806597|448018246|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
124562828|NCT01806597|448018241|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
124562829|NCT01806597|448018242|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
124562830|NCT01806597|448018243|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
124562831|NCT01806597|448018244|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
124562832|NCT01806597|448018245|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
124562833|NCT01806597|448018246|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
124562834|NCT01806597|448018241|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
124562835|NCT01806597|448018242|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
124562836|NCT01806597|448018243|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
124562837|NCT01806597|448018244|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
124562838|NCT01806597|448018245|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
124562839|NCT01806597|448018246|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
124562840|NCT01806597|448018241|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
124562841|NCT01806597|448018242|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
124562842|NCT01806597|448018243|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
124562843|NCT01806597|448018244|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
124562844|NCT01806597|448018245|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
124562845|NCT01806597|448018246|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
124562846|NCT01806597|448018241|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
124562847|NCT01806597|448018242|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
124562848|NCT01806597|448018243|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
124562849|NCT01806597|448018244|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
124562850|NCT01806597|448018245|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
124562851|NCT01806597|448018246|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
124562852|NCT01806597|448018241|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
124562853|NCT01806597|448018242|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
124562854|NCT01806597|448018243|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
124562855|NCT01806597|448018244|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
124562856|NCT01806597|448018245|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
124562857|NCT01806597|448018246|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
124562858|NCT01806597|448018241|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
124562859|NCT01806597|448018242|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
124562860|NCT01806597|448018243|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
124562861|NCT01806597|448018244|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
124562862|NCT01806597|448018245|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
124562863|NCT01806597|448018246|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
124562864|NCT01806597|448018241|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
124562865|NCT01806597|448018242|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
124562866|NCT01806597|448018243|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
124562867|NCT01806597|448018244|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
124562868|NCT01806597|448018245|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
124562869|NCT01806597|448018246|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
124562870|NCT01806597|448018241|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
124562871|NCT01806597|448018242|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
124562872|NCT01806597|448018243|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
124562873|NCT01806597|448018244|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
124562874|NCT01806597|448018245|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
124562875|NCT01806597|448018246|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
124562876|NCT01806597|448018241|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
124562877|NCT01806597|448018242|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
124562878|NCT01806597|448018243|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
124562879|NCT01806597|448018244|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
124562880|NCT01806597|448018245|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
124562881|NCT01806597|448018246|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
124562882|NCT01806597|448018241|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
124562883|NCT01806597|448018242|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
124562884|NCT01806597|448018243|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
124562885|NCT01806597|448018244|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
124562886|NCT01806597|448018245|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
124562887|NCT01806597|448018246|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
124562888|NCT01806597|448018241|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
124562889|NCT01806597|448018242|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
124505326|NCT04092816|447803419|FG000|Overall Study|Lost to Follow-up|1|||
124505327|NCT04092816|447803420|FG001|Overall Study|Lost to Follow-up|2|||
124505328|NCT02690207|447803430|FG000|Overall Study|Lost to Follow-up|48|||
124505329|NCT02690207|447803430|FG000|Overall Study|Withdrawal by Subject|46|||
124505330|NCT02690207|447803430|FG000|Overall Study|Protocol Violation|2|||
124505331|NCT02690207|447803430|FG000|Overall Study|Serious adverse event|110|||
124505332|NCT02690207|447803430|FG000|Overall Study|Non-serious Adverse Event|18|||
124505333|NCT02690207|447803430|FG000|Overall Study|Migrated/moved from study area|5|||
124505334|NCT02690207|447803430|FG000|Overall Study|Suspected HZ Episode|1|||
124505335|NCT02690207|447803430|FG000|Overall Study|Other reasons for withdrawal|23|||
124505336|NCT04348656|447803433|FG000|Overall Study|Withdrawal by Subject|2|||
124505337|NCT04348656|447803434|FG001|Overall Study|Withdrawal by Subject|0|||
124505338|NCT04348656|447803433|FG000|Overall Study|Lost to Follow-up|11|||
124505339|NCT04348656|447803434|FG001|Overall Study|Lost to Follow-up|6|||
124505340|NCT00937560|447803441|FG000|Initial Treatment|Death|6|||
124505341|NCT00937560|447803441|FG000|Initial Treatment|Withdraw consent|3|||
124505342|NCT00937560|447803441|FG000|Initial Treatment|Adverse Event|1|||
124505343|NCT00937560|447803441|FG000|Initial Treatment|Lost to Follow-up|1|||
124505344|NCT00937560|447803441|FG000|Initial Treatment|No end of study page|10|||
124505345|NCT00937560|447803441|FG000|Maintenance Treatment|Death|12|||
124505346|NCT00937560|447803441|FG000|Maintenance Treatment|Withdraw consent|5|||
124505347|NCT00937560|447803441|FG000|Maintenance Treatment|According to protocol|1|||
124505348|NCT03364608|447803444|FG000|Overall Study|Withdrawal by Subject|4|||
124505349|NCT03364608|447803444|FG000|Overall Study|Protocol Violation|2|||
124505350|NCT03364608|447803444|FG000|Overall Study|Lost to Follow-up|2|||
124505351|NCT02546674|447803451|FG000|Overall Study|Adverse Event|19|||
124505352|NCT02546674|447803451|FG000|Overall Study|Death|1|||
124505353|NCT02546674|447803451|FG000|Overall Study|Lost to Follow-up|1|||
124505354|NCT02546674|447803451|FG000|Overall Study|Physician Decision|13|||
124505355|NCT02546674|447803451|FG000|Overall Study|Pregnancy|1|||
124505356|NCT02546674|447803451|FG000|Overall Study|Progressive Disease|2|||
124505357|NCT02546674|447803451|FG000|Overall Study|Protocol Deviation|2|||
124505358|NCT02546674|447803451|FG000|Overall Study|Subject/Guardian Decision|6|||
124505359|NCT02546674|447803451|FG000|Overall Study|Withdrawal of Informed Consent|3|||
124505360|NCT01397552|447803456|FG000|Overall Study|Adverse Event|1|||
124505361|NCT01397552|447803457|FG001|Overall Study|Adverse Event|0|||
124505362|NCT01397552|447803456|FG000|Overall Study|Withdrawal by Subject|2|||
124505363|NCT01397552|447803457|FG001|Overall Study|Withdrawal by Subject|1|||
124505364|NCT03888391|447803460|FG000|Overall Study|Lost to Follow-up|15|||
124505365|NCT00423735|447803462|FG000|Overall Study|Ineligible / No protocol treatment|8|||
124505366|NCT00423735|447803463|FG001|Overall Study|Ineligible / No protocol treatment|6|||
124505367|NCT00423735|447803464|FG002|Overall Study|Ineligible / No protocol treatment|0|||
124505368|NCT01954251|447803468|FG000|Overall Study|Adverse Event|5|||
124505369|NCT01954251|447803469|FG001|Overall Study|Adverse Event|7|||
124505370|NCT01954251|447803468|FG000|Overall Study|Lost to Follow-up|6|||
124505371|NCT01954251|447803469|FG001|Overall Study|Lost to Follow-up|6|||
124505372|NCT01954251|447803468|FG000|Overall Study|Withdrawal by Subject|2|||
124505373|NCT01954251|447803469|FG001|Overall Study|Withdrawal by Subject|6|||
124505374|NCT02864940|447803470|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
124505375|NCT02864940|447803471|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
124505376|NCT02175771|447803474|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
124505377|NCT02175771|447803475|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124505378|NCT02175771|447803476|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124505379|NCT02175771|447803477|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124505380|NCT02175771|447803478|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124505381|NCT02175771|447803479|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124505382|NCT02175771|447803480|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124505383|NCT02175771|447803481|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124505384|NCT02175771|447803482|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124505385|NCT02175771|447803474|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
124505386|NCT02175771|447803475|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124505387|NCT02175771|447803476|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124505388|NCT02175771|447803477|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124505389|NCT02175771|447803478|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124505390|NCT02175771|447803479|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124505391|NCT02175771|447803480|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124505392|NCT02175771|447803481|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124505393|NCT02175771|447803482|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124505394|NCT02175771|447803474|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
124505395|NCT02175771|447803475|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124505396|NCT02175771|447803476|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124505397|NCT02175771|447803477|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124562890|NCT01806597|448018243|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
124505398|NCT02175771|447803478|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124505399|NCT02175771|447803479|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124505400|NCT02175771|447803480|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124505401|NCT02175771|447803481|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124505402|NCT02175771|447803482|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124505403|NCT02175771|447803474|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
124505404|NCT02175771|447803475|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
124505405|NCT02175771|447803476|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
124505406|NCT02175771|447803477|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
124505407|NCT02175771|447803478|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
124505408|NCT02175771|447803479|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
124505409|NCT02175771|447803480|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
124505410|NCT02175771|447803481|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
124505411|NCT02175771|447803482|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
124505412|NCT02175771|447803474|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
124505413|NCT02175771|447803475|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124505414|NCT02175771|447803476|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124505415|NCT02175771|447803477|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124505416|NCT02175771|447803478|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124505417|NCT02175771|447803479|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124505418|NCT02175771|447803480|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124505419|NCT02175771|447803481|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124505420|NCT02175771|447803482|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124505421|NCT02175771|447803474|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
124505422|NCT02175771|447803475|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124505423|NCT02175771|447803476|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124505424|NCT02175771|447803477|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124505425|NCT02175771|447803478|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124505426|NCT02175771|447803479|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124505427|NCT02175771|447803480|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124505428|NCT02175771|447803481|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124505429|NCT02175771|447803482|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124505430|NCT02175771|447803474|FG000|Run-In Period (Pre-assignment)|Other|8|||
124505431|NCT02175771|447803475|FG001|Run-In Period (Pre-assignment)|Other|0|||
124505432|NCT02175771|447803476|FG002|Run-In Period (Pre-assignment)|Other|0|||
124505433|NCT02175771|447803477|FG003|Run-In Period (Pre-assignment)|Other|0|||
124505434|NCT02175771|447803478|FG004|Run-In Period (Pre-assignment)|Other|0|||
124505435|NCT02175771|447803479|FG005|Run-In Period (Pre-assignment)|Other|0|||
124505436|NCT02175771|447803480|FG006|Run-In Period (Pre-assignment)|Other|0|||
124505437|NCT02175771|447803481|FG007|Run-In Period (Pre-assignment)|Other|0|||
124505438|NCT02175771|447803482|FG008|Run-In Period (Pre-assignment)|Other|0|||
124505439|NCT02175771|447803474|FG000|Treatment Period|Adverse Event|0|||
124505440|NCT02175771|447803475|FG001|Treatment Period|Adverse Event|2|||
124505441|NCT02175771|447803476|FG002|Treatment Period|Adverse Event|1|||
124505442|NCT02175771|447803477|FG003|Treatment Period|Adverse Event|1|||
124505443|NCT02175771|447803478|FG004|Treatment Period|Adverse Event|1|||
124505444|NCT02175771|447803479|FG005|Treatment Period|Adverse Event|3|||
124505445|NCT02175771|447803480|FG006|Treatment Period|Adverse Event|2|||
124505446|NCT02175771|447803481|FG007|Treatment Period|Adverse Event|0|||
124505447|NCT02175771|447803482|FG008|Treatment Period|Adverse Event|1|||
124505448|NCT02175771|447803474|FG000|Treatment Period|Withdrawal by Subject|0|||
124505449|NCT02175771|447803475|FG001|Treatment Period|Withdrawal by Subject|9|||
124505450|NCT02175771|447803476|FG002|Treatment Period|Withdrawal by Subject|3|||
124505451|NCT02175771|447803477|FG003|Treatment Period|Withdrawal by Subject|6|||
124505452|NCT02175771|447803478|FG004|Treatment Period|Withdrawal by Subject|2|||
124505453|NCT02175771|447803479|FG005|Treatment Period|Withdrawal by Subject|4|||
124505454|NCT02175771|447803480|FG006|Treatment Period|Withdrawal by Subject|2|||
124505455|NCT02175771|447803481|FG007|Treatment Period|Withdrawal by Subject|9|||
124505456|NCT02175771|447803482|FG008|Treatment Period|Withdrawal by Subject|2|||
124505457|NCT02175771|447803474|FG000|Treatment Period|Noncompliance|0|||
124505458|NCT02175771|447803475|FG001|Treatment Period|Noncompliance|1|||
124505459|NCT02175771|447803476|FG002|Treatment Period|Noncompliance|2|||
124505460|NCT02175771|447803477|FG003|Treatment Period|Noncompliance|0|||
124505461|NCT02175771|447803478|FG004|Treatment Period|Noncompliance|0|||
124505462|NCT02175771|447803479|FG005|Treatment Period|Noncompliance|0|||
124505463|NCT02175771|447803480|FG006|Treatment Period|Noncompliance|0|||
124505464|NCT02175771|447803481|FG007|Treatment Period|Noncompliance|0|||
124505465|NCT02175771|447803482|FG008|Treatment Period|Noncompliance|1|||
124505466|NCT02175771|447803474|FG000|Treatment Period|Protocol Violation|0|||
124505467|NCT02175771|447803475|FG001|Treatment Period|Protocol Violation|0|||
124505468|NCT02175771|447803476|FG002|Treatment Period|Protocol Violation|0|||
124562891|NCT01806597|448018244|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
124562892|NCT01806597|448018245|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
124562893|NCT01806597|448018246|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
124562894|NCT01806597|448018241|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
124562895|NCT01806597|448018242|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
124562896|NCT01806597|448018243|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
124562897|NCT01806597|448018244|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
124562898|NCT01806597|448018245|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
124562899|NCT01806597|448018246|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
124562900|NCT01806597|448018241|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
124562901|NCT01806597|448018242|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
124562902|NCT01806597|448018243|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
124562903|NCT01806597|448018244|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
124562904|NCT01806597|448018245|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
124562905|NCT01806597|448018246|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
124562906|NCT01806597|448018241|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
124562907|NCT01806597|448018242|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
124562908|NCT01806597|448018243|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
124562909|NCT01806597|448018244|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
124562910|NCT01806597|448018245|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
124562911|NCT01806597|448018246|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
124562912|NCT01806597|448018241|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
124562913|NCT01806597|448018242|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
124562914|NCT01806597|448018243|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
124562915|NCT01806597|448018244|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
124562916|NCT01806597|448018245|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
124562917|NCT01806597|448018246|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
124562918|NCT01806597|448018241|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
124562919|NCT01806597|448018242|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
124562920|NCT01806597|448018243|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
124562921|NCT01806597|448018244|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
124562922|NCT01806597|448018245|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
124562923|NCT01806597|448018246|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
124562924|NCT01806597|448018241|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
124562925|NCT01806597|448018242|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
124562926|NCT01806597|448018243|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
124562927|NCT01806597|448018244|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
124562928|NCT01806597|448018245|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
124562929|NCT01806597|448018246|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
124562930|NCT02247479|448018248|FG000|Overall Study|Adverse Event|8|||
124562931|NCT02247479|448018249|FG001|Overall Study|Adverse Event|9|||
124562932|NCT02247479|448018250|FG002|Overall Study|Adverse Event|8|||
124562933|NCT02247479|448018248|FG000|Overall Study|Death|5|||
124562934|NCT02247479|448018249|FG001|Overall Study|Death|4|||
124562935|NCT02247479|448018250|FG002|Overall Study|Death|6|||
124562936|NCT02247479|448018248|FG000|Overall Study|Lost to Follow-up|3|||
124562937|NCT02247479|448018249|FG001|Overall Study|Lost to Follow-up|3|||
124562938|NCT02247479|448018250|FG002|Overall Study|Lost to Follow-up|1|||
124562939|NCT02247479|448018248|FG000|Overall Study|Non-compliance|0|||
124562940|NCT02247479|448018249|FG001|Overall Study|Non-compliance|0|||
124562941|NCT02247479|448018250|FG002|Overall Study|Non-compliance|1|||
124562942|NCT02247479|448018248|FG000|Overall Study|Withdrawal by Subject|25|||
124562943|NCT02247479|448018249|FG001|Overall Study|Withdrawal by Subject|29|||
124562944|NCT02247479|448018250|FG002|Overall Study|Withdrawal by Subject|24|||
124562945|NCT02247479|448018248|FG000|Overall Study|Study Terminated by Sponsor|98|||
124562946|NCT02247479|448018249|FG001|Overall Study|Study Terminated by Sponsor|88|||
124562947|NCT02247479|448018250|FG002|Overall Study|Study Terminated by Sponsor|94|||
124562948|NCT02247479|448018248|FG000|Overall Study|Physician Decision|1|||
124562949|NCT02247479|448018249|FG001|Overall Study|Physician Decision|0|||
124562950|NCT02247479|448018250|FG002|Overall Study|Physician Decision|2|||
124562951|NCT02247479|448018248|FG000|Overall Study|Unspecified Reason|2|||
124562952|NCT02247479|448018249|FG001|Overall Study|Unspecified Reason|5|||
124562953|NCT02247479|448018250|FG002|Overall Study|Unspecified Reason|2|||
124562954|NCT01073020|448018251|FG000|Overall Study|Withdrawal by Subject|6|||
124562955|NCT01073020|448018252|FG001|Overall Study|Withdrawal by Subject|4|||
124562956|NCT01073020|448018253|FG002|Overall Study|Withdrawal by Subject|1|||
124562957|NCT01073020|448018254|FG003|Overall Study|Withdrawal by Subject|2|||
124562958|NCT01073020|448018251|FG000|Overall Study|Physician Decision|1|||
124562959|NCT01073020|448018252|FG001|Overall Study|Physician Decision|0|||
124562960|NCT01073020|448018253|FG002|Overall Study|Physician Decision|2|||
124562961|NCT01073020|448018254|FG003|Overall Study|Physician Decision|0|||
124562962|NCT01073020|448018251|FG000|Overall Study|Death|0|||
124562963|NCT01073020|448018252|FG001|Overall Study|Death|1|||
124562964|NCT01073020|448018253|FG002|Overall Study|Death|0|||
124562965|NCT01073020|448018254|FG003|Overall Study|Death|0|||
124562966|NCT03031899|448018261|FG000|Overall Study|Protocol Violation|1|||
124562967|NCT03031899|448018261|FG000|Overall Study|lesion disappeared after stopping habit|1|||
124562968|NCT03740698|448018263|FG000|Overall Study|Physician Decision|0|||
124562969|NCT03740698|448018264|FG001|Overall Study|Physician Decision|1|||
124562970|NCT03740698|448018265|FG002|Overall Study|Physician Decision|1|||
124562971|NCT01469364|448018267|FG000|Overall Study|Adverse Event|1|||
124562972|NCT01469364|448018267|FG000|Overall Study|Withdrawal by Subject|1|||
124562973|NCT01162499|448018270|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
124562974|NCT01162499|448018271|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
124562975|NCT01590433|448018272|FG000|Overall Study|Lost to Follow-up|20|||
124562976|NCT01590433|448018273|FG001|Overall Study|Lost to Follow-up|8|||
124562977|NCT01590433|448018272|FG000|Overall Study|Withdrawal by Subject|21|||
124562978|NCT01590433|448018273|FG001|Overall Study|Withdrawal by Subject|11|||
124562979|NCT01590433|448018272|FG000|Overall Study|Adverse Event|11|||
124562980|NCT01590433|448018273|FG001|Overall Study|Adverse Event|3|||
124562981|NCT00555009|448018274|FG000|Overall Study|Withdrawal by Subject|0|||
124562982|NCT00555009|448018275|FG001|Overall Study|Withdrawal by Subject|1|||
124562983|NCT00555009|448018274|FG000|Overall Study|Terminated by Sponsor|2|||
124562984|NCT00555009|448018275|FG001|Overall Study|Terminated by Sponsor|5|||
124562985|NCT00989261|448018276|FG000|Overall Study|Still in follow up|12|||
124562986|NCT00989261|448018277|FG001|Overall Study|Still in follow up|21|||
124562987|NCT00989261|448018276|FG000|Overall Study|Withdrawal by Subject|0|||
124562988|NCT00989261|448018277|FG001|Overall Study|Withdrawal by Subject|1|||
124562989|NCT00989261|448018276|FG000|Overall Study|Lost to Follow-up|3|||
124562990|NCT00989261|448018277|FG001|Overall Study|Lost to Follow-up|0|||
124562991|NCT00718159|448018278|FG000|Overall Study|Progressive Disease|3|||
124505469|NCT02175771|447803477|FG003|Treatment Period|Protocol Violation|0|||
124505470|NCT02175771|447803478|FG004|Treatment Period|Protocol Violation|0|||
124505471|NCT02175771|447803479|FG005|Treatment Period|Protocol Violation|0|||
124505472|NCT02175771|447803480|FG006|Treatment Period|Protocol Violation|0|||
124505473|NCT02175771|447803481|FG007|Treatment Period|Protocol Violation|1|||
124505474|NCT02175771|447803482|FG008|Treatment Period|Protocol Violation|0|||
124505475|NCT02175771|447803474|FG000|Treatment Period|Disease progression|0|||
124505476|NCT02175771|447803475|FG001|Treatment Period|Disease progression|0|||
124505477|NCT02175771|447803476|FG002|Treatment Period|Disease progression|0|||
124505478|NCT02175771|447803477|FG003|Treatment Period|Disease progression|0|||
124505479|NCT02175771|447803478|FG004|Treatment Period|Disease progression|0|||
124505480|NCT02175771|447803479|FG005|Treatment Period|Disease progression|0|||
124562992|NCT00718159|448018279|FG001|Overall Study|Progressive Disease|3|||
124562993|NCT00718159|448018280|FG002|Overall Study|Progressive Disease|2|||
124562994|NCT00718159|448018281|FG003|Overall Study|Progressive Disease|0|||
124562995|NCT00718159|448018282|FG004|Overall Study|Progressive Disease|6|||
124562996|NCT00718159|448018283|FG005|Overall Study|Progressive Disease|0|||
124562997|NCT00718159|448018284|FG006|Overall Study|Progressive Disease|0|||
124562998|NCT00718159|448018278|FG000|Overall Study|Death due to Adverse Event|0|||
124562999|NCT00718159|448018279|FG001|Overall Study|Death due to Adverse Event|0|||
124563000|NCT00718159|448018280|FG002|Overall Study|Death due to Adverse Event|0|||
124563001|NCT00718159|448018281|FG003|Overall Study|Death due to Adverse Event|2|||
124563002|NCT00718159|448018282|FG004|Overall Study|Death due to Adverse Event|2|||
124563003|NCT00718159|448018283|FG005|Overall Study|Death due to Adverse Event|0|||
124563004|NCT00718159|448018284|FG006|Overall Study|Death due to Adverse Event|0|||
124563005|NCT00718159|448018278|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
124563006|NCT00718159|448018279|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
124563007|NCT00718159|448018280|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
124563008|NCT00718159|448018281|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
124505481|NCT02175771|447803480|FG006|Treatment Period|Disease progression|0|||
124563009|NCT00718159|448018282|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
124563010|NCT00718159|448018283|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
124563011|NCT00718159|448018284|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
124505482|NCT02175771|447803481|FG007|Treatment Period|Disease progression|2|||
124563012|NCT00718159|448018278|FG000|Overall Study|Investigator Decision|0|||
124563013|NCT00718159|448018279|FG001|Overall Study|Investigator Decision|0|||
124563014|NCT00718159|448018280|FG002|Overall Study|Investigator Decision|0|||
124563015|NCT00718159|448018281|FG003|Overall Study|Investigator Decision|0|||
124563016|NCT00718159|448018282|FG004|Overall Study|Investigator Decision|0|||
124563017|NCT00718159|448018283|FG005|Overall Study|Investigator Decision|1|||
124563018|NCT00718159|448018284|FG006|Overall Study|Investigator Decision|1|||
124505483|NCT02175771|447803482|FG008|Treatment Period|Disease progression|0|||
124505484|NCT02175771|447803474|FG000|Treatment Period|Lost to Follow-up|0|||
124505485|NCT02175771|447803475|FG001|Treatment Period|Lost to Follow-up|3|||
124505486|NCT02175771|447803476|FG002|Treatment Period|Lost to Follow-up|1|||
124563019|NCT03532009|448018287|FG000|Overall Study|Other|1|||
124563020|NCT03532009|448018288|FG001|Overall Study|Other|1|||
124563021|NCT03532009|448018287|FG000|Overall Study|Death|1|||
124563022|NCT03532009|448018288|FG001|Overall Study|Death|1|||
124563023|NCT03532009|448018287|FG000|Overall Study|Withdrawal by Patient|0|||
124563024|NCT03532009|448018288|FG001|Overall Study|Withdrawal by Patient|2|||
124563025|NCT00681863|448018291|FG000|Overall Study|Adverse Event|1|||
124563026|NCT00681863|448018291|FG000|Overall Study|Lost to Follow-up|2|||
124563027|NCT00681863|448018291|FG000|Overall Study|Lack of Efficacy|2|||
124563028|NCT00681863|448018291|FG000|Overall Study|Other|18|||
124563029|NCT01333033|448018292|FG000|Overall Study|Ineligible|0|||
124563030|NCT01333033|448018293|FG001|Overall Study|Ineligible|0|||
124563031|NCT01333033|448018294|FG002|Overall Study|Ineligible|0|||
124563032|NCT01333033|448018295|FG003|Overall Study|Ineligible|0|||
124563033|NCT01333033|448018296|FG004|Overall Study|Ineligible|6|||
124563034|NCT01333033|448018297|FG005|Overall Study|Ineligible|8|||
124563035|NCT01333033|448018292|FG000|Overall Study|Withdrawal by Subject|0|||
124563036|NCT01333033|448018293|FG001|Overall Study|Withdrawal by Subject|0|||
124563037|NCT01333033|448018294|FG002|Overall Study|Withdrawal by Subject|0|||
124563038|NCT01333033|448018295|FG003|Overall Study|Withdrawal by Subject|0|||
124563039|NCT01333033|448018296|FG004|Overall Study|Withdrawal by Subject|4|||
124563040|NCT01333033|448018297|FG005|Overall Study|Withdrawal by Subject|2|||
124563041|NCT01333033|448018292|FG000|Overall Study|PET inevaluable|0|||
124563042|NCT01333033|448018293|FG001|Overall Study|PET inevaluable|0|||
124563043|NCT01333033|448018294|FG002|Overall Study|PET inevaluable|0|||
124563044|NCT01333033|448018295|FG003|Overall Study|PET inevaluable|0|||
124563045|NCT01333033|448018296|FG004|Overall Study|PET inevaluable|2|||
124563046|NCT01333033|448018297|FG005|Overall Study|PET inevaluable|4|||
124563047|NCT01333033|448018292|FG000|Overall Study|Adverse Event|0|||
124563048|NCT01333033|448018293|FG001|Overall Study|Adverse Event|0|||
124563049|NCT01333033|448018294|FG002|Overall Study|Adverse Event|0|||
124563050|NCT01333033|448018295|FG003|Overall Study|Adverse Event|0|||
124563051|NCT01333033|448018296|FG004|Overall Study|Adverse Event|2|||
124563052|NCT01333033|448018297|FG005|Overall Study|Adverse Event|1|||
124563053|NCT01333033|448018292|FG000|Overall Study|Progression|0|||
124563054|NCT01333033|448018293|FG001|Overall Study|Progression|0|||
124563055|NCT01333033|448018294|FG002|Overall Study|Progression|0|||
124563056|NCT01333033|448018295|FG003|Overall Study|Progression|0|||
124563057|NCT01333033|448018296|FG004|Overall Study|Progression|0|||
124563058|NCT01333033|448018297|FG005|Overall Study|Progression|1|||
124563059|NCT01333033|448018292|FG000|Overall Study|MD Decision|0|||
124563060|NCT01333033|448018293|FG001|Overall Study|MD Decision|0|||
124563061|NCT01333033|448018294|FG002|Overall Study|MD Decision|0|||
124563062|NCT01333033|448018295|FG003|Overall Study|MD Decision|0|||
124563063|NCT01333033|448018296|FG004|Overall Study|MD Decision|0|||
124563064|NCT01333033|448018297|FG005|Overall Study|MD Decision|2|||
124563065|NCT03687125|448018298|FG000|Overall Study|Progressive Disease|2|||
124505487|NCT02175771|447803477|FG003|Treatment Period|Lost to Follow-up|3|||
124505488|NCT02175771|447803478|FG004|Treatment Period|Lost to Follow-up|1|||
124505489|NCT02175771|447803479|FG005|Treatment Period|Lost to Follow-up|2|||
124505490|NCT02175771|447803480|FG006|Treatment Period|Lost to Follow-up|1|||
124505491|NCT02175771|447803481|FG007|Treatment Period|Lost to Follow-up|2|||
124505492|NCT02175771|447803482|FG008|Treatment Period|Lost to Follow-up|2|||
124505493|NCT02175771|447803474|FG000|Treatment Period|Lack of Efficacy|0|||
124505494|NCT02175771|447803475|FG001|Treatment Period|Lack of Efficacy|0|||
124505495|NCT02175771|447803476|FG002|Treatment Period|Lack of Efficacy|0|||
124505496|NCT02175771|447803477|FG003|Treatment Period|Lack of Efficacy|0|||
124505497|NCT02175771|447803478|FG004|Treatment Period|Lack of Efficacy|0|||
124505498|NCT02175771|447803479|FG005|Treatment Period|Lack of Efficacy|1|||
124505499|NCT02175771|447803480|FG006|Treatment Period|Lack of Efficacy|0|||
124505500|NCT02175771|447803481|FG007|Treatment Period|Lack of Efficacy|1|||
124505501|NCT02175771|447803482|FG008|Treatment Period|Lack of Efficacy|0|||
124505502|NCT02175771|447803474|FG000|Treatment Period|Other|0|||
124505503|NCT02175771|447803475|FG001|Treatment Period|Other|1|||
124505504|NCT02175771|447803476|FG002|Treatment Period|Other|0|||
124505505|NCT02175771|447803477|FG003|Treatment Period|Other|3|||
124505506|NCT02175771|447803478|FG004|Treatment Period|Other|1|||
124505507|NCT02175771|447803479|FG005|Treatment Period|Other|0|||
124505508|NCT02175771|447803480|FG006|Treatment Period|Other|0|||
124505509|NCT02175771|447803481|FG007|Treatment Period|Other|2|||
124505510|NCT02175771|447803482|FG008|Treatment Period|Other|0|||
124505511|NCT03364673|447803485|FG000|Overall Study|Withdrawal by Subject|2|||
124505512|NCT03364673|447803485|FG000|Overall Study|Injury unrelated to study|3|||
124505513|NCT02232087|447803486|FG000|Overall Study|Withdrawal by Subject|2|||
124505514|NCT02232087|447803487|FG001|Overall Study|Withdrawal by Subject|0|||
124505515|NCT02232087|447803488|FG002|Overall Study|Withdrawal by Subject|0|||
124505516|NCT02232087|447803489|FG003|Overall Study|Withdrawal by Subject|0|||
124505517|NCT02232087|447803490|FG004|Overall Study|Withdrawal by Subject|0|||
124563066|NCT03687125|448018299|FG001|Overall Study|Progressive Disease|1|||
124563067|NCT03687125|448018298|FG000|Overall Study|Protocol Violation|1|||
124563068|NCT03687125|448018299|FG001|Overall Study|Protocol Violation|0|||
124563069|NCT02035137|448018302|FG000|Overall Study|Physician Decision|0|||
124563070|NCT02035137|448018303|FG001|Overall Study|Physician Decision|0|||
124563071|NCT02035137|448018304|FG002|Overall Study|Physician Decision|1|||
124563072|NCT02035137|448018302|FG000|Overall Study|Withdrawal by Subject|0|||
124563073|NCT02035137|448018303|FG001|Overall Study|Withdrawal by Subject|1|||
124563074|NCT02035137|448018304|FG002|Overall Study|Withdrawal by Subject|2|||
124563075|NCT02035137|448018302|FG000|Overall Study|Ineligible|0|||
124563076|NCT02035137|448018303|FG001|Overall Study|Ineligible|1|||
124776657|NCT00892099|448809942|FG001|Overall Study|kidney function recovered|1|||
124776658|NCT00892099|448809943|FG002|Overall Study|kidney function recovered|0|||
124776659|NCT00892099|448809941|FG000|Overall Study|investigator decision|0|||
124776660|NCT00892099|448809942|FG001|Overall Study|investigator decision|0|||
124505518|NCT02232087|447803491|FG005|Overall Study|Withdrawal by Subject|1|||
124505519|NCT02232087|447803486|FG000|Overall Study|poor inhalation technique|0|||
124563077|NCT02035137|448018304|FG002|Overall Study|Ineligible|2|||
124563078|NCT02035137|448018302|FG000|Overall Study|Disease progression prior to treatment start|2|||
124563079|NCT02035137|448018303|FG001|Overall Study|Disease progression prior to treatment start|0|||
124563080|NCT02035137|448018304|FG002|Overall Study|Disease progression prior to treatment start|0|||
124563081|NCT01214603|448018311|FG000|Overall Study|Adverse Event|0|||
124563082|NCT01214603|448018312|FG001|Overall Study|Adverse Event|0|||
124563083|NCT01214603|448018313|FG002|Overall Study|Adverse Event|1|||
124563084|NCT01214603|448018311|FG000|Overall Study|Death|1|||
124563085|NCT01214603|448018312|FG001|Overall Study|Death|0|||
124563086|NCT01214603|448018313|FG002|Overall Study|Death|0|||
124563087|NCT01214603|448018311|FG000|Overall Study|Progressive Disease|4|||
124563088|NCT01214603|448018312|FG001|Overall Study|Progressive Disease|1|||
124563089|NCT01214603|448018313|FG002|Overall Study|Progressive Disease|3|||
124563090|NCT02444533|448018323|FG000|Overall Study|Not able to complete forms|0|||
124563091|NCT02444533|448018324|FG001|Overall Study|Not able to complete forms|2|||
124563092|NCT02444533|448018323|FG000|Overall Study|Only gave post-procedure complications|2|||
124563093|NCT02444533|448018324|FG001|Overall Study|Only gave post-procedure complications|2|||
124563094|NCT01388647|448018325|FG000|Overall Study|Adverse Event|1|||
124563095|NCT01388647|448018326|FG001|Overall Study|Adverse Event|2|||
124563096|NCT03567057|448018328|FG000|Overall Study|Adverse Event|56|||
124563097|NCT03567057|448018329|FG001|Overall Study|Adverse Event|53|||
124563098|NCT03567057|448018330|FG002|Overall Study|Adverse Event|28|||
124563099|NCT03567057|448018328|FG000|Overall Study|Withdrawal by Subject|22|||
124563100|NCT03567057|448018329|FG001|Overall Study|Withdrawal by Subject|24|||
124563101|NCT03567057|448018330|FG002|Overall Study|Withdrawal by Subject|13|||
124563102|NCT03567057|448018328|FG000|Overall Study|Lost to Follow-up|3|||
124563103|NCT03567057|448018329|FG001|Overall Study|Lost to Follow-up|5|||
124563104|NCT03567057|448018330|FG002|Overall Study|Lost to Follow-up|2|||
124563105|NCT03567057|448018328|FG000|Overall Study|COVID-19 pandemic|4|||
124563106|NCT03567057|448018329|FG001|Overall Study|COVID-19 pandemic|3|||
124563107|NCT03567057|448018330|FG002|Overall Study|COVID-19 pandemic|0|||
124563108|NCT03567057|448018328|FG000|Overall Study|Non-compliance with study drug|4|||
124563109|NCT03567057|448018329|FG001|Overall Study|Non-compliance with study drug|2|||
124563110|NCT03567057|448018330|FG002|Overall Study|Non-compliance with study drug|0|||
124563111|NCT03567057|448018328|FG000|Overall Study|Lack of Efficacy|3|||
124563112|NCT03567057|448018329|FG001|Overall Study|Lack of Efficacy|0|||
124563113|NCT03567057|448018330|FG002|Overall Study|Lack of Efficacy|1|||
124563114|NCT03567057|448018328|FG000|Overall Study|Death|1|||
124563115|NCT03567057|448018329|FG001|Overall Study|Death|0|||
124563116|NCT03567057|448018330|FG002|Overall Study|Death|0|||
124563117|NCT03567057|448018328|FG000|Overall Study|Physician Decision|1|||
124563118|NCT03567057|448018329|FG001|Overall Study|Physician Decision|0|||
124505520|NCT02232087|447803487|FG001|Overall Study|poor inhalation technique|1|||
124505521|NCT02232087|447803488|FG002|Overall Study|poor inhalation technique|0|||
124505522|NCT02232087|447803489|FG003|Overall Study|poor inhalation technique|0|||
124505523|NCT02232087|447803490|FG004|Overall Study|poor inhalation technique|0|||
124505524|NCT02232087|447803491|FG005|Overall Study|poor inhalation technique|2|||
124505525|NCT02232087|447803486|FG000|Overall Study|protocol stop criteria|0|||
124563119|NCT03567057|448018330|FG002|Overall Study|Physician Decision|0|||
124563120|NCT03567057|448018328|FG000|Overall Study|Unstable medical condition|1|||
124563121|NCT03567057|448018329|FG001|Overall Study|Unstable medical condition|0|||
124563122|NCT03567057|448018330|FG002|Overall Study|Unstable medical condition|0|||
124563123|NCT03567057|448018328|FG000|Overall Study|Medical history event|0|||
124563124|NCT03567057|448018329|FG001|Overall Study|Medical history event|0|||
124563125|NCT03567057|448018330|FG002|Overall Study|Medical history event|1|||
124563126|NCT03567057|448018328|FG000|Overall Study|Other|0|||
124563127|NCT03567057|448018329|FG001|Overall Study|Other|0|||
124563128|NCT03567057|448018330|FG002|Overall Study|Other|1|||
124563129|NCT01006707|448018331|FG000|Study Session 1|Lost to Follow-up|2|||
124563130|NCT01006707|448018332|FG001|Study Session 1|Lost to Follow-up|0|||
124563131|NCT01006707|448018333|FG002|Study Session 1|Lost to Follow-up|0|||
124505526|NCT02232087|447803487|FG001|Overall Study|protocol stop criteria|1|||
124563132|NCT01006707|448018331|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
124563133|NCT01006707|448018332|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
124505527|NCT02232087|447803488|FG002|Overall Study|protocol stop criteria|0|||
124505528|NCT02232087|447803489|FG003|Overall Study|protocol stop criteria|1|||
124505529|NCT02232087|447803490|FG004|Overall Study|protocol stop criteria|0|||
124505530|NCT02232087|447803491|FG005|Overall Study|protocol stop criteria|0|||
124505531|NCT02232087|447803486|FG000|Overall Study|Adverse Event|0|||
124505532|NCT02232087|447803487|FG001|Overall Study|Adverse Event|0|||
124505533|NCT02232087|447803488|FG002|Overall Study|Adverse Event|0|||
124505534|NCT02232087|447803489|FG003|Overall Study|Adverse Event|0|||
124505535|NCT02232087|447803490|FG004|Overall Study|Adverse Event|1|||
124505536|NCT02232087|447803491|FG005|Overall Study|Adverse Event|0|||
124505537|NCT02504268|447803493|FG000|Overall Study|Adverse Event|18|||
124505538|NCT02504268|447803494|FG001|Overall Study|Adverse Event|8|||
124505539|NCT02504268|447803495|FG002|Overall Study|Adverse Event|14|||
124505540|NCT02504268|447803496|FG003|Overall Study|Adverse Event|0|||
124505541|NCT02504268|447803497|FG004|Overall Study|Adverse Event|0|||
124563134|NCT01006707|448018333|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
124563135|NCT00490061|448018334|FG000|Overall Study|Physician Decision|1|||
124563136|NCT01155583|448018335|FG000|Phase I|Screen failure - did not start treatment|0|||
124563137|NCT01155583|448018336|FG001|Phase I|Screen failure - did not start treatment|0|||
124563138|NCT01155583|448018337|FG002|Phase I|Screen failure - did not start treatment|0|||
124563139|NCT01155583|448018338|FG003|Phase I|Screen failure - did not start treatment|0|||
124563140|NCT01155583|448018339|FG004|Phase I|Screen failure - did not start treatment|1|||
124563141|NCT01155583|448018340|FG005|Phase I|Screen failure - did not start treatment|0|||
124563142|NCT01155583|448018341|FG006|Phase I|Screen failure - did not start treatment|0|||
124563143|NCT01155583|448018342|FG007|Phase I|Screen failure - did not start treatment|2|||
124563144|NCT01155583|448018343|FG008|Phase I|Screen failure - did not start treatment|0|||
124563145|NCT01155583|448018335|FG000|Phase I|Withdrawal by Subject|0|||
124563146|NCT01155583|448018336|FG001|Phase I|Withdrawal by Subject|0|||
124563147|NCT01155583|448018337|FG002|Phase I|Withdrawal by Subject|0|||
124563148|NCT01155583|448018338|FG003|Phase I|Withdrawal by Subject|0|||
124563149|NCT01155583|448018339|FG004|Phase I|Withdrawal by Subject|0|||
124563150|NCT01155583|448018340|FG005|Phase I|Withdrawal by Subject|0|||
124563151|NCT01155583|448018341|FG006|Phase I|Withdrawal by Subject|0|||
124563152|NCT01155583|448018342|FG007|Phase I|Withdrawal by Subject|1|||
124563153|NCT01155583|448018343|FG008|Phase I|Withdrawal by Subject|0|||
124563154|NCT00952484|448018344|FG000|Overall Study|Withdrawal by Subject|0|||
124563155|NCT00952484|448018345|FG001|Overall Study|Withdrawal by Subject|1|||
124563156|NCT00952484|448018346|FG002|Overall Study|Withdrawal by Subject|0|||
124563157|NCT00585351|448018353|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
124563158|NCT00585351|448018354|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
124563159|NCT00585351|448018355|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
124563160|NCT00585351|448018356|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
124563161|NCT00585351|448018357|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
124563162|NCT00585351|448018358|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
124563163|NCT00585351|448018359|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
124563164|NCT00585351|448018360|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
124563165|NCT00585351|448018353|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
124563166|NCT00585351|448018354|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
124563167|NCT00585351|448018355|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
124563168|NCT00585351|448018356|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
124563169|NCT00585351|448018357|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
124563170|NCT00585351|448018358|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
124563171|NCT00585351|448018359|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
124563172|NCT00585351|448018360|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
124563173|NCT00585351|448018353|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
124563174|NCT00585351|448018354|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
124563175|NCT00585351|448018355|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
124563176|NCT00585351|448018356|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
124563177|NCT00585351|448018357|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
124563178|NCT00585351|448018358|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
124563179|NCT00585351|448018359|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
124563180|NCT00585351|448018360|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
124563181|NCT00585351|448018353|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
124563182|NCT00585351|448018354|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
124563183|NCT00585351|448018355|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
124563184|NCT00585351|448018356|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
124563185|NCT00585351|448018357|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
124563186|NCT00585351|448018358|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
124563187|NCT00585351|448018359|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
124505542|NCT02504268|447803498|FG005|Overall Study|Adverse Event|0|||
124505543|NCT02504268|447803499|FG006|Overall Study|Adverse Event|0|||
124505544|NCT02504268|447803500|FG007|Overall Study|Adverse Event|0|||
124505545|NCT02504268|447803501|FG008|Overall Study|Adverse Event|0|||
124505546|NCT02504268|447803493|FG000|Overall Study|Withdrawal of Consent|11|||
124505547|NCT02504268|447803494|FG001|Overall Study|Withdrawal of Consent|10|||
124505548|NCT02504268|447803495|FG002|Overall Study|Withdrawal of Consent|3|||
124505549|NCT02504268|447803496|FG003|Overall Study|Withdrawal of Consent|0|||
124505550|NCT02504268|447803497|FG004|Overall Study|Withdrawal of Consent|0|||
124505551|NCT02504268|447803498|FG005|Overall Study|Withdrawal of Consent|0|||
124505552|NCT02504268|447803499|FG006|Overall Study|Withdrawal of Consent|0|||
124505553|NCT02504268|447803500|FG007|Overall Study|Withdrawal of Consent|0|||
124505554|NCT02504268|447803501|FG008|Overall Study|Withdrawal of Consent|0|||
124505555|NCT02504268|447803493|FG000|Overall Study|Pregnancy|2|||
124505556|NCT02504268|447803494|FG001|Overall Study|Pregnancy|0|||
124505557|NCT02504268|447803495|FG002|Overall Study|Pregnancy|0|||
124505558|NCT02504268|447803496|FG003|Overall Study|Pregnancy|0|||
124505559|NCT02504268|447803497|FG004|Overall Study|Pregnancy|0|||
124505560|NCT02504268|447803498|FG005|Overall Study|Pregnancy|0|||
124505561|NCT02504268|447803499|FG006|Overall Study|Pregnancy|0|||
124505562|NCT02504268|447803500|FG007|Overall Study|Pregnancy|0|||
124505563|NCT02504268|447803501|FG008|Overall Study|Pregnancy|0|||
124505564|NCT02504268|447803493|FG000|Overall Study|Lost to Follow-up|3|||
124505565|NCT02504268|447803494|FG001|Overall Study|Lost to Follow-up|6|||
124505566|NCT02504268|447803495|FG002|Overall Study|Lost to Follow-up|4|||
124505567|NCT02504268|447803496|FG003|Overall Study|Lost to Follow-up|0|||
124505568|NCT02504268|447803497|FG004|Overall Study|Lost to Follow-up|0|||
124505569|NCT02504268|447803498|FG005|Overall Study|Lost to Follow-up|0|||
124505570|NCT02504268|447803499|FG006|Overall Study|Lost to Follow-up|0|||
124505571|NCT02504268|447803500|FG007|Overall Study|Lost to Follow-up|0|||
124505572|NCT02504268|447803501|FG008|Overall Study|Lost to Follow-up|0|||
124505573|NCT02504268|447803493|FG000|Overall Study|Death|1|||
124505574|NCT02504268|447803494|FG001|Overall Study|Death|1|||
124505575|NCT02504268|447803495|FG002|Overall Study|Death|0|||
124505576|NCT02504268|447803496|FG003|Overall Study|Death|0|||
124505577|NCT02504268|447803497|FG004|Overall Study|Death|0|||
124505578|NCT02504268|447803498|FG005|Overall Study|Death|0|||
124505579|NCT02504268|447803499|FG006|Overall Study|Death|0|||
124505580|NCT02504268|447803500|FG007|Overall Study|Death|0|||
124505581|NCT02504268|447803501|FG008|Overall Study|Death|0|||
124505582|NCT02504268|447803493|FG000|Overall Study|Subject Request to Discontinue|11|||
124505583|NCT02504268|447803494|FG001|Overall Study|Subject Request to Discontinue|3|||
124505584|NCT02504268|447803495|FG002|Overall Study|Subject Request to Discontinue|6|||
124505585|NCT02504268|447803496|FG003|Overall Study|Subject Request to Discontinue|0|||
124505586|NCT02504268|447803497|FG004|Overall Study|Subject Request to Discontinue|0|||
124505587|NCT02504268|447803498|FG005|Overall Study|Subject Request to Discontinue|0|||
124505588|NCT02504268|447803499|FG006|Overall Study|Subject Request to Discontinue|0|||
124505589|NCT02504268|447803500|FG007|Overall Study|Subject Request to Discontinue|0|||
124505590|NCT02504268|447803501|FG008|Overall Study|Subject Request to Discontinue|0|||
124505591|NCT02504268|447803493|FG000|Overall Study|No Longer Meets Study Criteria|2|||
124505592|NCT02504268|447803494|FG001|Overall Study|No Longer Meets Study Criteria|3|||
124505593|NCT02504268|447803495|FG002|Overall Study|No Longer Meets Study Criteria|0|||
124505594|NCT02504268|447803496|FG003|Overall Study|No Longer Meets Study Criteria|0|||
124505595|NCT02504268|447803497|FG004|Overall Study|No Longer Meets Study Criteria|0|||
124505596|NCT02504268|447803498|FG005|Overall Study|No Longer Meets Study Criteria|0|||
124505597|NCT02504268|447803499|FG006|Overall Study|No Longer Meets Study Criteria|0|||
124505598|NCT02504268|447803500|FG007|Overall Study|No Longer Meets Study Criteria|0|||
124505599|NCT02504268|447803501|FG008|Overall Study|No Longer Meets Study Criteria|0|||
124505600|NCT02504268|447803493|FG000|Overall Study|Lack of Efficacy|11|||
124505601|NCT02504268|447803494|FG001|Overall Study|Lack of Efficacy|35|||
124505602|NCT02504268|447803495|FG002|Overall Study|Lack of Efficacy|9|||
124505603|NCT02504268|447803496|FG003|Overall Study|Lack of Efficacy|0|||
124505604|NCT02504268|447803497|FG004|Overall Study|Lack of Efficacy|0|||
124637305|NCT00507455|448290464|FG002|Overall Study|Withdrawal by Subject|2|||
124505605|NCT02504268|447803498|FG005|Overall Study|Lack of Efficacy|0|||
124505606|NCT02504268|447803499|FG006|Overall Study|Lack of Efficacy|0|||
124505607|NCT02504268|447803500|FG007|Overall Study|Lack of Efficacy|0|||
124505608|NCT02504268|447803501|FG008|Overall Study|Lack of Efficacy|0|||
124505609|NCT02504268|447803493|FG000|Overall Study|Poor/Non-Compliance|3|||
124505610|NCT02504268|447803494|FG001|Overall Study|Poor/Non-Compliance|2|||
124505611|NCT02504268|447803495|FG002|Overall Study|Poor/Non-Compliance|3|||
124505612|NCT02504268|447803496|FG003|Overall Study|Poor/Non-Compliance|0|||
124505613|NCT02504268|447803497|FG004|Overall Study|Poor/Non-Compliance|0|||
124505614|NCT02504268|447803498|FG005|Overall Study|Poor/Non-Compliance|0|||
124505615|NCT02504268|447803499|FG006|Overall Study|Poor/Non-Compliance|0|||
124505616|NCT02504268|447803500|FG007|Overall Study|Poor/Non-Compliance|0|||
124505617|NCT02504268|447803501|FG008|Overall Study|Poor/Non-Compliance|0|||
124505618|NCT02504268|447803493|FG000|Overall Study|Not Disclosed|1|||
124505619|NCT02504268|447803494|FG001|Overall Study|Not Disclosed|0|||
124505620|NCT02504268|447803495|FG002|Overall Study|Not Disclosed|2|||
124505621|NCT02504268|447803496|FG003|Overall Study|Not Disclosed|0|||
124505622|NCT02504268|447803497|FG004|Overall Study|Not Disclosed|0|||
124505623|NCT02504268|447803498|FG005|Overall Study|Not Disclosed|0|||
124505624|NCT02504268|447803499|FG006|Overall Study|Not Disclosed|0|||
124505625|NCT02504268|447803500|FG007|Overall Study|Not Disclosed|0|||
124505626|NCT02504268|447803501|FG008|Overall Study|Not Disclosed|0|||
124505627|NCT00209170|447803504|FG000|Overall Study|Adverse Event|0|||
124505628|NCT00209170|447803505|FG001|Overall Study|Adverse Event|1|||
124505629|NCT00209170|447803504|FG000|Overall Study|Withdrawal by Subject|2|||
124505630|NCT00209170|447803505|FG001|Overall Study|Withdrawal by Subject|1|||
124505631|NCT00209170|447803504|FG000|Overall Study|Lack of Efficacy|0|||
124505632|NCT00209170|447803505|FG001|Overall Study|Lack of Efficacy|1|||
124505633|NCT02108600|447803506|FG000|Overall Study|Withdrawal by Subject|2|||
124505634|NCT02108600|447803507|FG001|Overall Study|Withdrawal by Subject|0|||
124505635|NCT02108600|447803506|FG000|Overall Study|Lost to Follow-up|1|||
124505636|NCT02108600|447803507|FG001|Overall Study|Lost to Follow-up|1|||
124505637|NCT03150095|447803508|FG000|Overall Study|Death|0|||
124505638|NCT03150095|447803509|FG001|Overall Study|Death|1|||
124505639|NCT03150095|447803508|FG000|Overall Study|Lost to Follow-up|1|||
124505640|NCT03150095|447803509|FG001|Overall Study|Lost to Follow-up|1|||
124505641|NCT03150095|447803508|FG000|Overall Study|Withdrawal by Subject|4|||
124505642|NCT03150095|447803509|FG001|Overall Study|Withdrawal by Subject|0|||
124505643|NCT03150095|447803508|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
124505644|NCT03150095|447803509|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
124505645|NCT04032171|447803510|FG000|Overall Study|Study Termination|1|||
124505646|NCT04032171|447803511|FG001|Overall Study|Study Termination|0|||
124505647|NCT02124707|447803512|FG000|Overall Study|Adverse Event|5|||
124505648|NCT02124707|447803512|FG000|Overall Study|Physician Decision|1|||
124505649|NCT02124707|447803512|FG000|Overall Study|Death|1|||
124505650|NCT00718666|447803520|FG000|Booster Phase Year 5|No active participation request|0|||
124505651|NCT00718666|447803521|FG001|Booster Phase Year 5|No active participation request|0|||
124505652|NCT00718666|447803522|FG002|Booster Phase Year 5|No active participation request|1|||
124505653|NCT00718666|447803520|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
124505654|NCT00718666|447803521|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
124505655|NCT00718666|447803522|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
124505656|NCT00718666|447803520|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
124505657|NCT00718666|447803521|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
124505658|NCT00718666|447803522|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
124505659|NCT00718666|447803520|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
124505660|NCT00718666|447803521|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
124505661|NCT00718666|447803522|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
124505662|NCT03806179|447803523|FG000|Overall Study|Progressive disease|0|||
124505663|NCT03806179|447803524|FG001|Overall Study|Progressive disease|2|||
124505664|NCT01952730|447803525|FG000|Overall Study|FDA shut down core lab used by study|1|||
124505665|NCT01357915|447803530|FG000|Overall Study|Lost to Follow-up|3|||
124505666|NCT01357915|447803531|FG001|Overall Study|Lost to Follow-up|0|||
124505667|NCT01479374|447803533|FG000|Overall Study|Adverse Event|2|||
124505668|NCT01479374|447803534|FG001|Overall Study|Adverse Event|1|||
124505669|NCT01479374|447803535|FG002|Overall Study|Adverse Event|0|||
124505670|NCT01479374|447803533|FG000|Overall Study|Lost to Follow-up|1|||
124505671|NCT01479374|447803534|FG001|Overall Study|Lost to Follow-up|2|||
124505672|NCT01479374|447803535|FG002|Overall Study|Lost to Follow-up|0|||
124505673|NCT01479374|447803533|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
124505674|NCT01479374|447803534|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
124505675|NCT01479374|447803535|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
124505676|NCT01479374|447803533|FG000|Overall Study|Other|0|||
124505677|NCT01479374|447803534|FG001|Overall Study|Other|4|||
124505678|NCT01479374|447803535|FG002|Overall Study|Other|5|||
124505679|NCT01606761|447803536|FG000|Prior to Week 24|Lost to Follow-up|0|||
124505680|NCT01606761|447803537|FG001|Prior to Week 24|Lost to Follow-up|3|||
124505681|NCT01606761|447803538|FG002|Prior to Week 24|Lost to Follow-up|2|||
124505682|NCT01606761|447803539|FG003|Prior to Week 24|Lost to Follow-up|0|||
124505683|NCT01606761|447803540|FG004|Prior to Week 24|Lost to Follow-up|0|||
124505684|NCT01606761|447803536|FG000|Prior to Week 24|Withdrawal by Subject|12|||
124724859|NCT03530995|448613334|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
124505685|NCT01606761|447803537|FG001|Prior to Week 24|Withdrawal by Subject|10|||
124505686|NCT01606761|447803538|FG002|Prior to Week 24|Withdrawal by Subject|9|||
124505687|NCT01606761|447803539|FG003|Prior to Week 24|Withdrawal by Subject|0|||
124505688|NCT01606761|447803540|FG004|Prior to Week 24|Withdrawal by Subject|0|||
124505689|NCT01606761|447803536|FG000|Prior to Week 24|Adverse Event|11|||
124505690|NCT01606761|447803537|FG001|Prior to Week 24|Adverse Event|18|||
124505691|NCT01606761|447803538|FG002|Prior to Week 24|Adverse Event|22|||
124505692|NCT01606761|447803539|FG003|Prior to Week 24|Adverse Event|0|||
124505693|NCT01606761|447803540|FG004|Prior to Week 24|Adverse Event|0|||
124505694|NCT01606761|447803536|FG000|Prior to Week 24|Lack of Efficacy|15|||
124505695|NCT01606761|447803537|FG001|Prior to Week 24|Lack of Efficacy|14|||
124563188|NCT00585351|448018360|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
124563189|NCT00585351|448018353|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
124563190|NCT00585351|448018354|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
124563191|NCT00585351|448018355|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
124563192|NCT00585351|448018356|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
124505696|NCT01606761|447803538|FG002|Prior to Week 24|Lack of Efficacy|8|||
124505697|NCT01606761|447803539|FG003|Prior to Week 24|Lack of Efficacy|0|||
124505698|NCT01606761|447803540|FG004|Prior to Week 24|Lack of Efficacy|0|||
124505699|NCT01606761|447803536|FG000|Prior to Week 24|Physician Decision|0|||
124505700|NCT01606761|447803537|FG001|Prior to Week 24|Physician Decision|3|||
124505701|NCT01606761|447803538|FG002|Prior to Week 24|Physician Decision|1|||
124505702|NCT01606761|447803539|FG003|Prior to Week 24|Physician Decision|0|||
124505703|NCT01606761|447803540|FG004|Prior to Week 24|Physician Decision|0|||
124505704|NCT01606761|447803536|FG000|Prior to Week 24|Other|4|||
124505705|NCT01606761|447803537|FG001|Prior to Week 24|Other|7|||
124505706|NCT01606761|447803538|FG002|Prior to Week 24|Other|5|||
124505707|NCT01606761|447803539|FG003|Prior to Week 24|Other|0|||
124505708|NCT01606761|447803540|FG004|Prior to Week 24|Other|0|||
124505709|NCT01606761|447803536|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
124505710|NCT01606761|447803537|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
124505711|NCT01606761|447803538|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
124505712|NCT01606761|447803539|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
124505713|NCT01606761|447803540|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
124505714|NCT01606761|447803536|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
124505715|NCT01606761|447803537|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
124505716|NCT01606761|447803538|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
124505717|NCT01606761|447803539|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
124505718|NCT01606761|447803540|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
124505719|NCT01606761|447803536|FG000|Week 24 to Week 52|Adverse Event|0|||
124505720|NCT01606761|447803537|FG001|Week 24 to Week 52|Adverse Event|11|||
124505721|NCT01606761|447803538|FG002|Week 24 to Week 52|Adverse Event|14|||
124505722|NCT01606761|447803539|FG003|Week 24 to Week 52|Adverse Event|3|||
124505723|NCT01606761|447803540|FG004|Week 24 to Week 52|Adverse Event|15|||
124505724|NCT01606761|447803536|FG000|Week 24 to Week 52|Death|0|||
124505725|NCT01606761|447803537|FG001|Week 24 to Week 52|Death|0|||
124505726|NCT01606761|447803538|FG002|Week 24 to Week 52|Death|2|||
124505727|NCT01606761|447803539|FG003|Week 24 to Week 52|Death|1|||
124505728|NCT01606761|447803540|FG004|Week 24 to Week 52|Death|0|||
124505729|NCT01606761|447803536|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
124505730|NCT01606761|447803537|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
124505731|NCT01606761|447803538|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
124505732|NCT01606761|447803539|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
124505733|NCT01606761|447803540|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
124505734|NCT01606761|447803536|FG000|Week 24 to Week 52|Physician Decision|0|||
124505735|NCT01606761|447803537|FG001|Week 24 to Week 52|Physician Decision|1|||
124505736|NCT01606761|447803538|FG002|Week 24 to Week 52|Physician Decision|1|||
124505737|NCT01606761|447803539|FG003|Week 24 to Week 52|Physician Decision|0|||
124505738|NCT01606761|447803540|FG004|Week 24 to Week 52|Physician Decision|0|||
124505739|NCT01606761|447803536|FG000|Week 24 to Week 52|Other|0|||
124505740|NCT01606761|447803537|FG001|Week 24 to Week 52|Other|1|||
124563193|NCT00585351|448018357|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
124563194|NCT00585351|448018358|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
124563195|NCT00585351|448018359|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
124563196|NCT00585351|448018360|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
124563197|NCT00585351|448018353|FG000|Enrollment Period (Intervention)|Death|0|||
124563198|NCT00585351|448018354|FG001|Enrollment Period (Intervention)|Death|0|||
124563199|NCT00585351|448018355|FG002|Enrollment Period (Intervention)|Death|0|||
124563200|NCT00585351|448018356|FG003|Enrollment Period (Intervention)|Death|0|||
124563201|NCT00585351|448018357|FG004|Enrollment Period (Intervention)|Death|1|||
124563202|NCT00585351|448018358|FG005|Enrollment Period (Intervention)|Death|0|||
124563203|NCT00585351|448018359|FG006|Enrollment Period (Intervention)|Death|1|||
124563204|NCT00585351|448018360|FG007|Enrollment Period (Intervention)|Death|0|||
124563205|NCT00585351|448018353|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
124563206|NCT00585351|448018354|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
124563207|NCT00585351|448018355|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
124505741|NCT01606761|447803538|FG002|Week 24 to Week 52|Other|5|||
124505742|NCT01606761|447803539|FG003|Week 24 to Week 52|Other|2|||
124505743|NCT01606761|447803540|FG004|Week 24 to Week 52|Other|2|||
124505744|NCT01606761|447803536|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
124505745|NCT01606761|447803537|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
124505746|NCT01606761|447803538|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
124505747|NCT01606761|447803539|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
124505748|NCT01606761|447803540|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
124505749|NCT01606761|447803536|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
124505750|NCT01606761|447803537|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
124563208|NCT00585351|448018356|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
124563209|NCT00585351|448018357|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
124563210|NCT00585351|448018358|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
124563211|NCT00585351|448018359|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
124563212|NCT00585351|448018360|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
124563213|NCT01842958|448018362|FG000|Overall Study|Lost to Follow-up|1|||
124563214|NCT01842958|448018363|FG001|Overall Study|Lost to Follow-up|1|||
124563215|NCT01829477|448018364|FG000|Overall Study|Study Terminated by Sponsor|15|||
124563216|NCT01829477|448018365|FG001|Overall Study|Study Terminated by Sponsor|15|||
124563217|NCT01829477|448018364|FG000|Overall Study|Withdrawal by Subject|1|||
124563218|NCT01829477|448018365|FG001|Overall Study|Withdrawal by Subject|0|||
124563219|NCT03361423|448018368|FG000|Overall Study|Withdrawal by Subject|4|||
124563220|NCT03361423|448018369|FG001|Overall Study|Withdrawal by Subject|3|||
124563221|NCT03361423|448018368|FG000|Overall Study|Did not treat|19|||
124563222|NCT03361423|448018369|FG001|Overall Study|Did not treat|18|||
124563223|NCT03361423|448018368|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
124563224|NCT03361423|448018369|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
124563225|NCT03361423|448018368|FG000|Overall Study|Missing data|4|||
124563226|NCT03361423|448018369|FG001|Overall Study|Missing data|1|||
124563227|NCT01336894|448018370|FG000|Follow-up|Study terminated prematurely|2|||
124563228|NCT01336894|448018371|FG001|Follow-up|Study terminated prematurely|7|||
124563229|NCT05034731|448018372|FG000|Overall Study|Screen fail|1|||
124563230|NCT05034731|448018373|FG001|Overall Study|Screen fail|1|||
124563231|NCT01325207|448018376|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
124563232|NCT01325207|448018377|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
124563233|NCT01325207|448018378|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
124563234|NCT01325207|448018379|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
124563235|NCT01325207|448018380|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
124563236|NCT01325207|448018381|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
124563237|NCT01325207|448018376|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
124563238|NCT01325207|448018377|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
124563239|NCT01325207|448018378|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
124563240|NCT01325207|448018379|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
124563241|NCT01325207|448018380|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
124563242|NCT01325207|448018381|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
124563243|NCT01325207|448018376|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
124563244|NCT01325207|448018377|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
124505751|NCT01606761|447803538|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
124505752|NCT01606761|447803539|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
124505753|NCT01606761|447803540|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
124505754|NCT01606761|447803536|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
124505755|NCT01606761|447803537|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
124505756|NCT01606761|447803538|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
124505757|NCT01606761|447803539|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
124505758|NCT01606761|447803540|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
124505759|NCT01606761|447803536|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
124505760|NCT01606761|447803537|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
124505761|NCT01606761|447803538|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
124505762|NCT01606761|447803539|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
124505763|NCT01606761|447803540|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
124505764|NCT05086289|447803541|FG000|Overall Study|Adverse Event|4|||
124505765|NCT05086289|447803542|FG001|Overall Study|Adverse Event|2|||
124505766|NCT05086289|447803541|FG000|Overall Study|Lost to Follow-up|2|||
124505767|NCT05086289|447803542|FG001|Overall Study|Lost to Follow-up|0|||
124505768|NCT05086289|447803541|FG000|Overall Study|Non-compliance with study drug|2|||
124505769|NCT05086289|447803542|FG001|Overall Study|Non-compliance with study drug|1|||
124505770|NCT05086289|447803541|FG000|Overall Study|Physician Decision|2|||
124505771|NCT05086289|447803542|FG001|Overall Study|Physician Decision|0|||
124563245|NCT01325207|448018378|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
124563246|NCT01325207|448018379|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
124505772|NCT05086289|447803541|FG000|Overall Study|Withdrawal by Subject|5|||
124505773|NCT05086289|447803542|FG001|Overall Study|Withdrawal by Subject|2|||
124505774|NCT02237157|447803543|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
124563247|NCT01325207|448018380|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
124505775|NCT02237157|447803544|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
124563248|NCT01325207|448018381|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
124505776|NCT02237157|447803545|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
124505777|NCT02237157|447803546|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
124505778|NCT02237157|447803543|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
124505779|NCT02237157|447803544|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
124505780|NCT02237157|447803545|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
124505781|NCT02237157|447803546|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
124505782|NCT01996748|447803548|FG000|Overall Study|Personal reason|1|||
124505783|NCT01996748|447803549|FG001|Overall Study|Personal reason|0|||
124505784|NCT01996748|447803548|FG000|Overall Study|Physician Decision|2|||
124505785|NCT01996748|447803549|FG001|Overall Study|Physician Decision|0|||
124505786|NCT01996748|447803548|FG000|Overall Study|Adverse Event|1|||
124505787|NCT01996748|447803549|FG001|Overall Study|Adverse Event|4|||
124505788|NCT01996748|447803548|FG000|Overall Study|Withdrawal by Subject|0|||
124505789|NCT01996748|447803549|FG001|Overall Study|Withdrawal by Subject|1|||
124505790|NCT01996748|447803548|FG000|Overall Study|Lost to Follow-up|4|||
124505791|NCT01996748|447803549|FG001|Overall Study|Lost to Follow-up|1|||
124563249|NCT01325207|448018376|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
124563250|NCT01325207|448018377|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
124563251|NCT01325207|448018378|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
124563252|NCT01325207|448018379|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
124563253|NCT01325207|448018380|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
124563254|NCT01325207|448018381|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
124563255|NCT01325207|448018376|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
124563256|NCT01325207|448018377|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
124563257|NCT01325207|448018378|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
124563258|NCT01325207|448018379|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
124563259|NCT01325207|448018380|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
124563260|NCT01325207|448018381|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
124563261|NCT01325207|448018376|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
124563262|NCT01325207|448018377|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
124563263|NCT01325207|448018378|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
124563264|NCT01325207|448018379|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
124563265|NCT01325207|448018380|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
124563266|NCT01325207|448018381|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
124563267|NCT01325207|448018376|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
124563268|NCT01325207|448018377|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
124563269|NCT01325207|448018378|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
124563270|NCT01325207|448018379|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
124563271|NCT01325207|448018380|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
124563272|NCT01325207|448018381|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
124563273|NCT00602030|448018382|FG000|Lead-in Phase|Disease Progression|2|||
124563274|NCT00602030|448018383|FG001|Lead-in Phase|Disease Progression|3|||
124563275|NCT00602030|448018384|FG002|Lead-in Phase|Disease Progression|0|||
124563276|NCT00602030|448018385|FG003|Lead-in Phase|Disease Progression|0|||
124563277|NCT00602030|448018386|FG004|Lead-in Phase|Disease Progression|0|||
124563278|NCT00602030|448018382|FG000|Lead-in Phase|Adverse Event|0|||
124563279|NCT00602030|448018383|FG001|Lead-in Phase|Adverse Event|2|||
124563280|NCT00602030|448018384|FG002|Lead-in Phase|Adverse Event|0|||
124563281|NCT00602030|448018385|FG003|Lead-in Phase|Adverse Event|0|||
124563282|NCT00602030|448018386|FG004|Lead-in Phase|Adverse Event|0|||
124563283|NCT00602030|448018382|FG000|Double-blind Phase|Disease progression|0|||
124563284|NCT00602030|448018383|FG001|Double-blind Phase|Disease progression|0|||
124563285|NCT00602030|448018384|FG002|Double-blind Phase|Disease progression|33|||
124563286|NCT00602030|448018385|FG003|Double-blind Phase|Disease progression|30|||
124563287|NCT00602030|448018386|FG004|Double-blind Phase|Disease progression|0|||
124563288|NCT00602030|448018382|FG000|Double-blind Phase|Adverse Event|0|||
124563289|NCT00602030|448018383|FG001|Double-blind Phase|Adverse Event|0|||
124563290|NCT00602030|448018384|FG002|Double-blind Phase|Adverse Event|9|||
124563291|NCT00602030|448018385|FG003|Double-blind Phase|Adverse Event|18|||
124563292|NCT00602030|448018386|FG004|Double-blind Phase|Adverse Event|0|||
124563293|NCT00602030|448018382|FG000|Double-blind Phase|Consent withdrawal|0|||
124563294|NCT00602030|448018383|FG001|Double-blind Phase|Consent withdrawal|0|||
124563295|NCT00602030|448018384|FG002|Double-blind Phase|Consent withdrawal|4|||
124563296|NCT00602030|448018385|FG003|Double-blind Phase|Consent withdrawal|3|||
124563297|NCT00602030|448018386|FG004|Double-blind Phase|Consent withdrawal|0|||
124563298|NCT00602030|448018382|FG000|Double-blind Phase|Death|0|||
124563299|NCT00602030|448018383|FG001|Double-blind Phase|Death|0|||
124563300|NCT00602030|448018384|FG002|Double-blind Phase|Death|3|||
124563301|NCT00602030|448018385|FG003|Double-blind Phase|Death|3|||
124563302|NCT00602030|448018386|FG004|Double-blind Phase|Death|0|||
124563303|NCT00602030|448018382|FG000|Double-blind Phase|Administrative decision|0|||
124563304|NCT00602030|448018383|FG001|Double-blind Phase|Administrative decision|0|||
124563305|NCT00602030|448018384|FG002|Double-blind Phase|Administrative decision|0|||
124563306|NCT00602030|448018385|FG003|Double-blind Phase|Administrative decision|2|||
124505792|NCT04533815|447803550|FG000|Overall Study|Adverse Event|2|||
124563307|NCT00602030|448018386|FG004|Double-blind Phase|Administrative decision|0|||
124563308|NCT00602030|448018382|FG000|Double-blind Phase|Ineligibility|0|||
124563309|NCT00602030|448018383|FG001|Double-blind Phase|Ineligibility|0|||
124563310|NCT00602030|448018384|FG002|Double-blind Phase|Ineligibility|0|||
124563311|NCT00602030|448018385|FG003|Double-blind Phase|Ineligibility|1|||
124563312|NCT00602030|448018386|FG004|Double-blind Phase|Ineligibility|0|||
124563313|NCT00602030|448018382|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
124563314|NCT00602030|448018383|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
124563315|NCT00602030|448018384|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
124563316|NCT00602030|448018385|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
124505793|NCT04533815|447803550|FG000|Overall Study|Site withdrew|5|||
124505794|NCT02951988|447803557|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
124505795|NCT02951988|447803558|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
124505796|NCT02951988|447803559|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
124505797|NCT02951988|447803560|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
124505798|NCT02951988|447803557|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
124505799|NCT02951988|447803558|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
124505800|NCT02951988|447803559|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
124505801|NCT02951988|447803560|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
124505802|NCT02951988|447803557|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
124505803|NCT02951988|447803558|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
124505804|NCT02951988|447803559|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
124505805|NCT02951988|447803560|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
124505806|NCT02951988|447803557|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
124505807|NCT02951988|447803558|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
124505808|NCT02951988|447803559|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
124505809|NCT02951988|447803560|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
124505810|NCT02951988|447803557|FG000|Open-Label Treatment Period|Protocol Violation|22|||
124505811|NCT02951988|447803558|FG001|Open-Label Treatment Period|Protocol Violation|0|||
124505812|NCT02951988|447803559|FG002|Open-Label Treatment Period|Protocol Violation|0|||
124505813|NCT02951988|447803560|FG003|Open-Label Treatment Period|Protocol Violation|0|||
124505814|NCT02951988|447803557|FG000|Open-Label Treatment Period|Pregnancy|2|||
124505815|NCT02951988|447803558|FG001|Open-Label Treatment Period|Pregnancy|0|||
124505816|NCT02951988|447803559|FG002|Open-Label Treatment Period|Pregnancy|0|||
124505817|NCT02951988|447803560|FG003|Open-Label Treatment Period|Pregnancy|0|||
124505818|NCT02951988|447803557|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
124505819|NCT02951988|447803558|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
124505820|NCT02951988|447803559|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
124505821|NCT02951988|447803560|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
124505822|NCT02951988|447803557|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
124505823|NCT02951988|447803558|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
124505824|NCT02951988|447803559|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
124505825|NCT02951988|447803560|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
124505826|NCT02951988|447803557|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
124505827|NCT02951988|447803558|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
124505828|NCT02951988|447803559|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
124505829|NCT02951988|447803560|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
124505830|NCT02951988|447803557|FG000|Open-Label Treatment Period|Adverse Event|45|||
124505831|NCT02951988|447803558|FG001|Open-Label Treatment Period|Adverse Event|0|||
124505832|NCT02951988|447803559|FG002|Open-Label Treatment Period|Adverse Event|0|||
124505833|NCT02951988|447803560|FG003|Open-Label Treatment Period|Adverse Event|0|||
124505834|NCT02951988|447803557|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
124505835|NCT02951988|447803558|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
124505836|NCT02951988|447803559|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
124505837|NCT02951988|447803560|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
124505838|NCT02951988|447803557|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
124505839|NCT02951988|447803558|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
124505840|NCT02951988|447803559|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
124505841|NCT02951988|447803560|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
124505842|NCT02951988|447803557|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
124505843|NCT02951988|447803558|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
124505844|NCT02951988|447803559|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
124505845|NCT02951988|447803560|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
124505846|NCT02951988|447803557|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
124505847|NCT02951988|447803558|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
124505848|NCT02951988|447803559|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
124505849|NCT02951988|447803560|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
124563317|NCT00602030|448018386|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
124505850|NCT02951988|447803557|FG000|Double-Blind Treatment Period|Pregnancy|0|||
124563318|NCT00602030|448018382|FG000|Double-blind Phase|Reason not specified|0|||
124563319|NCT00602030|448018383|FG001|Double-blind Phase|Reason not specified|0|||
124563320|NCT00602030|448018384|FG002|Double-blind Phase|Reason not specified|4|||
124563321|NCT00602030|448018385|FG003|Double-blind Phase|Reason not specified|2|||
124563322|NCT00602030|448018386|FG004|Double-blind Phase|Reason not specified|0|||
124563323|NCT00602030|448018382|FG000|Crossover Phase|Disease Progression|0|||
124563324|NCT00602030|448018383|FG001|Crossover Phase|Disease Progression|0|||
124563325|NCT00602030|448018384|FG002|Crossover Phase|Disease Progression|0|||
124563326|NCT00602030|448018385|FG003|Crossover Phase|Disease Progression|0|||
124563327|NCT00602030|448018386|FG004|Crossover Phase|Disease Progression|11|||
124563328|NCT00602030|448018382|FG000|Crossover Phase|Adverse Event|0|||
124563329|NCT00602030|448018383|FG001|Crossover Phase|Adverse Event|0|||
124563330|NCT00602030|448018384|FG002|Crossover Phase|Adverse Event|0|||
124563331|NCT00602030|448018385|FG003|Crossover Phase|Adverse Event|0|||
124563332|NCT00602030|448018386|FG004|Crossover Phase|Adverse Event|3|||
124563333|NCT00602030|448018382|FG000|Crossover Phase|Consent withdrawal|0|||
124563334|NCT00602030|448018383|FG001|Crossover Phase|Consent withdrawal|0|||
124563335|NCT00602030|448018384|FG002|Crossover Phase|Consent withdrawal|0|||
124563336|NCT00602030|448018385|FG003|Crossover Phase|Consent withdrawal|0|||
124563337|NCT00602030|448018386|FG004|Crossover Phase|Consent withdrawal|2|||
124563338|NCT00283686|448018387|FG000|Overall Study|Death|1|||
124563339|NCT00283686|448018388|FG001|Overall Study|Death|1|||
124563340|NCT00283686|448018389|FG002|Overall Study|Death|1|||
124563341|NCT00283686|448018390|FG003|Overall Study|Death|0|||
124563342|NCT00283686|448018387|FG000|Overall Study|Lost to Follow-up|21|||
124563343|NCT00283686|448018388|FG001|Overall Study|Lost to Follow-up|31|||
124563344|NCT00283686|448018389|FG002|Overall Study|Lost to Follow-up|26|||
124563345|NCT00283686|448018390|FG003|Overall Study|Lost to Follow-up|20|||
124563346|NCT00283686|448018387|FG000|Overall Study|Less than full participation|7|||
124563347|NCT00283686|448018388|FG001|Overall Study|Less than full participation|9|||
124563348|NCT00283686|448018389|FG002|Overall Study|Less than full participation|6|||
124563349|NCT00283686|448018390|FG003|Overall Study|Less than full participation|12|||
124563350|NCT01076166|448018391|FG000|Overall Study|Adverse Event|3|||
124563351|NCT01076166|448018391|FG000|Overall Study|Symptoms improved/resolved|6|||
124563352|NCT02970669|448018392|FG000|Double-blind Period|Adverse Event|4|||
124563353|NCT02970669|448018393|FG001|Double-blind Period|Adverse Event|0|||
124563354|NCT02970669|448018392|FG000|Double-blind Period|Death|1|||
124563355|NCT02970669|448018393|FG001|Double-blind Period|Death|0|||
124563356|NCT02970669|448018392|FG000|Double-blind Period|Study terminated by sponsor|1|||
124563357|NCT02970669|448018393|FG001|Double-blind Period|Study terminated by sponsor|2|||
124563358|NCT02970669|448018392|FG000|Double-blind Period|Physician Decision|0|||
124563359|NCT02970669|448018393|FG001|Double-blind Period|Physician Decision|2|||
124563360|NCT02970669|448018392|FG000|Double-blind Period|Withdrawal by Subject|2|||
124563361|NCT02970669|448018393|FG001|Double-blind Period|Withdrawal by Subject|2|||
124563362|NCT02970669|448018392|FG000|Open-label Period|Withdrawal by Subject|2|||
124563363|NCT02970669|448018393|FG001|Open-label Period|Withdrawal by Subject|2|||
124563364|NCT02970669|448018392|FG000|Open-label Period|Adverse Event|1|||
124563365|NCT02970669|448018393|FG001|Open-label Period|Adverse Event|0|||
124563366|NCT02970669|448018392|FG000|Open-label Period|Physician Decision|1|||
124563367|NCT02970669|448018393|FG001|Open-label Period|Physician Decision|0|||
124563368|NCT00876733|448018396|FG000|Overall Study|Adverse Event|34|||
124563369|NCT00876733|448018397|FG001|Overall Study|Adverse Event|20|||
124563370|NCT00876733|448018398|FG002|Overall Study|Adverse Event|10|||
124563371|NCT00876733|448018399|FG003|Overall Study|Adverse Event|3|||
124505851|NCT02951988|447803558|FG001|Double-Blind Treatment Period|Pregnancy|1|||
124505852|NCT02951988|447803559|FG002|Double-Blind Treatment Period|Pregnancy|1|||
124505853|NCT02951988|447803560|FG003|Double-Blind Treatment Period|Pregnancy|0|||
124505854|NCT02951988|447803557|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124505855|NCT02951988|447803558|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
124505856|NCT02951988|447803559|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
124505857|NCT02951988|447803560|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
124505858|NCT02951988|447803557|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124505859|NCT02951988|447803558|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
124505860|NCT02951988|447803559|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
124505861|NCT02951988|447803560|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
124505862|NCT02951988|447803557|FG000|Double-Blind Treatment Period|Adverse Event|0|||
124505863|NCT02951988|447803558|FG001|Double-Blind Treatment Period|Adverse Event|8|||
124563372|NCT00876733|448018396|FG000|Overall Study|Lack of Efficacy|17|||
124563373|NCT00876733|448018397|FG001|Overall Study|Lack of Efficacy|9|||
124563374|NCT00876733|448018398|FG002|Overall Study|Lack of Efficacy|10|||
124563375|NCT00876733|448018399|FG003|Overall Study|Lack of Efficacy|1|||
124505864|NCT02951988|447803559|FG002|Double-Blind Treatment Period|Adverse Event|3|||
124563376|NCT00876733|448018396|FG000|Overall Study|Lost to Follow-up|26|||
124563377|NCT00876733|448018397|FG001|Overall Study|Lost to Follow-up|10|||
124563378|NCT00876733|448018398|FG002|Overall Study|Lost to Follow-up|3|||
124563379|NCT00876733|448018399|FG003|Overall Study|Lost to Follow-up|2|||
124505865|NCT02951988|447803560|FG003|Double-Blind Treatment Period|Adverse Event|6|||
124505866|NCT02951988|447803557|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
124505867|NCT02951988|447803558|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
124505868|NCT02951988|447803559|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
124505869|NCT02951988|447803560|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
124505870|NCT05836818|447803561|FG000|Overall Study|Physician Decision|1|||
124505871|NCT05836818|447803562|FG001|Overall Study|Physician Decision|1|||
124505872|NCT05836818|447803563|FG002|Overall Study|Physician Decision|0|||
124505873|NCT05836818|447803561|FG000|Overall Study|Withdrawal by Subject|0|||
124505874|NCT05836818|447803562|FG001|Overall Study|Withdrawal by Subject|0|||
124505875|NCT05836818|447803563|FG002|Overall Study|Withdrawal by Subject|1|||
124505876|NCT05836818|447803561|FG000|Overall Study|Later found to be previously vaccinated|0|||
124505877|NCT05836818|447803562|FG001|Overall Study|Later found to be previously vaccinated|1|||
124505878|NCT05836818|447803563|FG002|Overall Study|Later found to be previously vaccinated|3|||
124505879|NCT05836818|447803561|FG000|Overall Study|Pregnancy|0|||
124505880|NCT05836818|447803562|FG001|Overall Study|Pregnancy|1|||
124505881|NCT05836818|447803563|FG002|Overall Study|Pregnancy|0|||
124505882|NCT05836818|447803561|FG000|Overall Study|Allergic to vaccines|0|||
124505883|NCT05836818|447803562|FG001|Overall Study|Allergic to vaccines|1|||
124505884|NCT05836818|447803563|FG002|Overall Study|Allergic to vaccines|0|||
124505885|NCT03011840|447803564|FG000|Overall Study|Not received PIL in post PIL phase|0|||
124505886|NCT03011840|447803565|FG001|Overall Study|Not received PIL in post PIL phase|21|||
124505887|NCT03738566|447803566|FG000|Initial Study Phase|Withdrawal by Subject|1|||
124505888|NCT03738566|447803567|FG001|Initial Study Phase|Withdrawal by Subject|1|||
124505889|NCT03738566|447803568|FG002|Initial Study Phase|Withdrawal by Subject|2|||
124505890|NCT03738566|447803569|FG003|Initial Study Phase|Withdrawal by Subject|0|||
124505891|NCT03738566|447803566|FG000|Initial Study Phase|Death|0|||
124505892|NCT03738566|447803567|FG001|Initial Study Phase|Death|1|||
124505893|NCT03738566|447803568|FG002|Initial Study Phase|Death|0|||
124505894|NCT03738566|447803569|FG003|Initial Study Phase|Death|0|||
124505895|NCT03738566|447803566|FG000|Initial Study Phase|Treatment failure|5|||
124505896|NCT03738566|447803567|FG001|Initial Study Phase|Treatment failure|0|||
124505897|NCT03738566|447803568|FG002|Initial Study Phase|Treatment failure|0|||
124505898|NCT03738566|447803569|FG003|Initial Study Phase|Treatment failure|0|||
124505899|NCT03738566|447803566|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
124505900|NCT03738566|447803567|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
124505901|NCT03738566|447803568|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
124505902|NCT03738566|447803569|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
124505903|NCT04799405|447803576|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
124505904|NCT00586924|447803577|FG000|Overall Study|Adverse event/serious adverse event|0|||
124505905|NCT00586924|447803578|FG001|Overall Study|Adverse event/serious adverse event|0|||
124505906|NCT00586924|447803579|FG002|Overall Study|Adverse event/serious adverse event|0|||
124505907|NCT00586924|447803580|FG003|Overall Study|Adverse event/serious adverse event|1|||
124505908|NCT00586924|447803581|FG004|Overall Study|Adverse event/serious adverse event|0|||
124505909|NCT00586924|447803582|FG005|Overall Study|Adverse event/serious adverse event|2|||
124505910|NCT00586924|447803577|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
124505911|NCT00586924|447803578|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
124505912|NCT00586924|447803579|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
124505913|NCT00586924|447803580|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
124505914|NCT00586924|447803581|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
124505915|NCT00586924|447803582|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
124505916|NCT00586924|447803577|FG000|Overall Study|Disease progression|0|||
124505917|NCT00586924|447803578|FG001|Overall Study|Disease progression|0|||
124505918|NCT00586924|447803579|FG002|Overall Study|Disease progression|0|||
124505919|NCT00586924|447803580|FG003|Overall Study|Disease progression|1|||
124505920|NCT00586924|447803581|FG004|Overall Study|Disease progression|1|||
124505921|NCT00586924|447803582|FG005|Overall Study|Disease progression|0|||
124505922|NCT00586924|447803577|FG000|Overall Study|Development of neutralizing antibodies|2|||
124505923|NCT00586924|447803578|FG001|Overall Study|Development of neutralizing antibodies|2|||
124505924|NCT00586924|447803579|FG002|Overall Study|Development of neutralizing antibodies|2|||
124505925|NCT00586924|447803580|FG003|Overall Study|Development of neutralizing antibodies|0|||
124505926|NCT00586924|447803581|FG004|Overall Study|Development of neutralizing antibodies|0|||
124505927|NCT00586924|447803582|FG005|Overall Study|Development of neutralizing antibodies|22|||
124505928|NCT00586924|447803577|FG000|Overall Study|Complete response|0|||
124505929|NCT00586924|447803578|FG001|Overall Study|Complete response|1|||
124505930|NCT00586924|447803579|FG002|Overall Study|Complete response|0|||
124505931|NCT00586924|447803580|FG003|Overall Study|Complete response|0|||
124505932|NCT00586924|447803581|FG004|Overall Study|Complete response|2|||
124505933|NCT00586924|447803582|FG005|Overall Study|Complete response|2|||
124505934|NCT00586924|447803577|FG000|Overall Study|Other|1|||
124505935|NCT00586924|447803578|FG001|Overall Study|Other|0|||
124505936|NCT00586924|447803579|FG002|Overall Study|Other|1|||
124505937|NCT00586924|447803580|FG003|Overall Study|Other|1|||
124505938|NCT00586924|447803581|FG004|Overall Study|Other|1|||
124505939|NCT00586924|447803582|FG005|Overall Study|Other|6|||
124505940|NCT00621855|447803590|FG000|Overall Study|Adverse Event|32|||
124505941|NCT00621855|447803591|FG001|Overall Study|Adverse Event|31|||
124505942|NCT00621855|447803592|FG002|Overall Study|Adverse Event|48|||
124505943|NCT00621855|447803593|FG003|Overall Study|Adverse Event|34|||
124505944|NCT00621855|447803594|FG004|Overall Study|Adverse Event|31|||
124505945|NCT00621855|447803590|FG000|Overall Study|Lost to Follow-up|0|||
124505946|NCT00621855|447803591|FG001|Overall Study|Lost to Follow-up|1|||
124505947|NCT00621855|447803592|FG002|Overall Study|Lost to Follow-up|3|||
124505948|NCT00621855|447803593|FG003|Overall Study|Lost to Follow-up|4|||
124505949|NCT00621855|447803594|FG004|Overall Study|Lost to Follow-up|1|||
124505950|NCT00621855|447803590|FG000|Overall Study|Protocol Violation|16|||
124505951|NCT00621855|447803591|FG001|Overall Study|Protocol Violation|8|||
124505952|NCT00621855|447803592|FG002|Overall Study|Protocol Violation|6|||
124505953|NCT00621855|447803593|FG003|Overall Study|Protocol Violation|7|||
124505954|NCT00621855|447803594|FG004|Overall Study|Protocol Violation|8|||
124505955|NCT00621855|447803590|FG000|Overall Study|Withdrawal by Subject|16|||
124505956|NCT00621855|447803591|FG001|Overall Study|Withdrawal by Subject|11|||
124505957|NCT00621855|447803592|FG002|Overall Study|Withdrawal by Subject|13|||
124505958|NCT00621855|447803593|FG003|Overall Study|Withdrawal by Subject|13|||
124505959|NCT00621855|447803594|FG004|Overall Study|Withdrawal by Subject|9|||
124505960|NCT00621855|447803590|FG000|Overall Study|Other|9|||
124505961|NCT00621855|447803591|FG001|Overall Study|Other|7|||
124505962|NCT00621855|447803592|FG002|Overall Study|Other|6|||
124505963|NCT00621855|447803593|FG003|Overall Study|Other|5|||
124505964|NCT00621855|447803594|FG004|Overall Study|Other|4|||
124505965|NCT00621855|447803590|FG000|Overall Study|Patients did not receive study drug|3|||
124505966|NCT00621855|447803591|FG001|Overall Study|Patients did not receive study drug|3|||
124505967|NCT00621855|447803592|FG002|Overall Study|Patients did not receive study drug|5|||
124505968|NCT00621855|447803593|FG003|Overall Study|Patients did not receive study drug|4|||
124505969|NCT00621855|447803594|FG004|Overall Study|Patients did not receive study drug|2|||
124505970|NCT03731364|447803595|FG000|Overall Study|Adverse Event|0|||
124505971|NCT03731364|447803596|FG001|Overall Study|Adverse Event|0|||
124505972|NCT03731364|447803597|FG002|Overall Study|Adverse Event|1|||
124505973|NCT03731364|447803598|FG003|Overall Study|Adverse Event|2|||
124505974|NCT03731364|447803599|FG004|Overall Study|Adverse Event|1|||
124505975|NCT02953782|447803600|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
124505976|NCT02953782|447803601|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
124505977|NCT02953782|447803602|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
124505978|NCT02953782|447803603|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
124505979|NCT02953782|447803604|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
124505980|NCT02953782|447803605|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
124505981|NCT02953782|447803606|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
124505982|NCT02953782|447803607|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
124505983|NCT02953782|447803600|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
124505984|NCT02953782|447803601|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
124505985|NCT02953782|447803602|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
124505986|NCT02953782|447803603|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
124505987|NCT02953782|447803604|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
124505988|NCT02953782|447803605|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
124505989|NCT02953782|447803606|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
124505990|NCT02953782|447803607|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
124505991|NCT02953782|447803600|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
124505992|NCT02953782|447803601|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
124505993|NCT02953782|447803602|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
124505994|NCT02953782|447803603|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
124505995|NCT02953782|447803604|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
124505996|NCT02953782|447803605|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
124505997|NCT02953782|447803606|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
124505998|NCT02953782|447803607|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
124505999|NCT02953782|447803600|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
124506000|NCT02953782|447803601|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
124506001|NCT02953782|447803602|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
124506002|NCT02953782|447803603|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
124506003|NCT02953782|447803604|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
124506004|NCT02953782|447803605|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
124506005|NCT02953782|447803606|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
124506006|NCT02953782|447803607|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
124506007|NCT02953782|447803600|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
124563380|NCT00876733|448018396|FG000|Overall Study|Data not available|14|||
124506008|NCT02953782|447803601|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
124506009|NCT02953782|447803602|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
124506010|NCT02953782|447803603|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
124506011|NCT02953782|447803604|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
124506012|NCT02953782|447803605|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
124506013|NCT02953782|447803606|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
124506014|NCT02953782|447803607|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
124506015|NCT02953782|447803600|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
124506016|NCT02953782|447803601|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
124506017|NCT02953782|447803602|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
124506018|NCT02953782|447803603|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
124506019|NCT02953782|447803604|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
124506020|NCT02953782|447803605|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
124506021|NCT02953782|447803606|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
124563381|NCT00876733|448018397|FG001|Overall Study|Data not available|3|||
124563382|NCT00876733|448018398|FG002|Overall Study|Data not available|7|||
124563383|NCT00876733|448018399|FG003|Overall Study|Data not available|1|||
124563384|NCT05476679|448018400|FG000|Overall Study|Withdrawal by Subject|0|||
124563385|NCT05476679|448018401|FG001|Overall Study|Withdrawal by Subject|0|||
124563386|NCT05476679|448018402|FG002|Overall Study|Withdrawal by Subject|0|||
124563387|NCT05476679|448018403|FG003|Overall Study|Withdrawal by Subject|1|||
124563388|NCT05476679|448018404|FG004|Overall Study|Withdrawal by Subject|0|||
124563389|NCT05476679|448018400|FG000|Overall Study|Lost to Follow-up|0|||
124563390|NCT05476679|448018401|FG001|Overall Study|Lost to Follow-up|0|||
124563391|NCT05476679|448018402|FG002|Overall Study|Lost to Follow-up|0|||
124563392|NCT05476679|448018403|FG003|Overall Study|Lost to Follow-up|1|||
124563393|NCT05476679|448018404|FG004|Overall Study|Lost to Follow-up|0|||
124563394|NCT00467584|448018409|FG000|Overall Study|Withdrawal by Subject|4|||
124563395|NCT00467584|448018410|FG001|Overall Study|Withdrawal by Subject|5|||
124563396|NCT00467584|448018411|FG002|Overall Study|Withdrawal by Subject|1|||
124563397|NCT00319956|448018412|FG000|Overall Study|Death|20|||
124563398|NCT00319956|448018413|FG001|Overall Study|Death|24|||
124563399|NCT02607800|448018415|FG000|Overall Study|Lost to Follow-up|7|||
124563400|NCT02607800|448018416|FG001|Overall Study|Lost to Follow-up|10|||
124563401|NCT02607800|448018415|FG000|Overall Study|Withdrew Consent|2|||
124563402|NCT02607800|448018416|FG001|Overall Study|Withdrew Consent|0|||
124563403|NCT02607800|448018415|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
124563404|NCT02607800|448018416|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
124563405|NCT00753714|448018417|FG000|Overall Study|Lack of Efficacy|21|||
124563406|NCT00753714|448018418|FG001|Overall Study|Lack of Efficacy|34|||
124563407|NCT00753714|448018417|FG000|Overall Study|Adverse Event|26|||
124563408|NCT00753714|448018418|FG001|Overall Study|Adverse Event|18|||
124563409|NCT00753714|448018417|FG000|Overall Study|Protocol Violation|1|||
124563410|NCT00753714|448018418|FG001|Overall Study|Protocol Violation|0|||
124563411|NCT00753714|448018417|FG000|Overall Study|Lost to Follow-up|0|||
124563412|NCT00753714|448018418|FG001|Overall Study|Lost to Follow-up|1|||
124563413|NCT00753714|448018417|FG000|Overall Study|Withdrawal by Subject|2|||
124563414|NCT00753714|448018418|FG001|Overall Study|Withdrawal by Subject|1|||
124563415|NCT00753714|448018417|FG000|Overall Study|Death|3|||
124563416|NCT00753714|448018418|FG001|Overall Study|Death|3|||
124563417|NCT00753714|448018417|FG000|Overall Study|Other|7|||
124563418|NCT00753714|448018418|FG001|Overall Study|Other|5|||
124563419|NCT02486796|448018419|FG000|Overall Study|Withdrawal by Subject|1|||
124563420|NCT02486796|448018420|FG001|Overall Study|Withdrawal by Subject|1|||
124563421|NCT02486796|448018419|FG000|Overall Study|Physician Decision|1|||
124563422|NCT02486796|448018420|FG001|Overall Study|Physician Decision|0|||
124563423|NCT02789111|448018423|FG000|Overall Study|Withdrawal by Subject|1|||
124563424|NCT02789111|448018424|FG001|Overall Study|Withdrawal by Subject|4|||
124563425|NCT01626885|448018427|FG000|Overall Study|Adverse Event|8|||
124563426|NCT01626885|448018427|FG000|Overall Study|Withdrawal by Subject|4|||
124563427|NCT00673790|448018428|FG000|Overall Study|Adverse Event|23|||
124563428|NCT00673790|448018429|FG001|Overall Study|Adverse Event|14|||
124563429|NCT00673790|448018430|FG002|Overall Study|Adverse Event|2|||
124563430|NCT00673790|448018428|FG000|Overall Study|Lack of Efficacy|2|||
124563431|NCT00673790|448018429|FG001|Overall Study|Lack of Efficacy|2|||
124563432|NCT00673790|448018430|FG002|Overall Study|Lack of Efficacy|2|||
124563433|NCT00673790|448018428|FG000|Overall Study|Protocol Violation|6|||
124563434|NCT00673790|448018429|FG001|Overall Study|Protocol Violation|9|||
124563435|NCT00673790|448018430|FG002|Overall Study|Protocol Violation|1|||
124563436|NCT00673790|448018428|FG000|Overall Study|Withdrawal by Subject|7|||
124563437|NCT00673790|448018429|FG001|Overall Study|Withdrawal by Subject|4|||
124563438|NCT00673790|448018430|FG002|Overall Study|Withdrawal by Subject|1|||
124563439|NCT00673790|448018428|FG000|Overall Study|Lost to Follow-up|6|||
124563440|NCT00673790|448018429|FG001|Overall Study|Lost to Follow-up|6|||
124563441|NCT00673790|448018430|FG002|Overall Study|Lost to Follow-up|5|||
124563442|NCT00673790|448018428|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
124506022|NCT02953782|447803607|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
124506023|NCT02953782|447803600|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
124506024|NCT02953782|447803601|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
124506025|NCT02953782|447803602|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
124506026|NCT02953782|447803603|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
124506027|NCT02953782|447803604|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
124506028|NCT02953782|447803605|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
124506029|NCT02953782|447803606|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
124506030|NCT02953782|447803607|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
124506031|NCT02953782|447803600|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
124506032|NCT02953782|447803601|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
124506033|NCT02953782|447803602|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
124506034|NCT02953782|447803603|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
124506035|NCT02953782|447803604|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
124506036|NCT02953782|447803605|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
124506037|NCT02953782|447803606|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
124506038|NCT02953782|447803607|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
124506039|NCT03260205|447803611|FG000|Overall Study|Adverse Event|2|||
124506040|NCT03260205|447803612|FG001|Overall Study|Adverse Event|0|||
124506041|NCT03260205|447803613|FG002|Overall Study|Adverse Event|2|||
124506042|NCT03260205|447803614|FG003|Overall Study|Adverse Event|2|||
124506043|NCT03260205|447803615|FG004|Overall Study|Adverse Event|4|||
124506044|NCT03260205|447803611|FG000|Overall Study|Lost to Follow-up|2|||
124506045|NCT03260205|447803612|FG001|Overall Study|Lost to Follow-up|2|||
124506046|NCT03260205|447803613|FG002|Overall Study|Lost to Follow-up|1|||
124506047|NCT03260205|447803614|FG003|Overall Study|Lost to Follow-up|1|||
124506048|NCT03260205|447803615|FG004|Overall Study|Lost to Follow-up|5|||
124506049|NCT03260205|447803611|FG000|Overall Study|Protocol Violation|0|||
124506050|NCT03260205|447803612|FG001|Overall Study|Protocol Violation|0|||
124506051|NCT03260205|447803613|FG002|Overall Study|Protocol Violation|2|||
124506052|NCT03260205|447803614|FG003|Overall Study|Protocol Violation|0|||
124506053|NCT03260205|447803615|FG004|Overall Study|Protocol Violation|1|||
124506054|NCT03260205|447803611|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
124506055|NCT03260205|447803612|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
124506056|NCT03260205|447803613|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
124506057|NCT03260205|447803614|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
124506058|NCT03260205|447803615|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
124506059|NCT03260205|447803611|FG000|Overall Study|Other: Unspecified|0|||
124506060|NCT03260205|447803612|FG001|Overall Study|Other: Unspecified|0|||
124506061|NCT03260205|447803613|FG002|Overall Study|Other: Unspecified|3|||
124506062|NCT03260205|447803614|FG003|Overall Study|Other: Unspecified|1|||
124506063|NCT03260205|447803615|FG004|Overall Study|Other: Unspecified|1|||
124506064|NCT03260205|447803611|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
124506065|NCT03260205|447803612|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
124506066|NCT03260205|447803613|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
124506067|NCT03260205|447803614|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
124563443|NCT00673790|448018429|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
124563444|NCT00673790|448018430|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
124563445|NCT00673790|448018428|FG000|Overall Study|Poor compliance|1|||
124563446|NCT00673790|448018429|FG001|Overall Study|Poor compliance|0|||
124563447|NCT00673790|448018430|FG002|Overall Study|Poor compliance|0|||
124563448|NCT00673790|448018428|FG000|Overall Study|Participated in two Nebivolol studies|0|||
124563449|NCT00673790|448018429|FG001|Overall Study|Participated in two Nebivolol studies|0|||
124563450|NCT00673790|448018430|FG002|Overall Study|Participated in two Nebivolol studies|1|||
124563451|NCT00673790|448018428|FG000|Overall Study|Unconfirmed pregnancy|0|||
124563452|NCT00673790|448018429|FG001|Overall Study|Unconfirmed pregnancy|1|||
124563453|NCT00673790|448018430|FG002|Overall Study|Unconfirmed pregnancy|0|||
124563454|NCT00673790|448018428|FG000|Overall Study|Randomization criteria not met|0|||
124563455|NCT00673790|448018429|FG001|Overall Study|Randomization criteria not met|1|||
124563456|NCT00673790|448018430|FG002|Overall Study|Randomization criteria not met|0|||
124563457|NCT01533428|448018433|FG000|Overall Study|Adverse Event|0|||
124563458|NCT01533428|448018434|FG001|Overall Study|Adverse Event|1|||
124563459|NCT01533428|448018433|FG000|Overall Study|Lost to Follow-up|2|||
124563460|NCT01533428|448018434|FG001|Overall Study|Lost to Follow-up|1|||
124563461|NCT01533428|448018433|FG000|Overall Study|Withdrawal by Subject|7|||
124563462|NCT01533428|448018434|FG001|Overall Study|Withdrawal by Subject|6|||
124563463|NCT01364870|448018437|FG000|Overall Study|Withdrawal by Subject|13|||
124563464|NCT01364870|448018438|FG001|Overall Study|Withdrawal by Subject|24|||
124563465|NCT01364870|448018439|FG002|Overall Study|Withdrawal by Subject|10|||
124563466|NCT01364870|448018437|FG000|Overall Study|Adverse Event|8|||
124506068|NCT03260205|447803615|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
124506069|NCT05301322|447803616|FG000|Overall Study|Adverse Event|7|||
124506070|NCT05301322|447803617|FG001|Overall Study|Adverse Event|3|||
124506071|NCT05301322|447803616|FG000|Overall Study|Death|0|||
124506072|NCT05301322|447803617|FG001|Overall Study|Death|1|||
124506073|NCT05301322|447803616|FG000|Overall Study|Lost to Follow-up|2|||
124506074|NCT05301322|447803617|FG001|Overall Study|Lost to Follow-up|1|||
124506075|NCT05301322|447803616|FG000|Overall Study|Protocol Violation|3|||
124506076|NCT05301322|447803617|FG001|Overall Study|Protocol Violation|1|||
124506077|NCT05301322|447803616|FG000|Overall Study|Withdrawal by Subject|3|||
124506078|NCT05301322|447803617|FG001|Overall Study|Withdrawal by Subject|0|||
124506079|NCT05301322|447803616|FG000|Overall Study|Other|4|||
124506080|NCT05301322|447803617|FG001|Overall Study|Other|0|||
124506081|NCT00430521|447803621|FG000|Overall Study|Adverse Event|0|||
124506082|NCT00430521|447803622|FG001|Overall Study|Adverse Event|0|||
124506083|NCT00430521|447803623|FG002|Overall Study|Adverse Event|0|||
124506084|NCT00430521|447803624|FG003|Overall Study|Adverse Event|0|||
124506085|NCT00430521|447803625|FG004|Overall Study|Adverse Event|0|||
124506086|NCT00430521|447803626|FG005|Overall Study|Adverse Event|2|||
124506087|NCT00430521|447803627|FG006|Overall Study|Adverse Event|1|||
124506088|NCT00430521|447803628|FG007|Overall Study|Adverse Event|0|||
124506089|NCT00430521|447803621|FG000|Overall Study|Lost to Follow-up|7|||
124506090|NCT00430521|447803622|FG001|Overall Study|Lost to Follow-up|8|||
124506091|NCT00430521|447803623|FG002|Overall Study|Lost to Follow-up|3|||
124506092|NCT00430521|447803624|FG003|Overall Study|Lost to Follow-up|5|||
124506093|NCT00430521|447803625|FG004|Overall Study|Lost to Follow-up|5|||
124506094|NCT00430521|447803626|FG005|Overall Study|Lost to Follow-up|2|||
124506095|NCT00430521|447803627|FG006|Overall Study|Lost to Follow-up|8|||
124506096|NCT00430521|447803628|FG007|Overall Study|Lost to Follow-up|10|||
124506097|NCT00430521|447803621|FG000|Overall Study|Pregnancy|0|||
124506098|NCT00430521|447803622|FG001|Overall Study|Pregnancy|0|||
124506099|NCT00430521|447803623|FG002|Overall Study|Pregnancy|0|||
124506100|NCT00430521|447803624|FG003|Overall Study|Pregnancy|0|||
124506101|NCT00430521|447803625|FG004|Overall Study|Pregnancy|0|||
124506102|NCT00430521|447803626|FG005|Overall Study|Pregnancy|0|||
124506103|NCT00430521|447803627|FG006|Overall Study|Pregnancy|1|||
124506104|NCT00430521|447803628|FG007|Overall Study|Pregnancy|0|||
124506105|NCT00430521|447803621|FG000|Overall Study|Vaccine Expired|0|||
124506106|NCT00430521|447803622|FG001|Overall Study|Vaccine Expired|0|||
124506107|NCT00430521|447803623|FG002|Overall Study|Vaccine Expired|0|||
124506108|NCT00430521|447803624|FG003|Overall Study|Vaccine Expired|0|||
124506109|NCT00430521|447803625|FG004|Overall Study|Vaccine Expired|0|||
124506110|NCT00430521|447803626|FG005|Overall Study|Vaccine Expired|1|||
124506111|NCT00430521|447803627|FG006|Overall Study|Vaccine Expired|0|||
124506112|NCT00430521|447803628|FG007|Overall Study|Vaccine Expired|0|||
124506113|NCT00430521|447803621|FG000|Overall Study|Protocol Violation|1|||
124506114|NCT00430521|447803622|FG001|Overall Study|Protocol Violation|0|||
124506115|NCT00430521|447803623|FG002|Overall Study|Protocol Violation|0|||
124506116|NCT00430521|447803624|FG003|Overall Study|Protocol Violation|0|||
124506117|NCT00430521|447803625|FG004|Overall Study|Protocol Violation|0|||
124506118|NCT00430521|447803626|FG005|Overall Study|Protocol Violation|0|||
124506119|NCT00430521|447803627|FG006|Overall Study|Protocol Violation|0|||
124506120|NCT00430521|447803628|FG007|Overall Study|Protocol Violation|0|||
124506121|NCT00430521|447803621|FG000|Overall Study|Withdrawal by Subject|3|||
124506122|NCT00430521|447803622|FG001|Overall Study|Withdrawal by Subject|1|||
124506123|NCT00430521|447803623|FG002|Overall Study|Withdrawal by Subject|0|||
124506124|NCT00430521|447803624|FG003|Overall Study|Withdrawal by Subject|3|||
124506125|NCT00430521|447803625|FG004|Overall Study|Withdrawal by Subject|0|||
124506126|NCT00430521|447803626|FG005|Overall Study|Withdrawal by Subject|0|||
124506127|NCT00430521|447803627|FG006|Overall Study|Withdrawal by Subject|0|||
124506128|NCT00430521|447803628|FG007|Overall Study|Withdrawal by Subject|2|||
124506129|NCT05108805|447803631|FG000|Overall Study|T-cell expansion was not successful.|5|||
124506130|NCT02198651|447805712|FG000|Lead-in Period|Withdrew consent|13|||
124506131|NCT02198651|447805713|FG001|Lead-in Period|Withdrew consent|0|||
124506132|NCT02198651|447805714|FG002|Lead-in Period|Withdrew consent|0|||
124506133|NCT02198651|447805715|FG003|Lead-in Period|Withdrew consent|0|||
124506134|NCT02198651|447805716|FG004|Lead-in Period|Withdrew consent|0|||
124506135|NCT02198651|447805712|FG000|Lead-in Period|Adverse Event|2|||
124506136|NCT02198651|447805713|FG001|Lead-in Period|Adverse Event|0|||
124506137|NCT02198651|447805714|FG002|Lead-in Period|Adverse Event|0|||
124506138|NCT02198651|447805715|FG003|Lead-in Period|Adverse Event|0|||
124506139|NCT02198651|447805716|FG004|Lead-in Period|Adverse Event|0|||
124506140|NCT02198651|447805712|FG000|Lead-in Period|Other, not specified|22|||
124506141|NCT02198651|447805713|FG001|Lead-in Period|Other, not specified|0|||
124506142|NCT02198651|447805714|FG002|Lead-in Period|Other, not specified|0|||
124506143|NCT02198651|447805715|FG003|Lead-in Period|Other, not specified|0|||
124506144|NCT02198651|447805716|FG004|Lead-in Period|Other, not specified|0|||
124506145|NCT02198651|447805712|FG000|Double-blind Period|Withdrew consent|0|||
124506146|NCT02198651|447805713|FG001|Double-blind Period|Withdrew consent|4|||
124506147|NCT02198651|447805714|FG002|Double-blind Period|Withdrew consent|0|||
124506148|NCT02198651|447805715|FG003|Double-blind Period|Withdrew consent|0|||
124506149|NCT02198651|447805716|FG004|Double-blind Period|Withdrew consent|0|||
124506150|NCT02198651|447805712|FG000|Double-blind Period|Adverse Event|0|||
124506151|NCT02198651|447805713|FG001|Double-blind Period|Adverse Event|1|||
124506152|NCT02198651|447805714|FG002|Double-blind Period|Adverse Event|0|||
124506153|NCT02198651|447805715|FG003|Double-blind Period|Adverse Event|0|||
124506154|NCT02198651|447805716|FG004|Double-blind Period|Adverse Event|0|||
124506155|NCT02198651|447805712|FG000|Double-blind Period|Other, not specified|0|||
124506156|NCT02198651|447805713|FG001|Double-blind Period|Other, not specified|4|||
124506157|NCT02198651|447805714|FG002|Double-blind Period|Other, not specified|1|||
124506158|NCT02198651|447805715|FG003|Double-blind Period|Other, not specified|0|||
124506159|NCT02198651|447805716|FG004|Double-blind Period|Other, not specified|0|||
124506160|NCT02198651|447805712|FG000|Open-label Rescue Period|Withdrew consent|0|||
124506161|NCT02198651|447805713|FG001|Open-label Rescue Period|Withdrew consent|0|||
124506162|NCT02198651|447805714|FG002|Open-label Rescue Period|Withdrew consent|0|||
124506163|NCT02198651|447805715|FG003|Open-label Rescue Period|Withdrew consent|2|||
124506164|NCT02198651|447805716|FG004|Open-label Rescue Period|Withdrew consent|0|||
124506165|NCT02198651|447805712|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
124506166|NCT02198651|447805713|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
124506167|NCT02198651|447805714|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
124563467|NCT01364870|448018438|FG001|Overall Study|Adverse Event|6|||
124506168|NCT02198651|447805715|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
124506169|NCT02198651|447805716|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
124506170|NCT02115113|447805717|FG000|Participants in Run-in Period|Death|0|||
124506171|NCT02115113|447805718|FG001|Participants in Run-in Period|Death|0|||
124506172|NCT02115113|447805719|FG002|Participants in Run-in Period|Death|1|||
124563468|NCT01364870|448018439|FG002|Overall Study|Adverse Event|4|||
124563469|NCT01364870|448018437|FG000|Overall Study|Protocol Violation|1|||
124563470|NCT01364870|448018438|FG001|Overall Study|Protocol Violation|0|||
124563471|NCT01364870|448018439|FG002|Overall Study|Protocol Violation|0|||
124563472|NCT01890707|448018440|FG000|Overall Study|Lost to Follow-up|1|||
124563473|NCT01890707|448018441|FG001|Overall Study|Lost to Follow-up|1|||
124563474|NCT00506753|448020032|FG000|Overall Study|Lost to Follow-up|21|||
124506173|NCT02115113|447805717|FG000|Participants in Run-in Period|Administrative problems|0|||
124506174|NCT02115113|447805718|FG001|Participants in Run-in Period|Administrative problems|0|||
124506175|NCT02115113|447805719|FG002|Participants in Run-in Period|Administrative problems|1|||
124506176|NCT02115113|447805717|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
124506177|NCT02115113|447805718|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
124506178|NCT02115113|447805719|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
124506179|NCT02115113|447805717|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
124506180|NCT02115113|447805718|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
124506181|NCT02115113|447805719|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
124506182|NCT02115113|447805717|FG000|Participants Randomized|Lost to Follow-up|1|||
124506183|NCT02115113|447805718|FG001|Participants Randomized|Lost to Follow-up|0|||
124506184|NCT02115113|447805719|FG002|Participants Randomized|Lost to Follow-up|0|||
124506185|NCT02115113|447805717|FG000|Participants Randomized|Death|1|||
124506186|NCT02115113|447805718|FG001|Participants Randomized|Death|0|||
124506187|NCT02115113|447805719|FG002|Participants Randomized|Death|0|||
124506188|NCT02622724|447805720|FG000|Overall Study|Death|51|||
124506189|NCT02622724|447805721|FG001|Overall Study|Death|53|||
124506190|NCT02622724|447805720|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
124506191|NCT02622724|447805721|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
124506192|NCT02622724|447805720|FG000|Overall Study|Early termination of study|38|||
124506193|NCT02622724|447805721|FG001|Overall Study|Early termination of study|43|||
124506194|NCT00356863|447805722|FG000|Overall Study|Death|16|||
124506195|NCT00356863|447805723|FG001|Overall Study|Death|32|||
124506196|NCT00356863|447805722|FG000|Overall Study|Lost to Follow-up|76|||
124506197|NCT00356863|447805723|FG001|Overall Study|Lost to Follow-up|43|||
124506198|NCT00343291|447805724|FG000|Overall Study|Adverse Event|13|||
124563475|NCT00506753|448020033|FG001|Overall Study|Lost to Follow-up|15|||
124506199|NCT00343291|447805725|FG001|Overall Study|Adverse Event|13|||
124506200|NCT00343291|447805724|FG000|Overall Study|Death|3|||
124506201|NCT00343291|447805725|FG001|Overall Study|Death|2|||
124563476|NCT00125359|448020034|FG000|Overall Study|Death|4|||
124563477|NCT00125359|448020034|FG000|Overall Study|Adverse Event|5|||
124506202|NCT00343291|447805724|FG000|Overall Study|Progressive disease|33|||
124506203|NCT00343291|447805725|FG001|Overall Study|Progressive disease|34|||
124506204|NCT00343291|447805724|FG000|Overall Study|Withdrawal by Subject|0|||
124506205|NCT00343291|447805725|FG001|Overall Study|Withdrawal by Subject|2|||
124506206|NCT00343291|447805724|FG000|Overall Study|Other|8|||
124506207|NCT00343291|447805725|FG001|Overall Study|Other|5|||
124506208|NCT00839423|447805730|FG000|Overall Study|Adverse Event|4|||
124506209|NCT00839423|447805731|FG001|Overall Study|Adverse Event|3|||
124563478|NCT00125359|448020034|FG000|Overall Study|Physician Decision|14|||
124563479|NCT02451670|448020035|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
124563480|NCT02451670|448020036|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
124563481|NCT01513551|448020037|FG000|Overall Study|Death|0|||
124506210|NCT00839423|447805732|FG002|Overall Study|Adverse Event|7|||
124506211|NCT00839423|447805733|FG003|Overall Study|Adverse Event|16|||
124506212|NCT00839423|447805730|FG000|Overall Study|Lack of Efficacy|6|||
124506213|NCT00839423|447805731|FG001|Overall Study|Lack of Efficacy|6|||
124506214|NCT00839423|447805732|FG002|Overall Study|Lack of Efficacy|3|||
124506215|NCT00839423|447805733|FG003|Overall Study|Lack of Efficacy|2|||
124506216|NCT00839423|447805730|FG000|Overall Study|Non-compliance|0|||
124506217|NCT00839423|447805731|FG001|Overall Study|Non-compliance|0|||
124506218|NCT00839423|447805732|FG002|Overall Study|Non-compliance|0|||
124506219|NCT00839423|447805733|FG003|Overall Study|Non-compliance|1|||
124506220|NCT00839423|447805730|FG000|Overall Study|Protocol Violation|0|||
124506221|NCT00839423|447805731|FG001|Overall Study|Protocol Violation|1|||
124506222|NCT00839423|447805732|FG002|Overall Study|Protocol Violation|2|||
124506223|NCT00839423|447805733|FG003|Overall Study|Protocol Violation|0|||
124506224|NCT00839423|447805730|FG000|Overall Study|Withdrawal of consent|4|||
124506225|NCT00839423|447805731|FG001|Overall Study|Withdrawal of consent|0|||
124506226|NCT00839423|447805732|FG002|Overall Study|Withdrawal of consent|4|||
124506227|NCT00839423|447805733|FG003|Overall Study|Withdrawal of consent|1|||
124506228|NCT00839423|447805730|FG000|Overall Study|Lost to Follow-up|1|||
124506229|NCT00839423|447805731|FG001|Overall Study|Lost to Follow-up|0|||
124506230|NCT00839423|447805732|FG002|Overall Study|Lost to Follow-up|1|||
124506231|NCT00839423|447805733|FG003|Overall Study|Lost to Follow-up|0|||
124506232|NCT00839423|447805730|FG000|Overall Study|Administrative or other reasons|3|||
124506233|NCT00839423|447805731|FG001|Overall Study|Administrative or other reasons|0|||
124506234|NCT00839423|447805732|FG002|Overall Study|Administrative or other reasons|1|||
124506235|NCT00839423|447805733|FG003|Overall Study|Administrative or other reasons|0|||
124506236|NCT01071096|447805734|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
124506237|NCT01071096|447805735|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
124506238|NCT00756886|447805739|FG000|Overall Study|Lost to Follow-up|1|||
124506239|NCT00756886|447805740|FG001|Overall Study|Lost to Follow-up|0|||
124506240|NCT00756886|447805739|FG000|Overall Study|Adverse Event|0|||
124506241|NCT00756886|447805740|FG001|Overall Study|Adverse Event|3|||
124506242|NCT00756886|447805739|FG000|Overall Study|Lack of Efficacy|1|||
124506243|NCT00756886|447805740|FG001|Overall Study|Lack of Efficacy|0|||
124506244|NCT00756886|447805739|FG000|Overall Study|Ineligible|9|||
124506245|NCT00756886|447805740|FG001|Overall Study|Ineligible|4|||
124506246|NCT03421964|447805746|FG000|Overall Study|Lost to Follow-up|11|||
124506247|NCT03421964|447805747|FG001|Overall Study|Lost to Follow-up|21|||
124506248|NCT03421964|447805746|FG000|Overall Study|Withdrawal by Subject|9|||
124506249|NCT03421964|447805747|FG001|Overall Study|Withdrawal by Subject|3|||
124506250|NCT03421964|447805746|FG000|Overall Study|Incarcerated|1|||
124506251|NCT03421964|447805747|FG001|Overall Study|Incarcerated|0|||
124506252|NCT03421964|447805746|FG000|Overall Study|Inpt Treatment Facility|1|||
124506253|NCT03421964|447805747|FG001|Overall Study|Inpt Treatment Facility|1|||
124506254|NCT03421964|447805746|FG000|Overall Study|Virtual Platform Issues|1|||
124506255|NCT03421964|447805747|FG001|Overall Study|Virtual Platform Issues|1|||
124506256|NCT03457103|447805748|FG000|Overall Study|illness/hospitalization|4|||
124506257|NCT03457103|447805749|FG001|Overall Study|illness/hospitalization|2|||
124506258|NCT03457103|447805748|FG000|Overall Study|Lost to Follow-up|2|||
124506259|NCT03457103|447805749|FG001|Overall Study|Lost to Follow-up|1|||
124506260|NCT03457103|447805748|FG000|Overall Study|Withdrawal by Subject|1|||
124506261|NCT03457103|447805749|FG001|Overall Study|Withdrawal by Subject|2|||
124506262|NCT03457103|447805748|FG000|Overall Study|financial/ insurance issues|1|||
124506263|NCT03457103|447805749|FG001|Overall Study|financial/ insurance issues|1|||
124506264|NCT00213980|447805750|FG000|Overall Study|Withdrawal by Subject|3|||
124506265|NCT00213980|447805751|FG001|Overall Study|Withdrawal by Subject|1|||
124506266|NCT00213980|447805750|FG000|Overall Study|Adverse Event|1|||
124506267|NCT00213980|447805751|FG001|Overall Study|Adverse Event|1|||
124506268|NCT00213980|447805750|FG000|Overall Study|Disease progression|0|||
124506269|NCT00213980|447805751|FG001|Overall Study|Disease progression|2|||
124506270|NCT00213980|447805750|FG000|Overall Study|Developed ovarian cancer|1|||
124506271|NCT00213980|447805751|FG001|Overall Study|Developed ovarian cancer|0|||
124506272|NCT00213980|447805750|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
124506273|NCT00213980|447805751|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
124506274|NCT02411201|447805752|FG000|Overall Study|Adverse Event|2|||
124506275|NCT02411201|447805752|FG000|Overall Study|Withdrawal by Subject|2|||
124506276|NCT02411201|447805752|FG000|Overall Study|Age group completed|2|||
124506277|NCT01260467|447805753|FG000|Overall Study|Withdrawal by Subject|2|||
124506278|NCT00798694|447805754|FG000|Overall Study|Lost to Follow-up|1|||
124506279|NCT00798694|447805755|FG001|Overall Study|Lost to Follow-up|1|||
124506280|NCT00798694|447805754|FG000|Overall Study|Physician Decision|1|||
124506281|NCT00798694|447805755|FG001|Overall Study|Physician Decision|0|||
124506282|NCT01774344|447805757|FG000|Overall Study|Withdrawal by Subject|3|||
124506283|NCT01774344|447805758|FG001|Overall Study|Withdrawal by Subject|10|||
124506284|NCT01774344|447805757|FG000|Overall Study|Protocol Violation|0|||
124506285|NCT01774344|447805758|FG001|Overall Study|Protocol Violation|1|||
124506286|NCT01774344|447805757|FG000|Overall Study|Lost to Follow-up|4|||
124506287|NCT01774344|447805758|FG001|Overall Study|Lost to Follow-up|10|||
124506288|NCT01774344|447805757|FG000|Overall Study|End of survival follow-up not available|2|||
124506289|NCT01774344|447805758|FG001|Overall Study|End of survival follow-up not available|2|||
124506290|NCT01774344|447805757|FG000|Overall Study|Data collection finished|4|||
124506291|NCT01774344|447805758|FG001|Overall Study|Data collection finished|14|||
124506292|NCT01774344|447805757|FG000|Overall Study|Other|0|||
124506293|NCT01774344|447805758|FG001|Overall Study|Other|1|||
124506294|NCT01774344|447805757|FG000|Overall Study|Did not enter Survival Follow up|49|||
124506295|NCT01774344|447805758|FG001|Overall Study|Did not enter Survival Follow up|83|||
124506296|NCT00992784|447805778|FG000|Overall Study|Adverse Event|2|||
124506297|NCT00992784|447805779|FG001|Overall Study|Adverse Event|1|||
124506298|NCT00992784|447805780|FG002|Overall Study|Adverse Event|0|||
124506299|NCT00992784|447805778|FG000|Overall Study|Withdrawal by Subject|1|||
124506300|NCT00992784|447805779|FG001|Overall Study|Withdrawal by Subject|1|||
124506301|NCT00992784|447805780|FG002|Overall Study|Withdrawal by Subject|1|||
124506302|NCT01363713|447805781|FG000|Overall Study|Adverse Event|1|||
124506303|NCT01363713|447805781|FG000|Overall Study|Protocol Violation|3|||
124506304|NCT01363713|447805781|FG000|Overall Study|Withdrawal by Subject|2|||
124506305|NCT01658579|447805782|FG000|Treatment Period A|Other|0|||
124506306|NCT01658579|447805783|FG001|Treatment Period A|Other|0|||
124506307|NCT01658579|447805784|FG002|Treatment Period A|Other|1|||
124506308|NCT01658579|447805785|FG003|Treatment Period A|Other|1|||
124506309|NCT01658579|447805782|FG000|Treatment Period A|Adverse Event|1|||
124506310|NCT01658579|447805783|FG001|Treatment Period A|Adverse Event|0|||
124506311|NCT01658579|447805784|FG002|Treatment Period A|Adverse Event|0|||
124506312|NCT01658579|447805785|FG003|Treatment Period A|Adverse Event|0|||
124506313|NCT01658579|447805782|FG000|Treatment Period B|Other|0|||
124506314|NCT01658579|447805783|FG001|Treatment Period B|Other|0|||
124506315|NCT01658579|447805784|FG002|Treatment Period B|Other|0|||
124506316|NCT01658579|447805785|FG003|Treatment Period B|Other|1|||
124506317|NCT00608530|447805788|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
124506318|NCT00608530|447805789|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
124506319|NCT00608530|447805790|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
124506320|NCT00608530|447805791|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
124506321|NCT00608530|447805788|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
124506322|NCT00608530|447805789|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
124506323|NCT00608530|447805790|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
124506324|NCT00608530|447805791|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
124506325|NCT00608530|447805788|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
124506326|NCT00608530|447805789|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
124506327|NCT00608530|447805790|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
124506328|NCT00608530|447805791|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
124506329|NCT00608530|447805788|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
124506330|NCT00608530|447805789|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
124506331|NCT00608530|447805790|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
124506332|NCT00608530|447805791|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
124506333|NCT00608530|447805788|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
124506334|NCT00608530|447805789|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
124506335|NCT00608530|447805790|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
124506336|NCT00608530|447805791|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
124506337|NCT00608530|447805788|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
124506338|NCT00608530|447805789|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
124506339|NCT00608530|447805790|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
124506340|NCT00608530|447805791|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
124506341|NCT01514188|447805792|FG000|Overall Study|Adverse Event|3|||
124506342|NCT01514188|447805793|FG001|Overall Study|Adverse Event|5|||
124506343|NCT01514188|447805792|FG000|Overall Study|Withdrawal by Subject|2|||
124506344|NCT01514188|447805793|FG001|Overall Study|Withdrawal by Subject|4|||
124506345|NCT01514188|447805792|FG000|Overall Study|Protocol Violation|2|||
124506346|NCT01514188|447805793|FG001|Overall Study|Protocol Violation|4|||
124506347|NCT01514188|447805792|FG000|Overall Study|Physician Decision|0|||
124506348|NCT01514188|447805793|FG001|Overall Study|Physician Decision|2|||
124506349|NCT01514188|447805792|FG000|Overall Study|Disease Progression|13|||
124506350|NCT01514188|447805793|FG001|Overall Study|Disease Progression|14|||
124506351|NCT01514188|447805792|FG000|Overall Study|Death|1|||
124506352|NCT01514188|447805793|FG001|Overall Study|Death|3|||
124776661|NCT00892099|448809943|FG002|Overall Study|investigator decision|1|||
124776662|NCT00892099|448809941|FG000|Overall Study|Lost to Follow-up|0|||
124776663|NCT00892099|448809942|FG001|Overall Study|Lost to Follow-up|0|||
124776664|NCT00892099|448809943|FG002|Overall Study|Lost to Follow-up|1|||
124506353|NCT01514188|447805792|FG000|Overall Study|Other|2|||
124506354|NCT01514188|447805793|FG001|Overall Study|Other|1|||
124506355|NCT01019486|447805794|FG000|Overall Study|Withdrawal by Subject|1|||
124506356|NCT01019486|447805795|FG001|Overall Study|Withdrawal by Subject|1|||
124563482|NCT01513551|448020038|FG001|Overall Study|Death|1|||
124776665|NCT01657019|448809944|FG000|Overall Study|Withdrawal by Subject|65|||
124563483|NCT01513551|448020039|FG002|Overall Study|Death|0|||
124563484|NCT01513551|448020037|FG000|Overall Study|Lost to Follow-up|3|||
124563485|NCT01513551|448020038|FG001|Overall Study|Lost to Follow-up|5|||
124563486|NCT01513551|448020039|FG002|Overall Study|Lost to Follow-up|2|||
124563487|NCT01513551|448020037|FG000|Overall Study|Withdrawal by Subject|1|||
124563488|NCT01513551|448020038|FG001|Overall Study|Withdrawal by Subject|0|||
124563489|NCT01513551|448020039|FG002|Overall Study|Withdrawal by Subject|2|||
124563490|NCT01513551|448020037|FG000|Overall Study|Randomized but not vaccinated|0|||
124563491|NCT01513551|448020038|FG001|Overall Study|Randomized but not vaccinated|0|||
124563492|NCT01513551|448020039|FG002|Overall Study|Randomized but not vaccinated|1|||
124563493|NCT00094302|448020041|FG000|Overall Study|Lost to Follow-up|43|||
124563494|NCT00094302|448020042|FG001|Overall Study|Lost to Follow-up|41|||
124563495|NCT00094302|448020041|FG000|Overall Study|Physician Decision|5|||
124563496|NCT00094302|448020042|FG001|Overall Study|Physician Decision|8|||
124563497|NCT00094302|448020041|FG000|Overall Study|Withdrawal by Subject|103|||
124776666|NCT01657019|448809944|FG000|Overall Study|Adverse Event|55|||
124563498|NCT00094302|448020042|FG001|Overall Study|Withdrawal by Subject|111|||
124563499|NCT00094302|448020041|FG000|Overall Study|Death|266|||
124563500|NCT00094302|448020042|FG001|Overall Study|Death|246|||
124563501|NCT03705351|448020043|FG000|Overall Study|Study termination|3|||
124563502|NCT03705351|448020043|FG000|Overall Study|Death|1|||
124563503|NCT03705351|448020043|FG000|Overall Study|Lack of Efficacy|2|||
124563504|NCT03705351|448020043|FG000|Overall Study|Withdrawal by Subject|1|||
124563505|NCT00322556|448020053|FG000|Overall Study|Adverse Event|1|||
124776667|NCT01657019|448809944|FG000|Overall Study|Lost to Follow-up|48|||
124506357|NCT01019486|447805796|FG002|Overall Study|Withdrawal by Subject|1|||
124506358|NCT02932332|447805801|FG000|Overall Study|Withdrawal by Subject|1|||
124563506|NCT00322556|448020053|FG000|Overall Study|Withdrawal by Subject|1|||
124563507|NCT00322556|448020053|FG000|Overall Study|Lost to Follow-up|3|||
124563508|NCT00322556|448020053|FG000|Overall Study|Other Reason|7|||
124563509|NCT02058628|448020054|FG000|Overall Study|Adverse Event|1|||
124563510|NCT02058628|448020055|FG001|Overall Study|Adverse Event|0|||
124563511|NCT02058628|448020054|FG000|Overall Study|Withdrawal by Subject|2|||
124563512|NCT02058628|448020055|FG001|Overall Study|Withdrawal by Subject|2|||
124563513|NCT02058628|448020054|FG000|Overall Study|Lost to Follow-up|2|||
124563514|NCT02058628|448020055|FG001|Overall Study|Lost to Follow-up|4|||
124563515|NCT02058628|448020054|FG000|Overall Study|Not in time schedule|0|||
124563516|NCT02058628|448020055|FG001|Overall Study|Not in time schedule|1|||
124563517|NCT02058628|448020054|FG000|Overall Study|The visit date was not in timeline|0|||
124563518|NCT02058628|448020055|FG001|Overall Study|The visit date was not in timeline|1|||
124563519|NCT02058628|448020054|FG000|Overall Study|A lot of time for study for participant|1|||
124563520|NCT02058628|448020055|FG001|Overall Study|A lot of time for study for participant|0|||
124563521|NCT02058628|448020054|FG000|Overall Study|Non compliance|1|||
124563522|NCT02058628|448020055|FG001|Overall Study|Non compliance|0|||
124563523|NCT01767597|448020056|FG000|Overall Study|Incomplete intervention|3|||
124563524|NCT01767597|448020057|FG001|Overall Study|Incomplete intervention|1|||
124506359|NCT02932332|447805802|FG001|Overall Study|Withdrawal by Subject|1|||
124506360|NCT02932332|447805803|FG002|Overall Study|Withdrawal by Subject|0|||
124506361|NCT02932332|447805804|FG003|Overall Study|Withdrawal by Subject|1|||
124506362|NCT02932332|447805801|FG000|Overall Study|Chest pain|0|||
124506363|NCT02932332|447805802|FG001|Overall Study|Chest pain|0|||
124506364|NCT02932332|447805803|FG002|Overall Study|Chest pain|0|||
124506365|NCT02932332|447805804|FG003|Overall Study|Chest pain|1|||
124506366|NCT02932332|447805801|FG000|Overall Study|Not Dyspneic cough|1|||
124506367|NCT02932332|447805802|FG001|Overall Study|Not Dyspneic cough|2|||
124506368|NCT02932332|447805803|FG002|Overall Study|Not Dyspneic cough|1|||
124506369|NCT02932332|447805804|FG003|Overall Study|Not Dyspneic cough|0|||
124563525|NCT01767597|448020056|FG000|Overall Study|Withdrawal by Subject|1|||
124563526|NCT01767597|448020057|FG001|Overall Study|Withdrawal by Subject|0|||
124563527|NCT02961920|448020058|FG000|Overall Study|did not achive stydy protocol schedule|1|||
124563528|NCT02961920|448020059|FG001|Overall Study|did not achive stydy protocol schedule|1|||
124563529|NCT04527471|448020062|FG000|Overall Study|Adverse Event|1|||
124563530|NCT04527471|448020063|FG001|Overall Study|Adverse Event|0|||
124563531|NCT04527471|448020062|FG000|Overall Study|Lost to Follow-up|1|||
124563532|NCT04527471|448020063|FG001|Overall Study|Lost to Follow-up|0|||
124563533|NCT00096265|448020065|FG000|Overall Study|Ineligible|1|||
124563534|NCT00096265|448020066|FG001|Overall Study|Ineligible|0|||
124563535|NCT00096265|448020067|FG002|Overall Study|Ineligible|0|||
124563536|NCT01506323|448020068|FG000|Overall Study|Lost to Follow-up|5|||
124563537|NCT01506323|448020069|FG001|Overall Study|Lost to Follow-up|4|||
124563538|NCT01506323|448020068|FG000|Overall Study|Withdrawal by Subject|4|||
124776668|NCT01657019|448809944|FG000|Overall Study|Protocol Violation|6|||
124506370|NCT05373706|447805806|FG000|Overall Study|Lost to Follow-up|2|||
124563539|NCT01506323|448020069|FG001|Overall Study|Withdrawal by Subject|4|||
124563540|NCT01506323|448020068|FG000|Overall Study|Lack of Efficacy|1|||
124563541|NCT01506323|448020069|FG001|Overall Study|Lack of Efficacy|3|||
124563542|NCT01506323|448020068|FG000|Overall Study|Moved out of area|5|||
124506371|NCT05373706|447805807|FG001|Overall Study|Lost to Follow-up|2|||
124506372|NCT02841787|447805808|FG000|Overall Study|Lost to Follow-up|1|||
124506373|NCT02841787|447805809|FG001|Overall Study|Lost to Follow-up|0|||
124506374|NCT02841787|447805810|FG002|Overall Study|Lost to Follow-up|0|||
124506375|NCT02841787|447805808|FG000|Overall Study|Symptoms dropped below threshold|1|||
124506376|NCT02841787|447805809|FG001|Overall Study|Symptoms dropped below threshold|0|||
124506377|NCT02841787|447805810|FG002|Overall Study|Symptoms dropped below threshold|0|||
124506378|NCT02841787|447805808|FG000|Overall Study|Withdrawal by Subject|1|||
124506379|NCT02841787|447805809|FG001|Overall Study|Withdrawal by Subject|4|||
124506380|NCT02841787|447805810|FG002|Overall Study|Withdrawal by Subject|0|||
124506381|NCT03029650|447805814|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
124506382|NCT03029650|447805815|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
124506383|NCT03029650|447805814|FG000|Washout (1 Week)|Physician Decision|0|||
124506384|NCT03029650|447805815|FG001|Washout (1 Week)|Physician Decision|1|||
124506385|NCT01875367|447805817|FG000|Overall Study|Not complete at least 2 questionaries|4|||
124506386|NCT01875367|447805818|FG001|Overall Study|Not complete at least 2 questionaries|2|||
124506387|NCT01875367|447805817|FG000|Overall Study|Not receive study treatment|1|||
124506388|NCT01875367|447805818|FG001|Overall Study|Not receive study treatment|0|||
124506389|NCT03977727|447805829|FG000|Second Treatment|Lost to Follow-up|0|||
124506390|NCT03977727|447805830|FG001|Second Treatment|Lost to Follow-up|3|||
124506391|NCT00603980|447805832|FG000|Study Qualification|Protocol Violation|3|||
124506392|NCT00603980|447805832|FG000|Study Qualification|Inconsistent data reporting|13|||
124506393|NCT00603980|447805832|FG000|Main Study|14th subject completed trial|1|||
124506394|NCT02683525|447805833|FG000|Overall Study|Lost to Follow-up|1|||
124506395|NCT02683525|447805833|FG000|Overall Study|Physician Decision|1|||
124506396|NCT02683525|447805833|FG000|Overall Study|Disease Progression|6|||
124506397|NCT01627067|447805838|FG000|Overall Study|Screen Failure|1|||
124506398|NCT00926796|447805842|FG000|Overall Study|Did not receive randomized treatment|4|||
124506399|NCT00926796|447805843|FG001|Overall Study|Did not receive randomized treatment|7|||
124506400|NCT00926796|447805842|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
124506401|NCT00926796|447805843|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
124506402|NCT00926796|447805842|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
124506403|NCT00926796|447805843|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
124506404|NCT00926796|447805842|FG000|Overall Study|Adverse Event|7|||
124506405|NCT00926796|447805843|FG001|Overall Study|Adverse Event|14|||
124506406|NCT00926796|447805842|FG000|Overall Study|Lost to Follow-up|22|||
124506407|NCT00926796|447805843|FG001|Overall Study|Lost to Follow-up|13|||
124506408|NCT00926796|447805842|FG000|Overall Study|Protocol Violation|15|||
124506409|NCT00926796|447805843|FG001|Overall Study|Protocol Violation|11|||
124506410|NCT00926796|447805842|FG000|Overall Study|Withdrawal by Subject|1|||
124506411|NCT00926796|447805843|FG001|Overall Study|Withdrawal by Subject|0|||
124506412|NCT01341652|447805844|FG000|Overall Study|Incorrect Random Assignment|0|||
124506413|NCT01341652|447805845|FG001|Overall Study|Incorrect Random Assignment|1|||
124506414|NCT01341652|447805844|FG000|Overall Study|ineligible; presence metastatic disease|0|||
124506415|NCT01341652|447805845|FG001|Overall Study|ineligible; presence metastatic disease|1|||
124506416|NCT00632463|447805850|FG000|Overall Study|Adverse Event|0|||
124506417|NCT00632463|447805851|FG001|Overall Study|Adverse Event|1|||
124506418|NCT00632463|447805852|FG002|Overall Study|Adverse Event|0|||
124506419|NCT04146467|447805854|FG000|Overall Study|Adverse Event|0|||
124506420|NCT04146467|447805855|FG001|Overall Study|Adverse Event|1|||
124506421|NCT04146467|447805854|FG000|Overall Study|Lost to Follow-up|0|||
124506422|NCT04146467|447805855|FG001|Overall Study|Lost to Follow-up|2|||
124506423|NCT01934192|447805858|FG000|Overall Study|Protocol Violation|0|||
124506424|NCT01934192|447805859|FG001|Overall Study|Protocol Violation|0|||
124506425|NCT01934192|447805860|FG002|Overall Study|Protocol Violation|0|||
124506426|NCT01934192|447805861|FG003|Overall Study|Protocol Violation|1|||
124506427|NCT01934192|447805858|FG000|Overall Study|Other: reached stopping criteria|6|||
124563543|NCT01506323|448020069|FG001|Overall Study|Moved out of area|2|||
124563544|NCT01506323|448020068|FG000|Overall Study|Schedule or Transportation conflict|8|||
124563545|NCT01506323|448020069|FG001|Overall Study|Schedule or Transportation conflict|0|||
124563546|NCT01506323|448020068|FG000|Overall Study|Started another treatment|1|||
124563547|NCT01506323|448020069|FG001|Overall Study|Started another treatment|0|||
124563548|NCT02192905|448020070|FG000|Overall Study|Lost to Follow-up|1|||
124563549|NCT04604184|448020082|FG000|Overall Study|Adverse Event|5|||
124563550|NCT04604184|448020083|FG001|Overall Study|Adverse Event|5|||
124563551|NCT04604184|448020082|FG000|Overall Study|Death|2|||
124563552|NCT04604184|448020083|FG001|Overall Study|Death|1|||
124563553|NCT04604184|448020082|FG000|Overall Study|Withdrawal by Subject|1|||
124563554|NCT04604184|448020083|FG001|Overall Study|Withdrawal by Subject|3|||
124563555|NCT04604184|448020082|FG000|Overall Study|Not treated|2|||
124563556|NCT04604184|448020083|FG001|Overall Study|Not treated|2|||
124563557|NCT04604184|448020082|FG000|Overall Study|Due to sponsor decision|9|||
124563558|NCT04604184|448020083|FG001|Overall Study|Due to sponsor decision|7|||
124563559|NCT04604184|448020082|FG000|Overall Study|Physician Decision|0|||
124563560|NCT04604184|448020083|FG001|Overall Study|Physician Decision|1|||
124563561|NCT04604184|448020082|FG000|Overall Study|Transfer to healthcare|1|||
124563562|NCT04604184|448020083|FG001|Overall Study|Transfer to healthcare|0|||
124506428|NCT01934192|447805859|FG001|Overall Study|Other: reached stopping criteria|5|||
124506429|NCT01934192|447805860|FG002|Overall Study|Other: reached stopping criteria|1|||
124506430|NCT01934192|447805861|FG003|Overall Study|Other: reached stopping criteria|0|||
124506431|NCT01934192|447805858|FG000|Overall Study|Physician Decision|3|||
124506432|NCT01934192|447805859|FG001|Overall Study|Physician Decision|2|||
124506433|NCT01934192|447805860|FG002|Overall Study|Physician Decision|0|||
124506434|NCT01934192|447805861|FG003|Overall Study|Physician Decision|0|||
124506435|NCT01737840|447805862|FG000|Overall Study|Diagnosed with an other pathology|2|||
124506436|NCT01737840|447805863|FG001|Overall Study|Diagnosed with an other pathology|2|||
124563563|NCT03294538|448020086|FG000|Overall Study|Adverse Event|0|||
124563564|NCT03294538|448020087|FG001|Overall Study|Adverse Event|1|||
124563565|NCT03294538|448020088|FG002|Overall Study|Adverse Event|1|||
124563566|NCT03294538|448020086|FG000|Overall Study|Lost to Follow-up|1|||
124563567|NCT03294538|448020087|FG001|Overall Study|Lost to Follow-up|0|||
124563568|NCT03294538|448020088|FG002|Overall Study|Lost to Follow-up|0|||
124563569|NCT03294538|448020086|FG000|Overall Study|Outside of Visit Window|4|||
124563570|NCT03294538|448020087|FG001|Overall Study|Outside of Visit Window|4|||
124563571|NCT03294538|448020088|FG002|Overall Study|Outside of Visit Window|1|||
124563572|NCT01769378|448020090|FG000|Overall Study|Adverse Event|10|||
124563573|NCT01769378|448020091|FG001|Overall Study|Adverse Event|0|||
124563574|NCT01769378|448020090|FG000|Overall Study|Entry criteria not met|1|||
124563575|NCT01769378|448020091|FG001|Overall Study|Entry criteria not met|0|||
124563576|NCT01769378|448020090|FG000|Overall Study|Protocol Violation|1|||
124563577|NCT01769378|448020091|FG001|Overall Study|Protocol Violation|1|||
124563578|NCT01769378|448020090|FG000|Overall Study|Withdrawal by Subject|10|||
124563579|NCT01769378|448020091|FG001|Overall Study|Withdrawal by Subject|3|||
124563580|NCT01769378|448020090|FG000|Overall Study|Sponsor Decision|1|||
124563581|NCT01769378|448020091|FG001|Overall Study|Sponsor Decision|0|||
124563582|NCT01769378|448020090|FG000|Overall Study|Lost to Follow-up|2|||
124563583|NCT01769378|448020091|FG001|Overall Study|Lost to Follow-up|0|||
124563584|NCT01787825|448020092|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
124563585|NCT01787825|448020093|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
124563586|NCT01787825|448020092|FG000|Overall Study|Data Not Analyzable|5|||
124563587|NCT01787825|448020093|FG001|Overall Study|Data Not Analyzable|1|||
124563588|NCT01338636|448020102|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
124563589|NCT02385526|448020103|FG000|Overall Study|Withdrawal by Subject|0|||
124563590|NCT02385526|448020104|FG001|Overall Study|Withdrawal by Subject|2|||
124563591|NCT02385526|448020105|FG002|Overall Study|Withdrawal by Subject|0|||
124563592|NCT02385526|448020103|FG000|Overall Study|Lost to Follow-up|0|||
124563593|NCT02385526|448020104|FG001|Overall Study|Lost to Follow-up|1|||
124563594|NCT02385526|448020105|FG002|Overall Study|Lost to Follow-up|0|||
124563595|NCT02385526|448020103|FG000|Overall Study|Physician Decision|1|||
124563596|NCT02385526|448020104|FG001|Overall Study|Physician Decision|0|||
124563597|NCT02385526|448020105|FG002|Overall Study|Physician Decision|0|||
124563598|NCT02385526|448020103|FG000|Overall Study|Protocol Violation|1|||
124506437|NCT01189435|447805864|FG000|Overall Study|Withdrawal by Subject|1|||
124506438|NCT01189435|447805864|FG000|Overall Study|Physician Decision|1|||
124506439|NCT03259490|447805870|FG000|Period 1|Withdrawal by Subject|0|||
124506440|NCT03259490|447805871|FG001|Period 1|Withdrawal by Subject|1|||
124506441|NCT03259490|447805870|FG000|Period 2|Protocol Violation|1|||
124506442|NCT03259490|447805871|FG001|Period 2|Protocol Violation|0|||
124506443|NCT03095521|447805872|FG000|Overall Study|Withdrawal by Subject|0|||
124506444|NCT03095521|447805873|FG001|Overall Study|Withdrawal by Subject|1|||
124506445|NCT03095521|447805872|FG000|Overall Study|Lost to Follow-up|0|||
124506446|NCT03095521|447805873|FG001|Overall Study|Lost to Follow-up|1|||
124506447|NCT00434122|447805874|FG000|Overall Study|Non-compliance with protocol|0|||
124506448|NCT00434122|447805875|FG001|Overall Study|Non-compliance with protocol|1|||
124506449|NCT00434122|447805874|FG000|Overall Study|loss of subject contact|1|||
124506450|NCT00434122|447805875|FG001|Overall Study|loss of subject contact|1|||
124506451|NCT00434122|447805874|FG000|Overall Study|Personal reasons|1|||
124506452|NCT00434122|447805875|FG001|Overall Study|Personal reasons|1|||
124506453|NCT00434122|447805874|FG000|Overall Study|Large follicle size|2|||
124506454|NCT00434122|447805875|FG001|Overall Study|Large follicle size|2|||
124506455|NCT00434122|447805874|FG000|Overall Study|Low follicular response.|1|||
124506456|NCT00434122|447805875|FG001|Overall Study|Low follicular response.|2|||
124506457|NCT00434122|447805874|FG000|Overall Study|Travelling of subject.|1|||
124506458|NCT00434122|447805875|FG001|Overall Study|Travelling of subject.|0|||
124563599|NCT02385526|448020104|FG001|Overall Study|Protocol Violation|0|||
124563600|NCT02385526|448020105|FG002|Overall Study|Protocol Violation|0|||
124563601|NCT01798485|448020110|FG000|Overall Study|Adverse Event|32|||
124563602|NCT01798485|448020111|FG001|Overall Study|Adverse Event|40|||
124506459|NCT01963208|447805876|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
124506460|NCT01963208|447805877|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
124506461|NCT01963208|447805878|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
124506462|NCT01963208|447805879|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
124563603|NCT01798485|448020110|FG000|Overall Study|Withdrawal by Subject|27|||
124563604|NCT01798485|448020111|FG001|Overall Study|Withdrawal by Subject|31|||
124506463|NCT01963208|447805880|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
124506464|NCT01963208|447805881|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
124506465|NCT01963208|447805876|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
124506466|NCT01963208|447805877|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
124506467|NCT01963208|447805878|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
124506468|NCT01963208|447805879|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
124506469|NCT01963208|447805880|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
124506470|NCT01963208|447805881|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
124506471|NCT01963208|447805876|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
124506472|NCT01963208|447805877|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
124506473|NCT01963208|447805878|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
124506474|NCT01963208|447805879|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
124506475|NCT01963208|447805880|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
124506476|NCT01963208|447805881|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
124506477|NCT01963208|447805876|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
124506478|NCT01963208|447805877|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
124506479|NCT01963208|447805878|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
124506480|NCT01963208|447805879|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
124506481|NCT01963208|447805880|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
124506482|NCT01963208|447805881|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
124506483|NCT01963208|447805876|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
124506484|NCT01963208|447805877|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
124506485|NCT01963208|447805878|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
124506486|NCT01963208|447805879|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
124506487|NCT01963208|447805880|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
124506488|NCT01963208|447805881|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
124506489|NCT01963208|447805876|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
124506490|NCT01963208|447805877|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
124506491|NCT01963208|447805878|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
124506492|NCT01963208|447805879|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
124506493|NCT01963208|447805880|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
124506494|NCT01963208|447805881|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
124506495|NCT01963208|447805876|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
124506496|NCT01963208|447805877|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
124506497|NCT01963208|447805878|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
124506498|NCT01963208|447805879|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
124506499|NCT01963208|447805880|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
124506500|NCT01963208|447805881|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
124506501|NCT01963208|447805876|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
124506502|NCT01963208|447805877|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
124506503|NCT01963208|447805878|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
124506504|NCT01963208|447805879|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
124506505|NCT01963208|447805880|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
124506506|NCT01963208|447805881|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
124506507|NCT01963208|447805876|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
124506508|NCT01963208|447805877|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
124506509|NCT01963208|447805878|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
124506510|NCT01963208|447805879|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
124506511|NCT01963208|447805880|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
124506512|NCT01963208|447805881|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
124506513|NCT01963208|447805876|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
124506514|NCT01963208|447805877|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
124506515|NCT01963208|447805878|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
124506516|NCT01963208|447805879|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
124506517|NCT01963208|447805880|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
124506518|NCT01963208|447805881|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
124506519|NCT01963208|447805876|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
124506520|NCT01963208|447805877|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
124506521|NCT01963208|447805878|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
124506522|NCT01963208|447805879|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
124506523|NCT01963208|447805880|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
124506524|NCT01963208|447805881|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
124506525|NCT01963208|447805876|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
124506526|NCT01963208|447805877|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
124506527|NCT01963208|447805878|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
124506528|NCT01963208|447805879|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
124506529|NCT01963208|447805880|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
124506530|NCT01963208|447805881|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
124506531|NCT01963208|447805876|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
124506532|NCT01963208|447805877|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
124506533|NCT01963208|447805878|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
124506534|NCT01963208|447805879|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
124506535|NCT01963208|447805880|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
124506536|NCT01963208|447805881|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
124506537|NCT01963208|447805876|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
124506538|NCT01963208|447805877|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
124506539|NCT01963208|447805878|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
124506540|NCT01963208|447805879|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
124506541|NCT01963208|447805880|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
124506542|NCT01963208|447805881|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
124506543|NCT04191577|447805882|FG000|Overall Study|Withdrawal by Subject|2|||
124506544|NCT04191577|447805883|FG001|Overall Study|Withdrawal by Subject|2|||
124506545|NCT04191577|447805884|FG002|Overall Study|Withdrawal by Subject|1|||
124506546|NCT04191577|447805882|FG000|Overall Study|Physician Decision|1|||
124506547|NCT04191577|447805883|FG001|Overall Study|Physician Decision|1|||
124506548|NCT04191577|447805884|FG002|Overall Study|Physician Decision|0|||
124506549|NCT04191577|447805882|FG000|Overall Study|Adverse Event|0|||
124506550|NCT04191577|447805883|FG001|Overall Study|Adverse Event|0|||
124506551|NCT04191577|447805884|FG002|Overall Study|Adverse Event|1|||
124506552|NCT04191577|447805882|FG000|Overall Study|Death|0|||
124506553|NCT04191577|447805883|FG001|Overall Study|Death|0|||
124506554|NCT04191577|447805884|FG002|Overall Study|Death|1|||
124506555|NCT00448916|447805885|FG000|Overall Study|Adverse Event|2|||
124506556|NCT00448916|447805886|FG001|Overall Study|Adverse Event|2|||
124506557|NCT00448916|447805887|FG002|Overall Study|Adverse Event|3|||
124506558|NCT00448916|447805888|FG003|Overall Study|Adverse Event|2|||
124506559|NCT00448916|447805885|FG000|Overall Study|Lack of Efficacy|1|||
124506560|NCT00448916|447805886|FG001|Overall Study|Lack of Efficacy|0|||
124506561|NCT00448916|447805887|FG002|Overall Study|Lack of Efficacy|2|||
124506562|NCT00448916|447805888|FG003|Overall Study|Lack of Efficacy|1|||
124506563|NCT00448916|447805885|FG000|Overall Study|Withdrawal by Subject|3|||
124506564|NCT00448916|447805886|FG001|Overall Study|Withdrawal by Subject|3|||
124506565|NCT00448916|447805887|FG002|Overall Study|Withdrawal by Subject|1|||
124506566|NCT00448916|447805888|FG003|Overall Study|Withdrawal by Subject|1|||
124506567|NCT00448916|447805885|FG000|Overall Study|Other|1|||
124506568|NCT00448916|447805886|FG001|Overall Study|Other|0|||
124506569|NCT00448916|447805887|FG002|Overall Study|Other|0|||
124506570|NCT00448916|447805888|FG003|Overall Study|Other|0|||
124506571|NCT00448916|447805885|FG000|Overall Study|Lost to Follow-up|0|||
124506572|NCT00448916|447805886|FG001|Overall Study|Lost to Follow-up|1|||
124506573|NCT00448916|447805887|FG002|Overall Study|Lost to Follow-up|0|||
124506574|NCT00448916|447805888|FG003|Overall Study|Lost to Follow-up|1|||
124506575|NCT00448916|447805885|FG000|Overall Study|Protocol Violation|0|||
124506576|NCT00448916|447805886|FG001|Overall Study|Protocol Violation|0|||
124506577|NCT00448916|447805887|FG002|Overall Study|Protocol Violation|0|||
124506578|NCT00448916|447805888|FG003|Overall Study|Protocol Violation|1|||
124506579|NCT01185249|447805889|FG000|Overall Study|Patients discharged or change in status|42|||
124506580|NCT03521193|447805890|FG000|Overall Study|Withdrawal by Subject|8|||
124506581|NCT03521193|447805891|FG001|Overall Study|Withdrawal by Subject|0|||
124506582|NCT03521193|447805890|FG000|Overall Study|non compliant to ASA treatment|8|||
124506583|NCT03521193|447805891|FG001|Overall Study|non compliant to ASA treatment|0|||
124506584|NCT01810042|447805894|FG000|Overall Study|Lost to Follow-up|10|||
124506585|NCT03707158|447805895|FG000|Midtreatment|Lost to Follow-up|16|||
124506586|NCT03707158|447805896|FG001|Midtreatment|Lost to Follow-up|7|||
124506587|NCT03707158|447805895|FG000|Midtreatment|Withdrawal by Subject|28|||
124506588|NCT03707158|447805896|FG001|Midtreatment|Withdrawal by Subject|19|||
124506589|NCT03707158|447805895|FG000|Posttreatment|Lost to Follow-up|0|||
124506590|NCT03707158|447805896|FG001|Posttreatment|Lost to Follow-up|5|||
124506591|NCT03707158|447805895|FG000|Follow-up|Lost to Follow-up|19|||
124506592|NCT03707158|447805896|FG001|Follow-up|Lost to Follow-up|18|||
124506593|NCT03707158|447805895|FG000|Follow-up|Withdrawal by Subject|13|||
124506594|NCT03707158|447805896|FG001|Follow-up|Withdrawal by Subject|6|||
124506595|NCT02773238|447805897|FG000|Overall Study|Lack of Efficacy|4|||
124506596|NCT01208038|447805898|FG000|Overall Study|Withdrawal by Subject|1|||
124506597|NCT01877382|447805904|FG000|Dose Escalation|Progressive disease|2|||
124506598|NCT01877382|447805905|FG001|Dose Escalation|Progressive disease|0|||
124506599|NCT01877382|447805906|FG002|Dose Escalation|Progressive disease|1|||
124506600|NCT01877382|447805907|FG003|Dose Escalation|Progressive disease|6|||
124506601|NCT01877382|447805908|FG004|Dose Escalation|Progressive disease|1|||
124506602|NCT01877382|447805909|FG005|Dose Escalation|Progressive disease|0|||
124506603|NCT01877382|447805910|FG006|Dose Escalation|Progressive disease|3|||
124506604|NCT01877382|447805911|FG007|Dose Escalation|Progressive disease|10|||
124506605|NCT01877382|447805912|FG008|Dose Escalation|Progressive disease|4|||
124506606|NCT01877382|447805913|FG009|Dose Escalation|Progressive disease|2|||
124506607|NCT01877382|447805914|FG010|Dose Escalation|Progressive disease|3|||
124506608|NCT01877382|447805915|FG011|Dose Escalation|Progressive disease|3|||
124506609|NCT01877382|447805916|FG012|Dose Escalation|Progressive disease|13|||
124506610|NCT01877382|447805917|FG013|Dose Escalation|Progressive disease|1|||
124506611|NCT01877382|447805918|FG014|Dose Escalation|Progressive disease|0|||
124506612|NCT01877382|447805904|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
124506613|NCT01877382|447805905|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506614|NCT01877382|447805906|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506615|NCT01877382|447805907|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
124506616|NCT01877382|447805908|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506617|NCT01877382|447805909|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506618|NCT01877382|447805910|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
124506619|NCT01877382|447805911|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506620|NCT01877382|447805912|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506621|NCT01877382|447805913|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506622|NCT01877382|447805914|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506623|NCT01877382|447805915|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506624|NCT01877382|447805916|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506625|NCT01877382|447805917|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506626|NCT01877382|447805918|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506627|NCT01877382|447805904|FG000|Dose Escalation|Clinical progression|0|||
124563605|NCT01798485|448020110|FG000|Overall Study|Lost to Follow-up|0|||
124563606|NCT01798485|448020111|FG001|Overall Study|Lost to Follow-up|3|||
124563607|NCT01798485|448020110|FG000|Overall Study|Physician Decision|14|||
124563608|NCT01798485|448020111|FG001|Overall Study|Physician Decision|10|||
124563609|NCT01798485|448020110|FG000|Overall Study|Objective Disease Progression|152|||
124563610|NCT01798485|448020111|FG001|Overall Study|Objective Disease Progression|106|||
124563611|NCT01798485|448020110|FG000|Overall Study|Death|25|||
124563612|NCT01798485|448020111|FG001|Overall Study|Death|22|||
124563613|NCT01798485|448020110|FG000|Overall Study|Sponsor Decision|61|||
124563614|NCT01798485|448020111|FG001|Overall Study|Sponsor Decision|54|||
124563615|NCT01798485|448020110|FG000|Overall Study|Clinical Progression|35|||
124563616|NCT01798485|448020111|FG001|Overall Study|Clinical Progression|24|||
124563617|NCT01254409|448020112|FG000|Overall Study|Adverse Event|0|||
124563618|NCT01254409|448020113|FG001|Overall Study|Adverse Event|1|||
124563619|NCT01254409|448020114|FG002|Overall Study|Adverse Event|0|||
124563620|NCT01254409|448020115|FG003|Overall Study|Adverse Event|0|||
124563621|NCT03521999|448020119|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
124563622|NCT03521999|448020120|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
124563623|NCT03521999|448020119|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
124563624|NCT03521999|448020120|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
124563625|NCT03521999|448020119|FG000|Completed 3 Month Follow up|Death|0|||
124563626|NCT03521999|448020120|FG001|Completed 3 Month Follow up|Death|1|||
124563627|NCT03521999|448020119|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
124563628|NCT03521999|448020120|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
124563629|NCT01564758|448020121|FG000|Overall Study|Death|8|||
124563630|NCT01564758|448020121|FG000|Overall Study|Adverse Event|3|||
124563631|NCT01564758|448020121|FG000|Overall Study|Other|3|||
124563632|NCT00249821|448020122|FG000|Overall Study|Technical problem|0|||
124563633|NCT00249821|448020123|FG001|Overall Study|Technical problem|1|||
124563634|NCT01862328|448020126|FG000|Overall Study|Progressive Disease|3|||
124563635|NCT01862328|448020127|FG001|Overall Study|Progressive Disease|11|||
124563636|NCT01862328|448020128|FG002|Overall Study|Progressive Disease|5|||
124563637|NCT01862328|448020129|FG003|Overall Study|Progressive Disease|6|||
124563638|NCT01862328|448020130|FG004|Overall Study|Progressive Disease|7|||
124563639|NCT01862328|448020131|FG005|Overall Study|Progressive Disease|4|||
124563640|NCT01862328|448020132|FG006|Overall Study|Progressive Disease|3|||
124563641|NCT01862328|448020126|FG000|Overall Study|Adverse Event|0|||
124776669|NCT01657019|448809944|FG000|Overall Study|Lack of Efficacy|3|||
124563642|NCT01862328|448020127|FG001|Overall Study|Adverse Event|4|||
124563643|NCT01862328|448020128|FG002|Overall Study|Adverse Event|0|||
124563644|NCT01862328|448020129|FG003|Overall Study|Adverse Event|1|||
124563645|NCT01862328|448020130|FG004|Overall Study|Adverse Event|0|||
124563646|NCT01862328|448020131|FG005|Overall Study|Adverse Event|2|||
124563647|NCT01862328|448020132|FG006|Overall Study|Adverse Event|4|||
124563648|NCT01862328|448020126|FG000|Overall Study|Other|0|||
124563649|NCT01862328|448020127|FG001|Overall Study|Other|2|||
124563650|NCT01862328|448020128|FG002|Overall Study|Other|1|||
124563651|NCT01862328|448020129|FG003|Overall Study|Other|0|||
124563652|NCT01862328|448020130|FG004|Overall Study|Other|4|||
124563653|NCT01862328|448020131|FG005|Overall Study|Other|0|||
124563654|NCT01862328|448020132|FG006|Overall Study|Other|1|||
124563655|NCT01862328|448020126|FG000|Overall Study|Withdrawal by Subject|1|||
124563656|NCT01862328|448020127|FG001|Overall Study|Withdrawal by Subject|1|||
124563657|NCT01862328|448020128|FG002|Overall Study|Withdrawal by Subject|0|||
124563658|NCT01862328|448020129|FG003|Overall Study|Withdrawal by Subject|0|||
124563659|NCT01862328|448020130|FG004|Overall Study|Withdrawal by Subject|1|||
124563660|NCT01862328|448020131|FG005|Overall Study|Withdrawal by Subject|1|||
124563661|NCT01862328|448020132|FG006|Overall Study|Withdrawal by Subject|1|||
124506628|NCT01877382|447805905|FG001|Dose Escalation|Clinical progression|1|||
124506629|NCT01877382|447805906|FG002|Dose Escalation|Clinical progression|0|||
124506630|NCT01877382|447805907|FG003|Dose Escalation|Clinical progression|2|||
124506631|NCT01877382|447805908|FG004|Dose Escalation|Clinical progression|0|||
124506632|NCT01877382|447805909|FG005|Dose Escalation|Clinical progression|0|||
124506633|NCT01877382|447805910|FG006|Dose Escalation|Clinical progression|1|||
124506634|NCT01877382|447805911|FG007|Dose Escalation|Clinical progression|0|||
124506635|NCT01877382|447805912|FG008|Dose Escalation|Clinical progression|0|||
124506636|NCT01877382|447805913|FG009|Dose Escalation|Clinical progression|1|||
124506637|NCT01877382|447805914|FG010|Dose Escalation|Clinical progression|0|||
124506638|NCT01877382|447805915|FG011|Dose Escalation|Clinical progression|0|||
124506639|NCT01877382|447805916|FG012|Dose Escalation|Clinical progression|2|||
124506640|NCT01877382|447805917|FG013|Dose Escalation|Clinical progression|1|||
124506641|NCT01877382|447805918|FG014|Dose Escalation|Clinical progression|0|||
124506642|NCT01877382|447805904|FG000|Dose Escalation|Adverse Event|0|||
124506643|NCT01877382|447805905|FG001|Dose Escalation|Adverse Event|0|||
124506644|NCT01877382|447805906|FG002|Dose Escalation|Adverse Event|0|||
124506645|NCT01877382|447805907|FG003|Dose Escalation|Adverse Event|4|||
124506646|NCT01877382|447805908|FG004|Dose Escalation|Adverse Event|1|||
124506647|NCT01877382|447805909|FG005|Dose Escalation|Adverse Event|2|||
124506648|NCT01877382|447805910|FG006|Dose Escalation|Adverse Event|1|||
124506649|NCT01877382|447805911|FG007|Dose Escalation|Adverse Event|2|||
124506650|NCT01877382|447805912|FG008|Dose Escalation|Adverse Event|0|||
124506651|NCT01877382|447805913|FG009|Dose Escalation|Adverse Event|0|||
124506652|NCT01877382|447805914|FG010|Dose Escalation|Adverse Event|0|||
124506653|NCT01877382|447805915|FG011|Dose Escalation|Adverse Event|0|||
124506654|NCT01877382|447805916|FG012|Dose Escalation|Adverse Event|1|||
124506655|NCT01877382|447805917|FG013|Dose Escalation|Adverse Event|0|||
124506656|NCT01877382|447805918|FG014|Dose Escalation|Adverse Event|0|||
124506657|NCT01877382|447805904|FG000|Dose Escalation|Withdrawal by Subject|0|||
124506658|NCT01877382|447805905|FG001|Dose Escalation|Withdrawal by Subject|0|||
124506659|NCT01877382|447805906|FG002|Dose Escalation|Withdrawal by Subject|0|||
124506660|NCT01877382|447805907|FG003|Dose Escalation|Withdrawal by Subject|0|||
124506661|NCT01877382|447805908|FG004|Dose Escalation|Withdrawal by Subject|0|||
124506662|NCT01877382|447805909|FG005|Dose Escalation|Withdrawal by Subject|3|||
124506663|NCT01877382|447805910|FG006|Dose Escalation|Withdrawal by Subject|2|||
124506664|NCT01877382|447805911|FG007|Dose Escalation|Withdrawal by Subject|1|||
124506665|NCT01877382|447805912|FG008|Dose Escalation|Withdrawal by Subject|1|||
124506666|NCT01877382|447805913|FG009|Dose Escalation|Withdrawal by Subject|0|||
124506667|NCT01877382|447805914|FG010|Dose Escalation|Withdrawal by Subject|0|||
124506668|NCT01877382|447805915|FG011|Dose Escalation|Withdrawal by Subject|0|||
124506669|NCT01877382|447805916|FG012|Dose Escalation|Withdrawal by Subject|0|||
124506670|NCT01877382|447805917|FG013|Dose Escalation|Withdrawal by Subject|0|||
124506671|NCT01877382|447805918|FG014|Dose Escalation|Withdrawal by Subject|0|||
124506672|NCT01877382|447805904|FG000|Dose Escalation|Protocol Violation|0|||
124506673|NCT01877382|447805905|FG001|Dose Escalation|Protocol Violation|0|||
124506674|NCT01877382|447805906|FG002|Dose Escalation|Protocol Violation|0|||
124506675|NCT01877382|447805907|FG003|Dose Escalation|Protocol Violation|0|||
124506676|NCT01877382|447805908|FG004|Dose Escalation|Protocol Violation|0|||
124506677|NCT01877382|447805909|FG005|Dose Escalation|Protocol Violation|0|||
124506678|NCT01877382|447805910|FG006|Dose Escalation|Protocol Violation|1|||
124563662|NCT01862328|448020126|FG000|Overall Study|Symptomatic Deterioration|0|||
124563663|NCT01862328|448020127|FG001|Overall Study|Symptomatic Deterioration|0|||
124563664|NCT01862328|448020128|FG002|Overall Study|Symptomatic Deterioration|0|||
124563665|NCT01862328|448020129|FG003|Overall Study|Symptomatic Deterioration|0|||
124563666|NCT01862328|448020130|FG004|Overall Study|Symptomatic Deterioration|0|||
124563667|NCT01862328|448020131|FG005|Overall Study|Symptomatic Deterioration|0|||
124563668|NCT01862328|448020132|FG006|Overall Study|Symptomatic Deterioration|1|||
124563669|NCT02482571|448020133|FG000|Overall Study|Adverse Event|1|||
124563670|NCT02482571|448020133|FG000|Overall Study|Scanner or Respiract failure|3|||
124563671|NCT02482571|448020133|FG000|Overall Study|Withdrawal by Subject|4|||
124563672|NCT01498484|448020137|FG000|Overall Study|Death|6|||
124506679|NCT01877382|447805911|FG007|Dose Escalation|Protocol Violation|0|||
124506680|NCT01877382|447805912|FG008|Dose Escalation|Protocol Violation|0|||
124506681|NCT01877382|447805913|FG009|Dose Escalation|Protocol Violation|0|||
124506682|NCT01877382|447805914|FG010|Dose Escalation|Protocol Violation|0|||
124506683|NCT01877382|447805915|FG011|Dose Escalation|Protocol Violation|0|||
124506684|NCT01877382|447805916|FG012|Dose Escalation|Protocol Violation|0|||
124776670|NCT01657019|448809944|FG000|Overall Study|Other|58|||
124506685|NCT01877382|447805917|FG013|Dose Escalation|Protocol Violation|0|||
124563673|NCT01498484|448020138|FG001|Overall Study|Death|3|||
124563674|NCT01498484|448020139|FG002|Overall Study|Death|1|||
124506686|NCT01877382|447805918|FG014|Dose Escalation|Protocol Violation|0|||
124506687|NCT01877382|447805904|FG000|Dose Escalation|Study terminated by sponsor|0|||
124506688|NCT01877382|447805905|FG001|Dose Escalation|Study terminated by sponsor|0|||
124506689|NCT01877382|447805906|FG002|Dose Escalation|Study terminated by sponsor|0|||
124506690|NCT01877382|447805907|FG003|Dose Escalation|Study terminated by sponsor|0|||
124506691|NCT01877382|447805908|FG004|Dose Escalation|Study terminated by sponsor|0|||
124506692|NCT01877382|447805909|FG005|Dose Escalation|Study terminated by sponsor|0|||
124506693|NCT01877382|447805910|FG006|Dose Escalation|Study terminated by sponsor|0|||
124506694|NCT01877382|447805911|FG007|Dose Escalation|Study terminated by sponsor|1|||
124506695|NCT01877382|447805912|FG008|Dose Escalation|Study terminated by sponsor|1|||
124506696|NCT01877382|447805913|FG009|Dose Escalation|Study terminated by sponsor|0|||
124506697|NCT01877382|447805914|FG010|Dose Escalation|Study terminated by sponsor|0|||
124506698|NCT01877382|447805915|FG011|Dose Escalation|Study terminated by sponsor|0|||
124506699|NCT01877382|447805916|FG012|Dose Escalation|Study terminated by sponsor|3|||
124506700|NCT01877382|447805917|FG013|Dose Escalation|Study terminated by sponsor|0|||
124506701|NCT01877382|447805918|FG014|Dose Escalation|Study terminated by sponsor|0|||
124506702|NCT01877382|447805904|FG000|Dose Escalation|Death|0|||
124506703|NCT01877382|447805905|FG001|Dose Escalation|Death|0|||
124506704|NCT01877382|447805906|FG002|Dose Escalation|Death|0|||
124506705|NCT01877382|447805907|FG003|Dose Escalation|Death|0|||
124506706|NCT01877382|447805908|FG004|Dose Escalation|Death|0|||
124506707|NCT01877382|447805909|FG005|Dose Escalation|Death|0|||
124506708|NCT01877382|447805910|FG006|Dose Escalation|Death|0|||
124506709|NCT01877382|447805911|FG007|Dose Escalation|Death|1|||
124506710|NCT01877382|447805912|FG008|Dose Escalation|Death|0|||
124506711|NCT01877382|447805913|FG009|Dose Escalation|Death|0|||
124506712|NCT01877382|447805914|FG010|Dose Escalation|Death|0|||
124506713|NCT01877382|447805915|FG011|Dose Escalation|Death|0|||
124506714|NCT01877382|447805916|FG012|Dose Escalation|Death|1|||
124506715|NCT01877382|447805917|FG013|Dose Escalation|Death|1|||
124506716|NCT01877382|447805918|FG014|Dose Escalation|Death|0|||
124506717|NCT01877382|447805904|FG000|Dose Expansion|Progressive disease|0|||
124506718|NCT01877382|447805905|FG001|Dose Expansion|Progressive disease|0|||
124506719|NCT01877382|447805906|FG002|Dose Expansion|Progressive disease|0|||
124506720|NCT01877382|447805907|FG003|Dose Expansion|Progressive disease|0|||
124506721|NCT01877382|447805908|FG004|Dose Expansion|Progressive disease|0|||
124506722|NCT01877382|447805909|FG005|Dose Expansion|Progressive disease|0|||
124506723|NCT01877382|447805910|FG006|Dose Expansion|Progressive disease|0|||
124506724|NCT01877382|447805911|FG007|Dose Expansion|Progressive disease|0|||
124506725|NCT01877382|447805912|FG008|Dose Expansion|Progressive disease|0|||
124506726|NCT01877382|447805913|FG009|Dose Expansion|Progressive disease|0|||
124506727|NCT01877382|447805914|FG010|Dose Expansion|Progressive disease|0|||
124506728|NCT01877382|447805915|FG011|Dose Expansion|Progressive disease|0|||
124506729|NCT01877382|447805916|FG012|Dose Expansion|Progressive disease|0|||
124506730|NCT01877382|447805917|FG013|Dose Expansion|Progressive disease|0|||
124506731|NCT01877382|447805918|FG014|Dose Expansion|Progressive disease|11|||
124506732|NCT01877382|447805904|FG000|Dose Expansion|Clinical progression|0|||
124506733|NCT01877382|447805905|FG001|Dose Expansion|Clinical progression|0|||
124506734|NCT01877382|447805906|FG002|Dose Expansion|Clinical progression|0|||
124506735|NCT01877382|447805907|FG003|Dose Expansion|Clinical progression|0|||
124506736|NCT01877382|447805908|FG004|Dose Expansion|Clinical progression|0|||
124506737|NCT01877382|447805909|FG005|Dose Expansion|Clinical progression|0|||
124506738|NCT01877382|447805910|FG006|Dose Expansion|Clinical progression|0|||
124506739|NCT01877382|447805911|FG007|Dose Expansion|Clinical progression|0|||
124506740|NCT01877382|447805912|FG008|Dose Expansion|Clinical progression|0|||
124506741|NCT01877382|447805913|FG009|Dose Expansion|Clinical progression|0|||
124506742|NCT01877382|447805914|FG010|Dose Expansion|Clinical progression|0|||
124506743|NCT01877382|447805915|FG011|Dose Expansion|Clinical progression|0|||
124506744|NCT01877382|447805916|FG012|Dose Expansion|Clinical progression|0|||
124506745|NCT01877382|447805917|FG013|Dose Expansion|Clinical progression|0|||
124506746|NCT01877382|447805918|FG014|Dose Expansion|Clinical progression|6|||
124506747|NCT01877382|447805904|FG000|Dose Expansion|Adverse Event|0|||
124506748|NCT01877382|447805905|FG001|Dose Expansion|Adverse Event|0|||
124506749|NCT01877382|447805906|FG002|Dose Expansion|Adverse Event|0|||
124506750|NCT01877382|447805907|FG003|Dose Expansion|Adverse Event|0|||
124506751|NCT01877382|447805908|FG004|Dose Expansion|Adverse Event|0|||
124506752|NCT01877382|447805909|FG005|Dose Expansion|Adverse Event|0|||
124506753|NCT01877382|447805910|FG006|Dose Expansion|Adverse Event|0|||
124506754|NCT01877382|447805911|FG007|Dose Expansion|Adverse Event|0|||
124506755|NCT01877382|447805912|FG008|Dose Expansion|Adverse Event|0|||
124506756|NCT01877382|447805913|FG009|Dose Expansion|Adverse Event|0|||
124506757|NCT01877382|447805914|FG010|Dose Expansion|Adverse Event|0|||
124506758|NCT01877382|447805915|FG011|Dose Expansion|Adverse Event|0|||
124506759|NCT01877382|447805916|FG012|Dose Expansion|Adverse Event|0|||
124506760|NCT01877382|447805917|FG013|Dose Expansion|Adverse Event|0|||
124506761|NCT01877382|447805918|FG014|Dose Expansion|Adverse Event|1|||
124506762|NCT01877382|447805904|FG000|Dose Expansion|Death|0|||
124506763|NCT01877382|447805905|FG001|Dose Expansion|Death|0|||
124506764|NCT01877382|447805906|FG002|Dose Expansion|Death|0|||
124506765|NCT01877382|447805907|FG003|Dose Expansion|Death|0|||
124506766|NCT01877382|447805908|FG004|Dose Expansion|Death|0|||
124506767|NCT01877382|447805909|FG005|Dose Expansion|Death|0|||
124506768|NCT01877382|447805910|FG006|Dose Expansion|Death|0|||
124506769|NCT01877382|447805911|FG007|Dose Expansion|Death|0|||
124506770|NCT01877382|447805912|FG008|Dose Expansion|Death|0|||
124506771|NCT01877382|447805913|FG009|Dose Expansion|Death|0|||
124506772|NCT01877382|447805914|FG010|Dose Expansion|Death|0|||
124506773|NCT01877382|447805915|FG011|Dose Expansion|Death|0|||
124506774|NCT01877382|447805916|FG012|Dose Expansion|Death|0|||
124506775|NCT01877382|447805917|FG013|Dose Expansion|Death|0|||
124506776|NCT01877382|447805918|FG014|Dose Expansion|Death|1|||
124506777|NCT01877382|447805904|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506778|NCT01877382|447805905|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506779|NCT01877382|447805906|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506780|NCT01877382|447805907|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506781|NCT01877382|447805908|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506782|NCT01877382|447805909|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506783|NCT01877382|447805910|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506784|NCT01877382|447805911|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506785|NCT01877382|447805912|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506786|NCT01877382|447805913|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506787|NCT01877382|447805914|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506788|NCT01877382|447805915|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506789|NCT01877382|447805916|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506790|NCT01877382|447805917|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
124506791|NCT01877382|447805918|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
124506792|NCT03829332|447805921|FG000|Overall Study|Death|225|||
124506793|NCT03829332|447805922|FG001|Overall Study|Death|230|||
124506794|NCT03829332|447805921|FG000|Overall Study|Lost to Follow-up|1|||
124506795|NCT03829332|447805922|FG001|Overall Study|Lost to Follow-up|3|||
124506796|NCT03829332|447805921|FG000|Overall Study|Physician Decision|1|||
124506797|NCT03829332|447805922|FG001|Overall Study|Physician Decision|0|||
124506798|NCT03829332|447805921|FG000|Overall Study|Sponsor Decision|71|||
124506799|NCT03829332|447805922|FG001|Overall Study|Sponsor Decision|72|||
124506800|NCT03829332|447805921|FG000|Overall Study|Withdrawal by Subject|11|||
124506801|NCT03829332|447805922|FG001|Overall Study|Withdrawal by Subject|9|||
124506802|NCT04752189|447805923|FG000|Overall Study|Withdrawal by Subject|0|||
124506803|NCT04752189|447805924|FG001|Overall Study|Withdrawal by Subject|150|||
124506804|NCT04752189|447805923|FG000|Overall Study|Lost to Follow-up|261|||
124506805|NCT04752189|447805924|FG001|Overall Study|Lost to Follow-up|126|||
124506806|NCT03422133|447805925|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
124506807|NCT03422133|447805926|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
124506808|NCT03003403|447805927|FG000|Overall Study|Ineligible|8|||
124506809|NCT03003403|447805928|FG001|Overall Study|Ineligible|7|||
124506810|NCT03003403|447805927|FG000|Overall Study|Withdrawal by Subject|3|||
124506811|NCT03003403|447805928|FG001|Overall Study|Withdrawal by Subject|1|||
124506812|NCT00296725|447807952|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
124506813|NCT00296725|447807952|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
124506814|NCT00296725|447807952|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
124506815|NCT03712345|447807955|FG000|Overall Study|Failure to meet randomization criteria|0|||
124506816|NCT03712345|447807956|FG001|Overall Study|Failure to meet randomization criteria|0|||
124506817|NCT03712345|447807957|FG002|Overall Study|Failure to meet randomization criteria|1|||
124506818|NCT02585999|447807961|FG000|Overall Study|Lost to Follow-up|1|||
124506819|NCT02585999|447807961|FG000|Overall Study|Protocol Violation|1|||
124506820|NCT00485589|447807962|FG000|Overall Study|Death|2|||
124506821|NCT00485589|447807963|FG001|Overall Study|Death|2|||
124506822|NCT00485589|447807964|FG002|Overall Study|Death|0|||
124506823|NCT00485589|447807962|FG000|Overall Study|Failure to return|6|||
124506824|NCT00485589|447807963|FG001|Overall Study|Failure to return|5|||
124506825|NCT00485589|447807964|FG002|Overall Study|Failure to return|1|||
124506826|NCT00485589|447807962|FG000|Overall Study|Protocol Violation|1|||
124506827|NCT00485589|447807963|FG001|Overall Study|Protocol Violation|0|||
124506828|NCT00485589|447807964|FG002|Overall Study|Protocol Violation|0|||
124506829|NCT00485589|447807962|FG000|Overall Study|Violation of selection criteria at entry|0|||
124506830|NCT00485589|447807963|FG001|Overall Study|Violation of selection criteria at entry|3|||
124506831|NCT00485589|447807964|FG002|Overall Study|Violation of selection criteria at entry|1|||
124506832|NCT00485589|447807962|FG000|Overall Study|Administrative/Other|1|||
124563675|NCT01498484|448020140|FG003|Overall Study|Death|1|||
124563676|NCT01498484|448020141|FG004|Overall Study|Death|0|||
124776671|NCT00998296|448809945|FG000|Overall Study|Progressive disease|0|||
124506833|NCT00485589|447807963|FG001|Overall Study|Administrative/Other|2|||
124506834|NCT00485589|447807964|FG002|Overall Study|Administrative/Other|1|||
124506835|NCT00485589|447807962|FG000|Overall Study|Insufficient therapeutic response|10|||
124506836|NCT00485589|447807963|FG001|Overall Study|Insufficient therapeutic response|3|||
124506837|NCT00485589|447807964|FG002|Overall Study|Insufficient therapeutic response|1|||
124506838|NCT00485589|447807962|FG000|Overall Study|Refused treatment/did not cooperate|1|||
124506839|NCT00485589|447807963|FG001|Overall Study|Refused treatment/did not cooperate|0|||
124506840|NCT00485589|447807964|FG002|Overall Study|Refused treatment/did not cooperate|2|||
124506841|NCT00485589|447807962|FG000|Overall Study|Withdrawal by Subject|3|||
124506842|NCT00485589|447807963|FG001|Overall Study|Withdrawal by Subject|2|||
124506843|NCT00485589|447807964|FG002|Overall Study|Withdrawal by Subject|2|||
124506844|NCT00485589|447807962|FG000|Overall Study|Adverse Event|3|||
124506845|NCT00485589|447807963|FG001|Overall Study|Adverse Event|3|||
124506846|NCT00485589|447807964|FG002|Overall Study|Adverse Event|10|||
124506847|NCT01369849|447807965|FG000|Overall Study|Ineligible prior to treatment|0|||
124506848|NCT01369849|447807966|FG001|Overall Study|Ineligible prior to treatment|0|||
124506849|NCT01369849|447807967|FG002|Overall Study|Ineligible prior to treatment|1|||
124563677|NCT01498484|448020142|FG005|Overall Study|Death|0|||
124563678|NCT01498484|448020143|FG006|Overall Study|Death|10|||
124563679|NCT01498484|448020144|FG007|Overall Study|Death|1|||
124563680|NCT01498484|448020145|FG008|Overall Study|Death|0|||
124563681|NCT01498484|448020137|FG000|Overall Study|Physician Decision|3|||
124563682|NCT01498484|448020138|FG001|Overall Study|Physician Decision|2|||
124563683|NCT01498484|448020139|FG002|Overall Study|Physician Decision|1|||
124563684|NCT01498484|448020140|FG003|Overall Study|Physician Decision|1|||
124563685|NCT01498484|448020141|FG004|Overall Study|Physician Decision|0|||
124563686|NCT01498484|448020142|FG005|Overall Study|Physician Decision|0|||
124563687|NCT01498484|448020143|FG006|Overall Study|Physician Decision|8|||
124563688|NCT01498484|448020144|FG007|Overall Study|Physician Decision|13|||
124563689|NCT01498484|448020145|FG008|Overall Study|Physician Decision|1|||
124563690|NCT01498484|448020137|FG000|Overall Study|Adverse Event|0|||
124563691|NCT01498484|448020138|FG001|Overall Study|Adverse Event|0|||
124563692|NCT01498484|448020139|FG002|Overall Study|Adverse Event|0|||
124563693|NCT01498484|448020140|FG003|Overall Study|Adverse Event|0|||
124563694|NCT01498484|448020141|FG004|Overall Study|Adverse Event|0|||
124563695|NCT01498484|448020142|FG005|Overall Study|Adverse Event|1|||
124563696|NCT01498484|448020143|FG006|Overall Study|Adverse Event|0|||
124563697|NCT01498484|448020144|FG007|Overall Study|Adverse Event|0|||
124563698|NCT01498484|448020145|FG008|Overall Study|Adverse Event|0|||
124563699|NCT01498484|448020137|FG000|Overall Study|Withdrawal by Subject|0|||
124563700|NCT01498484|448020138|FG001|Overall Study|Withdrawal by Subject|0|||
124563701|NCT01498484|448020139|FG002|Overall Study|Withdrawal by Subject|0|||
124563702|NCT01498484|448020140|FG003|Overall Study|Withdrawal by Subject|1|||
124563703|NCT01498484|448020141|FG004|Overall Study|Withdrawal by Subject|0|||
124563704|NCT01498484|448020142|FG005|Overall Study|Withdrawal by Subject|0|||
124563705|NCT01498484|448020143|FG006|Overall Study|Withdrawal by Subject|1|||
124563706|NCT01498484|448020144|FG007|Overall Study|Withdrawal by Subject|0|||
124563707|NCT01498484|448020145|FG008|Overall Study|Withdrawal by Subject|0|||
124563708|NCT01498484|448020137|FG000|Overall Study|Other|5|||
124563709|NCT01498484|448020138|FG001|Overall Study|Other|2|||
124563710|NCT01498484|448020139|FG002|Overall Study|Other|0|||
124563711|NCT01498484|448020140|FG003|Overall Study|Other|0|||
124563712|NCT01498484|448020141|FG004|Overall Study|Other|1|||
124563713|NCT01498484|448020142|FG005|Overall Study|Other|0|||
124563714|NCT01498484|448020143|FG006|Overall Study|Other|3|||
124563715|NCT01498484|448020144|FG007|Overall Study|Other|0|||
124563716|NCT01498484|448020145|FG008|Overall Study|Other|1|||
124563717|NCT00278512|448020146|FG000|Overall Study|Death|1|||
124563718|NCT00278512|448020147|FG001|Overall Study|Death|0|||
124563719|NCT01202747|448020148|FG000|Overall Study|Withdrawal by Subject|1|||
124563720|NCT01620177|448020149|FG000|Overall Study|Failure at Screening Visit|43|||
124563721|NCT01620177|448020149|FG000|Overall Study|Withdrawal by Subject|26|||
124563722|NCT01620177|448020149|FG000|Overall Study|Lost to Follow-up|7|||
124563723|NCT01620177|448020149|FG000|Overall Study|Physician Decision|2|||
124563724|NCT01620177|448020149|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
124563725|NCT02292238|448020153|FG000|Overall Study|Protocol Violation|1|||
124563726|NCT02292238|448020154|FG001|Overall Study|Protocol Violation|2|||
124506850|NCT01369849|447807965|FG000|Overall Study|Ineligible after receiving treatment|0|||
124506851|NCT01369849|447807966|FG001|Overall Study|Ineligible after receiving treatment|1|||
124506852|NCT01369849|447807967|FG002|Overall Study|Ineligible after receiving treatment|0|||
124506853|NCT02924688|447807968|FG000|Overall Study|Adverse Event|9|||
124563727|NCT02292238|448020153|FG000|Overall Study|Withdrawal by Subject|2|||
124563728|NCT02292238|448020154|FG001|Overall Study|Withdrawal by Subject|1|||
124563729|NCT02292238|448020153|FG000|Overall Study|Lost to Follow-up|1|||
124563730|NCT02292238|448020154|FG001|Overall Study|Lost to Follow-up|0|||
124563731|NCT02292238|448020153|FG000|Overall Study|Physician Decision|0|||
124563732|NCT02292238|448020154|FG001|Overall Study|Physician Decision|1|||
124563733|NCT01789320|448020155|FG000|Overall Study|Re-enrolled into study|1|||
124506854|NCT02924688|447807969|FG001|Overall Study|Adverse Event|3|||
124506855|NCT02924688|447807970|FG002|Overall Study|Adverse Event|2|||
124506856|NCT02924688|447807971|FG003|Overall Study|Adverse Event|2|||
124506857|NCT02924688|447807972|FG004|Overall Study|Adverse Event|3|||
124506858|NCT02924688|447807973|FG005|Overall Study|Adverse Event|2|||
124506859|NCT02924688|447807968|FG000|Overall Study|Lack of Efficacy|2|||
124506860|NCT02924688|447807969|FG001|Overall Study|Lack of Efficacy|3|||
124506861|NCT02924688|447807970|FG002|Overall Study|Lack of Efficacy|4|||
124506862|NCT02924688|447807971|FG003|Overall Study|Lack of Efficacy|2|||
124506863|NCT02924688|447807972|FG004|Overall Study|Lack of Efficacy|1|||
124506864|NCT02924688|447807973|FG005|Overall Study|Lack of Efficacy|1|||
124506865|NCT02924688|447807968|FG000|Overall Study|Protocol Violation|3|||
124506866|NCT02924688|447807969|FG001|Overall Study|Protocol Violation|7|||
124506867|NCT02924688|447807970|FG002|Overall Study|Protocol Violation|5|||
124506868|NCT02924688|447807971|FG003|Overall Study|Protocol Violation|6|||
124506869|NCT02924688|447807972|FG004|Overall Study|Protocol Violation|2|||
124506870|NCT02924688|447807973|FG005|Overall Study|Protocol Violation|2|||
124506871|NCT02924688|447807968|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
124506872|NCT02924688|447807969|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
124506873|NCT02924688|447807970|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
124506874|NCT02924688|447807971|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
124506875|NCT02924688|447807972|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
124506876|NCT02924688|447807973|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
124506877|NCT02924688|447807968|FG000|Overall Study|Lost to Follow-up|2|||
124506878|NCT02924688|447807969|FG001|Overall Study|Lost to Follow-up|4|||
124506879|NCT02924688|447807970|FG002|Overall Study|Lost to Follow-up|2|||
124506880|NCT02924688|447807971|FG003|Overall Study|Lost to Follow-up|4|||
124506881|NCT02924688|447807972|FG004|Overall Study|Lost to Follow-up|2|||
124506882|NCT02924688|447807973|FG005|Overall Study|Lost to Follow-up|4|||
124506883|NCT02924688|447807968|FG000|Overall Study|Physician Decision|2|||
124506884|NCT02924688|447807969|FG001|Overall Study|Physician Decision|1|||
124506885|NCT02924688|447807970|FG002|Overall Study|Physician Decision|0|||
124506886|NCT02924688|447807971|FG003|Overall Study|Physician Decision|1|||
124506887|NCT02924688|447807972|FG004|Overall Study|Physician Decision|1|||
124506888|NCT02924688|447807973|FG005|Overall Study|Physician Decision|1|||
124506889|NCT02924688|447807968|FG000|Overall Study|Withdrawal by Subject|14|||
124506890|NCT02924688|447807969|FG001|Overall Study|Withdrawal by Subject|13|||
124506891|NCT02924688|447807970|FG002|Overall Study|Withdrawal by Subject|9|||
124506892|NCT02924688|447807971|FG003|Overall Study|Withdrawal by Subject|12|||
124506893|NCT02924688|447807972|FG004|Overall Study|Withdrawal by Subject|13|||
124506894|NCT02924688|447807973|FG005|Overall Study|Withdrawal by Subject|14|||
124506895|NCT00174785|447807974|FG000|Overall Study|Adverse Event|293|||
124506896|NCT00174785|447807975|FG001|Overall Study|Adverse Event|191|||
124506897|NCT00174785|447807974|FG000|Overall Study|Protocol Violation|14|||
124506898|NCT00174785|447807975|FG001|Overall Study|Protocol Violation|14|||
124506899|NCT00174785|447807974|FG000|Overall Study|Withdrawal by Subject|173|||
124506900|NCT00174785|447807975|FG001|Overall Study|Withdrawal by Subject|175|||
124563734|NCT01789320|448020155|FG000|Overall Study|Lost to Follow-up|1|||
124563735|NCT00601484|448020159|FG000|Overall Study|Adverse Event|0|||
124563736|NCT00601484|448020160|FG001|Overall Study|Adverse Event|1|||
124563737|NCT00601484|448020159|FG000|Overall Study|Lost to Follow-up|4|||
124563738|NCT00601484|448020160|FG001|Overall Study|Lost to Follow-up|3|||
124563739|NCT00601484|448020159|FG000|Overall Study|Lack of Efficacy|0|||
124563740|NCT00601484|448020160|FG001|Overall Study|Lack of Efficacy|2|||
124563741|NCT00601484|448020159|FG000|Overall Study|Withdrawal by Subject|1|||
124563742|NCT00601484|448020160|FG001|Overall Study|Withdrawal by Subject|1|||
124563743|NCT00601484|448020159|FG000|Overall Study|Randomized, but not treated|0|||
124563744|NCT00601484|448020160|FG001|Overall Study|Randomized, but not treated|1|||
124563745|NCT01463683|448020165|FG000|Overall Study|Adverse Event|2|||
124563746|NCT01463683|448020166|FG001|Overall Study|Adverse Event|0|||
124563747|NCT01463683|448020167|FG002|Overall Study|Adverse Event|0|||
124563748|NCT01463683|448020165|FG000|Overall Study|Lost to Follow-up|10|||
124563749|NCT01463683|448020166|FG001|Overall Study|Lost to Follow-up|9|||
124506901|NCT00174785|447807974|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
124506902|NCT00174785|447807975|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
124563750|NCT01463683|448020167|FG002|Overall Study|Lost to Follow-up|7|||
124563751|NCT01463683|448020165|FG000|Overall Study|Physician Decision|0|||
124563752|NCT01463683|448020166|FG001|Overall Study|Physician Decision|3|||
124506903|NCT00174785|447807974|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
124506904|NCT00174785|447807975|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
124506905|NCT00174785|447807974|FG000|Overall Study|Other prohibited medication|5|||
124506906|NCT00174785|447807975|FG001|Overall Study|Other prohibited medication|3|||
124506907|NCT00174785|447807974|FG000|Overall Study|Family request|6|||
124506908|NCT00174785|447807975|FG001|Overall Study|Family request|8|||
124563753|NCT01463683|448020167|FG002|Overall Study|Physician Decision|1|||
124563754|NCT01463683|448020165|FG000|Overall Study|Pregnancy|2|||
124563755|NCT01463683|448020166|FG001|Overall Study|Pregnancy|2|||
124563756|NCT01463683|448020167|FG002|Overall Study|Pregnancy|1|||
124506909|NCT00174785|447807974|FG000|Overall Study|Not pre-specified/Not coded|56|||
124506910|NCT00174785|447807975|FG001|Overall Study|Not pre-specified/Not coded|70|||
124506911|NCT00120289|447807977|FG000|Overall Study|Death|96|||
124506912|NCT00120289|447807978|FG001|Overall Study|Death|82|||
124506913|NCT00120289|447807977|FG000|Overall Study|Lost to Follow-up|11|||
124506914|NCT00120289|447807978|FG001|Overall Study|Lost to Follow-up|14|||
124506915|NCT00120289|447807977|FG000|Overall Study|Withdrawal by Subject|14|||
124506916|NCT00120289|447807978|FG001|Overall Study|Withdrawal by Subject|13|||
124506917|NCT01754922|447807979|FG000|Overall Study|Adverse Event|0|||
124506918|NCT01754922|447807980|FG001|Overall Study|Adverse Event|1|||
124506919|NCT01944969|447807982|FG000|Overall Study|Adverse Event|1|||
124506920|NCT01944969|447807982|FG000|Overall Study|Lack of Efficacy|1|||
124506921|NCT01944969|447807982|FG000|Overall Study|Non-compliance with IMP|1|||
124506922|NCT01944969|447807982|FG000|Overall Study|Administrative or other reasons|23|||
124506923|NCT00310388|447807983|FG000|Primary Reporting Phase|Adverse Event|101|||
124506924|NCT00310388|447807984|FG001|Primary Reporting Phase|Adverse Event|0|||
124506925|NCT00310388|447807983|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
124506926|NCT00310388|447807984|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
124506927|NCT00310388|447807983|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
124506928|NCT00310388|447807984|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
124506929|NCT00310388|447807983|FG000|Primary Reporting Phase|Protocol Violation|10|||
124506930|NCT00310388|447807984|FG001|Primary Reporting Phase|Protocol Violation|0|||
124506931|NCT00310388|447807983|FG000|Primary Reporting Phase|Pregnancy|3|||
124506932|NCT00310388|447807984|FG001|Primary Reporting Phase|Pregnancy|0|||
124506933|NCT00310388|447807983|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
124506934|NCT00310388|447807984|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
124506935|NCT00310388|447807983|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
124506936|NCT00310388|447807984|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
124506937|NCT00310388|447807983|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
124506938|NCT00310388|447807984|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
124506939|NCT00310388|447807983|FG000|Primary Reporting Phase|Physician Decision|2|||
124506940|NCT00310388|447807984|FG001|Primary Reporting Phase|Physician Decision|0|||
124506941|NCT00310388|447807983|FG000|Primary Reporting Phase|Request of the sponsor|19|||
124506942|NCT00310388|447807984|FG001|Primary Reporting Phase|Request of the sponsor|0|||
124506943|NCT00310388|447807983|FG000|Primary Reporting Phase|Failed to return|8|||
124506944|NCT00310388|447807984|FG001|Primary Reporting Phase|Failed to return|0|||
124506945|NCT00310388|447807983|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
124506946|NCT00310388|447807984|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
124506947|NCT00310388|447807983|FG000|Primary Reporting Phase|Participant request|2|||
124506948|NCT00310388|447807984|FG001|Primary Reporting Phase|Participant request|0|||
124506949|NCT00310388|447807983|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
124506950|NCT00310388|447807984|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
124506951|NCT00310388|447807983|FG000|Primary Reporting Phase|Discontinuation of study|1|||
124506952|NCT00310388|447807984|FG001|Primary Reporting Phase|Discontinuation of study|0|||
124506953|NCT00310388|447807983|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
124506954|NCT00310388|447807984|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
124506955|NCT00310388|447807983|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
124506956|NCT00310388|447807984|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
124506957|NCT00310388|447807983|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
124506958|NCT00310388|447807984|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
124506959|NCT00310388|447807983|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
124506960|NCT00310388|447807984|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
124506961|NCT00310388|447807983|FG000|Primary Reporting Phase|Participant passed away|1|||
124506962|NCT00310388|447807984|FG001|Primary Reporting Phase|Participant passed away|0|||
124506963|NCT00310388|447807983|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
124506964|NCT00310388|447807984|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
124506965|NCT00310388|447807983|FG000|Primary Reporting Phase|Missing|1|||
124506966|NCT00310388|447807984|FG001|Primary Reporting Phase|Missing|0|||
124506967|NCT00310388|447807983|FG000|Primary Reporting Phase|Other|1|||
124506968|NCT00310388|447807984|FG001|Primary Reporting Phase|Other|0|||
124506969|NCT00310388|447807983|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
124506970|NCT00310388|447807984|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
124506971|NCT00310388|447807983|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
124506972|NCT00310388|447807984|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
124637306|NCT00507455|448290462|FG000|Overall Study|Protocol Violation|4|||
124506973|NCT00310388|447807983|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
124506974|NCT00310388|447807984|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
124506975|NCT00310388|447807983|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
124506976|NCT00310388|447807984|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
124506977|NCT00848250|447807986|FG000|Overall Study|surgery was completed without cardiopulm|0|||
124506978|NCT00848250|447807987|FG001|Overall Study|surgery was completed without cardiopulm|1|||
124506979|NCT02938585|447807988|FG000|Overall Study|Withdrawal by parent or guardian|0|||
124506980|NCT02938585|447807989|FG001|Overall Study|Withdrawal by parent or guardian|1|||
124506981|NCT02938585|447807990|FG002|Overall Study|Withdrawal by parent or guardian|0|||
124506982|NCT02938585|447807991|FG003|Overall Study|Withdrawal by parent or guardian|0|||
124506983|NCT02938585|447807988|FG000|Overall Study|Withdrawal by Subject|0|||
124506984|NCT02938585|447807989|FG001|Overall Study|Withdrawal by Subject|0|||
124506985|NCT02938585|447807990|FG002|Overall Study|Withdrawal by Subject|0|||
124506986|NCT02938585|447807991|FG003|Overall Study|Withdrawal by Subject|5|||
124506987|NCT01089582|447807995|FG000|Overall Study|Death|2|||
124506988|NCT01089582|447807995|FG000|Overall Study|Adverse Event|15|||
124506989|NCT01089582|447807995|FG000|Overall Study|Lost to Follow-up|8|||
124506990|NCT01089582|447807995|FG000|Overall Study|Other|4|||
124506991|NCT01089582|447807995|FG000|Overall Study|Withdrawal by Subject|1|||
124506992|NCT00862849|447807996|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
124506993|NCT00862849|447807997|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
124506994|NCT00862849|447807998|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
124506995|NCT00862849|447807999|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
124776672|NCT00998296|448809946|FG001|Overall Study|Progressive disease|1|||
124776673|NCT00998296|448809947|FG002|Overall Study|Progressive disease|0|||
124776674|NCT00998296|448809948|FG003|Overall Study|Progressive disease|0|||
124776675|NCT00998296|448809949|FG004|Overall Study|Progressive disease|0|||
124776676|NCT00998296|448809950|FG005|Overall Study|Progressive disease|0|||
124776677|NCT00998296|448809951|FG006|Overall Study|Progressive disease|1|||
124776678|NCT00998296|448809952|FG007|Overall Study|Progressive disease|0|||
124776679|NCT00998296|448809953|FG008|Overall Study|Progressive disease|0|||
124776680|NCT00998296|448809954|FG009|Overall Study|Progressive disease|14|||
124506996|NCT00862849|447808000|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
124506997|NCT00862849|447808001|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
124506998|NCT00862849|447807996|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
124506999|NCT00862849|447807997|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
124507000|NCT00862849|447807998|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
124507001|NCT00862849|447807999|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
124507002|NCT00862849|447808000|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
124507003|NCT00862849|447808001|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
124507004|NCT03943953|447808002|FG000|Trial of ITG 1|Lost to Follow-up|19|||
124507005|NCT03943953|447808003|FG001|Trial of ITG 1|Lost to Follow-up|1|||
124507006|NCT03943953|447808002|FG000|Trial of ITG 2|Lost to Follow-up|8|||
124507007|NCT03943953|447808003|FG001|Trial of ITG 2|Lost to Follow-up|0|||
124507008|NCT03943953|447808002|FG000|Trial of ITG 3|Lost to Follow-up|2|||
124507009|NCT03943953|447808003|FG001|Trial of ITG 3|Lost to Follow-up|0|||
124507010|NCT03943953|447808002|FG000|Trial of ITG 4|Lost to Follow-up|2|||
124507011|NCT03943953|447808003|FG001|Trial of ITG 4|Lost to Follow-up|0|||
124507012|NCT00289185|447808008|FG000|Overall Study|Withdrawal by Subject|4|||
124507013|NCT00289185|447808009|FG001|Overall Study|Withdrawal by Subject|8|||
124507014|NCT00289185|447808008|FG000|Overall Study|Lost to Follow-up|23|||
124507015|NCT00289185|447808009|FG001|Overall Study|Lost to Follow-up|17|||
124507016|NCT00289185|447808008|FG000|Overall Study|Death|1|||
124507017|NCT00289185|447808009|FG001|Overall Study|Death|1|||
124507018|NCT01199055|447808010|FG000|Overall Study|Death|0|||
124507019|NCT01199055|447808011|FG001|Overall Study|Death|1|||
124507020|NCT01199055|447808012|FG002|Overall Study|Death|0|||
124507021|NCT01199055|447808010|FG000|Overall Study|Physician Decision|0|||
124507022|NCT01199055|447808011|FG001|Overall Study|Physician Decision|1|||
124507023|NCT01199055|447808012|FG002|Overall Study|Physician Decision|1|||
124507024|NCT01199055|447808010|FG000|Overall Study|Progressive disease|2|||
124507025|NCT01199055|447808011|FG001|Overall Study|Progressive disease|1|||
124507026|NCT01199055|447808012|FG002|Overall Study|Progressive disease|2|||
124507027|NCT01199055|447808010|FG000|Overall Study|Withdrawal by Subject|0|||
124563757|NCT01463683|448020165|FG000|Overall Study|Withdrawal by Subject|5|||
124563758|NCT01463683|448020166|FG001|Overall Study|Withdrawal by Subject|17|||
124563759|NCT01463683|448020167|FG002|Overall Study|Withdrawal by Subject|2|||
124507028|NCT01199055|447808011|FG001|Overall Study|Withdrawal by Subject|0|||
124507029|NCT01199055|447808012|FG002|Overall Study|Withdrawal by Subject|1|||
124507030|NCT02432040|447808013|FG000|Overall Study|Lack of Efficacy|3|||
124563760|NCT01618305|448020168|FG000|Overall Study|Death|0|||
124563761|NCT01618305|448020169|FG001|Overall Study|Death|1|||
124507031|NCT02432040|447808014|FG001|Overall Study|Lack of Efficacy|0|||
124507032|NCT02432040|447808013|FG000|Overall Study|Lost to Follow-up|4|||
124507033|NCT02432040|447808014|FG001|Overall Study|Lost to Follow-up|5|||
124563762|NCT01618305|448020168|FG000|Overall Study|Lost to Follow-up|11|||
124563763|NCT01618305|448020169|FG001|Overall Study|Lost to Follow-up|7|||
124776681|NCT00998296|448809955|FG010|Overall Study|Progressive disease|5|||
124507034|NCT02432040|447808013|FG000|Overall Study|Physician Decision|1|||
124776682|NCT00998296|448809945|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
124507035|NCT02432040|447808014|FG001|Overall Study|Physician Decision|1|||
124563764|NCT01618305|448020168|FG000|Overall Study|Protocol Violation|1|||
124563765|NCT01618305|448020169|FG001|Overall Study|Protocol Violation|0|||
124507036|NCT03633227|447808015|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
124507037|NCT03633227|447808016|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
124507038|NCT03633227|447808015|FG000|Double Blind (DB), up to Week 48|Death|2|||
124507039|NCT03633227|447808016|FG001|Double Blind (DB), up to Week 48|Death|1|||
124507040|NCT03633227|447808015|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
124507041|NCT03633227|447808016|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
124507042|NCT03633227|447808015|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
124507043|NCT03633227|447808016|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
124507044|NCT03633227|447808015|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
124507045|NCT03633227|447808016|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
124507046|NCT03633227|447808015|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
124507047|NCT03633227|447808016|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
124507048|NCT03633227|447808015|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
124507049|NCT03633227|447808016|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
124507050|NCT03633227|447808015|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
124507051|NCT03633227|447808016|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
124507052|NCT03633227|447808015|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
124507053|NCT03633227|447808016|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
124507054|NCT03633227|447808015|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
124507055|NCT03633227|447808016|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
124507056|NCT03633227|447808015|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
124507057|NCT03633227|447808016|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
124507058|NCT03633227|447808015|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
124507059|NCT03633227|447808016|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
124507060|NCT01069523|447808017|FG000|Overall Study|Withdrawal by Subject|4|||
124507061|NCT01069523|447808018|FG001|Overall Study|Withdrawal by Subject|7|||
124507062|NCT04167306|447808026|FG000|Overall Study|Lost to Follow-up|2|||
124507063|NCT04167306|447808027|FG001|Overall Study|Lost to Follow-up|2|||
124507064|NCT04167306|447808028|FG002|Overall Study|Lost to Follow-up|5|||
124507065|NCT04167306|447808029|FG003|Overall Study|Lost to Follow-up|5|||
124507066|NCT04167306|447808026|FG000|Overall Study|Adverse Event|13|||
124507067|NCT04167306|447808027|FG001|Overall Study|Adverse Event|14|||
124507068|NCT04167306|447808028|FG002|Overall Study|Adverse Event|5|||
124507069|NCT04167306|447808029|FG003|Overall Study|Adverse Event|4|||
124507070|NCT04167306|447808026|FG000|Overall Study|Withdrawal by Subject|4|||
124507071|NCT04167306|447808027|FG001|Overall Study|Withdrawal by Subject|6|||
124507072|NCT04167306|447808028|FG002|Overall Study|Withdrawal by Subject|8|||
124507073|NCT04167306|447808029|FG003|Overall Study|Withdrawal by Subject|3|||
124507074|NCT04167306|447808026|FG000|Overall Study|covid|1|||
124507075|NCT04167306|447808027|FG001|Overall Study|covid|1|||
124507076|NCT04167306|447808028|FG002|Overall Study|covid|2|||
124507077|NCT04167306|447808029|FG003|Overall Study|covid|1|||
124507078|NCT04167306|447808026|FG000|Overall Study|concomitant medication|0|||
124507079|NCT04167306|447808027|FG001|Overall Study|concomitant medication|0|||
124507080|NCT04167306|447808028|FG002|Overall Study|concomitant medication|0|||
124507081|NCT04167306|447808029|FG003|Overall Study|concomitant medication|1|||
124507082|NCT04167306|447808026|FG000|Overall Study|Alcohol treatment|0|||
124507083|NCT04167306|447808027|FG001|Overall Study|Alcohol treatment|4|||
124507084|NCT04167306|447808028|FG002|Overall Study|Alcohol treatment|3|||
124507085|NCT04167306|447808029|FG003|Overall Study|Alcohol treatment|2|||
124507086|NCT04167306|447808026|FG000|Overall Study|non-compliance|0|||
124507087|NCT04167306|447808027|FG001|Overall Study|non-compliance|0|||
124507088|NCT04167306|447808028|FG002|Overall Study|non-compliance|1|||
124507089|NCT04167306|447808029|FG003|Overall Study|non-compliance|0|||
124507090|NCT04167306|447808026|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
124507091|NCT04167306|447808027|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
124507092|NCT04167306|447808028|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
124507093|NCT04167306|447808029|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
124507094|NCT00403559|447808030|FG000|Overall Study|Adverse Event|0|||
124507095|NCT00403559|447808031|FG001|Overall Study|Adverse Event|1|||
124507096|NCT00403559|447808030|FG000|Overall Study|Lost to Follow-up|3|||
124507097|NCT00403559|447808031|FG001|Overall Study|Lost to Follow-up|3|||
124507098|NCT00403559|447808030|FG000|Overall Study|Withdrawal by Subject|1|||
124507099|NCT00403559|447808031|FG001|Overall Study|Withdrawal by Subject|0|||
124507100|NCT03105700|447808032|FG000|Overall Study|screen fail|3|||
124507101|NCT03105700|447808032|FG000|Overall Study|Lost to Follow-up|4|||
124507102|NCT01253421|447808033|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
124507103|NCT01253421|447808034|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
124507104|NCT01253421|447808035|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
124507105|NCT01253421|447808036|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
124507106|NCT01253421|447808037|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
124507107|NCT01253421|447808033|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
124507108|NCT01253421|447808034|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
124507109|NCT01253421|447808035|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
124507110|NCT01253421|447808036|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
124507111|NCT01253421|447808037|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
124507112|NCT01253421|447808033|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
124507113|NCT01253421|447808034|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
124507114|NCT01253421|447808035|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
124507115|NCT01253421|447808036|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
124507116|NCT01253421|447808037|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
124507117|NCT01253421|447808033|FG000|Assessment and Scheduling|Physician Decision|1|||
124563766|NCT01618305|448020168|FG000|Overall Study|Withdrawal by Subject|3|||
124563767|NCT01618305|448020169|FG001|Overall Study|Withdrawal by Subject|2|||
124563768|NCT02708277|448020171|FG000|Overall Study|Lost to Follow-up|7|||
124563769|NCT02708277|448020172|FG001|Overall Study|Lost to Follow-up|4|||
124563770|NCT01960816|448020173|FG000|Overall Study|Lost to Follow-up|1|||
124507118|NCT01253421|447808034|FG001|Assessment and Scheduling|Physician Decision|0|||
124507119|NCT01253421|447808035|FG002|Assessment and Scheduling|Physician Decision|0|||
124507120|NCT01253421|447808036|FG003|Assessment and Scheduling|Physician Decision|0|||
124507121|NCT01253421|447808037|FG004|Assessment and Scheduling|Physician Decision|0|||
124507122|NCT01253421|447808033|FG000|Drug+Scanning Visit|Physician Decision|0|||
124507123|NCT01253421|447808034|FG001|Drug+Scanning Visit|Physician Decision|0|||
124507124|NCT01253421|447808035|FG002|Drug+Scanning Visit|Physician Decision|0|||
124507125|NCT01253421|447808036|FG003|Drug+Scanning Visit|Physician Decision|0|||
124507126|NCT01253421|447808037|FG004|Drug+Scanning Visit|Physician Decision|1|||
124507127|NCT00121992|447808038|FG000|Overall Study|Treatment not received|2|||
124507128|NCT00121992|447808039|FG001|Overall Study|Treatment not received|11|||
124507129|NCT04863014|447808040|FG000|Overall Study|Lost to Follow-up|3|||
124507130|NCT04863014|447808041|FG001|Overall Study|Lost to Follow-up|2|||
124507131|NCT04863014|447808040|FG000|Overall Study|Subject Decision|0|||
124507132|NCT04863014|447808041|FG001|Overall Study|Subject Decision|4|||
124507133|NCT00264849|447808042|FG000|Overall Study|Adverse Event|7|||
124507134|NCT00264849|447808043|FG001|Overall Study|Adverse Event|2|||
124507135|NCT00264849|447808042|FG000|Overall Study|Withdrawal by Subject|7|||
124507136|NCT00264849|447808043|FG001|Overall Study|Withdrawal by Subject|11|||
124507137|NCT00264849|447808042|FG000|Overall Study|Protocol Violation|5|||
124507138|NCT00264849|447808043|FG001|Overall Study|Protocol Violation|3|||
124507139|NCT00264849|447808042|FG000|Overall Study|Lack of Efficacy|1|||
124507140|NCT00264849|447808043|FG001|Overall Study|Lack of Efficacy|6|||
124507141|NCT00264849|447808042|FG000|Overall Study|Lost to Follow-up|0|||
124507142|NCT00264849|447808043|FG001|Overall Study|Lost to Follow-up|2|||
124507143|NCT00264849|447808042|FG000|Overall Study|Death|0|||
124507144|NCT00264849|447808043|FG001|Overall Study|Death|1|||
124507145|NCT00264849|447808042|FG000|Overall Study|Administrative Problems|2|||
124507146|NCT00264849|447808043|FG001|Overall Study|Administrative Problems|0|||
124507147|NCT04387136|447808045|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
124507148|NCT04387136|447808046|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
124507149|NCT01982773|447808051|FG000|Overall Study|Withdrawal by Subject|1|||
124507150|NCT01982773|447808052|FG001|Overall Study|Withdrawal by Subject|3|||
124507151|NCT01982773|447808051|FG000|Overall Study|Lost to Follow-up|7|||
124507152|NCT01982773|447808052|FG001|Overall Study|Lost to Follow-up|1|||
124507153|NCT01029886|447808053|FG000|Overall Study|Adverse Event|12|||
124507154|NCT01029886|447808054|FG001|Overall Study|Adverse Event|25|||
124507155|NCT01029886|447808053|FG000|Overall Study|Lost to Follow-up|1|||
124507156|NCT01029886|447808054|FG001|Overall Study|Lost to Follow-up|0|||
124507157|NCT01029886|447808053|FG000|Overall Study|Physician Decision|2|||
124507158|NCT01029886|447808054|FG001|Overall Study|Physician Decision|6|||
124507159|NCT01029886|447808053|FG000|Overall Study|Protocol Violation|17|||
124507160|NCT01029886|447808054|FG001|Overall Study|Protocol Violation|5|||
124507161|NCT01029886|447808053|FG000|Overall Study|Withdrawal by Subject|8|||
124563771|NCT01118728|448020177|FG000|Overall Study|Adverse Event|17|||
124563772|NCT01118728|448020177|FG000|Overall Study|Lack of Efficacy|27|||
124563773|NCT01118728|448020177|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
124563774|NCT01118728|448020177|FG000|Overall Study|Withdrawal by Subject|3|||
124563775|NCT01118728|448020177|FG000|Overall Study|Lost to Follow-up|4|||
124563776|NCT04345471|448020178|FG000|Overall Study|Adverse Event|8|||
124563777|NCT04345471|448020179|FG001|Overall Study|Adverse Event|5|||
124563778|NCT04345471|448020180|FG002|Overall Study|Adverse Event|6|||
124507162|NCT01029886|447808054|FG001|Overall Study|Withdrawal by Subject|18|||
124563779|NCT04345471|448020178|FG000|Overall Study|Lack of Efficacy|1|||
124563780|NCT04345471|448020179|FG001|Overall Study|Lack of Efficacy|1|||
124507163|NCT01029886|447808053|FG000|Overall Study|Entry Criteria Not Met|13|||
124507164|NCT01029886|447808054|FG001|Overall Study|Entry Criteria Not Met|5|||
124507165|NCT01029886|447808053|FG000|Overall Study|Sponsor Decision|1|||
124563781|NCT04345471|448020180|FG002|Overall Study|Lack of Efficacy|0|||
124563782|NCT04345471|448020178|FG000|Overall Study|Protocol Violation|0|||
124563783|NCT04345471|448020179|FG001|Overall Study|Protocol Violation|1|||
124507166|NCT01029886|447808054|FG001|Overall Study|Sponsor Decision|0|||
124507167|NCT01029886|447808053|FG000|Overall Study|Loss Glucose Control|7|||
124507168|NCT01029886|447808054|FG001|Overall Study|Loss Glucose Control|1|||
124507169|NCT03294681|447808055|FG000|Overall Study|Withdrawal by Subject|1|||
124507170|NCT01553916|447808056|FG000|Overall Study|Withdrawal by Subject|2|||
124507171|NCT01553916|447808056|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
124507172|NCT03089216|447808059|FG000|Overall Study|Adverse Event|0|||
124507173|NCT03089216|447808060|FG001|Overall Study|Adverse Event|0|||
124507174|NCT03089216|447808061|FG002|Overall Study|Adverse Event|0|||
124507175|NCT03089216|447808062|FG003|Overall Study|Adverse Event|1|||
124507176|NCT04348591|447808065|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
124507177|NCT04348591|447808066|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
124507178|NCT04348591|447808065|FG000|Imaging Session (120 Min)|Physician Decision|0|||
124507179|NCT04348591|447808066|FG001|Imaging Session (120 Min)|Physician Decision|1|||
124507180|NCT04348591|447808065|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
124507181|NCT04348591|447808066|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
124507182|NCT00417976|447808067|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
124507183|NCT00417976|447808067|FG000|Overall Study|Treatment -related toxicity|2|||
124507184|NCT01778127|447808070|FG000|Overall Study|Lost to Follow-up|5|||
124507185|NCT01778127|447808071|FG001|Overall Study|Lost to Follow-up|1|||
124507186|NCT01778127|447808072|FG002|Overall Study|Lost to Follow-up|2|||
124507187|NCT01778127|447808070|FG000|Overall Study|Withdrawal by Subject|3|||
124507188|NCT01778127|447808071|FG001|Overall Study|Withdrawal by Subject|1|||
124507189|NCT01778127|447808072|FG002|Overall Study|Withdrawal by Subject|4|||
124507190|NCT01348425|447808073|FG000|Overall Study|Imaging was not taken.|1|||
124507191|NCT01348425|447808074|FG001|Overall Study|Imaging was not taken.|1|||
124507192|NCT02104804|447808075|FG000|Overall Study|Did not take study medication|0|||
124507193|NCT02104804|447808076|FG001|Overall Study|Did not take study medication|1|||
124507194|NCT02104804|447808075|FG000|Overall Study|Study specific discontinuation criteria|6|||
124507195|NCT02104804|447808076|FG001|Overall Study|Study specific discontinuation criteria|1|||
124507196|NCT02104804|447808075|FG000|Overall Study|Other listed|2|||
124507197|NCT02104804|447808076|FG001|Overall Study|Other listed|1|||
124507198|NCT02104804|447808075|FG000|Overall Study|Protocol Violation|0|||
124507199|NCT02104804|447808076|FG001|Overall Study|Protocol Violation|1|||
124507200|NCT02104804|447808075|FG000|Overall Study|Adverse Event|4|||
124507201|NCT02104804|447808076|FG001|Overall Study|Adverse Event|3|||
124507202|NCT02104804|447808075|FG000|Overall Study|Withdrawal by Subject|4|||
124507203|NCT02104804|447808076|FG001|Overall Study|Withdrawal by Subject|12|||
124507204|NCT03722784|447808077|FG000|Overall Study|Withdrawal by Subject|1|||
124507205|NCT03722784|447808078|FG001|Overall Study|Withdrawal by Subject|0|||
124507206|NCT03722784|447808077|FG000|Overall Study|Physician Decision|1|||
124507207|NCT03722784|447808078|FG001|Overall Study|Physician Decision|1|||
124507208|NCT03722784|447808077|FG000|Overall Study|Protocol Violation|0|||
124507209|NCT03722784|447808078|FG001|Overall Study|Protocol Violation|1|||
124507210|NCT01968954|447808079|FG000|Overall Study|Adverse Event|6|||
124507211|NCT01968954|447808080|FG001|Overall Study|Adverse Event|3|||
124507212|NCT01968954|447808079|FG000|Overall Study|Death|1|||
124507213|NCT01968954|447808080|FG001|Overall Study|Death|2|||
124507214|NCT01968954|447808079|FG000|Overall Study|Lost to Follow-up|6|||
124507215|NCT01968954|447808080|FG001|Overall Study|Lost to Follow-up|4|||
124507216|NCT01968954|447808079|FG000|Overall Study|Withdrawal by Subject|20|||
124507217|NCT01968954|447808080|FG001|Overall Study|Withdrawal by Subject|23|||
124507218|NCT01968954|447808079|FG000|Overall Study|Other|7|||
124507219|NCT01968954|447808080|FG001|Overall Study|Other|8|||
124507220|NCT01968954|447808079|FG000|Overall Study|Protocol Violation|0|||
124507221|NCT01968954|447808080|FG001|Overall Study|Protocol Violation|1|||
124507222|NCT01968954|447808079|FG000|Overall Study|Did not met inclusion criteria|0|||
124507223|NCT01968954|447808080|FG001|Overall Study|Did not met inclusion criteria|2|||
124507224|NCT03655717|447808081|FG000|Overall Study|Withdrawal by Subject|4|||
124507225|NCT03655717|447808082|FG001|Overall Study|Withdrawal by Subject|8|||
124507226|NCT03655717|447808083|FG002|Overall Study|Withdrawal by Subject|1|||
124507227|NCT03655717|447808084|FG003|Overall Study|Withdrawal by Subject|0|||
124507228|NCT03655717|447808085|FG004|Overall Study|Withdrawal by Subject|0|||
124507229|NCT03655717|447808086|FG005|Overall Study|Withdrawal by Subject|1|||
124507230|NCT03655717|447808087|FG006|Overall Study|Withdrawal by Subject|3|||
124507231|NCT03655717|447808088|FG007|Overall Study|Withdrawal by Subject|1|||
124563784|NCT04345471|448020180|FG002|Overall Study|Protocol Violation|2|||
124507232|NCT03655717|447808089|FG008|Overall Study|Withdrawal by Subject|2|||
124507233|NCT03655717|447808090|FG009|Overall Study|Withdrawal by Subject|0|||
124507234|NCT03655717|447808091|FG010|Overall Study|Withdrawal by Subject|0|||
124507235|NCT03655717|447808092|FG011|Overall Study|Withdrawal by Subject|1|||
124507236|NCT03655717|447808093|FG012|Overall Study|Withdrawal by Subject|0|||
124507237|NCT03655717|447808094|FG013|Overall Study|Withdrawal by Subject|3|||
124507238|NCT03655717|447808095|FG014|Overall Study|Withdrawal by Subject|0|||
124507239|NCT03655717|447808096|FG015|Overall Study|Withdrawal by Subject|1|||
124507240|NCT03655717|447808097|FG016|Overall Study|Withdrawal by Subject|0|||
124507241|NCT03655717|447808098|FG017|Overall Study|Withdrawal by Subject|0|||
124507242|NCT03655717|447808099|FG018|Overall Study|Withdrawal by Subject|1|||
124507243|NCT03655717|447808100|FG019|Overall Study|Withdrawal by Subject|0|||
124507244|NCT03655717|447808101|FG020|Overall Study|Withdrawal by Subject|0|||
124507245|NCT03655717|447808102|FG021|Overall Study|Withdrawal by Subject|1|||
124507246|NCT03655717|447808103|FG022|Overall Study|Withdrawal by Subject|2|||
124507247|NCT03655717|447808104|FG023|Overall Study|Withdrawal by Subject|1|||
124507248|NCT03655717|447808105|FG024|Overall Study|Withdrawal by Subject|1|||
124507249|NCT03655717|447808106|FG025|Overall Study|Withdrawal by Subject|0|||
124507250|NCT03655717|447808081|FG000|Overall Study|Physician Decision|3|||
124507251|NCT03655717|447808082|FG001|Overall Study|Physician Decision|3|||
124507252|NCT03655717|447808083|FG002|Overall Study|Physician Decision|0|||
124507253|NCT03655717|447808084|FG003|Overall Study|Physician Decision|0|||
124507254|NCT03655717|447808085|FG004|Overall Study|Physician Decision|0|||
124507255|NCT03655717|447808086|FG005|Overall Study|Physician Decision|0|||
124507256|NCT03655717|447808087|FG006|Overall Study|Physician Decision|0|||
124507257|NCT03655717|447808088|FG007|Overall Study|Physician Decision|0|||
124507258|NCT03655717|447808089|FG008|Overall Study|Physician Decision|0|||
124507259|NCT03655717|447808090|FG009|Overall Study|Physician Decision|1|||
124507260|NCT03655717|447808091|FG010|Overall Study|Physician Decision|0|||
124507261|NCT03655717|447808092|FG011|Overall Study|Physician Decision|0|||
124507262|NCT03655717|447808093|FG012|Overall Study|Physician Decision|0|||
124507263|NCT03655717|447808094|FG013|Overall Study|Physician Decision|0|||
124507264|NCT03655717|447808095|FG014|Overall Study|Physician Decision|0|||
124507265|NCT03655717|447808096|FG015|Overall Study|Physician Decision|0|||
124507266|NCT03655717|447808097|FG016|Overall Study|Physician Decision|0|||
124507267|NCT03655717|447808098|FG017|Overall Study|Physician Decision|0|||
124507268|NCT03655717|447808099|FG018|Overall Study|Physician Decision|0|||
124507269|NCT03655717|447808100|FG019|Overall Study|Physician Decision|1|||
124507270|NCT03655717|447808101|FG020|Overall Study|Physician Decision|0|||
124507271|NCT03655717|447808102|FG021|Overall Study|Physician Decision|0|||
124507272|NCT03655717|447808103|FG022|Overall Study|Physician Decision|0|||
124507273|NCT03655717|447808104|FG023|Overall Study|Physician Decision|1|||
124507274|NCT03655717|447808105|FG024|Overall Study|Physician Decision|0|||
124507275|NCT03655717|447808106|FG025|Overall Study|Physician Decision|0|||
124507276|NCT03655717|447808081|FG000|Overall Study|Lost to Follow-up|3|||
124507277|NCT03655717|447808082|FG001|Overall Study|Lost to Follow-up|1|||
124507278|NCT03655717|447808083|FG002|Overall Study|Lost to Follow-up|0|||
124507279|NCT03655717|447808084|FG003|Overall Study|Lost to Follow-up|1|||
124507280|NCT03655717|447808085|FG004|Overall Study|Lost to Follow-up|0|||
124507281|NCT03655717|447808086|FG005|Overall Study|Lost to Follow-up|1|||
124507282|NCT03655717|447808087|FG006|Overall Study|Lost to Follow-up|0|||
124507283|NCT03655717|447808088|FG007|Overall Study|Lost to Follow-up|0|||
124507284|NCT03655717|447808089|FG008|Overall Study|Lost to Follow-up|0|||
124507285|NCT03655717|447808090|FG009|Overall Study|Lost to Follow-up|0|||
124507286|NCT03655717|447808091|FG010|Overall Study|Lost to Follow-up|0|||
124507287|NCT03655717|447808092|FG011|Overall Study|Lost to Follow-up|1|||
124507288|NCT03655717|447808093|FG012|Overall Study|Lost to Follow-up|0|||
124507289|NCT03655717|447808094|FG013|Overall Study|Lost to Follow-up|0|||
124507290|NCT03655717|447808095|FG014|Overall Study|Lost to Follow-up|0|||
124507291|NCT03655717|447808096|FG015|Overall Study|Lost to Follow-up|0|||
124507292|NCT03655717|447808097|FG016|Overall Study|Lost to Follow-up|0|||
124507293|NCT03655717|447808098|FG017|Overall Study|Lost to Follow-up|0|||
124507294|NCT03655717|447808099|FG018|Overall Study|Lost to Follow-up|0|||
124507295|NCT03655717|447808100|FG019|Overall Study|Lost to Follow-up|0|||
124507296|NCT03655717|447808101|FG020|Overall Study|Lost to Follow-up|0|||
124507297|NCT03655717|447808102|FG021|Overall Study|Lost to Follow-up|0|||
124507298|NCT03655717|447808103|FG022|Overall Study|Lost to Follow-up|0|||
124507299|NCT03655717|447808104|FG023|Overall Study|Lost to Follow-up|0|||
124507300|NCT03655717|447808105|FG024|Overall Study|Lost to Follow-up|0|||
124507301|NCT03655717|447808106|FG025|Overall Study|Lost to Follow-up|0|||
124507302|NCT00808249|447808109|FG000|Overall Study|Adverse Event|4|||
124507303|NCT00808249|447808110|FG001|Overall Study|Adverse Event|7|||
124507304|NCT00808249|447808111|FG002|Overall Study|Adverse Event|10|||
124507305|NCT00808249|447808112|FG003|Overall Study|Adverse Event|6|||
124507306|NCT00808249|447808109|FG000|Overall Study|Lost to Follow-up|2|||
124507307|NCT00808249|447808110|FG001|Overall Study|Lost to Follow-up|3|||
124507308|NCT00808249|447808111|FG002|Overall Study|Lost to Follow-up|3|||
124507309|NCT00808249|447808112|FG003|Overall Study|Lost to Follow-up|5|||
124507310|NCT00808249|447808109|FG000|Overall Study|Withdrawal by Subject|4|||
124507311|NCT00808249|447808110|FG001|Overall Study|Withdrawal by Subject|0|||
124507312|NCT00808249|447808111|FG002|Overall Study|Withdrawal by Subject|2|||
124507313|NCT00808249|447808112|FG003|Overall Study|Withdrawal by Subject|4|||
124507314|NCT00808249|447808109|FG000|Overall Study|Protocol Violation|3|||
124507315|NCT00808249|447808110|FG001|Overall Study|Protocol Violation|3|||
124507316|NCT00808249|447808111|FG002|Overall Study|Protocol Violation|3|||
124507317|NCT00808249|447808112|FG003|Overall Study|Protocol Violation|0|||
124507318|NCT00808249|447808109|FG000|Overall Study|Lack of Efficacy|1|||
124507319|NCT00808249|447808110|FG001|Overall Study|Lack of Efficacy|1|||
124507320|NCT00808249|447808111|FG002|Overall Study|Lack of Efficacy|0|||
124507321|NCT00808249|447808112|FG003|Overall Study|Lack of Efficacy|0|||
124507322|NCT00808249|447808109|FG000|Overall Study|study specific discontinuation criteria|1|||
124507323|NCT00808249|447808110|FG001|Overall Study|study specific discontinuation criteria|0|||
124507324|NCT00808249|447808111|FG002|Overall Study|study specific discontinuation criteria|1|||
124507325|NCT00808249|447808112|FG003|Overall Study|study specific discontinuation criteria|0|||
124507326|NCT00808249|447808109|FG000|Overall Study|All other reasons|2|||
124507327|NCT00808249|447808110|FG001|Overall Study|All other reasons|1|||
124507328|NCT00808249|447808111|FG002|Overall Study|All other reasons|3|||
124507329|NCT00808249|447808112|FG003|Overall Study|All other reasons|1|||
124507330|NCT00479557|447808113|FG000|Overall Study|Death|0|||
124507331|NCT00479557|447808114|FG001|Overall Study|Death|0|||
124507332|NCT00479557|447808115|FG002|Overall Study|Death|0|||
124507333|NCT00479557|447808116|FG003|Overall Study|Death|0|||
124507334|NCT00479557|447808117|FG004|Overall Study|Death|0|||
124507335|NCT00479557|447808118|FG005|Overall Study|Death|1|||
124507336|NCT00479557|447808119|FG006|Overall Study|Death|0|||
124507337|NCT00479557|447808113|FG000|Overall Study|Lack of Efficacy|1|||
124507338|NCT00479557|447808114|FG001|Overall Study|Lack of Efficacy|0|||
124507339|NCT00479557|447808115|FG002|Overall Study|Lack of Efficacy|0|||
124507340|NCT00479557|447808116|FG003|Overall Study|Lack of Efficacy|0|||
124507341|NCT00479557|447808117|FG004|Overall Study|Lack of Efficacy|0|||
124507342|NCT00479557|447808118|FG005|Overall Study|Lack of Efficacy|0|||
124507343|NCT00479557|447808119|FG006|Overall Study|Lack of Efficacy|0|||
124507344|NCT00479557|447808113|FG000|Overall Study|Lost to Follow-up|0|||
124507345|NCT00479557|447808114|FG001|Overall Study|Lost to Follow-up|2|||
124507346|NCT00479557|447808115|FG002|Overall Study|Lost to Follow-up|0|||
124507347|NCT00479557|447808116|FG003|Overall Study|Lost to Follow-up|2|||
124507348|NCT00479557|447808117|FG004|Overall Study|Lost to Follow-up|0|||
124507349|NCT00479557|447808118|FG005|Overall Study|Lost to Follow-up|0|||
124507350|NCT00479557|447808119|FG006|Overall Study|Lost to Follow-up|0|||
124507351|NCT00479557|447808113|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
124507352|NCT00479557|447808114|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
124507353|NCT00479557|447808115|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
124507354|NCT00479557|447808116|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
124507355|NCT00479557|447808117|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
124507356|NCT00479557|447808118|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
124507357|NCT00479557|447808119|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
124507358|NCT00479557|447808113|FG000|Overall Study|AE not related to Study Drug|1|||
124507359|NCT00479557|447808114|FG001|Overall Study|AE not related to Study Drug|3|||
124507360|NCT00479557|447808115|FG002|Overall Study|AE not related to Study Drug|0|||
124507361|NCT00479557|447808116|FG003|Overall Study|AE not related to Study Drug|0|||
124507362|NCT00479557|447808117|FG004|Overall Study|AE not related to Study Drug|2|||
124507363|NCT00479557|447808118|FG005|Overall Study|AE not related to Study Drug|2|||
124507364|NCT00479557|447808119|FG006|Overall Study|AE not related to Study Drug|1|||
124507365|NCT00479557|447808113|FG000|Overall Study|Caregiver Request|2|||
124507366|NCT00479557|447808114|FG001|Overall Study|Caregiver Request|2|||
124507367|NCT00479557|447808115|FG002|Overall Study|Caregiver Request|2|||
124507368|NCT00479557|447808116|FG003|Overall Study|Caregiver Request|0|||
124563785|NCT04345471|448020178|FG000|Overall Study|Withdrawal by Subject|10|||
124563786|NCT04345471|448020179|FG001|Overall Study|Withdrawal by Subject|5|||
124563787|NCT04345471|448020180|FG002|Overall Study|Withdrawal by Subject|10|||
124563788|NCT03896490|448020215|FG000|Overall Study|Withdrawal by Subject|1|||
124563789|NCT03896490|448020216|FG001|Overall Study|Withdrawal by Subject|1|||
124563790|NCT00003782|448020217|FG000|Overall Study|No follow up data|30|||
124563791|NCT00003782|448020218|FG001|Overall Study|No follow up data|31|||
124507369|NCT00479557|447808117|FG004|Overall Study|Caregiver Request|1|||
124507370|NCT00479557|447808118|FG005|Overall Study|Caregiver Request|2|||
124507371|NCT00479557|447808119|FG006|Overall Study|Caregiver Request|0|||
124507372|NCT00479557|447808113|FG000|Overall Study|Investigator Request|0|||
124507373|NCT00479557|447808114|FG001|Overall Study|Investigator Request|0|||
124507374|NCT00479557|447808115|FG002|Overall Study|Investigator Request|1|||
124507375|NCT00479557|447808116|FG003|Overall Study|Investigator Request|0|||
124507376|NCT00479557|447808117|FG004|Overall Study|Investigator Request|0|||
124507377|NCT00479557|447808118|FG005|Overall Study|Investigator Request|0|||
124507378|NCT00479557|447808119|FG006|Overall Study|Investigator Request|0|||
124563792|NCT00003782|448020219|FG002|Overall Study|No follow up data|26|||
124507379|NCT00479557|447808113|FG000|Overall Study|Subject Request|3|||
124507380|NCT00479557|447808114|FG001|Overall Study|Subject Request|0|||
124507381|NCT00479557|447808115|FG002|Overall Study|Subject Request|1|||
124507382|NCT00479557|447808116|FG003|Overall Study|Subject Request|1|||
124507383|NCT00479557|447808117|FG004|Overall Study|Subject Request|1|||
124507384|NCT00479557|447808118|FG005|Overall Study|Subject Request|4|||
124507385|NCT00479557|447808119|FG006|Overall Study|Subject Request|1|||
124507386|NCT00479557|447808113|FG000|Overall Study|Other|2|||
124507387|NCT00479557|447808114|FG001|Overall Study|Other|3|||
124563793|NCT00385541|448020220|FG000|Overall Study|severe pain, clinician requested unblind|0|||
124507388|NCT00479557|447808115|FG002|Overall Study|Other|1|||
124507389|NCT00479557|447808116|FG003|Overall Study|Other|0|||
124507390|NCT00479557|447808117|FG004|Overall Study|Other|0|||
124507391|NCT00479557|447808118|FG005|Overall Study|Other|3|||
124507392|NCT00479557|447808119|FG006|Overall Study|Other|0|||
124507393|NCT04124692|447809868|FG000|Overall Study|Medical reason|0|||
124507394|NCT04124692|447809869|FG001|Overall Study|Medical reason|1|||
124507395|NCT04124692|447809868|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
124507396|NCT04124692|447809869|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
124507397|NCT04124692|447809868|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
124507398|NCT04124692|447809869|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
124507399|NCT04124692|447809868|FG000|Overall Study|Lost to Follow-up|2|||
124507400|NCT04124692|447809869|FG001|Overall Study|Lost to Follow-up|4|||
124507401|NCT04124692|447809868|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
124507402|NCT04124692|447809869|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
124507403|NCT02370498|447809870|FG000|Overall Study|Adverse Event|10|||
124507404|NCT02370498|447809871|FG001|Overall Study|Adverse Event|8|||
124507405|NCT02370498|447809870|FG000|Overall Study|Death|263|||
124507406|NCT02370498|447809871|FG001|Overall Study|Death|265|||
124507407|NCT02370498|447809870|FG000|Overall Study|Protocol Violation|1|||
124507408|NCT02370498|447809871|FG001|Overall Study|Protocol Violation|2|||
124507409|NCT02370498|447809870|FG000|Overall Study|Withdrawal by Subject|7|||
124507410|NCT02370498|447809871|FG001|Overall Study|Withdrawal by Subject|12|||
124507411|NCT02370498|447809870|FG000|Overall Study|Sponsor's decision|15|||
124507412|NCT02370498|447809871|FG001|Overall Study|Sponsor's decision|9|||
124507413|NCT01453998|447809882|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
124507414|NCT01453998|447809883|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
124507415|NCT01453998|447809884|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
124507416|NCT01486784|447809885|FG000|Overall Study|Withdrawal by Subject|0|||
124507417|NCT01486784|447809886|FG001|Overall Study|Withdrawal by Subject|0|||
124507418|NCT01486784|447809887|FG002|Overall Study|Withdrawal by Subject|1|||
124507419|NCT01486784|447809888|FG003|Overall Study|Withdrawal by Subject|0|||
124507420|NCT01486784|447809889|FG004|Overall Study|Withdrawal by Subject|1|||
124507421|NCT01486784|447809890|FG005|Overall Study|Withdrawal by Subject|2|||
124507422|NCT01486784|447809885|FG000|Overall Study|Subject did not meet entry criteria|0|||
124507423|NCT01486784|447809886|FG001|Overall Study|Subject did not meet entry criteria|0|||
124507424|NCT01486784|447809887|FG002|Overall Study|Subject did not meet entry criteria|0|||
124507425|NCT01486784|447809888|FG003|Overall Study|Subject did not meet entry criteria|0|||
124507426|NCT01486784|447809889|FG004|Overall Study|Subject did not meet entry criteria|1|||
124507427|NCT01486784|447809890|FG005|Overall Study|Subject did not meet entry criteria|0|||
124507428|NCT01486784|447809885|FG000|Overall Study|Death|0|||
124507429|NCT01486784|447809886|FG001|Overall Study|Death|0|||
124507430|NCT01486784|447809887|FG002|Overall Study|Death|0|||
124507431|NCT01486784|447809888|FG003|Overall Study|Death|0|||
124507432|NCT01486784|447809889|FG004|Overall Study|Death|0|||
124507433|NCT01486784|447809890|FG005|Overall Study|Death|1|||
124507434|NCT03491553|447809891|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
124507435|NCT03491553|447809892|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
124507436|NCT03491553|447809893|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
124507437|NCT03491553|447809894|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
124507438|NCT03491553|447809895|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
124507439|NCT03491553|447809896|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
124507440|NCT03491553|447809891|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
124507441|NCT03491553|447809892|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
124507442|NCT03491553|447809893|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
124507443|NCT03491553|447809894|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
124507444|NCT03491553|447809895|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
124507445|NCT03491553|447809896|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
124507446|NCT00973921|447809899|FG000|Overall Study|IVUS results were not available|9|||
124507447|NCT00488592|447809900|FG000|Overall Study|Withdrawal by Subject|1|||
124507448|NCT00488592|447809900|FG000|Overall Study|Disease progression|1|||
124507449|NCT00488592|447809900|FG000|Overall Study|Enrolled but not treated|1|||
124507450|NCT01096849|447809905|FG000|Overall Study|Consent Withdrawn|1|||
124507451|NCT01096849|447809906|FG001|Overall Study|Consent Withdrawn|4|||
124507452|NCT01096849|447809907|FG002|Overall Study|Consent Withdrawn|2|||
124507453|NCT01096849|447809905|FG000|Overall Study|Lack of Efficacy|0|||
124507454|NCT01096849|447809906|FG001|Overall Study|Lack of Efficacy|2|||
124507455|NCT01096849|447809907|FG002|Overall Study|Lack of Efficacy|0|||
124507456|NCT01096849|447809905|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
124507457|NCT01096849|447809906|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
124507458|NCT01096849|447809907|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
124507459|NCT01096849|447809905|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
124507460|NCT01096849|447809906|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
124507461|NCT01096849|447809907|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
124507462|NCT01096849|447809905|FG000|Overall Study|Administrative Reasons|0|||
124507463|NCT01096849|447809906|FG001|Overall Study|Administrative Reasons|1|||
124507464|NCT01096849|447809907|FG002|Overall Study|Administrative Reasons|2|||
124507465|NCT01096849|447809905|FG000|Overall Study|Lost to Follow-up|1|||
124507466|NCT01096849|447809906|FG001|Overall Study|Lost to Follow-up|3|||
124507467|NCT01096849|447809907|FG002|Overall Study|Lost to Follow-up|1|||
124507468|NCT00242580|447809909|FG000|Overall Study|Adverse Event|3|||
124507469|NCT00242580|447809910|FG001|Overall Study|Adverse Event|0|||
124507470|NCT00242580|447809911|FG002|Overall Study|Adverse Event|2|||
124507471|NCT00242580|447809909|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
124507472|NCT00242580|447809910|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
124507473|NCT00242580|447809911|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
124507474|NCT00242580|447809909|FG000|Overall Study|Protocol Violation|0|||
124507475|NCT00242580|447809910|FG001|Overall Study|Protocol Violation|0|||
124507476|NCT00242580|447809911|FG002|Overall Study|Protocol Violation|1|||
124507477|NCT00242580|447809909|FG000|Overall Study|Subject withdrew consent|2|||
124507478|NCT00242580|447809910|FG001|Overall Study|Subject withdrew consent|2|||
124507479|NCT00242580|447809911|FG002|Overall Study|Subject withdrew consent|5|||
124507480|NCT00242580|447809909|FG000|Overall Study|Lost to Follow-up|0|||
124507481|NCT00242580|447809910|FG001|Overall Study|Lost to Follow-up|3|||
124507482|NCT00242580|447809911|FG002|Overall Study|Lost to Follow-up|0|||
124507483|NCT00242580|447809909|FG000|Overall Study|Death|1|||
124507484|NCT00242580|447809910|FG001|Overall Study|Death|2|||
124507485|NCT00242580|447809911|FG002|Overall Study|Death|1|||
124507486|NCT01232894|447809912|FG000|Overall Study|Lost to Follow-up|0|||
124507487|NCT01232894|447809913|FG001|Overall Study|Lost to Follow-up|1|||
124507488|NCT01232894|447809912|FG000|Overall Study|Death|1|||
124507489|NCT01232894|447809913|FG001|Overall Study|Death|0|||
124507490|NCT01232894|447809912|FG000|Overall Study|Protocol Violation|1|||
124507491|NCT01232894|447809913|FG001|Overall Study|Protocol Violation|1|||
124507492|NCT01232894|447809912|FG000|Overall Study|Withdrawal by Subject|8|||
124507493|NCT01232894|447809913|FG001|Overall Study|Withdrawal by Subject|5|||
124507494|NCT01232894|447809912|FG000|Overall Study|Physician Decision|2|||
124507495|NCT01232894|447809913|FG001|Overall Study|Physician Decision|1|||
124507496|NCT03970395|447809914|FG000|Overall Study|Withdrawal by Subject|3|||
124507497|NCT03970395|447809915|FG001|Overall Study|Withdrawal by Subject|4|||
124507498|NCT03970395|447809914|FG000|Overall Study|Lost to Follow-up|4|||
124507499|NCT03970395|447809915|FG001|Overall Study|Lost to Follow-up|8|||
124507500|NCT00125190|447809916|FG000|Overall Study|Subject/Parent Decision|7|||
124507501|NCT00125190|447809916|FG000|Overall Study|Non-compliance|2|||
124507502|NCT00125190|447809916|FG000|Overall Study|Adverse Event|1|||
124507503|NCT00125190|447809916|FG000|Overall Study|Other|1|||
124507504|NCT00125190|447809916|FG000|Overall Study|Lost to Follow-up|4|||
124507505|NCT00929734|447809918|FG000|Overall Study|Lost to Follow-up|2|||
124507506|NCT00929734|447809919|FG001|Overall Study|Lost to Follow-up|1|||
124507507|NCT00929734|447809918|FG000|Overall Study|Withdrawal by Subject|0|||
124507508|NCT00929734|447809919|FG001|Overall Study|Withdrawal by Subject|2|||
124507509|NCT00980980|447809921|FG000|Overall Study|Withdrawal by Hospital|0|||
124507510|NCT00980980|447809922|FG001|Overall Study|Withdrawal by Hospital|1|||
124507511|NCT00980980|447809923|FG002|Overall Study|Withdrawal by Hospital|0|||
124507512|NCT01449682|447809924|FG000|Overall Study|Death|0|||
124507513|NCT01449682|447809925|FG001|Overall Study|Death|1|||
124507514|NCT01449682|447809924|FG000|Overall Study|Adverse Event|1|||
124507515|NCT01449682|447809925|FG001|Overall Study|Adverse Event|0|||
124507516|NCT00414960|447809926|FG000|Overall Study|Adverse Event|4|||
124507517|NCT00414960|447809927|FG001|Overall Study|Adverse Event|0|||
124507518|NCT00414960|447809926|FG000|Overall Study|Withdrawal by Subject|3|||
124507519|NCT00414960|447809927|FG001|Overall Study|Withdrawal by Subject|0|||
124507520|NCT00414960|447809926|FG000|Overall Study|Physician Decision|0|||
124507521|NCT00414960|447809927|FG001|Overall Study|Physician Decision|1|||
124507522|NCT00975195|447809931|FG000|Overall Study|Adverse Event|108|||
124507523|NCT00975195|447809932|FG001|Overall Study|Adverse Event|101|||
124507524|NCT00975195|447809931|FG000|Overall Study|Lack of Efficacy|6|||
124507525|NCT00975195|447809932|FG001|Overall Study|Lack of Efficacy|6|||
124507526|NCT00975195|447809931|FG000|Overall Study|Protocol Violation|27|||
124507527|NCT00975195|447809932|FG001|Overall Study|Protocol Violation|23|||
124507528|NCT00975195|447809931|FG000|Overall Study|Lost to Follow-up|9|||
124507529|NCT00975195|447809932|FG001|Overall Study|Lost to Follow-up|7|||
124507530|NCT00975195|447809931|FG000|Overall Study|Withdrawal by Subject|48|||
124507531|NCT00975195|447809932|FG001|Overall Study|Withdrawal by Subject|61|||
124507532|NCT00975195|447809931|FG000|Overall Study|Other reason not defined above|29|||
124507533|NCT00975195|447809932|FG001|Overall Study|Other reason not defined above|33|||
124507534|NCT00975195|447809931|FG000|Overall Study|Not treated|1|||
124507535|NCT00975195|447809932|FG001|Overall Study|Not treated|2|||
124507536|NCT04633473|447809933|FG000|Overall Study|Withdrawal by Subject|6|||
124507537|NCT01608724|447809934|FG000|Overall Study|Withdrawal by Subject|131|||
124507538|NCT01608724|447809934|FG000|Overall Study|Lost to Follow-up|41|||
124507539|NCT01608724|447809934|FG000|Overall Study|Study-specific discontinuation criteria|32|||
124507540|NCT01608724|447809934|FG000|Overall Study|Adverse Event|29|||
124507541|NCT01608724|447809934|FG000|Overall Study|Protocol Violation|6|||
124507542|NCT01608724|447809934|FG000|Overall Study|bood sugar too high, etc.|3|||
124507543|NCT01608724|447809934|FG000|Overall Study|Safety reasons|1|||
124507544|NCT02720016|447809935|FG000|Overall Study|Separation of couple|6|||
124507545|NCT02720016|447809936|FG001|Overall Study|Separation of couple|8|||
124507546|NCT02720016|447809937|FG002|Overall Study|Separation of couple|2|||
124507547|NCT02720016|447809935|FG000|Overall Study|Withdrawal by Subject|6|||
124507548|NCT02720016|447809936|FG001|Overall Study|Withdrawal by Subject|6|||
124507549|NCT02720016|447809937|FG002|Overall Study|Withdrawal by Subject|4|||
124507550|NCT02720016|447809935|FG000|Overall Study|Scheduling issues|2|||
124507551|NCT02720016|447809936|FG001|Overall Study|Scheduling issues|4|||
124507552|NCT02720016|447809937|FG002|Overall Study|Scheduling issues|7|||
124507553|NCT02720016|447809935|FG000|Overall Study|Childcare|2|||
124507554|NCT02720016|447809936|FG001|Overall Study|Childcare|0|||
124507555|NCT02720016|447809937|FG002|Overall Study|Childcare|2|||
124507556|NCT02720016|447809935|FG000|Overall Study|Withdrawal by PI|2|||
124507557|NCT02720016|447809936|FG001|Overall Study|Withdrawal by PI|2|||
124507558|NCT02720016|447809937|FG002|Overall Study|Withdrawal by PI|0|||
124507559|NCT02720016|447809935|FG000|Overall Study|Moved away|2|||
124507560|NCT02720016|447809936|FG001|Overall Study|Moved away|0|||
124507561|NCT02720016|447809937|FG002|Overall Study|Moved away|0|||
124507562|NCT02720016|447809935|FG000|Overall Study|Not Primary Health Concern|0|||
124507563|NCT02720016|447809936|FG001|Overall Study|Not Primary Health Concern|0|||
124507564|NCT02720016|447809937|FG002|Overall Study|Not Primary Health Concern|2|||
124507565|NCT02720016|447809935|FG000|Overall Study|Transportation issues|0|||
124507566|NCT02720016|447809936|FG001|Overall Study|Transportation issues|0|||
124507567|NCT02720016|447809937|FG002|Overall Study|Transportation issues|1|||
124507568|NCT02720016|447809935|FG000|Overall Study|Other|0|||
124507569|NCT02720016|447809936|FG001|Overall Study|Other|0|||
124507570|NCT02720016|447809937|FG002|Overall Study|Other|2|||
124507571|NCT04501679|447809942|FG000|Overall Study|Pregnancy|0|||
124507572|NCT04501679|447809943|FG001|Overall Study|Pregnancy|1|||
124507573|NCT04501679|447809942|FG000|Overall Study|Adverse Event|4|||
124507574|NCT04501679|447809943|FG001|Overall Study|Adverse Event|2|||
124507575|NCT04501679|447809942|FG000|Overall Study|Withdrawal by Subject|2|||
124507576|NCT04501679|447809943|FG001|Overall Study|Withdrawal by Subject|0|||
124507577|NCT04501679|447809942|FG000|Overall Study|Physician Decision|1|||
124507578|NCT04501679|447809943|FG001|Overall Study|Physician Decision|0|||
124507579|NCT04501679|447809942|FG000|Overall Study|Lost to Follow-up|2|||
124507580|NCT04501679|447809943|FG001|Overall Study|Lost to Follow-up|0|||
124507581|NCT05319080|447809950|FG000|Overall Study|Withdrawal by Subject|2|||
124507582|NCT05319080|447809950|FG000|Overall Study|Physician Decision|4|||
124507583|NCT00751114|447809951|FG000|Overall Study|Adverse Event|2|||
124507584|NCT00751114|447809952|FG001|Overall Study|Adverse Event|4|||
124507585|NCT00751114|447809951|FG000|Overall Study|Protocol Violation|8|||
124507586|NCT00751114|447809952|FG001|Overall Study|Protocol Violation|9|||
124507587|NCT00751114|447809951|FG000|Overall Study|Withdrawal by Subject|9|||
124507588|NCT00751114|447809952|FG001|Overall Study|Withdrawal by Subject|4|||
124507589|NCT00751114|447809951|FG000|Overall Study|Lost to Follow-up|4|||
124507590|NCT00751114|447809952|FG001|Overall Study|Lost to Follow-up|7|||
124507591|NCT00751114|447809951|FG000|Overall Study|Lack of Efficacy|0|||
124507592|NCT00751114|447809952|FG001|Overall Study|Lack of Efficacy|7|||
124507593|NCT00751114|447809951|FG000|Overall Study|Not Treated|13|||
124507594|NCT00751114|447809952|FG001|Overall Study|Not Treated|1|||
124507595|NCT00751114|447809951|FG000|Overall Study|Out of country for 2 months|1|||
124507596|NCT00751114|447809952|FG001|Overall Study|Out of country for 2 months|0|||
124507597|NCT00751114|447809951|FG000|Overall Study|Move to another city|1|||
124507598|NCT00751114|447809952|FG001|Overall Study|Move to another city|0|||
124507599|NCT02648724|447809955|FG000|Overall Study|Withdrawal by Subject|0|||
124507600|NCT02648724|447809956|FG001|Overall Study|Withdrawal by Subject|1|||
124507601|NCT02648724|447809957|FG002|Overall Study|Withdrawal by Subject|1|||
124507602|NCT02648724|447809958|FG003|Overall Study|Withdrawal by Subject|0|||
124507603|NCT02648724|447809959|FG004|Overall Study|Withdrawal by Subject|1|||
124507604|NCT02648724|447809960|FG005|Overall Study|Withdrawal by Subject|0|||
124507605|NCT02648724|447809961|FG006|Overall Study|Withdrawal by Subject|0|||
124507606|NCT02648724|447809955|FG000|Overall Study|Progressive disease|2|||
124507607|NCT02648724|447809956|FG001|Overall Study|Progressive disease|2|||
124507608|NCT02648724|447809957|FG002|Overall Study|Progressive disease|2|||
124507609|NCT02648724|447809958|FG003|Overall Study|Progressive disease|3|||
124507610|NCT02648724|447809959|FG004|Overall Study|Progressive disease|22|||
124507611|NCT02648724|447809960|FG005|Overall Study|Progressive disease|7|||
124507612|NCT02648724|447809961|FG006|Overall Study|Progressive disease|8|||
124507613|NCT02648724|447809955|FG000|Overall Study|Other reason (unknown)|1|||
124507614|NCT02648724|447809956|FG001|Overall Study|Other reason (unknown)|0|||
124507615|NCT02648724|447809957|FG002|Overall Study|Other reason (unknown)|0|||
124507616|NCT02648724|447809958|FG003|Overall Study|Other reason (unknown)|0|||
124507617|NCT02648724|447809959|FG004|Overall Study|Other reason (unknown)|0|||
124507618|NCT02648724|447809960|FG005|Overall Study|Other reason (unknown)|0|||
124507619|NCT02648724|447809961|FG006|Overall Study|Other reason (unknown)|0|||
124507620|NCT02648724|447809955|FG000|Overall Study|Protocol Violation|0|||
124507621|NCT02648724|447809956|FG001|Overall Study|Protocol Violation|0|||
124507622|NCT02648724|447809957|FG002|Overall Study|Protocol Violation|0|||
124507623|NCT02648724|447809958|FG003|Overall Study|Protocol Violation|0|||
124507624|NCT02648724|447809959|FG004|Overall Study|Protocol Violation|1|||
124507625|NCT02648724|447809960|FG005|Overall Study|Protocol Violation|0|||
124507626|NCT02648724|447809961|FG006|Overall Study|Protocol Violation|0|||
124507627|NCT02648724|447809955|FG000|Overall Study|Death|0|||
124507628|NCT02648724|447809956|FG001|Overall Study|Death|0|||
124507629|NCT02648724|447809957|FG002|Overall Study|Death|0|||
124507630|NCT02648724|447809958|FG003|Overall Study|Death|0|||
124507631|NCT02648724|447809959|FG004|Overall Study|Death|0|||
124507632|NCT02648724|447809960|FG005|Overall Study|Death|0|||
124507633|NCT02648724|447809961|FG006|Overall Study|Death|3|||
124507634|NCT02648724|447809955|FG000|Overall Study|Physician Decision|0|||
124507635|NCT02648724|447809956|FG001|Overall Study|Physician Decision|0|||
124507636|NCT02648724|447809957|FG002|Overall Study|Physician Decision|0|||
124507637|NCT02648724|447809958|FG003|Overall Study|Physician Decision|0|||
124507638|NCT02648724|447809959|FG004|Overall Study|Physician Decision|1|||
124507639|NCT02648724|447809960|FG005|Overall Study|Physician Decision|0|||
124507640|NCT02648724|447809961|FG006|Overall Study|Physician Decision|1|||
124507641|NCT02648724|447809955|FG000|Overall Study|Transferred to named patient program|0|||
124507642|NCT02648724|447809956|FG001|Overall Study|Transferred to named patient program|0|||
124507643|NCT02648724|447809957|FG002|Overall Study|Transferred to named patient program|0|||
124507644|NCT02648724|447809958|FG003|Overall Study|Transferred to named patient program|0|||
124507645|NCT02648724|447809959|FG004|Overall Study|Transferred to named patient program|0|||
124507646|NCT02648724|447809960|FG005|Overall Study|Transferred to named patient program|1|||
124507647|NCT02648724|447809961|FG006|Overall Study|Transferred to named patient program|0|||
124507648|NCT03076190|447809962|FG000|Overall Study|Lost to Follow-up|9|||
124507649|NCT03076190|447809963|FG001|Overall Study|Lost to Follow-up|34|||
124507650|NCT03076190|447809962|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
124507651|NCT03076190|447809963|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
124507652|NCT00406783|447809967|FG000|Overall Study|Adverse Event|4|||
124507653|NCT00406783|447809968|FG001|Overall Study|Adverse Event|4|||
124507654|NCT00406783|447809967|FG000|Overall Study|Treatment Failure|2|||
124507655|NCT00406783|447809968|FG001|Overall Study|Treatment Failure|3|||
124507656|NCT00406783|447809967|FG000|Overall Study|Lost to Follow-up|3|||
124507657|NCT00406783|447809968|FG001|Overall Study|Lost to Follow-up|0|||
124507658|NCT00406783|447809967|FG000|Overall Study|Withdrawal by Subject|1|||
124507659|NCT00406783|447809968|FG001|Overall Study|Withdrawal by Subject|4|||
124507660|NCT00406783|447809967|FG000|Overall Study|Protocol Violation|4|||
124507661|NCT00406783|447809968|FG001|Overall Study|Protocol Violation|4|||
124507662|NCT05294211|447809969|FG000|Overall Study|Withdrawal by Subject|3|||
124507663|NCT05294211|447809969|FG000|Overall Study|Physician Decision|2|||
124507664|NCT05294211|447809969|FG000|Overall Study|Progressed to active labor|1|||
124507665|NCT05294211|447809969|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
124507666|NCT05294211|447809969|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
124507667|NCT00064350|447809970|FG000|Induction Treatment|Disease Progression|5|||
124507668|NCT00064350|447809971|FG001|Induction Treatment|Disease Progression|1|||
124507669|NCT00064350|447809972|FG002|Induction Treatment|Disease Progression|110|||
124507670|NCT00064350|447809970|FG000|Induction Treatment|Adverse Event|0|||
124507671|NCT00064350|447809971|FG001|Induction Treatment|Adverse Event|2|||
124507672|NCT00064350|447809972|FG002|Induction Treatment|Adverse Event|49|||
124507673|NCT00064350|447809970|FG000|Induction Treatment|Death|0|||
124507674|NCT00064350|447809971|FG001|Induction Treatment|Death|0|||
124507675|NCT00064350|447809972|FG002|Induction Treatment|Death|9|||
124507676|NCT00064350|447809970|FG000|Induction Treatment|Withdrawal by Subject|0|||
124507677|NCT00064350|447809971|FG001|Induction Treatment|Withdrawal by Subject|0|||
124507678|NCT00064350|447809972|FG002|Induction Treatment|Withdrawal by Subject|21|||
124507679|NCT00064350|447809970|FG000|Induction Treatment|Ineligible or never started treatment|3|||
124507680|NCT00064350|447809971|FG001|Induction Treatment|Ineligible or never started treatment|6|||
124507681|NCT00064350|447809972|FG002|Induction Treatment|Ineligible or never started treatment|34|||
124507682|NCT00064350|447809970|FG000|Induction Treatment|Other|0|||
124507683|NCT00064350|447809971|FG001|Induction Treatment|Other|0|||
124507684|NCT00064350|447809972|FG002|Induction Treatment|Other|13|||
124507685|NCT00064350|447809970|FG000|Randomization|Adverse Event|8|||
124507686|NCT00064350|447809971|FG001|Randomization|Adverse Event|3|||
124507687|NCT00064350|447809972|FG002|Randomization|Adverse Event|0|||
124507688|NCT00064350|447809970|FG000|Randomization|Death|3|||
124507689|NCT00064350|447809971|FG001|Randomization|Death|0|||
124507690|NCT00064350|447809972|FG002|Randomization|Death|0|||
124507691|NCT00064350|447809970|FG000|Randomization|Withdrawal by Subject|1|||
124507692|NCT00064350|447809971|FG001|Randomization|Withdrawal by Subject|0|||
124507693|NCT00064350|447809972|FG002|Randomization|Withdrawal by Subject|0|||
124507694|NCT00064350|447809970|FG000|Randomization|Ineligible or never started treatment|9|||
124563794|NCT00385541|448020221|FG001|Overall Study|severe pain, clinician requested unblind|1|||
124563795|NCT01326026|448020222|FG000|Overall Study|Adverse Event|4|||
124563796|NCT01326026|448020223|FG001|Overall Study|Adverse Event|3|||
124507695|NCT00064350|447809971|FG001|Randomization|Ineligible or never started treatment|15|||
124507696|NCT00064350|447809972|FG002|Randomization|Ineligible or never started treatment|0|||
124507697|NCT00064350|447809970|FG000|Randomization|Other|5|||
124507698|NCT00064350|447809971|FG001|Randomization|Other|0|||
124507699|NCT00064350|447809972|FG002|Randomization|Other|0|||
124507700|NCT00064350|447809970|FG000|Cross-Over|Adverse Event|0|||
124507701|NCT00064350|447809971|FG001|Cross-Over|Adverse Event|1|||
124507702|NCT00064350|447809972|FG002|Cross-Over|Adverse Event|0|||
124507703|NCT00064350|447809970|FG000|Cross-Over|Death|1|||
124507704|NCT00064350|447809971|FG001|Cross-Over|Death|3|||
124507705|NCT00064350|447809972|FG002|Cross-Over|Death|0|||
124507706|NCT00064350|447809970|FG000|Cross-Over|Withdrawal by Subject|2|||
124507707|NCT00064350|447809971|FG001|Cross-Over|Withdrawal by Subject|2|||
124507708|NCT00064350|447809972|FG002|Cross-Over|Withdrawal by Subject|0|||
124507709|NCT00064350|447809970|FG000|Cross-Over|Ineligible or never started treatment|3|||
124507710|NCT00064350|447809971|FG001|Cross-Over|Ineligible or never started treatment|6|||
124507711|NCT00064350|447809972|FG002|Cross-Over|Ineligible or never started treatment|0|||
124507712|NCT00064350|447809970|FG000|Cross-Over|Other|0|||
124507713|NCT00064350|447809971|FG001|Cross-Over|Other|2|||
124507714|NCT00064350|447809972|FG002|Cross-Over|Other|0|||
124507715|NCT00838916|447809973|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
124507716|NCT00838916|447809974|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
124507717|NCT00838916|447809973|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
124507718|NCT00838916|447809974|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
124507719|NCT00838916|447809973|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
124507720|NCT00838916|447809974|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
124507721|NCT00838916|447809973|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
124507722|NCT00838916|447809974|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
124507723|NCT00838916|447809973|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
124507724|NCT00838916|447809974|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
124507725|NCT00838916|447809973|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
124507726|NCT00838916|447809974|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
124507727|NCT00838916|447809973|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
124507728|NCT00838916|447809974|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
124507729|NCT00838916|447809973|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
124507730|NCT00838916|447809974|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
124507731|NCT00838916|447809973|FG000|Treatment Period (156 Weeks)|Missing|3|||
124507732|NCT00838916|447809974|FG001|Treatment Period (156 Weeks)|Missing|1|||
124507733|NCT00838916|447809973|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
124507734|NCT00838916|447809974|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
124507735|NCT00838916|447809973|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
124507736|NCT00838916|447809974|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
124507737|NCT00838916|447809973|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
124507738|NCT00838916|447809974|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
124507739|NCT00838916|447809973|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
124507740|NCT00838916|447809974|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
124507741|NCT00838916|447809973|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
124507742|NCT00838916|447809974|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
124507743|NCT00838916|447809973|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
124507744|NCT00838916|447809974|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
124507745|NCT00838916|447809973|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
124507746|NCT00838916|447809974|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
124507747|NCT00838916|447809973|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
124507748|NCT00838916|447809974|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
124507749|NCT00838916|447809973|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
124507750|NCT00838916|447809974|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
124507751|NCT00838916|447809973|FG000|Follow-up Period (8 Weeks)|Missing|3|||
124507752|NCT00838916|447809974|FG001|Follow-up Period (8 Weeks)|Missing|0|||
124507753|NCT01842607|447809976|FG000|Overall Study|Adverse Event|11|||
124507754|NCT01842607|447809976|FG000|Overall Study|Lack of Efficacy|19|||
124507755|NCT01842607|447809976|FG000|Overall Study|Protocol Violation|8|||
124507756|NCT01842607|447809976|FG000|Overall Study|Protocol defined stopping criteria|2|||
124507757|NCT01842607|447809976|FG000|Overall Study|Lost to Follow-up|3|||
124507758|NCT01842607|447809976|FG000|Overall Study|Physician Decision|9|||
124507759|NCT01842607|447809976|FG000|Overall Study|Withdrawal by Subject|14|||
124507760|NCT00012012|447809977|FG000|Overall Study|Protocol Violation|1|||
124507761|NCT00012012|447809978|FG001|Overall Study|Protocol Violation|1|||
124507762|NCT00012012|447809977|FG000|Overall Study|Withdrawal by Subject|0|||
124563797|NCT01326026|448020222|FG000|Overall Study|Withdrawal Criteria|5|||
124507763|NCT00012012|447809978|FG001|Overall Study|Withdrawal by Subject|2|||
124507764|NCT02034474|447809979|FG000|Overall Study|Adverse Event|3|||
124507765|NCT02034474|447809980|FG001|Overall Study|Adverse Event|2|||
124507766|NCT02034474|447809979|FG000|Overall Study|Withdrawal by Subject|1|||
124507767|NCT02034474|447809980|FG001|Overall Study|Withdrawal by Subject|2|||
124507768|NCT01391819|447809981|FG000|Overall Study|Withdrawal by Subject|56|||
124507769|NCT01391819|447809981|FG000|Overall Study|Migrated/moved from study area|82|||
124507770|NCT01391819|447809981|FG000|Overall Study|Lost to Follow-up|252|||
124507771|NCT01391819|447809981|FG000|Overall Study|Death|3|||
124507772|NCT01391819|447809981|FG000|Overall Study|Other|9|||
124507773|NCT03600714|447809982|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
124507774|NCT02509494|447809987|FG000|Overall Study|Lost to Follow-up|8|||
124507775|NCT02509494|447809988|FG001|Overall Study|Lost to Follow-up|47|||
124507776|NCT02509494|447809989|FG002|Overall Study|Lost to Follow-up|19|||
124507777|NCT02509494|447809990|FG003|Overall Study|Lost to Follow-up|6|||
124507778|NCT02509494|447809991|FG004|Overall Study|Lost to Follow-up|3|||
124507779|NCT02509494|447809992|FG005|Overall Study|Lost to Follow-up|3|||
124507780|NCT02509494|447809993|FG006|Overall Study|Lost to Follow-up|1|||
124507781|NCT02509494|447809994|FG007|Overall Study|Lost to Follow-up|3|||
124507782|NCT02509494|447809995|FG008|Overall Study|Lost to Follow-up|1|||
124507783|NCT02509494|447809987|FG000|Overall Study|Physician Decision|2|||
124507784|NCT02509494|447809988|FG001|Overall Study|Physician Decision|1|||
124507785|NCT02509494|447809989|FG002|Overall Study|Physician Decision|0|||
124507786|NCT02509494|447809990|FG003|Overall Study|Physician Decision|0|||
124507787|NCT02509494|447809991|FG004|Overall Study|Physician Decision|0|||
124507788|NCT02509494|447809992|FG005|Overall Study|Physician Decision|0|||
124507789|NCT02509494|447809993|FG006|Overall Study|Physician Decision|0|||
124507790|NCT02509494|447809994|FG007|Overall Study|Physician Decision|0|||
124507791|NCT02509494|447809995|FG008|Overall Study|Physician Decision|0|||
124507792|NCT02509494|447809987|FG000|Overall Study|Withdrawal by Subject|4|||
124507793|NCT02509494|447809988|FG001|Overall Study|Withdrawal by Subject|17|||
124507794|NCT02509494|447809989|FG002|Overall Study|Withdrawal by Subject|7|||
124507795|NCT02509494|447809990|FG003|Overall Study|Withdrawal by Subject|5|||
124507796|NCT02509494|447809991|FG004|Overall Study|Withdrawal by Subject|0|||
124507797|NCT02509494|447809992|FG005|Overall Study|Withdrawal by Subject|6|||
124507798|NCT02509494|447809993|FG006|Overall Study|Withdrawal by Subject|1|||
124507799|NCT02509494|447809994|FG007|Overall Study|Withdrawal by Subject|2|||
124507800|NCT02509494|447809995|FG008|Overall Study|Withdrawal by Subject|1|||
124507801|NCT02509494|447809987|FG000|Overall Study|Death|0|||
124507802|NCT02509494|447809988|FG001|Overall Study|Death|1|||
124507803|NCT02509494|447809989|FG002|Overall Study|Death|0|||
124507804|NCT02509494|447809990|FG003|Overall Study|Death|0|||
124507805|NCT02509494|447809991|FG004|Overall Study|Death|1|||
124563798|NCT01326026|448020223|FG001|Overall Study|Withdrawal Criteria|7|||
124563799|NCT01326026|448020222|FG000|Overall Study|Other|3|||
124563800|NCT01326026|448020223|FG001|Overall Study|Other|3|||
124563801|NCT05188521|448022203|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
124563802|NCT05188521|448022204|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
124563803|NCT04582266|448022205|FG000|Overall Study|Lost to Follow-up|7|||
124563804|NCT04582266|448022206|FG001|Overall Study|Lost to Follow-up|5|||
124563805|NCT04582266|448022205|FG000|Overall Study|Withdrawal by Subject|1|||
124563806|NCT04582266|448022206|FG001|Overall Study|Withdrawal by Subject|0|||
124563807|NCT04582266|448022205|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
124563808|NCT04582266|448022206|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
124563809|NCT01341639|448022207|FG000|Infant Series|Protocol Violation|1|||
124563810|NCT01341639|448022208|FG001|Infant Series|Protocol Violation|0|||
124563811|NCT01341639|448022207|FG000|Infant Series|Not Vaccinated|0|||
124563812|NCT01341639|448022208|FG001|Infant Series|Not Vaccinated|1|||
124563813|NCT01341639|448022207|FG000|Infant Series|Adverse Event|0|||
124563814|NCT01341639|448022208|FG001|Infant Series|Adverse Event|5|||
124563815|NCT01341639|448022207|FG000|Infant Series|Withdrawal by Subject|11|||
124563816|NCT01341639|448022208|FG001|Infant Series|Withdrawal by Subject|8|||
124563817|NCT01341639|448022207|FG000|Infant Series|Lost to Follow-up|0|||
124563818|NCT01341639|448022208|FG001|Infant Series|Lost to Follow-up|2|||
124563819|NCT01341639|448022207|FG000|Infant Series|Site 0048 Participants|17|||
124507806|NCT02509494|447809992|FG005|Overall Study|Death|0|||
124507807|NCT02509494|447809993|FG006|Overall Study|Death|0|||
124507808|NCT02509494|447809994|FG007|Overall Study|Death|1|||
124507809|NCT02509494|447809995|FG008|Overall Study|Death|0|||
124563820|NCT01341639|448022208|FG001|Infant Series|Site 0048 Participants|16|||
124507810|NCT02509494|447809987|FG000|Overall Study|Other|0|||
124507811|NCT02509494|447809988|FG001|Overall Study|Other|4|||
124507812|NCT02509494|447809989|FG002|Overall Study|Other|5|||
124507813|NCT02509494|447809990|FG003|Overall Study|Other|0|||
124507814|NCT02509494|447809991|FG004|Overall Study|Other|0|||
124563821|NCT01341639|448022207|FG000|Interim Period|Withdrawal by Subject|6|||
124563822|NCT01341639|448022208|FG001|Interim Period|Withdrawal by Subject|7|||
124563823|NCT01341639|448022207|FG000|Interim Period|Lost to Follow-up|2|||
124507815|NCT02509494|447809992|FG005|Overall Study|Other|0|||
124507816|NCT02509494|447809993|FG006|Overall Study|Other|0|||
124507817|NCT02509494|447809994|FG007|Overall Study|Other|0|||
124507818|NCT02509494|447809995|FG008|Overall Study|Other|0|||
124507819|NCT02509494|447809987|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124507820|NCT02509494|447809988|FG001|Overall Study|Non-Compliance With Study Drug|11|||
124507821|NCT02509494|447809989|FG002|Overall Study|Non-Compliance With Study Drug|7|||
124507822|NCT02509494|447809990|FG003|Overall Study|Non-Compliance With Study Drug|0|||
124507823|NCT02509494|447809991|FG004|Overall Study|Non-Compliance With Study Drug|1|||
124507824|NCT02509494|447809992|FG005|Overall Study|Non-Compliance With Study Drug|2|||
124507825|NCT02509494|447809993|FG006|Overall Study|Non-Compliance With Study Drug|1|||
124507826|NCT02509494|447809994|FG007|Overall Study|Non-Compliance With Study Drug|1|||
124507827|NCT02509494|447809995|FG008|Overall Study|Non-Compliance With Study Drug|0|||
124507828|NCT02871401|447811385|FG000|Overall Study|Adverse Event|1|||
124507829|NCT02871401|447811386|FG001|Overall Study|Adverse Event|0|||
124507830|NCT01120379|447811387|FG000|One Year Timepoint|Withdrawal by Subject|41|||
124507831|NCT01120379|447811387|FG000|One Year Timepoint|Lost to Follow-up|115|||
124507832|NCT01120379|447811387|FG000|One Year Timepoint|Death|108|||
124507833|NCT01120379|447811387|FG000|One Year Timepoint|Physician Decision|9|||
124507834|NCT01120379|447811387|FG000|One Year Timepoint|Any other reason for early termination|5|||
124507835|NCT01120379|447811387|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
124507836|NCT01120379|447811387|FG000|Two Year Timepoint|Lost to Follow-up|87|||
124507837|NCT01120379|447811387|FG000|Two Year Timepoint|Death|123|||
124507838|NCT01120379|447811387|FG000|Two Year Timepoint|Physician Decision|12|||
124507839|NCT01120379|447811387|FG000|Two Year Timepoint|Any other reason for early termination|4|||
124507840|NCT01120379|447811387|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
124507841|NCT01120379|447811387|FG000|Three Year Timepoint|Lost to Follow-up|43|||
124507842|NCT01120379|447811387|FG000|Three Year Timepoint|Death|120|||
124507843|NCT01120379|447811387|FG000|Three Year Timepoint|Physician Decision|9|||
124507844|NCT01120379|447811387|FG000|Three Year Timepoint|Any other reason for early termination|17|||
124507845|NCT01120379|447811387|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
124507846|NCT01120379|447811387|FG000|Four Year Timepoint|Lost to Follow-up|10|||
124507847|NCT01120379|447811387|FG000|Four Year Timepoint|Death|131|||
124507848|NCT01120379|447811387|FG000|Four Year Timepoint|Physician Decision|5|||
124507849|NCT01120379|447811387|FG000|Four Year Timepoint|Any other reason for early termination|217|||
124507850|NCT03162055|447811388|FG000|Overall Study|Adverse Event|6|||
124507851|NCT03162055|447811389|FG001|Overall Study|Adverse Event|5|||
124507852|NCT03162055|447811388|FG000|Overall Study|Death|3|||
124507853|NCT03162055|447811389|FG001|Overall Study|Death|3|||
124507854|NCT03162055|447811388|FG000|Overall Study|Lost to Follow-up|0|||
124507855|NCT03162055|447811389|FG001|Overall Study|Lost to Follow-up|1|||
124507856|NCT03162055|447811388|FG000|Overall Study|Study-specific withdrawal criteria|22|||
124507857|NCT03162055|447811389|FG001|Overall Study|Study-specific withdrawal criteria|14|||
124507858|NCT03162055|447811388|FG000|Overall Study|Withdrawal by Subject|17|||
124563824|NCT01341639|448022208|FG001|Interim Period|Lost to Follow-up|0|||
124563825|NCT01341639|448022207|FG000|Interim Period|Physician Decision|0|||
124563826|NCT01341639|448022208|FG001|Interim Period|Physician Decision|1|||
124563827|NCT01341639|448022207|FG000|Interim Period|Protocol Violation|0|||
124563828|NCT01341639|448022208|FG001|Interim Period|Protocol Violation|1|||
124563829|NCT01341639|448022207|FG000|Post-Treatment|Withdrawal by Subject|0|||
124563830|NCT01341639|448022208|FG001|Post-Treatment|Withdrawal by Subject|1|||
124563831|NCT01341639|448022207|FG000|Post-Treatment|Adverse Event|0|||
124563832|NCT01341639|448022208|FG001|Post-Treatment|Adverse Event|2|||
124563833|NCT01132118|448022209|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
124563834|NCT01132118|448022210|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
124563835|NCT01132118|448022209|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
124507859|NCT03162055|447811389|FG001|Overall Study|Withdrawal by Subject|2|||
124507860|NCT03162055|447811388|FG000|Overall Study|Did not receive treatment|2|||
124507861|NCT03162055|447811389|FG001|Overall Study|Did not receive treatment|0|||
124507862|NCT03162055|447811388|FG000|Overall Study|Incorrect randomization|4|||
124507863|NCT03162055|447811389|FG001|Overall Study|Incorrect randomization|3|||
124507864|NCT03162055|447811388|FG000|Overall Study|Other|8|||
124507865|NCT03162055|447811389|FG001|Overall Study|Other|15|||
124507866|NCT02586077|447811390|FG000|Overall Study|Withdrawal by Subject|1|||
124507867|NCT02586077|447811390|FG000|Overall Study|Physician Decision|4|||
124507868|NCT02586077|447811390|FG000|Overall Study|Lost to Follow-up|3|||
124507869|NCT01617655|447811391|FG000|Overall Study|Adverse Event|2|||
124507870|NCT01617655|447811392|FG001|Overall Study|Adverse Event|3|||
124507871|NCT01617655|447811391|FG000|Overall Study|Poor compliance to protocol|1|||
124507872|NCT01617655|447811392|FG001|Overall Study|Poor compliance to protocol|4|||
124507873|NCT01617655|447811391|FG000|Overall Study|Participants moved|0|||
124563836|NCT01132118|448022210|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
124507874|NCT01617655|447811392|FG001|Overall Study|Participants moved|4|||
124507875|NCT01617655|447811391|FG000|Overall Study|Consent withdrawn by participant|1|||
124507876|NCT01617655|447811392|FG001|Overall Study|Consent withdrawn by participant|1|||
124563837|NCT01132118|448022209|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
124563838|NCT01132118|448022210|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
124507877|NCT01617655|447811391|FG000|Overall Study|Last visit outside protocol visit window|1|||
124507878|NCT01617655|447811392|FG001|Overall Study|Last visit outside protocol visit window|10|||
124507879|NCT01617655|447811391|FG000|Overall Study|Site closure|3|||
124507880|NCT01617655|447811392|FG001|Overall Study|Site closure|5|||
124507881|NCT01617655|447811391|FG000|Overall Study|Other than specified above|1|||
124507882|NCT01617655|447811392|FG001|Overall Study|Other than specified above|2|||
124507883|NCT01844830|447811396|FG000|Overall Study|Withdrawal by Subject|1|||
124507884|NCT01844830|447811397|FG001|Overall Study|Withdrawal by Subject|0|||
124507885|NCT00502320|447811399|FG000|Overall Study|Lost to Follow-up|1|||
124507886|NCT00502320|447811400|FG001|Overall Study|Lost to Follow-up|1|||
124507887|NCT00502320|447811399|FG000|Overall Study|Withdrew Consent|1|||
124507888|NCT00502320|447811400|FG001|Overall Study|Withdrew Consent|0|||
124507889|NCT00502320|447811399|FG000|Overall Study|No longer met criteria|1|||
124507890|NCT00502320|447811400|FG001|Overall Study|No longer met criteria|0|||
124507891|NCT00502320|447811399|FG000|Overall Study|Screen Failure|0|||
124507892|NCT00502320|447811400|FG001|Overall Study|Screen Failure|1|||
124507893|NCT00502320|447811399|FG000|Overall Study|Adverse Event|3|||
124507894|NCT00502320|447811400|FG001|Overall Study|Adverse Event|5|||
124507895|NCT02394808|447811409|FG000|Period 1|Unsatisfactory lens fitting|0|||
124507896|NCT02394808|447811410|FG001|Period 1|Unsatisfactory lens fitting|1|||
124507897|NCT02394808|447811409|FG000|Period 2|Lost to Follow-up|1|||
124507898|NCT02394808|447811410|FG001|Period 2|Lost to Follow-up|0|||
124507899|NCT04724733|447811411|FG000|Overall Study|Lost to Follow-up|1|||
124507900|NCT04724733|447811412|FG001|Overall Study|Lost to Follow-up|1|||
124507901|NCT04724733|447811413|FG002|Overall Study|Lost to Follow-up|1|||
124507902|NCT03341923|447811414|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
124507903|NCT03341923|447811415|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
124507904|NCT01742078|447811416|FG000|Overall Study|Withdrawal by Subject|0|||
124507905|NCT01742078|447811417|FG001|Overall Study|Withdrawal by Subject|0|||
124507906|NCT01742078|447811418|FG002|Overall Study|Withdrawal by Subject|0|||
124507907|NCT01742078|447811419|FG003|Overall Study|Withdrawal by Subject|1|||
124507908|NCT01742078|447811420|FG004|Overall Study|Withdrawal by Subject|0|||
124507909|NCT01742078|447811421|FG005|Overall Study|Withdrawal by Subject|0|||
124507910|NCT01742078|447811422|FG006|Overall Study|Withdrawal by Subject|0|||
124507911|NCT01742078|447811423|FG007|Overall Study|Withdrawal by Subject|0|||
124507912|NCT01742078|447811424|FG008|Overall Study|Withdrawal by Subject|0|||
124507913|NCT04580394|447811425|FG000|First Intervention|Incorrectly Randomized|1|||
124507914|NCT04580394|447811425|FG000|First Intervention|Physician Decision|1|||
124507915|NCT04580394|447811425|FG000|First Intervention|Lost to Follow-up|1|||
124507916|NCT04580394|447811425|FG000|Washout (One Week)|Withdrawal by Subject|1|||
124507917|NCT04580394|447811425|FG000|Washout (One Week)|Adverse Event|1|||
124507918|NCT04580394|447811425|FG000|Washout (One Week)|Withdrawal by Subject|2|||
124507919|NCT04580394|447811425|FG000|Third Intervention|Adverse Event|1|||
124507920|NCT04580394|447811425|FG000|Third Intervention|Withdrawal by Subject|1|||
124507921|NCT04580394|447811425|FG000|Washout (One Week)|Withdrawal by Subject|2|||
124507922|NCT00084929|447811426|FG000|Overall Study|ineligible - medical contraindication|1|||
124507923|NCT00084929|447811426|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
124507924|NCT00084929|447811426|FG000|Overall Study|Ineligible - Medical history|6|||
124507925|NCT00084929|447811426|FG000|Overall Study|Withdrawal by Subject|10|||
124507926|NCT00084929|447811426|FG000|Overall Study|Missing/incomplete CTC exam|9|||
124507927|NCT00084929|447811426|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
124507928|NCT00642746|447811428|FG000|Overall Study|Patient unevaluable|1|||
124507929|NCT00642746|447811429|FG001|Overall Study|Patient unevaluable|0|||
124507930|NCT03337152|447811432|FG000|Overall Study|Physician Decision|1|||
124507931|NCT03337152|447811433|FG001|Overall Study|Physician Decision|0|||
124507932|NCT03337152|447811432|FG000|Overall Study|Lost to Follow-up|1|||
124507933|NCT03337152|447811433|FG001|Overall Study|Lost to Follow-up|3|||
124507934|NCT03337152|447811432|FG000|Overall Study|Adverse Event|3|||
124507935|NCT03337152|447811433|FG001|Overall Study|Adverse Event|1|||
124507936|NCT03337152|447811432|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
124507937|NCT03337152|447811433|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
124507938|NCT00077610|447811434|FG000|Overall Study|Adverse Event|9|||
124507939|NCT00077610|447811435|FG001|Overall Study|Adverse Event|7|||
124507940|NCT00077610|447811436|FG002|Overall Study|Adverse Event|1|||
124507941|NCT00077610|447811434|FG000|Overall Study|Lost to Follow-up|0|||
124507942|NCT00077610|447811435|FG001|Overall Study|Lost to Follow-up|1|||
124507943|NCT00077610|447811436|FG002|Overall Study|Lost to Follow-up|2|||
124563839|NCT02742090|448022215|FG000|Overall Study|Adverse Event|10|||
124507944|NCT00077610|447811434|FG000|Overall Study|Withdrawal by Subject|4|||
124507945|NCT00077610|447811435|FG001|Overall Study|Withdrawal by Subject|10|||
124507946|NCT00077610|447811436|FG002|Overall Study|Withdrawal by Subject|6|||
124507947|NCT00077610|447811434|FG000|Overall Study|Death|17|||
124507948|NCT00077610|447811435|FG001|Overall Study|Death|13|||
124507949|NCT00077610|447811436|FG002|Overall Study|Death|13|||
124507950|NCT00077610|447811434|FG000|Overall Study|Renal transplant|12|||
124507951|NCT00077610|447811435|FG001|Overall Study|Renal transplant|15|||
124507952|NCT00077610|447811436|FG002|Overall Study|Renal transplant|11|||
124507953|NCT00077610|447811434|FG000|Overall Study|Withdrew from dialysis care|5|||
124507954|NCT00077610|447811435|FG001|Overall Study|Withdrew from dialysis care|0|||
124507955|NCT00077610|447811436|FG002|Overall Study|Withdrew from dialysis care|3|||
124563840|NCT02742090|448022215|FG000|Overall Study|Death|3|||
124563841|NCT02742090|448022215|FG000|Overall Study|Disease Progression|25|||
124563842|NCT02742090|448022215|FG000|Overall Study|Investigator's Decision|1|||
124563843|NCT02742090|448022215|FG000|Overall Study|Lost to Follow-up|1|||
124563844|NCT02742090|448022215|FG000|Overall Study|Non-compliance with Study|1|||
124563845|NCT02742090|448022215|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
124563846|NCT02742090|448022215|FG000|Overall Study|Withdrawal by Subject|4|||
124563847|NCT02742090|448022215|FG000|Overall Study|Reason Not Specified|1|||
124563848|NCT01299038|448022216|FG000|Overall Study|Withdrawal by Subject|1|||
124563849|NCT01299038|448022217|FG001|Overall Study|Withdrawal by Subject|0|||
124563850|NCT00832078|448022218|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
124563851|NCT00832078|448022219|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
124563852|NCT00832078|448022218|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
124563853|NCT00832078|448022219|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
124563854|NCT03355742|448022220|FG000|Overall Study|Lost to Follow-up|4|||
124563855|NCT03355742|448022220|FG000|Overall Study|Withdrawal by Subject|29|||
124563856|NCT03355742|448022220|FG000|Overall Study|Physician Decision|6|||
124563857|NCT03355742|448022220|FG000|Overall Study|Death|55|||
124563858|NCT03355742|448022220|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
124563859|NCT02891200|448022230|FG000|Overall Study|Lost to Follow-up|31|||
124563860|NCT02891200|448022231|FG001|Overall Study|Lost to Follow-up|36|||
124563861|NCT02891200|448022230|FG000|Overall Study|Death|10|||
124563862|NCT02891200|448022231|FG001|Overall Study|Death|9|||
124563863|NCT02891200|448022230|FG000|Overall Study|Withdrawal by Subject|1|||
124563864|NCT02891200|448022231|FG001|Overall Study|Withdrawal by Subject|4|||
124563865|NCT04480463|448022234|FG000|Overall Study|Death|0|||
124563866|NCT04480463|448022235|FG001|Overall Study|Death|1|||
124563867|NCT04480463|448022234|FG000|Overall Study|Adverse Event|6|||
124563868|NCT04480463|448022235|FG001|Overall Study|Adverse Event|8|||
124563869|NCT04480463|448022234|FG000|Overall Study|Lost to Follow-up|3|||
124563870|NCT04480463|448022235|FG001|Overall Study|Lost to Follow-up|2|||
124563871|NCT04480463|448022234|FG000|Overall Study|Physician Decision|2|||
124563872|NCT04480463|448022235|FG001|Overall Study|Physician Decision|5|||
124563873|NCT04480463|448022234|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
124563874|NCT04480463|448022235|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
124563875|NCT04480463|448022234|FG000|Overall Study|Protocol Violation|2|||
124563876|NCT04480463|448022235|FG001|Overall Study|Protocol Violation|1|||
124563877|NCT04480463|448022234|FG000|Overall Study|Withdrawal by Subject|6|||
124563878|NCT04480463|448022235|FG001|Overall Study|Withdrawal by Subject|7|||
124563879|NCT04480463|448022234|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
124563880|NCT04480463|448022235|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
124563881|NCT04480463|448022234|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
124563882|NCT04480463|448022235|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
124563883|NCT04480463|448022234|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
124563884|NCT04480463|448022235|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
124563885|NCT04480463|448022234|FG000|Overall Study|Other|6|||
124563886|NCT04480463|448022235|FG001|Overall Study|Other|4|||
124563887|NCT00444795|448022237|FG000|Overall Study|Not Treated|1|||
124563888|NCT00444795|448022237|FG000|Overall Study|Treated Prior to the Contract Date|2|||
124563889|NCT00988169|448022238|FG000|Overall Study|Withdrawal by Subject|1|||
124563890|NCT00704418|448022240|FG000|Overall Study|Withdrawal by Subject|2|||
124563891|NCT00704418|448022241|FG001|Overall Study|Withdrawal by Subject|0|||
124563892|NCT00704418|448022240|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
124563893|NCT00704418|448022241|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
124563894|NCT02322879|448022242|FG000|First Intervention|Physician Decision|1|||
124563895|NCT02322879|448022243|FG001|First Intervention|Physician Decision|0|||
124563896|NCT02637076|448022244|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
124563897|NCT02637076|448022245|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
124563898|NCT02637076|448022244|FG000|Overall Study|Withdrawal by Subject|0|||
124563899|NCT02637076|448022245|FG001|Overall Study|Withdrawal by Subject|4|||
124563900|NCT02710071|448022247|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
124563901|NCT02710071|448022248|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
124563902|NCT02710071|448022247|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
124563903|NCT02710071|448022248|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
124563904|NCT02637557|448022252|FG000|Overall Study|Adverse Event|3|||
124563905|NCT02637557|448022253|FG001|Overall Study|Adverse Event|1|||
124563906|NCT02637557|448022254|FG002|Overall Study|Adverse Event|3|||
124563907|NCT02637557|448022255|FG003|Overall Study|Adverse Event|3|||
124563908|NCT02637557|448022252|FG000|Overall Study|Lost to Follow-up|1|||
124563909|NCT02637557|448022253|FG001|Overall Study|Lost to Follow-up|1|||
124563910|NCT02637557|448022254|FG002|Overall Study|Lost to Follow-up|0|||
124563911|NCT02637557|448022255|FG003|Overall Study|Lost to Follow-up|1|||
124563912|NCT02637557|448022252|FG000|Overall Study|Physician Decision|1|||
124563913|NCT02637557|448022253|FG001|Overall Study|Physician Decision|0|||
124563914|NCT02637557|448022254|FG002|Overall Study|Physician Decision|0|||
124563915|NCT02637557|448022255|FG003|Overall Study|Physician Decision|0|||
124563916|NCT02637557|448022252|FG000|Overall Study|Protocol Violation|2|||
124563917|NCT02637557|448022253|FG001|Overall Study|Protocol Violation|0|||
124563918|NCT02637557|448022254|FG002|Overall Study|Protocol Violation|2|||
124563919|NCT02637557|448022255|FG003|Overall Study|Protocol Violation|1|||
124563920|NCT02637557|448022252|FG000|Overall Study|Withdrawal by Subject|1|||
124563921|NCT02637557|448022253|FG001|Overall Study|Withdrawal by Subject|3|||
124563922|NCT02637557|448022254|FG002|Overall Study|Withdrawal by Subject|4|||
124563923|NCT02637557|448022255|FG003|Overall Study|Withdrawal by Subject|2|||
124563924|NCT00613574|448022256|FG000|Overall Study|Adverse Event|3|||
124563925|NCT00613574|448022256|FG000|Overall Study|Lost to Follow-up|2|||
124563926|NCT00613574|448022256|FG000|Overall Study|Other|1|||
124563927|NCT01751412|448022258|FG000|Overall Study|Disease Progression Before Treatment|1|||
124563928|NCT02711956|448022261|FG000|Overall Study|Adverse Event|0|||
124563929|NCT02711956|448022262|FG001|Overall Study|Adverse Event|0|||
124563930|NCT02711956|448022263|FG002|Overall Study|Adverse Event|0|||
124563931|NCT02711956|448022264|FG003|Overall Study|Adverse Event|1|||
124563932|NCT02711956|448022265|FG004|Overall Study|Adverse Event|2|||
124563933|NCT02711956|448022266|FG005|Overall Study|Adverse Event|0|||
124563934|NCT02711956|448022267|FG006|Overall Study|Adverse Event|0|||
124563935|NCT02711956|448022268|FG007|Overall Study|Adverse Event|1|||
124563936|NCT02711956|448022269|FG008|Overall Study|Adverse Event|1|||
124563937|NCT02711956|448022270|FG009|Overall Study|Adverse Event|1|||
124563938|NCT02711956|448022271|FG010|Overall Study|Adverse Event|1|||
124563939|NCT02711956|448022272|FG011|Overall Study|Adverse Event|0|||
124563940|NCT02711956|448022273|FG012|Overall Study|Adverse Event|0|||
124563941|NCT02711956|448022274|FG013|Overall Study|Adverse Event|0|||
124563942|NCT02711956|448022275|FG014|Overall Study|Adverse Event|2|||
124563943|NCT02711956|448022261|FG000|Overall Study|Physician Decision|0|||
124563944|NCT02711956|448022262|FG001|Overall Study|Physician Decision|0|||
124563945|NCT02711956|448022263|FG002|Overall Study|Physician Decision|0|||
124507956|NCT00077610|447811434|FG000|Overall Study|Insufficient Therapeutic Response|1|||
124507957|NCT00077610|447811435|FG001|Overall Study|Insufficient Therapeutic Response|0|||
124507958|NCT00077610|447811436|FG002|Overall Study|Insufficient Therapeutic Response|0|||
124507959|NCT00077610|447811434|FG000|Overall Study|Multiple blood transfusions|0|||
124507960|NCT00077610|447811435|FG001|Overall Study|Multiple blood transfusions|0|||
124507961|NCT00077610|447811436|FG002|Overall Study|Multiple blood transfusions|1|||
124507962|NCT00077610|447811434|FG000|Overall Study|Principal Investigator's decision|1|||
124507963|NCT00077610|447811435|FG001|Overall Study|Principal Investigator's decision|0|||
124507964|NCT00077610|447811436|FG002|Overall Study|Principal Investigator's decision|1|||
124507965|NCT00077610|447811434|FG000|Overall Study|Worsening of health condition|1|||
124507966|NCT00077610|447811435|FG001|Overall Study|Worsening of health condition|1|||
124507967|NCT00077610|447811436|FG002|Overall Study|Worsening of health condition|0|||
124507968|NCT00077610|447811434|FG000|Overall Study|Given Epogen in hospital|1|||
124507969|NCT00077610|447811435|FG001|Overall Study|Given Epogen in hospital|0|||
124507970|NCT00077610|447811436|FG002|Overall Study|Given Epogen in hospital|0|||
124507971|NCT00077610|447811434|FG000|Overall Study|Transferred to other unit|0|||
124507972|NCT00077610|447811435|FG001|Overall Study|Transferred to other unit|0|||
124507973|NCT00077610|447811436|FG002|Overall Study|Transferred to other unit|1|||
124507974|NCT00077610|447811434|FG000|Overall Study|Transferred to nursing home|0|||
124507975|NCT00077610|447811435|FG001|Overall Study|Transferred to nursing home|0|||
124507976|NCT00077610|447811436|FG002|Overall Study|Transferred to nursing home|1|||
124507977|NCT00077610|447811434|FG000|Overall Study|Transfer to satellite unit|1|||
124507978|NCT00077610|447811435|FG001|Overall Study|Transfer to satellite unit|0|||
124507979|NCT00077610|447811436|FG002|Overall Study|Transfer to satellite unit|0|||
124507980|NCT00077610|447811434|FG000|Overall Study|Transfer to other center for surgery|1|||
124507981|NCT00077610|447811435|FG001|Overall Study|Transfer to other center for surgery|0|||
124507982|NCT00077610|447811436|FG002|Overall Study|Transfer to other center for surgery|0|||
124507983|NCT00077610|447811434|FG000|Overall Study|Change in dialysis modality|1|||
124507984|NCT00077610|447811435|FG001|Overall Study|Change in dialysis modality|0|||
124507985|NCT00077610|447811436|FG002|Overall Study|Change in dialysis modality|0|||
124507986|NCT00077610|447811434|FG000|Overall Study|Relocation|0|||
124563946|NCT02711956|448022264|FG003|Overall Study|Physician Decision|2|||
124563947|NCT02711956|448022265|FG004|Overall Study|Physician Decision|0|||
124507987|NCT00077610|447811435|FG001|Overall Study|Relocation|8|||
124507988|NCT00077610|447811436|FG002|Overall Study|Relocation|5|||
124563948|NCT02711956|448022266|FG005|Overall Study|Physician Decision|0|||
124563949|NCT02711956|448022267|FG006|Overall Study|Physician Decision|0|||
124507989|NCT00077610|447811434|FG000|Overall Study|Financial issues|0|||
124507990|NCT00077610|447811435|FG001|Overall Study|Financial issues|1|||
124507991|NCT00077610|447811436|FG002|Overall Study|Financial issues|0|||
124563950|NCT02711956|448022268|FG007|Overall Study|Physician Decision|0|||
124563951|NCT02711956|448022269|FG008|Overall Study|Physician Decision|0|||
124507992|NCT00077610|447811434|FG000|Overall Study|Sponsors decision to withdraw|0|||
124507993|NCT00077610|447811435|FG001|Overall Study|Sponsors decision to withdraw|0|||
124507994|NCT00077610|447811436|FG002|Overall Study|Sponsors decision to withdraw|1|||
124507995|NCT02662985|447811439|FG000|Treatment Period 1|Adverse Event|0|||
124507996|NCT02662985|447811440|FG001|Treatment Period 1|Adverse Event|2|||
124507997|NCT02662985|447811439|FG000|Treatment Period 1|Protocol Violation|0|||
124507998|NCT02662985|447811440|FG001|Treatment Period 1|Protocol Violation|1|||
124507999|NCT02662985|447811439|FG000|Treatment Period 1|Physician Decision|1|||
124508000|NCT02662985|447811440|FG001|Treatment Period 1|Physician Decision|0|||
124508001|NCT02662985|447811439|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124508002|NCT02662985|447811440|FG001|Treatment Period 1|Withdrawal by Subject|1|||
124508003|NCT02662985|447811439|FG000|Treatment Period 2|Lack of Efficacy|0|||
124508004|NCT02662985|447811440|FG001|Treatment Period 2|Lack of Efficacy|1|||
124508005|NCT02662985|447811439|FG000|Treatment Period 2|Lost to Follow-up|1|||
124508006|NCT02662985|447811440|FG001|Treatment Period 2|Lost to Follow-up|0|||
124508007|NCT02662985|447811439|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
124508008|NCT02662985|447811440|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
124508009|NCT02662985|447811439|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
124508010|NCT02662985|447811440|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
124508011|NCT02662985|447811439|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
124508012|NCT02662985|447811440|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
124508013|NCT02662985|447811439|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
124508014|NCT02662985|447811440|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
124508015|NCT02662985|447811439|FG000|Treatment Period 3 (Extension Period)|Death|0|||
124508016|NCT02662985|447811440|FG001|Treatment Period 3 (Extension Period)|Death|1|||
124508017|NCT02493426|447811441|FG000|Overall Study|Withdrawal by Subject|0|||
124508018|NCT02493426|447811442|FG001|Overall Study|Withdrawal by Subject|1|||
124508019|NCT01025817|447811445|FG000|Completed Study Medication|Adverse Event|66|||
124508020|NCT01025817|447811446|FG001|Completed Study Medication|Adverse Event|39|||
124508021|NCT01025817|447811445|FG000|Completed Study Medication|Protocol Deviation|9|||
124508022|NCT01025817|447811446|FG001|Completed Study Medication|Protocol Deviation|8|||
124508023|NCT01025817|447811445|FG000|Completed Study Medication|Withdrawal by Subject|8|||
124508024|NCT01025817|447811446|FG001|Completed Study Medication|Withdrawal by Subject|9|||
124508025|NCT01025817|447811445|FG000|Completed Study Medication|Administrative problems|7|||
124508026|NCT01025817|447811446|FG001|Completed Study Medication|Administrative problems|5|||
124508027|NCT01025817|447811445|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
124508028|NCT01025817|447811446|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
124508029|NCT01025817|447811445|FG000|Completed Study Medication|Abnormal test procedure|4|||
124508030|NCT01025817|447811446|FG001|Completed Study Medication|Abnormal test procedure|0|||
124508031|NCT01025817|447811445|FG000|Completed Study Medication|Graft loss|2|||
124508032|NCT01025817|447811446|FG001|Completed Study Medication|Graft loss|5|||
124508033|NCT01025817|447811445|FG000|Completed Study Medication|Death|2|||
124508034|NCT01025817|447811446|FG001|Completed Study Medication|Death|2|||
124508035|NCT01025817|447811445|FG000|Completed Study Medication|Abnormal lab values|0|||
124508036|NCT01025817|447811446|FG001|Completed Study Medication|Abnormal lab values|2|||
124508037|NCT01025817|447811445|FG000|Completed Study Medication|Subject no longer required study drug|0|||
124508038|NCT01025817|447811446|FG001|Completed Study Medication|Subject no longer required study drug|1|||
124508039|NCT01025817|447811445|FG000|Completed Study Medication|Lost to Follow-up|0|||
124508040|NCT01025817|447811446|FG001|Completed Study Medication|Lost to Follow-up|1|||
124508041|NCT01025817|447811445|FG000|Completed Study|Withdrawal by Subject|8|||
124508042|NCT01025817|447811446|FG001|Completed Study|Withdrawal by Subject|16|||
124508043|NCT01025817|447811445|FG000|Completed Study|Death|6|||
124508044|NCT01025817|447811446|FG001|Completed Study|Death|5|||
124508045|NCT01025817|447811445|FG000|Completed Study|Missing|2|||
124508046|NCT01025817|447811446|FG001|Completed Study|Missing|0|||
124508047|NCT01025817|447811445|FG000|Completed Study|Lost to Follow-up|0|||
124508048|NCT01025817|447811446|FG001|Completed Study|Lost to Follow-up|1|||
124508049|NCT01599754|447811448|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
124508050|NCT01599754|447811449|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
124508051|NCT01599754|447811448|FG000|Overall Study|Participant noncompliance|4|||
124508052|NCT01599754|447811449|FG001|Overall Study|Participant noncompliance|4|||
124508053|NCT01599754|447811448|FG000|Overall Study|Lost to Follow-up|13|||
124508054|NCT01599754|447811449|FG001|Overall Study|Lost to Follow-up|6|||
124508055|NCT01599754|447811448|FG000|Overall Study|Death|31|||
124508056|NCT01599754|447811449|FG001|Overall Study|Death|33|||
124508057|NCT01599754|447811448|FG000|Overall Study|Adverse Event|3|||
124508058|NCT01599754|447811449|FG001|Overall Study|Adverse Event|2|||
124508059|NCT01599754|447811448|FG000|Overall Study|Investigator decision|1|||
124508060|NCT01599754|447811449|FG001|Overall Study|Investigator decision|3|||
124508061|NCT01599754|447811448|FG000|Overall Study|Withdrawal by Subject|24|||
124508062|NCT01599754|447811449|FG001|Overall Study|Withdrawal by Subject|25|||
124563952|NCT02711956|448022270|FG009|Overall Study|Physician Decision|0|||
124563953|NCT02711956|448022271|FG010|Overall Study|Physician Decision|0|||
124563954|NCT02711956|448022272|FG011|Overall Study|Physician Decision|0|||
124563955|NCT02711956|448022273|FG012|Overall Study|Physician Decision|0|||
124563956|NCT02711956|448022274|FG013|Overall Study|Physician Decision|0|||
124563957|NCT02711956|448022275|FG014|Overall Study|Physician Decision|0|||
124563958|NCT02711956|448022261|FG000|Overall Study|Withdrawal by Subject|0|||
124563959|NCT02711956|448022262|FG001|Overall Study|Withdrawal by Subject|0|||
124563960|NCT02711956|448022263|FG002|Overall Study|Withdrawal by Subject|0|||
124563961|NCT02711956|448022264|FG003|Overall Study|Withdrawal by Subject|0|||
124508063|NCT01599754|447811448|FG000|Overall Study|Study terminated by sponsor|282|||
124508064|NCT01599754|447811449|FG001|Overall Study|Study terminated by sponsor|285|||
124508065|NCT01029002|447811450|FG000|Overall Study|Lost to Follow-up|2|||
124508066|NCT01029002|447811451|FG001|Overall Study|Lost to Follow-up|4|||
124508067|NCT00702052|447811452|FG000|Overall Study|Adverse Event|23|||
124508068|NCT00702052|447811452|FG000|Overall Study|Disease Progression|30|||
124508069|NCT00702052|447811452|FG000|Overall Study|Withdrawal by Subject|5|||
124508070|NCT01577160|447811453|FG000|Overall Study|Adverse Event|9|||
124508071|NCT01577160|447811453|FG000|Overall Study|Lack of Efficacy|15|||
124508072|NCT01577160|447811453|FG000|Overall Study|Lost to Follow-up|40|||
124508073|NCT01577160|447811453|FG000|Overall Study|Withdrawal by Subject|18|||
124508074|NCT01577160|447811453|FG000|Overall Study|Subject Uncooperative|7|||
124508075|NCT01577160|447811453|FG000|Overall Study|Other|9|||
124508076|NCT01551758|447811454|FG000|Overall Study|Adverse Event|29|||
124508077|NCT01551758|447811455|FG001|Overall Study|Adverse Event|43|||
124508078|NCT01551758|447811454|FG000|Overall Study|Lack of Efficacy|0|||
124508079|NCT01551758|447811455|FG001|Overall Study|Lack of Efficacy|1|||
124508080|NCT01551758|447811454|FG000|Overall Study|Protocol Violation|5|||
124508081|NCT01551758|447811455|FG001|Overall Study|Protocol Violation|6|||
124508082|NCT01551758|447811454|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
124508083|NCT01551758|447811455|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
124508084|NCT01551758|447811454|FG000|Overall Study|Lost to Follow-up|29|||
124508085|NCT01551758|447811455|FG001|Overall Study|Lost to Follow-up|25|||
124508086|NCT01551758|447811454|FG000|Overall Study|Physician Decision|9|||
124508087|NCT01551758|447811455|FG001|Overall Study|Physician Decision|3|||
124508088|NCT01551758|447811454|FG000|Overall Study|Withdrawal by Subject|14|||
124508089|NCT01551758|447811455|FG001|Overall Study|Withdrawal by Subject|17|||
124508090|NCT00101192|447811456|FG000|Overall Study|Ineligible|6|||
124508091|NCT00101192|447811456|FG000|Overall Study|Inevaluable|1|||
124508092|NCT02618928|447811459|FG000|Overall Study|Failure to Return|28|||
124508093|NCT02618928|447811459|FG000|Overall Study|Insufficient Virological Response|1|||
124508094|NCT02618928|447811459|FG000|Overall Study|Withdrawal by Subject|2|||
124508095|NCT02618928|447811459|FG000|Overall Study|Death|3|||
124508096|NCT02618928|447811459|FG000|Overall Study|Other|11|||
124508097|NCT02618928|447811459|FG000|Overall Study|Missing|6|||
124508098|NCT02618928|447811459|FG000|Overall Study|Treatment Never Started|7|||
124508099|NCT03670641|447811460|FG000|Overall Study|Lost to Follow-up|3|||
124508100|NCT00118482|447811461|FG000|Overall Study|Lost to Follow-up|7|||
124508101|NCT00118482|447811462|FG001|Overall Study|Lost to Follow-up|7|||
124508102|NCT00118482|447811461|FG000|Overall Study|Withdrawal by Subject|23|||
124508103|NCT00118482|447811462|FG001|Overall Study|Withdrawal by Subject|22|||
124563962|NCT02711956|448022265|FG004|Overall Study|Withdrawal by Subject|0|||
124563963|NCT02711956|448022266|FG005|Overall Study|Withdrawal by Subject|0|||
124563964|NCT02711956|448022267|FG006|Overall Study|Withdrawal by Subject|1|||
124563965|NCT02711956|448022268|FG007|Overall Study|Withdrawal by Subject|0|||
124563966|NCT02711956|448022269|FG008|Overall Study|Withdrawal by Subject|0|||
124563967|NCT02711956|448022270|FG009|Overall Study|Withdrawal by Subject|0|||
124563968|NCT02711956|448022271|FG010|Overall Study|Withdrawal by Subject|0|||
124563969|NCT02711956|448022272|FG011|Overall Study|Withdrawal by Subject|1|||
124563970|NCT02711956|448022273|FG012|Overall Study|Withdrawal by Subject|6|||
124563971|NCT02711956|448022274|FG013|Overall Study|Withdrawal by Subject|0|||
124563972|NCT02711956|448022275|FG014|Overall Study|Withdrawal by Subject|1|||
124563973|NCT02711956|448022261|FG000|Overall Study|Clinical progression|1|||
124508104|NCT02128763|447811465|FG000|Overall Study|Death|1|||
124508105|NCT02128763|447811466|FG001|Overall Study|Death|0|||
124508106|NCT02128763|447811465|FG000|Overall Study|Lost to Follow-up|19|||
124508107|NCT02128763|447811466|FG001|Overall Study|Lost to Follow-up|16|||
124508108|NCT02921919|447811469|FG000|Overall Study|Other|5|||
124508109|NCT02921919|447811470|FG001|Overall Study|Other|6|||
124508110|NCT02921919|447811469|FG000|Overall Study|Lost to Follow-up|0|||
124508111|NCT02921919|447811470|FG001|Overall Study|Lost to Follow-up|1|||
124508112|NCT02921919|447811469|FG000|Overall Study|Withdrawal by Subject|5|||
124508113|NCT02921919|447811470|FG001|Overall Study|Withdrawal by Subject|1|||
124508114|NCT02921919|447811469|FG000|Overall Study|Disease Progression|47|||
124508115|NCT02921919|447811470|FG001|Overall Study|Disease Progression|38|||
124508116|NCT02921919|447811469|FG000|Overall Study|Physician Decision|3|||
124563974|NCT02711956|448022262|FG001|Overall Study|Clinical progression|0|||
124563975|NCT02711956|448022263|FG002|Overall Study|Clinical progression|0|||
124508117|NCT02921919|447811470|FG001|Overall Study|Physician Decision|2|||
124508118|NCT02921919|447811469|FG000|Overall Study|Adverse Event|6|||
124563976|NCT02711956|448022264|FG003|Overall Study|Clinical progression|0|||
124563977|NCT02711956|448022265|FG004|Overall Study|Clinical progression|0|||
124508119|NCT02921919|447811470|FG001|Overall Study|Adverse Event|4|||
124508120|NCT03666858|447811471|FG000|Cohort 1|Adverse Event|1|||
124508121|NCT03666858|447811472|FG001|Cohort 1|Adverse Event|0|||
124508122|NCT03666858|447811471|FG000|Cohort 2|Adverse Event|0|||
124508123|NCT03666858|447811472|FG001|Cohort 2|Adverse Event|1|||
124508124|NCT03282357|447811473|FG000|Overall Study|Lost to Follow-up|3|||
124508125|NCT03282357|447811473|FG000|Overall Study|Withdrawal by Subject|4|||
124508126|NCT03282357|447811473|FG000|Overall Study|Adverse Event|1|||
124508127|NCT03282357|447811473|FG000|Overall Study|Other|9|||
124508128|NCT01586156|447811474|FG000|Overall Study|Pregnancy|0|||
124508129|NCT01586156|447811475|FG001|Overall Study|Pregnancy|1|||
124508130|NCT01586156|447811476|FG002|Overall Study|Pregnancy|0|||
124508131|NCT00547378|447811477|FG000|Randomized Cohort|Withdrawal by Subject|7|||
124508132|NCT00547378|447811478|FG001|Randomized Cohort|Withdrawal by Subject|5|||
124508133|NCT00547378|447811479|FG002|Randomized Cohort|Withdrawal by Subject|0|||
124508134|NCT00547378|447811477|FG000|Randomized Cohort|Death|0|||
124508135|NCT00547378|447811478|FG001|Randomized Cohort|Death|1|||
124508136|NCT00547378|447811479|FG002|Randomized Cohort|Death|0|||
124508137|NCT00547378|447811477|FG000|Randomized Cohort|Lost to Follow-up|1|||
124508138|NCT00547378|447811478|FG001|Randomized Cohort|Lost to Follow-up|0|||
124508139|NCT00547378|447811479|FG002|Randomized Cohort|Lost to Follow-up|0|||
124508140|NCT00547378|447811477|FG000|Randomized Cohort|Adverse Event|1|||
124508141|NCT00547378|447811478|FG001|Randomized Cohort|Adverse Event|0|||
124508142|NCT00547378|447811479|FG002|Randomized Cohort|Adverse Event|0|||
124508143|NCT00547378|447811477|FG000|Randomized Cohort|Other reasons|2|||
124508144|NCT00547378|447811478|FG001|Randomized Cohort|Other reasons|0|||
124508145|NCT00547378|447811479|FG002|Randomized Cohort|Other reasons|0|||
124508146|NCT00547378|447811477|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
124508147|NCT00547378|447811478|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
124508148|NCT00547378|447811479|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
124508149|NCT00547378|447811477|FG000|All Implanted Cohort|Adverse Event|4|||
124508150|NCT00547378|447811478|FG001|All Implanted Cohort|Adverse Event|10|||
124508151|NCT00547378|447811479|FG002|All Implanted Cohort|Adverse Event|17|||
124508152|NCT00547378|447811477|FG000|All Implanted Cohort|Lost to Follow-up|0|||
124508153|NCT00547378|447811478|FG001|All Implanted Cohort|Lost to Follow-up|1|||
124508154|NCT00547378|447811479|FG002|All Implanted Cohort|Lost to Follow-up|14|||
124508155|NCT00547378|447811477|FG000|All Implanted Cohort|Death|3|||
124508156|NCT00547378|447811478|FG001|All Implanted Cohort|Death|1|||
124508157|NCT00547378|447811479|FG002|All Implanted Cohort|Death|4|||
124508158|NCT00547378|447811477|FG000|All Implanted Cohort|Physician Decision|0|||
124508159|NCT00547378|447811478|FG001|All Implanted Cohort|Physician Decision|2|||
124508160|NCT00547378|447811479|FG002|All Implanted Cohort|Physician Decision|6|||
124508161|NCT00547378|447811477|FG000|All Implanted Cohort|Site closure|2|||
124508162|NCT00547378|447811478|FG001|All Implanted Cohort|Site closure|0|||
124508163|NCT00547378|447811479|FG002|All Implanted Cohort|Site closure|1|||
124508164|NCT00547378|447811477|FG000|All Implanted Cohort|Other reasons|1|||
124508165|NCT00547378|447811478|FG001|All Implanted Cohort|Other reasons|0|||
124508166|NCT00547378|447811479|FG002|All Implanted Cohort|Other reasons|1|||
124508167|NCT04105244|447811480|FG000|Overall Study|Withdrawal by Subject|10|||
124508168|NCT04105244|447811481|FG001|Overall Study|Withdrawal by Subject|12|||
124508169|NCT04105244|447811480|FG000|Overall Study|Lost to Follow-up|20|||
124508170|NCT04105244|447811481|FG001|Overall Study|Lost to Follow-up|15|||
124508171|NCT04105244|447811480|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
124508172|NCT04105244|447811481|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
124508173|NCT04105244|447811480|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
124508174|NCT04105244|447811481|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
124508175|NCT02112994|447811482|FG000|Overall Study|Progressive Disease|0|||
124508176|NCT02112994|447811483|FG001|Overall Study|Progressive Disease|0|||
124508177|NCT02112994|447811484|FG002|Overall Study|Progressive Disease|1|||
124508178|NCT02112994|447811482|FG000|Overall Study|Pregnancy|0|||
124563978|NCT02711956|448022266|FG005|Overall Study|Clinical progression|0|||
124508179|NCT02112994|447811483|FG001|Overall Study|Pregnancy|1|||
124508180|NCT02112994|447811484|FG002|Overall Study|Pregnancy|1|||
124508181|NCT02112994|447811482|FG000|Overall Study|Liver Transplant|0|||
124563979|NCT02711956|448022267|FG006|Overall Study|Clinical progression|1|||
124563980|NCT02711956|448022268|FG007|Overall Study|Clinical progression|0|||
124563981|NCT02711956|448022269|FG008|Overall Study|Clinical progression|1|||
124563982|NCT02711956|448022270|FG009|Overall Study|Clinical progression|0|||
124508182|NCT02112994|447811483|FG001|Overall Study|Liver Transplant|1|||
124508183|NCT02112994|447811484|FG002|Overall Study|Liver Transplant|0|||
124508184|NCT02112994|447811482|FG000|Overall Study|Withdrawal by Subject|0|||
124508185|NCT02112994|447811483|FG001|Overall Study|Withdrawal by Subject|0|||
124508186|NCT02112994|447811484|FG002|Overall Study|Withdrawal by Subject|1|||
124508187|NCT02768194|447811486|FG000|Period 1|Adverse Event|0|||
124508188|NCT02768194|447811487|FG001|Period 1|Adverse Event|0|||
124508189|NCT02768194|447811488|FG002|Period 1|Adverse Event|0|||
124563983|NCT02711956|448022271|FG010|Overall Study|Clinical progression|0|||
124508190|NCT02768194|447811489|FG003|Period 1|Adverse Event|1|||
124563984|NCT02711956|448022272|FG011|Overall Study|Clinical progression|2|||
124563985|NCT02711956|448022273|FG012|Overall Study|Clinical progression|4|||
124563986|NCT02711956|448022274|FG013|Overall Study|Clinical progression|1|||
124563987|NCT02711956|448022275|FG014|Overall Study|Clinical progression|1|||
124563988|NCT02711956|448022261|FG000|Overall Study|Radiographic progression|1|||
124563989|NCT02711956|448022262|FG001|Overall Study|Radiographic progression|1|||
124563990|NCT02711956|448022263|FG002|Overall Study|Radiographic progression|2|||
124563991|NCT02711956|448022264|FG003|Overall Study|Radiographic progression|0|||
124563992|NCT02711956|448022265|FG004|Overall Study|Radiographic progression|1|||
124563993|NCT02711956|448022266|FG005|Overall Study|Radiographic progression|0|||
124563994|NCT02711956|448022267|FG006|Overall Study|Radiographic progression|0|||
124563995|NCT02711956|448022268|FG007|Overall Study|Radiographic progression|0|||
124563996|NCT02711956|448022269|FG008|Overall Study|Radiographic progression|2|||
124563997|NCT02711956|448022270|FG009|Overall Study|Radiographic progression|1|||
124563998|NCT02711956|448022271|FG010|Overall Study|Radiographic progression|0|||
124563999|NCT02711956|448022272|FG011|Overall Study|Radiographic progression|5|||
124564000|NCT02711956|448022273|FG012|Overall Study|Radiographic progression|3|||
124564001|NCT02711956|448022274|FG013|Overall Study|Radiographic progression|0|||
124564002|NCT02711956|448022275|FG014|Overall Study|Radiographic progression|1|||
124564003|NCT02711956|448022261|FG000|Overall Study|PSA progression with clinical progression|0|||
124564004|NCT02711956|448022262|FG001|Overall Study|PSA progression with clinical progression|0|||
124564005|NCT02711956|448022263|FG002|Overall Study|PSA progression with clinical progression|0|||
124564006|NCT02711956|448022264|FG003|Overall Study|PSA progression with clinical progression|0|||
124564007|NCT02711956|448022265|FG004|Overall Study|PSA progression with clinical progression|1|||
124564008|NCT02711956|448022266|FG005|Overall Study|PSA progression with clinical progression|0|||
124564009|NCT02711956|448022267|FG006|Overall Study|PSA progression with clinical progression|0|||
124564010|NCT02711956|448022268|FG007|Overall Study|PSA progression with clinical progression|0|||
124564011|NCT02711956|448022269|FG008|Overall Study|PSA progression with clinical progression|0|||
124564012|NCT02711956|448022270|FG009|Overall Study|PSA progression with clinical progression|0|||
124564013|NCT02711956|448022271|FG010|Overall Study|PSA progression with clinical progression|0|||
124564014|NCT02711956|448022272|FG011|Overall Study|PSA progression with clinical progression|0|||
124564015|NCT02711956|448022273|FG012|Overall Study|PSA progression with clinical progression|1|||
124564016|NCT02711956|448022274|FG013|Overall Study|PSA progression with clinical progression|1|||
124564017|NCT02711956|448022275|FG014|Overall Study|PSA progression with clinical progression|0|||
124508191|NCT02768194|447811490|FG004|Period 1|Adverse Event|0|||
124508192|NCT02768194|447811491|FG005|Period 1|Adverse Event|0|||
124508193|NCT02768194|447811486|FG000|Period 2|Other (Reason not specified)|1|||
124508194|NCT02768194|447811487|FG001|Period 2|Other (Reason not specified)|0|||
124508195|NCT02768194|447811488|FG002|Period 2|Other (Reason not specified)|0|||
124508196|NCT02768194|447811489|FG003|Period 2|Other (Reason not specified)|0|||
124508197|NCT02768194|447811490|FG004|Period 2|Other (Reason not specified)|0|||
124508198|NCT02768194|447811491|FG005|Period 2|Other (Reason not specified)|0|||
124508199|NCT02768194|447811486|FG000|Period 3|Other (Reason not specified)|0|||
124508200|NCT02768194|447811487|FG001|Period 3|Other (Reason not specified)|1|||
124508201|NCT02768194|447811488|FG002|Period 3|Other (Reason not specified)|0|||
124508202|NCT02768194|447811489|FG003|Period 3|Other (Reason not specified)|0|||
124508203|NCT02768194|447811490|FG004|Period 3|Other (Reason not specified)|0|||
124508204|NCT02768194|447811491|FG005|Period 3|Other (Reason not specified)|0|||
124508205|NCT00363246|447811496|FG000|Overall Study|Death|40|||
124508206|NCT00363246|447811496|FG000|Overall Study|Withdrawal by Subject|19|||
124508207|NCT00363246|447811496|FG000|Overall Study|Lost to Follow-up|14|||
124508208|NCT00363246|447811496|FG000|Overall Study|Bad health|6|||
124508209|NCT00363246|447811496|FG000|Overall Study|Stopped using wheelchair|11|||
124508210|NCT00363246|447811496|FG000|Overall Study|Subject expressed security concerns|2|||
124508211|NCT00363246|447811496|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
124508212|NCT00099359|447811497|FG000|Overall Study|Death|11|||
124508213|NCT00099359|447811498|FG001|Overall Study|Death|15|||
124508214|NCT00099359|447811499|FG002|Overall Study|Death|17|||
124508215|NCT00099359|447811497|FG000|Overall Study|Withdrawal by Subject|19|||
124508216|NCT00099359|447811498|FG001|Overall Study|Withdrawal by Subject|19|||
124508217|NCT00099359|447811499|FG002|Overall Study|Withdrawal by Subject|23|||
124508218|NCT00099359|447811497|FG000|Overall Study|Lost to Follow-up|15|||
124508219|NCT00099359|447811498|FG001|Overall Study|Lost to Follow-up|24|||
124564018|NCT02711956|448022261|FG000|Overall Study|PSA progression with radiographic progression|0|||
124564019|NCT02711956|448022262|FG001|Overall Study|PSA progression with radiographic progression|1|||
124508220|NCT00099359|447811499|FG002|Overall Study|Lost to Follow-up|24|||
124508221|NCT00099359|447811497|FG000|Overall Study|moved out of area|9|||
124564020|NCT02711956|448022263|FG002|Overall Study|PSA progression with radiographic progression|0|||
124564021|NCT02711956|448022264|FG003|Overall Study|PSA progression with radiographic progression|0|||
124637307|NCT00507455|448290463|FG001|Overall Study|Protocol Violation|1|||
124508222|NCT00099359|447811498|FG001|Overall Study|moved out of area|7|||
124508223|NCT00099359|447811499|FG002|Overall Study|moved out of area|4|||
124508224|NCT02756650|447811500|FG000|Overall Study|Physician Decision|1|||
124564022|NCT02711956|448022265|FG004|Overall Study|PSA progression with radiographic progression|0|||
124564023|NCT02711956|448022266|FG005|Overall Study|PSA progression with radiographic progression|2|||
124564024|NCT02711956|448022267|FG006|Overall Study|PSA progression with radiographic progression|2|||
124564025|NCT02711956|448022268|FG007|Overall Study|PSA progression with radiographic progression|1|||
124564026|NCT02711956|448022269|FG008|Overall Study|PSA progression with radiographic progression|0|||
124564027|NCT02711956|448022270|FG009|Overall Study|PSA progression with radiographic progression|1|||
124564028|NCT02711956|448022271|FG010|Overall Study|PSA progression with radiographic progression|0|||
124564029|NCT02711956|448022272|FG011|Overall Study|PSA progression with radiographic progression|1|||
124564030|NCT02711956|448022273|FG012|Overall Study|PSA progression with radiographic progression|2|||
124564031|NCT02711956|448022274|FG013|Overall Study|PSA progression with radiographic progression|3|||
124564032|NCT02711956|448022275|FG014|Overall Study|PSA progression with radiographic progression|3|||
124564033|NCT03734237|448022276|FG000|Overall Study|Lost to Follow-up|1|||
124564034|NCT03734237|448022277|FG001|Overall Study|Lost to Follow-up|3|||
124564035|NCT03734237|448022278|FG002|Overall Study|Lost to Follow-up|0|||
124564036|NCT03734237|448022276|FG000|Overall Study|Withdrawal by Subject|7|||
124564037|NCT03734237|448022277|FG001|Overall Study|Withdrawal by Subject|9|||
124564038|NCT03734237|448022278|FG002|Overall Study|Withdrawal by Subject|10|||
124564039|NCT01844583|448022279|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
124564040|NCT01844583|448022280|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
124564041|NCT01625377|448022281|FG000|Overall Study|Death|1|||
124564042|NCT01625377|448022282|FG001|Overall Study|Death|1|||
124564043|NCT01625377|448022281|FG000|Overall Study|Administrative Problem|1|||
124564044|NCT01625377|448022282|FG001|Overall Study|Administrative Problem|1|||
124564045|NCT01625377|448022281|FG000|Overall Study|Protocol Violation|0|||
124564046|NCT01625377|448022282|FG001|Overall Study|Protocol Violation|3|||
124564047|NCT01625377|448022281|FG000|Overall Study|Adverse Event|3|||
124564048|NCT01625377|448022282|FG001|Overall Study|Adverse Event|16|||
124564049|NCT01625377|448022281|FG000|Overall Study|Graft loss|1|||
124564050|NCT01625377|448022282|FG001|Overall Study|Graft loss|0|||
124564051|NCT01625377|448022281|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124564052|NCT01625377|448022282|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124564053|NCT01625377|448022281|FG000|Overall Study|Abnormal laboratory values|1|||
124564054|NCT01625377|448022282|FG001|Overall Study|Abnormal laboratory values|0|||
124564055|NCT02207621|448022287|FG000|Overall Study|Adverse Event|71|||
124564056|NCT02207621|448022288|FG001|Overall Study|Adverse Event|15|||
124564057|NCT02207621|448022289|FG002|Overall Study|Adverse Event|132|||
124564058|NCT02207621|448022287|FG000|Overall Study|Withdrawal by Subject|9|||
124564059|NCT02207621|448022288|FG001|Overall Study|Withdrawal by Subject|9|||
124564060|NCT02207621|448022289|FG002|Overall Study|Withdrawal by Subject|13|||
124564061|NCT02207621|448022287|FG000|Overall Study|Non-Compliant|3|||
124564062|NCT02207621|448022288|FG001|Overall Study|Non-Compliant|3|||
124564063|NCT02207621|448022289|FG002|Overall Study|Non-Compliant|1|||
124564064|NCT02207621|448022287|FG000|Overall Study|Lost to Follow-up|1|||
124564065|NCT02207621|448022288|FG001|Overall Study|Lost to Follow-up|0|||
124564066|NCT02207621|448022289|FG002|Overall Study|Lost to Follow-up|3|||
124564067|NCT02207621|448022287|FG000|Overall Study|Lack of Efficacy|10|||
124564068|NCT02207621|448022288|FG001|Overall Study|Lack of Efficacy|2|||
124564069|NCT02207621|448022289|FG002|Overall Study|Lack of Efficacy|4|||
124564070|NCT02207621|448022287|FG000|Overall Study|Disallowed Concurrent Medication|2|||
124564071|NCT02207621|448022288|FG001|Overall Study|Disallowed Concurrent Medication|5|||
124564072|NCT02207621|448022289|FG002|Overall Study|Disallowed Concurrent Medication|2|||
124564073|NCT02207621|448022287|FG000|Overall Study|Physician Decision|1|||
124564074|NCT02207621|448022288|FG001|Overall Study|Physician Decision|2|||
124564075|NCT02207621|448022289|FG002|Overall Study|Physician Decision|2|||
124564076|NCT02207621|448022287|FG000|Overall Study|Protocol Violation|4|||
124564077|NCT02207621|448022288|FG001|Overall Study|Protocol Violation|10|||
124564078|NCT02207621|448022289|FG002|Overall Study|Protocol Violation|6|||
124564079|NCT02207621|448022287|FG000|Overall Study|Death|2|||
124564080|NCT02207621|448022288|FG001|Overall Study|Death|0|||
124564081|NCT02207621|448022289|FG002|Overall Study|Death|0|||
124564082|NCT02207621|448022287|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
124564083|NCT02207621|448022288|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
124564084|NCT02207621|448022289|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
124564085|NCT01238848|448022296|FG000|Overall Study|Physician Decision|13|||
124564086|NCT01238848|448022297|FG001|Overall Study|Physician Decision|5|||
124564087|NCT00576901|448022298|FG000|Overall Study|Withdrawal by Subject|1|||
124564088|NCT00576901|448022298|FG000|Overall Study|Disease course|1|||
124564089|NCT00576901|448022298|FG000|Overall Study|Protocol Violation|1|||
124564090|NCT01755858|448022301|FG000|Overall Study|Adverse Event|1|||
124564091|NCT01755858|448022302|FG001|Overall Study|Adverse Event|1|||
124564092|NCT01259869|448022303|FG000|Overall Study|Duplicated registration|1|||
124564093|NCT00175019|448022304|FG000|Overall Study|Adverse Event|54|||
124564094|NCT00175019|448022305|FG001|Overall Study|Adverse Event|22|||
124564095|NCT00175019|448022306|FG002|Overall Study|Adverse Event|2|||
124564096|NCT00175019|448022304|FG000|Overall Study|Protocol Violation|6|||
124508225|NCT02756650|447811500|FG000|Overall Study|Adverse Event|1|||
124508226|NCT01822691|447811501|FG000|Overall Study|Withdrawal by Subject|2|||
124508227|NCT00910429|447811508|FG000|Overall Study|Death|18|||
124508228|NCT00910429|447811509|FG001|Overall Study|Death|12|||
124508229|NCT00910429|447811508|FG000|Overall Study|Withdrawal by Subject|3|||
124508230|NCT00910429|447811509|FG001|Overall Study|Withdrawal by Subject|2|||
124508231|NCT00910429|447811508|FG000|Overall Study|Protocol Violation|1|||
124508232|NCT00910429|447811509|FG001|Overall Study|Protocol Violation|0|||
124508233|NCT00910429|447811508|FG000|Overall Study|Lost to Follow-up|2|||
124508234|NCT00910429|447811509|FG001|Overall Study|Lost to Follow-up|1|||
124508235|NCT00910429|447811508|FG000|Overall Study|Adverse Event|10|||
124508236|NCT00910429|447811509|FG001|Overall Study|Adverse Event|5|||
124508237|NCT00910429|447811508|FG000|Overall Study|Drug non-compliance|1|||
124508238|NCT00910429|447811509|FG001|Overall Study|Drug non-compliance|0|||
124508239|NCT00910429|447811508|FG000|Overall Study|Lack of Efficacy|4|||
124508240|NCT00910429|447811509|FG001|Overall Study|Lack of Efficacy|1|||
124508241|NCT02358369|447811512|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
124508242|NCT02358369|447811513|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
124508243|NCT02358369|447811514|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
124508244|NCT02358369|447811515|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
124508245|NCT02358369|447811516|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
124508246|NCT02358369|447811512|FG000|Treatment Period A/B|Adverse Event|0|||
124508247|NCT02358369|447811513|FG001|Treatment Period A/B|Adverse Event|0|||
124508248|NCT02358369|447811514|FG002|Treatment Period A/B|Adverse Event|1|||
124508249|NCT02358369|447811515|FG003|Treatment Period A/B|Adverse Event|2|||
124508250|NCT02358369|447811516|FG004|Treatment Period A/B|Adverse Event|0|||
124508251|NCT02358369|447811512|FG000|Treatment Period A/B|Death|0|||
124508252|NCT02358369|447811513|FG001|Treatment Period A/B|Death|0|||
124508253|NCT02358369|447811514|FG002|Treatment Period A/B|Death|1|||
124508254|NCT02358369|447811515|FG003|Treatment Period A/B|Death|0|||
124508255|NCT02358369|447811516|FG004|Treatment Period A/B|Death|0|||
124508256|NCT02358369|447811512|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
124508257|NCT02358369|447811513|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
124508258|NCT02358369|447811514|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
124508259|NCT02358369|447811515|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
124508260|NCT02358369|447811516|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
124508261|NCT02358369|447811512|FG000|Treatment Period C|Adverse Event|0|||
124508262|NCT02358369|447811513|FG001|Treatment Period C|Adverse Event|0|||
124508263|NCT02358369|447811514|FG002|Treatment Period C|Adverse Event|0|||
124508264|NCT02358369|447811515|FG003|Treatment Period C|Adverse Event|0|||
124508265|NCT02358369|447811516|FG004|Treatment Period C|Adverse Event|7|||
124508266|NCT04465396|447811517|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
124508267|NCT04465396|447811518|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
124508268|NCT04465396|447811519|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
124508269|NCT04465396|447811520|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
124508270|NCT02365584|447811525|FG000|Overall Study|Adverse Event|2|||
124508271|NCT02365584|447811526|FG001|Overall Study|Adverse Event|2|||
124508272|NCT02365584|447811525|FG000|Overall Study|Withdrawal by Subject|1|||
124508273|NCT02365584|447811526|FG001|Overall Study|Withdrawal by Subject|0|||
124508274|NCT02365584|447811525|FG000|Overall Study|Disease Progression|9|||
124508275|NCT02365584|447811526|FG001|Overall Study|Disease Progression|12|||
124508276|NCT01973452|447811531|FG000|Overall Study|Lack of Efficacy|0|||
124508277|NCT01973452|447811532|FG001|Overall Study|Lack of Efficacy|1|||
124508278|NCT01973452|447811531|FG000|Overall Study|Lost to Follow-up|1|||
124508279|NCT01973452|447811532|FG001|Overall Study|Lost to Follow-up|0|||
124508280|NCT01973452|447811531|FG000|Overall Study|Withdrawal by Subject|10|||
124508281|NCT01973452|447811532|FG001|Overall Study|Withdrawal by Subject|9|||
124508282|NCT01973452|447811531|FG000|Overall Study|Ineligible|1|||
124508283|NCT01973452|447811532|FG001|Overall Study|Ineligible|1|||
124508284|NCT01973452|447811531|FG000|Overall Study|Surgery canceled by participant|5|||
124508285|NCT01973452|447811532|FG001|Overall Study|Surgery canceled by participant|3|||
124508286|NCT00349752|447811533|FG000|Overall Study|Adverse Event|8|||
124508287|NCT00349752|447811534|FG001|Overall Study|Adverse Event|12|||
124508288|NCT00349752|447811533|FG000|Overall Study|Lack of Efficacy|37|||
124508289|NCT00349752|447811534|FG001|Overall Study|Lack of Efficacy|42|||
124508290|NCT00349752|447811533|FG000|Overall Study|Lost to Follow-up|4|||
124508291|NCT00349752|447811534|FG001|Overall Study|Lost to Follow-up|2|||
124508292|NCT00349752|447811533|FG000|Overall Study|Personal reasons|6|||
124508293|NCT00349752|447811534|FG001|Overall Study|Personal reasons|5|||
124508294|NCT00349752|447811533|FG000|Overall Study|Other: Required exclusionary medication|0|||
124508295|NCT00349752|447811534|FG001|Overall Study|Other: Required exclusionary medication|1|||
124508296|NCT00349752|447811533|FG000|Overall Study|Other: Non compliance|0|||
124508297|NCT00349752|447811534|FG001|Overall Study|Other: Non compliance|1|||
124508298|NCT00349752|447811533|FG000|Overall Study|Other: Patient stopped steroids|0|||
124508299|NCT00349752|447811534|FG001|Overall Study|Other: Patient stopped steroids|1|||
124508300|NCT00349752|447811533|FG000|Overall Study|Other: Patient's steroid use|1|||
124508301|NCT00349752|447811534|FG001|Overall Study|Other: Patient's steroid use|0|||
124508302|NCT00349752|447811533|FG000|Overall Study|Other: Ineligible|1|||
124508303|NCT00349752|447811534|FG001|Overall Study|Other: Ineligible|0|||
124508304|NCT00349752|447811533|FG000|Overall Study|Other: Inadvertently unblinded|1|||
124508305|NCT00349752|447811534|FG001|Overall Study|Other: Inadvertently unblinded|0|||
124508306|NCT00349752|447811533|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
124508307|NCT00349752|447811534|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
124508308|NCT00675103|447811536|FG000|Overall Study|Lack of Efficacy|2|||
124508309|NCT00675103|447811536|FG000|Overall Study|Adverse Event|1|||
124508310|NCT02164513|447811539|FG000|Overall Study|Adverse Event|162|||
124508311|NCT02164513|447811540|FG001|Overall Study|Adverse Event|180|||
124508312|NCT02164513|447811541|FG002|Overall Study|Adverse Event|111|||
124508313|NCT02164513|447811539|FG000|Overall Study|Other: Study Closed or terminated|5|||
124508314|NCT02164513|447811540|FG001|Overall Study|Other: Study Closed or terminated|2|||
124508315|NCT02164513|447811541|FG002|Overall Study|Other: Study Closed or terminated|4|||
124508316|NCT02164513|447811539|FG000|Overall Study|Lost to Follow-up|30|||
124508317|NCT02164513|447811540|FG001|Overall Study|Lost to Follow-up|36|||
124508318|NCT02164513|447811541|FG002|Overall Study|Lost to Follow-up|22|||
124508319|NCT02164513|447811539|FG000|Overall Study|Physician Decision|47|||
124508320|NCT02164513|447811540|FG001|Overall Study|Physician Decision|57|||
124508321|NCT02164513|447811541|FG002|Overall Study|Physician Decision|28|||
124508322|NCT02164513|447811539|FG000|Overall Study|Withdrawal by Subject|192|||
124508323|NCT02164513|447811540|FG001|Overall Study|Withdrawal by Subject|261|||
124508324|NCT02164513|447811541|FG002|Overall Study|Withdrawal by Subject|130|||
124508325|NCT02164513|447811539|FG000|Overall Study|Other: Reason not provided by site|1|||
124508326|NCT02164513|447811540|FG001|Overall Study|Other: Reason not provided by site|0|||
124508327|NCT02164513|447811541|FG002|Overall Study|Other: Reason not provided by site|0|||
124508328|NCT03073213|447813540|FG000|Multiple Dose Period|Protocol Violation|0|||
124508329|NCT03073213|447813541|FG001|Multiple Dose Period|Protocol Violation|0|||
124508330|NCT03073213|447813542|FG002|Multiple Dose Period|Protocol Violation|1|||
124508331|NCT00280150|447813546|FG000|Overall Study|Adverse Event|0|||
124508332|NCT00280150|447813547|FG001|Overall Study|Adverse Event|1|||
124508333|NCT00280150|447813548|FG002|Overall Study|Adverse Event|2|||
124508334|NCT00280150|447813549|FG003|Overall Study|Adverse Event|3|||
124508335|NCT00280150|447813546|FG000|Overall Study|Lack of Efficacy|0|||
124508336|NCT00280150|447813547|FG001|Overall Study|Lack of Efficacy|0|||
124508337|NCT00280150|447813548|FG002|Overall Study|Lack of Efficacy|0|||
124508338|NCT00280150|447813549|FG003|Overall Study|Lack of Efficacy|3|||
124508339|NCT00280150|447813546|FG000|Overall Study|Physician Decision|0|||
124508340|NCT00280150|447813547|FG001|Overall Study|Physician Decision|0|||
124508341|NCT00280150|447813548|FG002|Overall Study|Physician Decision|0|||
124508342|NCT00280150|447813549|FG003|Overall Study|Physician Decision|1|||
124508343|NCT00280150|447813546|FG000|Overall Study|Protocol Violation|0|||
124508344|NCT00280150|447813547|FG001|Overall Study|Protocol Violation|0|||
124508345|NCT00280150|447813548|FG002|Overall Study|Protocol Violation|0|||
124508346|NCT00280150|447813549|FG003|Overall Study|Protocol Violation|1|||
124508347|NCT00280150|447813546|FG000|Overall Study|Withdrawal by Subject|0|||
124508348|NCT00280150|447813547|FG001|Overall Study|Withdrawal by Subject|0|||
124508349|NCT00280150|447813548|FG002|Overall Study|Withdrawal by Subject|0|||
124508350|NCT00280150|447813549|FG003|Overall Study|Withdrawal by Subject|1|||
124508351|NCT00280150|447813546|FG000|Overall Study|Did not get consolidation therapy|3|||
124508352|NCT00280150|447813547|FG001|Overall Study|Did not get consolidation therapy|0|||
124508353|NCT00280150|447813548|FG002|Overall Study|Did not get consolidation therapy|3|||
124508354|NCT00280150|447813549|FG003|Overall Study|Did not get consolidation therapy|0|||
124508355|NCT00280150|447813546|FG000|Overall Study|Declining Performance Status|0|||
124508356|NCT00280150|447813547|FG001|Overall Study|Declining Performance Status|0|||
124508357|NCT00280150|447813548|FG002|Overall Study|Declining Performance Status|0|||
124508358|NCT00280150|447813549|FG003|Overall Study|Declining Performance Status|1|||
124508359|NCT01993615|447813560|FG000|Overall Study|Death|1|||
124508360|NCT01993615|447813561|FG001|Overall Study|Death|0|||
124508361|NCT01175213|447813562|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
124508362|NCT01175213|447813563|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
124508363|NCT01175213|447813562|FG000|IGSC, 10%/rHuPH20|Death|1|||
124508364|NCT01175213|447813563|FG001|IGSC, 10%/rHuPH20|Death|0|||
124508365|NCT01175213|447813562|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
124508366|NCT01175213|447813563|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
124508367|NCT01175213|447813562|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
124508368|NCT01175213|447813563|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
124508369|NCT01175213|447813562|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
124508370|NCT01175213|447813563|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
124508371|NCT01175213|447813562|FG000|Safety Follow-up|Adverse Event|1|||
124508372|NCT01175213|447813563|FG001|Safety Follow-up|Adverse Event|0|||
124508373|NCT01245764|447813570|FG000|Study Phase A|Other|3|||
124508374|NCT01245764|447813571|FG001|Study Phase A|Other|2|||
124508375|NCT01245764|447813572|FG002|Study Phase A|Other|3|||
124508376|NCT01245764|447813573|FG003|Study Phase A|Other|1|||
124508377|NCT01245764|447813570|FG000|Study Phase A|Protocol Violation|6|||
124564097|NCT00175019|448022305|FG001|Overall Study|Protocol Violation|3|||
124564098|NCT00175019|448022306|FG002|Overall Study|Protocol Violation|3|||
124564099|NCT00175019|448022304|FG000|Overall Study|Lost to Follow-up|42|||
124564100|NCT00175019|448022305|FG001|Overall Study|Lost to Follow-up|39|||
124564101|NCT00175019|448022306|FG002|Overall Study|Lost to Follow-up|9|||
124564102|NCT00175019|448022304|FG000|Overall Study|Did not continue under Amendment 4|1|||
124564103|NCT00175019|448022305|FG001|Overall Study|Did not continue under Amendment 4|1|||
124564104|NCT00175019|448022306|FG002|Overall Study|Did not continue under Amendment 4|2|||
124564105|NCT00175019|448022304|FG000|Overall Study|Personal Reason(s)|39|||
124564106|NCT00175019|448022305|FG001|Overall Study|Personal Reason(s)|31|||
124564107|NCT00175019|448022306|FG002|Overall Study|Personal Reason(s)|8|||
124564108|NCT00175019|448022304|FG000|Overall Study|Therapeutic Failure|10|||
124564109|NCT00175019|448022305|FG001|Overall Study|Therapeutic Failure|38|||
124564110|NCT00175019|448022306|FG002|Overall Study|Therapeutic Failure|22|||
124564111|NCT00175019|448022304|FG000|Overall Study|Gout Flare|2|||
124564112|NCT00175019|448022305|FG001|Overall Study|Gout Flare|3|||
124564113|NCT00175019|448022306|FG002|Overall Study|Gout Flare|0|||
124564114|NCT00175019|448022304|FG000|Overall Study|Reason Not Specified|40|||
124564115|NCT00175019|448022305|FG001|Overall Study|Reason Not Specified|34|||
124564116|NCT00175019|448022306|FG002|Overall Study|Reason Not Specified|11|||
124564117|NCT03209570|448022307|FG000|Overall Study|Death|1|||
124564118|NCT03209570|448022308|FG001|Overall Study|Death|0|||
124564119|NCT03209570|448022307|FG000|Overall Study|Incomplete Data|8|||
124564120|NCT03209570|448022308|FG001|Overall Study|Incomplete Data|10|||
124564121|NCT03209570|448022307|FG000|Overall Study|Protocol Violation|1|||
124564122|NCT03209570|448022308|FG001|Overall Study|Protocol Violation|0|||
124564123|NCT03209570|448022307|FG000|Overall Study|Withdrawal by Subject|0|||
124564124|NCT03209570|448022308|FG001|Overall Study|Withdrawal by Subject|3|||
124564125|NCT00220701|448022319|FG000|Overall Study|Lost to Follow-up|5|||
124564126|NCT00220701|448022320|FG001|Overall Study|Lost to Follow-up|4|||
124564127|NCT00755326|448022321|FG000|Overall Study|Lost to Follow-up|2|||
124564128|NCT00755326|448022322|FG001|Overall Study|Lost to Follow-up|3|||
124564129|NCT04041570|448022325|FG000|Overall Study|Moved from Area|0|||
124564130|NCT04041570|448022326|FG001|Overall Study|Moved from Area|2|||
124564131|NCT00384033|448022330|FG000|Overall Study|Adverse Event|10|||
124564132|NCT00384033|448022331|FG001|Overall Study|Adverse Event|8|||
124564133|NCT00384033|448022332|FG002|Overall Study|Adverse Event|11|||
124564134|NCT00384033|448022333|FG003|Overall Study|Adverse Event|20|||
124564135|NCT00384033|448022330|FG000|Overall Study|Failed to return|1|||
124564136|NCT00384033|448022331|FG001|Overall Study|Failed to return|3|||
124564137|NCT00384033|448022332|FG002|Overall Study|Failed to return|2|||
124564138|NCT00384033|448022333|FG003|Overall Study|Failed to return|2|||
124564139|NCT00384033|448022330|FG000|Overall Study|Physician Decision|1|||
124564140|NCT00384033|448022331|FG001|Overall Study|Physician Decision|0|||
124564141|NCT00384033|448022332|FG002|Overall Study|Physician Decision|0|||
124564142|NCT00384033|448022333|FG003|Overall Study|Physician Decision|0|||
124564143|NCT00384033|448022330|FG000|Overall Study|Lost to Follow-up|6|||
124564144|NCT00384033|448022331|FG001|Overall Study|Lost to Follow-up|12|||
124564145|NCT00384033|448022332|FG002|Overall Study|Lost to Follow-up|7|||
124564146|NCT00384033|448022333|FG003|Overall Study|Lost to Follow-up|7|||
124564147|NCT00384033|448022330|FG000|Overall Study|Other|2|||
124564148|NCT00384033|448022331|FG001|Overall Study|Other|0|||
124564149|NCT00384033|448022332|FG002|Overall Study|Other|0|||
124564150|NCT00384033|448022333|FG003|Overall Study|Other|0|||
124564151|NCT00384033|448022330|FG000|Overall Study|Protocol Violation|5|||
124564152|NCT00384033|448022331|FG001|Overall Study|Protocol Violation|0|||
124564153|NCT00384033|448022332|FG002|Overall Study|Protocol Violation|5|||
124564154|NCT00384033|448022333|FG003|Overall Study|Protocol Violation|6|||
124564155|NCT00384033|448022330|FG000|Overall Study|Withdrawal by Subject|6|||
124564156|NCT00384033|448022331|FG001|Overall Study|Withdrawal by Subject|2|||
124564157|NCT00384033|448022332|FG002|Overall Study|Withdrawal by Subject|5|||
124564158|NCT00384033|448022333|FG003|Overall Study|Withdrawal by Subject|2|||
124564159|NCT00384033|448022330|FG000|Overall Study|Lack of Efficacy|7|||
124564160|NCT00384033|448022331|FG001|Overall Study|Lack of Efficacy|3|||
124564161|NCT00384033|448022332|FG002|Overall Study|Lack of Efficacy|3|||
124564162|NCT00384033|448022333|FG003|Overall Study|Lack of Efficacy|1|||
124564163|NCT00384033|448022330|FG000|Overall Study|Randomized but not treated|3|||
124564164|NCT00384033|448022331|FG001|Overall Study|Randomized but not treated|7|||
124564165|NCT00384033|448022332|FG002|Overall Study|Randomized but not treated|10|||
124564166|NCT00384033|448022333|FG003|Overall Study|Randomized but not treated|2|||
124564167|NCT03349333|448022334|FG000|Overall Study|Progression of Disease|36|||
124564168|NCT03349333|448022334|FG000|Overall Study|Adverse Event|11|||
124564169|NCT03349333|448022334|FG000|Overall Study|Other|6|||
124564170|NCT03349333|448022334|FG000|Overall Study|Withdrawal by Subject|5|||
124564171|NCT03349333|448022334|FG000|Overall Study|Conditions interfere with participation|2|||
124564172|NCT03349333|448022334|FG000|Overall Study|Physician Decision|2|||
124564173|NCT03349333|448022334|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
124564174|NCT03349333|448022334|FG000|Overall Study|Patients in treatment less than 24 month|8|||
124564175|NCT00290745|448022335|FG000|Overall Study|Withdrawal by Subject|4|||
124564176|NCT00290745|448022335|FG000|Overall Study|Physician Decision|2|||
124564177|NCT00290745|448022335|FG000|Overall Study|Surgery after 3 months for progression|3|||
124564178|NCT00290745|448022335|FG000|Overall Study|Baseline MRI not available|3|||
124564179|NCT02750306|448022336|FG000|Overall Study|Withdrawal by Subject|5|||
124564180|NCT02750306|448022337|FG001|Overall Study|Withdrawal by Subject|2|||
124564181|NCT02750306|448022336|FG000|Overall Study|Protocol Violation|1|||
124564182|NCT02750306|448022337|FG001|Overall Study|Protocol Violation|0|||
124564183|NCT02737306|448022338|FG000|Overall Study|Adverse Event|3|||
124564184|NCT02737306|448022339|FG001|Overall Study|Adverse Event|0|||
124564185|NCT02737306|448022338|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
124564186|NCT02737306|448022339|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
124564187|NCT03267264|448022340|FG000|Overall Study|Withdrawal by Subject|1|||
124564188|NCT03267264|448022341|FG001|Overall Study|Withdrawal by Subject|0|||
124564189|NCT03267264|448022342|FG002|Overall Study|Withdrawal by Subject|2|||
124564190|NCT03267264|448022343|FG003|Overall Study|Withdrawal by Subject|4|||
124564191|NCT04471935|448022344|FG000|Overall Study|Withdrawal by Subject|1|||
124564192|NCT04471935|448022344|FG000|Overall Study|Deemed ineligible to participate|1|||
124564193|NCT01915732|448022347|FG000|Overall Study|Withdrawal by Subject|18|||
124564194|NCT01915732|448022348|FG001|Overall Study|Withdrawal by Subject|18|||
124564195|NCT01915732|448022347|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
124564196|NCT01915732|448022348|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
124564197|NCT01915732|448022347|FG000|Overall Study|Adverse Event|12|||
124564198|NCT01915732|448022348|FG001|Overall Study|Adverse Event|4|||
124564199|NCT01915732|448022347|FG000|Overall Study|Protocol Violation|5|||
124564200|NCT01915732|448022348|FG001|Overall Study|Protocol Violation|5|||
124564201|NCT01915732|448022347|FG000|Overall Study|Lack of Efficacy|6|||
124564202|NCT01915732|448022348|FG001|Overall Study|Lack of Efficacy|11|||
124564203|NCT01915732|448022347|FG000|Overall Study|Lost to Follow-up|22|||
124564204|NCT01915732|448022348|FG001|Overall Study|Lost to Follow-up|26|||
124564205|NCT01915732|448022347|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
124564206|NCT01915732|448022348|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
124564207|NCT01915732|448022347|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
124564208|NCT01915732|448022348|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
124564209|NCT01915732|448022347|FG000|Overall Study|Drug Release Error|1|||
124564210|NCT01915732|448022348|FG001|Overall Study|Drug Release Error|0|||
124564211|NCT01915732|448022347|FG000|Overall Study|Recovered|1|||
124564212|NCT01915732|448022348|FG001|Overall Study|Recovered|0|||
124564213|NCT01915732|448022347|FG000|Overall Study|Pregnancy|1|||
124564214|NCT01915732|448022348|FG001|Overall Study|Pregnancy|0|||
124564215|NCT01915732|448022347|FG000|Overall Study|Poor Perceived Efficacy|1|||
124564216|NCT01915732|448022348|FG001|Overall Study|Poor Perceived Efficacy|0|||
124564217|NCT01915732|448022347|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
124564218|NCT01915732|448022348|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
124564219|NCT01915732|448022347|FG000|Overall Study|Got Well|0|||
124564220|NCT01915732|448022348|FG001|Overall Study|Got Well|1|||
124564221|NCT01915732|448022347|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
124564222|NCT01915732|448022348|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
124564223|NCT01915732|448022347|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
124564224|NCT01915732|448022348|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
124564225|NCT01915732|448022347|FG000|Overall Study|Job Transfer|0|||
124564226|NCT01915732|448022348|FG001|Overall Study|Job Transfer|1|||
124564227|NCT01915732|448022347|FG000|Overall Study|Improper Facial Procedure|0|||
124564228|NCT01915732|448022348|FG001|Overall Study|Improper Facial Procedure|1|||
124564229|NCT01915732|448022347|FG000|Overall Study|Poor Conscious Effect|0|||
124564230|NCT01915732|448022348|FG001|Overall Study|Poor Conscious Effect|1|||
124564231|NCT02015793|448022350|FG000|Overall Study|Adverse Event|3|||
124564232|NCT02015793|448022351|FG001|Overall Study|Adverse Event|3|||
124564233|NCT02015793|448022350|FG000|Overall Study|Withdrawal by Subject|1|||
124564234|NCT02015793|448022351|FG001|Overall Study|Withdrawal by Subject|1|||
124564235|NCT00601354|448022352|FG000|Overall Study|Lost to Follow-up|4|||
124564236|NCT00601354|448022353|FG001|Overall Study|Lost to Follow-up|5|||
124508378|NCT01245764|447813571|FG001|Study Phase A|Protocol Violation|3|||
124508379|NCT01245764|447813572|FG002|Study Phase A|Protocol Violation|2|||
124508380|NCT01245764|447813573|FG003|Study Phase A|Protocol Violation|2|||
124508381|NCT01245764|447813570|FG000|Study Phase A|Lost to Follow-up|0|||
124508382|NCT01245764|447813571|FG001|Study Phase A|Lost to Follow-up|0|||
124508383|NCT01245764|447813572|FG002|Study Phase A|Lost to Follow-up|5|||
124508384|NCT01245764|447813573|FG003|Study Phase A|Lost to Follow-up|0|||
124508385|NCT00003476|447813574|FG000|Overall Study|Not evaluable|1|||
124508386|NCT00781963|447813579|FG000|Overall Study|Death|3|||
124508387|NCT00781963|447813580|FG001|Overall Study|Death|0|||
124508388|NCT00781963|447813579|FG000|Overall Study|Lost to Follow-up|2|||
124564237|NCT01446913|448022354|FG000|Overall Study|Significant illness|1|||
124564238|NCT01446913|448022355|FG001|Overall Study|Significant illness|1|||
124564239|NCT01446913|448022356|FG002|Overall Study|Significant illness|1|||
124508389|NCT00781963|447813580|FG001|Overall Study|Lost to Follow-up|1|||
124508390|NCT00781963|447813579|FG000|Overall Study|Withdrawal by Subject|3|||
124508391|NCT00781963|447813580|FG001|Overall Study|Withdrawal by Subject|1|||
124508392|NCT00781963|447813579|FG000|Overall Study|Refused follow-up|9|||
124508393|NCT00781963|447813580|FG001|Overall Study|Refused follow-up|0|||
124508394|NCT03057951|447813581|FG000|Overall Study|Adverse Event|553|||
124508395|NCT03057951|447813582|FG001|Overall Study|Adverse Event|575|||
124508396|NCT03057951|447813581|FG000|Overall Study|Protocol Violation|30|||
124508397|NCT03057951|447813582|FG001|Overall Study|Protocol Violation|24|||
124508398|NCT03057951|447813581|FG000|Overall Study|Lost to Follow-up|6|||
124508399|NCT03057951|447813582|FG001|Overall Study|Lost to Follow-up|16|||
124508400|NCT03057951|447813581|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
124508401|NCT03057951|447813582|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
124508402|NCT03057951|447813581|FG000|Overall Study|Study drug stopped, reason missing|6|||
124508403|NCT03057951|447813582|FG001|Overall Study|Study drug stopped, reason missing|1|||
124508404|NCT03057951|447813581|FG000|Overall Study|Medical advice|6|||
124508405|NCT03057951|447813582|FG001|Overall Study|Medical advice|2|||
124508406|NCT03057951|447813581|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
124508407|NCT03057951|447813582|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
124508408|NCT03057951|447813581|FG000|Overall Study|Investigator decision|2|||
124508409|NCT03057951|447813582|FG001|Overall Study|Investigator decision|0|||
124508410|NCT03057951|447813581|FG000|Overall Study|Patient decision|5|||
124508411|NCT03057951|447813582|FG001|Overall Study|Patient decision|2|||
124508412|NCT03057951|447813581|FG000|Overall Study|Not attending study visits|3|||
124508413|NCT03057951|447813582|FG001|Overall Study|Not attending study visits|0|||
124508414|NCT03057951|447813581|FG000|Overall Study|Patient moved away|3|||
124508415|NCT03057951|447813582|FG001|Overall Study|Patient moved away|4|||
124564240|NCT01446913|448022354|FG000|Overall Study|Withdrawal by Subject|5|||
124564241|NCT01446913|448022355|FG001|Overall Study|Withdrawal by Subject|3|||
124564242|NCT01446913|448022356|FG002|Overall Study|Withdrawal by Subject|5|||
124564243|NCT01446913|448022354|FG000|Overall Study|Physician Decision|0|||
124564244|NCT01446913|448022355|FG001|Overall Study|Physician Decision|0|||
124564245|NCT01446913|448022356|FG002|Overall Study|Physician Decision|2|||
124564246|NCT01446913|448022354|FG000|Overall Study|Lost to Follow-up|3|||
124564247|NCT01446913|448022355|FG001|Overall Study|Lost to Follow-up|5|||
124564248|NCT01446913|448022356|FG002|Overall Study|Lost to Follow-up|3|||
124564249|NCT02521948|448022357|FG000|Overall Study|Adverse Event|2|||
124564250|NCT02521948|448022357|FG000|Overall Study|Death|4|||
124564251|NCT02521948|448022357|FG000|Overall Study|Lost to Follow-up|1|||
124564252|NCT02521948|448022357|FG000|Overall Study|Did not attend one or both follow-ups|6|||
124564253|NCT02427607|448022358|FG000|Overall Study|Withdrawal by Subject|1|||
124508416|NCT03057951|447813581|FG000|Overall Study|Other reason than stated above|23|||
124508417|NCT03057951|447813582|FG001|Overall Study|Other reason than stated above|29|||
124508418|NCT03057951|447813581|FG000|Overall Study|Not treated|2|||
124508419|NCT03057951|447813582|FG001|Overall Study|Not treated|1|||
124508420|NCT02064205|447813583|FG000|Overall Study|Withdrawal by Subject|1|||
124508421|NCT00696436|447813587|FG000|Overall Study|Adverse Event|7|||
124508422|NCT00696436|447813588|FG001|Overall Study|Adverse Event|9|||
124508423|NCT00696436|447813589|FG002|Overall Study|Adverse Event|8|||
124564254|NCT04000009|448022359|FG000|Overall Study|Adverse Event|13|||
124564255|NCT04000009|448022359|FG000|Overall Study|Lack of Efficacy|7|||
124564256|NCT04000009|448022359|FG000|Overall Study|Lost to Follow-up|8|||
124508424|NCT00696436|447813590|FG003|Overall Study|Adverse Event|6|||
124508425|NCT00696436|447813591|FG004|Overall Study|Adverse Event|4|||
124508426|NCT00696436|447813587|FG000|Overall Study|Protocol Violation|3|||
124508427|NCT00696436|447813588|FG001|Overall Study|Protocol Violation|2|||
124508428|NCT00696436|447813589|FG002|Overall Study|Protocol Violation|2|||
124508429|NCT00696436|447813590|FG003|Overall Study|Protocol Violation|0|||
124508430|NCT00696436|447813591|FG004|Overall Study|Protocol Violation|1|||
124508431|NCT00696436|447813587|FG000|Overall Study|Lost to Follow-up|1|||
124508432|NCT00696436|447813588|FG001|Overall Study|Lost to Follow-up|6|||
124508433|NCT00696436|447813589|FG002|Overall Study|Lost to Follow-up|2|||
124508434|NCT00696436|447813590|FG003|Overall Study|Lost to Follow-up|4|||
124508435|NCT00696436|447813591|FG004|Overall Study|Lost to Follow-up|3|||
124508436|NCT00696436|447813587|FG000|Overall Study|Withdrawal by Subject|4|||
124508437|NCT00696436|447813588|FG001|Overall Study|Withdrawal by Subject|11|||
124508438|NCT00696436|447813589|FG002|Overall Study|Withdrawal by Subject|5|||
124508439|NCT00696436|447813590|FG003|Overall Study|Withdrawal by Subject|7|||
124508440|NCT00696436|447813591|FG004|Overall Study|Withdrawal by Subject|1|||
124508441|NCT00696436|447813587|FG000|Overall Study|Lack of Efficacy|3|||
124508442|NCT00696436|447813588|FG001|Overall Study|Lack of Efficacy|1|||
124508443|NCT00696436|447813589|FG002|Overall Study|Lack of Efficacy|5|||
124508444|NCT00696436|447813590|FG003|Overall Study|Lack of Efficacy|2|||
124508445|NCT00696436|447813591|FG004|Overall Study|Lack of Efficacy|4|||
124564257|NCT04000009|448022359|FG000|Overall Study|Noncompliance with study drug|4|||
124564258|NCT04000009|448022359|FG000|Overall Study|Physician Decision|1|||
124564259|NCT04000009|448022359|FG000|Overall Study|Use of prohibited medication|3|||
124508446|NCT00696436|447813587|FG000|Overall Study|Participant Unavailability|2|||
124508447|NCT00696436|447813588|FG001|Overall Study|Participant Unavailability|0|||
124508448|NCT00696436|447813589|FG002|Overall Study|Participant Unavailability|2|||
124508449|NCT00696436|447813590|FG003|Overall Study|Participant Unavailability|1|||
124508450|NCT00696436|447813591|FG004|Overall Study|Participant Unavailability|0|||
124508451|NCT00696436|447813587|FG000|Overall Study|Administrative Error|2|||
124508452|NCT00696436|447813588|FG001|Overall Study|Administrative Error|0|||
124508453|NCT00696436|447813589|FG002|Overall Study|Administrative Error|2|||
124508454|NCT00696436|447813590|FG003|Overall Study|Administrative Error|0|||
124508455|NCT00696436|447813591|FG004|Overall Study|Administrative Error|0|||
124564260|NCT04000009|448022359|FG000|Overall Study|Pregnancy|1|||
124564261|NCT04000009|448022359|FG000|Overall Study|Withdrawal by Subject|22|||
124564262|NCT04000009|448022359|FG000|Overall Study|Study terminated by sponsor|98|||
124564263|NCT04000009|448022359|FG000|Overall Study|Not further specified|8|||
124564264|NCT00679783|448022360|FG000|Overall Study|Adverse Event|0|||
124564265|NCT00679783|448022361|FG001|Overall Study|Adverse Event|0|||
124564266|NCT00679783|448022362|FG002|Overall Study|Adverse Event|0|||
124564267|NCT00679783|448022363|FG003|Overall Study|Adverse Event|3|||
124564268|NCT00679783|448022364|FG004|Overall Study|Adverse Event|0|||
124564269|NCT00679783|448022365|FG005|Overall Study|Adverse Event|0|||
124564270|NCT00679783|448022366|FG006|Overall Study|Adverse Event|1|||
124564271|NCT00679783|448022360|FG000|Overall Study|Lack of Efficacy|0|||
124564272|NCT00679783|448022361|FG001|Overall Study|Lack of Efficacy|1|||
124564273|NCT00679783|448022362|FG002|Overall Study|Lack of Efficacy|0|||
124564274|NCT00679783|448022363|FG003|Overall Study|Lack of Efficacy|2|||
124564275|NCT00679783|448022364|FG004|Overall Study|Lack of Efficacy|0|||
124564276|NCT00679783|448022365|FG005|Overall Study|Lack of Efficacy|0|||
124564277|NCT00679783|448022366|FG006|Overall Study|Lack of Efficacy|0|||
124564278|NCT00679783|448022360|FG000|Overall Study|Withdrawal by Subject|0|||
124564279|NCT00679783|448022361|FG001|Overall Study|Withdrawal by Subject|0|||
124564280|NCT00679783|448022362|FG002|Overall Study|Withdrawal by Subject|1|||
124564281|NCT00679783|448022363|FG003|Overall Study|Withdrawal by Subject|1|||
124564282|NCT00679783|448022364|FG004|Overall Study|Withdrawal by Subject|0|||
124564283|NCT00679783|448022365|FG005|Overall Study|Withdrawal by Subject|0|||
124564284|NCT00679783|448022366|FG006|Overall Study|Withdrawal by Subject|0|||
124564285|NCT00679783|448022360|FG000|Overall Study|Not Captured|0|||
124564286|NCT00679783|448022361|FG001|Overall Study|Not Captured|0|||
124564287|NCT00679783|448022362|FG002|Overall Study|Not Captured|0|||
124564288|NCT00679783|448022363|FG003|Overall Study|Not Captured|5|||
124564289|NCT00679783|448022364|FG004|Overall Study|Not Captured|0|||
124564290|NCT00679783|448022365|FG005|Overall Study|Not Captured|0|||
124564291|NCT00679783|448022366|FG006|Overall Study|Not Captured|0|||
124564292|NCT00679783|448022360|FG000|Overall Study|Ongoing at data cut-off|2|||
124564293|NCT00679783|448022361|FG001|Overall Study|Ongoing at data cut-off|2|||
124564294|NCT00679783|448022362|FG002|Overall Study|Ongoing at data cut-off|0|||
124564295|NCT00679783|448022363|FG003|Overall Study|Ongoing at data cut-off|9|||
124564296|NCT00679783|448022364|FG004|Overall Study|Ongoing at data cut-off|1|||
124564297|NCT00679783|448022365|FG005|Overall Study|Ongoing at data cut-off|0|||
124564298|NCT00679783|448022366|FG006|Overall Study|Ongoing at data cut-off|0|||
124564299|NCT01754259|448022371|FG000|Overall Study|Withdrawal by Subject|2|||
124564300|NCT01754259|448022372|FG001|Overall Study|Withdrawal by Subject|4|||
124564301|NCT01754259|448022371|FG000|Overall Study|Adverse Event|3|||
124564302|NCT01754259|448022372|FG001|Overall Study|Adverse Event|1|||
124508456|NCT00696436|447813587|FG000|Overall Study|Participant Non-compliance|0|||
124508457|NCT00696436|447813588|FG001|Overall Study|Participant Non-compliance|0|||
124508458|NCT00696436|447813589|FG002|Overall Study|Participant Non-compliance|1|||
124508459|NCT00696436|447813590|FG003|Overall Study|Participant Non-compliance|2|||
124508460|NCT00696436|447813591|FG004|Overall Study|Participant Non-compliance|0|||
124508461|NCT00696436|447813587|FG000|Overall Study|Administrative Decision|1|||
124508462|NCT00696436|447813588|FG001|Overall Study|Administrative Decision|0|||
124508463|NCT00696436|447813589|FG002|Overall Study|Administrative Decision|0|||
124508464|NCT00696436|447813590|FG003|Overall Study|Administrative Decision|0|||
124508465|NCT00696436|447813591|FG004|Overall Study|Administrative Decision|0|||
124508466|NCT00696436|447813587|FG000|Overall Study|Missing|0|||
124508467|NCT00696436|447813588|FG001|Overall Study|Missing|1|||
124508468|NCT00696436|447813589|FG002|Overall Study|Missing|1|||
124508469|NCT00696436|447813590|FG003|Overall Study|Missing|0|||
124508470|NCT00696436|447813591|FG004|Overall Study|Missing|0|||
124508471|NCT02282982|447813592|FG000|Overall Study|Lost to Follow-up|15|||
124508472|NCT02282982|447813592|FG000|Overall Study|Withdrew consent|2|||
124508473|NCT02282982|447813592|FG000|Overall Study|Death|4|||
124508474|NCT02282982|447813592|FG000|Overall Study|Lack of product|156|||
124508475|NCT02282982|447813592|FG000|Overall Study|Palivizumab is ended|11|||
124508476|NCT02282982|447813592|FG000|Overall Study|Other, not specified|18|||
124508477|NCT02062463|447813593|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
124508478|NCT02062463|447813594|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
124508479|NCT02062463|447813595|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
124508480|NCT02062463|447813596|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
124508481|NCT02062463|447813593|FG000|Stage 2|Adverse Event|0|||
124564303|NCT01754259|448022371|FG000|Overall Study|Lost to Follow-up|0|||
124564304|NCT01754259|448022372|FG001|Overall Study|Lost to Follow-up|1|||
124637308|NCT00507455|448290464|FG002|Overall Study|Protocol Violation|1|||
124564305|NCT00814320|448022373|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
124564306|NCT00814320|448022374|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
124564307|NCT00814320|448022373|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
124564308|NCT00814320|448022374|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
124564309|NCT00814320|448022373|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
124564310|NCT00814320|448022374|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
124564311|NCT00814320|448022373|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
124564312|NCT00814320|448022374|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
124564313|NCT00814320|448022373|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
124564314|NCT00814320|448022374|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
124564315|NCT00814320|448022373|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
124564316|NCT00814320|448022374|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
124564317|NCT00814320|448022373|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
124564318|NCT00814320|448022374|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
124564319|NCT00814320|448022373|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
124564320|NCT00814320|448022374|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
124564321|NCT00814320|448022373|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
124564322|NCT00814320|448022374|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
124564323|NCT00814320|448022373|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
124564324|NCT00814320|448022374|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
124564325|NCT00491504|448022375|FG000|Overall Study|Adverse Event|0|||
124564326|NCT00491504|448022376|FG001|Overall Study|Adverse Event|1|||
124564327|NCT00491504|448022377|FG002|Overall Study|Adverse Event|0|||
124564328|NCT00491504|448022378|FG003|Overall Study|Adverse Event|0|||
124564329|NCT00491504|448022375|FG000|Overall Study|Withdrawal by Subject|0|||
124564330|NCT00491504|448022376|FG001|Overall Study|Withdrawal by Subject|0|||
124564331|NCT00491504|448022377|FG002|Overall Study|Withdrawal by Subject|1|||
124564332|NCT00491504|448022378|FG003|Overall Study|Withdrawal by Subject|2|||
124564333|NCT00491504|448022375|FG000|Overall Study|Protocol Violation|0|||
124564334|NCT00491504|448022376|FG001|Overall Study|Protocol Violation|0|||
124564335|NCT00491504|448022377|FG002|Overall Study|Protocol Violation|3|||
124564336|NCT00491504|448022378|FG003|Overall Study|Protocol Violation|2|||
124564337|NCT00306384|448022379|FG000|Overall Study|Adverse Event|103|||
124564338|NCT00306384|448022380|FG001|Overall Study|Adverse Event|87|||
124564339|NCT00306384|448022381|FG002|Overall Study|Adverse Event|40|||
124564340|NCT00306384|448022379|FG000|Overall Study|Major protocol deviation|43|||
124564341|NCT00306384|448022380|FG001|Overall Study|Major protocol deviation|51|||
124564342|NCT00306384|448022381|FG002|Overall Study|Major protocol deviation|18|||
124564343|NCT00306384|448022379|FG000|Overall Study|Lost to Follow-up|57|||
124564344|NCT00306384|448022380|FG001|Overall Study|Lost to Follow-up|41|||
124564345|NCT00306384|448022381|FG002|Overall Study|Lost to Follow-up|35|||
124564346|NCT00306384|448022379|FG000|Overall Study|Voluntary withdrawal|199|||
124564347|NCT00306384|448022380|FG001|Overall Study|Voluntary withdrawal|187|||
124564348|NCT00306384|448022381|FG002|Overall Study|Voluntary withdrawal|91|||
124564349|NCT00306384|448022379|FG000|Overall Study|Study termination|1|||
124564350|NCT00306384|448022380|FG001|Overall Study|Study termination|0|||
124564351|NCT00306384|448022381|FG002|Overall Study|Study termination|1|||
124564352|NCT00306384|448022379|FG000|Overall Study|Pregnancy|3|||
124564353|NCT00306384|448022380|FG001|Overall Study|Pregnancy|1|||
124564354|NCT00306384|448022381|FG002|Overall Study|Pregnancy|1|||
124564355|NCT00306384|448022379|FG000|Overall Study|Lack of Efficacy|26|||
124564356|NCT00306384|448022380|FG001|Overall Study|Lack of Efficacy|40|||
124564357|NCT00306384|448022381|FG002|Overall Study|Lack of Efficacy|38|||
124564358|NCT00306384|448022379|FG000|Overall Study|Investigator discretion|28|||
124564359|NCT00306384|448022380|FG001|Overall Study|Investigator discretion|31|||
124564360|NCT00306384|448022381|FG002|Overall Study|Investigator discretion|21|||
124564361|NCT00306384|448022379|FG000|Overall Study|Other|80|||
124564362|NCT00306384|448022380|FG001|Overall Study|Other|70|||
124564363|NCT00306384|448022381|FG002|Overall Study|Other|32|||
124564364|NCT00306384|448022379|FG000|Overall Study|Site closure|2|||
124564365|NCT00306384|448022380|FG001|Overall Study|Site closure|0|||
124564366|NCT00306384|448022381|FG002|Overall Study|Site closure|0|||
124564367|NCT00745251|448022382|FG000|Overall Study|Adverse Event|1|||
124564368|NCT00745251|448022383|FG001|Overall Study|Adverse Event|2|||
124564369|NCT00745251|448022382|FG000|Overall Study|Withdrawal by Subject|1|||
124564370|NCT00745251|448022383|FG001|Overall Study|Withdrawal by Subject|1|||
124564371|NCT00929708|448022385|FG000|Overall Study|Protocol Violation|2|||
124564372|NCT00929708|448022386|FG001|Overall Study|Protocol Violation|1|||
124564373|NCT00929708|448022387|FG002|Overall Study|Protocol Violation|1|||
124564374|NCT00929708|448022388|FG003|Overall Study|Protocol Violation|1|||
124564375|NCT00929708|448022389|FG004|Overall Study|Protocol Violation|1|||
124564376|NCT00929708|448022385|FG000|Overall Study|Withdrawal by Subject|2|||
124564377|NCT00929708|448022386|FG001|Overall Study|Withdrawal by Subject|0|||
124564378|NCT00929708|448022387|FG002|Overall Study|Withdrawal by Subject|0|||
124564379|NCT00929708|448022388|FG003|Overall Study|Withdrawal by Subject|2|||
124508482|NCT02062463|447813594|FG001|Stage 2|Adverse Event|0|||
124508483|NCT02062463|447813595|FG002|Stage 2|Adverse Event|12|||
124508484|NCT02062463|447813596|FG003|Stage 2|Adverse Event|20|||
124508485|NCT02062463|447813593|FG000|Stage 2|Lack of Efficacy|0|||
124564380|NCT00929708|448022389|FG004|Overall Study|Withdrawal by Subject|1|||
124564381|NCT00929708|448022385|FG000|Overall Study|Adverse Event|0|||
124564382|NCT00929708|448022386|FG001|Overall Study|Adverse Event|0|||
124564383|NCT00929708|448022387|FG002|Overall Study|Adverse Event|0|||
124564384|NCT00929708|448022388|FG003|Overall Study|Adverse Event|0|||
124564385|NCT00929708|448022389|FG004|Overall Study|Adverse Event|3|||
124564386|NCT00929708|448022385|FG000|Overall Study|Physician Decision|0|||
124564387|NCT00929708|448022386|FG001|Overall Study|Physician Decision|2|||
124564388|NCT00929708|448022387|FG002|Overall Study|Physician Decision|2|||
124564389|NCT00929708|448022388|FG003|Overall Study|Physician Decision|2|||
124564390|NCT00929708|448022389|FG004|Overall Study|Physician Decision|1|||
124564391|NCT00929708|448022385|FG000|Overall Study|Lost to Follow-up|0|||
124564392|NCT00929708|448022386|FG001|Overall Study|Lost to Follow-up|0|||
124564393|NCT00929708|448022387|FG002|Overall Study|Lost to Follow-up|0|||
124564394|NCT00929708|448022388|FG003|Overall Study|Lost to Follow-up|1|||
124564395|NCT00929708|448022389|FG004|Overall Study|Lost to Follow-up|0|||
124564396|NCT01893138|448022390|FG000|Double-Blind Period|Withdrawal by Subject|1|||
124564397|NCT01893138|448022391|FG001|Double-Blind Period|Withdrawal by Subject|1|||
124564398|NCT01893138|448022390|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
124564399|NCT01893138|448022391|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
124564400|NCT01893138|448022390|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
124564401|NCT01893138|448022391|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
124564402|NCT01893138|448022390|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
124564403|NCT01893138|448022391|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
124564404|NCT01893138|448022390|FG000|Open Label - Unblinded Period|Adverse Event|1|||
124564405|NCT01893138|448022391|FG001|Open Label - Unblinded Period|Adverse Event|0|||
124564406|NCT02154529|448022392|FG000|Overall Study|Death|1|||
124564407|NCT02154529|448022393|FG001|Overall Study|Death|1|||
124564408|NCT02154529|448022394|FG002|Overall Study|Death|5|||
124508486|NCT02062463|447813594|FG001|Stage 2|Lack of Efficacy|0|||
124508487|NCT02062463|447813595|FG002|Stage 2|Lack of Efficacy|3|||
124508488|NCT02062463|447813596|FG003|Stage 2|Lack of Efficacy|4|||
124508489|NCT02062463|447813593|FG000|Stage 2|Lost to Follow-up|0|||
124508490|NCT02062463|447813594|FG001|Stage 2|Lost to Follow-up|0|||
124508491|NCT02062463|447813595|FG002|Stage 2|Lost to Follow-up|20|||
124508492|NCT02062463|447813596|FG003|Stage 2|Lost to Follow-up|20|||
124508493|NCT02062463|447813593|FG000|Stage 2|Non-Compliance|0|||
124508494|NCT02062463|447813594|FG001|Stage 2|Non-Compliance|0|||
124508495|NCT02062463|447813595|FG002|Stage 2|Non-Compliance|0|||
124508496|NCT02062463|447813596|FG003|Stage 2|Non-Compliance|1|||
124508497|NCT02062463|447813593|FG000|Stage 2|Other than specified|0|||
124508498|NCT02062463|447813594|FG001|Stage 2|Other than specified|0|||
124508499|NCT02062463|447813595|FG002|Stage 2|Other than specified|3|||
124508500|NCT02062463|447813596|FG003|Stage 2|Other than specified|1|||
124508501|NCT02062463|447813593|FG000|Stage 2|Withdrawal by Subject|0|||
124508502|NCT02062463|447813594|FG001|Stage 2|Withdrawal by Subject|0|||
124508503|NCT02062463|447813595|FG002|Stage 2|Withdrawal by Subject|15|||
124508504|NCT02062463|447813596|FG003|Stage 2|Withdrawal by Subject|10|||
124508505|NCT00363051|447813603|FG000|Overall Study|Adminstrative problems|1|||
124508506|NCT00363051|447813604|FG001|Overall Study|Adminstrative problems|1|||
124508507|NCT00363051|447813603|FG000|Overall Study|Adverse Event|21|||
124508508|NCT00363051|447813604|FG001|Overall Study|Adverse Event|12|||
124508509|NCT00363051|447813603|FG000|Overall Study|New Cancer Therapy|2|||
124508510|NCT00363051|447813604|FG001|Overall Study|New Cancer Therapy|1|||
124508511|NCT00363051|447813603|FG000|Overall Study|Withdrawal by Subject|11|||
124508512|NCT00363051|447813604|FG001|Overall Study|Withdrawal by Subject|3|||
124508513|NCT00363051|447813603|FG000|Overall Study|Lost to Follow-up|0|||
124564409|NCT02154529|448022395|FG003|Overall Study|Death|1|||
124564410|NCT02154529|448022392|FG000|Overall Study|Termination of study by sponsor|2|||
124564411|NCT02154529|448022393|FG001|Overall Study|Termination of study by sponsor|2|||
124564412|NCT02154529|448022394|FG002|Overall Study|Termination of study by sponsor|3|||
124564413|NCT02154529|448022395|FG003|Overall Study|Termination of study by sponsor|1|||
124508514|NCT00363051|447813604|FG001|Overall Study|Lost to Follow-up|1|||
124508515|NCT00363051|447813603|FG000|Overall Study|Protocol Violation|0|||
124508516|NCT00363051|447813604|FG001|Overall Study|Protocol Violation|2|||
124508517|NCT00363051|447813603|FG000|Overall Study|Death|3|||
124508518|NCT00363051|447813604|FG001|Overall Study|Death|2|||
124564414|NCT02154529|448022392|FG000|Overall Study|Lost to Follow-up|1|||
124564415|NCT02154529|448022393|FG001|Overall Study|Lost to Follow-up|0|||
124564416|NCT02154529|448022394|FG002|Overall Study|Lost to Follow-up|0|||
124564417|NCT02154529|448022395|FG003|Overall Study|Lost to Follow-up|0|||
124508519|NCT00205699|447813607|FG000|Overall Study|Lost to Follow-up|1|||
124508520|NCT00205699|447813608|FG001|Overall Study|Lost to Follow-up|3|||
124508521|NCT00205699|447813609|FG002|Overall Study|Lost to Follow-up|5|||
124508522|NCT00205699|447813607|FG000|Overall Study|Adverse Event|1|||
124508523|NCT00205699|447813608|FG001|Overall Study|Adverse Event|0|||
124508524|NCT00205699|447813609|FG002|Overall Study|Adverse Event|0|||
124508525|NCT00205699|447813607|FG000|Overall Study|Withdrawal by Subject|1|||
124508526|NCT00205699|447813608|FG001|Overall Study|Withdrawal by Subject|2|||
124508527|NCT00205699|447813609|FG002|Overall Study|Withdrawal by Subject|1|||
124508528|NCT00205699|447813607|FG000|Overall Study|Lack of Efficacy|0|||
124508529|NCT00205699|447813608|FG001|Overall Study|Lack of Efficacy|1|||
124508530|NCT00205699|447813609|FG002|Overall Study|Lack of Efficacy|0|||
124508531|NCT03225716|447813611|FG000|Overall Study|Withdrawal by Subject|2|||
124508532|NCT03225716|447813612|FG001|Overall Study|Withdrawal by Subject|2|||
124508533|NCT03225716|447813613|FG002|Overall Study|Withdrawal by Subject|0|||
124508534|NCT03225716|447813611|FG000|Overall Study|Lack of Efficacy|1|||
124508535|NCT03225716|447813612|FG001|Overall Study|Lack of Efficacy|0|||
124508536|NCT03225716|447813613|FG002|Overall Study|Lack of Efficacy|0|||
124508537|NCT03225716|447813611|FG000|Overall Study|Adverse Event|2|||
124508538|NCT03225716|447813612|FG001|Overall Study|Adverse Event|0|||
124508539|NCT03225716|447813613|FG002|Overall Study|Adverse Event|1|||
124508540|NCT03225716|447813611|FG000|Overall Study|Study early termination by Sponsor|0|||
124508541|NCT03225716|447813612|FG001|Overall Study|Study early termination by Sponsor|0|||
124508542|NCT03225716|447813613|FG002|Overall Study|Study early termination by Sponsor|2|||
124508543|NCT01114373|447813614|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
124508544|NCT01114373|447813615|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
124508545|NCT01114373|447813614|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
124508546|NCT01114373|447813615|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
124508547|NCT01114373|447813614|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
124508548|NCT01114373|447813615|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
124508549|NCT01114373|447813614|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
124508550|NCT01114373|447813615|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
124508551|NCT01653158|447813619|FG000|Overall Study|Death|0|||
124508552|NCT01653158|447813620|FG001|Overall Study|Death|0|||
124508553|NCT01653158|447813621|FG002|Overall Study|Death|0|||
124508554|NCT01653158|447813622|FG003|Overall Study|Death|1|||
124508555|NCT01653158|447813623|FG004|Overall Study|Death|0|||
124508556|NCT01653158|447813624|FG005|Overall Study|Death|0|||
124508557|NCT01653158|447813625|FG006|Overall Study|Death|0|||
124508558|NCT01653158|447813626|FG007|Overall Study|Death|2|||
124508559|NCT01653158|447813619|FG000|Overall Study|Adverse Event|0|||
124508560|NCT01653158|447813620|FG001|Overall Study|Adverse Event|0|||
124508561|NCT01653158|447813621|FG002|Overall Study|Adverse Event|0|||
124508562|NCT01653158|447813622|FG003|Overall Study|Adverse Event|1|||
124508563|NCT01653158|447813623|FG004|Overall Study|Adverse Event|0|||
124564418|NCT00458302|448024168|FG000|Overall Study|Adverse Event|4|||
124564419|NCT00458302|448024169|FG001|Overall Study|Adverse Event|14|||
124564420|NCT00458302|448024168|FG000|Overall Study|Pregnancy|2|||
124564421|NCT00458302|448024169|FG001|Overall Study|Pregnancy|1|||
124564422|NCT00458302|448024168|FG000|Overall Study|Protocol Violation|0|||
124564423|NCT00458302|448024169|FG001|Overall Study|Protocol Violation|2|||
124564424|NCT00458302|448024168|FG000|Overall Study|Withdrawal by Subject|6|||
124564425|NCT00458302|448024169|FG001|Overall Study|Withdrawal by Subject|4|||
124564426|NCT00458302|448024168|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
124564427|NCT00458302|448024169|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
124564428|NCT00458302|448024168|FG000|Overall Study|Study Termination By Sponsor|1|||
124564429|NCT00458302|448024169|FG001|Overall Study|Study Termination By Sponsor|0|||
124564430|NCT00458302|448024168|FG000|Overall Study|Lost to Follow-up|2|||
124564431|NCT00458302|448024169|FG001|Overall Study|Lost to Follow-up|0|||
124564432|NCT00458302|448024168|FG000|Overall Study|Other|4|||
124564433|NCT00458302|448024169|FG001|Overall Study|Other|2|||
124564434|NCT01628120|448024172|FG000|Overall Study|Withdrawal by Subject|7|||
124508564|NCT01653158|447813624|FG005|Overall Study|Adverse Event|0|||
124508565|NCT01653158|447813625|FG006|Overall Study|Adverse Event|0|||
124508566|NCT01653158|447813626|FG007|Overall Study|Adverse Event|3|||
124508567|NCT01653158|447813619|FG000|Overall Study|Other|0|||
124508568|NCT01653158|447813620|FG001|Overall Study|Other|0|||
124508569|NCT01653158|447813621|FG002|Overall Study|Other|0|||
124508570|NCT01653158|447813622|FG003|Overall Study|Other|0|||
124508571|NCT01653158|447813623|FG004|Overall Study|Other|0|||
124508572|NCT01653158|447813624|FG005|Overall Study|Other|0|||
124508573|NCT01653158|447813625|FG006|Overall Study|Other|0|||
124508574|NCT01653158|447813626|FG007|Overall Study|Other|1|||
124564435|NCT01628120|448024172|FG000|Overall Study|Adverse Event|12|||
124564436|NCT01628120|448024172|FG000|Overall Study|Lost to Follow-up|1|||
124564437|NCT01628120|448024172|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
124564438|NCT01628120|448024172|FG000|Overall Study|Non-compliant with Study Procedures|1|||
124564439|NCT01628120|448024172|FG000|Overall Study|Not Treated|3|||
124508575|NCT01653158|447813619|FG000|Overall Study|Progressive disease|0|||
124508576|NCT01653158|447813620|FG001|Overall Study|Progressive disease|0|||
124508577|NCT01653158|447813621|FG002|Overall Study|Progressive disease|0|||
124508578|NCT01653158|447813622|FG003|Overall Study|Progressive disease|0|||
124508579|NCT01653158|447813623|FG004|Overall Study|Progressive disease|1|||
124508580|NCT01653158|447813624|FG005|Overall Study|Progressive disease|1|||
124508581|NCT01653158|447813625|FG006|Overall Study|Progressive disease|2|||
124508582|NCT01653158|447813626|FG007|Overall Study|Progressive disease|9|||
124508583|NCT01653158|447813619|FG000|Overall Study|Withdrawal by Subject|1|||
124508584|NCT01653158|447813620|FG001|Overall Study|Withdrawal by Subject|0|||
124508585|NCT01653158|447813621|FG002|Overall Study|Withdrawal by Subject|0|||
124508586|NCT01653158|447813622|FG003|Overall Study|Withdrawal by Subject|0|||
124508587|NCT01653158|447813623|FG004|Overall Study|Withdrawal by Subject|0|||
124508588|NCT01653158|447813624|FG005|Overall Study|Withdrawal by Subject|0|||
124508589|NCT01653158|447813625|FG006|Overall Study|Withdrawal by Subject|0|||
124508590|NCT01653158|447813626|FG007|Overall Study|Withdrawal by Subject|0|||
124508591|NCT03444870|447813631|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
124508592|NCT03444870|447813632|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
124508593|NCT03444870|447813633|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
124508594|NCT03444870|447813634|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
124508595|NCT03444870|447813635|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
124508596|NCT03444870|447813636|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
124508597|NCT03444870|447813631|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
124508598|NCT03444870|447813632|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
124508599|NCT03444870|447813633|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
124508600|NCT03444870|447813634|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
124508601|NCT03444870|447813635|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
124508602|NCT03444870|447813636|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
124508603|NCT03444870|447813631|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
124508604|NCT03444870|447813632|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
124508605|NCT03444870|447813633|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
124508606|NCT03444870|447813634|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
124508607|NCT03444870|447813635|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
124508608|NCT03444870|447813636|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
124508609|NCT03444870|447813631|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
124508610|NCT03444870|447813632|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
124508611|NCT03444870|447813633|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
124508612|NCT03444870|447813634|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
124508613|NCT03444870|447813635|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
124508614|NCT03444870|447813636|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
124508615|NCT03444870|447813631|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
124508616|NCT03444870|447813632|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
124508617|NCT03444870|447813633|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
124508618|NCT03444870|447813634|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
124508619|NCT03444870|447813635|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
124508620|NCT03444870|447813636|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
124508621|NCT03444870|447813631|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
124508622|NCT03444870|447813632|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
124508623|NCT03444870|447813633|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
124508624|NCT03444870|447813634|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
124508625|NCT03444870|447813635|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
124508626|NCT03444870|447813636|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
124508627|NCT03444870|447813631|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
124508628|NCT03444870|447813632|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
124508629|NCT03444870|447813633|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
124508630|NCT03444870|447813634|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
124508631|NCT03444870|447813635|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
124508632|NCT03444870|447813636|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
124508633|NCT03444870|447813631|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
124508634|NCT03444870|447813632|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
124508635|NCT03444870|447813633|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
124508636|NCT03444870|447813634|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
124508637|NCT03444870|447813635|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
124508638|NCT03444870|447813636|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
124508639|NCT03444870|447813631|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
124508640|NCT03444870|447813632|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
124508641|NCT03444870|447813633|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
124508642|NCT03444870|447813634|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
124508643|NCT03444870|447813635|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
124508644|NCT03444870|447813636|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
124508645|NCT03444870|447813631|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
124508646|NCT03444870|447813632|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
124508647|NCT03444870|447813633|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
124508648|NCT03444870|447813634|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
124508649|NCT03444870|447813635|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
124508650|NCT03444870|447813636|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
124508651|NCT03444870|447813631|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
124508652|NCT03444870|447813632|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
124508653|NCT03444870|447813633|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
124508654|NCT03444870|447813634|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
124508655|NCT03444870|447813635|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
124508656|NCT03444870|447813636|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
124508657|NCT03444870|447813631|FG000|Open-Label Extension (OLE) Period|Death|0|||
124508658|NCT03444870|447813632|FG001|Open-Label Extension (OLE) Period|Death|0|||
124508659|NCT03444870|447813633|FG002|Open-Label Extension (OLE) Period|Death|0|||
124508660|NCT03444870|447813634|FG003|Open-Label Extension (OLE) Period|Death|0|||
124508661|NCT03444870|447813635|FG004|Open-Label Extension (OLE) Period|Death|1|||
124508662|NCT03444870|447813636|FG005|Open-Label Extension (OLE) Period|Death|0|||
124508663|NCT01170702|447813639|FG000|Overall Study|Exclusion criteria met after consent|1|||
124508664|NCT01170702|447813640|FG001|Overall Study|Exclusion criteria met after consent|2|||
124508665|NCT01170702|447813641|FG002|Overall Study|Exclusion criteria met after consent|0|||
124508666|NCT01170702|447813642|FG003|Overall Study|Exclusion criteria met after consent|2|||
124508667|NCT01677507|447813643|FG000|Initial Assignment|Adverse Event|0|||
124508668|NCT01677507|447813644|FG001|Initial Assignment|Adverse Event|1|||
124508669|NCT01677507|447813643|FG000|Initial Assignment|Protocol Violation|0|||
124508670|NCT01677507|447813644|FG001|Initial Assignment|Protocol Violation|1|||
124508671|NCT01677507|447813643|FG000|Second Assigment|Withdrawal by Subject|2|||
124508672|NCT01677507|447813644|FG001|Second Assigment|Withdrawal by Subject|2|||
124508673|NCT01677507|447813643|FG000|Second Assigment|Adverse Event|1|||
124508674|NCT01677507|447813644|FG001|Second Assigment|Adverse Event|3|||
124508675|NCT00571688|447813645|FG000|Overall Study|Lost to Follow-up|3|||
124508676|NCT00571688|447813646|FG001|Overall Study|Lost to Follow-up|6|||
124508677|NCT00571688|447813645|FG000|Overall Study|subject did not tolerate Consta|1|||
124508678|NCT00571688|447813646|FG001|Overall Study|subject did not tolerate Consta|0|||
124508679|NCT00571688|447813645|FG000|Overall Study|subject moved out of the area|1|||
124508680|NCT00571688|447813646|FG001|Overall Study|subject moved out of the area|0|||
124508681|NCT00190983|447813647|FG000|Overall Study|Inevaluable (never treated)|2|||
124508682|NCT02287402|447813648|FG000|Treatment Period|Adverse Event|17|||
124508683|NCT02287402|447813648|FG000|Treatment Period|Voluntary Withdrawal|10|||
124508684|NCT02287402|447813648|FG000|Follow-up|Lost to Follow-up|1|||
124508685|NCT02287402|447813648|FG000|Follow-up|Voluntary Withdrawal|2|||
124508686|NCT04247815|447813649|FG000|Overall Study|Adverse Event|1|||
124508687|NCT04247815|447813650|FG001|Overall Study|Adverse Event|0|||
124508688|NCT04247815|447813649|FG000|Overall Study|Withdrawal by Subject|1|||
124508689|NCT04247815|447813650|FG001|Overall Study|Withdrawal by Subject|0|||
124508690|NCT04247815|447813649|FG000|Overall Study|Protocol Violation|0|||
124508691|NCT04247815|447813650|FG001|Overall Study|Protocol Violation|1|||
124508692|NCT03495453|447813654|FG000|Overall Study|Withdrawal by Subject|0|||
124508693|NCT03495453|447813655|FG001|Overall Study|Withdrawal by Subject|1|||
124508694|NCT00844649|447813657|FG000|Overall Study|Progressive Disease|196|||
124508695|NCT00844649|447813658|FG001|Overall Study|Progressive Disease|245|||
124508696|NCT00844649|447813657|FG000|Overall Study|Adverse Event|128|||
124508697|NCT00844649|447813658|FG001|Overall Study|Adverse Event|73|||
124508698|NCT00844649|447813657|FG000|Overall Study|Physician Decision|25|||
124508699|NCT00844649|447813658|FG001|Overall Study|Physician Decision|18|||
124508700|NCT00844649|447813657|FG000|Overall Study|Protocol Violation|10|||
124508701|NCT00844649|447813658|FG001|Overall Study|Protocol Violation|6|||
124508702|NCT00844649|447813657|FG000|Overall Study|Withdrawal by Subject|28|||
124508703|NCT00844649|447813658|FG001|Overall Study|Withdrawal by Subject|39|||
124508704|NCT00844649|447813657|FG000|Overall Study|Other|7|||
124508705|NCT00844649|447813658|FG001|Overall Study|Other|10|||
124508706|NCT00844649|447813657|FG000|Overall Study|Withdrew prior to starting treatment|11|||
124508707|NCT00844649|447813658|FG001|Overall Study|Withdrew prior to starting treatment|27|||
124508708|NCT00424294|447813659|FG000|Overall Study|Adverse Event|4|||
124508709|NCT00424294|447813660|FG001|Overall Study|Adverse Event|10|||
124508710|NCT00424294|447813659|FG000|Overall Study|Lack of Efficacy|2|||
124508711|NCT00424294|447813660|FG001|Overall Study|Lack of Efficacy|1|||
124508712|NCT00424294|447813659|FG000|Overall Study|Withdrawal by Subject|1|||
124508713|NCT00424294|447813660|FG001|Overall Study|Withdrawal by Subject|2|||
124508714|NCT00424294|447813659|FG000|Overall Study|Other|0|||
124508715|NCT00424294|447813660|FG001|Overall Study|Other|2|||
124508716|NCT00424294|447813659|FG000|Overall Study|Randomized but not Treated|1|||
124508717|NCT00424294|447813660|FG001|Overall Study|Randomized but not Treated|0|||
124508718|NCT00304915|447813661|FG000|Overall Study|Lost to Follow-up|11|||
124508719|NCT00304915|447813662|FG001|Overall Study|Lost to Follow-up|11|||
124508720|NCT00304915|447813661|FG000|Overall Study|Death|4|||
124508721|NCT00304915|447813662|FG001|Overall Study|Death|5|||
124508722|NCT00304915|447813661|FG000|Overall Study|Withdrawal by Subject|3|||
124508723|NCT00304915|447813662|FG001|Overall Study|Withdrawal by Subject|0|||
124508724|NCT03442829|447813669|FG000|Overall Study|Scheduling clash|3|||
124508725|NCT03442829|447813670|FG001|Overall Study|Scheduling clash|1|||
124508726|NCT03442829|447813669|FG000|Overall Study|Illness unrelated to study|1|||
124508727|NCT03442829|447813670|FG001|Overall Study|Illness unrelated to study|1|||
124508728|NCT00712322|447813673|FG000|Overall Study|Protocol deviation|0|||
124508729|NCT00712322|447813674|FG001|Overall Study|Protocol deviation|1|||
124508730|NCT00712322|447813675|FG002|Overall Study|Protocol deviation|0|||
124508731|NCT00916370|447813678|FG000|Overall Study|Death|3|||
124508732|NCT00916370|447813679|FG001|Overall Study|Death|1|||
124508733|NCT00916370|447813678|FG000|Overall Study|Withdrawal by Subject|2|||
124508734|NCT00916370|447813679|FG001|Overall Study|Withdrawal by Subject|0|||
124508735|NCT00916370|447813678|FG000|Overall Study|Physician Decision|0|||
124508736|NCT00916370|447813679|FG001|Overall Study|Physician Decision|1|||
124508737|NCT01318512|447813680|FG000|Maintenance Period (6 Months)|Death|2|||
124508738|NCT01318512|447813680|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
124508739|NCT01317615|447813685|FG000|Overall Study|Disease progression|25|||
124508740|NCT01317615|447813685|FG000|Overall Study|New cancer therapy|5|||
124508741|NCT01317615|447813685|FG000|Overall Study|Death|6|||
124508742|NCT01317615|447813685|FG000|Overall Study|Withdrawal by Subject|5|||
124508743|NCT01317615|447813685|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124508744|NCT01317615|447813685|FG000|Overall Study|Adverse Event|7|||
124508745|NCT02121756|447813686|FG000|Overall Study|Adverse Event|3|||
124508746|NCT02121756|447813687|FG001|Overall Study|Adverse Event|0|||
124508747|NCT02121756|447813686|FG000|Overall Study|Protocol Violation|1|||
124508748|NCT02121756|447813687|FG001|Overall Study|Protocol Violation|1|||
124508749|NCT02121756|447813686|FG000|Overall Study|Physician Decision|2|||
124508750|NCT02121756|447813687|FG001|Overall Study|Physician Decision|1|||
124508751|NCT00255086|447813688|FG000|Overall Study|Adverse Event|1|||
124508752|NCT00255086|447813689|FG001|Overall Study|Adverse Event|1|||
124508753|NCT00255086|447813688|FG000|Overall Study|Protocol Violation|1|||
124508754|NCT00255086|447813689|FG001|Overall Study|Protocol Violation|1|||
124508755|NCT00632541|447813690|FG000|Overall Study|Adverse Event|7|||
124508756|NCT03629041|447813691|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
124508757|NCT03629041|447813692|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
124508758|NCT03629041|447813693|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
124508759|NCT03629041|447813694|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
124508760|NCT00592553|447813698|FG000|Overall Study|Protocol Noncompliance|1|||
124508761|NCT00592553|447813699|FG001|Overall Study|Protocol Noncompliance|0|||
124508762|NCT00592553|447813700|FG002|Overall Study|Protocol Noncompliance|0|||
124508763|NCT02379390|447813701|FG000|Overall Study|Adverse Event|1|||
124508764|NCT02379390|447813702|FG001|Overall Study|Adverse Event|1|||
124508765|NCT02379390|447813701|FG000|Overall Study|Investigator's decision|1|||
124508766|NCT02379390|447813702|FG001|Overall Study|Investigator's decision|0|||
124508767|NCT02379390|447813701|FG000|Overall Study|Study Termination|0|||
124508768|NCT02379390|447813702|FG001|Overall Study|Study Termination|1|||
124508769|NCT01179347|447815660|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
124508770|NCT01179347|447815661|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
124508771|NCT01179347|447815660|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
124508772|NCT01179347|447815661|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
124508773|NCT01179347|447815660|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
124508774|NCT01179347|447815661|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
124508775|NCT01179347|447815660|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
124508776|NCT01179347|447815661|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
124564440|NCT01628120|448024172|FG000|Overall Study|Sponsor Decision|5|||
124564441|NCT01628120|448024172|FG000|Overall Study|Switched Dialysis Method|2|||
124564442|NCT01628120|448024172|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
124564443|NCT01628120|448024172|FG000|Overall Study|Moved or Relocated|5|||
124508777|NCT01179347|447815660|FG000|Double-blind Period (12 Weeks)|Other|2|||
124508778|NCT01179347|447815661|FG001|Double-blind Period (12 Weeks)|Other|4|||
124508779|NCT01179347|447815660|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
124508780|NCT01179347|447815661|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
124508781|NCT01179347|447815660|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
124508782|NCT01179347|447815661|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
124508783|NCT01179347|447815660|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
124508784|NCT01179347|447815661|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
124508785|NCT01179347|447815660|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
124508786|NCT01179347|447815661|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
124564444|NCT01628120|448024172|FG000|Overall Study|Kidney Transplant|2|||
124508787|NCT01179347|447815660|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
124508788|NCT01179347|447815661|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
124508789|NCT01179347|447815660|FG000|Open-label Period (12 Weeks)|Other|7|||
124508790|NCT01179347|447815661|FG001|Open-label Period (12 Weeks)|Other|4|||
124508791|NCT00369967|447815663|FG000|Overall Study|Lost to Follow-up|23|||
124508792|NCT00369967|447815664|FG001|Overall Study|Lost to Follow-up|12|||
124508793|NCT01677624|447815665|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
124508794|NCT00255034|447815670|FG000|Overall Study|Withdrawal by Subject|15|||
124508795|NCT00255034|447815671|FG001|Overall Study|Withdrawal by Subject|38|||
124508796|NCT01830816|447815677|FG000|Overall Study|Progressive Disease|12|||
124508797|NCT01830816|447815678|FG001|Overall Study|Progressive Disease|7|||
124508798|NCT01830816|447815679|FG002|Overall Study|Progressive Disease|7|||
124508799|NCT01830816|447815677|FG000|Overall Study|Adverse Event|3|||
124508800|NCT01830816|447815678|FG001|Overall Study|Adverse Event|4|||
124508801|NCT01830816|447815679|FG002|Overall Study|Adverse Event|0|||
124508802|NCT01830816|447815677|FG000|Overall Study|Study Terminated by Sponsor|1|||
124508803|NCT01830816|447815678|FG001|Overall Study|Study Terminated by Sponsor|1|||
124508804|NCT01830816|447815679|FG002|Overall Study|Study Terminated by Sponsor|0|||
124508805|NCT01830816|447815677|FG000|Overall Study|Withdrawal by Subject|1|||
124508806|NCT01830816|447815678|FG001|Overall Study|Withdrawal by Subject|1|||
124508807|NCT01830816|447815679|FG002|Overall Study|Withdrawal by Subject|0|||
124508808|NCT01830816|447815677|FG000|Overall Study|Lost to Follow-up|0|||
124508809|NCT01830816|447815678|FG001|Overall Study|Lost to Follow-up|1|||
124508810|NCT01830816|447815679|FG002|Overall Study|Lost to Follow-up|0|||
124508811|NCT01830816|447815677|FG000|Overall Study|Symptomatic Deterioration|1|||
124508812|NCT01830816|447815678|FG001|Overall Study|Symptomatic Deterioration|0|||
124508813|NCT01830816|447815679|FG002|Overall Study|Symptomatic Deterioration|0|||
124508814|NCT01830816|447815677|FG000|Overall Study|Reason not Specified|2|||
124508815|NCT01830816|447815678|FG001|Overall Study|Reason not Specified|0|||
124508816|NCT01830816|447815679|FG002|Overall Study|Reason not Specified|0|||
124508817|NCT00830115|447815680|FG000|Overall Study|Adverse Event|2|||
124508818|NCT00830115|447815680|FG000|Overall Study|Improvement/recovery|1|||
124508819|NCT01207388|447815683|FG000|Overall Study|Death|67|||
124508820|NCT01207388|447815683|FG000|Overall Study|Withdrawal by Subject|1|||
124508821|NCT01885078|447815684|FG000|Treatment Period|Adverse Event|52|||
124508822|NCT01885078|447815685|FG001|Treatment Period|Adverse Event|136|||
124508823|NCT01885078|447815686|FG002|Treatment Period|Adverse Event|30|||
124508824|NCT01885078|447815687|FG003|Treatment Period|Adverse Event|73|||
124508825|NCT01885078|447815688|FG004|Treatment Period|Adverse Event|17|||
124508826|NCT01885078|447815689|FG005|Treatment Period|Adverse Event|72|||
124508827|NCT01885078|447815690|FG006|Treatment Period|Adverse Event|24|||
124508828|NCT01885078|447815691|FG007|Treatment Period|Adverse Event|5|||
124508829|NCT01885078|447815692|FG008|Treatment Period|Adverse Event|0|||
124508830|NCT01885078|447815693|FG009|Treatment Period|Adverse Event|0|||
124508831|NCT01885078|447815684|FG000|Treatment Period|Death|13|||
124508832|NCT01885078|447815685|FG001|Treatment Period|Death|33|||
124508833|NCT01885078|447815686|FG002|Treatment Period|Death|5|||
124508834|NCT01885078|447815687|FG003|Treatment Period|Death|9|||
124508835|NCT01885078|447815688|FG004|Treatment Period|Death|2|||
124508836|NCT01885078|447815689|FG005|Treatment Period|Death|10|||
124508837|NCT01885078|447815690|FG006|Treatment Period|Death|3|||
124508838|NCT01885078|447815691|FG007|Treatment Period|Death|2|||
124508839|NCT01885078|447815692|FG008|Treatment Period|Death|0|||
124508840|NCT01885078|447815693|FG009|Treatment Period|Death|0|||
124508841|NCT01885078|447815684|FG000|Treatment Period|Lack of Efficacy|12|||
124508842|NCT01885078|447815685|FG001|Treatment Period|Lack of Efficacy|33|||
124508843|NCT01885078|447815686|FG002|Treatment Period|Lack of Efficacy|10|||
124508844|NCT01885078|447815687|FG003|Treatment Period|Lack of Efficacy|23|||
124508845|NCT01885078|447815688|FG004|Treatment Period|Lack of Efficacy|24|||
124508846|NCT01885078|447815689|FG005|Treatment Period|Lack of Efficacy|58|||
124508847|NCT01885078|447815690|FG006|Treatment Period|Lack of Efficacy|9|||
124508848|NCT01885078|447815691|FG007|Treatment Period|Lack of Efficacy|5|||
124508849|NCT01885078|447815692|FG008|Treatment Period|Lack of Efficacy|0|||
124508850|NCT01885078|447815693|FG009|Treatment Period|Lack of Efficacy|0|||
124508851|NCT01885078|447815684|FG000|Treatment Period|Lost to Follow-up|16|||
124508852|NCT01885078|447815685|FG001|Treatment Period|Lost to Follow-up|19|||
124508853|NCT01885078|447815686|FG002|Treatment Period|Lost to Follow-up|7|||
124508854|NCT01885078|447815687|FG003|Treatment Period|Lost to Follow-up|9|||
124508855|NCT01885078|447815688|FG004|Treatment Period|Lost to Follow-up|2|||
124508856|NCT01885078|447815689|FG005|Treatment Period|Lost to Follow-up|8|||
124508857|NCT01885078|447815690|FG006|Treatment Period|Lost to Follow-up|2|||
124508858|NCT01885078|447815691|FG007|Treatment Period|Lost to Follow-up|0|||
124508859|NCT01885078|447815692|FG008|Treatment Period|Lost to Follow-up|0|||
124508860|NCT01885078|447815693|FG009|Treatment Period|Lost to Follow-up|0|||
124508861|NCT01885078|447815684|FG000|Treatment Period|Physician Decision|19|||
124508862|NCT01885078|447815685|FG001|Treatment Period|Physician Decision|21|||
124508863|NCT01885078|447815686|FG002|Treatment Period|Physician Decision|5|||
124508864|NCT01885078|447815687|FG003|Treatment Period|Physician Decision|12|||
124508865|NCT01885078|447815688|FG004|Treatment Period|Physician Decision|9|||
124508866|NCT01885078|447815689|FG005|Treatment Period|Physician Decision|24|||
124508867|NCT01885078|447815690|FG006|Treatment Period|Physician Decision|4|||
124508868|NCT01885078|447815691|FG007|Treatment Period|Physician Decision|3|||
124508869|NCT01885078|447815692|FG008|Treatment Period|Physician Decision|0|||
124508870|NCT01885078|447815693|FG009|Treatment Period|Physician Decision|0|||
124508871|NCT01885078|447815684|FG000|Treatment Period|Protocol Violation|3|||
124508872|NCT01885078|447815685|FG001|Treatment Period|Protocol Violation|5|||
124508873|NCT01885078|447815686|FG002|Treatment Period|Protocol Violation|0|||
124508874|NCT01885078|447815687|FG003|Treatment Period|Protocol Violation|3|||
124508875|NCT01885078|447815688|FG004|Treatment Period|Protocol Violation|1|||
124508876|NCT01885078|447815689|FG005|Treatment Period|Protocol Violation|6|||
124508877|NCT01885078|447815690|FG006|Treatment Period|Protocol Violation|0|||
124508878|NCT01885078|447815691|FG007|Treatment Period|Protocol Violation|0|||
124508879|NCT01885078|447815692|FG008|Treatment Period|Protocol Violation|0|||
124508880|NCT01885078|447815693|FG009|Treatment Period|Protocol Violation|0|||
124508881|NCT01885078|447815684|FG000|Treatment Period|Sponsor Decision|245|||
124508882|NCT01885078|447815685|FG001|Treatment Period|Sponsor Decision|648|||
124508883|NCT01885078|447815686|FG002|Treatment Period|Sponsor Decision|49|||
124508884|NCT01885078|447815687|FG003|Treatment Period|Sponsor Decision|90|||
124508885|NCT01885078|447815688|FG004|Treatment Period|Sponsor Decision|20|||
124508886|NCT01885078|447815689|FG005|Treatment Period|Sponsor Decision|38|||
124508887|NCT01885078|447815690|FG006|Treatment Period|Sponsor Decision|162|||
124508888|NCT01885078|447815691|FG007|Treatment Period|Sponsor Decision|3|||
124508889|NCT01885078|447815692|FG008|Treatment Period|Sponsor Decision|0|||
124508890|NCT01885078|447815693|FG009|Treatment Period|Sponsor Decision|0|||
124508891|NCT01885078|447815684|FG000|Treatment Period|Withdrawal by Subject|72|||
124508892|NCT01885078|447815685|FG001|Treatment Period|Withdrawal by Subject|132|||
124508893|NCT01885078|447815686|FG002|Treatment Period|Withdrawal by Subject|25|||
124508894|NCT01885078|447815687|FG003|Treatment Period|Withdrawal by Subject|63|||
124508895|NCT01885078|447815688|FG004|Treatment Period|Withdrawal by Subject|15|||
124508896|NCT01885078|447815689|FG005|Treatment Period|Withdrawal by Subject|34|||
124508897|NCT01885078|447815690|FG006|Treatment Period|Withdrawal by Subject|17|||
124508898|NCT01885078|447815691|FG007|Treatment Period|Withdrawal by Subject|10|||
124508899|NCT01885078|447815692|FG008|Treatment Period|Withdrawal by Subject|0|||
124508900|NCT01885078|447815693|FG009|Treatment Period|Withdrawal by Subject|0|||
124508901|NCT01885078|447815684|FG000|Treatment Period|Other|0|||
124508902|NCT01885078|447815685|FG001|Treatment Period|Other|0|||
124508903|NCT01885078|447815686|FG002|Treatment Period|Other|0|||
124508904|NCT01885078|447815687|FG003|Treatment Period|Other|1|||
124508905|NCT01885078|447815688|FG004|Treatment Period|Other|0|||
124508906|NCT01885078|447815689|FG005|Treatment Period|Other|0|||
124508907|NCT01885078|447815690|FG006|Treatment Period|Other|0|||
124508908|NCT01885078|447815691|FG007|Treatment Period|Other|0|||
124508909|NCT01885078|447815692|FG008|Treatment Period|Other|0|||
124508910|NCT01885078|447815693|FG009|Treatment Period|Other|0|||
124508911|NCT01885078|447815684|FG000|Step-down Period|Sponsor Decision|0|||
124508912|NCT01885078|447815685|FG001|Step-down Period|Sponsor Decision|0|||
124508913|NCT01885078|447815686|FG002|Step-down Period|Sponsor Decision|0|||
124508914|NCT01885078|447815687|FG003|Step-down Period|Sponsor Decision|0|||
124508915|NCT01885078|447815688|FG004|Step-down Period|Sponsor Decision|0|||
124508916|NCT01885078|447815689|FG005|Step-down Period|Sponsor Decision|0|||
124508917|NCT01885078|447815690|FG006|Step-down Period|Sponsor Decision|0|||
124508918|NCT01885078|447815691|FG007|Step-down Period|Sponsor Decision|0|||
124508919|NCT01885078|447815692|FG008|Step-down Period|Sponsor Decision|1|||
124508920|NCT01885078|447815693|FG009|Step-down Period|Sponsor Decision|1|||
124508921|NCT01885078|447815684|FG000|Step-down Period|Adverse Event|0|||
124508922|NCT01885078|447815685|FG001|Step-down Period|Adverse Event|0|||
124508923|NCT01885078|447815686|FG002|Step-down Period|Adverse Event|0|||
124508924|NCT01885078|447815687|FG003|Step-down Period|Adverse Event|0|||
124508925|NCT01885078|447815688|FG004|Step-down Period|Adverse Event|0|||
124508926|NCT01885078|447815689|FG005|Step-down Period|Adverse Event|0|||
124508927|NCT01885078|447815690|FG006|Step-down Period|Adverse Event|0|||
124508928|NCT01885078|447815691|FG007|Step-down Period|Adverse Event|0|||
124508929|NCT01885078|447815692|FG008|Step-down Period|Adverse Event|29|||
124508930|NCT01885078|447815693|FG009|Step-down Period|Adverse Event|38|||
124508931|NCT01885078|447815684|FG000|Step-down Period|Withdrawal by Subject|0|||
124508932|NCT01885078|447815685|FG001|Step-down Period|Withdrawal by Subject|0|||
124508933|NCT01885078|447815686|FG002|Step-down Period|Withdrawal by Subject|0|||
124508934|NCT01885078|447815687|FG003|Step-down Period|Withdrawal by Subject|0|||
124508935|NCT01885078|447815688|FG004|Step-down Period|Withdrawal by Subject|0|||
124508936|NCT01885078|447815689|FG005|Step-down Period|Withdrawal by Subject|0|||
124508937|NCT01885078|447815690|FG006|Step-down Period|Withdrawal by Subject|0|||
124508938|NCT01885078|447815691|FG007|Step-down Period|Withdrawal by Subject|0|||
124508939|NCT01885078|447815692|FG008|Step-down Period|Withdrawal by Subject|25|||
124508940|NCT01885078|447815693|FG009|Step-down Period|Withdrawal by Subject|15|||
124508941|NCT01885078|447815684|FG000|Step-down Period|Physician Decision|0|||
124508942|NCT01885078|447815685|FG001|Step-down Period|Physician Decision|0|||
124508943|NCT01885078|447815686|FG002|Step-down Period|Physician Decision|0|||
124508944|NCT01885078|447815687|FG003|Step-down Period|Physician Decision|0|||
124508945|NCT01885078|447815688|FG004|Step-down Period|Physician Decision|0|||
124508946|NCT01885078|447815689|FG005|Step-down Period|Physician Decision|0|||
124508947|NCT01885078|447815690|FG006|Step-down Period|Physician Decision|0|||
124508948|NCT01885078|447815691|FG007|Step-down Period|Physician Decision|0|||
124508949|NCT01885078|447815692|FG008|Step-down Period|Physician Decision|7|||
124508950|NCT01885078|447815693|FG009|Step-down Period|Physician Decision|2|||
124508951|NCT01885078|447815684|FG000|Step-down Period|Death|0|||
124508952|NCT01885078|447815685|FG001|Step-down Period|Death|0|||
124508953|NCT01885078|447815686|FG002|Step-down Period|Death|0|||
124508954|NCT01885078|447815687|FG003|Step-down Period|Death|0|||
124508955|NCT01885078|447815688|FG004|Step-down Period|Death|0|||
124508956|NCT01885078|447815689|FG005|Step-down Period|Death|0|||
124508957|NCT01885078|447815690|FG006|Step-down Period|Death|0|||
124508958|NCT01885078|447815691|FG007|Step-down Period|Death|0|||
124508959|NCT01885078|447815692|FG008|Step-down Period|Death|4|||
124508960|NCT01885078|447815693|FG009|Step-down Period|Death|3|||
124508961|NCT01885078|447815684|FG000|Step-down Period|Lost to Follow-up|0|||
124508962|NCT01885078|447815685|FG001|Step-down Period|Lost to Follow-up|0|||
124508963|NCT01885078|447815686|FG002|Step-down Period|Lost to Follow-up|0|||
124508964|NCT01885078|447815687|FG003|Step-down Period|Lost to Follow-up|0|||
124508965|NCT01885078|447815688|FG004|Step-down Period|Lost to Follow-up|0|||
124508966|NCT01885078|447815689|FG005|Step-down Period|Lost to Follow-up|0|||
124508967|NCT01885078|447815690|FG006|Step-down Period|Lost to Follow-up|0|||
124508968|NCT01885078|447815691|FG007|Step-down Period|Lost to Follow-up|0|||
124508969|NCT01885078|447815692|FG008|Step-down Period|Lost to Follow-up|1|||
124508970|NCT01885078|447815693|FG009|Step-down Period|Lost to Follow-up|1|||
124508971|NCT01885078|447815684|FG000|Step-down Period|Lack of Efficacy|0|||
124508972|NCT01885078|447815685|FG001|Step-down Period|Lack of Efficacy|0|||
124508973|NCT01885078|447815686|FG002|Step-down Period|Lack of Efficacy|0|||
124508974|NCT01885078|447815687|FG003|Step-down Period|Lack of Efficacy|0|||
124508975|NCT01885078|447815688|FG004|Step-down Period|Lack of Efficacy|0|||
124508976|NCT01885078|447815689|FG005|Step-down Period|Lack of Efficacy|0|||
124508977|NCT01885078|447815690|FG006|Step-down Period|Lack of Efficacy|0|||
124508978|NCT01885078|447815691|FG007|Step-down Period|Lack of Efficacy|0|||
124508979|NCT01885078|447815692|FG008|Step-down Period|Lack of Efficacy|1|||
124508980|NCT01885078|447815693|FG009|Step-down Period|Lack of Efficacy|0|||
124508981|NCT01885078|447815684|FG000|Step-down Period|Protocol Violation|0|||
124508982|NCT01885078|447815685|FG001|Step-down Period|Protocol Violation|0|||
124508983|NCT01885078|447815686|FG002|Step-down Period|Protocol Violation|0|||
124508984|NCT01885078|447815687|FG003|Step-down Period|Protocol Violation|0|||
124508985|NCT01885078|447815688|FG004|Step-down Period|Protocol Violation|0|||
124508986|NCT01885078|447815689|FG005|Step-down Period|Protocol Violation|0|||
124508987|NCT01885078|447815690|FG006|Step-down Period|Protocol Violation|0|||
124508988|NCT01885078|447815691|FG007|Step-down Period|Protocol Violation|0|||
124508989|NCT01885078|447815692|FG008|Step-down Period|Protocol Violation|1|||
124508990|NCT01885078|447815693|FG009|Step-down Period|Protocol Violation|1|||
124508991|NCT01610076|447815695|FG000|Overall Study|Technical issue with video|0|||
124508992|NCT01610076|447815696|FG001|Overall Study|Technical issue with video|1|||
124508993|NCT01610076|447815695|FG000|Overall Study|Lost to Follow-up|3|||
124508994|NCT01610076|447815696|FG001|Overall Study|Lost to Follow-up|4|||
124508995|NCT01895452|447815701|FG000|Overall Study|Adverse Event|1|||
124508996|NCT01895452|447815702|FG001|Overall Study|Adverse Event|4|||
124508997|NCT01895452|447815701|FG000|Overall Study|Lost to Follow-up|1|||
124508998|NCT01895452|447815702|FG001|Overall Study|Lost to Follow-up|5|||
124508999|NCT01895452|447815701|FG000|Overall Study|Pregnancy|0|||
124509000|NCT01895452|447815702|FG001|Overall Study|Pregnancy|1|||
124509001|NCT01895452|447815701|FG000|Overall Study|Withdrawal by Subject|2|||
124509002|NCT01895452|447815702|FG001|Overall Study|Withdrawal by Subject|14|||
124509003|NCT01895452|447815701|FG000|Overall Study|Underlying disease|0|||
124509004|NCT01895452|447815702|FG001|Overall Study|Underlying disease|3|||
124509005|NCT01895452|447815701|FG000|Overall Study|Noncompliance with study drug|0|||
124509006|NCT01895452|447815702|FG001|Overall Study|Noncompliance with study drug|1|||
124509007|NCT01204697|447815704|FG000|Overall Study|Death|26|||
124509008|NCT01204697|447815705|FG001|Overall Study|Death|27|||
124509009|NCT01204697|447815704|FG000|Overall Study|Lost to Follow-up|3|||
124509010|NCT01204697|447815705|FG001|Overall Study|Lost to Follow-up|4|||
124509011|NCT01204697|447815704|FG000|Overall Study|Withdrawal by Subject|2|||
124509012|NCT01204697|447815705|FG001|Overall Study|Withdrawal by Subject|4|||
124509013|NCT01204697|447815704|FG000|Overall Study|Randomized, but not treated|0|||
124509014|NCT01204697|447815705|FG001|Overall Study|Randomized, but not treated|1|||
124509015|NCT01205451|447815706|FG000|Overall Study|Lost to Follow-up|1|||
124509016|NCT01205451|447815707|FG001|Overall Study|Lost to Follow-up|1|||
124509017|NCT01205451|447815706|FG000|Overall Study|Withdrawal by Subject|5|||
124509018|NCT01205451|447815707|FG001|Overall Study|Withdrawal by Subject|9|||
124509019|NCT01194869|447815708|FG000|Overall Study|Disease Progression|2|||
124509020|NCT01194869|447815708|FG000|Overall Study|Toxicity|2|||
124509021|NCT04321252|447815711|FG000|Overall Study|Withdrawal by Subject|0|||
124509022|NCT04321252|447815712|FG001|Overall Study|Withdrawal by Subject|0|||
124509023|NCT04321252|447815713|FG002|Overall Study|Withdrawal by Subject|0|||
124509024|NCT04321252|447815714|FG003|Overall Study|Withdrawal by Subject|0|||
124509025|NCT04321252|447815715|FG004|Overall Study|Withdrawal by Subject|0|||
124509026|NCT04321252|447815716|FG005|Overall Study|Withdrawal by Subject|1|||
124509027|NCT04321252|447815717|FG006|Overall Study|Withdrawal by Subject|0|||
124509028|NCT04321252|447815718|FG007|Overall Study|Withdrawal by Subject|0|||
124509029|NCT04321252|447815719|FG008|Overall Study|Withdrawal by Subject|0|||
124509030|NCT03004469|447815720|FG000|Overall Study|Adverse Event|6|||
124564445|NCT01628120|448024172|FG000|Overall Study|Use of Standard of Care|1|||
124564446|NCT02232074|448024173|FG000|Overall Study|Withdrawal by Subject|5|||
124564447|NCT02232074|448024174|FG001|Overall Study|Withdrawal by Subject|3|||
124564448|NCT02232074|448024173|FG000|Overall Study|No legal concerns at baseline|36|||
124509031|NCT03004469|447815721|FG001|Overall Study|Adverse Event|4|||
124509032|NCT03004469|447815722|FG002|Overall Study|Adverse Event|6|||
124509033|NCT03004469|447815720|FG000|Overall Study|Lack of Efficacy|1|||
124509034|NCT03004469|447815721|FG001|Overall Study|Lack of Efficacy|0|||
124509035|NCT03004469|447815722|FG002|Overall Study|Lack of Efficacy|1|||
124509036|NCT03004469|447815720|FG000|Overall Study|Lost to Follow-up|23|||
124509037|NCT03004469|447815721|FG001|Overall Study|Lost to Follow-up|14|||
124509038|NCT03004469|447815722|FG002|Overall Study|Lost to Follow-up|6|||
124509039|NCT03004469|447815720|FG000|Overall Study|Non-Compliance with Study Drug|2|||
124509040|NCT03004469|447815721|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124509041|NCT03004469|447815722|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124509042|NCT03004469|447815720|FG000|Overall Study|Protocol Violation|0|||
124509043|NCT03004469|447815721|FG001|Overall Study|Protocol Violation|0|||
124509044|NCT03004469|447815722|FG002|Overall Study|Protocol Violation|1|||
124509045|NCT03004469|447815720|FG000|Overall Study|Withdrawal by Subject|29|||
124509046|NCT03004469|447815721|FG001|Overall Study|Withdrawal by Subject|27|||
124509047|NCT03004469|447815722|FG002|Overall Study|Withdrawal by Subject|10|||
124509048|NCT03004469|447815720|FG000|Overall Study|Other unspecified reason|0|||
124509049|NCT03004469|447815721|FG001|Overall Study|Other unspecified reason|4|||
124509050|NCT03004469|447815722|FG002|Overall Study|Other unspecified reason|1|||
124509051|NCT00259740|447815723|FG000|Overall Study|Physician Decision|1|||
124509052|NCT00259740|447815724|FG001|Overall Study|Physician Decision|1|||
124509053|NCT00259740|447815723|FG000|Overall Study|Adverse Event|0|||
124509054|NCT00259740|447815724|FG001|Overall Study|Adverse Event|2|||
124509055|NCT00259740|447815723|FG000|Overall Study|Withdrawal by Subject|2|||
124509056|NCT00259740|447815724|FG001|Overall Study|Withdrawal by Subject|6|||
124509057|NCT00259740|447815723|FG000|Overall Study|Death|1|||
124509058|NCT00259740|447815724|FG001|Overall Study|Death|1|||
124509059|NCT00259740|447815723|FG000|Overall Study|Disease progression|19|||
124509060|NCT00259740|447815724|FG001|Overall Study|Disease progression|36|||
124509061|NCT00259740|447815723|FG000|Overall Study|Ongoing|17|||
124509062|NCT00259740|447815724|FG001|Overall Study|Ongoing|3|||
124509063|NCT00259740|447815723|FG000|Overall Study|Other|3|||
124509064|NCT00259740|447815724|FG001|Overall Study|Other|0|||
124509065|NCT00259740|447815723|FG000|Overall Study|Requirement for alternative therapy|0|||
124509066|NCT00259740|447815724|FG001|Overall Study|Requirement for alternative therapy|4|||
124509067|NCT03654755|447815725|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
124509068|NCT03654755|447815726|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
124509069|NCT03654755|447815727|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
124509070|NCT03654755|447815725|FG000|Overall Study|Withdrawal by Subject|2|||
124509071|NCT03654755|447815726|FG001|Overall Study|Withdrawal by Subject|4|||
124509072|NCT03654755|447815727|FG002|Overall Study|Withdrawal by Subject|8|||
124509073|NCT03654755|447815725|FG000|Overall Study|Lost to Follow-up|1|||
124509074|NCT03654755|447815726|FG001|Overall Study|Lost to Follow-up|3|||
124509075|NCT03654755|447815727|FG002|Overall Study|Lost to Follow-up|7|||
124509076|NCT03654755|447815725|FG000|Overall Study|Physician Decision|0|||
124509077|NCT03654755|447815726|FG001|Overall Study|Physician Decision|1|||
124509078|NCT03654755|447815727|FG002|Overall Study|Physician Decision|0|||
124509079|NCT03654755|447815725|FG000|Overall Study|Adverse Event|0|||
124564449|NCT02232074|448024174|FG001|Overall Study|No legal concerns at baseline|41|||
124564450|NCT02232074|448024173|FG000|Overall Study|deemed ineligible|0|||
124509080|NCT03654755|447815726|FG001|Overall Study|Adverse Event|0|||
124509081|NCT03654755|447815727|FG002|Overall Study|Adverse Event|4|||
124509082|NCT03654755|447815725|FG000|Overall Study|Lack of Efficacy|0|||
124509083|NCT03654755|447815726|FG001|Overall Study|Lack of Efficacy|0|||
124509084|NCT03654755|447815727|FG002|Overall Study|Lack of Efficacy|1|||
124509085|NCT01360762|447815734|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
124509086|NCT01360762|447815734|FG000|Main Study Period (12-month Treatment)|Death|5|||
124509087|NCT01360762|447815734|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
124509088|NCT01360762|447815734|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
124509089|NCT01360762|447815734|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
124509090|NCT01360762|447815734|FG000|Whole Study Period|Lost to Follow-up|10|||
124509091|NCT01360762|447815734|FG000|Whole Study Period|Death|7|||
124509092|NCT01360762|447815734|FG000|Whole Study Period|Patient relapsed|18|||
124564451|NCT02232074|448024174|FG001|Overall Study|deemed ineligible|1|||
124509093|NCT01360762|447815734|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
124564452|NCT01296932|448024177|FG000|Overall Study|Dose limiting toxicity|0|||
124509094|NCT04511819|447815735|FG000|Overall Study|Non-compliance with study drug|5|||
124509095|NCT04511819|447815736|FG001|Overall Study|Non-compliance with study drug|1|||
124509096|NCT04511819|447815735|FG000|Overall Study|Withdrawal by Subject|0|||
124509097|NCT04511819|447815736|FG001|Overall Study|Withdrawal by Subject|3|||
124509098|NCT04511819|447815735|FG000|Overall Study|Adverse Event|0|||
124564453|NCT01296932|448024178|FG001|Overall Study|Dose limiting toxicity|0|||
124564454|NCT01296932|448024179|FG002|Overall Study|Dose limiting toxicity|0|||
124564455|NCT01296932|448024180|FG003|Overall Study|Dose limiting toxicity|0|||
124564456|NCT01296932|448024181|FG004|Overall Study|Dose limiting toxicity|0|||
124564457|NCT01296932|448024182|FG005|Overall Study|Dose limiting toxicity|0|||
124564458|NCT01296932|448024183|FG006|Overall Study|Dose limiting toxicity|1|||
124564459|NCT01296932|448024184|FG007|Overall Study|Dose limiting toxicity|0|||
124564460|NCT01296932|448024185|FG008|Overall Study|Dose limiting toxicity|1|||
124564461|NCT01296932|448024177|FG000|Overall Study|Progressive disease|2|||
124564462|NCT01296932|448024178|FG001|Overall Study|Progressive disease|0|||
124564463|NCT01296932|448024179|FG002|Overall Study|Progressive disease|1|||
124564464|NCT01296932|448024180|FG003|Overall Study|Progressive disease|1|||
124564465|NCT01296932|448024181|FG004|Overall Study|Progressive disease|2|||
124564466|NCT01296932|448024182|FG005|Overall Study|Progressive disease|3|||
124564467|NCT01296932|448024183|FG006|Overall Study|Progressive disease|1|||
124564468|NCT01296932|448024184|FG007|Overall Study|Progressive disease|0|||
124564469|NCT01296932|448024185|FG008|Overall Study|Progressive disease|0|||
124564470|NCT01296932|448024177|FG000|Overall Study|Withdrawal by Subject|0|||
124564471|NCT01296932|448024178|FG001|Overall Study|Withdrawal by Subject|0|||
124564472|NCT01296932|448024179|FG002|Overall Study|Withdrawal by Subject|1|||
124564473|NCT01296932|448024180|FG003|Overall Study|Withdrawal by Subject|1|||
124564474|NCT01296932|448024181|FG004|Overall Study|Withdrawal by Subject|0|||
124564475|NCT01296932|448024182|FG005|Overall Study|Withdrawal by Subject|0|||
124564476|NCT01296932|448024183|FG006|Overall Study|Withdrawal by Subject|3|||
124564477|NCT01296932|448024184|FG007|Overall Study|Withdrawal by Subject|0|||
124564478|NCT01296932|448024185|FG008|Overall Study|Withdrawal by Subject|0|||
124564479|NCT01296932|448024177|FG000|Overall Study|Adverse Event|1|||
124564480|NCT01296932|448024178|FG001|Overall Study|Adverse Event|1|||
124564481|NCT01296932|448024179|FG002|Overall Study|Adverse Event|1|||
124564482|NCT01296932|448024180|FG003|Overall Study|Adverse Event|2|||
124564483|NCT01296932|448024181|FG004|Overall Study|Adverse Event|1|||
124564484|NCT01296932|448024182|FG005|Overall Study|Adverse Event|0|||
124564485|NCT01296932|448024183|FG006|Overall Study|Adverse Event|0|||
124564486|NCT01296932|448024184|FG007|Overall Study|Adverse Event|0|||
124564487|NCT01296932|448024185|FG008|Overall Study|Adverse Event|1|||
124564488|NCT01296932|448024177|FG000|Overall Study|Investigator decision|0|||
124564489|NCT01296932|448024178|FG001|Overall Study|Investigator decision|1|||
124564490|NCT01296932|448024179|FG002|Overall Study|Investigator decision|0|||
124564491|NCT01296932|448024180|FG003|Overall Study|Investigator decision|1|||
124564492|NCT01296932|448024181|FG004|Overall Study|Investigator decision|0|||
124564493|NCT01296932|448024182|FG005|Overall Study|Investigator decision|0|||
124564494|NCT01296932|448024183|FG006|Overall Study|Investigator decision|1|||
124564495|NCT01296932|448024184|FG007|Overall Study|Investigator decision|0|||
124564496|NCT01296932|448024185|FG008|Overall Study|Investigator decision|1|||
124564497|NCT01296932|448024177|FG000|Overall Study|No clinical benefit anymore|0|||
124564498|NCT01296932|448024178|FG001|Overall Study|No clinical benefit anymore|1|||
124564499|NCT01296932|448024179|FG002|Overall Study|No clinical benefit anymore|0|||
124564500|NCT01296932|448024180|FG003|Overall Study|No clinical benefit anymore|0|||
124564501|NCT01296932|448024181|FG004|Overall Study|No clinical benefit anymore|0|||
124564502|NCT01296932|448024182|FG005|Overall Study|No clinical benefit anymore|0|||
124564503|NCT01296932|448024183|FG006|Overall Study|No clinical benefit anymore|0|||
124564504|NCT01296932|448024184|FG007|Overall Study|No clinical benefit anymore|0|||
124564505|NCT01296932|448024185|FG008|Overall Study|No clinical benefit anymore|0|||
124564506|NCT01296932|448024177|FG000|Overall Study|Physician Decision|0|||
124564507|NCT01296932|448024178|FG001|Overall Study|Physician Decision|0|||
124564508|NCT01296932|448024179|FG002|Overall Study|Physician Decision|1|||
124564509|NCT01296932|448024180|FG003|Overall Study|Physician Decision|0|||
124564510|NCT01296932|448024181|FG004|Overall Study|Physician Decision|0|||
124564511|NCT01296932|448024182|FG005|Overall Study|Physician Decision|0|||
124564512|NCT01296932|448024183|FG006|Overall Study|Physician Decision|0|||
124564513|NCT01296932|448024184|FG007|Overall Study|Physician Decision|0|||
124564514|NCT01296932|448024185|FG008|Overall Study|Physician Decision|0|||
124564515|NCT01296932|448024177|FG000|Overall Study|IV problems, administration not possible|0|||
124564516|NCT01296932|448024178|FG001|Overall Study|IV problems, administration not possible|0|||
124564517|NCT01296932|448024179|FG002|Overall Study|IV problems, administration not possible|1|||
124564518|NCT01296932|448024180|FG003|Overall Study|IV problems, administration not possible|0|||
124564519|NCT01296932|448024181|FG004|Overall Study|IV problems, administration not possible|0|||
124564520|NCT01296932|448024182|FG005|Overall Study|IV problems, administration not possible|0|||
124564521|NCT01296932|448024183|FG006|Overall Study|IV problems, administration not possible|0|||
124564522|NCT01296932|448024184|FG007|Overall Study|IV problems, administration not possible|0|||
124564523|NCT01296932|448024185|FG008|Overall Study|IV problems, administration not possible|0|||
124564524|NCT01296932|448024177|FG000|Overall Study|per protocol|0|||
124564525|NCT01296932|448024178|FG001|Overall Study|per protocol|0|||
124564526|NCT01296932|448024179|FG002|Overall Study|per protocol|1|||
124564527|NCT01296932|448024180|FG003|Overall Study|per protocol|1|||
124564528|NCT01296932|448024181|FG004|Overall Study|per protocol|0|||
124509099|NCT04511819|447815736|FG001|Overall Study|Adverse Event|1|||
124509100|NCT04511819|447815735|FG000|Overall Study|Protocol deviation|1|||
124509101|NCT04511819|447815736|FG001|Overall Study|Protocol deviation|0|||
124509102|NCT03247413|447815739|FG000|Overall Study|Lost to Follow-up|28|||
124509103|NCT04397718|447815740|FG000|Overall Study|Death|7|||
124509104|NCT04397718|447815741|FG001|Overall Study|Death|11|||
124509105|NCT04397718|447815740|FG000|Overall Study|Lost to Follow-up|0|||
124509106|NCT04397718|447815741|FG001|Overall Study|Lost to Follow-up|4|||
124509107|NCT01797965|447815742|FG000|Overall Study|Adverse Event|104|||
124509108|NCT01797965|447815743|FG001|Overall Study|Adverse Event|129|||
124509109|NCT01797965|447815744|FG002|Overall Study|Adverse Event|4|||
124509110|NCT01797965|447815745|FG003|Overall Study|Adverse Event|21|||
124509111|NCT01797965|447815742|FG000|Overall Study|Lost to Follow-up|9|||
124509112|NCT01797965|447815743|FG001|Overall Study|Lost to Follow-up|8|||
124509113|NCT01797965|447815744|FG002|Overall Study|Lost to Follow-up|1|||
124509114|NCT01797965|447815745|FG003|Overall Study|Lost to Follow-up|2|||
124509115|NCT01797965|447815742|FG000|Overall Study|Consent withdrawn|130|||
124509116|NCT01797965|447815743|FG001|Overall Study|Consent withdrawn|117|||
124509117|NCT01797965|447815744|FG002|Overall Study|Consent withdrawn|3|||
124509118|NCT01797965|447815745|FG003|Overall Study|Consent withdrawn|35|||
124509119|NCT01797965|447815742|FG000|Overall Study|Investigator decision|21|||
124509120|NCT01797965|447815743|FG001|Overall Study|Investigator decision|15|||
124509121|NCT01797965|447815744|FG002|Overall Study|Investigator decision|0|||
124509122|NCT01797965|447815745|FG003|Overall Study|Investigator decision|0|||
124509123|NCT01797965|447815742|FG000|Overall Study|Death|2|||
124509124|NCT01797965|447815743|FG001|Overall Study|Death|4|||
124509125|NCT01797965|447815744|FG002|Overall Study|Death|0|||
124509126|NCT01797965|447815745|FG003|Overall Study|Death|0|||
124509127|NCT01797965|447815742|FG000|Overall Study|Disease progression, defined by protocol|3|||
124509128|NCT01797965|447815743|FG001|Overall Study|Disease progression, defined by protocol|1|||
124509129|NCT01797965|447815744|FG002|Overall Study|Disease progression, defined by protocol|0|||
124509130|NCT01797965|447815745|FG003|Overall Study|Disease progression, defined by protocol|0|||
124509131|NCT01797965|447815742|FG000|Overall Study|Reason Not Specified|280|||
124509132|NCT01797965|447815743|FG001|Overall Study|Reason Not Specified|295|||
124509133|NCT01797965|447815744|FG002|Overall Study|Reason Not Specified|0|||
124509134|NCT01797965|447815745|FG003|Overall Study|Reason Not Specified|15|||
124509135|NCT00976950|447815746|FG000|Overall Study|Adverse Event|3|||
124509136|NCT00976950|447815746|FG000|Overall Study|Events with no relationship to Aptivus|3|||
124509137|NCT01021852|447815747|FG000|Treatment Period 1|Adverse Event|3|||
124509138|NCT01021852|447815748|FG001|Treatment Period 1|Adverse Event|1|||
124509139|NCT01021852|447815749|FG002|Treatment Period 1|Adverse Event|1|||
124509140|NCT01021852|447815750|FG003|Treatment Period 1|Adverse Event|0|||
124509141|NCT01021852|447815751|FG004|Treatment Period 1|Adverse Event|2|||
124509142|NCT01021852|447815752|FG005|Treatment Period 1|Adverse Event|2|||
124509143|NCT01021852|447815753|FG006|Treatment Period 1|Adverse Event|0|||
124509144|NCT01021852|447815754|FG007|Treatment Period 1|Adverse Event|0|||
124509145|NCT01021852|447815747|FG000|Treatment Period 1|Pregnancy|0|||
124509146|NCT01021852|447815748|FG001|Treatment Period 1|Pregnancy|0|||
124509147|NCT01021852|447815749|FG002|Treatment Period 1|Pregnancy|1|||
124509148|NCT01021852|447815750|FG003|Treatment Period 1|Pregnancy|0|||
124509149|NCT01021852|447815751|FG004|Treatment Period 1|Pregnancy|0|||
124509150|NCT01021852|447815752|FG005|Treatment Period 1|Pregnancy|0|||
124509151|NCT01021852|447815753|FG006|Treatment Period 1|Pregnancy|0|||
124509152|NCT01021852|447815754|FG007|Treatment Period 1|Pregnancy|0|||
124509153|NCT01021852|447815747|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124509154|NCT01021852|447815748|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124509155|NCT01021852|447815749|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124509156|NCT01021852|447815750|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124509157|NCT01021852|447815751|FG004|Treatment Period 1|Withdrawal by Subject|1|||
124509158|NCT01021852|447815752|FG005|Treatment Period 1|Withdrawal by Subject|0|||
124509159|NCT01021852|447815753|FG006|Treatment Period 1|Withdrawal by Subject|0|||
124509160|NCT01021852|447815754|FG007|Treatment Period 1|Withdrawal by Subject|1|||
124509161|NCT01021852|447815747|FG000|Treatment Period 1|Not Treated|0|||
124509162|NCT01021852|447815748|FG001|Treatment Period 1|Not Treated|0|||
124509163|NCT01021852|447815749|FG002|Treatment Period 1|Not Treated|0|||
124509164|NCT01021852|447815750|FG003|Treatment Period 1|Not Treated|2|||
124509165|NCT01021852|447815751|FG004|Treatment Period 1|Not Treated|0|||
124509166|NCT01021852|447815752|FG005|Treatment Period 1|Not Treated|0|||
124509167|NCT01021852|447815753|FG006|Treatment Period 1|Not Treated|0|||
124509168|NCT01021852|447815754|FG007|Treatment Period 1|Not Treated|0|||
124509169|NCT01021852|447815747|FG000|Washout Period-Placebo|Adverse Event|0|||
124509170|NCT01021852|447815748|FG001|Washout Period-Placebo|Adverse Event|0|||
124509171|NCT01021852|447815749|FG002|Washout Period-Placebo|Adverse Event|0|||
124509172|NCT01021852|447815750|FG003|Washout Period-Placebo|Adverse Event|1|||
124509173|NCT01021852|447815751|FG004|Washout Period-Placebo|Adverse Event|0|||
124509174|NCT01021852|447815752|FG005|Washout Period-Placebo|Adverse Event|1|||
124509175|NCT01021852|447815753|FG006|Washout Period-Placebo|Adverse Event|0|||
124509176|NCT01021852|447815754|FG007|Washout Period-Placebo|Adverse Event|0|||
124564529|NCT01296932|448024182|FG005|Overall Study|per protocol|0|||
124564530|NCT01296932|448024183|FG006|Overall Study|per protocol|0|||
124564531|NCT01296932|448024184|FG007|Overall Study|per protocol|0|||
124564532|NCT01296932|448024185|FG008|Overall Study|per protocol|0|||
124564533|NCT01296932|448024177|FG000|Overall Study|Low benefit and too many side effects|0|||
124564534|NCT01296932|448024178|FG001|Overall Study|Low benefit and too many side effects|0|||
124564535|NCT01296932|448024179|FG002|Overall Study|Low benefit and too many side effects|0|||
124564536|NCT01296932|448024180|FG003|Overall Study|Low benefit and too many side effects|0|||
124564537|NCT01296932|448024181|FG004|Overall Study|Low benefit and too many side effects|0|||
124564538|NCT01296932|448024182|FG005|Overall Study|Low benefit and too many side effects|0|||
124564539|NCT01296932|448024183|FG006|Overall Study|Low benefit and too many side effects|0|||
124564540|NCT01296932|448024184|FG007|Overall Study|Low benefit and too many side effects|1|||
124564541|NCT01296932|448024185|FG008|Overall Study|Low benefit and too many side effects|0|||
124564542|NCT01296932|448024177|FG000|Overall Study|No adequate treatment response|0|||
124564543|NCT01296932|448024178|FG001|Overall Study|No adequate treatment response|0|||
124564544|NCT01296932|448024179|FG002|Overall Study|No adequate treatment response|0|||
124564545|NCT01296932|448024180|FG003|Overall Study|No adequate treatment response|0|||
124564546|NCT01296932|448024181|FG004|Overall Study|No adequate treatment response|0|||
124564547|NCT01296932|448024182|FG005|Overall Study|No adequate treatment response|0|||
124564548|NCT01296932|448024183|FG006|Overall Study|No adequate treatment response|0|||
124564549|NCT01296932|448024184|FG007|Overall Study|No adequate treatment response|1|||
124564550|NCT01296932|448024185|FG008|Overall Study|No adequate treatment response|0|||
124564551|NCT01296932|448024177|FG000|Overall Study|Dosage already reduced, AE still present|0|||
124564552|NCT01296932|448024178|FG001|Overall Study|Dosage already reduced, AE still present|0|||
124564553|NCT01296932|448024179|FG002|Overall Study|Dosage already reduced, AE still present|0|||
124564554|NCT01296932|448024180|FG003|Overall Study|Dosage already reduced, AE still present|0|||
124564555|NCT01296932|448024181|FG004|Overall Study|Dosage already reduced, AE still present|0|||
124564556|NCT01296932|448024182|FG005|Overall Study|Dosage already reduced, AE still present|0|||
124564557|NCT01296932|448024183|FG006|Overall Study|Dosage already reduced, AE still present|0|||
124564558|NCT01296932|448024184|FG007|Overall Study|Dosage already reduced, AE still present|0|||
124564559|NCT01296932|448024185|FG008|Overall Study|Dosage already reduced, AE still present|1|||
124564560|NCT01579474|448024188|FG000|Overall Study|Adverse Event|1|||
124564561|NCT01579474|448024189|FG001|Overall Study|Adverse Event|13|||
124564562|NCT01579474|448024190|FG002|Overall Study|Adverse Event|2|||
124564563|NCT01579474|448024191|FG003|Overall Study|Adverse Event|0|||
124564564|NCT01579474|448024192|FG004|Overall Study|Adverse Event|0|||
124564565|NCT01579474|448024193|FG005|Overall Study|Adverse Event|1|||
124564566|NCT01579474|448024188|FG000|Overall Study|Lack of Efficacy|1|||
124564567|NCT01579474|448024189|FG001|Overall Study|Lack of Efficacy|0|||
124564568|NCT01579474|448024190|FG002|Overall Study|Lack of Efficacy|0|||
124564569|NCT01579474|448024191|FG003|Overall Study|Lack of Efficacy|0|||
124564570|NCT01579474|448024192|FG004|Overall Study|Lack of Efficacy|1|||
124564571|NCT01579474|448024193|FG005|Overall Study|Lack of Efficacy|0|||
124564572|NCT01579474|448024188|FG000|Overall Study|Withdrawal by Subject|1|||
124564573|NCT01579474|448024189|FG001|Overall Study|Withdrawal by Subject|0|||
124564574|NCT01579474|448024190|FG002|Overall Study|Withdrawal by Subject|0|||
124564575|NCT01579474|448024191|FG003|Overall Study|Withdrawal by Subject|0|||
124564576|NCT01579474|448024192|FG004|Overall Study|Withdrawal by Subject|0|||
124564577|NCT01579474|448024193|FG005|Overall Study|Withdrawal by Subject|0|||
124564578|NCT00130520|448024194|FG000|Overall Study|Adverse Event|11|||
124564579|NCT00130520|448024194|FG000|Overall Study|Death|1|||
124564580|NCT00130520|448024194|FG000|Overall Study|Physician Decision|1|||
124564581|NCT00130520|448024194|FG000|Overall Study|Withdrawal by Subject|1|||
124564582|NCT00130520|448024194|FG000|Overall Study|Disease Progression|23|||
124564583|NCT00130520|448024194|FG000|Overall Study|Protocol non-compliance|1|||
124564584|NCT00130520|448024194|FG000|Overall Study|Did not meet re-treatment criteria|1|||
124564585|NCT02688400|448024196|FG000|Overall Study|Protocol Violation|2|||
124564586|NCT02688400|448024197|FG001|Overall Study|Protocol Violation|5|||
124564587|NCT02688400|448024196|FG000|Overall Study|Lack of Efficacy|7|||
124564588|NCT02688400|448024197|FG001|Overall Study|Lack of Efficacy|7|||
124564589|NCT02688400|448024196|FG000|Overall Study|Adverse Event|21|||
124564590|NCT02688400|448024197|FG001|Overall Study|Adverse Event|12|||
124564591|NCT02688400|448024196|FG000|Overall Study|Withdrawal by Subject|15|||
124564592|NCT02688400|448024197|FG001|Overall Study|Withdrawal by Subject|13|||
124564593|NCT02688400|448024196|FG000|Overall Study|No study medication intake|1|||
124564594|NCT02688400|448024197|FG001|Overall Study|No study medication intake|4|||
124564595|NCT02688400|448024196|FG000|Overall Study|Lost to Follow-up|0|||
124564596|NCT02688400|448024197|FG001|Overall Study|Lost to Follow-up|3|||
124564597|NCT02295774|448024199|FG000|Overall Study|Physician Decision|1|||
124564598|NCT02295774|448024199|FG000|Overall Study|Withdrawal by Subject|2|||
124564599|NCT01075763|448024200|FG000|Overall Study|Lost to Follow-up|2|||
124564600|NCT01075763|448024201|FG001|Overall Study|Lost to Follow-up|1|||
124564601|NCT01075763|448024200|FG000|Overall Study|Lack of Efficacy|0|||
124564602|NCT01075763|448024201|FG001|Overall Study|Lack of Efficacy|1|||
124776683|NCT00998296|448809946|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
124564603|NCT01075763|448024200|FG000|Overall Study|Withdrawal by Subject|2|||
124564604|NCT01075763|448024201|FG001|Overall Study|Withdrawal by Subject|2|||
124564605|NCT00586521|448024202|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
124564606|NCT03083483|448024212|FG000|Overall Study|Adverse Event|1|||
124564607|NCT03083483|448024213|FG001|Overall Study|Adverse Event|1|||
124564608|NCT03083483|448024214|FG002|Overall Study|Adverse Event|1|||
124564609|NCT03083483|448024212|FG000|Overall Study|Lost to Follow-up|2|||
124564610|NCT03083483|448024213|FG001|Overall Study|Lost to Follow-up|1|||
124564611|NCT03083483|448024214|FG002|Overall Study|Lost to Follow-up|1|||
124564612|NCT03083483|448024212|FG000|Overall Study|technological issues|1|||
124564613|NCT03083483|448024213|FG001|Overall Study|technological issues|0|||
124564614|NCT03083483|448024214|FG002|Overall Study|technological issues|1|||
124509177|NCT01021852|447815747|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
124509178|NCT01021852|447815748|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
124509179|NCT01021852|447815749|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
124509180|NCT01021852|447815750|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
124509181|NCT01021852|447815751|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
124509182|NCT01021852|447815752|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
124564615|NCT03731182|448024217|FG000|Overall Study|Lost to Follow-up|2|||
124564616|NCT03731182|448024218|FG001|Overall Study|Lost to Follow-up|0|||
124564617|NCT03731182|448024217|FG000|Overall Study|Physician Decision|1|||
124564618|NCT03731182|448024218|FG001|Overall Study|Physician Decision|0|||
124564619|NCT03731182|448024217|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
124564620|NCT03731182|448024218|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
124564621|NCT02006706|448024219|FG000|Overall Study|Lost to Follow-up|1|||
124564622|NCT00582036|448024220|FG000|Overall Study|Withdrawal by Subject|0|||
124564623|NCT00582036|448024221|FG001|Overall Study|Withdrawal by Subject|1|||
124564624|NCT01673009|448024222|FG000|Overall Study|Physician Decision|5|||
124564625|NCT01673009|448024222|FG000|Overall Study|Withdrawal by Subject|8|||
124564626|NCT04161144|448024224|FG000|Overall Study|Withdrawal by Subject|0|||
124564627|NCT04161144|448024225|FG001|Overall Study|Withdrawal by Subject|1|||
124564628|NCT04161144|448024224|FG000|Overall Study|Protocol Violation|1|||
124564629|NCT04161144|448024225|FG001|Overall Study|Protocol Violation|0|||
124564630|NCT00958256|448024226|FG000|Overall Study|Adverse Event|3|||
124564631|NCT01000337|448024233|FG000|Overall Study|Lost to Follow-up|4|||
124564632|NCT01000337|448024234|FG001|Overall Study|Lost to Follow-up|3|||
124564633|NCT01612000|448024235|FG000|Overall Study|Lost to Follow-up|6|||
124564634|NCT01612000|448024236|FG001|Overall Study|Lost to Follow-up|4|||
124509183|NCT01021852|447815753|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
124509184|NCT01021852|447815754|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
124509185|NCT01021852|447815747|FG000|Washout Period-Placebo|Protocol Violation|0|||
124509186|NCT01021852|447815748|FG001|Washout Period-Placebo|Protocol Violation|0|||
124509187|NCT01021852|447815749|FG002|Washout Period-Placebo|Protocol Violation|0|||
124509188|NCT01021852|447815750|FG003|Washout Period-Placebo|Protocol Violation|0|||
124509189|NCT01021852|447815751|FG004|Washout Period-Placebo|Protocol Violation|0|||
124509190|NCT01021852|447815752|FG005|Washout Period-Placebo|Protocol Violation|0|||
124509191|NCT01021852|447815753|FG006|Washout Period-Placebo|Protocol Violation|1|||
124509192|NCT01021852|447815754|FG007|Washout Period-Placebo|Protocol Violation|0|||
124509193|NCT01021852|447815747|FG000|Washout Period-No Drug|Adverse Event|1|||
124509194|NCT01021852|447815748|FG001|Washout Period-No Drug|Adverse Event|0|||
124509195|NCT01021852|447815749|FG002|Washout Period-No Drug|Adverse Event|0|||
124509196|NCT01021852|447815750|FG003|Washout Period-No Drug|Adverse Event|0|||
124509197|NCT01021852|447815751|FG004|Washout Period-No Drug|Adverse Event|0|||
124509198|NCT01021852|447815752|FG005|Washout Period-No Drug|Adverse Event|1|||
124509199|NCT01021852|447815753|FG006|Washout Period-No Drug|Adverse Event|0|||
124509200|NCT01021852|447815754|FG007|Washout Period-No Drug|Adverse Event|0|||
124509201|NCT01021852|447815747|FG000|Treatment Period 2|Adverse Event|0|||
124509202|NCT01021852|447815748|FG001|Treatment Period 2|Adverse Event|1|||
124509203|NCT01021852|447815749|FG002|Treatment Period 2|Adverse Event|0|||
124509204|NCT01021852|447815750|FG003|Treatment Period 2|Adverse Event|0|||
124564635|NCT01612000|448024237|FG002|Overall Study|Lost to Follow-up|4|||
124564636|NCT01612000|448024238|FG003|Overall Study|Lost to Follow-up|8|||
124564637|NCT01612000|448024235|FG000|Overall Study|Physician Decision|0|||
124509205|NCT01021852|447815751|FG004|Treatment Period 2|Adverse Event|1|||
124564638|NCT01612000|448024236|FG001|Overall Study|Physician Decision|0|||
124564639|NCT01612000|448024237|FG002|Overall Study|Physician Decision|1|||
124564640|NCT01612000|448024238|FG003|Overall Study|Physician Decision|0|||
124509206|NCT01021852|447815752|FG005|Treatment Period 2|Adverse Event|0|||
124509207|NCT01021852|447815753|FG006|Treatment Period 2|Adverse Event|1|||
124509208|NCT01021852|447815754|FG007|Treatment Period 2|Adverse Event|0|||
124509209|NCT01021852|447815747|FG000|Treatment Period 2|Lack of Efficacy|0|||
124509210|NCT01021852|447815748|FG001|Treatment Period 2|Lack of Efficacy|0|||
124509211|NCT01021852|447815749|FG002|Treatment Period 2|Lack of Efficacy|0|||
124564641|NCT01612000|448024235|FG000|Overall Study|Withdrawal by Subject|3|||
124564642|NCT01612000|448024236|FG001|Overall Study|Withdrawal by Subject|1|||
124564643|NCT01612000|448024237|FG002|Overall Study|Withdrawal by Subject|2|||
124564644|NCT01612000|448024238|FG003|Overall Study|Withdrawal by Subject|2|||
124509212|NCT01021852|447815750|FG003|Treatment Period 2|Lack of Efficacy|0|||
124509213|NCT01021852|447815751|FG004|Treatment Period 2|Lack of Efficacy|0|||
124509214|NCT01021852|447815752|FG005|Treatment Period 2|Lack of Efficacy|1|||
124509215|NCT01021852|447815753|FG006|Treatment Period 2|Lack of Efficacy|0|||
124509216|NCT01021852|447815754|FG007|Treatment Period 2|Lack of Efficacy|0|||
124509217|NCT01021852|447815747|FG000|Treatment Period 2|Physician Decision|0|||
124509218|NCT01021852|447815748|FG001|Treatment Period 2|Physician Decision|0|||
124509219|NCT01021852|447815749|FG002|Treatment Period 2|Physician Decision|1|||
124509220|NCT01021852|447815750|FG003|Treatment Period 2|Physician Decision|0|||
124509221|NCT01021852|447815751|FG004|Treatment Period 2|Physician Decision|0|||
124509222|NCT01021852|447815752|FG005|Treatment Period 2|Physician Decision|0|||
124509223|NCT01021852|447815753|FG006|Treatment Period 2|Physician Decision|0|||
124509224|NCT01021852|447815754|FG007|Treatment Period 2|Physician Decision|0|||
124509225|NCT01021852|447815747|FG000|Treatment Period 2|Protocol Violation|0|||
124509226|NCT01021852|447815748|FG001|Treatment Period 2|Protocol Violation|0|||
124509227|NCT01021852|447815749|FG002|Treatment Period 2|Protocol Violation|0|||
124509228|NCT01021852|447815750|FG003|Treatment Period 2|Protocol Violation|0|||
124509229|NCT01021852|447815751|FG004|Treatment Period 2|Protocol Violation|1|||
124509230|NCT01021852|447815752|FG005|Treatment Period 2|Protocol Violation|0|||
124509231|NCT01021852|447815753|FG006|Treatment Period 2|Protocol Violation|1|||
124509232|NCT01021852|447815754|FG007|Treatment Period 2|Protocol Violation|0|||
124509233|NCT01021852|447815747|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124509234|NCT01021852|447815748|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124509235|NCT01021852|447815749|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124509236|NCT01021852|447815750|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124509237|NCT01021852|447815751|FG004|Treatment Period 2|Withdrawal by Subject|0|||
124509238|NCT01021852|447815752|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124509239|NCT01021852|447815753|FG006|Treatment Period 2|Withdrawal by Subject|1|||
124509240|NCT01021852|447815754|FG007|Treatment Period 2|Withdrawal by Subject|2|||
124509241|NCT02802878|447815759|FG000|Overall Study|Withdrawal by Subject|3|||
124509242|NCT02802878|447815760|FG001|Overall Study|Withdrawal by Subject|3|||
124509243|NCT02802878|447815759|FG000|Overall Study|Protocol Violation|1|||
124509244|NCT02802878|447815760|FG001|Overall Study|Protocol Violation|0|||
124509245|NCT00536978|447815761|FG000|Overall Study|Not eligible for Adback Infusion|22|||
124509246|NCT03550131|447815762|FG000|Overall Study|Lost to Follow-up|16|||
124509247|NCT03550131|447815763|FG001|Overall Study|Lost to Follow-up|24|||
124509248|NCT03550131|447815762|FG000|Overall Study|Withdrawal by Subject|36|||
124509249|NCT03550131|447815763|FG001|Overall Study|Withdrawal by Subject|28|||
124509250|NCT03550131|447815762|FG000|Overall Study|Illness of dyad member|10|||
124509251|NCT03550131|447815763|FG001|Overall Study|Illness of dyad member|2|||
124509252|NCT03550131|447815762|FG000|Overall Study|Death of person with dementia|4|||
124509253|NCT03550131|447815763|FG001|Overall Study|Death of person with dementia|8|||
124509254|NCT00717366|447815764|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
124509255|NCT00717366|447815765|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
124509256|NCT00717366|447815764|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
124509257|NCT00717366|447815765|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
124509258|NCT00717366|447815764|FG000|Core Study Period (20 Weeks)|Death|0|||
124509259|NCT00717366|447815765|FG001|Core Study Period (20 Weeks)|Death|1|||
124509260|NCT00717366|447815764|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
124509261|NCT00717366|447815765|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
124509262|NCT00717366|447815764|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
124509263|NCT00717366|447815765|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
124509264|NCT00717366|447815764|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
124509265|NCT00717366|447815765|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
124509266|NCT00717366|447815764|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
124509267|NCT00717366|447815765|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
124509268|NCT01364233|447815769|FG000|Overall Study|Lost to Follow-up|1|||
124509269|NCT00438399|447815770|FG000|Overall Study|Lost to Follow-up|2|||
124509270|NCT00438399|447815771|FG001|Overall Study|Lost to Follow-up|2|||
124509271|NCT00438399|447815772|FG002|Overall Study|Lost to Follow-up|1|||
124509272|NCT00438399|447815773|FG003|Overall Study|Lost to Follow-up|1|||
124509273|NCT00438399|447815774|FG004|Overall Study|Lost to Follow-up|1|||
124509274|NCT00438399|447815775|FG005|Overall Study|Lost to Follow-up|1|||
124509275|NCT00438399|447815770|FG000|Overall Study|Adverse Event|0|||
124509276|NCT00438399|447815771|FG001|Overall Study|Adverse Event|0|||
124509277|NCT00438399|447815772|FG002|Overall Study|Adverse Event|1|||
124509278|NCT00438399|447815773|FG003|Overall Study|Adverse Event|1|||
124509279|NCT00438399|447815774|FG004|Overall Study|Adverse Event|0|||
124509280|NCT00438399|447815775|FG005|Overall Study|Adverse Event|1|||
124509281|NCT00438399|447815770|FG000|Overall Study|Withdrawal by Subject|5|||
124509282|NCT00438399|447815771|FG001|Overall Study|Withdrawal by Subject|6|||
124509283|NCT00438399|447815772|FG002|Overall Study|Withdrawal by Subject|3|||
124509284|NCT00438399|447815773|FG003|Overall Study|Withdrawal by Subject|2|||
124509285|NCT00438399|447815774|FG004|Overall Study|Withdrawal by Subject|2|||
124509286|NCT00438399|447815775|FG005|Overall Study|Withdrawal by Subject|2|||
124564645|NCT02173704|448024240|FG000|Overall Study|Adverse Event|1|||
124564646|NCT02173704|448024241|FG001|Overall Study|Adverse Event|0|||
124564647|NCT02173704|448024240|FG000|Overall Study|Lost to Follow-up|1|||
124564648|NCT02173704|448024241|FG001|Overall Study|Lost to Follow-up|0|||
124564649|NCT02173704|448024240|FG000|Overall Study|Other|1|||
124564650|NCT02173704|448024241|FG001|Overall Study|Other|0|||
124564651|NCT02173704|448024240|FG000|Overall Study|Protocol Violation|1|||
124564652|NCT02173704|448024241|FG001|Overall Study|Protocol Violation|0|||
124564653|NCT02173704|448024240|FG000|Overall Study|Withdrawal by Subject|9|||
124564654|NCT02173704|448024241|FG001|Overall Study|Withdrawal by Subject|4|||
124564655|NCT00419926|448024242|FG000|Overall Study|Withdrawal by Subject|7|||
124564656|NCT00419926|448024243|FG001|Overall Study|Withdrawal by Subject|3|||
124564657|NCT00419926|448024242|FG000|Overall Study|Administrative Problem|4|||
124564658|NCT00419926|448024243|FG001|Overall Study|Administrative Problem|4|||
124564659|NCT00419926|448024242|FG000|Overall Study|Lost to Follow-up|1|||
124564660|NCT00419926|448024243|FG001|Overall Study|Lost to Follow-up|2|||
124564661|NCT00419926|448024242|FG000|Overall Study|Death|2|||
124564662|NCT00419926|448024243|FG001|Overall Study|Death|1|||
124564663|NCT02374918|448024250|FG000|Overall Study|Protocol Violation|2|||
124564664|NCT02374918|448024251|FG001|Overall Study|Protocol Violation|0|||
124564665|NCT02374918|448024252|FG002|Overall Study|Protocol Violation|2|||
124564666|NCT02374918|448024253|FG003|Overall Study|Protocol Violation|1|||
124564667|NCT02374918|448024250|FG000|Overall Study|Withdrawal by Subject|1|||
124564668|NCT02374918|448024251|FG001|Overall Study|Withdrawal by Subject|1|||
124564669|NCT02374918|448024252|FG002|Overall Study|Withdrawal by Subject|1|||
124564670|NCT02374918|448024253|FG003|Overall Study|Withdrawal by Subject|0|||
124564671|NCT02374918|448024250|FG000|Overall Study|Lack of Efficacy|0|||
124564672|NCT02374918|448024251|FG001|Overall Study|Lack of Efficacy|0|||
124564673|NCT02374918|448024252|FG002|Overall Study|Lack of Efficacy|1|||
124564674|NCT02374918|448024253|FG003|Overall Study|Lack of Efficacy|1|||
124564675|NCT01180244|448024254|FG000|Overall Study|Lack of Efficacy|0|||
124564676|NCT01180244|448024255|FG001|Overall Study|Lack of Efficacy|7|||
124564677|NCT01180244|448024254|FG000|Overall Study|Physician Decision|3|||
124564678|NCT01180244|448024255|FG001|Overall Study|Physician Decision|0|||
124564679|NCT01180244|448024254|FG000|Overall Study|Adverse Event|1|||
124564680|NCT01180244|448024255|FG001|Overall Study|Adverse Event|0|||
124564681|NCT01180244|448024254|FG000|Overall Study|Withdrawal by Subject|0|||
124564682|NCT01180244|448024255|FG001|Overall Study|Withdrawal by Subject|1|||
124564683|NCT01180244|448024254|FG000|Overall Study|Protocol Violation|1|||
124564684|NCT01180244|448024255|FG001|Overall Study|Protocol Violation|0|||
124564685|NCT01180244|448024254|FG000|Overall Study|Lost to Follow-up|1|||
124564686|NCT01180244|448024255|FG001|Overall Study|Lost to Follow-up|0|||
124564687|NCT00729859|448024256|FG000|Overall Study|Adverse Event|0|||
124564688|NCT00729859|448024257|FG001|Overall Study|Adverse Event|1|||
124564689|NCT00729859|448024258|FG002|Overall Study|Adverse Event|0|||
124564690|NCT00729859|448024256|FG000|Overall Study|Withdrawal by Subject|0|||
124564691|NCT00729859|448024257|FG001|Overall Study|Withdrawal by Subject|1|||
124564692|NCT00729859|448024258|FG002|Overall Study|Withdrawal by Subject|0|||
124564693|NCT02623829|448024259|FG000|Overall Study|Lost to Follow-up|1|||
124564694|NCT02623829|448024260|FG001|Overall Study|Lost to Follow-up|1|||
124564695|NCT00760383|448024261|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
124564696|NCT00760383|448024262|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
124564697|NCT03937466|448024264|FG000|Overall Study|not eligbile after the 2-week diary|9|||
124564698|NCT03937466|448024264|FG000|Overall Study|never returned their diary|6|||
124564699|NCT03937466|448024264|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
124564700|NCT03937466|448024264|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
124564701|NCT00622908|448024265|FG000|Overall Study|Protocol Violation|1|||
124564702|NCT00622908|448024266|FG001|Overall Study|Protocol Violation|0|||
124564703|NCT00622908|448024265|FG000|Overall Study|Adverse Event|0|||
124564704|NCT00622908|448024266|FG001|Overall Study|Adverse Event|1|||
124564705|NCT00622908|448024265|FG000|Overall Study|Lack of Efficacy|1|||
124564706|NCT00622908|448024266|FG001|Overall Study|Lack of Efficacy|7|||
124564707|NCT00622908|448024265|FG000|Overall Study|Lost to Follow-up|1|||
124564708|NCT00622908|448024266|FG001|Overall Study|Lost to Follow-up|0|||
124564709|NCT00622908|448024265|FG000|Overall Study|Refusal|0|||
124564710|NCT00622908|448024266|FG001|Overall Study|Refusal|1|||
124564711|NCT00622908|448024265|FG000|Overall Study|Termination by study sponser|0|||
124564712|NCT00622908|448024266|FG001|Overall Study|Termination by study sponser|1|||
124564713|NCT00113490|448024267|FG000|Overall Study|Withdrawal by Subject|1|||
124564714|NCT00113490|448024268|FG001|Overall Study|Withdrawal by Subject|3|||
124564715|NCT00113490|448024267|FG000|Overall Study|Lost to Follow-up|1|||
124564716|NCT00113490|448024268|FG001|Overall Study|Lost to Follow-up|0|||
124564717|NCT02162758|448024269|FG000|Overall Study|Study termination|0|||
124564718|NCT02162758|448024270|FG001|Overall Study|Study termination|1|||
124564719|NCT01659567|448024271|FG000|Overall Study|Lack of Efficacy|22|||
124564720|NCT01659567|448024271|FG000|Overall Study|Switched to Pegferon|6|||
124564721|NCT01659567|448024271|FG000|Overall Study|Adverse Event|12|||
124564722|NCT01659567|448024271|FG000|Overall Study|Good result at early stage of treatment|5|||
124509287|NCT00438399|447815770|FG000|Overall Study|Protocol Violation|0|||
124509288|NCT00438399|447815771|FG001|Overall Study|Protocol Violation|0|||
124509289|NCT00438399|447815772|FG002|Overall Study|Protocol Violation|1|||
124509290|NCT00438399|447815773|FG003|Overall Study|Protocol Violation|0|||
124509291|NCT00438399|447815774|FG004|Overall Study|Protocol Violation|0|||
124509292|NCT00438399|447815775|FG005|Overall Study|Protocol Violation|1|||
124509293|NCT00438399|447815770|FG000|Overall Study|Subje stopped study|0|||
124509294|NCT00438399|447815771|FG001|Overall Study|Subje stopped study|0|||
124509295|NCT00438399|447815772|FG002|Overall Study|Subje stopped study|1|||
124509296|NCT00438399|447815773|FG003|Overall Study|Subje stopped study|0|||
124509297|NCT00438399|447815774|FG004|Overall Study|Subje stopped study|0|||
124509298|NCT00438399|447815775|FG005|Overall Study|Subje stopped study|0|||
124509299|NCT00438399|447815770|FG000|Overall Study|Pregnancy|0|||
124509300|NCT00438399|447815771|FG001|Overall Study|Pregnancy|0|||
124509301|NCT00438399|447815772|FG002|Overall Study|Pregnancy|0|||
124509302|NCT00438399|447815773|FG003|Overall Study|Pregnancy|0|||
124509303|NCT00438399|447815774|FG004|Overall Study|Pregnancy|0|||
124509304|NCT00438399|447815775|FG005|Overall Study|Pregnancy|1|||
124509305|NCT00438399|447815770|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
124509306|NCT00438399|447815771|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
124509307|NCT00438399|447815772|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
124509308|NCT00438399|447815773|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
124509309|NCT00438399|447815774|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
124509310|NCT00438399|447815775|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
124509311|NCT00878215|447815776|FG000|Overall Study|Determined to be ineligible|0|||
124509312|NCT00878215|447815777|FG001|Overall Study|Determined to be ineligible|10|||
124509313|NCT00878215|447815778|FG002|Overall Study|Determined to be ineligible|0|||
124509314|NCT00878215|447815779|FG003|Overall Study|Determined to be ineligible|0|||
124509315|NCT00302718|447815783|FG000|Overall Study|Participant left the hospital|1|||
124509316|NCT00302718|447815784|FG001|Overall Study|Participant left the hospital|0|||
124509317|NCT00302718|447815785|FG002|Overall Study|Participant left the hospital|0|||
124509318|NCT00302718|447815786|FG003|Overall Study|Participant left the hospital|1|||
124509319|NCT00302718|447815783|FG000|Overall Study|Withdrawal by Subject|0|||
124509320|NCT00302718|447815784|FG001|Overall Study|Withdrawal by Subject|1|||
124509321|NCT00302718|447815785|FG002|Overall Study|Withdrawal by Subject|0|||
124509322|NCT00302718|447815786|FG003|Overall Study|Withdrawal by Subject|0|||
124509323|NCT00302718|447815783|FG000|Overall Study|Participant left primary care setting|0|||
124509324|NCT00302718|447815784|FG001|Overall Study|Participant left primary care setting|0|||
124509325|NCT00302718|447815785|FG002|Overall Study|Participant left primary care setting|2|||
124509326|NCT00302718|447815786|FG003|Overall Study|Participant left primary care setting|1|||
124509327|NCT00819585|447815787|FG000|Core Study|Adverse Event|2|||
124509328|NCT00819585|447815788|FG001|Core Study|Adverse Event|1|||
124509329|NCT00819585|447815789|FG002|Core Study|Adverse Event|1|||
124509330|NCT00819585|447815790|FG003|Core Study|Adverse Event|4|||
124509331|NCT00819585|447815791|FG004|Core Study|Adverse Event|1|||
124509332|NCT00819585|447815792|FG005|Core Study|Adverse Event|0|||
124509333|NCT00819585|447815793|FG006|Core Study|Adverse Event|2|||
124509334|NCT00819585|447815794|FG007|Core Study|Adverse Event|0|||
124509335|NCT00819585|447815795|FG008|Core Study|Adverse Event|0|||
124509336|NCT00819585|447815796|FG009|Core Study|Adverse Event|0|||
124509337|NCT00819585|447815797|FG010|Core Study|Adverse Event|0|||
124509338|NCT00819585|447815787|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
124509339|NCT00819585|447815788|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
124509340|NCT00819585|447815789|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
124509341|NCT00819585|447815790|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
124509342|NCT00819585|447815791|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
124509343|NCT00819585|447815792|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
124509344|NCT00819585|447815793|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
124509345|NCT00819585|447815794|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
124509346|NCT00819585|447815795|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
124509347|NCT00819585|447815796|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
124509348|NCT00819585|447815797|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
124509349|NCT00819585|447815787|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
124509350|NCT00819585|447815788|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
124509351|NCT00819585|447815789|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
124509352|NCT00819585|447815790|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
124509353|NCT00819585|447815791|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
124509354|NCT00819585|447815792|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
124509355|NCT00819585|447815793|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
124509356|NCT00819585|447815794|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
124509357|NCT00819585|447815795|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
124509358|NCT00819585|447815796|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
124509359|NCT00819585|447815797|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
124509360|NCT00819585|447815787|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
124509361|NCT00819585|447815788|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
124509362|NCT00819585|447815789|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
124564723|NCT01659567|448024271|FG000|Overall Study|Withdrawal by Subject|64|||
124564724|NCT01659567|448024271|FG000|Overall Study|Progression of the main disease|1|||
124564725|NCT01659567|448024271|FG000|Overall Study|Other|13|||
124564726|NCT03019965|448024272|FG000|Overall Study|Withdrawal by Subject|1|||
124564727|NCT03019965|448024273|FG001|Overall Study|Withdrawal by Subject|0|||
124564728|NCT03019965|448024272|FG000|Overall Study|Protocol Violation|1|||
124564729|NCT03019965|448024273|FG001|Overall Study|Protocol Violation|3|||
124564730|NCT03019965|448024272|FG000|Overall Study|viral or fungal infection|3|||
124564731|NCT03019965|448024273|FG001|Overall Study|viral or fungal infection|4|||
124564732|NCT03019965|448024272|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
124564733|NCT03019965|448024273|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
124564734|NCT03019965|448024272|FG000|Overall Study|Physician Decision|1|||
124564735|NCT03019965|448024273|FG001|Overall Study|Physician Decision|1|||
124564736|NCT03213210|448024274|FG000|Overall Study|Lost to Follow-up|2|||
124564737|NCT03213210|448024274|FG000|Overall Study|Study termination|3|||
124564738|NCT00708422|448024282|FG000|Overall Study|Adverse Event|3|||
124564739|NCT00708422|448024283|FG001|Overall Study|Adverse Event|1|||
124564740|NCT00708422|448024282|FG000|Overall Study|Withdrawal by Subject|1|||
124564741|NCT00708422|448024283|FG001|Overall Study|Withdrawal by Subject|0|||
124564742|NCT00299156|448024286|FG000|Period 2 (Randomized)|Screen Failure|0|||
124564743|NCT00299156|448024287|FG001|Period 2 (Randomized)|Screen Failure|1|||
124564744|NCT00299156|448024288|FG002|Period 2 (Randomized)|Screen Failure|0|||
124564745|NCT01166568|448024302|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
124564746|NCT01166568|448024303|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
124564747|NCT01166568|448024304|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
124564748|NCT01166568|448024302|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
124564749|NCT01166568|448024303|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
124564750|NCT01166568|448024304|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
124564751|NCT01166568|448024302|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
124564752|NCT01166568|448024303|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
124564753|NCT01166568|448024304|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
124564754|NCT01654380|448024305|FG000|Part B, Period 1|Physician Decision|0|||
124564755|NCT01654380|448024306|FG001|Part B, Period 1|Physician Decision|0|||
124564756|NCT01654380|448024307|FG002|Part B, Period 1|Physician Decision|1|||
124564757|NCT01654380|448024308|FG003|Part B, Period 1|Physician Decision|0|||
124564758|NCT03335371|448024309|FG000|Overall Study|Lost to Follow-up|0|||
124564759|NCT03335371|448024310|FG001|Overall Study|Lost to Follow-up|0|||
124564760|NCT03335371|448024311|FG002|Overall Study|Lost to Follow-up|0|||
124564761|NCT03335371|448024312|FG003|Overall Study|Lost to Follow-up|0|||
124564762|NCT03335371|448024313|FG004|Overall Study|Lost to Follow-up|1|||
124564763|NCT03335371|448024309|FG000|Overall Study|Withdrawal by Subject|0|||
124564764|NCT03335371|448024310|FG001|Overall Study|Withdrawal by Subject|0|||
124564765|NCT03335371|448024311|FG002|Overall Study|Withdrawal by Subject|0|||
124564766|NCT03335371|448024312|FG003|Overall Study|Withdrawal by Subject|0|||
124564767|NCT03335371|448024313|FG004|Overall Study|Withdrawal by Subject|1|||
124564768|NCT03335371|448024309|FG000|Overall Study|Randomization Error|0|||
124564769|NCT03335371|448024310|FG001|Overall Study|Randomization Error|0|||
124564770|NCT03335371|448024311|FG002|Overall Study|Randomization Error|1|||
124564771|NCT03335371|448024312|FG003|Overall Study|Randomization Error|0|||
124564772|NCT03335371|448024313|FG004|Overall Study|Randomization Error|0|||
124564773|NCT00684671|448024314|FG000|Overall Study|Adverse Event|1|||
124564774|NCT00684671|448024315|FG001|Overall Study|Adverse Event|0|||
124564775|NCT00684671|448024316|FG002|Overall Study|Adverse Event|0|||
124564776|NCT00684671|448024314|FG000|Overall Study|Lost to Follow-up|1|||
124564777|NCT00684671|448024315|FG001|Overall Study|Lost to Follow-up|0|||
124564778|NCT00684671|448024316|FG002|Overall Study|Lost to Follow-up|0|||
124564779|NCT00684671|448024314|FG000|Overall Study|Alcoholic dependance|1|||
124564780|NCT00684671|448024315|FG001|Overall Study|Alcoholic dependance|0|||
124564781|NCT00684671|448024316|FG002|Overall Study|Alcoholic dependance|0|||
124564782|NCT01725451|448024318|FG000|Period 1|Withdrawal by Subject|1|||
124564783|NCT01725451|448024319|FG001|Period 1|Withdrawal by Subject|0|||
124564784|NCT01725451|448024320|FG002|Period 1|Withdrawal by Subject|0|||
124564785|NCT01725451|448024321|FG003|Period 1|Withdrawal by Subject|0|||
124564786|NCT01725451|448024318|FG000|Washout From Period 3|Protocol Violation|0|||
124564787|NCT01725451|448024319|FG001|Washout From Period 3|Protocol Violation|0|||
124564788|NCT01725451|448024320|FG002|Washout From Period 3|Protocol Violation|1|||
124564789|NCT01725451|448024321|FG003|Washout From Period 3|Protocol Violation|0|||
124564790|NCT01725451|448024318|FG000|Washout From Period 3|Adverse Event|0|||
124564791|NCT01725451|448024319|FG001|Washout From Period 3|Adverse Event|1|||
124564792|NCT01725451|448024320|FG002|Washout From Period 3|Adverse Event|0|||
124564793|NCT01725451|448024321|FG003|Washout From Period 3|Adverse Event|0|||
124564794|NCT01725451|448024318|FG000|Period 4|Adverse Event|0|||
124564795|NCT01725451|448024319|FG001|Period 4|Adverse Event|0|||
124564796|NCT01725451|448024320|FG002|Period 4|Adverse Event|1|||
124564797|NCT01725451|448024321|FG003|Period 4|Adverse Event|0|||
124564798|NCT00437281|448024322|FG000|Overall Study|Adverse Event|0|||
124564799|NCT00437281|448024323|FG001|Overall Study|Adverse Event|0|||
124564800|NCT00437281|448024324|FG002|Overall Study|Adverse Event|0|||
124564801|NCT00437281|448024325|FG003|Overall Study|Adverse Event|1|||
124564802|NCT00437281|448024326|FG004|Overall Study|Adverse Event|0|||
124564803|NCT00437281|448024327|FG005|Overall Study|Adverse Event|1|||
124564804|NCT00437281|448024328|FG006|Overall Study|Adverse Event|0|||
124564805|NCT00437281|448024329|FG007|Overall Study|Adverse Event|0|||
124564806|NCT00437281|448024330|FG008|Overall Study|Adverse Event|0|||
124564807|NCT00437281|448024331|FG009|Overall Study|Adverse Event|1|||
124564808|NCT00437281|448024332|FG010|Overall Study|Adverse Event|0|||
124564809|NCT00437281|448024333|FG011|Overall Study|Adverse Event|0|||
124564810|NCT00437281|448024334|FG012|Overall Study|Adverse Event|0|||
124564811|NCT00437281|448024335|FG013|Overall Study|Adverse Event|1|||
124564812|NCT00437281|448024336|FG014|Overall Study|Adverse Event|1|||
124564813|NCT00437281|448024337|FG015|Overall Study|Adverse Event|0|||
124564814|NCT00437281|448024338|FG016|Overall Study|Adverse Event|0|||
124564815|NCT00437281|448024339|FG017|Overall Study|Adverse Event|0|||
124564816|NCT00437281|448024340|FG018|Overall Study|Adverse Event|1|||
124564817|NCT00437281|448024341|FG019|Overall Study|Adverse Event|0|||
124564818|NCT00437281|448024322|FG000|Overall Study|Lost to Follow-up|0|||
124564819|NCT00437281|448024323|FG001|Overall Study|Lost to Follow-up|0|||
124564820|NCT00437281|448024324|FG002|Overall Study|Lost to Follow-up|0|||
124564821|NCT00437281|448024325|FG003|Overall Study|Lost to Follow-up|0|||
124564822|NCT00437281|448024326|FG004|Overall Study|Lost to Follow-up|0|||
124564823|NCT00437281|448024327|FG005|Overall Study|Lost to Follow-up|0|||
124564824|NCT00437281|448024328|FG006|Overall Study|Lost to Follow-up|0|||
124564825|NCT00437281|448024329|FG007|Overall Study|Lost to Follow-up|0|||
124564826|NCT00437281|448024330|FG008|Overall Study|Lost to Follow-up|0|||
124564827|NCT00437281|448024331|FG009|Overall Study|Lost to Follow-up|0|||
124564828|NCT00437281|448024332|FG010|Overall Study|Lost to Follow-up|0|||
124564829|NCT00437281|448024333|FG011|Overall Study|Lost to Follow-up|0|||
124564830|NCT00437281|448024334|FG012|Overall Study|Lost to Follow-up|0|||
124564831|NCT00437281|448024335|FG013|Overall Study|Lost to Follow-up|0|||
124564832|NCT00437281|448024336|FG014|Overall Study|Lost to Follow-up|0|||
124564833|NCT00437281|448024337|FG015|Overall Study|Lost to Follow-up|0|||
124564834|NCT00437281|448024338|FG016|Overall Study|Lost to Follow-up|0|||
124564835|NCT00437281|448024339|FG017|Overall Study|Lost to Follow-up|0|||
124564836|NCT00437281|448024340|FG018|Overall Study|Lost to Follow-up|0|||
124564837|NCT00437281|448024341|FG019|Overall Study|Lost to Follow-up|1|||
124564838|NCT01656889|448024343|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
124564839|NCT01656889|448024344|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
124564840|NCT01656889|448024343|FG000|Treatment Period, 12 Weeks|Death|0|||
124564841|NCT01656889|448024344|FG001|Treatment Period, 12 Weeks|Death|1|||
124564842|NCT01656889|448024343|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
124564843|NCT01656889|448024344|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
124564844|NCT01656889|448024343|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
124564845|NCT01656889|448024344|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
124564846|NCT01656889|448024343|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
124564847|NCT01656889|448024344|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
124564848|NCT01656889|448024343|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
124564849|NCT01656889|448024344|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
124564850|NCT01656889|448024343|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
124564851|NCT01656889|448024344|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
124564852|NCT01656889|448024343|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
124564853|NCT01656889|448024344|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
124564854|NCT01656889|448024343|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
124564855|NCT01656889|448024344|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
124564856|NCT01656889|448024343|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
124564857|NCT01656889|448024344|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
124564858|NCT00423800|448024345|FG000|Overall Study|Protocol Violation|0|||
124564859|NCT00423800|448024346|FG001|Overall Study|Protocol Violation|1|||
124564860|NCT02178709|448025988|FG000|Overall Study|Adverse Event|5|||
124564861|NCT02178709|448025988|FG000|Overall Study|Death|2|||
124564862|NCT02178709|448025988|FG000|Overall Study|Withdrawal by Subject|2|||
124564863|NCT02178709|448025988|FG000|Overall Study|Physician Decision|2|||
124564864|NCT02178709|448025988|FG000|Overall Study|Disease Progression|5|||
124564865|NCT01241461|448025989|FG000|Overall Study|Progressive Disease|3|||
124564866|NCT01241461|448025990|FG001|Overall Study|Progressive Disease|6|||
124564867|NCT01379781|448025994|FG000|Overall Study|Lost to Follow-up|11|||
124564868|NCT01379781|448025995|FG001|Overall Study|Lost to Follow-up|8|||
124564869|NCT03329027|448025998|FG000|Overall Study|Lost to Follow-up|1|||
124564870|NCT03329027|448025999|FG001|Overall Study|Lost to Follow-up|0|||
124564871|NCT03329027|448026000|FG002|Overall Study|Lost to Follow-up|1|||
124564872|NCT03329027|448025998|FG000|Overall Study|Protocol Violation|9|||
124564873|NCT03329027|448025999|FG001|Overall Study|Protocol Violation|5|||
124564874|NCT03329027|448026000|FG002|Overall Study|Protocol Violation|7|||
124564875|NCT04849988|448026005|FG000|Overall Study|Lack of Efficacy|3|||
124564876|NCT04849988|448026006|FG001|Overall Study|Lack of Efficacy|4|||
124564877|NCT04849988|448026007|FG002|Overall Study|Lack of Efficacy|1|||
124564878|NCT04849988|448026008|FG003|Overall Study|Lack of Efficacy|4|||
124564879|NCT04849988|448026005|FG000|Overall Study|Other reasons|1|||
124564880|NCT04849988|448026006|FG001|Overall Study|Other reasons|2|||
124564881|NCT04849988|448026007|FG002|Overall Study|Other reasons|2|||
124564882|NCT04849988|448026008|FG003|Overall Study|Other reasons|1|||
124564883|NCT01052116|448026016|FG000|Overall Study|Lost to Follow-up|11|||
124564884|NCT01052116|448026017|FG001|Overall Study|Lost to Follow-up|17|||
124564885|NCT01052116|448026016|FG000|Overall Study|Withdrawal by Subject|3|||
124564886|NCT01052116|448026017|FG001|Overall Study|Withdrawal by Subject|6|||
124564887|NCT01052116|448026016|FG000|Overall Study|Spirometry not performed|0|||
124564888|NCT01052116|448026017|FG001|Overall Study|Spirometry not performed|4|||
124564889|NCT00836927|448026024|FG000|Overall Study|Progressive disease|2|||
124564890|NCT00836927|448026025|FG001|Overall Study|Progressive disease|0|||
124564891|NCT00836927|448026026|FG002|Overall Study|Progressive disease|0|||
124564892|NCT00836927|448026027|FG003|Overall Study|Progressive disease|1|||
124564893|NCT00836927|448026028|FG004|Overall Study|Progressive disease|1|||
124564894|NCT00836927|448026024|FG000|Overall Study|Withdrawal by Subject|1|||
124564895|NCT00836927|448026025|FG001|Overall Study|Withdrawal by Subject|0|||
124564896|NCT00836927|448026026|FG002|Overall Study|Withdrawal by Subject|0|||
124564897|NCT00836927|448026027|FG003|Overall Study|Withdrawal by Subject|0|||
124564898|NCT00836927|448026028|FG004|Overall Study|Withdrawal by Subject|0|||
124564899|NCT00614055|448026032|FG000|Overall Study|Adverse Event|1|||
124564900|NCT00614055|448026033|FG001|Overall Study|Adverse Event|0|||
124564901|NCT00614055|448026034|FG002|Overall Study|Adverse Event|0|||
124564902|NCT00614055|448026032|FG000|Overall Study|Protocol Violation|2|||
124564903|NCT00614055|448026033|FG001|Overall Study|Protocol Violation|2|||
124564904|NCT00614055|448026034|FG002|Overall Study|Protocol Violation|1|||
124564905|NCT00614055|448026032|FG000|Overall Study|Lack of Efficacy|0|||
124564906|NCT00614055|448026033|FG001|Overall Study|Lack of Efficacy|0|||
124564907|NCT00614055|448026034|FG002|Overall Study|Lack of Efficacy|2|||
124564908|NCT00614055|448026032|FG000|Overall Study|Unclassified|1|||
124564909|NCT00614055|448026033|FG001|Overall Study|Unclassified|4|||
124564910|NCT00614055|448026034|FG002|Overall Study|Unclassified|2|||
124564911|NCT03036579|448026043|FG000|2 Years|Lost to Follow-up|1|||
124564912|NCT03036579|448026044|FG001|2 Years|Lost to Follow-up|0|||
124564913|NCT03036579|448026043|FG000|3 Years|Lost to Follow-up|0|||
124564914|NCT03036579|448026044|FG001|3 Years|Lost to Follow-up|1|||
124564915|NCT02848599|448026045|FG000|Overall Study|Protocol Violation|7|||
124564916|NCT02848599|448026046|FG001|Overall Study|Protocol Violation|9|||
124564917|NCT02352337|448026047|FG000|Overall Study|Patients never treated|4|||
124564918|NCT02352337|448026048|FG001|Overall Study|Patients never treated|1|||
124564919|NCT02352337|448026049|FG002|Overall Study|Patients never treated|2|||
124564920|NCT00992407|448026052|FG000|Overall Study|Protocol Violation|2|||
124564921|NCT00992407|448026053|FG001|Overall Study|Protocol Violation|1|||
124564922|NCT00992407|448026052|FG000|Overall Study|Lost to Follow-up|3|||
124564923|NCT00992407|448026053|FG001|Overall Study|Lost to Follow-up|3|||
124564924|NCT00992407|448026052|FG000|Overall Study|Adverse Event|3|||
124564925|NCT00992407|448026053|FG001|Overall Study|Adverse Event|2|||
124564926|NCT00992407|448026052|FG000|Overall Study|protocol Violation & Adverse events|2|||
124564927|NCT00992407|448026053|FG001|Overall Study|protocol Violation & Adverse events|4|||
124564928|NCT00992407|448026052|FG000|Overall Study|Other|2|||
124564929|NCT00992407|448026053|FG001|Overall Study|Other|0|||
124564930|NCT00992407|448026052|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
124564931|NCT00992407|448026053|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
124564932|NCT00992407|448026052|FG000|Overall Study|Study medication not administered|17|||
124509363|NCT00819585|447815790|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
124509364|NCT00819585|447815791|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
124509365|NCT00819585|447815792|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
124509366|NCT00819585|447815793|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
124509367|NCT00819585|447815794|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
124509368|NCT00819585|447815795|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
124509369|NCT00819585|447815796|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
124509370|NCT00819585|447815797|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
124509371|NCT00819585|447815787|FG000|Core Study|Subject Withdrew Consent|0|||
124509372|NCT00819585|447815788|FG001|Core Study|Subject Withdrew Consent|3|||
124509373|NCT00819585|447815789|FG002|Core Study|Subject Withdrew Consent|2|||
124509374|NCT00819585|447815790|FG003|Core Study|Subject Withdrew Consent|1|||
124509375|NCT00819585|447815791|FG004|Core Study|Subject Withdrew Consent|0|||
124509376|NCT00819585|447815792|FG005|Core Study|Subject Withdrew Consent|0|||
124509377|NCT00819585|447815793|FG006|Core Study|Subject Withdrew Consent|3|||
124509378|NCT00819585|447815794|FG007|Core Study|Subject Withdrew Consent|0|||
124564933|NCT00992407|448026053|FG001|Overall Study|Study medication not administered|13|||
124564934|NCT00782509|448026054|FG000|Overall Study|Adverse Event|20|||
124564935|NCT00782509|448026055|FG001|Overall Study|Adverse Event|10|||
124564936|NCT00782509|448026056|FG002|Overall Study|Adverse Event|20|||
124564937|NCT00782509|448026054|FG000|Overall Study|Lost to Follow-up|1|||
124564938|NCT00782509|448026055|FG001|Overall Study|Lost to Follow-up|2|||
124564939|NCT00782509|448026056|FG002|Overall Study|Lost to Follow-up|3|||
124564940|NCT00782509|448026054|FG000|Overall Study|Withdrawal by Subject|3|||
124564941|NCT00782509|448026055|FG001|Overall Study|Withdrawal by Subject|5|||
124564942|NCT00782509|448026056|FG002|Overall Study|Withdrawal by Subject|8|||
124564943|NCT00782509|448026054|FG000|Overall Study|Non compliance with protocol|2|||
124509379|NCT00819585|447815795|FG008|Core Study|Subject Withdrew Consent|0|||
124509380|NCT00819585|447815796|FG009|Core Study|Subject Withdrew Consent|0|||
124509381|NCT00819585|447815797|FG010|Core Study|Subject Withdrew Consent|0|||
124509382|NCT00819585|447815787|FG000|Core Study|Lost to Follow-up|2|||
124509383|NCT00819585|447815788|FG001|Core Study|Lost to Follow-up|1|||
124509384|NCT00819585|447815789|FG002|Core Study|Lost to Follow-up|2|||
124509385|NCT00819585|447815790|FG003|Core Study|Lost to Follow-up|0|||
124509386|NCT00819585|447815791|FG004|Core Study|Lost to Follow-up|1|||
124509387|NCT00819585|447815792|FG005|Core Study|Lost to Follow-up|1|||
124509388|NCT00819585|447815793|FG006|Core Study|Lost to Follow-up|1|||
124509389|NCT00819585|447815794|FG007|Core Study|Lost to Follow-up|0|||
124509390|NCT00819585|447815795|FG008|Core Study|Lost to Follow-up|0|||
124509391|NCT00819585|447815796|FG009|Core Study|Lost to Follow-up|0|||
124509392|NCT00819585|447815797|FG010|Core Study|Lost to Follow-up|0|||
124509393|NCT00819585|447815787|FG000|Core Study|Administrative Problems|0|||
124509394|NCT00819585|447815788|FG001|Core Study|Administrative Problems|0|||
124509395|NCT00819585|447815789|FG002|Core Study|Administrative Problems|0|||
124509396|NCT00819585|447815790|FG003|Core Study|Administrative Problems|0|||
124509397|NCT00819585|447815791|FG004|Core Study|Administrative Problems|0|||
124509398|NCT00819585|447815792|FG005|Core Study|Administrative Problems|0|||
124509399|NCT00819585|447815793|FG006|Core Study|Administrative Problems|2|||
124509400|NCT00819585|447815794|FG007|Core Study|Administrative Problems|0|||
124509401|NCT00819585|447815795|FG008|Core Study|Administrative Problems|0|||
124509402|NCT00819585|447815796|FG009|Core Study|Administrative Problems|0|||
124509403|NCT00819585|447815797|FG010|Core Study|Administrative Problems|0|||
124509404|NCT00819585|447815787|FG000|Core Study|Death|0|||
124509405|NCT00819585|447815788|FG001|Core Study|Death|0|||
124509406|NCT00819585|447815789|FG002|Core Study|Death|0|||
124509407|NCT00819585|447815790|FG003|Core Study|Death|0|||
124509408|NCT00819585|447815791|FG004|Core Study|Death|0|||
124509409|NCT00819585|447815792|FG005|Core Study|Death|0|||
124509410|NCT00819585|447815793|FG006|Core Study|Death|1|||
124509411|NCT00819585|447815794|FG007|Core Study|Death|0|||
124509412|NCT00819585|447815795|FG008|Core Study|Death|0|||
124509413|NCT00819585|447815796|FG009|Core Study|Death|0|||
124509414|NCT00819585|447815797|FG010|Core Study|Death|0|||
124509415|NCT00819585|447815787|FG000|Core Study|Protocol Violation|0|||
124509416|NCT00819585|447815788|FG001|Core Study|Protocol Violation|0|||
124509417|NCT00819585|447815789|FG002|Core Study|Protocol Violation|1|||
124509418|NCT00819585|447815790|FG003|Core Study|Protocol Violation|0|||
124509419|NCT00819585|447815791|FG004|Core Study|Protocol Violation|0|||
124509420|NCT00819585|447815792|FG005|Core Study|Protocol Violation|1|||
124509421|NCT00819585|447815793|FG006|Core Study|Protocol Violation|3|||
124509422|NCT00819585|447815794|FG007|Core Study|Protocol Violation|0|||
124509423|NCT00819585|447815795|FG008|Core Study|Protocol Violation|0|||
124509424|NCT00819585|447815796|FG009|Core Study|Protocol Violation|0|||
124509425|NCT00819585|447815797|FG010|Core Study|Protocol Violation|0|||
124509426|NCT00819585|447815787|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
124509427|NCT00819585|447815788|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
124509428|NCT00819585|447815789|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
124509429|NCT00819585|447815790|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
124509430|NCT00819585|447815791|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
124509431|NCT00819585|447815792|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
124509432|NCT00819585|447815793|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
124509433|NCT00819585|447815794|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
124564944|NCT00782509|448026055|FG001|Overall Study|Non compliance with protocol|0|||
124564945|NCT00782509|448026056|FG002|Overall Study|Non compliance with protocol|0|||
124564946|NCT00782509|448026054|FG000|Overall Study|Other reasons not stated above|5|||
124509434|NCT00819585|447815795|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
124509435|NCT00819585|447815796|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
124509436|NCT00819585|447815797|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
124509437|NCT00819585|447815787|FG000|Extension Study|Subject Withdrew Consent|0|||
124509438|NCT00819585|447815788|FG001|Extension Study|Subject Withdrew Consent|0|||
124509439|NCT00819585|447815789|FG002|Extension Study|Subject Withdrew Consent|0|||
124509440|NCT00819585|447815790|FG003|Extension Study|Subject Withdrew Consent|0|||
124509441|NCT00819585|447815791|FG004|Extension Study|Subject Withdrew Consent|0|||
124509442|NCT00819585|447815792|FG005|Extension Study|Subject Withdrew Consent|0|||
124509443|NCT00819585|447815793|FG006|Extension Study|Subject Withdrew Consent|0|||
124509444|NCT00819585|447815794|FG007|Extension Study|Subject Withdrew Consent|0|||
124509445|NCT00819585|447815795|FG008|Extension Study|Subject Withdrew Consent|3|||
124509446|NCT00819585|447815796|FG009|Extension Study|Subject Withdrew Consent|0|||
124509447|NCT00819585|447815797|FG010|Extension Study|Subject Withdrew Consent|1|||
124509448|NCT00819585|447815787|FG000|Extension Study|Lost to Follow-up|0|||
124564947|NCT00782509|448026055|FG001|Overall Study|Other reasons not stated above|2|||
124564948|NCT00782509|448026056|FG002|Overall Study|Other reasons not stated above|3|||
124564949|NCT00782509|448026054|FG000|Overall Study|Lack of Efficacy|10|||
124564950|NCT00782509|448026055|FG001|Overall Study|Lack of Efficacy|5|||
124564951|NCT00782509|448026056|FG002|Overall Study|Lack of Efficacy|2|||
124564952|NCT02398188|448026057|FG000|Overall Study|Adverse Event|2|||
124509449|NCT00819585|447815788|FG001|Extension Study|Lost to Follow-up|0|||
124509450|NCT00819585|447815789|FG002|Extension Study|Lost to Follow-up|0|||
124509451|NCT00819585|447815790|FG003|Extension Study|Lost to Follow-up|0|||
124509452|NCT00819585|447815791|FG004|Extension Study|Lost to Follow-up|0|||
124509453|NCT00819585|447815792|FG005|Extension Study|Lost to Follow-up|0|||
124509454|NCT00819585|447815793|FG006|Extension Study|Lost to Follow-up|0|||
124509455|NCT00819585|447815794|FG007|Extension Study|Lost to Follow-up|0|||
124509456|NCT00819585|447815795|FG008|Extension Study|Lost to Follow-up|2|||
124509457|NCT00819585|447815796|FG009|Extension Study|Lost to Follow-up|1|||
124509458|NCT00819585|447815797|FG010|Extension Study|Lost to Follow-up|1|||
124509459|NCT00819585|447815787|FG000|Extension Study|Death|0|||
124509460|NCT00819585|447815788|FG001|Extension Study|Death|0|||
124509461|NCT00819585|447815789|FG002|Extension Study|Death|0|||
124509462|NCT00819585|447815790|FG003|Extension Study|Death|0|||
124509463|NCT00819585|447815791|FG004|Extension Study|Death|0|||
124509464|NCT00819585|447815792|FG005|Extension Study|Death|0|||
124509465|NCT00819585|447815793|FG006|Extension Study|Death|0|||
124509466|NCT00819585|447815794|FG007|Extension Study|Death|0|||
124509467|NCT00819585|447815795|FG008|Extension Study|Death|2|||
124509468|NCT00819585|447815796|FG009|Extension Study|Death|0|||
124509469|NCT00819585|447815797|FG010|Extension Study|Death|0|||
124509470|NCT00738374|447815798|FG000|Induction Treatment Phase|Adverse Event|14|||
124509471|NCT00738374|447815799|FG001|Induction Treatment Phase|Adverse Event|0|||
124509472|NCT00738374|447815800|FG002|Induction Treatment Phase|Adverse Event|0|||
124509473|NCT00738374|447815801|FG003|Induction Treatment Phase|Adverse Event|0|||
124509474|NCT00738374|447815798|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
124509475|NCT00738374|447815799|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
124509476|NCT00738374|447815800|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
124509477|NCT00738374|447815801|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
124509478|NCT00738374|447815798|FG000|Induction Treatment Phase|Physician Decision|2|||
124509479|NCT00738374|447815799|FG001|Induction Treatment Phase|Physician Decision|0|||
124509480|NCT00738374|447815800|FG002|Induction Treatment Phase|Physician Decision|0|||
124509481|NCT00738374|447815801|FG003|Induction Treatment Phase|Physician Decision|0|||
124509482|NCT00738374|447815798|FG000|Induction Treatment Phase|Protocol Violation|2|||
124509483|NCT00738374|447815799|FG001|Induction Treatment Phase|Protocol Violation|0|||
124509484|NCT00738374|447815800|FG002|Induction Treatment Phase|Protocol Violation|0|||
124509485|NCT00738374|447815801|FG003|Induction Treatment Phase|Protocol Violation|0|||
124509486|NCT00738374|447815798|FG000|Induction Treatment Phase|Non-compliance|1|||
124509487|NCT00738374|447815799|FG001|Induction Treatment Phase|Non-compliance|0|||
124509488|NCT00738374|447815800|FG002|Induction Treatment Phase|Non-compliance|0|||
124509489|NCT00738374|447815801|FG003|Induction Treatment Phase|Non-compliance|0|||
124509490|NCT00738374|447815798|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
124509491|NCT00738374|447815799|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
124509492|NCT00738374|447815800|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
124509493|NCT00738374|447815801|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
124509494|NCT00738374|447815798|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
124509495|NCT00738374|447815799|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
124509496|NCT00738374|447815800|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
124509497|NCT00738374|447815801|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
124509498|NCT00738374|447815798|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
124509499|NCT00738374|447815799|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
124509500|NCT00738374|447815800|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
124509501|NCT00738374|447815801|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
124509502|NCT00738374|447815798|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
124509503|NCT00738374|447815799|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
124564953|NCT02398188|448026058|FG001|Overall Study|Adverse Event|3|||
124564954|NCT02398188|448026057|FG000|Overall Study|Lost to Follow-up|5|||
124564955|NCT02398188|448026058|FG001|Overall Study|Lost to Follow-up|0|||
124509504|NCT00738374|447815800|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
124509505|NCT00738374|447815801|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
124509506|NCT00738374|447815798|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
124509507|NCT00738374|447815799|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
124509508|NCT00738374|447815800|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
124564956|NCT02398188|448026057|FG000|Overall Study|Non-compliance|4|||
124564957|NCT02398188|448026058|FG001|Overall Study|Non-compliance|4|||
124509509|NCT00738374|447815801|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
124564958|NCT02398188|448026057|FG000|Overall Study|Protocol Violation|6|||
124564959|NCT02398188|448026058|FG001|Overall Study|Protocol Violation|10|||
124564960|NCT02398188|448026057|FG000|Overall Study|Sponsor Decision|2|||
124564961|NCT02398188|448026058|FG001|Overall Study|Sponsor Decision|1|||
124564962|NCT02398188|448026057|FG000|Overall Study|Pregnancy|1|||
124564963|NCT02398188|448026058|FG001|Overall Study|Pregnancy|0|||
124564964|NCT02398188|448026057|FG000|Overall Study|Withdrawal by Subject|7|||
124564965|NCT02398188|448026058|FG001|Overall Study|Withdrawal by Subject|16|||
124564966|NCT02918162|448026060|FG000|Overall Study|Withdrawal by Subject|1|||
124564967|NCT02918162|448026060|FG000|Overall Study|Omental Disease|1|||
124564968|NCT00395226|448026061|FG000|Overall Study|Adverse Event|4|||
124564969|NCT00395226|448026062|FG001|Overall Study|Adverse Event|3|||
124564970|NCT00395226|448026061|FG000|Overall Study|Withdrawal by Subject|0|||
124564971|NCT00395226|448026062|FG001|Overall Study|Withdrawal by Subject|1|||
124564972|NCT00395226|448026061|FG000|Overall Study|Lost to Follow-up|0|||
124564973|NCT00395226|448026062|FG001|Overall Study|Lost to Follow-up|1|||
124564974|NCT00282256|448026063|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
124564975|NCT00282256|448026063|FG000|Extension Treatment Period|Adverse Event|2|||
124564976|NCT01513148|448026071|FG000|Overall Study|Protocol Violation|2|||
124564977|NCT01513148|448026072|FG001|Overall Study|Protocol Violation|2|||
124564978|NCT04652453|448026073|FG000|Overall Study|Death|8|||
124564979|NCT04652453|448026074|FG001|Overall Study|Death|2|||
124564980|NCT04652453|448026075|FG002|Overall Study|Death|0|||
124564981|NCT04652453|448026073|FG000|Overall Study|Hospice|5|||
124564982|NCT04652453|448026074|FG001|Overall Study|Hospice|5|||
124564983|NCT04652453|448026075|FG002|Overall Study|Hospice|0|||
124564984|NCT04652453|448026073|FG000|Overall Study|Withdrawal by Subject|2|||
124564985|NCT04652453|448026074|FG001|Overall Study|Withdrawal by Subject|0|||
124564986|NCT04652453|448026075|FG002|Overall Study|Withdrawal by Subject|0|||
124564987|NCT00936975|448026079|FG000|Overall Study|Withdrawal by Subject|1|||
124564988|NCT00936975|448026079|FG000|Overall Study|Disease progression|3|||
124564989|NCT00936975|448026079|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
124564990|NCT00619385|448026080|FG000|Overall Study|Adverse Event|0|||
124564991|NCT00619385|448026081|FG001|Overall Study|Adverse Event|0|||
124564992|NCT00619385|448026082|FG002|Overall Study|Adverse Event|3|||
124564993|NCT00619385|448026080|FG000|Overall Study|Other|1|||
124564994|NCT00619385|448026081|FG001|Overall Study|Other|2|||
124564995|NCT00619385|448026082|FG002|Overall Study|Other|1|||
124564996|NCT02041702|448026085|FG000|Overall Study|Lost to Follow-up|1|||
124564997|NCT02041702|448026086|FG001|Overall Study|Lost to Follow-up|6|||
124564998|NCT02041702|448026085|FG000|Overall Study|Death|4|||
124564999|NCT02041702|448026086|FG001|Overall Study|Death|0|||
124565000|NCT02041702|448026085|FG000|Overall Study|Withdrawal by Subject|4|||
124565001|NCT02041702|448026086|FG001|Overall Study|Withdrawal by Subject|3|||
124565002|NCT02041702|448026085|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
124565003|NCT02041702|448026086|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
124565004|NCT02041702|448026085|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
124565005|NCT02041702|448026086|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
124509510|NCT00738374|447815798|FG000|Maintenance Treatment/Observation Phase|Other|0|||
124509511|NCT00738374|447815799|FG001|Maintenance Treatment/Observation Phase|Other|1|||
124509512|NCT00738374|447815800|FG002|Maintenance Treatment/Observation Phase|Other|0|||
124509513|NCT00738374|447815801|FG003|Maintenance Treatment/Observation Phase|Other|0|||
124509514|NCT03334396|447815802|FG000|Overall Study|Adverse Event|1|||
124509515|NCT03334396|447815803|FG001|Overall Study|Adverse Event|0|||
124509516|NCT03334396|447815804|FG002|Overall Study|Adverse Event|1|||
124509517|NCT03334396|447815805|FG003|Overall Study|Adverse Event|0|||
124509518|NCT03334396|447815806|FG004|Overall Study|Adverse Event|0|||
124509519|NCT03334396|447815807|FG005|Overall Study|Adverse Event|0|||
124509520|NCT03334396|447815808|FG006|Overall Study|Adverse Event|0|||
124509521|NCT03334396|447815809|FG007|Overall Study|Adverse Event|0|||
124509522|NCT03334396|447815802|FG000|Overall Study|Lack of Efficacy|10|||
124509523|NCT03334396|447815803|FG001|Overall Study|Lack of Efficacy|4|||
124509524|NCT03334396|447815804|FG002|Overall Study|Lack of Efficacy|1|||
124509525|NCT03334396|447815805|FG003|Overall Study|Lack of Efficacy|3|||
124509526|NCT03334396|447815806|FG004|Overall Study|Lack of Efficacy|1|||
124509527|NCT03334396|447815807|FG005|Overall Study|Lack of Efficacy|0|||
124509528|NCT03334396|447815808|FG006|Overall Study|Lack of Efficacy|0|||
124509529|NCT03334396|447815809|FG007|Overall Study|Lack of Efficacy|1|||
124565006|NCT00203307|448026087|FG000|First Intervention|Adverse Event|2|||
124565007|NCT00203307|448026088|FG001|First Intervention|Adverse Event|0|||
124565008|NCT03730103|448026089|FG000|Overall Study|Did not meet inclusion criteria|0|||
124509530|NCT03334396|447815802|FG000|Overall Study|Lost to Follow-up|0|||
124565009|NCT03730103|448026090|FG001|Overall Study|Did not meet inclusion criteria|5|||
124565010|NCT01488578|448026091|FG000|Overall Study|Protocol Violation|1836|||
124565011|NCT02308111|448026092|FG000|Overall Study|Adverse Event|31|||
124509531|NCT03334396|447815803|FG001|Overall Study|Lost to Follow-up|0|||
124509532|NCT03334396|447815804|FG002|Overall Study|Lost to Follow-up|1|||
124509533|NCT03334396|447815805|FG003|Overall Study|Lost to Follow-up|0|||
124565012|NCT02308111|448026093|FG001|Overall Study|Adverse Event|19|||
124724860|NCT03530995|448613335|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
124509534|NCT03334396|447815806|FG004|Overall Study|Lost to Follow-up|0|||
124509535|NCT03334396|447815807|FG005|Overall Study|Lost to Follow-up|0|||
124509536|NCT03334396|447815808|FG006|Overall Study|Lost to Follow-up|1|||
124509537|NCT03334396|447815809|FG007|Overall Study|Lost to Follow-up|0|||
124509538|NCT03334396|447815802|FG000|Overall Study|Physician Decision|1|||
124509539|NCT03334396|447815803|FG001|Overall Study|Physician Decision|0|||
124509540|NCT03334396|447815804|FG002|Overall Study|Physician Decision|0|||
124509541|NCT03334396|447815805|FG003|Overall Study|Physician Decision|0|||
124509542|NCT03334396|447815806|FG004|Overall Study|Physician Decision|0|||
124509543|NCT03334396|447815807|FG005|Overall Study|Physician Decision|0|||
124509544|NCT03334396|447815808|FG006|Overall Study|Physician Decision|0|||
124509545|NCT03334396|447815809|FG007|Overall Study|Physician Decision|0|||
124509546|NCT03334396|447815802|FG000|Overall Study|Withdrawal by Subject|10|||
124509547|NCT03334396|447815803|FG001|Overall Study|Withdrawal by Subject|5|||
124509548|NCT03334396|447815804|FG002|Overall Study|Withdrawal by Subject|7|||
124509549|NCT03334396|447815805|FG003|Overall Study|Withdrawal by Subject|2|||
124509550|NCT03334396|447815806|FG004|Overall Study|Withdrawal by Subject|2|||
124509551|NCT03334396|447815807|FG005|Overall Study|Withdrawal by Subject|1|||
124509552|NCT03334396|447815808|FG006|Overall Study|Withdrawal by Subject|2|||
124509553|NCT03334396|447815809|FG007|Overall Study|Withdrawal by Subject|0|||
124509554|NCT03334396|447815802|FG000|Overall Study|Pregnancy|0|||
124509555|NCT03334396|447815803|FG001|Overall Study|Pregnancy|1|||
124509556|NCT03334396|447815804|FG002|Overall Study|Pregnancy|0|||
124509557|NCT03334396|447815805|FG003|Overall Study|Pregnancy|0|||
124509558|NCT03334396|447815806|FG004|Overall Study|Pregnancy|0|||
124509559|NCT03334396|447815807|FG005|Overall Study|Pregnancy|0|||
124509560|NCT03334396|447815808|FG006|Overall Study|Pregnancy|0|||
124509561|NCT03334396|447815809|FG007|Overall Study|Pregnancy|0|||
124509562|NCT03334396|447815802|FG000|Overall Study|Ineligible|0|||
124509563|NCT03334396|447815803|FG001|Overall Study|Ineligible|1|||
124509564|NCT03334396|447815804|FG002|Overall Study|Ineligible|0|||
124509565|NCT03334396|447815805|FG003|Overall Study|Ineligible|0|||
124509566|NCT03334396|447815806|FG004|Overall Study|Ineligible|0|||
124509567|NCT03334396|447815807|FG005|Overall Study|Ineligible|0|||
124509568|NCT03334396|447815808|FG006|Overall Study|Ineligible|0|||
124509569|NCT03334396|447815809|FG007|Overall Study|Ineligible|0|||
124509570|NCT03334396|447815802|FG000|Overall Study|Started New Job|1|||
124509571|NCT03334396|447815803|FG001|Overall Study|Started New Job|0|||
124509572|NCT03334396|447815804|FG002|Overall Study|Started New Job|0|||
124509573|NCT03334396|447815805|FG003|Overall Study|Started New Job|0|||
124509574|NCT03334396|447815806|FG004|Overall Study|Started New Job|0|||
124509575|NCT03334396|447815807|FG005|Overall Study|Started New Job|0|||
124509576|NCT03334396|447815808|FG006|Overall Study|Started New Job|0|||
124509577|NCT03334396|447815809|FG007|Overall Study|Started New Job|0|||
124509578|NCT01969799|447815810|FG000|Overall Study|Adverse Event|0|||
124509579|NCT01969799|447815811|FG001|Overall Study|Adverse Event|1|||
124509580|NCT01969799|447815810|FG000|Overall Study|Death|16|||
124509581|NCT01969799|447815811|FG001|Overall Study|Death|11|||
124509582|NCT01969799|447815810|FG000|Overall Study|Lost to Follow-up|0|||
124509583|NCT01969799|447815811|FG001|Overall Study|Lost to Follow-up|2|||
124509584|NCT01969799|447815810|FG000|Overall Study|Physician Decision|1|||
124509585|NCT01969799|447815811|FG001|Overall Study|Physician Decision|0|||
124509586|NCT01244191|447815814|FG000|Overall Study|Progressive disease|295|||
124509587|NCT01244191|447815815|FG001|Overall Study|Progressive disease|350|||
124509588|NCT01244191|447815814|FG000|Overall Study|Clinical disease progression|54|||
124509589|NCT01244191|447815815|FG001|Overall Study|Clinical disease progression|36|||
124509590|NCT01244191|447815814|FG000|Overall Study|Adverse Event|65|||
124509591|NCT01244191|447815815|FG001|Overall Study|Adverse Event|48|||
124509592|NCT01244191|447815814|FG000|Overall Study|Death|22|||
124509593|NCT01244191|447815815|FG001|Overall Study|Death|29|||
124509594|NCT01244191|447815814|FG000|Overall Study|Lost to Follow-up|0|||
124509595|NCT01244191|447815815|FG001|Overall Study|Lost to Follow-up|2|||
124509596|NCT01244191|447815814|FG000|Overall Study|Protocol Violation|1|||
124509597|NCT01244191|447815815|FG001|Overall Study|Protocol Violation|2|||
124509598|NCT01244191|447815814|FG000|Overall Study|Withdrawal by Subject|31|||
124509599|NCT01244191|447815815|FG001|Overall Study|Withdrawal by Subject|23|||
124509600|NCT01244191|447815814|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
124509601|NCT01244191|447815815|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
124509602|NCT01255306|447817243|FG000|Overall Study|Physician Decision|1|||
124509603|NCT01255306|447817244|FG001|Overall Study|Physician Decision|1|||
124509604|NCT01283997|447817245|FG000|Overall Study|Physician Decision|8|||
124509605|NCT01283997|447817246|FG001|Overall Study|Physician Decision|10|||
124509606|NCT01283997|447817245|FG000|Overall Study|Withdrawal by Subject|3|||
124509607|NCT01283997|447817246|FG001|Overall Study|Withdrawal by Subject|2|||
124509608|NCT01283997|447817245|FG000|Overall Study|Physically unable to continue|0|||
124509609|NCT01283997|447817246|FG001|Overall Study|Physically unable to continue|1|||
124509610|NCT01283997|447817245|FG000|Overall Study|Progressive disease|1|||
124509611|NCT01283997|447817246|FG001|Overall Study|Progressive disease|0|||
124509612|NCT01283997|447817245|FG000|Overall Study|Other|4|||
124509613|NCT01283997|447817246|FG001|Overall Study|Other|4|||
124509614|NCT02017899|447817247|FG000|Overall Study|Withdrawal by Subject|0|||
124509615|NCT02017899|447817248|FG001|Overall Study|Withdrawal by Subject|0|||
124509616|NCT02017899|447817249|FG002|Overall Study|Withdrawal by Subject|0|||
124509617|NCT02017899|447817250|FG003|Overall Study|Withdrawal by Subject|1|||
124509618|NCT02017899|447817251|FG004|Overall Study|Withdrawal by Subject|1|||
124509619|NCT02017899|447817252|FG005|Overall Study|Withdrawal by Subject|0|||
124509620|NCT01747811|447817256|FG000|Overall Study|Lack of Efficacy|2|||
124509621|NCT01747811|447817257|FG001|Overall Study|Lack of Efficacy|4|||
124509622|NCT01337167|447817258|FG000|Infant Series|Adverse Event|1|||
124509623|NCT01337167|447817259|FG001|Infant Series|Adverse Event|1|||
124509624|NCT01337167|447817258|FG000|Infant Series|Death|1|||
124509625|NCT01337167|447817259|FG001|Infant Series|Death|1|||
124509626|NCT01337167|447817258|FG000|Infant Series|Lost to Follow-up|13|||
124509627|NCT01337167|447817259|FG001|Infant Series|Lost to Follow-up|7|||
124509628|NCT01337167|447817258|FG000|Infant Series|Non-compliance with study drug|2|||
124509629|NCT01337167|447817259|FG001|Infant Series|Non-compliance with study drug|1|||
124509630|NCT01337167|447817258|FG000|Infant Series|Physician Decision|3|||
124509631|NCT01337167|447817259|FG001|Infant Series|Physician Decision|1|||
124509632|NCT01337167|447817258|FG000|Infant Series|Protocol Violation|22|||
124509633|NCT01337167|447817259|FG001|Infant Series|Protocol Violation|9|||
124509634|NCT01337167|447817258|FG000|Infant Series|Withdrawal by Subject|15|||
124509635|NCT01337167|447817259|FG001|Infant Series|Withdrawal by Subject|4|||
124509636|NCT01337167|447817258|FG000|Infant Series|Randomized but not vaccinated|5|||
124509637|NCT01337167|447817259|FG001|Infant Series|Randomized but not vaccinated|3|||
124509638|NCT01337167|447817258|FG000|Interim Period|Lost to Follow-up|51|||
124509639|NCT01337167|447817259|FG001|Interim Period|Lost to Follow-up|23|||
124509640|NCT01337167|447817258|FG000|Interim Period|Non-compliance with study drug|1|||
124509641|NCT01337167|447817259|FG001|Interim Period|Non-compliance with study drug|0|||
124509642|NCT01337167|447817258|FG000|Interim Period|Physician Decision|6|||
124509643|NCT01337167|447817259|FG001|Interim Period|Physician Decision|3|||
124509644|NCT01337167|447817258|FG000|Interim Period|Protocol Violation|5|||
124509645|NCT01337167|447817259|FG001|Interim Period|Protocol Violation|3|||
124509646|NCT01337167|447817258|FG000|Interim Period|Withdrawal by Subject|18|||
124509647|NCT01337167|447817259|FG001|Interim Period|Withdrawal by Subject|10|||
124509648|NCT01337167|447817258|FG000|Interim Period|Other protocol criterion not met|0|||
124509649|NCT01337167|447817259|FG001|Interim Period|Other protocol criterion not met|1|||
124509650|NCT01337167|447817258|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
124509651|NCT01337167|447817259|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
124509652|NCT01337167|447817258|FG000|Toddler Vaccinations|Protocol Violation|0|||
124509653|NCT01337167|447817259|FG001|Toddler Vaccinations|Protocol Violation|1|||
124509654|NCT01337167|447817258|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
124509655|NCT01337167|447817259|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
124509656|NCT03833817|447817260|FG000|Overall Study|Withdrawal by Subject|3|||
124509657|NCT03833817|447817261|FG001|Overall Study|Withdrawal by Subject|3|||
124509658|NCT03833817|447817260|FG000|Overall Study|Lost to Follow-up|3|||
124509659|NCT03833817|447817261|FG001|Overall Study|Lost to Follow-up|3|||
124509660|NCT00884221|447817262|FG000|Overall Study|Withdrawal by Subject|0|||
124509661|NCT00884221|447817263|FG001|Overall Study|Withdrawal by Subject|3|||
124509662|NCT00884221|447817262|FG000|Overall Study|Adverse Event|6|||
124509663|NCT00884221|447817263|FG001|Overall Study|Adverse Event|3|||
124509664|NCT00884221|447817262|FG000|Overall Study|Protocol Violation|16|||
124509665|NCT00884221|447817263|FG001|Overall Study|Protocol Violation|13|||
124509666|NCT00884221|447817262|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
124509667|NCT00884221|447817263|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
124509668|NCT03363919|447817264|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
124509669|NCT03363919|447817265|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
124509670|NCT03363919|447817264|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
124509671|NCT03363919|447817265|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
124509672|NCT01646398|447817266|FG000|Overall Study|Withdrawal by Subject|1|||
124509673|NCT01646398|447817267|FG001|Overall Study|Withdrawal by Subject|0|||
124509674|NCT02499575|447817268|FG000|Overall Study|Protocol Violation|0|||
124509675|NCT02499575|447817269|FG001|Overall Study|Protocol Violation|1|||
124509676|NCT00574119|447817270|FG000|Overall Study|Adverse Event|1|||
124509677|NCT00574119|447817270|FG000|Overall Study|Protocol Violation|1|||
124509678|NCT00574119|447817270|FG000|Overall Study|Withdrawal by Subject|1|||
124509679|NCT00574119|447817270|FG000|Overall Study|Physician Decision|1|||
124509680|NCT02700919|447817279|FG000|Overall Study|Physician Decision|1|||
124509681|NCT02700919|447817280|FG001|Overall Study|Physician Decision|0|||
124509682|NCT02700919|447817281|FG002|Overall Study|Physician Decision|0|||
124509683|NCT02700919|447817279|FG000|Overall Study|Protocol Violation|1|||
124509684|NCT02700919|447817280|FG001|Overall Study|Protocol Violation|0|||
124509685|NCT02700919|447817281|FG002|Overall Study|Protocol Violation|0|||
124509686|NCT02700919|447817279|FG000|Overall Study|Adverse Event|1|||
124509687|NCT02700919|447817280|FG001|Overall Study|Adverse Event|3|||
124509688|NCT02700919|447817281|FG002|Overall Study|Adverse Event|1|||
124509689|NCT02700919|447817279|FG000|Overall Study|Withdrawal by Subject|5|||
124509690|NCT02700919|447817280|FG001|Overall Study|Withdrawal by Subject|8|||
124509691|NCT02700919|447817281|FG002|Overall Study|Withdrawal by Subject|2|||
124509692|NCT02700919|447817279|FG000|Overall Study|Lost to Follow-up|2|||
124509693|NCT02700919|447817280|FG001|Overall Study|Lost to Follow-up|0|||
124509694|NCT02700919|447817281|FG002|Overall Study|Lost to Follow-up|0|||
124509695|NCT02700919|447817279|FG000|Overall Study|Other|2|||
124509696|NCT02700919|447817280|FG001|Overall Study|Other|1|||
124509697|NCT02700919|447817281|FG002|Overall Study|Other|1|||
124509698|NCT03434418|447817283|FG000|Overall Study|Disease Progression|11|||
124509699|NCT03434418|447817283|FG000|Overall Study|Adverse Event|2|||
124509700|NCT03434418|447817283|FG000|Overall Study|Physician Decision|1|||
124509701|NCT03434418|447817283|FG000|Overall Study|Decline in Performance Status (PS)|1|||
124509702|NCT01956240|447817287|FG000|Overall Study|Lost to Follow-up|6|||
124509703|NCT01956240|447817288|FG001|Overall Study|Lost to Follow-up|20|||
124509704|NCT01956240|447817287|FG000|Overall Study|Adverse Event|17|||
124509705|NCT01956240|447817288|FG001|Overall Study|Adverse Event|4|||
124509706|NCT00600028|447817291|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
124509707|NCT00600028|447817292|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
124509708|NCT00600028|447817291|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
124509709|NCT00600028|447817292|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
124509710|NCT00600028|447817291|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
124509711|NCT00600028|447817292|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
124509712|NCT03172481|447817293|FG000|Double-blind|Withdrawal by Subject|1|||
124509713|NCT03172481|447817294|FG001|Double-blind|Withdrawal by Subject|0|||
124509714|NCT01957709|447817295|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
124509715|NCT01093755|447817307|FG000|Overall Study|Withdrawal by Subject|3|||
124509716|NCT01093755|447817308|FG001|Overall Study|Withdrawal by Subject|4|||
124509717|NCT03115112|447817309|FG000|Overall Study|Adverse Event|5|||
124509718|NCT03115112|447817310|FG001|Overall Study|Adverse Event|1|||
124509719|NCT03115112|447817309|FG000|Overall Study|Withdrawal by Subject|4|||
124509720|NCT03115112|447817310|FG001|Overall Study|Withdrawal by Subject|2|||
124509721|NCT03115112|447817309|FG000|Overall Study|Lost to Follow-up|0|||
124509722|NCT03115112|447817310|FG001|Overall Study|Lost to Follow-up|1|||
124509723|NCT03115112|447817309|FG000|Overall Study|Death|1|||
124509724|NCT03115112|447817310|FG001|Overall Study|Death|0|||
124509725|NCT03115112|447817309|FG000|Overall Study|Pregnancy|1|||
124509726|NCT03115112|447817310|FG001|Overall Study|Pregnancy|0|||
124509727|NCT03115112|447817309|FG000|Overall Study|Site closure|1|||
124509728|NCT03115112|447817310|FG001|Overall Study|Site closure|1|||
124509729|NCT04019795|447817311|FG000|Overall Study|Withdrawal by Subject|1|||
124509730|NCT04019795|447817312|FG001|Overall Study|Withdrawal by Subject|2|||
124509731|NCT04019795|447817313|FG002|Overall Study|Withdrawal by Subject|2|||
124509732|NCT04019795|447817314|FG003|Overall Study|Withdrawal by Subject|1|||
124509733|NCT04019795|447817311|FG000|Overall Study|Lost to Follow-up|0|||
124509734|NCT04019795|447817312|FG001|Overall Study|Lost to Follow-up|1|||
124509735|NCT04019795|447817313|FG002|Overall Study|Lost to Follow-up|1|||
124509736|NCT04019795|447817314|FG003|Overall Study|Lost to Follow-up|2|||
124509737|NCT04019795|447817311|FG000|Overall Study|Treatment non-compliance|3|||
124509738|NCT04019795|447817312|FG001|Overall Study|Treatment non-compliance|1|||
124509739|NCT04019795|447817313|FG002|Overall Study|Treatment non-compliance|2|||
124509740|NCT04019795|447817314|FG003|Overall Study|Treatment non-compliance|0|||
124509741|NCT04019795|447817311|FG000|Overall Study|Physician Decision|0|||
124509742|NCT04019795|447817312|FG001|Overall Study|Physician Decision|0|||
124509743|NCT04019795|447817313|FG002|Overall Study|Physician Decision|1|||
124509744|NCT04019795|447817314|FG003|Overall Study|Physician Decision|0|||
124509745|NCT04019795|447817311|FG000|Overall Study|Adverse Event|1|||
124509746|NCT04019795|447817312|FG001|Overall Study|Adverse Event|0|||
124509747|NCT04019795|447817313|FG002|Overall Study|Adverse Event|0|||
124509748|NCT04019795|447817314|FG003|Overall Study|Adverse Event|0|||
124509749|NCT02168803|447817315|FG000|Overall Study|Lost to Follow-up|1|||
124509750|NCT02168803|447817316|FG001|Overall Study|Lost to Follow-up|0|||
124509751|NCT02168803|447817317|FG002|Overall Study|Lost to Follow-up|1|||
124509752|NCT02168803|447817315|FG000|Overall Study|Withdrawal by Subject|1|||
124509753|NCT02168803|447817316|FG001|Overall Study|Withdrawal by Subject|1|||
124509754|NCT02168803|447817317|FG002|Overall Study|Withdrawal by Subject|2|||
124509755|NCT02168803|447817315|FG000|Overall Study|Physician Decision|0|||
124565013|NCT02308111|448026092|FG000|Overall Study|Death|9|||
124509756|NCT02168803|447817316|FG001|Overall Study|Physician Decision|1|||
124509757|NCT02168803|447817317|FG002|Overall Study|Physician Decision|0|||
124509758|NCT02168803|447817315|FG000|Overall Study|Adverse Event|0|||
124509759|NCT02168803|447817316|FG001|Overall Study|Adverse Event|1|||
124509760|NCT02168803|447817317|FG002|Overall Study|Adverse Event|1|||
124509761|NCT02168803|447817315|FG000|Overall Study|Death|0|||
124509762|NCT02168803|447817316|FG001|Overall Study|Death|0|||
124509763|NCT02168803|447817317|FG002|Overall Study|Death|1|||
124509764|NCT02168803|447817315|FG000|Overall Study|Sponsor Decision|0|||
124509765|NCT02168803|447817316|FG001|Overall Study|Sponsor Decision|0|||
124509766|NCT02168803|447817317|FG002|Overall Study|Sponsor Decision|1|||
124509767|NCT01107405|447817318|FG000|Overall Study|Adverse Event|1|||
124509768|NCT01107405|447817319|FG001|Overall Study|Adverse Event|1|||
124509769|NCT01107405|447817320|FG002|Overall Study|Adverse Event|0|||
124509770|NCT01107405|447817321|FG003|Overall Study|Adverse Event|0|||
124509771|NCT01107405|447817322|FG004|Overall Study|Adverse Event|2|||
124509772|NCT01107405|447817318|FG000|Overall Study|Withdrawal by Subject|1|||
124509773|NCT01107405|447817319|FG001|Overall Study|Withdrawal by Subject|0|||
124509774|NCT01107405|447817320|FG002|Overall Study|Withdrawal by Subject|1|||
124509775|NCT01107405|447817321|FG003|Overall Study|Withdrawal by Subject|2|||
124509776|NCT01107405|447817322|FG004|Overall Study|Withdrawal by Subject|1|||
124509777|NCT01107405|447817318|FG000|Overall Study|Protocol Violation|0|||
124509778|NCT01107405|447817319|FG001|Overall Study|Protocol Violation|0|||
124509779|NCT01107405|447817320|FG002|Overall Study|Protocol Violation|1|||
124509780|NCT01107405|447817321|FG003|Overall Study|Protocol Violation|1|||
124509781|NCT01107405|447817322|FG004|Overall Study|Protocol Violation|0|||
124509782|NCT00980343|447817323|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
124509783|NCT00980343|447817324|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
124509784|NCT02310906|447817329|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
124509785|NCT02310906|447817330|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
124509786|NCT02310906|447817331|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
124509787|NCT02310906|447817332|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
124509788|NCT02310906|447817329|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
124509789|NCT02310906|447817330|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
124509790|NCT02310906|447817331|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
124509791|NCT02310906|447817332|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
124509792|NCT02310906|447817329|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
124509793|NCT02310906|447817330|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
124509794|NCT02310906|447817331|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
124509795|NCT02310906|447817332|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
124509796|NCT02310906|447817329|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
124509797|NCT02310906|447817330|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
124509798|NCT02310906|447817331|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
124509799|NCT02310906|447817332|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
124509800|NCT00098020|447817338|FG000|Overall Study|Adverse Event|2|||
124509801|NCT00098020|447817338|FG000|Overall Study|Lost to Follow-up|1|||
124509802|NCT00098020|447817338|FG000|Overall Study|elevated liver enzymes|1|||
124509803|NCT00098020|447817338|FG000|Overall Study|Low urine PCR|1|||
124509804|NCT00098020|447817338|FG000|Overall Study|Low epidermal growth factor receptor|1|||
124509805|NCT01840228|447817342|FG000|Overall Study|Lost to Follow-up|1|||
124509806|NCT01840228|447817343|FG001|Overall Study|Lost to Follow-up|1|||
124509807|NCT01879319|447817346|FG000|Overall Study|Withdrawal by Subject|1|||
124509808|NCT01879319|447817347|FG001|Overall Study|Withdrawal by Subject|0|||
124509809|NCT01879319|447817346|FG000|Overall Study|Lost to Follow-up|1|||
124509810|NCT01879319|447817347|FG001|Overall Study|Lost to Follow-up|5|||
124509811|NCT02670330|447817350|FG000|Overall Study|Protocol Deviation|1|||
124509812|NCT02670330|447817351|FG001|Overall Study|Protocol Deviation|0|||
124509813|NCT02670330|447817350|FG000|Overall Study|Study Terminated By Sponsor|36|||
124509814|NCT02670330|447817351|FG001|Overall Study|Study Terminated By Sponsor|43|||
124509815|NCT02670330|447817350|FG000|Overall Study|Adverse Event|1|||
124509816|NCT02670330|447817351|FG001|Overall Study|Adverse Event|3|||
124509817|NCT02670330|447817350|FG000|Overall Study|Withdrawal by Subject|34|||
124509818|NCT02670330|447817351|FG001|Overall Study|Withdrawal by Subject|29|||
124509819|NCT02670330|447817350|FG000|Overall Study|Lost to Follow-up|3|||
124509820|NCT02670330|447817351|FG001|Overall Study|Lost to Follow-up|2|||
124509821|NCT04404010|447817354|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
124509822|NCT04404010|447817355|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
124509823|NCT02120157|447817356|FG000|Overall Study|Death|8|||
124509824|NCT00441103|447817360|FG000|Overall Study|Adverse Event|2|||
124509825|NCT00441103|447817361|FG001|Overall Study|Adverse Event|1|||
124509826|NCT00441103|447817360|FG000|Overall Study|Death|1|||
124509827|NCT00441103|447817361|FG001|Overall Study|Death|0|||
124509828|NCT00441103|447817360|FG000|Overall Study|Disease Progression|2|||
124509829|NCT00441103|447817361|FG001|Overall Study|Disease Progression|0|||
124509830|NCT00441103|447817360|FG000|Overall Study|Lost to Follow-up|1|||
124509831|NCT00441103|447817361|FG001|Overall Study|Lost to Follow-up|0|||
124509832|NCT00441103|447817360|FG000|Overall Study|Protocol Violation|1|||
124509833|NCT00441103|447817361|FG001|Overall Study|Protocol Violation|0|||
124509834|NCT00441103|447817360|FG000|Overall Study|Participant unable to use Rebiject II|1|||
124509835|NCT00441103|447817361|FG001|Overall Study|Participant unable to use Rebiject II|0|||
124509836|NCT00441103|447817360|FG000|Overall Study|Participant refused MRI|1|||
124509837|NCT00441103|447817361|FG001|Overall Study|Participant refused MRI|0|||
124509838|NCT00441103|447817360|FG000|Overall Study|Inclusion criteria absent|1|||
124509839|NCT00441103|447817361|FG001|Overall Study|Inclusion criteria absent|0|||
124509840|NCT00441103|447817360|FG000|Overall Study|Non-compliant|0|||
124509841|NCT00441103|447817361|FG001|Overall Study|Non-compliant|1|||
124509842|NCT00441103|447817360|FG000|Overall Study|Participant decided to withdraw|1|||
124509843|NCT00441103|447817361|FG001|Overall Study|Participant decided to withdraw|0|||
124509844|NCT00441103|447817360|FG000|Overall Study|Participant's reason|0|||
124509845|NCT00441103|447817361|FG001|Overall Study|Participant's reason|1|||
124509846|NCT00441103|447817360|FG000|Overall Study|Participant decided to stop|0|||
124509847|NCT00441103|447817361|FG001|Overall Study|Participant decided to stop|1|||
124509848|NCT00239837|447817364|FG000|Overall Study|Lost to Follow-up|3|||
124509849|NCT00239837|447817365|FG001|Overall Study|Lost to Follow-up|7|||
124509850|NCT01153893|447817366|FG000|Overall Study|Adverse Event|1|||
124509851|NCT01153893|447817367|FG001|Overall Study|Adverse Event|0|||
124509852|NCT01838590|447817368|FG000|Overall Study|Lack of Efficacy|12|||
124509853|NCT01838590|447817369|FG001|Overall Study|Lack of Efficacy|4|||
124509854|NCT01838590|447817368|FG000|Overall Study|Lost to Follow-up|0|||
124509855|NCT01838590|447817369|FG001|Overall Study|Lost to Follow-up|1|||
124509856|NCT01354431|447817370|FG000|Pre-Treatment Period|Not reported|1|||
124509857|NCT01354431|447817371|FG001|Pre-Treatment Period|Not reported|0|||
124509858|NCT01354431|447817372|FG002|Pre-Treatment Period|Not reported|0|||
124509859|NCT01354431|447817370|FG000|Treatment Period|Disease Progression|50|||
124509860|NCT01354431|447817371|FG001|Treatment Period|Disease Progression|40|||
124509861|NCT01354431|447817372|FG002|Treatment Period|Disease Progression|44|||
124509862|NCT01354431|447817370|FG000|Treatment Period|Study Drug Toxicity|5|||
124509863|NCT01354431|447817371|FG001|Treatment Period|Study Drug Toxicity|8|||
124509864|NCT01354431|447817372|FG002|Treatment Period|Study Drug Toxicity|4|||
124509865|NCT01354431|447817370|FG000|Treatment Period|Death|0|||
124509866|NCT01354431|447817371|FG001|Treatment Period|Death|1|||
124509867|NCT01354431|447817372|FG002|Treatment Period|Death|0|||
124509868|NCT01354431|447817370|FG000|Treatment Period|AE unrelated to study drug|1|||
124509869|NCT01354431|447817371|FG001|Treatment Period|AE unrelated to study drug|2|||
124509870|NCT01354431|447817372|FG002|Treatment Period|AE unrelated to study drug|5|||
124509871|NCT01354431|447817370|FG000|Treatment Period|Participant request to discontinue|2|||
124509872|NCT01354431|447817371|FG001|Treatment Period|Participant request to discontinue|2|||
124509873|NCT01354431|447817372|FG002|Treatment Period|Participant request to discontinue|1|||
124509874|NCT01354431|447817370|FG000|Treatment Period|Participant withdrew consent|0|||
124509875|NCT01354431|447817371|FG001|Treatment Period|Participant withdrew consent|1|||
124509876|NCT01354431|447817372|FG002|Treatment Period|Participant withdrew consent|0|||
124509877|NCT01354431|447817370|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
124509878|NCT01354431|447817371|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
124509879|NCT01354431|447817372|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
124509880|NCT02927873|447817378|FG000|Overall Study|Lost to Follow-up|0|||
124509881|NCT02927873|447817379|FG001|Overall Study|Lost to Follow-up|1|||
124509882|NCT02927873|447817380|FG002|Overall Study|Lost to Follow-up|0|||
124509883|NCT02927873|447817381|FG003|Overall Study|Lost to Follow-up|0|||
124509884|NCT02927873|447817382|FG004|Overall Study|Lost to Follow-up|0|||
124509885|NCT02927873|447817383|FG005|Overall Study|Lost to Follow-up|0|||
124509886|NCT02927873|447817378|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
124509887|NCT02927873|447817379|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
124509888|NCT02927873|447817380|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
124509889|NCT02927873|447817381|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
124509890|NCT02927873|447817382|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
124509891|NCT02927873|447817383|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
124509892|NCT02927873|447817378|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124509893|NCT02927873|447817379|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124509894|NCT02927873|447817380|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124509895|NCT02927873|447817381|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124509896|NCT02927873|447817382|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124509897|NCT02927873|447817383|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124509898|NCT02927873|447817378|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
124509899|NCT02927873|447817379|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
124509900|NCT02927873|447817380|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
124509901|NCT02927873|447817381|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
124509902|NCT02927873|447817382|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
124509903|NCT02927873|447817383|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
124509904|NCT02927873|447817378|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
124509905|NCT02927873|447817379|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
124509906|NCT02927873|447817380|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
124509907|NCT02927873|447817381|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
124509908|NCT02927873|447817382|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
124509909|NCT02927873|447817383|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
124509910|NCT02927873|447817378|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
124509911|NCT02927873|447817379|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
124509912|NCT02927873|447817380|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
124509913|NCT02927873|447817381|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
124509914|NCT02927873|447817382|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
124509915|NCT02927873|447817383|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
124509916|NCT01927419|447817390|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
124509917|NCT01927419|447817391|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
124509918|NCT01927419|447817390|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
124509919|NCT01927419|447817391|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
124509920|NCT01927419|447817390|FG000|Treatment Period|Disease progression|17|||
124509921|NCT01927419|447817391|FG001|Treatment Period|Disease progression|20|||
124509922|NCT01927419|447817390|FG000|Treatment Period|Study drug toxicity|48|||
124509923|NCT01927419|447817391|FG001|Treatment Period|Study drug toxicity|10|||
124509924|NCT01927419|447817390|FG000|Treatment Period|Death|0|||
124509925|NCT01927419|447817391|FG001|Treatment Period|Death|1|||
124509926|NCT01927419|447817390|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
124509927|NCT01927419|447817391|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
124509928|NCT01927419|447817390|FG000|Treatment Period|Participant request to discontinue|12|||
124509929|NCT01927419|447817391|FG001|Treatment Period|Participant request to discontinue|4|||
124509930|NCT01927419|447817390|FG000|Treatment Period|Withdrawal by Subject|1|||
124509931|NCT01927419|447817391|FG001|Treatment Period|Withdrawal by Subject|1|||
124509932|NCT01927419|447817390|FG000|Treatment Period|Maximum Clinical Benefit|6|||
124509933|NCT01927419|447817391|FG001|Treatment Period|Maximum Clinical Benefit|2|||
124509934|NCT01927419|447817390|FG000|Treatment Period|Other reasons|3|||
124509935|NCT01927419|447817391|FG001|Treatment Period|Other reasons|4|||
124509936|NCT01927419|447817390|FG000|Treatment Period|Not Reported|1|||
124509937|NCT01927419|447817391|FG001|Treatment Period|Not Reported|1|||
124509938|NCT00393913|447817392|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
124509939|NCT00393913|447817392|FG000|Initial Assessment|Withdrawal by Subject|16|||
124509940|NCT00393913|447817392|FG000|CPAP|Withdrawal by Subject|3|||
124509941|NCT00393913|447817392|FG000|CPAP|Physician Decision|1|||
124509942|NCT00393913|447817392|FG000|CPAP|TEchnical problem with CPAP|3|||
124509943|NCT03488251|447817393|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
124509944|NCT03488251|447817394|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
124509945|NCT03488251|447817395|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
124509946|NCT03488251|447817396|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
124509947|NCT03488251|447817393|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
124509948|NCT03488251|447817394|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
124509949|NCT03488251|447817395|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
124509950|NCT03488251|447817396|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
124509951|NCT03488251|447817393|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
124509952|NCT03488251|447817394|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
124509953|NCT03488251|447817395|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
124509954|NCT03488251|447817396|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
124509955|NCT03488251|447817393|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
124509956|NCT03488251|447817394|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
124509957|NCT03488251|447817395|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
124509958|NCT03488251|447817396|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
124509959|NCT03488251|447817393|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
124509960|NCT03488251|447817394|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
124509961|NCT03488251|447817395|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
124509962|NCT03488251|447817396|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
124509963|NCT01511107|447817400|FG000|Overall Study|Ineligible|3|||
124509964|NCT01511107|447817401|FG001|Overall Study|Ineligible|2|||
124509965|NCT01511107|447817400|FG000|Overall Study|Lost to Follow-up|10|||
124509966|NCT01511107|447817401|FG001|Overall Study|Lost to Follow-up|19|||
124509967|NCT01511107|447817400|FG000|Overall Study|Withdrawal by Subject|9|||
124509968|NCT01511107|447817401|FG001|Overall Study|Withdrawal by Subject|20|||
124509969|NCT01146951|447819121|FG000|Overall Study|Adverse Event|4|||
124509970|NCT01146951|447819122|FG001|Overall Study|Adverse Event|1|||
124509971|NCT00804843|447819126|FG000|Overall Study|Protocol Violation|1|||
124509972|NCT00804843|447819127|FG001|Overall Study|Protocol Violation|0|||
124509973|NCT00804843|447819126|FG000|Overall Study|Adverse Event|8|||
124509974|NCT00804843|447819127|FG001|Overall Study|Adverse Event|5|||
124509975|NCT00804843|447819126|FG000|Overall Study|Withdrawal by Subject|1|||
124509976|NCT00804843|447819127|FG001|Overall Study|Withdrawal by Subject|2|||
124509977|NCT02126670|447819136|FG000|Overall Study|Withdrawal by Subject|1|||
124565014|NCT02308111|448026093|FG001|Overall Study|Death|6|||
124509978|NCT02126670|447819137|FG001|Overall Study|Withdrawal by Subject|0|||
124509979|NCT02126670|447819138|FG002|Overall Study|Withdrawal by Subject|0|||
124509980|NCT02126670|447819139|FG003|Overall Study|Withdrawal by Subject|1|||
124509981|NCT01975246|447819140|FG000|Overall Study|Adverse Event|2|||
124509982|NCT01975246|447819141|FG001|Overall Study|Adverse Event|1|||
124509983|NCT01975246|447819140|FG000|Overall Study|Lack of Efficacy|1|||
124509984|NCT01975246|447819141|FG001|Overall Study|Lack of Efficacy|0|||
124509985|NCT01975246|447819140|FG000|Overall Study|Protocol Violation|1|||
124509986|NCT01975246|447819141|FG001|Overall Study|Protocol Violation|0|||
124509987|NCT01975246|447819140|FG000|Overall Study|Other than stated|0|||
124509988|NCT01975246|447819141|FG001|Overall Study|Other than stated|1|||
124509989|NCT01263093|447819142|FG000|Washout|Physician Decision|1|||
124509990|NCT01263093|447819143|FG001|Washout|Physician Decision|0|||
124509991|NCT01263093|447819142|FG000|Period 2|Adverse Event|1|||
124509992|NCT01263093|447819143|FG001|Period 2|Adverse Event|0|||
124509993|NCT00424346|447819144|FG000|Core Study|Adverse Event|5|||
124509994|NCT00424346|447819145|FG001|Core Study|Adverse Event|3|||
124509995|NCT00424346|447819146|FG002|Core Study|Adverse Event|1|||
124509996|NCT00424346|447819147|FG003|Core Study|Adverse Event|1|||
124509997|NCT00424346|447819144|FG000|Core Study|Abnormal Laboratory Values|0|||
124509998|NCT00424346|447819145|FG001|Core Study|Abnormal Laboratory Values|1|||
124509999|NCT00424346|447819146|FG002|Core Study|Abnormal Laboratory Values|0|||
124510000|NCT00424346|447819147|FG003|Core Study|Abnormal Laboratory Values|0|||
124510001|NCT00424346|447819144|FG000|Core Study|Lack of Efficacy|1|||
124510002|NCT00424346|447819145|FG001|Core Study|Lack of Efficacy|3|||
124510003|NCT00424346|447819146|FG002|Core Study|Lack of Efficacy|0|||
124510004|NCT00424346|447819147|FG003|Core Study|Lack of Efficacy|4|||
124510005|NCT00424346|447819144|FG000|Core Study|Withdrawal by Subject|1|||
124510006|NCT00424346|447819145|FG001|Core Study|Withdrawal by Subject|0|||
124510007|NCT00424346|447819146|FG002|Core Study|Withdrawal by Subject|0|||
124510008|NCT00424346|447819147|FG003|Core Study|Withdrawal by Subject|2|||
124510009|NCT00424346|447819144|FG000|Core Study|Lost to Follow-up|1|||
124510010|NCT00424346|447819145|FG001|Core Study|Lost to Follow-up|1|||
124510011|NCT00424346|447819146|FG002|Core Study|Lost to Follow-up|0|||
124510012|NCT00424346|447819147|FG003|Core Study|Lost to Follow-up|0|||
124510013|NCT00424346|447819144|FG000|Core Study|Administrative Problems|1|||
124510014|NCT00424346|447819145|FG001|Core Study|Administrative Problems|0|||
124510015|NCT00424346|447819146|FG002|Core Study|Administrative Problems|1|||
124510016|NCT00424346|447819147|FG003|Core Study|Administrative Problems|0|||
124510017|NCT00424346|447819144|FG000|Core Study|Protocol Violation|0|||
124510018|NCT00424346|447819145|FG001|Core Study|Protocol Violation|0|||
124510019|NCT00424346|447819146|FG002|Core Study|Protocol Violation|2|||
124510020|NCT00424346|447819147|FG003|Core Study|Protocol Violation|0|||
124510021|NCT00424346|447819144|FG000|Extension Phase|Adverse Event|0|||
124510022|NCT00424346|447819145|FG001|Extension Phase|Adverse Event|9|||
124510023|NCT00424346|447819146|FG002|Extension Phase|Adverse Event|5|||
124510024|NCT00424346|447819147|FG003|Extension Phase|Adverse Event|4|||
124510025|NCT00424346|447819144|FG000|Extension Phase|Lack of Efficacy|0|||
124510026|NCT00424346|447819145|FG001|Extension Phase|Lack of Efficacy|16|||
124510027|NCT00424346|447819146|FG002|Extension Phase|Lack of Efficacy|14|||
124510028|NCT00424346|447819147|FG003|Extension Phase|Lack of Efficacy|11|||
124510029|NCT00424346|447819144|FG000|Extension Phase|Withdrawal by Subject|0|||
124510030|NCT00424346|447819145|FG001|Extension Phase|Withdrawal by Subject|5|||
124510031|NCT00424346|447819146|FG002|Extension Phase|Withdrawal by Subject|3|||
124510032|NCT00424346|447819147|FG003|Extension Phase|Withdrawal by Subject|4|||
124510033|NCT00424346|447819144|FG000|Extension Phase|Lost to Follow-up|0|||
124510034|NCT00424346|447819145|FG001|Extension Phase|Lost to Follow-up|2|||
124510035|NCT00424346|447819146|FG002|Extension Phase|Lost to Follow-up|0|||
124510036|NCT00424346|447819147|FG003|Extension Phase|Lost to Follow-up|0|||
124510037|NCT00424346|447819144|FG000|Extension Phase|Administrative Problems|0|||
124510038|NCT00424346|447819145|FG001|Extension Phase|Administrative Problems|69|||
124510039|NCT00424346|447819146|FG002|Extension Phase|Administrative Problems|32|||
124510040|NCT00424346|447819147|FG003|Extension Phase|Administrative Problems|35|||
124510041|NCT00424346|447819144|FG000|Extension Phase|Death|0|||
124510042|NCT00424346|447819145|FG001|Extension Phase|Death|0|||
124510043|NCT00424346|447819146|FG002|Extension Phase|Death|0|||
124510044|NCT00424346|447819147|FG003|Extension Phase|Death|1|||
124510045|NCT00424346|447819144|FG000|Extension Phase|Protocol Violation|0|||
124510046|NCT00424346|447819145|FG001|Extension Phase|Protocol Violation|1|||
124510047|NCT00424346|447819146|FG002|Extension Phase|Protocol Violation|1|||
124510048|NCT00424346|447819147|FG003|Extension Phase|Protocol Violation|0|||
124510049|NCT01827319|447819148|FG000|Overall Study|Lost to Follow-up|3|||
124510050|NCT00571519|447819149|FG000|Overall Study|Subject withdrew consent|0|||
124510051|NCT00571519|447819150|FG001|Overall Study|Subject withdrew consent|1|||
124510052|NCT00571519|447819151|FG002|Overall Study|Subject withdrew consent|0|||
124510053|NCT00571519|447819152|FG003|Overall Study|Subject withdrew consent|2|||
124510054|NCT00571519|447819153|FG004|Overall Study|Subject withdrew consent|1|||
124510055|NCT00571519|447819154|FG005|Overall Study|Subject withdrew consent|1|||
124510056|NCT00571519|447819155|FG006|Overall Study|Subject withdrew consent|2|||
124565015|NCT02308111|448026092|FG000|Overall Study|Lost to Follow-up|2|||
124565016|NCT02308111|448026093|FG001|Overall Study|Lost to Follow-up|7|||
124565017|NCT02308111|448026092|FG000|Overall Study|Physician Decision|6|||
124565018|NCT02308111|448026093|FG001|Overall Study|Physician Decision|17|||
124565019|NCT02308111|448026092|FG000|Overall Study|Protocol Violation|0|||
124565020|NCT02308111|448026093|FG001|Overall Study|Protocol Violation|1|||
124565021|NCT02308111|448026092|FG000|Overall Study|Withdrawal by Subject|28|||
124565022|NCT02308111|448026093|FG001|Overall Study|Withdrawal by Subject|38|||
124565023|NCT02308111|448026092|FG000|Overall Study|Study Terminated by Sponsor|72|||
124565024|NCT02308111|448026093|FG001|Overall Study|Study Terminated by Sponsor|61|||
124565025|NCT02308111|448026092|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
124565026|NCT02308111|448026093|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
124565027|NCT02308111|448026092|FG000|Overall Study|Site Closure|3|||
124565028|NCT02308111|448026093|FG001|Overall Study|Site Closure|3|||
124565029|NCT02308111|448026092|FG000|Overall Study|Non-compliance with Study Drug|3|||
124565030|NCT02308111|448026093|FG001|Overall Study|Non-compliance with Study Drug|1|||
124565031|NCT02308111|448026092|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
124565032|NCT02308111|448026093|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
124565033|NCT02308111|448026092|FG000|Overall Study|Liver Transplant|3|||
124565034|NCT02308111|448026093|FG001|Overall Study|Liver Transplant|3|||
124565035|NCT02308111|448026092|FG000|Overall Study|Liver Transplant Waitlist|2|||
124565036|NCT02308111|448026093|FG001|Overall Study|Liver Transplant Waitlist|2|||
124565037|NCT02308111|448026092|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
124565038|NCT02308111|448026093|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
124565039|NCT03271528|448026097|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
124565040|NCT03271528|448026098|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
124565041|NCT03271528|448026097|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
124565042|NCT03271528|448026098|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
124565043|NCT03271528|448026097|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
124565044|NCT03271528|448026098|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
124565045|NCT03271528|448026097|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
124565046|NCT03271528|448026098|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
124565047|NCT03271528|448026097|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
124565048|NCT03271528|448026098|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
124565049|NCT03271528|448026097|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
124565050|NCT03271528|448026098|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
124565051|NCT03271528|448026097|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
124565052|NCT03271528|448026098|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
124565053|NCT00717756|448026099|FG000|Overall Study|Withdrawal by Subject|1|||
124565054|NCT01873859|448026102|FG000|Overall Study|Withdrawal by Subject|0|||
124565055|NCT01873859|448026103|FG001|Overall Study|Withdrawal by Subject|4|||
124565056|NCT03977584|448026104|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
124565057|NCT03977584|448026105|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
124565058|NCT03977584|448026106|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
124565059|NCT01066052|448026110|FG000|Overall Study|Enrolled But Not Treated|3|||
124565060|NCT01066052|448026111|FG001|Overall Study|Enrolled But Not Treated|0|||
124565061|NCT03850509|448026112|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
124565062|NCT03850509|448026113|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
124565063|NCT00969332|448026114|FG000|Overall Study|Physician Decision|8|||
124565064|NCT00969332|448026114|FG000|Overall Study|Withdrawal by Subject|3|||
124565065|NCT02729896|448026117|FG000|Overall Study|Death|0|||
124565066|NCT02729896|448026118|FG001|Overall Study|Death|2|||
124565067|NCT02729896|448026119|FG002|Overall Study|Death|13|||
124565068|NCT02729896|448026117|FG000|Overall Study|Lost to Follow-up|0|||
124565069|NCT02729896|448026118|FG001|Overall Study|Lost to Follow-up|2|||
124565070|NCT02729896|448026119|FG002|Overall Study|Lost to Follow-up|3|||
124565071|NCT02729896|448026117|FG000|Overall Study|Other|0|||
124565072|NCT02729896|448026118|FG001|Overall Study|Other|2|||
124565073|NCT02729896|448026119|FG002|Overall Study|Other|0|||
124565074|NCT02729896|448026117|FG000|Overall Study|Physician Decision|1|||
124565075|NCT02729896|448026118|FG001|Overall Study|Physician Decision|2|||
124565076|NCT02729896|448026119|FG002|Overall Study|Physician Decision|3|||
124565077|NCT02729896|448026117|FG000|Overall Study|Progressive Disease|0|||
124565078|NCT02729896|448026118|FG001|Overall Study|Progressive Disease|1|||
124565079|NCT02729896|448026119|FG002|Overall Study|Progressive Disease|0|||
124565080|NCT02729896|448026117|FG000|Overall Study|Withdrawal by Subject|1|||
124565081|NCT02729896|448026118|FG001|Overall Study|Withdrawal by Subject|0|||
124565082|NCT02729896|448026119|FG002|Overall Study|Withdrawal by Subject|3|||
124565083|NCT01835145|448026120|FG000|Overall Study|Ineligible prior to treatment|1|||
124565084|NCT01835145|448026121|FG001|Overall Study|Ineligible prior to treatment|0|||
124565085|NCT00582309|448026122|FG000|Overall Study|Protocol Violation|0|||
124565086|NCT00582309|448026123|FG001|Overall Study|Protocol Violation|0|||
124510057|NCT00571519|447819149|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
124510058|NCT00571519|447819150|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
124510059|NCT00571519|447819151|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
124510060|NCT00571519|447819152|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
124510061|NCT00571519|447819153|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
124510062|NCT00571519|447819154|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
124510063|NCT00571519|447819155|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
124510064|NCT00571519|447819149|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
124510065|NCT00571519|447819150|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
124510066|NCT00571519|447819151|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
124510067|NCT00571519|447819152|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
124510068|NCT00571519|447819153|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
124510069|NCT00571519|447819154|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
124510070|NCT00571519|447819155|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
124510071|NCT00571519|447819149|FG000|Overall Study|Termination of study by Sponsor|2|||
124510072|NCT00571519|447819150|FG001|Overall Study|Termination of study by Sponsor|7|||
124510073|NCT00571519|447819151|FG002|Overall Study|Termination of study by Sponsor|10|||
124510074|NCT00571519|447819152|FG003|Overall Study|Termination of study by Sponsor|24|||
124510075|NCT00571519|447819153|FG004|Overall Study|Termination of study by Sponsor|8|||
124510076|NCT00571519|447819154|FG005|Overall Study|Termination of study by Sponsor|9|||
124510077|NCT00571519|447819155|FG006|Overall Study|Termination of study by Sponsor|22|||
124510078|NCT00571519|447819149|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
124510079|NCT00571519|447819150|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
124510080|NCT00571519|447819151|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
124510081|NCT00571519|447819152|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
124510082|NCT00571519|447819153|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
124510083|NCT00571519|447819154|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
124510084|NCT00571519|447819155|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
124510085|NCT00562640|447819157|FG000|Overall Study|Death|0|||
124510086|NCT00562640|447819158|FG001|Overall Study|Death|1|||
124510087|NCT00562640|447819159|FG002|Overall Study|Death|1|||
124510088|NCT00562640|447819160|FG003|Overall Study|Death|0|||
124510089|NCT05263921|447819161|FG000|Overall Study|Other: family emergency.|0|||
124510090|NCT05263921|447819162|FG001|Overall Study|Other: family emergency.|0|||
124510091|NCT05263921|447819163|FG002|Overall Study|Other: family emergency.|1|||
124510092|NCT05263921|447819164|FG003|Overall Study|Other: family emergency.|0|||
124510093|NCT02658968|447819165|FG000|Received Rituximab|Adverse Event|0|||
124510094|NCT02658968|447819166|FG001|Received Rituximab|Adverse Event|0|||
124510095|NCT02658968|447819167|FG002|Received Rituximab|Adverse Event|0|||
124510096|NCT02658968|447819168|FG003|Received Rituximab|Adverse Event|0|||
124510097|NCT02658968|447819169|FG004|Received Rituximab|Adverse Event|1|||
124510098|NCT02658968|447819165|FG000|Received Rituximab|Progressive disease|0|||
124510099|NCT02658968|447819166|FG001|Received Rituximab|Progressive disease|0|||
124510100|NCT02658968|447819167|FG002|Received Rituximab|Progressive disease|0|||
124510101|NCT02658968|447819168|FG003|Received Rituximab|Progressive disease|0|||
124510102|NCT02658968|447819169|FG004|Received Rituximab|Progressive disease|1|||
124510103|NCT02658968|447819165|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
124510104|NCT02658968|447819166|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
124510105|NCT02658968|447819167|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
124510106|NCT02658968|447819168|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
124510107|NCT02658968|447819169|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
124510108|NCT02658968|447819165|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
124510109|NCT02658968|447819166|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
124510110|NCT02658968|447819167|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
124510111|NCT02658968|447819168|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
124510112|NCT02658968|447819169|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
124510113|NCT02658968|447819165|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
124510114|NCT02658968|447819166|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
124510115|NCT02658968|447819167|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
124510116|NCT02658968|447819168|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
124510117|NCT02658968|447819169|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
124510118|NCT02658968|447819165|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
124510119|NCT02658968|447819166|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
124510120|NCT02658968|447819167|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
124510121|NCT02658968|447819168|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
124510122|NCT02658968|447819169|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
124510123|NCT02658968|447819165|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
124510124|NCT02658968|447819166|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
124510125|NCT02658968|447819167|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
124510126|NCT02658968|447819168|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
124510127|NCT02658968|447819169|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
124510128|NCT02475850|447819173|FG000|Overall Study|Death|155|||
124510129|NCT02475850|447819174|FG001|Overall Study|Death|141|||
124510130|NCT02475850|447819173|FG000|Overall Study|Lost to Follow-up|217|||
124510131|NCT02475850|447819174|FG001|Overall Study|Lost to Follow-up|188|||
124510132|NCT02475850|447819173|FG000|Overall Study|Withdrawal by Subject|221|||
124510133|NCT02475850|447819174|FG001|Overall Study|Withdrawal by Subject|155|||
124510134|NCT02667457|447819175|FG000|Overall Study|Withdrawal by Subject|1|||
124510135|NCT02667457|447819176|FG001|Overall Study|Withdrawal by Subject|0|||
124510136|NCT02667457|447819175|FG000|Overall Study|Other Reason|0|||
124510137|NCT02667457|447819176|FG001|Overall Study|Other Reason|2|||
124510138|NCT03297216|447819182|FG000|Overall Study|Death|0|||
124510139|NCT03297216|447819183|FG001|Overall Study|Death|1|||
124510140|NCT03297216|447819182|FG000|Overall Study|Miscarriage|0|||
124510141|NCT03297216|447819183|FG001|Overall Study|Miscarriage|2|||
124510142|NCT03297216|447819182|FG000|Overall Study|Lost to Follow-up|3|||
124510143|NCT03297216|447819183|FG001|Overall Study|Lost to Follow-up|2|||
124510144|NCT00603733|447819184|FG000|Active Phase ITT|Adverse Event|8|||
124510145|NCT00603733|447819185|FG001|Active Phase ITT|Adverse Event|7|||
124510146|NCT00603733|447819184|FG000|Active Phase ITT|Withdrawal by Subject|0|||
124510147|NCT00603733|447819185|FG001|Active Phase ITT|Withdrawal by Subject|3|||
124510148|NCT00603733|447819184|FG000|Active Phase ITT|Lost to Follow-up|0|||
124510149|NCT00603733|447819185|FG001|Active Phase ITT|Lost to Follow-up|1|||
124510150|NCT00603733|447819184|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
124510151|NCT00603733|447819185|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
124510152|NCT00603733|447819184|FG000|Active Phase ITT|Lack of Efficacy|1|||
124510153|NCT00603733|447819185|FG001|Active Phase ITT|Lack of Efficacy|2|||
124510154|NCT00603733|447819184|FG000|Active Phase ITT|Subject moved, site closed|1|||
124510155|NCT00603733|447819185|FG001|Active Phase ITT|Subject moved, site closed|1|||
124510156|NCT00603733|447819184|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
124510157|NCT00603733|447819185|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
124510158|NCT00603733|447819184|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
124510159|NCT00603733|447819185|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
124510160|NCT00603733|447819184|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
124510161|NCT00603733|447819185|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
124510162|NCT00603733|447819184|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
124510163|NCT00603733|447819185|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
124510164|NCT00603733|447819184|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
124510165|NCT00603733|447819185|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
124510166|NCT00603733|447819184|FG000|Maintenance Phase ITT|Adverse Event|3|||
124510167|NCT00603733|447819185|FG001|Maintenance Phase ITT|Adverse Event|6|||
124510168|NCT00603733|447819184|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
124510169|NCT00603733|447819185|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
124510170|NCT00603733|447819184|FG000|Maintenance Phase ITT|Protocol Violation|1|||
124510171|NCT00603733|447819185|FG001|Maintenance Phase ITT|Protocol Violation|1|||
124510172|NCT00603733|447819184|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
124510173|NCT00603733|447819185|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
124510174|NCT00603733|447819184|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
124510175|NCT00603733|447819185|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
124510176|NCT00603733|447819184|FG000|Maintenance Phase ITT|Physician Decision|0|||
124510177|NCT00603733|447819185|FG001|Maintenance Phase ITT|Physician Decision|1|||
124510178|NCT00603733|447819184|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
124510179|NCT00603733|447819185|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
124510180|NCT00912340|447819191|FG000|Overall Study|Adverse Event|2|||
124510181|NCT00912340|447819192|FG001|Overall Study|Adverse Event|4|||
124510182|NCT00912340|447819193|FG002|Overall Study|Adverse Event|0|||
124510183|NCT00912340|447819191|FG000|Overall Study|Protocol revised to remove arm|0|||
124510184|NCT00912340|447819192|FG001|Overall Study|Protocol revised to remove arm|0|||
124510185|NCT00912340|447819193|FG002|Overall Study|Protocol revised to remove arm|4|||
124510186|NCT01517412|447819198|FG000|Overall Study|Adverse Event|10|||
124510187|NCT01517412|447819199|FG001|Overall Study|Adverse Event|11|||
124510188|NCT01517412|447819198|FG000|Overall Study|Lack of Efficacy|10|||
124510189|NCT01517412|447819199|FG001|Overall Study|Lack of Efficacy|5|||
124510190|NCT01517412|447819198|FG000|Overall Study|Poor compliance to protocol|8|||
124510191|NCT01517412|447819199|FG001|Overall Study|Poor compliance to protocol|3|||
124510192|NCT01517412|447819198|FG000|Overall Study|Other than specified above|8|||
124510193|NCT01517412|447819199|FG001|Overall Study|Other than specified above|5|||
124510194|NCT01253187|447819200|FG000|Period 2|Withdrawal by Subject|0|||
124510195|NCT01253187|447819201|FG001|Period 2|Withdrawal by Subject|0|||
124510196|NCT01253187|447819202|FG002|Period 2|Withdrawal by Subject|0|||
124510197|NCT01253187|447819203|FG003|Period 2|Withdrawal by Subject|0|||
124510198|NCT01253187|447819204|FG004|Period 2|Withdrawal by Subject|1|||
124510199|NCT01253187|447819205|FG005|Period 2|Withdrawal by Subject|0|||
124510200|NCT01253187|447819200|FG000|Period 3|Pregnancy|1|||
124510201|NCT01253187|447819201|FG001|Period 3|Pregnancy|0|||
124510202|NCT01253187|447819202|FG002|Period 3|Pregnancy|0|||
124510203|NCT01253187|447819203|FG003|Period 3|Pregnancy|0|||
124510204|NCT01253187|447819204|FG004|Period 3|Pregnancy|0|||
124510205|NCT01253187|447819205|FG005|Period 3|Pregnancy|0|||
124510206|NCT01253187|447819200|FG000|Period 3|difficulty with blood sampling|0|||
124510207|NCT01253187|447819201|FG001|Period 3|difficulty with blood sampling|1|||
124510208|NCT01253187|447819202|FG002|Period 3|difficulty with blood sampling|0|||
124510209|NCT01253187|447819203|FG003|Period 3|difficulty with blood sampling|0|||
124510210|NCT01253187|447819204|FG004|Period 3|difficulty with blood sampling|0|||
124510211|NCT01253187|447819205|FG005|Period 3|difficulty with blood sampling|0|||
124510212|NCT01253187|447819200|FG000|Period 3|non-compliance|0|||
124510213|NCT01253187|447819201|FG001|Period 3|non-compliance|0|||
124510214|NCT01253187|447819202|FG002|Period 3|non-compliance|0|||
124510215|NCT01253187|447819203|FG003|Period 3|non-compliance|0|||
124510216|NCT01253187|447819204|FG004|Period 3|non-compliance|1|||
124510217|NCT01253187|447819205|FG005|Period 3|non-compliance|0|||
124510218|NCT01149343|447819207|FG000|Overall Study|Withdrawal by Subject|1|||
124510219|NCT01149343|447819208|FG001|Overall Study|Withdrawal by Subject|1|||
124510220|NCT01149343|447819209|FG002|Overall Study|Withdrawal by Subject|1|||
124510221|NCT01149343|447819210|FG003|Overall Study|Withdrawal by Subject|5|||
124510222|NCT01149343|447819207|FG000|Overall Study|Death|10|||
124510223|NCT01149343|447819208|FG001|Overall Study|Death|13|||
124510224|NCT01149343|447819209|FG002|Overall Study|Death|18|||
124510225|NCT01149343|447819210|FG003|Overall Study|Death|18|||
124510226|NCT01149343|447819207|FG000|Overall Study|Lost to Follow-up|1|||
124510227|NCT01149343|447819208|FG001|Overall Study|Lost to Follow-up|0|||
124510228|NCT01149343|447819209|FG002|Overall Study|Lost to Follow-up|0|||
124510229|NCT01149343|447819210|FG003|Overall Study|Lost to Follow-up|1|||
124510230|NCT01149343|447819207|FG000|Overall Study|Other|8|||
124510231|NCT01149343|447819208|FG001|Overall Study|Other|10|||
124510232|NCT01149343|447819209|FG002|Overall Study|Other|2|||
124510233|NCT01149343|447819210|FG003|Overall Study|Other|14|||
124510234|NCT01149343|447819207|FG000|Overall Study|Sponsor study termination|0|||
124510235|NCT01149343|447819208|FG001|Overall Study|Sponsor study termination|0|||
124510236|NCT01149343|447819209|FG002|Overall Study|Sponsor study termination|0|||
124510237|NCT01149343|447819210|FG003|Overall Study|Sponsor study termination|2|||
124510238|NCT01149343|447819207|FG000|Overall Study|Recurrence / Progressive disease|0|||
124510239|NCT01149343|447819208|FG001|Overall Study|Recurrence / Progressive disease|0|||
124510240|NCT01149343|447819209|FG002|Overall Study|Recurrence / Progressive disease|1|||
124510241|NCT01149343|447819210|FG003|Overall Study|Recurrence / Progressive disease|0|||
124510242|NCT01061736|447819211|FG000|Overall Study|Dose regimen not selected|0|||
124510243|NCT01061736|447819212|FG001|Overall Study|Dose regimen not selected|0|||
124510244|NCT01061736|447819213|FG002|Overall Study|Dose regimen not selected|0|||
124510245|NCT01061736|447819214|FG003|Overall Study|Dose regimen not selected|0|||
124510246|NCT01061736|447819215|FG004|Overall Study|Dose regimen not selected|0|||
124510247|NCT01061736|447819216|FG005|Overall Study|Dose regimen not selected|0|||
124510248|NCT01061736|447819217|FG006|Overall Study|Dose regimen not selected|79|||
124510249|NCT01061736|447819218|FG007|Overall Study|Dose regimen not selected|0|||
124510250|NCT01061736|447819219|FG008|Overall Study|Dose regimen not selected|0|||
124510251|NCT01061736|447819220|FG009|Overall Study|Dose regimen not selected|0|||
124510252|NCT01061736|447819211|FG000|Overall Study|Adverse Event|13|||
124510253|NCT01061736|447819212|FG001|Overall Study|Adverse Event|1|||
124510254|NCT01061736|447819213|FG002|Overall Study|Adverse Event|3|||
124510255|NCT01061736|447819214|FG003|Overall Study|Adverse Event|2|||
124510256|NCT01061736|447819215|FG004|Overall Study|Adverse Event|4|||
124510257|NCT01061736|447819216|FG005|Overall Study|Adverse Event|1|||
124510258|NCT01061736|447819217|FG006|Overall Study|Adverse Event|4|||
124510259|NCT01061736|447819218|FG007|Overall Study|Adverse Event|63|||
124510260|NCT01061736|447819219|FG008|Overall Study|Adverse Event|67|||
124510261|NCT01061736|447819220|FG009|Overall Study|Adverse Event|34|||
124565087|NCT00582309|448026124|FG002|Overall Study|Protocol Violation|2|||
124565088|NCT01309919|448026143|FG000|Overall Study|Did not receive a postpartum IUD|17|||
124510262|NCT01061736|447819211|FG000|Overall Study|Lack of Efficacy|0|||
124510263|NCT01061736|447819212|FG001|Overall Study|Lack of Efficacy|2|||
124510264|NCT01061736|447819213|FG002|Overall Study|Lack of Efficacy|1|||
124510265|NCT01061736|447819214|FG003|Overall Study|Lack of Efficacy|1|||
124510266|NCT01061736|447819215|FG004|Overall Study|Lack of Efficacy|1|||
124510267|NCT01061736|447819216|FG005|Overall Study|Lack of Efficacy|2|||
124510268|NCT01061736|447819217|FG006|Overall Study|Lack of Efficacy|1|||
124510269|NCT01061736|447819218|FG007|Overall Study|Lack of Efficacy|9|||
124510270|NCT01061736|447819219|FG008|Overall Study|Lack of Efficacy|9|||
124510271|NCT01061736|447819220|FG009|Overall Study|Lack of Efficacy|10|||
124510272|NCT01061736|447819211|FG000|Overall Study|Poor compliance to protocol|0|||
124510273|NCT01061736|447819212|FG001|Overall Study|Poor compliance to protocol|0|||
124510274|NCT01061736|447819213|FG002|Overall Study|Poor compliance to protocol|0|||
124510275|NCT01061736|447819214|FG003|Overall Study|Poor compliance to protocol|0|||
124510276|NCT01061736|447819215|FG004|Overall Study|Poor compliance to protocol|0|||
124510277|NCT01061736|447819216|FG005|Overall Study|Poor compliance to protocol|0|||
124510278|NCT01061736|447819217|FG006|Overall Study|Poor compliance to protocol|0|||
124510279|NCT01061736|447819218|FG007|Overall Study|Poor compliance to protocol|2|||
124510280|NCT01061736|447819219|FG008|Overall Study|Poor compliance to protocol|5|||
124510281|NCT01061736|447819220|FG009|Overall Study|Poor compliance to protocol|9|||
124510282|NCT01061736|447819211|FG000|Overall Study|Not treated|0|||
124510283|NCT01061736|447819212|FG001|Overall Study|Not treated|0|||
124510284|NCT01061736|447819213|FG002|Overall Study|Not treated|0|||
124510285|NCT01061736|447819214|FG003|Overall Study|Not treated|0|||
124510286|NCT01061736|447819215|FG004|Overall Study|Not treated|1|||
124510287|NCT01061736|447819216|FG005|Overall Study|Not treated|0|||
124510288|NCT01061736|447819217|FG006|Overall Study|Not treated|0|||
124510289|NCT01061736|447819218|FG007|Overall Study|Not treated|2|||
124510290|NCT01061736|447819219|FG008|Overall Study|Not treated|1|||
124510291|NCT01061736|447819220|FG009|Overall Study|Not treated|0|||
124510292|NCT01061736|447819211|FG000|Overall Study|Other than specified above|0|||
124510293|NCT01061736|447819212|FG001|Overall Study|Other than specified above|1|||
124510294|NCT01061736|447819213|FG002|Overall Study|Other than specified above|2|||
124510295|NCT01061736|447819214|FG003|Overall Study|Other than specified above|0|||
124510296|NCT01061736|447819215|FG004|Overall Study|Other than specified above|1|||
124510297|NCT01061736|447819216|FG005|Overall Study|Other than specified above|0|||
124510298|NCT01061736|447819217|FG006|Overall Study|Other than specified above|0|||
124510299|NCT01061736|447819218|FG007|Overall Study|Other than specified above|18|||
124510300|NCT01061736|447819219|FG008|Overall Study|Other than specified above|15|||
124510301|NCT01061736|447819220|FG009|Overall Study|Other than specified above|21|||
124510302|NCT01429077|447819228|FG000|Overall Study|Lost to Follow-up|0|||
124510303|NCT01429077|447819229|FG001|Overall Study|Lost to Follow-up|3|||
124510304|NCT01103778|447819231|FG000|Overall Study|Lost to Follow-up|1|||
124510305|NCT01103778|447819231|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
124510306|NCT01103778|447819231|FG000|Overall Study|Screen failure|1|||
124510307|NCT03084718|447819232|FG000|Overall Study|Withdrawal by Subject|4|||
124510308|NCT03084718|447819233|FG001|Overall Study|Withdrawal by Subject|3|||
124510309|NCT03084718|447819234|FG002|Overall Study|Withdrawal by Subject|4|||
124510310|NCT03084718|447819235|FG003|Overall Study|Withdrawal by Subject|0|||
124510311|NCT03084718|447819236|FG004|Overall Study|Withdrawal by Subject|0|||
124510312|NCT03084718|447819232|FG000|Overall Study|Physician Decision|1|||
124510313|NCT03084718|447819233|FG001|Overall Study|Physician Decision|0|||
124510314|NCT03084718|447819234|FG002|Overall Study|Physician Decision|0|||
124510315|NCT03084718|447819235|FG003|Overall Study|Physician Decision|0|||
124510316|NCT03084718|447819236|FG004|Overall Study|Physician Decision|0|||
124510317|NCT03084718|447819232|FG000|Overall Study|Adverse Event|3|||
124510318|NCT03084718|447819233|FG001|Overall Study|Adverse Event|5|||
124510319|NCT03084718|447819234|FG002|Overall Study|Adverse Event|5|||
124510320|NCT03084718|447819235|FG003|Overall Study|Adverse Event|8|||
124510321|NCT03084718|447819236|FG004|Overall Study|Adverse Event|2|||
124510322|NCT03084718|447819232|FG000|Overall Study|Lack of Efficacy|2|||
124510323|NCT03084718|447819233|FG001|Overall Study|Lack of Efficacy|0|||
124510324|NCT03084718|447819234|FG002|Overall Study|Lack of Efficacy|1|||
124510325|NCT03084718|447819235|FG003|Overall Study|Lack of Efficacy|4|||
124510326|NCT03084718|447819236|FG004|Overall Study|Lack of Efficacy|0|||
124510327|NCT03084718|447819232|FG000|Overall Study|Lost to Follow-up|0|||
124510328|NCT03084718|447819233|FG001|Overall Study|Lost to Follow-up|1|||
124510329|NCT03084718|447819234|FG002|Overall Study|Lost to Follow-up|0|||
124510330|NCT03084718|447819235|FG003|Overall Study|Lost to Follow-up|0|||
124510331|NCT03084718|447819236|FG004|Overall Study|Lost to Follow-up|2|||
124510332|NCT03084718|447819232|FG000|Overall Study|Protocol Violation|0|||
124510333|NCT03084718|447819233|FG001|Overall Study|Protocol Violation|0|||
124510334|NCT03084718|447819234|FG002|Overall Study|Protocol Violation|1|||
124510335|NCT03084718|447819235|FG003|Overall Study|Protocol Violation|0|||
124510336|NCT03084718|447819236|FG004|Overall Study|Protocol Violation|0|||
124510337|NCT03084718|447819232|FG000|Overall Study|Death|0|||
124510338|NCT03084718|447819233|FG001|Overall Study|Death|1|||
124510339|NCT03084718|447819234|FG002|Overall Study|Death|0|||
124510340|NCT03084718|447819235|FG003|Overall Study|Death|0|||
124510341|NCT03084718|447819236|FG004|Overall Study|Death|0|||
124510342|NCT03084718|447819232|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
124510343|NCT03084718|447819233|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
124510344|NCT03084718|447819234|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
124510345|NCT03084718|447819235|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
124510346|NCT03084718|447819236|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
124510347|NCT04929613|447819237|FG000|Overall Study|Withdrawal by Subject|12|||
124510348|NCT00865189|447819238|FG000|Overall Study|Other|1|||
124510349|NCT00865189|447819239|FG001|Overall Study|Other|2|||
124510350|NCT00865189|447819238|FG000|Overall Study|Death|4|||
124510351|NCT00865189|447819239|FG001|Overall Study|Death|11|||
124510352|NCT00865189|447819238|FG000|Overall Study|Lost to Follow-up|6|||
124510353|NCT00865189|447819239|FG001|Overall Study|Lost to Follow-up|6|||
124565089|NCT01309919|448026144|FG001|Overall Study|Did not receive a postpartum IUD|48|||
124565090|NCT00319449|448026145|FG000|Overall Study|Subject did not wish to continue|1|||
124565091|NCT00319449|448026146|FG001|Overall Study|Subject did not wish to continue|0|||
124565092|NCT00319449|448026145|FG000|Overall Study|Noncompliance with the protocol|1|||
124565093|NCT00319449|448026146|FG001|Overall Study|Noncompliance with the protocol|0|||
124565094|NCT02102490|448026147|FG000|Overall Study|Death|6|||
124565095|NCT02102490|448026147|FG000|Overall Study|Lost to Follow-up|1|||
124565096|NCT01346410|448026148|FG000|Overall Study|Death|1|||
124565097|NCT00979628|448026149|FG000|Overall Study|received regimen < 24 hours|7|||
124565098|NCT00979628|448026150|FG001|Overall Study|received regimen < 24 hours|6|||
124565099|NCT00979628|448026151|FG002|Overall Study|received regimen < 24 hours|5|||
124565100|NCT00979628|448026149|FG000|Overall Study|received steroids|1|||
124565101|NCT00979628|448026150|FG001|Overall Study|received steroids|1|||
124565102|NCT00979628|448026151|FG002|Overall Study|received steroids|0|||
124565103|NCT00979628|448026149|FG000|Overall Study|transferred to ICU|1|||
124565104|NCT00979628|448026150|FG001|Overall Study|transferred to ICU|2|||
124565105|NCT00979628|448026151|FG002|Overall Study|transferred to ICU|1|||
124565106|NCT02146430|448027990|FG000|Overall Study|Protocol Violation|5|||
124565107|NCT02146430|448027991|FG001|Overall Study|Protocol Violation|4|||
124565108|NCT02146430|448027992|FG002|Overall Study|Protocol Violation|8|||
124565109|NCT02146430|448027993|FG003|Overall Study|Protocol Violation|6|||
124565110|NCT02146430|448027990|FG000|Overall Study|Lack of Efficacy|13|||
124565111|NCT02146430|448027991|FG001|Overall Study|Lack of Efficacy|11|||
124565112|NCT02146430|448027992|FG002|Overall Study|Lack of Efficacy|8|||
124565113|NCT02146430|448027993|FG003|Overall Study|Lack of Efficacy|5|||
124565114|NCT02146430|448027990|FG000|Overall Study|Adverse Event|20|||
124565115|NCT02146430|448027991|FG001|Overall Study|Adverse Event|40|||
124565116|NCT02146430|448027992|FG002|Overall Study|Adverse Event|32|||
124565117|NCT02146430|448027993|FG003|Overall Study|Adverse Event|49|||
124565118|NCT02146430|448027990|FG000|Overall Study|Reason missing or not reported|2|||
124565119|NCT02146430|448027991|FG001|Overall Study|Reason missing or not reported|3|||
124565120|NCT02146430|448027992|FG002|Overall Study|Reason missing or not reported|4|||
124565121|NCT02146430|448027993|FG003|Overall Study|Reason missing or not reported|5|||
124565122|NCT02146430|448027990|FG000|Overall Study|Withdrawal by Subject|27|||
124565123|NCT02146430|448027991|FG001|Overall Study|Withdrawal by Subject|29|||
124565124|NCT02146430|448027992|FG002|Overall Study|Withdrawal by Subject|30|||
124565125|NCT02146430|448027993|FG003|Overall Study|Withdrawal by Subject|34|||
124565126|NCT01893905|448027994|FG000|Overall Study|Withdrawal by Subject|1|||
124565127|NCT01893905|448027995|FG001|Overall Study|Withdrawal by Subject|0|||
124565128|NCT01893905|448027994|FG000|Overall Study|Adverse Event|9|||
124565129|NCT01893905|448027995|FG001|Overall Study|Adverse Event|3|||
124565130|NCT01893905|448027994|FG000|Overall Study|Lack of Efficacy|5|||
124565131|NCT01893905|448027995|FG001|Overall Study|Lack of Efficacy|7|||
124565132|NCT01893905|448027994|FG000|Overall Study|Lost to Follow-up|1|||
124565133|NCT01893905|448027995|FG001|Overall Study|Lost to Follow-up|0|||
124565134|NCT01893905|448027994|FG000|Overall Study|Protocol Violation|6|||
124565135|NCT01893905|448027995|FG001|Overall Study|Protocol Violation|1|||
124565136|NCT01893905|448027994|FG000|Overall Study|Lack of adherence to treatment|2|||
124510354|NCT00865189|447819238|FG000|Overall Study|Withdrawal by Subject|1|||
124510355|NCT00865189|447819239|FG001|Overall Study|Withdrawal by Subject|0|||
124510356|NCT02767856|447819251|FG000|Overall Study|Lost to Follow-up|9|||
124510357|NCT02767856|447819252|FG001|Overall Study|Lost to Follow-up|1|||
124510358|NCT02767856|447819251|FG000|Overall Study|Withdrawal by Subject|2|||
124510359|NCT02767856|447819252|FG001|Overall Study|Withdrawal by Subject|1|||
124510360|NCT01464788|447819255|FG000|Overall Study|Lost to Follow-up|0|||
124724861|NCT03530995|448613334|FG000|Part 1 Period 3|Protocol Violation|1|||
124724862|NCT03530995|448613335|FG001|Part 1 Period 3|Protocol Violation|0|||
124724863|NCT03530995|448613334|FG000|Part 1 Period 4|Physician Decision|1|||
124724864|NCT03530995|448613335|FG001|Part 1 Period 4|Physician Decision|0|||
124510361|NCT01464788|447819256|FG001|Overall Study|Lost to Follow-up|1|||
124510362|NCT01464788|447819257|FG002|Overall Study|Lost to Follow-up|0|||
124510363|NCT01464788|447819255|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
124510364|NCT01464788|447819256|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
124510365|NCT01464788|447819257|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
124565137|NCT01893905|448027995|FG001|Overall Study|Lack of adherence to treatment|0|||
124565138|NCT01893905|448027994|FG000|Overall Study|Other reason|1|||
124565139|NCT01893905|448027995|FG001|Overall Study|Other reason|3|||
124565140|NCT01768858|448027996|FG000|Overall Study|Lost to Follow-up|9|||
124565141|NCT01768858|448027996|FG000|Overall Study|Lack of Efficacy|8|||
124565142|NCT01768858|448027996|FG000|Overall Study|Serious Adverse Event|1|||
124565143|NCT01768858|448027996|FG000|Overall Study|Participant moved to Germany|1|||
124565144|NCT01768858|448027996|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
124565145|NCT01768858|448027996|FG000|Overall Study|Exanthema|1|||
124565146|NCT01768858|448027996|FG000|Overall Study|Withdrawal by Subject|1|||
124565147|NCT03312530|448027997|FG000|Overall Study|Death|5|||
124724865|NCT03530995|448613334|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
124724866|NCT03530995|448613335|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
124565148|NCT03312530|448027998|FG001|Overall Study|Death|5|||
124565149|NCT03312530|448027999|FG002|Overall Study|Death|4|||
124565150|NCT03312530|448028000|FG003|Overall Study|Death|10|||
124565151|NCT03312530|448028001|FG004|Overall Study|Death|8|||
124565152|NCT03312530|448027997|FG000|Overall Study|Lost to Follow-up|0|||
124565153|NCT03312530|448027998|FG001|Overall Study|Lost to Follow-up|0|||
124565154|NCT03312530|448027999|FG002|Overall Study|Lost to Follow-up|0|||
124565155|NCT03312530|448028000|FG003|Overall Study|Lost to Follow-up|1|||
124565156|NCT03312530|448028001|FG004|Overall Study|Lost to Follow-up|0|||
124565157|NCT03312530|448027997|FG000|Overall Study|Participant in another sponsor study.|0|||
124565158|NCT03312530|448027998|FG001|Overall Study|Participant in another sponsor study.|0|||
124565159|NCT03312530|448027999|FG002|Overall Study|Participant in another sponsor study.|0|||
124565160|NCT03312530|448028000|FG003|Overall Study|Participant in another sponsor study.|1|||
124565161|NCT03312530|448028001|FG004|Overall Study|Participant in another sponsor study.|0|||
124565162|NCT03312530|448027997|FG000|Overall Study|Study terminated by sponsor|1|||
124565163|NCT03312530|448027998|FG001|Overall Study|Study terminated by sponsor|0|||
124565164|NCT03312530|448027999|FG002|Overall Study|Study terminated by sponsor|2|||
124565165|NCT03312530|448028000|FG003|Overall Study|Study terminated by sponsor|3|||
124565166|NCT03312530|448028001|FG004|Overall Study|Study terminated by sponsor|7|||
124565167|NCT03312530|448027997|FG000|Overall Study|Withdrawal by Subject|0|||
124565168|NCT03312530|448027998|FG001|Overall Study|Withdrawal by Subject|1|||
124565169|NCT03312530|448027999|FG002|Overall Study|Withdrawal by Subject|0|||
124565170|NCT03312530|448028000|FG003|Overall Study|Withdrawal by Subject|0|||
124565171|NCT03312530|448028001|FG004|Overall Study|Withdrawal by Subject|0|||
124565172|NCT03312530|448027997|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
124565173|NCT03312530|448027998|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
124565174|NCT03312530|448027999|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
124565175|NCT03312530|448028000|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
124565176|NCT03312530|448028001|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
124565177|NCT01691859|448028004|FG000|Overall Study|Adverse Event|19|||
124565178|NCT01691859|448028004|FG000|Overall Study|Lack of Efficacy|11|||
124565179|NCT01691859|448028004|FG000|Overall Study|Protocol Violation|4|||
124565180|NCT01691859|448028004|FG000|Overall Study|Product commercially available|221|||
124565181|NCT01691859|448028004|FG000|Overall Study|Study closed/terminated|50|||
124565182|NCT01691859|448028004|FG000|Overall Study|Lost to Follow-up|5|||
124565183|NCT01691859|448028004|FG000|Overall Study|Physician Decision|6|||
124565184|NCT01691859|448028004|FG000|Overall Study|Withdrawal by Subject|31|||
124565185|NCT04820842|448028005|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
124565186|NCT04820842|448028006|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
124565187|NCT04820842|448028007|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
124565188|NCT04820842|448028008|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
124565189|NCT04820842|448028009|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
124565190|NCT04820842|448028010|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
124565191|NCT04820842|448028011|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
124565192|NCT04820842|448028005|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
124565193|NCT04820842|448028006|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
124565194|NCT04820842|448028007|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
124565195|NCT04820842|448028008|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
124565196|NCT04820842|448028009|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
124565197|NCT04820842|448028010|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
124565198|NCT04820842|448028011|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
124565199|NCT04820842|448028005|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
124565200|NCT04820842|448028006|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
124565201|NCT04820842|448028007|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
124565202|NCT04820842|448028008|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
124565203|NCT04820842|448028009|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
124565204|NCT04820842|448028010|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
124565205|NCT04820842|448028011|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
124565206|NCT04820842|448028005|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
124565207|NCT04820842|448028006|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
124724867|NCT01986231|448613339|FG000|Overall Study|Adverse Event|1|||
124724868|NCT01558115|448613340|FG000|Overall Study|Withdrawal by Subject|3|||
124565208|NCT04820842|448028007|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
124565209|NCT04820842|448028008|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
124565210|NCT04820842|448028009|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
124565211|NCT04820842|448028010|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
124565212|NCT04820842|448028011|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
124565213|NCT01090765|448028014|FG000|Overall Study|Patient withdrew consent|0|||
124565214|NCT01090765|448028015|FG001|Overall Study|Patient withdrew consent|0|||
124565215|NCT01090765|448028016|FG002|Overall Study|Patient withdrew consent|0|||
124565216|NCT01090765|448028017|FG003|Overall Study|Patient withdrew consent|0|||
124565217|NCT01090765|448028018|FG004|Overall Study|Patient withdrew consent|1|||
124565218|NCT01090765|448028019|FG005|Overall Study|Patient withdrew consent|1|||
124565219|NCT01090765|448028014|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
124565220|NCT01090765|448028015|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
124565221|NCT01090765|448028016|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
124565222|NCT01090765|448028017|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
124565223|NCT01090765|448028018|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
124565224|NCT01090765|448028019|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
124565225|NCT01090765|448028014|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
124565226|NCT01090765|448028015|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
124565227|NCT01090765|448028016|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
124565228|NCT01090765|448028017|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
124565229|NCT01090765|448028018|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
124565230|NCT01090765|448028019|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
124565231|NCT02623959|448028023|FG000|Overall Study|Progression|0|||
124565232|NCT02623959|448028024|FG001|Overall Study|Progression|1|||
124565233|NCT02336737|448028027|FG000|Overall Study|Withdrawal by Subject|5|||
124565234|NCT02336737|448028027|FG000|Overall Study|Physician Decision|8|||
124565235|NCT02396381|448028028|FG000|Overall Study|Adverse Event|3|||
124565236|NCT02396381|448028029|FG001|Overall Study|Adverse Event|2|||
124565237|NCT02396381|448028028|FG000|Overall Study|Withdrawal by Subject|33|||
124565238|NCT02396381|448028029|FG001|Overall Study|Withdrawal by Subject|24|||
124565239|NCT02396381|448028028|FG000|Overall Study|Lost to Follow-up|49|||
124565240|NCT02396381|448028029|FG001|Overall Study|Lost to Follow-up|31|||
124565241|NCT02396381|448028028|FG000|Overall Study|Protocol Violation|1|||
124565242|NCT02396381|448028029|FG001|Overall Study|Protocol Violation|0|||
124565243|NCT02396381|448028028|FG000|Overall Study|Site terminated by sponsor|7|||
124565244|NCT02396381|448028029|FG001|Overall Study|Site terminated by sponsor|8|||
124565245|NCT02396381|448028028|FG000|Overall Study|Physician Decision|5|||
124565246|NCT02396381|448028029|FG001|Overall Study|Physician Decision|5|||
124565247|NCT02396381|448028028|FG000|Overall Study|Pregnancy|2|||
124565248|NCT02396381|448028029|FG001|Overall Study|Pregnancy|0|||
124565249|NCT02396381|448028028|FG000|Overall Study|Non-compliance with study procedures|1|||
124565250|NCT02396381|448028029|FG001|Overall Study|Non-compliance with study procedures|0|||
124565251|NCT02396381|448028028|FG000|Overall Study|Moved out of town/state|1|||
124565252|NCT02396381|448028029|FG001|Overall Study|Moved out of town/state|3|||
124565253|NCT02396381|448028028|FG000|Overall Study|Could not complete visit|1|||
124565254|NCT02396381|448028029|FG001|Overall Study|Could not complete visit|0|||
124565255|NCT02396381|448028028|FG000|Overall Study|Possible conflict of interest|1|||
124565256|NCT02396381|448028029|FG001|Overall Study|Possible conflict of interest|0|||
124565257|NCT02396381|448028028|FG000|Overall Study|Randomization/Screening Error|3|||
124565258|NCT02396381|448028029|FG001|Overall Study|Randomization/Screening Error|1|||
124565259|NCT00635778|448028031|FG000|Overall Study|Adverse Event|1|||
124565260|NCT00635778|448028032|FG001|Overall Study|Adverse Event|0|||
124565261|NCT00635778|448028033|FG002|Overall Study|Adverse Event|0|||
124565262|NCT00635778|448028034|FG003|Overall Study|Adverse Event|3|||
124565263|NCT00635778|448028035|FG004|Overall Study|Adverse Event|3|||
124565264|NCT00635778|448028036|FG005|Overall Study|Adverse Event|6|||
124565265|NCT00635778|448028037|FG006|Overall Study|Adverse Event|1|||
124565266|NCT00635778|448028031|FG000|Overall Study|Withdrawal by Subject|0|||
124565267|NCT00635778|448028032|FG001|Overall Study|Withdrawal by Subject|0|||
124565268|NCT00635778|448028033|FG002|Overall Study|Withdrawal by Subject|0|||
124565269|NCT00635778|448028034|FG003|Overall Study|Withdrawal by Subject|1|||
124565270|NCT00635778|448028035|FG004|Overall Study|Withdrawal by Subject|0|||
124565271|NCT00635778|448028036|FG005|Overall Study|Withdrawal by Subject|1|||
124565272|NCT00635778|448028037|FG006|Overall Study|Withdrawal by Subject|1|||
124565273|NCT00635778|448028031|FG000|Overall Study|Progressive disease|0|||
124565274|NCT00635778|448028032|FG001|Overall Study|Progressive disease|3|||
124565275|NCT00635778|448028033|FG002|Overall Study|Progressive disease|3|||
124565276|NCT00635778|448028034|FG003|Overall Study|Progressive disease|4|||
124565277|NCT00635778|448028035|FG004|Overall Study|Progressive disease|5|||
124565278|NCT00635778|448028036|FG005|Overall Study|Progressive disease|14|||
124565279|NCT00635778|448028037|FG006|Overall Study|Progressive disease|4|||
124565280|NCT01884025|448028038|FG000|Overall Study|Lost to Follow-up|3|||
124565281|NCT01884025|448028039|FG001|Overall Study|Lost to Follow-up|4|||
124565282|NCT02324465|448028040|FG000|Overall Study|device failure|0|||
124565283|NCT02324465|448028041|FG001|Overall Study|device failure|1|||
124565284|NCT02655237|448028044|FG000|Overall Study|Adverse Event|10|||
124565285|NCT02655237|448028045|FG001|Overall Study|Adverse Event|7|||
124565286|NCT02655237|448028044|FG000|Overall Study|Protocol Deviation|2|||
124565287|NCT02655237|448028045|FG001|Overall Study|Protocol Deviation|0|||
124565288|NCT02655237|448028044|FG000|Overall Study|Withdrawal by Participant|1|||
124565289|NCT02655237|448028045|FG001|Overall Study|Withdrawal by Participant|2|||
124565290|NCT02655237|448028044|FG000|Overall Study|Lack of Efficacy|0|||
124565291|NCT02655237|448028045|FG001|Overall Study|Lack of Efficacy|1|||
124565292|NCT02655237|448028044|FG000|Overall Study|Recovery Leading to Surgery|2|||
124565293|NCT02655237|448028045|FG001|Overall Study|Recovery Leading to Surgery|1|||
124565294|NCT02655237|448028044|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
124565295|NCT02655237|448028045|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
124565296|NCT02655237|448028044|FG000|Overall Study|Randomized but Not Treated|1|||
124565297|NCT02655237|448028045|FG001|Overall Study|Randomized but Not Treated|0|||
124565298|NCT01860976|448028048|FG000|Blinded Treatment|Adverse Event|1|||
124565299|NCT01860976|448028049|FG001|Blinded Treatment|Adverse Event|3|||
124565300|NCT01860976|448028048|FG000|Blinded Treatment|Lack of Efficacy|5|||
124565301|NCT01860976|448028049|FG001|Blinded Treatment|Lack of Efficacy|12|||
124565302|NCT01860976|448028048|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
124565303|NCT01860976|448028049|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
124565304|NCT01860976|448028048|FG000|Blinded Treatment|Withdrawal by Subject|3|||
124565305|NCT01860976|448028049|FG001|Blinded Treatment|Withdrawal by Subject|5|||
124565306|NCT01860976|448028048|FG000|Blinded Treatment|Subject no longer met criteria|1|||
124565307|NCT01860976|448028049|FG001|Blinded Treatment|Subject no longer met criteria|0|||
124565308|NCT01860976|448028048|FG000|Blinded Treatment|Entered Open-Label in error|0|||
124565309|NCT01860976|448028049|FG001|Blinded Treatment|Entered Open-Label in error|1|||
124565310|NCT01860976|448028048|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
124565311|NCT01860976|448028049|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
124565312|NCT01860976|448028048|FG000|Open-Label|Adverse Event|2|||
124565313|NCT01860976|448028049|FG001|Open-Label|Adverse Event|4|||
124565314|NCT01860976|448028048|FG000|Open-Label|Lack of Efficacy|16|||
124565315|NCT01860976|448028049|FG001|Open-Label|Lack of Efficacy|8|||
124565316|NCT01860976|448028048|FG000|Open-Label|Lost to Follow-up|1|||
124565317|NCT01860976|448028049|FG001|Open-Label|Lost to Follow-up|2|||
124565318|NCT01860976|448028048|FG000|Open-Label|Subject request discontinue treatment|4|||
124565319|NCT01860976|448028049|FG001|Open-Label|Subject request discontinue treatment|3|||
124565320|NCT01860976|448028048|FG000|Open-Label|Withdrawal by Subject|4|||
124565321|NCT01860976|448028049|FG001|Open-Label|Withdrawal by Subject|1|||
124565322|NCT01860976|448028048|FG000|Open-Label|Other Reasons|1|||
124565323|NCT01860976|448028049|FG001|Open-Label|Other Reasons|1|||
124565324|NCT01860976|448028048|FG000|Long Term Extension|Adverse Event|4|||
124565325|NCT01860976|448028049|FG001|Long Term Extension|Adverse Event|0|||
124565326|NCT01860976|448028048|FG000|Long Term Extension|Lack of Efficacy|2|||
124565327|NCT01860976|448028049|FG001|Long Term Extension|Lack of Efficacy|0|||
124565328|NCT01860976|448028048|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
124565329|NCT01860976|448028049|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
124565330|NCT01860976|448028048|FG000|Long Term Extension|Lost to Follow-up|2|||
124565331|NCT01860976|448028049|FG001|Long Term Extension|Lost to Follow-up|0|||
124565332|NCT01860976|448028048|FG000|Long Term Extension|subject withdrew consent|7|||
124565333|NCT01860976|448028049|FG001|Long Term Extension|subject withdrew consent|0|||
124510366|NCT00091026|447819258|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
124510367|NCT00091026|447819259|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
124510368|NCT00091026|447819258|FG000|Overall Study|Patient withdrew and never received trea|0|||
124510369|NCT00091026|447819259|FG001|Overall Study|Patient withdrew and never received trea|2|||
124510370|NCT00091026|447819258|FG000|Overall Study|Unknown-never received treatment|0|||
124510371|NCT00091026|447819259|FG001|Overall Study|Unknown-never received treatment|1|||
124510372|NCT00418379|447819262|FG000|Year 1|Adverse Event|9|||
124565334|NCT02227862|448028050|FG000|Overall Study|Protocol Violation|7|||
124565335|NCT02227862|448028051|FG001|Overall Study|Protocol Violation|9|||
124565336|NCT02227862|448028050|FG000|Overall Study|Other|0|||
124565337|NCT02227862|448028051|FG001|Overall Study|Other|2|||
124565338|NCT02227862|448028050|FG000|Overall Study|Adverse Event|4|||
124565339|NCT02227862|448028051|FG001|Overall Study|Adverse Event|3|||
124565340|NCT02227862|448028050|FG000|Overall Study|Withdrawal by Subject|7|||
124565341|NCT02227862|448028051|FG001|Overall Study|Withdrawal by Subject|6|||
124565342|NCT02227862|448028050|FG000|Overall Study|Lost to Follow-up|1|||
124565343|NCT02227862|448028051|FG001|Overall Study|Lost to Follow-up|2|||
124565344|NCT02419313|448028057|FG000|First Intervention|Lost to Follow-up|2|||
124565345|NCT02419313|448028058|FG001|First Intervention|Lost to Follow-up|0|||
124565346|NCT02419313|448028057|FG000|Second Intervention|Lost to Follow-up|1|||
124510373|NCT00418379|447819263|FG001|Year 1|Adverse Event|15|||
124510374|NCT00418379|447819264|FG002|Year 1|Adverse Event|3|||
124510375|NCT00418379|447819262|FG000|Year 1|Withdrawal by Subject|7|||
124510376|NCT00418379|447819263|FG001|Year 1|Withdrawal by Subject|8|||
124565347|NCT02419313|448028058|FG001|Second Intervention|Lost to Follow-up|0|||
124565348|NCT00620763|448028059|FG000|Period: First Intervention|Withdrawal by Subject|0|||
124565349|NCT00620763|448028060|FG001|Period: First Intervention|Withdrawal by Subject|2|||
124510377|NCT00418379|447819264|FG002|Year 1|Withdrawal by Subject|5|||
124510378|NCT00418379|447819262|FG000|Year 1|Any other reason not above-mentioned|2|||
124510379|NCT00418379|447819263|FG001|Year 1|Any other reason not above-mentioned|5|||
124510380|NCT00418379|447819264|FG002|Year 1|Any other reason not above-mentioned|7|||
124510381|NCT00418379|447819262|FG000|Year 2|Adverse Event|5|||
124510382|NCT00418379|447819263|FG001|Year 2|Adverse Event|2|||
124510383|NCT00418379|447819264|FG002|Year 2|Adverse Event|1|||
124510384|NCT00418379|447819262|FG000|Year 2|Withdrawal by Subject|1|||
124510385|NCT00418379|447819263|FG001|Year 2|Withdrawal by Subject|1|||
124510386|NCT00418379|447819264|FG002|Year 2|Withdrawal by Subject|3|||
124510387|NCT00418379|447819262|FG000|Year 2|Any other reason not above-mentioned|2|||
124510388|NCT00418379|447819263|FG001|Year 2|Any other reason not above-mentioned|1|||
124510389|NCT00418379|447819264|FG002|Year 2|Any other reason not above-mentioned|6|||
124510390|NCT00418379|447819262|FG000|Year 3|Withdrawal by Subject|1|||
124510391|NCT00418379|447819263|FG001|Year 3|Withdrawal by Subject|1|||
124510392|NCT00418379|447819264|FG002|Year 3|Withdrawal by Subject|2|||
124510393|NCT00418379|447819262|FG000|Year 3|Any other reason not above-mentioned|2|||
124510394|NCT00418379|447819263|FG001|Year 3|Any other reason not above-mentioned|1|||
124510395|NCT00418379|447819264|FG002|Year 3|Any other reason not above-mentioned|1|||
124510396|NCT00418379|447819262|FG000|Year 4|Adverse Event|0|||
124510397|NCT00418379|447819263|FG001|Year 4|Adverse Event|1|||
124510398|NCT00418379|447819264|FG002|Year 4|Adverse Event|0|||
124510399|NCT00418379|447819262|FG000|Year 4|Withdrawal by Subject|2|||
124510400|NCT00418379|447819263|FG001|Year 4|Withdrawal by Subject|3|||
124510401|NCT00418379|447819264|FG002|Year 4|Withdrawal by Subject|2|||
124510402|NCT00418379|447819262|FG000|Year 4|Any other reason not above-mentioned|1|||
124510403|NCT00418379|447819263|FG001|Year 4|Any other reason not above-mentioned|1|||
124510404|NCT00418379|447819264|FG002|Year 4|Any other reason not above-mentioned|0|||
124510405|NCT00418379|447819262|FG000|Year 5|Adverse Event|0|||
124510406|NCT00418379|447819263|FG001|Year 5|Adverse Event|1|||
124510407|NCT00418379|447819264|FG002|Year 5|Adverse Event|0|||
124510408|NCT00418379|447819262|FG000|Year 5|Any other reason not above-mentioned|2|||
124510409|NCT00418379|447819263|FG001|Year 5|Any other reason not above-mentioned|4|||
124510410|NCT00418379|447819264|FG002|Year 5|Any other reason not above-mentioned|3|||
124510411|NCT00843843|447819265|FG000|Overall Study|Physician Decision|1|||
124510412|NCT00843843|447819266|FG001|Overall Study|Physician Decision|1|||
124510413|NCT00843843|447819265|FG000|Overall Study|Protocol Violation|1|||
124510414|NCT00843843|447819266|FG001|Overall Study|Protocol Violation|1|||
124510415|NCT00589979|447819267|FG000|Run-In Period|Adverse Event|5|||
124510416|NCT00589979|447819268|FG001|Run-In Period|Adverse Event|0|||
124510417|NCT00589979|447819269|FG002|Run-In Period|Adverse Event|0|||
124510418|NCT00589979|447819267|FG000|Run-In Period|Protocol Violation|3|||
124510419|NCT00589979|447819268|FG001|Run-In Period|Protocol Violation|0|||
124510420|NCT00589979|447819269|FG002|Run-In Period|Protocol Violation|0|||
124510421|NCT00589979|447819267|FG000|Run-In Period|Did not qualify for randomization|54|||
124510422|NCT00589979|447819268|FG001|Run-In Period|Did not qualify for randomization|0|||
124510423|NCT00589979|447819269|FG002|Run-In Period|Did not qualify for randomization|0|||
124510424|NCT00589979|447819267|FG000|Run-In Period|Withdrawal by Subject|10|||
124510425|NCT00589979|447819268|FG001|Run-In Period|Withdrawal by Subject|0|||
124510426|NCT00589979|447819269|FG002|Run-In Period|Withdrawal by Subject|0|||
124510427|NCT00589979|447819267|FG000|Run-In Period|Informed Consent Withdrawn|4|||
124510428|NCT00589979|447819268|FG001|Run-In Period|Informed Consent Withdrawn|0|||
124510429|NCT00589979|447819269|FG002|Run-In Period|Informed Consent Withdrawn|0|||
124510430|NCT00589979|447819267|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
124510431|NCT00589979|447819268|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
124510432|NCT00589979|447819269|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
124510433|NCT00589979|447819267|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
124510434|NCT00589979|447819268|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
124510435|NCT00589979|447819269|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
124510436|NCT00589979|447819267|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
124510437|NCT00589979|447819268|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
124565350|NCT00620763|448028059|FG000|Period: First Intervention|Protocol Violation|0|||
124510438|NCT00589979|447819269|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
124510439|NCT00589979|447819267|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
124510440|NCT00589979|447819268|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
124565351|NCT00620763|448028060|FG001|Period: First Intervention|Protocol Violation|3|||
124510441|NCT00589979|447819269|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
124510442|NCT00589979|447819267|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
124565352|NCT00620763|448028059|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
124510443|NCT00589979|447819268|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
124510444|NCT00589979|447819269|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
124510445|NCT00589979|447819267|FG000|Double-Blind Treatment Period 2|Other|0|||
124510446|NCT00589979|447819268|FG001|Double-Blind Treatment Period 2|Other|0|||
124510447|NCT00589979|447819269|FG002|Double-Blind Treatment Period 2|Other|1|||
124510448|NCT00589979|447819267|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
124510449|NCT00589979|447819268|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
124510450|NCT00589979|447819269|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
124510451|NCT00589979|447819267|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
124510452|NCT00589979|447819268|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
124510453|NCT00589979|447819269|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
124510454|NCT00565058|447819270|FG000|Overall Study|Adverse Event|1|||
124510455|NCT00565058|447819271|FG001|Overall Study|Adverse Event|0|||
124510456|NCT00510068|447819272|FG000|Double-blind Period|Disease progression|98|||
124510457|NCT00510068|447819273|FG001|Double-blind Period|Disease progression|169|||
124510458|NCT00510068|447819272|FG000|Double-blind Period|Final primary analysis|52|||
124510459|NCT00510068|447819273|FG001|Double-blind Period|Final primary analysis|18|||
124510460|NCT00510068|447819272|FG000|Double-blind Period|Adverse Event|37|||
124510461|NCT00510068|447819273|FG001|Double-blind Period|Adverse Event|7|||
124510462|NCT00510068|447819272|FG000|Double-blind Period|Withdrawal by Subject|8|||
124510463|NCT00510068|447819273|FG001|Double-blind Period|Withdrawal by Subject|6|||
124510464|NCT00510068|447819272|FG000|Double-blind Period|Death|4|||
124510465|NCT00510068|447819273|FG001|Double-blind Period|Death|3|||
124510466|NCT00510068|447819272|FG000|Double-blind Period|Abnormal test result (s)|1|||
124510467|NCT00510068|447819273|FG001|Double-blind Period|Abnormal test result (s)|0|||
124510468|NCT00510068|447819272|FG000|Double-blind Period|Lost to Follow-up|1|||
124510469|NCT00510068|447819273|FG001|Double-blind Period|Lost to Follow-up|0|||
124510470|NCT00510068|447819272|FG000|Double-blind Period|Protocol Violation|6|||
124510471|NCT00510068|447819273|FG001|Double-blind Period|Protocol Violation|0|||
124510472|NCT00510068|447819272|FG000|Open-label Period|Disease Progression|124|||
124510473|NCT00510068|447819273|FG001|Open-label Period|Disease Progression|0|||
124510474|NCT00510068|447819272|FG000|Open-label Period|Adverse Event|46|||
124510475|NCT00510068|447819273|FG001|Open-label Period|Adverse Event|0|||
124510476|NCT00510068|447819272|FG000|Open-label Period|Withdrawal by Subject|21|||
124510477|NCT00510068|447819273|FG001|Open-label Period|Withdrawal by Subject|0|||
124510478|NCT00510068|447819272|FG000|Open-label Period|Administrative problems|17|||
124510479|NCT00510068|447819273|FG001|Open-label Period|Administrative problems|0|||
124510480|NCT00510068|447819272|FG000|Open-label Period|Death|7|||
124510481|NCT00510068|447819273|FG001|Open-label Period|Death|0|||
124510482|NCT00510068|447819272|FG000|Open-label Period|New cancer therapy|7|||
124510483|NCT00510068|447819273|FG001|Open-label Period|New cancer therapy|0|||
124510484|NCT00510068|447819272|FG000|Open-label Period|Protocol Violation|2|||
124510485|NCT00510068|447819273|FG001|Open-label Period|Protocol Violation|0|||
124510486|NCT00510068|447819272|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
124510487|NCT00510068|447819273|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
124510488|NCT01397448|447819274|FG000|Overall Study|Adverse Event|4|||
124510489|NCT01397448|447819275|FG001|Overall Study|Adverse Event|4|||
124510490|NCT01397448|447819276|FG002|Overall Study|Adverse Event|6|||
124510491|NCT01397448|447819274|FG000|Overall Study|Withdrawal by Subject|4|||
124510492|NCT01397448|447819275|FG001|Overall Study|Withdrawal by Subject|4|||
124510493|NCT01397448|447819276|FG002|Overall Study|Withdrawal by Subject|3|||
124510494|NCT01397448|447819274|FG000|Overall Study|Lack of Efficacy|2|||
124510495|NCT01397448|447819275|FG001|Overall Study|Lack of Efficacy|0|||
124510496|NCT01397448|447819276|FG002|Overall Study|Lack of Efficacy|5|||
124510497|NCT01397448|447819274|FG000|Overall Study|Other|8|||
124510498|NCT01397448|447819275|FG001|Overall Study|Other|7|||
124510499|NCT01397448|447819276|FG002|Overall Study|Other|4|||
124510500|NCT02159469|447819281|FG000|Overall Study|Missing Completion status|1|||
124510501|NCT02159469|447819281|FG000|Overall Study|Adverse Event|5|||
124565353|NCT00620763|448028060|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
124565354|NCT02907203|448028064|FG000|Overall Study|Death|1|||
124565355|NCT02907203|448028064|FG000|Overall Study|Lost to Follow-up|3|||
124565356|NCT02907203|448028064|FG000|Overall Study|Withdrawal by Subject|3|||
124565357|NCT02907203|448028064|FG000|Overall Study|Surgical bypass|1|||
124565358|NCT04956666|448028065|FG000|Overall Study|Adverse Event|18|||
124510502|NCT02159469|447819281|FG000|Overall Study|Non-compliance|2|||
124510503|NCT02159469|447819281|FG000|Overall Study|Withdrawal by Subject|9|||
124510504|NCT02159469|447819281|FG000|Overall Study|Lost to Follow-up|1|||
124510505|NCT02159469|447819281|FG000|Overall Study|Sponsor's request|2|||
124565359|NCT04956666|448028065|FG000|Overall Study|Physician Decision|5|||
124565360|NCT00783796|448028069|FG000|Overall Study|Did not receive any stent|4|||
124510506|NCT02159469|447819281|FG000|Overall Study|Met Stopping Criteria|3|||
124510507|NCT02159469|447819281|FG000|Overall Study|Other|1|||
124510508|NCT02159469|447819281|FG000|Overall Study|Multiple|29|||
124510509|NCT02475395|447819282|FG000|Overall Study|Protocol Violation|30|||
124565361|NCT00783796|448028069|FG000|Overall Study|Received non-XIENCE V stent|1|||
124565362|NCT00783796|448028069|FG000|Overall Study|Received commercial XIENCE V stent|1|||
124565363|NCT01816477|448028070|FG000|Overall Study|Withdrawal by Subject|13|||
124565364|NCT01816477|448028071|FG001|Overall Study|Withdrawal by Subject|1|||
124565365|NCT01816477|448028070|FG000|Overall Study|Unable to tolerate catheter placement|3|||
124565366|NCT01816477|448028071|FG001|Overall Study|Unable to tolerate catheter placement|0|||
124565367|NCT00819247|448028072|FG000|Overall Study|Adverse Event|0|||
124510510|NCT02475395|447819283|FG001|Overall Study|Protocol Violation|3|||
124510511|NCT00995670|447819284|FG000|Overall Study|Failed arterial cannulation|1|||
124510512|NCT00995670|447819285|FG001|Overall Study|Failed arterial cannulation|0|||
124510513|NCT00995670|447819286|FG002|Overall Study|Failed arterial cannulation|3|||
124510514|NCT00383721|447819287|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
124510515|NCT00383721|447819288|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
124510516|NCT00383721|447819289|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
124510517|NCT00383721|447819290|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
124510518|NCT00383721|447819291|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
124510519|NCT00383721|447819287|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
124510520|NCT00383721|447819288|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
124510521|NCT00383721|447819289|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
124510522|NCT00383721|447819290|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
124510523|NCT00383721|447819291|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
124510524|NCT00383721|447819287|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
124510525|NCT00383721|447819288|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
124510526|NCT00383721|447819289|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
124510527|NCT00383721|447819290|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
124510528|NCT00383721|447819291|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
124510529|NCT00383721|447819287|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
124510530|NCT00383721|447819288|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
124510531|NCT00383721|447819289|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
124510532|NCT00383721|447819290|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
124510533|NCT00383721|447819291|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
124510534|NCT00383721|447819287|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
124510535|NCT00383721|447819288|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
124510536|NCT00383721|447819289|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
124510537|NCT00383721|447819290|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
124510538|NCT00383721|447819291|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
124510539|NCT00383721|447819287|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
124510540|NCT00383721|447819288|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
124510541|NCT00383721|447819289|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
124510542|NCT00383721|447819290|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
124510543|NCT00383721|447819291|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
124510544|NCT00383721|447819287|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
124510545|NCT00383721|447819288|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
124510546|NCT00383721|447819289|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
124510547|NCT00383721|447819290|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
124510548|NCT00383721|447819291|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
124510549|NCT00383721|447819287|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
124510550|NCT00383721|447819288|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
124510551|NCT00383721|447819289|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
124510552|NCT00383721|447819290|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
124510553|NCT00383721|447819291|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
124510554|NCT00383721|447819287|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
124510555|NCT00383721|447819288|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
124510556|NCT00383721|447819289|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
124510557|NCT00383721|447819290|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
124510558|NCT00383721|447819291|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
124510559|NCT00383721|447819287|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
124510560|NCT00383721|447819288|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
124510561|NCT00383721|447819289|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
124510562|NCT00383721|447819290|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
124510563|NCT00383721|447819291|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
124510564|NCT00383721|447819287|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
124510565|NCT00383721|447819288|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
124565368|NCT00819247|448028073|FG001|Overall Study|Adverse Event|5|||
124724869|NCT01558115|448613340|FG000|Overall Study|Study closed due to poor enrollment|4|||
124565369|NCT00819247|448028074|FG002|Overall Study|Adverse Event|3|||
124565370|NCT00819247|448028072|FG000|Overall Study|Insufficient testosterone response|5|||
124565371|NCT00819247|448028073|FG001|Overall Study|Insufficient testosterone response|8|||
124565372|NCT00819247|448028074|FG002|Overall Study|Insufficient testosterone response|10|||
124565373|NCT00819247|448028072|FG000|Overall Study|Withdrawal by Subject|1|||
124565374|NCT00819247|448028073|FG001|Overall Study|Withdrawal by Subject|0|||
124565375|NCT00819247|448028074|FG002|Overall Study|Withdrawal by Subject|0|||
124565376|NCT00819247|448028072|FG000|Overall Study|Protocol Violation|1|||
124565377|NCT00819247|448028073|FG001|Overall Study|Protocol Violation|0|||
124565378|NCT00819247|448028074|FG002|Overall Study|Protocol Violation|1|||
124565379|NCT00819247|448028072|FG000|Overall Study|Mistakenly withdrawn|0|||
124565380|NCT00819247|448028073|FG001|Overall Study|Mistakenly withdrawn|1|||
124565381|NCT00819247|448028074|FG002|Overall Study|Mistakenly withdrawn|0|||
124565382|NCT00819247|448028072|FG000|Overall Study|Bad prostate-specific antigen response|3|||
124565383|NCT00819247|448028073|FG001|Overall Study|Bad prostate-specific antigen response|2|||
124565384|NCT00819247|448028074|FG002|Overall Study|Bad prostate-specific antigen response|0|||
124565385|NCT00819247|448028072|FG000|Overall Study|Other|1|||
124565386|NCT00819247|448028073|FG001|Overall Study|Other|0|||
124565387|NCT00819247|448028074|FG002|Overall Study|Other|0|||
124565388|NCT01766921|448028075|FG000|Overall Study|Administrative Reason|5|||
124565389|NCT01766921|448028076|FG001|Overall Study|Administrative Reason|5|||
124565390|NCT01766921|448028075|FG000|Overall Study|Death|1|||
124565391|NCT01766921|448028076|FG001|Overall Study|Death|1|||
124565392|NCT01766921|448028075|FG000|Overall Study|Lost to Follow-up|1|||
124565393|NCT01766921|448028076|FG001|Overall Study|Lost to Follow-up|3|||
124565394|NCT01766921|448028075|FG000|Overall Study|Unclassified|2|||
124565395|NCT01766921|448028076|FG001|Overall Study|Unclassified|2|||
124565396|NCT01766921|448028075|FG000|Overall Study|Protocol Violation|1|||
124565397|NCT01766921|448028076|FG001|Overall Study|Protocol Violation|1|||
124565398|NCT01766921|448028075|FG000|Overall Study|Withdrawal by Subject|14|||
124565399|NCT01766921|448028076|FG001|Overall Study|Withdrawal by Subject|5|||
124565400|NCT00698685|448028079|FG000|Overall Study|Sister withdrew as donor|1|||
124565401|NCT00698685|448028079|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
124565402|NCT02540356|448028080|FG000|Overall Study|Terminated due to disease progression|1|||
124565403|NCT02540356|448028081|FG001|Overall Study|Terminated due to disease progression|0|||
124565404|NCT02978326|448028083|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
124565405|NCT02978326|448028084|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
124565406|NCT02978326|448028085|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
124565407|NCT02978326|448028083|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
124565408|NCT02978326|448028084|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
124565409|NCT02978326|448028085|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
124565410|NCT02978326|448028083|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
124565411|NCT02978326|448028084|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
124565412|NCT02978326|448028085|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
124565413|NCT02978326|448028083|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
124565414|NCT02978326|448028084|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
124565415|NCT02978326|448028085|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
124565416|NCT01411995|448028091|FG000|Overall Study|Failed IUD insertion|0|||
124565417|NCT01411995|448028092|FG001|Overall Study|Failed IUD insertion|1|||
124565418|NCT01937364|448028093|FG000|Overall Study|Adverse Event|2|||
124565419|NCT01937364|448028094|FG001|Overall Study|Adverse Event|1|||
124565420|NCT04104646|448028095|FG000|Overall Study|Withdrawal by Subject|1|||
124565421|NCT04104646|448028096|FG001|Overall Study|Withdrawal by Subject|1|||
124565422|NCT04104646|448028095|FG000|Overall Study|Lost to Follow-up|1|||
124565423|NCT04104646|448028096|FG001|Overall Study|Lost to Follow-up|0|||
124565424|NCT04104646|448028095|FG000|Overall Study|Physician Decision|2|||
124565425|NCT04104646|448028096|FG001|Overall Study|Physician Decision|0|||
124565426|NCT02974153|448028097|FG000|Overall Study|Adverse Event|6|||
124565427|NCT02974153|448028098|FG001|Overall Study|Adverse Event|0|||
124565428|NCT02974153|448028099|FG002|Overall Study|Adverse Event|1|||
124565429|NCT02974153|448028097|FG000|Overall Study|Lack of Efficacy|6|||
124565430|NCT02974153|448028098|FG001|Overall Study|Lack of Efficacy|5|||
124565431|NCT02974153|448028099|FG002|Overall Study|Lack of Efficacy|10|||
124565432|NCT02974153|448028097|FG000|Overall Study|Lost to Follow-up|9|||
124565433|NCT02974153|448028098|FG001|Overall Study|Lost to Follow-up|10|||
124565434|NCT02974153|448028099|FG002|Overall Study|Lost to Follow-up|17|||
124565435|NCT02974153|448028097|FG000|Overall Study|Physician Decision|0|||
124565436|NCT02974153|448028098|FG001|Overall Study|Physician Decision|2|||
124565437|NCT02974153|448028099|FG002|Overall Study|Physician Decision|1|||
124565438|NCT02974153|448028097|FG000|Overall Study|Withdrawal by Subject|9|||
124565439|NCT02974153|448028098|FG001|Overall Study|Withdrawal by Subject|16|||
124565440|NCT02974153|448028099|FG002|Overall Study|Withdrawal by Subject|11|||
124565441|NCT02974153|448028097|FG000|Overall Study|Study Burden|8|||
124565442|NCT02974153|448028098|FG001|Overall Study|Study Burden|7|||
124565443|NCT02974153|448028099|FG002|Overall Study|Study Burden|3|||
124565444|NCT02974153|448028097|FG000|Overall Study|Other|14|||
124565445|NCT02974153|448028098|FG001|Overall Study|Other|8|||
124565446|NCT02974153|448028099|FG002|Overall Study|Other|7|||
124565447|NCT02277769|448028100|FG000|Overall Study|Protocol Violation|3|||
124565448|NCT02277769|448028101|FG001|Overall Study|Protocol Violation|3|||
124565449|NCT02277769|448028102|FG002|Overall Study|Protocol Violation|5|||
124565450|NCT02277769|448028100|FG000|Overall Study|Lack of Efficacy|17|||
124565451|NCT02277769|448028101|FG001|Overall Study|Lack of Efficacy|0|||
124565452|NCT02277769|448028102|FG002|Overall Study|Lack of Efficacy|4|||
124565453|NCT02277769|448028100|FG000|Overall Study|Adverse Event|14|||
124565454|NCT02277769|448028101|FG001|Overall Study|Adverse Event|2|||
124565455|NCT02277769|448028102|FG002|Overall Study|Adverse Event|4|||
124565456|NCT02277769|448028100|FG000|Overall Study|Other than specified above|12|||
124565457|NCT02277769|448028101|FG001|Overall Study|Other than specified above|8|||
124565458|NCT02277769|448028102|FG002|Overall Study|Other than specified above|5|||
124565459|NCT03504852|448028107|FG000|Overall Study|Withdrawal of informed consent|2|||
124565460|NCT03504852|448028108|FG001|Overall Study|Withdrawal of informed consent|1|||
124565461|NCT03504852|448028109|FG002|Overall Study|Withdrawal of informed consent|0|||
124565462|NCT03504852|448028107|FG000|Overall Study|Withdrawal by Subject|5|||
124565463|NCT03504852|448028108|FG001|Overall Study|Withdrawal by Subject|5|||
124565464|NCT03504852|448028109|FG002|Overall Study|Withdrawal by Subject|1|||
124565465|NCT03504852|448028107|FG000|Overall Study|Lost to Follow-up|4|||
124565466|NCT03504852|448028108|FG001|Overall Study|Lost to Follow-up|1|||
124565467|NCT03504852|448028109|FG002|Overall Study|Lost to Follow-up|0|||
124565468|NCT03504852|448028107|FG000|Overall Study|New therapy for study indication|1|||
124565469|NCT03504852|448028108|FG001|Overall Study|New therapy for study indication|0|||
124565470|NCT03504852|448028109|FG002|Overall Study|New therapy for study indication|0|||
124565471|NCT03504852|448028107|FG000|Overall Study|Lack of Efficacy|1|||
124565472|NCT03504852|448028108|FG001|Overall Study|Lack of Efficacy|2|||
124565473|NCT03504852|448028109|FG002|Overall Study|Lack of Efficacy|0|||
124565474|NCT03504852|448028107|FG000|Overall Study|Death|0|||
124565475|NCT03504852|448028108|FG001|Overall Study|Death|1|||
124565476|NCT03504852|448028109|FG002|Overall Study|Death|0|||
124565477|NCT03504852|448028107|FG000|Overall Study|Adverse Event|4|||
124565478|NCT03504852|448028108|FG001|Overall Study|Adverse Event|8|||
124565479|NCT03504852|448028109|FG002|Overall Study|Adverse Event|2|||
124565480|NCT02928848|448028110|FG000|Arm 2|Withdrawal by Subject|1|||
124565481|NCT02928848|448028111|FG001|Arm 2|Withdrawal by Subject|0|||
124565482|NCT00663871|448028112|FG000|Overall Study|Lost to Follow-up|5|||
124565483|NCT00663871|448028113|FG001|Overall Study|Lost to Follow-up|5|||
124565484|NCT00663871|448028112|FG000|Overall Study|Withdrawal by Subject|5|||
124565485|NCT00663871|448028113|FG001|Overall Study|Withdrawal by Subject|2|||
124565486|NCT01565083|448028114|FG000|Overall Study|Withdrawal by Subject|6|||
124565487|NCT01565083|448028115|FG001|Overall Study|Withdrawal by Subject|4|||
124565488|NCT01565083|448028114|FG000|Overall Study|Lost to Follow-up|2|||
124565489|NCT01565083|448028115|FG001|Overall Study|Lost to Follow-up|7|||
124565490|NCT01565083|448028114|FG000|Overall Study|Death|22|||
124565491|NCT01565083|448028115|FG001|Overall Study|Death|23|||
124565492|NCT01565083|448028114|FG000|Overall Study|Other|3|||
124565493|NCT01565083|448028115|FG001|Overall Study|Other|5|||
124565494|NCT01058421|448028116|FG000|1 Month Outcomes|Death|10|||
124565495|NCT01058421|448028117|FG001|1 Month Outcomes|Death|6|||
124565496|NCT01058421|448028116|FG000|1 Month Outcomes|Lost to Follow-up|8|||
124565497|NCT01058421|448028117|FG001|1 Month Outcomes|Lost to Follow-up|7|||
124565498|NCT01058421|448028116|FG000|1 Month Outcomes|Remained in Hospital|5|||
124565499|NCT01058421|448028117|FG001|1 Month Outcomes|Remained in Hospital|12|||
124565500|NCT01058421|448028116|FG000|1 Month Outcomes|Remained in Other Facility|16|||
124565501|NCT01058421|448028117|FG001|1 Month Outcomes|Remained in Other Facility|17|||
124565502|NCT01058421|448028116|FG000|3 Month Outcomes|Death|3|||
124565503|NCT01058421|448028117|FG001|3 Month Outcomes|Death|5|||
124565504|NCT01058421|448028116|FG000|3 Month Outcomes|Lost to Follow-up|12|||
124565505|NCT01058421|448028117|FG001|3 Month Outcomes|Lost to Follow-up|11|||
124565506|NCT01058421|448028116|FG000|3 Month Outcomes|Remained in Hospital|0|||
124565507|NCT01058421|448028117|FG001|3 Month Outcomes|Remained in Hospital|2|||
124565508|NCT01058421|448028116|FG000|3 Month Outcomes|Remained in Other Facility|5|||
124565509|NCT01058421|448028117|FG001|3 Month Outcomes|Remained in Other Facility|8|||
124565510|NCT01058421|448028116|FG000|6 Month Outcomes|Death|2|||
124565511|NCT01058421|448028117|FG001|6 Month Outcomes|Death|2|||
124565512|NCT01058421|448028116|FG000|6 Month Outcomes|Lost to Follow-up|16|||
124565513|NCT01058421|448028117|FG001|6 Month Outcomes|Lost to Follow-up|21|||
124565514|NCT01058421|448028116|FG000|6 Month Outcomes|Remained in Other Facility|1|||
124565515|NCT01058421|448028117|FG001|6 Month Outcomes|Remained in Other Facility|3|||
124565516|NCT02742181|448028118|FG000|Overall Study|Physician Decision|1|||
124565517|NCT02742181|448028119|FG001|Overall Study|Physician Decision|0|||
124565518|NCT00455533|448028122|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
124565519|NCT00455533|448028123|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
124565520|NCT00455533|448028124|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
124565521|NCT00455533|448028122|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
124565522|NCT00455533|448028123|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
124510566|NCT00383721|447819289|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
124510567|NCT00383721|447819290|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
124510568|NCT00383721|447819291|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
124510569|NCT00383721|447819287|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
124510570|NCT00383721|447819288|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
124510571|NCT00383721|447819289|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
124510572|NCT00383721|447819290|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
124510573|NCT00383721|447819291|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
124510574|NCT00383721|447819287|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
124510575|NCT00383721|447819288|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
124510576|NCT00383721|447819289|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
124510577|NCT00383721|447819290|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
124510578|NCT00383721|447819291|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
124510579|NCT00383721|447819287|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
124510580|NCT00383721|447819288|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
124510581|NCT00383721|447819289|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
124510582|NCT00383721|447819290|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
124510583|NCT00383721|447819291|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
124510584|NCT00383721|447819287|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
124510585|NCT00383721|447819288|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
124510586|NCT00383721|447819289|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
124510587|NCT00383721|447819290|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
124510588|NCT00383721|447819291|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
124510589|NCT00383721|447819287|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
124510590|NCT00383721|447819288|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
124510591|NCT00383721|447819289|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
124510592|NCT00383721|447819290|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
124510593|NCT00383721|447819291|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
124510594|NCT00383721|447819287|FG000|26-Week Treatment Safety Extension|Administrative|1|||
124510595|NCT00383721|447819288|FG001|26-Week Treatment Safety Extension|Administrative|2|||
124510596|NCT00383721|447819289|FG002|26-Week Treatment Safety Extension|Administrative|3|||
124510597|NCT00383721|447819290|FG003|26-Week Treatment Safety Extension|Administrative|1|||
124510598|NCT00383721|447819291|FG004|26-Week Treatment Safety Extension|Administrative|0|||
124510599|NCT03784027|447819294|FG000|Period 1|Withdrawal by Subject|0|||
124510600|NCT03784027|447819295|FG001|Period 1|Withdrawal by Subject|1|||
124510601|NCT00646113|447822171|FG000|Overall Study|Lost to Follow-up|5|||
124510602|NCT00646113|447822171|FG000|Overall Study|Adverse Event|3|||
124510603|NCT02109744|447822172|FG000|Overall Study|Death|1|||
124510604|NCT02109744|447822173|FG001|Overall Study|Death|1|||
124510605|NCT02109744|447822172|FG000|Overall Study|no marrow exam|1|||
124510606|NCT02109744|447822173|FG001|Overall Study|no marrow exam|0|||
124510607|NCT04656418|447822174|FG000|Overall Study|Withdrawal by Subject|1|||
124510608|NCT04656418|447822175|FG001|Overall Study|Withdrawal by Subject|3|||
124510609|NCT03287245|447822176|FG000|Overall Study|Study terminated by sponsor|3|||
124510610|NCT03287245|447822177|FG001|Overall Study|Study terminated by sponsor|0|||
124510611|NCT03287245|447822178|FG002|Overall Study|Study terminated by sponsor|3|||
124510612|NCT03287245|447822179|FG003|Overall Study|Study terminated by sponsor|1|||
124510613|NCT03287245|447822176|FG000|Overall Study|Adverse Event|1|||
124510614|NCT03287245|447822177|FG001|Overall Study|Adverse Event|0|||
124510615|NCT03287245|447822178|FG002|Overall Study|Adverse Event|0|||
124510616|NCT03287245|447822179|FG003|Overall Study|Adverse Event|0|||
124510617|NCT03287245|447822176|FG000|Overall Study|Withdrawal by Subject|8|||
124510618|NCT03287245|447822177|FG001|Overall Study|Withdrawal by Subject|3|||
124510619|NCT03287245|447822178|FG002|Overall Study|Withdrawal by Subject|3|||
124510620|NCT03287245|447822179|FG003|Overall Study|Withdrawal by Subject|0|||
124510621|NCT03287245|447822176|FG000|Overall Study|Physician Decision|3|||
124510622|NCT03287245|447822177|FG001|Overall Study|Physician Decision|2|||
124510623|NCT03287245|447822178|FG002|Overall Study|Physician Decision|0|||
124510624|NCT03287245|447822179|FG003|Overall Study|Physician Decision|0|||
124510625|NCT02701192|447822180|FG000|Overall Study|Protocol Violation|2|||
124510626|NCT02701192|447822180|FG000|Overall Study|Lost to Follow-up|4|||
124510627|NCT02150213|447822183|FG000|Overall Study|Lost to Follow-up|1|||
124565523|NCT00455533|448028124|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
124510628|NCT02150213|447822183|FG000|Overall Study|Withdrawal by Subject|1|||
124510629|NCT01297309|447822187|FG000|Overall Study|Eligibility failure|2|||
124510630|NCT01297309|447822187|FG000|Overall Study|Screen failure|2|||
124510631|NCT01297309|447822187|FG000|Overall Study|Withdrawal by Subject|5|||
124510632|NCT01297309|447822187|FG000|Overall Study|Adverse Event|1|||
124510633|NCT01297309|447822187|FG000|Overall Study|Investigator Decision|2|||
124565524|NCT00455533|448028122|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
124565525|NCT00455533|448028123|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
124565526|NCT00455533|448028124|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
124565527|NCT00455533|448028122|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
124565528|NCT00455533|448028123|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
124565529|NCT00455533|448028124|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
124565530|NCT00455533|448028122|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
124565531|NCT00455533|448028123|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
124565532|NCT00455533|448028124|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
124565533|NCT00455533|448028122|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
124565534|NCT00455533|448028123|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
124565535|NCT00455533|448028124|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
124565536|NCT00455533|448028122|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
124565537|NCT00455533|448028123|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
124565538|NCT00455533|448028124|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
124565539|NCT00455533|448028122|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
124565540|NCT00455533|448028123|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
124565541|NCT00455533|448028124|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
124565542|NCT00455533|448028122|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
124565543|NCT00455533|448028123|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
124565544|NCT00455533|448028124|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
124565545|NCT00455533|448028122|FG000|Period Two: Randomized Period|Death|0|||
124565546|NCT00455533|448028123|FG001|Period Two: Randomized Period|Death|0|||
124565547|NCT00455533|448028124|FG002|Period Two: Randomized Period|Death|3|||
124565548|NCT00455533|448028122|FG000|Period Two: Randomized Period|Disease Progression|0|||
124565549|NCT00455533|448028123|FG001|Period Two: Randomized Period|Disease Progression|1|||
124565550|NCT00455533|448028124|FG002|Period Two: Randomized Period|Disease Progression|1|||
124565551|NCT00455533|448028122|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
124565552|NCT00455533|448028123|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
124565553|NCT00455533|448028124|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
124565554|NCT00455533|448028122|FG000|Period Two: Randomized Period|Other - need reasons|0|||
124565555|NCT00455533|448028123|FG001|Period Two: Randomized Period|Other - need reasons|1|||
124565556|NCT00455533|448028124|FG002|Period Two: Randomized Period|Other - need reasons|0|||
124565557|NCT00455533|448028122|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
124565558|NCT00455533|448028123|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
124565559|NCT00455533|448028124|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
124565560|NCT00455533|448028122|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
124565561|NCT00455533|448028123|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
124565562|NCT00455533|448028124|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
124565563|NCT02576990|448028129|FG000|Overall Study|Death|29|||
124565564|NCT02576990|448028130|FG001|Overall Study|Death|18|||
124565565|NCT02576990|448028129|FG000|Overall Study|Physician Decision|1|||
124565566|NCT02576990|448028130|FG001|Overall Study|Physician Decision|0|||
124565567|NCT02576990|448028129|FG000|Overall Study|Screen failure|2|||
124565568|NCT02576990|448028130|FG001|Overall Study|Screen failure|0|||
124565569|NCT02576990|448028129|FG000|Overall Study|Sponsor's decision|24|||
124565570|NCT02576990|448028130|FG001|Overall Study|Sponsor's decision|4|||
124565571|NCT02576990|448028129|FG000|Overall Study|Withdrawal by Subject|0|||
124565572|NCT02576990|448028130|FG001|Overall Study|Withdrawal by Subject|2|||
124565573|NCT01736553|448028135|FG000|Overall Study|Death|12|||
124565574|NCT01736553|448028136|FG001|Overall Study|Death|0|||
124565575|NCT01736553|448028135|FG000|Overall Study|Withdrawal by Subject|5|||
124565576|NCT01736553|448028136|FG001|Overall Study|Withdrawal by Subject|2|||
124565577|NCT01736553|448028135|FG000|Overall Study|Lost to Follow-up|2|||
124565578|NCT01736553|448028136|FG001|Overall Study|Lost to Follow-up|2|||
124565579|NCT02415959|448028137|FG000|Overall Study|Adverse Event|0|||
124565580|NCT02415959|448028138|FG001|Overall Study|Adverse Event|1|||
124565581|NCT02415959|448028139|FG002|Overall Study|Adverse Event|0|||
124565582|NCT02415959|448028140|FG003|Overall Study|Adverse Event|0|||
124565583|NCT02415959|448028141|FG004|Overall Study|Adverse Event|0|||
124565584|NCT02415959|448028137|FG000|Overall Study|Protocol Violation|0|||
124565585|NCT02415959|448028138|FG001|Overall Study|Protocol Violation|0|||
124565586|NCT02415959|448028139|FG002|Overall Study|Protocol Violation|0|||
124565587|NCT02415959|448028140|FG003|Overall Study|Protocol Violation|1|||
124565588|NCT02415959|448028141|FG004|Overall Study|Protocol Violation|0|||
124565589|NCT00911859|448028142|FG000|Treatment Period|Adverse Event|3|||
124565590|NCT00911859|448028143|FG001|Treatment Period|Adverse Event|3|||
124565591|NCT00911859|448028144|FG002|Treatment Period|Adverse Event|7|||
124565592|NCT00911859|448028142|FG000|Treatment Period|Death|1|||
124565593|NCT00911859|448028143|FG001|Treatment Period|Death|3|||
124565594|NCT00911859|448028144|FG002|Treatment Period|Death|5|||
124565595|NCT00911859|448028142|FG000|Treatment Period|Lack of Efficacy|1|||
124565596|NCT00911859|448028143|FG001|Treatment Period|Lack of Efficacy|7|||
124565597|NCT00911859|448028144|FG002|Treatment Period|Lack of Efficacy|5|||
124565598|NCT00911859|448028142|FG000|Treatment Period|Physician Decision|3|||
124565599|NCT00911859|448028143|FG001|Treatment Period|Physician Decision|3|||
124565600|NCT00911859|448028144|FG002|Treatment Period|Physician Decision|3|||
124565601|NCT00911859|448028142|FG000|Treatment Period|Withdrawal by Subject|0|||
124565602|NCT00911859|448028143|FG001|Treatment Period|Withdrawal by Subject|4|||
124565603|NCT00911859|448028144|FG002|Treatment Period|Withdrawal by Subject|5|||
124565604|NCT00911859|448028142|FG000|Treatment Period|Did not receive study treatment|0|||
124565605|NCT00911859|448028143|FG001|Treatment Period|Did not receive study treatment|1|||
124565606|NCT00911859|448028144|FG002|Treatment Period|Did not receive study treatment|0|||
124565607|NCT00911859|448028142|FG000|Maintainance Period|Lack of Efficacy|0|||
124565608|NCT00911859|448028143|FG001|Maintainance Period|Lack of Efficacy|0|||
124565609|NCT00911859|448028144|FG002|Maintainance Period|Lack of Efficacy|9|||
124565610|NCT00911859|448028142|FG000|Maintainance Period|Physician Decision|0|||
124565611|NCT00911859|448028143|FG001|Maintainance Period|Physician Decision|0|||
124565612|NCT00911859|448028144|FG002|Maintainance Period|Physician Decision|9|||
124565613|NCT00911859|448028142|FG000|Maintainance Period|Withdrawal by Subject|0|||
124565614|NCT00911859|448028143|FG001|Maintainance Period|Withdrawal by Subject|0|||
124565615|NCT00911859|448028144|FG002|Maintainance Period|Withdrawal by Subject|3|||
124565616|NCT00911859|448028142|FG000|Follow-up Period|Death|5|||
124565617|NCT00911859|448028143|FG001|Follow-up Period|Death|8|||
124565618|NCT00911859|448028144|FG002|Follow-up Period|Death|10|||
124565619|NCT00911859|448028142|FG000|Follow-up Period|Lost to Follow-up|1|||
124565620|NCT00911859|448028143|FG001|Follow-up Period|Lost to Follow-up|1|||
124565621|NCT00911859|448028144|FG002|Follow-up Period|Lost to Follow-up|0|||
124565622|NCT00911859|448028142|FG000|Follow-up Period|Withdrawal by Subject|0|||
124565623|NCT00911859|448028143|FG001|Follow-up Period|Withdrawal by Subject|4|||
124565624|NCT00911859|448028144|FG002|Follow-up Period|Withdrawal by Subject|4|||
124565625|NCT00911859|448028142|FG000|Follow-up Period|Study terminated by sponsor|5|||
124565626|NCT00911859|448028143|FG001|Follow-up Period|Study terminated by sponsor|33|||
124565627|NCT00911859|448028144|FG002|Follow-up Period|Study terminated by sponsor|27|||
124565628|NCT01048333|448028147|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
124565629|NCT01048333|448028148|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
124565630|NCT01048333|448028149|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
124565631|NCT01048333|448028150|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
124565632|NCT01048333|448028151|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
124565633|NCT01048333|448028152|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
124565634|NCT00634179|448028158|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
124565635|NCT00767325|448028161|FG000|Overall Study|Lack of Efficacy|2|||
124565636|NCT00767325|448028161|FG000|Overall Study|Adverse Event|7|||
124565637|NCT00767325|448028161|FG000|Overall Study|Lost to Follow-up|3|||
124565638|NCT00767325|448028161|FG000|Overall Study|No longer met study criteria|2|||
124565639|NCT00767325|448028161|FG000|Overall Study|Missed visit due to family reasons|1|||
124565640|NCT03538756|448028162|FG000|Long-Term Follow-up|Adverse Event|0|||
124565641|NCT03538756|448028163|FG001|Long-Term Follow-up|Adverse Event|0|||
124565642|NCT03538756|448028164|FG002|Long-Term Follow-up|Adverse Event|6|||
124565643|NCT03538756|448028162|FG000|Long-Term Follow-up|Death|0|||
124565644|NCT03538756|448028163|FG001|Long-Term Follow-up|Death|0|||
124565645|NCT03538756|448028164|FG002|Long-Term Follow-up|Death|1|||
124565646|NCT03538756|448028162|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
124565647|NCT03538756|448028163|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
124565648|NCT03538756|448028164|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
124565649|NCT03538756|448028162|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
124565650|NCT03538756|448028163|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
124565651|NCT03538756|448028164|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
124565652|NCT03538756|448028162|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
124565653|NCT03538756|448028163|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
124565654|NCT03538756|448028164|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
124565655|NCT00752856|448028165|FG000|Overall Study|randomized but did not do viral kinetics|0|||
124565656|NCT00752856|448028166|FG001|Overall Study|randomized but did not do viral kinetics|1|||
124565657|NCT03131999|448028167|FG000|Overall Study|Withdrawal by Subject|0|||
124565658|NCT03131999|448028168|FG001|Overall Study|Withdrawal by Subject|1|||
124565659|NCT02260492|448028169|FG000|Overall Study|Adverse Event|6|||
124565660|NCT02260492|448028170|FG001|Overall Study|Adverse Event|1|||
124565661|NCT02260492|448028171|FG002|Overall Study|Adverse Event|2|||
124565662|NCT02260492|448028169|FG000|Overall Study|Death|0|||
124565663|NCT02260492|448028170|FG001|Overall Study|Death|1|||
124565664|NCT02260492|448028171|FG002|Overall Study|Death|0|||
124565665|NCT02260492|448028169|FG000|Overall Study|Lost to Follow-up|12|||
124565666|NCT02260492|448028170|FG001|Overall Study|Lost to Follow-up|9|||
124565667|NCT02260492|448028171|FG002|Overall Study|Lost to Follow-up|0|||
124565668|NCT02260492|448028169|FG000|Overall Study|Physician Decision|2|||
124565669|NCT02260492|448028170|FG001|Overall Study|Physician Decision|0|||
124565670|NCT02260492|448028171|FG002|Overall Study|Physician Decision|1|||
124565671|NCT02260492|448028169|FG000|Overall Study|Withdrawal by Subject|3|||
124565672|NCT02260492|448028170|FG001|Overall Study|Withdrawal by Subject|2|||
124565673|NCT02260492|448028171|FG002|Overall Study|Withdrawal by Subject|2|||
124565674|NCT00996736|448028177|FG000|Overall Study|Death|1|||
124565675|NCT00996736|448028178|FG001|Overall Study|Death|1|||
124565676|NCT00996736|448028177|FG000|Overall Study|Lost to Follow-up|15|||
124565677|NCT00996736|448028178|FG001|Overall Study|Lost to Follow-up|14|||
124565678|NCT00996736|448028177|FG000|Overall Study|Visit not within 3-month window|5|||
124565679|NCT00996736|448028178|FG001|Overall Study|Visit not within 3-month window|3|||
124565680|NCT02688608|448028179|FG000|Overall Study|Lost to Follow-up|1|||
124565681|NCT02456909|448028180|FG000|Overall Study|Did not receive allocated intervention|24|||
124565682|NCT02456909|448028181|FG001|Overall Study|Did not receive allocated intervention|26|||
124565683|NCT02456909|448028180|FG000|Overall Study|Did not complete the primary outcome|0|||
124565684|NCT02456909|448028181|FG001|Overall Study|Did not complete the primary outcome|1|||
124565685|NCT01497938|448028182|FG000|Overall Study|Adverse Event|0|||
124565686|NCT01497938|448028183|FG001|Overall Study|Adverse Event|1|||
124565687|NCT01497938|448028182|FG000|Overall Study|Physician Decision|0|||
124565688|NCT01497938|448028183|FG001|Overall Study|Physician Decision|1|||
124565689|NCT01497938|448028182|FG000|Overall Study|Withdrawal by Subject|4|||
124565690|NCT01497938|448028183|FG001|Overall Study|Withdrawal by Subject|0|||
124565691|NCT01497938|448028182|FG000|Overall Study|Device Violation|1|||
124565692|NCT01497938|448028183|FG001|Overall Study|Device Violation|0|||
124565693|NCT00365352|448028184|FG000|Overall Study|Adverse Event|6|||
124565694|NCT00365352|448028185|FG001|Overall Study|Adverse Event|7|||
124565695|NCT00365352|448028186|FG002|Overall Study|Adverse Event|8|||
124565696|NCT00365352|448028184|FG000|Overall Study|Participant Withdrew Consent|8|||
124565697|NCT00365352|448028185|FG001|Overall Study|Participant Withdrew Consent|3|||
124565698|NCT00365352|448028186|FG002|Overall Study|Participant Withdrew Consent|4|||
124565699|NCT00365352|448028184|FG000|Overall Study|Lack of Efficacy|3|||
124565700|NCT00365352|448028185|FG001|Overall Study|Lack of Efficacy|0|||
124565701|NCT00365352|448028186|FG002|Overall Study|Lack of Efficacy|0|||
124565702|NCT00365352|448028184|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
124565703|NCT00365352|448028185|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
124565704|NCT00365352|448028186|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
124565705|NCT00365352|448028184|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
124565706|NCT00365352|448028185|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
124565707|NCT00365352|448028186|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
124565708|NCT00365352|448028184|FG000|Overall Study|Lost to Follow-up|1|||
124565709|NCT00365352|448028185|FG001|Overall Study|Lost to Follow-up|1|||
124565710|NCT00365352|448028186|FG002|Overall Study|Lost to Follow-up|0|||
124565711|NCT00365352|448028184|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
124565712|NCT00365352|448028185|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
124565713|NCT00365352|448028186|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
124565714|NCT02224456|448030006|FG000|Overall Study|Lack of Efficacy|1|||
124565715|NCT02224456|448030006|FG000|Overall Study|Lost to Follow-up|15|||
124565716|NCT02224456|448030006|FG000|Overall Study|Withdrawal by Subject|9|||
124565717|NCT02224456|448030006|FG000|Overall Study|Physician Decision|3|||
124565718|NCT02224456|448030006|FG000|Overall Study|Death|2|||
124565719|NCT02224456|448030006|FG000|Overall Study|Pregnancy|4|||
124565720|NCT02224456|448030006|FG000|Overall Study|Protocol Violation|1|||
124565721|NCT02224456|448030006|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
124565722|NCT01644890|448030007|FG000|Overall Study|Adverse Event|7|||
124565723|NCT01644890|448030008|FG001|Overall Study|Adverse Event|20|||
124565724|NCT01644890|448030007|FG000|Overall Study|Death|1|||
124565725|NCT01644890|448030008|FG001|Overall Study|Death|3|||
124565726|NCT01644890|448030007|FG000|Overall Study|Physician Decision|3|||
124565727|NCT01644890|448030008|FG001|Overall Study|Physician Decision|9|||
124565728|NCT01644890|448030007|FG000|Overall Study|Protocol Violation|6|||
124565729|NCT01644890|448030008|FG001|Overall Study|Protocol Violation|7|||
124565730|NCT01644890|448030007|FG000|Overall Study|Withdrawal by Subject|19|||
124565731|NCT01644890|448030008|FG001|Overall Study|Withdrawal by Subject|27|||
124565732|NCT01644890|448030007|FG000|Overall Study|Progression Disease|160|||
124565733|NCT01644890|448030008|FG001|Overall Study|Progression Disease|131|||
124565734|NCT01644890|448030007|FG000|Overall Study|Clinical Progression|6|||
124565735|NCT01644890|448030008|FG001|Overall Study|Clinical Progression|6|||
124565736|NCT01644890|448030007|FG000|Overall Study|> 28 days since last dose of study drug|6|||
124565737|NCT01644890|448030008|FG001|Overall Study|> 28 days since last dose of study drug|3|||
124565738|NCT01644890|448030007|FG000|Overall Study|Other|8|||
124565739|NCT01644890|448030008|FG001|Overall Study|Other|9|||
124565740|NCT02761980|448030011|FG000|Overall Study|Adverse Event|4|||
124565741|NCT02761980|448030012|FG001|Overall Study|Adverse Event|6|||
124565742|NCT02761980|448030013|FG002|Overall Study|Adverse Event|5|||
124565743|NCT02761980|448030014|FG003|Overall Study|Adverse Event|6|||
124565744|NCT02761980|448030011|FG000|Overall Study|Withdrawal by Subject|0|||
124565745|NCT02761980|448030012|FG001|Overall Study|Withdrawal by Subject|1|||
124565746|NCT02761980|448030013|FG002|Overall Study|Withdrawal by Subject|0|||
124565747|NCT02761980|448030014|FG003|Overall Study|Withdrawal by Subject|0|||
124565748|NCT02761980|448030011|FG000|Overall Study|Other|0|||
124565749|NCT02761980|448030012|FG001|Overall Study|Other|0|||
124565750|NCT02761980|448030013|FG002|Overall Study|Other|1|||
124565751|NCT02761980|448030014|FG003|Overall Study|Other|0|||
124565752|NCT00101582|448030015|FG000|Overall Study|Ineligibility determined|0|||
124565753|NCT00101582|448030016|FG001|Overall Study|Ineligibility determined|1|||
124565754|NCT00101582|448030015|FG000|Overall Study|Adverse Event|1|||
124565755|NCT00101582|448030016|FG001|Overall Study|Adverse Event|4|||
124565756|NCT00101582|448030015|FG000|Overall Study|Withdrawal by Subject|6|||
124565757|NCT00101582|448030016|FG001|Overall Study|Withdrawal by Subject|4|||
124565758|NCT00101582|448030015|FG000|Overall Study|Physician Decision|1|||
124565759|NCT00101582|448030016|FG001|Overall Study|Physician Decision|0|||
124565760|NCT00101582|448030015|FG000|Overall Study|Death|3|||
124565761|NCT00101582|448030016|FG001|Overall Study|Death|5|||
124565762|NCT00101582|448030015|FG000|Overall Study|Other|0|||
124565763|NCT00101582|448030016|FG001|Overall Study|Other|1|||
124565764|NCT00056160|448030017|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
124565765|NCT00056160|448030018|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
124565766|NCT00056160|448030017|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
124565767|NCT00056160|448030018|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
124565768|NCT00056160|448030017|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
124565769|NCT00056160|448030018|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
124565770|NCT00056160|448030017|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
124565771|NCT00056160|448030018|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
124565772|NCT00056160|448030017|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
124565773|NCT00056160|448030018|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
124565774|NCT00056160|448030017|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
124565775|NCT00056160|448030018|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
124565776|NCT00056160|448030017|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
124565777|NCT00056160|448030018|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
124565778|NCT00056160|448030017|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
124565779|NCT00056160|448030018|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
124565780|NCT00056160|448030017|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
124565781|NCT00056160|448030018|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
124565782|NCT00056160|448030017|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
124565783|NCT00056160|448030018|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
124565784|NCT00056160|448030017|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
124565785|NCT00056160|448030018|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
124565786|NCT00056160|448030017|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
124565787|NCT00056160|448030018|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
124565788|NCT00056160|448030017|FG000|Final Follow-up|Transferred into expanded access study.|3|||
124565789|NCT00056160|448030018|FG001|Final Follow-up|Transferred into expanded access study.|0|||
124565790|NCT00056160|448030017|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
124565791|NCT00056160|448030018|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
124565792|NCT00056160|448030017|FG000|Final Follow-up|Adverse Event|1|||
124565793|NCT00056160|448030018|FG001|Final Follow-up|Adverse Event|0|||
124565794|NCT03093324|448030020|FG000|Overall Study|Adverse Event|4|||
124565795|NCT03093324|448030021|FG001|Overall Study|Adverse Event|15|||
124565796|NCT03093324|448030020|FG000|Overall Study|Lost to Follow-up|1|||
124565797|NCT03093324|448030021|FG001|Overall Study|Lost to Follow-up|0|||
124565798|NCT03093324|448030020|FG000|Overall Study|Protocol Deviation|2|||
124565799|NCT03093324|448030021|FG001|Overall Study|Protocol Deviation|2|||
124565800|NCT03093324|448030020|FG000|Overall Study|Withdrawal by Subject|2|||
124565801|NCT03093324|448030021|FG001|Overall Study|Withdrawal by Subject|2|||
124565802|NCT04583579|448030022|FG000|Overall Study|Lost to Follow-up|4|||
124565803|NCT00278200|448030023|FG000|Overall Study|Death|1|||
124565804|NCT00278200|448030024|FG001|Overall Study|Death|3|||
124565805|NCT00278200|448030023|FG000|Overall Study|Physician Decision|0|||
124565806|NCT00278200|448030024|FG001|Overall Study|Physician Decision|1|||
124565807|NCT00135707|448030027|FG000|Overall Study|Lost to Follow-up|94|||
124565808|NCT00135707|448030028|FG001|Overall Study|Lost to Follow-up|89|||
124565809|NCT00135707|448030027|FG000|Overall Study|Withdrawal by Subject|0|||
124565810|NCT00135707|448030028|FG001|Overall Study|Withdrawal by Subject|1|||
124565811|NCT00135707|448030027|FG000|Overall Study|Institutional review board request|1|||
124565812|NCT00135707|448030028|FG001|Overall Study|Institutional review board request|0|||
124565813|NCT00421174|448030032|FG000|Overall Study|Withdrawal by Subject|0|||
124565814|NCT00421174|448030033|FG001|Overall Study|Withdrawal by Subject|1|||
124565815|NCT00421174|448030032|FG000|Overall Study|Ineligible due to infection|2|||
124565816|NCT00421174|448030033|FG001|Overall Study|Ineligible due to infection|0|||
124565817|NCT02524379|448030034|FG000|Overall Study|Death|1|||
124565818|NCT01829464|448030035|FG000|Overall Study|Adverse Event|1|||
124565819|NCT01829464|448030036|FG001|Overall Study|Adverse Event|0|||
124565820|NCT01829464|448030037|FG002|Overall Study|Adverse Event|0|||
124565821|NCT01829464|448030035|FG000|Overall Study|Lost to Follow-up|0|||
124565822|NCT01829464|448030036|FG001|Overall Study|Lost to Follow-up|0|||
124565823|NCT01829464|448030037|FG002|Overall Study|Lost to Follow-up|1|||
124565824|NCT01829464|448030035|FG000|Overall Study|Withdrawal by Subject|2|||
124565825|NCT01829464|448030036|FG001|Overall Study|Withdrawal by Subject|0|||
124510634|NCT01297309|447822187|FG000|Overall Study|Death|1|||
124510635|NCT01297309|447822187|FG000|Overall Study|Participant not entering extensionperiod|1|||
124510636|NCT03039738|447822188|FG000|Overall Study|Incomplete data sets|54|||
124510637|NCT03039738|447822189|FG001|Overall Study|Incomplete data sets|0|||
124510638|NCT02678312|447822190|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
124510639|NCT02678312|447822191|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
124510640|NCT02678312|447822192|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
124510641|NCT02678312|447822193|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
124510642|NCT02678312|447822194|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
124510643|NCT02678312|447822190|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
124510644|NCT02678312|447822191|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
124510645|NCT02678312|447822192|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
124510646|NCT02678312|447822193|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
124510647|NCT02678312|447822194|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
124510648|NCT02678312|447822190|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
124510649|NCT02678312|447822191|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
124510650|NCT02678312|447822192|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
124510651|NCT02678312|447822193|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
124510652|NCT02678312|447822194|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
124510653|NCT02678312|447822190|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
124510654|NCT02678312|447822191|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
124510655|NCT02678312|447822192|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
124510656|NCT02678312|447822193|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
124510657|NCT02678312|447822194|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
124510658|NCT02678312|447822190|FG000|Part 2 Double Blind Epoch|Death|0|||
124510659|NCT02678312|447822191|FG001|Part 2 Double Blind Epoch|Death|0|||
124510660|NCT02678312|447822192|FG002|Part 2 Double Blind Epoch|Death|0|||
124510661|NCT02678312|447822193|FG003|Part 2 Double Blind Epoch|Death|8|||
124510662|NCT02678312|447822194|FG004|Part 2 Double Blind Epoch|Death|12|||
124510663|NCT02678312|447822190|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
124510664|NCT02678312|447822191|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
124510665|NCT02678312|447822192|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
124510666|NCT02678312|447822193|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
124510667|NCT02678312|447822194|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
124510668|NCT02678312|447822190|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
124510669|NCT02678312|447822191|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
124510670|NCT02678312|447822192|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
124510671|NCT02678312|447822193|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
124510672|NCT02678312|447822194|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
124510673|NCT02678312|447822190|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
124510674|NCT02678312|447822191|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
124510675|NCT02678312|447822192|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
124510676|NCT02678312|447822193|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
124510677|NCT02678312|447822194|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
124510678|NCT02716194|447822197|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
124510679|NCT02716194|447822198|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
124510680|NCT02716194|447822199|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
124510681|NCT00971425|447822200|FG000|Overall Study|Adverse Event|1|||
124510682|NCT00971425|447822201|FG001|Overall Study|Adverse Event|1|||
124510683|NCT00971425|447822200|FG000|Overall Study|Withdrawal by Subject|0|||
124510684|NCT00971425|447822201|FG001|Overall Study|Withdrawal by Subject|1|||
124510685|NCT03587584|447822207|FG000|Overall Study|SOC deviations|4|||
124510686|NCT03587584|447822208|FG001|Overall Study|SOC deviations|6|||
124510687|NCT03587584|447822207|FG000|Overall Study|Incomplete data|0|||
124510688|NCT03587584|447822208|FG001|Overall Study|Incomplete data|3|||
124510689|NCT00225147|447822209|FG000|Open-label Phase|Lost to Follow-up|0|||
124510690|NCT00225147|447822210|FG001|Open-label Phase|Lost to Follow-up|0|||
124510691|NCT00225147|447822211|FG002|Open-label Phase|Lost to Follow-up|0|||
124510692|NCT00225147|447822212|FG003|Open-label Phase|Lost to Follow-up|4|||
124510693|NCT00225147|447822209|FG000|Open-label Phase|Withdrawal by Subject|0|||
124510694|NCT00225147|447822210|FG001|Open-label Phase|Withdrawal by Subject|0|||
124510695|NCT00225147|447822211|FG002|Open-label Phase|Withdrawal by Subject|0|||
124510696|NCT00225147|447822212|FG003|Open-label Phase|Withdrawal by Subject|6|||
124510697|NCT02685995|447822215|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
124510698|NCT02685995|447822216|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
124510699|NCT03625141|447822217|FG000|Overall Study|Adverse Event|0|||
124510700|NCT03625141|447822218|FG001|Overall Study|Adverse Event|2|||
124510701|NCT03625141|447822217|FG000|Overall Study|Study Terminated By Sponsor|1|||
124510702|NCT03625141|447822218|FG001|Overall Study|Study Terminated By Sponsor|13|||
124510703|NCT03625141|447822217|FG000|Overall Study|Withdrawal by Subject|3|||
124510704|NCT03625141|447822218|FG001|Overall Study|Withdrawal by Subject|0|||
124565826|NCT01829464|448030037|FG002|Overall Study|Withdrawal by Subject|0|||
124637309|NCT00507455|448290462|FG000|Overall Study|Lost to Follow-up|2|||
124565827|NCT01829464|448030035|FG000|Overall Study|Study terminated by sponsor|25|||
124565828|NCT01829464|448030036|FG001|Overall Study|Study terminated by sponsor|28|||
124510705|NCT03625141|447822217|FG000|Overall Study|Withdrawal Of Consent|0|||
124510706|NCT03625141|447822218|FG001|Overall Study|Withdrawal Of Consent|1|||
124510707|NCT03625141|447822217|FG000|Overall Study|Death|11|||
124510708|NCT03625141|447822218|FG001|Overall Study|Death|47|||
124510709|NCT03625141|447822217|FG000|Overall Study|Progressive Disease|0|||
124510710|NCT03625141|447822218|FG001|Overall Study|Progressive Disease|2|||
124510711|NCT00868166|447822220|FG000|Overall Study|Death|58|||
124510712|NCT00868166|447822221|FG001|Overall Study|Death|65|||
124510713|NCT00868166|447822220|FG000|Overall Study|Withdrawal by Subject|33|||
124510714|NCT00868166|447822221|FG001|Overall Study|Withdrawal by Subject|25|||
124510715|NCT00868166|447822220|FG000|Overall Study|Protocol Violation|1|||
124510716|NCT00868166|447822221|FG001|Overall Study|Protocol Violation|0|||
124510717|NCT00868166|447822220|FG000|Overall Study|Lost to Follow-up|1|||
124510718|NCT00868166|447822221|FG001|Overall Study|Lost to Follow-up|3|||
124510719|NCT00868166|447822220|FG000|Overall Study|Adverse Event|9|||
124510720|NCT00868166|447822221|FG001|Overall Study|Adverse Event|10|||
124510721|NCT00868166|447822220|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
124510722|NCT00868166|447822221|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
124510723|NCT00868166|447822220|FG000|Overall Study|Non-compliance with IMP|1|||
124510724|NCT00868166|447822221|FG001|Overall Study|Non-compliance with IMP|1|||
124510725|NCT03819218|447822228|FG000|Overall Study|Protocol Violation|1|||
124510726|NCT02680587|447822229|FG000|Overall Study|Withdrawal by Subject|1|||
124510727|NCT02680587|447822230|FG001|Overall Study|Withdrawal by Subject|0|||
124510728|NCT02899377|447822231|FG000|Overall Study|Adverse Event|1|||
124510729|NCT02899377|447822232|FG001|Overall Study|Adverse Event|0|||
124510730|NCT00469209|447822233|FG000|Overall Study|Adverse Event|1|||
124510731|NCT00469209|447822234|FG001|Overall Study|Adverse Event|0|||
124510732|NCT00469209|447822235|FG002|Overall Study|Adverse Event|1|||
124510733|NCT00712933|447822238|FG000|Overall Study|Adverse Event|69|||
124510734|NCT00712933|447822238|FG000|Overall Study|Lack of Efficacy|6|||
124510735|NCT00712933|447822238|FG000|Overall Study|Lost to Follow-up|22|||
124510736|NCT00712933|447822238|FG000|Overall Study|Non-compliance with study drug|13|||
124510737|NCT00712933|447822238|FG000|Overall Study|Other Pregnancy|37|||
124510738|NCT00712933|447822238|FG000|Overall Study|Sponsor decision|14|||
124510739|NCT00712933|447822238|FG000|Overall Study|Withdrew consent|4|||
124510740|NCT00712933|447822238|FG000|Overall Study|Hip replacement surgery|1|||
124510741|NCT00712933|447822238|FG000|Overall Study|Involved in Clinical research|3|||
124510742|NCT00712933|447822238|FG000|Overall Study|Participant hospitalized|1|||
124510743|NCT00712933|447822238|FG000|Overall Study|Participant travelled overseas|2|||
124510744|NCT00712933|447822238|FG000|Overall Study|Death of patient|1|||
124510745|NCT00712933|447822238|FG000|Overall Study|Other Physician decision|1|||
124510746|NCT00712933|447822238|FG000|Overall Study|Not committed to contraception|1|||
124510747|NCT00712933|447822238|FG000|Overall Study|Participant received medication|1|||
124510748|NCT00712933|447822238|FG000|Overall Study|Physician Decision|36|||
124510749|NCT00712933|447822238|FG000|Overall Study|Protocol Violation|4|||
124510750|NCT00712933|447822238|FG000|Overall Study|Withdrawal by Subject|151|||
124510751|NCT00085917|447822239|FG000|Overall Study|Adverse Event|4|||
124510752|NCT00085917|447822240|FG001|Overall Study|Adverse Event|3|||
124565829|NCT01829464|448030037|FG002|Overall Study|Study terminated by sponsor|25|||
124565830|NCT01829464|448030035|FG000|Overall Study|Lack of Efficacy|0|||
124565831|NCT01829464|448030036|FG001|Overall Study|Lack of Efficacy|1|||
124565832|NCT01829464|448030037|FG002|Overall Study|Lack of Efficacy|0|||
124565833|NCT02228382|448030042|FG000|Overall Study|Death|5|||
124565834|NCT02228382|448030043|FG001|Overall Study|Death|7|||
124565835|NCT02228382|448030044|FG002|Overall Study|Death|5|||
124565836|NCT02228382|448030045|FG003|Overall Study|Death|0|||
124565837|NCT02228382|448030046|FG004|Overall Study|Death|2|||
124510753|NCT01295580|447822241|FG000|Overall Study|Protocol Violation|4|||
124565838|NCT02228382|448030042|FG000|Overall Study|Participant refused further follow-up|0|||
124565839|NCT02228382|448030043|FG001|Overall Study|Participant refused further follow-up|0|||
124565840|NCT02228382|448030044|FG002|Overall Study|Participant refused further follow-up|1|||
124565841|NCT02228382|448030045|FG003|Overall Study|Participant refused further follow-up|0|||
124510754|NCT01295580|447822242|FG001|Overall Study|Protocol Violation|2|||
124510755|NCT01295580|447822241|FG000|Overall Study|Withdrawal by Subject|1|||
124510756|NCT01295580|447822242|FG001|Overall Study|Withdrawal by Subject|4|||
124510757|NCT01295580|447822241|FG000|Overall Study|Adverse Event|2|||
124510758|NCT01295580|447822242|FG001|Overall Study|Adverse Event|1|||
124510759|NCT01295580|447822241|FG000|Overall Study|Lost to Follow-up|1|||
124724870|NCT01696994|448613341|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
124510760|NCT01295580|447822242|FG001|Overall Study|Lost to Follow-up|0|||
124510761|NCT01295580|447822241|FG000|Overall Study|Lack of Efficacy|1|||
124510762|NCT01295580|447822242|FG001|Overall Study|Lack of Efficacy|0|||
124510763|NCT01295580|447822241|FG000|Overall Study|Other: inconvenience|1|||
124510764|NCT01295580|447822242|FG001|Overall Study|Other: inconvenience|0|||
124565842|NCT02228382|448030046|FG004|Overall Study|Participant refused further follow-up|0|||
124565843|NCT02228382|448030042|FG000|Overall Study|Study terminated by sponsor|3|||
124510765|NCT01295580|447822241|FG000|Overall Study|Other: family objection|0|||
124510766|NCT01295580|447822242|FG001|Overall Study|Other: family objection|1|||
124510767|NCT02022033|447822243|FG000|Overall Study|Physician Decision|1|||
124510768|NCT03067129|447822244|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
124510769|NCT03067129|447822245|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
124510770|NCT03067129|447822246|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
124510771|NCT03067129|447822247|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
124510772|NCT03067129|447822244|FG000|Overall Study|Withdrawal by Subject|0|||
124510773|NCT03067129|447822245|FG001|Overall Study|Withdrawal by Subject|0|||
124510774|NCT03067129|447822246|FG002|Overall Study|Withdrawal by Subject|1|||
124510775|NCT03067129|447822247|FG003|Overall Study|Withdrawal by Subject|2|||
124510776|NCT03067129|447822244|FG000|Overall Study|Lost to Follow-up|5|||
124510777|NCT03067129|447822245|FG001|Overall Study|Lost to Follow-up|5|||
124510778|NCT03067129|447822246|FG002|Overall Study|Lost to Follow-up|4|||
124510779|NCT03067129|447822247|FG003|Overall Study|Lost to Follow-up|3|||
124510780|NCT03986190|447822248|FG000|Overall Study|Withdrawal by Subject|12|||
124510781|NCT03986190|447822249|FG001|Overall Study|Withdrawal by Subject|0|||
124510782|NCT00830804|447822250|FG000|Overall Study|Lost to Follow-up|4|||
124510783|NCT00830804|447822250|FG000|Overall Study|Death|1|||
124510784|NCT00830804|447822250|FG000|Overall Study|Unable to get to clinic|7|||
124510785|NCT00830804|447822250|FG000|Overall Study|Consent withdrawn|2|||
124510786|NCT00830804|447822250|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
124510787|NCT02180217|447822251|FG000|Overall Study|Adverse Event|3|||
124510788|NCT02180217|447822252|FG001|Overall Study|Adverse Event|2|||
124510789|NCT02180217|447822253|FG002|Overall Study|Adverse Event|22|||
124510790|NCT02180217|447822251|FG000|Overall Study|Death|1|||
124510791|NCT02180217|447822252|FG001|Overall Study|Death|1|||
124510792|NCT02180217|447822253|FG002|Overall Study|Death|0|||
124510793|NCT02180217|447822251|FG000|Overall Study|Withdrawal by Subject|1|||
124510794|NCT02180217|447822252|FG001|Overall Study|Withdrawal by Subject|1|||
124510795|NCT02180217|447822253|FG002|Overall Study|Withdrawal by Subject|4|||
124565844|NCT02228382|448030043|FG001|Overall Study|Study terminated by sponsor|5|||
124565845|NCT02228382|448030044|FG002|Overall Study|Study terminated by sponsor|7|||
124565846|NCT02228382|448030045|FG003|Overall Study|Study terminated by sponsor|0|||
124565847|NCT02228382|448030046|FG004|Overall Study|Study terminated by sponsor|0|||
124565848|NCT02228382|448030042|FG000|Overall Study|Lost to Follow-up|0|||
124565849|NCT02228382|448030043|FG001|Overall Study|Lost to Follow-up|0|||
124565850|NCT02228382|448030044|FG002|Overall Study|Lost to Follow-up|3|||
124565851|NCT02228382|448030045|FG003|Overall Study|Lost to Follow-up|1|||
124565852|NCT02228382|448030046|FG004|Overall Study|Lost to Follow-up|0|||
124565853|NCT02228382|448030042|FG000|Overall Study|Withdrawal by Subject|0|||
124565854|NCT02228382|448030043|FG001|Overall Study|Withdrawal by Subject|3|||
124565855|NCT02228382|448030044|FG002|Overall Study|Withdrawal by Subject|2|||
124565856|NCT02228382|448030045|FG003|Overall Study|Withdrawal by Subject|1|||
124565857|NCT02228382|448030046|FG004|Overall Study|Withdrawal by Subject|0|||
124565858|NCT02228382|448030042|FG000|Overall Study|Other|2|||
124565859|NCT02228382|448030043|FG001|Overall Study|Other|3|||
124565860|NCT02228382|448030044|FG002|Overall Study|Other|3|||
124565861|NCT02228382|448030045|FG003|Overall Study|Other|0|||
124565862|NCT02228382|448030046|FG004|Overall Study|Other|0|||
124565863|NCT00356200|448030048|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
124565864|NCT00356200|448030049|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
124565865|NCT00356200|448030048|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
124565866|NCT00356200|448030049|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
124565867|NCT00812253|448030050|FG000|Overall Study|Withdrawal by Subject|3|||
124565868|NCT00812253|448030051|FG001|Overall Study|Withdrawal by Subject|2|||
124724871|NCT01696994|448613342|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
124724872|NCT01696994|448613341|FG000|Overall Study|Died Before Randomization|1|||
124510796|NCT02180217|447822251|FG000|Overall Study|Subject/Guardian decision|5|||
124510797|NCT02180217|447822252|FG001|Overall Study|Subject/Guardian decision|3|||
124724873|NCT01696994|448613342|FG001|Overall Study|Died Before Randomization|2|||
124510798|NCT02180217|447822253|FG002|Overall Study|Subject/Guardian decision|6|||
124510799|NCT02180217|447822251|FG000|Overall Study|Physician Decision|1|||
124565869|NCT00812253|448030050|FG000|Overall Study|Protocol Violation|1|||
124565870|NCT00812253|448030051|FG001|Overall Study|Protocol Violation|1|||
124565871|NCT00812253|448030050|FG000|Overall Study|Lost to Follow-up|2|||
124510800|NCT02180217|447822252|FG001|Overall Study|Physician Decision|1|||
124510801|NCT02180217|447822253|FG002|Overall Study|Physician Decision|6|||
124724874|NCT01696994|448613341|FG000|Overall Study|Died Before ASU (Control)|73|||
124510802|NCT02180217|447822251|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124510803|NCT02180217|447822252|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124565872|NCT00812253|448030051|FG001|Overall Study|Lost to Follow-up|0|||
124565873|NCT03679741|448030052|FG000|Period 1|No longer meet eligibility criteria|1|||
124565874|NCT03679741|448030053|FG001|Period 1|No longer meet eligibility criteria|0|||
124565875|NCT03679741|448030052|FG000|Period 1|Lost to Follow-up|0|||
124565876|NCT03679741|448030053|FG001|Period 1|Lost to Follow-up|1|||
124565877|NCT03679741|448030052|FG000|Period 1|Adverse Event|1|||
124565878|NCT03679741|448030053|FG001|Period 1|Adverse Event|1|||
124565879|NCT03679741|448030052|FG000|Period 1|Withdrawal by Subject|0|||
124565880|NCT03679741|448030053|FG001|Period 1|Withdrawal by Subject|1|||
124565881|NCT03679741|448030052|FG000|Period 2|Adverse Event|2|||
124565882|NCT03679741|448030053|FG001|Period 2|Adverse Event|1|||
124565883|NCT03679741|448030052|FG000|Period 2|Withdrawal by Subject|1|||
124565884|NCT03679741|448030053|FG001|Period 2|Withdrawal by Subject|1|||
124565885|NCT02204371|448030064|FG000|Overall Study|Adverse Event|1|||
124565886|NCT00368966|448030067|FG000|Infant Series|Withdrawal by Subject|11|||
124565887|NCT00368966|448030068|FG001|Infant Series|Withdrawal by Subject|6|||
124565888|NCT00368966|448030067|FG000|Infant Series|Protocol Violation|2|||
124565889|NCT00368966|448030068|FG001|Infant Series|Protocol Violation|1|||
124565890|NCT00368966|448030067|FG000|Infant Series|Lost to Follow-up|2|||
124565891|NCT00368966|448030068|FG001|Infant Series|Lost to Follow-up|0|||
124565892|NCT00368966|448030067|FG000|Infant Series|Randomization error|0|||
124565893|NCT00368966|448030068|FG001|Infant Series|Randomization error|1|||
124565894|NCT00368966|448030067|FG000|Infant Series|Failed to meet eligibility criteria|0|||
124565895|NCT00368966|448030068|FG001|Infant Series|Failed to meet eligibility criteria|1|||
124565896|NCT00368966|448030067|FG000|Infant Series|Adverse Event|0|||
124565897|NCT00368966|448030068|FG001|Infant Series|Adverse Event|1|||
124565898|NCT00368966|448030067|FG000|Infant Series|Failed to return|1|||
124565899|NCT00368966|448030068|FG001|Infant Series|Failed to return|0|||
124565900|NCT00368966|448030067|FG000|After Infant|Failed to return|3|||
124565901|NCT00368966|448030068|FG001|After Infant|Failed to return|1|||
124565902|NCT00368966|448030067|FG000|After Infant|Adverse Event|1|||
124565903|NCT00368966|448030068|FG001|After Infant|Adverse Event|2|||
124565904|NCT00368966|448030067|FG000|After Infant|Withdrawal by Subject|1|||
124565905|NCT00368966|448030068|FG001|After Infant|Withdrawal by Subject|1|||
124565906|NCT00368966|448030067|FG000|After Infant|Death|1|||
124565907|NCT00368966|448030068|FG001|After Infant|Death|0|||
124565908|NCT00368966|448030067|FG000|After Infant|Lost to Follow-up|0|||
124565909|NCT00368966|448030068|FG001|After Infant|Lost to Follow-up|1|||
124565910|NCT00368966|448030067|FG000|Toddler Dose|Withdrawal by Subject|1|||
124565911|NCT00368966|448030068|FG001|Toddler Dose|Withdrawal by Subject|1|||
124565912|NCT00368966|448030067|FG000|Toddler Dose|Lost to Follow-up|0|||
124565913|NCT00368966|448030068|FG001|Toddler Dose|Lost to Follow-up|2|||
124565914|NCT02866175|448030069|FG000|Overall Study|Adverse Event|56|||
124565915|NCT02866175|448030070|FG001|Overall Study|Adverse Event|54|||
124565916|NCT02866175|448030069|FG000|Overall Study|Withdrawal by Subject|31|||
124565917|NCT02866175|448030070|FG001|Overall Study|Withdrawal by Subject|52|||
124565918|NCT02866175|448030069|FG000|Overall Study|Death|30|||
124565919|NCT02866175|448030070|FG001|Overall Study|Death|23|||
124565920|NCT02866175|448030069|FG000|Overall Study|Other|7|||
124565921|NCT02866175|448030070|FG001|Overall Study|Other|14|||
124565922|NCT02866175|448030069|FG000|Overall Study|Progressive disease|1|||
124565923|NCT02866175|448030070|FG001|Overall Study|Progressive disease|1|||
124565924|NCT02866175|448030069|FG000|Overall Study|Lost to Follow-up|2|||
124565925|NCT02866175|448030070|FG001|Overall Study|Lost to Follow-up|0|||
124565926|NCT02866175|448030069|FG000|Overall Study|Lack of Efficacy|0|||
124565927|NCT02866175|448030070|FG001|Overall Study|Lack of Efficacy|1|||
124565928|NCT02866175|448030069|FG000|Overall Study|Physician Decision|3|||
124565929|NCT02866175|448030070|FG001|Overall Study|Physician Decision|15|||
124565930|NCT02866175|448030069|FG000|Overall Study|Did not receive treatment|5|||
124565931|NCT02866175|448030070|FG001|Overall Study|Did not receive treatment|15|||
124565932|NCT01694485|448030071|FG000|Overall Study|Withdrawal by Subject|20|||
124565933|NCT01694485|448030072|FG001|Overall Study|Withdrawal by Subject|6|||
124565934|NCT01694485|448030073|FG002|Overall Study|Withdrawal by Subject|7|||
124565935|NCT01694485|448030074|FG003|Overall Study|Withdrawal by Subject|25|||
124565936|NCT01694485|448030075|FG004|Overall Study|Withdrawal by Subject|18|||
124565937|NCT01694485|448030071|FG000|Overall Study|Sponsor Decision|3|||
124565938|NCT01694485|448030072|FG001|Overall Study|Sponsor Decision|0|||
124565939|NCT01694485|448030073|FG002|Overall Study|Sponsor Decision|0|||
124565940|NCT01694485|448030074|FG003|Overall Study|Sponsor Decision|2|||
124565941|NCT01694485|448030075|FG004|Overall Study|Sponsor Decision|0|||
124565942|NCT01694485|448030071|FG000|Overall Study|Lost to Follow-up|9|||
124565943|NCT01694485|448030072|FG001|Overall Study|Lost to Follow-up|1|||
124565944|NCT01694485|448030073|FG002|Overall Study|Lost to Follow-up|6|||
124565945|NCT01694485|448030074|FG003|Overall Study|Lost to Follow-up|10|||
124565946|NCT01694485|448030075|FG004|Overall Study|Lost to Follow-up|7|||
124565947|NCT01694485|448030071|FG000|Overall Study|Death|1|||
124565948|NCT01694485|448030072|FG001|Overall Study|Death|0|||
124565949|NCT01694485|448030073|FG002|Overall Study|Death|0|||
124565950|NCT01694485|448030074|FG003|Overall Study|Death|1|||
124565951|NCT01694485|448030075|FG004|Overall Study|Death|0|||
124565952|NCT01595009|448030076|FG000|Core|Patients completed per protocol|85|||
124565953|NCT01595009|448030077|FG001|Core|Patients completed per protocol|44|||
124565954|NCT01595009|448030078|FG002|Core|Patients completed per protocol|0|||
124565955|NCT01595009|448030079|FG003|Core|Patients completed per protocol|0|||
124565956|NCT01595009|448030076|FG000|Core|Adverse Event|19|||
124565957|NCT01595009|448030077|FG001|Core|Adverse Event|23|||
124565958|NCT01595009|448030078|FG002|Core|Adverse Event|0|||
124565959|NCT01595009|448030079|FG003|Core|Adverse Event|0|||
124565960|NCT01595009|448030076|FG000|Core|Disease progression|14|||
124565961|NCT01595009|448030077|FG001|Core|Disease progression|26|||
124565962|NCT01595009|448030078|FG002|Core|Disease progression|0|||
124565963|NCT01595009|448030079|FG003|Core|Disease progression|0|||
124565964|NCT01595009|448030076|FG000|Core|Withdrawal by Subject|4|||
124565965|NCT01595009|448030077|FG001|Core|Withdrawal by Subject|17|||
124565966|NCT01595009|448030078|FG002|Core|Withdrawal by Subject|0|||
124565967|NCT01595009|448030079|FG003|Core|Withdrawal by Subject|0|||
124565968|NCT01595009|448030076|FG000|Core|Death|3|||
124565969|NCT01595009|448030077|FG001|Core|Death|6|||
124565970|NCT01595009|448030078|FG002|Core|Death|0|||
124565971|NCT01595009|448030079|FG003|Core|Death|0|||
124565972|NCT01595009|448030076|FG000|Core|Lost to Follow-up|1|||
124565973|NCT01595009|448030077|FG001|Core|Lost to Follow-up|2|||
124565974|NCT01595009|448030078|FG002|Core|Lost to Follow-up|0|||
124565975|NCT01595009|448030079|FG003|Core|Lost to Follow-up|0|||
124565976|NCT01595009|448030076|FG000|Core|Protocol deviation|0|||
124565977|NCT01595009|448030077|FG001|Core|Protocol deviation|1|||
124565978|NCT01595009|448030078|FG002|Core|Protocol deviation|0|||
124565979|NCT01595009|448030079|FG003|Core|Protocol deviation|0|||
124565980|NCT01595009|448030076|FG000|Core|Administrative problems|0|||
124565981|NCT01595009|448030077|FG001|Core|Administrative problems|1|||
124565982|NCT01595009|448030078|FG002|Core|Administrative problems|0|||
124565983|NCT01595009|448030079|FG003|Core|Administrative problems|0|||
124565984|NCT01595009|448030076|FG000|Extension|Administrative problems|0|||
124565985|NCT01595009|448030077|FG001|Extension|Administrative problems|0|||
124565986|NCT01595009|448030078|FG002|Extension|Administrative problems|0|||
124565987|NCT01595009|448030079|FG003|Extension|Administrative problems|1|||
124565988|NCT01595009|448030076|FG000|Extension|Patients completed per protocol|0|||
124565989|NCT01595009|448030077|FG001|Extension|Patients completed per protocol|0|||
124565990|NCT01595009|448030078|FG002|Extension|Patients completed per protocol|0|||
124565991|NCT01595009|448030079|FG003|Extension|Patients completed per protocol|2|||
124565992|NCT01595009|448030076|FG000|Extension|Disease progression|0|||
124565993|NCT01595009|448030077|FG001|Extension|Disease progression|0|||
124565994|NCT01595009|448030078|FG002|Extension|Disease progression|4|||
124565995|NCT01595009|448030079|FG003|Extension|Disease progression|7|||
124565996|NCT01595009|448030076|FG000|Extension|Adverse Event|0|||
124565997|NCT01595009|448030077|FG001|Extension|Adverse Event|0|||
124565998|NCT01595009|448030078|FG002|Extension|Adverse Event|0|||
124565999|NCT01595009|448030079|FG003|Extension|Adverse Event|1|||
124566000|NCT00662025|448030081|FG000|Overall Study|Objective progression or relapse|51|||
124566001|NCT00662025|448030081|FG000|Overall Study|Adverse Event|7|||
124566002|NCT00662025|448030081|FG000|Overall Study|Withdrawal by Subject|1|||
124566003|NCT00662025|448030081|FG000|Overall Study|Results of other clinical study|2|||
124566004|NCT00662025|448030081|FG000|Overall Study|Target lesion cannot be evaluated|1|||
124566005|NCT00662025|448030081|FG000|Overall Study|Domestic circumstances|1|||
124566006|NCT00626925|448030090|FG000|Overall Study|Lost to Follow-up|1|||
124566007|NCT00626925|448030091|FG001|Overall Study|Lost to Follow-up|2|||
124566008|NCT00626925|448030090|FG000|Overall Study|relapse|1|||
124566009|NCT00626925|448030091|FG001|Overall Study|relapse|0|||
124566010|NCT00626925|448030090|FG000|Overall Study|Adverse effect|6|||
124566011|NCT00626925|448030091|FG001|Overall Study|Adverse effect|2|||
124566012|NCT00626925|448030090|FG000|Overall Study|Lack of Efficacy|1|||
124566013|NCT00626925|448030091|FG001|Overall Study|Lack of Efficacy|4|||
124566014|NCT00626925|448030090|FG000|Overall Study|Time constraints|3|||
124566015|NCT00626925|448030091|FG001|Overall Study|Time constraints|1|||
124566016|NCT01215942|448030098|FG000|Treatment Period|Adverse Event|15|||
124566017|NCT01215942|448030099|FG001|Treatment Period|Adverse Event|26|||
124566018|NCT01215942|448030098|FG000|Treatment Period|Death|2|||
124566019|NCT01215942|448030099|FG001|Treatment Period|Death|4|||
124566020|NCT01215942|448030098|FG000|Treatment Period|Lack of Efficacy|23|||
124566021|NCT01215942|448030099|FG001|Treatment Period|Lack of Efficacy|62|||
124566022|NCT01215942|448030098|FG000|Treatment Period|Lost to Follow-up|3|||
124566023|NCT01215942|448030099|FG001|Treatment Period|Lost to Follow-up|4|||
124566024|NCT01215942|448030098|FG000|Treatment Period|Withdrawal by Subject|17|||
124566025|NCT01215942|448030099|FG001|Treatment Period|Withdrawal by Subject|40|||
124566026|NCT01215942|448030098|FG000|Treatment Period|Physician Decision|5|||
124566027|NCT01215942|448030099|FG001|Treatment Period|Physician Decision|5|||
124566028|NCT01215942|448030098|FG000|Treatment Period|Protocol Violation|0|||
124566029|NCT01215942|448030099|FG001|Treatment Period|Protocol Violation|1|||
124566030|NCT01215942|448030098|FG000|Treatment Period|Sponsor Decision|349|||
124566031|NCT01215942|448030099|FG001|Treatment Period|Sponsor Decision|530|||
124566032|NCT01215942|448030098|FG000|Post-Treatment Follow-Up Period|Death|0|||
124566033|NCT01215942|448030099|FG001|Post-Treatment Follow-Up Period|Death|1|||
124566034|NCT01215942|448030098|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
124566035|NCT01215942|448030099|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
124566036|NCT01215942|448030098|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
124566037|NCT01215942|448030099|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
124566038|NCT01215942|448030098|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
124637310|NCT00507455|448290463|FG001|Overall Study|Lost to Follow-up|0|||
124566039|NCT01215942|448030099|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
124566040|NCT01215942|448030098|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
124566041|NCT01215942|448030099|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
124566042|NCT01966042|448030100|FG000|Overall Study|Death|2|||
124566043|NCT03522948|448030101|FG000|Overall Study|Lost to Follow-up|1|||
124566044|NCT03305055|448030102|FG000|Overall Study|Withdrawal by Subject|0|||
124566045|NCT03305055|448030103|FG001|Overall Study|Withdrawal by Subject|1|||
124566046|NCT03305055|448030102|FG000|Overall Study|Adverse Event|1|||
124566047|NCT03305055|448030103|FG001|Overall Study|Adverse Event|1|||
124566048|NCT01802879|448030104|FG000|Overall Study|Administrative problems|2|||
124566049|NCT01802879|448030104|FG000|Overall Study|Disease progression|6|||
124566050|NCT01047345|448030111|FG000|Base Study|Adverse Event|3|||
124566051|NCT01047345|448030112|FG001|Base Study|Adverse Event|0|||
124566052|NCT01047345|448030113|FG002|Base Study|Adverse Event|0|||
124566053|NCT01047345|448030111|FG000|Base Study|Lost to Follow-up|4|||
124566054|NCT01047345|448030112|FG001|Base Study|Lost to Follow-up|1|||
124566055|NCT01047345|448030113|FG002|Base Study|Lost to Follow-up|0|||
124566056|NCT01047345|448030111|FG000|Base Study|Protocol Violation|3|||
124566057|NCT01047345|448030112|FG001|Base Study|Protocol Violation|1|||
124566058|NCT01047345|448030113|FG002|Base Study|Protocol Violation|0|||
124566059|NCT01047345|448030111|FG000|Base Study|Withdrawal by Subject|12|||
124566060|NCT01047345|448030112|FG001|Base Study|Withdrawal by Subject|4|||
124566061|NCT01047345|448030113|FG002|Base Study|Withdrawal by Subject|0|||
124566062|NCT01047345|448030111|FG000|Extension|Withdrawal by Subject|0|||
124566063|NCT01047345|448030112|FG001|Extension|Withdrawal by Subject|0|||
124566064|NCT01047345|448030113|FG002|Extension|Withdrawal by Subject|1|||
124566065|NCT01047345|448030111|FG000|Extension|Lost to Follow-up|0|||
124566066|NCT01047345|448030112|FG001|Extension|Lost to Follow-up|0|||
124566067|NCT01047345|448030113|FG002|Extension|Lost to Follow-up|5|||
124566068|NCT02116803|448030114|FG000|Overall Study|Adverse Event|2|||
124566069|NCT02116803|448030115|FG001|Overall Study|Adverse Event|1|||
124566070|NCT02116803|448030114|FG000|Overall Study|Physician Decision|1|||
124566071|NCT02116803|448030115|FG001|Overall Study|Physician Decision|0|||
124566072|NCT02116803|448030114|FG000|Overall Study|Progressive disease|4|||
124566073|NCT02116803|448030115|FG001|Overall Study|Progressive disease|0|||
124566074|NCT02116803|448030114|FG000|Overall Study|Study terminated by sponsor|2|||
124566075|NCT02116803|448030115|FG001|Overall Study|Study terminated by sponsor|1|||
124566076|NCT02116803|448030114|FG000|Overall Study|Death|1|||
124566077|NCT02116803|448030115|FG001|Overall Study|Death|0|||
124566078|NCT01974895|448030118|FG000|Overall Study|Protocol Violation|1|||
124566079|NCT01974895|448030119|FG001|Overall Study|Protocol Violation|0|||
124566080|NCT01974895|448030118|FG000|Overall Study|Lost to Follow-up|4|||
124566081|NCT01974895|448030119|FG001|Overall Study|Lost to Follow-up|6|||
124566082|NCT01974895|448030118|FG000|Overall Study|Withdrawal by Subject|0|||
124566083|NCT01974895|448030119|FG001|Overall Study|Withdrawal by Subject|1|||
124566084|NCT01974895|448030118|FG000|Overall Study|Other (Missed Visit)|1|||
124566085|NCT01974895|448030119|FG001|Overall Study|Other (Missed Visit)|0|||
124566086|NCT01974895|448030118|FG000|Overall Study|Other (Reason unknown)|9|||
124566087|NCT01974895|448030119|FG001|Overall Study|Other (Reason unknown)|8|||
124566088|NCT01984242|448030120|FG000|Overall Study|Death|52|||
124566089|NCT01984242|448030121|FG001|Overall Study|Death|50|||
124566090|NCT01984242|448030122|FG002|Overall Study|Death|52|||
124566091|NCT01984242|448030120|FG000|Overall Study|Withdrawal by Subject|5|||
124566092|NCT01984242|448030121|FG001|Overall Study|Withdrawal by Subject|3|||
124566093|NCT01984242|448030122|FG002|Overall Study|Withdrawal by Subject|10|||
124566094|NCT01984242|448030120|FG000|Overall Study|Physician Decision|0|||
124566095|NCT01984242|448030121|FG001|Overall Study|Physician Decision|0|||
124566096|NCT01984242|448030122|FG002|Overall Study|Physician Decision|1|||
124566097|NCT01984242|448030120|FG000|Overall Study|Lost to Follow-up|4|||
124566098|NCT01984242|448030121|FG001|Overall Study|Lost to Follow-up|0|||
124566099|NCT01984242|448030122|FG002|Overall Study|Lost to Follow-up|3|||
124566100|NCT01984242|448030120|FG000|Overall Study|Sponsor Decision|1|||
124566101|NCT01984242|448030121|FG001|Overall Study|Sponsor Decision|0|||
124566102|NCT01984242|448030122|FG002|Overall Study|Sponsor Decision|0|||
124566103|NCT01984242|448030120|FG000|Overall Study|Non-Compliance|1|||
124566104|NCT01984242|448030121|FG001|Overall Study|Non-Compliance|0|||
124566105|NCT01984242|448030122|FG002|Overall Study|Non-Compliance|0|||
124566106|NCT01984242|448030120|FG000|Overall Study|Study terminated by Sponsor|38|||
124566107|NCT01984242|448030121|FG001|Overall Study|Study terminated by Sponsor|50|||
124566108|NCT01984242|448030122|FG002|Overall Study|Study terminated by Sponsor|34|||
124566109|NCT01984242|448030120|FG000|Overall Study|Disease Progression|0|||
124566110|NCT01984242|448030121|FG001|Overall Study|Disease Progression|0|||
124566111|NCT01984242|448030122|FG002|Overall Study|Disease Progression|1|||
124566112|NCT04543136|448030125|FG000|Overall Study|Withdrawal by Subject|0|||
124566113|NCT04543136|448030126|FG001|Overall Study|Withdrawal by Subject|1|||
124566114|NCT04543136|448030127|FG002|Overall Study|Withdrawal by Subject|0|||
124566115|NCT04543136|448030128|FG003|Overall Study|Withdrawal by Subject|1|||
124566116|NCT04543136|448030129|FG004|Overall Study|Withdrawal by Subject|0|||
124566117|NCT04543136|448030130|FG005|Overall Study|Withdrawal by Subject|0|||
124637311|NCT00507455|448290464|FG002|Overall Study|Lost to Follow-up|2|||
124724875|NCT01696994|448613342|FG001|Overall Study|Died Before ASU (Control)|0|||
124724876|NCT01696994|448613341|FG000|Overall Study|No Ovaries at Baseline|4807|||
124510804|NCT02180217|447822253|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
124510805|NCT00645567|447822254|FG000|Overall Study|Adverse Event|1|||
124510806|NCT04664855|447822255|FG000|Overall Study|Withdrawal by Subject|0|||
124510807|NCT04664855|447822256|FG001|Overall Study|Withdrawal by Subject|2|||
124510808|NCT02219087|447822257|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
124510809|NCT02219087|447822258|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
124510810|NCT03730194|447822264|FG000|First Stage Treatment|Withdrawal by Subject|1|||
124510811|NCT03730194|447822265|FG001|First Stage Treatment|Withdrawal by Subject|1|||
124510812|NCT03730194|447822266|FG002|First Stage Treatment|Withdrawal by Subject|0|||
124510813|NCT03730194|447822267|FG003|First Stage Treatment|Withdrawal by Subject|0|||
124510814|NCT03730194|447822268|FG004|First Stage Treatment|Withdrawal by Subject|0|||
124510815|NCT03730194|447822269|FG005|First Stage Treatment|Withdrawal by Subject|0|||
124510816|NCT03730194|447822264|FG000|First Stage Treatment|Protocol Violation|3|||
124510817|NCT03730194|447822265|FG001|First Stage Treatment|Protocol Violation|3|||
124510818|NCT03730194|447822266|FG002|First Stage Treatment|Protocol Violation|0|||
124510819|NCT03730194|447822267|FG003|First Stage Treatment|Protocol Violation|0|||
124510820|NCT03730194|447822268|FG004|First Stage Treatment|Protocol Violation|0|||
124510821|NCT03730194|447822269|FG005|First Stage Treatment|Protocol Violation|0|||
124510822|NCT00870818|447822272|FG000|Overall Study|Lost to Follow-up|3|||
124510823|NCT00870818|447822273|FG001|Overall Study|Lost to Follow-up|2|||
124510824|NCT00870818|447822274|FG002|Overall Study|Lost to Follow-up|1|||
124510825|NCT00870818|447822275|FG003|Overall Study|Lost to Follow-up|0|||
124510826|NCT00870818|447822276|FG004|Overall Study|Lost to Follow-up|0|||
124510827|NCT00870818|447822272|FG000|Overall Study|Withdrawal by Subject|0|||
124510828|NCT00870818|447822273|FG001|Overall Study|Withdrawal by Subject|0|||
124510829|NCT00870818|447822274|FG002|Overall Study|Withdrawal by Subject|1|||
124510830|NCT00870818|447822275|FG003|Overall Study|Withdrawal by Subject|2|||
124510831|NCT00870818|447822276|FG004|Overall Study|Withdrawal by Subject|0|||
124510832|NCT00870818|447822272|FG000|Overall Study|Terminated by sponsor|29|||
124510833|NCT00870818|447822273|FG001|Overall Study|Terminated by sponsor|70|||
124510834|NCT00870818|447822274|FG002|Overall Study|Terminated by sponsor|36|||
124510835|NCT00870818|447822275|FG003|Overall Study|Terminated by sponsor|36|||
124510836|NCT00870818|447822276|FG004|Overall Study|Terminated by sponsor|38|||
124510837|NCT00870818|447822272|FG000|Overall Study|Other|0|||
124510838|NCT00870818|447822273|FG001|Overall Study|Other|1|||
124510839|NCT00870818|447822274|FG002|Overall Study|Other|0|||
124510840|NCT00870818|447822275|FG003|Overall Study|Other|0|||
124510841|NCT00870818|447822276|FG004|Overall Study|Other|0|||
124510842|NCT00178464|447822277|FG000|Overall Study|Withdrawal by Subject|1|||
124510843|NCT00178464|447822277|FG000|Overall Study|Physician Decision|1|||
124510844|NCT04900038|447822278|FG000|Overall Study|Adverse Event|1|||
124510845|NCT04900038|447822279|FG001|Overall Study|Adverse Event|0|||
124510846|NCT04900038|447822280|FG002|Overall Study|Adverse Event|1|||
124510847|NCT04900038|447822281|FG003|Overall Study|Adverse Event|1|||
124510848|NCT04900038|447822278|FG000|Overall Study|Withdrawal by Subject|0|||
124510849|NCT04900038|447822279|FG001|Overall Study|Withdrawal by Subject|1|||
124510850|NCT04900038|447822280|FG002|Overall Study|Withdrawal by Subject|0|||
124510851|NCT04900038|447822281|FG003|Overall Study|Withdrawal by Subject|0|||
124510852|NCT04900038|447822278|FG000|Overall Study|Study terminated by sponsor|18|||
124510853|NCT04900038|447822279|FG001|Overall Study|Study terminated by sponsor|15|||
124510854|NCT04900038|447822280|FG002|Overall Study|Study terminated by sponsor|17|||
124510855|NCT04900038|447822281|FG003|Overall Study|Study terminated by sponsor|14|||
124510856|NCT04900038|447822278|FG000|Overall Study|Protocol Deviation|1|||
124510857|NCT04900038|447822279|FG001|Overall Study|Protocol Deviation|1|||
124510858|NCT04900038|447822280|FG002|Overall Study|Protocol Deviation|0|||
124510859|NCT04900038|447822281|FG003|Overall Study|Protocol Deviation|0|||
124510860|NCT04900038|447822278|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
124510861|NCT04900038|447822279|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
124510862|NCT04900038|447822280|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
124510863|NCT04900038|447822281|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
124510864|NCT04900038|447822278|FG000|Overall Study|Lost to Follow-up|0|||
124510865|NCT04900038|447822279|FG001|Overall Study|Lost to Follow-up|0|||
124510866|NCT04900038|447822280|FG002|Overall Study|Lost to Follow-up|0|||
124510867|NCT04900038|447822281|FG003|Overall Study|Lost to Follow-up|1|||
124510868|NCT02227108|447822282|FG000|Overall Study|Did not receive treatment|2|||
124510869|NCT02227108|447822282|FG000|Overall Study|Other|3|||
124510870|NCT02227108|447822282|FG000|Overall Study|Progressive disease|17|||
124510871|NCT02227108|447822282|FG000|Overall Study|Initiation of alternative therapy|2|||
124510872|NCT02227108|447822282|FG000|Overall Study|Investigator discretion|1|||
124510873|NCT02227108|447822282|FG000|Overall Study|Adverse Event|6|||
124510874|NCT02486952|447822283|FG000|Overall Study|Not Started Induction Therapy|3|||
124510875|NCT02486952|447822283|FG000|Overall Study|Adverse Event|1|||
124510876|NCT02486952|447822283|FG000|Overall Study|Death|15|||
124510877|NCT02486952|447822283|FG000|Overall Study|Lack of Efficacy|3|||
124724877|NCT01696994|448613342|FG001|Overall Study|No Ovaries at Baseline|4851|||
124510878|NCT02486952|447822283|FG000|Overall Study|Lost to Follow-up|26|||
124510879|NCT02486952|447822283|FG000|Overall Study|Other|2|||
124510880|NCT01928485|447822284|FG000|Overall Study|Physician Decision|0|||
124510881|NCT01928485|447822285|FG001|Overall Study|Physician Decision|1|||
124510882|NCT04111107|447822286|FG000|Overall Study|Withdrawal by Subject|6|||
124510883|NCT04111107|447822286|FG000|Overall Study|Declining Health|5|||
124510884|NCT03814590|447822289|FG000|Overall Study|Adverse Event|0|||
124510885|NCT03814590|447822290|FG001|Overall Study|Adverse Event|0|||
124510886|NCT03814590|447822291|FG002|Overall Study|Adverse Event|0|||
124510887|NCT03814590|447822292|FG003|Overall Study|Adverse Event|0|||
124510888|NCT03814590|447822293|FG004|Overall Study|Adverse Event|0|||
124510889|NCT03814590|447822294|FG005|Overall Study|Adverse Event|1|||
124510890|NCT03814590|447822295|FG006|Overall Study|Adverse Event|1|||
124510891|NCT03814590|447822296|FG007|Overall Study|Adverse Event|1|||
124510892|NCT03814590|447822297|FG008|Overall Study|Adverse Event|0|||
124510893|NCT03814590|447822298|FG009|Overall Study|Adverse Event|0|||
124510894|NCT03814590|447822299|FG010|Overall Study|Adverse Event|1|||
124510895|NCT03814590|447822300|FG011|Overall Study|Adverse Event|0|||
124510896|NCT03814590|447822301|FG012|Overall Study|Adverse Event|3|||
124510897|NCT03814590|447822302|FG013|Overall Study|Adverse Event|0|||
124510898|NCT03814590|447822289|FG000|Overall Study|Lost to Follow-up|0|||
124510899|NCT03814590|447822290|FG001|Overall Study|Lost to Follow-up|2|||
124510900|NCT03814590|447822291|FG002|Overall Study|Lost to Follow-up|1|||
124510901|NCT03814590|447822292|FG003|Overall Study|Lost to Follow-up|0|||
124510902|NCT03814590|447822293|FG004|Overall Study|Lost to Follow-up|1|||
124510903|NCT03814590|447822294|FG005|Overall Study|Lost to Follow-up|1|||
124510904|NCT03814590|447822295|FG006|Overall Study|Lost to Follow-up|1|||
124510905|NCT03814590|447822296|FG007|Overall Study|Lost to Follow-up|1|||
124510906|NCT03814590|447822297|FG008|Overall Study|Lost to Follow-up|0|||
124510907|NCT03814590|447822298|FG009|Overall Study|Lost to Follow-up|0|||
124510908|NCT03814590|447822299|FG010|Overall Study|Lost to Follow-up|1|||
124510909|NCT03814590|447822300|FG011|Overall Study|Lost to Follow-up|0|||
124510910|NCT03814590|447822301|FG012|Overall Study|Lost to Follow-up|0|||
124510911|NCT03814590|447822302|FG013|Overall Study|Lost to Follow-up|1|||
124510912|NCT03814590|447822289|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
124510913|NCT03814590|447822290|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
124510914|NCT03814590|447822291|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
124510915|NCT03814590|447822292|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
124510916|NCT03814590|447822293|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
124510917|NCT03814590|447822294|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
124510918|NCT03814590|447822295|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
124510919|NCT03814590|447822296|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
124510920|NCT03814590|447822297|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
124510921|NCT03814590|447822298|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
124510922|NCT03814590|447822299|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
124510923|NCT03814590|447822300|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
124510924|NCT03814590|447822301|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
124510925|NCT03814590|447822302|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
124510926|NCT03814590|447822289|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
124510927|NCT03814590|447822290|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
124510928|NCT03814590|447822291|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
124510929|NCT03814590|447822292|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
124510930|NCT03814590|447822293|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
124510931|NCT03814590|447822294|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
124510932|NCT03814590|447822295|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
124510933|NCT03814590|447822296|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
124510934|NCT03814590|447822297|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
124510935|NCT03814590|447822298|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
124510936|NCT03814590|447822299|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
124510937|NCT03814590|447822300|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
124510938|NCT03814590|447822301|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
124510939|NCT03814590|447822302|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
124510940|NCT03814590|447822289|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124724878|NCT01696994|448613341|FG000|Overall Study|Refused ASU (Control)|311|||
124724879|NCT01696994|448613342|FG001|Overall Study|Refused ASU (Control)|0|||
124566118|NCT00947427|448030135|FG000|Overall Study|Withdrawal by Subject|1|||
124566119|NCT00947427|448030136|FG001|Overall Study|Withdrawal by Subject|3|||
124566120|NCT00947427|448030135|FG000|Overall Study|Protocol Violation|0|||
124566121|NCT00947427|448030136|FG001|Overall Study|Protocol Violation|1|||
124566122|NCT00865709|448030137|FG000|Treatment|Adverse Event|9|||
124566123|NCT00865709|448030138|FG001|Treatment|Adverse Event|6|||
124566124|NCT00865709|448030137|FG000|Treatment|Withdrawal by Subject|10|||
124566125|NCT00865709|448030138|FG001|Treatment|Withdrawal by Subject|7|||
124566126|NCT00865709|448030137|FG000|Treatment|Physician Decision|3|||
124566127|NCT00865709|448030138|FG001|Treatment|Physician Decision|2|||
124566128|NCT00865709|448030137|FG000|Treatment|Surgery|8|||
124566129|NCT00865709|448030138|FG001|Treatment|Surgery|3|||
124566130|NCT00429923|448030139|FG000|Overall Study|Adverse Event|0|||
124566131|NCT00429923|448030140|FG001|Overall Study|Adverse Event|2|||
124566132|NCT00429923|448030141|FG002|Overall Study|Adverse Event|3|||
124566133|NCT00429923|448030139|FG000|Overall Study|Lack of Efficacy|4|||
124566134|NCT00429923|448030140|FG001|Overall Study|Lack of Efficacy|1|||
124566135|NCT00429923|448030141|FG002|Overall Study|Lack of Efficacy|33|||
124566136|NCT00429923|448030139|FG000|Overall Study|Lost to Follow-up|0|||
124566137|NCT00429923|448030140|FG001|Overall Study|Lost to Follow-up|0|||
124566138|NCT00429923|448030141|FG002|Overall Study|Lost to Follow-up|2|||
124566139|NCT00429923|448030139|FG000|Overall Study|Withdrew Consent|1|||
124566140|NCT00429923|448030140|FG001|Overall Study|Withdrew Consent|0|||
124566141|NCT00429923|448030141|FG002|Overall Study|Withdrew Consent|1|||
124566142|NCT00429923|448030139|FG000|Overall Study|Early Termination|0|||
124566143|NCT00429923|448030140|FG001|Overall Study|Early Termination|1|||
124566144|NCT00429923|448030141|FG002|Overall Study|Early Termination|0|||
124566145|NCT00662129|448030146|FG000|Overall Study|Protocol Violation|1|||
124566146|NCT00662129|448030146|FG000|Overall Study|Cancel prior to beginning treatment|1|||
124566147|NCT00662129|448030146|FG000|Overall Study|Ineligible|1|||
124566148|NCT02153736|448030147|FG000|Overall Study|Lost to Follow-up|1|||
124566149|NCT02153736|448030148|FG001|Overall Study|Lost to Follow-up|0|||
124566150|NCT02153736|448030147|FG000|Overall Study|Medical status change made ineligible|1|||
124566151|NCT02153736|448030148|FG001|Overall Study|Medical status change made ineligible|0|||
124566152|NCT02153736|448030147|FG000|Overall Study|Death|0|||
124566153|NCT02153736|448030148|FG001|Overall Study|Death|1|||
124566154|NCT02153736|448030147|FG000|Overall Study|Withdrawal by Subject|0|||
124566155|NCT02153736|448030148|FG001|Overall Study|Withdrawal by Subject|1|||
124566156|NCT00720122|448030157|FG000|Overall Study|Lost to Follow-up|1|||
124566157|NCT00720122|448030157|FG000|Overall Study|Physician Decision|1|||
124566158|NCT00720122|448030157|FG000|Overall Study|Withdrawal by Subject|7|||
124566159|NCT02275364|448030158|FG000|Period 1|Withdrawal by Subject|1|||
124566160|NCT02275364|448030159|FG001|Period 1|Withdrawal by Subject|0|||
124566161|NCT02275364|448030158|FG000|Period 1|Other reason|1|||
124566162|NCT02275364|448030159|FG001|Period 1|Other reason|0|||
124566163|NCT02579096|448030160|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
124776684|NCT00998296|448809947|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
124776685|NCT00998296|448809948|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
124566164|NCT02579096|448030161|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
124566165|NCT02579096|448030160|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
124566166|NCT02579096|448030161|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
124566167|NCT02579096|448030160|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
124566168|NCT02579096|448030161|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
124566169|NCT02579096|448030160|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
124566170|NCT02579096|448030161|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
124566171|NCT02579096|448030160|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
124566172|NCT02579096|448030161|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
124566173|NCT02579096|448030160|FG000|Phase 2, Weeks 25 - 48|Death|2|||
124566174|NCT02579096|448030161|FG001|Phase 2, Weeks 25 - 48|Death|4|||
124566175|NCT02579096|448030160|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
124566176|NCT02579096|448030161|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
124566177|NCT02579096|448030160|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
124566178|NCT02579096|448030161|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
124566179|NCT02579096|448030160|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
124566180|NCT02579096|448030161|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
124566181|NCT02579096|448030160|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
124566182|NCT02579096|448030161|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
124566183|NCT02579096|448030160|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
124566184|NCT02579096|448030161|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
124566185|NCT02579096|448030160|FG000|Phase 3, Weeks 49 - 72|Death|3|||
124566186|NCT02579096|448030161|FG001|Phase 3, Weeks 49 - 72|Death|2|||
124566187|NCT02579096|448030160|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
124566188|NCT02579096|448030161|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
124566189|NCT02579096|448030160|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
124566190|NCT02579096|448030161|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
124566191|NCT02579096|448030160|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
124566192|NCT02579096|448030161|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
124566193|NCT02579096|448030160|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
124566194|NCT02579096|448030161|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
124566195|NCT02579096|448030160|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
124566196|NCT02579096|448030161|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
124566197|NCT02579096|448030160|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
124566198|NCT02579096|448030161|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
124566199|NCT01361126|448030166|FG000|Overall Study|Sponsor decision|0|||
124566200|NCT01361126|448030167|FG001|Overall Study|Sponsor decision|2|||
124566201|NCT02946385|448031711|FG000|Overall Study|Lost to Follow-up|0|||
124566202|NCT02946385|448031712|FG001|Overall Study|Lost to Follow-up|0|||
124566203|NCT02946385|448031713|FG002|Overall Study|Lost to Follow-up|3|||
124566204|NCT02946385|448031714|FG003|Overall Study|Lost to Follow-up|0|||
124566205|NCT02946385|448031715|FG004|Overall Study|Lost to Follow-up|2|||
124566206|NCT02946385|448031716|FG005|Overall Study|Lost to Follow-up|1|||
124566207|NCT00313703|448031717|FG000|Overall Study|Lost to Follow-up|11|||
124566208|NCT00313703|448031718|FG001|Overall Study|Lost to Follow-up|2|||
124566209|NCT00313703|448031719|FG002|Overall Study|Lost to Follow-up|5|||
124566210|NCT00313703|448031720|FG003|Overall Study|Lost to Follow-up|12|||
124566211|NCT01060670|448031721|FG000|Run In|screen failure|0|||
124566212|NCT01060670|448031722|FG001|Run In|screen failure|238|||
124566213|NCT03519256|448031727|FG000|Overall Study|Disease recurrence|4|||
124566214|NCT03519256|448031728|FG001|Overall Study|Disease recurrence|4|||
124566215|NCT03519256|448031729|FG002|Overall Study|Disease recurrence|5|||
124566216|NCT03519256|448031730|FG003|Overall Study|Disease recurrence|2|||
124566217|NCT03519256|448031727|FG000|Overall Study|Study drug toxicity|0|||
124566218|NCT03519256|448031728|FG001|Overall Study|Study drug toxicity|2|||
124566219|NCT03519256|448031729|FG002|Overall Study|Study drug toxicity|5|||
124566220|NCT03519256|448031730|FG003|Overall Study|Study drug toxicity|2|||
124566221|NCT03519256|448031727|FG000|Overall Study|Adverse event unrelated to study drug|0|||
124566222|NCT03519256|448031728|FG001|Overall Study|Adverse event unrelated to study drug|1|||
124566223|NCT03519256|448031729|FG002|Overall Study|Adverse event unrelated to study drug|1|||
124566224|NCT03519256|448031730|FG003|Overall Study|Adverse event unrelated to study drug|0|||
124566225|NCT03519256|448031727|FG000|Overall Study|Participant request to discontinue study treatment|0|||
124566226|NCT03519256|448031728|FG001|Overall Study|Participant request to discontinue study treatment|0|||
124566227|NCT03519256|448031729|FG002|Overall Study|Participant request to discontinue study treatment|0|||
124566228|NCT03519256|448031730|FG003|Overall Study|Participant request to discontinue study treatment|2|||
124566229|NCT03519256|448031727|FG000|Overall Study|Other reasons|0|||
124510941|NCT03814590|447822290|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124510942|NCT03814590|447822291|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124510943|NCT03814590|447822292|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124510944|NCT03814590|447822293|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124510945|NCT03814590|447822294|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124510946|NCT03814590|447822295|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124510947|NCT03814590|447822296|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124510948|NCT03814590|447822297|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124510949|NCT03814590|447822298|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124510950|NCT03814590|447822299|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124510951|NCT03814590|447822300|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124510952|NCT03814590|447822301|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124510953|NCT03814590|447822302|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124510954|NCT03814590|447822289|FG000|Overall Study|UNKNOWN REASON|0|||
124510955|NCT03814590|447822290|FG001|Overall Study|UNKNOWN REASON|0|||
124510956|NCT03814590|447822291|FG002|Overall Study|UNKNOWN REASON|0|||
124510957|NCT03814590|447822292|FG003|Overall Study|UNKNOWN REASON|0|||
124510958|NCT03814590|447822293|FG004|Overall Study|UNKNOWN REASON|0|||
124510959|NCT03814590|447822294|FG005|Overall Study|UNKNOWN REASON|0|||
124510960|NCT03814590|447822295|FG006|Overall Study|UNKNOWN REASON|0|||
124510961|NCT03814590|447822296|FG007|Overall Study|UNKNOWN REASON|1|||
124510962|NCT03814590|447822297|FG008|Overall Study|UNKNOWN REASON|0|||
124510963|NCT03814590|447822298|FG009|Overall Study|UNKNOWN REASON|0|||
124510964|NCT03814590|447822299|FG010|Overall Study|UNKNOWN REASON|0|||
124510965|NCT03814590|447822300|FG011|Overall Study|UNKNOWN REASON|0|||
124510966|NCT03814590|447822301|FG012|Overall Study|UNKNOWN REASON|0|||
124510967|NCT03814590|447822302|FG013|Overall Study|UNKNOWN REASON|0|||
124510968|NCT00567541|447822306|FG000|Overall Study|Adverse Event|0|||
124510969|NCT00567541|447822307|FG001|Overall Study|Adverse Event|1|||
124510970|NCT03519516|447822308|FG000|Overall Study|Adverse Event|0|||
124510971|NCT03519516|447822309|FG001|Overall Study|Adverse Event|1|||
124510972|NCT01890512|447822310|FG000|Overall Study|Physician Decision|1|||
124510973|NCT01890512|447822310|FG000|Overall Study|Withdrawal by Subject|1|||
124510974|NCT01890512|447822310|FG000|Overall Study|Protocol Violation|1|||
124510975|NCT01935336|447822311|FG000|Overall Study|Adverse Event|1|||
124510976|NCT01935336|447822312|FG001|Overall Study|Adverse Event|0|||
124510977|NCT01935336|447822313|FG002|Overall Study|Adverse Event|0|||
124566230|NCT03519256|448031728|FG001|Overall Study|Other reasons|0|||
124566231|NCT03519256|448031729|FG002|Overall Study|Other reasons|2|||
124566232|NCT03519256|448031730|FG003|Overall Study|Other reasons|0|||
124566233|NCT03519256|448031727|FG000|Overall Study|Disease progression|6|||
124566234|NCT03519256|448031728|FG001|Overall Study|Disease progression|3|||
124566235|NCT03519256|448031729|FG002|Overall Study|Disease progression|2|||
124566236|NCT03519256|448031730|FG003|Overall Study|Disease progression|1|||
124566237|NCT03519256|448031727|FG000|Overall Study|Lost to Follow-up|0|||
124566238|NCT03519256|448031728|FG001|Overall Study|Lost to Follow-up|1|||
124566239|NCT03519256|448031729|FG002|Overall Study|Lost to Follow-up|0|||
124566240|NCT03519256|448031730|FG003|Overall Study|Lost to Follow-up|0|||
124566241|NCT04828161|448031731|FG000|Overall Study|Withdrawal by Subject|0|||
124566242|NCT04828161|448031732|FG001|Overall Study|Withdrawal by Subject|3|||
124566243|NCT04828161|448031733|FG002|Overall Study|Withdrawal by Subject|3|||
124566244|NCT04828161|448031734|FG003|Overall Study|Withdrawal by Subject|4|||
124566245|NCT04828161|448031731|FG000|Overall Study|Lost to Follow-up|1|||
124566246|NCT04828161|448031732|FG001|Overall Study|Lost to Follow-up|4|||
124566247|NCT04828161|448031733|FG002|Overall Study|Lost to Follow-up|2|||
124566248|NCT04828161|448031734|FG003|Overall Study|Lost to Follow-up|2|||
124566249|NCT04828161|448031731|FG000|Overall Study|Other|2|||
124566250|NCT04828161|448031732|FG001|Overall Study|Other|0|||
124566251|NCT04828161|448031733|FG002|Overall Study|Other|2|||
124566252|NCT04828161|448031734|FG003|Overall Study|Other|0|||
124566253|NCT04828161|448031731|FG000|Overall Study|Death|0|||
124566254|NCT04828161|448031732|FG001|Overall Study|Death|0|||
124566255|NCT04828161|448031733|FG002|Overall Study|Death|0|||
124566256|NCT04828161|448031734|FG003|Overall Study|Death|2|||
124566257|NCT05431153|448031735|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124566258|NCT05431153|448031736|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124566259|NCT05431153|448031737|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124566260|NCT05431153|448031738|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124566261|NCT05431153|448031739|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
124566262|NCT05431153|448031740|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
124566263|NCT02458638|448031743|FG000|Overall Study|Death|309|||
124566264|NCT02458638|448031743|FG000|Overall Study|End of Cohort/End of Study|67|||
124566265|NCT02458638|448031743|FG000|Overall Study|Lost to Follow-up|31|||
124566266|NCT02458638|448031743|FG000|Overall Study|Other Reasons|4|||
124566267|NCT02458638|448031743|FG000|Overall Study|Physician Decision|1|||
124566268|NCT02458638|448031743|FG000|Overall Study|Withdrawal by Subject|47|||
124566269|NCT03093454|448031752|FG000|Overall Study|Withdrawal by Subject|1|||
124566270|NCT03093454|448031753|FG001|Overall Study|Withdrawal by Subject|1|||
124566271|NCT03093454|448031752|FG000|Overall Study|Scheduling conflict|3|||
124566272|NCT03093454|448031753|FG001|Overall Study|Scheduling conflict|1|||
124566273|NCT03093454|448031752|FG000|Overall Study|Physician Decision|2|||
124566274|NCT03093454|448031753|FG001|Overall Study|Physician Decision|1|||
124566275|NCT04540497|448031754|FG000|Overall Study|Adverse Event|0|||
124566276|NCT04540497|448031755|FG001|Overall Study|Adverse Event|2|||
124566277|NCT04540497|448031754|FG000|Overall Study|Lost to Follow-up|1|||
124566278|NCT04540497|448031755|FG001|Overall Study|Lost to Follow-up|0|||
124566279|NCT04540497|448031754|FG000|Overall Study|Withdrawal by Subject|1|||
124566280|NCT04540497|448031755|FG001|Overall Study|Withdrawal by Subject|1|||
124566281|NCT04540497|448031754|FG000|Overall Study|Miscellaneous|2|||
124566282|NCT04540497|448031755|FG001|Overall Study|Miscellaneous|1|||
124566283|NCT03738332|448031762|FG000|Overall Study|Withdrawal by Subject|1|||
124510978|NCT01935336|447822314|FG003|Overall Study|Adverse Event|0|||
124510979|NCT01935336|447822311|FG000|Overall Study|Progressive disease|5|||
124510980|NCT01935336|447822312|FG001|Overall Study|Progressive disease|3|||
124510981|NCT01935336|447822313|FG002|Overall Study|Progressive disease|47|||
124510982|NCT01935336|447822314|FG003|Overall Study|Progressive disease|66|||
124510983|NCT01529385|447822315|FG000|Overall Study|Lost to Follow-up|2|||
124510984|NCT01529385|447822316|FG001|Overall Study|Lost to Follow-up|1|||
124510985|NCT00964158|447822319|FG000|Overall Study|Lost to Follow-up|0|||
124510986|NCT00964158|447822320|FG001|Overall Study|Lost to Follow-up|1|||
124510987|NCT00964158|447822321|FG002|Overall Study|Lost to Follow-up|2|||
124510988|NCT00964158|447822319|FG000|Overall Study|Withdrawal by Subject|0|||
124566284|NCT04700449|448031763|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
124566285|NCT04700449|448031764|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
124510989|NCT00964158|447822320|FG001|Overall Study|Withdrawal by Subject|0|||
124510990|NCT00964158|447822321|FG002|Overall Study|Withdrawal by Subject|6|||
124566286|NCT04700449|448031765|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
124566287|NCT04700449|448031766|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
124566288|NCT04700449|448031763|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
124566289|NCT04700449|448031764|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
124566290|NCT04700449|448031765|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
124566291|NCT04700449|448031766|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
124566292|NCT04700449|448031763|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
124566293|NCT04700449|448031764|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
124566294|NCT04700449|448031765|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
124510991|NCT01763866|447822330|FG000|Overall Study|Withdrawal by Subject|2|||
124510992|NCT01763866|447822331|FG001|Overall Study|Withdrawal by Subject|1|||
124510993|NCT01763866|447822332|FG002|Overall Study|Withdrawal by Subject|4|||
124510994|NCT01763866|447822333|FG003|Overall Study|Withdrawal by Subject|0|||
124510995|NCT01763866|447822334|FG004|Overall Study|Withdrawal by Subject|0|||
124510996|NCT01763866|447822335|FG005|Overall Study|Withdrawal by Subject|3|||
124510997|NCT01763866|447822336|FG006|Overall Study|Withdrawal by Subject|4|||
124510998|NCT01763866|447822337|FG007|Overall Study|Withdrawal by Subject|0|||
124510999|NCT01763866|447822338|FG008|Overall Study|Withdrawal by Subject|1|||
124511000|NCT01763866|447822339|FG009|Overall Study|Withdrawal by Subject|1|||
124511001|NCT01763866|447822340|FG010|Overall Study|Withdrawal by Subject|2|||
124511002|NCT01763866|447822341|FG011|Overall Study|Withdrawal by Subject|2|||
124511003|NCT01763866|447822342|FG012|Overall Study|Withdrawal by Subject|2|||
124511004|NCT01763866|447822343|FG013|Overall Study|Withdrawal by Subject|0|||
124511005|NCT01763866|447822344|FG014|Overall Study|Withdrawal by Subject|6|||
124511006|NCT01763866|447822345|FG015|Overall Study|Withdrawal by Subject|3|||
124511007|NCT01763866|447822346|FG016|Overall Study|Withdrawal by Subject|0|||
124511008|NCT01763866|447822347|FG017|Overall Study|Withdrawal by Subject|1|||
124511009|NCT01763866|447822348|FG018|Overall Study|Withdrawal by Subject|1|||
124511010|NCT01763866|447822349|FG019|Overall Study|Withdrawal by Subject|1|||
124511011|NCT01763866|447822350|FG020|Overall Study|Withdrawal by Subject|2|||
124511012|NCT01763866|447822351|FG021|Overall Study|Withdrawal by Subject|1|||
124511013|NCT01763866|447822352|FG022|Overall Study|Withdrawal by Subject|2|||
124511014|NCT01763866|447822353|FG023|Overall Study|Withdrawal by Subject|1|||
124511015|NCT01763866|447822330|FG000|Overall Study|Decision by sponsor|0|||
124511016|NCT01763866|447822331|FG001|Overall Study|Decision by sponsor|0|||
124511017|NCT01763866|447822332|FG002|Overall Study|Decision by sponsor|1|||
124511018|NCT01763866|447822333|FG003|Overall Study|Decision by sponsor|0|||
124511019|NCT01763866|447822334|FG004|Overall Study|Decision by sponsor|2|||
124511020|NCT01763866|447822335|FG005|Overall Study|Decision by sponsor|0|||
124511021|NCT01763866|447822336|FG006|Overall Study|Decision by sponsor|2|||
124511022|NCT01763866|447822337|FG007|Overall Study|Decision by sponsor|0|||
124511023|NCT01763866|447822338|FG008|Overall Study|Decision by sponsor|2|||
124511024|NCT01763866|447822339|FG009|Overall Study|Decision by sponsor|0|||
124511025|NCT01763866|447822340|FG010|Overall Study|Decision by sponsor|6|||
124511026|NCT01763866|447822341|FG011|Overall Study|Decision by sponsor|0|||
124511027|NCT01763866|447822342|FG012|Overall Study|Decision by sponsor|1|||
124511028|NCT01763866|447822343|FG013|Overall Study|Decision by sponsor|0|||
124511029|NCT01763866|447822344|FG014|Overall Study|Decision by sponsor|5|||
124511030|NCT01763866|447822345|FG015|Overall Study|Decision by sponsor|0|||
124511031|NCT01763866|447822346|FG016|Overall Study|Decision by sponsor|0|||
124511032|NCT01763866|447822347|FG017|Overall Study|Decision by sponsor|0|||
124511033|NCT01763866|447822348|FG018|Overall Study|Decision by sponsor|4|||
124511034|NCT01763866|447822349|FG019|Overall Study|Decision by sponsor|0|||
124511035|NCT01763866|447822350|FG020|Overall Study|Decision by sponsor|2|||
124511036|NCT01763866|447822351|FG021|Overall Study|Decision by sponsor|0|||
124511037|NCT01763866|447822352|FG022|Overall Study|Decision by sponsor|1|||
124511038|NCT01763866|447822353|FG023|Overall Study|Decision by sponsor|0|||
124511039|NCT01763866|447822330|FG000|Overall Study|Lost to Follow-up|0|||
124511040|NCT01763866|447822331|FG001|Overall Study|Lost to Follow-up|0|||
124511041|NCT01763866|447822332|FG002|Overall Study|Lost to Follow-up|0|||
124511042|NCT01763866|447822333|FG003|Overall Study|Lost to Follow-up|0|||
124511043|NCT01763866|447822334|FG004|Overall Study|Lost to Follow-up|0|||
124511044|NCT01763866|447822335|FG005|Overall Study|Lost to Follow-up|0|||
124511045|NCT01763866|447822336|FG006|Overall Study|Lost to Follow-up|1|||
124511046|NCT01763866|447822337|FG007|Overall Study|Lost to Follow-up|0|||
124511047|NCT01763866|447822338|FG008|Overall Study|Lost to Follow-up|0|||
124511048|NCT01763866|447822339|FG009|Overall Study|Lost to Follow-up|0|||
124511049|NCT01763866|447822340|FG010|Overall Study|Lost to Follow-up|0|||
124511050|NCT01763866|447822341|FG011|Overall Study|Lost to Follow-up|0|||
124511051|NCT01763866|447822342|FG012|Overall Study|Lost to Follow-up|1|||
124511052|NCT01763866|447822343|FG013|Overall Study|Lost to Follow-up|0|||
124511053|NCT01763866|447822344|FG014|Overall Study|Lost to Follow-up|1|||
124511054|NCT01763866|447822345|FG015|Overall Study|Lost to Follow-up|0|||
124511055|NCT01763866|447822346|FG016|Overall Study|Lost to Follow-up|0|||
124511056|NCT01763866|447822347|FG017|Overall Study|Lost to Follow-up|0|||
124511057|NCT01763866|447822348|FG018|Overall Study|Lost to Follow-up|1|||
124511058|NCT01763866|447822349|FG019|Overall Study|Lost to Follow-up|1|||
124511059|NCT01763866|447822350|FG020|Overall Study|Lost to Follow-up|0|||
124511060|NCT01763866|447822351|FG021|Overall Study|Lost to Follow-up|0|||
124511061|NCT01763866|447822352|FG022|Overall Study|Lost to Follow-up|0|||
124511062|NCT01763866|447822353|FG023|Overall Study|Lost to Follow-up|1|||
124511063|NCT01763866|447822330|FG000|Overall Study|Death|0|||
124511064|NCT01763866|447822331|FG001|Overall Study|Death|0|||
124511065|NCT01763866|447822332|FG002|Overall Study|Death|0|||
124511066|NCT01763866|447822333|FG003|Overall Study|Death|0|||
124511067|NCT01763866|447822334|FG004|Overall Study|Death|0|||
124511068|NCT01763866|447822335|FG005|Overall Study|Death|0|||
124511069|NCT01763866|447822336|FG006|Overall Study|Death|0|||
124511070|NCT01763866|447822337|FG007|Overall Study|Death|0|||
124511071|NCT01763866|447822338|FG008|Overall Study|Death|0|||
124511072|NCT01763866|447822339|FG009|Overall Study|Death|0|||
124511073|NCT01763866|447822340|FG010|Overall Study|Death|0|||
124511074|NCT01763866|447822341|FG011|Overall Study|Death|0|||
124511075|NCT01763866|447822342|FG012|Overall Study|Death|0|||
124511076|NCT01763866|447822343|FG013|Overall Study|Death|0|||
124511077|NCT01763866|447822344|FG014|Overall Study|Death|0|||
124511078|NCT01763866|447822345|FG015|Overall Study|Death|0|||
124511079|NCT01763866|447822346|FG016|Overall Study|Death|1|||
124511080|NCT01763866|447822347|FG017|Overall Study|Death|0|||
124511081|NCT01763866|447822348|FG018|Overall Study|Death|0|||
124511082|NCT01763866|447822349|FG019|Overall Study|Death|0|||
124511083|NCT01763866|447822350|FG020|Overall Study|Death|0|||
124511084|NCT01763866|447822351|FG021|Overall Study|Death|0|||
124511085|NCT01763866|447822352|FG022|Overall Study|Death|0|||
124511086|NCT01763866|447822353|FG023|Overall Study|Death|0|||
124511087|NCT03245723|447822359|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
124511088|NCT03245723|447822360|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
124511089|NCT03245723|447822359|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
124511090|NCT03245723|447822360|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
124511091|NCT03245723|447822359|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
124511092|NCT03245723|447822360|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
124511093|NCT03245723|447822359|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
124511094|NCT03245723|447822360|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
124511095|NCT03337139|447822361|FG000|Phase I|Withdrawal by Subject|10|||
124511096|NCT03337139|447822362|FG001|Phase I|Withdrawal by Subject|0|||
124511097|NCT02554253|447822363|FG000|Overall Study|ineligible after enrollment|1|||
124511098|NCT02554253|447822364|FG001|Overall Study|ineligible after enrollment|0|||
124511099|NCT02554253|447822363|FG000|Overall Study|converted to transcatheter procedure|0|||
124511100|NCT02554253|447822364|FG001|Overall Study|converted to transcatheter procedure|1|||
124511101|NCT02554253|447822363|FG000|Overall Study|received both drugs|0|||
124511102|NCT02554253|447822364|FG001|Overall Study|received both drugs|1|||
124511103|NCT03288493|447822365|FG000|Overall Study|Withdrawal by Subject|4|||
124511104|NCT03288493|447822366|FG001|Overall Study|Withdrawal by Subject|0|||
124511105|NCT03288493|447822367|FG002|Overall Study|Withdrawal by Subject|0|||
124511106|NCT03288493|447822368|FG003|Overall Study|Withdrawal by Subject|0|||
124511107|NCT03288493|447822369|FG004|Overall Study|Withdrawal by Subject|0|||
124511108|NCT03288493|447822370|FG005|Overall Study|Withdrawal by Subject|2|||
124511109|NCT03288493|447822371|FG006|Overall Study|Withdrawal by Subject|0|||
124511110|NCT03288493|447822365|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
124511111|NCT03288493|447822366|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
124511112|NCT03288493|447822367|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
124511113|NCT03288493|447822368|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
124511114|NCT03288493|447822369|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
124511115|NCT03288493|447822370|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
124511116|NCT03288493|447822371|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
124511117|NCT03288493|447822365|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
124511118|NCT03288493|447822366|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
124511119|NCT03288493|447822367|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
124511120|NCT03288493|447822368|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
124511121|NCT03288493|447822369|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
124511122|NCT03288493|447822370|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
124511123|NCT03288493|447822371|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
124511124|NCT03288493|447822365|FG000|Overall Study|Death|2|||
124511125|NCT03288493|447822366|FG001|Overall Study|Death|0|||
124511126|NCT03288493|447822367|FG002|Overall Study|Death|0|||
124511127|NCT03288493|447822368|FG003|Overall Study|Death|0|||
124511128|NCT03288493|447822369|FG004|Overall Study|Death|0|||
124511129|NCT03288493|447822370|FG005|Overall Study|Death|0|||
124511130|NCT03288493|447822371|FG006|Overall Study|Death|0|||
124511131|NCT03288493|447822365|FG000|Overall Study|other reason not listed above|2|||
124511132|NCT03288493|447822366|FG001|Overall Study|other reason not listed above|0|||
124511133|NCT03288493|447822367|FG002|Overall Study|other reason not listed above|0|||
124511134|NCT03288493|447822368|FG003|Overall Study|other reason not listed above|0|||
124511135|NCT03288493|447822369|FG004|Overall Study|other reason not listed above|0|||
124511136|NCT03288493|447822370|FG005|Overall Study|other reason not listed above|0|||
124511137|NCT03288493|447822371|FG006|Overall Study|other reason not listed above|0|||
124511138|NCT01736254|447822373|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
124511139|NCT01736254|447822373|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
124511140|NCT02559206|447822374|FG000|Overall Study|Adverse Event|0|||
124511141|NCT02559206|447822375|FG001|Overall Study|Adverse Event|4|||
124511142|NCT02559206|447822376|FG002|Overall Study|Adverse Event|1|||
124511143|NCT02559206|447822377|FG003|Overall Study|Adverse Event|5|||
124511144|NCT02559206|447822378|FG004|Overall Study|Adverse Event|3|||
124511145|NCT02559206|447822379|FG005|Overall Study|Adverse Event|0|||
124511146|NCT02559206|447822380|FG006|Overall Study|Adverse Event|1|||
124511147|NCT02559206|447822381|FG007|Overall Study|Adverse Event|0|||
124511148|NCT02559206|447822374|FG000|Overall Study|Protocol Violation|1|||
124511149|NCT02559206|447822375|FG001|Overall Study|Protocol Violation|0|||
124511150|NCT02559206|447822376|FG002|Overall Study|Protocol Violation|1|||
124511151|NCT02559206|447822377|FG003|Overall Study|Protocol Violation|0|||
124511152|NCT02559206|447822378|FG004|Overall Study|Protocol Violation|0|||
124511153|NCT02559206|447822379|FG005|Overall Study|Protocol Violation|2|||
124511154|NCT02559206|447822380|FG006|Overall Study|Protocol Violation|0|||
124511155|NCT02559206|447822381|FG007|Overall Study|Protocol Violation|0|||
124511156|NCT02559206|447822374|FG000|Overall Study|Withdrawal by Subject|3|||
124511157|NCT02559206|447822375|FG001|Overall Study|Withdrawal by Subject|3|||
124511158|NCT02559206|447822376|FG002|Overall Study|Withdrawal by Subject|1|||
124511159|NCT02559206|447822377|FG003|Overall Study|Withdrawal by Subject|3|||
124511160|NCT02559206|447822378|FG004|Overall Study|Withdrawal by Subject|5|||
124511161|NCT02559206|447822379|FG005|Overall Study|Withdrawal by Subject|4|||
124511162|NCT02559206|447822380|FG006|Overall Study|Withdrawal by Subject|1|||
124511163|NCT02559206|447822381|FG007|Overall Study|Withdrawal by Subject|2|||
124511164|NCT02559206|447822374|FG000|Overall Study|Lost to Follow-up|3|||
124511165|NCT02559206|447822375|FG001|Overall Study|Lost to Follow-up|5|||
124511166|NCT02559206|447822376|FG002|Overall Study|Lost to Follow-up|3|||
124511167|NCT02559206|447822377|FG003|Overall Study|Lost to Follow-up|3|||
124511168|NCT02559206|447822378|FG004|Overall Study|Lost to Follow-up|2|||
124511169|NCT02559206|447822379|FG005|Overall Study|Lost to Follow-up|5|||
124511170|NCT02559206|447822380|FG006|Overall Study|Lost to Follow-up|1|||
124511171|NCT02559206|447822381|FG007|Overall Study|Lost to Follow-up|4|||
124511172|NCT02559206|447822374|FG000|Overall Study|Lack of Efficacy|1|||
124511173|NCT02559206|447822375|FG001|Overall Study|Lack of Efficacy|0|||
124511174|NCT02559206|447822376|FG002|Overall Study|Lack of Efficacy|3|||
124511175|NCT02559206|447822377|FG003|Overall Study|Lack of Efficacy|2|||
124511176|NCT02559206|447822378|FG004|Overall Study|Lack of Efficacy|2|||
124511177|NCT02559206|447822379|FG005|Overall Study|Lack of Efficacy|3|||
124511178|NCT02559206|447822380|FG006|Overall Study|Lack of Efficacy|3|||
124511179|NCT02559206|447822381|FG007|Overall Study|Lack of Efficacy|3|||
124511180|NCT02559206|447822374|FG000|Overall Study|Other Not Specified|0|||
124511181|NCT02559206|447822375|FG001|Overall Study|Other Not Specified|0|||
124511182|NCT02559206|447822376|FG002|Overall Study|Other Not Specified|0|||
124511183|NCT02559206|447822377|FG003|Overall Study|Other Not Specified|1|||
124511184|NCT02559206|447822378|FG004|Overall Study|Other Not Specified|0|||
124511185|NCT02559206|447822379|FG005|Overall Study|Other Not Specified|0|||
124511186|NCT02559206|447822380|FG006|Overall Study|Other Not Specified|0|||
124511187|NCT02559206|447822381|FG007|Overall Study|Other Not Specified|0|||
124511188|NCT01561560|447822382|FG000|First Two Weeks of Wear|Time/job conflict|0|||
124511189|NCT01561560|447822383|FG001|First Two Weeks of Wear|Time/job conflict|1|||
124511190|NCT01561560|447822382|FG000|First Two Weeks of Wear|Adverse Event|0|||
124511191|NCT01561560|447822383|FG001|First Two Weeks of Wear|Adverse Event|1|||
124511192|NCT01561560|447822382|FG000|Second Two Weeks of Wear|Adverse Event|0|||
124511193|NCT01561560|447822383|FG001|Second Two Weeks of Wear|Adverse Event|1|||
124511194|NCT02267278|447823701|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
124511195|NCT02267278|447823701|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
124511196|NCT02267278|447823701|FG000|Overall Study|Developed new cancer diagnoses|2|||
124511197|NCT02267278|447823701|FG000|Overall Study|prescribed prohibited medication|1|||
124511198|NCT00650091|447823702|FG000|Amended Study Design|Withdrawal by Subject|12|||
124511199|NCT00650091|447823703|FG001|Amended Study Design|Withdrawal by Subject|11|||
124511200|NCT00650091|447823704|FG002|Amended Study Design|Withdrawal by Subject|0|||
124511201|NCT00650091|447823702|FG000|Amended Study Design|Physician Decision|5|||
124511202|NCT00650091|447823703|FG001|Amended Study Design|Physician Decision|0|||
124511203|NCT00650091|447823704|FG002|Amended Study Design|Physician Decision|0|||
124511204|NCT00650091|447823702|FG000|Amended Study Design|Adverse Event|1|||
124511205|NCT00650091|447823703|FG001|Amended Study Design|Adverse Event|4|||
124511206|NCT00650091|447823704|FG002|Amended Study Design|Adverse Event|0|||
124511207|NCT00650091|447823702|FG000|Amended Study Design|Lung transplantation|4|||
124511208|NCT00650091|447823703|FG001|Amended Study Design|Lung transplantation|2|||
124511209|NCT00650091|447823704|FG002|Amended Study Design|Lung transplantation|0|||
124511210|NCT00650091|447823702|FG000|Amended Study Design|Other|1|||
124511211|NCT00650091|447823703|FG001|Amended Study Design|Other|3|||
124511212|NCT00650091|447823704|FG002|Amended Study Design|Other|0|||
124511213|NCT01413542|447823710|FG000|Overall Study|Physician Decision|1|||
124511214|NCT01413542|447823711|FG001|Overall Study|Physician Decision|0|||
124511215|NCT01413542|447823712|FG002|Overall Study|Physician Decision|3|||
124566295|NCT04700449|448031766|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
124566296|NCT04700449|448031763|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
124566297|NCT04700449|448031764|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
124566298|NCT04700449|448031765|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
124566299|NCT04700449|448031766|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
124566300|NCT04700449|448031763|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
124566301|NCT04700449|448031764|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
124566302|NCT04700449|448031765|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
124566303|NCT04700449|448031766|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
124566304|NCT04700449|448031763|FG000|Stage 1: Double-Blind Period|Other|0|||
124566305|NCT04700449|448031764|FG001|Stage 1: Double-Blind Period|Other|0|||
124566306|NCT04700449|448031765|FG002|Stage 1: Double-Blind Period|Other|1|||
124566307|NCT04700449|448031766|FG003|Stage 1: Double-Blind Period|Other|0|||
124566308|NCT04700449|448031763|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
124566309|NCT04700449|448031764|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
124566310|NCT04700449|448031765|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
124566311|NCT04700449|448031766|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
124566312|NCT04700449|448031763|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
124566313|NCT04700449|448031764|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
124511216|NCT01413542|447823713|FG003|Overall Study|Physician Decision|0|||
124511217|NCT01413542|447823710|FG000|Overall Study|Adverse Event|0|||
124511218|NCT01413542|447823711|FG001|Overall Study|Adverse Event|0|||
124511219|NCT01413542|447823712|FG002|Overall Study|Adverse Event|0|||
124511220|NCT01413542|447823713|FG003|Overall Study|Adverse Event|1|||
124511221|NCT02505542|447823714|FG000|Part A: Open-Label Period|Adverse Event|31|||
124511222|NCT02505542|447823715|FG001|Part A: Open-Label Period|Adverse Event|0|||
124511223|NCT02505542|447823716|FG002|Part A: Open-Label Period|Adverse Event|0|||
124511224|NCT02505542|447823717|FG003|Part A: Open-Label Period|Adverse Event|0|||
124511225|NCT02505542|447823714|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
124511226|NCT02505542|447823715|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
124511227|NCT02505542|447823716|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
124511228|NCT02505542|447823717|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
124511229|NCT02505542|447823714|FG000|Part A: Open-Label Period|Protocol Violation|1|||
124511230|NCT02505542|447823715|FG001|Part A: Open-Label Period|Protocol Violation|0|||
124511231|NCT02505542|447823716|FG002|Part A: Open-Label Period|Protocol Violation|0|||
124511232|NCT02505542|447823717|FG003|Part A: Open-Label Period|Protocol Violation|0|||
124511233|NCT02505542|447823714|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
124511234|NCT02505542|447823715|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
124511235|NCT02505542|447823716|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
124511236|NCT02505542|447823717|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
124511237|NCT02505542|447823714|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
124511238|NCT02505542|447823715|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
124511239|NCT02505542|447823716|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
124511240|NCT02505542|447823717|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
124511241|NCT02505542|447823714|FG000|Part A: Open-Label Period|New medical history available|1|||
124511242|NCT02505542|447823715|FG001|Part A: Open-Label Period|New medical history available|0|||
124511243|NCT02505542|447823716|FG002|Part A: Open-Label Period|New medical history available|0|||
124511244|NCT02505542|447823717|FG003|Part A: Open-Label Period|New medical history available|0|||
124511245|NCT02505542|447823714|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
124511246|NCT02505542|447823715|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
124511247|NCT02505542|447823716|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
124511248|NCT02505542|447823717|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
124511249|NCT02505542|447823714|FG000|Part A: Open-Label Period|Pregnancy|2|||
124511250|NCT02505542|447823715|FG001|Part A: Open-Label Period|Pregnancy|0|||
124511251|NCT02505542|447823716|FG002|Part A: Open-Label Period|Pregnancy|0|||
124566314|NCT04700449|448031765|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
124566315|NCT04700449|448031766|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
124566316|NCT04700449|448031763|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
124566317|NCT04700449|448031764|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
124566318|NCT04700449|448031765|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
124566319|NCT04700449|448031766|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
124566320|NCT04700449|448031763|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
124566321|NCT04700449|448031764|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
124511252|NCT02505542|447823717|FG003|Part A: Open-Label Period|Pregnancy|0|||
124511253|NCT02505542|447823714|FG000|Part A: Open-Label Period|Sponsor directive|1|||
124566322|NCT04700449|448031765|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
124566323|NCT04700449|448031766|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
124566324|NCT04700449|448031763|FG000|Stage 2 Sub-study 1|Other|1|||
124566325|NCT04700449|448031764|FG001|Stage 2 Sub-study 1|Other|2|||
124566326|NCT04700449|448031765|FG002|Stage 2 Sub-study 1|Other|0|||
124566327|NCT04700449|448031766|FG003|Stage 2 Sub-study 1|Other|0|||
124566328|NCT04700449|448031763|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
124566329|NCT04700449|448031764|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
124511254|NCT02505542|447823715|FG001|Part A: Open-Label Period|Sponsor directive|0|||
124511255|NCT02505542|447823716|FG002|Part A: Open-Label Period|Sponsor directive|0|||
124511256|NCT02505542|447823717|FG003|Part A: Open-Label Period|Sponsor directive|0|||
124511257|NCT02505542|447823714|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
124511258|NCT02505542|447823715|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
124511259|NCT02505542|447823716|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
124511260|NCT02505542|447823717|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
124511261|NCT02505542|447823714|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
124511262|NCT02505542|447823715|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
124511263|NCT02505542|447823716|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
124511264|NCT02505542|447823717|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
124511265|NCT02505542|447823714|FG000|Part A: Open-Label Period|Non-compliance|1|||
124511266|NCT02505542|447823715|FG001|Part A: Open-Label Period|Non-compliance|0|||
124511267|NCT02505542|447823716|FG002|Part A: Open-Label Period|Non-compliance|0|||
124511268|NCT02505542|447823717|FG003|Part A: Open-Label Period|Non-compliance|0|||
124511269|NCT02505542|447823714|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
124511270|NCT02505542|447823715|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
124511271|NCT02505542|447823716|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
124511272|NCT02505542|447823717|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
124511273|NCT02505542|447823714|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
124511274|NCT02505542|447823715|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
124511275|NCT02505542|447823716|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
124511276|NCT02505542|447823717|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
124511277|NCT02505542|447823714|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
124511278|NCT02505542|447823715|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
124511279|NCT02505542|447823716|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
124511280|NCT02505542|447823717|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
124511281|NCT02505542|447823714|FG000|Part B: Double-Blind Period|Adverse Event|0|||
124511282|NCT02505542|447823715|FG001|Part B: Double-Blind Period|Adverse Event|0|||
124511283|NCT02505542|447823716|FG002|Part B: Double-Blind Period|Adverse Event|1|||
124511284|NCT02505542|447823717|FG003|Part B: Double-Blind Period|Adverse Event|3|||
124511285|NCT02505542|447823714|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
124511286|NCT02505542|447823715|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
124511287|NCT02505542|447823716|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
124511288|NCT02505542|447823717|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
124511289|NCT02505542|447823714|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
124511290|NCT02505542|447823715|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
124511291|NCT02505542|447823716|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
124511292|NCT02505542|447823717|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
124511293|NCT02505542|447823714|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
124511294|NCT02505542|447823715|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
124511295|NCT02505542|447823716|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
124511296|NCT02505542|447823717|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
124511297|NCT02505542|447823714|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
124511298|NCT02505542|447823715|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
124511299|NCT02505542|447823716|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
124511300|NCT02505542|447823717|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
124511301|NCT02505542|447823714|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
124511302|NCT02505542|447823715|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
124511303|NCT02505542|447823716|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
124511304|NCT02505542|447823717|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
124511305|NCT02505542|447823714|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
124511306|NCT02505542|447823715|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
124511307|NCT02505542|447823716|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
124511308|NCT02505542|447823717|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
124511309|NCT02505542|447823714|FG000|Part B: Double-Blind Period|Miscalculation|0|||
124511310|NCT02505542|447823715|FG001|Part B: Double-Blind Period|Miscalculation|1|||
124511311|NCT02505542|447823716|FG002|Part B: Double-Blind Period|Miscalculation|0|||
124511312|NCT02505542|447823717|FG003|Part B: Double-Blind Period|Miscalculation|0|||
124511313|NCT02505542|447823714|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
124511314|NCT02505542|447823715|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
124511315|NCT02505542|447823716|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
124511316|NCT02505542|447823717|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
124511317|NCT03372603|447823718|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
124511318|NCT03372603|447823719|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
124511319|NCT03372603|447823718|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
124511320|NCT03372603|447823719|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
124511321|NCT02806947|447823720|FG000|Overall Study|Withdrawal by Subject|5|||
124511322|NCT02806947|447823721|FG001|Overall Study|Withdrawal by Subject|1|||
124511323|NCT00664209|447823728|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
124511324|NCT00664209|447823728|FG000|Study Treatment Period|Physician Decision|4|||
124511325|NCT00664209|447823728|FG000|Study Treatment Period|Withdrawal by Subject|2|||
124511326|NCT00065442|447823730|FG000|Overall Study|Lost to Follow-up|1|||
124511327|NCT00065442|447823731|FG001|Overall Study|Lost to Follow-up|1|||
124511328|NCT00065442|447823730|FG000|Overall Study|Death|121|||
124511329|NCT00065442|447823731|FG001|Overall Study|Death|210|||
124511330|NCT00065442|447823730|FG000|Overall Study|Withdrawal by Subject|3|||
124511331|NCT00065442|447823731|FG001|Overall Study|Withdrawal by Subject|9|||
124511332|NCT01594333|447823732|FG000|Overall Study|Death|96|||
124511333|NCT01594333|447823733|FG001|Overall Study|Death|83|||
124511334|NCT01594333|447823732|FG000|Overall Study|Lost to Follow-up|5|||
124511335|NCT01594333|447823733|FG001|Overall Study|Lost to Follow-up|5|||
124511336|NCT01594333|447823732|FG000|Overall Study|Withdrawal by Subject|60|||
124511337|NCT01594333|447823733|FG001|Overall Study|Withdrawal by Subject|63|||
124511338|NCT01764256|447823734|FG000|Received All Vaccinations|Adverse Event|1|||
124511339|NCT01764256|447823735|FG001|Received All Vaccinations|Adverse Event|1|||
124511340|NCT01764256|447823736|FG002|Received All Vaccinations|Adverse Event|0|||
124511341|NCT01764256|447823737|FG003|Received All Vaccinations|Adverse Event|0|||
124511342|NCT01764256|447823734|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
124511343|NCT01764256|447823735|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
124511344|NCT01764256|447823736|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
124511345|NCT01764256|447823737|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
124511346|NCT01764256|447823734|FG000|Received All Vaccinations|Lost to Follow-up|1|||
124511347|NCT01764256|447823735|FG001|Received All Vaccinations|Lost to Follow-up|0|||
124511348|NCT01764256|447823736|FG002|Received All Vaccinations|Lost to Follow-up|0|||
124511349|NCT01764256|447823737|FG003|Received All Vaccinations|Lost to Follow-up|0|||
124511350|NCT01764256|447823734|FG000|Completed Study|Lost to Follow-up|0|||
124511351|NCT01764256|447823735|FG001|Completed Study|Lost to Follow-up|0|||
124511352|NCT01764256|447823736|FG002|Completed Study|Lost to Follow-up|0|||
124511353|NCT01764256|447823737|FG003|Completed Study|Lost to Follow-up|1|||
124511354|NCT02029638|447823738|FG000|Overall Study|Death|0|||
124511355|NCT02029638|447823739|FG001|Overall Study|Death|0|||
124511356|NCT02029638|447823740|FG002|Overall Study|Death|1|||
124511357|NCT02029638|447823738|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
124511358|NCT02029638|447823739|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
124511359|NCT02029638|447823740|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
124511360|NCT01153841|447823741|FG000|Overall Study|Adverse Event|1|||
124511361|NCT01153841|447823742|FG001|Overall Study|Adverse Event|0|||
124511362|NCT01153841|447823741|FG000|Overall Study|Withdrawal by Subject|1|||
124511363|NCT01153841|447823742|FG001|Overall Study|Withdrawal by Subject|0|||
124511364|NCT01153841|447823741|FG000|Overall Study|Protocol Violation|2|||
124511365|NCT01153841|447823742|FG001|Overall Study|Protocol Violation|0|||
124511366|NCT01153841|447823741|FG000|Overall Study|Lost to Follow-up|2|||
124511367|NCT01153841|447823742|FG001|Overall Study|Lost to Follow-up|0|||
124511368|NCT03428997|447823752|FG000|Overall Study|Sponsor decision.|1|||
124511369|NCT03428997|447823752|FG000|Overall Study|Withdrawal by Subject|3|||
124511370|NCT03428997|447823752|FG000|Overall Study|Lost to Follow-up|4|||
124511371|NCT02563925|447823756|FG000|Overall Study|Withdrawal by Subject|2|||
124511372|NCT00400712|447823757|FG000|Overall Study|Death|1|||
124511373|NCT00400712|447823758|FG001|Overall Study|Death|0|||
124511374|NCT00400712|447823757|FG000|Overall Study|Withdrawal by Subject|11|||
124511375|NCT00400712|447823758|FG001|Overall Study|Withdrawal by Subject|12|||
124511376|NCT00400712|447823757|FG000|Overall Study|Physician Decision|5|||
124566330|NCT04700449|448031765|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
124566331|NCT04700449|448031766|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
124566332|NCT04700449|448031763|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
124566333|NCT04700449|448031764|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
124566334|NCT04700449|448031765|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
124566335|NCT04700449|448031766|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
124511377|NCT00400712|447823758|FG001|Overall Study|Physician Decision|4|||
124511378|NCT02553317|447823762|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
124511379|NCT02553317|447823763|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
124511380|NCT02553317|447823762|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
124511381|NCT02553317|447823763|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
124511382|NCT02553317|447823762|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
124511383|NCT02553317|447823763|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
124511384|NCT02553317|447823762|FG000|Overall Treatment Period + Follow-up|Death|1|||
124511385|NCT02553317|447823763|FG001|Overall Treatment Period + Follow-up|Death|3|||
124511386|NCT02553317|447823762|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
124511387|NCT02553317|447823763|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
124566336|NCT04700449|448031763|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
124566337|NCT04700449|448031764|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
124566338|NCT04700449|448031765|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
124566339|NCT04700449|448031766|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
124566340|NCT04700449|448031763|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
124566341|NCT04700449|448031764|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
124566342|NCT04700449|448031765|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
124566343|NCT04700449|448031766|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
124566344|NCT04700449|448031763|FG000|Stage 2 Sub-study 2|Other|0|||
124566345|NCT04700449|448031764|FG001|Stage 2 Sub-study 2|Other|0|||
124566346|NCT04700449|448031765|FG002|Stage 2 Sub-study 2|Other|0|||
124566347|NCT04700449|448031766|FG003|Stage 2 Sub-study 2|Other|5|||
124566348|NCT01521559|448031767|FG000|Overall Study|Adverse Event|0|||
124566349|NCT01521559|448031768|FG001|Overall Study|Adverse Event|4|||
124566350|NCT01521559|448031767|FG000|Overall Study|Death|1|||
124566351|NCT01521559|448031768|FG001|Overall Study|Death|0|||
124566352|NCT01521559|448031767|FG000|Overall Study|Withdrawal by Subject|9|||
124566353|NCT01521559|448031768|FG001|Overall Study|Withdrawal by Subject|11|||
124566354|NCT01521559|448031767|FG000|Overall Study|Lost to Follow-up|3|||
124566355|NCT01521559|448031768|FG001|Overall Study|Lost to Follow-up|1|||
124566356|NCT01521559|448031767|FG000|Overall Study|Protocol Violation|1|||
124566357|NCT01521559|448031768|FG001|Overall Study|Protocol Violation|0|||
124566358|NCT01521559|448031767|FG000|Overall Study|Other|1|||
124566359|NCT01521559|448031768|FG001|Overall Study|Other|2|||
124566360|NCT00275002|448031769|FG000|Overall Study|Death|1|||
124566361|NCT00275002|448031770|FG001|Overall Study|Death|0|||
124566362|NCT00275002|448031769|FG000|Overall Study|Disease progression|21|||
124566363|NCT00275002|448031770|FG001|Overall Study|Disease progression|15|||
124566364|NCT00275002|448031769|FG000|Overall Study|Adverse Event|0|||
124566365|NCT00275002|448031770|FG001|Overall Study|Adverse Event|1|||
124566366|NCT00576381|448031777|FG000|Overall Study|Reoperation|3|||
124566367|NCT00576381|448031777|FG000|Overall Study|Adverse Event|4|||
124566368|NCT01031537|448031781|FG000|Overall Study|medical reasons not related to study|3|||
124566369|NCT01031537|448031781|FG000|Overall Study|Lack of Efficacy|1|||
124566370|NCT01031537|448031781|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
124566371|NCT01031537|448031781|FG000|Overall Study|moved, met exclusion criteria|10|||
124566372|NCT01031537|448031781|FG000|Overall Study|Withdrawal by Subject|5|||
124566373|NCT01031537|448031781|FG000|Overall Study|PI removal, no longer met eligibility|12|||
124566374|NCT02132247|448031782|FG000|Overall Study|Protocol Violation|1|||
124566375|NCT02132247|448031783|FG001|Overall Study|Protocol Violation|0|||
124566376|NCT00520741|448031784|FG000|Overall Study|Adverse Event|16|||
124566377|NCT00520741|448031785|FG001|Overall Study|Adverse Event|56|||
124566378|NCT00520741|448031784|FG000|Overall Study|Lack of Efficacy|11|||
124566379|NCT00520741|448031785|FG001|Overall Study|Lack of Efficacy|30|||
124566380|NCT00520741|448031784|FG000|Overall Study|Withdrawal by Subject|0|||
124566381|NCT00520741|448031785|FG001|Overall Study|Withdrawal by Subject|11|||
124566382|NCT00520741|448031784|FG000|Overall Study|Protocol Violation|2|||
124566383|NCT00520741|448031785|FG001|Overall Study|Protocol Violation|15|||
124566384|NCT00520741|448031784|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
124566385|NCT00520741|448031785|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
124566386|NCT00520741|448031784|FG000|Overall Study|Lost to Follow-up|4|||
124566387|NCT00520741|448031785|FG001|Overall Study|Lost to Follow-up|4|||
124566388|NCT00520741|448031784|FG000|Overall Study|Other reasons for premature termination|0|||
124566389|NCT00520741|448031785|FG001|Overall Study|Other reasons for premature termination|6|||
124566390|NCT02750761|448031786|FG000|Overall Study|Lost to Follow-up|0|||
124566391|NCT02750761|448031787|FG001|Overall Study|Lost to Follow-up|0|||
124566392|NCT02750761|448031788|FG002|Overall Study|Lost to Follow-up|1|||
124566393|NCT02750761|448031789|FG003|Overall Study|Lost to Follow-up|0|||
124566394|NCT02750761|448031790|FG004|Overall Study|Lost to Follow-up|0|||
124566395|NCT02750761|448031791|FG005|Overall Study|Lost to Follow-up|0|||
124566396|NCT02354586|448031793|FG000|Overall Study|Death|230|||
124566397|NCT02354586|448031793|FG000|Overall Study|Withdrawal by Subject|59|||
124566398|NCT02354586|448031793|FG000|Overall Study|Lost to Follow-up|11|||
124776686|NCT00998296|448809949|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
124566399|NCT02354586|448031793|FG000|Overall Study|Sponsor decision|51|||
124566400|NCT02354586|448031793|FG000|Overall Study|Site closure|2|||
124566401|NCT02354586|448031793|FG000|Overall Study|Intercurrent illness|1|||
124566402|NCT02354586|448031793|FG000|Overall Study|Protocol Violation|3|||
124566403|NCT02354586|448031793|FG000|Overall Study|Physician Decision|13|||
124566404|NCT02354586|448031793|FG000|Overall Study|Lack of Efficacy|86|||
124566405|NCT02354586|448031793|FG000|Overall Study|Adverse Event|7|||
124566406|NCT00634907|448031794|FG000|Overall Study|Withdrawal by Subject|3|||
124566407|NCT00634907|448031795|FG001|Overall Study|Withdrawal by Subject|0|||
124566408|NCT00634907|448031794|FG000|Overall Study|Physician Decision|3|||
124566409|NCT00634907|448031795|FG001|Overall Study|Physician Decision|9|||
124566410|NCT00634907|448031794|FG000|Overall Study|Withdrawal by Subject|11|||
124566411|NCT00634907|448031795|FG001|Overall Study|Withdrawal by Subject|8|||
124566412|NCT00688064|448031796|FG000|Overall Study|Protocol Violation|0|||
124776687|NCT00998296|448809950|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
124776688|NCT00998296|448809951|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
124776689|NCT00998296|448809952|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
124776690|NCT00998296|448809953|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
124776691|NCT00998296|448809954|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
124511388|NCT02553317|447823762|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
124511389|NCT02553317|447823763|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
124511390|NCT02553317|447823762|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
124511391|NCT02553317|447823763|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
124511392|NCT02553317|447823762|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
124511393|NCT02553317|447823763|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
124511394|NCT02553317|447823762|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
124511395|NCT02553317|447823763|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
124511396|NCT02553317|447823762|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
124511397|NCT02553317|447823763|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
124511398|NCT03176277|447823764|FG000|Part A Dose Escalation Study|Adverse Event|1|||
124511399|NCT03176277|447823765|FG001|Part A Dose Escalation Study|Adverse Event|0|||
124511400|NCT03176277|447823766|FG002|Part A Dose Escalation Study|Adverse Event|1|||
124511401|NCT03176277|447823767|FG003|Part A Dose Escalation Study|Adverse Event|0|||
124511402|NCT03176277|447823764|FG000|Part A Dose Escalation Study|Physician Decision|1|||
124511403|NCT03176277|447823765|FG001|Part A Dose Escalation Study|Physician Decision|1|||
124511404|NCT03176277|447823766|FG002|Part A Dose Escalation Study|Physician Decision|2|||
124511405|NCT03176277|447823767|FG003|Part A Dose Escalation Study|Physician Decision|0|||
124511406|NCT03176277|447823764|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
124511407|NCT03176277|447823765|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
124511408|NCT03176277|447823766|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
124511409|NCT03176277|447823767|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
124511410|NCT03176277|447823764|FG000|Part A Dose Escalation Study|Progressive disease|3|||
124511411|NCT03176277|447823765|FG001|Part A Dose Escalation Study|Progressive disease|1|||
124511412|NCT03176277|447823766|FG002|Part A Dose Escalation Study|Progressive disease|3|||
124511413|NCT03176277|447823767|FG003|Part A Dose Escalation Study|Progressive disease|0|||
124511414|NCT00634114|447823768|FG000|Overall Study|Adverse Event|6|||
124511415|NCT00634114|447823769|FG001|Overall Study|Adverse Event|8|||
124511416|NCT00634114|447823770|FG002|Overall Study|Adverse Event|3|||
124511417|NCT00634114|447823768|FG000|Overall Study|Withdrawal by Subject|9|||
124511418|NCT00634114|447823769|FG001|Overall Study|Withdrawal by Subject|6|||
124511419|NCT00634114|447823770|FG002|Overall Study|Withdrawal by Subject|11|||
124511420|NCT00634114|447823768|FG000|Overall Study|Lost to Follow-up|0|||
124511421|NCT00634114|447823769|FG001|Overall Study|Lost to Follow-up|0|||
124511422|NCT00634114|447823770|FG002|Overall Study|Lost to Follow-up|1|||
124511423|NCT00634114|447823768|FG000|Overall Study|Protocol Violation|3|||
124511424|NCT00634114|447823769|FG001|Overall Study|Protocol Violation|3|||
124511425|NCT00634114|447823770|FG002|Overall Study|Protocol Violation|1|||
124511426|NCT00634114|447823768|FG000|Overall Study|Pregnancy|1|||
124511427|NCT00634114|447823769|FG001|Overall Study|Pregnancy|0|||
124511428|NCT00634114|447823770|FG002|Overall Study|Pregnancy|0|||
124511429|NCT00634114|447823768|FG000|Overall Study|Incorrect enrolment|0|||
124511430|NCT00634114|447823769|FG001|Overall Study|Incorrect enrolment|1|||
124511431|NCT00634114|447823770|FG002|Overall Study|Incorrect enrolment|0|||
124511432|NCT00634114|447823768|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
124511433|NCT00634114|447823769|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
124511434|NCT00634114|447823770|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
124511435|NCT00634114|447823768|FG000|Overall Study|Difficult to continue|3|||
124511436|NCT00634114|447823769|FG001|Overall Study|Difficult to continue|1|||
124511437|NCT00634114|447823770|FG002|Overall Study|Difficult to continue|1|||
124511438|NCT00634114|447823768|FG000|Overall Study|Other reason|1|||
124511439|NCT00634114|447823769|FG001|Overall Study|Other reason|1|||
124511440|NCT00634114|447823770|FG002|Overall Study|Other reason|1|||
124511441|NCT03691610|447823771|FG000|Overall Study|Adverse Event|0|||
124511442|NCT03691610|447823772|FG001|Overall Study|Adverse Event|1|||
124511443|NCT03691610|447823773|FG002|Overall Study|Adverse Event|0|||
124511444|NCT03691610|447823774|FG003|Overall Study|Adverse Event|0|||
124511445|NCT03691610|447823771|FG000|Overall Study|Protocol Deviation|15|||
124511446|NCT03691610|447823772|FG001|Overall Study|Protocol Deviation|8|||
124511447|NCT03691610|447823773|FG002|Overall Study|Protocol Deviation|1|||
124511448|NCT03691610|447823774|FG003|Overall Study|Protocol Deviation|2|||
124511449|NCT03691610|447823771|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
124511450|NCT03691610|447823772|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
124511451|NCT03691610|447823773|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
124511452|NCT03691610|447823774|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
124511453|NCT03691610|447823771|FG000|Overall Study|Lost to Follow-up|20|||
124511454|NCT03691610|447823772|FG001|Overall Study|Lost to Follow-up|11|||
124566413|NCT00688064|448031797|FG001|Overall Study|Protocol Violation|1|||
124566414|NCT00688064|448031796|FG000|Overall Study|Adverse Event|2|||
124566415|NCT00688064|448031797|FG001|Overall Study|Adverse Event|4|||
124566416|NCT00688064|448031796|FG000|Overall Study|Withdrawal by Subject|7|||
124566417|NCT00688064|448031797|FG001|Overall Study|Withdrawal by Subject|7|||
124566418|NCT00688064|448031796|FG000|Overall Study|Lost to Follow-up|10|||
124566419|NCT00688064|448031797|FG001|Overall Study|Lost to Follow-up|10|||
124566420|NCT00688064|448031796|FG000|Overall Study|Lack of Efficacy|0|||
124566421|NCT00688064|448031797|FG001|Overall Study|Lack of Efficacy|1|||
124566422|NCT00688064|448031796|FG000|Overall Study|Pregnancy|1|||
124566423|NCT00688064|448031797|FG001|Overall Study|Pregnancy|0|||
124566424|NCT00688064|448031796|FG000|Overall Study|Any other reasons|1|||
124566425|NCT00688064|448031797|FG001|Overall Study|Any other reasons|3|||
124566426|NCT02224391|448031800|FG000|Overall Study|Lost to Follow-up|26|||
124566427|NCT02224391|448031801|FG001|Overall Study|Lost to Follow-up|19|||
124566428|NCT02224391|448031800|FG000|Overall Study|Withdrawal by Subject|6|||
124566429|NCT02224391|448031801|FG001|Overall Study|Withdrawal by Subject|5|||
124566430|NCT00084084|448031803|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
124566431|NCT00084084|448031803|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
124566432|NCT00108732|448031807|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
124566433|NCT00108732|448031807|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
124566434|NCT00108732|448031807|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
124566435|NCT00108732|448031807|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
124566436|NCT00108732|448031807|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
124566437|NCT00108732|448031807|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
124566438|NCT00108732|448031807|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
124566439|NCT03922477|448031810|FG000|Overall Study|Death|9|||
124566440|NCT03922477|448031810|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
124566441|NCT03922477|448031810|FG000|Overall Study|Physician Decision|1|||
124566442|NCT03922477|448031810|FG000|Overall Study|Withdrawal by Subject|2|||
124566443|NCT01485536|448031820|FG000|Overall Study|Withdrawal by Subject|3|||
124566444|NCT01485536|448031820|FG000|Overall Study|Adverse Event|1|||
124566445|NCT02626949|448031821|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
124566446|NCT02626949|448031822|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
124566447|NCT02626949|448031821|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
124566448|NCT02626949|448031822|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
124566449|NCT02626949|448031821|FG000|Enrolled|Lost to Follow-up|7|||
124566450|NCT02626949|448031822|FG001|Enrolled|Lost to Follow-up|6|||
124566451|NCT02626949|448031821|FG000|Enrolled|Withdrawal by Subject|3|||
124566452|NCT02626949|448031822|FG001|Enrolled|Withdrawal by Subject|2|||
124566453|NCT03072459|448031823|FG000|Overall Study|Device revised/removed|1|||
124566454|NCT03072459|448031823|FG000|Overall Study|Subject not able to return|1|||
124566455|NCT04094870|448031824|FG000|Overall Study|Lost to Follow-up|1|||
124724880|NCT01696994|448613341|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
124724881|NCT01696994|448613342|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
124724882|NCT04644276|448613343|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
124511455|NCT03691610|447823773|FG002|Overall Study|Lost to Follow-up|5|||
124511456|NCT03691610|447823774|FG003|Overall Study|Lost to Follow-up|2|||
124511457|NCT03699631|447823775|FG000|Overall Study|Adverse Event|3|||
124511458|NCT02940626|447823776|FG000|Overall Study|Death|40|||
124511459|NCT02940626|447823777|FG001|Overall Study|Death|32|||
124511460|NCT02940626|447823776|FG000|Overall Study|Lost to Follow-up|5|||
124511461|NCT02940626|447823777|FG001|Overall Study|Lost to Follow-up|2|||
124511462|NCT02940626|447823776|FG000|Overall Study|Withdrawal by Subject|1|||
124511463|NCT02940626|447823777|FG001|Overall Study|Withdrawal by Subject|0|||
124511464|NCT02940626|447823776|FG000|Overall Study|Transfer to Hospice Care|1|||
124511465|NCT02940626|447823777|FG001|Overall Study|Transfer to Hospice Care|0|||
124511466|NCT02940626|447823776|FG000|Overall Study|Prohibited Concomitant Medication|0|||
124511467|NCT02940626|447823777|FG001|Overall Study|Prohibited Concomitant Medication|1|||
124511468|NCT01996904|447823778|FG000|Overall Study|Lost to Follow-up|38|||
124511469|NCT01996904|447823779|FG001|Overall Study|Lost to Follow-up|27|||
124724883|NCT04644276|448613344|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
124511470|NCT00585923|447823781|FG000|Overall Study|Physician decided not to continue|31|||
124511471|NCT00585923|447823782|FG001|Overall Study|Physician decided not to continue|33|||
124511472|NCT00622869|447823783|FG000|Overall Study|Subject Withdrew Consent|13|||
124511473|NCT00622869|447823784|FG001|Overall Study|Subject Withdrew Consent|17|||
124511474|NCT00622869|447823785|FG002|Overall Study|Subject Withdrew Consent|11|||
124566456|NCT04094870|448031825|FG001|Overall Study|Lost to Follow-up|1|||
124566457|NCT03384745|448031828|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
124566458|NCT03384745|448031829|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
124566459|NCT03384745|448031830|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
124566460|NCT03384745|448031831|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
124566461|NCT03384745|448031832|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
124511475|NCT00622869|447823783|FG000|Overall Study|Administrative Problems|11|||
124511476|NCT00622869|447823784|FG001|Overall Study|Administrative Problems|17|||
124511477|NCT00622869|447823785|FG002|Overall Study|Administrative Problems|13|||
124511478|NCT00622869|447823783|FG000|Overall Study|Death|12|||
124511479|NCT00622869|447823784|FG001|Overall Study|Death|15|||
124511480|NCT00622869|447823785|FG002|Overall Study|Death|10|||
124511481|NCT00622869|447823783|FG000|Overall Study|Lost to Follow-up|2|||
124511482|NCT00622869|447823784|FG001|Overall Study|Lost to Follow-up|4|||
124511483|NCT00622869|447823785|FG002|Overall Study|Lost to Follow-up|2|||
124511484|NCT00622869|447823783|FG000|Overall Study|Graft Loss|5|||
124511485|NCT00622869|447823784|FG001|Overall Study|Graft Loss|3|||
124511486|NCT00622869|447823785|FG002|Overall Study|Graft Loss|2|||
124511487|NCT00622869|447823783|FG000|Overall Study|Missing|0|||
124511488|NCT00622869|447823784|FG001|Overall Study|Missing|1|||
124511489|NCT00622869|447823785|FG002|Overall Study|Missing|1|||
124511490|NCT01324622|447823786|FG000|Overall Study|Lost to Follow-up|7|||
124511491|NCT01324622|447823787|FG001|Overall Study|Lost to Follow-up|7|||
124511492|NCT01324622|447823786|FG000|Overall Study|Death|1|||
124511493|NCT01324622|447823787|FG001|Overall Study|Death|0|||
124511494|NCT01324622|447823786|FG000|Overall Study|Lack of Efficacy|1|||
124511495|NCT01324622|447823787|FG001|Overall Study|Lack of Efficacy|0|||
124511496|NCT00138424|447823788|FG000|Overall Study|Physician Decision|0|||
124511497|NCT00138424|447823789|FG001|Overall Study|Physician Decision|1|||
124511498|NCT00138424|447823790|FG002|Overall Study|Physician Decision|0|||
124511499|NCT00138424|447823791|FG003|Overall Study|Physician Decision|0|||
124511500|NCT02176291|447823794|FG000|Overall Study|Death|1|||
124511501|NCT02176291|447823795|FG001|Overall Study|Death|0|||
124511502|NCT02176291|447823794|FG000|Overall Study|non compliance with protocol|2|||
124511503|NCT02176291|447823795|FG001|Overall Study|non compliance with protocol|0|||
124511504|NCT02176291|447823794|FG000|Overall Study|Withdrawal by Subject|2|||
124511505|NCT02176291|447823795|FG001|Overall Study|Withdrawal by Subject|0|||
124511506|NCT03454412|447823796|FG000|Baseline Assesment|Physician Decision|12|||
124511507|NCT01167582|447823797|FG000|Overall Study|Lost to Follow-up|0|||
124511508|NCT01167582|447823798|FG001|Overall Study|Lost to Follow-up|1|||
124511509|NCT00115765|447823799|FG000|Overall Study|Withdrawal by Subject|22|||
124511510|NCT00115765|447823800|FG001|Overall Study|Withdrawal by Subject|53|||
124511511|NCT00115765|447823801|FG002|Overall Study|Withdrawal by Subject|76|||
124511512|NCT00115765|447823802|FG003|Overall Study|Withdrawal by Subject|15|||
124511513|NCT00115765|447823799|FG000|Overall Study|Physician Decision|4|||
124511514|NCT00115765|447823800|FG001|Overall Study|Physician Decision|15|||
124511515|NCT00115765|447823801|FG002|Overall Study|Physician Decision|18|||
124511516|NCT00115765|447823802|FG003|Overall Study|Physician Decision|13|||
124511517|NCT00115765|447823799|FG000|Overall Study|Lost to Follow-up|3|||
124511518|NCT00115765|447823800|FG001|Overall Study|Lost to Follow-up|20|||
124511519|NCT00115765|447823801|FG002|Overall Study|Lost to Follow-up|18|||
124511520|NCT00115765|447823802|FG003|Overall Study|Lost to Follow-up|1|||
124511521|NCT00115765|447823799|FG000|Overall Study|Other|6|||
124511522|NCT00115765|447823800|FG001|Overall Study|Other|12|||
124511523|NCT00115765|447823801|FG002|Overall Study|Other|9|||
124511524|NCT00115765|447823802|FG003|Overall Study|Other|2|||
124511525|NCT01518244|447823803|FG000|Overall Study|Adverse Event|3|||
124511526|NCT03543358|447823804|FG000|Overall Study|Death|1|||
124511527|NCT03543358|447823805|FG001|Overall Study|Death|0|||
124511528|NCT03543358|447823804|FG000|Overall Study|Disease Progression|1|||
124511529|NCT03543358|447823805|FG001|Overall Study|Disease Progression|0|||
124511530|NCT03543358|447823804|FG000|Overall Study|Parent Study Closure|1|||
124511531|NCT03543358|447823805|FG001|Overall Study|Parent Study Closure|0|||
124511532|NCT03956225|447823807|FG000|Overall Study|Lack of Efficacy|1|||
124511533|NCT03956225|447823808|FG001|Overall Study|Lack of Efficacy|1|||
124511534|NCT03956225|447823807|FG000|Overall Study|Lost to Follow-up|0|||
124511535|NCT03956225|447823808|FG001|Overall Study|Lost to Follow-up|1|||
124511536|NCT03956225|447823807|FG000|Overall Study|Withdrawal by Subject|2|||
124511537|NCT03956225|447823808|FG001|Overall Study|Withdrawal by Subject|1|||
124511538|NCT03956225|447823807|FG000|Overall Study|Other Reasons|2|||
124511539|NCT03956225|447823808|FG001|Overall Study|Other Reasons|1|||
124511540|NCT02260648|447823809|FG000|Overall Study|Adverse Event|3|||
124566462|NCT03384745|448031833|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
124511541|NCT02260648|447823810|FG001|Overall Study|Adverse Event|0|||
124511542|NCT02260648|447823811|FG002|Overall Study|Adverse Event|1|||
124511543|NCT02260648|447823809|FG000|Overall Study|Withdrawal by Subject|1|||
124511544|NCT02260648|447823810|FG001|Overall Study|Withdrawal by Subject|1|||
124511545|NCT02260648|447823811|FG002|Overall Study|Withdrawal by Subject|0|||
124511546|NCT02260648|447823809|FG000|Overall Study|Protocol Violation|1|||
124511547|NCT02260648|447823810|FG001|Overall Study|Protocol Violation|0|||
124511548|NCT02260648|447823811|FG002|Overall Study|Protocol Violation|0|||
124511549|NCT02260648|447823809|FG000|Overall Study|Discontinue Due to Study Termination|13|||
124511550|NCT02260648|447823810|FG001|Overall Study|Discontinue Due to Study Termination|12|||
124511551|NCT02260648|447823811|FG002|Overall Study|Discontinue Due to Study Termination|7|||
124511552|NCT04093258|447823812|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
124511553|NCT04093258|447823813|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
124511554|NCT00594204|447823814|FG000|Overall Study|Adverse Event|15|||
124511555|NCT00594204|447823815|FG001|Overall Study|Adverse Event|3|||
124511556|NCT00594204|447823814|FG000|Overall Study|Lost to Follow-up|9|||
124511557|NCT00594204|447823815|FG001|Overall Study|Lost to Follow-up|5|||
124511558|NCT00594204|447823814|FG000|Overall Study|Withdrawal by Subject|23|||
124511559|NCT00594204|447823815|FG001|Overall Study|Withdrawal by Subject|29|||
124511560|NCT00594204|447823814|FG000|Overall Study|Other|4|||
124511561|NCT00594204|447823815|FG001|Overall Study|Other|3|||
124511562|NCT00594204|447823814|FG000|Overall Study|Lack of Efficacy|3|||
124511563|NCT00594204|447823815|FG001|Overall Study|Lack of Efficacy|4|||
124511564|NCT00594204|447823814|FG000|Overall Study|Randomized but not treated|4|||
124511565|NCT00594204|447823815|FG001|Overall Study|Randomized but not treated|1|||
124511566|NCT00986427|447823816|FG000|Overall Study|Lost to Follow-up|2|||
124511567|NCT00986427|447823817|FG001|Overall Study|Lost to Follow-up|0|||
124511568|NCT00986427|447823816|FG000|Overall Study|Lack of Efficacy|1|||
124511569|NCT00986427|447823817|FG001|Overall Study|Lack of Efficacy|0|||
124511570|NCT00986427|447823816|FG000|Overall Study|Withdrawal by Subject|1|||
124511571|NCT00986427|447823817|FG001|Overall Study|Withdrawal by Subject|0|||
124511572|NCT01401465|447823818|FG000|Treatment Period 1|Adverse Event|4|||
124511573|NCT01401465|447823819|FG001|Treatment Period 1|Adverse Event|1|||
124511574|NCT01401465|447823818|FG000|Treatment Period 1|Pregnancy|0|||
124511575|NCT01401465|447823819|FG001|Treatment Period 1|Pregnancy|1|||
124511576|NCT01401465|447823818|FG000|Treatment Period 1|Protocol Violation|5|||
124511577|NCT01401465|447823819|FG001|Treatment Period 1|Protocol Violation|0|||
124511578|NCT01401465|447823818|FG000|Treatment Period 1|Withdrawal by Subject|1|||
124511579|NCT01401465|447823819|FG001|Treatment Period 1|Withdrawal by Subject|4|||
124511580|NCT01401465|447823818|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
124511581|NCT01401465|447823819|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
124511582|NCT01401465|447823818|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
124511583|NCT01401465|447823819|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
124511584|NCT01401465|447823818|FG000|Treatment Period 1|Scheduling Difficulties|1|||
124511585|NCT01401465|447823819|FG001|Treatment Period 1|Scheduling Difficulties|1|||
124511586|NCT01401465|447823818|FG000|Treatment Period 2|Lost to Follow-up|0|||
124511587|NCT01401465|447823819|FG001|Treatment Period 2|Lost to Follow-up|1|||
124511588|NCT01401465|447823818|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124511589|NCT01401465|447823819|FG001|Treatment Period 2|Withdrawal by Subject|1|||
124511590|NCT01115738|447823820|FG000|Overall Study|Death|1|||
124511591|NCT01115738|447823821|FG001|Overall Study|Death|0|||
124511592|NCT01115738|447823822|FG002|Overall Study|Death|0|||
124511593|NCT01115738|447823820|FG000|Overall Study|Lost to Follow-up|0|||
124511594|NCT01115738|447823821|FG001|Overall Study|Lost to Follow-up|0|||
124511595|NCT01115738|447823822|FG002|Overall Study|Lost to Follow-up|1|||
124511596|NCT01115738|447823820|FG000|Overall Study|Physician Decision|18|||
124511597|NCT01115738|447823821|FG001|Overall Study|Physician Decision|15|||
124511598|NCT01115738|447823822|FG002|Overall Study|Physician Decision|17|||
124511599|NCT01115738|447823820|FG000|Overall Study|Withdrawal by Subject|6|||
124511600|NCT01115738|447823821|FG001|Overall Study|Withdrawal by Subject|6|||
124511601|NCT01115738|447823822|FG002|Overall Study|Withdrawal by Subject|9|||
124511602|NCT01669811|447823826|FG000|Overall Study|Investigator decision|0|||
124511603|NCT01669811|447823827|FG001|Overall Study|Investigator decision|1|||
124511604|NCT01669811|447823826|FG000|Overall Study|Withdrawal by Subject|1|||
124511605|NCT01669811|447823827|FG001|Overall Study|Withdrawal by Subject|2|||
124511606|NCT01669811|447823826|FG000|Overall Study|Adverse Event|2|||
124511607|NCT01669811|447823827|FG001|Overall Study|Adverse Event|6|||
124511608|NCT01669811|447823826|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
124511609|NCT01669811|447823827|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
124511610|NCT05691829|447824981|FG000|Overall Study|Physician Decision|2|||
124511611|NCT05691829|447824981|FG000|Overall Study|Eligibility criteria not met|3|||
124511612|NCT04095442|447824982|FG000|Overall Study|Lost to Follow-up|0|||
124511613|NCT04095442|447824983|FG001|Overall Study|Lost to Follow-up|1|||
124511614|NCT04095442|447824982|FG000|Overall Study|Screen failure|1|||
124511615|NCT04095442|447824983|FG001|Overall Study|Screen failure|0|||
124511616|NCT00453180|447824988|FG000|Overall Study|Lost to Follow-up|2|||
124511617|NCT00453180|447824989|FG001|Overall Study|Lost to Follow-up|1|||
124511618|NCT00453180|447824988|FG000|Overall Study|Adverse Event|1|||
124511619|NCT00453180|447824989|FG001|Overall Study|Adverse Event|2|||
124511620|NCT01002742|447824996|FG000|Overall Study|Determined to be ineligible|0|||
124511621|NCT01002742|447824997|FG001|Overall Study|Determined to be ineligible|1|||
124511622|NCT03947255|447825000|FG000|Overall Study|Study Closure by Sponsor|2|||
124511623|NCT03947255|447825001|FG001|Overall Study|Study Closure by Sponsor|2|||
124511624|NCT03947255|447825000|FG000|Overall Study|Withdrawal by Subject|2|||
124511625|NCT03947255|447825001|FG001|Overall Study|Withdrawal by Subject|2|||
124511626|NCT03947255|447825000|FG000|Overall Study|Lost to Follow-up|2|||
124511627|NCT03947255|447825001|FG001|Overall Study|Lost to Follow-up|0|||
124511628|NCT03947255|447825000|FG000|Overall Study|Death|0|||
124511629|NCT03947255|447825001|FG001|Overall Study|Death|2|||
124511630|NCT02862548|447825002|FG000|Randomized Phase (Up to Week 48)|Death|0|||
124566463|NCT03384745|448031828|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
124566464|NCT03384745|448031829|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
124566465|NCT03384745|448031830|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
124566466|NCT03384745|448031831|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
124566467|NCT03384745|448031832|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
124566468|NCT03384745|448031833|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
124566469|NCT03384745|448031828|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
124566470|NCT03384745|448031829|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
124566471|NCT03384745|448031830|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
124566472|NCT03384745|448031831|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
124566473|NCT03384745|448031832|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
124566474|NCT03384745|448031833|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
124566475|NCT03384745|448031828|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
124566476|NCT03384745|448031829|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
124566477|NCT03384745|448031830|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
124566478|NCT03384745|448031831|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
124566479|NCT03384745|448031832|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
124566480|NCT03384745|448031833|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
124566481|NCT03384745|448031828|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
124566482|NCT03384745|448031829|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
124566483|NCT03384745|448031830|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
124566484|NCT03384745|448031831|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
124566485|NCT03384745|448031832|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
124566486|NCT03384745|448031833|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
124566487|NCT03384745|448031828|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
124566488|NCT03384745|448031829|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
124566489|NCT03384745|448031830|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
124566490|NCT03384745|448031831|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
124566491|NCT03384745|448031832|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
124566492|NCT03384745|448031833|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
124566493|NCT03384745|448031828|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
124566494|NCT03384745|448031829|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
124566495|NCT03384745|448031830|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
124566496|NCT03384745|448031831|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
124566497|NCT03384745|448031832|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
124511631|NCT02862548|447825003|FG001|Randomized Phase (Up to Week 48)|Death|1|||
124511632|NCT02862548|447825002|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
124511633|NCT02862548|447825003|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
124511634|NCT02862548|447825002|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
124511635|NCT02862548|447825003|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
124511636|NCT02862548|447825002|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
124511637|NCT02862548|447825003|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
124511638|NCT00880763|447825004|FG000|Extension Period (Part 2)|Adverse Event|0|||
124511639|NCT00880763|447825005|FG001|Extension Period (Part 2)|Adverse Event|0|||
124511640|NCT00880763|447825006|FG002|Extension Period (Part 2)|Adverse Event|1|||
124511641|NCT00880763|447825007|FG003|Extension Period (Part 2)|Adverse Event|1|||
124511642|NCT00880763|447825004|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
124511643|NCT00880763|447825005|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
124511644|NCT00880763|447825006|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
124511645|NCT00880763|447825007|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
124511646|NCT00880763|447825004|FG000|Extension Period (Part 2)|Physician Decision|0|||
124511647|NCT00880763|447825005|FG001|Extension Period (Part 2)|Physician Decision|1|||
124511648|NCT00880763|447825006|FG002|Extension Period (Part 2)|Physician Decision|1|||
124511649|NCT00880763|447825007|FG003|Extension Period (Part 2)|Physician Decision|0|||
124511650|NCT00880763|447825004|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
124511651|NCT00880763|447825005|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
124511652|NCT00880763|447825006|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
124511653|NCT00880763|447825007|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
124511654|NCT00949910|447825008|FG000|Overall Study|Progressive Disease|3750|||
124511655|NCT00949910|447825008|FG000|Overall Study|Symptomatic Deterioration|1088|||
124511656|NCT00949910|447825008|FG000|Overall Study|Lost to Follow-up|100|||
124511657|NCT00949910|447825008|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
124511658|NCT00949910|447825008|FG000|Overall Study|Participant Refusal|390|||
124566498|NCT03384745|448031833|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
124566499|NCT03384745|448031828|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
124511659|NCT00949910|447825008|FG000|Overall Study|Death Due to Malignant Disease|456|||
124511660|NCT00949910|447825008|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
124511661|NCT00949910|447825008|FG000|Overall Study|Death Due to Adverse Event|115|||
124637312|NCT00507455|448290462|FG000|Overall Study|Lack of Efficacy|0|||
124511662|NCT00949910|447825008|FG000|Overall Study|Death Due to Toxicity|3|||
124511663|NCT00949910|447825008|FG000|Overall Study|Death from Unknown Cause|5|||
124511664|NCT00949910|447825008|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
124511665|NCT00949910|447825008|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
124511666|NCT00949910|447825008|FG000|Overall Study|Switched to Commercial Treatment|4|||
124511667|NCT00949910|447825008|FG000|Overall Study|Violation of Eligibility|23|||
124511668|NCT00949910|447825008|FG000|Overall Study|Logistical Reasons|13|||
124511669|NCT00949910|447825008|FG000|Overall Study|Non-Compliance|10|||
124511670|NCT00949910|447825008|FG000|Overall Study|Prolonged Dosing Interruption|4|||
124511671|NCT00949910|447825008|FG000|Overall Study|Adverse Event|83|||
124511672|NCT00949910|447825008|FG000|Overall Study|Serious Adverse Event|6|||
124511673|NCT00949910|447825008|FG000|Overall Study|Physician/Participant Decision|7|||
124511674|NCT00949910|447825008|FG000|Overall Study|Other|4|||
124511675|NCT00949910|447825008|FG000|Overall Study|No Data|9|||
124511676|NCT03097614|447825009|FG000|Overall Study|Adverse Event|3|||
124511677|NCT02670928|447825010|FG000|Overall Study|Adverse Event|3|||
124511678|NCT02670928|447825011|FG001|Overall Study|Adverse Event|1|||
124511679|NCT02670928|447825010|FG000|Overall Study|Withdrawal by Subject|4|||
124511680|NCT02670928|447825011|FG001|Overall Study|Withdrawal by Subject|0|||
124511681|NCT02670928|447825010|FG000|Overall Study|Lost to Follow-up|1|||
124511682|NCT02670928|447825011|FG001|Overall Study|Lost to Follow-up|0|||
124511683|NCT02670928|447825010|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
124511684|NCT02670928|447825011|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
124511685|NCT02254551|447825018|FG000|Dose Escalation|Physician Decision|1|||
124511686|NCT02254551|447825018|FG000|Dose Escalation|Dose-limiting toxicity|2|||
124511687|NCT02215616|447825019|FG000|Overall Study|Sponsor requested to stop study drug|0|||
124511688|NCT02215616|447825020|FG001|Overall Study|Sponsor requested to stop study drug|0|||
124511689|NCT02215616|447825021|FG002|Overall Study|Sponsor requested to stop study drug|1|||
124511690|NCT02215616|447825022|FG003|Overall Study|Sponsor requested to stop study drug|4|||
124511691|NCT02215616|447825019|FG000|Overall Study|Death|1|||
124511692|NCT02215616|447825020|FG001|Overall Study|Death|0|||
124511693|NCT02215616|447825021|FG002|Overall Study|Death|0|||
124511694|NCT02215616|447825022|FG003|Overall Study|Death|0|||
124511695|NCT02215616|447825019|FG000|Overall Study|Adverse Event|7|||
124511696|NCT02215616|447825020|FG001|Overall Study|Adverse Event|4|||
124511697|NCT02215616|447825021|FG002|Overall Study|Adverse Event|9|||
124511698|NCT02215616|447825022|FG003|Overall Study|Adverse Event|2|||
124511699|NCT02215616|447825019|FG000|Overall Study|Withdrawal by Subject|1|||
124511700|NCT02215616|447825020|FG001|Overall Study|Withdrawal by Subject|8|||
124511701|NCT02215616|447825021|FG002|Overall Study|Withdrawal by Subject|2|||
124511702|NCT02215616|447825022|FG003|Overall Study|Withdrawal by Subject|5|||
124511703|NCT02215616|447825019|FG000|Overall Study|Non-compliance|0|||
124511704|NCT02215616|447825020|FG001|Overall Study|Non-compliance|2|||
124511705|NCT02215616|447825021|FG002|Overall Study|Non-compliance|1|||
124511706|NCT02215616|447825022|FG003|Overall Study|Non-compliance|0|||
124511707|NCT02215616|447825019|FG000|Overall Study|Protocol Violation|0|||
124511708|NCT02215616|447825020|FG001|Overall Study|Protocol Violation|2|||
124511709|NCT02215616|447825021|FG002|Overall Study|Protocol Violation|0|||
124511710|NCT02215616|447825022|FG003|Overall Study|Protocol Violation|0|||
124511711|NCT02215616|447825019|FG000|Overall Study|Lost to Follow-up|1|||
124511712|NCT02215616|447825020|FG001|Overall Study|Lost to Follow-up|1|||
124511713|NCT02215616|447825021|FG002|Overall Study|Lost to Follow-up|0|||
124511714|NCT02215616|447825022|FG003|Overall Study|Lost to Follow-up|1|||
124511715|NCT02215616|447825019|FG000|Overall Study|Other than specified|1|||
124511716|NCT02215616|447825020|FG001|Overall Study|Other than specified|0|||
124511717|NCT02215616|447825021|FG002|Overall Study|Other than specified|1|||
124511718|NCT02215616|447825022|FG003|Overall Study|Other than specified|1|||
124511719|NCT02759562|447825030|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
124511720|NCT02759562|447825031|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
124511721|NCT02759562|447825030|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
124511722|NCT02759562|447825031|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
124511723|NCT00387348|447825032|FG000|Overall Study|Death|1|||
124511724|NCT00387348|447825033|FG001|Overall Study|Death|1|||
124511725|NCT00387348|447825034|FG002|Overall Study|Death|0|||
124511726|NCT00387348|447825032|FG000|Overall Study|Physician Decision|1|||
124511727|NCT00387348|447825033|FG001|Overall Study|Physician Decision|0|||
124511728|NCT00387348|447825034|FG002|Overall Study|Physician Decision|1|||
124511729|NCT00387348|447825032|FG000|Overall Study|Withdrawal by Subject|0|||
124511730|NCT00387348|447825033|FG001|Overall Study|Withdrawal by Subject|2|||
124511731|NCT00387348|447825034|FG002|Overall Study|Withdrawal by Subject|2|||
124511732|NCT00387348|447825032|FG000|Overall Study|Adverse Event|1|||
124511733|NCT00387348|447825033|FG001|Overall Study|Adverse Event|0|||
124511734|NCT00387348|447825034|FG002|Overall Study|Adverse Event|1|||
124511735|NCT00505752|447825037|FG000|Overall Study|Adverse Event|1|||
124511736|NCT00505752|447825038|FG001|Overall Study|Adverse Event|0|||
124511737|NCT00505752|447825039|FG002|Overall Study|Adverse Event|1|||
124511738|NCT00505752|447825040|FG003|Overall Study|Adverse Event|0|||
124511739|NCT00505752|447825037|FG000|Overall Study|Lost to Follow-up|1|||
124511740|NCT00505752|447825038|FG001|Overall Study|Lost to Follow-up|0|||
124511741|NCT00505752|447825039|FG002|Overall Study|Lost to Follow-up|0|||
124511742|NCT00505752|447825040|FG003|Overall Study|Lost to Follow-up|0|||
124511743|NCT00505752|447825037|FG000|Overall Study|Lack of ovarian response|1|||
124511744|NCT00505752|447825038|FG001|Overall Study|Lack of ovarian response|3|||
124511745|NCT00505752|447825039|FG002|Overall Study|Lack of ovarian response|0|||
124511746|NCT00505752|447825040|FG003|Overall Study|Lack of ovarian response|0|||
124511747|NCT00505752|447825037|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
124511748|NCT00505752|447825038|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
124511749|NCT00505752|447825039|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
124511750|NCT00505752|447825040|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
124511751|NCT00505752|447825037|FG000|Overall Study|No oocytes retrieved|0|||
124511752|NCT00505752|447825038|FG001|Overall Study|No oocytes retrieved|2|||
124511753|NCT00505752|447825039|FG002|Overall Study|No oocytes retrieved|0|||
124511754|NCT00505752|447825040|FG003|Overall Study|No oocytes retrieved|1|||
124511755|NCT00505752|447825037|FG000|Overall Study|No Fertilization|1|||
124511756|NCT00505752|447825038|FG001|Overall Study|No Fertilization|1|||
124511757|NCT00505752|447825039|FG002|Overall Study|No Fertilization|2|||
124511758|NCT00505752|447825040|FG003|Overall Study|No Fertilization|1|||
124511759|NCT00505752|447825037|FG000|Overall Study|All embryos/blastocysts discarded|0|||
124511760|NCT00505752|447825038|FG001|Overall Study|All embryos/blastocysts discarded|0|||
124511761|NCT00505752|447825039|FG002|Overall Study|All embryos/blastocysts discarded|1|||
124511762|NCT00505752|447825040|FG003|Overall Study|All embryos/blastocysts discarded|1|||
124511763|NCT00505752|447825037|FG000|Overall Study|Other|1|||
124511764|NCT00505752|447825038|FG001|Overall Study|Other|2|||
124511765|NCT00505752|447825039|FG002|Overall Study|Other|1|||
124511766|NCT00505752|447825040|FG003|Overall Study|Other|2|||
124511767|NCT01925612|447825043|FG000|Overall Study|Progressive Disease|1|||
124511768|NCT01925612|447825044|FG001|Overall Study|Progressive Disease|1|||
124511769|NCT01925612|447825045|FG002|Overall Study|Progressive Disease|1|||
124511770|NCT01925612|447825046|FG003|Overall Study|Progressive Disease|0|||
124511771|NCT01925612|447825047|FG004|Overall Study|Progressive Disease|0|||
124511772|NCT01925612|447825043|FG000|Overall Study|Adverse Event|3|||
124511773|NCT01925612|447825044|FG001|Overall Study|Adverse Event|3|||
124511774|NCT01925612|447825045|FG002|Overall Study|Adverse Event|0|||
124511775|NCT01925612|447825046|FG003|Overall Study|Adverse Event|1|||
124511776|NCT01925612|447825047|FG004|Overall Study|Adverse Event|2|||
124511777|NCT04624672|447825053|FG000|Overall Study|Early Study Closure|2|||
124511778|NCT04624672|447825054|FG001|Overall Study|Early Study Closure|1|||
124511779|NCT03472040|447825055|FG000|Overall Study|Physician Decision|0|||
124511780|NCT03472040|447825056|FG001|Overall Study|Physician Decision|3|||
124511781|NCT03472040|447825055|FG000|Overall Study|Withdrawal by Subject|10|||
124511782|NCT03472040|447825056|FG001|Overall Study|Withdrawal by Subject|23|||
124511783|NCT03472040|447825055|FG000|Overall Study|Perceived Lack of Efficacy|29|||
124511784|NCT03472040|447825056|FG001|Overall Study|Perceived Lack of Efficacy|30|||
124511785|NCT03472040|447825055|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
124511786|NCT03472040|447825056|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
124511787|NCT03472040|447825055|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
124511788|NCT03472040|447825056|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
124511789|NCT03472040|447825055|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
124511790|NCT03472040|447825056|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
124511791|NCT03472040|447825055|FG000|Overall Study|Subject Non-compliance|2|||
124511792|NCT03472040|447825056|FG001|Overall Study|Subject Non-compliance|5|||
124511793|NCT03472040|447825055|FG000|Overall Study|Discontinuation due to Rash|0|||
124511794|NCT03472040|447825056|FG001|Overall Study|Discontinuation due to Rash|1|||
124511795|NCT03472040|447825055|FG000|Overall Study|Subsequent Ineligibility|0|||
124511796|NCT03472040|447825056|FG001|Overall Study|Subsequent Ineligibility|2|||
124511797|NCT03472040|447825055|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
124511798|NCT03472040|447825056|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
124511799|NCT02769832|447825057|FG000|Overall Study|Death|30|||
124511800|NCT01280266|447825078|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
124511801|NCT01280266|447825079|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
124511802|NCT01280266|447825078|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
124511803|NCT01280266|447825079|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
124511804|NCT00881361|447825084|FG000|Overall Study|Terminated prior to surgery|27|||
124511805|NCT00881361|447825085|FG001|Overall Study|Terminated prior to surgery|7|||
124511806|NCT00881361|447825086|FG002|Overall Study|Terminated prior to surgery|0|||
124511807|NCT00881361|447825084|FG000|Overall Study|Ineligible|17|||
124511808|NCT00881361|447825085|FG001|Overall Study|Ineligible|2|||
124511809|NCT00881361|447825086|FG002|Overall Study|Ineligible|2|||
124511810|NCT02988219|447825089|FG000|Overall Study|Lack of Efficacy|1|||
124566500|NCT03384745|448031829|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
124566501|NCT03384745|448031830|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
124566502|NCT03384745|448031831|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
124566503|NCT03384745|448031832|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
124566504|NCT03384745|448031833|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
124566505|NCT03384745|448031828|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
124566506|NCT03384745|448031829|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
124566507|NCT03384745|448031830|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
124566508|NCT03384745|448031831|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
124566509|NCT03384745|448031832|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
124566510|NCT03384745|448031833|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
124566511|NCT03384745|448031828|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
124566512|NCT03384745|448031829|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
124566513|NCT03384745|448031830|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
124566514|NCT03384745|448031831|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
124566515|NCT03384745|448031832|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
124566516|NCT03384745|448031833|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
124566517|NCT03384745|448031828|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
124566518|NCT03384745|448031829|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
124566519|NCT03384745|448031830|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
124566520|NCT03384745|448031831|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
124566521|NCT03384745|448031832|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
124566522|NCT03384745|448031833|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
124566523|NCT02984683|448031836|FG000|Overall Study|Adverse Event|3|||
124566524|NCT02984683|448031837|FG001|Overall Study|Adverse Event|3|||
124566525|NCT02984683|448031836|FG000|Overall Study|Withdrawal by Subject|1|||
124566526|NCT02984683|448031837|FG001|Overall Study|Withdrawal by Subject|0|||
124566527|NCT02984683|448031836|FG000|Overall Study|Disease progression|7|||
124566528|NCT02984683|448031837|FG001|Overall Study|Disease progression|9|||
124566529|NCT02739984|448031838|FG000|Overall Study|Sponsor Decision|1|||
124566530|NCT02739984|448031839|FG001|Overall Study|Sponsor Decision|0|||
124566531|NCT02739984|448031838|FG000|Overall Study|Withdrawal by Subject|1|||
124566532|NCT02739984|448031839|FG001|Overall Study|Withdrawal by Subject|1|||
124566533|NCT02739984|448031838|FG000|Overall Study|Death|0|||
124566534|NCT02739984|448031839|FG001|Overall Study|Death|1|||
124566535|NCT02739984|448031838|FG000|Overall Study|Lost to Follow-up|3|||
124566536|NCT02739984|448031839|FG001|Overall Study|Lost to Follow-up|0|||
124566537|NCT03008460|448031840|FG000|Overall Study|Protocol deviation|0|||
124566538|NCT03008460|448031841|FG001|Overall Study|Protocol deviation|2|||
124566539|NCT03008460|448031840|FG000|Overall Study|Study drug not dispensed|0|||
124566540|NCT03008460|448031841|FG001|Overall Study|Study drug not dispensed|1|||
124566541|NCT03008460|448031840|FG000|Overall Study|Adverse Event|0|||
124566542|NCT03008460|448031841|FG001|Overall Study|Adverse Event|1|||
124566543|NCT03008460|448031840|FG000|Overall Study|Withdrawal by Subject|5|||
124566544|NCT03008460|448031841|FG001|Overall Study|Withdrawal by Subject|6|||
124566545|NCT03008460|448031840|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
124566546|NCT03008460|448031841|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
124566547|NCT03008460|448031840|FG000|Overall Study|End of study visit outside permitted time window|0|||
124566548|NCT03008460|448031841|FG001|Overall Study|End of study visit outside permitted time window|1|||
124566549|NCT03008460|448031840|FG000|Overall Study|Lost to Follow-up|1|||
124566550|NCT03008460|448031841|FG001|Overall Study|Lost to Follow-up|3|||
124566551|NCT04947579|448031844|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
124566552|NCT04947579|448031845|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
124566553|NCT04947579|448031846|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
124566554|NCT04947579|448031847|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
124566555|NCT04947579|448031848|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
124566556|NCT04947579|448031849|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
124566557|NCT04947579|448031844|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
124566558|NCT04947579|448031845|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
124566559|NCT04947579|448031846|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
124566560|NCT04947579|448031847|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
124566561|NCT04947579|448031848|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
124566562|NCT04947579|448031849|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
124566563|NCT04947579|448031844|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
124566564|NCT04947579|448031845|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
124566565|NCT04947579|448031846|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
124566566|NCT04947579|448031847|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
124566567|NCT04947579|448031848|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
124566568|NCT04947579|448031849|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
124566569|NCT04947579|448031844|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
124566570|NCT04947579|448031845|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
124566571|NCT04947579|448031846|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
124566572|NCT04947579|448031847|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
124566573|NCT04947579|448031848|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
124566574|NCT04947579|448031849|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
124566575|NCT04947579|448031844|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
124566576|NCT04947579|448031845|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
124566577|NCT04947579|448031846|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
124566578|NCT04947579|448031847|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
124566579|NCT04947579|448031848|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
124566580|NCT04947579|448031849|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
124566581|NCT04947579|448031844|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
124566582|NCT04947579|448031845|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
124566583|NCT04947579|448031846|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
124566584|NCT04947579|448031847|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
124566585|NCT04947579|448031848|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
124566586|NCT04947579|448031849|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
124566587|NCT04947579|448031844|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
124566588|NCT04947579|448031845|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
124566589|NCT04947579|448031846|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
124566590|NCT04947579|448031847|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
124566591|NCT04947579|448031848|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
124566592|NCT04947579|448031849|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
124566593|NCT04947579|448031844|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
124566594|NCT04947579|448031845|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
124566595|NCT04947579|448031846|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
124566596|NCT04947579|448031847|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
124566597|NCT04947579|448031848|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
124566598|NCT04947579|448031849|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
124566599|NCT04947579|448031844|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
124566600|NCT04947579|448031845|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
124566601|NCT04947579|448031846|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
124566602|NCT04947579|448031847|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
124566603|NCT04947579|448031848|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
124566604|NCT04947579|448031849|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
124566605|NCT04947579|448031844|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
124566606|NCT04947579|448031845|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
124566607|NCT04947579|448031846|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
124566608|NCT04947579|448031847|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
124566609|NCT04947579|448031848|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
124566610|NCT04947579|448031849|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
124566611|NCT04947579|448031844|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
124566612|NCT04947579|448031845|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
124566613|NCT04947579|448031846|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
124566614|NCT04947579|448031847|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
124566615|NCT04947579|448031848|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
124566616|NCT04947579|448031849|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
124566617|NCT01575054|448031850|FG000|Overall Study|Other Reasons|5|||
124566618|NCT01575054|448031851|FG001|Overall Study|Other Reasons|3|||
124566619|NCT01575054|448031850|FG000|Overall Study|Protocol Violation|2|||
124566620|NCT01575054|448031851|FG001|Overall Study|Protocol Violation|1|||
124566621|NCT01575054|448031850|FG000|Overall Study|Personal Reasons|10|||
124566622|NCT01575054|448031851|FG001|Overall Study|Personal Reasons|11|||
124566623|NCT01575054|448031850|FG000|Overall Study|Lost to Follow-up|3|||
124566624|NCT01575054|448031851|FG001|Overall Study|Lost to Follow-up|3|||
124566625|NCT01575054|448031850|FG000|Overall Study|Adverse Event|9|||
124566626|NCT01575054|448031851|FG001|Overall Study|Adverse Event|8|||
124566627|NCT05200858|448031860|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
124566628|NCT05200858|448031861|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
124566629|NCT05200858|448031862|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
124566630|NCT05200858|448031863|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
124566631|NCT01691508|448033545|FG000|Overall Study|Adverse Event|3|||
124566632|NCT01691508|448033546|FG001|Overall Study|Adverse Event|3|||
124566633|NCT01691508|448033545|FG000|Overall Study|Withdrawal by Subject|1|||
124566634|NCT01691508|448033546|FG001|Overall Study|Withdrawal by Subject|0|||
124566635|NCT02322047|448033547|FG000|Overall Study|Physician Decision|1|||
124566636|NCT02322047|448033548|FG001|Overall Study|Physician Decision|0|||
124566637|NCT02322047|448033549|FG002|Overall Study|Physician Decision|0|||
124566638|NCT02322047|448033550|FG003|Overall Study|Physician Decision|0|||
124566639|NCT02322047|448033547|FG000|Overall Study|Withdrawal by Subject|1|||
124566640|NCT02322047|448033548|FG001|Overall Study|Withdrawal by Subject|0|||
124566641|NCT02322047|448033549|FG002|Overall Study|Withdrawal by Subject|0|||
124566642|NCT02322047|448033550|FG003|Overall Study|Withdrawal by Subject|1|||
124566643|NCT02322047|448033547|FG000|Overall Study|Adverse Event|0|||
124566644|NCT02322047|448033548|FG001|Overall Study|Adverse Event|1|||
124566645|NCT02322047|448033549|FG002|Overall Study|Adverse Event|0|||
124566646|NCT02322047|448033550|FG003|Overall Study|Adverse Event|0|||
124566647|NCT02322047|448033547|FG000|Overall Study|Lost to Follow-up|0|||
124566648|NCT02322047|448033548|FG001|Overall Study|Lost to Follow-up|0|||
124566649|NCT02322047|448033549|FG002|Overall Study|Lost to Follow-up|1|||
124566650|NCT02322047|448033550|FG003|Overall Study|Lost to Follow-up|1|||
124566651|NCT02207231|448033551|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
124566652|NCT02207231|448033552|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
124566653|NCT02207231|448033553|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
124566654|NCT02207231|448033554|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
124566655|NCT02207231|448033551|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
124566656|NCT02207231|448033552|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
124566657|NCT02207231|448033553|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
124566658|NCT02207231|448033554|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
124566659|NCT02207231|448033551|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
124566660|NCT02207231|448033552|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
124566661|NCT02207231|448033553|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
124566662|NCT02207231|448033554|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
124566663|NCT02207231|448033551|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
124566664|NCT02207231|448033552|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
124566665|NCT02207231|448033553|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
124566666|NCT02207231|448033554|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
124566667|NCT02207231|448033551|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
124566668|NCT02207231|448033552|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
124566669|NCT02207231|448033553|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
124566670|NCT02207231|448033554|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
124566671|NCT02207231|448033551|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
124566672|NCT02207231|448033552|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
124566673|NCT02207231|448033553|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
124566674|NCT02207231|448033554|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
124637313|NCT00507455|448290463|FG001|Overall Study|Lack of Efficacy|1|||
124637314|NCT00507455|448290464|FG002|Overall Study|Lack of Efficacy|0|||
124511811|NCT02988219|447825090|FG001|Overall Study|Lack of Efficacy|1|||
124511812|NCT02988219|447825089|FG000|Overall Study|Withdrawal by Subject|0|||
124511813|NCT02988219|447825090|FG001|Overall Study|Withdrawal by Subject|2|||
124511814|NCT01522443|447825091|FG000|Overall Study|No longer receiving clinical benefit|36|||
124511815|NCT01522443|447825092|FG001|Overall Study|No longer receiving clinical benefit|28|||
124511816|NCT01522443|447825091|FG000|Overall Study|Adverse Event|10|||
124511817|NCT01522443|447825092|FG001|Overall Study|Adverse Event|15|||
124511818|NCT01522443|447825091|FG000|Overall Study|Withdrawal by Subject|5|||
124511819|NCT01522443|447825092|FG001|Overall Study|Withdrawal by Subject|8|||
124511820|NCT01522443|447825091|FG000|Overall Study|No study treatment given|1|||
124511821|NCT01522443|447825092|FG001|Overall Study|No study treatment given|1|||
124511822|NCT01522443|447825091|FG000|Overall Study|Other|1|||
124511823|NCT01522443|447825092|FG001|Overall Study|Other|3|||
124511824|NCT05590767|447825095|FG000|Overall Study|Protocol Violation|1|||
124511825|NCT05590767|447825095|FG000|Overall Study|surgery canceled|1|||
124511826|NCT05590767|447825095|FG000|Overall Study|interscalene brachial block not performed|1|||
124511827|NCT00776555|447825098|FG000|Overall Study|Study terminated|3|||
124511828|NCT00776555|447825099|FG001|Overall Study|Study terminated|0|||
124511829|NCT00936117|447825100|FG000|Overall Study|Adverse Event|7|||
124511830|NCT00936117|447825100|FG000|Overall Study|Unable to continue oral medication|3|||
124511831|NCT04685499|447825101|FG000|Overall Study|Study Terminated Early|1|||
124511832|NCT00618449|447825102|FG000|Overall Study|Lost to Follow-up|98|||
124511833|NCT00618449|447825103|FG001|Overall Study|Lost to Follow-up|110|||
124511834|NCT05127421|447825104|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
124511835|NCT05127421|447825105|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
124511836|NCT05127421|447825106|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
124511837|NCT05127421|447825107|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
124511838|NCT05127421|447825104|FG000|4-Week Double-Blind Period|Physician Decision|1|||
124511839|NCT05127421|447825105|FG001|4-Week Double-Blind Period|Physician Decision|0|||
124511840|NCT05127421|447825106|FG002|4-Week Double-Blind Period|Physician Decision|0|||
124511841|NCT05127421|447825107|FG003|4-Week Double-Blind Period|Physician Decision|0|||
124511842|NCT05127421|447825104|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
124566675|NCT02207231|448033551|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
124566676|NCT02207231|448033552|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
124566677|NCT02207231|448033553|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
124566678|NCT02207231|448033554|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
124566679|NCT02207231|448033551|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
124566680|NCT02207231|448033552|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
124566681|NCT02207231|448033553|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
124566682|NCT02207231|448033554|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
124566683|NCT02207231|448033551|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
124566684|NCT02207231|448033552|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
124566685|NCT02207231|448033553|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
124566686|NCT02207231|448033554|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
124566687|NCT02207231|448033551|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
124566688|NCT02207231|448033552|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
124566689|NCT02207231|448033553|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
124566690|NCT02207231|448033554|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
124566691|NCT02207231|448033551|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
124566692|NCT02207231|448033552|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
124566693|NCT02207231|448033553|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
124566694|NCT02207231|448033554|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
124566695|NCT02207231|448033551|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
124566696|NCT02207231|448033552|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
124566697|NCT02207231|448033553|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
124566698|NCT02207231|448033554|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
124566699|NCT02207231|448033551|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
124566700|NCT02207231|448033552|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
124566701|NCT02207231|448033553|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
124566702|NCT02207231|448033554|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
124566703|NCT02207231|448033551|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
124566704|NCT02207231|448033552|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
124566705|NCT02207231|448033553|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
124566706|NCT02207231|448033554|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
124566707|NCT02207231|448033551|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
124566708|NCT02207231|448033552|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
124566709|NCT02207231|448033553|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
124566710|NCT02207231|448033554|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
124566711|NCT02207231|448033551|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
124566712|NCT02207231|448033552|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
124566713|NCT02207231|448033553|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
124566714|NCT02207231|448033554|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
124566715|NCT02207231|448033551|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
124566716|NCT02207231|448033552|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
124566717|NCT02207231|448033553|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
124566718|NCT02207231|448033554|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
124566719|NCT02207231|448033551|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
124566720|NCT02207231|448033552|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
124566721|NCT02207231|448033553|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
124566722|NCT02207231|448033554|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
124566723|NCT02207231|448033551|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
124566724|NCT02207231|448033552|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
124566725|NCT02207231|448033553|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
124566726|NCT02207231|448033554|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
124566727|NCT02207231|448033551|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
124566728|NCT02207231|448033552|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
124566729|NCT02207231|448033553|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
124566730|NCT02207231|448033554|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
124566731|NCT02207231|448033551|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
124566732|NCT02207231|448033552|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
124566733|NCT02207231|448033553|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
124566734|NCT02207231|448033554|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
124566735|NCT01290263|448033558|FG000|Overall Study|Adverse Event|0|||
124566736|NCT01290263|448033559|FG001|Overall Study|Adverse Event|0|||
124566737|NCT01290263|448033560|FG002|Overall Study|Adverse Event|0|||
124566738|NCT01290263|448033561|FG003|Overall Study|Adverse Event|1|||
124566739|NCT01290263|448033562|FG004|Overall Study|Adverse Event|1|||
124566740|NCT01290263|448033558|FG000|Overall Study|Lack of Efficacy|8|||
124566741|NCT01290263|448033559|FG001|Overall Study|Lack of Efficacy|2|||
124566742|NCT01290263|448033560|FG002|Overall Study|Lack of Efficacy|7|||
124566743|NCT01290263|448033561|FG003|Overall Study|Lack of Efficacy|24|||
124566744|NCT01290263|448033562|FG004|Overall Study|Lack of Efficacy|33|||
124566745|NCT01290263|448033558|FG000|Overall Study|Withdrawal by Subject|3|||
124566746|NCT01290263|448033559|FG001|Overall Study|Withdrawal by Subject|1|||
124566747|NCT01290263|448033560|FG002|Overall Study|Withdrawal by Subject|0|||
124566748|NCT01290263|448033561|FG003|Overall Study|Withdrawal by Subject|1|||
124566749|NCT01290263|448033562|FG004|Overall Study|Withdrawal by Subject|2|||
124566750|NCT01290263|448033558|FG000|Overall Study|Participant Non-Compliance|0|||
124566751|NCT01290263|448033559|FG001|Overall Study|Participant Non-Compliance|0|||
124566752|NCT01290263|448033560|FG002|Overall Study|Participant Non-Compliance|0|||
124566753|NCT01290263|448033561|FG003|Overall Study|Participant Non-Compliance|1|||
124566754|NCT01290263|448033562|FG004|Overall Study|Participant Non-Compliance|1|||
124566755|NCT02016300|448033568|FG000|Overall Study|Lost to Follow-up|0|||
124566756|NCT02016300|448033569|FG001|Overall Study|Lost to Follow-up|3|||
124566757|NCT02309099|448033570|FG000|Overall Study|Adverse Event|2|||
124566758|NCT02309099|448033571|FG001|Overall Study|Adverse Event|0|||
124566759|NCT06165744|448033572|FG000|Overall Study|Non device-related adverse event|1|||
124566760|NCT05456529|448033573|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
124566761|NCT05456529|448033573|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
124566762|NCT05456529|448033573|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
124566763|NCT05456529|448033573|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
124566764|NCT05456529|448033573|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
124566765|NCT05456529|448033573|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
124566766|NCT05456529|448033573|FG000|44-week Long-term Safety Period|Physician Decision|2|||
124566767|NCT05456529|448033573|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
124566768|NCT05456529|448033573|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
124566769|NCT05456529|448033573|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
124566770|NCT05456529|448033573|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
124566771|NCT01631864|448033574|FG000|Overall Study|Withdrawal by Subject|0|||
124566772|NCT01631864|448033575|FG001|Overall Study|Withdrawal by Subject|1|||
124566773|NCT01631864|448033574|FG000|Overall Study|Adverse Event|2|||
124566774|NCT01631864|448033575|FG001|Overall Study|Adverse Event|3|||
124566775|NCT00527423|448033602|FG000|Overall Study|Protocol Violation|1|||
124566776|NCT00527423|448033602|FG000|Overall Study|Adverse Event|5|||
124566777|NCT00527423|448033602|FG000|Overall Study|Physician Decision|4|||
124566778|NCT00527423|448033602|FG000|Overall Study|Withdrawal by Subject|10|||
124566779|NCT00527423|448033602|FG000|Overall Study|Lost to Follow-up|4|||
124566780|NCT00527423|448033602|FG000|Overall Study|OTHER|4|||
124566781|NCT00527423|448033602|FG000|Overall Study|Death|9|||
124566782|NCT01957488|448033604|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
124566783|NCT01957488|448033605|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
124566784|NCT01957488|448033606|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
124566785|NCT01957488|448033607|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
124566786|NCT01957488|448033608|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
124566787|NCT01957488|448033609|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
124566788|NCT01957488|448033604|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
124566789|NCT01957488|448033605|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
124566790|NCT01957488|448033606|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
124566791|NCT01957488|448033607|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
124566792|NCT01957488|448033608|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
124566793|NCT01957488|448033609|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
124566794|NCT01957488|448033604|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
124511843|NCT05127421|447825105|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
124511844|NCT05127421|447825106|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
124511845|NCT05127421|447825107|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
124511846|NCT05127421|447825104|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
124511847|NCT05127421|447825105|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
124511848|NCT05127421|447825106|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
124511849|NCT05127421|447825107|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
124511850|NCT05127421|447825104|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
124511851|NCT05127421|447825105|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
124511852|NCT05127421|447825106|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
124511853|NCT05127421|447825107|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
124511854|NCT05127421|447825104|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
124511855|NCT05127421|447825105|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
124511856|NCT05127421|447825106|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
124511857|NCT05127421|447825107|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
124511858|NCT05127421|447825104|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
124511859|NCT05127421|447825105|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
124511860|NCT05127421|447825106|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
124511861|NCT05127421|447825107|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
124511862|NCT05127421|447825104|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
124511863|NCT05127421|447825105|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
124511864|NCT05127421|447825106|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
124511865|NCT05127421|447825107|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
124511866|NCT01441115|447825108|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
124511867|NCT00574496|447825109|FG000|Overall Study|Withdrawal by Subject|1|||
124511868|NCT01766817|447825110|FG000|Overall Study|Drug-related adverse event|1|||
124511869|NCT01766817|447825111|FG001|Overall Study|Drug-related adverse event|2|||
124511870|NCT01766817|447825112|FG002|Overall Study|Drug-related adverse event|1|||
124511871|NCT01766817|447825110|FG000|Overall Study|Drug-unrelated adverse event|3|||
124511872|NCT01766817|447825111|FG001|Overall Study|Drug-unrelated adverse event|3|||
124511873|NCT01766817|447825112|FG002|Overall Study|Drug-unrelated adverse event|3|||
124511874|NCT01766817|447825110|FG000|Overall Study|Death|1|||
124511875|NCT01766817|447825111|FG001|Overall Study|Death|1|||
124511876|NCT01766817|447825112|FG002|Overall Study|Death|0|||
124511877|NCT01766817|447825110|FG000|Overall Study|Unable to take study drug|0|||
124511878|NCT01766817|447825111|FG001|Overall Study|Unable to take study drug|1|||
124511879|NCT01766817|447825112|FG002|Overall Study|Unable to take study drug|0|||
124511880|NCT01766817|447825110|FG000|Overall Study|Withdrawal by Subject|2|||
124511881|NCT01766817|447825111|FG001|Overall Study|Withdrawal by Subject|0|||
124511882|NCT01766817|447825112|FG002|Overall Study|Withdrawal by Subject|3|||
124511883|NCT01766817|447825110|FG000|Overall Study|Subject non-compliance|0|||
124511884|NCT01766817|447825111|FG001|Overall Study|Subject non-compliance|1|||
124511885|NCT01766817|447825112|FG002|Overall Study|Subject non-compliance|2|||
124511886|NCT01766817|447825110|FG000|Overall Study|Physician Decision|3|||
124511887|NCT01766817|447825111|FG001|Overall Study|Physician Decision|3|||
124511888|NCT01766817|447825112|FG002|Overall Study|Physician Decision|4|||
124511889|NCT01766817|447825110|FG000|Overall Study|Other|1|||
124511890|NCT01766817|447825111|FG001|Overall Study|Other|0|||
124511891|NCT01766817|447825112|FG002|Overall Study|Other|0|||
124511892|NCT02721251|447825116|FG000|Overall Study|Withdrawal by Subject|8|||
124511893|NCT02721251|447825117|FG001|Overall Study|Withdrawal by Subject|7|||
124511894|NCT02721251|447825118|FG002|Overall Study|Withdrawal by Subject|9|||
124511895|NCT02721251|447825116|FG000|Overall Study|poor adherence|2|||
124511896|NCT02721251|447825117|FG001|Overall Study|poor adherence|2|||
124511897|NCT02721251|447825118|FG002|Overall Study|poor adherence|2|||
124511898|NCT04142216|447825119|FG000|Overall Study|Hospitalization|0|||
124511899|NCT04142216|447825120|FG001|Overall Study|Hospitalization|2|||
124511900|NCT04142216|447825119|FG000|Overall Study|Death|3|||
124511901|NCT04142216|447825120|FG001|Overall Study|Death|1|||
124511902|NCT04142216|447825119|FG000|Overall Study|Referral to another hemodialysis unit|3|||
124511903|NCT04142216|447825120|FG001|Overall Study|Referral to another hemodialysis unit|2|||
124511904|NCT04142216|447825119|FG000|Overall Study|Use of clove|0|||
124511905|NCT04142216|447825120|FG001|Overall Study|Use of clove|1|||
124511906|NCT02007954|447825121|FG000|Overall Study|Received liver transplant|3|||
124511907|NCT02007954|447825121|FG000|Overall Study|Switch in treatment modality|2|||
124511908|NCT02007954|447825121|FG000|Overall Study|Disease progression and unrelated AE|1|||
124511909|NCT02007954|447825121|FG000|Overall Study|Death|1|||
124511910|NCT01054976|447825126|FG000|Overall Study|Adverse Event|16|||
124511911|NCT01054976|447825126|FG000|Overall Study|Uncooperative participations to study|7|||
124511912|NCT01054976|447825126|FG000|Overall Study|Withdrawal by Subject|4|||
124511913|NCT01054976|447825126|FG000|Overall Study|Other|8|||
124511914|NCT01195363|447825128|FG000|Overall Study|Lost to Follow-up|7|||
124511915|NCT01195363|447825129|FG001|Overall Study|Lost to Follow-up|4|||
124511916|NCT01195363|447825128|FG000|Overall Study|Adverse Event|3|||
124511917|NCT01195363|447825129|FG001|Overall Study|Adverse Event|1|||
124511918|NCT01195363|447825128|FG000|Overall Study|Lack of Efficacy|0|||
124511919|NCT01195363|447825129|FG001|Overall Study|Lack of Efficacy|4|||
124511920|NCT01195363|447825128|FG000|Overall Study|incarceration|1|||
124511921|NCT01195363|447825129|FG001|Overall Study|incarceration|0|||
124511922|NCT00077376|447825133|FG000|Overall Study|Adverse Event|8|||
124511923|NCT00077376|447825133|FG000|Overall Study|Withdrawal by Subject|2|||
124511924|NCT00077376|447825133|FG000|Overall Study|Death|1|||
124511925|NCT00077376|447825133|FG000|Overall Study|Physician Decision|1|||
124511926|NCT00077376|447825133|FG000|Overall Study|Alternative therapy|5|||
124511927|NCT00077376|447825133|FG000|Overall Study|Complicating disease|1|||
124511928|NCT00077376|447825133|FG000|Overall Study|Still on treatment|1|||
124511929|NCT00077376|447825133|FG000|Overall Study|Symptomatic deterioration|1|||
124511930|NCT00077376|447825133|FG000|Overall Study|Surgery|1|||
124511931|NCT00077376|447825133|FG000|Overall Study|Insurance ran out|1|||
124511932|NCT01871896|447825138|FG000|Overall Study|Lost to Follow-up|1|||
124511933|NCT06422377|447827248|FG000|Overall Study|Study Terminated by Sponsor|1|||
124511934|NCT02843178|447827249|FG000|Overall Study|Lost to Follow-up|8|||
124511935|NCT02843178|447827250|FG001|Overall Study|Lost to Follow-up|8|||
124511936|NCT02843178|447827251|FG002|Overall Study|Lost to Follow-up|6|||
124511937|NCT02843178|447827252|FG003|Overall Study|Lost to Follow-up|3|||
124511938|NCT02843178|447827249|FG000|Overall Study|Withdrawal by Subject|0|||
124511939|NCT02843178|447827250|FG001|Overall Study|Withdrawal by Subject|0|||
124566795|NCT01957488|448033605|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
124566796|NCT01957488|448033606|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
124566797|NCT01957488|448033607|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
124566798|NCT01957488|448033608|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
124566799|NCT01957488|448033609|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
124566800|NCT01957488|448033604|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
124566801|NCT01957488|448033605|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
124566802|NCT01957488|448033606|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
124566803|NCT01957488|448033607|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
124566804|NCT01957488|448033608|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
124566805|NCT01957488|448033609|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
124566806|NCT01957488|448033604|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
124566807|NCT01957488|448033605|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
124566808|NCT01957488|448033606|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
124566809|NCT01957488|448033607|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
124566810|NCT01957488|448033608|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
124566811|NCT01957488|448033609|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
124566812|NCT01957488|448033604|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
124566813|NCT01957488|448033605|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
124566814|NCT01957488|448033606|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
124566815|NCT01957488|448033607|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
124566816|NCT01957488|448033608|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
124566817|NCT01957488|448033609|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
124566818|NCT01957488|448033604|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
124566819|NCT01957488|448033605|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
124566820|NCT01957488|448033606|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
124566821|NCT01957488|448033607|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
124566822|NCT01957488|448033608|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
124566823|NCT01957488|448033609|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
124566824|NCT01957488|448033604|FG000|Test Period 2 (2 Weeks)|Other|1|||
124566825|NCT01957488|448033605|FG001|Test Period 2 (2 Weeks)|Other|0|||
124566826|NCT01957488|448033606|FG002|Test Period 2 (2 Weeks)|Other|0|||
124566827|NCT01957488|448033607|FG003|Test Period 2 (2 Weeks)|Other|0|||
124566828|NCT01957488|448033608|FG004|Test Period 2 (2 Weeks)|Other|0|||
124566829|NCT01957488|448033609|FG005|Test Period 2 (2 Weeks)|Other|0|||
124566830|NCT01957488|448033604|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
124566831|NCT01957488|448033605|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
124566832|NCT01957488|448033606|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
124566833|NCT01957488|448033607|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
124566834|NCT01957488|448033608|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
124566835|NCT01957488|448033609|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
124566836|NCT01957488|448033604|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
124566837|NCT01957488|448033605|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
124566838|NCT01957488|448033606|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
124566839|NCT01957488|448033607|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
124566840|NCT01957488|448033608|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
124566841|NCT01957488|448033609|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
124511940|NCT02843178|447827251|FG002|Overall Study|Withdrawal by Subject|1|||
124511941|NCT02843178|447827252|FG003|Overall Study|Withdrawal by Subject|1|||
124511942|NCT02420795|447827253|FG000|Overall Study|Withdrawal by Subject|1|||
124511943|NCT02420795|447827254|FG001|Overall Study|Withdrawal by Subject|0|||
124511944|NCT02420795|447827255|FG002|Overall Study|Withdrawal by Subject|0|||
124511945|NCT02420795|447827253|FG000|Overall Study|Adverse Event|1|||
124511946|NCT02420795|447827254|FG001|Overall Study|Adverse Event|0|||
124511947|NCT02420795|447827255|FG002|Overall Study|Adverse Event|0|||
124511948|NCT02420795|447827253|FG000|Overall Study|Progressive disease|2|||
124511949|NCT02420795|447827254|FG001|Overall Study|Progressive disease|2|||
124511950|NCT02420795|447827255|FG002|Overall Study|Progressive disease|4|||
124511951|NCT02420795|447827253|FG000|Overall Study|Death|0|||
124511952|NCT02420795|447827254|FG001|Overall Study|Death|0|||
124511953|NCT02420795|447827255|FG002|Overall Study|Death|1|||
124511954|NCT01293006|447827270|FG000|Period 2|Lost to Follow-up|1|||
124511955|NCT01293006|447827271|FG001|Period 2|Lost to Follow-up|0|||
124511956|NCT01293006|447827272|FG002|Period 2|Lost to Follow-up|0|||
124511957|NCT01293006|447827273|FG003|Period 2|Lost to Follow-up|0|||
124511958|NCT01494987|447827274|FG000|Overall Study|Adverse Event|6|||
124566842|NCT01957488|448033604|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
124566843|NCT01957488|448033605|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
124566844|NCT01957488|448033606|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
124511959|NCT01494987|447827275|FG001|Overall Study|Adverse Event|5|||
124511960|NCT01494987|447827274|FG000|Overall Study|Hyperglycemia|6|||
124511961|NCT01494987|447827275|FG001|Overall Study|Hyperglycemia|4|||
124511962|NCT01494987|447827274|FG000|Overall Study|Investigator's Discretion|1|||
124566845|NCT01957488|448033607|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
124566846|NCT01957488|448033608|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
124566847|NCT01957488|448033609|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
124566848|NCT01957488|448033604|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
124566849|NCT01957488|448033605|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
124566850|NCT01957488|448033606|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
124566851|NCT01957488|448033607|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
124566852|NCT01957488|448033608|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
124566853|NCT01957488|448033609|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
124566854|NCT01957488|448033604|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
124566855|NCT01957488|448033605|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
124566856|NCT01957488|448033606|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
124566857|NCT01957488|448033607|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
124566858|NCT01957488|448033608|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
124566859|NCT01957488|448033609|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
124566860|NCT01439165|448033610|FG000|Overall Study|Protocol Violation|3|||
124566861|NCT01439165|448033611|FG001|Overall Study|Protocol Violation|0|||
124566862|NCT01439165|448033610|FG000|Overall Study|Lost to Follow-up|11|||
124566863|NCT01439165|448033611|FG001|Overall Study|Lost to Follow-up|1|||
124566864|NCT01439165|448033610|FG000|Overall Study|Withdrawal by Subject|7|||
124566865|NCT01439165|448033611|FG001|Overall Study|Withdrawal by Subject|1|||
124566866|NCT00623103|448033612|FG000|Overall Study|Adverse Event|70|||
124566867|NCT00623103|448033613|FG001|Overall Study|Adverse Event|60|||
124566868|NCT00623103|448033612|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
124566869|NCT00623103|448033613|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
124566870|NCT00623103|448033612|FG000|Overall Study|Withdrawal by Subject|18|||
124566871|NCT00623103|448033613|FG001|Overall Study|Withdrawal by Subject|24|||
124566872|NCT00623103|448033612|FG000|Overall Study|Lost to Follow-up|4|||
124566873|NCT00623103|448033613|FG001|Overall Study|Lost to Follow-up|1|||
124566874|NCT00623103|448033612|FG000|Overall Study|Administrative problems|2|||
124566875|NCT00623103|448033613|FG001|Overall Study|Administrative problems|4|||
124566876|NCT00623103|448033612|FG000|Overall Study|Death|11|||
124566877|NCT00623103|448033613|FG001|Overall Study|Death|11|||
124566878|NCT00623103|448033612|FG000|Overall Study|Protocol deviation|2|||
124566879|NCT00623103|448033613|FG001|Overall Study|Protocol deviation|1|||
124566880|NCT00001849|448033615|FG000|Overall Study|Death|4|||
124566881|NCT00001849|448033615|FG000|Overall Study|Lost to Follow-up|2|||
124566882|NCT00001849|448033615|FG000|Overall Study|Withdrawal by Subject|2|||
124566883|NCT00001849|448033615|FG000|Overall Study|tumor remained occult|6|||
124566884|NCT00442936|448033616|FG000|Overall Study|Protocol Violation|1|||
124566885|NCT00442936|448033617|FG001|Overall Study|Protocol Violation|0|||
124566886|NCT00442936|448033618|FG002|Overall Study|Protocol Violation|1|||
124566887|NCT00442936|448033619|FG003|Overall Study|Protocol Violation|1|||
124566888|NCT02433678|448033621|FG000|Overall Study|Lost to Follow-up|1|||
124566889|NCT02433678|448033622|FG001|Overall Study|Lost to Follow-up|2|||
124566890|NCT01506947|448033626|FG000|Overall Study|Lost to Follow-up|7|||
124566891|NCT01506947|448033626|FG000|Overall Study|Adverse Event|5|||
124566892|NCT01506947|448033626|FG000|Overall Study|Death|1|||
124566893|NCT01506947|448033626|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
124566894|NCT01700621|448033627|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
124566895|NCT01700621|448033628|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
124566896|NCT01700621|448033627|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
124566897|NCT01700621|448033628|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
124566898|NCT01700621|448033627|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
124566899|NCT01700621|448033628|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
124566900|NCT02166697|448033629|FG000|Overall Study|Protocol Violation|347|||
124566901|NCT02720510|448033633|FG000|Overall Study|Study Terminated by the sponsor|2|||
124566902|NCT02720510|448033634|FG001|Overall Study|Study Terminated by the sponsor|0|||
124566903|NCT02720510|448033633|FG000|Overall Study|Adverse Event|0|||
124566904|NCT02720510|448033634|FG001|Overall Study|Adverse Event|1|||
124566905|NCT02720510|448033633|FG000|Overall Study|Physician Decision|1|||
124566906|NCT02720510|448033634|FG001|Overall Study|Physician Decision|2|||
124566907|NCT01618266|448033640|FG000|Overall Study|Lost to Follow-up|9|||
124566908|NCT01618266|448033640|FG000|Overall Study|Treatment satisfaction|10|||
124566909|NCT01618266|448033640|FG000|Overall Study|Other reasons|11|||
124566910|NCT01618266|448033640|FG000|Overall Study|Lack of Efficacy|23|||
124566911|NCT01618266|448033640|FG000|Overall Study|Protocol Violation|43|||
124566912|NCT02985151|448033641|FG000|Original Randomization|Withdrawal by Subject|0|||
124566913|NCT02985151|448033642|FG001|Original Randomization|Withdrawal by Subject|1|||
124566914|NCT00625807|448033645|FG000|Overall Study|schedule conflict|2|||
124566915|NCT00625807|448033646|FG001|Overall Study|schedule conflict|8|||
124566916|NCT02187042|448033647|FG000|Overall Study|Death|1|||
124566917|NCT02187042|448033648|FG001|Overall Study|Death|1|||
124566918|NCT02187042|448033647|FG000|Overall Study|Toxicity|6|||
124566919|NCT02187042|448033648|FG001|Overall Study|Toxicity|5|||
124566920|NCT02187042|448033647|FG000|Overall Study|Participant choice|1|||
124776692|NCT00998296|448809955|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
124776693|NCT00998296|448809945|FG000|Overall Study|Other adverse event|0|||
124776694|NCT00998296|448809946|FG001|Overall Study|Other adverse event|0|||
124776695|NCT00998296|448809947|FG002|Overall Study|Other adverse event|0|||
124776696|NCT00998296|448809948|FG003|Overall Study|Other adverse event|0|||
124776697|NCT00998296|448809949|FG004|Overall Study|Other adverse event|1|||
124776698|NCT00998296|448809950|FG005|Overall Study|Other adverse event|0|||
124776699|NCT00998296|448809951|FG006|Overall Study|Other adverse event|0|||
124776700|NCT00998296|448809952|FG007|Overall Study|Other adverse event|0|||
124776701|NCT00998296|448809953|FG008|Overall Study|Other adverse event|0|||
124776702|NCT00998296|448809954|FG009|Overall Study|Other adverse event|1|||
124776703|NCT00998296|448809955|FG010|Overall Study|Other adverse event|2|||
124776704|NCT00998296|448809945|FG000|Overall Study|Refused to continue taking trial med.|0|||
124511963|NCT01494987|447827275|FG001|Overall Study|Investigator's Discretion|2|||
124511964|NCT01494987|447827274|FG000|Overall Study|Lost to Follow-up|1|||
124511965|NCT01494987|447827275|FG001|Overall Study|Lost to Follow-up|1|||
124511966|NCT01494987|447827274|FG000|Overall Study|Protocol Violation|3|||
124511967|NCT01494987|447827275|FG001|Overall Study|Protocol Violation|3|||
124511968|NCT01494987|447827274|FG000|Overall Study|Subject Non-Compliance|9|||
124511969|NCT01494987|447827275|FG001|Overall Study|Subject Non-Compliance|10|||
124511970|NCT01494987|447827274|FG000|Overall Study|Subject Withdrew Consent|2|||
124511971|NCT01494987|447827275|FG001|Overall Study|Subject Withdrew Consent|3|||
124511972|NCT00436982|447827278|FG000|Overall Study|Withdrawal by Subject|3|||
124511973|NCT00436982|447827279|FG001|Overall Study|Withdrawal by Subject|1|||
124511974|NCT00436982|447827278|FG000|Overall Study|Did not receive allocated intervention|0|||
124511975|NCT00436982|447827279|FG001|Overall Study|Did not receive allocated intervention|1|||
124511976|NCT00436982|447827278|FG000|Overall Study|no RSA data|1|||
124511977|NCT00436982|447827279|FG001|Overall Study|no RSA data|2|||
124511978|NCT00520299|447827282|FG000|Overall Study|Withdrawal by Subject|0|||
124511979|NCT00520299|447827283|FG001|Overall Study|Withdrawal by Subject|0|||
124511980|NCT00520299|447827284|FG002|Overall Study|Withdrawal by Subject|2|||
124511981|NCT00520299|447827282|FG000|Overall Study|Progressive disease|0|||
124511982|NCT00520299|447827283|FG001|Overall Study|Progressive disease|3|||
124511983|NCT00520299|447827284|FG002|Overall Study|Progressive disease|4|||
124511984|NCT01352845|447827286|FG000|Overall Study|Lost to Follow-up|313|||
124511985|NCT01352845|447827287|FG001|Overall Study|Lost to Follow-up|92|||
124511986|NCT01352845|447827286|FG000|Overall Study|No Longer Willing to Participate|205|||
124511987|NCT01352845|447827287|FG001|Overall Study|No Longer Willing to Participate|58|||
124511988|NCT01352845|447827286|FG000|Overall Study|Withdrawal by Subject|48|||
124511989|NCT01352845|447827287|FG001|Overall Study|Withdrawal by Subject|16|||
124511990|NCT01352845|447827286|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
124511991|NCT01352845|447827287|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
124511992|NCT01352845|447827286|FG000|Overall Study|Pregnancy|27|||
124511993|NCT01352845|447827287|FG001|Overall Study|Pregnancy|7|||
124511994|NCT01352845|447827286|FG000|Overall Study|Adverse Event|22|||
124511995|NCT01352845|447827287|FG001|Overall Study|Adverse Event|6|||
124511996|NCT01352845|447827286|FG000|Overall Study|Other|17|||
124511997|NCT01352845|447827287|FG001|Overall Study|Other|7|||
124511998|NCT01352845|447827286|FG000|Overall Study|Protocol Violation|12|||
124511999|NCT01352845|447827287|FG001|Overall Study|Protocol Violation|6|||
124512000|NCT01352845|447827286|FG000|Overall Study|Death|3|||
124512001|NCT01352845|447827287|FG001|Overall Study|Death|0|||
124512002|NCT05905601|447827292|FG000|Overall Study|Lost to Follow-up|1|||
124512003|NCT05905601|447827293|FG001|Overall Study|Lost to Follow-up|3|||
124512004|NCT03024255|447827294|FG000|Overall Study|Adverse Event|1|||
124512005|NCT03024255|447827295|FG001|Overall Study|Adverse Event|4|||
124512006|NCT03024255|447827296|FG002|Overall Study|Adverse Event|8|||
124512007|NCT03024255|447827297|FG003|Overall Study|Adverse Event|0|||
124512008|NCT03024255|447827294|FG000|Overall Study|Withdrawal by Subject|3|||
124512009|NCT03024255|447827295|FG001|Overall Study|Withdrawal by Subject|1|||
124512010|NCT03024255|447827296|FG002|Overall Study|Withdrawal by Subject|0|||
124512011|NCT03024255|447827297|FG003|Overall Study|Withdrawal by Subject|3|||
124512012|NCT03024255|447827294|FG000|Overall Study|Protocol Violation|0|||
124512013|NCT03024255|447827295|FG001|Overall Study|Protocol Violation|0|||
124512014|NCT03024255|447827296|FG002|Overall Study|Protocol Violation|2|||
124512015|NCT03024255|447827297|FG003|Overall Study|Protocol Violation|0|||
124776705|NCT00998296|448809946|FG001|Overall Study|Refused to continue taking trial med.|0|||
124776706|NCT00998296|448809947|FG002|Overall Study|Refused to continue taking trial med.|0|||
124512016|NCT03024255|447827294|FG000|Overall Study|Lost to Follow-up|1|||
124512017|NCT03024255|447827295|FG001|Overall Study|Lost to Follow-up|2|||
124512018|NCT03024255|447827296|FG002|Overall Study|Lost to Follow-up|1|||
124512019|NCT03024255|447827297|FG003|Overall Study|Lost to Follow-up|1|||
124512020|NCT03024255|447827294|FG000|Overall Study|Lack of Efficacy|1|||
124512021|NCT03024255|447827295|FG001|Overall Study|Lack of Efficacy|0|||
124512022|NCT03024255|447827296|FG002|Overall Study|Lack of Efficacy|0|||
124512023|NCT03024255|447827297|FG003|Overall Study|Lack of Efficacy|0|||
124512024|NCT03024255|447827294|FG000|Overall Study|Protocol Noncompliance|1|||
124512025|NCT03024255|447827295|FG001|Overall Study|Protocol Noncompliance|1|||
124566921|NCT02187042|448033648|FG001|Overall Study|Participant choice|0|||
124566922|NCT02187042|448033647|FG000|Overall Study|Doctor choice|1|||
124566923|NCT02187042|448033648|FG001|Overall Study|Doctor choice|0|||
124566924|NCT02187042|448033647|FG000|Overall Study|Progressive disease|4|||
124566925|NCT02187042|448033648|FG001|Overall Study|Progressive disease|8|||
124566926|NCT00536575|448033650|FG000|Overall Study|Withdrawal by Subject|1|||
124566927|NCT00536575|448033650|FG000|Overall Study|Death|1|||
124566928|NCT00788957|448033653|FG000|Part 1|Death|8|||
124566929|NCT00788957|448033654|FG001|Part 1|Death|0|||
124566930|NCT00788957|448033655|FG002|Part 1|Death|0|||
124566931|NCT00788957|448033656|FG003|Part 1|Death|0|||
124566932|NCT00788957|448033657|FG004|Part 1|Death|0|||
124566933|NCT00788957|448033658|FG005|Part 1|Death|0|||
124566934|NCT00788957|448033653|FG000|Part 1|Lost to Follow-up|1|||
124566935|NCT00788957|448033654|FG001|Part 1|Lost to Follow-up|0|||
124566936|NCT00788957|448033655|FG002|Part 1|Lost to Follow-up|0|||
124566937|NCT00788957|448033656|FG003|Part 1|Lost to Follow-up|0|||
124566938|NCT00788957|448033657|FG004|Part 1|Lost to Follow-up|0|||
124566939|NCT00788957|448033658|FG005|Part 1|Lost to Follow-up|0|||
124566940|NCT00788957|448033653|FG000|Part 2|Withdrawal by Subject|0|||
124566941|NCT00788957|448033654|FG001|Part 2|Withdrawal by Subject|9|||
124566942|NCT00788957|448033655|FG002|Part 2|Withdrawal by Subject|5|||
124566943|NCT00788957|448033656|FG003|Part 2|Withdrawal by Subject|3|||
124566944|NCT00788957|448033657|FG004|Part 2|Withdrawal by Subject|0|||
124566945|NCT00788957|448033658|FG005|Part 2|Withdrawal by Subject|0|||
124566946|NCT00788957|448033653|FG000|Part 2|Death|0|||
124566947|NCT00788957|448033654|FG001|Part 2|Death|32|||
124566948|NCT00788957|448033655|FG002|Part 2|Death|35|||
124566949|NCT00788957|448033656|FG003|Part 2|Death|37|||
124566950|NCT00788957|448033657|FG004|Part 2|Death|0|||
124566951|NCT00788957|448033658|FG005|Part 2|Death|0|||
124566952|NCT00788957|448033653|FG000|Part 2|Lost to Follow-up|0|||
124566953|NCT00788957|448033654|FG001|Part 2|Lost to Follow-up|0|||
124566954|NCT00788957|448033655|FG002|Part 2|Lost to Follow-up|3|||
124566955|NCT00788957|448033656|FG003|Part 2|Lost to Follow-up|0|||
124566956|NCT00788957|448033657|FG004|Part 2|Lost to Follow-up|0|||
124566957|NCT00788957|448033658|FG005|Part 2|Lost to Follow-up|0|||
124566958|NCT00788957|448033653|FG000|Part 2|On-study at time of data cut-off|0|||
124566959|NCT00788957|448033654|FG001|Part 2|On-study at time of data cut-off|1|||
124566960|NCT00788957|448033655|FG002|Part 2|On-study at time of data cut-off|1|||
124566961|NCT00788957|448033656|FG003|Part 2|On-study at time of data cut-off|1|||
124566962|NCT00788957|448033657|FG004|Part 2|On-study at time of data cut-off|0|||
124566963|NCT00788957|448033658|FG005|Part 2|On-study at time of data cut-off|0|||
124566964|NCT00788957|448033653|FG000|Part 3|Withdrawal by Subject|0|||
124566965|NCT00788957|448033654|FG001|Part 3|Withdrawal by Subject|0|||
124566966|NCT00788957|448033655|FG002|Part 3|Withdrawal by Subject|0|||
124512026|NCT03024255|447827296|FG002|Overall Study|Protocol Noncompliance|0|||
124512027|NCT03024255|447827297|FG003|Overall Study|Protocol Noncompliance|1|||
124512028|NCT03583606|447827301|FG000|Overall Study|Lost to Follow-up|0|||
124512029|NCT03583606|447827302|FG001|Overall Study|Lost to Follow-up|1|||
124512030|NCT03583606|447827303|FG002|Overall Study|Lost to Follow-up|0|||
124512031|NCT03583606|447827301|FG000|Overall Study|Ineligible at baseline|1|||
124512032|NCT03583606|447827302|FG001|Overall Study|Ineligible at baseline|0|||
124512033|NCT03583606|447827303|FG002|Overall Study|Ineligible at baseline|0|||
124512034|NCT03728140|447827309|FG000|Overall Study|Abnormal embryo transfer operation|10|||
124512035|NCT03728140|447827310|FG001|Overall Study|Abnormal embryo transfer operation|7|||
124512036|NCT00433446|447827313|FG000|Overall Study|Adverse Event|4|||
124512037|NCT00433446|447827313|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
124512038|NCT00433446|447827313|FG000|Overall Study|Progression|44|||
124512039|NCT00433446|447827313|FG000|Overall Study|Other - Not Protocol specified|3|||
124512040|NCT00433446|447827313|FG000|Overall Study|Ineligible|9|||
124512041|NCT01188538|447827314|FG000|Overall Study|Lost to Follow-up|0|||
124512042|NCT01188538|447827315|FG001|Overall Study|Lost to Follow-up|1|||
124512043|NCT01231607|447827319|FG000|Overall Study|Adverse Event|0|||
124512044|NCT01231607|447827320|FG001|Overall Study|Adverse Event|8|||
124512045|NCT01231607|447827321|FG002|Overall Study|Adverse Event|4|||
124512046|NCT01231607|447827322|FG003|Overall Study|Adverse Event|4|||
124512047|NCT01231607|447827323|FG004|Overall Study|Adverse Event|5|||
124512048|NCT01231607|447827319|FG000|Overall Study|Lost to Follow-up|13|||
124512049|NCT01231607|447827320|FG001|Overall Study|Lost to Follow-up|11|||
124512050|NCT01231607|447827321|FG002|Overall Study|Lost to Follow-up|10|||
124512051|NCT01231607|447827322|FG003|Overall Study|Lost to Follow-up|10|||
124512052|NCT01231607|447827323|FG004|Overall Study|Lost to Follow-up|4|||
124512053|NCT01231607|447827319|FG000|Overall Study|Physician Decision|4|||
124512054|NCT01231607|447827320|FG001|Overall Study|Physician Decision|4|||
124566967|NCT00788957|448033656|FG003|Part 3|Withdrawal by Subject|0|||
124566968|NCT00788957|448033657|FG004|Part 3|Withdrawal by Subject|0|||
124566969|NCT00788957|448033658|FG005|Part 3|Withdrawal by Subject|2|||
124566970|NCT00788957|448033653|FG000|Part 3|Death|0|||
124566971|NCT00788957|448033654|FG001|Part 3|Death|0|||
124566972|NCT00788957|448033655|FG002|Part 3|Death|0|||
124566973|NCT00788957|448033656|FG003|Part 3|Death|0|||
124566974|NCT00788957|448033657|FG004|Part 3|Death|8|||
124566975|NCT00788957|448033658|FG005|Part 3|Death|8|||
124566976|NCT00788957|448033653|FG000|Part 3|On-study at time of data cut-off|0|||
124566977|NCT00788957|448033654|FG001|Part 3|On-study at time of data cut-off|0|||
124566978|NCT00788957|448033655|FG002|Part 3|On-study at time of data cut-off|0|||
124566979|NCT00788957|448033656|FG003|Part 3|On-study at time of data cut-off|0|||
124566980|NCT00788957|448033657|FG004|Part 3|On-study at time of data cut-off|1|||
124566981|NCT00788957|448033658|FG005|Part 3|On-study at time of data cut-off|0|||
124566982|NCT03387098|448033659|FG000|Overall Study|progressive disease|1|||
124566983|NCT03387098|448033659|FG000|Overall Study|Withdrawal by Subject|2|||
124566984|NCT03387098|448033659|FG000|Overall Study|study terminated by sponsor|1|||
124566985|NCT03276975|448033660|FG000|Overall Study|Withdrawal by Subject|1|||
124566986|NCT03276975|448033661|FG001|Overall Study|Withdrawal by Subject|0|||
124566987|NCT00918567|448033662|FG000|Overall Study|Lack of Efficacy|3|||
124566988|NCT00918567|448033663|FG001|Overall Study|Lack of Efficacy|1|||
124566989|NCT00918567|448033662|FG000|Overall Study|Withdrawal by Subject|1|||
124566990|NCT00918567|448033663|FG001|Overall Study|Withdrawal by Subject|1|||
124566991|NCT00918567|448033662|FG000|Overall Study|Adverse Event|1|||
124566992|NCT00918567|448033663|FG001|Overall Study|Adverse Event|0|||
124566993|NCT02568384|448033669|FG000|Overall Study|Mobile devices incompatible with App|2|||
124566994|NCT03283709|448033675|FG000|Overall Study|trial terminated|0|||
124566995|NCT03283709|448033676|FG001|Overall Study|trial terminated|1|||
124566996|NCT00796510|448033677|FG000|Overall Study|Death|1|||
124566997|NCT00796510|448033678|FG001|Overall Study|Death|0|||
124566998|NCT00796510|448033677|FG000|Overall Study|Study Terminated|2|||
124566999|NCT00796510|448033678|FG001|Overall Study|Study Terminated|0|||
124567000|NCT02799602|448033679|FG000|Overall Study|Protocol Violation|1|||
124567001|NCT02799602|448033680|FG001|Overall Study|Protocol Violation|0|||
124567002|NCT02799602|448033679|FG000|Overall Study|Physician Decision|5|||
124567003|NCT02799602|448033680|FG001|Overall Study|Physician Decision|6|||
124567004|NCT02799602|448033679|FG000|Overall Study|Lost to Follow-up|4|||
124567005|NCT02799602|448033680|FG001|Overall Study|Lost to Follow-up|2|||
124567006|NCT02799602|448033679|FG000|Overall Study|Additional primary malignancy|11|||
124567007|NCT02799602|448033680|FG001|Overall Study|Additional primary malignancy|6|||
124567008|NCT02799602|448033679|FG000|Overall Study|Non-compliance with study drug|14|||
124567009|NCT02799602|448033680|FG001|Overall Study|Non-compliance with study drug|12|||
124567010|NCT02799602|448033679|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
124567011|NCT02799602|448033680|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
124567012|NCT02799602|448033679|FG000|Overall Study|Withdrawal by Subject|26|||
124567013|NCT02799602|448033680|FG001|Overall Study|Withdrawal by Subject|40|||
124567014|NCT02799602|448033679|FG000|Overall Study|Progressive disease - clinical progression|131|||
124567015|NCT02799602|448033680|FG001|Overall Study|Progressive disease - clinical progression|276|||
124567016|NCT02799602|448033679|FG000|Overall Study|Progressive disease - radiological progression|90|||
124567017|NCT02799602|448033680|FG001|Overall Study|Progressive disease - radiological progression|133|||
124567018|NCT02799602|448033679|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
124567019|NCT02799602|448033680|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
124567020|NCT02799602|448033679|FG000|Overall Study|Death|9|||
124567021|NCT02799602|448033680|FG001|Overall Study|Death|5|||
124567022|NCT02799602|448033679|FG000|Overall Study|Other|287|||
124567023|NCT02799602|448033680|FG001|Overall Study|Other|118|||
124567024|NCT02799602|448033679|FG000|Overall Study|Study drug never administered|0|||
124567025|NCT02799602|448033680|FG001|Overall Study|Study drug never administered|3|||
124567026|NCT01734772|448033681|FG000|Overall Study|Adverse Event|1|||
124567027|NCT01734772|448033682|FG001|Overall Study|Adverse Event|2|||
124567028|NCT01734772|448033681|FG000|Overall Study|Withdrawal by Subject|0|||
124567029|NCT01734772|448033682|FG001|Overall Study|Withdrawal by Subject|1|||
124567030|NCT00329602|448033683|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
124567031|NCT00329602|448033684|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
124567032|NCT00329602|448033685|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
124567033|NCT00329602|448033683|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
124567034|NCT00329602|448033684|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
124567035|NCT00329602|448033685|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
124567036|NCT00329602|448033683|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
124567037|NCT00329602|448033684|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
124567038|NCT00329602|448033685|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
124567039|NCT00329602|448033683|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
124567040|NCT00329602|448033684|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
124567041|NCT00329602|448033685|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
124567042|NCT00329602|448033683|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
124567043|NCT00329602|448033684|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
124567044|NCT00329602|448033685|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
124567045|NCT00329602|448033683|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
124567046|NCT00329602|448033684|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
124567047|NCT00329602|448033685|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
124567048|NCT02097121|448033688|FG000|Overall Study|Other, not specified|4|||
124567049|NCT02097121|448033689|FG001|Overall Study|Other, not specified|2|||
124567050|NCT02097121|448033690|FG002|Overall Study|Other, not specified|3|||
124567051|NCT02097121|448033688|FG000|Overall Study|Lack of Efficacy|2|||
124567052|NCT02097121|448033689|FG001|Overall Study|Lack of Efficacy|1|||
124567053|NCT02097121|448033690|FG002|Overall Study|Lack of Efficacy|3|||
124567054|NCT02097121|448033688|FG000|Overall Study|Withdrawal by Subject|0|||
124567055|NCT02097121|448033689|FG001|Overall Study|Withdrawal by Subject|1|||
124567056|NCT02097121|448033690|FG002|Overall Study|Withdrawal by Subject|2|||
124567057|NCT02097121|448033688|FG000|Overall Study|Adverse Event|0|||
124567058|NCT02097121|448033689|FG001|Overall Study|Adverse Event|1|||
124567059|NCT02097121|448033690|FG002|Overall Study|Adverse Event|0|||
124567060|NCT02097121|448033688|FG000|Overall Study|Lost to Follow-up|1|||
124567061|NCT02097121|448033689|FG001|Overall Study|Lost to Follow-up|1|||
124567062|NCT02097121|448033690|FG002|Overall Study|Lost to Follow-up|2|||
124567063|NCT03066999|448033691|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
124567064|NCT03066999|448033692|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
124567065|NCT00661999|448033693|FG000|Overall Study|Adverse Event|11|||
124567066|NCT00661999|448033694|FG001|Overall Study|Adverse Event|5|||
124567067|NCT00661999|448033695|FG002|Overall Study|Adverse Event|8|||
124567068|NCT00661999|448033693|FG000|Overall Study|Death|8|||
124567069|NCT00661999|448033694|FG001|Overall Study|Death|6|||
124567070|NCT00661999|448033695|FG002|Overall Study|Death|3|||
124567071|NCT00661999|448033693|FG000|Overall Study|Other Reasons|5|||
124567072|NCT00661999|448033694|FG001|Overall Study|Other Reasons|12|||
124567073|NCT00661999|448033695|FG002|Overall Study|Other Reasons|23|||
124567074|NCT00661999|448033693|FG000|Overall Study|Withdrawal by Subject|30|||
124567075|NCT00661999|448033694|FG001|Overall Study|Withdrawal by Subject|23|||
124567076|NCT00661999|448033695|FG002|Overall Study|Withdrawal by Subject|14|||
124567077|NCT00661999|448033693|FG000|Overall Study|Alternative Treatment|1|||
124567078|NCT00661999|448033694|FG001|Overall Study|Alternative Treatment|0|||
124567079|NCT00661999|448033695|FG002|Overall Study|Alternative Treatment|0|||
124567080|NCT00661999|448033693|FG000|Overall Study|Other Medical Problems|4|||
124567081|NCT00661999|448033694|FG001|Overall Study|Other Medical Problems|4|||
124567082|NCT00661999|448033695|FG002|Overall Study|Other Medical Problems|9|||
124567083|NCT00510510|448033696|FG000|Overall Study|Adverse Event|4|||
124567084|NCT00510510|448033697|FG001|Overall Study|Adverse Event|3|||
124567085|NCT00510510|448033698|FG002|Overall Study|Adverse Event|6|||
124567086|NCT00510510|448033696|FG000|Overall Study|Lack of Efficacy|0|||
124567087|NCT00510510|448033697|FG001|Overall Study|Lack of Efficacy|1|||
124567088|NCT00510510|448033698|FG002|Overall Study|Lack of Efficacy|1|||
124567089|NCT00510510|448033696|FG000|Overall Study|Subjects no longer requires study drug|0|||
124567090|NCT00510510|448033697|FG001|Overall Study|Subjects no longer requires study drug|0|||
124567091|NCT00510510|448033698|FG002|Overall Study|Subjects no longer requires study drug|2|||
124567092|NCT00510510|448033696|FG000|Overall Study|Withdrawal by Subject|1|||
124567093|NCT00510510|448033697|FG001|Overall Study|Withdrawal by Subject|2|||
124567094|NCT00510510|448033698|FG002|Overall Study|Withdrawal by Subject|3|||
124567095|NCT00510510|448033696|FG000|Overall Study|Lost to Follow-up|0|||
124567096|NCT00510510|448033697|FG001|Overall Study|Lost to Follow-up|0|||
124567097|NCT00510510|448033698|FG002|Overall Study|Lost to Follow-up|1|||
124567098|NCT00510510|448033696|FG000|Overall Study|Protocol Violation|0|||
124567099|NCT00510510|448033697|FG001|Overall Study|Protocol Violation|3|||
124567100|NCT00510510|448033698|FG002|Overall Study|Protocol Violation|4|||
124567101|NCT03595657|448033699|FG000|Overall Study|Adverse Event|14|||
124567102|NCT03595657|448033699|FG000|Overall Study|Death|1|||
124567103|NCT03595657|448033699|FG000|Overall Study|Lack of Efficacy|40|||
124567104|NCT03595657|448033699|FG000|Overall Study|Withdrawal by Subject|10|||
124567105|NCT03595657|448033699|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
124567106|NCT03595657|448033699|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
124567107|NCT03481309|448033705|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
124567108|NCT03481309|448033706|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
124567109|NCT03481309|448033707|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
124567110|NCT03481309|448033708|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
124567111|NCT03481309|448033709|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
124567112|NCT03481309|448033710|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
124567113|NCT03495869|448033711|FG000|Overall Study|Lost to Follow-up|4|||
124567114|NCT03495869|448033712|FG001|Overall Study|Lost to Follow-up|17|||
124567115|NCT03495869|448033713|FG002|Overall Study|Lost to Follow-up|8|||
124567116|NCT03495869|448033714|FG003|Overall Study|Lost to Follow-up|14|||
124567117|NCT03495869|448033711|FG000|Overall Study|Withdrawal by Subject|0|||
124567118|NCT03495869|448033712|FG001|Overall Study|Withdrawal by Subject|3|||
124567119|NCT03495869|448033713|FG002|Overall Study|Withdrawal by Subject|0|||
124567120|NCT03495869|448033714|FG003|Overall Study|Withdrawal by Subject|3|||
124567121|NCT03495869|448033711|FG000|Overall Study|Dropped from study|0|||
124567122|NCT03495869|448033712|FG001|Overall Study|Dropped from study|7|||
124567123|NCT03495869|448033713|FG002|Overall Study|Dropped from study|2|||
124567124|NCT03495869|448033714|FG003|Overall Study|Dropped from study|4|||
124567125|NCT02346201|448033715|FG000|Overall Study|Adverse Event|3|||
124567126|NCT02346201|448033716|FG001|Overall Study|Adverse Event|2|||
124567127|NCT02346201|448033715|FG000|Overall Study|Lost to Follow-up|1|||
124567128|NCT02346201|448033716|FG001|Overall Study|Lost to Follow-up|0|||
124567129|NCT02346201|448033715|FG000|Overall Study|Withdrawal by Subject|6|||
124567130|NCT02346201|448033716|FG001|Overall Study|Withdrawal by Subject|3|||
124567131|NCT02346201|448033715|FG000|Overall Study|Unavailable for future follow-up|0|||
124567132|NCT02346201|448033716|FG001|Overall Study|Unavailable for future follow-up|1|||
124567133|NCT02346201|448033715|FG000|Overall Study|Physician Decision|0|||
124567134|NCT02346201|448033716|FG001|Overall Study|Physician Decision|1|||
124567135|NCT02346201|448033715|FG000|Overall Study|Missed final visit|0|||
124567136|NCT02346201|448033716|FG001|Overall Study|Missed final visit|2|||
124567137|NCT03708211|448033717|FG000|Overall Study|Progressive Disease|10|||
124567138|NCT03708211|448033718|FG001|Overall Study|Progressive Disease|7|||
124567139|NCT03708211|448033717|FG000|Overall Study|Withdrawal by Subject|0|||
124567140|NCT03708211|448033718|FG001|Overall Study|Withdrawal by Subject|1|||
124567141|NCT03708211|448033717|FG000|Overall Study|Other|2|||
124567142|NCT03708211|448033718|FG001|Overall Study|Other|0|||
124567143|NCT01508936|448033719|FG000|Overall Study|Adverse Event|11|||
124567144|NCT01508936|448033720|FG001|Overall Study|Adverse Event|32|||
124567145|NCT01508936|448033719|FG000|Overall Study|Lack of Efficacy|0|||
124567146|NCT01508936|448033720|FG001|Overall Study|Lack of Efficacy|1|||
124567147|NCT01508936|448033719|FG000|Overall Study|Withdrawal by Subject|4|||
124567148|NCT01508936|448033720|FG001|Overall Study|Withdrawal by Subject|18|||
124567149|NCT01508936|448033719|FG000|Overall Study|Protocol Violation|2|||
124567150|NCT01508936|448033720|FG001|Overall Study|Protocol Violation|3|||
124567151|NCT01508936|448033719|FG000|Overall Study|Lost to Follow-up|2|||
124567152|NCT01508936|448033720|FG001|Overall Study|Lost to Follow-up|9|||
124567153|NCT01508936|448033719|FG000|Overall Study|Other|0|||
124567154|NCT01508936|448033720|FG001|Overall Study|Other|5|||
124567155|NCT01508936|448033719|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
124567156|NCT01508936|448033720|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
124567157|NCT00462982|448033721|FG000|Overall Study|Adverse Event|1|||
124567158|NCT00462982|448033721|FG000|Overall Study|Patient Not Treated|2|||
124567159|NCT00679367|448033722|FG000|Overall Study|Adverse Event|7|||
124567160|NCT00679367|448033722|FG000|Overall Study|inability to swallow oral drugs|1|||
124567161|NCT00679367|448033722|FG000|Overall Study|Lack of Efficacy|3|||
124567162|NCT00679367|448033722|FG000|Overall Study|Withdrawal by Subject|1|||
124567163|NCT02109133|448033723|FG000|Overall Study|Lost to Follow-up|1|||
124567164|NCT02109133|448033724|FG001|Overall Study|Lost to Follow-up|0|||
124567165|NCT00409578|448033725|FG000|Overall Study|Adverse Event|27|||
124567166|NCT00409578|448033726|FG001|Overall Study|Adverse Event|37|||
124567167|NCT00409578|448033727|FG002|Overall Study|Adverse Event|25|||
124567168|NCT00409578|448033728|FG003|Overall Study|Adverse Event|33|||
124567169|NCT00409578|448033725|FG000|Overall Study|Abnormal laboratory value(s)|2|||
124567170|NCT00409578|448033726|FG001|Overall Study|Abnormal laboratory value(s)|2|||
124567171|NCT00409578|448033727|FG002|Overall Study|Abnormal laboratory value(s)|2|||
124567172|NCT00409578|448033728|FG003|Overall Study|Abnormal laboratory value(s)|4|||
124567173|NCT00409578|448033725|FG000|Overall Study|Lack of Efficacy|0|||
124567174|NCT00409578|448033726|FG001|Overall Study|Lack of Efficacy|0|||
124567175|NCT00409578|448033727|FG002|Overall Study|Lack of Efficacy|0|||
124567176|NCT00409578|448033728|FG003|Overall Study|Lack of Efficacy|2|||
124567177|NCT00409578|448033725|FG000|Overall Study|Subject no longer requires study drug|0|||
124567178|NCT00409578|448033726|FG001|Overall Study|Subject no longer requires study drug|0|||
124567179|NCT00409578|448033727|FG002|Overall Study|Subject no longer requires study drug|0|||
124567180|NCT00409578|448033728|FG003|Overall Study|Subject no longer requires study drug|1|||
124567181|NCT00409578|448033725|FG000|Overall Study|Withdrawal by Subject|8|||
124567182|NCT00409578|448033726|FG001|Overall Study|Withdrawal by Subject|15|||
124567183|NCT00409578|448033727|FG002|Overall Study|Withdrawal by Subject|16|||
124567184|NCT00409578|448033728|FG003|Overall Study|Withdrawal by Subject|17|||
124567185|NCT00409578|448033725|FG000|Overall Study|Lost to Follow-up|2|||
124567186|NCT00409578|448033726|FG001|Overall Study|Lost to Follow-up|0|||
124567187|NCT00409578|448033727|FG002|Overall Study|Lost to Follow-up|2|||
124567188|NCT00409578|448033728|FG003|Overall Study|Lost to Follow-up|2|||
124567189|NCT00409578|448033725|FG000|Overall Study|Administrative problems|8|||
124567190|NCT00409578|448033726|FG001|Overall Study|Administrative problems|9|||
124567191|NCT00409578|448033727|FG002|Overall Study|Administrative problems|2|||
124567192|NCT00409578|448033728|FG003|Overall Study|Administrative problems|4|||
124567193|NCT00409578|448033725|FG000|Overall Study|Death|2|||
124567194|NCT00409578|448033726|FG001|Overall Study|Death|4|||
124567195|NCT00409578|448033727|FG002|Overall Study|Death|4|||
124567196|NCT00409578|448033728|FG003|Overall Study|Death|2|||
124567197|NCT00409578|448033725|FG000|Overall Study|Protocol Violation|3|||
124567198|NCT00409578|448033726|FG001|Overall Study|Protocol Violation|2|||
124567199|NCT00409578|448033727|FG002|Overall Study|Protocol Violation|3|||
124567200|NCT00409578|448033728|FG003|Overall Study|Protocol Violation|1|||
124567201|NCT00409578|448033725|FG000|Overall Study|Missing|0|||
124567202|NCT00409578|448033726|FG001|Overall Study|Missing|1|||
124567203|NCT00409578|448033727|FG002|Overall Study|Missing|0|||
124567204|NCT00409578|448033728|FG003|Overall Study|Missing|1|||
124567205|NCT00922779|448033729|FG000|Overall Study|Adverse Event|67|||
124567206|NCT00922779|448033729|FG000|Overall Study|Pregnancy|7|||
124567207|NCT00922779|448033729|FG000|Overall Study|Withdrawal by Subject|308|||
124567208|NCT00922779|448033729|FG000|Overall Study|Lost to Follow-up|44|||
124567209|NCT00922779|448033729|FG000|Overall Study|Other|27|||
124567210|NCT00922779|448033729|FG000|Overall Study|Missing|1874|||
124567211|NCT02448771|448033730|FG000|Overall Study|Disease Progression|30|||
124567212|NCT02448771|448033730|FG000|Overall Study|Unacceptable Toxicity|1|||
124567213|NCT02448771|448033730|FG000|Overall Study|Physician Decision|3|||
124567214|NCT02448771|448033730|FG000|Overall Study|Started new therapy|2|||
124567215|NCT00770315|448033731|FG000|Overall Study|Adverse Event|11|||
124567216|NCT00770315|448033732|FG001|Overall Study|Adverse Event|17|||
124567217|NCT00770315|448033733|FG002|Overall Study|Adverse Event|16|||
124567218|NCT00770315|448033734|FG003|Overall Study|Adverse Event|6|||
124567219|NCT00770315|448033731|FG000|Overall Study|Lost to Follow-up|9|||
124567220|NCT00770315|448033732|FG001|Overall Study|Lost to Follow-up|5|||
124567221|NCT00770315|448033733|FG002|Overall Study|Lost to Follow-up|10|||
124567222|NCT00770315|448033734|FG003|Overall Study|Lost to Follow-up|3|||
124512055|NCT01231607|447827321|FG002|Overall Study|Physician Decision|3|||
124512056|NCT01231607|447827322|FG003|Overall Study|Physician Decision|5|||
124512057|NCT01231607|447827323|FG004|Overall Study|Physician Decision|4|||
124512058|NCT01231607|447827319|FG000|Overall Study|Protocol Violation|3|||
124512059|NCT01231607|447827320|FG001|Overall Study|Protocol Violation|2|||
124512060|NCT01231607|447827321|FG002|Overall Study|Protocol Violation|0|||
124512061|NCT01231607|447827322|FG003|Overall Study|Protocol Violation|2|||
124512062|NCT01231607|447827323|FG004|Overall Study|Protocol Violation|2|||
124512063|NCT01231607|447827319|FG000|Overall Study|Withdrawal by Subject|9|||
124512064|NCT01231607|447827320|FG001|Overall Study|Withdrawal by Subject|9|||
124512065|NCT01231607|447827321|FG002|Overall Study|Withdrawal by Subject|14|||
124512066|NCT01231607|447827322|FG003|Overall Study|Withdrawal by Subject|17|||
124512067|NCT01231607|447827323|FG004|Overall Study|Withdrawal by Subject|9|||
124512068|NCT02501902|447827324|FG000|Overall Study|Subject Refused Further Follow-up|0|||
124512069|NCT02501902|447827325|FG001|Overall Study|Subject Refused Further Follow-up|0|||
124512070|NCT02501902|447827326|FG002|Overall Study|Subject Refused Further Follow-up|0|||
124512071|NCT02501902|447827327|FG003|Overall Study|Subject Refused Further Follow-up|0|||
124512072|NCT02501902|447827328|FG004|Overall Study|Subject Refused Further Follow-up|0|||
124512073|NCT02501902|447827329|FG005|Overall Study|Subject Refused Further Follow-up|0|||
124512074|NCT02501902|447827330|FG006|Overall Study|Subject Refused Further Follow-up|0|||
124512075|NCT02501902|447827331|FG007|Overall Study|Subject Refused Further Follow-up|1|||
124512076|NCT02501902|447827324|FG000|Overall Study|Study Terminated by Sponsor|0|||
124512077|NCT02501902|447827325|FG001|Overall Study|Study Terminated by Sponsor|3|||
124512078|NCT02501902|447827326|FG002|Overall Study|Study Terminated by Sponsor|0|||
124512079|NCT02501902|447827327|FG003|Overall Study|Study Terminated by Sponsor|1|||
124512080|NCT02501902|447827328|FG004|Overall Study|Study Terminated by Sponsor|1|||
124512081|NCT02501902|447827329|FG005|Overall Study|Study Terminated by Sponsor|0|||
124512082|NCT02501902|447827330|FG006|Overall Study|Study Terminated by Sponsor|2|||
124512083|NCT02501902|447827331|FG007|Overall Study|Study Terminated by Sponsor|4|||
124512084|NCT02501902|447827324|FG000|Overall Study|Death|3|||
124512085|NCT02501902|447827325|FG001|Overall Study|Death|4|||
124512086|NCT02501902|447827326|FG002|Overall Study|Death|4|||
124512087|NCT02501902|447827327|FG003|Overall Study|Death|10|||
124512088|NCT02501902|447827328|FG004|Overall Study|Death|10|||
124512089|NCT02501902|447827329|FG005|Overall Study|Death|11|||
124512090|NCT02501902|447827330|FG006|Overall Study|Death|7|||
124512091|NCT02501902|447827331|FG007|Overall Study|Death|15|||
124512092|NCT02513771|447827332|FG000|Overall Study|Lost to Follow-up|1|||
124512093|NCT02513771|447827333|FG001|Overall Study|Lost to Follow-up|1|||
124512094|NCT02513771|447827332|FG000|Overall Study|Not being able to get to clinic|1|||
124512095|NCT02513771|447827333|FG001|Overall Study|Not being able to get to clinic|0|||
124512096|NCT01797445|447827334|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
124512097|NCT01797445|447827335|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
124567223|NCT00770315|448033731|FG000|Overall Study|Withdrawal by Subject|13|||
124567224|NCT00770315|448033732|FG001|Overall Study|Withdrawal by Subject|17|||
124567225|NCT00770315|448033733|FG002|Overall Study|Withdrawal by Subject|24|||
124512098|NCT01797445|447827334|FG000|Double-Blind Phase|Adverse Event|3|||
124512099|NCT01797445|447827335|FG001|Double-Blind Phase|Adverse Event|0|||
124512100|NCT01797445|447827334|FG000|Double-Blind Phase|Death|5|||
124512101|NCT01797445|447827335|FG001|Double-Blind Phase|Death|4|||
124512102|NCT01797445|447827334|FG000|Double-Blind Phase|Pregnancy|0|||
124512103|NCT01797445|447827335|FG001|Double-Blind Phase|Pregnancy|1|||
124512104|NCT01797445|447827334|FG000|Double-Blind Phase|Lack of Efficacy|1|||
124512105|NCT01797445|447827335|FG001|Double-Blind Phase|Lack of Efficacy|2|||
124512106|NCT01797445|447827334|FG000|Double-Blind Phase|Investigator's Discretion|15|||
124567226|NCT00770315|448033734|FG003|Overall Study|Withdrawal by Subject|20|||
124567227|NCT00770315|448033731|FG000|Overall Study|Noncompliance with Protocol|7|||
124567228|NCT00770315|448033732|FG001|Overall Study|Noncompliance with Protocol|4|||
124567229|NCT00770315|448033733|FG002|Overall Study|Noncompliance with Protocol|7|||
124512107|NCT01797445|447827335|FG001|Double-Blind Phase|Investigator's Discretion|17|||
124512108|NCT01797445|447827334|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
124512109|NCT01797445|447827335|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
124512110|NCT01797445|447827334|FG000|Double-Blind Phase|Protocol Violation|0|||
124512111|NCT01797445|447827335|FG001|Double-Blind Phase|Protocol Violation|1|||
124512112|NCT01797445|447827334|FG000|Double-Blind Phase|Withdrew Consent|20|||
124512113|NCT01797445|447827335|FG001|Double-Blind Phase|Withdrew Consent|35|||
124512114|NCT01797445|447827334|FG000|Double-Blind Phase|Lost to Follow-up|34|||
124512115|NCT01797445|447827335|FG001|Double-Blind Phase|Lost to Follow-up|26|||
124567230|NCT00770315|448033734|FG003|Overall Study|Noncompliance with Protocol|9|||
124567231|NCT02683187|448033735|FG000|Overall Study|Failed IV access|3|||
124567232|NCT02683187|448033735|FG000|Overall Study|Withdrawal by Subject|5|||
124567233|NCT02585258|448033736|FG000|Overall Study|Adverse Event|28|||
124567234|NCT02585258|448033737|FG001|Overall Study|Adverse Event|29|||
124567235|NCT02585258|448033736|FG000|Overall Study|Death|3|||
124567236|NCT02585258|448033737|FG001|Overall Study|Death|2|||
124567237|NCT02585258|448033736|FG000|Overall Study|Lack of Efficacy|7|||
124567238|NCT02585258|448033737|FG001|Overall Study|Lack of Efficacy|9|||
124567239|NCT02585258|448033736|FG000|Overall Study|includes covid-related access problems|42|||
124567240|NCT02585258|448033737|FG001|Overall Study|includes covid-related access problems|46|||
124567241|NCT02585258|448033736|FG000|Overall Study|Lost to Follow-up|5|||
124567242|NCT02585258|448033737|FG001|Overall Study|Lost to Follow-up|2|||
124567243|NCT03702621|448036235|FG000|Overall Study|Physician Decision|6|||
124567244|NCT03702621|448036236|FG001|Overall Study|Physician Decision|6|||
124567245|NCT03194464|448036238|FG000|Overall Study|data not usable|2|||
124567246|NCT03103100|448036239|FG000|Overall Study|Adverse Event|1|||
124567247|NCT03103100|448036240|FG001|Overall Study|Adverse Event|0|||
124567248|NCT03103100|448036241|FG002|Overall Study|Adverse Event|0|||
124567249|NCT03103100|448036239|FG000|Overall Study|Physician Decision|1|||
124567250|NCT03103100|448036240|FG001|Overall Study|Physician Decision|0|||
124567251|NCT03103100|448036241|FG002|Overall Study|Physician Decision|2|||
124567252|NCT00436007|448036244|FG000|Overall Study|Withdrawal by Subject|5|||
124567253|NCT00436007|448036245|FG001|Overall Study|Withdrawal by Subject|3|||
124567254|NCT00436007|448036246|FG002|Overall Study|Withdrawal by Subject|4|||
124567255|NCT00436007|448036244|FG000|Overall Study|Lost to Follow-up|14|||
124567256|NCT00436007|448036245|FG001|Overall Study|Lost to Follow-up|10|||
124567257|NCT00436007|448036246|FG002|Overall Study|Lost to Follow-up|13|||
124567258|NCT00436007|448036244|FG000|Overall Study|Physician Decision|0|||
124567259|NCT00436007|448036245|FG001|Overall Study|Physician Decision|0|||
124567260|NCT00436007|448036246|FG002|Overall Study|Physician Decision|2|||
124567261|NCT00436007|448036244|FG000|Overall Study|Death|0|||
124567262|NCT00436007|448036245|FG001|Overall Study|Death|1|||
124567263|NCT00436007|448036246|FG002|Overall Study|Death|3|||
124567264|NCT00436007|448036244|FG000|Overall Study|Other|0|||
124567265|NCT00436007|448036245|FG001|Overall Study|Other|0|||
124567266|NCT00436007|448036246|FG002|Overall Study|Other|1|||
124567267|NCT00810368|448036247|FG000|Overall Study|Lost to Follow-up|4|||
124567268|NCT00810368|448036248|FG001|Overall Study|Lost to Follow-up|2|||
124567269|NCT00810368|448036247|FG000|Overall Study|Lack of Efficacy|2|||
124567270|NCT00810368|448036248|FG001|Overall Study|Lack of Efficacy|0|||
124567271|NCT03331042|448036249|FG000|Overall Study|Protocol Violation|1|||
124567272|NCT03331042|448036250|FG001|Overall Study|Protocol Violation|0|||
124567273|NCT03331042|448036251|FG002|Overall Study|Protocol Violation|0|||
124567274|NCT03331042|448036252|FG003|Overall Study|Protocol Violation|0|||
124567275|NCT03331042|448036249|FG000|Overall Study|Physician Decision|0|||
124567276|NCT03331042|448036250|FG001|Overall Study|Physician Decision|0|||
124567277|NCT03331042|448036251|FG002|Overall Study|Physician Decision|1|||
124567278|NCT03331042|448036252|FG003|Overall Study|Physician Decision|0|||
124512116|NCT01797445|447827334|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
124512117|NCT01797445|447827335|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
124512118|NCT01595438|447827336|FG000|Overall Study|Lost to Follow-up|20|||
124567279|NCT03331042|448036249|FG000|Overall Study|Lost to Follow-up|0|||
124567280|NCT03331042|448036250|FG001|Overall Study|Lost to Follow-up|0|||
124567281|NCT03331042|448036251|FG002|Overall Study|Lost to Follow-up|0|||
124512119|NCT01595438|447827337|FG001|Overall Study|Lost to Follow-up|20|||
124512120|NCT01595438|447827336|FG000|Overall Study|Withdrawal by Subject|12|||
124567282|NCT03331042|448036252|FG003|Overall Study|Lost to Follow-up|1|||
124567283|NCT00720096|448036257|FG000|Overall Study|Withdrawal by Subject|0|||
124567284|NCT00720096|448036258|FG001|Overall Study|Withdrawal by Subject|2|||
124567285|NCT00524459|448036259|FG000|Overall Study|Withdrawal by Subject|1|||
124567286|NCT00524459|448036259|FG000|Overall Study|Other|1|||
124567287|NCT02428699|448036260|FG000|Washout Period 1|Screen Failure|1|||
124567288|NCT02428699|448036261|FG001|Washout Period 1|Screen Failure|2|||
124567289|NCT01574248|448036264|FG000|Overall Study|Withdrawal by Subject|2|||
124567290|NCT01574248|448036265|FG001|Overall Study|Withdrawal by Subject|0|||
124567291|NCT01574248|448036264|FG000|Overall Study|Missing primary endpoint data|1|||
124567292|NCT01574248|448036265|FG001|Overall Study|Missing primary endpoint data|0|||
124567293|NCT01781286|448036268|FG000|Overall Study|Lost to Follow-up|0|||
124512121|NCT01595438|447827337|FG001|Overall Study|Withdrawal by Subject|12|||
124512122|NCT01595438|447827336|FG000|Overall Study|Other Eligibility criteria|11|||
124512123|NCT01595438|447827337|FG001|Overall Study|Other Eligibility criteria|9|||
124512124|NCT04116073|447827340|FG000|Overall Study|Withdrawal by Subject|2|||
124512125|NCT04116073|447827340|FG000|Overall Study|failed to maintained eligibility|1|||
124512126|NCT04190186|447827347|FG000|Overall Study|ILR is no longer functioning|0|||
124512127|NCT04190186|447827348|FG001|Overall Study|ILR is no longer functioning|1|||
124512128|NCT04190186|447827347|FG000|Overall Study|Lost to Follow-up|0|||
124512129|NCT04190186|447827348|FG001|Overall Study|Lost to Follow-up|1|||
124512130|NCT04190186|447827347|FG000|Overall Study|Withdrawal by Subject|2|||
124512131|NCT04190186|447827348|FG001|Overall Study|Withdrawal by Subject|0|||
124512132|NCT04190186|447827347|FG000|Overall Study|Subject choice to explant|1|||
124512133|NCT04190186|447827348|FG001|Overall Study|Subject choice to explant|0|||
124512134|NCT04190186|447827347|FG000|Overall Study|Physician Decision|0|||
124512135|NCT04190186|447827348|FG001|Overall Study|Physician Decision|1|||
124512136|NCT04190186|447827347|FG000|Overall Study|Study was stopped|4|||
124512137|NCT04190186|447827348|FG001|Overall Study|Study was stopped|5|||
124512138|NCT00618995|447827353|FG000|Period 1|Adverse Event|0|||
124512139|NCT00618995|447827354|FG001|Period 1|Adverse Event|0|||
124512140|NCT00618995|447827355|FG002|Period 1|Adverse Event|1|||
124512141|NCT00618995|447827356|FG003|Period 1|Adverse Event|0|||
124512142|NCT00618995|447827353|FG000|Period 1|Protocol Violation|0|||
124512143|NCT00618995|447827354|FG001|Period 1|Protocol Violation|1|||
124512144|NCT00618995|447827355|FG002|Period 1|Protocol Violation|1|||
124512145|NCT00618995|447827356|FG003|Period 1|Protocol Violation|0|||
124512146|NCT00618995|447827353|FG000|Period 2|Protocol Violation|0|||
124512147|NCT00618995|447827354|FG001|Period 2|Protocol Violation|0|||
124512148|NCT00618995|447827355|FG002|Period 2|Protocol Violation|1|||
124512149|NCT00618995|447827356|FG003|Period 2|Protocol Violation|0|||
124512150|NCT00618995|447827353|FG000|Period 4|Adverse Event|1|||
124512151|NCT00618995|447827354|FG001|Period 4|Adverse Event|0|||
124512152|NCT00618995|447827355|FG002|Period 4|Adverse Event|0|||
124512153|NCT00618995|447827356|FG003|Period 4|Adverse Event|0|||
124512154|NCT02677220|447827366|FG000|Overall Study|Adverse Event|1|||
124512155|NCT00965146|447827367|FG000|Overall Study|Death|7|||
124512156|NCT00965146|447827367|FG000|Overall Study|Lost to Follow-up|22|||
124512157|NCT00965146|447827367|FG000|Overall Study|Withdrawal by Subject|17|||
124512158|NCT00965146|447827367|FG000|Overall Study|Unable to return|1|||
124512159|NCT00965146|447827367|FG000|Overall Study|Unwilling to return|11|||
124512160|NCT00965146|447827367|FG000|Overall Study|Intercurrent illness|1|||
124512161|NCT00965146|447827367|FG000|Overall Study|Revision / Removal of Study Implant|6|||
124512162|NCT00965146|447827367|FG000|Overall Study|Overall Study Termination|145|||
124512163|NCT01181102|447827368|FG000|Overall Study|Adverse Event|28|||
124512164|NCT01181102|447827369|FG001|Overall Study|Adverse Event|26|||
124512165|NCT01181102|447827368|FG000|Overall Study|Lack of Efficacy|3|||
124512166|NCT01181102|447827369|FG001|Overall Study|Lack of Efficacy|1|||
124512167|NCT01181102|447827368|FG000|Overall Study|Lost to Follow-up|2|||
124512168|NCT01181102|447827369|FG001|Overall Study|Lost to Follow-up|0|||
124512169|NCT01181102|447827368|FG000|Overall Study|Physician Decision|3|||
124512170|NCT01181102|447827369|FG001|Overall Study|Physician Decision|1|||
124512171|NCT01181102|447827368|FG000|Overall Study|Protocol Violation|5|||
124512172|NCT01181102|447827369|FG001|Overall Study|Protocol Violation|6|||
124512173|NCT01181102|447827368|FG000|Overall Study|Withdrawal by Subject|10|||
124512174|NCT01181102|447827369|FG001|Overall Study|Withdrawal by Subject|12|||
124512175|NCT01309841|447827378|FG000|Overall Study|Other|0|||
124512176|NCT01309841|447827379|FG001|Overall Study|Other|1|||
124567294|NCT01781286|448036269|FG001|Overall Study|Lost to Follow-up|0|||
124567295|NCT01781286|448036270|FG002|Overall Study|Lost to Follow-up|0|||
124567296|NCT01781286|448036271|FG003|Overall Study|Lost to Follow-up|0|||
124567297|NCT01781286|448036272|FG004|Overall Study|Lost to Follow-up|0|||
124567298|NCT01781286|448036273|FG005|Overall Study|Lost to Follow-up|1|||
124512177|NCT01309841|447827380|FG002|Overall Study|Other|1|||
124567299|NCT01781286|448036268|FG000|Overall Study|Time Constraints|2|||
124567300|NCT01781286|448036269|FG001|Overall Study|Time Constraints|0|||
124567301|NCT01781286|448036270|FG002|Overall Study|Time Constraints|2|||
124512178|NCT01309841|447827378|FG000|Overall Study|Lost to Follow-up|7|||
124512179|NCT01309841|447827379|FG001|Overall Study|Lost to Follow-up|6|||
124512180|NCT01309841|447827380|FG002|Overall Study|Lost to Follow-up|4|||
124512181|NCT01309841|447827378|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
124512182|NCT01309841|447827379|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
124512183|NCT01309841|447827380|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
124512184|NCT01309841|447827378|FG000|Overall Study|Lack of Efficacy|0|||
124512185|NCT01309841|447827379|FG001|Overall Study|Lack of Efficacy|0|||
124512186|NCT01309841|447827380|FG002|Overall Study|Lack of Efficacy|2|||
124512187|NCT01309841|447827378|FG000|Overall Study|Adverse Event|9|||
124512188|NCT01309841|447827379|FG001|Overall Study|Adverse Event|22|||
124512189|NCT01309841|447827380|FG002|Overall Study|Adverse Event|11|||
124512190|NCT01309841|447827378|FG000|Overall Study|Death|1|||
124512191|NCT01309841|447827379|FG001|Overall Study|Death|0|||
124567302|NCT01781286|448036271|FG003|Overall Study|Time Constraints|0|||
124567303|NCT01781286|448036272|FG004|Overall Study|Time Constraints|0|||
124567304|NCT01781286|448036273|FG005|Overall Study|Time Constraints|0|||
124567305|NCT01781286|448036268|FG000|Overall Study|Noncompliance|0|||
124567306|NCT01781286|448036269|FG001|Overall Study|Noncompliance|0|||
124567307|NCT01781286|448036270|FG002|Overall Study|Noncompliance|0|||
124567308|NCT01781286|448036271|FG003|Overall Study|Noncompliance|1|||
124567309|NCT01781286|448036272|FG004|Overall Study|Noncompliance|0|||
124567310|NCT01781286|448036273|FG005|Overall Study|Noncompliance|0|||
124567311|NCT00995410|448036274|FG000|Overall Study|Adverse Event|51|||
124567312|NCT00995410|448036274|FG000|Overall Study|Withdrawal by Subject|7|||
124567313|NCT00995410|448036274|FG000|Overall Study|Lost to Follow-up|2|||
124567314|NCT00995410|448036274|FG000|Overall Study|Misc|28|||
124567315|NCT03594123|448036275|FG000|Overall Study|Lost to Follow-up|0|||
124567316|NCT03594123|448036276|FG001|Overall Study|Lost to Follow-up|1|||
124567317|NCT03594123|448036275|FG000|Overall Study|Adverse Event|8|||
124567318|NCT03594123|448036276|FG001|Overall Study|Adverse Event|5|||
124567319|NCT03594123|448036275|FG000|Overall Study|Site Terminated by Sponsor|4|||
124567320|NCT03594123|448036276|FG001|Overall Study|Site Terminated by Sponsor|1|||
124567321|NCT03594123|448036275|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
124567322|NCT03594123|448036276|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
124567323|NCT03594123|448036275|FG000|Overall Study|Lack of Efficacy|1|||
124567324|NCT03594123|448036276|FG001|Overall Study|Lack of Efficacy|0|||
124567325|NCT03594123|448036275|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
124567326|NCT03594123|448036276|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
124567327|NCT02483975|448036277|FG000|Overall Study|Adverse Event|0|||
124567328|NCT02483975|448036278|FG001|Overall Study|Adverse Event|1|||
124567329|NCT02483975|448036277|FG000|Overall Study|Lost to Follow-up|0|||
124567330|NCT02483975|448036278|FG001|Overall Study|Lost to Follow-up|1|||
124567331|NCT02483975|448036277|FG000|Overall Study|Physician Decision|2|||
124567332|NCT02483975|448036278|FG001|Overall Study|Physician Decision|0|||
124567333|NCT03365375|448036279|FG000|Overall Study|Withdrawal by Subject|0|||
124567334|NCT03365375|448036280|FG001|Overall Study|Withdrawal by Subject|1|||
124567335|NCT03365375|448036279|FG000|Overall Study|Lost to Follow-up|0|||
124567336|NCT03365375|448036280|FG001|Overall Study|Lost to Follow-up|4|||
124567337|NCT03992196|448036281|FG000|Enrollment|lost to follow-up prior dosing|1|||
124567338|NCT03992196|448036282|FG001|Enrollment|lost to follow-up prior dosing|0|||
124567339|NCT03992196|448036283|FG002|Enrollment|lost to follow-up prior dosing|0|||
124567340|NCT03992196|448036281|FG000|Treatment|Protocol Violation|0|||
124567341|NCT03992196|448036282|FG001|Treatment|Protocol Violation|0|||
124567342|NCT03992196|448036283|FG002|Treatment|Protocol Violation|1|||
124567343|NCT03992196|448036281|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
124567344|NCT03992196|448036282|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
124567345|NCT03992196|448036283|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
124567346|NCT03992196|448036281|FG000|Treatment|Withdrawal due to non-compliance|0|||
124567347|NCT03992196|448036282|FG001|Treatment|Withdrawal due to non-compliance|0|||
124567348|NCT03992196|448036283|FG002|Treatment|Withdrawal due to non-compliance|1|||
124567349|NCT03992196|448036281|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
124567350|NCT03992196|448036282|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
124567351|NCT03992196|448036283|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
124567352|NCT03992196|448036281|FG000|Treatment|Withdrawal by parent/guardian|0|||
124567353|NCT03992196|448036282|FG001|Treatment|Withdrawal by parent/guardian|0|||
124567354|NCT03992196|448036283|FG002|Treatment|Withdrawal by parent/guardian|2|||
124567355|NCT02684578|448036284|FG000|Overall Study|Withdrawal by Subject|10|||
124567356|NCT02684578|448036285|FG001|Overall Study|Withdrawal by Subject|7|||
124567357|NCT02684578|448036284|FG000|Overall Study|Lost to Follow-up|0|||
124567358|NCT02684578|448036285|FG001|Overall Study|Lost to Follow-up|3|||
124567359|NCT02684578|448036284|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
124567360|NCT02684578|448036285|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
124567361|NCT02684578|448036284|FG000|Overall Study|Missing follow-up data|0|||
124567362|NCT02684578|448036285|FG001|Overall Study|Missing follow-up data|1|||
124567363|NCT01505530|448036286|FG000|Overall Study|Progressive Disease|19|||
124567364|NCT01505530|448036287|FG001|Overall Study|Progressive Disease|17|||
124567365|NCT01505530|448036288|FG002|Overall Study|Progressive Disease|18|||
124567366|NCT01505530|448036286|FG000|Overall Study|Adverse Event|1|||
124567367|NCT01505530|448036287|FG001|Overall Study|Adverse Event|1|||
124567368|NCT01505530|448036288|FG002|Overall Study|Adverse Event|0|||
124567369|NCT01505530|448036286|FG000|Overall Study|Withdrawal by Subject|7|||
124567370|NCT01505530|448036287|FG001|Overall Study|Withdrawal by Subject|8|||
124567371|NCT01505530|448036288|FG002|Overall Study|Withdrawal by Subject|6|||
124567372|NCT01505530|448036286|FG000|Overall Study|Physician Decision|6|||
124567373|NCT01505530|448036287|FG001|Overall Study|Physician Decision|2|||
124567374|NCT01505530|448036288|FG002|Overall Study|Physician Decision|5|||
124567375|NCT01505530|448036286|FG000|Overall Study|Sponsor Decision|1|||
124567376|NCT01505530|448036287|FG001|Overall Study|Sponsor Decision|8|||
124567377|NCT01505530|448036288|FG002|Overall Study|Sponsor Decision|7|||
124567378|NCT01505530|448036286|FG000|Overall Study|Death|7|||
124567379|NCT01505530|448036287|FG001|Overall Study|Death|6|||
124567380|NCT01505530|448036288|FG002|Overall Study|Death|5|||
124567381|NCT01505530|448036286|FG000|Overall Study|entry criteria not met|0|||
124567382|NCT01505530|448036287|FG001|Overall Study|entry criteria not met|1|||
124567383|NCT01505530|448036288|FG002|Overall Study|entry criteria not met|0|||
124567384|NCT02492958|448036292|FG000|Overall Study|Withdrawal by Subject|0|||
124567385|NCT02492958|448036293|FG001|Overall Study|Withdrawal by Subject|0|||
124567386|NCT02492958|448036294|FG002|Overall Study|Withdrawal by Subject|1|||
124567387|NCT02492958|448036295|FG003|Overall Study|Withdrawal by Subject|0|||
124567388|NCT02492958|448036292|FG000|Overall Study|Adverse Event|1|||
124567389|NCT02492958|448036293|FG001|Overall Study|Adverse Event|0|||
124567390|NCT02492958|448036294|FG002|Overall Study|Adverse Event|1|||
124567391|NCT02492958|448036295|FG003|Overall Study|Adverse Event|0|||
124567392|NCT01193608|448036296|FG000|Overall Study|Other|0|||
124567393|NCT01193608|448036297|FG001|Overall Study|Other|1|||
124567394|NCT01193608|448036298|FG002|Overall Study|Other|0|||
124567395|NCT01193608|448036299|FG003|Overall Study|Other|0|||
124567396|NCT01193608|448036300|FG004|Overall Study|Other|0|||
124567397|NCT01193608|448036301|FG005|Overall Study|Other|0|||
124567398|NCT01193608|448036296|FG000|Overall Study|Withdrawal by Subject|0|||
124567399|NCT01193608|448036297|FG001|Overall Study|Withdrawal by Subject|1|||
124567400|NCT01193608|448036298|FG002|Overall Study|Withdrawal by Subject|2|||
124512192|NCT01309841|447827380|FG002|Overall Study|Death|0|||
124512193|NCT01309841|447827378|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
124512194|NCT01309841|447827379|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
124512195|NCT01309841|447827380|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
124512196|NCT01309841|447827378|FG000|Overall Study|Withdrawal by Subject|17|||
124512197|NCT01309841|447827379|FG001|Overall Study|Withdrawal by Subject|6|||
124512198|NCT01309841|447827380|FG002|Overall Study|Withdrawal by Subject|13|||
124512199|NCT01309841|447827378|FG000|Overall Study|Did Not Receive Treatment|2|||
124512200|NCT01309841|447827379|FG001|Overall Study|Did Not Receive Treatment|0|||
124512201|NCT01309841|447827380|FG002|Overall Study|Did Not Receive Treatment|1|||
124512202|NCT01309841|447827378|FG000|Overall Study|Severe non-compliance with protocol|0|||
124512203|NCT01309841|447827379|FG001|Overall Study|Severe non-compliance with protocol|5|||
124512204|NCT01309841|447827380|FG002|Overall Study|Severe non-compliance with protocol|2|||
124512205|NCT00050960|447827381|FG000|Overall Study|Progressive Disease|137|||
124512206|NCT00050960|447827382|FG001|Overall Study|Progressive Disease|93|||
124512207|NCT00050960|447827381|FG000|Overall Study|Stable Disease|19|||
124512208|NCT00050960|447827382|FG001|Overall Study|Stable Disease|48|||
124512209|NCT00050960|447827381|FG000|Overall Study|Partial Response|14|||
124512210|NCT00050960|447827382|FG001|Overall Study|Partial Response|19|||
124512211|NCT00050960|447827381|FG000|Overall Study|Complete Response|0|||
124512212|NCT00050960|447827382|FG001|Overall Study|Complete Response|2|||
124512213|NCT00050960|447827381|FG000|Overall Study|Adverse Event|62|||
124512214|NCT00050960|447827382|FG001|Overall Study|Adverse Event|61|||
124512215|NCT00050960|447827381|FG000|Overall Study|Lost to Follow-up|0|||
124512216|NCT00050960|447827382|FG001|Overall Study|Lost to Follow-up|1|||
124512217|NCT00050960|447827381|FG000|Overall Study|Withdrawal by Subject|23|||
124512218|NCT00050960|447827382|FG001|Overall Study|Withdrawal by Subject|18|||
124512219|NCT00050960|447827381|FG000|Overall Study|Administrative|31|||
124512220|NCT00050960|447827382|FG001|Overall Study|Administrative|46|||
124512221|NCT00050960|447827381|FG000|Overall Study|Non-compliance|3|||
124512222|NCT00050960|447827382|FG001|Overall Study|Non-compliance|1|||
124512223|NCT00050960|447827381|FG000|Overall Study|Death|13|||
124512224|NCT00050960|447827382|FG001|Overall Study|Death|15|||
124512225|NCT04311177|447827385|FG000|Overall Study|Adverse Event|3|||
124512226|NCT04311177|447827386|FG001|Overall Study|Adverse Event|1|||
124512227|NCT04311177|447827385|FG000|Overall Study|Physician Decision|4|||
124512228|NCT04311177|447827386|FG001|Overall Study|Physician Decision|3|||
124512229|NCT04311177|447827385|FG000|Overall Study|Withdrawal by Subject|1|||
124512230|NCT04311177|447827386|FG001|Overall Study|Withdrawal by Subject|0|||
124512231|NCT00413062|447827389|FG000|Overall Study|Adverse event/serious adverse event|289|||
124512232|NCT00413062|447827390|FG001|Overall Study|Adverse event/serious adverse event|56|||
124512233|NCT00413062|447827389|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
124512234|NCT00413062|447827390|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
124512235|NCT00413062|447827389|FG000|Overall Study|Withdrawal of informed consent|111|||
124512236|NCT00413062|447827390|FG001|Overall Study|Withdrawal of informed consent|36|||
124512237|NCT00413062|447827389|FG000|Overall Study|Pregnancy|15|||
124567401|NCT01193608|448036299|FG003|Overall Study|Withdrawal by Subject|3|||
124567402|NCT01193608|448036300|FG004|Overall Study|Withdrawal by Subject|3|||
124512238|NCT00413062|447827390|FG001|Overall Study|Pregnancy|5|||
124512239|NCT00413062|447827389|FG000|Overall Study|Pregnancy wish|17|||
124512240|NCT00413062|447827390|FG001|Overall Study|Pregnancy wish|6|||
124512241|NCT00413062|447827389|FG000|Overall Study|Lost to Follow-up|175|||
124512242|NCT00413062|447827390|FG001|Overall Study|Lost to Follow-up|73|||
124512243|NCT00413062|447827389|FG000|Overall Study|Other reason|70|||
124512244|NCT00413062|447827390|FG001|Overall Study|Other reason|34|||
124567403|NCT01193608|448036301|FG005|Overall Study|Withdrawal by Subject|0|||
124512245|NCT02815293|447827393|FG000|Overall Study|Study termination by sponsor|10|||
124512246|NCT02815293|447827394|FG001|Overall Study|Study termination by sponsor|7|||
124512247|NCT02815293|447827395|FG002|Overall Study|Study termination by sponsor|0|||
124512248|NCT02815293|447827393|FG000|Overall Study|Participants not randomized|0|||
124512249|NCT02815293|447827394|FG001|Overall Study|Participants not randomized|0|||
124512250|NCT02815293|447827395|FG002|Overall Study|Participants not randomized|18|||
124512251|NCT02815293|447827393|FG000|Overall Study|Adverse Event|0|||
124512252|NCT02815293|447827394|FG001|Overall Study|Adverse Event|1|||
124512253|NCT02815293|447827395|FG002|Overall Study|Adverse Event|0|||
124512254|NCT00006604|447827396|FG000|Overall Study|Met study objective - no further FU|1|||
124512255|NCT00006604|447827397|FG001|Overall Study|Met study objective - no further FU|0|||
124512256|NCT00006604|447827398|FG002|Overall Study|Met study objective - no further FU|0|||
124512257|NCT00006604|447827399|FG003|Overall Study|Met study objective - no further FU|0|||
124512258|NCT00006604|447827400|FG004|Overall Study|Met study objective - no further FU|0|||
124512259|NCT00006604|447827401|FG005|Overall Study|Met study objective - no further FU|0|||
124512260|NCT00006604|447827402|FG006|Overall Study|Met study objective - no further FU|0|||
124512261|NCT00006604|447827403|FG007|Overall Study|Met study objective - no further FU|0|||
124512262|NCT00006604|447827404|FG008|Overall Study|Met study objective - no further FU|0|||
124512263|NCT00006604|447827405|FG009|Overall Study|Met study objective - no further FU|0|||
124512264|NCT00006604|447827406|FG010|Overall Study|Met study objective - no further FU|0|||
124512265|NCT00006604|447827407|FG011|Overall Study|Met study objective - no further FU|0|||
124512266|NCT00006604|447827408|FG012|Overall Study|Met study objective - no further FU|0|||
124512267|NCT00006604|447827409|FG013|Overall Study|Met study objective - no further FU|0|||
124512268|NCT00006604|447827410|FG014|Overall Study|Met study objective - no further FU|1|||
124512269|NCT00006604|447827411|FG015|Overall Study|Met study objective - no further FU|1|||
124512270|NCT00006604|447827412|FG016|Overall Study|Met study objective - no further FU|0|||
124512271|NCT00006604|447827396|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
124512272|NCT00006604|447827397|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
124512273|NCT00006604|447827398|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
124512274|NCT00006604|447827399|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
124512275|NCT00006604|447827400|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
124512276|NCT00006604|447827401|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
124512277|NCT00006604|447827402|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
124512278|NCT00006604|447827403|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
124512279|NCT00006604|447827404|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
124512280|NCT00006604|447827405|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
124512281|NCT00006604|447827406|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
124512282|NCT00006604|447827407|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
124512283|NCT00006604|447827408|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
124512284|NCT00006604|447827409|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
124512285|NCT00006604|447827410|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
124512286|NCT00006604|447827411|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
124512287|NCT00006604|447827412|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
124512288|NCT00006604|447827396|FG000|Overall Study|Death|0|||
124512289|NCT00006604|447827397|FG001|Overall Study|Death|0|||
124512290|NCT00006604|447827398|FG002|Overall Study|Death|0|||
124512291|NCT00006604|447827399|FG003|Overall Study|Death|0|||
124512292|NCT00006604|447827400|FG004|Overall Study|Death|0|||
124512293|NCT00006604|447827401|FG005|Overall Study|Death|0|||
124512294|NCT00006604|447827402|FG006|Overall Study|Death|0|||
124512295|NCT00006604|447827403|FG007|Overall Study|Death|0|||
124512296|NCT00006604|447827404|FG008|Overall Study|Death|0|||
124512297|NCT00006604|447827405|FG009|Overall Study|Death|1|||
124512298|NCT00006604|447827406|FG010|Overall Study|Death|1|||
124512299|NCT00006604|447827407|FG011|Overall Study|Death|1|||
124512300|NCT00006604|447827408|FG012|Overall Study|Death|0|||
124512301|NCT00006604|447827409|FG013|Overall Study|Death|0|||
124512302|NCT00006604|447827410|FG014|Overall Study|Death|0|||
124512303|NCT00006604|447827411|FG015|Overall Study|Death|0|||
124512304|NCT00006604|447827412|FG016|Overall Study|Death|0|||
124512305|NCT00006604|447827396|FG000|Overall Study|Severe debilitation, unable to continue|0|||
124512306|NCT00006604|447827397|FG001|Overall Study|Severe debilitation, unable to continue|0|||
124512307|NCT00006604|447827398|FG002|Overall Study|Severe debilitation, unable to continue|0|||
124512308|NCT00006604|447827399|FG003|Overall Study|Severe debilitation, unable to continue|0|||
124512309|NCT00006604|447827400|FG004|Overall Study|Severe debilitation, unable to continue|0|||
124512310|NCT00006604|447827401|FG005|Overall Study|Severe debilitation, unable to continue|0|||
124512311|NCT00006604|447827402|FG006|Overall Study|Severe debilitation, unable to continue|3|||
124512312|NCT00006604|447827403|FG007|Overall Study|Severe debilitation, unable to continue|0|||
124512313|NCT00006604|447827404|FG008|Overall Study|Severe debilitation, unable to continue|0|||
124512314|NCT00006604|447827405|FG009|Overall Study|Severe debilitation, unable to continue|5|||
124512315|NCT00006604|447827406|FG010|Overall Study|Severe debilitation, unable to continue|0|||
124512316|NCT00006604|447827407|FG011|Overall Study|Severe debilitation, unable to continue|2|||
124567404|NCT01193608|448036296|FG000|Overall Study|Lost to Follow-up|0|||
124567405|NCT01193608|448036297|FG001|Overall Study|Lost to Follow-up|0|||
124567406|NCT01193608|448036298|FG002|Overall Study|Lost to Follow-up|0|||
124567407|NCT01193608|448036299|FG003|Overall Study|Lost to Follow-up|0|||
124567408|NCT01193608|448036300|FG004|Overall Study|Lost to Follow-up|1|||
124567409|NCT01193608|448036301|FG005|Overall Study|Lost to Follow-up|2|||
124567410|NCT01193608|448036296|FG000|Overall Study|Adverse Event|0|||
124567411|NCT01193608|448036297|FG001|Overall Study|Adverse Event|0|||
124567412|NCT01193608|448036298|FG002|Overall Study|Adverse Event|0|||
124567413|NCT01193608|448036299|FG003|Overall Study|Adverse Event|0|||
124567414|NCT01193608|448036300|FG004|Overall Study|Adverse Event|1|||
124567415|NCT01193608|448036301|FG005|Overall Study|Adverse Event|0|||
124567416|NCT00266409|448036302|FG000|Overall Study|Lack of Efficacy|2|||
124567417|NCT00266409|448036303|FG001|Overall Study|Lack of Efficacy|6|||
124567418|NCT00266409|448036304|FG002|Overall Study|Lack of Efficacy|1|||
124567419|NCT00266409|448036305|FG003|Overall Study|Lack of Efficacy|2|||
124567420|NCT00266409|448036302|FG000|Overall Study|Adverse Event|7|||
124567421|NCT00266409|448036303|FG001|Overall Study|Adverse Event|2|||
124567422|NCT00266409|448036304|FG002|Overall Study|Adverse Event|1|||
124567423|NCT00266409|448036305|FG003|Overall Study|Adverse Event|1|||
124567424|NCT00266409|448036302|FG000|Overall Study|Lost to Follow-up|18|||
124567425|NCT00266409|448036303|FG001|Overall Study|Lost to Follow-up|21|||
124567426|NCT00266409|448036304|FG002|Overall Study|Lost to Follow-up|6|||
124567427|NCT00266409|448036305|FG003|Overall Study|Lost to Follow-up|8|||
124567428|NCT00266409|448036302|FG000|Overall Study|Withdrawal by Subject|6|||
124567429|NCT00266409|448036303|FG001|Overall Study|Withdrawal by Subject|10|||
124567430|NCT00266409|448036304|FG002|Overall Study|Withdrawal by Subject|3|||
124567431|NCT00266409|448036305|FG003|Overall Study|Withdrawal by Subject|9|||
124567432|NCT00266409|448036302|FG000|Overall Study|Protocol Violation|5|||
124567433|NCT00266409|448036303|FG001|Overall Study|Protocol Violation|3|||
124567434|NCT00266409|448036304|FG002|Overall Study|Protocol Violation|4|||
124567435|NCT00266409|448036305|FG003|Overall Study|Protocol Violation|2|||
124567436|NCT00266409|448036302|FG000|Overall Study|Other|7|||
124567437|NCT00266409|448036303|FG001|Overall Study|Other|4|||
124567438|NCT00266409|448036304|FG002|Overall Study|Other|2|||
124567439|NCT00266409|448036305|FG003|Overall Study|Other|0|||
124567440|NCT00712010|448036306|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
124567441|NCT00635154|448036307|FG000|Overall Study|Alternative Treatment|8|||
124567442|NCT00635154|448036307|FG000|Overall Study|Other|4|||
124567443|NCT00635154|448036307|FG000|Overall Study|Still on treatment|21|||
124567444|NCT01399736|448036308|FG000|Overall Study|Withdrawal by Subject|4|||
124567445|NCT01399736|448036309|FG001|Overall Study|Withdrawal by Subject|2|||
124567446|NCT01399736|448036308|FG000|Overall Study|Lost to Follow-up|0|||
124567447|NCT01399736|448036309|FG001|Overall Study|Lost to Follow-up|2|||
124567448|NCT03500484|448036310|FG000|Overall Study|Adverse Event|2|||
124567449|NCT03500484|448036311|FG001|Overall Study|Adverse Event|0|||
124567450|NCT03500484|448036310|FG000|Overall Study|Physician Decision|1|||
124567451|NCT03500484|448036311|FG001|Overall Study|Physician Decision|0|||
124567452|NCT03500484|448036310|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
124567453|NCT03500484|448036311|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
124567454|NCT02795104|448036312|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
124567455|NCT02795104|448036313|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
124567456|NCT02795104|448036314|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
124567457|NCT02795104|448036312|FG000|Overall Study|Withdrawal by Subject|0|||
124567458|NCT02795104|448036313|FG001|Overall Study|Withdrawal by Subject|2|||
124567459|NCT02795104|448036314|FG002|Overall Study|Withdrawal by Subject|0|||
124567460|NCT02795104|448036312|FG000|Overall Study|Lost to Follow-up|0|||
124567461|NCT02795104|448036313|FG001|Overall Study|Lost to Follow-up|0|||
124567462|NCT02795104|448036314|FG002|Overall Study|Lost to Follow-up|1|||
124567463|NCT01089647|448036318|FG000|Overall Study|Lost to Follow-up|2|||
124567464|NCT01089647|448036319|FG001|Overall Study|Lost to Follow-up|2|||
124567465|NCT01089647|448036318|FG000|Overall Study|Withdrawal by Subject|2|||
124567466|NCT01089647|448036319|FG001|Overall Study|Withdrawal by Subject|1|||
124567467|NCT01089647|448036318|FG000|Overall Study|Adverse Event|0|||
124567468|NCT01089647|448036319|FG001|Overall Study|Adverse Event|1|||
124567469|NCT00995553|448036320|FG000|Overall Study|Withdrawal by Subject|2|||
124567470|NCT00995553|448036321|FG001|Overall Study|Withdrawal by Subject|6|||
124567471|NCT00927810|448036322|FG000|Overall Study|Withdrawal by Subject|0|||
124567472|NCT00927810|448036323|FG001|Overall Study|Withdrawal by Subject|3|||
124567473|NCT00927810|448036324|FG002|Overall Study|Withdrawal by Subject|0|||
124567474|NCT00927810|448036325|FG003|Overall Study|Withdrawal by Subject|1|||
124567475|NCT00927810|448036322|FG000|Overall Study|Lost to Follow-up|0|||
124567476|NCT00927810|448036323|FG001|Overall Study|Lost to Follow-up|2|||
124567477|NCT00927810|448036324|FG002|Overall Study|Lost to Follow-up|1|||
124567478|NCT00927810|448036325|FG003|Overall Study|Lost to Follow-up|1|||
124567479|NCT00927810|448036322|FG000|Overall Study|Death|0|||
124567480|NCT00927810|448036323|FG001|Overall Study|Death|2|||
124567481|NCT00927810|448036324|FG002|Overall Study|Death|0|||
124567482|NCT00927810|448036325|FG003|Overall Study|Death|0|||
124512317|NCT00006604|447827408|FG012|Overall Study|Severe debilitation, unable to continue|1|||
124512318|NCT00006604|447827409|FG013|Overall Study|Severe debilitation, unable to continue|0|||
124512319|NCT00006604|447827410|FG014|Overall Study|Severe debilitation, unable to continue|2|||
124512320|NCT00006604|447827411|FG015|Overall Study|Severe debilitation, unable to continue|0|||
124512321|NCT00006604|447827412|FG016|Overall Study|Severe debilitation, unable to continue|0|||
124512322|NCT00006604|447827396|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
124512323|NCT00006604|447827397|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
124512324|NCT00006604|447827398|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
124512325|NCT00006604|447827399|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
124512326|NCT00006604|447827400|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
124512327|NCT00006604|447827401|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
124512328|NCT00006604|447827402|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
124512329|NCT00006604|447827403|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
124512330|NCT00006604|447827404|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
124512331|NCT00006604|447827405|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
124512332|NCT00006604|447827406|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
124512333|NCT00006604|447827407|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
124512334|NCT00006604|447827408|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
124512335|NCT00006604|447827409|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
124512336|NCT00006604|447827410|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
124512337|NCT00006604|447827411|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
124512338|NCT00006604|447827412|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
124512339|NCT00006604|447827396|FG000|Overall Study|Site closing|0|||
124512340|NCT00006604|447827397|FG001|Overall Study|Site closing|0|||
124512341|NCT00006604|447827398|FG002|Overall Study|Site closing|1|||
124512342|NCT00006604|447827399|FG003|Overall Study|Site closing|1|||
124512343|NCT00006604|447827400|FG004|Overall Study|Site closing|0|||
124512344|NCT00006604|447827401|FG005|Overall Study|Site closing|0|||
124512345|NCT00006604|447827402|FG006|Overall Study|Site closing|0|||
124512346|NCT00006604|447827403|FG007|Overall Study|Site closing|1|||
124512347|NCT00006604|447827404|FG008|Overall Study|Site closing|0|||
124512348|NCT00006604|447827405|FG009|Overall Study|Site closing|0|||
124512349|NCT00006604|447827406|FG010|Overall Study|Site closing|0|||
124512350|NCT00006604|447827407|FG011|Overall Study|Site closing|1|||
124512351|NCT00006604|447827408|FG012|Overall Study|Site closing|1|||
124512352|NCT00006604|447827409|FG013|Overall Study|Site closing|1|||
124512353|NCT00006604|447827410|FG014|Overall Study|Site closing|0|||
124512354|NCT00006604|447827411|FG015|Overall Study|Site closing|0|||
124512355|NCT00006604|447827412|FG016|Overall Study|Site closing|1|||
124512356|NCT00006604|447827396|FG000|Overall Study|Withdrawal by Subject|1|||
124512357|NCT00006604|447827397|FG001|Overall Study|Withdrawal by Subject|0|||
124512358|NCT00006604|447827398|FG002|Overall Study|Withdrawal by Subject|2|||
124512359|NCT00006604|447827399|FG003|Overall Study|Withdrawal by Subject|0|||
124512360|NCT00006604|447827400|FG004|Overall Study|Withdrawal by Subject|1|||
124512361|NCT00006604|447827401|FG005|Overall Study|Withdrawal by Subject|2|||
124512362|NCT00006604|447827402|FG006|Overall Study|Withdrawal by Subject|2|||
124512363|NCT00006604|447827403|FG007|Overall Study|Withdrawal by Subject|0|||
124512364|NCT00006604|447827404|FG008|Overall Study|Withdrawal by Subject|1|||
124512365|NCT00006604|447827405|FG009|Overall Study|Withdrawal by Subject|3|||
124512366|NCT00006604|447827406|FG010|Overall Study|Withdrawal by Subject|2|||
124512367|NCT00006604|447827407|FG011|Overall Study|Withdrawal by Subject|0|||
124512368|NCT00006604|447827408|FG012|Overall Study|Withdrawal by Subject|1|||
124512369|NCT00006604|447827409|FG013|Overall Study|Withdrawal by Subject|2|||
124512370|NCT00006604|447827410|FG014|Overall Study|Withdrawal by Subject|1|||
124512371|NCT00006604|447827411|FG015|Overall Study|Withdrawal by Subject|0|||
124512372|NCT00006604|447827412|FG016|Overall Study|Withdrawal by Subject|1|||
124512373|NCT00006604|447827396|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
124512374|NCT00006604|447827397|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
124512375|NCT00006604|447827398|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
124512376|NCT00006604|447827399|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
124512377|NCT00006604|447827400|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
124512378|NCT00006604|447827401|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
124512379|NCT00006604|447827402|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
124512380|NCT00006604|447827403|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
124512381|NCT00006604|447827404|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
124512382|NCT00006604|447827405|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
124512383|NCT00006604|447827406|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
124512384|NCT00006604|447827407|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
124512385|NCT00006604|447827408|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
124512386|NCT00006604|447827409|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
124512387|NCT00006604|447827410|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
124512388|NCT00006604|447827411|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
124512389|NCT00006604|447827412|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
124512390|NCT00006604|447827396|FG000|Overall Study|Lost to Follow-up|0|||
124512391|NCT00006604|447827397|FG001|Overall Study|Lost to Follow-up|0|||
124512392|NCT00006604|447827398|FG002|Overall Study|Lost to Follow-up|0|||
124512393|NCT00006604|447827399|FG003|Overall Study|Lost to Follow-up|0|||
124512394|NCT00006604|447827400|FG004|Overall Study|Lost to Follow-up|0|||
124512395|NCT00006604|447827401|FG005|Overall Study|Lost to Follow-up|0|||
124512396|NCT00006604|447827402|FG006|Overall Study|Lost to Follow-up|0|||
124512397|NCT00006604|447827403|FG007|Overall Study|Lost to Follow-up|1|||
124512398|NCT00006604|447827404|FG008|Overall Study|Lost to Follow-up|0|||
124512399|NCT00006604|447827405|FG009|Overall Study|Lost to Follow-up|2|||
124512400|NCT00006604|447827406|FG010|Overall Study|Lost to Follow-up|0|||
124512401|NCT00006604|447827407|FG011|Overall Study|Lost to Follow-up|0|||
124512402|NCT00006604|447827408|FG012|Overall Study|Lost to Follow-up|0|||
124512403|NCT00006604|447827409|FG013|Overall Study|Lost to Follow-up|0|||
124512404|NCT00006604|447827410|FG014|Overall Study|Lost to Follow-up|0|||
124512405|NCT00006604|447827411|FG015|Overall Study|Lost to Follow-up|1|||
124512406|NCT00006604|447827412|FG016|Overall Study|Lost to Follow-up|3|||
124512407|NCT00006604|447827396|FG000|Overall Study|Other Reason|0|||
124512408|NCT00006604|447827397|FG001|Overall Study|Other Reason|0|||
124512409|NCT00006604|447827398|FG002|Overall Study|Other Reason|0|||
124512410|NCT00006604|447827399|FG003|Overall Study|Other Reason|0|||
124512411|NCT00006604|447827400|FG004|Overall Study|Other Reason|0|||
124512412|NCT00006604|447827401|FG005|Overall Study|Other Reason|1|||
124512413|NCT00006604|447827402|FG006|Overall Study|Other Reason|0|||
124512414|NCT00006604|447827403|FG007|Overall Study|Other Reason|0|||
124512415|NCT00006604|447827404|FG008|Overall Study|Other Reason|0|||
124512416|NCT00006604|447827405|FG009|Overall Study|Other Reason|1|||
124512417|NCT00006604|447827406|FG010|Overall Study|Other Reason|0|||
124512418|NCT00006604|447827407|FG011|Overall Study|Other Reason|0|||
124512419|NCT00006604|447827408|FG012|Overall Study|Other Reason|0|||
124512420|NCT00006604|447827409|FG013|Overall Study|Other Reason|0|||
124512421|NCT00006604|447827410|FG014|Overall Study|Other Reason|0|||
124512422|NCT00006604|447827411|FG015|Overall Study|Other Reason|0|||
124512423|NCT00006604|447827412|FG016|Overall Study|Other Reason|0|||
124512424|NCT01056341|447827415|FG000|Overall Study|Treatment Intolerance|0|||
124512425|NCT01056341|447827416|FG001|Overall Study|Treatment Intolerance|2|||
124512426|NCT01056341|447827417|FG002|Overall Study|Treatment Intolerance|0|||
124512427|NCT01056341|447827418|FG003|Overall Study|Treatment Intolerance|2|||
124512428|NCT01056341|447827419|FG004|Overall Study|Treatment Intolerance|0|||
124512429|NCT01056341|447827415|FG000|Overall Study|Lack of Efficacy|32|||
124512430|NCT01056341|447827416|FG001|Overall Study|Lack of Efficacy|30|||
124512431|NCT01056341|447827417|FG002|Overall Study|Lack of Efficacy|7|||
124512432|NCT01056341|447827418|FG003|Overall Study|Lack of Efficacy|25|||
124512433|NCT01056341|447827419|FG004|Overall Study|Lack of Efficacy|9|||
124512434|NCT01056341|447827415|FG000|Overall Study|Other reasons|4|||
124512435|NCT01056341|447827416|FG001|Overall Study|Other reasons|4|||
124512436|NCT01056341|447827417|FG002|Overall Study|Other reasons|8|||
124512437|NCT01056341|447827418|FG003|Overall Study|Other reasons|9|||
124512438|NCT01056341|447827419|FG004|Overall Study|Other reasons|5|||
124512439|NCT01086150|447827420|FG000|Overall Study|Withdrawal by Subject|0|||
124512440|NCT01086150|447827421|FG001|Overall Study|Withdrawal by Subject|4|||
124512441|NCT01086150|447827422|FG002|Overall Study|Withdrawal by Subject|1|||
124512442|NCT01086150|447827420|FG000|Overall Study|Lost to Follow-up|0|||
124512443|NCT01086150|447827421|FG001|Overall Study|Lost to Follow-up|1|||
124512444|NCT01086150|447827422|FG002|Overall Study|Lost to Follow-up|0|||
124512445|NCT01086150|447827420|FG000|Overall Study|Screen Failure|0|||
124512446|NCT01086150|447827421|FG001|Overall Study|Screen Failure|1|||
124512447|NCT01086150|447827422|FG002|Overall Study|Screen Failure|0|||
124512448|NCT01681576|447827423|FG000|Period 1|Adverse Event|1|||
124512449|NCT01681576|447827424|FG001|Period 1|Adverse Event|0|||
124512450|NCT01681576|447827423|FG000|Period 1|Protocol Deviation|1|||
124512451|NCT01681576|447827424|FG001|Period 1|Protocol Deviation|0|||
124512452|NCT01681576|447827423|FG000|Period 2|subject/guardian decision|3|||
124512453|NCT01681576|447827424|FG001|Period 2|subject/guardian decision|1|||
124512454|NCT01681576|447827423|FG000|Period 2|Non-compliance with study treatment|1|||
124512455|NCT01681576|447827424|FG001|Period 2|Non-compliance with study treatment|0|||
124512456|NCT01714817|447827427|FG000|Year 1 Period|Lack of Efficacy|11|||
124512457|NCT01714817|447827428|FG001|Year 1 Period|Lack of Efficacy|9|||
124512458|NCT01714817|447827427|FG000|Year 1 Period|Adverse Event|20|||
124512459|NCT01714817|447827428|FG001|Year 1 Period|Adverse Event|17|||
124512460|NCT01714817|447827427|FG000|Year 1 Period|Withdrawal by Subject|6|||
124512461|NCT01714817|447827428|FG001|Year 1 Period|Withdrawal by Subject|7|||
124512462|NCT01714817|447827427|FG000|Year 1 Period|Death|1|||
124512463|NCT01714817|447827428|FG001|Year 1 Period|Death|1|||
124512464|NCT01714817|447827427|FG000|Year 1 Period|Lost to Follow-up|0|||
124512465|NCT01714817|447827428|FG001|Year 1 Period|Lost to Follow-up|2|||
124512466|NCT01714817|447827427|FG000|Year 1 Period|Poor / non-compliance|0|||
124512467|NCT01714817|447827428|FG001|Year 1 Period|Poor / non-compliance|1|||
124567483|NCT00927810|448036322|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124567484|NCT00927810|448036323|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124567485|NCT00927810|448036324|FG002|Overall Study|Abnormal laboratory value(s)|0|||
124567486|NCT00927810|448036325|FG003|Overall Study|Abnormal laboratory value(s)|0|||
124567487|NCT00198029|448036331|FG000|Overall Study|Withdrawal by Subject|4|||
124567488|NCT01626079|448036334|FG000|Overall Study|Death|167|||
124567489|NCT01626079|448036335|FG001|Overall Study|Death|192|||
124567490|NCT01626079|448036336|FG002|Overall Study|Death|39|||
124567491|NCT01626079|448036334|FG000|Overall Study|Withdrawal by Subject|23|||
124567492|NCT01626079|448036335|FG001|Overall Study|Withdrawal by Subject|37|||
124567493|NCT01626079|448036336|FG002|Overall Study|Withdrawal by Subject|5|||
124567494|NCT01626079|448036334|FG000|Overall Study|Lost to Follow-up|7|||
124567495|NCT01626079|448036335|FG001|Overall Study|Lost to Follow-up|4|||
124567496|NCT01626079|448036336|FG002|Overall Study|Lost to Follow-up|2|||
124567497|NCT01626079|448036334|FG000|Overall Study|Missed Visits|1|||
124567498|NCT01626079|448036335|FG001|Overall Study|Missed Visits|4|||
124567499|NCT01626079|448036336|FG002|Overall Study|Missed Visits|6|||
124567500|NCT01457053|448036338|FG000|Overall Study|Unable to undergo selected treatment|1|||
124567501|NCT01457053|448036339|FG001|Overall Study|Unable to undergo selected treatment|1|||
124567502|NCT00814463|448036340|FG000|Overall Study|Lost to Follow-up|1|||
124567503|NCT03982433|448036341|FG000|Overall Study|Lost to Follow-up|1|||
124567504|NCT00368277|448036342|FG000|Overall Study|Adverse Event|33|||
124567505|NCT00368277|448036343|FG001|Overall Study|Adverse Event|49|||
124567506|NCT00368277|448036342|FG000|Overall Study|Death|2|||
124567507|NCT00368277|448036343|FG001|Overall Study|Death|1|||
124567508|NCT00368277|448036342|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
124567509|NCT00368277|448036343|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
124567510|NCT00368277|448036342|FG000|Overall Study|Protocol deviation|7|||
124567511|NCT00368277|448036343|FG001|Overall Study|Protocol deviation|0|||
124567512|NCT00368277|448036342|FG000|Overall Study|Patient withdrew consent|32|||
124567513|NCT00368277|448036343|FG001|Overall Study|Patient withdrew consent|28|||
124567514|NCT00368277|448036342|FG000|Overall Study|Lost to Follow-up|8|||
124567515|NCT00368277|448036343|FG001|Overall Study|Lost to Follow-up|6|||
124567516|NCT00984295|448036344|FG000|Overall Study|Lost to Follow-up|31|||
124567517|NCT00984295|448036345|FG001|Overall Study|Lost to Follow-up|12|||
124567518|NCT00984295|448036346|FG002|Overall Study|Lost to Follow-up|13|||
124567519|NCT00984295|448036344|FG000|Overall Study|Protocol Violation|2|||
124567520|NCT00984295|448036345|FG001|Overall Study|Protocol Violation|1|||
124567521|NCT00984295|448036346|FG002|Overall Study|Protocol Violation|4|||
124567522|NCT00984295|448036344|FG000|Overall Study|Withdrawal by Subject|18|||
124567523|NCT00984295|448036345|FG001|Overall Study|Withdrawal by Subject|9|||
124567524|NCT00984295|448036346|FG002|Overall Study|Withdrawal by Subject|12|||
124567525|NCT00984295|448036344|FG000|Overall Study|CAE - discontinued test vaccine|0|||
124567526|NCT00984295|448036345|FG001|Overall Study|CAE - discontinued test vaccine|1|||
124567527|NCT00984295|448036346|FG002|Overall Study|CAE - discontinued test vaccine|3|||
124567528|NCT00984295|448036344|FG000|Overall Study|Missed one or more blood samplings|3|||
124567529|NCT00984295|448036345|FG001|Overall Study|Missed one or more blood samplings|7|||
124567530|NCT00984295|448036346|FG002|Overall Study|Missed one or more blood samplings|2|||
124567531|NCT00984295|448036344|FG000|Overall Study|Incomplete safety follow-up|11|||
124567532|NCT00984295|448036345|FG001|Overall Study|Incomplete safety follow-up|2|||
124567533|NCT00984295|448036346|FG002|Overall Study|Incomplete safety follow-up|3|||
124567534|NCT04799158|448036347|FG000|Run-In Period|Adverse Event|6|||
124567535|NCT04799158|448036348|FG001|Run-In Period|Adverse Event|0|||
124567536|NCT04799158|448036349|FG002|Run-In Period|Adverse Event|0|||
124567537|NCT04799158|448036350|FG003|Run-In Period|Adverse Event|0|||
124567538|NCT04799158|448036351|FG004|Run-In Period|Adverse Event|0|||
124567539|NCT04799158|448036347|FG000|Run-In Period|Lost to Follow-up|4|||
124567540|NCT04799158|448036348|FG001|Run-In Period|Lost to Follow-up|0|||
124567541|NCT04799158|448036349|FG002|Run-In Period|Lost to Follow-up|0|||
124567542|NCT04799158|448036350|FG003|Run-In Period|Lost to Follow-up|0|||
124567543|NCT04799158|448036351|FG004|Run-In Period|Lost to Follow-up|0|||
124567544|NCT04799158|448036347|FG000|Run-In Period|Significant Protocol Deviation|1|||
124567545|NCT04799158|448036348|FG001|Run-In Period|Significant Protocol Deviation|0|||
124567546|NCT04799158|448036349|FG002|Run-In Period|Significant Protocol Deviation|0|||
124567547|NCT04799158|448036350|FG003|Run-In Period|Significant Protocol Deviation|0|||
124567548|NCT04799158|448036351|FG004|Run-In Period|Significant Protocol Deviation|0|||
124567549|NCT04799158|448036347|FG000|Run-In Period|Withdrawal by Subject|11|||
124567550|NCT04799158|448036348|FG001|Run-In Period|Withdrawal by Subject|0|||
124567551|NCT04799158|448036349|FG002|Run-In Period|Withdrawal by Subject|0|||
124567552|NCT04799158|448036350|FG003|Run-In Period|Withdrawal by Subject|0|||
124567553|NCT04799158|448036351|FG004|Run-In Period|Withdrawal by Subject|0|||
124567554|NCT04799158|448036347|FG000|Run-In Period|Miscellaneous|3|||
124567555|NCT04799158|448036348|FG001|Run-In Period|Miscellaneous|0|||
124567556|NCT04799158|448036349|FG002|Run-In Period|Miscellaneous|0|||
124567557|NCT04799158|448036350|FG003|Run-In Period|Miscellaneous|0|||
124567558|NCT04799158|448036351|FG004|Run-In Period|Miscellaneous|0|||
124567559|NCT04799158|448036347|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
124567560|NCT04799158|448036348|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
124567561|NCT04799158|448036349|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
124567562|NCT04799158|448036350|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
124567563|NCT04799158|448036351|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
124567564|NCT04799158|448036347|FG000|On-Demand Treatment Period|Adverse Event|0|||
124567565|NCT04799158|448036348|FG001|On-Demand Treatment Period|Adverse Event|1|||
124567566|NCT04799158|448036349|FG002|On-Demand Treatment Period|Adverse Event|0|||
124567567|NCT04799158|448036350|FG003|On-Demand Treatment Period|Adverse Event|0|||
124567568|NCT04799158|448036351|FG004|On-Demand Treatment Period|Adverse Event|1|||
124567569|NCT04799158|448036347|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
124567570|NCT04799158|448036348|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
124567571|NCT04799158|448036349|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
124567572|NCT04799158|448036350|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
124567573|NCT04799158|448036351|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
124567574|NCT04799158|448036347|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
124567575|NCT04799158|448036348|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
124567576|NCT04799158|448036349|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
124567577|NCT04799158|448036350|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
124567578|NCT04799158|448036351|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
124567579|NCT04799158|448036347|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
124567580|NCT04799158|448036348|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
124567581|NCT04799158|448036349|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
124567582|NCT04799158|448036350|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
124567583|NCT04799158|448036351|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
124567584|NCT04799158|448036347|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
124567585|NCT04799158|448036348|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
124567586|NCT04799158|448036349|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
124567587|NCT04799158|448036350|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
124567588|NCT04799158|448036351|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
124567589|NCT04799158|448036347|FG000|On-Demand Treatment Period|Miscellaneous|0|||
124567590|NCT04799158|448036348|FG001|On-Demand Treatment Period|Miscellaneous|0|||
124567591|NCT04799158|448036349|FG002|On-Demand Treatment Period|Miscellaneous|0|||
124512468|NCT01714817|447827427|FG000|Year 1 Period|Pregnancy|2|||
124512469|NCT01714817|447827428|FG001|Year 1 Period|Pregnancy|0|||
124512470|NCT01714817|447827427|FG000|Year 1 Period|Participant no longer meets criteria|6|||
124512471|NCT01714817|447827428|FG001|Year 1 Period|Participant no longer meets criteria|2|||
124512472|NCT01714817|447827427|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
124512473|NCT01714817|447827428|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
124512474|NCT01714817|447827427|FG000|Year 1 Period|Change in Concomitant Medication|0|||
124512475|NCT01714817|447827428|FG001|Year 1 Period|Change in Concomitant Medication|1|||
124512476|NCT01714817|447827427|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
124512477|NCT01714817|447827428|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
124512478|NCT01714817|447827427|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
124512479|NCT01714817|447827428|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
124512480|NCT01714817|447827427|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
124512481|NCT01714817|447827428|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
124512482|NCT01714817|447827427|FG000|Year 2 Period|Lack of Efficacy|4|||
124512483|NCT01714817|447827428|FG001|Year 2 Period|Lack of Efficacy|12|||
124512484|NCT01714817|447827427|FG000|Year 2 Period|Adverse Event|7|||
124512485|NCT01714817|447827428|FG001|Year 2 Period|Adverse Event|6|||
124512486|NCT01714817|447827427|FG000|Year 2 Period|Participant request to stop treatment|4|||
124512487|NCT01714817|447827428|FG001|Year 2 Period|Participant request to stop treatment|4|||
124512488|NCT01714817|447827427|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
124512489|NCT01714817|447827428|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
124512490|NCT01714817|447827427|FG000|Year 2 Period|Participant withdrew consent|1|||
124512491|NCT01714817|447827428|FG001|Year 2 Period|Participant withdrew consent|5|||
124512492|NCT01714817|447827427|FG000|Year 2 Period|Participant no longer meets criteria|1|||
124512493|NCT01714817|447827428|FG001|Year 2 Period|Participant no longer meets criteria|4|||
124512494|NCT01714817|447827427|FG000|Year 2 Period|Lost to Follow-up|2|||
124567592|NCT04799158|448036350|FG003|On-Demand Treatment Period|Miscellaneous|0|||
124567593|NCT04799158|448036351|FG004|On-Demand Treatment Period|Miscellaneous|1|||
124567594|NCT01790568|448036358|FG000|Overall Study|Progression prior to transplant|0|||
124567595|NCT01790568|448036359|FG001|Overall Study|Progression prior to transplant|1|||
124567596|NCT02994056|448036360|FG000|Overall Study|Death|8|||
124567597|NCT02994056|448036360|FG000|Overall Study|Withdrew Consent|1|||
124567598|NCT02199509|448036361|FG000|Overall Study|Suicidal Ideation|0|||
124567599|NCT02199509|448036362|FG001|Overall Study|Suicidal Ideation|1|||
124567600|NCT02199509|448036361|FG000|Overall Study|Misunderstood titration schedule|1|||
124567601|NCT02199509|448036362|FG001|Overall Study|Misunderstood titration schedule|0|||
124567602|NCT03309956|448036363|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
124567603|NCT02768298|448036364|FG000|Overall Study|Adverse Event|1|||
124567604|NCT02768298|448036365|FG001|Overall Study|Adverse Event|4|||
124567605|NCT02768298|448036364|FG000|Overall Study|Death|2|||
124567606|NCT02768298|448036365|FG001|Overall Study|Death|1|||
124567607|NCT02768298|448036364|FG000|Overall Study|Non-compliance with study treatment|0|||
124567608|NCT02768298|448036365|FG001|Overall Study|Non-compliance with study treatment|1|||
124567609|NCT02768298|448036364|FG000|Overall Study|Subject/guardian decision|1|||
124567610|NCT02768298|448036365|FG001|Overall Study|Subject/guardian decision|0|||
124567611|NCT02768298|448036364|FG000|Overall Study|Withdrawal of informed consent|0|||
124567612|NCT02768298|448036365|FG001|Overall Study|Withdrawal of informed consent|1|||
124567613|NCT04603937|448036369|FG000|Overall Study|Adverse Event|9|||
124567614|NCT04603937|448036370|FG001|Overall Study|Adverse Event|10|||
124567615|NCT04603937|448036369|FG000|Overall Study|Withdrawal by Subject|7|||
124567616|NCT04603937|448036370|FG001|Overall Study|Withdrawal by Subject|6|||
124567617|NCT04603937|448036369|FG000|Overall Study|Lost to Follow-up|5|||
124567618|NCT04603937|448036370|FG001|Overall Study|Lost to Follow-up|6|||
124567619|NCT04603937|448036369|FG000|Overall Study|Physician Decision|0|||
124567620|NCT04603937|448036370|FG001|Overall Study|Physician Decision|1|||
124567621|NCT04603937|448036369|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
124567622|NCT04603937|448036370|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
124567623|NCT02518685|448036371|FG000|Overall Study|Adverse Event|29|||
124567624|NCT02518685|448036372|FG001|Overall Study|Adverse Event|1|||
124567625|NCT02518685|448036371|FG000|Overall Study|Withdrawal by Subject|10|||
124567626|NCT02518685|448036372|FG001|Overall Study|Withdrawal by Subject|3|||
124567627|NCT02518685|448036371|FG000|Overall Study|relocation, study fatigue|7|||
124567628|NCT02518685|448036372|FG001|Overall Study|relocation, study fatigue|2|||
124567629|NCT02518685|448036371|FG000|Overall Study|Pregnancy|1|||
124567630|NCT02518685|448036372|FG001|Overall Study|Pregnancy|0|||
124567631|NCT02518685|448036371|FG000|Overall Study|Physician Decision|1|||
124567632|NCT02518685|448036372|FG001|Overall Study|Physician Decision|0|||
124567633|NCT02518685|448036371|FG000|Overall Study|Lost to Follow-up|1|||
124567634|NCT02518685|448036372|FG001|Overall Study|Lost to Follow-up|4|||
124567635|NCT01922349|448036373|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
124567636|NCT01922349|448036374|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
124567637|NCT01922349|448036375|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
124567638|NCT01922349|448036376|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
124567639|NCT01611090|448036377|FG000|Randomized Period|Lost to Follow-up|8|||
124567640|NCT01611090|448036378|FG001|Randomized Period|Lost to Follow-up|3|||
124567641|NCT01611090|448036379|FG002|Randomized Period|Lost to Follow-up|0|||
124567642|NCT01611090|448036377|FG000|Randomized Period|Withdrawal by Subject|22|||
124567643|NCT01611090|448036378|FG001|Randomized Period|Withdrawal by Subject|26|||
124567644|NCT01611090|448036379|FG002|Randomized Period|Withdrawal by Subject|0|||
124567645|NCT01611090|448036377|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
124567646|NCT01611090|448036378|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
124567647|NCT01611090|448036379|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
124567648|NCT01611090|448036377|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
124567649|NCT01611090|448036378|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
124567650|NCT01611090|448036379|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
124567651|NCT01919190|448038768|FG000|Overall Study|Intra-op findings, etc.|3|||
124567652|NCT01919190|448038769|FG001|Overall Study|Intra-op findings, etc.|0|||
124567653|NCT01545076|448038774|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
124567654|NCT01545076|448038775|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
124567655|NCT01545076|448038776|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
124567656|NCT01545076|448038777|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
124567657|NCT01545076|448038778|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
124567658|NCT01545076|448038774|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
124567659|NCT01545076|448038775|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
124567660|NCT01545076|448038776|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
124567661|NCT01545076|448038777|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
124567662|NCT01545076|448038778|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
124567663|NCT01545076|448038774|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
124567664|NCT01545076|448038775|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
124567665|NCT01545076|448038776|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
124567666|NCT01545076|448038777|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
124567667|NCT01545076|448038778|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
124567668|NCT01545076|448038774|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
124567669|NCT01545076|448038775|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
124567670|NCT01545076|448038776|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
124567671|NCT01545076|448038777|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
124567672|NCT01545076|448038778|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
124567673|NCT01545076|448038774|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
124567674|NCT01545076|448038775|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
124567675|NCT01545076|448038776|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
124567676|NCT01545076|448038777|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
124567677|NCT01545076|448038778|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
124567678|NCT01545076|448038774|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
124567679|NCT01545076|448038775|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
124567680|NCT01545076|448038776|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
124567681|NCT01545076|448038777|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
124567682|NCT01545076|448038778|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
124567683|NCT01545076|448038774|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
124567684|NCT01545076|448038775|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
124567685|NCT01545076|448038776|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
124567686|NCT01545076|448038777|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
124567687|NCT01545076|448038778|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
124567688|NCT01545076|448038774|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
124567689|NCT01545076|448038775|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
124567690|NCT01545076|448038776|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
124567691|NCT01545076|448038777|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
124567692|NCT01545076|448038778|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
124567693|NCT01545076|448038774|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
124567694|NCT01545076|448038775|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
124567695|NCT01545076|448038776|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
124567696|NCT01545076|448038777|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
124567697|NCT01545076|448038778|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
124567698|NCT02518113|448038779|FG000|Overall Study|Adverse Event|1|||
124567699|NCT02518113|448038780|FG001|Overall Study|Adverse Event|0|||
124567700|NCT02518113|448038781|FG002|Overall Study|Adverse Event|1|||
124567701|NCT02518113|448038782|FG003|Overall Study|Adverse Event|0|||
124567702|NCT02518113|448038779|FG000|Overall Study|Death|1|||
124567703|NCT02518113|448038780|FG001|Overall Study|Death|2|||
124567704|NCT02518113|448038781|FG002|Overall Study|Death|0|||
124567705|NCT02518113|448038782|FG003|Overall Study|Death|0|||
124567706|NCT02518113|448038779|FG000|Overall Study|Physician Decision|0|||
124567707|NCT02518113|448038780|FG001|Overall Study|Physician Decision|1|||
124567708|NCT02518113|448038781|FG002|Overall Study|Physician Decision|0|||
124567709|NCT02518113|448038782|FG003|Overall Study|Physician Decision|0|||
124567710|NCT02518113|448038779|FG000|Overall Study|Progressive Disease|1|||
124567711|NCT02518113|448038780|FG001|Overall Study|Progressive Disease|2|||
124567712|NCT02518113|448038781|FG002|Overall Study|Progressive Disease|3|||
124567713|NCT02518113|448038782|FG003|Overall Study|Progressive Disease|0|||
124567714|NCT00797108|448038783|FG000|Overall Study|Adverse Event|1|||
124567715|NCT00797108|448038784|FG001|Overall Study|Adverse Event|0|||
124567716|NCT00797108|448038785|FG002|Overall Study|Adverse Event|3|||
124567717|NCT00797108|448038783|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
124567718|NCT00797108|448038784|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
124567719|NCT00797108|448038785|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
124567720|NCT00797108|448038783|FG000|Overall Study|Global Deterioration of Health Status|0|||
124567721|NCT00797108|448038784|FG001|Overall Study|Global Deterioration of Health Status|1|||
124567722|NCT00797108|448038785|FG002|Overall Study|Global Deterioration of Health Status|0|||
124567723|NCT00797108|448038783|FG000|Overall Study|Lack of Efficacy|1|||
124567724|NCT00797108|448038784|FG001|Overall Study|Lack of Efficacy|0|||
124567725|NCT00797108|448038785|FG002|Overall Study|Lack of Efficacy|1|||
124567726|NCT00797108|448038783|FG000|Overall Study|Other|0|||
124567727|NCT00797108|448038784|FG001|Overall Study|Other|0|||
124567728|NCT00797108|448038785|FG002|Overall Study|Other|2|||
124567729|NCT00797108|448038783|FG000|Overall Study|Randomized but not Treated|2|||
124567730|NCT00797108|448038784|FG001|Overall Study|Randomized but not Treated|0|||
124567731|NCT00797108|448038785|FG002|Overall Study|Randomized but not Treated|0|||
124567732|NCT02270736|448038786|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
124567733|NCT02270736|448038787|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
124567734|NCT02270736|448038788|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
124567735|NCT02270736|448038789|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
124567736|NCT02270736|448038790|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
124567737|NCT02270736|448038786|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
124567738|NCT02270736|448038787|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
124567739|NCT02270736|448038788|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
124567740|NCT02270736|448038789|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
124567741|NCT02270736|448038790|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
124567742|NCT02270736|448038786|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
124567743|NCT02270736|448038787|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
124567744|NCT02270736|448038788|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
124567745|NCT02270736|448038789|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
124567746|NCT02270736|448038790|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
124567747|NCT02270736|448038786|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
124567748|NCT02270736|448038787|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
124567749|NCT02270736|448038788|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
124567750|NCT02270736|448038789|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
124567751|NCT02270736|448038790|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
124567752|NCT02270736|448038786|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
124567753|NCT02270736|448038787|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
124567754|NCT02270736|448038788|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
124567755|NCT02270736|448038789|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
124567756|NCT02270736|448038790|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
124567757|NCT02270736|448038786|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
124567758|NCT02270736|448038787|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
124567759|NCT02270736|448038788|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
124567760|NCT02270736|448038789|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
124567761|NCT02270736|448038790|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
124567762|NCT02270736|448038786|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
124567763|NCT02270736|448038787|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
124567764|NCT02270736|448038788|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
124567765|NCT02270736|448038789|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
124567766|NCT02270736|448038790|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
124567767|NCT02270736|448038786|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
124567768|NCT02270736|448038787|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
124567769|NCT02270736|448038788|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
124567770|NCT02270736|448038789|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
124567771|NCT02270736|448038790|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
124567772|NCT02270736|448038786|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
124567773|NCT02270736|448038787|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
124567774|NCT02270736|448038788|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
124567775|NCT02270736|448038789|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
124567776|NCT02270736|448038790|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
124567777|NCT04471207|448038793|FG000|Overall Study|Lost to Follow-up|4|||
124567778|NCT04471207|448038794|FG001|Overall Study|Lost to Follow-up|1|||
124567779|NCT04471207|448038793|FG000|Overall Study|Medication Contraindication|0|||
124567780|NCT04471207|448038794|FG001|Overall Study|Medication Contraindication|1|||
124567781|NCT04471207|448038793|FG000|Overall Study|Loss of Interest|2|||
124567782|NCT04471207|448038794|FG001|Overall Study|Loss of Interest|1|||
124567783|NCT04471207|448038793|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
124567784|NCT04471207|448038794|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
124567785|NCT04471207|448038793|FG000|Overall Study|Scheduling Conflicts|3|||
124567786|NCT04471207|448038794|FG001|Overall Study|Scheduling Conflicts|1|||
124567787|NCT04471207|448038793|FG000|Overall Study|Physician Decision|1|||
124567788|NCT04471207|448038794|FG001|Overall Study|Physician Decision|0|||
124567789|NCT04471207|448038793|FG000|Overall Study|Unwilling to Use System|0|||
124567790|NCT04471207|448038794|FG001|Overall Study|Unwilling to Use System|1|||
124567791|NCT00561730|448038795|FG000|Overall Study|Adverse Event|2|||
124567792|NCT00561730|448038795|FG000|Overall Study|Handling of the drug|1|||
124567793|NCT00561730|448038795|FG000|Overall Study|Lost to Follow-up|5|||
124567794|NCT00561730|448038795|FG000|Overall Study|Not specified reasons|1|||
124567795|NCT00376220|448038796|FG000|Overall Study|Lost to Follow-up|7|||
124567796|NCT00376220|448038797|FG001|Overall Study|Lost to Follow-up|10|||
124567797|NCT00376220|448038796|FG000|Overall Study|Withdrawal by Subject|3|||
124567798|NCT00376220|448038797|FG001|Overall Study|Withdrawal by Subject|2|||
124567799|NCT00531206|448038802|FG000|Overall Study|Adverse Event related|5|||
124567800|NCT00531206|448038802|FG000|Overall Study|Lack of Efficacy|2|||
124567801|NCT00531206|448038802|FG000|Overall Study|Lost to Follow-up|5|||
124567802|NCT00531206|448038802|FG000|Overall Study|including non-related adverse events|8|||
124567803|NCT00920140|448038803|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
124567804|NCT00920140|448038804|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
124567805|NCT00920140|448038805|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
124567806|NCT00920140|448038806|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
124567807|NCT00920140|448038807|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
124567808|NCT00920140|448038803|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
124567809|NCT00920140|448038804|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
124567810|NCT00920140|448038805|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
124567811|NCT00920140|448038806|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
124567812|NCT00920140|448038807|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
124567813|NCT00920140|448038803|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124567814|NCT00920140|448038804|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
124567815|NCT00920140|448038805|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124567816|NCT00920140|448038806|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124567817|NCT00920140|448038807|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
124512495|NCT01714817|447827428|FG001|Year 2 Period|Lost to Follow-up|0|||
124512496|NCT01714817|447827427|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
124512497|NCT01714817|447827428|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
124512498|NCT01714817|447827427|FG000|Year 2 Period|Pregnancy|1|||
124512499|NCT01714817|447827428|FG001|Year 2 Period|Pregnancy|1|||
124512500|NCT01714817|447827427|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
124512501|NCT01714817|447827428|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
124512502|NCT01714817|447827427|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
124512503|NCT01714817|447827428|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
124512504|NCT01714817|447827427|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
124512505|NCT01714817|447827428|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
124512506|NCT01714817|447827427|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
124512507|NCT01714817|447827428|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
124512508|NCT01714817|447827427|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
124512509|NCT01714817|447827428|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
124512510|NCT01714817|447827427|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
124512511|NCT01714817|447827428|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
124512512|NCT01714817|447827427|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
124512513|NCT01714817|447827428|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
124512514|NCT01714817|447827427|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
124512515|NCT01714817|447827428|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
124512516|NCT01714817|447827427|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
124512517|NCT01714817|447827428|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
124512518|NCT01714817|447827427|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
124512519|NCT01714817|447827428|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
124512520|NCT01714817|447827427|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
124512521|NCT01714817|447827428|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
124512522|NCT01714817|447827427|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
124512523|NCT01714817|447827428|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
124512524|NCT01714817|447827427|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
124512525|NCT01714817|447827428|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
124512526|NCT01714817|447827427|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
124512527|NCT01714817|447827428|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
124512528|NCT01714817|447827427|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
124512529|NCT01714817|447827428|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
124512530|NCT01714817|447827427|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
124512531|NCT01714817|447827428|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
124512532|NCT02921763|447827429|FG000|Overall Study|Adverse Event|4|||
124512533|NCT02921763|447827429|FG000|Overall Study|Lost to Follow-up|4|||
124512534|NCT02921763|447827429|FG000|Overall Study|Lack of Efficacy|3|||
124512535|NCT02921763|447827429|FG000|Overall Study|Protocol Violation|2|||
124512536|NCT02921763|447827429|FG000|Overall Study|Withdrawal by Subject|2|||
124512537|NCT02921763|447827429|FG000|Overall Study|Physician Decision|1|||
124512538|NCT02921763|447827429|FG000|Overall Study|No data obtained|2|||
124512539|NCT01582971|447827430|FG000|Overall Study|Death|2|||
124512540|NCT01582971|447827431|FG001|Overall Study|Death|1|||
124512541|NCT01582971|447827430|FG000|Overall Study|Lost to Follow-up|18|||
124512542|NCT01582971|447827431|FG001|Overall Study|Lost to Follow-up|21|||
124512543|NCT01582971|447827430|FG000|Overall Study|Withdrawal by Subject|4|||
124512544|NCT01582971|447827431|FG001|Overall Study|Withdrawal by Subject|2|||
124512545|NCT01582971|447827430|FG000|Overall Study|Other|15|||
124512546|NCT01582971|447827431|FG001|Overall Study|Other|13|||
124512547|NCT06025396|447829128|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
124512548|NCT06025396|447829129|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
124512549|NCT06025396|447829130|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
124512550|NCT06025396|447829131|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
124512551|NCT06025396|447829132|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
124512552|NCT06025396|447829128|FG000|Overall Study|Withdrawal by Subject|0|||
124512553|NCT06025396|447829129|FG001|Overall Study|Withdrawal by Subject|1|||
124512554|NCT06025396|447829130|FG002|Overall Study|Withdrawal by Subject|1|||
124512555|NCT06025396|447829131|FG003|Overall Study|Withdrawal by Subject|0|||
124512556|NCT06025396|447829132|FG004|Overall Study|Withdrawal by Subject|0|||
124512557|NCT02528253|447829143|FG000|Overall Study|Adverse Event|3|||
124512558|NCT02528253|447829144|FG001|Overall Study|Adverse Event|4|||
124512559|NCT02528253|447829145|FG002|Overall Study|Adverse Event|4|||
124512560|NCT02528253|447829146|FG003|Overall Study|Adverse Event|8|||
124512561|NCT02528253|447829147|FG004|Overall Study|Adverse Event|18|||
124512562|NCT02528253|447829143|FG000|Overall Study|Death|2|||
124512563|NCT02528253|447829144|FG001|Overall Study|Death|2|||
124567818|NCT00920140|448038803|FG000|Phase 2|Adverse Event|0|||
124567819|NCT00920140|448038804|FG001|Phase 2|Adverse Event|0|||
124567820|NCT00920140|448038805|FG002|Phase 2|Adverse Event|14|||
124567821|NCT00920140|448038806|FG003|Phase 2|Adverse Event|2|||
124567822|NCT00920140|448038807|FG004|Phase 2|Adverse Event|3|||
124567823|NCT00920140|448038803|FG000|Phase 2|Lack of Efficacy|0|||
124567824|NCT00920140|448038804|FG001|Phase 2|Lack of Efficacy|0|||
124567825|NCT00920140|448038805|FG002|Phase 2|Lack of Efficacy|29|||
124567826|NCT00920140|448038806|FG003|Phase 2|Lack of Efficacy|14|||
124567827|NCT00920140|448038807|FG004|Phase 2|Lack of Efficacy|5|||
124567828|NCT00920140|448038803|FG000|Phase 2|Lost to Follow-up|0|||
124567829|NCT00920140|448038804|FG001|Phase 2|Lost to Follow-up|0|||
124567830|NCT00920140|448038805|FG002|Phase 2|Lost to Follow-up|0|||
124567831|NCT00920140|448038806|FG003|Phase 2|Lost to Follow-up|1|||
124567832|NCT00920140|448038807|FG004|Phase 2|Lost to Follow-up|0|||
124567833|NCT00920140|448038803|FG000|Phase 2|Physician Decision|0|||
124567834|NCT00920140|448038804|FG001|Phase 2|Physician Decision|0|||
124567835|NCT00920140|448038805|FG002|Phase 2|Physician Decision|3|||
124567836|NCT00920140|448038806|FG003|Phase 2|Physician Decision|3|||
124567837|NCT00920140|448038807|FG004|Phase 2|Physician Decision|2|||
124567838|NCT00920140|448038803|FG000|Phase 2|Withdrawal by Subject|0|||
124567839|NCT00920140|448038804|FG001|Phase 2|Withdrawal by Subject|0|||
124567840|NCT00920140|448038805|FG002|Phase 2|Withdrawal by Subject|4|||
124567841|NCT00920140|448038806|FG003|Phase 2|Withdrawal by Subject|2|||
124567842|NCT00920140|448038807|FG004|Phase 2|Withdrawal by Subject|1|||
124567843|NCT01124149|448038808|FG000|Acute Phase|Withdrawal by Subject|22|||
124567844|NCT01124149|448038808|FG000|Acute Phase|Adverse Event|21|||
124567845|NCT01124149|448038808|FG000|Acute Phase|Lack of Efficacy|17|||
124567846|NCT01124149|448038808|FG000|Acute Phase|Protocol Violation|14|||
124567847|NCT01124149|448038808|FG000|Acute Phase|Lost to Follow-up|2|||
124567848|NCT01124149|448038808|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
124567849|NCT01124149|448038808|FG000|Acute Phase|Sponsor request|1|||
124567850|NCT01124149|448038808|FG000|Acute Phase|UC symptoms not ameliorated|1|||
124567851|NCT01124149|448038808|FG000|Acute Phase|Non-compliance|1|||
124567852|NCT01124149|448038808|FG000|Acute Phase|Low hemoglobin|1|||
124567853|NCT01124149|448038808|FG000|Acute Phase|Travelling to another country|1|||
124567854|NCT01124149|448038808|FG000|Acute Phase|Sponsor decision|1|||
124567855|NCT01124149|448038808|FG000|Maintenance Phase|Lack of Efficacy|40|||
124567856|NCT01124149|448038808|FG000|Maintenance Phase|Adverse Event|24|||
124567857|NCT01124149|448038808|FG000|Maintenance Phase|Lost to Follow-up|15|||
124567858|NCT01124149|448038808|FG000|Maintenance Phase|Withdrawal by Subject|10|||
124567859|NCT01124149|448038808|FG000|Maintenance Phase|Protocol Violation|5|||
124567860|NCT01124149|448038808|FG000|Maintenance Phase|Coordinator error|1|||
124567861|NCT01124149|448038808|FG000|Maintenance Phase|Non-compliance|1|||
124567862|NCT01644500|448038809|FG000|Overall Study|Adverse Event|6|||
124567863|NCT01644500|448038810|FG001|Overall Study|Adverse Event|1|||
124567864|NCT01644500|448038811|FG002|Overall Study|Adverse Event|2|||
124567865|NCT01644500|448038809|FG000|Overall Study|Death|0|||
124567866|NCT01644500|448038810|FG001|Overall Study|Death|1|||
124567867|NCT01644500|448038811|FG002|Overall Study|Death|0|||
124567868|NCT01644500|448038809|FG000|Overall Study|Lost to Follow-up|3|||
124567869|NCT01644500|448038810|FG001|Overall Study|Lost to Follow-up|8|||
124567870|NCT01644500|448038811|FG002|Overall Study|Lost to Follow-up|0|||
124567871|NCT01644500|448038809|FG000|Overall Study|Protocol Violation|1|||
124567872|NCT01644500|448038810|FG001|Overall Study|Protocol Violation|1|||
124567873|NCT01644500|448038811|FG002|Overall Study|Protocol Violation|0|||
124567874|NCT01644500|448038809|FG000|Overall Study|Withdrawal by Subject|11|||
124567875|NCT01644500|448038810|FG001|Overall Study|Withdrawal by Subject|12|||
124567876|NCT01644500|448038811|FG002|Overall Study|Withdrawal by Subject|12|||
124567877|NCT01644500|448038809|FG000|Overall Study|Physician Decision|1|||
124567878|NCT01644500|448038810|FG001|Overall Study|Physician Decision|1|||
124567879|NCT01644500|448038811|FG002|Overall Study|Physician Decision|1|||
124567880|NCT02153398|448038818|FG000|Overall Study|Withdrawal by Subject|1|||
124567881|NCT02153398|448038819|FG001|Overall Study|Withdrawal by Subject|0|||
124567882|NCT02153398|448038820|FG002|Overall Study|Withdrawal by Subject|0|||
124567883|NCT02153398|448038821|FG003|Overall Study|Withdrawal by Subject|0|||
124567884|NCT02153398|448038822|FG004|Overall Study|Withdrawal by Subject|0|||
124567885|NCT02153398|448038818|FG000|Overall Study|Adverse Event|0|||
124567886|NCT02153398|448038819|FG001|Overall Study|Adverse Event|0|||
124567887|NCT02153398|448038820|FG002|Overall Study|Adverse Event|1|||
124567888|NCT02153398|448038821|FG003|Overall Study|Adverse Event|1|||
124567889|NCT02153398|448038822|FG004|Overall Study|Adverse Event|0|||
124567890|NCT00721409|448038823|FG000|Overall Study|Global deterioration of health status|2|||
124567891|NCT00721409|448038824|FG001|Overall Study|Global deterioration of health status|6|||
124567892|NCT00721409|448038825|FG002|Overall Study|Global deterioration of health status|3|||
124567893|NCT00721409|448038823|FG000|Overall Study|Death|0|||
124567894|NCT00721409|448038824|FG001|Overall Study|Death|1|||
124567895|NCT00721409|448038825|FG002|Overall Study|Death|0|||
124567896|NCT00721409|448038823|FG000|Overall Study|Randomized not Treated|0|||
124567897|NCT00721409|448038824|FG001|Overall Study|Randomized not Treated|1|||
124567898|NCT00721409|448038825|FG002|Overall Study|Randomized not Treated|4|||
124567899|NCT00721409|448038823|FG000|Overall Study|Reason not specified|1|||
124512564|NCT02528253|447829145|FG002|Overall Study|Death|1|||
124512565|NCT02528253|447829146|FG003|Overall Study|Death|0|||
124512566|NCT02528253|447829147|FG004|Overall Study|Death|1|||
124512567|NCT02528253|447829143|FG000|Overall Study|Insufficient clinical response|7|||
124512568|NCT02528253|447829144|FG001|Overall Study|Insufficient clinical response|10|||
124512569|NCT02528253|447829145|FG002|Overall Study|Insufficient clinical response|13|||
124512570|NCT02528253|447829146|FG003|Overall Study|Insufficient clinical response|12|||
124512571|NCT02528253|447829147|FG004|Overall Study|Insufficient clinical response|16|||
124512572|NCT02528253|447829143|FG000|Overall Study|Lost to Follow-up|16|||
124512573|NCT02528253|447829144|FG001|Overall Study|Lost to Follow-up|9|||
124512574|NCT02528253|447829145|FG002|Overall Study|Lost to Follow-up|31|||
124512575|NCT02528253|447829146|FG003|Overall Study|Lost to Follow-up|16|||
124512576|NCT02528253|447829147|FG004|Overall Study|Lost to Follow-up|34|||
124512577|NCT02528253|447829143|FG000|Overall Study|Other|21|||
124512578|NCT02528253|447829144|FG001|Overall Study|Other|22|||
124512579|NCT02528253|447829145|FG002|Overall Study|Other|58|||
124512580|NCT02528253|447829146|FG003|Overall Study|Other|52|||
124512581|NCT02528253|447829147|FG004|Overall Study|Other|76|||
124512582|NCT02528253|447829143|FG000|Overall Study|Withdrawal by Subject|25|||
124512583|NCT02528253|447829144|FG001|Overall Study|Withdrawal by Subject|20|||
124512584|NCT02528253|447829145|FG002|Overall Study|Withdrawal by Subject|29|||
124512585|NCT02528253|447829146|FG003|Overall Study|Withdrawal by Subject|48|||
124512586|NCT02528253|447829147|FG004|Overall Study|Withdrawal by Subject|73|||
124512587|NCT02528253|447829143|FG000|Overall Study|Protocol Violation|1|||
124512588|NCT02528253|447829144|FG001|Overall Study|Protocol Violation|2|||
124512589|NCT02528253|447829145|FG002|Overall Study|Protocol Violation|4|||
124512590|NCT02528253|447829146|FG003|Overall Study|Protocol Violation|0|||
124512591|NCT02528253|447829147|FG004|Overall Study|Protocol Violation|4|||
124512592|NCT02528253|447829143|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
124512593|NCT02528253|447829144|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
124512594|NCT02528253|447829145|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
124512595|NCT02528253|447829146|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
124512596|NCT02528253|447829147|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
124512597|NCT01357980|447829148|FG000|Overall Study|Lack of Efficacy|0|||
124512598|NCT01357980|447829149|FG001|Overall Study|Lack of Efficacy|1|||
124512599|NCT01357980|447829150|FG002|Overall Study|Lack of Efficacy|0|||
124512600|NCT01357980|447829151|FG003|Overall Study|Lack of Efficacy|0|||
124512601|NCT01357980|447829148|FG000|Overall Study|Consent withdrawn|0|||
124512602|NCT01357980|447829149|FG001|Overall Study|Consent withdrawn|0|||
124512603|NCT01357980|447829150|FG002|Overall Study|Consent withdrawn|1|||
124512604|NCT01357980|447829151|FG003|Overall Study|Consent withdrawn|0|||
124512605|NCT02293993|447829153|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
124512606|NCT02293993|447829154|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
124512607|NCT02293993|447829155|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
124512608|NCT02293993|447829156|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
124512609|NCT02293993|447829153|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
124512610|NCT02293993|447829154|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
124512611|NCT02293993|447829155|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
124512612|NCT02293993|447829156|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
124512613|NCT02293993|447829153|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
124512614|NCT02293993|447829154|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
124512615|NCT02293993|447829155|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
124512616|NCT02293993|447829156|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
124512617|NCT02293993|447829153|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
124512618|NCT02293993|447829154|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
124512619|NCT02293993|447829155|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
124512620|NCT02293993|447829156|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
124512621|NCT02293993|447829153|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
124512622|NCT02293993|447829154|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
124512623|NCT02293993|447829155|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
124512624|NCT02293993|447829156|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
124512625|NCT00094835|447829157|FG000|Overall Study|Physician Decision|1|||
124512626|NCT00094835|447829158|FG001|Overall Study|Physician Decision|0|||
124512627|NCT00094835|447829159|FG002|Overall Study|Physician Decision|0|||
124512628|NCT00094835|447829160|FG003|Overall Study|Physician Decision|0|||
124512629|NCT00094835|447829161|FG004|Overall Study|Physician Decision|0|||
124512630|NCT00094835|447829162|FG005|Overall Study|Physician Decision|1|||
124512631|NCT00094835|447829163|FG006|Overall Study|Physician Decision|0|||
124512632|NCT00094835|447829157|FG000|Overall Study|Withdrawal by Subject|0|||
124567900|NCT00721409|448038824|FG001|Overall Study|Reason not specified|0|||
124567901|NCT00721409|448038825|FG002|Overall Study|Reason not specified|2|||
124567902|NCT00721409|448038823|FG000|Overall Study|Adverse Event|0|||
124567903|NCT00721409|448038824|FG001|Overall Study|Adverse Event|13|||
124567904|NCT00721409|448038825|FG002|Overall Study|Adverse Event|2|||
124567905|NCT00721409|448038823|FG000|Overall Study|Lost to Follow-up|0|||
124567906|NCT00721409|448038824|FG001|Overall Study|Lost to Follow-up|0|||
124567907|NCT00721409|448038825|FG002|Overall Study|Lost to Follow-up|1|||
124567908|NCT00721409|448038823|FG000|Overall Study|Withdrawal by Subject|1|||
124567909|NCT00721409|448038824|FG001|Overall Study|Withdrawal by Subject|6|||
124567910|NCT00721409|448038825|FG002|Overall Study|Withdrawal by Subject|5|||
124567911|NCT00721409|448038823|FG000|Overall Study|Objective progression or relapse|8|||
124567912|NCT00721409|448038824|FG001|Overall Study|Objective progression or relapse|55|||
124567913|NCT00721409|448038825|FG002|Overall Study|Objective progression or relapse|62|||
124567914|NCT02402166|448038826|FG000|Overall Study|Adverse Event|2|||
124567915|NCT02402166|448038826|FG000|Overall Study|Withdrawal by Subject|2|||
124567916|NCT02402166|448038826|FG000|Overall Study|Lost to Follow-up|1|||
124567917|NCT00322491|448038830|FG000|Overall Study|Adverse Event|1|||
124567918|NCT00322491|448038831|FG001|Overall Study|Adverse Event|0|||
124567919|NCT00322491|448038830|FG000|Overall Study|Death|1|||
124567920|NCT00322491|448038831|FG001|Overall Study|Death|2|||
124567921|NCT01400425|448038833|FG000|Overall Study|Withdrawal by Subject|10|||
124567922|NCT01424722|448038834|FG000|Overall Study|Sponsor terminated investigation|2258|||
124567923|NCT00818883|448038835|FG000|Overall Study|Adverse Event|28|||
124567924|NCT00818883|448038836|FG001|Overall Study|Adverse Event|19|||
124567925|NCT00818883|448038835|FG000|Overall Study|Protocol Violation|2|||
124567926|NCT00818883|448038836|FG001|Overall Study|Protocol Violation|2|||
124567927|NCT00818883|448038835|FG000|Overall Study|Lost to Follow-up|3|||
124567928|NCT00818883|448038836|FG001|Overall Study|Lost to Follow-up|2|||
124567929|NCT00818883|448038835|FG000|Overall Study|Withdrawal by Subject|16|||
124567930|NCT00818883|448038836|FG001|Overall Study|Withdrawal by Subject|14|||
124567931|NCT00818883|448038835|FG000|Overall Study|Lack of Efficacy|0|||
124567932|NCT00818883|448038836|FG001|Overall Study|Lack of Efficacy|2|||
124567933|NCT00818883|448038835|FG000|Overall Study|Other|2|||
124567934|NCT00818883|448038836|FG001|Overall Study|Other|7|||
124567935|NCT00048048|448038837|FG000|Core Treatment|Withdrawal by Subject|0|||
124567936|NCT00048048|448038838|FG001|Core Treatment|Withdrawal by Subject|0|||
124567937|NCT00048048|448038839|FG002|Core Treatment|Withdrawal by Subject|1|||
124567938|NCT00048048|448038840|FG003|Core Treatment|Withdrawal by Subject|0|||
124567939|NCT00048048|448038841|FG004|Core Treatment|Withdrawal by Subject|0|||
124567940|NCT00048048|448038842|FG005|Core Treatment|Withdrawal by Subject|0|||
124567941|NCT00048048|448038843|FG006|Core Treatment|Withdrawal by Subject|0|||
124567942|NCT00048048|448038844|FG007|Core Treatment|Withdrawal by Subject|0|||
124567943|NCT00048048|448038845|FG008|Core Treatment|Withdrawal by Subject|0|||
124567944|NCT00048048|448038846|FG009|Core Treatment|Withdrawal by Subject|0|||
124567945|NCT00048048|448038847|FG010|Core Treatment|Withdrawal by Subject|0|||
124567946|NCT00048048|448038848|FG011|Core Treatment|Withdrawal by Subject|0|||
124567947|NCT00048048|448038837|FG000|Core Treatment|Adverse Event|0|||
124567948|NCT00048048|448038838|FG001|Core Treatment|Adverse Event|0|||
124567949|NCT00048048|448038839|FG002|Core Treatment|Adverse Event|0|||
124567950|NCT00048048|448038840|FG003|Core Treatment|Adverse Event|0|||
124567951|NCT00048048|448038841|FG004|Core Treatment|Adverse Event|0|||
124567952|NCT00048048|448038842|FG005|Core Treatment|Adverse Event|0|||
124567953|NCT00048048|448038843|FG006|Core Treatment|Adverse Event|0|||
124567954|NCT00048048|448038844|FG007|Core Treatment|Adverse Event|1|||
124567955|NCT00048048|448038845|FG008|Core Treatment|Adverse Event|0|||
124567956|NCT00048048|448038846|FG009|Core Treatment|Adverse Event|0|||
124567957|NCT00048048|448038847|FG010|Core Treatment|Adverse Event|0|||
124567958|NCT00048048|448038848|FG011|Core Treatment|Adverse Event|0|||
124567959|NCT00048048|448038837|FG000|Extension Year 1|Early withdrawals|0|||
124567960|NCT00048048|448038838|FG001|Extension Year 1|Early withdrawals|0|||
124567961|NCT00048048|448038839|FG002|Extension Year 1|Early withdrawals|0|||
124567962|NCT00048048|448038840|FG003|Extension Year 1|Early withdrawals|0|||
124567963|NCT00048048|448038841|FG004|Extension Year 1|Early withdrawals|0|||
124567964|NCT00048048|448038842|FG005|Extension Year 1|Early withdrawals|0|||
124567965|NCT00048048|448038843|FG006|Extension Year 1|Early withdrawals|0|||
124567966|NCT00048048|448038844|FG007|Extension Year 1|Early withdrawals|0|||
124567967|NCT00048048|448038845|FG008|Extension Year 1|Early withdrawals|0|||
124567968|NCT00048048|448038846|FG009|Extension Year 1|Early withdrawals|2|||
124776707|NCT00998296|448809948|FG003|Overall Study|Refused to continue taking trial med.|0|||
124776708|NCT00998296|448809949|FG004|Overall Study|Refused to continue taking trial med.|0|||
124567969|NCT00048048|448038847|FG010|Extension Year 1|Early withdrawals|2|||
124567970|NCT00048048|448038848|FG011|Extension Year 1|Early withdrawals|4|||
124567971|NCT00048048|448038837|FG000|Extension Year 2|Early withdrawals|0|||
124776709|NCT00998296|448809950|FG005|Overall Study|Refused to continue taking trial med.|0|||
124567972|NCT00048048|448038838|FG001|Extension Year 2|Early withdrawals|0|||
124567973|NCT00048048|448038839|FG002|Extension Year 2|Early withdrawals|0|||
124512633|NCT00094835|447829158|FG001|Overall Study|Withdrawal by Subject|0|||
124512634|NCT00094835|447829159|FG002|Overall Study|Withdrawal by Subject|0|||
124512635|NCT00094835|447829160|FG003|Overall Study|Withdrawal by Subject|0|||
124512636|NCT00094835|447829161|FG004|Overall Study|Withdrawal by Subject|0|||
124512637|NCT00094835|447829162|FG005|Overall Study|Withdrawal by Subject|0|||
124512638|NCT00094835|447829163|FG006|Overall Study|Withdrawal by Subject|1|||
124512639|NCT00094835|447829157|FG000|Overall Study|Lost to Follow-up|0|||
124512640|NCT00094835|447829158|FG001|Overall Study|Lost to Follow-up|0|||
124512641|NCT00094835|447829159|FG002|Overall Study|Lost to Follow-up|0|||
124512642|NCT00094835|447829160|FG003|Overall Study|Lost to Follow-up|0|||
124512643|NCT00094835|447829161|FG004|Overall Study|Lost to Follow-up|1|||
124512644|NCT00094835|447829162|FG005|Overall Study|Lost to Follow-up|0|||
124512645|NCT00094835|447829163|FG006|Overall Study|Lost to Follow-up|0|||
124512646|NCT00094835|447829157|FG000|Overall Study|Death|1|||
124512647|NCT00094835|447829158|FG001|Overall Study|Death|0|||
124512648|NCT00094835|447829159|FG002|Overall Study|Death|0|||
124512649|NCT00094835|447829160|FG003|Overall Study|Death|0|||
124512650|NCT00094835|447829161|FG004|Overall Study|Death|1|||
124512651|NCT00094835|447829162|FG005|Overall Study|Death|0|||
124512652|NCT00094835|447829163|FG006|Overall Study|Death|0|||
124512653|NCT00094835|447829157|FG000|Overall Study|Non-compliance|1|||
124512654|NCT00094835|447829158|FG001|Overall Study|Non-compliance|2|||
124512655|NCT00094835|447829159|FG002|Overall Study|Non-compliance|2|||
124512656|NCT00094835|447829160|FG003|Overall Study|Non-compliance|0|||
124512657|NCT00094835|447829161|FG004|Overall Study|Non-compliance|2|||
124512658|NCT00094835|447829162|FG005|Overall Study|Non-compliance|2|||
124512659|NCT00094835|447829163|FG006|Overall Study|Non-compliance|1|||
124512660|NCT00094835|447829157|FG000|Overall Study|Other|1|||
124512661|NCT00094835|447829158|FG001|Overall Study|Other|1|||
124512662|NCT00094835|447829159|FG002|Overall Study|Other|1|||
124512663|NCT00094835|447829160|FG003|Overall Study|Other|1|||
124512664|NCT00094835|447829161|FG004|Overall Study|Other|0|||
124512665|NCT00094835|447829162|FG005|Overall Study|Other|0|||
124512666|NCT00094835|447829163|FG006|Overall Study|Other|0|||
124512667|NCT00126581|447829164|FG000|Overall Study|Adverse Event|3|||
124512668|NCT00126581|447829165|FG001|Overall Study|Adverse Event|7|||
124512669|NCT00126581|447829164|FG000|Overall Study|Death|3|||
124512670|NCT00126581|447829165|FG001|Overall Study|Death|2|||
124512671|NCT00126581|447829164|FG000|Overall Study|Withdrawal by Subject|1|||
124512672|NCT00126581|447829165|FG001|Overall Study|Withdrawal by Subject|4|||
124512673|NCT00126581|447829164|FG000|Overall Study|Alternative therapy|3|||
124512674|NCT00126581|447829165|FG001|Overall Study|Alternative therapy|3|||
124512675|NCT00126581|447829164|FG000|Overall Study|Other illness/MD discretion|3|||
124512676|NCT00126581|447829165|FG001|Overall Study|Other illness/MD discretion|4|||
124512677|NCT00793182|447829166|FG000|Overall Study|Adverse Event|0|||
124512678|NCT00793182|447829167|FG001|Overall Study|Adverse Event|1|||
124512679|NCT02384395|447829168|FG000|Overall Study|Physician Decision|4|||
124512680|NCT02384395|447829168|FG000|Overall Study|Withdrawal by Subject|3|||
124512681|NCT02384395|447829168|FG000|Overall Study|Lost to Follow-up|3|||
124512682|NCT04295356|447829170|FG000|Overall Study|Physician Decision|1|||
124512683|NCT04295356|447829171|FG001|Overall Study|Physician Decision|0|||
124512684|NCT04295356|447829170|FG000|Overall Study|Lost to Follow-up|0|||
124512685|NCT04295356|447829171|FG001|Overall Study|Lost to Follow-up|3|||
124512686|NCT04295356|447829170|FG000|Overall Study|Protocol Violation|0|||
124512687|NCT04295356|447829171|FG001|Overall Study|Protocol Violation|1|||
124512688|NCT04268004|447829172|FG000|Overall Study|Excluded from analyses|0|||
124512689|NCT04268004|447829173|FG001|Overall Study|Excluded from analyses|1|||
124512690|NCT03783442|447829174|FG000|Overall Study|Death|252|||
124512691|NCT03783442|447829175|FG001|Overall Study|Death|268|||
124512692|NCT03783442|447829174|FG000|Overall Study|Withdrawal by Subject|19|||
124512693|NCT03783442|447829175|FG001|Overall Study|Withdrawal by Subject|21|||
124512694|NCT03783442|447829174|FG000|Overall Study|Lost to Follow-up|7|||
124512695|NCT03783442|447829175|FG001|Overall Study|Lost to Follow-up|6|||
124512696|NCT03783442|447829174|FG000|Overall Study|Sponsor Ended Study|48|||
124512697|NCT03783442|447829175|FG001|Overall Study|Sponsor Ended Study|28|||
124512698|NCT01381718|447829176|FG000|Overall Study|Withdrawal by Subject|2|||
124512699|NCT01381718|447829177|FG001|Overall Study|Withdrawal by Subject|5|||
124567974|NCT00048048|448038840|FG003|Extension Year 2|Early withdrawals|0|||
124512700|NCT01381718|447829176|FG000|Overall Study|Lost to Follow-up|3|||
124512701|NCT01381718|447829177|FG001|Overall Study|Lost to Follow-up|5|||
124567975|NCT00048048|448038841|FG004|Extension Year 2|Early withdrawals|0|||
124512702|NCT01381718|447829176|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
124512703|NCT01381718|447829177|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
124512704|NCT00992186|447829180|FG000|Overall Study|Withdrawal by Subject|2|||
124512705|NCT00992186|447829180|FG000|Overall Study|Protocol Violation|1|||
124512706|NCT00992186|447829180|FG000|Overall Study|Physician Decision|1|||
124512707|NCT00992186|447829180|FG000|Overall Study|Adverse Event|9|||
124512708|NCT00992186|447829180|FG000|Overall Study|Progressive Disease|30|||
124512709|NCT00992186|447829180|FG000|Overall Study|Refusal To Receive Study Agent|3|||
124512710|NCT00830960|447829181|FG000|Overall Study|Death|5|||
124567976|NCT00048048|448038842|FG005|Extension Year 2|Early withdrawals|0|||
124567977|NCT00048048|448038843|FG006|Extension Year 2|Early withdrawals|0|||
124567978|NCT00048048|448038844|FG007|Extension Year 2|Early withdrawals|0|||
124567979|NCT00048048|448038845|FG008|Extension Year 2|Early withdrawals|0|||
124567980|NCT00048048|448038846|FG009|Extension Year 2|Early withdrawals|0|||
124567981|NCT00048048|448038847|FG010|Extension Year 2|Early withdrawals|4|||
124567982|NCT00048048|448038848|FG011|Extension Year 2|Early withdrawals|2|||
124567983|NCT00973700|448038851|FG000|Overall Study|Withdrawal by Subject|2|||
124567984|NCT00973700|448038852|FG001|Overall Study|Withdrawal by Subject|2|||
124567985|NCT00973700|448038853|FG002|Overall Study|Withdrawal by Subject|8|||
124567986|NCT00973700|448038854|FG003|Overall Study|Withdrawal by Subject|4|||
124567987|NCT00973700|448038855|FG004|Overall Study|Withdrawal by Subject|4|||
124567988|NCT00973700|448038851|FG000|Overall Study|Lost to Follow-up|5|||
124567989|NCT00973700|448038852|FG001|Overall Study|Lost to Follow-up|0|||
124567990|NCT00973700|448038853|FG002|Overall Study|Lost to Follow-up|1|||
124567991|NCT00973700|448038854|FG003|Overall Study|Lost to Follow-up|8|||
124567992|NCT00973700|448038855|FG004|Overall Study|Lost to Follow-up|5|||
124567993|NCT00973700|448038851|FG000|Overall Study|Inappropriate enrolment|0|||
124567994|NCT00973700|448038852|FG001|Overall Study|Inappropriate enrolment|0|||
124567995|NCT00973700|448038853|FG002|Overall Study|Inappropriate enrolment|0|||
124567996|NCT00973700|448038854|FG003|Overall Study|Inappropriate enrolment|4|||
124567997|NCT00973700|448038855|FG004|Overall Study|Inappropriate enrolment|0|||
124567998|NCT00973700|448038851|FG000|Overall Study|Unable to Classify|0|||
124567999|NCT00973700|448038852|FG001|Overall Study|Unable to Classify|0|||
124568000|NCT00973700|448038853|FG002|Overall Study|Unable to Classify|1|||
124568001|NCT00973700|448038854|FG003|Overall Study|Unable to Classify|2|||
124568002|NCT00973700|448038855|FG004|Overall Study|Unable to Classify|1|||
124568003|NCT01901055|448038856|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
124568004|NCT01901055|448038857|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
124568005|NCT01901055|448038856|FG000|Randomization But Not Titrated|Physician Decision|0|||
124568006|NCT01901055|448038857|FG001|Randomization But Not Titrated|Physician Decision|1|||
124568007|NCT01901055|448038856|FG000|Started Protocol to Week 6|Physician Decision|2|||
124568008|NCT01901055|448038857|FG001|Started Protocol to Week 6|Physician Decision|1|||
124568009|NCT01901055|448038856|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
124512711|NCT00830960|447829182|FG001|Overall Study|Death|4|||
124512712|NCT00830960|447829183|FG002|Overall Study|Death|3|||
124512713|NCT00830960|447829184|FG003|Overall Study|Death|2|||
124512714|NCT00830960|447829185|FG004|Overall Study|Death|6|||
124512715|NCT00830960|447829186|FG005|Overall Study|Death|1|||
124512716|NCT00830960|447829181|FG000|Overall Study|Lost to Follow-up|1|||
124512717|NCT00830960|447829182|FG001|Overall Study|Lost to Follow-up|1|||
124512718|NCT00830960|447829183|FG002|Overall Study|Lost to Follow-up|1|||
124512719|NCT00830960|447829184|FG003|Overall Study|Lost to Follow-up|0|||
124512720|NCT00830960|447829185|FG004|Overall Study|Lost to Follow-up|0|||
124512721|NCT00830960|447829186|FG005|Overall Study|Lost to Follow-up|1|||
124512722|NCT00830960|447829181|FG000|Overall Study|Withdrawal by Subject|19|||
124512723|NCT00830960|447829182|FG001|Overall Study|Withdrawal by Subject|19|||
124512724|NCT00830960|447829183|FG002|Overall Study|Withdrawal by Subject|18|||
124512725|NCT00830960|447829184|FG003|Overall Study|Withdrawal by Subject|23|||
124512726|NCT00830960|447829185|FG004|Overall Study|Withdrawal by Subject|16|||
124512727|NCT00830960|447829186|FG005|Overall Study|Withdrawal by Subject|21|||
124512728|NCT00830960|447829181|FG000|Overall Study|Sponsor Decision|1|||
124512729|NCT00830960|447829182|FG001|Overall Study|Sponsor Decision|2|||
124512730|NCT00830960|447829183|FG002|Overall Study|Sponsor Decision|3|||
124512731|NCT00830960|447829184|FG003|Overall Study|Sponsor Decision|4|||
124512732|NCT00830960|447829185|FG004|Overall Study|Sponsor Decision|5|||
124512733|NCT00830960|447829186|FG005|Overall Study|Sponsor Decision|7|||
124512734|NCT00830960|447829181|FG000|Overall Study|No study drug received|7|||
124512735|NCT00830960|447829182|FG001|Overall Study|No study drug received|2|||
124512736|NCT00830960|447829183|FG002|Overall Study|No study drug received|4|||
124512737|NCT00830960|447829184|FG003|Overall Study|No study drug received|3|||
124512738|NCT00830960|447829185|FG004|Overall Study|No study drug received|5|||
124512739|NCT00830960|447829186|FG005|Overall Study|No study drug received|7|||
124512740|NCT01504971|447829187|FG000|Overall Study|Physician Decision|13|||
124512741|NCT03483116|447829188|FG000|Overall Study|Adverse Event|0|||
124512742|NCT03483116|447829189|FG001|Overall Study|Adverse Event|1|||
124512743|NCT03483116|447829190|FG002|Overall Study|Adverse Event|0|||
124512744|NCT03483116|447829191|FG003|Overall Study|Adverse Event|1|||
124512745|NCT03483116|447829188|FG000|Overall Study|Protocol Violation|1|||
124512746|NCT03483116|447829189|FG001|Overall Study|Protocol Violation|0|||
124512747|NCT03483116|447829190|FG002|Overall Study|Protocol Violation|0|||
124512748|NCT03483116|447829191|FG003|Overall Study|Protocol Violation|7|||
124512749|NCT03483116|447829188|FG000|Overall Study|Lost to Follow-up|9|||
124512750|NCT03483116|447829189|FG001|Overall Study|Lost to Follow-up|4|||
124512751|NCT03483116|447829190|FG002|Overall Study|Lost to Follow-up|9|||
124512752|NCT03483116|447829191|FG003|Overall Study|Lost to Follow-up|5|||
124512753|NCT03483116|447829188|FG000|Overall Study|Death|1|||
124512754|NCT03483116|447829189|FG001|Overall Study|Death|0|||
124512755|NCT03483116|447829190|FG002|Overall Study|Death|2|||
124512756|NCT03483116|447829191|FG003|Overall Study|Death|1|||
124512757|NCT03483116|447829188|FG000|Overall Study|Withdrawal by Subject|14|||
124512758|NCT03483116|447829189|FG001|Overall Study|Withdrawal by Subject|16|||
124512759|NCT03483116|447829190|FG002|Overall Study|Withdrawal by Subject|14|||
124512760|NCT03483116|447829191|FG003|Overall Study|Withdrawal by Subject|16|||
124512761|NCT03483116|447829188|FG000|Overall Study|Unknown other reason|3|||
124512762|NCT03483116|447829189|FG001|Overall Study|Unknown other reason|2|||
124512763|NCT03483116|447829190|FG002|Overall Study|Unknown other reason|1|||
124512764|NCT03483116|447829191|FG003|Overall Study|Unknown other reason|1|||
124512765|NCT00426556|447829194|FG000|Phase I - Core Phase|Disease Progression|0|||
124512766|NCT00426556|447829195|FG001|Phase I - Core Phase|Disease Progression|6|||
124512767|NCT00426556|447829196|FG002|Phase I - Core Phase|Disease Progression|2|||
124512768|NCT00426556|447829197|FG003|Phase I - Core Phase|Disease Progression|0|||
124512769|NCT00426556|447829194|FG000|Phase I - Core Phase|Adverse Event|1|||
124512770|NCT00426556|447829195|FG001|Phase I - Core Phase|Adverse Event|3|||
124512771|NCT00426556|447829196|FG002|Phase I - Core Phase|Adverse Event|1|||
124512772|NCT00426556|447829197|FG003|Phase I - Core Phase|Adverse Event|0|||
124512773|NCT00426556|447829194|FG000|Phase I - Core Phase|Death|0|||
124512774|NCT00426556|447829195|FG001|Phase I - Core Phase|Death|1|||
124512775|NCT00426556|447829196|FG002|Phase I - Core Phase|Death|0|||
124512776|NCT00426556|447829197|FG003|Phase I - Core Phase|Death|0|||
124512777|NCT00426556|447829194|FG000|Phase I - Extension Phase|Adverse Event|0|||
124512778|NCT00426556|447829195|FG001|Phase I - Extension Phase|Adverse Event|1|||
124512779|NCT00426556|447829196|FG002|Phase I - Extension Phase|Adverse Event|1|||
124512780|NCT00426556|447829197|FG003|Phase I - Extension Phase|Adverse Event|0|||
124512781|NCT00426556|447829194|FG000|Phase I - Extension Phase|Disease Progression|5|||
124512782|NCT00426556|447829195|FG001|Phase I - Extension Phase|Disease Progression|5|||
124512783|NCT00426556|447829196|FG002|Phase I - Extension Phase|Disease Progression|6|||
124512784|NCT00426556|447829197|FG003|Phase I - Extension Phase|Disease Progression|0|||
124512785|NCT00426556|447829194|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
124512786|NCT00426556|447829195|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
124512787|NCT00426556|447829196|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
124512788|NCT00426556|447829197|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
124512789|NCT00426556|447829194|FG000|Phase II - Core Phase|Disease Progression|0|||
124512790|NCT00426556|447829195|FG001|Phase II - Core Phase|Disease Progression|0|||
124512791|NCT00426556|447829196|FG002|Phase II - Core Phase|Disease Progression|0|||
124512792|NCT00426556|447829197|FG003|Phase II - Core Phase|Disease Progression|16|||
124512793|NCT00426556|447829194|FG000|Phase II - Core Phase|Adverse Event|0|||
124512794|NCT00426556|447829195|FG001|Phase II - Core Phase|Adverse Event|0|||
124512795|NCT00426556|447829196|FG002|Phase II - Core Phase|Adverse Event|0|||
124512796|NCT00426556|447829197|FG003|Phase II - Core Phase|Adverse Event|8|||
124512797|NCT00426556|447829194|FG000|Phase II - Extension Phase|Disease Progression|0|||
124512798|NCT00426556|447829195|FG001|Phase II - Extension Phase|Disease Progression|0|||
124512799|NCT00426556|447829196|FG002|Phase II - Extension Phase|Disease Progression|0|||
124512800|NCT00426556|447829197|FG003|Phase II - Extension Phase|Disease Progression|21|||
124512801|NCT00426556|447829194|FG000|Phase II - Extension Phase|Adverse Event|0|||
124512802|NCT00426556|447829195|FG001|Phase II - Extension Phase|Adverse Event|0|||
124512803|NCT00426556|447829196|FG002|Phase II - Extension Phase|Adverse Event|0|||
124512804|NCT00426556|447829197|FG003|Phase II - Extension Phase|Adverse Event|2|||
124512805|NCT00225212|447829198|FG000|Overall Study|Disease progression|2|||
124512806|NCT00225212|447829198|FG000|Overall Study|Death|1|||
124512807|NCT00225212|447829198|FG000|Overall Study|Adverse Event|2|||
124512808|NCT00225212|447829198|FG000|Overall Study|Intercurrent illness|1|||
124512809|NCT01182337|447829205|FG000|Overall Study|Withdrawal by Subject|3|||
124512810|NCT01182337|447829206|FG001|Overall Study|Withdrawal by Subject|1|||
124512811|NCT01182337|447829205|FG000|Overall Study|Lost to Follow-up|0|||
124512812|NCT01182337|447829206|FG001|Overall Study|Lost to Follow-up|1|||
124512813|NCT03448224|447829207|FG000|Overall Study|Provided same answer to every question|1|||
124512814|NCT03448224|447829208|FG001|Overall Study|Provided same answer to every question|0|||
124512815|NCT03103906|447829209|FG000|Overall Study|Adverse Event|2|||
124512816|NCT03103906|447829210|FG001|Overall Study|Adverse Event|3|||
124512817|NCT03103906|447829209|FG000|Overall Study|Other|2|||
124512818|NCT03103906|447829210|FG001|Overall Study|Other|0|||
124512819|NCT03571256|447829211|FG000|Overall Study|Adverse Event|3|||
124512820|NCT03571256|447829212|FG001|Overall Study|Adverse Event|0|||
124512821|NCT03571256|447829213|FG002|Overall Study|Adverse Event|1|||
124512822|NCT03571256|447829211|FG000|Overall Study|Withdrawal by Subject|3|||
124512823|NCT03571256|447829212|FG001|Overall Study|Withdrawal by Subject|1|||
124512824|NCT03571256|447829213|FG002|Overall Study|Withdrawal by Subject|1|||
124512825|NCT03571256|447829211|FG000|Overall Study|Other than specified|0|||
124512826|NCT03571256|447829212|FG001|Overall Study|Other than specified|1|||
124512827|NCT03571256|447829213|FG002|Overall Study|Other than specified|1|||
124512828|NCT03571256|447829211|FG000|Overall Study|Protocol Violation|0|||
124512829|NCT03571256|447829212|FG001|Overall Study|Protocol Violation|1|||
124512830|NCT03571256|447829213|FG002|Overall Study|Protocol Violation|1|||
124512831|NCT00575094|447829216|FG000|Overall Study|Adverse Event|2|||
124512832|NCT00575094|447829216|FG000|Overall Study|Withdrawal by Subject|1|||
124512833|NCT00772382|447829217|FG000|Overall Study|Adverse Event|19|||
124512834|NCT00772382|447829217|FG000|Overall Study|Death|6|||
124512835|NCT00772382|447829217|FG000|Overall Study|Lack of Efficacy|4|||
124512836|NCT00772382|447829217|FG000|Overall Study|Physician Decision|5|||
124512837|NCT00772382|447829217|FG000|Overall Study|Protocol Violation|1|||
124512838|NCT00772382|447829217|FG000|Overall Study|Withdrawal by Subject|10|||
124512839|NCT00772382|447829217|FG000|Overall Study|Other Reasons|10|||
124512840|NCT00643604|447829225|FG000|Overall Study|Death|1|||
124512841|NCT02702011|447829227|FG000|Overall Study|Withdrawal by Subject|0|||
124512842|NCT02702011|447829228|FG001|Overall Study|Withdrawal by Subject|1|||
124512843|NCT02702011|447829229|FG002|Overall Study|Withdrawal by Subject|0|||
124512844|NCT02702011|447829230|FG003|Overall Study|Withdrawal by Subject|0|||
124512845|NCT01374217|447829232|FG000|Overall Study|Lack of Efficacy|13|||
124512846|NCT01740388|447829233|FG000|Overall Study|Withdrawal by Subject|1|||
124512847|NCT01740388|447829234|FG001|Overall Study|Withdrawal by Subject|2|||
124512848|NCT01740388|447829233|FG000|Overall Study|Lost to Follow-up|2|||
124512849|NCT01740388|447829234|FG001|Overall Study|Lost to Follow-up|0|||
124512850|NCT01740388|447829233|FG000|Overall Study|Physician Decision|2|||
124512851|NCT01740388|447829234|FG001|Overall Study|Physician Decision|6|||
124512852|NCT01740388|447829233|FG000|Overall Study|Subjects missing data, completed|41|||
124512853|NCT01740388|447829234|FG001|Overall Study|Subjects missing data, completed|36|||
124512854|NCT00862121|447829237|FG000|Overall Study|Adverse Event|1|||
124512855|NCT00862121|447829238|FG001|Overall Study|Adverse Event|2|||
124512856|NCT00862121|447829237|FG000|Overall Study|Lack of Efficacy|0|||
124512857|NCT00862121|447829238|FG001|Overall Study|Lack of Efficacy|3|||
124512858|NCT00862121|447829237|FG000|Overall Study|Protocol Violation|0|||
124512859|NCT00862121|447829238|FG001|Overall Study|Protocol Violation|1|||
124512860|NCT00862121|447829237|FG000|Overall Study|Exclusion criterion violation|0|||
124512861|NCT00862121|447829238|FG001|Overall Study|Exclusion criterion violation|1|||
124512862|NCT00862121|447829237|FG000|Overall Study|Incorrect randomisation|0|||
124512863|NCT00862121|447829238|FG001|Overall Study|Incorrect randomisation|1|||
124512864|NCT01641991|447829239|FG000|Overall Study|Physician Decision|0|||
124512865|NCT01641991|447829240|FG001|Overall Study|Physician Decision|1|||
124512866|NCT01641991|447829241|FG002|Overall Study|Physician Decision|7|||
124512867|NCT01641991|447829242|FG003|Overall Study|Physician Decision|5|||
124512868|NCT01641991|447829239|FG000|Overall Study|Withdrawal by Subject|4|||
124512869|NCT01641991|447829240|FG001|Overall Study|Withdrawal by Subject|2|||
124512870|NCT01641991|447829241|FG002|Overall Study|Withdrawal by Subject|1|||
124512871|NCT01641991|447829242|FG003|Overall Study|Withdrawal by Subject|5|||
124512872|NCT01641991|447829239|FG000|Overall Study|Adverse Event|2|||
124512873|NCT01641991|447829240|FG001|Overall Study|Adverse Event|1|||
124512874|NCT01641991|447829241|FG002|Overall Study|Adverse Event|2|||
124512875|NCT01641991|447829242|FG003|Overall Study|Adverse Event|1|||
124512876|NCT01641991|447829239|FG000|Overall Study|Lost to Follow-up|0|||
124512877|NCT01641991|447829240|FG001|Overall Study|Lost to Follow-up|2|||
124512878|NCT01641991|447829241|FG002|Overall Study|Lost to Follow-up|3|||
124512879|NCT01641991|447829242|FG003|Overall Study|Lost to Follow-up|1|||
124512880|NCT01641991|447829239|FG000|Overall Study|Protocol Violation|1|||
124512881|NCT01641991|447829240|FG001|Overall Study|Protocol Violation|1|||
124512882|NCT01641991|447829241|FG002|Overall Study|Protocol Violation|3|||
124512883|NCT01641991|447829242|FG003|Overall Study|Protocol Violation|0|||
124512884|NCT01641991|447829239|FG000|Overall Study|Pregnancy|0|||
124512885|NCT01641991|447829240|FG001|Overall Study|Pregnancy|0|||
124512886|NCT01641991|447829241|FG002|Overall Study|Pregnancy|1|||
124512887|NCT01641991|447829242|FG003|Overall Study|Pregnancy|0|||
124512888|NCT01641991|447829239|FG000|Overall Study|no longer eligible|2|||
124512889|NCT01641991|447829240|FG001|Overall Study|no longer eligible|1|||
124568010|NCT01901055|448038857|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
124568011|NCT01901055|448038856|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
124512890|NCT01641991|447829241|FG002|Overall Study|no longer eligible|0|||
124512891|NCT01641991|447829242|FG003|Overall Study|no longer eligible|4|||
124512892|NCT01578785|447829247|FG000|Overall Study|Withdrawal by Subject|0|||
124512893|NCT01578785|447829248|FG001|Overall Study|Withdrawal by Subject|1|||
124512894|NCT01578785|447829247|FG000|Overall Study|Study terminated by sponsor|59|||
124512895|NCT01578785|447829248|FG001|Overall Study|Study terminated by sponsor|118|||
124512896|NCT03371732|447829249|FG000|Overall Study|Withdrawal by Subject|9|||
124512897|NCT03371732|447829250|FG001|Overall Study|Withdrawal by Subject|3|||
124512898|NCT03371732|447829249|FG000|Overall Study|Refusal to continue|3|||
124512899|NCT03371732|447829250|FG001|Overall Study|Refusal to continue|4|||
124512900|NCT00171314|447829251|FG000|Overall Study|Adverse Event|44|||
124637315|NCT00507455|448290462|FG000|Overall Study|Other - miscellaneous reason|1|||
124512901|NCT00171314|447829252|FG001|Overall Study|Adverse Event|41|||
124512902|NCT00171314|447829251|FG000|Overall Study|Lack of Efficacy|19|||
124512903|NCT00171314|447829252|FG001|Overall Study|Lack of Efficacy|14|||
124512904|NCT00171314|447829251|FG000|Overall Study|Withdrawal by Subject|9|||
124568012|NCT01901055|448038857|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
124568013|NCT01901055|448038856|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
124568014|NCT01901055|448038857|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
124568015|NCT01901055|448038856|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
124568016|NCT01901055|448038857|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
124568017|NCT01901055|448038856|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
124568018|NCT01901055|448038857|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
124568019|NCT01901055|448038856|FG000|Week 24|Withdrawal by Subject|13|||
124568020|NCT01901055|448038857|FG001|Week 24|Withdrawal by Subject|19|||
124568021|NCT01901055|448038856|FG000|Week 24|Physician Decision|1|||
124568022|NCT01901055|448038857|FG001|Week 24|Physician Decision|0|||
124568023|NCT01901055|448038856|FG000|Week 36|Withdrawal by Subject|0|||
124568024|NCT01901055|448038857|FG001|Week 36|Withdrawal by Subject|5|||
124568025|NCT00525590|448038863|FG000|Overall Study|Adverse Event|3|||
124568026|NCT00525590|448038863|FG000|Overall Study|Physician Decision|3|||
124568027|NCT00525590|448038863|FG000|Overall Study|Withdrawal by Subject|16|||
124568028|NCT00525590|448038863|FG000|Overall Study|Lost to Follow-up|1|||
124568029|NCT00525590|448038863|FG000|Overall Study|Death|9|||
124568030|NCT00525590|448038863|FG000|Overall Study|Other|13|||
124568031|NCT00948675|448038864|FG000|Overall Study|Lost to Follow-up|1|||
124568032|NCT00948675|448038865|FG001|Overall Study|Lost to Follow-up|0|||
124568033|NCT00770510|448038871|FG000|Overall Study|Lost to Follow-up|2|||
124568034|NCT00770510|448038871|FG000|Overall Study|Pregnancy|1|||
124568035|NCT00770510|448038871|FG000|Overall Study|Withdrawal by Subject|2|||
124568036|NCT02192099|448038875|FG000|Overall Study|Adverse Event|1|||
124568037|NCT02192099|448038875|FG000|Overall Study|Lost to Follow-up|2|||
124568038|NCT02192099|448038875|FG000|Overall Study|Physician Decision|1|||
124568039|NCT02192099|448038875|FG000|Overall Study|Pregnancy|1|||
124568040|NCT02192099|448038875|FG000|Overall Study|Protocol Violation|8|||
124568041|NCT02192099|448038875|FG000|Overall Study|Study Terminated by Sponsor|32|||
124568042|NCT02192099|448038875|FG000|Overall Study|Withdrawal by Subject|11|||
124568043|NCT02192099|448038875|FG000|Overall Study|Miscellaneous Reasons|5|||
124568044|NCT02796664|448038878|FG000|Overall Study|Withdrawal by Subject|0|||
124568045|NCT02796664|448038879|FG001|Overall Study|Withdrawal by Subject|3|||
124568046|NCT02796664|448038878|FG000|Overall Study|Noncompliance|1|||
124568047|NCT02796664|448038879|FG001|Overall Study|Noncompliance|1|||
124568048|NCT02796664|448038878|FG000|Overall Study|Death|0|||
124568049|NCT02796664|448038879|FG001|Overall Study|Death|1|||
124568050|NCT02246478|448038880|FG000|Multiple-dose Phase|Protocol Violation|1|||
124568051|NCT02246478|448038881|FG001|Multiple-dose Phase|Protocol Violation|0|||
124568052|NCT02246478|448038882|FG002|Multiple-dose Phase|Protocol Violation|0|||
124568053|NCT02246478|448038883|FG003|Multiple-dose Phase|Protocol Violation|1|||
124568054|NCT01531205|448038888|FG000|Overall Study|Did not proceed to surgery|1|||
124568055|NCT02001558|448038889|FG000|Overall Study|Lost to Follow-up|8|||
124568056|NCT02001558|448038890|FG001|Overall Study|Lost to Follow-up|14|||
124568057|NCT04128007|448038891|FG000|Overall Study|Withdrawal by Subject|9|||
124568058|NCT04128007|448038892|FG001|Overall Study|Withdrawal by Subject|6|||
124568059|NCT04128007|448038891|FG000|Overall Study|Protocol Violation|1|||
124568060|NCT04128007|448038892|FG001|Overall Study|Protocol Violation|0|||
124568061|NCT04128007|448038891|FG000|Overall Study|Lost to Follow-up|8|||
124568062|NCT04128007|448038892|FG001|Overall Study|Lost to Follow-up|7|||
124568063|NCT04128007|448038891|FG000|Overall Study|Adverse Event|5|||
124568064|NCT04128007|448038892|FG001|Overall Study|Adverse Event|2|||
124568065|NCT04128007|448038891|FG000|Overall Study|Not reported|0|||
124568066|NCT04128007|448038892|FG001|Overall Study|Not reported|2|||
124568067|NCT04117607|448038893|FG000|Overall Study|Early Termination|0|||
124568068|NCT04117607|448038894|FG001|Overall Study|Early Termination|1|||
124568069|NCT04117607|448038895|FG002|Overall Study|Early Termination|0|||
124568070|NCT04117607|448038896|FG003|Overall Study|Early Termination|0|||
124568071|NCT04117607|448038897|FG004|Overall Study|Early Termination|0|||
124568072|NCT04117607|448038898|FG005|Overall Study|Early Termination|0|||
124568073|NCT04117607|448038899|FG006|Overall Study|Early Termination|1|||
124568074|NCT04117607|448038900|FG007|Overall Study|Early Termination|0|||
124568075|NCT04117607|448038901|FG008|Overall Study|Early Termination|0|||
124568076|NCT04117607|448038902|FG009|Overall Study|Early Termination|0|||
124568077|NCT04117607|448038903|FG010|Overall Study|Early Termination|0|||
124568078|NCT04117607|448038904|FG011|Overall Study|Early Termination|0|||
124568079|NCT04117607|448038905|FG012|Overall Study|Early Termination|0|||
124568080|NCT04117607|448038906|FG013|Overall Study|Early Termination|0|||
124568081|NCT00950807|448038910|FG000|Treatment Period 1|Lack of Efficacy|1|||
124568082|NCT00950807|448038911|FG001|Treatment Period 1|Lack of Efficacy|0|||
124568083|NCT00950807|448038912|FG002|Treatment Period 1|Lack of Efficacy|0|||
124568084|NCT00950807|448038913|FG003|Treatment Period 1|Lack of Efficacy|0|||
124568085|NCT00950807|448038914|FG004|Treatment Period 1|Lack of Efficacy|0|||
124568086|NCT00950807|448038915|FG005|Treatment Period 1|Lack of Efficacy|1|||
124568087|NCT00950807|448038916|FG006|Treatment Period 1|Lack of Efficacy|0|||
124568088|NCT00950807|448038917|FG007|Treatment Period 1|Lack of Efficacy|0|||
124568089|NCT00950807|448038918|FG008|Treatment Period 1|Lack of Efficacy|0|||
124512905|NCT00171314|447829252|FG001|Overall Study|Withdrawal by Subject|6|||
124512906|NCT00171314|447829251|FG000|Overall Study|Abnormal Test Procedure Results|9|||
124512907|NCT00171314|447829252|FG001|Overall Study|Abnormal Test Procedure Results|3|||
124512908|NCT00171314|447829251|FG000|Overall Study|Protocol Violation|3|||
124512909|NCT00171314|447829252|FG001|Overall Study|Protocol Violation|7|||
124512910|NCT00171314|447829251|FG000|Overall Study|Administrative Problems|4|||
124512911|NCT00171314|447829252|FG001|Overall Study|Administrative Problems|3|||
124512912|NCT00171314|447829251|FG000|Overall Study|Lost to Follow-up|1|||
124512913|NCT00171314|447829252|FG001|Overall Study|Lost to Follow-up|3|||
124512914|NCT00171314|447829251|FG000|Overall Study|Death|2|||
124512915|NCT00171314|447829252|FG001|Overall Study|Death|1|||
124512916|NCT00475540|447829253|FG000|36 Months|Lost to Follow-up|4|||
124512917|NCT00475540|447829254|FG001|36 Months|Lost to Follow-up|4|||
124512918|NCT00475540|447829253|FG000|36 Months|Death|1|||
124512919|NCT00475540|447829254|FG001|36 Months|Death|2|||
124512920|NCT00475540|447829253|FG000|36 Months|Censored due to reoperation|3|||
124512921|NCT00475540|447829254|FG001|36 Months|Censored due to reoperation|0|||
124512922|NCT00377429|447829255|FG000|Overall Study|Withdrawal by Subject|5|||
124512923|NCT00377429|447829255|FG000|Overall Study|Adverse Event|8|||
124512924|NCT00377429|447829255|FG000|Overall Study|Physician Decision|1|||
124512925|NCT00377429|447829255|FG000|Overall Study|Patient non-compliance|1|||
124512926|NCT01033487|447829261|FG000|Fourth Intervention Period|Adverse Event|0|||
124512927|NCT01033487|447829262|FG001|Fourth Intervention Period|Adverse Event|0|||
124512928|NCT01033487|447829263|FG002|Fourth Intervention Period|Adverse Event|0|||
124512929|NCT01033487|447829264|FG003|Fourth Intervention Period|Adverse Event|0|||
124512930|NCT01033487|447829265|FG004|Fourth Intervention Period|Adverse Event|0|||
124512931|NCT01033487|447829266|FG005|Fourth Intervention Period|Adverse Event|0|||
124512932|NCT01033487|447829267|FG006|Fourth Intervention Period|Adverse Event|0|||
124512933|NCT01033487|447829268|FG007|Fourth Intervention Period|Adverse Event|0|||
124512934|NCT01033487|447829269|FG008|Fourth Intervention Period|Adverse Event|1|||
124512935|NCT01033487|447829270|FG009|Fourth Intervention Period|Adverse Event|0|||
124512936|NCT02939599|447829271|FG000|Overall Study|Adverse Event|1|||
124512937|NCT02939599|447829272|FG001|Overall Study|Adverse Event|0|||
124512938|NCT02939599|447829271|FG000|Overall Study|Study Terminated By Sponsor|2|||
124512939|NCT02939599|447829272|FG001|Overall Study|Study Terminated By Sponsor|2|||
124512940|NCT02148211|447829273|FG000|Overall Study|Lost to Follow-up|352|||
124512941|NCT02726113|447829274|FG000|Total Enrollment|Physician Decision|0|||
124512942|NCT02726113|447829275|FG001|Total Enrollment|Physician Decision|1|||
124512943|NCT02726113|447829274|FG000|Total Enrollment|Protocol Violation|1|||
124512944|NCT02726113|447829275|FG001|Total Enrollment|Protocol Violation|0|||
124512945|NCT02726113|447829274|FG000|Total Enrollment|Withdrawal by Subject|2|||
124512946|NCT02726113|447829275|FG001|Total Enrollment|Withdrawal by Subject|1|||
124512947|NCT02726113|447829274|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
124512948|NCT02726113|447829275|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
124512949|NCT02726113|447829274|FG000|Genomic Analysis|Protocol Violation|1|||
124512950|NCT02726113|447829275|FG001|Genomic Analysis|Protocol Violation|0|||
124512951|NCT02726113|447829274|FG000|Genomic Analysis|Withdrawal by Subject|2|||
124512952|NCT02726113|447829275|FG001|Genomic Analysis|Withdrawal by Subject|1|||
124512953|NCT02726113|447829274|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
124512954|NCT02726113|447829275|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
124512955|NCT01512108|447830939|FG000|Overall Study|Adverse Event|9|||
124512956|NCT01512108|447830940|FG001|Overall Study|Adverse Event|4|||
124512957|NCT01512108|447830939|FG000|Overall Study|Protocol Violation|1|||
124512958|NCT01512108|447830940|FG001|Overall Study|Protocol Violation|2|||
124512959|NCT01512108|447830939|FG000|Overall Study|Withdrawal Criteria|1|||
124512960|NCT01512108|447830940|FG001|Overall Study|Withdrawal Criteria|0|||
124512961|NCT01512108|447830939|FG000|Overall Study|Unclassified|11|||
124512962|NCT01512108|447830940|FG001|Overall Study|Unclassified|3|||
124512963|NCT01824693|447830941|FG000|Overall Study|Death|0|||
124512964|NCT01824693|447830942|FG001|Overall Study|Death|1|||
124512965|NCT01824693|447830943|FG002|Overall Study|Death|0|||
124512966|NCT01824693|447830941|FG000|Overall Study|Physician Decision|1|||
124512967|NCT01824693|447830942|FG001|Overall Study|Physician Decision|1|||
124512968|NCT01824693|447830943|FG002|Overall Study|Physician Decision|1|||
124512969|NCT01824693|447830941|FG000|Overall Study|Withdrawal by Subject|0|||
124512970|NCT01824693|447830942|FG001|Overall Study|Withdrawal by Subject|0|||
124512971|NCT01824693|447830943|FG002|Overall Study|Withdrawal by Subject|1|||
124512972|NCT01824693|447830941|FG000|Overall Study|Progressive Disease|0|||
124512973|NCT01824693|447830942|FG001|Overall Study|Progressive Disease|5|||
124512974|NCT01824693|447830943|FG002|Overall Study|Progressive Disease|0|||
124512975|NCT01824693|447830941|FG000|Overall Study|Ineligible|0|||
124512976|NCT01824693|447830942|FG001|Overall Study|Ineligible|0|||
124512977|NCT01824693|447830943|FG002|Overall Study|Ineligible|3|||
124512978|NCT01824693|447830941|FG000|Overall Study|No Transplant Planned|0|||
124512979|NCT01824693|447830942|FG001|Overall Study|No Transplant Planned|0|||
124512980|NCT01824693|447830943|FG002|Overall Study|No Transplant Planned|10|||
124512981|NCT03287869|447830946|FG000|Overall Study|Adverse Event|14|||
124512982|NCT03287869|447830947|FG001|Overall Study|Adverse Event|12|||
124512983|NCT03287869|447830946|FG000|Overall Study|Lack of Efficacy|1|||
124512984|NCT03287869|447830947|FG001|Overall Study|Lack of Efficacy|0|||
124512985|NCT03287869|447830946|FG000|Overall Study|Lost to Follow-up|13|||
124512986|NCT03287869|447830947|FG001|Overall Study|Lost to Follow-up|19|||
124512987|NCT03287869|447830946|FG000|Overall Study|Non-Compliance With Study Drug|5|||
124512988|NCT03287869|447830947|FG001|Overall Study|Non-Compliance With Study Drug|9|||
124512989|NCT03287869|447830946|FG000|Overall Study|Progressive Disease|1|||
124512990|NCT03287869|447830947|FG001|Overall Study|Progressive Disease|0|||
124512991|NCT03287869|447830946|FG000|Overall Study|Protocol Deviation|2|||
124512992|NCT03287869|447830947|FG001|Overall Study|Protocol Deviation|1|||
124512993|NCT03287869|447830946|FG000|Overall Study|Withdrawal by Subject|36|||
124512994|NCT03287869|447830947|FG001|Overall Study|Withdrawal by Subject|43|||
124512995|NCT03287869|447830946|FG000|Overall Study|Early Closure of the Site|0|||
124512996|NCT03287869|447830947|FG001|Overall Study|Early Closure of the Site|1|||
124512997|NCT03287869|447830946|FG000|Overall Study|Physician Decision|5|||
124512998|NCT03287869|447830947|FG001|Overall Study|Physician Decision|5|||
124512999|NCT03287869|447830946|FG000|Overall Study|Reason not Specified|6|||
124513000|NCT03287869|447830947|FG001|Overall Study|Reason not Specified|3|||
124513001|NCT03488238|447830948|FG000|Overall Study|Equipment malfunction|1|||
124513002|NCT03488238|447830948|FG000|Overall Study|Adverse Event|1|||
124513003|NCT00656084|447830949|FG000|Overall Study|Adverse Event|4|||
124513004|NCT00656084|447830949|FG000|Overall Study|Withdrawal by Subject|1|||
124513005|NCT00656084|447830949|FG000|Overall Study|Patient Request|1|||
124513006|NCT00656084|447830949|FG000|Overall Study|Investigator Request|1|||
124513007|NCT02591238|447830950|FG000|Overall Study|Pregnancy|1|||
124513008|NCT02591238|447830951|FG001|Overall Study|Pregnancy|0|||
124513009|NCT02591238|447830952|FG002|Overall Study|Pregnancy|0|||
124513010|NCT02591238|447830953|FG003|Overall Study|Pregnancy|0|||
124513011|NCT02591238|447830950|FG000|Overall Study|Withdrawal by Subject|0|||
124513012|NCT02591238|447830951|FG001|Overall Study|Withdrawal by Subject|0|||
124513013|NCT02591238|447830952|FG002|Overall Study|Withdrawal by Subject|0|||
124513014|NCT02591238|447830953|FG003|Overall Study|Withdrawal by Subject|1|||
124513015|NCT02591238|447830950|FG000|Overall Study|influenza|0|||
124513016|NCT02591238|447830951|FG001|Overall Study|influenza|0|||
124513017|NCT02591238|447830952|FG002|Overall Study|influenza|0|||
124513018|NCT02591238|447830953|FG003|Overall Study|influenza|1|||
124513019|NCT02591238|447830950|FG000|Overall Study|personal circumstances|0|||
124513020|NCT02591238|447830951|FG001|Overall Study|personal circumstances|0|||
124513021|NCT02591238|447830952|FG002|Overall Study|personal circumstances|0|||
124513022|NCT02591238|447830953|FG003|Overall Study|personal circumstances|1|||
124513023|NCT02591238|447830950|FG000|Overall Study|personal circumstances|0|||
124513024|NCT02591238|447830951|FG001|Overall Study|personal circumstances|1|||
124513025|NCT02591238|447830952|FG002|Overall Study|personal circumstances|0|||
124513026|NCT02591238|447830953|FG003|Overall Study|personal circumstances|0|||
124513027|NCT00953225|447830954|FG000|Overall Study|Withdrawal by Subject|2|||
124513028|NCT00953225|447830955|FG001|Overall Study|Withdrawal by Subject|0|||
124513029|NCT00640146|447830959|FG000|Overall Study|Adverse Event|2|||
124513030|NCT00640146|447830960|FG001|Overall Study|Adverse Event|0|||
124513031|NCT00640146|447830959|FG000|Overall Study|Lost to Follow-up|0|||
124513032|NCT00640146|447830960|FG001|Overall Study|Lost to Follow-up|1|||
124513033|NCT00640146|447830959|FG000|Overall Study|Lack of Efficacy|0|||
124513034|NCT00640146|447830960|FG001|Overall Study|Lack of Efficacy|1|||
124513035|NCT00640146|447830959|FG000|Overall Study|Withdrawal by Subject|1|||
124513036|NCT00640146|447830960|FG001|Overall Study|Withdrawal by Subject|1|||
124513037|NCT00640146|447830959|FG000|Overall Study|Randomized but not treated|1|||
124513038|NCT00640146|447830960|FG001|Overall Study|Randomized but not treated|3|||
124513039|NCT04058158|447830961|FG000|Period 1|Death|1|||
124513040|NCT04058158|447830962|FG001|Period 1|Death|0|||
124513041|NCT04058158|447830961|FG000|Period 1|Adverse Event|1|||
124513042|NCT04058158|447830962|FG001|Period 1|Adverse Event|1|||
124513043|NCT04058158|447830961|FG000|Period 1|Pregnancy|0|||
124513044|NCT04058158|447830962|FG001|Period 1|Pregnancy|1|||
124513045|NCT01634113|447830963|FG000|Overall Study|Not treated|0|||
124513046|NCT01634113|447830964|FG001|Overall Study|Not treated|0|||
124513047|NCT01634113|447830965|FG002|Overall Study|Not treated|1|||
124513048|NCT00324740|447830966|FG000|Overall Study|Withdrawal by Subject|1|||
124513049|NCT00324740|447830967|FG001|Overall Study|Withdrawal by Subject|0|||
124513050|NCT00324740|447830968|FG002|Overall Study|Withdrawal by Subject|1|||
124513051|NCT03628599|447830969|FG000|Overall Study|Adverse Event|0|||
124513052|NCT03628599|447830970|FG001|Overall Study|Adverse Event|1|||
124513053|NCT02514772|447830971|FG000|Overall Study|Adverse Event|1|||
124513054|NCT02514772|447830972|FG001|Overall Study|Adverse Event|0|||
124513055|NCT02514772|447830971|FG000|Overall Study|Death|0|||
124513056|NCT02514772|447830972|FG001|Overall Study|Death|1|||
124513057|NCT02514772|447830971|FG000|Overall Study|Withdrawal by Subject|2|||
124513058|NCT02514772|447830972|FG001|Overall Study|Withdrawal by Subject|1|||
124513059|NCT03250377|447830973|FG000|Overall Study|Adverse Event|2|||
124513060|NCT03250377|447830974|FG001|Overall Study|Adverse Event|4|||
124513061|NCT03250377|447830975|FG002|Overall Study|Adverse Event|0|||
124513062|NCT03250377|447830976|FG003|Overall Study|Adverse Event|4|||
124568090|NCT00950807|448038919|FG009|Treatment Period 1|Lack of Efficacy|0|||
124568091|NCT00950807|448038910|FG000|Treatment Period 1|Protocol Violation|1|||
124568092|NCT00950807|448038911|FG001|Treatment Period 1|Protocol Violation|0|||
124568093|NCT00950807|448038912|FG002|Treatment Period 1|Protocol Violation|0|||
124568094|NCT00950807|448038913|FG003|Treatment Period 1|Protocol Violation|0|||
124568095|NCT00950807|448038914|FG004|Treatment Period 1|Protocol Violation|0|||
124568096|NCT00950807|448038915|FG005|Treatment Period 1|Protocol Violation|0|||
124568097|NCT00950807|448038916|FG006|Treatment Period 1|Protocol Violation|0|||
124568098|NCT00950807|448038917|FG007|Treatment Period 1|Protocol Violation|0|||
124568099|NCT00950807|448038918|FG008|Treatment Period 1|Protocol Violation|0|||
124568100|NCT00950807|448038919|FG009|Treatment Period 1|Protocol Violation|0|||
124568101|NCT00950807|448038910|FG000|Treatment Period 1|Lost to Follow-up|0|||
124568102|NCT00950807|448038911|FG001|Treatment Period 1|Lost to Follow-up|0|||
124568103|NCT00950807|448038912|FG002|Treatment Period 1|Lost to Follow-up|1|||
124568104|NCT00950807|448038913|FG003|Treatment Period 1|Lost to Follow-up|0|||
124568105|NCT00950807|448038914|FG004|Treatment Period 1|Lost to Follow-up|0|||
124568106|NCT00950807|448038915|FG005|Treatment Period 1|Lost to Follow-up|0|||
124568107|NCT00950807|448038916|FG006|Treatment Period 1|Lost to Follow-up|0|||
124568108|NCT00950807|448038917|FG007|Treatment Period 1|Lost to Follow-up|0|||
124568109|NCT00950807|448038918|FG008|Treatment Period 1|Lost to Follow-up|0|||
124568110|NCT00950807|448038919|FG009|Treatment Period 1|Lost to Follow-up|0|||
124568111|NCT00950807|448038910|FG000|Treatment Period 1|Withdrawal by Subject|1|||
124568112|NCT00950807|448038911|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124568113|NCT00950807|448038912|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124568114|NCT00950807|448038913|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124568115|NCT00950807|448038914|FG004|Treatment Period 1|Withdrawal by Subject|1|||
124568116|NCT00950807|448038915|FG005|Treatment Period 1|Withdrawal by Subject|0|||
124568117|NCT00950807|448038916|FG006|Treatment Period 1|Withdrawal by Subject|0|||
124568118|NCT00950807|448038917|FG007|Treatment Period 1|Withdrawal by Subject|0|||
124568119|NCT00950807|448038918|FG008|Treatment Period 1|Withdrawal by Subject|1|||
124568120|NCT00950807|448038919|FG009|Treatment Period 1|Withdrawal by Subject|0|||
124568121|NCT00950807|448038910|FG000|Treatment Period 1|Adverse Event|0|||
124568122|NCT00950807|448038911|FG001|Treatment Period 1|Adverse Event|0|||
124568123|NCT00950807|448038912|FG002|Treatment Period 1|Adverse Event|0|||
124568124|NCT00950807|448038913|FG003|Treatment Period 1|Adverse Event|0|||
124568125|NCT00950807|448038914|FG004|Treatment Period 1|Adverse Event|0|||
124568126|NCT00950807|448038915|FG005|Treatment Period 1|Adverse Event|1|||
124568127|NCT00950807|448038916|FG006|Treatment Period 1|Adverse Event|0|||
124568128|NCT00950807|448038917|FG007|Treatment Period 1|Adverse Event|0|||
124568129|NCT00950807|448038918|FG008|Treatment Period 1|Adverse Event|0|||
124568130|NCT00950807|448038919|FG009|Treatment Period 1|Adverse Event|0|||
124568131|NCT00950807|448038910|FG000|Washout Period 1|Lack of Efficacy|0|||
124568132|NCT00950807|448038911|FG001|Washout Period 1|Lack of Efficacy|0|||
124568133|NCT00950807|448038912|FG002|Washout Period 1|Lack of Efficacy|0|||
124568134|NCT00950807|448038913|FG003|Washout Period 1|Lack of Efficacy|0|||
124568135|NCT00950807|448038914|FG004|Washout Period 1|Lack of Efficacy|0|||
124568136|NCT00950807|448038915|FG005|Washout Period 1|Lack of Efficacy|0|||
124568137|NCT00950807|448038916|FG006|Washout Period 1|Lack of Efficacy|1|||
124568138|NCT00950807|448038917|FG007|Washout Period 1|Lack of Efficacy|0|||
124568139|NCT00950807|448038918|FG008|Washout Period 1|Lack of Efficacy|0|||
124568140|NCT00950807|448038919|FG009|Washout Period 1|Lack of Efficacy|0|||
124568141|NCT00950807|448038910|FG000|Washout Period 1|Withdrawal by Subject|0|||
124568142|NCT00950807|448038911|FG001|Washout Period 1|Withdrawal by Subject|0|||
124568143|NCT00950807|448038912|FG002|Washout Period 1|Withdrawal by Subject|0|||
124568144|NCT00950807|448038913|FG003|Washout Period 1|Withdrawal by Subject|0|||
124568145|NCT00950807|448038914|FG004|Washout Period 1|Withdrawal by Subject|0|||
124568146|NCT00950807|448038915|FG005|Washout Period 1|Withdrawal by Subject|0|||
124568147|NCT00950807|448038916|FG006|Washout Period 1|Withdrawal by Subject|0|||
124568148|NCT00950807|448038917|FG007|Washout Period 1|Withdrawal by Subject|0|||
124568149|NCT00950807|448038918|FG008|Washout Period 1|Withdrawal by Subject|1|||
124568150|NCT00950807|448038919|FG009|Washout Period 1|Withdrawal by Subject|0|||
124568151|NCT00950807|448038910|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
124568152|NCT00950807|448038911|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
124568153|NCT00950807|448038912|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
124568154|NCT00950807|448038913|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
124568155|NCT00950807|448038914|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
124568156|NCT00950807|448038915|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
124568157|NCT00950807|448038916|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
124568158|NCT00950807|448038917|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
124568159|NCT00950807|448038918|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
124568160|NCT00950807|448038919|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
124568161|NCT00950807|448038910|FG000|Washout Period 1|Adverse Event|2|||
124568162|NCT00950807|448038911|FG001|Washout Period 1|Adverse Event|0|||
124568163|NCT00950807|448038912|FG002|Washout Period 1|Adverse Event|0|||
124568164|NCT00950807|448038913|FG003|Washout Period 1|Adverse Event|1|||
124568165|NCT00950807|448038914|FG004|Washout Period 1|Adverse Event|1|||
124568166|NCT00950807|448038915|FG005|Washout Period 1|Adverse Event|0|||
124568167|NCT00950807|448038916|FG006|Washout Period 1|Adverse Event|0|||
124568168|NCT00950807|448038917|FG007|Washout Period 1|Adverse Event|0|||
124568169|NCT00950807|448038918|FG008|Washout Period 1|Adverse Event|0|||
124568170|NCT00950807|448038919|FG009|Washout Period 1|Adverse Event|0|||
124568171|NCT00950807|448038910|FG000|Treatment Period 2|Lack of Efficacy|1|||
124568172|NCT00950807|448038911|FG001|Treatment Period 2|Lack of Efficacy|0|||
124568173|NCT00950807|448038912|FG002|Treatment Period 2|Lack of Efficacy|0|||
124568174|NCT00950807|448038913|FG003|Treatment Period 2|Lack of Efficacy|0|||
124568175|NCT00950807|448038914|FG004|Treatment Period 2|Lack of Efficacy|0|||
124568176|NCT00950807|448038915|FG005|Treatment Period 2|Lack of Efficacy|0|||
124568177|NCT00950807|448038916|FG006|Treatment Period 2|Lack of Efficacy|0|||
124568178|NCT00950807|448038917|FG007|Treatment Period 2|Lack of Efficacy|0|||
124568179|NCT00950807|448038918|FG008|Treatment Period 2|Lack of Efficacy|0|||
124568180|NCT00950807|448038919|FG009|Treatment Period 2|Lack of Efficacy|0|||
124568181|NCT00950807|448038910|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124568182|NCT00950807|448038911|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124568183|NCT00950807|448038912|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124568184|NCT00950807|448038913|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124568185|NCT00950807|448038914|FG004|Treatment Period 2|Withdrawal by Subject|0|||
124568186|NCT00950807|448038915|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124568187|NCT00950807|448038916|FG006|Treatment Period 2|Withdrawal by Subject|1|||
124568188|NCT00950807|448038917|FG007|Treatment Period 2|Withdrawal by Subject|2|||
124568189|NCT00950807|448038918|FG008|Treatment Period 2|Withdrawal by Subject|0|||
124568190|NCT00950807|448038919|FG009|Treatment Period 2|Withdrawal by Subject|0|||
124568191|NCT00950807|448038910|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
124568192|NCT00950807|448038911|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124568193|NCT00950807|448038912|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124568194|NCT00950807|448038913|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124568195|NCT00950807|448038914|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124568196|NCT00950807|448038915|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124568197|NCT00950807|448038916|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124568198|NCT00950807|448038917|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124568199|NCT00950807|448038918|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124568200|NCT00950807|448038919|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124568201|NCT00950807|448038910|FG000|Treatment Period 2|Adverse Event|0|||
124568202|NCT00950807|448038911|FG001|Treatment Period 2|Adverse Event|1|||
124568203|NCT00950807|448038912|FG002|Treatment Period 2|Adverse Event|0|||
124568204|NCT00950807|448038913|FG003|Treatment Period 2|Adverse Event|1|||
124568205|NCT00950807|448038914|FG004|Treatment Period 2|Adverse Event|0|||
124568206|NCT00950807|448038915|FG005|Treatment Period 2|Adverse Event|1|||
124568207|NCT00950807|448038916|FG006|Treatment Period 2|Adverse Event|0|||
124568208|NCT00950807|448038917|FG007|Treatment Period 2|Adverse Event|1|||
124568209|NCT00950807|448038918|FG008|Treatment Period 2|Adverse Event|0|||
124568210|NCT00950807|448038919|FG009|Treatment Period 2|Adverse Event|0|||
124568211|NCT00950807|448038910|FG000|Washout Period 2|Lack of Efficacy|1|||
124568212|NCT00950807|448038911|FG001|Washout Period 2|Lack of Efficacy|0|||
124568213|NCT00950807|448038912|FG002|Washout Period 2|Lack of Efficacy|0|||
124568214|NCT00950807|448038913|FG003|Washout Period 2|Lack of Efficacy|0|||
124568215|NCT00950807|448038914|FG004|Washout Period 2|Lack of Efficacy|0|||
124568216|NCT00950807|448038915|FG005|Washout Period 2|Lack of Efficacy|0|||
124568217|NCT00950807|448038916|FG006|Washout Period 2|Lack of Efficacy|0|||
124568218|NCT00950807|448038917|FG007|Washout Period 2|Lack of Efficacy|0|||
124568219|NCT00950807|448038918|FG008|Washout Period 2|Lack of Efficacy|0|||
124568220|NCT00950807|448038919|FG009|Washout Period 2|Lack of Efficacy|0|||
124568221|NCT00950807|448038910|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
124568222|NCT00950807|448038911|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
124568223|NCT00950807|448038912|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
124568224|NCT00950807|448038913|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
124568225|NCT00950807|448038914|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
124568226|NCT00950807|448038915|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
124568227|NCT00950807|448038916|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
124568228|NCT00950807|448038917|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
124568229|NCT00950807|448038918|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
124568230|NCT00950807|448038919|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
124568231|NCT00950807|448038910|FG000|Washout Period 2|Adverse Event|3|||
124568232|NCT00950807|448038911|FG001|Washout Period 2|Adverse Event|0|||
124568233|NCT00950807|448038912|FG002|Washout Period 2|Adverse Event|0|||
124568234|NCT00950807|448038913|FG003|Washout Period 2|Adverse Event|1|||
124568235|NCT00950807|448038914|FG004|Washout Period 2|Adverse Event|0|||
124568236|NCT00950807|448038915|FG005|Washout Period 2|Adverse Event|0|||
124568237|NCT00950807|448038916|FG006|Washout Period 2|Adverse Event|0|||
124568238|NCT00950807|448038917|FG007|Washout Period 2|Adverse Event|0|||
124568239|NCT00950807|448038918|FG008|Washout Period 2|Adverse Event|0|||
124568240|NCT00950807|448038919|FG009|Washout Period 2|Adverse Event|0|||
124568241|NCT00950807|448038910|FG000|Treatment Period 3|Withdrawal by Subject|0|||
124568242|NCT00950807|448038911|FG001|Treatment Period 3|Withdrawal by Subject|0|||
124568243|NCT00950807|448038912|FG002|Treatment Period 3|Withdrawal by Subject|0|||
124568244|NCT00950807|448038913|FG003|Treatment Period 3|Withdrawal by Subject|0|||
124568245|NCT00950807|448038914|FG004|Treatment Period 3|Withdrawal by Subject|0|||
124568246|NCT00950807|448038915|FG005|Treatment Period 3|Withdrawal by Subject|0|||
124568247|NCT00950807|448038916|FG006|Treatment Period 3|Withdrawal by Subject|0|||
124568248|NCT00950807|448038917|FG007|Treatment Period 3|Withdrawal by Subject|0|||
124568249|NCT00950807|448038918|FG008|Treatment Period 3|Withdrawal by Subject|0|||
124568250|NCT00950807|448038919|FG009|Treatment Period 3|Withdrawal by Subject|1|||
124568251|NCT00950807|448038910|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
124568252|NCT00950807|448038911|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124568253|NCT00950807|448038912|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124568254|NCT00950807|448038913|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124568255|NCT00950807|448038914|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124568256|NCT00950807|448038915|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124568257|NCT00950807|448038916|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124568258|NCT00950807|448038917|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
124568259|NCT00950807|448038918|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124568260|NCT00950807|448038919|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124568261|NCT00950807|448038910|FG000|Treatment Period 3|Adverse Event|0|||
124568262|NCT00950807|448038911|FG001|Treatment Period 3|Adverse Event|0|||
124568263|NCT00950807|448038912|FG002|Treatment Period 3|Adverse Event|0|||
124568264|NCT00950807|448038913|FG003|Treatment Period 3|Adverse Event|0|||
124568265|NCT00950807|448038914|FG004|Treatment Period 3|Adverse Event|0|||
124568266|NCT00950807|448038915|FG005|Treatment Period 3|Adverse Event|0|||
124568267|NCT00950807|448038916|FG006|Treatment Period 3|Adverse Event|1|||
124568268|NCT00950807|448038917|FG007|Treatment Period 3|Adverse Event|0|||
124568269|NCT00950807|448038918|FG008|Treatment Period 3|Adverse Event|0|||
124568270|NCT00950807|448038919|FG009|Treatment Period 3|Adverse Event|0|||
124568271|NCT00337077|448038920|FG000|Overall Study|Progressive disease|25|||
124568272|NCT00337077|448038921|FG001|Overall Study|Progressive disease|37|||
124568273|NCT00337077|448038922|FG002|Overall Study|Progressive disease|19|||
124568274|NCT00337077|448038920|FG000|Overall Study|Adverse Event|7|||
124568275|NCT00337077|448038921|FG001|Overall Study|Adverse Event|7|||
124568276|NCT00337077|448038922|FG002|Overall Study|Adverse Event|1|||
124568277|NCT00337077|448038920|FG000|Overall Study|Death|0|||
124568278|NCT00337077|448038921|FG001|Overall Study|Death|1|||
124568279|NCT00337077|448038922|FG002|Overall Study|Death|0|||
124568280|NCT00337077|448038920|FG000|Overall Study|Withdrawal by Subject|7|||
124568281|NCT00337077|448038921|FG001|Overall Study|Withdrawal by Subject|2|||
124568282|NCT00337077|448038922|FG002|Overall Study|Withdrawal by Subject|2|||
124568283|NCT00337077|448038920|FG000|Overall Study|Alternative therapy|1|||
124568284|NCT00337077|448038921|FG001|Overall Study|Alternative therapy|0|||
124568285|NCT00337077|448038922|FG002|Overall Study|Alternative therapy|0|||
124568286|NCT00337077|448038920|FG000|Overall Study|Physician Decision|1|||
124568287|NCT00337077|448038921|FG001|Overall Study|Physician Decision|4|||
124568288|NCT00337077|448038922|FG002|Overall Study|Physician Decision|2|||
124513063|NCT03250377|447830973|FG000|Overall Study|Lack of Efficacy|5|||
124513064|NCT03250377|447830974|FG001|Overall Study|Lack of Efficacy|14|||
124513065|NCT03250377|447830975|FG002|Overall Study|Lack of Efficacy|1|||
124513066|NCT03250377|447830976|FG003|Overall Study|Lack of Efficacy|3|||
124513067|NCT03250377|447830973|FG000|Overall Study|Protocol Violation|0|||
124513068|NCT03250377|447830974|FG001|Overall Study|Protocol Violation|2|||
124513069|NCT03250377|447830975|FG002|Overall Study|Protocol Violation|0|||
124513070|NCT03250377|447830976|FG003|Overall Study|Protocol Violation|1|||
124513071|NCT03250377|447830973|FG000|Overall Study|Lost to Follow-up|0|||
124513072|NCT03250377|447830974|FG001|Overall Study|Lost to Follow-up|1|||
124513073|NCT03250377|447830975|FG002|Overall Study|Lost to Follow-up|0|||
124513074|NCT03250377|447830976|FG003|Overall Study|Lost to Follow-up|0|||
124513075|NCT03250377|447830973|FG000|Overall Study|Withdrawal by Subject|7|||
124513076|NCT03250377|447830974|FG001|Overall Study|Withdrawal by Subject|7|||
124568289|NCT00337077|448038920|FG000|Overall Study|Never started treatment|1|||
124568290|NCT00337077|448038921|FG001|Overall Study|Never started treatment|1|||
124568291|NCT00337077|448038922|FG002|Overall Study|Never started treatment|0|||
124568292|NCT00337077|448038920|FG000|Overall Study|Ineligible|1|||
124568293|NCT00337077|448038921|FG001|Overall Study|Ineligible|1|||
124568294|NCT00337077|448038922|FG002|Overall Study|Ineligible|1|||
124568295|NCT02430870|448038935|FG000|Part 2|Voluntary Withdrawal|0|||
124568296|NCT02430870|448038936|FG001|Part 2|Voluntary Withdrawal|0|||
124724884|NCT04644276|448613345|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
124513077|NCT03250377|447830975|FG002|Overall Study|Withdrawal by Subject|0|||
124513078|NCT03250377|447830976|FG003|Overall Study|Withdrawal by Subject|4|||
124513079|NCT03250377|447830973|FG000|Overall Study|Investigator's Judgment|1|||
124513080|NCT03250377|447830974|FG001|Overall Study|Investigator's Judgment|0|||
124513081|NCT03250377|447830975|FG002|Overall Study|Investigator's Judgment|0|||
124568297|NCT02430870|448038937|FG002|Part 2|Voluntary Withdrawal|0|||
124513082|NCT03250377|447830976|FG003|Overall Study|Investigator's Judgment|0|||
124513083|NCT03250377|447830973|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
124513084|NCT03250377|447830974|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
124513085|NCT03250377|447830975|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
124513086|NCT03250377|447830976|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
124513087|NCT03250377|447830973|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
124513088|NCT03250377|447830974|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
124513089|NCT03250377|447830975|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
124513090|NCT03250377|447830976|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
124513091|NCT03250377|447830973|FG000|Overall Study|Epilepsy Surgery|0|||
124513092|NCT03250377|447830974|FG001|Overall Study|Epilepsy Surgery|1|||
124513093|NCT03250377|447830975|FG002|Overall Study|Epilepsy Surgery|2|||
124568298|NCT02430870|448038938|FG003|Part 2|Voluntary Withdrawal|0|||
124568299|NCT02430870|448038939|FG004|Part 2|Voluntary Withdrawal|0|||
124568300|NCT02430870|448038940|FG005|Part 2|Voluntary Withdrawal|0|||
124568301|NCT02430870|448038941|FG006|Part 2|Voluntary Withdrawal|1|||
124568302|NCT02430870|448038942|FG007|Part 2|Voluntary Withdrawal|0|||
124568303|NCT02430870|448038935|FG000|Part 2|Other Reason Not Specified|0|||
124568304|NCT02430870|448038936|FG001|Part 2|Other Reason Not Specified|0|||
124568305|NCT02430870|448038937|FG002|Part 2|Other Reason Not Specified|0|||
124568306|NCT02430870|448038938|FG003|Part 2|Other Reason Not Specified|0|||
124568307|NCT02430870|448038939|FG004|Part 2|Other Reason Not Specified|0|||
124568308|NCT02430870|448038940|FG005|Part 2|Other Reason Not Specified|0|||
124568309|NCT02430870|448038941|FG006|Part 2|Other Reason Not Specified|0|||
124568310|NCT02430870|448038942|FG007|Part 2|Other Reason Not Specified|1|||
124568311|NCT01265784|448038943|FG000|Overall Study|Lost to Follow-up|5|||
124568312|NCT01265784|448038944|FG001|Overall Study|Lost to Follow-up|3|||
124568313|NCT01265784|448038945|FG002|Overall Study|Lost to Follow-up|2|||
124568314|NCT01265784|448038943|FG000|Overall Study|Withdrawal by Subject|0|||
124568315|NCT01265784|448038944|FG001|Overall Study|Withdrawal by Subject|5|||
124568316|NCT01265784|448038945|FG002|Overall Study|Withdrawal by Subject|0|||
124568317|NCT01265784|448038943|FG000|Overall Study|Physician Decision|1|||
124568318|NCT01265784|448038944|FG001|Overall Study|Physician Decision|0|||
124568319|NCT01265784|448038945|FG002|Overall Study|Physician Decision|1|||
124568320|NCT01265784|448038943|FG000|Overall Study|Adverse Event|1|||
124568321|NCT01265784|448038944|FG001|Overall Study|Adverse Event|0|||
124568322|NCT01265784|448038945|FG002|Overall Study|Adverse Event|0|||
124568323|NCT01265784|448038943|FG000|Overall Study|Death|3|||
124568324|NCT01265784|448038944|FG001|Overall Study|Death|0|||
124568325|NCT01265784|448038945|FG002|Overall Study|Death|0|||
124568326|NCT01265784|448038943|FG000|Overall Study|Protocol Violation|2|||
124568327|NCT01265784|448038944|FG001|Overall Study|Protocol Violation|0|||
124568328|NCT01265784|448038945|FG002|Overall Study|Protocol Violation|0|||
124568329|NCT01265784|448038943|FG000|Overall Study|Incorrectly Randomized|0|||
124568330|NCT01265784|448038944|FG001|Overall Study|Incorrectly Randomized|0|||
124568331|NCT01265784|448038945|FG002|Overall Study|Incorrectly Randomized|1|||
124568332|NCT00796822|448038946|FG000|Overall Study|Lost to Follow-up|2|||
124568333|NCT00796822|448038947|FG001|Overall Study|Lost to Follow-up|0|||
124568334|NCT00796822|448038946|FG000|Overall Study|Adverse Event|1|||
124568335|NCT00796822|448038947|FG001|Overall Study|Adverse Event|0|||
124568336|NCT02603952|448038948|FG000|Overall Study|Withdrawal by Subject|1|||
124568337|NCT02603952|448038949|FG001|Overall Study|Withdrawal by Subject|0|||
124568338|NCT02603952|448038950|FG002|Overall Study|Withdrawal by Subject|0|||
124568339|NCT02603952|448038951|FG003|Overall Study|Withdrawal by Subject|0|||
124568340|NCT02603952|448038948|FG000|Overall Study|Received oseltamivir by error|0|||
124568341|NCT02603952|448038949|FG001|Overall Study|Received oseltamivir by error|0|||
124568342|NCT02603952|448038950|FG002|Overall Study|Received oseltamivir by error|0|||
124568343|NCT02603952|448038951|FG003|Overall Study|Received oseltamivir by error|1|||
124568344|NCT04646109|448038954|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
124568345|NCT04646109|448038955|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
124568346|NCT01867242|448038958|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
124568347|NCT01867242|448038959|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
124568348|NCT01867242|448038960|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
124513094|NCT03250377|447830976|FG003|Overall Study|Epilepsy Surgery|0|||
124513095|NCT03250377|447830973|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
124513096|NCT03250377|447830974|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
124513097|NCT03250377|447830975|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
124513098|NCT03250377|447830976|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
124568349|NCT03184441|448038968|FG000|Overall Study|Withdrawal by Subject|1|||
124568350|NCT00264810|448038969|FG000|Baseline|Withdrawal by Subject|10|||
124568351|NCT00264810|448038970|FG001|Baseline|Withdrawal by Subject|10|||
124568352|NCT00264810|448038969|FG000|Baseline|Physician Decision|7|||
124568353|NCT00264810|448038970|FG001|Baseline|Physician Decision|8|||
124568354|NCT00264810|448038969|FG000|Baseline|Subject Compliance Failure|3|||
124568355|NCT00264810|448038970|FG001|Baseline|Subject Compliance Failure|3|||
124568356|NCT00264810|448038969|FG000|Baseline|Insufficient Seizure Frequency|2|||
124568357|NCT00264810|448038970|FG001|Baseline|Insufficient Seizure Frequency|2|||
124568358|NCT00264810|448038969|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
124568359|NCT00264810|448038970|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
124568360|NCT00264810|448038969|FG000|Baseline|Other|0|||
124568361|NCT00264810|448038970|FG001|Baseline|Other|1|||
124568362|NCT00264810|448038969|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
124568363|NCT00264810|448038970|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
124568364|NCT00264810|448038969|FG000|Stimulation Optimization Period|Death|0|||
124568365|NCT00264810|448038970|FG001|Stimulation Optimization Period|Death|1|||
124568366|NCT00264810|448038969|FG000|Blinded Evaluation Period|Explant due to infection|1|||
124568367|NCT00264810|448038970|FG001|Blinded Evaluation Period|Explant due to infection|1|||
124568368|NCT00264810|448038969|FG000|Open Label Evaluation Period|Explant due to infection|1|||
124568369|NCT00264810|448038970|FG001|Open Label Evaluation Period|Explant due to infection|1|||
124568370|NCT00264810|448038969|FG000|Open Label Evaluation Period|Death|3|||
124568371|NCT00264810|448038970|FG001|Open Label Evaluation Period|Death|2|||
124568372|NCT00264810|448038969|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
124568373|NCT00264810|448038970|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
124568374|NCT00182091|448038971|FG000|Overall Study|Withdrawal by Subject|1|||
124568375|NCT00182091|448038972|FG001|Overall Study|Withdrawal by Subject|0|||
124568376|NCT00182091|448038973|FG002|Overall Study|Withdrawal by Subject|0|||
124568377|NCT00182091|448038974|FG003|Overall Study|Withdrawal by Subject|0|||
124568378|NCT02093689|448038980|FG000|Overall Study|Physician Decision|4|||
124568379|NCT02093689|448038981|FG001|Overall Study|Physician Decision|0|||
124568380|NCT02093689|448038982|FG002|Overall Study|Physician Decision|0|||
124568381|NCT04634409|448038983|FG000|Overall Study|Death|0|||
124568382|NCT04634409|448038984|FG001|Overall Study|Death|0|||
124568383|NCT04634409|448038985|FG002|Overall Study|Death|0|||
124568384|NCT04634409|448038986|FG003|Overall Study|Death|0|||
124568385|NCT04634409|448038987|FG004|Overall Study|Death|0|||
124568386|NCT04634409|448038988|FG005|Overall Study|Death|0|||
124568387|NCT04634409|448038989|FG006|Overall Study|Death|0|||
124568388|NCT04634409|448038990|FG007|Overall Study|Death|0|||
124568389|NCT04634409|448038991|FG008|Overall Study|Death|0|||
124568390|NCT04634409|448038992|FG009|Overall Study|Death|0|||
124568391|NCT04634409|448038993|FG010|Overall Study|Death|1|||
124568392|NCT04634409|448038994|FG011|Overall Study|Death|0|||
124568393|NCT04634409|448038995|FG012|Overall Study|Death|1|||
124568394|NCT04634409|448038996|FG013|Overall Study|Death|0|||
124568395|NCT04634409|448038997|FG014|Overall Study|Death|0|||
124568396|NCT04634409|448038998|FG015|Overall Study|Death|0|||
124568397|NCT04634409|448038999|FG016|Overall Study|Death|0|||
124568398|NCT04634409|448039000|FG017|Overall Study|Death|0|||
124568399|NCT04634409|448039001|FG018|Overall Study|Death|0|||
124568400|NCT04634409|448039002|FG019|Overall Study|Death|0|||
124568401|NCT04634409|448039003|FG020|Overall Study|Death|0|||
124568402|NCT04634409|448039004|FG021|Overall Study|Death|0|||
124568403|NCT04634409|448039005|FG022|Overall Study|Death|0|||
124568404|NCT04634409|448039006|FG023|Overall Study|Death|0|||
124568405|NCT04634409|448039007|FG024|Overall Study|Death|0|||
124568406|NCT04634409|448039008|FG025|Overall Study|Death|0|||
124568407|NCT04634409|448039009|FG026|Overall Study|Death|0|||
124568408|NCT04634409|448038983|FG000|Overall Study|Adverse Event|0|||
124568409|NCT04634409|448038984|FG001|Overall Study|Adverse Event|0|||
124568410|NCT04634409|448038985|FG002|Overall Study|Adverse Event|1|||
124568411|NCT04634409|448038986|FG003|Overall Study|Adverse Event|0|||
124568412|NCT04634409|448038987|FG004|Overall Study|Adverse Event|0|||
124568413|NCT04634409|448038988|FG005|Overall Study|Adverse Event|1|||
124568414|NCT04634409|448038989|FG006|Overall Study|Adverse Event|0|||
124568415|NCT04634409|448038990|FG007|Overall Study|Adverse Event|0|||
124568416|NCT04634409|448038991|FG008|Overall Study|Adverse Event|0|||
124568417|NCT04634409|448038992|FG009|Overall Study|Adverse Event|0|||
124568418|NCT04634409|448038993|FG010|Overall Study|Adverse Event|0|||
124568419|NCT04634409|448038994|FG011|Overall Study|Adverse Event|0|||
124568420|NCT04634409|448038995|FG012|Overall Study|Adverse Event|0|||
124568421|NCT04634409|448038996|FG013|Overall Study|Adverse Event|0|||
124568422|NCT04634409|448038997|FG014|Overall Study|Adverse Event|0|||
124568423|NCT04634409|448038998|FG015|Overall Study|Adverse Event|0|||
124568424|NCT04634409|448038999|FG016|Overall Study|Adverse Event|0|||
124568425|NCT04634409|448039000|FG017|Overall Study|Adverse Event|0|||
124568426|NCT04634409|448039001|FG018|Overall Study|Adverse Event|0|||
124568427|NCT04634409|448039002|FG019|Overall Study|Adverse Event|0|||
124568428|NCT04634409|448039003|FG020|Overall Study|Adverse Event|0|||
124568429|NCT04634409|448039004|FG021|Overall Study|Adverse Event|0|||
124568430|NCT04634409|448039005|FG022|Overall Study|Adverse Event|0|||
124568431|NCT04634409|448039006|FG023|Overall Study|Adverse Event|0|||
124568432|NCT04634409|448039007|FG024|Overall Study|Adverse Event|0|||
124568433|NCT04634409|448039008|FG025|Overall Study|Adverse Event|0|||
124568434|NCT04634409|448039009|FG026|Overall Study|Adverse Event|0|||
124568435|NCT04634409|448038983|FG000|Overall Study|Lost to Follow-up|3|||
124568436|NCT04634409|448038984|FG001|Overall Study|Lost to Follow-up|1|||
124568437|NCT04634409|448038985|FG002|Overall Study|Lost to Follow-up|1|||
124568438|NCT04634409|448038986|FG003|Overall Study|Lost to Follow-up|3|||
124568439|NCT04634409|448038987|FG004|Overall Study|Lost to Follow-up|1|||
124568440|NCT04634409|448038988|FG005|Overall Study|Lost to Follow-up|1|||
124568441|NCT04634409|448038989|FG006|Overall Study|Lost to Follow-up|1|||
124568442|NCT04634409|448038990|FG007|Overall Study|Lost to Follow-up|3|||
124568443|NCT04634409|448038991|FG008|Overall Study|Lost to Follow-up|3|||
124568444|NCT04634409|448038992|FG009|Overall Study|Lost to Follow-up|11|||
124568445|NCT04634409|448038993|FG010|Overall Study|Lost to Follow-up|8|||
124568446|NCT04634409|448038994|FG011|Overall Study|Lost to Follow-up|15|||
124513099|NCT03250377|447830973|FG000|Overall Study|Request From The Sponsor|0|||
124513100|NCT03250377|447830974|FG001|Overall Study|Request From The Sponsor|1|||
124513101|NCT03250377|447830975|FG002|Overall Study|Request From The Sponsor|0|||
124513102|NCT03250377|447830976|FG003|Overall Study|Request From The Sponsor|0|||
124513103|NCT03250377|447830973|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
124513104|NCT03250377|447830974|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
124513105|NCT03250377|447830975|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
124513106|NCT03250377|447830976|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
124513107|NCT03250377|447830973|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
124513108|NCT03250377|447830974|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
124513109|NCT03250377|447830975|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
124513110|NCT03250377|447830976|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
124513111|NCT03250377|447830973|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
124513112|NCT03250377|447830974|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
124513113|NCT03250377|447830975|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
124513114|NCT03250377|447830976|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
124513115|NCT03250377|447830973|FG000|Overall Study|Pregnancy Event|0|||
124513116|NCT03250377|447830974|FG001|Overall Study|Pregnancy Event|1|||
124513117|NCT03250377|447830975|FG002|Overall Study|Pregnancy Event|0|||
124513118|NCT03250377|447830976|FG003|Overall Study|Pregnancy Event|0|||
124513119|NCT03250377|447830973|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
124513120|NCT03250377|447830974|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
124513121|NCT03250377|447830975|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
124513122|NCT03250377|447830976|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
124513123|NCT03250377|447830973|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
124513124|NCT03250377|447830974|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
124513125|NCT03250377|447830975|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
124513126|NCT03250377|447830976|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
124513127|NCT03250377|447830973|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
124513128|NCT03250377|447830974|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
124513129|NCT03250377|447830975|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
124513130|NCT03250377|447830976|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
124513131|NCT03250377|447830973|FG000|Overall Study|Patient requested to change hospital|0|||
124513132|NCT03250377|447830974|FG001|Overall Study|Patient requested to change hospital|0|||
124513133|NCT03250377|447830975|FG002|Overall Study|Patient requested to change hospital|0|||
124513134|NCT03250377|447830976|FG003|Overall Study|Patient requested to change hospital|1|||
124513135|NCT03250377|447830973|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
124513136|NCT03250377|447830974|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
124513137|NCT03250377|447830975|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
124513138|NCT03250377|447830976|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
124513139|NCT00817206|447830977|FG000|Overall Study|Adverse Event|10|||
124513140|NCT00817206|447830978|FG001|Overall Study|Adverse Event|3|||
124513141|NCT00817206|447830977|FG000|Overall Study|Protocol Violation|0|||
124513142|NCT00817206|447830978|FG001|Overall Study|Protocol Violation|2|||
124513143|NCT00817206|447830977|FG000|Overall Study|Lost to Follow-up|0|||
124513144|NCT00817206|447830978|FG001|Overall Study|Lost to Follow-up|1|||
124513145|NCT00817206|447830977|FG000|Overall Study|Death|2|||
124513146|NCT00817206|447830978|FG001|Overall Study|Death|0|||
124513147|NCT00817206|447830977|FG000|Overall Study|Withdrawal by Subject|7|||
124513148|NCT00817206|447830978|FG001|Overall Study|Withdrawal by Subject|3|||
124513149|NCT00817206|447830977|FG000|Overall Study|Physician Decision|2|||
124568447|NCT04634409|448038995|FG012|Overall Study|Lost to Follow-up|3|||
124513150|NCT00817206|447830978|FG001|Overall Study|Physician Decision|0|||
124568448|NCT04634409|448038996|FG013|Overall Study|Lost to Follow-up|2|||
124568449|NCT04634409|448038997|FG014|Overall Study|Lost to Follow-up|7|||
124568450|NCT04634409|448038998|FG015|Overall Study|Lost to Follow-up|0|||
124568451|NCT04634409|448038999|FG016|Overall Study|Lost to Follow-up|0|||
124568452|NCT04634409|448039000|FG017|Overall Study|Lost to Follow-up|0|||
124568453|NCT04634409|448039001|FG018|Overall Study|Lost to Follow-up|0|||
124568454|NCT04634409|448039002|FG019|Overall Study|Lost to Follow-up|0|||
124568455|NCT04634409|448039003|FG020|Overall Study|Lost to Follow-up|0|||
124568456|NCT04634409|448039004|FG021|Overall Study|Lost to Follow-up|0|||
124568457|NCT04634409|448039005|FG022|Overall Study|Lost to Follow-up|0|||
124568458|NCT04634409|448039006|FG023|Overall Study|Lost to Follow-up|0|||
124568459|NCT04634409|448039007|FG024|Overall Study|Lost to Follow-up|0|||
124568460|NCT04634409|448039008|FG025|Overall Study|Lost to Follow-up|0|||
124568461|NCT04634409|448039009|FG026|Overall Study|Lost to Follow-up|0|||
124568462|NCT04634409|448038983|FG000|Overall Study|Withdrawal by Subject|3|||
124568463|NCT04634409|448038984|FG001|Overall Study|Withdrawal by Subject|1|||
124568464|NCT04634409|448038985|FG002|Overall Study|Withdrawal by Subject|6|||
124568465|NCT04634409|448038986|FG003|Overall Study|Withdrawal by Subject|4|||
124568466|NCT04634409|448038987|FG004|Overall Study|Withdrawal by Subject|2|||
124568467|NCT04634409|448038988|FG005|Overall Study|Withdrawal by Subject|0|||
124568468|NCT04634409|448038989|FG006|Overall Study|Withdrawal by Subject|0|||
124568469|NCT04634409|448038990|FG007|Overall Study|Withdrawal by Subject|2|||
124568470|NCT04634409|448038991|FG008|Overall Study|Withdrawal by Subject|3|||
124568471|NCT04634409|448038992|FG009|Overall Study|Withdrawal by Subject|2|||
124568472|NCT04634409|448038993|FG010|Overall Study|Withdrawal by Subject|3|||
124568473|NCT04634409|448038994|FG011|Overall Study|Withdrawal by Subject|2|||
124568474|NCT04634409|448038995|FG012|Overall Study|Withdrawal by Subject|2|||
124568475|NCT04634409|448038996|FG013|Overall Study|Withdrawal by Subject|1|||
124568476|NCT04634409|448038997|FG014|Overall Study|Withdrawal by Subject|5|||
124568477|NCT04634409|448038998|FG015|Overall Study|Withdrawal by Subject|0|||
124568478|NCT04634409|448038999|FG016|Overall Study|Withdrawal by Subject|0|||
124568479|NCT04634409|448039000|FG017|Overall Study|Withdrawal by Subject|1|||
124568480|NCT04634409|448039001|FG018|Overall Study|Withdrawal by Subject|0|||
124568481|NCT04634409|448039002|FG019|Overall Study|Withdrawal by Subject|0|||
124568482|NCT04634409|448039003|FG020|Overall Study|Withdrawal by Subject|0|||
124568483|NCT04634409|448039004|FG021|Overall Study|Withdrawal by Subject|0|||
124568484|NCT04634409|448039005|FG022|Overall Study|Withdrawal by Subject|0|||
124568485|NCT04634409|448039006|FG023|Overall Study|Withdrawal by Subject|1|||
124568486|NCT04634409|448039007|FG024|Overall Study|Withdrawal by Subject|0|||
124568487|NCT04634409|448039008|FG025|Overall Study|Withdrawal by Subject|0|||
124568488|NCT04634409|448039009|FG026|Overall Study|Withdrawal by Subject|0|||
124568489|NCT04634409|448038983|FG000|Overall Study|Other - As reported by Investigator|1|||
124568490|NCT04634409|448038984|FG001|Overall Study|Other - As reported by Investigator|0|||
124568491|NCT04634409|448038985|FG002|Overall Study|Other - As reported by Investigator|0|||
124568492|NCT04634409|448038986|FG003|Overall Study|Other - As reported by Investigator|0|||
124568493|NCT04634409|448038987|FG004|Overall Study|Other - As reported by Investigator|0|||
124568494|NCT04634409|448038988|FG005|Overall Study|Other - As reported by Investigator|0|||
124568495|NCT04634409|448038989|FG006|Overall Study|Other - As reported by Investigator|0|||
124568496|NCT04634409|448038990|FG007|Overall Study|Other - As reported by Investigator|6|||
124568497|NCT04634409|448038991|FG008|Overall Study|Other - As reported by Investigator|4|||
124568498|NCT04634409|448038992|FG009|Overall Study|Other - As reported by Investigator|0|||
124568499|NCT04634409|448038993|FG010|Overall Study|Other - As reported by Investigator|1|||
124568500|NCT04634409|448038994|FG011|Overall Study|Other - As reported by Investigator|2|||
124568501|NCT04634409|448038995|FG012|Overall Study|Other - As reported by Investigator|2|||
124568502|NCT04634409|448038996|FG013|Overall Study|Other - As reported by Investigator|1|||
124568503|NCT04634409|448038997|FG014|Overall Study|Other - As reported by Investigator|0|||
124568504|NCT04634409|448038998|FG015|Overall Study|Other - As reported by Investigator|0|||
124568505|NCT04634409|448038999|FG016|Overall Study|Other - As reported by Investigator|0|||
124568506|NCT04634409|448039000|FG017|Overall Study|Other - As reported by Investigator|0|||
124568507|NCT04634409|448039001|FG018|Overall Study|Other - As reported by Investigator|0|||
124568508|NCT04634409|448039002|FG019|Overall Study|Other - As reported by Investigator|0|||
124568509|NCT04634409|448039003|FG020|Overall Study|Other - As reported by Investigator|0|||
124568510|NCT04634409|448039004|FG021|Overall Study|Other - As reported by Investigator|0|||
124568511|NCT04634409|448039005|FG022|Overall Study|Other - As reported by Investigator|0|||
124568512|NCT04634409|448039006|FG023|Overall Study|Other - As reported by Investigator|0|||
124568513|NCT04634409|448039007|FG024|Overall Study|Other - As reported by Investigator|0|||
124568514|NCT04634409|448039008|FG025|Overall Study|Other - As reported by Investigator|0|||
124568515|NCT04634409|448039009|FG026|Overall Study|Other - As reported by Investigator|0|||
124568516|NCT01402908|448040535|FG000|Overall Study|Withdrawal by Subject|30|||
124568517|NCT01402908|448040536|FG001|Overall Study|Withdrawal by Subject|17|||
124568518|NCT01402908|448040535|FG000|Overall Study|Lost to Follow-up|3|||
124568519|NCT01402908|448040536|FG001|Overall Study|Lost to Follow-up|1|||
124568520|NCT01402908|448040535|FG000|Overall Study|Physician Decision|1|||
124568521|NCT01402908|448040536|FG001|Overall Study|Physician Decision|0|||
124568522|NCT01739790|448040537|FG000|Overall Study|Early Trial Termination|2|||
124568523|NCT01739790|448040538|FG001|Overall Study|Early Trial Termination|4|||
124568524|NCT02581345|448040539|FG000|Part 1: up to Week 16|Adverse Event|3|||
124568525|NCT02581345|448040540|FG001|Part 1: up to Week 16|Adverse Event|8|||
124568526|NCT02581345|448040541|FG002|Part 1: up to Week 16|Adverse Event|0|||
124568527|NCT02581345|448040542|FG003|Part 1: up to Week 16|Adverse Event|0|||
124568528|NCT02581345|448040539|FG000|Part 1: up to Week 16|Physician Decision|2|||
124568529|NCT02581345|448040540|FG001|Part 1: up to Week 16|Physician Decision|4|||
124568530|NCT02581345|448040541|FG002|Part 1: up to Week 16|Physician Decision|0|||
124568531|NCT02581345|448040542|FG003|Part 1: up to Week 16|Physician Decision|0|||
124568532|NCT02581345|448040539|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
124568533|NCT02581345|448040540|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
124568534|NCT02581345|448040541|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
124568535|NCT02581345|448040542|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
124568536|NCT02581345|448040539|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
124568537|NCT02581345|448040540|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
124568538|NCT02581345|448040541|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
124568539|NCT02581345|448040542|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
124568540|NCT02581345|448040539|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
124568541|NCT02581345|448040540|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
124568542|NCT02581345|448040541|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
124568543|NCT02581345|448040542|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
124568544|NCT02581345|448040539|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
124568545|NCT02581345|448040540|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
124568546|NCT02581345|448040541|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
124568547|NCT02581345|448040542|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
124568548|NCT02581345|448040539|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
124568549|NCT02581345|448040540|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
124568550|NCT02581345|448040541|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
124568551|NCT02581345|448040542|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
124568552|NCT02581345|448040539|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
124568553|NCT02581345|448040540|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
124568554|NCT02581345|448040541|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
124568555|NCT02581345|448040542|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
124568556|NCT02581345|448040539|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
124568557|NCT02581345|448040540|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
124568558|NCT02581345|448040541|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
124568559|NCT02581345|448040542|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
124568560|NCT02581345|448040539|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
124568561|NCT02581345|448040540|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
124568562|NCT02581345|448040541|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
124568563|NCT02581345|448040542|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
124568564|NCT02581345|448040539|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
124568565|NCT02581345|448040540|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
124568566|NCT02581345|448040541|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
124568567|NCT02581345|448040542|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
124568568|NCT02581345|448040539|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
124568569|NCT02581345|448040540|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
124568570|NCT02581345|448040541|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
124568571|NCT02581345|448040542|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
124568572|NCT01244126|448040548|FG000|Overall Study|Protocol Violation|3|||
124568573|NCT01244126|448040549|FG001|Overall Study|Protocol Violation|3|||
124568574|NCT01244126|448040550|FG002|Overall Study|Protocol Violation|9|||
124568575|NCT01451762|448040551|FG000|Overall Study|Lost to Follow-up|3|||
124568576|NCT01451762|448040552|FG001|Overall Study|Lost to Follow-up|6|||
124568577|NCT01451762|448040553|FG002|Overall Study|Lost to Follow-up|6|||
124568578|NCT00863746|448040558|FG000|Treatment|Not treated|4|||
124568579|NCT00863746|448040559|FG001|Treatment|Not treated|2|||
124568580|NCT00863746|448040558|FG000|Treatment|Adverse Event|41|||
124568581|NCT00863746|448040559|FG001|Treatment|Adverse Event|16|||
124568582|NCT00863746|448040558|FG000|Treatment|non-compliant with study medication|4|||
124568583|NCT00863746|448040559|FG001|Treatment|non-compliant with study medication|0|||
124568584|NCT00863746|448040558|FG000|Treatment|Consent withdrawn|15|||
124568585|NCT00863746|448040559|FG001|Treatment|Consent withdrawn|14|||
124568586|NCT00863746|448040558|FG000|Treatment|Lost to Follow-up|1|||
124568587|NCT00863746|448040559|FG001|Treatment|Lost to Follow-up|0|||
124568588|NCT00863746|448040558|FG000|Treatment|Protocol Violation|5|||
124568589|NCT00863746|448040559|FG001|Treatment|Protocol Violation|3|||
124568590|NCT00863746|448040558|FG000|Treatment|Other|1|||
124568591|NCT00863746|448040559|FG001|Treatment|Other|0|||
124568592|NCT00863746|448040558|FG000|Survival Follow up|Death|244|||
124568593|NCT00863746|448040559|FG001|Survival Follow up|Death|271|||
124568594|NCT00863746|448040558|FG000|Survival Follow up|Lost to Follow-up|2|||
124568595|NCT00863746|448040559|FG001|Survival Follow up|Lost to Follow-up|1|||
124568596|NCT00863746|448040558|FG000|Survival Follow up|Consent Withdrawn|7|||
124568597|NCT00863746|448040559|FG001|Survival Follow up|Consent Withdrawn|8|||
124568598|NCT00862979|448040565|FG000|Overall Study|Adverse Event|6|||
124568599|NCT00862979|448040566|FG001|Overall Study|Adverse Event|3|||
124568600|NCT00862979|448040565|FG000|Overall Study|Protocol Violation|0|||
124568601|NCT00862979|448040566|FG001|Overall Study|Protocol Violation|1|||
124568602|NCT00862979|448040565|FG000|Overall Study|Patient withdrew consent|2|||
124568603|NCT00862979|448040566|FG001|Overall Study|Patient withdrew consent|1|||
124568604|NCT00862979|448040565|FG000|Overall Study|Administrative problems|0|||
124568605|NCT00862979|448040566|FG001|Overall Study|Administrative problems|1|||
124568606|NCT00862979|448040565|FG000|Overall Study|Death|0|||
124568607|NCT00862979|448040566|FG001|Overall Study|Death|1|||
124568608|NCT01367275|448040569|FG000|Overall Study|Ineligible|1|||
124568609|NCT01367275|448040569|FG000|Overall Study|Disease Progression|2|||
124568610|NCT00502775|448040572|FG000|Overall Study|Adverse Event|1|||
124568611|NCT00502775|448040573|FG001|Overall Study|Adverse Event|2|||
124568612|NCT00502775|448040574|FG002|Overall Study|Adverse Event|1|||
124568613|NCT00502775|448040572|FG000|Overall Study|Protocol Violation|1|||
124568614|NCT00502775|448040573|FG001|Overall Study|Protocol Violation|5|||
124568615|NCT00502775|448040574|FG002|Overall Study|Protocol Violation|2|||
124568616|NCT00502775|448040572|FG000|Overall Study|Withdrawal by Subject|1|||
124568617|NCT00502775|448040573|FG001|Overall Study|Withdrawal by Subject|1|||
124568618|NCT00502775|448040574|FG002|Overall Study|Withdrawal by Subject|2|||
124568619|NCT00502775|448040572|FG000|Overall Study|Sponsor Terminated Study|1|||
124568620|NCT00502775|448040573|FG001|Overall Study|Sponsor Terminated Study|0|||
124568621|NCT00502775|448040574|FG002|Overall Study|Sponsor Terminated Study|1|||
124568622|NCT00502775|448040572|FG000|Overall Study|Non-compliance with eDiary|4|||
124568623|NCT00502775|448040573|FG001|Overall Study|Non-compliance with eDiary|1|||
124568624|NCT00502775|448040574|FG002|Overall Study|Non-compliance with eDiary|1|||
124568625|NCT00502775|448040572|FG000|Overall Study|Subject unable to swallow capsule|1|||
124568626|NCT00502775|448040573|FG001|Overall Study|Subject unable to swallow capsule|0|||
124568627|NCT00502775|448040574|FG002|Overall Study|Subject unable to swallow capsule|1|||
124568628|NCT00502775|448040572|FG000|Overall Study|Logpad compliance <80%|1|||
124568629|NCT00502775|448040573|FG001|Overall Study|Logpad compliance <80%|0|||
124568630|NCT00502775|448040574|FG002|Overall Study|Logpad compliance <80%|0|||
124568631|NCT00502775|448040572|FG000|Overall Study|Randomized in error|0|||
124568632|NCT00502775|448040573|FG001|Overall Study|Randomized in error|1|||
124568633|NCT00502775|448040574|FG002|Overall Study|Randomized in error|1|||
124568634|NCT00502775|448040572|FG000|Overall Study|Non-compliance|0|||
124568635|NCT00502775|448040573|FG001|Overall Study|Non-compliance|2|||
124568636|NCT00502775|448040574|FG002|Overall Study|Non-compliance|2|||
124568637|NCT00502775|448040572|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
124568638|NCT00502775|448040573|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
124568639|NCT00502775|448040574|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
124568640|NCT00502775|448040572|FG000|Overall Study|Declining pollen counts|0|||
124568641|NCT00502775|448040573|FG001|Overall Study|Declining pollen counts|1|||
124568642|NCT00502775|448040574|FG002|Overall Study|Declining pollen counts|1|||
124568643|NCT00502775|448040572|FG000|Overall Study|Subject in jail|0|||
124568644|NCT00502775|448040573|FG001|Overall Study|Subject in jail|1|||
124568645|NCT00502775|448040574|FG002|Overall Study|Subject in jail|0|||
124568646|NCT00502775|448040572|FG000|Overall Study|Subject took disallowed drug|0|||
124568647|NCT00502775|448040573|FG001|Overall Study|Subject took disallowed drug|0|||
124568648|NCT00502775|448040574|FG002|Overall Study|Subject took disallowed drug|1|||
124568649|NCT00287118|448040576|FG000|Overall Study|Adverse Event|30|||
124568650|NCT00287118|448040576|FG000|Overall Study|Death|1|||
124568651|NCT00287118|448040576|FG000|Overall Study|Lack of Efficacy|11|||
124568652|NCT00287118|448040576|FG000|Overall Study|Lost to Follow-up|1|||
124568653|NCT00287118|448040576|FG000|Overall Study|Protocol Violation|2|||
124568654|NCT00287118|448040576|FG000|Overall Study|Other|7|||
124568655|NCT00262600|448040577|FG000|Overall Study|Lost to Follow-up|17|||
124568656|NCT00262600|448040578|FG001|Overall Study|Lost to Follow-up|31|||
124568657|NCT00262600|448040579|FG002|Overall Study|Lost to Follow-up|41|||
124568658|NCT00262600|448040577|FG000|Overall Study|Withdrawal by Subject|128|||
124568659|NCT00262600|448040578|FG001|Overall Study|Withdrawal by Subject|145|||
124568660|NCT00262600|448040579|FG002|Overall Study|Withdrawal by Subject|139|||
124568661|NCT00262600|448040577|FG000|Overall Study|Not Treated|32|||
124568662|NCT00262600|448040578|FG001|Overall Study|Not Treated|17|||
124568663|NCT00262600|448040579|FG002|Overall Study|Not Treated|24|||
124568664|NCT00262600|448040577|FG000|Overall Study|Other|58|||
124568665|NCT00262600|448040578|FG001|Overall Study|Other|59|||
124568666|NCT00262600|448040579|FG002|Overall Study|Other|62|||
124568667|NCT02906709|448040586|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
124568668|NCT02906709|448040587|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
124568669|NCT02906709|448040586|FG000|Phase A (Week 0 to Week 16)|Death|0|||
124568670|NCT02906709|448040587|FG001|Phase A (Week 0 to Week 16)|Death|1|||
124568671|NCT02906709|448040586|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
124568672|NCT02906709|448040587|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
124568673|NCT02906709|448040586|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
124568674|NCT02906709|448040587|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
124568675|NCT05518487|448040589|FG000|Overall Study|Withdrawal by Subject|3|||
124568676|NCT02752776|448040593|FG000|Overall Study|Adverse Event|15|||
124568677|NCT02752776|448040594|FG001|Overall Study|Adverse Event|23|||
124513156|NCT02197897|447830980|FG000|Overall Study|not eligible|1|||
124513157|NCT01106391|447830981|FG000|Overall Study|Death|12|||
124513158|NCT01106391|447830981|FG000|Overall Study|Withdrawal by Subject|7|||
124513159|NCT02759861|447830988|FG000|Overall Study|Death|1|||
124513160|NCT00282867|447830990|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
124513161|NCT00282867|447830991|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
124513162|NCT00282867|447830992|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
124513163|NCT02855450|447830993|FG000|Overall Study|Adverse Event|1|||
124513164|NCT02855450|447830994|FG001|Overall Study|Adverse Event|0|||
124513165|NCT02855450|447830993|FG000|Overall Study|Lost to Follow-up|4|||
124513166|NCT02855450|447830994|FG001|Overall Study|Lost to Follow-up|0|||
124513167|NCT01376245|447830997|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
124513168|NCT01376245|447830998|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
124513169|NCT01376245|447830999|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
124513170|NCT01376245|447831000|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
124513171|NCT01376245|447831001|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
124513172|NCT01376245|447830997|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
124513173|NCT01376245|447830998|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
124513174|NCT01376245|447830999|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
124513175|NCT01376245|447831000|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
124513176|NCT01376245|447831001|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
124513177|NCT01376245|447830997|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
124513178|NCT01376245|447830998|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
124513179|NCT01376245|447830999|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
124513180|NCT01376245|447831000|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
124513181|NCT01376245|447831001|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
124513182|NCT01376245|447830997|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
124513183|NCT01376245|447830998|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
124513184|NCT01376245|447830999|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
124513185|NCT01376245|447831000|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
124513186|NCT01376245|447831001|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
124513187|NCT01376245|447830997|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
124513188|NCT01376245|447830998|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
124513189|NCT01376245|447830999|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
124513190|NCT01376245|447831000|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
124513191|NCT01376245|447831001|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
124513192|NCT01376245|447830997|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
124513193|NCT01376245|447830998|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
124513194|NCT01376245|447830999|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
124513195|NCT01376245|447831000|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
124513196|NCT01376245|447831001|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
124513197|NCT01376245|447830997|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
124513198|NCT01376245|447830998|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
124513199|NCT01376245|447830999|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
124513200|NCT01376245|447831000|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
124513201|NCT01376245|447831001|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
124513202|NCT01376245|447830997|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
124513203|NCT01376245|447830998|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
124513204|NCT01376245|447830999|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
124513205|NCT01376245|447831000|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
124513206|NCT01376245|447831001|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
124513207|NCT01376245|447830997|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
124513208|NCT01376245|447830998|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
124513209|NCT01376245|447830999|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
124513210|NCT01376245|447831000|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
124513211|NCT01376245|447831001|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
124513212|NCT01376245|447830997|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
124513213|NCT01376245|447830998|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
124513214|NCT01376245|447830999|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
124513215|NCT01376245|447831000|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
124513216|NCT01376245|447831001|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
124513217|NCT01376245|447830997|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
124513218|NCT01376245|447830998|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
124568678|NCT02752776|448040595|FG002|Overall Study|Adverse Event|11|||
124568679|NCT02752776|448040593|FG000|Overall Study|Lack of Efficacy|2|||
124568680|NCT02752776|448040594|FG001|Overall Study|Lack of Efficacy|6|||
124568681|NCT02752776|448040595|FG002|Overall Study|Lack of Efficacy|14|||
124568682|NCT02752776|448040593|FG000|Overall Study|Lost to Follow-up|11|||
124568683|NCT02752776|448040594|FG001|Overall Study|Lost to Follow-up|12|||
124568684|NCT02752776|448040595|FG002|Overall Study|Lost to Follow-up|4|||
124568685|NCT02752776|448040593|FG000|Overall Study|Non-compliance with study treatment|0|||
124568686|NCT02752776|448040594|FG001|Overall Study|Non-compliance with study treatment|0|||
124568687|NCT02752776|448040595|FG002|Overall Study|Non-compliance with study treatment|1|||
124568688|NCT02752776|448040593|FG000|Overall Study|Physician Decision|2|||
124568689|NCT02752776|448040594|FG001|Overall Study|Physician Decision|6|||
124568690|NCT02752776|448040595|FG002|Overall Study|Physician Decision|2|||
124568691|NCT02752776|448040593|FG000|Overall Study|Pregnancy|1|||
124568692|NCT02752776|448040594|FG001|Overall Study|Pregnancy|6|||
124568693|NCT02752776|448040595|FG002|Overall Study|Pregnancy|3|||
124568694|NCT02752776|448040593|FG000|Overall Study|Protocol Violation|10|||
124568695|NCT02752776|448040594|FG001|Overall Study|Protocol Violation|13|||
124568696|NCT02752776|448040595|FG002|Overall Study|Protocol Violation|6|||
124568697|NCT02752776|448040593|FG000|Overall Study|Subject/guardian decision|8|||
124568698|NCT02752776|448040594|FG001|Overall Study|Subject/guardian decision|6|||
124568699|NCT02752776|448040595|FG002|Overall Study|Subject/guardian decision|4|||
124568700|NCT02752776|448040593|FG000|Overall Study|Death|0|||
124568701|NCT02752776|448040594|FG001|Overall Study|Death|0|||
124568702|NCT02752776|448040595|FG002|Overall Study|Death|1|||
124568703|NCT02752776|448040593|FG000|Overall Study|Withdrawal by Subject|3|||
124568704|NCT02752776|448040594|FG001|Overall Study|Withdrawal by Subject|4|||
124568705|NCT02752776|448040595|FG002|Overall Study|Withdrawal by Subject|2|||
124568706|NCT01946165|448040596|FG000|Overall Study|Physician Decision|2|||
124568707|NCT01946165|448040597|FG001|Overall Study|Physician Decision|0|||
124568708|NCT01946165|448040596|FG000|Overall Study|Withdrawal by Subject|0|||
124568709|NCT01946165|448040597|FG001|Overall Study|Withdrawal by Subject|2|||
124568710|NCT01179919|448040598|FG000|Overall Study|Protocol Violation|1|||
124568711|NCT01179919|448040598|FG000|Overall Study|Adverse Event|1|||
124568712|NCT00806156|448040599|FG000|Overall Study|Death|35|||
124568713|NCT00806156|448040600|FG001|Overall Study|Death|95|||
124568714|NCT00806156|448040599|FG000|Overall Study|Did not meet eligibility criteria|1|||
124568715|NCT00806156|448040600|FG001|Overall Study|Did not meet eligibility criteria|0|||
124568716|NCT00806156|448040599|FG000|Overall Study|Study terminated by Sponsor|2|||
124568717|NCT00806156|448040600|FG001|Overall Study|Study terminated by Sponsor|40|||
124568718|NCT00806156|448040599|FG000|Overall Study|Consent withdrawn by subject|1|||
124568719|NCT00806156|448040600|FG001|Overall Study|Consent withdrawn by subject|3|||
124568720|NCT00806156|448040599|FG000|Overall Study|Lost to Follow-up|0|||
124568721|NCT00806156|448040600|FG001|Overall Study|Lost to Follow-up|1|||
124568722|NCT00337571|448040604|FG000|Overall Study|Lack of Efficacy|3|||
124568723|NCT00337571|448040605|FG001|Overall Study|Lack of Efficacy|0|||
124568724|NCT00337571|448040606|FG002|Overall Study|Lack of Efficacy|0|||
124568725|NCT00337571|448040607|FG003|Overall Study|Lack of Efficacy|0|||
124568726|NCT00337571|448040604|FG000|Overall Study|Adverse Event|4|||
124568727|NCT00337571|448040605|FG001|Overall Study|Adverse Event|5|||
124568728|NCT00337571|448040606|FG002|Overall Study|Adverse Event|8|||
124568729|NCT00337571|448040607|FG003|Overall Study|Adverse Event|4|||
124568730|NCT00337571|448040604|FG000|Overall Study|Withdrawal by Subject|2|||
124568731|NCT00337571|448040605|FG001|Overall Study|Withdrawal by Subject|2|||
124568732|NCT00337571|448040606|FG002|Overall Study|Withdrawal by Subject|1|||
124568733|NCT00337571|448040607|FG003|Overall Study|Withdrawal by Subject|0|||
124568734|NCT00337571|448040604|FG000|Overall Study|Lost to Follow-up|3|||
124568735|NCT00337571|448040605|FG001|Overall Study|Lost to Follow-up|1|||
124568736|NCT00337571|448040606|FG002|Overall Study|Lost to Follow-up|0|||
124568737|NCT00337571|448040607|FG003|Overall Study|Lost to Follow-up|1|||
124568738|NCT00337571|448040604|FG000|Overall Study|Poor/noncompliance|1|||
124568739|NCT00337571|448040605|FG001|Overall Study|Poor/noncompliance|1|||
124568740|NCT00337571|448040606|FG002|Overall Study|Poor/noncompliance|1|||
124568741|NCT00337571|448040607|FG003|Overall Study|Poor/noncompliance|1|||
124568742|NCT00337571|448040604|FG000|Overall Study|No longer met study criteria|1|||
124568743|NCT00337571|448040605|FG001|Overall Study|No longer met study criteria|0|||
124568744|NCT00337571|448040606|FG002|Overall Study|No longer met study criteria|0|||
124568745|NCT00337571|448040607|FG003|Overall Study|No longer met study criteria|0|||
124568746|NCT00337571|448040604|FG000|Overall Study|High Potassium level|0|||
124568747|NCT00337571|448040605|FG001|Overall Study|High Potassium level|0|||
124568748|NCT00337571|448040606|FG002|Overall Study|High Potassium level|0|||
124568749|NCT00337571|448040607|FG003|Overall Study|High Potassium level|1|||
124568750|NCT02674334|448040610|FG000|Overall Study|Lost to Follow-up|5|||
124568751|NCT02674334|448040611|FG001|Overall Study|Lost to Follow-up|3|||
124568752|NCT02674334|448040610|FG000|Overall Study|participant difficulty breathing|1|||
124568753|NCT02674334|448040611|FG001|Overall Study|participant difficulty breathing|0|||
124568754|NCT02674334|448040610|FG000|Overall Study|NIRS not recording|1|||
124568755|NCT02674334|448040611|FG001|Overall Study|NIRS not recording|0|||
124513219|NCT01376245|447830999|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
124724885|NCT00705250|448613346|FG000|Overall Study|Withdrawal by Subject|1|||
124724886|NCT00705250|448613346|FG000|Overall Study|Patient died in car accident|1|||
124724887|NCT01951586|448613353|FG000|Overall Study|Death|61|||
124513220|NCT01376245|447831000|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
124513221|NCT01376245|447831001|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
124513222|NCT01376245|447830997|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
124513223|NCT01376245|447830998|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
124513224|NCT01376245|447830999|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
124513225|NCT01376245|447831000|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
124513226|NCT01376245|447831001|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
124513227|NCT05159362|447831002|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
124513228|NCT05159362|447831003|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
124513229|NCT05159362|447831004|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
124513230|NCT01357889|447831005|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
124513231|NCT01357889|447831006|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
124513232|NCT01357889|447831005|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
124513233|NCT01357889|447831006|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
124513234|NCT01357889|447831005|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
124513235|NCT01357889|447831006|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
124513236|NCT01357889|447831005|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
124513237|NCT01357889|447831006|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
124513238|NCT01357889|447831005|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
124513239|NCT01357889|447831006|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
124513240|NCT01357889|447831005|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
124513241|NCT01357889|447831006|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
124513242|NCT01357889|447831005|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
124513243|NCT01357889|447831006|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
124513244|NCT01357889|447831005|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
124513245|NCT01357889|447831006|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
124513246|NCT01357889|447831005|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
124513247|NCT01357889|447831006|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
124513248|NCT01357889|447831005|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
124513249|NCT01357889|447831006|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
124513250|NCT01357889|447831005|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
124513251|NCT01357889|447831006|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
124513252|NCT01357889|447831005|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
124513253|NCT01357889|447831006|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
124513254|NCT01357889|447831005|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
124513255|NCT01357889|447831006|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
124513256|NCT01335698|447831007|FG000|Treatment Stage 1|Lack of Efficacy|3|||
124513257|NCT01335698|447831008|FG001|Treatment Stage 1|Lack of Efficacy|1|||
124513258|NCT01335698|447831009|FG002|Treatment Stage 1|Lack of Efficacy|3|||
124513259|NCT01335698|447831010|FG003|Treatment Stage 1|Lack of Efficacy|3|||
124513260|NCT01335698|447831011|FG004|Treatment Stage 1|Lack of Efficacy|1|||
124513261|NCT01335698|447831007|FG000|Treatment Stage 1|Adverse Event|1|||
124513262|NCT01335698|447831008|FG001|Treatment Stage 1|Adverse Event|2|||
124513263|NCT01335698|447831009|FG002|Treatment Stage 1|Adverse Event|2|||
124513264|NCT01335698|447831010|FG003|Treatment Stage 1|Adverse Event|1|||
124513265|NCT01335698|447831011|FG004|Treatment Stage 1|Adverse Event|1|||
124513266|NCT01335698|447831007|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
124513267|NCT01335698|447831008|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
124513268|NCT01335698|447831009|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
124513269|NCT01335698|447831010|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
124513270|NCT01335698|447831011|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
124513271|NCT01335698|447831007|FG000|Treatment Stage 1|Lost to Follow-up|1|||
124513272|NCT01335698|447831008|FG001|Treatment Stage 1|Lost to Follow-up|1|||
124513273|NCT01335698|447831009|FG002|Treatment Stage 1|Lost to Follow-up|0|||
124513274|NCT01335698|447831010|FG003|Treatment Stage 1|Lost to Follow-up|0|||
124513275|NCT01335698|447831011|FG004|Treatment Stage 1|Lost to Follow-up|0|||
124513276|NCT01335698|447831007|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
124513277|NCT01335698|447831008|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
124513278|NCT01335698|447831009|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
124513279|NCT01335698|447831010|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
124513280|NCT01335698|447831011|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
124513281|NCT01335698|447831007|FG000|Treatment Stage 1|No longer meets study criteria|1|||
124513282|NCT01335698|447831008|FG001|Treatment Stage 1|No longer meets study criteria|1|||
124513283|NCT01335698|447831009|FG002|Treatment Stage 1|No longer meets study criteria|0|||
124724888|NCT01951586|448613354|FG001|Overall Study|Death|120|||
124724889|NCT01951586|448613353|FG000|Overall Study|Withdrawal by Subject|8|||
124568756|NCT03552757|448040612|FG000|Overall Study|Withdrawal by Subject|10|||
124568757|NCT03552757|448040613|FG001|Overall Study|Withdrawal by Subject|5|||
124568758|NCT03552757|448040614|FG002|Overall Study|Withdrawal by Subject|12|||
124568759|NCT03552757|448040612|FG000|Overall Study|Lost to Follow-up|2|||
124568760|NCT03552757|448040613|FG001|Overall Study|Lost to Follow-up|7|||
124568761|NCT03552757|448040614|FG002|Overall Study|Lost to Follow-up|7|||
124568762|NCT03552757|448040612|FG000|Overall Study|Death|1|||
124568763|NCT03552757|448040613|FG001|Overall Study|Death|1|||
124568764|NCT03552757|448040614|FG002|Overall Study|Death|1|||
124568765|NCT00449150|448040615|FG000|Overall Study|Adverse Event|11|||
124568766|NCT00449150|448040616|FG001|Overall Study|Adverse Event|18|||
124568767|NCT00449150|448040617|FG002|Overall Study|Adverse Event|9|||
124568768|NCT00449150|448040615|FG000|Overall Study|Lack of Efficacy|1|||
124568769|NCT00449150|448040616|FG001|Overall Study|Lack of Efficacy|2|||
124568770|NCT00449150|448040617|FG002|Overall Study|Lack of Efficacy|2|||
124568771|NCT00449150|448040615|FG000|Overall Study|Other|16|||
124568772|NCT00449150|448040616|FG001|Overall Study|Other|13|||
124568773|NCT00449150|448040617|FG002|Overall Study|Other|14|||
124568774|NCT00449150|448040615|FG000|Overall Study|Withdrawal by Subject|17|||
124568775|NCT00449150|448040616|FG001|Overall Study|Withdrawal by Subject|18|||
124568776|NCT00449150|448040617|FG002|Overall Study|Withdrawal by Subject|21|||
124568777|NCT00449150|448040615|FG000|Overall Study|Protocol Violation|1|||
124568778|NCT00449150|448040616|FG001|Overall Study|Protocol Violation|2|||
124568779|NCT00449150|448040617|FG002|Overall Study|Protocol Violation|1|||
124568780|NCT02660242|448040622|FG000|Glucose Tabs|Lost to Follow-up|1|||
124568781|NCT02660242|448040622|FG000|Glucagon Injection|Lost to Follow-up|1|||
124568782|NCT01345019|448040624|FG000|Blinded Treatment Phase|Death|147|||
124568783|NCT01345019|448040625|FG001|Blinded Treatment Phase|Death|137|||
124568784|NCT01345019|448040624|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
124568785|NCT01345019|448040625|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
124568786|NCT01345019|448040624|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
124568787|NCT01345019|448040625|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
124568788|NCT01345019|448040624|FG000|Blinded Treatment Phase|Disease Progression|12|||
124568789|NCT01345019|448040625|FG001|Blinded Treatment Phase|Disease Progression|10|||
124568790|NCT01345019|448040624|FG000|Blinded Treatment Phase|Adverse Event|6|||
124568791|NCT01345019|448040625|FG001|Blinded Treatment Phase|Adverse Event|13|||
124568792|NCT01345019|448040624|FG000|Blinded Treatment Phase|Administrative Decision|10|||
124568793|NCT01345019|448040625|FG001|Blinded Treatment Phase|Administrative Decision|8|||
124568794|NCT01345019|448040624|FG000|Blinded Treatment Phase|Noncompliance|5|||
124568795|NCT01345019|448040625|FG001|Blinded Treatment Phase|Noncompliance|3|||
124568796|NCT01345019|448040624|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
124568797|NCT01345019|448040625|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
124568798|NCT01345019|448040624|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
124568799|NCT01345019|448040625|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
124568800|NCT01345019|448040624|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
124568801|NCT01345019|448040625|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
124568802|NCT01345019|448040624|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
124568803|NCT01345019|448040625|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
124568804|NCT01345019|448040624|FG000|Open Label Treatment Phase|Death|49|||
124568805|NCT01345019|448040625|FG001|Open Label Treatment Phase|Death|48|||
124568806|NCT01345019|448040624|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
124568807|NCT01345019|448040625|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
124568808|NCT01345019|448040624|FG000|Open Label Treatment Phase|Adverse Event|30|||
124568809|NCT01345019|448040625|FG001|Open Label Treatment Phase|Adverse Event|51|||
124568810|NCT01345019|448040624|FG000|Open Label Treatment Phase|Administrative Decision|30|||
124568811|NCT01345019|448040625|FG001|Open Label Treatment Phase|Administrative Decision|15|||
124568812|NCT01345019|448040624|FG000|Open Label Treatment Phase|Disease Progression|17|||
124568813|NCT01345019|448040625|FG001|Open Label Treatment Phase|Disease Progression|18|||
124568814|NCT01345019|448040624|FG000|Open Label Treatment Phase|Noncompliance|5|||
124568815|NCT01345019|448040625|FG001|Open Label Treatment Phase|Noncompliance|4|||
124568816|NCT01345019|448040624|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
124568817|NCT01345019|448040625|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
124568818|NCT01345019|448040624|FG000|Open Label Treatment Phase|Pregnancy|1|||
124568819|NCT01345019|448040625|FG001|Open Label Treatment Phase|Pregnancy|0|||
124568820|NCT01345019|448040624|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
124568821|NCT01345019|448040625|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
124568822|NCT01345019|448040624|FG000|Open Label Treatment Phase|Protocol Violation|0|||
124568823|NCT01345019|448040625|FG001|Open Label Treatment Phase|Protocol Violation|1|||
124568824|NCT03830164|448040628|FG000|Overall Study|Adverse Event|0|||
124568825|NCT03830164|448040629|FG001|Overall Study|Adverse Event|2|||
124568826|NCT03830164|448040630|FG002|Overall Study|Adverse Event|0|||
124568827|NCT03830164|448040628|FG000|Overall Study|Lack of Efficacy|1|||
124568828|NCT03830164|448040629|FG001|Overall Study|Lack of Efficacy|5|||
124568829|NCT03830164|448040630|FG002|Overall Study|Lack of Efficacy|0|||
124568830|NCT03830164|448040628|FG000|Overall Study|Lost to Follow-up|0|||
124568831|NCT03830164|448040629|FG001|Overall Study|Lost to Follow-up|1|||
124568832|NCT03830164|448040630|FG002|Overall Study|Lost to Follow-up|0|||
124568833|NCT03830164|448040628|FG000|Overall Study|Withdrawal by Subject|1|||
124568834|NCT03830164|448040629|FG001|Overall Study|Withdrawal by Subject|0|||
124568835|NCT03830164|448040630|FG002|Overall Study|Withdrawal by Subject|0|||
124568836|NCT00386009|448040631|FG000|Overall Study|Adverse Event|0|||
124568837|NCT00386009|448040632|FG001|Overall Study|Adverse Event|2|||
124568838|NCT00386009|448040631|FG000|Overall Study|Death|1|||
124568839|NCT00386009|448040632|FG001|Overall Study|Death|0|||
124568840|NCT00386009|448040631|FG000|Overall Study|Entry Criteria Not Met|0|||
124568841|NCT00386009|448040632|FG001|Overall Study|Entry Criteria Not Met|2|||
124568842|NCT00386009|448040631|FG000|Overall Study|Lost to Follow-up|1|||
124568843|NCT00386009|448040632|FG001|Overall Study|Lost to Follow-up|1|||
124568844|NCT00386009|448040631|FG000|Overall Study|Protocol Violation|1|||
124568845|NCT00386009|448040632|FG001|Overall Study|Protocol Violation|0|||
124568846|NCT00386009|448040631|FG000|Overall Study|Sponsor Decision|1|||
124568847|NCT00386009|448040632|FG001|Overall Study|Sponsor Decision|1|||
124568848|NCT00386009|448040631|FG000|Overall Study|Withdrawal by Subject|5|||
124568849|NCT00386009|448040632|FG001|Overall Study|Withdrawal by Subject|4|||
124568850|NCT01492400|448040634|FG000|Overall Study|Miscellaneous Reasons|2|||
124568851|NCT01492400|448040635|FG001|Overall Study|Miscellaneous Reasons|3|||
124568852|NCT01492400|448040634|FG000|Overall Study|Personal Reasons|0|||
124568853|NCT01492400|448040635|FG001|Overall Study|Personal Reasons|5|||
124568854|NCT01492400|448040634|FG000|Overall Study|Lost to Follow-up|3|||
124568855|NCT01492400|448040635|FG001|Overall Study|Lost to Follow-up|1|||
124568856|NCT01492400|448040634|FG000|Overall Study|Pregnancy|0|||
124568857|NCT01492400|448040635|FG001|Overall Study|Pregnancy|1|||
124568858|NCT01492400|448040634|FG000|Overall Study|Lack of Efficacy|1|||
124568859|NCT01492400|448040635|FG001|Overall Study|Lack of Efficacy|1|||
124568860|NCT01492400|448040634|FG000|Overall Study|Adverse Event|10|||
124568861|NCT01492400|448040635|FG001|Overall Study|Adverse Event|5|||
124568862|NCT00604500|448040636|FG000|Overall Study|Adverse Event|2|||
124568863|NCT00604500|448040636|FG000|Overall Study|Protocol Violation|2|||
124568864|NCT00604500|448040636|FG000|Overall Study|Treatment Failure|1|||
124568865|NCT00604500|448040636|FG000|Overall Study|Withdrawal by Subject|4|||
124568866|NCT00604500|448040636|FG000|Overall Study|Administrative|1|||
124568867|NCT00604500|448040636|FG000|Overall Study|Did not meet protocol eligibility|1|||
124568868|NCT00320112|448040638|FG000|Overall Study|Lost to Follow-up|3|||
124568869|NCT00320112|448040639|FG001|Overall Study|Lost to Follow-up|4|||
124568870|NCT00320112|448040638|FG000|Overall Study|Withdrawal by Subject|3|||
124568871|NCT00320112|448040639|FG001|Overall Study|Withdrawal by Subject|0|||
124568872|NCT00320112|448040638|FG000|Overall Study|Death|2|||
124568873|NCT00320112|448040639|FG001|Overall Study|Death|1|||
124568874|NCT02899338|448040640|FG000|Overall Study|Adverse Event|1|||
124568875|NCT02899338|448040641|FG001|Overall Study|Adverse Event|2|||
124568876|NCT02899338|448040640|FG000|Overall Study|Withdrawal by Subject|2|||
124568877|NCT02899338|448040641|FG001|Overall Study|Withdrawal by Subject|0|||
124568878|NCT02353169|448040642|FG000|Overall Study|QTc > 450 msec|1|||
124568879|NCT02353169|448040643|FG001|Overall Study|QTc > 450 msec|1|||
124568880|NCT02353169|448040644|FG002|Overall Study|QTc > 450 msec|1|||
124568881|NCT02353169|448040645|FG003|Overall Study|QTc > 450 msec|1|||
124568882|NCT02353169|448040642|FG000|Overall Study|OR team declined|2|||
124568883|NCT02353169|448040643|FG001|Overall Study|OR team declined|0|||
124568884|NCT02353169|448040644|FG002|Overall Study|OR team declined|0|||
124568885|NCT02353169|448040645|FG003|Overall Study|OR team declined|0|||
124568886|NCT02353169|448040642|FG000|Overall Study|Inhalational induction|0|||
124568887|NCT02353169|448040643|FG001|Overall Study|Inhalational induction|2|||
124568888|NCT02353169|448040644|FG002|Overall Study|Inhalational induction|0|||
124568889|NCT02353169|448040645|FG003|Overall Study|Inhalational induction|0|||
124568890|NCT02353169|448040642|FG000|Overall Study|ECG data error|0|||
124568891|NCT02353169|448040643|FG001|Overall Study|ECG data error|3|||
124568892|NCT02353169|448040644|FG002|Overall Study|ECG data error|2|||
124568893|NCT02353169|448040645|FG003|Overall Study|ECG data error|2|||
124568894|NCT02353169|448040642|FG000|Overall Study|Pre-op medication|0|||
124568895|NCT02353169|448040643|FG001|Overall Study|Pre-op medication|0|||
124568896|NCT02353169|448040644|FG002|Overall Study|Pre-op medication|1|||
124568897|NCT02353169|448040645|FG003|Overall Study|Pre-op medication|0|||
124568898|NCT00906347|448040646|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
124568899|NCT00906347|448040647|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
124568900|NCT00906347|448040646|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
124568901|NCT00906347|448040647|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
124568902|NCT00906347|448040646|FG000|Received Study Drug|Refused study drug|1|||
124568903|NCT00906347|448040647|FG001|Received Study Drug|Refused study drug|0|||
124568904|NCT00906347|448040646|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
124568905|NCT00906347|448040647|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
124568906|NCT00577460|448040650|FG000|Overall Study|Adverse Event|11|||
124568907|NCT00577460|448040651|FG001|Overall Study|Adverse Event|7|||
124568908|NCT00577460|448040652|FG002|Overall Study|Adverse Event|14|||
124568909|NCT00577460|448040650|FG000|Overall Study|Protocol Violation|0|||
124568910|NCT00577460|448040651|FG001|Overall Study|Protocol Violation|1|||
124568911|NCT00577460|448040652|FG002|Overall Study|Protocol Violation|1|||
124568912|NCT00577460|448040650|FG000|Overall Study|Lost to Follow-up|0|||
124513284|NCT01335698|447831010|FG003|Treatment Stage 1|No longer meets study criteria|1|||
124513285|NCT01335698|447831011|FG004|Treatment Stage 1|No longer meets study criteria|0|||
124568913|NCT00577460|448040651|FG001|Overall Study|Lost to Follow-up|3|||
124568914|NCT00577460|448040652|FG002|Overall Study|Lost to Follow-up|4|||
124568915|NCT00577460|448040650|FG000|Overall Study|Withdrawal by Subject|5|||
124568916|NCT00577460|448040651|FG001|Overall Study|Withdrawal by Subject|5|||
124568917|NCT00577460|448040652|FG002|Overall Study|Withdrawal by Subject|6|||
124568918|NCT00577460|448040650|FG000|Overall Study|Other|0|||
124568919|NCT00577460|448040651|FG001|Overall Study|Other|3|||
124568920|NCT00577460|448040652|FG002|Overall Study|Other|2|||
124568921|NCT04591626|448040653|FG000|Overall Study|Adverse Event|4|||
124568922|NCT04591626|448040654|FG001|Overall Study|Adverse Event|0|||
124568923|NCT04591626|448040653|FG000|Overall Study|Withdrawal by Subject|5|||
124568924|NCT04591626|448040654|FG001|Overall Study|Withdrawal by Subject|3|||
124568925|NCT04591626|448040653|FG000|Overall Study|Physician Decision|0|||
124568926|NCT04591626|448040654|FG001|Overall Study|Physician Decision|1|||
124568927|NCT04591626|448040653|FG000|Overall Study|Death|0|||
124568928|NCT04591626|448040654|FG001|Overall Study|Death|1|||
124568929|NCT04591626|448040653|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124568930|NCT04591626|448040654|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124568931|NCT02672553|448040655|FG000|Overall Study|Death|3|||
124568932|NCT02672553|448040656|FG001|Overall Study|Death|5|||
124568933|NCT02672553|448040655|FG000|Overall Study|Valve Explant|1|||
124568934|NCT02672553|448040656|FG001|Overall Study|Valve Explant|0|||
124568935|NCT02672553|448040655|FG000|Overall Study|Conversion to Commercial Valve|3|||
124568936|NCT02672553|448040656|FG001|Overall Study|Conversion to Commercial Valve|0|||
124568937|NCT02672553|448040655|FG000|Overall Study|Withdrawal by Subject|3|||
124568938|NCT02672553|448040656|FG001|Overall Study|Withdrawal by Subject|3|||
124568939|NCT02672553|448040655|FG000|Overall Study|Intraoperative screen failure|2|||
124568940|NCT02672553|448040656|FG001|Overall Study|Intraoperative screen failure|0|||
124568941|NCT02507375|448040660|FG000|Overall Study|Progressive Disease|4|||
124568942|NCT02507375|448040661|FG001|Overall Study|Progressive Disease|5|||
124568943|NCT02507375|448040660|FG000|Overall Study|Death|0|||
124568944|NCT02507375|448040661|FG001|Overall Study|Death|1|||
124568945|NCT02507375|448040660|FG000|Overall Study|Refused treatment|0|||
124568946|NCT02507375|448040661|FG001|Overall Study|Refused treatment|1|||
124568947|NCT02507375|448040660|FG000|Overall Study|Adverse Event|0|||
124568948|NCT02507375|448040661|FG001|Overall Study|Adverse Event|1|||
124568949|NCT00522457|448040662|FG000|Overall Study|Due to disease progression|16|||
124568950|NCT00522457|448040662|FG000|Overall Study|Adverse Event|2|||
124568951|NCT01691248|448040663|FG000|Overall Study|Protocol Violation|43|||
124568952|NCT01691248|448040664|FG001|Overall Study|Protocol Violation|27|||
124568953|NCT01691248|448040663|FG000|Overall Study|Adverse Event|24|||
124513286|NCT01335698|447831007|FG000|Treatment Stage 1|Other|1|||
124513287|NCT01335698|447831008|FG001|Treatment Stage 1|Other|0|||
124513288|NCT01335698|447831009|FG002|Treatment Stage 1|Other|0|||
124513289|NCT01335698|447831010|FG003|Treatment Stage 1|Other|1|||
124513290|NCT01335698|447831011|FG004|Treatment Stage 1|Other|0|||
124513291|NCT01335698|447831007|FG000|Treatment Stage 2|Lack of Efficacy|2|||
124513292|NCT01335698|447831008|FG001|Treatment Stage 2|Lack of Efficacy|1|||
124513293|NCT01335698|447831009|FG002|Treatment Stage 2|Lack of Efficacy|3|||
124513294|NCT01335698|447831010|FG003|Treatment Stage 2|Lack of Efficacy|1|||
124513295|NCT01335698|447831011|FG004|Treatment Stage 2|Lack of Efficacy|0|||
124513296|NCT01335698|447831007|FG000|Treatment Stage 2|Adverse Event|2|||
124513297|NCT01335698|447831008|FG001|Treatment Stage 2|Adverse Event|0|||
124513298|NCT01335698|447831009|FG002|Treatment Stage 2|Adverse Event|0|||
124513299|NCT01335698|447831010|FG003|Treatment Stage 2|Adverse Event|3|||
124513300|NCT01335698|447831011|FG004|Treatment Stage 2|Adverse Event|0|||
124568954|NCT01691248|448040664|FG001|Overall Study|Adverse Event|22|||
124568955|NCT01691248|448040663|FG000|Overall Study|Withdrawal by Subject|20|||
124568956|NCT01691248|448040664|FG001|Overall Study|Withdrawal by Subject|18|||
124513301|NCT01335698|447831007|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
124513302|NCT01335698|447831008|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
124513303|NCT01335698|447831009|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
124513304|NCT01335698|447831010|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
124513305|NCT01335698|447831011|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
124568957|NCT01691248|448040663|FG000|Overall Study|Confirmed CDAD|14|||
124513306|NCT01335698|447831007|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
124513307|NCT01335698|447831008|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
124568958|NCT01691248|448040664|FG001|Overall Study|Confirmed CDAD|31|||
124568959|NCT01691248|448040663|FG000|Overall Study|Lost to Follow-up|2|||
124568960|NCT01691248|448040664|FG001|Overall Study|Lost to Follow-up|5|||
124568961|NCT01691248|448040663|FG000|Overall Study|Reason not provided|4|||
124568962|NCT01691248|448040664|FG001|Overall Study|Reason not provided|4|||
124568963|NCT01691248|448040663|FG000|Overall Study|Not Treated|4|||
124568964|NCT01691248|448040664|FG001|Overall Study|Not Treated|7|||
124568965|NCT02863575|448040665|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
124568966|NCT02863575|448040666|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
124568967|NCT02863575|448040667|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
124568968|NCT02863575|448040665|FG000|Overall Study|Withdrawal by Subject|0|||
124568969|NCT02863575|448040666|FG001|Overall Study|Withdrawal by Subject|1|||
124568970|NCT02863575|448040667|FG002|Overall Study|Withdrawal by Subject|1|||
124568971|NCT02863575|448040665|FG000|Overall Study|Adverse Event|0|||
124568972|NCT02863575|448040666|FG001|Overall Study|Adverse Event|1|||
124568973|NCT02863575|448040667|FG002|Overall Study|Adverse Event|0|||
124568974|NCT00993616|448040668|FG000|Overall Study|No tumor at entry|1|||
124568975|NCT00993616|448040668|FG000|Overall Study|Never treated|1|||
124568976|NCT03815942|448042035|FG000|Overall Study|Withdrawal by Subject|0|||
124568977|NCT03815942|448042036|FG001|Overall Study|Withdrawal by Subject|17|||
124568978|NCT02785913|448042037|FG000|Overall Study|Adverse Event|5|||
124568979|NCT02785913|448042037|FG000|Overall Study|Death|2|||
124568980|NCT02785913|448042037|FG000|Overall Study|Progression|18|||
124568981|NCT02785913|448042037|FG000|Overall Study|Not protocol specified|1|||
124568982|NCT03717064|448042038|FG000|Period 2|Adverse Event|1|||
124568983|NCT01298570|448042039|FG000|Overall Study|Disease progression, relapse during acti|64|||
124568984|NCT01298570|448042040|FG001|Overall Study|Disease progression, relapse during acti|40|||
124568985|NCT01298570|448042039|FG000|Overall Study|Adverse Event|20|||
124568986|NCT01298570|448042040|FG001|Overall Study|Adverse Event|2|||
124568987|NCT01298570|448042039|FG000|Overall Study|Withdrawal by Subject|21|||
124568988|NCT01298570|448042040|FG001|Overall Study|Withdrawal by Subject|6|||
124568989|NCT01298570|448042039|FG000|Overall Study|Treatment delay > 4 weeks|4|||
124568990|NCT01298570|448042040|FG001|Overall Study|Treatment delay > 4 weeks|5|||
124568991|NCT01298570|448042039|FG000|Overall Study|Physician Decision|4|||
124568992|NCT01298570|448042040|FG001|Overall Study|Physician Decision|2|||
124568993|NCT01298570|448042039|FG000|Overall Study|Other complicating disease|2|||
124568994|NCT01298570|448042040|FG001|Overall Study|Other complicating disease|1|||
124568995|NCT01298570|448042039|FG000|Overall Study|Surgery|2|||
124568996|NCT01298570|448042040|FG001|Overall Study|Surgery|1|||
124568997|NCT01298570|448042039|FG000|Overall Study|Symptomatic progression/deterioration|3|||
124568998|NCT01298570|448042040|FG001|Overall Study|Symptomatic progression/deterioration|2|||
124568999|NCT01298570|448042039|FG000|Overall Study|Death|0|||
124569000|NCT01298570|448042040|FG001|Overall Study|Death|1|||
124569001|NCT01298570|448042039|FG000|Overall Study|Ineligibility|0|||
124569002|NCT01298570|448042040|FG001|Overall Study|Ineligibility|1|||
124569003|NCT02841709|448042041|FG000|5th Intervention|Adverse Event|2|||
124569004|NCT02841709|448042042|FG001|5th Intervention|Adverse Event|0|||
124569005|NCT02841709|448042043|FG002|5th Intervention|Adverse Event|0|||
124569006|NCT02841709|448042044|FG003|5th Intervention|Adverse Event|0|||
124569007|NCT02841709|448042045|FG004|5th Intervention|Adverse Event|2|||
124569008|NCT01929109|448042046|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
124569009|NCT01929109|448042047|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
124569010|NCT01929109|448042048|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
124569011|NCT01929109|448042049|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
124569012|NCT01929109|448042050|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
124569013|NCT00076102|448042051|FG000|Overall Study|Clinical progression|1|||
124569014|NCT00076102|448042051|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
124569015|NCT00076102|448042051|FG000|Overall Study|plexiform neurofibroma surgery|1|||
124569016|NCT00076102|448042051|FG000|Overall Study|refusal of further therapy|2|||
124569017|NCT01210001|448042052|FG000|Overall Study|Not treated|1|||
124569018|NCT01210001|448042053|FG001|Overall Study|Not treated|0|||
124569019|NCT01210001|448042054|FG002|Overall Study|Not treated|0|||
124569020|NCT01210001|448042052|FG000|Overall Study|Adverse Event|4|||
124569021|NCT01210001|448042053|FG001|Overall Study|Adverse Event|2|||
124569022|NCT01210001|448042054|FG002|Overall Study|Adverse Event|5|||
124569023|NCT01210001|448042052|FG000|Overall Study|Non compliant with protocol|2|||
124569024|NCT01210001|448042053|FG001|Overall Study|Non compliant with protocol|2|||
124569025|NCT01210001|448042054|FG002|Overall Study|Non compliant with protocol|3|||
124569026|NCT01210001|448042052|FG000|Overall Study|Lost to Follow-up|4|||
124569027|NCT01210001|448042053|FG001|Overall Study|Lost to Follow-up|3|||
124569028|NCT01210001|448042054|FG002|Overall Study|Lost to Follow-up|2|||
124724890|NCT01951586|448613354|FG001|Overall Study|Withdrawal by Subject|17|||
124724891|NCT01951586|448613353|FG000|Overall Study|Lost to Follow-up|0|||
124569029|NCT01210001|448042052|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
124724892|NCT01951586|448613354|FG001|Overall Study|Lost to Follow-up|1|||
124724893|NCT01951586|448613353|FG000|Overall Study|Sponsor Decision|9|||
124724894|NCT01951586|448613354|FG001|Overall Study|Sponsor Decision|10|||
124569030|NCT01210001|448042053|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
124569031|NCT01210001|448042054|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
124569032|NCT01210001|448042052|FG000|Overall Study|Other reason not defined above|2|||
124569033|NCT01210001|448042053|FG001|Overall Study|Other reason not defined above|2|||
124569034|NCT01210001|448042054|FG002|Overall Study|Other reason not defined above|1|||
124569035|NCT00788125|448042055|FG000|Overall Study|Death|6|||
124569036|NCT05346055|448042066|FG000|Overall Study|Withdrawal by Subject|1|||
124569037|NCT05346055|448042066|FG000|Overall Study|Protocol Violation|1|||
124569038|NCT05346055|448042066|FG000|Overall Study|Therapist decision|1|||
124569039|NCT00977106|448042067|FG000|Overall Study|Adverse Event|5|||
124569040|NCT00977106|448042068|FG001|Overall Study|Adverse Event|6|||
124569041|NCT00977106|448042067|FG000|Overall Study|Withdrawal by Subject|2|||
124569042|NCT00977106|448042068|FG001|Overall Study|Withdrawal by Subject|2|||
124569043|NCT00977106|448042067|FG000|Overall Study|Lack of Efficacy|2|||
124569044|NCT00977106|448042068|FG001|Overall Study|Lack of Efficacy|2|||
124569045|NCT00977106|448042067|FG000|Overall Study|Protocol Violation|0|||
124569046|NCT00977106|448042068|FG001|Overall Study|Protocol Violation|1|||
124569047|NCT00977106|448042067|FG000|Overall Study|Other|1|||
124569048|NCT00977106|448042068|FG001|Overall Study|Other|0|||
124569049|NCT02319148|448042075|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
124569050|NCT02319148|448042076|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
124569051|NCT02319148|448042077|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
124569052|NCT02319148|448042078|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
124569053|NCT02319148|448042075|FG000|Second Intervention Period|No longer willing to participate|0|||
124569054|NCT02319148|448042076|FG001|Second Intervention Period|No longer willing to participate|1|||
124569055|NCT02319148|448042077|FG002|Second Intervention Period|No longer willing to participate|0|||
124569056|NCT02319148|448042078|FG003|Second Intervention Period|No longer willing to participate|0|||
124569057|NCT02319148|448042075|FG000|Second Intervention Period|Other|0|||
124569058|NCT02319148|448042076|FG001|Second Intervention Period|Other|0|||
124569059|NCT02319148|448042077|FG002|Second Intervention Period|Other|0|||
124569060|NCT02319148|448042078|FG003|Second Intervention Period|Other|1|||
124569061|NCT02388763|448042081|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
124569062|NCT02388763|448042082|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
124569063|NCT02388763|448042081|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
124569064|NCT02388763|448042082|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
124569065|NCT01153984|448042083|FG000|Overall Study|Withdrawal by Subject|1|||
124569066|NCT01153984|448042083|FG000|Overall Study|Adverse Event|1|||
124569067|NCT02460159|448042084|FG000|Overall Study|Adverse Event|4|||
124569068|NCT02460159|448042085|FG001|Overall Study|Adverse Event|1|||
124569069|NCT02460159|448042084|FG000|Overall Study|Withdrawal by Subject|2|||
124569070|NCT02460159|448042085|FG001|Overall Study|Withdrawal by Subject|0|||
124569071|NCT01458405|448042092|FG000|Phase 1 (up to 12 Months)|Other|0|||
124569072|NCT01458405|448042093|FG001|Phase 1 (up to 12 Months)|Other|1|||
124569073|NCT01458405|448042094|FG002|Phase 1 (up to 12 Months)|Other|0|||
124569074|NCT01458405|448042095|FG003|Phase 1 (up to 12 Months)|Other|0|||
124569075|NCT01458405|448042092|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
124569076|NCT01458405|448042093|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
124569077|NCT01458405|448042094|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
124569078|NCT01458405|448042095|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
124569079|NCT01458405|448042092|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
124569080|NCT01458405|448042093|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
124569081|NCT01458405|448042094|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
124569082|NCT01458405|448042095|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
124569083|NCT01458405|448042092|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
124569084|NCT01458405|448042093|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
124569085|NCT01458405|448042094|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
124569086|NCT01458405|448042095|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
124569087|NCT02194998|448042096|FG000|On-HCV Treatment|Did not pick up study medication|0|||
124569088|NCT02194998|448042097|FG001|On-HCV Treatment|Did not pick up study medication|1|||
124569089|NCT02194998|448042098|FG002|On-HCV Treatment|Did not pick up study medication|0|||
124569090|NCT02194998|448042099|FG003|On-HCV Treatment|Did not pick up study medication|0|||
124569091|NCT02194998|448042096|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
124569092|NCT02194998|448042097|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
124569093|NCT02194998|448042098|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
124569094|NCT02194998|448042099|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
124569095|NCT02497781|448042102|FG000|Overall Study|Withdrawal by Subject|2|||
124569096|NCT02497781|448042103|FG001|Overall Study|Withdrawal by Subject|0|||
124569097|NCT02497781|448042102|FG000|Overall Study|Lack of Efficacy|0|||
124569098|NCT02497781|448042103|FG001|Overall Study|Lack of Efficacy|1|||
124569099|NCT02497781|448042102|FG000|Overall Study|Randomised but not treated|1|||
124569100|NCT02497781|448042103|FG001|Overall Study|Randomised but not treated|1|||
124569101|NCT02497781|448042102|FG000|Overall Study|Lost to Follow-up|1|||
124569102|NCT02497781|448042103|FG001|Overall Study|Lost to Follow-up|1|||
124569103|NCT02236130|448042104|FG000|Overall Study|Lost to Follow-up|7|||
124569104|NCT02236130|448042105|FG001|Overall Study|Lost to Follow-up|12|||
124569105|NCT00454636|448042106|FG000|Overall Study|Adverse Event|10|||
124569106|NCT00454636|448042107|FG001|Overall Study|Adverse Event|6|||
124569107|NCT00454636|448042108|FG002|Overall Study|Adverse Event|9|||
124569108|NCT00454636|448042109|FG003|Overall Study|Adverse Event|15|||
124569109|NCT00454636|448042106|FG000|Overall Study|Disease Progression|11|||
124569110|NCT00454636|448042107|FG001|Overall Study|Disease Progression|12|||
124569111|NCT00454636|448042108|FG002|Overall Study|Disease Progression|4|||
124569112|NCT00454636|448042109|FG003|Overall Study|Disease Progression|11|||
124569113|NCT00454636|448042106|FG000|Overall Study|Protocol Violation|3|||
124569114|NCT00454636|448042107|FG001|Overall Study|Protocol Violation|2|||
124569115|NCT00454636|448042108|FG002|Overall Study|Protocol Violation|3|||
124569116|NCT00454636|448042109|FG003|Overall Study|Protocol Violation|3|||
124569117|NCT00454636|448042106|FG000|Overall Study|Death|6|||
124569118|NCT00454636|448042107|FG001|Overall Study|Death|1|||
124569119|NCT00454636|448042108|FG002|Overall Study|Death|1|||
124569120|NCT00454636|448042109|FG003|Overall Study|Death|1|||
124569121|NCT00454636|448042106|FG000|Overall Study|Patient refusal|1|||
124569122|NCT00454636|448042107|FG001|Overall Study|Patient refusal|1|||
124569123|NCT00454636|448042108|FG002|Overall Study|Patient refusal|3|||
124569124|NCT00454636|448042109|FG003|Overall Study|Patient refusal|2|||
124569125|NCT00454636|448042106|FG000|Overall Study|Lost to Follow-up|0|||
124569126|NCT00454636|448042107|FG001|Overall Study|Lost to Follow-up|1|||
124569127|NCT00454636|448042108|FG002|Overall Study|Lost to Follow-up|0|||
124569128|NCT00454636|448042109|FG003|Overall Study|Lost to Follow-up|0|||
124569129|NCT01400113|448042110|FG000|Overall Study|Withdrawal by Subject|1|||
124569130|NCT01400113|448042111|FG001|Overall Study|Withdrawal by Subject|1|||
124569131|NCT01025037|448042116|FG000|Overall Study|Adverse Event|3|||
124569132|NCT01025037|448042116|FG000|Overall Study|Lost to Follow-up|7|||
124569133|NCT01025037|448042116|FG000|Overall Study|Withdrawal by Subject|1|||
124569134|NCT01890915|448042118|FG000|Overall Study|Adverse Event|1|||
124569135|NCT01890915|448042119|FG001|Overall Study|Adverse Event|0|||
124569136|NCT01890915|448042118|FG000|Overall Study|Protocol Violation|2|||
124569137|NCT01890915|448042119|FG001|Overall Study|Protocol Violation|0|||
124569138|NCT01890915|448042118|FG000|Overall Study|Equipment Malfunction|0|||
124569139|NCT01890915|448042119|FG001|Overall Study|Equipment Malfunction|1|||
124569140|NCT02114697|448042120|FG000|Overall Study|Study terminated|5|||
124569141|NCT02114697|448042121|FG001|Overall Study|Study terminated|4|||
124569142|NCT00424489|448042122|FG000|Overall Study|Death|3|||
124569143|NCT00860405|448042132|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
124569144|NCT00860405|448042133|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
124569145|NCT02465567|448042134|FG000|Overall Study|Adverse Event|118|||
124569146|NCT02465567|448042135|FG001|Overall Study|Adverse Event|113|||
124569147|NCT02465567|448042136|FG002|Overall Study|Adverse Event|147|||
124569148|NCT02465567|448042137|FG003|Overall Study|Adverse Event|138|||
124569149|NCT02465567|448042134|FG000|Overall Study|Lack of Efficacy|103|||
124569150|NCT02465567|448042135|FG001|Overall Study|Lack of Efficacy|102|||
124569151|NCT02465567|448042136|FG002|Overall Study|Lack of Efficacy|171|||
124569152|NCT02465567|448042137|FG003|Overall Study|Lack of Efficacy|135|||
124569153|NCT02465567|448042134|FG000|Overall Study|Withdrawal by Subject|104|||
124569154|NCT02465567|448042135|FG001|Overall Study|Withdrawal by Subject|94|||
124569155|NCT02465567|448042136|FG002|Overall Study|Withdrawal by Subject|123|||
124569156|NCT02465567|448042137|FG003|Overall Study|Withdrawal by Subject|130|||
124569157|NCT02465567|448042134|FG000|Overall Study|Physician Decision|23|||
124569158|NCT02465567|448042135|FG001|Overall Study|Physician Decision|33|||
124569159|NCT02465567|448042136|FG002|Overall Study|Physician Decision|38|||
124569160|NCT02465567|448042137|FG003|Overall Study|Physician Decision|28|||
124569161|NCT02465567|448042134|FG000|Overall Study|Major Protocol Deviation|24|||
124569162|NCT02465567|448042135|FG001|Overall Study|Major Protocol Deviation|26|||
124569163|NCT02465567|448042136|FG002|Overall Study|Major Protocol Deviation|22|||
124569164|NCT02465567|448042137|FG003|Overall Study|Major Protocol Deviation|25|||
124569165|NCT02465567|448042134|FG000|Overall Study|Lost to Follow-up|25|||
124569166|NCT02465567|448042135|FG001|Overall Study|Lost to Follow-up|21|||
124569167|NCT02465567|448042136|FG002|Overall Study|Lost to Follow-up|19|||
124569168|NCT02465567|448042137|FG003|Overall Study|Lost to Follow-up|15|||
124569169|NCT02465567|448042134|FG000|Overall Study|Protocol Specified Criteria|20|||
124569170|NCT02465567|448042135|FG001|Overall Study|Protocol Specified Criteria|10|||
124569171|NCT02465567|448042136|FG002|Overall Study|Protocol Specified Criteria|9|||
124569172|NCT02465567|448042137|FG003|Overall Study|Protocol Specified Criteria|12|||
124569173|NCT02465567|448042134|FG000|Overall Study|Administrative Reasons|12|||
124569174|NCT02465567|448042135|FG001|Overall Study|Administrative Reasons|9|||
124569175|NCT02465567|448042136|FG002|Overall Study|Administrative Reasons|11|||
124569176|NCT02465567|448042137|FG003|Overall Study|Administrative Reasons|5|||
124569177|NCT02465567|448042134|FG000|Overall Study|Randomized but not treated|1|||
124569178|NCT02465567|448042135|FG001|Overall Study|Randomized but not treated|5|||
124569179|NCT02465567|448042136|FG002|Overall Study|Randomized but not treated|4|||
124569180|NCT02465567|448042137|FG003|Overall Study|Randomized but not treated|5|||
124569181|NCT02465567|448042134|FG000|Overall Study|enrolled in >1 studies|18|||
124569182|NCT02465567|448042135|FG001|Overall Study|enrolled in >1 studies|11|||
124569183|NCT02465567|448042136|FG002|Overall Study|enrolled in >1 studies|19|||
124569184|NCT02465567|448042137|FG003|Overall Study|enrolled in >1 studies|15|||
124569185|NCT02465567|448042134|FG000|Overall Study|missing PI Signature|1|||
124569186|NCT02465567|448042135|FG001|Overall Study|missing PI Signature|0|||
124569187|NCT02465567|448042136|FG002|Overall Study|missing PI Signature|0|||
124569188|NCT02465567|448042137|FG003|Overall Study|missing PI Signature|0|||
124569189|NCT01074554|448042140|FG000|Overall Study|Adverse Event|3|||
124569190|NCT01074554|448042141|FG001|Overall Study|Adverse Event|3|||
124569191|NCT01074554|448042140|FG000|Overall Study|Lost to Follow-up|0|||
124569192|NCT01074554|448042141|FG001|Overall Study|Lost to Follow-up|1|||
124569193|NCT00497796|448042142|FG000|Overall Study|Adverse event (not related)|9|||
124569194|NCT00497796|448042143|FG001|Overall Study|Adverse event (not related)|9|||
124569195|NCT00497796|448042142|FG000|Overall Study|Adverse event (related)|5|||
124569196|NCT00497796|448042143|FG001|Overall Study|Adverse event (related)|4|||
124569197|NCT00497796|448042142|FG000|Overall Study|CMV infection or disease treatment|30|||
124569198|NCT00497796|448042143|FG001|Overall Study|CMV infection or disease treatment|4|||
124569199|NCT00497796|448042142|FG000|Overall Study|Consent withdrawn|10|||
124569200|NCT00497796|448042143|FG001|Overall Study|Consent withdrawn|3|||
124569201|NCT00497796|448042142|FG000|Overall Study|Investigator/sponsor discretion|31|||
124569202|NCT00497796|448042143|FG001|Overall Study|Investigator/sponsor discretion|34|||
124569203|NCT00497796|448042142|FG000|Overall Study|Lost to Follow-up|0|||
124569204|NCT00497796|448042143|FG001|Overall Study|Lost to Follow-up|1|||
124569205|NCT00497796|448042142|FG000|Overall Study|Not applicable (randomized not treated)|0|||
124569206|NCT00497796|448042143|FG001|Overall Study|Not applicable (randomized not treated)|4|||
124569207|NCT04276883|448042146|FG000|Overall Study|Withdrawal by Subject|2|||
124569208|NCT04276883|448042147|FG001|Overall Study|Withdrawal by Subject|3|||
124569209|NCT04276883|448042148|FG002|Overall Study|Withdrawal by Subject|6|||
124569210|NCT04276883|448042146|FG000|Overall Study|Lost to Follow-up|1|||
124569211|NCT04276883|448042147|FG001|Overall Study|Lost to Follow-up|3|||
124569212|NCT04276883|448042148|FG002|Overall Study|Lost to Follow-up|0|||
124569213|NCT04276883|448042146|FG000|Overall Study|Adverse Event|0|||
124569214|NCT04276883|448042147|FG001|Overall Study|Adverse Event|1|||
124569215|NCT04276883|448042148|FG002|Overall Study|Adverse Event|0|||
124569216|NCT04276883|448042146|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
124569217|NCT04276883|448042147|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
124569218|NCT04276883|448042148|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
124569219|NCT01876706|448042149|FG000|Overall Study|BPH Intervention|9|||
124569220|NCT01876706|448042149|FG000|Overall Study|Lost to Follow-up|7|||
124569221|NCT01876706|448042149|FG000|Overall Study|Withdrawals|6|||
124569222|NCT01876706|448042149|FG000|Overall Study|Death|3|||
124569223|NCT01370408|448042154|FG000|Overall Study|treatment failure|9|||
124569224|NCT02073643|448042156|FG000|Overall Study|Lost to Follow-up|24|||
124569225|NCT02780687|448042157|FG000|Overall Study|Adverse Event|1|||
124569226|NCT02780687|448042158|FG001|Overall Study|Adverse Event|1|||
124569227|NCT02780687|448042157|FG000|Overall Study|Withdrawal by Subject|2|||
124569228|NCT02780687|448042158|FG001|Overall Study|Withdrawal by Subject|1|||
124724895|NCT06004895|448613359|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
124724896|NCT06004895|448613359|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
124513308|NCT01335698|447831009|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
124513309|NCT01335698|447831010|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
124513310|NCT01335698|447831011|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
124513311|NCT01335698|447831007|FG000|Treatment Stage 2|Lost to Follow-up|1|||
124513312|NCT01335698|447831008|FG001|Treatment Stage 2|Lost to Follow-up|0|||
124513313|NCT01335698|447831009|FG002|Treatment Stage 2|Lost to Follow-up|0|||
124513314|NCT01335698|447831010|FG003|Treatment Stage 2|Lost to Follow-up|0|||
124513315|NCT01335698|447831011|FG004|Treatment Stage 2|Lost to Follow-up|0|||
124513316|NCT01335698|447831007|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
124513317|NCT01335698|447831008|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
124513318|NCT01335698|447831009|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
124513319|NCT01335698|447831010|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
124513320|NCT01335698|447831011|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
124513321|NCT01335698|447831007|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
124513322|NCT01335698|447831008|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
124513323|NCT01335698|447831009|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
124513324|NCT01335698|447831010|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
124513325|NCT01335698|447831011|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
124513326|NCT01335698|447831007|FG000|Treatment Stage 2|Switched to another formulation|1|||
124513327|NCT01335698|447831008|FG001|Treatment Stage 2|Switched to another formulation|1|||
124513328|NCT01335698|447831009|FG002|Treatment Stage 2|Switched to another formulation|0|||
124513329|NCT01335698|447831010|FG003|Treatment Stage 2|Switched to another formulation|0|||
124513330|NCT01335698|447831011|FG004|Treatment Stage 2|Switched to another formulation|0|||
124513331|NCT03970824|447831012|FG000|Overall Study|Withdrawal by Subject|1|||
124513332|NCT03970824|447831013|FG001|Overall Study|Withdrawal by Subject|1|||
124569229|NCT02780687|448042157|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
124569230|NCT02780687|448042158|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
124569231|NCT02780687|448042157|FG000|Overall Study|progressive disease|29|||
124569232|NCT02780687|448042158|FG001|Overall Study|progressive disease|6|||
124513333|NCT03970824|447831014|FG002|Overall Study|Withdrawal by Subject|3|||
124513334|NCT03970824|447831012|FG000|Overall Study|Lost to Follow-up|0|||
124513335|NCT03970824|447831013|FG001|Overall Study|Lost to Follow-up|2|||
124513336|NCT03970824|447831014|FG002|Overall Study|Lost to Follow-up|1|||
124513337|NCT03970824|447831012|FG000|Overall Study|Adverse Event|1|||
124513338|NCT03970824|447831013|FG001|Overall Study|Adverse Event|0|||
124513339|NCT03970824|447831014|FG002|Overall Study|Adverse Event|0|||
124513340|NCT00416312|447831015|FG000|Overall Study|tumors not visible on imaging|2|||
124513341|NCT02727660|447831018|FG000|Overall Study|Lack of Efficacy|40|||
124513342|NCT02727660|447831019|FG001|Overall Study|Lack of Efficacy|40|||
124513343|NCT02727660|447831020|FG002|Overall Study|Lack of Efficacy|70|||
124513344|NCT02727660|447831018|FG000|Overall Study|Adverse Event|28|||
124513345|NCT02727660|447831019|FG001|Overall Study|Adverse Event|21|||
124513346|NCT02727660|447831020|FG002|Overall Study|Adverse Event|32|||
124513347|NCT02727660|447831018|FG000|Overall Study|Withdrawal by Subject|26|||
124513348|NCT02727660|447831019|FG001|Overall Study|Withdrawal by Subject|25|||
124513349|NCT02727660|447831020|FG002|Overall Study|Withdrawal by Subject|30|||
124513350|NCT02727660|447831018|FG000|Overall Study|Physician Decision|3|||
124513351|NCT02727660|447831019|FG001|Overall Study|Physician Decision|8|||
124513352|NCT02727660|447831020|FG002|Overall Study|Physician Decision|14|||
124513353|NCT02727660|447831018|FG000|Overall Study|Lost to Follow-up|5|||
124513354|NCT02727660|447831019|FG001|Overall Study|Lost to Follow-up|9|||
124513355|NCT02727660|447831020|FG002|Overall Study|Lost to Follow-up|8|||
124513356|NCT02727660|447831018|FG000|Overall Study|Protocol Violation|7|||
124513357|NCT02727660|447831019|FG001|Overall Study|Protocol Violation|5|||
124513358|NCT02727660|447831020|FG002|Overall Study|Protocol Violation|5|||
124513359|NCT02727660|447831018|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
124513360|NCT02727660|447831019|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
124513361|NCT02727660|447831020|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
124513362|NCT02727660|447831018|FG000|Overall Study|Administrative Reasons|2|||
124513363|NCT02727660|447831019|FG001|Overall Study|Administrative Reasons|3|||
124513364|NCT02727660|447831020|FG002|Overall Study|Administrative Reasons|4|||
124513365|NCT00305604|447831021|FG000|Overall Study|Adverse Event|6|||
124513366|NCT00305604|447831022|FG001|Overall Study|Adverse Event|3|||
124513367|NCT00305604|447831021|FG000|Overall Study|Lack of Efficacy|11|||
124513368|NCT00305604|447831022|FG001|Overall Study|Lack of Efficacy|18|||
124513369|NCT00305604|447831021|FG000|Overall Study|Lost to Follow-up|0|||
124513370|NCT00305604|447831022|FG001|Overall Study|Lost to Follow-up|4|||
124513371|NCT00305604|447831021|FG000|Overall Study|Protocol Violation|2|||
124513372|NCT00305604|447831022|FG001|Overall Study|Protocol Violation|1|||
124513373|NCT00305604|447831021|FG000|Overall Study|Withdrawal by Subject|12|||
124513374|NCT00305604|447831022|FG001|Overall Study|Withdrawal by Subject|21|||
124513375|NCT00305604|447831021|FG000|Overall Study|Patient moved|1|||
124513376|NCT00305604|447831022|FG001|Overall Study|Patient moved|0|||
124513377|NCT00105560|447831023|FG000|Overall Study|Lost to Follow-up|1|||
124513378|NCT01248364|447831027|FG000|Overall Study|Adverse Event|0|||
124513379|NCT01248364|447831028|FG001|Overall Study|Adverse Event|1|||
124513380|NCT01248364|447831029|FG002|Overall Study|Adverse Event|0|||
124513381|NCT01248364|447831030|FG003|Overall Study|Adverse Event|0|||
124513382|NCT00764946|447831033|FG000|Overall Study|Lack of Efficacy|1|||
124513383|NCT00764946|447831034|FG001|Overall Study|Lack of Efficacy|0|||
124513384|NCT00764946|447831035|FG002|Overall Study|Lack of Efficacy|0|||
124513385|NCT00764946|447831033|FG000|Overall Study|Lost to Follow-up|3|||
124513386|NCT00764946|447831034|FG001|Overall Study|Lost to Follow-up|4|||
124513387|NCT00764946|447831035|FG002|Overall Study|Lost to Follow-up|0|||
124513388|NCT00764946|447831033|FG000|Overall Study|Physician Decision|2|||
124513389|NCT00764946|447831034|FG001|Overall Study|Physician Decision|4|||
124513390|NCT00764946|447831035|FG002|Overall Study|Physician Decision|0|||
124513391|NCT00764946|447831033|FG000|Overall Study|Adverse Event|3|||
124513392|NCT00764946|447831034|FG001|Overall Study|Adverse Event|2|||
124513393|NCT00764946|447831035|FG002|Overall Study|Adverse Event|1|||
124513394|NCT00764946|447831033|FG000|Overall Study|Withdrawal by Subject|3|||
124513395|NCT00764946|447831034|FG001|Overall Study|Withdrawal by Subject|6|||
124513396|NCT00764946|447831035|FG002|Overall Study|Withdrawal by Subject|2|||
124513397|NCT00764946|447831033|FG000|Overall Study|Never Treated|1|||
124513398|NCT00764946|447831034|FG001|Overall Study|Never Treated|1|||
124513399|NCT00764946|447831035|FG002|Overall Study|Never Treated|1|||
124513400|NCT02431468|447831039|FG000|Overall Study|Adverse Event|2|||
124513401|NCT02431468|447831040|FG001|Overall Study|Adverse Event|4|||
124513402|NCT02431468|447831041|FG002|Overall Study|Adverse Event|5|||
124513403|NCT02431468|447831039|FG000|Overall Study|Withdrawal by Subject|4|||
124513404|NCT02431468|447831040|FG001|Overall Study|Withdrawal by Subject|12|||
124513405|NCT02431468|447831041|FG002|Overall Study|Withdrawal by Subject|2|||
124513406|NCT02431468|447831039|FG000|Overall Study|noncompliance, investigator termination,|2|||
124513407|NCT02431468|447831040|FG001|Overall Study|noncompliance, investigator termination,|2|||
124513408|NCT02431468|447831041|FG002|Overall Study|noncompliance, investigator termination,|2|||
124513409|NCT01361919|447831042|FG000|Overall Study|technical issues|10|||
124513410|NCT01361919|447831043|FG001|Overall Study|technical issues|12|||
124513411|NCT01361919|447831044|FG002|Overall Study|technical issues|10|||
124569233|NCT01062256|448042161|FG000|Overall Study|Adverse Event|1|||
124569234|NCT01062256|448042162|FG001|Overall Study|Adverse Event|0|||
124569235|NCT01062256|448042163|FG002|Overall Study|Adverse Event|0|||
124569236|NCT01062256|448042161|FG000|Overall Study|Withdrawal by Subject|1|||
124569237|NCT01062256|448042162|FG001|Overall Study|Withdrawal by Subject|1|||
124569238|NCT01062256|448042163|FG002|Overall Study|Withdrawal by Subject|1|||
124569239|NCT01062256|448042161|FG000|Overall Study|Ineligible|1|||
124569240|NCT01062256|448042162|FG001|Overall Study|Ineligible|4|||
124569241|NCT01062256|448042163|FG002|Overall Study|Ineligible|3|||
124569242|NCT01062256|448042161|FG000|Overall Study|Administrative|0|||
124569243|NCT01062256|448042162|FG001|Overall Study|Administrative|2|||
124569244|NCT01062256|448042163|FG002|Overall Study|Administrative|0|||
124569245|NCT03049488|448042164|FG000|Overall Study|Lost to Follow-up|1|||
124569246|NCT03049488|448042165|FG001|Overall Study|Lost to Follow-up|1|||
124569247|NCT03049488|448042166|FG002|Overall Study|Lost to Follow-up|0|||
124569248|NCT03049488|448042167|FG003|Overall Study|Lost to Follow-up|0|||
124569249|NCT03049488|448042168|FG004|Overall Study|Lost to Follow-up|0|||
124569250|NCT03049488|448042169|FG005|Overall Study|Lost to Follow-up|0|||
124569251|NCT03049488|448042164|FG000|Overall Study|Moved from Area|1|||
124569252|NCT03049488|448042165|FG001|Overall Study|Moved from Area|0|||
124569253|NCT03049488|448042166|FG002|Overall Study|Moved from Area|0|||
124569254|NCT03049488|448042167|FG003|Overall Study|Moved from Area|1|||
124569255|NCT03049488|448042168|FG004|Overall Study|Moved from Area|1|||
124569256|NCT03049488|448042169|FG005|Overall Study|Moved from Area|0|||
124569257|NCT03049488|448042164|FG000|Overall Study|Physician Decision|0|||
124569258|NCT03049488|448042165|FG001|Overall Study|Physician Decision|1|||
124569259|NCT03049488|448042166|FG002|Overall Study|Physician Decision|0|||
124569260|NCT03049488|448042167|FG003|Overall Study|Physician Decision|0|||
124569261|NCT03049488|448042168|FG004|Overall Study|Physician Decision|0|||
124569262|NCT03049488|448042169|FG005|Overall Study|Physician Decision|0|||
124569263|NCT03049488|448042164|FG000|Overall Study|Withdrawal by Subject|0|||
124569264|NCT03049488|448042165|FG001|Overall Study|Withdrawal by Subject|0|||
124569265|NCT03049488|448042166|FG002|Overall Study|Withdrawal by Subject|0|||
124569266|NCT03049488|448042167|FG003|Overall Study|Withdrawal by Subject|1|||
124569267|NCT03049488|448042168|FG004|Overall Study|Withdrawal by Subject|1|||
124569268|NCT03049488|448042169|FG005|Overall Study|Withdrawal by Subject|0|||
124569269|NCT00891293|448042172|FG000|Overall Study|Adverse Event|2|||
124569270|NCT00891293|448042172|FG000|Overall Study|Protocol Violation|2|||
124569271|NCT00891293|448042172|FG000|Overall Study|Laboratory abnormality|4|||
124569272|NCT00891293|448042172|FG000|Overall Study|Lost to Follow-up|7|||
124569273|NCT00891293|448042172|FG000|Overall Study|Subject withdrew consent|7|||
124569274|NCT00891293|448042172|FG000|Overall Study|Sponsor termination|62|||
124569275|NCT01448057|448042173|FG000|Overall Study|Protocol Violation|3|||
124569276|NCT01448057|448042174|FG001|Overall Study|Protocol Violation|2|||
124724897|NCT02314156|448613360|FG000|Overall Study|Adverse Event|1|||
124724898|NCT02314156|448613361|FG001|Overall Study|Adverse Event|0|||
124724899|NCT02314156|448613360|FG000|Overall Study|Withdrawal by Subject|1|||
124724900|NCT02314156|448613361|FG001|Overall Study|Withdrawal by Subject|0|||
124513412|NCT00039741|447831048|FG000|Overall Study|Death|0|||
124513413|NCT00039741|447831049|FG001|Overall Study|Death|1|||
124513414|NCT00039741|447831050|FG002|Overall Study|Death|0|||
124513415|NCT00039741|447831051|FG003|Overall Study|Death|0|||
124513416|NCT00039741|447831048|FG000|Overall Study|Lost to Follow-up|3|||
124513417|NCT00039741|447831049|FG001|Overall Study|Lost to Follow-up|1|||
124513418|NCT00039741|447831050|FG002|Overall Study|Lost to Follow-up|5|||
124513419|NCT00039741|447831051|FG003|Overall Study|Lost to Follow-up|2|||
124513420|NCT00039741|447831048|FG000|Overall Study|Confounding medical condition|1|||
124513421|NCT00039741|447831049|FG001|Overall Study|Confounding medical condition|0|||
124513422|NCT00039741|447831050|FG002|Overall Study|Confounding medical condition|0|||
124513423|NCT00039741|447831051|FG003|Overall Study|Confounding medical condition|0|||
124513424|NCT00039741|447831048|FG000|Overall Study|Not able to get to clinic|5|||
124513425|NCT00039741|447831049|FG001|Overall Study|Not able to get to clinic|2|||
124513426|NCT00039741|447831050|FG002|Overall Study|Not able to get to clinic|0|||
124513427|NCT00039741|447831051|FG003|Overall Study|Not able to get to clinic|3|||
124513428|NCT00039741|447831048|FG000|Overall Study|Moved|3|||
124513429|NCT00039741|447831049|FG001|Overall Study|Moved|2|||
124513430|NCT00039741|447831050|FG002|Overall Study|Moved|3|||
124513431|NCT00039741|447831051|FG003|Overall Study|Moved|6|||
124513432|NCT00039741|447831048|FG000|Overall Study|Non-compliance with protocol|1|||
124513433|NCT00039741|447831049|FG001|Overall Study|Non-compliance with protocol|0|||
124513434|NCT00039741|447831050|FG002|Overall Study|Non-compliance with protocol|1|||
124513435|NCT00039741|447831051|FG003|Overall Study|Non-compliance with protocol|0|||
124513436|NCT00039741|447831048|FG000|Overall Study|Withdrew consent|0|||
124569277|NCT01448057|448042173|FG000|Overall Study|Lost to Follow-up|3|||
124569278|NCT01448057|448042174|FG001|Overall Study|Lost to Follow-up|0|||
124569279|NCT01448057|448042173|FG000|Overall Study|Adverse Event|0|||
124569280|NCT01448057|448042174|FG001|Overall Study|Adverse Event|2|||
124569281|NCT01448057|448042173|FG000|Overall Study|Withdrawal by Subject|2|||
124569282|NCT01448057|448042174|FG001|Overall Study|Withdrawal by Subject|0|||
124569283|NCT02777528|448043430|FG000|Overall Study|Still in study|24|||
124513437|NCT00039741|447831049|FG001|Overall Study|Withdrew consent|5|||
124513438|NCT00039741|447831050|FG002|Overall Study|Withdrew consent|0|||
124513439|NCT00039741|447831051|FG003|Overall Study|Withdrew consent|1|||
124513440|NCT00039741|447831048|FG000|Overall Study|Missed final visit|2|||
124513441|NCT00039741|447831049|FG001|Overall Study|Missed final visit|1|||
124513442|NCT00039741|447831050|FG002|Overall Study|Missed final visit|2|||
124513443|NCT00039741|447831051|FG003|Overall Study|Missed final visit|2|||
124513444|NCT01767519|447831052|FG000|Overall Study|Other Reasons|4|||
124513445|NCT01767519|447831053|FG001|Overall Study|Other Reasons|4|||
124513446|NCT01767519|447831054|FG002|Overall Study|Other Reasons|2|||
124513447|NCT01767519|447831052|FG000|Overall Study|Protocol Violation|0|||
124513448|NCT01767519|447831053|FG001|Overall Study|Protocol Violation|3|||
124513449|NCT01767519|447831054|FG002|Overall Study|Protocol Violation|0|||
124513450|NCT01767519|447831052|FG000|Overall Study|Personal Reasons|1|||
124513451|NCT01767519|447831053|FG001|Overall Study|Personal Reasons|0|||
124513452|NCT01767519|447831054|FG002|Overall Study|Personal Reasons|0|||
124513453|NCT01767519|447831052|FG000|Overall Study|Lost to Follow-up|3|||
124513454|NCT01767519|447831053|FG001|Overall Study|Lost to Follow-up|1|||
124513455|NCT01767519|447831054|FG002|Overall Study|Lost to Follow-up|2|||
124513456|NCT01767519|447831052|FG000|Overall Study|Lack of Efficacy|1|||
124513457|NCT01767519|447831053|FG001|Overall Study|Lack of Efficacy|0|||
124513458|NCT01767519|447831054|FG002|Overall Study|Lack of Efficacy|0|||
124513459|NCT01767519|447831052|FG000|Overall Study|Adverse Event|5|||
124513460|NCT01767519|447831053|FG001|Overall Study|Adverse Event|5|||
124513461|NCT01767519|447831054|FG002|Overall Study|Adverse Event|1|||
124513462|NCT00946881|447831055|FG000|First Treatment|Withdrawal by Subject|1|||
124513463|NCT00946881|447831055|FG000|First Treatment|Patient relocated to another state|1|||
124513464|NCT00946881|447831055|FG000|Retreatment|Withdrawal by Subject|1|||
124513465|NCT00293423|447831056|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
124513466|NCT00293423|447831057|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
124513467|NCT00293423|447831056|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
124513468|NCT00293423|447831057|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
124513469|NCT00293423|447831056|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
124513470|NCT00293423|447831057|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
124513471|NCT00293423|447831056|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
124513472|NCT00293423|447831057|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
124513473|NCT00293423|447831056|FG000|Surgical Resection|processing error during surgical resection|1|||
124513474|NCT00293423|447831057|FG001|Surgical Resection|processing error during surgical resection|0|||
124513475|NCT00293423|447831056|FG000|Surgical Resection|Withdrawal by Subject|4|||
124513476|NCT00293423|447831057|FG001|Surgical Resection|Withdrawal by Subject|0|||
124513477|NCT00293423|447831056|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
124513478|NCT00293423|447831057|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
124513479|NCT00805545|447831058|FG000|Overall Study|Protocol Violation|3|||
124513480|NCT00805545|447831059|FG001|Overall Study|Protocol Violation|2|||
124513481|NCT00805545|447831058|FG000|Overall Study|Protocol Violation|3|||
124513482|NCT00805545|447831059|FG001|Overall Study|Protocol Violation|1|||
124513483|NCT00507416|447831060|FG000|Overall Study|Adverse Event|58|||
124513484|NCT00507416|447831061|FG001|Overall Study|Adverse Event|67|||
124513485|NCT00507416|447831062|FG002|Overall Study|Adverse Event|65|||
124513486|NCT00507416|447831060|FG000|Overall Study|Protocol Violation|1|||
124513487|NCT00507416|447831061|FG001|Overall Study|Protocol Violation|2|||
124513488|NCT00507416|447831062|FG002|Overall Study|Protocol Violation|0|||
124513489|NCT00507416|447831060|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
124513490|NCT00507416|447831061|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
124513491|NCT00507416|447831062|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
124513492|NCT00507416|447831060|FG000|Overall Study|Progressive Disease|20|||
124513493|NCT00507416|447831061|FG001|Overall Study|Progressive Disease|10|||
124513494|NCT00507416|447831062|FG002|Overall Study|Progressive Disease|13|||
124513495|NCT00507416|447831060|FG000|Overall Study|Patient declined further treatment|18|||
124513496|NCT00507416|447831061|FG001|Overall Study|Patient declined further treatment|14|||
124513497|NCT00507416|447831062|FG002|Overall Study|Patient declined further treatment|11|||
124513498|NCT00507416|447831060|FG000|Overall Study|Other|11|||
124513499|NCT00507416|447831061|FG001|Overall Study|Other|16|||
124513500|NCT00507416|447831062|FG002|Overall Study|Other|13|||
124513501|NCT00507416|447831060|FG000|Overall Study|Did not Receive Study Treatment|3|||
124513502|NCT00507416|447831061|FG001|Overall Study|Did not Receive Study Treatment|9|||
124569284|NCT02777528|448043431|FG001|Overall Study|Still in study|10|||
124513503|NCT00507416|447831062|FG002|Overall Study|Did not Receive Study Treatment|4|||
124513504|NCT02157506|447831065|FG000|Overall Study|Adverse Event|0|||
124513505|NCT02157506|447831066|FG001|Overall Study|Adverse Event|1|||
124513506|NCT02157506|447831067|FG002|Overall Study|Adverse Event|0|||
124569285|NCT02777528|448043432|FG002|Overall Study|Still in study|1|||
124513507|NCT02157506|447831068|FG003|Overall Study|Adverse Event|0|||
124513508|NCT02157506|447831069|FG004|Overall Study|Adverse Event|0|||
124569286|NCT02777528|448043430|FG000|Overall Study|Study Device Explanted|1|||
124569287|NCT02777528|448043431|FG001|Overall Study|Study Device Explanted|0|||
124569288|NCT02777528|448043432|FG002|Overall Study|Study Device Explanted|0|||
124569289|NCT02777528|448043430|FG000|Overall Study|Death|14|||
124569290|NCT02777528|448043431|FG001|Overall Study|Death|7|||
124569291|NCT02777528|448043432|FG002|Overall Study|Death|1|||
124569292|NCT02777528|448043430|FG000|Overall Study|Withdrawal by Subject|2|||
124569293|NCT02777528|448043431|FG001|Overall Study|Withdrawal by Subject|2|||
124569294|NCT02777528|448043432|FG002|Overall Study|Withdrawal by Subject|1|||
124569295|NCT02777528|448043430|FG000|Overall Study|Physician Decision|2|||
124569296|NCT02777528|448043431|FG001|Overall Study|Physician Decision|1|||
124569297|NCT02777528|448043432|FG002|Overall Study|Physician Decision|0|||
124569298|NCT02777528|448043430|FG000|Overall Study|Lost to Follow-up|2|||
124569299|NCT02777528|448043431|FG001|Overall Study|Lost to Follow-up|0|||
124569300|NCT02777528|448043432|FG002|Overall Study|Lost to Follow-up|0|||
124569301|NCT02777528|448043430|FG000|Overall Study|Discontinued due to Other|1|||
124569302|NCT02777528|448043431|FG001|Overall Study|Discontinued due to Other|0|||
124569303|NCT02777528|448043432|FG002|Overall Study|Discontinued due to Other|0|||
124569304|NCT00453362|448043433|FG000|Overall Study|Adverse Event|5|||
124569305|NCT00453362|448043433|FG000|Overall Study|Death|7|||
124569306|NCT00453362|448043433|FG000|Overall Study|Physician Decision|2|||
124569307|NCT00453362|448043433|FG000|Overall Study|Withdrawal by Subject|3|||
124569308|NCT00453362|448043433|FG000|Overall Study|Progression of disease|56|||
124569309|NCT00453362|448043433|FG000|Overall Study|Screening Failure|14|||
124569310|NCT04885296|448043434|FG000|Period 1|Covid-19 Related|1|||
124569311|NCT04885296|448043435|FG001|Period 1|Covid-19 Related|0|||
124569312|NCT04885296|448043434|FG000|Period 1|Adverse Event|0|||
124569313|NCT04885296|448043435|FG001|Period 1|Adverse Event|1|||
124569314|NCT04885296|448043434|FG000|Period 1|Withdrawal by Subject|1|||
124569315|NCT04885296|448043435|FG001|Period 1|Withdrawal by Subject|1|||
124569316|NCT04885296|448043434|FG000|Period 1|Test Article No Longer Available|1|||
124569317|NCT04885296|448043435|FG001|Period 1|Test Article No Longer Available|0|||
124569318|NCT04885296|448043434|FG000|Period 1|Dispensed Study lens in Error|1|||
124569319|NCT04885296|448043435|FG001|Period 1|Dispensed Study lens in Error|0|||
124569320|NCT04885296|448043434|FG000|Period 1|Lost to Follow-up|1|||
124569321|NCT04885296|448043435|FG001|Period 1|Lost to Follow-up|0|||
124569322|NCT04885296|448043434|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
124569323|NCT04885296|448043435|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
124569324|NCT01027143|448043437|FG000|Overall Study|Lost to Follow-up|9|||
124569325|NCT01027143|448043438|FG001|Overall Study|Lost to Follow-up|4|||
124569326|NCT02564263|448043439|FG000|Overall Study|Adverse Event|31|||
124569327|NCT02564263|448043440|FG001|Overall Study|Adverse Event|29|||
124569328|NCT02564263|448043439|FG000|Overall Study|Death|270|||
124569329|NCT02564263|448043440|FG001|Overall Study|Death|262|||
124569330|NCT02564263|448043439|FG000|Overall Study|Withdrawal by Subject|4|||
124569331|NCT02564263|448043440|FG001|Overall Study|Withdrawal by Subject|19|||
124569332|NCT02564263|448043439|FG000|Overall Study|Sponsor's decision|9|||
124569333|NCT02564263|448043440|FG001|Overall Study|Sponsor's decision|4|||
124569334|NCT01087970|448043444|FG000|Overall Study|Protocol Violation|2|||
124569335|NCT00264797|448043445|FG000|Overall Study|Withdrawal by Subject|11|||
124569336|NCT00264797|448043446|FG001|Overall Study|Withdrawal by Subject|11|||
124569337|NCT00264797|448043445|FG000|Overall Study|Lost to Follow-up|9|||
124569338|NCT00264797|448043446|FG001|Overall Study|Lost to Follow-up|17|||
124569339|NCT00264797|448043445|FG000|Overall Study|Moved from area|3|||
124569340|NCT00264797|448043446|FG001|Overall Study|Moved from area|1|||
124569341|NCT00264797|448043445|FG000|Overall Study|Practical Problems|2|||
124569342|NCT00264797|448043446|FG001|Overall Study|Practical Problems|3|||
124569343|NCT00264797|448043445|FG000|Overall Study|Incarceration|4|||
124569344|NCT00264797|448043446|FG001|Overall Study|Incarceration|5|||
124569345|NCT00264797|448043445|FG000|Overall Study|Pressure/advice from Outsiders|1|||
124569346|NCT00264797|448043446|FG001|Overall Study|Pressure/advice from Outsiders|1|||
124569347|NCT00264797|448043445|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
124569348|NCT00264797|448043446|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
124569349|NCT00264797|448043445|FG000|Overall Study|Other|3|||
124569350|NCT00264797|448043446|FG001|Overall Study|Other|4|||
124569351|NCT02636907|448043452|FG000|Autoinjector Assessment Period|Adverse Event|2|||
124569352|NCT02636907|448043452|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
124569353|NCT02636907|448043452|FG000|Extension Phase|Adverse Event|2|||
124569354|NCT02636907|448043452|FG000|Extension Phase|Withdrawal by Subject|4|||
124569355|NCT02636907|448043452|FG000|Extension Phase|Physician Decision|1|||
124569356|NCT02636907|448043452|FG000|Extension Phase|Lost to Follow-up|2|||
124569357|NCT02636907|448043452|FG000|Extension Phase|Lack of Efficacy|1|||
124569358|NCT00762086|448043453|FG000|Overall Study|Adverse Event|2|||
124569359|NCT00762086|448043454|FG001|Overall Study|Adverse Event|0|||
124569360|NCT00762086|448043453|FG000|Overall Study|Lost to Follow-up|0|||
124569361|NCT00762086|448043454|FG001|Overall Study|Lost to Follow-up|2|||
124569362|NCT00762086|448043453|FG000|Overall Study|Non compliance|1|||
124569363|NCT00762086|448043454|FG001|Overall Study|Non compliance|0|||
124569364|NCT00762086|448043453|FG000|Overall Study|Withdrawal by Subject|2|||
124513509|NCT02157506|447831065|FG000|Overall Study|Lost to Follow-up|0|||
124513510|NCT02157506|447831066|FG001|Overall Study|Lost to Follow-up|0|||
124513511|NCT02157506|447831067|FG002|Overall Study|Lost to Follow-up|1|||
124513512|NCT02157506|447831068|FG003|Overall Study|Lost to Follow-up|0|||
124513513|NCT02157506|447831069|FG004|Overall Study|Lost to Follow-up|0|||
124513514|NCT03101514|447831070|FG000|Overall Study|Withdrawal by Subject|4|||
124513515|NCT03101514|447831070|FG000|Overall Study|Protocol Violation|2|||
124513516|NCT03101514|447831070|FG000|Overall Study|patient's information was incomplete|1|||
124513517|NCT01021813|447831071|FG000|DB Treatment Phase|Adverse Event|60|||
124513518|NCT01021813|447831072|FG001|DB Treatment Phase|Adverse Event|22|||
124513519|NCT01021813|447831073|FG002|DB Treatment Phase|Adverse Event|0|||
124513520|NCT01021813|447831074|FG003|DB Treatment Phase|Adverse Event|0|||
124513521|NCT01021813|447831075|FG004|DB Treatment Phase|Adverse Event|0|||
124513522|NCT01021813|447831071|FG000|DB Treatment Phase|Lack of Efficacy|44|||
124513523|NCT01021813|447831072|FG001|DB Treatment Phase|Lack of Efficacy|28|||
124513524|NCT01021813|447831073|FG002|DB Treatment Phase|Lack of Efficacy|0|||
124513525|NCT01021813|447831074|FG003|DB Treatment Phase|Lack of Efficacy|0|||
124513526|NCT01021813|447831075|FG004|DB Treatment Phase|Lack of Efficacy|0|||
124513527|NCT01021813|447831071|FG000|DB Treatment Phase|Lost to Follow-up|14|||
124513528|NCT01021813|447831072|FG001|DB Treatment Phase|Lost to Follow-up|12|||
124513529|NCT01021813|447831073|FG002|DB Treatment Phase|Lost to Follow-up|0|||
124513530|NCT01021813|447831074|FG003|DB Treatment Phase|Lost to Follow-up|0|||
124513531|NCT01021813|447831075|FG004|DB Treatment Phase|Lost to Follow-up|0|||
124513532|NCT01021813|447831071|FG000|DB Treatment Phase|Physician Decision|17|||
124513533|NCT01021813|447831072|FG001|DB Treatment Phase|Physician Decision|8|||
124513534|NCT01021813|447831073|FG002|DB Treatment Phase|Physician Decision|0|||
124513535|NCT01021813|447831074|FG003|DB Treatment Phase|Physician Decision|0|||
124513536|NCT01021813|447831075|FG004|DB Treatment Phase|Physician Decision|0|||
124513537|NCT01021813|447831071|FG000|DB Treatment Phase|Pregnancy|1|||
124513538|NCT01021813|447831072|FG001|DB Treatment Phase|Pregnancy|0|||
124513539|NCT01021813|447831073|FG002|DB Treatment Phase|Pregnancy|0|||
124513540|NCT01021813|447831074|FG003|DB Treatment Phase|Pregnancy|0|||
124513541|NCT01021813|447831075|FG004|DB Treatment Phase|Pregnancy|0|||
124513542|NCT01021813|447831071|FG000|DB Treatment Phase|Protocol Violation|4|||
124513543|NCT01021813|447831072|FG001|DB Treatment Phase|Protocol Violation|3|||
124513544|NCT01021813|447831073|FG002|DB Treatment Phase|Protocol Violation|0|||
124513545|NCT01021813|447831074|FG003|DB Treatment Phase|Protocol Violation|0|||
124513546|NCT01021813|447831075|FG004|DB Treatment Phase|Protocol Violation|0|||
124513547|NCT01021813|447831071|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
124513548|NCT01021813|447831072|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
124513549|NCT01021813|447831073|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
124513550|NCT01021813|447831074|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
124513551|NCT01021813|447831075|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
124513552|NCT01021813|447831071|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
124513553|NCT01021813|447831072|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
124513554|NCT01021813|447831073|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
124513555|NCT01021813|447831074|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
124513556|NCT01021813|447831075|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
124513557|NCT01021813|447831071|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
124513558|NCT01021813|447831072|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
124513559|NCT01021813|447831073|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
124513560|NCT01021813|447831074|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
124513561|NCT01021813|447831075|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
124513562|NCT01021813|447831071|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
124513563|NCT01021813|447831072|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
124513564|NCT01021813|447831073|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
124513565|NCT01021813|447831074|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
124513566|NCT01021813|447831075|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
124513567|NCT01021813|447831071|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
124513568|NCT01021813|447831072|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
124513569|NCT01021813|447831073|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
124513570|NCT01021813|447831074|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
124513571|NCT01021813|447831075|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
124513572|NCT01021813|447831071|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
124513573|NCT01021813|447831072|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
124513574|NCT01021813|447831073|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
124513575|NCT01021813|447831074|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
124513576|NCT01021813|447831075|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
124513577|NCT00764478|447831076|FG000|Overall Study|Adverse Event|1|||
124513578|NCT00764478|447831077|FG001|Overall Study|Adverse Event|1|||
124513579|NCT00764478|447831078|FG002|Overall Study|Adverse Event|1|||
124513580|NCT00764478|447831076|FG000|Overall Study|Withdrawal by Subject|7|||
124513581|NCT00764478|447831077|FG001|Overall Study|Withdrawal by Subject|12|||
124513582|NCT00764478|447831078|FG002|Overall Study|Withdrawal by Subject|1|||
124513583|NCT00764478|447831076|FG000|Overall Study|Lost to Follow-up|7|||
124513584|NCT00764478|447831077|FG001|Overall Study|Lost to Follow-up|8|||
124513585|NCT00764478|447831078|FG002|Overall Study|Lost to Follow-up|5|||
124513586|NCT00764478|447831076|FG000|Overall Study|Protocol Violation|0|||
124513587|NCT00764478|447831077|FG001|Overall Study|Protocol Violation|1|||
124513588|NCT00764478|447831078|FG002|Overall Study|Protocol Violation|1|||
124513589|NCT02270684|447831079|FG000|Overall Study|Lost to Follow-up|0|||
124513590|NCT02270684|447831080|FG001|Overall Study|Lost to Follow-up|3|||
124513591|NCT02270684|447831079|FG000|Overall Study|Study terminated|1|||
124513592|NCT02270684|447831080|FG001|Overall Study|Study terminated|0|||
124513593|NCT03498287|447831087|FG000|Overall Study|Withdrawal by Subject|3|||
124513594|NCT03498287|447831088|FG001|Overall Study|Withdrawal by Subject|0|||
124513595|NCT03498287|447831087|FG000|Overall Study|Protocol Violation|0|||
124513596|NCT03498287|447831088|FG001|Overall Study|Protocol Violation|4|||
124513597|NCT03498287|447831087|FG000|Overall Study|Adverse Event|0|||
124513598|NCT03498287|447831088|FG001|Overall Study|Adverse Event|1|||
124513599|NCT00493974|447831091|FG000|Overall Study|Death|1|||
124513600|NCT00493974|447831092|FG001|Overall Study|Death|2|||
124513601|NCT00493974|447831091|FG000|Overall Study|Withdrawal by Subject|8|||
124513602|NCT00493974|447831092|FG001|Overall Study|Withdrawal by Subject|6|||
124513603|NCT00493974|447831091|FG000|Overall Study|Lost to Follow-up|4|||
124513604|NCT00493974|447831092|FG001|Overall Study|Lost to Follow-up|6|||
124513605|NCT02555657|447831093|FG000|Overall Study|Death|274|||
124513606|NCT02555657|447831094|FG001|Overall Study|Death|262|||
124513607|NCT02555657|447831093|FG000|Overall Study|Physician Decision|0|||
124513608|NCT02555657|447831094|FG001|Overall Study|Physician Decision|1|||
124513609|NCT02555657|447831093|FG000|Overall Study|Sponsor Decision|27|||
124513610|NCT02555657|447831094|FG001|Overall Study|Sponsor Decision|15|||
124513611|NCT02555657|447831093|FG000|Overall Study|Withdrawal by Subject|11|||
124513612|NCT02555657|447831094|FG001|Overall Study|Withdrawal by Subject|32|||
124513613|NCT02188719|447831095|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
124513614|NCT02188719|447831096|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
124513615|NCT02188719|447831097|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
124513616|NCT02188719|447831098|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
124513617|NCT00966693|447831099|FG000|Overall Study|Adverse Event|0|||
124513618|NCT00966693|447831100|FG001|Overall Study|Adverse Event|0|||
124513619|NCT00966693|447831101|FG002|Overall Study|Adverse Event|1|||
124513620|NCT00966693|447831102|FG003|Overall Study|Adverse Event|2|||
124513621|NCT00966693|447831099|FG000|Overall Study|Death|0|||
124513622|NCT00966693|447831100|FG001|Overall Study|Death|0|||
124513623|NCT00966693|447831101|FG002|Overall Study|Death|1|||
124513624|NCT00966693|447831102|FG003|Overall Study|Death|0|||
124513625|NCT00966693|447831099|FG000|Overall Study|Withdrawal by Subject|1|||
124513626|NCT00966693|447831100|FG001|Overall Study|Withdrawal by Subject|0|||
124513627|NCT00966693|447831101|FG002|Overall Study|Withdrawal by Subject|0|||
124513628|NCT00966693|447831102|FG003|Overall Study|Withdrawal by Subject|5|||
124513629|NCT00966693|447831099|FG000|Overall Study|Disease Progression|0|||
124513630|NCT00966693|447831100|FG001|Overall Study|Disease Progression|0|||
124513631|NCT00966693|447831101|FG002|Overall Study|Disease Progression|1|||
124513632|NCT00966693|447831102|FG003|Overall Study|Disease Progression|16|||
124513633|NCT00599027|447831103|FG000|Overall Study|Withdrawal by Subject|1|||
124513634|NCT00599027|447831104|FG001|Overall Study|Withdrawal by Subject|1|||
124513635|NCT00599027|447831103|FG000|Overall Study|Adverse Event|0|||
124513636|NCT00599027|447831104|FG001|Overall Study|Adverse Event|1|||
124513637|NCT00599027|447831103|FG000|Overall Study|Treatment Failure|0|||
124513638|NCT00599027|447831104|FG001|Overall Study|Treatment Failure|1|||
124513639|NCT02581982|447831105|FG000|Overall Study|Lack of Efficacy|12|||
124513640|NCT02581982|447831105|FG000|Overall Study|Adverse Event|3|||
124513641|NCT02581982|447831105|FG000|Overall Study|Physician Decision|1|||
124513642|NCT03479216|447831107|FG000|Overall Study|Withdrawal by Subject|3|||
124513643|NCT03479216|447831108|FG001|Overall Study|Withdrawal by Subject|2|||
124513644|NCT03479216|447831107|FG000|Overall Study|Physician Decision|2|||
124513645|NCT03479216|447831108|FG001|Overall Study|Physician Decision|3|||
124513646|NCT03326869|447832384|FG000|Overall Study|Study data has been lost to natural disa|1|||
124513647|NCT03326869|447832385|FG001|Overall Study|Study data has been lost to natural disa|1|||
124513648|NCT03788967|447832386|FG000|Overall Study|Lost to Follow-up|14|||
124513649|NCT03788967|447832387|FG001|Overall Study|Lost to Follow-up|10|||
124513650|NCT03788967|447832386|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
124513651|NCT03788967|447832387|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
124513652|NCT03788967|447832386|FG000|Overall Study|Participant Withdrawal of Consent|13|||
124513653|NCT03788967|447832387|FG001|Overall Study|Participant Withdrawal of Consent|5|||
124513654|NCT03788967|447832386|FG000|Overall Study|Adverse Event|1|||
124513655|NCT03788967|447832387|FG001|Overall Study|Adverse Event|1|||
124513656|NCT03788967|447832386|FG000|Overall Study|COVID-19|1|||
124513657|NCT03788967|447832387|FG001|Overall Study|COVID-19|2|||
124513658|NCT03927911|447832388|FG000|Overall Study|problems with eDiary|0|||
124513659|NCT03927911|447832389|FG001|Overall Study|problems with eDiary|1|||
124569365|NCT00762086|448043454|FG001|Overall Study|Withdrawal by Subject|2|||
124569366|NCT00762086|448043453|FG000|Overall Study|Ineligible to participate in the study|1|||
124569367|NCT00762086|448043454|FG001|Overall Study|Ineligible to participate in the study|0|||
124569368|NCT03883906|448043462|FG000|Overall Study|Withdrawal by Subject|2|||
124569369|NCT03883906|448043462|FG000|Overall Study|Physician Decision|5|||
124569370|NCT00486837|448043463|FG000|Overall Study|Withdrawal by Subject|1|||
124569371|NCT00486837|448043464|FG001|Overall Study|Withdrawal by Subject|0|||
124569372|NCT00486837|448043463|FG000|Overall Study|Adverse Event|1|||
124569373|NCT00486837|448043464|FG001|Overall Study|Adverse Event|1|||
124569374|NCT00486837|448043463|FG000|Overall Study|Protocol Violation|4|||
124569375|NCT00486837|448043464|FG001|Overall Study|Protocol Violation|2|||
124569376|NCT00486837|448043463|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
124569377|NCT00486837|448043464|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
124569378|NCT00874237|448043467|FG000|Overall Study|Physician Decision|0|||
124569379|NCT00874237|448043468|FG001|Overall Study|Physician Decision|1|||
124569380|NCT00874237|448043469|FG002|Overall Study|Physician Decision|0|||
124569381|NCT00874237|448043470|FG003|Overall Study|Physician Decision|0|||
124569382|NCT00874237|448043471|FG004|Overall Study|Physician Decision|0|||
124569383|NCT00874237|448043472|FG005|Overall Study|Physician Decision|0|||
124569384|NCT00874237|448043467|FG000|Overall Study|Withdrawal by Subject|0|||
124569385|NCT00874237|448043468|FG001|Overall Study|Withdrawal by Subject|0|||
124569386|NCT00874237|448043469|FG002|Overall Study|Withdrawal by Subject|1|||
124569387|NCT00874237|448043470|FG003|Overall Study|Withdrawal by Subject|0|||
124569388|NCT00874237|448043471|FG004|Overall Study|Withdrawal by Subject|0|||
124569389|NCT00874237|448043472|FG005|Overall Study|Withdrawal by Subject|0|||
124569390|NCT02468778|448043473|FG000|Overall Study|Death|2|||
124569391|NCT02468778|448043474|FG001|Overall Study|Death|1|||
124569392|NCT02468778|448043475|FG002|Overall Study|Death|0|||
124569393|NCT02468778|448043473|FG000|Overall Study|Lost to Follow-up|1|||
124569394|NCT02468778|448043474|FG001|Overall Study|Lost to Follow-up|2|||
124569395|NCT02468778|448043475|FG002|Overall Study|Lost to Follow-up|2|||
124569396|NCT02468778|448043473|FG000|Overall Study|Withdrawal by Subject|0|||
124569397|NCT02468778|448043474|FG001|Overall Study|Withdrawal by Subject|1|||
124569398|NCT02468778|448043475|FG002|Overall Study|Withdrawal by Subject|1|||
124569399|NCT03130699|448043483|FG000|Overall Study|Lost to Follow-up|34|||
124569400|NCT03130699|448043484|FG001|Overall Study|Lost to Follow-up|37|||
124569401|NCT03130699|448043485|FG002|Overall Study|Lost to Follow-up|26|||
124569402|NCT03130699|448043483|FG000|Overall Study|Withdrawal by Subject|5|||
124569403|NCT03130699|448043484|FG001|Overall Study|Withdrawal by Subject|1|||
124569404|NCT03130699|448043485|FG002|Overall Study|Withdrawal by Subject|0|||
124569405|NCT03130699|448043483|FG000|Overall Study|Withdrawal by PI|1|||
124569406|NCT03130699|448043484|FG001|Overall Study|Withdrawal by PI|2|||
124569407|NCT03130699|448043485|FG002|Overall Study|Withdrawal by PI|5|||
124569408|NCT03130699|448043483|FG000|Overall Study|Death|0|||
124569409|NCT03130699|448043484|FG001|Overall Study|Death|0|||
124569410|NCT03130699|448043485|FG002|Overall Study|Death|1|||
124569411|NCT01199861|448043486|FG000|Overall Study|Administrative problems|1|||
124569412|NCT01199861|448043487|FG001|Overall Study|Administrative problems|0|||
124569413|NCT01199861|448043486|FG000|Overall Study|Adverse Event|1|||
124569414|NCT01199861|448043487|FG001|Overall Study|Adverse Event|0|||
124569415|NCT00669864|448043490|FG000|Overall Study|Lost to Follow-up|2|||
124569416|NCT00669864|448043490|FG000|Overall Study|Protocol Violation|2|||
124569417|NCT00669864|448043490|FG000|Overall Study|Withdrawal by Subject|3|||
124569418|NCT00669864|448043490|FG000|Overall Study|Other|2|||
124569419|NCT00680121|448043496|FG000|Overall Study|Lost to Follow-up|27|||
124569420|NCT00680121|448043497|FG001|Overall Study|Lost to Follow-up|23|||
124569421|NCT02545998|448043506|FG000|Overall Study|Lost to Follow-up|12|||
124569422|NCT02545998|448043507|FG001|Overall Study|Lost to Follow-up|3|||
124569423|NCT02545998|448043506|FG000|Overall Study|Withdrawal by Subject|3|||
124569424|NCT02545998|448043507|FG001|Overall Study|Withdrawal by Subject|2|||
124569425|NCT00117949|448043530|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
124569426|NCT00117949|448043531|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
124569427|NCT00117949|448043532|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
124569428|NCT00117949|448043533|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
124569429|NCT00117949|448043530|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
124569430|NCT00117949|448043531|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
124569431|NCT00117949|448043532|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
124569432|NCT00117949|448043533|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
124569433|NCT00117949|448043530|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
124569434|NCT00117949|448043531|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
124569435|NCT00117949|448043532|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
124569436|NCT00117949|448043533|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
124569437|NCT00117949|448043530|FG000|Overall Study|PSA increase >=10ng/mL|0|||
124569438|NCT00117949|448043531|FG001|Overall Study|PSA increase >=10ng/mL|1|||
124569439|NCT00117949|448043532|FG002|Overall Study|PSA increase >=10ng/mL|1|||
124569440|NCT00117949|448043533|FG003|Overall Study|PSA increase >=10ng/mL|0|||
124569441|NCT00117949|448043530|FG000|Overall Study|PSA reduction <=50%|0|||
124513660|NCT03927911|447832390|FG002|Overall Study|problems with eDiary|0|||
124513661|NCT03927911|447832391|FG003|Overall Study|problems with eDiary|1|||
124513662|NCT03927911|447832392|FG004|Overall Study|problems with eDiary|0|||
124513663|NCT03927911|447832393|FG005|Overall Study|problems with eDiary|4|||
124513664|NCT03927911|447832388|FG000|Overall Study|Adverse Event|0|||
124513665|NCT03927911|447832389|FG001|Overall Study|Adverse Event|0|||
124513666|NCT03927911|447832390|FG002|Overall Study|Adverse Event|0|||
124513667|NCT03927911|447832391|FG003|Overall Study|Adverse Event|0|||
124513668|NCT03927911|447832392|FG004|Overall Study|Adverse Event|0|||
124513669|NCT03927911|447832393|FG005|Overall Study|Adverse Event|1|||
124513670|NCT03927911|447832388|FG000|Overall Study|not treated -study terminated by sponsor|0|||
124513671|NCT03927911|447832389|FG001|Overall Study|not treated -study terminated by sponsor|1|||
124513672|NCT03927911|447832390|FG002|Overall Study|not treated -study terminated by sponsor|0|||
124513673|NCT03927911|447832391|FG003|Overall Study|not treated -study terminated by sponsor|0|||
124513674|NCT03927911|447832392|FG004|Overall Study|not treated -study terminated by sponsor|0|||
124513675|NCT03927911|447832393|FG005|Overall Study|not treated -study terminated by sponsor|0|||
124513676|NCT03927911|447832388|FG000|Overall Study|Surgery cancelled|0|||
124513677|NCT03927911|447832389|FG001|Overall Study|Surgery cancelled|0|||
124513678|NCT03927911|447832390|FG002|Overall Study|Surgery cancelled|0|||
124513679|NCT03927911|447832391|FG003|Overall Study|Surgery cancelled|1|||
124513680|NCT03927911|447832392|FG004|Overall Study|Surgery cancelled|0|||
124513681|NCT03927911|447832393|FG005|Overall Study|Surgery cancelled|1|||
124513682|NCT03927911|447832388|FG000|Overall Study|Protocol Violation|0|||
124513683|NCT03927911|447832389|FG001|Overall Study|Protocol Violation|0|||
124513684|NCT03927911|447832390|FG002|Overall Study|Protocol Violation|0|||
124513685|NCT03927911|447832391|FG003|Overall Study|Protocol Violation|0|||
124513686|NCT03927911|447832392|FG004|Overall Study|Protocol Violation|0|||
124513687|NCT03927911|447832393|FG005|Overall Study|Protocol Violation|1|||
124513688|NCT04432376|447832394|FG000|Double-blind Treatment Period|Adverse Event|2|||
124513689|NCT04432376|447832395|FG001|Double-blind Treatment Period|Adverse Event|6|||
124513690|NCT04432376|447832396|FG002|Double-blind Treatment Period|Adverse Event|0|||
124513691|NCT04432376|447832394|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
124513692|NCT04432376|447832395|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
124513693|NCT04432376|447832396|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
124513694|NCT04432376|447832394|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
124513695|NCT04432376|447832395|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
124513696|NCT04432376|447832396|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
124513697|NCT04432376|447832394|FG000|Double-blind Treatment Period|Protocol Violation|0|||
124513698|NCT04432376|447832395|FG001|Double-blind Treatment Period|Protocol Violation|1|||
124513699|NCT04432376|447832396|FG002|Double-blind Treatment Period|Protocol Violation|0|||
124513700|NCT04432376|447832394|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
124513701|NCT04432376|447832395|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
124513702|NCT04432376|447832396|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
124513703|NCT04847141|447832397|FG000|Overall Study|Adverse Event|1|||
124513704|NCT04847141|447832398|FG001|Overall Study|Adverse Event|0|||
124513705|NCT04847141|447832399|FG002|Overall Study|Adverse Event|1|||
124513706|NCT04847141|447832397|FG000|Overall Study|Withdrawal by Subject|2|||
124513707|NCT04847141|447832398|FG001|Overall Study|Withdrawal by Subject|4|||
124513708|NCT04847141|447832399|FG002|Overall Study|Withdrawal by Subject|3|||
124513709|NCT04847141|447832397|FG000|Overall Study|Lost to Follow-up|7|||
124513710|NCT04847141|447832398|FG001|Overall Study|Lost to Follow-up|5|||
124513711|NCT04847141|447832399|FG002|Overall Study|Lost to Follow-up|7|||
124513712|NCT04847141|447832397|FG000|Overall Study|Reason not Specified|0|||
124513713|NCT04847141|447832398|FG001|Overall Study|Reason not Specified|1|||
124513714|NCT04847141|447832399|FG002|Overall Study|Reason not Specified|0|||
124513715|NCT04507776|447832400|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
124513716|NCT01624506|447832401|FG000|Overall Study|Lost to Follow-up|29|||
124513717|NCT01624506|447832402|FG001|Overall Study|Lost to Follow-up|15|||
124513718|NCT01624506|447832401|FG000|Overall Study|Withdrawal by Subject|9|||
124569442|NCT00117949|448043531|FG001|Overall Study|PSA reduction <=50%|2|||
124569443|NCT00117949|448043532|FG002|Overall Study|PSA reduction <=50%|2|||
124513719|NCT01624506|447832402|FG001|Overall Study|Withdrawal by Subject|2|||
124569444|NCT00117949|448043533|FG003|Overall Study|PSA reduction <=50%|4|||
124513720|NCT01624506|447832401|FG000|Overall Study|Death|1|||
124513721|NCT01624506|447832402|FG001|Overall Study|Death|0|||
124513722|NCT01624506|447832401|FG000|Overall Study|LINX explants|23|||
124513723|NCT01624506|447832402|FG001|Overall Study|LINX explants|0|||
124513724|NCT01624506|447832401|FG000|Overall Study|Adverse Event|3|||
124513725|NCT01624506|447832402|FG001|Overall Study|Adverse Event|0|||
124513726|NCT01711541|447832405|FG000|Overall Study|Cancel prior to treatment|0|||
124513727|NCT01711541|447832406|FG001|Overall Study|Cancel prior to treatment|0|||
124513728|NCT01711541|447832407|FG002|Overall Study|Cancel prior to treatment|0|||
124513729|NCT01711541|447832408|FG003|Overall Study|Cancel prior to treatment|1|||
124513730|NCT01711541|447832409|FG004|Overall Study|Cancel prior to treatment|0|||
124569445|NCT00117949|448043530|FG000|Overall Study|Hepatic abnormalities|0|||
124513731|NCT01711541|447832405|FG000|Overall Study|Ineligible|0|||
124513732|NCT01711541|447832406|FG001|Overall Study|Ineligible|1|||
124513733|NCT01711541|447832407|FG002|Overall Study|Ineligible|0|||
124513734|NCT01711541|447832408|FG003|Overall Study|Ineligible|0|||
124513735|NCT01711541|447832409|FG004|Overall Study|Ineligible|0|||
124513736|NCT00132314|447832410|FG000|Overall Study|Lost to Follow-up|70|||
124513737|NCT00132314|447832411|FG001|Overall Study|Lost to Follow-up|62|||
124513738|NCT00132314|447832410|FG000|Overall Study|Lacked SSN|1|||
124513739|NCT00132314|447832411|FG001|Overall Study|Lacked SSN|3|||
124513740|NCT00132314|447832410|FG000|Overall Study|Refused intervention at baseline|2|||
124513741|NCT00132314|447832411|FG001|Overall Study|Refused intervention at baseline|7|||
124513742|NCT00877006|447832422|FG000|Treatment Period|Death|2|||
124513743|NCT00877006|447832423|FG001|Treatment Period|Death|1|||
124513744|NCT00877006|447832422|FG000|Treatment Period|Adverse Event|10|||
124513745|NCT00877006|447832423|FG001|Treatment Period|Adverse Event|3|||
124513746|NCT00877006|447832422|FG000|Treatment Period|Withdrawal by Subject|2|||
124513747|NCT00877006|447832423|FG001|Treatment Period|Withdrawal by Subject|3|||
124513748|NCT00877006|447832422|FG000|Treatment Period|Protocol Violation|1|||
124513749|NCT00877006|447832423|FG001|Treatment Period|Protocol Violation|0|||
124513750|NCT00877006|447832422|FG000|Treatment Period|Lost to Follow-up|0|||
124513751|NCT00877006|447832423|FG001|Treatment Period|Lost to Follow-up|1|||
124513752|NCT00877006|447832422|FG000|Treatment Period|Disease Progression|1|||
124513753|NCT00877006|447832423|FG001|Treatment Period|Disease Progression|2|||
124513754|NCT00877006|447832422|FG000|Treatment Period|Started New Treatment Regimen|2|||
124513755|NCT00877006|447832423|FG001|Treatment Period|Started New Treatment Regimen|5|||
124513756|NCT00877006|447832422|FG000|Treatment Period|Other|4|||
124513757|NCT00877006|447832423|FG001|Treatment Period|Other|4|||
124724901|NCT02752633|448613362|FG000|Overall Study|Withdrawal by Subject|1|||
124724902|NCT02846389|448613363|FG000|Overall Study|Withdrawal by Subject|1|||
124724903|NCT02846389|448613364|FG001|Overall Study|Withdrawal by Subject|1|||
124724904|NCT00853242|448613366|FG000|Overall Study|Adverse Event|0|||
124724905|NCT00853242|448613367|FG001|Overall Study|Adverse Event|1|||
124513758|NCT00877006|447832422|FG000|Treatment Period|Randomized but Not Treated|3|||
124513759|NCT00877006|447832423|FG001|Treatment Period|Randomized but Not Treated|8|||
124513760|NCT00877006|447832422|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
124513761|NCT00877006|447832423|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
124513762|NCT00877006|447832422|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
124513763|NCT00877006|447832423|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
124513764|NCT00877006|447832422|FG000|Long-Term Follow-up Period|Death|26|||
124513765|NCT00877006|447832423|FG001|Long-Term Follow-up Period|Death|18|||
124513766|NCT00877006|447832422|FG000|Long-Term Follow-up Period|Other|7|||
124513767|NCT00877006|447832423|FG001|Long-Term Follow-up Period|Other|9|||
124513768|NCT01415908|447832424|FG000|Overall Study|Withdrawal by Subject|1|||
124513769|NCT01415908|447832425|FG001|Overall Study|Withdrawal by Subject|0|||
124513770|NCT02034552|447832426|FG000|Overall Study|Never treated|3|||
124513771|NCT02034552|447832427|FG001|Overall Study|Never treated|2|||
124513772|NCT02034552|447832428|FG002|Overall Study|Never treated|0|||
124513773|NCT02034552|447832426|FG000|Overall Study|Radiological progression|3|||
124724906|NCT00853242|448613368|FG002|Overall Study|Adverse Event|1|||
124724907|NCT00853242|448613369|FG003|Overall Study|Adverse Event|0|||
124724908|NCT00853242|448613370|FG004|Overall Study|Adverse Event|3|||
124724909|NCT00853242|448613371|FG005|Overall Study|Adverse Event|1|||
124724910|NCT00853242|448613372|FG006|Overall Study|Adverse Event|1|||
124724911|NCT00853242|448613366|FG000|Overall Study|Noncompliant|0|||
124724912|NCT00853242|448613367|FG001|Overall Study|Noncompliant|0|||
124776710|NCT00998296|448809951|FG006|Overall Study|Refused to continue taking trial med.|0|||
124513774|NCT02034552|447832427|FG001|Overall Study|Radiological progression|5|||
124513775|NCT02034552|447832428|FG002|Overall Study|Radiological progression|4|||
124513776|NCT02034552|447832426|FG000|Overall Study|AE not assoc. with disease progression|1|||
124724913|NCT00853242|448613368|FG002|Overall Study|Noncompliant|0|||
124724914|NCT00853242|448613369|FG003|Overall Study|Noncompliant|0|||
124724915|NCT00853242|448613370|FG004|Overall Study|Noncompliant|1|||
124724916|NCT00853242|448613371|FG005|Overall Study|Noncompliant|0|||
124513777|NCT02034552|447832427|FG001|Overall Study|AE not assoc. with disease progression|4|||
124513778|NCT02034552|447832428|FG002|Overall Study|AE not assoc. with disease progression|2|||
124569446|NCT00117949|448043531|FG001|Overall Study|Hepatic abnormalities|1|||
124724917|NCT00853242|448613372|FG006|Overall Study|Noncompliant|0|||
124724918|NCT00853242|448613366|FG000|Overall Study|Withdrawal by Subject|1|||
124724919|NCT00853242|448613367|FG001|Overall Study|Withdrawal by Subject|2|||
124724920|NCT00853242|448613368|FG002|Overall Study|Withdrawal by Subject|0|||
124513779|NCT02034552|447832426|FG000|Overall Study|AE associated with disease progression|0|||
124513780|NCT02034552|447832427|FG001|Overall Study|AE associated with disease progression|1|||
124513781|NCT02034552|447832428|FG002|Overall Study|AE associated with disease progression|0|||
124513782|NCT02034552|447832426|FG000|Overall Study|Withdrawal by Subject|2|||
124569447|NCT00117949|448043532|FG002|Overall Study|Hepatic abnormalities|0|||
124513783|NCT02034552|447832427|FG001|Overall Study|Withdrawal by Subject|1|||
124724921|NCT00853242|448613369|FG003|Overall Study|Withdrawal by Subject|4|||
124569448|NCT00117949|448043533|FG003|Overall Study|Hepatic abnormalities|1|||
124569449|NCT01226797|448043534|FG000|Overall Study|Adverse Event|1|||
124569450|NCT01226797|448043535|FG001|Overall Study|Adverse Event|0|||
124569451|NCT01226797|448043534|FG000|Overall Study|No longer willing to participate|1|||
124569452|NCT01226797|448043535|FG001|Overall Study|No longer willing to participate|0|||
124569453|NCT01226797|448043534|FG000|Overall Study|Protocol Violation|0|||
124569454|NCT01226797|448043535|FG001|Overall Study|Protocol Violation|1|||
124569455|NCT01606306|448043537|FG000|Overall Study|Lack of Efficacy|2|||
124569456|NCT01606306|448043538|FG001|Overall Study|Lack of Efficacy|1|||
124569457|NCT01606306|448043539|FG002|Overall Study|Lack of Efficacy|4|||
124569458|NCT01606306|448043540|FG003|Overall Study|Lack of Efficacy|4|||
124569459|NCT01606306|448043541|FG004|Overall Study|Lack of Efficacy|1|||
124569460|NCT01606306|448043542|FG005|Overall Study|Lack of Efficacy|2|||
124569461|NCT01606306|448043537|FG000|Overall Study|Adverse Event|1|||
124569462|NCT01606306|448043538|FG001|Overall Study|Adverse Event|0|||
124569463|NCT01606306|448043539|FG002|Overall Study|Adverse Event|1|||
124569464|NCT01606306|448043540|FG003|Overall Study|Adverse Event|1|||
124569465|NCT01606306|448043541|FG004|Overall Study|Adverse Event|2|||
124569466|NCT01606306|448043542|FG005|Overall Study|Adverse Event|0|||
124569467|NCT01606306|448043537|FG000|Overall Study|Lost to Follow-up|7|||
124569468|NCT01606306|448043538|FG001|Overall Study|Lost to Follow-up|4|||
124569469|NCT01606306|448043539|FG002|Overall Study|Lost to Follow-up|5|||
124569470|NCT01606306|448043540|FG003|Overall Study|Lost to Follow-up|4|||
124569471|NCT01606306|448043541|FG004|Overall Study|Lost to Follow-up|3|||
124569472|NCT01606306|448043542|FG005|Overall Study|Lost to Follow-up|5|||
124569473|NCT01606306|448043537|FG000|Overall Study|Withdrawal by Subject|4|||
124569474|NCT01606306|448043538|FG001|Overall Study|Withdrawal by Subject|3|||
124569475|NCT01606306|448043539|FG002|Overall Study|Withdrawal by Subject|4|||
124569476|NCT01606306|448043540|FG003|Overall Study|Withdrawal by Subject|4|||
124569477|NCT01606306|448043541|FG004|Overall Study|Withdrawal by Subject|5|||
124569478|NCT01606306|448043542|FG005|Overall Study|Withdrawal by Subject|4|||
124569479|NCT01606306|448043537|FG000|Overall Study|Physician Decision|1|||
124569480|NCT01606306|448043538|FG001|Overall Study|Physician Decision|2|||
124569481|NCT01606306|448043539|FG002|Overall Study|Physician Decision|0|||
124569482|NCT01606306|448043540|FG003|Overall Study|Physician Decision|0|||
124569483|NCT01606306|448043541|FG004|Overall Study|Physician Decision|0|||
124569484|NCT01606306|448043542|FG005|Overall Study|Physician Decision|0|||
124569485|NCT00841100|448043545|FG000|Phase 1 (28 Days)|Adverse Event|1|||
124569486|NCT00841100|448043545|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
124569487|NCT01355081|448043546|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
124569488|NCT01355081|448043547|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
124569489|NCT01355081|448043548|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
124569490|NCT01355081|448043546|FG000|Overall Study|Major Protocol Deviation|0|||
124569491|NCT01355081|448043547|FG001|Overall Study|Major Protocol Deviation|1|||
124569492|NCT01355081|448043548|FG002|Overall Study|Major Protocol Deviation|0|||
124569493|NCT01355081|448043546|FG000|Overall Study|Lost to Follow-up|0|||
124569494|NCT01355081|448043547|FG001|Overall Study|Lost to Follow-up|0|||
124569495|NCT01355081|448043548|FG002|Overall Study|Lost to Follow-up|1|||
124569496|NCT01355081|448043546|FG000|Overall Study|Withdrawal of Consent|2|||
124569497|NCT01355081|448043547|FG001|Overall Study|Withdrawal of Consent|3|||
124569498|NCT01355081|448043548|FG002|Overall Study|Withdrawal of Consent|3|||
124569499|NCT01355081|448043546|FG000|Overall Study|Lack of Efficacy|2|||
124569500|NCT01355081|448043547|FG001|Overall Study|Lack of Efficacy|1|||
124569501|NCT01355081|448043548|FG002|Overall Study|Lack of Efficacy|1|||
124569502|NCT01355081|448043546|FG000|Overall Study|Non Compliance with Study Medication|0|||
124569503|NCT01355081|448043547|FG001|Overall Study|Non Compliance with Study Medication|1|||
124569504|NCT01355081|448043548|FG002|Overall Study|Non Compliance with Study Medication|0|||
124569505|NCT04803357|448043553|FG000|Overall Study|Withdrawal by Subject|31|||
124569506|NCT04803357|448043554|FG001|Overall Study|Withdrawal by Subject|5|||
124569507|NCT01046253|448043555|FG000|Second Intervention|Adverse Event|0|||
124569508|NCT01046253|448043556|FG001|Second Intervention|Adverse Event|1|||
124569509|NCT01046253|448043555|FG000|Second Intervention|Protocol Violation|0|||
124569510|NCT01046253|448043556|FG001|Second Intervention|Protocol Violation|1|||
124569511|NCT02339909|448043559|FG000|Overall Study|Became ineligible after randomisation|89|||
124569512|NCT02339909|448043560|FG001|Overall Study|Became ineligible after randomisation|63|||
124569513|NCT02339909|448043561|FG002|Overall Study|Became ineligible after randomisation|71|||
124724922|NCT00853242|448613370|FG004|Overall Study|Withdrawal by Subject|0|||
124724923|NCT00853242|448613371|FG005|Overall Study|Withdrawal by Subject|0|||
124569514|NCT00860028|448043564|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
124569515|NCT00860028|448043565|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
124569516|NCT01658943|448043567|FG000|Overall Study|Adverse Event|6|||
124569517|NCT01658943|448043568|FG001|Overall Study|Adverse Event|13|||
124569518|NCT01658943|448043567|FG000|Overall Study|Withdrawal by Subject|9|||
124569519|NCT01658943|448043568|FG001|Overall Study|Withdrawal by Subject|2|||
124724924|NCT00853242|448613372|FG006|Overall Study|Withdrawal by Subject|2|||
124724925|NCT00853242|448613366|FG000|Overall Study|Other|2|||
124569520|NCT01658943|448043567|FG000|Overall Study|Progression/Relapse|39|||
124569521|NCT01658943|448043568|FG001|Overall Study|Progression/Relapse|40|||
124513784|NCT02034552|447832428|FG002|Overall Study|Withdrawal by Subject|1|||
124513785|NCT02034552|447832426|FG000|Overall Study|Non-compliance with study drug|0|||
124513786|NCT02034552|447832427|FG001|Overall Study|Non-compliance with study drug|0|||
124513787|NCT02034552|447832428|FG002|Overall Study|Non-compliance with study drug|1|||
124513788|NCT02034552|447832426|FG000|Overall Study|Clinical progression|5|||
124513789|NCT02034552|447832427|FG001|Overall Study|Clinical progression|7|||
124513790|NCT02034552|447832428|FG002|Overall Study|Clinical progression|9|||
124513791|NCT02062398|447832433|FG000|Overall Study|Implant removal|1|||
124513792|NCT03485222|447832434|FG000|Overall Study|Death|0|||
124513793|NCT03485222|447832435|FG001|Overall Study|Death|1|||
124513794|NCT03485222|447832434|FG000|Overall Study|Lost to Follow-up|2|||
124513795|NCT03485222|447832435|FG001|Overall Study|Lost to Follow-up|1|||
124513796|NCT03657810|447832438|FG000|Overall Study|Adverse Event|0|||
124513797|NCT03657810|447832439|FG001|Overall Study|Adverse Event|1|||
124513798|NCT03657810|447832440|FG002|Overall Study|Adverse Event|0|||
124513799|NCT03657810|447832438|FG000|Overall Study|Lack of Efficacy|4|||
124513800|NCT03657810|447832439|FG001|Overall Study|Lack of Efficacy|1|||
124513801|NCT03657810|447832440|FG002|Overall Study|Lack of Efficacy|3|||
124513802|NCT03657810|447832438|FG000|Overall Study|Protocol Violation|1|||
124513803|NCT03657810|447832439|FG001|Overall Study|Protocol Violation|0|||
124513804|NCT03657810|447832440|FG002|Overall Study|Protocol Violation|0|||
124513805|NCT03657810|447832438|FG000|Overall Study|Lost to Follow-up|0|||
124513806|NCT03657810|447832439|FG001|Overall Study|Lost to Follow-up|1|||
124513807|NCT03657810|447832440|FG002|Overall Study|Lost to Follow-up|0|||
124513808|NCT03657810|447832438|FG000|Overall Study|Not provided|0|||
124513809|NCT03657810|447832439|FG001|Overall Study|Not provided|1|||
124513810|NCT03657810|447832440|FG002|Overall Study|Not provided|0|||
124513811|NCT03325556|447832442|FG000|Open-label Period|Lack of Response in OL period|70|||
124513812|NCT03325556|447832443|FG001|Open-label Period|Lack of Response in OL period|0|||
124513813|NCT03325556|447832444|FG002|Open-label Period|Lack of Response in OL period|0|||
124513814|NCT03325556|447832442|FG000|Open-label Period|Adverse Event|27|||
124513815|NCT03325556|447832443|FG001|Open-label Period|Adverse Event|0|||
124513816|NCT03325556|447832444|FG002|Open-label Period|Adverse Event|0|||
124513817|NCT03325556|447832442|FG000|Open-label Period|Death|1|||
124513818|NCT03325556|447832443|FG001|Open-label Period|Death|0|||
124513819|NCT03325556|447832444|FG002|Open-label Period|Death|0|||
124513820|NCT03325556|447832442|FG000|Open-label Period|Lost to Follow-up|1|||
124513821|NCT03325556|447832443|FG001|Open-label Period|Lost to Follow-up|0|||
124513822|NCT03325556|447832444|FG002|Open-label Period|Lost to Follow-up|0|||
124513823|NCT03325556|447832442|FG000|Open-label Period|Non-compliance with study drug|5|||
124513824|NCT03325556|447832443|FG001|Open-label Period|Non-compliance with study drug|0|||
124513825|NCT03325556|447832444|FG002|Open-label Period|Non-compliance with study drug|0|||
124513826|NCT03325556|447832442|FG000|Open-label Period|Use of prohibited medication|1|||
124513827|NCT03325556|447832443|FG001|Open-label Period|Use of prohibited medication|0|||
124513828|NCT03325556|447832444|FG002|Open-label Period|Use of prohibited medication|0|||
124513829|NCT03325556|447832442|FG000|Open-label Period|Protocol Violation|4|||
124513830|NCT03325556|447832443|FG001|Open-label Period|Protocol Violation|0|||
124513831|NCT03325556|447832444|FG002|Open-label Period|Protocol Violation|0|||
124513832|NCT03325556|447832442|FG000|Open-label Period|Withdrawal by Subject|17|||
124513833|NCT03325556|447832443|FG001|Open-label Period|Withdrawal by Subject|0|||
124513834|NCT03325556|447832444|FG002|Open-label Period|Withdrawal by Subject|0|||
124513835|NCT03325556|447832442|FG000|Open-label Period|Not otherwise specified|8|||
124513836|NCT03325556|447832443|FG001|Open-label Period|Not otherwise specified|0|||
124513837|NCT03325556|447832444|FG002|Open-label Period|Not otherwise specified|0|||
124513838|NCT03325556|447832442|FG000|Open-label Period|Administrative discont. at study termination|41|||
124513839|NCT03325556|447832443|FG001|Open-label Period|Administrative discont. at study termination|0|||
124513840|NCT03325556|447832444|FG002|Open-label Period|Administrative discont. at study termination|0|||
124513841|NCT03325556|447832442|FG000|Double-blind Period|Relapse|0|||
124513842|NCT03325556|447832443|FG001|Double-blind Period|Relapse|15|||
124513843|NCT03325556|447832444|FG002|Double-blind Period|Relapse|34|||
124776711|NCT00998296|448809952|FG007|Overall Study|Refused to continue taking trial med.|0|||
124776712|NCT00998296|448809953|FG008|Overall Study|Refused to continue taking trial med.|0|||
124776713|NCT00998296|448809954|FG009|Overall Study|Refused to continue taking trial med.|2|||
124513844|NCT03325556|447832442|FG000|Double-blind Period|Adverse Event|0|||
124513845|NCT03325556|447832443|FG001|Double-blind Period|Adverse Event|3|||
124513846|NCT03325556|447832444|FG002|Double-blind Period|Adverse Event|1|||
124513847|NCT03325556|447832442|FG000|Double-blind Period|Noncompliance with study drug|0|||
124513848|NCT03325556|447832443|FG001|Double-blind Period|Noncompliance with study drug|0|||
124513849|NCT03325556|447832444|FG002|Double-blind Period|Noncompliance with study drug|1|||
124513850|NCT03325556|447832442|FG000|Double-blind Period|Use of prohibited medication|0|||
124513851|NCT03325556|447832443|FG001|Double-blind Period|Use of prohibited medication|1|||
124513852|NCT03325556|447832444|FG002|Double-blind Period|Use of prohibited medication|0|||
124513853|NCT03325556|447832442|FG000|Double-blind Period|Physician Decision|0|||
124569522|NCT01658943|448043567|FG000|Overall Study|Death|4|||
124569523|NCT01658943|448043568|FG001|Overall Study|Death|2|||
124569524|NCT01658943|448043567|FG000|Overall Study|not protocol specified|4|||
124569525|NCT01658943|448043568|FG001|Overall Study|not protocol specified|1|||
124569526|NCT01658943|448043567|FG000|Overall Study|Not eligible|7|||
124569527|NCT01658943|448043568|FG001|Overall Study|Not eligible|9|||
124569528|NCT01658943|448043567|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
124569529|NCT01658943|448043568|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
124569530|NCT03144687|448043570|FG000|Overall Study|Death|0|||
124569531|NCT03144687|448043571|FG001|Overall Study|Death|2|||
124569532|NCT03144687|448043570|FG000|Overall Study|Lost to Follow-up|0|||
124569533|NCT03144687|448043571|FG001|Overall Study|Lost to Follow-up|1|||
124569534|NCT03144687|448043570|FG000|Overall Study|Physician Decision|0|||
124569535|NCT03144687|448043571|FG001|Overall Study|Physician Decision|1|||
124569536|NCT03144687|448043570|FG000|Overall Study|Withdrawal by Subject|1|||
124569537|NCT03144687|448043571|FG001|Overall Study|Withdrawal by Subject|3|||
124569538|NCT03144687|448043570|FG000|Overall Study|Not Reported|2|||
124569539|NCT03144687|448043571|FG001|Overall Study|Not Reported|0|||
124569540|NCT01054599|448043572|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
124569541|NCT01054599|448043573|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
124569542|NCT01054599|448043572|FG000|Overall Study|Protocol Violation|1|||
124569543|NCT01054599|448043573|FG001|Overall Study|Protocol Violation|0|||
124569544|NCT01054599|448043572|FG000|Overall Study|Spells/seizure-like episodes|1|||
124569545|NCT01054599|448043573|FG001|Overall Study|Spells/seizure-like episodes|1|||
124569546|NCT01054599|448043572|FG000|Overall Study|Timing/scheduling difficulties|1|||
124569547|NCT01054599|448043573|FG001|Overall Study|Timing/scheduling difficulties|1|||
124569548|NCT01054599|448043572|FG000|Overall Study|Visual impairment, WTAR <80|0|||
124569549|NCT01054599|448043573|FG001|Overall Study|Visual impairment, WTAR <80|1|||
124569550|NCT01054599|448043572|FG000|Overall Study|Lost to Follow-up|0|||
124569551|NCT01054599|448043573|FG001|Overall Study|Lost to Follow-up|2|||
124569552|NCT01054599|448043572|FG000|Overall Study|Adverse Event|0|||
124569553|NCT01054599|448043573|FG001|Overall Study|Adverse Event|1|||
124569554|NCT01054599|448043572|FG000|Overall Study|Withdrawal by Subject|0|||
124569555|NCT01054599|448043573|FG001|Overall Study|Withdrawal by Subject|1|||
124569556|NCT00475020|448043574|FG000|Overall Study|Physician Decision|3|||
124569557|NCT00475020|448043574|FG000|Overall Study|Insurance Denial|1|||
124569558|NCT00475020|448043574|FG000|Overall Study|Donor not able to donate the last minute|1|||
124569559|NCT02514174|448043578|FG000|Overall Study|Patient refused to continue medication|1|||
124569560|NCT02514174|448043578|FG000|Overall Study|Adverse Event|2|||
124569561|NCT02514174|448043578|FG000|Overall Study|Study closed by sponsor|9|||
124569562|NCT02514174|448043578|FG000|Overall Study|Progressive disease|11|||
124569563|NCT02514174|448043578|FG000|Overall Study|Treatment change|1|||
124569564|NCT02514174|448043578|FG000|Overall Study|Treated off study with Afatinib.|1|||
124569565|NCT02170688|448043579|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
124569566|NCT02170688|448043580|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
124569567|NCT02170688|448043581|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
124569568|NCT02170688|448043582|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
124569569|NCT02170688|448043583|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
124569570|NCT02170688|448043579|FG000|Overall Study|Full dose not received|0|||
124569571|NCT02170688|448043580|FG001|Overall Study|Full dose not received|1|||
124569572|NCT02170688|448043581|FG002|Overall Study|Full dose not received|0|||
124569573|NCT02170688|448043582|FG003|Overall Study|Full dose not received|0|||
124569574|NCT02170688|448043583|FG004|Overall Study|Full dose not received|0|||
124569575|NCT02170688|448043579|FG000|Overall Study|Physician Decision|0|||
124569576|NCT02170688|448043580|FG001|Overall Study|Physician Decision|0|||
124569577|NCT02170688|448043581|FG002|Overall Study|Physician Decision|1|||
124569578|NCT02170688|448043582|FG003|Overall Study|Physician Decision|0|||
124569579|NCT02170688|448043583|FG004|Overall Study|Physician Decision|0|||
124569580|NCT00543309|448045464|FG000|Overall Study|Physician Decision|0|||
124569581|NCT00543309|448045465|FG001|Overall Study|Physician Decision|1|||
124569582|NCT00543309|448045466|FG002|Overall Study|Physician Decision|0|||
124569583|NCT02143102|448045469|FG000|Overall Study|Lost to Follow-up|11|||
124569584|NCT02143102|448045470|FG001|Overall Study|Lost to Follow-up|0|||
124569585|NCT03247556|448045475|FG000|Overall Study|Adverse Event|1|||
124569586|NCT03247556|448045476|FG001|Overall Study|Adverse Event|4|||
124569587|NCT03247556|448045477|FG002|Overall Study|Adverse Event|5|||
124569588|NCT03247556|448045475|FG000|Overall Study|Lost to Follow-up|5|||
124569589|NCT03247556|448045476|FG001|Overall Study|Lost to Follow-up|5|||
124569590|NCT03247556|448045477|FG002|Overall Study|Lost to Follow-up|4|||
124569591|NCT03247556|448045475|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
124569592|NCT03247556|448045476|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
124569593|NCT03247556|448045477|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
124569594|NCT03247556|448045475|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
124569595|NCT03247556|448045476|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
124569596|NCT03247556|448045477|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
124569597|NCT03247556|448045475|FG000|Overall Study|Protocol Violation|2|||
124569598|NCT03247556|448045476|FG001|Overall Study|Protocol Violation|0|||
124513854|NCT03325556|447832443|FG001|Double-blind Period|Physician Decision|0|||
124513855|NCT03325556|447832444|FG002|Double-blind Period|Physician Decision|1|||
124513856|NCT03325556|447832442|FG000|Double-blind Period|Withdrawal by Subject|0|||
124513857|NCT03325556|447832443|FG001|Double-blind Period|Withdrawal by Subject|6|||
124513858|NCT03325556|447832444|FG002|Double-blind Period|Withdrawal by Subject|4|||
124513859|NCT03325556|447832442|FG000|Double-blind Period|Not otherwise specified|0|||
124513860|NCT03325556|447832443|FG001|Double-blind Period|Not otherwise specified|1|||
124513861|NCT03325556|447832444|FG002|Double-blind Period|Not otherwise specified|5|||
124513862|NCT03325556|447832442|FG000|Double-blind Period|Administrative discont. at study termination|0|||
124513863|NCT03325556|447832443|FG001|Double-blind Period|Administrative discont. at study termination|35|||
124513864|NCT03325556|447832444|FG002|Double-blind Period|Administrative discont. at study termination|31|||
124513865|NCT02119026|447832447|FG000|1st-line Treatment|Adverse Event|9|||
124513866|NCT02119026|447832448|FG001|1st-line Treatment|Adverse Event|14|||
124513867|NCT02119026|447832447|FG000|1st-line Treatment|Physician Decision|3|||
124513868|NCT02119026|447832448|FG001|1st-line Treatment|Physician Decision|8|||
124513869|NCT02119026|447832447|FG000|1st-line Treatment|Withdrawal by Subject|4|||
124513870|NCT02119026|447832448|FG001|1st-line Treatment|Withdrawal by Subject|10|||
124513871|NCT02119026|447832447|FG000|1st-line Treatment|Patient condition or compliance|6|||
124513872|NCT02119026|447832448|FG001|1st-line Treatment|Patient condition or compliance|4|||
124513873|NCT02119026|447832447|FG000|1st-line Treatment|Surgery of metastases|2|||
124513874|NCT02119026|447832448|FG001|1st-line Treatment|Surgery of metastases|1|||
124513875|NCT02119026|447832447|FG000|1st-line Treatment|Death|2|||
124513876|NCT02119026|447832448|FG001|1st-line Treatment|Death|1|||
124513877|NCT02119026|447832447|FG000|2nd-line Treatment|Lost to Follow-up|2|||
124513878|NCT02119026|447832448|FG001|2nd-line Treatment|Lost to Follow-up|0|||
124513879|NCT02119026|447832447|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
124513880|NCT02119026|447832448|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
124513881|NCT02119026|447832447|FG000|2nd-line Treatment|Adverse Event|4|||
124513882|NCT02119026|447832448|FG001|2nd-line Treatment|Adverse Event|1|||
124513883|NCT01373918|447832449|FG000|Overall Study|Physician Decision|0|||
124513884|NCT01373918|447832450|FG001|Overall Study|Physician Decision|1|||
124513885|NCT00340834|447832452|FG000|Core Phase of Study|Adverse Event|26|||
124513886|NCT00340834|447832453|FG001|Core Phase of Study|Adverse Event|9|||
124513887|NCT00340834|447832454|FG002|Core Phase of Study|Adverse Event|9|||
124513888|NCT00340834|447832455|FG003|Core Phase of Study|Adverse Event|0|||
124513889|NCT00340834|447832456|FG004|Core Phase of Study|Adverse Event|0|||
124513890|NCT00340834|447832452|FG000|Core Phase of Study|Withdrawal by Subject|11|||
124513891|NCT00340834|447832453|FG001|Core Phase of Study|Withdrawal by Subject|9|||
124513892|NCT00340834|447832454|FG002|Core Phase of Study|Withdrawal by Subject|16|||
124513893|NCT00340834|447832455|FG003|Core Phase of Study|Withdrawal by Subject|0|||
124513894|NCT00340834|447832456|FG004|Core Phase of Study|Withdrawal by Subject|0|||
124513895|NCT00340834|447832452|FG000|Core Phase of Study|Administrative Problems|6|||
124513896|NCT00340834|447832453|FG001|Core Phase of Study|Administrative Problems|2|||
124513897|NCT00340834|447832454|FG002|Core Phase of Study|Administrative Problems|7|||
124513898|NCT00340834|447832455|FG003|Core Phase of Study|Administrative Problems|0|||
124513899|NCT00340834|447832456|FG004|Core Phase of Study|Administrative Problems|0|||
124513900|NCT00340834|447832452|FG000|Core Phase of Study|Lack of Efficacy|3|||
124513901|NCT00340834|447832453|FG001|Core Phase of Study|Lack of Efficacy|3|||
124513902|NCT00340834|447832454|FG002|Core Phase of Study|Lack of Efficacy|7|||
124513903|NCT00340834|447832455|FG003|Core Phase of Study|Lack of Efficacy|0|||
124513904|NCT00340834|447832456|FG004|Core Phase of Study|Lack of Efficacy|0|||
124513905|NCT00340834|447832452|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
124513906|NCT00340834|447832453|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
124513907|NCT00340834|447832454|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
124513908|NCT00340834|447832455|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
124513909|NCT00340834|447832456|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
124513910|NCT00340834|447832452|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
124513911|NCT00340834|447832453|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
124513912|NCT00340834|447832454|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
124513913|NCT00340834|447832455|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
124513914|NCT00340834|447832456|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
124513915|NCT00340834|447832452|FG000|Core Phase of Study|Lost to Follow-up|1|||
124513916|NCT00340834|447832453|FG001|Core Phase of Study|Lost to Follow-up|1|||
124513917|NCT00340834|447832454|FG002|Core Phase of Study|Lost to Follow-up|4|||
124513918|NCT00340834|447832455|FG003|Core Phase of Study|Lost to Follow-up|0|||
124513919|NCT00340834|447832456|FG004|Core Phase of Study|Lost to Follow-up|0|||
124513920|NCT00340834|447832452|FG000|Core Phase of Study|Death|2|||
124513921|NCT00340834|447832453|FG001|Core Phase of Study|Death|0|||
124513922|NCT00340834|447832454|FG002|Core Phase of Study|Death|0|||
124513923|NCT00340834|447832455|FG003|Core Phase of Study|Death|0|||
124513924|NCT00340834|447832456|FG004|Core Phase of Study|Death|0|||
124513925|NCT00340834|447832452|FG000|Core Phase of Study|Protocol Violation|0|||
124513926|NCT00340834|447832453|FG001|Core Phase of Study|Protocol Violation|0|||
124513927|NCT00340834|447832454|FG002|Core Phase of Study|Protocol Violation|2|||
124513928|NCT00340834|447832455|FG003|Core Phase of Study|Protocol Violation|0|||
124513929|NCT00340834|447832456|FG004|Core Phase of Study|Protocol Violation|0|||
124513930|NCT00340834|447832452|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
124513931|NCT00340834|447832453|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
124513932|NCT00340834|447832454|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
124513933|NCT00340834|447832455|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
124513934|NCT00340834|447832456|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
124513935|NCT00340834|447832452|FG000|Extension Phase of Study|Subject withdrew consent|26|||
124513936|NCT00340834|447832453|FG001|Extension Phase of Study|Subject withdrew consent|31|||
124513937|NCT00340834|447832454|FG002|Extension Phase of Study|Subject withdrew consent|0|||
124513938|NCT00340834|447832455|FG003|Extension Phase of Study|Subject withdrew consent|12|||
124513939|NCT00340834|447832456|FG004|Extension Phase of Study|Subject withdrew consent|15|||
124513940|NCT00340834|447832452|FG000|Extension Phase of Study|Adverse Event|21|||
124513941|NCT00340834|447832453|FG001|Extension Phase of Study|Adverse Event|22|||
124513942|NCT00340834|447832454|FG002|Extension Phase of Study|Adverse Event|0|||
124513943|NCT00340834|447832455|FG003|Extension Phase of Study|Adverse Event|19|||
124513944|NCT00340834|447832456|FG004|Extension Phase of Study|Adverse Event|7|||
124513945|NCT00340834|447832452|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
124513946|NCT00340834|447832453|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
124513947|NCT00340834|447832454|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
124513948|NCT00340834|447832455|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
124513949|NCT00340834|447832456|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
124513950|NCT00340834|447832452|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
124513951|NCT00340834|447832453|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
124513952|NCT00340834|447832454|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
124513953|NCT00340834|447832455|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
124513954|NCT00340834|447832456|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
124513955|NCT00340834|447832452|FG000|Extension Phase of Study|Lost to Follow-up|1|||
124513956|NCT00340834|447832453|FG001|Extension Phase of Study|Lost to Follow-up|1|||
124513957|NCT00340834|447832454|FG002|Extension Phase of Study|Lost to Follow-up|0|||
124513958|NCT00340834|447832455|FG003|Extension Phase of Study|Lost to Follow-up|2|||
124513959|NCT00340834|447832456|FG004|Extension Phase of Study|Lost to Follow-up|3|||
124513960|NCT00340834|447832452|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
124513961|NCT00340834|447832453|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
124513962|NCT00340834|447832454|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
124513963|NCT00340834|447832455|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
124513964|NCT00340834|447832456|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
124513965|NCT00340834|447832452|FG000|Extension Phase of Study|Administrative problems|3|||
124513966|NCT00340834|447832453|FG001|Extension Phase of Study|Administrative problems|0|||
124513967|NCT00340834|447832454|FG002|Extension Phase of Study|Administrative problems|0|||
124513968|NCT00340834|447832455|FG003|Extension Phase of Study|Administrative problems|1|||
124513969|NCT00340834|447832456|FG004|Extension Phase of Study|Administrative problems|1|||
124513970|NCT00340834|447832452|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
124513971|NCT00340834|447832453|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
124513972|NCT00340834|447832454|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
124513973|NCT00340834|447832455|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
124513974|NCT00340834|447832456|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
124513975|NCT00340834|447832452|FG000|Extension Phase of Study|Protocol Violation|3|||
124513976|NCT00340834|447832453|FG001|Extension Phase of Study|Protocol Violation|0|||
124513977|NCT00340834|447832454|FG002|Extension Phase of Study|Protocol Violation|0|||
124513978|NCT00340834|447832455|FG003|Extension Phase of Study|Protocol Violation|0|||
124513979|NCT00340834|447832456|FG004|Extension Phase of Study|Protocol Violation|0|||
124513980|NCT00340834|447832452|FG000|Extension Phase of Study|Death|0|||
124513981|NCT00340834|447832453|FG001|Extension Phase of Study|Death|0|||
124513982|NCT00340834|447832454|FG002|Extension Phase of Study|Death|0|||
124513983|NCT00340834|447832455|FG003|Extension Phase of Study|Death|0|||
124513984|NCT00340834|447832456|FG004|Extension Phase of Study|Death|1|||
124513985|NCT03939637|447832459|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
124513986|NCT03939637|447832460|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
124513987|NCT03939637|447832459|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
124513988|NCT03939637|447832460|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
124513989|NCT05224076|447832461|FG000|Overall Study|Lost to Follow-up|24|||
124513990|NCT01082367|447832462|FG000|Double-blind Period|Administrative problems|0|||
124513991|NCT01082367|447832463|FG001|Double-blind Period|Administrative problems|1|||
124513992|NCT01082367|447832462|FG000|Double-blind Period|Lack of Efficacy|5|||
124513993|NCT01082367|447832463|FG001|Double-blind Period|Lack of Efficacy|11|||
124513994|NCT01082367|447832462|FG000|Double-blind Period|Adverse Event|0|||
124724926|NCT00853242|448613367|FG001|Overall Study|Other|0|||
124724927|NCT00853242|448613368|FG002|Overall Study|Other|2|||
124724928|NCT00853242|448613369|FG003|Overall Study|Other|0|||
124724929|NCT00853242|448613370|FG004|Overall Study|Other|0|||
124724930|NCT00853242|448613371|FG005|Overall Study|Other|1|||
124724931|NCT00853242|448613372|FG006|Overall Study|Other|2|||
124724932|NCT01265563|448613373|FG000|Overall Study|Withdrawal by Subject|0|||
124724933|NCT01265563|448613374|FG001|Overall Study|Withdrawal by Subject|1|||
124513995|NCT01082367|447832463|FG001|Double-blind Period|Adverse Event|1|||
124513996|NCT01082367|447832462|FG000|Follow-up (F-U) Period|Administrative problems|1|||
124513997|NCT01082367|447832463|FG001|Follow-up (F-U) Period|Administrative problems|0|||
124513998|NCT01082367|447832462|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
124513999|NCT01082367|447832463|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
124514000|NCT01082367|447832462|FG000|Follow-up (F-U) Period|Adverse Event|0|||
124514001|NCT01082367|447832463|FG001|Follow-up (F-U) Period|Adverse Event|1|||
124514002|NCT02016898|447832464|FG000|Overall Study|Death|1|||
124514003|NCT02016898|447832465|FG001|Overall Study|Death|1|||
124514004|NCT02016898|447832464|FG000|Overall Study|Lost to Follow-up|4|||
124514005|NCT02016898|447832465|FG001|Overall Study|Lost to Follow-up|4|||
124514006|NCT01665768|447832466|FG000|Overall Study|Adverse Event|3|||
124514007|NCT01665768|447832466|FG000|Overall Study|Lack of Efficacy|19|||
124514008|NCT01665768|447832466|FG000|Overall Study|Withdrawal by Subject|1|||
124514009|NCT01329341|447832467|FG000|Overall Study|Withdrawal by Subject|44|||
124514010|NCT03017846|447832468|FG000|Overall Study|Lost to Follow-up|3|||
124514011|NCT03017846|447832468|FG000|Overall Study|Adverse Event|2|||
124514012|NCT04603391|447832469|FG000|First Intervention (4 Days)|Adverse Event|1|||
124514013|NCT04603391|447832470|FG001|First Intervention (4 Days)|Adverse Event|0|||
124514014|NCT04603391|447832469|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
124514015|NCT04603391|447832470|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
124514016|NCT02151682|447832471|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
124514017|NCT02151682|447832472|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
124514018|NCT02151682|447832473|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
124514019|NCT02151682|447832474|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
124514020|NCT02151682|447832475|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
124514021|NCT02151682|447832476|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
124514022|NCT02151682|447832471|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
124514023|NCT02151682|447832472|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
124514024|NCT02151682|447832473|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
124514025|NCT02151682|447832474|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
124514026|NCT02151682|447832475|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
124514027|NCT02151682|447832476|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
124514028|NCT02151682|447832471|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
124514029|NCT02151682|447832472|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
124514030|NCT02151682|447832473|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
124514031|NCT02151682|447832474|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
124514032|NCT02151682|447832475|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
124514033|NCT02151682|447832476|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
124514034|NCT02151682|447832471|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
124514035|NCT02151682|447832472|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
124514036|NCT02151682|447832473|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
124514037|NCT02151682|447832474|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
124514038|NCT02151682|447832475|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
124514039|NCT02151682|447832476|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
124514040|NCT02151682|447832471|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
124514041|NCT02151682|447832472|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
124514042|NCT02151682|447832473|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
124514043|NCT02151682|447832474|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
124514044|NCT02151682|447832475|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
124514045|NCT02151682|447832476|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
124514046|NCT02151682|447832471|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
124514047|NCT02151682|447832472|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
124514048|NCT02151682|447832473|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
124514049|NCT02151682|447832474|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
124514050|NCT02151682|447832475|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
124514051|NCT02151682|447832476|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
124514052|NCT02151682|447832471|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
124514053|NCT02151682|447832472|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
124514054|NCT02151682|447832473|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
124514055|NCT02151682|447832474|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
124514056|NCT02151682|447832475|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
124724934|NCT01265563|448613375|FG002|Overall Study|Withdrawal by Subject|1|||
124569599|NCT03247556|448045477|FG002|Overall Study|Protocol Violation|1|||
124569600|NCT03247556|448045475|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
124569601|NCT03247556|448045476|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
124569602|NCT03247556|448045477|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
124569603|NCT01203878|448045478|FG000|Overall Study|Withdrawal by Subject|0|||
124569604|NCT01203878|448045479|FG001|Overall Study|Withdrawal by Subject|0|||
124569605|NCT01203878|448045480|FG002|Overall Study|Withdrawal by Subject|1|||
124569606|NCT01203878|448045478|FG000|Overall Study|Adverse Event|0|||
124569607|NCT01203878|448045479|FG001|Overall Study|Adverse Event|0|||
124569608|NCT01203878|448045480|FG002|Overall Study|Adverse Event|2|||
124569609|NCT03952143|448045481|FG000|Lead-In Period|Adverse Event|2|||
124569610|NCT03952143|448045482|FG001|Lead-In Period|Adverse Event|0|||
124569611|NCT03952143|448045483|FG002|Lead-In Period|Adverse Event|0|||
124569612|NCT03952143|448045481|FG000|Lead-In Period|Lack of Efficacy|2|||
124569613|NCT03952143|448045482|FG001|Lead-In Period|Lack of Efficacy|0|||
124569614|NCT03952143|448045483|FG002|Lead-In Period|Lack of Efficacy|0|||
124569615|NCT03952143|448045481|FG000|Lead-In Period|Physician Decision|5|||
124569616|NCT03952143|448045482|FG001|Lead-In Period|Physician Decision|0|||
124569617|NCT03952143|448045483|FG002|Lead-In Period|Physician Decision|0|||
124569618|NCT03952143|448045481|FG000|Lead-In Period|Protocol Violation|5|||
124569619|NCT03952143|448045482|FG001|Lead-In Period|Protocol Violation|0|||
124569620|NCT03952143|448045483|FG002|Lead-In Period|Protocol Violation|0|||
124569621|NCT03952143|448045481|FG000|Lead-In Period|Withdrawal by Subject|19|||
124569622|NCT03952143|448045482|FG001|Lead-In Period|Withdrawal by Subject|0|||
124569623|NCT03952143|448045483|FG002|Lead-In Period|Withdrawal by Subject|0|||
124569624|NCT03952143|448045481|FG000|Treatment Period|Adverse Event|0|||
124569625|NCT03952143|448045482|FG001|Treatment Period|Adverse Event|0|||
124569626|NCT03952143|448045483|FG002|Treatment Period|Adverse Event|1|||
124569627|NCT03952143|448045481|FG000|Treatment Period|Lost to Follow-up|0|||
124569628|NCT03952143|448045482|FG001|Treatment Period|Lost to Follow-up|2|||
124569629|NCT03952143|448045483|FG002|Treatment Period|Lost to Follow-up|0|||
124569630|NCT03952143|448045481|FG000|Treatment Period|Physician Decision|0|||
124569631|NCT03952143|448045482|FG001|Treatment Period|Physician Decision|0|||
124569632|NCT03952143|448045483|FG002|Treatment Period|Physician Decision|2|||
124569633|NCT03952143|448045481|FG000|Treatment Period|Protocol Violation|0|||
124569634|NCT03952143|448045482|FG001|Treatment Period|Protocol Violation|0|||
124569635|NCT03952143|448045483|FG002|Treatment Period|Protocol Violation|1|||
124569636|NCT03952143|448045481|FG000|Treatment Period|Withdrawal by Subject|0|||
124569637|NCT03952143|448045482|FG001|Treatment Period|Withdrawal by Subject|5|||
124569638|NCT03952143|448045483|FG002|Treatment Period|Withdrawal by Subject|26|||
124569639|NCT03952143|448045481|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
124569640|NCT03952143|448045482|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
124569641|NCT03952143|448045483|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
124569642|NCT03952143|448045481|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
124569643|NCT03952143|448045482|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
124569644|NCT03952143|448045483|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
124569645|NCT01866319|448045484|FG000|Overall Study|Adverse Event|12|||
124569646|NCT01866319|448045485|FG001|Overall Study|Adverse Event|5|||
124569647|NCT01866319|448045486|FG002|Overall Study|Adverse Event|9|||
124569648|NCT01866319|448045484|FG000|Overall Study|Clinical progression|3|||
124569649|NCT01866319|448045485|FG001|Overall Study|Clinical progression|2|||
124569650|NCT01866319|448045486|FG002|Overall Study|Clinical progression|2|||
124569651|NCT01866319|448045484|FG000|Overall Study|Death|153|||
124724935|NCT01265563|448613376|FG003|Overall Study|Withdrawal by Subject|0|||
124724936|NCT01265563|448613377|FG004|Overall Study|Withdrawal by Subject|2|||
124724937|NCT01257230|448613382|FG000|Overall Study|Not Treated|0|||
124724938|NCT01257230|448613383|FG001|Overall Study|Not Treated|0|||
124724939|NCT01257230|448613384|FG002|Overall Study|Not Treated|1|||
124724940|NCT01257230|448613382|FG000|Overall Study|Adverse Event|2|||
124724941|NCT01257230|448613383|FG001|Overall Study|Adverse Event|0|||
124724942|NCT01257230|448613384|FG002|Overall Study|Adverse Event|0|||
124724943|NCT01257230|448613382|FG000|Overall Study|Lack of Efficacy|0|||
124569652|NCT01866319|448045485|FG001|Overall Study|Death|154|||
124569653|NCT01866319|448045486|FG002|Overall Study|Death|147|||
124569654|NCT01866319|448045484|FG000|Overall Study|Lost to Follow-up|6|||
124569655|NCT01866319|448045485|FG001|Overall Study|Lost to Follow-up|3|||
124569656|NCT01866319|448045486|FG002|Overall Study|Lost to Follow-up|8|||
124569657|NCT01866319|448045484|FG000|Overall Study|Physician Decision|1|||
124569658|NCT01866319|448045485|FG001|Overall Study|Physician Decision|0|||
124569659|NCT01866319|448045486|FG002|Overall Study|Physician Decision|1|||
124569660|NCT01866319|448045484|FG000|Overall Study|Protocol Violation|0|||
124569661|NCT01866319|448045485|FG001|Overall Study|Protocol Violation|0|||
124724944|NCT01257230|448613383|FG001|Overall Study|Lack of Efficacy|1|||
124724945|NCT01257230|448613384|FG002|Overall Study|Lack of Efficacy|0|||
124569662|NCT01866319|448045486|FG002|Overall Study|Protocol Violation|1|||
124569663|NCT01866319|448045484|FG000|Overall Study|Withdrawal by Subject|32|||
124724946|NCT01257230|448613382|FG000|Overall Study|Protocol Violation|3|||
124514057|NCT02151682|447832476|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
124514058|NCT02151682|447832471|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
124514059|NCT02151682|447832472|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
124514060|NCT02151682|447832473|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
124514061|NCT02151682|447832474|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
124514062|NCT02151682|447832475|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
124514063|NCT02151682|447832476|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
124514064|NCT02151682|447832471|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
124514065|NCT02151682|447832472|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
124514066|NCT02151682|447832473|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
124514067|NCT02151682|447832474|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
124514068|NCT02151682|447832475|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
124514069|NCT02151682|447832476|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
124514070|NCT02151682|447832471|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
124514071|NCT02151682|447832472|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
124514072|NCT02151682|447832473|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
124514073|NCT02151682|447832474|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
124514074|NCT02151682|447832475|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
124514075|NCT02151682|447832476|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
124514076|NCT02151682|447832471|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
124514077|NCT02151682|447832472|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
124514078|NCT02151682|447832473|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
124514079|NCT02151682|447832474|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
124514080|NCT02151682|447832475|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
124514081|NCT02151682|447832476|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
124514082|NCT02151682|447832471|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
124514083|NCT02151682|447832472|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
124514084|NCT02151682|447832473|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
124514085|NCT02151682|447832474|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
124514086|NCT02151682|447832475|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
124514087|NCT02151682|447832476|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
124514088|NCT02151682|447832471|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
124514089|NCT02151682|447832472|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
124514090|NCT02151682|447832473|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
124514091|NCT02151682|447832474|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
124514092|NCT02151682|447832475|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
124514093|NCT02151682|447832476|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
124514094|NCT02151682|447832471|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
124514095|NCT02151682|447832472|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
124514096|NCT02151682|447832473|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
124514097|NCT02151682|447832474|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
124514098|NCT02151682|447832475|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
124514099|NCT02151682|447832476|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
124514100|NCT02151682|447832471|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
124514101|NCT02151682|447832472|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
124514102|NCT02151682|447832473|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
124514103|NCT02151682|447832474|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
124514104|NCT02151682|447832475|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
124514105|NCT02151682|447832476|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
124514106|NCT02151682|447832471|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
124514107|NCT02151682|447832472|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
124514108|NCT02151682|447832473|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
124514109|NCT02151682|447832474|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
124514110|NCT02151682|447832475|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
124514111|NCT02151682|447832476|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
124514112|NCT02151682|447832471|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
124514113|NCT02151682|447832472|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
124514114|NCT02151682|447832473|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
124514115|NCT02151682|447832474|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
124514116|NCT02151682|447832475|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
124514117|NCT02151682|447832476|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
124514118|NCT02151682|447832471|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
124514119|NCT02151682|447832472|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
124514120|NCT02151682|447832473|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
124569664|NCT01866319|448045485|FG001|Overall Study|Withdrawal by Subject|14|||
124569665|NCT01866319|448045486|FG002|Overall Study|Withdrawal by Subject|12|||
124569666|NCT03980483|448045490|FG000|Overall Study|Adverse Event|13|||
124569667|NCT03980483|448045491|FG001|Overall Study|Adverse Event|29|||
124569668|NCT03980483|448045492|FG002|Overall Study|Adverse Event|11|||
124569669|NCT03980483|448045493|FG003|Overall Study|Adverse Event|2|||
124569670|NCT03980483|448045494|FG004|Overall Study|Adverse Event|2|||
124569671|NCT03980483|448045495|FG005|Overall Study|Adverse Event|2|||
124569672|NCT03980483|448045490|FG000|Overall Study|Lack of Efficacy|7|||
124569673|NCT03980483|448045491|FG001|Overall Study|Lack of Efficacy|6|||
124569674|NCT03980483|448045492|FG002|Overall Study|Lack of Efficacy|0|||
124569675|NCT03980483|448045493|FG003|Overall Study|Lack of Efficacy|3|||
124569676|NCT03980483|448045494|FG004|Overall Study|Lack of Efficacy|1|||
124569677|NCT03980483|448045495|FG005|Overall Study|Lack of Efficacy|1|||
124569678|NCT03980483|448045490|FG000|Overall Study|Lost to Follow-up|2|||
124569679|NCT03980483|448045491|FG001|Overall Study|Lost to Follow-up|4|||
124569680|NCT03980483|448045492|FG002|Overall Study|Lost to Follow-up|2|||
124569681|NCT03980483|448045493|FG003|Overall Study|Lost to Follow-up|1|||
124569682|NCT03980483|448045494|FG004|Overall Study|Lost to Follow-up|2|||
124569683|NCT03980483|448045495|FG005|Overall Study|Lost to Follow-up|0|||
124569684|NCT03980483|448045490|FG000|Overall Study|Protocol Violation|4|||
124569685|NCT03980483|448045491|FG001|Overall Study|Protocol Violation|2|||
124569686|NCT03980483|448045492|FG002|Overall Study|Protocol Violation|1|||
124569687|NCT03980483|448045493|FG003|Overall Study|Protocol Violation|1|||
124569688|NCT03980483|448045494|FG004|Overall Study|Protocol Violation|0|||
124569689|NCT03980483|448045495|FG005|Overall Study|Protocol Violation|0|||
124569690|NCT03980483|448045490|FG000|Overall Study|Physician Decision|14|||
124569691|NCT03980483|448045491|FG001|Overall Study|Physician Decision|10|||
124569692|NCT03980483|448045492|FG002|Overall Study|Physician Decision|7|||
124569693|NCT03980483|448045493|FG003|Overall Study|Physician Decision|4|||
124569694|NCT03980483|448045494|FG004|Overall Study|Physician Decision|4|||
124724947|NCT01257230|448613383|FG001|Overall Study|Protocol Violation|0|||
124724948|NCT01257230|448613384|FG002|Overall Study|Protocol Violation|1|||
124724949|NCT01257230|448613382|FG000|Overall Study|Withdrawal by Subject|0|||
124724950|NCT01257230|448613383|FG001|Overall Study|Withdrawal by Subject|4|||
124724951|NCT01257230|448613384|FG002|Overall Study|Withdrawal by Subject|1|||
124724952|NCT01257230|448613382|FG000|Overall Study|Other reason not defined above|1|||
124724953|NCT01257230|448613383|FG001|Overall Study|Other reason not defined above|5|||
124724954|NCT01257230|448613384|FG002|Overall Study|Other reason not defined above|3|||
124514121|NCT02151682|447832474|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
124514122|NCT02151682|447832475|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
124514123|NCT02151682|447832476|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
124514124|NCT01306032|447832477|FG000|First Intervention|Adverse Event|1|||
124514125|NCT01306032|447832478|FG001|First Intervention|Adverse Event|0|||
124514126|NCT01306032|447832479|FG002|First Intervention|Adverse Event|1|||
124514127|NCT01306032|447832480|FG003|First Intervention|Adverse Event|0|||
124514128|NCT01306032|447832481|FG004|First Intervention|Adverse Event|0|||
124514129|NCT01306032|447832482|FG005|First Intervention|Adverse Event|1|||
124514130|NCT01306032|447832477|FG000|First Intervention|Withdrawal by Subject|0|||
124514131|NCT01306032|447832478|FG001|First Intervention|Withdrawal by Subject|2|||
124514132|NCT01306032|447832479|FG002|First Intervention|Withdrawal by Subject|0|||
124514133|NCT01306032|447832480|FG003|First Intervention|Withdrawal by Subject|1|||
124514134|NCT01306032|447832481|FG004|First Intervention|Withdrawal by Subject|0|||
124514135|NCT01306032|447832482|FG005|First Intervention|Withdrawal by Subject|0|||
124514136|NCT01306032|447832477|FG000|First Intervention|Death|0|||
124514137|NCT01306032|447832478|FG001|First Intervention|Death|0|||
124514138|NCT01306032|447832479|FG002|First Intervention|Death|1|||
124514139|NCT01306032|447832480|FG003|First Intervention|Death|0|||
124514140|NCT01306032|447832481|FG004|First Intervention|Death|0|||
124569695|NCT03980483|448045495|FG005|Overall Study|Physician Decision|2|||
124569696|NCT03980483|448045490|FG000|Overall Study|Withdrawal by Subject|38|||
124569697|NCT03980483|448045491|FG001|Overall Study|Withdrawal by Subject|21|||
124514141|NCT01306032|447832482|FG005|First Intervention|Death|0|||
124514142|NCT01306032|447832477|FG000|First Intervention|Ineligible|0|||
124514143|NCT01306032|447832478|FG001|First Intervention|Ineligible|0|||
124569698|NCT03980483|448045492|FG002|Overall Study|Withdrawal by Subject|15|||
124514144|NCT01306032|447832479|FG002|First Intervention|Ineligible|0|||
124514145|NCT01306032|447832480|FG003|First Intervention|Ineligible|0|||
124514146|NCT01306032|447832481|FG004|First Intervention|Ineligible|0|||
124569699|NCT03980483|448045493|FG003|Overall Study|Withdrawal by Subject|5|||
124569700|NCT03980483|448045494|FG004|Overall Study|Withdrawal by Subject|3|||
124569701|NCT03980483|448045495|FG005|Overall Study|Withdrawal by Subject|4|||
124569702|NCT03980483|448045490|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
124569703|NCT03980483|448045491|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
124569704|NCT03980483|448045492|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
124724955|NCT01126268|448613385|FG000|Overall Study|Adverse Event|1|||
124514147|NCT01306032|447832482|FG005|First Intervention|Ineligible|1|||
124724956|NCT04026009|448613386|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124569705|NCT03980483|448045493|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
124569706|NCT03980483|448045494|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
124569707|NCT03980483|448045495|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
124569708|NCT03980483|448045490|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
124569709|NCT03980483|448045491|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
124569710|NCT03980483|448045492|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
124569711|NCT03980483|448045493|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
124569712|NCT03980483|448045494|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
124569713|NCT03980483|448045495|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
124569714|NCT03980483|448045490|FG000|Overall Study|Other|0|||
124569715|NCT03980483|448045491|FG001|Overall Study|Other|1|||
124569716|NCT03980483|448045492|FG002|Overall Study|Other|0|||
124569717|NCT03980483|448045493|FG003|Overall Study|Other|0|||
124569718|NCT03980483|448045494|FG004|Overall Study|Other|0|||
124569719|NCT03980483|448045495|FG005|Overall Study|Other|0|||
124569720|NCT00760266|448045498|FG000|Overall Study|Adverse Event|13|||
124569721|NCT00760266|448045499|FG001|Overall Study|Adverse Event|7|||
124569722|NCT00760266|448045498|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124514148|NCT01306032|447832477|FG000|First Intervention|Progressive disease|0|||
124514149|NCT01306032|447832478|FG001|First Intervention|Progressive disease|0|||
124514150|NCT01306032|447832479|FG002|First Intervention|Progressive disease|0|||
124514151|NCT01306032|447832480|FG003|First Intervention|Progressive disease|0|||
124514152|NCT01306032|447832481|FG004|First Intervention|Progressive disease|2|||
124514153|NCT01306032|447832482|FG005|First Intervention|Progressive disease|0|||
124514154|NCT01306032|447832477|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
124514155|NCT01306032|447832478|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
124514156|NCT01306032|447832479|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
124514157|NCT01306032|447832480|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
124514158|NCT01306032|447832481|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
124514159|NCT01306032|447832482|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
124514160|NCT01306032|447832477|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
124514161|NCT01306032|447832478|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
124514162|NCT01306032|447832479|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
124514163|NCT01306032|447832480|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
124514164|NCT01306032|447832481|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
124514165|NCT01306032|447832482|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
124514166|NCT03260894|447832484|FG000|Overall Study|Death|6|||
124514167|NCT03260894|447832485|FG001|Overall Study|Death|8|||
124514168|NCT03260894|447832484|FG000|Overall Study|Withdrawal by Subject|4|||
124514169|NCT03260894|447832485|FG001|Overall Study|Withdrawal by Subject|11|||
124514170|NCT03260894|447832484|FG000|Overall Study|On-going at clinical cut off date|36|||
124514171|NCT03260894|447832485|FG001|Overall Study|On-going at clinical cut off date|31|||
124514172|NCT00168064|447832487|FG000|Overall Study|Adverse Event|26|||
124514173|NCT00168064|447832488|FG001|Overall Study|Adverse Event|22|||
124514174|NCT00168064|447832487|FG000|Overall Study|Withdrawal by Subject|3|||
124514175|NCT00168064|447832488|FG001|Overall Study|Withdrawal by Subject|4|||
124514176|NCT00168064|447832487|FG000|Overall Study|Lack of Efficacy|4|||
124514177|NCT00168064|447832488|FG001|Overall Study|Lack of Efficacy|4|||
124514178|NCT00168064|447832487|FG000|Overall Study|Lost to Follow-up|4|||
124514179|NCT00168064|447832488|FG001|Overall Study|Lost to Follow-up|3|||
124514180|NCT00168064|447832487|FG000|Overall Study|Non-compliance|2|||
124514181|NCT00168064|447832488|FG001|Overall Study|Non-compliance|3|||
124514182|NCT00168064|447832487|FG000|Overall Study|Concurrent Illness|4|||
124514183|NCT00168064|447832488|FG001|Overall Study|Concurrent Illness|3|||
124514184|NCT00168064|447832487|FG000|Overall Study|Subject's Best interest|2|||
124514185|NCT00168064|447832488|FG001|Overall Study|Subject's Best interest|2|||
124514186|NCT00168064|447832487|FG000|Overall Study|Various|4|||
124514187|NCT00168064|447832488|FG001|Overall Study|Various|3|||
124514188|NCT00290589|447832489|FG000|Overall Study|Lost to Follow-up|2|||
124514189|NCT00290589|447832490|FG001|Overall Study|Lost to Follow-up|2|||
124514190|NCT05014542|447832491|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
124514191|NCT05014542|447832492|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
124514192|NCT05014542|447832491|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
124514193|NCT05014542|447832492|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
124514194|NCT05014542|447832491|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
124514195|NCT05014542|447832492|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
124514196|NCT05014542|447832491|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
124514197|NCT05014542|447832492|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
124514198|NCT06000501|447832493|FG000|Overall Study|Screen failure|3|||
124514199|NCT06000501|447832493|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
124514200|NCT06000501|447832493|FG000|Overall Study|Physician Decision|4|||
124514201|NCT06000501|447832493|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
124514202|NCT06000501|447832493|FG000|Overall Study|Scheduling issues|2|||
124514203|NCT00318565|447832494|FG000|Overall Study|Excluded per protocol|24|||
124514204|NCT01896856|447832495|FG000|Overall Study|Transportation issues / Non-compliance|0|||
124514205|NCT01896856|447832496|FG001|Overall Study|Transportation issues / Non-compliance|0|||
124514206|NCT01896856|447832497|FG002|Overall Study|Transportation issues / Non-compliance|1|||
124514207|NCT01896856|447832498|FG003|Overall Study|Transportation issues / Non-compliance|0|||
124514208|NCT01896856|447832499|FG004|Overall Study|Transportation issues / Non-compliance|0|||
124514209|NCT01896856|447832500|FG005|Overall Study|Transportation issues / Non-compliance|0|||
124514210|NCT03589885|447832502|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
124514211|NCT03589885|447832503|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
124514212|NCT03589885|447832504|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
124514213|NCT03589885|447832505|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
124514214|NCT03589885|447832506|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
124514215|NCT03589885|447832502|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
124514216|NCT03589885|447832503|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
124514217|NCT03589885|447832504|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
124514218|NCT03589885|447832505|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
124514219|NCT03589885|447832506|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
124514220|NCT03589885|447832502|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
124514221|NCT03589885|447832503|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
124514222|NCT03589885|447832504|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
124514223|NCT03589885|447832505|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
124514224|NCT03589885|447832506|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
124514225|NCT03589885|447832502|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
124514226|NCT03589885|447832503|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
124514227|NCT03589885|447832504|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
124514228|NCT03589885|447832505|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
124514229|NCT03589885|447832506|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
124514230|NCT03589885|447832502|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
124514231|NCT03589885|447832503|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
124514232|NCT03589885|447832504|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
124514233|NCT03589885|447832505|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
124514234|NCT03589885|447832506|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
124514235|NCT03589885|447832502|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
124514236|NCT03589885|447832503|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
124514237|NCT03589885|447832504|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
124514238|NCT03589885|447832505|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
124514239|NCT03589885|447832506|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
124514240|NCT03589885|447832502|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
124514241|NCT03589885|447832503|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
124514242|NCT03589885|447832504|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
124514243|NCT03589885|447832505|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
124514244|NCT03589885|447832506|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
124514245|NCT03589885|447832502|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
124514246|NCT03589885|447832503|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
124514247|NCT03589885|447832504|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
124514248|NCT03589885|447832505|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
124514249|NCT03589885|447832506|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
124514250|NCT02807363|447832509|FG000|Dosing Period|Adverse Event|0|||
124514251|NCT02807363|447832510|FG001|Dosing Period|Adverse Event|1|||
124514252|NCT02807363|447832511|FG002|Dosing Period|Adverse Event|0|||
124514253|NCT02807363|447832512|FG003|Dosing Period|Adverse Event|0|||
124514254|NCT00476996|447832513|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
124514255|NCT00476996|447832514|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
124514256|NCT00476996|447832515|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
124514257|NCT00476996|447832516|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
124514258|NCT00476996|447832513|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
124514259|NCT00476996|447832514|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
124514260|NCT00476996|447832515|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
124514261|NCT00476996|447832516|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
124514262|NCT00476996|447832513|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
124514263|NCT00476996|447832514|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
124514264|NCT00476996|447832515|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
124514265|NCT00476996|447832516|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
124514266|NCT00476996|447832513|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
124514267|NCT00476996|447832514|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
124514268|NCT00476996|447832515|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
124514269|NCT00476996|447832516|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
124514270|NCT00476996|447832513|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
124514271|NCT00476996|447832514|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
124514272|NCT00476996|447832515|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
124514273|NCT00476996|447832516|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
124514274|NCT00476996|447832513|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
124514275|NCT00476996|447832514|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
124514276|NCT00476996|447832515|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
124514277|NCT00476996|447832516|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
124514278|NCT00476996|447832513|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
124514279|NCT00476996|447832514|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
124514280|NCT00476996|447832515|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
124514281|NCT00476996|447832516|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
124514282|NCT00476996|447832513|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
124514283|NCT00476996|447832514|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
124514284|NCT00476996|447832515|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
124514285|NCT00476996|447832516|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
124514286|NCT00476996|447832513|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
124514287|NCT00476996|447832514|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
124514288|NCT00476996|447832515|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
124514289|NCT00476996|447832516|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
124514290|NCT00476996|447832513|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
124514291|NCT00476996|447832514|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
124514292|NCT00476996|447832515|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
124514293|NCT00476996|447832516|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
124514294|NCT00476996|447832513|FG000|OLE Phase (From Week 48)|Death|0|||
124514295|NCT00476996|447832514|FG001|OLE Phase (From Week 48)|Death|0|||
124514296|NCT00476996|447832515|FG002|OLE Phase (From Week 48)|Death|0|||
124514297|NCT00476996|447832516|FG003|OLE Phase (From Week 48)|Death|7|||
124514298|NCT00476996|447832513|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
124514299|NCT00476996|447832514|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
124514300|NCT00476996|447832515|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
124514301|NCT00476996|447832516|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
124514302|NCT00476996|447832513|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
124514303|NCT00476996|447832514|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
124514304|NCT00476996|447832515|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
124514305|NCT00476996|447832516|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
124514306|NCT00476996|447832513|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
124514307|NCT00476996|447832514|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
124514308|NCT00476996|447832515|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
124514309|NCT00476996|447832516|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
124514310|NCT00476996|447832513|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
124514311|NCT00476996|447832514|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
124514312|NCT00476996|447832515|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
124514313|NCT00476996|447832516|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
124514314|NCT01181778|447832527|FG000|Overall Study|Physician Decision|48|||
124514315|NCT01265420|447832528|FG000|Overall Study|Lost to Follow-up|1|||
124514316|NCT02332798|447834593|FG000|Overall Study|Unwilling to Participate in Study|0|||
124514317|NCT02332798|447834594|FG001|Overall Study|Unwilling to Participate in Study|1|||
124514318|NCT02332798|447834595|FG002|Overall Study|Unwilling to Participate in Study|1|||
124514319|NCT02332798|447834593|FG000|Overall Study|Positive Urine Drug Test|0|||
124514320|NCT02332798|447834594|FG001|Overall Study|Positive Urine Drug Test|1|||
124514321|NCT02332798|447834595|FG002|Overall Study|Positive Urine Drug Test|0|||
124514322|NCT02332798|447834593|FG000|Overall Study|Abnormal Laboratory Findings|1|||
124514323|NCT02332798|447834594|FG001|Overall Study|Abnormal Laboratory Findings|0|||
124514324|NCT02332798|447834595|FG002|Overall Study|Abnormal Laboratory Findings|0|||
124514325|NCT05406440|447834596|FG000|Overall Study|Lost to Follow-up|0|||
124514326|NCT05406440|447834597|FG001|Overall Study|Lost to Follow-up|0|||
124514327|NCT05406440|447834598|FG002|Overall Study|Lost to Follow-up|0|||
124514328|NCT05406440|447834599|FG003|Overall Study|Lost to Follow-up|0|||
124514329|NCT05406440|447834600|FG004|Overall Study|Lost to Follow-up|2|||
124514330|NCT05406440|447834601|FG005|Overall Study|Lost to Follow-up|0|||
124514331|NCT05406440|447834602|FG006|Overall Study|Lost to Follow-up|0|||
124514332|NCT05406440|447834596|FG000|Overall Study|Physician Decision|0|||
124514333|NCT05406440|447834597|FG001|Overall Study|Physician Decision|0|||
124514334|NCT05406440|447834598|FG002|Overall Study|Physician Decision|0|||
124514335|NCT05406440|447834599|FG003|Overall Study|Physician Decision|0|||
124514336|NCT05406440|447834600|FG004|Overall Study|Physician Decision|1|||
124514337|NCT05406440|447834601|FG005|Overall Study|Physician Decision|0|||
124514338|NCT05406440|447834602|FG006|Overall Study|Physician Decision|0|||
124514339|NCT05406440|447834596|FG000|Overall Study|Withdrawal by Subject|0|||
124514340|NCT05406440|447834597|FG001|Overall Study|Withdrawal by Subject|0|||
124569723|NCT00760266|448045499|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124569724|NCT00760266|448045498|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124569725|NCT00760266|448045499|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124569726|NCT00760266|448045498|FG000|Overall Study|Lack of Efficacy|2|||
124569727|NCT00760266|448045499|FG001|Overall Study|Lack of Efficacy|2|||
124514341|NCT05406440|447834598|FG002|Overall Study|Withdrawal by Subject|0|||
124514342|NCT05406440|447834599|FG003|Overall Study|Withdrawal by Subject|0|||
124514343|NCT05406440|447834600|FG004|Overall Study|Withdrawal by Subject|0|||
124569728|NCT00760266|448045498|FG000|Overall Study|Protocol deviation|2|||
124569729|NCT00760266|448045499|FG001|Overall Study|Protocol deviation|4|||
124569730|NCT00760266|448045498|FG000|Overall Study|Patient withdrew consent|3|||
124569731|NCT00760266|448045499|FG001|Overall Study|Patient withdrew consent|3|||
124569732|NCT00760266|448045498|FG000|Overall Study|Lost to Follow-up|2|||
124569733|NCT00760266|448045499|FG001|Overall Study|Lost to Follow-up|1|||
124569734|NCT00760266|448045498|FG000|Overall Study|Administrative Problems|0|||
124569735|NCT00760266|448045499|FG001|Overall Study|Administrative Problems|1|||
124569736|NCT01225146|448045500|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
124569737|NCT01225146|448045501|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
124569738|NCT00659607|448045504|FG000|Overall Study|No blood pressure recorded|147|||
124569739|NCT00659607|448045504|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
124569740|NCT00659607|448045504|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
124569741|NCT00659607|448045504|FG000|Overall Study|No recorded efficacy data|15|||
124569742|NCT00659607|448045504|FG000|Overall Study|Inconsistent BP measuring date|2|||
124569743|NCT02191891|448045505|FG000|Overall Study|Withdrawal by Subject|0|||
124569744|NCT02191891|448045506|FG001|Overall Study|Withdrawal by Subject|1|||
124569745|NCT02191891|448045507|FG002|Overall Study|Withdrawal by Subject|0|||
124569746|NCT02191891|448045508|FG003|Overall Study|Withdrawal by Subject|0|||
124569747|NCT02191891|448045509|FG004|Overall Study|Withdrawal by Subject|1|||
124569748|NCT02191891|448045505|FG000|Overall Study|Adverse Event|0|||
124569749|NCT02191891|448045506|FG001|Overall Study|Adverse Event|1|||
124569750|NCT02191891|448045507|FG002|Overall Study|Adverse Event|0|||
124569751|NCT02191891|448045508|FG003|Overall Study|Adverse Event|0|||
124569752|NCT02191891|448045509|FG004|Overall Study|Adverse Event|2|||
124569753|NCT02191891|448045505|FG000|Overall Study|Disease Progression|4|||
124569754|NCT02191891|448045506|FG001|Overall Study|Disease Progression|10|||
124569755|NCT02191891|448045507|FG002|Overall Study|Disease Progression|4|||
124569756|NCT02191891|448045508|FG003|Overall Study|Disease Progression|2|||
124569757|NCT02191891|448045509|FG004|Overall Study|Disease Progression|7|||
124569758|NCT03912337|448045515|FG000|Overall Study|Withdrawal of Consent From Study|1|||
124569759|NCT03912337|448045516|FG001|Overall Study|Withdrawal of Consent From Study|0|||
124569760|NCT03912337|448045515|FG000|Overall Study|Lost to Follow-up|1|||
124569761|NCT03912337|448045516|FG001|Overall Study|Lost to Follow-up|1|||
124569762|NCT03752528|448045517|FG000|Part A|Lost to Follow-up|1|||
124569763|NCT03752528|448045517|FG000|Part A|Protocol Violation|1|||
124569764|NCT03752528|448045517|FG000|Part B|Protocol Violation|1|||
124569765|NCT03752528|448045517|FG000|Part B|Study terminated by sponsor|3|||
124569766|NCT00414765|448045518|FG000|Overall Study|Adverse Event|5|||
124569767|NCT00414765|448045519|FG001|Overall Study|Adverse Event|9|||
124569768|NCT00414765|448045518|FG000|Overall Study|Withdrawal by Subject|1|||
124569769|NCT00414765|448045519|FG001|Overall Study|Withdrawal by Subject|1|||
124569770|NCT00414765|448045518|FG000|Overall Study|Disease Progression|0|||
124569771|NCT00414765|448045519|FG001|Overall Study|Disease Progression|1|||
124569772|NCT02458469|448045520|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
124569773|NCT02458469|448045521|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
124514344|NCT05406440|447834601|FG005|Overall Study|Withdrawal by Subject|2|||
124514345|NCT05406440|447834602|FG006|Overall Study|Withdrawal by Subject|0|||
124514346|NCT00525785|447834603|FG000|Overall Study|Withdrawal by Subject|1|||
124514347|NCT00525785|447834603|FG000|Overall Study|Lack of Efficacy|1|||
124514348|NCT00525785|447834603|FG000|Overall Study|Physician Decision|1|||
124514349|NCT02455388|447834604|FG000|Overall Study|Protocol Violation|1|||
124514350|NCT02455388|447834605|FG001|Overall Study|Protocol Violation|0|||
124514351|NCT02455388|447834606|FG002|Overall Study|Protocol Violation|4|||
124514352|NCT02455388|447834604|FG000|Overall Study|Withdrawal by Subject|0|||
124514353|NCT02455388|447834605|FG001|Overall Study|Withdrawal by Subject|0|||
124514354|NCT02455388|447834606|FG002|Overall Study|Withdrawal by Subject|7|||
124569774|NCT02458469|448045522|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
124569775|NCT02458469|448045523|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
124569776|NCT02458469|448045524|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
124569777|NCT02458469|448045525|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
124569778|NCT02458469|448045520|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
124569779|NCT02458469|448045521|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
124569780|NCT02458469|448045522|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
124569781|NCT02458469|448045523|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
124569782|NCT02458469|448045524|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
124514355|NCT01316939|447834607|FG000|Overall Study|Study closed/terminated|26|||
124514356|NCT01316939|447834608|FG001|Overall Study|Study closed/terminated|25|||
124514357|NCT01316939|447834609|FG002|Overall Study|Study closed/terminated|23|||
124514358|NCT01316939|447834607|FG000|Overall Study|Lack of Efficacy|24|||
124514359|NCT01316939|447834608|FG001|Overall Study|Lack of Efficacy|25|||
124514360|NCT01316939|447834609|FG002|Overall Study|Lack of Efficacy|25|||
124514361|NCT01316939|447834607|FG000|Overall Study|Adverse Event|9|||
124514362|NCT01316939|447834608|FG001|Overall Study|Adverse Event|12|||
124514363|NCT01316939|447834609|FG002|Overall Study|Adverse Event|11|||
124514364|NCT01316939|447834607|FG000|Overall Study|Withdrawal by Subject|1|||
124514365|NCT01316939|447834608|FG001|Overall Study|Withdrawal by Subject|3|||
124514366|NCT01316939|447834609|FG002|Overall Study|Withdrawal by Subject|6|||
124514367|NCT01316939|447834607|FG000|Overall Study|Physician Decision|2|||
124514368|NCT01316939|447834608|FG001|Overall Study|Physician Decision|2|||
124514369|NCT01316939|447834609|FG002|Overall Study|Physician Decision|1|||
124514370|NCT01316939|447834607|FG000|Overall Study|Lost to Follow-up|0|||
124514371|NCT01316939|447834608|FG001|Overall Study|Lost to Follow-up|0|||
124514372|NCT01316939|447834609|FG002|Overall Study|Lost to Follow-up|2|||
124514373|NCT01316939|447834607|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
124514374|NCT01316939|447834608|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
124514375|NCT01316939|447834609|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
124514376|NCT01316939|447834607|FG000|Overall Study|Protocol Violation|0|||
124514377|NCT01316939|447834608|FG001|Overall Study|Protocol Violation|1|||
124514378|NCT01316939|447834609|FG002|Overall Study|Protocol Violation|0|||
124514379|NCT00801892|447834610|FG000|Main Study Period|Withdrawal by Subject|0|||
124514380|NCT00801892|447834611|FG001|Main Study Period|Withdrawal by Subject|1|||
124514381|NCT00801892|447834610|FG000|Sham Crossover Period|Lost to Follow-up|0|||
124514382|NCT00801892|447834611|FG001|Sham Crossover Period|Lost to Follow-up|2|||
124514383|NCT00728936|447834620|FG000|Overall Study|Withdrawal by Subject|0|||
124514384|NCT00728936|447834621|FG001|Overall Study|Withdrawal by Subject|0|||
124514385|NCT00728936|447834622|FG002|Overall Study|Withdrawal by Subject|0|||
124514386|NCT00728936|447834623|FG003|Overall Study|Withdrawal by Subject|0|||
124514387|NCT00728936|447834624|FG004|Overall Study|Withdrawal by Subject|0|||
124514388|NCT00728936|447834625|FG005|Overall Study|Withdrawal by Subject|1|||
124514389|NCT00728936|447834626|FG006|Overall Study|Withdrawal by Subject|0|||
124514390|NCT02966353|447834627|FG000|Overall Study|Withdrawal by Subject|7|||
124514391|NCT02966353|447834627|FG000|Overall Study|Adverse Event|4|||
124514392|NCT02966353|447834627|FG000|Overall Study|Death|4|||
124514393|NCT02966353|447834627|FG000|Overall Study|Physician Decision|3|||
124514394|NCT02966353|447834627|FG000|Overall Study|Progressive disease|2|||
124514395|NCT02966353|447834627|FG000|Overall Study|Protocol deviation|2|||
124514396|NCT00093470|447834628|FG000|Overall Study|Disease progression|39|||
124514397|NCT00093470|447834629|FG001|Overall Study|Disease progression|0|||
124514398|NCT00093470|447834628|FG000|Overall Study|Adverse Event|15|||
124514399|NCT00093470|447834629|FG001|Overall Study|Adverse Event|0|||
124514400|NCT00093470|447834628|FG000|Overall Study|Death|2|||
124514401|NCT00093470|447834629|FG001|Overall Study|Death|0|||
124514402|NCT00093470|447834628|FG000|Overall Study|Withdrawal by Subject|8|||
124514403|NCT00093470|447834629|FG001|Overall Study|Withdrawal by Subject|0|||
124514404|NCT00093470|447834628|FG000|Overall Study|Alternative therapy|2|||
124514405|NCT00093470|447834629|FG001|Overall Study|Alternative therapy|0|||
124514406|NCT00093470|447834628|FG000|Overall Study|Other complicating disease|3|||
124514407|NCT00093470|447834629|FG001|Overall Study|Other complicating disease|0|||
124514408|NCT00093470|447834628|FG000|Overall Study|Physician Decision|2|||
124514409|NCT00093470|447834629|FG001|Overall Study|Physician Decision|0|||
124514410|NCT00093470|447834628|FG000|Overall Study|Never started treatment|1|||
124514411|NCT00093470|447834629|FG001|Overall Study|Never started treatment|0|||
124514412|NCT00093470|447834628|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
124514413|NCT00093470|447834629|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
124514414|NCT01188096|447834630|FG000|Overall Study|progression of disease|4|||
124514415|NCT01188096|447834630|FG000|Overall Study|Withdrawal by Subject|2|||
124514416|NCT00851253|447834631|FG000|Overall Study|Disease Progression|1|||
124514417|NCT00851253|447834632|FG001|Overall Study|Disease Progression|0|||
124514418|NCT01779648|447834633|FG000|Overall Study|Protocol Violation|1|||
124514419|NCT01779648|447834634|FG001|Overall Study|Protocol Violation|0|||
124514420|NCT00415519|447834635|FG000|Overall Study|Adverse Event|1|||
124514421|NCT00415519|447834636|FG001|Overall Study|Adverse Event|0|||
124514422|NCT00415519|447834635|FG000|Overall Study|Withdrawal by Subject|2|||
124514423|NCT00415519|447834636|FG001|Overall Study|Withdrawal by Subject|0|||
124514424|NCT00415519|447834635|FG000|Overall Study|Patient's convenience|1|||
124514425|NCT00415519|447834636|FG001|Overall Study|Patient's convenience|0|||
124514426|NCT01705587|447834641|FG000|Overall Study|Withdrawal by Subject|0|||
124514427|NCT01705587|447834642|FG001|Overall Study|Withdrawal by Subject|1|||
124514428|NCT03004976|447834643|FG000|Overall Study|Lost to Follow-up|7|||
124514429|NCT03004976|447834644|FG001|Overall Study|Lost to Follow-up|5|||
124514430|NCT03004976|447834643|FG000|Overall Study|Physician Decision|1|||
124514431|NCT03004976|447834644|FG001|Overall Study|Physician Decision|0|||
124514432|NCT03004976|447834643|FG000|Overall Study|Withdrawal by Subject|1|||
124514433|NCT03004976|447834644|FG001|Overall Study|Withdrawal by Subject|0|||
124514434|NCT03004976|447834643|FG000|Overall Study|Death|4|||
124514435|NCT03004976|447834644|FG001|Overall Study|Death|1|||
124514436|NCT00291499|447834645|FG000|Overall Study|Adverse Event|3|||
124514437|NCT00291499|447834646|FG001|Overall Study|Adverse Event|8|||
124514438|NCT00291499|447834645|FG000|Overall Study|Change to other therapy|2|||
124514439|NCT00291499|447834646|FG001|Overall Study|Change to other therapy|1|||
124514440|NCT00291499|447834645|FG000|Overall Study|Intercurrent illness|1|||
124514441|NCT00291499|447834646|FG001|Overall Study|Intercurrent illness|0|||
124514442|NCT00291499|447834645|FG000|Overall Study|Protocol Violation|2|||
124514443|NCT00291499|447834646|FG001|Overall Study|Protocol Violation|2|||
124514444|NCT00291499|447834645|FG000|Overall Study|Other reasons|1|||
124514445|NCT00291499|447834646|FG001|Overall Study|Other reasons|4|||
124514446|NCT01532570|447834650|FG000|Overall Study|Lack of Efficacy|1|||
124514447|NCT01532570|447834651|FG001|Overall Study|Lack of Efficacy|0|||
124514448|NCT01532570|447834652|FG002|Overall Study|Lack of Efficacy|0|||
124514449|NCT01532570|447834653|FG003|Overall Study|Lack of Efficacy|0|||
124514450|NCT01532570|447834650|FG000|Overall Study|Withdrawal by Subject|0|||
124514451|NCT01532570|447834651|FG001|Overall Study|Withdrawal by Subject|1|||
124514452|NCT01532570|447834652|FG002|Overall Study|Withdrawal by Subject|0|||
124514453|NCT01532570|447834653|FG003|Overall Study|Withdrawal by Subject|0|||
124514454|NCT03892707|447834656|FG000|Overall Study|Screen failure|6|||
124514455|NCT03892707|447834657|FG001|Overall Study|Screen failure|0|||
124514456|NCT03892707|447834656|FG000|Overall Study|Pain resolution|0|||
124514457|NCT03892707|447834657|FG001|Overall Study|Pain resolution|4|||
124514458|NCT03892707|447834656|FG000|Overall Study|Withdrawal by Subject|0|||
124514459|NCT03892707|447834657|FG001|Overall Study|Withdrawal by Subject|1|||
124514460|NCT03892707|447834656|FG000|Overall Study|Other (long business trip)|0|||
124514461|NCT03892707|447834657|FG001|Overall Study|Other (long business trip)|1|||
124514462|NCT01807949|447834659|FG000|Overall Study|Adverse Event|1|||
124514463|NCT01807949|447834660|FG001|Overall Study|Adverse Event|2|||
124514464|NCT01807949|447834661|FG002|Overall Study|Adverse Event|2|||
124514465|NCT01807949|447834659|FG000|Overall Study|Withdrawal by Subject|1|||
124514466|NCT01807949|447834660|FG001|Overall Study|Withdrawal by Subject|2|||
124514467|NCT01807949|447834661|FG002|Overall Study|Withdrawal by Subject|2|||
124514468|NCT01807949|447834659|FG000|Overall Study|Non-Compliance|0|||
124514469|NCT01807949|447834660|FG001|Overall Study|Non-Compliance|0|||
124514470|NCT01807949|447834661|FG002|Overall Study|Non-Compliance|1|||
124514471|NCT01807949|447834659|FG000|Overall Study|Undefined|0|||
124514472|NCT01807949|447834660|FG001|Overall Study|Undefined|1|||
124514473|NCT01807949|447834661|FG002|Overall Study|Undefined|2|||
124514474|NCT01807949|447834659|FG000|Overall Study|Randomized But Not Treated|0|||
124514475|NCT01807949|447834660|FG001|Overall Study|Randomized But Not Treated|2|||
124514476|NCT01807949|447834661|FG002|Overall Study|Randomized But Not Treated|2|||
124514477|NCT04325906|447834664|FG000|Overall Study|Withdrawal by Subject|2|||
124514478|NCT04325906|447834665|FG001|Overall Study|Withdrawal by Subject|0|||
124514479|NCT02141217|447834666|FG000|Overall Study|Adverse Event|1|||
124514480|NCT02141217|447834667|FG001|Overall Study|Adverse Event|2|||
124514481|NCT02141217|447834666|FG000|Overall Study|Protocol Violation|1|||
124514482|NCT02141217|447834667|FG001|Overall Study|Protocol Violation|4|||
124514483|NCT02141217|447834666|FG000|Overall Study|Withdrawal by Subject|6|||
124514484|NCT02141217|447834667|FG001|Overall Study|Withdrawal by Subject|0|||
124514485|NCT02141217|447834666|FG000|Overall Study|Lost to Follow-up|1|||
124514486|NCT02141217|447834667|FG001|Overall Study|Lost to Follow-up|1|||
124514487|NCT02141217|447834666|FG000|Overall Study|Physician Decision|1|||
124514488|NCT02141217|447834667|FG001|Overall Study|Physician Decision|0|||
124514489|NCT02141217|447834666|FG000|Overall Study|Surgical Intervention|1|||
124514490|NCT02141217|447834667|FG001|Overall Study|Surgical Intervention|1|||
124514491|NCT01181141|447834672|FG000|Overall Study|Adverse Event|2|||
124514492|NCT01181141|447834673|FG001|Overall Study|Adverse Event|1|||
124514493|NCT01181141|447834672|FG000|Overall Study|Lack of Efficacy|1|||
124514494|NCT01181141|447834673|FG001|Overall Study|Lack of Efficacy|0|||
124514495|NCT01181141|447834672|FG000|Overall Study|Lost to Follow-up|1|||
124514496|NCT01181141|447834673|FG001|Overall Study|Lost to Follow-up|1|||
124514497|NCT01181141|447834672|FG000|Overall Study|Physician Decision|2|||
124514498|NCT01181141|447834673|FG001|Overall Study|Physician Decision|0|||
124514499|NCT01181141|447834672|FG000|Overall Study|Protocol Violation|3|||
124514500|NCT01181141|447834673|FG001|Overall Study|Protocol Violation|1|||
124514501|NCT01181141|447834672|FG000|Overall Study|Withdrawal by Subject|3|||
124514502|NCT01181141|447834673|FG001|Overall Study|Withdrawal by Subject|1|||
124514503|NCT00448760|447834674|FG000|Overall Study|Death|3|||
124514504|NCT01213264|447834680|FG000|Overall Study|Adverse Event|1|||
124514505|NCT01213264|447834681|FG001|Overall Study|Adverse Event|0|||
124514506|NCT01213264|447834682|FG002|Overall Study|Adverse Event|0|||
124514507|NCT01213264|447834680|FG000|Overall Study|Lost to Follow-up|1|||
124514508|NCT01213264|447834681|FG001|Overall Study|Lost to Follow-up|2|||
124514509|NCT01213264|447834682|FG002|Overall Study|Lost to Follow-up|6|||
124514510|NCT00118911|447834686|FG000|Overall Study|Withdrawal by Subject|2|||
124514511|NCT00118911|447834687|FG001|Overall Study|Withdrawal by Subject|5|||
124514512|NCT05507580|447834688|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124569783|NCT02458469|448045525|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
124569784|NCT02458469|448045520|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
124569785|NCT02458469|448045521|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
124569786|NCT02458469|448045522|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
124569787|NCT02458469|448045523|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
124569788|NCT02458469|448045524|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
124514513|NCT05507580|447834689|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
124514514|NCT05507580|447834690|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
124514515|NCT05507580|447834691|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
124514516|NCT05507580|447834692|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
124514517|NCT05507580|447834693|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
124514518|NCT05507580|447834688|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
124514519|NCT05507580|447834689|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
124514520|NCT05507580|447834690|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124514521|NCT05507580|447834691|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124514522|NCT05507580|447834692|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124514523|NCT05507580|447834693|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124514524|NCT05507580|447834688|FG000|Double-Blind Treatment Period|Other, not specified|5|||
124514525|NCT05507580|447834689|FG001|Double-Blind Treatment Period|Other, not specified|4|||
124514526|NCT05507580|447834690|FG002|Double-Blind Treatment Period|Other, not specified|0|||
124514527|NCT05507580|447834691|FG003|Double-Blind Treatment Period|Other, not specified|0|||
124514528|NCT05507580|447834692|FG004|Double-Blind Treatment Period|Other, not specified|0|||
124514529|NCT05507580|447834693|FG005|Double-Blind Treatment Period|Other, not specified|0|||
124514530|NCT05507580|447834688|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
124514531|NCT05507580|447834689|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
124514532|NCT05507580|447834690|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
124514533|NCT05507580|447834691|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
124514534|NCT05507580|447834692|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
124514535|NCT05507580|447834693|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
124514536|NCT05507580|447834688|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
124514537|NCT05507580|447834689|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
124514538|NCT05507580|447834690|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
124514539|NCT05507580|447834691|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
124514540|NCT05507580|447834692|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
124514541|NCT05507580|447834693|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
124514542|NCT05507580|447834688|FG000|Single-Blind Treatment Period|Other, not specified|0|||
124514543|NCT05507580|447834689|FG001|Single-Blind Treatment Period|Other, not specified|0|||
124514544|NCT05507580|447834690|FG002|Single-Blind Treatment Period|Other, not specified|2|||
124514545|NCT05507580|447834691|FG003|Single-Blind Treatment Period|Other, not specified|7|||
124514546|NCT05507580|447834692|FG004|Single-Blind Treatment Period|Other, not specified|3|||
124514547|NCT05507580|447834693|FG005|Single-Blind Treatment Period|Other, not specified|5|||
124514548|NCT01438307|447834694|FG000|Overall Study|Death|1|||
124514549|NCT01438307|447834695|FG001|Overall Study|Death|1|||
124514550|NCT04702984|447834696|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
124514551|NCT03496662|447834697|FG000|Overall Study|Adverse Event|0|||
124514552|NCT03496662|447834698|FG001|Overall Study|Adverse Event|0|||
124514553|NCT03496662|447834699|FG002|Overall Study|Adverse Event|4|||
124514554|NCT03496662|447834697|FG000|Overall Study|Withdrawal by Subject|1|||
124514555|NCT03496662|447834698|FG001|Overall Study|Withdrawal by Subject|0|||
124514556|NCT03496662|447834699|FG002|Overall Study|Withdrawal by Subject|2|||
124514557|NCT03496662|447834697|FG000|Overall Study|Death|0|||
124514558|NCT03496662|447834698|FG001|Overall Study|Death|0|||
124514559|NCT03496662|447834699|FG002|Overall Study|Death|2|||
124514560|NCT03496662|447834697|FG000|Overall Study|Noncompliance|0|||
124514561|NCT03496662|447834698|FG001|Overall Study|Noncompliance|0|||
124514562|NCT03496662|447834699|FG002|Overall Study|Noncompliance|1|||
124514563|NCT02378883|447834700|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
124514564|NCT02378883|447834700|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
124514565|NCT02378883|447834700|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
124514566|NCT02378883|447834700|FG000|30 Day Follow-Up|Physician Decision|2|||
124514567|NCT02378883|447834700|FG000|30 Day Follow-Up|Missed Visit|2|||
124514568|NCT02378883|447834700|FG000|30 Day Follow-Up|Death|1|||
124514569|NCT02378883|447834700|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
124514570|NCT02378883|447834700|FG000|12 Months Follow-Up|Death|2|||
124514571|NCT03037307|447834701|FG000|Period 1|Did Not Meet Study Criteria|0|||
124514572|NCT03037307|447834702|FG001|Period 1|Did Not Meet Study Criteria|0|||
124514573|NCT03037307|447834703|FG002|Period 1|Did Not Meet Study Criteria|0|||
124514574|NCT03037307|447834704|FG003|Period 1|Did Not Meet Study Criteria|1|||
124514575|NCT03037307|447834705|FG004|Period 1|Did Not Meet Study Criteria|0|||
124514576|NCT03037307|447834706|FG005|Period 1|Did Not Meet Study Criteria|0|||
124514577|NCT00691093|447834707|FG000|Overall Study|Adverse Event|1|||
124514578|NCT00691093|447834707|FG000|Overall Study|Lost to Follow-up|1|||
124514579|NCT00691093|447834707|FG000|Overall Study|Lack of Efficacy|1|||
124514580|NCT00691093|447834707|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
124514581|NCT01588353|447834708|FG000|Step2|Withdrawal by Subject|0|||
124514582|NCT01588353|447834709|FG001|Step2|Withdrawal by Subject|1|||
124514583|NCT01588353|447834710|FG002|Step2|Withdrawal by Subject|0|||
124514584|NCT01588353|447834708|FG000|Step3|Adverse Event|0|||
124514585|NCT01588353|447834709|FG001|Step3|Adverse Event|0|||
124514586|NCT01588353|447834710|FG002|Step3|Adverse Event|2|||
124514587|NCT03814005|447834713|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
124514588|NCT03814005|447834714|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
124514589|NCT03814005|447834715|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
124514590|NCT03814005|447834713|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
124514591|NCT03814005|447834714|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
124514592|NCT03814005|447834715|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
124514593|NCT03814005|447834713|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
124514594|NCT03814005|447834714|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
124514595|NCT03814005|447834715|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
124514596|NCT03814005|447834713|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
124514597|NCT03814005|447834714|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
124514598|NCT03814005|447834715|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
124514599|NCT03814005|447834713|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
124514600|NCT03814005|447834714|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
124514601|NCT03814005|447834715|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
124514602|NCT03814005|447834713|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
124514603|NCT03814005|447834714|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
124514604|NCT03814005|447834715|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
124514605|NCT05489081|447834716|FG000|Overall Study|student left classroom|0|||
124514606|NCT05489081|447834717|FG001|Overall Study|student left classroom|1|||
124514607|NCT05489081|447834716|FG000|Overall Study|teacher left school|0|||
124514608|NCT05489081|447834717|FG001|Overall Study|teacher left school|2|||
124514609|NCT00810810|447834718|FG000|Overall Study|Withdrawal by Subject|0|||
124514610|NCT00810810|447834719|FG001|Overall Study|Withdrawal by Subject|8|||
124514611|NCT00810810|447834720|FG002|Overall Study|Withdrawal by Subject|10|||
124514612|NCT00810810|447834721|FG003|Overall Study|Withdrawal by Subject|8|||
124514613|NCT00810810|447834718|FG000|Overall Study|Physician Decision|0|||
124514614|NCT00810810|447834719|FG001|Overall Study|Physician Decision|3|||
124514615|NCT00810810|447834720|FG002|Overall Study|Physician Decision|1|||
124514616|NCT00810810|447834721|FG003|Overall Study|Physician Decision|5|||
124514617|NCT01409993|447834722|FG000|Overall Study|Adverse Event|4|||
124514618|NCT01409993|447834723|FG001|Overall Study|Adverse Event|4|||
124514619|NCT01409993|447834724|FG002|Overall Study|Adverse Event|3|||
124514620|NCT01409993|447834725|FG003|Overall Study|Adverse Event|1|||
124514621|NCT01409993|447834722|FG000|Overall Study|Withdrawal by Subject|0|||
124514622|NCT01409993|447834723|FG001|Overall Study|Withdrawal by Subject|0|||
124514623|NCT01409993|447834724|FG002|Overall Study|Withdrawal by Subject|0|||
124514624|NCT01409993|447834725|FG003|Overall Study|Withdrawal by Subject|4|||
124514625|NCT01409993|447834722|FG000|Overall Study|Lost to Follow-up|0|||
124514626|NCT01409993|447834723|FG001|Overall Study|Lost to Follow-up|1|||
124514627|NCT01409993|447834724|FG002|Overall Study|Lost to Follow-up|0|||
124514628|NCT01409993|447834725|FG003|Overall Study|Lost to Follow-up|0|||
124514629|NCT01700985|447834726|FG000|Overall Study|Incarcerated|0|||
124514630|NCT01700985|447834727|FG001|Overall Study|Incarcerated|1|||
124514631|NCT05067452|447834728|FG000|Overall Study|Lost to Follow-up|0|||
124514632|NCT05067452|447834729|FG001|Overall Study|Lost to Follow-up|4|||
124514633|NCT03074149|447834732|FG000|Overall Study|Reason unknown|22|||
124514634|NCT03074149|447834733|FG001|Overall Study|Reason unknown|35|||
124514635|NCT03074149|447834732|FG000|Overall Study|Death|10|||
124514636|NCT03074149|447834733|FG001|Overall Study|Death|45|||
124514637|NCT00067470|447834734|FG000|Overall Study|Withdrawal by Subject|0|||
124514638|NCT00067470|447834735|FG001|Overall Study|Withdrawal by Subject|1|||
124514639|NCT00050622|447834736|FG000|Overall Study|Adverse Event|1|||
124514640|NCT01192204|447834737|FG000|Overall Study|could not keep recall appointments|1|||
124514641|NCT01192204|447834738|FG001|Overall Study|could not keep recall appointments|0|||
124514642|NCT02146248|447834739|FG000|Overall Study|Withdrawal by Subject|2|||
124514643|NCT01315847|447834740|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
124514644|NCT01315847|447834741|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
124514645|NCT01315847|447834740|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
124514646|NCT01315847|447834741|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
124514647|NCT02247401|447834742|FG000|Overall Study|Adverse Event|1|||
124514648|NCT02247401|447834743|FG001|Overall Study|Adverse Event|0|||
124514649|NCT02247401|447834744|FG002|Overall Study|Adverse Event|0|||
124514650|NCT02247401|447834742|FG000|Overall Study|Withdrawal by Subject|4|||
124514651|NCT02247401|447834743|FG001|Overall Study|Withdrawal by Subject|1|||
124514652|NCT02247401|447834744|FG002|Overall Study|Withdrawal by Subject|1|||
124514653|NCT02247401|447834742|FG000|Overall Study|Lost to Follow-up|1|||
124514654|NCT02247401|447834743|FG001|Overall Study|Lost to Follow-up|1|||
124514655|NCT02247401|447834744|FG002|Overall Study|Lost to Follow-up|1|||
124514656|NCT01117012|447834746|FG000|Overall Study|Adverse Event|0|||
124514657|NCT01117012|447834747|FG001|Overall Study|Adverse Event|1|||
124514658|NCT01117012|447834746|FG000|Overall Study|Death|1|||
124514659|NCT01117012|447834747|FG001|Overall Study|Death|1|||
124514660|NCT01117012|447834746|FG000|Overall Study|Withdrawal by Subject|3|||
124514661|NCT01117012|447834747|FG001|Overall Study|Withdrawal by Subject|0|||
124514662|NCT01117012|447834746|FG000|Overall Study|Undefined|4|||
124514663|NCT01117012|447834747|FG001|Overall Study|Undefined|3|||
124514664|NCT03695393|447834748|FG000|Overall Study|Death|3|||
124514665|NCT03695393|447834749|FG001|Overall Study|Death|1|||
124514666|NCT03695393|447834748|FG000|Overall Study|Lost to Follow-up|0|||
124514667|NCT03695393|447834749|FG001|Overall Study|Lost to Follow-up|1|||
124514668|NCT00673894|447834750|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
124514669|NCT00673894|447834751|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
124514670|NCT00673894|447834750|FG000|First Intervention 4 Weeks|Adverse Event|1|||
124514671|NCT00673894|447834751|FG001|First Intervention 4 Weeks|Adverse Event|0|||
124514672|NCT01164865|447834752|FG000|Overall Study|Lost to Follow-up|2|||
124514673|NCT01164865|447834753|FG001|Overall Study|Lost to Follow-up|1|||
124514674|NCT00405821|447834758|FG000|Overall Study|Death|5|||
124514675|NCT00405821|447834759|FG001|Overall Study|Death|7|||
124514676|NCT00405821|447834758|FG000|Overall Study|Lost to Follow-up|7|||
124514677|NCT00405821|447834759|FG001|Overall Study|Lost to Follow-up|7|||
124514678|NCT00405821|447834758|FG000|Overall Study|Protocol Violation|1|||
124514679|NCT00405821|447834759|FG001|Overall Study|Protocol Violation|0|||
124514680|NCT00405821|447834758|FG000|Overall Study|initiated ART|9|||
124514681|NCT00405821|447834759|FG001|Overall Study|initiated ART|8|||
124514682|NCT01586806|447834761|FG000|Overall Study|Protocol Violation|0|||
124514683|NCT01586806|447834762|FG001|Overall Study|Protocol Violation|1|||
124514684|NCT01586806|447834763|FG002|Overall Study|Protocol Violation|0|||
124514685|NCT01586806|447834761|FG000|Overall Study|Withdrawal by Subject|1|||
124514686|NCT01586806|447834762|FG001|Overall Study|Withdrawal by Subject|0|||
124514687|NCT01586806|447834763|FG002|Overall Study|Withdrawal by Subject|0|||
124514688|NCT01586806|447834761|FG000|Overall Study|Lost to Follow-up|2|||
124514689|NCT01586806|447834762|FG001|Overall Study|Lost to Follow-up|3|||
124514690|NCT01586806|447834763|FG002|Overall Study|Lost to Follow-up|2|||
124514691|NCT01769469|447834765|FG000|Overall Study|Consent Withdrawn|5|||
124514692|NCT01769469|447834765|FG000|Overall Study|Moved Out Of Area|3|||
124514693|NCT01769469|447834765|FG000|Overall Study|Lost to Follow-up|17|||
124514694|NCT01769469|447834765|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
124514695|NCT01769469|447834765|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
124514696|NCT02031432|447834766|FG000|Overall Study|Protocol Violation|1|||
124514697|NCT02031432|447834766|FG000|Overall Study|Lack of Efficacy|5|||
124514698|NCT02031432|447834766|FG000|Overall Study|Cancer Progression|2|||
124514699|NCT02031432|447834766|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
124514700|NCT02031432|447834766|FG000|Overall Study|Adverse Event|8|||
124514701|NCT02031432|447834766|FG000|Overall Study|Withdrawal by Subject|5|||
124514702|NCT02031432|447834766|FG000|Overall Study|Lost to Follow-up|1|||
124514703|NCT02031432|447834766|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
124514704|NCT02031432|447834766|FG000|Overall Study|Death|10|||
124514705|NCT00888615|447834767|FG000|Overall Study|No treatment|2|||
124514706|NCT01617187|447834768|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
124514707|NCT01617187|447834769|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
124514708|NCT01617187|447834770|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
124514709|NCT01617187|447834771|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
124514710|NCT01617187|447834768|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
124514711|NCT01617187|447834769|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
124514712|NCT01617187|447834770|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
124514713|NCT01617187|447834771|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
124514714|NCT01617187|447834768|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
124514715|NCT01617187|447834769|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
124514716|NCT01617187|447834770|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
124514717|NCT01617187|447834771|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
124514718|NCT01617187|447834768|FG000|Treatment Through Study Completion|Adverse Event|1|||
124514719|NCT01617187|447834769|FG001|Treatment Through Study Completion|Adverse Event|1|||
124514720|NCT01617187|447834770|FG002|Treatment Through Study Completion|Adverse Event|0|||
124514721|NCT01617187|447834771|FG003|Treatment Through Study Completion|Adverse Event|1|||
124514722|NCT01617187|447834768|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
124514723|NCT01617187|447834769|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
124514724|NCT01617187|447834770|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
124569789|NCT02458469|448045525|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
124514725|NCT01617187|447834771|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
124514726|NCT01617187|447834768|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
124569790|NCT00661505|448045526|FG000|Overall Study|Adverse Event|3|||
124569791|NCT00661505|448045526|FG000|Overall Study|Protocol Violation|14|||
124569792|NCT00661505|448045526|FG000|Overall Study|Withdrawal by Subject|8|||
124569793|NCT00661505|448045526|FG000|Overall Study|Lost to Follow-up|3|||
124569794|NCT00661505|448045526|FG000|Overall Study|Other|2|||
124569795|NCT04534283|448045527|FG000|Overall Study|Physician Decision|2|||
124569796|NCT04534283|448045527|FG000|Overall Study|Withdrawal by Subject|1|||
124569797|NCT04534283|448045527|FG000|Overall Study|Disease Progression|12|||
124514727|NCT01617187|447834769|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
124514728|NCT01617187|447834770|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
124514729|NCT01617187|447834771|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
124514730|NCT01617187|447834768|FG000|Treatment Through Study Completion|Protocol Violation|1|||
124514731|NCT01617187|447834769|FG001|Treatment Through Study Completion|Protocol Violation|0|||
124514732|NCT01617187|447834770|FG002|Treatment Through Study Completion|Protocol Violation|0|||
124514733|NCT01617187|447834771|FG003|Treatment Through Study Completion|Protocol Violation|1|||
124514734|NCT02293902|447834775|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
124514735|NCT02293902|447834776|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
124514736|NCT02293902|447834777|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
124514737|NCT02293902|447834778|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
124514738|NCT02293902|447834779|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
124514739|NCT02293902|447834775|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
124514740|NCT02293902|447834776|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
124514741|NCT02293902|447834777|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
124514742|NCT02293902|447834778|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
124514743|NCT02293902|447834779|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
124514744|NCT02293902|447834775|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
124514745|NCT02293902|447834776|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
124514746|NCT02293902|447834777|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
124514747|NCT02293902|447834778|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
124514748|NCT02293902|447834779|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
124514749|NCT02293902|447834775|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
124514750|NCT02293902|447834776|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
124514751|NCT02293902|447834777|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
124514752|NCT02293902|447834778|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
124514753|NCT02293902|447834779|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
124514754|NCT02293902|447834775|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
124514755|NCT02293902|447834776|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
124514756|NCT02293902|447834777|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
124514757|NCT02293902|447834778|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
124514758|NCT02293902|447834779|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
124514759|NCT01770145|447836215|FG000|Baseline|Adverse Event|20|||
124514760|NCT01770145|447836215|FG000|Baseline|Withdrawal by Subject|1|||
124514761|NCT01770145|447836215|FG000|Baseline|Lost to Follow-up|1|||
124514762|NCT01770145|447836215|FG000|Baseline|Unable to define optimal dose|4|||
124514763|NCT01770145|447836215|FG000|Treatment|Adverse Event|3|||
124514764|NCT01770145|447836215|FG000|Treatment|Withdrawal by Subject|1|||
124514765|NCT00595868|447836216|FG000|Overall Study|Lost to Follow-up|45|||
124514766|NCT00595868|447836217|FG001|Overall Study|Lost to Follow-up|50|||
124514767|NCT04268303|447836219|FG000|Overall Study|Lost to Follow-up|1|||
124514768|NCT04268303|447836220|FG001|Overall Study|Lost to Follow-up|1|||
124514769|NCT04268303|447836221|FG002|Overall Study|Lost to Follow-up|2|||
124514770|NCT04268303|447836219|FG000|Overall Study|Withdrawal by Subject|0|||
124514771|NCT04268303|447836220|FG001|Overall Study|Withdrawal by Subject|1|||
124514772|NCT04268303|447836221|FG002|Overall Study|Withdrawal by Subject|1|||
124514773|NCT04268303|447836219|FG000|Overall Study|Adverse Event|2|||
124514774|NCT04268303|447836220|FG001|Overall Study|Adverse Event|0|||
124514775|NCT04268303|447836221|FG002|Overall Study|Adverse Event|0|||
124514776|NCT05742841|447836226|FG000|Overall Study|Withdrawal by Subject|1|||
124514777|NCT05742841|447836226|FG000|Overall Study|Lost to Follow-up|1|||
124514778|NCT01175590|447836232|FG000|Overall Study|Lost to Follow-up|1|||
124514779|NCT01175590|447836233|FG001|Overall Study|Lost to Follow-up|0|||
124514780|NCT01175590|447836232|FG000|Overall Study|Withdrawal by Subject|0|||
124514781|NCT01175590|447836233|FG001|Overall Study|Withdrawal by Subject|2|||
124514782|NCT01175590|447836232|FG000|Overall Study|Adverse Event|4|||
124514783|NCT01175590|447836233|FG001|Overall Study|Adverse Event|0|||
124514784|NCT01175590|447836232|FG000|Overall Study|Physician Decision|1|||
124514785|NCT01175590|447836233|FG001|Overall Study|Physician Decision|4|||
124514786|NCT01175590|447836232|FG000|Overall Study|Lack of Efficacy|1|||
124514787|NCT01175590|447836233|FG001|Overall Study|Lack of Efficacy|1|||
124569798|NCT04534283|448045527|FG000|Overall Study|Adverse Event|1|||
124724957|NCT04026009|448613387|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124514788|NCT01175590|447836232|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
124514789|NCT01175590|447836233|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
124514790|NCT01175590|447836232|FG000|Overall Study|Treated not as randomized|3|||
124514791|NCT01175590|447836233|FG001|Overall Study|Treated not as randomized|2|||
124514792|NCT01175590|447836232|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
124514793|NCT01175590|447836233|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
124514794|NCT01175590|447836232|FG000|Overall Study|Protocol Violation|0|||
124514795|NCT01175590|447836233|FG001|Overall Study|Protocol Violation|1|||
124514796|NCT04671342|447836239|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
124514797|NCT04671342|447836239|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
124514798|NCT04671342|447836239|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
124514799|NCT04671342|447836239|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
124514800|NCT04671342|447836239|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
124514801|NCT04671342|447836239|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
124514802|NCT03911869|447836240|FG000|Safety Lead-in Phase|Death|7|||
124514803|NCT03911869|447836241|FG001|Safety Lead-in Phase|Death|0|||
124514804|NCT03911869|447836242|FG002|Safety Lead-in Phase|Death|0|||
124514805|NCT03911869|447836240|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
124514806|NCT03911869|447836241|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
124514807|NCT03911869|447836242|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
124514808|NCT03911869|447836240|FG000|Safety Lead-in Phase|Other|1|||
124514809|NCT03911869|447836241|FG001|Safety Lead-in Phase|Other|0|||
124514810|NCT03911869|447836242|FG002|Safety Lead-in Phase|Other|0|||
124514811|NCT03911869|447836240|FG000|Phase 2|Death|0|||
124514812|NCT03911869|447836241|FG001|Phase 2|Death|3|||
124514813|NCT03911869|447836242|FG002|Phase 2|Death|0|||
124514814|NCT00688545|447836243|FG000|Overall Study|Lost to Follow-up|1|||
124514815|NCT00688545|447836244|FG001|Overall Study|Lost to Follow-up|4|||
124514816|NCT00688545|447836243|FG000|Overall Study|Insurance/cost of drug|0|||
124514817|NCT00688545|447836244|FG001|Overall Study|Insurance/cost of drug|1|||
124514818|NCT00688545|447836243|FG000|Overall Study|Withdrawal by Subject|2|||
124514819|NCT00688545|447836244|FG001|Overall Study|Withdrawal by Subject|3|||
124514820|NCT00688545|447836243|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
124514821|NCT00688545|447836244|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
124514822|NCT01878097|447836245|FG000|Baseline|Surveys not fully completed|2497|||
124514823|NCT01878097|447836246|FG001|Baseline|Surveys not fully completed|1800|||
124514824|NCT01878097|447836245|FG000|Implementation Year 1|Surveys not fully completed|3202|||
124514825|NCT01878097|447836246|FG001|Implementation Year 1|Surveys not fully completed|2549|||
124514826|NCT01878097|447836245|FG000|Implementation Year 2|Surveys not fully completed|3281|||
124514827|NCT01878097|447836246|FG001|Implementation Year 2|Surveys not fully completed|2841|||
124514828|NCT01878097|447836245|FG000|Implementation Year 3|Surveys not fully completed|3494|||
124514829|NCT01878097|447836246|FG001|Implementation Year 3|Surveys not fully completed|2980|||
124514830|NCT01878097|447836245|FG000|Implementation Year 4|Surveys not fully completed|3604|||
124514831|NCT01878097|447836246|FG001|Implementation Year 4|Surveys not fully completed|3007|||
124514832|NCT00367341|447836247|FG000|Overall Study|Physician Decision|1|||
124514833|NCT00367341|447836248|FG001|Overall Study|Physician Decision|0|||
124514834|NCT00367341|447836247|FG000|Overall Study|Protocol Violation|1|||
124514835|NCT00367341|447836248|FG001|Overall Study|Protocol Violation|0|||
124514836|NCT02533401|447836251|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
124514837|NCT02533401|447836251|FG000|Overall Study|Death|5|||
124514838|NCT02533401|447836251|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
124514839|NCT02533401|447836251|FG000|Overall Study|Lost to Follow-up|1|||
124514840|NCT02533401|447836251|FG000|Overall Study|Violation of Selection Criteria|1|||
124514841|NCT02786836|447836255|FG000|Overall Study|Death|1|||
124514842|NCT02786836|447836255|FG000|Overall Study|Lack of Efficacy|2|||
124514843|NCT02786836|447836255|FG000|Overall Study|Protocol Violation|3|||
124514844|NCT02786836|447836255|FG000|Overall Study|Withdrawal by Subject|3|||
124514845|NCT02786836|447836255|FG000|Overall Study|Liver Transplantation|2|||
124514846|NCT02786836|447836255|FG000|Overall Study|Device or Pharmacy Issues|3|||
124514847|NCT01143714|447836257|FG000|Overall Study|Adverse Event|4|||
124514848|NCT01143714|447836258|FG001|Overall Study|Adverse Event|2|||
124514849|NCT01143714|447836257|FG000|Overall Study|Withdrawal by Subject|1|||
124514850|NCT01143714|447836258|FG001|Overall Study|Withdrawal by Subject|0|||
124514851|NCT01143714|447836257|FG000|Overall Study|Subject non-compliance|0|||
124514852|NCT01143714|447836258|FG001|Overall Study|Subject non-compliance|1|||
124514853|NCT01143714|447836257|FG000|Overall Study|wound closed = deemed healed|1|||
124514854|NCT01143714|447836258|FG001|Overall Study|wound closed = deemed healed|0|||
124514855|NCT01143714|447836257|FG000|Overall Study|wound size increased|1|||
124514856|NCT01143714|447836258|FG001|Overall Study|wound size increased|0|||
124514857|NCT01387074|447836259|FG000|Overall Study|Lost to Follow-up|7|||
124514858|NCT01387074|447836259|FG000|Overall Study|Lack of Efficacy|1|||
124514859|NCT02137837|447836263|FG000|Overall Study|Adverse Event|0|||
124514860|NCT02137837|447836264|FG001|Overall Study|Adverse Event|2|||
124514861|NCT02137837|447836265|FG002|Overall Study|Adverse Event|1|||
124514862|NCT02137837|447836263|FG000|Overall Study|Refusal unrelated to adverse event|2|||
124514863|NCT02137837|447836264|FG001|Overall Study|Refusal unrelated to adverse event|2|||
124514864|NCT02137837|447836265|FG002|Overall Study|Refusal unrelated to adverse event|1|||
124514865|NCT02137837|447836263|FG000|Overall Study|Progression/relapse|9|||
124514866|NCT02137837|447836264|FG001|Overall Study|Progression/relapse|7|||
124514867|NCT02137837|447836265|FG002|Overall Study|Progression/relapse|7|||
124514868|NCT02137837|447836263|FG000|Overall Study|Not protocol specified|2|||
124514869|NCT02137837|447836264|FG001|Overall Study|Not protocol specified|1|||
124514870|NCT02137837|447836265|FG002|Overall Study|Not protocol specified|3|||
124514871|NCT00555568|447836267|FG000|Overall Study|Lost to Follow-up|26|||
124724958|NCT04026009|448613388|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
124724959|NCT04026009|448613389|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
124514872|NCT00555568|447836268|FG001|Overall Study|Lost to Follow-up|16|||
124514873|NCT00555568|447836269|FG002|Overall Study|Lost to Follow-up|16|||
124514874|NCT01135017|447836277|FG000|Overall Study|Adverse Event|3|||
124514875|NCT01135017|447836278|FG001|Overall Study|Adverse Event|8|||
124514876|NCT01135017|447836277|FG000|Overall Study|Other than above|3|||
124514877|NCT01135017|447836278|FG001|Overall Study|Other than above|4|||
124514878|NCT01170221|447836280|FG000|Overall Study|Lost to Follow-up|22|||
124514879|NCT01170221|447836281|FG001|Overall Study|Lost to Follow-up|21|||
124514880|NCT01170221|447836280|FG000|Overall Study|Withdrawal by Subject|9|||
124514881|NCT01170221|447836281|FG001|Overall Study|Withdrawal by Subject|7|||
124514882|NCT01170221|447836280|FG000|Overall Study|Subject completed only screening and LFU|1|||
124514883|NCT01170221|447836281|FG001|Overall Study|Subject completed only screening and LFU|0|||
124514884|NCT01170221|447836280|FG000|Overall Study|Randomized but not treated|1|||
124514885|NCT01170221|447836281|FG001|Overall Study|Randomized but not treated|0|||
124514886|NCT00432562|447836282|FG000|Overall Study|Death|3|||
124514887|NCT00432562|447836283|FG001|Overall Study|Death|0|||
124514888|NCT02693691|447836284|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
124514889|NCT02693691|447836284|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
124514890|NCT02693691|447836284|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
124514891|NCT02693691|447836284|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
124514892|NCT02693691|447836284|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
124514893|NCT02693691|447836284|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
124514894|NCT02693691|447836284|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
124514895|NCT04169061|447836285|FG000|Overall Study|Adverse Event|2|||
124514896|NCT04169061|447836285|FG000|Overall Study|Death|1|||
124514897|NCT04169061|447836285|FG000|Overall Study|Withdrawal by Subject|1|||
124514898|NCT04169061|447836285|FG000|Overall Study|Protocol Violation|1|||
124514899|NCT00844285|447836287|FG000|Overall Study|Other|0|||
124514900|NCT00844285|447836288|FG001|Overall Study|Other|1|||
124514901|NCT00844285|447836289|FG002|Overall Study|Other|0|||
124514902|NCT00844285|447836287|FG000|Overall Study|Other than specified|95|||
124514903|NCT00844285|447836288|FG001|Overall Study|Other than specified|129|||
124514904|NCT00844285|447836289|FG002|Overall Study|Other than specified|12|||
124514905|NCT00844285|447836287|FG000|Overall Study|Site closure|256|||
124514906|NCT00844285|447836288|FG001|Overall Study|Site closure|450|||
124514907|NCT00844285|447836289|FG002|Overall Study|Site closure|50|||
124514908|NCT00844285|447836287|FG000|Overall Study|Follow-up < 8 years|16|||
124514909|NCT00844285|447836288|FG001|Overall Study|Follow-up < 8 years|23|||
124514910|NCT00844285|447836289|FG002|Overall Study|Follow-up < 8 years|4|||
124514911|NCT00844285|447836287|FG000|Overall Study|Protocol Violation|26|||
124514912|NCT00844285|447836288|FG001|Overall Study|Protocol Violation|28|||
124514913|NCT00844285|447836289|FG002|Overall Study|Protocol Violation|54|||
124514914|NCT00844285|447836287|FG000|Overall Study|Death|22|||
124514915|NCT00844285|447836288|FG001|Overall Study|Death|21|||
124514916|NCT00844285|447836289|FG002|Overall Study|Death|8|||
124514917|NCT00844285|447836287|FG000|Overall Study|Withdrew Consent|344|||
124514918|NCT00844285|447836288|FG001|Overall Study|Withdrew Consent|466|||
124514919|NCT00844285|447836289|FG002|Overall Study|Withdrew Consent|70|||
124514920|NCT00844285|447836287|FG000|Overall Study|Lost to Follow-up|330|||
124514921|NCT00844285|447836288|FG001|Overall Study|Lost to Follow-up|486|||
124514922|NCT00844285|447836289|FG002|Overall Study|Lost to Follow-up|74|||
124514923|NCT00192036|447836292|FG000|Overall Study|Protocol Violation|3|||
124514924|NCT00192036|447836292|FG000|Overall Study|Adverse Event|6|||
124514925|NCT00192036|447836292|FG000|Overall Study|Patient/Physician Perception|1|||
124514926|NCT00192036|447836292|FG000|Overall Study|Objective Tumor Progression|4|||
124514927|NCT00192036|447836292|FG000|Overall Study|Clinical Disease Progression|1|||
124514928|NCT00192036|447836292|FG000|Overall Study|Death|1|||
124514929|NCT00192036|447836292|FG000|Overall Study|Unknown or Not Specified|5|||
124514930|NCT05425719|447836293|FG000|Overall Study|Lost to Follow-up|4|||
124514931|NCT05425719|447836294|FG001|Overall Study|Lost to Follow-up|0|||
124514932|NCT05425719|447836293|FG000|Overall Study|Withdrew consent|1|||
124514933|NCT05425719|447836294|FG001|Overall Study|Withdrew consent|1|||
124514934|NCT04682353|447836295|FG000|Overall Study|Lost to Follow-up|0|||
124514935|NCT04682353|447836296|FG001|Overall Study|Lost to Follow-up|1|||
124514936|NCT04682353|447836297|FG002|Overall Study|Lost to Follow-up|0|||
124514937|NCT04682353|447836298|FG003|Overall Study|Lost to Follow-up|1|||
124514938|NCT04682353|447836295|FG000|Overall Study|Personal reasons|0|||
124569799|NCT03561883|448045528|FG000|Overall Study|Adverse Event|10|||
124569800|NCT03561883|448045529|FG001|Overall Study|Adverse Event|13|||
124569801|NCT03561883|448045528|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124569802|NCT03561883|448045529|FG001|Overall Study|Non-Compliance With Study Drug|2|||
124569803|NCT03561883|448045528|FG000|Overall Study|Protocol Violation|2|||
124569804|NCT03561883|448045529|FG001|Overall Study|Protocol Violation|3|||
124569805|NCT03561883|448045528|FG000|Overall Study|Withdrawal by Subject|14|||
124569806|NCT03561883|448045529|FG001|Overall Study|Withdrawal by Subject|6|||
124569807|NCT03561883|448045528|FG000|Overall Study|Lost to Follow-up|2|||
124514939|NCT04682353|447836296|FG001|Overall Study|Personal reasons|1|||
124724960|NCT04026009|448613390|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
124514940|NCT04682353|447836297|FG002|Overall Study|Personal reasons|0|||
124514941|NCT04682353|447836298|FG003|Overall Study|Personal reasons|0|||
124514942|NCT02394795|447836304|FG000|Overall Study|Adverse Event|92|||
124514943|NCT02394795|447836305|FG001|Overall Study|Adverse Event|70|||
124514944|NCT02394795|447836304|FG000|Overall Study|Lost to Follow-up|0|||
124514945|NCT02394795|447836305|FG001|Overall Study|Lost to Follow-up|1|||
124514946|NCT02394795|447836304|FG000|Overall Study|Withdrawal by Subject|17|||
124514947|NCT02394795|447836305|FG001|Overall Study|Withdrawal by Subject|26|||
124514948|NCT02394795|447836304|FG000|Overall Study|Lack of Efficacy|181|||
124514949|NCT02394795|447836305|FG001|Overall Study|Lack of Efficacy|211|||
124514950|NCT02394795|447836304|FG000|Overall Study|Death|4|||
124514951|NCT02394795|447836305|FG001|Overall Study|Death|5|||
124514952|NCT02394795|447836304|FG000|Overall Study|Physician Decision|109|||
124514953|NCT02394795|447836305|FG001|Overall Study|Physician Decision|93|||
124514954|NCT01313208|447836310|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
124514955|NCT01313208|447836311|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
124514956|NCT01313208|447836310|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
124514957|NCT01313208|447836311|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
124514958|NCT01313208|447836310|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
124514959|NCT01313208|447836311|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
124514960|NCT01313208|447836310|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
124514961|NCT01313208|447836311|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
124514962|NCT01313208|447836310|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
124514963|NCT01313208|447836311|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
124514964|NCT01313208|447836310|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
124514965|NCT01313208|447836311|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
124514966|NCT01313208|447836310|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
124514967|NCT01313208|447836311|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
124514968|NCT01313208|447836310|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
124514969|NCT01313208|447836311|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
124514970|NCT01313208|447836310|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
124514971|NCT01313208|447836311|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
124514972|NCT04377672|447836315|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
124514973|NCT03954444|447836318|FG000|Overall Study|Withdrawal by Subject|5|||
124514974|NCT03954444|447836319|FG001|Overall Study|Withdrawal by Subject|5|||
124514975|NCT03954444|447836320|FG002|Overall Study|Withdrawal by Subject|5|||
124514976|NCT03954444|447836318|FG000|Overall Study|Adverse Event|1|||
124514977|NCT03954444|447836319|FG001|Overall Study|Adverse Event|3|||
124514978|NCT03954444|447836320|FG002|Overall Study|Adverse Event|2|||
124514979|NCT03954444|447836318|FG000|Overall Study|Protocol Violation|0|||
124514980|NCT03954444|447836319|FG001|Overall Study|Protocol Violation|3|||
124514981|NCT03954444|447836320|FG002|Overall Study|Protocol Violation|5|||
124514982|NCT03954444|447836318|FG000|Overall Study|Use of prohibited therapy|1|||
124514983|NCT03954444|447836319|FG001|Overall Study|Use of prohibited therapy|1|||
124514984|NCT03954444|447836320|FG002|Overall Study|Use of prohibited therapy|2|||
124514985|NCT03954444|447836318|FG000|Overall Study|Lost to Follow-up|1|||
124514986|NCT03954444|447836319|FG001|Overall Study|Lost to Follow-up|0|||
124514987|NCT03954444|447836320|FG002|Overall Study|Lost to Follow-up|1|||
124514988|NCT03954444|447836318|FG000|Overall Study|Non-compliant with study drug application|2|||
124514989|NCT03954444|447836319|FG001|Overall Study|Non-compliant with study drug application|2|||
124514990|NCT03954444|447836320|FG002|Overall Study|Non-compliant with study drug application|0|||
124514991|NCT03954444|447836318|FG000|Overall Study|Administrative reasons|0|||
124514992|NCT03954444|447836319|FG001|Overall Study|Administrative reasons|0|||
124514993|NCT03954444|447836320|FG002|Overall Study|Administrative reasons|1|||
124514994|NCT03954444|447836318|FG000|Overall Study|Miscellaneous|3|||
124514995|NCT03954444|447836319|FG001|Overall Study|Miscellaneous|2|||
124514996|NCT03954444|447836320|FG002|Overall Study|Miscellaneous|1|||
124514997|NCT03505749|447836322|FG000|Overall Study|Lost to Follow-up|7|||
124569808|NCT03561883|448045529|FG001|Overall Study|Lost to Follow-up|6|||
124514998|NCT03505749|447836323|FG001|Overall Study|Lost to Follow-up|11|||
124514999|NCT03505749|447836322|FG000|Overall Study|Withdrawal by Subject|6|||
124515000|NCT03505749|447836323|FG001|Overall Study|Withdrawal by Subject|0|||
124515001|NCT03505749|447836322|FG000|Overall Study|Discharged from treatment|3|||
124569809|NCT03561883|448045528|FG000|Overall Study|Study Terminated by Sponsor|12|||
124569810|NCT03561883|448045529|FG001|Overall Study|Study Terminated by Sponsor|11|||
124569811|NCT03561883|448045528|FG000|Overall Study|Physician Decision|1|||
124569812|NCT03561883|448045529|FG001|Overall Study|Physician Decision|0|||
124569813|NCT03561883|448045528|FG000|Overall Study|Randomized by Mistake|1|||
124569814|NCT03561883|448045529|FG001|Overall Study|Randomized by Mistake|0|||
124569815|NCT03561883|448045528|FG000|Overall Study|Other, Not Specified|3|||
124569816|NCT03561883|448045529|FG001|Overall Study|Other, Not Specified|2|||
124569817|NCT01318499|448045530|FG000|Overall Study|Adverse Event|16|||
124569818|NCT01318499|448045531|FG001|Overall Study|Adverse Event|11|||
124569819|NCT01318499|448045532|FG002|Overall Study|Adverse Event|6|||
124569820|NCT01318499|448045530|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
124569821|NCT01318499|448045531|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
124569822|NCT01318499|448045532|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
124569823|NCT01318499|448045530|FG000|Overall Study|Noncompliance|2|||
124569824|NCT01318499|448045531|FG001|Overall Study|Noncompliance|3|||
124569825|NCT01318499|448045532|FG002|Overall Study|Noncompliance|0|||
124569826|NCT01318499|448045530|FG000|Overall Study|Treatment Failure|19|||
124569827|NCT01318499|448045531|FG001|Overall Study|Treatment Failure|19|||
124569828|NCT01318499|448045532|FG002|Overall Study|Treatment Failure|101|||
124569829|NCT01318499|448045530|FG000|Overall Study|Protocol Violation|2|||
124569830|NCT01318499|448045531|FG001|Overall Study|Protocol Violation|4|||
124569831|NCT01318499|448045532|FG002|Overall Study|Protocol Violation|2|||
124569832|NCT01318499|448045530|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
124569833|NCT01318499|448045531|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
124569834|NCT01318499|448045532|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
124569835|NCT01318499|448045530|FG000|Overall Study|Other|7|||
124569836|NCT01318499|448045531|FG001|Overall Study|Other|10|||
124569837|NCT01318499|448045532|FG002|Overall Study|Other|22|||
124569838|NCT01974141|448045538|FG000|Overall Study|Other Reasons|28|||
124569839|NCT01974141|448045539|FG001|Overall Study|Other Reasons|18|||
124569840|NCT01974141|448045538|FG000|Overall Study|Protocol Violation|2|||
124569841|NCT01974141|448045539|FG001|Overall Study|Protocol Violation|6|||
124569842|NCT01974141|448045538|FG000|Overall Study|Personal Reasons|21|||
124569843|NCT01974141|448045539|FG001|Overall Study|Personal Reasons|20|||
124569844|NCT01974141|448045538|FG000|Overall Study|Lost to Follow-up|38|||
124569845|NCT01974141|448045539|FG001|Overall Study|Lost to Follow-up|29|||
124569846|NCT01974141|448045538|FG000|Overall Study|Pregnancy|3|||
124569847|NCT01974141|448045539|FG001|Overall Study|Pregnancy|3|||
124569848|NCT01974141|448045538|FG000|Overall Study|Lack of Efficacy|0|||
124569849|NCT01974141|448045539|FG001|Overall Study|Lack of Efficacy|1|||
124569850|NCT01974141|448045538|FG000|Overall Study|Adverse Event|4|||
124569851|NCT01974141|448045539|FG001|Overall Study|Adverse Event|5|||
124569852|NCT04977336|448045540|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
124569853|NCT04977336|448045541|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
124569854|NCT04977336|448045542|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
124569855|NCT04977336|448045543|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
124569856|NCT04977336|448045544|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
124569857|NCT04977336|448045540|FG000|Overall Study|Lost to Follow-up|0|||
124569858|NCT04977336|448045541|FG001|Overall Study|Lost to Follow-up|0|||
124569859|NCT04977336|448045542|FG002|Overall Study|Lost to Follow-up|1|||
124569860|NCT04977336|448045543|FG003|Overall Study|Lost to Follow-up|0|||
124569861|NCT04977336|448045544|FG004|Overall Study|Lost to Follow-up|0|||
124569862|NCT01347710|448045545|FG000|Overall Study|Withdrawal by Subject|2|||
124569863|NCT01347710|448045545|FG000|Overall Study|Adverse Event|4|||
124569864|NCT01347710|448045545|FG000|Overall Study|Angio or SPECT not completed|18|||
124569865|NCT01347710|448045545|FG000|Overall Study|issue with vitals prior to dosing|1|||
124569866|NCT01347710|448045545|FG000|Overall Study|Lost to Follow-up|1|||
124569867|NCT01347710|448045545|FG000|Overall Study|Physician Decision|2|||
124569868|NCT01347710|448045545|FG000|Overall Study|Other|3|||
124569869|NCT01004172|448045549|FG000|Overall Study|Progressive Disease in CNS Only|16|||
124569870|NCT01004172|448045549|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
124569871|NCT01004172|448045549|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
124569872|NCT01004172|448045549|FG000|Overall Study|Adverse Event|1|||
124569873|NCT01004172|448045549|FG000|Overall Study|Physician Decision|1|||
124569874|NCT01004172|448045549|FG000|Overall Study|Symptomatic Deterioration|2|||
124569875|NCT00950872|448045550|FG000|Overall Study|Withdrawal by Subject|1|||
124569876|NCT00950872|448045550|FG000|Overall Study|Did not have surgery|2|||
124569877|NCT00970281|448045553|FG000|Overall Study|Lack of Efficacy|1|||
124569878|NCT00970281|448045554|FG001|Overall Study|Lack of Efficacy|14|||
124569879|NCT00970281|448045553|FG000|Overall Study|Withdrawal by Subject|0|||
124569880|NCT00970281|448045554|FG001|Overall Study|Withdrawal by Subject|1|||
124569881|NCT00970281|448045553|FG000|Overall Study|Physician Decision|1|||
124569882|NCT00970281|448045554|FG001|Overall Study|Physician Decision|1|||
124569883|NCT00408902|448045555|FG000|Overall Study|Lack of Efficacy|7|||
124569884|NCT00408902|448045555|FG000|Overall Study|Adverse Event|3|||
124569885|NCT01139164|448045557|FG000|Overall Study|Withdrawn prior to study start|0|||
124569886|NCT01139164|448045558|FG001|Overall Study|Withdrawn prior to study start|2|||
124569887|NCT01139164|448045559|FG002|Overall Study|Withdrawn prior to study start|0|||
124569888|NCT02003183|448045560|FG000|Overall Study|Lost to Follow-up|0|||
124569889|NCT02003183|448045561|FG001|Overall Study|Lost to Follow-up|2|||
124569890|NCT00878995|448045562|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
124569891|NCT00878995|448045563|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
124569892|NCT01759290|448045566|FG000|Overall Study|Subjects withdrawn consent|5|||
124569893|NCT01759290|448045566|FG000|Overall Study|Physician Decision|2|||
124569894|NCT01759290|448045566|FG000|Overall Study|Death|17|||
124569895|NCT01759290|448045566|FG000|Overall Study|Lost to Follow-up|53|||
124569896|NCT01759290|448045566|FG000|Overall Study|Unknown reason|4|||
124569897|NCT03338972|448045569|FG000|Overall Study|Death|1|||
124569898|NCT03338972|448045570|FG001|Overall Study|Death|1|||
124569899|NCT03338972|448045571|FG002|Overall Study|Death|0|||
124569900|NCT03338972|448045572|FG003|Overall Study|Death|0|||
124569901|NCT03338972|448045569|FG000|Overall Study|Withdrawal by Subject|1|||
124569902|NCT03338972|448045570|FG001|Overall Study|Withdrawal by Subject|0|||
124569903|NCT03338972|448045571|FG002|Overall Study|Withdrawal by Subject|0|||
124569904|NCT03338972|448045572|FG003|Overall Study|Withdrawal by Subject|0|||
124569905|NCT02480764|448045573|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
124569906|NCT02480764|448045574|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
124569907|NCT02480764|448045575|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
124569908|NCT02480764|448045573|FG000|Overall Study|Major Protocol Deviation|1|||
124569909|NCT02480764|448045574|FG001|Overall Study|Major Protocol Deviation|4|||
124569910|NCT02480764|448045575|FG002|Overall Study|Major Protocol Deviation|3|||
124569911|NCT02480764|448045573|FG000|Overall Study|Lost to Follow-up|0|||
124569912|NCT02480764|448045574|FG001|Overall Study|Lost to Follow-up|1|||
124569913|NCT02480764|448045575|FG002|Overall Study|Lost to Follow-up|2|||
124569914|NCT02480764|448045573|FG000|Overall Study|Voluntary Withdrawal|6|||
124569915|NCT02480764|448045574|FG001|Overall Study|Voluntary Withdrawal|5|||
124569916|NCT02480764|448045575|FG002|Overall Study|Voluntary Withdrawal|10|||
124569917|NCT02480764|448045573|FG000|Overall Study|Lack of Efficacy|0|||
124569918|NCT02480764|448045574|FG001|Overall Study|Lack of Efficacy|3|||
124569919|NCT02480764|448045575|FG002|Overall Study|Lack of Efficacy|3|||
124569920|NCT02480764|448045573|FG000|Overall Study|Reason not Specified|0|||
124569921|NCT02480764|448045574|FG001|Overall Study|Reason not Specified|1|||
124569922|NCT02480764|448045575|FG002|Overall Study|Reason not Specified|0|||
124569923|NCT03629249|448045576|FG000|Overall Study|Study terminated by sponsor|197|||
124569924|NCT03629249|448045577|FG001|Overall Study|Study terminated by sponsor|197|||
124569925|NCT03629249|448045578|FG002|Overall Study|Study terminated by sponsor|194|||
124569926|NCT03629249|448045576|FG000|Overall Study|Protocol deviation|0|||
124569927|NCT03629249|448045577|FG001|Overall Study|Protocol deviation|2|||
124569928|NCT03629249|448045578|FG002|Overall Study|Protocol deviation|5|||
124569929|NCT03629249|448045576|FG000|Overall Study|Subject decision|1|||
124569930|NCT03629249|448045577|FG001|Overall Study|Subject decision|1|||
124569931|NCT03629249|448045578|FG002|Overall Study|Subject decision|3|||
124569932|NCT03629249|448045576|FG000|Overall Study|Adverse Event|1|||
124569933|NCT03629249|448045577|FG001|Overall Study|Adverse Event|1|||
124569934|NCT03629249|448045578|FG002|Overall Study|Adverse Event|0|||
124569935|NCT03629249|448045576|FG000|Overall Study|Death|1|||
124569936|NCT03629249|448045577|FG001|Overall Study|Death|0|||
124569937|NCT03629249|448045578|FG002|Overall Study|Death|0|||
124569938|NCT03629249|448045576|FG000|Overall Study|Physician Decision|1|||
124569939|NCT03629249|448045577|FG001|Overall Study|Physician Decision|0|||
124569940|NCT03629249|448045578|FG002|Overall Study|Physician Decision|0|||
124569941|NCT01475474|448045581|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
124569942|NCT01475474|448045581|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
124569943|NCT01030965|448045582|FG000|Overall Study|Lack of Efficacy|3|||
124569944|NCT01030965|448045583|FG001|Overall Study|Lack of Efficacy|2|||
124569945|NCT01030965|448045584|FG002|Overall Study|Lack of Efficacy|0|||
124569946|NCT01030965|448045585|FG003|Overall Study|Lack of Efficacy|3|||
124569947|NCT01030965|448045582|FG000|Overall Study|Protocol Violation|1|||
124569948|NCT01030965|448045583|FG001|Overall Study|Protocol Violation|1|||
124569949|NCT01030965|448045584|FG002|Overall Study|Protocol Violation|1|||
124569950|NCT01030965|448045585|FG003|Overall Study|Protocol Violation|1|||
124569951|NCT01030965|448045582|FG000|Overall Study|Adverse Event|0|||
124569952|NCT01030965|448045583|FG001|Overall Study|Adverse Event|1|||
124569953|NCT01030965|448045584|FG002|Overall Study|Adverse Event|2|||
124569954|NCT01030965|448045585|FG003|Overall Study|Adverse Event|1|||
124569955|NCT01030965|448045582|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
124569956|NCT01030965|448045583|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
124569957|NCT01030965|448045584|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
124569958|NCT01030965|448045585|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
124569959|NCT01030965|448045582|FG000|Overall Study|Withdrawal by Subject|0|||
124569960|NCT01030965|448045583|FG001|Overall Study|Withdrawal by Subject|1|||
124569961|NCT01030965|448045584|FG002|Overall Study|Withdrawal by Subject|0|||
124569962|NCT01030965|448045585|FG003|Overall Study|Withdrawal by Subject|2|||
124569963|NCT02097290|448045588|FG000|Overall Study|Death|6|||
124569964|NCT02097290|448045588|FG000|Overall Study|Total Withdrawals|3|||
124569965|NCT02097290|448045588|FG000|Overall Study|Attempt|8|||
124569966|NCT05277389|448045589|FG000|Overall Study|Lost to Follow-up|1|||
124569967|NCT05277389|448045590|FG001|Overall Study|Lost to Follow-up|4|||
124569968|NCT06096168|448045591|FG000|Overall Study|Death|30|||
124569969|NCT06096168|448045591|FG000|Overall Study|Revision|2|||
124569970|NCT01868009|448045592|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
124569971|NCT01868009|448045593|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
124569972|NCT01868009|448045592|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
124569973|NCT01868009|448045593|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
124569974|NCT01868009|448045592|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
124569975|NCT01868009|448045593|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
124569976|NCT00743197|448045594|FG000|Overall Study|Study terminated due to departure of PI.|1|||
124569977|NCT00743197|448045595|FG001|Overall Study|Study terminated due to departure of PI.|2|||
124569978|NCT01478620|448045596|FG000|Overall Study|Lost to Follow-up|6|||
124569979|NCT02130466|448045601|FG000|Overall Study|Death|4|||
124569980|NCT02130466|448045602|FG001|Overall Study|Death|1|||
124569981|NCT02130466|448045603|FG002|Overall Study|Death|1|||
124569982|NCT02130466|448045604|FG003|Overall Study|Death|3|||
124569983|NCT02130466|448045605|FG004|Overall Study|Death|2|||
124569984|NCT02130466|448045606|FG005|Overall Study|Death|30|||
124569985|NCT02130466|448045607|FG006|Overall Study|Death|45|||
124569986|NCT02130466|448045608|FG007|Overall Study|Death|2|||
124569987|NCT02130466|448045609|FG008|Overall Study|Death|3|||
124569988|NCT02130466|448045610|FG009|Overall Study|Death|4|||
124569989|NCT02130466|448045611|FG010|Overall Study|Death|5|||
124569990|NCT02130466|448045612|FG011|Overall Study|Death|3|||
124569991|NCT02130466|448045613|FG012|Overall Study|Death|11|||
124569992|NCT02130466|448045614|FG013|Overall Study|Death|7|||
124569993|NCT02130466|448045601|FG000|Overall Study|Lost to Follow-up|1|||
124569994|NCT02130466|448045602|FG001|Overall Study|Lost to Follow-up|0|||
124569995|NCT02130466|448045603|FG002|Overall Study|Lost to Follow-up|0|||
124569996|NCT02130466|448045604|FG003|Overall Study|Lost to Follow-up|0|||
124569997|NCT02130466|448045605|FG004|Overall Study|Lost to Follow-up|0|||
124569998|NCT02130466|448045606|FG005|Overall Study|Lost to Follow-up|1|||
124569999|NCT02130466|448045607|FG006|Overall Study|Lost to Follow-up|0|||
124570000|NCT02130466|448045608|FG007|Overall Study|Lost to Follow-up|0|||
124570001|NCT02130466|448045609|FG008|Overall Study|Lost to Follow-up|0|||
124570002|NCT02130466|448045610|FG009|Overall Study|Lost to Follow-up|0|||
124570003|NCT02130466|448045611|FG010|Overall Study|Lost to Follow-up|0|||
124570004|NCT02130466|448045612|FG011|Overall Study|Lost to Follow-up|0|||
124570005|NCT02130466|448045613|FG012|Overall Study|Lost to Follow-up|1|||
124570006|NCT02130466|448045614|FG013|Overall Study|Lost to Follow-up|0|||
124570007|NCT02130466|448045601|FG000|Overall Study|Physician Decision|0|||
124570008|NCT02130466|448045602|FG001|Overall Study|Physician Decision|0|||
124570009|NCT02130466|448045603|FG002|Overall Study|Physician Decision|0|||
124570010|NCT02130466|448045604|FG003|Overall Study|Physician Decision|0|||
124570011|NCT02130466|448045605|FG004|Overall Study|Physician Decision|0|||
124570012|NCT02130466|448045606|FG005|Overall Study|Physician Decision|1|||
124570013|NCT02130466|448045607|FG006|Overall Study|Physician Decision|1|||
124570014|NCT02130466|448045608|FG007|Overall Study|Physician Decision|0|||
124570015|NCT02130466|448045609|FG008|Overall Study|Physician Decision|0|||
124570016|NCT02130466|448045610|FG009|Overall Study|Physician Decision|0|||
124570017|NCT02130466|448045611|FG010|Overall Study|Physician Decision|0|||
124570018|NCT02130466|448045612|FG011|Overall Study|Physician Decision|0|||
124570019|NCT02130466|448045613|FG012|Overall Study|Physician Decision|0|||
124570020|NCT02130466|448045614|FG013|Overall Study|Physician Decision|0|||
124570021|NCT02130466|448045601|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
124570022|NCT02130466|448045602|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
124570023|NCT02130466|448045603|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
124570024|NCT02130466|448045604|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
124570025|NCT02130466|448045605|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
124570026|NCT02130466|448045606|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
124570027|NCT02130466|448045607|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
124570028|NCT02130466|448045608|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
124570029|NCT02130466|448045609|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
124570030|NCT02130466|448045610|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
124570031|NCT02130466|448045611|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
124570032|NCT02130466|448045612|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
124570033|NCT02130466|448045613|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
124570034|NCT02130466|448045614|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
124570035|NCT02130466|448045601|FG000|Overall Study|Withdrawal by Subject|1|||
124570036|NCT02130466|448045602|FG001|Overall Study|Withdrawal by Subject|0|||
124570037|NCT02130466|448045603|FG002|Overall Study|Withdrawal by Subject|0|||
124570038|NCT02130466|448045604|FG003|Overall Study|Withdrawal by Subject|0|||
124570039|NCT02130466|448045605|FG004|Overall Study|Withdrawal by Subject|0|||
124570040|NCT02130466|448045606|FG005|Overall Study|Withdrawal by Subject|1|||
124515002|NCT03505749|447836323|FG001|Overall Study|Discharged from treatment|6|||
124515003|NCT03846219|447836324|FG000|Overall Study|Withdrawal by Subject|3|||
124515004|NCT03846219|447836325|FG001|Overall Study|Withdrawal by Subject|2|||
124515005|NCT03846219|447836326|FG002|Overall Study|Withdrawal by Subject|2|||
124515006|NCT03846219|447836324|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
124515007|NCT03846219|447836325|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
124515008|NCT03846219|447836326|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
124515009|NCT03846219|447836324|FG000|Overall Study|Physician Decision|0|||
124515010|NCT03846219|447836325|FG001|Overall Study|Physician Decision|0|||
124515011|NCT03846219|447836326|FG002|Overall Study|Physician Decision|2|||
124515012|NCT01688635|447836327|FG000|Washout 1|Withdrawal by Subject|1|||
124515013|NCT01688635|447836328|FG001|Washout 1|Withdrawal by Subject|0|||
124515014|NCT01688635|447836327|FG000|Washout 1|Adverse Event|0|||
124515015|NCT01688635|447836328|FG001|Washout 1|Adverse Event|1|||
124515016|NCT01688635|447836327|FG000|Washout 1|Physician Decision|0|||
124515017|NCT01688635|447836328|FG001|Washout 1|Physician Decision|1|||
124515018|NCT01688635|447836327|FG000|Washout 2|Physician Decision|1|||
124515019|NCT01688635|447836328|FG001|Washout 2|Physician Decision|0|||
124515020|NCT01688635|447836327|FG000|Washout 2|Withdrawal by Subject|1|||
124515021|NCT01688635|447836328|FG001|Washout 2|Withdrawal by Subject|0|||
124515022|NCT01688635|447836327|FG000|Washout 2|Sponsor Decision|1|||
124515023|NCT01688635|447836328|FG001|Washout 2|Sponsor Decision|2|||
124515024|NCT01688635|447836327|FG000|Washout 3|Withdrawal by Subject|1|||
124515025|NCT01688635|447836328|FG001|Washout 3|Withdrawal by Subject|0|||
124515026|NCT03862131|447836330|FG000|Overall Study|Lost to Follow-up|1|||
124515027|NCT03862131|447836331|FG001|Overall Study|Lost to Follow-up|0|||
124515028|NCT03862131|447836332|FG002|Overall Study|Lost to Follow-up|1|||
124515029|NCT03862131|447836330|FG000|Overall Study|Determined to be ineligible|0|||
124515030|NCT03862131|447836331|FG001|Overall Study|Determined to be ineligible|0|||
124515031|NCT03862131|447836332|FG002|Overall Study|Determined to be ineligible|5|||
124515032|NCT03862131|447836330|FG000|Overall Study|Death|4|||
124515033|NCT03862131|447836331|FG001|Overall Study|Death|4|||
124515034|NCT03862131|447836332|FG002|Overall Study|Death|0|||
124515035|NCT03862131|447836330|FG000|Overall Study|Withdrawal by Subject|5|||
124515036|NCT03862131|447836331|FG001|Overall Study|Withdrawal by Subject|3|||
124515037|NCT03862131|447836332|FG002|Overall Study|Withdrawal by Subject|0|||
124515038|NCT03862131|447836330|FG000|Overall Study|Physician Decision|0|||
124515039|NCT03862131|447836331|FG001|Overall Study|Physician Decision|1|||
124515040|NCT03862131|447836332|FG002|Overall Study|Physician Decision|0|||
124515041|NCT02947022|447836333|FG000|Overall Study|Study Stopped|1|||
124515042|NCT04021706|447838155|FG000|Overall Study|Adverse Event|2|||
124515043|NCT04021706|447838156|FG001|Overall Study|Adverse Event|0|||
124515044|NCT04021706|447838155|FG000|Overall Study|Withdrawal by Subject|1|||
124515045|NCT04021706|447838156|FG001|Overall Study|Withdrawal by Subject|2|||
124515046|NCT04021706|447838155|FG000|Overall Study|Physician Decision|1|||
124515047|NCT04021706|447838156|FG001|Overall Study|Physician Decision|0|||
124515048|NCT00355134|447838159|FG000|Core Phase|Withdrawal by Subject|35|||
124515049|NCT00355134|447838160|FG001|Core Phase|Withdrawal by Subject|24|||
124515050|NCT00355134|447838161|FG002|Core Phase|Withdrawal by Subject|35|||
124515051|NCT00355134|447838162|FG003|Core Phase|Withdrawal by Subject|0|||
124515052|NCT00355134|447838163|FG004|Core Phase|Withdrawal by Subject|0|||
124515053|NCT00355134|447838159|FG000|Core Phase|Adverse Event|28|||
124515054|NCT00355134|447838160|FG001|Core Phase|Adverse Event|22|||
124515055|NCT00355134|447838161|FG002|Core Phase|Adverse Event|16|||
124515056|NCT00355134|447838162|FG003|Core Phase|Adverse Event|0|||
124515057|NCT00355134|447838163|FG004|Core Phase|Adverse Event|0|||
124515058|NCT00355134|447838159|FG000|Core Phase|Lost to Follow-up|17|||
124515059|NCT00355134|447838160|FG001|Core Phase|Lost to Follow-up|13|||
124515060|NCT00355134|447838161|FG002|Core Phase|Lost to Follow-up|21|||
124515061|NCT00355134|447838162|FG003|Core Phase|Lost to Follow-up|0|||
124515062|NCT00355134|447838163|FG004|Core Phase|Lost to Follow-up|0|||
124515063|NCT00355134|447838159|FG000|Core Phase|Abnormal laboratory value(s)|19|||
124515064|NCT00355134|447838160|FG001|Core Phase|Abnormal laboratory value(s)|14|||
124515065|NCT00355134|447838161|FG002|Core Phase|Abnormal laboratory value(s)|2|||
124515066|NCT00355134|447838162|FG003|Core Phase|Abnormal laboratory value(s)|0|||
124515067|NCT00355134|447838163|FG004|Core Phase|Abnormal laboratory value(s)|0|||
124515068|NCT00355134|447838159|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
124515069|NCT00355134|447838160|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
124515070|NCT00355134|447838161|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
124515071|NCT00355134|447838162|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
124515072|NCT00355134|447838163|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
124515073|NCT00355134|447838159|FG000|Core Phase|Administrative problems|5|||
124515074|NCT00355134|447838160|FG001|Core Phase|Administrative problems|3|||
124515075|NCT00355134|447838161|FG002|Core Phase|Administrative problems|5|||
124515076|NCT00355134|447838162|FG003|Core Phase|Administrative problems|0|||
124515077|NCT00355134|447838163|FG004|Core Phase|Administrative problems|0|||
124515078|NCT00355134|447838159|FG000|Core Phase|Protocol Violation|3|||
124515079|NCT00355134|447838160|FG001|Core Phase|Protocol Violation|2|||
124570041|NCT02130466|448045607|FG006|Overall Study|Withdrawal by Subject|0|||
124570042|NCT02130466|448045608|FG007|Overall Study|Withdrawal by Subject|0|||
124570043|NCT02130466|448045609|FG008|Overall Study|Withdrawal by Subject|1|||
124570044|NCT02130466|448045610|FG009|Overall Study|Withdrawal by Subject|0|||
124570045|NCT02130466|448045611|FG010|Overall Study|Withdrawal by Subject|0|||
124570046|NCT02130466|448045612|FG011|Overall Study|Withdrawal by Subject|0|||
124570047|NCT02130466|448045613|FG012|Overall Study|Withdrawal by Subject|0|||
124570048|NCT02130466|448045614|FG013|Overall Study|Withdrawal by Subject|0|||
124570049|NCT04529109|448045615|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
124570050|NCT04529109|448045616|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
124570051|NCT01411332|448045617|FG000|Enrollment|Protocol Violation|0|||
124570052|NCT01411332|448045618|FG001|Enrollment|Protocol Violation|1|||
124570053|NCT01411332|448045617|FG000|Enrollment|Withdrawal by Subject|0|||
124570054|NCT01411332|448045618|FG001|Enrollment|Withdrawal by Subject|1|||
124570055|NCT01411332|448045617|FG000|Treatment|Lost to Follow-up|1|||
124570056|NCT01411332|448045618|FG001|Treatment|Lost to Follow-up|0|||
124570057|NCT01471522|448045620|FG000|Overall Study|Withdrawal by Subject|28|||
124570058|NCT01471522|448045621|FG001|Overall Study|Withdrawal by Subject|22|||
124570059|NCT01471522|448045620|FG000|Overall Study|Lost to Follow-up|36|||
124570060|NCT01471522|448045621|FG001|Overall Study|Lost to Follow-up|26|||
124570061|NCT00444145|448047134|FG000|Overall Study|Withdrawal by Subject|2|||
124570062|NCT00444145|448047134|FG000|Overall Study|Lost to Follow-up|1|||
124570063|NCT00444145|448047134|FG000|Overall Study|non-compliant|11|||
124570064|NCT00444145|448047134|FG000|Overall Study|Screen Failures|5|||
124570065|NCT01374919|448047135|FG000|Overall Study|Withdrawal by Subject|2|||
124570066|NCT00090857|448047136|FG000|Overall Study|Lost to Follow-up|0|||
124570067|NCT00090857|448047137|FG001|Overall Study|Lost to Follow-up|1|||
124570068|NCT00090857|448047136|FG000|Overall Study|Withdrawal by Subject|2|||
124570069|NCT00090857|448047137|FG001|Overall Study|Withdrawal by Subject|0|||
124570070|NCT00090857|448047136|FG000|Overall Study|Adverse Event|2|||
124570071|NCT00090857|448047137|FG001|Overall Study|Adverse Event|2|||
124570072|NCT05097326|448047138|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
124570073|NCT05097326|448047139|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
124570074|NCT02684344|448047140|FG000|Overall Study|Withdrawal by Subject|0|||
124570075|NCT02684344|448047141|FG001|Overall Study|Withdrawal by Subject|1|||
124570076|NCT03480425|448047142|FG000|Overall Study|Force transducer technical failure|1|||
124570077|NCT02424188|448047143|FG000|Overall Study|Death|2|||
124570078|NCT02424188|448047144|FG001|Overall Study|Death|2|||
124570079|NCT02424188|448047143|FG000|Overall Study|Lost to Follow-up|1|||
124570080|NCT02424188|448047144|FG001|Overall Study|Lost to Follow-up|3|||
124570081|NCT02424188|448047143|FG000|Overall Study|Incarceration|1|||
124570082|NCT02424188|448047144|FG001|Overall Study|Incarceration|0|||
124570083|NCT00630305|448047145|FG000|Overall Study|Withdrawal by Subject|1|||
124570084|NCT00630305|448047145|FG000|Overall Study|Inability to insert contact lens|1|||
124570085|NCT01494506|448047152|FG000|Overall Study|Lack of Efficacy|77|||
124570086|NCT01494506|448047153|FG001|Overall Study|Lack of Efficacy|83|||
124570087|NCT01494506|448047154|FG002|Overall Study|Lack of Efficacy|57|||
124570088|NCT01494506|448047152|FG000|Overall Study|Adverse Event|17|||
124570089|NCT01494506|448047153|FG001|Overall Study|Adverse Event|10|||
124570090|NCT01494506|448047154|FG002|Overall Study|Adverse Event|11|||
124570091|NCT01494506|448047152|FG000|Overall Study|Death|9|||
124570092|NCT01494506|448047153|FG001|Overall Study|Death|5|||
124570093|NCT01494506|448047154|FG002|Overall Study|Death|2|||
124570094|NCT01494506|448047152|FG000|Overall Study|Physician Decision|7|||
124570095|NCT01494506|448047153|FG001|Overall Study|Physician Decision|5|||
124570096|NCT01494506|448047154|FG002|Overall Study|Physician Decision|4|||
124570097|NCT01494506|448047152|FG000|Overall Study|Withdrawal by Subject|17|||
124570098|NCT01494506|448047153|FG001|Overall Study|Withdrawal by Subject|20|||
124570099|NCT01494506|448047154|FG002|Overall Study|Withdrawal by Subject|14|||
124570100|NCT01494506|448047152|FG000|Overall Study|Clinical Deterioration|21|||
124570101|NCT01494506|448047153|FG001|Overall Study|Clinical Deterioration|17|||
124570102|NCT01494506|448047154|FG002|Overall Study|Clinical Deterioration|13|||
124570103|NCT01494506|448047152|FG000|Overall Study|Sponsor Decision|0|||
124570104|NCT01494506|448047153|FG001|Overall Study|Sponsor Decision|0|||
124570105|NCT01494506|448047154|FG002|Overall Study|Sponsor Decision|1|||
124570106|NCT01494506|448047152|FG000|Overall Study|Other|0|||
124570107|NCT01494506|448047153|FG001|Overall Study|Other|3|||
124570108|NCT01494506|448047154|FG002|Overall Study|Other|1|||
124570109|NCT03100903|448047160|FG000|Overall Study|Withdrawal by Subject|0|||
124570110|NCT03100903|448047161|FG001|Overall Study|Withdrawal by Subject|0|||
124570111|NCT03100903|448047162|FG002|Overall Study|Withdrawal by Subject|1|||
124570112|NCT00433147|448047163|FG000|Overall Study|Adverse Event|0|||
124570113|NCT00433147|448047164|FG001|Overall Study|Adverse Event|1|||
124570114|NCT00433147|448047165|FG002|Overall Study|Adverse Event|0|||
124570115|NCT00433147|448047166|FG003|Overall Study|Adverse Event|0|||
124570116|NCT01882647|448047167|FG000|Overall Study|Lost to Follow-up|2|||
124570117|NCT01882647|448047168|FG001|Overall Study|Lost to Follow-up|2|||
124570118|NCT01882647|448047167|FG000|Overall Study|Withdrawal by Subject|0|||
124724961|NCT04026009|448613386|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
124724962|NCT04026009|448613387|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
124515080|NCT00355134|447838161|FG002|Core Phase|Protocol Violation|2|||
124515081|NCT00355134|447838162|FG003|Core Phase|Protocol Violation|0|||
124515082|NCT00355134|447838163|FG004|Core Phase|Protocol Violation|0|||
124515083|NCT00355134|447838159|FG000|Core Phase|Abnormal test procedure result(s)|1|||
124515084|NCT00355134|447838160|FG001|Core Phase|Abnormal test procedure result(s)|2|||
124515085|NCT00355134|447838161|FG002|Core Phase|Abnormal test procedure result(s)|1|||
124515086|NCT00355134|447838162|FG003|Core Phase|Abnormal test procedure result(s)|0|||
124515087|NCT00355134|447838163|FG004|Core Phase|Abnormal test procedure result(s)|0|||
124515088|NCT00355134|447838159|FG000|Core Phase|Condition no longer requires study drug|1|||
124515089|NCT00355134|447838160|FG001|Core Phase|Condition no longer requires study drug|0|||
124515090|NCT00355134|447838161|FG002|Core Phase|Condition no longer requires study drug|1|||
124515091|NCT00355134|447838162|FG003|Core Phase|Condition no longer requires study drug|0|||
124515092|NCT00355134|447838163|FG004|Core Phase|Condition no longer requires study drug|0|||
124515093|NCT00355134|447838159|FG000|Extension Phase|Withdrawal by Subject|7|||
124515094|NCT00355134|447838160|FG001|Extension Phase|Withdrawal by Subject|11|||
124515095|NCT00355134|447838161|FG002|Extension Phase|Withdrawal by Subject|0|||
124515096|NCT00355134|447838162|FG003|Extension Phase|Withdrawal by Subject|7|||
124515097|NCT00355134|447838163|FG004|Extension Phase|Withdrawal by Subject|5|||
124515098|NCT00355134|447838159|FG000|Extension Phase|Adverse Event|13|||
124515099|NCT00355134|447838160|FG001|Extension Phase|Adverse Event|9|||
124515100|NCT00355134|447838161|FG002|Extension Phase|Adverse Event|0|||
124515101|NCT00355134|447838162|FG003|Extension Phase|Adverse Event|3|||
124515102|NCT00355134|447838163|FG004|Extension Phase|Adverse Event|5|||
124515103|NCT00355134|447838159|FG000|Extension Phase|Lost to Follow-up|2|||
124515104|NCT00355134|447838160|FG001|Extension Phase|Lost to Follow-up|6|||
124515105|NCT00355134|447838161|FG002|Extension Phase|Lost to Follow-up|0|||
124515106|NCT00355134|447838162|FG003|Extension Phase|Lost to Follow-up|2|||
124515107|NCT00355134|447838163|FG004|Extension Phase|Lost to Follow-up|4|||
124515108|NCT00355134|447838159|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
124515109|NCT00355134|447838160|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
124515110|NCT00355134|447838161|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
124515111|NCT00355134|447838162|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
124515112|NCT00355134|447838163|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
124515113|NCT00355134|447838159|FG000|Extension Phase|Administrative problems|2|||
124515114|NCT00355134|447838160|FG001|Extension Phase|Administrative problems|4|||
124515115|NCT00355134|447838161|FG002|Extension Phase|Administrative problems|0|||
124515116|NCT00355134|447838162|FG003|Extension Phase|Administrative problems|1|||
124515117|NCT00355134|447838163|FG004|Extension Phase|Administrative problems|1|||
124515118|NCT00355134|447838159|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
124515119|NCT00355134|447838160|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
124515120|NCT00355134|447838161|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
124515121|NCT00355134|447838162|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
124515122|NCT00355134|447838163|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
124515123|NCT00355134|447838159|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
124515124|NCT00355134|447838160|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
124515125|NCT00355134|447838161|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
124515126|NCT00355134|447838162|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
124515127|NCT00355134|447838163|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
124515128|NCT00355134|447838159|FG000|Extension Phase|Protocol Violation|0|||
124515129|NCT00355134|447838160|FG001|Extension Phase|Protocol Violation|0|||
124515130|NCT00355134|447838161|FG002|Extension Phase|Protocol Violation|0|||
124515131|NCT00355134|447838162|FG003|Extension Phase|Protocol Violation|1|||
124515132|NCT00355134|447838163|FG004|Extension Phase|Protocol Violation|0|||
124515133|NCT01412151|447838164|FG000|Week 0 - 306 - Treatment Period|Death|1|||
124515134|NCT01412151|447838164|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
124515135|NCT01412151|447838164|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
124515136|NCT01412151|447838164|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
124515137|NCT03127852|447838166|FG000|Overall Study|Withdrawal by Subject|4|||
124515138|NCT03127852|447838167|FG001|Overall Study|Withdrawal by Subject|1|||
124515139|NCT03127852|447838166|FG000|Overall Study|Death|1|||
124515140|NCT03127852|447838167|FG001|Overall Study|Death|1|||
124515141|NCT00859573|447838169|FG000|Overall Study|Withdrawal by Subject|4|||
124515142|NCT00859573|447838170|FG001|Overall Study|Withdrawal by Subject|1|||
124515143|NCT00859573|447838169|FG000|Overall Study|Physician Decision|1|||
124515144|NCT00859573|447838170|FG001|Overall Study|Physician Decision|1|||
124515145|NCT04134728|447838171|FG000|Overall Study|Adverse Event|3|||
124515146|NCT04134728|447838172|FG001|Overall Study|Adverse Event|2|||
124515147|NCT04134728|447838173|FG002|Overall Study|Adverse Event|9|||
124515148|NCT04134728|447838174|FG003|Overall Study|Adverse Event|0|||
124515149|NCT04134728|447838175|FG004|Overall Study|Adverse Event|0|||
124515150|NCT04134728|447838176|FG005|Overall Study|Adverse Event|0|||
124515151|NCT04134728|447838171|FG000|Overall Study|Lack of Efficacy|3|||
124570119|NCT01882647|448047168|FG001|Overall Study|Withdrawal by Subject|4|||
124570120|NCT03311646|448047171|FG000|Overall Study|Physician Decision|1|||
124570121|NCT03311646|448047171|FG000|Overall Study|Withdrawal by Subject|5|||
124570122|NCT03311646|448047171|FG000|Overall Study|Lost to Follow-up|5|||
124570123|NCT03311646|448047171|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
124570124|NCT01492361|448047172|FG000|Overall Study|Withdrawal by Subject|281|||
124570125|NCT01492361|448047173|FG001|Overall Study|Withdrawal by Subject|297|||
124570126|NCT01492361|448047172|FG000|Overall Study|Physician Decision|12|||
124570127|NCT01492361|448047173|FG001|Overall Study|Physician Decision|12|||
124570128|NCT01492361|448047172|FG000|Overall Study|Lost to Follow-up|6|||
124570129|NCT01492361|448047173|FG001|Overall Study|Lost to Follow-up|13|||
124570130|NCT01492361|448047172|FG000|Overall Study|Other than specified above|106|||
124570131|NCT01492361|448047173|FG001|Overall Study|Other than specified above|138|||
124570132|NCT03444038|448047174|FG000|Overall Study|Adverse Event|12|||
124570133|NCT03444038|448047174|FG000|Overall Study|Withdrawal by Subject|7|||
124570134|NCT03444038|448047174|FG000|Overall Study|Lost to Follow-up|1|||
124570135|NCT03444038|448047174|FG000|Overall Study|Physician Decision|2|||
124570136|NCT03444038|448047174|FG000|Overall Study|Lack of Efficacy|7|||
124570137|NCT00728949|448047185|FG000|Overall Study|Adverse Event|8|||
124570138|NCT00728949|448047186|FG001|Overall Study|Adverse Event|0|||
124570139|NCT00728949|448047185|FG000|Overall Study|Withdrawal by Subject|2|||
124570140|NCT00728949|448047186|FG001|Overall Study|Withdrawal by Subject|2|||
124570141|NCT00728949|448047185|FG000|Overall Study|Abnormal Lab Results|0|||
124570142|NCT00728949|448047186|FG001|Overall Study|Abnormal Lab Results|2|||
124570143|NCT00728949|448047185|FG000|Overall Study|On treatment at cutoff date|1|||
124570144|NCT00728949|448047186|FG001|Overall Study|On treatment at cutoff date|0|||
124570145|NCT03127137|448047188|FG000|Overall Study|Requested sedation after consent|1|||
124570146|NCT03127137|448047189|FG001|Overall Study|Requested sedation after consent|0|||
124570147|NCT03127137|448047188|FG000|Overall Study|Malfunction in electronic data collection|1|||
124570148|NCT03127137|448047189|FG001|Overall Study|Malfunction in electronic data collection|0|||
124570149|NCT03127137|448047188|FG000|Overall Study|Post procedure testing could not be obtained|0|||
124570150|NCT03127137|448047189|FG001|Overall Study|Post procedure testing could not be obtained|1|||
124570151|NCT01996033|448047190|FG000|Overall Study|Death|1|||
124570152|NCT01996033|448047190|FG000|Overall Study|Physician Decision|1|||
124570153|NCT01996033|448047190|FG000|Overall Study|Withdrawal by Subject|4|||
124570154|NCT01996033|448047190|FG000|Overall Study|Lost to Follow-up|3|||
124570155|NCT01249664|448047191|FG000|Overall Study|Withdrawal by Subject|5|||
124570156|NCT01249664|448047192|FG001|Overall Study|Withdrawal by Subject|0|||
124570157|NCT01249664|448047191|FG000|Overall Study|Adverse Event|1|||
124570158|NCT01249664|448047192|FG001|Overall Study|Adverse Event|0|||
124570159|NCT01682083|448047193|FG000|Overall Study|Lost to Follow-up|11|||
124570160|NCT01682083|448047194|FG001|Overall Study|Lost to Follow-up|18|||
124570161|NCT01682083|448047193|FG000|Overall Study|Withdrawal by Subject|31|||
124570162|NCT01682083|448047194|FG001|Overall Study|Withdrawal by Subject|40|||
124570163|NCT01682083|448047193|FG000|Overall Study|Death|60|||
124570164|NCT01682083|448047194|FG001|Overall Study|Death|93|||
124570165|NCT01682083|448047193|FG000|Overall Study|Physician Decision|5|||
124570166|NCT01682083|448047194|FG001|Overall Study|Physician Decision|4|||
124515152|NCT04134728|447838172|FG001|Overall Study|Lack of Efficacy|3|||
124515153|NCT04134728|447838173|FG002|Overall Study|Lack of Efficacy|1|||
124515154|NCT04134728|447838174|FG003|Overall Study|Lack of Efficacy|2|||
124515155|NCT04134728|447838175|FG004|Overall Study|Lack of Efficacy|0|||
124515156|NCT04134728|447838176|FG005|Overall Study|Lack of Efficacy|0|||
124515157|NCT04134728|447838171|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
124515158|NCT04134728|447838172|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
124515159|NCT04134728|447838173|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
124515160|NCT04134728|447838174|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
124515161|NCT04134728|447838175|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
124515162|NCT04134728|447838176|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
124515163|NCT04134728|447838171|FG000|Overall Study|Protocol Deviation|0|||
124515164|NCT04134728|447838172|FG001|Overall Study|Protocol Deviation|0|||
124515165|NCT04134728|447838173|FG002|Overall Study|Protocol Deviation|1|||
124515166|NCT04134728|447838174|FG003|Overall Study|Protocol Deviation|0|||
124515167|NCT04134728|447838175|FG004|Overall Study|Protocol Deviation|0|||
124515168|NCT04134728|447838176|FG005|Overall Study|Protocol Deviation|0|||
124515169|NCT04134728|447838171|FG000|Overall Study|Informed Consent Withdrawn|3|||
124515170|NCT04134728|447838172|FG001|Overall Study|Informed Consent Withdrawn|6|||
124515171|NCT04134728|447838173|FG002|Overall Study|Informed Consent Withdrawn|8|||
124515172|NCT04134728|447838174|FG003|Overall Study|Informed Consent Withdrawn|1|||
124515173|NCT04134728|447838175|FG004|Overall Study|Informed Consent Withdrawn|1|||
124515174|NCT04134728|447838176|FG005|Overall Study|Informed Consent Withdrawn|0|||
124515175|NCT04134728|447838171|FG000|Overall Study|Physician Decision|2|||
124515176|NCT04134728|447838172|FG001|Overall Study|Physician Decision|0|||
124570167|NCT01239121|448047196|FG000|Overall Study|Withdrawal by Subject|2|||
124515177|NCT04134728|447838173|FG002|Overall Study|Physician Decision|0|||
124515178|NCT04134728|447838174|FG003|Overall Study|Physician Decision|0|||
124515179|NCT04134728|447838175|FG004|Overall Study|Physician Decision|0|||
124515180|NCT04134728|447838176|FG005|Overall Study|Physician Decision|0|||
124515181|NCT04134728|447838171|FG000|Overall Study|Lost to Follow-up|1|||
124515182|NCT04134728|447838172|FG001|Overall Study|Lost to Follow-up|2|||
124515183|NCT04134728|447838173|FG002|Overall Study|Lost to Follow-up|1|||
124515184|NCT04134728|447838174|FG003|Overall Study|Lost to Follow-up|0|||
124515185|NCT04134728|447838175|FG004|Overall Study|Lost to Follow-up|0|||
124515186|NCT04134728|447838176|FG005|Overall Study|Lost to Follow-up|1|||
124515187|NCT04134728|447838171|FG000|Overall Study|Investigator Site Closed|0|||
124515188|NCT04134728|447838172|FG001|Overall Study|Investigator Site Closed|1|||
124515189|NCT04134728|447838173|FG002|Overall Study|Investigator Site Closed|1|||
124515190|NCT04134728|447838174|FG003|Overall Study|Investigator Site Closed|0|||
124515191|NCT04134728|447838175|FG004|Overall Study|Investigator Site Closed|0|||
124515192|NCT04134728|447838176|FG005|Overall Study|Investigator Site Closed|0|||
124515193|NCT03382262|447838177|FG000|Overall Study|Physician Decision|0|||
124515194|NCT03382262|447838178|FG001|Overall Study|Physician Decision|0|||
124515195|NCT03382262|447838179|FG002|Overall Study|Physician Decision|1|||
124515196|NCT03382262|447838180|FG003|Overall Study|Physician Decision|0|||
124515197|NCT03382262|447838177|FG000|Overall Study|Withdrawal by Subject|0|||
124515198|NCT03382262|447838178|FG001|Overall Study|Withdrawal by Subject|0|||
124515199|NCT03382262|447838179|FG002|Overall Study|Withdrawal by Subject|0|||
124515200|NCT03382262|447838180|FG003|Overall Study|Withdrawal by Subject|1|||
124515201|NCT02905825|447838188|FG000|Overall Study|Protocol Violation|11|||
124515202|NCT02905825|447838188|FG000|Overall Study|Device Malfunction|1|||
124515203|NCT01136746|447838189|FG000|Overall Study|Lost to Follow-up|0|||
124515204|NCT01136746|447838190|FG001|Overall Study|Lost to Follow-up|2|||
124515205|NCT01136746|447838189|FG000|Overall Study|Protocol Violation|2|||
124515206|NCT01136746|447838190|FG001|Overall Study|Protocol Violation|1|||
124515207|NCT01136746|447838189|FG000|Overall Study|Death|1|||
124515208|NCT01136746|447838190|FG001|Overall Study|Death|0|||
124515209|NCT01019252|447838191|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
124515210|NCT01019252|447838192|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
124515211|NCT01019252|447838191|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
124515212|NCT01019252|447838192|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
124515213|NCT01019252|447838191|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
124515214|NCT01019252|447838192|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
124515215|NCT01019252|447838191|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
124515216|NCT01019252|447838192|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
124515217|NCT02273037|447838193|FG000|Overall Study|Lost to Follow-up|1|||
124515218|NCT02273037|447838194|FG001|Overall Study|Lost to Follow-up|0|||
124515219|NCT02273037|447838193|FG000|Overall Study|Delivered before monitoring initiated|1|||
124515220|NCT02273037|447838194|FG001|Overall Study|Delivered before monitoring initiated|3|||
124515221|NCT02273037|447838193|FG000|Overall Study|Breech delivery|2|||
124515222|NCT02273037|447838194|FG001|Overall Study|Breech delivery|3|||
124515223|NCT02273037|447838193|FG000|Overall Study|Multiple delivery|2|||
124515224|NCT02273037|447838194|FG001|Overall Study|Multiple delivery|2|||
124515225|NCT02273037|447838193|FG000|Overall Study|Other complication|2|||
124515226|NCT02273037|447838194|FG001|Overall Study|Other complication|0|||
124515227|NCT03351478|447838197|FG000|Overall Study|At the subject's own request|11|||
124515228|NCT03351478|447838198|FG001|Overall Study|At the subject's own request|12|||
124515229|NCT03351478|447838199|FG002|Overall Study|At the subject's own request|5|||
124515230|NCT03351478|447838197|FG000|Overall Study|Adverse Event|1|||
124515231|NCT03351478|447838198|FG001|Overall Study|Adverse Event|2|||
124515232|NCT03351478|447838199|FG002|Overall Study|Adverse Event|1|||
124515233|NCT03351478|447838197|FG000|Overall Study|Poor compliance to protocol|1|||
124515234|NCT03351478|447838198|FG001|Overall Study|Poor compliance to protocol|0|||
124515235|NCT03351478|447838199|FG002|Overall Study|Poor compliance to protocol|0|||
124515236|NCT03351478|447838197|FG000|Overall Study|Reason not Specified|1|||
124515237|NCT03351478|447838198|FG001|Overall Study|Reason not Specified|3|||
124515238|NCT03351478|447838199|FG002|Overall Study|Reason not Specified|0|||
124515239|NCT03351478|447838197|FG000|Overall Study|Lost to Follow-up|0|||
124515240|NCT03351478|447838198|FG001|Overall Study|Lost to Follow-up|0|||
124515241|NCT03351478|447838199|FG002|Overall Study|Lost to Follow-up|1|||
124515242|NCT00510484|447838200|FG000|Wash-out Period|Adverse Event|0|||
124515243|NCT00510484|447838201|FG001|Wash-out Period|Adverse Event|1|||
124515244|NCT00762268|447838202|FG000|Overall Study|Withdrawal by Subject|3|||
124515245|NCT00762268|447838203|FG001|Overall Study|Withdrawal by Subject|3|||
124515246|NCT00973622|447838206|FG000|Overall Study|did not attend MRI|14|||
124515247|NCT00973622|447838207|FG001|Overall Study|did not attend MRI|3|||
124515248|NCT00973622|447838206|FG000|Overall Study|did not pass MRI screen|6|||
124515249|NCT00973622|447838207|FG001|Overall Study|did not pass MRI screen|0|||
124515250|NCT00973622|447838206|FG000|Overall Study|did not complete rTMS sessions|11|||
124515251|NCT00973622|447838207|FG001|Overall Study|did not complete rTMS sessions|2|||
124515252|NCT00493467|447838208|FG000|Overall Study|Death|1|||
124515253|NCT03395223|447838211|FG000|Overall Study|Lost to Follow-up|3|||
124515254|NCT03395223|447838211|FG000|Overall Study|Other|1|||
124515255|NCT01855945|447838214|FG000|Overall Study|Adverse Event|0|||
124570168|NCT01239121|448047197|FG001|Overall Study|Withdrawal by Subject|4|||
124570169|NCT01239121|448047198|FG002|Overall Study|Withdrawal by Subject|0|||
124515256|NCT01855945|447838215|FG001|Overall Study|Adverse Event|0|||
124515257|NCT01855945|447838216|FG002|Overall Study|Adverse Event|0|||
124515258|NCT01855945|447838217|FG003|Overall Study|Adverse Event|0|||
124515259|NCT01855945|447838218|FG004|Overall Study|Adverse Event|0|||
124515260|NCT01855945|447838219|FG005|Overall Study|Adverse Event|0|||
124515261|NCT01855945|447838220|FG006|Overall Study|Adverse Event|1|||
124515262|NCT01855945|447838221|FG007|Overall Study|Adverse Event|0|||
124515263|NCT01855945|447838222|FG008|Overall Study|Adverse Event|0|||
124515264|NCT01855945|447838223|FG009|Overall Study|Adverse Event|0|||
124515265|NCT01855945|447838224|FG010|Overall Study|Adverse Event|0|||
124515266|NCT01855945|447838225|FG011|Overall Study|Adverse Event|0|||
124515267|NCT01855945|447838214|FG000|Overall Study|Death|0|||
124515268|NCT01855945|447838215|FG001|Overall Study|Death|0|||
124515269|NCT01855945|447838216|FG002|Overall Study|Death|0|||
124515270|NCT01855945|447838217|FG003|Overall Study|Death|0|||
124515271|NCT01855945|447838218|FG004|Overall Study|Death|0|||
124515272|NCT01855945|447838219|FG005|Overall Study|Death|0|||
124515273|NCT01855945|447838220|FG006|Overall Study|Death|2|||
124515274|NCT01855945|447838221|FG007|Overall Study|Death|0|||
124515275|NCT01855945|447838222|FG008|Overall Study|Death|0|||
124515276|NCT01855945|447838223|FG009|Overall Study|Death|0|||
124515277|NCT01855945|447838224|FG010|Overall Study|Death|0|||
124515278|NCT01855945|447838225|FG011|Overall Study|Death|0|||
124515279|NCT01855945|447838214|FG000|Overall Study|Lost to Follow-up|11|||
124515280|NCT01855945|447838215|FG001|Overall Study|Lost to Follow-up|10|||
124515281|NCT01855945|447838216|FG002|Overall Study|Lost to Follow-up|7|||
124515282|NCT01855945|447838217|FG003|Overall Study|Lost to Follow-up|3|||
124515283|NCT01855945|447838218|FG004|Overall Study|Lost to Follow-up|0|||
124515284|NCT01855945|447838219|FG005|Overall Study|Lost to Follow-up|3|||
124515285|NCT01855945|447838220|FG006|Overall Study|Lost to Follow-up|4|||
124515286|NCT01855945|447838221|FG007|Overall Study|Lost to Follow-up|7|||
124515287|NCT01855945|447838222|FG008|Overall Study|Lost to Follow-up|2|||
124515288|NCT01855945|447838223|FG009|Overall Study|Lost to Follow-up|0|||
124515289|NCT01855945|447838224|FG010|Overall Study|Lost to Follow-up|0|||
124515290|NCT01855945|447838225|FG011|Overall Study|Lost to Follow-up|2|||
124515291|NCT01855945|447838214|FG000|Overall Study|Other - Unclassified|1|||
124515292|NCT01855945|447838215|FG001|Overall Study|Other - Unclassified|1|||
124515293|NCT01855945|447838216|FG002|Overall Study|Other - Unclassified|1|||
124515294|NCT01855945|447838217|FG003|Overall Study|Other - Unclassified|0|||
124515295|NCT01855945|447838218|FG004|Overall Study|Other - Unclassified|0|||
124515296|NCT01855945|447838219|FG005|Overall Study|Other - Unclassified|0|||
124515297|NCT01855945|447838220|FG006|Overall Study|Other - Unclassified|2|||
124515298|NCT01855945|447838221|FG007|Overall Study|Other - Unclassified|1|||
124515299|NCT01855945|447838222|FG008|Overall Study|Other - Unclassified|0|||
124515300|NCT01855945|447838223|FG009|Overall Study|Other - Unclassified|0|||
124515301|NCT01855945|447838224|FG010|Overall Study|Other - Unclassified|1|||
124515302|NCT01855945|447838225|FG011|Overall Study|Other - Unclassified|0|||
124515303|NCT01855945|447838214|FG000|Overall Study|Withdrawal by Subject|4|||
124515304|NCT01855945|447838215|FG001|Overall Study|Withdrawal by Subject|0|||
124515305|NCT01855945|447838216|FG002|Overall Study|Withdrawal by Subject|4|||
124515306|NCT01855945|447838217|FG003|Overall Study|Withdrawal by Subject|1|||
124515307|NCT01855945|447838218|FG004|Overall Study|Withdrawal by Subject|1|||
124515308|NCT01855945|447838219|FG005|Overall Study|Withdrawal by Subject|0|||
124515309|NCT01855945|447838220|FG006|Overall Study|Withdrawal by Subject|1|||
124515310|NCT01855945|447838221|FG007|Overall Study|Withdrawal by Subject|0|||
124515311|NCT01855945|447838222|FG008|Overall Study|Withdrawal by Subject|0|||
124515312|NCT01855945|447838223|FG009|Overall Study|Withdrawal by Subject|2|||
124515313|NCT01855945|447838224|FG010|Overall Study|Withdrawal by Subject|4|||
124515314|NCT01855945|447838225|FG011|Overall Study|Withdrawal by Subject|1|||
124515315|NCT01148693|447838226|FG000|Overall Study|Attempts for cannulation were failed|13|||
124515316|NCT01148693|447838227|FG001|Overall Study|Attempts for cannulation were failed|10|||
124515317|NCT03228394|447838228|FG000|Overall Study|Lost to Follow-up|0|||
124515318|NCT03228394|447838229|FG001|Overall Study|Lost to Follow-up|0|||
124570170|NCT01856309|448047201|FG000|Overall Study|Death|4|||
124515319|NCT03228394|447838230|FG002|Overall Study|Lost to Follow-up|1|||
124515320|NCT03228394|447838231|FG003|Overall Study|Lost to Follow-up|1|||
124515321|NCT03228394|447838232|FG004|Overall Study|Lost to Follow-up|0|||
124515322|NCT03228394|447838233|FG005|Overall Study|Lost to Follow-up|0|||
124515323|NCT03228394|447838234|FG006|Overall Study|Lost to Follow-up|2|||
124515324|NCT03228394|447838235|FG007|Overall Study|Lost to Follow-up|0|||
124515325|NCT03228394|447838228|FG000|Overall Study|Withdrawal by Subject|0|||
124515326|NCT03228394|447838229|FG001|Overall Study|Withdrawal by Subject|0|||
124570171|NCT01856309|448047202|FG001|Overall Study|Death|6|||
124515327|NCT03228394|447838230|FG002|Overall Study|Withdrawal by Subject|1|||
124515328|NCT03228394|447838231|FG003|Overall Study|Withdrawal by Subject|0|||
124515329|NCT03228394|447838232|FG004|Overall Study|Withdrawal by Subject|0|||
124515330|NCT03228394|447838233|FG005|Overall Study|Withdrawal by Subject|0|||
124776714|NCT00998296|448809955|FG010|Overall Study|Refused to continue taking trial med.|0|||
124515331|NCT03228394|447838234|FG006|Overall Study|Withdrawal by Subject|1|||
124515332|NCT03228394|447838235|FG007|Overall Study|Withdrawal by Subject|3|||
124515333|NCT03228394|447838228|FG000|Overall Study|Protocol Violation|0|||
124515334|NCT03228394|447838229|FG001|Overall Study|Protocol Violation|0|||
124515335|NCT03228394|447838230|FG002|Overall Study|Protocol Violation|0|||
124515336|NCT03228394|447838231|FG003|Overall Study|Protocol Violation|1|||
124515337|NCT03228394|447838232|FG004|Overall Study|Protocol Violation|0|||
124515338|NCT03228394|447838233|FG005|Overall Study|Protocol Violation|0|||
124515339|NCT03228394|447838234|FG006|Overall Study|Protocol Violation|0|||
124515340|NCT03228394|447838235|FG007|Overall Study|Protocol Violation|0|||
124515341|NCT03228394|447838228|FG000|Overall Study|Physician Decision|0|||
124515342|NCT03228394|447838229|FG001|Overall Study|Physician Decision|0|||
124515343|NCT03228394|447838230|FG002|Overall Study|Physician Decision|0|||
124515344|NCT03228394|447838231|FG003|Overall Study|Physician Decision|0|||
124515345|NCT03228394|447838232|FG004|Overall Study|Physician Decision|0|||
124515346|NCT03228394|447838233|FG005|Overall Study|Physician Decision|0|||
124515347|NCT03228394|447838234|FG006|Overall Study|Physician Decision|1|||
124515348|NCT03228394|447838235|FG007|Overall Study|Physician Decision|0|||
124515349|NCT03228394|447838228|FG000|Overall Study|Noncompliance|0|||
124515350|NCT03228394|447838229|FG001|Overall Study|Noncompliance|0|||
124515351|NCT03228394|447838230|FG002|Overall Study|Noncompliance|0|||
124515352|NCT03228394|447838231|FG003|Overall Study|Noncompliance|0|||
124515353|NCT03228394|447838232|FG004|Overall Study|Noncompliance|0|||
124515354|NCT03228394|447838233|FG005|Overall Study|Noncompliance|0|||
124515355|NCT03228394|447838234|FG006|Overall Study|Noncompliance|1|||
124515356|NCT03228394|447838235|FG007|Overall Study|Noncompliance|0|||
124515357|NCT01162304|447838246|FG000|Overall Study|Beck scale to high|11|||
124515358|NCT00326417|447838250|FG000|Overall Study|Withdrawal by Subject|0|||
124515359|NCT00326417|447838251|FG001|Overall Study|Withdrawal by Subject|0|||
124515360|NCT00326417|447838252|FG002|Overall Study|Withdrawal by Subject|1|||
124515361|NCT00326417|447838253|FG003|Overall Study|Withdrawal by Subject|0|||
124515362|NCT00326417|447838250|FG000|Overall Study|Arm Closed|7|||
124515363|NCT00326417|447838251|FG001|Overall Study|Arm Closed|0|||
124515364|NCT00326417|447838252|FG002|Overall Study|Arm Closed|0|||
124515365|NCT00326417|447838253|FG003|Overall Study|Arm Closed|3|||
124515366|NCT00326417|447838250|FG000|Overall Study|Death|7|||
124515367|NCT00326417|447838251|FG001|Overall Study|Death|0|||
124515368|NCT00326417|447838252|FG002|Overall Study|Death|0|||
124515369|NCT00326417|447838253|FG003|Overall Study|Death|0|||
124515370|NCT00862654|447838256|FG000|Overall Study|Lack of Efficacy|1|||
124515371|NCT00862654|447838257|FG001|Overall Study|Lack of Efficacy|0|||
124515372|NCT00862654|447838258|FG002|Overall Study|Lack of Efficacy|1|||
124515373|NCT00862654|447838259|FG003|Overall Study|Lack of Efficacy|0|||
124515374|NCT00862654|447838256|FG000|Overall Study|Lost to Follow-up|1|||
124515375|NCT00862654|447838257|FG001|Overall Study|Lost to Follow-up|2|||
124515376|NCT00862654|447838258|FG002|Overall Study|Lost to Follow-up|1|||
124515377|NCT00862654|447838259|FG003|Overall Study|Lost to Follow-up|3|||
124515378|NCT00862654|447838256|FG000|Overall Study|Adverse Event|0|||
124515379|NCT00862654|447838257|FG001|Overall Study|Adverse Event|1|||
124515380|NCT00862654|447838258|FG002|Overall Study|Adverse Event|1|||
124515381|NCT00862654|447838259|FG003|Overall Study|Adverse Event|0|||
124515382|NCT00862654|447838256|FG000|Overall Study|Pregnancy|1|||
124515383|NCT00862654|447838257|FG001|Overall Study|Pregnancy|1|||
124515384|NCT00862654|447838258|FG002|Overall Study|Pregnancy|0|||
124515385|NCT00862654|447838259|FG003|Overall Study|Pregnancy|0|||
124515386|NCT00862654|447838256|FG000|Overall Study|Withdrawal by Subject|2|||
124515387|NCT00862654|447838257|FG001|Overall Study|Withdrawal by Subject|2|||
124515388|NCT00862654|447838258|FG002|Overall Study|Withdrawal by Subject|2|||
124515389|NCT00862654|447838259|FG003|Overall Study|Withdrawal by Subject|3|||
124515390|NCT00862654|447838256|FG000|Overall Study|Subject mistake|0|||
124515391|NCT00862654|447838257|FG001|Overall Study|Subject mistake|1|||
124515392|NCT00862654|447838258|FG002|Overall Study|Subject mistake|0|||
124515393|NCT00862654|447838259|FG003|Overall Study|Subject mistake|0|||
124515394|NCT00862654|447838256|FG000|Overall Study|Familly constraint|0|||
124515395|NCT00862654|447838257|FG001|Overall Study|Familly constraint|1|||
124515396|NCT00862654|447838258|FG002|Overall Study|Familly constraint|0|||
124515397|NCT00862654|447838259|FG003|Overall Study|Familly constraint|0|||
124515398|NCT00862654|447838256|FG000|Overall Study|Never used study drugs|1|||
124515399|NCT00862654|447838257|FG001|Overall Study|Never used study drugs|0|||
124515400|NCT00862654|447838258|FG002|Overall Study|Never used study drugs|0|||
124515401|NCT00862654|447838259|FG003|Overall Study|Never used study drugs|0|||
124515402|NCT00862654|447838256|FG000|Overall Study|Included after end of inclusions|0|||
124515403|NCT00862654|447838257|FG001|Overall Study|Included after end of inclusions|0|||
124515404|NCT00862654|447838258|FG002|Overall Study|Included after end of inclusions|1|||
124515405|NCT00862654|447838259|FG003|Overall Study|Included after end of inclusions|0|||
124515406|NCT03219567|447838260|FG000|Overall Study|Withdrawal by Subject|0|||
124515407|NCT03219567|447838261|FG001|Overall Study|Withdrawal by Subject|1|||
124570172|NCT01856309|448047203|FG002|Overall Study|Death|11|||
124515408|NCT01654523|447838262|FG000|Overall Study|Withdrawal by Subject|1|||
124570173|NCT01856309|448047204|FG003|Overall Study|Death|6|||
124570174|NCT01856309|448047201|FG000|Overall Study|Lost to Follow-up|6|||
124570175|NCT01856309|448047202|FG001|Overall Study|Lost to Follow-up|2|||
124570176|NCT01856309|448047203|FG002|Overall Study|Lost to Follow-up|4|||
124570177|NCT01856309|448047204|FG003|Overall Study|Lost to Follow-up|8|||
124570178|NCT01856309|448047201|FG000|Overall Study|Withdrawal by Subject|11|||
124570179|NCT01856309|448047202|FG001|Overall Study|Withdrawal by Subject|13|||
124570180|NCT01856309|448047203|FG002|Overall Study|Withdrawal by Subject|28|||
124570181|NCT01856309|448047204|FG003|Overall Study|Withdrawal by Subject|26|||
124570182|NCT01856309|448047201|FG000|Overall Study|Other|227|||
124570183|NCT01856309|448047202|FG001|Overall Study|Other|225|||
124570184|NCT01856309|448047203|FG002|Overall Study|Other|447|||
124570185|NCT01856309|448047204|FG003|Overall Study|Other|469|||
124570186|NCT01856309|448047201|FG000|Overall Study|Lack of Efficacy|14|||
124570187|NCT01856309|448047202|FG001|Overall Study|Lack of Efficacy|9|||
124570188|NCT01856309|448047203|FG002|Overall Study|Lack of Efficacy|40|||
124570189|NCT01856309|448047204|FG003|Overall Study|Lack of Efficacy|25|||
124570190|NCT01856309|448047201|FG000|Overall Study|Adverse Event|31|||
124570191|NCT01856309|448047202|FG001|Overall Study|Adverse Event|31|||
124570192|NCT01856309|448047203|FG002|Overall Study|Adverse Event|55|||
124570193|NCT01856309|448047204|FG003|Overall Study|Adverse Event|65|||
124570194|NCT01856309|448047201|FG000|Overall Study|Pregnancy|0|||
124570195|NCT01856309|448047202|FG001|Overall Study|Pregnancy|0|||
124570196|NCT01856309|448047203|FG002|Overall Study|Pregnancy|0|||
124570197|NCT01856309|448047204|FG003|Overall Study|Pregnancy|1|||
124570198|NCT01856309|448047201|FG000|Overall Study|Physician Decision|6|||
124570199|NCT01856309|448047202|FG001|Overall Study|Physician Decision|1|||
124570200|NCT01856309|448047203|FG002|Overall Study|Physician Decision|6|||
124570201|NCT01856309|448047204|FG003|Overall Study|Physician Decision|8|||
124570202|NCT01856309|448047201|FG000|Overall Study|Noncompliance With Study Drug|0|||
124570203|NCT01856309|448047202|FG001|Overall Study|Noncompliance With Study Drug|1|||
124570204|NCT01856309|448047203|FG002|Overall Study|Noncompliance With Study Drug|4|||
124570205|NCT01856309|448047204|FG003|Overall Study|Noncompliance With Study Drug|1|||
124570206|NCT00220337|448047205|FG000|Overall Study|Adverse Event|70|||
124570207|NCT00220337|448047205|FG000|Overall Study|Lack of Efficacy|17|||
124570208|NCT00220337|448047205|FG000|Overall Study|Withdrawal by Subject|68|||
124570209|NCT00220337|448047205|FG000|Overall Study|Protocol Violation|2|||
124570210|NCT00220337|448047205|FG000|Overall Study|Lost to Follow-up|5|||
124570211|NCT00220337|448047205|FG000|Overall Study|Other|12|||
124570212|NCT00220337|448047205|FG000|Overall Study|Unsatisfactory compliance|5|||
124570213|NCT00944697|448047208|FG000|Overall Study|Withdrawal by Subject|1|||
124570214|NCT00944697|448047209|FG001|Overall Study|Withdrawal by Subject|1|||
124570215|NCT00944697|448047208|FG000|Overall Study|Adverse Event|0|||
124570216|NCT00944697|448047209|FG001|Overall Study|Adverse Event|3|||
124570217|NCT00944697|448047208|FG000|Overall Study|Administrative|1|||
124570218|NCT00944697|448047209|FG001|Overall Study|Administrative|1|||
124570219|NCT01273181|448047210|FG000|Phase I, Dose 1|Study termination|1|||
124570220|NCT01273181|448047211|FG001|Phase I, Dose 1|Study termination|0|||
124515409|NCT02447458|447838263|FG000|Overall Study|Other|0|||
124515410|NCT02447458|447838264|FG001|Overall Study|Other|0|||
124515411|NCT02447458|447838265|FG002|Overall Study|Other|1|||
124515412|NCT02447458|447838266|FG003|Overall Study|Other|0|||
124515413|NCT02447458|447838267|FG004|Overall Study|Other|0|||
124515414|NCT02447458|447838268|FG005|Overall Study|Other|0|||
124515415|NCT02133742|447838269|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
124515416|NCT02133742|447838269|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
124570221|NCT01273181|448047212|FG002|Phase I, Dose 1|Study termination|0|||
124570222|NCT01273181|448047213|FG003|Phase I, Dose 1|Study termination|0|||
124570223|NCT01273181|448047210|FG000|Phase I, Dose 2|Death during treatment|0|||
124570224|NCT01273181|448047211|FG001|Phase I, Dose 2|Death during treatment|1|||
124570225|NCT01273181|448047212|FG002|Phase I, Dose 2|Death during treatment|0|||
124570226|NCT01273181|448047213|FG003|Phase I, Dose 2|Death during treatment|0|||
124570227|NCT01273181|448047210|FG000|Phase 2, Dose 1|Study termination|0|||
124570228|NCT01273181|448047211|FG001|Phase 2, Dose 1|Study termination|0|||
124570229|NCT01273181|448047212|FG002|Phase 2, Dose 1|Study termination|1|||
124570230|NCT01273181|448047213|FG003|Phase 2, Dose 1|Study termination|0|||
124570231|NCT01273181|448047210|FG000|Phase 2, Dose 2|Death during treatment|0|||
124570232|NCT01273181|448047211|FG001|Phase 2, Dose 2|Death during treatment|0|||
124570233|NCT01273181|448047212|FG002|Phase 2, Dose 2|Death during treatment|0|||
124570234|NCT01273181|448047213|FG003|Phase 2, Dose 2|Death during treatment|1|||
124515417|NCT02133742|447838269|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
124515418|NCT02133742|447838269|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
124515419|NCT02133742|447838269|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
124515420|NCT00405652|447838270|FG000|Overall Study|Adverse Event|4|||
124570235|NCT03657160|448047214|FG000|Overall Study|Adverse Event|5|||
124570236|NCT03657160|448047215|FG001|Overall Study|Adverse Event|6|||
124570237|NCT03657160|448047214|FG000|Overall Study|Protocol Deviation|3|||
124570238|NCT03657160|448047215|FG001|Overall Study|Protocol Deviation|0|||
124570239|NCT03657160|448047214|FG000|Overall Study|Withdrawal by Subject|18|||
124570240|NCT03657160|448047215|FG001|Overall Study|Withdrawal by Subject|16|||
124570241|NCT03657160|448047214|FG000|Overall Study|Site Termination|1|||
124570242|NCT03657160|448047215|FG001|Overall Study|Site Termination|0|||
124570243|NCT03657160|448047214|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
124570244|NCT03657160|448047215|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
124570245|NCT03657160|448047214|FG000|Overall Study|Death|33|||
124570246|NCT03657160|448047215|FG001|Overall Study|Death|26|||
124570247|NCT03657160|448047214|FG000|Overall Study|Death (COVID-19-Related)|1|||
124570248|NCT03657160|448047215|FG001|Overall Study|Death (COVID-19-Related)|0|||
124570249|NCT03657160|448047214|FG000|Overall Study|Reason Not Specified|5|||
124570250|NCT03657160|448047215|FG001|Overall Study|Reason Not Specified|5|||
124570251|NCT03657160|448047214|FG000|Overall Study|Other (COVID-19-Related)|0|||
124570252|NCT03657160|448047215|FG001|Overall Study|Other (COVID-19-Related)|1|||
124570253|NCT02732210|448047217|FG000|Overall Study|Site Closed|0|||
124570254|NCT02732210|448047218|FG001|Overall Study|Site Closed|11|||
124570255|NCT02732210|448047217|FG000|Overall Study|Study Ended|13|||
124570256|NCT02732210|448047218|FG001|Overall Study|Study Ended|13|||
124570257|NCT02732210|448047217|FG000|Overall Study|Withdrawal by Subject|28|||
124570258|NCT02732210|448047218|FG001|Overall Study|Withdrawal by Subject|87|||
124570259|NCT02732210|448047217|FG000|Overall Study|Lost to Follow-up|5|||
124570260|NCT02732210|448047218|FG001|Overall Study|Lost to Follow-up|57|||
124570261|NCT02732210|448047217|FG000|Overall Study|Death|4|||
124570262|NCT02732210|448047218|FG001|Overall Study|Death|15|||
124570263|NCT02732210|448047217|FG000|Overall Study|Other|35|||
124570264|NCT02732210|448047218|FG001|Overall Study|Other|103|||
124570265|NCT02732210|448047217|FG000|Overall Study|Missing|0|||
124570266|NCT02732210|448047218|FG001|Overall Study|Missing|8|||
124570267|NCT04638153|448047219|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124570268|NCT04638153|448047220|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124570269|NCT04638153|448047221|FG002|Overall Study|Withdrawal by parent/guardian|1|||
124570270|NCT04638153|448047219|FG000|Overall Study|Study terminated by sponsor|4|||
124570271|NCT04638153|448047220|FG001|Overall Study|Study terminated by sponsor|2|||
124570272|NCT04638153|448047221|FG002|Overall Study|Study terminated by sponsor|14|||
124570273|NCT04006171|448047222|FG000|Overall Study|Withdrawal by Subject|8|||
124570274|NCT04006171|448047223|FG001|Overall Study|Withdrawal by Subject|7|||
124570275|NCT04006171|448047222|FG000|Overall Study|missing serum samples|2|||
124570276|NCT04006171|448047223|FG001|Overall Study|missing serum samples|2|||
124570277|NCT04006171|448047222|FG000|Overall Study|insufficient sample volume|2|||
124570278|NCT04006171|448047223|FG001|Overall Study|insufficient sample volume|3|||
124570279|NCT01440283|448047224|FG000|Overall Study|Death|3|||
124570280|NCT01440283|448047224|FG000|Overall Study|Withdrawal by Subject|4|||
124570281|NCT01440283|448047224|FG000|Overall Study|Physician Decision|3|||
124570282|NCT00537030|448047225|FG000|Overall Study|Physician Decision|2|||
124570283|NCT00537030|448047225|FG000|Overall Study|Withdrawal by Subject|2|||
124570284|NCT00537030|448047225|FG000|Overall Study|≥ Grade 2 allergy|7|||
124570285|NCT00537030|448047225|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
124570286|NCT00537030|448047225|FG000|Overall Study|Ineligible|2|||
124570287|NCT00537030|448047225|FG000|Overall Study|Inevaluable|2|||
124570288|NCT06354270|448047226|FG000|Overall Study|Withdrawal by Subject|1|||
124570289|NCT06354270|448047227|FG001|Overall Study|Withdrawal by Subject|0|||
124570290|NCT01939197|448047228|FG000|Overall Study|Withdrawal by Subject|1|||
124570291|NCT01939197|448047229|FG001|Overall Study|Withdrawal by Subject|0|||
124570292|NCT01939197|448047230|FG002|Overall Study|Withdrawal by Subject|0|||
124570293|NCT01939197|448047231|FG003|Overall Study|Withdrawal by Subject|0|||
124570294|NCT01939197|448047232|FG004|Overall Study|Withdrawal by Subject|1|||
124570295|NCT01939197|448047233|FG005|Overall Study|Withdrawal by Subject|0|||
124570296|NCT01939197|448047234|FG006|Overall Study|Withdrawal by Subject|0|||
124570297|NCT01939197|448047228|FG000|Overall Study|Lost to Follow-up|0|||
124570298|NCT01939197|448047229|FG001|Overall Study|Lost to Follow-up|1|||
124570299|NCT01939197|448047230|FG002|Overall Study|Lost to Follow-up|0|||
124570300|NCT01939197|448047231|FG003|Overall Study|Lost to Follow-up|1|||
124570301|NCT01939197|448047232|FG004|Overall Study|Lost to Follow-up|3|||
124570302|NCT01939197|448047233|FG005|Overall Study|Lost to Follow-up|1|||
124570303|NCT01939197|448047234|FG006|Overall Study|Lost to Follow-up|2|||
124570304|NCT00745095|448047235|FG000|Overall Study|Declined to participate|1|||
124570305|NCT00745095|448047236|FG001|Overall Study|Declined to participate|0|||
124570306|NCT00745095|448047237|FG002|Overall Study|Declined to participate|0|||
124570307|NCT00745095|448047238|FG003|Overall Study|Declined to participate|0|||
124724963|NCT04026009|448613388|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
124570308|NCT00745095|448047239|FG004|Overall Study|Declined to participate|92|||
124724964|NCT04026009|448613389|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
124570309|NCT00745095|448047240|FG005|Overall Study|Declined to participate|95|||
124570310|NCT00745095|448047235|FG000|Overall Study|Ineligible due to GFR criteria|0|||
124570311|NCT00745095|448047236|FG001|Overall Study|Ineligible due to GFR criteria|2|||
124570312|NCT00745095|448047237|FG002|Overall Study|Ineligible due to GFR criteria|3|||
124570313|NCT00745095|448047238|FG003|Overall Study|Ineligible due to GFR criteria|3|||
124570314|NCT00745095|448047239|FG004|Overall Study|Ineligible due to GFR criteria|30|||
124724965|NCT04026009|448613390|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
124515421|NCT00435994|447838272|FG000|Overall Study|Lost to Follow-up|7|||
124515422|NCT00435994|447838273|FG001|Overall Study|Lost to Follow-up|0|||
124515423|NCT00435994|447838274|FG002|Overall Study|Lost to Follow-up|0|||
124515424|NCT02472795|447838278|FG000|Overall Study|Adverse Event|0|||
124515425|NCT02472795|447838279|FG001|Overall Study|Adverse Event|1|||
124515426|NCT02472795|447838280|FG002|Overall Study|Adverse Event|0|||
124515427|NCT02472795|447838281|FG003|Overall Study|Adverse Event|0|||
124515428|NCT02472795|447838282|FG004|Overall Study|Adverse Event|2|||
124515429|NCT02472795|447838278|FG000|Overall Study|Withdrawal by Subject|0|||
124515430|NCT02472795|447838279|FG001|Overall Study|Withdrawal by Subject|0|||
124515431|NCT02472795|447838280|FG002|Overall Study|Withdrawal by Subject|0|||
124515432|NCT02472795|447838281|FG003|Overall Study|Withdrawal by Subject|0|||
124515433|NCT02472795|447838282|FG004|Overall Study|Withdrawal by Subject|1|||
124515434|NCT05109702|447838283|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
124515435|NCT05109702|447838284|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
124515436|NCT05109702|447838285|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
124515437|NCT05109702|447838283|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
124515438|NCT05109702|447838284|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
124515439|NCT05109702|447838285|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
124515440|NCT05109702|447838283|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
124515441|NCT05109702|447838284|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
124515442|NCT05109702|447838285|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
124515443|NCT05109702|447838283|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
124515444|NCT05109702|447838284|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
124515445|NCT05109702|447838285|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
124515446|NCT05109702|447838283|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
124515447|NCT05109702|447838284|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
124515448|NCT05109702|447838285|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
124515449|NCT01392378|447838294|FG000|Infant Series|Adverse Event|0|||
124515450|NCT01392378|447838295|FG001|Infant Series|Adverse Event|0|||
124515451|NCT01392378|447838296|FG002|Infant Series|Adverse Event|0|||
124515452|NCT01392378|447838297|FG003|Infant Series|Adverse Event|1|||
124515453|NCT01392378|447838298|FG004|Infant Series|Adverse Event|0|||
124515454|NCT01392378|447838294|FG000|Infant Series|Lost to Follow-up|0|||
124515455|NCT01392378|447838295|FG001|Infant Series|Lost to Follow-up|0|||
124515456|NCT01392378|447838296|FG002|Infant Series|Lost to Follow-up|0|||
124515457|NCT01392378|447838297|FG003|Infant Series|Lost to Follow-up|1|||
124515458|NCT01392378|447838298|FG004|Infant Series|Lost to Follow-up|0|||
124515459|NCT01392378|447838294|FG000|Infant Series|Protocol Violation|0|||
124515460|NCT01392378|447838295|FG001|Infant Series|Protocol Violation|1|||
124515461|NCT01392378|447838296|FG002|Infant Series|Protocol Violation|0|||
124515462|NCT01392378|447838297|FG003|Infant Series|Protocol Violation|0|||
124515463|NCT01392378|447838298|FG004|Infant Series|Protocol Violation|0|||
124515464|NCT01392378|447838294|FG000|Infant Series|Withdrawal by Parent|4|||
124515465|NCT01392378|447838295|FG001|Infant Series|Withdrawal by Parent|1|||
124515466|NCT01392378|447838296|FG002|Infant Series|Withdrawal by Parent|0|||
124515467|NCT01392378|447838297|FG003|Infant Series|Withdrawal by Parent|0|||
124515468|NCT01392378|447838298|FG004|Infant Series|Withdrawal by Parent|0|||
124515469|NCT01392378|447838294|FG000|After Infant Series|Lost to Follow-up|0|||
124515470|NCT01392378|447838295|FG001|After Infant Series|Lost to Follow-up|0|||
124515471|NCT01392378|447838296|FG002|After Infant Series|Lost to Follow-up|1|||
124515472|NCT01392378|447838297|FG003|After Infant Series|Lost to Follow-up|0|||
124515473|NCT01392378|447838298|FG004|After Infant Series|Lost to Follow-up|0|||
124515474|NCT01392378|447838294|FG000|After Infant Series|Withdrawal by Parent|0|||
124515475|NCT01392378|447838295|FG001|After Infant Series|Withdrawal by Parent|1|||
124515476|NCT01392378|447838296|FG002|After Infant Series|Withdrawal by Parent|1|||
124515477|NCT01392378|447838297|FG003|After Infant Series|Withdrawal by Parent|0|||
124515478|NCT01392378|447838298|FG004|After Infant Series|Withdrawal by Parent|1|||
124515479|NCT01392378|447838294|FG000|Toddler Dose|Lost to Follow-up|0|||
124515480|NCT01392378|447838295|FG001|Toddler Dose|Lost to Follow-up|0|||
124515481|NCT01392378|447838296|FG002|Toddler Dose|Lost to Follow-up|0|||
124515482|NCT01392378|447838297|FG003|Toddler Dose|Lost to Follow-up|1|||
124515483|NCT01392378|447838298|FG004|Toddler Dose|Lost to Follow-up|0|||
124515484|NCT01392378|447838294|FG000|Toddler Dose|Withdrawal by Parent|0|||
124515485|NCT01392378|447838295|FG001|Toddler Dose|Withdrawal by Parent|1|||
124515486|NCT01392378|447838296|FG002|Toddler Dose|Withdrawal by Parent|0|||
124515487|NCT01392378|447838297|FG003|Toddler Dose|Withdrawal by Parent|1|||
124515488|NCT01392378|447838298|FG004|Toddler Dose|Withdrawal by Parent|1|||
124515489|NCT02322411|447838299|FG000|Overall Study|Lost to Follow-up|4|||
124515490|NCT02322411|447838300|FG001|Overall Study|Lost to Follow-up|7|||
124515491|NCT02322411|447838299|FG000|Overall Study|Withdrawal by Subject|1|||
124515492|NCT02322411|447838300|FG001|Overall Study|Withdrawal by Subject|0|||
124515493|NCT02261883|447838302|FG000|Overall Study|Death|3|||
124515494|NCT02261883|447838303|FG001|Overall Study|Death|2|||
124515495|NCT02261883|447838302|FG000|Overall Study|Physician Decision|1|||
124515496|NCT02261883|447838303|FG001|Overall Study|Physician Decision|0|||
124570315|NCT00745095|448047240|FG005|Overall Study|Ineligible due to GFR criteria|28|||
124570316|NCT00958243|448047241|FG000|Overall Study|Withdrawal by Subject|0|||
124570317|NCT00958243|448047242|FG001|Overall Study|Withdrawal by Subject|1|||
124570318|NCT00958243|448047243|FG002|Overall Study|Withdrawal by Subject|3|||
124570319|NCT00958243|448047244|FG003|Overall Study|Withdrawal by Subject|1|||
124570320|NCT00958243|448047245|FG004|Overall Study|Withdrawal by Subject|1|||
124570321|NCT00958243|448047246|FG005|Overall Study|Withdrawal by Subject|5|||
124570322|NCT00958243|448047241|FG000|Overall Study|Lost to Follow-up|2|||
124570323|NCT00958243|448047242|FG001|Overall Study|Lost to Follow-up|5|||
124570324|NCT00958243|448047243|FG002|Overall Study|Lost to Follow-up|11|||
124570325|NCT00958243|448047244|FG003|Overall Study|Lost to Follow-up|2|||
124570326|NCT00958243|448047245|FG004|Overall Study|Lost to Follow-up|8|||
124570327|NCT00958243|448047246|FG005|Overall Study|Lost to Follow-up|5|||
124570328|NCT00162123|448047249|FG000|Overall Study|Disease progression|27|||
124570329|NCT00162123|448047250|FG001|Overall Study|Disease progression|19|||
124570330|NCT00162123|448047251|FG002|Overall Study|Disease progression|10|||
124570331|NCT00162123|448047252|FG003|Overall Study|Disease progression|4|||
124570332|NCT00162123|448047253|FG004|Overall Study|Disease progression|8|||
124570333|NCT00162123|448047254|FG005|Overall Study|Disease progression|3|||
124570334|NCT00162123|448047255|FG006|Overall Study|Disease progression|1|||
124570335|NCT00162123|448047256|FG007|Overall Study|Disease progression|0|||
124570336|NCT00162123|448047249|FG000|Overall Study|Study drug toxicity|6|||
124570337|NCT00162123|448047250|FG001|Overall Study|Study drug toxicity|1|||
124570338|NCT00162123|448047251|FG002|Overall Study|Study drug toxicity|5|||
124570339|NCT00162123|448047252|FG003|Overall Study|Study drug toxicity|0|||
124570340|NCT00162123|448047253|FG004|Overall Study|Study drug toxicity|4|||
124570341|NCT00162123|448047254|FG005|Overall Study|Study drug toxicity|1|||
124570342|NCT00162123|448047255|FG006|Overall Study|Study drug toxicity|1|||
124570343|NCT00162123|448047256|FG007|Overall Study|Study drug toxicity|0|||
124570344|NCT00162123|448047249|FG000|Overall Study|Death|3|||
124570345|NCT00162123|448047250|FG001|Overall Study|Death|3|||
124570346|NCT00162123|448047251|FG002|Overall Study|Death|1|||
124570347|NCT00162123|448047252|FG003|Overall Study|Death|1|||
124570348|NCT00162123|448047253|FG004|Overall Study|Death|1|||
124570349|NCT00162123|448047254|FG005|Overall Study|Death|1|||
124570350|NCT00162123|448047255|FG006|Overall Study|Death|0|||
124570351|NCT00162123|448047256|FG007|Overall Study|Death|0|||
124570352|NCT00162123|448047249|FG000|Overall Study|Withdrawal by Subject|2|||
124570353|NCT00162123|448047250|FG001|Overall Study|Withdrawal by Subject|0|||
124570354|NCT00162123|448047251|FG002|Overall Study|Withdrawal by Subject|2|||
124570355|NCT00162123|448047252|FG003|Overall Study|Withdrawal by Subject|1|||
124570356|NCT00162123|448047253|FG004|Overall Study|Withdrawal by Subject|1|||
124570357|NCT00162123|448047254|FG005|Overall Study|Withdrawal by Subject|2|||
124570358|NCT00162123|448047255|FG006|Overall Study|Withdrawal by Subject|1|||
124570359|NCT00162123|448047256|FG007|Overall Study|Withdrawal by Subject|0|||
124570360|NCT00162123|448047249|FG000|Overall Study|Deterioration without progression|2|||
124570361|NCT00162123|448047250|FG001|Overall Study|Deterioration without progression|2|||
124570362|NCT00162123|448047251|FG002|Overall Study|Deterioration without progression|3|||
124570363|NCT00162123|448047252|FG003|Overall Study|Deterioration without progression|0|||
124570364|NCT00162123|448047253|FG004|Overall Study|Deterioration without progression|1|||
124570365|NCT00162123|448047254|FG005|Overall Study|Deterioration without progression|0|||
124724966|NCT00842153|448613393|FG000|Overall Study|Adverse Event|0|||
124724967|NCT00842153|448613394|FG001|Overall Study|Adverse Event|1|||
124724968|NCT00842153|448613393|FG000|Overall Study|Lost to Follow-up|1|||
124724969|NCT00842153|448613394|FG001|Overall Study|Lost to Follow-up|2|||
124724970|NCT00002540|448613395|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
124724971|NCT00002540|448613396|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
124724972|NCT00002540|448613395|FG000|Overall Study|Died Before Randomization|2|||
124724973|NCT00002540|448613396|FG001|Overall Study|Died Before Randomization|6|||
124515497|NCT02261883|447838302|FG000|Overall Study|Protocol Violation|1|||
124515498|NCT02261883|447838303|FG001|Overall Study|Protocol Violation|0|||
124515499|NCT02261883|447838302|FG000|Overall Study|Withdrawal by Subject|0|||
124515500|NCT02261883|447838303|FG001|Overall Study|Withdrawal by Subject|1|||
124515501|NCT02261883|447838302|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
124515502|NCT02261883|447838303|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
124515503|NCT03549117|447838308|FG000|Overall Study|Withdrawal by Subject|1|||
124515504|NCT03549117|447838309|FG001|Overall Study|Withdrawal by Subject|0|||
124570366|NCT00162123|448047255|FG006|Overall Study|Deterioration without progression|0|||
124570367|NCT00162123|448047256|FG007|Overall Study|Deterioration without progression|0|||
124570368|NCT00162123|448047249|FG000|Overall Study|Adverse Event|1|||
124570369|NCT00162123|448047250|FG001|Overall Study|Adverse Event|2|||
124570370|NCT00162123|448047251|FG002|Overall Study|Adverse Event|0|||
124570371|NCT00162123|448047252|FG003|Overall Study|Adverse Event|2|||
124570372|NCT00162123|448047253|FG004|Overall Study|Adverse Event|1|||
124570373|NCT00162123|448047254|FG005|Overall Study|Adverse Event|0|||
124724974|NCT00002540|448613395|FG000|Overall Study|Died Before ASU (Control)|202|||
124724975|NCT00002540|448613396|FG001|Overall Study|Died Before ASU (Control)|0|||
124570374|NCT00162123|448047255|FG006|Overall Study|Adverse Event|0|||
124570375|NCT00162123|448047256|FG007|Overall Study|Adverse Event|0|||
124570376|NCT00162123|448047249|FG000|Overall Study|Not specified (before treatment)|2|||
124570377|NCT00162123|448047250|FG001|Overall Study|Not specified (before treatment)|0|||
124570378|NCT00162123|448047251|FG002|Overall Study|Not specified (before treatment)|0|||
124570379|NCT00162123|448047252|FG003|Overall Study|Not specified (before treatment)|0|||
124570380|NCT00162123|448047253|FG004|Overall Study|Not specified (before treatment)|12|||
124570381|NCT00162123|448047254|FG005|Overall Study|Not specified (before treatment)|1|||
124570382|NCT00162123|448047255|FG006|Overall Study|Not specified (before treatment)|0|||
124570383|NCT00162123|448047256|FG007|Overall Study|Not specified (before treatment)|0|||
124570384|NCT00162123|448047249|FG000|Overall Study|Not specified (after start of treatment)|0|||
124570385|NCT00162123|448047250|FG001|Overall Study|Not specified (after start of treatment)|0|||
124570386|NCT00162123|448047251|FG002|Overall Study|Not specified (after start of treatment)|0|||
124570387|NCT00162123|448047252|FG003|Overall Study|Not specified (after start of treatment)|0|||
124570388|NCT00162123|448047253|FG004|Overall Study|Not specified (after start of treatment)|3|||
124570389|NCT00162123|448047254|FG005|Overall Study|Not specified (after start of treatment)|0|||
124570390|NCT00162123|448047255|FG006|Overall Study|Not specified (after start of treatment)|0|||
124570391|NCT00162123|448047256|FG007|Overall Study|Not specified (after start of treatment)|0|||
124570392|NCT00162123|448047249|FG000|Overall Study|Physician Decision|1|||
124570393|NCT00162123|448047250|FG001|Overall Study|Physician Decision|2|||
124570394|NCT00162123|448047251|FG002|Overall Study|Physician Decision|0|||
124570395|NCT00162123|448047252|FG003|Overall Study|Physician Decision|0|||
124570396|NCT00162123|448047253|FG004|Overall Study|Physician Decision|0|||
124570397|NCT00162123|448047254|FG005|Overall Study|Physician Decision|1|||
124570398|NCT00162123|448047255|FG006|Overall Study|Physician Decision|1|||
124570399|NCT00162123|448047256|FG007|Overall Study|Physician Decision|0|||
124570400|NCT00162123|448047249|FG000|Overall Study|Tumor assessment only (not treated)|0|||
124570401|NCT00162123|448047250|FG001|Overall Study|Tumor assessment only (not treated)|0|||
124570402|NCT00162123|448047251|FG002|Overall Study|Tumor assessment only (not treated)|0|||
124570403|NCT00162123|448047252|FG003|Overall Study|Tumor assessment only (not treated)|0|||
124570404|NCT00162123|448047253|FG004|Overall Study|Tumor assessment only (not treated)|0|||
124570405|NCT00162123|448047254|FG005|Overall Study|Tumor assessment only (not treated)|0|||
124570406|NCT00162123|448047255|FG006|Overall Study|Tumor assessment only (not treated)|0|||
124570407|NCT00162123|448047256|FG007|Overall Study|Tumor assessment only (not treated)|1|||
124570408|NCT00162123|448047249|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
124570409|NCT00162123|448047250|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
124570410|NCT00162123|448047251|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
124570411|NCT00162123|448047252|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
124570412|NCT00162123|448047253|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
124570413|NCT00162123|448047254|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
124570414|NCT00162123|448047255|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
124570415|NCT00162123|448047256|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
124570416|NCT01936948|448047260|FG000|Overall Study|no 30-day follow-up data|0|||
124570417|NCT01936948|448047261|FG001|Overall Study|no 30-day follow-up data|3|||
124570418|NCT01936948|448047262|FG002|Overall Study|no 30-day follow-up data|3|||
124570419|NCT01936948|448047263|FG003|Overall Study|no 30-day follow-up data|3|||
124570420|NCT02781727|448047264|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
124570421|NCT02781727|448047265|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
124570422|NCT02781727|448047264|FG000|Treatment Period|Withdrawal by Subject|1|||
124570423|NCT02781727|448047265|FG001|Treatment Period|Withdrawal by Subject|0|||
124570424|NCT02781727|448047264|FG000|Treatment Period|Lost to Follow-up|0|||
124570425|NCT02781727|448047265|FG001|Treatment Period|Lost to Follow-up|1|||
124570426|NCT02327130|448047266|FG000|Overall Study|Discharged in less than 5 days|5|||
124570427|NCT02327130|448047266|FG000|Overall Study|Physician Decision|2|||
124570428|NCT02327130|448047266|FG000|Overall Study|Unable to provide breath sample|1|||
124570429|NCT02327130|448047266|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
124570430|NCT02327130|448047266|FG000|Overall Study|Met exclusion criteria|3|||
124570431|NCT00406848|448047267|FG000|Overall Study|Withdrawal by Subject|27|||
124570432|NCT00406848|448047268|FG001|Overall Study|Withdrawal by Subject|22|||
124570433|NCT00406848|448047267|FG000|Overall Study|Adverse Event|38|||
124570434|NCT00406848|448047268|FG001|Overall Study|Adverse Event|7|||
124570435|NCT00406848|448047267|FG000|Overall Study|Lack of Efficacy|9|||
124570436|NCT00406848|448047268|FG001|Overall Study|Lack of Efficacy|14|||
124570437|NCT00406848|448047267|FG000|Overall Study|Protocol Violation|10|||
124570438|NCT00406848|448047268|FG001|Overall Study|Protocol Violation|6|||
124570439|NCT00406848|448047267|FG000|Overall Study|Lost to Follow-up|6|||
124570440|NCT00406848|448047268|FG001|Overall Study|Lost to Follow-up|2|||
124570441|NCT00406848|448047267|FG000|Overall Study|Physician Decision|2|||
124570442|NCT00406848|448047268|FG001|Overall Study|Physician Decision|2|||
124570443|NCT00406848|448047267|FG000|Overall Study|Sponsor Decision|1|||
124570444|NCT00406848|448047268|FG001|Overall Study|Sponsor Decision|1|||
124570445|NCT00352690|448047269|FG000|Overall Study|Determined to be ineligible|2|||
124570446|NCT00352690|448047270|FG001|Overall Study|Determined to be ineligible|0|||
124570447|NCT02719522|448047275|FG000|Overall Study|Implant Failure|4|||
124570448|NCT02719522|448047275|FG000|Overall Study|Death|2|||
124570449|NCT02719522|448047275|FG000|Overall Study|Lost to Follow-up|5|||
124570450|NCT04025879|448047279|FG000|Randomization|Participant withdrew consent|0|||
124570451|NCT04025879|448047280|FG001|Randomization|Participant withdrew consent|1|||
124570452|NCT04025879|448047279|FG000|Randomization|Participant no longer met study criteria|1|||
124570453|NCT04025879|448047280|FG001|Randomization|Participant no longer met study criteria|1|||
124570454|NCT04025879|448047279|FG000|Treatment|Ongoing treatment|10|||
124570455|NCT04025879|448047280|FG001|Treatment|Ongoing treatment|8|||
124570456|NCT04025879|448047279|FG000|Treatment|Disease progression/recurrence|36|||
124570457|NCT04025879|448047280|FG001|Treatment|Disease progression/recurrence|72|||
124570458|NCT04025879|448047279|FG000|Treatment|Study drug toxicity|36|||
124570459|NCT04025879|448047280|FG001|Treatment|Study drug toxicity|13|||
124570460|NCT04025879|448047279|FG000|Treatment|Death|2|||
124570461|NCT04025879|448047280|FG001|Treatment|Death|0|||
124570462|NCT04025879|448047279|FG000|Treatment|Adverse event unrelated to study drug|21|||
124570463|NCT04025879|448047280|FG001|Treatment|Adverse event unrelated to study drug|14|||
124570464|NCT04025879|448047279|FG000|Treatment|Participant request to discontinue study treatment|16|||
124570465|NCT04025879|448047280|FG001|Treatment|Participant request to discontinue study treatment|8|||
124570466|NCT04025879|448047279|FG000|Treatment|Participant withdrew consent|1|||
124515505|NCT00367432|447838310|FG000|First Period (16 Weeks)|Adverse Event|6|||
124570467|NCT04025879|448047280|FG001|Treatment|Participant withdrew consent|3|||
124570468|NCT04025879|448047279|FG000|Treatment|Participant no longer meets study criteria|3|||
124570469|NCT04025879|448047280|FG001|Treatment|Participant no longer meets study criteria|2|||
124570470|NCT04025879|448047279|FG000|Treatment|Lost to Follow-up|1|||
124570471|NCT04025879|448047280|FG001|Treatment|Lost to Follow-up|0|||
124570472|NCT04025879|448047279|FG000|Treatment|Other reasons|15|||
124570473|NCT04025879|448047280|FG001|Treatment|Other reasons|17|||
124570474|NCT04025879|448047279|FG000|Treatment|Administrative reason by sponsor|0|||
124570475|NCT04025879|448047280|FG001|Treatment|Administrative reason by sponsor|1|||
124570476|NCT04025879|448047279|FG000|Treatment|Not reported|2|||
124570477|NCT04025879|448047280|FG001|Treatment|Not reported|0|||
124515506|NCT00367432|447838311|FG001|First Period (16 Weeks)|Adverse Event|0|||
124515507|NCT00367432|447838310|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
124515508|NCT00367432|447838311|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
124515509|NCT00367432|447838310|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
124515510|NCT00367432|447838311|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
124515511|NCT00367432|447838310|FG000|First Period (16 Weeks)|Other Reason|2|||
124515512|NCT00367432|447838311|FG001|First Period (16 Weeks)|Other Reason|0|||
124515513|NCT00367432|447838310|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
124515514|NCT00367432|447838311|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
124515515|NCT00367432|447838310|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
124515516|NCT00367432|447838311|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
124515517|NCT00367432|447838310|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
124515518|NCT00367432|447838311|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
124515519|NCT00367432|447838310|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
124515520|NCT00367432|447838311|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
124515521|NCT00367432|447838310|FG000|Second Period (up to 54 Months)|Other Reason|6|||
124515522|NCT00367432|447838311|FG001|Second Period (up to 54 Months)|Other Reason|2|||
124515523|NCT00903370|447838312|FG000|Overall Study|Death|13|||
124515524|NCT00903370|447838313|FG001|Overall Study|Death|10|||
124515525|NCT00903370|447838312|FG000|Overall Study|Withdrawal by Subject|9|||
124515526|NCT00903370|447838313|FG001|Overall Study|Withdrawal by Subject|6|||
124515527|NCT00903370|447838312|FG000|Overall Study|Lost to Follow-up|6|||
124515528|NCT00903370|447838313|FG001|Overall Study|Lost to Follow-up|8|||
124515529|NCT00014911|447838314|FG000|Overall Study|Adverse Event|1|||
124515530|NCT00014911|447838314|FG000|Overall Study|Lost to Follow-up|1|||
124515531|NCT00014911|447838314|FG000|Overall Study|Withdrawal by Subject|6|||
124515532|NCT00014911|447838314|FG000|Overall Study|Unknown Reasons|2|||
124515533|NCT00014911|447838314|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
124515534|NCT01924299|447838315|FG000|Period 2|Withdrawal by Subject|1|||
124570478|NCT02888171|448047281|FG000|Overall Study|Lost to Follow-up|2|||
124570479|NCT02888171|448047282|FG001|Overall Study|Lost to Follow-up|1|||
124570480|NCT02888171|448047281|FG000|Overall Study|Withdrawal by Subject|3|||
124570481|NCT02888171|448047282|FG001|Overall Study|Withdrawal by Subject|2|||
124570482|NCT02888171|448047281|FG000|Overall Study|Adverse Event|0|||
124570483|NCT02888171|448047282|FG001|Overall Study|Adverse Event|1|||
124515535|NCT01924299|447838316|FG001|Period 2|Withdrawal by Subject|0|||
124515536|NCT01924299|447838315|FG000|Period 2|Adverse Event|0|||
124515537|NCT01924299|447838316|FG001|Period 2|Adverse Event|1|||
124515538|NCT01999946|447838320|FG000|Overall Study|Participant not released from jail|2|||
124515539|NCT01999946|447838321|FG001|Overall Study|Participant not released from jail|2|||
124570484|NCT03805438|448048827|FG000|Overall Study|Lack of Efficacy|1|||
124570485|NCT03805438|448048827|FG000|Overall Study|Protocol Violation|1|||
124570486|NCT00366899|448048828|FG000|Infant Series|Withdrawal by Subject|4|||
124570487|NCT00366899|448048829|FG001|Infant Series|Withdrawal by Subject|7|||
124515540|NCT01999946|447838322|FG002|Overall Study|Participant not released from jail|0|||
124515541|NCT01999946|447838320|FG000|Overall Study|Not included in primary outcome analysis|0|||
124515542|NCT01999946|447838321|FG001|Overall Study|Not included in primary outcome analysis|0|||
124515543|NCT01999946|447838322|FG002|Overall Study|Not included in primary outcome analysis|79|||
124515544|NCT00642018|447838330|FG000|Overall Study|Adverse Event|11|||
124515545|NCT00642018|447838331|FG001|Overall Study|Adverse Event|36|||
124515546|NCT00642018|447838330|FG000|Overall Study|Withdrawal by Subject|4|||
124515547|NCT00642018|447838331|FG001|Overall Study|Withdrawal by Subject|10|||
124515548|NCT00642018|447838330|FG000|Overall Study|Progressive Disease|13|||
124515549|NCT00642018|447838331|FG001|Overall Study|Progressive Disease|18|||
124515550|NCT00642018|447838330|FG000|Overall Study|Physician Decision|0|||
124515551|NCT00642018|447838331|FG001|Overall Study|Physician Decision|10|||
124515552|NCT00642018|447838330|FG000|Overall Study|Protocol Violation|0|||
124515553|NCT00642018|447838331|FG001|Overall Study|Protocol Violation|1|||
124515554|NCT00642018|447838330|FG000|Overall Study|Death|0|||
124515555|NCT00642018|447838331|FG001|Overall Study|Death|3|||
124515556|NCT00642018|447838330|FG000|Overall Study|Entry Criteria Not Met|0|||
124515557|NCT00642018|447838331|FG001|Overall Study|Entry Criteria Not Met|1|||
124515558|NCT01544478|447840234|FG000|Overall Study|Adverse Event|1|||
124515559|NCT01544478|447840234|FG000|Overall Study|Death|1|||
124515560|NCT01544478|447840234|FG000|Overall Study|Lost to Follow-up|48|||
124515561|NCT01544478|447840234|FG000|Overall Study|Physician Decision|15|||
124515562|NCT01544478|447840234|FG000|Overall Study|Pregnancy|1|||
124515563|NCT01544478|447840234|FG000|Overall Study|Withdrawal by Subject|52|||
124515564|NCT02574481|447840235|FG000|Overall Study|Withdrawal by Subject|29|||
124515565|NCT02574481|447840236|FG001|Overall Study|Withdrawal by Subject|15|||
124515566|NCT02574481|447840237|FG002|Overall Study|Withdrawal by Subject|4|||
124515567|NCT02574481|447840238|FG003|Overall Study|Withdrawal by Subject|1|||
124515568|NCT02574481|447840235|FG000|Overall Study|Adverse Event|5|||
124515569|NCT02574481|447840236|FG001|Overall Study|Adverse Event|1|||
124515570|NCT02574481|447840237|FG002|Overall Study|Adverse Event|1|||
124515571|NCT02574481|447840238|FG003|Overall Study|Adverse Event|0|||
124515572|NCT02574481|447840235|FG000|Overall Study|Visit Missed|15|||
124515573|NCT02574481|447840236|FG001|Overall Study|Visit Missed|7|||
124515574|NCT02574481|447840237|FG002|Overall Study|Visit Missed|5|||
124515575|NCT02574481|447840238|FG003|Overall Study|Visit Missed|0|||
124515576|NCT02574481|447840235|FG000|Overall Study|Other|7|||
124515577|NCT02574481|447840236|FG001|Overall Study|Other|2|||
124515578|NCT02574481|447840237|FG002|Overall Study|Other|0|||
124515579|NCT02574481|447840238|FG003|Overall Study|Other|0|||
124515580|NCT02574481|447840235|FG000|Overall Study|Death|48|||
124515581|NCT02574481|447840236|FG001|Overall Study|Death|26|||
124515582|NCT02574481|447840237|FG002|Overall Study|Death|12|||
124515583|NCT02574481|447840238|FG003|Overall Study|Death|4|||
124515584|NCT02574481|447840235|FG000|Overall Study|Physician Decision|5|||
124515585|NCT02574481|447840236|FG001|Overall Study|Physician Decision|2|||
124515586|NCT02574481|447840237|FG002|Overall Study|Physician Decision|0|||
124515587|NCT02574481|447840238|FG003|Overall Study|Physician Decision|0|||
124515588|NCT02574481|447840235|FG000|Overall Study|Lost to Follow-up|5|||
124515589|NCT02574481|447840236|FG001|Overall Study|Lost to Follow-up|1|||
124515590|NCT02574481|447840237|FG002|Overall Study|Lost to Follow-up|3|||
124515591|NCT02574481|447840238|FG003|Overall Study|Lost to Follow-up|0|||
124515592|NCT02038790|447840243|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
124515593|NCT02038790|447840244|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
124515594|NCT00438464|447840248|FG000|Overall Study|Terminated Early|14|||
124515595|NCT00438464|447840249|FG001|Overall Study|Terminated Early|5|||
124515596|NCT00438464|447840248|FG000|Overall Study|Incomplete data submission|0|||
124515597|NCT00438464|447840249|FG001|Overall Study|Incomplete data submission|2|||
124515598|NCT03943446|447840250|FG000|Overall Study|Lost to Follow-up|0|||
124515599|NCT03943446|447840251|FG001|Overall Study|Lost to Follow-up|0|||
124515600|NCT03943446|447840252|FG002|Overall Study|Lost to Follow-up|1|||
124515601|NCT03943446|447840250|FG000|Overall Study|Withdrawal by Subject|1|||
124515602|NCT03943446|447840251|FG001|Overall Study|Withdrawal by Subject|1|||
124515603|NCT03943446|447840252|FG002|Overall Study|Withdrawal by Subject|2|||
124515604|NCT03943446|447840250|FG000|Overall Study|Study Terminated by Sponsor|1|||
124515605|NCT03943446|447840251|FG001|Overall Study|Study Terminated by Sponsor|2|||
124515606|NCT03943446|447840252|FG002|Overall Study|Study Terminated by Sponsor|1|||
124515607|NCT03943446|447840250|FG000|Overall Study|Reason not Specified|5|||
124515608|NCT03943446|447840251|FG001|Overall Study|Reason not Specified|1|||
124515609|NCT03943446|447840252|FG002|Overall Study|Reason not Specified|3|||
124515610|NCT01281189|447840257|FG000|Overall Study|Adverse Event|7|||
124515611|NCT01281189|447840258|FG001|Overall Study|Adverse Event|9|||
124515612|NCT01281189|447840257|FG000|Overall Study|Lost to Follow-up|6|||
124515613|NCT01281189|447840258|FG001|Overall Study|Lost to Follow-up|4|||
124515614|NCT01281189|447840257|FG000|Overall Study|Withdrawal by Subject|21|||
124515615|NCT01281189|447840258|FG001|Overall Study|Withdrawal by Subject|24|||
124515616|NCT01281189|447840257|FG000|Overall Study|Physician Decision|2|||
124515617|NCT01281189|447840258|FG001|Overall Study|Physician Decision|3|||
124515618|NCT01281189|447840257|FG000|Overall Study|Death|103|||
124570488|NCT00366899|448048828|FG000|Infant Series|Protocol Violation|2|||
124570489|NCT00366899|448048829|FG001|Infant Series|Protocol Violation|1|||
124570490|NCT00366899|448048828|FG000|Infant Series|Failed to return|1|||
124570491|NCT00366899|448048829|FG001|Infant Series|Failed to return|1|||
124570492|NCT00366899|448048828|FG000|Infant Series|Lost to Follow-up|0|||
124570493|NCT00366899|448048829|FG001|Infant Series|Lost to Follow-up|2|||
124570494|NCT00366899|448048828|FG000|Infant Series|Adverse Event|0|||
124570495|NCT00366899|448048829|FG001|Infant Series|Adverse Event|1|||
124570496|NCT00366899|448048828|FG000|Infant Series|Physician Decision|1|||
124570497|NCT00366899|448048829|FG001|Infant Series|Physician Decision|0|||
124570498|NCT00366899|448048828|FG000|Infant Series|Randomized but not consented|1|||
124570499|NCT00366899|448048829|FG001|Infant Series|Randomized but not consented|0|||
124570500|NCT00366899|448048828|FG000|After Infant Series|Lost to Follow-up|4|||
124570501|NCT00366899|448048829|FG001|After Infant Series|Lost to Follow-up|3|||
124570502|NCT00366899|448048828|FG000|After Infant Series|Withdrawal by Subject|1|||
124570503|NCT00366899|448048829|FG001|After Infant Series|Withdrawal by Subject|4|||
124570504|NCT00366899|448048828|FG000|After Infant Series|Adverse Event|1|||
124570505|NCT00366899|448048829|FG001|After Infant Series|Adverse Event|2|||
124570506|NCT00366899|448048828|FG000|After Infant Series|Protocol Violation|1|||
124570507|NCT00366899|448048829|FG001|After Infant Series|Protocol Violation|0|||
124570508|NCT00366899|448048828|FG000|Toddler Dose|Withdrawal by Subject|1|||
124570509|NCT00366899|448048829|FG001|Toddler Dose|Withdrawal by Subject|1|||
124570510|NCT00366899|448048828|FG000|Toddler Dose|Protocol Violation|1|||
124570511|NCT00366899|448048829|FG001|Toddler Dose|Protocol Violation|0|||
124570512|NCT01619800|448048830|FG000|Overall Study|study terminated|2|||
124570513|NCT01619800|448048831|FG001|Overall Study|study terminated|0|||
124570514|NCT00419770|448048833|FG000|Overall Study|Withdrawal by Subject|5|||
124570515|NCT00419770|448048834|FG001|Overall Study|Withdrawal by Subject|1|||
124570516|NCT02848326|448048835|FG000|Treatment Period|Adverse Event|5|||
124570517|NCT02848326|448048836|FG001|Treatment Period|Adverse Event|4|||
124570518|NCT02848326|448048837|FG002|Treatment Period|Adverse Event|11|||
124570519|NCT02848326|448048838|FG003|Treatment Period|Adverse Event|6|||
124570520|NCT02848326|448048839|FG004|Treatment Period|Adverse Event|5|||
124570521|NCT02848326|448048840|FG005|Treatment Period|Adverse Event|7|||
124570522|NCT02848326|448048835|FG000|Treatment Period|Withdrawal of Consent|20|||
124570523|NCT02848326|448048836|FG001|Treatment Period|Withdrawal of Consent|6|||
124570524|NCT02848326|448048837|FG002|Treatment Period|Withdrawal of Consent|9|||
124570525|NCT02848326|448048838|FG003|Treatment Period|Withdrawal of Consent|6|||
124570526|NCT02848326|448048839|FG004|Treatment Period|Withdrawal of Consent|9|||
124570527|NCT02848326|448048840|FG005|Treatment Period|Withdrawal of Consent|6|||
124570528|NCT02848326|448048835|FG000|Treatment Period|Lost to Follow-up|5|||
124570529|NCT02848326|448048836|FG001|Treatment Period|Lost to Follow-up|1|||
124570530|NCT02848326|448048837|FG002|Treatment Period|Lost to Follow-up|11|||
124570531|NCT02848326|448048838|FG003|Treatment Period|Lost to Follow-up|7|||
124570532|NCT02848326|448048839|FG004|Treatment Period|Lost to Follow-up|2|||
124570533|NCT02848326|448048840|FG005|Treatment Period|Lost to Follow-up|3|||
124570534|NCT02848326|448048835|FG000|Treatment Period|Pregnancy|0|||
124570535|NCT02848326|448048836|FG001|Treatment Period|Pregnancy|0|||
124570536|NCT02848326|448048837|FG002|Treatment Period|Pregnancy|1|||
124570537|NCT02848326|448048838|FG003|Treatment Period|Pregnancy|1|||
124570538|NCT02848326|448048839|FG004|Treatment Period|Pregnancy|0|||
124570539|NCT02848326|448048840|FG005|Treatment Period|Pregnancy|1|||
124570540|NCT02848326|448048835|FG000|Treatment Period|Protocol Violation|4|||
124570541|NCT02848326|448048836|FG001|Treatment Period|Protocol Violation|3|||
124570542|NCT02848326|448048837|FG002|Treatment Period|Protocol Violation|4|||
124570543|NCT02848326|448048838|FG003|Treatment Period|Protocol Violation|2|||
124570544|NCT02848326|448048839|FG004|Treatment Period|Protocol Violation|3|||
124570545|NCT02848326|448048840|FG005|Treatment Period|Protocol Violation|3|||
124570546|NCT02848326|448048835|FG000|Treatment Period|Non-compliance with Study Drug|4|||
124570547|NCT02848326|448048836|FG001|Treatment Period|Non-compliance with Study Drug|0|||
124570548|NCT02848326|448048837|FG002|Treatment Period|Non-compliance with Study Drug|0|||
124570549|NCT02848326|448048838|FG003|Treatment Period|Non-compliance with Study Drug|1|||
124570550|NCT02848326|448048839|FG004|Treatment Period|Non-compliance with Study Drug|0|||
124570551|NCT02848326|448048840|FG005|Treatment Period|Non-compliance with Study Drug|0|||
124570552|NCT02848326|448048835|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
124570553|NCT02848326|448048836|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
124570554|NCT02848326|448048837|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
124570555|NCT02848326|448048838|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
124570556|NCT02848326|448048839|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
124570557|NCT02848326|448048840|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
124570558|NCT02848326|448048835|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
124570559|NCT02848326|448048836|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
124570560|NCT02848326|448048837|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
124570561|NCT02848326|448048838|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
124570562|NCT02848326|448048839|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
124570563|NCT02848326|448048840|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
124570564|NCT04526210|448048847|FG000|Overall Study|Sponsor decision|7|||
124570565|NCT04526210|448048848|FG001|Overall Study|Sponsor decision|5|||
124570566|NCT04526210|448048847|FG000|Overall Study|Withdrawal by Subject|3|||
124570567|NCT04526210|448048848|FG001|Overall Study|Withdrawal by Subject|2|||
124570568|NCT01781637|448048849|FG000|Overall Study|Adverse Event|1|||
124570569|NCT01781637|448048850|FG001|Overall Study|Adverse Event|0|||
124570570|NCT01781637|448048849|FG000|Overall Study|Lack of Efficacy|2|||
124570571|NCT01781637|448048850|FG001|Overall Study|Lack of Efficacy|6|||
124570572|NCT01781637|448048849|FG000|Overall Study|Withdrawal by Subject|1|||
124570573|NCT01781637|448048850|FG001|Overall Study|Withdrawal by Subject|0|||
124570574|NCT02999178|448048851|FG000|Overall Study|Adverse Event|85|||
124570575|NCT02999178|448048852|FG001|Overall Study|Adverse Event|62|||
124570576|NCT02999178|448048851|FG000|Overall Study|Protocol Violation|1|||
124570577|NCT02999178|448048852|FG001|Overall Study|Protocol Violation|2|||
124570578|NCT02999178|448048851|FG000|Overall Study|Lost to Follow-up|0|||
124570579|NCT02999178|448048852|FG001|Overall Study|Lost to Follow-up|2|||
124570580|NCT02999178|448048851|FG000|Overall Study|Withdrawal by Subject|21|||
124570581|NCT02999178|448048852|FG001|Overall Study|Withdrawal by Subject|21|||
124570582|NCT02999178|448048851|FG000|Overall Study|Other reason not defined above|7|||
124570583|NCT02999178|448048852|FG001|Overall Study|Other reason not defined above|13|||
124570584|NCT03471078|448048860|FG000|Overall Study|Withdrawal by Subject|9|||
124570585|NCT03471078|448048861|FG001|Overall Study|Withdrawal by Subject|1|||
124570586|NCT03471078|448048860|FG000|Overall Study|Adverse Event|4|||
124570587|NCT03471078|448048861|FG001|Overall Study|Adverse Event|1|||
124570588|NCT03471078|448048860|FG000|Overall Study|Physician Decision|3|||
124570589|NCT03471078|448048861|FG001|Overall Study|Physician Decision|2|||
124515619|NCT01281189|447840258|FG001|Overall Study|Death|91|||
124515620|NCT01281189|447840257|FG000|Overall Study|Other|8|||
124515621|NCT01281189|447840258|FG001|Overall Study|Other|12|||
124515622|NCT05355818|447840259|FG000|Overall Study|Adverse Event|1|||
124515623|NCT05355818|447840260|FG001|Overall Study|Adverse Event|1|||
124515624|NCT05355818|447840259|FG000|Overall Study|Lack of Efficacy|2|||
124515625|NCT05355818|447840260|FG001|Overall Study|Lack of Efficacy|1|||
124515626|NCT05355818|447840259|FG000|Overall Study|Lost to Follow-up|0|||
124515627|NCT05355818|447840260|FG001|Overall Study|Lost to Follow-up|1|||
124515628|NCT00092677|447840269|FG000|Overall Study|Lost to Follow-up|0|||
124515629|NCT00092677|447840270|FG001|Overall Study|Lost to Follow-up|2|||
124515630|NCT00092677|447840269|FG000|Overall Study|Adminstrative|5|||
124515631|NCT00092677|447840270|FG001|Overall Study|Adminstrative|9|||
124515632|NCT01601704|447840271|FG000|Overall Study|Randomized but not dispensed study med|1|||
124515633|NCT01601704|447840272|FG001|Overall Study|Randomized but not dispensed study med|4|||
124515634|NCT01090102|447840273|FG000|First 12 Weeks|Withdrawal by Subject|1|||
124515635|NCT01090102|447840274|FG001|First 12 Weeks|Withdrawal by Subject|1|||
124515636|NCT01090102|447840273|FG000|First 12 Weeks|Adverse Event|2|||
124515637|NCT01090102|447840274|FG001|First 12 Weeks|Adverse Event|0|||
124515638|NCT01090102|447840273|FG000|First 12 Weeks|Death|1|||
124515639|NCT01090102|447840274|FG001|First 12 Weeks|Death|1|||
124515640|NCT01090102|447840273|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
124515641|NCT01090102|447840274|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
124515642|NCT03518034|447840275|FG000|Overall Study|Not Treated|5|||
124515643|NCT03518034|447840276|FG001|Overall Study|Not Treated|1|||
124515644|NCT03518034|447840275|FG000|Overall Study|Withdrawal by Subject|309|||
124515645|NCT03518034|447840276|FG001|Overall Study|Withdrawal by Subject|351|||
124515646|NCT03518034|447840275|FG000|Overall Study|Lost to Follow-up|446|||
124515647|NCT03518034|447840276|FG001|Overall Study|Lost to Follow-up|458|||
124515648|NCT03518034|447840275|FG000|Overall Study|Adverse Event|138|||
124570590|NCT03471078|448048860|FG000|Overall Study|Death|2|||
124570591|NCT03471078|448048861|FG001|Overall Study|Death|0|||
124570592|NCT03471078|448048860|FG000|Overall Study|Other|3|||
124570593|NCT03471078|448048861|FG001|Overall Study|Other|2|||
124570594|NCT02473640|448048862|FG000|Treatment Period 1|Adverse Event|1|||
124570595|NCT02127281|448048863|FG000|Overall Study|Lost to Follow-up|1|||
124570596|NCT02127281|448048864|FG001|Overall Study|Lost to Follow-up|0|||
124570597|NCT03292653|448048868|FG000|Overall Study|Adverse Event|0|||
124570598|NCT03292653|448048869|FG001|Overall Study|Adverse Event|0|||
124570599|NCT03292653|448048870|FG002|Overall Study|Adverse Event|1|||
124570600|NCT03292653|448048868|FG000|Overall Study|Did not Receive Treatment|1|||
124570601|NCT03292653|448048869|FG001|Overall Study|Did not Receive Treatment|0|||
124776715|NCT00998296|448809945|FG000|Overall Study|Reason other than those specified above|0|||
124515649|NCT03518034|447840276|FG001|Overall Study|Adverse Event|130|||
124515650|NCT03518034|447840275|FG000|Overall Study|Lack of Efficacy|11|||
124515651|NCT03518034|447840276|FG001|Overall Study|Lack of Efficacy|23|||
124515652|NCT03518034|447840275|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
124515653|NCT03518034|447840276|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
124515654|NCT03518034|447840275|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
124515655|NCT03518034|447840276|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
124515656|NCT03518034|447840275|FG000|Overall Study|Other, Not Specified|84|||
124515657|NCT03518034|447840276|FG001|Overall Study|Other, Not Specified|53|||
124570602|NCT03292653|448048870|FG002|Overall Study|Did not Receive Treatment|0|||
124515658|NCT03518034|447840275|FG000|Overall Study|Reason Missing|2|||
124515659|NCT03518034|447840276|FG001|Overall Study|Reason Missing|3|||
124515660|NCT00010803|447840282|FG000|Overall Study|Withdrawal by Subject|97|||
124515661|NCT00010803|447840283|FG001|Overall Study|Withdrawal by Subject|98|||
124515662|NCT04209530|447840284|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
124515663|NCT04209530|447840285|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
124515664|NCT04209530|447840284|FG000|Overall Study|Withdrawal by Subject|0|||
124515665|NCT04209530|447840285|FG001|Overall Study|Withdrawal by Subject|1|||
124515666|NCT00985738|447840299|FG000|Overall Study|Study closed prematurely|8|||
124515667|NCT00985738|447840300|FG001|Overall Study|Study closed prematurely|8|||
124515668|NCT02227849|447840302|FG000|Overall Study|Adverse Event|4|||
124515669|NCT02227849|447840302|FG000|Overall Study|Physician Decision|1|||
124515670|NCT02227849|447840302|FG000|Overall Study|Withdrawal by Subject|3|||
124515671|NCT01590212|447840303|FG000|Overall Study|Withdrawal by Subject|2|||
124515672|NCT01590212|447840304|FG001|Overall Study|Withdrawal by Subject|2|||
124515673|NCT01590212|447840305|FG002|Overall Study|Withdrawal by Subject|2|||
124515674|NCT01590212|447840303|FG000|Overall Study|Lost to Follow-up|1|||
124515675|NCT01590212|447840304|FG001|Overall Study|Lost to Follow-up|2|||
124515676|NCT01590212|447840305|FG002|Overall Study|Lost to Follow-up|3|||
124515677|NCT04897594|447840306|FG000|Overall Study|Lost to Follow-up|0|||
124515678|NCT04897594|447840307|FG001|Overall Study|Lost to Follow-up|1|||
124515679|NCT04897594|447840308|FG002|Overall Study|Lost to Follow-up|1|||
124515680|NCT04897594|447840306|FG000|Overall Study|Sponsor Decision|0|||
124515681|NCT04897594|447840307|FG001|Overall Study|Sponsor Decision|0|||
124515682|NCT04897594|447840308|FG002|Overall Study|Sponsor Decision|1|||
124515683|NCT04897594|447840306|FG000|Overall Study|Withdrawal by Subject|1|||
124515684|NCT04897594|447840307|FG001|Overall Study|Withdrawal by Subject|0|||
124515685|NCT04897594|447840308|FG002|Overall Study|Withdrawal by Subject|1|||
124515686|NCT01628393|447840315|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
124515687|NCT01628393|447840316|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
124515688|NCT01628393|447840317|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
124515689|NCT01628393|447840318|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
124515690|NCT01628393|447840319|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
124515691|NCT01628393|447840315|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
124515692|NCT01628393|447840316|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
124515693|NCT01628393|447840317|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
124515694|NCT01628393|447840318|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
124515695|NCT01628393|447840319|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
124515696|NCT01628393|447840315|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
124515697|NCT01628393|447840316|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
124515698|NCT01628393|447840317|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
124515699|NCT01628393|447840318|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
124515700|NCT01628393|447840319|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
124515701|NCT01628393|447840315|FG000|Blinded Active Extension Period|Adverse Event|0|||
124515702|NCT01628393|447840316|FG001|Blinded Active Extension Period|Adverse Event|1|||
124515703|NCT01628393|447840317|FG002|Blinded Active Extension Period|Adverse Event|0|||
124515704|NCT01628393|447840318|FG003|Blinded Active Extension Period|Adverse Event|2|||
124515705|NCT01628393|447840319|FG004|Blinded Active Extension Period|Adverse Event|2|||
124515706|NCT01628393|447840315|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
124515707|NCT01628393|447840316|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
124515708|NCT01628393|447840317|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
124515709|NCT01628393|447840318|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
124515710|NCT01628393|447840319|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
124515711|NCT01628393|447840315|FG000|Blinded Active Extension Period|Physician Decision|0|||
124515712|NCT01628393|447840316|FG001|Blinded Active Extension Period|Physician Decision|3|||
124515713|NCT01628393|447840317|FG002|Blinded Active Extension Period|Physician Decision|0|||
124515714|NCT01628393|447840318|FG003|Blinded Active Extension Period|Physician Decision|1|||
124515715|NCT01628393|447840319|FG004|Blinded Active Extension Period|Physician Decision|0|||
124515716|NCT01628393|447840315|FG000|Blinded Active Extension Period|Protocol Violation|0|||
124515717|NCT01628393|447840316|FG001|Blinded Active Extension Period|Protocol Violation|0|||
124515718|NCT01628393|447840317|FG002|Blinded Active Extension Period|Protocol Violation|2|||
124515719|NCT01628393|447840318|FG003|Blinded Active Extension Period|Protocol Violation|1|||
124515720|NCT01628393|447840319|FG004|Blinded Active Extension Period|Protocol Violation|0|||
124515721|NCT01628393|447840315|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
124515722|NCT01628393|447840316|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
124515723|NCT01628393|447840317|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
124515724|NCT01628393|447840318|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
124515725|NCT01628393|447840319|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
124515726|NCT00792701|447840321|FG000|Overall Study|Adverse Event|0|||
124515727|NCT00792701|447840322|FG001|Overall Study|Adverse Event|22|||
124515728|NCT00792701|447840321|FG000|Overall Study|Ineligible|1|||
124515729|NCT00792701|447840322|FG001|Overall Study|Ineligible|3|||
124515730|NCT00792701|447840321|FG000|Overall Study|Withdrawal by Subject|1|||
124515731|NCT00792701|447840322|FG001|Overall Study|Withdrawal by Subject|19|||
124515732|NCT00792701|447840321|FG000|Overall Study|Not protocol specified|17|||
124515733|NCT00792701|447840322|FG001|Overall Study|Not protocol specified|0|||
124515734|NCT03862495|447840331|FG000|Overall Study|Lost to Follow-up|37|||
124515735|NCT03862495|447840332|FG001|Overall Study|Lost to Follow-up|35|||
124515736|NCT01467661|447840333|FG000|Overall Study|Adverse Event|16|||
124515737|NCT01467661|447840333|FG000|Overall Study|Withdrawal by Subject|1|||
124515738|NCT01467661|447840333|FG000|Overall Study|Lack of Efficacy|3|||
124515739|NCT01467661|447840333|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
124515740|NCT03673956|447840334|FG000|Overall Study|Lost to Follow-up|1|||
124515741|NCT03673956|447840335|FG001|Overall Study|Lost to Follow-up|0|||
124515742|NCT03673956|447840336|FG002|Overall Study|Lost to Follow-up|0|||
124515743|NCT03673956|447840337|FG003|Overall Study|Lost to Follow-up|0|||
124515744|NCT03673956|447840334|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
124515745|NCT03673956|447840335|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
124515746|NCT03673956|447840336|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
124515747|NCT03673956|447840337|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
124515748|NCT00425113|447840338|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
124515749|NCT00425113|447840339|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
124515750|NCT00425113|447840338|FG000|Overall Study|diagnosis of abdominal TB|0|||
124515751|NCT00425113|447840339|FG001|Overall Study|diagnosis of abdominal TB|1|||
124515752|NCT00425113|447840338|FG000|Overall Study|missing study drug more than 14 days|0|||
124515753|NCT00425113|447840339|FG001|Overall Study|missing study drug more than 14 days|1|||
124515754|NCT00425113|447840338|FG000|Overall Study|Withdrawal by Subject|1|||
124515755|NCT00425113|447840339|FG001|Overall Study|Withdrawal by Subject|0|||
124515756|NCT01074658|447840340|FG000|Overall Study|No implant attempted|19|||
124515757|NCT01342952|447840341|FG000|Overall Study|Adverse Event|0|||
124515758|NCT01342952|447840342|FG001|Overall Study|Adverse Event|5|||
124515759|NCT01342952|447840343|FG002|Overall Study|Adverse Event|1|||
124515760|NCT01342952|447840344|FG003|Overall Study|Adverse Event|0|||
124515761|NCT01342952|447840341|FG000|Overall Study|Lost to Follow-up|0|||
124515762|NCT01342952|447840342|FG001|Overall Study|Lost to Follow-up|2|||
124515763|NCT01342952|447840343|FG002|Overall Study|Lost to Follow-up|0|||
124515764|NCT01342952|447840344|FG003|Overall Study|Lost to Follow-up|0|||
124515765|NCT01342952|447840341|FG000|Overall Study|Withdrawal by Subject|1|||
124515766|NCT01342952|447840342|FG001|Overall Study|Withdrawal by Subject|1|||
124515767|NCT01342952|447840343|FG002|Overall Study|Withdrawal by Subject|0|||
124515768|NCT01342952|447840344|FG003|Overall Study|Withdrawal by Subject|0|||
124515769|NCT01342952|447840341|FG000|Overall Study|Physician Decision|3|||
124515770|NCT01342952|447840342|FG001|Overall Study|Physician Decision|3|||
124515771|NCT01342952|447840343|FG002|Overall Study|Physician Decision|1|||
124515772|NCT01342952|447840344|FG003|Overall Study|Physician Decision|0|||
124515773|NCT02156804|447840345|FG000|Overall Study|Withdrawal by Subject|1|||
124515774|NCT00879437|447840346|FG000|Overall Study|Protocol Violation|0|||
124515775|NCT00879437|447840347|FG001|Overall Study|Protocol Violation|1|||
124515776|NCT00879437|447840346|FG000|Overall Study|Death|1|||
124515777|NCT00879437|447840347|FG001|Overall Study|Death|0|||
124515778|NCT04581863|447840348|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
124515779|NCT04581863|447840349|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
124515780|NCT01803711|447840350|FG000|Overall Study|Adverse Event|1|||
124515781|NCT01803711|447840351|FG001|Overall Study|Adverse Event|1|||
124515782|NCT00636441|447840352|FG000|Overall Study|Adverse Event|0|||
124515783|NCT00636441|447840353|FG001|Overall Study|Adverse Event|1|||
124515784|NCT00636441|447840354|FG002|Overall Study|Adverse Event|1|||
124515785|NCT00636441|447840355|FG003|Overall Study|Adverse Event|0|||
124515786|NCT00636441|447840356|FG004|Overall Study|Adverse Event|0|||
124515787|NCT00636441|447840357|FG005|Overall Study|Adverse Event|1|||
124515788|NCT00636441|447840358|FG006|Overall Study|Adverse Event|0|||
124515789|NCT00636441|447840352|FG000|Overall Study|Late, ineligible|0|||
124515790|NCT00636441|447840353|FG001|Overall Study|Late, ineligible|0|||
124515791|NCT00636441|447840354|FG002|Overall Study|Late, ineligible|0|||
124515792|NCT00636441|447840355|FG003|Overall Study|Late, ineligible|0|||
124515793|NCT00636441|447840356|FG004|Overall Study|Late, ineligible|0|||
124515794|NCT00636441|447840357|FG005|Overall Study|Late, ineligible|0|||
124515795|NCT00636441|447840358|FG006|Overall Study|Late, ineligible|1|||
124515796|NCT00636441|447840352|FG000|Overall Study|Screen Failure|0|||
124515797|NCT00636441|447840353|FG001|Overall Study|Screen Failure|0|||
124515798|NCT00636441|447840354|FG002|Overall Study|Screen Failure|0|||
124515799|NCT00636441|447840355|FG003|Overall Study|Screen Failure|0|||
124515800|NCT00636441|447840356|FG004|Overall Study|Screen Failure|0|||
124515801|NCT00636441|447840357|FG005|Overall Study|Screen Failure|0|||
124515802|NCT00636441|447840358|FG006|Overall Study|Screen Failure|17|||
124515803|NCT03495817|447840362|FG000|26 Week Open Label|Adverse Event|3|||
124570603|NCT04720664|448048871|FG000|Overall Study|Adverse Event|2|||
124570604|NCT04720664|448048871|FG000|Overall Study|Lack of Efficacy|9|||
124570605|NCT05628675|448048872|FG000|Overall Study|Lost to Follow-up|2|||
124570606|NCT05628675|448048872|FG000|Overall Study|Withdrawal by Subject|1|||
124570607|NCT05818137|448048876|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
124570608|NCT05818137|448048876|FG000|Extension Treatment Period|Ongoing participants|44|||
124570609|NCT01648166|448048879|FG000|Overall Study|inadequate toenail samples|53|||
124570610|NCT01648166|448048880|FG001|Overall Study|inadequate toenail samples|100|||
124515804|NCT03495817|447840362|FG000|26 Week Open Label|Withdrawal by Subject|4|||
124515805|NCT03495817|447840362|FG000|26 Week Open Label|Lost to Follow-up|1|||
124515806|NCT03495817|447840362|FG000|26 Week Extension|Lost to Follow-up|2|||
124515807|NCT04585451|447840366|FG000|Overall Study|Withdrawal by Subject|26|||
124515808|NCT04585451|447840367|FG001|Overall Study|Withdrawal by Subject|0|||
124515809|NCT02849626|447840374|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
124515810|NCT02849626|447840375|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
124515811|NCT02849626|447840376|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
124515812|NCT02849626|447840377|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
124515813|NCT02849626|447840374|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
124515814|NCT02849626|447840375|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
124515815|NCT02849626|447840376|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
124515816|NCT02849626|447840377|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
124515817|NCT02849626|447840374|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
124515818|NCT02849626|447840375|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
124515819|NCT02849626|447840376|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
124515820|NCT02849626|447840377|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
124515821|NCT02849626|447840374|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
124515822|NCT02849626|447840375|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
124515823|NCT02849626|447840376|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
124515824|NCT02849626|447840377|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
124515825|NCT02849626|447840374|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
124515826|NCT02849626|447840375|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
124515827|NCT02849626|447840376|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
124515828|NCT02849626|447840377|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
124515829|NCT02849626|447840374|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
124515830|NCT02849626|447840375|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
124515831|NCT02849626|447840376|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
124515832|NCT02849626|447840377|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
124515833|NCT02849626|447840374|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
124515834|NCT02849626|447840375|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
124515835|NCT02849626|447840376|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
124515836|NCT02849626|447840377|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
124515837|NCT02849626|447840374|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
124515838|NCT02849626|447840375|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
124515839|NCT02849626|447840376|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
124515840|NCT02849626|447840377|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
124515841|NCT02849626|447840374|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
124515842|NCT02849626|447840375|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
124515843|NCT02849626|447840376|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
124515844|NCT02849626|447840377|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
124515845|NCT02849626|447840374|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
124515846|NCT02849626|447840375|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
124515847|NCT02849626|447840376|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
124515848|NCT02849626|447840377|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
124515849|NCT02849626|447840374|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
124515850|NCT02849626|447840375|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
124515851|NCT02849626|447840376|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
124515852|NCT02849626|447840377|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
124515853|NCT01957787|447840378|FG000|Overall Study|Death|18|||
124570611|NCT00883090|448048881|FG000|Overall Study|Sponsor's decision|1|||
124515854|NCT01957787|447840378|FG000|Overall Study|Lost to Follow-up|3|||
124515855|NCT01957787|447840378|FG000|Overall Study|Withdrawal by Subject|3|||
124515856|NCT01957787|447840378|FG000|Overall Study|Entered Hospice or Similar Program|2|||
124515857|NCT01957787|447840378|FG000|Overall Study|Index Tumor(s) Resected|2|||
124515858|NCT01957787|447840378|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
124515859|NCT01957787|447840378|FG000|Overall Study|Local therapy, not cryoablation|6|||
124515860|NCT04176445|447840379|FG000|Overall Study|Adverse Event|0|||
124515861|NCT04176445|447840380|FG001|Overall Study|Adverse Event|1|||
124515862|NCT04176445|447840379|FG000|Overall Study|change plans weaning after first intervention|0|||
124570612|NCT00883090|448048881|FG000|Overall Study|Withdrawal by Subject|1|||
124570613|NCT01475838|448048884|FG000|Randomized Phase|Randomized but Not Treated|0|||
124570614|NCT01475838|448048885|FG001|Randomized Phase|Randomized but Not Treated|5|||
124515863|NCT04176445|447840380|FG001|Overall Study|change plans weaning after first intervention|1|||
124515864|NCT02248857|447840381|FG000|3 Month|Withdrawal by Subject|9|||
124515865|NCT02248857|447840382|FG001|3 Month|Withdrawal by Subject|3|||
124515866|NCT02248857|447840383|FG002|3 Month|Withdrawal by Subject|4|||
124515867|NCT02248857|447840381|FG000|3 Month|Unable to reach for 3 month|35|||
124515868|NCT02248857|447840382|FG001|3 Month|Unable to reach for 3 month|29|||
124515869|NCT02248857|447840383|FG002|3 Month|Unable to reach for 3 month|26|||
124515870|NCT02248857|447840381|FG000|3 Month|Partially completed, unable to finish|2|||
124515871|NCT02248857|447840382|FG001|3 Month|Partially completed, unable to finish|2|||
124515872|NCT02248857|447840383|FG002|3 Month|Partially completed, unable to finish|1|||
124515873|NCT02248857|447840381|FG000|6 Month|Lost to Follow-up|27|||
124515874|NCT02248857|447840382|FG001|6 Month|Lost to Follow-up|26|||
124515875|NCT02248857|447840383|FG002|6 Month|Lost to Follow-up|15|||
124515876|NCT02248857|447840381|FG000|6 Month|Partially completed, unable to finish|0|||
124515877|NCT02248857|447840382|FG001|6 Month|Partially completed, unable to finish|1|||
124515878|NCT02248857|447840383|FG002|6 Month|Partially completed, unable to finish|0|||
124515879|NCT02248857|447840381|FG000|6 Month|Withdrawal by Subject|0|||
124515880|NCT02248857|447840382|FG001|6 Month|Withdrawal by Subject|2|||
124515881|NCT02248857|447840383|FG002|6 Month|Withdrawal by Subject|2|||
124515882|NCT02248857|447840381|FG000|6 Month|Death|1|||
124515883|NCT02248857|447840382|FG001|6 Month|Death|0|||
124515884|NCT02248857|447840383|FG002|6 Month|Death|0|||
124515885|NCT01412060|447840384|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
124515886|NCT01412060|447840385|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
124515887|NCT01412060|447840386|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
124515888|NCT01412060|447840384|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
124515889|NCT01412060|447840385|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
124515890|NCT01412060|447840386|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
124515891|NCT01412060|447840384|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
124515892|NCT01412060|447840385|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
124515893|NCT01412060|447840386|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
124515894|NCT01412060|447840384|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
124515895|NCT01412060|447840385|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
124515896|NCT01412060|447840386|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
124515897|NCT01412060|447840384|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
124515898|NCT01412060|447840385|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
124515899|NCT01412060|447840386|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
124515900|NCT01412060|447840384|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
124515901|NCT01412060|447840385|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
124515902|NCT01412060|447840386|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
124515903|NCT01412060|447840384|FG000|Period Between RIP and SP|Adverse Event|4|||
124515904|NCT01412060|447840385|FG001|Period Between RIP and SP|Adverse Event|0|||
124515905|NCT01412060|447840386|FG002|Period Between RIP and SP|Adverse Event|0|||
124515906|NCT01412060|447840384|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
124515907|NCT01412060|447840385|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
124515908|NCT01412060|447840386|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
124515909|NCT01412060|447840384|FG000|Period Between RIP and SP|Protocol Violation|2|||
124515910|NCT01412060|447840385|FG001|Period Between RIP and SP|Protocol Violation|0|||
124515911|NCT01412060|447840386|FG002|Period Between RIP and SP|Protocol Violation|0|||
124515912|NCT01412060|447840384|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
124515913|NCT01412060|447840385|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
124515914|NCT01412060|447840386|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
124515915|NCT01412060|447840384|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
124515916|NCT01412060|447840385|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
124515917|NCT01412060|447840386|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
124515918|NCT01412060|447840384|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
124515919|NCT01412060|447840385|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
124515920|NCT01412060|447840386|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
124515921|NCT01412060|447840384|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
124515922|NCT01412060|447840385|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
124515923|NCT01412060|447840386|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
124515924|NCT01412060|447840384|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
124515925|NCT01412060|447840385|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
124515926|NCT01412060|447840386|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
124515927|NCT01412060|447840384|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
124515928|NCT01412060|447840385|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
124515929|NCT01412060|447840386|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
124515930|NCT01412060|447840384|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
124515931|NCT01412060|447840385|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
124570615|NCT01475838|448048884|FG000|Randomized Phase|Adverse Event|6|||
124570616|NCT01475838|448048885|FG001|Randomized Phase|Adverse Event|1|||
124570617|NCT01475838|448048884|FG000|Randomized Phase|Pregnancy|0|||
124570618|NCT01475838|448048885|FG001|Randomized Phase|Pregnancy|1|||
124570619|NCT01475838|448048884|FG000|Randomized Phase|Investigators Discretion|1|||
124570620|NCT01475838|448048885|FG001|Randomized Phase|Investigators Discretion|2|||
124570621|NCT01475838|448048884|FG000|Randomized Phase|Withdrew Consent|10|||
124570622|NCT01475838|448048885|FG001|Randomized Phase|Withdrew Consent|14|||
124570623|NCT01475838|448048884|FG000|Randomized Phase|Lost to Follow-up|3|||
124570624|NCT01475838|448048885|FG001|Randomized Phase|Lost to Follow-up|4|||
124570625|NCT01475838|448048884|FG000|Randomized Phase|Participant Noncompliance|1|||
124570626|NCT01475838|448048885|FG001|Randomized Phase|Participant Noncompliance|5|||
124570627|NCT01475838|448048884|FG000|Randomized Phase|Protocol Violation|9|||
124570628|NCT01475838|448048885|FG001|Randomized Phase|Protocol Violation|4|||
124570629|NCT01475838|448048884|FG000|Extension Phase|Participant Noncompliance|1|||
124570630|NCT01475838|448048885|FG001|Extension Phase|Participant Noncompliance|0|||
124570631|NCT00048568|448048886|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
124570632|NCT00048568|448048887|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
124570633|NCT00048568|448048888|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
124570634|NCT00048568|448048886|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
124570635|NCT00048568|448048887|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
124570636|NCT00048568|448048888|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
124570637|NCT00048568|448048886|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
124570638|NCT00048568|448048887|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
124570639|NCT00048568|448048888|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
124570640|NCT00048568|448048886|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
124570641|NCT00048568|448048887|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
124570642|NCT00048568|448048888|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
124570643|NCT00048568|448048886|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
124570644|NCT00048568|448048887|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
124570645|NCT00048568|448048888|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
124570646|NCT00048568|448048886|FG000|Double-Blind Period Days 170 to 365|Death|1|||
124570647|NCT00048568|448048887|FG001|Double-Blind Period Days 170 to 365|Death|1|||
124570648|NCT00048568|448048888|FG002|Double-Blind Period Days 170 to 365|Death|0|||
124570649|NCT00048568|448048886|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
124570650|NCT00048568|448048887|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
124570651|NCT00048568|448048888|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
124570652|NCT00048568|448048886|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
124570653|NCT00048568|448048887|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
124570654|NCT00048568|448048888|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
124570655|NCT00048568|448048886|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
124570656|NCT00048568|448048887|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
124570657|NCT00048568|448048888|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
124570658|NCT00048568|448048886|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
124570659|NCT00048568|448048887|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
124570660|NCT00048568|448048888|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
124570661|NCT00048568|448048886|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
124570662|NCT00048568|448048887|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
124570663|NCT00048568|448048888|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
124570664|NCT00048568|448048886|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
124570665|NCT00048568|448048887|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
124570666|NCT00048568|448048888|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
124570667|NCT00048568|448048886|FG000|Open-Label Period|Death|0|||
124570668|NCT00048568|448048887|FG001|Open-Label Period|Death|0|||
124570669|NCT00048568|448048888|FG002|Open-Label Period|Death|13|||
124570670|NCT00048568|448048886|FG000|Open-Label Period|Adverse Event|0|||
124570671|NCT00048568|448048887|FG001|Open-Label Period|Adverse Event|0|||
124570672|NCT00048568|448048888|FG002|Open-Label Period|Adverse Event|49|||
124570673|NCT00048568|448048886|FG000|Open-Label Period|Lack of Efficacy|0|||
124570674|NCT00048568|448048887|FG001|Open-Label Period|Lack of Efficacy|0|||
124570675|NCT00048568|448048888|FG002|Open-Label Period|Lack of Efficacy|32|||
124570676|NCT00048568|448048886|FG000|Open-Label Period|Withdrawal by Subject|0|||
124570677|NCT00048568|448048887|FG001|Open-Label Period|Withdrawal by Subject|0|||
124570678|NCT00048568|448048888|FG002|Open-Label Period|Withdrawal by Subject|26|||
124776716|NCT00998296|448809946|FG001|Overall Study|Reason other than those specified above|0|||
124570679|NCT00048568|448048886|FG000|Open-Label Period|Pregnancy|0|||
124570680|NCT00048568|448048887|FG001|Open-Label Period|Pregnancy|0|||
124570681|NCT00048568|448048888|FG002|Open-Label Period|Pregnancy|5|||
124570682|NCT00048568|448048886|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
124570683|NCT00048568|448048887|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
124570684|NCT00048568|448048888|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
124570685|NCT00048568|448048886|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
124570686|NCT00048568|448048887|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
124570687|NCT00048568|448048888|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
124515932|NCT01412060|447840386|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
124515933|NCT01412060|447840384|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
124570688|NCT00048568|448048886|FG000|Open-Label Period|Unknown Reasons|0|||
124570689|NCT00048568|448048887|FG001|Open-Label Period|Unknown Reasons|0|||
124570690|NCT00048568|448048888|FG002|Open-Label Period|Unknown Reasons|25|||
124570691|NCT00048568|448048886|FG000|Open-Label Period|Lost to Follow-up|0|||
124570692|NCT00048568|448048887|FG001|Open-Label Period|Lost to Follow-up|0|||
124570693|NCT00048568|448048888|FG002|Open-Label Period|Lost to Follow-up|7|||
124570694|NCT03831048|448048889|FG000|Overall Study|Protocol Violation|9|||
124570695|NCT03831048|448048890|FG001|Overall Study|Protocol Violation|3|||
124570696|NCT03831048|448048889|FG000|Overall Study|Death|4|||
124570697|NCT03831048|448048890|FG001|Overall Study|Death|9|||
124570698|NCT03831048|448048889|FG000|Overall Study|Re-transplant|0|||
124570699|NCT03831048|448048890|FG001|Overall Study|Re-transplant|2|||
124570700|NCT03831048|448048889|FG000|Overall Study|Protocol violation and death|1|||
124570701|NCT03831048|448048890|FG001|Overall Study|Protocol violation and death|1|||
124570702|NCT00560235|448048894|FG000|Phase 1|Discontinued|8|||
124570703|NCT00560235|448048895|FG001|Phase 1|Discontinued|0|||
124570704|NCT00560235|448048896|FG002|Phase 1|Discontinued|0|||
124570705|NCT00560235|448048894|FG000|Phase 1B|Discontinued|0|||
124570706|NCT00560235|448048895|FG001|Phase 1B|Discontinued|19|||
124570707|NCT00560235|448048896|FG002|Phase 1B|Discontinued|0|||
124570708|NCT00560235|448048894|FG000|Phase 2|Discontinued|0|||
124515934|NCT01412060|447840385|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
124515935|NCT01412060|447840386|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
124515936|NCT01412060|447840384|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
124515937|NCT01412060|447840385|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
124515938|NCT01412060|447840386|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
124515939|NCT01412060|447840384|FG000|Period Between SP and DBP|Protocol Violation|2|||
124515940|NCT01412060|447840385|FG001|Period Between SP and DBP|Protocol Violation|0|||
124515941|NCT01412060|447840386|FG002|Period Between SP and DBP|Protocol Violation|0|||
124515942|NCT01412060|447840384|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
124515943|NCT01412060|447840385|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
124515944|NCT01412060|447840386|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
124515945|NCT01412060|447840384|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
124515946|NCT01412060|447840385|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
124515947|NCT01412060|447840386|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
124515948|NCT01412060|447840384|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
124515949|NCT01412060|447840385|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
124515950|NCT01412060|447840386|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
124515951|NCT01412060|447840384|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
124515952|NCT01412060|447840385|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
124515953|NCT01412060|447840386|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
124515954|NCT01412060|447840384|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
124515955|NCT01412060|447840385|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
124515956|NCT01412060|447840386|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
124515957|NCT01412060|447840384|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
124515958|NCT01412060|447840385|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
124515959|NCT01412060|447840386|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
124515960|NCT01412060|447840384|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
124515961|NCT01412060|447840385|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
124570709|NCT00560235|448048895|FG001|Phase 2|Discontinued|0|||
124570710|NCT00560235|448048896|FG002|Phase 2|Discontinued|96|||
124570711|NCT00560235|448048894|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
124570712|NCT00560235|448048895|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
124570713|NCT00560235|448048896|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
124570714|NCT01315249|448048899|FG000|Overall Study|Adverse Event|22|||
124724976|NCT00002540|448613395|FG000|Overall Study|Refused ASU (Control)|597|||
124515962|NCT01412060|447840386|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
124515963|NCT01412060|447840384|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
124515964|NCT01412060|447840385|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
124515965|NCT01412060|447840386|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
124515966|NCT01412060|447840384|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
124515967|NCT01412060|447840385|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
124515968|NCT01412060|447840386|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
124515969|NCT01412060|447840384|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
124515970|NCT01412060|447840385|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
124570715|NCT01315249|448048900|FG001|Overall Study|Adverse Event|26|||
124570716|NCT01315249|448048899|FG000|Overall Study|Withdrawal by Subject|11|||
124570717|NCT01315249|448048900|FG001|Overall Study|Withdrawal by Subject|10|||
124570718|NCT01315249|448048899|FG000|Overall Study|Protocol Violation|8|||
124570719|NCT01315249|448048900|FG001|Overall Study|Protocol Violation|5|||
124570720|NCT01315249|448048899|FG000|Overall Study|Abnormal test results|1|||
124570721|NCT01315249|448048900|FG001|Overall Study|Abnormal test results|2|||
124570722|NCT01315249|448048899|FG000|Overall Study|Administrative problems|1|||
124570723|NCT01315249|448048900|FG001|Overall Study|Administrative problems|0|||
124570724|NCT01315249|448048899|FG000|Overall Study|inability to use device|1|||
124570725|NCT01315249|448048900|FG001|Overall Study|inability to use device|0|||
124570726|NCT01315249|448048899|FG000|Overall Study|Lack of Efficacy|0|||
124570727|NCT01315249|448048900|FG001|Overall Study|Lack of Efficacy|1|||
124570728|NCT01315249|448048899|FG000|Overall Study|Lost to Follow-up|0|||
124570729|NCT01315249|448048900|FG001|Overall Study|Lost to Follow-up|2|||
124515971|NCT01412060|447840386|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
124515972|NCT00004732|447840387|FG000|Overall Study|Withdrawal by Subject|36|||
124515973|NCT00004732|447840388|FG001|Overall Study|Withdrawal by Subject|64|||
124515974|NCT00004732|447840387|FG000|Overall Study|Lost to Follow-up|33|||
124515975|NCT00004732|447840388|FG001|Overall Study|Lost to Follow-up|47|||
124515976|NCT02674685|447840392|FG000|Overall Study|Withdrawal by Subject|4|||
124515977|NCT02713789|447840393|FG000|Overall Study|Lost to Follow-up|0|||
124515978|NCT02713789|447840394|FG001|Overall Study|Lost to Follow-up|1|||
124515979|NCT02713789|447840395|FG002|Overall Study|Lost to Follow-up|1|||
124515980|NCT02091921|447840396|FG000|Overall Study|Adverse Event|3|||
124515981|NCT03307629|447840397|FG000|Overall Study|Withdrawal by Subject|0|||
124515982|NCT03307629|447840398|FG001|Overall Study|Withdrawal by Subject|0|||
124515983|NCT03307629|447840399|FG002|Overall Study|Withdrawal by Subject|0|||
124515984|NCT03307629|447840400|FG003|Overall Study|Withdrawal by Subject|2|||
124515985|NCT03307629|447840397|FG000|Overall Study|Disease Progression|0|||
124515986|NCT03307629|447840398|FG001|Overall Study|Disease Progression|0|||
124515987|NCT03307629|447840399|FG002|Overall Study|Disease Progression|0|||
124515988|NCT03307629|447840400|FG003|Overall Study|Disease Progression|3|||
124515989|NCT03307629|447840397|FG000|Overall Study|Death|0|||
124515990|NCT03307629|447840398|FG001|Overall Study|Death|3|||
124515991|NCT03307629|447840399|FG002|Overall Study|Death|0|||
124515992|NCT03307629|447840400|FG003|Overall Study|Death|1|||
124515993|NCT00719953|447840405|FG000|Overall Study|Adverse Event|4|||
124515994|NCT01626989|447840406|FG000|Screening Period|Screen Failure|15|||
124515995|NCT01626989|447840407|FG001|Screening Period|Screen Failure|0|||
124515996|NCT01626989|447840408|FG002|Screening Period|Screen Failure|0|||
124515997|NCT01626989|447840406|FG000|Screening Period|Withdrawal by Subject|2|||
124515998|NCT01626989|447840407|FG001|Screening Period|Withdrawal by Subject|0|||
124515999|NCT01626989|447840408|FG002|Screening Period|Withdrawal by Subject|0|||
124516000|NCT01230749|447840411|FG000|Overall Study|Adverse Event|0|||
124516001|NCT01230749|447840412|FG001|Overall Study|Adverse Event|0|||
124516002|NCT01230749|447840413|FG002|Overall Study|Adverse Event|0|||
124516003|NCT01230749|447840414|FG003|Overall Study|Adverse Event|1|||
124516004|NCT01230749|447840411|FG000|Overall Study|Physician Decision|0|||
124516005|NCT01230749|447840412|FG001|Overall Study|Physician Decision|0|||
124516006|NCT01230749|447840413|FG002|Overall Study|Physician Decision|1|||
124516007|NCT01230749|447840414|FG003|Overall Study|Physician Decision|0|||
124516008|NCT01230749|447840411|FG000|Overall Study|Withdrawal by Subject|0|||
124516009|NCT01230749|447840412|FG001|Overall Study|Withdrawal by Subject|1|||
124516010|NCT01230749|447840413|FG002|Overall Study|Withdrawal by Subject|0|||
124516011|NCT01230749|447840414|FG003|Overall Study|Withdrawal by Subject|0|||
124516012|NCT01230749|447840411|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
124570730|NCT01315249|448048899|FG000|Overall Study|Death|0|||
124570731|NCT01315249|448048900|FG001|Overall Study|Death|1|||
124570732|NCT03227445|448048905|FG000|Period 1 (28 Days)|Adverse Event|1|||
124570733|NCT03227445|448048906|FG001|Period 1 (28 Days)|Adverse Event|2|||
124516013|NCT01230749|447840412|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
124516014|NCT01230749|447840413|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
124516015|NCT01230749|447840414|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
124516016|NCT02687711|447842701|FG000|Overall Study|Adverse Event|89|||
124516017|NCT02687711|447842701|FG000|Overall Study|Lack of Efficacy|70|||
124516018|NCT02687711|447842701|FG000|Overall Study|Lost to Follow-up|20|||
124516019|NCT02687711|447842701|FG000|Overall Study|Consent withdrawn|15|||
124516020|NCT02687711|447842701|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
124516021|NCT02687711|447842701|FG000|Overall Study|Too expensive|4|||
124516022|NCT02687711|447842701|FG000|Overall Study|Participant moved abroad|1|||
124516023|NCT02687711|447842701|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
124516024|NCT02687711|447842701|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
124516025|NCT02687711|447842701|FG000|Overall Study|Disliked taste|1|||
124516026|NCT02687711|447842701|FG000|Overall Study|Low mood|1|||
124516027|NCT02687711|447842701|FG000|Overall Study|Side effects|1|||
124516028|NCT02687711|447842701|FG000|Overall Study|Change of Hospital|1|||
124516029|NCT02687711|447842701|FG000|Overall Study|Liver Encephalopathy|1|||
124570734|NCT03227445|448048907|FG002|Period 1 (28 Days)|Adverse Event|0|||
124570735|NCT03227445|448048908|FG003|Period 1 (28 Days)|Adverse Event|1|||
124570736|NCT03227445|448048905|FG000|Period 1 (28 Days)|Protocol Violation|1|||
124570737|NCT03227445|448048906|FG001|Period 1 (28 Days)|Protocol Violation|0|||
124570738|NCT03227445|448048907|FG002|Period 1 (28 Days)|Protocol Violation|0|||
124570739|NCT03227445|448048908|FG003|Period 1 (28 Days)|Protocol Violation|0|||
124570740|NCT03227445|448048905|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
124570741|NCT03227445|448048906|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
124570742|NCT03227445|448048907|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
124570743|NCT03227445|448048908|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
124570744|NCT03227445|448048905|FG000|Period 2 (28 Days)|Adverse Event|1|||
124570745|NCT03227445|448048906|FG001|Period 2 (28 Days)|Adverse Event|0|||
124570746|NCT03227445|448048907|FG002|Period 2 (28 Days)|Adverse Event|2|||
124570747|NCT03227445|448048908|FG003|Period 2 (28 Days)|Adverse Event|1|||
124570748|NCT03227445|448048905|FG000|Period 2 (28 Days)|Protocol Violation|0|||
124570749|NCT03227445|448048906|FG001|Period 2 (28 Days)|Protocol Violation|0|||
124570750|NCT03227445|448048907|FG002|Period 2 (28 Days)|Protocol Violation|0|||
124570751|NCT03227445|448048908|FG003|Period 2 (28 Days)|Protocol Violation|1|||
124570752|NCT03227445|448048905|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
124570753|NCT03227445|448048906|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
124570754|NCT03227445|448048907|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
124570755|NCT03227445|448048908|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
124570756|NCT00755196|448048910|FG000|Overall Study|Lost to Follow-up|1|||
124570757|NCT00755196|448048910|FG000|Overall Study|Lack of Efficiency|1|||
124570758|NCT01703832|448048911|FG000|Overall Study|Withdrawal by Subject|1|||
124570759|NCT01703832|448048912|FG001|Overall Study|Withdrawal by Subject|0|||
124570760|NCT01991470|448048913|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
124570761|NCT01991470|448048913|FG000|Enlite 1 Period|Adverse Event|1|||
124570762|NCT01991470|448048913|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
124570763|NCT01991470|448048913|FG000|Enlite 3 Period|Lost to Follow-up|1|||
124570764|NCT01991470|448048913|FG000|Enlite 3 Period|Physician Decision|2|||
124570765|NCT01991470|448048913|FG000|Enlite 3 Period|Physician Decision|8|||
124570766|NCT01991470|448048913|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
124570767|NCT00623779|448048931|FG000|Overall Study|Adverse Event|1|||
124570768|NCT00623779|448048932|FG001|Overall Study|Adverse Event|3|||
124570769|NCT00623779|448048933|FG002|Overall Study|Adverse Event|0|||
124570770|NCT00623779|448048931|FG000|Overall Study|Criteria from CSR|2|||
124570771|NCT00623779|448048932|FG001|Overall Study|Criteria from CSR|0|||
124570772|NCT00623779|448048933|FG002|Overall Study|Criteria from CSR|1|||
124570773|NCT01434693|448048936|FG000|Overall Study|Adverse Event|1|||
124570774|NCT01434693|448048937|FG001|Overall Study|Adverse Event|0|||
124570775|NCT01434693|448048938|FG002|Overall Study|Adverse Event|0|||
124570776|NCT01434693|448048939|FG003|Overall Study|Adverse Event|0|||
124570777|NCT01434693|448048936|FG000|Overall Study|Withdrawal by Subject|1|||
124570778|NCT01434693|448048937|FG001|Overall Study|Withdrawal by Subject|0|||
124570779|NCT01434693|448048938|FG002|Overall Study|Withdrawal by Subject|1|||
124570780|NCT01434693|448048939|FG003|Overall Study|Withdrawal by Subject|1|||
124570781|NCT01434693|448048936|FG000|Overall Study|Lost to Follow-up|1|||
124570782|NCT01434693|448048937|FG001|Overall Study|Lost to Follow-up|0|||
124570783|NCT01434693|448048938|FG002|Overall Study|Lost to Follow-up|0|||
124570784|NCT01434693|448048939|FG003|Overall Study|Lost to Follow-up|0|||
124570785|NCT00440557|448048941|FG000|Overall Study|Withdrawal by Subject|10|||
124570786|NCT00440557|448048942|FG001|Overall Study|Withdrawal by Subject|5|||
124570787|NCT00440557|448048943|FG002|Overall Study|Withdrawal by Subject|11|||
124570788|NCT00440557|448048941|FG000|Overall Study|Lost to Follow-up|1|||
124570789|NCT00440557|448048942|FG001|Overall Study|Lost to Follow-up|2|||
124570790|NCT00440557|448048943|FG002|Overall Study|Lost to Follow-up|6|||
124570791|NCT00440557|448048941|FG000|Overall Study|Adverse Event|3|||
124570792|NCT00440557|448048942|FG001|Overall Study|Adverse Event|3|||
124570793|NCT00440557|448048943|FG002|Overall Study|Adverse Event|5|||
124570794|NCT00440557|448048941|FG000|Overall Study|Death|2|||
124570795|NCT00440557|448048942|FG001|Overall Study|Death|6|||
124570796|NCT00440557|448048943|FG002|Overall Study|Death|3|||
124570797|NCT00440557|448048941|FG000|Overall Study|Began Dialysis|4|||
124570798|NCT00440557|448048942|FG001|Overall Study|Began Dialysis|1|||
124570799|NCT00440557|448048943|FG002|Overall Study|Began Dialysis|4|||
124570800|NCT00440557|448048941|FG000|Overall Study|Principal Investigator decision|0|||
124570801|NCT00440557|448048942|FG001|Overall Study|Principal Investigator decision|3|||
124570802|NCT00440557|448048943|FG002|Overall Study|Principal Investigator decision|1|||
124570803|NCT00440557|448048941|FG000|Overall Study|Patient moved|1|||
124570804|NCT00440557|448048942|FG001|Overall Study|Patient moved|2|||
124570805|NCT00440557|448048943|FG002|Overall Study|Patient moved|1|||
124570806|NCT00440557|448048941|FG000|Overall Study|Principal Investigator's office closed|3|||
124570807|NCT00440557|448048942|FG001|Overall Study|Principal Investigator's office closed|6|||
124570808|NCT00440557|448048943|FG002|Overall Study|Principal Investigator's office closed|4|||
124570809|NCT00440557|448048941|FG000|Overall Study|Patient transferred to nursing home|0|||
124570810|NCT00440557|448048942|FG001|Overall Study|Patient transferred to nursing home|1|||
124570811|NCT00440557|448048943|FG002|Overall Study|Patient transferred to nursing home|0|||
124570812|NCT00440557|448048941|FG000|Overall Study|Patient had surgery|1|||
124570813|NCT00440557|448048942|FG001|Overall Study|Patient had surgery|0|||
124570814|NCT00440557|448048943|FG002|Overall Study|Patient had surgery|0|||
124570815|NCT01378975|448048946|FG000|Overall Study|Death|77|||
124570816|NCT01378975|448048947|FG001|Overall Study|Death|46|||
124570817|NCT01378975|448048946|FG000|Overall Study|Investigator Request|1|||
124570818|NCT01378975|448048947|FG001|Overall Study|Investigator Request|0|||
124570819|NCT01378975|448048946|FG000|Overall Study|Lost to Follow-up|4|||
124570820|NCT01378975|448048947|FG001|Overall Study|Lost to Follow-up|1|||
124570821|NCT01378975|448048946|FG000|Overall Study|Withdrew Consent|4|||
124570822|NCT01378975|448048947|FG001|Overall Study|Withdrew Consent|3|||
124570823|NCT02343120|448048951|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
124570824|NCT02343120|448048952|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
124570825|NCT02343120|448048953|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
124570826|NCT02343120|448048954|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
124570827|NCT02343120|448048955|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
124570828|NCT02343120|448048951|FG000|Part 1: Dose Escalation|Death|1|||
124570829|NCT02343120|448048952|FG001|Part 1: Dose Escalation|Death|2|||
124570830|NCT02343120|448048953|FG002|Part 1: Dose Escalation|Death|2|||
124570831|NCT02343120|448048954|FG003|Part 1: Dose Escalation|Death|2|||
124570832|NCT02343120|448048955|FG004|Part 1: Dose Escalation|Death|1|||
124570833|NCT02343120|448048951|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
124570834|NCT02343120|448048952|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
124570835|NCT02343120|448048953|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
124570836|NCT02343120|448048954|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
124570837|NCT02343120|448048955|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
124570838|NCT02343120|448048951|FG000|Part 2: Expansion|Sponsor decision|0|||
124570839|NCT02343120|448048952|FG001|Part 2: Expansion|Sponsor decision|0|||
124570840|NCT02343120|448048953|FG002|Part 2: Expansion|Sponsor decision|0|||
124570841|NCT02343120|448048954|FG003|Part 2: Expansion|Sponsor decision|165|||
124570842|NCT02343120|448048955|FG004|Part 2: Expansion|Sponsor decision|67|||
124516030|NCT02687711|447842701|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
124516031|NCT02687711|447842701|FG000|Overall Study|Withdrawn due to intake interruption|1|||
124516032|NCT02687711|447842701|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
124516033|NCT02687711|447842701|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
124516034|NCT02687711|447842701|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
124516035|NCT03621189|447842702|FG000|Overall Study|Withdrawal by Subject|0|||
124516036|NCT03621189|447842703|FG001|Overall Study|Withdrawal by Subject|3|||
124516037|NCT03621189|447842702|FG000|Overall Study|Physician Decision|0|||
124516038|NCT03621189|447842703|FG001|Overall Study|Physician Decision|2|||
124516039|NCT03077243|447842704|FG000|Overall Study|Death|1|||
124516040|NCT03077243|447842705|FG001|Overall Study|Death|2|||
124516041|NCT03077243|447842706|FG002|Overall Study|Death|0|||
124516042|NCT03077243|447842707|FG003|Overall Study|Death|0|||
124516043|NCT03077243|447842704|FG000|Overall Study|Withdrawal by Subject|1|||
124516044|NCT03077243|447842705|FG001|Overall Study|Withdrawal by Subject|3|||
124516045|NCT03077243|447842706|FG002|Overall Study|Withdrawal by Subject|0|||
124516046|NCT03077243|447842707|FG003|Overall Study|Withdrawal by Subject|0|||
124516047|NCT03077243|447842704|FG000|Overall Study|Physician Decision|1|||
124516048|NCT03077243|447842705|FG001|Overall Study|Physician Decision|0|||
124516049|NCT03077243|447842706|FG002|Overall Study|Physician Decision|0|||
124516050|NCT03077243|447842707|FG003|Overall Study|Physician Decision|0|||
124516051|NCT03077243|447842704|FG000|Overall Study|Research at two study sites terminated early|0|||
124516052|NCT03077243|447842705|FG001|Overall Study|Research at two study sites terminated early|0|||
124516053|NCT03077243|447842706|FG002|Overall Study|Research at two study sites terminated early|0|||
124516054|NCT03077243|447842707|FG003|Overall Study|Research at two study sites terminated early|69|||
124516055|NCT02848313|447842708|FG000|Overall Study|Adverse Event|1|||
124516056|NCT02848313|447842709|FG001|Overall Study|Adverse Event|2|||
124516057|NCT02848313|447842708|FG000|Overall Study|Lack of Efficacy|0|||
124516058|NCT02848313|447842709|FG001|Overall Study|Lack of Efficacy|1|||
124516059|NCT02848313|447842708|FG000|Overall Study|Withdrawal by Subject|1|||
124516060|NCT02848313|447842709|FG001|Overall Study|Withdrawal by Subject|1|||
124516061|NCT02848313|447842708|FG000|Overall Study|Lost to follow up|1|||
124570843|NCT02343120|448048951|FG000|Part 2: Expansion|Death|0|||
124570844|NCT02343120|448048952|FG001|Part 2: Expansion|Death|0|||
124570845|NCT02343120|448048953|FG002|Part 2: Expansion|Death|0|||
124516062|NCT02848313|447842709|FG001|Overall Study|Lost to follow up|0|||
124516063|NCT01432457|447842710|FG000|Overall Study|Adverse Event|7|||
124516064|NCT01432457|447842711|FG001|Overall Study|Adverse Event|10|||
124516065|NCT01432457|447842712|FG002|Overall Study|Adverse Event|16|||
124516066|NCT01432457|447842710|FG000|Overall Study|Lack of Efficacy|2|||
124516067|NCT01432457|447842711|FG001|Overall Study|Lack of Efficacy|1|||
124516068|NCT01432457|447842712|FG002|Overall Study|Lack of Efficacy|1|||
124516069|NCT01432457|447842710|FG000|Overall Study|Lost to Follow-up|11|||
124570846|NCT02343120|448048954|FG003|Part 2: Expansion|Death|74|||
124570847|NCT02343120|448048955|FG004|Part 2: Expansion|Death|17|||
124570848|NCT02343120|448048951|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
124516070|NCT01432457|447842711|FG001|Overall Study|Lost to Follow-up|15|||
124516071|NCT01432457|447842712|FG002|Overall Study|Lost to Follow-up|20|||
124516072|NCT01432457|447842710|FG000|Overall Study|Protocol Violation|3|||
124516073|NCT01432457|447842711|FG001|Overall Study|Protocol Violation|2|||
124516074|NCT01432457|447842712|FG002|Overall Study|Protocol Violation|6|||
124516075|NCT01432457|447842710|FG000|Overall Study|Withdrawal by Subject|6|||
124516076|NCT01432457|447842711|FG001|Overall Study|Withdrawal by Subject|11|||
124516077|NCT01432457|447842712|FG002|Overall Study|Withdrawal by Subject|9|||
124516078|NCT01432457|447842710|FG000|Overall Study|Reasons not defined|2|||
124516079|NCT01432457|447842711|FG001|Overall Study|Reasons not defined|3|||
124516080|NCT01432457|447842712|FG002|Overall Study|Reasons not defined|4|||
124516081|NCT01432457|447842710|FG000|Overall Study|Did not take study drug|6|||
124516082|NCT01432457|447842711|FG001|Overall Study|Did not take study drug|6|||
124516083|NCT01432457|447842712|FG002|Overall Study|Did not take study drug|3|||
124516084|NCT00247273|447842718|FG000|Overall Study|Adverse Event|85|||
124516085|NCT00247273|447842719|FG001|Overall Study|Adverse Event|80|||
124516086|NCT00247273|447842718|FG000|Overall Study|Physician Decision|6|||
124516087|NCT00247273|447842719|FG001|Overall Study|Physician Decision|3|||
124516088|NCT00247273|447842718|FG000|Overall Study|Lost to Follow-up|7|||
124516089|NCT00247273|447842719|FG001|Overall Study|Lost to Follow-up|7|||
124516090|NCT00247273|447842718|FG000|Overall Study|Withdrawal by Subject|46|||
124516091|NCT00247273|447842719|FG001|Overall Study|Withdrawal by Subject|47|||
124516092|NCT00247273|447842718|FG000|Overall Study|Did not take any study drug|2|||
124516093|NCT00247273|447842719|FG001|Overall Study|Did not take any study drug|0|||
124516094|NCT01419015|447842720|FG000|Overall Study|Death|2|||
124516095|NCT02580240|447842721|FG000|Overall Study|Physician Decision|2|||
124516096|NCT02580240|447842722|FG001|Overall Study|Physician Decision|0|||
124516097|NCT00607919|447842723|FG000|Acute Phase|Adverse Event|9|||
124516098|NCT00607919|447842724|FG001|Acute Phase|Adverse Event|2|||
124516099|NCT00607919|447842723|FG000|Acute Phase|Entry Criteria Not Met|1|||
124516100|NCT00607919|447842724|FG001|Acute Phase|Entry Criteria Not Met|1|||
124516101|NCT00607919|447842723|FG000|Acute Phase|Lack of Efficacy|1|||
124516102|NCT00607919|447842724|FG001|Acute Phase|Lack of Efficacy|2|||
124516103|NCT00607919|447842723|FG000|Acute Phase|Lost to Follow-up|9|||
124516104|NCT00607919|447842724|FG001|Acute Phase|Lost to Follow-up|3|||
124516105|NCT00607919|447842723|FG000|Acute Phase|Parent/Caregiver Decision|6|||
124516106|NCT00607919|447842724|FG001|Acute Phase|Parent/Caregiver Decision|4|||
124516107|NCT00607919|447842723|FG000|Acute Phase|Protocol Violation|5|||
124516108|NCT00607919|447842724|FG001|Acute Phase|Protocol Violation|1|||
124516109|NCT00607919|447842723|FG000|Acute Phase|Withdrawal by Subject|3|||
124516110|NCT00607919|447842724|FG001|Acute Phase|Withdrawal by Subject|3|||
124516111|NCT00607919|447842723|FG000|Open-Label Phase|Adverse Event|1|||
124516112|NCT00607919|447842724|FG001|Open-Label Phase|Adverse Event|5|||
124516113|NCT00607919|447842723|FG000|Open-Label Phase|Lost to Follow-up|4|||
124516114|NCT00607919|447842724|FG001|Open-Label Phase|Lost to Follow-up|1|||
124516115|NCT00607919|447842723|FG000|Open-Label Phase|Protocol Violation|2|||
124516116|NCT00607919|447842724|FG001|Open-Label Phase|Protocol Violation|2|||
124516117|NCT00607919|447842723|FG000|Open-Label Phase|Withdrawal by Subject|2|||
124516118|NCT00607919|447842724|FG001|Open-Label Phase|Withdrawal by Subject|2|||
124516119|NCT00607919|447842723|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
124516120|NCT00607919|447842724|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
124516121|NCT01527110|447842727|FG000|Overall Study|Adverse Event|1|||
124516122|NCT02007252|447842728|FG000|Overall Study|Administrative problems|3|||
124516123|NCT02007252|447842729|FG001|Overall Study|Administrative problems|7|||
124516124|NCT02007252|447842728|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124516125|NCT02007252|447842729|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124516126|NCT02007252|447842728|FG000|Overall Study|Adverse Event|7|||
124516127|NCT02007252|447842729|FG001|Overall Study|Adverse Event|4|||
124516128|NCT00150345|447842735|FG000|Overall Study|Death|5|||
124516129|NCT00150345|447842736|FG001|Overall Study|Death|2|||
124516130|NCT00150345|447842735|FG000|Overall Study|Adverse Event|8|||
124516131|NCT00150345|447842736|FG001|Overall Study|Adverse Event|6|||
124516132|NCT00150345|447842735|FG000|Overall Study|Lack of Efficacy|5|||
124516133|NCT00150345|447842736|FG001|Overall Study|Lack of Efficacy|4|||
124516134|NCT00150345|447842735|FG000|Overall Study|Withdrawal by Subject|3|||
124516135|NCT00150345|447842736|FG001|Overall Study|Withdrawal by Subject|4|||
124516136|NCT00150345|447842735|FG000|Overall Study|Laboratory abnormality|1|||
124516137|NCT00150345|447842736|FG001|Overall Study|Laboratory abnormality|2|||
124516138|NCT00150345|447842735|FG000|Overall Study|Other|12|||
124516139|NCT00150345|447842736|FG001|Overall Study|Other|14|||
124516140|NCT01457924|447842739|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
124516141|NCT01457924|447842740|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
124516142|NCT01457924|447842741|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
124516143|NCT01457924|447842742|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
124516144|NCT01457924|447842743|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
124516145|NCT01457924|447842739|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
124570849|NCT02343120|448048952|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
124570850|NCT02343120|448048953|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
124570851|NCT02343120|448048954|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
124570852|NCT02343120|448048955|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
124570853|NCT02343120|448048951|FG000|Part 2: Expansion|Lost to Follow-up|0|||
124570854|NCT02343120|448048952|FG001|Part 2: Expansion|Lost to Follow-up|0|||
124570855|NCT02343120|448048953|FG002|Part 2: Expansion|Lost to Follow-up|0|||
124570856|NCT02343120|448048954|FG003|Part 2: Expansion|Lost to Follow-up|5|||
124570857|NCT02343120|448048955|FG004|Part 2: Expansion|Lost to Follow-up|2|||
124570858|NCT02343120|448048951|FG000|Part 2: Expansion|Other|0|||
124570859|NCT02343120|448048952|FG001|Part 2: Expansion|Other|0|||
124570860|NCT02343120|448048953|FG002|Part 2: Expansion|Other|0|||
124570861|NCT02343120|448048954|FG003|Part 2: Expansion|Other|1|||
124570862|NCT02343120|448048955|FG004|Part 2: Expansion|Other|5|||
124570863|NCT02343120|448048951|FG000|Part 2: Expansion|Adverse Event|0|||
124570864|NCT02343120|448048952|FG001|Part 2: Expansion|Adverse Event|0|||
124570865|NCT02343120|448048953|FG002|Part 2: Expansion|Adverse Event|0|||
124570866|NCT02343120|448048954|FG003|Part 2: Expansion|Adverse Event|1|||
124570867|NCT02343120|448048955|FG004|Part 2: Expansion|Adverse Event|1|||
124570868|NCT03544138|448048960|FG000|Overall Study|Lost to Follow-up|29|||
124570869|NCT01766778|448048961|FG000|Overall Study|Adverse Event|4|||
124570870|NCT01766778|448048962|FG001|Overall Study|Adverse Event|4|||
124570871|NCT01766778|448048961|FG000|Overall Study|Withdrawal by Subject|1|||
124570872|NCT01766778|448048962|FG001|Overall Study|Withdrawal by Subject|0|||
124570873|NCT01104662|448048963|FG000|Overall Study|Adverse Event|2|||
124570874|NCT01104662|448048964|FG001|Overall Study|Adverse Event|2|||
124570875|NCT01104662|448048965|FG002|Overall Study|Adverse Event|0|||
124570876|NCT01104662|448048966|FG003|Overall Study|Adverse Event|1|||
124570877|NCT01104662|448048967|FG004|Overall Study|Adverse Event|1|||
124570878|NCT01104662|448048968|FG005|Overall Study|Adverse Event|1|||
124570879|NCT01104662|448048969|FG006|Overall Study|Adverse Event|0|||
124570880|NCT01104662|448048970|FG007|Overall Study|Adverse Event|0|||
124570881|NCT01104662|448048963|FG000|Overall Study|Clinical Failure|1|||
124570882|NCT01104662|448048964|FG001|Overall Study|Clinical Failure|0|||
124570883|NCT01104662|448048965|FG002|Overall Study|Clinical Failure|0|||
124570884|NCT01104662|448048966|FG003|Overall Study|Clinical Failure|0|||
124570885|NCT01104662|448048967|FG004|Overall Study|Clinical Failure|0|||
124570886|NCT01104662|448048968|FG005|Overall Study|Clinical Failure|1|||
124570887|NCT01104662|448048969|FG006|Overall Study|Clinical Failure|0|||
124570888|NCT01104662|448048970|FG007|Overall Study|Clinical Failure|0|||
124570889|NCT01104662|448048963|FG000|Overall Study|Participant left investigator's care|1|||
124570890|NCT01104662|448048964|FG001|Overall Study|Participant left investigator's care|1|||
124570891|NCT01104662|448048965|FG002|Overall Study|Participant left investigator's care|0|||
124570892|NCT01104662|448048966|FG003|Overall Study|Participant left investigator's care|0|||
124570893|NCT01104662|448048967|FG004|Overall Study|Participant left investigator's care|0|||
124570894|NCT01104662|448048968|FG005|Overall Study|Participant left investigator's care|0|||
124570895|NCT01104662|448048969|FG006|Overall Study|Participant left investigator's care|0|||
124570896|NCT01104662|448048970|FG007|Overall Study|Participant left investigator's care|0|||
124570897|NCT01104662|448048963|FG000|Overall Study|Reason not specified|3|||
124570898|NCT01104662|448048964|FG001|Overall Study|Reason not specified|3|||
124570899|NCT01104662|448048965|FG002|Overall Study|Reason not specified|0|||
124570900|NCT01104662|448048966|FG003|Overall Study|Reason not specified|0|||
124570901|NCT01104662|448048967|FG004|Overall Study|Reason not specified|0|||
124570902|NCT01104662|448048968|FG005|Overall Study|Reason not specified|1|||
124570903|NCT01104662|448048969|FG006|Overall Study|Reason not specified|0|||
124570904|NCT01104662|448048970|FG007|Overall Study|Reason not specified|0|||
124570905|NCT01104662|448048963|FG000|Overall Study|Randomized but not treated|3|||
124570906|NCT01104662|448048964|FG001|Overall Study|Randomized but not treated|4|||
124570907|NCT01104662|448048965|FG002|Overall Study|Randomized but not treated|1|||
124570908|NCT01104662|448048966|FG003|Overall Study|Randomized but not treated|0|||
124570909|NCT01104662|448048967|FG004|Overall Study|Randomized but not treated|0|||
124570910|NCT01104662|448048968|FG005|Overall Study|Randomized but not treated|1|||
124570911|NCT01104662|448048969|FG006|Overall Study|Randomized but not treated|0|||
124570912|NCT01104662|448048970|FG007|Overall Study|Randomized but not treated|0|||
124570913|NCT02158936|448048971|FG000|Overall Study|Study closed/ terminated|57|||
124570914|NCT02158936|448048972|FG001|Overall Study|Study closed/ terminated|77|||
124570915|NCT02158936|448048971|FG000|Overall Study|Azacitidine tx discontinued|53|||
124570916|NCT02158936|448048972|FG001|Overall Study|Azacitidine tx discontinued|46|||
124570917|NCT02158936|448048971|FG000|Overall Study|Adverse Event|39|||
124570918|NCT02158936|448048972|FG001|Overall Study|Adverse Event|24|||
124570919|NCT02158936|448048971|FG000|Overall Study|Withdrawal by Subject|15|||
124570920|NCT02158936|448048972|FG001|Overall Study|Withdrawal by Subject|16|||
124570921|NCT02158936|448048971|FG000|Overall Study|Physician Decision|15|||
124570922|NCT02158936|448048972|FG001|Overall Study|Physician Decision|13|||
124570923|NCT02158936|448048971|FG000|Overall Study|Lost to Follow-up|0|||
124570924|NCT02158936|448048972|FG001|Overall Study|Lost to Follow-up|1|||
124570925|NCT01706926|448048973|FG000|Overall Study|Lost to Follow-up|0|||
124570926|NCT01706926|448048974|FG001|Overall Study|Lost to Follow-up|0|||
124516146|NCT01457924|447842740|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
124516147|NCT01457924|447842741|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
124516148|NCT01457924|447842742|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
124516149|NCT01457924|447842743|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
124516150|NCT01457924|447842739|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
124516151|NCT01457924|447842740|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
124516152|NCT01457924|447842741|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
124516153|NCT01457924|447842742|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
124516154|NCT01457924|447842743|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
124516155|NCT01457924|447842739|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
124516156|NCT01457924|447842740|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
124516157|NCT01457924|447842741|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
124516158|NCT01457924|447842742|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
124516159|NCT01457924|447842743|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
124516160|NCT01457924|447842739|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
124516161|NCT01457924|447842740|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
124516162|NCT01457924|447842741|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
124516163|NCT01457924|447842742|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
124516164|NCT01457924|447842743|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
124516165|NCT01457924|447842739|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
124516166|NCT01457924|447842740|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
124516167|NCT01457924|447842741|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
124516168|NCT01457924|447842742|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
124516169|NCT01457924|447842743|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
124516170|NCT01457924|447842739|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
124516171|NCT01457924|447842740|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
124516172|NCT01457924|447842741|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
124516173|NCT01457924|447842742|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
124516174|NCT01457924|447842743|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
124516175|NCT01457924|447842739|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
124516176|NCT01457924|447842740|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
124516177|NCT01457924|447842741|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
124516178|NCT01457924|447842742|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
124516179|NCT01457924|447842743|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
124516180|NCT01457924|447842739|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
124516181|NCT01457924|447842740|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
124516182|NCT01457924|447842741|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
124516183|NCT01457924|447842742|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
124516184|NCT01457924|447842743|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
124516185|NCT01457924|447842739|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
124516186|NCT01457924|447842740|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
124516187|NCT01457924|447842741|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
124516188|NCT01457924|447842742|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
124516189|NCT01457924|447842743|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
124516190|NCT01457924|447842739|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
124516191|NCT01457924|447842740|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
124516192|NCT01457924|447842741|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
124516193|NCT01457924|447842742|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
124516194|NCT01457924|447842743|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
124516195|NCT01457924|447842739|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
124516196|NCT01457924|447842740|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
124516197|NCT01457924|447842741|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
124516198|NCT01457924|447842742|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
124516199|NCT01457924|447842743|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
124516200|NCT01457924|447842739|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
124516201|NCT01457924|447842740|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
124516202|NCT01457924|447842741|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
124516203|NCT01457924|447842742|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
124516204|NCT01457924|447842743|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
124516205|NCT02001688|447842744|FG000|Overall Study|Withdrawal by Subject|0|||
124516206|NCT02001688|447842745|FG001|Overall Study|Withdrawal by Subject|0|||
124516207|NCT02001688|447842746|FG002|Overall Study|Withdrawal by Subject|1|||
124516208|NCT02001688|447842744|FG000|Overall Study|Adverse Event|0|||
124516209|NCT02001688|447842745|FG001|Overall Study|Adverse Event|1|||
124516210|NCT02001688|447842746|FG002|Overall Study|Adverse Event|0|||
124516211|NCT05441540|447842750|FG000|Overall Study|Withdrawal by Subject|2|||
124516212|NCT00813917|447842751|FG000|Overall Study|Adverse Event|0|||
124516213|NCT00813917|447842752|FG001|Overall Study|Adverse Event|1|||
124516214|NCT00813917|447842751|FG000|Overall Study|Withdrawal by Subject|3|||
124516215|NCT00813917|447842752|FG001|Overall Study|Withdrawal by Subject|4|||
124516216|NCT00813917|447842751|FG000|Overall Study|Lost to Follow-up|3|||
124516217|NCT00813917|447842752|FG001|Overall Study|Lost to Follow-up|1|||
124516218|NCT02143141|447842756|FG000|Overall Study|pain scores at 24 hours not collected|1|||
124516219|NCT02143141|447842757|FG001|Overall Study|pain scores at 24 hours not collected|0|||
124516220|NCT00615914|447842758|FG000|Overall Study|Adverse Event|274|||
124516221|NCT00615914|447842758|FG000|Overall Study|Death|20|||
124516222|NCT00615914|447842758|FG000|Overall Study|Lack of Efficacy|59|||
124516223|NCT00615914|447842758|FG000|Overall Study|Lost to Follow-up|187|||
124516224|NCT00615914|447842758|FG000|Overall Study|Withdrawal by Subject|16|||
124516225|NCT00615914|447842758|FG000|Overall Study|Physician Decision|4|||
124516226|NCT00615914|447842758|FG000|Overall Study|No data was collected.|65|||
124516227|NCT00615914|447842758|FG000|Overall Study|No treatment|2|||
124516228|NCT00615914|447842758|FG000|Overall Study|Irregularly enrolled patients|10|||
124516229|NCT00270998|447842759|FG000|3 Month Follow-up|Adverse Event|1|||
124516230|NCT00270998|447842760|FG001|3 Month Follow-up|Adverse Event|0|||
124516231|NCT00270998|447842761|FG002|3 Month Follow-up|Adverse Event|0|||
124516232|NCT00270998|447842759|FG000|3 Month Follow-up|Lack of Efficacy|1|||
124516233|NCT00270998|447842760|FG001|3 Month Follow-up|Lack of Efficacy|2|||
124516234|NCT00270998|447842761|FG002|3 Month Follow-up|Lack of Efficacy|1|||
124516235|NCT00270998|447842759|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
124516236|NCT00270998|447842760|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
124516237|NCT00270998|447842761|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
124516238|NCT00270998|447842759|FG000|3 Month Follow-up|Pessary did not fit|12|||
124516239|NCT00270998|447842760|FG001|3 Month Follow-up|Pessary did not fit|0|||
124516240|NCT00270998|447842761|FG002|3 Month Follow-up|Pessary did not fit|0|||
124516241|NCT00270998|447842759|FG000|3 Month Follow-up|Personal/family health|1|||
124516242|NCT00270998|447842760|FG001|3 Month Follow-up|Personal/family health|1|||
124516243|NCT00270998|447842761|FG002|3 Month Follow-up|Personal/family health|0|||
124516244|NCT00270998|447842759|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
124516245|NCT00270998|447842760|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
124516246|NCT00270998|447842761|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
124516247|NCT00270998|447842759|FG000|12 Month Follow-up|Lack of Efficacy|5|||
124516248|NCT00270998|447842760|FG001|12 Month Follow-up|Lack of Efficacy|4|||
124516249|NCT00270998|447842761|FG002|12 Month Follow-up|Lack of Efficacy|3|||
124516250|NCT00270998|447842759|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
124516251|NCT00270998|447842760|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
124516252|NCT00270998|447842761|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
124516253|NCT00270998|447842759|FG000|12 Month Follow-up|Pessary did not fit|1|||
124516254|NCT00270998|447842760|FG001|12 Month Follow-up|Pessary did not fit|0|||
124516255|NCT00270998|447842761|FG002|12 Month Follow-up|Pessary did not fit|0|||
124516256|NCT00270998|447842759|FG000|12 Month Follow-up|Personal/family health|0|||
124516257|NCT00270998|447842760|FG001|12 Month Follow-up|Personal/family health|5|||
124516258|NCT00270998|447842761|FG002|12 Month Follow-up|Personal/family health|1|||
124516259|NCT00270998|447842759|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
124516260|NCT00270998|447842760|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
124516261|NCT00270998|447842761|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
124516262|NCT00563368|447842762|FG000|Overall Study|Lost to Follow-up|14|||
124516263|NCT00563368|447842763|FG001|Overall Study|Lost to Follow-up|14|||
124516264|NCT00563368|447842764|FG002|Overall Study|Lost to Follow-up|12|||
124516265|NCT00563368|447842765|FG003|Overall Study|Lost to Follow-up|6|||
124516266|NCT00563368|447842766|FG004|Overall Study|Lost to Follow-up|9|||
124516267|NCT00563368|447842767|FG005|Overall Study|Lost to Follow-up|8|||
124516268|NCT00563368|447842768|FG006|Overall Study|Lost to Follow-up|9|||
124516269|NCT00563368|447842762|FG000|Overall Study|Adverse Event|3|||
124516270|NCT00563368|447842763|FG001|Overall Study|Adverse Event|4|||
124516271|NCT00563368|447842764|FG002|Overall Study|Adverse Event|5|||
124516272|NCT00563368|447842765|FG003|Overall Study|Adverse Event|9|||
124516273|NCT00563368|447842766|FG004|Overall Study|Adverse Event|6|||
124516274|NCT00563368|447842767|FG005|Overall Study|Adverse Event|10|||
124516275|NCT00563368|447842768|FG006|Overall Study|Adverse Event|17|||
124516276|NCT00563368|447842762|FG000|Overall Study|Withdrawal by Subject|11|||
124516277|NCT00563368|447842763|FG001|Overall Study|Withdrawal by Subject|6|||
124516278|NCT00563368|447842764|FG002|Overall Study|Withdrawal by Subject|5|||
124516279|NCT00563368|447842765|FG003|Overall Study|Withdrawal by Subject|7|||
124516280|NCT00563368|447842766|FG004|Overall Study|Withdrawal by Subject|8|||
124516281|NCT00563368|447842767|FG005|Overall Study|Withdrawal by Subject|5|||
124516282|NCT00563368|447842768|FG006|Overall Study|Withdrawal by Subject|4|||
124516283|NCT00563368|447842762|FG000|Overall Study|protocol non-compliance|1|||
124516284|NCT00563368|447842763|FG001|Overall Study|protocol non-compliance|1|||
124516285|NCT00563368|447842764|FG002|Overall Study|protocol non-compliance|2|||
124516286|NCT00563368|447842765|FG003|Overall Study|protocol non-compliance|1|||
124516287|NCT00563368|447842766|FG004|Overall Study|protocol non-compliance|0|||
124516288|NCT00563368|447842767|FG005|Overall Study|protocol non-compliance|1|||
124516289|NCT00563368|447842768|FG006|Overall Study|protocol non-compliance|3|||
124516290|NCT00563368|447842762|FG000|Overall Study|Pregnancy|1|||
124516291|NCT00563368|447842763|FG001|Overall Study|Pregnancy|0|||
124570927|NCT01706926|448048975|FG002|Overall Study|Lost to Follow-up|1|||
124570928|NCT01706926|448048976|FG003|Overall Study|Lost to Follow-up|0|||
124570929|NCT01706926|448048973|FG000|Overall Study|Withdrawal by Subject|2|||
124570930|NCT01706926|448048974|FG001|Overall Study|Withdrawal by Subject|0|||
124570931|NCT01706926|448048975|FG002|Overall Study|Withdrawal by Subject|1|||
124570932|NCT01706926|448048976|FG003|Overall Study|Withdrawal by Subject|2|||
124570933|NCT01706926|448048973|FG000|Overall Study|Other|4|||
124570934|NCT01706926|448048974|FG001|Overall Study|Other|4|||
124570935|NCT01706926|448048975|FG002|Overall Study|Other|4|||
124570936|NCT01706926|448048976|FG003|Overall Study|Other|3|||
124516292|NCT00563368|447842764|FG002|Overall Study|Pregnancy|1|||
124516293|NCT00563368|447842765|FG003|Overall Study|Pregnancy|2|||
124516294|NCT00563368|447842766|FG004|Overall Study|Pregnancy|1|||
124724977|NCT00002540|448613396|FG001|Overall Study|Refused ASU (Control)|0|||
124570937|NCT00414466|448050550|FG000|Overall Study|Adverse Event|0|||
124570938|NCT00414466|448050551|FG001|Overall Study|Adverse Event|0|||
124570939|NCT00414466|448050552|FG002|Overall Study|Adverse Event|1|||
124570940|NCT00414466|448050553|FG003|Overall Study|Adverse Event|1|||
124570941|NCT00414466|448050550|FG000|Overall Study|Lack of Efficacy|1|||
124570942|NCT00414466|448050551|FG001|Overall Study|Lack of Efficacy|0|||
124570943|NCT00414466|448050552|FG002|Overall Study|Lack of Efficacy|0|||
124570944|NCT00414466|448050553|FG003|Overall Study|Lack of Efficacy|0|||
124570945|NCT00414466|448050550|FG000|Overall Study|Withdrawn by Sponsor|1|||
124570946|NCT00414466|448050551|FG001|Overall Study|Withdrawn by Sponsor|0|||
124570947|NCT00414466|448050552|FG002|Overall Study|Withdrawn by Sponsor|0|||
124570948|NCT00414466|448050553|FG003|Overall Study|Withdrawn by Sponsor|0|||
124570949|NCT02637232|448050554|FG000|Overall Study|Lost to Follow-up|42|||
124570950|NCT02637232|448050554|FG000|Overall Study|Adverse Event|11|||
124570951|NCT02637232|448050554|FG000|Overall Study|patient 's decision|2|||
124570952|NCT02395822|448050558|FG000|Overall Study|Withdrawal by Subject|1|||
124570953|NCT02395822|448050558|FG000|Overall Study|Death|1|||
124570954|NCT02937701|448050559|FG000|Day 1 to Week 22|Adverse Event|11|||
124570955|NCT02937701|448050560|FG001|Day 1 to Week 22|Adverse Event|14|||
124570956|NCT02937701|448050561|FG002|Day 1 to Week 22|Adverse Event|0|||
124570957|NCT02937701|448050562|FG003|Day 1 to Week 22|Adverse Event|0|||
124570958|NCT02937701|448050563|FG004|Day 1 to Week 22|Adverse Event|0|||
124570959|NCT02937701|448050559|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
124570960|NCT02937701|448050560|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
124570961|NCT02937701|448050561|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
124570962|NCT02937701|448050562|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
124570963|NCT02937701|448050563|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
124570964|NCT02937701|448050559|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
124570965|NCT02937701|448050560|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
124570966|NCT02937701|448050561|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
124570967|NCT02937701|448050562|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
124570968|NCT02937701|448050563|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
124570969|NCT02937701|448050559|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
124570970|NCT02937701|448050560|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
124570971|NCT02937701|448050561|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
124570972|NCT02937701|448050562|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
124570973|NCT02937701|448050563|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
124570974|NCT02937701|448050559|FG000|Day 1 to Week 22|Death|1|||
124570975|NCT02937701|448050560|FG001|Day 1 to Week 22|Death|1|||
124570976|NCT02937701|448050561|FG002|Day 1 to Week 22|Death|0|||
124570977|NCT02937701|448050562|FG003|Day 1 to Week 22|Death|0|||
124570978|NCT02937701|448050563|FG004|Day 1 to Week 22|Death|0|||
124570979|NCT02937701|448050559|FG000|Day 1 to Week 22|Protocol Violation|1|||
124570980|NCT02937701|448050560|FG001|Day 1 to Week 22|Protocol Violation|1|||
124570981|NCT02937701|448050561|FG002|Day 1 to Week 22|Protocol Violation|0|||
124570982|NCT02937701|448050562|FG003|Day 1 to Week 22|Protocol Violation|0|||
124570983|NCT02937701|448050563|FG004|Day 1 to Week 22|Protocol Violation|0|||
124570984|NCT02937701|448050559|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
124724978|NCT00002540|448613395|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
124724979|NCT00002540|448613396|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
124724980|NCT01345929|448613397|FG000|Overall Study|Withdrawal by Subject|9|||
124516295|NCT00563368|447842767|FG005|Overall Study|Pregnancy|2|||
124516296|NCT00563368|447842768|FG006|Overall Study|Pregnancy|0|||
124516297|NCT00563368|447842762|FG000|Overall Study|requirement for restricted medication|0|||
124516298|NCT00563368|447842763|FG001|Overall Study|requirement for restricted medication|0|||
124516299|NCT00563368|447842764|FG002|Overall Study|requirement for restricted medication|2|||
124570985|NCT02937701|448050560|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
124570986|NCT02937701|448050561|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
124570987|NCT02937701|448050562|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
124570988|NCT02937701|448050563|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
124570989|NCT02937701|448050559|FG000|Day 1 to Week 22|Physician Decision|2|||
124570990|NCT02937701|448050560|FG001|Day 1 to Week 22|Physician Decision|0|||
124570991|NCT02937701|448050561|FG002|Day 1 to Week 22|Physician Decision|0|||
124516300|NCT00563368|447842765|FG003|Overall Study|requirement for restricted medication|0|||
124516301|NCT00563368|447842766|FG004|Overall Study|requirement for restricted medication|0|||
124516302|NCT00563368|447842767|FG005|Overall Study|requirement for restricted medication|0|||
124516303|NCT00563368|447842768|FG006|Overall Study|requirement for restricted medication|0|||
124516304|NCT00563368|447842762|FG000|Overall Study|Other|5|||
124516305|NCT00563368|447842763|FG001|Overall Study|Other|5|||
124516306|NCT00563368|447842764|FG002|Overall Study|Other|3|||
124516307|NCT00563368|447842765|FG003|Overall Study|Other|4|||
124516308|NCT00563368|447842766|FG004|Overall Study|Other|4|||
124516309|NCT00563368|447842767|FG005|Overall Study|Other|4|||
124516310|NCT00563368|447842768|FG006|Overall Study|Other|0|||
124516311|NCT03379376|447842774|FG000|Overall Study|Lost to Follow-up|2|||
124516312|NCT03379376|447842774|FG000|Overall Study|Did not wish to complete follow up|1|||
124516313|NCT03379376|447842774|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
124516314|NCT03379376|447842774|FG000|Overall Study|Death|1|||
124516315|NCT01611298|447842775|FG000|Overall Study|Relapsed|2|||
124516316|NCT00753623|447842776|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
124516317|NCT00753623|447842777|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
124516318|NCT00753623|447842776|FG000|Phase I (14 Days)|Physician Decision|1|||
124516319|NCT00753623|447842777|FG001|Phase I (14 Days)|Physician Decision|2|||
124516320|NCT00753623|447842776|FG000|Phase I (14 Days)|Adverse Event|0|||
124516321|NCT00753623|447842777|FG001|Phase I (14 Days)|Adverse Event|1|||
124516322|NCT00753623|447842776|FG000|Washout (7 Days)|Physician Decision|1|||
124516323|NCT00753623|447842777|FG001|Washout (7 Days)|Physician Decision|0|||
124516324|NCT00753623|447842776|FG000|Phase II (14 Days)|Physician Decision|0|||
124516325|NCT00753623|447842777|FG001|Phase II (14 Days)|Physician Decision|1|||
124516326|NCT03332303|447842778|FG000|Overall Study|Participant did not dose|1|||
124516327|NCT03332303|447842779|FG001|Overall Study|Participant did not dose|2|||
124516328|NCT03332303|447842780|FG002|Overall Study|Participant did not dose|0|||
124516329|NCT03332303|447842778|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
124516330|NCT03332303|447842779|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
124516331|NCT03332303|447842780|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
124516332|NCT03332303|447842778|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
124516333|NCT03332303|447842779|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
124516334|NCT03332303|447842780|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
124516335|NCT03332303|447842778|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
124516336|NCT03332303|447842779|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
124516337|NCT03332303|447842780|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
124516338|NCT03332303|447842778|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
124516339|NCT03332303|447842779|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
124516340|NCT03332303|447842780|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
124516341|NCT03332303|447842778|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
124516342|NCT03332303|447842779|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
124516343|NCT03332303|447842780|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
124516344|NCT03332303|447842778|FG000|Overall Study|Participant had a significant protocol deviation|0|||
124516345|NCT03332303|447842779|FG001|Overall Study|Participant had a significant protocol deviation|1|||
124516346|NCT03332303|447842780|FG002|Overall Study|Participant had a significant protocol deviation|0|||
124516347|NCT03383614|447842781|FG000|Overall Study|Withdrawal by Subject|0|||
124516348|NCT03383614|447842782|FG001|Overall Study|Withdrawal by Subject|1|||
124516349|NCT03383614|447842783|FG002|Overall Study|Withdrawal by Subject|0|||
124516350|NCT03383614|447842784|FG003|Overall Study|Withdrawal by Subject|0|||
124516351|NCT03639987|447842787|FG000|Overall Study|Study terminated by sponsor|26|||
124516352|NCT03639987|447842788|FG001|Overall Study|Study terminated by sponsor|25|||
124516353|NCT03639987|447842787|FG000|Overall Study|Lost to Follow-up|0|||
124516354|NCT03639987|447842788|FG001|Overall Study|Lost to Follow-up|1|||
124570992|NCT02937701|448050562|FG003|Day 1 to Week 22|Physician Decision|0|||
124570993|NCT02937701|448050563|FG004|Day 1 to Week 22|Physician Decision|0|||
124570994|NCT02937701|448050559|FG000|Day 1 to Week 22|Other|1|||
124570995|NCT02937701|448050560|FG001|Day 1 to Week 22|Other|0|||
124570996|NCT02937701|448050561|FG002|Day 1 to Week 22|Other|0|||
124516355|NCT00425100|447842789|FG000|Overall Study|Adverse Event|36|||
124516356|NCT00425100|447842789|FG000|Overall Study|Lack of Efficacy|4|||
124570997|NCT02937701|448050562|FG003|Day 1 to Week 22|Other|0|||
124570998|NCT02937701|448050563|FG004|Day 1 to Week 22|Other|0|||
124516357|NCT00425100|447842789|FG000|Overall Study|Lost to Follow-up|2|||
124516358|NCT00425100|447842789|FG000|Overall Study|Protocol Violation|4|||
124516359|NCT00425100|447842789|FG000|Overall Study|Withdrawal by Subject|7|||
124516360|NCT02559713|447842790|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
124516361|NCT00555906|447842794|FG000|Phase 1|Objective Progression or Relapse|3|||
124516362|NCT00555906|447842795|FG001|Phase 1|Objective Progression or Relapse|5|||
124570999|NCT02937701|448050559|FG000|Week 22 to Week 50|Adverse Event|0|||
124571000|NCT02937701|448050560|FG001|Week 22 to Week 50|Adverse Event|0|||
124571001|NCT02937701|448050561|FG002|Week 22 to Week 50|Adverse Event|10|||
124571002|NCT02937701|448050562|FG003|Week 22 to Week 50|Adverse Event|3|||
124571003|NCT02937701|448050563|FG004|Week 22 to Week 50|Adverse Event|3|||
124571004|NCT02937701|448050559|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
124571005|NCT02937701|448050560|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
124571006|NCT02937701|448050561|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
124571007|NCT02937701|448050562|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
124571008|NCT02937701|448050563|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
124571009|NCT02937701|448050559|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
124571010|NCT02937701|448050560|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
124571011|NCT02937701|448050561|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
124571012|NCT02937701|448050562|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
124571013|NCT02937701|448050563|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
124571014|NCT02937701|448050559|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
124571015|NCT02937701|448050560|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
124571016|NCT02937701|448050561|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
124571017|NCT02937701|448050562|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
124571018|NCT02937701|448050563|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
124571019|NCT02937701|448050559|FG000|Week 22 to Week 50|Physician Decision|0|||
124571020|NCT02937701|448050560|FG001|Week 22 to Week 50|Physician Decision|0|||
124571021|NCT02937701|448050561|FG002|Week 22 to Week 50|Physician Decision|2|||
124571022|NCT02937701|448050562|FG003|Week 22 to Week 50|Physician Decision|0|||
124571023|NCT02937701|448050563|FG004|Week 22 to Week 50|Physician Decision|1|||
124571024|NCT02937701|448050559|FG000|Week 22 to Week 50|Other|0|||
124571025|NCT02937701|448050560|FG001|Week 22 to Week 50|Other|0|||
124571026|NCT02937701|448050561|FG002|Week 22 to Week 50|Other|0|||
124571027|NCT02937701|448050562|FG003|Week 22 to Week 50|Other|0|||
124571028|NCT02937701|448050563|FG004|Week 22 to Week 50|Other|1|||
124571029|NCT01101022|448050570|FG000|Overall Study|Adverse Event|6|||
124571030|NCT01101022|448050571|FG001|Overall Study|Adverse Event|2|||
124571031|NCT01101022|448050570|FG000|Overall Study|Protocol Violation|4|||
124571032|NCT01101022|448050571|FG001|Overall Study|Protocol Violation|3|||
124571033|NCT01101022|448050570|FG000|Overall Study|Withdrawal by Subject|3|||
124571034|NCT01101022|448050571|FG001|Overall Study|Withdrawal by Subject|8|||
124571035|NCT01101022|448050570|FG000|Overall Study|Lost to Follow-up|1|||
124571036|NCT01101022|448050571|FG001|Overall Study|Lost to Follow-up|4|||
124571037|NCT01101022|448050570|FG000|Overall Study|Lack of Efficacy|0|||
124571038|NCT01101022|448050571|FG001|Overall Study|Lack of Efficacy|7|||
124571039|NCT01101022|448050570|FG000|Overall Study|Sponsor decision|1|||
124571040|NCT01101022|448050571|FG001|Overall Study|Sponsor decision|1|||
124571041|NCT01101022|448050570|FG000|Overall Study|Non-compliance|1|||
124571042|NCT01101022|448050571|FG001|Overall Study|Non-compliance|0|||
124571043|NCT01101022|448050570|FG000|Overall Study|Work schedule|1|||
124571044|NCT01101022|448050571|FG001|Overall Study|Work schedule|1|||
124571045|NCT01101022|448050570|FG000|Overall Study|Vacation|0|||
124571046|NCT01101022|448050571|FG001|Overall Study|Vacation|1|||
124571047|NCT01519661|448050572|FG000|Overall Study|Protocol deviation|6|||
124571048|NCT01519661|448050572|FG000|Overall Study|Lost to Follow-up|3|||
124571049|NCT01519661|448050572|FG000|Overall Study|Withdrawal by Subject|17|||
124571050|NCT01519661|448050572|FG000|Overall Study|Lack of Efficacy|6|||
124571051|NCT01519661|448050572|FG000|Overall Study|Adverse Event|29|||
124571052|NCT01139047|448050573|FG000|Overall Study|Withdrawal by Subject|1|||
124571053|NCT01941095|448050574|FG000|Overall Study|Insufficient therapeutic response|13|||
124571054|NCT01941095|448050574|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
124571055|NCT01941095|448050574|FG000|Overall Study|Adverse Event|11|||
124571056|NCT01941095|448050574|FG000|Overall Study|Physician Decision|3|||
124571057|NCT01941095|448050574|FG000|Overall Study|Withdrawal by Subject|17|||
124571058|NCT01941095|448050574|FG000|Overall Study|Lost to Follow-up|10|||
124571059|NCT02918877|448050577|FG000|Overall Study|Withdrawal by Subject|2|||
124571060|NCT02918877|448050578|FG001|Overall Study|Withdrawal by Subject|2|||
124571061|NCT02918877|448050577|FG000|Overall Study|Surgery cancelled|1|||
124571062|NCT02918877|448050578|FG001|Overall Study|Surgery cancelled|0|||
124571063|NCT02918877|448050577|FG000|Overall Study|Physician Decision|1|||
124571064|NCT02918877|448050578|FG001|Overall Study|Physician Decision|0|||
124571065|NCT02918877|448050577|FG000|Overall Study|Received intraoperative steroids|1|||
124571066|NCT02918877|448050578|FG001|Overall Study|Received intraoperative steroids|0|||
124571067|NCT02918877|448050577|FG000|Overall Study|Unable to obtain lab samples|1|||
124571068|NCT02918877|448050578|FG001|Overall Study|Unable to obtain lab samples|0|||
124571069|NCT02918877|448050577|FG000|Overall Study|Unsafe to perform BAL|0|||
124571070|NCT02918877|448050578|FG001|Overall Study|Unsafe to perform BAL|1|||
124571071|NCT03527745|448050579|FG000|Overall Study|Lost to Follow-up|3|||
124571072|NCT03527745|448050580|FG001|Overall Study|Lost to Follow-up|6|||
124571073|NCT03527745|448050581|FG002|Overall Study|Lost to Follow-up|7|||
124571074|NCT03527745|448050582|FG003|Overall Study|Lost to Follow-up|9|||
124571075|NCT03527745|448050583|FG004|Overall Study|Lost to Follow-up|0|||
124571076|NCT03527745|448050584|FG005|Overall Study|Lost to Follow-up|2|||
124571077|NCT03527745|448050585|FG006|Overall Study|Lost to Follow-up|3|||
124571078|NCT03527745|448050586|FG007|Overall Study|Lost to Follow-up|2|||
124571079|NCT03527745|448050587|FG008|Overall Study|Lost to Follow-up|3|||
124571080|NCT03527745|448050588|FG009|Overall Study|Lost to Follow-up|2|||
124571081|NCT03527745|448050589|FG010|Overall Study|Lost to Follow-up|1|||
124571082|NCT03527745|448050590|FG011|Overall Study|Lost to Follow-up|1|||
124571083|NCT03527745|448050591|FG012|Overall Study|Lost to Follow-up|0|||
124571084|NCT03527745|448050592|FG013|Overall Study|Lost to Follow-up|0|||
124571085|NCT03527745|448050593|FG014|Overall Study|Lost to Follow-up|0|||
124571086|NCT03527745|448050594|FG015|Overall Study|Lost to Follow-up|0|||
124571087|NCT03527745|448050595|FG016|Overall Study|Lost to Follow-up|1|||
124571088|NCT03527745|448050596|FG017|Overall Study|Lost to Follow-up|0|||
124571089|NCT03527745|448050597|FG018|Overall Study|Lost to Follow-up|0|||
124571090|NCT03527745|448050598|FG019|Overall Study|Lost to Follow-up|1|||
124571091|NCT03527745|448050599|FG020|Overall Study|Lost to Follow-up|1|||
124571092|NCT03527745|448050600|FG021|Overall Study|Lost to Follow-up|5|||
124571093|NCT03527745|448050601|FG022|Overall Study|Lost to Follow-up|6|||
124571094|NCT03527745|448050602|FG023|Overall Study|Lost to Follow-up|8|||
124571095|NCT03527745|448050603|FG024|Overall Study|Lost to Follow-up|1|||
124571096|NCT03527745|448050604|FG025|Overall Study|Lost to Follow-up|3|||
124571097|NCT01604850|448050605|FG000|Overall Study|Enrolled but never treated|0|||
124571098|NCT01604850|448050606|FG001|Overall Study|Enrolled but never treated|1|||
124571099|NCT01604850|448050605|FG000|Overall Study|Efficacy Failure|50|||
124571100|NCT01604850|448050606|FG001|Overall Study|Efficacy Failure|29|||
124571101|NCT01604850|448050605|FG000|Overall Study|Lost to Follow-up|1|||
124571102|NCT01604850|448050606|FG001|Overall Study|Lost to Follow-up|0|||
124571103|NCT01604850|448050605|FG000|Overall Study|Subject withdrew consent|1|||
124571104|NCT01604850|448050606|FG001|Overall Study|Subject withdrew consent|0|||
124571105|NCT00243932|448050607|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
124571106|NCT00243932|448050608|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
124571107|NCT00243932|448050609|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
124571108|NCT00880568|448050611|FG000|Overall Study|Disease progression|3|||
124571109|NCT00880568|448050612|FG001|Overall Study|Disease progression|3|||
124571110|NCT00880568|448050613|FG002|Overall Study|Disease progression|3|||
124571111|NCT00880568|448050614|FG003|Overall Study|Disease progression|1|||
124571112|NCT00880568|448050615|FG004|Overall Study|Disease progression|3|||
124571113|NCT00880568|448050616|FG005|Overall Study|Disease progression|3|||
124571114|NCT00880568|448050617|FG006|Overall Study|Disease progression|5|||
124571115|NCT00880568|448050618|FG007|Overall Study|Disease progression|0|||
124571116|NCT00880568|448050619|FG008|Overall Study|Disease progression|3|||
124571117|NCT00880568|448050611|FG000|Overall Study|Adverse Event|0|||
124571118|NCT00880568|448050612|FG001|Overall Study|Adverse Event|0|||
124571119|NCT00880568|448050613|FG002|Overall Study|Adverse Event|0|||
124571120|NCT00880568|448050614|FG003|Overall Study|Adverse Event|0|||
124571121|NCT00880568|448050615|FG004|Overall Study|Adverse Event|0|||
124571122|NCT00880568|448050616|FG005|Overall Study|Adverse Event|0|||
124571123|NCT00880568|448050617|FG006|Overall Study|Adverse Event|1|||
124571124|NCT00880568|448050618|FG007|Overall Study|Adverse Event|1|||
124571125|NCT00880568|448050619|FG008|Overall Study|Adverse Event|0|||
124571126|NCT00880568|448050611|FG000|Overall Study|Withdrawal by Subject|0|||
124571127|NCT00880568|448050612|FG001|Overall Study|Withdrawal by Subject|0|||
124571128|NCT00880568|448050613|FG002|Overall Study|Withdrawal by Subject|0|||
124571129|NCT00880568|448050614|FG003|Overall Study|Withdrawal by Subject|0|||
124571130|NCT00880568|448050615|FG004|Overall Study|Withdrawal by Subject|0|||
124571131|NCT00880568|448050616|FG005|Overall Study|Withdrawal by Subject|0|||
124571132|NCT00880568|448050617|FG006|Overall Study|Withdrawal by Subject|0|||
124571133|NCT00880568|448050618|FG007|Overall Study|Withdrawal by Subject|1|||
124571134|NCT00880568|448050619|FG008|Overall Study|Withdrawal by Subject|0|||
124571135|NCT00849901|448050620|FG000|Acute Treatment Phase|Adverse Event|9|||
124571136|NCT00849901|448050621|FG001|Acute Treatment Phase|Adverse Event|1|||
124571137|NCT00849901|448050622|FG002|Acute Treatment Phase|Adverse Event|3|||
124571138|NCT00849901|448050620|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
124571139|NCT00849901|448050621|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
124776717|NCT00998296|448809947|FG002|Overall Study|Reason other than those specified above|0|||
124776718|NCT00998296|448809948|FG003|Overall Study|Reason other than those specified above|0|||
124571140|NCT00849901|448050622|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
124571141|NCT00849901|448050620|FG000|Acute Treatment Phase|Protocol Violation|0|||
124571142|NCT00849901|448050621|FG001|Acute Treatment Phase|Protocol Violation|2|||
124571143|NCT00849901|448050622|FG002|Acute Treatment Phase|Protocol Violation|1|||
124571144|NCT00849901|448050620|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
124571145|NCT00849901|448050621|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
124571146|NCT00849901|448050622|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
124571147|NCT00849901|448050620|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
124571148|NCT00849901|448050621|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
124571149|NCT00849901|448050622|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
124571150|NCT00849901|448050620|FG000|Acute Treatment Phase|Physician Decision|1|||
124571151|NCT00849901|448050621|FG001|Acute Treatment Phase|Physician Decision|1|||
124571152|NCT00849901|448050622|FG002|Acute Treatment Phase|Physician Decision|1|||
124516363|NCT00555906|447842796|FG002|Phase 1|Objective Progression or Relapse|3|||
124516364|NCT00555906|447842797|FG003|Phase 1|Objective Progression or Relapse|1|||
124516365|NCT00555906|447842798|FG004|Phase 1|Objective Progression or Relapse|0|||
124516366|NCT00555906|447842794|FG000|Phase 1|Global Deterioration of Health Status|0|||
124516367|NCT00555906|447842795|FG001|Phase 1|Global Deterioration of Health Status|1|||
124516368|NCT00555906|447842796|FG002|Phase 1|Global Deterioration of Health Status|1|||
124516369|NCT00555906|447842797|FG003|Phase 1|Global Deterioration of Health Status|1|||
124516370|NCT00555906|447842798|FG004|Phase 1|Global Deterioration of Health Status|0|||
124516371|NCT00555906|447842794|FG000|Phase 1|Adverse Event|0|||
124516372|NCT00555906|447842795|FG001|Phase 1|Adverse Event|0|||
124516373|NCT00555906|447842796|FG002|Phase 1|Adverse Event|3|||
124516374|NCT00555906|447842797|FG003|Phase 1|Adverse Event|2|||
124516375|NCT00555906|447842798|FG004|Phase 1|Adverse Event|0|||
124516376|NCT00555906|447842794|FG000|Phase 1|Withdrawal by Subject|0|||
124516377|NCT00555906|447842795|FG001|Phase 1|Withdrawal by Subject|0|||
124516378|NCT00555906|447842796|FG002|Phase 1|Withdrawal by Subject|0|||
124516379|NCT00555906|447842797|FG003|Phase 1|Withdrawal by Subject|1|||
124516380|NCT00555906|447842798|FG004|Phase 1|Withdrawal by Subject|0|||
124516381|NCT00555906|447842794|FG000|Phase 2|Adverse Event|0|||
124516382|NCT00555906|447842795|FG001|Phase 2|Adverse Event|0|||
124516383|NCT00555906|447842796|FG002|Phase 2|Adverse Event|0|||
124516384|NCT00555906|447842797|FG003|Phase 2|Adverse Event|0|||
124516385|NCT00555906|447842798|FG004|Phase 2|Adverse Event|4|||
124516386|NCT00555906|447842794|FG000|Phase 2|Global Deterioration of Health Status|0|||
124516387|NCT00555906|447842795|FG001|Phase 2|Global Deterioration of Health Status|0|||
124516388|NCT00555906|447842796|FG002|Phase 2|Global Deterioration of Health Status|0|||
124516389|NCT00555906|447842797|FG003|Phase 2|Global Deterioration of Health Status|0|||
124516390|NCT00555906|447842798|FG004|Phase 2|Global Deterioration of Health Status|2|||
124516391|NCT00555906|447842794|FG000|Phase 2|Objective Progression or Relapse|0|||
124516392|NCT00555906|447842795|FG001|Phase 2|Objective Progression or Relapse|0|||
124516393|NCT00555906|447842796|FG002|Phase 2|Objective Progression or Relapse|0|||
124516394|NCT00555906|447842797|FG003|Phase 2|Objective Progression or Relapse|0|||
124516395|NCT00555906|447842798|FG004|Phase 2|Objective Progression or Relapse|16|||
124516396|NCT00555906|447842794|FG000|Phase 2|Withdrawal by Subject|0|||
124516397|NCT00555906|447842795|FG001|Phase 2|Withdrawal by Subject|0|||
124516398|NCT00555906|447842796|FG002|Phase 2|Withdrawal by Subject|0|||
124516399|NCT00555906|447842797|FG003|Phase 2|Withdrawal by Subject|0|||
124516400|NCT00555906|447842798|FG004|Phase 2|Withdrawal by Subject|2|||
124516401|NCT00555906|447842794|FG000|Phase 2|Other|0|||
124516402|NCT00555906|447842795|FG001|Phase 2|Other|0|||
124516403|NCT00555906|447842796|FG002|Phase 2|Other|0|||
124516404|NCT00555906|447842797|FG003|Phase 2|Other|0|||
124516405|NCT00555906|447842798|FG004|Phase 2|Other|6|||
124516406|NCT00555906|447842794|FG000|Phase 2|Randomized but not Treated|0|||
124516407|NCT00555906|447842795|FG001|Phase 2|Randomized but not Treated|0|||
124516408|NCT00555906|447842796|FG002|Phase 2|Randomized but not Treated|0|||
124516409|NCT00555906|447842797|FG003|Phase 2|Randomized but not Treated|0|||
124516410|NCT00555906|447842798|FG004|Phase 2|Randomized but not Treated|2|||
124516411|NCT00889681|447842799|FG000|Overall Study|Not meeting qualification Criteria|2|||
124516412|NCT00889681|447842799|FG000|Overall Study|Insurance disapproval|1|||
124516413|NCT01686958|447842804|FG000|Overall Study|Withdrawal by Subject|1|||
124516414|NCT00187889|447842805|FG000|Overall Study|Withdrawal by Subject|6|||
124516415|NCT00187889|447842806|FG001|Overall Study|Withdrawal by Subject|4|||
124516416|NCT04046341|447842807|FG000|Overall Study|Lost to Follow-up|2|||
124516417|NCT04046341|447842807|FG000|Overall Study|Withdrawal by Subject|1|||
124516418|NCT03094832|447842810|FG000|Overall Study|Lost to Follow-up|0|||
124516419|NCT03094832|447842811|FG001|Overall Study|Lost to Follow-up|0|||
124516420|NCT03094832|447842812|FG002|Overall Study|Lost to Follow-up|0|||
124516421|NCT03094832|447842813|FG003|Overall Study|Lost to Follow-up|1|||
124516422|NCT03094832|447842814|FG004|Overall Study|Lost to Follow-up|1|||
124516423|NCT03094832|447842810|FG000|Overall Study|Death|1|||
124516424|NCT03094832|447842811|FG001|Overall Study|Death|0|||
124516425|NCT03094832|447842812|FG002|Overall Study|Death|0|||
124516426|NCT03094832|447842813|FG003|Overall Study|Death|0|||
124516427|NCT03094832|447842814|FG004|Overall Study|Death|0|||
124516428|NCT03094832|447842810|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
124516429|NCT03094832|447842811|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124516430|NCT03094832|447842812|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
124516431|NCT03094832|447842813|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
124516432|NCT03094832|447842814|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
124516433|NCT03094832|447842810|FG000|Overall Study|Other|13|||
124516434|NCT03094832|447842811|FG001|Overall Study|Other|20|||
124516435|NCT03094832|447842812|FG002|Overall Study|Other|1|||
124516436|NCT03094832|447842813|FG003|Overall Study|Other|7|||
124516437|NCT03094832|447842814|FG004|Overall Study|Other|1|||
124516438|NCT01419080|447842818|FG000|Overall Study|Withdrawal by Subject|75|||
124516439|NCT01419080|447842818|FG000|Overall Study|Death|30|||
124516440|NCT01419080|447842818|FG000|Overall Study|Lost to Follow-up|23|||
124516441|NCT01419080|447842818|FG000|Overall Study|Too Ill|3|||
124571153|NCT00849901|448050620|FG000|Acute Treatment Phase|Sponsor Decision|1|||
124571154|NCT00849901|448050621|FG001|Acute Treatment Phase|Sponsor Decision|0|||
124571155|NCT00849901|448050622|FG002|Acute Treatment Phase|Sponsor Decision|0|||
124571156|NCT00849901|448050620|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
124571157|NCT00849901|448050621|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
124571158|NCT00849901|448050622|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
124571159|NCT00849901|448050620|FG000|Extension Phase|Adverse Event|2|||
124571160|NCT00849901|448050621|FG001|Extension Phase|Adverse Event|8|||
124571161|NCT00849901|448050622|FG002|Extension Phase|Adverse Event|4|||
124571162|NCT00849901|448050620|FG000|Extension Phase|Lost to Follow-up|3|||
124571163|NCT00849901|448050621|FG001|Extension Phase|Lost to Follow-up|0|||
124571164|NCT00849901|448050622|FG002|Extension Phase|Lost to Follow-up|1|||
124571165|NCT00849901|448050620|FG000|Extension Phase|Protocol Violation|2|||
124571166|NCT00849901|448050621|FG001|Extension Phase|Protocol Violation|2|||
124571167|NCT00849901|448050622|FG002|Extension Phase|Protocol Violation|4|||
124571168|NCT00849901|448050620|FG000|Extension Phase|Withdrawal by Subject|7|||
124571169|NCT00849901|448050621|FG001|Extension Phase|Withdrawal by Subject|6|||
124571170|NCT00849901|448050622|FG002|Extension Phase|Withdrawal by Subject|3|||
124571171|NCT00849901|448050620|FG000|Extension Phase|Parent or Caregiver Decision|10|||
124571172|NCT00849901|448050621|FG001|Extension Phase|Parent or Caregiver Decision|4|||
124571173|NCT00849901|448050622|FG002|Extension Phase|Parent or Caregiver Decision|4|||
124571174|NCT00849901|448050620|FG000|Extension Phase|Physician Decision|1|||
124571175|NCT00849901|448050621|FG001|Extension Phase|Physician Decision|2|||
124571176|NCT00849901|448050622|FG002|Extension Phase|Physician Decision|0|||
124571177|NCT00849901|448050620|FG000|Extension Phase|Lack of Efficacy|2|||
124571178|NCT00849901|448050621|FG001|Extension Phase|Lack of Efficacy|4|||
124571179|NCT00849901|448050622|FG002|Extension Phase|Lack of Efficacy|1|||
124571180|NCT00437658|448050623|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
124571181|NCT00437658|448050624|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
124571182|NCT00437658|448050625|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
124571183|NCT00437658|448050623|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
124571184|NCT00437658|448050624|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
124571185|NCT00437658|448050625|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
124571186|NCT00437658|448050623|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
124571187|NCT00437658|448050624|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
124571188|NCT00437658|448050625|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
124571189|NCT00437658|448050623|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
124571190|NCT00437658|448050624|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
124571191|NCT00437658|448050625|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
124571192|NCT00437658|448050623|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
124571193|NCT00437658|448050624|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
124571194|NCT00437658|448050625|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
124571195|NCT00437658|448050623|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
124571196|NCT00437658|448050624|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
124571197|NCT00437658|448050625|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
124571198|NCT00437658|448050623|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
124571199|NCT00437658|448050624|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
124571200|NCT00437658|448050625|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
124571201|NCT00437658|448050623|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
124571202|NCT00437658|448050624|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
124571203|NCT00437658|448050625|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
124571204|NCT00437658|448050623|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
124571205|NCT00437658|448050624|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
124571206|NCT00437658|448050625|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
124571207|NCT00437658|448050623|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
124571208|NCT00437658|448050624|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
124571209|NCT00437658|448050625|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
124571210|NCT00437658|448050623|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
124571211|NCT00437658|448050624|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
124571212|NCT00437658|448050625|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
124571213|NCT00437658|448050623|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
124571214|NCT00437658|448050624|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
124571215|NCT00437658|448050625|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
124571216|NCT04407806|448050627|FG000|Overall Study|Withdrawal by Subject|1|||
124571217|NCT04407806|448050628|FG001|Overall Study|Withdrawal by Subject|2|||
124571218|NCT02731157|448050629|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
124571219|NCT00832377|448050630|FG000|Overall Study|Protocol Violation|1|||
124571220|NCT01449630|448050631|FG000|Period 1|Physician Decision|1|||
124571221|NCT01449630|448050632|FG001|Period 1|Physician Decision|0|||
124571222|NCT01449630|448050633|FG002|Period 1|Physician Decision|0|||
124571223|NCT01449630|448050634|FG003|Period 1|Physician Decision|1|||
124571224|NCT01449630|448050635|FG004|Period 1|Physician Decision|0|||
124776719|NCT00998296|448809949|FG004|Overall Study|Reason other than those specified above|0|||
124516442|NCT01998880|447842819|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
124516443|NCT01998880|447842820|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
124516444|NCT01998880|447842819|FG000|Overall Study|Disease Progression|1|||
124516445|NCT01998880|447842820|FG001|Overall Study|Disease Progression|8|||
124516446|NCT01998880|447842819|FG000|Overall Study|Withdrew Consent|2|||
124516447|NCT01998880|447842820|FG001|Overall Study|Withdrew Consent|1|||
124516448|NCT01998880|447842819|FG000|Overall Study|Death|3|||
124516449|NCT01998880|447842820|FG001|Overall Study|Death|6|||
124516450|NCT01998880|447842819|FG000|Overall Study|Insufficient Therapeutic Response|1|||
124516451|NCT01998880|447842820|FG001|Overall Study|Insufficient Therapeutic Response|5|||
124516452|NCT01998880|447842819|FG000|Overall Study|Administrative/Other|1|||
124516453|NCT01998880|447842820|FG001|Overall Study|Administrative/Other|1|||
124516454|NCT01998880|447842819|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
124516455|NCT01998880|447842820|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
124516456|NCT01998880|447842819|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
124516457|NCT01998880|447842820|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
124516458|NCT01998880|447842819|FG000|Overall Study|Did Not Receive Treatment|3|||
124516459|NCT01998880|447842820|FG001|Overall Study|Did Not Receive Treatment|2|||
124516460|NCT01575899|447842821|FG000|Overall Study|Lost to Follow-up|3|||
124516461|NCT01575899|447842822|FG001|Overall Study|Lost to Follow-up|4|||
124516462|NCT01575899|447842823|FG002|Overall Study|Lost to Follow-up|2|||
124516463|NCT01575899|447842821|FG000|Overall Study|Protocol Violation|2|||
124516464|NCT01575899|447842822|FG001|Overall Study|Protocol Violation|1|||
124516465|NCT01575899|447842823|FG002|Overall Study|Protocol Violation|0|||
124516466|NCT02671461|447842824|FG000|Treatment|Adverse Event|0|||
124516467|NCT02671461|447842825|FG001|Treatment|Adverse Event|0|||
124516468|NCT02671461|447842826|FG002|Treatment|Adverse Event|1|||
124516469|NCT02671461|447842824|FG000|Treatment|Administrative Reason by Sponsor|1|||
124516470|NCT02671461|447842825|FG001|Treatment|Administrative Reason by Sponsor|3|||
124516471|NCT02671461|447842826|FG002|Treatment|Administrative Reason by Sponsor|4|||
124516472|NCT02671461|447842824|FG000|Treatment|Randomized, not treated|1|||
124516473|NCT02671461|447842825|FG001|Treatment|Randomized, not treated|0|||
124516474|NCT02671461|447842826|FG002|Treatment|Randomized, not treated|0|||
124516475|NCT02671461|447842824|FG000|Follow-up|Withdrawal by Subject|1|||
124516476|NCT02671461|447842825|FG001|Follow-up|Withdrawal by Subject|0|||
124516477|NCT02671461|447842826|FG002|Follow-up|Withdrawal by Subject|0|||
124516478|NCT02671461|447842824|FG000|Follow-up|Lost to Follow-up|0|||
124516479|NCT02671461|447842825|FG001|Follow-up|Lost to Follow-up|0|||
124516480|NCT02671461|447842826|FG002|Follow-up|Lost to Follow-up|1|||
124516481|NCT02671461|447842824|FG000|Follow-up|Administrative Reason by Sponsor|0|||
124516482|NCT02671461|447842825|FG001|Follow-up|Administrative Reason by Sponsor|1|||
124516483|NCT02671461|447842826|FG002|Follow-up|Administrative Reason by Sponsor|0|||
124516484|NCT02807844|447842827|FG000|Overall Study|Physician Decision|0|||
124516485|NCT02807844|447842828|FG001|Overall Study|Physician Decision|0|||
124516486|NCT02807844|447842829|FG002|Overall Study|Physician Decision|0|||
124516487|NCT02807844|447842830|FG003|Overall Study|Physician Decision|0|||
124516488|NCT02807844|447842831|FG004|Overall Study|Physician Decision|0|||
124516489|NCT02807844|447842832|FG005|Overall Study|Physician Decision|0|||
124516490|NCT02807844|447842833|FG006|Overall Study|Physician Decision|3|||
124516491|NCT02807844|447842834|FG007|Overall Study|Physician Decision|0|||
124516492|NCT02807844|447842835|FG008|Overall Study|Physician Decision|1|||
124516493|NCT02807844|447842836|FG009|Overall Study|Physician Decision|2|||
124516494|NCT02807844|447842827|FG000|Overall Study|Death|0|||
124516495|NCT02807844|447842828|FG001|Overall Study|Death|0|||
124516496|NCT02807844|447842829|FG002|Overall Study|Death|2|||
124776720|NCT00998296|448809950|FG005|Overall Study|Reason other than those specified above|0|||
124516497|NCT02807844|447842830|FG003|Overall Study|Death|4|||
124516498|NCT02807844|447842831|FG004|Overall Study|Death|1|||
124516499|NCT02807844|447842832|FG005|Overall Study|Death|2|||
124516500|NCT02807844|447842833|FG006|Overall Study|Death|1|||
124516501|NCT02807844|447842834|FG007|Overall Study|Death|2|||
124516502|NCT02807844|447842835|FG008|Overall Study|Death|0|||
124516503|NCT02807844|447842836|FG009|Overall Study|Death|1|||
124516504|NCT02807844|447842827|FG000|Overall Study|Withdrawal by Subject|0|||
124516505|NCT02807844|447842828|FG001|Overall Study|Withdrawal by Subject|0|||
124516506|NCT02807844|447842829|FG002|Overall Study|Withdrawal by Subject|2|||
124516507|NCT02807844|447842830|FG003|Overall Study|Withdrawal by Subject|1|||
124516508|NCT02807844|447842831|FG004|Overall Study|Withdrawal by Subject|1|||
124516509|NCT02807844|447842832|FG005|Overall Study|Withdrawal by Subject|0|||
124516510|NCT02807844|447842833|FG006|Overall Study|Withdrawal by Subject|1|||
124516511|NCT02807844|447842834|FG007|Overall Study|Withdrawal by Subject|0|||
124516512|NCT02807844|447842835|FG008|Overall Study|Withdrawal by Subject|0|||
124516513|NCT02807844|447842836|FG009|Overall Study|Withdrawal by Subject|0|||
124516514|NCT02807844|447842827|FG000|Overall Study|Progressive disease|5|||
124516515|NCT02807844|447842828|FG001|Overall Study|Progressive disease|12|||
124516516|NCT02807844|447842829|FG002|Overall Study|Progressive disease|8|||
124516517|NCT02807844|447842830|FG003|Overall Study|Progressive disease|8|||
124571225|NCT01449630|448050636|FG005|Period 1|Physician Decision|0|||
124571226|NCT01449630|448050637|FG006|Period 1|Physician Decision|0|||
124571227|NCT01449630|448050638|FG007|Period 1|Physician Decision|0|||
124571228|NCT01449630|448050639|FG008|Period 1|Physician Decision|0|||
124571229|NCT01449630|448050631|FG000|Period 1|Sponsor Decision|0|||
124571230|NCT01449630|448050632|FG001|Period 1|Sponsor Decision|0|||
124571231|NCT01449630|448050633|FG002|Period 1|Sponsor Decision|0|||
124571232|NCT01449630|448050634|FG003|Period 1|Sponsor Decision|0|||
124571233|NCT01449630|448050635|FG004|Period 1|Sponsor Decision|0|||
124571234|NCT01449630|448050636|FG005|Period 1|Sponsor Decision|1|||
124571235|NCT01449630|448050637|FG006|Period 1|Sponsor Decision|0|||
124571236|NCT01449630|448050638|FG007|Period 1|Sponsor Decision|0|||
124571237|NCT01449630|448050639|FG008|Period 1|Sponsor Decision|0|||
124571238|NCT01449630|448050631|FG000|Period 2|Sponsor Decision|0|||
124571239|NCT01449630|448050632|FG001|Period 2|Sponsor Decision|0|||
124571240|NCT01449630|448050633|FG002|Period 2|Sponsor Decision|0|||
124571241|NCT01449630|448050634|FG003|Period 2|Sponsor Decision|0|||
124571242|NCT01449630|448050635|FG004|Period 2|Sponsor Decision|0|||
124571243|NCT01449630|448050636|FG005|Period 2|Sponsor Decision|0|||
124571244|NCT01449630|448050637|FG006|Period 2|Sponsor Decision|1|||
124571245|NCT01449630|448050638|FG007|Period 2|Sponsor Decision|0|||
124571246|NCT01449630|448050639|FG008|Period 2|Sponsor Decision|0|||
124571247|NCT01735630|448050644|FG000|Overall Study|Adverse Event|8|||
124571248|NCT01735630|448050645|FG001|Overall Study|Adverse Event|7|||
124571249|NCT01735630|448050644|FG000|Overall Study|Lost to Follow-up|1|||
124571250|NCT01735630|448050645|FG001|Overall Study|Lost to Follow-up|0|||
124571251|NCT01735630|448050644|FG000|Overall Study|Physician Decision|0|||
124571252|NCT01735630|448050645|FG001|Overall Study|Physician Decision|1|||
124571253|NCT01735630|448050644|FG000|Overall Study|Sponsor Decision|2|||
124516518|NCT02807844|447842831|FG004|Overall Study|Progressive disease|3|||
124516519|NCT02807844|447842832|FG005|Overall Study|Progressive disease|8|||
124516520|NCT02807844|447842833|FG006|Overall Study|Progressive disease|14|||
124516521|NCT02807844|447842834|FG007|Overall Study|Progressive disease|17|||
124516522|NCT02807844|447842835|FG008|Overall Study|Progressive disease|19|||
124516523|NCT02807844|447842836|FG009|Overall Study|Progressive disease|15|||
124516524|NCT02807844|447842827|FG000|Overall Study|Adverse Event|1|||
124516525|NCT02807844|447842828|FG001|Overall Study|Adverse Event|0|||
124516526|NCT02807844|447842829|FG002|Overall Study|Adverse Event|0|||
124516527|NCT02807844|447842830|FG003|Overall Study|Adverse Event|0|||
124516528|NCT02807844|447842831|FG004|Overall Study|Adverse Event|1|||
124516529|NCT02807844|447842832|FG005|Overall Study|Adverse Event|1|||
124516530|NCT02807844|447842833|FG006|Overall Study|Adverse Event|1|||
124516531|NCT02807844|447842834|FG007|Overall Study|Adverse Event|1|||
124516532|NCT02807844|447842835|FG008|Overall Study|Adverse Event|1|||
124516533|NCT02807844|447842836|FG009|Overall Study|Adverse Event|2|||
124516534|NCT00709124|447842837|FG000|Overall Study|Death|3|||
124516535|NCT00709124|447842838|FG001|Overall Study|Death|1|||
124516536|NCT00709124|447842837|FG000|Overall Study|encephalopathy; can't do assessment|1|||
124516537|NCT00709124|447842838|FG001|Overall Study|encephalopathy; can't do assessment|0|||
124516538|NCT04294095|447842839|FG000|Overall Study|Adverse Event|1|||
124516539|NCT04294095|447842840|FG001|Overall Study|Adverse Event|0|||
124516540|NCT05567393|447842848|FG000|Overall Study|Voluntary Withdrawal|0|||
124516541|NCT05567393|447842849|FG001|Overall Study|Voluntary Withdrawal|0|||
124516542|NCT05567393|447842850|FG002|Overall Study|Voluntary Withdrawal|0|||
124516543|NCT05567393|447842851|FG003|Overall Study|Voluntary Withdrawal|0|||
124516544|NCT05567393|447842852|FG004|Overall Study|Voluntary Withdrawal|0|||
124516545|NCT05567393|447842853|FG005|Overall Study|Voluntary Withdrawal|0|||
124516546|NCT05567393|447842854|FG006|Overall Study|Voluntary Withdrawal|0|||
124516547|NCT05567393|447842855|FG007|Overall Study|Voluntary Withdrawal|0|||
124516548|NCT05567393|447842856|FG008|Overall Study|Voluntary Withdrawal|0|||
124516549|NCT05567393|447842857|FG009|Overall Study|Voluntary Withdrawal|0|||
124516550|NCT05567393|447842858|FG010|Overall Study|Voluntary Withdrawal|0|||
124516551|NCT05567393|447842859|FG011|Overall Study|Voluntary Withdrawal|0|||
124516552|NCT05567393|447842860|FG012|Overall Study|Voluntary Withdrawal|0|||
124571254|NCT01735630|448050645|FG001|Overall Study|Sponsor Decision|1|||
124516553|NCT05567393|447842861|FG013|Overall Study|Voluntary Withdrawal|1|||
124516554|NCT05567393|447842862|FG014|Overall Study|Voluntary Withdrawal|0|||
124516555|NCT05567393|447842863|FG015|Overall Study|Voluntary Withdrawal|0|||
124516556|NCT05567393|447842864|FG016|Overall Study|Voluntary Withdrawal|0|||
124516557|NCT05567393|447842865|FG017|Overall Study|Voluntary Withdrawal|0|||
124516558|NCT04199793|447842866|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
124516559|NCT04199793|447842867|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
124516560|NCT04199793|447842866|FG000|Overall Study|Withdrawal by Subject|1|||
124516561|NCT04199793|447842867|FG001|Overall Study|Withdrawal by Subject|1|||
124516562|NCT04186663|447842874|FG000|Overall Study|Lost to Follow-up|1|||
124516563|NCT04186663|447842874|FG000|Overall Study|Unable to complete blood draw|3|||
124571255|NCT01735630|448050644|FG000|Overall Study|Withdrawal by Subject|7|||
124516564|NCT01602549|447842878|FG000|Overall Study|Protocol Violation|0|||
124571256|NCT01735630|448050645|FG001|Overall Study|Withdrawal by Subject|9|||
124571257|NCT03099538|448050646|FG000|Overall Study|Lack of Efficacy|3|||
124571258|NCT01941030|448050659|FG000|Overall Study|Death|3|||
124571259|NCT01941030|448050660|FG001|Overall Study|Death|2|||
124571260|NCT01941030|448050659|FG000|Overall Study|Lost to Follow-up|6|||
124571261|NCT01941030|448050660|FG001|Overall Study|Lost to Follow-up|5|||
124571262|NCT01941030|448050659|FG000|Overall Study|Withdrawal by Subject|4|||
124571263|NCT01941030|448050660|FG001|Overall Study|Withdrawal by Subject|6|||
124571264|NCT02930005|448050661|FG000|Overall Study|Lost to Follow-up|1|||
124571265|NCT02930005|448050662|FG001|Overall Study|Lost to Follow-up|5|||
124571266|NCT00822926|448050665|FG000|Second Injection Visit|Lost to Follow-up|1|||
124571267|NCT00822926|448050666|FG001|Second Injection Visit|Lost to Follow-up|0|||
124571268|NCT00822926|448050665|FG000|Second Injection Visit|Withdrawal by Subject|0|||
124571269|NCT00822926|448050666|FG001|Second Injection Visit|Withdrawal by Subject|1|||
124571270|NCT02534493|448050676|FG000|Overall Study|Lost to Follow-up|1|||
124571271|NCT02534493|448050676|FG000|Overall Study|Withdrawal by Subject|1|||
124571272|NCT03125200|448050679|FG000|Overall Study|Study Termination|0|||
124571273|NCT03125200|448050680|FG001|Overall Study|Study Termination|0|||
124571274|NCT03125200|448050681|FG002|Overall Study|Study Termination|0|||
124571275|NCT03125200|448050682|FG003|Overall Study|Study Termination|1|||
124571276|NCT03125200|448050683|FG004|Overall Study|Study Termination|1|||
124571277|NCT03125200|448050684|FG005|Overall Study|Study Termination|2|||
124571278|NCT03125200|448050685|FG006|Overall Study|Study Termination|1|||
124571279|NCT03125200|448050679|FG000|Overall Study|Clinical Progression|0|||
124571280|NCT03125200|448050680|FG001|Overall Study|Clinical Progression|0|||
124571281|NCT03125200|448050681|FG002|Overall Study|Clinical Progression|0|||
124571282|NCT03125200|448050682|FG003|Overall Study|Clinical Progression|1|||
124571283|NCT03125200|448050683|FG004|Overall Study|Clinical Progression|0|||
124571284|NCT03125200|448050684|FG005|Overall Study|Clinical Progression|1|||
124571285|NCT03125200|448050685|FG006|Overall Study|Clinical Progression|0|||
124571286|NCT03125200|448050679|FG000|Overall Study|Progressive Disease|2|||
124571287|NCT03125200|448050680|FG001|Overall Study|Progressive Disease|1|||
124571288|NCT03125200|448050681|FG002|Overall Study|Progressive Disease|2|||
124571289|NCT03125200|448050682|FG003|Overall Study|Progressive Disease|1|||
124571290|NCT03125200|448050683|FG004|Overall Study|Progressive Disease|2|||
124571291|NCT03125200|448050684|FG005|Overall Study|Progressive Disease|0|||
124571292|NCT03125200|448050685|FG006|Overall Study|Progressive Disease|1|||
124571293|NCT03125200|448050679|FG000|Overall Study|Lack of Efficacy|0|||
124571294|NCT03125200|448050680|FG001|Overall Study|Lack of Efficacy|0|||
124571295|NCT03125200|448050681|FG002|Overall Study|Lack of Efficacy|0|||
124571296|NCT03125200|448050682|FG003|Overall Study|Lack of Efficacy|1|||
124571297|NCT03125200|448050683|FG004|Overall Study|Lack of Efficacy|0|||
124571298|NCT03125200|448050684|FG005|Overall Study|Lack of Efficacy|0|||
124571299|NCT03125200|448050685|FG006|Overall Study|Lack of Efficacy|0|||
124571300|NCT03125200|448050679|FG000|Overall Study|Toxicity|0|||
124571301|NCT03125200|448050680|FG001|Overall Study|Toxicity|0|||
124571302|NCT03125200|448050681|FG002|Overall Study|Toxicity|0|||
124571303|NCT03125200|448050682|FG003|Overall Study|Toxicity|1|||
124571304|NCT03125200|448050683|FG004|Overall Study|Toxicity|0|||
124571305|NCT03125200|448050684|FG005|Overall Study|Toxicity|0|||
124571306|NCT03125200|448050685|FG006|Overall Study|Toxicity|0|||
124571307|NCT03125200|448050679|FG000|Overall Study|Consent Withdrawn by Subject|0|||
124571308|NCT03125200|448050680|FG001|Overall Study|Consent Withdrawn by Subject|1|||
124571309|NCT03125200|448050681|FG002|Overall Study|Consent Withdrawn by Subject|0|||
124571310|NCT03125200|448050682|FG003|Overall Study|Consent Withdrawn by Subject|0|||
124571311|NCT03125200|448050683|FG004|Overall Study|Consent Withdrawn by Subject|1|||
124571312|NCT03125200|448050684|FG005|Overall Study|Consent Withdrawn by Subject|0|||
124571313|NCT03125200|448050685|FG006|Overall Study|Consent Withdrawn by Subject|1|||
124571314|NCT00119379|448050689|FG000|Overall Study|Adverse Event|4|||
124571315|NCT00119379|448050690|FG001|Overall Study|Adverse Event|1|||
124571316|NCT01569152|448050693|FG000|Phase IIa, Period 1|Early Escape|5|||
124571317|NCT01569152|448050694|FG001|Phase IIa, Period 1|Early Escape|22|||
124571318|NCT01569152|448050695|FG002|Phase IIa, Period 1|Early Escape|0|||
124571319|NCT01569152|448050693|FG000|Phase IIa, Period 1|Adverse Event|4|||
124571320|NCT01569152|448050694|FG001|Phase IIa, Period 1|Adverse Event|0|||
124571321|NCT01569152|448050695|FG002|Phase IIa, Period 1|Adverse Event|0|||
124571322|NCT01569152|448050693|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
124571323|NCT01569152|448050694|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
124571324|NCT01569152|448050695|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
124571325|NCT01569152|448050693|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
124571326|NCT01569152|448050694|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
124571327|NCT01569152|448050695|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
124571328|NCT01569152|448050693|FG000|Phase IIa, Period 1|Protocol Violation|0|||
124571329|NCT01569152|448050694|FG001|Phase IIa, Period 1|Protocol Violation|1|||
124571330|NCT01569152|448050695|FG002|Phase IIa, Period 1|Protocol Violation|0|||
124571331|NCT01569152|448050693|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
124571332|NCT01569152|448050694|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
124571333|NCT01569152|448050695|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
124571334|NCT01569152|448050693|FG000|Safety Extension, Period 3|Adverse Event|0|||
124571335|NCT01569152|448050694|FG001|Safety Extension, Period 3|Adverse Event|0|||
124516565|NCT01602549|447842879|FG001|Overall Study|Protocol Violation|1|||
124516566|NCT01602549|447842878|FG000|Overall Study|Withdrawal by Subject|1|||
124516567|NCT01602549|447842879|FG001|Overall Study|Withdrawal by Subject|0|||
124516568|NCT05200455|447842882|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
124516569|NCT00719862|447842883|FG000|Overall Study|Adverse Event|1|||
124516570|NCT00719862|447842884|FG001|Overall Study|Adverse Event|2|||
124516571|NCT00719862|447842883|FG000|Overall Study|Lack of Efficacy|3|||
124516572|NCT00719862|447842884|FG001|Overall Study|Lack of Efficacy|0|||
124516573|NCT00719862|447842883|FG000|Overall Study|Non-Compliance|1|||
124516574|NCT00719862|447842884|FG001|Overall Study|Non-Compliance|0|||
124516575|NCT00719862|447842883|FG000|Overall Study|Withdrawal by Subject|1|||
124516576|NCT00719862|447842884|FG001|Overall Study|Withdrawal by Subject|0|||
124516577|NCT00719862|447842883|FG000|Overall Study|Lost to Follow-up|0|||
124516578|NCT00719862|447842884|FG001|Overall Study|Lost to Follow-up|1|||
124516579|NCT00719862|447842883|FG000|Overall Study|Other|2|||
124516580|NCT00719862|447842884|FG001|Overall Study|Other|3|||
124516581|NCT01184846|447842886|FG000|Overall Study|Adverse Event|2|||
124516582|NCT01184846|447842886|FG000|Overall Study|Insufficient response|1|||
124516583|NCT02483078|447842887|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
124516584|NCT02483078|447842888|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
124516585|NCT02483078|447842887|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
124516586|NCT02483078|447842888|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
124516587|NCT02483078|447842887|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
124516588|NCT02483078|447842888|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
124516589|NCT02483078|447842887|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
124516590|NCT02483078|447842888|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
124516591|NCT02483078|447842887|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
124516592|NCT02483078|447842888|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
124516593|NCT02483078|447842887|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
124516594|NCT02483078|447842888|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
124516595|NCT02853032|447842889|FG000|Overall Study|Adverse Event|4|||
124516596|NCT02853032|447842890|FG001|Overall Study|Adverse Event|0|||
124516597|NCT02853032|447842889|FG000|Overall Study|Withdrawal by Subject|3|||
124516598|NCT02853032|447842890|FG001|Overall Study|Withdrawal by Subject|1|||
124516599|NCT02853032|447842889|FG000|Overall Study|Requested to withdraw from all treatment|2|||
124516600|NCT02853032|447842890|FG001|Overall Study|Requested to withdraw from all treatment|2|||
124516601|NCT03366844|447845293|FG000|Overall Study|Physician Decision|1|||
124516602|NCT03366844|447845293|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
124516603|NCT02688153|447845294|FG000|Overall Study|Death|7|||
124516604|NCT02688153|447845295|FG001|Overall Study|Death|5|||
124516605|NCT02688153|447845294|FG000|Overall Study|Withdrawal by Subject|4|||
124516606|NCT02688153|447845295|FG001|Overall Study|Withdrawal by Subject|2|||
124516607|NCT02688153|447845294|FG000|Overall Study|Valve Explant|1|||
124516608|NCT02688153|447845295|FG001|Overall Study|Valve Explant|0|||
124516609|NCT02688153|447845294|FG000|Overall Study|Conversion to Commercial Valve|3|||
124516610|NCT02688153|447845295|FG001|Overall Study|Conversion to Commercial Valve|0|||
124516611|NCT00107172|447845296|FG000|Overall Study|Withdrawal by Subject|1|||
124516612|NCT00107172|447845297|FG001|Overall Study|Withdrawal by Subject|0|||
124516613|NCT00107172|447845296|FG000|Overall Study|Death|0|||
124516614|NCT00107172|447845297|FG001|Overall Study|Death|2|||
124516615|NCT00107172|447845296|FG000|Overall Study|Other Reason|4|||
124516616|NCT00107172|447845297|FG001|Overall Study|Other Reason|3|||
124516617|NCT01102140|447845300|FG000|Overall Study|Lost to Follow-up|1|||
124516618|NCT01102140|447845301|FG001|Overall Study|Lost to Follow-up|0|||
124516619|NCT01102140|447845300|FG000|Overall Study|Investigator terminated study|2|||
124516620|NCT01102140|447845301|FG001|Overall Study|Investigator terminated study|2|||
124516621|NCT03682055|447845302|FG000|Overall Study|Lack of Efficacy|1|||
124516622|NCT03682055|447845303|FG001|Overall Study|Lack of Efficacy|2|||
124516623|NCT03682055|447845304|FG002|Overall Study|Lack of Efficacy|1|||
124571336|NCT01569152|448050695|FG002|Safety Extension, Period 3|Adverse Event|4|||
124516624|NCT03682055|447845305|FG003|Overall Study|Lack of Efficacy|2|||
124516625|NCT03682055|447845306|FG004|Overall Study|Lack of Efficacy|1|||
124516626|NCT03682055|447845307|FG005|Overall Study|Lack of Efficacy|3|||
124516627|NCT03682055|447845302|FG000|Overall Study|Withdrawal by Subject|0|||
124516628|NCT03682055|447845303|FG001|Overall Study|Withdrawal by Subject|0|||
124516629|NCT03682055|447845304|FG002|Overall Study|Withdrawal by Subject|0|||
124516630|NCT03682055|447845305|FG003|Overall Study|Withdrawal by Subject|0|||
124516631|NCT03682055|447845306|FG004|Overall Study|Withdrawal by Subject|0|||
124516632|NCT03682055|447845307|FG005|Overall Study|Withdrawal by Subject|1|||
124516633|NCT03682055|447845302|FG000|Overall Study|Termination of Study by Sponsor|0|||
124516634|NCT03682055|447845303|FG001|Overall Study|Termination of Study by Sponsor|0|||
124516635|NCT03682055|447845304|FG002|Overall Study|Termination of Study by Sponsor|0|||
124516636|NCT03682055|447845305|FG003|Overall Study|Termination of Study by Sponsor|0|||
124516637|NCT03682055|447845306|FG004|Overall Study|Termination of Study by Sponsor|0|||
124571337|NCT01569152|448050693|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
124571338|NCT01569152|448050694|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
124571339|NCT01569152|448050695|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
124571340|NCT01569152|448050693|FG000|Safety Extension, Period 3|Physician Decision|0|||
124571341|NCT01569152|448050694|FG001|Safety Extension, Period 3|Physician Decision|0|||
124571342|NCT01569152|448050695|FG002|Safety Extension, Period 3|Physician Decision|2|||
124571343|NCT01569152|448050693|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
124571344|NCT01569152|448050694|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
124571345|NCT01569152|448050695|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
124571346|NCT01706536|448050696|FG000|Overall Study|Withdrawal by Subject|1|||
124571347|NCT01706536|448050697|FG001|Overall Study|Withdrawal by Subject|0|||
124571348|NCT01706536|448050698|FG002|Overall Study|Withdrawal by Subject|1|||
124571349|NCT01706536|448050699|FG003|Overall Study|Withdrawal by Subject|0|||
124571350|NCT01706536|448050700|FG004|Overall Study|Withdrawal by Subject|0|||
124571351|NCT01706536|448050696|FG000|Overall Study|Adverse Event|2|||
124571352|NCT01706536|448050697|FG001|Overall Study|Adverse Event|3|||
124571353|NCT01706536|448050698|FG002|Overall Study|Adverse Event|4|||
124571354|NCT01706536|448050699|FG003|Overall Study|Adverse Event|3|||
124571355|NCT01706536|448050700|FG004|Overall Study|Adverse Event|2|||
124571356|NCT01706536|448050696|FG000|Overall Study|Lack of Efficacy|1|||
124571357|NCT01706536|448050697|FG001|Overall Study|Lack of Efficacy|0|||
124571358|NCT01706536|448050698|FG002|Overall Study|Lack of Efficacy|0|||
124571359|NCT01706536|448050699|FG003|Overall Study|Lack of Efficacy|1|||
124571360|NCT01706536|448050700|FG004|Overall Study|Lack of Efficacy|0|||
124571361|NCT01706536|448050696|FG000|Overall Study|non compliance|0|||
124571362|NCT01706536|448050697|FG001|Overall Study|non compliance|1|||
124571363|NCT01706536|448050698|FG002|Overall Study|non compliance|0|||
124571364|NCT01706536|448050699|FG003|Overall Study|non compliance|0|||
124571365|NCT01706536|448050700|FG004|Overall Study|non compliance|0|||
124571366|NCT00683293|448050712|FG000|Overall Study|Withdrawal by Subject|2|||
124571367|NCT00683293|448050713|FG001|Overall Study|Withdrawal by Subject|3|||
124571368|NCT03262012|448050714|FG000|Overall Study|Withdrawal by Subject|15|||
124571369|NCT03262012|448050715|FG001|Overall Study|Withdrawal by Subject|13|||
124571370|NCT03262012|448050716|FG002|Overall Study|Withdrawal by Subject|8|||
124571371|NCT03262012|448050717|FG003|Overall Study|Withdrawal by Subject|7|||
124571372|NCT03262012|448050714|FG000|Overall Study|Adverse Event|10|||
124571373|NCT03262012|448050715|FG001|Overall Study|Adverse Event|12|||
124571374|NCT03262012|448050716|FG002|Overall Study|Adverse Event|4|||
124571375|NCT03262012|448050717|FG003|Overall Study|Adverse Event|6|||
124571376|NCT03262012|448050714|FG000|Overall Study|Physician Decision|2|||
124571377|NCT03262012|448050715|FG001|Overall Study|Physician Decision|5|||
124571378|NCT03262012|448050716|FG002|Overall Study|Physician Decision|1|||
124571379|NCT03262012|448050717|FG003|Overall Study|Physician Decision|0|||
124571380|NCT03262012|448050714|FG000|Overall Study|Lack of Efficacy|0|||
124571381|NCT03262012|448050715|FG001|Overall Study|Lack of Efficacy|5|||
124571382|NCT03262012|448050716|FG002|Overall Study|Lack of Efficacy|1|||
124571383|NCT03262012|448050717|FG003|Overall Study|Lack of Efficacy|2|||
124571384|NCT03262012|448050714|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
124571385|NCT03262012|448050715|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
124571386|NCT03262012|448050716|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
124571387|NCT03262012|448050717|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
124571388|NCT01469546|448050718|FG000|Received 5 mg Dose|Adverse Event|13|||
124571389|NCT01469546|448050718|FG000|Received 5 mg Dose|Death|2|||
124571390|NCT01469546|448050718|FG000|Received 5 mg Dose|Protocol Violation|2|||
124571391|NCT01469546|448050718|FG000|Received 5 mg Dose|Progressive Disease|3|||
124571392|NCT01469546|448050718|FG000|Received 5 mg Dose|Physician Decision|3|||
124571393|NCT02079532|448050721|FG000|Overall Study|Adverse Event|7|||
124571394|NCT02079532|448050721|FG000|Overall Study|Additional or changed therapy|2|||
124571395|NCT02079532|448050721|FG000|Overall Study|Lack of Efficacy|9|||
124571396|NCT02079532|448050721|FG000|Overall Study|Protocol Violation|3|||
124571397|NCT02079532|448050721|FG000|Overall Study|Withdrawal by Subject|1|||
124571398|NCT02079532|448050721|FG000|Overall Study|Administrative problems|1|||
124571399|NCT02079532|448050721|FG000|Overall Study|Inclusion into ReFIRST|3|||
124571400|NCT02079532|448050721|FG000|Overall Study|Other|3|||
124571401|NCT01085045|448051993|FG000|Part A|Withdrawal by Subject|4|||
124571402|NCT01085045|448051993|FG000|Part A|Adverse Event|6|||
124571403|NCT01085045|448051993|FG000|Part A|Protocol Violation|1|||
124571404|NCT01085045|448051993|FG000|Part A|Protocol Specified Criteria|7|||
124571405|NCT01085045|448051993|FG000|Part B|Withdrawal by Subject|2|||
124571406|NCT01085045|448051993|FG000|Part B|Protocol Specified Criteria|6|||
124571407|NCT01085045|448051993|FG000|Part B|Lost to Follow-up|1|||
124571408|NCT01085045|448051993|FG000|Part B|Adverse Event|6|||
124571409|NCT04455633|448052001|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
124571410|NCT04455633|448052002|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
124571411|NCT04455633|448052003|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
124571412|NCT04455633|448052001|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
124571413|NCT04455633|448052002|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
124571414|NCT04455633|448052003|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
124571415|NCT04455633|448052001|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
124571416|NCT04455633|448052002|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
124571417|NCT04455633|448052003|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
124571418|NCT04455633|448052001|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
124571419|NCT04455633|448052002|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
124571420|NCT04455633|448052003|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
124571421|NCT02532764|448052004|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
124571422|NCT02532764|448052005|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
124571423|NCT02532764|448052006|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
124571424|NCT02532764|448052007|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
124571425|NCT02532764|448052008|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
124571426|NCT02532764|448052009|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
124571427|NCT02532764|448052010|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
124571428|NCT02532764|448052011|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
124571429|NCT02532764|448052012|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
124571430|NCT02532764|448052013|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
124571431|NCT01717976|448052014|FG000|Overall Study|Protocol Violation|0|||
124571432|NCT01717976|448052015|FG001|Overall Study|Protocol Violation|1|||
124571433|NCT00727571|448052020|FG000|Overall Study|Ineligibility determined|1|||
124571434|NCT00727571|448052021|FG001|Overall Study|Ineligibility determined|1|||
124571435|NCT00727571|448052022|FG002|Overall Study|Ineligibility determined|1|||
124571436|NCT00727571|448052023|FG003|Overall Study|Ineligibility determined|0|||
124571437|NCT00727571|448052020|FG000|Overall Study|Death|0|||
124571438|NCT00727571|448052021|FG001|Overall Study|Death|19|||
124571439|NCT00727571|448052022|FG002|Overall Study|Death|5|||
124571440|NCT00727571|448052023|FG003|Overall Study|Death|1|||
124571441|NCT00727571|448052020|FG000|Overall Study|Physician Decision|0|||
124571442|NCT00727571|448052021|FG001|Overall Study|Physician Decision|5|||
124571443|NCT00727571|448052022|FG002|Overall Study|Physician Decision|0|||
124571444|NCT00727571|448052023|FG003|Overall Study|Physician Decision|0|||
124571445|NCT00727571|448052020|FG000|Overall Study|Withdrawal by Subject|0|||
124571446|NCT00727571|448052021|FG001|Overall Study|Withdrawal by Subject|10|||
124571447|NCT00727571|448052022|FG002|Overall Study|Withdrawal by Subject|11|||
124571448|NCT00727571|448052023|FG003|Overall Study|Withdrawal by Subject|0|||
124571449|NCT00727571|448052020|FG000|Overall Study|Subject Non Compliance|0|||
124571450|NCT00727571|448052021|FG001|Overall Study|Subject Non Compliance|6|||
124571451|NCT00727571|448052022|FG002|Overall Study|Subject Non Compliance|0|||
124571452|NCT00727571|448052023|FG003|Overall Study|Subject Non Compliance|4|||
124571453|NCT00727571|448052020|FG000|Overall Study|Dismissed from nursing home|0|||
124571454|NCT00727571|448052021|FG001|Overall Study|Dismissed from nursing home|9|||
124571455|NCT00727571|448052022|FG002|Overall Study|Dismissed from nursing home|5|||
124571456|NCT00727571|448052023|FG003|Overall Study|Dismissed from nursing home|0|||
124571457|NCT00727571|448052020|FG000|Overall Study|Hospitalization|0|||
124571458|NCT00727571|448052021|FG001|Overall Study|Hospitalization|1|||
124571459|NCT00727571|448052022|FG002|Overall Study|Hospitalization|0|||
124571460|NCT00727571|448052023|FG003|Overall Study|Hospitalization|1|||
124571461|NCT00727571|448052020|FG000|Overall Study|AE not leading to hospitalization|0|||
124571462|NCT00727571|448052021|FG001|Overall Study|AE not leading to hospitalization|0|||
124571463|NCT00727571|448052022|FG002|Overall Study|AE not leading to hospitalization|2|||
124571464|NCT00727571|448052023|FG003|Overall Study|AE not leading to hospitalization|0|||
124571465|NCT00727571|448052020|FG000|Overall Study|Other|0|||
124571466|NCT00727571|448052021|FG001|Overall Study|Other|4|||
124571467|NCT00727571|448052022|FG002|Overall Study|Other|6|||
124571468|NCT00727571|448052023|FG003|Overall Study|Other|0|||
124571469|NCT03164772|448052024|FG000|Overall Study|Death|4|||
124571470|NCT03164772|448052025|FG001|Overall Study|Death|2|||
124571471|NCT03164772|448052024|FG000|Overall Study|Adverse Event|1|||
124571472|NCT03164772|448052025|FG001|Overall Study|Adverse Event|4|||
124571473|NCT03164772|448052024|FG000|Overall Study|Progressive Disease|11|||
124571474|NCT03164772|448052025|FG001|Overall Study|Progressive Disease|21|||
124571475|NCT03164772|448052024|FG000|Overall Study|Physician Decision|2|||
124571476|NCT03164772|448052025|FG001|Overall Study|Physician Decision|0|||
124571477|NCT03164772|448052024|FG000|Overall Study|Withdrawal by Subject|0|||
124571478|NCT03164772|448052025|FG001|Overall Study|Withdrawal by Subject|4|||
124571479|NCT04099888|448052029|FG000|Overall Study|Study terminated by sponsor|9|||
124571480|NCT04099888|448052030|FG001|Overall Study|Study terminated by sponsor|11|||
124571481|NCT04099888|448052029|FG000|Overall Study|Lost to Follow-up|1|||
124571482|NCT04099888|448052030|FG001|Overall Study|Lost to Follow-up|1|||
124571483|NCT04099888|448052029|FG000|Overall Study|Withdrawal by Subject|5|||
124571484|NCT04099888|448052030|FG001|Overall Study|Withdrawal by Subject|6|||
124571485|NCT04099888|448052029|FG000|Overall Study|Death|5|||
124571486|NCT04099888|448052030|FG001|Overall Study|Death|2|||
124516638|NCT03682055|447845307|FG005|Overall Study|Termination of Study by Sponsor|3|||
124516639|NCT01135394|447845308|FG000|Screening|Lost to Follow-up|2|||
124516640|NCT01135394|447845308|FG000|Screening|Withdrawal by Subject|10|||
124516641|NCT01135394|447845308|FG000|Screening|Screening failure|16|||
124516642|NCT01135394|447845308|FG000|Screening|Physician Decision|5|||
124516643|NCT01135394|447845308|FG000|Baseline Assessment|Withdrawal by Subject|9|||
124516644|NCT01135394|447845308|FG000|Baseline Assessment|Physician Decision|3|||
124516645|NCT01135394|447845308|FG000|Baseline Assessment|Lost to Follow-up|2|||
124516646|NCT01135394|447845308|FG000|Baseline Assessment|Adverse Event|1|||
124516647|NCT01135394|447845308|FG000|Study Treatment|Withdrawal by Subject|1|||
124516648|NCT01135394|447845308|FG000|Study Treatment|Physician Decision|1|||
124516649|NCT01135394|447845308|FG000|Study Treatment|Adverse Event|2|||
124516650|NCT00462488|447845309|FG000|Overall Study|Protocol Violation|1|||
124516651|NCT00462488|447845310|FG001|Overall Study|Protocol Violation|0|||
124516652|NCT00462488|447845309|FG000|Overall Study|Lack of Efficacy|19|||
124516653|NCT00462488|447845310|FG001|Overall Study|Lack of Efficacy|17|||
124516654|NCT00927758|447845311|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
124516655|NCT00927758|447845312|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
124516656|NCT00927758|447845313|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
124516657|NCT00927758|447845314|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
124516658|NCT00927758|447845315|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
124516659|NCT00927758|447845316|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
124516660|NCT00927758|447845311|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
124516661|NCT00927758|447845312|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
124516662|NCT00927758|447845313|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
124516663|NCT00927758|447845314|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
124516664|NCT00927758|447845315|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
124516665|NCT00927758|447845316|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
124516666|NCT00212758|447845321|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
124516667|NCT00212758|447845322|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
124516668|NCT00212758|447845321|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
124516669|NCT00212758|447845322|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
124516670|NCT01673490|447845323|FG000|Overall Study|Lost to Follow-up|1|||
124516671|NCT01673490|447845323|FG000|Overall Study|Adverse Event|3|||
124516672|NCT01673490|447845323|FG000|Overall Study|Withdrawal by Subject|3|||
124516673|NCT00379236|447845324|FG000|Double-blind|Adverse Event|11|||
124516674|NCT00379236|447845325|FG001|Double-blind|Adverse Event|6|||
124516675|NCT00379236|447845326|FG002|Double-blind|Adverse Event|0|||
124516676|NCT00379236|447845324|FG000|Double-blind|Protocol Violation|3|||
124516677|NCT00379236|447845325|FG001|Double-blind|Protocol Violation|3|||
124516678|NCT00379236|447845326|FG002|Double-blind|Protocol Violation|0|||
124516679|NCT00379236|447845324|FG000|Double-blind|Withdrawal by Subject|12|||
124516680|NCT00379236|447845325|FG001|Double-blind|Withdrawal by Subject|13|||
124516681|NCT00379236|447845326|FG002|Double-blind|Withdrawal by Subject|0|||
124516682|NCT00379236|447845324|FG000|Double-blind|Lost to Follow-up|4|||
124516683|NCT00379236|447845325|FG001|Double-blind|Lost to Follow-up|3|||
124516684|NCT00379236|447845326|FG002|Double-blind|Lost to Follow-up|0|||
124516685|NCT00379236|447845324|FG000|Double-blind|Use of exclusionary medication|1|||
124516686|NCT00379236|447845325|FG001|Double-blind|Use of exclusionary medication|2|||
124516687|NCT00379236|447845326|FG002|Double-blind|Use of exclusionary medication|0|||
124516688|NCT00379236|447845324|FG000|Double-blind|Other|3|||
124516689|NCT00379236|447845325|FG001|Double-blind|Other|7|||
124516690|NCT00379236|447845326|FG002|Double-blind|Other|0|||
124516691|NCT00379236|447845324|FG000|Double-blind|Data could not be retrieved|2|||
124516692|NCT00379236|447845325|FG001|Double-blind|Data could not be retrieved|2|||
124516693|NCT00379236|447845326|FG002|Double-blind|Data could not be retrieved|0|||
124516694|NCT00379236|447845324|FG000|Open-label Extension|Adverse Event|0|||
124516695|NCT00379236|447845325|FG001|Open-label Extension|Adverse Event|0|||
124516696|NCT00379236|447845326|FG002|Open-label Extension|Adverse Event|13|||
124516697|NCT00379236|447845324|FG000|Open-label Extension|Protocol Violation|0|||
124516698|NCT00379236|447845325|FG001|Open-label Extension|Protocol Violation|0|||
124516699|NCT00379236|447845326|FG002|Open-label Extension|Protocol Violation|7|||
124516700|NCT00379236|447845324|FG000|Open-label Extension|Withdrawal by Subject|0|||
124516701|NCT00379236|447845325|FG001|Open-label Extension|Withdrawal by Subject|0|||
124516702|NCT00379236|447845326|FG002|Open-label Extension|Withdrawal by Subject|13|||
124571487|NCT04099888|448052029|FG000|Overall Study|Other|1|||
124516703|NCT00379236|447845324|FG000|Open-label Extension|Lost to Follow-up|0|||
124516704|NCT00379236|447845325|FG001|Open-label Extension|Lost to Follow-up|0|||
124516705|NCT00379236|447845326|FG002|Open-label Extension|Lost to Follow-up|12|||
124516706|NCT00379236|447845324|FG000|Open-label Extension|Use of exclusionary medication|0|||
124516707|NCT00379236|447845325|FG001|Open-label Extension|Use of exclusionary medication|0|||
124516708|NCT00379236|447845326|FG002|Open-label Extension|Use of exclusionary medication|3|||
124516709|NCT00379236|447845324|FG000|Open-label Extension|Other|0|||
124571488|NCT04099888|448052030|FG001|Overall Study|Other|0|||
124571489|NCT04538170|448052031|FG000|Overall Study|Withdrawal by Subject|104|||
124571490|NCT04538170|448052032|FG001|Overall Study|Withdrawal by Subject|210|||
124571491|NCT00051025|448052036|FG000|Overall Study|Progressive Disease|1|||
124571492|NCT00051025|448052037|FG001|Overall Study|Progressive Disease|1|||
124571493|NCT00051025|448052036|FG000|Overall Study|Adverse Event|1|||
124571494|NCT00051025|448052037|FG001|Overall Study|Adverse Event|1|||
124571495|NCT00051025|448052036|FG000|Overall Study|Withdrawal by Subject|0|||
124571496|NCT00051025|448052037|FG001|Overall Study|Withdrawal by Subject|1|||
124571497|NCT00051025|448052036|FG000|Overall Study|Death|0|||
124571498|NCT00051025|448052037|FG001|Overall Study|Death|1|||
124571499|NCT00274937|448052038|FG000|Overall Study|Physician Decision|10|||
124571500|NCT00274937|448052038|FG000|Overall Study|Withdrawal by Subject|6|||
124571501|NCT00274937|448052038|FG000|Overall Study|Progressive Disease|4|||
124571502|NCT02189941|448052039|FG000|Overall Study|Non-compliance|0|||
124571503|NCT02189941|448052040|FG001|Overall Study|Non-compliance|0|||
124571504|NCT02189941|448052041|FG002|Overall Study|Non-compliance|1|||
124571505|NCT00445003|448052042|FG000|Overall Study|Death|1|||
124571506|NCT00445003|448052043|FG001|Overall Study|Death|2|||
124571507|NCT00445003|448052044|FG002|Overall Study|Death|1|||
124571508|NCT00445003|448052042|FG000|Overall Study|Missed Visit|3|||
124571509|NCT00445003|448052043|FG001|Overall Study|Missed Visit|5|||
124571510|NCT00445003|448052044|FG002|Overall Study|Missed Visit|1|||
124571511|NCT00445003|448052042|FG000|Overall Study|Dropped|1|||
124571512|NCT00445003|448052043|FG001|Overall Study|Dropped|3|||
124571513|NCT00445003|448052044|FG002|Overall Study|Dropped|2|||
124571514|NCT01471093|448052045|FG000|Overall Study|Adverse Event|1|||
124571515|NCT01471093|448052046|FG001|Overall Study|Adverse Event|0|||
124571516|NCT01471093|448052047|FG002|Overall Study|Adverse Event|0|||
124571517|NCT01471093|448052048|FG003|Overall Study|Adverse Event|0|||
124571518|NCT02475954|448052049|FG000|Overall Study|Withdrawal by Subject|2|||
124571519|NCT02475954|448052050|FG001|Overall Study|Withdrawal by Subject|2|||
124571520|NCT02475954|448052049|FG000|Overall Study|Lost to Follow-up|11|||
124571521|NCT02475954|448052050|FG001|Overall Study|Lost to Follow-up|9|||
124571522|NCT02475954|448052049|FG000|Overall Study|Death|1|||
124571523|NCT02475954|448052050|FG001|Overall Study|Death|1|||
124571524|NCT02932878|448052051|FG000|Overall Study|Due to Lab Results|2|||
124571525|NCT02932878|448052052|FG001|Overall Study|Due to Lab Results|1|||
124571526|NCT01918397|448052055|FG000|Overall Study|Never started treatment|2|||
124571527|NCT01918397|448052056|FG001|Overall Study|Never started treatment|1|||
124571528|NCT01918397|448052057|FG002|Overall Study|Never started treatment|0|||
124571529|NCT01918397|448052058|FG003|Overall Study|Never started treatment|0|||
124571530|NCT01918397|448052055|FG000|Overall Study|Adverse Event|1|||
124571531|NCT01918397|448052056|FG001|Overall Study|Adverse Event|1|||
124571532|NCT01918397|448052057|FG002|Overall Study|Adverse Event|1|||
124571533|NCT01918397|448052058|FG003|Overall Study|Adverse Event|0|||
124571534|NCT01918397|448052055|FG000|Overall Study|Lack of compliance|2|||
124571535|NCT01918397|448052056|FG001|Overall Study|Lack of compliance|2|||
124571536|NCT01918397|448052057|FG002|Overall Study|Lack of compliance|3|||
124571537|NCT01918397|448052058|FG003|Overall Study|Lack of compliance|0|||
124776721|NCT00998296|448809951|FG006|Overall Study|Reason other than those specified above|0|||
124516710|NCT00379236|447845325|FG001|Open-label Extension|Other|0|||
124516711|NCT00379236|447845326|FG002|Open-label Extension|Other|7|||
124516712|NCT02940860|447845327|FG000|Overall Study|Non-serious AE|1|||
124516713|NCT02940860|447845328|FG001|Overall Study|Non-serious AE|2|||
124516714|NCT02940860|447845327|FG000|Overall Study|Serious AE|7|||
124516715|NCT02940860|447845328|FG001|Overall Study|Serious AE|3|||
124516716|NCT02940860|447845327|FG000|Overall Study|Withdrawal by Subject|19|||
124516717|NCT02940860|447845328|FG001|Overall Study|Withdrawal by Subject|9|||
124516718|NCT02940860|447845327|FG000|Overall Study|Lost to Follow-up|13|||
124571538|NCT01918397|448052055|FG000|Overall Study|Pregnancy|0|||
124571539|NCT01918397|448052056|FG001|Overall Study|Pregnancy|1|||
124571540|NCT01918397|448052057|FG002|Overall Study|Pregnancy|0|||
124571541|NCT01918397|448052058|FG003|Overall Study|Pregnancy|0|||
124571542|NCT01918397|448052055|FG000|Overall Study|Rifampin susceptible|0|||
124571543|NCT01918397|448052056|FG001|Overall Study|Rifampin susceptible|0|||
124571544|NCT01918397|448052057|FG002|Overall Study|Rifampin susceptible|0|||
124571545|NCT01918397|448052058|FG003|Overall Study|Rifampin susceptible|2|||
124571546|NCT01918397|448052055|FG000|Overall Study|Treatment failure|0|||
124571547|NCT01918397|448052056|FG001|Overall Study|Treatment failure|0|||
124571548|NCT01918397|448052057|FG002|Overall Study|Treatment failure|0|||
124571549|NCT01918397|448052058|FG003|Overall Study|Treatment failure|1|||
124571550|NCT01918397|448052055|FG000|Overall Study|Withdrawal by Subject|3|||
124571551|NCT01918397|448052056|FG001|Overall Study|Withdrawal by Subject|2|||
124516719|NCT02940860|447845328|FG001|Overall Study|Lost to Follow-up|7|||
124571552|NCT01918397|448052057|FG002|Overall Study|Withdrawal by Subject|1|||
124516720|NCT02940860|447845327|FG000|Overall Study|Physician Decision|5|||
124516721|NCT02940860|447845328|FG001|Overall Study|Physician Decision|3|||
124571553|NCT01918397|448052058|FG003|Overall Study|Withdrawal by Subject|1|||
124516722|NCT02940860|447845327|FG000|Overall Study|Sponsor Decision|0|||
124571554|NCT01918397|448052055|FG000|Overall Study|XDR at baseline|0|||
124571555|NCT01918397|448052056|FG001|Overall Study|XDR at baseline|0|||
124571556|NCT01918397|448052057|FG002|Overall Study|XDR at baseline|1|||
124571557|NCT01918397|448052058|FG003|Overall Study|XDR at baseline|0|||
124571558|NCT01918397|448052055|FG000|Overall Study|Lost to Follow-up|2|||
124571559|NCT01918397|448052056|FG001|Overall Study|Lost to Follow-up|1|||
124571560|NCT01918397|448052057|FG002|Overall Study|Lost to Follow-up|1|||
124571561|NCT01918397|448052058|FG003|Overall Study|Lost to Follow-up|1|||
124571562|NCT01918397|448052055|FG000|Overall Study|Increased QTc|1|||
124571563|NCT01918397|448052056|FG001|Overall Study|Increased QTc|0|||
124571564|NCT01918397|448052057|FG002|Overall Study|Increased QTc|0|||
124571565|NCT01918397|448052058|FG003|Overall Study|Increased QTc|1|||
124571566|NCT01918397|448052055|FG000|Overall Study|Death|0|||
124571567|NCT01918397|448052056|FG001|Overall Study|Death|0|||
124571568|NCT01918397|448052057|FG002|Overall Study|Death|1|||
124571569|NCT01918397|448052058|FG003|Overall Study|Death|0|||
124571570|NCT01918397|448052055|FG000|Overall Study|Involved in another investigative trial|0|||
124571571|NCT01918397|448052056|FG001|Overall Study|Involved in another investigative trial|0|||
124571572|NCT01918397|448052057|FG002|Overall Study|Involved in another investigative trial|0|||
124571573|NCT01918397|448052058|FG003|Overall Study|Involved in another investigative trial|1|||
124571574|NCT00864097|448052059|FG000|Overall Study|Death|0|||
124571575|NCT00864097|448052060|FG001|Overall Study|Death|1|||
124571576|NCT00864097|448052061|FG002|Overall Study|Death|0|||
124571577|NCT00864097|448052062|FG003|Overall Study|Death|0|||
124571578|NCT00864097|448052059|FG000|Overall Study|Adverse Event|6|||
124571579|NCT00864097|448052060|FG001|Overall Study|Adverse Event|8|||
124571580|NCT00864097|448052061|FG002|Overall Study|Adverse Event|11|||
124571581|NCT00864097|448052062|FG003|Overall Study|Adverse Event|9|||
124516723|NCT02940860|447845328|FG001|Overall Study|Sponsor Decision|1|||
124516724|NCT02940860|447845327|FG000|Overall Study|Protocol Violation|0|||
124516725|NCT02940860|447845328|FG001|Overall Study|Protocol Violation|2|||
124516726|NCT02940860|447845327|FG000|Overall Study|Death|3|||
124516727|NCT02940860|447845328|FG001|Overall Study|Death|2|||
124516728|NCT02940860|447845327|FG000|Overall Study|Moved, poor venous access, transport|6|||
124516729|NCT02940860|447845328|FG001|Overall Study|Moved, poor venous access, transport|4|||
124516730|NCT02940860|447845327|FG000|Overall Study|Not treated|2|||
124516731|NCT02940860|447845328|FG001|Overall Study|Not treated|2|||
124516732|NCT04914819|447845329|FG000|Overall Study|Pregnancy|3|||
124516733|NCT04914819|447845330|FG001|Overall Study|Pregnancy|1|||
124516734|NCT04914819|447845329|FG000|Overall Study|Discontinued study|4|||
124516735|NCT04914819|447845330|FG001|Overall Study|Discontinued study|1|||
124516736|NCT04914819|447845329|FG000|Overall Study|Lost to Follow-up|7|||
124516737|NCT04914819|447845330|FG001|Overall Study|Lost to Follow-up|0|||
124516738|NCT00233324|447845333|FG000|Main Study|Death|68|||
124516739|NCT00233324|447845334|FG001|Main Study|Death|60|||
124516740|NCT00233324|447845335|FG002|Main Study|Death|62|||
124516741|NCT00233324|447845336|FG003|Main Study|Death|47|||
124516742|NCT00233324|447845333|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
124516743|NCT00233324|447845334|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
124516744|NCT00233324|447845335|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
124516745|NCT00233324|447845336|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
124516746|NCT00233324|447845333|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
124516747|NCT00233324|447845334|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
124516748|NCT00233324|447845335|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
124516749|NCT00233324|447845336|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
124516750|NCT03276572|447845343|FG000|Overall Study|In follow-up|0|||
124516751|NCT03276572|447845344|FG001|Overall Study|In follow-up|0|||
124516752|NCT03276572|447845345|FG002|Overall Study|In follow-up|0|||
124516753|NCT03276572|447845346|FG003|Overall Study|In follow-up|0|||
124571582|NCT00864097|448052059|FG000|Overall Study|Lack of Efficacy|9|||
124571583|NCT00864097|448052060|FG001|Overall Study|Lack of Efficacy|3|||
124516754|NCT03276572|447845347|FG004|Overall Study|In follow-up|0|||
124516755|NCT03276572|447845348|FG005|Overall Study|In follow-up|1|||
124571584|NCT00864097|448052061|FG002|Overall Study|Lack of Efficacy|7|||
124571585|NCT00864097|448052062|FG003|Overall Study|Lack of Efficacy|2|||
124571586|NCT00864097|448052059|FG000|Overall Study|Lost to Follow-up|0|||
124571587|NCT00864097|448052060|FG001|Overall Study|Lost to Follow-up|1|||
124571588|NCT00864097|448052061|FG002|Overall Study|Lost to Follow-up|0|||
124571589|NCT00864097|448052062|FG003|Overall Study|Lost to Follow-up|1|||
124571590|NCT00864097|448052059|FG000|Overall Study|Withdrawal by Subject|15|||
124516756|NCT03276572|447845349|FG006|Overall Study|In follow-up|1|||
124516757|NCT03276572|447845343|FG000|Overall Study|Lost to Follow-up|0|||
124516758|NCT03276572|447845344|FG001|Overall Study|Lost to Follow-up|0|||
124516759|NCT03276572|447845345|FG002|Overall Study|Lost to Follow-up|0|||
124516760|NCT03276572|447845346|FG003|Overall Study|Lost to Follow-up|0|||
124516761|NCT03276572|447845347|FG004|Overall Study|Lost to Follow-up|0|||
124516762|NCT03276572|447845348|FG005|Overall Study|Lost to Follow-up|0|||
124571591|NCT00864097|448052060|FG001|Overall Study|Withdrawal by Subject|11|||
124571592|NCT00864097|448052061|FG002|Overall Study|Withdrawal by Subject|11|||
124571593|NCT00864097|448052062|FG003|Overall Study|Withdrawal by Subject|12|||
124571594|NCT00864097|448052059|FG000|Overall Study|Protocol Violation|2|||
124571595|NCT00864097|448052060|FG001|Overall Study|Protocol Violation|1|||
124571596|NCT00864097|448052061|FG002|Overall Study|Protocol Violation|0|||
124571597|NCT00864097|448052062|FG003|Overall Study|Protocol Violation|1|||
124571598|NCT00864097|448052059|FG000|Overall Study|Terminated by sponsor|105|||
124571599|NCT00864097|448052060|FG001|Overall Study|Terminated by sponsor|112|||
124571600|NCT00864097|448052061|FG002|Overall Study|Terminated by sponsor|102|||
124571601|NCT00864097|448052062|FG003|Overall Study|Terminated by sponsor|99|||
124571602|NCT00864097|448052059|FG000|Overall Study|Randomized but not treated|2|||
124571603|NCT00864097|448052060|FG001|Overall Study|Randomized but not treated|0|||
124571604|NCT00864097|448052061|FG002|Overall Study|Randomized but not treated|1|||
124571605|NCT00864097|448052062|FG003|Overall Study|Randomized but not treated|0|||
124516763|NCT03276572|447845349|FG006|Overall Study|Lost to Follow-up|1|||
124516764|NCT01709708|447845350|FG000|Overall Study|Protocol Violation|1|||
124516765|NCT01709708|447845351|FG001|Overall Study|Protocol Violation|2|||
124516766|NCT00527072|447845352|FG000|Overall Study|Adverse Event|13|||
124516767|NCT00527072|447845352|FG000|Overall Study|Lack of Efficacy|11|||
124516768|NCT00527072|447845352|FG000|Overall Study|Lost to Follow-up|3|||
124516769|NCT00527072|447845352|FG000|Overall Study|Protocol Violation|2|||
124516770|NCT00527072|447845352|FG000|Overall Study|Withdrawal by Subject|7|||
124516771|NCT00810043|447845353|FG000|Overall Study|Withdrawal by Subject|1|||
124516772|NCT00810043|447845354|FG001|Overall Study|Withdrawal by Subject|0|||
124516773|NCT00810043|447845355|FG002|Overall Study|Withdrawal by Subject|2|||
124516774|NCT00810043|447845353|FG000|Overall Study|Lost to Follow-up|1|||
124516775|NCT00810043|447845354|FG001|Overall Study|Lost to Follow-up|0|||
124516776|NCT00810043|447845355|FG002|Overall Study|Lost to Follow-up|0|||
124516777|NCT00810043|447845353|FG000|Overall Study|Physician Decision|0|||
124516778|NCT00810043|447845354|FG001|Overall Study|Physician Decision|0|||
124516779|NCT00810043|447845355|FG002|Overall Study|Physician Decision|2|||
124516780|NCT00810043|447845353|FG000|Overall Study|Death|2|||
124516781|NCT00810043|447845354|FG001|Overall Study|Death|0|||
124516782|NCT00810043|447845355|FG002|Overall Study|Death|0|||
124516783|NCT00810043|447845353|FG000|Overall Study|Unrelated medical problem|0|||
124516784|NCT00810043|447845354|FG001|Overall Study|Unrelated medical problem|1|||
124516785|NCT00810043|447845355|FG002|Overall Study|Unrelated medical problem|0|||
124516786|NCT00810043|447845353|FG000|Overall Study|Non-medical problem|0|||
124516787|NCT00810043|447845354|FG001|Overall Study|Non-medical problem|0|||
124516788|NCT00810043|447845355|FG002|Overall Study|Non-medical problem|1|||
124516789|NCT00810043|447845353|FG000|Overall Study|No longer met enrollment criteria|0|||
124516790|NCT00810043|447845354|FG001|Overall Study|No longer met enrollment criteria|0|||
124516791|NCT00810043|447845355|FG002|Overall Study|No longer met enrollment criteria|3|||
124516792|NCT01989754|447845356|FG000|Overall Study|Withdrawal by Subject|10|||
124516793|NCT01989754|447845357|FG001|Overall Study|Withdrawal by Subject|14|||
124516794|NCT01989754|447845356|FG000|Overall Study|Lost to Follow-up|28|||
124516795|NCT01989754|447845357|FG001|Overall Study|Lost to Follow-up|20|||
124516796|NCT01989754|447845356|FG000|Overall Study|Closed Site|1|||
124516797|NCT01989754|447845357|FG001|Overall Study|Closed Site|1|||
124516798|NCT01369225|447845363|FG000|Overall Study|Withdrawal by Subject|1|||
124516799|NCT01369225|447845364|FG001|Overall Study|Withdrawal by Subject|0|||
124516800|NCT01369225|447845365|FG002|Overall Study|Withdrawal by Subject|2|||
124516801|NCT01369225|447845366|FG003|Overall Study|Withdrawal by Subject|1|||
124516802|NCT01369225|447845367|FG004|Overall Study|Withdrawal by Subject|0|||
124516803|NCT01369225|447845368|FG005|Overall Study|Withdrawal by Subject|0|||
124516804|NCT01369225|447845363|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
124571606|NCT00864097|448052059|FG000|Overall Study|Other|0|||
124571607|NCT00864097|448052060|FG001|Overall Study|Other|0|||
124516805|NCT01369225|447845364|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
124516806|NCT01369225|447845365|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
124516807|NCT01369225|447845366|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
124516808|NCT01369225|447845367|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
124516809|NCT01369225|447845368|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
124571608|NCT00864097|448052061|FG002|Overall Study|Other|0|||
124571609|NCT00864097|448052062|FG003|Overall Study|Other|1|||
124571610|NCT00620022|448052066|FG000|Treatment Period 1|Adverse Event|4|||
124571611|NCT00620022|448052067|FG001|Treatment Period 1|Adverse Event|6|||
124516810|NCT01369225|447845363|FG000|Overall Study|Other|1|||
124516811|NCT01369225|447845364|FG001|Overall Study|Other|0|||
124516812|NCT01369225|447845365|FG002|Overall Study|Other|0|||
124516813|NCT01369225|447845366|FG003|Overall Study|Other|0|||
124516814|NCT01369225|447845367|FG004|Overall Study|Other|1|||
124516815|NCT01369225|447845368|FG005|Overall Study|Other|0|||
124516816|NCT01369225|447845363|FG000|Overall Study|Adverse Event|0|||
124516817|NCT01369225|447845364|FG001|Overall Study|Adverse Event|0|||
124516818|NCT01369225|447845365|FG002|Overall Study|Adverse Event|0|||
124516819|NCT01369225|447845366|FG003|Overall Study|Adverse Event|1|||
124516820|NCT01369225|447845367|FG004|Overall Study|Adverse Event|1|||
124516821|NCT01369225|447845368|FG005|Overall Study|Adverse Event|0|||
124516822|NCT02980692|447845369|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
124571612|NCT00620022|448052066|FG000|Treatment Period 1|Subject withdrew consent|1|||
124571613|NCT00620022|448052067|FG001|Treatment Period 1|Subject withdrew consent|0|||
124571614|NCT00620022|448052066|FG000|Treatment Period 2|Adverse Event|2|||
124571615|NCT00620022|448052067|FG001|Treatment Period 2|Adverse Event|2|||
124571616|NCT00262223|448052068|FG000|Treatment Phase|Withdrawal by Subject|3|||
124571617|NCT00262223|448052069|FG001|Treatment Phase|Withdrawal by Subject|6|||
124571618|NCT00262223|448052068|FG000|Treatment Phase|Adverse Event|1|||
124571619|NCT00262223|448052069|FG001|Treatment Phase|Adverse Event|2|||
124571620|NCT00262223|448052068|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
124571621|NCT00262223|448052069|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
124571622|NCT00262223|448052068|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
124571623|NCT00262223|448052069|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
124571624|NCT00262223|448052068|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
124571625|NCT00262223|448052069|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
124571626|NCT01804270|448052072|FG000|Overall Study|Withdrawal by Subject|1|||
124571627|NCT01804270|448052073|FG001|Overall Study|Withdrawal by Subject|1|||
124571628|NCT01328093|448052077|FG000|Double-Blind Phase|Adverse Event|78|||
124571629|NCT01328093|448052078|FG001|Double-Blind Phase|Adverse Event|15|||
124571630|NCT01328093|448052077|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
124571631|NCT01328093|448052078|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
124571632|NCT01328093|448052077|FG000|Double-Blind Phase|Lost to Follow-up|39|||
124571633|NCT01328093|448052078|FG001|Double-Blind Phase|Lost to Follow-up|14|||
124571634|NCT01328093|448052077|FG000|Double-Blind Phase|Protocol Violation|30|||
124571635|NCT01328093|448052078|FG001|Double-Blind Phase|Protocol Violation|10|||
124571636|NCT01328093|448052077|FG000|Double-Blind Phase|Lack of Efficacy|55|||
124571637|NCT01328093|448052078|FG001|Double-Blind Phase|Lack of Efficacy|13|||
124571638|NCT01328093|448052077|FG000|Double-Blind Phase|Sponsor Decision|17|||
124571639|NCT01328093|448052078|FG001|Double-Blind Phase|Sponsor Decision|3|||
124571640|NCT01328093|448052077|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
124571641|NCT01328093|448052078|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
124571642|NCT01328093|448052077|FG000|Double-Blind Phase|Scheduling conflict|8|||
124571643|NCT01328093|448052078|FG001|Double-Blind Phase|Scheduling conflict|3|||
124571644|NCT01328093|448052077|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
124571645|NCT01328093|448052078|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
124571646|NCT01328093|448052077|FG000|Double-Blind Phase|Death|1|||
124571647|NCT01328093|448052078|FG001|Double-Blind Phase|Death|0|||
124571648|NCT01328093|448052077|FG000|Open-Label Phase|Sponsor Decision|98|||
124571649|NCT01328093|448052078|FG001|Open-Label Phase|Sponsor Decision|34|||
124571650|NCT01328093|448052077|FG000|Open-Label Phase|Protocol Violation|8|||
124571651|NCT01328093|448052078|FG001|Open-Label Phase|Protocol Violation|3|||
124571652|NCT01328093|448052077|FG000|Open-Label Phase|Lost to Follow-up|10|||
124571653|NCT01328093|448052078|FG001|Open-Label Phase|Lost to Follow-up|1|||
124571654|NCT01328093|448052077|FG000|Open-Label Phase|Adverse Event|10|||
124516823|NCT02980692|447845370|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
124516824|NCT02980692|447845371|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
124516825|NCT02980692|447845372|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
124516826|NCT02980692|447845373|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
124516827|NCT02980692|447845369|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
124516828|NCT02980692|447845370|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
124516829|NCT02980692|447845371|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
124516830|NCT02980692|447845372|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
124516831|NCT02980692|447845373|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
124516832|NCT02980692|447845369|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
124516833|NCT02980692|447845370|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
124516834|NCT02980692|447845371|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
124516835|NCT02980692|447845372|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
124571655|NCT01328093|448052078|FG001|Open-Label Phase|Adverse Event|4|||
124571656|NCT01328093|448052077|FG000|Open-Label Phase|Lack of Efficacy|5|||
124571657|NCT01328093|448052078|FG001|Open-Label Phase|Lack of Efficacy|6|||
124571658|NCT01328093|448052077|FG000|Open-Label Phase|Withdrawal by Subject|4|||
124571659|NCT01328093|448052078|FG001|Open-Label Phase|Withdrawal by Subject|1|||
124571660|NCT01328093|448052077|FG000|Open-Label Phase|Scheduling conflict|2|||
124571661|NCT01328093|448052078|FG001|Open-Label Phase|Scheduling conflict|1|||
124571662|NCT01328093|448052077|FG000|Open-Label Phase|Subject is moving or has moved|2|||
124571663|NCT01328093|448052078|FG001|Open-Label Phase|Subject is moving or has moved|0|||
124571664|NCT01328093|448052077|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
124571665|NCT01328093|448052078|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
124571666|NCT05150964|448052081|FG000|Overall Study|Lost to Follow-up|2|||
124571667|NCT03661528|448052082|FG000|Overall Study|Death|1|||
124571668|NCT03661528|448052083|FG001|Overall Study|Death|0|||
124571669|NCT03661528|448052082|FG000|Overall Study|Physician Decision|3|||
124776722|NCT00998296|448809952|FG007|Overall Study|Reason other than those specified above|0|||
124516836|NCT02980692|447845373|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
124516837|NCT02980692|447845369|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
124516838|NCT02980692|447845370|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
124516839|NCT02980692|447845371|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
124516840|NCT02980692|447845372|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
124516841|NCT02980692|447845373|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
124516842|NCT02980692|447845369|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
124516843|NCT02980692|447845370|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
124516844|NCT02980692|447845371|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
124516845|NCT02980692|447845372|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
124516846|NCT02980692|447845373|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
124516847|NCT02980692|447845369|FG000|Double Blind Placebo Controlled Period|Other|1|||
124516848|NCT02980692|447845370|FG001|Double Blind Placebo Controlled Period|Other|0|||
124516849|NCT02980692|447845371|FG002|Double Blind Placebo Controlled Period|Other|0|||
124516850|NCT02980692|447845372|FG003|Double Blind Placebo Controlled Period|Other|0|||
124516851|NCT02980692|447845373|FG004|Double Blind Placebo Controlled Period|Other|1|||
124516852|NCT02980692|447845369|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
124516853|NCT02980692|447845370|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
124516854|NCT02980692|447845371|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
124516855|NCT02980692|447845372|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
124516856|NCT02980692|447845373|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
124516857|NCT02980692|447845369|FG000|Double-blind Follow-up Period|Adverse Event|0|||
124516858|NCT02980692|447845370|FG001|Double-blind Follow-up Period|Adverse Event|0|||
124516859|NCT02980692|447845371|FG002|Double-blind Follow-up Period|Adverse Event|0|||
124516860|NCT02980692|447845372|FG003|Double-blind Follow-up Period|Adverse Event|1|||
124516861|NCT02980692|447845373|FG004|Double-blind Follow-up Period|Adverse Event|1|||
124516862|NCT02980692|447845369|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
124516863|NCT02980692|447845370|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
124516864|NCT02980692|447845371|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
124516865|NCT02980692|447845372|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
124516866|NCT02980692|447845373|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
124516867|NCT02980692|447845369|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
124516868|NCT02980692|447845370|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
124516869|NCT02980692|447845371|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
124516870|NCT02980692|447845372|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
124516871|NCT02980692|447845373|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
124516872|NCT02980692|447845369|FG000|Double-blind Follow-up Period|Pregnancy|0|||
124516873|NCT02980692|447845370|FG001|Double-blind Follow-up Period|Pregnancy|0|||
124516874|NCT02980692|447845371|FG002|Double-blind Follow-up Period|Pregnancy|1|||
124516875|NCT02980692|447845372|FG003|Double-blind Follow-up Period|Pregnancy|1|||
124516876|NCT02980692|447845373|FG004|Double-blind Follow-up Period|Pregnancy|0|||
124516877|NCT02980692|447845369|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
124516878|NCT02980692|447845370|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
124516879|NCT02980692|447845371|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
124516880|NCT02980692|447845372|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
124516881|NCT02980692|447845373|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
124516882|NCT02980692|447845369|FG000|Double-blind Follow-up Period|Other|0|||
124516883|NCT02980692|447845370|FG001|Double-blind Follow-up Period|Other|0|||
124516884|NCT02980692|447845371|FG002|Double-blind Follow-up Period|Other|1|||
124516885|NCT02980692|447845372|FG003|Double-blind Follow-up Period|Other|1|||
124516886|NCT02980692|447845373|FG004|Double-blind Follow-up Period|Other|3|||
124516887|NCT00064077|447845376|FG000|Overall Study|Improper prior treatment|1|||
124516888|NCT00064077|447845377|FG001|Overall Study|Improper prior treatment|0|||
124516889|NCT00064077|447845378|FG002|Overall Study|Improper prior treatment|0|||
124516890|NCT00064077|447845379|FG003|Overall Study|Improper prior treatment|0|||
124516891|NCT00064077|447845376|FG000|Overall Study|Poor risk|2|||
124516892|NCT00064077|447845377|FG001|Overall Study|Poor risk|0|||
124516893|NCT00064077|447845378|FG002|Overall Study|Poor risk|1|||
124516894|NCT00064077|447845379|FG003|Overall Study|Poor risk|1|||
124516895|NCT00064077|447845376|FG000|Overall Study|Pathology|10|||
124516896|NCT00064077|447845377|FG001|Overall Study|Pathology|7|||
124516897|NCT00064077|447845378|FG002|Overall Study|Pathology|3|||
124516898|NCT00064077|447845379|FG003|Overall Study|Pathology|4|||
124516899|NCT00064077|447845376|FG000|Overall Study|No surgery|0|||
124516900|NCT00064077|447845377|FG001|Overall Study|No surgery|0|||
124516901|NCT00064077|447845378|FG002|Overall Study|No surgery|1|||
124516902|NCT00064077|447845379|FG003|Overall Study|No surgery|0|||
124516903|NCT00064077|447845376|FG000|Overall Study|No tumor|0|||
124571670|NCT03661528|448052083|FG001|Overall Study|Physician Decision|1|||
124516904|NCT00064077|447845377|FG001|Overall Study|No tumor|0|||
124516905|NCT00064077|447845378|FG002|Overall Study|No tumor|1|||
124516906|NCT00064077|447845379|FG003|Overall Study|No tumor|0|||
124516907|NCT00064077|447845376|FG000|Overall Study|Other reasons|2|||
124516908|NCT00064077|447845377|FG001|Overall Study|Other reasons|2|||
124516909|NCT00064077|447845378|FG002|Overall Study|Other reasons|1|||
124516910|NCT00064077|447845379|FG003|Overall Study|Other reasons|2|||
124516911|NCT01112982|447845383|FG000|Overall Study|Withdrawal by Subject|1|||
124516912|NCT01112982|447845383|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
124516913|NCT01001234|447845388|FG000|Overall Study|Withdrawal by Subject|2|||
124516914|NCT01001234|447845389|FG001|Overall Study|Withdrawal by Subject|0|||
124516915|NCT01001234|447845390|FG002|Overall Study|Withdrawal by Subject|3|||
124516916|NCT01001234|447845391|FG003|Overall Study|Withdrawal by Subject|0|||
124516917|NCT01001234|447845392|FG004|Overall Study|Withdrawal by Subject|0|||
124516918|NCT01001234|447845388|FG000|Overall Study|Protocol Violation|34|||
124516919|NCT01001234|447845389|FG001|Overall Study|Protocol Violation|3|||
124516920|NCT01001234|447845390|FG002|Overall Study|Protocol Violation|19|||
124516921|NCT01001234|447845391|FG003|Overall Study|Protocol Violation|18|||
124516922|NCT01001234|447845392|FG004|Overall Study|Protocol Violation|0|||
124516923|NCT01001234|447845388|FG000|Overall Study|Lost to Follow-up|0|||
124516924|NCT01001234|447845389|FG001|Overall Study|Lost to Follow-up|0|||
124516925|NCT01001234|447845390|FG002|Overall Study|Lost to Follow-up|1|||
124516926|NCT01001234|447845391|FG003|Overall Study|Lost to Follow-up|2|||
124516927|NCT01001234|447845392|FG004|Overall Study|Lost to Follow-up|0|||
124516928|NCT01001234|447845388|FG000|Overall Study|Physician Decision|1|||
124516929|NCT01001234|447845389|FG001|Overall Study|Physician Decision|0|||
124516930|NCT01001234|447845390|FG002|Overall Study|Physician Decision|0|||
124516931|NCT01001234|447845391|FG003|Overall Study|Physician Decision|0|||
124516932|NCT01001234|447845392|FG004|Overall Study|Physician Decision|0|||
124516933|NCT01001234|447845388|FG000|Overall Study|Not Treated: Adverse Event|1|||
124516934|NCT01001234|447845389|FG001|Overall Study|Not Treated: Adverse Event|0|||
124516935|NCT01001234|447845390|FG002|Overall Study|Not Treated: Adverse Event|0|||
124516936|NCT01001234|447845391|FG003|Overall Study|Not Treated: Adverse Event|0|||
124516937|NCT01001234|447845392|FG004|Overall Study|Not Treated: Adverse Event|0|||
124516938|NCT01001234|447845388|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
124516939|NCT01001234|447845389|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
124516940|NCT01001234|447845390|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
124516941|NCT01001234|447845391|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
124571671|NCT03661528|448052082|FG000|Overall Study|Other than Specified|5|||
124571672|NCT03661528|448052083|FG001|Overall Study|Other than Specified|2|||
124571673|NCT03661528|448052082|FG000|Overall Study|Withdrawal by Subject|5|||
124571674|NCT03661528|448052083|FG001|Overall Study|Withdrawal by Subject|3|||
124571675|NCT03661528|448052082|FG000|Overall Study|Disease Progression|8|||
124571676|NCT03661528|448052083|FG001|Overall Study|Disease Progression|13|||
124571677|NCT03661528|448052082|FG000|Overall Study|Adverse Event|61|||
124571678|NCT03661528|448052083|FG001|Overall Study|Adverse Event|55|||
124571679|NCT02178722|448052084|FG000|Overall Study|Withdrawal by Subject|0|||
124571680|NCT02178722|448052085|FG001|Overall Study|Withdrawal by Subject|0|||
124571681|NCT02178722|448052086|FG002|Overall Study|Withdrawal by Subject|0|||
124571682|NCT02178722|448052087|FG003|Overall Study|Withdrawal by Subject|2|||
124571683|NCT02178722|448052088|FG004|Overall Study|Withdrawal by Subject|33|||
124571684|NCT02178722|448052084|FG000|Overall Study|Death|2|||
124571685|NCT02178722|448052085|FG001|Overall Study|Death|13|||
124571686|NCT02178722|448052086|FG002|Overall Study|Death|12|||
124571687|NCT02178722|448052087|FG003|Overall Study|Death|12|||
124571688|NCT02178722|448052088|FG004|Overall Study|Death|205|||
124571689|NCT02178722|448052084|FG000|Overall Study|Lost to Follow-up|0|||
124571690|NCT02178722|448052085|FG001|Overall Study|Lost to Follow-up|0|||
124571691|NCT02178722|448052086|FG002|Overall Study|Lost to Follow-up|0|||
124571692|NCT02178722|448052087|FG003|Overall Study|Lost to Follow-up|2|||
124571693|NCT02178722|448052088|FG004|Overall Study|Lost to Follow-up|11|||
124571694|NCT02178722|448052084|FG000|Overall Study|Study terminated by Sponsor|2|||
124516942|NCT01001234|447845392|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
124516943|NCT01001234|447845388|FG000|Overall Study|Not Treated: Protocol Violation|3|||
124516944|NCT01001234|447845389|FG001|Overall Study|Not Treated: Protocol Violation|0|||
124516945|NCT01001234|447845390|FG002|Overall Study|Not Treated: Protocol Violation|0|||
124516946|NCT01001234|447845391|FG003|Overall Study|Not Treated: Protocol Violation|0|||
124516947|NCT01001234|447845392|FG004|Overall Study|Not Treated: Protocol Violation|0|||
124516948|NCT01001234|447845388|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
124516949|NCT01001234|447845389|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
124516950|NCT01001234|447845390|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
124516951|NCT01001234|447845391|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
124516952|NCT01001234|447845392|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
124571695|NCT02178722|448052085|FG001|Overall Study|Study terminated by Sponsor|7|||
124516953|NCT01001234|447845388|FG000|Overall Study|Not Treated: Pregnancy|3|||
124571696|NCT02178722|448052086|FG002|Overall Study|Study terminated by Sponsor|6|||
124571697|NCT02178722|448052087|FG003|Overall Study|Study terminated by Sponsor|4|||
124571698|NCT02178722|448052088|FG004|Overall Study|Study terminated by Sponsor|128|||
124571699|NCT02178722|448052084|FG000|Overall Study|Physician Decision|0|||
124571700|NCT02178722|448052085|FG001|Overall Study|Physician Decision|0|||
124571701|NCT02178722|448052086|FG002|Overall Study|Physician Decision|0|||
124571702|NCT02178722|448052087|FG003|Overall Study|Physician Decision|0|||
124571703|NCT02178722|448052088|FG004|Overall Study|Physician Decision|3|||
124571704|NCT02178722|448052084|FG000|Overall Study|Other|0|||
124571705|NCT02178722|448052085|FG001|Overall Study|Other|0|||
124571706|NCT02178722|448052086|FG002|Overall Study|Other|0|||
124571707|NCT02178722|448052087|FG003|Overall Study|Other|0|||
124571708|NCT02178722|448052088|FG004|Overall Study|Other|2|||
124571709|NCT03340727|448052089|FG000|Overall Study|Death|1|||
124571710|NCT03340727|448052090|FG001|Overall Study|Death|0|||
124571711|NCT03340727|448052089|FG000|Overall Study|Lost to Follow-up|31|||
124571712|NCT03340727|448052090|FG001|Overall Study|Lost to Follow-up|35|||
124571713|NCT03340727|448052089|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
124571714|NCT03340727|448052090|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
124571715|NCT03340727|448052089|FG000|Overall Study|Transferred to another facility|10|||
124571716|NCT03340727|448052090|FG001|Overall Study|Transferred to another facility|7|||
124571717|NCT03340727|448052089|FG000|Overall Study|Withdrawal by Subject|28|||
124571718|NCT03340727|448052090|FG001|Overall Study|Withdrawal by Subject|17|||
124571719|NCT03553823|448052091|FG000|Overall Study|Physician Decision|0|||
124571720|NCT03553823|448052092|FG001|Overall Study|Physician Decision|1|||
124571721|NCT03991494|448052099|FG000|Overall Study|Progressive Disease|4|||
124571722|NCT01937390|448052105|FG000|Overall Study|Death|2|||
124571723|NCT01937390|448052105|FG000|Overall Study|Lost to Follow-up|7|||
124571724|NCT01937390|448052105|FG000|Overall Study|Withdrawal by Subject|5|||
124571725|NCT01937390|448052105|FG000|Overall Study|Fail to return|21|||
124571726|NCT02920996|448052110|FG000|Overall Study|Adverse Event|8|||
124571727|NCT02920996|448052111|FG001|Overall Study|Adverse Event|0|||
124571728|NCT02920996|448052110|FG000|Overall Study|Physician Decision|1|||
124571729|NCT02920996|448052111|FG001|Overall Study|Physician Decision|0|||
124571730|NCT02920996|448052110|FG000|Overall Study|Death|1|||
124571731|NCT02920996|448052111|FG001|Overall Study|Death|0|||
124571732|NCT02920996|448052110|FG000|Overall Study|Missing|1|||
124571733|NCT02920996|448052111|FG001|Overall Study|Missing|0|||
124571734|NCT02920996|448052110|FG000|Overall Study|Subject Non-Compliance|1|||
124571735|NCT02920996|448052111|FG001|Overall Study|Subject Non-Compliance|0|||
124571736|NCT00154102|448052114|FG000|Overall Study|investigational study phase ongoing|7|||
124571737|NCT00154102|448052115|FG001|Overall Study|investigational study phase ongoing|2|||
124571738|NCT00591630|448052116|FG000|Overall Study|Death|0|||
124571739|NCT00591630|448052117|FG001|Overall Study|Death|0|||
124571740|NCT00591630|448052118|FG002|Overall Study|Death|1|||
124571741|NCT00591630|448052119|FG003|Overall Study|Death|0|||
124571742|NCT00463606|448052120|FG000|Overall Study|Adverse Event|21|||
124571743|NCT00463606|448052121|FG001|Overall Study|Adverse Event|18|||
124571744|NCT00463606|448052122|FG002|Overall Study|Adverse Event|11|||
124571745|NCT00463606|448052120|FG000|Overall Study|Withdrawal by Subject|11|||
124571746|NCT00463606|448052121|FG001|Overall Study|Withdrawal by Subject|11|||
124571747|NCT00463606|448052122|FG002|Overall Study|Withdrawal by Subject|5|||
124571748|NCT00463606|448052120|FG000|Overall Study|Lost to Follow-up|2|||
124571749|NCT00463606|448052121|FG001|Overall Study|Lost to Follow-up|2|||
124571750|NCT00463606|448052122|FG002|Overall Study|Lost to Follow-up|3|||
124571751|NCT00463606|448052120|FG000|Overall Study|Subject noncompliance|1|||
124571752|NCT00463606|448052121|FG001|Overall Study|Subject noncompliance|1|||
124571753|NCT00463606|448052122|FG002|Overall Study|Subject noncompliance|0|||
124571754|NCT00463606|448052120|FG000|Overall Study|Subject moved out of town|1|||
124571755|NCT00463606|448052121|FG001|Overall Study|Subject moved out of town|0|||
124571756|NCT00463606|448052122|FG002|Overall Study|Subject moved out of town|0|||
124571757|NCT00463606|448052120|FG000|Overall Study|Physician Decision|0|||
124571758|NCT00463606|448052121|FG001|Overall Study|Physician Decision|1|||
124571759|NCT00463606|448052122|FG002|Overall Study|Physician Decision|0|||
124571760|NCT00463606|448052120|FG000|Overall Study|Sponsor request|0|||
124571761|NCT00463606|448052121|FG001|Overall Study|Sponsor request|1|||
124571762|NCT00463606|448052122|FG002|Overall Study|Sponsor request|0|||
124571763|NCT00463606|448052120|FG000|Overall Study|Exclusion criteria violation|2|||
124571764|NCT00463606|448052121|FG001|Overall Study|Exclusion criteria violation|0|||
124571765|NCT00463606|448052122|FG002|Overall Study|Exclusion criteria violation|0|||
124571766|NCT00463606|448052120|FG000|Overall Study|Coordinator error|1|||
124571767|NCT00463606|448052121|FG001|Overall Study|Coordinator error|0|||
124571768|NCT00463606|448052122|FG002|Overall Study|Coordinator error|0|||
124571769|NCT00463606|448052120|FG000|Overall Study|Patient randomized in error|1|||
124571770|NCT00463606|448052121|FG001|Overall Study|Patient randomized in error|0|||
124571771|NCT00463606|448052122|FG002|Overall Study|Patient randomized in error|0|||
124571772|NCT00463606|448052120|FG000|Overall Study|Participation in another ABT-335 trial|1|||
124571773|NCT00463606|448052121|FG001|Overall Study|Participation in another ABT-335 trial|0|||
124571774|NCT00463606|448052122|FG002|Overall Study|Participation in another ABT-335 trial|0|||
124571775|NCT00463606|448052120|FG000|Overall Study|Protocol Violation|0|||
124571776|NCT00463606|448052121|FG001|Overall Study|Protocol Violation|0|||
124571777|NCT00463606|448052122|FG002|Overall Study|Protocol Violation|1|||
124571778|NCT02682602|448052124|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
124571779|NCT02682602|448052125|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
124571780|NCT02682602|448052124|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
124571781|NCT02682602|448052125|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
124571782|NCT01432171|448052129|FG000|Overall Study|Death|1|||
124571783|NCT01432171|448052130|FG001|Overall Study|Death|2|||
124571784|NCT01432171|448052129|FG000|Overall Study|Lost to Follow-up|6|||
124571785|NCT01432171|448052130|FG001|Overall Study|Lost to Follow-up|5|||
124571786|NCT01432171|448052129|FG000|Overall Study|Withdrawal by Subject|3|||
124571787|NCT01432171|448052130|FG001|Overall Study|Withdrawal by Subject|1|||
124571788|NCT01432171|448052129|FG000|Overall Study|Noncompliance|2|||
124571789|NCT01432171|448052130|FG001|Overall Study|Noncompliance|3|||
124571790|NCT01432171|448052129|FG000|Overall Study|Insurance denial trial coverage|1|||
124571791|NCT01432171|448052130|FG001|Overall Study|Insurance denial trial coverage|0|||
124571792|NCT01432171|448052129|FG000|Overall Study|Patient moved to palliative care|1|||
124571793|NCT01432171|448052130|FG001|Overall Study|Patient moved to palliative care|0|||
124571794|NCT00416520|448053340|FG000|Open-label Period|Adverse Event|28|||
124571795|NCT00416520|448053341|FG001|Open-label Period|Adverse Event|10|||
124571796|NCT00416520|448053342|FG002|Open-label Period|Adverse Event|0|||
124571797|NCT00416520|448053343|FG003|Open-label Period|Adverse Event|0|||
124571798|NCT00416520|448053340|FG000|Open-label Period|Death|2|||
124571799|NCT00416520|448053341|FG001|Open-label Period|Death|1|||
124571800|NCT00416520|448053342|FG002|Open-label Period|Death|0|||
124571801|NCT00416520|448053343|FG003|Open-label Period|Death|0|||
124571802|NCT00416520|448053340|FG000|Open-label Period|Lack of Efficacy|8|||
124571803|NCT00416520|448053341|FG001|Open-label Period|Lack of Efficacy|1|||
124571804|NCT00416520|448053342|FG002|Open-label Period|Lack of Efficacy|0|||
124516954|NCT01001234|447845389|FG001|Overall Study|Not Treated: Pregnancy|0|||
124516955|NCT01001234|447845390|FG002|Overall Study|Not Treated: Pregnancy|0|||
124516956|NCT01001234|447845391|FG003|Overall Study|Not Treated: Pregnancy|0|||
124516957|NCT01001234|447845392|FG004|Overall Study|Not Treated: Pregnancy|0|||
124516958|NCT01001234|447845388|FG000|Overall Study|Not Treated: Physician Decision|37|||
124516959|NCT01001234|447845389|FG001|Overall Study|Not Treated: Physician Decision|4|||
124516960|NCT01001234|447845390|FG002|Overall Study|Not Treated: Physician Decision|0|||
124516961|NCT01001234|447845391|FG003|Overall Study|Not Treated: Physician Decision|0|||
124516962|NCT01001234|447845392|FG004|Overall Study|Not Treated: Physician Decision|0|||
124516963|NCT01001234|447845388|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
124516964|NCT01001234|447845389|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
124571805|NCT00416520|448053343|FG003|Open-label Period|Lack of Efficacy|0|||
124571806|NCT00416520|448053340|FG000|Open-label Period|Protocol Violation|3|||
124571807|NCT00416520|448053341|FG001|Open-label Period|Protocol Violation|3|||
124571808|NCT00416520|448053342|FG002|Open-label Period|Protocol Violation|0|||
124571809|NCT00416520|448053343|FG003|Open-label Period|Protocol Violation|0|||
124571810|NCT00416520|448053340|FG000|Open-label Period|Withdrawal by Subject|16|||
124571811|NCT00416520|448053341|FG001|Open-label Period|Withdrawal by Subject|5|||
124571812|NCT00416520|448053342|FG002|Open-label Period|Withdrawal by Subject|0|||
124571813|NCT00416520|448053343|FG003|Open-label Period|Withdrawal by Subject|0|||
124571814|NCT00416520|448053340|FG000|Open-label Period|Other Reasons|3|||
124571815|NCT00416520|448053341|FG001|Open-label Period|Other Reasons|12|||
124571816|NCT00416520|448053342|FG002|Open-label Period|Other Reasons|0|||
124571817|NCT00416520|448053343|FG003|Open-label Period|Other Reasons|0|||
124571818|NCT00416520|448053340|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
124571819|NCT00416520|448053341|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
124571820|NCT00416520|448053342|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
124571821|NCT00416520|448053343|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
124571822|NCT00416520|448053340|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
124571823|NCT00416520|448053341|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
124516965|NCT01001234|447845390|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
124516966|NCT01001234|447845391|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
124516967|NCT01001234|447845392|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
124516968|NCT00928512|447845393|FG000|Overall Study|Adverse Event|4|||
124571824|NCT00416520|448053342|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
124571825|NCT00416520|448053343|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
124571826|NCT00416520|448053340|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
124571827|NCT00416520|448053341|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
124571828|NCT00416520|448053342|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
124571829|NCT00416520|448053343|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
124571830|NCT04015232|448053354|FG000|Overall Study|Withdrawal by Subject|7|||
124516969|NCT00928512|447845394|FG001|Overall Study|Adverse Event|3|||
124516970|NCT00928512|447845395|FG002|Overall Study|Adverse Event|2|||
124516971|NCT00928512|447845396|FG003|Overall Study|Adverse Event|8|||
124571831|NCT04015232|448053355|FG001|Overall Study|Withdrawal by Subject|4|||
124571832|NCT04015232|448053354|FG000|Overall Study|Protocol Violation|1|||
124571833|NCT04015232|448053355|FG001|Overall Study|Protocol Violation|0|||
124571834|NCT04015232|448053354|FG000|Overall Study|Medical Grounds|3|||
124571835|NCT04015232|448053355|FG001|Overall Study|Medical Grounds|3|||
124571836|NCT02152566|448053356|FG000|Overall Study|Lost to Follow-up|1|||
124571837|NCT02152566|448053356|FG000|Overall Study|Withdrawal by Subject|2|||
124571838|NCT02334722|448053361|FG000|Overall Study|Lost to Follow-up|4|||
124571839|NCT02334722|448053362|FG001|Overall Study|Lost to Follow-up|0|||
124571840|NCT02334722|448053361|FG000|Overall Study|6 week questionnaire not completed|2|||
124571841|NCT02334722|448053362|FG001|Overall Study|6 week questionnaire not completed|0|||
124571842|NCT02334722|448053361|FG000|Overall Study|Unable to obtain medication|1|||
124571843|NCT02334722|448053362|FG001|Overall Study|Unable to obtain medication|1|||
124571844|NCT02334722|448053361|FG000|Overall Study|Withdrawal by Subject|0|||
124571845|NCT02334722|448053362|FG001|Overall Study|Withdrawal by Subject|3|||
124516972|NCT00928512|447845397|FG004|Overall Study|Adverse Event|6|||
124516973|NCT00928512|447845393|FG000|Overall Study|Lack of Efficacy|2|||
124516974|NCT00928512|447845394|FG001|Overall Study|Lack of Efficacy|0|||
124516975|NCT00928512|447845395|FG002|Overall Study|Lack of Efficacy|4|||
124516976|NCT00928512|447845396|FG003|Overall Study|Lack of Efficacy|7|||
124516977|NCT00928512|447845397|FG004|Overall Study|Lack of Efficacy|3|||
124516978|NCT00928512|447845393|FG000|Overall Study|Protocol Violation|0|||
124516979|NCT00928512|447845394|FG001|Overall Study|Protocol Violation|1|||
124516980|NCT00928512|447845395|FG002|Overall Study|Protocol Violation|0|||
124516981|NCT00928512|447845396|FG003|Overall Study|Protocol Violation|1|||
124516982|NCT00928512|447845397|FG004|Overall Study|Protocol Violation|3|||
124516983|NCT00928512|447845393|FG000|Overall Study|Withdrawal by Subject|3|||
124516984|NCT00928512|447845394|FG001|Overall Study|Withdrawal by Subject|0|||
124516985|NCT00928512|447845395|FG002|Overall Study|Withdrawal by Subject|3|||
124516986|NCT00928512|447845396|FG003|Overall Study|Withdrawal by Subject|4|||
124516987|NCT00928512|447845397|FG004|Overall Study|Withdrawal by Subject|0|||
124516988|NCT00928512|447845393|FG000|Overall Study|Lost to Follow-up|1|||
124516989|NCT00928512|447845394|FG001|Overall Study|Lost to Follow-up|1|||
124516990|NCT00928512|447845395|FG002|Overall Study|Lost to Follow-up|2|||
124516991|NCT00928512|447845396|FG003|Overall Study|Lost to Follow-up|1|||
124516992|NCT00928512|447845397|FG004|Overall Study|Lost to Follow-up|3|||
124516993|NCT00928512|447845393|FG000|Overall Study|Administrative Problems|0|||
124516994|NCT00928512|447845394|FG001|Overall Study|Administrative Problems|1|||
124516995|NCT00928512|447845395|FG002|Overall Study|Administrative Problems|0|||
124516996|NCT00928512|447845396|FG003|Overall Study|Administrative Problems|0|||
124516997|NCT00928512|447845397|FG004|Overall Study|Administrative Problems|0|||
124516998|NCT04153929|447845398|FG000|Overall Study|Other than listed|2|||
124516999|NCT04153929|447845399|FG001|Overall Study|Other than listed|2|||
124517000|NCT04153929|447845400|FG002|Overall Study|Other than listed|0|||
124517001|NCT04153929|447845401|FG003|Overall Study|Other than listed|1|||
124517002|NCT04153929|447845402|FG004|Overall Study|Other than listed|0|||
124517003|NCT04153929|447845403|FG005|Overall Study|Other than listed|2|||
124517004|NCT04153929|447845404|FG006|Overall Study|Other than listed|2|||
124517005|NCT04153929|447845405|FG007|Overall Study|Other than listed|1|||
124517006|NCT04153929|447845398|FG000|Overall Study|Lost to Follow-up|2|||
124517007|NCT04153929|447845399|FG001|Overall Study|Lost to Follow-up|1|||
124517008|NCT04153929|447845400|FG002|Overall Study|Lost to Follow-up|0|||
124517009|NCT04153929|447845401|FG003|Overall Study|Lost to Follow-up|1|||
124517010|NCT04153929|447845402|FG004|Overall Study|Lost to Follow-up|1|||
124517011|NCT04153929|447845403|FG005|Overall Study|Lost to Follow-up|0|||
124517012|NCT04153929|447845404|FG006|Overall Study|Lost to Follow-up|0|||
124517013|NCT04153929|447845405|FG007|Overall Study|Lost to Follow-up|0|||
124517014|NCT04153929|447845398|FG000|Overall Study|Withdrawal by Subject|3|||
124517015|NCT04153929|447845399|FG001|Overall Study|Withdrawal by Subject|1|||
124517016|NCT04153929|447845400|FG002|Overall Study|Withdrawal by Subject|0|||
124517017|NCT04153929|447845401|FG003|Overall Study|Withdrawal by Subject|3|||
124517018|NCT04153929|447845402|FG004|Overall Study|Withdrawal by Subject|1|||
124517019|NCT04153929|447845403|FG005|Overall Study|Withdrawal by Subject|0|||
124517020|NCT04153929|447845404|FG006|Overall Study|Withdrawal by Subject|1|||
124517021|NCT04153929|447845405|FG007|Overall Study|Withdrawal by Subject|0|||
124517022|NCT04153929|447845398|FG000|Overall Study|Protocol Violation|0|||
124517023|NCT04153929|447845399|FG001|Overall Study|Protocol Violation|0|||
124517024|NCT04153929|447845400|FG002|Overall Study|Protocol Violation|0|||
124517025|NCT04153929|447845401|FG003|Overall Study|Protocol Violation|0|||
124517026|NCT04153929|447845402|FG004|Overall Study|Protocol Violation|0|||
124517027|NCT04153929|447845403|FG005|Overall Study|Protocol Violation|0|||
124517028|NCT04153929|447845404|FG006|Overall Study|Protocol Violation|1|||
124517029|NCT04153929|447845405|FG007|Overall Study|Protocol Violation|2|||
124517030|NCT04153929|447845398|FG000|Overall Study|Adverse Event|3|||
124517031|NCT04153929|447845399|FG001|Overall Study|Adverse Event|5|||
124517032|NCT04153929|447845400|FG002|Overall Study|Adverse Event|5|||
124517033|NCT04153929|447845401|FG003|Overall Study|Adverse Event|11|||
124517034|NCT04153929|447845402|FG004|Overall Study|Adverse Event|15|||
124571846|NCT02334722|448053361|FG000|Overall Study|Adverse Event|0|||
124571847|NCT02334722|448053362|FG001|Overall Study|Adverse Event|2|||
124571848|NCT02334722|448053361|FG000|Overall Study|Physician Decision|0|||
124571849|NCT02334722|448053362|FG001|Overall Study|Physician Decision|1|||
124571850|NCT00856388|448053363|FG000|Overall Study|Other|1|||
124571851|NCT01617668|448053366|FG000|Overall Study|Adverse Event|7|||
124571852|NCT01617668|448053367|FG001|Overall Study|Adverse Event|0|||
124571853|NCT01617668|448053368|FG002|Overall Study|Adverse Event|12|||
124571854|NCT01617668|448053369|FG003|Overall Study|Adverse Event|5|||
124571855|NCT01617668|448053366|FG000|Overall Study|Physician Decision|1|||
124571856|NCT01617668|448053367|FG001|Overall Study|Physician Decision|2|||
124571857|NCT01617668|448053368|FG002|Overall Study|Physician Decision|3|||
124571858|NCT01617668|448053369|FG003|Overall Study|Physician Decision|0|||
124571859|NCT01617668|448053366|FG000|Overall Study|Progressive Disease|4|||
124571860|NCT01617668|448053367|FG001|Overall Study|Progressive Disease|4|||
124571861|NCT01617668|448053368|FG002|Overall Study|Progressive Disease|6|||
124571862|NCT01617668|448053369|FG003|Overall Study|Progressive Disease|9|||
124571863|NCT01617668|448053366|FG000|Overall Study|Subject/guardian decision|1|||
124571864|NCT01617668|448053367|FG001|Overall Study|Subject/guardian decision|3|||
124571865|NCT01617668|448053368|FG002|Overall Study|Subject/guardian decision|2|||
124571866|NCT01617668|448053369|FG003|Overall Study|Subject/guardian decision|1|||
124571867|NCT00925769|448053370|FG000|Overall Study|Major toxicity|1|||
124571868|NCT00925769|448053371|FG001|Overall Study|Major toxicity|0|||
124571869|NCT00925769|448053372|FG002|Overall Study|Major toxicity|1|||
124571870|NCT00925769|448053373|FG003|Overall Study|Major toxicity|1|||
124571871|NCT00925769|448053374|FG004|Overall Study|Major toxicity|0|||
124571872|NCT00925769|448053375|FG005|Overall Study|Major toxicity|0|||
124571873|NCT00925769|448053370|FG000|Overall Study|Disease progression|4|||
124571874|NCT00925769|448053371|FG001|Overall Study|Disease progression|5|||
124571875|NCT00925769|448053372|FG002|Overall Study|Disease progression|3|||
124571876|NCT00925769|448053373|FG003|Overall Study|Disease progression|4|||
124571877|NCT00925769|448053374|FG004|Overall Study|Disease progression|2|||
124571878|NCT00925769|448053375|FG005|Overall Study|Disease progression|3|||
124571879|NCT00925769|448053370|FG000|Overall Study|Death|0|||
124571880|NCT00925769|448053371|FG001|Overall Study|Death|0|||
124571881|NCT00925769|448053372|FG002|Overall Study|Death|1|||
124571882|NCT00925769|448053373|FG003|Overall Study|Death|0|||
124571883|NCT00925769|448053374|FG004|Overall Study|Death|0|||
124571884|NCT00925769|448053375|FG005|Overall Study|Death|0|||
124571885|NCT00925769|448053370|FG000|Overall Study|Physician Decision|1|||
124571886|NCT00925769|448053371|FG001|Overall Study|Physician Decision|0|||
124571887|NCT00925769|448053372|FG002|Overall Study|Physician Decision|0|||
124571888|NCT00925769|448053373|FG003|Overall Study|Physician Decision|0|||
124571889|NCT00925769|448053374|FG004|Overall Study|Physician Decision|0|||
124571890|NCT00925769|448053375|FG005|Overall Study|Physician Decision|0|||
124571891|NCT00925769|448053370|FG000|Overall Study|Missing documentation|0|||
124571892|NCT00925769|448053371|FG001|Overall Study|Missing documentation|1|||
124571893|NCT00925769|448053372|FG002|Overall Study|Missing documentation|0|||
124571894|NCT00925769|448053373|FG003|Overall Study|Missing documentation|0|||
124571895|NCT00925769|448053374|FG004|Overall Study|Missing documentation|0|||
124571896|NCT00925769|448053375|FG005|Overall Study|Missing documentation|0|||
124571897|NCT00925769|448053370|FG000|Overall Study|End of study visit not done|0|||
124571898|NCT00925769|448053371|FG001|Overall Study|End of study visit not done|0|||
124571899|NCT00925769|448053372|FG002|Overall Study|End of study visit not done|1|||
124571900|NCT00925769|448053373|FG003|Overall Study|End of study visit not done|0|||
124571901|NCT00925769|448053374|FG004|Overall Study|End of study visit not done|0|||
124571902|NCT00925769|448053375|FG005|Overall Study|End of study visit not done|0|||
124571903|NCT00925769|448053370|FG000|Overall Study|Participant is unable to swallow drug|0|||
124571904|NCT00925769|448053371|FG001|Overall Study|Participant is unable to swallow drug|0|||
124571905|NCT00925769|448053372|FG002|Overall Study|Participant is unable to swallow drug|0|||
124571906|NCT00925769|448053373|FG003|Overall Study|Participant is unable to swallow drug|1|||
124571907|NCT00925769|448053374|FG004|Overall Study|Participant is unable to swallow drug|0|||
124571908|NCT00925769|448053375|FG005|Overall Study|Participant is unable to swallow drug|0|||
124571909|NCT00925769|448053370|FG000|Overall Study|Adverse Event|0|||
124571910|NCT00925769|448053371|FG001|Overall Study|Adverse Event|0|||
124571911|NCT00925769|448053372|FG002|Overall Study|Adverse Event|0|||
124571912|NCT00925769|448053373|FG003|Overall Study|Adverse Event|0|||
124571913|NCT00925769|448053374|FG004|Overall Study|Adverse Event|1|||
124571914|NCT00925769|448053375|FG005|Overall Study|Adverse Event|0|||
124571915|NCT02017964|448053376|FG000|Overall Study|Patient deemed ineligible|1|||
124571916|NCT00686959|448053378|FG000|Overall Study|Participants censored (no death events)|124|||
124571917|NCT00686959|448053379|FG001|Overall Study|Participants censored (no death events)|117|||
124571918|NCT00150462|448053380|FG000|Overall Study|Disease Progression or Relapse|3|||
124571919|NCT00150462|448053381|FG001|Overall Study|Disease Progression or Relapse|1|||
124571920|NCT00150462|448053382|FG002|Overall Study|Disease Progression or Relapse|2|||
124571921|NCT00150462|448053383|FG003|Overall Study|Disease Progression or Relapse|1|||
124571922|NCT00150462|448053384|FG004|Overall Study|Disease Progression or Relapse|2|||
124571923|NCT00150462|448053385|FG005|Overall Study|Disease Progression or Relapse|2|||
124571924|NCT00150462|448053386|FG006|Overall Study|Disease Progression or Relapse|3|||
124571925|NCT00150462|448053387|FG007|Overall Study|Disease Progression or Relapse|5|||
124571926|NCT00150462|448053388|FG008|Overall Study|Disease Progression or Relapse|5|||
124571927|NCT00150462|448053389|FG009|Overall Study|Disease Progression or Relapse|3|||
124571928|NCT00150462|448053390|FG010|Overall Study|Disease Progression or Relapse|2|||
124571929|NCT00150462|448053380|FG000|Overall Study|Withdrawal by Subject|0|||
124571930|NCT00150462|448053381|FG001|Overall Study|Withdrawal by Subject|1|||
124571931|NCT00150462|448053382|FG002|Overall Study|Withdrawal by Subject|1|||
124571932|NCT00150462|448053383|FG003|Overall Study|Withdrawal by Subject|0|||
124571933|NCT00150462|448053384|FG004|Overall Study|Withdrawal by Subject|1|||
124571934|NCT00150462|448053385|FG005|Overall Study|Withdrawal by Subject|2|||
124571935|NCT00150462|448053386|FG006|Overall Study|Withdrawal by Subject|0|||
124571936|NCT00150462|448053387|FG007|Overall Study|Withdrawal by Subject|1|||
124571937|NCT00150462|448053388|FG008|Overall Study|Withdrawal by Subject|0|||
124571938|NCT00150462|448053389|FG009|Overall Study|Withdrawal by Subject|1|||
124571939|NCT00150462|448053390|FG010|Overall Study|Withdrawal by Subject|0|||
124571940|NCT00150462|448053380|FG000|Overall Study|Death|0|||
124571941|NCT00150462|448053381|FG001|Overall Study|Death|1|||
124571942|NCT00150462|448053382|FG002|Overall Study|Death|0|||
124571943|NCT00150462|448053383|FG003|Overall Study|Death|0|||
124571944|NCT00150462|448053384|FG004|Overall Study|Death|0|||
124571945|NCT00150462|448053385|FG005|Overall Study|Death|0|||
124571946|NCT00150462|448053386|FG006|Overall Study|Death|0|||
124571947|NCT00150462|448053387|FG007|Overall Study|Death|0|||
124571948|NCT00150462|448053388|FG008|Overall Study|Death|1|||
124571949|NCT00150462|448053389|FG009|Overall Study|Death|0|||
124571950|NCT00150462|448053390|FG010|Overall Study|Death|0|||
124571951|NCT00150462|448053380|FG000|Overall Study|Adverse Event|0|||
124571952|NCT00150462|448053381|FG001|Overall Study|Adverse Event|0|||
124571953|NCT00150462|448053382|FG002|Overall Study|Adverse Event|0|||
124571954|NCT00150462|448053383|FG003|Overall Study|Adverse Event|1|||
124571955|NCT00150462|448053384|FG004|Overall Study|Adverse Event|0|||
124571956|NCT00150462|448053385|FG005|Overall Study|Adverse Event|0|||
124571957|NCT00150462|448053386|FG006|Overall Study|Adverse Event|0|||
124571958|NCT00150462|448053387|FG007|Overall Study|Adverse Event|2|||
124517035|NCT04153929|447845403|FG005|Overall Study|Adverse Event|4|||
124517036|NCT04153929|447845404|FG006|Overall Study|Adverse Event|8|||
124517037|NCT04153929|447845405|FG007|Overall Study|Adverse Event|2|||
124517038|NCT04153929|447845398|FG000|Overall Study|Not treated|1|||
124517039|NCT04153929|447845399|FG001|Overall Study|Not treated|0|||
124517040|NCT04153929|447845400|FG002|Overall Study|Not treated|0|||
124517041|NCT04153929|447845401|FG003|Overall Study|Not treated|0|||
124517042|NCT04153929|447845402|FG004|Overall Study|Not treated|0|||
124517043|NCT04153929|447845403|FG005|Overall Study|Not treated|0|||
124517044|NCT04153929|447845404|FG006|Overall Study|Not treated|1|||
124517045|NCT04153929|447845405|FG007|Overall Study|Not treated|0|||
124517046|NCT01963780|447845406|FG000|Overall Study|Death|7|||
124517047|NCT00729326|447845411|FG000|Overall Study|Lost to Follow-up|2|||
124517048|NCT00729326|447845412|FG001|Overall Study|Lost to Follow-up|0|||
124517049|NCT00729326|447845411|FG000|Overall Study|Physician Decision|0|||
124517050|NCT00729326|447845412|FG001|Overall Study|Physician Decision|1|||
124517051|NCT00729326|447845411|FG000|Overall Study|Protocol Violation|3|||
124517052|NCT00729326|447845412|FG001|Overall Study|Protocol Violation|2|||
124517053|NCT00729326|447845411|FG000|Overall Study|Subject Decision|4|||
124517054|NCT00729326|447845412|FG001|Overall Study|Subject Decision|4|||
124517055|NCT00729326|447845411|FG000|Overall Study|Sponsor Decision|1|||
124517056|NCT00729326|447845412|FG001|Overall Study|Sponsor Decision|2|||
124517057|NCT01235728|447845413|FG000|Overall Study|Protocol Violation|0|||
124517058|NCT01235728|447845414|FG001|Overall Study|Protocol Violation|0|||
124517059|NCT01235728|447845415|FG002|Overall Study|Protocol Violation|0|||
124517060|NCT01235728|447845416|FG003|Overall Study|Protocol Violation|1|||
124517061|NCT01235728|447845417|FG004|Overall Study|Protocol Violation|0|||
124517062|NCT01235728|447845418|FG005|Overall Study|Protocol Violation|0|||
124517063|NCT01235728|447845419|FG006|Overall Study|Protocol Violation|0|||
124517064|NCT01235728|447845420|FG007|Overall Study|Protocol Violation|0|||
124517065|NCT02193828|447845421|FG000|Overall Study|Withdrawal by Subject|0|||
124517066|NCT02193828|447845422|FG001|Overall Study|Withdrawal by Subject|0|||
124517067|NCT02193828|447845423|FG002|Overall Study|Withdrawal by Subject|1|||
124517068|NCT02193828|447845424|FG003|Overall Study|Withdrawal by Subject|1|||
124517069|NCT01185704|447845425|FG000|Overall Study|Randomized but not treated|3|||
124517070|NCT01185704|447845426|FG001|Overall Study|Randomized but not treated|3|||
124517071|NCT01185704|447845425|FG000|Overall Study|Lack of ovarian response|5|||
124517072|NCT01185704|447845426|FG001|Overall Study|Lack of ovarian response|1|||
124517073|NCT01185704|447845425|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
124517074|NCT01185704|447845426|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
124571959|NCT00150462|448053388|FG008|Overall Study|Adverse Event|0|||
124571960|NCT00150462|448053389|FG009|Overall Study|Adverse Event|1|||
124571961|NCT00150462|448053390|FG010|Overall Study|Adverse Event|0|||
124571962|NCT00150462|448053380|FG000|Overall Study|Physician Decision|0|||
124571963|NCT00150462|448053381|FG001|Overall Study|Physician Decision|0|||
124517075|NCT01185704|447845425|FG000|Overall Study|Ectopic pregnancy|0|||
124517076|NCT01185704|447845426|FG001|Overall Study|Ectopic pregnancy|1|||
124517077|NCT01151540|447845427|FG000|Overall Study|Other|2|||
124517078|NCT01151540|447845427|FG000|Overall Study|Adverse event, non-fatal|4|||
124517079|NCT01151540|447845427|FG000|Overall Study|Withdrawal by Subject|7|||
124517080|NCT00788697|447845430|FG000|Overall Study|No study drug administered|12|||
124517081|NCT00788697|447845430|FG000|Overall Study|Training Patients|74|||
124517082|NCT00788697|447845430|FG000|Overall Study|no truth standard procedure available|5|||
124517083|NCT00788697|447845430|FG000|Overall Study|Technically inadequate truth standard|1|||
124517084|NCT00788697|447845430|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
124517085|NCT03199638|447845434|FG000|Overall Study|inability to drink glutamine during regularly|0|||
124517086|NCT03199638|447845435|FG001|Overall Study|inability to drink glutamine during regularly|2|||
124517087|NCT00373490|447845436|FG000|Overall Study|Adverse Event|0|||
124517088|NCT00373490|447845437|FG001|Overall Study|Adverse Event|1|||
124517089|NCT00373490|447845436|FG000|Overall Study|Lack of Efficacy|9|||
124517090|NCT00373490|447845437|FG001|Overall Study|Lack of Efficacy|4|||
124517091|NCT00373490|447845436|FG000|Overall Study|Withdrawal by Subject|0|||
124517092|NCT00373490|447845437|FG001|Overall Study|Withdrawal by Subject|1|||
124517093|NCT00141037|447845440|FG000|Overall Study|Physician Decision|1|||
124517094|NCT00141037|447845441|FG001|Overall Study|Physician Decision|2|||
124517095|NCT00141037|447845440|FG000|Overall Study|Lost to Follow-up|3|||
124517096|NCT00141037|447845441|FG001|Overall Study|Lost to Follow-up|1|||
124517097|NCT00141037|447845440|FG000|Overall Study|Protocol Violation|0|||
124517098|NCT00141037|447845441|FG001|Overall Study|Protocol Violation|2|||
124517099|NCT00141037|447845440|FG000|Overall Study|Withdrawal by Subject|2|||
124517100|NCT00141037|447845441|FG001|Overall Study|Withdrawal by Subject|1|||
124517101|NCT00141037|447845440|FG000|Overall Study|Other|0|||
124517102|NCT00141037|447845441|FG001|Overall Study|Other|1|||
124517103|NCT00141037|447845440|FG000|Overall Study|Moved from area|1|||
124517104|NCT00141037|447845441|FG001|Overall Study|Moved from area|7|||
124517105|NCT00141037|447845440|FG000|Overall Study|Graft Failure|3|||
124517106|NCT00141037|447845441|FG001|Overall Study|Graft Failure|4|||
124517107|NCT00260429|447845442|FG000|Overall Study|failure to follow appointments|1|||
124517108|NCT00260429|447845443|FG001|Overall Study|failure to follow appointments|0|||
124517109|NCT00260429|447845442|FG000|Overall Study|scheduled hand surgery|1|||
124517110|NCT00260429|447845443|FG001|Overall Study|scheduled hand surgery|0|||
124517111|NCT00628758|447845444|FG000|Overall Study|Adverse Event|2|||
124517112|NCT00628758|447845445|FG001|Overall Study|Adverse Event|3|||
124517113|NCT00628758|447845444|FG000|Overall Study|Withdrawal by Subject|6|||
124517114|NCT00628758|447845445|FG001|Overall Study|Withdrawal by Subject|3|||
124517115|NCT00628758|447845444|FG000|Overall Study|Death|1|||
124517116|NCT00628758|447845445|FG001|Overall Study|Death|0|||
124517117|NCT00628758|447845444|FG000|Overall Study|Protocol Violation|5|||
124517118|NCT00628758|447845445|FG001|Overall Study|Protocol Violation|1|||
124517119|NCT00628758|447845444|FG000|Overall Study|Lost to Follow-up|25|||
124517120|NCT00628758|447845445|FG001|Overall Study|Lost to Follow-up|31|||
124517121|NCT00628758|447845444|FG000|Overall Study|Pregnancy|2|||
124517122|NCT00628758|447845445|FG001|Overall Study|Pregnancy|2|||
124517123|NCT00628758|447845444|FG000|Overall Study|Investigator Moved|3|||
124517124|NCT00628758|447845445|FG001|Overall Study|Investigator Moved|0|||
124517125|NCT00628758|447845444|FG000|Overall Study|Treatment Failure|0|||
124517126|NCT00628758|447845445|FG001|Overall Study|Treatment Failure|2|||
124517127|NCT04179786|447845446|FG000|Overall Study|Withdrawal by Subject|8|||
124517128|NCT01938001|447845447|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
124517129|NCT01938001|447845448|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
124517130|NCT01938001|447845447|FG000|Pre-Treatment|Death|1|||
124517131|NCT01938001|447845448|FG001|Pre-Treatment|Death|0|||
124517132|NCT01938001|447845447|FG000|Treatment|Death|2|||
124517133|NCT01938001|447845448|FG001|Treatment|Death|0|||
124517134|NCT01938001|447845447|FG000|Treatment|Adverse Event|14|||
124517135|NCT01938001|447845448|FG001|Treatment|Adverse Event|8|||
124517136|NCT01938001|447845447|FG000|Treatment|Progressive Disease|21|||
124517137|NCT01938001|447845448|FG001|Treatment|Progressive Disease|54|||
124517138|NCT01938001|447845447|FG000|Treatment|Withdrawal by Subject|13|||
124517139|NCT01938001|447845448|FG001|Treatment|Withdrawal by Subject|7|||
124517140|NCT01938001|447845447|FG000|Treatment|Other reasons|2|||
124517141|NCT01938001|447845448|FG001|Treatment|Other reasons|1|||
124517142|NCT03310580|447845449|FG000|Overall Study|Adverse Event|0|||
124517143|NCT03310580|447845450|FG001|Overall Study|Adverse Event|1|||
124517144|NCT03310580|447845451|FG002|Overall Study|Adverse Event|0|||
124517145|NCT02762708|447845456|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
124517146|NCT02762708|447845457|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
124517147|NCT02762708|447845458|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
124776723|NCT00998296|448809953|FG008|Overall Study|Reason other than those specified above|0|||
124517148|NCT02762708|447845459|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
124517149|NCT01468701|447845464|FG000|Overall Study|Not eligible|91|||
124517150|NCT01468701|447845465|FG001|Overall Study|Not eligible|140|||
124517151|NCT01468701|447845466|FG002|Overall Study|Not eligible|29|||
124517152|NCT01468701|447845467|FG003|Overall Study|Not eligible|12|||
124517153|NCT01468701|447845468|FG004|Overall Study|Not eligible|22|||
124517154|NCT01468701|447845469|FG005|Overall Study|Not eligible|2|||
124517155|NCT01468701|447845470|FG006|Overall Study|Not eligible|39|||
124517156|NCT01468701|447845471|FG007|Overall Study|Not eligible|1|||
124517157|NCT01468701|447845472|FG008|Overall Study|Not eligible|40|||
124517158|NCT01468701|447845473|FG009|Overall Study|Not eligible|126|||
124517159|NCT01468701|447845474|FG010|Overall Study|Not eligible|39|||
124517160|NCT01468701|447845475|FG011|Overall Study|Not eligible|33|||
124517161|NCT01468701|447845476|FG012|Overall Study|Not eligible|1|||
124517162|NCT01468701|447845477|FG013|Overall Study|Not eligible|19|||
124517163|NCT01468701|447845478|FG014|Overall Study|Not eligible|1|||
124517164|NCT01468701|447845479|FG015|Overall Study|Not eligible|32|||
124517165|NCT01468701|447845480|FG016|Overall Study|Not eligible|0|||
124517166|NCT01468701|447845464|FG000|Overall Study|Lost to Follow-up|306|||
124517167|NCT01468701|447845465|FG001|Overall Study|Lost to Follow-up|0|||
124517168|NCT01468701|447845466|FG002|Overall Study|Lost to Follow-up|0|||
124517169|NCT01468701|447845467|FG003|Overall Study|Lost to Follow-up|0|||
124517170|NCT01468701|447845468|FG004|Overall Study|Lost to Follow-up|0|||
124517171|NCT01468701|447845469|FG005|Overall Study|Lost to Follow-up|0|||
124517172|NCT01468701|447845470|FG006|Overall Study|Lost to Follow-up|0|||
124517173|NCT01468701|447845471|FG007|Overall Study|Lost to Follow-up|0|||
124517174|NCT01468701|447845472|FG008|Overall Study|Lost to Follow-up|215|||
124517175|NCT01468701|447845473|FG009|Overall Study|Lost to Follow-up|309|||
124517176|NCT01468701|447845474|FG010|Overall Study|Lost to Follow-up|224|||
124517177|NCT01468701|447845475|FG011|Overall Study|Lost to Follow-up|212|||
124517178|NCT01468701|447845476|FG012|Overall Study|Lost to Follow-up|11|||
124517179|NCT01468701|447845477|FG013|Overall Study|Lost to Follow-up|164|||
124517180|NCT01468701|447845478|FG014|Overall Study|Lost to Follow-up|17|||
124517181|NCT01468701|447845479|FG015|Overall Study|Lost to Follow-up|127|||
124517182|NCT01468701|447845480|FG016|Overall Study|Lost to Follow-up|1|||
124517183|NCT01468701|447845464|FG000|Overall Study|Withdrawal by Subject|165|||
124517184|NCT01468701|447845465|FG001|Overall Study|Withdrawal by Subject|0|||
124517185|NCT01468701|447845466|FG002|Overall Study|Withdrawal by Subject|0|||
124517186|NCT01468701|447845467|FG003|Overall Study|Withdrawal by Subject|0|||
124517187|NCT01468701|447845468|FG004|Overall Study|Withdrawal by Subject|0|||
124517188|NCT01468701|447845469|FG005|Overall Study|Withdrawal by Subject|0|||
124517189|NCT01468701|447845470|FG006|Overall Study|Withdrawal by Subject|0|||
124517190|NCT01468701|447845471|FG007|Overall Study|Withdrawal by Subject|0|||
124517191|NCT01468701|447845472|FG008|Overall Study|Withdrawal by Subject|83|||
124517192|NCT01468701|447845473|FG009|Overall Study|Withdrawal by Subject|88|||
124517193|NCT01468701|447845474|FG010|Overall Study|Withdrawal by Subject|100|||
124517194|NCT01468701|447845475|FG011|Overall Study|Withdrawal by Subject|114|||
124517195|NCT01468701|447845476|FG012|Overall Study|Withdrawal by Subject|9|||
124517196|NCT01468701|447845477|FG013|Overall Study|Withdrawal by Subject|47|||
124517197|NCT01468701|447845478|FG014|Overall Study|Withdrawal by Subject|6|||
124517198|NCT01468701|447845479|FG015|Overall Study|Withdrawal by Subject|31|||
124517199|NCT01468701|447845480|FG016|Overall Study|Withdrawal by Subject|0|||
124517200|NCT01468701|447845464|FG000|Overall Study|Other reasons than listed|437|||
124517201|NCT01468701|447845465|FG001|Overall Study|Other reasons than listed|0|||
124517202|NCT01468701|447845466|FG002|Overall Study|Other reasons than listed|0|||
124517203|NCT01468701|447845467|FG003|Overall Study|Other reasons than listed|0|||
124517204|NCT01468701|447845468|FG004|Overall Study|Other reasons than listed|0|||
124517205|NCT01468701|447845469|FG005|Overall Study|Other reasons than listed|0|||
124517206|NCT01468701|447845470|FG006|Overall Study|Other reasons than listed|0|||
124517207|NCT01468701|447845471|FG007|Overall Study|Other reasons than listed|0|||
124517208|NCT01468701|447845472|FG008|Overall Study|Other reasons than listed|318|||
124517209|NCT01468701|447845473|FG009|Overall Study|Other reasons than listed|658|||
124517210|NCT01468701|447845474|FG010|Overall Study|Other reasons than listed|433|||
124517211|NCT01468701|447845475|FG011|Overall Study|Other reasons than listed|504|||
124517212|NCT01468701|447845476|FG012|Overall Study|Other reasons than listed|28|||
124517213|NCT01468701|447845477|FG013|Overall Study|Other reasons than listed|239|||
124517214|NCT01468701|447845478|FG014|Overall Study|Other reasons than listed|39|||
124517215|NCT01468701|447845479|FG015|Overall Study|Other reasons than listed|172|||
124517216|NCT01468701|447845480|FG016|Overall Study|Other reasons than listed|0|||
124517217|NCT01468701|447845464|FG000|Overall Study|No end of study case report form|0|||
124517218|NCT01468701|447845465|FG001|Overall Study|No end of study case report form|0|||
124517219|NCT01468701|447845466|FG002|Overall Study|No end of study case report form|0|||
124517220|NCT01468701|447845467|FG003|Overall Study|No end of study case report form|0|||
124517221|NCT01468701|447845468|FG004|Overall Study|No end of study case report form|0|||
124517222|NCT01468701|447845469|FG005|Overall Study|No end of study case report form|0|||
124517223|NCT01468701|447845470|FG006|Overall Study|No end of study case report form|0|||
124517224|NCT01468701|447845471|FG007|Overall Study|No end of study case report form|0|||
124517225|NCT01468701|447845472|FG008|Overall Study|No end of study case report form|4|||
124517226|NCT01468701|447845473|FG009|Overall Study|No end of study case report form|1|||
124517227|NCT01468701|447845474|FG010|Overall Study|No end of study case report form|2|||
124517228|NCT01468701|447845475|FG011|Overall Study|No end of study case report form|3|||
124724981|NCT01345929|448613398|FG001|Overall Study|Withdrawal by Subject|8|||
124724982|NCT01345929|448613397|FG000|Overall Study|Lost to Follow-up|9|||
124724983|NCT01345929|448613398|FG001|Overall Study|Lost to Follow-up|9|||
124517229|NCT01468701|447845476|FG012|Overall Study|No end of study case report form|0|||
124517230|NCT01468701|447845477|FG013|Overall Study|No end of study case report form|1|||
124517231|NCT01468701|447845478|FG014|Overall Study|No end of study case report form|0|||
124517232|NCT01468701|447845479|FG015|Overall Study|No end of study case report form|0|||
124517233|NCT01468701|447845480|FG016|Overall Study|No end of study case report form|0|||
124517234|NCT01468701|447845464|FG000|Overall Study|Not being followed up|0|||
124517235|NCT01468701|447845465|FG001|Overall Study|Not being followed up|4963|||
124517236|NCT01468701|447845466|FG002|Overall Study|Not being followed up|1755|||
124517237|NCT01468701|447845467|FG003|Overall Study|Not being followed up|703|||
124517238|NCT01468701|447845468|FG004|Overall Study|Not being followed up|1714|||
124517239|NCT01468701|447845469|FG005|Overall Study|Not being followed up|126|||
124517240|NCT01468701|447845470|FG006|Overall Study|Not being followed up|1170|||
124517241|NCT01468701|447845471|FG007|Overall Study|Not being followed up|4|||
124517242|NCT01468701|447845472|FG008|Overall Study|Not being followed up|0|||
124517243|NCT01468701|447845473|FG009|Overall Study|Not being followed up|0|||
124517244|NCT01468701|447845474|FG010|Overall Study|Not being followed up|0|||
124517245|NCT01468701|447845475|FG011|Overall Study|Not being followed up|0|||
124517246|NCT01468701|447845476|FG012|Overall Study|Not being followed up|0|||
124517247|NCT01468701|447845477|FG013|Overall Study|Not being followed up|0|||
124517248|NCT01468701|447845478|FG014|Overall Study|Not being followed up|0|||
124517249|NCT01468701|447845479|FG015|Overall Study|Not being followed up|0|||
124517250|NCT01468701|447845480|FG016|Overall Study|Not being followed up|0|||
124517251|NCT01068717|447845481|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
124517252|NCT01068717|447845482|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
124517253|NCT01068717|447845483|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
124517254|NCT01068717|447845484|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
124517255|NCT01822223|447845485|FG000|Overall Study|Death|0|||
124517256|NCT01822223|447845486|FG001|Overall Study|Death|1|||
124517257|NCT00631540|447845488|FG000|Overall Study|Withdrawal by Subject|5|||
124517258|NCT00631540|447845488|FG000|Overall Study|Death|4|||
124517259|NCT00631540|447845488|FG000|Overall Study|Lost to Follow-up|2|||
124517260|NCT00631540|447845488|FG000|Overall Study|Core Lab Data Unavailable|3|||
124517261|NCT03136367|447845490|FG000|T1 Consultation|discontinued mistakenly included|2|||
124517262|NCT03136367|447845491|FG001|T1 Consultation|discontinued mistakenly included|6|||
124517263|NCT03136367|447845492|FG002|T1 Consultation|discontinued mistakenly included|1|||
124517264|NCT03136367|447845490|FG000|T1 Consultation|Discontinued other|0|||
124517265|NCT03136367|447845491|FG001|T1 Consultation|Discontinued other|1|||
124517266|NCT03136367|447845492|FG002|T1 Consultation|Discontinued other|0|||
124517267|NCT03136367|447845490|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
124517268|NCT03136367|447845491|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
124517269|NCT03136367|447845492|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
124517270|NCT03136367|447845490|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
124517271|NCT03136367|447845491|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
124517272|NCT03136367|447845492|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
124517273|NCT03136367|447845490|FG000|T2 Post-consultation|Discontinued other|0|||
124517274|NCT03136367|447845491|FG001|T2 Post-consultation|Discontinued other|2|||
124517275|NCT03136367|447845492|FG002|T2 Post-consultation|Discontinued other|6|||
124517276|NCT03136367|447845490|FG000|T2 Post-consultation|Discontinued transferred care|0|||
124517277|NCT03136367|447845491|FG001|T2 Post-consultation|Discontinued transferred care|0|||
124517278|NCT03136367|447845492|FG002|T2 Post-consultation|Discontinued transferred care|3|||
124517279|NCT03136367|447845490|FG000|T2 Post-consultation|Discontinued lost contact|0|||
124517280|NCT03136367|447845491|FG001|T2 Post-consultation|Discontinued lost contact|1|||
124517281|NCT03136367|447845492|FG002|T2 Post-consultation|Discontinued lost contact|0|||
124517282|NCT03136367|447845490|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
124517283|NCT03136367|447845491|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
124517284|NCT03136367|447845492|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
124517285|NCT03136367|447845490|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
124517286|NCT03136367|447845491|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
124517287|NCT03136367|447845492|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
124517288|NCT03136367|447845490|FG000|T3 1 Week After Surgery|other discontinued|2|||
124517289|NCT03136367|447845491|FG001|T3 1 Week After Surgery|other discontinued|4|||
124517290|NCT03136367|447845492|FG002|T3 1 Week After Surgery|other discontinued|3|||
124517291|NCT03136367|447845490|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
124517292|NCT03136367|447845491|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
124517293|NCT03136367|447845492|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
124517294|NCT03136367|447845490|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
124724984|NCT01345929|448613397|FG000|Overall Study|Adverse Event|0|||
124724985|NCT01345929|448613398|FG001|Overall Study|Adverse Event|1|||
124517295|NCT03136367|447845491|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
124517296|NCT03136367|447845492|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
124517297|NCT03136367|447845490|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
124517298|NCT03136367|447845491|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
124517299|NCT03136367|447845492|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
124517300|NCT03136367|447845490|FG000|T4 12 Weeks After Surgery|Death|0|||
124517301|NCT03136367|447845491|FG001|T4 12 Weeks After Surgery|Death|1|||
124517302|NCT03136367|447845492|FG002|T4 12 Weeks After Surgery|Death|3|||
124517303|NCT03136367|447845490|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
124517304|NCT03136367|447845491|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
124517305|NCT03136367|447845492|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
124517306|NCT03136367|447845490|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
124517307|NCT03136367|447845491|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
124517308|NCT03136367|447845492|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
124517309|NCT03136367|447845490|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
124517310|NCT03136367|447845491|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
124517311|NCT03136367|447845492|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
124517312|NCT03136367|447845490|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
124517313|NCT03136367|447845491|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
124517314|NCT03136367|447845492|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
124517315|NCT03136367|447845490|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
124517316|NCT03136367|447845491|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
124517317|NCT03136367|447845492|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
124517318|NCT03136367|447845490|FG000|T5 1 Year After Surgery|Death|0|||
124517319|NCT03136367|447845491|FG001|T5 1 Year After Surgery|Death|0|||
124517320|NCT03136367|447845492|FG002|T5 1 Year After Surgery|Death|1|||
124517321|NCT03136367|447845490|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
124517322|NCT03136367|447845491|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
124517323|NCT03136367|447845492|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
124517324|NCT03136367|447845490|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
124517325|NCT03136367|447845491|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
124517326|NCT03136367|447845492|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
124517327|NCT03136367|447845490|FG000|T5 1 Year After Surgery|study ended before due|31|||
124517328|NCT03136367|447845491|FG001|T5 1 Year After Surgery|study ended before due|103|||
124517329|NCT03136367|447845492|FG002|T5 1 Year After Surgery|study ended before due|110|||
124517330|NCT03136367|447845490|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
124517331|NCT03136367|447845491|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
124517332|NCT03136367|447845492|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
124517333|NCT00892957|447845493|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
124517334|NCT00892957|447845494|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
124517335|NCT00892957|447845493|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
124517336|NCT00892957|447845494|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
124517337|NCT03175562|447845503|FG000|Overall Study|Adverse Event|1|||
124517338|NCT03175562|447845503|FG000|Overall Study|Lost to Follow-up|3|||
124517339|NCT03175562|447845503|FG000|Overall Study|Withdrawal by Subject|7|||
124517340|NCT03175562|447845503|FG000|Overall Study|Other (Not Specified)|5|||
124517341|NCT00676208|447845506|FG000|Overall Study|Lost to Follow-up|0|||
124517342|NCT00676208|447845507|FG001|Overall Study|Lost to Follow-up|2|||
124517343|NCT00676208|447845506|FG000|Overall Study|Incomplete data|2|||
124517344|NCT00676208|447845507|FG001|Overall Study|Incomplete data|4|||
124517345|NCT03700736|447845508|FG000|Overall Study|Pregnancy|1|||
124517346|NCT03700736|447845509|FG001|Overall Study|Pregnancy|1|||
124517347|NCT03700736|447845508|FG000|Overall Study|Withdrawal by Subject|2|||
124517348|NCT03700736|447845509|FG001|Overall Study|Withdrawal by Subject|6|||
124517349|NCT01410799|447845511|FG000|Overall Study|PI decision|13|||
124517350|NCT00191386|447847198|FG000|Overall Study|Adverse Event|16|||
124517351|NCT00191386|447847198|FG000|Overall Study|Lost to Follow-up|1|||
124517352|NCT00191386|447847198|FG000|Overall Study|Entry Criteria Exclusion|3|||
124517353|NCT00191386|447847198|FG000|Overall Study|Protocol Violation|18|||
124517354|NCT00191386|447847198|FG000|Overall Study|Withdrawal by Subject|96|||
124517355|NCT00191386|447847198|FG000|Overall Study|Physician Decision|11|||
124517356|NCT00191386|447847198|FG000|Overall Study|Lack of Efficacy|15|||
124517357|NCT01742091|447847203|FG000|Overall Study|Adverse Event|0|||
124517358|NCT01742091|447847204|FG001|Overall Study|Adverse Event|0|||
124517359|NCT01742091|447847205|FG002|Overall Study|Adverse Event|0|||
124517360|NCT01742091|447847206|FG003|Overall Study|Adverse Event|0|||
124517361|NCT01742091|447847207|FG004|Overall Study|Adverse Event|1|||
124517362|NCT01742091|447847208|FG005|Overall Study|Adverse Event|0|||
124517363|NCT01742091|447847203|FG000|Overall Study|Physician Decision|0|||
124517364|NCT01742091|447847204|FG001|Overall Study|Physician Decision|0|||
124517365|NCT01742091|447847205|FG002|Overall Study|Physician Decision|0|||
124517366|NCT01742091|447847206|FG003|Overall Study|Physician Decision|0|||
124517367|NCT01742091|447847207|FG004|Overall Study|Physician Decision|0|||
124517368|NCT01742091|447847208|FG005|Overall Study|Physician Decision|1|||
124517369|NCT01742091|447847203|FG000|Overall Study|Withdrawal by Subject|0|||
124517370|NCT01742091|447847204|FG001|Overall Study|Withdrawal by Subject|0|||
124724986|NCT01345929|448613397|FG000|Overall Study|Didn't meet eligibility criteria|2|||
124724987|NCT01345929|448613398|FG001|Overall Study|Didn't meet eligibility criteria|0|||
124724988|NCT01345929|448613397|FG000|Overall Study|40,000 CFU/ML|1|||
124724989|NCT01345929|448613398|FG001|Overall Study|40,000 CFU/ML|0|||
124517371|NCT01742091|447847205|FG002|Overall Study|Withdrawal by Subject|0|||
124517372|NCT01742091|447847206|FG003|Overall Study|Withdrawal by Subject|1|||
124517373|NCT01742091|447847207|FG004|Overall Study|Withdrawal by Subject|0|||
124517374|NCT01742091|447847208|FG005|Overall Study|Withdrawal by Subject|0|||
124517375|NCT01742091|447847203|FG000|Overall Study|Lost to Follow-up|0|||
124517376|NCT01742091|447847204|FG001|Overall Study|Lost to Follow-up|0|||
124517377|NCT01742091|447847205|FG002|Overall Study|Lost to Follow-up|0|||
124517378|NCT01742091|447847206|FG003|Overall Study|Lost to Follow-up|0|||
124517379|NCT01742091|447847207|FG004|Overall Study|Lost to Follow-up|0|||
124517380|NCT01742091|447847208|FG005|Overall Study|Lost to Follow-up|1|||
124517381|NCT03750240|447847209|FG000|Overall Study|Technical Difficulties|2|||
124517382|NCT03706040|447847210|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
124517383|NCT03706040|447847211|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
124517384|NCT03706040|447847212|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
124517385|NCT03706040|447847213|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
124517386|NCT03706040|447847214|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
124517387|NCT03706040|447847215|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
124517388|NCT03706040|447847216|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
124517389|NCT03706040|447847210|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
124517390|NCT03706040|447847211|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
124517391|NCT03706040|447847212|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
124517392|NCT03706040|447847213|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
124517393|NCT03706040|447847214|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
124517394|NCT03706040|447847215|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
124517395|NCT03706040|447847216|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
124517396|NCT03706040|447847210|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
124517397|NCT03706040|447847211|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
124517398|NCT03706040|447847212|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
124517399|NCT03706040|447847213|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
124517400|NCT03706040|447847214|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
124517401|NCT03706040|447847215|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
124517402|NCT03706040|447847216|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
124517403|NCT03706040|447847210|FG000|Period A (Week 0 to Week 16)|Other|2|||
124517404|NCT03706040|447847211|FG001|Period A (Week 0 to Week 16)|Other|0|||
124517405|NCT03706040|447847212|FG002|Period A (Week 0 to Week 16)|Other|2|||
124517406|NCT03706040|447847213|FG003|Period A (Week 0 to Week 16)|Other|0|||
124517407|NCT03706040|447847214|FG004|Period A (Week 0 to Week 16)|Other|0|||
124517408|NCT03706040|447847215|FG005|Period A (Week 0 to Week 16)|Other|0|||
124517409|NCT03706040|447847216|FG006|Period A (Week 0 to Week 16)|Other|0|||
124517410|NCT03706040|447847210|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
124517411|NCT03706040|447847211|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
124517412|NCT03706040|447847212|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
124517413|NCT03706040|447847213|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
124517414|NCT03706040|447847214|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
124517415|NCT03706040|447847215|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
124517416|NCT03706040|447847216|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
124517417|NCT03706040|447847210|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
124517418|NCT03706040|447847211|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
124517419|NCT03706040|447847212|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
124517420|NCT03706040|447847213|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
124517421|NCT03706040|447847214|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
124517422|NCT03706040|447847215|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
124517423|NCT03706040|447847216|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
124517424|NCT03706040|447847210|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
124517425|NCT03706040|447847211|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
124517426|NCT03706040|447847212|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
124517427|NCT03706040|447847213|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
124517428|NCT03706040|447847214|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
124517429|NCT03706040|447847215|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
124517430|NCT03706040|447847216|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
124517431|NCT03706040|447847210|FG000|Period B (Week 16 to Week 52)|Other|0|||
124517432|NCT03706040|447847211|FG001|Period B (Week 16 to Week 52)|Other|0|||
124517433|NCT03706040|447847212|FG002|Period B (Week 16 to Week 52)|Other|0|||
124517434|NCT03706040|447847213|FG003|Period B (Week 16 to Week 52)|Other|4|||
124517435|NCT03706040|447847214|FG004|Period B (Week 16 to Week 52)|Other|5|||
124724990|NCT01345929|448613397|FG000|Overall Study|Patient withdrawal|0|||
124724991|NCT01345929|448613398|FG001|Overall Study|Patient withdrawal|1|||
124517436|NCT03706040|447847215|FG005|Period B (Week 16 to Week 52)|Other|23|||
124517437|NCT03706040|447847216|FG006|Period B (Week 16 to Week 52)|Other|17|||
124517438|NCT00439725|447847217|FG000|Treatment Period|Withdrawal by Subject|22|||
124517439|NCT00439725|447847218|FG001|Treatment Period|Withdrawal by Subject|19|||
124517440|NCT00439725|447847217|FG000|Treatment Period|Study terminated by sponsor|156|||
124517441|NCT00439725|447847218|FG001|Treatment Period|Study terminated by sponsor|148|||
124517442|NCT00439725|447847217|FG000|Treatment Period|Site closed by investigator|1|||
124517443|NCT00439725|447847218|FG001|Treatment Period|Site closed by investigator|2|||
124517444|NCT00439725|447847217|FG000|Treatment Period|Adverse Event|39|||
124517445|NCT00439725|447847218|FG001|Treatment Period|Adverse Event|18|||
124517446|NCT00439725|447847217|FG000|Treatment Period|Physician Decision|1|||
124517447|NCT00439725|447847218|FG001|Treatment Period|Physician Decision|1|||
124517448|NCT00439725|447847217|FG000|Treatment Period|Protocol Violation|2|||
124517449|NCT00439725|447847218|FG001|Treatment Period|Protocol Violation|1|||
124517450|NCT00439725|447847217|FG000|Treatment Period|Clinical endpoint reached|6|||
124517451|NCT00439725|447847218|FG001|Treatment Period|Clinical endpoint reached|50|||
124517452|NCT00439725|447847217|FG000|Treatment Period|Technical problems|1|||
124517453|NCT00439725|447847218|FG001|Treatment Period|Technical problems|0|||
124517454|NCT00439725|447847217|FG000|Treatment Period|Lost to Follow-up|1|||
124517455|NCT00439725|447847218|FG001|Treatment Period|Lost to Follow-up|1|||
124517456|NCT00439725|447847217|FG000|Treatment Period|Participant convenience|1|||
124517457|NCT00439725|447847218|FG001|Treatment Period|Participant convenience|0|||
124517458|NCT00439725|447847217|FG000|Treatment Period|Protocol driven decision point|1|||
124517459|NCT00439725|447847218|FG001|Treatment Period|Protocol driven decision point|1|||
124517460|NCT00439725|447847217|FG000|Treatment Period|Death|1|||
124517461|NCT00439725|447847218|FG001|Treatment Period|Death|1|||
124517462|NCT00439725|447847217|FG000|Treatment Period|Participant did not receive treatment|4|||
124517463|NCT00439725|447847218|FG001|Treatment Period|Participant did not receive treatment|4|||
124517464|NCT00439725|447847217|FG000|Observational Period|Withdrawal by Subject|2|||
124517465|NCT00439725|447847218|FG001|Observational Period|Withdrawal by Subject|2|||
124517466|NCT00439725|447847217|FG000|Observational Period|Lost to Follow-up|0|||
124517467|NCT00439725|447847218|FG001|Observational Period|Lost to Follow-up|1|||
124517468|NCT00439725|447847217|FG000|Observational Period|Death|0|||
124517469|NCT00439725|447847218|FG001|Observational Period|Death|2|||
124517470|NCT00439725|447847217|FG000|Observational Period|Study termination by sponsor|1|||
124517471|NCT00439725|447847218|FG001|Observational Period|Study termination by sponsor|1|||
124517472|NCT00439725|447847217|FG000|Observational Period|Clinical endpoint reached|3|||
124517473|NCT00439725|447847218|FG001|Observational Period|Clinical endpoint reached|1|||
124517474|NCT00439725|447847217|FG000|Observational Period|Technical problems|1|||
124517475|NCT00439725|447847218|FG001|Observational Period|Technical problems|0|||
124517476|NCT00439725|447847217|FG000|Observational Period|Participant convenience|1|||
124517477|NCT00439725|447847218|FG001|Observational Period|Participant convenience|0|||
124517478|NCT03510910|447847219|FG000|Overall Study|Incomplete Survey|2|||
124517479|NCT03510910|447847220|FG001|Overall Study|Incomplete Survey|3|||
124517480|NCT02715804|447847226|FG000|Overall Study|Death|222|||
124517481|NCT02715804|447847227|FG001|Overall Study|Death|106|||
124517482|NCT02715804|447847226|FG000|Overall Study|Withdrawal by Subject|5|||
124517483|NCT02715804|447847227|FG001|Overall Study|Withdrawal by Subject|4|||
124517484|NCT02715804|447847226|FG000|Overall Study|Other than specified|2|||
124517485|NCT02715804|447847227|FG001|Overall Study|Other than specified|3|||
124517486|NCT04038385|447847228|FG000|Overall Study|Completed baseline assessment only|7|||
124517487|NCT04038385|447847229|FG001|Overall Study|Completed baseline assessment only|4|||
124517488|NCT04038385|447847228|FG000|Overall Study|Moved out of area|4|||
124517489|NCT04038385|447847229|FG001|Overall Study|Moved out of area|2|||
124517490|NCT04038385|447847228|FG000|Overall Study|Discontinued study involvement|6|||
124517491|NCT04038385|447847229|FG001|Overall Study|Discontinued study involvement|1|||
124517492|NCT00948194|447847230|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
124517493|NCT00948194|447847231|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
124517494|NCT00724815|447847240|FG000|Overall Study|Randomized, not treated|31|||
124517495|NCT00724815|447847241|FG001|Overall Study|Randomized, not treated|30|||
124517496|NCT00724815|447847240|FG000|Overall Study|Adverse Event|5|||
124517497|NCT00724815|447847241|FG001|Overall Study|Adverse Event|3|||
124517498|NCT00724815|447847240|FG000|Overall Study|Lost to Follow-up|4|||
124517499|NCT00724815|447847241|FG001|Overall Study|Lost to Follow-up|1|||
124517500|NCT00724815|447847240|FG000|Overall Study|Other Various|3|||
124517501|NCT00724815|447847241|FG001|Overall Study|Other Various|5|||
124517502|NCT00105183|447847246|FG000|Overall Study|Death|19|||
124517503|NCT00105183|447847247|FG001|Overall Study|Death|13|||
124517504|NCT00105183|447847248|FG002|Overall Study|Death|15|||
124517505|NCT00105183|447847246|FG000|Overall Study|Withdrawal by Subject|1|||
124517506|NCT00105183|447847247|FG001|Overall Study|Withdrawal by Subject|1|||
124517507|NCT00105183|447847248|FG002|Overall Study|Withdrawal by Subject|4|||
124517508|NCT00105183|447847246|FG000|Overall Study|Physician Decision|1|||
124517509|NCT00105183|447847247|FG001|Overall Study|Physician Decision|2|||
124517510|NCT00105183|447847248|FG002|Overall Study|Physician Decision|3|||
124517511|NCT00105183|447847246|FG000|Overall Study|Lost to Follow-up|0|||
124517512|NCT00105183|447847247|FG001|Overall Study|Lost to Follow-up|1|||
124517513|NCT00105183|447847248|FG002|Overall Study|Lost to Follow-up|1|||
124517514|NCT00105183|447847246|FG000|Overall Study|Other reason|1|||
124517515|NCT00105183|447847247|FG001|Overall Study|Other reason|2|||
124517516|NCT00105183|447847248|FG002|Overall Study|Other reason|0|||
124517517|NCT01819506|447847249|FG000|Overall Study|Physician Decision|5|||
124517518|NCT01819506|447847250|FG001|Overall Study|Physician Decision|2|||
124517519|NCT01819506|447847249|FG000|Overall Study|Withdrawal by Subject|3|||
124517520|NCT01819506|447847250|FG001|Overall Study|Withdrawal by Subject|3|||
124517521|NCT03000686|447847251|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
124517522|NCT03000686|447847252|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
124517523|NCT03000686|447847253|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
124517524|NCT03000686|447847254|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
124517525|NCT00294684|447847255|FG000|Overall Study|Lost to Follow-up|5|||
124517526|NCT00294684|447847256|FG001|Overall Study|Lost to Follow-up|8|||
124517527|NCT00968708|447847257|FG000|Overall Study|Adverse Event|169|||
124517528|NCT00968708|447847258|FG001|Overall Study|Adverse Event|150|||
124517529|NCT00968708|447847257|FG000|Overall Study|Major Protocol Deviation|0|||
124517530|NCT00968708|447847258|FG001|Overall Study|Major Protocol Deviation|1|||
124517531|NCT00968708|447847257|FG000|Overall Study|Lost to Follow-up|19|||
124517532|NCT00968708|447847258|FG001|Overall Study|Lost to Follow-up|11|||
124517533|NCT00968708|447847257|FG000|Overall Study|Voluntary Withdrawal|104|||
124517534|NCT00968708|447847258|FG001|Overall Study|Voluntary Withdrawal|101|||
124517535|NCT00968708|447847257|FG000|Overall Study|Investigator Discretion|0|||
124517536|NCT00968708|447847258|FG001|Overall Study|Investigator Discretion|1|||
124517537|NCT00968708|447847257|FG000|Overall Study|Other|26|||
124517538|NCT00968708|447847258|FG001|Overall Study|Other|34|||
124517539|NCT00389441|447847259|FG000|Overall Study|Adverse Event|7|||
124517540|NCT00389441|447847259|FG000|Overall Study|Death|4|||
124517541|NCT00389441|447847259|FG000|Overall Study|Lost to Follow-up|2|||
124517542|NCT00389441|447847259|FG000|Overall Study|Withdrawal by Subject|4|||
124517543|NCT00389441|447847259|FG000|Overall Study|Physician Decision|1|||
124517544|NCT00389441|447847259|FG000|Overall Study|Protocol Violation|1|||
124517545|NCT00389441|447847259|FG000|Overall Study|Global deterioration of health status|4|||
124517546|NCT00389441|447847259|FG000|Overall Study|Objective progression or relapse|26|||
124517547|NCT00389441|447847259|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
124517548|NCT00389441|447847259|FG000|Overall Study|Clinical progression|1|||
124517549|NCT01981109|447847260|FG000|Overall Study|Death|36|||
124517550|NCT01981109|447847260|FG000|Overall Study|Withdrawal by Subject|40|||
124517551|NCT01981109|447847260|FG000|Overall Study|Lost to Follow-up|9|||
124517552|NCT01981109|447847260|FG000|Overall Study|No Discontinuation Documentation|37|||
124517553|NCT01981109|447847260|FG000|Overall Study|Study Termination|100|||
124517554|NCT01981109|447847260|FG000|Overall Study|No data available|2|||
124517555|NCT00126672|447847262|FG000|Overall Study|Adverse Event|4|||
124517556|NCT00126672|447847262|FG000|Overall Study|Lost to Follow-up|4|||
124517557|NCT01851863|447847263|FG000|Overall Study|Did not receive study medication|2|||
124517558|NCT01851863|447847264|FG001|Overall Study|Did not receive study medication|5|||
124517559|NCT01851863|447847265|FG002|Overall Study|Did not receive study medication|3|||
124517560|NCT01851863|447847266|FG003|Overall Study|Did not receive study medication|0|||
124517561|NCT01851863|447847263|FG000|Overall Study|Lost to Follow-up|3|||
124517562|NCT01851863|447847264|FG001|Overall Study|Lost to Follow-up|4|||
124517563|NCT01851863|447847265|FG002|Overall Study|Lost to Follow-up|2|||
124517564|NCT01851863|447847266|FG003|Overall Study|Lost to Follow-up|3|||
124517565|NCT03238352|447847267|FG000|Overall Study|Lost to Follow-up|0|||
124517566|NCT03238352|447847268|FG001|Overall Study|Lost to Follow-up|2|||
124517567|NCT03238352|447847269|FG002|Overall Study|Lost to Follow-up|1|||
124517568|NCT03238352|447847267|FG000|Overall Study|Withdrawal by Subject|0|||
124517569|NCT03238352|447847268|FG001|Overall Study|Withdrawal by Subject|1|||
124517570|NCT03238352|447847269|FG002|Overall Study|Withdrawal by Subject|0|||
124517571|NCT04083794|447847270|FG000|Overall Study|Lost to Follow-up|9|||
124517572|NCT01296698|447847271|FG000|Overall Study|Adverse Event|1|||
124517573|NCT01296698|447847272|FG001|Overall Study|Adverse Event|0|||
124517574|NCT01296698|447847271|FG000|Overall Study|Death|1|||
124517575|NCT01296698|447847272|FG001|Overall Study|Death|0|||
124517576|NCT01296698|447847271|FG000|Overall Study|Lost to Follow-up|19|||
124517577|NCT01296698|447847272|FG001|Overall Study|Lost to Follow-up|1|||
124517578|NCT01296698|447847271|FG000|Overall Study|Withdrawal by Subject|12|||
124517579|NCT01296698|447847272|FG001|Overall Study|Withdrawal by Subject|0|||
124517580|NCT01296698|447847271|FG000|Overall Study|Difficulty Contacting Subject|2|||
124517581|NCT01296698|447847272|FG001|Overall Study|Difficulty Contacting Subject|0|||
124517582|NCT01296698|447847271|FG000|Overall Study|Study Terminated by Sponsor|209|||
124517583|NCT01296698|447847272|FG001|Overall Study|Study Terminated by Sponsor|12|||
124517584|NCT00224003|447847273|FG000|Overall Study|Adverse Event|1|||
124517585|NCT00224003|447847273|FG000|Overall Study|Protocol Violation|2|||
124517586|NCT00224003|447847273|FG000|Overall Study|Withdrawal by Subject|1|||
124517587|NCT00224003|447847273|FG000|Overall Study|unk|3|||
124517588|NCT01202760|447847276|FG000|Overall Study|Entry Criteria Not Met|0|||
124517589|NCT01202760|447847277|FG001|Overall Study|Entry Criteria Not Met|3|||
124517590|NCT01202760|447847278|FG002|Overall Study|Entry Criteria Not Met|1|||
124517591|NCT01202760|447847276|FG000|Overall Study|Adverse Event|11|||
124517592|NCT01202760|447847277|FG001|Overall Study|Adverse Event|9|||
124517593|NCT01202760|447847278|FG002|Overall Study|Adverse Event|10|||
124517594|NCT01202760|447847276|FG000|Overall Study|Death|2|||
124517595|NCT01202760|447847277|FG001|Overall Study|Death|1|||
124517596|NCT01202760|447847278|FG002|Overall Study|Death|0|||
124517597|NCT01202760|447847276|FG000|Overall Study|Lack of Efficacy|6|||
124517598|NCT01202760|447847277|FG001|Overall Study|Lack of Efficacy|8|||
124517599|NCT01202760|447847278|FG002|Overall Study|Lack of Efficacy|7|||
124517600|NCT01202760|447847276|FG000|Overall Study|Lost to Follow-up|0|||
124517601|NCT01202760|447847277|FG001|Overall Study|Lost to Follow-up|2|||
124517602|NCT01202760|447847278|FG002|Overall Study|Lost to Follow-up|1|||
124517603|NCT01202760|447847276|FG000|Overall Study|Parent / Caregiver Decision|0|||
124517604|NCT01202760|447847277|FG001|Overall Study|Parent / Caregiver Decision|1|||
124517605|NCT01202760|447847278|FG002|Overall Study|Parent / Caregiver Decision|0|||
124517606|NCT01202760|447847276|FG000|Overall Study|Withdrawal by Subject|17|||
124517607|NCT01202760|447847277|FG001|Overall Study|Withdrawal by Subject|18|||
124517608|NCT01202760|447847278|FG002|Overall Study|Withdrawal by Subject|14|||
124517609|NCT01202760|447847276|FG000|Overall Study|Physician Decision|0|||
124517610|NCT01202760|447847277|FG001|Overall Study|Physician Decision|1|||
124517611|NCT01202760|447847278|FG002|Overall Study|Physician Decision|0|||
124517612|NCT01202760|447847276|FG000|Overall Study|Protocol Violation|7|||
124517613|NCT01202760|447847277|FG001|Overall Study|Protocol Violation|5|||
124517614|NCT01202760|447847278|FG002|Overall Study|Protocol Violation|2|||
124517615|NCT01202760|447847276|FG000|Overall Study|Sponsor Decision|4|||
124517616|NCT01202760|447847277|FG001|Overall Study|Sponsor Decision|4|||
124517617|NCT01202760|447847278|FG002|Overall Study|Sponsor Decision|0|||
124517618|NCT03097029|447847284|FG000|Overall Study|Withdrawal by Subject|1|||
124517619|NCT00108953|447847292|FG000|Follow-up|Death|18|||
124517620|NCT00108953|447847293|FG001|Follow-up|Death|26|||
124517621|NCT00108953|447847292|FG000|Follow-up|Lost to Follow-up|1|||
124517622|NCT00108953|447847293|FG001|Follow-up|Lost to Follow-up|1|||
124517623|NCT00108953|447847292|FG000|Follow-up|Study terminated by sponsor|10|||
124517624|NCT00108953|447847293|FG001|Follow-up|Study terminated by sponsor|6|||
124517625|NCT02661464|447847294|FG000|Overall Study|Lost to Follow-up|28|||
124517626|NCT02661464|447847295|FG001|Overall Study|Lost to Follow-up|0|||
124517627|NCT02661464|447847296|FG002|Overall Study|Lost to Follow-up|0|||
124517628|NCT02661464|447847297|FG003|Overall Study|Lost to Follow-up|0|||
124517629|NCT02661464|447847294|FG000|Overall Study|Withdrawal by Subject|3|||
124517630|NCT02661464|447847295|FG001|Overall Study|Withdrawal by Subject|1|||
124517631|NCT02661464|447847296|FG002|Overall Study|Withdrawal by Subject|0|||
124517632|NCT02661464|447847297|FG003|Overall Study|Withdrawal by Subject|0|||
124517633|NCT02661464|447847294|FG000|Overall Study|Participants terminated prematurely|288|||
124517634|NCT02661464|447847295|FG001|Overall Study|Participants terminated prematurely|52|||
124517635|NCT02661464|447847296|FG002|Overall Study|Participants terminated prematurely|1|||
124517636|NCT02661464|447847297|FG003|Overall Study|Participants terminated prematurely|1|||
124517637|NCT02661464|447847294|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
124517638|NCT02661464|447847295|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
124517639|NCT02661464|447847296|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
124517640|NCT02661464|447847297|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
124517641|NCT01125293|447847298|FG000|Overall Study|Disease Progression|1|||
124517642|NCT01125293|447847299|FG001|Overall Study|Disease Progression|3|||
124517643|NCT01125293|447847300|FG002|Overall Study|Disease Progression|4|||
124517644|NCT01125293|447847301|FG003|Overall Study|Disease Progression|3|||
124517645|NCT01125293|447847302|FG004|Overall Study|Disease Progression|5|||
124517646|NCT01125293|447847303|FG005|Overall Study|Disease Progression|12|||
124517647|NCT01125293|447847298|FG000|Overall Study|Adverse Event|1|||
124517648|NCT01125293|447847299|FG001|Overall Study|Adverse Event|0|||
124517649|NCT01125293|447847300|FG002|Overall Study|Adverse Event|0|||
124517650|NCT01125293|447847301|FG003|Overall Study|Adverse Event|0|||
124517651|NCT01125293|447847302|FG004|Overall Study|Adverse Event|2|||
124517652|NCT01125293|447847303|FG005|Overall Study|Adverse Event|8|||
124517653|NCT01125293|447847298|FG000|Overall Study|Symptomatic Deterioration|1|||
124517654|NCT01125293|447847299|FG001|Overall Study|Symptomatic Deterioration|0|||
124517655|NCT01125293|447847300|FG002|Overall Study|Symptomatic Deterioration|0|||
124517656|NCT01125293|447847301|FG003|Overall Study|Symptomatic Deterioration|0|||
124517657|NCT01125293|447847302|FG004|Overall Study|Symptomatic Deterioration|0|||
124517658|NCT01125293|447847303|FG005|Overall Study|Symptomatic Deterioration|0|||
124517659|NCT01125293|447847298|FG000|Overall Study|Death|0|||
124517660|NCT01125293|447847299|FG001|Overall Study|Death|0|||
124517661|NCT01125293|447847300|FG002|Overall Study|Death|0|||
124517662|NCT01125293|447847301|FG003|Overall Study|Death|0|||
124517663|NCT01125293|447847302|FG004|Overall Study|Death|1|||
124517664|NCT01125293|447847303|FG005|Overall Study|Death|0|||
124517665|NCT01125293|447847298|FG000|Overall Study|Withdrawal by Subject|0|||
124517666|NCT01125293|447847299|FG001|Overall Study|Withdrawal by Subject|0|||
124517667|NCT01125293|447847300|FG002|Overall Study|Withdrawal by Subject|0|||
124517668|NCT01125293|447847301|FG003|Overall Study|Withdrawal by Subject|0|||
124517669|NCT01125293|447847302|FG004|Overall Study|Withdrawal by Subject|2|||
124517670|NCT01125293|447847303|FG005|Overall Study|Withdrawal by Subject|1|||
124517671|NCT01125293|447847298|FG000|Overall Study|Physician Decision|0|||
124517672|NCT01125293|447847299|FG001|Overall Study|Physician Decision|0|||
124517673|NCT01125293|447847300|FG002|Overall Study|Physician Decision|0|||
124517674|NCT01125293|447847301|FG003|Overall Study|Physician Decision|0|||
124517675|NCT01125293|447847302|FG004|Overall Study|Physician Decision|0|||
124517676|NCT01125293|447847303|FG005|Overall Study|Physician Decision|2|||
124517677|NCT03148756|447847304|FG000|Overall Study|Study Terminated|0|||
124517678|NCT03148756|447847305|FG001|Overall Study|Study Terminated|1|||
124517679|NCT01270958|447847306|FG000|Overall Study|Lost to Follow-up|2|||
124517680|NCT01270958|447847306|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
124517681|NCT02177175|447847311|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
124517682|NCT02177175|447847312|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
124517683|NCT03820726|447847313|FG000|Overall Study|Other than listed|23|||
124517684|NCT03820726|447847313|FG000|Overall Study|Withdrawal by Subject|37|||
124517685|NCT03820726|447847313|FG000|Overall Study|Lost to Follow-up|3|||
124517686|NCT03820726|447847313|FG000|Overall Study|Protocol deviation|1|||
124517687|NCT03820726|447847313|FG000|Overall Study|Adverse Event|146|||
124517688|NCT03820726|447847313|FG000|Overall Study|Not treated|1|||
124517689|NCT00345540|447847318|FG000|Overall Study|Withdrawal by Subject|1|||
124517690|NCT01406652|447847319|FG000|Overall Study|Lost-to-follow-up|3|||
124517691|NCT01406652|447847320|FG001|Overall Study|Lost-to-follow-up|4|||
124517692|NCT01406652|447847319|FG000|Overall Study|Withdrawal by Subject|2|||
124517693|NCT01406652|447847320|FG001|Overall Study|Withdrawal by Subject|2|||
124517694|NCT01406652|447847319|FG000|Overall Study|Insufficient follow-up|5|||
124517695|NCT01406652|447847320|FG001|Overall Study|Insufficient follow-up|4|||
124517696|NCT01406652|447847319|FG000|Overall Study|Infection not sure|10|||
124517697|NCT01406652|447847320|FG001|Overall Study|Infection not sure|10|||
124517698|NCT00861380|447847321|FG000|Overall Study|Withdrawal Information not recorded|8427|||
124517699|NCT00861380|447847322|FG001|Overall Study|Withdrawal Information not recorded|9112|||
124517700|NCT00861380|447847323|FG002|Overall Study|Withdrawal Information not recorded|8872|||
124517701|NCT00861380|447847324|FG003|Overall Study|Withdrawal Information not recorded|3689|||
124517702|NCT00861380|447847325|FG004|Overall Study|Withdrawal Information not recorded|1812|||
124517703|NCT00861380|447847326|FG005|Overall Study|Withdrawal Information not recorded|6249|||
124517704|NCT00861380|447847327|FG006|Overall Study|Withdrawal Information not recorded|3020|||
124517705|NCT00637377|447847331|FG000|Overall Study|Adverse Event|2|||
124517706|NCT00637377|447847332|FG001|Overall Study|Adverse Event|6|||
124517707|NCT00637377|447847333|FG002|Overall Study|Adverse Event|8|||
124517708|NCT00637377|447847334|FG003|Overall Study|Adverse Event|9|||
124517709|NCT00637377|447847331|FG000|Overall Study|Death|1|||
124517710|NCT00637377|447847332|FG001|Overall Study|Death|3|||
124517711|NCT00637377|447847333|FG002|Overall Study|Death|2|||
124517712|NCT00637377|447847334|FG003|Overall Study|Death|1|||
124517713|NCT00637377|447847331|FG000|Overall Study|Lack of Efficacy|0|||
124517714|NCT00637377|447847332|FG001|Overall Study|Lack of Efficacy|0|||
124517715|NCT00637377|447847333|FG002|Overall Study|Lack of Efficacy|1|||
124517716|NCT00637377|447847334|FG003|Overall Study|Lack of Efficacy|1|||
124517717|NCT00637377|447847331|FG000|Overall Study|Lost to Follow-up|4|||
124517718|NCT00637377|447847332|FG001|Overall Study|Lost to Follow-up|1|||
124517719|NCT00637377|447847333|FG002|Overall Study|Lost to Follow-up|2|||
124517720|NCT00637377|447847334|FG003|Overall Study|Lost to Follow-up|2|||
124517721|NCT00637377|447847331|FG000|Overall Study|Protocol Violation|2|||
124517722|NCT00637377|447847332|FG001|Overall Study|Protocol Violation|1|||
124517723|NCT00637377|447847333|FG002|Overall Study|Protocol Violation|1|||
124517724|NCT00637377|447847334|FG003|Overall Study|Protocol Violation|0|||
124517725|NCT00637377|447847331|FG000|Overall Study|Withdrawal by Subject|11|||
124517726|NCT00637377|447847332|FG001|Overall Study|Withdrawal by Subject|15|||
124517727|NCT00637377|447847333|FG002|Overall Study|Withdrawal by Subject|13|||
124517728|NCT00637377|447847334|FG003|Overall Study|Withdrawal by Subject|11|||
124517729|NCT00637377|447847331|FG000|Overall Study|Other (no further information available)|7|||
124517730|NCT00637377|447847332|FG001|Overall Study|Other (no further information available)|6|||
124571964|NCT00150462|448053382|FG002|Overall Study|Physician Decision|1|||
124517731|NCT00637377|447847333|FG002|Overall Study|Other (no further information available)|10|||
124517732|NCT00637377|447847334|FG003|Overall Study|Other (no further information available)|5|||
124517733|NCT04876599|447847339|FG000|Overall Study|Missed|2|||
124517734|NCT04876599|447847340|FG001|Overall Study|Missed|0|||
124517735|NCT04876599|447847339|FG000|Overall Study|Declined|2|||
124517736|NCT04876599|447847340|FG001|Overall Study|Declined|3|||
124517737|NCT02146833|447847341|FG000|Overall Study|Death|10|||
124517738|NCT02146833|447847341|FG000|Overall Study|No longer consented to study treatment|1|||
124517739|NCT04126031|447847343|FG000|Part A|Withdrawal by Subject|0|||
124517740|NCT04126031|447847344|FG001|Part A|Withdrawal by Subject|0|||
124517741|NCT04126031|447847345|FG002|Part A|Withdrawal by Subject|1|||
124517742|NCT04126031|447847346|FG003|Part A|Withdrawal by Subject|0|||
124517743|NCT04126031|447847347|FG004|Part A|Withdrawal by Subject|0|||
124517744|NCT04126031|447847348|FG005|Part A|Withdrawal by Subject|0|||
124517745|NCT04126031|447847343|FG000|Part A|Other|1|||
124517746|NCT04126031|447847344|FG001|Part A|Other|0|||
124517747|NCT04126031|447847345|FG002|Part A|Other|0|||
124517748|NCT04126031|447847346|FG003|Part A|Other|0|||
124517749|NCT04126031|447847347|FG004|Part A|Other|0|||
124517750|NCT04126031|447847348|FG005|Part A|Other|0|||
124517751|NCT04126031|447847343|FG000|Part B|Adverse Event|0|||
124517752|NCT04126031|447847344|FG001|Part B|Adverse Event|0|||
124517753|NCT04126031|447847345|FG002|Part B|Adverse Event|0|||
124517754|NCT04126031|447847346|FG003|Part B|Adverse Event|0|||
124517755|NCT04126031|447847347|FG004|Part B|Adverse Event|0|||
124517756|NCT04126031|447847348|FG005|Part B|Adverse Event|2|||
124517757|NCT04126031|447847343|FG000|Part B|Pre-existing hypertransaminasemia|0|||
124517758|NCT04126031|447847344|FG001|Part B|Pre-existing hypertransaminasemia|0|||
124517759|NCT04126031|447847345|FG002|Part B|Pre-existing hypertransaminasemia|0|||
124517760|NCT04126031|447847346|FG003|Part B|Pre-existing hypertransaminasemia|0|||
124517761|NCT04126031|447847347|FG004|Part B|Pre-existing hypertransaminasemia|1|||
124517762|NCT04126031|447847348|FG005|Part B|Pre-existing hypertransaminasemia|0|||
124517763|NCT00617656|447847349|FG000|Overall Study|Inclusion error|4|||
124517764|NCT00617656|447847350|FG001|Overall Study|Inclusion error|4|||
124517765|NCT00617656|447847351|FG002|Overall Study|Inclusion error|0|||
124517766|NCT00617656|447847352|FG003|Overall Study|Inclusion error|0|||
124517767|NCT00617656|447847349|FG000|Overall Study|Missing data|44|||
124517768|NCT00617656|447847350|FG001|Overall Study|Missing data|30|||
124517769|NCT00617656|447847351|FG002|Overall Study|Missing data|13|||
124517770|NCT00617656|447847352|FG003|Overall Study|Missing data|6|||
124517771|NCT00617656|447847349|FG000|Overall Study|Withdrawal by Subject|0|||
124517772|NCT00617656|447847350|FG001|Overall Study|Withdrawal by Subject|2|||
124517773|NCT00617656|447847351|FG002|Overall Study|Withdrawal by Subject|0|||
124517774|NCT00617656|447847352|FG003|Overall Study|Withdrawal by Subject|0|||
124517775|NCT00131664|447847353|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
124517776|NCT00131664|447847354|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
124517777|NCT00131664|447847355|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
124517778|NCT00131664|447847356|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
124517779|NCT00131664|447847357|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
124517780|NCT00131664|447847358|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
124517781|NCT00131664|447847353|FG000|First Period (First 6 Months)|Death|0|||
124517782|NCT00131664|447847354|FG001|First Period (First 6 Months)|Death|1|||
124517783|NCT00131664|447847355|FG002|First Period (First 6 Months)|Death|0|||
124517784|NCT00131664|447847356|FG003|First Period (First 6 Months)|Death|0|||
124517785|NCT00131664|447847357|FG004|First Period (First 6 Months)|Death|0|||
124517786|NCT00131664|447847358|FG005|First Period (First 6 Months)|Death|0|||
124517787|NCT00131664|447847353|FG000|First Period (First 6 Months)|Protocol Violation|2|||
124517788|NCT00131664|447847354|FG001|First Period (First 6 Months)|Protocol Violation|2|||
124517789|NCT00131664|447847355|FG002|First Period (First 6 Months)|Protocol Violation|1|||
124517790|NCT00131664|447847356|FG003|First Period (First 6 Months)|Protocol Violation|0|||
124517791|NCT00131664|447847357|FG004|First Period (First 6 Months)|Protocol Violation|0|||
124517792|NCT00131664|447847358|FG005|First Period (First 6 Months)|Protocol Violation|0|||
124517793|NCT00131664|447847353|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
124517794|NCT00131664|447847354|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
124517795|NCT00131664|447847355|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
124517796|NCT00131664|447847356|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
124517797|NCT00131664|447847357|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
124517798|NCT00131664|447847358|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
124517799|NCT00131664|447847353|FG000|First Period (First 6 Months)|Adverse Event|9|||
124517800|NCT00131664|447847354|FG001|First Period (First 6 Months)|Adverse Event|4|||
124517801|NCT00131664|447847355|FG002|First Period (First 6 Months)|Adverse Event|5|||
124517802|NCT00131664|447847356|FG003|First Period (First 6 Months)|Adverse Event|0|||
124517803|NCT00131664|447847357|FG004|First Period (First 6 Months)|Adverse Event|0|||
124517804|NCT00131664|447847358|FG005|First Period (First 6 Months)|Adverse Event|0|||
124517805|NCT00131664|447847353|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
124517806|NCT00131664|447847354|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
124517807|NCT00131664|447847355|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
124517808|NCT00131664|447847356|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
124517809|NCT00131664|447847357|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
124517810|NCT00131664|447847358|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
124517811|NCT00131664|447847353|FG000|First Period (First 6 Months)|Administrative reasons|2|||
124517812|NCT00131664|447847354|FG001|First Period (First 6 Months)|Administrative reasons|0|||
124517813|NCT00131664|447847355|FG002|First Period (First 6 Months)|Administrative reasons|5|||
124517814|NCT00131664|447847356|FG003|First Period (First 6 Months)|Administrative reasons|0|||
124571965|NCT00150462|448053383|FG003|Overall Study|Physician Decision|1|||
124571966|NCT00150462|448053384|FG004|Overall Study|Physician Decision|0|||
124517815|NCT00131664|447847357|FG004|First Period (First 6 Months)|Administrative reasons|0|||
124517816|NCT00131664|447847358|FG005|First Period (First 6 Months)|Administrative reasons|0|||
124517817|NCT00131664|447847353|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
124517818|NCT00131664|447847354|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
124517819|NCT00131664|447847355|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
124517820|NCT00131664|447847356|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
124517821|NCT00131664|447847357|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
124517822|NCT00131664|447847358|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
124517823|NCT00131664|447847353|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
124517824|NCT00131664|447847354|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
124517825|NCT00131664|447847355|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
124517826|NCT00131664|447847356|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
124517827|NCT00131664|447847357|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
124517828|NCT00131664|447847358|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
124517829|NCT00131664|447847353|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
124517830|NCT00131664|447847354|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
124517831|NCT00131664|447847355|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
124517832|NCT00131664|447847356|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
124517833|NCT00131664|447847357|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
124517834|NCT00131664|447847358|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
124517835|NCT00131664|447847353|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
124517836|NCT00131664|447847354|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
124517837|NCT00131664|447847355|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
124517838|NCT00131664|447847356|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
124517839|NCT00131664|447847357|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
124517840|NCT00131664|447847358|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
124517841|NCT00131664|447847353|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
124517842|NCT00131664|447847354|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
124517843|NCT00131664|447847355|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
124517844|NCT00131664|447847356|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
124517845|NCT00131664|447847357|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
124517846|NCT00131664|447847358|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
124517847|NCT00131664|447847353|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
124517848|NCT00131664|447847354|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
124517849|NCT00131664|447847355|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
124517850|NCT00131664|447847356|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
124517851|NCT00131664|447847357|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
124517852|NCT00131664|447847358|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
124517853|NCT02088541|447849036|FG000|Overall Study|Adverse Event|3|||
124517854|NCT02088541|447849037|FG001|Overall Study|Adverse Event|0|||
124517855|NCT02088541|447849038|FG002|Overall Study|Adverse Event|3|||
124517856|NCT02088541|447849039|FG003|Overall Study|Adverse Event|3|||
124517857|NCT02088541|447849040|FG004|Overall Study|Adverse Event|0|||
124517858|NCT02088541|447849036|FG000|Overall Study|Death|51|||
124517859|NCT02088541|447849037|FG001|Overall Study|Death|21|||
124517860|NCT02088541|447849038|FG002|Overall Study|Death|85|||
124517861|NCT02088541|447849039|FG003|Overall Study|Death|28|||
124517862|NCT02088541|447849040|FG004|Overall Study|Death|38|||
124517863|NCT02088541|447849036|FG000|Overall Study|Lost to Follow-up|2|||
124517864|NCT02088541|447849037|FG001|Overall Study|Lost to Follow-up|0|||
124517865|NCT02088541|447849038|FG002|Overall Study|Lost to Follow-up|1|||
124517866|NCT02088541|447849039|FG003|Overall Study|Lost to Follow-up|0|||
124517867|NCT02088541|447849040|FG004|Overall Study|Lost to Follow-up|0|||
124517868|NCT02088541|447849036|FG000|Overall Study|Physician Decision|2|||
124517869|NCT02088541|447849037|FG001|Overall Study|Physician Decision|1|||
124517870|NCT02088541|447849038|FG002|Overall Study|Physician Decision|2|||
124517871|NCT02088541|447849039|FG003|Overall Study|Physician Decision|0|||
124517872|NCT02088541|447849040|FG004|Overall Study|Physician Decision|2|||
124517873|NCT02088541|447849036|FG000|Overall Study|Disease progression|7|||
124517874|NCT02088541|447849037|FG001|Overall Study|Disease progression|1|||
124517875|NCT02088541|447849038|FG002|Overall Study|Disease progression|2|||
124517876|NCT02088541|447849039|FG003|Overall Study|Disease progression|3|||
124517877|NCT02088541|447849040|FG004|Overall Study|Disease progression|1|||
124517878|NCT02088541|447849036|FG000|Overall Study|Study terminated by sponsor|1|||
124517879|NCT02088541|447849037|FG001|Overall Study|Study terminated by sponsor|1|||
124517880|NCT02088541|447849038|FG002|Overall Study|Study terminated by sponsor|12|||
124517881|NCT02088541|447849039|FG003|Overall Study|Study terminated by sponsor|2|||
124517882|NCT02088541|447849040|FG004|Overall Study|Study terminated by sponsor|6|||
124517883|NCT02088541|447849036|FG000|Overall Study|Withdrawal by Subject|3|||
124517884|NCT02088541|447849037|FG001|Overall Study|Withdrawal by Subject|2|||
124517885|NCT02088541|447849038|FG002|Overall Study|Withdrawal by Subject|9|||
124517886|NCT02088541|447849039|FG003|Overall Study|Withdrawal by Subject|7|||
124517887|NCT02088541|447849040|FG004|Overall Study|Withdrawal by Subject|10|||
124517888|NCT02088541|447849036|FG000|Overall Study|Other|2|||
124517889|NCT02088541|447849037|FG001|Overall Study|Other|1|||
124517890|NCT02088541|447849038|FG002|Overall Study|Other|3|||
124517891|NCT02088541|447849039|FG003|Overall Study|Other|1|||
124517892|NCT02088541|447849040|FG004|Overall Study|Other|1|||
124517893|NCT01105936|447849042|FG000|Period 1|Adverse Event|0|||
124517894|NCT01105936|447849043|FG001|Period 1|Adverse Event|0|||
124517895|NCT01105936|447849044|FG002|Period 1|Adverse Event|0|||
124517896|NCT01105936|447849045|FG003|Period 1|Adverse Event|1|||
124517897|NCT01105936|447849042|FG000|Period 2|Adverse Event|1|||
124517898|NCT01105936|447849043|FG001|Period 2|Adverse Event|0|||
124517899|NCT01105936|447849044|FG002|Period 2|Adverse Event|0|||
124517900|NCT01105936|447849045|FG003|Period 2|Adverse Event|0|||
124517901|NCT01105936|447849042|FG000|Period 3|Protocol Violation|0|||
124517902|NCT01105936|447849043|FG001|Period 3|Protocol Violation|2|||
124517903|NCT01105936|447849044|FG002|Period 3|Protocol Violation|0|||
124517904|NCT01105936|447849045|FG003|Period 3|Protocol Violation|0|||
124517905|NCT02431793|447849048|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
124517906|NCT02431793|447849049|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
124517907|NCT02431793|447849050|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
124517908|NCT02431793|447849048|FG000|Overall Study|Withdrawal by Subject|7|||
124517909|NCT02431793|447849049|FG001|Overall Study|Withdrawal by Subject|5|||
124517910|NCT02431793|447849050|FG002|Overall Study|Withdrawal by Subject|5|||
124517911|NCT02431793|447849048|FG000|Overall Study|Lost to Follow-up|101|||
124517912|NCT02431793|447849049|FG001|Overall Study|Lost to Follow-up|122|||
124517913|NCT02431793|447849050|FG002|Overall Study|Lost to Follow-up|104|||
124517914|NCT03170258|447849054|FG000|Overall Study|Physician Decision|4|||
124517915|NCT03170258|447849055|FG001|Overall Study|Physician Decision|0|||
124517916|NCT03170258|447849054|FG000|Overall Study|Equipment issues|1|||
124517917|NCT03170258|447849055|FG001|Overall Study|Equipment issues|0|||
124517918|NCT03170258|447849054|FG000|Overall Study|Medication|1|||
124517919|NCT03170258|447849055|FG001|Overall Study|Medication|0|||
124517920|NCT03170258|447849054|FG000|Overall Study|Sleep issues|1|||
124517921|NCT03170258|447849055|FG001|Overall Study|Sleep issues|0|||
124517922|NCT01563107|447849056|FG000|Overall Study|Physician Decision|0|||
124517923|NCT01563107|447849057|FG001|Overall Study|Physician Decision|1|||
124517924|NCT01563107|447849058|FG002|Overall Study|Physician Decision|1|||
124517925|NCT01563107|447849059|FG003|Overall Study|Physician Decision|3|||
124517926|NCT01563107|447849056|FG000|Overall Study|Withdrawal by Subject|1|||
124517927|NCT01563107|447849057|FG001|Overall Study|Withdrawal by Subject|2|||
124517928|NCT01563107|447849058|FG002|Overall Study|Withdrawal by Subject|1|||
124517929|NCT01563107|447849059|FG003|Overall Study|Withdrawal by Subject|2|||
124517930|NCT03907969|447849060|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
124517931|NCT03907969|447849061|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
124517932|NCT03907969|447849062|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
124517933|NCT03907969|447849063|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
124517934|NCT03907969|447849064|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
124517935|NCT03907969|447849065|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
124517936|NCT03907969|447849066|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
124517937|NCT03907969|447849067|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
124517938|NCT03907969|447849068|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
124517939|NCT03907969|447849069|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
124517940|NCT03907969|447849070|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
124517941|NCT03907969|447849060|FG000|Monotherapy Part A|Progressive Disease|0|||
124517942|NCT03907969|447849061|FG001|Monotherapy Part A|Progressive Disease|1|||
124517943|NCT03907969|447849062|FG002|Monotherapy Part A|Progressive Disease|0|||
124517944|NCT03907969|447849063|FG003|Monotherapy Part A|Progressive Disease|0|||
124517945|NCT03907969|447849064|FG004|Monotherapy Part A|Progressive Disease|0|||
124517946|NCT03907969|447849065|FG005|Monotherapy Part A|Progressive Disease|1|||
124517947|NCT03907969|447849066|FG006|Monotherapy Part A|Progressive Disease|2|||
124517948|NCT03907969|447849067|FG007|Monotherapy Part A|Progressive Disease|0|||
124517949|NCT03907969|447849068|FG008|Monotherapy Part A|Progressive Disease|0|||
124571967|NCT00150462|448053385|FG005|Overall Study|Physician Decision|0|||
124517950|NCT03907969|447849069|FG009|Monotherapy Part A|Progressive Disease|0|||
124517951|NCT03907969|447849070|FG010|Monotherapy Part A|Progressive Disease|0|||
124517952|NCT03907969|447849060|FG000|Monotherapy Part A|Death|0|||
124517953|NCT03907969|447849061|FG001|Monotherapy Part A|Death|0|||
124517954|NCT03907969|447849062|FG002|Monotherapy Part A|Death|1|||
124517955|NCT03907969|447849063|FG003|Monotherapy Part A|Death|1|||
124517956|NCT03907969|447849064|FG004|Monotherapy Part A|Death|0|||
124517957|NCT03907969|447849065|FG005|Monotherapy Part A|Death|1|||
124517958|NCT03907969|447849066|FG006|Monotherapy Part A|Death|0|||
124517959|NCT03907969|447849067|FG007|Monotherapy Part A|Death|0|||
124517960|NCT03907969|447849068|FG008|Monotherapy Part A|Death|0|||
124517961|NCT03907969|447849069|FG009|Monotherapy Part A|Death|0|||
124517962|NCT03907969|447849070|FG010|Monotherapy Part A|Death|0|||
124517963|NCT03907969|447849060|FG000|Combination Therapy Part A|Adverse Event|0|||
124517964|NCT03907969|447849061|FG001|Combination Therapy Part A|Adverse Event|0|||
124517965|NCT03907969|447849062|FG002|Combination Therapy Part A|Adverse Event|0|||
124517966|NCT03907969|447849063|FG003|Combination Therapy Part A|Adverse Event|0|||
124517967|NCT03907969|447849064|FG004|Combination Therapy Part A|Adverse Event|0|||
124517968|NCT03907969|447849065|FG005|Combination Therapy Part A|Adverse Event|0|||
124517969|NCT03907969|447849066|FG006|Combination Therapy Part A|Adverse Event|0|||
124517970|NCT03907969|447849067|FG007|Combination Therapy Part A|Adverse Event|0|||
124517971|NCT03907969|447849068|FG008|Combination Therapy Part A|Adverse Event|0|||
124517972|NCT03907969|447849069|FG009|Combination Therapy Part A|Adverse Event|1|||
124517973|NCT03907969|447849070|FG010|Combination Therapy Part A|Adverse Event|1|||
124517974|NCT03907969|447849060|FG000|Combination Therapy Part A|Progressive disease|0|||
124517975|NCT03907969|447849061|FG001|Combination Therapy Part A|Progressive disease|0|||
124517976|NCT03907969|447849062|FG002|Combination Therapy Part A|Progressive disease|0|||
124517977|NCT03907969|447849063|FG003|Combination Therapy Part A|Progressive disease|0|||
124517978|NCT03907969|447849064|FG004|Combination Therapy Part A|Progressive disease|0|||
124517979|NCT03907969|447849065|FG005|Combination Therapy Part A|Progressive disease|0|||
124517980|NCT03907969|447849066|FG006|Combination Therapy Part A|Progressive disease|0|||
124517981|NCT03907969|447849067|FG007|Combination Therapy Part A|Progressive disease|1|||
124517982|NCT03907969|447849068|FG008|Combination Therapy Part A|Progressive disease|0|||
124517983|NCT03907969|447849069|FG009|Combination Therapy Part A|Progressive disease|2|||
124517984|NCT03907969|447849070|FG010|Combination Therapy Part A|Progressive disease|3|||
124517985|NCT03907969|447849060|FG000|Combination Therapy Part A|Death|0|||
124517986|NCT03907969|447849061|FG001|Combination Therapy Part A|Death|0|||
124517987|NCT03907969|447849062|FG002|Combination Therapy Part A|Death|0|||
124517988|NCT03907969|447849063|FG003|Combination Therapy Part A|Death|0|||
124517989|NCT03907969|447849064|FG004|Combination Therapy Part A|Death|0|||
124517990|NCT03907969|447849065|FG005|Combination Therapy Part A|Death|0|||
124517991|NCT03907969|447849066|FG006|Combination Therapy Part A|Death|0|||
124517992|NCT03907969|447849067|FG007|Combination Therapy Part A|Death|0|||
124517993|NCT03907969|447849068|FG008|Combination Therapy Part A|Death|1|||
124517994|NCT03907969|447849069|FG009|Combination Therapy Part A|Death|0|||
124517995|NCT03907969|447849070|FG010|Combination Therapy Part A|Death|1|||
124517996|NCT03907969|447849060|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
124517997|NCT03907969|447849061|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
124517998|NCT03907969|447849062|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
124517999|NCT03907969|447849063|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
124518000|NCT03907969|447849064|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
124518001|NCT03907969|447849065|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
124518002|NCT03907969|447849066|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
124518003|NCT03907969|447849067|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
124518004|NCT03907969|447849068|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
124518005|NCT03907969|447849069|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
124518006|NCT03907969|447849070|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
124518007|NCT03907969|447849060|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
124518008|NCT03907969|447849061|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
124518009|NCT03907969|447849062|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
124518010|NCT03907969|447849063|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
124518011|NCT03907969|447849064|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
124518012|NCT03907969|447849065|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
124518013|NCT03907969|447849066|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
124518014|NCT03907969|447849067|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
124518015|NCT03907969|447849068|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
124518016|NCT03907969|447849069|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
124518017|NCT03907969|447849070|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
124518018|NCT03907969|447849060|FG000|Combination Therapy Part A|Physician Decision|0|||
124518019|NCT03907969|447849061|FG001|Combination Therapy Part A|Physician Decision|0|||
124518020|NCT03907969|447849062|FG002|Combination Therapy Part A|Physician Decision|0|||
124518021|NCT03907969|447849063|FG003|Combination Therapy Part A|Physician Decision|0|||
124518022|NCT03907969|447849064|FG004|Combination Therapy Part A|Physician Decision|0|||
124518023|NCT03907969|447849065|FG005|Combination Therapy Part A|Physician Decision|0|||
124518024|NCT03907969|447849066|FG006|Combination Therapy Part A|Physician Decision|0|||
124518025|NCT03907969|447849067|FG007|Combination Therapy Part A|Physician Decision|1|||
124518026|NCT03907969|447849068|FG008|Combination Therapy Part A|Physician Decision|0|||
124518027|NCT03907969|447849069|FG009|Combination Therapy Part A|Physician Decision|0|||
124518028|NCT03907969|447849070|FG010|Combination Therapy Part A|Physician Decision|1|||
124518029|NCT00666536|447849071|FG000|Overall Study|Adverse Event|9|||
124518030|NCT00666536|447849072|FG001|Overall Study|Adverse Event|19|||
124518031|NCT00666536|447849071|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124518032|NCT00666536|447849072|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124518033|NCT00666536|447849071|FG000|Overall Study|Protocol deviation(s)|8|||
124518034|NCT00666536|447849072|FG001|Overall Study|Protocol deviation(s)|6|||
124518035|NCT00666536|447849071|FG000|Overall Study|Withdrawal by Subject|10|||
124518036|NCT00666536|447849072|FG001|Overall Study|Withdrawal by Subject|9|||
124518037|NCT00666536|447849071|FG000|Overall Study|Lost to Follow-up|4|||
124518038|NCT00666536|447849072|FG001|Overall Study|Lost to Follow-up|3|||
124518039|NCT02657434|447849075|FG000|Overall Study|Study Terminated By Sponsor|64|||
124518040|NCT02657434|447849076|FG001|Overall Study|Study Terminated By Sponsor|82|||
124518041|NCT02657434|447849075|FG000|Overall Study|Death|189|||
124518042|NCT02657434|447849076|FG001|Overall Study|Death|190|||
124518043|NCT02657434|447849075|FG000|Overall Study|Lost to Follow-up|2|||
124518044|NCT02657434|447849076|FG001|Overall Study|Lost to Follow-up|2|||
124518045|NCT02657434|447849075|FG000|Overall Study|Randomization by Error|2|||
124518046|NCT02657434|447849076|FG001|Overall Study|Randomization by Error|0|||
124518047|NCT02657434|447849075|FG000|Overall Study|Withdrawal by Subject|28|||
124518048|NCT02657434|447849076|FG001|Overall Study|Withdrawal by Subject|17|||
124518049|NCT02657434|447849075|FG000|Overall Study|Protocol Violation|1|||
124518050|NCT02657434|447849076|FG001|Overall Study|Protocol Violation|0|||
124518051|NCT02657434|447849075|FG000|Overall Study|Physician Decision|0|||
124518052|NCT02657434|447849076|FG001|Overall Study|Physician Decision|1|||
124518053|NCT00608881|447849077|FG000|Overall Study|Death|22|||
124518054|NCT00608881|447849078|FG001|Overall Study|Death|13|||
124518055|NCT00608881|447849077|FG000|Overall Study|Adverse Event|5|||
124518056|NCT00608881|447849078|FG001|Overall Study|Adverse Event|3|||
124518057|NCT00608881|447849077|FG000|Overall Study|Lost to Follow-up|28|||
124518058|NCT00608881|447849078|FG001|Overall Study|Lost to Follow-up|14|||
124518059|NCT00608881|447849077|FG000|Overall Study|Withdrawal by Subject|18|||
124518060|NCT00608881|447849078|FG001|Overall Study|Withdrawal by Subject|29|||
124518061|NCT00608881|447849077|FG000|Overall Study|Physician Decision|5|||
124518062|NCT00608881|447849078|FG001|Overall Study|Physician Decision|5|||
124518063|NCT00608881|447849077|FG000|Overall Study|Institutionalized|1|||
124518064|NCT00608881|447849078|FG001|Overall Study|Institutionalized|2|||
124518065|NCT01392742|447849081|FG000|Overall Study|Premature study termination|42|||
124518066|NCT01392742|447849081|FG000|Overall Study|Failure to return|35|||
124518067|NCT01392742|447849081|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
124518068|NCT01392742|447849081|FG000|Overall Study|Lost to Follow-up|34|||
124518069|NCT01392742|447849081|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
124518070|NCT01392742|447849081|FG000|Overall Study|ITR and Protocol deviation|1|||
124518071|NCT01392742|447849081|FG000|Overall Study|Adverse event/intercurrent illness|17|||
124518072|NCT01392742|447849081|FG000|Overall Study|Protocol Violation|14|||
124518073|NCT01392742|447849081|FG000|Overall Study|Other|3|||
124518074|NCT01392742|447849081|FG000|Overall Study|Missing information|13|||
124518075|NCT01998958|447849082|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518076|NCT01998958|447849083|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
124518077|NCT01998958|447849084|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518078|NCT01998958|447849085|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518079|NCT01998958|447849086|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518080|NCT01998958|447849087|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518081|NCT01998958|447849088|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518082|NCT01998958|447849089|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518083|NCT01998958|447849090|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518084|NCT01998958|447849091|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518085|NCT01998958|447849092|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518086|NCT01998958|447849093|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518087|NCT01998958|447849094|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518088|NCT01998958|447849095|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518089|NCT01998958|447849096|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518090|NCT01998958|447849097|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518091|NCT01998958|447849098|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518092|NCT01998958|447849099|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518093|NCT01998958|447849100|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518094|NCT01998958|447849101|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518095|NCT01998958|447849102|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518096|NCT01998958|447849103|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518097|NCT01998958|447849104|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518098|NCT01998958|447849105|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518099|NCT01998958|447849106|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518100|NCT01998958|447849107|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518101|NCT01998958|447849108|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518102|NCT01998958|447849109|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518103|NCT01998958|447849110|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518104|NCT01998958|447849111|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518105|NCT01998958|447849112|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124571968|NCT00150462|448053386|FG006|Overall Study|Physician Decision|0|||
124518106|NCT01998958|447849113|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
124518107|NCT01998958|447849082|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518108|NCT01998958|447849083|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
124518109|NCT01998958|447849084|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124724992|NCT02151903|448613399|FG000|Overall Study|Withdrawal by Subject|1|||
124724993|NCT02151903|448613400|FG001|Overall Study|Withdrawal by Subject|0|||
124724994|NCT02151903|448613399|FG000|Overall Study|Progressive disease|2|||
124724995|NCT02151903|448613400|FG001|Overall Study|Progressive disease|1|||
124724996|NCT05319600|448613403|FG000|Overall Study|Withdrawal by Subject|1|||
124724997|NCT05319600|448613404|FG001|Overall Study|Withdrawal by Subject|0|||
124518110|NCT01998958|447849085|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518111|NCT01998958|447849086|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518112|NCT01998958|447849087|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518113|NCT01998958|447849088|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518114|NCT01998958|447849089|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518115|NCT01998958|447849090|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518116|NCT01998958|447849091|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518117|NCT01998958|447849092|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518118|NCT01998958|447849093|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518119|NCT01998958|447849094|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518120|NCT01998958|447849095|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518121|NCT01998958|447849096|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518122|NCT01998958|447849097|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518123|NCT01998958|447849098|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518124|NCT01998958|447849099|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518125|NCT01998958|447849100|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518126|NCT01998958|447849101|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518127|NCT01998958|447849102|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518128|NCT01998958|447849103|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518129|NCT01998958|447849104|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518130|NCT01998958|447849105|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518131|NCT01998958|447849106|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518132|NCT01998958|447849107|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518133|NCT01998958|447849108|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518134|NCT01998958|447849109|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518135|NCT01998958|447849110|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518136|NCT01998958|447849111|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518137|NCT01998958|447849112|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518138|NCT01998958|447849113|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
124518139|NCT01998958|447849082|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
124518140|NCT01998958|447849083|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
124518141|NCT01998958|447849084|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
124518142|NCT01998958|447849085|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
124518143|NCT01998958|447849086|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
124518144|NCT01998958|447849087|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
124518145|NCT01998958|447849088|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
124518146|NCT01998958|447849089|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
124518147|NCT01998958|447849090|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
124518148|NCT01998958|447849091|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
124518149|NCT01998958|447849092|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
124518150|NCT01998958|447849093|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
124518151|NCT01998958|447849094|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
124518152|NCT01998958|447849095|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
124518153|NCT01998958|447849096|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
124518154|NCT01998958|447849097|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
124518155|NCT01998958|447849098|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
124518156|NCT01998958|447849099|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
124724998|NCT05319600|448613403|FG000|Overall Study|Lost to Follow-up|0|||
124518157|NCT01998958|447849100|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
124518158|NCT01998958|447849101|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
124518159|NCT01998958|447849102|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
124724999|NCT05319600|448613404|FG001|Overall Study|Lost to Follow-up|4|||
124518160|NCT01998958|447849103|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
124725000|NCT03768089|448613408|FG000|Part A|Lost to Follow-up|0|||
124518161|NCT01998958|447849104|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
124518162|NCT01998958|447849105|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
124518163|NCT01998958|447849106|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
124518164|NCT01998958|447849107|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
124518165|NCT01998958|447849108|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
124518166|NCT01998958|447849109|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
124518167|NCT01998958|447849110|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
124518168|NCT01998958|447849111|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
124518169|NCT01998958|447849112|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
124518170|NCT01998958|447849113|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
124518171|NCT01998958|447849082|FG000|Period 1 (Panel A and B)|Other|1|||
124518172|NCT01998958|447849083|FG001|Period 1 (Panel A and B)|Other|0|||
124518173|NCT01998958|447849084|FG002|Period 1 (Panel A and B)|Other|0|||
124725001|NCT03768089|448613409|FG001|Part A|Lost to Follow-up|0|||
124725002|NCT03768089|448613410|FG002|Part A|Lost to Follow-up|0|||
124518174|NCT01998958|447849085|FG003|Period 1 (Panel A and B)|Other|0|||
124518175|NCT01998958|447849086|FG004|Period 1 (Panel A and B)|Other|0|||
124518176|NCT01998958|447849087|FG005|Period 1 (Panel A and B)|Other|0|||
124518177|NCT01998958|447849088|FG006|Period 1 (Panel A and B)|Other|0|||
124518178|NCT01998958|447849089|FG007|Period 1 (Panel A and B)|Other|0|||
124518179|NCT01998958|447849090|FG008|Period 1 (Panel A and B)|Other|0|||
124518180|NCT01998958|447849091|FG009|Period 1 (Panel A and B)|Other|0|||
124518181|NCT01998958|447849092|FG010|Period 1 (Panel A and B)|Other|0|||
124518182|NCT01998958|447849093|FG011|Period 1 (Panel A and B)|Other|0|||
124518183|NCT01998958|447849094|FG012|Period 1 (Panel A and B)|Other|0|||
124518184|NCT01998958|447849095|FG013|Period 1 (Panel A and B)|Other|0|||
124518185|NCT01998958|447849096|FG014|Period 1 (Panel A and B)|Other|0|||
124518186|NCT01998958|447849097|FG015|Period 1 (Panel A and B)|Other|0|||
124518187|NCT01998958|447849098|FG016|Period 1 (Panel A and B)|Other|0|||
124518188|NCT01998958|447849099|FG017|Period 1 (Panel A and B)|Other|0|||
124518189|NCT01998958|447849100|FG018|Period 1 (Panel A and B)|Other|0|||
124518190|NCT01998958|447849101|FG019|Period 1 (Panel A and B)|Other|0|||
124518191|NCT01998958|447849102|FG020|Period 1 (Panel A and B)|Other|0|||
124518192|NCT01998958|447849103|FG021|Period 1 (Panel A and B)|Other|0|||
124518193|NCT01998958|447849104|FG022|Period 1 (Panel A and B)|Other|0|||
124518194|NCT01998958|447849105|FG023|Period 1 (Panel A and B)|Other|0|||
124518195|NCT01998958|447849106|FG024|Period 1 (Panel A and B)|Other|0|||
124518196|NCT01998958|447849107|FG025|Period 1 (Panel A and B)|Other|0|||
124518197|NCT01998958|447849108|FG026|Period 1 (Panel A and B)|Other|0|||
124518198|NCT01998958|447849109|FG027|Period 1 (Panel A and B)|Other|0|||
124518199|NCT01998958|447849110|FG028|Period 1 (Panel A and B)|Other|0|||
124518200|NCT01998958|447849111|FG029|Period 1 (Panel A and B)|Other|0|||
124518201|NCT01998958|447849112|FG030|Period 1 (Panel A and B)|Other|0|||
124518202|NCT01998958|447849113|FG031|Period 1 (Panel A and B)|Other|0|||
124518203|NCT01998958|447849082|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
124518204|NCT01998958|447849083|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
124518205|NCT01998958|447849084|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
124518206|NCT01998958|447849085|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
124518207|NCT01998958|447849086|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
124518208|NCT01998958|447849087|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
124518209|NCT01998958|447849088|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
124518210|NCT01998958|447849089|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
124518211|NCT01998958|447849090|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
124518212|NCT01998958|447849091|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
124518213|NCT01998958|447849092|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
124518214|NCT01998958|447849093|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
124518215|NCT01998958|447849094|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
124518216|NCT01998958|447849095|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
124518217|NCT01998958|447849096|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
124518218|NCT01998958|447849097|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
124518219|NCT01998958|447849098|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
124518220|NCT01998958|447849099|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
124518221|NCT01998958|447849100|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
124518222|NCT01998958|447849101|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
124518223|NCT01998958|447849102|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
124518224|NCT01998958|447849103|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
124518225|NCT01998958|447849104|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
124518226|NCT01998958|447849105|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
124518227|NCT01998958|447849106|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
124518228|NCT01998958|447849107|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
124518229|NCT01998958|447849108|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
124518230|NCT01998958|447849109|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
124518231|NCT01998958|447849110|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
124518232|NCT01998958|447849111|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
124518233|NCT01998958|447849112|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
124518234|NCT01998958|447849113|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
124518235|NCT01998958|447849082|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518236|NCT01998958|447849083|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518237|NCT01998958|447849084|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518238|NCT01998958|447849085|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518239|NCT01998958|447849086|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518240|NCT01998958|447849087|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518241|NCT01998958|447849088|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518242|NCT01998958|447849089|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518243|NCT01998958|447849090|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518244|NCT01998958|447849091|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518245|NCT01998958|447849092|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518246|NCT01998958|447849093|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518247|NCT01998958|447849094|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518248|NCT01998958|447849095|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518249|NCT01998958|447849096|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
124725003|NCT03768089|448613411|FG003|Part A|Lost to Follow-up|0|||
124725004|NCT03768089|448613412|FG004|Part A|Lost to Follow-up|1|||
124725005|NCT03768089|448613413|FG005|Part A|Lost to Follow-up|0|||
124725006|NCT03768089|448613414|FG006|Part A|Lost to Follow-up|0|||
124518250|NCT01998958|447849097|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518251|NCT01998958|447849098|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518252|NCT01998958|447849099|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518253|NCT01998958|447849100|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
124518254|NCT01998958|447849101|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518255|NCT01998958|447849102|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518256|NCT01998958|447849103|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518257|NCT01998958|447849104|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518258|NCT01998958|447849105|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518259|NCT01998958|447849106|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518260|NCT01998958|447849107|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518261|NCT01998958|447849108|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518262|NCT01998958|447849109|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518263|NCT01998958|447849110|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518264|NCT01998958|447849111|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518265|NCT01998958|447849112|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518266|NCT01998958|447849113|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
124518267|NCT01998958|447849082|FG000|Open Label Phase (Optional)|Adverse Event|0|||
124518268|NCT01998958|447849083|FG001|Open Label Phase (Optional)|Adverse Event|0|||
124518269|NCT01998958|447849084|FG002|Open Label Phase (Optional)|Adverse Event|0|||
124518270|NCT01998958|447849085|FG003|Open Label Phase (Optional)|Adverse Event|0|||
124518271|NCT01998958|447849086|FG004|Open Label Phase (Optional)|Adverse Event|0|||
124518272|NCT01998958|447849087|FG005|Open Label Phase (Optional)|Adverse Event|0|||
124518273|NCT01998958|447849088|FG006|Open Label Phase (Optional)|Adverse Event|0|||
124518274|NCT01998958|447849089|FG007|Open Label Phase (Optional)|Adverse Event|0|||
124518275|NCT01998958|447849090|FG008|Open Label Phase (Optional)|Adverse Event|0|||
124518276|NCT01998958|447849091|FG009|Open Label Phase (Optional)|Adverse Event|0|||
124518277|NCT01998958|447849092|FG010|Open Label Phase (Optional)|Adverse Event|0|||
124518278|NCT01998958|447849093|FG011|Open Label Phase (Optional)|Adverse Event|0|||
124518279|NCT01998958|447849094|FG012|Open Label Phase (Optional)|Adverse Event|0|||
124518280|NCT01998958|447849095|FG013|Open Label Phase (Optional)|Adverse Event|0|||
124518281|NCT01998958|447849096|FG014|Open Label Phase (Optional)|Adverse Event|0|||
124518282|NCT01998958|447849097|FG015|Open Label Phase (Optional)|Adverse Event|0|||
124518283|NCT01998958|447849098|FG016|Open Label Phase (Optional)|Adverse Event|0|||
124518284|NCT01998958|447849099|FG017|Open Label Phase (Optional)|Adverse Event|0|||
124518285|NCT01998958|447849100|FG018|Open Label Phase (Optional)|Adverse Event|0|||
124518286|NCT01998958|447849101|FG019|Open Label Phase (Optional)|Adverse Event|0|||
124518287|NCT01998958|447849102|FG020|Open Label Phase (Optional)|Adverse Event|0|||
124518288|NCT01998958|447849103|FG021|Open Label Phase (Optional)|Adverse Event|0|||
124518289|NCT01998958|447849104|FG022|Open Label Phase (Optional)|Adverse Event|0|||
124518290|NCT01998958|447849105|FG023|Open Label Phase (Optional)|Adverse Event|1|||
124518291|NCT01998958|447849106|FG024|Open Label Phase (Optional)|Adverse Event|0|||
124518292|NCT01998958|447849107|FG025|Open Label Phase (Optional)|Adverse Event|0|||
124518293|NCT01998958|447849108|FG026|Open Label Phase (Optional)|Adverse Event|0|||
124518294|NCT01998958|447849109|FG027|Open Label Phase (Optional)|Adverse Event|0|||
124518295|NCT01998958|447849110|FG028|Open Label Phase (Optional)|Adverse Event|0|||
124518296|NCT01998958|447849111|FG029|Open Label Phase (Optional)|Adverse Event|0|||
124518297|NCT01998958|447849112|FG030|Open Label Phase (Optional)|Adverse Event|0|||
124518298|NCT01998958|447849113|FG031|Open Label Phase (Optional)|Adverse Event|0|||
124518299|NCT01998958|447849082|FG000|Open Label Phase (Optional)|Other|0|||
124518300|NCT01998958|447849083|FG001|Open Label Phase (Optional)|Other|0|||
124518301|NCT01998958|447849084|FG002|Open Label Phase (Optional)|Other|0|||
124518302|NCT01998958|447849085|FG003|Open Label Phase (Optional)|Other|0|||
124518303|NCT01998958|447849086|FG004|Open Label Phase (Optional)|Other|0|||
124518304|NCT01998958|447849087|FG005|Open Label Phase (Optional)|Other|0|||
124518305|NCT01998958|447849088|FG006|Open Label Phase (Optional)|Other|0|||
124518306|NCT01998958|447849089|FG007|Open Label Phase (Optional)|Other|0|||
124518307|NCT01998958|447849090|FG008|Open Label Phase (Optional)|Other|0|||
124518308|NCT01998958|447849091|FG009|Open Label Phase (Optional)|Other|0|||
124518309|NCT01998958|447849092|FG010|Open Label Phase (Optional)|Other|0|||
124518310|NCT01998958|447849093|FG011|Open Label Phase (Optional)|Other|0|||
124518311|NCT01998958|447849094|FG012|Open Label Phase (Optional)|Other|0|||
124518312|NCT01998958|447849095|FG013|Open Label Phase (Optional)|Other|0|||
124518313|NCT01998958|447849096|FG014|Open Label Phase (Optional)|Other|0|||
124518314|NCT01998958|447849097|FG015|Open Label Phase (Optional)|Other|0|||
124518315|NCT01998958|447849098|FG016|Open Label Phase (Optional)|Other|0|||
124518316|NCT01998958|447849099|FG017|Open Label Phase (Optional)|Other|0|||
124518317|NCT01998958|447849100|FG018|Open Label Phase (Optional)|Other|0|||
124518318|NCT01998958|447849101|FG019|Open Label Phase (Optional)|Other|0|||
124518319|NCT01998958|447849102|FG020|Open Label Phase (Optional)|Other|0|||
124518320|NCT01998958|447849103|FG021|Open Label Phase (Optional)|Other|0|||
124725007|NCT03768089|448613415|FG007|Part A|Lost to Follow-up|0|||
124518321|NCT01998958|447849104|FG022|Open Label Phase (Optional)|Other|5|||
124518322|NCT01998958|447849105|FG023|Open Label Phase (Optional)|Other|1|||
124518323|NCT01998958|447849106|FG024|Open Label Phase (Optional)|Other|0|||
124518324|NCT01998958|447849107|FG025|Open Label Phase (Optional)|Other|0|||
124518325|NCT01998958|447849108|FG026|Open Label Phase (Optional)|Other|0|||
124518326|NCT01998958|447849109|FG027|Open Label Phase (Optional)|Other|0|||
124518327|NCT01998958|447849110|FG028|Open Label Phase (Optional)|Other|0|||
124518328|NCT01998958|447849111|FG029|Open Label Phase (Optional)|Other|0|||
124518329|NCT01998958|447849112|FG030|Open Label Phase (Optional)|Other|0|||
124518330|NCT01998958|447849113|FG031|Open Label Phase (Optional)|Other|0|||
124518331|NCT01998958|447849082|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518332|NCT01998958|447849083|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518333|NCT01998958|447849084|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518334|NCT01998958|447849085|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518335|NCT01998958|447849086|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518336|NCT01998958|447849087|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518337|NCT01998958|447849088|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518338|NCT01998958|447849089|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518339|NCT01998958|447849090|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518340|NCT01998958|447849091|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518341|NCT01998958|447849092|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518342|NCT01998958|447849093|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518343|NCT01998958|447849094|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518344|NCT01998958|447849095|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518345|NCT01998958|447849096|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518346|NCT01998958|447849097|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518347|NCT01998958|447849098|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518348|NCT01998958|447849099|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518349|NCT01998958|447849100|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518350|NCT01998958|447849101|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518351|NCT01998958|447849102|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518352|NCT01998958|447849103|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518353|NCT01998958|447849104|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
124518354|NCT01998958|447849105|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518355|NCT01998958|447849106|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518356|NCT01998958|447849107|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518357|NCT01998958|447849108|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518358|NCT01998958|447849109|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518359|NCT01998958|447849110|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518360|NCT01998958|447849111|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518361|NCT01998958|447849112|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518362|NCT01998958|447849113|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
124518363|NCT01998958|447849082|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518364|NCT01998958|447849083|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518365|NCT01998958|447849084|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518366|NCT01998958|447849085|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518367|NCT01998958|447849086|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518368|NCT01998958|447849087|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518369|NCT01998958|447849088|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518370|NCT01998958|447849089|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518371|NCT01998958|447849090|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518372|NCT01998958|447849091|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518373|NCT01998958|447849092|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518374|NCT01998958|447849093|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518375|NCT01998958|447849094|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518376|NCT01998958|447849095|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518377|NCT01998958|447849096|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518378|NCT01998958|447849097|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518379|NCT01998958|447849098|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518380|NCT01998958|447849099|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518381|NCT01998958|447849100|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518382|NCT01998958|447849101|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518383|NCT01998958|447849102|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518384|NCT01998958|447849103|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
124518385|NCT01998958|447849104|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
124518386|NCT01998958|447849105|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518387|NCT01998958|447849106|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518388|NCT01998958|447849107|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518389|NCT01998958|447849108|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518390|NCT01998958|447849109|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518391|NCT01998958|447849110|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518392|NCT01998958|447849111|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518393|NCT01998958|447849112|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518394|NCT01998958|447849113|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
124518395|NCT01998958|447849082|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518396|NCT01998958|447849083|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518397|NCT01998958|447849084|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518398|NCT01998958|447849085|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518399|NCT01998958|447849086|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518400|NCT01998958|447849087|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518401|NCT01998958|447849088|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518402|NCT01998958|447849089|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518403|NCT01998958|447849090|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518404|NCT01998958|447849091|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518405|NCT01998958|447849092|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518406|NCT01998958|447849093|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518407|NCT01998958|447849094|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518408|NCT01998958|447849095|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518409|NCT01998958|447849096|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518410|NCT01998958|447849097|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518411|NCT01998958|447849098|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518412|NCT01998958|447849099|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518413|NCT01998958|447849100|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518414|NCT01998958|447849101|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518415|NCT01998958|447849102|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518416|NCT01998958|447849103|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
124518417|NCT01998958|447849104|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
124518418|NCT01998958|447849105|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
124518419|NCT01998958|447849106|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518420|NCT01998958|447849107|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518421|NCT01998958|447849108|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518422|NCT01998958|447849109|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518423|NCT01998958|447849110|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518424|NCT01998958|447849111|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518425|NCT01998958|447849112|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518426|NCT01998958|447849113|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
124518427|NCT03210220|447849114|FG000|Overall Study|Physician Decision|1|||
124518428|NCT03210220|447849115|FG001|Overall Study|Physician Decision|0|||
124518429|NCT02911519|447849116|FG000|Overall Study|Lost to Follow-up|2|||
124518430|NCT02911519|447849117|FG001|Overall Study|Lost to Follow-up|2|||
124518431|NCT02911519|447849116|FG000|Overall Study|Death|0|||
124518432|NCT02911519|447849117|FG001|Overall Study|Death|2|||
124518433|NCT00839436|447849120|FG000|Overall Study|Developed exclusionary condition|1|||
124518434|NCT00839436|447849121|FG001|Overall Study|Developed exclusionary condition|0|||
124518435|NCT00839436|447849122|FG002|Overall Study|Developed exclusionary condition|0|||
124518436|NCT00839436|447849120|FG000|Overall Study|Withdrawal by Subject|0|||
124518437|NCT00839436|447849121|FG001|Overall Study|Withdrawal by Subject|1|||
124518438|NCT00839436|447849122|FG002|Overall Study|Withdrawal by Subject|0|||
124518439|NCT00839436|447849120|FG000|Overall Study|Study drug no longer available|0|||
124518440|NCT00839436|447849121|FG001|Overall Study|Study drug no longer available|0|||
124518441|NCT00839436|447849122|FG002|Overall Study|Study drug no longer available|1|||
124518442|NCT01444898|447849124|FG000|Overall Study|Withdrawal by Subject|1|||
124518443|NCT02580591|447849126|FG000|Overall Study|Adverse Event|0|||
124518444|NCT02580591|447849127|FG001|Overall Study|Adverse Event|1|||
124518445|NCT02580591|447849128|FG002|Overall Study|Adverse Event|2|||
124518446|NCT02580591|447849129|FG003|Overall Study|Adverse Event|5|||
124518447|NCT02580591|447849126|FG000|Overall Study|Protocol Violation|3|||
124518448|NCT02580591|447849127|FG001|Overall Study|Protocol Violation|2|||
124518449|NCT02580591|447849128|FG002|Overall Study|Protocol Violation|1|||
124518450|NCT02580591|447849129|FG003|Overall Study|Protocol Violation|1|||
124518451|NCT02580591|447849126|FG000|Overall Study|Lost to Follow-up|5|||
124518452|NCT02580591|447849127|FG001|Overall Study|Lost to Follow-up|3|||
124518453|NCT02580591|447849128|FG002|Overall Study|Lost to Follow-up|3|||
124518454|NCT02580591|447849129|FG003|Overall Study|Lost to Follow-up|1|||
124518455|NCT02580591|447849126|FG000|Overall Study|Withdrawal by Subject|6|||
124518456|NCT02580591|447849127|FG001|Overall Study|Withdrawal by Subject|1|||
124518457|NCT02580591|447849128|FG002|Overall Study|Withdrawal by Subject|2|||
124725008|NCT03768089|448613416|FG008|Part A|Lost to Follow-up|0|||
124518458|NCT02580591|447849129|FG003|Overall Study|Withdrawal by Subject|3|||
124518459|NCT02580591|447849126|FG000|Overall Study|Not treated|1|||
124518460|NCT02580591|447849127|FG001|Overall Study|Not treated|1|||
124518461|NCT02580591|447849128|FG002|Overall Study|Not treated|0|||
124518462|NCT02580591|447849129|FG003|Overall Study|Not treated|0|||
124518463|NCT02580591|447849126|FG000|Overall Study|Other than specified|3|||
124518464|NCT02580591|447849127|FG001|Overall Study|Other than specified|2|||
124518465|NCT02580591|447849128|FG002|Overall Study|Other than specified|5|||
124518466|NCT02580591|447849129|FG003|Overall Study|Other than specified|2|||
124518467|NCT00445341|447849133|FG000|Overall Study|refused further treatment|1|||
124518468|NCT00445341|447849133|FG000|Overall Study|taken off treatment too early|1|||
124518469|NCT01831804|447849140|FG000|Overall Study|Adverse Event|0|||
124518470|NCT01831804|447849141|FG001|Overall Study|Adverse Event|0|||
124518471|NCT01831804|447849142|FG002|Overall Study|Adverse Event|0|||
124518472|NCT01831804|447849143|FG003|Overall Study|Adverse Event|0|||
124518473|NCT01831804|447849144|FG004|Overall Study|Adverse Event|0|||
124518474|NCT01831804|447849145|FG005|Overall Study|Adverse Event|0|||
124518475|NCT01831804|447849146|FG006|Overall Study|Adverse Event|1|||
124518476|NCT01831804|447849147|FG007|Overall Study|Adverse Event|0|||
124518477|NCT01831804|447849148|FG008|Overall Study|Adverse Event|1|||
124518478|NCT01831804|447849140|FG000|Overall Study|Protocol Violation|0|||
124518479|NCT01831804|447849141|FG001|Overall Study|Protocol Violation|0|||
124518480|NCT01831804|447849142|FG002|Overall Study|Protocol Violation|2|||
124518481|NCT01831804|447849143|FG003|Overall Study|Protocol Violation|0|||
124518482|NCT01831804|447849144|FG004|Overall Study|Protocol Violation|0|||
124518483|NCT01831804|447849145|FG005|Overall Study|Protocol Violation|0|||
124518484|NCT01831804|447849146|FG006|Overall Study|Protocol Violation|0|||
124518485|NCT01831804|447849147|FG007|Overall Study|Protocol Violation|0|||
124518486|NCT01831804|447849148|FG008|Overall Study|Protocol Violation|0|||
124518487|NCT01831804|447849140|FG000|Overall Study|Protocol defined stopping criteria|1|||
124518488|NCT01831804|447849141|FG001|Overall Study|Protocol defined stopping criteria|1|||
124518489|NCT01831804|447849142|FG002|Overall Study|Protocol defined stopping criteria|3|||
124518490|NCT01831804|447849143|FG003|Overall Study|Protocol defined stopping criteria|0|||
124518491|NCT01831804|447849144|FG004|Overall Study|Protocol defined stopping criteria|1|||
124518492|NCT01831804|447849145|FG005|Overall Study|Protocol defined stopping criteria|0|||
124518493|NCT01831804|447849146|FG006|Overall Study|Protocol defined stopping criteria|0|||
124518494|NCT01831804|447849147|FG007|Overall Study|Protocol defined stopping criteria|0|||
124518495|NCT01831804|447849148|FG008|Overall Study|Protocol defined stopping criteria|0|||
124518496|NCT01831804|447849140|FG000|Overall Study|Lost to Follow-up|0|||
124518497|NCT01831804|447849141|FG001|Overall Study|Lost to Follow-up|0|||
124518498|NCT01831804|447849142|FG002|Overall Study|Lost to Follow-up|1|||
124518499|NCT01831804|447849143|FG003|Overall Study|Lost to Follow-up|0|||
124518500|NCT01831804|447849144|FG004|Overall Study|Lost to Follow-up|0|||
124518501|NCT01831804|447849145|FG005|Overall Study|Lost to Follow-up|0|||
124518502|NCT01831804|447849146|FG006|Overall Study|Lost to Follow-up|0|||
124518503|NCT01831804|447849147|FG007|Overall Study|Lost to Follow-up|0|||
124518504|NCT01831804|447849148|FG008|Overall Study|Lost to Follow-up|1|||
124518505|NCT01831804|447849140|FG000|Overall Study|Investigator discretion|0|||
124518506|NCT01831804|447849141|FG001|Overall Study|Investigator discretion|0|||
124518507|NCT01831804|447849142|FG002|Overall Study|Investigator discretion|0|||
124518508|NCT01831804|447849143|FG003|Overall Study|Investigator discretion|0|||
124518509|NCT01831804|447849144|FG004|Overall Study|Investigator discretion|1|||
124518510|NCT01831804|447849145|FG005|Overall Study|Investigator discretion|0|||
124518511|NCT01831804|447849146|FG006|Overall Study|Investigator discretion|0|||
124518512|NCT01831804|447849147|FG007|Overall Study|Investigator discretion|1|||
124518513|NCT01831804|447849148|FG008|Overall Study|Investigator discretion|0|||
124518514|NCT01831804|447849140|FG000|Overall Study|Withdrew Consent|0|||
124518515|NCT01831804|447849141|FG001|Overall Study|Withdrew Consent|1|||
124518516|NCT01831804|447849142|FG002|Overall Study|Withdrew Consent|0|||
124518517|NCT01831804|447849143|FG003|Overall Study|Withdrew Consent|0|||
124518518|NCT01831804|447849144|FG004|Overall Study|Withdrew Consent|0|||
124518519|NCT01831804|447849145|FG005|Overall Study|Withdrew Consent|0|||
124518520|NCT01831804|447849146|FG006|Overall Study|Withdrew Consent|0|||
124518521|NCT01831804|447849147|FG007|Overall Study|Withdrew Consent|2|||
124518522|NCT01831804|447849148|FG008|Overall Study|Withdrew Consent|0|||
124518523|NCT00268463|447849149|FG000|Overall Study|study terminated due to low accrual|10|||
124518524|NCT00268463|447849150|FG001|Overall Study|study terminated due to low accrual|12|||
124518525|NCT02920450|447849151|FG000|Overall Study|Death|1|||
124518526|NCT02920450|447849152|FG001|Overall Study|Death|0|||
124518527|NCT02920450|447849153|FG002|Overall Study|Death|0|||
124518528|NCT02920450|447849154|FG003|Overall Study|Death|0|||
124518529|NCT02920450|447849151|FG000|Overall Study|Withdrawal by Subject|1|||
124518530|NCT02920450|447849152|FG001|Overall Study|Withdrawal by Subject|0|||
124518531|NCT02920450|447849153|FG002|Overall Study|Withdrawal by Subject|0|||
124518532|NCT02920450|447849154|FG003|Overall Study|Withdrawal by Subject|0|||
124518533|NCT01732107|447849157|FG000|Overall Study|Adverse Event|2|||
124518534|NCT01732107|447849157|FG000|Overall Study|Disease Progression|8|||
124518535|NCT01732107|447849157|FG000|Overall Study|Physician Decision|1|||
124518536|NCT01732107|447849157|FG000|Overall Study|Withdrawal by Subject|2|||
124518537|NCT03407170|447849158|FG000|Overall Study|Adverse Event|1|||
124518538|NCT00615459|447849160|FG000|Period I|Adverse Event|2|||
124518539|NCT00615459|447849161|FG001|Period I|Adverse Event|0|||
124518540|NCT00615459|447849162|FG002|Period I|Adverse Event|1|||
124518541|NCT00615459|447849163|FG003|Period I|Adverse Event|0|||
124518542|NCT00615459|447849160|FG000|Period I|Subject withdrew consent|1|||
124518543|NCT00615459|447849161|FG001|Period I|Subject withdrew consent|0|||
124518544|NCT00615459|447849162|FG002|Period I|Subject withdrew consent|0|||
124518545|NCT00615459|447849163|FG003|Period I|Subject withdrew consent|1|||
124518546|NCT00615459|447849160|FG000|Period I|Abnormal test procedure results|1|||
124518547|NCT00615459|447849161|FG001|Period I|Abnormal test procedure results|1|||
124518548|NCT00615459|447849162|FG002|Period I|Abnormal test procedure results|1|||
124518549|NCT00615459|447849163|FG003|Period I|Abnormal test procedure results|0|||
124518550|NCT00615459|447849160|FG000|Period II|Adverse Event|1|||
124518551|NCT00615459|447849161|FG001|Period II|Adverse Event|0|||
124518552|NCT00615459|447849162|FG002|Period II|Adverse Event|0|||
124518553|NCT00615459|447849163|FG003|Period II|Adverse Event|0|||
124518554|NCT00615459|447849160|FG000|Period II|Lost to Follow-up|0|||
124518555|NCT00615459|447849161|FG001|Period II|Lost to Follow-up|0|||
124518556|NCT00615459|447849162|FG002|Period II|Lost to Follow-up|0|||
124518557|NCT00615459|447849163|FG003|Period II|Lost to Follow-up|1|||
124518558|NCT00615459|447849160|FG000|Period III|Adverse Event|0|||
124518559|NCT00615459|447849161|FG001|Period III|Adverse Event|1|||
124518560|NCT00615459|447849162|FG002|Period III|Adverse Event|0|||
124518561|NCT00615459|447849163|FG003|Period III|Adverse Event|0|||
124518562|NCT00615459|447849160|FG000|Period III|Administrative problems|0|||
124518563|NCT00615459|447849161|FG001|Period III|Administrative problems|1|||
124518564|NCT00615459|447849162|FG002|Period III|Administrative problems|1|||
124518565|NCT00615459|447849163|FG003|Period III|Administrative problems|0|||
124518566|NCT00615459|447849160|FG000|Period III|Unsatisfactory therapeutic effect|0|||
124518567|NCT00615459|447849161|FG001|Period III|Unsatisfactory therapeutic effect|1|||
124518568|NCT00615459|447849162|FG002|Period III|Unsatisfactory therapeutic effect|0|||
124518569|NCT00615459|447849163|FG003|Period III|Unsatisfactory therapeutic effect|0|||
124518570|NCT02076334|447849166|FG000|Overall Study|Protocol Violation|1|||
124518571|NCT02076334|447849167|FG001|Overall Study|Protocol Violation|0|||
124518572|NCT02076334|447849168|FG002|Overall Study|Protocol Violation|0|||
124518573|NCT02076334|447849169|FG003|Overall Study|Protocol Violation|0|||
124518574|NCT02076334|447849166|FG000|Overall Study|Lost to Follow-up|0|||
124518575|NCT02076334|447849167|FG001|Overall Study|Lost to Follow-up|1|||
124518576|NCT02076334|447849168|FG002|Overall Study|Lost to Follow-up|1|||
124518577|NCT02076334|447849169|FG003|Overall Study|Lost to Follow-up|0|||
124518578|NCT02076334|447849166|FG000|Overall Study|muscle soreness|0|||
124518579|NCT02076334|447849167|FG001|Overall Study|muscle soreness|0|||
124518580|NCT02076334|447849168|FG002|Overall Study|muscle soreness|0|||
124518581|NCT02076334|447849169|FG003|Overall Study|muscle soreness|1|||
124518582|NCT01975675|447849170|FG000|Overall Study|Death|0|||
124518583|NCT01975675|447849171|FG001|Overall Study|Death|1|||
124518584|NCT01975675|447849172|FG002|Overall Study|Death|0|||
124518585|NCT01975675|447849173|FG003|Overall Study|Death|0|||
124518586|NCT00871572|447849174|FG000|Overall Study|Adverse Event|0|||
124518587|NCT00871572|447849175|FG001|Overall Study|Adverse Event|2|||
124518588|NCT00871572|447849176|FG002|Overall Study|Adverse Event|0|||
124518589|NCT00871572|447849177|FG003|Overall Study|Adverse Event|3|||
124518590|NCT00871572|447849174|FG000|Overall Study|Investigator Decision|0|||
124518591|NCT00871572|447849175|FG001|Overall Study|Investigator Decision|1|||
124518592|NCT00871572|447849176|FG002|Overall Study|Investigator Decision|0|||
124518593|NCT00871572|447849177|FG003|Overall Study|Investigator Decision|1|||
124518594|NCT00871572|447849174|FG000|Overall Study|Lost to Follow-up|0|||
124518595|NCT00871572|447849175|FG001|Overall Study|Lost to Follow-up|1|||
124518596|NCT00871572|447849176|FG002|Overall Study|Lost to Follow-up|0|||
124518597|NCT00871572|447849177|FG003|Overall Study|Lost to Follow-up|1|||
124518598|NCT00871572|447849174|FG000|Overall Study|Protocol Violation|0|||
124518599|NCT00871572|447849175|FG001|Overall Study|Protocol Violation|0|||
124518600|NCT00871572|447849176|FG002|Overall Study|Protocol Violation|1|||
124518601|NCT00871572|447849177|FG003|Overall Study|Protocol Violation|1|||
124518602|NCT00871572|447849174|FG000|Overall Study|Sponsor Decision|1|||
124518603|NCT00871572|447849175|FG001|Overall Study|Sponsor Decision|0|||
124518604|NCT00871572|447849176|FG002|Overall Study|Sponsor Decision|0|||
124518605|NCT00871572|447849177|FG003|Overall Study|Sponsor Decision|0|||
124518606|NCT00871572|447849174|FG000|Overall Study|Withdrawal by Subject|1|||
124518607|NCT00871572|447849175|FG001|Overall Study|Withdrawal by Subject|2|||
124518608|NCT00871572|447849176|FG002|Overall Study|Withdrawal by Subject|3|||
124518609|NCT00871572|447849177|FG003|Overall Study|Withdrawal by Subject|1|||
124518610|NCT03803202|447849180|FG000|Overall Study|Other|0|||
124518611|NCT03803202|447849181|FG001|Overall Study|Other|1|||
124518612|NCT03803202|447849182|FG002|Overall Study|Other|0|||
124518613|NCT03803202|447849183|FG003|Overall Study|Other|0|||
124518614|NCT03803202|447849184|FG004|Overall Study|Other|0|||
124518615|NCT03803202|447849185|FG005|Overall Study|Other|0|||
124518616|NCT03803202|447849186|FG006|Overall Study|Other|0|||
124518617|NCT03803202|447849187|FG007|Overall Study|Other|0|||
124518618|NCT03803202|447849188|FG008|Overall Study|Other|0|||
124518619|NCT03803202|447849180|FG000|Overall Study|Death|0|||
124518620|NCT03803202|447849181|FG001|Overall Study|Death|0|||
124518621|NCT03803202|447849182|FG002|Overall Study|Death|0|||
124518622|NCT03803202|447849183|FG003|Overall Study|Death|0|||
124518623|NCT03803202|447849184|FG004|Overall Study|Death|0|||
124518624|NCT03803202|447849185|FG005|Overall Study|Death|1|||
124518625|NCT03803202|447849186|FG006|Overall Study|Death|0|||
124518626|NCT03803202|447849187|FG007|Overall Study|Death|0|||
124518627|NCT03803202|447849188|FG008|Overall Study|Death|0|||
124518628|NCT03803202|447849180|FG000|Overall Study|Withdrawal by Subject|0|||
124518629|NCT03803202|447849181|FG001|Overall Study|Withdrawal by Subject|0|||
124518630|NCT03803202|447849182|FG002|Overall Study|Withdrawal by Subject|1|||
124518631|NCT03803202|447849183|FG003|Overall Study|Withdrawal by Subject|0|||
124518632|NCT03803202|447849184|FG004|Overall Study|Withdrawal by Subject|0|||
124518633|NCT03803202|447849185|FG005|Overall Study|Withdrawal by Subject|0|||
124518634|NCT03803202|447849186|FG006|Overall Study|Withdrawal by Subject|0|||
124518635|NCT03803202|447849187|FG007|Overall Study|Withdrawal by Subject|1|||
124518636|NCT03803202|447849188|FG008|Overall Study|Withdrawal by Subject|0|||
124518637|NCT03803202|447849180|FG000|Overall Study|Lost to Follow-up|0|||
124518638|NCT03803202|447849181|FG001|Overall Study|Lost to Follow-up|0|||
124518639|NCT03803202|447849182|FG002|Overall Study|Lost to Follow-up|0|||
124518640|NCT03803202|447849183|FG003|Overall Study|Lost to Follow-up|1|||
124518641|NCT03803202|447849184|FG004|Overall Study|Lost to Follow-up|1|||
124518642|NCT03803202|447849185|FG005|Overall Study|Lost to Follow-up|0|||
124518643|NCT03803202|447849186|FG006|Overall Study|Lost to Follow-up|1|||
124518644|NCT03803202|447849187|FG007|Overall Study|Lost to Follow-up|0|||
124518645|NCT03803202|447849188|FG008|Overall Study|Lost to Follow-up|0|||
124518646|NCT00659126|447849193|FG000|Overall Study|Adverse Event|2|||
124518647|NCT00659126|447849194|FG001|Overall Study|Adverse Event|2|||
124518648|NCT00659126|447849193|FG000|Overall Study|Screen failure|1|||
124518649|NCT00659126|447849194|FG001|Overall Study|Screen failure|1|||
124518650|NCT00659126|447849193|FG000|Overall Study|Technical problems with MRI|0|||
124518651|NCT00659126|447849194|FG001|Overall Study|Technical problems with MRI|1|||
124518652|NCT02633046|447849195|FG000|Overall Study|Adverse Event|8|||
124518653|NCT02633046|447849195|FG000|Overall Study|Physician Decision|7|||
124518654|NCT02633046|447849195|FG000|Overall Study|Withdrawal by Subject|8|||
124518655|NCT02633046|447849195|FG000|Overall Study|Increased proteinuria|2|||
124518656|NCT02633046|447849195|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
124518657|NCT02633046|447849195|FG000|Overall Study|Mutual decision patient and physician|1|||
124518658|NCT02925312|447849196|FG000|Overall Study|Lost to Follow-up|25|||
124518659|NCT02925312|447849197|FG001|Overall Study|Lost to Follow-up|0|||
124518660|NCT02925312|447849196|FG000|Overall Study|Adverse Event|2|||
124518661|NCT02925312|447849197|FG001|Overall Study|Adverse Event|0|||
124518662|NCT03205982|447849205|FG000|Overall Study|Lost to Follow-up|20|||
124518663|NCT03205982|447849206|FG001|Overall Study|Lost to Follow-up|19|||
124518664|NCT03205982|447849205|FG000|Overall Study|Withdrawal by Subject|4|||
124518665|NCT03205982|447849206|FG001|Overall Study|Withdrawal by Subject|3|||
124518666|NCT03205982|447849205|FG000|Overall Study|Withdrawal by PI|0|||
124518667|NCT03205982|447849206|FG001|Overall Study|Withdrawal by PI|1|||
124518668|NCT00994162|447849207|FG000|Overall Study|Withdrawal by Subject|1|||
124518669|NCT00994162|447849207|FG000|Overall Study|Lost to Follow-up|2|||
124518670|NCT00994162|447849207|FG000|Overall Study|Product Complaint|1|||
124518671|NCT00994162|447849207|FG000|Overall Study|Poor Compliance|5|||
124518672|NCT00994162|447849207|FG000|Overall Study|Lack of Response|3|||
124518673|NCT00994162|447849207|FG000|Overall Study|Discharged from Hospital|4|||
124518674|NCT00994162|447849207|FG000|Overall Study|Death|2|||
124518675|NCT00994162|447849207|FG000|Overall Study|Care Transferred to Another Physician|2|||
124518676|NCT00994162|447849207|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
124518677|NCT00994162|447849207|FG000|Overall Study|Physician Decision|2|||
124518678|NCT00994162|447849207|FG000|Overall Study|Surrounding Wound Erythematous|1|||
124518679|NCT00994162|447849207|FG000|Overall Study|Machine Losing Vaccum|1|||
124518680|NCT00994162|447849207|FG000|Overall Study|Patient Lived Too Far Away|1|||
124518681|NCT00994162|447849207|FG000|Overall Study|Above Knee Amputation|1|||
124518682|NCT00994162|447849207|FG000|Overall Study|Reason Not Reported By Site|1|||
124518683|NCT01425749|447849208|FG000|Overall Study|progression of melanoma|0|||
124518684|NCT01425749|447849209|FG001|Overall Study|progression of melanoma|1|||
124518685|NCT01293084|447849210|FG000|Overall Study|Physician Decision|3|||
124518686|NCT01293084|447849210|FG000|Overall Study|Withdrawal by Subject|2|||
124518687|NCT02096042|447849211|FG000|Overall Study|Disease Progression|1|||
124518688|NCT02096042|447849212|FG001|Overall Study|Disease Progression|0|||
124518689|NCT02096042|447849213|FG002|Overall Study|Disease Progression|0|||
124518690|NCT02983799|447849214|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
124518691|NCT02983799|447849215|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
124518692|NCT02983799|447849216|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
124518693|NCT02983799|447849217|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
124518694|NCT02983799|447849218|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
124518695|NCT02983799|447849214|FG000|Overall Study|Death|20|||
124518696|NCT02983799|447849215|FG001|Overall Study|Death|5|||
124518697|NCT02983799|447849216|FG002|Overall Study|Death|23|||
124518698|NCT02983799|447849217|FG003|Overall Study|Death|47|||
124518699|NCT02983799|447849218|FG004|Overall Study|Death|7|||
124518700|NCT02983799|447849214|FG000|Overall Study|Withdrawal by Subject|1|||
124518701|NCT02983799|447849215|FG001|Overall Study|Withdrawal by Subject|0|||
124518702|NCT02983799|447849216|FG002|Overall Study|Withdrawal by Subject|3|||
124518703|NCT02983799|447849217|FG003|Overall Study|Withdrawal by Subject|4|||
124518704|NCT02983799|447849218|FG004|Overall Study|Withdrawal by Subject|1|||
124518705|NCT02983799|447849214|FG000|Overall Study|Protocol Violation|0|||
124518706|NCT02983799|447849215|FG001|Overall Study|Protocol Violation|1|||
124518707|NCT02983799|447849216|FG002|Overall Study|Protocol Violation|0|||
124518708|NCT02983799|447849217|FG003|Overall Study|Protocol Violation|0|||
124518709|NCT02983799|447849218|FG004|Overall Study|Protocol Violation|1|||
124518710|NCT02983799|447849214|FG000|Overall Study|Lost to Follow-up|1|||
124518711|NCT02983799|447849215|FG001|Overall Study|Lost to Follow-up|0|||
124518712|NCT02983799|447849216|FG002|Overall Study|Lost to Follow-up|1|||
124518713|NCT02983799|447849217|FG003|Overall Study|Lost to Follow-up|0|||
124518714|NCT02983799|447849218|FG004|Overall Study|Lost to Follow-up|0|||
124518715|NCT01225172|447849225|FG000|Overall Study|Subject decision to stop|1|||
124518716|NCT01225172|447849226|FG001|Overall Study|Subject decision to stop|0|||
124518717|NCT01225172|447849225|FG000|Overall Study|Subject request to discontinue treatment|3|||
124518718|NCT01225172|447849226|FG001|Overall Study|Subject request to discontinue treatment|1|||
124518719|NCT01225172|447849225|FG000|Overall Study|Subject no longer meets study criteria|1|||
124518720|NCT01225172|447849226|FG001|Overall Study|Subject no longer meets study criteria|0|||
124518721|NCT01225172|447849225|FG000|Overall Study|Withdrawal by Subject|1|||
124518722|NCT01225172|447849226|FG001|Overall Study|Withdrawal by Subject|0|||
124518723|NCT00795509|447849228|FG000|Overall Study|Protocol Violation|31|||
124518724|NCT01601470|447849229|FG000|Period 2 - LCZ696|Physician Decision|1|||
124518725|NCT02079519|447849230|FG000|Overall Study|Disease Progression|9|||
124518726|NCT02079519|447849230|FG000|Overall Study|Adverse Event|1|||
124518727|NCT01041404|447849233|FG000|Overall Study|Adverse Event|45|||
124518728|NCT01041404|447849234|FG001|Overall Study|Adverse Event|35|||
124518729|NCT01041404|447849233|FG000|Overall Study|Lack of Efficacy|200|||
124518730|NCT01041404|447849234|FG001|Overall Study|Lack of Efficacy|210|||
124518731|NCT01041404|447849233|FG000|Overall Study|Violation of Selection Criteria|0|||
124518732|NCT01041404|447849234|FG001|Overall Study|Violation of Selection Criteria|1|||
124518733|NCT01041404|447849233|FG000|Overall Study|Protocol Violation|4|||
124518734|NCT01041404|447849234|FG001|Overall Study|Protocol Violation|0|||
124518735|NCT01041404|447849233|FG000|Overall Study|Withdrawal by Subject|29|||
124518736|NCT01041404|447849234|FG001|Overall Study|Withdrawal by Subject|23|||
124518737|NCT01041404|447849233|FG000|Overall Study|Failure to Return|1|||
124518738|NCT01041404|447849234|FG001|Overall Study|Failure to Return|2|||
124518739|NCT01041404|447849233|FG000|Overall Study|Other|11|||
124518740|NCT01041404|447849234|FG001|Overall Study|Other|23|||
124518741|NCT01607073|447849235|FG000|Overall Study|Adverse Event|1|||
124518742|NCT03726333|447849236|FG000|Overall Study|Progressive Disease|0|||
124518743|NCT03726333|447849237|FG001|Overall Study|Progressive Disease|0|||
124518744|NCT03726333|447849238|FG002|Overall Study|Progressive Disease|1|||
124518745|NCT03726333|447849239|FG003|Overall Study|Progressive Disease|0|||
124518746|NCT03726333|447849240|FG004|Overall Study|Progressive Disease|0|||
124518747|NCT01946412|447849241|FG000|Overall Study|Adverse Event|1|||
124518748|NCT01946412|447849241|FG000|Overall Study|Non-Compliance|1|||
124518749|NCT01946412|447849241|FG000|Overall Study|Continued with commercial Kalydeco|2|||
124518750|NCT01946412|447849241|FG000|Overall Study|Difficulty in swallowing|1|||
124518751|NCT01625611|447851137|FG000|Overall Study|No adlib drinks Lab 1|3|||
124518752|NCT01625611|447851138|FG001|Overall Study|No adlib drinks Lab 1|0|||
124518753|NCT01625611|447851137|FG000|Overall Study|Technical issues with PET|1|||
124518754|NCT01625611|447851138|FG001|Overall Study|Technical issues with PET|0|||
124518755|NCT01625611|447851137|FG000|Overall Study|Unable to complete study procedures|1|||
124518756|NCT01625611|447851138|FG001|Overall Study|Unable to complete study procedures|0|||
124518757|NCT01625611|447851137|FG000|Overall Study|Withdrawal by Subject|3|||
124518758|NCT01625611|447851138|FG001|Overall Study|Withdrawal by Subject|0|||
124518759|NCT05091918|447851139|FG000|Overall Study|Adverse Event|1|||
124518760|NCT05091918|447851139|FG000|Overall Study|Withdrawal by Subject|81|||
124518761|NCT00239356|447851141|FG000|Overall Study|Lack of Efficacy|1|||
124518762|NCT00239356|447851142|FG001|Overall Study|Lack of Efficacy|0|||
124518763|NCT00239356|447851141|FG000|Overall Study|Adverse Event|6|||
124518764|NCT00239356|447851142|FG001|Overall Study|Adverse Event|0|||
124518765|NCT00239356|447851141|FG000|Overall Study|Withdrawal by Subject|15|||
124518766|NCT00239356|447851142|FG001|Overall Study|Withdrawal by Subject|6|||
124518767|NCT00239356|447851141|FG000|Overall Study|Lost to Follow-up|3|||
124518768|NCT00239356|447851142|FG001|Overall Study|Lost to Follow-up|0|||
124518769|NCT00239356|447851141|FG000|Overall Study|poor/non-compliance|2|||
124518770|NCT00239356|447851142|FG001|Overall Study|poor/non-compliance|0|||
124518771|NCT00239356|447851141|FG000|Overall Study|Pregnancy|1|||
124518772|NCT00239356|447851142|FG001|Overall Study|Pregnancy|0|||
124518773|NCT00239356|447851141|FG000|Overall Study|Administrative reason|0|||
124518774|NCT00239356|447851142|FG001|Overall Study|Administrative reason|1|||
124518775|NCT00239356|447851141|FG000|Overall Study|Drug available on market|11|||
124518776|NCT00239356|447851142|FG001|Overall Study|Drug available on market|2|||
124518777|NCT00511108|447851143|FG000|Overall Study|Adverse Event|2|||
124518778|NCT00511108|447851144|FG001|Overall Study|Adverse Event|0|||
124518779|NCT00511108|447851145|FG002|Overall Study|Adverse Event|1|||
124518780|NCT00511108|447851146|FG003|Overall Study|Adverse Event|2|||
124518781|NCT00511108|447851143|FG000|Overall Study|Lost to Follow-up|0|||
124518782|NCT00511108|447851144|FG001|Overall Study|Lost to Follow-up|2|||
124518783|NCT00511108|447851145|FG002|Overall Study|Lost to Follow-up|1|||
124518784|NCT00511108|447851146|FG003|Overall Study|Lost to Follow-up|0|||
124518785|NCT00511108|447851143|FG000|Overall Study|Physician Decision|0|||
124518786|NCT00511108|447851144|FG001|Overall Study|Physician Decision|0|||
124518787|NCT00511108|447851145|FG002|Overall Study|Physician Decision|0|||
124518788|NCT00511108|447851146|FG003|Overall Study|Physician Decision|1|||
124518789|NCT00511108|447851143|FG000|Overall Study|Withdrawal by Subject|4|||
124518790|NCT00511108|447851144|FG001|Overall Study|Withdrawal by Subject|0|||
124518791|NCT00511108|447851145|FG002|Overall Study|Withdrawal by Subject|3|||
124518792|NCT00511108|447851146|FG003|Overall Study|Withdrawal by Subject|2|||
124518793|NCT02044822|447851149|FG000|Overall Study|Study Terminated by Sponsor|77|||
124518794|NCT02044822|447851149|FG000|Overall Study|Investigator's Discretion|10|||
124518795|NCT02044822|447851149|FG000|Overall Study|Withdrew Consent|3|||
124518796|NCT02044822|447851149|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
124518797|NCT02044822|447851149|FG000|Overall Study|Lost to Follow-up|1|||
124518798|NCT02147691|447851150|FG000|Overall Study|Withdrawal by Subject|2|||
124518799|NCT02147691|447851151|FG001|Overall Study|Withdrawal by Subject|0|||
124518800|NCT02147691|447851150|FG000|Overall Study|Adverse Event|2|||
124518801|NCT02147691|447851151|FG001|Overall Study|Adverse Event|0|||
124518802|NCT02147691|447851150|FG000|Overall Study|Lost to Follow-up|0|||
124518803|NCT02147691|447851151|FG001|Overall Study|Lost to Follow-up|1|||
124518804|NCT03417505|447851154|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
124518805|NCT03417505|447851155|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
124518806|NCT02954952|447851156|FG000|Overall Study|Withdrawal by Subject|1|||
124518807|NCT02954952|447851157|FG001|Overall Study|Withdrawal by Subject|0|||
124518808|NCT02954952|447851158|FG002|Overall Study|Withdrawal by Subject|0|||
124518809|NCT02954952|447851156|FG000|Overall Study|No data collected|0|||
124518810|NCT02954952|447851157|FG001|Overall Study|No data collected|1|||
124518811|NCT02954952|447851158|FG002|Overall Study|No data collected|0|||
124518812|NCT04179032|447851159|FG000|Part B (Up to Week 52)|Adverse Event|1|||
124518813|NCT04179032|447851159|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
124518814|NCT04179032|447851159|FG000|Access Extension Phase|Ongoing|11|||
124518815|NCT02432703|447851160|FG000|Overall Study|Adverse Event|1|||
124518816|NCT02432703|447851161|FG001|Overall Study|Adverse Event|4|||
124518817|NCT02432703|447851160|FG000|Overall Study|Lack of Efficacy|1|||
124518818|NCT02432703|447851161|FG001|Overall Study|Lack of Efficacy|0|||
124518819|NCT02432703|447851160|FG000|Overall Study|Lost to Follow-up|5|||
124518820|NCT02432703|447851161|FG001|Overall Study|Lost to Follow-up|3|||
124518821|NCT02432703|447851160|FG000|Overall Study|Withdrawal by Subject|9|||
124518822|NCT02432703|447851161|FG001|Overall Study|Withdrawal by Subject|6|||
124518823|NCT02432703|447851160|FG000|Overall Study|Other|6|||
124518824|NCT02432703|447851161|FG001|Overall Study|Other|5|||
124518825|NCT00653328|447851162|FG000|Overall Study|Withdrawal by Subject|1|||
124518826|NCT00653328|447851162|FG000|Overall Study|Adverse Event|2|||
124518827|NCT00653328|447851162|FG000|Overall Study|Disease progression|10|||
124518828|NCT00653328|447851162|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
124518829|NCT00561340|447851163|FG000|Overall Study|refused to drink pediasure|6|||
124518830|NCT00561340|447851164|FG001|Overall Study|refused to drink pediasure|0|||
124518831|NCT01359046|447851167|FG000|Overall Study|Did not receive allocated intervention|6|||
124518832|NCT01359046|447851168|FG001|Overall Study|Did not receive allocated intervention|6|||
124518833|NCT01359046|447851167|FG000|Overall Study|Physician Decision|1|||
124518834|NCT01359046|447851168|FG001|Overall Study|Physician Decision|11|||
124518835|NCT01484561|447851169|FG000|Overall Study|Lack of Efficacy|3|||
124518836|NCT01484561|447851170|FG001|Overall Study|Lack of Efficacy|1|||
124518837|NCT01484561|447851169|FG000|Overall Study|Lost to Follow-up|1|||
124518838|NCT01484561|447851170|FG001|Overall Study|Lost to Follow-up|0|||
124518839|NCT01484561|447851169|FG000|Overall Study|Withdrawal by Subject|3|||
124518840|NCT01484561|447851170|FG001|Overall Study|Withdrawal by Subject|0|||
124518841|NCT01484561|447851169|FG000|Overall Study|Other|1|||
124518842|NCT01484561|447851170|FG001|Overall Study|Other|1|||
124518843|NCT01484561|447851169|FG000|Overall Study|Adverse Event|1|||
124518844|NCT01484561|447851170|FG001|Overall Study|Adverse Event|4|||
124518845|NCT02443805|447851173|FG000|Overall Study|Adverse Event|100|||
124518846|NCT02443805|447851174|FG001|Overall Study|Adverse Event|18|||
124571969|NCT00150462|448053387|FG007|Overall Study|Physician Decision|0|||
124518847|NCT02443805|447851173|FG000|Overall Study|Withdrawal by Subject|73|||
124518848|NCT02443805|447851174|FG001|Overall Study|Withdrawal by Subject|74|||
124518849|NCT02443805|447851173|FG000|Overall Study|Lost to Follow-up|19|||
124518850|NCT02443805|447851174|FG001|Overall Study|Lost to Follow-up|14|||
124518851|NCT02443805|447851173|FG000|Overall Study|Pregnancy|6|||
124518852|NCT02443805|447851174|FG001|Overall Study|Pregnancy|5|||
124518853|NCT02443805|447851173|FG000|Overall Study|Protocol Violation|2|||
124518854|NCT02443805|447851174|FG001|Overall Study|Protocol Violation|4|||
124571970|NCT00150462|448053388|FG008|Overall Study|Physician Decision|0|||
124571971|NCT00150462|448053389|FG009|Overall Study|Physician Decision|0|||
124518855|NCT02443805|447851173|FG000|Overall Study|Lack of Efficacy|1|||
124518856|NCT02443805|447851174|FG001|Overall Study|Lack of Efficacy|1|||
124518857|NCT02443805|447851173|FG000|Overall Study|Non-compliance with study drug|6|||
124518858|NCT02443805|447851174|FG001|Overall Study|Non-compliance with study drug|4|||
124518859|NCT02443805|447851173|FG000|Overall Study|Withdrawal by parent/guardian|3|||
124518860|NCT02443805|447851174|FG001|Overall Study|Withdrawal by parent/guardian|5|||
124518861|NCT02443805|447851173|FG000|Overall Study|Any other reason not above-mentioned|3|||
124518862|NCT02443805|447851174|FG001|Overall Study|Any other reason not above-mentioned|2|||
124518863|NCT04362813|447851175|FG000|Overall Study|Death|12|||
124518864|NCT04362813|447851176|FG001|Overall Study|Death|16|||
124518865|NCT04362813|447851175|FG000|Overall Study|Withdrawal by Subject|3|||
124518866|NCT04362813|447851176|FG001|Overall Study|Withdrawal by Subject|1|||
124518867|NCT04362813|447851175|FG000|Overall Study|Protocol Violation|0|||
124518868|NCT04362813|447851176|FG001|Overall Study|Protocol Violation|3|||
124518869|NCT04362813|447851175|FG000|Overall Study|Lost to Follow-up|1|||
124518870|NCT04362813|447851176|FG001|Overall Study|Lost to Follow-up|1|||
124518871|NCT04362813|447851175|FG000|Overall Study|Enrolled but did not receive treatment|2|||
124518872|NCT04362813|447851176|FG001|Overall Study|Enrolled but did not receive treatment|4|||
124518873|NCT00961116|447851177|FG000|Washout Period of 7 Days|Adverse Event|1|||
124518874|NCT00961116|447851178|FG001|Washout Period of 7 Days|Adverse Event|1|||
124518875|NCT00961116|447851177|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
124518876|NCT00961116|447851178|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
124518877|NCT00961116|447851177|FG000|Washout Period of 7 Days|Protocol Violation|0|||
124518878|NCT00961116|447851178|FG001|Washout Period of 7 Days|Protocol Violation|1|||
124518879|NCT04354155|447851183|FG000|Overall Study|Withdrawal by Subject|1|||
124518880|NCT04354155|447851183|FG000|Overall Study|Did not meet criteria for study intervention|1|||
124518881|NCT02565615|447851184|FG000|Overall Study|Death|0|||
124518882|NCT02565615|447851185|FG001|Overall Study|Death|1|||
124518883|NCT02565615|447851186|FG002|Overall Study|Death|0|||
124518884|NCT02565615|447851187|FG003|Overall Study|Death|0|||
124518885|NCT02565615|447851188|FG004|Overall Study|Death|4|||
124518886|NCT02565615|447851184|FG000|Overall Study|Not willing to participate in study|2|||
124518887|NCT02565615|447851185|FG001|Overall Study|Not willing to participate in study|21|||
124518888|NCT02565615|447851186|FG002|Overall Study|Not willing to participate in study|0|||
124518889|NCT02565615|447851187|FG003|Overall Study|Not willing to participate in study|1|||
124518890|NCT02565615|447851188|FG004|Overall Study|Not willing to participate in study|169|||
124518891|NCT02565615|447851184|FG000|Overall Study|Lost to Follow-up|0|||
124518892|NCT02565615|447851185|FG001|Overall Study|Lost to Follow-up|4|||
124518893|NCT02565615|447851186|FG002|Overall Study|Lost to Follow-up|0|||
124518894|NCT02565615|447851187|FG003|Overall Study|Lost to Follow-up|1|||
124518895|NCT02565615|447851188|FG004|Overall Study|Lost to Follow-up|765|||
124518896|NCT02565615|447851184|FG000|Overall Study|Not meeting eligibility criteria|0|||
124518897|NCT02565615|447851185|FG001|Overall Study|Not meeting eligibility criteria|7|||
124518898|NCT02565615|447851186|FG002|Overall Study|Not meeting eligibility criteria|0|||
124518899|NCT02565615|447851187|FG003|Overall Study|Not meeting eligibility criteria|0|||
124518900|NCT02565615|447851188|FG004|Overall Study|Not meeting eligibility criteria|25|||
124518901|NCT02565615|447851184|FG000|Overall Study|Reason not defined|0|||
124518902|NCT02565615|447851185|FG001|Overall Study|Reason not defined|2|||
124518903|NCT02565615|447851186|FG002|Overall Study|Reason not defined|0|||
124518904|NCT02565615|447851187|FG003|Overall Study|Reason not defined|1|||
124518905|NCT02565615|447851188|FG004|Overall Study|Reason not defined|62|||
124518906|NCT02565615|447851184|FG000|Overall Study|Adverse Event|1|||
124518907|NCT02565615|447851185|FG001|Overall Study|Adverse Event|1|||
124518908|NCT02565615|447851186|FG002|Overall Study|Adverse Event|0|||
124518909|NCT02565615|447851187|FG003|Overall Study|Adverse Event|0|||
124518910|NCT02565615|447851188|FG004|Overall Study|Adverse Event|9|||
124518911|NCT02565615|447851184|FG000|Overall Study|Untreated|0|||
124518912|NCT02565615|447851185|FG001|Overall Study|Untreated|0|||
124518913|NCT02565615|447851186|FG002|Overall Study|Untreated|0|||
124518914|NCT02565615|447851187|FG003|Overall Study|Untreated|0|||
124518915|NCT02565615|447851188|FG004|Overall Study|Untreated|567|||
124518916|NCT00753688|447851191|FG000|Overall Study|Death|102|||
124518917|NCT00753688|447851192|FG001|Overall Study|Death|203|||
124518918|NCT00753688|447851191|FG000|Overall Study|Missing|4|||
124518919|NCT00753688|447851192|FG001|Overall Study|Missing|9|||
124518920|NCT00753688|447851191|FG000|Overall Study|Participant Withdrew Consent|2|||
124518921|NCT00753688|447851192|FG001|Overall Study|Participant Withdrew Consent|2|||
124518922|NCT00753688|447851191|FG000|Overall Study|Ongoing - in Follow-up|15|||
124518923|NCT00753688|447851192|FG001|Overall Study|Ongoing - in Follow-up|31|||
124518924|NCT00753688|447851191|FG000|Overall Study|Adverse Event|0|||
124518925|NCT00753688|447851192|FG001|Overall Study|Adverse Event|1|||
124518926|NCT02999100|447851196|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
124518927|NCT02999100|447851197|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
124518928|NCT02999100|447851198|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
124518929|NCT02999100|447851199|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
124518930|NCT02999100|447851200|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
124518931|NCT02999100|447851201|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
124518932|NCT02999100|447851196|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
124518933|NCT02999100|447851197|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
124518934|NCT02999100|447851198|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
124518935|NCT02999100|447851199|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
124518936|NCT02999100|447851200|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
124518937|NCT02999100|447851201|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
124518938|NCT02999100|447851196|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
124518939|NCT02999100|447851197|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
124518940|NCT02999100|447851198|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
124518941|NCT02999100|447851199|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
124518942|NCT02999100|447851200|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
124518943|NCT02999100|447851201|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
124518944|NCT03595384|447851205|FG000|Overall Study|Other time commitments|8|||
124518945|NCT03595384|447851205|FG000|Overall Study|Changes to session time|7|||
124518946|NCT03595384|447851205|FG000|Overall Study|Relocation out of country|1|||
124518947|NCT00293241|447851206|FG000|Overall Study|Lost to Follow-up|9|||
124518948|NCT00293241|447851207|FG001|Overall Study|Lost to Follow-up|16|||
124518949|NCT00293241|447851206|FG000|Overall Study|Physician Decision|23|||
124518950|NCT00293241|447851207|FG001|Overall Study|Physician Decision|17|||
124518951|NCT00293241|447851206|FG000|Overall Study|Withdrawal by Subject|4|||
124518952|NCT00293241|447851207|FG001|Overall Study|Withdrawal by Subject|8|||
124518953|NCT02224638|447851208|FG000|Overall Study|Adverse Event|1|||
124518954|NCT02224638|447851209|FG001|Overall Study|Adverse Event|1|||
124518955|NCT01455415|447851221|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
124518956|NCT01455415|447851222|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
124518957|NCT01455415|447851221|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
124518958|NCT01455415|447851222|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
124518959|NCT01455415|447851221|FG000|Period 1|Drug Error not Associated to AE|0|||
124518960|NCT01455415|447851222|FG001|Period 1|Drug Error not Associated to AE|1|||
124518961|NCT01455415|447851221|FG000|Period 1|AE Not Related to Study Drug|2|||
124518962|NCT01455415|447851222|FG001|Period 1|AE Not Related to Study Drug|6|||
124518963|NCT01455415|447851221|FG000|Period 1|Withdrawal by Subject|4|||
124518964|NCT01455415|447851222|FG001|Period 1|Withdrawal by Subject|5|||
124518965|NCT01455415|447851221|FG000|Period 1|Unspecified Reason|1|||
124518966|NCT01455415|447851222|FG001|Period 1|Unspecified Reason|1|||
124518967|NCT01455415|447851221|FG000|Period 1|Protocol Violation|0|||
124518968|NCT01455415|447851222|FG001|Period 1|Protocol Violation|2|||
124518969|NCT01455415|447851221|FG000|Washout|AE Related to Study Drug|2|||
124518970|NCT01455415|447851222|FG001|Washout|AE Related to Study Drug|0|||
124518971|NCT01455415|447851221|FG000|Washout|Lost to Follow-up|1|||
124518972|NCT01455415|447851222|FG001|Washout|Lost to Follow-up|0|||
124518973|NCT01455415|447851221|FG000|Washout|Drug Error not Associated to AE|2|||
124518974|NCT01455415|447851222|FG001|Washout|Drug Error not Associated to AE|1|||
124518975|NCT01455415|447851221|FG000|Washout|AE Not Related to Study Drug|2|||
124518976|NCT01455415|447851222|FG001|Washout|AE Not Related to Study Drug|3|||
124518977|NCT01455415|447851221|FG000|Washout|Unspecified Reason|1|||
124518978|NCT01455415|447851222|FG001|Washout|Unspecified Reason|2|||
124518979|NCT01455415|447851221|FG000|Washout|Protocol Violation|0|||
124518980|NCT01455415|447851222|FG001|Washout|Protocol Violation|1|||
124518981|NCT01455415|447851221|FG000|Period 2|AE Related to Study Drug|1|||
124518982|NCT01455415|447851222|FG001|Period 2|AE Related to Study Drug|2|||
124518983|NCT01455415|447851221|FG000|Period 2|Lost to Follow-up|2|||
124725009|NCT03768089|448613417|FG009|Part A|Lost to Follow-up|0|||
124725010|NCT03768089|448613418|FG010|Part A|Lost to Follow-up|0|||
124725011|NCT03768089|448613419|FG011|Part A|Lost to Follow-up|0|||
124725012|NCT03768089|448613420|FG012|Part A|Lost to Follow-up|0|||
124518984|NCT01455415|447851222|FG001|Period 2|Lost to Follow-up|1|||
124518985|NCT01455415|447851221|FG000|Period 2|AE Not Related to Study Drug|2|||
124725013|NCT03768089|448613421|FG013|Part A|Lost to Follow-up|0|||
124725014|NCT03768089|448613422|FG014|Part A|Lost to Follow-up|0|||
124518986|NCT01455415|447851222|FG001|Period 2|AE Not Related to Study Drug|1|||
124518987|NCT01455415|447851221|FG000|Period 2|Lack of Efficacy|2|||
124518988|NCT01455415|447851222|FG001|Period 2|Lack of Efficacy|0|||
124518989|NCT01455415|447851221|FG000|Period 2|Withdrawal by Subject|2|||
124518990|NCT01455415|447851222|FG001|Period 2|Withdrawal by Subject|3|||
124518991|NCT01455415|447851221|FG000|Period 2|Unspecified Reason|2|||
124518992|NCT01455415|447851222|FG001|Period 2|Unspecified Reason|3|||
124518993|NCT01455415|447851221|FG000|Period 2|Protocol Violation|2|||
124518994|NCT01455415|447851222|FG001|Period 2|Protocol Violation|0|||
124725015|NCT03768089|448613423|FG015|Part A|Lost to Follow-up|0|||
124518995|NCT01455415|447851221|FG000|Follow-up|AE Related to Study Drug|0|||
124518996|NCT01455415|447851222|FG001|Follow-up|AE Related to Study Drug|1|||
124518997|NCT01455415|447851221|FG000|Follow-up|Lack of Efficacy|0|||
124518998|NCT01455415|447851222|FG001|Follow-up|Lack of Efficacy|1|||
124518999|NCT01455415|447851221|FG000|Follow-up|Withdrawal by Subject|2|||
124519000|NCT01455415|447851222|FG001|Follow-up|Withdrawal by Subject|0|||
124725016|NCT03768089|448613424|FG016|Part A|Lost to Follow-up|0|||
124519001|NCT01455415|447851221|FG000|Follow-up|Unspecified Reason|1|||
124519002|NCT01455415|447851222|FG001|Follow-up|Unspecified Reason|0|||
124519003|NCT00587301|447851223|FG000|Overall Study|Screen Failure|9|||
124519004|NCT00587301|447851223|FG000|Overall Study|Lost to Follow-up|22|||
124519005|NCT00587301|447851223|FG000|Overall Study|Withdrawal by Subject|7|||
124519006|NCT00587301|447851223|FG000|Overall Study|Protocol Violation|7|||
124519007|NCT01496274|447851225|FG000|Overall Study|Protocol Violation|0|||
124519008|NCT01496274|447851226|FG001|Overall Study|Protocol Violation|1|||
124519009|NCT01496274|447851225|FG000|Overall Study|Adverse Event|1|||
124519010|NCT01496274|447851226|FG001|Overall Study|Adverse Event|1|||
124519011|NCT01496274|447851225|FG000|Overall Study|Withdrawal by Subject|2|||
124519012|NCT01496274|447851226|FG001|Overall Study|Withdrawal by Subject|0|||
124519013|NCT01496274|447851225|FG000|Overall Study|Lost to Follow-up|0|||
124519014|NCT01496274|447851226|FG001|Overall Study|Lost to Follow-up|3|||
124519015|NCT02758613|447851227|FG000|Treatment|Physician and Sponsor Decision|1|||
124519016|NCT02758613|447851228|FG001|Treatment|Physician and Sponsor Decision|0|||
124519017|NCT02758613|447851229|FG002|Treatment|Physician and Sponsor Decision|0|||
124519018|NCT02758613|447851230|FG003|Treatment|Physician and Sponsor Decision|0|||
124519019|NCT02758613|447851227|FG000|Treatment|Withdrawal by Subject|1|||
124519020|NCT02758613|447851228|FG001|Treatment|Withdrawal by Subject|0|||
124519021|NCT02758613|447851229|FG002|Treatment|Withdrawal by Subject|1|||
124519022|NCT02758613|447851230|FG003|Treatment|Withdrawal by Subject|0|||
124519023|NCT00351819|447851232|FG000|Overall Study|Lost to Follow-up|4|||
124519024|NCT00351819|447851233|FG001|Overall Study|Lost to Follow-up|4|||
124519025|NCT00351819|447851232|FG000|Overall Study|Withdrawal by Subject|0|||
124519026|NCT00351819|447851233|FG001|Overall Study|Withdrawal by Subject|4|||
124519027|NCT00351819|447851232|FG000|Overall Study|Elevated PSA|1|||
124519028|NCT00351819|447851233|FG001|Overall Study|Elevated PSA|1|||
124519029|NCT00351819|447851232|FG000|Overall Study|Traumatic ankle fracture|1|||
124519030|NCT00351819|447851233|FG001|Overall Study|Traumatic ankle fracture|0|||
124519031|NCT00351819|447851232|FG000|Overall Study|Unprofessional behavior|1|||
124519032|NCT00351819|447851233|FG001|Overall Study|Unprofessional behavior|0|||
124519033|NCT00351819|447851232|FG000|Overall Study|Non-compliance|0|||
124519034|NCT00351819|447851233|FG001|Overall Study|Non-compliance|1|||
124519035|NCT00351819|447851232|FG000|Overall Study|Incarcerated|0|||
124519036|NCT00351819|447851233|FG001|Overall Study|Incarcerated|1|||
124519037|NCT00351819|447851232|FG000|Overall Study|Enrolled in another trial|0|||
124519038|NCT00351819|447851233|FG001|Overall Study|Enrolled in another trial|1|||
124519039|NCT00719537|447851236|FG000|Overall Study|Withdrawal by Subject|1|||
124519040|NCT00719537|447851237|FG001|Overall Study|Withdrawal by Subject|0|||
124519041|NCT00719537|447851236|FG000|Overall Study|Lost to Follow-up|0|||
124519042|NCT00719537|447851237|FG001|Overall Study|Lost to Follow-up|1|||
124519043|NCT01459068|447851238|FG000|Overall Study|Withdrawal by Subject|8|||
124519044|NCT01459068|447851239|FG001|Overall Study|Withdrawal by Subject|18|||
124519045|NCT01459068|447851238|FG000|Overall Study|Lost to Follow-up|31|||
124519046|NCT01459068|447851239|FG001|Overall Study|Lost to Follow-up|15|||
124519047|NCT01459068|447851238|FG000|Overall Study|Death|0|||
124519048|NCT01459068|447851239|FG001|Overall Study|Death|1|||
124519049|NCT00196196|447851242|FG000|Overall Study|Withdrawal by Subject|2|||
124519050|NCT00196196|447851242|FG000|Overall Study|Did not have required condition (hydroce|5|||
124519051|NCT02910219|447851243|FG000|Overall Study|Withdrawal by Subject|1|||
124519052|NCT02910219|447851244|FG001|Overall Study|Withdrawal by Subject|1|||
124519053|NCT01015820|447851245|FG000|Overall Study|Suboptimal measurements|1|||
124519054|NCT01015820|447851246|FG001|Overall Study|Suboptimal measurements|0|||
124519055|NCT00701441|447851247|FG000|Overall Study|failure in cpap compliance|0|||
124519056|NCT00701441|447851248|FG001|Overall Study|failure in cpap compliance|4|||
124519057|NCT01313078|447851254|FG000|Overall Study|Death|1|||
124519058|NCT01313078|447851254|FG000|Overall Study|Discontinued study drug|1|||
124519059|NCT01313078|447851254|FG000|Overall Study|Withdrawal by Subject|1|||
124519060|NCT02679781|447851256|FG000|Overall Study|Lost to Follow-up|1|||
124519061|NCT02679781|447851257|FG001|Overall Study|Lost to Follow-up|2|||
124519062|NCT02679781|447851256|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
124519063|NCT02679781|447851257|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
124519064|NCT04209400|447851258|FG000|Overall Study|Withdrawal by Subject|0|||
124519065|NCT04209400|447851259|FG001|Overall Study|Withdrawal by Subject|1|||
124519066|NCT01203787|447851267|FG000|Overall Study|Death|12|||
124519067|NCT01203787|447851268|FG001|Overall Study|Death|10|||
124519068|NCT01203787|447851267|FG000|Overall Study|Withdrawal by Subject|6|||
124519069|NCT01203787|447851268|FG001|Overall Study|Withdrawal by Subject|2|||
124519070|NCT01203787|447851267|FG000|Overall Study|Lost to Follow-up|2|||
124519071|NCT01203787|447851268|FG001|Overall Study|Lost to Follow-up|0|||
124519072|NCT01203787|447851267|FG000|Overall Study|Adverse Event|11|||
124519073|NCT01203787|447851268|FG001|Overall Study|Adverse Event|15|||
124519074|NCT00970268|447851269|FG000|Overall Study|Withdrawal by Subject|12|||
124519075|NCT00970268|447851270|FG001|Overall Study|Withdrawal by Subject|19|||
124519076|NCT00970268|447851269|FG000|Overall Study|Adverse Event|15|||
124519077|NCT00970268|447851270|FG001|Overall Study|Adverse Event|12|||
124519078|NCT00970268|447851269|FG000|Overall Study|Lack of Efficacy|3|||
124519079|NCT00970268|447851270|FG001|Overall Study|Lack of Efficacy|6|||
124519080|NCT00970268|447851269|FG000|Overall Study|Protocol Violation|4|||
124519081|NCT00970268|447851270|FG001|Overall Study|Protocol Violation|7|||
124519082|NCT00970268|447851269|FG000|Overall Study|Other Reason|3|||
124519083|NCT00970268|447851270|FG001|Overall Study|Other Reason|1|||
124519084|NCT00970268|447851269|FG000|Overall Study|COPD Exacerbation|4|||
124519085|NCT00970268|447851270|FG001|Overall Study|COPD Exacerbation|2|||
124519086|NCT00970268|447851269|FG000|Overall Study|Lost to Follow-up|1|||
124519087|NCT00970268|447851270|FG001|Overall Study|Lost to Follow-up|2|||
124519088|NCT00970268|447851269|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
124519089|NCT00970268|447851270|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
124519090|NCT03404518|447851271|FG000|Overall Study|Lost to Follow-up|28|||
124519091|NCT03404518|447851272|FG001|Overall Study|Lost to Follow-up|30|||
124519092|NCT03404518|447851271|FG000|Overall Study|Protocol Violation|13|||
124519093|NCT03404518|447851272|FG001|Overall Study|Protocol Violation|6|||
124519094|NCT01079195|447851273|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
124519095|NCT01079195|447851273|FG000|Overall Study|No Documentation Available|437|||
124519096|NCT01079195|447851273|FG000|Overall Study|Adverse Event|157|||
124519097|NCT01079195|447851273|FG000|Overall Study|Reason Unknown|39|||
124519098|NCT01079195|447851273|FG000|Overall Study|Withdrawal by Subject|18|||
124519099|NCT01079195|447851273|FG000|Overall Study|Financial Reasons|15|||
124519100|NCT01079195|447851273|FG000|Overall Study|Lack of Effectiveness|12|||
124519101|NCT01079195|447851273|FG000|Overall Study|Physician Decision|4|||
124519102|NCT01079195|447851273|FG000|Overall Study|Improved Status of Participant|4|||
124519103|NCT01079195|447851273|FG000|Overall Study|No Follow-up Documentation Available|4|||
124519104|NCT01079195|447851273|FG000|Overall Study|Non-compliance|2|||
124519105|NCT03693404|447851278|FG000|Overall Study|Withdrawal by Subject|1|||
124519106|NCT03693404|447851279|FG001|Overall Study|Withdrawal by Subject|0|||
124519107|NCT03693404|447851278|FG000|Overall Study|Lost to Follow-up|0|||
124519108|NCT03693404|447851279|FG001|Overall Study|Lost to Follow-up|5|||
124519109|NCT03693404|447851278|FG000|Overall Study|Excluded from Analysis|0|||
124519110|NCT03693404|447851279|FG001|Overall Study|Excluded from Analysis|1|||
124519111|NCT01685203|447851284|FG000|Overall Study|Lost to Follow-up|3|||
124519112|NCT01685203|447851285|FG001|Overall Study|Lost to Follow-up|3|||
124519113|NCT01685203|447851286|FG002|Overall Study|Lost to Follow-up|0|||
124519114|NCT01685203|447851287|FG003|Overall Study|Lost to Follow-up|1|||
124519115|NCT01685203|447851288|FG004|Overall Study|Lost to Follow-up|0|||
124519116|NCT01685203|447851289|FG005|Overall Study|Lost to Follow-up|0|||
124519117|NCT01685203|447851290|FG006|Overall Study|Lost to Follow-up|0|||
124519118|NCT01685203|447851284|FG000|Overall Study|Adverse Event|0|||
124519119|NCT01685203|447851285|FG001|Overall Study|Adverse Event|0|||
124519120|NCT01685203|447851286|FG002|Overall Study|Adverse Event|0|||
124519121|NCT01685203|447851287|FG003|Overall Study|Adverse Event|0|||
124519122|NCT01685203|447851288|FG004|Overall Study|Adverse Event|0|||
124519123|NCT01685203|447851289|FG005|Overall Study|Adverse Event|2|||
124519124|NCT01685203|447851290|FG006|Overall Study|Adverse Event|0|||
124519125|NCT01685203|447851284|FG000|Overall Study|Adverse event and withdrew consent|1|||
124519126|NCT01685203|447851285|FG001|Overall Study|Adverse event and withdrew consent|0|||
124519127|NCT01685203|447851286|FG002|Overall Study|Adverse event and withdrew consent|0|||
124519128|NCT01685203|447851287|FG003|Overall Study|Adverse event and withdrew consent|0|||
124519129|NCT01685203|447851288|FG004|Overall Study|Adverse event and withdrew consent|0|||
124519130|NCT01685203|447851289|FG005|Overall Study|Adverse event and withdrew consent|0|||
124519131|NCT01685203|447851290|FG006|Overall Study|Adverse event and withdrew consent|0|||
124519132|NCT01685203|447851284|FG000|Overall Study|Patient's decision|0|||
124519133|NCT01685203|447851285|FG001|Overall Study|Patient's decision|0|||
124519134|NCT01685203|447851286|FG002|Overall Study|Patient's decision|0|||
124519135|NCT01685203|447851287|FG003|Overall Study|Patient's decision|0|||
124519136|NCT01685203|447851288|FG004|Overall Study|Patient's decision|0|||
124519137|NCT01685203|447851289|FG005|Overall Study|Patient's decision|1|||
124519138|NCT01685203|447851290|FG006|Overall Study|Patient's decision|0|||
124519139|NCT01576406|447851292|FG000|Overall Study|Lost to Follow-up|1|||
124519140|NCT01576406|447851293|FG001|Overall Study|Lost to Follow-up|2|||
124519141|NCT01576406|447851294|FG002|Overall Study|Lost to Follow-up|0|||
124519142|NCT01576406|447851295|FG003|Overall Study|Lost to Follow-up|0|||
124519143|NCT01576406|447851296|FG004|Overall Study|Lost to Follow-up|0|||
124519144|NCT01576406|447851297|FG005|Overall Study|Lost to Follow-up|0|||
124519145|NCT01576406|447851292|FG000|Overall Study|Death|3|||
124519146|NCT01576406|447851293|FG001|Overall Study|Death|4|||
124519147|NCT01576406|447851294|FG002|Overall Study|Death|8|||
124519148|NCT01576406|447851295|FG003|Overall Study|Death|5|||
124519149|NCT01576406|447851296|FG004|Overall Study|Death|7|||
124519150|NCT01576406|447851297|FG005|Overall Study|Death|9|||
124571972|NCT00150462|448053390|FG010|Overall Study|Physician Decision|0|||
124571973|NCT00150462|448053380|FG000|Overall Study|Other|0|||
124519151|NCT01576406|447851292|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
124519152|NCT01576406|447851293|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
124519153|NCT01576406|447851294|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
124519154|NCT01576406|447851295|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
124519155|NCT01576406|447851296|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
124519156|NCT01576406|447851297|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
124519157|NCT01576406|447851292|FG000|Overall Study|Withdrawal the consent|2|||
124519158|NCT01576406|447851293|FG001|Overall Study|Withdrawal the consent|2|||
124519159|NCT01576406|447851294|FG002|Overall Study|Withdrawal the consent|5|||
124519160|NCT01576406|447851295|FG003|Overall Study|Withdrawal the consent|1|||
124519161|NCT01576406|447851296|FG004|Overall Study|Withdrawal the consent|1|||
124519162|NCT01576406|447851297|FG005|Overall Study|Withdrawal the consent|3|||
124519163|NCT01576406|447851292|FG000|Overall Study|Other|0|||
124519164|NCT01576406|447851293|FG001|Overall Study|Other|0|||
124519165|NCT01576406|447851294|FG002|Overall Study|Other|2|||
124519166|NCT01576406|447851295|FG003|Overall Study|Other|2|||
124519167|NCT01576406|447851296|FG004|Overall Study|Other|0|||
124519168|NCT01576406|447851297|FG005|Overall Study|Other|0|||
124519169|NCT00669032|447851302|FG000|Overall Study|Lost to Follow-up|6|||
124519170|NCT00669032|447851303|FG001|Overall Study|Lost to Follow-up|5|||
124519171|NCT00669032|447851302|FG000|Overall Study|Lack of Efficacy|8|||
124519172|NCT00669032|447851303|FG001|Overall Study|Lack of Efficacy|19|||
124519173|NCT00669032|447851302|FG000|Overall Study|Withdrawal by Subject|12|||
124519174|NCT00669032|447851303|FG001|Overall Study|Withdrawal by Subject|13|||
124519175|NCT00669032|447851302|FG000|Overall Study|Adverse Event|12|||
124519176|NCT00669032|447851303|FG001|Overall Study|Adverse Event|16|||
124519177|NCT00669032|447851302|FG000|Overall Study|Physician Decision|1|||
124519178|NCT00669032|447851303|FG001|Overall Study|Physician Decision|1|||
124519179|NCT00669032|447851302|FG000|Overall Study|No fulfilment of the selection criteria|5|||
124519180|NCT00669032|447851303|FG001|Overall Study|No fulfilment of the selection criteria|5|||
124519181|NCT01375647|447853698|FG000|Overall Study|Lost to Follow-up|3|||
124519182|NCT01375647|447853699|FG001|Overall Study|Lost to Follow-up|3|||
124519183|NCT01375647|447853700|FG002|Overall Study|Lost to Follow-up|7|||
124519184|NCT01375647|447853701|FG003|Overall Study|Lost to Follow-up|10|||
124519185|NCT01375647|447853698|FG000|Overall Study|Death|1|||
124519186|NCT01375647|447853699|FG001|Overall Study|Death|2|||
124519187|NCT01375647|447853700|FG002|Overall Study|Death|1|||
124519188|NCT01375647|447853701|FG003|Overall Study|Death|0|||
124519189|NCT01375647|447853698|FG000|Overall Study|Withdrawal by Subject|17|||
124519190|NCT01375647|447853699|FG001|Overall Study|Withdrawal by Subject|20|||
124519191|NCT01375647|447853700|FG002|Overall Study|Withdrawal by Subject|26|||
124519192|NCT01375647|447853701|FG003|Overall Study|Withdrawal by Subject|14|||
124519193|NCT01375647|447853698|FG000|Overall Study|Physician Decision|1|||
124519194|NCT01375647|447853699|FG001|Overall Study|Physician Decision|0|||
124519195|NCT01375647|447853700|FG002|Overall Study|Physician Decision|0|||
124519196|NCT01375647|447853701|FG003|Overall Study|Physician Decision|0|||
124519197|NCT03984812|447853704|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
124519198|NCT03984812|447853705|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
124519199|NCT03984812|447853706|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
124519200|NCT03984812|447853707|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
124519201|NCT03984812|447853708|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
124519202|NCT03984812|447853709|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
124519203|NCT03984812|447853710|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
124519204|NCT03984812|447853711|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
124519205|NCT03984812|447853712|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
124725017|NCT03768089|448613425|FG017|Part A|Lost to Follow-up|0|||
124725018|NCT03768089|448613408|FG000|Part C|Randomized, Never Dosed|0|||
124725019|NCT03768089|448613409|FG001|Part C|Randomized, Never Dosed|0|||
124519206|NCT03984812|447853713|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
124519207|NCT03984812|447853714|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
124519208|NCT03565991|447853715|FG000|Overall Study|Other|11|||
124519209|NCT03565991|447853716|FG001|Overall Study|Other|0|||
124519210|NCT03565991|447853715|FG000|Overall Study|Global deterioration of health status|14|||
124519211|NCT03565991|447853716|FG001|Overall Study|Global deterioration of health status|4|||
124519212|NCT03565991|447853715|FG000|Overall Study|Withdrawal by Subject|2|||
124519213|NCT03565991|447853716|FG001|Overall Study|Withdrawal by Subject|6|||
124519214|NCT03565991|447853715|FG000|Overall Study|Progressive disease|121|||
124725020|NCT03768089|448613410|FG002|Part C|Randomized, Never Dosed|0|||
124725021|NCT03768089|448613411|FG003|Part C|Randomized, Never Dosed|0|||
124519215|NCT03565991|447853716|FG001|Overall Study|Progressive disease|29|||
124519216|NCT03565991|447853715|FG000|Overall Study|Death|3|||
124519217|NCT03565991|447853716|FG001|Overall Study|Death|0|||
124519218|NCT03565991|447853715|FG000|Overall Study|Adverse Event|7|||
124519219|NCT03565991|447853716|FG001|Overall Study|Adverse Event|2|||
124519220|NCT03424044|447853718|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
124519221|NCT03424044|447853719|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
124519222|NCT03424044|447853720|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
124519223|NCT03424044|447853721|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
124519224|NCT03424044|447853722|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
124725022|NCT03768089|448613412|FG004|Part C|Randomized, Never Dosed|0|||
124571974|NCT00150462|448053381|FG001|Overall Study|Other|0|||
124519225|NCT03424044|447853723|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
124519226|NCT03424044|447853724|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
124519227|NCT03424044|447853725|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
124519228|NCT03424044|447853726|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
124519229|NCT03424044|447853718|FG000|First Intervention (76 Hours)|Adverse Event|0|||
124519230|NCT03424044|447853719|FG001|First Intervention (76 Hours)|Adverse Event|0|||
124519231|NCT03424044|447853720|FG002|First Intervention (76 Hours)|Adverse Event|0|||
124519232|NCT03424044|447853721|FG003|First Intervention (76 Hours)|Adverse Event|0|||
124519233|NCT03424044|447853722|FG004|First Intervention (76 Hours)|Adverse Event|1|||
124519234|NCT03424044|447853723|FG005|First Intervention (76 Hours)|Adverse Event|0|||
124519235|NCT03424044|447853724|FG006|First Intervention (76 Hours)|Adverse Event|0|||
124519236|NCT03424044|447853725|FG007|First Intervention (76 Hours)|Adverse Event|0|||
124519237|NCT03424044|447853726|FG008|First Intervention (76 Hours)|Adverse Event|0|||
124519238|NCT03424044|447853718|FG000|First Intervention (76 Hours)|device issues|0|||
124519239|NCT03424044|447853719|FG001|First Intervention (76 Hours)|device issues|0|||
124519240|NCT03424044|447853720|FG002|First Intervention (76 Hours)|device issues|0|||
124519241|NCT03424044|447853721|FG003|First Intervention (76 Hours)|device issues|0|||
124519242|NCT03424044|447853722|FG004|First Intervention (76 Hours)|device issues|0|||
124519243|NCT03424044|447853723|FG005|First Intervention (76 Hours)|device issues|0|||
124519244|NCT03424044|447853724|FG006|First Intervention (76 Hours)|device issues|1|||
124519245|NCT03424044|447853725|FG007|First Intervention (76 Hours)|device issues|1|||
124519246|NCT03424044|447853726|FG008|First Intervention (76 Hours)|device issues|1|||
124519247|NCT03424044|447853718|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
124519248|NCT03424044|447853719|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
124519249|NCT03424044|447853720|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
124519250|NCT03424044|447853721|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
124519251|NCT03424044|447853722|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
124519252|NCT03424044|447853723|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
124519253|NCT03424044|447853724|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
124519254|NCT03424044|447853725|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
124519255|NCT03424044|447853726|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
124519256|NCT03424044|447853718|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
124519257|NCT03424044|447853719|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
124519258|NCT03424044|447853720|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
124519259|NCT03424044|447853721|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
124519260|NCT03424044|447853722|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
124519261|NCT03424044|447853723|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
124519262|NCT03424044|447853724|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
124519263|NCT03424044|447853725|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
124519264|NCT03424044|447853726|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
124519265|NCT02971007|447853727|FG000|Overall Study|Adverse Event|1|||
124519266|NCT02971007|447853728|FG001|Overall Study|Adverse Event|0|||
124519267|NCT02971007|447853729|FG002|Overall Study|Adverse Event|0|||
124519268|NCT02971007|447853727|FG000|Overall Study|Lost to Follow-up|0|||
124519269|NCT02971007|447853728|FG001|Overall Study|Lost to Follow-up|1|||
124519270|NCT02971007|447853729|FG002|Overall Study|Lost to Follow-up|1|||
124519271|NCT02971007|447853727|FG000|Overall Study|Withdrawal by Subject|0|||
124519272|NCT02971007|447853728|FG001|Overall Study|Withdrawal by Subject|1|||
124519273|NCT02971007|447853729|FG002|Overall Study|Withdrawal by Subject|0|||
124519274|NCT02971007|447853727|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
124519275|NCT02971007|447853728|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
124519276|NCT02971007|447853729|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
124519277|NCT02971007|447853727|FG000|Overall Study|Patient discontinued study drug|0|||
124519278|NCT02971007|447853728|FG001|Overall Study|Patient discontinued study drug|1|||
124519279|NCT02971007|447853729|FG002|Overall Study|Patient discontinued study drug|0|||
124519280|NCT00402285|447853734|FG000|Overall Study|insufficient RNA quality|7|||
124519281|NCT00402285|447853735|FG001|Overall Study|insufficient RNA quality|6|||
124519282|NCT00402285|447853736|FG002|Overall Study|insufficient RNA quality|2|||
124519283|NCT00784459|447853737|FG000|Overall Study|Adverse Event|0|||
124519284|NCT00784459|447853738|FG001|Overall Study|Adverse Event|2|||
124519285|NCT02707601|447853739|FG000|Overall Study|Death|0|||
124725023|NCT03768089|448613413|FG005|Part C|Randomized, Never Dosed|0|||
124725024|NCT03768089|448613414|FG006|Part C|Randomized, Never Dosed|0|||
124519286|NCT02707601|447853740|FG001|Overall Study|Death|1|||
124519287|NCT02707601|447853739|FG000|Overall Study|Lack of Efficacy|0|||
124519288|NCT02707601|447853740|FG001|Overall Study|Lack of Efficacy|1|||
124519289|NCT02707601|447853739|FG000|Overall Study|Investigator's Discretion|1|||
124519290|NCT02707601|447853740|FG001|Overall Study|Investigator's Discretion|0|||
124519291|NCT02707601|447853739|FG000|Overall Study|Withdrew Consent|0|||
124519292|NCT02707601|447853740|FG001|Overall Study|Withdrew Consent|1|||
124725025|NCT03768089|448613415|FG007|Part C|Randomized, Never Dosed|0|||
124725026|NCT03768089|448613416|FG008|Part C|Randomized, Never Dosed|0|||
124519293|NCT02707601|447853739|FG000|Overall Study|Lost to Follow-up|1|||
124519294|NCT02707601|447853740|FG001|Overall Study|Lost to Follow-up|1|||
124519295|NCT02707601|447853739|FG000|Overall Study|Participants Randomized but Not Treated|2|||
124519296|NCT02707601|447853740|FG001|Overall Study|Participants Randomized but Not Treated|0|||
124519297|NCT02009930|447853741|FG000|Overall Study|withdrawn|5|||
124519298|NCT02959970|447853743|FG000|Overall Study|Adverse Event|1|||
124519299|NCT02959970|447853744|FG001|Overall Study|Adverse Event|0|||
124519300|NCT02959970|447853743|FG000|Overall Study|Withdrawal by Subject|0|||
124519301|NCT02959970|447853744|FG001|Overall Study|Withdrawal by Subject|2|||
124519302|NCT02959970|447853743|FG000|Overall Study|Lost to Follow-up|1|||
124519303|NCT02959970|447853744|FG001|Overall Study|Lost to Follow-up|5|||
124519304|NCT00693420|447853747|FG000|Overall Study|Adverse Event|4|||
124519305|NCT00693420|447853748|FG001|Overall Study|Adverse Event|4|||
124519306|NCT00693420|447853747|FG000|Overall Study|Lost to Follow-up|0|||
124519307|NCT00693420|447853748|FG001|Overall Study|Lost to Follow-up|3|||
124519308|NCT00693420|447853747|FG000|Overall Study|Withdrawal by Subject|1|||
124519309|NCT00693420|447853748|FG001|Overall Study|Withdrawal by Subject|0|||
124519310|NCT00693420|447853747|FG000|Overall Study|Protocol Violation|0|||
124519311|NCT00693420|447853748|FG001|Overall Study|Protocol Violation|2|||
124519312|NCT00693420|447853747|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
124519313|NCT00693420|447853748|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
124519314|NCT00693420|447853747|FG000|Overall Study|Personal Reasons|1|||
124519315|NCT00693420|447853748|FG001|Overall Study|Personal Reasons|4|||
124519316|NCT00063986|447853754|FG000|Overall Study|Withdrawal by Subject|1|||
124519317|NCT00063986|447853754|FG000|Overall Study|Ineligible|1|||
124519318|NCT00063986|447853754|FG000|Overall Study|Intra-operatively ineligible|4|||
124519319|NCT01235338|447853755|FG000|Overall Study|Adverse Event|3|||
124519320|NCT01235338|447853756|FG001|Overall Study|Adverse Event|2|||
124519321|NCT01235338|447853755|FG000|Overall Study|Protocol Violation|1|||
124519322|NCT01235338|447853756|FG001|Overall Study|Protocol Violation|1|||
124519323|NCT01235338|447853755|FG000|Overall Study|Withdrawal by Subject|5|||
124519324|NCT01235338|447853756|FG001|Overall Study|Withdrawal by Subject|0|||
124519325|NCT01235338|447853755|FG000|Overall Study|Exclusion criteria violations|1|||
124519326|NCT01235338|447853756|FG001|Overall Study|Exclusion criteria violations|1|||
124519327|NCT01235338|447853755|FG000|Overall Study|Positive drug screen|0|||
124519328|NCT01235338|447853756|FG001|Overall Study|Positive drug screen|1|||
124519329|NCT01235338|447853755|FG000|Overall Study|Prohibited meds|1|||
124519330|NCT01235338|447853756|FG001|Overall Study|Prohibited meds|0|||
124519331|NCT00948428|447853760|FG000|Overall Study|Withdrawal by Subject|6|||
124519332|NCT00948428|447853761|FG001|Overall Study|Withdrawal by Subject|12|||
124519333|NCT00948428|447853762|FG002|Overall Study|Withdrawal by Subject|7|||
124519334|NCT00948428|447853760|FG000|Overall Study|Adverse Event|6|||
124519335|NCT00948428|447853761|FG001|Overall Study|Adverse Event|3|||
124519336|NCT00948428|447853762|FG002|Overall Study|Adverse Event|0|||
124519337|NCT00948428|447853760|FG000|Overall Study|Lost to Follow-up|2|||
124519338|NCT00948428|447853761|FG001|Overall Study|Lost to Follow-up|1|||
124519339|NCT00948428|447853762|FG002|Overall Study|Lost to Follow-up|1|||
124519340|NCT00948428|447853760|FG000|Overall Study|Death|2|||
124519341|NCT00948428|447853761|FG001|Overall Study|Death|0|||
124519342|NCT00948428|447853762|FG002|Overall Study|Death|0|||
124519343|NCT00948428|447853760|FG000|Overall Study|Intercurrent Illness|1|||
124519344|NCT00948428|447853761|FG001|Overall Study|Intercurrent Illness|0|||
124519345|NCT00948428|447853762|FG002|Overall Study|Intercurrent Illness|0|||
124519346|NCT00948428|447853760|FG000|Overall Study|Non-compliance|1|||
124519347|NCT00948428|447853761|FG001|Overall Study|Non-compliance|2|||
124519348|NCT00948428|447853762|FG002|Overall Study|Non-compliance|0|||
124519349|NCT00509028|447853763|FG000|Overall Study|Adverse Event|2|||
124519350|NCT00509028|447853764|FG001|Overall Study|Adverse Event|0|||
124519351|NCT00509028|447853763|FG000|Overall Study|Withdrawal by Subject|4|||
124519352|NCT00509028|447853764|FG001|Overall Study|Withdrawal by Subject|3|||
124519353|NCT00509028|447853763|FG000|Overall Study|Lost to Follow-up|0|||
124519354|NCT00509028|447853764|FG001|Overall Study|Lost to Follow-up|1|||
124519355|NCT00509028|447853763|FG000|Overall Study|Protocol Violation|4|||
124519356|NCT00509028|447853764|FG001|Overall Study|Protocol Violation|2|||
124725027|NCT03768089|448613417|FG009|Part C|Randomized, Never Dosed|0|||
124519357|NCT00509028|447853763|FG000|Overall Study|Non-compliance|2|||
124519358|NCT00509028|447853764|FG001|Overall Study|Non-compliance|1|||
124519359|NCT04839393|447853768|FG000|Overall Study|Adverse Event|0|||
124519360|NCT04839393|447853769|FG001|Overall Study|Adverse Event|0|||
124519361|NCT04839393|447853770|FG002|Overall Study|Adverse Event|2|||
124519362|NCT04839393|447853768|FG000|Overall Study|Withdrawal by participant|0|||
124519363|NCT04839393|447853769|FG001|Overall Study|Withdrawal by participant|0|||
124519364|NCT04839393|447853770|FG002|Overall Study|Withdrawal by participant|1|||
124519365|NCT00633893|447853773|FG000|Overall Study|Death|1|||
124725028|NCT03768089|448613418|FG010|Part C|Randomized, Never Dosed|0|||
124725029|NCT03768089|448613419|FG011|Part C|Randomized, Never Dosed|0|||
124519366|NCT00633893|447853774|FG001|Overall Study|Death|3|||
124519367|NCT00633893|447853775|FG002|Overall Study|Death|9|||
124725030|NCT03768089|448613420|FG012|Part C|Randomized, Never Dosed|0|||
124519368|NCT00633893|447853773|FG000|Overall Study|Adverse Event|65|||
124519369|NCT00633893|447853774|FG001|Overall Study|Adverse Event|58|||
124519370|NCT00633893|447853775|FG002|Overall Study|Adverse Event|126|||
124519371|NCT00633893|447853773|FG000|Overall Study|Withdrawal by Subject|7|||
124519372|NCT00633893|447853774|FG001|Overall Study|Withdrawal by Subject|12|||
124519373|NCT00633893|447853775|FG002|Overall Study|Withdrawal by Subject|6|||
124519374|NCT00633893|447853773|FG000|Overall Study|Lost to Follow-up|2|||
124519375|NCT00633893|447853774|FG001|Overall Study|Lost to Follow-up|4|||
124519376|NCT00633893|447853775|FG002|Overall Study|Lost to Follow-up|8|||
124519377|NCT00633893|447853773|FG000|Overall Study|Poor/non-compliance|5|||
124519378|NCT00633893|447853774|FG001|Overall Study|Poor/non-compliance|12|||
124519379|NCT00633893|447853775|FG002|Overall Study|Poor/non-compliance|3|||
124519380|NCT00633893|447853773|FG000|Overall Study|Pregnancy|2|||
124519381|NCT00633893|447853774|FG001|Overall Study|Pregnancy|1|||
124519382|NCT00633893|447853775|FG002|Overall Study|Pregnancy|1|||
124519383|NCT00633893|447853773|FG000|Overall Study|Not meet/no longer meets criteria|4|||
124519384|NCT00633893|447853774|FG001|Overall Study|Not meet/no longer meets criteria|6|||
124519385|NCT00633893|447853775|FG002|Overall Study|Not meet/no longer meets criteria|4|||
124519386|NCT00633893|447853773|FG000|Overall Study|Other|28|||
124519387|NCT00633893|447853774|FG001|Overall Study|Other|33|||
124519388|NCT00633893|447853775|FG002|Overall Study|Other|31|||
124519389|NCT02741310|447853776|FG000|Overall Study|Sponsor Decision|2|||
124519390|NCT02741310|447853777|FG001|Overall Study|Sponsor Decision|2|||
124519391|NCT03051217|447853778|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
124519392|NCT03051217|447853779|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124519393|NCT03051217|447853780|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
124519394|NCT03051217|447853781|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124519395|NCT03051217|447853782|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124519396|NCT03051217|447853783|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124519397|NCT03051217|447853784|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
124519398|NCT03051217|447853778|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
124519399|NCT03051217|447853779|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
124519400|NCT03051217|447853780|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
124519401|NCT03051217|447853781|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
124519402|NCT03051217|447853782|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
124519403|NCT03051217|447853783|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
124519404|NCT03051217|447853784|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
124519405|NCT03051217|447853778|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
124519406|NCT03051217|447853779|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
124519407|NCT03051217|447853780|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
124519408|NCT03051217|447853781|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124519409|NCT03051217|447853782|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124519410|NCT03051217|447853783|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124519411|NCT03051217|447853784|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
124519412|NCT03051217|447853778|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
124519413|NCT03051217|447853779|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
124519414|NCT03051217|447853780|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
124519415|NCT03051217|447853781|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
124519416|NCT03051217|447853782|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
124519417|NCT03051217|447853783|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
124519418|NCT03051217|447853784|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
124519419|NCT03051217|447853778|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
124519420|NCT03051217|447853779|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
124519421|NCT03051217|447853780|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
124519422|NCT03051217|447853781|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
124519423|NCT03051217|447853782|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
124519424|NCT03051217|447853783|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
124519425|NCT03051217|447853784|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
124519426|NCT03051217|447853778|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
124519427|NCT03051217|447853779|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
124519428|NCT03051217|447853780|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
124519429|NCT03051217|447853781|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
124519430|NCT03051217|447853782|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
124519431|NCT03051217|447853783|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
124519432|NCT03051217|447853784|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
124519433|NCT03051217|447853778|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
124519434|NCT03051217|447853779|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
124519435|NCT03051217|447853780|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
124519436|NCT03051217|447853781|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
124571975|NCT00150462|448053382|FG002|Overall Study|Other|0|||
124519437|NCT03051217|447853782|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
124519438|NCT03051217|447853783|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
124519439|NCT03051217|447853784|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
124519440|NCT03051217|447853778|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
124519441|NCT03051217|447853779|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
124519442|NCT03051217|447853780|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
124519443|NCT03051217|447853781|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
124519444|NCT03051217|447853782|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
124519445|NCT03051217|447853783|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
124519446|NCT03051217|447853784|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
124519447|NCT00109772|447853785|FG000|Double-blind Treatment|Adverse Event|14|||
124519448|NCT00109772|447853786|FG001|Double-blind Treatment|Adverse Event|5|||
124519449|NCT00109772|447853785|FG000|Double-blind Treatment|Lack of Efficacy|1|||
124519450|NCT00109772|447853786|FG001|Double-blind Treatment|Lack of Efficacy|0|||
124519451|NCT00109772|447853785|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
124519452|NCT00109772|447853786|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
124519453|NCT00109772|447853785|FG000|Double-blind Treatment|Lost to Follow-up|2|||
124519454|NCT00109772|447853786|FG001|Double-blind Treatment|Lost to Follow-up|3|||
124519455|NCT00109772|447853785|FG000|Double-blind Treatment|Protocol Violation|0|||
124519456|NCT00109772|447853786|FG001|Double-blind Treatment|Protocol Violation|1|||
124519457|NCT00109772|447853785|FG000|Double-blind Treatment|Other|0|||
124519458|NCT00109772|447853786|FG001|Double-blind Treatment|Other|4|||
124519459|NCT00109772|447853785|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
124519460|NCT00109772|447853786|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
124519461|NCT00109772|447853785|FG000|Open-label Extension|Adverse Event|10|||
124519462|NCT00109772|447853786|FG001|Open-label Extension|Adverse Event|19|||
124519463|NCT00109772|447853785|FG000|Open-label Extension|Lack of Efficacy|19|||
124519464|NCT00109772|447853786|FG001|Open-label Extension|Lack of Efficacy|11|||
124519465|NCT00109772|447853785|FG000|Open-label Extension|Withdrawal by Subject|9|||
124519466|NCT00109772|447853786|FG001|Open-label Extension|Withdrawal by Subject|6|||
124519467|NCT00109772|447853785|FG000|Open-label Extension|Lost to Follow-up|1|||
124519468|NCT00109772|447853786|FG001|Open-label Extension|Lost to Follow-up|0|||
124519469|NCT00109772|447853785|FG000|Open-label Extension|Death|0|||
124519470|NCT00109772|447853786|FG001|Open-label Extension|Death|1|||
124519471|NCT00109772|447853785|FG000|Open-label Extension|Protocol Violation|2|||
124519472|NCT00109772|447853786|FG001|Open-label Extension|Protocol Violation|2|||
124519473|NCT00109772|447853785|FG000|Open-label Extension|Other|4|||
124519474|NCT00109772|447853786|FG001|Open-label Extension|Other|10|||
124519475|NCT04539262|447853787|FG000|Overall Study|Adverse Event|0|||
124519476|NCT04539262|447853788|FG001|Overall Study|Adverse Event|0|||
124519477|NCT04539262|447853789|FG002|Overall Study|Adverse Event|1|||
124519478|NCT04539262|447853790|FG003|Overall Study|Adverse Event|0|||
124519479|NCT04539262|447853791|FG004|Overall Study|Adverse Event|0|||
124519480|NCT04539262|447853792|FG005|Overall Study|Adverse Event|0|||
124519481|NCT04539262|447853793|FG006|Overall Study|Adverse Event|0|||
124519482|NCT04539262|447853794|FG007|Overall Study|Adverse Event|0|||
124519483|NCT04539262|447853787|FG000|Overall Study|Withdrew Consent|0|||
124519484|NCT04539262|447853788|FG001|Overall Study|Withdrew Consent|0|||
124571976|NCT00150462|448053383|FG003|Overall Study|Other|0|||
124519485|NCT04539262|447853789|FG002|Overall Study|Withdrew Consent|0|||
124519486|NCT04539262|447853790|FG003|Overall Study|Withdrew Consent|1|||
124519487|NCT04539262|447853791|FG004|Overall Study|Withdrew Consent|0|||
124519488|NCT04539262|447853792|FG005|Overall Study|Withdrew Consent|0|||
124519489|NCT04539262|447853793|FG006|Overall Study|Withdrew Consent|0|||
124519490|NCT04539262|447853794|FG007|Overall Study|Withdrew Consent|0|||
124571977|NCT00150462|448053384|FG004|Overall Study|Other|0|||
124571978|NCT00150462|448053385|FG005|Overall Study|Other|0|||
124571979|NCT00150462|448053386|FG006|Overall Study|Other|0|||
124571980|NCT00150462|448053387|FG007|Overall Study|Other|0|||
124571981|NCT00150462|448053388|FG008|Overall Study|Other|0|||
124571982|NCT00150462|448053389|FG009|Overall Study|Other|1|||
124571983|NCT00150462|448053390|FG010|Overall Study|Other|1|||
124725031|NCT03768089|448613421|FG013|Part C|Randomized, Never Dosed|0|||
124519491|NCT04539262|447853787|FG000|Overall Study|Randomized, Not treated|0|||
124519492|NCT04539262|447853788|FG001|Overall Study|Randomized, Not treated|1|||
124519493|NCT04539262|447853789|FG002|Overall Study|Randomized, Not treated|0|||
124519494|NCT04539262|447853790|FG003|Overall Study|Randomized, Not treated|0|||
124519495|NCT04539262|447853791|FG004|Overall Study|Randomized, Not treated|0|||
124519496|NCT04539262|447853792|FG005|Overall Study|Randomized, Not treated|0|||
124519497|NCT04539262|447853793|FG006|Overall Study|Randomized, Not treated|1|||
124519498|NCT04539262|447853794|FG007|Overall Study|Randomized, Not treated|0|||
124519499|NCT03725293|447853799|FG000|Overall Study|Physician Decision|9|||
124519500|NCT03725293|447853800|FG001|Overall Study|Physician Decision|6|||
124519501|NCT03725293|447853799|FG000|Overall Study|alternative vascular access needs|1|||
124571984|NCT01196052|448053393|FG000|Overall Study|Adverse Event|9|||
124571985|NCT01196052|448053393|FG000|Overall Study|Lost to Follow-up|1|||
124571986|NCT01196052|448053393|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
124571987|NCT01196052|448053393|FG000|Overall Study|Reason not Specified|5|||
124571988|NCT01196052|448053393|FG000|Overall Study|Withdrawal by Subject|6|||
124571989|NCT01572948|448053394|FG000|Overall Study|Lost to Follow-up|1|||
124571990|NCT01572948|448053395|FG001|Overall Study|Lost to Follow-up|0|||
124571991|NCT01572948|448053394|FG000|Overall Study|unable to contact|0|||
124571992|NCT01572948|448053395|FG001|Overall Study|unable to contact|1|||
124571993|NCT03603314|448053396|FG000|Overall Study|Lost to Follow-up|0|||
124571994|NCT03603314|448053397|FG001|Overall Study|Lost to Follow-up|3|||
124571995|NCT03603314|448053398|FG002|Overall Study|Lost to Follow-up|0|||
124571996|NCT03603314|448053396|FG000|Overall Study|Protocol Violation|0|||
124571997|NCT03603314|448053397|FG001|Overall Study|Protocol Violation|1|||
124571998|NCT03603314|448053398|FG002|Overall Study|Protocol Violation|0|||
124571999|NCT03603314|448053396|FG000|Overall Study|Adverse Event|2|||
124572000|NCT03603314|448053397|FG001|Overall Study|Adverse Event|0|||
124572001|NCT03603314|448053398|FG002|Overall Study|Adverse Event|0|||
124572002|NCT03603314|448053396|FG000|Overall Study|Physician Decision|1|||
124572003|NCT03603314|448053397|FG001|Overall Study|Physician Decision|1|||
124572004|NCT03603314|448053398|FG002|Overall Study|Physician Decision|0|||
124572005|NCT03603314|448053396|FG000|Overall Study|Withdrawal by Subject|4|||
124572006|NCT03603314|448053397|FG001|Overall Study|Withdrawal by Subject|5|||
124572007|NCT03603314|448053398|FG002|Overall Study|Withdrawal by Subject|3|||
124572008|NCT03603314|448053396|FG000|Overall Study|Other|0|||
124572009|NCT03603314|448053397|FG001|Overall Study|Other|1|||
124572010|NCT03603314|448053398|FG002|Overall Study|Other|0|||
124572011|NCT03450070|448053399|FG000|Overall Study|Withdrawal by Subject|8|||
124572012|NCT01720264|448053402|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
124572013|NCT01720264|448053402|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
124572014|NCT01720264|448053402|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
124572015|NCT00877032|448053403|FG000|Overall Study|Did not meet entrance criteria|0|||
124572016|NCT00877032|448053404|FG001|Overall Study|Did not meet entrance criteria|0|||
124572017|NCT00877032|448053405|FG002|Overall Study|Did not meet entrance criteria|0|||
124572018|NCT00877032|448053406|FG003|Overall Study|Did not meet entrance criteria|1|||
124572019|NCT00877032|448053407|FG004|Overall Study|Did not meet entrance criteria|0|||
124572020|NCT00877032|448053408|FG005|Overall Study|Did not meet entrance criteria|0|||
124572021|NCT00877032|448053409|FG006|Overall Study|Did not meet entrance criteria|2|||
124572022|NCT00615069|448053419|FG000|Overall Study|Death|10|||
124572023|NCT00615069|448053419|FG000|Overall Study|Physician Decision|2|||
124572024|NCT00615069|448053419|FG000|Overall Study|Withdrawal by Subject|4|||
124572025|NCT00669942|448053421|FG000|Parts 2 and 3|Adverse Event|0|||
124572026|NCT00669942|448053422|FG001|Parts 2 and 3|Adverse Event|0|||
124572027|NCT00669942|448053423|FG002|Parts 2 and 3|Adverse Event|0|||
124572028|NCT00669942|448053424|FG003|Parts 2 and 3|Adverse Event|0|||
124572029|NCT00669942|448053425|FG004|Parts 2 and 3|Adverse Event|0|||
124572030|NCT00669942|448053426|FG005|Parts 2 and 3|Adverse Event|0|||
124572031|NCT00669942|448053427|FG006|Parts 2 and 3|Adverse Event|0|||
124572032|NCT00669942|448053428|FG007|Parts 2 and 3|Adverse Event|2|||
124572033|NCT00669942|448053429|FG008|Parts 2 and 3|Adverse Event|1|||
124572034|NCT00669942|448053430|FG009|Parts 2 and 3|Adverse Event|0|||
124572035|NCT00669942|448053431|FG010|Parts 2 and 3|Adverse Event|0|||
124572036|NCT00669942|448053432|FG011|Parts 2 and 3|Adverse Event|0|||
124572037|NCT00669942|448053421|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
124572038|NCT00669942|448053422|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
124572039|NCT00669942|448053423|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
124572040|NCT00669942|448053424|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
124572041|NCT00669942|448053425|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
124572042|NCT00669942|448053426|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
124572043|NCT00669942|448053427|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
124572044|NCT00669942|448053428|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
124572045|NCT00669942|448053429|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
124572046|NCT00669942|448053430|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
124572047|NCT00669942|448053431|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
124572048|NCT00669942|448053432|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
124572049|NCT00669942|448053421|FG000|Parts 2 and 3|Protocol Violation|0|||
124572050|NCT00669942|448053422|FG001|Parts 2 and 3|Protocol Violation|0|||
124572051|NCT00669942|448053423|FG002|Parts 2 and 3|Protocol Violation|0|||
124572052|NCT00669942|448053424|FG003|Parts 2 and 3|Protocol Violation|0|||
124572053|NCT00669942|448053425|FG004|Parts 2 and 3|Protocol Violation|0|||
124572054|NCT00669942|448053426|FG005|Parts 2 and 3|Protocol Violation|1|||
124572055|NCT00669942|448053427|FG006|Parts 2 and 3|Protocol Violation|0|||
124572056|NCT00669942|448053428|FG007|Parts 2 and 3|Protocol Violation|0|||
124572057|NCT00669942|448053429|FG008|Parts 2 and 3|Protocol Violation|0|||
124572058|NCT00669942|448053430|FG009|Parts 2 and 3|Protocol Violation|0|||
124572059|NCT00669942|448053431|FG010|Parts 2 and 3|Protocol Violation|0|||
124572060|NCT00669942|448053432|FG011|Parts 2 and 3|Protocol Violation|0|||
124725032|NCT03768089|448613422|FG014|Part C|Randomized, Never Dosed|1|||
124572061|NCT00259012|448053434|FG000|Overall Study|Adverse Event|0|||
124572062|NCT00259012|448053435|FG001|Overall Study|Adverse Event|1|||
124572063|NCT00259012|448053434|FG000|Overall Study|Withdrawal by Subject|1|||
124572064|NCT00259012|448053435|FG001|Overall Study|Withdrawal by Subject|0|||
124572065|NCT00259012|448053434|FG000|Overall Study|Physician Decision|0|||
124572066|NCT00259012|448053435|FG001|Overall Study|Physician Decision|1|||
124572067|NCT00259012|448053434|FG000|Overall Study|Lost to Follow-up|0|||
124572068|NCT00259012|448053435|FG001|Overall Study|Lost to Follow-up|1|||
124572069|NCT00259012|448053434|FG000|Overall Study|Protocol Violation|1|||
124572070|NCT00259012|448053435|FG001|Overall Study|Protocol Violation|1|||
124572071|NCT01496183|448053442|FG000|Overall Study|Physician Decision|3|||
124572072|NCT01496183|448053443|FG001|Overall Study|Physician Decision|1|||
124572073|NCT01496183|448053442|FG000|Overall Study|Withdrawal by Subject|0|||
124572074|NCT01496183|448053443|FG001|Overall Study|Withdrawal by Subject|1|||
124572075|NCT03002077|448053444|FG000|Overall Study|Non-compliance with Study Drug|4|||
124572076|NCT03002077|448053444|FG000|Overall Study|Non-compliance w/Background ADT|1|||
124572077|NCT03002077|448053444|FG000|Overall Study|Study Terminated by Sponsor|257|||
124572078|NCT03002077|448053444|FG000|Overall Study|Site Terminated by Sponsor|5|||
124572079|NCT03002077|448053444|FG000|Overall Study|Miscellaneous Reasons|10|||
124572080|NCT03002077|448053444|FG000|Overall Study|Adverse Event|23|||
124572081|NCT03002077|448053444|FG000|Overall Study|Lack of Efficacy|20|||
124572082|NCT03002077|448053444|FG000|Overall Study|Withdrawal by Subject|72|||
124572083|NCT03002077|448053444|FG000|Overall Study|Lost to Follow-up|21|||
124572084|NCT03002077|448053444|FG000|Overall Study|Pregnancy|4|||
124572085|NCT03002077|448053444|FG000|Overall Study|Protocol Violation|21|||
124572086|NCT04625114|448053447|FG000|Overall Study|Adverse Event|3|||
124572087|NCT04625114|448053448|FG001|Overall Study|Adverse Event|1|||
124572088|NCT04625114|448053447|FG000|Overall Study|Withdrawal by Subject|2|||
124572089|NCT04625114|448053448|FG001|Overall Study|Withdrawal by Subject|0|||
124572090|NCT00336479|448053459|FG000|Overall Study|Adverse Event|8|||
124572091|NCT00336479|448053460|FG001|Overall Study|Adverse Event|11|||
124572092|NCT00336479|448053461|FG002|Overall Study|Adverse Event|18|||
124572093|NCT00336479|448053462|FG003|Overall Study|Adverse Event|4|||
124572094|NCT00336479|448053459|FG000|Overall Study|Noncompliant|1|||
124572095|NCT00336479|448053460|FG001|Overall Study|Noncompliant|7|||
124572096|NCT00336479|448053461|FG002|Overall Study|Noncompliant|3|||
124572097|NCT00336479|448053462|FG003|Overall Study|Noncompliant|0|||
124572098|NCT00336479|448053459|FG000|Overall Study|Physician Decision|2|||
124572099|NCT00336479|448053460|FG001|Overall Study|Physician Decision|3|||
124572100|NCT00336479|448053461|FG002|Overall Study|Physician Decision|1|||
124572101|NCT00336479|448053462|FG003|Overall Study|Physician Decision|0|||
124572102|NCT00336479|448053459|FG000|Overall Study|Lost to Follow-up|3|||
124572103|NCT00336479|448053460|FG001|Overall Study|Lost to Follow-up|2|||
124572104|NCT00336479|448053461|FG002|Overall Study|Lost to Follow-up|0|||
124572105|NCT00336479|448053462|FG003|Overall Study|Lost to Follow-up|0|||
124572106|NCT00336479|448053459|FG000|Overall Study|Withdrawal by Subject|3|||
124572107|NCT00336479|448053460|FG001|Overall Study|Withdrawal by Subject|2|||
124572108|NCT00336479|448053461|FG002|Overall Study|Withdrawal by Subject|3|||
124572109|NCT00336479|448053462|FG003|Overall Study|Withdrawal by Subject|0|||
124572110|NCT00336479|448053459|FG000|Overall Study|Other|0|||
124572111|NCT00336479|448053460|FG001|Overall Study|Other|0|||
124572112|NCT00336479|448053461|FG002|Overall Study|Other|1|||
124572113|NCT00336479|448053462|FG003|Overall Study|Other|0|||
124572114|NCT00336479|448053459|FG000|Overall Study|Virologic Stopping Rule|20|||
124572115|NCT00336479|448053460|FG001|Overall Study|Virologic Stopping Rule|0|||
124572116|NCT00336479|448053461|FG002|Overall Study|Virologic Stopping Rule|0|||
124572117|NCT00336479|448053462|FG003|Overall Study|Virologic Stopping Rule|0|||
124572118|NCT01479439|448053463|FG000|Overall Study|Adverse Event|1|||
124572119|NCT01479439|448053464|FG001|Overall Study|Adverse Event|0|||
124572120|NCT01479439|448053465|FG002|Overall Study|Adverse Event|0|||
124572121|NCT01479439|448053463|FG000|Overall Study|Lost to Follow-up|0|||
124572122|NCT01479439|448053464|FG001|Overall Study|Lost to Follow-up|1|||
124572123|NCT01479439|448053465|FG002|Overall Study|Lost to Follow-up|0|||
124572124|NCT01479439|448053463|FG000|Overall Study|Protocol Violation|0|||
124572125|NCT01479439|448053464|FG001|Overall Study|Protocol Violation|0|||
124572126|NCT01479439|448053465|FG002|Overall Study|Protocol Violation|2|||
124572127|NCT02365207|448053466|FG000|Overall Study|Withdrawal by Subject|1|||
124572128|NCT02365207|448053466|FG000|Overall Study|Physician Decision|1|||
124572129|NCT01722877|448053467|FG000|Overall Study|Death|1|||
124572130|NCT01722877|448053467|FG000|Overall Study|Lost to Follow-up|1|||
124572131|NCT01395030|448053468|FG000|Overall Study|Did not complete FCH PET/CT|7|||
124572132|NCT02079766|448053469|FG000|Overall Study|Physician Decision|1|||
124572133|NCT02079766|448053470|FG001|Overall Study|Physician Decision|0|||
124572134|NCT02079766|448053469|FG000|Overall Study|Withdrawal by Subject|1|||
124572135|NCT02079766|448053470|FG001|Overall Study|Withdrawal by Subject|0|||
124572136|NCT05067647|448053474|FG000|Overall Study|Lost to Follow-up|1|||
124572137|NCT00857623|448053476|FG000|Overall Study|Adverse Event|5|||
124572138|NCT00857623|448053477|FG001|Overall Study|Adverse Event|2|||
124572139|NCT00857623|448053476|FG000|Overall Study|Study-specific discontinuation criteria|5|||
124572140|NCT00857623|448053477|FG001|Overall Study|Study-specific discontinuation criteria|3|||
124572141|NCT00857623|448053476|FG000|Overall Study|Withdrawal by Subject|2|||
124572142|NCT00857623|448053477|FG001|Overall Study|Withdrawal by Subject|1|||
124572143|NCT00857623|448053476|FG000|Overall Study|Lack of Efficacy|1|||
124572144|NCT00857623|448053477|FG001|Overall Study|Lack of Efficacy|1|||
124572145|NCT00857623|448053476|FG000|Overall Study|Severe non-compliance to protocol|1|||
124572146|NCT00857623|448053477|FG001|Overall Study|Severe non-compliance to protocol|1|||
124572147|NCT00857623|448053476|FG000|Overall Study|Intake of prohibited medication|0|||
124572148|NCT00857623|448053477|FG001|Overall Study|Intake of prohibited medication|1|||
124572149|NCT00857623|448053476|FG000|Overall Study|Positive for HEP C|0|||
124572150|NCT00857623|448053477|FG001|Overall Study|Positive for HEP C|1|||
124572151|NCT00870870|448053480|FG000|Overall Study|Withdrawal by Subject|0|||
124572152|NCT00870870|448053481|FG001|Overall Study|Withdrawal by Subject|1|||
124572153|NCT00870870|448053482|FG002|Overall Study|Withdrawal by Subject|1|||
124572154|NCT00870870|448053483|FG003|Overall Study|Withdrawal by Subject|3|||
124572155|NCT00870870|448053480|FG000|Overall Study|Adverse Event|0|||
124572156|NCT00870870|448053481|FG001|Overall Study|Adverse Event|0|||
124572157|NCT00870870|448053482|FG002|Overall Study|Adverse Event|2|||
124572158|NCT00870870|448053483|FG003|Overall Study|Adverse Event|2|||
124572159|NCT00694551|448053486|FG000|Overall Study|Disease Progression|1|||
124572160|NCT00694551|448053487|FG001|Overall Study|Disease Progression|0|||
124572161|NCT00694551|448053488|FG002|Overall Study|Disease Progression|1|||
124572162|NCT00385684|448053491|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
124572163|NCT00385684|448053492|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
124572164|NCT00385684|448053491|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
124572165|NCT00385684|448053492|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
124572166|NCT00385684|448053491|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
124572167|NCT00385684|448053492|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
124572168|NCT02801877|448053493|FG000|Overall Study|Lost to Follow-up|1|||
124572169|NCT02801877|448053494|FG001|Overall Study|Lost to Follow-up|1|||
124572170|NCT02801877|448053495|FG002|Overall Study|Lost to Follow-up|2|||
124572171|NCT02801877|448053496|FG003|Overall Study|Lost to Follow-up|0|||
124572172|NCT02801877|448053493|FG000|Overall Study|Never Started Treatment|2|||
124572173|NCT02801877|448053494|FG001|Overall Study|Never Started Treatment|0|||
124572174|NCT02801877|448053495|FG002|Overall Study|Never Started Treatment|4|||
124572175|NCT02801877|448053496|FG003|Overall Study|Never Started Treatment|0|||
124572176|NCT02924038|448055047|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
124572177|NCT02924038|448055048|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
124572178|NCT03601637|448055049|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
124572179|NCT03601637|448055050|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
124572180|NCT03601637|448055049|FG000|Overall Study|Adverse Event|1|||
124572181|NCT03601637|448055050|FG001|Overall Study|Adverse Event|1|||
124572182|NCT03601637|448055049|FG000|Overall Study|Other|0|||
124572183|NCT03601637|448055050|FG001|Overall Study|Other|1|||
124572184|NCT00420303|448055053|FG000|Overall Study|Serious Adverse Event|1|||
124572185|NCT00420303|448055054|FG001|Overall Study|Serious Adverse Event|0|||
124572186|NCT00420303|448055053|FG000|Overall Study|Lack of Efficacy|0|||
124572187|NCT00420303|448055054|FG001|Overall Study|Lack of Efficacy|3|||
124572188|NCT00420303|448055053|FG000|Overall Study|Physician Decision|0|||
124572189|NCT00420303|448055054|FG001|Overall Study|Physician Decision|1|||
124572190|NCT01029353|448055056|FG000|Overall Study|Lost to Follow-up|4|||
124572191|NCT01029353|448055057|FG001|Overall Study|Lost to Follow-up|5|||
124572192|NCT01029353|448055058|FG002|Overall Study|Lost to Follow-up|5|||
124572193|NCT01029353|448055059|FG003|Overall Study|Lost to Follow-up|4|||
124572194|NCT01029353|448055056|FG000|Overall Study|Consent Withdrawn|2|||
124572195|NCT01029353|448055057|FG001|Overall Study|Consent Withdrawn|0|||
124572196|NCT01029353|448055058|FG002|Overall Study|Consent Withdrawn|0|||
124572197|NCT01029353|448055059|FG003|Overall Study|Consent Withdrawn|0|||
124572198|NCT01029353|448055056|FG000|Overall Study|Primary Outcome Indeterminate|1|||
124725033|NCT03768089|448613423|FG015|Part C|Randomized, Never Dosed|0|||
124725034|NCT03768089|448613424|FG016|Part C|Randomized, Never Dosed|0|||
124725035|NCT03768089|448613425|FG017|Part C|Randomized, Never Dosed|0|||
124572199|NCT01029353|448055057|FG001|Overall Study|Primary Outcome Indeterminate|3|||
124572200|NCT01029353|448055058|FG002|Overall Study|Primary Outcome Indeterminate|2|||
124572201|NCT01029353|448055059|FG003|Overall Study|Primary Outcome Indeterminate|0|||
124572202|NCT01900730|448055060|FG000|Overall Study|Withdrawal by Subject|1|||
124572203|NCT01900730|448055061|FG001|Overall Study|Withdrawal by Subject|0|||
124572204|NCT01900730|448055060|FG000|Overall Study|Screen Failure|1|||
124572205|NCT01900730|448055061|FG001|Overall Study|Screen Failure|0|||
124572206|NCT01520909|448055062|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
124572207|NCT01520909|448055063|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
124572208|NCT01520909|448055064|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
124572209|NCT01520909|448055062|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
124572210|NCT01520909|448055063|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
124725036|NCT02120300|448613428|FG000|Overall Study|Enrolled but Never Treated|2|||
124725037|NCT02120300|448613429|FG001|Overall Study|Enrolled but Never Treated|0|||
124572211|NCT01520909|448055064|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
124572212|NCT01520909|448055062|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
124572213|NCT01520909|448055063|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
124572214|NCT01520909|448055064|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
124572215|NCT01520909|448055062|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
124572216|NCT01520909|448055063|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
124572217|NCT01520909|448055064|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
124519502|NCT03725293|447853800|FG001|Overall Study|alternative vascular access needs|2|||
124519503|NCT03725293|447853799|FG000|Overall Study|venous anatomy screen failures|2|||
124519504|NCT03725293|447853800|FG001|Overall Study|venous anatomy screen failures|1|||
124519505|NCT04397796|447853803|FG000|Overall Study|Death|3|||
124519506|NCT04397796|447853804|FG001|Overall Study|Death|1|||
124519507|NCT00802867|447853805|FG000|Overall Study|Lost to Follow-up|6|||
124519508|NCT00802867|447853805|FG000|Overall Study|Protocol Violation|6|||
124519509|NCT00802867|447853805|FG000|Overall Study|Withdrawal by Subject|1|||
124519510|NCT01061567|447853806|FG000|Overall Study|Adverse Event|32|||
124519511|NCT01061567|447853806|FG000|Overall Study|Death|2|||
124519512|NCT01061567|447853806|FG000|Overall Study|Lack of Efficacy|3|||
124519513|NCT01061567|447853806|FG000|Overall Study|Lost to Follow-up|24|||
124519514|NCT01061567|447853806|FG000|Overall Study|Protocol Violation|1|||
124519515|NCT01061567|447853806|FG000|Overall Study|Withdrawal by Subject|11|||
124519516|NCT01061567|447853806|FG000|Overall Study|Other reason than stated above|3|||
124519517|NCT01156532|447853813|FG000|Overall Study|Family Reasons|1|||
124519518|NCT01156532|447853813|FG000|Overall Study|Lost to Follow-up|1|||
124519519|NCT03371251|447853814|FG000|Overall Study|Withdrawal by Subject|1|||
124519520|NCT03371251|447853815|FG001|Overall Study|Withdrawal by Subject|0|||
124519521|NCT03371251|447853816|FG002|Overall Study|Withdrawal by Subject|1|||
124519522|NCT03371251|447853817|FG003|Overall Study|Withdrawal by Subject|0|||
124519523|NCT03371251|447853818|FG004|Overall Study|Withdrawal by Subject|2|||
124519524|NCT03371251|447853819|FG005|Overall Study|Withdrawal by Subject|2|||
124519525|NCT03371251|447853814|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
124519526|NCT03371251|447853815|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
124519527|NCT03371251|447853816|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
124519528|NCT03371251|447853817|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
124519529|NCT03371251|447853818|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
124519530|NCT03371251|447853819|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
124519531|NCT03371251|447853814|FG000|Overall Study|Adverse Event|0|||
124519532|NCT03371251|447853815|FG001|Overall Study|Adverse Event|0|||
124519533|NCT03371251|447853816|FG002|Overall Study|Adverse Event|0|||
124519534|NCT03371251|447853817|FG003|Overall Study|Adverse Event|0|||
124519535|NCT03371251|447853818|FG004|Overall Study|Adverse Event|1|||
124519536|NCT03371251|447853819|FG005|Overall Study|Adverse Event|0|||
124519537|NCT03371251|447853814|FG000|Overall Study|Decision by Sponsor|0|||
124519538|NCT03371251|447853815|FG001|Overall Study|Decision by Sponsor|0|||
124519539|NCT03371251|447853816|FG002|Overall Study|Decision by Sponsor|0|||
124519540|NCT03371251|447853817|FG003|Overall Study|Decision by Sponsor|0|||
124519541|NCT03371251|447853818|FG004|Overall Study|Decision by Sponsor|2|||
124519542|NCT03371251|447853819|FG005|Overall Study|Decision by Sponsor|0|||
124519543|NCT00114218|447853820|FG000|Overall Study|Wrong Cell Type|2|||
124519544|NCT00114218|447853820|FG000|Overall Study|Wrong Primary|1|||
124519545|NCT00114218|447853820|FG000|Overall Study|Never Treated|1|||
124519546|NCT00291187|447853821|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
124519547|NCT00291187|447853822|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
124519548|NCT00291187|447853823|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
124519549|NCT00291187|447853824|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
124519550|NCT03168555|447853826|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
124519551|NCT03168555|447853826|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
124519552|NCT03168555|447853826|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
124519553|NCT03168555|447853826|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
124519554|NCT01040845|447853827|FG000|Overall Study|Withdrawal by Subject|1|||
124519555|NCT01040845|447853828|FG001|Overall Study|Withdrawal by Subject|1|||
124519556|NCT01040845|447853827|FG000|Overall Study|Physician Decision|1|||
124519557|NCT01040845|447853828|FG001|Overall Study|Physician Decision|0|||
124519558|NCT02708966|447853832|FG000|Overall Study|Lost to Follow-up|2|||
124519559|NCT02708966|447853833|FG001|Overall Study|Lost to Follow-up|2|||
124519560|NCT02959190|447853837|FG000|Open Label|Adverse Event|5|||
124519561|NCT02959190|447853838|FG001|Open Label|Adverse Event|7|||
124519562|NCT02959190|447853839|FG002|Open Label|Adverse Event|3|||
124519563|NCT02959190|447853840|FG003|Open Label|Adverse Event|4|||
124519564|NCT02959190|447853837|FG000|Open Label|Pregnancy|0|||
124519565|NCT02959190|447853838|FG001|Open Label|Pregnancy|1|||
124519566|NCT02959190|447853839|FG002|Open Label|Pregnancy|0|||
124519567|NCT02959190|447853840|FG003|Open Label|Pregnancy|0|||
124519568|NCT02959190|447853837|FG000|Open Label|Withdrawal by Subject|2|||
124519569|NCT02959190|447853838|FG001|Open Label|Withdrawal by Subject|8|||
124519570|NCT02959190|447853839|FG002|Open Label|Withdrawal by Subject|0|||
124519571|NCT02959190|447853840|FG003|Open Label|Withdrawal by Subject|0|||
124519572|NCT02959190|447853837|FG000|Open Label|Physician Decision|0|||
124519573|NCT02959190|447853838|FG001|Open Label|Physician Decision|0|||
124519574|NCT02959190|447853839|FG002|Open Label|Physician Decision|1|||
124519575|NCT02959190|447853840|FG003|Open Label|Physician Decision|0|||
124519576|NCT02959190|447853837|FG000|Open Label|Protocol Violation|0|||
124519577|NCT02959190|447853838|FG001|Open Label|Protocol Violation|0|||
124519578|NCT02959190|447853839|FG002|Open Label|Protocol Violation|0|||
124519579|NCT02959190|447853840|FG003|Open Label|Protocol Violation|2|||
124519580|NCT02959190|447853837|FG000|Post Treatment Follow Up|Adverse Event|1|||
124519581|NCT02959190|447853838|FG001|Post Treatment Follow Up|Adverse Event|1|||
124519582|NCT02959190|447853839|FG002|Post Treatment Follow Up|Adverse Event|0|||
124519583|NCT02959190|447853840|FG003|Post Treatment Follow Up|Adverse Event|0|||
124519584|NCT02959190|447853837|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
124519585|NCT02959190|447853838|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
124519586|NCT02959190|447853839|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
124519587|NCT02959190|447853840|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
124519588|NCT02023268|447853841|FG000|Overall Study|Lack of Efficacy|0|||
124519589|NCT02023268|447853842|FG001|Overall Study|Lack of Efficacy|1|||
124519590|NCT02023268|447853841|FG000|Overall Study|Adverse Event|0|||
124519591|NCT02023268|447853842|FG001|Overall Study|Adverse Event|2|||
124519592|NCT02023268|447853841|FG000|Overall Study|Withdrawal by Subject|0|||
124519593|NCT02023268|447853842|FG001|Overall Study|Withdrawal by Subject|1|||
124519594|NCT04445688|447853843|FG000|Washout (One Week)|Adverse Event|2|||
124519595|NCT04445688|447853843|FG000|Washout (One Week)|Withdrawal by Subject|1|||
124519596|NCT01998399|447853847|FG000|Overall Study|Lost to Follow-up|1|||
124519597|NCT01998399|447853848|FG001|Overall Study|Lost to Follow-up|3|||
124519598|NCT01998399|447853847|FG000|Overall Study|Death|4|||
124519599|NCT01998399|447853848|FG001|Overall Study|Death|2|||
124519600|NCT01998399|447853847|FG000|Overall Study|Study stopped before dosing completed|3|||
124519601|NCT01998399|447853848|FG001|Overall Study|Study stopped before dosing completed|3|||
124519602|NCT01998399|447853847|FG000|Overall Study|Withdrawal by Subject|0|||
124519603|NCT01998399|447853848|FG001|Overall Study|Withdrawal by Subject|1|||
124519604|NCT00617591|447853852|FG000|Overall Study|Withdrew consent during Induction|4|||
124519605|NCT00617591|447853852|FG000|Overall Study|Withdrew consent during Maintenance|6|||
124519606|NCT04114539|447853853|FG000|Overall Study|Adverse Event|14|||
124519607|NCT04114539|447853853|FG000|Overall Study|Lost to Follow-up|2|||
124519608|NCT04114539|447853853|FG000|Overall Study|Non-compliance with Protocol|2|||
124519609|NCT04114539|447853853|FG000|Overall Study|Non-compliance with Study Drug|1|||
124519610|NCT04114539|447853853|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
124519611|NCT04114539|447853853|FG000|Overall Study|Withdrew consent|10|||
124519612|NCT04114539|447853853|FG000|Overall Study|Others not specified|5|||
124519613|NCT04114539|447853853|FG000|Overall Study|Investigator Decision|2|||
124519614|NCT00376246|447853854|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
124519615|NCT00376246|447853855|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
124519616|NCT00376246|447853854|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
124519617|NCT00376246|447853855|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
124519618|NCT00376246|447853854|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
124519619|NCT00376246|447853855|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
124519620|NCT01072448|447853864|FG000|Overall Study|Adverse Event|9|||
124519621|NCT01072448|447853865|FG001|Overall Study|Adverse Event|10|||
124519622|NCT01072448|447853864|FG000|Overall Study|Subject withdrew consent|4|||
124519623|NCT01072448|447853865|FG001|Overall Study|Subject withdrew consent|9|||
124519624|NCT01072448|447853864|FG000|Overall Study|Protocol deviation|3|||
124519625|NCT01072448|447853865|FG001|Overall Study|Protocol deviation|4|||
124519626|NCT01072448|447853864|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124519627|NCT01072448|447853865|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124519628|NCT01072448|447853864|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124519629|NCT01072448|447853865|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
124519630|NCT01072448|447853864|FG000|Overall Study|Lost to Follow-up|1|||
124519631|NCT01072448|447853865|FG001|Overall Study|Lost to Follow-up|1|||
124519632|NCT01072448|447853864|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124519633|NCT01072448|447853865|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124519634|NCT01072448|447853864|FG000|Overall Study|Death|0|||
124519635|NCT01072448|447853865|FG001|Overall Study|Death|2|||
124519636|NCT00418717|447853868|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
124519637|NCT00418717|447853868|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
124519638|NCT01400139|447853869|FG000|HYD Core Study|Adverse Event|210|||
124519639|NCT01400139|447853869|FG000|HYD Core Study|Lack of Efficacy|59|||
124519640|NCT01400139|447853869|FG000|HYD Core Study|Withdrawal by Subject|114|||
124519641|NCT01400139|447853869|FG000|HYD Core Study|Lost to Follow-up|39|||
124519642|NCT01400139|447853869|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
124519643|NCT01400139|447853869|FG000|HYD Core Study|Administrative|56|||
124572218|NCT02942264|448055065|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
124572219|NCT02942264|448055066|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
124572220|NCT02942264|448055067|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
124572221|NCT02942264|448055068|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
124572222|NCT02942264|448055069|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
124572223|NCT02942264|448055070|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
124519644|NCT01400139|447853869|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
124519645|NCT01400139|447853869|FG000|HYD Extension Period|Adverse Event|8|||
124519646|NCT01400139|447853869|FG000|HYD Extension Period|Withdrawal by Subject|5|||
124519647|NCT01400139|447853869|FG000|HYD Extension Period|Administrative|10|||
124519648|NCT00249795|447853871|FG000|Overall Study|Not treated|16|||
124519649|NCT00249795|447853872|FG001|Overall Study|Not treated|14|||
124519650|NCT00249795|447853871|FG000|Overall Study|Symptomatic hypotension|127|||
124519651|NCT00249795|447853872|FG001|Overall Study|Symptomatic hypotension|64|||
124519652|NCT00249795|447853871|FG000|Overall Study|Other Serious Adverse Event|84|||
124519653|NCT00249795|447853872|FG001|Overall Study|Other Serious Adverse Event|93|||
124519654|NCT00249795|447853871|FG000|Overall Study|Qualifying condition not present|26|||
124519655|NCT00249795|447853872|FG001|Overall Study|Qualifying condition not present|29|||
124519656|NCT00249795|447853871|FG000|Overall Study|Withdrawal by Subject|678|||
124519657|NCT00249795|447853872|FG001|Overall Study|Withdrawal by Subject|742|||
124519658|NCT00249795|447853871|FG000|Overall Study|Thromboembolic / outcome event|39|||
124519659|NCT00249795|447853872|FG001|Overall Study|Thromboembolic / outcome event|45|||
124519660|NCT00249795|447853871|FG000|Overall Study|Oral anticoagulant required|2|||
124519661|NCT00249795|447853872|FG001|Overall Study|Oral anticoagulant required|0|||
124519662|NCT00249795|447853871|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
124519663|NCT00249795|447853872|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
124519664|NCT00249795|447853871|FG000|Overall Study|Non-compliance|71|||
124519665|NCT00249795|447853872|FG001|Overall Study|Non-compliance|69|||
124519666|NCT00249795|447853871|FG000|Overall Study|Study drug intolerance|3|||
124519667|NCT00249795|447853872|FG001|Overall Study|Study drug intolerance|3|||
124519668|NCT00249795|447853871|FG000|Overall Study|Other adverse events (non-serious)|188|||
124519669|NCT00249795|447853872|FG001|Overall Study|Other adverse events (non-serious)|159|||
124519670|NCT00249795|447853871|FG000|Overall Study|Physician withdrew consent|71|||
124519671|NCT00249795|447853872|FG001|Overall Study|Physician withdrew consent|63|||
124519672|NCT00249795|447853871|FG000|Overall Study|Surgery / procedure|4|||
124519673|NCT00249795|447853872|FG001|Overall Study|Surgery / procedure|5|||
124519674|NCT00249795|447853871|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
124519675|NCT00249795|447853872|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
124519676|NCT00249795|447853871|FG000|Overall Study|Lightheadedness / dizziness|15|||
124519677|NCT00249795|447853872|FG001|Overall Study|Lightheadedness / dizziness|11|||
124519678|NCT00249795|447853871|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
124519679|NCT00249795|447853872|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
124519680|NCT00249795|447853871|FG000|Overall Study|Other contraindicated medication|1|||
124519681|NCT00249795|447853872|FG001|Overall Study|Other contraindicated medication|1|||
124519682|NCT00249795|447853871|FG000|Overall Study|Event related to cardiac condition|17|||
124519683|NCT00249795|447853872|FG001|Overall Study|Event related to cardiac condition|16|||
124519684|NCT00249795|447853871|FG000|Overall Study|Patient not wish to continue after May08|4|||
124519685|NCT00249795|447853872|FG001|Overall Study|Patient not wish to continue after May08|6|||
124519686|NCT00249795|447853871|FG000|Overall Study|Site not agree to continue after May08|1|||
124519687|NCT00249795|447853872|FG001|Overall Study|Site not agree to continue after May08|1|||
124519688|NCT00249795|447853871|FG000|Overall Study|Lost to Follow-up|0|||
124519689|NCT00249795|447853872|FG001|Overall Study|Lost to Follow-up|2|||
124519690|NCT00249795|447853871|FG000|Overall Study|Missing|0|||
124519691|NCT00249795|447853872|FG001|Overall Study|Missing|1|||
124519692|NCT02460978|447853874|FG000|Overall Study|Adverse Event|17|||
124519693|NCT02460978|447853875|FG001|Overall Study|Adverse Event|11|||
124519694|NCT02460978|447853876|FG002|Overall Study|Adverse Event|11|||
124519695|NCT02460978|447853874|FG000|Overall Study|Withdrawal by Subject|5|||
124519696|NCT02460978|447853875|FG001|Overall Study|Withdrawal by Subject|5|||
124519697|NCT02460978|447853876|FG002|Overall Study|Withdrawal by Subject|14|||
124519698|NCT02460978|447853874|FG000|Overall Study|Lost to Follow-up|2|||
124519699|NCT02460978|447853875|FG001|Overall Study|Lost to Follow-up|3|||
124519700|NCT02460978|447853876|FG002|Overall Study|Lost to Follow-up|1|||
124519701|NCT02460978|447853874|FG000|Overall Study|Protocol Violation|1|||
124519702|NCT02460978|447853875|FG001|Overall Study|Protocol Violation|1|||
124519703|NCT02460978|447853876|FG002|Overall Study|Protocol Violation|1|||
124519704|NCT02460978|447853874|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
124519705|NCT02460978|447853875|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
124519706|NCT02460978|447853876|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
124519707|NCT02460978|447853874|FG000|Overall Study|Pregnancy|0|||
124519708|NCT02460978|447853875|FG001|Overall Study|Pregnancy|0|||
124572224|NCT02942264|448055071|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
124572225|NCT02942264|448055072|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
124572226|NCT02942264|448055073|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
124519709|NCT02460978|447853876|FG002|Overall Study|Pregnancy|2|||
124519710|NCT01142193|447853877|FG000|Overall Study|Adverse Event|12|||
124519711|NCT01142193|447853878|FG001|Overall Study|Adverse Event|4|||
124519712|NCT01142193|447853877|FG000|Overall Study|Lack of Efficacy|2|||
124725038|NCT02120300|448613430|FG002|Overall Study|Enrolled but Never Treated|0|||
124725039|NCT02120300|448613431|FG003|Overall Study|Enrolled but Never Treated|0|||
124725040|NCT02120300|448613428|FG000|Overall Study|Lack of Efficacy|0|||
124725041|NCT02120300|448613429|FG001|Overall Study|Lack of Efficacy|0|||
124519713|NCT01142193|447853878|FG001|Overall Study|Lack of Efficacy|1|||
124519714|NCT01142193|447853877|FG000|Overall Study|Physician Decision|1|||
124519715|NCT01142193|447853878|FG001|Overall Study|Physician Decision|1|||
124519716|NCT01142193|447853877|FG000|Overall Study|Withdrawal by Subject|4|||
124519717|NCT01142193|447853878|FG001|Overall Study|Withdrawal by Subject|3|||
124519718|NCT01142193|447853877|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
124519719|NCT01142193|447853878|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
124519720|NCT01142193|447853877|FG000|Overall Study|Other|1|||
124519721|NCT01142193|447853878|FG001|Overall Study|Other|2|||
124519722|NCT03549429|447853881|FG000|Overall Study|Protocol Violation|5|||
124519723|NCT03549429|447853882|FG001|Overall Study|Protocol Violation|3|||
124519724|NCT00588523|447853886|FG000|Overall Study|Not treated|3|||
124519725|NCT03032510|447853887|FG000|Overall Study|Adverse Event|5|||
124519726|NCT03032510|447853888|FG001|Overall Study|Adverse Event|2|||
124519727|NCT03032510|447853887|FG000|Overall Study|Lost to Follow-up|8|||
124519728|NCT03032510|447853888|FG001|Overall Study|Lost to Follow-up|7|||
124519729|NCT03032510|447853887|FG000|Overall Study|Withdrawal by Subject|8|||
124519730|NCT03032510|447853888|FG001|Overall Study|Withdrawal by Subject|7|||
124519731|NCT03032510|447853887|FG000|Overall Study|Subject noncompliance|4|||
124519732|NCT03032510|447853888|FG001|Overall Study|Subject noncompliance|2|||
124519733|NCT03032510|447853887|FG000|Overall Study|Physician Decision|2|||
124519734|NCT03032510|447853888|FG001|Overall Study|Physician Decision|0|||
124519735|NCT00383708|447853891|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
124519736|NCT00383708|447853891|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
124519737|NCT00383708|447853891|FG000|Run-in Period|Protocol Violation|4|||
124519738|NCT00383708|447853891|FG000|Run-in Period|Adverse Event|2|||
124519739|NCT00383708|447853891|FG000|Run-in Period|Claustrophobia|1|||
124519740|NCT00383708|447853891|FG000|Co-administration Period|Adverse Event|5|||
124519741|NCT00318370|447853892|FG000|Period 1|Lack of Efficacy|5|||
124519742|NCT00318370|447853893|FG001|Period 1|Lack of Efficacy|0|||
124519743|NCT00318370|447853894|FG002|Period 1|Lack of Efficacy|0|||
124519744|NCT00318370|447853892|FG000|Period 1|Physician Decision|1|||
124519745|NCT00318370|447853893|FG001|Period 1|Physician Decision|0|||
124572227|NCT02942264|448055065|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
124572228|NCT02942264|448055066|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
124572229|NCT02942264|448055067|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
124572230|NCT02942264|448055068|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
124572231|NCT02942264|448055069|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
124572232|NCT02942264|448055070|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
124572233|NCT02942264|448055071|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
124572234|NCT02942264|448055072|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
124572235|NCT02942264|448055073|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
124572236|NCT00569374|448055076|FG000|Overall Study|Withdrawal by Subject|4|||
124572237|NCT00064753|448055077|FG000|Overall Study|Death|251|||
124572238|NCT00064753|448055078|FG001|Overall Study|Death|242|||
124572239|NCT00064753|448055077|FG000|Overall Study|Withdrawal by Subject|198|||
124572240|NCT00064753|448055078|FG001|Overall Study|Withdrawal by Subject|171|||
124572241|NCT00064753|448055077|FG000|Overall Study|Lost to Follow-up|225|||
124572242|NCT00064753|448055078|FG001|Overall Study|Lost to Follow-up|235|||
124572243|NCT01544127|448055084|FG000|Overall Study|Lost to Follow-up|4|||
124572244|NCT01544127|448055085|FG001|Overall Study|Lost to Follow-up|2|||
124572245|NCT01544127|448055086|FG002|Overall Study|Lost to Follow-up|9|||
124572246|NCT01544127|448055084|FG000|Overall Study|Withdrawal by Subject|2|||
124572247|NCT01544127|448055085|FG001|Overall Study|Withdrawal by Subject|2|||
124725042|NCT02120300|448613430|FG002|Overall Study|Lack of Efficacy|0|||
124519746|NCT00318370|447853894|FG002|Period 1|Physician Decision|0|||
124519747|NCT00318370|447853892|FG000|Period 1|Withdrawal by Subject|1|||
124519748|NCT00318370|447853893|FG001|Period 1|Withdrawal by Subject|0|||
124519749|NCT00318370|447853894|FG002|Period 1|Withdrawal by Subject|0|||
124519750|NCT00318370|447853892|FG000|Period 2|Adverse Event|0|||
124572248|NCT01544127|448055086|FG002|Overall Study|Withdrawal by Subject|1|||
124572249|NCT01544127|448055084|FG000|Overall Study|Discharged out of catchment area|1|||
124519751|NCT00318370|447853893|FG001|Period 2|Adverse Event|3|||
124519752|NCT00318370|447853894|FG002|Period 2|Adverse Event|0|||
124519753|NCT00318370|447853892|FG000|Period 2|Lack of Efficacy|0|||
124519754|NCT00318370|447853893|FG001|Period 2|Lack of Efficacy|5|||
124572250|NCT01544127|448055085|FG001|Overall Study|Discharged out of catchment area|1|||
124725043|NCT02120300|448613431|FG003|Overall Study|Lack of Efficacy|1|||
124725044|NCT02120300|448613428|FG000|Overall Study|Lost to Follow-up|1|||
124725045|NCT02120300|448613429|FG001|Overall Study|Lost to Follow-up|0|||
124572251|NCT01544127|448055086|FG002|Overall Study|Discharged out of catchment area|1|||
124572252|NCT01544127|448055084|FG000|Overall Study|Death|1|||
124572253|NCT01544127|448055085|FG001|Overall Study|Death|0|||
124572254|NCT01544127|448055086|FG002|Overall Study|Death|0|||
124572255|NCT01544127|448055084|FG000|Overall Study|Jail or Prison|1|||
124572256|NCT01544127|448055085|FG001|Overall Study|Jail or Prison|1|||
124572257|NCT01544127|448055086|FG002|Overall Study|Jail or Prison|2|||
124572258|NCT01544127|448055084|FG000|Overall Study|Became Psychotic|1|||
124572259|NCT01544127|448055085|FG001|Overall Study|Became Psychotic|0|||
124572260|NCT01544127|448055086|FG002|Overall Study|Became Psychotic|0|||
124572261|NCT01544127|448055084|FG000|Overall Study|Researcher withdrew|1|||
124572262|NCT01544127|448055085|FG001|Overall Study|Researcher withdrew|0|||
124572263|NCT01544127|448055086|FG002|Overall Study|Researcher withdrew|0|||
124572264|NCT01544127|448055084|FG000|Overall Study|Went active duty|0|||
124572265|NCT01544127|448055085|FG001|Overall Study|Went active duty|0|||
124572266|NCT01544127|448055086|FG002|Overall Study|Went active duty|1|||
124572267|NCT00533273|448055089|FG000|Double-blind|Withdrew consent|0|||
124572268|NCT00533273|448055090|FG001|Double-blind|Withdrew consent|2|||
124572269|NCT00533273|448055089|FG000|Open-label|Withdrawal by Subject|6|||
124572270|NCT00533273|448055090|FG001|Open-label|Withdrawal by Subject|0|||
124572271|NCT02914600|448055091|FG000|Overall Study|Adverse Event|298|||
124572272|NCT02914600|448055092|FG001|Overall Study|Adverse Event|35|||
124572273|NCT02914600|448055093|FG002|Overall Study|Adverse Event|25|||
124572274|NCT02914600|448055091|FG000|Overall Study|Sponsors decision|287|||
124572275|NCT02914600|448055092|FG001|Overall Study|Sponsors decision|41|||
124572276|NCT02914600|448055093|FG002|Overall Study|Sponsors decision|12|||
124572277|NCT02914600|448055091|FG000|Overall Study|Withdrawal by Subject|158|||
124572278|NCT02914600|448055092|FG001|Overall Study|Withdrawal by Subject|20|||
124572279|NCT02914600|448055093|FG002|Overall Study|Withdrawal by Subject|18|||
124572280|NCT02914600|448055091|FG000|Overall Study|Investigators discretion|169|||
124572281|NCT02914600|448055092|FG001|Overall Study|Investigators discretion|14|||
124572282|NCT02914600|448055093|FG002|Overall Study|Investigators discretion|13|||
124572283|NCT02914600|448055091|FG000|Overall Study|Lost to Follow-up|10|||
124572284|NCT02914600|448055092|FG001|Overall Study|Lost to Follow-up|4|||
124572285|NCT02914600|448055093|FG002|Overall Study|Lost to Follow-up|0|||
124572286|NCT02914600|448055091|FG000|Overall Study|Pregnancy|8|||
124572287|NCT02914600|448055092|FG001|Overall Study|Pregnancy|0|||
124572288|NCT02914600|448055093|FG002|Overall Study|Pregnancy|0|||
124572289|NCT02914600|448055091|FG000|Overall Study|Protocol Violation|5|||
124572290|NCT02914600|448055092|FG001|Overall Study|Protocol Violation|3|||
124572291|NCT02914600|448055093|FG002|Overall Study|Protocol Violation|0|||
124572292|NCT02914600|448055091|FG000|Overall Study|Non-compliance with study drug|6|||
124572293|NCT02914600|448055092|FG001|Overall Study|Non-compliance with study drug|1|||
124572294|NCT02914600|448055093|FG002|Overall Study|Non-compliance with study drug|0|||
124572295|NCT02914600|448055091|FG000|Overall Study|Death|3|||
124572296|NCT02914600|448055092|FG001|Overall Study|Death|1|||
124572297|NCT02914600|448055093|FG002|Overall Study|Death|1|||
124572298|NCT02914600|448055091|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
124572299|NCT02914600|448055092|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
124572300|NCT02914600|448055093|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
124572301|NCT02914600|448055091|FG000|Overall Study|Enrolled but not treated|1|||
124572302|NCT02914600|448055092|FG001|Overall Study|Enrolled but not treated|0|||
124572303|NCT02914600|448055093|FG002|Overall Study|Enrolled but not treated|0|||
124572304|NCT00454909|448055094|FG000|Overall Study|Withdrawal by Subject|1|||
124572305|NCT00454909|448055095|FG001|Overall Study|Withdrawal by Subject|0|||
124572306|NCT00454909|448055096|FG002|Overall Study|Withdrawal by Subject|0|||
124572307|NCT00454909|448055094|FG000|Overall Study|Migrated/moved from study area|0|||
124572308|NCT00454909|448055095|FG001|Overall Study|Migrated/moved from study area|0|||
124572309|NCT00454909|448055096|FG002|Overall Study|Migrated/moved from study area|1|||
124725046|NCT02120300|448613430|FG002|Overall Study|Lost to Follow-up|0|||
124725047|NCT02120300|448613431|FG003|Overall Study|Lost to Follow-up|0|||
124725048|NCT00361231|448613435|FG000|Overall Study|Physician Decision|3|||
124572310|NCT00454909|448055094|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
124572311|NCT00454909|448055095|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
124572312|NCT00454909|448055096|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
124572313|NCT00454909|448055094|FG000|Overall Study|Others|1|||
124572314|NCT00454909|448055095|FG001|Overall Study|Others|0|||
124572315|NCT00454909|448055096|FG002|Overall Study|Others|0|||
124572316|NCT02457520|448055097|FG000|Active Treatment Phase|Adverse Event|10|||
124572317|NCT02457520|448055097|FG000|Active Treatment Phase|Lost to Follow-up|8|||
124572318|NCT02457520|448055097|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
124572319|NCT02457520|448055097|FG000|Active Treatment Phase|other|4|||
124572320|NCT02457520|448055097|FG000|Active Treatment Phase|Physician Decision|1|||
124572321|NCT02457520|448055097|FG000|Active Treatment Phase|Protocol Violation|1|||
124572322|NCT02457520|448055097|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
124572323|NCT02457520|448055097|FG000|Post-treatment Period|Other: Retreatment Required|7|||
124725049|NCT00361231|448613435|FG000|Overall Study|Symptomatic deterioration|5|||
124572324|NCT02457520|448055097|FG000|Post-treatment Period|Lost to Follow-up|23|||
124572325|NCT02457520|448055097|FG000|Post-treatment Period|Other|3|||
124572326|NCT02457520|448055097|FG000|Post-treatment Period|Physician Decision|1|||
124776724|NCT00998296|448809954|FG009|Overall Study|Reason other than those specified above|1|||
124519755|NCT00318370|447853894|FG002|Period 2|Lack of Efficacy|0|||
124519756|NCT00318370|447853892|FG000|Period 2|Physician Decision|0|||
124519757|NCT00318370|447853893|FG001|Period 2|Physician Decision|1|||
124519758|NCT00318370|447853894|FG002|Period 2|Physician Decision|0|||
124519759|NCT00318370|447853892|FG000|Period 2|Withdrawal by Subject|0|||
124519760|NCT00318370|447853893|FG001|Period 2|Withdrawal by Subject|1|||
124519761|NCT00318370|447853894|FG002|Period 2|Withdrawal by Subject|0|||
124519762|NCT00318370|447853892|FG000|Period 2|Other|0|||
124519763|NCT00318370|447853893|FG001|Period 2|Other|1|||
124519764|NCT00318370|447853894|FG002|Period 2|Other|0|||
124519765|NCT00318370|447853892|FG000|Period 3|Adverse Event|0|||
124519766|NCT00318370|447853893|FG001|Period 3|Adverse Event|0|||
124519767|NCT00318370|447853894|FG002|Period 3|Adverse Event|1|||
124519768|NCT00318370|447853892|FG000|Period 3|Lack of Efficacy|0|||
124519769|NCT00318370|447853893|FG001|Period 3|Lack of Efficacy|0|||
124519770|NCT00318370|447853894|FG002|Period 3|Lack of Efficacy|24|||
124519771|NCT00318370|447853892|FG000|Period 3|Death|0|||
124519772|NCT00318370|447853893|FG001|Period 3|Death|0|||
124519773|NCT00318370|447853894|FG002|Period 3|Death|1|||
124519774|NCT00318370|447853892|FG000|Period 3|Physician Decision|0|||
124519775|NCT00318370|447853893|FG001|Period 3|Physician Decision|0|||
124519776|NCT00318370|447853894|FG002|Period 3|Physician Decision|1|||
124519777|NCT00318370|447853892|FG000|Period 3|Withdrawal by Subject|0|||
124519778|NCT00318370|447853893|FG001|Period 3|Withdrawal by Subject|0|||
124519779|NCT00318370|447853894|FG002|Period 3|Withdrawal by Subject|3|||
124519780|NCT00318370|447853892|FG000|Period 3|Other|0|||
124519781|NCT00318370|447853893|FG001|Period 3|Other|0|||
124519782|NCT00318370|447853894|FG002|Period 3|Other|3|||
124519783|NCT01750840|447853895|FG000|Overall Study|Lost to Follow-up|4|||
124519784|NCT03627494|447853896|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
124519785|NCT03627494|447853897|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
124519786|NCT03627494|447853898|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
124519787|NCT03627494|447853899|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
124519788|NCT03627494|447853900|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
124519789|NCT03627494|447853901|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
124519790|NCT03627494|447853902|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
124519791|NCT03627494|447853903|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
124519792|NCT03627494|447853904|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
124519793|NCT03627494|447853905|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
124519794|NCT03627494|447853906|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
124519795|NCT03627494|447853907|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
124519796|NCT03627494|447853896|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
124519797|NCT03627494|447853897|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
124519798|NCT03627494|447853898|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
124519799|NCT03627494|447853899|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
124519800|NCT03627494|447853900|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
124519801|NCT03627494|447853901|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
124519802|NCT03627494|447853902|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
124519803|NCT03627494|447853903|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
124519804|NCT03627494|447853904|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
124519805|NCT03627494|447853905|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
124519806|NCT03627494|447853906|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
124519807|NCT03627494|447853907|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
124519808|NCT03627494|447853896|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
124519809|NCT03627494|447853897|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
124519810|NCT03627494|447853898|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
124519811|NCT03627494|447853899|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
124519812|NCT03627494|447853900|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
124519813|NCT03627494|447853901|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
124519814|NCT03627494|447853902|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
124519815|NCT03627494|447853903|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
124519816|NCT03627494|447853904|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
124519817|NCT03627494|447853905|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
124519818|NCT03627494|447853906|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
124519819|NCT03627494|447853907|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
124519820|NCT03906136|447855934|FG000|Overall Study|Adverse Event|1|||
124519821|NCT03906136|447855935|FG001|Overall Study|Adverse Event|0|||
124572327|NCT02457520|448055097|FG000|Post-treatment Period|Withdrawal by Subject|14|||
124572328|NCT02107092|448055098|FG000|Overall Study|Miscellaneous|3|||
124519822|NCT03906136|447855934|FG000|Overall Study|Lost to Follow-up|7|||
124519823|NCT03906136|447855935|FG001|Overall Study|Lost to Follow-up|4|||
124519824|NCT03906136|447855934|FG000|Overall Study|Physician Decision|1|||
124519825|NCT03906136|447855935|FG001|Overall Study|Physician Decision|0|||
124519826|NCT03906136|447855934|FG000|Overall Study|Withdrawal by Subject|3|||
124519827|NCT03906136|447855935|FG001|Overall Study|Withdrawal by Subject|7|||
124572329|NCT02107092|448055098|FG000|Overall Study|Subject compliance|3|||
124572330|NCT02107092|448055098|FG000|Overall Study|Hypo-or hyperkalemia|2|||
124572331|NCT02107092|448055098|FG000|Overall Study|Met ECG withdrawal criteria|3|||
124572332|NCT02107092|448055098|FG000|Overall Study|Physician Decision|3|||
124572333|NCT02107092|448055098|FG000|Overall Study|Lost to Follow-up|2|||
124572334|NCT02107092|448055098|FG000|Overall Study|Withdrawal by Subject|9|||
124572335|NCT02107092|448055098|FG000|Overall Study|Adverse Event|7|||
124572336|NCT02107092|448055098|FG000|Overall Study|Expected progression of CKD|12|||
124572337|NCT03522675|448055100|FG000|Overall Study|Screen fail|1|||
124572338|NCT03522675|448055100|FG000|Overall Study|Non-reactive to histamine|1|||
124572339|NCT00707161|448055101|FG000|Overall Study|Physician Decision|6|||
124572340|NCT02076022|448055104|FG000|Overall Study|Withdrawal by Subject|2|||
124572341|NCT02076022|448055105|FG001|Overall Study|Withdrawal by Subject|0|||
124572342|NCT00312663|448055106|FG000|Immunization Phase|Adverse Event|0|||
124572343|NCT00312663|448055107|FG001|Immunization Phase|Adverse Event|1|||
124572344|NCT00312663|448055108|FG002|Immunization Phase|Adverse Event|0|||
124572345|NCT02661295|448055113|FG000|Overall Study|Death|1|||
124572346|NCT02661295|448055113|FG000|Overall Study|Transferred Out|1|||
124572347|NCT02661295|448055113|FG000|Overall Study|Kidney Transplant|1|||
124572348|NCT02661295|448055113|FG000|Overall Study|Withdrawn due to side effects|8|||
124572349|NCT02661295|448055113|FG000|Overall Study|Withdrawn due to access type|1|||
124572350|NCT02661295|448055113|FG000|Overall Study|Withdrawn due to allergies|1|||
124572351|NCT02661295|448055113|FG000|Overall Study|Withdrawn due to non-compliance|1|||
124572352|NCT02661295|448055113|FG000|Overall Study|Withdrawal by Subject|3|||
124572353|NCT02661295|448055113|FG000|Overall Study|Failed screening|2|||
124572354|NCT01376167|448055114|FG000|Overall Study|Lost to Follow-up|2|||
124572355|NCT01376167|448055115|FG001|Overall Study|Lost to Follow-up|4|||
124572356|NCT01376167|448055116|FG002|Overall Study|Lost to Follow-up|2|||
124572357|NCT01376167|448055114|FG000|Overall Study|Physician Decision|1|||
124572358|NCT01376167|448055115|FG001|Overall Study|Physician Decision|1|||
124572359|NCT01376167|448055116|FG002|Overall Study|Physician Decision|0|||
124572360|NCT01376167|448055114|FG000|Overall Study|Withdrawal by Subject|1|||
124572361|NCT01376167|448055115|FG001|Overall Study|Withdrawal by Subject|5|||
124572362|NCT01376167|448055116|FG002|Overall Study|Withdrawal by Subject|4|||
124572363|NCT02849652|448055125|FG000|Overall Study|Lost to Follow-up|104|||
124572364|NCT02849652|448055126|FG001|Overall Study|Lost to Follow-up|35|||
124572365|NCT02849652|448055127|FG002|Overall Study|Lost to Follow-up|116|||
124572366|NCT02849652|448055128|FG003|Overall Study|Lost to Follow-up|22|||
124572367|NCT02849652|448055125|FG000|Overall Study|Withdrawal by Subject|10|||
124572368|NCT02849652|448055126|FG001|Overall Study|Withdrawal by Subject|2|||
124572369|NCT02849652|448055127|FG002|Overall Study|Withdrawal by Subject|8|||
124572370|NCT02849652|448055128|FG003|Overall Study|Withdrawal by Subject|4|||
124572371|NCT00565448|448055129|FG000|Overall Study|Adverse Event|1|||
124572372|NCT00565448|448055130|FG001|Overall Study|Adverse Event|2|||
124572373|NCT00565448|448055129|FG000|Overall Study|Disease progression|1|||
124572374|NCT00565448|448055130|FG001|Overall Study|Disease progression|0|||
124572375|NCT00565448|448055129|FG000|Overall Study|Withdrawal by Subject|1|||
124572376|NCT00565448|448055130|FG001|Overall Study|Withdrawal by Subject|0|||
124572377|NCT00472290|448055131|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
124572378|NCT00472290|448055131|FG000|Overall Study|Protocol Specified Criteria|7|||
124572379|NCT00472290|448055131|FG000|Overall Study|Administrative Decision|37|||
124572380|NCT00472290|448055131|FG000|Overall Study|Death|3|||
124572381|NCT00472290|448055131|FG000|Overall Study|Lost to Follow-up|1|||
124572382|NCT00472290|448055131|FG000|Overall Study|Lack of Efficacy|1|||
124572383|NCT00472290|448055131|FG000|Overall Study|Disease Progression|4|||
124572384|NCT00472290|448055131|FG000|Overall Study|Withdrawal by Subject|5|||
124572385|NCT00472290|448055131|FG000|Overall Study|Adverse Event|6|||
124572386|NCT00472290|448055131|FG000|Overall Study|Requirement for alternative therapy|7|||
124572387|NCT00777829|448055132|FG000|Overall Study|Withdrawal by Subject|0|||
124572388|NCT00777829|448055133|FG001|Overall Study|Withdrawal by Subject|2|||
124572389|NCT02016170|448055137|FG000|Overall Study|Adverse Event|1|||
124572390|NCT02016170|448055138|FG001|Overall Study|Adverse Event|1|||
124572391|NCT02016170|448055139|FG002|Overall Study|Adverse Event|0|||
124572392|NCT02016170|448055137|FG000|Overall Study|Protocol Violation|1|||
124572393|NCT02016170|448055138|FG001|Overall Study|Protocol Violation|0|||
124572394|NCT02016170|448055139|FG002|Overall Study|Protocol Violation|0|||
124572395|NCT00302952|448055140|FG000|Overall Study|Physician Decision|1|||
124572396|NCT00302952|448055141|FG001|Overall Study|Physician Decision|1|||
124572397|NCT00302952|448055140|FG000|Overall Study|Withdrawal by Subject|2|||
124572398|NCT00302952|448055141|FG001|Overall Study|Withdrawal by Subject|3|||
124572399|NCT00302952|448055140|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
124725050|NCT00361231|448613435|FG000|Overall Study|Radiographic disease progression|16|||
124725051|NCT00361231|448613435|FG000|Overall Study|Withdrawal by Subject|4|||
124572400|NCT00302952|448055141|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
124572401|NCT02373098|448055145|FG000|Overall Study|Lost to Follow-up|1|||
124572402|NCT02373098|448055146|FG001|Overall Study|Lost to Follow-up|0|||
124572403|NCT02373098|448055145|FG000|Overall Study|Protocol Violation|3|||
124572404|NCT02373098|448055146|FG001|Overall Study|Protocol Violation|0|||
124572405|NCT02373098|448055145|FG000|Overall Study|Withdrawal by Subject|5|||
124572406|NCT02373098|448055146|FG001|Overall Study|Withdrawal by Subject|0|||
124572407|NCT02373098|448055145|FG000|Overall Study|Adverse Event|3|||
124572408|NCT02373098|448055146|FG001|Overall Study|Adverse Event|0|||
124572409|NCT02008565|448055148|FG000|Overall Study|Protocol Violation|1|||
124572410|NCT02008565|448055149|FG001|Overall Study|Protocol Violation|1|||
124572411|NCT02008565|448055150|FG002|Overall Study|Protocol Violation|2|||
124572412|NCT02008565|448055151|FG003|Overall Study|Protocol Violation|0|||
124572413|NCT02193178|448055152|FG000|Overall Study|Lost to Follow-up|1|||
124572414|NCT02193178|448055152|FG000|Overall Study|Dry eyes|1|||
124572415|NCT03435081|448055153|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
124572416|NCT03435081|448055154|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
124572417|NCT03435081|448055155|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
124572418|NCT03435081|448055153|FG000|Week 0 to Week 16|Adverse Event|2|||
124572419|NCT03435081|448055154|FG001|Week 0 to Week 16|Adverse Event|2|||
124572420|NCT03435081|448055155|FG002|Week 0 to Week 16|Adverse Event|2|||
124572421|NCT03435081|448055153|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
124572422|NCT03435081|448055154|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
124572423|NCT03435081|448055155|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
124572424|NCT03435081|448055153|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
124572425|NCT03435081|448055154|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
124572426|NCT03435081|448055155|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
124572427|NCT03435081|448055153|FG000|Week 0 to Week 16|Pregnancy|1|||
124572428|NCT03435081|448055154|FG001|Week 0 to Week 16|Pregnancy|0|||
124572429|NCT03435081|448055155|FG002|Week 0 to Week 16|Pregnancy|0|||
124572430|NCT03435081|448055153|FG000|Week 0 to Week 16|Non-compliance|1|||
124572431|NCT03435081|448055154|FG001|Week 0 to Week 16|Non-compliance|0|||
124572432|NCT03435081|448055155|FG002|Week 0 to Week 16|Non-compliance|2|||
124572433|NCT03435081|448055153|FG000|Week 0 to Week 16|Inadequate Response|0|||
124572434|NCT03435081|448055154|FG001|Week 0 to Week 16|Inadequate Response|1|||
124572435|NCT03435081|448055155|FG002|Week 0 to Week 16|Inadequate Response|0|||
124572436|NCT03435081|448055153|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
124572437|NCT03435081|448055154|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
124572438|NCT03435081|448055155|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
124572439|NCT03435081|448055153|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
124572440|NCT03435081|448055154|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
124572441|NCT03435081|448055155|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
124572442|NCT03435081|448055153|FG000|Week 16 to Week 104|Adverse Event|1|||
124572443|NCT03435081|448055154|FG001|Week 16 to Week 104|Adverse Event|0|||
124572444|NCT03435081|448055155|FG002|Week 16 to Week 104|Adverse Event|2|||
124572445|NCT03435081|448055153|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
124572446|NCT03435081|448055154|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
124572447|NCT03435081|448055155|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
124572448|NCT03435081|448055153|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
124572449|NCT03435081|448055154|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
124572450|NCT03435081|448055155|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
124572451|NCT03435081|448055153|FG000|Week 16 to Week 104|Non--Compliance|0|||
124572452|NCT03435081|448055154|FG001|Week 16 to Week 104|Non--Compliance|0|||
124572453|NCT03435081|448055155|FG002|Week 16 to Week 104|Non--Compliance|1|||
124572454|NCT00420238|448055156|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
124572455|NCT00420238|448055157|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
124572456|NCT00420238|448055156|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
124572457|NCT00420238|448055157|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
124572458|NCT00420238|448055156|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
124572459|NCT00420238|448055157|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
124572460|NCT00420238|448055156|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
124572461|NCT00420238|448055157|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
124572462|NCT00420238|448055156|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
124572463|NCT00420238|448055157|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
124572464|NCT00420238|448055156|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
124572465|NCT00420238|448055157|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
124572466|NCT05214560|448055158|FG000|Overall Study|Screening Failure|1|||
124572467|NCT05214560|448055158|FG000|Overall Study|Physician Decision|4|||
124572468|NCT05214560|448055158|FG000|Overall Study|Withdrawal by Subject|1|||
124572469|NCT05214560|448055158|FG000|Overall Study|Lost to Follow-up|2|||
124572470|NCT05214560|448055158|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
124572471|NCT05214560|448055158|FG000|Overall Study|Study physician not available for the anesthesia|3|||
124572472|NCT05214560|448055158|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
124572473|NCT05214560|448055158|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
124572474|NCT05214560|448055158|FG000|Overall Study|Surgery not performed|3|||
124572475|NCT03639311|448055159|FG000|Maintenance Phase|Lost to Follow-up|1|||
124572476|NCT03639311|448055160|FG001|Maintenance Phase|Lost to Follow-up|0|||
124572477|NCT03639311|448055161|FG002|Maintenance Phase|Lost to Follow-up|0|||
124519828|NCT00323310|447855936|FG000|Overall Study|Withdrawal by Subject|1|||
124519829|NCT00323310|447855936|FG000|Overall Study|a parent refused blood draw|1|||
124519830|NCT00323310|447855936|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
124519831|NCT00446641|447855937|FG000|Overall Study|Withdrawal by Subject|8|||
124519832|NCT00446641|447855938|FG001|Overall Study|Withdrawal by Subject|3|||
124519833|NCT00446641|447855937|FG000|Overall Study|poor compliance|8|||
124519834|NCT00446641|447855938|FG001|Overall Study|poor compliance|6|||
124519835|NCT00446641|447855937|FG000|Overall Study|Lost to Follow-up|1|||
124519836|NCT00446641|447855938|FG001|Overall Study|Lost to Follow-up|1|||
124519837|NCT01826448|447855940|FG000|Overall Study|Adverse Event|1|||
124519838|NCT01826448|447855941|FG001|Overall Study|Adverse Event|3|||
124519839|NCT01826448|447855940|FG000|Overall Study|Disease progression|2|||
124519840|NCT01826448|447855941|FG001|Overall Study|Disease progression|4|||
124519841|NCT01826448|447855940|FG000|Overall Study|Withdrawal by Subject|1|||
124519842|NCT01826448|447855941|FG001|Overall Study|Withdrawal by Subject|0|||
124519843|NCT01826448|447855940|FG000|Overall Study|Physician Decision|0|||
124519844|NCT01826448|447855941|FG001|Overall Study|Physician Decision|1|||
124519845|NCT01826448|447855940|FG000|Overall Study|2 active cancers|0|||
124519846|NCT01826448|447855941|FG001|Overall Study|2 active cancers|1|||
124519847|NCT02431702|447855944|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
124519848|NCT02431702|447855945|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
124519849|NCT02431702|447855946|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
124519850|NCT02431702|447855947|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
124519851|NCT02431702|447855948|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
124519852|NCT02431702|447855949|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
124519853|NCT02431702|447855950|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
124519854|NCT02431702|447855944|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
124519855|NCT02431702|447855945|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
124519856|NCT02431702|447855946|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
124519857|NCT02431702|447855947|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
124519858|NCT02431702|447855948|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
124519859|NCT02431702|447855949|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
124519860|NCT02431702|447855950|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
124519861|NCT02431702|447855944|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
124519862|NCT02431702|447855945|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
124519863|NCT02431702|447855946|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
124519864|NCT02431702|447855947|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
124519865|NCT02431702|447855948|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
124519866|NCT02431702|447855949|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
124519867|NCT02431702|447855950|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
124519868|NCT02431702|447855944|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
124519869|NCT02431702|447855945|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
124519870|NCT02431702|447855946|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
124519871|NCT02431702|447855947|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
124519872|NCT02431702|447855948|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
124519873|NCT02431702|447855949|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
124519874|NCT02431702|447855950|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
124519875|NCT02431702|447855944|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
124519876|NCT02431702|447855945|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
124519877|NCT02431702|447855946|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
124519878|NCT02431702|447855947|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
124519879|NCT02431702|447855948|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
124519880|NCT02431702|447855949|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
124519881|NCT02431702|447855950|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
124519882|NCT02431702|447855944|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
124519883|NCT02431702|447855945|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
124519884|NCT02431702|447855946|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
124519885|NCT02431702|447855947|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
124519886|NCT02431702|447855948|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
124519887|NCT02431702|447855949|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
124519888|NCT02431702|447855950|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
124519889|NCT02431702|447855944|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
124519890|NCT02431702|447855945|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
124519891|NCT02431702|447855946|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
124519892|NCT02431702|447855947|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
124519893|NCT02431702|447855948|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
124519894|NCT02431702|447855949|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
124572478|NCT03639311|448055159|FG000|Maintenance Phase|Adverse Event|1|||
124519895|NCT02431702|447855950|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
124572479|NCT03639311|448055160|FG001|Maintenance Phase|Adverse Event|0|||
124572480|NCT03639311|448055161|FG002|Maintenance Phase|Adverse Event|0|||
124572481|NCT03639311|448055159|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
124572482|NCT03639311|448055160|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
124572483|NCT03639311|448055161|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
124572484|NCT03639311|448055159|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
124572485|NCT03639311|448055160|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
124572486|NCT03639311|448055161|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
124572487|NCT03639311|448055159|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
124572488|NCT03639311|448055160|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
124572489|NCT03639311|448055161|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
124572490|NCT03639311|448055159|FG000|Maintenance Phase|Lack of Efficacy|1|||
124572491|NCT03639311|448055160|FG001|Maintenance Phase|Lack of Efficacy|0|||
124572492|NCT03639311|448055161|FG002|Maintenance Phase|Lack of Efficacy|0|||
124572493|NCT03018249|448055164|FG000|Overall Study|Withdrawal by Subject|2|||
124572494|NCT03018249|448055165|FG001|Overall Study|Withdrawal by Subject|2|||
124572495|NCT04320849|448055166|FG000|Overall Study|Withdrawal by Subject|4|||
124572496|NCT04320849|448055166|FG000|Overall Study|Imaging data unavailable|2|||
124572497|NCT04320849|448055166|FG000|Overall Study|Incomplete imaging|2|||
124572498|NCT00304083|448055174|FG000|Overall Study|Withdrawal by Subject|4|||
124572499|NCT00304083|448055175|FG001|Overall Study|Withdrawal by Subject|2|||
124572500|NCT00304083|448055174|FG000|Overall Study|Physician Decision|8|||
124572501|NCT00304083|448055175|FG001|Overall Study|Physician Decision|3|||
124572502|NCT00304083|448055174|FG000|Overall Study|Disease Progression|5|||
124572503|NCT00304083|448055175|FG001|Overall Study|Disease Progression|1|||
124572504|NCT00304083|448055174|FG000|Overall Study|Other|5|||
124572505|NCT00304083|448055175|FG001|Overall Study|Other|2|||
124572506|NCT03966365|448055178|FG000|Overall Study|Protocol Violation|1|||
124572507|NCT03966365|448055179|FG001|Overall Study|Protocol Violation|0|||
124572508|NCT01044732|448055180|FG000|Overall Study|Lost to Follow-up|2|||
124572509|NCT01044732|448055181|FG001|Overall Study|Lost to Follow-up|1|||
124572510|NCT01044732|448055180|FG000|Overall Study|Physician Decision|5|||
124572511|NCT01044732|448055181|FG001|Overall Study|Physician Decision|3|||
124572512|NCT01044732|448055180|FG000|Overall Study|Protocol Violation|11|||
124572513|NCT01044732|448055181|FG001|Overall Study|Protocol Violation|12|||
124572514|NCT01044732|448055180|FG000|Overall Study|Withdrawal by Subject|0|||
124572515|NCT01044732|448055181|FG001|Overall Study|Withdrawal by Subject|1|||
124572516|NCT01044732|448055180|FG000|Overall Study|Inadequate bowel preparation|11|||
124572517|NCT01044732|448055181|FG001|Overall Study|Inadequate bowel preparation|17|||
124572518|NCT01044732|448055180|FG000|Overall Study|Inability to reach cecum|5|||
124572519|NCT01044732|448055181|FG001|Overall Study|Inability to reach cecum|2|||
124572520|NCT01044732|448055180|FG000|Overall Study|Technical error or malfunction|15|||
124572521|NCT01044732|448055181|FG001|Overall Study|Technical error or malfunction|14|||
124572522|NCT00824265|448055184|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
124572523|NCT00824265|448055185|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
124572524|NCT00824265|448055184|FG000|Treatment Phase|Protocol Violation|1|||
124572525|NCT00824265|448055185|FG001|Treatment Phase|Protocol Violation|0|||
124572526|NCT00824265|448055184|FG000|Treatment Phase|Lost to Follow-up|1|||
124572527|NCT00824265|448055185|FG001|Treatment Phase|Lost to Follow-up|1|||
124572528|NCT00824265|448055184|FG000|Treatment Phase|Physician Decision|6|||
124572529|NCT00824265|448055185|FG001|Treatment Phase|Physician Decision|12|||
124572530|NCT00824265|448055184|FG000|Treatment Phase|Withdrawal by Subject|6|||
124572531|NCT00824265|448055185|FG001|Treatment Phase|Withdrawal by Subject|15|||
124572532|NCT00824265|448055184|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
124572533|NCT00824265|448055185|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
124572534|NCT00824265|448055184|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
124572535|NCT00824265|448055185|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
124572536|NCT01402947|448055186|FG000|First Intervention|Adverse Event|0|||
124572537|NCT01402947|448055187|FG001|First Intervention|Adverse Event|1|||
124572538|NCT01248247|448056922|FG000|Overall Study|Adverse Event|2|||
124572539|NCT01248247|448056923|FG001|Overall Study|Adverse Event|4|||
124572540|NCT01248247|448056924|FG002|Overall Study|Adverse Event|4|||
124572541|NCT01248247|448056925|FG003|Overall Study|Adverse Event|2|||
124572542|NCT01248247|448056922|FG000|Overall Study|Death|0|||
124572543|NCT01248247|448056923|FG001|Overall Study|Death|1|||
124572544|NCT01248247|448056924|FG002|Overall Study|Death|4|||
124572545|NCT01248247|448056925|FG003|Overall Study|Death|7|||
124572546|NCT01248247|448056922|FG000|Overall Study|Lost to Follow-up|0|||
124572547|NCT01248247|448056923|FG001|Overall Study|Lost to Follow-up|1|||
124572548|NCT01248247|448056924|FG002|Overall Study|Lost to Follow-up|1|||
124572549|NCT01248247|448056925|FG003|Overall Study|Lost to Follow-up|0|||
124725052|NCT00361231|448613435|FG000|Overall Study|Adverse Event|6|||
124572550|NCT01248247|448056922|FG000|Overall Study|Alternative treatment|0|||
124572551|NCT01248247|448056923|FG001|Overall Study|Alternative treatment|1|||
124572552|NCT01248247|448056924|FG002|Overall Study|Alternative treatment|0|||
124725053|NCT01208961|448613438|FG000|High-Fat Period III|Protocol Violation|1|||
124572553|NCT01248247|448056925|FG003|Overall Study|Alternative treatment|0|||
124572554|NCT01248247|448056922|FG000|Overall Study|Other|2|||
124572555|NCT01248247|448056923|FG001|Overall Study|Other|8|||
124572556|NCT01248247|448056924|FG002|Overall Study|Other|8|||
124572557|NCT01248247|448056925|FG003|Overall Study|Other|5|||
124572558|NCT01248247|448056922|FG000|Overall Study|Progression|18|||
124572559|NCT01248247|448056923|FG001|Overall Study|Progression|27|||
124572560|NCT01248247|448056924|FG002|Overall Study|Progression|56|||
124572561|NCT01248247|448056925|FG003|Overall Study|Progression|44|||
124572562|NCT01248247|448056922|FG000|Overall Study|Refuse further treatment|0|||
124572563|NCT01248247|448056923|FG001|Overall Study|Refuse further treatment|0|||
124572564|NCT01248247|448056924|FG002|Overall Study|Refuse further treatment|1|||
124572565|NCT01248247|448056925|FG003|Overall Study|Refuse further treatment|2|||
124572566|NCT01248247|448056922|FG000|Overall Study|Complicating disease|0|||
124572567|NCT01248247|448056923|FG001|Overall Study|Complicating disease|0|||
124572568|NCT01248247|448056924|FG002|Overall Study|Complicating disease|1|||
124572569|NCT01248247|448056925|FG003|Overall Study|Complicating disease|1|||
124572570|NCT01108094|448056926|FG000|Overall Study|Adverse Event|2|||
124572571|NCT01108094|448056927|FG001|Overall Study|Adverse Event|0|||
124572572|NCT01108094|448056928|FG002|Overall Study|Adverse Event|0|||
124572573|NCT01108094|448056929|FG003|Overall Study|Adverse Event|0|||
124572574|NCT01108094|448056926|FG000|Overall Study|Withdrawal by Subject|1|||
124572575|NCT01108094|448056927|FG001|Overall Study|Withdrawal by Subject|0|||
124572576|NCT01108094|448056928|FG002|Overall Study|Withdrawal by Subject|0|||
124572577|NCT01108094|448056929|FG003|Overall Study|Withdrawal by Subject|0|||
124572578|NCT04349917|448056930|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
124572579|NCT04349917|448056931|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
124572580|NCT04349917|448056930|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
124572581|NCT04349917|448056931|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
124572582|NCT00705536|448056932|FG000|Start Period 1|Withdrawal by Subject|0|||
124572583|NCT00705536|448056933|FG001|Start Period 1|Withdrawal by Subject|0|||
124572584|NCT00705536|448056934|FG002|Start Period 1|Withdrawal by Subject|0|||
124572585|NCT00705536|448056935|FG003|Start Period 1|Withdrawal by Subject|1|||
124572586|NCT04188106|448056936|FG000|Overall Study|Lost to Follow-up|5|||
124572587|NCT04188106|448056936|FG000|Overall Study|Non-Compliance|1|||
124572588|NCT00441467|448056937|FG000|Overall Study|Adverse Event|6|||
124572589|NCT00441467|448056937|FG000|Overall Study|Withdrawal by Subject|3|||
124572590|NCT00441467|448056937|FG000|Overall Study|Progressive disease|9|||
124572591|NCT02289963|448056938|FG000|Overall Study|Adverse Event|1|||
124572592|NCT02289963|448056939|FG001|Overall Study|Adverse Event|2|||
124572593|NCT02289963|448056938|FG000|Overall Study|Poor compliance to protocol|1|||
124572594|NCT02289963|448056939|FG001|Overall Study|Poor compliance to protocol|0|||
124572595|NCT02289963|448056938|FG000|Overall Study|Withdrawal by Subject|1|||
124572596|NCT02289963|448056939|FG001|Overall Study|Withdrawal by Subject|0|||
124572597|NCT02289963|448056938|FG000|Overall Study|Last injection missed|2|||
124572598|NCT02289963|448056939|FG001|Overall Study|Last injection missed|2|||
124572599|NCT02289963|448056938|FG000|Overall Study|End treatment visit outside visit window|0|||
124572600|NCT02289963|448056939|FG001|Overall Study|End treatment visit outside visit window|4|||
124572601|NCT02289963|448056938|FG000|Overall Study|Other than specified above|0|||
124572602|NCT02289963|448056939|FG001|Overall Study|Other than specified above|2|||
124572603|NCT01042522|448056941|FG000|Overall Study|Adverse Event|1|||
124572604|NCT01042522|448056942|FG001|Overall Study|Adverse Event|2|||
124572605|NCT01042522|448056941|FG000|Overall Study|Disease Progression|5|||
124572606|NCT01042522|448056942|FG001|Overall Study|Disease Progression|0|||
124572607|NCT01042522|448056941|FG000|Overall Study|Death|1|||
124572608|NCT01042522|448056942|FG001|Overall Study|Death|0|||
124572609|NCT01042522|448056941|FG000|Overall Study|Patient Refused|0|||
124572610|NCT01042522|448056942|FG001|Overall Study|Patient Refused|3|||
124572611|NCT01042522|448056941|FG000|Overall Study|Withdrawal by Subject|1|||
124572612|NCT01042522|448056942|FG001|Overall Study|Withdrawal by Subject|1|||
124572613|NCT00549718|448056943|FG000|Overall Study|Insufficient clinical response|20|||
124572614|NCT00549718|448056944|FG001|Overall Study|Insufficient clinical response|7|||
124572615|NCT00549718|448056945|FG002|Overall Study|Insufficient clinical response|18|||
124572616|NCT00549718|448056946|FG003|Overall Study|Insufficient clinical response|32|||
124572617|NCT00549718|448056943|FG000|Overall Study|Adverse Event|6|||
124572618|NCT00549718|448056944|FG001|Overall Study|Adverse Event|8|||
124572619|NCT00549718|448056945|FG002|Overall Study|Adverse Event|7|||
124572620|NCT00549718|448056946|FG003|Overall Study|Adverse Event|3|||
124572621|NCT00549718|448056943|FG000|Overall Study|Lost to Follow-up|4|||
124572622|NCT00549718|448056944|FG001|Overall Study|Lost to Follow-up|2|||
124572623|NCT00549718|448056945|FG002|Overall Study|Lost to Follow-up|0|||
124572624|NCT00549718|448056946|FG003|Overall Study|Lost to Follow-up|6|||
124572625|NCT00549718|448056943|FG000|Overall Study|Withdrawal by Subject|9|||
124572626|NCT00549718|448056944|FG001|Overall Study|Withdrawal by Subject|18|||
124572627|NCT00549718|448056945|FG002|Overall Study|Withdrawal by Subject|12|||
124572628|NCT00549718|448056946|FG003|Overall Study|Withdrawal by Subject|13|||
124572629|NCT00549718|448056943|FG000|Overall Study|Administrative|2|||
124572630|NCT00549718|448056944|FG001|Overall Study|Administrative|2|||
124572631|NCT00549718|448056945|FG002|Overall Study|Administrative|2|||
124519896|NCT02431702|447855944|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
124519897|NCT02431702|447855945|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
124519898|NCT02431702|447855946|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
124519899|NCT02431702|447855947|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
124519900|NCT02431702|447855948|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
124572632|NCT00549718|448056946|FG003|Overall Study|Administrative|1|||
124572633|NCT01507051|448056949|FG000|Overall Study|Withdrawal by Subject|1|||
124519901|NCT02431702|447855949|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
124519902|NCT02431702|447855950|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
124519903|NCT02431702|447855944|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
124519904|NCT02431702|447855945|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
124519905|NCT02431702|447855946|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
124519906|NCT02431702|447855947|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
124519907|NCT02431702|447855948|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
124519908|NCT02431702|447855949|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
124519909|NCT02431702|447855950|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
124519910|NCT02431702|447855944|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
124519911|NCT02431702|447855945|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
124519912|NCT02431702|447855946|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
124519913|NCT02431702|447855947|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
124572634|NCT01507051|448056950|FG001|Overall Study|Withdrawal by Subject|3|||
124572635|NCT01507051|448056951|FG002|Overall Study|Withdrawal by Subject|1|||
124572636|NCT01507051|448056952|FG003|Overall Study|Withdrawal by Subject|6|||
124572637|NCT01507051|448056949|FG000|Overall Study|Physician Decision|0|||
124572638|NCT01507051|448056950|FG001|Overall Study|Physician Decision|0|||
124572639|NCT01507051|448056951|FG002|Overall Study|Physician Decision|0|||
124572640|NCT01507051|448056952|FG003|Overall Study|Physician Decision|1|||
124572641|NCT01507051|448056949|FG000|Overall Study|Adverse Event|1|||
124572642|NCT01507051|448056950|FG001|Overall Study|Adverse Event|0|||
124572643|NCT01507051|448056951|FG002|Overall Study|Adverse Event|0|||
124572644|NCT01507051|448056952|FG003|Overall Study|Adverse Event|0|||
124572645|NCT01675622|448056953|FG000|Overall Study|Withdrawal by Subject|2|||
124572646|NCT01675622|448056954|FG001|Overall Study|Withdrawal by Subject|2|||
124572647|NCT01675622|448056953|FG000|Overall Study|Adverse Event|12|||
124572648|NCT01675622|448056954|FG001|Overall Study|Adverse Event|10|||
124572649|NCT01675622|448056953|FG000|Overall Study|Protocol Violation|4|||
124572650|NCT01675622|448056954|FG001|Overall Study|Protocol Violation|1|||
124572651|NCT01675622|448056953|FG000|Overall Study|Lack of Efficacy|2|||
124572652|NCT01675622|448056954|FG001|Overall Study|Lack of Efficacy|4|||
124572653|NCT01675622|448056953|FG000|Overall Study|Lost to Follow-up|1|||
124725054|NCT01208961|448613439|FG001|High-Fat Period III|Protocol Violation|0|||
124519914|NCT02431702|447855948|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
124519915|NCT02431702|447855949|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
124519916|NCT02431702|447855950|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
124519917|NCT02431702|447855944|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
124519918|NCT02431702|447855945|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
124519919|NCT02431702|447855946|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
124519920|NCT02431702|447855947|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
124519921|NCT02431702|447855948|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
124519922|NCT02431702|447855949|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
124519923|NCT02431702|447855950|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
124519924|NCT02431702|447855944|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
124519925|NCT02431702|447855945|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
124519926|NCT02431702|447855946|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
124519927|NCT02431702|447855947|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
124572654|NCT01675622|448056954|FG001|Overall Study|Lost to Follow-up|3|||
124725055|NCT02241733|448613442|FG000|Overall Study|Lost to Follow-up|9|||
124725056|NCT02241733|448613443|FG001|Overall Study|Lost to Follow-up|4|||
124725057|NCT02241733|448613442|FG000|Overall Study|Physician Decision|6|||
124725058|NCT02241733|448613443|FG001|Overall Study|Physician Decision|2|||
124725059|NCT02241733|448613442|FG000|Overall Study|Withdrawal by Subject|0|||
124725060|NCT02241733|448613443|FG001|Overall Study|Withdrawal by Subject|2|||
124519928|NCT02431702|447855948|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
124572655|NCT01675622|448056953|FG000|Overall Study|Other|5|||
124572656|NCT01675622|448056954|FG001|Overall Study|Other|4|||
124572657|NCT04032977|448056955|FG000|Overall Study|Withdrawal by Subject|6|||
124572658|NCT04032977|448056956|FG001|Overall Study|Withdrawal by Subject|1|||
124725061|NCT02241733|448613442|FG000|Overall Study|Death|0|||
124519929|NCT02431702|447855949|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
124519930|NCT02431702|447855950|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
124519931|NCT02431702|447855944|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
124519932|NCT02431702|447855945|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
124519933|NCT02431702|447855946|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
124519934|NCT02431702|447855947|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
124519935|NCT02431702|447855948|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
124519936|NCT02431702|447855949|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
124519937|NCT02431702|447855950|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
124519938|NCT02431702|447855944|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
124519939|NCT02431702|447855945|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
124519940|NCT02431702|447855946|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
124519941|NCT02431702|447855947|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
124519942|NCT02431702|447855948|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
124519943|NCT02431702|447855949|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
124519944|NCT02431702|447855950|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
124519945|NCT02431702|447855944|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
124519946|NCT02431702|447855945|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
124519947|NCT02431702|447855946|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
124519948|NCT02431702|447855947|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
124519949|NCT02431702|447855948|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
124519950|NCT02431702|447855949|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
124519951|NCT02431702|447855950|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
124519952|NCT03250624|447855957|FG000|Overall Study|Lack of Efficacy|1|||
124519953|NCT03250624|447855958|FG001|Overall Study|Lack of Efficacy|4|||
124519954|NCT03250624|447855957|FG000|Overall Study|Adverse Event|0|||
124519955|NCT03250624|447855958|FG001|Overall Study|Adverse Event|1|||
124519956|NCT03250624|447855957|FG000|Overall Study|Other|1|||
124519957|NCT03250624|447855958|FG001|Overall Study|Other|2|||
124519958|NCT02809118|447855959|FG000|Overall Study|Withdrawal by Subject|0|||
124519959|NCT02809118|447855960|FG001|Overall Study|Withdrawal by Subject|1|||
124519960|NCT02809118|447855961|FG002|Overall Study|Withdrawal by Subject|1|||
124519961|NCT02408484|447855966|FG000|Overall Study|Withdrawal by Subject|3|||
124519962|NCT02408484|447855966|FG000|Overall Study|Not treated during study period|1|||
124519963|NCT03805971|447855977|FG000|Overall Study|Withdrawal by Subject|1|||
124519964|NCT03805971|447855977|FG000|Overall Study|Protocol Violation|2|||
124519965|NCT01510028|447855983|FG000|Overall Study|Lack of Efficacy|1|||
124519966|NCT01510028|447855984|FG001|Overall Study|Lack of Efficacy|0|||
124519967|NCT01510028|447855985|FG002|Overall Study|Lack of Efficacy|0|||
124519968|NCT01510028|447855986|FG003|Overall Study|Lack of Efficacy|0|||
124519969|NCT01355497|447855987|FG000|Overall Study|Death|19|||
124519970|NCT01355497|447855988|FG001|Overall Study|Death|18|||
124519971|NCT01355497|447855987|FG000|Overall Study|Lost to Follow-up|3|||
124519972|NCT01355497|447855988|FG001|Overall Study|Lost to Follow-up|0|||
124519973|NCT01355497|447855987|FG000|Overall Study|Protocol Violation|0|||
124519974|NCT01355497|447855988|FG001|Overall Study|Protocol Violation|1|||
124519975|NCT01355497|447855987|FG000|Overall Study|other-not provided|9|||
124519976|NCT01355497|447855988|FG001|Overall Study|other-not provided|4|||
124519977|NCT01355497|447855987|FG000|Overall Study|Withdrawal by Subject|12|||
124519978|NCT01355497|447855988|FG001|Overall Study|Withdrawal by Subject|20|||
124519979|NCT01355497|447855987|FG000|Overall Study|noncompliance|1|||
124519980|NCT01355497|447855988|FG001|Overall Study|noncompliance|2|||
124519981|NCT01355497|447855987|FG000|Overall Study|progressive disease|11|||
124519982|NCT01355497|447855988|FG001|Overall Study|progressive disease|8|||
124519983|NCT01355497|447855987|FG000|Overall Study|Adverse Event|11|||
124519984|NCT01355497|447855988|FG001|Overall Study|Adverse Event|10|||
124519985|NCT03235726|447855989|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
124519986|NCT03235726|447855990|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
124519987|NCT03235726|447855991|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
124519988|NCT03235726|447855992|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
124519989|NCT03235726|447855993|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
124519990|NCT03235726|447855994|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
124519991|NCT03235726|447855995|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
124519992|NCT03235726|447855996|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
124519993|NCT03235726|447855997|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
124572659|NCT04032977|448056955|FG000|Overall Study|Lost to Follow-up|2|||
124572660|NCT04032977|448056956|FG001|Overall Study|Lost to Follow-up|7|||
124725062|NCT02241733|448613443|FG001|Overall Study|Death|2|||
124519994|NCT03235726|447855998|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
124519995|NCT03235726|447855989|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
124519996|NCT03235726|447855990|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
124572661|NCT04032977|448056955|FG000|Overall Study|Pregnancy|1|||
124572662|NCT04032977|448056956|FG001|Overall Study|Pregnancy|0|||
124572663|NCT02880761|448056957|FG000|Overall Study|Death|6|||
124572664|NCT02880761|448056958|FG001|Overall Study|Death|8|||
124572665|NCT02880761|448056957|FG000|Overall Study|Withdrawal by Subject|3|||
124572666|NCT02880761|448056958|FG001|Overall Study|Withdrawal by Subject|6|||
124572667|NCT02880761|448056957|FG000|Overall Study|Protocol Violation|4|||
124572668|NCT02880761|448056958|FG001|Overall Study|Protocol Violation|3|||
124572669|NCT02880761|448056957|FG000|Overall Study|Lost to Follow-up|3|||
124572670|NCT02880761|448056958|FG001|Overall Study|Lost to Follow-up|4|||
124572671|NCT03597256|448056959|FG000|Overall Study|Lost to Follow-up|3|||
124572672|NCT03597256|448056960|FG001|Overall Study|Lost to Follow-up|1|||
124572673|NCT03597256|448056959|FG000|Overall Study|Withdrawal by Subject|0|||
124572674|NCT03597256|448056960|FG001|Overall Study|Withdrawal by Subject|1|||
124572675|NCT03597256|448056959|FG000|Overall Study|Could not return for treatment|0|||
124572676|NCT03597256|448056960|FG001|Overall Study|Could not return for treatment|1|||
124572677|NCT03597256|448056959|FG000|Overall Study|Moved from location|0|||
124572678|NCT03597256|448056960|FG001|Overall Study|Moved from location|1|||
124572679|NCT03597256|448056959|FG000|Overall Study|Not accepted the treatment|0|||
124572680|NCT03597256|448056960|FG001|Overall Study|Not accepted the treatment|1|||
124572681|NCT02106156|448056961|FG000|Overall Study|Patient Died|19|||
124572682|NCT02106156|448056962|FG001|Overall Study|Patient Died|0|||
124572683|NCT02106156|448056963|FG002|Overall Study|Patient Died|0|||
124572684|NCT02106156|448056961|FG000|Overall Study|Lack of Tolerability|305|||
124572685|NCT02106156|448056962|FG001|Overall Study|Lack of Tolerability|3|||
124572686|NCT02106156|448056963|FG002|Overall Study|Lack of Tolerability|0|||
124572687|NCT02106156|448056961|FG000|Overall Study|Lack of Virological Response|1044|||
124572688|NCT02106156|448056962|FG001|Overall Study|Lack of Virological Response|8|||
124572689|NCT02106156|448056963|FG002|Overall Study|Lack of Virological Response|0|||
124572690|NCT02106156|448056961|FG000|Overall Study|Concomitant Disease|74|||
124572691|NCT02106156|448056962|FG001|Overall Study|Concomitant Disease|2|||
124572692|NCT02106156|448056963|FG002|Overall Study|Concomitant Disease|0|||
124572693|NCT02106156|448056961|FG000|Overall Study|Lack of Compliance|211|||
124572694|NCT02106156|448056962|FG001|Overall Study|Lack of Compliance|7|||
124572695|NCT02106156|448056963|FG002|Overall Study|Lack of Compliance|0|||
124572696|NCT02106156|448056961|FG000|Overall Study|Patients Request|307|||
124572697|NCT02106156|448056962|FG001|Overall Study|Patients Request|9|||
124572698|NCT02106156|448056963|FG002|Overall Study|Patients Request|0|||
124572699|NCT02106156|448056961|FG000|Overall Study|Lost to Follow-up|451|||
124572700|NCT02106156|448056962|FG001|Overall Study|Lost to Follow-up|8|||
124572701|NCT02106156|448056963|FG002|Overall Study|Lost to Follow-up|0|||
124572702|NCT02106156|448056961|FG000|Overall Study|Unplanned Event|82|||
124572703|NCT02106156|448056962|FG001|Overall Study|Unplanned Event|2|||
124572704|NCT02106156|448056963|FG002|Overall Study|Unplanned Event|0|||
124572705|NCT02106156|448056961|FG000|Overall Study|Change of Laboratory Parameter|10|||
124572706|NCT02106156|448056962|FG001|Overall Study|Change of Laboratory Parameter|0|||
124572707|NCT02106156|448056963|FG002|Overall Study|Change of Laboratory Parameter|0|||
124572708|NCT02106156|448056961|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
124572709|NCT02106156|448056962|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
124572710|NCT02106156|448056963|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
124572711|NCT02106156|448056961|FG000|Overall Study|Relocation/Change of Physician|40|||
124572712|NCT02106156|448056962|FG001|Overall Study|Relocation/Change of Physician|1|||
124572713|NCT02106156|448056963|FG002|Overall Study|Relocation/Change of Physician|0|||
124572714|NCT02943447|448056964|FG000|Blinded Study Phase|Withdrew Consent|1|||
124572715|NCT02943447|448056965|FG001|Blinded Study Phase|Withdrew Consent|2|||
124572716|NCT02943447|448056966|FG002|Blinded Study Phase|Withdrew Consent|1|||
124572717|NCT02943447|448056964|FG000|Blinded Study Phase|Adverse Event|3|||
124572718|NCT02943447|448056965|FG001|Blinded Study Phase|Adverse Event|0|||
124572719|NCT02943447|448056966|FG002|Blinded Study Phase|Adverse Event|0|||
124572720|NCT02943447|448056964|FG000|Blinded Study Phase|Investigator's discretion|1|||
124572721|NCT02943447|448056965|FG001|Blinded Study Phase|Investigator's discretion|0|||
124572722|NCT02943447|448056966|FG002|Blinded Study Phase|Investigator's discretion|0|||
124572723|NCT02943447|448056964|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
124572724|NCT02943447|448056965|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
124572725|NCT02943447|448056966|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
124572726|NCT02943447|448056964|FG000|Open-Label Extension Phase|Adverse Event|4|||
124572727|NCT02943447|448056965|FG001|Open-Label Extension Phase|Adverse Event|7|||
124572728|NCT02943447|448056966|FG002|Open-Label Extension Phase|Adverse Event|3|||
124572729|NCT02943447|448056964|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
124572730|NCT02943447|448056965|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
124572731|NCT02943447|448056966|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
124572732|NCT02943447|448056964|FG000|Open-Label Extension Phase|Withdrew consent|1|||
124572733|NCT02943447|448056965|FG001|Open-Label Extension Phase|Withdrew consent|1|||
124572734|NCT02943447|448056966|FG002|Open-Label Extension Phase|Withdrew consent|1|||
124572735|NCT02943447|448056964|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
124572736|NCT02943447|448056965|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
124572737|NCT02943447|448056966|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
124572738|NCT05017480|448056973|FG000|Stage 1 Study|Withdrawal by Subject|8|||
124572739|NCT05017480|448056974|FG001|Stage 1 Study|Withdrawal by Subject|6|||
124572740|NCT05017480|448056975|FG002|Stage 1 Study|Withdrawal by Subject|0|||
124572741|NCT05017480|448056976|FG003|Stage 1 Study|Withdrawal by Subject|0|||
124572742|NCT05017480|448056977|FG004|Stage 1 Study|Withdrawal by Subject|0|||
124572743|NCT05017480|448056973|FG000|Stage 1 Study|Adverse Event|1|||
124572744|NCT05017480|448056974|FG001|Stage 1 Study|Adverse Event|1|||
124572745|NCT05017480|448056975|FG002|Stage 1 Study|Adverse Event|0|||
124572746|NCT05017480|448056976|FG003|Stage 1 Study|Adverse Event|0|||
124572747|NCT05017480|448056977|FG004|Stage 1 Study|Adverse Event|0|||
124572748|NCT05017480|448056973|FG000|Stage 1 Study|Poor Compliance|1|||
124572749|NCT05017480|448056974|FG001|Stage 1 Study|Poor Compliance|1|||
124572750|NCT05017480|448056975|FG002|Stage 1 Study|Poor Compliance|0|||
124572751|NCT05017480|448056976|FG003|Stage 1 Study|Poor Compliance|0|||
124572752|NCT05017480|448056977|FG004|Stage 1 Study|Poor Compliance|0|||
124572753|NCT05017480|448056973|FG000|Stage 1 Study|Physician Decision|0|||
124572754|NCT05017480|448056974|FG001|Stage 1 Study|Physician Decision|1|||
124572755|NCT05017480|448056975|FG002|Stage 1 Study|Physician Decision|0|||
124572756|NCT05017480|448056976|FG003|Stage 1 Study|Physician Decision|0|||
124572757|NCT05017480|448056977|FG004|Stage 1 Study|Physician Decision|0|||
124572758|NCT05017480|448056973|FG000|Stage 2 Study|Withdrawal by Subject|0|||
124572759|NCT05017480|448056974|FG001|Stage 2 Study|Withdrawal by Subject|0|||
124572760|NCT05017480|448056975|FG002|Stage 2 Study|Withdrawal by Subject|6|||
124572761|NCT05017480|448056976|FG003|Stage 2 Study|Withdrawal by Subject|9|||
124572762|NCT05017480|448056977|FG004|Stage 2 Study|Withdrawal by Subject|11|||
124572763|NCT05017480|448056973|FG000|Stage 2 Study|Lost to Follow-up|0|||
124572764|NCT05017480|448056974|FG001|Stage 2 Study|Lost to Follow-up|0|||
124572765|NCT05017480|448056975|FG002|Stage 2 Study|Lost to Follow-up|0|||
124572766|NCT05017480|448056976|FG003|Stage 2 Study|Lost to Follow-up|2|||
124572767|NCT05017480|448056977|FG004|Stage 2 Study|Lost to Follow-up|1|||
124572768|NCT05017480|448056973|FG000|Stage 2 Study|Adverse Event|0|||
124572769|NCT05017480|448056974|FG001|Stage 2 Study|Adverse Event|0|||
124572770|NCT05017480|448056975|FG002|Stage 2 Study|Adverse Event|0|||
124572771|NCT05017480|448056976|FG003|Stage 2 Study|Adverse Event|1|||
124572772|NCT05017480|448056977|FG004|Stage 2 Study|Adverse Event|0|||
124572773|NCT05017480|448056973|FG000|Stage 2 Study|COVID-19|0|||
124572774|NCT05017480|448056974|FG001|Stage 2 Study|COVID-19|0|||
124572775|NCT05017480|448056975|FG002|Stage 2 Study|COVID-19|0|||
124572776|NCT05017480|448056976|FG003|Stage 2 Study|COVID-19|1|||
124572777|NCT05017480|448056977|FG004|Stage 2 Study|COVID-19|0|||
124572778|NCT05017480|448056973|FG000|Stage 2 Study|Pregnancy|0|||
124572779|NCT05017480|448056974|FG001|Stage 2 Study|Pregnancy|0|||
124572780|NCT05017480|448056975|FG002|Stage 2 Study|Pregnancy|0|||
124572781|NCT05017480|448056976|FG003|Stage 2 Study|Pregnancy|0|||
124572782|NCT05017480|448056977|FG004|Stage 2 Study|Pregnancy|1|||
124572783|NCT01136382|448056978|FG000|Overall Study|Other|8|||
124572784|NCT01136382|448056979|FG001|Overall Study|Other|3|||
124572785|NCT01136382|448056978|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
124572786|NCT01136382|448056979|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
124572787|NCT01136382|448056978|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
124519997|NCT03235726|447855991|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
124519998|NCT03235726|447855992|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
124519999|NCT03235726|447855993|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
124520000|NCT03235726|447855994|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
124520001|NCT03235726|447855995|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
124520002|NCT03235726|447855996|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
124572788|NCT01136382|448056979|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
124572789|NCT01136382|448056978|FG000|Overall Study|Withdrawal by Subject|4|||
124572790|NCT01136382|448056979|FG001|Overall Study|Withdrawal by Subject|1|||
124572791|NCT00485472|448056984|FG000|Overall Study|Adverse Event|8|||
124572792|NCT00485472|448056985|FG001|Overall Study|Adverse Event|5|||
124572793|NCT00485472|448056984|FG000|Overall Study|Lack of Efficacy|5|||
124572794|NCT00485472|448056985|FG001|Overall Study|Lack of Efficacy|4|||
124572795|NCT00485472|448056984|FG000|Overall Study|Withdrawal by Subject|1|||
124572796|NCT00485472|448056985|FG001|Overall Study|Withdrawal by Subject|0|||
124572797|NCT00485472|448056984|FG000|Overall Study|Protocol Violation|0|||
124572798|NCT00485472|448056985|FG001|Overall Study|Protocol Violation|1|||
124572799|NCT00485472|448056984|FG000|Overall Study|Other|2|||
124572800|NCT00485472|448056985|FG001|Overall Study|Other|1|||
124572801|NCT00485472|448056984|FG000|Overall Study|Lost to Follow-up|0|||
124572802|NCT00485472|448056985|FG001|Overall Study|Lost to Follow-up|1|||
124572803|NCT00088829|448056987|FG000|Overall Study|PI left institution and study was close|22|||
124572804|NCT00633594|448056988|FG000|Overall Study|Adverse Event|0|||
124572805|NCT00633594|448056989|FG001|Overall Study|Adverse Event|4|||
124572806|NCT00633594|448056990|FG002|Overall Study|Adverse Event|7|||
124572807|NCT00633594|448056988|FG000|Overall Study|Death|0|||
124572808|NCT00633594|448056989|FG001|Overall Study|Death|1|||
124572809|NCT00633594|448056990|FG002|Overall Study|Death|2|||
124572810|NCT00633594|448056988|FG000|Overall Study|Disease Progression|0|||
124520003|NCT03235726|447855997|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
124520004|NCT03235726|447855998|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
124520005|NCT00443846|447855999|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
124520006|NCT00443846|447856000|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
124520007|NCT00443846|447855999|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
124520008|NCT00443846|447856000|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
124520009|NCT00443846|447855999|FG000|Overall Study|Adverse Event|0|||
124520010|NCT00443846|447856000|FG001|Overall Study|Adverse Event|1|||
124520011|NCT00443846|447855999|FG000|Overall Study|Personal reason|8|||
124520012|NCT00443846|447856000|FG001|Overall Study|Personal reason|3|||
124520013|NCT00443846|447855999|FG000|Overall Study|Lost to Follow-up|1|||
124520014|NCT00443846|447856000|FG001|Overall Study|Lost to Follow-up|2|||
124520015|NCT00282568|447856015|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
124520016|NCT00282568|447856015|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
124520017|NCT00282568|447856015|FG000|Extended Treatment Period|Adverse Event|17|||
124520018|NCT00282568|447856015|FG000|Extended Treatment Period|Non-compliance|4|||
124520019|NCT00282568|447856015|FG000|Extended Treatment Period|Physician Decision|1|||
124520020|NCT00282568|447856015|FG000|Extended Treatment Period|Lost to Follow-up|2|||
124520021|NCT03006926|447856016|FG000|Overall Study|Adverse Event|0|||
124520022|NCT03006926|447856017|FG001|Overall Study|Adverse Event|27|||
124520023|NCT03006926|447856016|FG000|Overall Study|Withdrawal by Subject|0|||
124520024|NCT03006926|447856017|FG001|Overall Study|Withdrawal by Subject|1|||
124520025|NCT03006926|447856016|FG000|Overall Study|Radiological Disease Progression|0|||
124520026|NCT03006926|447856017|FG001|Overall Study|Radiological Disease Progression|52|||
124520027|NCT03006926|447856016|FG000|Overall Study|Clinical Disease Progression|0|||
124520028|NCT03006926|447856017|FG001|Overall Study|Clinical Disease Progression|10|||
124520029|NCT03006926|447856016|FG000|Overall Study|Other|0|||
124520030|NCT03006926|447856017|FG001|Overall Study|Other|8|||
124520031|NCT03689972|447856018|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
124520032|NCT03689972|447856019|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
124520033|NCT03689972|447856020|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
124520034|NCT03689972|447856021|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
124520035|NCT03689972|447856022|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
124520036|NCT03689972|447856018|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
124520037|NCT03689972|447856019|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
124520038|NCT03689972|447856020|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
124520039|NCT03689972|447856021|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
124520040|NCT03689972|447856022|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
124520041|NCT03689972|447856018|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
124520042|NCT03689972|447856019|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
124520043|NCT03689972|447856020|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
124520044|NCT03689972|447856021|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
124520045|NCT03689972|447856022|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
124520046|NCT03689972|447856018|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
124520047|NCT03689972|447856019|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
124520048|NCT03689972|447856020|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
124520049|NCT03689972|447856021|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
124520050|NCT03689972|447856022|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
124520051|NCT03689972|447856018|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
124520052|NCT03689972|447856019|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
124520053|NCT03689972|447856020|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
124520054|NCT03689972|447856021|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
124520055|NCT03689972|447856022|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
124520056|NCT03689972|447856018|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
124520057|NCT03689972|447856019|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
124520058|NCT03689972|447856020|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
124520059|NCT03689972|447856021|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
124520060|NCT03689972|447856022|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
124520061|NCT03689972|447856018|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
124520062|NCT03689972|447856019|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
124572811|NCT00633594|448056989|FG001|Overall Study|Disease Progression|0|||
124572812|NCT00633594|448056990|FG002|Overall Study|Disease Progression|1|||
124572813|NCT00365300|448056995|FG000|Open-label Phase|Adverse Event|4|||
124776725|NCT00998296|448809955|FG010|Overall Study|Reason other than those specified above|0|||
124776726|NCT02346721|448809956|FG000|Overall Study|Withdrew Consent|3|||
124572814|NCT00365300|448056996|FG001|Open-label Phase|Adverse Event|0|||
124572815|NCT00365300|448056995|FG000|Open-label Phase|Failed to Return|1|||
124520063|NCT03689972|447856020|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
124520064|NCT03689972|447856021|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
124520065|NCT03689972|447856022|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
124520066|NCT03689972|447856018|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
124520067|NCT03689972|447856019|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
124520068|NCT03689972|447856020|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
124520069|NCT03689972|447856021|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
124520070|NCT03689972|447856022|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
124520071|NCT03689972|447856018|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
124520072|NCT03689972|447856019|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
124520073|NCT03689972|447856020|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
124520074|NCT03689972|447856021|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
124520075|NCT03689972|447856022|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
124520076|NCT03689972|447856018|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
124520077|NCT03689972|447856019|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
124520078|NCT03689972|447856020|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
124520079|NCT03689972|447856021|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
124520080|NCT03689972|447856022|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
124520081|NCT03689972|447856018|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
124520082|NCT03689972|447856019|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
124520083|NCT03689972|447856020|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
124520084|NCT03689972|447856021|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
124520085|NCT03689972|447856022|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
124520086|NCT03689972|447856018|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
124520087|NCT03689972|447856019|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
124520088|NCT03689972|447856020|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
124520089|NCT03689972|447856021|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
124520090|NCT03689972|447856022|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
124520091|NCT03689972|447856018|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
124520092|NCT03689972|447856019|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
124520093|NCT03689972|447856020|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
124520094|NCT03689972|447856021|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
124520095|NCT03689972|447856022|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
124520096|NCT03689972|447856018|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
124520097|NCT03689972|447856019|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
124520098|NCT03689972|447856020|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
124520099|NCT03689972|447856021|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
124520100|NCT03689972|447856022|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
124520101|NCT03689972|447856018|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
124520102|NCT03689972|447856019|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
124520103|NCT03689972|447856020|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
124520104|NCT03689972|447856021|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
124520105|NCT03689972|447856022|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
124520106|NCT03689972|447856018|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
124520107|NCT03689972|447856019|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
124520108|NCT03689972|447856020|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
124520109|NCT03689972|447856021|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
124520110|NCT03689972|447856022|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
124520111|NCT03689972|447856018|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
124520112|NCT03689972|447856019|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
124520113|NCT03689972|447856020|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
124520114|NCT03689972|447856021|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
124520115|NCT03689972|447856022|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
124520116|NCT03689972|447856018|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
124520117|NCT03689972|447856019|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
124520118|NCT03689972|447856020|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
124520119|NCT03689972|447856021|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
124520120|NCT03689972|447856022|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
124520121|NCT03689972|447856018|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
124520122|NCT03689972|447856019|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
124520123|NCT03689972|447856020|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
124520124|NCT03689972|447856021|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
124520125|NCT03689972|447856022|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
124520126|NCT01838213|447856023|FG000|Overall Study|Ineligible|166|||
124572816|NCT00365300|448056996|FG001|Open-label Phase|Failed to Return|0|||
124572817|NCT00365300|448056995|FG000|Open-label Phase|Physician Decision|1|||
124572818|NCT00365300|448056996|FG001|Open-label Phase|Physician Decision|0|||
124572819|NCT00365300|448056995|FG000|Open-label Phase|Noncompliance|9|||
124572820|NCT00365300|448056996|FG001|Open-label Phase|Noncompliance|0|||
124572821|NCT00365300|448056995|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
124572822|NCT00365300|448056996|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
124572823|NCT00365300|448056995|FG000|Open-label Phase|Protocol Violation|1|||
124572824|NCT00365300|448056996|FG001|Open-label Phase|Protocol Violation|0|||
124572825|NCT00365300|448056995|FG000|Open-label Phase|Lack of Efficacy|1|||
124572826|NCT00365300|448056996|FG001|Open-label Phase|Lack of Efficacy|0|||
124572827|NCT00365300|448056995|FG000|Open-label Phase|Patient skipped open label phase|1|||
124572828|NCT00365300|448056996|FG001|Open-label Phase|Patient skipped open label phase|0|||
124572829|NCT00365300|448056995|FG000|Double-blind Phase|Failed to return|1|||
124572830|NCT00365300|448056996|FG001|Double-blind Phase|Failed to return|0|||
124572831|NCT00365300|448056995|FG000|Double-blind Phase|Noncompliance|1|||
124572832|NCT00365300|448056996|FG001|Double-blind Phase|Noncompliance|1|||
124572833|NCT00365300|448056995|FG000|Double-blind Phase|Withdrawal by Subject|0|||
124572834|NCT00365300|448056996|FG001|Double-blind Phase|Withdrawal by Subject|1|||
124572835|NCT00365300|448056995|FG000|Double-blind Phase|Protocol Violation|3|||
124572836|NCT00365300|448056996|FG001|Double-blind Phase|Protocol Violation|1|||
124572837|NCT00365300|448056995|FG000|Double-blind Phase|Lack of Efficacy|6|||
124572838|NCT00365300|448056996|FG001|Double-blind Phase|Lack of Efficacy|6|||
124572839|NCT02896361|448056997|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
124572840|NCT02896361|448056998|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
124572841|NCT02896361|448056999|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
124572842|NCT02896361|448056997|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
124572843|NCT02896361|448056998|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
124572844|NCT02896361|448056999|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
124572845|NCT01287013|448057002|FG000|Overall Study|Non-evaluable|3|||
124572846|NCT01287013|448057003|FG001|Overall Study|Non-evaluable|5|||
124572847|NCT01287013|448057004|FG002|Overall Study|Non-evaluable|21|||
124572848|NCT01045096|448057005|FG000|Overall Study|Withdrawal by Subject|2|||
124572849|NCT01045096|448057006|FG001|Overall Study|Withdrawal by Subject|0|||
124572850|NCT01045096|448057007|FG002|Overall Study|Withdrawal by Subject|0|||
124572851|NCT01045096|448057005|FG000|Overall Study|Other|1|||
124572852|NCT01045096|448057006|FG001|Overall Study|Other|0|||
124572853|NCT01045096|448057007|FG002|Overall Study|Other|0|||
124572854|NCT01179048|448057008|FG000|Overall Study|Withdrawn - does not allow contact|4|||
124572855|NCT01179048|448057009|FG001|Overall Study|Withdrawn - does not allow contact|8|||
124572856|NCT01179048|448057008|FG000|Overall Study|Lost to Follow-up|8|||
124572857|NCT01179048|448057009|FG001|Overall Study|Lost to Follow-up|9|||
124572858|NCT01179048|448057008|FG000|Overall Study|Alive|127|||
124572859|NCT01179048|448057009|FG001|Overall Study|Alive|142|||
124572860|NCT02109042|448057010|FG000|Overall Study|Sponsor Decision|15|||
124572861|NCT01511939|448057011|FG000|Overall Study|Withdrawal by Subject|2|||
124572862|NCT01511939|448057012|FG001|Overall Study|Withdrawal by Subject|1|||
124572863|NCT01511939|448057013|FG002|Overall Study|Withdrawal by Subject|0|||
124572864|NCT03203447|448057014|FG000|Overall Study|Withdrawal by Subject|2|||
124572865|NCT03203447|448057015|FG001|Overall Study|Withdrawal by Subject|1|||
124572866|NCT03203447|448057014|FG000|Overall Study|Lost to Follow-up|1|||
124572867|NCT03203447|448057015|FG001|Overall Study|Lost to Follow-up|10|||
124572868|NCT03203447|448057014|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
124572869|NCT03203447|448057015|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
124572870|NCT00324168|448057016|FG000|Overall Study|Lost to Follow-up|19|||
124572871|NCT00324168|448057017|FG001|Overall Study|Lost to Follow-up|18|||
124572872|NCT00324168|448057016|FG000|Overall Study|Death|3|||
124572873|NCT00324168|448057017|FG001|Overall Study|Death|3|||
124572874|NCT00324168|448057016|FG000|Overall Study|Patient did not visit in f/u window|6|||
124572875|NCT00324168|448057017|FG001|Overall Study|Patient did not visit in f/u window|9|||
124572876|NCT03497897|448057020|FG000|Overall Study|Adverse Event|1|||
124572877|NCT03497897|448057021|FG001|Overall Study|Adverse Event|1|||
124572878|NCT03497897|448057022|FG002|Overall Study|Adverse Event|1|||
124572879|NCT03497897|448057020|FG000|Overall Study|Lost to Follow-up|2|||
124572880|NCT03497897|448057021|FG001|Overall Study|Lost to Follow-up|0|||
124572881|NCT03497897|448057022|FG002|Overall Study|Lost to Follow-up|2|||
124572882|NCT03497897|448057020|FG000|Overall Study|Physician Decision|1|||
124572883|NCT03497897|448057021|FG001|Overall Study|Physician Decision|0|||
124572884|NCT03497897|448057022|FG002|Overall Study|Physician Decision|0|||
124572885|NCT03497897|448057020|FG000|Overall Study|Subject/Guardian Decision|2|||
124572886|NCT03497897|448057021|FG001|Overall Study|Subject/Guardian Decision|1|||
124572887|NCT03497897|448057022|FG002|Overall Study|Subject/Guardian Decision|3|||
124572888|NCT00528606|448057029|FG000|Overall Study|Withdrew consent|4|||
124572889|NCT00528606|448057030|FG001|Overall Study|Withdrew consent|3|||
124572890|NCT00528606|448057029|FG000|Overall Study|Lost to Follow-up|4|||
124572891|NCT00528606|448057030|FG001|Overall Study|Lost to Follow-up|1|||
124520127|NCT01838213|447856024|FG001|Overall Study|Ineligible|191|||
124520128|NCT02417064|447856029|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
124520129|NCT02417064|447856030|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
124520130|NCT02417064|447856031|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
124520131|NCT02417064|447856029|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
124520132|NCT02417064|447856030|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
124520133|NCT02417064|447856031|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
124520134|NCT02417064|447856029|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
124520135|NCT02417064|447856030|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
124520136|NCT02417064|447856031|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
124520137|NCT02417064|447856029|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
124520138|NCT02417064|447856030|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
124520139|NCT02417064|447856031|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
124520140|NCT02417064|447856029|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
124520141|NCT02417064|447856030|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
124520142|NCT02417064|447856031|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
124520143|NCT02417064|447856029|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
124520144|NCT02417064|447856030|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
124520145|NCT02417064|447856031|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
124520146|NCT02417064|447856029|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
124520147|NCT02417064|447856030|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
124520148|NCT02417064|447856031|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
124520149|NCT02417064|447856029|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
124520150|NCT02417064|447856030|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
124520151|NCT02417064|447856031|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
124520152|NCT02417064|447856029|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
124520153|NCT02417064|447856030|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
124520154|NCT02417064|447856031|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
124520155|NCT02417064|447856029|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
124520156|NCT02417064|447856030|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
124520157|NCT02417064|447856031|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
124520158|NCT02417064|447856029|FG000|Follow-up Phase (24 Weeks)|Other|2|||
124520159|NCT02417064|447856030|FG001|Follow-up Phase (24 Weeks)|Other|2|||
124520160|NCT02417064|447856031|FG002|Follow-up Phase (24 Weeks)|Other|3|||
124520161|NCT00990249|447856032|FG000|Overall Study|Disease Progression|8|||
124520162|NCT00990249|447856032|FG000|Overall Study|Non-Compliance|1|||
124520163|NCT00990249|447856032|FG000|Overall Study|Death|2|||
124520164|NCT00990249|447856032|FG000|Overall Study|Not treated|2|||
124520165|NCT01548417|447856035|FG000|Overall Study|Withdrawal by Subject|0|||
124520166|NCT01548417|447856036|FG001|Overall Study|Withdrawal by Subject|2|||
124520167|NCT04583969|447856037|FG000|Overall Study|Death|31|||
124520168|NCT04583969|447856038|FG001|Overall Study|Death|38|||
124520169|NCT04583969|447856037|FG000|Overall Study|Lost to Follow-up|16|||
124520170|NCT04583969|447856038|FG001|Overall Study|Lost to Follow-up|13|||
124520171|NCT04583969|447856037|FG000|Overall Study|Protocol Violation|1|||
124520172|NCT04583969|447856038|FG001|Overall Study|Protocol Violation|0|||
124520173|NCT04583969|447856037|FG000|Overall Study|Withdrawal by Subject|3|||
124520174|NCT04583969|447856038|FG001|Overall Study|Withdrawal by Subject|3|||
124520175|NCT04583969|447856037|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
124520176|NCT04583969|447856038|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
124520177|NCT04583969|447856037|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
124520178|NCT04583969|447856038|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
124520179|NCT04583969|447856037|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
124520180|NCT04583969|447856038|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
124520181|NCT04583969|447856037|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
124520182|NCT04583969|447856038|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
124520183|NCT04583969|447856037|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
124520184|NCT04583969|447856038|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
124520185|NCT01057862|447856039|FG000|Overall Study|Withdrawal by Subject|1|||
124520186|NCT01057862|447856040|FG001|Overall Study|Withdrawal by Subject|2|||
124520187|NCT00415584|447856041|FG000|Overall Study|Withdrawal by Subject|1|||
124520188|NCT02640755|447856042|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
124520189|NCT02640755|447856043|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
124520190|NCT02640755|447856042|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
124520191|NCT02640755|447856043|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
124520192|NCT02640755|447856042|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
124520193|NCT02640755|447856043|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
124520194|NCT04075396|447856044|FG000|Overall Study|Death|11|||
124520195|NCT04075396|447856045|FG001|Overall Study|Death|9|||
124520196|NCT04075396|447856044|FG000|Overall Study|Withdrawal by Subject|1|||
124520197|NCT04075396|447856045|FG001|Overall Study|Withdrawal by Subject|2|||
124572892|NCT00528606|448057029|FG000|Overall Study|Adverse Event|3|||
124572893|NCT00528606|448057030|FG001|Overall Study|Adverse Event|0|||
124572894|NCT00528606|448057029|FG000|Overall Study|Other|2|||
124572895|NCT00528606|448057030|FG001|Overall Study|Other|0|||
124572896|NCT03478397|448057037|FG000|Overall Study|Refused to participate|31|||
124572897|NCT03478397|448057038|FG001|Overall Study|Refused to participate|7|||
124572898|NCT02188303|448057039|FG000|Overall Study|Adverse Event|0|||
124572899|NCT02188303|448057040|FG001|Overall Study|Adverse Event|0|||
124572900|NCT02188303|448057041|FG002|Overall Study|Adverse Event|0|||
124572901|NCT02188303|448057042|FG003|Overall Study|Adverse Event|0|||
124572902|NCT02188303|448057043|FG004|Overall Study|Adverse Event|0|||
124572903|NCT02188303|448057044|FG005|Overall Study|Adverse Event|2|||
124572904|NCT02188303|448057045|FG006|Overall Study|Adverse Event|0|||
124572905|NCT02188303|448057046|FG007|Overall Study|Adverse Event|2|||
124572906|NCT02188303|448057039|FG000|Overall Study|Dose Termination Criteria Met|0|||
124572907|NCT02188303|448057040|FG001|Overall Study|Dose Termination Criteria Met|0|||
124572908|NCT02188303|448057041|FG002|Overall Study|Dose Termination Criteria Met|0|||
124572909|NCT02188303|448057042|FG003|Overall Study|Dose Termination Criteria Met|0|||
124572910|NCT02188303|448057043|FG004|Overall Study|Dose Termination Criteria Met|0|||
124572911|NCT02188303|448057044|FG005|Overall Study|Dose Termination Criteria Met|0|||
124572912|NCT02188303|448057045|FG006|Overall Study|Dose Termination Criteria Met|2|||
124572913|NCT02188303|448057046|FG007|Overall Study|Dose Termination Criteria Met|4|||
124572914|NCT04206332|448057047|FG000|Part A|Lost to Follow-up|0|||
124572915|NCT04206332|448057048|FG001|Part A|Lost to Follow-up|1|||
124572916|NCT04206332|448057049|FG002|Part A|Lost to Follow-up|0|||
124572917|NCT04206332|448057050|FG003|Part A|Lost to Follow-up|0|||
124572918|NCT04206332|448057051|FG004|Part A|Lost to Follow-up|0|||
124572919|NCT04206332|448057052|FG005|Part A|Lost to Follow-up|0|||
124572920|NCT04206332|448057053|FG006|Part A|Lost to Follow-up|0|||
124572921|NCT04206332|448057054|FG007|Part A|Lost to Follow-up|0|||
124572922|NCT04206332|448057055|FG008|Part A|Lost to Follow-up|0|||
124572923|NCT04206332|448057056|FG009|Part A|Lost to Follow-up|0|||
124572924|NCT04206332|448057057|FG010|Part A|Lost to Follow-up|0|||
124572925|NCT04206332|448057058|FG011|Part A|Lost to Follow-up|0|||
124572926|NCT04206332|448057059|FG012|Part A|Lost to Follow-up|0|||
124572927|NCT04206332|448057060|FG013|Part A|Lost to Follow-up|0|||
124572928|NCT04206332|448057061|FG014|Part A|Lost to Follow-up|0|||
124572929|NCT04206332|448057062|FG015|Part A|Lost to Follow-up|0|||
124572930|NCT04206332|448057063|FG016|Part A|Lost to Follow-up|0|||
124572931|NCT04206332|448057047|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
124572932|NCT04206332|448057048|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
124572933|NCT04206332|448057049|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
124572934|NCT04206332|448057050|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
124572935|NCT04206332|448057051|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
124572936|NCT04206332|448057052|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
124572937|NCT04206332|448057053|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
124572938|NCT04206332|448057054|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
124572939|NCT04206332|448057055|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
124572940|NCT04206332|448057056|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
124572941|NCT04206332|448057057|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
124572942|NCT04206332|448057058|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
124572943|NCT04206332|448057059|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
124572944|NCT04206332|448057060|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
124572945|NCT04206332|448057061|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
124572946|NCT04206332|448057062|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
124572947|NCT04206332|448057063|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
124572948|NCT04206332|448057047|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572949|NCT04206332|448057048|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572950|NCT04206332|448057049|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572951|NCT04206332|448057050|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572952|NCT04206332|448057051|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572953|NCT04206332|448057052|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572954|NCT04206332|448057053|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572955|NCT04206332|448057054|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
124572956|NCT04206332|448057055|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572957|NCT04206332|448057056|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572958|NCT04206332|448057057|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
124572959|NCT04206332|448057058|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572960|NCT04206332|448057059|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572961|NCT04206332|448057060|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572962|NCT04206332|448057061|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572963|NCT04206332|448057062|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572964|NCT04206332|448057063|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572965|NCT04206332|448057047|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572966|NCT04206332|448057048|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572967|NCT04206332|448057049|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572968|NCT04206332|448057050|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572969|NCT04206332|448057051|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572970|NCT04206332|448057052|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572971|NCT04206332|448057053|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572972|NCT04206332|448057054|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572973|NCT04206332|448057055|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572974|NCT04206332|448057056|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572975|NCT04206332|448057057|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572976|NCT04206332|448057058|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572977|NCT04206332|448057059|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572978|NCT04206332|448057060|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572979|NCT04206332|448057061|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572980|NCT04206332|448057062|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
124572981|NCT04206332|448057063|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
124572982|NCT04206332|448057047|FG000|Part C|Withdrawal by Subject|0|||
124572983|NCT04206332|448057048|FG001|Part C|Withdrawal by Subject|0|||
124572984|NCT04206332|448057049|FG002|Part C|Withdrawal by Subject|0|||
124572985|NCT04206332|448057050|FG003|Part C|Withdrawal by Subject|0|||
124572986|NCT04206332|448057051|FG004|Part C|Withdrawal by Subject|0|||
124572987|NCT04206332|448057052|FG005|Part C|Withdrawal by Subject|0|||
124572988|NCT04206332|448057053|FG006|Part C|Withdrawal by Subject|0|||
124572989|NCT04206332|448057054|FG007|Part C|Withdrawal by Subject|0|||
124572990|NCT04206332|448057055|FG008|Part C|Withdrawal by Subject|0|||
124572991|NCT04206332|448057056|FG009|Part C|Withdrawal by Subject|0|||
124572992|NCT04206332|448057057|FG010|Part C|Withdrawal by Subject|0|||
124572993|NCT04206332|448057058|FG011|Part C|Withdrawal by Subject|0|||
124572994|NCT04206332|448057059|FG012|Part C|Withdrawal by Subject|0|||
124572995|NCT04206332|448057060|FG013|Part C|Withdrawal by Subject|0|||
124572996|NCT04206332|448057061|FG014|Part C|Withdrawal by Subject|2|||
124572997|NCT04206332|448057062|FG015|Part C|Withdrawal by Subject|0|||
124572998|NCT04206332|448057063|FG016|Part C|Withdrawal by Subject|0|||
124572999|NCT00912288|448057066|FG000|Overall Study|Death|0|||
124573000|NCT00912288|448057067|FG001|Overall Study|Death|1|||
124573001|NCT00912288|448057066|FG000|Overall Study|Adverse Event|1|||
124573002|NCT00912288|448057067|FG001|Overall Study|Adverse Event|1|||
124573003|NCT00912288|448057066|FG000|Overall Study|Lost to Follow-up|1|||
124573004|NCT00912288|448057067|FG001|Overall Study|Lost to Follow-up|0|||
124573005|NCT00912288|448057066|FG000|Overall Study|Protocol Violation|1|||
124573006|NCT00912288|448057067|FG001|Overall Study|Protocol Violation|0|||
124573007|NCT00912288|448057066|FG000|Overall Study|Withdrawal by Subject|3|||
124573008|NCT00912288|448057067|FG001|Overall Study|Withdrawal by Subject|3|||
124573009|NCT00912288|448057066|FG000|Overall Study|Study terminated by sponsor|34|||
124573010|NCT00912288|448057067|FG001|Overall Study|Study terminated by sponsor|35|||
124573011|NCT00912288|448057066|FG000|Overall Study|Other|1|||
124573012|NCT00912288|448057067|FG001|Overall Study|Other|0|||
124573013|NCT00893464|448057072|FG000|Overall Study|Did not complete therapy/experience PD|0|||
124573014|NCT00893464|448057073|FG001|Overall Study|Did not complete therapy/experience PD|0|||
124573015|NCT00893464|448057074|FG002|Overall Study|Did not complete therapy/experience PD|0|||
124573016|NCT00893464|448057075|FG003|Overall Study|Did not complete therapy/experience PD|0|||
124573017|NCT00893464|448057076|FG004|Overall Study|Did not complete therapy/experience PD|0|||
124573018|NCT00893464|448057077|FG005|Overall Study|Did not complete therapy/experience PD|0|||
124573019|NCT00893464|448057078|FG006|Overall Study|Did not complete therapy/experience PD|2|||
124776727|NCT02346721|448809956|FG000|Overall Study|Lack of Efficacy|1|||
124573020|NCT00893464|448057079|FG007|Overall Study|Did not complete therapy/experience PD|2|||
124573021|NCT00050778|448057080|FG000|Overall Study|Adverse Event|13|||
124573022|NCT00050778|448057081|FG001|Overall Study|Adverse Event|3|||
124573023|NCT00050778|448057082|FG002|Overall Study|Adverse Event|2|||
124573024|NCT00050778|448057080|FG000|Overall Study|Death|0|||
124573025|NCT00050778|448057081|FG001|Overall Study|Death|1|||
124573026|NCT00050778|448057082|FG002|Overall Study|Death|1|||
124573027|NCT00050778|448057080|FG000|Overall Study|Lack of Efficacy|16|||
124573028|NCT00050778|448057081|FG001|Overall Study|Lack of Efficacy|2|||
124573029|NCT00050778|448057082|FG002|Overall Study|Lack of Efficacy|2|||
124573030|NCT00050778|448057080|FG000|Overall Study|Lost to Follow-up|0|||
124573031|NCT00050778|448057081|FG001|Overall Study|Lost to Follow-up|2|||
124573032|NCT00050778|448057082|FG002|Overall Study|Lost to Follow-up|4|||
124573033|NCT00050778|448057080|FG000|Overall Study|Physician Decision|3|||
124573034|NCT00050778|448057081|FG001|Overall Study|Physician Decision|0|||
124573035|NCT00050778|448057082|FG002|Overall Study|Physician Decision|2|||
124573036|NCT00050778|448057080|FG000|Overall Study|Protocol Violation|2|||
124573037|NCT00050778|448057081|FG001|Overall Study|Protocol Violation|0|||
124573038|NCT00050778|448057082|FG002|Overall Study|Protocol Violation|1|||
124573039|NCT00050778|448057080|FG000|Overall Study|Withdrawal by Subject|6|||
124573040|NCT00050778|448057081|FG001|Overall Study|Withdrawal by Subject|8|||
124573041|NCT00050778|448057082|FG002|Overall Study|Withdrawal by Subject|4|||
124573042|NCT00050778|448057080|FG000|Overall Study|Randomized but not treated|4|||
124573043|NCT00050778|448057081|FG001|Overall Study|Randomized but not treated|5|||
124573044|NCT00050778|448057082|FG002|Overall Study|Randomized but not treated|2|||
124573045|NCT00050778|448057080|FG000|Overall Study|Familial and personal reasons|1|||
124573046|NCT00050778|448057081|FG001|Overall Study|Familial and personal reasons|0|||
124573047|NCT00050778|448057082|FG002|Overall Study|Familial and personal reasons|0|||
124573048|NCT01126736|448057087|FG000|Overall Study|Death|2|||
124573049|NCT01126736|448057088|FG001|Overall Study|Death|2|||
124573050|NCT01126736|448057089|FG002|Overall Study|Death|1|||
124573051|NCT01126736|448057090|FG003|Overall Study|Death|19|||
124573052|NCT01126736|448057091|FG004|Overall Study|Death|19|||
124573053|NCT01126736|448057087|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
124573054|NCT01126736|448057088|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
124573055|NCT01126736|448057089|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
124573056|NCT01126736|448057090|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
124573057|NCT01126736|448057091|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
124573058|NCT01126736|448057087|FG000|Overall Study|Lost to Follow-up|0|||
124573059|NCT01126736|448057088|FG001|Overall Study|Lost to Follow-up|0|||
124573060|NCT01126736|448057089|FG002|Overall Study|Lost to Follow-up|0|||
124573061|NCT01126736|448057090|FG003|Overall Study|Lost to Follow-up|1|||
124573062|NCT01126736|448057091|FG004|Overall Study|Lost to Follow-up|1|||
124573063|NCT01126736|448057087|FG000|Overall Study|Administrative reasons|0|||
124573064|NCT01126736|448057088|FG001|Overall Study|Administrative reasons|0|||
124573065|NCT01126736|448057089|FG002|Overall Study|Administrative reasons|0|||
124573066|NCT01126736|448057090|FG003|Overall Study|Administrative reasons|0|||
124573067|NCT01126736|448057091|FG004|Overall Study|Administrative reasons|1|||
124573068|NCT01126736|448057087|FG000|Overall Study|Progressive disease|0|||
124573069|NCT01126736|448057088|FG001|Overall Study|Progressive disease|0|||
124573070|NCT01126736|448057089|FG002|Overall Study|Progressive disease|0|||
124520198|NCT04075396|447856044|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
124520199|NCT04075396|447856045|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
124520200|NCT04075396|447856044|FG000|Overall Study|Enrolled but not-treated|0|||
124520201|NCT04075396|447856045|FG001|Overall Study|Enrolled but not-treated|1|||
124520202|NCT03434041|447856046|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
124520203|NCT03434041|447856047|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
124573071|NCT01126736|448057090|FG003|Overall Study|Progressive disease|2|||
124573072|NCT01126736|448057091|FG004|Overall Study|Progressive disease|1|||
124573073|NCT01126736|448057087|FG000|Overall Study|Withdrawal by Subject|0|||
124573074|NCT01126736|448057088|FG001|Overall Study|Withdrawal by Subject|0|||
124573075|NCT01126736|448057089|FG002|Overall Study|Withdrawal by Subject|0|||
124573076|NCT01126736|448057090|FG003|Overall Study|Withdrawal by Subject|1|||
124573077|NCT01126736|448057091|FG004|Overall Study|Withdrawal by Subject|1|||
124573078|NCT01126736|448057087|FG000|Overall Study|Other|2|||
124573079|NCT01126736|448057088|FG001|Overall Study|Other|4|||
124573080|NCT01126736|448057089|FG002|Overall Study|Other|4|||
124573081|NCT01126736|448057090|FG003|Overall Study|Other|16|||
124573082|NCT01126736|448057091|FG004|Overall Study|Other|15|||
124573083|NCT04869787|448057092|FG000|Screening|Physician Decision|1|||
124573084|NCT04869787|448057092|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
124573085|NCT00813293|448057093|FG000|Overall Study|Intercurrent illness|1|||
124573086|NCT00813293|448057094|FG001|Overall Study|Intercurrent illness|0|||
124573087|NCT00813293|448057093|FG000|Overall Study|Adverse Event|0|||
124573088|NCT00813293|448057094|FG001|Overall Study|Adverse Event|1|||
124573089|NCT00282048|448057096|FG000|Overall Study|Lack of Efficacy|30|||
124573090|NCT00282048|448057096|FG000|Overall Study|Adverse Event|22|||
124573091|NCT00282048|448057096|FG000|Overall Study|Withdrawal by Subject|1|||
124573092|NCT00282048|448057096|FG000|Overall Study|Other|8|||
124573093|NCT00282048|448057096|FG000|Overall Study|Ongoing|1|||
124573094|NCT01536405|448057099|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
124573095|NCT01536405|448057100|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
124573096|NCT01536405|448057099|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
124573097|NCT01536405|448057100|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
124573098|NCT01536405|448057099|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
124573099|NCT01536405|448057100|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
124573100|NCT01536405|448057099|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
124573101|NCT01536405|448057100|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
124573102|NCT01536405|448057099|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
124573103|NCT01536405|448057100|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
124573104|NCT01536405|448057099|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
124573105|NCT01536405|448057100|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
124520204|NCT03434041|447856046|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
124520205|NCT03434041|447856047|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
124520206|NCT03434041|447856046|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
124520207|NCT03434041|447856047|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
124520208|NCT03434041|447856046|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
124520209|NCT03434041|447856047|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
124520210|NCT03434041|447856046|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
124520211|NCT03434041|447856047|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
124520212|NCT03434041|447856046|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
124520213|NCT03434041|447856047|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
124520214|NCT03434041|447856046|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
124520215|NCT03434041|447856047|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
124520216|NCT03434041|447856046|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
124520217|NCT03434041|447856047|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
124520218|NCT03434041|447856046|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
124520219|NCT03434041|447856047|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
124520220|NCT03434041|447856046|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
124520221|NCT03434041|447856047|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
124520222|NCT03434041|447856046|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
124520223|NCT03434041|447856047|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
124520224|NCT03363165|447856048|FG000|3-month Follow-up|Death|0|||
124520225|NCT03363165|447856049|FG001|3-month Follow-up|Death|1|||
124520226|NCT03363165|447856048|FG000|6-month Follow-up|Death|0|||
124520227|NCT03363165|447856049|FG001|6-month Follow-up|Death|1|||
124520228|NCT03363165|447856048|FG000|6-month Follow-up|Withdrawal by Subject|1|||
124520229|NCT03363165|447856049|FG001|6-month Follow-up|Withdrawal by Subject|1|||
124520230|NCT03363165|447856048|FG000|12-month Follow-up|Death|1|||
124520231|NCT03363165|447856049|FG001|12-month Follow-up|Death|1|||
124520232|NCT03363165|447856048|FG000|12-month Follow-up|Withdrawal by Subject|1|||
124520233|NCT03363165|447856049|FG001|12-month Follow-up|Withdrawal by Subject|1|||
124520234|NCT02255760|447856050|FG000|Overall Study|Lost to Follow-up|0|||
124520235|NCT02255760|447856051|FG001|Overall Study|Lost to Follow-up|1|||
124520236|NCT02255760|447856052|FG002|Overall Study|Lost to Follow-up|0|||
124520237|NCT02255760|447856053|FG003|Overall Study|Lost to Follow-up|0|||
124520238|NCT02255760|447856054|FG004|Overall Study|Lost to Follow-up|0|||
124520239|NCT00618813|447856055|FG000|Overall Study|Lack of Efficacy|1|||
124520240|NCT00618813|447856055|FG000|Overall Study|Physician Decision|2|||
124520241|NCT00618813|447856055|FG000|Overall Study|Withdrawal by Subject|1|||
124520242|NCT00003838|447856056|FG000|Overall Study|Death|0|||
124520243|NCT00003838|447856057|FG001|Overall Study|Death|12|||
124520244|NCT00003838|447856058|FG002|Overall Study|Death|7|||
124520245|NCT00003838|447856056|FG000|Overall Study|Lost to Follow-up|0|||
124520246|NCT00003838|447856057|FG001|Overall Study|Lost to Follow-up|1|||
124520247|NCT00003838|447856058|FG002|Overall Study|Lost to Follow-up|1|||
124520248|NCT00003838|447856056|FG000|Overall Study|Disease Progression|0|||
124520249|NCT00003838|447856057|FG001|Overall Study|Disease Progression|12|||
124520250|NCT00003838|447856058|FG002|Overall Study|Disease Progression|0|||
124520251|NCT01809197|447856059|FG000|Overall Study|Lost to Follow-up|4|||
124520252|NCT01809197|447856060|FG001|Overall Study|Lost to Follow-up|2|||
124520253|NCT01809197|447856059|FG000|Overall Study|Adverse Event|2|||
124520254|NCT01809197|447856060|FG001|Overall Study|Adverse Event|3|||
124520255|NCT01809197|447856059|FG000|Overall Study|Failed slit lamp exam|1|||
124520256|NCT01809197|447856060|FG001|Overall Study|Failed slit lamp exam|0|||
124520257|NCT01809197|447856059|FG000|Overall Study|Non-Compliance|1|||
124520258|NCT01809197|447856060|FG001|Overall Study|Non-Compliance|1|||
124520259|NCT01809197|447856059|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
124520260|NCT01809197|447856060|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
124520261|NCT01809197|447856059|FG000|Overall Study|Withdrawal by Subject|1|||
124520262|NCT01809197|447856060|FG001|Overall Study|Withdrawal by Subject|1|||
124520263|NCT01809197|447856059|FG000|Overall Study|Product not available|0|||
124520264|NCT01809197|447856060|FG001|Overall Study|Product not available|1|||
124520265|NCT04685538|447856069|FG000|Overall Study|Adverse Event|0|||
124520266|NCT04685538|447856070|FG001|Overall Study|Adverse Event|1|||
124520267|NCT04685538|447856069|FG000|Overall Study|Lost to Follow-up|0|||
124520268|NCT04685538|447856070|FG001|Overall Study|Lost to Follow-up|2|||
124520269|NCT01235507|447856083|FG000|Overall Study|Adverse Event|1|||
124520270|NCT01235507|447856083|FG000|Overall Study|Withdrawal by Subject|1|||
124520271|NCT02475629|447856084|FG000|Overall Study|Adverse Event|1|||
124520272|NCT02475629|447856084|FG000|Overall Study|Death|4|||
124520273|NCT02475629|447856084|FG000|Overall Study|Physician Decision|1|||
124520274|NCT02475629|447856084|FG000|Overall Study|Withdrawal by Subject|1|||
124520275|NCT02475629|447856084|FG000|Overall Study|Lost to Follow-up|1|||
124520276|NCT02475629|447856084|FG000|Overall Study|Subject non-compliance|1|||
124520277|NCT04423757|447856095|FG000|Overall Study|Adverse Event|2|||
124520278|NCT04423757|447856096|FG001|Overall Study|Adverse Event|0|||
124520279|NCT04423757|447856095|FG000|Overall Study|Not treated|1|||
124520280|NCT04423757|447856096|FG001|Overall Study|Not treated|1|||
124520281|NCT02709109|447856097|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
124520282|NCT02709109|447856098|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
124520283|NCT02709109|447856099|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
124520284|NCT02709109|447856100|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
124520285|NCT02709109|447856097|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
124520286|NCT02709109|447856098|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
124520287|NCT02709109|447856099|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
124520288|NCT02709109|447856100|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
124520289|NCT02709109|447856097|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
124520290|NCT02709109|447856098|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
124520291|NCT02709109|447856099|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
124520292|NCT02709109|447856100|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
124520293|NCT02709109|447856097|FG000|Washout Period (28 Days)|Other|2|||
124520294|NCT02709109|447856098|FG001|Washout Period (28 Days)|Other|2|||
124520295|NCT02709109|447856099|FG002|Washout Period (28 Days)|Other|3|||
124520296|NCT02709109|447856100|FG003|Washout Period (28 Days)|Other|0|||
124520297|NCT02709109|447856097|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
124520298|NCT02709109|447856098|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
124520299|NCT02709109|447856099|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
124520300|NCT02709109|447856100|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
124520301|NCT02709109|447856097|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
124520302|NCT02709109|447856098|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
124520303|NCT02709109|447856099|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
124520304|NCT02709109|447856100|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
124520305|NCT02709109|447856097|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
124520306|NCT02709109|447856098|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
124520307|NCT02709109|447856099|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
124520308|NCT02709109|447856100|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
124520309|NCT02709109|447856097|FG000|Treatment Period 2 (28 Days)|Other|0|||
124520310|NCT02709109|447856098|FG001|Treatment Period 2 (28 Days)|Other|0|||
124520311|NCT02709109|447856099|FG002|Treatment Period 2 (28 Days)|Other|1|||
124520312|NCT02709109|447856100|FG003|Treatment Period 2 (28 Days)|Other|0|||
124520313|NCT05563714|447856101|FG000|Overall Study|Death|2|||
124520314|NCT05563714|447856102|FG001|Overall Study|Death|2|||
124520315|NCT05563714|447856103|FG002|Overall Study|Death|0|||
124520316|NCT05563714|447856104|FG003|Overall Study|Death|0|||
124520317|NCT05563714|447856101|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
124520318|NCT05563714|447856102|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
124520319|NCT05563714|447856103|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
124520320|NCT05563714|447856104|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
124520321|NCT05563714|447856101|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
124520322|NCT05563714|447856102|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
124520323|NCT05563714|447856103|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
124520324|NCT05563714|447856104|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
124520325|NCT05563714|447856101|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
124520326|NCT05563714|447856102|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
124573106|NCT01536405|448057099|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
124573107|NCT01536405|448057100|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
124573108|NCT01536405|448057099|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
124573109|NCT01536405|448057100|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
124573110|NCT01536405|448057099|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
124573111|NCT01536405|448057100|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
124573112|NCT01536405|448057099|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
124573113|NCT01536405|448057100|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
124573114|NCT01536405|448057099|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
124573115|NCT01536405|448057100|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
124573116|NCT01536405|448057099|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
124573117|NCT01536405|448057100|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
124573118|NCT01536405|448057099|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
124573119|NCT01536405|448057100|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
124573120|NCT00301366|448057101|FG000|Overall Study|Adverse Event|1|||
124573121|NCT04213326|448057102|FG000|Overall Study|Consent withdrawn|51|||
124573122|NCT04213326|448057103|FG001|Overall Study|Consent withdrawn|241|||
124573123|NCT04213326|448057102|FG000|Overall Study|Lost to Follow-up|50|||
124573124|NCT04213326|448057103|FG001|Overall Study|Lost to Follow-up|902|||
124573125|NCT04213326|448057102|FG000|Overall Study|Protocol Violation|3|||
124573126|NCT04213326|448057103|FG001|Overall Study|Protocol Violation|25|||
124573127|NCT04213326|448057102|FG000|Overall Study|Participant eligibility changed|106|||
124573128|NCT04213326|448057103|FG001|Overall Study|Participant eligibility changed|19|||
124573129|NCT04213326|448057102|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
124573130|NCT04213326|448057103|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
124573131|NCT04213326|448057102|FG000|Overall Study|Incomplete study visit|0|||
124573132|NCT04213326|448057103|FG001|Overall Study|Incomplete study visit|367|||
124573133|NCT02549092|448057106|FG000|Treatment Period|Adverse Event|2|||
124573134|NCT02549092|448057107|FG001|Treatment Period|Adverse Event|2|||
124573135|NCT02549092|448057106|FG000|Treatment Period|Withdrawal by Subject|1|||
124573136|NCT02549092|448057107|FG001|Treatment Period|Withdrawal by Subject|3|||
124573137|NCT02549092|448057106|FG000|Treatment Period|Lack of Efficacy|0|||
124573138|NCT02549092|448057107|FG001|Treatment Period|Lack of Efficacy|2|||
124573139|NCT02549092|448057106|FG000|Extension/Transition Period|Adverse Event|1|||
124573140|NCT02549092|448057107|FG001|Extension/Transition Period|Adverse Event|1|||
124573141|NCT02549092|448057106|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
124573142|NCT02549092|448057107|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
124573143|NCT02549092|448057106|FG000|Extension/Transition Period|Other, Not Specified|4|||
124573144|NCT02549092|448057107|FG001|Extension/Transition Period|Other, Not Specified|2|||
124573145|NCT02511782|448057108|FG000|Overall Study|Withdrawal by Subject|1|||
124573146|NCT02511782|448057109|FG001|Overall Study|Withdrawal by Subject|0|||
124573147|NCT02511782|448057110|FG002|Overall Study|Withdrawal by Subject|0|||
124573148|NCT03627091|448057111|FG000|Overall Study|Adverse Event|0|||
124573149|NCT03627091|448057112|FG001|Overall Study|Adverse Event|0|||
124573150|NCT03627091|448057113|FG002|Overall Study|Adverse Event|2|||
124573151|NCT03627091|448057111|FG000|Overall Study|Withdrawal by Subject|2|||
124573152|NCT03627091|448057112|FG001|Overall Study|Withdrawal by Subject|0|||
124573153|NCT03627091|448057113|FG002|Overall Study|Withdrawal by Subject|2|||
124573154|NCT03627091|448057111|FG000|Overall Study|Physician Decision|2|||
124573155|NCT03627091|448057112|FG001|Overall Study|Physician Decision|0|||
124573156|NCT03627091|448057113|FG002|Overall Study|Physician Decision|0|||
124573157|NCT03627091|448057111|FG000|Overall Study|Site terminated by sponsor|0|||
124573158|NCT03627091|448057112|FG001|Overall Study|Site terminated by sponsor|1|||
124573159|NCT03627091|448057113|FG002|Overall Study|Site terminated by sponsor|0|||
124573160|NCT03627091|448057111|FG000|Overall Study|Disease relapse|7|||
124573161|NCT03627091|448057112|FG001|Overall Study|Disease relapse|5|||
124573162|NCT03627091|448057113|FG002|Overall Study|Disease relapse|1|||
124573163|NCT03627091|448057111|FG000|Overall Study|Other|1|||
124573164|NCT03627091|448057112|FG001|Overall Study|Other|0|||
124573165|NCT03627091|448057113|FG002|Overall Study|Other|0|||
124573166|NCT00450190|448057114|FG000|Overall Study|Withdrawal by Subject|2|||
124573167|NCT04149964|448057126|FG000|Overall Study|Lost to Follow-up|19|||
124573168|NCT04149964|448057127|FG001|Overall Study|Lost to Follow-up|18|||
124573169|NCT04753437|448057128|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
124573170|NCT04753437|448057129|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
124573171|NCT04753437|448057128|FG000|Overall Study|Liver Function Test Abnormalities|2|||
124776728|NCT03219528|448809962|FG000|Overall Study|Lost to Follow-up|5|||
124573172|NCT04753437|448057129|FG001|Overall Study|Liver Function Test Abnormalities|4|||
124573173|NCT02424097|448058762|FG000|Overall Study|Lost to Follow-up|1|||
124573174|NCT02424097|448058763|FG001|Overall Study|Lost to Follow-up|2|||
124573175|NCT02311361|448058764|FG000|Overall Study|Did not receive treatment|0|||
124573176|NCT02311361|448058765|FG001|Overall Study|Did not receive treatment|1|||
124573177|NCT02311361|448058766|FG002|Overall Study|Did not receive treatment|0|||
124573178|NCT02311361|448058767|FG003|Overall Study|Did not receive treatment|1|||
124573179|NCT00745420|448058769|FG000|Overall Study|Ineligible|1|||
124573180|NCT02653664|448058770|FG000|Post-Treatment|Withdrawal by Subject|6|||
124573181|NCT02653664|448058771|FG001|Post-Treatment|Withdrawal by Subject|5|||
124573182|NCT02653664|448058772|FG002|Post-Treatment|Withdrawal by Subject|7|||
124573183|NCT02653664|448058770|FG000|Post-Treatment|Lost to Follow-up|8|||
124573184|NCT02653664|448058771|FG001|Post-Treatment|Lost to Follow-up|1|||
124573185|NCT02653664|448058772|FG002|Post-Treatment|Lost to Follow-up|7|||
124573186|NCT02653664|448058770|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
124573187|NCT02653664|448058771|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
124573188|NCT02653664|448058772|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
124573189|NCT02653664|448058770|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
124573190|NCT02653664|448058771|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
124573191|NCT02653664|448058772|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
124573192|NCT02653664|448058770|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
124573193|NCT02653664|448058771|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
124573194|NCT02653664|448058772|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
124573195|NCT02653664|448058770|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
124573196|NCT02653664|448058771|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
124573197|NCT02653664|448058772|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
124573198|NCT02653664|448058770|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
124573199|NCT02653664|448058771|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
124573200|NCT02653664|448058772|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
124573201|NCT02653664|448058770|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
124573202|NCT02653664|448058771|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
124573203|NCT02653664|448058772|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
124573204|NCT02653664|448058770|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
124573205|NCT02653664|448058771|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
124573206|NCT02653664|448058772|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
124573207|NCT02653664|448058770|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
124573208|NCT02653664|448058771|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
124573209|NCT02653664|448058772|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
124573210|NCT04657770|448058773|FG000|Overall Study|Withdrawal by Subject|3|||
124573211|NCT04657770|448058773|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
124573212|NCT00746798|448058774|FG000|Overall Study|Protocol Violation|0|||
124573213|NCT00746798|448058775|FG001|Overall Study|Protocol Violation|1|||
124520327|NCT05563714|447856103|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
124520328|NCT05563714|447856104|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
124520329|NCT05563714|447856101|FG000|Overall Study|Lost to Follow-up|22|||
124520330|NCT05563714|447856102|FG001|Overall Study|Lost to Follow-up|19|||
124520331|NCT05563714|447856103|FG002|Overall Study|Lost to Follow-up|0|||
124520332|NCT05563714|447856104|FG003|Overall Study|Lost to Follow-up|0|||
124520333|NCT01815580|447856105|FG000|Overall Study|Lost to Follow-up|4|||
124520334|NCT01815580|447856106|FG001|Overall Study|Lost to Follow-up|7|||
124520335|NCT01815580|447856105|FG000|Overall Study|Withdrawal by Subject|3|||
124520336|NCT01815580|447856106|FG001|Overall Study|Withdrawal by Subject|4|||
124520337|NCT01815580|447856105|FG000|Overall Study|Excluded from analysis|5|||
124520338|NCT01815580|447856106|FG001|Overall Study|Excluded from analysis|4|||
124520339|NCT02228564|447856107|FG000|Overall Study|Withdrawal by Subject|10|||
124520340|NCT02228564|447856107|FG000|Overall Study|Death|11|||
124520341|NCT02228564|447856107|FG000|Overall Study|Physician Decision|5|||
124520342|NCT02228564|447856107|FG000|Overall Study|Lost to Follow-up|17|||
124520343|NCT02228564|447856107|FG000|Overall Study|Other|6|||
124520344|NCT01802515|447856110|FG000|Overall Study|Withdrawal by Subject|3|||
124520345|NCT01802515|447856111|FG001|Overall Study|Withdrawal by Subject|0|||
124520346|NCT01802515|447856112|FG002|Overall Study|Withdrawal by Subject|0|||
124520347|NCT00517413|447857704|FG000|Overall Study|Adverse Event|7|||
124520348|NCT00517413|447857704|FG000|Overall Study|Death|13|||
124520349|NCT00517413|447857704|FG000|Overall Study|Protocol Violation|15|||
124520350|NCT00517413|447857704|FG000|Overall Study|Withdrawal by Subject|2|||
124520351|NCT00517413|447857704|FG000|Overall Study|Failure to return|1|||
124520352|NCT00517413|447857704|FG000|Overall Study|Other-Reasons|23|||
124520353|NCT00441727|447857711|FG000|Overall Study|Protocol Violation|19|||
124520354|NCT00441727|447857712|FG001|Overall Study|Protocol Violation|28|||
124520355|NCT00441727|447857713|FG002|Overall Study|Protocol Violation|32|||
124520356|NCT00441727|447857711|FG000|Overall Study|Adverse Event|26|||
124520357|NCT00441727|447857712|FG001|Overall Study|Adverse Event|33|||
124520358|NCT00441727|447857713|FG002|Overall Study|Adverse Event|28|||
124520359|NCT00441727|447857711|FG000|Overall Study|Lack of Efficacy|7|||
124520360|NCT00441727|447857712|FG001|Overall Study|Lack of Efficacy|8|||
124520361|NCT00441727|447857713|FG002|Overall Study|Lack of Efficacy|48|||
124573214|NCT00746798|448058776|FG002|Overall Study|Protocol Violation|0|||
124573215|NCT00746798|448058777|FG003|Overall Study|Protocol Violation|0|||
124573216|NCT00746798|448058774|FG000|Overall Study|Withdrawal by Subject|0|||
124573217|NCT00746798|448058775|FG001|Overall Study|Withdrawal by Subject|1|||
124776729|NCT03219528|448809963|FG001|Overall Study|Lost to Follow-up|4|||
124573218|NCT00746798|448058776|FG002|Overall Study|Withdrawal by Subject|1|||
124573219|NCT00746798|448058777|FG003|Overall Study|Withdrawal by Subject|0|||
124573220|NCT00746798|448058774|FG000|Overall Study|Death|0|||
124573221|NCT00746798|448058775|FG001|Overall Study|Death|0|||
124573222|NCT00746798|448058776|FG002|Overall Study|Death|2|||
124573223|NCT00746798|448058777|FG003|Overall Study|Death|0|||
124573224|NCT00746798|448058774|FG000|Overall Study|Participant unable to return for visit|1|||
124573225|NCT00746798|448058775|FG001|Overall Study|Participant unable to return for visit|0|||
124573226|NCT00746798|448058776|FG002|Overall Study|Participant unable to return for visit|0|||
124573227|NCT00746798|448058777|FG003|Overall Study|Participant unable to return for visit|0|||
124573228|NCT03655106|448058778|FG000|Overall Study|Withdrawal by Subject|3|||
124573229|NCT03655106|448058779|FG001|Overall Study|Withdrawal by Subject|2|||
124573230|NCT03655106|448058778|FG000|Overall Study|Lost to Follow-up|2|||
124573231|NCT03655106|448058779|FG001|Overall Study|Lost to Follow-up|1|||
124573232|NCT03655106|448058778|FG000|Overall Study|Duplicate Enrollment|1|||
124573233|NCT03655106|448058779|FG001|Overall Study|Duplicate Enrollment|1|||
124573234|NCT03655106|448058778|FG000|Overall Study|Protocol Violation|3|||
124573235|NCT03655106|448058779|FG001|Overall Study|Protocol Violation|0|||
124573236|NCT01367457|448058789|FG000|Overall Study|Death|2|||
124573237|NCT01367457|448058790|FG001|Overall Study|Death|0|||
124573238|NCT01367457|448058791|FG002|Overall Study|Death|0|||
124573239|NCT01367457|448058789|FG000|Overall Study|Investigator's decision|2|||
124573240|NCT01367457|448058790|FG001|Overall Study|Investigator's decision|0|||
124573241|NCT01367457|448058791|FG002|Overall Study|Investigator's decision|0|||
124573242|NCT01367457|448058789|FG000|Overall Study|Clinical decline (CD)|2|||
124573243|NCT01367457|448058790|FG001|Overall Study|Clinical decline (CD)|0|||
124573244|NCT01367457|448058791|FG002|Overall Study|Clinical decline (CD)|0|||
124573245|NCT01367457|448058789|FG000|Overall Study|Progression and death|8|||
124573246|NCT01367457|448058790|FG001|Overall Study|Progression and death|0|||
124573247|NCT01367457|448058791|FG002|Overall Study|Progression and death|0|||
124573248|NCT01367457|448058789|FG000|Overall Study|Toxicity|16|||
124573249|NCT01367457|448058790|FG001|Overall Study|Toxicity|0|||
124573250|NCT01367457|448058791|FG002|Overall Study|Toxicity|0|||
124573251|NCT01367457|448058789|FG000|Overall Study|Progression|137|||
124573252|NCT01367457|448058790|FG001|Overall Study|Progression|0|||
124573253|NCT01367457|448058791|FG002|Overall Study|Progression|0|||
124573254|NCT01367457|448058789|FG000|Overall Study|Patient asks for rest + slow progression|1|||
124573255|NCT01367457|448058790|FG001|Overall Study|Patient asks for rest + slow progression|0|||
124573256|NCT01367457|448058791|FG002|Overall Study|Patient asks for rest + slow progression|0|||
124573257|NCT01367457|448058789|FG000|Overall Study|Investigator's opinion, stable disease|1|||
124573258|NCT01367457|448058790|FG001|Overall Study|Investigator's opinion, stable disease|0|||
124573259|NCT01367457|448058791|FG002|Overall Study|Investigator's opinion, stable disease|0|||
124573260|NCT01367457|448058789|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
124573261|NCT01367457|448058790|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
124573262|NCT01367457|448058791|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
124573263|NCT01367457|448058789|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
124573264|NCT01367457|448058790|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
124573265|NCT01367457|448058791|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
124573266|NCT01367457|448058789|FG000|Overall Study|low grade toxicities + stable disease|1|||
124573267|NCT01367457|448058790|FG001|Overall Study|low grade toxicities + stable disease|0|||
124573268|NCT01367457|448058791|FG002|Overall Study|low grade toxicities + stable disease|0|||
124573269|NCT01367457|448058789|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
124573270|NCT01367457|448058790|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
124573271|NCT01367457|448058791|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
124573272|NCT01367457|448058789|FG000|Overall Study|Withdrawal by Subject|1|||
124573273|NCT01367457|448058790|FG001|Overall Study|Withdrawal by Subject|0|||
124573274|NCT01367457|448058791|FG002|Overall Study|Withdrawal by Subject|0|||
124573275|NCT01367457|448058789|FG000|Overall Study|CD, associated leukaemia|1|||
124573276|NCT01367457|448058790|FG001|Overall Study|CD, associated leukaemia|0|||
124573277|NCT01367457|448058791|FG002|Overall Study|CD, associated leukaemia|0|||
124776730|NCT03219528|448809962|FG000|Overall Study|Withdrawal by Subject|4|||
124573278|NCT01367457|448058789|FG000|Overall Study|Uncontrolled pain|1|||
124573279|NCT01367457|448058790|FG001|Overall Study|Uncontrolled pain|0|||
124573280|NCT01367457|448058791|FG002|Overall Study|Uncontrolled pain|0|||
124573281|NCT01367457|448058789|FG000|Overall Study|Overall status worsens to grade 4|1|||
124573282|NCT01367457|448058790|FG001|Overall Study|Overall status worsens to grade 4|0|||
124573283|NCT01367457|448058791|FG002|Overall Study|Overall status worsens to grade 4|0|||
124573284|NCT01367457|448058789|FG000|Overall Study|Stabilisation + frequent infections|1|||
124573285|NCT01367457|448058790|FG001|Overall Study|Stabilisation + frequent infections|0|||
124573286|NCT01367457|448058791|FG002|Overall Study|Stabilisation + frequent infections|0|||
124573287|NCT01367457|448058789|FG000|Overall Study|No clinical benefit|1|||
124573288|NCT01367457|448058790|FG001|Overall Study|No clinical benefit|0|||
124573289|NCT01367457|448058791|FG002|Overall Study|No clinical benefit|0|||
124573290|NCT01367457|448058789|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
124573291|NCT01367457|448058790|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
124573292|NCT01367457|448058791|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
124573293|NCT01367457|448058789|FG000|Overall Study|Overall decline|1|||
124573294|NCT01367457|448058790|FG001|Overall Study|Overall decline|0|||
124573295|NCT01367457|448058791|FG002|Overall Study|Overall decline|0|||
124573296|NCT01367457|448058789|FG000|Overall Study|Rejection of treatment|1|||
124573297|NCT01367457|448058790|FG001|Overall Study|Rejection of treatment|0|||
124573298|NCT01367457|448058791|FG002|Overall Study|Rejection of treatment|0|||
124573299|NCT01367457|448058789|FG000|Overall Study|Lost to Follow-up|1|||
124573300|NCT01367457|448058790|FG001|Overall Study|Lost to Follow-up|0|||
124573301|NCT01367457|448058791|FG002|Overall Study|Lost to Follow-up|0|||
124573302|NCT01367457|448058789|FG000|Overall Study|Death from septic shock|1|||
124573303|NCT01367457|448058790|FG001|Overall Study|Death from septic shock|0|||
124573304|NCT01367457|448058791|FG002|Overall Study|Death from septic shock|0|||
124573305|NCT01367457|448058789|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
124573306|NCT01367457|448058790|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
124573307|NCT01367457|448058791|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
124573308|NCT01367457|448058789|FG000|Overall Study|Patient's Wish|1|||
124573309|NCT01367457|448058790|FG001|Overall Study|Patient's Wish|0|||
124573310|NCT01367457|448058791|FG002|Overall Study|Patient's Wish|0|||
124573311|NCT01367457|448058789|FG000|Overall Study|Palliative. Overall decline|1|||
124573312|NCT01367457|448058790|FG001|Overall Study|Palliative. Overall decline|0|||
124573313|NCT01367457|448058791|FG002|Overall Study|Palliative. Overall decline|0|||
124573314|NCT01367457|448058789|FG000|Overall Study|Suspected DP/suspected active infection|1|||
124573315|NCT01367457|448058790|FG001|Overall Study|Suspected DP/suspected active infection|0|||
124573316|NCT01367457|448058791|FG002|Overall Study|Suspected DP/suspected active infection|0|||
124573317|NCT01882257|448058794|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
124573318|NCT01882257|448058795|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
124573319|NCT01882257|448058796|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
124573320|NCT01882257|448058794|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
124573321|NCT01882257|448058795|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
124573322|NCT01882257|448058796|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
124573323|NCT02058498|448058797|FG000|Overall Study|Withdrawal by Subject|4|||
124573324|NCT01038856|448058799|FG000|Overall Study|Adverse Event|2|||
124573325|NCT01391793|448058802|FG000|Overall Study|Ineligible|3|||
124573326|NCT01391793|448058803|FG001|Overall Study|Ineligible|0|||
124573327|NCT01391793|448058802|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
124573328|NCT01391793|448058803|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
124573329|NCT01391793|448058802|FG000|Overall Study|No DMSA|73|||
124573330|NCT01391793|448058803|FG001|Overall Study|No DMSA|57|||
124573331|NCT01666730|448058804|FG000|Overall Study|Adverse Event|16|||
124573332|NCT01666730|448058804|FG000|Overall Study|Death|2|||
124573333|NCT01666730|448058804|FG000|Overall Study|Physician Decision|5|||
124573334|NCT01666730|448058804|FG000|Overall Study|Withdrawal by Subject|9|||
124573335|NCT01666730|448058804|FG000|Overall Study|Disease progression/relapse|18|||
124573336|NCT02087904|448058805|FG000|Overall Study|Did Not Receive Study Drug|0|||
124573337|NCT02087904|448058806|FG001|Overall Study|Did Not Receive Study Drug|0|||
124573338|NCT02087904|448058807|FG002|Overall Study|Did Not Receive Study Drug|2|||
124573339|NCT02087904|448058808|FG003|Overall Study|Did Not Receive Study Drug|1|||
124573340|NCT02087904|448058805|FG000|Overall Study|Adverse Event|8|||
124573341|NCT02087904|448058806|FG001|Overall Study|Adverse Event|4|||
124573342|NCT02087904|448058807|FG002|Overall Study|Adverse Event|4|||
124573343|NCT02087904|448058808|FG003|Overall Study|Adverse Event|12|||
124573344|NCT02087904|448058805|FG000|Overall Study|Lack of Efficacy|3|||
124573345|NCT02087904|448058806|FG001|Overall Study|Lack of Efficacy|6|||
124573346|NCT02087904|448058807|FG002|Overall Study|Lack of Efficacy|3|||
124573347|NCT02087904|448058808|FG003|Overall Study|Lack of Efficacy|2|||
124573348|NCT02087904|448058805|FG000|Overall Study|Other|6|||
124573349|NCT02087904|448058806|FG001|Overall Study|Other|2|||
124573350|NCT02087904|448058807|FG002|Overall Study|Other|4|||
124573351|NCT02087904|448058808|FG003|Overall Study|Other|4|||
124573352|NCT02087904|448058805|FG000|Overall Study|Withdrawal by Subject|8|||
124573353|NCT02087904|448058806|FG001|Overall Study|Withdrawal by Subject|3|||
124573354|NCT02087904|448058807|FG002|Overall Study|Withdrawal by Subject|7|||
124573355|NCT02087904|448058808|FG003|Overall Study|Withdrawal by Subject|4|||
124573356|NCT02087904|448058805|FG000|Overall Study|Lost to Follow-up|0|||
124573357|NCT02087904|448058806|FG001|Overall Study|Lost to Follow-up|4|||
124573358|NCT02087904|448058807|FG002|Overall Study|Lost to Follow-up|2|||
124573359|NCT02087904|448058808|FG003|Overall Study|Lost to Follow-up|2|||
124573360|NCT01389102|448058810|FG000|Overall Study|Adverse Event|1|||
124573361|NCT01389102|448058811|FG001|Overall Study|Adverse Event|3|||
124573362|NCT01389102|448058812|FG002|Overall Study|Adverse Event|2|||
124573363|NCT01389102|448058813|FG003|Overall Study|Adverse Event|2|||
124573364|NCT01389102|448058814|FG004|Overall Study|Adverse Event|2|||
124573365|NCT01389102|448058815|FG005|Overall Study|Adverse Event|2|||
124573366|NCT01389102|448058810|FG000|Overall Study|Hurricane Katrina|4|||
124573367|NCT01389102|448058811|FG001|Overall Study|Hurricane Katrina|2|||
124573368|NCT01389102|448058812|FG002|Overall Study|Hurricane Katrina|3|||
124573369|NCT01389102|448058813|FG003|Overall Study|Hurricane Katrina|0|||
124573370|NCT01389102|448058814|FG004|Overall Study|Hurricane Katrina|3|||
124573371|NCT01389102|448058815|FG005|Overall Study|Hurricane Katrina|1|||
124573372|NCT01389102|448058810|FG000|Overall Study|Lost to Follow-up|4|||
124573373|NCT01389102|448058811|FG001|Overall Study|Lost to Follow-up|1|||
124573374|NCT01389102|448058812|FG002|Overall Study|Lost to Follow-up|1|||
124573375|NCT01389102|448058813|FG003|Overall Study|Lost to Follow-up|2|||
124573376|NCT01389102|448058814|FG004|Overall Study|Lost to Follow-up|4|||
124573377|NCT01389102|448058815|FG005|Overall Study|Lost to Follow-up|1|||
124573378|NCT01389102|448058810|FG000|Overall Study|Protocol Violation|0|||
124573379|NCT01389102|448058811|FG001|Overall Study|Protocol Violation|0|||
124573380|NCT01389102|448058812|FG002|Overall Study|Protocol Violation|3|||
124573381|NCT01389102|448058813|FG003|Overall Study|Protocol Violation|0|||
124573382|NCT01389102|448058814|FG004|Overall Study|Protocol Violation|1|||
124573383|NCT01389102|448058815|FG005|Overall Study|Protocol Violation|1|||
124573384|NCT01389102|448058810|FG000|Overall Study|Withdrawal by Subject|7|||
124573385|NCT01389102|448058811|FG001|Overall Study|Withdrawal by Subject|4|||
124573386|NCT01389102|448058812|FG002|Overall Study|Withdrawal by Subject|9|||
124573387|NCT01389102|448058813|FG003|Overall Study|Withdrawal by Subject|2|||
124573388|NCT01389102|448058814|FG004|Overall Study|Withdrawal by Subject|3|||
124573389|NCT01389102|448058815|FG005|Overall Study|Withdrawal by Subject|3|||
124573390|NCT01389102|448058810|FG000|Overall Study|Subject Traveling Out of Country|0|||
124573391|NCT01389102|448058811|FG001|Overall Study|Subject Traveling Out of Country|0|||
124573392|NCT01389102|448058812|FG002|Overall Study|Subject Traveling Out of Country|0|||
124573393|NCT01389102|448058813|FG003|Overall Study|Subject Traveling Out of Country|1|||
124573394|NCT01389102|448058814|FG004|Overall Study|Subject Traveling Out of Country|0|||
124573395|NCT01389102|448058815|FG005|Overall Study|Subject Traveling Out of Country|0|||
124573396|NCT01389102|448058810|FG000|Overall Study|Subject Moved|2|||
124573397|NCT01389102|448058811|FG001|Overall Study|Subject Moved|0|||
124573398|NCT01389102|448058812|FG002|Overall Study|Subject Moved|1|||
124573399|NCT01389102|448058813|FG003|Overall Study|Subject Moved|0|||
124573400|NCT01389102|448058814|FG004|Overall Study|Subject Moved|0|||
124573401|NCT01389102|448058815|FG005|Overall Study|Subject Moved|0|||
124573402|NCT01389102|448058810|FG000|Overall Study|Unavailable due to husband's illness|0|||
124573403|NCT01389102|448058811|FG001|Overall Study|Unavailable due to husband's illness|1|||
124573404|NCT01389102|448058812|FG002|Overall Study|Unavailable due to husband's illness|0|||
124573405|NCT01389102|448058813|FG003|Overall Study|Unavailable due to husband's illness|0|||
124573406|NCT01389102|448058814|FG004|Overall Study|Unavailable due to husband's illness|0|||
124573407|NCT01389102|448058815|FG005|Overall Study|Unavailable due to husband's illness|0|||
124573408|NCT01389102|448058810|FG000|Overall Study|Investigator Judgement|0|||
124573409|NCT01389102|448058811|FG001|Overall Study|Investigator Judgement|1|||
124573410|NCT01389102|448058812|FG002|Overall Study|Investigator Judgement|0|||
124573411|NCT01389102|448058813|FG003|Overall Study|Investigator Judgement|0|||
124573412|NCT01389102|448058814|FG004|Overall Study|Investigator Judgement|0|||
124573413|NCT01389102|448058815|FG005|Overall Study|Investigator Judgement|0|||
124573414|NCT02910037|448058816|FG000|Overall Study|Withdrawal by Subject|4|||
124520362|NCT00441727|447857711|FG000|Overall Study|Withdrawal by Subject|40|||
124520363|NCT00441727|447857712|FG001|Overall Study|Withdrawal by Subject|34|||
124520364|NCT00441727|447857713|FG002|Overall Study|Withdrawal by Subject|47|||
124520365|NCT00441727|447857711|FG000|Overall Study|Lost to Follow-up|5|||
124520366|NCT00441727|447857712|FG001|Overall Study|Lost to Follow-up|6|||
124520367|NCT00441727|447857713|FG002|Overall Study|Lost to Follow-up|5|||
124520368|NCT00441727|447857711|FG000|Overall Study|Safety Reasons|3|||
124520369|NCT00441727|447857712|FG001|Overall Study|Safety Reasons|1|||
124520370|NCT00441727|447857713|FG002|Overall Study|Safety Reasons|3|||
124520371|NCT00441727|447857711|FG000|Overall Study|Various reason specified|6|||
124520372|NCT00441727|447857712|FG001|Overall Study|Various reason specified|8|||
124520373|NCT00441727|447857713|FG002|Overall Study|Various reason specified|5|||
124520374|NCT01237223|447857720|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
124520375|NCT01237223|447857721|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
124520376|NCT01237223|447857722|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
124520377|NCT01237223|447857723|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
124520378|NCT01237223|447857724|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
124573415|NCT02910037|448058816|FG000|Overall Study|Lost to Follow-up|6|||
124573416|NCT00436553|448058817|FG000|Overall Study|Adverse Event|4|||
124573417|NCT00436553|448058818|FG001|Overall Study|Adverse Event|3|||
124573418|NCT00436553|448058819|FG002|Overall Study|Adverse Event|4|||
124573419|NCT00436553|448058817|FG000|Overall Study|Death|3|||
124573420|NCT00436553|448058818|FG001|Overall Study|Death|1|||
124573421|NCT00436553|448058819|FG002|Overall Study|Death|3|||
124520379|NCT01237223|447857725|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
124520380|NCT01237223|447857720|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
124573422|NCT00436553|448058817|FG000|Overall Study|Lost to Follow-up|0|||
124573423|NCT00436553|448058818|FG001|Overall Study|Lost to Follow-up|2|||
124573424|NCT00436553|448058819|FG002|Overall Study|Lost to Follow-up|0|||
124573425|NCT00436553|448058817|FG000|Overall Study|Protocol Violation|1|||
124573426|NCT00436553|448058818|FG001|Overall Study|Protocol Violation|0|||
124573427|NCT00436553|448058819|FG002|Overall Study|Protocol Violation|0|||
124573428|NCT00436553|448058817|FG000|Overall Study|Withdrawal by Subject|5|||
124573429|NCT00436553|448058818|FG001|Overall Study|Withdrawal by Subject|6|||
124573430|NCT00436553|448058819|FG002|Overall Study|Withdrawal by Subject|3|||
124573431|NCT01661686|448058828|FG000|Overall Study|Lost to Follow-up|2|||
124573432|NCT01661686|448058829|FG001|Overall Study|Lost to Follow-up|1|||
124573433|NCT01661686|448058828|FG000|Overall Study|did not receive allocated intervention|0|||
124573434|NCT01661686|448058829|FG001|Overall Study|did not receive allocated intervention|1|||
124573435|NCT01873586|448058830|FG000|Overall Study|Lost to Follow-up|3|||
124573436|NCT00624065|448058831|FG000|Overall Study|Adverse Event|5|||
124573437|NCT00624065|448058832|FG001|Overall Study|Adverse Event|6|||
124573438|NCT00624065|448058831|FG000|Overall Study|Lost to Follow-up|4|||
124573439|NCT00624065|448058832|FG001|Overall Study|Lost to Follow-up|1|||
124573440|NCT00624065|448058831|FG000|Overall Study|Consent withdrawn|6|||
124573441|NCT00624065|448058832|FG001|Overall Study|Consent withdrawn|5|||
124573442|NCT00624065|448058831|FG000|Overall Study|Lack of Efficacy|0|||
124573443|NCT00624065|448058832|FG001|Overall Study|Lack of Efficacy|3|||
124573444|NCT00624065|448058831|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
124573445|NCT00624065|448058832|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
124573446|NCT00696020|448058833|FG000|Overall Study|Adverse Event|3|||
124573447|NCT00696020|448058834|FG001|Overall Study|Adverse Event|1|||
124573448|NCT00696020|448058835|FG002|Overall Study|Adverse Event|2|||
124573449|NCT00696020|448058836|FG003|Overall Study|Adverse Event|1|||
124573450|NCT00696020|448058833|FG000|Overall Study|Lack of Efficacy|1|||
124573451|NCT00696020|448058834|FG001|Overall Study|Lack of Efficacy|0|||
124573452|NCT00696020|448058835|FG002|Overall Study|Lack of Efficacy|0|||
124573453|NCT00696020|448058836|FG003|Overall Study|Lack of Efficacy|0|||
124573454|NCT00696020|448058833|FG000|Overall Study|Protocol Violation|0|||
124573455|NCT00696020|448058834|FG001|Overall Study|Protocol Violation|0|||
124573456|NCT00696020|448058835|FG002|Overall Study|Protocol Violation|0|||
124573457|NCT00696020|448058836|FG003|Overall Study|Protocol Violation|1|||
124725063|NCT01866111|448613445|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
124725064|NCT01866111|448613446|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
124725065|NCT01866111|448613447|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
124725066|NCT01866111|448613448|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
124725067|NCT01866111|448613445|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
124725068|NCT01866111|448613446|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
124520381|NCT01237223|447857721|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
124520382|NCT01237223|447857722|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
124520383|NCT01237223|447857723|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
124520384|NCT01237223|447857724|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
124520385|NCT01237223|447857725|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
124520386|NCT01237223|447857720|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
124520387|NCT01237223|447857721|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
124520388|NCT01237223|447857722|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
124520389|NCT01237223|447857723|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
124520390|NCT01237223|447857724|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
124520391|NCT01237223|447857725|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
124520392|NCT01237223|447857720|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
124520393|NCT01237223|447857721|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
124520394|NCT01237223|447857722|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
124520395|NCT01237223|447857723|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
124520396|NCT01237223|447857724|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
124520397|NCT01237223|447857725|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
124520398|NCT01237223|447857720|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
124520399|NCT01237223|447857721|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
124520400|NCT01237223|447857722|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
124520401|NCT01237223|447857723|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
124520402|NCT01237223|447857724|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
124520403|NCT01237223|447857725|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
124520404|NCT01237223|447857720|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
124573458|NCT00696020|448058833|FG000|Overall Study|Withdrawal by Subject|0|||
124573459|NCT00696020|448058834|FG001|Overall Study|Withdrawal by Subject|1|||
124573460|NCT00696020|448058835|FG002|Overall Study|Withdrawal by Subject|0|||
124573461|NCT00696020|448058836|FG003|Overall Study|Withdrawal by Subject|1|||
124573462|NCT00696020|448058833|FG000|Overall Study|Other not stated above|0|||
124573463|NCT00696020|448058834|FG001|Overall Study|Other not stated above|0|||
124520405|NCT01237223|447857721|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
124520406|NCT01237223|447857722|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
124520407|NCT01237223|447857723|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
124520408|NCT01237223|447857724|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
124520409|NCT01237223|447857725|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
124520410|NCT01237223|447857720|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
124520411|NCT01237223|447857721|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
124520412|NCT01237223|447857722|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
124520413|NCT01237223|447857723|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
124520414|NCT01237223|447857724|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
124520415|NCT01237223|447857725|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
124520416|NCT01237223|447857720|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
124520417|NCT01237223|447857721|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
124520418|NCT01237223|447857722|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
124520419|NCT01237223|447857723|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
124520420|NCT01237223|447857724|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
124520421|NCT01237223|447857725|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
124520422|NCT01237223|447857720|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
124520423|NCT01237223|447857721|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
124520424|NCT01237223|447857722|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
124520425|NCT01237223|447857723|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
124520426|NCT01237223|447857724|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
124520427|NCT01237223|447857725|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
124520428|NCT01237223|447857720|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
124520429|NCT01237223|447857721|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
124520430|NCT01237223|447857722|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
124520431|NCT01237223|447857723|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
124520432|NCT01237223|447857724|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
124520433|NCT01237223|447857725|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
124520434|NCT00407550|447857732|FG000|Overall Study|Adverse Event|0|||
124520435|NCT00407550|447857733|FG001|Overall Study|Adverse Event|1|||
124520436|NCT00407550|447857732|FG000|Overall Study|Withdrawal by Subject|0|||
124520437|NCT00407550|447857733|FG001|Overall Study|Withdrawal by Subject|2|||
124520438|NCT00407550|447857732|FG000|Overall Study|Death|1|||
124520439|NCT00407550|447857733|FG001|Overall Study|Death|0|||
124520440|NCT00407550|447857732|FG000|Overall Study|Insurance or Other medical condition|2|||
124520441|NCT00407550|447857733|FG001|Overall Study|Insurance or Other medical condition|1|||
124520442|NCT00641706|447857734|FG000|Overall Study|Adverse Event|2|||
124520443|NCT00641706|447857735|FG001|Overall Study|Adverse Event|1|||
124520444|NCT00641706|447857734|FG000|Overall Study|Withdrawal by Subject|6|||
124520445|NCT00641706|447857735|FG001|Overall Study|Withdrawal by Subject|1|||
124520446|NCT00641706|447857734|FG000|Overall Study|Clinical Decline|1|||
124520447|NCT00641706|447857735|FG001|Overall Study|Clinical Decline|0|||
124520448|NCT00641706|447857734|FG000|Overall Study|Lead Investigator Decision|0|||
124520449|NCT00641706|447857735|FG001|Overall Study|Lead Investigator Decision|1|||
124520450|NCT01599806|447857738|FG000|Overall Study|Lost to Follow-up|20|||
124520451|NCT01599806|447857739|FG001|Overall Study|Lost to Follow-up|20|||
124520452|NCT01599806|447857738|FG000|Overall Study|Withdrawal by Subject|12|||
124520453|NCT01599806|447857739|FG001|Overall Study|Withdrawal by Subject|12|||
124520454|NCT01599806|447857738|FG000|Overall Study|Other Eligibility criteria|11|||
124520455|NCT01599806|447857739|FG001|Overall Study|Other Eligibility criteria|9|||
124520456|NCT00391807|447857741|FG000|Overall Study|Did not receive study medication|23|||
124520457|NCT00391807|447857741|FG000|Overall Study|Adverse Event|177|||
124520458|NCT00391807|447857741|FG000|Overall Study|Pregnancy|25|||
124520459|NCT00391807|447857741|FG000|Overall Study|Lost to Follow-up|227|||
124520460|NCT00391807|447857741|FG000|Overall Study|Withdrawal by Subject|147|||
124520461|NCT00391807|447857741|FG000|Overall Study|Protocol Violation|20|||
124520462|NCT00391807|447857741|FG000|Overall Study|Various|96|||
124520463|NCT01266070|447857742|FG000|Overall Study|Adverse Event|3|||
124520464|NCT01266070|447857742|FG000|Overall Study|Protocol Violation|1|||
124520465|NCT04080752|447857743|FG000|Overall Study|Adverse Event|2|||
124520466|NCT04080752|447857744|FG001|Overall Study|Adverse Event|3|||
124520467|NCT04080752|447857743|FG000|Overall Study|Lack of Efficacy|1|||
124520468|NCT04080752|447857744|FG001|Overall Study|Lack of Efficacy|0|||
124520469|NCT04080752|447857743|FG000|Overall Study|Lost to Follow-up|1|||
124520470|NCT04080752|447857744|FG001|Overall Study|Lost to Follow-up|0|||
124520471|NCT04080752|447857743|FG000|Overall Study|Pregnancy|0|||
124520472|NCT04080752|447857744|FG001|Overall Study|Pregnancy|1|||
124520473|NCT04080752|447857743|FG000|Overall Study|Withdrawal by Subject|7|||
124520474|NCT04080752|447857744|FG001|Overall Study|Withdrawal by Subject|0|||
124573464|NCT00696020|448058835|FG002|Overall Study|Other not stated above|1|||
124573465|NCT00696020|448058836|FG003|Overall Study|Other not stated above|1|||
124573466|NCT01387022|448058837|FG000|Overall Study|Death|1|||
124573467|NCT01387022|448058838|FG001|Overall Study|Death|1|||
124573468|NCT01387022|448058837|FG000|Overall Study|Lost to Follow-up|0|||
124573469|NCT01387022|448058838|FG001|Overall Study|Lost to Follow-up|3|||
124573470|NCT01536574|448058846|FG000|Overall Study|Adverse Event|4|||
124573471|NCT01536574|448058847|FG001|Overall Study|Adverse Event|5|||
124573472|NCT01536574|448058846|FG000|Overall Study|Withdrawal by Subject|1|||
124573473|NCT01536574|448058847|FG001|Overall Study|Withdrawal by Subject|2|||
124573474|NCT01536574|448058846|FG000|Overall Study|Lack of Efficacy|1|||
124573475|NCT01536574|448058847|FG001|Overall Study|Lack of Efficacy|0|||
124573476|NCT02193165|448058850|FG000|4 Week Product Use|Lost to Follow-up|1|||
124573477|NCT02193165|448058851|FG001|4 Week Product Use|Lost to Follow-up|1|||
124573478|NCT02193165|448058852|FG002|4 Week Product Use|Lost to Follow-up|1|||
124573479|NCT02193165|448058850|FG000|6 Week Product Use|Lost to Follow-up|0|||
124573480|NCT02193165|448058851|FG001|6 Week Product Use|Lost to Follow-up|1|||
124573481|NCT02193165|448058852|FG002|6 Week Product Use|Lost to Follow-up|0|||
124573482|NCT01498120|448058853|FG000|Overall Study|Lost to Follow-up|1|||
124573483|NCT01498120|448058853|FG000|Overall Study|Withdrawal by Subject|5|||
124573484|NCT01498120|448058853|FG000|Overall Study|AE, non-serious non-fatal|3|||
124573485|NCT01498120|448058853|FG000|Overall Study|Other|4|||
124573486|NCT01173692|448058854|FG000|Overall Study|Adverse Event|1|||
124573487|NCT01173692|448058855|FG001|Overall Study|Adverse Event|2|||
124573488|NCT01173692|448058854|FG000|Overall Study|Withdrawal by Subject|1|||
124573489|NCT01173692|448058855|FG001|Overall Study|Withdrawal by Subject|3|||
124573490|NCT00678639|448058856|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
124573491|NCT00678639|448058857|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
124573492|NCT00986245|448058858|FG000|First Intervention|Poor compliance|8|||
124573493|NCT00986245|448058859|FG001|First Intervention|Poor compliance|4|||
124573494|NCT00986245|448058858|FG000|First Intervention|Lack of Efficacy|1|||
124573495|NCT00986245|448058859|FG001|First Intervention|Lack of Efficacy|2|||
124573496|NCT00986245|448058858|FG000|First Intervention|Withdrawal by Subject|0|||
124573497|NCT00986245|448058859|FG001|First Intervention|Withdrawal by Subject|1|||
124573498|NCT00986245|448058858|FG000|First Intervention|Protocol Violation|0|||
124573499|NCT00986245|448058859|FG001|First Intervention|Protocol Violation|1|||
124573500|NCT00986245|448058858|FG000|First Intervention|Out of indication|1|||
124573501|NCT00986245|448058859|FG001|First Intervention|Out of indication|0|||
124573502|NCT00986245|448058858|FG000|Second Intervention|Poor compliance|1|||
124573503|NCT00986245|448058859|FG001|Second Intervention|Poor compliance|0|||
124573504|NCT00986245|448058858|FG000|Second Intervention|Lost to Follow-up|1|||
124573505|NCT00986245|448058859|FG001|Second Intervention|Lost to Follow-up|0|||
124573506|NCT00986245|448058858|FG000|Second Intervention|Protocol Violation|0|||
124573507|NCT00986245|448058859|FG001|Second Intervention|Protocol Violation|1|||
124573508|NCT01629381|448058860|FG000|Overall Study|Withdrawal by Subject|2|||
124573509|NCT01629381|448058861|FG001|Overall Study|Withdrawal by Subject|5|||
124573510|NCT01214850|448058862|FG000|Overall Study|Withdrawal by Subject|38|||
124573511|NCT01214850|448058863|FG001|Overall Study|Withdrawal by Subject|31|||
124573512|NCT01214850|448058864|FG002|Overall Study|Withdrawal by Subject|28|||
124573513|NCT01214850|448058862|FG000|Overall Study|Lost to Follow-up|124|||
124573514|NCT01214850|448058863|FG001|Overall Study|Lost to Follow-up|98|||
124573515|NCT01214850|448058864|FG002|Overall Study|Lost to Follow-up|123|||
124573516|NCT01214850|448058862|FG000|Overall Study|Protocol Violation|5|||
124573517|NCT01214850|448058863|FG001|Overall Study|Protocol Violation|5|||
124573518|NCT01214850|448058864|FG002|Overall Study|Protocol Violation|6|||
124573519|NCT01214850|448058862|FG000|Overall Study|Adverse event or death|11|||
124573520|NCT01214850|448058863|FG001|Overall Study|Adverse event or death|8|||
124573521|NCT01214850|448058864|FG002|Overall Study|Adverse event or death|3|||
124573522|NCT01214850|448058862|FG000|Overall Study|Inappropriate enrollment|2|||
124573523|NCT01214850|448058863|FG001|Overall Study|Inappropriate enrollment|1|||
124573524|NCT01214850|448058864|FG002|Overall Study|Inappropriate enrollment|0|||
124573525|NCT01214850|448058862|FG000|Overall Study|Administrative reason|1|||
124573526|NCT01214850|448058863|FG001|Overall Study|Administrative reason|0|||
124573527|NCT01214850|448058864|FG002|Overall Study|Administrative reason|0|||
124573528|NCT01214850|448058862|FG000|Overall Study|Unable to classify|2|||
124573529|NCT01214850|448058863|FG001|Overall Study|Unable to classify|1|||
124573530|NCT01214850|448058864|FG002|Overall Study|Unable to classify|1|||
124573531|NCT01863745|448058865|FG000|Overall Study|Disease Progression|9|||
124573532|NCT01863745|448058865|FG000|Overall Study|Adverse Event|2|||
124573533|NCT01863745|448058865|FG000|Overall Study|Death|1|||
124573534|NCT01863745|448058865|FG000|Overall Study|Withdrawal by Subject|1|||
124573535|NCT00193609|448058866|FG000|Overall Study|Lack of Efficacy|2|||
124573536|NCT00193609|448058866|FG000|Overall Study|Adverse Event|2|||
124573537|NCT00854308|448058867|FG000|Overall Study|Disease progression|42|||
124573538|NCT00854308|448058868|FG001|Overall Study|Disease progression|50|||
124573539|NCT00854308|448058867|FG000|Overall Study|Adverse Event|8|||
124573540|NCT00854308|448058868|FG001|Overall Study|Adverse Event|3|||
124573541|NCT00854308|448058867|FG000|Overall Study|Death|2|||
124573542|NCT00854308|448058868|FG001|Overall Study|Death|5|||
124573543|NCT00854308|448058867|FG000|Overall Study|Physician Decision|6|||
124573544|NCT00854308|448058868|FG001|Overall Study|Physician Decision|6|||
124573545|NCT00854308|448058867|FG000|Overall Study|Withdrawal by Subject|4|||
124573546|NCT00854308|448058868|FG001|Overall Study|Withdrawal by Subject|2|||
124573547|NCT00854308|448058867|FG000|Overall Study|Sponsor's decision to terminate study|0|||
124573548|NCT00854308|448058868|FG001|Overall Study|Sponsor's decision to terminate study|1|||
124573549|NCT00610363|448058871|FG000|Overall Study|Non-compliance with protocol|0|||
124573550|NCT00610363|448058872|FG001|Overall Study|Non-compliance with protocol|1|||
124573551|NCT00610363|448058871|FG000|Overall Study|Adverse Event|3|||
124573552|NCT00610363|448058872|FG001|Overall Study|Adverse Event|1|||
124573553|NCT00610363|448058871|FG000|Overall Study|Lack of Efficacy|2|||
124573554|NCT00610363|448058872|FG001|Overall Study|Lack of Efficacy|0|||
124573555|NCT00610363|448058871|FG000|Overall Study|Lost to Follow-up|4|||
124573556|NCT00610363|448058872|FG001|Overall Study|Lost to Follow-up|0|||
124573557|NCT00610363|448058871|FG000|Overall Study|Withdrawal by Subject|1|||
124573558|NCT00610363|448058872|FG001|Overall Study|Withdrawal by Subject|0|||
124573559|NCT00610363|448058871|FG000|Overall Study|Other than specified above|1|||
124573560|NCT00610363|448058872|FG001|Overall Study|Other than specified above|1|||
124573561|NCT03048500|448058873|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
124573562|NCT03048500|448058873|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
124573563|NCT03048500|448058873|FG000|Reached 1st Response/Continued Treatment|Death|1|||
124573564|NCT03048500|448058873|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
124573565|NCT03048500|448058873|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
124573566|NCT03048500|448058873|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
124573567|NCT03048500|448058873|FG000|Follow up for 3 Years|Death|12|||
124573568|NCT01171963|448058874|FG000|Overall Study|Adverse Event|10|||
124573569|NCT01171963|448058875|FG001|Overall Study|Adverse Event|15|||
124573570|NCT01171963|448058874|FG000|Overall Study|Lost to Follow-up|23|||
124573571|NCT01171963|448058875|FG001|Overall Study|Lost to Follow-up|24|||
124573572|NCT01171963|448058874|FG000|Overall Study|Other - diarrhoea|1|||
124573573|NCT01171963|448058875|FG001|Overall Study|Other - diarrhoea|0|||
124573574|NCT01171963|448058874|FG000|Overall Study|Withdrawal by Subject|114|||
124573575|NCT01171963|448058875|FG001|Overall Study|Withdrawal by Subject|129|||
124573576|NCT00626548|448058878|FG000|Overall Study|Adverse Event|164|||
124573577|NCT00626548|448058879|FG001|Overall Study|Adverse Event|44|||
124573578|NCT00626548|448058878|FG000|Overall Study|Withdrawal by Subject|42|||
124573579|NCT00626548|448058879|FG001|Overall Study|Withdrawal by Subject|46|||
124573580|NCT00626548|448058878|FG000|Overall Study|Protocol Violation|4|||
124573581|NCT00626548|448058879|FG001|Overall Study|Protocol Violation|11|||
124573582|NCT00626548|448058878|FG000|Overall Study|Lost to Follow-up|2|||
124573583|NCT00626548|448058879|FG001|Overall Study|Lost to Follow-up|2|||
124573584|NCT00626548|448058878|FG000|Overall Study|Other termination reason|493|||
124573585|NCT00626548|448058879|FG001|Overall Study|Other termination reason|613|||
124573586|NCT00048581|448058880|FG000|Double-Blind Period|Adverse Event|9|||
124573587|NCT00048581|448058881|FG001|Double-Blind Period|Adverse Event|5|||
124573588|NCT00048581|448058882|FG002|Double-Blind Period|Adverse Event|0|||
124573589|NCT00048581|448058880|FG000|Double-Blind Period|Lack of Efficacy|14|||
124573590|NCT00048581|448058881|FG001|Double-Blind Period|Lack of Efficacy|27|||
124573591|NCT00048581|448058882|FG002|Double-Blind Period|Lack of Efficacy|0|||
124573592|NCT00048581|448058880|FG000|Double-Blind Period|Lost to Follow-up|5|||
124573593|NCT00048581|448058881|FG001|Double-Blind Period|Lost to Follow-up|0|||
124573594|NCT00048581|448058882|FG002|Double-Blind Period|Lost to Follow-up|0|||
124573595|NCT00048581|448058880|FG000|Double-Blind Period|Withdrawal by Subject|5|||
124573596|NCT00048581|448058881|FG001|Double-Blind Period|Withdrawal by Subject|2|||
124573597|NCT00048581|448058882|FG002|Double-Blind Period|Withdrawal by Subject|0|||
124573598|NCT00048581|448058880|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
124573599|NCT00048581|448058881|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
124573600|NCT00048581|448058882|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
124573601|NCT00048581|448058880|FG000|Double-Blind Period|Investigator Decision|1|||
124573602|NCT00048581|448058881|FG001|Double-Blind Period|Investigator Decision|0|||
124573603|NCT00048581|448058882|FG002|Double-Blind Period|Investigator Decision|0|||
124573604|NCT00048581|448058880|FG000|Open-Label Period|Death|0|||
124573605|NCT00048581|448058881|FG001|Open-Label Period|Death|0|||
124573606|NCT00048581|448058882|FG002|Open-Label Period|Death|4|||
124573607|NCT00048581|448058880|FG000|Open-Label Period|Adverse Event|0|||
124573608|NCT00048581|448058881|FG001|Open-Label Period|Adverse Event|0|||
124573609|NCT00048581|448058882|FG002|Open-Label Period|Adverse Event|37|||
124573610|NCT00048581|448058880|FG000|Open-Label Period|Lack of Efficacy|0|||
124573611|NCT00048581|448058881|FG001|Open-Label Period|Lack of Efficacy|0|||
124573612|NCT00048581|448058882|FG002|Open-Label Period|Lack of Efficacy|69|||
124573613|NCT00048581|448058880|FG000|Open-Label Period|Lost to Follow-up|0|||
124573614|NCT00048581|448058881|FG001|Open-Label Period|Lost to Follow-up|0|||
124573615|NCT00048581|448058882|FG002|Open-Label Period|Lost to Follow-up|14|||
124573616|NCT00048581|448058880|FG000|Open-Label Period|Withdrawal by Subject|0|||
124573617|NCT00048581|448058881|FG001|Open-Label Period|Withdrawal by Subject|0|||
124520475|NCT04080752|447857743|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124520476|NCT04080752|447857744|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124520477|NCT04080752|447857743|FG000|Overall Study|Other|2|||
124520478|NCT04080752|447857744|FG001|Overall Study|Other|1|||
124520479|NCT01585168|447857745|FG000|Overall Study|Lost to Follow-up|3|||
124520480|NCT01585168|447857746|FG001|Overall Study|Lost to Follow-up|1|||
124520481|NCT01585168|447857747|FG002|Overall Study|Lost to Follow-up|1|||
124520482|NCT01585168|447857748|FG003|Overall Study|Lost to Follow-up|1|||
124520483|NCT01194414|447857749|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
124520484|NCT01194414|447857750|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
124520485|NCT01194414|447857751|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
124520486|NCT01194414|447857752|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
124520487|NCT01194414|447857749|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
124520488|NCT01194414|447857750|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
124520489|NCT01194414|447857751|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
124520490|NCT01194414|447857752|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
124520491|NCT01194414|447857749|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
124520492|NCT01194414|447857750|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
124520493|NCT01194414|447857751|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
124520494|NCT01194414|447857752|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
124520495|NCT01194414|447857749|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
124520496|NCT01194414|447857750|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
124520497|NCT01194414|447857751|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
124520498|NCT01194414|447857752|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
124520499|NCT01194414|447857749|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
124520500|NCT01194414|447857750|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
124520501|NCT01194414|447857751|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
124520502|NCT01194414|447857752|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
124520503|NCT01194414|447857749|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
124520504|NCT01194414|447857750|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
124520505|NCT01194414|447857751|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
124520506|NCT01194414|447857752|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
124520507|NCT01194414|447857749|FG000|24 Weeks Double Blind Period|Other|0|||
124520508|NCT01194414|447857750|FG001|24 Weeks Double Blind Period|Other|1|||
124520509|NCT01194414|447857751|FG002|24 Weeks Double Blind Period|Other|0|||
124520510|NCT01194414|447857752|FG003|24 Weeks Double Blind Period|Other|0|||
124520511|NCT01194414|447857749|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
124520512|NCT01194414|447857750|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
124520513|NCT01194414|447857751|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
124520514|NCT01194414|447857752|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
124520515|NCT01194414|447857749|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
124520516|NCT01194414|447857750|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
124520517|NCT01194414|447857751|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
124520518|NCT01194414|447857752|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
124520519|NCT01194414|447857749|FG000|24 Weeks Double Blind Period|Death|0|||
124520520|NCT01194414|447857750|FG001|24 Weeks Double Blind Period|Death|1|||
124520521|NCT01194414|447857751|FG002|24 Weeks Double Blind Period|Death|0|||
124520522|NCT01194414|447857752|FG003|24 Weeks Double Blind Period|Death|0|||
124520523|NCT01194414|447857749|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
124520524|NCT01194414|447857750|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
124520525|NCT01194414|447857751|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
124520526|NCT01194414|447857752|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
124520527|NCT01194414|447857749|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
124520528|NCT01194414|447857750|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
124520529|NCT01194414|447857751|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
124520530|NCT01194414|447857752|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
124520531|NCT01194414|447857749|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
124520532|NCT01194414|447857750|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
124520533|NCT01194414|447857751|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
124520534|NCT01194414|447857752|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
124520535|NCT01194414|447857749|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
124520536|NCT01194414|447857750|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
124520537|NCT01194414|447857751|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
124520538|NCT01194414|447857752|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
124520539|NCT01194414|447857749|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
124520540|NCT01194414|447857750|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
124520541|NCT01194414|447857751|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
124520542|NCT01194414|447857752|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
124520543|NCT01194414|447857749|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
124725069|NCT01866111|448613447|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
124725070|NCT01866111|448613448|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
124725071|NCT01866111|448613445|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
124725072|NCT01866111|448613446|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
124725073|NCT01866111|448613447|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
124725074|NCT01866111|448613448|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
124725075|NCT01866111|448613445|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
124520544|NCT01194414|447857750|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
124520545|NCT01194414|447857751|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
124520546|NCT01194414|447857752|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
124520547|NCT01194414|447857749|FG000|72 Weeks Open Label Extension|Other|2|||
124520548|NCT01194414|447857750|FG001|72 Weeks Open Label Extension|Other|1|||
124520549|NCT01194414|447857751|FG002|72 Weeks Open Label Extension|Other|0|||
124520550|NCT01194414|447857752|FG003|72 Weeks Open Label Extension|Other|0|||
124520551|NCT01194414|447857749|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
124520552|NCT01194414|447857750|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
124520553|NCT01194414|447857751|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
124520554|NCT01194414|447857752|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
124520555|NCT01194414|447857749|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
124520556|NCT01194414|447857750|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
124520557|NCT01194414|447857751|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
124520558|NCT01194414|447857752|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
124520559|NCT01194414|447857749|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
124520560|NCT01194414|447857750|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
124520561|NCT01194414|447857751|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
124520562|NCT01194414|447857752|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
124520563|NCT01194414|447857749|FG000|72 Weeks Open Label Extension|Death|1|||
124520564|NCT01194414|447857750|FG001|72 Weeks Open Label Extension|Death|2|||
124520565|NCT01194414|447857751|FG002|72 Weeks Open Label Extension|Death|0|||
124520566|NCT01194414|447857752|FG003|72 Weeks Open Label Extension|Death|2|||
124520567|NCT00770224|447857755|FG000|Step 1: Induction|Adverse Event|3|||
124520568|NCT00770224|447857756|FG001|Step 1: Induction|Adverse Event|0|||
124520569|NCT00770224|447857755|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
124520570|NCT00770224|447857756|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
124520571|NCT00770224|447857755|FG000|Step 1: Induction|Other reason not protocol specified|2|||
124520572|NCT00770224|447857756|FG001|Step 1: Induction|Other reason not protocol specified|0|||
124520573|NCT00770224|447857755|FG000|Step 1: Induction|Ineligible|2|||
124520574|NCT00770224|447857756|FG001|Step 1: Induction|Ineligible|0|||
124520575|NCT00770224|447857755|FG000|Step 1: Induction|No protocol treatment given|1|||
124520576|NCT00770224|447857756|FG001|Step 1: Induction|No protocol treatment given|0|||
124520577|NCT00770224|447857755|FG000|Step 2: Maintenance|Adverse Event|0|||
124520578|NCT00770224|447857756|FG001|Step 2: Maintenance|Adverse Event|10|||
124520579|NCT00770224|447857755|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
124520580|NCT00770224|447857756|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
124520581|NCT00770224|447857755|FG000|Step 2: Maintenance|Progression/relapse|0|||
124520582|NCT00770224|447857756|FG001|Step 2: Maintenance|Progression/relapse|1|||
124520583|NCT00770224|447857755|FG000|Step 2: Maintenance|Death|0|||
124520584|NCT00770224|447857756|FG001|Step 2: Maintenance|Death|2|||
124520585|NCT00770224|447857755|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
124520586|NCT00770224|447857756|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
124520587|NCT00770224|447857755|FG000|Step 2: Maintenance|Ineligible|0|||
124520588|NCT00770224|447857756|FG001|Step 2: Maintenance|Ineligible|2|||
124520589|NCT04737759|447857757|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
124520590|NCT04737759|447857758|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
124520591|NCT04737759|447857757|FG000|Overall Study|Death|2|||
124520592|NCT04737759|447857758|FG001|Overall Study|Death|0|||
124520593|NCT04737759|447857757|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
124520594|NCT04737759|447857758|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
124520595|NCT04737759|447857757|FG000|Overall Study|Lost to Follow-up|4|||
124520596|NCT04737759|447857758|FG001|Overall Study|Lost to Follow-up|12|||
124520597|NCT01505114|447857759|FG000|Overall Study|Withdrawal by Subject|5|||
124520598|NCT01505114|447857760|FG001|Overall Study|Withdrawal by Subject|4|||
124520599|NCT01505114|447857761|FG002|Overall Study|Withdrawal by Subject|4|||
124520600|NCT01505114|447857762|FG003|Overall Study|Withdrawal by Subject|7|||
124520601|NCT01505114|447857759|FG000|Overall Study|Death|1|||
124520602|NCT01505114|447857760|FG001|Overall Study|Death|0|||
124520603|NCT01505114|447857761|FG002|Overall Study|Death|0|||
124520604|NCT01505114|447857762|FG003|Overall Study|Death|1|||
124725076|NCT01866111|448613446|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
124573618|NCT00048581|448058882|FG002|Open-Label Period|Withdrawal by Subject|20|||
124573619|NCT00048581|448058880|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
124573620|NCT00048581|448058881|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
124573621|NCT00048581|448058882|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
124573622|NCT00048581|448058880|FG000|Open-Label Period|Poor/Non-compliance|0|||
124573623|NCT00048581|448058881|FG001|Open-Label Period|Poor/Non-compliance|0|||
124573624|NCT00048581|448058882|FG002|Open-Label Period|Poor/Non-compliance|5|||
124573625|NCT00048581|448058880|FG000|Open-Label Period|Pregnancy|0|||
124573626|NCT00048581|448058881|FG001|Open-Label Period|Pregnancy|0|||
124573627|NCT00048581|448058882|FG002|Open-Label Period|Pregnancy|7|||
124573628|NCT00048581|448058880|FG000|Open-Label Period|Study Site Closure|0|||
124573629|NCT00048581|448058881|FG001|Open-Label Period|Study Site Closure|0|||
124573630|NCT00048581|448058882|FG002|Open-Label Period|Study Site Closure|2|||
124573631|NCT00048581|448058880|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
124573632|NCT00048581|448058881|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
124573633|NCT00048581|448058882|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
124573634|NCT00048581|448058880|FG000|Open-Label Period|Problem With Transportation To Site|0|||
124573635|NCT00048581|448058881|FG001|Open-Label Period|Problem With Transportation To Site|0|||
124573636|NCT00048581|448058882|FG002|Open-Label Period|Problem With Transportation To Site|1|||
124573637|NCT00048581|448058880|FG000|Open-Label Period|Primary Investigator Retired|0|||
124573638|NCT00048581|448058881|FG001|Open-Label Period|Primary Investigator Retired|0|||
124573639|NCT00048581|448058882|FG002|Open-Label Period|Primary Investigator Retired|2|||
124573640|NCT00048581|448058880|FG000|Open-Label Period|Study Ended By Sponsor|0|||
124573641|NCT00048581|448058881|FG001|Open-Label Period|Study Ended By Sponsor|0|||
124573642|NCT00048581|448058882|FG002|Open-Label Period|Study Ended By Sponsor|1|||
124573643|NCT01059903|448058883|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
124573644|NCT01059903|448058884|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
124573645|NCT00385593|448058885|FG000|Overall Study|Adverse Event|3|||
124573646|NCT00385593|448058886|FG001|Overall Study|Adverse Event|2|||
124573647|NCT00385593|448058885|FG000|Overall Study|Withdrawal by Subject|17|||
124573648|NCT00385593|448058886|FG001|Overall Study|Withdrawal by Subject|7|||
124573649|NCT00385593|448058885|FG000|Overall Study|Lost to Follow-up|12|||
124573650|NCT00385593|448058886|FG001|Overall Study|Lost to Follow-up|8|||
124573651|NCT00385593|448058885|FG000|Overall Study|Protocol Violation|7|||
124573652|NCT00385593|448058886|FG001|Overall Study|Protocol Violation|4|||
124573653|NCT00385593|448058885|FG000|Overall Study|Several reasons|17|||
124573654|NCT00385593|448058886|FG001|Overall Study|Several reasons|15|||
124573655|NCT00385593|448058885|FG000|Overall Study|Incorrect inclusion|2|||
124573656|NCT00385593|448058886|FG001|Overall Study|Incorrect inclusion|0|||
124573657|NCT00385593|448058885|FG000|Overall Study|Incorrect randomization|0|||
124573658|NCT00385593|448058886|FG001|Overall Study|Incorrect randomization|1|||
124573659|NCT00214422|448058887|FG000|Overall Study|Physician Decision|2|||
124573660|NCT00214422|448058888|FG001|Overall Study|Physician Decision|0|||
124573661|NCT00214422|448058889|FG002|Overall Study|Physician Decision|0|||
124573662|NCT00214422|448058887|FG000|Overall Study|Developed esophageal ca|1|||
124573663|NCT00214422|448058888|FG001|Overall Study|Developed esophageal ca|0|||
124573664|NCT00214422|448058889|FG002|Overall Study|Developed esophageal ca|0|||
124573665|NCT00214422|448058887|FG000|Overall Study|Pt taken off study|1|||
124573666|NCT00214422|448058888|FG001|Overall Study|Pt taken off study|1|||
124573667|NCT00214422|448058889|FG002|Overall Study|Pt taken off study|0|||
124573668|NCT00214422|448058887|FG000|Overall Study|Disease progression on study|1|||
124573669|NCT00214422|448058888|FG001|Overall Study|Disease progression on study|0|||
124573670|NCT00214422|448058889|FG002|Overall Study|Disease progression on study|0|||
124573671|NCT00214422|448058887|FG000|Overall Study|Unable to make a radiation treatment|0|||
124573672|NCT00214422|448058888|FG001|Overall Study|Unable to make a radiation treatment|0|||
124573673|NCT00214422|448058889|FG002|Overall Study|Unable to make a radiation treatment|1|||
124573674|NCT00319735|448058890|FG000|Overall Study|Death|2|||
124573675|NCT03929393|448058891|FG000|Overall Study|Death|1|||
124573676|NCT03929393|448058892|FG001|Overall Study|Death|0|||
124573677|NCT03929393|448058891|FG000|Overall Study|Time Commitment|2|||
124573678|NCT03929393|448058892|FG001|Overall Study|Time Commitment|5|||
124573679|NCT03929393|448058891|FG000|Overall Study|Motor Vehicle Accident|0|||
124573680|NCT03929393|448058892|FG001|Overall Study|Motor Vehicle Accident|1|||
124573681|NCT03929393|448058891|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
124573682|NCT03929393|448058892|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
124573683|NCT03929393|448058891|FG000|Overall Study|Other|1|||
124573684|NCT03929393|448058892|FG001|Overall Study|Other|3|||
124573685|NCT03420300|448058893|FG000|Overall Study|Death|2|||
124573686|NCT02421952|448058894|FG000|Overall Study|Diary Not Returned|93|||
124573687|NCT02421952|448058894|FG000|Overall Study|Failed seriation task|13|||
124573688|NCT02421952|448058894|FG000|Overall Study|Subject uncooperative for baseline test|2|||
124573689|NCT02421952|448058894|FG000|Overall Study|Surgery cancelled|1|||
124573690|NCT02140060|448058895|FG000|Overall Study|Adverse Event|0|||
124573691|NCT02140060|448058896|FG001|Overall Study|Adverse Event|0|||
124573692|NCT02140060|448058897|FG002|Overall Study|Adverse Event|0|||
124573693|NCT02140060|448058898|FG003|Overall Study|Adverse Event|1|||
124573694|NCT02140060|448058899|FG004|Overall Study|Adverse Event|1|||
124573695|NCT02140060|448058900|FG005|Overall Study|Adverse Event|1|||
124573696|NCT02140060|448058895|FG000|Overall Study|Lack of Efficacy|0|||
124573697|NCT02140060|448058896|FG001|Overall Study|Lack of Efficacy|0|||
124573698|NCT02140060|448058897|FG002|Overall Study|Lack of Efficacy|0|||
124573699|NCT02140060|448058898|FG003|Overall Study|Lack of Efficacy|1|||
124573700|NCT02140060|448058899|FG004|Overall Study|Lack of Efficacy|0|||
124573701|NCT02140060|448058900|FG005|Overall Study|Lack of Efficacy|0|||
124573702|NCT04466111|448060777|FG000|Prior to Trial Phase|Physician Decision|1|||
124573703|NCT00105196|448060778|FG000|Overall Study|Lack of Efficacy|2|||
124573704|NCT00105196|448060779|FG001|Overall Study|Lack of Efficacy|3|||
124573705|NCT00105196|448060778|FG000|Overall Study|Adverse Event|11|||
124573706|NCT00105196|448060779|FG001|Overall Study|Adverse Event|3|||
124573707|NCT00105196|448060778|FG000|Overall Study|Withdrawal by Subject|6|||
124573708|NCT00105196|448060779|FG001|Overall Study|Withdrawal by Subject|6|||
124573709|NCT00105196|448060778|FG000|Overall Study|Lost to Follow-up|3|||
124573710|NCT00105196|448060779|FG001|Overall Study|Lost to Follow-up|2|||
124573711|NCT00105196|448060778|FG000|Overall Study|Poor/noncompliance|3|||
124573712|NCT00105196|448060779|FG001|Overall Study|Poor/noncompliance|4|||
124573713|NCT00105196|448060778|FG000|Overall Study|Protocol Violation|5|||
124573714|NCT00105196|448060779|FG001|Overall Study|Protocol Violation|2|||
124520605|NCT01505114|447857759|FG000|Overall Study|unable to adhere to visit schedule|3|||
124573715|NCT00105196|448060778|FG000|Overall Study|pending surgery|0|||
124573716|NCT00105196|448060779|FG001|Overall Study|pending surgery|1|||
124573717|NCT00105196|448060778|FG000|Overall Study|marijuana use|0|||
124573718|NCT00105196|448060779|FG001|Overall Study|marijuana use|1|||
124573719|NCT00105196|448060778|FG000|Overall Study|Subject became unblinded|0|||
124573720|NCT00105196|448060779|FG001|Overall Study|Subject became unblinded|1|||
124520606|NCT01505114|447857760|FG001|Overall Study|unable to adhere to visit schedule|2|||
124520607|NCT01505114|447857761|FG002|Overall Study|unable to adhere to visit schedule|3|||
124520608|NCT01505114|447857762|FG003|Overall Study|unable to adhere to visit schedule|3|||
124520609|NCT01505114|447857759|FG000|Overall Study|Lost to Follow-up|11|||
124520610|NCT01505114|447857760|FG001|Overall Study|Lost to Follow-up|5|||
124520611|NCT01505114|447857761|FG002|Overall Study|Lost to Follow-up|8|||
124520612|NCT01505114|447857762|FG003|Overall Study|Lost to Follow-up|7|||
124520613|NCT01505114|447857759|FG000|Overall Study|relocated|4|||
124520614|NCT01505114|447857760|FG001|Overall Study|relocated|2|||
124520615|NCT01505114|447857761|FG002|Overall Study|relocated|2|||
124520616|NCT01505114|447857762|FG003|Overall Study|relocated|3|||
124520617|NCT01505114|447857759|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
124520618|NCT01505114|447857760|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
124520619|NCT01505114|447857761|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
124520620|NCT01505114|447857762|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
124520621|NCT01505114|447857759|FG000|Overall Study|staff safety concerns|0|||
124520622|NCT01505114|447857760|FG001|Overall Study|staff safety concerns|0|||
124520623|NCT01505114|447857761|FG002|Overall Study|staff safety concerns|0|||
124520624|NCT01505114|447857762|FG003|Overall Study|staff safety concerns|1|||
124520625|NCT01505114|447857759|FG000|Overall Study|investigator decision|1|||
124520626|NCT01505114|447857760|FG001|Overall Study|investigator decision|0|||
124520627|NCT01505114|447857761|FG002|Overall Study|investigator decision|1|||
124520628|NCT01505114|447857762|FG003|Overall Study|investigator decision|0|||
124520629|NCT02260388|447857763|FG000|Overall Study|Lost to Follow-up|2|||
124520630|NCT02260388|447857764|FG001|Overall Study|Lost to Follow-up|8|||
124520631|NCT02260388|447857765|FG002|Overall Study|Lost to Follow-up|3|||
124520632|NCT02260388|447857766|FG003|Overall Study|Lost to Follow-up|4|||
124520633|NCT01587274|447857770|FG000|Overall Study|Lost to Follow-up|4|||
124520634|NCT01587274|447857771|FG001|Overall Study|Lost to Follow-up|5|||
124520635|NCT01587274|447857772|FG002|Overall Study|Lost to Follow-up|3|||
124520636|NCT01421069|447857773|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
124520637|NCT01421069|447857773|FG000|Parent Study|Failed to return|3|||
124520638|NCT01421069|447857773|FG000|Parent Study|Withdrawal by Subject|1|||
124520639|NCT01421069|447857773|FG000|Parent Study|Lost to Follow-up|2|||
124520640|NCT01421069|447857773|FG000|Parent Study|Lack of Efficacy|1|||
124520641|NCT01421069|447857773|FG000|Overall Period for Extension Study|Other|2|||
124520642|NCT01421069|447857773|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
124520643|NCT01421069|447857773|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
124520644|NCT01421069|447857773|FG000|Overall Period for Extension Study|Pregnancy|1|||
124520645|NCT01421069|447857773|FG000|Overall Period for Extension Study|Adverse Event|1|||
124520646|NCT01421069|447857773|FG000|Overall Period for Extension Study|Protocol Violation|1|||
124520647|NCT01421069|447857773|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
124520648|NCT01421069|447857773|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
124520649|NCT01421069|447857773|FG000|Active Treatment Period|Other|1|||
124520650|NCT01421069|447857773|FG000|Active Treatment Period|No longer willing to participate in study|8|||
124573721|NCT03025880|448060780|FG000|Overall Study|Adverse Event|1|||
124573722|NCT03025880|448060781|FG001|Overall Study|Adverse Event|0|||
124520651|NCT01421069|447857773|FG000|Active Treatment Period|Insufficient clinical response|1|||
124520652|NCT01421069|447857773|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
124520653|NCT01421069|447857773|FG000|Active Treatment Period|Pregnancy|1|||
124520654|NCT01421069|447857773|FG000|Active Treatment Period|Adverse Event|1|||
124520655|NCT01421069|447857773|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
124520656|NCT01421069|447857773|FG000|Active Treatment Period|Enrolled in observational period|29|||
124520657|NCT01421069|447857773|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
124520658|NCT01421069|447857773|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
124520659|NCT01421069|447857773|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
124520660|NCT01421069|447857773|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
124520661|NCT01421069|447857773|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
124520662|NCT01421069|447857773|FG000|2b. Retreatment Period|Protocol Violation|1|||
124520663|NCT01421069|447857773|FG000|Observational Period|Other|1|||
124520664|NCT01421069|447857773|FG000|Observational Period|No longer willing to participate in study|4|||
124520665|NCT01421069|447857773|FG000|Observational Period|Lost to Follow-up|3|||
124520666|NCT01641081|447857774|FG000|Period 1|Sponsor request (potential unblinding)|0|||
124520667|NCT01641081|447857775|FG001|Period 1|Sponsor request (potential unblinding)|0|||
124520668|NCT01641081|447857776|FG002|Period 1|Sponsor request (potential unblinding)|0|||
124520669|NCT01641081|447857777|FG003|Period 1|Sponsor request (potential unblinding)|0|||
124520670|NCT01641081|447857778|FG004|Period 1|Sponsor request (potential unblinding)|0|||
124520671|NCT01641081|447857779|FG005|Period 1|Sponsor request (potential unblinding)|0|||
124520672|NCT01641081|447857780|FG006|Period 1|Sponsor request (potential unblinding)|1|||
124520673|NCT01641081|447857781|FG007|Period 1|Sponsor request (potential unblinding)|0|||
124520674|NCT01641081|447857782|FG008|Period 1|Sponsor request (potential unblinding)|0|||
124520675|NCT01641081|447857783|FG009|Period 1|Sponsor request (potential unblinding)|0|||
124520676|NCT01641081|447857774|FG000|Period 1|Protocol Violation|0|||
124520677|NCT01641081|447857775|FG001|Period 1|Protocol Violation|0|||
124520678|NCT01641081|447857776|FG002|Period 1|Protocol Violation|0|||
124520679|NCT01641081|447857777|FG003|Period 1|Protocol Violation|0|||
124520680|NCT01641081|447857778|FG004|Period 1|Protocol Violation|1|||
124520681|NCT01641081|447857779|FG005|Period 1|Protocol Violation|0|||
124520682|NCT01641081|447857780|FG006|Period 1|Protocol Violation|0|||
124520683|NCT01641081|447857781|FG007|Period 1|Protocol Violation|1|||
124520684|NCT01641081|447857782|FG008|Period 1|Protocol Violation|0|||
124520685|NCT01641081|447857783|FG009|Period 1|Protocol Violation|0|||
124520686|NCT01641081|447857774|FG000|Period 1|Adverse Event|1|||
124520687|NCT01641081|447857775|FG001|Period 1|Adverse Event|0|||
124520688|NCT01641081|447857776|FG002|Period 1|Adverse Event|0|||
124520689|NCT01641081|447857777|FG003|Period 1|Adverse Event|0|||
124520690|NCT01641081|447857778|FG004|Period 1|Adverse Event|0|||
124520691|NCT01641081|447857779|FG005|Period 1|Adverse Event|0|||
124520692|NCT01641081|447857780|FG006|Period 1|Adverse Event|0|||
124520693|NCT01641081|447857781|FG007|Period 1|Adverse Event|2|||
124520694|NCT01641081|447857782|FG008|Period 1|Adverse Event|0|||
124520695|NCT01641081|447857783|FG009|Period 1|Adverse Event|0|||
124520696|NCT01641081|447857774|FG000|Period 2|Adverse Event|0|||
124520697|NCT01641081|447857775|FG001|Period 2|Adverse Event|0|||
124520698|NCT01641081|447857776|FG002|Period 2|Adverse Event|0|||
124520699|NCT01641081|447857777|FG003|Period 2|Adverse Event|0|||
124520700|NCT01641081|447857778|FG004|Period 2|Adverse Event|0|||
124520701|NCT01641081|447857779|FG005|Period 2|Adverse Event|1|||
124520702|NCT01641081|447857780|FG006|Period 2|Adverse Event|0|||
124520703|NCT01641081|447857781|FG007|Period 2|Adverse Event|0|||
124520704|NCT01641081|447857782|FG008|Period 2|Adverse Event|0|||
124520705|NCT01641081|447857783|FG009|Period 2|Adverse Event|0|||
124520706|NCT01641081|447857774|FG000|Period 2|Withdrawal by Subject|0|||
124520707|NCT01641081|447857775|FG001|Period 2|Withdrawal by Subject|0|||
124520708|NCT01641081|447857776|FG002|Period 2|Withdrawal by Subject|0|||
124520709|NCT01641081|447857777|FG003|Period 2|Withdrawal by Subject|1|||
124520710|NCT01641081|447857778|FG004|Period 2|Withdrawal by Subject|0|||
124520711|NCT01641081|447857779|FG005|Period 2|Withdrawal by Subject|0|||
124520712|NCT01641081|447857780|FG006|Period 2|Withdrawal by Subject|2|||
124520713|NCT01641081|447857781|FG007|Period 2|Withdrawal by Subject|0|||
124520714|NCT01641081|447857782|FG008|Period 2|Withdrawal by Subject|0|||
124520715|NCT01641081|447857783|FG009|Period 2|Withdrawal by Subject|0|||
124520716|NCT01641081|447857774|FG000|Period 2|Protocol Violation|1|||
124520717|NCT01641081|447857775|FG001|Period 2|Protocol Violation|0|||
124520718|NCT01641081|447857776|FG002|Period 2|Protocol Violation|0|||
124520719|NCT01641081|447857777|FG003|Period 2|Protocol Violation|0|||
124520720|NCT01641081|447857778|FG004|Period 2|Protocol Violation|0|||
124520721|NCT01641081|447857779|FG005|Period 2|Protocol Violation|0|||
124573723|NCT03025880|448060780|FG000|Overall Study|Death|1|||
124520722|NCT01641081|447857780|FG006|Period 2|Protocol Violation|0|||
124520723|NCT01641081|447857781|FG007|Period 2|Protocol Violation|0|||
124520724|NCT01641081|447857782|FG008|Period 2|Protocol Violation|0|||
124573724|NCT03025880|448060781|FG001|Overall Study|Death|1|||
124520725|NCT01641081|447857783|FG009|Period 2|Protocol Violation|0|||
124520726|NCT01641081|447857774|FG000|Period 3|Adverse Event|0|||
124520727|NCT01641081|447857775|FG001|Period 3|Adverse Event|0|||
124520728|NCT01641081|447857776|FG002|Period 3|Adverse Event|1|||
124520729|NCT01641081|447857777|FG003|Period 3|Adverse Event|0|||
124520730|NCT01641081|447857778|FG004|Period 3|Adverse Event|0|||
124520731|NCT01641081|447857779|FG005|Period 3|Adverse Event|0|||
124520732|NCT01641081|447857780|FG006|Period 3|Adverse Event|0|||
124520733|NCT01641081|447857781|FG007|Period 3|Adverse Event|0|||
124520734|NCT01641081|447857782|FG008|Period 3|Adverse Event|0|||
124520735|NCT01641081|447857783|FG009|Period 3|Adverse Event|0|||
124520736|NCT01641081|447857774|FG000|Period 3|Withdrawal by Subject|0|||
124520737|NCT01641081|447857775|FG001|Period 3|Withdrawal by Subject|0|||
124520738|NCT01641081|447857776|FG002|Period 3|Withdrawal by Subject|0|||
124520739|NCT01641081|447857777|FG003|Period 3|Withdrawal by Subject|0|||
124520740|NCT01641081|447857778|FG004|Period 3|Withdrawal by Subject|0|||
124520741|NCT01641081|447857779|FG005|Period 3|Withdrawal by Subject|0|||
124520742|NCT01641081|447857780|FG006|Period 3|Withdrawal by Subject|0|||
124520743|NCT01641081|447857781|FG007|Period 3|Withdrawal by Subject|0|||
124520744|NCT01641081|447857782|FG008|Period 3|Withdrawal by Subject|1|||
124520745|NCT01641081|447857783|FG009|Period 3|Withdrawal by Subject|0|||
124520746|NCT01641081|447857774|FG000|Period 4|Adverse Event|0|||
124520747|NCT01641081|447857775|FG001|Period 4|Adverse Event|1|||
124520748|NCT01641081|447857776|FG002|Period 4|Adverse Event|0|||
124520749|NCT01641081|447857777|FG003|Period 4|Adverse Event|1|||
124520750|NCT01641081|447857778|FG004|Period 4|Adverse Event|0|||
124520751|NCT01641081|447857779|FG005|Period 4|Adverse Event|0|||
124520752|NCT01641081|447857780|FG006|Period 4|Adverse Event|0|||
124520753|NCT01641081|447857781|FG007|Period 4|Adverse Event|0|||
124520754|NCT01641081|447857782|FG008|Period 4|Adverse Event|0|||
124520755|NCT01641081|447857783|FG009|Period 4|Adverse Event|0|||
124520756|NCT01641081|447857774|FG000|Period 5|Adverse Event|0|||
124520757|NCT01641081|447857775|FG001|Period 5|Adverse Event|0|||
124520758|NCT01641081|447857776|FG002|Period 5|Adverse Event|2|||
124520759|NCT01641081|447857777|FG003|Period 5|Adverse Event|0|||
124520760|NCT01641081|447857778|FG004|Period 5|Adverse Event|0|||
124520761|NCT01641081|447857779|FG005|Period 5|Adverse Event|0|||
124520762|NCT01641081|447857780|FG006|Period 5|Adverse Event|0|||
124520763|NCT01641081|447857781|FG007|Period 5|Adverse Event|0|||
124520764|NCT01641081|447857782|FG008|Period 5|Adverse Event|0|||
124520765|NCT01641081|447857783|FG009|Period 5|Adverse Event|0|||
124520766|NCT01749800|447857787|FG000|Overall Study|not meeting inclusion criteria|3|||
124520767|NCT01749800|447857788|FG001|Overall Study|not meeting inclusion criteria|0|||
124520768|NCT01749800|447857789|FG002|Overall Study|not meeting inclusion criteria|0|||
124520769|NCT01749800|447857787|FG000|Overall Study|Withdrawal by Subject|0|||
124520770|NCT01749800|447857788|FG001|Overall Study|Withdrawal by Subject|1|||
124520771|NCT01749800|447857789|FG002|Overall Study|Withdrawal by Subject|0|||
124520772|NCT01451398|447857795|FG000|Overall Study|Adverse Event|7|||
124520773|NCT01451398|447857796|FG001|Overall Study|Adverse Event|9|||
124520774|NCT01451398|447857795|FG000|Overall Study|Protocol Violation|1|||
124520775|NCT01451398|447857796|FG001|Overall Study|Protocol Violation|2|||
124520776|NCT01451398|447857795|FG000|Overall Study|Physician Decision|1|||
124520777|NCT01451398|447857796|FG001|Overall Study|Physician Decision|1|||
124520778|NCT01451398|447857795|FG000|Overall Study|Withdrawal by Subject|10|||
124520779|NCT01451398|447857796|FG001|Overall Study|Withdrawal by Subject|14|||
124520780|NCT01451398|447857795|FG000|Overall Study|Lost to Follow-up|6|||
124520781|NCT01451398|447857796|FG001|Overall Study|Lost to Follow-up|4|||
124520782|NCT01451398|447857795|FG000|Overall Study|Non-compliance with study drug|1|||
124520783|NCT01451398|447857796|FG001|Overall Study|Non-compliance with study drug|3|||
124520784|NCT01451398|447857795|FG000|Overall Study|Non-compliance with protocol|1|||
124520785|NCT01451398|447857796|FG001|Overall Study|Non-compliance with protocol|1|||
124520786|NCT01451398|447857795|FG000|Overall Study|Moved out of country|0|||
124520787|NCT01451398|447857796|FG001|Overall Study|Moved out of country|1|||
124520788|NCT01451398|447857795|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
124520789|NCT01451398|447857796|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
124520790|NCT01451398|447857795|FG000|Overall Study|Lack of Efficacy|0|||
124520791|NCT01451398|447857796|FG001|Overall Study|Lack of Efficacy|1|||
124520792|NCT01000025|447857798|FG000|Overall Study|Adverse Event|43|||
124520793|NCT01000025|447857799|FG001|Overall Study|Adverse Event|2|||
124520794|NCT01000025|447857798|FG000|Overall Study|Withdrawal by Subject|13|||
124520795|NCT01000025|447857799|FG001|Overall Study|Withdrawal by Subject|8|||
124520796|NCT01000025|447857798|FG000|Overall Study|Death|23|||
124520797|NCT01000025|447857799|FG001|Overall Study|Death|13|||
124520798|NCT01000025|447857798|FG000|Overall Study|Lack of Efficacy|363|||
124520799|NCT01000025|447857799|FG001|Overall Study|Lack of Efficacy|208|||
124520800|NCT01000025|447857798|FG000|Overall Study|Intercurrent Illness|26|||
124520801|NCT01000025|447857799|FG001|Overall Study|Intercurrent Illness|7|||
124520802|NCT00422669|447857800|FG000|Overall Study|The study was terminated early.|98|||
124520803|NCT00422669|447857801|FG001|Overall Study|The study was terminated early.|100|||
124520804|NCT00422669|447857802|FG002|Overall Study|The study was terminated early.|7|||
124520805|NCT00996593|447857803|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
124520806|NCT00996593|447857803|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
124520807|NCT00996593|447857803|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
124573725|NCT03025880|448060780|FG000|Overall Study|Withdrawal by Subject|0|||
124573726|NCT03025880|448060781|FG001|Overall Study|Withdrawal by Subject|1|||
124573727|NCT03025880|448060780|FG000|Overall Study|Physician Decision|0|||
124573728|NCT03025880|448060781|FG001|Overall Study|Physician Decision|1|||
124573729|NCT03025880|448060780|FG000|Overall Study|Progressive Disease|12|||
124573730|NCT03025880|448060781|FG001|Overall Study|Progressive Disease|19|||
124573731|NCT01035060|448060782|FG000|Overall Study|Lost to Follow-up|0|||
124573732|NCT01035060|448060783|FG001|Overall Study|Lost to Follow-up|7|||
124573733|NCT01035060|448060782|FG000|Overall Study|Did not quality after 2nd screening|14|||
124573734|NCT01035060|448060783|FG001|Overall Study|Did not quality after 2nd screening|1|||
124573735|NCT01035060|448060782|FG000|Overall Study|Withdrawal by Subject|8|||
124573736|NCT01035060|448060783|FG001|Overall Study|Withdrawal by Subject|6|||
124573737|NCT01035060|448060782|FG000|Overall Study|Physician Decision|2|||
124573738|NCT01035060|448060783|FG001|Overall Study|Physician Decision|0|||
124573739|NCT02015390|448060788|FG000|Overall Study|Lost to Follow-up|1|||
124573740|NCT02015390|448060789|FG001|Overall Study|Lost to Follow-up|0|||
124573741|NCT02015390|448060788|FG000|Overall Study|Adverse Event|0|||
124573742|NCT02015390|448060789|FG001|Overall Study|Adverse Event|3|||
124573743|NCT02015390|448060788|FG000|Overall Study|Physician Decision|0|||
124573744|NCT02015390|448060789|FG001|Overall Study|Physician Decision|1|||
124573745|NCT02193880|448060790|FG000|Overall Study|patients did not collect enough HPC|3|||
124573746|NCT03136380|448060791|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
124573747|NCT03136380|448060792|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
124573748|NCT03136380|448060793|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
124573749|NCT03136380|448060794|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
124573750|NCT03136380|448060795|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
124573751|NCT00553280|448060799|FG000|Overall Study|Adverse Event|19|||
124573752|NCT00553280|448060799|FG000|Overall Study|Lack of Efficacy|3|||
124573753|NCT00553280|448060799|FG000|Overall Study|Withdrawal by Subject|3|||
124573754|NCT00553280|448060799|FG000|Overall Study|Physician Decision|1|||
124573755|NCT02794974|448060800|FG000|Overall Study|Physician Decision|0|||
124573756|NCT02794974|448060801|FG001|Overall Study|Physician Decision|1|||
124573757|NCT02202850|448060802|FG000|Overall Study|Other|2|||
124573758|NCT02202850|448060803|FG001|Overall Study|Other|2|||
124573759|NCT02202850|448060802|FG000|Overall Study|Enbrel treatment discontinued|15|||
124573760|NCT02202850|448060803|FG001|Overall Study|Enbrel treatment discontinued|3|||
124573761|NCT02202850|448060802|FG000|Overall Study|Lost to Follow-up|7|||
124573762|NCT02202850|448060803|FG001|Overall Study|Lost to Follow-up|1|||
124573763|NCT02996682|448060804|FG000|Overall Study|Death|0|||
124573764|NCT02996682|448060805|FG001|Overall Study|Death|3|||
124573765|NCT02587962|448060806|FG000|Overall Study|Adverse Event|0|||
124573766|NCT02587962|448060807|FG001|Overall Study|Adverse Event|0|||
124573767|NCT02587962|448060808|FG002|Overall Study|Adverse Event|1|||
124573768|NCT02587962|448060809|FG003|Overall Study|Adverse Event|0|||
124573769|NCT02587962|448060810|FG004|Overall Study|Adverse Event|0|||
124573770|NCT02587962|448060806|FG000|Overall Study|Withdrawal by Subject|0|||
124573771|NCT02587962|448060807|FG001|Overall Study|Withdrawal by Subject|0|||
124573772|NCT02587962|448060808|FG002|Overall Study|Withdrawal by Subject|1|||
124573773|NCT02587962|448060809|FG003|Overall Study|Withdrawal by Subject|1|||
124573774|NCT02587962|448060810|FG004|Overall Study|Withdrawal by Subject|4|||
124573775|NCT02587962|448060806|FG000|Overall Study|Radiological progression|2|||
124573776|NCT02587962|448060807|FG001|Overall Study|Radiological progression|2|||
124573777|NCT02587962|448060808|FG002|Overall Study|Radiological progression|2|||
124573778|NCT02587962|448060809|FG003|Overall Study|Radiological progression|5|||
124573779|NCT02587962|448060810|FG004|Overall Study|Radiological progression|10|||
124573780|NCT02587962|448060806|FG000|Overall Study|Clinical progression|0|||
124573781|NCT02587962|448060807|FG001|Overall Study|Clinical progression|1|||
124573782|NCT02587962|448060808|FG002|Overall Study|Clinical progression|2|||
124573783|NCT02587962|448060809|FG003|Overall Study|Clinical progression|0|||
124573784|NCT02587962|448060810|FG004|Overall Study|Clinical progression|1|||
124573785|NCT00086996|448060812|FG000|Overall Study|Adverse Event|29|||
124725077|NCT01866111|448613447|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
124573786|NCT00086996|448060812|FG000|Overall Study|Death|4|||
124573787|NCT00086996|448060812|FG000|Overall Study|progression/relapse|7|||
124573788|NCT00086996|448060812|FG000|Overall Study|Withdrawal by Subject|13|||
124573789|NCT00086996|448060812|FG000|Overall Study|Other|6|||
124573790|NCT00086996|448060812|FG000|Overall Study|not eligible|5|||
124573791|NCT00184600|448060815|FG000|Overall Study|Adverse Event|9|||
124573792|NCT00184600|448060816|FG001|Overall Study|Adverse Event|0|||
124573793|NCT00184600|448060817|FG002|Overall Study|Adverse Event|5|||
124573794|NCT00184600|448060815|FG000|Overall Study|Death|3|||
124573795|NCT00184600|448060816|FG001|Overall Study|Death|9|||
124573796|NCT00184600|448060817|FG002|Overall Study|Death|7|||
124573797|NCT00184600|448060815|FG000|Overall Study|Lack of Efficacy|3|||
124573798|NCT00184600|448060816|FG001|Overall Study|Lack of Efficacy|1|||
124573799|NCT00184600|448060817|FG002|Overall Study|Lack of Efficacy|3|||
124573800|NCT00184600|448060815|FG000|Overall Study|Lost to Follow-up|4|||
124573801|NCT00184600|448060816|FG001|Overall Study|Lost to Follow-up|6|||
124573802|NCT00184600|448060817|FG002|Overall Study|Lost to Follow-up|1|||
124573803|NCT00184600|448060815|FG000|Overall Study|Protocol Violation|2|||
124573804|NCT00184600|448060816|FG001|Overall Study|Protocol Violation|2|||
124573805|NCT00184600|448060817|FG002|Overall Study|Protocol Violation|3|||
124573806|NCT00184600|448060815|FG000|Overall Study|Withdrawal by Subject|20|||
124573807|NCT00184600|448060816|FG001|Overall Study|Withdrawal by Subject|28|||
124573808|NCT00184600|448060817|FG002|Overall Study|Withdrawal by Subject|12|||
124573809|NCT00184600|448060815|FG000|Overall Study|Unclassified|4|||
124573810|NCT00184600|448060816|FG001|Overall Study|Unclassified|5|||
124573811|NCT00184600|448060817|FG002|Overall Study|Unclassified|3|||
124573812|NCT04274686|448060819|FG000|Overall Study|Physician Decision|1|||
124573813|NCT04274686|448060820|FG001|Overall Study|Physician Decision|0|||
124573814|NCT00376623|448060821|FG000|Overall Study|Progressive disease|35|||
124573815|NCT00376623|448060822|FG001|Overall Study|Progressive disease|22|||
124573816|NCT00376623|448060823|FG002|Overall Study|Progressive disease|17|||
124573817|NCT00376623|448060821|FG000|Overall Study|Lost to Follow-up|0|||
124573818|NCT00376623|448060822|FG001|Overall Study|Lost to Follow-up|1|||
124573819|NCT00376623|448060823|FG002|Overall Study|Lost to Follow-up|0|||
124573820|NCT00376623|448060821|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
124573821|NCT00376623|448060822|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
124573822|NCT00376623|448060823|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
124573823|NCT00376623|448060821|FG000|Overall Study|Not treated with BI 2536|1|||
124573824|NCT00376623|448060822|FG001|Overall Study|Not treated with BI 2536|0|||
124573825|NCT00376623|448060823|FG002|Overall Study|Not treated with BI 2536|0|||
124573826|NCT00376623|448060821|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
124573827|NCT00376623|448060822|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
124573828|NCT00376623|448060823|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
124573829|NCT00376623|448060821|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
124573830|NCT00376623|448060822|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
124573831|NCT00376623|448060823|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
124573832|NCT00376623|448060821|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
124573833|NCT00376623|448060822|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
124573834|NCT00376623|448060823|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
124573835|NCT00376623|448060821|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
124573836|NCT00376623|448060822|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
124573837|NCT00376623|448060823|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
124573838|NCT00376623|448060821|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
124573839|NCT00376623|448060822|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
124573840|NCT00376623|448060823|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
124573841|NCT00376623|448060821|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
124573842|NCT00376623|448060822|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
124573843|NCT00376623|448060823|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
124573844|NCT00376623|448060821|FG000|Overall Study|Increase of tumour markers|0|||
124573845|NCT00376623|448060822|FG001|Overall Study|Increase of tumour markers|1|||
124573846|NCT00376623|448060823|FG002|Overall Study|Increase of tumour markers|0|||
124573847|NCT00376623|448060821|FG000|Overall Study|Bone metastasis|1|||
124573848|NCT00376623|448060822|FG001|Overall Study|Bone metastasis|0|||
124573849|NCT00376623|448060823|FG002|Overall Study|Bone metastasis|0|||
124573850|NCT00286754|448060824|FG000|Overall Study|Adverse Event|2|||
124573851|NCT00286754|448060825|FG001|Overall Study|Adverse Event|2|||
124573852|NCT00286754|448060826|FG002|Overall Study|Adverse Event|3|||
124573853|NCT00286754|448060824|FG000|Overall Study|Withdrawal by Subject|6|||
124573854|NCT00286754|448060825|FG001|Overall Study|Withdrawal by Subject|2|||
124573855|NCT00286754|448060826|FG002|Overall Study|Withdrawal by Subject|0|||
124573856|NCT00286754|448060824|FG000|Overall Study|Lost to Follow-up|12|||
124573857|NCT00286754|448060825|FG001|Overall Study|Lost to Follow-up|14|||
124573858|NCT00286754|448060826|FG002|Overall Study|Lost to Follow-up|6|||
124573859|NCT00286754|448060824|FG000|Overall Study|Moved out of state|0|||
124573860|NCT00286754|448060825|FG001|Overall Study|Moved out of state|0|||
124573861|NCT00286754|448060826|FG002|Overall Study|Moved out of state|1|||
124573862|NCT00910663|448060827|FG000|Period 1|Withdrawal by Subject|0|||
124725078|NCT01866111|448613448|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
124725079|NCT01866111|448613445|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
124725080|NCT01866111|448613446|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
124573863|NCT00910663|448060828|FG001|Period 1|Withdrawal by Subject|1|||
124573864|NCT02865850|448060829|FG000|Overall Study|Death|15|||
124573865|NCT02865850|448060830|FG001|Overall Study|Death|19|||
124573866|NCT02865850|448060829|FG000|Overall Study|Withdrawal by Subject|3|||
124573867|NCT02865850|448060830|FG001|Overall Study|Withdrawal by Subject|2|||
124573868|NCT02865850|448060829|FG000|Overall Study|Lost to Follow-up|3|||
124573869|NCT02865850|448060830|FG001|Overall Study|Lost to Follow-up|2|||
124573870|NCT02726581|448060831|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
124573871|NCT02726581|448060832|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
124573872|NCT02726581|448060833|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
124573873|NCT02726581|448060831|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
124573874|NCT02726581|448060832|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
124573875|NCT02726581|448060833|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
124573876|NCT02726581|448060831|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
124573877|NCT02726581|448060832|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124573878|NCT02726581|448060833|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124573879|NCT02726581|448060831|FG000|Treatment Period|Disease progression|47|||
124573880|NCT02726581|448060832|FG001|Treatment Period|Disease progression|50|||
124573881|NCT02726581|448060833|FG002|Treatment Period|Disease progression|16|||
124573882|NCT02726581|448060831|FG000|Treatment Period|Other reasons|9|||
124573883|NCT02726581|448060832|FG001|Treatment Period|Other reasons|8|||
124573884|NCT02726581|448060833|FG002|Treatment Period|Other reasons|2|||
124573885|NCT02726581|448060831|FG000|Treatment Period|Study drug toxicity|6|||
124573886|NCT02726581|448060832|FG001|Treatment Period|Study drug toxicity|3|||
124573887|NCT02726581|448060833|FG002|Treatment Period|Study drug toxicity|2|||
124573888|NCT02726581|448060831|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
124573889|NCT02726581|448060832|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
124573890|NCT02726581|448060833|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
124573891|NCT02726581|448060831|FG000|Treatment Period|Participant withdrew consent|3|||
124573892|NCT02726581|448060832|FG001|Treatment Period|Participant withdrew consent|1|||
124573893|NCT02726581|448060833|FG002|Treatment Period|Participant withdrew consent|1|||
124573894|NCT02726581|448060831|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
124573895|NCT02726581|448060832|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
124573896|NCT02726581|448060833|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
124573897|NCT02726581|448060831|FG000|Treatment Period|Maximum clinical benefit|0|||
124573898|NCT02726581|448060832|FG001|Treatment Period|Maximum clinical benefit|2|||
124573899|NCT02726581|448060833|FG002|Treatment Period|Maximum clinical benefit|0|||
124573900|NCT02726581|448060831|FG000|Treatment Period|Death|1|||
124573901|NCT02726581|448060832|FG001|Treatment Period|Death|0|||
124573902|NCT02726581|448060833|FG002|Treatment Period|Death|0|||
124573903|NCT02726581|448060831|FG000|Treatment Period|Poor/non-compliance|1|||
124573904|NCT02726581|448060832|FG001|Treatment Period|Poor/non-compliance|0|||
124573905|NCT02726581|448060833|FG002|Treatment Period|Poor/non-compliance|0|||
124573906|NCT02726581|448060831|FG000|Treatment Period|Participant no longer meets study criteria|0|||
124573907|NCT02726581|448060832|FG001|Treatment Period|Participant no longer meets study criteria|1|||
124573908|NCT02726581|448060833|FG002|Treatment Period|Participant no longer meets study criteria|0|||
124573909|NCT00552669|448060834|FG000|Overall Study|Death|3|||
124573910|NCT00552669|448060835|FG001|Overall Study|Death|7|||
124573911|NCT01844375|448060839|FG000|Overall Study|Protocol Violation|1|||
124573912|NCT01844375|448060840|FG001|Overall Study|Protocol Violation|1|||
124573913|NCT01772537|448060842|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
124573914|NCT01772537|448060843|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
124573915|NCT01772537|448060844|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
124573916|NCT01263704|448060845|FG000|Overall Study|Progressive disease|18|||
124573917|NCT01263704|448060845|FG000|Overall Study|Adverse Event|3|||
124573918|NCT01263704|448060845|FG000|Overall Study|Death|2|||
124573919|NCT01263704|448060845|FG000|Overall Study|Patient withdrew consent|2|||
124573920|NCT01263704|448060845|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
124573921|NCT01263704|448060845|FG000|Overall Study|Lost to Follow-up|1|||
124573922|NCT01263704|448060845|FG000|Overall Study|Colon metastases|1|||
124573923|NCT01263704|448060845|FG000|Overall Study|Principal Investigator (PI) decision|1|||
124573924|NCT03020615|448060846|FG000|Overall Study|Physician Decision|3|||
124573925|NCT03020615|448060847|FG001|Overall Study|Physician Decision|1|||
124573926|NCT03020615|448060848|FG002|Overall Study|Physician Decision|2|||
124725081|NCT01866111|448613447|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
124725082|NCT01866111|448613448|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
124725083|NCT01866111|448613445|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
124725084|NCT01866111|448613446|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
124725085|NCT01866111|448613447|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
124725086|NCT01866111|448613448|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
124725087|NCT01866111|448613445|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
124573927|NCT03020615|448060846|FG000|Overall Study|Parent/guardian/patient choice|3|||
124573928|NCT03020615|448060847|FG001|Overall Study|Parent/guardian/patient choice|0|||
124573929|NCT03020615|448060848|FG002|Overall Study|Parent/guardian/patient choice|4|||
124573930|NCT03020615|448060846|FG000|Overall Study|Screen failure|0|||
124573931|NCT03020615|448060847|FG001|Overall Study|Screen failure|0|||
124573932|NCT03020615|448060848|FG002|Overall Study|Screen failure|1|||
124573933|NCT03020615|448060846|FG000|Overall Study|Death|1|||
124573934|NCT03020615|448060847|FG001|Overall Study|Death|0|||
124573935|NCT03020615|448060848|FG002|Overall Study|Death|0|||
124573936|NCT03020615|448060846|FG000|Overall Study|Lost to Follow-up|0|||
124573937|NCT03020615|448060847|FG001|Overall Study|Lost to Follow-up|1|||
124573938|NCT03020615|448060848|FG002|Overall Study|Lost to Follow-up|0|||
124573939|NCT00252720|448060850|FG000|Overall Study|Withdrawal by Subject|95|||
124573940|NCT00252720|448060851|FG001|Overall Study|Withdrawal by Subject|97|||
124573941|NCT00252720|448060850|FG000|Overall Study|Death|7|||
124573942|NCT00252720|448060851|FG001|Overall Study|Death|8|||
124573943|NCT00252720|448060850|FG000|Overall Study|Moving|23|||
124573944|NCT00252720|448060851|FG001|Overall Study|Moving|42|||
124573945|NCT00252720|448060850|FG000|Overall Study|Mainly patients lost to follow-up|7|||
124573946|NCT00252720|448060851|FG001|Overall Study|Mainly patients lost to follow-up|18|||
124573947|NCT02514122|448060856|FG000|Overall Study|Withdrawal by Subject|2|||
124573948|NCT02514122|448060857|FG001|Overall Study|Withdrawal by Subject|0|||
124573949|NCT00112463|448060858|FG000|Overall Study|Physician Decision|1|||
124573950|NCT00112463|448060858|FG000|Overall Study|Progression|30|||
124573951|NCT00112463|448060858|FG000|Overall Study|Second Primary|1|||
124573952|NCT00112463|448060858|FG000|Overall Study|Toxicity|3|||
124573953|NCT00112463|448060858|FG000|Overall Study|Withdrawal by Subject|2|||
124573954|NCT00112463|448060858|FG000|Overall Study|Never started treatment|2|||
124573955|NCT01118312|448060865|FG000|Overall Study|Lost to Follow-up|33|||
124573956|NCT01118312|448060866|FG001|Overall Study|Lost to Follow-up|32|||
124573957|NCT01118312|448060865|FG000|Overall Study|Withdrawal by Subject|1|||
124573958|NCT01118312|448060866|FG001|Overall Study|Withdrawal by Subject|3|||
124573959|NCT01546545|448060870|FG000|Overall Study|Withdrawal by Subject|1|||
124573960|NCT00735904|448060871|FG000|Overall Study|Adverse Event|3|||
124573961|NCT00735904|448060871|FG000|Overall Study|Death|20|||
124573962|NCT00735904|448060871|FG000|Overall Study|Protocol Violation|1|||
124573963|NCT00735904|448060871|FG000|Overall Study|Withdrawal by Subject|1|||
124573964|NCT00735904|448060871|FG000|Overall Study|Study Terminated by Sponsor|5|||
124573965|NCT00735904|448060871|FG000|Overall Study|Other|8|||
124573966|NCT01390844|448060872|FG000|Treatment Phase|Adverse Event|12|||
124573967|NCT01390844|448060873|FG001|Treatment Phase|Adverse Event|2|||
124573968|NCT01390844|448060874|FG002|Treatment Phase|Adverse Event|3|||
124573969|NCT01390844|448060875|FG003|Treatment Phase|Adverse Event|2|||
124573970|NCT01390844|448060872|FG000|Treatment Phase|Treatment Failure|23|||
124573971|NCT01390844|448060873|FG001|Treatment Phase|Treatment Failure|25|||
124573972|NCT01390844|448060874|FG002|Treatment Phase|Treatment Failure|10|||
124573973|NCT01390844|448060875|FG003|Treatment Phase|Treatment Failure|13|||
124573974|NCT01390844|448060872|FG000|Treatment Phase|Non-Medical Reasons|5|||
124573975|NCT01390844|448060873|FG001|Treatment Phase|Non-Medical Reasons|1|||
124573976|NCT01390844|448060874|FG002|Treatment Phase|Non-Medical Reasons|8|||
124573977|NCT01390844|448060875|FG003|Treatment Phase|Non-Medical Reasons|1|||
124725088|NCT01866111|448613446|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
124725089|NCT01866111|448613447|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
124725090|NCT01866111|448613448|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
124725091|NCT01866111|448613445|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
124573978|NCT01390844|448060872|FG000|Treatment Phase|Non-GCP Compliant|0|||
124573979|NCT01390844|448060873|FG001|Treatment Phase|Non-GCP Compliant|0|||
124573980|NCT01390844|448060874|FG002|Treatment Phase|Non-GCP Compliant|10|||
124573981|NCT01390844|448060875|FG003|Treatment Phase|Non-GCP Compliant|3|||
124573982|NCT01390844|448060872|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
124573983|NCT01390844|448060873|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
124573984|NCT01390844|448060874|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
124573985|NCT01390844|448060875|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
124573986|NCT03204539|448060878|FG000|Overall Study|Loss of funding|0|||
124573987|NCT03204539|448060879|FG001|Overall Study|Loss of funding|1|||
124725092|NCT01866111|448613446|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
124725093|NCT01866111|448613447|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
124725094|NCT01866111|448613448|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
124573988|NCT05093205|448060880|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
124573989|NCT05093205|448060881|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
124573990|NCT05093205|448060882|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
124573991|NCT05093205|448060883|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
124573992|NCT05093205|448060884|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
124725095|NCT01866111|448613445|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
124573993|NCT05093205|448060885|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
124573994|NCT05093205|448060886|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
124573995|NCT05093205|448060887|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
124573996|NCT05093205|448060888|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
124573997|NCT05093205|448060889|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
124573998|NCT05093205|448060890|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
124573999|NCT05093205|448060891|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
124574000|NCT05093205|448060892|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
124574001|NCT05093205|448060880|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
124574002|NCT05093205|448060881|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
124574003|NCT05093205|448060882|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
124574004|NCT05093205|448060883|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
124574005|NCT05093205|448060884|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
124574006|NCT05093205|448060885|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
124574007|NCT05093205|448060886|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
124574008|NCT05093205|448060887|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
124574009|NCT05093205|448060888|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
124574010|NCT05093205|448060889|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
124574011|NCT05093205|448060890|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
124574012|NCT05093205|448060891|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
124574013|NCT05093205|448060892|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
124574014|NCT05093205|448060880|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
124574015|NCT05093205|448060881|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
124574016|NCT05093205|448060882|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
124574017|NCT05093205|448060883|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
124574018|NCT05093205|448060884|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
124574019|NCT05093205|448060885|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
124574020|NCT05093205|448060886|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
124574021|NCT05093205|448060887|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
124574022|NCT05093205|448060888|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
124574023|NCT05093205|448060889|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
124574024|NCT05093205|448060890|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
124574025|NCT05093205|448060891|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
124574026|NCT05093205|448060892|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
124574027|NCT05093205|448060880|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
124574028|NCT05093205|448060881|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
124574029|NCT05093205|448060882|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
124574030|NCT05093205|448060883|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
124574031|NCT05093205|448060884|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
124574032|NCT05093205|448060885|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
124574033|NCT05093205|448060886|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
124574034|NCT05093205|448060887|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
124574035|NCT05093205|448060888|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
124574036|NCT05093205|448060889|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
124574037|NCT05093205|448060890|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
124574038|NCT05093205|448060891|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
124574039|NCT05093205|448060892|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
124574040|NCT05093205|448060880|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
124574041|NCT05093205|448060881|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
124574042|NCT05093205|448060882|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
124574043|NCT05093205|448060883|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
124574044|NCT05093205|448060884|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
124574045|NCT05093205|448060885|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
124574046|NCT05093205|448060886|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
124574047|NCT05093205|448060887|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
124574048|NCT05093205|448060888|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
124574049|NCT05093205|448060889|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
124574050|NCT05093205|448060890|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
124574051|NCT05093205|448060891|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
124725096|NCT01866111|448613446|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
124574052|NCT05093205|448060892|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
124574053|NCT05093205|448060880|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
124574054|NCT05093205|448060881|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
124574055|NCT05093205|448060882|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
124574056|NCT05093205|448060883|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
124574057|NCT05093205|448060884|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
124574058|NCT05093205|448060885|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
124574059|NCT05093205|448060886|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
124574060|NCT05093205|448060887|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
124574061|NCT05093205|448060888|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
124574062|NCT05093205|448060889|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
124574063|NCT05093205|448060890|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
124574064|NCT05093205|448060891|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
124574065|NCT05093205|448060892|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
124574066|NCT05093205|448060880|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
124574067|NCT05093205|448060881|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
124574068|NCT05093205|448060882|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
124574069|NCT05093205|448060883|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
124574070|NCT05093205|448060884|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
124725097|NCT01866111|448613447|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
124725098|NCT01866111|448613448|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
124725099|NCT01866111|448613445|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
124520808|NCT00996593|447857803|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
124520809|NCT00996593|447857803|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
124520810|NCT00996593|447857803|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
124520811|NCT00996593|447857803|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
124520812|NCT00996593|447857803|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
124520813|NCT00996593|447857803|FG000|Long-Term Follow-Up|Site Closed|1|||
124520814|NCT02738580|447857804|FG000|Overall Study|Adverse Event|1|||
124520815|NCT02738580|447857805|FG001|Overall Study|Adverse Event|0|||
124520816|NCT02738580|447857804|FG000|Overall Study|Lack of Efficacy|3|||
124520817|NCT02738580|447857805|FG001|Overall Study|Lack of Efficacy|2|||
124520818|NCT02738580|447857804|FG000|Overall Study|Withdrawal by Subject|0|||
124520819|NCT02738580|447857805|FG001|Overall Study|Withdrawal by Subject|1|||
124520820|NCT02738580|447857804|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
124520821|NCT02738580|447857805|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
124520822|NCT00741260|447857807|FG000|Overall Study|Disease Progression|3|||
124520823|NCT00741260|447857808|FG001|Overall Study|Disease Progression|5|||
124520824|NCT00741260|447857809|FG002|Overall Study|Disease Progression|3|||
124520825|NCT00741260|447857810|FG003|Overall Study|Disease Progression|3|||
124520826|NCT00741260|447857811|FG004|Overall Study|Disease Progression|5|||
124520827|NCT00741260|447857812|FG005|Overall Study|Disease Progression|37|||
124520828|NCT00741260|447857813|FG006|Overall Study|Disease Progression|4|||
124520829|NCT00741260|447857807|FG000|Overall Study|Death|0|||
124520830|NCT00741260|447857808|FG001|Overall Study|Death|1|||
124520831|NCT00741260|447857809|FG002|Overall Study|Death|0|||
124520832|NCT00741260|447857810|FG003|Overall Study|Death|1|||
124520833|NCT00741260|447857811|FG004|Overall Study|Death|2|||
124520834|NCT00741260|447857812|FG005|Overall Study|Death|2|||
124520835|NCT00741260|447857813|FG006|Overall Study|Death|1|||
124520836|NCT00741260|447857807|FG000|Overall Study|Withdrawal by Subject|0|||
124520837|NCT00741260|447857808|FG001|Overall Study|Withdrawal by Subject|0|||
124520838|NCT00741260|447857809|FG002|Overall Study|Withdrawal by Subject|0|||
124520839|NCT00741260|447857810|FG003|Overall Study|Withdrawal by Subject|0|||
124520840|NCT00741260|447857811|FG004|Overall Study|Withdrawal by Subject|1|||
124520841|NCT00741260|447857812|FG005|Overall Study|Withdrawal by Subject|3|||
124520842|NCT00741260|447857813|FG006|Overall Study|Withdrawal by Subject|1|||
124520843|NCT00741260|447857807|FG000|Overall Study|Physician Decision|1|||
124520844|NCT00741260|447857808|FG001|Overall Study|Physician Decision|1|||
124520845|NCT00741260|447857809|FG002|Overall Study|Physician Decision|0|||
124520846|NCT00741260|447857810|FG003|Overall Study|Physician Decision|0|||
124520847|NCT00741260|447857811|FG004|Overall Study|Physician Decision|0|||
124520848|NCT00741260|447857812|FG005|Overall Study|Physician Decision|0|||
124520849|NCT00741260|447857813|FG006|Overall Study|Physician Decision|0|||
124520850|NCT00741260|447857807|FG000|Overall Study|Other|2|||
124520851|NCT00741260|447857808|FG001|Overall Study|Other|1|||
124520852|NCT00741260|447857809|FG002|Overall Study|Other|1|||
124520853|NCT00741260|447857810|FG003|Overall Study|Other|2|||
124520854|NCT00741260|447857811|FG004|Overall Study|Other|1|||
124520855|NCT00741260|447857812|FG005|Overall Study|Other|3|||
124520856|NCT00741260|447857813|FG006|Overall Study|Other|1|||
124520857|NCT02810951|447857814|FG000|Overall Study|Adverse Event|1|||
124520858|NCT01250756|447857815|FG000|Infant Series|Withdrawal by Subject|4|||
124520859|NCT01250756|447857816|FG001|Infant Series|Withdrawal by Subject|5|||
124520860|NCT01250756|447857815|FG000|Infant Series|Randomized, Not Vaccinated|2|||
124520861|NCT01250756|447857816|FG001|Infant Series|Randomized, Not Vaccinated|2|||
124520862|NCT01250756|447857815|FG000|Infant Series|Other|22|||
124520863|NCT01250756|447857816|FG001|Infant Series|Other|0|||
124520864|NCT01250756|447857815|FG000|After Infant Series|Adverse Event|5|||
124520865|NCT01250756|447857816|FG001|After Infant Series|Adverse Event|2|||
124520866|NCT01250756|447857815|FG000|After Infant Series|Withdrawal by Subject|4|||
124520867|NCT01250756|447857816|FG001|After Infant Series|Withdrawal by Subject|1|||
124520868|NCT01250756|447857815|FG000|After Infant Series|Other|2|||
124520869|NCT01250756|447857816|FG001|After Infant Series|Other|1|||
124520870|NCT01250756|447857815|FG000|Toddler Dose|Adverse Event|0|||
124520871|NCT01250756|447857816|FG001|Toddler Dose|Adverse Event|1|||
124520872|NCT01250756|447857815|FG000|After Toddler Dose|Adverse Event|0|||
124520873|NCT01250756|447857816|FG001|After Toddler Dose|Adverse Event|1|||
124520874|NCT01928082|447857817|FG000|Overall Study|Study terminated.|1|||
124520875|NCT02142504|447857823|FG000|Overall Study|Protocol Violation|2|||
124520876|NCT02142504|447857824|FG001|Overall Study|Protocol Violation|1|||
124520877|NCT02142504|447857825|FG002|Overall Study|Protocol Violation|2|||
124520878|NCT02142504|447857823|FG000|Overall Study|Adverse Event|2|||
124520879|NCT02142504|447857824|FG001|Overall Study|Adverse Event|3|||
124520880|NCT02142504|447857825|FG002|Overall Study|Adverse Event|4|||
124520881|NCT02142504|447857823|FG000|Overall Study|Lost to Follow-up|12|||
124520882|NCT02142504|447857824|FG001|Overall Study|Lost to Follow-up|19|||
124520883|NCT02142504|447857825|FG002|Overall Study|Lost to Follow-up|17|||
124574071|NCT05093205|448060885|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
124574072|NCT05093205|448060886|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
124574073|NCT05093205|448060887|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
124574074|NCT05093205|448060888|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
124574075|NCT05093205|448060889|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
124574076|NCT05093205|448060890|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
124574077|NCT05093205|448060891|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
124574078|NCT05093205|448060892|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
124574079|NCT05093205|448060880|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
124574080|NCT05093205|448060881|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
124574081|NCT05093205|448060882|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
124574082|NCT05093205|448060883|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
124574083|NCT05093205|448060884|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
124574084|NCT05093205|448060885|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
124574085|NCT05093205|448060886|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
124574086|NCT05093205|448060887|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
124574087|NCT05093205|448060888|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
124574088|NCT05093205|448060889|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
124574089|NCT05093205|448060890|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
124574090|NCT05093205|448060891|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
124574091|NCT05093205|448060892|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
124574092|NCT05093205|448060880|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
124574093|NCT05093205|448060881|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
124574094|NCT05093205|448060882|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
124574095|NCT05093205|448060883|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
124574096|NCT05093205|448060884|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
124574097|NCT05093205|448060885|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
124574098|NCT05093205|448060886|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
124574099|NCT05093205|448060887|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
124574100|NCT05093205|448060888|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
124574101|NCT05093205|448060889|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
124574102|NCT05093205|448060890|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
124574103|NCT05093205|448060891|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
124574104|NCT05093205|448060892|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
124574105|NCT05093205|448060880|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
124574106|NCT05093205|448060881|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
124574107|NCT05093205|448060882|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
124574108|NCT05093205|448060883|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
124574109|NCT05093205|448060884|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
124725100|NCT01866111|448613446|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
124725101|NCT01866111|448613447|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
124725102|NCT01866111|448613448|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
124725103|NCT01866111|448613445|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
124725104|NCT01866111|448613446|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
124725105|NCT01866111|448613447|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
124520884|NCT02142504|447857823|FG000|Overall Study|Withdrawal by Subject|7|||
124520885|NCT02142504|447857824|FG001|Overall Study|Withdrawal by Subject|9|||
124520886|NCT02142504|447857825|FG002|Overall Study|Withdrawal by Subject|11|||
124520887|NCT02142504|447857823|FG000|Overall Study|Pregnancy|4|||
124520888|NCT02142504|447857824|FG001|Overall Study|Pregnancy|4|||
124520889|NCT02142504|447857825|FG002|Overall Study|Pregnancy|2|||
124520890|NCT02142504|447857823|FG000|Overall Study|Physician Decision|0|||
124520891|NCT02142504|447857824|FG001|Overall Study|Physician Decision|1|||
124520892|NCT02142504|447857825|FG002|Overall Study|Physician Decision|3|||
124520893|NCT02142504|447857823|FG000|Overall Study|Reason Not Specified|4|||
124520894|NCT02142504|447857824|FG001|Overall Study|Reason Not Specified|5|||
124520895|NCT02142504|447857825|FG002|Overall Study|Reason Not Specified|4|||
124520896|NCT02120352|447857828|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
124520897|NCT02120352|447857829|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
124520898|NCT02120352|447857830|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
124520899|NCT02120352|447857831|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
124520900|NCT02120352|447857832|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
124520901|NCT02120352|447857833|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
124520902|NCT02120352|447857834|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
124520903|NCT02120352|447857828|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
124520904|NCT02120352|447857829|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
124520905|NCT02120352|447857830|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
124520906|NCT02120352|447857831|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
124520907|NCT02120352|447857832|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
124574110|NCT05093205|448060885|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
124574111|NCT05093205|448060886|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
124574112|NCT05093205|448060887|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
124520908|NCT02120352|447857833|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
124520909|NCT02120352|447857834|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
124520910|NCT02120352|447857828|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
124520911|NCT02120352|447857829|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
124520912|NCT02120352|447857830|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
124520913|NCT02120352|447857831|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
124520914|NCT02120352|447857832|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
124520915|NCT02120352|447857833|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
124520916|NCT02120352|447857834|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
124520917|NCT02120352|447857828|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
124520918|NCT02120352|447857829|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
124520919|NCT02120352|447857830|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
124520920|NCT02120352|447857831|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
124520921|NCT02120352|447857832|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
124520922|NCT02120352|447857833|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
124520923|NCT02120352|447857834|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
124520924|NCT02120352|447857828|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
124520925|NCT02120352|447857829|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
124520926|NCT02120352|447857830|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
124520927|NCT02120352|447857831|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
124520928|NCT02120352|447857832|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
124520929|NCT02120352|447857833|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
124520930|NCT02120352|447857834|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
124520931|NCT02120352|447857828|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
124520932|NCT02120352|447857829|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
124520933|NCT02120352|447857830|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
124520934|NCT02120352|447857831|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
124520935|NCT02120352|447857832|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
124520936|NCT02120352|447857833|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
124520937|NCT02120352|447857834|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
124520938|NCT02120352|447857828|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
124520939|NCT02120352|447857829|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
124520940|NCT02120352|447857830|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
124520941|NCT02120352|447857831|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
124520942|NCT02120352|447857832|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
124520943|NCT02120352|447857833|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
124520944|NCT02120352|447857834|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
124520945|NCT02120352|447857828|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
124520946|NCT02120352|447857829|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
124520947|NCT02120352|447857830|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
124520948|NCT02120352|447857831|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
124520949|NCT02120352|447857832|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
124520950|NCT02120352|447857833|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
124520951|NCT02120352|447857834|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
124520952|NCT02120352|447857828|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
124520953|NCT02120352|447857829|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
124520954|NCT02120352|447857830|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
124520955|NCT02120352|447857831|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
124520956|NCT02120352|447857832|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
124520957|NCT02120352|447857833|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
124520958|NCT02120352|447857834|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
124520959|NCT02120352|447857828|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
124520960|NCT02120352|447857829|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
124520961|NCT02120352|447857830|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
124520962|NCT02120352|447857831|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
124520963|NCT02120352|447857832|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
124520964|NCT02120352|447857833|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
124520965|NCT02120352|447857834|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
124520966|NCT02120352|447857828|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
124520967|NCT02120352|447857829|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
124520968|NCT02120352|447857830|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
124520969|NCT02120352|447857831|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
124520970|NCT02120352|447857832|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
124520971|NCT02120352|447857833|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
124520972|NCT02120352|447857834|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
124520973|NCT02120352|447857828|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
124574113|NCT05093205|448060888|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
124725106|NCT01866111|448613448|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
124725107|NCT01866111|448613445|FG000|Open-label Extension Study YKP3089C017|Death|1|||
124725108|NCT01866111|448613446|FG001|Open-label Extension Study YKP3089C017|Death|1|||
124725109|NCT01866111|448613447|FG002|Open-label Extension Study YKP3089C017|Death|3|||
124725110|NCT01866111|448613448|FG003|Open-label Extension Study YKP3089C017|Death|2|||
124725111|NCT01866111|448613445|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
124725112|NCT01866111|448613446|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
124725113|NCT01866111|448613447|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
124574114|NCT05093205|448060889|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
124574115|NCT05093205|448060890|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
124574116|NCT05093205|448060891|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
124574117|NCT05093205|448060892|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
124574118|NCT05093205|448060880|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
124574119|NCT05093205|448060881|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
124574120|NCT05093205|448060882|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
124574121|NCT05093205|448060883|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
124574122|NCT05093205|448060884|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
124574123|NCT05093205|448060885|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
124574124|NCT05093205|448060886|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
124574125|NCT05093205|448060887|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
124574126|NCT05093205|448060888|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
124574127|NCT05093205|448060889|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
124574128|NCT05093205|448060890|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
124574129|NCT05093205|448060891|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
124574130|NCT05093205|448060892|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
124574131|NCT05093205|448060880|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
124520974|NCT02120352|447857829|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
124520975|NCT02120352|447857830|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
124520976|NCT02120352|447857831|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
124520977|NCT02120352|447857832|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
124520978|NCT02120352|447857833|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
124520979|NCT02120352|447857834|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
124520980|NCT02120352|447857828|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
124520981|NCT02120352|447857829|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
124520982|NCT02120352|447857830|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
124520983|NCT02120352|447857831|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
124520984|NCT02120352|447857832|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
124520985|NCT02120352|447857833|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
124520986|NCT02120352|447857834|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
124520987|NCT02120352|447857828|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
124520988|NCT02120352|447857829|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
124520989|NCT02120352|447857830|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
124520990|NCT02120352|447857831|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
124520991|NCT02120352|447857832|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
124520992|NCT02120352|447857833|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
124520993|NCT02120352|447857834|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
124520994|NCT02120352|447857828|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
124520995|NCT02120352|447857829|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
124520996|NCT02120352|447857830|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
124520997|NCT02120352|447857831|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
124520998|NCT02120352|447857832|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
124520999|NCT02120352|447857833|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
124521000|NCT02120352|447857834|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
124521001|NCT02120352|447857828|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
124521002|NCT02120352|447857829|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
124521003|NCT02120352|447857830|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
124521004|NCT02120352|447857831|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
124521005|NCT02120352|447857832|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
124574132|NCT05093205|448060881|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
124574133|NCT05093205|448060882|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
124521006|NCT02120352|447857833|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
124521007|NCT02120352|447857834|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
124521008|NCT02120352|447857828|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
124521009|NCT02120352|447857829|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
124521010|NCT02120352|447857830|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
124521011|NCT02120352|447857831|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
124574134|NCT05093205|448060883|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
124574135|NCT05093205|448060884|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
124574136|NCT05093205|448060885|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
124574137|NCT05093205|448060886|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
124574138|NCT05093205|448060887|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
124574139|NCT05093205|448060888|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
124574140|NCT05093205|448060889|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
124574141|NCT05093205|448060890|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
124574142|NCT05093205|448060891|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
124574143|NCT05093205|448060892|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
124574144|NCT05093205|448060880|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
124574145|NCT05093205|448060881|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
124574146|NCT05093205|448060882|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
124574147|NCT05093205|448060883|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
124574148|NCT05093205|448060884|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
124574149|NCT05093205|448060885|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
124574150|NCT05093205|448060886|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
124574151|NCT05093205|448060887|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
124574152|NCT05093205|448060888|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
124574153|NCT05093205|448060889|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
124574154|NCT05093205|448060890|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
124574155|NCT05093205|448060891|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
124574156|NCT05093205|448060892|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
124574157|NCT05093205|448060880|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
124574158|NCT05093205|448060881|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
124574159|NCT05093205|448060882|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
124574160|NCT05093205|448060883|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
124574161|NCT05093205|448060884|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
124574162|NCT05093205|448060885|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
124574163|NCT05093205|448060886|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
124574164|NCT05093205|448060887|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
124574165|NCT05093205|448060888|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
124574166|NCT05093205|448060889|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
124574167|NCT05093205|448060890|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
124574168|NCT05093205|448060891|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
124574169|NCT05093205|448060892|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
124574170|NCT03361228|448060894|FG000|Overall Study|Other|1|||
124574171|NCT03361228|448060895|FG001|Overall Study|Other|1|||
124574172|NCT03361228|448060894|FG000|Overall Study|Death|3|||
124574173|NCT03361228|448060895|FG001|Overall Study|Death|0|||
124574174|NCT03693430|448060903|FG000|Overall Study|Lost to Follow-up|3|||
124574175|NCT03693430|448060904|FG001|Overall Study|Lost to Follow-up|14|||
124574176|NCT03693430|448060903|FG000|Overall Study|Death|1|||
124574177|NCT03693430|448060904|FG001|Overall Study|Death|0|||
124574178|NCT03693430|448060903|FG000|Overall Study|Withdrawal by Subject|0|||
124574179|NCT03693430|448060904|FG001|Overall Study|Withdrawal by Subject|4|||
124574180|NCT04185909|448060905|FG000|Overall Study|Lost to Follow-up|1|||
124574181|NCT01417078|448060906|FG000|Overall Study|Withdrawal by Subject|1|||
124521012|NCT02120352|447857832|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
124521013|NCT02120352|447857833|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
124521014|NCT02120352|447857834|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
124521015|NCT02120352|447857828|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
124521016|NCT02120352|447857829|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
124521017|NCT02120352|447857830|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
124521018|NCT02120352|447857831|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
124521019|NCT02120352|447857832|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
124521020|NCT02120352|447857833|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
124521021|NCT02120352|447857834|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
124521022|NCT02120352|447857828|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
124574182|NCT01223365|448060915|FG000|Open-label Titration Period|Enrolled but not treated|1|||
124574183|NCT01223365|448060915|FG000|Open-label Titration Period|Adverse Event|23|||
124574184|NCT01223365|448060915|FG000|Open-label Titration Period|Lack of Efficacy|3|||
124574185|NCT01223365|448060915|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
124574186|NCT01223365|448060915|FG000|Open-label Titration Period|Protocol Violation|1|||
124521023|NCT02120352|447857829|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
124521024|NCT02120352|447857830|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
124574187|NCT01223365|448060915|FG000|Open-label Titration Period|Lost to Follow-up|2|||
124574188|NCT01223365|448060915|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
124574189|NCT01223365|448060915|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
124574190|NCT01223365|448060915|FG000|Open-label Titration Period|Starting physical therapy|1|||
124574191|NCT01223365|448060915|FG000|Open-label Treatment Period|Adverse Event|39|||
124574192|NCT01223365|448060915|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
124574193|NCT01223365|448060915|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
124574194|NCT01223365|448060915|FG000|Open-label Treatment Period|Protocol Violation|15|||
124574195|NCT01223365|448060915|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
124574196|NCT01223365|448060915|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
124574197|NCT01223365|448060915|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
124574198|NCT01223365|448060915|FG000|Open-label Treatment Period|Moved out of area|2|||
124574199|NCT01223365|448060915|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
124574200|NCT01223365|448060915|FG000|Open-label Treatment Period|"Out of window"|1|||
124574201|NCT01223365|448060915|FG000|Open-label Treatment Period|Starting physical therapy|1|||
124574202|NCT01223365|448060915|FG000|Open-label Treatment Period|Physician Decision|2|||
124725114|NCT01866111|448613448|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
124725115|NCT01866111|448613445|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
124725116|NCT01866111|448613446|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
124725117|NCT01866111|448613447|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
124725118|NCT01866111|448613448|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
124725119|NCT01866111|448613445|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
124725120|NCT01866111|448613446|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
124725121|NCT01866111|448613447|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
124725122|NCT01866111|448613448|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
124725123|NCT04576455|448613450|FG000|Overall Study|Ongoing in the Study|48|||
124725124|NCT04576455|448613451|FG001|Overall Study|Ongoing in the Study|58|||
124725125|NCT04576455|448613450|FG000|Overall Study|Death|83|||
124725126|NCT04576455|448613451|FG001|Overall Study|Death|77|||
124574203|NCT03567174|448060916|FG000|Overall Study|Death|24|||
124574204|NCT03567174|448060917|FG001|Overall Study|Death|31|||
124574205|NCT03567174|448060916|FG000|Overall Study|Lost to Follow-up|165|||
124574206|NCT03567174|448060917|FG001|Overall Study|Lost to Follow-up|174|||
124574207|NCT03243630|448060918|FG000|Overall Study|Protocol Violation|1|||
124574208|NCT03243630|448060918|FG000|Overall Study|Physician Decision|1|||
124574209|NCT01387737|448062379|FG000|Overall Study|Adverse Event|20|||
124574210|NCT01387737|448062380|FG001|Overall Study|Adverse Event|30|||
124574211|NCT01387737|448062379|FG000|Overall Study|Lack of Efficacy|1|||
124574212|NCT01387737|448062380|FG001|Overall Study|Lack of Efficacy|0|||
124574213|NCT01387737|448062379|FG000|Overall Study|Physician Decision|3|||
124574214|NCT01387737|448062380|FG001|Overall Study|Physician Decision|10|||
124574215|NCT01387737|448062379|FG000|Overall Study|Withdrawal by Subject|27|||
124574216|NCT01387737|448062380|FG001|Overall Study|Withdrawal by Subject|31|||
124574217|NCT01387737|448062379|FG000|Overall Study|Clearly not eligible for the study|1|||
124574218|NCT01387737|448062380|FG001|Overall Study|Clearly not eligible for the study|3|||
124574219|NCT02817841|448062382|FG000|Overall Study|Lost to Follow-up|287|||
124574220|NCT02817841|448062382|FG000|Overall Study|Withdrawal by Subject|183|||
124574221|NCT02817841|448062382|FG000|Overall Study|Adverse event not related to bleeding|131|||
124574222|NCT02817841|448062382|FG000|Overall Study|Adverse event related to bleeding|51|||
124574223|NCT02817841|448062382|FG000|Overall Study|Pregnancy|32|||
124574224|NCT02817841|448062382|FG000|Overall Study|Pregnancy wish|17|||
124574225|NCT02817841|448062382|FG000|Overall Study|Other reasons|53|||
124574226|NCT02817841|448062382|FG000|Overall Study|Protocol Violation|94|||
124574227|NCT01746017|448062391|FG000|Period 1|Withdrawal by Subject|0|||
124574228|NCT01746017|448062392|FG001|Period 1|Withdrawal by Subject|0|||
124574229|NCT01746017|448062393|FG002|Period 1|Withdrawal by Subject|0|||
124574230|NCT01746017|448062394|FG003|Period 1|Withdrawal by Subject|0|||
124574231|NCT01746017|448062395|FG004|Period 1|Withdrawal by Subject|0|||
124574232|NCT01746017|448062396|FG005|Period 1|Withdrawal by Subject|0|||
124574233|NCT01746017|448062397|FG006|Period 1|Withdrawal by Subject|1|||
124574234|NCT01746017|448062398|FG007|Period 1|Withdrawal by Subject|0|||
124574235|NCT01746017|448062399|FG008|Period 1|Withdrawal by Subject|0|||
124574236|NCT01746017|448062400|FG009|Period 1|Withdrawal by Subject|0|||
124574237|NCT01746017|448062401|FG010|Period 1|Withdrawal by Subject|0|||
124574238|NCT01746017|448062391|FG000|Period 3|Withdrawal by Subject|0|||
124574239|NCT01746017|448062392|FG001|Period 3|Withdrawal by Subject|0|||
124725127|NCT04576455|448613450|FG000|Overall Study|Lost to Follow-up|4|||
124574240|NCT01746017|448062393|FG002|Period 3|Withdrawal by Subject|0|||
124574241|NCT01746017|448062394|FG003|Period 3|Withdrawal by Subject|0|||
124574242|NCT01746017|448062395|FG004|Period 3|Withdrawal by Subject|0|||
124725128|NCT04576455|448613451|FG001|Overall Study|Lost to Follow-up|5|||
124725129|NCT04576455|448613450|FG000|Overall Study|Withdrawal by Subject|16|||
124725130|NCT04576455|448613451|FG001|Overall Study|Withdrawal by Subject|12|||
124574243|NCT01746017|448062396|FG005|Period 3|Withdrawal by Subject|1|||
124574244|NCT01746017|448062397|FG006|Period 3|Withdrawal by Subject|0|||
124574245|NCT01746017|448062398|FG007|Period 3|Withdrawal by Subject|0|||
124574246|NCT01746017|448062399|FG008|Period 3|Withdrawal by Subject|0|||
124574247|NCT01746017|448062400|FG009|Period 3|Withdrawal by Subject|0|||
124574248|NCT01746017|448062401|FG010|Period 3|Withdrawal by Subject|0|||
124574249|NCT00397488|448062402|FG000|Overall Study|Withdrawal by Subject|3|||
124574250|NCT00397488|448062402|FG000|Overall Study|Adverse Event|3|||
124574251|NCT00397488|448062402|FG000|Overall Study|Death|1|||
124574252|NCT01215981|448062405|FG000|Overall Study|Physician Decision|0|||
124574253|NCT01215981|448062406|FG001|Overall Study|Physician Decision|1|||
124574254|NCT01215981|448062405|FG000|Overall Study|Protocol Violation|1|||
124574255|NCT01215981|448062406|FG001|Overall Study|Protocol Violation|0|||
124574256|NCT01215981|448062405|FG000|Overall Study|Withdrawal by Subject|1|||
124574257|NCT01215981|448062406|FG001|Overall Study|Withdrawal by Subject|0|||
124574258|NCT03075761|448062407|FG000|Overall Study|Lost to Follow-up|1|||
124574259|NCT03075761|448062408|FG001|Overall Study|Lost to Follow-up|6|||
124574260|NCT00840632|448062412|FG000|First Intervention|Withdrawal by Subject|0|||
124574261|NCT00840632|448062413|FG001|First Intervention|Withdrawal by Subject|1|||
124574262|NCT00840632|448062412|FG000|Washout|Withdrawal by Subject|1|||
124574263|NCT00840632|448062413|FG001|Washout|Withdrawal by Subject|1|||
124574264|NCT01294787|448062414|FG000|Period 1|Adverse Event|0|||
124574265|NCT01294787|448062415|FG001|Period 1|Adverse Event|0|||
124574266|NCT01294787|448062416|FG002|Period 1|Adverse Event|0|||
124574267|NCT01294787|448062417|FG003|Period 1|Adverse Event|0|||
124574268|NCT01294787|448062418|FG004|Period 1|Adverse Event|1|||
124574269|NCT01294787|448062419|FG005|Period 1|Adverse Event|0|||
124574270|NCT01294787|448062414|FG000|Period 1|Withdrawal by Subject|0|||
124574271|NCT01294787|448062415|FG001|Period 1|Withdrawal by Subject|0|||
124574272|NCT01294787|448062416|FG002|Period 1|Withdrawal by Subject|0|||
124574273|NCT01294787|448062417|FG003|Period 1|Withdrawal by Subject|1|||
124574274|NCT01294787|448062418|FG004|Period 1|Withdrawal by Subject|1|||
124574275|NCT01294787|448062419|FG005|Period 1|Withdrawal by Subject|1|||
124574276|NCT01294787|448062414|FG000|Period 1|Administrative problem|0|||
124574277|NCT01294787|448062415|FG001|Period 1|Administrative problem|0|||
124574278|NCT01294787|448062416|FG002|Period 1|Administrative problem|1|||
124574279|NCT01294787|448062417|FG003|Period 1|Administrative problem|0|||
124574280|NCT01294787|448062418|FG004|Period 1|Administrative problem|0|||
124574281|NCT01294787|448062419|FG005|Period 1|Administrative problem|1|||
124574282|NCT01294787|448062414|FG000|Period 2|Adverse Event|0|||
124574283|NCT01294787|448062415|FG001|Period 2|Adverse Event|3|||
124574284|NCT01294787|448062416|FG002|Period 2|Adverse Event|0|||
124574285|NCT01294787|448062417|FG003|Period 2|Adverse Event|1|||
124574286|NCT01294787|448062418|FG004|Period 2|Adverse Event|0|||
124574287|NCT01294787|448062419|FG005|Period 2|Adverse Event|0|||
124574288|NCT01294787|448062414|FG000|Period 2|No longer needs study drug|0|||
124574289|NCT01294787|448062415|FG001|Period 2|No longer needs study drug|0|||
124574290|NCT01294787|448062416|FG002|Period 2|No longer needs study drug|0|||
124574291|NCT01294787|448062417|FG003|Period 2|No longer needs study drug|1|||
124574292|NCT01294787|448062418|FG004|Period 2|No longer needs study drug|0|||
124574293|NCT01294787|448062419|FG005|Period 2|No longer needs study drug|0|||
124574294|NCT01294787|448062414|FG000|Period 3|Adverse Event|0|||
124574295|NCT01294787|448062415|FG001|Period 3|Adverse Event|0|||
124574296|NCT01294787|448062416|FG002|Period 3|Adverse Event|0|||
124574297|NCT01294787|448062417|FG003|Period 3|Adverse Event|0|||
124574298|NCT01294787|448062418|FG004|Period 3|Adverse Event|1|||
124574299|NCT01294787|448062419|FG005|Period 3|Adverse Event|0|||
124574300|NCT01725529|448062420|FG000|Overall Study|Adverse Event|1|||
124574301|NCT01725529|448062421|FG001|Overall Study|Adverse Event|0|||
124574302|NCT01725529|448062422|FG002|Overall Study|Adverse Event|0|||
124574303|NCT01725529|448062420|FG000|Overall Study|Lost to Follow-up|2|||
124574304|NCT01725529|448062421|FG001|Overall Study|Lost to Follow-up|1|||
124574305|NCT01725529|448062422|FG002|Overall Study|Lost to Follow-up|1|||
124574306|NCT01725529|448062420|FG000|Overall Study|Protocol Violation|0|||
124574307|NCT01725529|448062421|FG001|Overall Study|Protocol Violation|1|||
124574308|NCT01725529|448062422|FG002|Overall Study|Protocol Violation|1|||
124574309|NCT01725529|448062420|FG000|Overall Study|Withdrawal by Subject|12|||
124574310|NCT01725529|448062421|FG001|Overall Study|Withdrawal by Subject|14|||
124574311|NCT01725529|448062422|FG002|Overall Study|Withdrawal by Subject|8|||
124574312|NCT01948258|448062427|FG000|Overall Study|Pregnancy|41|||
124574313|NCT01948258|448062427|FG000|Overall Study|Did not complete by cut-off date|35|||
124574314|NCT01948258|448062427|FG000|Overall Study|Lost to Follow-up|27|||
124574315|NCT01948258|448062427|FG000|Overall Study|Withdrawal by SPD|8|||
124574316|NCT01948258|448062427|FG000|Overall Study|Withdrawal by Subject|6|||
124574317|NCT01948258|448062427|FG000|Overall Study|Health Care Professional|43|||
124574318|NCT01948258|448062427|FG000|Overall Study|Removed from statistical analysis|2|||
124574319|NCT02262377|448062428|FG000|Overall Study|Lost to Follow-up|5|||
124574320|NCT02262377|448062429|FG001|Overall Study|Lost to Follow-up|6|||
124574321|NCT02262377|448062428|FG000|Overall Study|Found ineligible after enrollment|3|||
124574322|NCT02262377|448062429|FG001|Overall Study|Found ineligible after enrollment|0|||
124574323|NCT02262377|448062428|FG000|Overall Study|Withdrawal by Subject|4|||
124574324|NCT02262377|448062429|FG001|Overall Study|Withdrawal by Subject|0|||
124574325|NCT00723528|448062433|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
124574326|NCT00723528|448062434|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
124574327|NCT00723528|448062435|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
124574328|NCT00723528|448062436|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
124574329|NCT00723528|448062437|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
124574330|NCT00723528|448062438|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
124574331|NCT00723528|448062439|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
124574332|NCT00723528|448062433|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
124574333|NCT00723528|448062434|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
124574334|NCT00723528|448062435|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
124574335|NCT00723528|448062436|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
124574336|NCT00723528|448062437|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
124574337|NCT00723528|448062438|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
124574338|NCT00723528|448062439|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
124574339|NCT00723528|448062433|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
124574340|NCT00723528|448062434|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
124574341|NCT00723528|448062435|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
124574342|NCT00723528|448062436|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
124574343|NCT00723528|448062437|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
124574344|NCT00723528|448062438|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
124574345|NCT00723528|448062439|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
124574346|NCT00723528|448062433|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
124574347|NCT00723528|448062434|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
124574348|NCT00723528|448062435|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
124574349|NCT00723528|448062436|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
124574350|NCT00723528|448062437|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
124574351|NCT00723528|448062438|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
124574352|NCT00723528|448062439|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
124574353|NCT00723528|448062433|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
124574354|NCT00723528|448062434|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
124574355|NCT00723528|448062435|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
124574356|NCT00723528|448062436|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
124574357|NCT00723528|448062437|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
124574358|NCT00723528|448062438|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
124574359|NCT00723528|448062439|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
124574360|NCT00723528|448062433|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
124574361|NCT00723528|448062434|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
124574362|NCT00723528|448062435|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
124574363|NCT00723528|448062436|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
124574364|NCT00723528|448062437|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
124574365|NCT00723528|448062438|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
124574366|NCT00723528|448062439|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
124574367|NCT00723528|448062433|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
124574368|NCT00723528|448062434|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
124574369|NCT00723528|448062435|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
124574370|NCT00723528|448062436|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
124574371|NCT00723528|448062437|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
124574372|NCT00723528|448062438|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
124725131|NCT03989349|448613452|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
124725132|NCT03989349|448613453|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
124725133|NCT03989349|448613454|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
124725134|NCT03989349|448613455|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
124574373|NCT00723528|448062439|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
124574374|NCT00723528|448062433|FG000|Period 2: After Controlled Period|Other|0|||
124574375|NCT00723528|448062434|FG001|Period 2: After Controlled Period|Other|0|||
124574376|NCT00723528|448062435|FG002|Period 2: After Controlled Period|Other|0|||
124574377|NCT00723528|448062436|FG003|Period 2: After Controlled Period|Other|0|||
124574378|NCT00723528|448062437|FG004|Period 2: After Controlled Period|Other|1|||
124574379|NCT00723528|448062438|FG005|Period 2: After Controlled Period|Other|4|||
124574380|NCT00723528|448062439|FG006|Period 2: After Controlled Period|Other|0|||
124574381|NCT00723528|448062433|FG000|Period 2: After Controlled Period|Adverse Event|0|||
124574382|NCT00723528|448062434|FG001|Period 2: After Controlled Period|Adverse Event|0|||
124574383|NCT00723528|448062435|FG002|Period 2: After Controlled Period|Adverse Event|0|||
124574384|NCT00723528|448062436|FG003|Period 2: After Controlled Period|Adverse Event|0|||
124574385|NCT00723528|448062437|FG004|Period 2: After Controlled Period|Adverse Event|1|||
124574386|NCT00723528|448062438|FG005|Period 2: After Controlled Period|Adverse Event|0|||
124574387|NCT00723528|448062439|FG006|Period 2: After Controlled Period|Adverse Event|1|||
124574388|NCT00723528|448062433|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
124725135|NCT03989349|448613456|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
124725136|NCT03989349|448613457|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
124574389|NCT00723528|448062434|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
124574390|NCT00723528|448062435|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
124574391|NCT00723528|448062436|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
124574392|NCT00723528|448062437|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
124574393|NCT00723528|448062438|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
124574394|NCT00723528|448062439|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
124574395|NCT00723528|448062433|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
124574396|NCT00723528|448062434|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
124574397|NCT00723528|448062435|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
124574398|NCT00723528|448062436|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
124574399|NCT00723528|448062437|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
124574400|NCT00723528|448062438|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
124574401|NCT00723528|448062439|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
124574402|NCT01993030|448062440|FG000|Overall Study|Adverse Event|0|||
124574403|NCT01993030|448062441|FG001|Overall Study|Adverse Event|4|||
124574404|NCT03785548|448062442|FG000|Overall Study|age > 80|1|||
124574405|NCT03785548|448062443|FG001|Overall Study|age > 80|0|||
124574406|NCT03785548|448062442|FG000|Overall Study|no Postop queries|1|||
124574407|NCT03785548|448062443|FG001|Overall Study|no Postop queries|0|||
124574408|NCT01710657|448062444|FG000|Overall Study|Lost to Follow-up|2|||
124574409|NCT01710657|448062445|FG001|Overall Study|Lost to Follow-up|0|||
124574410|NCT01710657|448062446|FG002|Overall Study|Lost to Follow-up|1|||
124574411|NCT01710657|448062444|FG000|Overall Study|Protocol Violation|2|||
124574412|NCT01710657|448062445|FG001|Overall Study|Protocol Violation|2|||
124574413|NCT01710657|448062446|FG002|Overall Study|Protocol Violation|0|||
124574414|NCT01710657|448062444|FG000|Overall Study|Adverse Event|14|||
124574415|NCT01710657|448062445|FG001|Overall Study|Adverse Event|8|||
124574416|NCT01710657|448062446|FG002|Overall Study|Adverse Event|28|||
124574417|NCT01710657|448062444|FG000|Overall Study|Withdrawal by Subject|0|||
124574418|NCT01710657|448062445|FG001|Overall Study|Withdrawal by Subject|1|||
124574419|NCT01710657|448062446|FG002|Overall Study|Withdrawal by Subject|2|||
124574420|NCT01710657|448062444|FG000|Overall Study|Lack of Efficacy|0|||
124574421|NCT01710657|448062445|FG001|Overall Study|Lack of Efficacy|1|||
124574422|NCT01710657|448062446|FG002|Overall Study|Lack of Efficacy|1|||
124574423|NCT01591785|448062449|FG000|Overall Study|worsening condition|1|||
124574424|NCT01591785|448062450|FG001|Overall Study|worsening condition|2|||
124574425|NCT01591785|448062449|FG000|Overall Study|Protocol Violation|2|||
124574426|NCT01591785|448062450|FG001|Overall Study|Protocol Violation|0|||
124574427|NCT01591785|448062449|FG000|Overall Study|Lost to Follow-up|1|||
124574428|NCT01591785|448062450|FG001|Overall Study|Lost to Follow-up|0|||
124574429|NCT00358449|448062451|FG000|Overall Study|Adverse Event|1|||
124574430|NCT00358449|448062452|FG001|Overall Study|Adverse Event|0|||
124574431|NCT00358449|448062453|FG002|Overall Study|Adverse Event|1|||
124574432|NCT00358449|448062451|FG000|Overall Study|Lost to Follow-up|1|||
124574433|NCT00358449|448062452|FG001|Overall Study|Lost to Follow-up|0|||
124574434|NCT00358449|448062453|FG002|Overall Study|Lost to Follow-up|0|||
124574435|NCT00358449|448062451|FG000|Overall Study|Withdrawal by Subject|2|||
124574436|NCT00358449|448062452|FG001|Overall Study|Withdrawal by Subject|0|||
124574437|NCT00358449|448062453|FG002|Overall Study|Withdrawal by Subject|0|||
124574438|NCT00358449|448062451|FG000|Overall Study|Lack of Efficacy|0|||
124574439|NCT00358449|448062452|FG001|Overall Study|Lack of Efficacy|1|||
124574440|NCT00358449|448062453|FG002|Overall Study|Lack of Efficacy|0|||
124574441|NCT00358449|448062451|FG000|Overall Study|Steriod Inhaler was Increased|0|||
124574442|NCT00358449|448062452|FG001|Overall Study|Steriod Inhaler was Increased|0|||
124725137|NCT03989349|448613452|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
124725138|NCT03989349|448613453|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
124725139|NCT03989349|448613454|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
124725140|NCT03989349|448613455|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
124725141|NCT03989349|448613456|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
124725142|NCT03989349|448613457|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
124725143|NCT03989349|448613452|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
124725144|NCT03989349|448613453|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
124574443|NCT00358449|448062453|FG002|Overall Study|Steriod Inhaler was Increased|1|||
124574444|NCT00496964|448062461|FG000|Overall Study|Withdrawal by Subject|0|||
124574445|NCT00496964|448062462|FG001|Overall Study|Withdrawal by Subject|1|||
124574446|NCT00469417|448062463|FG000|Overall Study|Treatment failure all lesions|18|||
124574447|NCT00469417|448062464|FG001|Overall Study|Treatment failure all lesions|11|||
124574448|NCT00469417|448062463|FG000|Overall Study|Consent withdrawn|1|||
124574449|NCT00469417|448062464|FG001|Overall Study|Consent withdrawn|1|||
124574450|NCT00469417|448062463|FG000|Overall Study|Adverse Event|8|||
124574451|NCT00469417|448062464|FG001|Overall Study|Adverse Event|2|||
124574452|NCT00469417|448062463|FG000|Overall Study|Lost to Follow-up|1|||
124574453|NCT00469417|448062464|FG001|Overall Study|Lost to Follow-up|2|||
124574454|NCT00469417|448062463|FG000|Overall Study|Intercurrent disease|0|||
124574455|NCT00469417|448062464|FG001|Overall Study|Intercurrent disease|1|||
124574456|NCT00469417|448062463|FG000|Overall Study|Randomized but not treated|2|||
124574457|NCT00469417|448062464|FG001|Overall Study|Randomized but not treated|0|||
124574458|NCT00909610|448062465|FG000|Period: First Intervention|Adverse Event|0|||
124574459|NCT00909610|448062466|FG001|Period: First Intervention|Adverse Event|1|||
124574460|NCT00909610|448062465|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
124574461|NCT00909610|448062466|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
124574462|NCT00909610|448062465|FG000|Period: Second Intervention|Adverse Event|1|||
124574463|NCT00909610|448062466|FG001|Period: Second Intervention|Adverse Event|0|||
124574464|NCT05327491|448062471|FG000|Periods 1 & 2|Miscellaneous|0|||
124574465|NCT05327491|448062472|FG001|Periods 1 & 2|Miscellaneous|1|||
124574466|NCT05327491|448062473|FG002|Periods 1 & 2|Miscellaneous|0|||
124574467|NCT05327491|448062474|FG003|Periods 1 & 2|Miscellaneous|0|||
124574468|NCT05327491|448062471|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
124574469|NCT05327491|448062472|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
124574470|NCT05327491|448062473|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
124574471|NCT05327491|448062474|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
124574472|NCT05038293|448062475|FG000|Overall Study|device was not operating properly for one subject.|1|||
124574473|NCT05038293|448062476|FG001|Overall Study|device was not operating properly for one subject.|0|||
124574474|NCT05038293|448062475|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
124574475|NCT05038293|448062476|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
124574476|NCT01247701|448062480|FG000|Overall Study|Death|2|||
124574477|NCT01247701|448062480|FG000|Overall Study|Relapsed|8|||
124574478|NCT04166630|448062481|FG000|Overall Study|Withdrawal by Subject|0|||
124574479|NCT04166630|448062482|FG001|Overall Study|Withdrawal by Subject|1|||
124574480|NCT00096447|448062483|FG000|Overall Study|Never treated|1|||
124574481|NCT00834743|448062484|FG000|Second Intervention|Withdrawal by Subject|1|||
124574482|NCT00834743|448062485|FG001|Second Intervention|Withdrawal by Subject|0|||
124574483|NCT04088760|448062486|FG000|Overall Study|Physician Decision|1|||
124574484|NCT04091971|448062487|FG000|Overall Study|Withdrawal by Subject|1|||
124574485|NCT04091971|448062487|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
124574486|NCT04091971|448062487|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
124574487|NCT02472366|448062491|FG000|Overall Study|Lost to Follow-up|1|||
124574488|NCT02472366|448062492|FG001|Overall Study|Lost to Follow-up|0|||
124574489|NCT02728102|448062493|FG000|Overall Study|Death|3|||
124574490|NCT02728102|448062494|FG001|Overall Study|Death|0|||
124574491|NCT02728102|448062495|FG002|Overall Study|Death|1|||
124574492|NCT02728102|448062493|FG000|Overall Study|Withdrawal by Subject|0|||
124574493|NCT02728102|448062494|FG001|Overall Study|Withdrawal by Subject|2|||
124574494|NCT02728102|448062495|FG002|Overall Study|Withdrawal by Subject|3|||
124574495|NCT02728102|448062493|FG000|Overall Study|Physician Decision|1|||
124574496|NCT02728102|448062494|FG001|Overall Study|Physician Decision|1|||
124574497|NCT02728102|448062495|FG002|Overall Study|Physician Decision|0|||
124574498|NCT02728102|448062493|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
124574499|NCT02728102|448062494|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
124574500|NCT02728102|448062495|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
124574501|NCT02728102|448062493|FG000|Overall Study|Covid|0|||
124574502|NCT02728102|448062494|FG001|Overall Study|Covid|0|||
124574503|NCT02728102|448062495|FG002|Overall Study|Covid|1|||
124776731|NCT03219528|448809963|FG001|Overall Study|Withdrawal by Subject|4|||
124776732|NCT02120898|448809964|FG000|Overall Study|Withdrawal by Subject|4|||
124574504|NCT02419937|448062498|FG000|Overall Study|Lost to Follow-up|1|||
124574505|NCT02419937|448062499|FG001|Overall Study|Lost to Follow-up|0|||
124574506|NCT02924883|448062500|FG000|Overall Study|Death|39|||
124574507|NCT02924883|448062501|FG001|Overall Study|Death|20|||
124574508|NCT02924883|448062500|FG000|Overall Study|Lost to Follow-up|1|||
124574509|NCT02924883|448062501|FG001|Overall Study|Lost to Follow-up|0|||
124574510|NCT02924883|448062500|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
124574511|NCT02924883|448062501|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
124574512|NCT02924883|448062500|FG000|Overall Study|Protocol Violation|1|||
124574513|NCT02924883|448062501|FG001|Overall Study|Protocol Violation|0|||
124574514|NCT02924883|448062500|FG000|Overall Study|Withdrawal by Subject|22|||
124574515|NCT02924883|448062501|FG001|Overall Study|Withdrawal by Subject|16|||
124574516|NCT02924883|448062500|FG000|Overall Study|Progressive Disease|1|||
124574517|NCT02924883|448062501|FG001|Overall Study|Progressive Disease|0|||
124574518|NCT02924883|448062500|FG000|Overall Study|Study Terminated by Sponsor|69|||
124574519|NCT02924883|448062501|FG001|Overall Study|Study Terminated by Sponsor|32|||
124574520|NCT01182415|448062502|FG000|Overall Study|Lost to Follow-up|1|||
124574521|NCT01981720|448062503|FG000|Overall Study|Adverse Event|1|||
124574522|NCT01981720|448062503|FG000|Overall Study|Withdrawal by Subject|3|||
124574523|NCT01981720|448062503|FG000|Overall Study|Pregnancy|1|||
124574524|NCT00004562|448062504|FG000|Overall Study|Lost to Follow-up|102|||
124574525|NCT00004562|448062505|FG001|Overall Study|Lost to Follow-up|91|||
124574526|NCT02770820|448062506|FG000|Overall Study|Death|1|||
124574527|NCT02770820|448062506|FG000|Overall Study|Physician Decision|2|||
124574528|NCT02336165|448062507|FG000|Overall Study|Death|3|||
124574529|NCT02336165|448062508|FG001|Overall Study|Death|0|||
124574530|NCT02336165|448062509|FG002|Overall Study|Death|0|||
124574531|NCT02336165|448062510|FG003|Overall Study|Death|0|||
124574532|NCT02336165|448062511|FG004|Overall Study|Death|1|||
124574533|NCT02336165|448062507|FG000|Overall Study|Physician Decision|2|||
124574534|NCT02336165|448062508|FG001|Overall Study|Physician Decision|2|||
124574535|NCT02336165|448062509|FG002|Overall Study|Physician Decision|1|||
124574536|NCT02336165|448062510|FG003|Overall Study|Physician Decision|1|||
124574537|NCT02336165|448062511|FG004|Overall Study|Physician Decision|0|||
124574538|NCT02336165|448062507|FG000|Overall Study|Withdrawal by Subject|0|||
124574539|NCT02336165|448062508|FG001|Overall Study|Withdrawal by Subject|0|||
124574540|NCT02336165|448062509|FG002|Overall Study|Withdrawal by Subject|1|||
124574541|NCT02336165|448062510|FG003|Overall Study|Withdrawal by Subject|0|||
124574542|NCT02336165|448062511|FG004|Overall Study|Withdrawal by Subject|1|||
124574543|NCT02336165|448062507|FG000|Overall Study|Adverse Event|4|||
124574544|NCT02336165|448062508|FG001|Overall Study|Adverse Event|1|||
124574545|NCT02336165|448062509|FG002|Overall Study|Adverse Event|2|||
124574546|NCT02336165|448062510|FG003|Overall Study|Adverse Event|4|||
124574547|NCT02336165|448062511|FG004|Overall Study|Adverse Event|1|||
124574548|NCT02336165|448062507|FG000|Overall Study|Progressive disease|23|||
124574549|NCT02336165|448062508|FG001|Overall Study|Progressive disease|22|||
124574550|NCT02336165|448062509|FG002|Overall Study|Progressive disease|27|||
124574551|NCT02336165|448062510|FG003|Overall Study|Progressive disease|24|||
124574552|NCT02336165|448062511|FG004|Overall Study|Progressive disease|19|||
124574553|NCT02336165|448062507|FG000|Overall Study|Non-compliance|1|||
124574554|NCT02336165|448062508|FG001|Overall Study|Non-compliance|0|||
124574555|NCT02336165|448062509|FG002|Overall Study|Non-compliance|0|||
124574556|NCT02336165|448062510|FG003|Overall Study|Non-compliance|1|||
124574557|NCT02336165|448062511|FG004|Overall Study|Non-compliance|0|||
124574558|NCT02336165|448062507|FG000|Overall Study|Other|1|||
124574559|NCT02336165|448062508|FG001|Overall Study|Other|0|||
124574560|NCT02336165|448062509|FG002|Overall Study|Other|0|||
124574561|NCT02336165|448062510|FG003|Overall Study|Other|1|||
124574562|NCT02336165|448062511|FG004|Overall Study|Other|0|||
124574563|NCT03195491|448062517|FG000|Overall Study|Study drug toxicity|25|||
124574564|NCT03195491|448062518|FG001|Overall Study|Study drug toxicity|3|||
124574565|NCT03195491|448062517|FG000|Overall Study|Maximum clinical benefit|5|||
124574566|NCT03195491|448062518|FG001|Overall Study|Maximum clinical benefit|0|||
124574567|NCT03195491|448062517|FG000|Overall Study|Lost to Follow-up|1|||
124574568|NCT03195491|448062518|FG001|Overall Study|Lost to Follow-up|0|||
124574569|NCT03195491|448062517|FG000|Overall Study|Death|3|||
124574570|NCT03195491|448062518|FG001|Overall Study|Death|0|||
124574571|NCT03195491|448062517|FG000|Overall Study|Adverse event unrelated to study drug|19|||
124574572|NCT03195491|448062518|FG001|Overall Study|Adverse event unrelated to study drug|2|||
124574573|NCT03195491|448062517|FG000|Overall Study|Disease progression|266|||
124574574|NCT03195491|448062518|FG001|Overall Study|Disease progression|8|||
124574575|NCT03195491|448062517|FG000|Overall Study|Other reasons|10|||
124574576|NCT03195491|448062518|FG001|Overall Study|Other reasons|0|||
124574577|NCT03195491|448062517|FG000|Overall Study|Participant withdrew consent|8|||
124574578|NCT03195491|448062518|FG001|Overall Study|Participant withdrew consent|1|||
124574579|NCT03195491|448062517|FG000|Overall Study|Participant no longer meets study criteria|0|||
124574580|NCT03195491|448062518|FG001|Overall Study|Participant no longer meets study criteria|1|||
124574581|NCT03195491|448062517|FG000|Overall Study|Participant request to discontinue study treatment|10|||
124574582|NCT03195491|448062518|FG001|Overall Study|Participant request to discontinue study treatment|0|||
124574583|NCT04239872|448062520|FG000|Overall Study|Lost to Follow-up|0|||
124574584|NCT04239872|448062521|FG001|Overall Study|Lost to Follow-up|1|||
124574585|NCT01185821|448062528|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124574586|NCT01185821|448062529|FG001|Overall Study|Abnormal laboratory value(s)|2|||
124574587|NCT01185821|448062530|FG002|Overall Study|Abnormal laboratory value(s)|1|||
124574588|NCT01185821|448062531|FG003|Overall Study|Abnormal laboratory value(s)|0|||
124574589|NCT01185821|448062532|FG004|Overall Study|Abnormal laboratory value(s)|0|||
124574590|NCT01185821|448062528|FG000|Overall Study|Protocol Violation|0|||
124574591|NCT01185821|448062529|FG001|Overall Study|Protocol Violation|0|||
124574592|NCT01185821|448062530|FG002|Overall Study|Protocol Violation|0|||
124574593|NCT01185821|448062531|FG003|Overall Study|Protocol Violation|1|||
124574594|NCT01185821|448062532|FG004|Overall Study|Protocol Violation|1|||
124574595|NCT01185821|448062528|FG000|Overall Study|Abnormal test procedure result|0|||
124574596|NCT01185821|448062529|FG001|Overall Study|Abnormal test procedure result|0|||
124574597|NCT01185821|448062530|FG002|Overall Study|Abnormal test procedure result|0|||
124574598|NCT01185821|448062531|FG003|Overall Study|Abnormal test procedure result|0|||
124574599|NCT01185821|448062532|FG004|Overall Study|Abnormal test procedure result|1|||
124574600|NCT01185821|448062528|FG000|Overall Study|Death|0|||
124574601|NCT01185821|448062529|FG001|Overall Study|Death|1|||
124574602|NCT01185821|448062530|FG002|Overall Study|Death|0|||
124574603|NCT01185821|448062531|FG003|Overall Study|Death|0|||
124574604|NCT01185821|448062532|FG004|Overall Study|Death|0|||
124521025|NCT02120352|447857831|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
124521026|NCT02120352|447857832|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
124521027|NCT02120352|447857833|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
124521028|NCT02120352|447857834|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
124521029|NCT02120352|447857828|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
124521030|NCT02120352|447857829|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
124521031|NCT02120352|447857830|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
124521032|NCT02120352|447857831|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
124521033|NCT02120352|447857832|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
124521034|NCT02120352|447857833|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
124521035|NCT02120352|447857834|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
124521036|NCT02120352|447857828|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
124521037|NCT02120352|447857829|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
124521038|NCT02120352|447857830|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
124521039|NCT02120352|447857831|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
124521040|NCT02120352|447857832|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
124521041|NCT02120352|447857833|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
124521042|NCT02120352|447857834|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
124521043|NCT02120352|447857828|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
124521044|NCT02120352|447857829|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
124521045|NCT02120352|447857830|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
124521046|NCT02120352|447857831|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
124521047|NCT02120352|447857832|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
124521048|NCT02120352|447857833|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
124521049|NCT02120352|447857834|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
124521050|NCT01610206|447857835|FG000|Overall Study|Adverse Event|10|||
124521051|NCT01610206|447857836|FG001|Overall Study|Adverse Event|30|||
124521052|NCT00166517|447857838|FG000|Overall Study|Lost to Follow-up|1|||
124521053|NCT00166517|447857839|FG001|Overall Study|Lost to Follow-up|0|||
124521054|NCT00166517|447857838|FG000|Overall Study|Protocol Violation|4|||
124521055|NCT00166517|447857839|FG001|Overall Study|Protocol Violation|1|||
124521056|NCT00166517|447857838|FG000|Overall Study|Withdrawal by Subject|0|||
124521057|NCT00166517|447857839|FG001|Overall Study|Withdrawal by Subject|1|||
124521058|NCT02186561|447857840|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
124521059|NCT02186561|447857840|FG000|Enrollment|Enrollment Cap Reached|5|||
124521060|NCT02186561|447857840|FG000|Enrollment|Insurance Denial|2|||
124521061|NCT02186561|447857840|FG000|Enrollment|Withdrawal by Subject|2|||
124521062|NCT02186561|447857840|FG000|Enrollment|Investigator Withdrew Consent|1|||
124521063|NCT02186561|447857840|FG000|30-Day Post Index Procedure Visit|Death|1|||
124521064|NCT02186561|447857840|FG000|1- Year Post Index Procedure Visit|Death|1|||
124521065|NCT02186561|447857840|FG000|1- Year Post Index Procedure Visit|Missed|1|||
124521066|NCT03094611|447857841|FG000|Overall Study|Lack of Efficacy|1|||
124521067|NCT03094611|447857841|FG000|Overall Study|Stem Cell Transplant|1|||
124521068|NCT04285853|447857842|FG000|Overall Study|Withdrawal by Subject|1|||
124521069|NCT04285853|447857843|FG001|Overall Study|Withdrawal by Subject|0|||
124521070|NCT04285853|447857842|FG000|Overall Study|Lost to Follow-up|9|||
124521071|NCT04285853|447857843|FG001|Overall Study|Lost to Follow-up|5|||
124521072|NCT01042938|447857848|FG000|Overall Study|Withdrawal by Subject|1|||
124521073|NCT01042938|447857849|FG001|Overall Study|Withdrawal by Subject|1|||
124521074|NCT01042938|447857848|FG000|Overall Study|Protocol Violation|1|||
124521075|NCT01042938|447857849|FG001|Overall Study|Protocol Violation|1|||
124521076|NCT01042938|447857848|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
124521077|NCT01042938|447857849|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
124521078|NCT05041062|447857850|FG000|Overall Study|Adverse Event|2|||
124521079|NCT04018612|447857851|FG000|Overall Study|Withdrawal by Subject|1|||
124521080|NCT04018612|447857852|FG001|Overall Study|Withdrawal by Subject|0|||
124521081|NCT04018612|447857853|FG002|Overall Study|Withdrawal by Subject|1|||
124521082|NCT01915095|447857854|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
124521083|NCT01915095|447857855|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
124521084|NCT01915095|447857856|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
124521085|NCT01915095|447857857|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
124521086|NCT01915095|447857858|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
124521087|NCT02671760|447857860|FG000|Overall Study|Lost to Follow-up|0|||
124521088|NCT02671760|447857861|FG001|Overall Study|Lost to Follow-up|1|||
124521089|NCT02671760|447857862|FG002|Overall Study|Lost to Follow-up|0|||
124521090|NCT02999191|447857863|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
124521091|NCT02999191|447857864|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
124521092|NCT02999191|447857865|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
124521093|NCT02371980|447859922|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
124521094|NCT02371980|447859923|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
124521095|NCT02371980|447859924|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
124574605|NCT01185821|448062528|FG000|Overall Study|Condition no longer required study drug|0|||
124574606|NCT01185821|448062529|FG001|Overall Study|Condition no longer required study drug|0|||
124574607|NCT01185821|448062530|FG002|Overall Study|Condition no longer required study drug|0|||
124574608|NCT01185821|448062531|FG003|Overall Study|Condition no longer required study drug|0|||
124574609|NCT01185821|448062532|FG004|Overall Study|Condition no longer required study drug|1|||
124574610|NCT01185821|448062528|FG000|Overall Study|Adverse Event|2|||
124574611|NCT01185821|448062529|FG001|Overall Study|Adverse Event|3|||
124574612|NCT01185821|448062530|FG002|Overall Study|Adverse Event|1|||
124574613|NCT01185821|448062531|FG003|Overall Study|Adverse Event|2|||
124725145|NCT03989349|448613454|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
124725146|NCT03989349|448613455|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
124725147|NCT03989349|448613456|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
124725148|NCT03989349|448613457|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
124725149|NCT03989349|448613452|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
124725150|NCT03989349|448613453|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
124725151|NCT03989349|448613454|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
124725152|NCT03989349|448613455|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
124574614|NCT01185821|448062532|FG004|Overall Study|Adverse Event|5|||
124574615|NCT01185821|448062528|FG000|Overall Study|Lack of Efficacy|0|||
124574616|NCT01185821|448062529|FG001|Overall Study|Lack of Efficacy|0|||
124574617|NCT01185821|448062530|FG002|Overall Study|Lack of Efficacy|3|||
124574618|NCT01185821|448062531|FG003|Overall Study|Lack of Efficacy|0|||
124574619|NCT01185821|448062532|FG004|Overall Study|Lack of Efficacy|9|||
124574620|NCT01185821|448062528|FG000|Overall Study|Withdrawal by Subject|3|||
124574621|NCT01185821|448062529|FG001|Overall Study|Withdrawal by Subject|2|||
124574622|NCT01185821|448062530|FG002|Overall Study|Withdrawal by Subject|2|||
124574623|NCT01185821|448062531|FG003|Overall Study|Withdrawal by Subject|1|||
124574624|NCT01185821|448062532|FG004|Overall Study|Withdrawal by Subject|3|||
124574625|NCT01185821|448062528|FG000|Overall Study|Lost to Follow-up|1|||
124574626|NCT01185821|448062529|FG001|Overall Study|Lost to Follow-up|1|||
124574627|NCT01185821|448062530|FG002|Overall Study|Lost to Follow-up|2|||
124574628|NCT01185821|448062531|FG003|Overall Study|Lost to Follow-up|1|||
124574629|NCT01185821|448062532|FG004|Overall Study|Lost to Follow-up|2|||
124574630|NCT01185821|448062528|FG000|Overall Study|Administrative problems|0|||
124574631|NCT01185821|448062529|FG001|Overall Study|Administrative problems|0|||
124574632|NCT01185821|448062530|FG002|Overall Study|Administrative problems|1|||
124574633|NCT01185821|448062531|FG003|Overall Study|Administrative problems|1|||
124574634|NCT01185821|448062532|FG004|Overall Study|Administrative problems|2|||
124574635|NCT00296647|448062534|FG000|Overall Study|Death|4|||
124574636|NCT00296647|448062535|FG001|Overall Study|Death|1|||
124574637|NCT00296647|448062536|FG002|Overall Study|Death|2|||
124574638|NCT00296647|448062537|FG003|Overall Study|Death|1|||
124574639|NCT00296647|448062538|FG004|Overall Study|Death|1|||
124574640|NCT00296647|448062534|FG000|Overall Study|Withdrawal by Subject|28|||
124574641|NCT00296647|448062535|FG001|Overall Study|Withdrawal by Subject|27|||
124574642|NCT00296647|448062536|FG002|Overall Study|Withdrawal by Subject|32|||
124574643|NCT00296647|448062537|FG003|Overall Study|Withdrawal by Subject|16|||
124574644|NCT00296647|448062538|FG004|Overall Study|Withdrawal by Subject|19|||
124574645|NCT00854100|448062543|FG000|Overall Study|Inability to complete the study visits|0|||
124574646|NCT00854100|448062544|FG001|Overall Study|Inability to complete the study visits|0|||
124574647|NCT00854100|448062545|FG002|Overall Study|Inability to complete the study visits|1|||
124574648|NCT00854100|448062543|FG000|Overall Study|Lost to Follow-up|2|||
124574649|NCT00854100|448062544|FG001|Overall Study|Lost to Follow-up|0|||
124574650|NCT00854100|448062545|FG002|Overall Study|Lost to Follow-up|3|||
124574651|NCT00854100|448062543|FG000|Overall Study|Withdrawal by Subject|3|||
124574652|NCT00854100|448062544|FG001|Overall Study|Withdrawal by Subject|1|||
124574653|NCT00854100|448062545|FG002|Overall Study|Withdrawal by Subject|2|||
124574654|NCT00854100|448062543|FG000|Overall Study|Protocol Violation|2|||
124574655|NCT00854100|448062544|FG001|Overall Study|Protocol Violation|4|||
124574656|NCT00854100|448062545|FG002|Overall Study|Protocol Violation|3|||
124574657|NCT00854100|448062543|FG000|Overall Study|Adverse Event|2|||
124574658|NCT00854100|448062544|FG001|Overall Study|Adverse Event|1|||
124574659|NCT00854100|448062545|FG002|Overall Study|Adverse Event|2|||
124574660|NCT02883452|448064003|FG000|Overall Study|Withdrawal by Subject|1|||
124574661|NCT02883452|448064004|FG001|Overall Study|Withdrawal by Subject|1|||
124574662|NCT02883452|448064005|FG002|Overall Study|Withdrawal by Subject|3|||
124574663|NCT02883452|448064006|FG003|Overall Study|Withdrawal by Subject|0|||
124574664|NCT02883452|448064007|FG004|Overall Study|Withdrawal by Subject|2|||
124574665|NCT02883452|448064008|FG005|Overall Study|Withdrawal by Subject|5|||
124574666|NCT02883452|448064003|FG000|Overall Study|Disease progression|1|||
124574667|NCT02883452|448064004|FG001|Overall Study|Disease progression|0|||
124574668|NCT02883452|448064005|FG002|Overall Study|Disease progression|0|||
124574669|NCT02883452|448064006|FG003|Overall Study|Disease progression|1|||
124574670|NCT02883452|448064007|FG004|Overall Study|Disease progression|4|||
124574671|NCT02883452|448064008|FG005|Overall Study|Disease progression|5|||
124574672|NCT02883452|448064003|FG000|Overall Study|Adverse Event|2|||
124574673|NCT02883452|448064004|FG001|Overall Study|Adverse Event|1|||
124574674|NCT02883452|448064005|FG002|Overall Study|Adverse Event|1|||
124574675|NCT02883452|448064006|FG003|Overall Study|Adverse Event|1|||
124574676|NCT02883452|448064007|FG004|Overall Study|Adverse Event|1|||
124574677|NCT02883452|448064008|FG005|Overall Study|Adverse Event|3|||
124574678|NCT02883452|448064003|FG000|Overall Study|Physician Decision|0|||
124574679|NCT02883452|448064004|FG001|Overall Study|Physician Decision|0|||
124574680|NCT02883452|448064005|FG002|Overall Study|Physician Decision|0|||
124574681|NCT02883452|448064006|FG003|Overall Study|Physician Decision|0|||
124574682|NCT02883452|448064007|FG004|Overall Study|Physician Decision|4|||
124574683|NCT02883452|448064008|FG005|Overall Study|Physician Decision|1|||
124574684|NCT02883452|448064003|FG000|Overall Study|Death|1|||
124574685|NCT02883452|448064004|FG001|Overall Study|Death|0|||
124574686|NCT02883452|448064005|FG002|Overall Study|Death|1|||
124574687|NCT02883452|448064006|FG003|Overall Study|Death|0|||
124574688|NCT02883452|448064007|FG004|Overall Study|Death|0|||
124574689|NCT02883452|448064008|FG005|Overall Study|Death|0|||
124574690|NCT02883452|448064003|FG000|Overall Study|Other|0|||
124574691|NCT02883452|448064004|FG001|Overall Study|Other|0|||
124574692|NCT02883452|448064005|FG002|Overall Study|Other|0|||
124574693|NCT02883452|448064006|FG003|Overall Study|Other|0|||
124574694|NCT02883452|448064007|FG004|Overall Study|Other|0|||
124574695|NCT02883452|448064008|FG005|Overall Study|Other|1|||
124574696|NCT03447262|448064009|FG000|Overall Study|Adverse Event|7|||
124574697|NCT03447262|448064009|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
124574698|NCT03447262|448064009|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
124574699|NCT03447262|448064009|FG000|Overall Study|Death|2|||
124574700|NCT03447262|448064009|FG000|Overall Study|Study Termination by Sponsor|455|||
124574701|NCT03447262|448064009|FG000|Overall Study|Other|4|||
124574702|NCT00830206|448064010|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
124574703|NCT00830206|448064011|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
124574704|NCT00328926|448064012|FG000|Overall Study|Pregnancy|2|||
124574705|NCT00328926|448064013|FG001|Overall Study|Pregnancy|1|||
124574706|NCT00328926|448064014|FG002|Overall Study|Pregnancy|0|||
124574707|NCT00328926|448064012|FG000|Overall Study|Lost to Follow-up|0|||
124574708|NCT00328926|448064013|FG001|Overall Study|Lost to Follow-up|1|||
124574709|NCT00328926|448064014|FG002|Overall Study|Lost to Follow-up|0|||
124574710|NCT00328926|448064012|FG000|Overall Study|Death|0|||
124574711|NCT00328926|448064013|FG001|Overall Study|Death|0|||
124574712|NCT00328926|448064014|FG002|Overall Study|Death|1|||
124574713|NCT00328926|448064012|FG000|Overall Study|In vitro fertilization treatment|0|||
124574714|NCT00328926|448064013|FG001|Overall Study|In vitro fertilization treatment|0|||
124574715|NCT00328926|448064014|FG002|Overall Study|In vitro fertilization treatment|1|||
124574716|NCT00328926|448064012|FG000|Overall Study|Lack of ovarian response|0|||
124574717|NCT00328926|448064013|FG001|Overall Study|Lack of ovarian response|1|||
124574718|NCT00328926|448064014|FG002|Overall Study|Lack of ovarian response|0|||
124574719|NCT04123548|448064015|FG000|Overall Study|Withdrawal by Subject|1|||
124574720|NCT04123548|448064015|FG000|Overall Study|Lost to Follow-up|8|||
124574721|NCT04123548|448064015|FG000|Overall Study|Death|4|||
124574722|NCT04123548|448064015|FG000|Overall Study|Reason Not Specified|1|||
124574723|NCT01171989|448064016|FG000|Overall Study|Lost to Follow-up|0|||
124574724|NCT01171989|448064017|FG001|Overall Study|Lost to Follow-up|0|||
124574725|NCT01171989|448064018|FG002|Overall Study|Lost to Follow-up|1|||
124574726|NCT00418184|448064019|FG000|Double-blind Phase|Withdrawal by Subject|22|||
124574727|NCT00418184|448064020|FG001|Double-blind Phase|Withdrawal by Subject|9|||
124574728|NCT00418184|448064019|FG000|Double-blind Phase|Adverse Event|2|||
124574729|NCT00418184|448064020|FG001|Double-blind Phase|Adverse Event|1|||
124574730|NCT00418184|448064019|FG000|Double-blind Phase|Poor compliance|3|||
124574731|NCT00418184|448064020|FG001|Double-blind Phase|Poor compliance|1|||
124574732|NCT02300103|448064021|FG000|Overall Study|Lack of Efficacy|3|||
124574733|NCT02300103|448064021|FG000|Overall Study|Protocol Violation|1|||
124574734|NCT02300103|448064021|FG000|Overall Study|Withdrew Consent|2|||
124574735|NCT01015625|448064022|FG000|Overall Study|Lost to Follow-up|3|||
124574736|NCT01015625|448064023|FG001|Overall Study|Lost to Follow-up|1|||
124574737|NCT01015625|448064022|FG000|Overall Study|Withdrawal by Subject|2|||
124574738|NCT01015625|448064023|FG001|Overall Study|Withdrawal by Subject|3|||
124725153|NCT03989349|448613456|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
124574739|NCT01015625|448064022|FG000|Overall Study|Physician Decision|2|||
124574740|NCT01015625|448064023|FG001|Overall Study|Physician Decision|0|||
124574741|NCT01015625|448064022|FG000|Overall Study|Death|30|||
124574742|NCT01015625|448064023|FG001|Overall Study|Death|22|||
124574743|NCT01256684|448064024|FG000|Overall Study|Adverse Event|1|||
124574744|NCT01256684|448064025|FG001|Overall Study|Adverse Event|4|||
124574745|NCT01256684|448064026|FG002|Overall Study|Adverse Event|2|||
124574746|NCT01256684|448064024|FG000|Overall Study|Withdrawal by Subject|4|||
124574747|NCT01256684|448064025|FG001|Overall Study|Withdrawal by Subject|0|||
124574748|NCT01256684|448064026|FG002|Overall Study|Withdrawal by Subject|2|||
124574749|NCT01256684|448064024|FG000|Overall Study|Physician Decision|0|||
124574750|NCT01256684|448064025|FG001|Overall Study|Physician Decision|1|||
124725154|NCT03989349|448613457|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
124725155|NCT03989349|448613452|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
124725156|NCT03989349|448613453|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
124725157|NCT03989349|448613454|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
124725158|NCT03989349|448613455|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
124725159|NCT03989349|448613456|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
124725160|NCT03989349|448613457|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
124725161|NCT03989349|448613452|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
124725162|NCT03989349|448613453|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
124725163|NCT03989349|448613454|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
124725164|NCT03989349|448613455|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
124752797|NCT04427072|448716840|FG001|Randomized Treatment Phase|Adverse Event|1|||
124521096|NCT02371980|447859925|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
124521097|NCT02371980|447859926|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
124521098|NCT02371980|447859922|FG000|Open-label Period|Significant Protocol Deviation|19|||
124521099|NCT02371980|447859923|FG001|Open-label Period|Significant Protocol Deviation|0|||
124521100|NCT02371980|447859924|FG002|Open-label Period|Significant Protocol Deviation|0|||
124521101|NCT02371980|447859925|FG003|Open-label Period|Significant Protocol Deviation|0|||
124521102|NCT02371980|447859926|FG004|Open-label Period|Significant Protocol Deviation|0|||
124521103|NCT02371980|447859922|FG000|Open-label Period|Noncompliance with Study Drug|10|||
124521104|NCT02371980|447859923|FG001|Open-label Period|Noncompliance with Study Drug|0|||
124521105|NCT02371980|447859924|FG002|Open-label Period|Noncompliance with Study Drug|0|||
124521106|NCT02371980|447859925|FG003|Open-label Period|Noncompliance with Study Drug|0|||
124521107|NCT02371980|447859926|FG004|Open-label Period|Noncompliance with Study Drug|0|||
124521108|NCT02371980|447859922|FG000|Open-label Period|Lost to Follow-up|55|||
124521109|NCT02371980|447859923|FG001|Open-label Period|Lost to Follow-up|0|||
124521110|NCT02371980|447859924|FG002|Open-label Period|Lost to Follow-up|0|||
124521111|NCT02371980|447859925|FG003|Open-label Period|Lost to Follow-up|0|||
124521112|NCT02371980|447859926|FG004|Open-label Period|Lost to Follow-up|0|||
124521113|NCT02371980|447859922|FG000|Open-label Period|Voluntary Withdrawal|91|||
124521114|NCT02371980|447859923|FG001|Open-label Period|Voluntary Withdrawal|0|||
124521115|NCT02371980|447859924|FG002|Open-label Period|Voluntary Withdrawal|0|||
124521116|NCT02371980|447859925|FG003|Open-label Period|Voluntary Withdrawal|0|||
124521117|NCT02371980|447859926|FG004|Open-label Period|Voluntary Withdrawal|0|||
124521118|NCT02371980|447859922|FG000|Open-label Period|Pregnancy|1|||
124521119|NCT02371980|447859923|FG001|Open-label Period|Pregnancy|0|||
124521120|NCT02371980|447859924|FG002|Open-label Period|Pregnancy|0|||
124521121|NCT02371980|447859925|FG003|Open-label Period|Pregnancy|0|||
124521122|NCT02371980|447859926|FG004|Open-label Period|Pregnancy|0|||
124521123|NCT02371980|447859922|FG000|Open-label Period|Lack of Efficacy|116|||
124521124|NCT02371980|447859923|FG001|Open-label Period|Lack of Efficacy|0|||
124521125|NCT02371980|447859924|FG002|Open-label Period|Lack of Efficacy|0|||
124521126|NCT02371980|447859925|FG003|Open-label Period|Lack of Efficacy|0|||
124521127|NCT02371980|447859926|FG004|Open-label Period|Lack of Efficacy|0|||
124521128|NCT02371980|447859922|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
124521129|NCT02371980|447859923|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
124521130|NCT02371980|447859924|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
124521131|NCT02371980|447859925|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
124521132|NCT02371980|447859926|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
124521133|NCT02371980|447859922|FG000|Open-label Period|Reason not Specified|9|||
124521134|NCT02371980|447859923|FG001|Open-label Period|Reason not Specified|0|||
124521135|NCT02371980|447859924|FG002|Open-label Period|Reason not Specified|0|||
124521136|NCT02371980|447859925|FG003|Open-label Period|Reason not Specified|0|||
124521137|NCT02371980|447859926|FG004|Open-label Period|Reason not Specified|0|||
124521138|NCT02371980|447859922|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
124521139|NCT02371980|447859923|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
124521140|NCT02371980|447859924|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
124521141|NCT02371980|447859925|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
124521142|NCT02371980|447859926|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
124521143|NCT02371980|447859922|FG000|Double-blind Period|Significant Protocol Deviation|0|||
124521144|NCT02371980|447859923|FG001|Double-blind Period|Significant Protocol Deviation|2|||
124521145|NCT02371980|447859924|FG002|Double-blind Period|Significant Protocol Deviation|7|||
124521146|NCT02371980|447859925|FG003|Double-blind Period|Significant Protocol Deviation|3|||
124521147|NCT02371980|447859926|FG004|Double-blind Period|Significant Protocol Deviation|3|||
124521148|NCT02371980|447859922|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
124521149|NCT02371980|447859923|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
124521150|NCT02371980|447859924|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
124574751|NCT01256684|448064026|FG002|Overall Study|Physician Decision|0|||
124574752|NCT01256684|448064024|FG000|Overall Study|Lack of Efficacy|0|||
124574753|NCT01256684|448064025|FG001|Overall Study|Lack of Efficacy|1|||
124574754|NCT01256684|448064026|FG002|Overall Study|Lack of Efficacy|1|||
124574755|NCT01256684|448064024|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
124574756|NCT01256684|448064025|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
124574757|NCT01256684|448064026|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
124574758|NCT02674477|448064028|FG000|Overall Study|Protocol Violation|8|||
124574759|NCT02674477|448064029|FG001|Overall Study|Protocol Violation|2|||
124574760|NCT02098876|448064033|FG000|Overall Study|Withdrawal by Subject|5|||
124574761|NCT02098876|448064034|FG001|Overall Study|Withdrawal by Subject|5|||
124574762|NCT01061866|448064035|FG000|Overall Study|Adverse Event|2|||
124574763|NCT00772941|448064036|FG000|Overall Study|CRFs not available|195|||
124574764|NCT00772941|448064036|FG000|Overall Study|Study not completed|16|||
124574765|NCT00772941|448064036|FG000|Overall Study|Missed Visits|374|||
124574766|NCT00772941|448064036|FG000|Overall Study|Poor Compliance|7|||
124574767|NCT00772941|448064036|FG000|Overall Study|GPSP Violation|90|||
124574768|NCT04786184|448064037|FG000|Overall Study|Adverse Event|4|||
124574769|NCT04786184|448064038|FG001|Overall Study|Adverse Event|0|||
124574770|NCT04786184|448064037|FG000|Overall Study|Withdrawal by Subject|3|||
124574771|NCT04786184|448064038|FG001|Overall Study|Withdrawal by Subject|1|||
124574772|NCT04786184|448064037|FG000|Overall Study|Lost to Follow-up|4|||
124574773|NCT04786184|448064038|FG001|Overall Study|Lost to Follow-up|2|||
124574774|NCT00834756|448064039|FG000|First Intervention|Adverse Event|1|||
124574775|NCT00834756|448064040|FG001|First Intervention|Adverse Event|0|||
124574776|NCT00834756|448064039|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
124574777|NCT00834756|448064040|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
124574778|NCT01472341|448064041|FG000|Overall Study|Started insulin therapy|55|||
124574779|NCT01472341|448064041|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
124574780|NCT01472341|448064041|FG000|Overall Study|Withdrawal by Subject|39|||
124574781|NCT01472341|448064041|FG000|Overall Study|Lost to Follow-up|52|||
124574782|NCT01472341|448064041|FG000|Overall Study|Laboratory parameters unavailable|25|||
124574783|NCT01472341|448064041|FG000|Overall Study|Death|9|||
124725165|NCT03989349|448613456|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
124725166|NCT03989349|448613457|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
124574784|NCT04060147|448064049|FG000|Overall Study|Withdrew consent|1|||
124574785|NCT02057458|448064053|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
124574786|NCT02057458|448064054|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
124574787|NCT02057458|448064055|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
124574788|NCT02057458|448064053|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
124574789|NCT02057458|448064054|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
124574790|NCT02057458|448064055|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
124574791|NCT02057458|448064053|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
124574792|NCT02057458|448064054|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
124574793|NCT02057458|448064055|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
124574794|NCT01534520|448064056|FG000|Overall Study|Adverse Event|0|||
124574795|NCT01534520|448064057|FG001|Overall Study|Adverse Event|1|||
124574796|NCT02979353|448064060|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
124574797|NCT02979353|448064061|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
124574798|NCT02979353|448064060|FG000|Overall Study|Withdrawal by Subject|16|||
124574799|NCT02979353|448064061|FG001|Overall Study|Withdrawal by Subject|12|||
124574800|NCT02979353|448064060|FG000|Overall Study|Death|10|||
124574801|NCT02979353|448064061|FG001|Overall Study|Death|11|||
124574802|NCT02979353|448064060|FG000|Overall Study|Transfer to Hospice Care|19|||
124574803|NCT02979353|448064061|FG001|Overall Study|Transfer to Hospice Care|14|||
124574804|NCT02979353|448064060|FG000|Overall Study|Lost to Follow-up|1|||
124574805|NCT02979353|448064061|FG001|Overall Study|Lost to Follow-up|5|||
124574806|NCT01079988|448064062|FG000|Overall Study|Lost to Follow-up|0|||
124574807|NCT01079988|448064063|FG001|Overall Study|Lost to Follow-up|0|||
124574808|NCT01079988|448064064|FG002|Overall Study|Lost to Follow-up|0|||
124574809|NCT01079988|448064065|FG003|Overall Study|Lost to Follow-up|1|||
124574810|NCT01079988|448064066|FG004|Overall Study|Lost to Follow-up|0|||
124574811|NCT01079988|448064062|FG000|Overall Study|Lack of Efficacy|1|||
124574812|NCT01079988|448064063|FG001|Overall Study|Lack of Efficacy|0|||
124574813|NCT01079988|448064064|FG002|Overall Study|Lack of Efficacy|0|||
124574814|NCT01079988|448064065|FG003|Overall Study|Lack of Efficacy|0|||
124574815|NCT01079988|448064066|FG004|Overall Study|Lack of Efficacy|0|||
124574816|NCT01079988|448064062|FG000|Overall Study|Other|0|||
124574817|NCT01079988|448064063|FG001|Overall Study|Other|0|||
124574818|NCT01079988|448064064|FG002|Overall Study|Other|0|||
124574819|NCT01079988|448064065|FG003|Overall Study|Other|2|||
124574820|NCT01079988|448064066|FG004|Overall Study|Other|1|||
124574821|NCT00585689|448064067|FG000|Overall Study|Received different ABI-007 schedule|3|||
124574822|NCT00585689|448064067|FG000|Overall Study|Adverse Event|1|||
124574823|NCT00585689|448064067|FG000|Overall Study|Patient Declined Surgery|1|||
124574824|NCT00585689|448064067|FG000|Overall Study|Patient had unresectable disease|1|||
124574825|NCT00585689|448064067|FG000|Overall Study|Death|1|||
124574826|NCT00550537|448064068|FG000|Overall Study|Death|18|||
124574827|NCT00550537|448064068|FG000|Overall Study|Adverse Event|20|||
124574828|NCT00550537|448064068|FG000|Overall Study|Disease progression before|46|||
124574829|NCT00550537|448064068|FG000|Overall Study|Withdrawal by Subject|7|||
124574830|NCT00550537|448064068|FG000|Overall Study|Change in treatment plan|4|||
124574831|NCT00550537|448064068|FG000|Overall Study|Other complicating ilness|3|||
124574832|NCT00550537|448064068|FG000|Overall Study|Declining performance status|2|||
124574833|NCT00550537|448064068|FG000|Overall Study|Treated closer to home|4|||
124574834|NCT00268905|448064069|FG000|Overall Study|Adverse Event|3|||
124574835|NCT00268905|448064070|FG001|Overall Study|Adverse Event|0|||
124574836|NCT00268905|448064071|FG002|Overall Study|Adverse Event|4|||
124574837|NCT00268905|448064069|FG000|Overall Study|Lost to Follow-up|0|||
124574838|NCT00268905|448064070|FG001|Overall Study|Lost to Follow-up|1|||
124574839|NCT00268905|448064071|FG002|Overall Study|Lost to Follow-up|0|||
124574840|NCT00268905|448064069|FG000|Overall Study|Withdrawal by Subject|0|||
124574841|NCT00268905|448064070|FG001|Overall Study|Withdrawal by Subject|0|||
124574842|NCT00268905|448064071|FG002|Overall Study|Withdrawal by Subject|3|||
124574843|NCT00268905|448064069|FG000|Overall Study|Progressive Disease|28|||
124574844|NCT00268905|448064070|FG001|Overall Study|Progressive Disease|4|||
124574845|NCT00268905|448064071|FG002|Overall Study|Progressive Disease|3|||
124574846|NCT00268905|448064069|FG000|Overall Study|Physician Decision|3|||
124574847|NCT00268905|448064070|FG001|Overall Study|Physician Decision|0|||
124574848|NCT00268905|448064071|FG002|Overall Study|Physician Decision|1|||
124574849|NCT00268905|448064069|FG000|Overall Study|Clinical Progression|9|||
124574850|NCT00268905|448064070|FG001|Overall Study|Clinical Progression|4|||
124574851|NCT00268905|448064071|FG002|Overall Study|Clinical Progression|1|||
124574852|NCT00617305|448064072|FG000|Overall Study|Adverse Event|4|||
124574853|NCT00617305|448064073|FG001|Overall Study|Adverse Event|0|||
124574854|NCT00617305|448064074|FG002|Overall Study|Adverse Event|0|||
124574855|NCT00617305|448064072|FG000|Overall Study|Death|1|||
124574856|NCT00617305|448064073|FG001|Overall Study|Death|0|||
124574857|NCT00617305|448064074|FG002|Overall Study|Death|0|||
124574858|NCT00617305|448064072|FG000|Overall Study|Physician Decision|1|||
124574859|NCT00617305|448064073|FG001|Overall Study|Physician Decision|0|||
124574860|NCT00617305|448064074|FG002|Overall Study|Physician Decision|0|||
124574861|NCT00617305|448064072|FG000|Overall Study|Protocol Violation|1|||
124574862|NCT00617305|448064073|FG001|Overall Study|Protocol Violation|0|||
124574863|NCT00617305|448064074|FG002|Overall Study|Protocol Violation|1|||
124574864|NCT00617305|448064072|FG000|Overall Study|Withdrawal by Subject|1|||
124574865|NCT00617305|448064073|FG001|Overall Study|Withdrawal by Subject|0|||
124574866|NCT00617305|448064074|FG002|Overall Study|Withdrawal by Subject|0|||
124574867|NCT03459807|448064076|FG000|Overall Study|Withdrawal due to transplant|0|||
124574868|NCT03459807|448064077|FG001|Overall Study|Withdrawal due to transplant|1|||
124574869|NCT04510285|448064078|FG000|Overall Study|Death|1|||
124574870|NCT01406795|448064079|FG000|Overall Study|Withdrawal by Subject|1|||
124574871|NCT03897088|448064082|FG000|Overall Study|Withdrawal by Subject|12|||
124574872|NCT03897088|448064083|FG001|Overall Study|Withdrawal by Subject|12|||
124574873|NCT03897088|448064082|FG000|Overall Study|Lost to Follow-up|7|||
124574874|NCT03897088|448064083|FG001|Overall Study|Lost to Follow-up|15|||
124574875|NCT03897088|448064082|FG000|Overall Study|Sponsor Decision|1|||
124574876|NCT03897088|448064083|FG001|Overall Study|Sponsor Decision|2|||
124574877|NCT03897088|448064082|FG000|Overall Study|COVID-19|2|||
124574878|NCT03897088|448064083|FG001|Overall Study|COVID-19|0|||
124574879|NCT03897088|448064082|FG000|Overall Study|Other|3|||
124574880|NCT03897088|448064083|FG001|Overall Study|Other|0|||
124574881|NCT03897088|448064082|FG000|Overall Study|Non-compliance with Study Drug|1|||
124574882|NCT03897088|448064083|FG001|Overall Study|Non-compliance with Study Drug|1|||
124574883|NCT03897088|448064082|FG000|Overall Study|Pregnancy|0|||
124574884|NCT03897088|448064083|FG001|Overall Study|Pregnancy|1|||
124574885|NCT00855738|448064084|FG000|Overall Study|Lost to Follow-up|2|||
124574886|NCT00855738|448064084|FG000|Overall Study|Adverse Event|1|||
124574887|NCT00855738|448064084|FG000|Overall Study|Subject Defaulted|1|||
124574888|NCT00855738|448064084|FG000|Overall Study|Death|1|||
124574889|NCT02392000|448064087|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
124574890|NCT02392000|448064087|FG000|Overall Study|Withdrawal by Subject|1|||
124574891|NCT02392000|448064087|FG000|Overall Study|Lost to Follow-up|8|||
124574892|NCT04384978|448064088|FG000|Overall Study|Withdrawal by Subject|4|||
124574893|NCT04384978|448064089|FG001|Overall Study|Withdrawal by Subject|0|||
124574894|NCT03725605|448064090|FG000|Overall Study|Unsuccessful TIL expansion|2|||
124574895|NCT03555305|448064091|FG000|Period 1|Physician Decision|0|||
124574896|NCT03555305|448064092|FG001|Period 1|Physician Decision|1|||
124574897|NCT03555305|448064091|FG000|Period 1|Adverse Event|0|||
124574898|NCT03555305|448064092|FG001|Period 1|Adverse Event|1|||
124574899|NCT03586726|448064100|FG000|Overall Study|Withdrawal by Subject|1|||
124574900|NCT00965185|448064101|FG000|Overall Study|Lost to Follow-up|2|||
124574901|NCT00965185|448064102|FG001|Overall Study|Lost to Follow-up|0|||
124574902|NCT00965185|448064101|FG000|Overall Study|Withdrawal by Subject|0|||
124574903|NCT00965185|448064102|FG001|Overall Study|Withdrawal by Subject|1|||
124574904|NCT02100228|448064105|FG000|Overall Study|Other|19|||
124574905|NCT02100228|448064106|FG001|Overall Study|Other|19|||
124574906|NCT02100228|448064105|FG000|Overall Study|Administrative reason|0|||
124574907|NCT02100228|448064106|FG001|Overall Study|Administrative reason|1|||
124574908|NCT02100228|448064105|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
124574909|NCT02100228|448064106|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
124574910|NCT02100228|448064105|FG000|Overall Study|Non-compliance|0|||
124574911|NCT02100228|448064106|FG001|Overall Study|Non-compliance|3|||
124574912|NCT02100228|448064105|FG000|Overall Study|Lost to Follow-up|0|||
124574913|NCT02100228|448064106|FG001|Overall Study|Lost to Follow-up|1|||
124574914|NCT02100228|448064105|FG000|Overall Study|Withdrawal by Subject|27|||
124574915|NCT02100228|448064106|FG001|Overall Study|Withdrawal by Subject|37|||
124574916|NCT02100228|448064105|FG000|Overall Study|Adverse Event|16|||
124574917|NCT02100228|448064106|FG001|Overall Study|Adverse Event|12|||
124574918|NCT02100228|448064105|FG000|Overall Study|Death|1|||
124574919|NCT02100228|448064106|FG001|Overall Study|Death|1|||
124574920|NCT02216071|448064131|FG000|Overall Study|Withdrawal by Subject|7|||
124574921|NCT02216071|448064132|FG001|Overall Study|Withdrawal by Subject|2|||
124574922|NCT02216071|448064131|FG000|Overall Study|Lost to Follow-up|3|||
124574923|NCT02216071|448064132|FG001|Overall Study|Lost to Follow-up|3|||
124574924|NCT02216071|448064131|FG000|Overall Study|Protocol Violation|3|||
124574925|NCT02216071|448064132|FG001|Overall Study|Protocol Violation|5|||
124574926|NCT02216071|448064131|FG000|Overall Study|Other|2|||
124574927|NCT02216071|448064132|FG001|Overall Study|Other|2|||
124574928|NCT00389064|448064133|FG000|Overall Study|Adverse Event|11|||
124574929|NCT00389064|448064134|FG001|Overall Study|Adverse Event|3|||
124574930|NCT00389064|448064133|FG000|Overall Study|Lack of Efficacy|3|||
124574931|NCT00389064|448064134|FG001|Overall Study|Lack of Efficacy|14|||
124574932|NCT00389064|448064133|FG000|Overall Study|Withdrawal by Subject|17|||
124574933|NCT00389064|448064134|FG001|Overall Study|Withdrawal by Subject|27|||
124574934|NCT00389064|448064133|FG000|Overall Study|Physician Decision|2|||
124574935|NCT00389064|448064134|FG001|Overall Study|Physician Decision|2|||
124574936|NCT00389064|448064133|FG000|Overall Study|Lost to Follow-up|1|||
124574937|NCT00389064|448064134|FG001|Overall Study|Lost to Follow-up|2|||
124574938|NCT00389064|448064133|FG000|Overall Study|Protocol Violation|2|||
124574939|NCT00389064|448064134|FG001|Overall Study|Protocol Violation|0|||
124574940|NCT00389064|448064133|FG000|Overall Study|Multiple Reasons|9|||
124574941|NCT00389064|448064134|FG001|Overall Study|Multiple Reasons|11|||
124574942|NCT03707912|448064143|FG000|Overall Study|Violation of inclusion criteria|1|||
124574943|NCT03707912|448064144|FG001|Overall Study|Violation of inclusion criteria|0|||
124574944|NCT01811953|448065715|FG000|Overall Study|Adverse Event|0|||
124574945|NCT01811953|448065716|FG001|Overall Study|Adverse Event|0|||
124574946|NCT01811953|448065717|FG002|Overall Study|Adverse Event|0|||
124574947|NCT01811953|448065718|FG003|Overall Study|Adverse Event|1|||
124574948|NCT01811953|448065719|FG004|Overall Study|Adverse Event|0|||
124574949|NCT01811953|448065720|FG005|Overall Study|Adverse Event|1|||
124574950|NCT01811953|448065715|FG000|Overall Study|Protocol Violation|0|||
124574951|NCT01811953|448065716|FG001|Overall Study|Protocol Violation|0|||
124574952|NCT01811953|448065717|FG002|Overall Study|Protocol Violation|0|||
124574953|NCT01811953|448065718|FG003|Overall Study|Protocol Violation|0|||
124574954|NCT01811953|448065719|FG004|Overall Study|Protocol Violation|1|||
124574955|NCT01811953|448065720|FG005|Overall Study|Protocol Violation|0|||
124574956|NCT00371839|448065721|FG000|Overall Study|Death|4|||
124574957|NCT00371839|448065722|FG001|Overall Study|Death|0|||
124574958|NCT00371839|448065723|FG002|Overall Study|Death|0|||
124574959|NCT00371839|448065721|FG000|Overall Study|Withdrawal by Subject|7|||
124574960|NCT00371839|448065722|FG001|Overall Study|Withdrawal by Subject|4|||
124574961|NCT00371839|448065723|FG002|Overall Study|Withdrawal by Subject|0|||
124574962|NCT00371839|448065721|FG000|Overall Study|Lost to Follow-up|6|||
124574963|NCT00371839|448065722|FG001|Overall Study|Lost to Follow-up|3|||
124574964|NCT00371839|448065723|FG002|Overall Study|Lost to Follow-up|2|||
124574965|NCT01049334|448065724|FG000|Overall Study|Withdrawal by Subject|5|||
124574966|NCT01049334|448065725|FG001|Overall Study|Withdrawal by Subject|3|||
124574967|NCT01049334|448065724|FG000|Overall Study|Adverse Event|2|||
124574968|NCT01049334|448065725|FG001|Overall Study|Adverse Event|3|||
124574969|NCT01049334|448065724|FG000|Overall Study|Physician Decision|2|||
124574970|NCT01049334|448065725|FG001|Overall Study|Physician Decision|0|||
124574971|NCT01049334|448065724|FG000|Overall Study|Protocol Violation|0|||
124574972|NCT01049334|448065725|FG001|Overall Study|Protocol Violation|1|||
124574973|NCT00396279|448065726|FG000|Overall Study|Ongoing in study|26|||
124574974|NCT00396279|448065726|FG000|Overall Study|Disease progression|2|||
124574975|NCT00396279|448065726|FG000|Overall Study|Withdrawal by Subject|1|||
124574976|NCT00396279|448065726|FG000|Overall Study|Physician Decision|1|||
124574977|NCT00667095|448065734|FG000|Overall Study|Withdrawal by Subject|0|||
124574978|NCT00667095|448065735|FG001|Overall Study|Withdrawal by Subject|1|||
124574979|NCT00905346|448065739|FG000|Period 1|Withdrawal by Subject|1|||
124574980|NCT00905346|448065740|FG001|Period 1|Withdrawal by Subject|0|||
124574981|NCT03351335|448065741|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
124574982|NCT03351335|448065742|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
124574983|NCT03351335|448065743|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
124574984|NCT05612724|448065748|FG000|Overall Study|Lost to Follow-up|4|||
124574985|NCT04000815|448065751|FG000|Overall Study|Lost to Follow-up|9|||
124574986|NCT04000815|448065752|FG001|Overall Study|Lost to Follow-up|2|||
124574987|NCT04000815|448065753|FG002|Overall Study|Lost to Follow-up|3|||
124574988|NCT04000815|448065751|FG000|Overall Study|Withdrawal by Subject|4|||
124574989|NCT04000815|448065752|FG001|Overall Study|Withdrawal by Subject|3|||
124574990|NCT04000815|448065753|FG002|Overall Study|Withdrawal by Subject|2|||
124574991|NCT04000815|448065751|FG000|Overall Study|Right ovarian cyst occured|1|||
124574992|NCT04000815|448065752|FG001|Overall Study|Right ovarian cyst occured|0|||
124574993|NCT04000815|448065753|FG002|Overall Study|Right ovarian cyst occured|0|||
124574994|NCT04000815|448065751|FG000|Overall Study|Hypertension occured on follow up|0|||
124574995|NCT04000815|448065752|FG001|Overall Study|Hypertension occured on follow up|0|||
124574996|NCT04000815|448065753|FG002|Overall Study|Hypertension occured on follow up|2|||
124574997|NCT00239577|448065754|FG000|Primary Phase|Adverse Event|0|||
124574998|NCT00239577|448065755|FG001|Primary Phase|Adverse Event|0|||
124574999|NCT00239577|448065756|FG002|Primary Phase|Adverse Event|1|||
124575000|NCT00239577|448065757|FG003|Primary Phase|Adverse Event|0|||
124575001|NCT00239577|448065754|FG000|Primary Phase|Other|5|||
124575002|NCT00239577|448065755|FG001|Primary Phase|Other|3|||
124575003|NCT00239577|448065756|FG002|Primary Phase|Other|2|||
124575004|NCT00239577|448065757|FG003|Primary Phase|Other|0|||
124575005|NCT02736721|448065760|FG000|Overall Study|Adverse Event|8|||
124575006|NCT02736721|448065760|FG000|Overall Study|Lost to Follow-up|3|||
124575007|NCT02736721|448065760|FG000|Overall Study|Other|5|||
124575008|NCT03988803|448065761|FG000|Period 2|Prematurely discontinued from medication|2|||
124575009|NCT03988803|448065761|FG000|Period 2|Adverse Event|1|||
124575010|NCT03021018|448065764|FG000|Overall Study|Adverse Event|1|||
124575011|NCT03021018|448065765|FG001|Overall Study|Adverse Event|0|||
124575012|NCT03021018|448065766|FG002|Overall Study|Adverse Event|0|||
124575013|NCT03021018|448065764|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
124575014|NCT03021018|448065765|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
124575015|NCT03021018|448065766|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
124575016|NCT02269657|448065779|FG000|Overall Study|Protocol Violation|3|||
124575017|NCT00620074|448065780|FG000|Overall Study|Adverse Event|1|||
124575018|NCT03450057|448065781|FG000|Overall Study|Death|17|||
124575019|NCT03450057|448065781|FG000|Overall Study|ICF withdrawal|4|||
124575020|NCT03450057|448065781|FG000|Overall Study|Lost to Follow-up|2|||
124575021|NCT01838941|448065782|FG000|Overall Study|Adverse Event|1|||
124575022|NCT01838941|448065782|FG000|Overall Study|Withdrawal by Subject|1|||
124575023|NCT02822235|448065783|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
124575024|NCT02822235|448065784|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
124575025|NCT02822235|448065783|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
124575026|NCT02822235|448065784|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
124575027|NCT02822235|448065783|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
124575028|NCT02822235|448065784|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
124575029|NCT02822235|448065783|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
124575030|NCT02822235|448065784|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
124575031|NCT02822235|448065783|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
124575032|NCT02822235|448065784|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
124575033|NCT02822235|448065783|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
124575034|NCT02822235|448065784|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
124575035|NCT03214952|448065785|FG000|Overall Study|Protocol Deviation|45|||
124575036|NCT03214952|448065785|FG000|Overall Study|Case Report Forms Uncollected|13|||
124575037|NCT02246166|448065788|FG000|Overall Study|Protocol Violation|1|||
124575038|NCT02246166|448065789|FG001|Overall Study|Protocol Violation|0|||
124575039|NCT03769896|448065790|FG000|Open-label Phase|Lack of Efficacy|5|||
124575040|NCT03769896|448065791|FG001|Open-label Phase|Lack of Efficacy|0|||
124575041|NCT03769896|448065790|FG000|Open-label Phase|Adverse Event|3|||
124575042|NCT03769896|448065791|FG001|Open-label Phase|Adverse Event|0|||
124575043|NCT03769896|448065790|FG000|Open-label Phase|Withdrawal by Subject|1|||
124575044|NCT03769896|448065791|FG001|Open-label Phase|Withdrawal by Subject|0|||
124575045|NCT00377260|448065792|FG000|Overall Study|Lost to Follow-up|0|||
124575046|NCT00377260|448065793|FG001|Overall Study|Lost to Follow-up|1|||
124575047|NCT00377260|448065792|FG000|Overall Study|Withdrawal by Subject|2|||
124575048|NCT00377260|448065793|FG001|Overall Study|Withdrawal by Subject|4|||
124575049|NCT00829530|448065794|FG000|First Intervention|Adverse Event|0|||
124575050|NCT00829530|448065795|FG001|First Intervention|Adverse Event|1|||
124575051|NCT00829530|448065794|FG000|First Intervention|Intolerance to Venopuncture|0|||
124575052|NCT00829530|448065795|FG001|First Intervention|Intolerance to Venopuncture|1|||
124575053|NCT00829530|448065794|FG000|Second Intervention|Intolerance to Venopuncture|1|||
124575054|NCT00829530|448065795|FG001|Second Intervention|Intolerance to Venopuncture|0|||
124575055|NCT04112823|448065798|FG000|Overall Study|Lost to Follow-up|2|||
124575056|NCT04112823|448065799|FG001|Overall Study|Lost to Follow-up|3|||
124575057|NCT00625443|448065800|FG000|Overall Study|Adverse Event|1|||
124575058|NCT00625443|448065801|FG001|Overall Study|Adverse Event|4|||
124575059|NCT00625443|448065802|FG002|Overall Study|Adverse Event|0|||
124575060|NCT00625443|448065800|FG000|Overall Study|Non-compliance with protocol|0|||
124575061|NCT00625443|448065801|FG001|Overall Study|Non-compliance with protocol|1|||
124575062|NCT00625443|448065802|FG002|Overall Study|Non-compliance with protocol|0|||
124575063|NCT00625443|448065800|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
124575064|NCT00625443|448065801|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
124575065|NCT00625443|448065802|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
124575066|NCT00625443|448065800|FG000|Overall Study|Withdrawal by Subject|0|||
124575067|NCT00625443|448065801|FG001|Overall Study|Withdrawal by Subject|1|||
124575068|NCT00625443|448065802|FG002|Overall Study|Withdrawal by Subject|2|||
124575069|NCT00625443|448065800|FG000|Overall Study|Physician Decision|0|||
124575070|NCT00625443|448065801|FG001|Overall Study|Physician Decision|4|||
124575071|NCT00625443|448065802|FG002|Overall Study|Physician Decision|2|||
124575072|NCT00625443|448065800|FG000|Overall Study|Other|0|||
124575073|NCT00625443|448065801|FG001|Overall Study|Other|1|||
124575074|NCT00625443|448065802|FG002|Overall Study|Other|1|||
124575075|NCT02678286|448065807|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
124575076|NCT02678286|448065808|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
124575077|NCT02678286|448065807|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
124575078|NCT02678286|448065808|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
124575079|NCT02678286|448065807|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
124725167|NCT03989349|448613452|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
124725168|NCT03989349|448613453|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
124725169|NCT03989349|448613454|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
124725170|NCT03989349|448613455|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
124725171|NCT03989349|448613456|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
124725172|NCT03989349|448613457|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
124725173|NCT03989349|448613452|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
124725174|NCT03989349|448613453|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
124725175|NCT03989349|448613454|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
124725176|NCT03989349|448613455|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
124575080|NCT02678286|448065808|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
124575081|NCT02678286|448065807|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
124575082|NCT02678286|448065808|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
124575083|NCT02678286|448065807|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
124575084|NCT02678286|448065808|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
124575085|NCT01422538|448065811|FG000|Overall Study|Lost to Follow-up|0|||
124575086|NCT01422538|448065812|FG001|Overall Study|Lost to Follow-up|1|||
124575087|NCT01422538|448065813|FG002|Overall Study|Lost to Follow-up|1|||
124575088|NCT01422538|448065811|FG000|Overall Study|Missed visit|0|||
124575089|NCT01422538|448065812|FG001|Overall Study|Missed visit|1|||
124575090|NCT01422538|448065813|FG002|Overall Study|Missed visit|1|||
124575091|NCT01270503|448065814|FG000|Overall Study|Lost to Follow-up|1|||
124575092|NCT02481830|448065818|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
124575093|NCT02481830|448065819|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
124575094|NCT02481830|448065818|FG000|Pre-treatment|Withdrawal by Subject|0|||
124575095|NCT02481830|448065819|FG001|Pre-treatment|Withdrawal by Subject|10|||
124575096|NCT02481830|448065818|FG000|Pre-treatment|Disease Progression|1|||
124575097|NCT02481830|448065819|FG001|Pre-treatment|Disease Progression|1|||
124575098|NCT02481830|448065818|FG000|Pre-treatment|Other reasons|0|||
124575099|NCT02481830|448065819|FG001|Pre-treatment|Other reasons|1|||
124575100|NCT02481830|448065818|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
124575101|NCT02481830|448065819|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
124575102|NCT02481830|448065818|FG000|Treatment|Disease Progression|233|||
124575103|NCT02481830|448065819|FG001|Treatment|Disease Progression|171|||
124575104|NCT02481830|448065818|FG000|Treatment|Study drug toxicity|18|||
124575105|NCT02481830|448065819|FG001|Treatment|Study drug toxicity|38|||
124575106|NCT02481830|448065818|FG000|Treatment|Death|1|||
124575107|NCT02481830|448065819|FG001|Treatment|Death|1|||
124575108|NCT02481830|448065818|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
124575109|NCT02481830|448065819|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
124725177|NCT03989349|448613456|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
124575110|NCT02481830|448065818|FG000|Treatment|Participants request to discontinue Study treatment|6|||
124575111|NCT02481830|448065819|FG001|Treatment|Participants request to discontinue Study treatment|34|||
124575112|NCT02481830|448065818|FG000|Treatment|Withdrawal by Subject|2|||
124575113|NCT02481830|448065819|FG001|Treatment|Withdrawal by Subject|3|||
124575114|NCT02481830|448065818|FG000|Treatment|Lost to Follow-up|1|||
124575115|NCT02481830|448065819|FG001|Treatment|Lost to Follow-up|0|||
124575116|NCT02481830|448065818|FG000|Treatment|Maximum Clinical Benefit|0|||
124575117|NCT02481830|448065819|FG001|Treatment|Maximum Clinical Benefit|5|||
124575118|NCT02481830|448065818|FG000|Treatment|Administrative reason by sponsor|1|||
124575119|NCT02481830|448065819|FG001|Treatment|Administrative reason by sponsor|1|||
124575120|NCT02481830|448065818|FG000|Treatment|Other reasons|6|||
124725178|NCT03989349|448613457|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
124725179|NCT03989349|448613452|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
124725180|NCT03989349|448613453|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
124725181|NCT03989349|448613454|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
124725182|NCT03989349|448613455|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
124725183|NCT03989349|448613456|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
124575121|NCT02481830|448065819|FG001|Treatment|Other reasons|1|||
124575122|NCT04627038|448065820|FG000|Overall Study|Adverse Event|36|||
124575123|NCT04627038|448065821|FG001|Overall Study|Adverse Event|8|||
124575124|NCT04627038|448065820|FG000|Overall Study|Lost to Follow-up|1|||
124575125|NCT04627038|448065821|FG001|Overall Study|Lost to Follow-up|0|||
124575126|NCT04627038|448065820|FG000|Overall Study|Physician Decision|0|||
124575127|NCT04627038|448065821|FG001|Overall Study|Physician Decision|1|||
124575128|NCT04627038|448065820|FG000|Overall Study|Protocol Violation|3|||
124575129|NCT04627038|448065821|FG001|Overall Study|Protocol Violation|1|||
124575130|NCT04627038|448065820|FG000|Overall Study|Withdrawal by Subject|13|||
124575131|NCT04627038|448065821|FG001|Overall Study|Withdrawal by Subject|3|||
124575132|NCT04627038|448065820|FG000|Overall Study|Non-compliance with study drug|0|||
124575133|NCT04627038|448065821|FG001|Overall Study|Non-compliance with study drug|1|||
124575134|NCT04627038|448065820|FG000|Overall Study|Prohibited Concomitant Medication|1|||
124575135|NCT04627038|448065821|FG001|Overall Study|Prohibited Concomitant Medication|0|||
124575136|NCT03956862|448065826|FG000|Overall Study|Lost to Follow-up|1|||
124575137|NCT03956862|448065827|FG001|Overall Study|Lost to Follow-up|1|||
124575138|NCT03956862|448065826|FG000|Overall Study|Withdrawal by Subject|1|||
124575139|NCT03956862|448065827|FG001|Overall Study|Withdrawal by Subject|1|||
124575140|NCT01363765|448065831|FG000|Overall Study|non-diagnostic|2621|||
124575141|NCT01363765|448065832|FG001|Overall Study|non-diagnostic|1124|||
124575142|NCT01363765|448065831|FG000|Overall Study|duplicate records|736|||
124575143|NCT01363765|448065832|FG001|Overall Study|duplicate records|3177|||
124575144|NCT01363765|448065831|FG000|Overall Study|non-resident|156|||
124575145|NCT01363765|448065832|FG001|Overall Study|non-resident|76|||
124575146|NCT01363765|448065831|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
124575147|NCT01363765|448065832|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
124575148|NCT01363765|448065831|FG000|Overall Study|smear during intervention|2170|||
124575149|NCT01363765|448065832|FG001|Overall Study|smear during intervention|0|||
124575150|NCT02601560|448065835|FG000|Overall Study|Other|0|||
124575151|NCT02601560|448065836|FG001|Overall Study|Other|0|||
124575152|NCT02601560|448065837|FG002|Overall Study|Other|0|||
124575153|NCT02601560|448065838|FG003|Overall Study|Other|0|||
124575154|NCT02601560|448065839|FG004|Overall Study|Other|0|||
124575155|NCT02601560|448065840|FG005|Overall Study|Other|0|||
124575156|NCT02601560|448065841|FG006|Overall Study|Other|1|||
124575157|NCT02601560|448065842|FG007|Overall Study|Other|0|||
124575158|NCT03500692|448065843|FG000|Overall Study|Death|163|||
124575159|NCT03500692|448065843|FG000|Overall Study|Lost to Follow-up|75|||
124575160|NCT03500692|448065843|FG000|Overall Study|Termination Reasons|3|||
124575161|NCT01880593|448065844|FG000|Overall Study|Adverse Event|1|||
124575162|NCT01880593|448065845|FG001|Overall Study|Adverse Event|0|||
124575163|NCT01880593|448065844|FG000|Overall Study|Lack of Efficacy|1|||
124575164|NCT01880593|448065845|FG001|Overall Study|Lack of Efficacy|5|||
124575165|NCT01880593|448065844|FG000|Overall Study|Withdrawal by Subject|6|||
124575166|NCT01880593|448065845|FG001|Overall Study|Withdrawal by Subject|1|||
124575167|NCT02272777|448065846|FG000|Overall Study|Adverse Event|0|||
124575168|NCT02272777|448065847|FG001|Overall Study|Adverse Event|1|||
124575169|NCT02272777|448065846|FG000|Overall Study|Withdrawal by Subject|0|||
124725184|NCT03989349|448613457|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
124575170|NCT02272777|448065847|FG001|Overall Study|Withdrawal by Subject|3|||
124575171|NCT02272777|448065846|FG000|Overall Study|Lost to Follow-up|2|||
124575172|NCT02272777|448065847|FG001|Overall Study|Lost to Follow-up|0|||
124575173|NCT02272777|448065846|FG000|Overall Study|Other|2|||
124575174|NCT02272777|448065847|FG001|Overall Study|Other|0|||
124575175|NCT02066922|448065848|FG000|Overall Study|Adverse Event|1|||
124575176|NCT05275205|448065849|FG000|Overall Study|Adverse Event|1|||
124575177|NCT05275205|448065850|FG001|Overall Study|Adverse Event|2|||
124575178|NCT05275205|448065849|FG000|Overall Study|Physician Decision|1|||
124575179|NCT05275205|448065850|FG001|Overall Study|Physician Decision|1|||
124575180|NCT05275205|448065849|FG000|Overall Study|Withdrawal by Subject|2|||
124575181|NCT05275205|448065850|FG001|Overall Study|Withdrawal by Subject|3|||
124725185|NCT03989349|448613452|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
124725186|NCT03989349|448613453|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
124575182|NCT05275205|448065849|FG000|Overall Study|Death|1|||
124575183|NCT05275205|448065850|FG001|Overall Study|Death|0|||
124575184|NCT05275205|448065849|FG000|Overall Study|Patient unable to attend visits|1|||
124575185|NCT05275205|448065850|FG001|Overall Study|Patient unable to attend visits|0|||
124575186|NCT00440297|448065851|FG000|Overall Study|Adverse Event|8|||
124575187|NCT00440297|448065852|FG001|Overall Study|Adverse Event|5|||
124575188|NCT00440297|448065851|FG000|Overall Study|Lost to Follow-up|1|||
124575189|NCT00440297|448065852|FG001|Overall Study|Lost to Follow-up|0|||
124725187|NCT03989349|448613454|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
124725188|NCT03989349|448613455|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
124725189|NCT03989349|448613456|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
124725190|NCT03989349|448613457|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
124725191|NCT03989349|448613452|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
124725192|NCT03989349|448613453|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
124725193|NCT03989349|448613454|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
124725194|NCT03989349|448613455|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
124725195|NCT03989349|448613456|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
124725196|NCT03989349|448613457|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
124725197|NCT03989349|448613452|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
124725198|NCT03989349|448613453|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
124725199|NCT03989349|448613454|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
124725200|NCT03989349|448613455|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
124725201|NCT03989349|448613456|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
124725202|NCT03989349|448613457|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
124725203|NCT03989349|448613452|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
124725204|NCT03989349|448613453|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
124725205|NCT03989349|448613454|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
124725206|NCT03989349|448613455|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
124725207|NCT03989349|448613456|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
124725208|NCT03989349|448613457|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
124725209|NCT03989349|448613452|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
124725210|NCT03989349|448613453|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
124725211|NCT03989349|448613454|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
124725212|NCT03989349|448613455|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
124725213|NCT03989349|448613456|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
124725214|NCT03989349|448613457|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
124725215|NCT01352221|448613458|FG000|Double-blind Phase|Adverse Event|6|||
124725216|NCT01352221|448613459|FG001|Double-blind Phase|Adverse Event|4|||
124725217|NCT01352221|448613460|FG002|Double-blind Phase|Adverse Event|0|||
124725218|NCT01352221|448613461|FG003|Double-blind Phase|Adverse Event|0|||
124725219|NCT01352221|448613458|FG000|Double-blind Phase|Withdrawal by Subject|3|||
124725220|NCT01352221|448613459|FG001|Double-blind Phase|Withdrawal by Subject|5|||
124725221|NCT01352221|448613460|FG002|Double-blind Phase|Withdrawal by Subject|0|||
124725222|NCT01352221|448613461|FG003|Double-blind Phase|Withdrawal by Subject|0|||
124725223|NCT01352221|448613458|FG000|Double-blind Phase|Lost to Follow-up|0|||
124725224|NCT01352221|448613459|FG001|Double-blind Phase|Lost to Follow-up|1|||
124725225|NCT01352221|448613460|FG002|Double-blind Phase|Lost to Follow-up|0|||
124725226|NCT01352221|448613461|FG003|Double-blind Phase|Lost to Follow-up|0|||
124575190|NCT00440297|448065851|FG000|Overall Study|Physician Decision|1|||
124575191|NCT00440297|448065852|FG001|Overall Study|Physician Decision|0|||
124575192|NCT00440297|448065851|FG000|Overall Study|Protocol Violation|11|||
124575193|NCT00440297|448065852|FG001|Overall Study|Protocol Violation|7|||
124575194|NCT00440297|448065851|FG000|Overall Study|Withdrawal by Subject|1|||
124575195|NCT00440297|448065852|FG001|Overall Study|Withdrawal by Subject|6|||
124575196|NCT00440297|448065851|FG000|Overall Study|Randomized by mistake|1|||
124575197|NCT00440297|448065852|FG001|Overall Study|Randomized by mistake|0|||
124575198|NCT02039908|448065855|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
124575199|NCT02039908|448065856|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
124575200|NCT02039908|448065857|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
124575201|NCT02039908|448065858|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
124725227|NCT01352221|448613458|FG000|Double-blind Phase|Protocol Violation|0|||
124725228|NCT01352221|448613459|FG001|Double-blind Phase|Protocol Violation|1|||
124725229|NCT01352221|448613460|FG002|Double-blind Phase|Protocol Violation|0|||
124725230|NCT01352221|448613461|FG003|Double-blind Phase|Protocol Violation|0|||
124725231|NCT01352221|448613458|FG000|Open-label Phase|Physician Decision|0|||
124725232|NCT01352221|448613459|FG001|Open-label Phase|Physician Decision|0|||
124725233|NCT01352221|448613460|FG002|Open-label Phase|Physician Decision|2|||
124725234|NCT01352221|448613461|FG003|Open-label Phase|Physician Decision|1|||
124725235|NCT01352221|448613458|FG000|Open-label Phase|Pregnancy|0|||
124725236|NCT01352221|448613459|FG001|Open-label Phase|Pregnancy|0|||
124725237|NCT01352221|448613460|FG002|Open-label Phase|Pregnancy|1|||
124725238|NCT01352221|448613461|FG003|Open-label Phase|Pregnancy|0|||
124725239|NCT01352221|448613458|FG000|Open-label Phase|Adverse Event|0|||
124725240|NCT01352221|448613459|FG001|Open-label Phase|Adverse Event|0|||
124725241|NCT01352221|448613460|FG002|Open-label Phase|Adverse Event|8|||
124725242|NCT01352221|448613461|FG003|Open-label Phase|Adverse Event|4|||
124725243|NCT01352221|448613458|FG000|Open-label Phase|Withdrawal by Subject|0|||
124725244|NCT01352221|448613459|FG001|Open-label Phase|Withdrawal by Subject|0|||
124725245|NCT01352221|448613460|FG002|Open-label Phase|Withdrawal by Subject|1|||
124575202|NCT02039908|448065855|FG000|Phase 1-Summer|Protocol Violation|6|||
124575203|NCT02039908|448065856|FG001|Phase 1-Summer|Protocol Violation|0|||
124575204|NCT02039908|448065857|FG002|Phase 1-Summer|Protocol Violation|0|||
124575205|NCT02039908|448065858|FG003|Phase 1-Summer|Protocol Violation|0|||
124575206|NCT02039908|448065855|FG000|Phase 2-School Year|Lost to Follow-up|0|||
124575207|NCT02039908|448065856|FG001|Phase 2-School Year|Lost to Follow-up|0|||
124575208|NCT02039908|448065857|FG002|Phase 2-School Year|Lost to Follow-up|1|||
124575209|NCT02039908|448065858|FG003|Phase 2-School Year|Lost to Follow-up|3|||
124575210|NCT02039908|448065855|FG000|Phase 2-School Year|Protocol Violation|0|||
124575211|NCT02039908|448065856|FG001|Phase 2-School Year|Protocol Violation|0|||
124575212|NCT02039908|448065857|FG002|Phase 2-School Year|Protocol Violation|3|||
124575213|NCT02039908|448065858|FG003|Phase 2-School Year|Protocol Violation|0|||
124575214|NCT02039908|448065855|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
124575215|NCT02039908|448065856|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
124575216|NCT02039908|448065857|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
124575217|NCT02039908|448065858|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
124575218|NCT01802320|448065859|FG000|Overall Study|Death|1|||
124575219|NCT01802320|448065859|FG000|Overall Study|Withdrawal by Subject|1|||
124575220|NCT01066143|448067176|FG000|Overall Study|ineligible for the study|8|||
124575221|NCT05376319|448067177|FG000|Overall Study|Funding termination|2|||
124575222|NCT05376319|448067178|FG001|Overall Study|Funding termination|4|||
124575223|NCT00942968|448067179|FG000|Overall Study|Adverse Event|60|||
124575224|NCT00942968|448067179|FG000|Overall Study|Death|76|||
124575225|NCT00942968|448067179|FG000|Overall Study|Protocol Violation|9|||
124575226|NCT00942968|448067179|FG000|Overall Study|Lost to Follow-up|4|||
124575227|NCT00942968|448067179|FG000|Overall Study|Withdrawal by Subject|44|||
124575228|NCT00942968|448067179|FG000|Overall Study|Sponsor request|5|||
124575229|NCT00942968|448067179|FG000|Overall Study|Physician Decision|11|||
124575230|NCT00942968|448067179|FG000|Overall Study|Progression of disease|12|||
124575231|NCT00942968|448067179|FG000|Overall Study|Inferior vena cava filter placement|4|||
124575232|NCT00942968|448067179|FG000|Overall Study|Pulmonary embolism (PE)|1|||
124575233|NCT00942968|448067179|FG000|Overall Study|Participant required pancreatic biopsy|1|||
124575234|NCT00942968|448067179|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
124575235|NCT01466166|448067182|FG000|Overall Study|Death|1|||
124575236|NCT01466166|448067182|FG000|Overall Study|Lost to Follow-up|7|||
124575237|NCT01466166|448067182|FG000|Overall Study|Infusion Reaction (IR)|27|||
124575238|NCT01466166|448067182|FG000|Overall Study|Adverse Event (Other than IR)|11|||
124575239|NCT01466166|448067182|FG000|Overall Study|Elevated Serum Uric Acid|78|||
124575240|NCT01466166|448067182|FG000|Overall Study|Withdrawal by Subject|13|||
124575241|NCT01466166|448067182|FG000|Overall Study|Sponsor Decision|4|||
124575242|NCT01466166|448067182|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
124575243|NCT01466166|448067182|FG000|Overall Study|Other|20|||
124575244|NCT01340495|448067185|FG000|Overall Study|Withdrawal by Subject|1|||
124575245|NCT00667862|448067188|FG000|Overall Study|Adverse Event|9|||
124575246|NCT00667862|448067188|FG000|Overall Study|Death|1|||
124575247|NCT00667862|448067188|FG000|Overall Study|Disease Progression|22|||
124575248|NCT00667862|448067188|FG000|Overall Study|Withdrawal by Subject|3|||
124575249|NCT02495857|448067190|FG000|Overall Study|Adverse Event|5|||
124575250|NCT02495857|448067191|FG001|Overall Study|Adverse Event|0|||
124575251|NCT02495857|448067192|FG002|Overall Study|Adverse Event|1|||
124575252|NCT02495857|448067190|FG000|Overall Study|Withdrawal by Subject|9|||
124575253|NCT02495857|448067191|FG001|Overall Study|Withdrawal by Subject|6|||
124575254|NCT02495857|448067192|FG002|Overall Study|Withdrawal by Subject|10|||
124575255|NCT02495857|448067190|FG000|Overall Study|Physician Decision|0|||
124725246|NCT01352221|448613461|FG003|Open-label Phase|Withdrawal by Subject|6|||
124725247|NCT01352221|448613458|FG000|Open-label Phase|Worsening of IBD|0|||
124725248|NCT01352221|448613459|FG001|Open-label Phase|Worsening of IBD|0|||
124725249|NCT01352221|448613460|FG002|Open-label Phase|Worsening of IBD|1|||
124725250|NCT01352221|448613461|FG003|Open-label Phase|Worsening of IBD|0|||
124575256|NCT02495857|448067191|FG001|Overall Study|Physician Decision|1|||
124575257|NCT02495857|448067192|FG002|Overall Study|Physician Decision|0|||
124575258|NCT02495857|448067190|FG000|Overall Study|Protocol Violation|1|||
124575259|NCT02495857|448067191|FG001|Overall Study|Protocol Violation|1|||
124575260|NCT02495857|448067192|FG002|Overall Study|Protocol Violation|2|||
124575261|NCT02495857|448067190|FG000|Overall Study|Lost to Follow-up|4|||
124575262|NCT02495857|448067191|FG001|Overall Study|Lost to Follow-up|5|||
124575263|NCT02495857|448067192|FG002|Overall Study|Lost to Follow-up|3|||
124575264|NCT02495857|448067190|FG000|Overall Study|Other|3|||
124575265|NCT02495857|448067191|FG001|Overall Study|Other|3|||
124575266|NCT02495857|448067192|FG002|Overall Study|Other|2|||
124575267|NCT01435265|448067194|FG000|Overall Study|Lost to Follow-up|0|||
124575268|NCT01435265|448067195|FG001|Overall Study|Lost to Follow-up|1|||
124575269|NCT04605094|448067196|FG000|Overall Study|Adverse Event|2|||
124575270|NCT04605094|448067197|FG001|Overall Study|Adverse Event|2|||
124575271|NCT04605094|448067196|FG000|Overall Study|Lost to Follow-up|1|||
124575272|NCT04605094|448067197|FG001|Overall Study|Lost to Follow-up|4|||
124725251|NCT02016716|448613462|FG000|Overall Study|Withdrawal by Subject|5|||
124725252|NCT02016716|448613463|FG001|Overall Study|Withdrawal by Subject|5|||
124575273|NCT04605094|448067196|FG000|Overall Study|Physician Decision|2|||
124521151|NCT02371980|447859925|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
124521152|NCT02371980|447859926|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
124521153|NCT02371980|447859922|FG000|Double-blind Period|Lost to Follow-up|0|||
124521154|NCT02371980|447859923|FG001|Double-blind Period|Lost to Follow-up|8|||
124521155|NCT02371980|447859924|FG002|Double-blind Period|Lost to Follow-up|8|||
124521156|NCT02371980|447859925|FG003|Double-blind Period|Lost to Follow-up|6|||
124521157|NCT02371980|447859926|FG004|Double-blind Period|Lost to Follow-up|5|||
124521158|NCT02371980|447859922|FG000|Double-blind Period|Voluntary Withdrawal|0|||
124521159|NCT02371980|447859923|FG001|Double-blind Period|Voluntary Withdrawal|12|||
124521160|NCT02371980|447859924|FG002|Double-blind Period|Voluntary Withdrawal|8|||
124521161|NCT02371980|447859925|FG003|Double-blind Period|Voluntary Withdrawal|9|||
124521162|NCT02371980|447859926|FG004|Double-blind Period|Voluntary Withdrawal|11|||
124521163|NCT02371980|447859922|FG000|Double-blind Period|Relapse|0|||
124521164|NCT02371980|447859923|FG001|Double-blind Period|Relapse|50|||
124521165|NCT02371980|447859924|FG002|Double-blind Period|Relapse|25|||
124521166|NCT02371980|447859925|FG003|Double-blind Period|Relapse|25|||
124521167|NCT02371980|447859926|FG004|Double-blind Period|Relapse|26|||
124521168|NCT02371980|447859922|FG000|Double-blind Period|Reason not Specified|0|||
124521169|NCT02371980|447859923|FG001|Double-blind Period|Reason not Specified|3|||
124521170|NCT02371980|447859924|FG002|Double-blind Period|Reason not Specified|3|||
124521171|NCT02371980|447859925|FG003|Double-blind Period|Reason not Specified|2|||
124521172|NCT02371980|447859926|FG004|Double-blind Period|Reason not Specified|1|||
124521173|NCT02371980|447859922|FG000|Double-blind Period|Missing|0|||
124521174|NCT02371980|447859923|FG001|Double-blind Period|Missing|1|||
124521175|NCT02371980|447859924|FG002|Double-blind Period|Missing|0|||
124521176|NCT02371980|447859925|FG003|Double-blind Period|Missing|0|||
124521177|NCT02371980|447859926|FG004|Double-blind Period|Missing|0|||
124521178|NCT01731990|447859927|FG000|Overall Study|Adverse Event|1|||
124521179|NCT01731990|447859928|FG001|Overall Study|Adverse Event|5|||
124521180|NCT01731990|447859927|FG000|Overall Study|Withdrawal by Subject|1|||
124521181|NCT01731990|447859928|FG001|Overall Study|Withdrawal by Subject|1|||
124521182|NCT01731990|447859927|FG000|Overall Study|Protocol deviation|1|||
124521183|NCT01731990|447859928|FG001|Overall Study|Protocol deviation|2|||
124521184|NCT01731990|447859927|FG000|Overall Study|Death|1|||
124521185|NCT01731990|447859928|FG001|Overall Study|Death|0|||
124521186|NCT01280812|447859929|FG000|Overall Study|Withdrawal by Subject|2|||
124521187|NCT01280812|447859930|FG001|Overall Study|Withdrawal by Subject|1|||
124521188|NCT01280812|447859931|FG002|Overall Study|Withdrawal by Subject|0|||
124521189|NCT01280812|447859929|FG000|Overall Study|Lost to Follow-up|1|||
124521190|NCT01280812|447859930|FG001|Overall Study|Lost to Follow-up|1|||
124521191|NCT01280812|447859931|FG002|Overall Study|Lost to Follow-up|1|||
124521192|NCT04483544|447859932|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
124521193|NCT04483544|447859932|FG000|Post-Treatment|Admitted to hospice|2|||
124521194|NCT04483544|447859932|FG000|Post-Treatment|Study terminated|3|||
124521195|NCT01131078|447859935|FG000|Overall Study|Adverse Event|22|||
124521196|NCT01131078|447859936|FG001|Overall Study|Adverse Event|12|||
124521197|NCT01131078|447859937|FG002|Overall Study|Adverse Event|17|||
124521198|NCT01131078|447859935|FG000|Overall Study|Progressive Disease|58|||
124521199|NCT01131078|447859936|FG001|Overall Study|Progressive Disease|77|||
124521200|NCT01131078|447859937|FG002|Overall Study|Progressive Disease|71|||
124521201|NCT01131078|447859935|FG000|Overall Study|Protocol Violation|1|||
124521202|NCT01131078|447859936|FG001|Overall Study|Protocol Violation|0|||
124521203|NCT01131078|447859937|FG002|Overall Study|Protocol Violation|0|||
124521204|NCT01131078|447859935|FG000|Overall Study|Lost to Follow-up|1|||
124521205|NCT01131078|447859936|FG001|Overall Study|Lost to Follow-up|1|||
124521206|NCT01131078|447859937|FG002|Overall Study|Lost to Follow-up|1|||
124521207|NCT01131078|447859935|FG000|Overall Study|Withdrawal by Subject|2|||
124521208|NCT01131078|447859936|FG001|Overall Study|Withdrawal by Subject|4|||
124521209|NCT01131078|447859937|FG002|Overall Study|Withdrawal by Subject|3|||
124521210|NCT01131078|447859935|FG000|Overall Study|Non-compliance|3|||
124521211|NCT01131078|447859936|FG001|Overall Study|Non-compliance|0|||
124521212|NCT01131078|447859937|FG002|Overall Study|Non-compliance|0|||
124521213|NCT01131078|447859935|FG000|Overall Study|Physician Decision|10|||
124521214|NCT01131078|447859936|FG001|Overall Study|Physician Decision|6|||
124521215|NCT01131078|447859937|FG002|Overall Study|Physician Decision|8|||
124521216|NCT01131078|447859935|FG000|Overall Study|Death|4|||
124521217|NCT01131078|447859936|FG001|Overall Study|Death|0|||
124521218|NCT01131078|447859937|FG002|Overall Study|Death|2|||
124521219|NCT01131078|447859935|FG000|Overall Study|Other|0|||
124521220|NCT01131078|447859936|FG001|Overall Study|Other|1|||
124521221|NCT01131078|447859937|FG002|Overall Study|Other|0|||
124521222|NCT00790218|447859939|FG000|Overall Study|Death|1|||
124521223|NCT00790218|447859940|FG001|Overall Study|Death|0|||
124521224|NCT00790218|447859941|FG002|Overall Study|Death|0|||
124521225|NCT00880100|447859942|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
124521226|NCT00880100|447859942|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
124521227|NCT00880100|447859942|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
124521228|NCT02853123|447859945|FG000|Treatment Period 1|Adverse Event|0|||
124521229|NCT02853123|447859946|FG001|Treatment Period 1|Adverse Event|3|||
124575274|NCT04605094|448067197|FG001|Overall Study|Physician Decision|2|||
124575275|NCT04605094|448067196|FG000|Overall Study|Study terminated by Sponsor|31|||
124575276|NCT04605094|448067197|FG001|Overall Study|Study terminated by Sponsor|33|||
124575277|NCT04605094|448067196|FG000|Overall Study|Withdrawal by Subject|22|||
124575278|NCT04605094|448067197|FG001|Overall Study|Withdrawal by Subject|19|||
124575279|NCT04605094|448067196|FG000|Overall Study|Other|1|||
124575280|NCT04605094|448067197|FG001|Overall Study|Other|1|||
124575281|NCT01900691|448067198|FG000|Overall Study|Death|7|||
124575282|NCT01900691|448067198|FG000|Overall Study|Lost to Follow-up|4|||
124575283|NCT01900691|448067198|FG000|Overall Study|Study Device Not Placed|3|||
124575284|NCT01900691|448067198|FG000|Overall Study|Non study stent placed|2|||
124575285|NCT01900691|448067198|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
124575286|NCT01900691|448067198|FG000|Overall Study|Complete stent migration through digestive tract|1|||
124575287|NCT02724462|448067199|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
124575288|NCT02724462|448067200|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
124575289|NCT02724462|448067199|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
124575290|NCT02724462|448067200|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
124575291|NCT02724462|448067199|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
124575292|NCT02724462|448067200|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
124575293|NCT02724462|448067199|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
124575294|NCT02724462|448067200|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
124575295|NCT02724462|448067199|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
124575296|NCT02724462|448067200|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
124575297|NCT02724462|448067199|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
124575298|NCT02724462|448067200|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
124575299|NCT02128997|448067208|FG000|Overall Study|Lost to Follow-up|6|||
124575300|NCT02128997|448067209|FG001|Overall Study|Lost to Follow-up|11|||
124575301|NCT02422264|448067218|FG000|Overall Study|Serious Adverse Event|1|||
124575302|NCT02422264|448067219|FG001|Overall Study|Serious Adverse Event|0|||
124575303|NCT02422264|448067218|FG000|Overall Study|Withdrawal by Subject|1|||
124575304|NCT02422264|448067219|FG001|Overall Study|Withdrawal by Subject|2|||
124575305|NCT02422264|448067218|FG000|Overall Study|Migrated/moved from study area|3|||
124575306|NCT02422264|448067219|FG001|Overall Study|Migrated/moved from study area|1|||
124575307|NCT02422264|448067218|FG000|Overall Study|Subject vaccinated outside of the study|0|||
124575308|NCT02422264|448067219|FG001|Overall Study|Subject vaccinated outside of the study|1|||
124575309|NCT03874715|448067221|FG000|Overall Study|Adverse Event|2|||
124575310|NCT03874715|448067222|FG001|Overall Study|Adverse Event|0|||
124575311|NCT03874715|448067221|FG000|Overall Study|Poor compliance to protocol|5|||
124575312|NCT03874715|448067222|FG001|Overall Study|Poor compliance to protocol|1|||
124575313|NCT03874715|448067221|FG000|Overall Study|Withdrawal by Subject|1|||
124575314|NCT03874715|448067222|FG001|Overall Study|Withdrawal by Subject|0|||
124575315|NCT03874715|448067221|FG000|Overall Study|Other-unspecified|1|||
124575316|NCT03874715|448067222|FG001|Overall Study|Other-unspecified|0|||
124575317|NCT00851877|448067225|FG000|Phase I-1|Death|1|||
124575318|NCT00851877|448067226|FG001|Phase I-1|Death|0|||
124575319|NCT00851877|448067227|FG002|Phase I-1|Death|0|||
124575320|NCT00851877|448067225|FG000|Phase II|Withdrawal by Subject|0|||
124575321|NCT00851877|448067226|FG001|Phase II|Withdrawal by Subject|0|||
124575322|NCT00851877|448067227|FG002|Phase II|Withdrawal by Subject|3|||
124575323|NCT00829673|448067228|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
124575324|NCT00829673|448067229|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
124575325|NCT00573066|448067230|FG000|Overall Study|Exclusion criteria|18|||
124575326|NCT00573066|448067230|FG000|Overall Study|IV malfunction|1|||
124575327|NCT00573066|448067230|FG000|Overall Study|Postoperative bleeding|1|||
124575328|NCT01034358|448067231|FG000|Overall Study|Withdrawal by Subject|1|||
124575329|NCT01034358|448067231|FG000|Overall Study|Protocol Violation|1|||
124575330|NCT00829790|448067234|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
124575331|NCT00829790|448067235|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
124725253|NCT02016716|448613464|FG002|Overall Study|Withdrawal by Subject|5|||
124725254|NCT02016716|448613462|FG000|Overall Study|Protocol-specified Criteria|0|||
124725255|NCT02016716|448613463|FG001|Overall Study|Protocol-specified Criteria|1|||
124725256|NCT02016716|448613464|FG002|Overall Study|Protocol-specified Criteria|0|||
124725257|NCT02016716|448613462|FG000|Overall Study|Lost to Follow-up|1|||
124575332|NCT01534663|448067236|FG000|Overall Study|Lost to Follow-up|0|||
124575333|NCT01534663|448067237|FG001|Overall Study|Lost to Follow-up|2|||
124575334|NCT01534663|448067236|FG000|Overall Study|Adverse Event|2|||
124575335|NCT01534663|448067237|FG001|Overall Study|Adverse Event|1|||
124575336|NCT00627016|448067238|FG000|Overall Study|Adverse Event|1|||
124575337|NCT00627016|448067239|FG001|Overall Study|Adverse Event|1|||
124575338|NCT00627016|448067238|FG000|Overall Study|Protocol Violation|0|||
124725258|NCT02016716|448613463|FG001|Overall Study|Lost to Follow-up|2|||
124575339|NCT00627016|448067239|FG001|Overall Study|Protocol Violation|2|||
124575340|NCT00627016|448067238|FG000|Overall Study|Lost to Follow-up|0|||
124575341|NCT00627016|448067239|FG001|Overall Study|Lost to Follow-up|1|||
124725259|NCT02016716|448613464|FG002|Overall Study|Lost to Follow-up|1|||
124575342|NCT00627016|448067238|FG000|Overall Study|Withdrawal by Subject|2|||
124575343|NCT00627016|448067239|FG001|Overall Study|Withdrawal by Subject|1|||
124575344|NCT00627016|448067238|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
124575345|NCT00627016|448067239|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
124575346|NCT00627016|448067238|FG000|Overall Study|Lack of Efficacy|1|||
124575347|NCT00627016|448067239|FG001|Overall Study|Lack of Efficacy|0|||
124575348|NCT00627016|448067238|FG000|Overall Study|Placed on Excluded Drugs|1|||
124575349|NCT00627016|448067239|FG001|Overall Study|Placed on Excluded Drugs|0|||
124575350|NCT00627016|448067238|FG000|Overall Study|Pregnancy|1|||
124575351|NCT00627016|448067239|FG001|Overall Study|Pregnancy|0|||
124575352|NCT03107091|448067240|FG000|Overall Study|Physician Decision|1|||
124575353|NCT04567186|448067241|FG000|Period 1|COVID-19 related|1|||
124575354|NCT04567186|448067242|FG001|Period 1|COVID-19 related|0|||
124575355|NCT04567186|448067241|FG000|Period 1|Protocol Violation|0|||
124575356|NCT04567186|448067242|FG001|Period 1|Protocol Violation|1|||
124575357|NCT04567186|448067241|FG000|Period 1|Adverse Event|0|||
124575358|NCT04567186|448067242|FG001|Period 1|Adverse Event|2|||
124575359|NCT04567186|448067241|FG000|Period 2|COVID-19 Related|0|||
124575360|NCT04567186|448067242|FG001|Period 2|COVID-19 Related|1|||
124575361|NCT04567186|448067241|FG000|Period 2|Protocol Violation|0|||
124575362|NCT04567186|448067242|FG001|Period 2|Protocol Violation|1|||
124575363|NCT04567186|448067241|FG000|Period 2|Lost to Follow-up|0|||
124575364|NCT04567186|448067242|FG001|Period 2|Lost to Follow-up|1|||
124575365|NCT04567186|448067241|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
124575366|NCT04567186|448067242|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
124575367|NCT01185548|448067245|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
124575368|NCT02331394|448067246|FG000|Overall Study|Disease progression|1|||
124575369|NCT01313273|448067247|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
124575370|NCT01313273|448067248|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
124575371|NCT01313273|448067247|FG000|Overall Study|Withdrawal by Subject|1|||
124575372|NCT01313273|448067248|FG001|Overall Study|Withdrawal by Subject|0|||
124521230|NCT02853123|447859945|FG000|Washout Period|Worsening of COPD|0|||
124521231|NCT02853123|447859946|FG001|Washout Period|Worsening of COPD|3|||
124521232|NCT02853123|447859945|FG000|Washout Period|Adverse Event|1|||
124521233|NCT02853123|447859946|FG001|Washout Period|Adverse Event|0|||
124521234|NCT05283499|447859947|FG000|Overall Study|Did not receive intervention|1|||
124521235|NCT05283499|447859948|FG001|Overall Study|Did not receive intervention|2|||
124521236|NCT05516134|447859949|FG000|Overall Study|Lost to Follow-up|1|||
124521237|NCT05516134|447859950|FG001|Overall Study|Lost to Follow-up|0|||
124521238|NCT05516134|447859951|FG002|Overall Study|Lost to Follow-up|0|||
124521239|NCT01094808|447859953|FG000|Overall Study|Withdrawal by Subject|1|||
124521240|NCT01094808|447859954|FG001|Overall Study|Withdrawal by Subject|1|||
124521241|NCT01094808|447859955|FG002|Overall Study|Withdrawal by Subject|0|||
124521242|NCT00369278|447859956|FG000|Overall Study|Adverse Event|14|||
124521243|NCT00369278|447859957|FG001|Overall Study|Adverse Event|11|||
124521244|NCT00369278|447859956|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
124521245|NCT00369278|447859957|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
124521246|NCT00369278|447859956|FG000|Overall Study|Protocol Violation|2|||
124521247|NCT00369278|447859957|FG001|Overall Study|Protocol Violation|1|||
124521248|NCT00369278|447859956|FG000|Overall Study|Withdrawal by Subject|2|||
124521249|NCT00369278|447859957|FG001|Overall Study|Withdrawal by Subject|2|||
124521250|NCT00369278|447859956|FG000|Overall Study|Lost to Follow-up|1|||
124521251|NCT00369278|447859957|FG001|Overall Study|Lost to Follow-up|0|||
124521252|NCT00369278|447859956|FG000|Overall Study|Graft loss|1|||
124575373|NCT01313273|448067247|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
124575374|NCT01313273|448067248|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
124575375|NCT03687736|448067249|FG000|Overall Study|Lost to Follow-up|7|||
124575376|NCT03687736|448067249|FG000|Overall Study|Withdrawal by Subject|3|||
124575377|NCT02459951|448067250|FG000|Overall Study|Unable to meet holding requirement|1|||
124575378|NCT00102440|448067251|FG000|Overall Study|Lost to Follow-up|25|||
124575379|NCT00102440|448067252|FG001|Overall Study|Lost to Follow-up|18|||
124575380|NCT00102440|448067253|FG002|Overall Study|Lost to Follow-up|21|||
124575381|NCT00102440|448067251|FG000|Overall Study|Adverse Event|16|||
124575382|NCT00102440|448067252|FG001|Overall Study|Adverse Event|23|||
124575383|NCT00102440|448067253|FG002|Overall Study|Adverse Event|8|||
124575384|NCT00102440|448067251|FG000|Overall Study|Gout Flare|10|||
124521253|NCT00369278|447859957|FG001|Overall Study|Graft loss|2|||
124521254|NCT01224106|447859958|FG000|Double-Blind Treatment Phase|Death|3|||
124575385|NCT00102440|448067252|FG001|Overall Study|Gout Flare|28|||
124575386|NCT00102440|448067253|FG002|Overall Study|Gout Flare|9|||
124575387|NCT00102440|448067251|FG000|Overall Study|Personal Reason(s)|19|||
124521255|NCT01224106|447859959|FG001|Double-Blind Treatment Phase|Death|0|||
124521256|NCT01224106|447859960|FG002|Double-Blind Treatment Phase|Death|0|||
124575388|NCT00102440|448067252|FG001|Overall Study|Personal Reason(s)|13|||
124521257|NCT01224106|447859961|FG003|Double-Blind Treatment Phase|Death|0|||
124521258|NCT01224106|447859962|FG004|Double-Blind Treatment Phase|Death|0|||
124575389|NCT00102440|448067253|FG002|Overall Study|Personal Reason(s)|13|||
124575390|NCT00102440|448067251|FG000|Overall Study|Other|11|||
124575391|NCT00102440|448067252|FG001|Overall Study|Other|14|||
124575392|NCT00102440|448067253|FG002|Overall Study|Other|14|||
124575393|NCT00102440|448067251|FG000|Overall Study|Protocol Violation|7|||
124575394|NCT00102440|448067252|FG001|Overall Study|Protocol Violation|2|||
124575395|NCT00102440|448067253|FG002|Overall Study|Protocol Violation|1|||
124575396|NCT02255097|448067254|FG000|Overall Study|Death|151|||
124575397|NCT02255097|448067254|FG000|Overall Study|Lost to Follow-up|5|||
124575398|NCT02255097|448067254|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
124575399|NCT02255097|448067254|FG000|Overall Study|Withdrawal by Subject|7|||
124575400|NCT02255097|448067254|FG000|Overall Study|Allocated but not treated|1|||
124575401|NCT01010542|448067258|FG000|Overall Study|Adverse Event|0|||
124575402|NCT01010542|448067259|FG001|Overall Study|Adverse Event|1|||
124575403|NCT01010542|448067260|FG002|Overall Study|Adverse Event|0|||
124575404|NCT01010542|448067258|FG000|Overall Study|Lost to Follow-up|0|||
124575405|NCT01010542|448067259|FG001|Overall Study|Lost to Follow-up|1|||
124575406|NCT01010542|448067260|FG002|Overall Study|Lost to Follow-up|0|||
124575407|NCT01010542|448067258|FG000|Overall Study|Withdrawal by Subject|0|||
124575408|NCT01010542|448067259|FG001|Overall Study|Withdrawal by Subject|3|||
124575409|NCT01010542|448067260|FG002|Overall Study|Withdrawal by Subject|2|||
124575410|NCT01745120|448067261|FG000|Overall Study|Investigator decision|1|||
124575411|NCT01745120|448067262|FG001|Overall Study|Investigator decision|0|||
124575412|NCT00579670|448067265|FG000|Overall Study|Death|1|||
124575413|NCT00579670|448067266|FG001|Overall Study|Death|0|||
124575414|NCT00579670|448067267|FG002|Overall Study|Death|0|||
124575415|NCT00579670|448067268|FG003|Overall Study|Death|0|||
124575416|NCT00579670|448067269|FG004|Overall Study|Death|0|||
124575417|NCT00579670|448067265|FG000|Overall Study|Adverse Event|1|||
124575418|NCT00579670|448067266|FG001|Overall Study|Adverse Event|0|||
124575419|NCT00579670|448067267|FG002|Overall Study|Adverse Event|1|||
124575420|NCT00579670|448067268|FG003|Overall Study|Adverse Event|2|||
124575421|NCT00579670|448067269|FG004|Overall Study|Adverse Event|0|||
124575422|NCT00579670|448067265|FG000|Overall Study|Lack of Efficacy|0|||
124575423|NCT00579670|448067266|FG001|Overall Study|Lack of Efficacy|0|||
124575424|NCT00579670|448067267|FG002|Overall Study|Lack of Efficacy|1|||
124575425|NCT00579670|448067268|FG003|Overall Study|Lack of Efficacy|14|||
124575426|NCT00579670|448067269|FG004|Overall Study|Lack of Efficacy|0|||
124575427|NCT00579670|448067265|FG000|Overall Study|Lost to Follow-up|0|||
124575428|NCT00579670|448067266|FG001|Overall Study|Lost to Follow-up|1|||
124575429|NCT00579670|448067267|FG002|Overall Study|Lost to Follow-up|0|||
124575430|NCT00579670|448067268|FG003|Overall Study|Lost to Follow-up|4|||
124575431|NCT00579670|448067269|FG004|Overall Study|Lost to Follow-up|0|||
124575432|NCT00579670|448067265|FG000|Overall Study|Other|0|||
124575433|NCT00579670|448067266|FG001|Overall Study|Other|0|||
124575434|NCT00579670|448067267|FG002|Overall Study|Other|1|||
124575435|NCT00579670|448067268|FG003|Overall Study|Other|2|||
124575436|NCT00579670|448067269|FG004|Overall Study|Other|0|||
124575437|NCT00579670|448067265|FG000|Overall Study|Withdrawal by Subject|0|||
124575438|NCT00579670|448067266|FG001|Overall Study|Withdrawal by Subject|0|||
124575439|NCT00579670|448067267|FG002|Overall Study|Withdrawal by Subject|1|||
124575440|NCT00579670|448067268|FG003|Overall Study|Withdrawal by Subject|0|||
124575441|NCT00579670|448067269|FG004|Overall Study|Withdrawal by Subject|0|||
124575442|NCT00850174|448067270|FG000|Washout: One Week|Withdrawal by Subject|0|||
124575443|NCT00850174|448067271|FG001|Washout: One Week|Withdrawal by Subject|2|||
124575444|NCT00850174|448067270|FG000|Second Intervention|Withdrawal by Subject|1|||
124575445|NCT00850174|448067271|FG001|Second Intervention|Withdrawal by Subject|0|||
124575446|NCT01900626|448067272|FG000|Overall Study|study was closed due to low enrollment|1|||
124575447|NCT01900626|448067273|FG001|Overall Study|study was closed due to low enrollment|1|||
124575448|NCT00635492|448067274|FG000|Overall Study|Death|12|||
124575449|NCT00635492|448067275|FG001|Overall Study|Death|40|||
124725260|NCT02248649|448613465|FG000|Overall Study|Death|7|||
124575450|NCT00635492|448067274|FG000|Overall Study|Lost to Follow-up|151|||
124575451|NCT00635492|448067275|FG001|Overall Study|Lost to Follow-up|172|||
124575452|NCT00635492|448067274|FG000|Overall Study|Physician Decision|32|||
124575453|NCT00635492|448067275|FG001|Overall Study|Physician Decision|22|||
124575454|NCT00635492|448067274|FG000|Overall Study|Sponsor decision|2|||
124575455|NCT00635492|448067275|FG001|Overall Study|Sponsor decision|3|||
124575456|NCT00635492|448067274|FG000|Overall Study|Withdrawal by Subject|82|||
124575457|NCT00635492|448067275|FG001|Overall Study|Withdrawal by Subject|45|||
124575458|NCT01702987|448067276|FG000|Overall Study|Withdrawal by Subject|1|||
124575459|NCT01702987|448067277|FG001|Overall Study|Withdrawal by Subject|0|||
124575460|NCT02017223|448067278|FG000|Overall Study|Algorithm problems|2|||
124575461|NCT04263649|448067279|FG000|Overall Study|Adverse Event|53|||
124575462|NCT04263649|448067279|FG000|Overall Study|Lost to Follow-up|3|||
124575463|NCT04263649|448067279|FG000|Overall Study|Death|29|||
124575464|NCT04263649|448067279|FG000|Overall Study|Device deficiency|19|||
124575465|NCT04263649|448067279|FG000|Overall Study|other reasons|11|||
124575466|NCT05169710|448067281|FG000|Overall Study|Adverse Event|1|||
124575467|NCT05169710|448067282|FG001|Overall Study|Adverse Event|2|||
124575468|NCT05169710|448067283|FG002|Overall Study|Adverse Event|2|||
124575469|NCT05169710|448067281|FG000|Overall Study|Lost to Follow-up|0|||
124575470|NCT05169710|448067282|FG001|Overall Study|Lost to Follow-up|0|||
124575471|NCT05169710|448067283|FG002|Overall Study|Lost to Follow-up|1|||
124575472|NCT05169710|448067281|FG000|Overall Study|Withdrawal by Subject|2|||
124575473|NCT05169710|448067282|FG001|Overall Study|Withdrawal by Subject|1|||
124575474|NCT05169710|448067283|FG002|Overall Study|Withdrawal by Subject|0|||
124575475|NCT05169710|448067281|FG000|Overall Study|Other Study Discontinuation Reason|0|||
124575476|NCT05169710|448067282|FG001|Overall Study|Other Study Discontinuation Reason|2|||
124575477|NCT05169710|448067283|FG002|Overall Study|Other Study Discontinuation Reason|0|||
124575478|NCT00846495|448067292|FG000|Overall Study|Lost to Follow-up|1|||
124575479|NCT00846495|448067293|FG001|Overall Study|Lost to Follow-up|0|||
124575480|NCT00846495|448067292|FG000|Overall Study|Adverse Event|5|||
124575481|NCT00846495|448067293|FG001|Overall Study|Adverse Event|1|||
124575482|NCT00846495|448067292|FG000|Overall Study|Lack of Efficacy|1|||
124575483|NCT00846495|448067293|FG001|Overall Study|Lack of Efficacy|2|||
124575484|NCT00846495|448067292|FG000|Overall Study|Physician Decision|1|||
124575485|NCT00846495|448067293|FG001|Overall Study|Physician Decision|0|||
124575486|NCT01686438|448067294|FG000|Overall Study|Lost to Follow-up|8|||
124575487|NCT01686438|448067295|FG001|Overall Study|Lost to Follow-up|9|||
124575488|NCT01686438|448067296|FG002|Overall Study|Lost to Follow-up|10|||
124575489|NCT01686438|448067294|FG000|Overall Study|Adverse Event|0|||
124575490|NCT01686438|448067295|FG001|Overall Study|Adverse Event|0|||
124575491|NCT01686438|448067296|FG002|Overall Study|Adverse Event|1|||
124575492|NCT01686438|448067294|FG000|Overall Study|Protocol Violation|0|||
124575493|NCT01686438|448067295|FG001|Overall Study|Protocol Violation|0|||
124575494|NCT01686438|448067296|FG002|Overall Study|Protocol Violation|1|||
124575495|NCT01686438|448067294|FG000|Overall Study|Withdrawal by Subject|0|||
124575496|NCT01686438|448067295|FG001|Overall Study|Withdrawal by Subject|0|||
124575497|NCT01686438|448067296|FG002|Overall Study|Withdrawal by Subject|1|||
124575498|NCT06358820|448069147|FG000|Overall Study|Adverse Event|11|||
124575499|NCT06358820|448069147|FG000|Overall Study|kidney transplantation|3|||
124575500|NCT06358820|448069147|FG000|Overall Study|patient voluntary withdrawal|6|||
124575501|NCT06358820|448069147|FG000|Overall Study|Physician Decision|1|||
124575502|NCT01124175|448069148|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
124575503|NCT01124175|448069149|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
124575504|NCT00218257|448069155|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
124575505|NCT00218257|448069156|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
124575506|NCT00462345|448069159|FG000|Overall Study|Withdrawal by Subject|2|||
124575507|NCT00462345|448069159|FG000|Overall Study|Did not complete second course|1|||
124575508|NCT00070291|448069162|FG000|Step 1|Withdrawal by Subject|1|||
124575509|NCT00070291|448069162|FG000|Step 1|Adverse Event|1|||
124575510|NCT00070291|448069162|FG000|Step 2|Adverse Event|1|||
124575511|NCT00520130|448069163|FG000|Overall Study|Disease progression on study|4|||
124575512|NCT00520130|448069164|FG001|Overall Study|Disease progression on study|0|||
124575513|NCT00520130|448069163|FG000|Overall Study|Physician Decision|1|||
124575514|NCT00520130|448069164|FG001|Overall Study|Physician Decision|1|||
124575515|NCT02028715|448069167|FG000|Overall Study|Adverse Event|2|||
124575516|NCT02028715|448069168|FG001|Overall Study|Adverse Event|2|||
124575517|NCT02028715|448069167|FG000|Overall Study|Physician Decision|1|||
124575518|NCT02028715|448069168|FG001|Overall Study|Physician Decision|0|||
124575519|NCT02028715|448069167|FG000|Overall Study|Did not complete satisfaction surveys|2|||
124575520|NCT02028715|448069168|FG001|Overall Study|Did not complete satisfaction surveys|2|||
124575521|NCT04915755|448069169|FG000|Overall Study|Physician Decision|3|||
124575522|NCT04915755|448069170|FG001|Overall Study|Physician Decision|2|||
124575523|NCT04915755|448069169|FG000|Overall Study|Withdrawal by Subject|1|||
124575524|NCT04915755|448069170|FG001|Overall Study|Withdrawal by Subject|1|||
124575525|NCT04915755|448069169|FG000|Overall Study|Ongoing for PACT|3|||
124575526|NCT04915755|448069170|FG001|Overall Study|Ongoing for PACT|2|||
124575527|NCT04915755|448069169|FG000|Overall Study|Other|7|||
124575528|NCT04915755|448069170|FG001|Overall Study|Other|11|||
124575529|NCT02533258|448069171|FG000|Overall Study|Adverse Event|1|||
124575530|NCT02533258|448069171|FG000|Overall Study|Death|2|||
124575531|NCT02533258|448069171|FG000|Overall Study|Other|1|||
124575532|NCT02533258|448069171|FG000|Overall Study|Economic factor|1|||
124776733|NCT02120898|448809965|FG001|Overall Study|Withdrawal by Subject|2|||
124575533|NCT02533258|448069171|FG000|Overall Study|Progression of pleural effusion|1|||
124575534|NCT02533258|448069171|FG000|Overall Study|Lack of Efficacy|2|||
124575535|NCT01149473|448069172|FG000|First Intervention|Adverse Event|1|||
124575536|NCT01149473|448069173|FG001|First Intervention|Adverse Event|1|||
124575537|NCT01149473|448069172|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
124575538|NCT01149473|448069173|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
124575539|NCT01954394|448069176|FG000|Overall Study|Enrolled but not treated|1|||
124575540|NCT01954394|448069177|FG001|Overall Study|Enrolled but not treated|0|||
124575541|NCT01954394|448069176|FG000|Overall Study|Adverse Event|10|||
124575542|NCT01954394|448069177|FG001|Overall Study|Adverse Event|23|||
124575543|NCT01954394|448069176|FG000|Overall Study|Poor compliance to protocol|7|||
124575544|NCT01954394|448069177|FG001|Overall Study|Poor compliance to protocol|7|||
124776734|NCT02120898|448809966|FG002|Overall Study|Withdrawal by Subject|2|||
124575545|NCT01954394|448069176|FG000|Overall Study|Participant Moved|0|||
124725261|NCT02248649|448613466|FG001|Overall Study|Death|11|||
124725262|NCT02248649|448613465|FG000|Overall Study|Lost to Follow-up|14|||
124725263|NCT02248649|448613466|FG001|Overall Study|Lost to Follow-up|10|||
124725264|NCT01439971|448613467|FG000|Overall Study|Required number in cohort dosed|0|||
124725265|NCT01439971|448613468|FG001|Overall Study|Required number in cohort dosed|1|||
124725266|NCT01439971|448613469|FG002|Overall Study|Required number in cohort dosed|2|||
124725267|NCT01439971|448613470|FG003|Overall Study|Required number in cohort dosed|0|||
124725268|NCT01439971|448613471|FG004|Overall Study|Required number in cohort dosed|1|||
124725269|NCT02628600|448613475|FG000|Overall Study|Death|2|||
124725270|NCT02628600|448613476|FG001|Overall Study|Death|1|||
124725271|NCT02628600|448613475|FG000|Overall Study|Adverse Event|3|||
124725272|NCT02628600|448613476|FG001|Overall Study|Adverse Event|20|||
124725273|NCT02628600|448613475|FG000|Overall Study|Protocol Violation|0|||
124725274|NCT02628600|448613476|FG001|Overall Study|Protocol Violation|1|||
124725275|NCT02628600|448613475|FG000|Overall Study|Lack of Efficacy|2|||
124725276|NCT02628600|448613476|FG001|Overall Study|Lack of Efficacy|0|||
124725277|NCT02628600|448613475|FG000|Overall Study|Withdrawal by Subject|13|||
124725278|NCT02628600|448613476|FG001|Overall Study|Withdrawal by Subject|8|||
124725279|NCT02628600|448613475|FG000|Overall Study|Lost to Follow-up|1|||
124725280|NCT02628600|448613476|FG001|Overall Study|Lost to Follow-up|0|||
124725281|NCT02628600|448613475|FG000|Overall Study|Physician Decision|2|||
124725282|NCT02628600|448613476|FG001|Overall Study|Physician Decision|2|||
124725283|NCT02628600|448613475|FG000|Overall Study|Other not specified|1|||
124725284|NCT02628600|448613476|FG001|Overall Study|Other not specified|0|||
124725285|NCT01221623|448613481|FG000|Overall Study|Withdrawal by Subject|19|||
124725286|NCT01221623|448613482|FG001|Overall Study|Withdrawal by Subject|8|||
124725287|NCT01221623|448613481|FG000|Overall Study|Lost to Follow-up|7|||
124725288|NCT01221623|448613482|FG001|Overall Study|Lost to Follow-up|1|||
124725289|NCT01221623|448613481|FG000|Overall Study|Adverse Event|6|||
124725290|NCT01221623|448613482|FG001|Overall Study|Adverse Event|3|||
124725291|NCT01221623|448613481|FG000|Overall Study|Death|1|||
124725292|NCT01221623|448613482|FG001|Overall Study|Death|0|||
124725293|NCT01221623|448613481|FG000|Overall Study|Other|5|||
124725294|NCT01221623|448613482|FG001|Overall Study|Other|2|||
124725295|NCT00875485|448616474|FG000|Challenge Dose Epoch|Pregnancy|1|||
124725296|NCT00875485|448616475|FG001|Challenge Dose Epoch|Pregnancy|0|||
124725297|NCT01271010|448616476|FG000|Overall Study|Reason not specified|11|||
124725298|NCT01271010|448616476|FG000|Overall Study|Start of new CLL therapy|1|||
124725299|NCT01271010|448616476|FG000|Overall Study|Protocol Violation|1|||
124725300|NCT01271010|448616476|FG000|Overall Study|Death|2|||
124725301|NCT01271010|448616476|FG000|Overall Study|Progression and relapse of disease|1|||
124725302|NCT01271010|448616476|FG000|Overall Study|Withdrawal by Subject|18|||
124725303|NCT01271010|448616476|FG000|Overall Study|Disease progression|27|||
124725304|NCT01631747|448616477|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
124725305|NCT01631747|448616478|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
124725306|NCT01631747|448616477|FG000|Live Birth|Pregnancy Termination|1|||
124725307|NCT01631747|448616478|FG001|Live Birth|Pregnancy Termination|0|||
124725308|NCT01631747|448616477|FG000|Live Birth|MIscarriage|2|||
124725309|NCT01631747|448616478|FG001|Live Birth|MIscarriage|0|||
124725310|NCT01631747|448616477|FG000|Live Birth|Stillbirth|1|||
124521259|NCT01224106|447859958|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
124521260|NCT01224106|447859959|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
124521261|NCT01224106|447859960|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
124521262|NCT01224106|447859961|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
124521263|NCT01224106|447859962|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
124521264|NCT01224106|447859958|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
124521265|NCT01224106|447859959|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
124521266|NCT01224106|447859960|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
124521267|NCT01224106|447859961|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
124521268|NCT01224106|447859962|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
124521269|NCT01224106|447859958|FG000|Double-Blind Treatment Phase|Other|0|||
124521270|NCT01224106|447859959|FG001|Double-Blind Treatment Phase|Other|0|||
124521271|NCT01224106|447859960|FG002|Double-Blind Treatment Phase|Other|1|||
124521272|NCT01224106|447859961|FG003|Double-Blind Treatment Phase|Other|0|||
124521273|NCT01224106|447859962|FG004|Double-Blind Treatment Phase|Other|0|||
124521274|NCT01224106|447859958|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
124521275|NCT01224106|447859959|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
124521276|NCT01224106|447859960|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
124521277|NCT01224106|447859961|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
124521278|NCT01224106|447859962|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
124521279|NCT01224106|447859958|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
124521280|NCT01224106|447859959|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
124521281|NCT01224106|447859960|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
124521282|NCT01224106|447859961|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
124521283|NCT01224106|447859962|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
124725311|NCT01631747|448616478|FG001|Live Birth|Stillbirth|1|||
124725312|NCT01631747|448616477|FG000|One Year Infant Outcomes|Patient Refused|13|||
124725313|NCT01631747|448616478|FG001|One Year Infant Outcomes|Patient Refused|9|||
124725314|NCT02908685|448616479|FG000|Part 1 OLE|Withdrawal by Subject|0|||
124725315|NCT02908685|448616480|FG001|Part 1 OLE|Withdrawal by Subject|0|||
124725316|NCT02908685|448616481|FG002|Part 1 OLE|Withdrawal by Subject|0|||
124725317|NCT02908685|448616482|FG003|Part 1 OLE|Withdrawal by Subject|0|||
124725318|NCT02908685|448616483|FG004|Part 1 OLE|Withdrawal by Subject|0|||
124725319|NCT02908685|448616484|FG005|Part 1 OLE|Withdrawal by Subject|0|||
124725320|NCT02908685|448616485|FG006|Part 1 OLE|Withdrawal by Subject|0|||
124725321|NCT02908685|448616486|FG007|Part 1 OLE|Withdrawal by Subject|0|||
124725322|NCT02908685|448616487|FG008|Part 1 OLE|Withdrawal by Subject|0|||
124725323|NCT02908685|448616488|FG009|Part 1 OLE|Withdrawal by Subject|0|||
124725324|NCT02908685|448616489|FG010|Part 1 OLE|Withdrawal by Subject|2|||
124725325|NCT02908685|448616490|FG011|Part 1 OLE|Withdrawal by Subject|1|||
124725326|NCT02908685|448616491|FG012|Part 1 OLE|Withdrawal by Subject|0|||
124725327|NCT02908685|448616492|FG013|Part 1 OLE|Withdrawal by Subject|0|||
124725328|NCT02908685|448616479|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
124725329|NCT02908685|448616480|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
124725330|NCT02908685|448616481|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
124725331|NCT02908685|448616482|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
124725332|NCT02908685|448616483|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
124725333|NCT02908685|448616484|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
124725334|NCT02908685|448616485|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
124725335|NCT02908685|448616486|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
124725336|NCT02908685|448616487|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
124725337|NCT02908685|448616488|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
124725338|NCT02908685|448616489|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
124725339|NCT02908685|448616490|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
124725340|NCT02908685|448616491|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
124725341|NCT02908685|448616492|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
124725342|NCT02908685|448616479|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
124725343|NCT02908685|448616480|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
124725344|NCT02908685|448616481|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
124725345|NCT02908685|448616482|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
124725346|NCT02908685|448616483|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
124725347|NCT02908685|448616484|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
124725348|NCT02908685|448616485|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
124725349|NCT02908685|448616486|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
124725350|NCT02908685|448616487|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
124725351|NCT02908685|448616488|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
124725352|NCT02908685|448616489|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
124725353|NCT02908685|448616490|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
124521284|NCT01224106|447859958|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
124521285|NCT01224106|447859959|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
124521286|NCT01224106|447859960|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
124521287|NCT01224106|447859961|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
124521288|NCT01224106|447859962|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
124521289|NCT01224106|447859958|FG000|Open-Label Extension (OLE) Phase|Death|0|||
124521290|NCT01224106|447859959|FG001|Open-Label Extension (OLE) Phase|Death|0|||
124521291|NCT01224106|447859960|FG002|Open-Label Extension (OLE) Phase|Death|0|||
124725354|NCT02908685|448616491|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
124725355|NCT02908685|448616492|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
124725356|NCT02908685|448616479|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
124725357|NCT02908685|448616480|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
124725358|NCT02908685|448616481|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
124725359|NCT02908685|448616482|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
124725360|NCT02908685|448616483|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
124725361|NCT02908685|448616484|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
124725362|NCT02908685|448616485|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
124521292|NCT01224106|447859961|FG003|Open-Label Extension (OLE) Phase|Death|1|||
124521293|NCT01224106|447859962|FG004|Open-Label Extension (OLE) Phase|Death|3|||
124521294|NCT01224106|447859958|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
124521295|NCT01224106|447859959|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
124776735|NCT02120898|448809964|FG000|Overall Study|Non-compliance with study drug|3|||
124725363|NCT02908685|448616486|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
124725364|NCT02908685|448616487|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
124725365|NCT02908685|448616488|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
124725366|NCT02908685|448616489|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
124575546|NCT01954394|448069177|FG001|Overall Study|Participant Moved|4|||
124521296|NCT01224106|447859960|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
124521297|NCT01224106|447859961|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
124521298|NCT01224106|447859962|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
124521299|NCT01224106|447859958|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
124521300|NCT01224106|447859959|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
124521301|NCT01224106|447859960|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
124521302|NCT01224106|447859961|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
124521303|NCT01224106|447859962|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
124521304|NCT01224106|447859958|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
124521305|NCT01224106|447859959|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
124521306|NCT01224106|447859960|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
124521307|NCT01224106|447859961|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
124521308|NCT01224106|447859962|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
124521309|NCT01224106|447859958|FG000|Open-Label Extension (OLE) Phase|Other|0|||
124521310|NCT01224106|447859959|FG001|Open-Label Extension (OLE) Phase|Other|0|||
124521311|NCT01224106|447859960|FG002|Open-Label Extension (OLE) Phase|Other|0|||
124521312|NCT01224106|447859961|FG003|Open-Label Extension (OLE) Phase|Other|5|||
124521313|NCT01224106|447859962|FG004|Open-Label Extension (OLE) Phase|Other|3|||
124521314|NCT00446797|447859963|FG000|Overall Study|Lack of Efficacy|0|||
124521315|NCT00446797|447859964|FG001|Overall Study|Lack of Efficacy|2|||
124521316|NCT00446797|447859963|FG000|Overall Study|Lost to Follow-up|5|||
124521317|NCT00446797|447859964|FG001|Overall Study|Lost to Follow-up|3|||
124521318|NCT00446797|447859963|FG000|Overall Study|Withdrawal by Subject|2|||
124521319|NCT00446797|447859964|FG001|Overall Study|Withdrawal by Subject|2|||
124521320|NCT00446797|447859963|FG000|Overall Study|Protocol Violation|1|||
124521321|NCT00446797|447859964|FG001|Overall Study|Protocol Violation|3|||
124521322|NCT00446797|447859963|FG000|Overall Study|subject entered at another site|0|||
124521323|NCT00446797|447859964|FG001|Overall Study|subject entered at another site|1|||
124521324|NCT00446797|447859963|FG000|Overall Study|did not meet entrance criteria|0|||
124521325|NCT00446797|447859964|FG001|Overall Study|did not meet entrance criteria|1|||
124521326|NCT02133001|447859965|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
124521327|NCT02133001|447859966|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
124521328|NCT02133001|447859965|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
124521329|NCT02133001|447859966|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
124521330|NCT02133001|447859965|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
124521331|NCT02133001|447859966|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
124521332|NCT02133001|447859965|FG000|Double Blind (Day 1-25)|Other|2|||
124521333|NCT02133001|447859966|FG001|Double Blind (Day 1-25)|Other|2|||
124521334|NCT02133001|447859965|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
124521335|NCT02133001|447859966|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
124521336|NCT02133001|447859965|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
124521337|NCT02133001|447859966|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
124521338|NCT02133001|447859965|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
124521339|NCT02133001|447859966|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
124521340|NCT02133001|447859965|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
124521341|NCT02133001|447859966|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
124521342|NCT02498392|447859971|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
124521343|NCT02498392|447859972|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
124521344|NCT02498392|447859971|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
124521345|NCT02498392|447859972|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
124521346|NCT02498392|447859971|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
124521347|NCT02498392|447859972|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
124521348|NCT02498392|447859971|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
124521349|NCT02498392|447859972|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
124521350|NCT02498392|447859971|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
124521351|NCT02498392|447859972|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
124521352|NCT02498392|447859971|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
124521353|NCT02498392|447859972|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
124521354|NCT03135262|447859975|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
124521355|NCT03135262|447859976|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
124521356|NCT03135262|447859977|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
124521357|NCT03135262|447859978|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
124521358|NCT03135262|447859979|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
124521359|NCT03135262|447859975|FG000|Overall Study|Progression of disease|0|||
124521360|NCT03135262|447859976|FG001|Overall Study|Progression of disease|0|||
124521361|NCT03135262|447859977|FG002|Overall Study|Progression of disease|0|||
124521362|NCT03135262|447859978|FG003|Overall Study|Progression of disease|1|||
124521363|NCT03135262|447859979|FG004|Overall Study|Progression of disease|0|||
124521364|NCT03135262|447859975|FG000|Overall Study|Death|6|||
124521365|NCT03135262|447859976|FG001|Overall Study|Death|2|||
124521366|NCT03135262|447859977|FG002|Overall Study|Death|2|||
124521367|NCT03135262|447859978|FG003|Overall Study|Death|2|||
124521368|NCT03135262|447859979|FG004|Overall Study|Death|0|||
124521369|NCT03135262|447859975|FG000|Overall Study|Withdrawal by Subject|0|||
124521370|NCT03135262|447859976|FG001|Overall Study|Withdrawal by Subject|0|||
124521371|NCT03135262|447859977|FG002|Overall Study|Withdrawal by Subject|1|||
124521372|NCT03135262|447859978|FG003|Overall Study|Withdrawal by Subject|0|||
124521373|NCT03135262|447859979|FG004|Overall Study|Withdrawal by Subject|1|||
124521374|NCT03135262|447859975|FG000|Overall Study|Study terminated by sponsor|2|||
124521375|NCT03135262|447859976|FG001|Overall Study|Study terminated by sponsor|4|||
124521376|NCT03135262|447859977|FG002|Overall Study|Study terminated by sponsor|4|||
124521377|NCT03135262|447859978|FG003|Overall Study|Study terminated by sponsor|3|||
124521378|NCT03135262|447859979|FG004|Overall Study|Study terminated by sponsor|0|||
124521379|NCT01675141|447859980|FG000|Overall Study|Lenalidomide outside NIH|3|||
124521380|NCT01675141|447859980|FG000|Overall Study|Withdrawal by Subject|3|||
124521381|NCT01675141|447859980|FG000|Overall Study|Physician Decision|4|||
124521382|NCT01675141|447859980|FG000|Overall Study|No treatment, per protocol|1|||
124521383|NCT03097133|447859981|FG000|Overall Study|Lost to Follow-up|3|||
124521384|NCT03097133|447859982|FG001|Overall Study|Lost to Follow-up|2|||
124521385|NCT03097133|447859981|FG000|Overall Study|Withdrawal by Subject|2|||
124521386|NCT03097133|447859982|FG001|Overall Study|Withdrawal by Subject|5|||
124521387|NCT03097133|447859981|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
124521388|NCT03097133|447859982|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
124521389|NCT03097133|447859981|FG000|Overall Study|Other|3|||
124521390|NCT03097133|447859982|FG001|Overall Study|Other|2|||
124521391|NCT03097133|447859981|FG000|Overall Study|Adverse Event|1|||
124521392|NCT03097133|447859982|FG001|Overall Study|Adverse Event|0|||
124521393|NCT02873208|447859983|FG000|Overall Study|Withdrawal by Subject|36|||
124521394|NCT02873208|447859983|FG000|Overall Study|Lost to Follow-up|22|||
124521395|NCT02873208|447859983|FG000|Overall Study|Adverse Event|15|||
124521396|NCT02873208|447859983|FG000|Overall Study|Non-compliance with study drug|12|||
124521397|NCT02873208|447859983|FG000|Overall Study|Protocol Violation|8|||
124521398|NCT02873208|447859983|FG000|Overall Study|Pregnancy|2|||
124521399|NCT02873208|447859983|FG000|Overall Study|Incarceration|1|||
124521400|NCT02873208|447859983|FG000|Overall Study|Lack of Efficacy|1|||
124521401|NCT02873208|447859983|FG000|Overall Study|Physician Decision|1|||
124521402|NCT01192100|447859984|FG000|Overall Study|Withdrawal by Subject|0|||
124521403|NCT01192100|447859985|FG001|Overall Study|Withdrawal by Subject|0|||
124521404|NCT01192100|447859986|FG002|Overall Study|Withdrawal by Subject|0|||
124521405|NCT01192100|447859987|FG003|Overall Study|Withdrawal by Subject|0|||
124521406|NCT01192100|447859988|FG004|Overall Study|Withdrawal by Subject|1|||
124521407|NCT01192100|447859989|FG005|Overall Study|Withdrawal by Subject|0|||
124521408|NCT01192100|447859984|FG000|Overall Study|Protocol Violation|0|||
124521409|NCT01192100|447859985|FG001|Overall Study|Protocol Violation|0|||
124521410|NCT01192100|447859986|FG002|Overall Study|Protocol Violation|0|||
124521411|NCT01192100|447859987|FG003|Overall Study|Protocol Violation|1|||
124521412|NCT01192100|447859988|FG004|Overall Study|Protocol Violation|0|||
124521413|NCT01192100|447859989|FG005|Overall Study|Protocol Violation|0|||
124521414|NCT02017704|447859993|FG000|Overall Study|Withdrawal by Subject|2|||
124521415|NCT02017704|447859994|FG001|Overall Study|Withdrawal by Subject|0|||
124521416|NCT00918346|447859995|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
124521417|NCT00918346|447859996|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
124521418|NCT01095666|447859997|FG000|Overall Study|Lack of Efficacy|0|||
124521419|NCT01095666|447859998|FG001|Overall Study|Lack of Efficacy|0|||
124521420|NCT01095666|447859999|FG002|Overall Study|Lack of Efficacy|1|||
124521421|NCT01095666|447859997|FG000|Overall Study|Adverse Event|2|||
124521422|NCT01095666|447859998|FG001|Overall Study|Adverse Event|1|||
124521423|NCT01095666|447859999|FG002|Overall Study|Adverse Event|3|||
124521424|NCT01095666|447859997|FG000|Overall Study|Lost to Follow-up|2|||
124521425|NCT01095666|447859998|FG001|Overall Study|Lost to Follow-up|2|||
124521426|NCT01095666|447859999|FG002|Overall Study|Lost to Follow-up|0|||
124521427|NCT01095666|447859997|FG000|Overall Study|Withdrawal by Subject|6|||
124521428|NCT01095666|447859998|FG001|Overall Study|Withdrawal by Subject|6|||
124521429|NCT01095666|447859999|FG002|Overall Study|Withdrawal by Subject|1|||
124521430|NCT01095666|447859997|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
124521431|NCT01095666|447859998|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
124521432|NCT01095666|447859999|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
124521433|NCT00841672|447860004|FG000|Overall Study|Adverse Event|7|||
124521434|NCT00841672|447860005|FG001|Overall Study|Adverse Event|16|||
124521435|NCT00841672|447860004|FG000|Overall Study|Abnormal test procedure result(s)|0|||
124521436|NCT00841672|447860005|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124521437|NCT00841672|447860004|FG000|Overall Study|Subject withdrew consent|2|||
124521438|NCT00841672|447860005|FG001|Overall Study|Subject withdrew consent|4|||
124521439|NCT00841672|447860004|FG000|Overall Study|Lost to Follow-up|1|||
124521440|NCT00841672|447860005|FG001|Overall Study|Lost to Follow-up|1|||
124521441|NCT00841672|447860004|FG000|Overall Study|Administrative problems|9|||
124521442|NCT00841672|447860005|FG001|Overall Study|Administrative problems|9|||
124521443|NCT00841672|447860004|FG000|Overall Study|Misrandomized|1|||
124521444|NCT00841672|447860005|FG001|Overall Study|Misrandomized|0|||
124521445|NCT00841672|447860004|FG000|Overall Study|Protocol Deviation|0|||
124521446|NCT00841672|447860005|FG001|Overall Study|Protocol Deviation|1|||
124521447|NCT02427100|447860012|FG000|Overall Study|Lost to Follow-up|0|||
124521448|NCT02427100|447860013|FG001|Overall Study|Lost to Follow-up|2|||
124521449|NCT00842361|447860014|FG000|Overall Study|Protocol Violation|1|||
124521450|NCT00842361|447860015|FG001|Overall Study|Protocol Violation|0|||
124521451|NCT00842361|447860014|FG000|Overall Study|Unclassified|0|||
124521452|NCT00842361|447860015|FG001|Overall Study|Unclassified|2|||
124521453|NCT00924729|447860017|FG000|Overall Study|insufficient volume for analysis|1|||
124521454|NCT00924729|447860018|FG001|Overall Study|insufficient volume for analysis|0|||
124521455|NCT00924729|447860017|FG000|Overall Study|Protocol Violation|1|||
124521456|NCT00924729|447860018|FG001|Overall Study|Protocol Violation|0|||
124521457|NCT00981747|447860021|FG000|Losartan|Withdrawal by Subject|1|||
124521458|NCT00981747|447860021|FG000|Losartan|Death|1|||
124521459|NCT00981747|447860021|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
124521460|NCT01814826|447860022|FG000|Overall Study|Other|3|||
124521461|NCT01814826|447860023|FG001|Overall Study|Other|5|||
124521462|NCT01814826|447860024|FG002|Overall Study|Other|0|||
124521463|NCT01814826|447860022|FG000|Overall Study|Death|29|||
124521464|NCT01814826|447860023|FG001|Overall Study|Death|24|||
124521465|NCT01814826|447860024|FG002|Overall Study|Death|3|||
124521466|NCT02917629|447860025|FG000|Overall Study|Withdrawal by Subject|0|||
124521467|NCT02917629|447860026|FG001|Overall Study|Withdrawal by Subject|1|||
124521468|NCT03339401|447860027|FG000|Overall Study|Death|2|||
124521469|NCT03339401|447860028|FG001|Overall Study|Death|1|||
124521470|NCT03339401|447860027|FG000|Overall Study|Withdrawal by Subject|2|||
124521471|NCT03339401|447860028|FG001|Overall Study|Withdrawal by Subject|0|||
124521472|NCT03339401|447860027|FG000|Overall Study|Study terminated|4|||
124521473|NCT03339401|447860028|FG001|Overall Study|Study terminated|3|||
124521474|NCT03339401|447860027|FG000|Overall Study|Investigator Decision|1|||
124521475|NCT03339401|447860028|FG001|Overall Study|Investigator Decision|0|||
124521476|NCT00718523|447860029|FG000|Overall Study|Withdrawal by Subject|5|||
124521477|NCT00718523|447860030|FG001|Overall Study|Withdrawal by Subject|7|||
124521478|NCT00718523|447860029|FG000|Overall Study|Death|13|||
124521479|NCT00718523|447860030|FG001|Overall Study|Death|17|||
124521480|NCT03271307|447860031|FG000|Overall Study|Lost to Follow-up|0|||
124521481|NCT03271307|447860032|FG001|Overall Study|Lost to Follow-up|0|||
124521482|NCT03271307|447860033|FG002|Overall Study|Lost to Follow-up|0|||
124521483|NCT03271307|447860034|FG003|Overall Study|Lost to Follow-up|28|||
124521484|NCT03271307|447860035|FG004|Overall Study|Lost to Follow-up|91|||
124521485|NCT03365947|447860036|FG000|Overall Study|Lost to Follow-up|0|||
124521486|NCT03365947|447860037|FG001|Overall Study|Lost to Follow-up|0|||
124521487|NCT03365947|447860038|FG002|Overall Study|Lost to Follow-up|0|||
124521488|NCT03365947|447860039|FG003|Overall Study|Lost to Follow-up|0|||
124521489|NCT03365947|447860040|FG004|Overall Study|Lost to Follow-up|0|||
124521490|NCT03365947|447860041|FG005|Overall Study|Lost to Follow-up|1|||
124521491|NCT03365947|447860042|FG006|Overall Study|Lost to Follow-up|0|||
124521492|NCT03365947|447860043|FG007|Overall Study|Lost to Follow-up|0|||
124521493|NCT03365947|447860044|FG008|Overall Study|Lost to Follow-up|0|||
124521494|NCT03365947|447860045|FG009|Overall Study|Lost to Follow-up|0|||
124521495|NCT03365947|447860046|FG010|Overall Study|Lost to Follow-up|0|||
124521496|NCT03365947|447860047|FG011|Overall Study|Lost to Follow-up|0|||
124521497|NCT03365947|447860048|FG012|Overall Study|Lost to Follow-up|0|||
124521498|NCT03365947|447860049|FG013|Overall Study|Lost to Follow-up|0|||
124521499|NCT03365947|447860050|FG014|Overall Study|Lost to Follow-up|0|||
124521500|NCT03365947|447860051|FG015|Overall Study|Lost to Follow-up|0|||
124521501|NCT03365947|447860052|FG016|Overall Study|Lost to Follow-up|0|||
124521502|NCT03365947|447860053|FG017|Overall Study|Lost to Follow-up|0|||
124521503|NCT03365947|447860054|FG018|Overall Study|Lost to Follow-up|0|||
124521504|NCT03136484|447860055|FG000|Overall Study|Withdrawal by Subject|19|||
124521505|NCT03136484|447860056|FG001|Overall Study|Withdrawal by Subject|14|||
124521506|NCT03136484|447860055|FG000|Overall Study|Lost to Follow-up|7|||
124521507|NCT03136484|447860056|FG001|Overall Study|Lost to Follow-up|8|||
124521508|NCT03136484|447860055|FG000|Overall Study|Death|1|||
124521509|NCT03136484|447860056|FG001|Overall Study|Death|0|||
124521510|NCT03997760|447860061|FG000|Overall Study|Protocol Deviation|0|||
124521511|NCT03997760|447860062|FG001|Overall Study|Protocol Deviation|1|||
124521512|NCT03997760|447860063|FG002|Overall Study|Protocol Deviation|0|||
124521513|NCT03997760|447860064|FG003|Overall Study|Protocol Deviation|0|||
124521514|NCT00856986|447860065|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
124521515|NCT00856986|447860066|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
124521516|NCT00856986|447860067|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
124521517|NCT00856986|447860068|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
124521518|NCT00856986|447860069|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
124521519|NCT00856986|447860065|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
124521520|NCT00856986|447860066|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
124521521|NCT00856986|447860067|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
124521522|NCT00856986|447860068|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
124521523|NCT00856986|447860069|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
124521524|NCT00856986|447860065|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
124521525|NCT00856986|447860066|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
124521526|NCT00856986|447860067|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
124521527|NCT00856986|447860068|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
124521528|NCT00856986|447860069|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
124521529|NCT00856986|447860065|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
124521530|NCT00856986|447860066|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
124521531|NCT00856986|447860067|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
124521532|NCT00856986|447860068|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
124521533|NCT00856986|447860069|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
124521534|NCT00856986|447860065|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
124521535|NCT00856986|447860066|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
124521536|NCT00856986|447860067|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
124521537|NCT00856986|447860068|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
124521538|NCT00856986|447860069|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
124521539|NCT00856986|447860065|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
124521540|NCT00856986|447860066|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
124521541|NCT00856986|447860067|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
124521542|NCT00856986|447860068|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
124521543|NCT00856986|447860069|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
124521544|NCT00856986|447860065|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
124521545|NCT00856986|447860066|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
124521546|NCT00856986|447860067|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
124521547|NCT00856986|447860068|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
124521548|NCT00856986|447860069|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
124521549|NCT00856986|447860065|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
124521550|NCT00856986|447860066|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
124521551|NCT00856986|447860067|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
124521552|NCT00856986|447860068|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
124521553|NCT00856986|447860069|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
124521554|NCT00856986|447860065|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
124521555|NCT00856986|447860066|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
124521556|NCT00856986|447860067|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
124521557|NCT00856986|447860068|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
124521558|NCT00856986|447860069|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
124521559|NCT00856986|447860065|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
124521560|NCT00856986|447860066|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
124521561|NCT00856986|447860067|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
124521562|NCT00856986|447860068|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
124521563|NCT00856986|447860069|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
124521564|NCT00856986|447860065|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
124521565|NCT00856986|447860066|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
124521566|NCT00856986|447860067|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
124521567|NCT00856986|447860068|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
124521568|NCT00856986|447860069|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
124521569|NCT00856986|447860065|FG000|Main Period, Weeks 0-26|Unclassified|7|||
124521570|NCT00856986|447860066|FG001|Main Period, Weeks 0-26|Unclassified|6|||
124521571|NCT00856986|447860067|FG002|Main Period, Weeks 0-26|Unclassified|7|||
124521572|NCT00856986|447860068|FG003|Main Period, Weeks 0-26|Unclassified|0|||
124521573|NCT00856986|447860069|FG004|Main Period, Weeks 0-26|Unclassified|0|||
124521574|NCT00856986|447860065|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
124521575|NCT00856986|447860066|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
124521576|NCT00856986|447860067|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
124521577|NCT00856986|447860068|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
124521578|NCT00856986|447860069|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
124521579|NCT00856986|447860065|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
124521580|NCT00856986|447860066|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
124521581|NCT00856986|447860067|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
124521582|NCT00856986|447860068|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
124521583|NCT00856986|447860069|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
124521584|NCT00856986|447860065|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
124521585|NCT00856986|447860066|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
124521586|NCT00856986|447860067|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
124521587|NCT00856986|447860068|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
124521588|NCT00856986|447860069|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
124521589|NCT00856986|447860065|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
124521590|NCT00856986|447860066|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
124521591|NCT00856986|447860067|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
124521592|NCT00856986|447860068|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
124521593|NCT00856986|447860069|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
124521594|NCT00856986|447860065|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
124521595|NCT00856986|447860066|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
124521596|NCT00856986|447860067|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
124521597|NCT00856986|447860068|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
124521598|NCT00856986|447860069|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
124521599|NCT00856986|447860065|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
124521600|NCT00856986|447860066|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
124521601|NCT00856986|447860067|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
124521602|NCT00856986|447860068|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
124521603|NCT00856986|447860069|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
124521604|NCT01906476|447860074|FG000|Overall Study|Lost to Follow-up|17|||
124521605|NCT01906476|447860075|FG001|Overall Study|Lost to Follow-up|16|||
124521606|NCT01176240|447860078|FG000|Study 306A|Lack of Efficacy|2|||
124521607|NCT01176240|447860079|FG001|Study 306A|Lack of Efficacy|1|||
124521608|NCT01176240|447860078|FG000|Study 306A|Protocol Violation|0|||
124521609|NCT01176240|447860079|FG001|Study 306A|Protocol Violation|1|||
124521610|NCT01176240|447860078|FG000|Study 306A|Withdrawal by Subject|0|||
124521611|NCT01176240|447860079|FG001|Study 306A|Withdrawal by Subject|1|||
124521612|NCT01176240|447860078|FG000|Study 306A|Stop due to diverse problems|1|||
124521613|NCT01176240|447860079|FG001|Study 306A|Stop due to diverse problems|0|||
124521614|NCT01176240|447860078|FG000|Study 306B|Lack of Efficacy|5|||
124521615|NCT01176240|447860079|FG001|Study 306B|Lack of Efficacy|3|||
124521616|NCT01176240|447860078|FG000|Study 306B|Adverse Event|10|||
124521617|NCT01176240|447860079|FG001|Study 306B|Adverse Event|5|||
124521618|NCT01176240|447860078|FG000|Study 306B|Protocol Violation|2|||
124521619|NCT01176240|447860079|FG001|Study 306B|Protocol Violation|3|||
124521620|NCT01176240|447860078|FG000|Study 306B|Withdrawal by Subject|4|||
124521621|NCT01176240|447860079|FG001|Study 306B|Withdrawal by Subject|1|||
124521622|NCT01176240|447860078|FG000|Study 306B|Physician Decision|2|||
124521623|NCT01176240|447860079|FG001|Study 306B|Physician Decision|1|||
124521624|NCT01176240|447860078|FG000|Study 306B|Supine Hypertension|1|||
124521625|NCT01176240|447860079|FG001|Study 306B|Supine Hypertension|2|||
124521626|NCT01176240|447860078|FG000|Study 306B|Lost to Follow-up|0|||
124521627|NCT01176240|447860079|FG001|Study 306B|Lost to Follow-up|1|||
124521628|NCT01176240|447860078|FG000|Study 306B|withdrew prior to dosing|2|||
124521629|NCT01176240|447860079|FG001|Study 306B|withdrew prior to dosing|1|||
124521630|NCT01931150|447860080|FG000|Overall Study|Withdrawal by Subject|1|||
124521631|NCT01931150|447860081|FG001|Overall Study|Withdrawal by Subject|2|||
124521632|NCT02896192|447860082|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
124521633|NCT02896192|447860082|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
124521634|NCT02896192|447860082|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
124521635|NCT00479167|447860090|FG000|Overall Study|Withdrawal by Subject|1|||
124521636|NCT01390038|447860093|FG000|Overall Study|Death|1|||
124521637|NCT01390038|447860093|FG000|Overall Study|Lost to Follow-up|1|||
124521638|NCT01390038|447860093|FG000|Overall Study|Withdrawal by Subject|4|||
124521639|NCT01390038|447860093|FG000|Overall Study|Simpliciti System Removal|2|||
124521640|NCT03619837|447860097|FG000|Screening|received organs from HCV-negative donors|47|||
124521641|NCT03619837|447860097|FG000|Screening|died on the wait-list|2|||
124521642|NCT03619837|447860097|FG000|Screening|remained on the wait list|40|||
124521643|NCT03619837|447860097|FG000|Screening|didn't meet eligibility criteria|3|||
124521644|NCT03619837|447860097|FG000|Screening|withdrew consent|2|||
124575547|NCT01954394|448069176|FG000|Overall Study|Related to Study Drug administration|2|||
124575548|NCT01954394|448069177|FG001|Overall Study|Related to Study Drug administration|2|||
124575549|NCT01954394|448069176|FG000|Overall Study|Other than specified above|10|||
124575550|NCT01954394|448069177|FG001|Overall Study|Other than specified above|21|||
124575551|NCT04089735|448069178|FG000|Overall Study|Adverse Event|1|||
124575552|NCT04089735|448069179|FG001|Overall Study|Adverse Event|0|||
124575553|NCT04089735|448069180|FG002|Overall Study|Adverse Event|1|||
124575554|NCT04089735|448069181|FG003|Overall Study|Adverse Event|1|||
124725367|NCT02908685|448616490|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
124725368|NCT02908685|448616491|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
124575555|NCT04089735|448069182|FG004|Overall Study|Adverse Event|0|||
124575556|NCT04089735|448069183|FG005|Overall Study|Adverse Event|0|||
124725369|NCT02908685|448616492|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
124725370|NCT02908685|448616479|FG000|Part 2 OLE: > Month 24|Death|0|||
124725371|NCT02908685|448616480|FG001|Part 2 OLE: > Month 24|Death|0|||
124725372|NCT02908685|448616481|FG002|Part 2 OLE: > Month 24|Death|0|||
124725373|NCT02908685|448616482|FG003|Part 2 OLE: > Month 24|Death|0|||
124725374|NCT02908685|448616483|FG004|Part 2 OLE: > Month 24|Death|0|||
124725375|NCT02908685|448616484|FG005|Part 2 OLE: > Month 24|Death|0|||
124725376|NCT02908685|448616485|FG006|Part 2 OLE: > Month 24|Death|0|||
124725377|NCT02908685|448616486|FG007|Part 2 OLE: > Month 24|Death|0|||
124725378|NCT02908685|448616487|FG008|Part 2 OLE: > Month 24|Death|0|||
124725379|NCT02908685|448616488|FG009|Part 2 OLE: > Month 24|Death|0|||
124725380|NCT02908685|448616489|FG010|Part 2 OLE: > Month 24|Death|0|||
124521645|NCT03619837|447860097|FG000|Screening|never listed for HCV-viremic donor|1|||
124575557|NCT04089735|448069178|FG000|Overall Study|Physician Decision|0|||
124575558|NCT04089735|448069179|FG001|Overall Study|Physician Decision|3|||
124521646|NCT03619837|447860097|FG000|Screening|developed exclusion criteria|2|||
124521647|NCT03619837|447860097|FG000|Screening|excluded by the investigator due to non-compliance|1|||
124521648|NCT02650895|447860101|FG000|Overall Study|Withdrawal by Subject|0|||
124521649|NCT02650895|447860102|FG001|Overall Study|Withdrawal by Subject|1|||
124521650|NCT02650895|447860103|FG002|Overall Study|Withdrawal by Subject|0|||
124521651|NCT02650895|447860104|FG003|Overall Study|Withdrawal by Subject|0|||
124521652|NCT02650895|447860105|FG004|Overall Study|Withdrawal by Subject|0|||
124521653|NCT02650895|447860106|FG005|Overall Study|Withdrawal by Subject|0|||
124521654|NCT03038672|447862114|FG000|Initial Treatment|Unacceptable chemistry|0|||
124521655|NCT03038672|447862115|FG001|Initial Treatment|Unacceptable chemistry|1|||
124521656|NCT03038672|447862114|FG000|Initial Treatment|Progression prior to treatment|1|||
124521657|NCT03038672|447862115|FG001|Initial Treatment|Progression prior to treatment|0|||
124521658|NCT03038672|447862114|FG000|Initial Treatment|No treatment per protocol|1|||
124521659|NCT03038672|447862115|FG001|Initial Treatment|No treatment per protocol|0|||
124521660|NCT01696396|447862116|FG000|Overall Study|Withdrawal by Subject|19|||
124521661|NCT01696396|447862117|FG001|Overall Study|Withdrawal by Subject|5|||
124521662|NCT01696396|447862118|FG002|Overall Study|Withdrawal by Subject|19|||
124521663|NCT01696396|447862119|FG003|Overall Study|Withdrawal by Subject|11|||
124521664|NCT01696396|447862116|FG000|Overall Study|Decision by Sponsor|3|||
124521665|NCT01696396|447862117|FG001|Overall Study|Decision by Sponsor|1|||
124521666|NCT01696396|447862118|FG002|Overall Study|Decision by Sponsor|2|||
124521667|NCT01696396|447862119|FG003|Overall Study|Decision by Sponsor|2|||
124521668|NCT01696396|447862116|FG000|Overall Study|Lost to Follow-up|9|||
124521669|NCT01696396|447862117|FG001|Overall Study|Lost to Follow-up|1|||
124521670|NCT01696396|447862118|FG002|Overall Study|Lost to Follow-up|4|||
124521671|NCT01696396|447862119|FG003|Overall Study|Lost to Follow-up|1|||
124521672|NCT01696396|447862116|FG000|Overall Study|Death|0|||
124521673|NCT01696396|447862117|FG001|Overall Study|Death|0|||
124521674|NCT01696396|447862118|FG002|Overall Study|Death|1|||
124521675|NCT01696396|447862119|FG003|Overall Study|Death|0|||
124521676|NCT00959894|447862125|FG000|Overall Study|Lost to Follow-up|10|||
124521677|NCT00959894|447862125|FG000|Overall Study|Adverse Event|3|||
124521678|NCT00959894|447862125|FG000|Overall Study|Withdrawal by Subject|1|||
124521679|NCT00959894|447862125|FG000|Overall Study|Need for contraindicated medication|1|||
124521680|NCT00959894|447862125|FG000|Overall Study|Subject moved out of town|1|||
124521681|NCT00653068|447862126|FG000|Overall Study|Death|9|||
124521682|NCT00653068|447862126|FG000|Overall Study|Lack of Efficacy|34|||
124521683|NCT00653068|447862126|FG000|Overall Study|Physician Decision|4|||
124521684|NCT00653068|447862126|FG000|Overall Study|Withdrawal by Subject|1|||
124521685|NCT00653068|447862126|FG000|Overall Study|Ineligible|2|||
124521686|NCT01305941|447862127|FG000|Overall Study|Adverse Event|6|||
124521687|NCT01305941|447862127|FG000|Overall Study|Clinical decline|2|||
124521688|NCT01305941|447862127|FG000|Overall Study|Withdrawal by Subject|1|||
124521689|NCT01305941|447862127|FG000|Overall Study|Death|1|||
124521690|NCT03950440|447862128|FG000|Overall Study|Death|8|||
124521691|NCT03950440|447862129|FG001|Overall Study|Death|2|||
124521692|NCT03950440|447862130|FG002|Overall Study|Death|1|||
124521693|NCT02892734|447862131|FG000|Treatment on Study|Progressive Disease|2|||
124521694|NCT02892734|447862131|FG000|Follow up for 2 Years|Death|2|||
124521695|NCT02892734|447862131|FG000|Follow up for 2 Years|Study closed early|1|||
124521696|NCT02043509|447862132|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
124521697|NCT02043509|447862133|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
124521698|NCT02043509|447862132|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
124521699|NCT02043509|447862133|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
124521700|NCT02043509|447862132|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
124521701|NCT02043509|447862133|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
124521702|NCT02043509|447862132|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
124521703|NCT02043509|447862133|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
124521704|NCT00608244|447862138|FG000|Overall Study|Adverse Event|1|||
124521705|NCT00608244|447862138|FG000|Overall Study|Low trough levels|1|||
124521706|NCT01957215|447862143|FG000|Overall Study|Adverse Event|2|||
124521707|NCT01957215|447862144|FG001|Overall Study|Adverse Event|2|||
124521708|NCT01957215|447862143|FG000|Overall Study|Lost to Follow-up|3|||
124521709|NCT01957215|447862144|FG001|Overall Study|Lost to Follow-up|3|||
124521710|NCT01957215|447862143|FG000|Overall Study|Protocol Violation|1|||
124521711|NCT01957215|447862144|FG001|Overall Study|Protocol Violation|2|||
124521712|NCT01957215|447862143|FG000|Overall Study|Withdrawal by Subject|7|||
124521713|NCT01957215|447862144|FG001|Overall Study|Withdrawal by Subject|5|||
124521714|NCT01685060|447862152|FG000|Overall Study|Rollover patients|16|||
124521715|NCT01685060|447862152|FG000|Overall Study|Adverse Event|12|||
124521716|NCT01685060|447862152|FG000|Overall Study|Progressive disease|69|||
124521717|NCT01685060|447862152|FG000|Overall Study|Physician Decision|14|||
124521718|NCT01685060|447862152|FG000|Overall Study|Subject/guardian decision|20|||
124521719|NCT01685060|447862152|FG000|Overall Study|Lost to Follow-up|1|||
124521720|NCT01685060|447862152|FG000|Overall Study|Death|8|||
124521721|NCT03597503|447862153|FG000|Overall Study|Withdrawal by Subject|0|||
124521722|NCT03597503|447862154|FG001|Overall Study|Withdrawal by Subject|2|||
124521723|NCT03597503|447862153|FG000|Overall Study|Lost to Follow-up|1|||
124521724|NCT03597503|447862154|FG001|Overall Study|Lost to Follow-up|2|||
124575559|NCT04089735|448069180|FG002|Overall Study|Physician Decision|0|||
124575560|NCT04089735|448069181|FG003|Overall Study|Physician Decision|0|||
124575561|NCT04089735|448069182|FG004|Overall Study|Physician Decision|0|||
124575562|NCT04089735|448069183|FG005|Overall Study|Physician Decision|0|||
124521725|NCT03597503|447862153|FG000|Overall Study|Protocol Violation|1|||
124521726|NCT03597503|447862154|FG001|Overall Study|Protocol Violation|0|||
124521727|NCT02944513|447862155|FG000|Overall Study|Withdrawal by Subject|4|||
124521728|NCT02944513|447862156|FG001|Overall Study|Withdrawal by Subject|1|||
124521729|NCT00937326|447862160|FG000|Overall Study|Adverse Event|0|||
124521730|NCT00937326|447862161|FG001|Overall Study|Adverse Event|3|||
124521731|NCT00937326|447862162|FG002|Overall Study|Adverse Event|1|||
124521732|NCT00937326|447862163|FG003|Overall Study|Adverse Event|1|||
124521733|NCT00937326|447862164|FG004|Overall Study|Adverse Event|2|||
124521734|NCT00937326|447862160|FG000|Overall Study|Death|0|||
124521735|NCT00937326|447862161|FG001|Overall Study|Death|0|||
124521736|NCT00937326|447862162|FG002|Overall Study|Death|1|||
124521737|NCT00937326|447862163|FG003|Overall Study|Death|0|||
124521738|NCT00937326|447862164|FG004|Overall Study|Death|0|||
124521739|NCT00937326|447862160|FG000|Overall Study|Withdrawal by Subject|3|||
124521740|NCT00937326|447862161|FG001|Overall Study|Withdrawal by Subject|4|||
124521741|NCT00937326|447862162|FG002|Overall Study|Withdrawal by Subject|1|||
124521742|NCT00937326|447862163|FG003|Overall Study|Withdrawal by Subject|4|||
124521743|NCT00937326|447862164|FG004|Overall Study|Withdrawal by Subject|3|||
124521744|NCT00937326|447862160|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
124521745|NCT00937326|447862161|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
124521746|NCT00937326|447862162|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
124521747|NCT00937326|447862163|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
124521748|NCT00937326|447862164|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
124521749|NCT02578992|447862165|FG000|Overall Study|equipment not available or malfunction|3|||
124521750|NCT02578992|447862166|FG001|Overall Study|equipment not available or malfunction|3|||
124521751|NCT00086385|447862169|FG000|Overall Study|Death|2|||
124521752|NCT00086385|447862170|FG001|Overall Study|Death|2|||
124521753|NCT00086385|447862171|FG002|Overall Study|Death|1|||
124521754|NCT00086385|447862172|FG003|Overall Study|Death|1|||
124521755|NCT00405275|447862176|FG000|Overall Study|Death|1|||
124521756|NCT00405275|447862177|FG001|Overall Study|Death|0|||
124521757|NCT00405275|447862176|FG000|Overall Study|Lost to Follow-up|5|||
124521758|NCT00405275|447862177|FG001|Overall Study|Lost to Follow-up|1|||
124521759|NCT00405275|447862176|FG000|Overall Study|Withdrawal by Subject|7|||
124521760|NCT00405275|447862177|FG001|Overall Study|Withdrawal by Subject|9|||
124521761|NCT00405275|447862176|FG000|Overall Study|Unwilling to continue|10|||
124521762|NCT00405275|447862177|FG001|Overall Study|Unwilling to continue|9|||
124521763|NCT00731666|447862178|FG000|Overall Study|Adverse Event|2|||
124521764|NCT00731666|447862178|FG000|Overall Study|Lost to Follow-up|8|||
124521765|NCT00731666|447862178|FG000|Overall Study|Withdrawal by Subject|2|||
124521766|NCT02471586|447862181|FG000|Overall Study|Lost to Follow-up|3|||
124521767|NCT02471586|447862182|FG001|Overall Study|Lost to Follow-up|8|||
124521768|NCT02471586|447862183|FG002|Overall Study|Lost to Follow-up|4|||
124521769|NCT02471586|447862181|FG000|Overall Study|Death|2|||
124521770|NCT02471586|447862182|FG001|Overall Study|Death|2|||
124521771|NCT02471586|447862183|FG002|Overall Study|Death|0|||
124521772|NCT01495689|447862191|FG000|Overall Study|Death|0|||
124521773|NCT01495689|447862192|FG001|Overall Study|Death|1|||
124521774|NCT01495689|447862191|FG000|Overall Study|Withdrawal by Subject|3|||
124521775|NCT01495689|447862192|FG001|Overall Study|Withdrawal by Subject|0|||
124521776|NCT01495689|447862191|FG000|Overall Study|Lost to Follow-up|7|||
124521777|NCT01495689|447862192|FG001|Overall Study|Lost to Follow-up|6|||
124521778|NCT00254163|447862193|FG000|Overall Study|Adverse Event|29|||
124521779|NCT00254163|447862194|FG001|Overall Study|Adverse Event|26|||
124521780|NCT00254163|447862193|FG000|Overall Study|Patient request/withdrew consent|6|||
124521781|NCT00254163|447862194|FG001|Overall Study|Patient request/withdrew consent|4|||
124521782|NCT00254163|447862193|FG000|Overall Study|Investigator request|1|||
124521783|NCT00254163|447862194|FG001|Overall Study|Investigator request|3|||
124521784|NCT00254163|447862193|FG000|Overall Study|Failed entry|1|||
124521785|NCT00254163|447862194|FG001|Overall Study|Failed entry|3|||
124521786|NCT00254163|447862193|FG000|Overall Study|Progressive disease|0|||
124521787|NCT00254163|447862194|FG001|Overall Study|Progressive disease|1|||
124521788|NCT00254163|447862193|FG000|Overall Study|Death|0|||
124521789|NCT00254163|447862194|FG001|Overall Study|Death|1|||
124521790|NCT00254163|447862193|FG000|Overall Study|Other|8|||
124521791|NCT00254163|447862194|FG001|Overall Study|Other|8|||
124521792|NCT00606177|447862197|FG000|Overall Study|Adverse Event|9|||
124521793|NCT00606177|447862198|FG001|Overall Study|Adverse Event|5|||
124521794|NCT00606177|447862197|FG000|Overall Study|Lack of Efficacy|3|||
124521795|NCT00606177|447862198|FG001|Overall Study|Lack of Efficacy|7|||
124521796|NCT00606177|447862197|FG000|Overall Study|Physician Decision|1|||
124521797|NCT00606177|447862198|FG001|Overall Study|Physician Decision|0|||
124575563|NCT04089735|448069178|FG000|Overall Study|Withdrawal by Subject|0|||
124575564|NCT04089735|448069179|FG001|Overall Study|Withdrawal by Subject|0|||
124575565|NCT04089735|448069180|FG002|Overall Study|Withdrawal by Subject|1|||
124575566|NCT04089735|448069181|FG003|Overall Study|Withdrawal by Subject|0|||
124575567|NCT04089735|448069182|FG004|Overall Study|Withdrawal by Subject|0|||
124575568|NCT04089735|448069183|FG005|Overall Study|Withdrawal by Subject|0|||
124575569|NCT04089735|448069178|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
124575570|NCT04089735|448069179|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
124575571|NCT04089735|448069180|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
124575572|NCT04089735|448069181|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
124575573|NCT04089735|448069182|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
124575574|NCT04089735|448069183|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
124575575|NCT01439880|448069184|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
124575576|NCT01439880|448069185|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
124575577|NCT01439880|448069184|FG000|SOC-controlled Period (Year 1)|Death|2|||
124575578|NCT01439880|448069185|FG001|SOC-controlled Period (Year 1)|Death|1|||
124575579|NCT01439880|448069184|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
124575580|NCT01439880|448069185|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
124575581|NCT01439880|448069184|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
124575582|NCT01439880|448069185|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
124575583|NCT01439880|448069184|FG000|SOC-controlled Period (Year 1)|Other|8|||
124575584|NCT01439880|448069185|FG001|SOC-controlled Period (Year 1)|Other|13|||
124575585|NCT01439880|448069184|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
124575586|NCT01439880|448069185|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
124575587|NCT01439880|448069184|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
124575588|NCT01439880|448069185|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
124575589|NCT01439880|448069184|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
124575590|NCT01439880|448069185|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
124575591|NCT01439880|448069184|FG000|All-IP Period (Years 2 to 5)|Death|3|||
124575592|NCT01439880|448069185|FG001|All-IP Period (Years 2 to 5)|Death|13|||
124575593|NCT01439880|448069184|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
124575594|NCT01439880|448069185|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
124575595|NCT01439880|448069184|FG000|All-IP Period (Years 2 to 5)|Other|14|||
124575596|NCT01439880|448069185|FG001|All-IP Period (Years 2 to 5)|Other|31|||
124575597|NCT01439880|448069184|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
124575598|NCT01439880|448069185|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
124575599|NCT02956460|448069186|FG000|Lens 1|Lost to Follow-up|1|||
124575600|NCT02956460|448069187|FG001|Lens 1|Lost to Follow-up|0|||
124575601|NCT00834067|448069190|FG000|Washout of 21 Days|Protocol Violation|0|||
124575602|NCT00834067|448069191|FG001|Washout of 21 Days|Protocol Violation|1|||
124575603|NCT04129346|448069192|FG000|Overall Study|Death|1|||
124575604|NCT04129346|448069193|FG001|Overall Study|Death|0|||
124575605|NCT01083693|448069194|FG000|Overall Study|Adverse Event|1|||
124575606|NCT01083693|448069195|FG001|Overall Study|Adverse Event|1|||
124575607|NCT01083693|448069196|FG002|Overall Study|Adverse Event|0|||
124575608|NCT01083693|448069194|FG000|Overall Study|Lost to Follow-up|2|||
124575609|NCT01083693|448069195|FG001|Overall Study|Lost to Follow-up|0|||
124575610|NCT01083693|448069196|FG002|Overall Study|Lost to Follow-up|2|||
124575611|NCT01083693|448069194|FG000|Overall Study|Lack of effectiveness|13|||
124575612|NCT01083693|448069195|FG001|Overall Study|Lack of effectiveness|2|||
124575613|NCT01083693|448069196|FG002|Overall Study|Lack of effectiveness|2|||
124575614|NCT01083693|448069194|FG000|Overall Study|Patient Moved|0|||
124575615|NCT01083693|448069195|FG001|Overall Study|Patient Moved|1|||
124575616|NCT01083693|448069196|FG002|Overall Study|Patient Moved|0|||
124575617|NCT01083693|448069194|FG000|Overall Study|Complete remission|0|||
124575618|NCT01083693|448069195|FG001|Overall Study|Complete remission|1|||
124575619|NCT01083693|448069196|FG002|Overall Study|Complete remission|0|||
124575620|NCT01083693|448069194|FG000|Overall Study|Other medical condition/surgery|1|||
124575621|NCT01083693|448069195|FG001|Overall Study|Other medical condition/surgery|1|||
124575622|NCT01083693|448069196|FG002|Overall Study|Other medical condition/surgery|0|||
124575623|NCT01083693|448069194|FG000|Overall Study|Withdrawal by Subject|3|||
124575624|NCT01083693|448069195|FG001|Overall Study|Withdrawal by Subject|0|||
124575625|NCT01083693|448069196|FG002|Overall Study|Withdrawal by Subject|2|||
124575626|NCT01083693|448069194|FG000|Overall Study|Reason unknown|0|||
124575627|NCT01083693|448069195|FG001|Overall Study|Reason unknown|0|||
124575628|NCT01083693|448069196|FG002|Overall Study|Reason unknown|1|||
124575629|NCT00836056|448069204|FG000|First Intervention|Adverse Event|1|||
124575630|NCT00836056|448069205|FG001|First Intervention|Adverse Event|0|||
124575631|NCT01029340|448069207|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
124575632|NCT01029340|448069208|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
124575633|NCT01029340|448069209|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
124575634|NCT01029340|448069210|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
124521798|NCT00606177|447862197|FG000|Overall Study|Protocol Violation|1|||
124521799|NCT00606177|447862198|FG001|Overall Study|Protocol Violation|4|||
124521800|NCT00606177|447862197|FG000|Overall Study|Withdrawal by Subject|5|||
124725381|NCT02908685|448616490|FG011|Part 2 OLE: > Month 24|Death|0|||
124725382|NCT02908685|448616491|FG012|Part 2 OLE: > Month 24|Death|1|||
124725383|NCT02908685|448616492|FG013|Part 2 OLE: > Month 24|Death|0|||
124725384|NCT02908685|448616479|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
124725385|NCT02908685|448616480|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
124725386|NCT02908685|448616481|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
124725387|NCT02908685|448616482|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
124725388|NCT02908685|448616483|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
124725389|NCT02908685|448616484|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
124725390|NCT02908685|448616485|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
124725391|NCT02908685|448616486|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
124725392|NCT02908685|448616487|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
124725393|NCT02908685|448616488|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
124725394|NCT02908685|448616489|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
124725395|NCT02908685|448616490|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
124725396|NCT02908685|448616491|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
124725397|NCT02908685|448616492|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
124725398|NCT02908685|448616479|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
124725399|NCT02908685|448616480|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
124725400|NCT02908685|448616481|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
124725401|NCT02908685|448616482|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
124725402|NCT02908685|448616483|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
124725403|NCT02908685|448616484|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
124725404|NCT02908685|448616485|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
124725405|NCT02908685|448616486|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
124725406|NCT02908685|448616487|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
124725407|NCT02908685|448616488|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
124725408|NCT02908685|448616489|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
124725409|NCT02908685|448616490|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
124725410|NCT02908685|448616491|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
124725411|NCT02908685|448616492|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
124725412|NCT02370537|448616495|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
124725413|NCT02370537|448616496|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
124725414|NCT02370537|448616497|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
124725415|NCT02370537|448616495|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
124725416|NCT02370537|448616496|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
124725417|NCT02370537|448616497|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
124725418|NCT02370537|448616495|FG000|Part B|Not randomised to receive treatment|1|||
124725419|NCT02370537|448616496|FG001|Part B|Not randomised to receive treatment|2|||
124725420|NCT02370537|448616497|FG002|Part B|Not randomised to receive treatment|259|||
124725421|NCT02370537|448616495|FG000|Part B|Withdrawal by Subject|0|||
124725422|NCT02370537|448616496|FG001|Part B|Withdrawal by Subject|1|||
124725423|NCT02370537|448616497|FG002|Part B|Withdrawal by Subject|0|||
124725424|NCT01691014|448616498|FG000|Overall Study|Premature Termination|1|||
124725425|NCT01691014|448616499|FG001|Overall Study|Premature Termination|6|||
124725426|NCT01691014|448616500|FG002|Overall Study|Premature Termination|0|||
124725427|NCT01691014|448616501|FG003|Overall Study|Premature Termination|3|||
124725428|NCT01691014|448616498|FG000|Overall Study|Other|0|||
124725429|NCT01691014|448616499|FG001|Overall Study|Other|0|||
124725430|NCT01691014|448616500|FG002|Overall Study|Other|2|||
124725431|NCT01691014|448616501|FG003|Overall Study|Other|0|||
124725432|NCT01691014|448616498|FG000|Overall Study|Withdrawal by Subject|0|||
124725433|NCT01691014|448616499|FG001|Overall Study|Withdrawal by Subject|1|||
124725434|NCT01691014|448616500|FG002|Overall Study|Withdrawal by Subject|1|||
124725435|NCT01691014|448616501|FG003|Overall Study|Withdrawal by Subject|1|||
124725436|NCT01691014|448616498|FG000|Overall Study|Adverse Event|0|||
124725437|NCT01691014|448616499|FG001|Overall Study|Adverse Event|5|||
124725438|NCT01691014|448616500|FG002|Overall Study|Adverse Event|1|||
124725439|NCT01691014|448616501|FG003|Overall Study|Adverse Event|1|||
124725440|NCT01691014|448616498|FG000|Overall Study|Lack of Efficacy|2|||
124725441|NCT01691014|448616499|FG001|Overall Study|Lack of Efficacy|3|||
124725442|NCT01691014|448616500|FG002|Overall Study|Lack of Efficacy|7|||
124725443|NCT01691014|448616501|FG003|Overall Study|Lack of Efficacy|0|||
124521801|NCT00606177|447862198|FG001|Overall Study|Withdrawal by Subject|6|||
124725444|NCT03100539|448616508|FG000|Overall Study|Lost to Follow-up|60|||
124725445|NCT03100539|448616509|FG001|Overall Study|Lost to Follow-up|54|||
124725446|NCT03100539|448616510|FG002|Overall Study|Lost to Follow-up|17|||
124725447|NCT03100539|448616508|FG000|Overall Study|Uncollected|8|||
124725448|NCT03100539|448616509|FG001|Overall Study|Uncollected|8|||
124725449|NCT03100539|448616510|FG002|Overall Study|Uncollected|0|||
124521802|NCT00606177|447862197|FG000|Overall Study|Progression to depressive phase|6|||
124725450|NCT03100539|448616508|FG000|Overall Study|Ally Health|0|||
124575635|NCT01029340|448069211|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
124575636|NCT01029340|448069212|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
124575637|NCT01029340|448069207|FG000|Part B Treatment Period|Protocol Violation|0|||
124575638|NCT01029340|448069208|FG001|Part B Treatment Period|Protocol Violation|0|||
124575639|NCT01029340|448069209|FG002|Part B Treatment Period|Protocol Violation|1|||
124575640|NCT01029340|448069210|FG003|Part B Treatment Period|Protocol Violation|0|||
124575641|NCT01029340|448069211|FG004|Part B Treatment Period|Protocol Violation|0|||
124575642|NCT01029340|448069212|FG005|Part B Treatment Period|Protocol Violation|0|||
124575643|NCT01029340|448069207|FG000|Extension Period|Adverse Event|0|||
124575644|NCT01029340|448069208|FG001|Extension Period|Adverse Event|0|||
124575645|NCT01029340|448069209|FG002|Extension Period|Adverse Event|0|||
124575646|NCT01029340|448069210|FG003|Extension Period|Adverse Event|0|||
124575647|NCT01029340|448069211|FG004|Extension Period|Adverse Event|0|||
124575648|NCT01029340|448069212|FG005|Extension Period|Adverse Event|1|||
124575649|NCT01029340|448069207|FG000|Extension Period|starting another study|0|||
124575650|NCT01029340|448069208|FG001|Extension Period|starting another study|0|||
124575651|NCT01029340|448069209|FG002|Extension Period|starting another study|0|||
124575652|NCT01029340|448069210|FG003|Extension Period|starting another study|0|||
124575653|NCT01029340|448069211|FG004|Extension Period|starting another study|0|||
124575654|NCT01029340|448069212|FG005|Extension Period|starting another study|8|||
124575655|NCT01029340|448069207|FG000|Extension Period|non-compliance|0|||
124575656|NCT01029340|448069208|FG001|Extension Period|non-compliance|0|||
124575657|NCT01029340|448069209|FG002|Extension Period|non-compliance|0|||
124575658|NCT01029340|448069210|FG003|Extension Period|non-compliance|0|||
124575659|NCT01029340|448069211|FG004|Extension Period|non-compliance|0|||
124575660|NCT01029340|448069212|FG005|Extension Period|non-compliance|1|||
124575661|NCT01029340|448069207|FG000|Extension Period|Withdrawal by Subject|0|||
124575662|NCT01029340|448069208|FG001|Extension Period|Withdrawal by Subject|0|||
124575663|NCT01029340|448069209|FG002|Extension Period|Withdrawal by Subject|0|||
124575664|NCT01029340|448069210|FG003|Extension Period|Withdrawal by Subject|0|||
124575665|NCT01029340|448069211|FG004|Extension Period|Withdrawal by Subject|0|||
124575666|NCT01029340|448069212|FG005|Extension Period|Withdrawal by Subject|1|||
124575667|NCT01029340|448069207|FG000|Extension Period|Physician Decision|0|||
124575668|NCT01029340|448069208|FG001|Extension Period|Physician Decision|0|||
124575669|NCT01029340|448069209|FG002|Extension Period|Physician Decision|0|||
124575670|NCT01029340|448069210|FG003|Extension Period|Physician Decision|0|||
124575671|NCT01029340|448069211|FG004|Extension Period|Physician Decision|0|||
124575672|NCT01029340|448069212|FG005|Extension Period|Physician Decision|1|||
124575673|NCT02648347|448069213|FG000|Overall Study|Death|174|||
124575674|NCT02648347|448069214|FG001|Overall Study|Death|167|||
124575675|NCT02648347|448069213|FG000|Overall Study|Withdrawal by Subject|16|||
124575676|NCT02648347|448069214|FG001|Overall Study|Withdrawal by Subject|9|||
124575677|NCT02648347|448069213|FG000|Overall Study|Lost to Follow-up|18|||
124575678|NCT02648347|448069214|FG001|Overall Study|Lost to Follow-up|21|||
124575679|NCT02648347|448069213|FG000|Overall Study|Missing|1|||
124575680|NCT02648347|448069214|FG001|Overall Study|Missing|0|||
124575681|NCT03546842|448069216|FG000|Overall Study|Protocol Violation|1|||
124575682|NCT03546842|448069216|FG000|Overall Study|Withdrawal by Subject|2|||
124575683|NCT01265056|448069225|FG000|Initial Study Period|Withdrawal by Subject|1|||
124575684|NCT01265056|448069226|FG001|Initial Study Period|Withdrawal by Subject|1|||
124575685|NCT01265056|448069225|FG000|Initial Study Period|Withdrawal by Subject|1|||
124575686|NCT01265056|448069226|FG001|Initial Study Period|Withdrawal by Subject|1|||
124575687|NCT01265056|448069225|FG000|Follow up|Lost to Follow-up|7|||
124575688|NCT01265056|448069226|FG001|Follow up|Lost to Follow-up|3|||
124575689|NCT00833937|448069235|FG000|Washout|Withdrawal by Subject|1|||
124575690|NCT00833937|448069236|FG001|Washout|Withdrawal by Subject|0|||
124575691|NCT04419311|448069237|FG000|Overall Study|Lost to Follow-up|1|||
124575692|NCT04419311|448069238|FG001|Overall Study|Lost to Follow-up|0|||
124575693|NCT00465270|448069239|FG000|Overall Study|Death|7|||
124575694|NCT00465270|448069240|FG001|Overall Study|Death|11|||
124575695|NCT00465270|448069239|FG000|Overall Study|Withdrawal by Subject|34|||
124575696|NCT00465270|448069240|FG001|Overall Study|Withdrawal by Subject|78|||
124575697|NCT00465270|448069239|FG000|Overall Study|Lost to Follow-up|60|||
124575698|NCT00465270|448069240|FG001|Overall Study|Lost to Follow-up|67|||
124575699|NCT00465270|448069239|FG000|Overall Study|Investigator request|3|||
124575700|NCT00465270|448069240|FG001|Overall Study|Investigator request|4|||
124575701|NCT03233724|448069241|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
124575702|NCT03233724|448069242|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
124575703|NCT03233724|448069243|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
124575704|NCT03233724|448069244|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
124575705|NCT03233724|448069245|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
124575706|NCT03233724|448069241|FG000|Phase I Dose Escalation|Best interest of participant|1|||
124575707|NCT03233724|448069242|FG001|Phase I Dose Escalation|Best interest of participant|1|||
124725451|NCT03100539|448616509|FG001|Overall Study|Ally Health|0|||
124725452|NCT03100539|448616510|FG002|Overall Study|Ally Health|3|||
124725453|NCT03100539|448616508|FG000|Overall Study|Disinterest|0|||
124725454|NCT03100539|448616509|FG001|Overall Study|Disinterest|0|||
124725455|NCT03100539|448616510|FG002|Overall Study|Disinterest|22|||
124725456|NCT03100539|448616508|FG000|Overall Study|Veteran Health|0|||
124725457|NCT03100539|448616509|FG001|Overall Study|Veteran Health|0|||
124725458|NCT03100539|448616510|FG002|Overall Study|Veteran Health|8|||
124725459|NCT03100539|448616508|FG000|Overall Study|Moved|0|||
124725460|NCT03100539|448616509|FG001|Overall Study|Moved|0|||
124725461|NCT03100539|448616510|FG002|Overall Study|Moved|1|||
124725462|NCT03100539|448616508|FG000|Overall Study|Scheduling Conflicts|0|||
124521803|NCT00606177|447862198|FG001|Overall Study|Progression to depressive phase|1|||
124521804|NCT00606177|447862197|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
124521805|NCT00606177|447862198|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
124521806|NCT00606177|447862197|FG000|Overall Study|Change of residence or other commitments|1|||
124521807|NCT00606177|447862198|FG001|Overall Study|Change of residence or other commitments|1|||
124521808|NCT00136357|447862199|FG000|Overall Study|Withdrawal by Subject|3|||
124521809|NCT00136357|447862200|FG001|Overall Study|Withdrawal by Subject|2|||
124521810|NCT00216086|447862205|FG000|Overall Study|Protocol Violation|1|||
124521811|NCT00216086|447862205|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
124521812|NCT00216086|447862205|FG000|Overall Study|Social Reasons|2|||
124521813|NCT01784211|447862209|FG000|Part A (Days 1-15)|Adverse Event|1|||
124521814|NCT01784211|447862210|FG001|Part A (Days 1-15)|Adverse Event|1|||
124521815|NCT01784211|447862211|FG002|Part A (Days 1-15)|Adverse Event|0|||
124521816|NCT01784211|447862212|FG003|Part A (Days 1-15)|Adverse Event|0|||
124521817|NCT01784211|447862213|FG004|Part A (Days 1-15)|Adverse Event|0|||
124521818|NCT01784211|447862214|FG005|Part A (Days 1-15)|Adverse Event|0|||
124521819|NCT01784211|447862209|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
124521820|NCT01784211|447862210|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
124521821|NCT01784211|447862211|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
124521822|NCT01784211|447862212|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
124521823|NCT01784211|447862213|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
124521824|NCT01784211|447862214|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
124521825|NCT01001572|447862215|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
124521826|NCT01001572|447862216|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
124521827|NCT01001572|447862217|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
124521828|NCT01001572|447862215|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
124521829|NCT01001572|447862216|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
124521830|NCT01001572|447862217|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
124521831|NCT01001572|447862215|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
124521832|NCT01001572|447862216|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
124521833|NCT01001572|447862217|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
124521834|NCT01001572|447862215|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
124521835|NCT01001572|447862216|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
124521836|NCT01001572|447862217|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
124521837|NCT01001572|447862215|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
124521838|NCT01001572|447862216|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
124521839|NCT01001572|447862217|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
124521840|NCT01001572|447862215|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
124521841|NCT01001572|447862216|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
124521842|NCT01001572|447862217|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
124521843|NCT01001572|447862215|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
124521844|NCT01001572|447862216|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
124521845|NCT01001572|447862217|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
124521846|NCT01001572|447862215|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
124521847|NCT01001572|447862216|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
124521848|NCT01001572|447862217|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
124521849|NCT01001572|447862215|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
124521850|NCT01001572|447862216|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
124521851|NCT01001572|447862217|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
124521852|NCT01001572|447862215|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
124521853|NCT01001572|447862216|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
124521854|NCT01001572|447862217|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
124521855|NCT01001572|447862215|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
124521856|NCT01001572|447862216|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
124521857|NCT01001572|447862217|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
124521858|NCT01001572|447862215|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
124725463|NCT03100539|448616509|FG001|Overall Study|Scheduling Conflicts|0|||
124725464|NCT03100539|448616510|FG002|Overall Study|Scheduling Conflicts|12|||
124725465|NCT05897242|448616511|FG000|Overall Study|Lost to Follow-up|6|||
124575708|NCT03233724|448069243|FG002|Phase I Dose Escalation|Best interest of participant|1|||
124575709|NCT03233724|448069244|FG003|Phase I Dose Escalation|Best interest of participant|0|||
124575710|NCT03233724|448069245|FG004|Phase I Dose Escalation|Best interest of participant|0|||
124575711|NCT03233724|448069241|FG000|Phase I Dose Escalation|Physician Decision|0|||
124575712|NCT03233724|448069242|FG001|Phase I Dose Escalation|Physician Decision|0|||
124575713|NCT03233724|448069243|FG002|Phase I Dose Escalation|Physician Decision|1|||
124575714|NCT03233724|448069244|FG003|Phase I Dose Escalation|Physician Decision|0|||
124575715|NCT03233724|448069245|FG004|Phase I Dose Escalation|Physician Decision|0|||
124575716|NCT03233724|448069241|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
124575717|NCT03233724|448069242|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
124575718|NCT03233724|448069243|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
124575719|NCT03233724|448069244|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
124575720|NCT03233724|448069245|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
124575721|NCT03135834|448069246|FG000|Stage 1|Adverse Event|1|||
124575722|NCT03135834|448069247|FG001|Stage 1|Adverse Event|2|||
124575723|NCT03135834|448069248|FG002|Stage 1|Adverse Event|2|||
124575724|NCT03135834|448069249|FG003|Stage 1|Adverse Event|1|||
124575725|NCT03135834|448069246|FG000|Stage 1|Death|1|||
124575726|NCT03135834|448069247|FG001|Stage 1|Death|0|||
124575727|NCT03135834|448069248|FG002|Stage 1|Death|0|||
124575728|NCT03135834|448069249|FG003|Stage 1|Death|0|||
124575729|NCT03135834|448069246|FG000|Stage 1|Lost to Follow-up|17|||
124575730|NCT03135834|448069247|FG001|Stage 1|Lost to Follow-up|24|||
124575731|NCT03135834|448069248|FG002|Stage 1|Lost to Follow-up|21|||
124575732|NCT03135834|448069249|FG003|Stage 1|Lost to Follow-up|38|||
124575733|NCT03135834|448069246|FG000|Stage 1|No longer met eligibility criteria|1|||
124575734|NCT03135834|448069247|FG001|Stage 1|No longer met eligibility criteria|6|||
124575735|NCT03135834|448069248|FG002|Stage 1|No longer met eligibility criteria|2|||
124575736|NCT03135834|448069249|FG003|Stage 1|No longer met eligibility criteria|5|||
124575737|NCT03135834|448069246|FG000|Stage 1|Other|0|||
124575738|NCT03135834|448069247|FG001|Stage 1|Other|2|||
124575739|NCT03135834|448069248|FG002|Stage 1|Other|1|||
124575740|NCT03135834|448069249|FG003|Stage 1|Other|0|||
124575741|NCT03135834|448069246|FG000|Stage 1|Physician Decision|0|||
124575742|NCT03135834|448069247|FG001|Stage 1|Physician Decision|1|||
124575743|NCT03135834|448069248|FG002|Stage 1|Physician Decision|0|||
124575744|NCT03135834|448069249|FG003|Stage 1|Physician Decision|0|||
124575745|NCT03135834|448069246|FG000|Stage 1|Pregnancy|0|||
124575746|NCT03135834|448069247|FG001|Stage 1|Pregnancy|4|||
124575747|NCT03135834|448069248|FG002|Stage 1|Pregnancy|2|||
124575748|NCT03135834|448069249|FG003|Stage 1|Pregnancy|4|||
124575749|NCT03135834|448069246|FG000|Stage 1|Protocol Violation|1|||
124575750|NCT03135834|448069247|FG001|Stage 1|Protocol Violation|1|||
124575751|NCT03135834|448069248|FG002|Stage 1|Protocol Violation|2|||
124575752|NCT03135834|448069249|FG003|Stage 1|Protocol Violation|1|||
124575753|NCT03135834|448069246|FG000|Stage 1|Withdrawal by parent/guardian|2|||
124575754|NCT03135834|448069247|FG001|Stage 1|Withdrawal by parent/guardian|10|||
124575755|NCT03135834|448069248|FG002|Stage 1|Withdrawal by parent/guardian|2|||
124575756|NCT03135834|448069249|FG003|Stage 1|Withdrawal by parent/guardian|1|||
124575757|NCT03135834|448069246|FG000|Stage 1|Withdrawal by Subject|16|||
124575758|NCT03135834|448069247|FG001|Stage 1|Withdrawal by Subject|22|||
124575759|NCT03135834|448069248|FG002|Stage 1|Withdrawal by Subject|7|||
124575760|NCT03135834|448069249|FG003|Stage 1|Withdrawal by Subject|10|||
124575761|NCT03135834|448069246|FG000|Stage 1|Randomized but not Vaccinated|0|||
124575762|NCT03135834|448069247|FG001|Stage 1|Randomized but not Vaccinated|3|||
124575763|NCT03135834|448069248|FG002|Stage 1|Randomized but not Vaccinated|1|||
124575764|NCT03135834|448069249|FG003|Stage 1|Randomized but not Vaccinated|6|||
124575765|NCT03135834|448069246|FG000|Stage 2|Lost to Follow-up|0|||
124575766|NCT03135834|448069247|FG001|Stage 2|Lost to Follow-up|1|||
124575767|NCT03135834|448069248|FG002|Stage 2|Lost to Follow-up|0|||
124575768|NCT03135834|448069249|FG003|Stage 2|Lost to Follow-up|0|||
124575769|NCT03135834|448069246|FG000|Stage 2|Withdrawal by Subject|0|||
124575770|NCT03135834|448069247|FG001|Stage 2|Withdrawal by Subject|1|||
124575771|NCT03135834|448069248|FG002|Stage 2|Withdrawal by Subject|0|||
124575772|NCT03135834|448069249|FG003|Stage 2|Withdrawal by Subject|0|||
124575773|NCT03135834|448069246|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
124575774|NCT03135834|448069247|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
124575775|NCT03135834|448069248|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
124725466|NCT05897242|448616512|FG001|Overall Study|Lost to Follow-up|1|||
124575776|NCT03135834|448069249|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
124575777|NCT03135834|448069246|FG000|Stage 2|Did not receive Booster Vaccination|1|||
124575778|NCT03135834|448069247|FG001|Stage 2|Did not receive Booster Vaccination|1|||
124575779|NCT03135834|448069248|FG002|Stage 2|Did not receive Booster Vaccination|0|||
124575780|NCT03135834|448069249|FG003|Stage 2|Did not receive Booster Vaccination|0|||
124575781|NCT01045161|448069250|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
124575782|NCT01045161|448069251|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
124725467|NCT05897242|448616511|FG000|Overall Study|Incomplete|1|||
124575783|NCT01045161|448069252|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
124725468|NCT05897242|448616512|FG001|Overall Study|Incomplete|0|||
124725469|NCT05897242|448616511|FG000|Overall Study|Withdrawal by Subject|1|||
124725470|NCT05897242|448616512|FG001|Overall Study|Withdrawal by Subject|0|||
124725471|NCT00809835|448616513|FG000|Overall Study|Lost to Follow-up|7|||
124725472|NCT00809835|448616514|FG001|Overall Study|Lost to Follow-up|6|||
124725473|NCT00809835|448616515|FG002|Overall Study|Lost to Follow-up|10|||
124725474|NCT00809835|448616516|FG003|Overall Study|Lost to Follow-up|2|||
124725475|NCT00809835|448616513|FG000|Overall Study|Withdrawal by Subject|1|||
124725476|NCT00809835|448616514|FG001|Overall Study|Withdrawal by Subject|1|||
124725477|NCT00809835|448616515|FG002|Overall Study|Withdrawal by Subject|1|||
124725478|NCT00809835|448616516|FG003|Overall Study|Withdrawal by Subject|0|||
124725479|NCT00066703|448616517|FG000|Overall Study|Adverse Event|80|||
124725480|NCT00066703|448616518|FG001|Overall Study|Adverse Event|111|||
124725481|NCT00066703|448616517|FG000|Overall Study|Death|3|||
124725482|NCT00066703|448616518|FG001|Overall Study|Death|0|||
124725483|NCT00066703|448616517|FG000|Overall Study|Lack of Efficacy|114|||
124725484|NCT00066703|448616518|FG001|Overall Study|Lack of Efficacy|69|||
124725485|NCT00066703|448616517|FG000|Overall Study|Lost to Follow-up|31|||
124725486|NCT00066703|448616518|FG001|Overall Study|Lost to Follow-up|28|||
124725487|NCT00066703|448616517|FG000|Overall Study|Withdrawal by Subject|38|||
124725488|NCT00066703|448616518|FG001|Overall Study|Withdrawal by Subject|63|||
124725489|NCT00066703|448616517|FG000|Overall Study|Treatment ongoing|346|||
124725490|NCT00066703|448616518|FG001|Overall Study|Treatment ongoing|311|||
124725491|NCT01696968|448616519|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
124725492|NCT01696968|448616520|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
124725493|NCT01696968|448616519|FG000|Overall Study|Died Before Randomization|3|||
124725494|NCT01696968|448616520|FG001|Overall Study|Died Before Randomization|8|||
124725495|NCT01696968|448616519|FG000|Overall Study|Died Before ASU (Control)|278|||
124725496|NCT01696968|448616520|FG001|Overall Study|Died Before ASU (Control)|0|||
124725497|NCT01696968|448616519|FG000|Overall Study|Refused ASU (Control)|920|||
124725498|NCT01696968|448616520|FG001|Overall Study|Refused ASU (Control)|0|||
124725499|NCT01696968|448616519|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
124725500|NCT01696968|448616520|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
124725501|NCT05659719|448616521|FG000|Overall Study|At sponsor's request|0|||
124725502|NCT05659719|448616522|FG001|Overall Study|At sponsor's request|0|||
124725503|NCT05659719|448616523|FG002|Overall Study|At sponsor's request|0|||
124725504|NCT05659719|448616524|FG003|Overall Study|At sponsor's request|95|||
124725505|NCT05659719|448616521|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
124725506|NCT05659719|448616522|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
124725507|NCT05659719|448616523|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
124725508|NCT05659719|448616524|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
124725509|NCT05659719|448616521|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
124725510|NCT05659719|448616522|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
124725511|NCT05659719|448616523|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
124725512|NCT05659719|448616524|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
124725513|NCT05659719|448616521|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
124725514|NCT05659719|448616522|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
124725515|NCT05659719|448616523|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
124725516|NCT05659719|448616524|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
124725517|NCT05659719|448616521|FG000|Overall Study|Lost to Follow-up|0|||
124725518|NCT05659719|448616522|FG001|Overall Study|Lost to Follow-up|0|||
124725519|NCT05659719|448616523|FG002|Overall Study|Lost to Follow-up|0|||
124725520|NCT05659719|448616524|FG003|Overall Study|Lost to Follow-up|2|||
124725521|NCT05659719|448616521|FG000|Overall Study|Moved to another observational study|0|||
124725522|NCT05659719|448616522|FG001|Overall Study|Moved to another observational study|0|||
124725523|NCT05659719|448616523|FG002|Overall Study|Moved to another observational study|0|||
124725524|NCT05659719|448616524|FG003|Overall Study|Moved to another observational study|1|||
124725525|NCT05659719|448616521|FG000|Overall Study|The child was enrolled in an interventional study|0|||
124725526|NCT05659719|448616522|FG001|Overall Study|The child was enrolled in an interventional study|0|||
124725527|NCT05659719|448616523|FG002|Overall Study|The child was enrolled in an interventional study|0|||
124725528|NCT05659719|448616524|FG003|Overall Study|The child was enrolled in an interventional study|55|||
124725529|NCT05659719|448616521|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
124725530|NCT05659719|448616522|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
124725531|NCT05659719|448616523|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
124725532|NCT05659719|448616524|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
124521859|NCT01001572|447862216|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
124521860|NCT01001572|447862217|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
124575784|NCT01045161|448069250|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
124575785|NCT01045161|448069251|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
124575786|NCT01045161|448069252|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
124575787|NCT01045161|448069250|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
124575788|NCT01045161|448069251|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
124575789|NCT01045161|448069252|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
124575790|NCT01045161|448069250|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
124575791|NCT01045161|448069251|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
124575792|NCT01045161|448069252|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
124575793|NCT01045161|448069250|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
124575794|NCT01045161|448069251|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
124575795|NCT01045161|448069252|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
124575796|NCT01045161|448069250|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
124575797|NCT01045161|448069251|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
124575798|NCT01045161|448069252|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
124575799|NCT01045161|448069250|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
124575800|NCT01045161|448069251|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
124575801|NCT01045161|448069252|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
124575802|NCT01045161|448069250|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
124575803|NCT01045161|448069251|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
124575804|NCT01045161|448069252|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
124575805|NCT01045161|448069250|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
124575806|NCT01045161|448069251|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
124575807|NCT01045161|448069252|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
124575808|NCT01045161|448069250|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
124575809|NCT01045161|448069251|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
124575810|NCT01045161|448069252|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
124575811|NCT01045161|448069250|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
124575812|NCT01045161|448069251|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
124575813|NCT01045161|448069252|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
124575814|NCT01045161|448069250|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
124575815|NCT01045161|448069251|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
124575816|NCT01045161|448069252|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
124575817|NCT01045161|448069250|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
124575818|NCT01045161|448069251|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
124575819|NCT01045161|448069252|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
124575820|NCT01045161|448069250|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
124575821|NCT01045161|448069251|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
124575822|NCT01045161|448069252|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
124575823|NCT02605928|448069255|FG000|Overall Study|Model tuning phase|28|||
124575824|NCT02605928|448069255|FG000|Overall Study|Lack of Efficacy|5|||
124575825|NCT02612337|448069258|FG000|Overall Study|Lack of Efficacy|1|||
124575826|NCT02612337|448069259|FG001|Overall Study|Lack of Efficacy|0|||
124575827|NCT02612337|448069258|FG000|Overall Study|Withdrawal by Subject|2|||
124575828|NCT02612337|448069259|FG001|Overall Study|Withdrawal by Subject|2|||
124575829|NCT02612337|448069258|FG000|Overall Study|Did not receive study drug|0|||
124575830|NCT02612337|448069259|FG001|Overall Study|Did not receive study drug|1|||
124575831|NCT02242201|448069262|FG000|Overall Study|preoperative identified neuropathy|2|||
124575832|NCT02242201|448069263|FG001|Overall Study|preoperative identified neuropathy|0|||
124575833|NCT02242201|448069264|FG002|Overall Study|preoperative identified neuropathy|0|||
124575834|NCT02242201|448069262|FG000|Overall Study|planned post-op anticoagulation|1|||
124575835|NCT02242201|448069263|FG001|Overall Study|planned post-op anticoagulation|0|||
124575836|NCT02242201|448069264|FG002|Overall Study|planned post-op anticoagulation|0|||
124575837|NCT02242201|448069262|FG000|Overall Study|changed surgical procedure|1|||
124575838|NCT02242201|448069263|FG001|Overall Study|changed surgical procedure|0|||
124575839|NCT02242201|448069264|FG002|Overall Study|changed surgical procedure|0|||
124575840|NCT02242201|448069262|FG000|Overall Study|postponed surgery|0|||
124575841|NCT02242201|448069263|FG001|Overall Study|postponed surgery|0|||
124575842|NCT02242201|448069264|FG002|Overall Study|postponed surgery|1|||
124575843|NCT02242201|448069262|FG000|Overall Study|preoperative opioid consumption|0|||
124575844|NCT02242201|448069263|FG001|Overall Study|preoperative opioid consumption|1|||
124575845|NCT02242201|448069264|FG002|Overall Study|preoperative opioid consumption|0|||
124575846|NCT02374853|448069268|FG000|Overall Study|Surgery Cancelled|5|||
124575847|NCT02374853|448069269|FG001|Overall Study|Surgery Cancelled|11|||
124575848|NCT02281084|448069271|FG000|Overall Study|Death|21|||
124575849|NCT02281084|448069272|FG001|Overall Study|Death|18|||
124575850|NCT02281084|448069273|FG002|Overall Study|Death|3|||
124575851|NCT02281084|448069274|FG003|Overall Study|Death|5|||
124575852|NCT02281084|448069271|FG000|Overall Study|Adverse Event|1|||
124575853|NCT02281084|448069272|FG001|Overall Study|Adverse Event|0|||
124575854|NCT02281084|448069273|FG002|Overall Study|Adverse Event|0|||
124575855|NCT02281084|448069274|FG003|Overall Study|Adverse Event|0|||
124575856|NCT02281084|448069271|FG000|Overall Study|Withdrawal by Subject|2|||
124575857|NCT02281084|448069272|FG001|Overall Study|Withdrawal by Subject|2|||
124575858|NCT02281084|448069273|FG002|Overall Study|Withdrawal by Subject|0|||
124575859|NCT02281084|448069274|FG003|Overall Study|Withdrawal by Subject|0|||
124575860|NCT02281084|448069271|FG000|Overall Study|Site Closure by Sponsor|5|||
124575861|NCT02281084|448069272|FG001|Overall Study|Site Closure by Sponsor|1|||
124575862|NCT02281084|448069273|FG002|Overall Study|Site Closure by Sponsor|2|||
124575863|NCT02281084|448069274|FG003|Overall Study|Site Closure by Sponsor|0|||
124575864|NCT01697696|448069275|FG000|Overall Study|Study terminated by sponsor|0|||
124575865|NCT01697696|448069276|FG001|Overall Study|Study terminated by sponsor|3|||
124575866|NCT01697696|448069275|FG000|Overall Study|Protocol deviation|1|||
124575867|NCT01697696|448069276|FG001|Overall Study|Protocol deviation|0|||
124575868|NCT01697696|448069275|FG000|Overall Study|Physician Decision|1|||
124575869|NCT01697696|448069276|FG001|Overall Study|Physician Decision|0|||
124575870|NCT01697696|448069275|FG000|Overall Study|Death|4|||
124575871|NCT01697696|448069276|FG001|Overall Study|Death|2|||
124575872|NCT01697696|448069275|FG000|Overall Study|Lost to Follow-up|10|||
124575873|NCT01697696|448069276|FG001|Overall Study|Lost to Follow-up|7|||
124575874|NCT01697696|448069275|FG000|Overall Study|Subject/guardian decision|31|||
124575875|NCT01697696|448069276|FG001|Overall Study|Subject/guardian decision|35|||
124575876|NCT01424644|448069277|FG000|Overall Study|Adverse Event|2|||
124575877|NCT01424644|448069278|FG001|Overall Study|Adverse Event|0|||
124575878|NCT01424644|448069277|FG000|Overall Study|Withdrawal by Subject|9|||
124575879|NCT01424644|448069278|FG001|Overall Study|Withdrawal by Subject|12|||
124575880|NCT01424644|448069277|FG000|Overall Study|Lost to Follow-up|16|||
124575881|NCT01424644|448069278|FG001|Overall Study|Lost to Follow-up|12|||
124575882|NCT01424644|448069277|FG000|Overall Study|Protocol Violation|4|||
124575883|NCT01424644|448069278|FG001|Overall Study|Protocol Violation|3|||
124575884|NCT01424644|448069277|FG000|Overall Study|Administrative Reason|1|||
124575885|NCT01424644|448069278|FG001|Overall Study|Administrative Reason|0|||
124575886|NCT01424644|448069277|FG000|Overall Study|Unable to Classify|1|||
124575887|NCT01424644|448069278|FG001|Overall Study|Unable to Classify|0|||
124575888|NCT05593965|448069279|FG000|1st Intervention (1 Day)|Technical error|1|||
124575889|NCT05593965|448069280|FG001|1st Intervention (1 Day)|Technical error|0|||
124575890|NCT02024932|448069299|FG000|Overall Study|Adverse Event|2|||
124575891|NCT02024932|448069300|FG001|Overall Study|Adverse Event|3|||
124575892|NCT02024932|448069301|FG002|Overall Study|Adverse Event|0|||
124575893|NCT02024932|448069302|FG003|Overall Study|Adverse Event|0|||
124575894|NCT02024932|448069303|FG004|Overall Study|Adverse Event|2|||
124575895|NCT02024932|448069304|FG005|Overall Study|Adverse Event|0|||
124575896|NCT02024932|448069299|FG000|Overall Study|Abnormal laboratory value|0|||
124575897|NCT02024932|448069300|FG001|Overall Study|Abnormal laboratory value|0|||
124575898|NCT02024932|448069301|FG002|Overall Study|Abnormal laboratory value|0|||
124575899|NCT02024932|448069302|FG003|Overall Study|Abnormal laboratory value|2|||
124575900|NCT02024932|448069303|FG004|Overall Study|Abnormal laboratory value|0|||
124575901|NCT02024932|448069304|FG005|Overall Study|Abnormal laboratory value|0|||
124575902|NCT02445339|448069305|FG000|Overall Study|Physician Decision|1|||
124575903|NCT02445339|448069306|FG001|Overall Study|Physician Decision|0|||
124575904|NCT02445339|448069305|FG000|Overall Study|Lost to Follow-up|11|||
124575905|NCT02445339|448069306|FG001|Overall Study|Lost to Follow-up|15|||
124575906|NCT03020641|448069307|FG000|Overall Study|Lost to Follow-up|0|||
124575907|NCT03020641|448069308|FG001|Overall Study|Lost to Follow-up|1|||
124575908|NCT03020641|448069307|FG000|Overall Study|Converted to open surgery|2|||
124575909|NCT03020641|448069308|FG001|Overall Study|Converted to open surgery|1|||
124575910|NCT03020641|448069307|FG000|Overall Study|for surgery not performed|0|||
124575911|NCT03020641|448069308|FG001|Overall Study|for surgery not performed|1|||
124575912|NCT03041025|448069309|FG000|Overall Study|Adverse Event|0|||
124575913|NCT03041025|448069310|FG001|Overall Study|Adverse Event|0|||
124575914|NCT03041025|448069311|FG002|Overall Study|Adverse Event|1|||
124575915|NCT03041025|448069309|FG000|Overall Study|Lost to Follow-up|1|||
124575916|NCT03041025|448069310|FG001|Overall Study|Lost to Follow-up|0|||
124575917|NCT03041025|448069311|FG002|Overall Study|Lost to Follow-up|0|||
124575918|NCT03041025|448069309|FG000|Overall Study|Withdrawal by Subject|0|||
124575919|NCT03041025|448069310|FG001|Overall Study|Withdrawal by Subject|0|||
124575920|NCT03041025|448069311|FG002|Overall Study|Withdrawal by Subject|1|||
124575921|NCT02963259|448069313|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
124575922|NCT02963259|448069313|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
124575923|NCT02963259|448069313|FG000|Overall Study|Death|1|||
124575924|NCT02963259|448069313|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
124575925|NCT00939003|448069314|FG000|Double-blind Treatment Period|Adverse Event|1|||
124575926|NCT00939003|448069315|FG001|Double-blind Treatment Period|Adverse Event|1|||
124575927|NCT00939003|448069314|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
124575928|NCT00939003|448069315|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
124575929|NCT00939003|448069314|FG000|Double-blind Treatment Period|Pregnancy|0|||
124575930|NCT00939003|448069315|FG001|Double-blind Treatment Period|Pregnancy|1|||
124575931|NCT00939003|448069314|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
124575932|NCT00939003|448069315|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
124575933|NCT00939003|448069314|FG000|Open-label Treatment Period|Adverse Event|4|||
124575934|NCT00939003|448069315|FG001|Open-label Treatment Period|Adverse Event|8|||
124575935|NCT00939003|448069314|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
124575936|NCT00939003|448069315|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
124575937|NCT00939003|448069314|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
124575938|NCT00939003|448069315|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
124575939|NCT00939003|448069314|FG000|Open-label Treatment Period|Pregnancy|1|||
124575940|NCT00939003|448069315|FG001|Open-label Treatment Period|Pregnancy|1|||
124575941|NCT00939003|448069314|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
124575942|NCT00939003|448069315|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
124575943|NCT00939003|448069314|FG000|Open-label Treatment Period|Site Closure|3|||
124575944|NCT00939003|448069315|FG001|Open-label Treatment Period|Site Closure|4|||
124575945|NCT02131129|448069316|FG000|Overall Study|Withdrawal by Subject|1|||
124575946|NCT02131129|448069317|FG001|Overall Study|Withdrawal by Subject|0|||
124575947|NCT00727961|448069318|FG000|Overall Study|Lost to Follow-up|1|||
124575948|NCT00727961|448069318|FG000|Overall Study|Adverse Event|4|||
124575949|NCT00727961|448069318|FG000|Overall Study|Patient's refusal|2|||
124575950|NCT00727961|448069318|FG000|Overall Study|Progression|30|||
124575951|NCT02865122|448069319|FG000|Overall Study|Adverse Event|1|||
124575952|NCT02865122|448069320|FG001|Overall Study|Adverse Event|0|||
124575953|NCT02865122|448069321|FG002|Overall Study|Adverse Event|0|||
124575954|NCT01421277|448069323|FG000|Overall Study|Lack of qualifying event|0|||
124575955|NCT01421277|448069324|FG001|Overall Study|Lack of qualifying event|61|||
124575956|NCT01421277|448069323|FG000|Overall Study|Incomplete baseline data|0|||
124575957|NCT01421277|448069324|FG001|Overall Study|Incomplete baseline data|31|||
124575958|NCT01015703|448071036|FG000|Overall Study|Withdrawal by Subject|0|||
124575959|NCT01015703|448071037|FG001|Overall Study|Withdrawal by Subject|1|||
124575960|NCT01015703|448071038|FG002|Overall Study|Withdrawal by Subject|0|||
124575961|NCT01015703|448071039|FG003|Overall Study|Withdrawal by Subject|0|||
124575962|NCT01015703|448071040|FG004|Overall Study|Withdrawal by Subject|0|||
124575963|NCT01015703|448071036|FG000|Overall Study|Adverse Event|1|||
124575964|NCT01015703|448071037|FG001|Overall Study|Adverse Event|0|||
124575965|NCT01015703|448071038|FG002|Overall Study|Adverse Event|0|||
124575966|NCT01015703|448071039|FG003|Overall Study|Adverse Event|0|||
124575967|NCT01015703|448071040|FG004|Overall Study|Adverse Event|0|||
124575968|NCT01015703|448071036|FG000|Overall Study|Protocol Violation|1|||
124575969|NCT01015703|448071037|FG001|Overall Study|Protocol Violation|0|||
124575970|NCT01015703|448071038|FG002|Overall Study|Protocol Violation|0|||
124575971|NCT01015703|448071039|FG003|Overall Study|Protocol Violation|0|||
124575972|NCT01015703|448071040|FG004|Overall Study|Protocol Violation|0|||
124575973|NCT00834418|448071041|FG000|Overall Study|Adverse Event|0|||
124521861|NCT01001572|447862215|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
124521862|NCT01001572|447862216|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
124521863|NCT01001572|447862217|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
124521864|NCT01001572|447862215|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
124521865|NCT01001572|447862216|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
124521866|NCT01001572|447862217|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
124521867|NCT02025530|447862220|FG000|Overall Study|No longer met elligibility criteria|5|||
124521868|NCT02025530|447862221|FG001|Overall Study|No longer met elligibility criteria|1|||
124521869|NCT00711412|447862222|FG000|Induction Treatment|Death|2|||
124521870|NCT00711412|447862222|FG000|Induction Treatment|Adverse Event|1|||
124521871|NCT00711412|447862222|FG000|Induction Treatment|Other|1|||
124521872|NCT00711412|447862222|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
124521873|NCT00711412|447862222|FG000|Evaluated for Combination Treatment|Death|1|||
124521874|NCT00711412|447862222|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
124521875|NCT00711412|447862222|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
124521876|NCT00711412|447862222|FG000|Combination Treatment|Progressive Disease|1|||
124521877|NCT00711412|447862222|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
124521878|NCT00711412|447862222|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
124521879|NCT00711412|447862222|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
124521880|NCT00711412|447862222|FG000|Evaluation for Response and Surgery|Death|1|||
124575974|NCT00834418|448071042|FG001|Overall Study|Adverse Event|2|||
124575975|NCT01705574|448071043|FG000|Double-Blind Phase|Lost to Follow-up|12|||
124575976|NCT01705574|448071044|FG001|Double-Blind Phase|Lost to Follow-up|16|||
124575977|NCT01705574|448071045|FG002|Double-Blind Phase|Lost to Follow-up|0|||
124521881|NCT00711412|447862222|FG000|Survival Follow up Until Death|Other|12|||
124575978|NCT01705574|448071046|FG003|Double-Blind Phase|Lost to Follow-up|0|||
124575979|NCT01705574|448071043|FG000|Double-Blind Phase|Adverse Event|3|||
124521882|NCT03551626|447862227|FG000|Overall Study|Adverse Event|88|||
124521883|NCT03551626|447862227|FG000|Overall Study|Disease relapse|18|||
124575980|NCT01705574|448071044|FG001|Double-Blind Phase|Adverse Event|10|||
124575981|NCT01705574|448071045|FG002|Double-Blind Phase|Adverse Event|0|||
124521884|NCT03551626|447862227|FG000|Overall Study|Withdrawal of informed consent|6|||
124521885|NCT03551626|447862227|FG000|Overall Study|Patient decision|5|||
124521886|NCT03551626|447862227|FG000|Overall Study|Physician Decision|4|||
124521887|NCT03551626|447862227|FG000|Overall Study|Lost to Follow-up|3|||
124521888|NCT03551626|447862227|FG000|Overall Study|Pregnancy|1|||
124521889|NCT03551626|447862227|FG000|Overall Study|Protocol deviation|1|||
124521890|NCT03551626|447862227|FG000|Overall Study|Technical problems|1|||
124521891|NCT04211961|447862228|FG000|Overall Study|Death|0|||
124521892|NCT04211961|447862229|FG001|Overall Study|Death|1|||
124521893|NCT04211961|447862228|FG000|Overall Study|Lost to Follow-up|0|||
124521894|NCT04211961|447862229|FG001|Overall Study|Lost to Follow-up|1|||
124521895|NCT04211961|447862228|FG000|Overall Study|Withdrawal by Subject|0|||
124521896|NCT04211961|447862229|FG001|Overall Study|Withdrawal by Subject|1|||
124521897|NCT00429572|447862233|FG000|Overall Study|Disease progression|1|||
124521898|NCT04882072|447862234|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
124521899|NCT04882072|447862235|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
124521900|NCT04882072|447862234|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
124521901|NCT04882072|447862235|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
124521902|NCT04882072|447862234|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
124521903|NCT04882072|447862235|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
124521904|NCT02918318|447862236|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
124521905|NCT02918318|447862237|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
124521906|NCT02918318|447862238|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
124521907|NCT02918318|447862239|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
124521908|NCT02918318|447862240|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
124521909|NCT02918318|447862236|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
124521910|NCT02918318|447862237|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
124521911|NCT02918318|447862238|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
124521912|NCT02918318|447862239|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
124521913|NCT02918318|447862240|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
124521914|NCT02918318|447862236|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
124521915|NCT02918318|447862237|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
124521916|NCT02918318|447862238|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
124521917|NCT02918318|447862239|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
124521918|NCT02918318|447862240|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
124521919|NCT02918318|447862236|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
124521920|NCT02918318|447862237|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
124521921|NCT02918318|447862238|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
124521922|NCT02918318|447862239|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
124521923|NCT02918318|447862240|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
124521924|NCT02918318|447862236|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
124521925|NCT02918318|447862237|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
124521926|NCT02918318|447862238|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
124521927|NCT02918318|447862239|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
124521928|NCT02918318|447862240|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
124521929|NCT02918318|447862236|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
124521930|NCT02918318|447862237|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
124521931|NCT02918318|447862238|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
124521932|NCT02918318|447862239|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
124521933|NCT02918318|447862240|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
124521934|NCT02918318|447862236|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
124521935|NCT02918318|447862237|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
124521936|NCT02918318|447862238|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
124521937|NCT02918318|447862239|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
124521938|NCT02918318|447862240|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
124521939|NCT02918318|447862236|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
124521940|NCT02918318|447862237|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
124521941|NCT02918318|447862238|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
124521942|NCT02918318|447862239|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
124521943|NCT02918318|447862240|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
124521944|NCT02918318|447862236|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
124521945|NCT02918318|447862237|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
124521946|NCT02918318|447862238|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
124521947|NCT02918318|447862239|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
124521948|NCT02918318|447862240|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
124521949|NCT02918318|447862236|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
124521950|NCT02918318|447862237|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
124521951|NCT02918318|447862238|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
124575982|NCT01705574|448071046|FG003|Double-Blind Phase|Adverse Event|0|||
124575983|NCT01705574|448071043|FG000|Double-Blind Phase|Withdrew Consent|8|||
124575984|NCT01705574|448071044|FG001|Double-Blind Phase|Withdrew Consent|5|||
124575985|NCT01705574|448071045|FG002|Double-Blind Phase|Withdrew Consent|0|||
124575986|NCT01705574|448071046|FG003|Double-Blind Phase|Withdrew Consent|0|||
124575987|NCT01705574|448071043|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
124575988|NCT01705574|448071044|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
124575989|NCT01705574|448071045|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
124575990|NCT01705574|448071046|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
124575991|NCT01705574|448071043|FG000|Double-Blind Phase|Pregnancy|1|||
124575992|NCT01705574|448071044|FG001|Double-Blind Phase|Pregnancy|1|||
124575993|NCT01705574|448071045|FG002|Double-Blind Phase|Pregnancy|0|||
124575994|NCT01705574|448071046|FG003|Double-Blind Phase|Pregnancy|0|||
124575995|NCT01705574|448071043|FG000|Double-Blind Phase|Protocol Violation|1|||
124575996|NCT01705574|448071044|FG001|Double-Blind Phase|Protocol Violation|0|||
124575997|NCT01705574|448071045|FG002|Double-Blind Phase|Protocol Violation|0|||
124575998|NCT01705574|448071046|FG003|Double-Blind Phase|Protocol Violation|0|||
124575999|NCT01705574|448071043|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
124576000|NCT01705574|448071044|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
124576001|NCT01705574|448071045|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
124576002|NCT01705574|448071046|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
124576003|NCT01705574|448071043|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
124576004|NCT01705574|448071044|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
124576005|NCT01705574|448071045|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
124576006|NCT01705574|448071046|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
124576007|NCT01705574|448071043|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
124576008|NCT01705574|448071044|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
124576009|NCT01705574|448071045|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
124576010|NCT01705574|448071046|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
124576011|NCT01705574|448071043|FG000|Open-Label Extension Phase|Adverse Event|3|||
124576012|NCT01705574|448071044|FG001|Open-Label Extension Phase|Adverse Event|0|||
124576013|NCT01705574|448071045|FG002|Open-Label Extension Phase|Adverse Event|0|||
124576014|NCT01705574|448071046|FG003|Open-Label Extension Phase|Adverse Event|1|||
124576015|NCT01705574|448071043|FG000|Open-Label Extension Phase|Death|2|||
124576016|NCT01705574|448071044|FG001|Open-Label Extension Phase|Death|0|||
124576017|NCT01705574|448071045|FG002|Open-Label Extension Phase|Death|1|||
124576018|NCT01705574|448071046|FG003|Open-Label Extension Phase|Death|0|||
124576019|NCT01705574|448071043|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
124576020|NCT01705574|448071044|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
124576021|NCT01705574|448071045|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
124576022|NCT01705574|448071046|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
124576023|NCT01705574|448071043|FG000|Open-Label Extension Phase|Physician Decision|0|||
124576024|NCT01705574|448071044|FG001|Open-Label Extension Phase|Physician Decision|0|||
124576025|NCT01705574|448071045|FG002|Open-Label Extension Phase|Physician Decision|2|||
124576026|NCT01705574|448071046|FG003|Open-Label Extension Phase|Physician Decision|0|||
124576027|NCT01705574|448071043|FG000|Open-Label Extension Phase|Pregnancy|0|||
124576028|NCT01705574|448071044|FG001|Open-Label Extension Phase|Pregnancy|0|||
124576029|NCT01705574|448071045|FG002|Open-Label Extension Phase|Pregnancy|1|||
124576030|NCT01705574|448071046|FG003|Open-Label Extension Phase|Pregnancy|1|||
124576031|NCT00089661|448071051|FG000|Overall Study|Adverse Event|0|||
124576032|NCT00089661|448071052|FG001|Overall Study|Adverse Event|2|||
124576033|NCT00089661|448071051|FG000|Overall Study|Death|1|||
124576034|NCT00089661|448071052|FG001|Overall Study|Death|0|||
124576035|NCT00089661|448071051|FG000|Overall Study|Lost to Follow-up|0|||
124576036|NCT00089661|448071052|FG001|Overall Study|Lost to Follow-up|3|||
124725533|NCT05659719|448616521|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
124725534|NCT05659719|448616522|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
124725535|NCT05659719|448616523|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
124725536|NCT05659719|448616524|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
124725537|NCT01681186|448616525|FG000|Washout Period From Second Intervention|Adverse Event|0|||
124725538|NCT01681186|448616526|FG001|Washout Period From Second Intervention|Adverse Event|0|||
124725539|NCT01681186|448616527|FG002|Washout Period From Second Intervention|Adverse Event|0|||
124725540|NCT01681186|448616528|FG003|Washout Period From Second Intervention|Adverse Event|0|||
124725541|NCT01681186|448616529|FG004|Washout Period From Second Intervention|Adverse Event|0|||
124725542|NCT01681186|448616530|FG005|Washout Period From Second Intervention|Adverse Event|0|||
124725543|NCT01681186|448616531|FG006|Washout Period From Second Intervention|Adverse Event|1|||
124725544|NCT01681186|448616532|FG007|Washout Period From Second Intervention|Adverse Event|0|||
124725545|NCT01681186|448616525|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
124725546|NCT01681186|448616526|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
124576037|NCT00089661|448071051|FG000|Overall Study|Withdrawal by Subject|11|||
124521952|NCT02918318|447862239|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
124521953|NCT02918318|447862240|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
124521954|NCT02918318|447862236|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
124521955|NCT02918318|447862237|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
124521956|NCT02918318|447862238|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
124521957|NCT02918318|447862239|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
124521958|NCT02918318|447862240|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
124725547|NCT01681186|448616527|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
124725548|NCT01681186|448616528|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
124521959|NCT02918318|447862236|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
124521960|NCT02918318|447862237|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
124521961|NCT02918318|447862238|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
124521962|NCT02918318|447862239|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
124521963|NCT02918318|447862240|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
124521964|NCT03345342|447862241|FG000|Open-Label Phase|Adverse Event|30|||
124521965|NCT03345342|447862242|FG001|Open-Label Phase|Adverse Event|0|||
124521966|NCT03345342|447862243|FG002|Open-Label Phase|Adverse Event|0|||
124521967|NCT03345342|447862244|FG003|Open-Label Phase|Adverse Event|0|||
124521968|NCT03345342|447862245|FG004|Open-Label Phase|Adverse Event|0|||
124521969|NCT03345342|447862241|FG000|Open-Label Phase|Death|1|||
124521970|NCT03345342|447862242|FG001|Open-Label Phase|Death|0|||
124521971|NCT03345342|447862243|FG002|Open-Label Phase|Death|0|||
124521972|NCT03345342|447862244|FG003|Open-Label Phase|Death|0|||
124521973|NCT03345342|447862245|FG004|Open-Label Phase|Death|0|||
124521974|NCT03345342|447862241|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
124521975|NCT03345342|447862242|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
124521976|NCT03345342|447862243|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
124521977|NCT03345342|447862244|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
124521978|NCT03345342|447862245|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
124521979|NCT03345342|447862241|FG000|Open-Label Phase|Lack of Efficacy|6|||
124521980|NCT03345342|447862242|FG001|Open-Label Phase|Lack of Efficacy|0|||
124521981|NCT03345342|447862243|FG002|Open-Label Phase|Lack of Efficacy|0|||
124521982|NCT03345342|447862244|FG003|Open-Label Phase|Lack of Efficacy|0|||
124521983|NCT03345342|447862245|FG004|Open-Label Phase|Lack of Efficacy|0|||
124521984|NCT03345342|447862241|FG000|Open-Label Phase|Lost to Follow-up|9|||
124521985|NCT03345342|447862242|FG001|Open-Label Phase|Lost to Follow-up|0|||
124521986|NCT03345342|447862243|FG002|Open-Label Phase|Lost to Follow-up|0|||
124521987|NCT03345342|447862244|FG003|Open-Label Phase|Lost to Follow-up|0|||
124521988|NCT03345342|447862245|FG004|Open-Label Phase|Lost to Follow-up|0|||
124521989|NCT03345342|447862241|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
124521990|NCT03345342|447862242|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
124521991|NCT03345342|447862243|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
124521992|NCT03345342|447862244|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
124521993|NCT03345342|447862245|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
124521994|NCT03345342|447862241|FG000|Open-Label Phase|Physician Decision|4|||
124521995|NCT03345342|447862242|FG001|Open-Label Phase|Physician Decision|0|||
124521996|NCT03345342|447862243|FG002|Open-Label Phase|Physician Decision|0|||
124521997|NCT03345342|447862244|FG003|Open-Label Phase|Physician Decision|0|||
124521998|NCT03345342|447862245|FG004|Open-Label Phase|Physician Decision|0|||
124521999|NCT03345342|447862241|FG000|Open-Label Phase|Protocol Violation|8|||
124522000|NCT03345342|447862242|FG001|Open-Label Phase|Protocol Violation|0|||
124522001|NCT03345342|447862243|FG002|Open-Label Phase|Protocol Violation|0|||
124522002|NCT03345342|447862244|FG003|Open-Label Phase|Protocol Violation|0|||
124522003|NCT03345342|447862245|FG004|Open-Label Phase|Protocol Violation|0|||
124522004|NCT03345342|447862241|FG000|Open-Label Phase|Withdrawal by Subject|57|||
124522005|NCT03345342|447862242|FG001|Open-Label Phase|Withdrawal by Subject|0|||
124522006|NCT03345342|447862243|FG002|Open-Label Phase|Withdrawal by Subject|0|||
124522007|NCT03345342|447862244|FG003|Open-Label Phase|Withdrawal by Subject|0|||
124522008|NCT03345342|447862245|FG004|Open-Label Phase|Withdrawal by Subject|0|||
124522009|NCT03345342|447862241|FG000|Open-Label Phase|Other|15|||
124522010|NCT03345342|447862242|FG001|Open-Label Phase|Other|0|||
124522011|NCT03345342|447862243|FG002|Open-Label Phase|Other|0|||
124522012|NCT03345342|447862244|FG003|Open-Label Phase|Other|0|||
124522013|NCT03345342|447862245|FG004|Open-Label Phase|Other|0|||
124522014|NCT03345342|447862241|FG000|Double-Blind Phase|Adverse Event|0|||
124522015|NCT03345342|447862242|FG001|Double-Blind Phase|Adverse Event|1|||
124522016|NCT03345342|447862243|FG002|Double-Blind Phase|Adverse Event|6|||
124522017|NCT03345342|447862244|FG003|Double-Blind Phase|Adverse Event|0|||
124522018|NCT03345342|447862245|FG004|Double-Blind Phase|Adverse Event|0|||
124522019|NCT03345342|447862241|FG000|Double-Blind Phase|Death|0|||
124522020|NCT03345342|447862242|FG001|Double-Blind Phase|Death|2|||
124522021|NCT03345342|447862243|FG002|Double-Blind Phase|Death|1|||
124522022|NCT03345342|447862244|FG003|Double-Blind Phase|Death|0|||
124522023|NCT03345342|447862245|FG004|Double-Blind Phase|Death|0|||
124522024|NCT03345342|447862241|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
124522025|NCT03345342|447862242|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
124725549|NCT01681186|448616529|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
124725550|NCT01681186|448616530|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
124725551|NCT01681186|448616531|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
124725552|NCT01681186|448616532|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
124725553|NCT01681186|448616525|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
124725554|NCT01681186|448616526|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
124725555|NCT01681186|448616527|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
124725556|NCT01681186|448616528|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
124725557|NCT01681186|448616529|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
124725558|NCT01681186|448616530|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
124725559|NCT01681186|448616531|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
124725560|NCT01681186|448616532|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
124725561|NCT01681186|448616525|FG000|Fourth Intervention|Protocol Violation|0|||
124725562|NCT01681186|448616526|FG001|Fourth Intervention|Protocol Violation|0|||
124725563|NCT01681186|448616527|FG002|Fourth Intervention|Protocol Violation|0|||
124725564|NCT01681186|448616528|FG003|Fourth Intervention|Protocol Violation|0|||
124725565|NCT01681186|448616529|FG004|Fourth Intervention|Protocol Violation|0|||
124725566|NCT01681186|448616530|FG005|Fourth Intervention|Protocol Violation|0|||
124725567|NCT01681186|448616531|FG006|Fourth Intervention|Protocol Violation|0|||
124725568|NCT01681186|448616532|FG007|Fourth Intervention|Protocol Violation|1|||
124725569|NCT05160415|448616533|FG000|Overall Study|Withdrawal by Subject|3|||
124725570|NCT04848220|448616534|FG000|Overall Study|Unable to proceed to study procedure|0|||
124725571|NCT04848220|448616535|FG001|Overall Study|Unable to proceed to study procedure|1|||
124725572|NCT04848220|448616536|FG002|Overall Study|Unable to proceed to study procedure|0|||
124725573|NCT04848220|448616534|FG000|Overall Study|Fractional flow not significant|0|||
124725574|NCT04848220|448616535|FG001|Overall Study|Fractional flow not significant|1|||
124576038|NCT00089661|448071052|FG001|Overall Study|Withdrawal by Subject|9|||
124576039|NCT00089661|448071051|FG000|Overall Study|Disease progression|1|||
124576040|NCT00089661|448071052|FG001|Overall Study|Disease progression|3|||
124576041|NCT00089661|448071051|FG000|Overall Study|Ineligibility determined|4|||
124576042|NCT00089661|448071052|FG001|Overall Study|Ineligibility determined|4|||
124576043|NCT00089661|448071051|FG000|Overall Study|Noncompliance|2|||
124576044|NCT00089661|448071052|FG001|Overall Study|Noncompliance|4|||
124576045|NCT00089661|448071051|FG000|Overall Study|Other|2|||
124576046|NCT00089661|448071052|FG001|Overall Study|Other|1|||
124576047|NCT01273805|448071053|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
124576048|NCT01273805|448071054|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
124576049|NCT02647944|448071055|FG000|Overall Study|Withdrawal by Subject|0|||
124576050|NCT02647944|448071056|FG001|Overall Study|Withdrawal by Subject|3|||
124576051|NCT02647944|448071055|FG000|Overall Study|Adverse Event|2|||
124576052|NCT02647944|448071056|FG001|Overall Study|Adverse Event|0|||
124576053|NCT02760368|448071058|FG000|Overall Study|Withdrawal by Subject|8|||
124576054|NCT02760368|448071059|FG001|Overall Study|Withdrawal by Subject|12|||
124576055|NCT02760368|448071060|FG002|Overall Study|Withdrawal by Subject|9|||
124576056|NCT02760368|448071058|FG000|Overall Study|Screen Failure|0|||
124576057|NCT02760368|448071059|FG001|Overall Study|Screen Failure|0|||
124576058|NCT02760368|448071060|FG002|Overall Study|Screen Failure|1|||
124576059|NCT02760368|448071058|FG000|Overall Study|Death|0|||
124576060|NCT02760368|448071059|FG001|Overall Study|Death|1|||
124576061|NCT02760368|448071060|FG002|Overall Study|Death|0|||
124576062|NCT02760368|448071058|FG000|Overall Study|Withdrawal by Sponsor|0|||
124576063|NCT02760368|448071059|FG001|Overall Study|Withdrawal by Sponsor|0|||
124576064|NCT02760368|448071060|FG002|Overall Study|Withdrawal by Sponsor|1|||
124576065|NCT03375463|448071061|FG000|Period 1|Lost to Follow-up|0|||
124725575|NCT04848220|448616536|FG002|Overall Study|Fractional flow not significant|0|||
124725576|NCT02923830|448616537|FG000|Overall Study|Physician Decision|13|||
124725577|NCT02923830|448616538|FG001|Overall Study|Physician Decision|15|||
124725578|NCT01751906|448616539|FG000|Overall Study|Lost to Follow-up|151|||
124725579|NCT01751906|448616540|FG001|Overall Study|Lost to Follow-up|68|||
124725580|NCT01751906|448616539|FG000|Overall Study|Withdrawal by Subject|22|||
124576066|NCT03375463|448071062|FG001|Period 1|Lost to Follow-up|0|||
124576067|NCT03375463|448071063|FG002|Period 1|Lost to Follow-up|1|||
124576068|NCT03375463|448071064|FG003|Period 1|Lost to Follow-up|0|||
124576069|NCT03375463|448071065|FG004|Period 1|Lost to Follow-up|0|||
124576070|NCT03375463|448071066|FG005|Period 1|Lost to Follow-up|0|||
124576071|NCT03375463|448071061|FG000|Period 1|Adverse Event|0|||
124576072|NCT03375463|448071062|FG001|Period 1|Adverse Event|0|||
124576073|NCT03375463|448071063|FG002|Period 1|Adverse Event|0|||
124725581|NCT01751906|448616540|FG001|Overall Study|Withdrawal by Subject|18|||
124725582|NCT01751906|448616539|FG000|Overall Study|Physician Decision|5|||
124576074|NCT03375463|448071064|FG003|Period 1|Adverse Event|0|||
124576075|NCT03375463|448071065|FG004|Period 1|Adverse Event|1|||
124576076|NCT03375463|448071066|FG005|Period 1|Adverse Event|0|||
124576077|NCT03375463|448071061|FG000|Period 2|Lost to Follow-up|1|||
124576078|NCT03375463|448071062|FG001|Period 2|Lost to Follow-up|1|||
124725583|NCT01751906|448616540|FG001|Overall Study|Physician Decision|2|||
124725584|NCT01751906|448616539|FG000|Overall Study|Death|84|||
124725585|NCT01751906|448616540|FG001|Overall Study|Death|43|||
124725586|NCT01751906|448616539|FG000|Overall Study|Denied on premises for follow-up by law|1|||
124725587|NCT01751906|448616540|FG001|Overall Study|Denied on premises for follow-up by law|0|||
124725588|NCT01110330|448616541|FG000|Overall Study|Adverse Event|0|||
124725589|NCT01110330|448616542|FG001|Overall Study|Adverse Event|4|||
124725590|NCT01110330|448616543|FG002|Overall Study|Adverse Event|3|||
124725591|NCT01110330|448616541|FG000|Overall Study|Lack of Efficacy|3|||
124725592|NCT01110330|448616542|FG001|Overall Study|Lack of Efficacy|1|||
124725593|NCT01110330|448616543|FG002|Overall Study|Lack of Efficacy|1|||
124725594|NCT01110330|448616541|FG000|Overall Study|Lost to Follow-up|9|||
124725595|NCT01110330|448616542|FG001|Overall Study|Lost to Follow-up|10|||
124725596|NCT01110330|448616543|FG002|Overall Study|Lost to Follow-up|15|||
124725597|NCT01110330|448616541|FG000|Overall Study|Physician Decision|0|||
124725598|NCT01110330|448616542|FG001|Overall Study|Physician Decision|1|||
124725599|NCT01110330|448616543|FG002|Overall Study|Physician Decision|0|||
124725600|NCT01110330|448616541|FG000|Overall Study|Protocol Violation|2|||
124725601|NCT01110330|448616542|FG001|Overall Study|Protocol Violation|0|||
124725602|NCT01110330|448616543|FG002|Overall Study|Protocol Violation|4|||
124725603|NCT01110330|448616541|FG000|Overall Study|Withdrawal by Subject|0|||
124725604|NCT01110330|448616542|FG001|Overall Study|Withdrawal by Subject|6|||
124725605|NCT01110330|448616543|FG002|Overall Study|Withdrawal by Subject|2|||
124725606|NCT01110330|448616541|FG000|Overall Study|Other|1|||
124725607|NCT01110330|448616542|FG001|Overall Study|Other|1|||
124725608|NCT01110330|448616543|FG002|Overall Study|Other|1|||
124725609|NCT02557100|448616552|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
124725610|NCT02557100|448616553|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
124725611|NCT02557100|448616554|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
124725612|NCT02557100|448616552|FG000|Single Blind Treatment Period|Death|0|||
124725613|NCT02557100|448616553|FG001|Single Blind Treatment Period|Death|1|||
124725614|NCT02557100|448616554|FG002|Single Blind Treatment Period|Death|0|||
124725615|NCT02557100|448616552|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
124725616|NCT02557100|448616553|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
124725617|NCT02557100|448616554|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
124725618|NCT02557100|448616552|FG000|Single Blind Treatment Period|Adverse Event|0|||
124725619|NCT02557100|448616553|FG001|Single Blind Treatment Period|Adverse Event|1|||
124725620|NCT02557100|448616554|FG002|Single Blind Treatment Period|Adverse Event|0|||
124725621|NCT02557100|448616552|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
124725622|NCT02557100|448616553|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
124725623|NCT02557100|448616554|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
124725624|NCT02557100|448616552|FG000|Cumulative Abatacept Period|Other Reasons|0|||
124725625|NCT02557100|448616553|FG001|Cumulative Abatacept Period|Other Reasons|0|||
124725626|NCT02557100|448616554|FG002|Cumulative Abatacept Period|Other Reasons|1|||
124725627|NCT02557100|448616552|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
124725628|NCT02557100|448616553|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
124725629|NCT02557100|448616554|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
124725630|NCT02557100|448616552|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
124725631|NCT02557100|448616553|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
124725632|NCT02557100|448616554|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
124725633|NCT00510718|448616557|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
124725634|NCT00510718|448616558|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
124725635|NCT00510718|448616557|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
124725636|NCT00510718|448616558|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
124725637|NCT00510718|448616557|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
124725638|NCT00510718|448616558|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
124725639|NCT00510718|448616557|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
124725640|NCT00510718|448616558|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
124725641|NCT00510718|448616557|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
124725642|NCT00510718|448616558|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
124725643|NCT00510718|448616557|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
124725644|NCT00510718|448616558|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
124725645|NCT02150057|448616568|FG000|Overall Study|Lost to Follow-up|6|||
124725646|NCT02150057|448616569|FG001|Overall Study|Lost to Follow-up|4|||
124725647|NCT00489424|448616570|FG000|Overall Study|Adverse Event|3|||
124725648|NCT00489424|448616571|FG001|Overall Study|Adverse Event|3|||
124725649|NCT00489424|448616572|FG002|Overall Study|Adverse Event|4|||
124725650|NCT00489424|448616570|FG000|Overall Study|Lack of Efficacy|1|||
124725651|NCT00489424|448616571|FG001|Overall Study|Lack of Efficacy|0|||
124725652|NCT00489424|448616572|FG002|Overall Study|Lack of Efficacy|0|||
124725653|NCT00489424|448616570|FG000|Overall Study|Administrative problems|0|||
124725654|NCT00489424|448616571|FG001|Overall Study|Administrative problems|2|||
124576079|NCT03375463|448071063|FG002|Period 2|Lost to Follow-up|0|||
124725655|NCT00489424|448616572|FG002|Overall Study|Administrative problems|1|||
124725656|NCT00394251|448616573|FG000|Overall Study|Adverse Event|7|||
124725657|NCT00394251|448616574|FG001|Overall Study|Adverse Event|5|||
124725658|NCT00394251|448616573|FG000|Overall Study|Unacceptable Toxicity|20|||
124725659|NCT00394251|448616574|FG001|Overall Study|Unacceptable Toxicity|18|||
124725660|NCT00394251|448616573|FG000|Overall Study|Physician Decision|1|||
124725661|NCT00394251|448616574|FG001|Overall Study|Physician Decision|1|||
124725662|NCT00394251|448616573|FG000|Overall Study|Protocol Violation|0|||
124725663|NCT00394251|448616574|FG001|Overall Study|Protocol Violation|1|||
124725664|NCT00394251|448616573|FG000|Overall Study|Withdrawal by Subject|7|||
124522026|NCT03345342|447862243|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
124522027|NCT03345342|447862244|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
124522028|NCT03345342|447862245|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
124522029|NCT03345342|447862241|FG000|Double-Blind Phase|Lost to Follow-up|0|||
124522030|NCT03345342|447862242|FG001|Double-Blind Phase|Lost to Follow-up|1|||
124522031|NCT03345342|447862243|FG002|Double-Blind Phase|Lost to Follow-up|7|||
124522032|NCT03345342|447862244|FG003|Double-Blind Phase|Lost to Follow-up|0|||
124522033|NCT03345342|447862245|FG004|Double-Blind Phase|Lost to Follow-up|0|||
124522034|NCT03345342|447862241|FG000|Double-Blind Phase|Physician Decision|0|||
124522035|NCT03345342|447862242|FG001|Double-Blind Phase|Physician Decision|1|||
124522036|NCT03345342|447862243|FG002|Double-Blind Phase|Physician Decision|4|||
124522037|NCT03345342|447862244|FG003|Double-Blind Phase|Physician Decision|0|||
124522038|NCT03345342|447862245|FG004|Double-Blind Phase|Physician Decision|0|||
124522039|NCT03345342|447862241|FG000|Double-Blind Phase|Protocol Violation|0|||
124522040|NCT03345342|447862242|FG001|Double-Blind Phase|Protocol Violation|0|||
124522041|NCT03345342|447862243|FG002|Double-Blind Phase|Protocol Violation|1|||
124522042|NCT03345342|447862244|FG003|Double-Blind Phase|Protocol Violation|0|||
124522043|NCT03345342|447862245|FG004|Double-Blind Phase|Protocol Violation|0|||
124522044|NCT03345342|447862241|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
124522045|NCT03345342|447862242|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
124522046|NCT03345342|447862243|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
124522047|NCT03345342|447862244|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
124522048|NCT03345342|447862245|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
124522049|NCT03345342|447862241|FG000|Double-Blind Phase|Other|0|||
124522050|NCT03345342|447862242|FG001|Double-Blind Phase|Other|1|||
124522051|NCT03345342|447862243|FG002|Double-Blind Phase|Other|3|||
124522052|NCT03345342|447862244|FG003|Double-Blind Phase|Other|0|||
124522053|NCT03345342|447862245|FG004|Double-Blind Phase|Other|0|||
124522054|NCT03345342|447862241|FG000|Follow-Up Phase|Adverse Event|0|||
124522055|NCT03345342|447862242|FG001|Follow-Up Phase|Adverse Event|0|||
124522056|NCT03345342|447862243|FG002|Follow-Up Phase|Adverse Event|0|||
124522057|NCT03345342|447862244|FG003|Follow-Up Phase|Adverse Event|0|||
124522058|NCT03345342|447862245|FG004|Follow-Up Phase|Adverse Event|4|||
124522059|NCT03345342|447862241|FG000|Follow-Up Phase|Lost to Follow-up|0|||
124522060|NCT03345342|447862242|FG001|Follow-Up Phase|Lost to Follow-up|0|||
124522061|NCT03345342|447862243|FG002|Follow-Up Phase|Lost to Follow-up|0|||
124522062|NCT03345342|447862244|FG003|Follow-Up Phase|Lost to Follow-up|0|||
124522063|NCT03345342|447862245|FG004|Follow-Up Phase|Lost to Follow-up|6|||
124522064|NCT03345342|447862241|FG000|Follow-Up Phase|Physician Decision|0|||
124522065|NCT03345342|447862242|FG001|Follow-Up Phase|Physician Decision|0|||
124522066|NCT03345342|447862243|FG002|Follow-Up Phase|Physician Decision|0|||
124522067|NCT03345342|447862244|FG003|Follow-Up Phase|Physician Decision|0|||
124522068|NCT03345342|447862245|FG004|Follow-Up Phase|Physician Decision|5|||
124522069|NCT03345342|447862241|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
124522070|NCT03345342|447862242|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
124522071|NCT03345342|447862243|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
124522072|NCT03345342|447862244|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
124522073|NCT03345342|447862245|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
124522074|NCT03345342|447862241|FG000|Follow-Up Phase|Other|0|||
124522075|NCT03345342|447862242|FG001|Follow-Up Phase|Other|0|||
124522076|NCT03345342|447862243|FG002|Follow-Up Phase|Other|0|||
124522077|NCT03345342|447862244|FG003|Follow-Up Phase|Other|3|||
124522078|NCT03345342|447862245|FG004|Follow-Up Phase|Other|1|||
124522079|NCT02782104|447862250|FG000|Overall Study|Other|215|||
124522080|NCT02782104|447862250|FG000|Overall Study|Induction Day 28 Non Responder|9|||
124522081|NCT02782104|447862250|FG000|Overall Study|Non-Compliance with Study Drug|2|||
124522082|NCT02782104|447862250|FG000|Overall Study|Death|8|||
124522083|NCT02782104|447862250|FG000|Overall Study|Pregnancy|6|||
124522084|NCT02782104|447862250|FG000|Overall Study|Withdrawal by Subject|63|||
124522085|NCT02782104|447862250|FG000|Overall Study|Protocol Violation|7|||
124522086|NCT02782104|447862250|FG000|Overall Study|Lack of Efficacy|61|||
124725665|NCT00394251|448616574|FG001|Overall Study|Withdrawal by Subject|11|||
124522087|NCT02782104|447862250|FG000|Overall Study|Lost to Follow-up|23|||
124522088|NCT02782104|447862250|FG000|Overall Study|Adverse Event|74|||
124522089|NCT03185819|447862251|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
124522090|NCT03185819|447862252|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
124522091|NCT03185819|447862253|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
124576080|NCT03375463|448071064|FG003|Period 2|Lost to Follow-up|0|||
124576081|NCT03375463|448071065|FG004|Period 2|Lost to Follow-up|0|||
124576082|NCT03375463|448071066|FG005|Period 2|Lost to Follow-up|0|||
124576083|NCT01602419|448071067|FG000|Overall Study|Not treated with Wilate|9|||
124576084|NCT01602419|448071067|FG000|Overall Study|Adverse Drug Reaction|4|||
124576085|NCT01602419|448071067|FG000|Overall Study|Insurance issues|3|||
124576086|NCT01602419|448071067|FG000|Overall Study|Changed treatment centre|1|||
124576087|NCT01602419|448071067|FG000|Overall Study|Treatment centre closed|1|||
124576088|NCT01602419|448071067|FG000|Overall Study|Withdrawal by Subject|5|||
124576089|NCT01602419|448071067|FG000|Overall Study|Lost to Follow-up|6|||
124576090|NCT01792635|448071068|FG000|Part B|Adverse Event|0|||
124576091|NCT01792635|448071069|FG001|Part B|Adverse Event|0|||
124576092|NCT01792635|448071070|FG002|Part B|Adverse Event|1|||
124576093|NCT01792635|448071068|FG000|Part B|Study terminated|0|||
124576094|NCT01792635|448071069|FG001|Part B|Study terminated|4|||
124576095|NCT01792635|448071070|FG002|Part B|Study terminated|3|||
124576096|NCT02902211|448071074|FG000|First Three Months|Withdrawal by Subject|7|||
124576097|NCT02902211|448071075|FG001|First Three Months|Withdrawal by Subject|3|||
124576098|NCT01513174|448071078|FG000|Overall Study|Inclusion Error|1|||
124576099|NCT01513174|448071079|FG001|Overall Study|Inclusion Error|7|||
124576100|NCT01513174|448071078|FG000|Overall Study|Not receive study treatment|3|||
124576101|NCT01513174|448071079|FG001|Overall Study|Not receive study treatment|1|||
124576102|NCT02682784|448071087|FG000|Overall Study|Withdrawal by Subject|0|||
124576103|NCT02682784|448071088|FG001|Overall Study|Withdrawal by Subject|2|||
124576104|NCT02682784|448071089|FG002|Overall Study|Withdrawal by Subject|1|||
124576105|NCT02682784|448071090|FG003|Overall Study|Withdrawal by Subject|2|||
124576106|NCT02682784|448071087|FG000|Overall Study|Physician Decision|1|||
124576107|NCT02682784|448071088|FG001|Overall Study|Physician Decision|0|||
124576108|NCT02682784|448071089|FG002|Overall Study|Physician Decision|1|||
124576109|NCT02682784|448071090|FG003|Overall Study|Physician Decision|1|||
124576110|NCT00467363|448071091|FG000|Overall Study|Lost to Follow-up|80|||
124576111|NCT00467363|448071092|FG001|Overall Study|Lost to Follow-up|70|||
124576112|NCT04533594|448071093|FG000|Overall Study|Death|26|||
124576113|NCT01401647|448071096|FG000|Overall Study|Withdrawal by Subject|1|||
124576114|NCT01401647|448071097|FG001|Overall Study|Withdrawal by Subject|5|||
124576115|NCT01401647|448071098|FG002|Overall Study|Withdrawal by Subject|2|||
124576116|NCT01401647|448071096|FG000|Overall Study|Lost to Follow-up|3|||
124576117|NCT01401647|448071097|FG001|Overall Study|Lost to Follow-up|3|||
124576118|NCT01401647|448071098|FG002|Overall Study|Lost to Follow-up|1|||
124576119|NCT00473330|448071102|FG000|Core Study|Adverse Event|4|||
124576120|NCT00473330|448071103|FG001|Core Study|Adverse Event|4|||
124576121|NCT00473330|448071104|FG002|Core Study|Adverse Event|1|||
124576122|NCT00473330|448071102|FG000|Core Study|Death|6|||
124576123|NCT00473330|448071103|FG001|Core Study|Death|4|||
124576124|NCT00473330|448071104|FG002|Core Study|Death|4|||
124576125|NCT00473330|448071102|FG000|Core Study|Lost to Follow-up|5|||
124576126|NCT00473330|448071103|FG001|Core Study|Lost to Follow-up|5|||
124576127|NCT00473330|448071104|FG002|Core Study|Lost to Follow-up|10|||
124576128|NCT00473330|448071102|FG000|Core Study|Physician Decision|2|||
124576129|NCT00473330|448071103|FG001|Core Study|Physician Decision|1|||
124576130|NCT00473330|448071104|FG002|Core Study|Physician Decision|3|||
124576131|NCT00473330|448071102|FG000|Core Study|Subject Non-compliance|1|||
124576132|NCT00473330|448071103|FG001|Core Study|Subject Non-compliance|2|||
124576133|NCT00473330|448071104|FG002|Core Study|Subject Non-compliance|1|||
124576134|NCT00473330|448071102|FG000|Core Study|Subject Required Other Therapy|0|||
124576135|NCT00473330|448071103|FG001|Core Study|Subject Required Other Therapy|1|||
124576136|NCT00473330|448071104|FG002|Core Study|Subject Required Other Therapy|3|||
124576137|NCT00473330|448071102|FG000|Core Study|Subject's Decision|9|||
124576138|NCT00473330|448071103|FG001|Core Study|Subject's Decision|8|||
124576139|NCT00473330|448071104|FG002|Core Study|Subject's Decision|19|||
124576140|NCT00473330|448071102|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
124576141|NCT00473330|448071103|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
124576142|NCT00473330|448071104|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
124576143|NCT00473330|448071102|FG000|Open-label Extension Through Month 48|Death|2|||
124576144|NCT00473330|448071103|FG001|Open-label Extension Through Month 48|Death|0|||
124576145|NCT00473330|448071104|FG002|Open-label Extension Through Month 48|Death|0|||
124576146|NCT00473330|448071102|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
124576147|NCT00473330|448071103|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
124576148|NCT00473330|448071104|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
124576149|NCT00473330|448071102|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
124576150|NCT00473330|448071103|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
124576151|NCT00473330|448071104|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
124576152|NCT00473330|448071102|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
124576153|NCT00473330|448071103|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
124576154|NCT00473330|448071104|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
124576155|NCT00473330|448071102|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
124576156|NCT00473330|448071103|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
124576157|NCT00473330|448071104|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
124576158|NCT00473330|448071102|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
124576159|NCT00473330|448071103|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
124576160|NCT00473330|448071104|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
124576161|NCT00473330|448071102|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
124576162|NCT00473330|448071103|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
124576163|NCT00473330|448071104|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
124576164|NCT00473330|448071102|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
124576165|NCT00473330|448071103|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
124576166|NCT00473330|448071104|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
124576167|NCT00473330|448071102|FG000|Open-label Extension Through Month 60|Death|2|||
124576168|NCT00473330|448071103|FG001|Open-label Extension Through Month 60|Death|2|||
124576169|NCT00473330|448071104|FG002|Open-label Extension Through Month 60|Death|1|||
124576170|NCT00473330|448071102|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
124576171|NCT00473330|448071103|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
124576172|NCT00473330|448071104|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
124576173|NCT00473330|448071102|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
124576174|NCT00473330|448071103|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
124576175|NCT00473330|448071104|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
124576176|NCT00473330|448071102|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
124576177|NCT00473330|448071103|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
124576178|NCT00473330|448071104|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
124576179|NCT00473330|448071102|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
124576180|NCT00473330|448071103|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
124576181|NCT00473330|448071104|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
124576182|NCT00473330|448071102|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
124576183|NCT00473330|448071103|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
124576184|NCT00473330|448071104|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
124576185|NCT00473330|448071102|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
124576186|NCT00473330|448071103|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
124576187|NCT00473330|448071104|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
124576188|NCT01975948|448071106|FG000|Overall Study|Withdrawal by Subject|17|||
124576189|NCT01975948|448071107|FG001|Overall Study|Withdrawal by Subject|21|||
124576190|NCT01975948|448071108|FG002|Overall Study|Withdrawal by Subject|7|||
124576191|NCT01975948|448071109|FG003|Overall Study|Withdrawal by Subject|6|||
124576192|NCT01675765|448071110|FG000|Overall Study|Progressive disease|4|||
124576193|NCT01675765|448071111|FG001|Overall Study|Progressive disease|4|||
124576194|NCT01675765|448071110|FG000|Overall Study|Adverse Event|1|||
124576195|NCT01675765|448071111|FG001|Overall Study|Adverse Event|2|||
124576196|NCT01675765|448071110|FG000|Overall Study|Withdrawal by Subject|2|||
124576197|NCT01675765|448071111|FG001|Overall Study|Withdrawal by Subject|0|||
124576198|NCT01675765|448071110|FG000|Overall Study|Death|1|||
124576199|NCT01675765|448071111|FG001|Overall Study|Death|0|||
124576200|NCT01675765|448071110|FG000|Overall Study|Clinical progression|3|||
124576201|NCT01675765|448071111|FG001|Overall Study|Clinical progression|2|||
124576202|NCT01723397|448071116|FG000|Study Period 1|Protocol Violation|0|||
124576203|NCT01723397|448071117|FG001|Study Period 1|Protocol Violation|1|||
124576204|NCT01723397|448071116|FG000|Study Period 2|Protocol Violation|0|||
124576205|NCT01723397|448071117|FG001|Study Period 2|Protocol Violation|1|||
124576206|NCT02196675|448071118|FG000|Overall Study|Withdrawal by Subject|1|||
124576207|NCT02196675|448071119|FG001|Overall Study|Withdrawal by Subject|0|||
124576208|NCT02196675|448071120|FG002|Overall Study|Withdrawal by Subject|0|||
124576209|NCT02196675|448071118|FG000|Overall Study|Intra-operative surgical exclusion|1|||
124576210|NCT02196675|448071119|FG001|Overall Study|Intra-operative surgical exclusion|1|||
124576211|NCT02196675|448071120|FG002|Overall Study|Intra-operative surgical exclusion|0|||
124576212|NCT02196675|448071118|FG000|Overall Study|Protocol Violation|0|||
124576213|NCT02196675|448071119|FG001|Overall Study|Protocol Violation|1|||
124576214|NCT02196675|448071120|FG002|Overall Study|Protocol Violation|0|||
124576215|NCT02196675|448071118|FG000|Overall Study|Death|0|||
124576216|NCT02196675|448071119|FG001|Overall Study|Death|0|||
124576217|NCT02196675|448071120|FG002|Overall Study|Death|1|||
124576218|NCT02711852|448071121|FG000|Overall Study|Death|5|||
124576219|NCT02711852|448071121|FG000|Overall Study|Lost to Follow-up|1|||
124576220|NCT02711852|448071121|FG000|Overall Study|Completed follow-up|3|||
124576221|NCT02711852|448071121|FG000|Overall Study|Withdrawal by Subject|1|||
124576222|NCT00537979|448071122|FG000|Overall Study|Adverse Event|2|||
124576223|NCT00537979|448071123|FG001|Overall Study|Adverse Event|2|||
124576224|NCT00537979|448071122|FG000|Overall Study|Withdrawal by Subject|1|||
124576225|NCT00537979|448071123|FG001|Overall Study|Withdrawal by Subject|4|||
124576226|NCT00537979|448071122|FG000|Overall Study|Lost to Follow-up|1|||
124725666|NCT00394251|448616573|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
124725667|NCT00394251|448616574|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
124725668|NCT05791565|448616575|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
124725669|NCT05791565|448616576|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
124725670|NCT02388165|448616577|FG000|Overall Study|Study terminated by sponsor|5|||
124576227|NCT00537979|448071123|FG001|Overall Study|Lost to Follow-up|4|||
124576228|NCT00537979|448071122|FG000|Overall Study|Lack of Efficacy|0|||
124576229|NCT00537979|448071123|FG001|Overall Study|Lack of Efficacy|1|||
124576230|NCT00537979|448071122|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
124576231|NCT00537979|448071123|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
124576232|NCT00537979|448071122|FG000|Overall Study|Death|0|||
124576233|NCT00537979|448071123|FG001|Overall Study|Death|3|||
124576234|NCT00537979|448071122|FG000|Overall Study|Kidney transplant|0|||
124576235|NCT00537979|448071123|FG001|Overall Study|Kidney transplant|3|||
124576236|NCT00537979|448071122|FG000|Overall Study|Heart failure|0|||
124576237|NCT00537979|448071123|FG001|Overall Study|Heart failure|1|||
124576238|NCT02009163|448071124|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
124576239|NCT02009163|448071125|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
124576240|NCT02009163|448071126|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
124576241|NCT02009163|448071124|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
124576242|NCT02009163|448071125|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
124576243|NCT02009163|448071126|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
124576244|NCT02009163|448071124|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
124576245|NCT02009163|448071125|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
124576246|NCT02009163|448071126|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
124576247|NCT02009163|448071124|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
124576248|NCT02009163|448071125|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
124576249|NCT02009163|448071126|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
124576250|NCT02009163|448071124|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
124576251|NCT02009163|448071125|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
124576252|NCT02009163|448071126|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
124576253|NCT02009163|448071124|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
124576254|NCT02009163|448071125|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
124576255|NCT02009163|448071126|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
124576256|NCT02009163|448071124|FG000|Open-label Period (Non-randomized)|Other|13|||
124576257|NCT02009163|448071125|FG001|Open-label Period (Non-randomized)|Other|0|||
124576258|NCT02009163|448071126|FG002|Open-label Period (Non-randomized)|Other|0|||
124576259|NCT02009163|448071124|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
124576260|NCT02009163|448071125|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
124576261|NCT02009163|448071126|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
124576262|NCT02009163|448071124|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
124576263|NCT02009163|448071125|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
124576264|NCT02009163|448071126|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
124576265|NCT02009163|448071124|FG000|Randomized-withdrawal Period|Adverse Event|0|||
124576266|NCT02009163|448071125|FG001|Randomized-withdrawal Period|Adverse Event|0|||
124576267|NCT02009163|448071126|FG002|Randomized-withdrawal Period|Adverse Event|6|||
124576268|NCT02009163|448071124|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
124576269|NCT02009163|448071125|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
124576270|NCT02009163|448071126|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
124576271|NCT02009163|448071124|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
124576272|NCT02009163|448071125|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
124576273|NCT02009163|448071126|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
124576274|NCT02009163|448071124|FG000|Randomized-withdrawal Period|Pregnancy|0|||
124576275|NCT02009163|448071125|FG001|Randomized-withdrawal Period|Pregnancy|0|||
124576276|NCT02009163|448071126|FG002|Randomized-withdrawal Period|Pregnancy|2|||
124576277|NCT02009163|448071124|FG000|Randomized-withdrawal Period|Other|0|||
124576278|NCT02009163|448071125|FG001|Randomized-withdrawal Period|Other|9|||
124576279|NCT02009163|448071126|FG002|Randomized-withdrawal Period|Other|5|||
124576280|NCT02453386|448071127|FG000|Overall Study|Adverse Event|22|||
124725671|NCT02388165|448616578|FG001|Overall Study|Study terminated by sponsor|5|||
124725672|NCT02388165|448616577|FG000|Overall Study|Other|11|||
124725673|NCT02388165|448616578|FG001|Overall Study|Other|13|||
124576281|NCT02453386|448071128|FG001|Overall Study|Adverse Event|30|||
124576282|NCT02453386|448071129|FG002|Overall Study|Adverse Event|15|||
124576283|NCT02453386|448071127|FG000|Overall Study|Protocol Violation|1|||
124576284|NCT02453386|448071128|FG001|Overall Study|Protocol Violation|0|||
124576285|NCT02453386|448071129|FG002|Overall Study|Protocol Violation|1|||
124576286|NCT02453386|448071127|FG000|Overall Study|Withdrawal by Subject|10|||
124725674|NCT02388165|448616577|FG000|Overall Study|No longer meet eligibility criteria|40|||
124725675|NCT02388165|448616578|FG001|Overall Study|No longer meet eligibility criteria|43|||
124576287|NCT02453386|448071128|FG001|Overall Study|Withdrawal by Subject|9|||
124576288|NCT02453386|448071129|FG002|Overall Study|Withdrawal by Subject|9|||
124576289|NCT02453386|448071127|FG000|Overall Study|Sponsor Terminated Study|14|||
124576290|NCT02453386|448071128|FG001|Overall Study|Sponsor Terminated Study|8|||
124576291|NCT02453386|448071129|FG002|Overall Study|Sponsor Terminated Study|11|||
124576292|NCT02453386|448071127|FG000|Overall Study|Subject Terminated by Sponsor|1|||
124576293|NCT02453386|448071128|FG001|Overall Study|Subject Terminated by Sponsor|1|||
124576294|NCT02453386|448071129|FG002|Overall Study|Subject Terminated by Sponsor|1|||
124576295|NCT02453386|448071127|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
124576296|NCT02453386|448071128|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
124576297|NCT02453386|448071129|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
124576298|NCT02453386|448071127|FG000|Overall Study|Lost to Follow-up|0|||
124576299|NCT02453386|448071128|FG001|Overall Study|Lost to Follow-up|0|||
124576300|NCT02453386|448071129|FG002|Overall Study|Lost to Follow-up|1|||
124576301|NCT02453386|448071127|FG000|Overall Study|Other|1|||
124576302|NCT02453386|448071128|FG001|Overall Study|Other|0|||
124576303|NCT02453386|448071129|FG002|Overall Study|Other|1|||
124576304|NCT02388191|448071152|FG000|Overall Study|Patient did not receive IUD|1|||
124576305|NCT02388191|448071153|FG001|Overall Study|Patient did not receive IUD|0|||
124576306|NCT03197883|448071154|FG000|Overall Study|Adverse Event|1|||
124576307|NCT03197883|448071155|FG001|Overall Study|Adverse Event|1|||
124576308|NCT03197883|448071154|FG000|Overall Study|Lost to Follow-up|1|||
124576309|NCT03197883|448071155|FG001|Overall Study|Lost to Follow-up|0|||
124576310|NCT03197883|448071154|FG000|Overall Study|Protocol Violation|1|||
124576311|NCT03197883|448071155|FG001|Overall Study|Protocol Violation|0|||
124576312|NCT03197883|448071154|FG000|Overall Study|Other (Not Specified)|0|||
124576313|NCT03197883|448071155|FG001|Overall Study|Other (Not Specified)|5|||
124576314|NCT03686033|448071156|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
124576315|NCT03686033|448071157|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
124576316|NCT03686033|448071158|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
124576317|NCT03686033|448071159|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
124576318|NCT03686033|448071160|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
124576319|NCT03686033|448071161|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
124576320|NCT03031847|448071162|FG000|Overall Study|Death|1|||
124576321|NCT03031847|448071163|FG001|Overall Study|Death|1|||
124576322|NCT03031847|448071164|FG002|Overall Study|Death|2|||
124576323|NCT03031847|448071165|FG003|Overall Study|Death|3|||
124576324|NCT03031847|448071162|FG000|Overall Study|Lost to Follow-up|1|||
124576325|NCT03031847|448071163|FG001|Overall Study|Lost to Follow-up|1|||
124576326|NCT03031847|448071164|FG002|Overall Study|Lost to Follow-up|2|||
124576327|NCT03031847|448071165|FG003|Overall Study|Lost to Follow-up|3|||
124576328|NCT00858845|448071166|FG000|Overall Study|Patient underwent heart transplant.|0|||
124576329|NCT00858845|448071167|FG001|Overall Study|Patient underwent heart transplant.|1|||
124576330|NCT01353664|448071170|FG000|Overall Study|Other|3|||
124576331|NCT01353664|448071170|FG000|Overall Study|Disease Progression|16|||
124576332|NCT02089997|448071178|FG000|Overall Study|Case report forms uncollected|99|||
124576333|NCT02089997|448071178|FG000|Overall Study|Protocol Violation|147|||
124576334|NCT02441309|448071179|FG000|Overall Study|Disease progression|2|||
124576335|NCT02441309|448071180|FG001|Overall Study|Disease progression|1|||
124576336|NCT02441309|448071181|FG002|Overall Study|Disease progression|2|||
124576337|NCT02441309|448071179|FG000|Overall Study|Adverse Event|0|||
124576338|NCT02441309|448071180|FG001|Overall Study|Adverse Event|1|||
124576339|NCT02441309|448071181|FG002|Overall Study|Adverse Event|0|||
124576340|NCT02441309|448071179|FG000|Overall Study|Withdrawal by Subject|1|||
124576341|NCT02441309|448071180|FG001|Overall Study|Withdrawal by Subject|0|||
124576342|NCT02441309|448071181|FG002|Overall Study|Withdrawal by Subject|1|||
124576343|NCT00415363|448071182|FG000|Overall Study|Withdrawal by Subject|4|||
124576344|NCT00415363|448071183|FG001|Overall Study|Withdrawal by Subject|4|||
124576345|NCT00415363|448071182|FG000|Overall Study|Adverse Event|4|||
124576346|NCT00415363|448071183|FG001|Overall Study|Adverse Event|4|||
124576347|NCT00415363|448071182|FG000|Overall Study|Lost to Follow-up|2|||
124576348|NCT00415363|448071183|FG001|Overall Study|Lost to Follow-up|1|||
124576349|NCT00415363|448071182|FG000|Overall Study|Physician Decision|3|||
124576350|NCT00415363|448071183|FG001|Overall Study|Physician Decision|1|||
124576351|NCT00415363|448071182|FG000|Overall Study|Death|16|||
124576352|NCT00415363|448071183|FG001|Overall Study|Death|12|||
124576353|NCT00415363|448071182|FG000|Overall Study|Progressive disease|26|||
124576354|NCT00415363|448071183|FG001|Overall Study|Progressive disease|32|||
124576355|NCT00095212|448071188|FG000|Overall Study|Withdrawal by Subject|1|||
124576356|NCT00095212|448071189|FG001|Overall Study|Withdrawal by Subject|3|||
124576357|NCT02335658|448071190|FG000|Overall Study|Adverse Event|18|||
124576358|NCT02335658|448071191|FG001|Overall Study|Adverse Event|12|||
124576359|NCT02335658|448071190|FG000|Overall Study|Lack of Efficacy|4|||
124576360|NCT02335658|448071191|FG001|Overall Study|Lack of Efficacy|5|||
124576361|NCT02335658|448071190|FG000|Overall Study|Pregnancy|1|||
124576362|NCT02335658|448071191|FG001|Overall Study|Pregnancy|0|||
124725676|NCT02388165|448616577|FG000|Overall Study|Withdrawal of consent|31|||
124576363|NCT02335658|448071190|FG000|Overall Study|Withdrawal by Subject|13|||
124576364|NCT02335658|448071191|FG001|Overall Study|Withdrawal by Subject|21|||
124576365|NCT02335658|448071190|FG000|Overall Study|non-compliance|2|||
124576366|NCT02335658|448071191|FG001|Overall Study|non-compliance|3|||
124522092|NCT03185819|447862254|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
124522093|NCT03185819|447862251|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
124522094|NCT03185819|447862252|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
124522095|NCT03185819|447862253|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
124522096|NCT03185819|447862254|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
124522097|NCT03185819|447862251|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
124522098|NCT03185819|447862252|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
124522099|NCT03185819|447862253|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
124522100|NCT03185819|447862254|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
124522101|NCT03185819|447862251|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
124522102|NCT03185819|447862252|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
124522103|NCT03185819|447862253|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
124522104|NCT03185819|447862254|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
124522105|NCT03185819|447862251|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
124522106|NCT03185819|447862252|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
124522107|NCT03185819|447862253|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
124522108|NCT03185819|447862254|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
124522109|NCT03185819|447862251|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
124522110|NCT03185819|447862252|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
124522111|NCT03185819|447862253|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
124522112|NCT03185819|447862254|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
124522113|NCT03185819|447862251|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
124522114|NCT03185819|447862252|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
124522115|NCT03185819|447862253|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
124522116|NCT03185819|447862254|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
124522117|NCT03185819|447862251|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
124522118|NCT03185819|447862252|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
124522119|NCT03185819|447862253|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
124522120|NCT03185819|447862254|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
124522121|NCT03185819|447862251|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
124522122|NCT03185819|447862252|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
124522123|NCT03185819|447862253|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
124522124|NCT03185819|447862254|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
124522125|NCT03185819|447862251|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
124522126|NCT03185819|447862252|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
124522127|NCT03185819|447862253|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
124522128|NCT03185819|447862254|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
124522129|NCT03185819|447862251|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
124522130|NCT03185819|447862252|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
124522131|NCT03185819|447862253|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
124522132|NCT03185819|447862254|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
124522133|NCT03185819|447862251|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
124522134|NCT03185819|447862252|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
124522135|NCT03185819|447862253|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
124522136|NCT03185819|447862254|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
124522137|NCT03185819|447862251|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
124522138|NCT03185819|447862252|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
124522139|NCT03185819|447862253|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
124522140|NCT03185819|447862254|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
124522141|NCT03375203|447862255|FG000|Overall Study|Protocol Violation|0|||
124522142|NCT03375203|447862256|FG001|Overall Study|Protocol Violation|0|||
124522143|NCT03375203|447862257|FG002|Overall Study|Protocol Violation|1|||
124522144|NCT03375203|447862258|FG003|Overall Study|Protocol Violation|0|||
124522145|NCT03375203|447862259|FG004|Overall Study|Protocol Violation|0|||
124522146|NCT03375203|447862255|FG000|Overall Study|Adverse Event|2|||
124522147|NCT03375203|447862256|FG001|Overall Study|Adverse Event|3|||
124522148|NCT03375203|447862257|FG002|Overall Study|Adverse Event|0|||
124522149|NCT03375203|447862258|FG003|Overall Study|Adverse Event|2|||
124522150|NCT03375203|447862259|FG004|Overall Study|Adverse Event|2|||
124522151|NCT03375203|447862255|FG000|Overall Study|Withdrawal by Subject|3|||
124522152|NCT03375203|447862256|FG001|Overall Study|Withdrawal by Subject|0|||
124522153|NCT03375203|447862257|FG002|Overall Study|Withdrawal by Subject|1|||
124522154|NCT03375203|447862258|FG003|Overall Study|Withdrawal by Subject|0|||
124576367|NCT02335658|448071190|FG000|Overall Study|other reason|2|||
124576368|NCT02335658|448071191|FG001|Overall Study|other reason|3|||
124576369|NCT05341622|448071192|FG000|Overall Study|Death|0|||
124576370|NCT05341622|448071193|FG001|Overall Study|Death|0|||
124576371|NCT05341622|448071194|FG002|Overall Study|Death|0|||
124576372|NCT05341622|448071195|FG003|Overall Study|Death|0|||
124576373|NCT05341622|448071196|FG004|Overall Study|Death|1|||
124576374|NCT05341622|448071197|FG005|Overall Study|Death|0|||
124576375|NCT05341622|448071198|FG006|Overall Study|Death|0|||
124576376|NCT05341622|448071199|FG007|Overall Study|Death|1|||
124576377|NCT05341622|448071192|FG000|Overall Study|Invalid Address|0|||
124576378|NCT05341622|448071193|FG001|Overall Study|Invalid Address|1|||
124576379|NCT05341622|448071194|FG002|Overall Study|Invalid Address|0|||
124576380|NCT05341622|448071195|FG003|Overall Study|Invalid Address|0|||
124576381|NCT05341622|448071196|FG004|Overall Study|Invalid Address|0|||
124576382|NCT05341622|448071197|FG005|Overall Study|Invalid Address|0|||
124576383|NCT05341622|448071198|FG006|Overall Study|Invalid Address|0|||
124576384|NCT05341622|448071199|FG007|Overall Study|Invalid Address|0|||
124576385|NCT05341622|448071192|FG000|Overall Study|Ineligible|26|||
124576386|NCT05341622|448071193|FG001|Overall Study|Ineligible|21|||
124576387|NCT05341622|448071194|FG002|Overall Study|Ineligible|28|||
124576388|NCT05341622|448071195|FG003|Overall Study|Ineligible|24|||
124576389|NCT05341622|448071196|FG004|Overall Study|Ineligible|29|||
124576390|NCT05341622|448071197|FG005|Overall Study|Ineligible|31|||
124576391|NCT05341622|448071198|FG006|Overall Study|Ineligible|28|||
124576392|NCT05341622|448071199|FG007|Overall Study|Ineligible|26|||
124576393|NCT02658084|448071200|FG000|Overall Study|Withdrawal by Subject|1|||
124576394|NCT02658084|448071201|FG001|Overall Study|Withdrawal by Subject|0|||
124576395|NCT02658084|448071200|FG000|Overall Study|Study Termination|1|||
124576396|NCT02658084|448071201|FG001|Overall Study|Study Termination|0|||
124576397|NCT02305758|448071202|FG000|Overall Study|Death|27|||
124576398|NCT02305758|448071203|FG001|Overall Study|Death|27|||
124576399|NCT02305758|448071202|FG000|Overall Study|Withdrew consent|9|||
124576400|NCT02305758|448071203|FG001|Overall Study|Withdrew consent|2|||
124576401|NCT02305758|448071202|FG000|Overall Study|Lost to Follow-up|6|||
124576402|NCT02305758|448071203|FG001|Overall Study|Lost to Follow-up|1|||
124576403|NCT02305758|448071202|FG000|Overall Study|Study Terminated by Sponsor|21|||
124576404|NCT02305758|448071203|FG001|Overall Study|Study Terminated by Sponsor|34|||
124576405|NCT02305758|448071202|FG000|Overall Study|Other, not specified|2|||
124576406|NCT02305758|448071203|FG001|Overall Study|Other, not specified|1|||
124576407|NCT02032888|448071206|FG000|Treatment Period|Poor compliance/noncompliance|1|||
124576408|NCT02032888|448071207|FG001|Treatment Period|Poor compliance/noncompliance|1|||
124576409|NCT02032888|448071208|FG002|Treatment Period|Poor compliance/noncompliance|0|||
124576410|NCT02032888|448071206|FG000|Treatment Period|Other|1|||
124576411|NCT02032888|448071207|FG001|Treatment Period|Other|1|||
124576412|NCT02032888|448071208|FG002|Treatment Period|Other|0|||
124576413|NCT02032888|448071206|FG000|Follow-up Period|Lost to Follow-up|1|||
124576414|NCT02032888|448071207|FG001|Follow-up Period|Lost to Follow-up|1|||
124576415|NCT02032888|448071208|FG002|Follow-up Period|Lost to Follow-up|0|||
124576416|NCT02032888|448071206|FG000|Follow-up Period|Death|1|||
124576417|NCT02032888|448071207|FG001|Follow-up Period|Death|1|||
124576418|NCT02032888|448071208|FG002|Follow-up Period|Death|0|||
124576419|NCT02032888|448071206|FG000|Follow-up Period|Other|1|||
124576420|NCT02032888|448071207|FG001|Follow-up Period|Other|0|||
124576421|NCT02032888|448071208|FG002|Follow-up Period|Other|0|||
124576422|NCT03616106|448071211|FG000|Overall Study|Removed by PI|6|||
124576423|NCT03616106|448071212|FG001|Overall Study|Removed by PI|0|||
124576424|NCT03616106|448071211|FG000|Overall Study|Withdrawal by Subject|1|||
124576425|NCT03616106|448071212|FG001|Overall Study|Withdrawal by Subject|1|||
124576426|NCT03616106|448071211|FG000|Overall Study|Lost to Follow-up|7|||
124576427|NCT03616106|448071212|FG001|Overall Study|Lost to Follow-up|0|||
124576428|NCT03206177|448071214|FG000|Overall Study|Withdrawal by Subject|1|||
124576429|NCT04611789|448071216|FG000|Overall Study|Lost to Follow-up|1|||
124576430|NCT04611789|448071217|FG001|Overall Study|Lost to Follow-up|0|||
124576431|NCT04611789|448071218|FG002|Overall Study|Lost to Follow-up|0|||
124576432|NCT03880266|448071219|FG000|Overall Study|Withdrawal by Subject|0|||
124576433|NCT03880266|448071220|FG001|Overall Study|Withdrawal by Subject|1|||
124576434|NCT03880266|448071221|FG002|Overall Study|Withdrawal by Subject|1|||
124576435|NCT03880266|448071222|FG003|Overall Study|Withdrawal by Subject|0|||
124576436|NCT03880266|448071223|FG004|Overall Study|Withdrawal by Subject|0|||
124576437|NCT03880266|448071224|FG005|Overall Study|Withdrawal by Subject|0|||
124576438|NCT03880266|448071225|FG006|Overall Study|Withdrawal by Subject|0|||
124576439|NCT03880266|448071226|FG007|Overall Study|Withdrawal by Subject|0|||
124576440|NCT03161405|448071227|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
124576441|NCT00837486|448071228|FG000|Blinded-treatment Phase|Physician Decision|1|||
124576442|NCT00837486|448071229|FG001|Blinded-treatment Phase|Physician Decision|0|||
124576443|NCT00837486|448071228|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
124576444|NCT00837486|448071229|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
124576445|NCT00837486|448071228|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
124576446|NCT00837486|448071229|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
124576447|NCT00837486|448071228|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
124725677|NCT02388165|448616578|FG001|Overall Study|Withdrawal of consent|32|||
124725678|NCT02388165|448616577|FG000|Overall Study|Lost to Follow-up|19|||
124725679|NCT02388165|448616578|FG001|Overall Study|Lost to Follow-up|20|||
124725680|NCT02388165|448616577|FG000|Overall Study|Death|13|||
124725681|NCT02388165|448616578|FG001|Overall Study|Death|10|||
124725682|NCT02388165|448616577|FG000|Overall Study|Adverse Event|3|||
124725683|NCT02388165|448616578|FG001|Overall Study|Adverse Event|5|||
124725684|NCT02388165|448616577|FG000|Overall Study|Did not meet entrance criteria|5|||
124522155|NCT03375203|447862259|FG004|Overall Study|Withdrawal by Subject|2|||
124522156|NCT03375203|447862255|FG000|Overall Study|Non-compliance with study drug|1|||
124522157|NCT03375203|447862256|FG001|Overall Study|Non-compliance with study drug|0|||
124522158|NCT03375203|447862257|FG002|Overall Study|Non-compliance with study drug|0|||
124522159|NCT03375203|447862258|FG003|Overall Study|Non-compliance with study drug|0|||
124522160|NCT03375203|447862259|FG004|Overall Study|Non-compliance with study drug|0|||
124522161|NCT03375203|447862255|FG000|Overall Study|Randomized, not treated.|0|||
124522162|NCT03375203|447862256|FG001|Overall Study|Randomized, not treated.|1|||
124522163|NCT03375203|447862257|FG002|Overall Study|Randomized, not treated.|0|||
124522164|NCT03375203|447862258|FG003|Overall Study|Randomized, not treated.|0|||
124522165|NCT03375203|447862259|FG004|Overall Study|Randomized, not treated.|0|||
124522166|NCT03321526|447862260|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
124522167|NCT03321526|447862261|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
124522168|NCT03321526|447862260|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
124522169|NCT03321526|447862261|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
124522170|NCT03321526|447862260|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
124522171|NCT03321526|447862261|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
124522172|NCT03321526|447862260|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
124522173|NCT03321526|447862261|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
124522174|NCT03321526|447862260|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
124522175|NCT03321526|447862261|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
124522176|NCT03321526|447862260|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
124522177|NCT03321526|447862261|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
124522178|NCT03321526|447862260|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
124522179|NCT03321526|447862261|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
124522180|NCT03321526|447862260|FG000|Follow-up Phase (2 Weeks)|Other|24|||
124522181|NCT03321526|447862261|FG001|Follow-up Phase (2 Weeks)|Other|24|||
124522182|NCT00732641|447862262|FG000|Overall Study|Relapse or Progressive Disease|65|||
124522183|NCT00732641|447862263|FG001|Overall Study|Relapse or Progressive Disease|101|||
124522184|NCT00732641|447862262|FG000|Overall Study|Serious Adverse Events|12|||
124522185|NCT00732641|447862263|FG001|Overall Study|Serious Adverse Events|3|||
124522186|NCT00732641|447862262|FG000|Overall Study|Physician Decision|6|||
124522187|NCT00732641|447862263|FG001|Overall Study|Physician Decision|0|||
124522188|NCT00732641|447862262|FG000|Overall Study|Withdrawal by Subject|4|||
124522189|NCT00732641|447862263|FG001|Overall Study|Withdrawal by Subject|2|||
124522190|NCT00732641|447862262|FG000|Overall Study|Unable to Complete|1|||
124522191|NCT00732641|447862263|FG001|Overall Study|Unable to Complete|1|||
124522192|NCT00732641|447862262|FG000|Overall Study|Other|18|||
124522193|NCT00732641|447862263|FG001|Overall Study|Other|5|||
124522194|NCT02910089|447862264|FG000|Overall Study|Lost insurance eligibility|22|||
124522195|NCT02910089|447862265|FG001|Overall Study|Lost insurance eligibility|16|||
124522196|NCT00045630|447862271|FG000|Overall Study|Adverse Event|1|||
124522197|NCT00045630|447862271|FG000|Overall Study|Refusal unrelated to adverse event|1|||
124522198|NCT00045630|447862271|FG000|Overall Study|Progression/relapse|1|||
124522199|NCT00045630|447862271|FG000|Overall Study|Death|1|||
124522200|NCT00045630|447862271|FG000|Overall Study|Ineligible|2|||
124522201|NCT02023112|447862276|FG000|Overall Study|Withdrawal by Subject|2|||
124522202|NCT02023112|447862277|FG001|Overall Study|Withdrawal by Subject|1|||
124522203|NCT00807014|447862281|FG000|Overall Study|Participant Considered Disease Cured|13|||
124522204|NCT00807014|447862282|FG001|Overall Study|Participant Considered Disease Cured|2|||
124522205|NCT00807014|447862281|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
124725685|NCT02388165|448616578|FG001|Overall Study|Did not meet entrance criteria|2|||
124522206|NCT00807014|447862282|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
124522207|NCT00807014|447862281|FG000|Overall Study|Protocol Violation|2|||
124522208|NCT00807014|447862282|FG001|Overall Study|Protocol Violation|8|||
124522209|NCT00807014|447862281|FG000|Overall Study|Adverse Event|0|||
124522210|NCT00807014|447862282|FG001|Overall Study|Adverse Event|2|||
124522211|NCT00807014|447862281|FG000|Overall Study|Lost to Follow-up|9|||
124522212|NCT00807014|447862282|FG001|Overall Study|Lost to Follow-up|7|||
124522213|NCT00807014|447862281|FG000|Overall Study|Recovery|1|||
124725686|NCT00880269|448616579|FG000|Overall Study|Protocol Violation|1|||
124725687|NCT00880269|448616580|FG001|Overall Study|Protocol Violation|0|||
124725688|NCT00880269|448616579|FG000|Overall Study|Disease Progression|13|||
124725689|NCT00880269|448616580|FG001|Overall Study|Disease Progression|11|||
124725690|NCT00880269|448616579|FG000|Overall Study|New Cancer Therapy|1|||
124725691|NCT00880269|448616580|FG001|Overall Study|New Cancer Therapy|0|||
124522214|NCT00807014|447862282|FG001|Overall Study|Recovery|0|||
124725692|NCT00880269|448616579|FG000|Overall Study|Death|4|||
124522215|NCT00807014|447862281|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
124522216|NCT00807014|447862282|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
124522217|NCT02712008|447864296|FG000|Baseline (Day 1) up to Week 12|Death|3|||
124522218|NCT02712008|447864297|FG001|Baseline (Day 1) up to Week 12|Death|0|||
124522219|NCT02712008|447864298|FG002|Baseline (Day 1) up to Week 12|Death|0|||
124522220|NCT02712008|447864299|FG003|Baseline (Day 1) up to Week 12|Death|0|||
124522221|NCT02712008|447864300|FG004|Baseline (Day 1) up to Week 12|Death|0|||
124522222|NCT02712008|447864301|FG005|Baseline (Day 1) up to Week 12|Death|0|||
124522223|NCT02712008|447864302|FG006|Baseline (Day 1) up to Week 12|Death|0|||
124522224|NCT02712008|447864303|FG007|Baseline (Day 1) up to Week 12|Death|0|||
124522225|NCT02712008|447864296|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124522226|NCT02712008|447864297|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
124522227|NCT02712008|447864298|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
124522228|NCT02712008|447864299|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124522229|NCT02712008|447864300|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124522230|NCT02712008|447864301|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124522231|NCT02712008|447864302|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124522232|NCT02712008|447864303|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124522233|NCT02712008|447864296|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
124522234|NCT02712008|447864297|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124522235|NCT02712008|447864298|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
124522236|NCT02712008|447864299|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124522237|NCT02712008|447864300|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124522238|NCT02712008|447864301|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124522239|NCT02712008|447864302|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124522240|NCT02712008|447864303|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124522241|NCT02712008|447864296|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
124522242|NCT02712008|447864297|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
124522243|NCT02712008|447864298|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
124522244|NCT02712008|447864299|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
124522245|NCT02712008|447864300|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
124522246|NCT02712008|447864301|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
124522247|NCT02712008|447864302|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
124522248|NCT02712008|447864303|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
124522249|NCT02712008|447864296|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
124522250|NCT02712008|447864297|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
124522251|NCT02712008|447864298|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
124522252|NCT02712008|447864299|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
124522253|NCT02712008|447864300|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
124522254|NCT02712008|447864301|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
124522255|NCT02712008|447864302|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
124522256|NCT02712008|447864303|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
124522257|NCT02712008|447864296|FG000|From Week 12 up to Week 36|Adverse Event|0|||
124522258|NCT02712008|447864297|FG001|From Week 12 up to Week 36|Adverse Event|0|||
124522259|NCT02712008|447864298|FG002|From Week 12 up to Week 36|Adverse Event|0|||
124522260|NCT02712008|447864299|FG003|From Week 12 up to Week 36|Adverse Event|0|||
124522261|NCT02712008|447864300|FG004|From Week 12 up to Week 36|Adverse Event|1|||
124522262|NCT02712008|447864301|FG005|From Week 12 up to Week 36|Adverse Event|0|||
124522263|NCT02712008|447864302|FG006|From Week 12 up to Week 36|Adverse Event|0|||
124522264|NCT02712008|447864303|FG007|From Week 12 up to Week 36|Adverse Event|2|||
124522265|NCT02712008|447864296|FG000|From Week 12 up to Week 36|Death|1|||
124522266|NCT02712008|447864297|FG001|From Week 12 up to Week 36|Death|0|||
124522267|NCT02712008|447864298|FG002|From Week 12 up to Week 36|Death|0|||
124522268|NCT02712008|447864299|FG003|From Week 12 up to Week 36|Death|0|||
124522269|NCT02712008|447864300|FG004|From Week 12 up to Week 36|Death|0|||
124522270|NCT02712008|447864301|FG005|From Week 12 up to Week 36|Death|0|||
124522271|NCT02712008|447864302|FG006|From Week 12 up to Week 36|Death|1|||
124522272|NCT02712008|447864303|FG007|From Week 12 up to Week 36|Death|0|||
124522273|NCT02712008|447864296|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
124522274|NCT02712008|447864297|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
124522275|NCT02712008|447864298|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
124522276|NCT02712008|447864299|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
124522277|NCT02712008|447864300|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
124522278|NCT02712008|447864301|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
124522279|NCT02712008|447864302|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
124522280|NCT02712008|447864303|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
124522281|NCT02712008|447864296|FG000|From Week 12 up to Week 36|Physician Decision|0|||
124522282|NCT02712008|447864297|FG001|From Week 12 up to Week 36|Physician Decision|0|||
124725693|NCT00880269|448616580|FG001|Overall Study|Death|2|||
124522283|NCT02712008|447864298|FG002|From Week 12 up to Week 36|Physician Decision|0|||
124522284|NCT02712008|447864299|FG003|From Week 12 up to Week 36|Physician Decision|1|||
124576448|NCT00837486|448071229|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
124576449|NCT02655679|448071230|FG000|Overall Study|Adverse Event|0|||
124576450|NCT02655679|448071231|FG001|Overall Study|Adverse Event|1|||
124576451|NCT02655679|448071232|FG002|Overall Study|Adverse Event|0|||
124576452|NCT02655679|448071233|FG003|Overall Study|Adverse Event|0|||
124576453|NCT02655679|448071234|FG004|Overall Study|Adverse Event|0|||
124576454|NCT02655679|448071230|FG000|Overall Study|Withdrawal by Subject|1|||
124576455|NCT02655679|448071231|FG001|Overall Study|Withdrawal by Subject|1|||
124576456|NCT02655679|448071232|FG002|Overall Study|Withdrawal by Subject|0|||
124576457|NCT02655679|448071233|FG003|Overall Study|Withdrawal by Subject|3|||
124576458|NCT02655679|448071234|FG004|Overall Study|Withdrawal by Subject|1|||
124576459|NCT02655679|448071230|FG000|Overall Study|Inability to Comply with the Protocol|1|||
124576460|NCT02655679|448071231|FG001|Overall Study|Inability to Comply with the Protocol|0|||
124576461|NCT02655679|448071232|FG002|Overall Study|Inability to Comply with the Protocol|0|||
124576462|NCT02655679|448071233|FG003|Overall Study|Inability to Comply with the Protocol|0|||
124576463|NCT02655679|448071234|FG004|Overall Study|Inability to Comply with the Protocol|0|||
124576464|NCT02655679|448071230|FG000|Overall Study|Lost to Follow-up|0|||
124576465|NCT02655679|448071231|FG001|Overall Study|Lost to Follow-up|1|||
124576466|NCT02655679|448071232|FG002|Overall Study|Lost to Follow-up|1|||
124576467|NCT02655679|448071233|FG003|Overall Study|Lost to Follow-up|1|||
124576468|NCT02655679|448071234|FG004|Overall Study|Lost to Follow-up|0|||
124576469|NCT02655679|448071230|FG000|Overall Study|Other Miscellaneous Reasons|1|||
124576470|NCT02655679|448071231|FG001|Overall Study|Other Miscellaneous Reasons|0|||
124576471|NCT02655679|448071232|FG002|Overall Study|Other Miscellaneous Reasons|0|||
124576472|NCT02655679|448071233|FG003|Overall Study|Other Miscellaneous Reasons|0|||
124576473|NCT02655679|448071234|FG004|Overall Study|Other Miscellaneous Reasons|0|||
124576474|NCT01577381|448071235|FG000|Overall Study|Discontinued|2|||
124576475|NCT01577381|448071236|FG001|Overall Study|Discontinued|1|||
124576476|NCT01577381|448071237|FG002|Overall Study|Discontinued|2|||
124576477|NCT01577381|448071238|FG003|Overall Study|Discontinued|2|||
124576478|NCT01577381|448071235|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
124576479|NCT01577381|448071236|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
124576480|NCT01577381|448071237|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
124576481|NCT01577381|448071238|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
124576482|NCT02186821|448071239|FG000|Overall Study|Adverse Event|9|||
124576483|NCT02186821|448071239|FG000|Overall Study|Death|2|||
124576484|NCT02186821|448071239|FG000|Overall Study|Disease progression|32|||
124576485|NCT02186821|448071239|FG000|Overall Study|Protocol Violation|1|||
124576486|NCT02186821|448071239|FG000|Overall Study|Physician Decision|1|||
124576487|NCT02186821|448071239|FG000|Overall Study|Study terminated by sponsor|2|||
124576488|NCT00819741|448071244|FG000|Overall Study|Adverse Event|5|||
124576489|NCT00819741|448071245|FG001|Overall Study|Adverse Event|2|||
124576490|NCT00819741|448071244|FG000|Overall Study|Lack of Efficacy|0|||
124576491|NCT00819741|448071245|FG001|Overall Study|Lack of Efficacy|2|||
124576492|NCT00819741|448071244|FG000|Overall Study|Lost to Follow-up|3|||
124576493|NCT00819741|448071245|FG001|Overall Study|Lost to Follow-up|1|||
124576494|NCT00819741|448071244|FG000|Overall Study|Protocol Violation|3|||
124576495|NCT00819741|448071245|FG001|Overall Study|Protocol Violation|4|||
124576496|NCT00819741|448071244|FG000|Overall Study|Withdrawal by Subject|2|||
124576497|NCT00819741|448071245|FG001|Overall Study|Withdrawal by Subject|2|||
124576498|NCT00819741|448071244|FG000|Overall Study|Unclassified|6|||
124576499|NCT00819741|448071245|FG001|Overall Study|Unclassified|0|||
124576500|NCT00819741|448071244|FG000|Overall Study|Reasons unknown|3|||
124576501|NCT00819741|448071245|FG001|Overall Study|Reasons unknown|3|||
124576502|NCT00119015|448071246|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
124576503|NCT00119015|448071247|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
124576504|NCT00119015|448071248|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
124576505|NCT01313780|448071249|FG000|Overall Study|Lack of Efficacy|4|||
124576506|NCT01313780|448071250|FG001|Overall Study|Lack of Efficacy|2|||
124576507|NCT01313780|448071249|FG000|Overall Study|Adverse Event|6|||
124576508|NCT01313780|448071250|FG001|Overall Study|Adverse Event|11|||
124576509|NCT01313780|448071249|FG000|Overall Study|Withdrawal by Subject|2|||
124576510|NCT01313780|448071250|FG001|Overall Study|Withdrawal by Subject|8|||
124576511|NCT01313780|448071249|FG000|Overall Study|Protocol Violation|10|||
124576512|NCT01313780|448071250|FG001|Overall Study|Protocol Violation|4|||
124576513|NCT01313780|448071249|FG000|Overall Study|missing data|3|||
124576514|NCT01313780|448071250|FG001|Overall Study|missing data|3|||
124576515|NCT03235739|448072710|FG000|Overall Study|Withdrawal by Subject|2|||
124576516|NCT03235739|448072711|FG001|Overall Study|Withdrawal by Subject|2|||
124576517|NCT03235739|448072710|FG000|Overall Study|Physician Decision|0|||
124576518|NCT03235739|448072711|FG001|Overall Study|Physician Decision|1|||
124576519|NCT00834522|448072714|FG000|Washout|Adverse Event|1|||
124576520|NCT00834522|448072715|FG001|Washout|Adverse Event|0|||
124576521|NCT00834522|448072714|FG000|Washout|Withdrawal by Subject|2|||
124576522|NCT00834522|448072715|FG001|Washout|Withdrawal by Subject|1|||
124576523|NCT00834249|448072716|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
124576524|NCT00834249|448072717|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
124576525|NCT00834249|448072716|FG000|Second Intervention|Adverse Event|1|||
124522285|NCT02712008|447864300|FG004|From Week 12 up to Week 36|Physician Decision|1|||
124522286|NCT02712008|447864301|FG005|From Week 12 up to Week 36|Physician Decision|0|||
124522287|NCT02712008|447864302|FG006|From Week 12 up to Week 36|Physician Decision|0|||
124522288|NCT02712008|447864303|FG007|From Week 12 up to Week 36|Physician Decision|0|||
124522289|NCT02712008|447864296|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
124522290|NCT02712008|447864297|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
124522291|NCT02712008|447864298|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
124522292|NCT02712008|447864299|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
124522293|NCT02712008|447864300|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
124522294|NCT02712008|447864301|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
124522295|NCT02712008|447864302|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
124522296|NCT02712008|447864303|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
124522297|NCT00430027|447864304|FG000|Overall Study|Study terminated|8|||
124522298|NCT02443155|447864307|FG000|Overall Study|Adverse Event|3|||
124522299|NCT02443155|447864308|FG001|Overall Study|Adverse Event|4|||
124522300|NCT02443155|447864309|FG002|Overall Study|Adverse Event|1|||
124522301|NCT02443155|447864310|FG003|Overall Study|Adverse Event|2|||
124522302|NCT02443155|447864307|FG000|Overall Study|Unclassified|0|||
124522303|NCT02443155|447864308|FG001|Overall Study|Unclassified|0|||
124522304|NCT02443155|447864309|FG002|Overall Study|Unclassified|2|||
124522305|NCT02443155|447864310|FG003|Overall Study|Unclassified|1|||
124522306|NCT02443155|447864307|FG000|Overall Study|Withdrawal by Subject|4|||
124522307|NCT02443155|447864308|FG001|Overall Study|Withdrawal by Subject|7|||
124522308|NCT02443155|447864309|FG002|Overall Study|Withdrawal by Subject|3|||
124522309|NCT02443155|447864310|FG003|Overall Study|Withdrawal by Subject|9|||
124522310|NCT02443155|447864307|FG000|Overall Study|Pregnancy|3|||
124522311|NCT02443155|447864308|FG001|Overall Study|Pregnancy|1|||
124522312|NCT02443155|447864309|FG002|Overall Study|Pregnancy|1|||
124522313|NCT02443155|447864310|FG003|Overall Study|Pregnancy|2|||
124522314|NCT02443155|447864307|FG000|Overall Study|Lost to Follow-up|1|||
124522315|NCT02443155|447864308|FG001|Overall Study|Lost to Follow-up|2|||
124522316|NCT02443155|447864309|FG002|Overall Study|Lost to Follow-up|0|||
124522317|NCT02443155|447864310|FG003|Overall Study|Lost to Follow-up|1|||
124522318|NCT02443155|447864307|FG000|Overall Study|Protocol Violation|1|||
124522319|NCT02443155|447864308|FG001|Overall Study|Protocol Violation|0|||
124522320|NCT02443155|447864309|FG002|Overall Study|Protocol Violation|1|||
124522321|NCT02443155|447864310|FG003|Overall Study|Protocol Violation|1|||
124522322|NCT02443155|447864307|FG000|Overall Study|Death|0|||
124522323|NCT02443155|447864308|FG001|Overall Study|Death|0|||
124522324|NCT02443155|447864309|FG002|Overall Study|Death|1|||
124522325|NCT02443155|447864310|FG003|Overall Study|Death|0|||
124522326|NCT02000219|447864311|FG000|14-Week Study Period|Physician Decision|1|||
124522327|NCT02000219|447864311|FG000|14-Week Study Period|Adverse Event|1|||
124522328|NCT02000219|447864311|FG000|14-Week Study Period|Underwent transplantation|1|||
124522329|NCT02000219|447864311|FG000|Continuation Period|Withdrawal by Subject|1|||
124522330|NCT02000219|447864311|FG000|Continuation Period|Had liver transplant|2|||
124522331|NCT02000219|447864311|FG000|Continuation Period|Non-compliance with study drug|2|||
124522332|NCT00634751|447864315|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
124522333|NCT00634751|447864316|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
124522334|NCT00634751|447864317|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
124522335|NCT00634751|447864318|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
124522336|NCT00634751|447864315|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
124522337|NCT00634751|447864316|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
124522338|NCT00634751|447864317|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
124522339|NCT00634751|447864318|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
124522340|NCT00634751|447864315|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
124522341|NCT00634751|447864316|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
124522342|NCT00634751|447864317|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
124522343|NCT00634751|447864318|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
124522344|NCT00088595|447864319|FG000|Overall Study|Adverse Event|11|||
124522345|NCT00088595|447864319|FG000|Overall Study|Withdrawal by Subject|8|||
124522346|NCT00088595|447864319|FG000|Overall Study|Ongoing (After Core)|7|||
124522347|NCT00088595|447864319|FG000|Overall Study|New Cancer Therapy|2|||
124522348|NCT01473355|447864332|FG000|Overall Study|Protocol Violation|2|||
124522349|NCT01473355|447864332|FG000|Overall Study|Adverse Event|2|||
124522350|NCT01473355|447864332|FG000|Overall Study|Lost to Follow-up|2|||
124522351|NCT00106249|447864333|FG000|Overall Study|Lost to Follow-up|3|||
124522352|NCT00106249|447864334|FG001|Overall Study|Lost to Follow-up|2|||
124522353|NCT00524043|447864335|FG000|Overall Study|Lack of Efficacy|15|||
124522354|NCT00524043|447864336|FG001|Overall Study|Lack of Efficacy|13|||
124522355|NCT00524043|447864337|FG002|Overall Study|Lack of Efficacy|14|||
124522356|NCT00524043|447864335|FG000|Overall Study|Withdrawal by Subject|5|||
124522357|NCT00524043|447864336|FG001|Overall Study|Withdrawal by Subject|7|||
124522358|NCT00524043|447864337|FG002|Overall Study|Withdrawal by Subject|7|||
124522359|NCT00524043|447864335|FG000|Overall Study|Adverse Event|5|||
124522360|NCT00524043|447864336|FG001|Overall Study|Adverse Event|2|||
124522361|NCT00524043|447864337|FG002|Overall Study|Adverse Event|7|||
124576526|NCT00834249|448072717|FG001|Second Intervention|Adverse Event|0|||
124576527|NCT02146105|448072720|FG000|Overall Study|Adverse Event|1|||
124576528|NCT02146105|448072720|FG000|Overall Study|Withdrawal by Subject|5|||
124576529|NCT05755282|448072721|FG000|Overall Study|Protocol Violation|0|||
124576530|NCT05755282|448072722|FG001|Overall Study|Protocol Violation|1|||
124576531|NCT02476994|448072724|FG000|Overall Study|Based on feedback from FDA|1|||
124576532|NCT02476994|448072725|FG001|Overall Study|Based on feedback from FDA|0|||
124576533|NCT01558635|448072728|FG000|Overall Study|Death|1|||
124576534|NCT01558635|448072728|FG000|Overall Study|Withdrawal by Subject|2|||
124576535|NCT01558635|448072728|FG000|Overall Study|Physician Decision|1|||
124576536|NCT01558635|448072728|FG000|Overall Study|Subject received other treatment|1|||
124576537|NCT01558635|448072728|FG000|Overall Study|Reveal XT was explanted|1|||
124576538|NCT03699020|448072729|FG000|Overall Study|Withdrawal by Subject|3|||
124576539|NCT03699020|448072730|FG001|Overall Study|Withdrawal by Subject|2|||
124576540|NCT02246920|448072731|FG000|Overall Study|Adverse Event|3|||
124576541|NCT02246920|448072732|FG001|Overall Study|Adverse Event|1|||
124576542|NCT02246920|448072733|FG002|Overall Study|Adverse Event|1|||
124576543|NCT02246920|448072731|FG000|Overall Study|Lost to Follow-up|2|||
124576544|NCT02246920|448072732|FG001|Overall Study|Lost to Follow-up|1|||
124576545|NCT02246920|448072733|FG002|Overall Study|Lost to Follow-up|0|||
124576546|NCT02246920|448072731|FG000|Overall Study|Protocol Violation|2|||
124576547|NCT02246920|448072732|FG001|Overall Study|Protocol Violation|5|||
124576548|NCT02246920|448072733|FG002|Overall Study|Protocol Violation|1|||
124576549|NCT02246920|448072731|FG000|Overall Study|Withdrawal by Subject|0|||
124576550|NCT02246920|448072732|FG001|Overall Study|Withdrawal by Subject|0|||
124576551|NCT02246920|448072733|FG002|Overall Study|Withdrawal by Subject|1|||
124576552|NCT00448019|448072736|FG000|Overall Study|Withdrawal by Subject|3|||
124576553|NCT00448019|448072736|FG000|Overall Study|Disease progression|1|||
124576554|NCT00448019|448072736|FG000|Overall Study|Death|2|||
124576555|NCT00448019|448072736|FG000|Overall Study|Insurance Issues|1|||
124576556|NCT02543203|448072737|FG000|Overall Study|Unpalatable Fragrance|2|||
124576557|NCT02543203|448072738|FG001|Overall Study|Unpalatable Fragrance|2|||
124576558|NCT02543203|448072737|FG000|Overall Study|Lost to Follow-up|1|||
124576559|NCT02543203|448072738|FG001|Overall Study|Lost to Follow-up|0|||
124576560|NCT02543203|448072737|FG000|Overall Study|Increased Irritability|1|||
124576561|NCT02543203|448072738|FG001|Overall Study|Increased Irritability|0|||
124576562|NCT02543203|448072737|FG000|Overall Study|Family|1|||
124576563|NCT02543203|448072738|FG001|Overall Study|Family|2|||
124576564|NCT02543203|448072737|FG000|Overall Study|Negative Behavior|1|||
124576565|NCT02543203|448072738|FG001|Overall Study|Negative Behavior|0|||
124576566|NCT02543203|448072737|FG000|Overall Study|Withdrawal by Subject|0|||
124576567|NCT02543203|448072738|FG001|Overall Study|Withdrawal by Subject|1|||
124576568|NCT02077465|448072739|FG000|Overall Study|Withdrew Consent|0|||
124576569|NCT02077465|448072740|FG001|Overall Study|Withdrew Consent|1|||
124576570|NCT02077465|448072739|FG000|Overall Study|Lost to Follow-up|1|||
124576571|NCT02077465|448072740|FG001|Overall Study|Lost to Follow-up|0|||
124576572|NCT01827163|448072741|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
124576573|NCT01827163|448072741|FG000|Overall Study|Adverse Event|9|||
124576574|NCT03620747|448072743|FG000|Overall Study|Participant decision|7|||
124576575|NCT03620747|448072743|FG000|Overall Study|Adverse Event|6|||
124576576|NCT03620747|448072743|FG000|Overall Study|Lack of Efficacy|1|||
124576577|NCT03620747|448072743|FG000|Overall Study|Poor compliance to protocol|2|||
124576578|NCT03620747|448072743|FG000|Overall Study|Other-unspecified|3|||
124576579|NCT02714062|448072744|FG000|Overall Study|Adverse Event|0|||
124576580|NCT02714062|448072745|FG001|Overall Study|Adverse Event|0|||
124576581|NCT02714062|448072746|FG002|Overall Study|Adverse Event|2|||
124576582|NCT02714062|448072744|FG000|Overall Study|Withdrawal by Subject|1|||
124576583|NCT02714062|448072745|FG001|Overall Study|Withdrawal by Subject|0|||
124576584|NCT02714062|448072746|FG002|Overall Study|Withdrawal by Subject|1|||
124576585|NCT02714062|448072744|FG000|Overall Study|Protocol Violation|0|||
124576586|NCT02714062|448072745|FG001|Overall Study|Protocol Violation|1|||
124576587|NCT02714062|448072746|FG002|Overall Study|Protocol Violation|0|||
124576588|NCT02294604|448072747|FG000|Overall Study|Did not provide samples for culture|0|||
124576589|NCT02294604|448072748|FG001|Overall Study|Did not provide samples for culture|1|||
124576590|NCT02294604|448072749|FG002|Overall Study|Did not provide samples for culture|0|||
124576591|NCT02294604|448072747|FG000|Overall Study|Culture contamination|1|||
124576592|NCT02294604|448072748|FG001|Overall Study|Culture contamination|2|||
124576593|NCT02294604|448072749|FG002|Overall Study|Culture contamination|0|||
124576594|NCT01200810|448072754|FG000|Overall Study|Physician Decision|1|||
124576595|NCT01200810|448072755|FG001|Overall Study|Physician Decision|0|||
124576596|NCT01200810|448072754|FG000|Overall Study|Withdrawal by Subject|1|||
124576597|NCT01200810|448072755|FG001|Overall Study|Withdrawal by Subject|2|||
124576598|NCT01200810|448072754|FG000|Overall Study|Sponsor stopped making study drug|3|||
124576599|NCT01200810|448072755|FG001|Overall Study|Sponsor stopped making study drug|3|||
124576600|NCT00365846|448072756|FG000|Overall Study|Lost to Follow-up|1|||
124576601|NCT00904215|448072758|FG000|Overall Study|Adverse Event|25|||
124576602|NCT00904215|448072758|FG000|Overall Study|Protocol Violation|10|||
124576603|NCT00904215|448072758|FG000|Overall Study|Lost to Follow-up|63|||
124576604|NCT00904215|448072758|FG000|Overall Study|Withdrawal by Subject|9|||
124576605|NCT00904215|448072758|FG000|Overall Study|Other|28|||
124576606|NCT00960297|448072759|FG000|Overall Study|Physician Decision|1|||
124576607|NCT00960297|448072759|FG000|Overall Study|Venous port infection|1|||
124576608|NCT00960297|448072759|FG000|Overall Study|Disease progression|1|||
124576609|NCT03965091|448072767|FG000|Overall Study|Adverse Event|0|||
124576610|NCT03965091|448072768|FG001|Overall Study|Adverse Event|2|||
124576611|NCT03965091|448072769|FG002|Overall Study|Adverse Event|3|||
124576612|NCT03965091|448072767|FG000|Overall Study|Withdrawal by Subject|11|||
124576613|NCT03965091|448072768|FG001|Overall Study|Withdrawal by Subject|3|||
124776736|NCT02120898|448809965|FG001|Overall Study|Non-compliance with study drug|0|||
124776737|NCT02120898|448809966|FG002|Overall Study|Non-compliance with study drug|0|||
124776738|NCT02120898|448809964|FG000|Overall Study|Adverse Event|1|||
124776739|NCT02120898|448809965|FG001|Overall Study|Adverse Event|2|||
124776740|NCT02120898|448809966|FG002|Overall Study|Adverse Event|1|||
124776741|NCT02120898|448809964|FG000|Overall Study|Protocol Violation|1|||
124522362|NCT00524043|447864335|FG000|Overall Study|Lost to Follow-up|3|||
124576614|NCT03965091|448072769|FG002|Overall Study|Withdrawal by Subject|5|||
124576615|NCT03965091|448072767|FG000|Overall Study|Non-compliance with study drug|0|||
124576616|NCT03965091|448072768|FG001|Overall Study|Non-compliance with study drug|0|||
124576617|NCT03965091|448072769|FG002|Overall Study|Non-compliance with study drug|1|||
124576618|NCT03965091|448072767|FG000|Overall Study|Lost to Follow-up|1|||
124576619|NCT03965091|448072768|FG001|Overall Study|Lost to Follow-up|1|||
124576620|NCT03965091|448072769|FG002|Overall Study|Lost to Follow-up|1|||
124576621|NCT03965091|448072767|FG000|Overall Study|Lack of Efficacy|2|||
124576622|NCT03965091|448072768|FG001|Overall Study|Lack of Efficacy|0|||
124576623|NCT03965091|448072769|FG002|Overall Study|Lack of Efficacy|0|||
124522363|NCT00524043|447864336|FG001|Overall Study|Lost to Follow-up|5|||
124522364|NCT00524043|447864337|FG002|Overall Study|Lost to Follow-up|3|||
124522365|NCT00524043|447864335|FG000|Overall Study|Various (eg, incarceration)|2|||
124522366|NCT00524043|447864336|FG001|Overall Study|Various (eg, incarceration)|1|||
124522367|NCT00524043|447864337|FG002|Overall Study|Various (eg, incarceration)|0|||
124522368|NCT01843205|447864338|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
124522369|NCT01843205|447864339|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
124522370|NCT02062827|447864342|FG000|Overall Study|Death|1|||
124522371|NCT02062827|447864343|FG001|Overall Study|Death|0|||
124522372|NCT02062827|447864344|FG002|Overall Study|Death|0|||
124522373|NCT02062827|447864345|FG003|Overall Study|Death|0|||
124522374|NCT02062827|447864346|FG004|Overall Study|Death|0|||
124522375|NCT02062827|447864347|FG005|Overall Study|Death|0|||
124522376|NCT02062827|447864348|FG006|Overall Study|Death|0|||
124522377|NCT02062827|447864349|FG007|Overall Study|Death|0|||
124522378|NCT02062827|447864342|FG000|Overall Study|Withdrawal by Subject|3|||
124522379|NCT02062827|447864343|FG001|Overall Study|Withdrawal by Subject|1|||
124522380|NCT02062827|447864344|FG002|Overall Study|Withdrawal by Subject|1|||
124522381|NCT02062827|447864345|FG003|Overall Study|Withdrawal by Subject|2|||
124522382|NCT02062827|447864346|FG004|Overall Study|Withdrawal by Subject|6|||
124522383|NCT02062827|447864347|FG005|Overall Study|Withdrawal by Subject|0|||
124522384|NCT02062827|447864348|FG006|Overall Study|Withdrawal by Subject|5|||
124522385|NCT02062827|447864349|FG007|Overall Study|Withdrawal by Subject|0|||
124522386|NCT02062827|447864342|FG000|Overall Study|Screen Fail|0|||
124522387|NCT02062827|447864343|FG001|Overall Study|Screen Fail|0|||
124522388|NCT02062827|447864344|FG002|Overall Study|Screen Fail|0|||
124522389|NCT02062827|447864345|FG003|Overall Study|Screen Fail|0|||
124522390|NCT02062827|447864346|FG004|Overall Study|Screen Fail|0|||
124522391|NCT02062827|447864347|FG005|Overall Study|Screen Fail|0|||
124522392|NCT02062827|447864348|FG006|Overall Study|Screen Fail|0|||
124522393|NCT02062827|447864349|FG007|Overall Study|Screen Fail|8|||
124522394|NCT05784129|447864350|FG000|Overall Study|Study terminated by sponsor|2|||
124522395|NCT05784129|447864351|FG001|Overall Study|Study terminated by sponsor|2|||
124522396|NCT01156363|447864352|FG000|Overall Study|Adverse Event|6|||
124522397|NCT01156363|447864352|FG000|Overall Study|Insufficient Therapeutic Response|5|||
124522398|NCT01156363|447864352|FG000|Overall Study|Failure to Return|1|||
124576624|NCT03965091|448072767|FG000|Overall Study|Other than specified|9|||
124576625|NCT03965091|448072768|FG001|Overall Study|Other than specified|11|||
124576626|NCT03965091|448072769|FG002|Overall Study|Other than specified|8|||
124576627|NCT02159950|448072779|FG000|Overall Study|Adverse Event|0|||
124576628|NCT02159950|448072780|FG001|Overall Study|Adverse Event|1|||
124576629|NCT02159950|448072779|FG000|Overall Study|Progression|0|||
124576630|NCT02159950|448072780|FG001|Overall Study|Progression|1|||
124522399|NCT01156363|447864352|FG000|Overall Study|Refused Treatment|4|||
124522400|NCT01156363|447864352|FG000|Overall Study|Other|6|||
124522401|NCT02728206|447864354|FG000|Overall Study|Death|1|||
124522402|NCT02773368|447864357|FG000|Overall Study|Lost to Follow-up|4|||
124522403|NCT02773368|447864358|FG001|Overall Study|Lost to Follow-up|1|||
124522404|NCT02773368|447864357|FG000|Overall Study|Withdrawal by Subject|5|||
124522405|NCT02773368|447864358|FG001|Overall Study|Withdrawal by Subject|1|||
124576631|NCT00003659|448072781|FG000|Overall Study|Withdrawal by Subject|3|||
124576632|NCT02648438|448072784|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124576633|NCT02648438|448072785|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
124576634|NCT02648438|448072786|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
124576635|NCT02648438|448072784|FG000|Overall Study|Protocol Violation|2|||
124776742|NCT02120898|448809965|FG001|Overall Study|Protocol Violation|2|||
124776743|NCT02120898|448809966|FG002|Overall Study|Protocol Violation|0|||
124576636|NCT02648438|448072785|FG001|Overall Study|Protocol Violation|0|||
124576637|NCT02648438|448072786|FG002|Overall Study|Protocol Violation|0|||
124576638|NCT02648438|448072784|FG000|Overall Study|Withdrawal by Subject|1|||
124576639|NCT02648438|448072785|FG001|Overall Study|Withdrawal by Subject|1|||
124576640|NCT02648438|448072786|FG002|Overall Study|Withdrawal by Subject|0|||
124576641|NCT03138967|448072787|FG000|Overall Study|Death|0|||
124576642|NCT03138967|448072788|FG001|Overall Study|Death|1|||
124576643|NCT03138967|448072787|FG000|Overall Study|Physician Decision|1|||
124576644|NCT03138967|448072788|FG001|Overall Study|Physician Decision|3|||
124576645|NCT04400890|448072789|FG000|Overall Study|Withdrawal by Subject|3|||
124576646|NCT04400890|448072790|FG001|Overall Study|Withdrawal by Subject|2|||
124576647|NCT03925532|448072791|FG000|Overall Study|Lost to Follow-up|1|||
124576648|NCT02258074|448072792|FG000|Overall Study|Withdrawal by Subject|1|||
124576649|NCT02258074|448072793|FG001|Overall Study|Withdrawal by Subject|0|||
124576650|NCT02258074|448072794|FG002|Overall Study|Withdrawal by Subject|0|||
124576651|NCT02258074|448072795|FG003|Overall Study|Withdrawal by Subject|0|||
124576652|NCT00723710|448072796|FG000|Overall Study|Disease progression|48|||
124576653|NCT00723710|448072796|FG000|Overall Study|Adverse Event|88|||
124576654|NCT00723710|448072796|FG000|Overall Study|Withdrawal by Subject|36|||
124576655|NCT00723710|448072796|FG000|Overall Study|Physician Decision|2|||
124576656|NCT04405570|448072797|FG000|Overall Study|Adverse Event|0|||
124576657|NCT04405570|448072798|FG001|Overall Study|Adverse Event|1|||
124576658|NCT04405570|448072799|FG002|Overall Study|Adverse Event|1|||
124576659|NCT04405570|448072800|FG003|Overall Study|Adverse Event|1|||
124576660|NCT04405570|448072797|FG000|Overall Study|Lost to Follow-up|0|||
124576661|NCT04405570|448072798|FG001|Overall Study|Lost to Follow-up|1|||
124576662|NCT04405570|448072799|FG002|Overall Study|Lost to Follow-up|0|||
124576663|NCT04405570|448072800|FG003|Overall Study|Lost to Follow-up|0|||
124576664|NCT04405570|448072797|FG000|Overall Study|Physician Decision|0|||
124576665|NCT04405570|448072798|FG001|Overall Study|Physician Decision|0|||
124576666|NCT04405570|448072799|FG002|Overall Study|Physician Decision|1|||
124576667|NCT04405570|448072800|FG003|Overall Study|Physician Decision|0|||
124576668|NCT04405570|448072797|FG000|Overall Study|Withdrawal by Subject|0|||
124576669|NCT04405570|448072798|FG001|Overall Study|Withdrawal by Subject|1|||
124576670|NCT04405570|448072799|FG002|Overall Study|Withdrawal by Subject|1|||
124576671|NCT04405570|448072800|FG003|Overall Study|Withdrawal by Subject|0|||
124576672|NCT04405570|448072797|FG000|Overall Study|Randomized not dosed|0|||
124576673|NCT04405570|448072798|FG001|Overall Study|Randomized not dosed|2|||
124576674|NCT04405570|448072799|FG002|Overall Study|Randomized not dosed|0|||
124576675|NCT04405570|448072800|FG003|Overall Study|Randomized not dosed|0|||
124576676|NCT04499963|448072801|FG000|Overall Study|Adverse Event|3|||
124576677|NCT04499963|448072802|FG001|Overall Study|Adverse Event|0|||
124576678|NCT04499963|448072801|FG000|Overall Study|Death|3|||
124576679|NCT04499963|448072802|FG001|Overall Study|Death|0|||
124576680|NCT04499963|448072801|FG000|Overall Study|Lack of Efficacy|7|||
124576681|NCT04499963|448072802|FG001|Overall Study|Lack of Efficacy|0|||
124576682|NCT04499963|448072801|FG000|Overall Study|Lost to Follow-up|2|||
124576683|NCT04499963|448072802|FG001|Overall Study|Lost to Follow-up|0|||
124576684|NCT01208337|448072805|FG000|Overall Study|Death|3|||
124576685|NCT03663179|448072811|FG000|Overall Study|Withdrawal by Subject|2|||
124576686|NCT03663179|448072812|FG001|Overall Study|Withdrawal by Subject|0|||
124576687|NCT03663179|448072811|FG000|Overall Study|Lost to Follow-up|1|||
124576688|NCT03663179|448072812|FG001|Overall Study|Lost to Follow-up|1|||
124576689|NCT03663179|448072811|FG000|Overall Study|Revealed exclusionary condition|1|||
124576690|NCT03663179|448072812|FG001|Overall Study|Revealed exclusionary condition|0|||
124576691|NCT00984126|448072816|FG000|Overall Study|Protocol Violation|0|||
124576692|NCT00984126|448072817|FG001|Overall Study|Protocol Violation|0|||
124576693|NCT00984126|448072818|FG002|Overall Study|Protocol Violation|1|||
124576694|NCT00984126|448072819|FG003|Overall Study|Protocol Violation|2|||
124576695|NCT00984126|448072816|FG000|Overall Study|Adverse Event|0|||
124576696|NCT00984126|448072817|FG001|Overall Study|Adverse Event|0|||
124576697|NCT00984126|448072818|FG002|Overall Study|Adverse Event|0|||
124576698|NCT00984126|448072819|FG003|Overall Study|Adverse Event|2|||
124576699|NCT00984126|448072816|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
124576700|NCT00984126|448072817|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
124576701|NCT00984126|448072818|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
124576702|NCT00984126|448072819|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
124576703|NCT00984126|448072816|FG000|Overall Study|Withdrawal criteria|0|||
124576704|NCT00984126|448072817|FG001|Overall Study|Withdrawal criteria|1|||
124576705|NCT00984126|448072818|FG002|Overall Study|Withdrawal criteria|3|||
124576706|NCT00984126|448072819|FG003|Overall Study|Withdrawal criteria|9|||
124576707|NCT01001208|448072820|FG000|Overall Study|Adverse Event|10|||
124576708|NCT01001208|448072821|FG001|Overall Study|Adverse Event|5|||
124522406|NCT02773368|447864357|FG000|Overall Study|Unclassified|1|||
124522407|NCT02773368|447864358|FG001|Overall Study|Unclassified|1|||
124522408|NCT02773368|447864357|FG000|Overall Study|Missing|0|||
124522409|NCT02773368|447864358|FG001|Overall Study|Missing|1|||
124522410|NCT01929018|447864362|FG000|Overall Study|Lost to Follow-up|1|||
124522411|NCT01929018|447864363|FG001|Overall Study|Lost to Follow-up|0|||
124522412|NCT01929018|447864362|FG000|Overall Study|Hospitalization|0|||
124522413|NCT01929018|447864363|FG001|Overall Study|Hospitalization|1|||
124522414|NCT01366534|447864364|FG000|Overall Study|Lost to Follow-up|1|||
124725694|NCT00880269|448616579|FG000|Overall Study|Lost to Follow-up|0|||
124725695|NCT00880269|448616580|FG001|Overall Study|Lost to Follow-up|1|||
124725696|NCT00880269|448616579|FG000|Overall Study|Withdrawal by Subject|3|||
124522415|NCT01366534|447864365|FG001|Overall Study|Lost to Follow-up|0|||
124522416|NCT01366534|447864366|FG002|Overall Study|Lost to Follow-up|0|||
124522417|NCT01366534|447864364|FG000|Overall Study|Migrated|1|||
124522418|NCT01366534|447864365|FG001|Overall Study|Migrated|1|||
124522419|NCT01366534|447864366|FG002|Overall Study|Migrated|0|||
124522420|NCT01366534|447864364|FG000|Overall Study|Declined challenged|0|||
124522421|NCT01366534|447864365|FG001|Overall Study|Declined challenged|1|||
124522422|NCT01366534|447864366|FG002|Overall Study|Declined challenged|0|||
124522423|NCT02635867|447864373|FG000|Overall Study|Lost to Follow-up|4|||
124522424|NCT02635867|447864374|FG001|Overall Study|Lost to Follow-up|3|||
124522425|NCT02635867|447864375|FG002|Overall Study|Lost to Follow-up|3|||
124522426|NCT02635867|447864376|FG003|Overall Study|Lost to Follow-up|4|||
124522427|NCT02635867|447864377|FG004|Overall Study|Lost to Follow-up|1|||
124522428|NCT02565576|447864378|FG000|Overall Study|abnormal lab value|2|||
124522429|NCT02565576|447864379|FG001|Overall Study|abnormal lab value|0|||
124522430|NCT02565576|447864378|FG000|Overall Study|subject / guardian decision|1|||
124522431|NCT02565576|447864379|FG001|Overall Study|subject / guardian decision|3|||
124522432|NCT02565576|447864378|FG000|Overall Study|Lost to Follow-up|1|||
124522433|NCT02565576|447864379|FG001|Overall Study|Lost to Follow-up|0|||
124522434|NCT02565576|447864378|FG000|Overall Study|Death|0|||
124522435|NCT02565576|447864379|FG001|Overall Study|Death|2|||
124522436|NCT02565576|447864378|FG000|Overall Study|Adverse Event|1|||
124522437|NCT02565576|447864379|FG001|Overall Study|Adverse Event|0|||
124522438|NCT03377452|447864380|FG000|Overall Study|Refused assessment|0|||
124522439|NCT03377452|447864381|FG001|Overall Study|Refused assessment|2|||
124522440|NCT03377452|447864380|FG000|Overall Study|Lost to Follow-up|5|||
124522441|NCT03377452|447864381|FG001|Overall Study|Lost to Follow-up|4|||
124522442|NCT02438787|447864382|FG000|Overall Study|Adverse Event|1|||
124522443|NCT02438787|447864383|FG001|Overall Study|Adverse Event|0|||
124522444|NCT02438787|447864384|FG002|Overall Study|Adverse Event|2|||
124522445|NCT02438787|447864382|FG000|Overall Study|Lack of Efficacy|1|||
124522446|NCT02438787|447864383|FG001|Overall Study|Lack of Efficacy|2|||
124522447|NCT02438787|447864384|FG002|Overall Study|Lack of Efficacy|0|||
124522448|NCT02438787|447864382|FG000|Overall Study|Lost to Follow-up|0|||
124522449|NCT02438787|447864383|FG001|Overall Study|Lost to Follow-up|1|||
124522450|NCT02438787|447864384|FG002|Overall Study|Lost to Follow-up|0|||
124522451|NCT02438787|447864382|FG000|Overall Study|Protocol Violation|0|||
124522452|NCT02438787|447864383|FG001|Overall Study|Protocol Violation|0|||
124522453|NCT02438787|447864384|FG002|Overall Study|Protocol Violation|1|||
124522454|NCT02438787|447864382|FG000|Overall Study|Withdrawal by Subject|15|||
124522455|NCT02438787|447864383|FG001|Overall Study|Withdrawal by Subject|7|||
124522456|NCT02438787|447864384|FG002|Overall Study|Withdrawal by Subject|10|||
124522457|NCT02438787|447864382|FG000|Overall Study|Study discontinued by sponsor|64|||
124522458|NCT02438787|447864383|FG001|Overall Study|Study discontinued by sponsor|72|||
124522459|NCT02438787|447864384|FG002|Overall Study|Study discontinued by sponsor|69|||
124522460|NCT02438787|447864382|FG000|Overall Study|Other|0|||
124522461|NCT02438787|447864383|FG001|Overall Study|Other|1|||
124522462|NCT02438787|447864384|FG002|Overall Study|Other|0|||
124522463|NCT02438787|447864382|FG000|Overall Study|Site terminated by sponsor|0|||
124522464|NCT02438787|447864383|FG001|Overall Study|Site terminated by sponsor|0|||
124522465|NCT02438787|447864384|FG002|Overall Study|Site terminated by sponsor|1|||
124522466|NCT03034057|447864387|FG000|Overall Study|Withdrawal by Subject|10|||
124522467|NCT03034057|447864387|FG000|Overall Study|Protocol Violation|1|||
124522468|NCT03034057|447864387|FG000|Overall Study|Not defined|2|||
124522469|NCT03034057|447864387|FG000|Overall Study|Lost to Follow-up|19|||
124522470|NCT03034057|447864387|FG000|Overall Study|Adverse Event|22|||
124522471|NCT03034057|447864387|FG000|Overall Study|Medication error without associated AE|1|||
124522472|NCT00701103|447864391|FG000|Overall Study|Adverse Event|0|||
124522473|NCT00701103|447864392|FG001|Overall Study|Adverse Event|0|||
124522474|NCT00701103|447864393|FG002|Overall Study|Adverse Event|1|||
124522475|NCT00701103|447864394|FG003|Overall Study|Adverse Event|1|||
124522476|NCT00701103|447864395|FG004|Overall Study|Adverse Event|0|||
124522477|NCT00701103|447864396|FG005|Overall Study|Adverse Event|1|||
124522478|NCT00701103|447864397|FG006|Overall Study|Adverse Event|1|||
124522479|NCT00701103|447864398|FG007|Overall Study|Adverse Event|0|||
124522480|NCT00701103|447864399|FG008|Overall Study|Adverse Event|0|||
124522481|NCT00701103|447864400|FG009|Overall Study|Adverse Event|2|||
124522482|NCT00701103|447864401|FG010|Overall Study|Adverse Event|0|||
124776744|NCT02120898|448809964|FG000|Overall Study|Lost to Follow-up|0|||
124725697|NCT00880269|448616580|FG001|Overall Study|Withdrawal by Subject|4|||
124725698|NCT00880269|448616579|FG000|Overall Study|Adverse Event|10|||
124725699|NCT00880269|448616580|FG001|Overall Study|Adverse Event|9|||
124725700|NCT01667224|448616587|FG000|Overall Study|Withdrawal by Subject|3|||
124725701|NCT01667224|448616588|FG001|Overall Study|Withdrawal by Subject|1|||
124522483|NCT00701103|447864391|FG000|Overall Study|Progressive Disease|5|||
124522484|NCT00701103|447864392|FG001|Overall Study|Progressive Disease|2|||
124576709|NCT01001208|448072820|FG000|Overall Study|Lost to Follow-up|5|||
124576710|NCT01001208|448072821|FG001|Overall Study|Lost to Follow-up|9|||
124725702|NCT01667224|448616587|FG000|Overall Study|Protocol Violation|1|||
124725703|NCT01667224|448616588|FG001|Overall Study|Protocol Violation|1|||
124522485|NCT00701103|447864393|FG002|Overall Study|Progressive Disease|6|||
124522486|NCT00701103|447864394|FG003|Overall Study|Progressive Disease|5|||
124522487|NCT00701103|447864395|FG004|Overall Study|Progressive Disease|6|||
124522488|NCT00701103|447864396|FG005|Overall Study|Progressive Disease|5|||
124522489|NCT00701103|447864397|FG006|Overall Study|Progressive Disease|7|||
124522490|NCT00701103|447864398|FG007|Overall Study|Progressive Disease|7|||
124522491|NCT00701103|447864399|FG008|Overall Study|Progressive Disease|8|||
124522492|NCT00701103|447864400|FG009|Overall Study|Progressive Disease|8|||
124522493|NCT00701103|447864401|FG010|Overall Study|Progressive Disease|11|||
124522494|NCT00701103|447864391|FG000|Overall Study|Withdrawal by Subject|0|||
124522495|NCT00701103|447864392|FG001|Overall Study|Withdrawal by Subject|1|||
124522496|NCT00701103|447864393|FG002|Overall Study|Withdrawal by Subject|1|||
124522497|NCT00701103|447864394|FG003|Overall Study|Withdrawal by Subject|0|||
124522498|NCT00701103|447864395|FG004|Overall Study|Withdrawal by Subject|0|||
124522499|NCT00701103|447864396|FG005|Overall Study|Withdrawal by Subject|0|||
124522500|NCT00701103|447864397|FG006|Overall Study|Withdrawal by Subject|0|||
124522501|NCT00701103|447864398|FG007|Overall Study|Withdrawal by Subject|0|||
124522502|NCT00701103|447864399|FG008|Overall Study|Withdrawal by Subject|0|||
124522503|NCT00701103|447864400|FG009|Overall Study|Withdrawal by Subject|0|||
124522504|NCT00701103|447864401|FG010|Overall Study|Withdrawal by Subject|0|||
124522505|NCT00701103|447864391|FG000|Overall Study|Other|0|||
124522506|NCT00701103|447864392|FG001|Overall Study|Other|0|||
124522507|NCT00701103|447864393|FG002|Overall Study|Other|0|||
124522508|NCT00701103|447864394|FG003|Overall Study|Other|0|||
124522509|NCT00701103|447864395|FG004|Overall Study|Other|0|||
124522510|NCT00701103|447864396|FG005|Overall Study|Other|0|||
124522511|NCT00701103|447864397|FG006|Overall Study|Other|0|||
124522512|NCT00701103|447864398|FG007|Overall Study|Other|0|||
124522513|NCT00701103|447864399|FG008|Overall Study|Other|1|||
124522514|NCT00701103|447864400|FG009|Overall Study|Other|1|||
124522515|NCT00701103|447864401|FG010|Overall Study|Other|0|||
124522516|NCT01929707|447864402|FG000|Intervention Period 1|Lost to Follow-up|0|||
124522517|NCT01929707|447864403|FG001|Intervention Period 1|Lost to Follow-up|0|||
124522518|NCT01929707|447864404|FG002|Intervention Period 1|Lost to Follow-up|0|||
124522519|NCT01929707|447864405|FG003|Intervention Period 1|Lost to Follow-up|1|||
124522520|NCT01929707|447864406|FG004|Intervention Period 1|Lost to Follow-up|0|||
124522521|NCT01929707|447864407|FG005|Intervention Period 1|Lost to Follow-up|0|||
124522522|NCT01929707|447864408|FG006|Intervention Period 1|Lost to Follow-up|0|||
124522523|NCT01929707|447864409|FG007|Intervention Period 1|Lost to Follow-up|0|||
124522524|NCT01929707|447864402|FG000|Intervention Period 1|Withdrawal by Subject|0|||
124522525|NCT01929707|447864403|FG001|Intervention Period 1|Withdrawal by Subject|0|||
124522526|NCT01929707|447864404|FG002|Intervention Period 1|Withdrawal by Subject|0|||
124522527|NCT01929707|447864405|FG003|Intervention Period 1|Withdrawal by Subject|2|||
124522528|NCT01929707|447864406|FG004|Intervention Period 1|Withdrawal by Subject|0|||
124522529|NCT01929707|447864407|FG005|Intervention Period 1|Withdrawal by Subject|0|||
124522530|NCT01929707|447864408|FG006|Intervention Period 1|Withdrawal by Subject|0|||
124522531|NCT01929707|447864409|FG007|Intervention Period 1|Withdrawal by Subject|0|||
124522532|NCT01929707|447864402|FG000|Intervention Period 2|Withdrawal by Subject|0|||
124522533|NCT01929707|447864403|FG001|Intervention Period 2|Withdrawal by Subject|0|||
124522534|NCT01929707|447864404|FG002|Intervention Period 2|Withdrawal by Subject|0|||
124522535|NCT01929707|447864405|FG003|Intervention Period 2|Withdrawal by Subject|0|||
124522536|NCT01929707|447864406|FG004|Intervention Period 2|Withdrawal by Subject|0|||
124522537|NCT01929707|447864407|FG005|Intervention Period 2|Withdrawal by Subject|2|||
124522538|NCT01929707|447864408|FG006|Intervention Period 2|Withdrawal by Subject|0|||
124576711|NCT01001208|448072820|FG000|Overall Study|Physician Decision|1|||
124725704|NCT00316225|448616589|FG000|Overall Study|Adverse Event|2|||
124522539|NCT01929707|447864409|FG007|Intervention Period 2|Withdrawal by Subject|0|||
124522540|NCT00179517|447864410|FG000|Overall Study|Withdrawal by Subject|2|||
124522541|NCT00179517|447864411|FG001|Overall Study|Withdrawal by Subject|1|||
124576712|NCT01001208|448072821|FG001|Overall Study|Physician Decision|0|||
124725705|NCT00316225|448616589|FG000|Overall Study|Physician Decision|3|||
124522542|NCT00437203|447864412|FG000|Overall Study|Death|0|||
124522543|NCT00437203|447864413|FG001|Overall Study|Death|0|||
124522544|NCT00437203|447864414|FG002|Overall Study|Death|1|||
124522545|NCT00437203|447864415|FG003|Overall Study|Death|0|||
124522546|NCT00437203|447864416|FG004|Overall Study|Death|0|||
124522547|NCT00437203|447864417|FG005|Overall Study|Death|0|||
124576713|NCT01001208|448072820|FG000|Overall Study|Withdrawal by Subject|4|||
124576714|NCT01001208|448072821|FG001|Overall Study|Withdrawal by Subject|5|||
124576715|NCT01001208|448072820|FG000|Overall Study|Ineligibility Determined|4|||
124576716|NCT01001208|448072821|FG001|Overall Study|Ineligibility Determined|2|||
124576717|NCT01001208|448072820|FG000|Overall Study|Noncompliance|4|||
124576718|NCT01001208|448072821|FG001|Overall Study|Noncompliance|7|||
124576719|NCT01001208|448072820|FG000|Overall Study|Disease Progression|0|||
124576720|NCT01001208|448072821|FG001|Overall Study|Disease Progression|3|||
124576721|NCT01001208|448072820|FG000|Overall Study|Other|0|||
124576722|NCT01001208|448072821|FG001|Overall Study|Other|2|||
124576723|NCT01864174|448072822|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
124576724|NCT01864174|448072823|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
124576725|NCT01864174|448072822|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
124576726|NCT01864174|448072823|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
124576727|NCT01864174|448072822|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
124576728|NCT01864174|448072823|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
124576729|NCT01864174|448072822|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
124576730|NCT01864174|448072823|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
124576731|NCT01864174|448072822|FG000|Double Blind - Compliant Randomized|Death|1|||
124576732|NCT01864174|448072823|FG001|Double Blind - Compliant Randomized|Death|0|||
124576733|NCT01864174|448072822|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
124576734|NCT01864174|448072823|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
124576735|NCT01864174|448072822|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
124576736|NCT01864174|448072823|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
124576737|NCT01864174|448072822|FG000|Double Blind - Compliant Randomized|Other|6|||
124576738|NCT01864174|448072823|FG001|Double Blind - Compliant Randomized|Other|10|||
124576739|NCT01864174|448072822|FG000|Off Treatment Follow-Up|Other|2|||
124576740|NCT01864174|448072823|FG001|Off Treatment Follow-Up|Other|0|||
124576741|NCT01864174|448072822|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
124576742|NCT01864174|448072823|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
124576743|NCT02739997|448072824|FG000|Overall Study|Death|1|||
124576744|NCT02739997|448072824|FG000|Overall Study|Withdrawal by Subject|1|||
124576745|NCT00468286|448072825|FG000|Overall Study|Adverse Event|1|||
124576746|NCT00468286|448072826|FG001|Overall Study|Adverse Event|6|||
124576747|NCT00468286|448072825|FG000|Overall Study|Protocol Violation|2|||
124576748|NCT00468286|448072826|FG001|Overall Study|Protocol Violation|2|||
124576749|NCT00468286|448072825|FG000|Overall Study|Withdrawal by Subject|4|||
124576750|NCT00468286|448072826|FG001|Overall Study|Withdrawal by Subject|3|||
124576751|NCT00468286|448072825|FG000|Overall Study|Physician Decision|0|||
124576752|NCT00468286|448072826|FG001|Overall Study|Physician Decision|1|||
124576753|NCT02158663|448072827|FG000|Overall Study|Withdrawal by Subject|5|||
124576754|NCT02158663|448072828|FG001|Overall Study|Withdrawal by Subject|4|||
124576755|NCT03552393|448072833|FG000|Core Period|Kidney Transplant|1|||
124576756|NCT03552393|448072833|FG000|Core Period|Prohibited Medication|1|||
124576757|NCT03552393|448072833|FG000|Safety Extension Period|Kidney Transplant|4|||
124576758|NCT02414152|448072835|FG000|Overall Study|Withdrawal by Subject|1|||
124576759|NCT02414152|448072835|FG000|Overall Study|Lack of Efficacy|1|||
124576760|NCT02601625|448072836|FG000|Overall Study|Lost to Follow-up|0|||
124576761|NCT02601625|448072837|FG001|Overall Study|Lost to Follow-up|0|||
124576762|NCT02601625|448072838|FG002|Overall Study|Lost to Follow-up|1|||
124576763|NCT02601625|448072839|FG003|Overall Study|Lost to Follow-up|1|||
124576764|NCT00359281|448072840|FG000|Overall Study|Adverse Event|1|||
124576765|NCT00359281|448072841|FG001|Overall Study|Adverse Event|0|||
124576766|NCT00359281|448072842|FG002|Overall Study|Adverse Event|0|||
124576767|NCT00359281|448072843|FG003|Overall Study|Adverse Event|0|||
124576768|NCT00359281|448072844|FG004|Overall Study|Adverse Event|0|||
124576769|NCT00359281|448072845|FG005|Overall Study|Adverse Event|0|||
124576770|NCT00359281|448072846|FG006|Overall Study|Adverse Event|1|||
124576771|NCT00359281|448072847|FG007|Overall Study|Adverse Event|0|||
124576772|NCT00359281|448072848|FG008|Overall Study|Adverse Event|0|||
124576773|NCT00359281|448072840|FG000|Overall Study|Withdrawal by Subject|0|||
124576774|NCT00359281|448072841|FG001|Overall Study|Withdrawal by Subject|0|||
124576775|NCT00359281|448072842|FG002|Overall Study|Withdrawal by Subject|0|||
124576776|NCT00359281|448072843|FG003|Overall Study|Withdrawal by Subject|0|||
124576777|NCT00359281|448072844|FG004|Overall Study|Withdrawal by Subject|0|||
124576778|NCT00359281|448072845|FG005|Overall Study|Withdrawal by Subject|0|||
124576779|NCT00359281|448072846|FG006|Overall Study|Withdrawal by Subject|1|||
124576780|NCT00359281|448072847|FG007|Overall Study|Withdrawal by Subject|0|||
124576781|NCT00359281|448072848|FG008|Overall Study|Withdrawal by Subject|0|||
124576782|NCT04887415|448072849|FG000|Overall Study|Lost to Follow-up|2|||
124576783|NCT01415986|448072850|FG000|Overall Study|Lost to Follow-up|1|||
124576784|NCT03792477|448072851|FG000|Overall Study|Adverse Event|0|||
124576785|NCT03792477|448072852|FG001|Overall Study|Adverse Event|0|||
124576786|NCT03792477|448072853|FG002|Overall Study|Adverse Event|0|||
124576787|NCT03792477|448072854|FG003|Overall Study|Adverse Event|1|||
124576788|NCT03792477|448072855|FG004|Overall Study|Adverse Event|0|||
124725706|NCT00316225|448616589|FG000|Overall Study|Progressive Disease|15|||
124725707|NCT00316225|448616589|FG000|Overall Study|Withdrawal by Subject|3|||
124725708|NCT00316225|448616589|FG000|Overall Study|Death|2|||
124725709|NCT03497975|448616603|FG000|Overall Study|Withdrew Consent|34|||
124725710|NCT03497975|448616604|FG001|Overall Study|Withdrew Consent|35|||
124725711|NCT03497975|448616603|FG000|Overall Study|Lost to Follow-up|7|||
124725712|NCT03497975|448616604|FG001|Overall Study|Lost to Follow-up|7|||
124725713|NCT03497975|448616603|FG000|Overall Study|Physician Decision|4|||
124725714|NCT03497975|448616604|FG001|Overall Study|Physician Decision|5|||
124725715|NCT03497975|448616603|FG000|Overall Study|Discontinued|42|||
124725716|NCT03497975|448616604|FG001|Overall Study|Discontinued|39|||
124725717|NCT03497975|448616603|FG000|Overall Study|Reason Not Specified|15|||
124725718|NCT03497975|448616604|FG001|Overall Study|Reason Not Specified|14|||
124725719|NCT01205061|448616607|FG000|Overall Study|Adverse Event|4|||
124725720|NCT01205061|448616607|FG000|Overall Study|Withdrawal by Subject|11|||
124725721|NCT01205061|448616607|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
124725722|NCT01205061|448616607|FG000|Overall Study|Lost to Follow-up|9|||
124725723|NCT01205061|448616607|FG000|Overall Study|Other|1|||
124725724|NCT00765037|448616608|FG000|Overall Study|Lost to Follow-up|5|||
124725725|NCT00765037|448616608|FG000|Overall Study|Adverse Event|1|||
124725726|NCT01988662|448616613|FG000|Overall Study|Subject/guardian decision|1|||
124725727|NCT01988662|448616614|FG001|Overall Study|Subject/guardian decision|1|||
124725728|NCT01988662|448616613|FG000|Overall Study|Adverse Event|3|||
124725729|NCT01988662|448616614|FG001|Overall Study|Adverse Event|1|||
124725730|NCT03070171|448616616|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
124725731|NCT03070171|448616617|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
124725732|NCT03070171|448616616|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
124725733|NCT03070171|448616617|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
124725734|NCT01471028|448616621|FG000|VTI-208|Adverse Event|39|||
124725735|NCT01471028|448616622|FG001|VTI-208|Adverse Event|41|||
124725736|NCT01471028|448616621|FG000|VTI-208|Withdrawal by Subject|0|||
124725737|NCT01471028|448616622|FG001|VTI-208|Withdrawal by Subject|2|||
124725738|NCT01471028|448616621|FG000|VTI-208|Lost to Follow-up|1|||
124725739|NCT01471028|448616622|FG001|VTI-208|Lost to Follow-up|1|||
124725740|NCT01471028|448616621|FG000|VTI-208E|Death|7|||
124725741|NCT01471028|448616622|FG001|VTI-208E|Death|10|||
124725742|NCT01471028|448616621|FG000|VTI-208E|Withdrawal by Subject|1|||
124725743|NCT01471028|448616622|FG001|VTI-208E|Withdrawal by Subject|0|||
124725744|NCT01471028|448616621|FG000|VTI-208E|Lost to Follow-up|0|||
124725745|NCT01471028|448616622|FG001|VTI-208E|Lost to Follow-up|2|||
124725746|NCT00610857|448616624|FG000|Overall Study|Not evaluable for response|2|||
124725747|NCT04826094|448616625|FG000|Overall Study|Lost to Follow-up|2|||
124725748|NCT04826094|448616626|FG001|Overall Study|Lost to Follow-up|1|||
124725749|NCT04826094|448616627|FG002|Overall Study|Lost to Follow-up|0|||
124725750|NCT04826094|448616628|FG003|Overall Study|Lost to Follow-up|0|||
124725751|NCT04826094|448616629|FG004|Overall Study|Lost to Follow-up|1|||
124725752|NCT04826094|448616630|FG005|Overall Study|Lost to Follow-up|3|||
124725753|NCT04826094|448616631|FG006|Overall Study|Lost to Follow-up|1|||
124725754|NCT04826094|448616632|FG007|Overall Study|Lost to Follow-up|1|||
124725755|NCT04826094|448616625|FG000|Overall Study|Participant withdrew consent|1|||
124725756|NCT04826094|448616626|FG001|Overall Study|Participant withdrew consent|0|||
124725757|NCT04826094|448616627|FG002|Overall Study|Participant withdrew consent|0|||
124725758|NCT04826094|448616628|FG003|Overall Study|Participant withdrew consent|1|||
124725759|NCT04826094|448616629|FG004|Overall Study|Participant withdrew consent|1|||
124725760|NCT04826094|448616630|FG005|Overall Study|Participant withdrew consent|1|||
124725761|NCT04826094|448616631|FG006|Overall Study|Participant withdrew consent|0|||
124725762|NCT04826094|448616632|FG007|Overall Study|Participant withdrew consent|1|||
124725763|NCT04826094|448616625|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
124725764|NCT04826094|448616626|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
124725765|NCT04826094|448616627|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
124725766|NCT04826094|448616628|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
124725767|NCT04826094|448616629|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
124725768|NCT04826094|448616630|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
124522548|NCT00437203|447864418|FG006|Overall Study|Death|0|||
124522549|NCT00437203|447864419|FG007|Overall Study|Death|1|||
124522550|NCT00437203|447864420|FG008|Overall Study|Death|0|||
124522551|NCT00437203|447864421|FG009|Overall Study|Death|1|||
124522552|NCT00437203|447864412|FG000|Overall Study|Adverse Event|1|||
124522553|NCT00437203|447864413|FG001|Overall Study|Adverse Event|1|||
124522554|NCT00437203|447864414|FG002|Overall Study|Adverse Event|0|||
124522555|NCT00437203|447864415|FG003|Overall Study|Adverse Event|0|||
124522556|NCT00437203|447864416|FG004|Overall Study|Adverse Event|0|||
124522557|NCT00437203|447864417|FG005|Overall Study|Adverse Event|0|||
124522558|NCT00437203|447864418|FG006|Overall Study|Adverse Event|0|||
124522559|NCT00437203|447864419|FG007|Overall Study|Adverse Event|1|||
124522560|NCT00437203|447864420|FG008|Overall Study|Adverse Event|0|||
124522561|NCT00437203|447864421|FG009|Overall Study|Adverse Event|1|||
124522562|NCT00437203|447864412|FG000|Overall Study|Study terminated by sponsor|0|||
124576789|NCT03792477|448072851|FG000|Overall Study|Lost to Follow-up|0|||
124576790|NCT03792477|448072852|FG001|Overall Study|Lost to Follow-up|0|||
124576791|NCT03792477|448072853|FG002|Overall Study|Lost to Follow-up|2|||
124576792|NCT03792477|448072854|FG003|Overall Study|Lost to Follow-up|0|||
124576793|NCT03792477|448072855|FG004|Overall Study|Lost to Follow-up|0|||
124576794|NCT03792477|448072851|FG000|Overall Study|Other|0|||
124576795|NCT03792477|448072852|FG001|Overall Study|Other|0|||
124576796|NCT03792477|448072853|FG002|Overall Study|Other|0|||
124576797|NCT03792477|448072854|FG003|Overall Study|Other|0|||
124576798|NCT03792477|448072855|FG004|Overall Study|Other|1|||
124576799|NCT00840411|448072857|FG000|First Intervention|Adverse Event|1|||
124576800|NCT00840411|448072858|FG001|First Intervention|Adverse Event|0|||
124576801|NCT00840411|448072857|FG000|Washout|Withdrawal by Subject|1|||
124576802|NCT00840411|448072858|FG001|Washout|Withdrawal by Subject|0|||
124576803|NCT00576056|448072863|FG000|Overall Study|Adverse Event|1|||
124576804|NCT00576056|448072863|FG000|Overall Study|Death|1|||
124576805|NCT00576056|448072863|FG000|Overall Study|Lack of Efficacy|1|||
124576806|NCT00576056|448072863|FG000|Overall Study|Withdrawal by Subject|2|||
124576807|NCT00576056|448072863|FG000|Overall Study|did not meet eligibility criteria|8|||
124576808|NCT00576056|448072863|FG000|Overall Study|Physician Decision|1|||
124576809|NCT01854047|448072864|FG000|Overall Study|Lack of Efficacy|1|||
124576810|NCT01854047|448072865|FG001|Overall Study|Lack of Efficacy|0|||
124576811|NCT01854047|448072866|FG002|Overall Study|Lack of Efficacy|0|||
124576812|NCT01854047|448072867|FG003|Overall Study|Lack of Efficacy|0|||
124576813|NCT01854047|448072868|FG004|Overall Study|Lack of Efficacy|0|||
124576814|NCT01854047|448072864|FG000|Overall Study|Poor compliance to protocol|3|||
124576815|NCT01854047|448072865|FG001|Overall Study|Poor compliance to protocol|0|||
124576816|NCT01854047|448072866|FG002|Overall Study|Poor compliance to protocol|2|||
124576817|NCT01854047|448072867|FG003|Overall Study|Poor compliance to protocol|0|||
124576818|NCT01854047|448072868|FG004|Overall Study|Poor compliance to protocol|0|||
124576819|NCT01854047|448072864|FG000|Overall Study|Adverse Event|5|||
124576820|NCT01854047|448072865|FG001|Overall Study|Adverse Event|4|||
124576821|NCT01854047|448072866|FG002|Overall Study|Adverse Event|6|||
124576822|NCT01854047|448072867|FG003|Overall Study|Adverse Event|10|||
124576823|NCT01854047|448072868|FG004|Overall Study|Adverse Event|7|||
124576824|NCT01854047|448072864|FG000|Overall Study|Randomized but not treated|0|||
124576825|NCT01854047|448072865|FG001|Overall Study|Randomized but not treated|1|||
124725769|NCT04826094|448616631|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
124725770|NCT04826094|448616632|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
124725771|NCT04826094|448616625|FG000|Overall Study|Withdrawn by Investigator|0|||
124725772|NCT04826094|448616626|FG001|Overall Study|Withdrawn by Investigator|0|||
124725773|NCT04826094|448616627|FG002|Overall Study|Withdrawn by Investigator|0|||
124725774|NCT04826094|448616628|FG003|Overall Study|Withdrawn by Investigator|0|||
124725775|NCT04826094|448616629|FG004|Overall Study|Withdrawn by Investigator|0|||
124725776|NCT04826094|448616630|FG005|Overall Study|Withdrawn by Investigator|1|||
124725777|NCT04826094|448616631|FG006|Overall Study|Withdrawn by Investigator|0|||
124725778|NCT04826094|448616632|FG007|Overall Study|Withdrawn by Investigator|1|||
124725779|NCT04826094|448616625|FG000|Overall Study|Other: Moved from area|1|||
124725780|NCT04826094|448616626|FG001|Overall Study|Other: Moved from area|1|||
124725781|NCT04826094|448616627|FG002|Overall Study|Other: Moved from area|1|||
124725782|NCT04826094|448616628|FG003|Overall Study|Other: Moved from area|0|||
124725783|NCT04826094|448616629|FG004|Overall Study|Other: Moved from area|0|||
124725784|NCT04826094|448616630|FG005|Overall Study|Other: Moved from area|0|||
124725785|NCT04826094|448616631|FG006|Overall Study|Other: Moved from area|0|||
124576826|NCT01854047|448072866|FG002|Overall Study|Randomized but not treated|2|||
124576827|NCT01854047|448072867|FG003|Overall Study|Randomized but not treated|0|||
124576828|NCT01854047|448072868|FG004|Overall Study|Randomized but not treated|4|||
124725786|NCT04826094|448616632|FG007|Overall Study|Other: Moved from area|0|||
124725787|NCT04826094|448616625|FG000|Overall Study|Other: Declined|0|||
124725788|NCT04826094|448616626|FG001|Overall Study|Other: Declined|0|||
124576829|NCT01854047|448072864|FG000|Overall Study|Other than specified above|3|||
124576830|NCT01854047|448072865|FG001|Overall Study|Other than specified above|3|||
124576831|NCT01854047|448072866|FG002|Overall Study|Other than specified above|3|||
124576832|NCT01854047|448072867|FG003|Overall Study|Other than specified above|5|||
124576833|NCT01854047|448072868|FG004|Overall Study|Other than specified above|8|||
124576834|NCT02847650|448074695|FG000|Overall Study|Adverse Event|2|||
124576835|NCT02847650|448074696|FG001|Overall Study|Adverse Event|4|||
124576836|NCT02847650|448074695|FG000|Overall Study|Lost to Follow-up|1|||
124576837|NCT02847650|448074696|FG001|Overall Study|Lost to Follow-up|0|||
124725789|NCT04826094|448616627|FG002|Overall Study|Other: Declined|0|||
124725790|NCT04826094|448616628|FG003|Overall Study|Other: Declined|0|||
124725791|NCT04826094|448616629|FG004|Overall Study|Other: Declined|1|||
124725792|NCT04826094|448616630|FG005|Overall Study|Other: Declined|0|||
124725793|NCT04826094|448616631|FG006|Overall Study|Other: Declined|0|||
124576838|NCT02847650|448074695|FG000|Overall Study|Protocol Violation|0|||
124576839|NCT02847650|448074696|FG001|Overall Study|Protocol Violation|1|||
124576840|NCT02847650|448074695|FG000|Overall Study|Withdrawal by Subject|1|||
124576841|NCT02847650|448074696|FG001|Overall Study|Withdrawal by Subject|1|||
124576842|NCT03818581|448074697|FG000|Overall Study|Adverse Event|1|||
124576843|NCT03818581|448074698|FG001|Overall Study|Adverse Event|0|||
124576844|NCT03818581|448074699|FG002|Overall Study|Adverse Event|0|||
124576845|NCT03818581|448074700|FG003|Overall Study|Adverse Event|0|||
124576846|NCT03818581|448074701|FG004|Overall Study|Adverse Event|0|||
124576847|NCT03818581|448074697|FG000|Overall Study|Covid-19|2|||
124576848|NCT03818581|448074698|FG001|Overall Study|Covid-19|0|||
124576849|NCT03818581|448074699|FG002|Overall Study|Covid-19|0|||
124576850|NCT03818581|448074700|FG003|Overall Study|Covid-19|0|||
124576851|NCT03818581|448074701|FG004|Overall Study|Covid-19|1|||
124576852|NCT03818581|448074697|FG000|Overall Study|Withdrawal by Subject|0|||
124576853|NCT03818581|448074698|FG001|Overall Study|Withdrawal by Subject|0|||
124576854|NCT03818581|448074699|FG002|Overall Study|Withdrawal by Subject|0|||
124576855|NCT03818581|448074700|FG003|Overall Study|Withdrawal by Subject|0|||
124576856|NCT03818581|448074701|FG004|Overall Study|Withdrawal by Subject|1|||
124576857|NCT03818581|448074697|FG000|Overall Study|No longer met study criteria|0|||
124576858|NCT03818581|448074698|FG001|Overall Study|No longer met study criteria|0|||
124576859|NCT03818581|448074699|FG002|Overall Study|No longer met study criteria|0|||
124576860|NCT03818581|448074700|FG003|Overall Study|No longer met study criteria|0|||
124576861|NCT03818581|448074701|FG004|Overall Study|No longer met study criteria|1|||
124576862|NCT02096211|448074704|FG000|Overall Study|Death|2|||
124576863|NCT02096211|448074704|FG000|Overall Study|Withdrawal by Subject|8|||
124576864|NCT02096211|448074704|FG000|Overall Study|Revision of implant|7|||
124576865|NCT02096211|448074704|FG000|Overall Study|Lost to Follow-up|43|||
124576866|NCT00519194|448074707|FG000|Overall Study|Withdrawal by Subject|9|||
124576867|NCT00519194|448074707|FG000|Overall Study|Death|9|||
124576868|NCT00519194|448074707|FG000|Overall Study|Lost to Follow-up|3|||
124576869|NCT03165994|448074708|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
124576870|NCT03165994|448074708|FG000|Overall Study|Death|2|||
124576871|NCT03165994|448074708|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
124576872|NCT03165994|448074708|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
124576873|NCT03165994|448074708|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
124576874|NCT03165994|448074708|FG000|Overall Study|Miscellaneous|1|||
124576875|NCT00934050|448074715|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
124576876|NCT00934050|448074716|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
124576877|NCT00934050|448074717|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
124576878|NCT00934050|448074718|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
124576879|NCT00934050|448074719|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
124576880|NCT00934050|448074720|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
124725794|NCT04826094|448616632|FG007|Overall Study|Other: Declined|0|||
124725795|NCT04826094|448616625|FG000|Overall Study|Other: Vaccine not administered|0|||
124725796|NCT04826094|448616626|FG001|Overall Study|Other: Vaccine not administered|0|||
124725797|NCT04826094|448616627|FG002|Overall Study|Other: Vaccine not administered|1|||
124725798|NCT04826094|448616628|FG003|Overall Study|Other: Vaccine not administered|0|||
124725799|NCT04826094|448616629|FG004|Overall Study|Other: Vaccine not administered|0|||
124725800|NCT04826094|448616630|FG005|Overall Study|Other: Vaccine not administered|1|||
124725801|NCT04826094|448616631|FG006|Overall Study|Other: Vaccine not administered|1|||
124725802|NCT04826094|448616632|FG007|Overall Study|Other: Vaccine not administered|3|||
124725803|NCT05312697|448616633|FG000|Overall Study|Sponsor Terminated Trial|2|||
124725804|NCT04445519|448616634|FG000|Overall Study|Due to adaptive design|3|||
124725805|NCT04445519|448616635|FG001|Overall Study|Due to adaptive design|0|||
124725806|NCT04445519|448616636|FG002|Overall Study|Due to adaptive design|0|||
124725807|NCT04445519|448616634|FG000|Overall Study|Lost to Follow-up|0|||
124725808|NCT04445519|448616635|FG001|Overall Study|Lost to Follow-up|1|||
124725809|NCT04445519|448616636|FG002|Overall Study|Lost to Follow-up|4|||
124725810|NCT04445519|448616634|FG000|Overall Study|Sponsor or IRB Decision|0|||
124725811|NCT04445519|448616635|FG001|Overall Study|Sponsor or IRB Decision|1|||
124725812|NCT04445519|448616636|FG002|Overall Study|Sponsor or IRB Decision|2|||
124725813|NCT04445519|448616634|FG000|Overall Study|Withdrawal by Subject|0|||
124725814|NCT04445519|448616635|FG001|Overall Study|Withdrawal by Subject|3|||
124725815|NCT04445519|448616636|FG002|Overall Study|Withdrawal by Subject|3|||
124725816|NCT04445519|448616634|FG000|Overall Study|Adverse Event|0|||
124725817|NCT04445519|448616635|FG001|Overall Study|Adverse Event|8|||
124725818|NCT04445519|448616636|FG002|Overall Study|Adverse Event|6|||
124725819|NCT04445519|448616634|FG000|Overall Study|Other Reason|0|||
124725820|NCT04445519|448616635|FG001|Overall Study|Other Reason|1|||
124576881|NCT00934050|448074715|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
124576882|NCT00934050|448074716|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
124576883|NCT00934050|448074717|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
124725821|NCT04445519|448616636|FG002|Overall Study|Other Reason|1|||
124725822|NCT04445519|448616634|FG000|Overall Study|Protocol Violation|0|||
124576884|NCT00934050|448074718|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
124576885|NCT00934050|448074719|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
124576886|NCT00934050|448074720|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
124725823|NCT04445519|448616635|FG001|Overall Study|Protocol Violation|0|||
124576887|NCT00934050|448074715|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
124576888|NCT00934050|448074716|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
124576889|NCT00934050|448074717|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
124576890|NCT00934050|448074718|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
124576891|NCT00934050|448074719|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
124576892|NCT00934050|448074720|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
124576893|NCT00934050|448074715|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
124576894|NCT00934050|448074716|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
124576895|NCT00934050|448074717|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
124576896|NCT00934050|448074718|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
124576897|NCT00934050|448074719|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
124576898|NCT00934050|448074720|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
124576899|NCT00934050|448074715|FG000|Enrolled After 15 Dec 2009|Death|0|||
124576900|NCT00934050|448074716|FG001|Enrolled After 15 Dec 2009|Death|0|||
124576901|NCT00934050|448074717|FG002|Enrolled After 15 Dec 2009|Death|0|||
124576902|NCT00934050|448074718|FG003|Enrolled After 15 Dec 2009|Death|0|||
124576903|NCT00934050|448074719|FG004|Enrolled After 15 Dec 2009|Death|0|||
124576904|NCT00934050|448074720|FG005|Enrolled After 15 Dec 2009|Death|1|||
124576905|NCT00934050|448074715|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
124576906|NCT00934050|448074716|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
124576907|NCT00934050|448074717|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
124576908|NCT00934050|448074718|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
124576909|NCT00934050|448074719|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
124576910|NCT00934050|448074720|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
124576911|NCT00934050|448074715|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
124576912|NCT00934050|448074716|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
124576913|NCT00934050|448074717|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
124576914|NCT00934050|448074718|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
124576915|NCT00934050|448074719|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
124576916|NCT00934050|448074720|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
124576917|NCT00461786|448074721|FG000|Overall Study|Entry Criteria Not Met|2|||
124576918|NCT00461786|448074721|FG000|Overall Study|Inevaluable (Never Treated)|1|||
124576919|NCT00835991|448074722|FG000|First Intervention|Adverse Event|0|||
124576920|NCT00835991|448074723|FG001|First Intervention|Adverse Event|1|||
124576921|NCT00835991|448074722|FG000|Washout|Protocol Violation|0|||
124576922|NCT00835991|448074723|FG001|Washout|Protocol Violation|2|||
124576923|NCT00835991|448074722|FG000|Washout|Withdrawal by Subject|3|||
124576924|NCT00835991|448074723|FG001|Washout|Withdrawal by Subject|1|||
124576925|NCT02149420|448074724|FG000|Core Study|Administrative problems|0|||
124576926|NCT02149420|448074725|FG001|Core Study|Administrative problems|1|||
124576927|NCT02149420|448074726|FG002|Core Study|Administrative problems|2|||
124576928|NCT02149420|448074724|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
124576929|NCT02149420|448074725|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
124576930|NCT02149420|448074726|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
124576931|NCT02378935|448074729|FG000|Overall Study|Lack of Efficacy|10|||
124576932|NCT02378935|448074730|FG001|Overall Study|Lack of Efficacy|0|||
124576933|NCT02378935|448074731|FG002|Overall Study|Lack of Efficacy|2|||
124576934|NCT02378935|448074732|FG003|Overall Study|Lack of Efficacy|6|||
124576935|NCT02378935|448074733|FG004|Overall Study|Lack of Efficacy|0|||
124576936|NCT02378935|448074734|FG005|Overall Study|Lack of Efficacy|0|||
124576937|NCT02378935|448074735|FG006|Overall Study|Lack of Efficacy|0|||
124576938|NCT02378935|448074729|FG000|Overall Study|Death|0|||
124576939|NCT02378935|448074730|FG001|Overall Study|Death|0|||
124576940|NCT02378935|448074731|FG002|Overall Study|Death|1|||
124576941|NCT02378935|448074732|FG003|Overall Study|Death|0|||
124576942|NCT02378935|448074733|FG004|Overall Study|Death|0|||
124576943|NCT02378935|448074734|FG005|Overall Study|Death|0|||
124576944|NCT02378935|448074735|FG006|Overall Study|Death|0|||
124576945|NCT00272779|448074736|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
124576946|NCT00272779|448074737|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
124576947|NCT00272779|448074736|FG000|Baseline Through Week 48|Death before Week 48|4|||
124576948|NCT00272779|448074737|FG001|Baseline Through Week 48|Death before Week 48|4|||
124576949|NCT00272779|448074736|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
124576950|NCT00272779|448074737|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
124576951|NCT00272779|448074736|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
124576952|NCT00272779|448074737|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
124576953|NCT00272779|448074736|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
124576954|NCT00272779|448074737|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
124576955|NCT00272779|448074736|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
124576956|NCT00272779|448074737|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
124576957|NCT00272779|448074736|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
124576958|NCT00272779|448074737|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
124576959|NCT00272779|448074736|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
124522563|NCT00437203|447864413|FG001|Overall Study|Study terminated by sponsor|0|||
124522564|NCT00437203|447864414|FG002|Overall Study|Study terminated by sponsor|0|||
124522565|NCT00437203|447864415|FG003|Overall Study|Study terminated by sponsor|0|||
124522566|NCT00437203|447864416|FG004|Overall Study|Study terminated by sponsor|0|||
124522567|NCT00437203|447864417|FG005|Overall Study|Study terminated by sponsor|0|||
124522568|NCT00437203|447864418|FG006|Overall Study|Study terminated by sponsor|0|||
124522569|NCT00437203|447864419|FG007|Overall Study|Study terminated by sponsor|0|||
124522570|NCT00437203|447864420|FG008|Overall Study|Study terminated by sponsor|1|||
124522571|NCT00437203|447864421|FG009|Overall Study|Study terminated by sponsor|0|||
124522572|NCT00437203|447864412|FG000|Overall Study|Objective progression or relapse|5|||
124522573|NCT00437203|447864413|FG001|Overall Study|Objective progression or relapse|6|||
124522574|NCT00437203|447864414|FG002|Overall Study|Objective progression or relapse|2|||
124522575|NCT00437203|447864415|FG003|Overall Study|Objective progression or relapse|3|||
124522576|NCT00437203|447864416|FG004|Overall Study|Objective progression or relapse|3|||
124522577|NCT00437203|447864417|FG005|Overall Study|Objective progression or relapse|3|||
124522578|NCT00437203|447864418|FG006|Overall Study|Objective progression or relapse|6|||
124522579|NCT00437203|447864419|FG007|Overall Study|Objective progression or relapse|1|||
124522580|NCT00437203|447864420|FG008|Overall Study|Objective progression or relapse|2|||
124522581|NCT00437203|447864421|FG009|Overall Study|Objective progression or relapse|2|||
124522582|NCT00437203|447864412|FG000|Overall Study|Other|0|||
124522583|NCT00437203|447864413|FG001|Overall Study|Other|1|||
124522584|NCT00437203|447864414|FG002|Overall Study|Other|0|||
124522585|NCT00437203|447864415|FG003|Overall Study|Other|0|||
124522586|NCT00437203|447864416|FG004|Overall Study|Other|0|||
124522587|NCT00437203|447864417|FG005|Overall Study|Other|0|||
124522588|NCT00437203|447864418|FG006|Overall Study|Other|1|||
124522589|NCT00437203|447864419|FG007|Overall Study|Other|0|||
124522590|NCT00437203|447864420|FG008|Overall Study|Other|0|||
124522591|NCT00437203|447864421|FG009|Overall Study|Other|0|||
124522592|NCT01449955|447864422|FG000|Overall Study|Withdrawal by Subject|1|||
124522593|NCT01449955|447864423|FG001|Overall Study|Withdrawal by Subject|2|||
124522594|NCT02067533|447864430|FG000|Overall Study|Lost to Follow-up|4|||
124522595|NCT02067533|447864431|FG001|Overall Study|Lost to Follow-up|2|||
124522596|NCT02566109|447864432|FG000|Overall Study|Withdrawal by Subject|1|||
124522597|NCT01993667|447864433|FG000|Overall Study|Insufficient data to analyze|16|||
124522598|NCT01993667|447864434|FG001|Overall Study|Insufficient data to analyze|16|||
124522599|NCT01993667|447864433|FG000|Overall Study|Insufficient altitude reached|3|||
124522600|NCT01993667|447864434|FG001|Overall Study|Insufficient altitude reached|1|||
124522601|NCT01993667|447864433|FG000|Overall Study|Lost to Follow-up|2|||
124522602|NCT01993667|447864434|FG001|Overall Study|Lost to Follow-up|2|||
124522603|NCT01997281|447864439|FG000|Overall Study|Withdrawal by Subject|1|||
124522604|NCT01997281|447864440|FG001|Overall Study|Withdrawal by Subject|0|||
124522605|NCT01570309|447864441|FG000|Overall Study|Withdrawal by Subject|3|||
124522606|NCT01570309|447864442|FG001|Overall Study|Withdrawal by Subject|3|||
124522607|NCT00560794|447864443|FG000|Overall Study|Adverse Event|2|||
124522608|NCT00560794|447864443|FG000|Overall Study|Patient was not Compliant|1|||
124522609|NCT00560794|447864443|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
124522610|NCT00560794|447864443|FG000|Overall Study|Hematological Relapse|1|||
124522611|NCT00560794|447864443|FG000|Overall Study|Received Bone Marrow Transplant|6|||
124522612|NCT04857892|447864444|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
124522613|NCT04857892|447864445|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
124522614|NCT04857892|447864446|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
124522615|NCT04857892|447864447|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
124522616|NCT04857892|447864448|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
124522617|NCT04857892|447864444|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
124522618|NCT04857892|447864445|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
124522619|NCT04857892|447864446|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
124522620|NCT04857892|447864447|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
124522621|NCT04857892|447864448|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
124522622|NCT04857892|447864444|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
124522623|NCT04857892|447864445|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
124522624|NCT04857892|447864446|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
124522625|NCT04857892|447864447|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
124522626|NCT04857892|447864448|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
124522627|NCT00368472|447864453|FG000|Overall Study|Adverse Event|22|||
124522628|NCT00368472|447864453|FG000|Overall Study|Medication non-compliance|4|||
124522629|NCT00368472|447864453|FG000|Overall Study|Protocol Violation|2|||
124522630|NCT00368472|447864453|FG000|Overall Study|Request of Investigator or Sponsor|3|||
124522631|NCT00368472|447864453|FG000|Overall Study|Withdrawal by Subject|40|||
124522632|NCT00368472|447864453|FG000|Overall Study|Diary non-compliance|1|||
124522633|NCT00368472|447864453|FG000|Overall Study|Other|32|||
124522634|NCT00368472|447864453|FG000|Overall Study|Missing Final Disposition Date|1|||
124522635|NCT00981682|447864454|FG000|Overall Study|Adverse Event|48|||
124522636|NCT00981682|447864454|FG000|Overall Study|Withdrawal by Subject|52|||
124576960|NCT00272779|448074737|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
124576961|NCT00272779|448074736|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
124576962|NCT00272779|448074737|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
124576963|NCT00272779|448074736|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
124576964|NCT00272779|448074737|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
124576965|NCT00272779|448074736|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
124576966|NCT00272779|448074737|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
124576967|NCT00272779|448074736|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
124576968|NCT00272779|448074737|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
124576969|NCT00272779|448074736|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
124576970|NCT00272779|448074737|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
124576971|NCT00272779|448074736|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
124576972|NCT00272779|448074737|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
124576973|NCT00272779|448074736|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
124576974|NCT00272779|448074737|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
124576975|NCT00272779|448074736|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
124576976|NCT00272779|448074737|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
124576977|NCT00272779|448074736|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
124576978|NCT00272779|448074737|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
124576979|NCT00272779|448074736|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
124576980|NCT00272779|448074737|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
124576981|NCT00272779|448074736|FG000|Baseline Through Week 48|Continuing treatment|385|||
124576982|NCT00272779|448074737|FG001|Baseline Through Week 48|Continuing treatment|368|||
124576983|NCT00272779|448074736|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
124576984|NCT00272779|448074737|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
124576985|NCT00272779|448074736|FG000|Baseline Through Week 48|Never treated|2|||
124576986|NCT00272779|448074737|FG001|Baseline Through Week 48|Never treated|3|||
124576987|NCT00272779|448074736|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
124576988|NCT00272779|448074737|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
124576989|NCT00272779|448074736|FG000|Baseline Through Week 96|Death before Week 96|6|||
124576990|NCT00272779|448074737|FG001|Baseline Through Week 96|Death before Week 96|5|||
124576991|NCT00272779|448074736|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
124576992|NCT00272779|448074737|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
124576993|NCT00272779|448074736|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
124576994|NCT00272779|448074737|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
124576995|NCT00272779|448074736|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
124576996|NCT00272779|448074737|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
124576997|NCT00272779|448074736|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
124576998|NCT00272779|448074737|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
124576999|NCT00272779|448074736|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
124577000|NCT00272779|448074737|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
124577001|NCT00272779|448074736|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
124577002|NCT00272779|448074737|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
124577003|NCT00272779|448074736|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
124577004|NCT00272779|448074737|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
124577005|NCT00272779|448074736|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
124725824|NCT04445519|448616636|FG002|Overall Study|Protocol Violation|1|||
124725825|NCT04590404|448616642|FG000|Overall Study|Death|16|||
124725826|NCT04590404|448616643|FG001|Overall Study|Death|17|||
124725827|NCT04590404|448616642|FG000|Overall Study|Withdrawal by Subject|7|||
124725828|NCT04590404|448616643|FG001|Overall Study|Withdrawal by Subject|2|||
124725829|NCT00177294|448616644|FG000|Overall Study|Withdrawal by Subject|7|||
124725830|NCT00177294|448616645|FG001|Overall Study|Withdrawal by Subject|5|||
124725831|NCT04154605|448616646|FG000|Overall Study|Procedure Canceled|1|||
124725832|NCT04154605|448616647|FG001|Overall Study|Procedure Canceled|1|||
124725833|NCT04154605|448616646|FG000|Overall Study|Missed follow up|1|||
124725834|NCT04154605|448616647|FG001|Overall Study|Missed follow up|1|||
124725835|NCT04154605|448616646|FG000|Overall Study|Withdrawal by Subject|1|||
124725836|NCT04154605|448616647|FG001|Overall Study|Withdrawal by Subject|0|||
124725837|NCT06359028|448616652|FG000|Overall Study|Adverse Event|1|||
124725838|NCT06359028|448616653|FG001|Overall Study|Adverse Event|0|||
124577006|NCT00272779|448074737|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
124577007|NCT00272779|448074736|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
124577008|NCT00272779|448074737|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
124725839|NCT06359028|448616652|FG000|Overall Study|Withdrawal by Subject|1|||
124725840|NCT06359028|448616653|FG001|Overall Study|Withdrawal by Subject|0|||
124725841|NCT04382586|448616654|FG000|Overall Study|Death|3|||
124725842|NCT04382586|448616655|FG001|Overall Study|Death|4|||
124577009|NCT00272779|448074736|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
124577010|NCT00272779|448074737|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
124577011|NCT00272779|448074736|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
124577012|NCT00272779|448074737|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
124577013|NCT00272779|448074736|FG000|Baseline Through Week 96|Never treated|2|||
124577014|NCT00272779|448074737|FG001|Baseline Through Week 96|Never treated|3|||
124577015|NCT00272779|448074736|FG000|Baseline Through Week 96|Continuing on treatment|61|||
124577016|NCT00272779|448074737|FG001|Baseline Through Week 96|Continuing on treatment|38|||
124577017|NCT00561015|448074738|FG000|Overall Study|Adverse Event|0|||
124776745|NCT02120898|448809965|FG001|Overall Study|Lost to Follow-up|0|||
124776746|NCT02120898|448809966|FG002|Overall Study|Lost to Follow-up|1|||
124776747|NCT00831181|448809967|FG000|Overall Study|Adverse Event|12|||
124776748|NCT00196313|448809970|FG000|Overall Study|Protocol Violation|2|||
124776749|NCT00196313|448809971|FG001|Overall Study|Protocol Violation|3|||
124776750|NCT00196313|448809970|FG000|Overall Study|Withdrawal by Subject|3|||
124776751|NCT00196313|448809971|FG001|Overall Study|Withdrawal by Subject|1|||
124776752|NCT00196313|448809970|FG000|Overall Study|Adverse Event|3|||
124776753|NCT00196313|448809971|FG001|Overall Study|Adverse Event|1|||
124776754|NCT00196313|448809970|FG000|Overall Study|Subject Pregnant|1|||
124776755|NCT00196313|448809971|FG001|Overall Study|Subject Pregnant|1|||
124776756|NCT00196313|448809970|FG000|Overall Study|Lost to Follow-up|2|||
124776757|NCT00196313|448809971|FG001|Overall Study|Lost to Follow-up|2|||
124776758|NCT00043979|448809972|FG000|Period 1|recipient with progressive disease|7|||
124776759|NCT00043979|448809973|FG001|Period 1|recipient with progressive disease|4|||
124776760|NCT00043979|448809974|FG002|Period 1|recipient with progressive disease|3|||
124776761|NCT04085289|448809975|FG000|Overall Study|Withdrawal by Subject|0|||
124776762|NCT04085289|448809976|FG001|Overall Study|Withdrawal by Subject|0|||
124776763|NCT04085289|448809977|FG002|Overall Study|Withdrawal by Subject|1|||
124776764|NCT02919995|448809981|FG000|Overall Study|Adverse Event|0|||
124776765|NCT02919995|448809982|FG001|Overall Study|Adverse Event|0|||
124776766|NCT02919995|448809983|FG002|Overall Study|Adverse Event|0|||
124776767|NCT02919995|448809984|FG003|Overall Study|Adverse Event|0|||
124776768|NCT02919995|448809985|FG004|Overall Study|Adverse Event|0|||
124776769|NCT02919995|448809986|FG005|Overall Study|Adverse Event|1|||
124776770|NCT03196349|448809987|FG000|Overall Study|Did not receive study drug|0|||
124776771|NCT03196349|448809988|FG001|Overall Study|Did not receive study drug|1|||
124776772|NCT03196349|448809989|FG002|Overall Study|Did not receive study drug|2|||
124776773|NCT03196349|448809987|FG000|Overall Study|No data entered|2|||
124776774|NCT03196349|448809988|FG001|Overall Study|No data entered|4|||
124522637|NCT00981682|447864454|FG000|Overall Study|Lost to Follow-up|14|||
124522638|NCT00981682|447864454|FG000|Overall Study|Lack of Efficacy|13|||
124522639|NCT00981682|447864454|FG000|Overall Study|Protocol Violation|6|||
124522640|NCT00981682|447864454|FG000|Overall Study|administrative|9|||
124522641|NCT04095793|447864455|FG000|Overall Study|Adverse Event|3|||
124522642|NCT04095793|447864455|FG000|Overall Study|Study Terminated by Sponsor|103|||
124522643|NCT04095793|447864455|FG000|Overall Study|Withdrawal by Subject|4|||
124522644|NCT02384993|447864456|FG000|Overall Study|Adverse Event|0|||
124522645|NCT02384993|447864457|FG001|Overall Study|Adverse Event|1|||
124522646|NCT00651313|447864458|FG000|Overall Study|Adverse Event|0|||
124522647|NCT00651313|447864459|FG001|Overall Study|Adverse Event|1|||
124522648|NCT00651313|447864458|FG000|Overall Study|Withdrawal by Subject|3|||
124522649|NCT00651313|447864459|FG001|Overall Study|Withdrawal by Subject|1|||
124522650|NCT00651313|447864458|FG000|Overall Study|Lost to Follow-up|1|||
124522651|NCT00651313|447864459|FG001|Overall Study|Lost to Follow-up|1|||
124522652|NCT00651313|447864458|FG000|Overall Study|Adminstrative Discontinuation|2|||
124522653|NCT00651313|447864459|FG001|Overall Study|Adminstrative Discontinuation|3|||
124522654|NCT01199198|447866498|FG000|Overall Study|Adverse Event|3|||
124522655|NCT01199198|447866499|FG001|Overall Study|Adverse Event|0|||
124522656|NCT01199198|447866498|FG000|Overall Study|Lost to Follow-up|1|||
124522657|NCT01199198|447866499|FG001|Overall Study|Lost to Follow-up|5|||
124522658|NCT01199198|447866498|FG000|Overall Study|Withdrawal by Subject|1|||
124522659|NCT01199198|447866499|FG001|Overall Study|Withdrawal by Subject|2|||
124522660|NCT01199198|447866498|FG000|Overall Study|ICU Transfer|1|||
124522661|NCT01199198|447866499|FG001|Overall Study|ICU Transfer|2|||
124776775|NCT03196349|448809989|FG002|Overall Study|No data entered|0|||
124776776|NCT03196349|448809987|FG000|Overall Study|Study Terminated early|15|||
124776777|NCT03196349|448809988|FG001|Overall Study|Study Terminated early|9|||
124776778|NCT03196349|448809989|FG002|Overall Study|Study Terminated early|11|||
124776779|NCT02892448|448809999|FG000|Overall Study|Screening failure|2|||
124522662|NCT01199198|447866498|FG000|Overall Study|Hospice-care transfer|1|||
124522663|NCT01199198|447866499|FG001|Overall Study|Hospice-care transfer|2|||
124522664|NCT00922974|447866500|FG000|Phase II Component|Protocol Violation|2|||
124776780|NCT02892448|448810000|FG001|Overall Study|Screening failure|2|||
124776781|NCT02892448|448810001|FG002|Overall Study|Screening failure|1|||
124776782|NCT01012440|448810002|FG000|Overall Study|Withdrawal by Subject|2|||
124522665|NCT00922974|447866501|FG001|Phase II Component|Protocol Violation|0|||
124522666|NCT00922974|447866500|FG000|Phase II Component|Not evaluable for treatment review|5|||
124725843|NCT04382586|448616654|FG000|Overall Study|Lost to Follow-up|11|||
124725844|NCT04382586|448616655|FG001|Overall Study|Lost to Follow-up|8|||
124725845|NCT04382586|448616654|FG000|Overall Study|Withdrawal by Subject|3|||
124725846|NCT04382586|448616655|FG001|Overall Study|Withdrawal by Subject|1|||
124725847|NCT04382586|448616654|FG000|Overall Study|Physician Decision|0|||
124725848|NCT04382586|448616655|FG001|Overall Study|Physician Decision|3|||
124725849|NCT03479541|448616658|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
124725850|NCT03479541|448616659|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
124725851|NCT03479541|448616660|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
124725852|NCT03479541|448616661|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
124725853|NCT03479541|448616658|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
124725854|NCT03479541|448616659|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
124725855|NCT03479541|448616660|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
124725856|NCT03479541|448616661|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
124725857|NCT03479541|448616658|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
124725858|NCT03479541|448616659|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
124725859|NCT03479541|448616660|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
124725860|NCT03479541|448616661|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
124725861|NCT03479541|448616658|FG000|Home Monitoring|Lost to Follow-up|0|||
124725862|NCT03479541|448616659|FG001|Home Monitoring|Lost to Follow-up|0|||
124725863|NCT03479541|448616660|FG002|Home Monitoring|Lost to Follow-up|8|||
124725864|NCT03479541|448616661|FG003|Home Monitoring|Lost to Follow-up|12|||
124522667|NCT00922974|447866501|FG001|Phase II Component|Not evaluable for treatment review|0|||
124522668|NCT00922974|447866500|FG000|Phase III Component|Protocol Violation|8|||
124522669|NCT00922974|447866501|FG001|Phase III Component|Protocol Violation|6|||
124522670|NCT00608894|447866502|FG000|Overall Study|Withdrawal by Subject|0|||
124522671|NCT00608894|447866503|FG001|Overall Study|Withdrawal by Subject|2|||
124522672|NCT01376388|447866504|FG000|Overall Study|Adverse Event|13|||
124522673|NCT01376388|447866504|FG000|Overall Study|Lack of Efficacy|2|||
124522674|NCT01376388|447866504|FG000|Overall Study|Withdrawal by Subject|3|||
124522675|NCT01119963|447866505|FG000|Overall Study|Lost to Follow-up|1|||
124522676|NCT01119963|447866506|FG001|Overall Study|Lost to Follow-up|1|||
124522677|NCT03938636|447866511|FG000|Overall Study|Protocol Violation|0|||
124522678|NCT03938636|447866512|FG001|Overall Study|Protocol Violation|1|||
124522679|NCT03938636|447866513|FG002|Overall Study|Protocol Violation|1|||
124522680|NCT03938636|447866511|FG000|Overall Study|Subject withdrew due to death in family|0|||
124522681|NCT03938636|447866512|FG001|Overall Study|Subject withdrew due to death in family|1|||
124522682|NCT03938636|447866513|FG002|Overall Study|Subject withdrew due to death in family|0|||
124522683|NCT03938636|447866511|FG000|Overall Study|Missed visit|0|||
124522684|NCT03938636|447866512|FG001|Overall Study|Missed visit|1|||
124522685|NCT03938636|447866513|FG002|Overall Study|Missed visit|0|||
124522686|NCT03938636|447866511|FG000|Overall Study|Adverse Event|0|||
124522687|NCT03938636|447866512|FG001|Overall Study|Adverse Event|0|||
124522688|NCT03938636|447866513|FG002|Overall Study|Adverse Event|1|||
124522689|NCT03938636|447866511|FG000|Overall Study|Lost to Follow-up|0|||
124522690|NCT03938636|447866512|FG001|Overall Study|Lost to Follow-up|0|||
124522691|NCT03938636|447866513|FG002|Overall Study|Lost to Follow-up|1|||
124522692|NCT02603172|447866514|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
124522693|NCT02603172|447866515|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
124522694|NCT02603172|447866516|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
124522695|NCT02603172|447866517|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
124522696|NCT02603172|447866518|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
124522697|NCT02603172|447866519|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
124522698|NCT02603172|447866520|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
124522699|NCT02603172|447866521|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
124522700|NCT03285490|447866522|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
124522701|NCT03285490|447866523|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
124522702|NCT03285490|447866522|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
124522703|NCT03285490|447866523|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
124522704|NCT03745989|447866524|FG000|Overall Study|Death|3|||
124522705|NCT03745989|447866525|FG001|Overall Study|Death|7|||
124522706|NCT03745989|447866526|FG002|Overall Study|Death|4|||
124522707|NCT03745989|447866524|FG000|Overall Study|Lost to Follow-up|0|||
124522708|NCT03745989|447866525|FG001|Overall Study|Lost to Follow-up|2|||
124522709|NCT03745989|447866526|FG002|Overall Study|Lost to Follow-up|0|||
124522710|NCT03745989|447866524|FG000|Overall Study|Sponsor Decision|0|||
124522711|NCT03745989|447866525|FG001|Overall Study|Sponsor Decision|2|||
124522712|NCT03745989|447866526|FG002|Overall Study|Sponsor Decision|8|||
124522713|NCT03745989|447866524|FG000|Overall Study|Withdrawal by Subject|0|||
124522714|NCT03745989|447866525|FG001|Overall Study|Withdrawal by Subject|1|||
124522715|NCT03745989|447866526|FG002|Overall Study|Withdrawal by Subject|3|||
124522716|NCT01047436|447866527|FG000|Overall Study|Protocol Violation|1|||
124522717|NCT01047436|447866528|FG001|Overall Study|Protocol Violation|0|||
124522718|NCT00939341|447866529|FG000|Overall Study|Adverse Event|15|||
124522719|NCT00939341|447866529|FG000|Overall Study|Pregnancy|1|||
124522720|NCT00939341|447866529|FG000|Overall Study|Lost to Follow-up|23|||
124522721|NCT00939341|447866529|FG000|Overall Study|Withdrawal by Subject|13|||
124522722|NCT00939341|447866529|FG000|Overall Study|Protocol Violation|6|||
124522723|NCT00939341|447866529|FG000|Overall Study|Incorrect enrolment|8|||
124522724|NCT00424099|447866530|FG000|Overall Study|Adverse Event|0|||
124522725|NCT00424099|447866531|FG001|Overall Study|Adverse Event|1|||
124522726|NCT00424099|447866532|FG002|Overall Study|Adverse Event|1|||
124522727|NCT00424099|447866533|FG003|Overall Study|Adverse Event|0|||
124522728|NCT00424099|447866530|FG000|Overall Study|Death|0|||
124522729|NCT00424099|447866531|FG001|Overall Study|Death|1|||
124522730|NCT00424099|447866532|FG002|Overall Study|Death|0|||
124522731|NCT00424099|447866533|FG003|Overall Study|Death|0|||
124522732|NCT00424099|447866530|FG000|Overall Study|Illness|2|||
124522733|NCT00424099|447866531|FG001|Overall Study|Illness|0|||
124522734|NCT00424099|447866532|FG002|Overall Study|Illness|1|||
124522735|NCT00424099|447866533|FG003|Overall Study|Illness|4|||
124522736|NCT00424099|447866530|FG000|Overall Study|Lost to Follow-up|0|||
124522737|NCT00424099|447866531|FG001|Overall Study|Lost to Follow-up|0|||
124522738|NCT00424099|447866532|FG002|Overall Study|Lost to Follow-up|3|||
124522739|NCT00424099|447866533|FG003|Overall Study|Lost to Follow-up|0|||
124522740|NCT00424099|447866530|FG000|Overall Study|Hospitalized|1|||
124522741|NCT00424099|447866531|FG001|Overall Study|Hospitalized|2|||
124522742|NCT00424099|447866532|FG002|Overall Study|Hospitalized|1|||
124522743|NCT00424099|447866533|FG003|Overall Study|Hospitalized|3|||
124522744|NCT00424099|447866530|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
124522745|NCT00424099|447866531|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
124522746|NCT00424099|447866532|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
124522747|NCT00424099|447866533|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
124522748|NCT00424099|447866530|FG000|Overall Study|Withdrawal by Subject|1|||
124522749|NCT00424099|447866531|FG001|Overall Study|Withdrawal by Subject|9|||
124522750|NCT00424099|447866532|FG002|Overall Study|Withdrawal by Subject|4|||
124522751|NCT00424099|447866533|FG003|Overall Study|Withdrawal by Subject|6|||
124522752|NCT00424099|447866530|FG000|Overall Study|Physician Decision|0|||
124522753|NCT00424099|447866531|FG001|Overall Study|Physician Decision|0|||
124522754|NCT00424099|447866532|FG002|Overall Study|Physician Decision|1|||
124522755|NCT00424099|447866533|FG003|Overall Study|Physician Decision|0|||
124522756|NCT00424099|447866530|FG000|Overall Study|Missing|0|||
124522757|NCT00424099|447866531|FG001|Overall Study|Missing|0|||
124522758|NCT00424099|447866532|FG002|Overall Study|Missing|1|||
124522759|NCT00424099|447866533|FG003|Overall Study|Missing|0|||
124522760|NCT02280096|447866534|FG000|Overall Study|Pregnancy|1|||
124522761|NCT02280096|447866535|FG001|Overall Study|Pregnancy|0|||
124522762|NCT02280096|447866534|FG000|Overall Study|Functional neurological disorder|1|||
124522763|NCT02280096|447866535|FG001|Overall Study|Functional neurological disorder|0|||
124522764|NCT02280096|447866534|FG000|Overall Study|Lack of attachment|0|||
124522765|NCT02280096|447866535|FG001|Overall Study|Lack of attachment|1|||
124522766|NCT02939976|447866536|FG000|Overall Study|Lost to Follow-up|7|||
124522767|NCT02939976|447866537|FG001|Overall Study|Lost to Follow-up|1|||
124522768|NCT02939976|447866538|FG002|Overall Study|Lost to Follow-up|1|||
124522769|NCT02939976|447866539|FG003|Overall Study|Lost to Follow-up|2|||
124522770|NCT02939976|447866536|FG000|Overall Study|Withdrawal by Subject|4|||
124522771|NCT02939976|447866537|FG001|Overall Study|Withdrawal by Subject|0|||
124522772|NCT02939976|447866538|FG002|Overall Study|Withdrawal by Subject|2|||
124522773|NCT02939976|447866539|FG003|Overall Study|Withdrawal by Subject|4|||
124522774|NCT02939976|447866536|FG000|Overall Study|Due to early study closure|4|||
124522775|NCT02939976|447866537|FG001|Overall Study|Due to early study closure|3|||
124522776|NCT02939976|447866538|FG002|Overall Study|Due to early study closure|2|||
124522777|NCT02939976|447866539|FG003|Overall Study|Due to early study closure|3|||
124522778|NCT01872897|447866540|FG000|Overall Study|Withdrawal by Subject|1|||
124522779|NCT01872897|447866541|FG001|Overall Study|Withdrawal by Subject|0|||
124522780|NCT02418585|447866542|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
124522781|NCT02418585|447866543|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
124522782|NCT02418585|447866542|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
124522783|NCT02418585|447866543|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
124522784|NCT02418585|447866542|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
124522785|NCT02418585|447866543|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
124522786|NCT02418585|447866542|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
124522787|NCT02418585|447866543|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
124522788|NCT02418585|447866542|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
124522789|NCT02418585|447866543|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
124522790|NCT02418585|447866542|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
124522791|NCT02418585|447866543|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
124522792|NCT02418585|447866542|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
124522793|NCT02418585|447866543|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
124522794|NCT02418585|447866542|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
124522795|NCT02418585|447866543|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
124522796|NCT02418585|447866542|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
124522797|NCT02418585|447866543|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
124522798|NCT02418585|447866542|FG000|Follow-up Phase (24 Weeks)|Other|3|||
124522799|NCT02418585|447866543|FG001|Follow-up Phase (24 Weeks)|Other|2|||
124522800|NCT02040857|447866544|FG000|Overall Study|Adverse Event|14|||
124522801|NCT02040857|447866544|FG000|Overall Study|Physician Decision|5|||
124522802|NCT02040857|447866544|FG000|Overall Study|Withdrawal by Subject|31|||
124522803|NCT02040857|447866544|FG000|Overall Study|patient non-compliance|3|||
124522804|NCT02040857|447866544|FG000|Overall Study|Lost to Follow-up|2|||
124522805|NCT02040857|447866544|FG000|Overall Study|recurrence|4|||
124522806|NCT02040857|447866544|FG000|Overall Study|ineligible|1|||
124522807|NCT04159701|447866545|FG000|Period 1: Treatment Period|Pregnancy|1|||
124522808|NCT04159701|447866546|FG001|Period 1: Treatment Period|Pregnancy|0|||
124522809|NCT04159701|447866545|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
124522810|NCT04159701|447866546|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
124522811|NCT04159701|447866545|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
124522812|NCT04159701|447866546|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
124522813|NCT04159701|447866545|FG000|Washout Period|site terminated by sponsor|0|||
124522814|NCT04159701|447866546|FG001|Washout Period|site terminated by sponsor|1|||
124522815|NCT04159701|447866545|FG000|Washout Period|study terminated by sponsor|10|||
124522816|NCT04159701|447866546|FG001|Washout Period|study terminated by sponsor|3|||
124522817|NCT04159701|447866545|FG000|Washout Period|Withdrawal by Subject|1|||
124522818|NCT04159701|447866546|FG001|Washout Period|Withdrawal by Subject|0|||
124522819|NCT04159701|447866545|FG000|Washout Period|Inadvertent Enrollment|1|||
124522820|NCT04159701|447866546|FG001|Washout Period|Inadvertent Enrollment|0|||
124522821|NCT04159701|447866545|FG000|Washout Period|Miscellaneous|1|||
124522822|NCT04159701|447866546|FG001|Washout Period|Miscellaneous|0|||
124522823|NCT04159701|447866545|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
124522824|NCT04159701|447866546|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
124522825|NCT04159701|447866545|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
124522826|NCT04159701|447866546|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
124522827|NCT04159701|447866545|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
124522828|NCT04159701|447866546|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
124522829|NCT04159701|447866545|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
124522830|NCT04159701|447866546|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
124522831|NCT04159701|447866545|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
124522832|NCT04159701|447866546|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
124522833|NCT03605836|447866547|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
124522834|NCT03605836|447866548|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
124522835|NCT03605836|447866549|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
124522836|NCT03605836|447866550|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
124522837|NCT03605836|447866547|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
124522838|NCT03605836|447866548|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
124522839|NCT03605836|447866549|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
124522840|NCT03605836|447866550|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
124522841|NCT03605836|447866547|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
124522842|NCT03605836|447866548|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
124522843|NCT03605836|447866549|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
124522844|NCT03605836|447866550|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
124522845|NCT03605836|447866547|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
124522846|NCT03605836|447866548|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
124522847|NCT03605836|447866549|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
124522848|NCT03605836|447866550|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
124522849|NCT03605836|447866547|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
124522850|NCT03605836|447866548|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
124522851|NCT03605836|447866549|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
124522852|NCT03605836|447866550|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
124522853|NCT03605836|447866547|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
124522854|NCT03605836|447866548|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
124522855|NCT03605836|447866549|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
124522856|NCT03605836|447866550|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
124522857|NCT03605836|447866547|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
124522858|NCT03605836|447866548|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
124522859|NCT03605836|447866549|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
124522860|NCT03605836|447866550|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
124522861|NCT03605836|447866547|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
124522862|NCT03605836|447866548|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
124522863|NCT03605836|447866549|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
124522864|NCT03605836|447866550|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
124522865|NCT03605836|447866547|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
124522866|NCT03605836|447866548|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
124522867|NCT03605836|447866549|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
124522868|NCT03605836|447866550|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
124522869|NCT03605836|447866547|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
124522870|NCT03605836|447866548|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
124522871|NCT03605836|447866549|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
124522872|NCT03605836|447866550|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
124522873|NCT03605836|447866547|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
124522874|NCT03605836|447866548|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
124522875|NCT03605836|447866549|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
124522876|NCT03605836|447866550|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
124522877|NCT03605836|447866547|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
124522878|NCT03605836|447866548|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
124522879|NCT03605836|447866549|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
124522880|NCT03605836|447866550|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
124522881|NCT03605836|447866547|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
124522882|NCT03605836|447866548|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
124522883|NCT03605836|447866549|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
124522884|NCT03605836|447866550|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
124522885|NCT03605836|447866547|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
124522886|NCT03605836|447866548|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
124522887|NCT03605836|447866549|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
124522888|NCT03605836|447866550|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
124522889|NCT03605836|447866547|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
124522890|NCT03605836|447866548|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
124577018|NCT00561015|448074739|FG001|Overall Study|Adverse Event|0|||
124577019|NCT00561015|448074740|FG002|Overall Study|Adverse Event|0|||
124577020|NCT00561015|448074741|FG003|Overall Study|Adverse Event|0|||
124725865|NCT03479541|448616658|FG000|Home Monitoring|Withdrawal by Subject|0|||
124725866|NCT03479541|448616659|FG001|Home Monitoring|Withdrawal by Subject|0|||
124725867|NCT03479541|448616660|FG002|Home Monitoring|Withdrawal by Subject|17|||
124725868|NCT03479541|448616661|FG003|Home Monitoring|Withdrawal by Subject|30|||
124725869|NCT03479541|448616658|FG000|Home Monitoring|Early Termination - PI Decision|0|||
124725870|NCT03479541|448616659|FG001|Home Monitoring|Early Termination - PI Decision|0|||
124725871|NCT03479541|448616660|FG002|Home Monitoring|Early Termination - PI Decision|4|||
124725872|NCT03479541|448616661|FG003|Home Monitoring|Early Termination - PI Decision|6|||
124725873|NCT00661726|448616662|FG000|Overall Study|Adverse Event|1|||
124725874|NCT02109432|448618539|FG000|Overall Study|Withdrawal by Subject|1|||
124725875|NCT02920528|448618540|FG000|Overall Study|Incomplete Data|1|||
124725876|NCT02920528|448618541|FG001|Overall Study|Incomplete Data|1|||
124725877|NCT02920528|448618542|FG002|Overall Study|Incomplete Data|1|||
124725878|NCT02920528|448618540|FG000|Overall Study|Adverse Event|0|||
124725879|NCT02920528|448618541|FG001|Overall Study|Adverse Event|0|||
124725880|NCT02920528|448618542|FG002|Overall Study|Adverse Event|3|||
124725881|NCT02920528|448618540|FG000|Overall Study|Did not meet inclusion criteria|2|||
124725882|NCT02920528|448618541|FG001|Overall Study|Did not meet inclusion criteria|0|||
124725883|NCT02920528|448618542|FG002|Overall Study|Did not meet inclusion criteria|1|||
124725884|NCT00623233|448618554|FG000|Overall Study|Adverse Event|10|||
124725885|NCT00623233|448618554|FG000|Overall Study|Physician Decision|10|||
124725886|NCT00623233|448618554|FG000|Overall Study|Lost to Follow-up|1|||
124725887|NCT00623233|448618554|FG000|Overall Study|Withdrawal by Subject|3|||
124725888|NCT01811485|448618555|FG000|Overall Study|Adverse Event|1|||
124725889|NCT01811485|448618556|FG001|Overall Study|Adverse Event|3|||
124725890|NCT01811485|448618557|FG002|Overall Study|Adverse Event|2|||
124725891|NCT01811485|448618555|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124725892|NCT01811485|448618556|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124725893|NCT01811485|448618557|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
124725894|NCT01811485|448618555|FG000|Overall Study|Administrative problems|1|||
124725895|NCT01811485|448618556|FG001|Overall Study|Administrative problems|0|||
124725896|NCT01811485|448618557|FG002|Overall Study|Administrative problems|0|||
124725897|NCT01811485|448618555|FG000|Overall Study|Protocol Deviation|0|||
124725898|NCT01811485|448618556|FG001|Overall Study|Protocol Deviation|1|||
124725899|NCT01811485|448618557|FG002|Overall Study|Protocol Deviation|0|||
124725900|NCT01545934|448618558|FG000|Overall Study|Withdrawal by Subject|4|||
124725901|NCT01545934|448618559|FG001|Overall Study|Withdrawal by Subject|3|||
124725902|NCT01545934|448618558|FG000|Overall Study|Lost to Follow-up|1|||
124725903|NCT01545934|448618559|FG001|Overall Study|Lost to Follow-up|0|||
124725904|NCT03654404|448618560|FG000|Overall Study|Death|1|||
124725905|NCT03654404|448618560|FG000|Overall Study|Lost to Follow-up|2|||
124577021|NCT00561015|448074742|FG004|Overall Study|Adverse Event|1|||
124577022|NCT00561015|448074743|FG005|Overall Study|Adverse Event|0|||
124577023|NCT00561015|448074738|FG000|Overall Study|Lost to Follow-up|2|||
124725906|NCT03654404|448618560|FG000|Overall Study|Withdrawal by Subject|5|||
124725907|NCT03215758|448618561|FG000|Overall Study|Technical Problems|1|||
124725908|NCT03215758|448618562|FG001|Overall Study|Technical Problems|0|||
124725909|NCT03215758|448618561|FG000|Overall Study|Protocol deviation|0|||
124725910|NCT03215758|448618562|FG001|Overall Study|Protocol deviation|1|||
124725911|NCT03215758|448618561|FG000|Overall Study|Physician Decision|0|||
124725912|NCT03215758|448618562|FG001|Overall Study|Physician Decision|1|||
124725913|NCT03215758|448618561|FG000|Overall Study|Death|0|||
124522891|NCT03605836|447866549|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
124522892|NCT03605836|447866550|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
124522893|NCT03605836|447866547|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
124522894|NCT03605836|447866548|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
124522895|NCT03605836|447866549|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
124522896|NCT03605836|447866550|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
124522897|NCT03605836|447866547|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
124522898|NCT03605836|447866548|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
124522899|NCT03605836|447866549|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
124522900|NCT03605836|447866550|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
124522901|NCT03605836|447866547|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
124522902|NCT03605836|447866548|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
124522903|NCT03605836|447866549|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
124522904|NCT03605836|447866550|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
124522905|NCT03605836|447866547|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
124522906|NCT03605836|447866548|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
124522907|NCT03605836|447866549|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
124522908|NCT03605836|447866550|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
124522909|NCT03605836|447866547|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
124522910|NCT03605836|447866548|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
124522911|NCT03605836|447866549|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
124522912|NCT03605836|447866550|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
124522913|NCT03605836|447866547|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
124522914|NCT03605836|447866548|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
124522915|NCT03605836|447866549|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
124522916|NCT03605836|447866550|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
124522917|NCT03605836|447866547|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
124522918|NCT03605836|447866548|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
124522919|NCT03605836|447866549|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
124522920|NCT03605836|447866550|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
124522921|NCT02057068|447866557|FG000|Overall Study|Withdrawal by Subject|2|||
124522922|NCT02057068|447866558|FG001|Overall Study|Withdrawal by Subject|2|||
124522923|NCT02057068|447866557|FG000|Overall Study|Caregiver (CG) Health|0|||
124522924|NCT02057068|447866558|FG001|Overall Study|Caregiver (CG) Health|2|||
124522925|NCT02057068|447866557|FG000|Overall Study|Carepartner (CP) Health|4|||
124522926|NCT02057068|447866558|FG001|Overall Study|Carepartner (CP) Health|2|||
124522927|NCT02057068|447866557|FG000|Overall Study|Lost to Follow-up|2|||
124522928|NCT02057068|447866558|FG001|Overall Study|Lost to Follow-up|2|||
124522929|NCT01782885|447866559|FG000|Overall Study|Lost to Follow-up|4|||
124522930|NCT01782885|447866560|FG001|Overall Study|Lost to Follow-up|6|||
124522931|NCT03447821|447866561|FG000|Overall Study|Withdrawal by Subject|1|||
124522932|NCT03447821|447866562|FG001|Overall Study|Withdrawal by Subject|1|||
124522933|NCT03447821|447866563|FG002|Overall Study|Withdrawal by Subject|0|||
124522934|NCT03447821|447866561|FG000|Overall Study|Lost to Follow-up|0|||
124522935|NCT03447821|447866562|FG001|Overall Study|Lost to Follow-up|0|||
124522936|NCT03447821|447866563|FG002|Overall Study|Lost to Follow-up|1|||
124522937|NCT00329784|447866566|FG000|Overall Study|Lost to Follow-up|0|||
124522938|NCT00329784|447866567|FG001|Overall Study|Lost to Follow-up|1|||
124522939|NCT00329784|447866568|FG002|Overall Study|Lost to Follow-up|0|||
124522940|NCT00329784|447866569|FG003|Overall Study|Lost to Follow-up|0|||
124522941|NCT00329784|447866566|FG000|Overall Study|Withdrawal by Subject|4|||
124522942|NCT00329784|447866567|FG001|Overall Study|Withdrawal by Subject|2|||
124522943|NCT00329784|447866568|FG002|Overall Study|Withdrawal by Subject|0|||
124577024|NCT00561015|448074739|FG001|Overall Study|Lost to Follow-up|0|||
124577025|NCT00561015|448074740|FG002|Overall Study|Lost to Follow-up|0|||
124725914|NCT03215758|448618562|FG001|Overall Study|Death|1|||
124577026|NCT00561015|448074741|FG003|Overall Study|Lost to Follow-up|1|||
124725915|NCT03215758|448618561|FG000|Overall Study|Adverse Event|1|||
124725916|NCT03215758|448618562|FG001|Overall Study|Adverse Event|2|||
124725917|NCT03215758|448618561|FG000|Overall Study|Subject/Guardian Decision|3|||
124577027|NCT00561015|448074742|FG004|Overall Study|Lost to Follow-up|0|||
124577028|NCT00561015|448074743|FG005|Overall Study|Lost to Follow-up|3|||
124577029|NCT00561015|448074738|FG000|Overall Study|Participant non-compliance|2|||
124577030|NCT00561015|448074739|FG001|Overall Study|Participant non-compliance|0|||
124577031|NCT00561015|448074740|FG002|Overall Study|Participant non-compliance|0|||
124577032|NCT00561015|448074741|FG003|Overall Study|Participant non-compliance|0|||
124577033|NCT00561015|448074742|FG004|Overall Study|Participant non-compliance|0|||
124577034|NCT00561015|448074743|FG005|Overall Study|Participant non-compliance|0|||
124577035|NCT03616535|448074744|FG000|Overall Study|Death|2|||
124577036|NCT03616535|448074745|FG001|Overall Study|Death|0|||
124577037|NCT03616535|448074746|FG002|Overall Study|Death|0|||
124577038|NCT03616535|448074747|FG003|Overall Study|Death|1|||
124577039|NCT03616535|448074744|FG000|Overall Study|Lost to Follow-up|2|||
124577040|NCT03616535|448074745|FG001|Overall Study|Lost to Follow-up|1|||
124577041|NCT03616535|448074746|FG002|Overall Study|Lost to Follow-up|0|||
124577042|NCT03616535|448074747|FG003|Overall Study|Lost to Follow-up|2|||
124577043|NCT03616535|448074744|FG000|Overall Study|Withdrawal by Subject|1|||
124577044|NCT03616535|448074745|FG001|Overall Study|Withdrawal by Subject|2|||
124577045|NCT03616535|448074746|FG002|Overall Study|Withdrawal by Subject|5|||
124577046|NCT03616535|448074747|FG003|Overall Study|Withdrawal by Subject|1|||
124577047|NCT03616535|448074744|FG000|Overall Study|Not specified or change in eligibility|2|||
124577048|NCT03616535|448074745|FG001|Overall Study|Not specified or change in eligibility|3|||
124577049|NCT03616535|448074746|FG002|Overall Study|Not specified or change in eligibility|3|||
124577050|NCT03616535|448074747|FG003|Overall Study|Not specified or change in eligibility|1|||
124577051|NCT02440711|448074748|FG000|Second Intervention|Lost to Follow-up|1|||
124577052|NCT02440711|448074749|FG001|Second Intervention|Lost to Follow-up|0|||
124577053|NCT00163657|448074754|FG000|Overall Study|Death|12|||
124577054|NCT00163657|448074755|FG001|Overall Study|Death|14|||
124577055|NCT00163657|448074756|FG002|Overall Study|Death|19|||
124577056|NCT00163657|448074754|FG000|Overall Study|graft loss|4|||
124577057|NCT00163657|448074755|FG001|Overall Study|graft loss|1|||
124577058|NCT00163657|448074756|FG002|Overall Study|graft loss|2|||
124577059|NCT00163657|448074754|FG000|Overall Study|Withdrawal by Subject|2|||
124577060|NCT00163657|448074755|FG001|Overall Study|Withdrawal by Subject|3|||
124577061|NCT00163657|448074756|FG002|Overall Study|Withdrawal by Subject|2|||
124577062|NCT00163657|448074754|FG000|Overall Study|Physician Decision|0|||
124577063|NCT00163657|448074755|FG001|Overall Study|Physician Decision|1|||
124577064|NCT00163657|448074756|FG002|Overall Study|Physician Decision|1|||
124577065|NCT00163657|448074754|FG000|Overall Study|Non Compliance|1|||
124577066|NCT00163657|448074755|FG001|Overall Study|Non Compliance|0|||
124577067|NCT00163657|448074756|FG002|Overall Study|Non Compliance|0|||
124577068|NCT00163657|448074754|FG000|Overall Study|Lost to Follow-up|1|||
124577069|NCT00163657|448074755|FG001|Overall Study|Lost to Follow-up|3|||
124577070|NCT00163657|448074756|FG002|Overall Study|Lost to Follow-up|10|||
124577071|NCT00163657|448074754|FG000|Overall Study|Other reason|0|||
124577072|NCT00163657|448074755|FG001|Overall Study|Other reason|1|||
124577073|NCT00163657|448074756|FG002|Overall Study|Other reason|3|||
124577074|NCT03935880|448074757|FG000|Overall Study|Lost to Follow-up|0|||
124577075|NCT03935880|448074758|FG001|Overall Study|Lost to Follow-up|1|||
124577076|NCT02563561|448074759|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
124577077|NCT02563561|448074760|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
124577078|NCT02563561|448074761|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
124577079|NCT02563561|448074759|FG000|Overall Study|Withdrew of Consent|1|||
124577080|NCT02563561|448074760|FG001|Overall Study|Withdrew of Consent|1|||
124577081|NCT02563561|448074761|FG002|Overall Study|Withdrew of Consent|2|||
124577082|NCT02563561|448074759|FG000|Overall Study|Lost to Follow-up|1|||
124577083|NCT02563561|448074760|FG001|Overall Study|Lost to Follow-up|1|||
124577084|NCT02563561|448074761|FG002|Overall Study|Lost to Follow-up|0|||
124577085|NCT02563561|448074759|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
124577086|NCT02563561|448074760|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
124577087|NCT02563561|448074761|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
124577088|NCT02563561|448074759|FG000|Overall Study|Investigator Decision|3|||
124577089|NCT02563561|448074760|FG001|Overall Study|Investigator Decision|4|||
124577090|NCT02563561|448074761|FG002|Overall Study|Investigator Decision|2|||
124577091|NCT02563561|448074759|FG000|Overall Study|Sponsor Decision|5|||
124577092|NCT02563561|448074760|FG001|Overall Study|Sponsor Decision|2|||
124577093|NCT02563561|448074761|FG002|Overall Study|Sponsor Decision|4|||
124577094|NCT02563561|448074759|FG000|Overall Study|Other|1|||
124577095|NCT02563561|448074760|FG001|Overall Study|Other|5|||
124577096|NCT02563561|448074761|FG002|Overall Study|Other|2|||
124577097|NCT02718326|448074764|FG000|Overall Study|Adverse Event|4|||
124577098|NCT02718326|448074765|FG001|Overall Study|Adverse Event|9|||
124577099|NCT02718326|448074766|FG002|Overall Study|Adverse Event|0|||
124577100|NCT02718326|448074764|FG000|Overall Study|Death|8|||
124577101|NCT02718326|448074765|FG001|Overall Study|Death|1|||
124577102|NCT02718326|448074766|FG002|Overall Study|Death|2|||
124577103|NCT02718326|448074764|FG000|Overall Study|Withdrawal by Subject|4|||
124577104|NCT02718326|448074765|FG001|Overall Study|Withdrawal by Subject|9|||
124725918|NCT03215758|448618562|FG001|Overall Study|Subject/Guardian Decision|3|||
124522944|NCT00329784|447866569|FG003|Overall Study|Withdrawal by Subject|0|||
124522945|NCT00329784|447866566|FG000|Overall Study|Other|1|||
124522946|NCT00329784|447866567|FG001|Overall Study|Other|2|||
124522947|NCT00329784|447866568|FG002|Overall Study|Other|0|||
124522948|NCT00329784|447866569|FG003|Overall Study|Other|0|||
124522949|NCT01098032|447866570|FG000|Overall Study|Withdrawal by Subject|1|||
124522950|NCT01098032|447866571|FG001|Overall Study|Withdrawal by Subject|1|||
124522951|NCT00481988|447866572|FG000|Overall Study|Withdrawal by Subject|1|||
124522952|NCT00481988|447866573|FG001|Overall Study|Withdrawal by Subject|1|||
124522953|NCT00654420|447866574|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
124522954|NCT00654420|447866575|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
124522955|NCT00654420|447866576|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
124522956|NCT00654420|447866577|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
124522957|NCT00654420|447866574|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
124522958|NCT00654420|447866575|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
124522959|NCT00654420|447866576|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
124522960|NCT00654420|447866577|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
124522961|NCT00654420|447866574|FG000|Phase II|Adverse Event|0|||
124522962|NCT00654420|447866575|FG001|Phase II|Adverse Event|0|||
124522963|NCT00654420|447866576|FG002|Phase II|Adverse Event|3|||
124522964|NCT00654420|447866577|FG003|Phase II|Adverse Event|3|||
124522965|NCT00654420|447866574|FG000|Phase II|Lost to Follow-up|0|||
124522966|NCT00654420|447866575|FG001|Phase II|Lost to Follow-up|0|||
124522967|NCT00654420|447866576|FG002|Phase II|Lost to Follow-up|0|||
124522968|NCT00654420|447866577|FG003|Phase II|Lost to Follow-up|1|||
124522969|NCT00654420|447866574|FG000|Phase II|Physician Decision|0|||
124522970|NCT00654420|447866575|FG001|Phase II|Physician Decision|0|||
124522971|NCT00654420|447866576|FG002|Phase II|Physician Decision|0|||
124522972|NCT00654420|447866577|FG003|Phase II|Physician Decision|4|||
124522973|NCT00654420|447866574|FG000|Phase II|Progressive Disease|0|||
124522974|NCT00654420|447866575|FG001|Phase II|Progressive Disease|0|||
124522975|NCT00654420|447866576|FG002|Phase II|Progressive Disease|29|||
124522976|NCT00654420|447866577|FG003|Phase II|Progressive Disease|29|||
124522977|NCT00654420|447866574|FG000|Phase II|Withdrawal by Subject|0|||
124522978|NCT00654420|447866575|FG001|Phase II|Withdrawal by Subject|0|||
124522979|NCT00654420|447866576|FG002|Phase II|Withdrawal by Subject|4|||
124522980|NCT00654420|447866577|FG003|Phase II|Withdrawal by Subject|1|||
124522981|NCT00654420|447866574|FG000|Phase II|Missing Disposition Record|0|||
124522982|NCT00654420|447866575|FG001|Phase II|Missing Disposition Record|0|||
124522983|NCT00654420|447866576|FG002|Phase II|Missing Disposition Record|1|||
124522984|NCT00654420|447866577|FG003|Phase II|Missing Disposition Record|0|||
124522985|NCT00471276|447866580|FG000|Overall Study|Death|2|||
124522986|NCT00471276|447866580|FG000|Overall Study|Adverse Event|16|||
124522987|NCT00471276|447866580|FG000|Overall Study|Protocol Violation|1|||
124522988|NCT00471276|447866580|FG000|Overall Study|Objective progression or relapse|54|||
124522989|NCT00471276|447866580|FG000|Overall Study|Global deterioration of health status|1|||
124522990|NCT00471276|447866580|FG000|Overall Study|Other|3|||
124522991|NCT00471276|447866580|FG000|Overall Study|Refused treatment|6|||
124522992|NCT01594411|447866581|FG000|Overall Study|Lost to Follow-up|2|||
124522993|NCT00910728|447866585|FG000|Overall Study|Lack of Efficacy|2|||
124522994|NCT00910728|447866586|FG001|Overall Study|Lack of Efficacy|3|||
124522995|NCT00910728|447866587|FG002|Overall Study|Lack of Efficacy|1|||
124522996|NCT00910728|447866588|FG003|Overall Study|Lack of Efficacy|2|||
124522997|NCT00910728|447866589|FG004|Overall Study|Lack of Efficacy|1|||
124522998|NCT00910728|447866590|FG005|Overall Study|Lack of Efficacy|0|||
124522999|NCT00910728|447866591|FG006|Overall Study|Lack of Efficacy|2|||
124523000|NCT00910728|447866592|FG007|Overall Study|Lack of Efficacy|2|||
124523001|NCT00910728|447866593|FG008|Overall Study|Lack of Efficacy|2|||
124523002|NCT00910728|447866585|FG000|Overall Study|Withdrawal by Subject|0|||
124523003|NCT00910728|447866586|FG001|Overall Study|Withdrawal by Subject|0|||
124523004|NCT00910728|447866587|FG002|Overall Study|Withdrawal by Subject|0|||
124523005|NCT00910728|447866588|FG003|Overall Study|Withdrawal by Subject|0|||
124523006|NCT00910728|447866589|FG004|Overall Study|Withdrawal by Subject|3|||
124523007|NCT00910728|447866590|FG005|Overall Study|Withdrawal by Subject|1|||
124523008|NCT00910728|447866591|FG006|Overall Study|Withdrawal by Subject|2|||
124523009|NCT00910728|447866592|FG007|Overall Study|Withdrawal by Subject|0|||
124523010|NCT00910728|447866593|FG008|Overall Study|Withdrawal by Subject|0|||
124523011|NCT00910728|447866585|FG000|Overall Study|(not specified)|2|||
124523012|NCT00910728|447866586|FG001|Overall Study|(not specified)|0|||
124523013|NCT00910728|447866587|FG002|Overall Study|(not specified)|1|||
124523014|NCT00910728|447866588|FG003|Overall Study|(not specified)|0|||
124523015|NCT00910728|447866589|FG004|Overall Study|(not specified)|1|||
124523016|NCT00910728|447866590|FG005|Overall Study|(not specified)|0|||
124523017|NCT00910728|447866591|FG006|Overall Study|(not specified)|0|||
124523018|NCT00910728|447866592|FG007|Overall Study|(not specified)|0|||
124523019|NCT00910728|447866593|FG008|Overall Study|(not specified)|0|||
124523020|NCT00910728|447866585|FG000|Overall Study|Adverse Event|2|||
124523021|NCT00910728|447866586|FG001|Overall Study|Adverse Event|0|||
124577105|NCT02718326|448074766|FG002|Overall Study|Withdrawal by Subject|6|||
124577106|NCT02718326|448074764|FG000|Overall Study|Lost to Follow-up|18|||
124577107|NCT02718326|448074765|FG001|Overall Study|Lost to Follow-up|5|||
124577108|NCT02718326|448074766|FG002|Overall Study|Lost to Follow-up|14|||
124577109|NCT02718326|448074764|FG000|Overall Study|Protocol Deviation|1|||
124577110|NCT02718326|448074765|FG001|Overall Study|Protocol Deviation|0|||
124577111|NCT02718326|448074766|FG002|Overall Study|Protocol Deviation|0|||
124577112|NCT02718326|448074764|FG000|Overall Study|Pregnancy|1|||
124577113|NCT02718326|448074765|FG001|Overall Study|Pregnancy|0|||
124577114|NCT02718326|448074766|FG002|Overall Study|Pregnancy|0|||
124577115|NCT03122535|448074767|FG000|Overall Study|Lost to Follow-up|68|||
124577116|NCT03122535|448074768|FG001|Overall Study|Lost to Follow-up|68|||
124577117|NCT03122535|448074767|FG000|Overall Study|Physician Decision|3|||
124577118|NCT03122535|448074768|FG001|Overall Study|Physician Decision|3|||
124577119|NCT03122535|448074767|FG000|Overall Study|Withdrawal by Subject|2|||
124577120|NCT03122535|448074768|FG001|Overall Study|Withdrawal by Subject|2|||
124577121|NCT02646124|448074769|FG000|Overall Study|Lost to Follow-up|0|||
124577122|NCT02646124|448074770|FG001|Overall Study|Lost to Follow-up|2|||
124577123|NCT00857454|448074772|FG000|Overall Study|Withdrawal by Subject|2|||
124577124|NCT00857454|448074772|FG000|Overall Study|Lost to Follow-up|1|||
124577125|NCT00857454|448074772|FG000|Overall Study|Adverse Event|2|||
124577126|NCT00857454|448074772|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
124577127|NCT00857454|448074772|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
124577128|NCT00857454|448074772|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
124577129|NCT03154047|448074773|FG000|Overall Study|Death|1|||
124577130|NCT03154047|448074773|FG000|Overall Study|Study terminated by sponsor|76|||
124577131|NCT03154047|448074773|FG000|Overall Study|Withdrawal by Subject|3|||
124577132|NCT02436005|448074774|FG000|Second Intervention|Adverse Event|0|||
124577133|NCT02436005|448074775|FG001|Second Intervention|Adverse Event|1|||
124577134|NCT00573443|448074776|FG000|Double-Blind Phase|Lost to Follow-up|1|||
124577135|NCT00573443|448074777|FG001|Double-Blind Phase|Lost to Follow-up|3|||
124577136|NCT00573443|448074778|FG002|Double-Blind Phase|Lost to Follow-up|2|||
124577137|NCT00573443|448074776|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
124577138|NCT00573443|448074777|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
124577139|NCT00573443|448074778|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
124577140|NCT00573443|448074776|FG000|Double-Blind Phase|Adverse Event|1|||
124577141|NCT00573443|448074777|FG001|Double-Blind Phase|Adverse Event|5|||
124577142|NCT00573443|448074778|FG002|Double-Blind Phase|Adverse Event|0|||
124577143|NCT00573443|448074776|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
124577144|NCT00573443|448074777|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
124577145|NCT00573443|448074778|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
124577146|NCT00573443|448074776|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
124577147|NCT00573443|448074777|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
124577148|NCT00573443|448074778|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
124577149|NCT00573443|448074776|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
124577150|NCT00573443|448074777|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
124577151|NCT00573443|448074778|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
124577152|NCT00573443|448074776|FG000|Double-Blind Phase|Protocol Violation|0|||
124577153|NCT00573443|448074777|FG001|Double-Blind Phase|Protocol Violation|2|||
124577154|NCT00573443|448074778|FG002|Double-Blind Phase|Protocol Violation|1|||
124577155|NCT00573443|448074776|FG000|Double-Blind Phase|Other|0|||
124577156|NCT00573443|448074777|FG001|Double-Blind Phase|Other|2|||
124577157|NCT00573443|448074778|FG002|Double-Blind Phase|Other|3|||
124577158|NCT00573443|448074776|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
124577159|NCT00573443|448074777|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
124577160|NCT00573443|448074778|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
124577161|NCT00573443|448074776|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
124577162|NCT00573443|448074777|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
124577163|NCT00573443|448074778|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
124577164|NCT00573443|448074776|FG000|Open-Label Extension Phase|Adverse Event|3|||
124577165|NCT00573443|448074777|FG001|Open-Label Extension Phase|Adverse Event|0|||
124577166|NCT00573443|448074778|FG002|Open-Label Extension Phase|Adverse Event|0|||
124577167|NCT00573443|448074776|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
124577168|NCT00573443|448074777|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
124725919|NCT02003638|448618563|FG000|Overall Study|Withdrawal by Subject|1|||
124725920|NCT02003638|448618564|FG001|Overall Study|Withdrawal by Subject|0|||
124577169|NCT00573443|448074778|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
124577170|NCT00573443|448074776|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
124577171|NCT00573443|448074777|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
124577172|NCT00573443|448074778|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
124577173|NCT00573443|448074776|FG000|Open-Label Extension Phase|Protocol Violation|2|||
124577174|NCT00573443|448074777|FG001|Open-Label Extension Phase|Protocol Violation|0|||
124577175|NCT00573443|448074778|FG002|Open-Label Extension Phase|Protocol Violation|0|||
124577176|NCT00573443|448074776|FG000|Open-Label Extension Phase|Other|2|||
124725921|NCT04115748|448618565|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
124725922|NCT04115748|448618566|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
124725923|NCT04115748|448618567|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
124725924|NCT04115748|448618568|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
124725925|NCT04115748|448618569|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
124725926|NCT04115748|448618570|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
124725927|NCT04115748|448618571|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
124725928|NCT04115748|448618572|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
124725929|NCT04115748|448618573|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
124725930|NCT04115748|448618574|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
124725931|NCT04115748|448618565|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
124725932|NCT04115748|448618566|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
124725933|NCT04115748|448618567|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
124725934|NCT04115748|448618568|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
124523022|NCT00910728|447866587|FG002|Overall Study|Adverse Event|1|||
124523023|NCT00910728|447866588|FG003|Overall Study|Adverse Event|1|||
124523024|NCT00910728|447866589|FG004|Overall Study|Adverse Event|0|||
124523025|NCT00910728|447866590|FG005|Overall Study|Adverse Event|0|||
124523026|NCT00910728|447866591|FG006|Overall Study|Adverse Event|2|||
124523027|NCT00910728|447866592|FG007|Overall Study|Adverse Event|1|||
124523028|NCT00910728|447866593|FG008|Overall Study|Adverse Event|1|||
124523029|NCT00431496|447866594|FG000|Overall Study|Adverse Event|3|||
124523030|NCT00431496|447866594|FG000|Overall Study|Lost to Follow-up|1|||
124523031|NCT00431496|447866594|FG000|Overall Study|Withdrawal by Subject|2|||
124523032|NCT00431496|447866594|FG000|Overall Study|Protocol-specified criteria|5|||
124523033|NCT00361218|447866595|FG000|Overall Study|Lost to Follow-up|11|||
124523034|NCT00361218|447866595|FG000|Overall Study|Personal Reasons|7|||
124523035|NCT00361218|447866595|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
124523036|NCT02820038|447866598|FG000|Overall Study|Lost to Follow-up|7|||
124523037|NCT02820038|447866599|FG001|Overall Study|Lost to Follow-up|11|||
124523038|NCT02820038|447866600|FG002|Overall Study|Lost to Follow-up|2|||
124523039|NCT02820038|447866601|FG003|Overall Study|Lost to Follow-up|9|||
124523040|NCT02820038|447866598|FG000|Overall Study|Withdrawal by Subject|3|||
124523041|NCT02820038|447866599|FG001|Overall Study|Withdrawal by Subject|14|||
124523042|NCT02820038|447866600|FG002|Overall Study|Withdrawal by Subject|3|||
124523043|NCT02820038|447866601|FG003|Overall Study|Withdrawal by Subject|13|||
124523044|NCT00044213|447866603|FG000|Overall Study|Withdrawal by Subject|50|||
124523045|NCT00044213|447866604|FG001|Overall Study|Withdrawal by Subject|65|||
124523046|NCT00044213|447866605|FG002|Overall Study|Withdrawal by Subject|91|||
124523047|NCT00044213|447866606|FG003|Overall Study|Withdrawal by Subject|83|||
124523048|NCT00044213|447866603|FG000|Overall Study|Death|42|||
124523049|NCT00044213|447866604|FG001|Overall Study|Death|42|||
124523050|NCT00044213|447866605|FG002|Overall Study|Death|42|||
124523051|NCT00044213|447866606|FG003|Overall Study|Death|49|||
124523052|NCT00044213|447866603|FG000|Overall Study|Lost to Follow-up|8|||
124523053|NCT00044213|447866604|FG001|Overall Study|Lost to Follow-up|5|||
124523054|NCT00044213|447866605|FG002|Overall Study|Lost to Follow-up|5|||
124523055|NCT00044213|447866606|FG003|Overall Study|Lost to Follow-up|4|||
124523056|NCT03148795|447866607|FG000|Overall Study|Progressive Disease|1|||
124523057|NCT01927068|447866608|FG000|Overall Study|Death|37|||
124523058|NCT01927068|447866609|FG001|Overall Study|Death|3|||
124523059|NCT01927068|447866608|FG000|Overall Study|Withdrawal by Subject|50|||
124523060|NCT01927068|447866609|FG001|Overall Study|Withdrawal by Subject|3|||
124523061|NCT01927068|447866608|FG000|Overall Study|Lost to Follow-up|10|||
124523062|NCT01927068|447866609|FG001|Overall Study|Lost to Follow-up|2|||
124523063|NCT01927068|447866608|FG000|Overall Study|Physician Decision|9|||
124523064|NCT01927068|447866609|FG001|Overall Study|Physician Decision|0|||
124523065|NCT01927068|447866608|FG000|Overall Study|Missed last follow-up visit|2|||
124523066|NCT01927068|447866609|FG001|Overall Study|Missed last follow-up visit|0|||
124523067|NCT00880607|447866610|FG000|Overall Study|Physician Decision|2|||
124523068|NCT00880607|447866611|FG001|Overall Study|Physician Decision|2|||
124523069|NCT00880607|447866610|FG000|Overall Study|Protocol Violation|2|||
124523070|NCT00880607|447866611|FG001|Overall Study|Protocol Violation|1|||
124523071|NCT00880607|447866610|FG000|Overall Study|surgery did not extend past L1 level|3|||
124523072|NCT00880607|447866611|FG001|Overall Study|surgery did not extend past L1 level|0|||
124523073|NCT02963766|447866613|FG000|Double-Blind Period|Adverse Event|1|||
124523074|NCT02963766|447866614|FG001|Double-Blind Period|Adverse Event|0|||
124523075|NCT02963766|447866615|FG002|Double-Blind Period|Adverse Event|1|||
124725935|NCT04115748|448618569|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
124523076|NCT02963766|447866613|FG000|Double-Blind Period|Physician Decision|1|||
124523077|NCT02963766|447866614|FG001|Double-Blind Period|Physician Decision|0|||
124523078|NCT02963766|447866615|FG002|Double-Blind Period|Physician Decision|0|||
124523079|NCT02963766|447866613|FG000|Double-Blind Period|Withdrawal by Subject|1|||
124523080|NCT02963766|447866614|FG001|Double-Blind Period|Withdrawal by Subject|1|||
124523081|NCT02963766|447866615|FG002|Double-Blind Period|Withdrawal by Subject|0|||
124523082|NCT02963766|447866613|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
124577177|NCT00573443|448074777|FG001|Open-Label Extension Phase|Other|0|||
124577178|NCT00573443|448074778|FG002|Open-Label Extension Phase|Other|0|||
124577179|NCT00804856|448074779|FG000|Overall Study|Progressive Disease|3|||
124577180|NCT00804856|448074780|FG001|Overall Study|Progressive Disease|2|||
124577181|NCT00804856|448074781|FG002|Overall Study|Progressive Disease|4|||
124577182|NCT00804856|448074782|FG003|Overall Study|Progressive Disease|6|||
124577183|NCT00804856|448074783|FG004|Overall Study|Progressive Disease|4|||
124577184|NCT00804856|448074784|FG005|Overall Study|Progressive Disease|1|||
124577185|NCT00804856|448074785|FG006|Overall Study|Progressive Disease|8|||
124577186|NCT00804856|448074786|FG007|Overall Study|Progressive Disease|2|||
124577187|NCT00804856|448074787|FG008|Overall Study|Progressive Disease|4|||
124577188|NCT00804856|448074788|FG009|Overall Study|Progressive Disease|5|||
124577189|NCT00804856|448074789|FG010|Overall Study|Progressive Disease|12|||
124577190|NCT00804856|448074790|FG011|Overall Study|Progressive Disease|2|||
124577191|NCT00804856|448074791|FG012|Overall Study|Progressive Disease|2|||
124577192|NCT00804856|448074792|FG013|Overall Study|Progressive Disease|26|||
124577193|NCT00804856|448074793|FG014|Overall Study|Progressive Disease|20|||
124577194|NCT00804856|448074779|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124577195|NCT00804856|448074780|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124577196|NCT00804856|448074781|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124577197|NCT00804856|448074782|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124577198|NCT00804856|448074783|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
124577199|NCT00804856|448074784|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124577200|NCT00804856|448074785|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124577201|NCT00804856|448074786|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124577202|NCT00804856|448074787|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124577203|NCT00804856|448074788|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124577204|NCT00804856|448074789|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124577205|NCT00804856|448074790|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124577206|NCT00804856|448074791|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124577207|NCT00804856|448074792|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
124577208|NCT00804856|448074793|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
124577209|NCT00804856|448074779|FG000|Overall Study|Other Adverse Event|1|||
124577210|NCT00804856|448074780|FG001|Overall Study|Other Adverse Event|1|||
124577211|NCT00804856|448074781|FG002|Overall Study|Other Adverse Event|1|||
124577212|NCT00804856|448074782|FG003|Overall Study|Other Adverse Event|2|||
124577213|NCT00804856|448074783|FG004|Overall Study|Other Adverse Event|2|||
124577214|NCT00804856|448074784|FG005|Overall Study|Other Adverse Event|1|||
124577215|NCT00804856|448074785|FG006|Overall Study|Other Adverse Event|3|||
124577216|NCT00804856|448074786|FG007|Overall Study|Other Adverse Event|0|||
124577217|NCT00804856|448074787|FG008|Overall Study|Other Adverse Event|0|||
124577218|NCT00804856|448074788|FG009|Overall Study|Other Adverse Event|1|||
124577219|NCT00804856|448074789|FG010|Overall Study|Other Adverse Event|5|||
124577220|NCT00804856|448074790|FG011|Overall Study|Other Adverse Event|2|||
124577221|NCT00804856|448074791|FG012|Overall Study|Other Adverse Event|0|||
124577222|NCT00804856|448074792|FG013|Overall Study|Other Adverse Event|6|||
124577223|NCT00804856|448074793|FG014|Overall Study|Other Adverse Event|13|||
124577224|NCT00804856|448074779|FG000|Overall Study|Non compliance with protocol|0|||
124577225|NCT00804856|448074780|FG001|Overall Study|Non compliance with protocol|0|||
124577226|NCT00804856|448074781|FG002|Overall Study|Non compliance with protocol|0|||
124577227|NCT00804856|448074782|FG003|Overall Study|Non compliance with protocol|0|||
124577228|NCT00804856|448074783|FG004|Overall Study|Non compliance with protocol|0|||
124577229|NCT00804856|448074784|FG005|Overall Study|Non compliance with protocol|0|||
124577230|NCT00804856|448074785|FG006|Overall Study|Non compliance with protocol|0|||
124577231|NCT00804856|448074786|FG007|Overall Study|Non compliance with protocol|0|||
124577232|NCT00804856|448074787|FG008|Overall Study|Non compliance with protocol|0|||
124577233|NCT00804856|448074788|FG009|Overall Study|Non compliance with protocol|0|||
124577234|NCT00804856|448074789|FG010|Overall Study|Non compliance with protocol|0|||
124577235|NCT00804856|448074790|FG011|Overall Study|Non compliance with protocol|0|||
124577236|NCT00804856|448074791|FG012|Overall Study|Non compliance with protocol|0|||
124577237|NCT00804856|448074792|FG013|Overall Study|Non compliance with protocol|2|||
124577238|NCT00804856|448074793|FG014|Overall Study|Non compliance with protocol|0|||
124577239|NCT00804856|448074779|FG000|Overall Study|Refused to continue medication|0|||
124577240|NCT00804856|448074780|FG001|Overall Study|Refused to continue medication|0|||
124577241|NCT00804856|448074781|FG002|Overall Study|Refused to continue medication|0|||
124577242|NCT00804856|448074782|FG003|Overall Study|Refused to continue medication|1|||
124577243|NCT00804856|448074783|FG004|Overall Study|Refused to continue medication|1|||
124577244|NCT00804856|448074784|FG005|Overall Study|Refused to continue medication|0|||
124577245|NCT00804856|448074785|FG006|Overall Study|Refused to continue medication|0|||
124577246|NCT00804856|448074786|FG007|Overall Study|Refused to continue medication|0|||
124577247|NCT00804856|448074787|FG008|Overall Study|Refused to continue medication|0|||
124577248|NCT00804856|448074788|FG009|Overall Study|Refused to continue medication|0|||
124577249|NCT00804856|448074789|FG010|Overall Study|Refused to continue medication|3|||
124776783|NCT00594815|448810003|FG000|Overall Study|Never Treated|3|||
124577250|NCT00804856|448074790|FG011|Overall Study|Refused to continue medication|0|||
124523083|NCT02963766|447866614|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
124523084|NCT02963766|447866615|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
124523085|NCT02963766|447866613|FG000|Double-Blind Period|Protocol Violation|1|||
124523086|NCT02963766|447866614|FG001|Double-Blind Period|Protocol Violation|0|||
124523087|NCT02963766|447866615|FG002|Double-Blind Period|Protocol Violation|0|||
124523088|NCT02963766|447866613|FG000|Double-Blind Period|Lost to Follow-up|0|||
124523089|NCT02963766|447866614|FG001|Double-Blind Period|Lost to Follow-up|1|||
124523090|NCT02963766|447866615|FG002|Double-Blind Period|Lost to Follow-up|0|||
124523091|NCT02963766|447866613|FG000|Open Label Extension (OLE)|Physician Decision|1|||
124523092|NCT02963766|447866614|FG001|Open Label Extension (OLE)|Physician Decision|2|||
124523093|NCT02963766|447866615|FG002|Open Label Extension (OLE)|Physician Decision|2|||
124523094|NCT02963766|447866613|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
124523095|NCT02963766|447866614|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
124523096|NCT02963766|447866615|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
124523097|NCT00499460|447866616|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
124523098|NCT00499460|447866617|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
124523099|NCT00499460|447866616|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
124523100|NCT00499460|447866617|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
124523101|NCT00499460|447866616|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
124523102|NCT00499460|447866617|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
124523103|NCT00814307|447866618|FG000|Overall Study|Randomized but not treated|1|||
124523104|NCT00814307|447866619|FG001|Overall Study|Randomized but not treated|0|||
124523105|NCT00814307|447866620|FG002|Overall Study|Randomized but not treated|0|||
124523106|NCT00814307|447866621|FG003|Overall Study|Randomized but not treated|0|||
124523107|NCT00814307|447866618|FG000|Overall Study|Adverse Event|3|||
124523108|NCT00814307|447866619|FG001|Overall Study|Adverse Event|9|||
124523109|NCT00814307|447866620|FG002|Overall Study|Adverse Event|3|||
124523110|NCT00814307|447866621|FG003|Overall Study|Adverse Event|2|||
124523111|NCT00814307|447866618|FG000|Overall Study|Lack of Efficacy|1|||
124523112|NCT00814307|447866619|FG001|Overall Study|Lack of Efficacy|1|||
124523113|NCT00814307|447866620|FG002|Overall Study|Lack of Efficacy|3|||
124523114|NCT00814307|447866621|FG003|Overall Study|Lack of Efficacy|4|||
124523115|NCT00814307|447866618|FG000|Overall Study|Other|1|||
124523116|NCT00814307|447866619|FG001|Overall Study|Other|2|||
124523117|NCT00814307|447866620|FG002|Overall Study|Other|0|||
124523118|NCT00814307|447866621|FG003|Overall Study|Other|1|||
124523119|NCT00814307|447866618|FG000|Overall Study|Protocol Violation|2|||
124523120|NCT00814307|447866619|FG001|Overall Study|Protocol Violation|8|||
124523121|NCT00814307|447866620|FG002|Overall Study|Protocol Violation|1|||
124523122|NCT00814307|447866621|FG003|Overall Study|Protocol Violation|1|||
124523123|NCT00814307|447866618|FG000|Overall Study|Withdrawal by Subject|4|||
124523124|NCT00814307|447866619|FG001|Overall Study|Withdrawal by Subject|6|||
124523125|NCT00814307|447866620|FG002|Overall Study|Withdrawal by Subject|0|||
124523126|NCT00814307|447866621|FG003|Overall Study|Withdrawal by Subject|2|||
124523127|NCT00814307|447866618|FG000|Overall Study|Death|0|||
124523128|NCT00814307|447866619|FG001|Overall Study|Death|1|||
124523129|NCT00814307|447866620|FG002|Overall Study|Death|0|||
124523130|NCT00814307|447866621|FG003|Overall Study|Death|0|||
124523131|NCT02290340|447866623|FG000|Overall Study|Lost to Follow-up|0|||
124523132|NCT02290340|447866624|FG001|Overall Study|Lost to Follow-up|0|||
124523133|NCT02290340|447866625|FG002|Overall Study|Lost to Follow-up|0|||
124523134|NCT02290340|447866626|FG003|Overall Study|Lost to Follow-up|1|||
124523135|NCT02290340|447866623|FG000|Overall Study|Withdrawal by Subject|1|||
124523136|NCT02290340|447866624|FG001|Overall Study|Withdrawal by Subject|0|||
124523137|NCT02290340|447866625|FG002|Overall Study|Withdrawal by Subject|0|||
124523138|NCT02290340|447866626|FG003|Overall Study|Withdrawal by Subject|0|||
124523139|NCT02290340|447866623|FG000|Overall Study|Other|1|||
124523140|NCT02290340|447866624|FG001|Overall Study|Other|0|||
124523141|NCT02290340|447866625|FG002|Overall Study|Other|0|||
124523142|NCT02290340|447866626|FG003|Overall Study|Other|1|||
124523143|NCT03209362|447866630|FG000|Overall Study|Adverse Event|0|||
124523144|NCT03209362|447866631|FG001|Overall Study|Adverse Event|1|||
124523145|NCT03209362|447866630|FG000|Overall Study|Lost to Follow-up|0|||
124523146|NCT03209362|447866631|FG001|Overall Study|Lost to Follow-up|1|||
124523147|NCT03209362|447866630|FG000|Overall Study|Withdrawal by Subject|2|||
124523148|NCT03209362|447866631|FG001|Overall Study|Withdrawal by Subject|0|||
124523149|NCT03209362|447866630|FG000|Overall Study|Other|0|||
124523150|NCT03209362|447866631|FG001|Overall Study|Other|1|||
124523151|NCT00251589|447866634|FG000|Overall Study|Adverse Event|5|||
124523152|NCT00251589|447866635|FG001|Overall Study|Adverse Event|1|||
124523153|NCT00251589|447866636|FG002|Overall Study|Adverse Event|2|||
124523154|NCT00251589|447866637|FG003|Overall Study|Adverse Event|1|||
124523155|NCT00251589|447866634|FG000|Overall Study|Withdrawal by Subject|1|||
124523156|NCT00251589|447866635|FG001|Overall Study|Withdrawal by Subject|1|||
124523157|NCT00251589|447866636|FG002|Overall Study|Withdrawal by Subject|0|||
124523158|NCT00251589|447866637|FG003|Overall Study|Withdrawal by Subject|0|||
124523159|NCT00251589|447866634|FG000|Overall Study|Discontinued due to progressive disease|9|||
124577251|NCT00804856|448074791|FG012|Overall Study|Refused to continue medication|1|||
124577252|NCT00804856|448074792|FG013|Overall Study|Refused to continue medication|1|||
124577253|NCT00804856|448074793|FG014|Overall Study|Refused to continue medication|5|||
124577254|NCT00804856|448074779|FG000|Overall Study|Other reason than listed above|0|||
124577255|NCT00804856|448074780|FG001|Overall Study|Other reason than listed above|0|||
124577256|NCT00804856|448074781|FG002|Overall Study|Other reason than listed above|0|||
124577257|NCT00804856|448074782|FG003|Overall Study|Other reason than listed above|0|||
124577258|NCT00804856|448074783|FG004|Overall Study|Other reason than listed above|0|||
124577259|NCT00804856|448074784|FG005|Overall Study|Other reason than listed above|1|||
124577260|NCT00804856|448074785|FG006|Overall Study|Other reason than listed above|0|||
124577261|NCT00804856|448074786|FG007|Overall Study|Other reason than listed above|0|||
124577262|NCT00804856|448074787|FG008|Overall Study|Other reason than listed above|1|||
124577263|NCT00804856|448074788|FG009|Overall Study|Other reason than listed above|0|||
124577264|NCT00804856|448074789|FG010|Overall Study|Other reason than listed above|3|||
124577265|NCT00804856|448074790|FG011|Overall Study|Other reason than listed above|1|||
124577266|NCT00804856|448074791|FG012|Overall Study|Other reason than listed above|1|||
124577267|NCT00804856|448074792|FG013|Overall Study|Other reason than listed above|10|||
124577268|NCT00804856|448074793|FG014|Overall Study|Other reason than listed above|3|||
124577269|NCT01796171|448074794|FG000|Enrolled|Death|0|||
124577270|NCT01796171|448074795|FG001|Enrolled|Death|0|||
124577271|NCT01796171|448074796|FG002|Enrolled|Death|0|||
124577272|NCT01796171|448074797|FG003|Enrolled|Death|0|||
124577273|NCT01796171|448074798|FG004|Enrolled|Death|0|||
124577274|NCT01796171|448074799|FG005|Enrolled|Death|0|||
124577275|NCT01796171|448074800|FG006|Enrolled|Death|0|||
124577276|NCT01796171|448074801|FG007|Enrolled|Death|0|||
124577277|NCT01796171|448074802|FG008|Enrolled|Death|0|||
124577278|NCT01796171|448074803|FG009|Enrolled|Death|0|||
124577279|NCT01796171|448074804|FG010|Enrolled|Death|0|||
124577280|NCT01796171|448074805|FG011|Enrolled|Death|0|||
124577281|NCT01796171|448074806|FG012|Enrolled|Death|0|||
124577282|NCT01796171|448074807|FG013|Enrolled|Death|0|||
124577283|NCT01796171|448074808|FG014|Enrolled|Death|1|||
124577284|NCT01796171|448074794|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
124577285|NCT01796171|448074795|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
124577286|NCT01796171|448074796|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
124577287|NCT01796171|448074797|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
124577288|NCT01796171|448074798|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
124577289|NCT01796171|448074799|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
124577290|NCT01796171|448074800|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
124577291|NCT01796171|448074801|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
124577292|NCT01796171|448074802|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
124577293|NCT01796171|448074803|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
124577294|NCT01796171|448074804|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
124577295|NCT01796171|448074805|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
124577296|NCT01796171|448074806|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
124577297|NCT01796171|448074807|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
124577298|NCT01796171|448074808|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
124577299|NCT01796171|448074794|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
124577300|NCT01796171|448074795|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
124577301|NCT01796171|448074796|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
124577302|NCT01796171|448074797|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
124577303|NCT01796171|448074798|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
124577304|NCT01796171|448074799|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
124577305|NCT01796171|448074800|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
124577306|NCT01796171|448074801|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
124577307|NCT01796171|448074802|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
124577308|NCT01796171|448074803|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
124725936|NCT04115748|448618570|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
124725937|NCT04115748|448618571|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
124725938|NCT04115748|448618572|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
124725939|NCT04115748|448618573|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
124577309|NCT01796171|448074804|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
124577310|NCT01796171|448074805|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
124577311|NCT01796171|448074806|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
124577312|NCT01796171|448074807|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
124577313|NCT01796171|448074808|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
124577314|NCT01796171|448074794|FG000|Treatment Period With Betalutin|Progressive disease|0|||
124577315|NCT01796171|448074795|FG001|Treatment Period With Betalutin|Progressive disease|1|||
124577316|NCT01796171|448074796|FG002|Treatment Period With Betalutin|Progressive disease|0|||
124577317|NCT01796171|448074797|FG003|Treatment Period With Betalutin|Progressive disease|0|||
124577318|NCT01796171|448074798|FG004|Treatment Period With Betalutin|Progressive disease|0|||
124577319|NCT01796171|448074799|FG005|Treatment Period With Betalutin|Progressive disease|0|||
124577320|NCT01796171|448074800|FG006|Treatment Period With Betalutin|Progressive disease|0|||
124725940|NCT04115748|448618574|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
124523160|NCT00251589|447866635|FG001|Overall Study|Discontinued due to progressive disease|1|||
124523161|NCT00251589|447866636|FG002|Overall Study|Discontinued due to progressive disease|0|||
124523162|NCT00251589|447866637|FG003|Overall Study|Discontinued due to progressive disease|1|||
124577321|NCT01796171|448074801|FG007|Treatment Period With Betalutin|Progressive disease|0|||
124577322|NCT01796171|448074802|FG008|Treatment Period With Betalutin|Progressive disease|0|||
124577323|NCT01796171|448074803|FG009|Treatment Period With Betalutin|Progressive disease|0|||
124577324|NCT01796171|448074804|FG010|Treatment Period With Betalutin|Progressive disease|0|||
124577325|NCT01796171|448074805|FG011|Treatment Period With Betalutin|Progressive disease|0|||
124577326|NCT01796171|448074806|FG012|Treatment Period With Betalutin|Progressive disease|0|||
124577327|NCT01796171|448074807|FG013|Treatment Period With Betalutin|Progressive disease|0|||
124577328|NCT01796171|448074808|FG014|Treatment Period With Betalutin|Progressive disease|0|||
124577329|NCT01796171|448074794|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
124577330|NCT01796171|448074795|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
124577331|NCT01796171|448074796|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
124577332|NCT01796171|448074797|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
124577333|NCT01796171|448074798|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
124577334|NCT01796171|448074799|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
124577335|NCT01796171|448074800|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
124577336|NCT01796171|448074801|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
124577337|NCT01796171|448074802|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
124577338|NCT01796171|448074803|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
124577339|NCT01796171|448074804|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
124577340|NCT01796171|448074805|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
124577341|NCT01796171|448074806|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
124577342|NCT01796171|448074807|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
124577343|NCT01796171|448074808|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
124577344|NCT01796171|448074794|FG000|Treatment Period With Betalutin|Physician Decision|0|||
124577345|NCT01796171|448074795|FG001|Treatment Period With Betalutin|Physician Decision|0|||
124577346|NCT01796171|448074796|FG002|Treatment Period With Betalutin|Physician Decision|0|||
124577347|NCT01796171|448074797|FG003|Treatment Period With Betalutin|Physician Decision|0|||
124577348|NCT01796171|448074798|FG004|Treatment Period With Betalutin|Physician Decision|0|||
124577349|NCT01796171|448074799|FG005|Treatment Period With Betalutin|Physician Decision|0|||
124577350|NCT01796171|448074800|FG006|Treatment Period With Betalutin|Physician Decision|0|||
124577351|NCT01796171|448074801|FG007|Treatment Period With Betalutin|Physician Decision|0|||
124577352|NCT01796171|448074802|FG008|Treatment Period With Betalutin|Physician Decision|0|||
124577353|NCT01796171|448074803|FG009|Treatment Period With Betalutin|Physician Decision|0|||
124577354|NCT01796171|448074804|FG010|Treatment Period With Betalutin|Physician Decision|5|||
124577355|NCT01796171|448074805|FG011|Treatment Period With Betalutin|Physician Decision|1|||
124577356|NCT01796171|448074806|FG012|Treatment Period With Betalutin|Physician Decision|1|||
124577357|NCT01796171|448074807|FG013|Treatment Period With Betalutin|Physician Decision|0|||
124577358|NCT01796171|448074808|FG014|Treatment Period With Betalutin|Physician Decision|0|||
124577359|NCT01796171|448074794|FG000|Treatment Period With Betalutin|Death|0|||
124577360|NCT01796171|448074795|FG001|Treatment Period With Betalutin|Death|0|||
124577361|NCT01796171|448074796|FG002|Treatment Period With Betalutin|Death|0|||
124577362|NCT01796171|448074797|FG003|Treatment Period With Betalutin|Death|0|||
124577363|NCT01796171|448074798|FG004|Treatment Period With Betalutin|Death|0|||
124577364|NCT01796171|448074799|FG005|Treatment Period With Betalutin|Death|0|||
124577365|NCT01796171|448074800|FG006|Treatment Period With Betalutin|Death|0|||
124577366|NCT01796171|448074801|FG007|Treatment Period With Betalutin|Death|0|||
124577367|NCT01796171|448074802|FG008|Treatment Period With Betalutin|Death|0|||
124577368|NCT01796171|448074803|FG009|Treatment Period With Betalutin|Death|0|||
124577369|NCT01796171|448074804|FG010|Treatment Period With Betalutin|Death|2|||
124577370|NCT01796171|448074805|FG011|Treatment Period With Betalutin|Death|0|||
124577371|NCT01796171|448074806|FG012|Treatment Period With Betalutin|Death|0|||
124577372|NCT01796171|448074807|FG013|Treatment Period With Betalutin|Death|0|||
124577373|NCT01796171|448074808|FG014|Treatment Period With Betalutin|Death|0|||
124577374|NCT01796171|448074794|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
124577375|NCT01796171|448074795|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
124577376|NCT01796171|448074796|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
124523163|NCT03039192|447866640|FG000|Overall Study|Lost to Follow-up|4|||
124523164|NCT03039192|447866641|FG001|Overall Study|Lost to Follow-up|4|||
124523165|NCT03039192|447866640|FG000|Overall Study|Adverse event, serious fatal|0|||
124523166|NCT03039192|447866641|FG001|Overall Study|Adverse event, serious fatal|1|||
124523167|NCT03039192|447866640|FG000|Overall Study|Adverse event, non-fatal|0|||
124523168|NCT03039192|447866641|FG001|Overall Study|Adverse event, non-fatal|2|||
124577377|NCT01796171|448074797|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
124523169|NCT03039192|447866640|FG000|Overall Study|Withdrawal by Subject|6|||
124523170|NCT03039192|447866641|FG001|Overall Study|Withdrawal by Subject|9|||
124523171|NCT03039192|447866640|FG000|Overall Study|Discontinued from treatment phase|19|||
124523172|NCT03039192|447866641|FG001|Overall Study|Discontinued from treatment phase|12|||
124523173|NCT03039192|447866640|FG000|Overall Study|Other|3|||
124523174|NCT03039192|447866641|FG001|Overall Study|Other|2|||
124523175|NCT03074318|447866642|FG000|Overall Study|Adverse Event|0|||
124523176|NCT03074318|447866643|FG001|Overall Study|Adverse Event|1|||
124523177|NCT03074318|447866644|FG002|Overall Study|Adverse Event|1|||
124523178|NCT03074318|447866645|FG003|Overall Study|Adverse Event|1|||
124523179|NCT03074318|447866642|FG000|Overall Study|Death|1|||
124523180|NCT03074318|447866643|FG001|Overall Study|Death|0|||
124523181|NCT03074318|447866644|FG002|Overall Study|Death|0|||
124523182|NCT03074318|447866645|FG003|Overall Study|Death|0|||
124523183|NCT03074318|447866642|FG000|Overall Study|Withdrawal by Subject|1|||
124523184|NCT03074318|447866643|FG001|Overall Study|Withdrawal by Subject|2|||
124523185|NCT03074318|447866644|FG002|Overall Study|Withdrawal by Subject|2|||
124523186|NCT03074318|447866645|FG003|Overall Study|Withdrawal by Subject|4|||
124523187|NCT03074318|447866642|FG000|Overall Study|Trial Closure|2|||
124523188|NCT03074318|447866643|FG001|Overall Study|Trial Closure|2|||
124523189|NCT03074318|447866644|FG002|Overall Study|Trial Closure|3|||
124523190|NCT03074318|447866645|FG003|Overall Study|Trial Closure|11|||
124523191|NCT00643448|447866649|FG000|Overall Study|Lack of Efficacy|2|||
124523192|NCT00643448|447866650|FG001|Overall Study|Lack of Efficacy|0|||
124523193|NCT00643448|447866651|FG002|Overall Study|Lack of Efficacy|4|||
124523194|NCT00643448|447866649|FG000|Overall Study|Adverse Event|2|||
124523195|NCT00643448|447866650|FG001|Overall Study|Adverse Event|2|||
124523196|NCT00643448|447866651|FG002|Overall Study|Adverse Event|2|||
124523197|NCT00643448|447866649|FG000|Overall Study|QTcF>550 ms|0|||
124523198|NCT00643448|447866650|FG001|Overall Study|QTcF>550 ms|3|||
124523199|NCT00643448|447866651|FG002|Overall Study|QTcF>550 ms|0|||
124523200|NCT02177812|447866652|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
124523201|NCT02177812|447866653|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
124523202|NCT02177812|447866654|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
124523203|NCT02177812|447866655|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
124523204|NCT02177812|447866656|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
124523205|NCT02177812|447866657|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
124523206|NCT02177812|447866658|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
124523207|NCT02177812|447866659|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
124523208|NCT02177812|447866660|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
124523209|NCT02177812|447866652|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
124523210|NCT02177812|447866653|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
124523211|NCT02177812|447866654|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
124523212|NCT02177812|447866655|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
124523213|NCT02177812|447866656|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
124523214|NCT02177812|447866657|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
124523215|NCT02177812|447866658|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
124523216|NCT02177812|447866659|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
124523217|NCT02177812|447866660|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
124523218|NCT02177812|447866652|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
124523219|NCT02177812|447866653|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
124523220|NCT02177812|447866654|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
124523221|NCT02177812|447866655|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
124523222|NCT02177812|447866656|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
124523223|NCT02177812|447866657|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
124523224|NCT02177812|447866658|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
124523225|NCT02177812|447866659|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
124523226|NCT02177812|447866660|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
124523227|NCT01167153|447866661|FG000|Overall Study|Non-effective therapy|1|||
124523228|NCT01167153|447866662|FG001|Overall Study|Non-effective therapy|4|||
124523229|NCT01167153|447866661|FG000|Overall Study|AE including clinical laboratory AE|2|||
124523230|NCT01167153|447866662|FG001|Overall Study|AE including clinical laboratory AE|8|||
124523231|NCT01167153|447866661|FG000|Overall Study|Hypotension|1|||
124523232|NCT01167153|447866662|FG001|Overall Study|Hypotension|0|||
124523233|NCT01167153|447866661|FG000|Overall Study|Lost to Follow-up|7|||
124523234|NCT01167153|447866662|FG001|Overall Study|Lost to Follow-up|9|||
124523235|NCT01167153|447866661|FG000|Overall Study|Non-compliance to concomitant medication|0|||
124523236|NCT01167153|447866662|FG001|Overall Study|Non-compliance to concomitant medication|2|||
124523237|NCT01167153|447866661|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
124523238|NCT01167153|447866662|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
124523239|NCT01167153|447866661|FG000|Overall Study|Withdrawal consent|1|||
124523240|NCT01167153|447866662|FG001|Overall Study|Withdrawal consent|1|||
124523241|NCT01167153|447866661|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
124523242|NCT01167153|447866662|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
124577378|NCT01796171|448074798|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
124523243|NCT05166603|447866663|FG000|Overall Study|Withdrawal by Subject|68|||
124523244|NCT05166603|447866664|FG001|Overall Study|Withdrawal by Subject|0|||
124523245|NCT01594749|447868853|FG000|Overall Study|Adverse Event|2|||
124523246|NCT01594749|447868854|FG001|Overall Study|Adverse Event|1|||
124523247|NCT01594749|447868853|FG000|Overall Study|Withdrawal by Subject|2|||
124523248|NCT01594749|447868854|FG001|Overall Study|Withdrawal by Subject|2|||
124523249|NCT01594749|447868853|FG000|Overall Study|Protocol Violation|2|||
124523250|NCT01594749|447868854|FG001|Overall Study|Protocol Violation|0|||
124523251|NCT01594749|447868853|FG000|Overall Study|Physician Decision|1|||
124523252|NCT01594749|447868854|FG001|Overall Study|Physician Decision|1|||
124523253|NCT01594749|447868853|FG000|Overall Study|Non-compliance with Protocol|0|||
124523254|NCT01594749|447868854|FG001|Overall Study|Non-compliance with Protocol|1|||
124523255|NCT01594749|447868853|FG000|Overall Study|Lost to Follow-up|1|||
124523256|NCT01594749|447868854|FG001|Overall Study|Lost to Follow-up|0|||
124523257|NCT01594749|447868853|FG000|Overall Study|Death|9|||
124577379|NCT01796171|448074799|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
124577380|NCT01796171|448074800|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
124577381|NCT01796171|448074801|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
124577382|NCT01796171|448074802|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
124577383|NCT01796171|448074803|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
124577384|NCT01796171|448074804|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
124577385|NCT01796171|448074805|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
124577386|NCT01796171|448074806|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
124577387|NCT01796171|448074807|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
124577388|NCT01796171|448074808|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
124523258|NCT01594749|447868854|FG001|Overall Study|Death|3|||
124523259|NCT01594749|447868853|FG000|Overall Study|Not Treated|4|||
124523260|NCT01594749|447868854|FG001|Overall Study|Not Treated|10|||
124523261|NCT01594749|447868853|FG000|Overall Study|Lost Source Documentation|1|||
124523262|NCT01594749|447868854|FG001|Overall Study|Lost Source Documentation|0|||
124523263|NCT02177786|447868855|FG000|Overall Study|Withdrew Consent|2|||
124523264|NCT02177786|447868856|FG001|Overall Study|Withdrew Consent|6|||
124523265|NCT02177786|447868857|FG002|Overall Study|Withdrew Consent|9|||
124523266|NCT02177786|447868858|FG003|Overall Study|Withdrew Consent|5|||
124523267|NCT02177786|447868855|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
124523268|NCT02177786|447868856|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
124523269|NCT02177786|447868857|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
124523270|NCT02177786|447868858|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
124523271|NCT02177786|447868855|FG000|Overall Study|Adverse Event|1|||
124523272|NCT02177786|447868856|FG001|Overall Study|Adverse Event|1|||
124523273|NCT02177786|447868857|FG002|Overall Study|Adverse Event|2|||
124523274|NCT02177786|447868858|FG003|Overall Study|Adverse Event|3|||
124523275|NCT02177786|447868855|FG000|Overall Study|Death|1|||
124523276|NCT02177786|447868856|FG001|Overall Study|Death|1|||
124523277|NCT02177786|447868857|FG002|Overall Study|Death|1|||
124523278|NCT02177786|447868858|FG003|Overall Study|Death|1|||
124523279|NCT02177786|447868855|FG000|Overall Study|Lost to Follow-up|0|||
124523280|NCT02177786|447868856|FG001|Overall Study|Lost to Follow-up|0|||
124523281|NCT02177786|447868857|FG002|Overall Study|Lost to Follow-up|2|||
124523282|NCT02177786|447868858|FG003|Overall Study|Lost to Follow-up|2|||
124523283|NCT02177786|447868855|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124523284|NCT02177786|447868856|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124523285|NCT02177786|447868857|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124523286|NCT02177786|447868858|FG003|Overall Study|Non-Compliance with Study Drug|1|||
124523287|NCT02177786|447868855|FG000|Overall Study|Protocol Violation|0|||
124523288|NCT02177786|447868856|FG001|Overall Study|Protocol Violation|0|||
124523289|NCT02177786|447868857|FG002|Overall Study|Protocol Violation|2|||
124523290|NCT02177786|447868858|FG003|Overall Study|Protocol Violation|0|||
124523291|NCT02177786|447868855|FG000|Overall Study|Progressive Disease|0|||
124523292|NCT02177786|447868856|FG001|Overall Study|Progressive Disease|1|||
124523293|NCT02177786|447868857|FG002|Overall Study|Progressive Disease|0|||
124523294|NCT02177786|447868858|FG003|Overall Study|Progressive Disease|0|||
124523295|NCT02177786|447868855|FG000|Overall Study|Missing study completion status|0|||
124577389|NCT01796171|448074794|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
124577390|NCT01796171|448074795|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
124577391|NCT01796171|448074796|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
124523296|NCT02177786|447868856|FG001|Overall Study|Missing study completion status|1|||
124523297|NCT02177786|447868857|FG002|Overall Study|Missing study completion status|0|||
124523298|NCT02177786|447868858|FG003|Overall Study|Missing study completion status|0|||
124577392|NCT01796171|448074797|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
124577393|NCT01796171|448074798|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
124577394|NCT01796171|448074799|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
124523299|NCT00439309|447868859|FG000|Follow-Up|Death|1|||
124523300|NCT00439309|447868860|FG001|Follow-Up|Death|0|||
124523301|NCT00439309|447868859|FG000|Follow-Up|Lost to Follow-up|2|||
124523302|NCT00439309|447868860|FG001|Follow-Up|Lost to Follow-up|0|||
124523303|NCT00439309|447868859|FG000|Follow-Up|Withdrawal by Subject|0|||
124523304|NCT00439309|447868860|FG001|Follow-Up|Withdrawal by Subject|1|||
124523305|NCT00439309|447868859|FG000|Follow-Up|Late response by subject|0|||
124523306|NCT00439309|447868860|FG001|Follow-Up|Late response by subject|1|||
124523307|NCT01977040|447868861|FG000|Overall Study|Vasa previa not confirmed|2|||
124523308|NCT04402385|447868869|FG000|Overall Study|Withdrawal by Subject|4|||
124523309|NCT04402385|447868870|FG001|Overall Study|Withdrawal by Subject|4|||
124523310|NCT04402385|447868869|FG000|Overall Study|Lost to Follow-up|1|||
124523311|NCT04402385|447868870|FG001|Overall Study|Lost to Follow-up|1|||
124523312|NCT04402385|447868869|FG000|Overall Study|Physician Decision|0|||
124523313|NCT04402385|447868870|FG001|Overall Study|Physician Decision|1|||
124523314|NCT01308853|447868879|FG000|Overall Study|Adverse Event|1|||
124523315|NCT01308853|447868879|FG000|Overall Study|Lost to Follow-up|2|||
124523316|NCT01308853|447868879|FG000|Overall Study|Insertion of permanent implants|1|||
124523317|NCT04984876|447868882|FG000|Overall Study|Subject decision|2|||
124523318|NCT04984876|447868883|FG001|Overall Study|Subject decision|10|||
124523319|NCT04984876|447868884|FG002|Overall Study|Subject decision|3|||
124523320|NCT04984876|447868885|FG003|Overall Study|Subject decision|3|||
124523321|NCT04984876|447868886|FG004|Overall Study|Subject decision|3|||
124523322|NCT04984876|447868887|FG005|Overall Study|Subject decision|0|||
124523323|NCT04984876|447868882|FG000|Overall Study|Guardian decision|0|||
124523324|NCT04984876|447868883|FG001|Overall Study|Guardian decision|1|||
124523325|NCT04984876|447868884|FG002|Overall Study|Guardian decision|0|||
124523326|NCT04984876|447868885|FG003|Overall Study|Guardian decision|2|||
124523327|NCT04984876|447868886|FG004|Overall Study|Guardian decision|0|||
124523328|NCT04984876|447868887|FG005|Overall Study|Guardian decision|1|||
124523329|NCT04984876|447868882|FG000|Overall Study|Lost to Follow-up|0|||
124523330|NCT04984876|447868883|FG001|Overall Study|Lost to Follow-up|0|||
124523331|NCT04984876|447868884|FG002|Overall Study|Lost to Follow-up|1|||
124523332|NCT04984876|447868885|FG003|Overall Study|Lost to Follow-up|1|||
124523333|NCT04984876|447868886|FG004|Overall Study|Lost to Follow-up|0|||
124523334|NCT04984876|447868887|FG005|Overall Study|Lost to Follow-up|0|||
124523335|NCT04984876|447868882|FG000|Overall Study|Physician Decision|1|||
124523336|NCT04984876|447868883|FG001|Overall Study|Physician Decision|0|||
124523337|NCT04984876|447868884|FG002|Overall Study|Physician Decision|0|||
124523338|NCT04984876|447868885|FG003|Overall Study|Physician Decision|1|||
124523339|NCT04984876|447868886|FG004|Overall Study|Physician Decision|0|||
124523340|NCT04984876|447868887|FG005|Overall Study|Physician Decision|0|||
124523341|NCT04984876|447868882|FG000|Overall Study|Adverse Event|0|||
124523342|NCT04984876|447868883|FG001|Overall Study|Adverse Event|0|||
124523343|NCT04984876|447868884|FG002|Overall Study|Adverse Event|1|||
124523344|NCT04984876|447868885|FG003|Overall Study|Adverse Event|0|||
124523345|NCT04984876|447868886|FG004|Overall Study|Adverse Event|0|||
124523346|NCT04984876|447868887|FG005|Overall Study|Adverse Event|0|||
124523347|NCT02204410|447868888|FG000|Overall Study|Lost to Follow-up|5|||
124523348|NCT02204410|447868888|FG000|Overall Study|Physician Decision|2|||
124523349|NCT02204410|447868888|FG000|Overall Study|Protocol Violation|1|||
124523350|NCT02204410|447868888|FG000|Overall Study|Withdrawal by Subject|3|||
124523351|NCT03654560|447868891|FG000|Overall Study|Death|3|||
124523352|NCT03654560|447868892|FG001|Overall Study|Death|1|||
124523353|NCT03654560|447868891|FG000|Overall Study|Lost to Follow-up|1|||
124523354|NCT03654560|447868892|FG001|Overall Study|Lost to Follow-up|0|||
124523355|NCT00209092|447868893|FG000|Overall Study|Progression of disease|7|||
124523356|NCT00209092|447868894|FG001|Overall Study|Progression of disease|1|||
124523357|NCT00209092|447868893|FG000|Overall Study|Adverse Event|0|||
124523358|NCT00209092|447868894|FG001|Overall Study|Adverse Event|1|||
124523359|NCT00209092|447868893|FG000|Overall Study|Withdrawal by Subject|1|||
124523360|NCT00209092|447868894|FG001|Overall Study|Withdrawal by Subject|0|||
124523361|NCT01462045|447868897|FG000|Overall Study|Family matter|0|||
124523362|NCT01462045|447868898|FG001|Overall Study|Family matter|1|||
124523363|NCT01462045|447868899|FG002|Overall Study|Family matter|0|||
124523364|NCT01117181|447868910|FG000|Overall Study|Lost to Follow-up|1|||
124523365|NCT01117181|447868911|FG001|Overall Study|Lost to Follow-up|0|||
124523366|NCT01117181|447868910|FG000|Overall Study|Withdrawal by Subject|0|||
124523367|NCT01117181|447868911|FG001|Overall Study|Withdrawal by Subject|2|||
124523368|NCT01100658|447868912|FG000|Overall Study|Withdrawal by Subject|1|||
124523369|NCT02658149|447868913|FG000|Overall Study|Physician Decision|1|||
124523370|NCT02658149|447868914|FG001|Overall Study|Physician Decision|0|||
124523371|NCT00420342|447868919|FG000|Overall Study|Lost to Follow-up|1|||
124523372|NCT00420342|447868920|FG001|Overall Study|Lost to Follow-up|0|||
124523373|NCT00420342|447868921|FG002|Overall Study|Lost to Follow-up|1|||
124523374|NCT00420342|447868919|FG000|Overall Study|Withdrawal by Subject|0|||
124523375|NCT00420342|447868920|FG001|Overall Study|Withdrawal by Subject|2|||
124523376|NCT00420342|447868921|FG002|Overall Study|Withdrawal by Subject|0|||
124523377|NCT01017549|447868924|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
124523378|NCT01017549|447868924|FG000|One-year Follow-up|Lost to Follow-up|2|||
124523379|NCT01017549|447868924|FG000|One-year Follow-up|Withdrawal by Subject|5|||
124523380|NCT01017549|447868924|FG000|5 Year Follow-up|Lost to Follow-up|9|||
124523381|NCT01017549|447868924|FG000|5 Year Follow-up|Mastectomy|3|||
124577395|NCT01796171|448074800|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
124577396|NCT01796171|448074801|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
124577397|NCT01796171|448074802|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
124577398|NCT01796171|448074803|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
124577399|NCT01796171|448074804|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
124577400|NCT01796171|448074805|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
124577401|NCT01796171|448074806|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
124577402|NCT01796171|448074807|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
124577403|NCT01796171|448074808|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
124577404|NCT01796171|448074794|FG000|Follow-up Period|Start of further anticancer therapy|4|||
124577405|NCT01796171|448074795|FG001|Follow-up Period|Start of further anticancer therapy|25|||
124577406|NCT01796171|448074796|FG002|Follow-up Period|Start of further anticancer therapy|2|||
124577407|NCT01796171|448074797|FG003|Follow-up Period|Start of further anticancer therapy|1|||
124577408|NCT01796171|448074798|FG004|Follow-up Period|Start of further anticancer therapy|2|||
124577409|NCT01796171|448074799|FG005|Follow-up Period|Start of further anticancer therapy|2|||
124577410|NCT01796171|448074800|FG006|Follow-up Period|Start of further anticancer therapy|1|||
124577411|NCT01796171|448074801|FG007|Follow-up Period|Start of further anticancer therapy|15|||
124577412|NCT01796171|448074802|FG008|Follow-up Period|Start of further anticancer therapy|2|||
124577413|NCT01796171|448074803|FG009|Follow-up Period|Start of further anticancer therapy|0|||
124577414|NCT01796171|448074804|FG010|Follow-up Period|Start of further anticancer therapy|0|||
124577415|NCT01796171|448074805|FG011|Follow-up Period|Start of further anticancer therapy|0|||
124577416|NCT01796171|448074806|FG012|Follow-up Period|Start of further anticancer therapy|0|||
124577417|NCT01796171|448074807|FG013|Follow-up Period|Start of further anticancer therapy|0|||
124577418|NCT01796171|448074808|FG014|Follow-up Period|Start of further anticancer therapy|0|||
124577419|NCT01796171|448074794|FG000|Follow-up Period|Progressive disease|0|||
124577420|NCT01796171|448074795|FG001|Follow-up Period|Progressive disease|1|||
124577421|NCT01796171|448074796|FG002|Follow-up Period|Progressive disease|0|||
124577422|NCT01796171|448074797|FG003|Follow-up Period|Progressive disease|0|||
124577423|NCT01796171|448074798|FG004|Follow-up Period|Progressive disease|0|||
124577424|NCT01796171|448074799|FG005|Follow-up Period|Progressive disease|0|||
124577425|NCT01796171|448074800|FG006|Follow-up Period|Progressive disease|0|||
124577426|NCT01796171|448074801|FG007|Follow-up Period|Progressive disease|3|||
124577427|NCT01796171|448074802|FG008|Follow-up Period|Progressive disease|0|||
124577428|NCT01796171|448074803|FG009|Follow-up Period|Progressive disease|0|||
124577429|NCT01796171|448074804|FG010|Follow-up Period|Progressive disease|0|||
124577430|NCT01796171|448074805|FG011|Follow-up Period|Progressive disease|0|||
124577431|NCT01796171|448074806|FG012|Follow-up Period|Progressive disease|0|||
124577432|NCT01796171|448074807|FG013|Follow-up Period|Progressive disease|0|||
124577433|NCT01796171|448074808|FG014|Follow-up Period|Progressive disease|0|||
124577434|NCT01796171|448074794|FG000|Follow-up Period|Physician Decision|0|||
124577435|NCT01796171|448074795|FG001|Follow-up Period|Physician Decision|2|||
124577436|NCT01796171|448074796|FG002|Follow-up Period|Physician Decision|0|||
124577437|NCT01796171|448074797|FG003|Follow-up Period|Physician Decision|0|||
124577438|NCT01796171|448074798|FG004|Follow-up Period|Physician Decision|0|||
124577439|NCT01796171|448074799|FG005|Follow-up Period|Physician Decision|0|||
124577440|NCT01796171|448074800|FG006|Follow-up Period|Physician Decision|0|||
124577441|NCT01796171|448074801|FG007|Follow-up Period|Physician Decision|0|||
124577442|NCT01796171|448074802|FG008|Follow-up Period|Physician Decision|0|||
124577443|NCT01796171|448074803|FG009|Follow-up Period|Physician Decision|0|||
124577444|NCT01796171|448074804|FG010|Follow-up Period|Physician Decision|5|||
124577445|NCT01796171|448074805|FG011|Follow-up Period|Physician Decision|0|||
124577446|NCT01796171|448074806|FG012|Follow-up Period|Physician Decision|0|||
124577447|NCT01796171|448074807|FG013|Follow-up Period|Physician Decision|0|||
124577448|NCT01796171|448074808|FG014|Follow-up Period|Physician Decision|0|||
124577449|NCT01796171|448074794|FG000|Follow-up Period|Withdrawal by Subject|0|||
124577450|NCT01796171|448074795|FG001|Follow-up Period|Withdrawal by Subject|1|||
124577451|NCT01796171|448074796|FG002|Follow-up Period|Withdrawal by Subject|0|||
124577452|NCT01796171|448074797|FG003|Follow-up Period|Withdrawal by Subject|0|||
124577453|NCT01796171|448074798|FG004|Follow-up Period|Withdrawal by Subject|0|||
124577454|NCT01796171|448074799|FG005|Follow-up Period|Withdrawal by Subject|1|||
124577455|NCT01796171|448074800|FG006|Follow-up Period|Withdrawal by Subject|0|||
124577456|NCT01796171|448074801|FG007|Follow-up Period|Withdrawal by Subject|0|||
124523382|NCT01804842|447868925|FG000|Overall Study|Adverse Event|1|||
124523383|NCT01804842|447868926|FG001|Overall Study|Adverse Event|1|||
124523384|NCT01804842|447868927|FG002|Overall Study|Adverse Event|0|||
124523385|NCT01804842|447868925|FG000|Overall Study|Lost to Follow-up|1|||
124523386|NCT01804842|447868926|FG001|Overall Study|Lost to Follow-up|0|||
124523387|NCT01804842|447868927|FG002|Overall Study|Lost to Follow-up|0|||
124523388|NCT01804842|447868925|FG000|Overall Study|Non-Compliance|1|||
124577457|NCT01796171|448074802|FG008|Follow-up Period|Withdrawal by Subject|0|||
124523389|NCT01804842|447868926|FG001|Overall Study|Non-Compliance|1|||
124523390|NCT01804842|447868927|FG002|Overall Study|Non-Compliance|0|||
124577458|NCT01796171|448074803|FG009|Follow-up Period|Withdrawal by Subject|0|||
124577459|NCT01796171|448074804|FG010|Follow-up Period|Withdrawal by Subject|3|||
124577460|NCT01796171|448074805|FG011|Follow-up Period|Withdrawal by Subject|1|||
124577461|NCT01796171|448074806|FG012|Follow-up Period|Withdrawal by Subject|0|||
124577462|NCT01796171|448074807|FG013|Follow-up Period|Withdrawal by Subject|0|||
124577463|NCT01796171|448074808|FG014|Follow-up Period|Withdrawal by Subject|0|||
124577464|NCT01796171|448074794|FG000|Follow-up Period|Death|0|||
124577465|NCT01796171|448074795|FG001|Follow-up Period|Death|0|||
124577466|NCT01796171|448074796|FG002|Follow-up Period|Death|0|||
124577467|NCT01796171|448074797|FG003|Follow-up Period|Death|0|||
124577468|NCT01796171|448074798|FG004|Follow-up Period|Death|0|||
124577469|NCT01796171|448074799|FG005|Follow-up Period|Death|0|||
124577470|NCT01796171|448074800|FG006|Follow-up Period|Death|1|||
124577471|NCT01796171|448074801|FG007|Follow-up Period|Death|0|||
124577472|NCT01796171|448074802|FG008|Follow-up Period|Death|0|||
124577473|NCT01796171|448074803|FG009|Follow-up Period|Death|0|||
124577474|NCT01796171|448074804|FG010|Follow-up Period|Death|17|||
124577475|NCT01796171|448074805|FG011|Follow-up Period|Death|9|||
124577476|NCT01796171|448074806|FG012|Follow-up Period|Death|1|||
124577477|NCT01796171|448074807|FG013|Follow-up Period|Death|0|||
124577478|NCT01796171|448074808|FG014|Follow-up Period|Death|0|||
124577479|NCT01796171|448074794|FG000|Follow-up Period|Patient transferred to other hospital|0|||
124577480|NCT01796171|448074795|FG001|Follow-up Period|Patient transferred to other hospital|1|||
124577481|NCT01796171|448074796|FG002|Follow-up Period|Patient transferred to other hospital|0|||
124577482|NCT01796171|448074797|FG003|Follow-up Period|Patient transferred to other hospital|0|||
124577483|NCT01796171|448074798|FG004|Follow-up Period|Patient transferred to other hospital|0|||
124577484|NCT01796171|448074799|FG005|Follow-up Period|Patient transferred to other hospital|0|||
124577485|NCT01796171|448074800|FG006|Follow-up Period|Patient transferred to other hospital|0|||
124577486|NCT01796171|448074801|FG007|Follow-up Period|Patient transferred to other hospital|0|||
124577487|NCT01796171|448074802|FG008|Follow-up Period|Patient transferred to other hospital|0|||
124577488|NCT01796171|448074803|FG009|Follow-up Period|Patient transferred to other hospital|0|||
124577489|NCT01796171|448074804|FG010|Follow-up Period|Patient transferred to other hospital|0|||
124577490|NCT01796171|448074805|FG011|Follow-up Period|Patient transferred to other hospital|0|||
124577491|NCT01796171|448074806|FG012|Follow-up Period|Patient transferred to other hospital|0|||
124577492|NCT01796171|448074807|FG013|Follow-up Period|Patient transferred to other hospital|0|||
124577493|NCT01796171|448074808|FG014|Follow-up Period|Patient transferred to other hospital|0|||
124577494|NCT01796171|448074794|FG000|Follow-up Period|Sponsor Decision|0|||
124577495|NCT01796171|448074795|FG001|Follow-up Period|Sponsor Decision|0|||
124577496|NCT01796171|448074796|FG002|Follow-up Period|Sponsor Decision|0|||
124577497|NCT01796171|448074797|FG003|Follow-up Period|Sponsor Decision|0|||
124577498|NCT01796171|448074798|FG004|Follow-up Period|Sponsor Decision|0|||
124577499|NCT01796171|448074799|FG005|Follow-up Period|Sponsor Decision|0|||
124577500|NCT01796171|448074800|FG006|Follow-up Period|Sponsor Decision|0|||
124577501|NCT01796171|448074801|FG007|Follow-up Period|Sponsor Decision|0|||
124577502|NCT01796171|448074802|FG008|Follow-up Period|Sponsor Decision|0|||
124577503|NCT01796171|448074803|FG009|Follow-up Period|Sponsor Decision|0|||
124577504|NCT01796171|448074804|FG010|Follow-up Period|Sponsor Decision|40|||
124577505|NCT01796171|448074805|FG011|Follow-up Period|Sponsor Decision|15|||
124577506|NCT01796171|448074806|FG012|Follow-up Period|Sponsor Decision|7|||
124577507|NCT01796171|448074807|FG013|Follow-up Period|Sponsor Decision|0|||
124577508|NCT01796171|448074808|FG014|Follow-up Period|Sponsor Decision|0|||
124577509|NCT00418561|448074809|FG000|Overall Study|Participant's (guardian's) decision|0|||
124577510|NCT00418561|448074810|FG001|Overall Study|Participant's (guardian's) decision|1|||
124577511|NCT00418561|448074811|FG002|Overall Study|Participant's (guardian's) decision|0|||
124577512|NCT00829309|448074812|FG000|Washout: 7 Days|Protocol Violation|1|||
124577513|NCT00829309|448074813|FG001|Washout: 7 Days|Protocol Violation|0|||
124725941|NCT04115748|448618565|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
124725942|NCT04115748|448618566|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
124725943|NCT04115748|448618567|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
124725944|NCT04115748|448618568|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
124577514|NCT00455312|448074818|FG000|Overall Study|Death|0|||
124577515|NCT00455312|448074819|FG001|Overall Study|Death|1|||
124577516|NCT01693523|448074820|FG000|Overall Study|Adverse Event|2|||
124577517|NCT01693523|448074821|FG001|Overall Study|Adverse Event|1|||
124725945|NCT04115748|448618569|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
124577518|NCT01693523|448074822|FG002|Overall Study|Adverse Event|0|||
124577519|NCT01693523|448074820|FG000|Overall Study|Death|0|||
124577520|NCT01693523|448074821|FG001|Overall Study|Death|1|||
124577521|NCT01693523|448074822|FG002|Overall Study|Death|1|||
124577522|NCT01693523|448074820|FG000|Overall Study|Lost to Follow-up|0|||
124577523|NCT01693523|448074821|FG001|Overall Study|Lost to Follow-up|0|||
124577524|NCT01693523|448074822|FG002|Overall Study|Lost to Follow-up|4|||
124577525|NCT01693523|448074820|FG000|Overall Study|Physician Decision|0|||
124577526|NCT01693523|448074821|FG001|Overall Study|Physician Decision|0|||
124577527|NCT01693523|448074822|FG002|Overall Study|Physician Decision|1|||
124577528|NCT01693523|448074820|FG000|Overall Study|Withdrawal by Subject|1|||
124725946|NCT04115748|448618570|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
124523391|NCT01804842|447868925|FG000|Overall Study|Personal Reason|0|||
124523392|NCT01804842|447868926|FG001|Overall Study|Personal Reason|0|||
124523393|NCT01804842|447868927|FG002|Overall Study|Personal Reason|1|||
124523394|NCT03933215|447868928|FG000|Overall Study|Other|6|||
124523395|NCT03933215|447868928|FG000|Overall Study|Sponsor decision|5|||
124523396|NCT03933215|447868928|FG000|Overall Study|Protocol Violation|5|||
124523397|NCT03933215|447868928|FG000|Overall Study|Withdrawal by Subject|6|||
124523398|NCT03933215|447868928|FG000|Overall Study|Lost to Follow-up|6|||
124523399|NCT03933215|447868928|FG000|Overall Study|Enrolled but not treated|38|||
124523400|NCT04222673|447868929|FG000|Overall Study|Lost to Follow-up|5|||
124523401|NCT04097028|447868930|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
124523402|NCT04097028|447868930|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
124523403|NCT04097028|447868930|FG000|Overall Study|Disease Progression prior to Surgery|2|||
124523404|NCT04097028|447868930|FG000|Overall Study|Adverse Event prior to Surgery|1|||
124523405|NCT04072575|447868931|FG000|Overall Study|Physician Decision|1|||
124523406|NCT04072575|447868931|FG000|Overall Study|Adverse Event|7|||
124523407|NCT04072575|447868931|FG000|Overall Study|Withdrawal by Subject|14|||
124523408|NCT04072575|447868931|FG000|Overall Study|Other|2|||
124523409|NCT02473289|447868932|FG000|Overall Study|Adverse Event|2|||
124523410|NCT02473289|447868933|FG001|Overall Study|Adverse Event|3|||
124523411|NCT02473289|447868932|FG000|Overall Study|Lost to Follow-up|1|||
124523412|NCT02473289|447868933|FG001|Overall Study|Lost to Follow-up|1|||
124523413|NCT02473289|447868932|FG000|Overall Study|Protocol Violation|0|||
124523414|NCT02473289|447868933|FG001|Overall Study|Protocol Violation|1|||
124523415|NCT02473289|447868932|FG000|Overall Study|Withdrawal of consent|6|||
124523416|NCT02473289|447868933|FG001|Overall Study|Withdrawal of consent|7|||
124523417|NCT02473289|447868932|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
124523418|NCT02473289|447868933|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
124523419|NCT02473289|447868932|FG000|Overall Study|Other|2|||
124523420|NCT02473289|447868933|FG001|Overall Study|Other|0|||
124523421|NCT02244619|447868934|FG000|Overall Study|Did not receive study intervention|8|||
124523422|NCT02244619|447868935|FG001|Overall Study|Did not receive study intervention|21|||
124523423|NCT01291511|447868937|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
124523424|NCT01291511|447868938|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
124523425|NCT01291511|447868937|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
124523426|NCT01291511|447868938|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
124523427|NCT01291511|447868937|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
124523428|NCT01291511|447868938|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
124523429|NCT01291511|447868937|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
124523430|NCT01291511|447868938|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
124523431|NCT01291511|447868937|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
124523432|NCT01291511|447868938|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
124523433|NCT01291511|447868937|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
124523434|NCT01291511|447868938|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
124523435|NCT01291511|447868937|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
124523436|NCT01291511|447868938|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
124523437|NCT01291511|447868937|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
124523438|NCT01291511|447868938|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
124523439|NCT01291511|447868937|FG000|Cross-Titration and Stabilization Phase|Death|1|||
124523440|NCT01291511|447868938|FG001|Cross-Titration and Stabilization Phase|Death|0|||
124523441|NCT01291511|447868937|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
124523442|NCT01291511|447868938|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
124523443|NCT01291511|447868937|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
124523444|NCT01291511|447868938|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
124523445|NCT01291511|447868937|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
124523446|NCT01291511|447868938|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
124523447|NCT01291511|447868937|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
124523448|NCT01291511|447868938|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
124523449|NCT01291511|447868937|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
124523450|NCT01291511|447868938|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
124523451|NCT01291511|447868937|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
124523452|NCT01291511|447868938|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
124523453|NCT01291511|447868937|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
124523454|NCT01291511|447868938|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
124523455|NCT01291511|447868937|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
124523456|NCT01291511|447868938|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
124523457|NCT01291511|447868937|FG000|Double-blind Relapse Prevention Phase|Death|1|||
124523458|NCT01291511|447868938|FG001|Double-blind Relapse Prevention Phase|Death|0|||
124523459|NCT00047008|447868940|FG000|Overall Study|Withdrawn consent|2|||
124523460|NCT00047008|447868941|FG001|Overall Study|Withdrawn consent|3|||
124523461|NCT00047008|447868940|FG000|Overall Study|Ineligible|9|||
124523462|NCT00047008|447868941|FG001|Overall Study|Ineligible|8|||
124523463|NCT01408732|447868943|FG000|Overall Study|Withdrawal by Subject|2|||
124523464|NCT01408732|447868944|FG001|Overall Study|Withdrawal by Subject|2|||
124523465|NCT00796003|447868946|FG000|Overall Study|Disease Progression|2|||
124523466|NCT00796003|447868947|FG001|Overall Study|Disease Progression|13|||
124523467|NCT00796003|447868946|FG000|Overall Study|Adverse Event|1|||
124523468|NCT00796003|447868947|FG001|Overall Study|Adverse Event|7|||
124523469|NCT00796003|447868946|FG000|Overall Study|Specified organ function not met|0|||
124523470|NCT00796003|447868947|FG001|Overall Study|Specified organ function not met|1|||
124523471|NCT00796003|447868946|FG000|Overall Study|Physician Decision|0|||
124523472|NCT00796003|447868947|FG001|Overall Study|Physician Decision|4|||
124523473|NCT00796003|447868946|FG000|Overall Study|Withdrawal by Subject|0|||
124523474|NCT00796003|447868947|FG001|Overall Study|Withdrawal by Subject|1|||
124523475|NCT00796003|447868946|FG000|Overall Study|Other|0|||
124523476|NCT00796003|447868947|FG001|Overall Study|Other|1|||
124523477|NCT00796003|447868946|FG000|Overall Study|Participants Not treated|0|||
124523478|NCT00796003|447868947|FG001|Overall Study|Participants Not treated|2|||
124523479|NCT05179057|447868948|FG000|Overall Study|Adverse Event|3|||
124523480|NCT05179057|447868949|FG001|Overall Study|Adverse Event|2|||
124523481|NCT05179057|447868948|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
124523482|NCT05179057|447868949|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
124523483|NCT05179057|447868948|FG000|Overall Study|Study terminated|13|||
124523484|NCT05179057|447868949|FG001|Overall Study|Study terminated|7|||
124523485|NCT05179057|447868948|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
124523486|NCT05179057|447868949|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
124523487|NCT05179057|447868948|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
124523488|NCT05179057|447868949|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
124523489|NCT02437162|447868950|FG000|Overall Study|Protocol Violation|0|||
124523490|NCT02437162|447868951|FG001|Overall Study|Protocol Violation|1|||
124523491|NCT02437162|447868952|FG002|Overall Study|Protocol Violation|0|||
124523492|NCT02437162|447868950|FG000|Overall Study|Randomized but not treated|0|||
124523493|NCT02437162|447868951|FG001|Overall Study|Randomized but not treated|0|||
124523494|NCT02437162|447868952|FG002|Overall Study|Randomized but not treated|1|||
124523495|NCT02437162|447868950|FG000|Overall Study|Study discontinued by Sponsor|93|||
124523496|NCT02437162|447868951|FG001|Overall Study|Study discontinued by Sponsor|98|||
124523497|NCT02437162|447868952|FG002|Overall Study|Study discontinued by Sponsor|97|||
124523498|NCT02437162|447868950|FG000|Overall Study|Withdrawal by Subject|13|||
124523499|NCT02437162|447868951|FG001|Overall Study|Withdrawal by Subject|7|||
124523500|NCT02437162|447868952|FG002|Overall Study|Withdrawal by Subject|9|||
124523501|NCT02437162|447868950|FG000|Overall Study|Adverse Event|0|||
124523502|NCT02437162|447868951|FG001|Overall Study|Adverse Event|1|||
124523503|NCT02437162|447868952|FG002|Overall Study|Adverse Event|0|||
124523504|NCT02437162|447868950|FG000|Overall Study|Lost to Follow-up|1|||
124523505|NCT02437162|447868951|FG001|Overall Study|Lost to Follow-up|0|||
124523506|NCT02437162|447868952|FG002|Overall Study|Lost to Follow-up|1|||
124523507|NCT02437162|447868950|FG000|Overall Study|Death|0|||
124523508|NCT02437162|447868951|FG001|Overall Study|Death|1|||
124523509|NCT02437162|447868952|FG002|Overall Study|Death|0|||
124523510|NCT02437162|447868950|FG000|Overall Study|Other|0|||
124523511|NCT02437162|447868951|FG001|Overall Study|Other|0|||
124523512|NCT02437162|447868952|FG002|Overall Study|Other|1|||
124523513|NCT04338321|447868953|FG000|Overall Study|Adverse Event|4|||
124523514|NCT04338321|447868954|FG001|Overall Study|Adverse Event|10|||
124523515|NCT04338321|447868953|FG000|Overall Study|Death|1|||
124523516|NCT04338321|447868954|FG001|Overall Study|Death|1|||
124523517|NCT04338321|447868953|FG000|Overall Study|Lost to Follow-up|4|||
124523518|NCT04338321|447868954|FG001|Overall Study|Lost to Follow-up|9|||
124523519|NCT04338321|447868953|FG000|Overall Study|Withdrawal by Subject|45|||
124523520|NCT04338321|447868954|FG001|Overall Study|Withdrawal by Subject|69|||
124523521|NCT04338321|447868953|FG000|Overall Study|Physician Decision|5|||
124523522|NCT04338321|447868954|FG001|Overall Study|Physician Decision|9|||
124523523|NCT04338321|447868953|FG000|Overall Study|Other|3|||
124523524|NCT04338321|447868954|FG001|Overall Study|Other|10|||
124577529|NCT01693523|448074821|FG001|Overall Study|Withdrawal by Subject|2|||
124725947|NCT04115748|448618571|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
124523525|NCT03107793|447868955|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
124523526|NCT03107793|447868956|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
124523527|NCT03107793|447868957|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
124523528|NCT03107793|447868958|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
124523529|NCT03107793|447868959|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
124523530|NCT03107793|447868955|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
124523531|NCT03107793|447868956|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
124523532|NCT03107793|447868957|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
124523533|NCT03107793|447868958|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
124523534|NCT03107793|447868959|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
124523535|NCT03107793|447868955|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
124523536|NCT03107793|447868956|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
124523537|NCT03107793|447868957|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
124523538|NCT03107793|447868958|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
124523539|NCT03107793|447868959|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
124523540|NCT03107793|447868955|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
124523541|NCT03107793|447868956|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124523542|NCT03107793|447868957|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124523543|NCT03107793|447868958|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124523544|NCT03107793|447868959|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124523545|NCT03107793|447868955|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
124523546|NCT03107793|447868956|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
124523547|NCT03107793|447868957|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
124523548|NCT03107793|447868958|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
124523549|NCT03107793|447868959|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
124523550|NCT03107793|447868955|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
124523551|NCT03107793|447868956|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
124523552|NCT03107793|447868957|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
124523553|NCT03107793|447868958|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
124523554|NCT03107793|447868959|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
124523555|NCT03107793|447868955|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
124523556|NCT03107793|447868956|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
124523557|NCT03107793|447868957|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
124523558|NCT03107793|447868958|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
124523559|NCT03107793|447868959|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
124523560|NCT03107793|447868955|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
124523561|NCT03107793|447868956|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
124523562|NCT03107793|447868957|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
124523563|NCT03107793|447868958|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
124523564|NCT03107793|447868959|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
124523565|NCT03107793|447868955|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
124523566|NCT03107793|447868956|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
124523567|NCT03107793|447868957|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
124523568|NCT03107793|447868958|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
124523569|NCT03107793|447868959|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
124523570|NCT03107793|447868955|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
124523571|NCT03107793|447868956|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
124523572|NCT03107793|447868957|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
124523573|NCT03107793|447868958|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
124523574|NCT03107793|447868959|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
124523575|NCT03107793|447868955|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
124523576|NCT03107793|447868956|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
124523577|NCT03107793|447868957|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
124523578|NCT03107793|447868958|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
124523579|NCT03107793|447868959|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
124523580|NCT03107793|447868955|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
124523581|NCT03107793|447868956|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
124523582|NCT03107793|447868957|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
124523583|NCT03107793|447868958|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
124523584|NCT03107793|447868959|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
124523585|NCT03107793|447868955|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
124523586|NCT03107793|447868956|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
124523587|NCT03107793|447868957|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
124523588|NCT03107793|447868958|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
124523589|NCT03107793|447868959|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
124523590|NCT03107793|447868955|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
124523591|NCT03107793|447868956|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
124523592|NCT03107793|447868957|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
124523593|NCT03107793|447868958|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
124523594|NCT03107793|447868959|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
124523595|NCT03107793|447868955|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
124523596|NCT03107793|447868956|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
124523597|NCT03107793|447868957|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
124523598|NCT03107793|447868958|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
124725948|NCT04115748|448618572|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
124523599|NCT03107793|447868959|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
124523600|NCT03107793|447868955|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
124523601|NCT03107793|447868956|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
124523602|NCT03107793|447868957|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
124523603|NCT03107793|447868958|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
124523604|NCT03107793|447868959|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
124523605|NCT03107793|447868955|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
124523606|NCT03107793|447868956|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
124523607|NCT03107793|447868957|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
124523608|NCT03107793|447868958|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
124523609|NCT03107793|447868959|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
124523610|NCT03107793|447868955|FG000|Extension Period (Week 48- Week 104)|Death|0|||
124523611|NCT03107793|447868956|FG001|Extension Period (Week 48- Week 104)|Death|0|||
124523612|NCT03107793|447868957|FG002|Extension Period (Week 48- Week 104)|Death|0|||
124523613|NCT03107793|447868958|FG003|Extension Period (Week 48- Week 104)|Death|0|||
124523614|NCT03107793|447868959|FG004|Extension Period (Week 48- Week 104)|Death|1|||
124523615|NCT03107793|447868955|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
124523616|NCT03107793|447868956|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
124523617|NCT03107793|447868957|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
124523618|NCT03107793|447868958|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
124523619|NCT03107793|447868959|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
124523620|NCT03107793|447868955|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
124523621|NCT03107793|447868956|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
124523622|NCT03107793|447868957|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
124523623|NCT03107793|447868958|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
124523624|NCT03107793|447868959|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
124523625|NCT03107793|447868955|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
124523626|NCT03107793|447868956|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
124523627|NCT03107793|447868957|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
124523628|NCT03107793|447868958|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
124523629|NCT03107793|447868959|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
124523630|NCT03107793|447868955|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
124523631|NCT03107793|447868956|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
124523632|NCT03107793|447868957|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
124523633|NCT03107793|447868958|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
124523634|NCT03107793|447868959|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
124523635|NCT03107793|447868955|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
124523636|NCT03107793|447868956|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
124523637|NCT03107793|447868957|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
124523638|NCT03107793|447868958|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
124523639|NCT03107793|447868959|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
124523640|NCT03107793|447868955|FG000|Extension Period (Week 48- Week 104)|Other|0|||
124523641|NCT03107793|447868956|FG001|Extension Period (Week 48- Week 104)|Other|0|||
124523642|NCT03107793|447868957|FG002|Extension Period (Week 48- Week 104)|Other|0|||
124523643|NCT03107793|447868958|FG003|Extension Period (Week 48- Week 104)|Other|1|||
124523644|NCT03107793|447868959|FG004|Extension Period (Week 48- Week 104)|Other|3|||
124523645|NCT03107793|447868955|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
124523646|NCT03107793|447868956|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
124523647|NCT03107793|447868957|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
124523648|NCT03107793|447868958|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
124523649|NCT03107793|447868959|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
124523650|NCT01989572|447868963|FG000|Overall Study|Lack of Efficacy|35|||
124523651|NCT01989572|447868964|FG001|Overall Study|Lack of Efficacy|48|||
124523652|NCT01989572|447868965|FG002|Overall Study|Lack of Efficacy|48|||
124523653|NCT01989572|447868966|FG003|Overall Study|Lack of Efficacy|43|||
124523654|NCT01989572|447868967|FG004|Overall Study|Lack of Efficacy|71|||
124523655|NCT01989572|447868968|FG005|Overall Study|Lack of Efficacy|79|||
124523656|NCT01989572|447868963|FG000|Overall Study|Adverse Event|2|||
124523657|NCT01989572|447868964|FG001|Overall Study|Adverse Event|1|||
124523658|NCT01989572|447868965|FG002|Overall Study|Adverse Event|3|||
124523659|NCT01989572|447868966|FG003|Overall Study|Adverse Event|0|||
124523660|NCT01989572|447868967|FG004|Overall Study|Adverse Event|3|||
124523661|NCT01989572|447868968|FG005|Overall Study|Adverse Event|0|||
124523662|NCT01989572|447868963|FG000|Overall Study|Death|0|||
124523663|NCT01989572|447868964|FG001|Overall Study|Death|0|||
124523664|NCT01989572|447868965|FG002|Overall Study|Death|0|||
124523665|NCT01989572|447868966|FG003|Overall Study|Death|0|||
124577530|NCT01693523|448074822|FG002|Overall Study|Withdrawal by Subject|2|||
124577531|NCT01693523|448074820|FG000|Overall Study|Lack of compliance study medication|1|||
124577532|NCT01693523|448074821|FG001|Overall Study|Lack of compliance study medication|2|||
124577533|NCT01693523|448074822|FG002|Overall Study|Lack of compliance study medication|0|||
124577534|NCT01693523|448074820|FG000|Overall Study|Chemotherapy was held|1|||
124577535|NCT01693523|448074821|FG001|Overall Study|Chemotherapy was held|2|||
124577536|NCT01693523|448074822|FG002|Overall Study|Chemotherapy was held|0|||
124577537|NCT03343535|448074823|FG000|Overall Study|Lost to Follow-up|1|||
124577538|NCT03343535|448074823|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
124577539|NCT03343535|448074823|FG000|Overall Study|Death|12|||
124577540|NCT02659150|448074825|FG000|Subject Enrollment|Physician Decision|3|||
124577541|NCT02659150|448074825|FG000|Subject Enrollment|Withdrawal by Subject|2|||
124577542|NCT02659150|448074825|FG000|Baseline Imaging|Withdrawal by Subject|1|||
124577543|NCT02659150|448074825|FG000|Baseline Imaging|Physician Decision|1|||
124577544|NCT02659150|448074825|FG000|Study Drug Dosing|Adverse Event|1|||
124577545|NCT03500341|448074836|FG000|Overall Study|Withdrawn prior to Completion|2|||
124577546|NCT02576938|448074837|FG000|Overall Study|Adverse Event|5|||
124577547|NCT02576938|448074838|FG001|Overall Study|Adverse Event|3|||
124577548|NCT02576938|448074839|FG002|Overall Study|Adverse Event|6|||
124577549|NCT02576938|448074837|FG000|Overall Study|Protocol Violation|1|||
124577550|NCT02576938|448074838|FG001|Overall Study|Protocol Violation|1|||
124577551|NCT02576938|448074839|FG002|Overall Study|Protocol Violation|1|||
124577552|NCT02576938|448074837|FG000|Overall Study|Withdrawal by Subject|3|||
124577553|NCT02576938|448074838|FG001|Overall Study|Withdrawal by Subject|2|||
124577554|NCT02576938|448074839|FG002|Overall Study|Withdrawal by Subject|4|||
124577555|NCT02576938|448074837|FG000|Overall Study|Lack of Efficacy|9|||
124577556|NCT02576938|448074838|FG001|Overall Study|Lack of Efficacy|4|||
124577557|NCT02576938|448074839|FG002|Overall Study|Lack of Efficacy|0|||
124577558|NCT02576938|448074837|FG000|Overall Study|Lost to Follow-up|2|||
124577559|NCT02576938|448074838|FG001|Overall Study|Lost to Follow-up|0|||
124577560|NCT02576938|448074839|FG002|Overall Study|Lost to Follow-up|1|||
124577561|NCT02576938|448074837|FG000|Overall Study|Physician Decision|0|||
124577562|NCT02576938|448074838|FG001|Overall Study|Physician Decision|1|||
124577563|NCT02576938|448074839|FG002|Overall Study|Physician Decision|0|||
124577564|NCT02576938|448074837|FG000|Overall Study|Met Exclusion Criteria|0|||
124577565|NCT02576938|448074838|FG001|Overall Study|Met Exclusion Criteria|1|||
124577566|NCT02576938|448074839|FG002|Overall Study|Met Exclusion Criteria|0|||
124577567|NCT00838630|448074841|FG000|First Intervention|Adverse Event|1|||
124577568|NCT00838630|448074842|FG001|First Intervention|Adverse Event|0|||
124577569|NCT00838630|448074841|FG000|Washout: 7 Days|Protocol Violation|1|||
124577570|NCT00838630|448074842|FG001|Washout: 7 Days|Protocol Violation|0|||
124577571|NCT00448591|448074843|FG000|Overall Study|Withdrawal by Subject|178|||
124577572|NCT00448591|448074843|FG000|Overall Study|Progressive Disease|1382|||
124577573|NCT00448591|448074843|FG000|Overall Study|Adverse Event|382|||
124577574|NCT00448591|448074843|FG000|Overall Study|Protocol Violation|41|||
124577575|NCT00448591|448074843|FG000|Overall Study|Lost to Follow-up|19|||
124577576|NCT00448591|448074843|FG000|Overall Study|Treatment Regimen Completed|70|||
124577577|NCT00448591|448074843|FG000|Overall Study|Other|154|||
124577578|NCT00448591|448074843|FG000|Overall Study|Termination of Study|70|||
124577579|NCT03017885|448074844|FG000|Overall Study|Adverse Event|2|||
124577580|NCT03017885|448074845|FG001|Overall Study|Adverse Event|0|||
124577581|NCT03017885|448074846|FG002|Overall Study|Adverse Event|0|||
124577582|NCT03017885|448074847|FG003|Overall Study|Adverse Event|0|||
124577583|NCT03017885|448074848|FG004|Overall Study|Adverse Event|0|||
124577584|NCT03017885|448074849|FG005|Overall Study|Adverse Event|0|||
124577585|NCT03017885|448074844|FG000|Overall Study|Progression of disease|4|||
124577586|NCT03017885|448074845|FG001|Overall Study|Progression of disease|3|||
124577587|NCT03017885|448074846|FG002|Overall Study|Progression of disease|4|||
124577588|NCT03017885|448074847|FG003|Overall Study|Progression of disease|0|||
124577589|NCT03017885|448074848|FG004|Overall Study|Progression of disease|0|||
124577590|NCT03017885|448074849|FG005|Overall Study|Progression of disease|0|||
124577591|NCT03017885|448074844|FG000|Overall Study|Other than listed|1|||
124577592|NCT03017885|448074845|FG001|Overall Study|Other than listed|2|||
124577593|NCT03017885|448074846|FG002|Overall Study|Other than listed|1|||
124577594|NCT03017885|448074847|FG003|Overall Study|Other than listed|0|||
124577595|NCT03017885|448074848|FG004|Overall Study|Other than listed|0|||
124577596|NCT03017885|448074849|FG005|Overall Study|Other than listed|0|||
124577597|NCT03017885|448074844|FG000|Overall Study|Lost to Follow-up|2|||
124577598|NCT03017885|448074845|FG001|Overall Study|Lost to Follow-up|0|||
124577599|NCT03017885|448074846|FG002|Overall Study|Lost to Follow-up|3|||
124577600|NCT03017885|448074847|FG003|Overall Study|Lost to Follow-up|0|||
124577601|NCT03017885|448074848|FG004|Overall Study|Lost to Follow-up|0|||
124577602|NCT03017885|448074849|FG005|Overall Study|Lost to Follow-up|0|||
124577603|NCT03017885|448074844|FG000|Overall Study|Change to other anti-cancer therapy|0|||
124577604|NCT03017885|448074845|FG001|Overall Study|Change to other anti-cancer therapy|0|||
124577605|NCT03017885|448074846|FG002|Overall Study|Change to other anti-cancer therapy|1|||
124577606|NCT03017885|448074847|FG003|Overall Study|Change to other anti-cancer therapy|0|||
124776784|NCT00594815|448810003|FG000|Overall Study|Withdrawal by Subject|2|||
124577607|NCT03017885|448074848|FG004|Overall Study|Change to other anti-cancer therapy|0|||
124577608|NCT03017885|448074849|FG005|Overall Study|Change to other anti-cancer therapy|0|||
124577609|NCT01289262|448074850|FG000|Overall Study|Lost to Follow-up|29|||
124577610|NCT01289262|448074851|FG001|Overall Study|Lost to Follow-up|16|||
124577611|NCT01289262|448074850|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
124577612|NCT01289262|448074851|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
124577613|NCT00838279|448074852|FG000|Washout|Protocol Violation|1|||
124577614|NCT00838279|448074853|FG001|Washout|Protocol Violation|0|||
124577615|NCT00838279|448074852|FG000|Washout|Withdrawal by Subject|0|||
124577616|NCT00838279|448074853|FG001|Washout|Withdrawal by Subject|1|||
124577617|NCT01250912|448074857|FG000|Overall Study|Lost to Follow-up|1|||
124577618|NCT01218867|448074860|FG000|Overall Study|Death during treatment|0|||
124577619|NCT01218867|448074861|FG001|Overall Study|Death during treatment|0|||
124577620|NCT01218867|448074862|FG002|Overall Study|Death during treatment|0|||
124577621|NCT01218867|448074863|FG003|Overall Study|Death during treatment|0|||
124577622|NCT01218867|448074864|FG004|Overall Study|Death during treatment|0|||
124725949|NCT04115748|448618573|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
124725950|NCT04115748|448618574|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
124725951|NCT04115748|448618565|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
124725952|NCT04115748|448618566|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
124725953|NCT04115748|448618567|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
124725954|NCT04115748|448618568|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
124725955|NCT04115748|448618569|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
124725956|NCT04115748|448618570|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
124725957|NCT04115748|448618571|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
124725958|NCT04115748|448618572|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
124725959|NCT04115748|448618573|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
124725960|NCT04115748|448618574|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
124725961|NCT00713349|448618575|FG000|Overall Study|Protocol Violation|1|||
124725962|NCT03764631|448618576|FG000|Overall Study|Personal Reasons|3|||
124725963|NCT03764631|448618577|FG001|Overall Study|Personal Reasons|2|||
124725964|NCT03764631|448618576|FG000|Overall Study|Switching Therapy|3|||
124725965|NCT03764631|448618577|FG001|Overall Study|Switching Therapy|3|||
124725966|NCT03764631|448618576|FG000|Overall Study|Adverse Event|0|||
124725967|NCT03764631|448618577|FG001|Overall Study|Adverse Event|1|||
124725968|NCT03764631|448618576|FG000|Overall Study|Lost to Follow-up|33|||
124523666|NCT01989572|447868967|FG004|Overall Study|Death|1|||
124523667|NCT01989572|447868968|FG005|Overall Study|Death|0|||
124523668|NCT01989572|447868963|FG000|Overall Study|Withdrawal by Subject|4|||
124523669|NCT01989572|447868964|FG001|Overall Study|Withdrawal by Subject|1|||
124523670|NCT01989572|447868965|FG002|Overall Study|Withdrawal by Subject|5|||
124523671|NCT01989572|447868966|FG003|Overall Study|Withdrawal by Subject|1|||
124523672|NCT01989572|447868967|FG004|Overall Study|Withdrawal by Subject|12|||
124523673|NCT01989572|447868968|FG005|Overall Study|Withdrawal by Subject|4|||
124523674|NCT01989572|447868963|FG000|Overall Study|complicating disease|1|||
124523675|NCT01989572|447868964|FG001|Overall Study|complicating disease|1|||
124523676|NCT01989572|447868965|FG002|Overall Study|complicating disease|2|||
124523677|NCT01989572|447868966|FG003|Overall Study|complicating disease|0|||
124523678|NCT01989572|447868967|FG004|Overall Study|complicating disease|1|||
124523679|NCT01989572|447868968|FG005|Overall Study|complicating disease|0|||
124523680|NCT01989572|447868963|FG000|Overall Study|error|2|||
124523681|NCT01989572|447868964|FG001|Overall Study|error|1|||
124523682|NCT01989572|447868965|FG002|Overall Study|error|1|||
124523683|NCT01989572|447868966|FG003|Overall Study|error|1|||
124523684|NCT01989572|447868967|FG004|Overall Study|error|1|||
124523685|NCT01989572|447868968|FG005|Overall Study|error|1|||
124523686|NCT01989572|447868963|FG000|Overall Study|maximum dose reached|0|||
124523687|NCT01989572|447868964|FG001|Overall Study|maximum dose reached|1|||
124523688|NCT01989572|447868965|FG002|Overall Study|maximum dose reached|0|||
124577623|NCT01218867|448074865|FG005|Overall Study|Death during treatment|0|||
124577624|NCT01218867|448074866|FG006|Overall Study|Death during treatment|1|||
124577625|NCT01218867|448074867|FG007|Overall Study|Death during treatment|0|||
124577626|NCT01218867|448074868|FG008|Overall Study|Death during treatment|0|||
124577627|NCT01218867|448074869|FG009|Overall Study|Death during treatment|0|||
124577628|NCT01218867|448074870|FG010|Overall Study|Death during treatment|0|||
124577629|NCT01474551|448074871|FG000|Overall Study|Death|1|||
124577630|NCT01921062|448074872|FG000|Overall Study|Withdrawal by Subject|0|||
124577631|NCT01921062|448074873|FG001|Overall Study|Withdrawal by Subject|7|||
124725969|NCT03764631|448618577|FG001|Overall Study|Lost to Follow-up|41|||
124725970|NCT03764631|448618576|FG000|Overall Study|No data as study site was closed|2|||
124725971|NCT03764631|448618577|FG001|Overall Study|No data as study site was closed|6|||
124523689|NCT01989572|447868966|FG003|Overall Study|maximum dose reached|0|||
124523690|NCT01989572|447868967|FG004|Overall Study|maximum dose reached|1|||
124523691|NCT01989572|447868968|FG005|Overall Study|maximum dose reached|0|||
124523692|NCT01989572|447868963|FG000|Overall Study|unknown/not specify|3|||
124523693|NCT01989572|447868964|FG001|Overall Study|unknown/not specify|4|||
124577632|NCT01921062|448074872|FG000|Overall Study|Adverse Event|5|||
124577633|NCT01921062|448074873|FG001|Overall Study|Adverse Event|6|||
124577634|NCT01921062|448074872|FG000|Overall Study|Protocol Violation|0|||
124577635|NCT01921062|448074873|FG001|Overall Study|Protocol Violation|1|||
124577636|NCT01921062|448074872|FG000|Overall Study|VMIQ score > 72|4|||
124577637|NCT01921062|448074873|FG001|Overall Study|VMIQ score > 72|1|||
124577638|NCT01921062|448074872|FG000|Overall Study|Logistic error|0|||
124577639|NCT01921062|448074873|FG001|Overall Study|Logistic error|1|||
124577640|NCT05323396|448074874|FG000|Overall Study|Lost to Follow-up|1|||
124577641|NCT05323396|448074875|FG001|Overall Study|Lost to Follow-up|35|||
124577642|NCT05323396|448074874|FG000|Overall Study|Pregnancy|1|||
124577643|NCT05323396|448074875|FG001|Overall Study|Pregnancy|0|||
124725972|NCT01200407|448618578|FG000|Overall Study|Lost to Follow-up|56|||
124523694|NCT01989572|447868965|FG002|Overall Study|unknown/not specify|1|||
124523695|NCT01989572|447868966|FG003|Overall Study|unknown/not specify|3|||
124523696|NCT01989572|447868967|FG004|Overall Study|unknown/not specify|3|||
124523697|NCT01989572|447868968|FG005|Overall Study|unknown/not specify|5|||
124523698|NCT01989572|447868963|FG000|Overall Study|not start protocol therapy|5|||
124523699|NCT01989572|447868964|FG001|Overall Study|not start protocol therapy|1|||
124523700|NCT01989572|447868965|FG002|Overall Study|not start protocol therapy|2|||
124523701|NCT01989572|447868966|FG003|Overall Study|not start protocol therapy|3|||
124523702|NCT01989572|447868967|FG004|Overall Study|not start protocol therapy|4|||
124523703|NCT01989572|447868968|FG005|Overall Study|not start protocol therapy|18|||
124523704|NCT01989572|447868963|FG000|Overall Study|alternative therapy|3|||
124523705|NCT01989572|447868964|FG001|Overall Study|alternative therapy|0|||
124523706|NCT01989572|447868965|FG002|Overall Study|alternative therapy|0|||
124523707|NCT01989572|447868966|FG003|Overall Study|alternative therapy|0|||
124523708|NCT01989572|447868967|FG004|Overall Study|alternative therapy|1|||
124523709|NCT01989572|447868968|FG005|Overall Study|alternative therapy|3|||
124523710|NCT00865046|447868969|FG000|Overall Study|Lost to Follow-up|1|||
124523711|NCT00865046|447868970|FG001|Overall Study|Lost to Follow-up|4|||
124523712|NCT00865046|447868971|FG002|Overall Study|Lost to Follow-up|0|||
124523713|NCT00865046|447868969|FG000|Overall Study|Death|0|||
124523714|NCT00865046|447868970|FG001|Overall Study|Death|1|||
124523715|NCT00865046|447868971|FG002|Overall Study|Death|1|||
124523716|NCT00865046|447868969|FG000|Overall Study|Withdrawal by Subject|5|||
124523717|NCT00865046|447868970|FG001|Overall Study|Withdrawal by Subject|0|||
124523718|NCT00865046|447868971|FG002|Overall Study|Withdrawal by Subject|0|||
124523719|NCT01024920|447868974|FG000|Overall Study|Progressive disease|47|||
124523720|NCT01024920|447868975|FG001|Overall Study|Progressive disease|25|||
124523721|NCT01024920|447868974|FG000|Overall Study|Adverse Event|8|||
124523722|NCT01024920|447868975|FG001|Overall Study|Adverse Event|4|||
124523723|NCT01024920|447868974|FG000|Overall Study|Lost to Follow-up|0|||
124523724|NCT01024920|447868975|FG001|Overall Study|Lost to Follow-up|1|||
124523725|NCT01024920|447868974|FG000|Overall Study|Patient refusal to continue|4|||
124523726|NCT01024920|447868975|FG001|Overall Study|Patient refusal to continue|0|||
124523727|NCT01024920|447868974|FG000|Overall Study|Other than listed|5|||
124523728|NCT01024920|447868975|FG001|Overall Study|Other than listed|1|||
124523729|NCT01024920|447868974|FG000|Overall Study|Not treated|3|||
124523730|NCT01024920|447868975|FG001|Overall Study|Not treated|0|||
124523731|NCT01024920|447868974|FG000|Overall Study|Protocol Violation|0|||
124523732|NCT01024920|447868975|FG001|Overall Study|Protocol Violation|1|||
124523733|NCT02977507|447868976|FG000|Overall Study|Protocol Deviation|1|||
124523734|NCT02977507|447868977|FG001|Overall Study|Protocol Deviation|0|||
124523735|NCT02977507|447868976|FG000|Overall Study|Lost to Follow-up|1|||
124523736|NCT02977507|447868977|FG001|Overall Study|Lost to Follow-up|0|||
124523737|NCT00633360|447868978|FG000|Overall Study|Lost to Follow-up|1|||
124523738|NCT00633360|447868979|FG001|Overall Study|Lost to Follow-up|1|||
124523739|NCT00633360|447868978|FG000|Overall Study|Adverse Event|3|||
124523740|NCT00633360|447868979|FG001|Overall Study|Adverse Event|1|||
124523741|NCT00633360|447868978|FG000|Overall Study|Protocol Violation|0|||
124523742|NCT00633360|447868979|FG001|Overall Study|Protocol Violation|1|||
124523743|NCT00621244|447868984|FG000|Overall Study|Withdrawal by Subject|7|||
124523744|NCT00621244|447868985|FG001|Overall Study|Withdrawal by Subject|3|||
124523745|NCT00621244|447868986|FG002|Overall Study|Withdrawal by Subject|3|||
124523746|NCT00621244|447868987|FG003|Overall Study|Withdrawal by Subject|3|||
124523747|NCT00621244|447868984|FG000|Overall Study|Disease progression|44|||
124523748|NCT00621244|447868985|FG001|Overall Study|Disease progression|20|||
124523749|NCT00621244|447868986|FG002|Overall Study|Disease progression|20|||
124523750|NCT00621244|447868987|FG003|Overall Study|Disease progression|15|||
124523751|NCT00621244|447868984|FG000|Overall Study|Death|3|||
124523752|NCT00621244|447868985|FG001|Overall Study|Death|3|||
124523753|NCT00621244|447868986|FG002|Overall Study|Death|1|||
124523754|NCT00621244|447868987|FG003|Overall Study|Death|1|||
124523755|NCT00621244|447868984|FG000|Overall Study|Adverse Event|27|||
124523756|NCT00621244|447868985|FG001|Overall Study|Adverse Event|7|||
124523757|NCT00621244|447868986|FG002|Overall Study|Adverse Event|9|||
124523758|NCT00621244|447868987|FG003|Overall Study|Adverse Event|2|||
124577644|NCT01110005|448074876|FG000|Overall Study|ineligible|1|||
124577645|NCT01110005|448074877|FG001|Overall Study|ineligible|2|||
124577646|NCT01110005|448074876|FG000|Overall Study|missing consent|3|||
124577647|NCT01110005|448074877|FG001|Overall Study|missing consent|2|||
124577648|NCT01110005|448074876|FG000|Overall Study|Withdrawal by Subject|0|||
124577649|NCT01110005|448074877|FG001|Overall Study|Withdrawal by Subject|1|||
124577650|NCT04646213|448074878|FG000|Overall Study|Physician Decision|3|||
124577651|NCT04646213|448074878|FG000|Overall Study|Withdrawal by Subject|2|||
124577652|NCT00731783|448074885|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
124577653|NCT00731783|448074886|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
124577654|NCT00731783|448074885|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
124577655|NCT00731783|448074886|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
124577656|NCT00731783|448074885|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
124577657|NCT00731783|448074886|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
124577658|NCT00731783|448074885|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
124577659|NCT00731783|448074886|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
124577660|NCT00467896|448076441|FG000|Overall Study|Consent Withdrawal|18|||
124577661|NCT00467896|448076441|FG000|Overall Study|Adverse Event|7|||
124577662|NCT00467896|448076441|FG000|Overall Study|Serious Adverse Event|13|||
124577663|NCT00467896|448076441|FG000|Overall Study|Non-compliance|3|||
124577664|NCT00467896|448076441|FG000|Overall Study|Changed therapy|2|||
124577665|NCT00467896|448076441|FG000|Overall Study|Patient received transplant|2|||
124577666|NCT00467896|448076441|FG000|Overall Study|Patient had atrial septostomy|1|||
124577667|NCT00467896|448076441|FG000|Overall Study|Patient weaned off iloprost|1|||
124577668|NCT00467896|448076441|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
124577669|NCT00467896|448076441|FG000|Overall Study|Started intravenous prostacyclin|1|||
124577670|NCT00467896|448076441|FG000|Overall Study|Started inhaled Remodulin|1|||
124577671|NCT00467896|448076441|FG000|Overall Study|Patient had no improvement|1|||
124577672|NCT03772522|448076442|FG000|Pre-intervention|Withdrawal by Subject|3|||
124577673|NCT03772522|448076443|FG001|Pre-intervention|Withdrawal by Subject|4|||
124577674|NCT03772522|448076442|FG000|Intervention|Withdrawal by Subject|1|||
124577675|NCT03772522|448076443|FG001|Intervention|Withdrawal by Subject|0|||
124577676|NCT03772522|448076442|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
124577677|NCT03772522|448076443|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
124577678|NCT00834795|448076444|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
124577679|NCT00834795|448076445|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
124577680|NCT00834795|448076444|FG000|Second Intervention|Adverse Event|1|||
124577681|NCT00834795|448076445|FG001|Second Intervention|Adverse Event|0|||
124577682|NCT00579345|448076446|FG000|Overall Study|Withdrawal by Subject|2|||
124577683|NCT00579345|448076447|FG001|Overall Study|Withdrawal by Subject|0|||
124577684|NCT00579345|448076448|FG002|Overall Study|Withdrawal by Subject|0|||
124577685|NCT00579345|448076449|FG003|Overall Study|Withdrawal by Subject|0|||
124577686|NCT00579345|448076450|FG004|Overall Study|Withdrawal by Subject|0|||
124577687|NCT00579345|448076451|FG005|Overall Study|Withdrawal by Subject|0|||
124577688|NCT00579345|448076452|FG006|Overall Study|Withdrawal by Subject|0|||
124577689|NCT00579345|448076453|FG007|Overall Study|Withdrawal by Subject|1|||
124577690|NCT00579345|448076446|FG000|Overall Study|Lost to Follow-up|1|||
124776785|NCT00594815|448810003|FG000|Overall Study|Toxicity|4|||
124776786|NCT02691507|448810004|FG000|Overall Study|Missed Visit 3|0|||
124776787|NCT02691507|448810005|FG001|Overall Study|Missed Visit 3|1|||
124776788|NCT01812252|448810006|FG000|Overall Study|Persistent Disease|1|||
124776789|NCT01812252|448810007|FG001|Overall Study|Persistent Disease|0|||
124776790|NCT01812252|448810006|FG000|Overall Study|Not transplanted|11|||
124776791|NCT01812252|448810007|FG001|Overall Study|Not transplanted|11|||
124776792|NCT01812252|448810006|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
124776793|NCT01812252|448810007|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
124776794|NCT01812252|448810006|FG000|Overall Study|Withdrawal by Subject|1|||
124776795|NCT01812252|448810007|FG001|Overall Study|Withdrawal by Subject|1|||
124776796|NCT01812252|448810006|FG000|Overall Study|Screen Failure|1|||
124776797|NCT01812252|448810007|FG001|Overall Study|Screen Failure|0|||
124776798|NCT04634253|448810009|FG000|Overall Study|Adverse Event|1|||
124776799|NCT04634253|448810010|FG001|Overall Study|Adverse Event|1|||
124776800|NCT04634253|448810011|FG002|Overall Study|Adverse Event|0|||
124776801|NCT04634253|448810009|FG000|Overall Study|Physician Decision|0|||
124776802|NCT04634253|448810010|FG001|Overall Study|Physician Decision|1|||
124776803|NCT04634253|448810011|FG002|Overall Study|Physician Decision|0|||
124577691|NCT00579345|448076447|FG001|Overall Study|Lost to Follow-up|0|||
124577692|NCT00579345|448076448|FG002|Overall Study|Lost to Follow-up|0|||
124577693|NCT00579345|448076449|FG003|Overall Study|Lost to Follow-up|0|||
124577694|NCT00579345|448076450|FG004|Overall Study|Lost to Follow-up|0|||
124577695|NCT00579345|448076451|FG005|Overall Study|Lost to Follow-up|0|||
124577696|NCT00579345|448076452|FG006|Overall Study|Lost to Follow-up|0|||
124776804|NCT04634253|448810009|FG000|Overall Study|Withdrawal by Subject|1|||
124776805|NCT04634253|448810010|FG001|Overall Study|Withdrawal by Subject|0|||
124776806|NCT04634253|448810011|FG002|Overall Study|Withdrawal by Subject|3|||
124776807|NCT03155841|448810012|FG000|Overall Study|Protocol Violation|3|||
124577697|NCT00579345|448076453|FG007|Overall Study|Lost to Follow-up|0|||
124577698|NCT00579345|448076446|FG000|Overall Study|Adverse Event|0|||
124577699|NCT00579345|448076447|FG001|Overall Study|Adverse Event|0|||
124577700|NCT00579345|448076448|FG002|Overall Study|Adverse Event|1|||
124577701|NCT00579345|448076449|FG003|Overall Study|Adverse Event|0|||
124577702|NCT00579345|448076450|FG004|Overall Study|Adverse Event|0|||
124577703|NCT00579345|448076451|FG005|Overall Study|Adverse Event|0|||
124577704|NCT00579345|448076452|FG006|Overall Study|Adverse Event|0|||
124577705|NCT00579345|448076453|FG007|Overall Study|Adverse Event|0|||
124577706|NCT00579345|448076446|FG000|Overall Study|Protocol Violation|1|||
124577707|NCT00579345|448076447|FG001|Overall Study|Protocol Violation|0|||
124577708|NCT00579345|448076448|FG002|Overall Study|Protocol Violation|0|||
124577709|NCT00579345|448076449|FG003|Overall Study|Protocol Violation|0|||
124577710|NCT00579345|448076450|FG004|Overall Study|Protocol Violation|0|||
124577711|NCT00579345|448076451|FG005|Overall Study|Protocol Violation|0|||
124577712|NCT00579345|448076452|FG006|Overall Study|Protocol Violation|0|||
124577713|NCT00579345|448076453|FG007|Overall Study|Protocol Violation|1|||
124577714|NCT00579345|448076446|FG000|Overall Study|Death|1|||
124577715|NCT00579345|448076447|FG001|Overall Study|Death|1|||
124577716|NCT00579345|448076448|FG002|Overall Study|Death|1|||
124577717|NCT00579345|448076449|FG003|Overall Study|Death|1|||
124577718|NCT00579345|448076450|FG004|Overall Study|Death|0|||
124577719|NCT00579345|448076451|FG005|Overall Study|Death|0|||
124577720|NCT00579345|448076452|FG006|Overall Study|Death|0|||
124577721|NCT00579345|448076453|FG007|Overall Study|Death|0|||
124577722|NCT02175095|448076454|FG000|Overall Study|Withdrawal by Subject|3|||
124577723|NCT03697109|448076455|FG000|Open-label (OL) Phase|Adverse Event|24|||
124577724|NCT03697109|448076456|FG001|Open-label (OL) Phase|Adverse Event|0|||
124577725|NCT03697109|448076457|FG002|Open-label (OL) Phase|Adverse Event|0|||
124577726|NCT03697109|448076455|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
124577727|NCT03697109|448076456|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
124577728|NCT03697109|448076457|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
124577729|NCT03697109|448076455|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
124577730|NCT03697109|448076456|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
124577731|NCT03697109|448076457|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
124577732|NCT03697109|448076455|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
124577733|NCT03697109|448076456|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
124577734|NCT03697109|448076457|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
124577735|NCT03697109|448076455|FG000|Open-label (OL) Phase|Physician Decision|2|||
124577736|NCT03697109|448076456|FG001|Open-label (OL) Phase|Physician Decision|0|||
124577737|NCT03697109|448076457|FG002|Open-label (OL) Phase|Physician Decision|0|||
124577738|NCT03697109|448076455|FG000|Open-label (OL) Phase|Death|2|||
124577739|NCT03697109|448076456|FG001|Open-label (OL) Phase|Death|0|||
124577740|NCT03697109|448076457|FG002|Open-label (OL) Phase|Death|0|||
124577741|NCT03697109|448076455|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
124577742|NCT03697109|448076456|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
124577743|NCT03697109|448076457|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
124577744|NCT03697109|448076455|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
124523759|NCT00621244|447868984|FG000|Overall Study|Administrative problems|5|||
124523760|NCT00621244|447868985|FG001|Overall Study|Administrative problems|1|||
124523761|NCT00621244|447868986|FG002|Overall Study|Administrative problems|0|||
124523762|NCT00621244|447868987|FG003|Overall Study|Administrative problems|2|||
124523763|NCT04449276|447868993|FG000|Overall Study|Adverse Event|1|||
124523764|NCT04449276|447868994|FG001|Overall Study|Adverse Event|2|||
124523765|NCT04449276|447868995|FG002|Overall Study|Adverse Event|0|||
124523766|NCT04449276|447868996|FG003|Overall Study|Adverse Event|0|||
124523767|NCT04449276|447868997|FG004|Overall Study|Adverse Event|2|||
124523768|NCT04449276|447868998|FG005|Overall Study|Adverse Event|0|||
124523769|NCT04449276|447868999|FG006|Overall Study|Adverse Event|0|||
124523770|NCT04449276|447869000|FG007|Overall Study|Adverse Event|1|||
124523771|NCT04449276|447868993|FG000|Overall Study|Withdrawal by Subject|2|||
124523772|NCT04449276|447868994|FG001|Overall Study|Withdrawal by Subject|0|||
124523773|NCT04449276|447868995|FG002|Overall Study|Withdrawal by Subject|0|||
124523774|NCT04449276|447868996|FG003|Overall Study|Withdrawal by Subject|1|||
124523775|NCT04449276|447868997|FG004|Overall Study|Withdrawal by Subject|0|||
124523776|NCT04449276|447868998|FG005|Overall Study|Withdrawal by Subject|0|||
124523777|NCT04449276|447868999|FG006|Overall Study|Withdrawal by Subject|0|||
124523778|NCT04449276|447869000|FG007|Overall Study|Withdrawal by Subject|0|||
124523779|NCT04449276|447868993|FG000|Overall Study|Other|0|||
124523780|NCT04449276|447868994|FG001|Overall Study|Other|2|||
124523781|NCT04449276|447868995|FG002|Overall Study|Other|3|||
124523782|NCT04449276|447868996|FG003|Overall Study|Other|2|||
124523783|NCT04449276|447868997|FG004|Overall Study|Other|0|||
124523784|NCT04449276|447868998|FG005|Overall Study|Other|0|||
124523785|NCT04449276|447868999|FG006|Overall Study|Other|0|||
124523786|NCT04449276|447869000|FG007|Overall Study|Other|1|||
124523787|NCT01614795|447869001|FG000|Overall Study|Adverse Event|0|||
124523788|NCT01614795|447869002|FG001|Overall Study|Adverse Event|0|||
124577745|NCT03697109|448076456|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
124577746|NCT03697109|448076457|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
124577747|NCT03697109|448076455|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
124577748|NCT03697109|448076456|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
124577749|NCT03697109|448076457|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
124577750|NCT01111461|448076458|FG000|Overall Study|Adverse Event|32|||
124577751|NCT01111461|448076458|FG000|Overall Study|Participant choice|11|||
124577752|NCT01111461|448076458|FG000|Overall Study|Lost to Follow-up|1|||
124577753|NCT01111461|448076458|FG000|Overall Study|Withdrawal by Subject|1|||
124577754|NCT01111461|448076458|FG000|Overall Study|Other|6|||
124577755|NCT00440518|448076459|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
124577756|NCT00440518|448076460|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
124577757|NCT00440518|448076461|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
124577758|NCT00440518|448076459|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
124577759|NCT00440518|448076460|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
124577760|NCT00440518|448076461|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
124577761|NCT00440518|448076459|FG000|Randomized /Titration Period|Protocol Deviation|1|||
124577762|NCT00440518|448076460|FG001|Randomized /Titration Period|Protocol Deviation|0|||
124577763|NCT00440518|448076461|FG002|Randomized /Titration Period|Protocol Deviation|0|||
124577764|NCT00440518|448076459|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
124577765|NCT00440518|448076460|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
124577766|NCT00440518|448076461|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
124577767|NCT00440518|448076459|FG000|Randomized /Titration Period|Other|1|||
124577768|NCT00440518|448076460|FG001|Randomized /Titration Period|Other|0|||
124577769|NCT00440518|448076461|FG002|Randomized /Titration Period|Other|0|||
124577770|NCT00440518|448076459|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
124577771|NCT00440518|448076460|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
124577772|NCT00440518|448076461|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
124577773|NCT00440518|448076459|FG000|Randomized /Titration Period|Adverse Event|2|||
124577774|NCT00440518|448076460|FG001|Randomized /Titration Period|Adverse Event|3|||
124577775|NCT00440518|448076461|FG002|Randomized /Titration Period|Adverse Event|0|||
124577776|NCT00440518|448076459|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
124577777|NCT00440518|448076460|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
124577778|NCT00440518|448076461|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
124577779|NCT00440518|448076459|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
124577780|NCT00440518|448076460|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
124577781|NCT00440518|448076461|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
124577782|NCT00440518|448076459|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
124577783|NCT00440518|448076460|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
124577784|NCT00440518|448076461|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
124577785|NCT00440518|448076459|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
124577786|NCT00440518|448076460|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
124577787|NCT00440518|448076461|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
124577788|NCT00440518|448076459|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
124577789|NCT00440518|448076460|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
124577790|NCT00440518|448076461|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
124577791|NCT00440518|448076459|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
124577792|NCT00440518|448076460|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
124577793|NCT00440518|448076461|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
124577794|NCT00365365|448076463|FG000|Overall Study|Randomized but not treated|0|||
124577795|NCT00365365|448076464|FG001|Overall Study|Randomized but not treated|2|||
124577796|NCT00365365|448076465|FG002|Overall Study|Randomized but not treated|0|||
124577797|NCT00365365|448076463|FG000|Overall Study|Poor compliance to protocol|0|||
124577798|NCT00365365|448076464|FG001|Overall Study|Poor compliance to protocol|1|||
124577799|NCT00365365|448076465|FG002|Overall Study|Poor compliance to protocol|0|||
124577800|NCT00365365|448076463|FG000|Overall Study|Lost to Follow-up|3|||
124577801|NCT00365365|448076464|FG001|Overall Study|Lost to Follow-up|3|||
124577802|NCT00365365|448076465|FG002|Overall Study|Lost to Follow-up|3|||
124577803|NCT00365365|448076463|FG000|Overall Study|Death|1|||
124577804|NCT00365365|448076464|FG001|Overall Study|Death|3|||
124577805|NCT00365365|448076465|FG002|Overall Study|Death|0|||
124577806|NCT00365365|448076463|FG000|Overall Study|Subject's request|11|||
124577807|NCT00365365|448076464|FG001|Overall Study|Subject's request|13|||
124577808|NCT00365365|448076465|FG002|Overall Study|Subject's request|1|||
124577809|NCT00365365|448076463|FG000|Overall Study|Disease progression/relapse|9|||
124577810|NCT00365365|448076464|FG001|Overall Study|Disease progression/relapse|6|||
124725973|NCT01200407|448618578|FG000|Overall Study|Adverse Event|3|||
124725974|NCT01200407|448618578|FG000|Overall Study|Withdrawal by Subject|4|||
124577811|NCT00365365|448076465|FG002|Overall Study|Disease progression/relapse|7|||
124577812|NCT00365365|448076463|FG000|Overall Study|Adverse Event|6|||
124577813|NCT00365365|448076464|FG001|Overall Study|Adverse Event|6|||
124577814|NCT00365365|448076465|FG002|Overall Study|Adverse Event|3|||
124577815|NCT00365365|448076463|FG000|Overall Study|Moved|2|||
124577816|NCT00365365|448076464|FG001|Overall Study|Moved|0|||
124577817|NCT00365365|448076465|FG002|Overall Study|Moved|0|||
124577818|NCT00365365|448076463|FG000|Overall Study|New cancer|1|||
124577819|NCT00365365|448076464|FG001|Overall Study|New cancer|0|||
124725975|NCT01200407|448618578|FG000|Overall Study|Other|19|||
124523789|NCT01614795|447869003|FG002|Overall Study|Adverse Event|1|||
124523790|NCT01614795|447869004|FG003|Overall Study|Adverse Event|1|||
124523791|NCT01614795|447869001|FG000|Overall Study|Lack of Efficacy|10|||
124523792|NCT01614795|447869002|FG001|Overall Study|Lack of Efficacy|10|||
124523793|NCT01614795|447869003|FG002|Overall Study|Lack of Efficacy|9|||
124523794|NCT01614795|447869004|FG003|Overall Study|Lack of Efficacy|8|||
124523795|NCT01614795|447869001|FG000|Overall Study|Physician Decision|1|||
124523796|NCT01614795|447869002|FG001|Overall Study|Physician Decision|0|||
124523797|NCT01614795|447869003|FG002|Overall Study|Physician Decision|1|||
124523798|NCT01614795|447869004|FG003|Overall Study|Physician Decision|1|||
124523799|NCT01614795|447869001|FG000|Overall Study|Withdrawal by Subject|0|||
124523800|NCT01614795|447869002|FG001|Overall Study|Withdrawal by Subject|1|||
124523801|NCT01614795|447869003|FG002|Overall Study|Withdrawal by Subject|0|||
124523802|NCT01614795|447869004|FG003|Overall Study|Withdrawal by Subject|2|||
124523803|NCT01614795|447869001|FG000|Overall Study|Ineligible|0|||
124523804|NCT01614795|447869002|FG001|Overall Study|Ineligible|1|||
124523805|NCT01614795|447869003|FG002|Overall Study|Ineligible|0|||
124523806|NCT01614795|447869004|FG003|Overall Study|Ineligible|0|||
124523807|NCT00565812|447869005|FG000|Overall Study|Death|2|||
124523808|NCT00565812|447869006|FG001|Overall Study|Death|1|||
124523809|NCT00565812|447869007|FG002|Overall Study|Death|3|||
124523810|NCT00565812|447869005|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
124523811|NCT00565812|447869006|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
124523812|NCT00565812|447869007|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
124523813|NCT00565812|447869005|FG000|Overall Study|Lost to Follow-up|10|||
124523814|NCT00565812|447869006|FG001|Overall Study|Lost to Follow-up|8|||
124523815|NCT00565812|447869007|FG002|Overall Study|Lost to Follow-up|8|||
124523816|NCT00565812|447869005|FG000|Overall Study|Withdrawal by Subject|58|||
124523817|NCT00565812|447869006|FG001|Overall Study|Withdrawal by Subject|47|||
124523818|NCT00565812|447869007|FG002|Overall Study|Withdrawal by Subject|48|||
124523819|NCT00565812|447869005|FG000|Overall Study|Work Schedule|5|||
124523820|NCT00565812|447869006|FG001|Overall Study|Work Schedule|3|||
124523821|NCT00565812|447869007|FG002|Overall Study|Work Schedule|1|||
124523822|NCT00565812|447869005|FG000|Overall Study|Protocol Violation|2|||
124523823|NCT00565812|447869006|FG001|Overall Study|Protocol Violation|6|||
124523824|NCT00565812|447869007|FG002|Overall Study|Protocol Violation|4|||
124523825|NCT00565812|447869005|FG000|Overall Study|Adverse Event|41|||
124523826|NCT00565812|447869006|FG001|Overall Study|Adverse Event|54|||
124523827|NCT00565812|447869007|FG002|Overall Study|Adverse Event|40|||
124523828|NCT00565812|447869005|FG000|Overall Study|Jury Duty|1|||
124523829|NCT00565812|447869006|FG001|Overall Study|Jury Duty|0|||
124523830|NCT00565812|447869007|FG002|Overall Study|Jury Duty|0|||
124523831|NCT00565812|447869005|FG000|Overall Study|Relocated Out of Area|5|||
124523832|NCT00565812|447869006|FG001|Overall Study|Relocated Out of Area|8|||
124523833|NCT00565812|447869007|FG002|Overall Study|Relocated Out of Area|9|||
124523834|NCT00565812|447869005|FG000|Overall Study|Sponsor Decision|1|||
124523835|NCT00565812|447869006|FG001|Overall Study|Sponsor Decision|5|||
124523836|NCT00565812|447869007|FG002|Overall Study|Sponsor Decision|1|||
124523837|NCT00565812|447869005|FG000|Overall Study|Domestic Reasons|7|||
124523838|NCT00565812|447869006|FG001|Overall Study|Domestic Reasons|1|||
124523839|NCT00565812|447869007|FG002|Overall Study|Domestic Reasons|3|||
124523840|NCT00565812|447869005|FG000|Overall Study|Research Site Closure|6|||
124523841|NCT00565812|447869006|FG001|Overall Study|Research Site Closure|1|||
124523842|NCT00565812|447869007|FG002|Overall Study|Research Site Closure|8|||
124523843|NCT00565812|447869005|FG000|Overall Study|Surgical Intervention|0|||
124523844|NCT00565812|447869006|FG001|Overall Study|Surgical Intervention|1|||
124523845|NCT00565812|447869007|FG002|Overall Study|Surgical Intervention|2|||
124523846|NCT00565812|447869005|FG000|Overall Study|Low Compliance|1|||
124523847|NCT00565812|447869006|FG001|Overall Study|Low Compliance|0|||
124523848|NCT00565812|447869007|FG002|Overall Study|Low Compliance|1|||
124523849|NCT00565812|447869005|FG000|Overall Study|Follow-up Visit Not Completed|2|||
124523850|NCT00565812|447869006|FG001|Overall Study|Follow-up Visit Not Completed|0|||
124523851|NCT00565812|447869007|FG002|Overall Study|Follow-up Visit Not Completed|1|||
124523852|NCT00565812|447869005|FG000|Overall Study|Physician Decision|2|||
124523853|NCT00565812|447869006|FG001|Overall Study|Physician Decision|0|||
124523854|NCT00565812|447869007|FG002|Overall Study|Physician Decision|0|||
124523855|NCT04968353|447869008|FG000|Overall Study|Non-compliance|1|||
124523856|NCT04968353|447869009|FG001|Overall Study|Non-compliance|0|||
124523857|NCT04968353|447869010|FG002|Overall Study|Non-compliance|2|||
124523858|NCT04968353|447869011|FG003|Overall Study|Non-compliance|0|||
124523859|NCT00845845|447869012|FG000|Overall Study|Lost to Follow-up|0|||
124577820|NCT00365365|448076465|FG002|Overall Study|New cancer|0|||
124577821|NCT00365365|448076463|FG000|Overall Study|Withdrew consent|1|||
124577822|NCT00365365|448076464|FG001|Overall Study|Withdrew consent|1|||
124577823|NCT00365365|448076465|FG002|Overall Study|Withdrew consent|0|||
124577824|NCT00365365|448076463|FG000|Overall Study|Second malignancy|0|||
124577825|NCT00365365|448076464|FG001|Overall Study|Second malignancy|1|||
124577826|NCT00365365|448076465|FG002|Overall Study|Second malignancy|0|||
124577827|NCT00365365|448076463|FG000|Overall Study|Patient/physician decision|0|||
124577828|NCT00365365|448076464|FG001|Overall Study|Patient/physician decision|0|||
124577829|NCT00365365|448076465|FG002|Overall Study|Patient/physician decision|1|||
124577830|NCT00984022|448076466|FG000|Overall Study|Lost to Follow-up|10|||
124577831|NCT00984022|448076467|FG001|Overall Study|Lost to Follow-up|14|||
124577832|NCT00905606|448076471|FG000|Period 1|Adverse Event|0|||
124577833|NCT00905606|448076472|FG001|Period 1|Adverse Event|1|||
124577834|NCT00905606|448076471|FG000|Washout|Withdrawal by Subject|1|||
124577835|NCT00905606|448076472|FG001|Washout|Withdrawal by Subject|0|||
124577836|NCT03868891|448076479|FG000|Overall Study|Adverse Event|1|||
124577837|NCT03868891|448076480|FG001|Overall Study|Adverse Event|0|||
124577838|NCT03868891|448076479|FG000|Overall Study|Lost to Follow-up|2|||
124577839|NCT03868891|448076480|FG001|Overall Study|Lost to Follow-up|1|||
124577840|NCT03868891|448076479|FG000|Overall Study|COVID-19 Restrictions|1|||
124577841|NCT03868891|448076480|FG001|Overall Study|COVID-19 Restrictions|2|||
124577842|NCT00777023|448076481|FG000|Overall Study|Adverse Event|15|||
124577843|NCT00777023|448076482|FG001|Overall Study|Adverse Event|21|||
124577844|NCT00777023|448076483|FG002|Overall Study|Adverse Event|8|||
124577845|NCT00777023|448076481|FG000|Overall Study|Lack of Efficacy|1|||
124577846|NCT00777023|448076482|FG001|Overall Study|Lack of Efficacy|0|||
124577847|NCT00777023|448076483|FG002|Overall Study|Lack of Efficacy|14|||
124577848|NCT00777023|448076481|FG000|Overall Study|Protocol Violation|2|||
124577849|NCT00777023|448076482|FG001|Overall Study|Protocol Violation|1|||
124577850|NCT00777023|448076483|FG002|Overall Study|Protocol Violation|1|||
124577851|NCT00777023|448076481|FG000|Overall Study|Lost to Follow-up|2|||
124577852|NCT00777023|448076482|FG001|Overall Study|Lost to Follow-up|3|||
124577853|NCT00777023|448076483|FG002|Overall Study|Lost to Follow-up|3|||
124577854|NCT00777023|448076481|FG000|Overall Study|Death|0|||
124577855|NCT00777023|448076482|FG001|Overall Study|Death|1|||
124577856|NCT00777023|448076483|FG002|Overall Study|Death|0|||
124577857|NCT00777023|448076481|FG000|Overall Study|Withdrawal by Subject|7|||
124577858|NCT00777023|448076482|FG001|Overall Study|Withdrawal by Subject|7|||
124577859|NCT00777023|448076483|FG002|Overall Study|Withdrawal by Subject|8|||
124577860|NCT00777023|448076481|FG000|Overall Study|Missing data|1|||
124577861|NCT00777023|448076482|FG001|Overall Study|Missing data|1|||
124577862|NCT00777023|448076483|FG002|Overall Study|Missing data|0|||
124577863|NCT00777023|448076481|FG000|Overall Study|Reasons not specified|4|||
124577864|NCT00777023|448076482|FG001|Overall Study|Reasons not specified|4|||
124577865|NCT00777023|448076483|FG002|Overall Study|Reasons not specified|2|||
124577866|NCT00777023|448076481|FG000|Overall Study|Last dose date unknown|3|||
124577867|NCT00777023|448076482|FG001|Overall Study|Last dose date unknown|3|||
124577868|NCT00777023|448076483|FG002|Overall Study|Last dose date unknown|1|||
124577869|NCT03123094|448076484|FG000|Overall Study|Withdrawal by Subject|0|||
124577870|NCT03123094|448076485|FG001|Overall Study|Withdrawal by Subject|2|||
124577871|NCT03123094|448076486|FG002|Overall Study|Withdrawal by Subject|1|||
124577872|NCT03123094|448076487|FG003|Overall Study|Withdrawal by Subject|0|||
124577873|NCT03123094|448076488|FG004|Overall Study|Withdrawal by Subject|1|||
124577874|NCT04247282|448076489|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
124577875|NCT04247282|448076490|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
124577876|NCT04247282|448076491|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
124577877|NCT04247282|448076492|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
124577878|NCT04247282|448076489|FG000|Overall Study|Refused further treatment|0|||
124577879|NCT04247282|448076490|FG001|Overall Study|Refused further treatment|1|||
124577880|NCT04247282|448076491|FG002|Overall Study|Refused further treatment|0|||
124577881|NCT04247282|448076492|FG003|Overall Study|Refused further treatment|0|||
124577882|NCT03496623|448076497|FG000|Run-In Period (2 Weeks)|Death|1|||
124577883|NCT03496623|448076498|FG001|Run-In Period (2 Weeks)|Death|0|||
124577884|NCT03496623|448076499|FG002|Run-In Period (2 Weeks)|Death|0|||
124577885|NCT03496623|448076500|FG003|Run-In Period (2 Weeks)|Death|0|||
124577886|NCT03496623|448076501|FG004|Run-In Period (2 Weeks)|Death|0|||
124577887|NCT03496623|448076497|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
124577888|NCT03496623|448076498|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
124577889|NCT03496623|448076499|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
124577890|NCT03496623|448076500|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
124577891|NCT03496623|448076501|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
124577892|NCT03496623|448076497|FG000|Period 1 (12 Weeks)|Death|0|||
124577893|NCT03496623|448076498|FG001|Period 1 (12 Weeks)|Death|3|||
124577894|NCT03496623|448076499|FG002|Period 1 (12 Weeks)|Death|0|||
124577895|NCT03496623|448076500|FG003|Period 1 (12 Weeks)|Death|0|||
124577896|NCT03496623|448076501|FG004|Period 1 (12 Weeks)|Death|0|||
124523860|NCT00845845|447869013|FG001|Overall Study|Lost to Follow-up|4|||
124523861|NCT02033850|447869018|FG000|Overall Study|Death|1|||
124523862|NCT02033850|447869019|FG001|Overall Study|Death|0|||
124523863|NCT02033850|447869018|FG000|Overall Study|unrelated medical reason|1|||
124523864|NCT02033850|447869019|FG001|Overall Study|unrelated medical reason|1|||
124523865|NCT02571972|447869025|FG000|Overall Study|Protocol Violation|2|||
124523866|NCT02571972|447869025|FG000|Overall Study|Withdrawal by Subject|2|||
124523867|NCT02493868|447869026|FG000|Induction Phase: DE Participants|Adverse Event|22|||
124523868|NCT02493868|447869027|FG001|Induction Phase: DE Participants|Adverse Event|0|||
124523869|NCT02493868|447869026|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
124523870|NCT02493868|447869027|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
124523871|NCT02493868|447869026|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
124523872|NCT02493868|447869027|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
124523873|NCT02493868|447869026|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
124523874|NCT02493868|447869027|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
124523875|NCT02493868|447869026|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
124523876|NCT02493868|447869027|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
124523877|NCT02493868|447869026|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
124523878|NCT02493868|447869027|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
124523879|NCT02493868|447869026|FG000|Induction Phase: DE Participants|Other|8|||
124523880|NCT02493868|447869027|FG001|Induction Phase: DE Participants|Other|0|||
124523881|NCT02493868|447869026|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
124523882|NCT02493868|447869027|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
124523883|NCT02493868|447869026|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
124523884|NCT02493868|447869027|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
124523885|NCT02493868|447869026|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
124523886|NCT02493868|447869027|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
124523887|NCT02493868|447869026|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
124523888|NCT02493868|447869027|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
124523889|NCT02493868|447869026|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
124523890|NCT02493868|447869027|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
124523891|NCT02493868|447869026|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
124523892|NCT02493868|447869027|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
124523893|NCT02493868|447869026|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
124523894|NCT02493868|447869027|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
124523895|NCT02493868|447869026|FG000|Optimization Phase: DE+TE Participants|Other|10|||
124523896|NCT02493868|447869027|FG001|Optimization Phase: DE+TE Participants|Other|2|||
124523897|NCT02493868|447869026|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
124523898|NCT02493868|447869027|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
124523899|NCT02493868|447869026|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
124523900|NCT02493868|447869027|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
124523901|NCT02493868|447869026|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
124523902|NCT02493868|447869027|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
124523903|NCT02493868|447869026|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
124523904|NCT02493868|447869027|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
124523905|NCT02493868|447869026|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
124523906|NCT02493868|447869027|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
124523907|NCT02493868|447869026|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
124523908|NCT02493868|447869027|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
124523909|NCT02493868|447869026|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
124523910|NCT02493868|447869027|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
124523911|NCT02493868|447869026|FG000|Follow-up Phase|Lost to Follow-up|1|||
124523912|NCT02493868|447869027|FG001|Follow-up Phase|Lost to Follow-up|0|||
124523913|NCT02493868|447869026|FG000|Follow-up Phase|Withdrawal by Subject|3|||
124523914|NCT02493868|447869027|FG001|Follow-up Phase|Withdrawal by Subject|0|||
124523915|NCT02493868|447869026|FG000|Follow-up Phase|Investigator Decision|5|||
124523916|NCT02493868|447869027|FG001|Follow-up Phase|Investigator Decision|1|||
124523917|NCT02493868|447869026|FG000|Follow-up Phase|Other|2|||
124523918|NCT02493868|447869027|FG001|Follow-up Phase|Other|1|||
124523919|NCT02407236|447869028|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
124523920|NCT02407236|447869029|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
124523921|NCT02407236|447869030|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
124523922|NCT02407236|447869031|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
124523923|NCT02407236|447869032|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
124523924|NCT02407236|447869033|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
124523925|NCT02407236|447869034|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
124523926|NCT02407236|447869035|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
124523927|NCT02407236|447869036|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
124523928|NCT02407236|447869037|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
124577897|NCT03496623|448076497|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
124523929|NCT02407236|447869038|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
124523930|NCT02407236|447869039|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
124523931|NCT02407236|447869040|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
124523932|NCT02407236|447869028|FG000|Induction Study (8 Weeks)|Death|0|||
124523933|NCT02407236|447869029|FG001|Induction Study (8 Weeks)|Death|0|||
124523934|NCT02407236|447869030|FG002|Induction Study (8 Weeks)|Death|1|||
124523935|NCT02407236|447869031|FG003|Induction Study (8 Weeks)|Death|0|||
124577898|NCT03496623|448076498|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
124577899|NCT03496623|448076499|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
124577900|NCT03496623|448076500|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
124577901|NCT03496623|448076501|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
124523936|NCT02407236|447869032|FG004|Induction Study (8 Weeks)|Death|0|||
124523937|NCT02407236|447869033|FG005|Induction Study (8 Weeks)|Death|0|||
124523938|NCT02407236|447869034|FG006|Induction Study (8 Weeks)|Death|0|||
124523939|NCT02407236|447869035|FG007|Induction Study (8 Weeks)|Death|0|||
124523940|NCT02407236|447869036|FG008|Induction Study (8 Weeks)|Death|0|||
124523941|NCT02407236|447869037|FG009|Induction Study (8 Weeks)|Death|0|||
124523942|NCT02407236|447869038|FG010|Induction Study (8 Weeks)|Death|0|||
124523943|NCT02407236|447869039|FG011|Induction Study (8 Weeks)|Death|0|||
124523944|NCT02407236|447869040|FG012|Induction Study (8 Weeks)|Death|0|||
124523945|NCT02407236|447869028|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
124523946|NCT02407236|447869029|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
124523947|NCT02407236|447869030|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
124523948|NCT02407236|447869031|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
124523949|NCT02407236|447869032|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
124523950|NCT02407236|447869033|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
124523951|NCT02407236|447869034|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
124523952|NCT02407236|447869035|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
124523953|NCT02407236|447869036|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
124523954|NCT02407236|447869037|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
124523955|NCT02407236|447869038|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
124523956|NCT02407236|447869039|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
124523957|NCT02407236|447869040|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
124523958|NCT02407236|447869028|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
124523959|NCT02407236|447869029|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
124523960|NCT02407236|447869030|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
124523961|NCT02407236|447869031|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
124523962|NCT02407236|447869032|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
124523963|NCT02407236|447869033|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
124523964|NCT02407236|447869034|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
124523965|NCT02407236|447869035|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
124523966|NCT02407236|447869036|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
124523967|NCT02407236|447869037|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
124523968|NCT02407236|447869038|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
124523969|NCT02407236|447869039|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
124523970|NCT02407236|447869040|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
124523971|NCT02407236|447869028|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
124523972|NCT02407236|447869029|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
124523973|NCT02407236|447869030|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
124523974|NCT02407236|447869031|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
124523975|NCT02407236|447869032|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
124523976|NCT02407236|447869033|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
124523977|NCT02407236|447869034|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
124523978|NCT02407236|447869035|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
124523979|NCT02407236|447869036|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
124523980|NCT02407236|447869037|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
124577902|NCT03496623|448076497|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
124577903|NCT03496623|448076498|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
124577904|NCT03496623|448076499|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
124577905|NCT03496623|448076500|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
124577906|NCT03496623|448076501|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
124577907|NCT03496623|448076497|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
124577908|NCT03496623|448076498|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
124577909|NCT03496623|448076499|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
124577910|NCT03496623|448076500|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
124523981|NCT02407236|447869038|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
124523982|NCT02407236|447869039|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
124523983|NCT02407236|447869040|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
124523984|NCT02407236|447869028|FG000|Induction Study (8 Weeks)|Other|2|||
124523985|NCT02407236|447869029|FG001|Induction Study (8 Weeks)|Other|1|||
124523986|NCT02407236|447869030|FG002|Induction Study (8 Weeks)|Other|5|||
124523987|NCT02407236|447869031|FG003|Induction Study (8 Weeks)|Other|0|||
124725976|NCT03299881|448618579|FG000|Overall Study|Study Termination|17|||
124725977|NCT03299881|448618580|FG001|Overall Study|Study Termination|13|||
124725978|NCT01549886|448618583|FG000|Overall Study|Sponsor's decision|2|||
124523988|NCT02407236|447869032|FG004|Induction Study (8 Weeks)|Other|0|||
124725979|NCT01549886|448618584|FG001|Overall Study|Sponsor's decision|3|||
124725980|NCT00473668|448618585|FG000|Overall Study|Withdrawal by Subject|0|||
124725981|NCT00473668|448618586|FG001|Overall Study|Withdrawal by Subject|2|||
124725982|NCT00473668|448618587|FG002|Overall Study|Withdrawal by Subject|0|||
124725983|NCT00473668|448618585|FG000|Overall Study|Migrated/moved from study area|3|||
124725984|NCT00473668|448618586|FG001|Overall Study|Migrated/moved from study area|2|||
124725985|NCT00473668|448618587|FG002|Overall Study|Migrated/moved from study area|0|||
124725986|NCT00473668|448618585|FG000|Overall Study|Lost to Follow-up|0|||
124725987|NCT00473668|448618586|FG001|Overall Study|Lost to Follow-up|4|||
124725988|NCT00473668|448618587|FG002|Overall Study|Lost to Follow-up|6|||
124725989|NCT00473668|448618585|FG000|Overall Study|Other|2|||
124725990|NCT00473668|448618586|FG001|Overall Study|Other|3|||
124725991|NCT00473668|448618587|FG002|Overall Study|Other|4|||
124725992|NCT03195660|448618588|FG000|Overall Study|The study was terminated|2|||
124725993|NCT05260073|448618590|FG000|Overall Study|Physician Decision|1|||
124725994|NCT05260073|448618590|FG000|Overall Study|Withdrawal by Subject|6|||
124725995|NCT05260073|448618590|FG000|Overall Study|Lost to Follow-up|14|||
124725996|NCT03458910|448618591|FG000|Overall Study|Withdrawal by Subject|7|||
124725997|NCT03458910|448618592|FG001|Overall Study|Withdrawal by Subject|8|||
124725998|NCT03458910|448618593|FG002|Overall Study|Withdrawal by Subject|6|||
124725999|NCT03458910|448618594|FG003|Overall Study|Withdrawal by Subject|4|||
124726000|NCT03458910|448618591|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
124726001|NCT03458910|448618592|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
124726002|NCT03458910|448618593|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
124726003|NCT03458910|448618594|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
124726004|NCT04484649|448618595|FG000|Overall Study|Lost to Follow-up|2|||
124726005|NCT04484649|448618596|FG001|Overall Study|Lost to Follow-up|1|||
124726006|NCT04484649|448618595|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
124726007|NCT04484649|448618596|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
124726008|NCT01450696|448618599|FG000|Overall Study|Never Treated|1|||
124726009|NCT01450696|448618600|FG001|Overall Study|Never Treated|1|||
124726010|NCT01450696|448618599|FG000|Overall Study|Death|77|||
124726011|NCT01450696|448618600|FG001|Overall Study|Death|84|||
124726012|NCT01450696|448618599|FG000|Overall Study|Lost to Follow-up|3|||
124726013|NCT01450696|448618600|FG001|Overall Study|Lost to Follow-up|3|||
124726014|NCT01450696|448618599|FG000|Overall Study|Non-Compliance|1|||
124726015|NCT01450696|448618600|FG001|Overall Study|Non-Compliance|0|||
124726016|NCT01450696|448618599|FG000|Overall Study|Withdrawal by Subject|13|||
124726017|NCT01450696|448618600|FG001|Overall Study|Withdrawal by Subject|2|||
124776808|NCT03155841|448810013|FG001|Overall Study|Protocol Violation|4|||
124776809|NCT03529422|448810018|FG000|Overall Study|Withdrawal by Subject|1|||
124523989|NCT02407236|447869033|FG005|Induction Study (8 Weeks)|Other|0|||
124523990|NCT02407236|447869034|FG006|Induction Study (8 Weeks)|Other|0|||
124523991|NCT02407236|447869035|FG007|Induction Study (8 Weeks)|Other|0|||
124523992|NCT02407236|447869036|FG008|Induction Study (8 Weeks)|Other|0|||
124523993|NCT02407236|447869037|FG009|Induction Study (8 Weeks)|Other|0|||
124523994|NCT02407236|447869038|FG010|Induction Study (8 Weeks)|Other|0|||
124523995|NCT02407236|447869039|FG011|Induction Study (8 Weeks)|Other|0|||
124523996|NCT02407236|447869040|FG012|Induction Study (8 Weeks)|Other|0|||
124523997|NCT02407236|447869028|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
124523998|NCT02407236|447869029|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
124523999|NCT02407236|447869030|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
124524000|NCT02407236|447869031|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
124524001|NCT02407236|447869032|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
124524002|NCT02407236|447869033|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
124524003|NCT02407236|447869034|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
124524004|NCT02407236|447869035|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
124524005|NCT02407236|447869036|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
124524006|NCT02407236|447869037|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
124524007|NCT02407236|447869038|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
124524008|NCT02407236|447869039|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
124726018|NCT01450696|448618599|FG000|Overall Study|Study Terminated by Sponsor|53|||
124776810|NCT03529422|448810018|FG000|Overall Study|Protocol Violation|1|||
124776811|NCT03529422|448810018|FG000|Overall Study|Disease progression|2|||
124524009|NCT02407236|447869040|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
124726019|NCT01450696|448618600|FG001|Overall Study|Study Terminated by Sponsor|58|||
124726020|NCT00967694|448618601|FG000|Overall Study|Withdrawal by Subject|6|||
124726021|NCT02321319|448618604|FG000|Overall Study|Product discontinued|5|||
124726022|NCT02249091|448618605|FG000|Overall Study|Lack of Efficacy|8|||
124726023|NCT02249091|448618606|FG001|Overall Study|Lack of Efficacy|3|||
124726024|NCT02249091|448618605|FG000|Overall Study|Physician Decision|4|||
124776812|NCT05006573|448810019|FG000|Double-blind Treatment Period|Physician Decision|2|||
124577911|NCT03496623|448076501|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
124577912|NCT03496623|448076497|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
124577913|NCT03496623|448076498|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
124577914|NCT03496623|448076499|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
124524010|NCT02407236|447869028|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
124524011|NCT02407236|447869029|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
124577915|NCT03496623|448076500|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
124577916|NCT03496623|448076501|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
124577917|NCT03496623|448076497|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
124577918|NCT03496623|448076498|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
124577919|NCT03496623|448076499|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
124577920|NCT03496623|448076500|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
124577921|NCT03496623|448076501|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
124577922|NCT03496623|448076497|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124577923|NCT03496623|448076498|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
124577924|NCT03496623|448076499|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
124577925|NCT03496623|448076500|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124577926|NCT03496623|448076501|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124577927|NCT01037114|448076502|FG000|Year 20|Others|1|||
124577928|NCT03181594|448076510|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
124577929|NCT03181594|448076510|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
124577930|NCT03181594|448076510|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
124577931|NCT03181594|448076510|FG000|Initial Study Protocol (12-month FU)|Death|1|||
124577932|NCT03181594|448076510|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
124577933|NCT03181594|448076510|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
124577934|NCT03247972|448076512|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
124577935|NCT03247972|448076512|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
124577936|NCT00968812|448076513|FG000|Overall Study|Adverse Event|30|||
124524012|NCT02407236|447869030|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
124524013|NCT02407236|447869031|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
124524014|NCT02407236|447869032|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
124524015|NCT02407236|447869033|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
124524016|NCT02407236|447869034|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
124524017|NCT02407236|447869035|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
124524018|NCT02407236|447869036|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
124524019|NCT02407236|447869037|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
124524020|NCT02407236|447869038|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
124524021|NCT02407236|447869039|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
124524022|NCT02407236|447869040|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
124524023|NCT02407236|447869028|FG000|Maintenance Study (44 Weeks)|Other|0|||
124524024|NCT02407236|447869029|FG001|Maintenance Study (44 Weeks)|Other|0|||
124524025|NCT02407236|447869030|FG002|Maintenance Study (44 Weeks)|Other|0|||
124524026|NCT02407236|447869031|FG003|Maintenance Study (44 Weeks)|Other|5|||
124524027|NCT02407236|447869032|FG004|Maintenance Study (44 Weeks)|Other|7|||
124524028|NCT02407236|447869033|FG005|Maintenance Study (44 Weeks)|Other|8|||
124524029|NCT02407236|447869034|FG006|Maintenance Study (44 Weeks)|Other|4|||
124524030|NCT02407236|447869035|FG007|Maintenance Study (44 Weeks)|Other|6|||
124524031|NCT02407236|447869036|FG008|Maintenance Study (44 Weeks)|Other|0|||
124524032|NCT02407236|447869037|FG009|Maintenance Study (44 Weeks)|Other|0|||
124524033|NCT02407236|447869038|FG010|Maintenance Study (44 Weeks)|Other|0|||
124524034|NCT02407236|447869039|FG011|Maintenance Study (44 Weeks)|Other|0|||
124524035|NCT02407236|447869040|FG012|Maintenance Study (44 Weeks)|Other|0|||
124524036|NCT02407236|447869028|FG000|Maintenance Study (44 Weeks)|Death|0|||
124524037|NCT02407236|447869029|FG001|Maintenance Study (44 Weeks)|Death|0|||
124524038|NCT02407236|447869030|FG002|Maintenance Study (44 Weeks)|Death|0|||
124524039|NCT02407236|447869031|FG003|Maintenance Study (44 Weeks)|Death|0|||
124524040|NCT02407236|447869032|FG004|Maintenance Study (44 Weeks)|Death|0|||
124524041|NCT02407236|447869033|FG005|Maintenance Study (44 Weeks)|Death|0|||
124524042|NCT02407236|447869034|FG006|Maintenance Study (44 Weeks)|Death|0|||
124524043|NCT02407236|447869035|FG007|Maintenance Study (44 Weeks)|Death|1|||
124524044|NCT02407236|447869036|FG008|Maintenance Study (44 Weeks)|Death|0|||
124524045|NCT02407236|447869037|FG009|Maintenance Study (44 Weeks)|Death|0|||
124524046|NCT02407236|447869038|FG010|Maintenance Study (44 Weeks)|Death|0|||
124577937|NCT00968812|448076514|FG001|Overall Study|Adverse Event|46|||
124577938|NCT00968812|448076515|FG002|Overall Study|Adverse Event|33|||
124577939|NCT00968812|448076513|FG000|Overall Study|Death|2|||
124577940|NCT00968812|448076514|FG001|Overall Study|Death|2|||
124524047|NCT02407236|447869039|FG011|Maintenance Study (44 Weeks)|Death|0|||
124524048|NCT02407236|447869040|FG012|Maintenance Study (44 Weeks)|Death|0|||
124524049|NCT02407236|447869028|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
124524050|NCT02407236|447869029|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
124524051|NCT02407236|447869030|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
124524052|NCT02407236|447869031|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
124524053|NCT02407236|447869032|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
124524054|NCT02407236|447869033|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
124524055|NCT02407236|447869034|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
124524056|NCT02407236|447869035|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
124524057|NCT02407236|447869036|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
124524058|NCT02407236|447869037|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
124524059|NCT02407236|447869038|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
124524060|NCT02407236|447869039|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
124524061|NCT02407236|447869040|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
124524062|NCT02407236|447869028|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
124524063|NCT02407236|447869029|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
124524064|NCT02407236|447869030|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
124524065|NCT02407236|447869031|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
124524066|NCT02407236|447869032|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
124524067|NCT02407236|447869033|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
124524068|NCT02407236|447869034|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
124524069|NCT02407236|447869035|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
124524070|NCT02407236|447869036|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
124524071|NCT02407236|447869037|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
124524072|NCT02407236|447869038|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
124524073|NCT02407236|447869039|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
124524074|NCT02407236|447869040|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
124524075|NCT02407236|447869028|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
124524076|NCT02407236|447869029|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
124524077|NCT02407236|447869030|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
124524078|NCT02407236|447869031|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
124524079|NCT02407236|447869032|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
124524080|NCT02407236|447869033|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
124524081|NCT02407236|447869034|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
124524082|NCT02407236|447869035|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
124524083|NCT02407236|447869036|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
124524084|NCT02407236|447869037|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
124524085|NCT02407236|447869038|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
124524086|NCT02407236|447869039|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
124524087|NCT02407236|447869040|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
124524088|NCT02407236|447869028|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
124524089|NCT02407236|447869029|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
124524090|NCT02407236|447869030|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
124524091|NCT02407236|447869031|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
124524092|NCT02407236|447869032|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
124524093|NCT02407236|447869033|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
124524094|NCT02407236|447869034|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
124524095|NCT02407236|447869035|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
124524096|NCT02407236|447869036|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
124524097|NCT02407236|447869037|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
124524098|NCT02407236|447869038|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
124524099|NCT02407236|447869039|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
124524100|NCT02407236|447869040|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
124524101|NCT00089999|447869041|FG000|Overall Study|Adverse Event|4|||
124524102|NCT00089999|447869042|FG001|Overall Study|Adverse Event|7|||
124524103|NCT00089999|447869041|FG000|Overall Study|Withdrawal by Subject|0|||
124524104|NCT00089999|447869042|FG001|Overall Study|Withdrawal by Subject|4|||
124524105|NCT00089999|447869041|FG000|Overall Study|Lost to Follow-up|2|||
124524106|NCT00089999|447869042|FG001|Overall Study|Lost to Follow-up|1|||
124524107|NCT00089999|447869041|FG000|Overall Study|Radiological Progression of Cancer|52|||
124524108|NCT00089999|447869042|FG001|Overall Study|Radiological Progression of Cancer|44|||
124524109|NCT00089999|447869041|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
124524110|NCT00089999|447869042|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
124524111|NCT00089999|447869041|FG000|Overall Study|Death|3|||
124524112|NCT00089999|447869042|FG001|Overall Study|Death|3|||
124524113|NCT00089999|447869041|FG000|Overall Study|Poor General Condition|1|||
124524114|NCT00089999|447869042|FG001|Overall Study|Poor General Condition|0|||
124524115|NCT00089999|447869041|FG000|Overall Study|Clinical Progression|1|||
124524116|NCT00089999|447869042|FG001|Overall Study|Clinical Progression|2|||
124524117|NCT00089999|447869041|FG000|Overall Study|Physician Decision|2|||
124524118|NCT00089999|447869042|FG001|Overall Study|Physician Decision|2|||
124524119|NCT00089999|447869041|FG000|Overall Study|Patient Underwent Surgery|2|||
124524120|NCT00089999|447869042|FG001|Overall Study|Patient Underwent Surgery|0|||
124577941|NCT00968812|448076515|FG002|Overall Study|Death|1|||
124577942|NCT00968812|448076513|FG000|Overall Study|Lack of Efficacy|9|||
124524121|NCT00089999|447869041|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
124524122|NCT00089999|447869042|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
124524123|NCT02828644|447870811|FG000|Overall Study|Lost to Follow-up|23|||
124524124|NCT02828644|447870812|FG001|Overall Study|Lost to Follow-up|22|||
124524125|NCT02436915|447870813|FG000|Overall Study|Withdrawal by Subject|0|||
124524126|NCT02436915|447870814|FG001|Overall Study|Withdrawal by Subject|1|||
124524127|NCT02158728|447870815|FG000|Overall Study|no procedure according to CIP done|3|||
124524128|NCT02158728|447870815|FG000|Overall Study|no qualified dataset|24|||
124524129|NCT00863317|447870816|FG000|Overall Study|Lost to Follow-up|8|||
124524130|NCT00863317|447870817|FG001|Overall Study|Lost to Follow-up|9|||
124524131|NCT03878160|447870818|FG000|Overall Study|Lost to Follow-up|1|||
124524132|NCT03878160|447870819|FG001|Overall Study|Lost to Follow-up|1|||
124524133|NCT03878160|447870820|FG002|Overall Study|Lost to Follow-up|1|||
124524134|NCT03878160|447870818|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
124524135|NCT03878160|447870819|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
124524136|NCT03878160|447870820|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
124524137|NCT00809614|447870827|FG000|Overall Study|Lack of Efficacy|2|||
124524138|NCT00809614|447870828|FG001|Overall Study|Lack of Efficacy|3|||
124524139|NCT00809614|447870827|FG000|Overall Study|Withdrawal by Subject|1|||
124524140|NCT00809614|447870828|FG001|Overall Study|Withdrawal by Subject|1|||
124524141|NCT01080625|447870829|FG000|Overall Study|Physician Decision|0|||
124524142|NCT01080625|447870830|FG001|Overall Study|Physician Decision|2|||
124524143|NCT01080625|447870831|FG002|Overall Study|Physician Decision|1|||
124524144|NCT00364832|447870835|FG000|Core Period|Early Withdrawals|2|||
124524145|NCT00364832|447870836|FG001|Core Period|Early Withdrawals|2|||
124524146|NCT00364832|447870837|FG002|Core Period|Early Withdrawals|1|||
124524147|NCT00364832|447870838|FG003|Core Period|Early Withdrawals|1|||
124524148|NCT00364832|447870839|FG004|Core Period|Early Withdrawals|0|||
124524149|NCT00364832|447870840|FG005|Core Period|Early Withdrawals|0|||
124524150|NCT00364832|447870841|FG006|Core Period|Early Withdrawals|4|||
124524151|NCT00364832|447870842|FG007|Core Period|Early Withdrawals|1|||
124524152|NCT00364832|447870843|FG008|Core Period|Early Withdrawals|0|||
124524153|NCT00364832|447870844|FG009|Core Period|Early Withdrawals|0|||
124524154|NCT00364832|447870845|FG010|Core Period|Early Withdrawals|0|||
124524155|NCT00364832|447870846|FG011|Core Period|Early Withdrawals|0|||
124524156|NCT00364832|447870835|FG000|Extension Year 1|Early Withdrawals|0|||
124524157|NCT00364832|447870836|FG001|Extension Year 1|Early Withdrawals|0|||
124524158|NCT00364832|447870837|FG002|Extension Year 1|Early Withdrawals|0|||
124524159|NCT00364832|447870838|FG003|Extension Year 1|Early Withdrawals|0|||
124524160|NCT00364832|447870839|FG004|Extension Year 1|Early Withdrawals|0|||
124524161|NCT00364832|447870840|FG005|Extension Year 1|Early Withdrawals|0|||
124524162|NCT00364832|447870841|FG006|Extension Year 1|Early Withdrawals|0|||
124524163|NCT00364832|447870842|FG007|Extension Year 1|Early Withdrawals|0|||
124524164|NCT00364832|447870843|FG008|Extension Year 1|Early Withdrawals|0|||
124524165|NCT00364832|447870844|FG009|Extension Year 1|Early Withdrawals|4|||
124524166|NCT00364832|447870845|FG010|Extension Year 1|Early Withdrawals|2|||
124524167|NCT00364832|447870846|FG011|Extension Year 1|Early Withdrawals|10|||
124524168|NCT00364832|447870835|FG000|Extension Year 2|Early Withdrawals|0|||
124524169|NCT00364832|447870836|FG001|Extension Year 2|Early Withdrawals|0|||
124524170|NCT00364832|447870837|FG002|Extension Year 2|Early Withdrawals|0|||
124524171|NCT00364832|447870838|FG003|Extension Year 2|Early Withdrawals|0|||
124524172|NCT00364832|447870839|FG004|Extension Year 2|Early Withdrawals|0|||
124524173|NCT00364832|447870840|FG005|Extension Year 2|Early Withdrawals|0|||
124524174|NCT00364832|447870841|FG006|Extension Year 2|Early Withdrawals|0|||
124524175|NCT00364832|447870842|FG007|Extension Year 2|Early Withdrawals|0|||
124524176|NCT00364832|447870843|FG008|Extension Year 2|Early Withdrawals|0|||
124524177|NCT00364832|447870844|FG009|Extension Year 2|Early Withdrawals|5|||
124524178|NCT00364832|447870845|FG010|Extension Year 2|Early Withdrawals|5|||
124524179|NCT00364832|447870846|FG011|Extension Year 2|Early Withdrawals|3|||
124524180|NCT01440972|447870852|FG000|Overall Study|Withdrawal by Subject|3|||
124524181|NCT01440972|447870853|FG001|Overall Study|Withdrawal by Subject|2|||
124524182|NCT00068822|447870854|FG000|First Randomized Intervention|Lost to Follow-up|1|||
124524183|NCT00068822|447870855|FG001|First Randomized Intervention|Lost to Follow-up|2|||
124524184|NCT00735072|447870859|FG000|Overall Study|interrupted study med during ARV change|1|||
124524185|NCT00735072|447870860|FG001|Overall Study|interrupted study med during ARV change|0|||
124524186|NCT00735072|447870859|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
124524187|NCT00735072|447870860|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
124524188|NCT00911144|447870861|FG000|Overall Study|Withdrawal by Subject|16|||
124524189|NCT00911144|447870862|FG001|Overall Study|Withdrawal by Subject|5|||
124524190|NCT03981744|447870863|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
124524191|NCT03981744|447870864|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
124524192|NCT03981744|447870865|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
124524193|NCT03981744|447870866|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
124524194|NCT03981744|447870863|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
124726025|NCT02249091|448618606|FG001|Overall Study|Physician Decision|1|||
124726026|NCT02249091|448618605|FG000|Overall Study|Withdrawal by Subject|2|||
124726027|NCT02249091|448618606|FG001|Overall Study|Withdrawal by Subject|2|||
124726028|NCT02249091|448618605|FG000|Overall Study|Death|3|||
124524195|NCT03981744|447870864|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
124524196|NCT03981744|447870865|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
124524197|NCT03981744|447870866|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
124524198|NCT03981744|447870863|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
124524199|NCT03981744|447870864|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
124524200|NCT03981744|447870865|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
124524201|NCT03981744|447870866|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
124524202|NCT00732238|447870867|FG000|Overall Study|Bacteremia|4|||
124524203|NCT00732238|447870868|FG001|Overall Study|Bacteremia|1|||
124524204|NCT00732238|447870867|FG000|Overall Study|Asymptomatic bacteriuria|1|||
124524205|NCT00732238|447870868|FG001|Overall Study|Asymptomatic bacteriuria|0|||
124524206|NCT00246376|447870871|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
124524207|NCT00246376|447870872|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
124524208|NCT00246376|447870873|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
124524209|NCT00246376|447870874|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
124524210|NCT00246376|447870875|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
124524211|NCT00246376|447870871|FG000|Overall Study|Adverse Event|2|||
124524212|NCT00246376|447870872|FG001|Overall Study|Adverse Event|3|||
124524213|NCT00246376|447870873|FG002|Overall Study|Adverse Event|1|||
124524214|NCT00246376|447870874|FG003|Overall Study|Adverse Event|3|||
124524215|NCT00246376|447870875|FG004|Overall Study|Adverse Event|1|||
124524216|NCT00246376|447870871|FG000|Overall Study|Lost to Follow-up|2|||
124524217|NCT00246376|447870872|FG001|Overall Study|Lost to Follow-up|11|||
124524218|NCT00246376|447870873|FG002|Overall Study|Lost to Follow-up|11|||
124524219|NCT00246376|447870874|FG003|Overall Study|Lost to Follow-up|16|||
124524220|NCT00246376|447870875|FG004|Overall Study|Lost to Follow-up|13|||
124524221|NCT00610207|447870879|FG000|Overall Study|Lost to Follow-up|3|||
124524222|NCT02465489|447870882|FG000|Overall Study|Adverse Event|5|||
124524223|NCT00693693|447870883|FG000|Overall Study|Lost to Follow-up|1|||
124524224|NCT00693693|447870884|FG001|Overall Study|Lost to Follow-up|1|||
124524225|NCT00693693|447870885|FG002|Overall Study|Lost to Follow-up|2|||
124524226|NCT02972593|447870886|FG000|Overall Study|Lost to Follow-up|19|||
124524227|NCT02972593|447870887|FG001|Overall Study|Lost to Follow-up|15|||
124524228|NCT02972593|447870886|FG000|Overall Study|Protocol Violation|1|||
124524229|NCT02972593|447870887|FG001|Overall Study|Protocol Violation|0|||
124524230|NCT04599972|447870888|FG000|Overall Study|Withdrawal by Subject|6|||
124524231|NCT04599972|447870889|FG001|Overall Study|Withdrawal by Subject|1|||
124524232|NCT04599972|447870888|FG000|Overall Study|Adverse Event|1|||
124524233|NCT04599972|447870889|FG001|Overall Study|Adverse Event|1|||
124524234|NCT04599972|447870888|FG000|Overall Study|Lost to Follow-up|1|||
124524235|NCT04599972|447870889|FG001|Overall Study|Lost to Follow-up|6|||
124524236|NCT04599972|447870888|FG000|Overall Study|Protocol Violation|1|||
124524237|NCT04599972|447870889|FG001|Overall Study|Protocol Violation|0|||
124524238|NCT04599972|447870888|FG000|Overall Study|Other reason|1|||
124524239|NCT04599972|447870889|FG001|Overall Study|Other reason|0|||
124524240|NCT00638690|447870896|FG000|Overall Study|Death|655|||
124524241|NCT00638690|447870897|FG001|Overall Study|Death|335|||
124524242|NCT00638690|447870896|FG000|Overall Study|Withdrawal by Subject|22|||
124524243|NCT00638690|447870897|FG001|Overall Study|Withdrawal by Subject|5|||
124524244|NCT00638690|447870896|FG000|Overall Study|Lost to Follow-up|4|||
124524245|NCT00638690|447870897|FG001|Overall Study|Lost to Follow-up|2|||
124524246|NCT01347073|447870905|FG000|Overall Study|Adverse Event|1|||
124524247|NCT01347073|447870905|FG000|Overall Study|Liver Transplant|1|||
124524248|NCT01690988|447870910|FG000|Overall Study|Withdrawal by Subject|2|||
124524249|NCT01690988|447870911|FG001|Overall Study|Withdrawal by Subject|2|||
124524250|NCT01690988|447870912|FG002|Overall Study|Withdrawal by Subject|3|||
124524251|NCT01690988|447870910|FG000|Overall Study|Physician Decision|0|||
124524252|NCT01690988|447870911|FG001|Overall Study|Physician Decision|0|||
124524253|NCT01690988|447870912|FG002|Overall Study|Physician Decision|1|||
124524254|NCT01690988|447870910|FG000|Overall Study|Operation Cancelled|1|||
124524255|NCT01690988|447870911|FG001|Overall Study|Operation Cancelled|1|||
124524256|NCT01690988|447870912|FG002|Overall Study|Operation Cancelled|0|||
124524257|NCT01690988|447870910|FG000|Overall Study|Determined ineligible|1|||
124524258|NCT01690988|447870911|FG001|Overall Study|Determined ineligible|0|||
124524259|NCT01690988|447870912|FG002|Overall Study|Determined ineligible|0|||
124524260|NCT01690988|447870910|FG000|Overall Study|Death|1|||
124524261|NCT01690988|447870911|FG001|Overall Study|Death|1|||
124524262|NCT01690988|447870912|FG002|Overall Study|Death|1|||
124524263|NCT01690988|447870910|FG000|Overall Study|Sedated|1|||
124524264|NCT01690988|447870911|FG001|Overall Study|Sedated|1|||
124524265|NCT01690988|447870912|FG002|Overall Study|Sedated|2|||
124524266|NCT00372489|447870917|FG000|Overall Study|Adverse Event|18|||
124524267|NCT00372489|447870917|FG000|Overall Study|Lack of Efficacy|1|||
124726029|NCT02249091|448618606|FG001|Overall Study|Death|4|||
124577943|NCT00968812|448076514|FG001|Overall Study|Lack of Efficacy|7|||
124577944|NCT00968812|448076515|FG002|Overall Study|Lack of Efficacy|16|||
124577945|NCT00968812|448076513|FG000|Overall Study|Lost to Follow-up|17|||
124577946|NCT00968812|448076514|FG001|Overall Study|Lost to Follow-up|12|||
124577947|NCT00968812|448076515|FG002|Overall Study|Lost to Follow-up|11|||
124577948|NCT00968812|448076513|FG000|Overall Study|Physician Decision|8|||
124577949|NCT00968812|448076514|FG001|Overall Study|Physician Decision|5|||
124577950|NCT00968812|448076515|FG002|Overall Study|Physician Decision|9|||
124726030|NCT02249091|448618605|FG000|Overall Study|Adverse Event|1|||
124726031|NCT02249091|448618606|FG001|Overall Study|Adverse Event|0|||
124726032|NCT02249091|448618605|FG000|Overall Study|Stable disease with following SCT|0|||
124726033|NCT02249091|448618606|FG001|Overall Study|Stable disease with following SCT|1|||
124726034|NCT02249091|448618605|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
124726035|NCT02249091|448618606|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
124726036|NCT02249091|448618605|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
124726037|NCT02249091|448618606|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
124524268|NCT00372489|447870917|FG000|Overall Study|Lost to Follow-up|3|||
124524269|NCT00372489|447870917|FG000|Overall Study|Physician Decision|3|||
124524270|NCT00372489|447870917|FG000|Overall Study|Withdrawal by Subject|5|||
124524271|NCT00372489|447870917|FG000|Overall Study|Patient Relocation|2|||
124524272|NCT00372489|447870917|FG000|Overall Study|Renal transplant|6|||
124524273|NCT00372489|447870917|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
124524274|NCT00552344|447870922|FG000|Overall Study|Lack of Efficacy|55|||
124524275|NCT00552344|447870922|FG000|Overall Study|Loss of efficacy|75|||
124524276|NCT00552344|447870922|FG000|Overall Study|Lost to Follow-up|8|||
124524277|NCT00552344|447870922|FG000|Overall Study|Withdrawal by Subject|48|||
124524278|NCT00552344|447870922|FG000|Overall Study|SAE, non-fatal|6|||
124524279|NCT00552344|447870922|FG000|Overall Study|AE, non-serious non-fatal|38|||
124524280|NCT00552344|447870922|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
124524281|NCT00552344|447870922|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
124524282|NCT00552344|447870922|FG000|Overall Study|Other Reason|22|||
124524283|NCT00023712|447870923|FG000|Overall Study|Not platinum sensitive|1|||
124524284|NCT00023712|447870924|FG001|Overall Study|Not platinum sensitive|0|||
124524285|NCT00023712|447870923|FG000|Overall Study|Never treated|1|||
124524286|NCT00023712|447870924|FG001|Overall Study|Never treated|1|||
124524287|NCT01448707|447870928|FG000|Overall Study|Adverse Event|3|||
124524288|NCT01448707|447870929|FG001|Overall Study|Adverse Event|1|||
124524289|NCT01448707|447870928|FG000|Overall Study|Lost to Follow-up|2|||
124524290|NCT01448707|447870929|FG001|Overall Study|Lost to Follow-up|6|||
124524291|NCT01448707|447870928|FG000|Overall Study|Withdrawal by Subject|6|||
124524292|NCT01448707|447870929|FG001|Overall Study|Withdrawal by Subject|7|||
124524293|NCT01448707|447870928|FG000|Overall Study|Other|7|||
124524294|NCT01448707|447870929|FG001|Overall Study|Other|4|||
124524295|NCT03215667|447870931|FG000|Overall Study|Physician Decision|4|||
124524296|NCT01810380|447870933|FG000|Overall Study|Randomised not treated|2|||
124524297|NCT01810380|447870934|FG001|Overall Study|Randomised not treated|1|||
124524298|NCT01810380|447870935|FG002|Overall Study|Randomised not treated|1|||
124524299|NCT01810380|447870933|FG000|Overall Study|Adverse Event|11|||
124524300|NCT01810380|447870934|FG001|Overall Study|Adverse Event|14|||
124524301|NCT01810380|447870935|FG002|Overall Study|Adverse Event|4|||
124524302|NCT01810380|447870933|FG000|Overall Study|Lack of Efficacy|24|||
124524303|NCT01810380|447870934|FG001|Overall Study|Lack of Efficacy|10|||
124524304|NCT01810380|447870935|FG002|Overall Study|Lack of Efficacy|11|||
124524305|NCT01810380|447870933|FG000|Overall Study|Protocol Violation|1|||
124524306|NCT01810380|447870934|FG001|Overall Study|Protocol Violation|0|||
124524307|NCT01810380|447870935|FG002|Overall Study|Protocol Violation|1|||
124524308|NCT01810380|447870933|FG000|Overall Study|Withdrawal by Subject|6|||
124577951|NCT00968812|448076513|FG000|Overall Study|Protocol Violation|7|||
124524309|NCT01810380|447870934|FG001|Overall Study|Withdrawal by Subject|0|||
124524310|NCT01810380|447870935|FG002|Overall Study|Withdrawal by Subject|6|||
124524311|NCT01810380|447870933|FG000|Overall Study|Administrative or other reasons|11|||
124524312|NCT01810380|447870934|FG001|Overall Study|Administrative or other reasons|13|||
124524313|NCT01810380|447870935|FG002|Overall Study|Administrative or other reasons|9|||
124577952|NCT00968812|448076514|FG001|Overall Study|Protocol Violation|4|||
124577953|NCT00968812|448076515|FG002|Overall Study|Protocol Violation|3|||
124577954|NCT00968812|448076513|FG000|Overall Study|Withdrawal by Subject|17|||
124577955|NCT00968812|448076514|FG001|Overall Study|Withdrawal by Subject|23|||
124524314|NCT00614991|447870936|FG000|Overall Study|Adverse Event|3|||
124524315|NCT00614991|447870937|FG001|Overall Study|Adverse Event|3|||
124524316|NCT00614991|447870938|FG002|Overall Study|Adverse Event|0|||
124524317|NCT00614991|447870939|FG003|Overall Study|Adverse Event|0|||
124524318|NCT00614991|447870940|FG004|Overall Study|Adverse Event|1|||
124524319|NCT00614991|447870941|FG005|Overall Study|Adverse Event|0|||
124524320|NCT02623699|447870942|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
124577956|NCT00968812|448076515|FG002|Overall Study|Withdrawal by Subject|25|||
124726038|NCT02249091|448618605|FG000|Overall Study|Refractory AML|1|||
124726039|NCT02249091|448618606|FG001|Overall Study|Refractory AML|1|||
124577957|NCT00968812|448076513|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
124524321|NCT02623699|447870943|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
124524322|NCT02623699|447870944|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
124524323|NCT02623699|447870945|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
124524324|NCT02623699|447870946|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
124524325|NCT02623699|447870947|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
124524326|NCT02623699|447870948|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
124524327|NCT02623699|447870949|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
124524328|NCT02623699|447870950|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
124524329|NCT02623699|447870951|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
124524330|NCT02623699|447870952|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
124524331|NCT02623699|447870953|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
124524332|NCT02623699|447870942|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
124524333|NCT02623699|447870943|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
124524334|NCT02623699|447870944|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
124524335|NCT02623699|447870945|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
124524336|NCT02623699|447870946|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
124524337|NCT02623699|447870947|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
124524338|NCT02623699|447870948|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
124524339|NCT02623699|447870949|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
124524340|NCT02623699|447870950|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
124524341|NCT02623699|447870951|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
124524342|NCT02623699|447870952|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
124524343|NCT02623699|447870953|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
124524344|NCT02623699|447870942|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
124524345|NCT02623699|447870943|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
124524346|NCT02623699|447870944|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
124524347|NCT02623699|447870945|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
124524348|NCT02623699|447870946|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
124524349|NCT02623699|447870947|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
124524350|NCT02623699|447870948|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
124524351|NCT02623699|447870949|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
124524352|NCT02623699|447870950|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
124524353|NCT02623699|447870951|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
124524354|NCT02623699|447870952|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
124524355|NCT02623699|447870953|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
124524356|NCT02623699|447870942|FG000|Part B (Up to 289 Days)|Death|0|||
124524357|NCT02623699|447870943|FG001|Part B (Up to 289 Days)|Death|0|||
124524358|NCT02623699|447870944|FG002|Part B (Up to 289 Days)|Death|0|||
124524359|NCT02623699|447870945|FG003|Part B (Up to 289 Days)|Death|0|||
124524360|NCT02623699|447870946|FG004|Part B (Up to 289 Days)|Death|0|||
124524361|NCT02623699|447870947|FG005|Part B (Up to 289 Days)|Death|1|||
124524362|NCT02623699|447870948|FG006|Part B (Up to 289 Days)|Death|1|||
124524363|NCT02623699|447870949|FG007|Part B (Up to 289 Days)|Death|0|||
124524364|NCT02623699|447870950|FG008|Part B (Up to 289 Days)|Death|1|||
124524365|NCT02623699|447870951|FG009|Part B (Up to 289 Days)|Death|0|||
124524366|NCT02623699|447870952|FG010|Part B (Up to 289 Days)|Death|0|||
124524367|NCT02623699|447870953|FG011|Part B (Up to 289 Days)|Death|0|||
124524368|NCT02623699|447870942|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
124524369|NCT02623699|447870943|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
124524370|NCT02623699|447870944|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
124524371|NCT02623699|447870945|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
124524372|NCT02623699|447870946|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
124524373|NCT02623699|447870947|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
124524374|NCT02623699|447870948|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
124524375|NCT02623699|447870949|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
124524376|NCT02623699|447870950|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
124524377|NCT02623699|447870951|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
124524378|NCT02623699|447870952|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
124524379|NCT02623699|447870953|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
124577958|NCT00968812|448076514|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
124577959|NCT00968812|448076515|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
124726040|NCT00433966|448618607|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
124726041|NCT00433966|448618608|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
124726042|NCT00433966|448618609|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
124524380|NCT02623699|447870942|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
124524381|NCT02623699|447870943|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
124524382|NCT02623699|447870944|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
124524383|NCT02623699|447870945|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
124524384|NCT02623699|447870946|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
124524385|NCT02623699|447870947|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
124524386|NCT02623699|447870948|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
124524387|NCT02623699|447870949|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
124524388|NCT02623699|447870950|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
124524389|NCT02623699|447870951|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
124524390|NCT02623699|447870952|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
124524391|NCT02623699|447870953|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
124524392|NCT02623699|447870942|FG000|Part C (Up to 236 Days)|Death|0|||
124524393|NCT02623699|447870943|FG001|Part C (Up to 236 Days)|Death|0|||
124524394|NCT02623699|447870944|FG002|Part C (Up to 236 Days)|Death|0|||
124524395|NCT02623699|447870945|FG003|Part C (Up to 236 Days)|Death|0|||
124524396|NCT02623699|447870946|FG004|Part C (Up to 236 Days)|Death|0|||
124524397|NCT02623699|447870947|FG005|Part C (Up to 236 Days)|Death|0|||
124524398|NCT02623699|447870948|FG006|Part C (Up to 236 Days)|Death|0|||
124524399|NCT02623699|447870949|FG007|Part C (Up to 236 Days)|Death|0|||
124524400|NCT02623699|447870950|FG008|Part C (Up to 236 Days)|Death|0|||
124524401|NCT02623699|447870951|FG009|Part C (Up to 236 Days)|Death|0|||
124524402|NCT02623699|447870952|FG010|Part C (Up to 236 Days)|Death|0|||
124524403|NCT02623699|447870953|FG011|Part C (Up to 236 Days)|Death|1|||
124524404|NCT02623699|447870942|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
124524405|NCT02623699|447870943|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
124524406|NCT02623699|447870944|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
124524407|NCT02623699|447870945|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
124524408|NCT02623699|447870946|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
124524409|NCT02623699|447870947|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
124524410|NCT02623699|447870948|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
124524411|NCT02623699|447870949|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
124524412|NCT02623699|447870950|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
124524413|NCT02623699|447870951|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
124524414|NCT02623699|447870952|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
124524415|NCT02623699|447870953|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
124524416|NCT00899678|447870954|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
124524417|NCT00899678|447870955|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
124524418|NCT00899678|447870956|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
124524419|NCT00899678|447870954|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
124524420|NCT00899678|447870955|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
124524421|NCT00899678|447870956|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
124524422|NCT00899678|447870954|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
124524423|NCT00899678|447870955|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
124524424|NCT00899678|447870956|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
124524425|NCT00899678|447870954|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
124524426|NCT00899678|447870955|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
124524427|NCT00899678|447870956|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
124524428|NCT00899678|447870954|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
124524429|NCT00899678|447870955|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
124524430|NCT00899678|447870956|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
124524431|NCT00899678|447870954|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
124577960|NCT00968812|448076513|FG000|Overall Study|Noncompliance with study drug|4|||
124577961|NCT00968812|448076514|FG001|Overall Study|Noncompliance with study drug|1|||
124577962|NCT00968812|448076515|FG002|Overall Study|Noncompliance with study drug|6|||
124577963|NCT00968812|448076513|FG000|Overall Study|Unable to take rescue therapy|12|||
124577964|NCT00968812|448076514|FG001|Overall Study|Unable to take rescue therapy|12|||
124577965|NCT00968812|448076515|FG002|Overall Study|Unable to take rescue therapy|17|||
124577966|NCT00968812|448076513|FG000|Overall Study|Other|25|||
124577967|NCT00968812|448076514|FG001|Overall Study|Other|37|||
124577968|NCT00968812|448076515|FG002|Overall Study|Other|40|||
124577969|NCT00123734|448076520|FG000|Overall Study|Death|3|||
124577970|NCT00123734|448076520|FG000|Overall Study|Lost to Follow-up|3|||
124577971|NCT00123734|448076520|FG000|Overall Study|Dropout|1|||
124577972|NCT00123734|448076520|FG000|Overall Study|Withdrawal by Subject|1|||
124577973|NCT00113386|448076521|FG000|Overall Study|Withdrawal by Subject|1|||
124577974|NCT00113386|448076522|FG001|Overall Study|Withdrawal by Subject|0|||
124577975|NCT00113386|448076521|FG000|Overall Study|Physician Decision|0|||
124577976|NCT00113386|448076522|FG001|Overall Study|Physician Decision|1|||
124577977|NCT00113386|448076521|FG000|Overall Study|Toxicity|3|||
124726043|NCT00433966|448618610|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
124524432|NCT00899678|447870955|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
124524433|NCT00899678|447870956|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
124524434|NCT00899678|447870954|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
124524435|NCT00899678|447870955|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
124524436|NCT00899678|447870956|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
124524437|NCT00899678|447870954|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
124524438|NCT00899678|447870955|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
124524439|NCT00899678|447870956|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
124524440|NCT00899678|447870954|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
124524441|NCT00899678|447870955|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
124524442|NCT00899678|447870956|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
124524443|NCT00033371|447870957|FG000|Overall Study|Adverse Event|1|||
124577978|NCT00113386|448076522|FG001|Overall Study|Toxicity|0|||
124577979|NCT00113386|448076521|FG000|Overall Study|Ineligible|1|||
124577980|NCT00113386|448076522|FG001|Overall Study|Ineligible|2|||
124577981|NCT00113386|448076521|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
124577982|NCT00113386|448076522|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
124577983|NCT00640562|448076523|FG000|Overall Study|Adverse Event|8|||
124577984|NCT00640562|448076524|FG001|Overall Study|Adverse Event|5|||
124577985|NCT00640562|448076523|FG000|Overall Study|Lack of Efficacy|1|||
124577986|NCT00640562|448076524|FG001|Overall Study|Lack of Efficacy|4|||
124577987|NCT00640562|448076523|FG000|Overall Study|Protocol Violation|2|||
124577988|NCT00640562|448076524|FG001|Overall Study|Protocol Violation|4|||
124577989|NCT00640562|448076523|FG000|Overall Study|Withdrawal by Subject|6|||
124577990|NCT00640562|448076524|FG001|Overall Study|Withdrawal by Subject|10|||
124577991|NCT00640562|448076523|FG000|Overall Study|Known risperidone intolerance|0|||
124577992|NCT00640562|448076524|FG001|Overall Study|Known risperidone intolerance|1|||
124577993|NCT00640562|448076523|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
124577994|NCT00640562|448076524|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
124577995|NCT00640562|448076523|FG000|Overall Study|Low study drug dose|0|||
124577996|NCT00640562|448076524|FG001|Overall Study|Low study drug dose|1|||
124577997|NCT00640562|448076523|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
124577998|NCT00640562|448076524|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
124577999|NCT02937870|448076525|FG000|Overall Study|Adverse Event|1|||
124578000|NCT02937870|448076525|FG000|Overall Study|Protocol Deviation|2|||
124578001|NCT03098394|448076529|FG000|Overall Study|Pregnancy|0|||
124578002|NCT03098394|448076530|FG001|Overall Study|Pregnancy|1|||
124578003|NCT00609674|448076531|FG000|Overall Study|Adverse Event|1|||
124578004|NCT00609674|448076532|FG001|Overall Study|Adverse Event|1|||
124578005|NCT00609674|448076531|FG000|Overall Study|Protocol Violation|3|||
124578006|NCT00609674|448076532|FG001|Overall Study|Protocol Violation|5|||
124578007|NCT00609674|448076531|FG000|Overall Study|Lost to Follow-up|1|||
124578008|NCT00609674|448076532|FG001|Overall Study|Lost to Follow-up|0|||
124578009|NCT00609674|448076531|FG000|Overall Study|Withdrew consent|2|||
124578010|NCT00609674|448076532|FG001|Overall Study|Withdrew consent|1|||
124578011|NCT00571064|448076534|FG000|Overall Study|Adverse Event|13|||
124578012|NCT00571064|448076534|FG000|Overall Study|Protocol Violation|4|||
124578013|NCT00571064|448076534|FG000|Overall Study|Withdrawal by Subject|2|||
124578014|NCT00571064|448076534|FG000|Overall Study|Other|2|||
124578015|NCT00244764|448076535|FG000|Overall Study|Adverse Event|37|||
124578016|NCT00244764|448076535|FG000|Overall Study|Lost to Follow-up|23|||
124578017|NCT00244764|448076535|FG000|Overall Study|Withdrawal by Subject|12|||
124578018|NCT00244764|448076535|FG000|Overall Study|Disease Progression|13|||
124578019|NCT00244764|448076535|FG000|Overall Study|Protocol Violation|2|||
124578020|NCT00244764|448076535|FG000|Overall Study|Death|1|||
124578021|NCT00244764|448076535|FG000|Overall Study|Off Study Medication for >21 Days|1|||
124578022|NCT00244764|448076535|FG000|Overall Study|Declining Performance Status|1|||
124578023|NCT00244764|448076535|FG000|Overall Study|Participant was Hospitalized until Death|1|||
124578024|NCT00244764|448076535|FG000|Overall Study|Primary Investigator Discretion|2|||
124578025|NCT00244764|448076535|FG000|Overall Study|Sponsor Terminated Study|2|||
124578026|NCT00244764|448076535|FG000|Overall Study|Developed Secondary Malignancy|1|||
124578027|NCT00840073|448076548|FG000|Second Intervention|Missed 72 hour blood draw|1|||
124578028|NCT00840073|448076549|FG001|Second Intervention|Missed 72 hour blood draw|1|||
124578029|NCT03285594|448076550|FG000|Overall Study|At the Participant's Own Request|10|||
124578030|NCT03285594|448076551|FG001|Overall Study|At the Participant's Own Request|5|||
124578031|NCT03285594|448076552|FG002|Overall Study|At the Participant's Own Request|21|||
124578032|NCT03285594|448076550|FG000|Overall Study|Adverse Event|2|||
124578033|NCT03285594|448076551|FG001|Overall Study|Adverse Event|2|||
124578034|NCT03285594|448076552|FG002|Overall Study|Adverse Event|6|||
124578035|NCT03285594|448076550|FG000|Overall Study|Poor Compliance to Protocol|0|||
124726044|NCT00433966|448618607|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
124726045|NCT00433966|448618608|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
124726046|NCT00433966|448618609|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
124578036|NCT03285594|448076551|FG001|Overall Study|Poor Compliance to Protocol|0|||
124578037|NCT03285594|448076552|FG002|Overall Study|Poor Compliance to Protocol|1|||
124578038|NCT03285594|448076550|FG000|Overall Study|Lost to Follow-up|0|||
124578039|NCT03285594|448076551|FG001|Overall Study|Lost to Follow-up|0|||
124726047|NCT00433966|448618610|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
124726048|NCT00433966|448618607|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
124726049|NCT00433966|448618608|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
124578040|NCT03285594|448076552|FG002|Overall Study|Lost to Follow-up|1|||
124578041|NCT03285594|448076550|FG000|Overall Study|Reason Not Specified|3|||
124578042|NCT03285594|448076551|FG001|Overall Study|Reason Not Specified|4|||
124578043|NCT03285594|448076552|FG002|Overall Study|Reason Not Specified|8|||
124578044|NCT01615198|448076558|FG000|Overall Study|Withdrawal by Subject|5|||
124578045|NCT01615198|448076559|FG001|Overall Study|Withdrawal by Subject|5|||
124578046|NCT01615198|448076558|FG000|Overall Study|Protocol deviation|1|||
124726050|NCT00433966|448618609|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
124578047|NCT01615198|448076559|FG001|Overall Study|Protocol deviation|1|||
124578048|NCT01615198|448076558|FG000|Overall Study|Physician Decision|5|||
124578049|NCT01615198|448076559|FG001|Overall Study|Physician Decision|1|||
124578050|NCT01615198|448076558|FG000|Overall Study|Lost to Follow-up|1|||
124578051|NCT01615198|448076559|FG001|Overall Study|Lost to Follow-up|1|||
124578052|NCT01615198|448076558|FG000|Overall Study|Lack of Efficacy|1|||
124578053|NCT01615198|448076559|FG001|Overall Study|Lack of Efficacy|6|||
124578054|NCT01615198|448076558|FG000|Overall Study|Adverse Event|11|||
124578055|NCT01615198|448076559|FG001|Overall Study|Adverse Event|5|||
124578056|NCT04608188|448076561|FG000|Overall Study|Withdrawal by Subject|4|||
124578057|NCT04608188|448076562|FG001|Overall Study|Withdrawal by Subject|8|||
124578058|NCT03122457|448076563|FG000|Overall Study|Withdrawal by Subject|6|||
124578059|NCT03273153|448076567|FG000|Overall Study|Adverse Event|1|||
124578060|NCT03273153|448076568|FG001|Overall Study|Adverse Event|2|||
124578061|NCT03273153|448076567|FG000|Overall Study|Missing|0|||
124578062|NCT03273153|448076568|FG001|Overall Study|Missing|2|||
124578063|NCT03273153|448076567|FG000|Overall Study|Other|3|||
124578064|NCT03273153|448076568|FG001|Overall Study|Other|2|||
124578065|NCT03273153|448076567|FG000|Overall Study|Symptomatic Deterioration|0|||
124578066|NCT03273153|448076568|FG001|Overall Study|Symptomatic Deterioration|1|||
124578067|NCT03273153|448076567|FG000|Overall Study|Progressive Disease|6|||
124578068|NCT03273153|448076568|FG001|Overall Study|Progressive Disease|5|||
124578069|NCT03273153|448076567|FG000|Overall Study|Physician Decision|1|||
124578070|NCT03273153|448076568|FG001|Overall Study|Physician Decision|3|||
124578071|NCT03273153|448076567|FG000|Overall Study|Study Terminated by Sponsor|112|||
124578072|NCT03273153|448076568|FG001|Overall Study|Study Terminated by Sponsor|102|||
124578073|NCT03273153|448076567|FG000|Overall Study|Withdrawal by Subject|26|||
124578074|NCT03273153|448076568|FG001|Overall Study|Withdrawal by Subject|25|||
124578075|NCT03273153|448076567|FG000|Overall Study|Protocol Deviation|3|||
124578076|NCT03273153|448076568|FG001|Overall Study|Protocol Deviation|0|||
124578077|NCT03273153|448076567|FG000|Overall Study|Lost to Follow-up|6|||
124578078|NCT03273153|448076568|FG001|Overall Study|Lost to Follow-up|11|||
124578079|NCT03273153|448076567|FG000|Overall Study|Death|66|||
124578080|NCT03273153|448076568|FG001|Overall Study|Death|69|||
124578081|NCT01908205|448076569|FG000|Overall Study|Lost to Follow-up|2|||
124578082|NCT01908205|448076570|FG001|Overall Study|Lost to Follow-up|0|||
124578083|NCT01908205|448076569|FG000|Overall Study|Withdrawal by Subject|3|||
124578084|NCT01908205|448076570|FG001|Overall Study|Withdrawal by Subject|1|||
124578085|NCT03134222|448076575|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
124578086|NCT03134222|448076576|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
124578087|NCT03134222|448076577|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
124578088|NCT03134222|448076578|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
124578089|NCT03134222|448076579|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
124578090|NCT03134222|448076575|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
124578091|NCT03134222|448076576|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
124578092|NCT03134222|448076577|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
124578093|NCT03134222|448076578|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
124578094|NCT03134222|448076579|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
124578095|NCT03134222|448076575|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
124578096|NCT03134222|448076576|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
124578097|NCT03134222|448076577|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
124578098|NCT03134222|448076578|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
124578099|NCT03134222|448076579|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
124578100|NCT03134222|448076575|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
124578101|NCT03134222|448076576|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
124578102|NCT03134222|448076577|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
124578103|NCT03134222|448076578|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
124578104|NCT03134222|448076579|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
124578105|NCT03134222|448076575|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
124578106|NCT03134222|448076576|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
124578107|NCT03134222|448076577|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
124578108|NCT03134222|448076578|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
124726051|NCT00433966|448618610|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
124726052|NCT00433966|448618607|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
124578109|NCT03134222|448076579|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
124578110|NCT03134222|448076575|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
124578111|NCT03134222|448076576|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
124578112|NCT03134222|448076577|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
124578113|NCT03134222|448076578|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
124578114|NCT03134222|448076579|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
124578115|NCT03134222|448076575|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
124578116|NCT03134222|448076576|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
124578117|NCT03134222|448076577|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
124578118|NCT03134222|448076578|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
124578119|NCT03134222|448076579|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
124578120|NCT03134222|448076575|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
124578121|NCT03134222|448076576|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
124578122|NCT03134222|448076577|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
124578123|NCT03134222|448076578|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
124578124|NCT03134222|448076579|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
124578125|NCT03681470|448076582|FG000|Overall Study|Lack of Efficacy|3|||
124578126|NCT03681470|448076582|FG000|Overall Study|Lost to Follow-up|1|||
124578127|NCT03681470|448076582|FG000|Overall Study|Protocol Violation|3|||
124578128|NCT03681470|448076582|FG000|Overall Study|Withdrawal by Subject|1|||
124578129|NCT01686477|448076583|FG000|Feeding Intervention|Death|1|||
124578130|NCT01686477|448076584|FG001|Feeding Intervention|Death|0|||
124578131|NCT01686477|448076585|FG002|Feeding Intervention|Death|1|||
124578132|NCT01686477|448076583|FG000|Feeding Intervention|Withdrawal by Subject|0|||
124578133|NCT01686477|448076584|FG001|Feeding Intervention|Withdrawal by Subject|6|||
124578134|NCT01686477|448076585|FG002|Feeding Intervention|Withdrawal by Subject|0|||
124578135|NCT01686477|448076583|FG000|Feeding Intervention|Physician Decision|1|||
124578136|NCT01686477|448076584|FG001|Feeding Intervention|Physician Decision|2|||
124578137|NCT01686477|448076585|FG002|Feeding Intervention|Physician Decision|0|||
124578138|NCT01686477|448076583|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
124578139|NCT01686477|448076584|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
124578140|NCT01686477|448076585|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
124578141|NCT01686477|448076583|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
124578142|NCT01686477|448076584|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
124578143|NCT01686477|448076585|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
124578144|NCT01686477|448076583|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
124578145|NCT01686477|448076584|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
124578146|NCT01686477|448076585|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
124578147|NCT01686477|448076583|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
124578148|NCT01686477|448076584|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
124578149|NCT01686477|448076585|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
124578150|NCT01686477|448076583|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
124524444|NCT00033371|447870958|FG001|Overall Study|Adverse Event|5|||
124524445|NCT00033371|447870957|FG000|Overall Study|Lost to Follow-up|2|||
124524446|NCT00033371|447870958|FG001|Overall Study|Lost to Follow-up|1|||
124524447|NCT00033371|447870957|FG000|Overall Study|Withdrawal by Subject|3|||
124524448|NCT00033371|447870958|FG001|Overall Study|Withdrawal by Subject|3|||
124524449|NCT00033371|447870957|FG000|Overall Study|Disease Progression|0|||
124524450|NCT00033371|447870958|FG001|Overall Study|Disease Progression|1|||
124524451|NCT02699125|447870961|FG000|Placebo|Lost to Follow-up|2|||
124524452|NCT02699125|447870962|FG001|Placebo|Lost to Follow-up|0|||
124524453|NCT02699125|447870961|FG000|Placebo|Protocol Violation|1|||
124524454|NCT02699125|447870962|FG001|Placebo|Protocol Violation|0|||
124524455|NCT02699125|447870961|FG000|Placebo|Withdrawal by Subject|0|||
124524456|NCT02699125|447870962|FG001|Placebo|Withdrawal by Subject|4|||
124524457|NCT02699125|447870961|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
124578151|NCT01686477|448076584|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
124578152|NCT01686477|448076585|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
124578153|NCT01686477|448076583|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
124578154|NCT01686477|448076584|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
124578155|NCT01686477|448076585|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
124578156|NCT01686477|448076583|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
124578157|NCT01686477|448076584|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
124578158|NCT01686477|448076585|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
124578159|NCT03290781|448076587|FG000|Overall Study|Adverse Event|5|||
124578160|NCT03290781|448076588|FG001|Overall Study|Adverse Event|7|||
124578161|NCT03290781|448076589|FG002|Overall Study|Adverse Event|4|||
124578162|NCT03290781|448076590|FG003|Overall Study|Adverse Event|1|||
124524458|NCT02699125|447870962|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
124578163|NCT03290781|448076591|FG004|Overall Study|Adverse Event|0|||
124578164|NCT03290781|448076592|FG005|Overall Study|Adverse Event|0|||
124578165|NCT03290781|448076593|FG006|Overall Study|Adverse Event|0|||
124578166|NCT03290781|448076587|FG000|Overall Study|Death|0|||
124578167|NCT03290781|448076588|FG001|Overall Study|Death|0|||
124578168|NCT03290781|448076589|FG002|Overall Study|Death|1|||
124578169|NCT03290781|448076590|FG003|Overall Study|Death|0|||
124578170|NCT03290781|448076591|FG004|Overall Study|Death|1|||
124524459|NCT03796195|447870963|FG000|Overall Study|Study closed early|1|||
124524460|NCT03799627|447870964|FG000|Overall Study|Adverse Event|1|||
124524461|NCT03799627|447870965|FG001|Overall Study|Adverse Event|2|||
124524462|NCT03799627|447870966|FG002|Overall Study|Adverse Event|0|||
124524463|NCT03799627|447870967|FG003|Overall Study|Adverse Event|0|||
124524464|NCT03799627|447870968|FG004|Overall Study|Adverse Event|2|||
124524465|NCT03799627|447870969|FG005|Overall Study|Adverse Event|5|||
124524466|NCT03799627|447870970|FG006|Overall Study|Adverse Event|0|||
124524467|NCT03799627|447870971|FG007|Overall Study|Adverse Event|2|||
124524468|NCT03799627|447870972|FG008|Overall Study|Adverse Event|0|||
124524469|NCT03799627|447870964|FG000|Overall Study|Physician Decision|2|||
124524470|NCT03799627|447870965|FG001|Overall Study|Physician Decision|2|||
124524471|NCT03799627|447870966|FG002|Overall Study|Physician Decision|0|||
124524472|NCT03799627|447870967|FG003|Overall Study|Physician Decision|0|||
124524473|NCT03799627|447870968|FG004|Overall Study|Physician Decision|2|||
124524474|NCT03799627|447870969|FG005|Overall Study|Physician Decision|2|||
124524475|NCT03799627|447870970|FG006|Overall Study|Physician Decision|0|||
124524476|NCT03799627|447870971|FG007|Overall Study|Physician Decision|0|||
124524477|NCT03799627|447870972|FG008|Overall Study|Physician Decision|0|||
124524478|NCT03799627|447870964|FG000|Overall Study|Withdrawal by Subject|1|||
124524479|NCT03799627|447870965|FG001|Overall Study|Withdrawal by Subject|1|||
124524480|NCT03799627|447870966|FG002|Overall Study|Withdrawal by Subject|0|||
124524481|NCT03799627|447870967|FG003|Overall Study|Withdrawal by Subject|2|||
124524482|NCT03799627|447870968|FG004|Overall Study|Withdrawal by Subject|0|||
124524483|NCT03799627|447870969|FG005|Overall Study|Withdrawal by Subject|3|||
124524484|NCT03799627|447870970|FG006|Overall Study|Withdrawal by Subject|0|||
124524485|NCT03799627|447870971|FG007|Overall Study|Withdrawal by Subject|0|||
124524486|NCT03799627|447870972|FG008|Overall Study|Withdrawal by Subject|0|||
124524487|NCT03799627|447870964|FG000|Overall Study|Lack of Efficacy|0|||
124524488|NCT03799627|447870965|FG001|Overall Study|Lack of Efficacy|0|||
124524489|NCT03799627|447870966|FG002|Overall Study|Lack of Efficacy|0|||
124524490|NCT03799627|447870967|FG003|Overall Study|Lack of Efficacy|1|||
124524491|NCT03799627|447870968|FG004|Overall Study|Lack of Efficacy|0|||
124524492|NCT03799627|447870969|FG005|Overall Study|Lack of Efficacy|0|||
124524493|NCT03799627|447870970|FG006|Overall Study|Lack of Efficacy|0|||
124524494|NCT03799627|447870971|FG007|Overall Study|Lack of Efficacy|0|||
124524495|NCT03799627|447870972|FG008|Overall Study|Lack of Efficacy|0|||
124524496|NCT03799627|447870964|FG000|Overall Study|Lost to Follow-up|0|||
124524497|NCT03799627|447870965|FG001|Overall Study|Lost to Follow-up|0|||
124524498|NCT03799627|447870966|FG002|Overall Study|Lost to Follow-up|0|||
124524499|NCT03799627|447870967|FG003|Overall Study|Lost to Follow-up|0|||
124524500|NCT03799627|447870968|FG004|Overall Study|Lost to Follow-up|0|||
124524501|NCT03799627|447870969|FG005|Overall Study|Lost to Follow-up|0|||
124524502|NCT03799627|447870970|FG006|Overall Study|Lost to Follow-up|1|||
124524503|NCT03799627|447870971|FG007|Overall Study|Lost to Follow-up|0|||
124524504|NCT03799627|447870972|FG008|Overall Study|Lost to Follow-up|1|||
124524505|NCT03799627|447870964|FG000|Overall Study|Death|0|||
124524506|NCT03799627|447870965|FG001|Overall Study|Death|0|||
124524507|NCT03799627|447870966|FG002|Overall Study|Death|0|||
124524508|NCT03799627|447870967|FG003|Overall Study|Death|1|||
124524509|NCT03799627|447870968|FG004|Overall Study|Death|0|||
124524510|NCT03799627|447870969|FG005|Overall Study|Death|0|||
124524511|NCT03799627|447870970|FG006|Overall Study|Death|0|||
124524512|NCT03799627|447870971|FG007|Overall Study|Death|0|||
124524513|NCT03799627|447870972|FG008|Overall Study|Death|0|||
124524514|NCT03799627|447870964|FG000|Overall Study|Study Drug Put on Hold|1|||
124524515|NCT03799627|447870965|FG001|Overall Study|Study Drug Put on Hold|0|||
124524516|NCT03799627|447870966|FG002|Overall Study|Study Drug Put on Hold|0|||
124524517|NCT03799627|447870967|FG003|Overall Study|Study Drug Put on Hold|0|||
124524518|NCT03799627|447870968|FG004|Overall Study|Study Drug Put on Hold|0|||
124524519|NCT03799627|447870969|FG005|Overall Study|Study Drug Put on Hold|0|||
124524520|NCT03799627|447870970|FG006|Overall Study|Study Drug Put on Hold|0|||
124524521|NCT03799627|447870971|FG007|Overall Study|Study Drug Put on Hold|0|||
124524522|NCT03799627|447870972|FG008|Overall Study|Study Drug Put on Hold|0|||
124524523|NCT03799627|447870964|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
124524524|NCT03799627|447870965|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
124524525|NCT03799627|447870966|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
124524526|NCT03799627|447870967|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
124524527|NCT03799627|447870968|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
124524528|NCT03799627|447870969|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
124524529|NCT03799627|447870970|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
124524530|NCT03799627|447870971|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
124524531|NCT03799627|447870972|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
124524532|NCT03799627|447870964|FG000|Overall Study|Kidney Transplantation|1|||
124524533|NCT03799627|447870965|FG001|Overall Study|Kidney Transplantation|0|||
124524534|NCT03799627|447870966|FG002|Overall Study|Kidney Transplantation|0|||
124524535|NCT03799627|447870967|FG003|Overall Study|Kidney Transplantation|1|||
124524536|NCT03799627|447870968|FG004|Overall Study|Kidney Transplantation|1|||
124524537|NCT03799627|447870969|FG005|Overall Study|Kidney Transplantation|0|||
124524538|NCT03799627|447870970|FG006|Overall Study|Kidney Transplantation|0|||
124524539|NCT03799627|447870971|FG007|Overall Study|Kidney Transplantation|0|||
124524540|NCT03799627|447870972|FG008|Overall Study|Kidney Transplantation|0|||
124578171|NCT03290781|448076592|FG005|Overall Study|Death|0|||
124524541|NCT03799627|447870964|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
124524542|NCT03799627|447870965|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
124524543|NCT03799627|447870966|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
124524544|NCT03799627|447870967|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
124524545|NCT03799627|447870968|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
124524546|NCT03799627|447870969|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
124524547|NCT03799627|447870970|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
124524548|NCT03799627|447870971|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
124524549|NCT03799627|447870972|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
124524550|NCT03799627|447870964|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
124524551|NCT03799627|447870965|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
124524552|NCT03799627|447870966|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
124524553|NCT03799627|447870967|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
124524554|NCT03799627|447870968|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
124524555|NCT03799627|447870969|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
124524556|NCT03799627|447870970|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
124524557|NCT03799627|447870971|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
124524558|NCT03799627|447870972|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
124524559|NCT03799627|447870964|FG000|Overall Study|Met Exclusion Criteria|0|||
124524560|NCT03799627|447870965|FG001|Overall Study|Met Exclusion Criteria|0|||
124524561|NCT03799627|447870966|FG002|Overall Study|Met Exclusion Criteria|0|||
124524562|NCT03799627|447870967|FG003|Overall Study|Met Exclusion Criteria|1|||
124524563|NCT03799627|447870968|FG004|Overall Study|Met Exclusion Criteria|0|||
124524564|NCT03799627|447870969|FG005|Overall Study|Met Exclusion Criteria|0|||
124524565|NCT03799627|447870970|FG006|Overall Study|Met Exclusion Criteria|0|||
124524566|NCT03799627|447870971|FG007|Overall Study|Met Exclusion Criteria|0|||
124524567|NCT03799627|447870972|FG008|Overall Study|Met Exclusion Criteria|0|||
124524568|NCT03799627|447870964|FG000|Overall Study|Investigational Product Noncompliance|0|||
124524569|NCT03799627|447870965|FG001|Overall Study|Investigational Product Noncompliance|0|||
124524570|NCT03799627|447870966|FG002|Overall Study|Investigational Product Noncompliance|0|||
124524571|NCT03799627|447870967|FG003|Overall Study|Investigational Product Noncompliance|1|||
124524572|NCT03799627|447870968|FG004|Overall Study|Investigational Product Noncompliance|0|||
124524573|NCT03799627|447870969|FG005|Overall Study|Investigational Product Noncompliance|0|||
124524574|NCT03799627|447870970|FG006|Overall Study|Investigational Product Noncompliance|0|||
124524575|NCT03799627|447870971|FG007|Overall Study|Investigational Product Noncompliance|0|||
124524576|NCT03799627|447870972|FG008|Overall Study|Investigational Product Noncompliance|0|||
124524577|NCT03799627|447870964|FG000|Overall Study|Participant Relocation|0|||
124524578|NCT03799627|447870965|FG001|Overall Study|Participant Relocation|0|||
124524579|NCT03799627|447870966|FG002|Overall Study|Participant Relocation|0|||
124524580|NCT03799627|447870967|FG003|Overall Study|Participant Relocation|1|||
124524581|NCT03799627|447870968|FG004|Overall Study|Participant Relocation|0|||
124524582|NCT03799627|447870969|FG005|Overall Study|Participant Relocation|1|||
124524583|NCT03799627|447870970|FG006|Overall Study|Participant Relocation|0|||
124524584|NCT03799627|447870971|FG007|Overall Study|Participant Relocation|0|||
124524585|NCT03799627|447870972|FG008|Overall Study|Participant Relocation|0|||
124524586|NCT03799627|447870964|FG000|Overall Study|Eurofin Issue|0|||
124524587|NCT03799627|447870965|FG001|Overall Study|Eurofin Issue|0|||
124524588|NCT03799627|447870966|FG002|Overall Study|Eurofin Issue|0|||
124524589|NCT03799627|447870967|FG003|Overall Study|Eurofin Issue|0|||
124524590|NCT03799627|447870968|FG004|Overall Study|Eurofin Issue|1|||
124524591|NCT03799627|447870969|FG005|Overall Study|Eurofin Issue|0|||
124524592|NCT03799627|447870970|FG006|Overall Study|Eurofin Issue|0|||
124524593|NCT03799627|447870971|FG007|Overall Study|Eurofin Issue|0|||
124524594|NCT03799627|447870972|FG008|Overall Study|Eurofin Issue|0|||
124524595|NCT03799627|447870964|FG000|Overall Study|Noncompliance with Site Instructions|0|||
124524596|NCT03799627|447870965|FG001|Overall Study|Noncompliance with Site Instructions|0|||
124524597|NCT03799627|447870966|FG002|Overall Study|Noncompliance with Site Instructions|0|||
124524598|NCT03799627|447870967|FG003|Overall Study|Noncompliance with Site Instructions|0|||
124524599|NCT03799627|447870968|FG004|Overall Study|Noncompliance with Site Instructions|1|||
124524600|NCT03799627|447870969|FG005|Overall Study|Noncompliance with Site Instructions|0|||
124524601|NCT03799627|447870970|FG006|Overall Study|Noncompliance with Site Instructions|0|||
124524602|NCT03799627|447870971|FG007|Overall Study|Noncompliance with Site Instructions|0|||
124524603|NCT03799627|447870972|FG008|Overall Study|Noncompliance with Site Instructions|0|||
124524604|NCT03799627|447870964|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
124524605|NCT03799627|447870965|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
124524606|NCT03799627|447870966|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
124524607|NCT03799627|447870967|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
124524608|NCT03799627|447870968|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
124524609|NCT03799627|447870969|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
124524610|NCT03799627|447870970|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
124524611|NCT03799627|447870971|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
124524612|NCT03799627|447870972|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
124524613|NCT03799627|447870964|FG000|Overall Study|Changes In Hemoglobin Values|1|||
124524614|NCT03799627|447870965|FG001|Overall Study|Changes In Hemoglobin Values|2|||
124524615|NCT03799627|447870966|FG002|Overall Study|Changes In Hemoglobin Values|1|||
124524616|NCT03799627|447870967|FG003|Overall Study|Changes In Hemoglobin Values|0|||
124524617|NCT03799627|447870968|FG004|Overall Study|Changes In Hemoglobin Values|0|||
124524618|NCT03799627|447870969|FG005|Overall Study|Changes In Hemoglobin Values|2|||
124524619|NCT03799627|447870970|FG006|Overall Study|Changes In Hemoglobin Values|1|||
124524620|NCT03799627|447870971|FG007|Overall Study|Changes In Hemoglobin Values|0|||
124524621|NCT03799627|447870972|FG008|Overall Study|Changes In Hemoglobin Values|1|||
124524622|NCT02092324|447870979|FG000|Overall Study|Adverse Event|1|||
124524623|NCT02092324|447870979|FG000|Overall Study|Lack of Efficacy|6|||
124524624|NCT02092324|447870979|FG000|Overall Study|Proceed to Transplant|3|||
124524625|NCT02092324|447870979|FG000|Overall Study|Physician Decision|7|||
124524626|NCT02092324|447870979|FG000|Overall Study|Misdiagnosis|2|||
124524627|NCT01190020|447870988|FG000|Overall Study|Adverse Event|2|||
124524628|NCT01190020|447870989|FG001|Overall Study|Adverse Event|0|||
124524629|NCT01190020|447870988|FG000|Overall Study|Lost to Follow-up|2|||
124524630|NCT01190020|447870989|FG001|Overall Study|Lost to Follow-up|0|||
124524631|NCT01190020|447870988|FG000|Overall Study|Withdrawal by Subject|3|||
124524632|NCT01190020|447870989|FG001|Overall Study|Withdrawal by Subject|0|||
124524633|NCT00777257|447872478|FG000|Overall Study|Adverse Event|3|||
124524634|NCT00777257|447872479|FG001|Overall Study|Adverse Event|1|||
124524635|NCT00777257|447872480|FG002|Overall Study|Adverse Event|0|||
124524636|NCT00777257|447872478|FG000|Overall Study|Lost to Follow-up|3|||
124524637|NCT00777257|447872479|FG001|Overall Study|Lost to Follow-up|3|||
124524638|NCT00777257|447872480|FG002|Overall Study|Lost to Follow-up|2|||
124524639|NCT00777257|447872478|FG000|Overall Study|Protocol Violation|2|||
124524640|NCT00777257|447872479|FG001|Overall Study|Protocol Violation|2|||
124524641|NCT00777257|447872480|FG002|Overall Study|Protocol Violation|2|||
124524642|NCT00777257|447872478|FG000|Overall Study|Withdrawal by Subject|3|||
124524643|NCT00777257|447872479|FG001|Overall Study|Withdrawal by Subject|6|||
124524644|NCT00777257|447872480|FG002|Overall Study|Withdrawal by Subject|5|||
124524645|NCT01183104|447872481|FG000|Overall Study|Adverse Event|8|||
124524646|NCT01183104|447872482|FG001|Overall Study|Adverse Event|6|||
124524647|NCT01183104|447872481|FG000|Overall Study|Death|0|||
124524648|NCT01183104|447872482|FG001|Overall Study|Death|1|||
124524649|NCT01183104|447872481|FG000|Overall Study|Lost to Follow-up|14|||
124524650|NCT01183104|447872482|FG001|Overall Study|Lost to Follow-up|7|||
124524651|NCT01183104|447872481|FG000|Overall Study|Physician Decision|5|||
124524652|NCT01183104|447872482|FG001|Overall Study|Physician Decision|8|||
124524653|NCT01183104|447872481|FG000|Overall Study|Withdrawal by Subject|6|||
124524654|NCT01183104|447872482|FG001|Overall Study|Withdrawal by Subject|11|||
124524655|NCT01183104|447872481|FG000|Overall Study|Nonparticipation in Extension Study|39|||
124524656|NCT01183104|447872482|FG001|Overall Study|Nonparticipation in Extension Study|50|||
124524657|NCT01183104|447872481|FG000|Overall Study|Did not receive study drug|5|||
124524658|NCT01183104|447872482|FG001|Overall Study|Did not receive study drug|9|||
124524659|NCT03267511|447872483|FG000|Overall Study|Lost to Follow-up|0|||
124524660|NCT03267511|447872484|FG001|Overall Study|Lost to Follow-up|0|||
124524661|NCT03267511|447872485|FG002|Overall Study|Lost to Follow-up|0|||
124524662|NCT03267511|447872486|FG003|Overall Study|Lost to Follow-up|1|||
124524663|NCT00364351|447872487|FG000|Overall Study|Adverse Event|90|||
124524664|NCT00364351|447872488|FG001|Overall Study|Adverse Event|44|||
124524665|NCT00364351|447872487|FG000|Overall Study|Condition under investigation worsened|469|||
124524666|NCT00364351|447872488|FG001|Overall Study|Condition under investigation worsened|497|||
124524667|NCT00364351|447872487|FG000|Overall Study|Prohibited concomitant medication|0|||
124524668|NCT00364351|447872488|FG001|Overall Study|Prohibited concomitant medication|2|||
124524669|NCT00364351|447872487|FG000|Overall Study|Lost to Follow-up|1|||
124524670|NCT00364351|447872488|FG001|Overall Study|Lost to Follow-up|1|||
124524671|NCT00364351|447872487|FG000|Overall Study|Withdrawal by Subject|30|||
124524672|NCT00364351|447872488|FG001|Overall Study|Withdrawal by Subject|29|||
124524673|NCT00364351|447872487|FG000|Overall Study|Incorrect enrollment|1|||
124524674|NCT00364351|447872488|FG001|Overall Study|Incorrect enrollment|1|||
124524675|NCT00364351|447872487|FG000|Overall Study|Sponsor decision|1|||
124524676|NCT00364351|447872488|FG001|Overall Study|Sponsor decision|0|||
124524677|NCT00364351|447872487|FG000|Overall Study|Poor treatment compliance|0|||
124524678|NCT00364351|447872488|FG001|Overall Study|Poor treatment compliance|3|||
124524679|NCT00364351|447872487|FG000|Overall Study|Investigator error|0|||
124524680|NCT00364351|447872488|FG001|Overall Study|Investigator error|2|||
124524681|NCT00364351|447872487|FG000|Overall Study|Patient could not travel to site|0|||
124524682|NCT00364351|447872488|FG001|Overall Study|Patient could not travel to site|1|||
124524683|NCT00364351|447872487|FG000|Overall Study|Randomised treatment not started|0|||
124524684|NCT00364351|447872488|FG001|Overall Study|Randomised treatment not started|3|||
124524685|NCT00464620|447872489|FG000|Overall Study|Physician Decision|1|||
124524686|NCT00464620|447872490|FG001|Overall Study|Physician Decision|0|||
124524687|NCT00464620|447872491|FG002|Overall Study|Physician Decision|0|||
124524688|NCT00464620|447872489|FG000|Overall Study|Withdrawal by Subject|1|||
124524689|NCT00464620|447872490|FG001|Overall Study|Withdrawal by Subject|0|||
124524690|NCT00464620|447872491|FG002|Overall Study|Withdrawal by Subject|3|||
124524691|NCT00464620|447872489|FG000|Overall Study|Ineligible sarcoma subtype|0|||
124524692|NCT00464620|447872490|FG001|Overall Study|Ineligible sarcoma subtype|2|||
124524693|NCT00464620|447872491|FG002|Overall Study|Ineligible sarcoma subtype|2|||
124524694|NCT00464620|447872489|FG000|Overall Study|Use of prohibited concomitant medication|0|||
124524695|NCT00464620|447872490|FG001|Overall Study|Use of prohibited concomitant medication|0|||
124524696|NCT00464620|447872491|FG002|Overall Study|Use of prohibited concomitant medication|2|||
124524697|NCT01518309|447872492|FG000|Overall Study|Adverse Event|6|||
124524698|NCT01518309|447872492|FG000|Overall Study|Death|6|||
124524699|NCT01518309|447872492|FG000|Overall Study|Lack of Efficacy|7|||
124524700|NCT01518309|447872492|FG000|Overall Study|Withdrawal by Subject|6|||
124524701|NCT01518309|447872492|FG000|Overall Study|Physician Decision|3|||
124524702|NCT01518309|447872492|FG000|Overall Study|Sponsor Decision|2|||
124524703|NCT01518309|447872492|FG000|Overall Study|Not in Predefined Categories|9|||
124578172|NCT03290781|448076593|FG006|Overall Study|Death|0|||
124578173|NCT03290781|448076587|FG000|Overall Study|Withdrawal by Subject|6|||
124578174|NCT03290781|448076588|FG001|Overall Study|Withdrawal by Subject|5|||
124578175|NCT03290781|448076589|FG002|Overall Study|Withdrawal by Subject|9|||
124578176|NCT03290781|448076590|FG003|Overall Study|Withdrawal by Subject|10|||
124578177|NCT03290781|448076591|FG004|Overall Study|Withdrawal by Subject|1|||
124578178|NCT03290781|448076592|FG005|Overall Study|Withdrawal by Subject|2|||
124578179|NCT03290781|448076593|FG006|Overall Study|Withdrawal by Subject|0|||
124578180|NCT03290781|448076587|FG000|Overall Study|Physician Decision|0|||
124578181|NCT03290781|448076588|FG001|Overall Study|Physician Decision|1|||
124578182|NCT03290781|448076589|FG002|Overall Study|Physician Decision|0|||
124578183|NCT03290781|448076590|FG003|Overall Study|Physician Decision|0|||
124578184|NCT03290781|448076591|FG004|Overall Study|Physician Decision|0|||
124578185|NCT03290781|448076592|FG005|Overall Study|Physician Decision|0|||
124578186|NCT03290781|448076593|FG006|Overall Study|Physician Decision|0|||
124578187|NCT03290781|448076587|FG000|Overall Study|Site Terminated by Sponsor|1|||
124578188|NCT03290781|448076588|FG001|Overall Study|Site Terminated by Sponsor|0|||
124578189|NCT03290781|448076589|FG002|Overall Study|Site Terminated by Sponsor|2|||
124578190|NCT03290781|448076590|FG003|Overall Study|Site Terminated by Sponsor|1|||
124578191|NCT03290781|448076591|FG004|Overall Study|Site Terminated by Sponsor|0|||
124578192|NCT03290781|448076592|FG005|Overall Study|Site Terminated by Sponsor|0|||
124578193|NCT03290781|448076593|FG006|Overall Study|Site Terminated by Sponsor|0|||
124578194|NCT03290781|448076587|FG000|Overall Study|Lost to Follow-up|0|||
124578195|NCT03290781|448076588|FG001|Overall Study|Lost to Follow-up|0|||
124578196|NCT03290781|448076589|FG002|Overall Study|Lost to Follow-up|0|||
124578197|NCT03290781|448076590|FG003|Overall Study|Lost to Follow-up|1|||
124578198|NCT03290781|448076591|FG004|Overall Study|Lost to Follow-up|0|||
124578199|NCT03290781|448076592|FG005|Overall Study|Lost to Follow-up|0|||
124578200|NCT03290781|448076593|FG006|Overall Study|Lost to Follow-up|0|||
124578201|NCT03290781|448076587|FG000|Overall Study|Protocol Deviation|2|||
124578202|NCT03290781|448076588|FG001|Overall Study|Protocol Deviation|0|||
124578203|NCT03290781|448076589|FG002|Overall Study|Protocol Deviation|0|||
124578204|NCT03290781|448076590|FG003|Overall Study|Protocol Deviation|1|||
124578205|NCT03290781|448076591|FG004|Overall Study|Protocol Deviation|0|||
124578206|NCT03290781|448076592|FG005|Overall Study|Protocol Deviation|0|||
124578207|NCT03290781|448076593|FG006|Overall Study|Protocol Deviation|0|||
124524704|NCT02579863|447872495|FG000|Overall Study|Final Disposition Unknown|2|||
124524705|NCT02579863|447872496|FG001|Overall Study|Final Disposition Unknown|1|||
124524706|NCT02579863|447872495|FG000|Overall Study|Adverse Event|18|||
124524707|NCT02579863|447872496|FG001|Overall Study|Adverse Event|11|||
124524708|NCT02579863|447872495|FG000|Overall Study|Death|31|||
124524709|NCT02579863|447872496|FG001|Overall Study|Death|29|||
124578208|NCT03290781|448076587|FG000|Overall Study|Disease Relapse|32|||
124578209|NCT03290781|448076588|FG001|Overall Study|Disease Relapse|5|||
124578210|NCT03290781|448076589|FG002|Overall Study|Disease Relapse|38|||
124578211|NCT03290781|448076590|FG003|Overall Study|Disease Relapse|7|||
124578212|NCT03290781|448076591|FG004|Overall Study|Disease Relapse|3|||
124578213|NCT03290781|448076592|FG005|Overall Study|Disease Relapse|1|||
124578214|NCT03290781|448076593|FG006|Overall Study|Disease Relapse|4|||
124578215|NCT03290781|448076587|FG000|Overall Study|Other|3|||
124578216|NCT03290781|448076588|FG001|Overall Study|Other|0|||
124578217|NCT03290781|448076589|FG002|Overall Study|Other|2|||
124578218|NCT03290781|448076590|FG003|Overall Study|Other|2|||
124578219|NCT03290781|448076591|FG004|Overall Study|Other|0|||
124578220|NCT03290781|448076592|FG005|Overall Study|Other|0|||
124578221|NCT03290781|448076593|FG006|Overall Study|Other|0|||
124578222|NCT01136174|448076594|FG000|Overall Study|Adverse Event|0|||
124524710|NCT02579863|447872495|FG000|Overall Study|Lost to Follow-up|2|||
124524711|NCT02579863|447872496|FG001|Overall Study|Lost to Follow-up|1|||
124578223|NCT01136174|448076595|FG001|Overall Study|Adverse Event|0|||
124578224|NCT01136174|448076596|FG002|Overall Study|Adverse Event|0|||
124578225|NCT01136174|448076597|FG003|Overall Study|Adverse Event|4|||
124578226|NCT02820350|448076607|FG000|Overall Study|Withdrawal by Subject|3|||
124578227|NCT02820350|448076607|FG000|Overall Study|Death|4|||
124578228|NCT01597245|448076608|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
124578229|NCT01597245|448076609|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
124578230|NCT01597245|448076610|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
124578231|NCT01597245|448076611|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
124578232|NCT01597245|448076612|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
124578233|NCT01597245|448076613|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
124578234|NCT01597245|448076614|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
124578235|NCT01597245|448076615|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
124578236|NCT01597245|448076616|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
124578237|NCT01597245|448076617|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
124578238|NCT01597245|448076618|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
124578239|NCT01597245|448076619|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
124578240|NCT01597245|448076620|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
124578241|NCT01597245|448076621|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
124578242|NCT01597245|448076622|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
124578243|NCT01597245|448076623|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
124578244|NCT01597245|448076624|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
124578245|NCT01597245|448076625|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
124578246|NCT01597245|448076626|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
124578247|NCT01597245|448076627|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
124578248|NCT01597245|448076628|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
124578249|NCT01597245|448076608|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
124578250|NCT01597245|448076609|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
124578251|NCT01597245|448076610|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
124578252|NCT01597245|448076611|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
124578253|NCT01597245|448076612|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
124578254|NCT01597245|448076613|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
124578255|NCT01597245|448076614|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
124578256|NCT01597245|448076615|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
124578257|NCT01597245|448076616|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
124578258|NCT01597245|448076617|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
124578259|NCT01597245|448076618|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
124578260|NCT01597245|448076619|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
124578261|NCT01597245|448076620|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
124578262|NCT01597245|448076621|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
124578263|NCT01597245|448076622|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
124578264|NCT01597245|448076623|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
124578265|NCT01597245|448076624|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
124578266|NCT01597245|448076625|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
124578267|NCT01597245|448076626|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
124578268|NCT01597245|448076627|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
124578269|NCT01597245|448076628|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
124578270|NCT01597245|448076608|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
124578271|NCT01597245|448076609|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
124578272|NCT01597245|448076610|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
124578273|NCT01597245|448076611|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
124578274|NCT01597245|448076612|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
124578275|NCT01597245|448076613|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
124578276|NCT01597245|448076614|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
124578277|NCT01597245|448076615|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
124578278|NCT01597245|448076616|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
124578279|NCT01597245|448076617|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
124578280|NCT01597245|448076618|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
124578281|NCT01597245|448076619|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
124578282|NCT01597245|448076620|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
124578283|NCT01597245|448076621|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
124578284|NCT01597245|448076622|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
124578285|NCT01597245|448076623|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
124578286|NCT01597245|448076624|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
124578287|NCT01597245|448076625|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
124578288|NCT01597245|448076626|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
124578289|NCT01597245|448076627|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
124578290|NCT01597245|448076628|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
124578291|NCT01597245|448076608|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
124578292|NCT01597245|448076609|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
124524712|NCT02579863|447872495|FG000|Overall Study|Physician Decision|1|||
124524713|NCT02579863|447872496|FG001|Overall Study|Physician Decision|2|||
124524714|NCT02579863|447872495|FG000|Overall Study|Screen Failure|0|||
124524715|NCT02579863|447872496|FG001|Overall Study|Screen Failure|2|||
124524716|NCT02579863|447872495|FG000|Overall Study|Study Terminated at Selected Sites|82|||
124524717|NCT02579863|447872496|FG001|Overall Study|Study Terminated at Selected Sites|88|||
124524718|NCT02579863|447872495|FG000|Overall Study|Withdrawal by Subject|20|||
124524719|NCT02579863|447872496|FG001|Overall Study|Withdrawal by Subject|20|||
124524720|NCT00038142|447872502|FG000|Overall Study|Ineligible|1|||
124524721|NCT00038142|447872503|FG001|Overall Study|Ineligible|0|||
124524722|NCT00038142|447872502|FG000|Overall Study|Progressive Disease|11|||
124524723|NCT00038142|447872503|FG001|Overall Study|Progressive Disease|7|||
124524724|NCT00038142|447872502|FG000|Overall Study|Death|1|||
124524725|NCT00038142|447872503|FG001|Overall Study|Death|0|||
124524726|NCT00038142|447872502|FG000|Overall Study|Adverse Event|1|||
124524727|NCT00038142|447872503|FG001|Overall Study|Adverse Event|0|||
124524728|NCT00038142|447872502|FG000|Overall Study|Unknown Reason|8|||
124524729|NCT00038142|447872503|FG001|Overall Study|Unknown Reason|0|||
124524730|NCT00589602|447872504|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
124524731|NCT02352090|447872512|FG000|Overall Study|general malaise|1|||
124524732|NCT02352090|447872513|FG001|Overall Study|general malaise|0|||
124524733|NCT02352090|447872514|FG002|Overall Study|general malaise|0|||
124524734|NCT02352090|447872512|FG000|Overall Study|non-specified mild side-effects|0|||
124524735|NCT02352090|447872513|FG001|Overall Study|non-specified mild side-effects|0|||
124524736|NCT02352090|447872514|FG002|Overall Study|non-specified mild side-effects|2|||
124524737|NCT01678313|447872515|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
124524738|NCT01678313|447872516|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
124524739|NCT01678313|447872515|FG000|Completed the 3-month Therapy|Physician Decision|3|||
124524740|NCT01678313|447872516|FG001|Completed the 3-month Therapy|Physician Decision|4|||
124524741|NCT01678313|447872515|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
124524742|NCT01678313|447872516|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
124524743|NCT01678313|447872515|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
124524744|NCT01678313|447872516|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
124524745|NCT00981292|447872517|FG000|Day 1|Protocol Violation|1|||
124524746|NCT00981292|447872518|FG001|Day 1|Protocol Violation|0|||
124524747|NCT00981292|447872519|FG002|Day 1|Protocol Violation|0|||
124524748|NCT00981292|447872520|FG003|Day 1|Protocol Violation|0|||
124524749|NCT00981292|447872521|FG004|Day 1|Protocol Violation|0|||
124524750|NCT00981292|447872522|FG005|Day 1|Protocol Violation|2|||
124524751|NCT00981292|447872517|FG000|Day 2|Protocol Violation|2|||
124524752|NCT00981292|447872518|FG001|Day 2|Protocol Violation|0|||
124524753|NCT00981292|447872519|FG002|Day 2|Protocol Violation|0|||
124524754|NCT00981292|447872520|FG003|Day 2|Protocol Violation|0|||
124524755|NCT00981292|447872521|FG004|Day 2|Protocol Violation|0|||
124524756|NCT00981292|447872522|FG005|Day 2|Protocol Violation|0|||
124524757|NCT00981292|447872517|FG000|Day 3|Protocol Violation|0|||
124524758|NCT00981292|447872518|FG001|Day 3|Protocol Violation|0|||
124524759|NCT00981292|447872519|FG002|Day 3|Protocol Violation|0|||
124524760|NCT00981292|447872520|FG003|Day 3|Protocol Violation|0|||
124524761|NCT00981292|447872521|FG004|Day 3|Protocol Violation|0|||
124524762|NCT00981292|447872522|FG005|Day 3|Protocol Violation|1|||
124524763|NCT01131130|447872523|FG000|Period 1 - Baseline|Pregnancy|1|||
124524764|NCT01131130|447872523|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
124524765|NCT03464136|447872524|FG000|Overall Study|Lost to Follow-up|5|||
124524766|NCT03464136|447872525|FG001|Overall Study|Lost to Follow-up|8|||
124524767|NCT03464136|447872524|FG000|Overall Study|Withdrawal by Subject|16|||
124524768|NCT03464136|447872525|FG001|Overall Study|Withdrawal by Subject|13|||
124524769|NCT03464136|447872524|FG000|Overall Study|Death|1|||
124524770|NCT03464136|447872525|FG001|Overall Study|Death|0|||
124524771|NCT03464136|447872524|FG000|Overall Study|Other|8|||
124524772|NCT03464136|447872525|FG001|Overall Study|Other|4|||
124524773|NCT03412565|447872526|FG000|Overall Study|Lost to Follow-up|0|||
124524774|NCT03412565|447872527|FG001|Overall Study|Lost to Follow-up|0|||
124524775|NCT03412565|447872528|FG002|Overall Study|Lost to Follow-up|1|||
124524776|NCT03412565|447872529|FG003|Overall Study|Lost to Follow-up|0|||
124524777|NCT03412565|447872526|FG000|Overall Study|Physician Decision|0|||
124524778|NCT03412565|447872527|FG001|Overall Study|Physician Decision|0|||
124524779|NCT03412565|447872528|FG002|Overall Study|Physician Decision|0|||
124524780|NCT03412565|447872529|FG003|Overall Study|Physician Decision|1|||
124524781|NCT03412565|447872526|FG000|Overall Study|Withdrawal by Subject|0|||
124524782|NCT03412565|447872527|FG001|Overall Study|Withdrawal by Subject|4|||
124524783|NCT03412565|447872528|FG002|Overall Study|Withdrawal by Subject|5|||
124524784|NCT03412565|447872529|FG003|Overall Study|Withdrawal by Subject|5|||
124524785|NCT03412565|447872526|FG000|Overall Study|Death|1|||
124524786|NCT03412565|447872527|FG001|Overall Study|Death|3|||
124524787|NCT03412565|447872528|FG002|Overall Study|Death|4|||
124524788|NCT03412565|447872529|FG003|Overall Study|Death|5|||
124524789|NCT03412565|447872526|FG000|Overall Study|Data collection ended|0|||
124524790|NCT03412565|447872527|FG001|Overall Study|Data collection ended|41|||
124524791|NCT03412565|447872528|FG002|Overall Study|Data collection ended|41|||
124524792|NCT03412565|447872529|FG003|Overall Study|Data collection ended|40|||
124524793|NCT03277105|447872530|FG000|Overall Study|Death|129|||
124524794|NCT03277105|447872531|FG001|Overall Study|Death|124|||
124524795|NCT03277105|447872530|FG000|Overall Study|Lost to Follow-up|2|||
124524796|NCT03277105|447872531|FG001|Overall Study|Lost to Follow-up|4|||
124524797|NCT03277105|447872530|FG000|Overall Study|Withdrawal by Subject|10|||
124524798|NCT03277105|447872531|FG001|Overall Study|Withdrawal by Subject|10|||
124524799|NCT03277105|447872530|FG000|Overall Study|Other|118|||
124524800|NCT03277105|447872531|FG001|Overall Study|Other|125|||
124524816|NCT01849562|447872553|FG000|Overall Study|Lost to Follow-up|1|||
124524817|NCT01849562|447872554|FG001|Overall Study|Lost to Follow-up|0|||
124524818|NCT01849562|447872555|FG002|Overall Study|Lost to Follow-up|0|||
124524819|NCT01849562|447872553|FG000|Overall Study|Non-compliance with Study Drug|1|||
124524820|NCT01849562|447872554|FG001|Overall Study|Non-compliance with Study Drug|0|||
124524821|NCT01849562|447872555|FG002|Overall Study|Non-compliance with Study Drug|0|||
124524822|NCT03146403|447872556|FG000|Overall Study|Withdrawal by Subject|0|||
124524823|NCT03146403|447872557|FG001|Overall Study|Withdrawal by Subject|3|||
124524824|NCT03146403|447872556|FG000|Overall Study|Lost to Follow-up|2|||
124524825|NCT03146403|447872557|FG001|Overall Study|Lost to Follow-up|0|||
124524826|NCT02182999|447872561|FG000|Overall Study|Adverse Event|4|||
124524827|NCT02182999|447872562|FG001|Overall Study|Adverse Event|3|||
124524828|NCT02182999|447872561|FG000|Overall Study|Physician Decision|1|||
124524829|NCT02182999|447872562|FG001|Overall Study|Physician Decision|0|||
124524830|NCT02252588|447872563|FG000|Overall Study|Withdrawal by Subject|4|||
124524831|NCT02252588|447872564|FG001|Overall Study|Withdrawal by Subject|0|||
124524832|NCT03039790|447872565|FG000|Overall Study|Lost to Follow-up|2|||
124524833|NCT03039790|447872566|FG001|Overall Study|Lost to Follow-up|0|||
124524834|NCT03039790|447872567|FG002|Overall Study|Lost to Follow-up|1|||
124524835|NCT03039790|447872568|FG003|Overall Study|Lost to Follow-up|1|||
124524836|NCT03039790|447872569|FG004|Overall Study|Lost to Follow-up|0|||
124524837|NCT03039790|447872570|FG005|Overall Study|Lost to Follow-up|1|||
124524838|NCT03039790|447872571|FG006|Overall Study|Lost to Follow-up|1|||
124524839|NCT03039790|447872572|FG007|Overall Study|Lost to Follow-up|1|||
124524840|NCT03039790|447872573|FG008|Overall Study|Lost to Follow-up|0|||
124524841|NCT03039790|447872574|FG009|Overall Study|Lost to Follow-up|1|||
124524842|NCT03039790|447872575|FG010|Overall Study|Lost to Follow-up|1|||
124524843|NCT03039790|447872576|FG011|Overall Study|Lost to Follow-up|0|||
124524844|NCT03039790|447872577|FG012|Overall Study|Lost to Follow-up|1|||
124524845|NCT03039790|447872578|FG013|Overall Study|Lost to Follow-up|0|||
124524846|NCT03039790|447872579|FG014|Overall Study|Lost to Follow-up|3|||
124524847|NCT03039790|447872580|FG015|Overall Study|Lost to Follow-up|1|||
124524848|NCT03039790|447872581|FG016|Overall Study|Lost to Follow-up|2|||
124524849|NCT03039790|447872582|FG017|Overall Study|Lost to Follow-up|2|||
124524850|NCT03039790|447872583|FG018|Overall Study|Lost to Follow-up|1|||
124524851|NCT03039790|447872584|FG019|Overall Study|Lost to Follow-up|3|||
124524852|NCT03039790|447872565|FG000|Overall Study|Withdrawal of Consent|1|||
124524853|NCT03039790|447872566|FG001|Overall Study|Withdrawal of Consent|0|||
124524854|NCT03039790|447872567|FG002|Overall Study|Withdrawal of Consent|0|||
124524855|NCT03039790|447872568|FG003|Overall Study|Withdrawal of Consent|1|||
124524856|NCT03039790|447872569|FG004|Overall Study|Withdrawal of Consent|0|||
124524857|NCT03039790|447872570|FG005|Overall Study|Withdrawal of Consent|0|||
124524858|NCT03039790|447872571|FG006|Overall Study|Withdrawal of Consent|0|||
124524859|NCT03039790|447872572|FG007|Overall Study|Withdrawal of Consent|0|||
124524860|NCT03039790|447872573|FG008|Overall Study|Withdrawal of Consent|0|||
124524861|NCT03039790|447872574|FG009|Overall Study|Withdrawal of Consent|1|||
124524862|NCT03039790|447872575|FG010|Overall Study|Withdrawal of Consent|0|||
124524863|NCT03039790|447872576|FG011|Overall Study|Withdrawal of Consent|0|||
124524864|NCT03039790|447872577|FG012|Overall Study|Withdrawal of Consent|2|||
124524865|NCT03039790|447872578|FG013|Overall Study|Withdrawal of Consent|0|||
124524866|NCT03039790|447872579|FG014|Overall Study|Withdrawal of Consent|1|||
124524867|NCT03039790|447872580|FG015|Overall Study|Withdrawal of Consent|5|||
124524868|NCT03039790|447872581|FG016|Overall Study|Withdrawal of Consent|3|||
124524869|NCT03039790|447872582|FG017|Overall Study|Withdrawal of Consent|0|||
124524870|NCT03039790|447872583|FG018|Overall Study|Withdrawal of Consent|2|||
124524871|NCT03039790|447872584|FG019|Overall Study|Withdrawal of Consent|5|||
124524872|NCT03039790|447872565|FG000|Overall Study|Death|0|||
124524873|NCT03039790|447872566|FG001|Overall Study|Death|0|||
124524874|NCT03039790|447872567|FG002|Overall Study|Death|0|||
124524875|NCT03039790|447872568|FG003|Overall Study|Death|0|||
124524876|NCT03039790|447872569|FG004|Overall Study|Death|0|||
124524877|NCT03039790|447872570|FG005|Overall Study|Death|0|||
124524878|NCT03039790|447872571|FG006|Overall Study|Death|0|||
124524879|NCT03039790|447872572|FG007|Overall Study|Death|0|||
124524880|NCT03039790|447872573|FG008|Overall Study|Death|0|||
124524881|NCT03039790|447872574|FG009|Overall Study|Death|0|||
124524882|NCT03039790|447872575|FG010|Overall Study|Death|0|||
124524883|NCT03039790|447872576|FG011|Overall Study|Death|0|||
124524884|NCT03039790|447872577|FG012|Overall Study|Death|0|||
124524885|NCT03039790|447872578|FG013|Overall Study|Death|0|||
124524886|NCT03039790|447872579|FG014|Overall Study|Death|0|||
124524887|NCT03039790|447872580|FG015|Overall Study|Death|1|||
124524888|NCT03039790|447872581|FG016|Overall Study|Death|3|||
124524889|NCT03039790|447872582|FG017|Overall Study|Death|0|||
124524890|NCT03039790|447872583|FG018|Overall Study|Death|2|||
124524891|NCT03039790|447872584|FG019|Overall Study|Death|0|||
124524892|NCT03039790|447872565|FG000|Overall Study|Reason, not Specified|1|||
124524893|NCT03039790|447872566|FG001|Overall Study|Reason, not Specified|0|||
124524894|NCT03039790|447872567|FG002|Overall Study|Reason, not Specified|0|||
124524895|NCT03039790|447872568|FG003|Overall Study|Reason, not Specified|0|||
124524896|NCT03039790|447872569|FG004|Overall Study|Reason, not Specified|0|||
124524897|NCT03039790|447872570|FG005|Overall Study|Reason, not Specified|0|||
124524898|NCT03039790|447872571|FG006|Overall Study|Reason, not Specified|0|||
124524899|NCT03039790|447872572|FG007|Overall Study|Reason, not Specified|0|||
124524900|NCT03039790|447872573|FG008|Overall Study|Reason, not Specified|0|||
124524901|NCT03039790|447872574|FG009|Overall Study|Reason, not Specified|0|||
124524902|NCT03039790|447872575|FG010|Overall Study|Reason, not Specified|0|||
124524903|NCT03039790|447872576|FG011|Overall Study|Reason, not Specified|0|||
124524904|NCT03039790|447872577|FG012|Overall Study|Reason, not Specified|0|||
124524905|NCT03039790|447872578|FG013|Overall Study|Reason, not Specified|0|||
124524906|NCT03039790|447872579|FG014|Overall Study|Reason, not Specified|0|||
124524907|NCT03039790|447872580|FG015|Overall Study|Reason, not Specified|0|||
124524908|NCT03039790|447872581|FG016|Overall Study|Reason, not Specified|2|||
124524909|NCT03039790|447872582|FG017|Overall Study|Reason, not Specified|0|||
124524910|NCT03039790|447872583|FG018|Overall Study|Reason, not Specified|1|||
124524911|NCT03039790|447872584|FG019|Overall Study|Reason, not Specified|0|||
124524912|NCT02266004|447872594|FG000|Overall Study|unrelated adverse event|1|||
124524913|NCT02266004|447872594|FG000|Overall Study|Physician Decision|1|||
124524914|NCT00537771|447872599|FG000|Overall Study|Withdrawal by Subject|6|||
124524915|NCT00537771|447872600|FG001|Overall Study|Withdrawal by Subject|23|||
124524916|NCT00537771|447872599|FG000|Overall Study|Adverse Event|8|||
124524917|NCT00537771|447872600|FG001|Overall Study|Adverse Event|15|||
124524918|NCT00537771|447872599|FG000|Overall Study|Lost to Follow-up|9|||
124524919|NCT00537771|447872600|FG001|Overall Study|Lost to Follow-up|15|||
124524920|NCT00537771|447872599|FG000|Overall Study|Protocol Violation|2|||
124524921|NCT00537771|447872600|FG001|Overall Study|Protocol Violation|6|||
124524922|NCT00537771|447872599|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
124524923|NCT00537771|447872600|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
124524924|NCT02736929|447872604|FG000|Main Study|Lost to Follow-up|7|||
124524925|NCT02736929|447872605|FG001|Main Study|Lost to Follow-up|1|||
124524926|NCT02736929|447872606|FG002|Main Study|Lost to Follow-up|0|||
124524927|NCT02736929|447872604|FG000|Main Study|Withdrawal by Subject|1|||
124524928|NCT02736929|447872605|FG001|Main Study|Withdrawal by Subject|1|||
124524929|NCT02736929|447872606|FG002|Main Study|Withdrawal by Subject|0|||
124524930|NCT02736929|447872604|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
124524931|NCT02736929|447872605|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
124524932|NCT02736929|447872606|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
124524933|NCT01855425|447872611|FG000|Overall Study|Physician Decision|20|||
124524934|NCT00373880|447872615|FG000|Overall Study|Physician Decision|3|||
124524935|NCT00373880|447872615|FG000|Overall Study|Arrested|1|||
124524936|NCT00373880|447872615|FG000|Overall Study|Protocol Violation|14|||
124524937|NCT01634100|447872616|FG000|Overall Study|Withdrawal by Subject|1|||
124524938|NCT01634100|447872617|FG001|Overall Study|Withdrawal by Subject|0|||
124524939|NCT01634100|447872618|FG002|Overall Study|Withdrawal by Subject|1|||
124524940|NCT01634100|447872619|FG003|Overall Study|Withdrawal by Subject|0|||
124524941|NCT01634100|447872620|FG004|Overall Study|Withdrawal by Subject|0|||
124524942|NCT01634100|447872621|FG005|Overall Study|Withdrawal by Subject|0|||
124524943|NCT01662986|447872625|FG000|Overall Study|Adverse Event|5|||
124524944|NCT01662986|447872626|FG001|Overall Study|Adverse Event|4|||
124524945|NCT01662986|447872625|FG000|Overall Study|Protocol Violation|2|||
124524946|NCT01662986|447872626|FG001|Overall Study|Protocol Violation|3|||
124524947|NCT01662986|447872625|FG000|Overall Study|Lost to Follow-up|5|||
124524948|NCT01662986|447872626|FG001|Overall Study|Lost to Follow-up|4|||
124524949|NCT01662986|447872625|FG000|Overall Study|Withdrawal by Subject|2|||
124578293|NCT01597245|448076610|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
124578294|NCT01597245|448076611|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578295|NCT01597245|448076612|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578296|NCT01597245|448076613|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578297|NCT01597245|448076614|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578298|NCT01597245|448076615|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578299|NCT01597245|448076616|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578300|NCT01597245|448076617|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578301|NCT01597245|448076618|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578302|NCT01597245|448076619|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578303|NCT01597245|448076620|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578304|NCT01597245|448076621|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578305|NCT01597245|448076622|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578306|NCT01597245|448076623|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578307|NCT01597245|448076624|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578308|NCT01597245|448076625|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578309|NCT01597245|448076626|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578310|NCT01597245|448076627|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578311|NCT01597245|448076628|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
124578312|NCT01597245|448076608|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
124578313|NCT01597245|448076609|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578314|NCT01597245|448076610|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578315|NCT01597245|448076611|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
124578316|NCT01597245|448076612|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578317|NCT01597245|448076613|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578318|NCT01597245|448076614|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578319|NCT01597245|448076615|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578320|NCT01597245|448076616|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578321|NCT01597245|448076617|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578322|NCT01597245|448076618|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578323|NCT01597245|448076619|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578324|NCT01597245|448076620|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578325|NCT01597245|448076621|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578326|NCT01597245|448076622|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578327|NCT01597245|448076623|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578328|NCT01597245|448076624|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578329|NCT01597245|448076625|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578330|NCT01597245|448076626|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578331|NCT01597245|448076627|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578332|NCT01597245|448076628|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
124578333|NCT01597245|448076608|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
124578334|NCT01597245|448076609|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
124578335|NCT01597245|448076610|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
124578336|NCT01597245|448076611|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578337|NCT01597245|448076612|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578338|NCT01597245|448076613|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578339|NCT01597245|448076614|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578340|NCT01597245|448076615|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578341|NCT01597245|448076616|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578342|NCT01597245|448076617|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578343|NCT01597245|448076618|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578344|NCT01597245|448076619|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578345|NCT01597245|448076620|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578346|NCT01597245|448076621|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578347|NCT01597245|448076622|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578348|NCT01597245|448076623|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578349|NCT01597245|448076624|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578350|NCT01597245|448076625|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578351|NCT01597245|448076626|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578352|NCT01597245|448076627|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578353|NCT01597245|448076628|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
124578354|NCT01597245|448076608|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578355|NCT01597245|448076609|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578356|NCT01597245|448076610|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578357|NCT01597245|448076611|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578358|NCT01597245|448076612|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578359|NCT01597245|448076613|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
124578360|NCT01597245|448076614|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
124578361|NCT01597245|448076615|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578362|NCT01597245|448076616|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578363|NCT01597245|448076617|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578364|NCT01597245|448076618|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578365|NCT01597245|448076619|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578366|NCT01597245|448076620|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578367|NCT01597245|448076621|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578368|NCT01597245|448076622|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578369|NCT01597245|448076623|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578370|NCT01597245|448076624|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578371|NCT01597245|448076625|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578372|NCT01597245|448076626|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578373|NCT01597245|448076627|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578374|NCT01597245|448076628|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
124578375|NCT01597245|448076608|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
124578376|NCT01597245|448076609|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
124726053|NCT00433966|448618608|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
124726054|NCT00433966|448618609|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
124726055|NCT00433966|448618610|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
124726056|NCT00433966|448618607|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
124726057|NCT00433966|448618608|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
124726058|NCT00433966|448618609|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
124726059|NCT00433966|448618610|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
124726060|NCT02570152|448618611|FG000|Overall Study|Protocol Violation|2|||
124726061|NCT02570152|448618611|FG000|Overall Study|Migrated/moved from study area|13|||
124726062|NCT02957747|448618612|FG000|Overall Study|Withdrawal by Subject|0|||
124726063|NCT02957747|448618613|FG001|Overall Study|Withdrawal by Subject|3|||
124726064|NCT02957747|448618612|FG000|Overall Study|Lost to Follow-up|10|||
124726065|NCT02957747|448618613|FG001|Overall Study|Lost to Follow-up|5|||
124726066|NCT00960011|448618614|FG000|Overall Study|Death|5|||
124726067|NCT00960011|448618615|FG001|Overall Study|Death|0|||
124726068|NCT00960011|448618614|FG000|Overall Study|Lost to Follow-up|6|||
124726069|NCT00960011|448618615|FG001|Overall Study|Lost to Follow-up|2|||
124726070|NCT00632827|448618616|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
124726071|NCT00632827|448618616|FG000|Overall Study|Death|2|||
124726072|NCT00632827|448618616|FG000|Overall Study|Adverse Event|5|||
124726073|NCT00632827|448618616|FG000|Overall Study|Lost to Follow-up|1|||
124726074|NCT01177553|448618617|FG000|Overall Study|babies not yet 6 months of age|1|||
124726075|NCT01177553|448618618|FG001|Overall Study|babies not yet 6 months of age|0|||
124726076|NCT03931382|448618621|FG000|Overall Study|Equipment malfunction|2|||
124726077|NCT03931382|448618622|FG001|Overall Study|Equipment malfunction|0|||
124726078|NCT03931382|448618623|FG002|Overall Study|Equipment malfunction|2|||
124726079|NCT03931382|448618621|FG000|Overall Study|Withdrawal by Subject|0|||
124726080|NCT03931382|448618622|FG001|Overall Study|Withdrawal by Subject|1|||
124726081|NCT03931382|448618623|FG002|Overall Study|Withdrawal by Subject|0|||
124726082|NCT00778375|448618630|FG000|Overall Study|Ineligible|3|||
124726083|NCT00675441|448618637|FG000|Overall Study|Withdrawal by Subject|2|||
124726084|NCT00675441|448618637|FG000|Overall Study|Death|1|||
124726085|NCT01581021|448618638|FG000|Overall Study|Lost to Follow-up|4|||
124726086|NCT01581021|448618639|FG001|Overall Study|Lost to Follow-up|6|||
124726087|NCT01581021|448618638|FG000|Overall Study|More than 2 hooks in thoracic|3|||
124726088|NCT01581021|448618639|FG001|Overall Study|More than 2 hooks in thoracic|0|||
124726089|NCT01581021|448618638|FG000|Overall Study|Neuromuscular|2|||
124726090|NCT01581021|448618639|FG001|Overall Study|Neuromuscular|1|||
124726091|NCT01581021|448618638|FG000|Overall Study|Not Randomized|1|||
124726092|NCT01581021|448618639|FG001|Overall Study|Not Randomized|2|||
124726093|NCT01581021|448618638|FG000|Overall Study|Lenke 6 Classification|0|||
124726094|NCT01581021|448618639|FG001|Overall Study|Lenke 6 Classification|1|||
124726095|NCT01581021|448618638|FG000|Overall Study|Lack of Efficacy|0|||
124726096|NCT01581021|448618639|FG001|Overall Study|Lack of Efficacy|1|||
124726097|NCT00054327|448618645|FG000|Overall Study|Engraftment failure|1|||
124726098|NCT00054327|448618646|FG001|Overall Study|Engraftment failure|0|||
124726099|NCT00054327|448618647|FG002|Overall Study|Engraftment failure|0|||
124726100|NCT00054327|448618648|FG003|Overall Study|Engraftment failure|0|||
124726101|NCT00054327|448618649|FG004|Overall Study|Engraftment failure|0|||
124726102|NCT00054327|448618650|FG005|Overall Study|Engraftment failure|0|||
124726103|NCT00700882|448618651|FG000|Overall Study|Never received treatment|6|||
124726104|NCT00700882|448618651|FG000|Overall Study|Ineligible|2|||
124726105|NCT00700882|448618651|FG000|Overall Study|No KIT mutation|51|||
124776813|NCT05006573|448810020|FG001|Double-blind Treatment Period|Physician Decision|0|||
124524950|NCT01662986|447872626|FG001|Overall Study|Withdrawal by Subject|2|||
124524951|NCT01662986|447872625|FG000|Overall Study|Not Treated|1|||
124524952|NCT01662986|447872626|FG001|Overall Study|Not Treated|0|||
124524953|NCT01662986|447872625|FG000|Overall Study|Other than stated above|3|||
124524954|NCT01662986|447872626|FG001|Overall Study|Other than stated above|0|||
124524955|NCT01512693|447872629|FG000|Overall Study|Withdrawal by Subject|0|||
124524956|NCT01512693|447872630|FG001|Overall Study|Withdrawal by Subject|1|||
124524957|NCT01975376|447872631|FG000|Overall Study|Adverse Event|5|||
124524958|NCT01975376|447872632|FG001|Overall Study|Adverse Event|5|||
124524959|NCT01975376|447872631|FG000|Overall Study|Death|65|||
124524960|NCT01975376|447872632|FG001|Overall Study|Death|72|||
124524961|NCT01975376|447872631|FG000|Overall Study|Lost to Follow-up|70|||
124524962|NCT01975376|447872632|FG001|Overall Study|Lost to Follow-up|66|||
124524963|NCT01975376|447872631|FG000|Overall Study|Withdrew consent|68|||
124524964|NCT01975376|447872632|FG001|Overall Study|Withdrew consent|62|||
124524965|NCT01975376|447872631|FG000|Overall Study|Other|2|||
124524966|NCT01975376|447872632|FG001|Overall Study|Other|4|||
124524967|NCT01975376|447872631|FG000|Overall Study|Randomized, Not Treated|16|||
124524968|NCT01975376|447872632|FG001|Overall Study|Randomized, Not Treated|8|||
124524969|NCT04731922|447872633|FG000|Overall Study|Adverse Event|0|||
124524970|NCT04731922|447872634|FG001|Overall Study|Adverse Event|0|||
124524971|NCT04731922|447872635|FG002|Overall Study|Adverse Event|0|||
124524972|NCT04731922|447872636|FG003|Overall Study|Adverse Event|0|||
124524973|NCT04731922|447872637|FG004|Overall Study|Adverse Event|0|||
124524974|NCT04731922|447872638|FG005|Overall Study|Adverse Event|0|||
124524975|NCT04731922|447872639|FG006|Overall Study|Adverse Event|0|||
124524976|NCT04731922|447872640|FG007|Overall Study|Adverse Event|0|||
124524977|NCT04731922|447872641|FG008|Overall Study|Adverse Event|0|||
124524978|NCT04731922|447872642|FG009|Overall Study|Adverse Event|0|||
124524979|NCT04731922|447872643|FG010|Overall Study|Adverse Event|1|||
124524980|NCT04731922|447872644|FG011|Overall Study|Adverse Event|0|||
124524981|NCT04731922|447872645|FG012|Overall Study|Adverse Event|0|||
124524982|NCT04731922|447872646|FG013|Overall Study|Adverse Event|0|||
124524983|NCT04731922|447872647|FG014|Overall Study|Adverse Event|0|||
124524984|NCT04731922|447872648|FG015|Overall Study|Adverse Event|0|||
124524985|NCT04731922|447872649|FG016|Overall Study|Adverse Event|0|||
124524986|NCT04731922|447872633|FG000|Overall Study|Lost to Follow-up|0|||
124524987|NCT04731922|447872634|FG001|Overall Study|Lost to Follow-up|0|||
124524988|NCT04731922|447872635|FG002|Overall Study|Lost to Follow-up|0|||
124524989|NCT04731922|447872636|FG003|Overall Study|Lost to Follow-up|1|||
124524990|NCT04731922|447872637|FG004|Overall Study|Lost to Follow-up|0|||
124524991|NCT04731922|447872638|FG005|Overall Study|Lost to Follow-up|1|||
124524992|NCT04731922|447872639|FG006|Overall Study|Lost to Follow-up|0|||
124524993|NCT04731922|447872640|FG007|Overall Study|Lost to Follow-up|0|||
124524994|NCT04731922|447872641|FG008|Overall Study|Lost to Follow-up|0|||
124524995|NCT04731922|447872642|FG009|Overall Study|Lost to Follow-up|0|||
124524996|NCT04731922|447872643|FG010|Overall Study|Lost to Follow-up|0|||
124524997|NCT04731922|447872644|FG011|Overall Study|Lost to Follow-up|0|||
124524998|NCT04731922|447872645|FG012|Overall Study|Lost to Follow-up|0|||
124524999|NCT04731922|447872646|FG013|Overall Study|Lost to Follow-up|0|||
124525000|NCT04731922|447872647|FG014|Overall Study|Lost to Follow-up|0|||
124525001|NCT04731922|447872648|FG015|Overall Study|Lost to Follow-up|0|||
124525002|NCT04731922|447872649|FG016|Overall Study|Lost to Follow-up|0|||
124525003|NCT04731922|447872633|FG000|Overall Study|Withdrawal by Subject|1|||
124525004|NCT04731922|447872634|FG001|Overall Study|Withdrawal by Subject|0|||
124525005|NCT04731922|447872635|FG002|Overall Study|Withdrawal by Subject|0|||
124525006|NCT04731922|447872636|FG003|Overall Study|Withdrawal by Subject|0|||
124525007|NCT04731922|447872637|FG004|Overall Study|Withdrawal by Subject|1|||
124525008|NCT04731922|447872638|FG005|Overall Study|Withdrawal by Subject|0|||
124525009|NCT04731922|447872639|FG006|Overall Study|Withdrawal by Subject|1|||
124525010|NCT04731922|447872640|FG007|Overall Study|Withdrawal by Subject|0|||
124525011|NCT04731922|447872641|FG008|Overall Study|Withdrawal by Subject|0|||
124525012|NCT04731922|447872642|FG009|Overall Study|Withdrawal by Subject|0|||
124525013|NCT04731922|447872643|FG010|Overall Study|Withdrawal by Subject|0|||
124525014|NCT04731922|447872644|FG011|Overall Study|Withdrawal by Subject|0|||
124525015|NCT04731922|447872645|FG012|Overall Study|Withdrawal by Subject|0|||
124525016|NCT04731922|447872646|FG013|Overall Study|Withdrawal by Subject|1|||
124525017|NCT04731922|447872647|FG014|Overall Study|Withdrawal by Subject|0|||
124525018|NCT04731922|447872648|FG015|Overall Study|Withdrawal by Subject|0|||
124525019|NCT04731922|447872649|FG016|Overall Study|Withdrawal by Subject|0|||
124525020|NCT04731922|447872633|FG000|Overall Study|Other|0|||
124525021|NCT04731922|447872634|FG001|Overall Study|Other|0|||
124525022|NCT04731922|447872635|FG002|Overall Study|Other|0|||
124525023|NCT04731922|447872636|FG003|Overall Study|Other|0|||
124525024|NCT04731922|447872637|FG004|Overall Study|Other|0|||
124525025|NCT04731922|447872638|FG005|Overall Study|Other|0|||
124525026|NCT04731922|447872639|FG006|Overall Study|Other|1|||
124525027|NCT04731922|447872640|FG007|Overall Study|Other|0|||
124525028|NCT04731922|447872641|FG008|Overall Study|Other|0|||
124578377|NCT01597245|448076610|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
124578378|NCT01597245|448076611|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
124578379|NCT01597245|448076612|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
124578380|NCT01597245|448076613|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
124578381|NCT01597245|448076614|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
124578382|NCT01597245|448076615|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
124578383|NCT01597245|448076616|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
124578384|NCT01597245|448076617|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
124578385|NCT01597245|448076618|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
124578386|NCT01597245|448076619|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
124578387|NCT01597245|448076620|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
124578388|NCT01597245|448076621|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
124578389|NCT01597245|448076622|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
124578390|NCT01597245|448076623|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
124578391|NCT01597245|448076624|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
124578392|NCT01597245|448076625|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
124578393|NCT01597245|448076626|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
124578394|NCT01597245|448076627|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
124578395|NCT01597245|448076628|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
124578396|NCT01597245|448076608|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
124578397|NCT01597245|448076609|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
124578398|NCT01597245|448076610|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
124578399|NCT01597245|448076611|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
124578400|NCT01597245|448076612|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
124578401|NCT01597245|448076613|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
124578402|NCT01597245|448076614|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
124578403|NCT01597245|448076615|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
124578404|NCT01597245|448076616|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
124578405|NCT01597245|448076617|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
124578406|NCT01597245|448076618|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
124578407|NCT01597245|448076619|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
124578408|NCT01597245|448076620|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
124578409|NCT01597245|448076621|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
124578410|NCT01597245|448076622|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
124578411|NCT01597245|448076623|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
124578412|NCT01597245|448076624|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
124578413|NCT01597245|448076625|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
124578414|NCT01597245|448076626|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
124578415|NCT01597245|448076627|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
124578416|NCT01597245|448076628|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
124578417|NCT01597245|448076608|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
124578418|NCT01597245|448076609|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
124578419|NCT01597245|448076610|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
124578420|NCT01597245|448076611|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
124578421|NCT01597245|448076612|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
124578422|NCT01597245|448076613|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
124578423|NCT01597245|448076614|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
124578424|NCT01597245|448076615|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
124578425|NCT01597245|448076616|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
124578426|NCT01597245|448076617|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
124578427|NCT01597245|448076618|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
124578428|NCT01597245|448076619|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
124578429|NCT01597245|448076620|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
124578430|NCT01597245|448076621|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
124578431|NCT01597245|448076622|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
124578432|NCT01597245|448076623|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
124578433|NCT01597245|448076624|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
124578434|NCT01597245|448076625|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
124578435|NCT01597245|448076626|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
124578436|NCT01597245|448076627|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
124578437|NCT01597245|448076628|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
124578438|NCT01597245|448076608|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
124578439|NCT01597245|448076609|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
124578440|NCT01597245|448076610|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
124578441|NCT01597245|448076611|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
124578442|NCT01597245|448076612|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
124525029|NCT04731922|447872642|FG009|Overall Study|Other|0|||
124525030|NCT04731922|447872643|FG010|Overall Study|Other|0|||
124525031|NCT04731922|447872644|FG011|Overall Study|Other|0|||
124525032|NCT04731922|447872645|FG012|Overall Study|Other|0|||
124525033|NCT04731922|447872646|FG013|Overall Study|Other|0|||
124525034|NCT04731922|447872647|FG014|Overall Study|Other|0|||
124525035|NCT04731922|447872648|FG015|Overall Study|Other|0|||
124525036|NCT04731922|447872649|FG016|Overall Study|Other|0|||
124525037|NCT01819194|447872651|FG000|Overall Study|Loss of study articles|2|||
124525038|NCT02343952|447872656|FG000|Study Treatment|Disease Progression|23|||
124525039|NCT02343952|447872656|FG000|Study Treatment|Death|3|||
124525040|NCT02343952|447872656|FG000|Study Treatment|Adverse Event|19|||
124525041|NCT02343952|447872656|FG000|Study Treatment|Withdrawal by Subject|7|||
124525042|NCT02343952|447872656|FG000|Study Treatment|other complicating Diseases|1|||
124525043|NCT02343952|447872656|FG000|Follow up|Withdrawal by Subject|3|||
124525044|NCT02343952|447872656|FG000|Follow up|Death|33|||
124525045|NCT02343952|447872656|FG000|Follow up|Patient does not meet eligibility for study.|1|||
124525046|NCT02343952|447872656|FG000|Follow up|Research department closed by the practice.|5|||
124525047|NCT02343952|447872656|FG000|Follow up|Patient went home to Russia|1|||
124525048|NCT02343952|447872656|FG000|Follow up|Disease Progression|1|||
124525049|NCT02343952|447872656|FG000|Follow up|study terminated|1|||
124525050|NCT01922739|447872659|FG000|Titration/Adjustment Period|Adverse Event|3|||
124525051|NCT01922739|447872659|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
124525052|NCT01922739|447872659|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
124525053|NCT01922739|447872659|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
124525054|NCT01922739|447872659|FG000|Open-label Treatment Period|Adverse Event|6|||
124525055|NCT01922739|447872659|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
124525056|NCT01922739|447872659|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
124525057|NCT01922739|447872659|FG000|Open-label Treatment Period|Protocol Violation|5|||
124525058|NCT01922739|447872659|FG000|Open-label Treatment Period|Pregnancy|1|||
124525059|NCT01922739|447872659|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
124525060|NCT01922739|447872659|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
124525061|NCT01922739|447872659|FG000|Open-label Treatment Period|Physician Decision|1|||
124525062|NCT01922739|447872659|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
124525063|NCT02725268|447872660|FG000|Overall Study|Death|58|||
124525064|NCT02725268|447872661|FG001|Overall Study|Death|59|||
124525065|NCT02725268|447872662|FG002|Overall Study|Death|30|||
124525066|NCT02725268|447872663|FG003|Overall Study|Death|16|||
124525067|NCT02725268|447872660|FG000|Overall Study|Lost to Follow-up|4|||
124525068|NCT02725268|447872661|FG001|Overall Study|Lost to Follow-up|3|||
124525069|NCT02725268|447872662|FG002|Overall Study|Lost to Follow-up|0|||
124525070|NCT02725268|447872663|FG003|Overall Study|Lost to Follow-up|1|||
124525071|NCT02725268|447872660|FG000|Overall Study|Site Terminated by Sponsor|0|||
124525072|NCT02725268|447872661|FG001|Overall Study|Site Terminated by Sponsor|1|||
124525073|NCT02725268|447872662|FG002|Overall Study|Site Terminated by Sponsor|0|||
124525074|NCT02725268|447872663|FG003|Overall Study|Site Terminated by Sponsor|0|||
124525075|NCT02725268|447872660|FG000|Overall Study|Withdrawal by Subject|8|||
124525076|NCT02725268|447872661|FG001|Overall Study|Withdrawal by Subject|6|||
124525077|NCT02725268|447872662|FG002|Overall Study|Withdrawal by Subject|8|||
124525078|NCT02725268|447872663|FG003|Overall Study|Withdrawal by Subject|1|||
124525079|NCT02725268|447872660|FG000|Overall Study|Reason not Specified|2|||
124525080|NCT02725268|447872661|FG001|Overall Study|Reason not Specified|1|||
124525081|NCT02725268|447872662|FG002|Overall Study|Reason not Specified|0|||
124525082|NCT02725268|447872663|FG003|Overall Study|Reason not Specified|0|||
124525083|NCT04498468|447872664|FG000|Overall Study|Lost to Follow-up|3|||
124525084|NCT02224274|447872666|FG000|Overall Study|Death|1|||
124525085|NCT02224274|447872667|FG001|Overall Study|Death|0|||
124525086|NCT01976624|447872668|FG000|Overall Study|Participants contraindicated|2|||
124525087|NCT01976624|447872668|FG000|Overall Study|Participants age less than 19 years|12|||
124525088|NCT04350372|447872669|FG000|Overall Study|Death|1|||
124525089|NCT00412113|447872671|FG000|Overall Study|Adverse Event|11|||
124525090|NCT00412113|447872672|FG001|Overall Study|Adverse Event|15|||
124525091|NCT00412113|447872671|FG000|Overall Study|did not receive treatment|1|||
124525092|NCT00412113|447872672|FG001|Overall Study|did not receive treatment|0|||
124525093|NCT01627782|447872675|FG000|Overall Study|Adverse Event|1|||
124525094|NCT01627782|447872676|FG001|Overall Study|Adverse Event|2|||
124525095|NCT01627782|447872677|FG002|Overall Study|Adverse Event|0|||
124525096|NCT01627782|447872678|FG003|Overall Study|Adverse Event|1|||
124525097|NCT01627782|447872675|FG000|Overall Study|Lack of Efficacy|11|||
124525098|NCT01627782|447872676|FG001|Overall Study|Lack of Efficacy|1|||
124525099|NCT01627782|447872677|FG002|Overall Study|Lack of Efficacy|15|||
124525100|NCT01627782|447872678|FG003|Overall Study|Lack of Efficacy|2|||
124525101|NCT01627782|447872675|FG000|Overall Study|Protocol Violation|1|||
124525102|NCT01627782|447872676|FG001|Overall Study|Protocol Violation|0|||
124525103|NCT01627782|447872677|FG002|Overall Study|Protocol Violation|0|||
124578443|NCT01597245|448076613|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
124578444|NCT01597245|448076614|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
124578445|NCT01597245|448076615|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
124578446|NCT01597245|448076616|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
124578447|NCT01597245|448076617|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
124578448|NCT01597245|448076618|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
124578449|NCT01597245|448076619|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
124578450|NCT01597245|448076620|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
124578451|NCT01597245|448076621|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
124578452|NCT01597245|448076622|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
124578453|NCT01597245|448076623|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
124578454|NCT01597245|448076624|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
124578455|NCT01597245|448076625|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
124578456|NCT01597245|448076626|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
124578457|NCT01597245|448076627|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
124578458|NCT01597245|448076628|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
124578459|NCT01597245|448076608|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
124578460|NCT01597245|448076609|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
124578461|NCT01597245|448076610|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
124578462|NCT01597245|448076611|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
124578463|NCT01597245|448076612|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
124578464|NCT01597245|448076613|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
124578465|NCT01597245|448076614|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
124525104|NCT01627782|447872678|FG003|Overall Study|Protocol Violation|0|||
124525105|NCT01627782|447872675|FG000|Overall Study|Withdrawal by Subject|2|||
124525106|NCT01627782|447872676|FG001|Overall Study|Withdrawal by Subject|1|||
124525107|NCT01627782|447872677|FG002|Overall Study|Withdrawal by Subject|0|||
124525108|NCT01627782|447872678|FG003|Overall Study|Withdrawal by Subject|0|||
124525109|NCT01627782|447872675|FG000|Overall Study|Other|0|||
124525110|NCT01627782|447872676|FG001|Overall Study|Other|2|||
124525111|NCT01627782|447872677|FG002|Overall Study|Other|0|||
124525112|NCT01627782|447872678|FG003|Overall Study|Other|3|||
124525113|NCT01627782|447872675|FG000|Overall Study|Randomized But Not Treated|1|||
124525114|NCT01627782|447872676|FG001|Overall Study|Randomized But Not Treated|0|||
124525115|NCT01627782|447872677|FG002|Overall Study|Randomized But Not Treated|0|||
124525116|NCT01627782|447872678|FG003|Overall Study|Randomized But Not Treated|0|||
124525117|NCT03573401|447872679|FG000|Overall Study|Withdrawal by Subject|2|||
124525118|NCT03573401|447872680|FG001|Overall Study|Withdrawal by Subject|0|||
124525119|NCT03573401|447872679|FG000|Overall Study|Subject non-compliance with study schedule|1|||
124525120|NCT03573401|447872680|FG001|Overall Study|Subject non-compliance with study schedule|0|||
124525121|NCT03573401|447872679|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
124525122|NCT03573401|447872680|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
124525123|NCT03573401|447872679|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
124525124|NCT03573401|447872680|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
124525125|NCT04315298|447874729|FG000|Overall Study|Withdrawal by Subject|0|||
124525126|NCT04315298|447874730|FG001|Overall Study|Withdrawal by Subject|0|||
124525127|NCT04315298|447874731|FG002|Overall Study|Withdrawal by Subject|0|||
124525128|NCT04315298|447874732|FG003|Overall Study|Withdrawal by Subject|2|||
124525129|NCT04315298|447874733|FG004|Overall Study|Withdrawal by Subject|2|||
124525130|NCT04315298|447874734|FG005|Overall Study|Withdrawal by Subject|2|||
124525131|NCT04315298|447874735|FG006|Overall Study|Withdrawal by Subject|0|||
124525132|NCT04315298|447874736|FG007|Overall Study|Withdrawal by Subject|1|||
124525133|NCT04315298|447874737|FG008|Overall Study|Withdrawal by Subject|1|||
124525134|NCT04315298|447874738|FG009|Overall Study|Withdrawal by Subject|1|||
124525135|NCT04315298|447874739|FG010|Overall Study|Withdrawal by Subject|0|||
124525136|NCT04315298|447874740|FG011|Overall Study|Withdrawal by Subject|0|||
124525137|NCT04315298|447874741|FG012|Overall Study|Withdrawal by Subject|0|||
124525138|NCT04315298|447874742|FG013|Overall Study|Withdrawal by Subject|0|||
124525139|NCT04315298|447874743|FG014|Overall Study|Withdrawal by Subject|0|||
124525140|NCT04315298|447874744|FG015|Overall Study|Withdrawal by Subject|0|||
124525141|NCT04315298|447874745|FG016|Overall Study|Withdrawal by Subject|0|||
124578466|NCT01597245|448076615|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
124578467|NCT01597245|448076616|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
124578468|NCT01597245|448076617|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
124525142|NCT04315298|447874746|FG017|Overall Study|Withdrawal by Subject|0|||
124525143|NCT04315298|447874747|FG018|Overall Study|Withdrawal by Subject|0|||
124525144|NCT04315298|447874729|FG000|Overall Study|Physician Decision|0|||
124525145|NCT04315298|447874730|FG001|Overall Study|Physician Decision|0|||
124578469|NCT01597245|448076618|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
124578470|NCT01597245|448076619|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
124578471|NCT01597245|448076620|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
124578472|NCT01597245|448076621|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
124578473|NCT01597245|448076622|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
124578474|NCT01597245|448076623|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
124525146|NCT04315298|447874731|FG002|Overall Study|Physician Decision|0|||
124525147|NCT04315298|447874732|FG003|Overall Study|Physician Decision|0|||
124525148|NCT04315298|447874733|FG004|Overall Study|Physician Decision|1|||
124525149|NCT04315298|447874734|FG005|Overall Study|Physician Decision|0|||
124525150|NCT04315298|447874735|FG006|Overall Study|Physician Decision|0|||
124525151|NCT04315298|447874736|FG007|Overall Study|Physician Decision|0|||
124525152|NCT04315298|447874737|FG008|Overall Study|Physician Decision|0|||
124525153|NCT04315298|447874738|FG009|Overall Study|Physician Decision|0|||
124525154|NCT04315298|447874739|FG010|Overall Study|Physician Decision|0|||
124525155|NCT04315298|447874740|FG011|Overall Study|Physician Decision|0|||
124525156|NCT04315298|447874741|FG012|Overall Study|Physician Decision|0|||
124525157|NCT04315298|447874742|FG013|Overall Study|Physician Decision|0|||
124525158|NCT04315298|447874743|FG014|Overall Study|Physician Decision|0|||
124525159|NCT04315298|447874744|FG015|Overall Study|Physician Decision|0|||
124525160|NCT04315298|447874745|FG016|Overall Study|Physician Decision|0|||
124525161|NCT04315298|447874746|FG017|Overall Study|Physician Decision|0|||
124525162|NCT04315298|447874747|FG018|Overall Study|Physician Decision|0|||
124525163|NCT04315298|447874729|FG000|Overall Study|Lost to Follow-up|5|||
124525164|NCT04315298|447874730|FG001|Overall Study|Lost to Follow-up|10|||
124525165|NCT04315298|447874731|FG002|Overall Study|Lost to Follow-up|6|||
124525166|NCT04315298|447874732|FG003|Overall Study|Lost to Follow-up|8|||
124525167|NCT04315298|447874733|FG004|Overall Study|Lost to Follow-up|12|||
124525168|NCT04315298|447874734|FG005|Overall Study|Lost to Follow-up|13|||
124525169|NCT04315298|447874735|FG006|Overall Study|Lost to Follow-up|9|||
124525170|NCT04315298|447874736|FG007|Overall Study|Lost to Follow-up|16|||
124525171|NCT04315298|447874737|FG008|Overall Study|Lost to Follow-up|14|||
124525172|NCT04315298|447874738|FG009|Overall Study|Lost to Follow-up|0|||
124525173|NCT04315298|447874739|FG010|Overall Study|Lost to Follow-up|2|||
124525174|NCT04315298|447874740|FG011|Overall Study|Lost to Follow-up|1|||
124525175|NCT04315298|447874741|FG012|Overall Study|Lost to Follow-up|0|||
124525176|NCT04315298|447874742|FG013|Overall Study|Lost to Follow-up|0|||
124525177|NCT04315298|447874743|FG014|Overall Study|Lost to Follow-up|0|||
124525178|NCT04315298|447874744|FG015|Overall Study|Lost to Follow-up|2|||
124525179|NCT04315298|447874745|FG016|Overall Study|Lost to Follow-up|0|||
124525180|NCT04315298|447874746|FG017|Overall Study|Lost to Follow-up|0|||
124525181|NCT04315298|447874747|FG018|Overall Study|Lost to Follow-up|0|||
124525182|NCT04315298|447874729|FG000|Overall Study|Death|24|||
124525183|NCT04315298|447874730|FG001|Overall Study|Death|60|||
124525184|NCT04315298|447874731|FG002|Overall Study|Death|49|||
124525185|NCT04315298|447874732|FG003|Overall Study|Death|59|||
124525186|NCT04315298|447874733|FG004|Overall Study|Death|70|||
124525187|NCT04315298|447874734|FG005|Overall Study|Death|114|||
124525188|NCT04315298|447874735|FG006|Overall Study|Death|9|||
124525189|NCT04315298|447874736|FG007|Overall Study|Death|12|||
124525190|NCT04315298|447874737|FG008|Overall Study|Death|21|||
124525191|NCT04315298|447874738|FG009|Overall Study|Death|16|||
124525192|NCT04315298|447874739|FG010|Overall Study|Death|40|||
124525193|NCT04315298|447874740|FG011|Overall Study|Death|40|||
124525194|NCT04315298|447874741|FG012|Overall Study|Death|3|||
124525195|NCT04315298|447874742|FG013|Overall Study|Death|4|||
124525196|NCT04315298|447874743|FG014|Overall Study|Death|6|||
124525197|NCT04315298|447874744|FG015|Overall Study|Death|4|||
124525198|NCT04315298|447874745|FG016|Overall Study|Death|3|||
124525199|NCT04315298|447874746|FG017|Overall Study|Death|1|||
124525200|NCT04315298|447874747|FG018|Overall Study|Death|0|||
124525201|NCT00736385|447874748|FG000|Overall Study|Withdrawal by Subject|2|||
124578475|NCT01597245|448076624|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
124578476|NCT01597245|448076625|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
124525202|NCT00736385|447874749|FG001|Overall Study|Withdrawal by Subject|2|||
124525203|NCT00736385|447874748|FG000|Overall Study|Adverse Event|0|||
124525204|NCT00736385|447874749|FG001|Overall Study|Adverse Event|1|||
124525205|NCT00098865|447874750|FG000|Overall Study|Progressive Disease|6|||
124525206|NCT00098865|447874750|FG000|Overall Study|Adverse Event|2|||
124525207|NCT00098865|447874750|FG000|Overall Study|Alternative Therapy|1|||
124525208|NCT00688623|447874752|FG000|Overall Study|Adverse Event|22|||
124525209|NCT00688623|447874752|FG000|Overall Study|abnormal lab value|1|||
124525210|NCT00688623|447874752|FG000|Overall Study|Withdrawal by Subject|4|||
124525211|NCT00688623|447874752|FG000|Overall Study|Death|3|||
124525212|NCT00688623|447874752|FG000|Overall Study|disease progression|23|||
124525213|NCT00688623|447874752|FG000|Overall Study|Protocol Violation|2|||
124525214|NCT02667236|447874753|FG000|Overall Study|Adverse Event|1|||
124525215|NCT02667236|447874754|FG001|Overall Study|Adverse Event|1|||
124525216|NCT02667236|447874753|FG000|Overall Study|Withdrawal by Subject|2|||
124726106|NCT04154293|448618661|FG000|Overall Study|Withdrawal by Subject|2|||
124726107|NCT04154293|448618662|FG001|Overall Study|Withdrawal by Subject|3|||
124726108|NCT04154293|448618663|FG002|Overall Study|Withdrawal by Subject|1|||
124726109|NCT04154293|448618661|FG000|Overall Study|Physician Decision|0|||
124726110|NCT04154293|448618662|FG001|Overall Study|Physician Decision|0|||
124726111|NCT04154293|448618663|FG002|Overall Study|Physician Decision|1|||
124726112|NCT02487654|448618664|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
124726113|NCT02487654|448618665|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
124726114|NCT02487654|448618664|FG000|Overall Study|Withdrawal by Subject|3|||
124726115|NCT02487654|448618665|FG001|Overall Study|Withdrawal by Subject|7|||
124726116|NCT02152371|448618667|FG000|Overall Study|Adverse Event|6|||
124726117|NCT02152371|448618668|FG001|Overall Study|Adverse Event|2|||
124726118|NCT02152371|448618667|FG000|Overall Study|Withdrawal by Subject|3|||
124726119|NCT02152371|448618668|FG001|Overall Study|Withdrawal by Subject|7|||
124726120|NCT02152371|448618667|FG000|Overall Study|Protocol Violation|2|||
124726121|NCT02152371|448618668|FG001|Overall Study|Protocol Violation|3|||
124726122|NCT02152371|448618667|FG000|Overall Study|Lost to Follow-up|1|||
124726123|NCT02152371|448618668|FG001|Overall Study|Lost to Follow-up|0|||
124726124|NCT02152371|448618667|FG000|Overall Study|Lack of Efficacy|0|||
124726125|NCT02152371|448618668|FG001|Overall Study|Lack of Efficacy|1|||
124726126|NCT02152371|448618667|FG000|Overall Study|Physician Decision|0|||
124726127|NCT02152371|448618668|FG001|Overall Study|Physician Decision|2|||
124726128|NCT02152371|448618667|FG000|Overall Study|Reason Not Given|0|||
124726129|NCT02152371|448618668|FG001|Overall Study|Reason Not Given|1|||
124726130|NCT05596734|448618676|FG000|Substudy A|Withdrawal by Subject|1|||
124578477|NCT01597245|448076626|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
124578478|NCT01597245|448076627|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
124578479|NCT01597245|448076628|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
124578480|NCT01597245|448076608|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
124578481|NCT01597245|448076609|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
124578482|NCT01597245|448076610|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
124578483|NCT01597245|448076611|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
124578484|NCT01597245|448076612|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
124578485|NCT01597245|448076613|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
124578486|NCT01597245|448076614|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
124578487|NCT01597245|448076615|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
124578488|NCT01597245|448076616|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
124578489|NCT01597245|448076617|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
124578490|NCT01597245|448076618|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
124578491|NCT01597245|448076619|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
124578492|NCT01597245|448076620|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
124578493|NCT01597245|448076621|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
124578494|NCT01597245|448076622|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
124578495|NCT01597245|448076623|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
124578496|NCT01597245|448076624|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
124578497|NCT01597245|448076625|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
124578498|NCT01597245|448076626|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
124578499|NCT01597245|448076627|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
124578500|NCT01597245|448076628|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
124578501|NCT01597245|448076608|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
124578502|NCT01597245|448076609|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
124726131|NCT05596734|448618677|FG001|Substudy A|Withdrawal by Subject|0|||
124726132|NCT05596734|448618678|FG002|Substudy A|Withdrawal by Subject|0|||
124726133|NCT05596734|448618679|FG003|Substudy A|Withdrawal by Subject|0|||
124726134|NCT05596734|448618680|FG004|Substudy A|Withdrawal by Subject|0|||
124726135|NCT05596734|448618681|FG005|Substudy A|Withdrawal by Subject|0|||
124726136|NCT05596734|448618682|FG006|Substudy A|Withdrawal by Subject|1|||
124726137|NCT05596734|448618683|FG007|Substudy A|Withdrawal by Subject|0|||
124726138|NCT05596734|448618684|FG008|Substudy A|Withdrawal by Subject|0|||
124726139|NCT05596734|448618685|FG009|Substudy A|Withdrawal by Subject|0|||
124578503|NCT01597245|448076610|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
124578504|NCT01597245|448076611|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
124726140|NCT05596734|448618686|FG010|Substudy A|Withdrawal by Subject|0|||
124726141|NCT05596734|448618687|FG011|Substudy A|Withdrawal by Subject|0|||
124726142|NCT05596734|448618688|FG012|Substudy A|Withdrawal by Subject|0|||
124726143|NCT05596734|448618689|FG013|Substudy A|Withdrawal by Subject|0|||
124726144|NCT05596734|448618690|FG014|Substudy A|Withdrawal by Subject|0|||
124726145|NCT05596734|448618691|FG015|Substudy A|Withdrawal by Subject|0|||
124726146|NCT05596734|448618692|FG016|Substudy A|Withdrawal by Subject|0|||
124726147|NCT05596734|448618693|FG017|Substudy A|Withdrawal by Subject|0|||
124726148|NCT05596734|448618694|FG018|Substudy A|Withdrawal by Subject|0|||
124726149|NCT05596734|448618695|FG019|Substudy A|Withdrawal by Subject|0|||
124525217|NCT02667236|447874754|FG001|Overall Study|Withdrawal by Subject|0|||
124525218|NCT03887052|447874757|FG000|Overall Study|Adverse Event|2|||
124525219|NCT03887052|447874757|FG000|Overall Study|Physician Decision|2|||
124525220|NCT03887052|447874757|FG000|Overall Study|Withdrawal by Subject|3|||
124525221|NCT03887052|447874757|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
124525222|NCT03887052|447874757|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
124525223|NCT03687827|447874761|FG000|Treatment Period 1|Death|0|||
124525224|NCT03687827|447874762|FG001|Treatment Period 1|Death|1|||
124525225|NCT03687827|447874761|FG000|Treatment Period 1|Lost to Follow-up|2|||
124525226|NCT03687827|447874762|FG001|Treatment Period 1|Lost to Follow-up|2|||
124525227|NCT03687827|447874761|FG000|Treatment Period 1|Physician Decision|5|||
124525228|NCT03687827|447874762|FG001|Treatment Period 1|Physician Decision|2|||
124525229|NCT03687827|447874761|FG000|Treatment Period 1|Withdrawal by Subject|7|||
124525230|NCT03687827|447874762|FG001|Treatment Period 1|Withdrawal by Subject|3|||
124525231|NCT03687827|447874761|FG000|Treatment Period 2|Physician Decision|4|||
124525232|NCT03687827|447874762|FG001|Treatment Period 2|Physician Decision|1|||
124578505|NCT01597245|448076612|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
124578506|NCT01597245|448076613|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
124578507|NCT01597245|448076614|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
124578508|NCT01597245|448076615|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
124578509|NCT01597245|448076616|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
124578510|NCT01597245|448076617|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
124578511|NCT01597245|448076618|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
124578512|NCT01597245|448076619|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
124578513|NCT01597245|448076620|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
124578514|NCT01597245|448076621|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
124578515|NCT01597245|448076622|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
124578516|NCT01597245|448076623|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
124578517|NCT01597245|448076624|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
124578518|NCT01597245|448076625|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
124578519|NCT01597245|448076626|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
124578520|NCT01597245|448076627|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
124578521|NCT01597245|448076628|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
124578522|NCT01597245|448076608|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578523|NCT01597245|448076609|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578524|NCT01597245|448076610|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578525|NCT01597245|448076611|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124726150|NCT05596734|448618696|FG020|Substudy A|Withdrawal by Subject|0|||
124726151|NCT05596734|448618697|FG021|Substudy A|Withdrawal by Subject|0|||
124726152|NCT05596734|448618698|FG022|Substudy A|Withdrawal by Subject|0|||
124726153|NCT05596734|448618699|FG023|Substudy A|Withdrawal by Subject|0|||
124726154|NCT05596734|448618676|FG000|Substudy A|Lost to Follow-up|1|||
124726155|NCT05596734|448618677|FG001|Substudy A|Lost to Follow-up|0|||
124726156|NCT05596734|448618678|FG002|Substudy A|Lost to Follow-up|1|||
124726157|NCT05596734|448618679|FG003|Substudy A|Lost to Follow-up|0|||
124726158|NCT05596734|448618680|FG004|Substudy A|Lost to Follow-up|0|||
124726159|NCT05596734|448618681|FG005|Substudy A|Lost to Follow-up|0|||
124726160|NCT05596734|448618682|FG006|Substudy A|Lost to Follow-up|0|||
124726161|NCT05596734|448618683|FG007|Substudy A|Lost to Follow-up|0|||
124726162|NCT05596734|448618684|FG008|Substudy A|Lost to Follow-up|0|||
124726163|NCT05596734|448618685|FG009|Substudy A|Lost to Follow-up|0|||
124726164|NCT05596734|448618686|FG010|Substudy A|Lost to Follow-up|0|||
124525233|NCT03687827|447874761|FG000|Treatment Period 2|Withdrawal by Subject|1|||
124525234|NCT03687827|447874762|FG001|Treatment Period 2|Withdrawal by Subject|2|||
124525235|NCT00498368|447874765|FG000|Overall Study|Withdrawal by Subject|3|||
124525236|NCT00498368|447874766|FG001|Overall Study|Withdrawal by Subject|2|||
124525237|NCT00285649|447874769|FG000|Overall Study|Lost to Follow-up|6|||
124525238|NCT00285649|447874770|FG001|Overall Study|Lost to Follow-up|4|||
124578526|NCT01597245|448076612|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578527|NCT01597245|448076613|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578528|NCT01597245|448076614|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578529|NCT01597245|448076615|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578530|NCT01597245|448076616|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124726165|NCT05596734|448618687|FG011|Substudy A|Lost to Follow-up|0|||
124726166|NCT05596734|448618688|FG012|Substudy A|Lost to Follow-up|0|||
124525239|NCT00285649|447874771|FG002|Overall Study|Lost to Follow-up|4|||
124525240|NCT00285649|447874769|FG000|Overall Study|Withdrawal by Subject|3|||
124525241|NCT00285649|447874770|FG001|Overall Study|Withdrawal by Subject|2|||
124726167|NCT05596734|448618689|FG013|Substudy A|Lost to Follow-up|0|||
124726168|NCT05596734|448618690|FG014|Substudy A|Lost to Follow-up|0|||
124726169|NCT05596734|448618691|FG015|Substudy A|Lost to Follow-up|0|||
124726170|NCT05596734|448618692|FG016|Substudy A|Lost to Follow-up|0|||
124525242|NCT00285649|447874771|FG002|Overall Study|Withdrawal by Subject|2|||
124525243|NCT03342404|447874772|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
124525244|NCT03342404|447874773|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
124525245|NCT03342404|447874772|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
124525246|NCT03342404|447874773|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
124525247|NCT03342404|447874772|FG000|Blinded Treatment Phase|Adverse Event|5|||
124525248|NCT03342404|447874773|FG001|Blinded Treatment Phase|Adverse Event|4|||
124525249|NCT03342404|447874772|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
124525250|NCT03342404|447874773|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
124525251|NCT03342404|447874772|FG000|Blinded Treatment Phase|Other reasons|1|||
124525252|NCT03342404|447874773|FG001|Blinded Treatment Phase|Other reasons|0|||
124525253|NCT03342404|447874772|FG000|Blinded Treatment Phase|Physician Decision|1|||
124525254|NCT03342404|447874773|FG001|Blinded Treatment Phase|Physician Decision|0|||
124525255|NCT03342404|447874772|FG000|Blinded Treatment Phase|Death|1|||
124525256|NCT03342404|447874773|FG001|Blinded Treatment Phase|Death|0|||
124525257|NCT03342404|447874772|FG000|Open-Label Phase|Lost to Follow-up|0|||
124525258|NCT03342404|447874773|FG001|Open-Label Phase|Lost to Follow-up|1|||
124525259|NCT03342404|447874772|FG000|Open-Label Phase|Other reasons|0|||
124525260|NCT03342404|447874773|FG001|Open-Label Phase|Other reasons|1|||
124525261|NCT03342404|447874772|FG000|Open-Label Phase|Adverse Event|0|||
124525262|NCT03342404|447874773|FG001|Open-Label Phase|Adverse Event|3|||
124525263|NCT03342404|447874772|FG000|Open-Label Phase|Withdrawal by Subject|0|||
124525264|NCT03342404|447874773|FG001|Open-Label Phase|Withdrawal by Subject|6|||
124726171|NCT05596734|448618693|FG017|Substudy A|Lost to Follow-up|0|||
124726172|NCT05596734|448618694|FG018|Substudy A|Lost to Follow-up|0|||
124726173|NCT05596734|448618695|FG019|Substudy A|Lost to Follow-up|0|||
124726174|NCT05596734|448618696|FG020|Substudy A|Lost to Follow-up|0|||
124726175|NCT05596734|448618697|FG021|Substudy A|Lost to Follow-up|0|||
124726176|NCT05596734|448618698|FG022|Substudy A|Lost to Follow-up|0|||
124726177|NCT05596734|448618699|FG023|Substudy A|Lost to Follow-up|0|||
124726178|NCT05596734|448618676|FG000|Substudy B|Withdrawal by Subject|0|||
124726179|NCT05596734|448618677|FG001|Substudy B|Withdrawal by Subject|0|||
124726180|NCT05596734|448618678|FG002|Substudy B|Withdrawal by Subject|0|||
124726181|NCT05596734|448618679|FG003|Substudy B|Withdrawal by Subject|0|||
124726182|NCT05596734|448618680|FG004|Substudy B|Withdrawal by Subject|0|||
124726183|NCT05596734|448618681|FG005|Substudy B|Withdrawal by Subject|0|||
124726184|NCT05596734|448618682|FG006|Substudy B|Withdrawal by Subject|0|||
124726185|NCT05596734|448618683|FG007|Substudy B|Withdrawal by Subject|0|||
124726186|NCT05596734|448618684|FG008|Substudy B|Withdrawal by Subject|0|||
124726187|NCT05596734|448618685|FG009|Substudy B|Withdrawal by Subject|0|||
124726188|NCT05596734|448618686|FG010|Substudy B|Withdrawal by Subject|0|||
124726189|NCT05596734|448618687|FG011|Substudy B|Withdrawal by Subject|0|||
124726190|NCT05596734|448618688|FG012|Substudy B|Withdrawal by Subject|1|||
124726191|NCT05596734|448618689|FG013|Substudy B|Withdrawal by Subject|0|||
124525265|NCT03748420|447874775|FG000|Overall Study|No 12 month medication adherence data available|0|||
124525266|NCT03748420|447874776|FG001|Overall Study|No 12 month medication adherence data available|1|||
124525267|NCT03748420|447874775|FG000|Overall Study|Death|24|||
124525268|NCT03748420|447874776|FG001|Overall Study|Death|28|||
124525269|NCT03748420|447874775|FG000|Overall Study|Lost to Follow-up|231|||
124525270|NCT03748420|447874776|FG001|Overall Study|Lost to Follow-up|230|||
124525271|NCT00312728|447874784|FG000|Overall Study|Progressive disease|53|||
124525272|NCT00312728|447874784|FG000|Overall Study|Adverse Event|32|||
124525273|NCT00312728|447874784|FG000|Overall Study|Withdrawal by Subject|10|||
124525274|NCT00312728|447874784|FG000|Overall Study|Required non-protocol cancer treatment|2|||
124726192|NCT05596734|448618690|FG014|Substudy B|Withdrawal by Subject|1|||
124525275|NCT00312728|447874784|FG000|Overall Study|Protocol Violation|2|||
124525276|NCT00312728|447874784|FG000|Overall Study|Other|10|||
124525277|NCT00312728|447874784|FG000|Overall Study|Other|1|||
124525278|NCT00423592|447874788|FG000|Overall Study|Adverse Event (through Week 12)|2|||
124525279|NCT00423592|447874788|FG000|Overall Study|Adverse Event (post Week 12)|5|||
124525280|NCT03446612|447874789|FG000|Overall Study|Protocol defined stopping criteria|0|||
124525281|NCT03446612|447874790|FG001|Overall Study|Protocol defined stopping criteria|1|||
124525282|NCT01437267|447874791|FG000|Overall Study|Withdrawal by Subject|0|||
124525283|NCT01437267|447874792|FG001|Overall Study|Withdrawal by Subject|0|||
124525284|NCT01437267|447874793|FG002|Overall Study|Withdrawal by Subject|0|||
124525285|NCT01437267|447874794|FG003|Overall Study|Withdrawal by Subject|1|||
124525286|NCT01437267|447874795|FG004|Overall Study|Withdrawal by Subject|0|||
124525287|NCT01437267|447874796|FG005|Overall Study|Withdrawal by Subject|0|||
124525288|NCT01437267|447874791|FG000|Overall Study|Protocol Violation|0|||
124726193|NCT05596734|448618691|FG015|Substudy B|Withdrawal by Subject|2|||
124726194|NCT05596734|448618692|FG016|Substudy B|Withdrawal by Subject|2|||
124726195|NCT05596734|448618693|FG017|Substudy B|Withdrawal by Subject|1|||
124726196|NCT05596734|448618694|FG018|Substudy B|Withdrawal by Subject|2|||
124726197|NCT05596734|448618695|FG019|Substudy B|Withdrawal by Subject|0|||
124726198|NCT05596734|448618696|FG020|Substudy B|Withdrawal by Subject|0|||
124726199|NCT05596734|448618697|FG021|Substudy B|Withdrawal by Subject|0|||
124525289|NCT01437267|447874792|FG001|Overall Study|Protocol Violation|1|||
124726200|NCT05596734|448618698|FG022|Substudy B|Withdrawal by Subject|0|||
124726201|NCT05596734|448618699|FG023|Substudy B|Withdrawal by Subject|1|||
124525290|NCT01437267|447874793|FG002|Overall Study|Protocol Violation|0|||
124525291|NCT01437267|447874794|FG003|Overall Study|Protocol Violation|0|||
124525292|NCT01437267|447874795|FG004|Overall Study|Protocol Violation|0|||
124525293|NCT01437267|447874796|FG005|Overall Study|Protocol Violation|0|||
124525294|NCT03934203|447874799|FG000|Overall Study|Adverse Event|0|||
124525295|NCT03934203|447874800|FG001|Overall Study|Adverse Event|0|||
124525296|NCT03934203|447874801|FG002|Overall Study|Adverse Event|1|||
124525297|NCT03934203|447874802|FG003|Overall Study|Adverse Event|0|||
124525298|NCT03934203|447874803|FG004|Overall Study|Adverse Event|1|||
124525299|NCT03934203|447874804|FG005|Overall Study|Adverse Event|0|||
124525300|NCT03934203|447874805|FG006|Overall Study|Adverse Event|2|||
124525301|NCT03934203|447874806|FG007|Overall Study|Adverse Event|0|||
124525302|NCT03934203|447874807|FG008|Overall Study|Adverse Event|0|||
124525303|NCT03934203|447874808|FG009|Overall Study|Adverse Event|0|||
124525304|NCT03934203|447874809|FG010|Overall Study|Adverse Event|0|||
124525305|NCT03934203|447874810|FG011|Overall Study|Adverse Event|0|||
124525306|NCT03934203|447874811|FG012|Overall Study|Adverse Event|0|||
124525307|NCT03934203|447874812|FG013|Overall Study|Adverse Event|1|||
124525308|NCT03934203|447874813|FG014|Overall Study|Adverse Event|0|||
124525309|NCT00608842|447874816|FG000|Overall Study|Participant's Request|0|||
124525310|NCT00608842|447874817|FG001|Overall Study|Participant's Request|1|||
124525311|NCT00608842|447874818|FG002|Overall Study|Participant's Request|2|||
124525312|NCT00608842|447874819|FG003|Overall Study|Participant's Request|1|||
124525313|NCT00608842|447874816|FG000|Overall Study|Lost to Follow-up|1|||
124525314|NCT00608842|447874817|FG001|Overall Study|Lost to Follow-up|0|||
124525315|NCT00608842|447874818|FG002|Overall Study|Lost to Follow-up|0|||
124525316|NCT00608842|447874819|FG003|Overall Study|Lost to Follow-up|0|||
124525317|NCT01039428|447874822|FG000|Overall Study|Protocol Violation|1|||
124525318|NCT01039428|447874823|FG001|Overall Study|Protocol Violation|0|||
124525319|NCT01039428|447874822|FG000|Overall Study|Withdrawal by Subject|1|||
124525320|NCT01039428|447874823|FG001|Overall Study|Withdrawal by Subject|0|||
124525321|NCT00422240|447874826|FG000|Overall Study|Lack of Efficacy|1|||
124525322|NCT00422240|447874827|FG001|Overall Study|Lack of Efficacy|2|||
124525323|NCT00422240|447874828|FG002|Overall Study|Lack of Efficacy|0|||
124525324|NCT00422240|447874829|FG003|Overall Study|Lack of Efficacy|1|||
124525325|NCT00422240|447874826|FG000|Overall Study|Adverse Event|11|||
124525326|NCT00422240|447874827|FG001|Overall Study|Adverse Event|4|||
124525327|NCT00422240|447874828|FG002|Overall Study|Adverse Event|5|||
124525328|NCT00422240|447874829|FG003|Overall Study|Adverse Event|2|||
124525329|NCT00422240|447874826|FG000|Overall Study|Subject request|21|||
124525330|NCT00422240|447874827|FG001|Overall Study|Subject request|17|||
124525331|NCT00422240|447874828|FG002|Overall Study|Subject request|18|||
124525332|NCT00422240|447874829|FG003|Overall Study|Subject request|30|||
124525333|NCT00422240|447874826|FG000|Overall Study|Protocol Violation|0|||
124525334|NCT00422240|447874827|FG001|Overall Study|Protocol Violation|1|||
124525335|NCT00422240|447874828|FG002|Overall Study|Protocol Violation|0|||
124525336|NCT00422240|447874829|FG003|Overall Study|Protocol Violation|1|||
124525337|NCT00422240|447874826|FG000|Overall Study|Lost to Follow-up|31|||
124525338|NCT00422240|447874827|FG001|Overall Study|Lost to Follow-up|32|||
124525339|NCT00422240|447874828|FG002|Overall Study|Lost to Follow-up|19|||
124525340|NCT00422240|447874829|FG003|Overall Study|Lost to Follow-up|34|||
124525341|NCT00422240|447874826|FG000|Overall Study|Other|1|||
124525342|NCT00422240|447874827|FG001|Overall Study|Other|0|||
124525343|NCT00422240|447874828|FG002|Overall Study|Other|0|||
124525344|NCT00422240|447874829|FG003|Overall Study|Other|1|||
124525345|NCT00422240|447874826|FG000|Overall Study|Pregnancy|3|||
124525346|NCT00422240|447874827|FG001|Overall Study|Pregnancy|1|||
124525347|NCT00422240|447874828|FG002|Overall Study|Pregnancy|1|||
124525348|NCT00422240|447874829|FG003|Overall Study|Pregnancy|2|||
124525349|NCT04489940|447874830|FG000|Overall Study|Other|2|||
124525350|NCT04489940|447874830|FG000|Overall Study|Withdrawal by Subject|2|||
124525351|NCT04489940|447874830|FG000|Overall Study|Death|5|||
124525352|NCT04489940|447874830|FG000|Overall Study|Lost to Follow-up|1|||
124726202|NCT05596734|448618676|FG000|Substudy B|Physician Decision|0|||
124525353|NCT01624467|447874831|FG000|Overall Study|Withdrawal by Subject|2|||
124525354|NCT01624467|447874831|FG000|Overall Study|Lost to Follow-up|1|||
124525355|NCT01624467|447874831|FG000|Overall Study|Adverse Event|7|||
124525356|NCT01624467|447874831|FG000|Overall Study|Progressive Disease|19|||
124525357|NCT01624467|447874831|FG000|Overall Study|Per Sponsor Requirement|1|||
124525358|NCT01624467|447874831|FG000|Overall Study|Subject Withdrew from Treatment|1|||
124525359|NCT03964493|447874834|FG000|Overall Study|Withdrawal by Subject|4|||
124525360|NCT03964493|447874835|FG001|Overall Study|Withdrawal by Subject|1|||
124525361|NCT03964493|447874834|FG000|Overall Study|Lost to Follow-up|13|||
124525362|NCT03964493|447874835|FG001|Overall Study|Lost to Follow-up|4|||
124525363|NCT02470429|447874836|FG000|Overall Study|Adverse Event|1|||
124726203|NCT05596734|448618677|FG001|Substudy B|Physician Decision|0|||
124525364|NCT02470429|447874837|FG001|Overall Study|Adverse Event|0|||
124525365|NCT02470429|447874836|FG000|Overall Study|Withdrawal by Subject|1|||
124525366|NCT02470429|447874837|FG001|Overall Study|Withdrawal by Subject|0|||
124525367|NCT00398138|447874838|FG000|Overall Study|Adverse Event|2|||
124578531|NCT01597245|448076617|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578532|NCT01597245|448076618|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
124578533|NCT01597245|448076619|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578534|NCT01597245|448076620|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578535|NCT01597245|448076621|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578536|NCT01597245|448076622|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578537|NCT01597245|448076623|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578538|NCT01597245|448076624|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578539|NCT01597245|448076625|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578540|NCT01597245|448076626|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578541|NCT01597245|448076627|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578542|NCT01597245|448076628|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
124578543|NCT01597245|448076608|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124578544|NCT01597245|448076609|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124578545|NCT01597245|448076610|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124578546|NCT01597245|448076611|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124578547|NCT01597245|448076612|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124726204|NCT05596734|448618678|FG002|Substudy B|Physician Decision|0|||
124525368|NCT01188811|447874841|FG000|Overall Study|Withdrawal by Subject|0|||
124525369|NCT01188811|447874842|FG001|Overall Study|Withdrawal by Subject|2|||
124525370|NCT01188811|447874841|FG000|Overall Study|Adverse Event|6|||
124525371|NCT01188811|447874842|FG001|Overall Study|Adverse Event|0|||
124525372|NCT01602744|447874843|FG000|Overall Study|Death|17|||
124525373|NCT01602744|447874844|FG001|Overall Study|Death|15|||
124525374|NCT01602744|447874843|FG000|Overall Study|Lost to Follow-up|13|||
124525375|NCT01602744|447874844|FG001|Overall Study|Lost to Follow-up|8|||
124525376|NCT03418376|447874845|FG000|Overall Study|Musculoskeletal injury|1|||
124525377|NCT03418376|447874846|FG001|Overall Study|Musculoskeletal injury|2|||
124525378|NCT03418376|447874847|FG002|Overall Study|Musculoskeletal injury|1|||
124525379|NCT03418376|447874848|FG003|Overall Study|Musculoskeletal injury|0|||
124525380|NCT03418376|447874845|FG000|Overall Study|Personal reasons|0|||
124525381|NCT03418376|447874846|FG001|Overall Study|Personal reasons|2|||
124525382|NCT03418376|447874847|FG002|Overall Study|Personal reasons|2|||
124525383|NCT03418376|447874848|FG003|Overall Study|Personal reasons|1|||
124525384|NCT03418376|447874845|FG000|Overall Study|Exacerbation|0|||
124525385|NCT03418376|447874846|FG001|Overall Study|Exacerbation|1|||
124525386|NCT03418376|447874847|FG002|Overall Study|Exacerbation|0|||
124525387|NCT03418376|447874848|FG003|Overall Study|Exacerbation|0|||
124525388|NCT01387594|447874853|FG000|Overall Study|Withdrawal by Subject|0|||
124525389|NCT01387594|447874854|FG001|Overall Study|Withdrawal by Subject|2|||
124525390|NCT01387594|447874853|FG000|Overall Study|Lost to Follow-up|0|||
124525391|NCT01387594|447874854|FG001|Overall Study|Lost to Follow-up|1|||
124525392|NCT00796224|447874867|FG000|Overall Study|Adverse Event|1|||
124525393|NCT00796224|447874868|FG001|Overall Study|Adverse Event|0|||
124525394|NCT00796224|447874867|FG000|Overall Study|Protocol Violation|0|||
124525395|NCT00796224|447874868|FG001|Overall Study|Protocol Violation|1|||
124525396|NCT02569398|447874869|FG000|Overall Study|Adverse Event|0|||
124525397|NCT02569398|447874870|FG001|Overall Study|Adverse Event|1|||
124525398|NCT02569398|447874871|FG002|Overall Study|Adverse Event|6|||
124525399|NCT02569398|447874869|FG000|Overall Study|Withdrawal by Subject|43|||
124525400|NCT02569398|447874870|FG001|Overall Study|Withdrawal by Subject|43|||
124525401|NCT02569398|447874871|FG002|Overall Study|Withdrawal by Subject|30|||
124525402|NCT02569398|447874869|FG000|Overall Study|Study terminated by sponsor|130|||
124525403|NCT02569398|447874870|FG001|Overall Study|Study terminated by sponsor|131|||
124525404|NCT02569398|447874871|FG002|Overall Study|Study terminated by sponsor|134|||
124525405|NCT02569398|447874869|FG000|Overall Study|Other|12|||
124525406|NCT02569398|447874870|FG001|Overall Study|Other|14|||
124525407|NCT02569398|447874871|FG002|Overall Study|Other|13|||
124525408|NCT02116361|447874872|FG000|Overall Study|Pregnancy|0|||
124525409|NCT02116361|447874873|FG001|Overall Study|Pregnancy|0|||
124525410|NCT02116361|447874874|FG002|Overall Study|Pregnancy|0|||
124578548|NCT01597245|448076613|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124578549|NCT01597245|448076614|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124525411|NCT02116361|447874875|FG003|Overall Study|Pregnancy|1|||
124578550|NCT01597245|448076615|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124578551|NCT01597245|448076616|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124525412|NCT02116361|447874872|FG000|Overall Study|Protocol Violation|1|||
124525413|NCT02116361|447874873|FG001|Overall Study|Protocol Violation|0|||
124525414|NCT02116361|447874874|FG002|Overall Study|Protocol Violation|0|||
124525415|NCT02116361|447874875|FG003|Overall Study|Protocol Violation|2|||
124525416|NCT02116361|447874872|FG000|Overall Study|Physician Decision|2|||
124525417|NCT02116361|447874873|FG001|Overall Study|Physician Decision|3|||
124525418|NCT02116361|447874874|FG002|Overall Study|Physician Decision|0|||
124525419|NCT02116361|447874875|FG003|Overall Study|Physician Decision|0|||
124525420|NCT02116361|447874872|FG000|Overall Study|Adverse Event|1|||
124578552|NCT01597245|448076617|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124578553|NCT01597245|448076618|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124578554|NCT01597245|448076619|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124578555|NCT01597245|448076620|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124578556|NCT01597245|448076621|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
124578557|NCT01597245|448076622|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
124578558|NCT01597245|448076623|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
124578559|NCT01597245|448076624|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124578560|NCT01597245|448076625|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124578561|NCT01597245|448076626|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124578562|NCT01597245|448076627|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124578563|NCT01597245|448076628|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
124578564|NCT01597245|448076608|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578565|NCT01597245|448076609|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578566|NCT01597245|448076610|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578567|NCT01597245|448076611|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578568|NCT01597245|448076612|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578569|NCT01597245|448076613|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578570|NCT01597245|448076614|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578571|NCT01597245|448076615|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578572|NCT01597245|448076616|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578573|NCT01597245|448076617|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578574|NCT01597245|448076618|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578575|NCT01597245|448076619|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578576|NCT01597245|448076620|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578577|NCT01597245|448076621|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
124578578|NCT01597245|448076622|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
124578579|NCT01597245|448076623|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
124578580|NCT01597245|448076624|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578581|NCT01597245|448076625|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578582|NCT01597245|448076626|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578583|NCT01597245|448076627|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578584|NCT01597245|448076628|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
124578585|NCT01597245|448076608|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578586|NCT01597245|448076609|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578587|NCT01597245|448076610|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578588|NCT01597245|448076611|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578589|NCT01597245|448076612|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578590|NCT01597245|448076613|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578591|NCT01597245|448076614|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578592|NCT01597245|448076615|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578593|NCT01597245|448076616|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578594|NCT01597245|448076617|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578595|NCT01597245|448076618|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578596|NCT01597245|448076619|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578597|NCT01597245|448076620|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578598|NCT01597245|448076621|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578599|NCT01597245|448076622|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
124578600|NCT01597245|448076623|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
124578601|NCT01597245|448076624|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578602|NCT01597245|448076625|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578603|NCT01597245|448076626|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578604|NCT01597245|448076627|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578605|NCT01597245|448076628|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
124578606|NCT01597245|448076608|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124578607|NCT01597245|448076609|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124578608|NCT01597245|448076610|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124578609|NCT01597245|448076611|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124578610|NCT01597245|448076612|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124726205|NCT05596734|448618679|FG003|Substudy B|Physician Decision|0|||
124726206|NCT05596734|448618680|FG004|Substudy B|Physician Decision|0|||
124726207|NCT05596734|448618681|FG005|Substudy B|Physician Decision|0|||
124726208|NCT05596734|448618682|FG006|Substudy B|Physician Decision|0|||
124726209|NCT05596734|448618683|FG007|Substudy B|Physician Decision|0|||
124525421|NCT02116361|447874873|FG001|Overall Study|Adverse Event|0|||
124525422|NCT02116361|447874874|FG002|Overall Study|Adverse Event|0|||
124525423|NCT02116361|447874875|FG003|Overall Study|Adverse Event|3|||
124525424|NCT02116361|447874872|FG000|Overall Study|Other Reasons|3|||
124525425|NCT02116361|447874873|FG001|Overall Study|Other Reasons|3|||
124525426|NCT02116361|447874874|FG002|Overall Study|Other Reasons|3|||
124525427|NCT02116361|447874875|FG003|Overall Study|Other Reasons|3|||
124525428|NCT02116361|447874872|FG000|Overall Study|Lack of Efficacy|5|||
124525429|NCT02116361|447874873|FG001|Overall Study|Lack of Efficacy|7|||
124525430|NCT02116361|447874874|FG002|Overall Study|Lack of Efficacy|4|||
124525431|NCT02116361|447874875|FG003|Overall Study|Lack of Efficacy|3|||
124525432|NCT02116361|447874872|FG000|Overall Study|Lost to Follow-up|4|||
124525433|NCT02116361|447874873|FG001|Overall Study|Lost to Follow-up|5|||
124525434|NCT02116361|447874874|FG002|Overall Study|Lost to Follow-up|7|||
124525435|NCT02116361|447874875|FG003|Overall Study|Lost to Follow-up|5|||
124525436|NCT02116361|447874872|FG000|Overall Study|Personal Reasons|6|||
124525437|NCT02116361|447874873|FG001|Overall Study|Personal Reasons|6|||
124525438|NCT02116361|447874874|FG002|Overall Study|Personal Reasons|4|||
124525439|NCT02116361|447874875|FG003|Overall Study|Personal Reasons|9|||
124525440|NCT02116361|447874872|FG000|Overall Study|Investigator Decision - Relapse|9|||
124525441|NCT02116361|447874873|FG001|Overall Study|Investigator Decision - Relapse|7|||
124525442|NCT02116361|447874874|FG002|Overall Study|Investigator Decision - Relapse|8|||
124525443|NCT02116361|447874875|FG003|Overall Study|Investigator Decision - Relapse|5|||
124525444|NCT03227224|447874876|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
124525445|NCT03227224|447874877|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
124525446|NCT03227224|447874878|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
124525447|NCT03227224|447874879|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
124525448|NCT03227224|447874876|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
124525449|NCT03227224|447874877|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
124525450|NCT03227224|447874878|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
124525451|NCT03227224|447874879|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
124525452|NCT03227224|447874876|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
124525453|NCT03227224|447874877|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
124525454|NCT03227224|447874878|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
124525455|NCT03227224|447874879|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
124525456|NCT03227224|447874876|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
124525457|NCT03227224|447874877|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
124525458|NCT03227224|447874878|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
124525459|NCT03227224|447874879|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
124525460|NCT03227224|447874876|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
124525461|NCT03227224|447874877|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
124525462|NCT03227224|447874878|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
124525463|NCT03227224|447874879|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
124525464|NCT03227224|447874876|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
124525465|NCT03227224|447874877|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
124525466|NCT03227224|447874878|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
124525467|NCT03227224|447874879|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
124525468|NCT03227224|447874876|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
124525469|NCT03227224|447874877|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
124525470|NCT03227224|447874878|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
124525471|NCT03227224|447874879|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
124525472|NCT03227224|447874876|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
124525473|NCT03227224|447874877|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
124525474|NCT03227224|447874878|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
124525475|NCT03227224|447874879|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
124525476|NCT03227224|447874876|FG000|Follow-up Phase (2 Weeks)|Other|4|||
124525477|NCT03227224|447874877|FG001|Follow-up Phase (2 Weeks)|Other|4|||
124525478|NCT03227224|447874878|FG002|Follow-up Phase (2 Weeks)|Other|6|||
124525479|NCT03227224|447874879|FG003|Follow-up Phase (2 Weeks)|Other|3|||
124525480|NCT02406027|447874880|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
124525481|NCT02406027|447874881|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
124525482|NCT02406027|447874882|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
124525483|NCT02406027|447874883|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
124525484|NCT02406027|447874884|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
124525485|NCT02406027|447874885|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
124525486|NCT02406027|447874886|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
124525487|NCT02406027|447874880|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
124525488|NCT02406027|447874881|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
124525489|NCT02406027|447874882|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
124525490|NCT02406027|447874883|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
124525491|NCT02406027|447874884|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
124525492|NCT02406027|447874885|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
124525493|NCT02406027|447874886|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
124525494|NCT02406027|447874880|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
124525495|NCT02406027|447874881|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
124525496|NCT02406027|447874882|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
124525497|NCT02406027|447874883|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
124525498|NCT02406027|447874884|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
124525499|NCT02406027|447874885|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
124525500|NCT02406027|447874886|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
124525501|NCT02406027|447874880|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
124525502|NCT02406027|447874881|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
124525503|NCT02406027|447874882|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
124525504|NCT02406027|447874883|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
124525505|NCT02406027|447874884|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
124525506|NCT02406027|447874885|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
124525507|NCT02406027|447874886|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
124525508|NCT02406027|447874880|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
124525509|NCT02406027|447874881|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
124525510|NCT02406027|447874882|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
124525511|NCT02406027|447874883|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
124525512|NCT02406027|447874884|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
124525513|NCT02406027|447874885|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
124525514|NCT02406027|447874886|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
124525515|NCT02406027|447874880|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
124525516|NCT02406027|447874881|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
124525517|NCT02406027|447874882|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
124525518|NCT02406027|447874883|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
124525519|NCT02406027|447874884|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
124525520|NCT02406027|447874885|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
124525521|NCT02406027|447874886|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
124525522|NCT02406027|447874880|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
124525523|NCT02406027|447874881|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
124525524|NCT02406027|447874882|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
124525525|NCT02406027|447874883|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
124525526|NCT02406027|447874884|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
124525527|NCT02406027|447874885|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
124525528|NCT02406027|447874886|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
124525529|NCT02406027|447874880|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
124525530|NCT02406027|447874881|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
124525531|NCT02406027|447874882|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
124525532|NCT02406027|447874883|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
124525533|NCT02406027|447874884|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
124525534|NCT02406027|447874885|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
124525535|NCT02406027|447874886|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
124525536|NCT02406027|447874880|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
124525537|NCT02406027|447874881|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
124525538|NCT02406027|447874882|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
124525539|NCT02406027|447874883|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
124525540|NCT02406027|447874884|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
124525541|NCT02406027|447874885|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
124525542|NCT02406027|447874886|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
124525543|NCT02406027|447874880|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
124525544|NCT02406027|447874881|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
124525545|NCT02406027|447874882|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
124525546|NCT02406027|447874883|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
124525547|NCT02406027|447874884|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
124525548|NCT02406027|447874885|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
124525549|NCT02406027|447874886|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
124525550|NCT02497287|447874887|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
124578611|NCT01597245|448076613|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124525551|NCT02497287|447874887|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
124726210|NCT05596734|448618684|FG008|Substudy B|Physician Decision|0|||
124726211|NCT05596734|448618685|FG009|Substudy B|Physician Decision|0|||
124726212|NCT05596734|448618686|FG010|Substudy B|Physician Decision|0|||
124726213|NCT05596734|448618687|FG011|Substudy B|Physician Decision|0|||
124726214|NCT05596734|448618688|FG012|Substudy B|Physician Decision|0|||
124726215|NCT05596734|448618689|FG013|Substudy B|Physician Decision|0|||
124726216|NCT05596734|448618690|FG014|Substudy B|Physician Decision|0|||
124726217|NCT05596734|448618691|FG015|Substudy B|Physician Decision|1|||
124726218|NCT05596734|448618692|FG016|Substudy B|Physician Decision|0|||
124726219|NCT05596734|448618693|FG017|Substudy B|Physician Decision|0|||
124726220|NCT05596734|448618694|FG018|Substudy B|Physician Decision|0|||
124726221|NCT05596734|448618695|FG019|Substudy B|Physician Decision|0|||
124726222|NCT05596734|448618696|FG020|Substudy B|Physician Decision|0|||
124726223|NCT05596734|448618697|FG021|Substudy B|Physician Decision|0|||
124726224|NCT05596734|448618698|FG022|Substudy B|Physician Decision|0|||
124726225|NCT05596734|448618699|FG023|Substudy B|Physician Decision|0|||
124726226|NCT05596734|448618676|FG000|Substudy B|Lost to Follow-up|0|||
124726227|NCT05596734|448618677|FG001|Substudy B|Lost to Follow-up|0|||
124726228|NCT05596734|448618678|FG002|Substudy B|Lost to Follow-up|0|||
124726229|NCT05596734|448618679|FG003|Substudy B|Lost to Follow-up|0|||
124726230|NCT05596734|448618680|FG004|Substudy B|Lost to Follow-up|0|||
124726231|NCT05596734|448618681|FG005|Substudy B|Lost to Follow-up|0|||
124726232|NCT05596734|448618682|FG006|Substudy B|Lost to Follow-up|0|||
124726233|NCT05596734|448618683|FG007|Substudy B|Lost to Follow-up|0|||
124726234|NCT05596734|448618684|FG008|Substudy B|Lost to Follow-up|0|||
124726235|NCT05596734|448618685|FG009|Substudy B|Lost to Follow-up|0|||
124726236|NCT05596734|448618686|FG010|Substudy B|Lost to Follow-up|0|||
124726237|NCT05596734|448618687|FG011|Substudy B|Lost to Follow-up|0|||
124726238|NCT05596734|448618688|FG012|Substudy B|Lost to Follow-up|1|||
124525552|NCT02497287|447874887|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
124525553|NCT02497287|447874887|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
124525554|NCT02497287|447874887|FG000|Induction Phase (4 Weeks)|Other|13|||
124525555|NCT02497287|447874887|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
124525556|NCT02497287|447874887|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
124525557|NCT02497287|447874887|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
124525558|NCT02497287|447874887|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
124525559|NCT02497287|447874887|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
124525560|NCT02497287|447874887|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
124525561|NCT02497287|447874887|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
124525562|NCT02497287|447874887|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
124525563|NCT02497287|447874887|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
124525564|NCT02497287|447874887|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
124525565|NCT02497287|447874887|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
124525566|NCT02497287|447874887|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
124525567|NCT02497287|447874887|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
124525568|NCT02497287|447874887|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
124525569|NCT02497287|447874887|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
124525570|NCT02497287|447874887|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
124525571|NCT02497287|447874887|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
124525572|NCT02497287|447874887|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
124525573|NCT02497287|447874887|FG000|Follow-up Phase (4 Week)|Other|1|||
124525574|NCT03559192|447874888|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
124525575|NCT03559192|447874889|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
124525576|NCT03559192|447874890|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
124525577|NCT03559192|447874888|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
124525578|NCT03559192|447874889|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
124525579|NCT03559192|447874890|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
124525580|NCT03559192|447874888|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
124525581|NCT03559192|447874889|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
124525582|NCT03559192|447874890|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
124525583|NCT03559192|447874888|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
124525584|NCT03559192|447874889|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
124525585|NCT03559192|447874890|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
124525586|NCT03559192|447874888|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
124726239|NCT05596734|448618689|FG013|Substudy B|Lost to Follow-up|0|||
124726240|NCT05596734|448618690|FG014|Substudy B|Lost to Follow-up|1|||
124726241|NCT05596734|448618691|FG015|Substudy B|Lost to Follow-up|1|||
124726242|NCT05596734|448618692|FG016|Substudy B|Lost to Follow-up|0|||
124726243|NCT05596734|448618693|FG017|Substudy B|Lost to Follow-up|0|||
124726244|NCT05596734|448618694|FG018|Substudy B|Lost to Follow-up|0|||
124726245|NCT05596734|448618695|FG019|Substudy B|Lost to Follow-up|0|||
124726246|NCT05596734|448618696|FG020|Substudy B|Lost to Follow-up|0|||
124726247|NCT05596734|448618697|FG021|Substudy B|Lost to Follow-up|0|||
124726248|NCT05596734|448618698|FG022|Substudy B|Lost to Follow-up|0|||
124726249|NCT05596734|448618699|FG023|Substudy B|Lost to Follow-up|0|||
124578612|NCT01597245|448076614|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124578613|NCT01597245|448076615|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124578614|NCT01597245|448076616|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124578615|NCT01597245|448076617|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124578616|NCT01597245|448076618|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124578617|NCT01597245|448076619|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124578618|NCT01597245|448076620|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124578619|NCT01597245|448076621|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124578620|NCT01597245|448076622|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
124578621|NCT01597245|448076623|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
124578622|NCT01597245|448076624|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124578623|NCT01597245|448076625|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124578624|NCT01597245|448076626|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124578625|NCT01597245|448076627|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124578626|NCT01597245|448076628|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
124578627|NCT01597245|448076608|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578628|NCT01597245|448076609|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578629|NCT01597245|448076610|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578630|NCT01597245|448076611|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578631|NCT01597245|448076612|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578632|NCT01597245|448076613|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578633|NCT01597245|448076614|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578634|NCT01597245|448076615|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578635|NCT01597245|448076616|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578636|NCT01597245|448076617|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578637|NCT01597245|448076618|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578638|NCT01597245|448076619|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578639|NCT01597245|448076620|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578640|NCT01597245|448076621|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
124578641|NCT01597245|448076622|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
124578642|NCT01597245|448076623|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
124578643|NCT01597245|448076624|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578644|NCT01597245|448076625|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578645|NCT01597245|448076626|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578646|NCT01597245|448076627|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578647|NCT01597245|448076628|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
124578648|NCT01597245|448076608|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578649|NCT01597245|448076609|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578650|NCT01597245|448076610|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578651|NCT01597245|448076611|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578652|NCT01597245|448076612|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578653|NCT01597245|448076613|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578654|NCT01597245|448076614|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578655|NCT01597245|448076615|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578656|NCT01597245|448076616|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578657|NCT01597245|448076617|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578658|NCT01597245|448076618|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578659|NCT01597245|448076619|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578660|NCT01597245|448076620|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578661|NCT01597245|448076621|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578662|NCT01597245|448076622|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
124578663|NCT01597245|448076623|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
124578664|NCT01597245|448076624|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578665|NCT01597245|448076625|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578666|NCT01597245|448076626|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578667|NCT01597245|448076627|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578668|NCT01597245|448076628|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
124578669|NCT01597245|448076608|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124578670|NCT01597245|448076609|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124578671|NCT01597245|448076610|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124578672|NCT01597245|448076611|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124578673|NCT01597245|448076612|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124578674|NCT01597245|448076613|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124578675|NCT01597245|448076614|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124578676|NCT01597245|448076615|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124726250|NCT04113018|448618700|FG000|Overall Study|Death|2|||
124525587|NCT03559192|447874889|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
124525588|NCT03559192|447874890|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
124525589|NCT03559192|447874888|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
124525590|NCT03559192|447874889|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
124525591|NCT03559192|447874890|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
124525592|NCT03559192|447874888|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
124525593|NCT03559192|447874889|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
124525594|NCT03559192|447874890|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
124525595|NCT03559192|447874888|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
124525596|NCT03559192|447874889|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
124525597|NCT03559192|447874890|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
124525598|NCT03559192|447874888|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
124525599|NCT03559192|447874889|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
124525600|NCT03559192|447874890|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
124525601|NCT03517722|447874891|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
124525602|NCT03517722|447874892|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
124525603|NCT03517722|447874891|FG000|Double Blind Period: Week 0-52|Death|0|||
124525604|NCT03517722|447874892|FG001|Double Blind Period: Week 0-52|Death|4|||
124525605|NCT03517722|447874891|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
124525606|NCT03517722|447874892|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
124525607|NCT03517722|447874891|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
124525608|NCT03517722|447874892|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
124525609|NCT03517722|447874891|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
124525610|NCT03517722|447874892|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
124525611|NCT03517722|447874891|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
124525612|NCT03517722|447874892|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
124525613|NCT03517722|447874891|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
124525614|NCT03517722|447874892|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
124525615|NCT03517722|447874891|FG000|Double Blind Period: Week 0-52|Other|4|||
124525616|NCT03517722|447874892|FG001|Double Blind Period: Week 0-52|Other|3|||
124525617|NCT03517722|447874891|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
124525618|NCT03517722|447874892|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
124525619|NCT03517722|447874891|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
124525620|NCT03517722|447874892|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
124525621|NCT03517722|447874891|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
124525622|NCT03517722|447874892|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
124525623|NCT03517722|447874891|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
124525624|NCT03517722|447874892|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
124525625|NCT03517722|447874891|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
124525626|NCT03517722|447874892|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
124525627|NCT03277794|447874897|FG000|Overall Study|Lost to Follow-up|2|||
124525628|NCT03277794|447874898|FG001|Overall Study|Lost to Follow-up|4|||
124525629|NCT03277794|447874897|FG000|Overall Study|Withdrew due to high acuity|1|||
124525630|NCT03277794|447874898|FG001|Overall Study|Withdrew due to high acuity|0|||
124525631|NCT01226472|447874903|FG000|Overall Study|Progressive Disease|1|||
124525632|NCT03573804|447874906|FG000|Overall Study|claustrophobia or MRI table problems|10|||
124525633|NCT03399786|447874907|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
124525634|NCT03399786|447874908|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
124525635|NCT03399786|447874909|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
124525636|NCT03399786|447874910|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
124525637|NCT03399786|447874907|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
124525638|NCT03399786|447874908|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
124525639|NCT03399786|447874909|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
124525640|NCT03399786|447874910|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
124525641|NCT03399786|447874907|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
124525642|NCT03399786|447874908|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
124525643|NCT03399786|447874909|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
124525644|NCT03399786|447874910|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
124525645|NCT03050307|447876462|FG000|Overall Study|Adverse Event|4|||
124525646|NCT03050307|447876463|FG001|Overall Study|Adverse Event|2|||
124525647|NCT03050307|447876462|FG000|Overall Study|Significant Protocol Deviation|0|||
124525648|NCT03050307|447876463|FG001|Overall Study|Significant Protocol Deviation|1|||
124525649|NCT03050307|447876462|FG000|Overall Study|Lost to Follow-up|0|||
124525650|NCT03050307|447876463|FG001|Overall Study|Lost to Follow-up|1|||
124726251|NCT04113018|448618700|FG000|Overall Study|Lost to Follow-up|1|||
124726252|NCT04113018|448618700|FG000|Overall Study|Still On Study (on study treatment)|24|||
124525651|NCT03050307|447876462|FG000|Overall Study|Voluntary Withdrawal|3|||
124525652|NCT03050307|447876463|FG001|Overall Study|Voluntary Withdrawal|4|||
124525653|NCT03050307|447876462|FG000|Overall Study|Reason not Specified|1|||
124525654|NCT03050307|447876463|FG001|Overall Study|Reason not Specified|1|||
124525655|NCT01998906|447876464|FG000|Overall Study|Participants ongoing in follow-up|77|||
124525656|NCT01998906|447876465|FG001|Overall Study|Participants ongoing in follow-up|60|||
124525657|NCT01998906|447876466|FG002|Overall Study|Participants ongoing in follow-up|58|||
124525658|NCT01998906|447876464|FG000|Overall Study|Death|21|||
124525659|NCT01998906|447876465|FG001|Overall Study|Death|30|||
124525660|NCT01998906|447876466|FG002|Overall Study|Death|17|||
124525661|NCT01998906|447876464|FG000|Overall Study|Lack of Efficacy|10|||
124525662|NCT01998906|447876465|FG001|Overall Study|Lack of Efficacy|9|||
124525663|NCT01998906|447876466|FG002|Overall Study|Lack of Efficacy|8|||
124525664|NCT01998906|447876464|FG000|Overall Study|Failure to return|0|||
124525665|NCT01998906|447876465|FG001|Overall Study|Failure to return|2|||
124525666|NCT01998906|447876466|FG002|Overall Study|Failure to return|4|||
124525667|NCT01998906|447876464|FG000|Overall Study|Violation of Selection Criteria|0|||
124525668|NCT01998906|447876465|FG001|Overall Study|Violation of Selection Criteria|0|||
124525669|NCT01998906|447876466|FG002|Overall Study|Violation of Selection Criteria|1|||
124525670|NCT01998906|447876464|FG000|Overall Study|Withdrawal by Subject|1|||
124525671|NCT01998906|447876465|FG001|Overall Study|Withdrawal by Subject|4|||
124525672|NCT01998906|447876466|FG002|Overall Study|Withdrawal by Subject|3|||
124525673|NCT01998906|447876464|FG000|Overall Study|Administrative/Other|2|||
124525674|NCT01998906|447876465|FG001|Overall Study|Administrative/Other|1|||
124525675|NCT01998906|447876466|FG002|Overall Study|Administrative/Other|3|||
124525676|NCT01998906|447876464|FG000|Overall Study|Other|3|||
124525677|NCT01998906|447876465|FG001|Overall Study|Other|8|||
124525678|NCT01998906|447876466|FG002|Overall Study|Other|4|||
124525679|NCT02996110|447876467|FG000|Pre-Treatment|Other Reasons|0|||
124525680|NCT02996110|447876468|FG001|Pre-Treatment|Other Reasons|1|||
124525681|NCT02996110|447876469|FG002|Pre-Treatment|Other Reasons|0|||
124525682|NCT02996110|447876470|FG003|Pre-Treatment|Other Reasons|0|||
124525683|NCT02996110|447876471|FG004|Pre-Treatment|Other Reasons|1|||
124525684|NCT02996110|447876467|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
124525685|NCT02996110|447876468|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
124525686|NCT02996110|447876469|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
124525687|NCT02996110|447876470|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
124525688|NCT02996110|447876471|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
124525689|NCT02996110|447876467|FG000|Track 1|Disease Progression|15|||
124525690|NCT02996110|447876468|FG001|Track 1|Disease Progression|17|||
124525691|NCT02996110|447876469|FG002|Track 1|Disease Progression|0|||
124525692|NCT02996110|447876470|FG003|Track 1|Disease Progression|0|||
124525693|NCT02996110|447876471|FG004|Track 1|Disease Progression|0|||
124525694|NCT02996110|447876467|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
124525695|NCT02996110|447876468|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
124525696|NCT02996110|447876469|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
124525697|NCT02996110|447876470|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
124525698|NCT02996110|447876471|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
124525699|NCT02996110|447876467|FG000|Track 1|Study Drug Toxicity|5|||
124578677|NCT01597245|448076616|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124578678|NCT01597245|448076617|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124578679|NCT01597245|448076618|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124578680|NCT01597245|448076619|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124578681|NCT01597245|448076620|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124578682|NCT01597245|448076621|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124578683|NCT01597245|448076622|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
124578684|NCT01597245|448076623|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
124578685|NCT01597245|448076624|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124525700|NCT02996110|447876468|FG001|Track 1|Study Drug Toxicity|3|||
124525701|NCT02996110|447876469|FG002|Track 1|Study Drug Toxicity|0|||
124525702|NCT02996110|447876470|FG003|Track 1|Study Drug Toxicity|0|||
124525703|NCT02996110|447876471|FG004|Track 1|Study Drug Toxicity|0|||
124525704|NCT02996110|447876467|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
124525705|NCT02996110|447876468|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
124525706|NCT02996110|447876469|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
124525707|NCT02996110|447876470|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
124525708|NCT02996110|447876471|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
124525709|NCT02996110|447876467|FG000|Track 1|Administrative Reason by Sponsor|0|||
124578686|NCT01597245|448076625|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124578687|NCT01597245|448076626|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124525710|NCT02996110|447876468|FG001|Track 1|Administrative Reason by Sponsor|1|||
124525711|NCT02996110|447876469|FG002|Track 1|Administrative Reason by Sponsor|0|||
124525712|NCT02996110|447876470|FG003|Track 1|Administrative Reason by Sponsor|0|||
124726253|NCT04113018|448618700|FG000|Overall Study|Still On Study (in follow up)|12|||
124726254|NCT00079391|448618701|FG000|Overall Study|Withdrawal by Subject|1|||
124726255|NCT02791516|448618702|FG000|Overall Study|Withdrawal by Subject|1|||
124726256|NCT02791516|448618703|FG001|Overall Study|Withdrawal by Subject|1|||
124726257|NCT00107900|448618710|FG000|Overall Study|Adverse Event|3|||
124726258|NCT00107900|448618711|FG001|Overall Study|Adverse Event|2|||
124726259|NCT00107900|448618712|FG002|Overall Study|Adverse Event|10|||
124726260|NCT00107900|448618713|FG003|Overall Study|Adverse Event|3|||
124726261|NCT00107900|448618714|FG004|Overall Study|Adverse Event|5|||
124726262|NCT00107900|448618715|FG005|Overall Study|Adverse Event|3|||
124726263|NCT00107900|448618710|FG000|Overall Study|Death|0|||
124726264|NCT00107900|448618711|FG001|Overall Study|Death|0|||
124726265|NCT00107900|448618712|FG002|Overall Study|Death|0|||
124726266|NCT00107900|448618713|FG003|Overall Study|Death|0|||
124726267|NCT00107900|448618714|FG004|Overall Study|Death|1|||
124726268|NCT00107900|448618715|FG005|Overall Study|Death|0|||
124726269|NCT00107900|448618710|FG000|Overall Study|Lost to Follow-up|4|||
124726270|NCT00107900|448618711|FG001|Overall Study|Lost to Follow-up|1|||
124726271|NCT00107900|448618712|FG002|Overall Study|Lost to Follow-up|3|||
124726272|NCT00107900|448618713|FG003|Overall Study|Lost to Follow-up|2|||
124726273|NCT00107900|448618714|FG004|Overall Study|Lost to Follow-up|5|||
124726274|NCT00107900|448618715|FG005|Overall Study|Lost to Follow-up|5|||
124726275|NCT00107900|448618710|FG000|Overall Study|Protocol Violation|1|||
124726276|NCT00107900|448618711|FG001|Overall Study|Protocol Violation|0|||
124726277|NCT00107900|448618712|FG002|Overall Study|Protocol Violation|5|||
124726278|NCT00107900|448618713|FG003|Overall Study|Protocol Violation|5|||
124726279|NCT00107900|448618714|FG004|Overall Study|Protocol Violation|7|||
124726280|NCT00107900|448618715|FG005|Overall Study|Protocol Violation|0|||
124726281|NCT00107900|448618710|FG000|Overall Study|Withdrawal by Subject|1|||
124726282|NCT00107900|448618711|FG001|Overall Study|Withdrawal by Subject|0|||
124726283|NCT00107900|448618712|FG002|Overall Study|Withdrawal by Subject|5|||
124726284|NCT00107900|448618713|FG003|Overall Study|Withdrawal by Subject|0|||
124726285|NCT00107900|448618714|FG004|Overall Study|Withdrawal by Subject|1|||
124726286|NCT00107900|448618715|FG005|Overall Study|Withdrawal by Subject|1|||
124726287|NCT00107900|448618710|FG000|Overall Study|Administrative Reasons|1|||
124726288|NCT00107900|448618711|FG001|Overall Study|Administrative Reasons|0|||
124726289|NCT00107900|448618712|FG002|Overall Study|Administrative Reasons|2|||
124726290|NCT00107900|448618713|FG003|Overall Study|Administrative Reasons|2|||
124726291|NCT00107900|448618714|FG004|Overall Study|Administrative Reasons|2|||
124726292|NCT00107900|448618715|FG005|Overall Study|Administrative Reasons|0|||
124726293|NCT02644096|448618716|FG000|Overall Study|Withdrawal by Subject|28|||
124726294|NCT02644096|448618717|FG001|Overall Study|Withdrawal by Subject|25|||
124726295|NCT02461290|448618718|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
124726296|NCT02461290|448618718|FG000|Overall Study|Lost to Follow-up|3|||
124726297|NCT00526656|448618719|FG000|Overall Study|Death|1|||
124726298|NCT00526656|448618719|FG000|Overall Study|Refused surgery|1|||
124726299|NCT01456195|448620237|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
124726300|NCT01456195|448620238|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
124525713|NCT02996110|447876471|FG004|Track 1|Administrative Reason by Sponsor|0|||
124525714|NCT02996110|447876467|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
124525715|NCT02996110|447876468|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
124525716|NCT02996110|447876469|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
124525717|NCT02996110|447876470|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
124525718|NCT02996110|447876471|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
124525719|NCT02996110|447876467|FG000|Track 2|Disease Progression|33|||
124525720|NCT02996110|447876468|FG001|Track 2|Disease Progression|26|||
124525721|NCT02996110|447876469|FG002|Track 2|Disease Progression|19|||
124525722|NCT02996110|447876470|FG003|Track 2|Disease Progression|16|||
124525723|NCT02996110|447876471|FG004|Track 2|Disease Progression|15|||
124525724|NCT02996110|447876467|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
124525725|NCT02996110|447876468|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
124525726|NCT02996110|447876469|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
124578688|NCT01597245|448076627|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124578689|NCT01597245|448076628|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
124578690|NCT01597245|448076608|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124726301|NCT01456195|448620239|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
124726302|NCT01456195|448620237|FG000|Overall Study|Lost to Follow-up|3|||
124726303|NCT01456195|448620238|FG001|Overall Study|Lost to Follow-up|1|||
124726304|NCT01456195|448620239|FG002|Overall Study|Lost to Follow-up|3|||
124726305|NCT01456195|448620237|FG000|Overall Study|Voluntary Withdrawal|5|||
124726306|NCT01456195|448620238|FG001|Overall Study|Voluntary Withdrawal|3|||
124726307|NCT01456195|448620239|FG002|Overall Study|Voluntary Withdrawal|7|||
124726308|NCT01456195|448620237|FG000|Overall Study|Lack of Efficacy|0|||
124726309|NCT01456195|448620238|FG001|Overall Study|Lack of Efficacy|1|||
124726310|NCT01456195|448620239|FG002|Overall Study|Lack of Efficacy|0|||
124726311|NCT01456195|448620237|FG000|Overall Study|Other Reasons|2|||
124726312|NCT01456195|448620238|FG001|Overall Study|Other Reasons|1|||
124525727|NCT02996110|447876470|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
124578691|NCT01597245|448076609|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578692|NCT01597245|448076610|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578693|NCT01597245|448076611|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578694|NCT01597245|448076612|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578695|NCT01597245|448076613|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578696|NCT01597245|448076614|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578697|NCT01597245|448076615|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578698|NCT01597245|448076616|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578699|NCT01597245|448076617|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578700|NCT01597245|448076618|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578701|NCT01597245|448076619|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578702|NCT01597245|448076620|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578703|NCT01597245|448076621|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578704|NCT01597245|448076622|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
124578705|NCT01597245|448076623|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
124578706|NCT01597245|448076624|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578707|NCT01597245|448076625|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578708|NCT01597245|448076626|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578709|NCT01597245|448076627|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578710|NCT01597245|448076628|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
124578711|NCT01597245|448076608|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578712|NCT01597245|448076609|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578713|NCT01597245|448076610|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578714|NCT01597245|448076611|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578715|NCT01597245|448076612|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578716|NCT01597245|448076613|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578717|NCT01597245|448076614|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578718|NCT01597245|448076615|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578719|NCT01597245|448076616|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578720|NCT01597245|448076617|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578721|NCT01597245|448076618|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578722|NCT01597245|448076619|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578723|NCT01597245|448076620|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578724|NCT01597245|448076621|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578725|NCT01597245|448076622|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
124578726|NCT01597245|448076623|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
124578727|NCT01597245|448076624|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578728|NCT01597245|448076625|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578729|NCT01597245|448076626|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578730|NCT01597245|448076627|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124578731|NCT01597245|448076628|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
124726313|NCT01456195|448620239|FG002|Overall Study|Other Reasons|3|||
124525728|NCT02996110|447876471|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
124525729|NCT02996110|447876467|FG000|Track 2|Death|0|||
124525730|NCT02996110|447876468|FG001|Track 2|Death|0|||
124525731|NCT02996110|447876469|FG002|Track 2|Death|1|||
124525732|NCT02996110|447876470|FG003|Track 2|Death|0|||
124525733|NCT02996110|447876471|FG004|Track 2|Death|1|||
124525734|NCT02996110|447876467|FG000|Track 2|Study Drug Toxicity|4|||
124525735|NCT02996110|447876468|FG001|Track 2|Study Drug Toxicity|1|||
124525736|NCT02996110|447876469|FG002|Track 2|Study Drug Toxicity|4|||
124525737|NCT02996110|447876470|FG003|Track 2|Study Drug Toxicity|1|||
124525738|NCT02996110|447876471|FG004|Track 2|Study Drug Toxicity|0|||
124525739|NCT02996110|447876467|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
124525740|NCT02996110|447876468|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
124525741|NCT02996110|447876469|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
124525742|NCT02996110|447876470|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
124525743|NCT02996110|447876471|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
124525744|NCT02996110|447876467|FG000|Track 2|Participant Withdrew Consent|1|||
124525745|NCT02996110|447876468|FG001|Track 2|Participant Withdrew Consent|2|||
124525746|NCT02996110|447876469|FG002|Track 2|Participant Withdrew Consent|3|||
124525747|NCT02996110|447876470|FG003|Track 2|Participant Withdrew Consent|1|||
124726314|NCT02547038|448620240|FG000|Overall Study|Lost to Follow-up|3|||
124726315|NCT02547038|448620241|FG001|Overall Study|Lost to Follow-up|2|||
124525748|NCT02996110|447876471|FG004|Track 2|Participant Withdrew Consent|1|||
124525749|NCT02996110|447876467|FG000|Track 2|Other Reasons|0|||
124525750|NCT02996110|447876468|FG001|Track 2|Other Reasons|0|||
124525751|NCT02996110|447876469|FG002|Track 2|Other Reasons|1|||
124525752|NCT02996110|447876470|FG003|Track 2|Other Reasons|0|||
124525753|NCT02996110|447876471|FG004|Track 2|Other Reasons|1|||
124525754|NCT01077193|447876472|FG000|Overall Study|Lost to Follow-up|1|||
124525755|NCT01077193|447876472|FG000|Overall Study|Withdrawal by Subject|2|||
124525756|NCT01077193|447876472|FG000|Overall Study|Lack of Efficacy|1|||
124525757|NCT01077193|447876472|FG000|Overall Study|Study Terminated by Sponsor|40|||
124525758|NCT06048809|447876477|FG000|Overall Study|Adverse Event|2|||
124525759|NCT06048809|447876478|FG001|Overall Study|Adverse Event|0|||
124525760|NCT06048809|447876477|FG000|Overall Study|Withdrawal by Subject|1|||
124525761|NCT06048809|447876478|FG001|Overall Study|Withdrawal by Subject|1|||
124525762|NCT00673816|447876493|FG000|Overall Study|Adverse Event|1|||
124525763|NCT00673816|447876493|FG000|Overall Study|Withdrawal by Subject|1|||
124525764|NCT02148952|447876500|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
124525765|NCT02148952|447876501|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
124525766|NCT02148952|447876500|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
124525767|NCT02148952|447876501|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
124525768|NCT02148952|447876500|FG000|Follow-Up|Lost to Follow-up|219|||
124525769|NCT02148952|447876501|FG001|Follow-Up|Lost to Follow-up|231|||
124525770|NCT02148952|447876500|FG000|Follow-Up|Withdrawal by Subject|46|||
124525771|NCT02148952|447876501|FG001|Follow-Up|Withdrawal by Subject|48|||
124525772|NCT01600105|447876502|FG000|Total Participants|Withdrawal by Subject|1|||
124525773|NCT01600105|447876503|FG001|Total Participants|Withdrawal by Subject|0|||
124525774|NCT01600105|447876502|FG000|Total Participants|No images in PACS|10|||
124525775|NCT01600105|447876503|FG001|Total Participants|No images in PACS|0|||
124525776|NCT01600105|447876502|FG000|Total Participants|Insufficient image quality|30|||
124525777|NCT01600105|447876503|FG001|Total Participants|Insufficient image quality|10|||
124525778|NCT01600105|447876502|FG000|Sub Study I|Insufficient image quality|0|||
124525779|NCT01600105|447876503|FG001|Sub Study I|Insufficient image quality|10|||
124525780|NCT01600105|447876502|FG000|Sub Study II|Withdrawal by Subject|1|||
124525781|NCT01600105|447876503|FG001|Sub Study II|Withdrawal by Subject|0|||
124525782|NCT01600105|447876502|FG000|Sub Study II|No images in PACS|1|||
124525783|NCT01600105|447876503|FG001|Sub Study II|No images in PACS|0|||
124525784|NCT01600105|447876502|FG000|Sub Study II|Insufficient image quality|3|||
124525785|NCT01600105|447876503|FG001|Sub Study II|Insufficient image quality|0|||
124525786|NCT01600105|447876502|FG000|Sub Study III|Insufficient image quality|5|||
124525787|NCT01600105|447876503|FG001|Sub Study III|Insufficient image quality|0|||
124525788|NCT01600105|447876502|FG000|Sub Study V|Poor Image Quality|2|||
124525789|NCT01600105|447876503|FG001|Sub Study V|Poor Image Quality|0|||
124525790|NCT04007367|447876504|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
124525791|NCT04007367|447876505|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
124525792|NCT04007367|447876506|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
124525793|NCT04007367|447876504|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
124525794|NCT04007367|447876505|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
124525795|NCT04007367|447876506|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
124525796|NCT04007367|447876504|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
124525797|NCT04007367|447876505|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
124525798|NCT04007367|447876506|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
124525799|NCT04007367|447876504|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
124525800|NCT04007367|447876505|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
124525801|NCT04007367|447876506|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
124525802|NCT04007367|447876504|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
124525803|NCT04007367|447876505|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
124525804|NCT04007367|447876506|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
124525805|NCT01764022|447876507|FG000|Overall Study|Death|3|||
124525806|NCT01764022|447876508|FG001|Overall Study|Death|5|||
124525807|NCT01764022|447876507|FG000|Overall Study|Withdrawal by Subject|2|||
124525808|NCT01764022|447876508|FG001|Overall Study|Withdrawal by Subject|6|||
124525809|NCT01764022|447876507|FG000|Overall Study|Lack of Efficacy|0|||
124525810|NCT01764022|447876508|FG001|Overall Study|Lack of Efficacy|1|||
124525811|NCT01764022|447876507|FG000|Overall Study|Physician Decision|0|||
124525812|NCT01764022|447876508|FG001|Overall Study|Physician Decision|2|||
124525813|NCT01764022|447876507|FG000|Overall Study|Lost to Follow-up|2|||
124525814|NCT01764022|447876508|FG001|Overall Study|Lost to Follow-up|0|||
124525815|NCT01764022|447876507|FG000|Overall Study|Protocol Violation|1|||
124525816|NCT01764022|447876508|FG001|Overall Study|Protocol Violation|0|||
124525817|NCT01899768|447876510|FG000|Part A|Adverse Event|2|||
124525818|NCT01899768|447876510|FG000|Part A|Withdrawal by Subject|1|||
124525819|NCT01899768|447876510|FG000|Part B|Adverse Event|1|||
124525820|NCT01899768|447876510|FG000|Part B|Withdrawal by Subject|1|||
124525821|NCT04043416|447876512|FG000|Washout|Change in health condition|0|||
124525822|NCT04043416|447876513|FG001|Washout|Change in health condition|1|||
124525823|NCT02203916|447876514|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
124525824|NCT02203916|447876515|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
124525825|NCT02203916|447876516|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
124525826|NCT02203916|447876514|FG000|Overall Study|Major Protocol Deviation|1|||
124525827|NCT02203916|447876515|FG001|Overall Study|Major Protocol Deviation|1|||
124578732|NCT01597245|448076608|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578733|NCT01597245|448076609|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578734|NCT01597245|448076610|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578735|NCT01597245|448076611|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578736|NCT01597245|448076612|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578737|NCT01597245|448076613|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578738|NCT01597245|448076614|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578739|NCT01597245|448076615|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578740|NCT01597245|448076616|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578741|NCT01597245|448076617|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578742|NCT01597245|448076618|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578743|NCT01597245|448076619|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578744|NCT01597245|448076620|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578745|NCT01597245|448076621|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
124578746|NCT01597245|448076622|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578747|NCT01597245|448076623|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578748|NCT01597245|448076624|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578749|NCT01597245|448076625|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578750|NCT01597245|448076626|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578751|NCT01597245|448076627|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578752|NCT01597245|448076628|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
124578753|NCT01597245|448076608|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
124578754|NCT01597245|448076609|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
124578755|NCT01597245|448076610|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
124578756|NCT01597245|448076611|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
124578757|NCT01597245|448076612|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
124578758|NCT01597245|448076613|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
124578759|NCT01597245|448076614|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
124578760|NCT01597245|448076615|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
124578761|NCT01597245|448076616|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
124578762|NCT01597245|448076617|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
124578763|NCT01597245|448076618|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
124578764|NCT01597245|448076619|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
124578765|NCT01597245|448076620|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
124726316|NCT01340625|448620242|FG000|First Intervention|Adverse Event|1|||
124525828|NCT02203916|447876516|FG002|Overall Study|Major Protocol Deviation|0|||
124525829|NCT02203916|447876514|FG000|Overall Study|Lost to Follow-up|0|||
124525830|NCT02203916|447876515|FG001|Overall Study|Lost to Follow-up|1|||
124525831|NCT02203916|447876516|FG002|Overall Study|Lost to Follow-up|0|||
124525832|NCT02203916|447876514|FG000|Overall Study|Voluntary Withdrawal|3|||
124525833|NCT02203916|447876515|FG001|Overall Study|Voluntary Withdrawal|3|||
124525834|NCT02203916|447876516|FG002|Overall Study|Voluntary Withdrawal|8|||
124525835|NCT02203916|447876514|FG000|Overall Study|Lack of Efficacy|3|||
124525836|NCT02203916|447876515|FG001|Overall Study|Lack of Efficacy|0|||
124525837|NCT02203916|447876516|FG002|Overall Study|Lack of Efficacy|0|||
124525838|NCT02203916|447876514|FG000|Overall Study|Reason Not Specified|0|||
124525839|NCT02203916|447876515|FG001|Overall Study|Reason Not Specified|2|||
124525840|NCT02203916|447876516|FG002|Overall Study|Reason Not Specified|1|||
124525841|NCT00414973|447876517|FG000|Overall Study|Withdrawal by Subject|14|||
124525842|NCT00414973|447876518|FG001|Overall Study|Withdrawal by Subject|4|||
124525843|NCT00414973|447876519|FG002|Overall Study|Withdrawal by Subject|1|||
124525844|NCT00414973|447876520|FG003|Overall Study|Withdrawal by Subject|0|||
124525845|NCT00414973|447876517|FG000|Overall Study|Adverse Event|10|||
124525846|NCT00414973|447876518|FG001|Overall Study|Adverse Event|0|||
124525847|NCT00414973|447876519|FG002|Overall Study|Adverse Event|1|||
124525848|NCT00414973|447876520|FG003|Overall Study|Adverse Event|0|||
124525849|NCT00414973|447876517|FG000|Overall Study|Protocol Violation|3|||
124525850|NCT00414973|447876518|FG001|Overall Study|Protocol Violation|4|||
124525851|NCT00414973|447876519|FG002|Overall Study|Protocol Violation|0|||
124525852|NCT00414973|447876520|FG003|Overall Study|Protocol Violation|0|||
124525853|NCT00414973|447876517|FG000|Overall Study|Lost to Follow-up|0|||
124525854|NCT00414973|447876518|FG001|Overall Study|Lost to Follow-up|2|||
124525855|NCT00414973|447876519|FG002|Overall Study|Lost to Follow-up|0|||
124525856|NCT00414973|447876520|FG003|Overall Study|Lost to Follow-up|0|||
124525857|NCT00414973|447876517|FG000|Overall Study|Sponsor Decision|1|||
124525858|NCT00414973|447876518|FG001|Overall Study|Sponsor Decision|0|||
124525859|NCT00414973|447876519|FG002|Overall Study|Sponsor Decision|0|||
124525860|NCT00414973|447876520|FG003|Overall Study|Sponsor Decision|0|||
124525861|NCT00414973|447876517|FG000|Overall Study|Death|0|||
124525862|NCT00414973|447876518|FG001|Overall Study|Death|0|||
124525863|NCT00414973|447876519|FG002|Overall Study|Death|1|||
124578766|NCT01597245|448076621|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
124578767|NCT01597245|448076622|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
124578768|NCT01597245|448076623|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
124578769|NCT01597245|448076624|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
124578770|NCT01597245|448076625|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
124578771|NCT01597245|448076626|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
124578772|NCT01597245|448076627|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
124578773|NCT01597245|448076628|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
124578774|NCT01597245|448076608|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
124578775|NCT01597245|448076609|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
124578776|NCT01597245|448076610|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
124578777|NCT01597245|448076611|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
124578778|NCT01597245|448076612|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
124578779|NCT01597245|448076613|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
124578780|NCT01597245|448076614|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
124578781|NCT01597245|448076615|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
124578782|NCT01597245|448076616|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
124578783|NCT01597245|448076617|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
124578784|NCT01597245|448076618|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
124578785|NCT01597245|448076619|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
124578786|NCT01597245|448076620|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
124578787|NCT01597245|448076621|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
124578788|NCT01597245|448076622|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
124578789|NCT01597245|448076623|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
124578790|NCT01597245|448076624|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
124578791|NCT01597245|448076625|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
124578792|NCT01597245|448076626|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
124578793|NCT01597245|448076627|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
124578794|NCT01597245|448076628|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
124578795|NCT01597245|448076608|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124578796|NCT01597245|448076609|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124578797|NCT01597245|448076610|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124578798|NCT01597245|448076611|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124578799|NCT01597245|448076612|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124578800|NCT01597245|448076613|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124578801|NCT01597245|448076614|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124578802|NCT01597245|448076615|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124578803|NCT01597245|448076616|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124578804|NCT01597245|448076617|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124578805|NCT01597245|448076618|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124578806|NCT01597245|448076619|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124578807|NCT01597245|448076620|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124578808|NCT01597245|448076621|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124578809|NCT01597245|448076622|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124578810|NCT01597245|448076623|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124726317|NCT01340625|448620243|FG001|First Intervention|Adverse Event|0|||
124726318|NCT01340625|448620242|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
124726319|NCT01340625|448620243|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
124525864|NCT00414973|447876520|FG003|Overall Study|Death|0|||
124525865|NCT01925014|447876529|FG000|Overall Study|Inappropriate enrollment|4|||
124525866|NCT01925014|447876530|FG001|Overall Study|Inappropriate enrollment|6|||
124525867|NCT01925014|447876529|FG000|Overall Study|Withdrawal by Subject|5|||
124525868|NCT01925014|447876530|FG001|Overall Study|Withdrawal by Subject|13|||
124525869|NCT03696576|447876534|FG000|Overall Study|Soreness of throat after therapy|1|||
124525870|NCT03696576|447876535|FG001|Overall Study|Soreness of throat after therapy|1|||
124525871|NCT03696576|447876534|FG000|Overall Study|Lost to Follow-up|2|||
124525872|NCT03696576|447876535|FG001|Overall Study|Lost to Follow-up|4|||
124525873|NCT00850135|447876538|FG000|Overall Study|Physician Decision|1|||
124525874|NCT00338806|447876539|FG000|Acute Phase|Withdrawal by Subject|0|||
124525875|NCT00338806|447876540|FG001|Acute Phase|Withdrawal by Subject|1|||
124525876|NCT00338806|447876539|FG000|Follow-up|Lost to Follow-up|1|||
124525877|NCT00338806|447876540|FG001|Follow-up|Lost to Follow-up|3|||
124525878|NCT00744991|447876543|FG000|Overall Study|Progressive Disease|11|||
124525879|NCT00744991|447876543|FG000|Overall Study|Withdrawal by Subject|8|||
124525880|NCT00744991|447876543|FG000|Overall Study|Physician Decision|3|||
124525881|NCT00744991|447876543|FG000|Overall Study|Adverse Event|2|||
124525882|NCT00744991|447876543|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
124525883|NCT01487863|447876548|FG000|Overall Study|Death|19|||
124525884|NCT01487863|447876549|FG001|Overall Study|Death|19|||
124525885|NCT03198728|447876550|FG000|Overall Study|Adverse Event|10|||
124525886|NCT03198728|447876551|FG001|Overall Study|Adverse Event|5|||
124525887|NCT03198728|447876550|FG000|Overall Study|Lost to Follow-up|21|||
124525888|NCT03198728|447876551|FG001|Overall Study|Lost to Follow-up|7|||
124525889|NCT03198728|447876550|FG000|Overall Study|Physician Decision|7|||
124525890|NCT03198728|447876551|FG001|Overall Study|Physician Decision|2|||
124525891|NCT03198728|447876550|FG000|Overall Study|Withdrawal by Subject|14|||
124525892|NCT03198728|447876551|FG001|Overall Study|Withdrawal by Subject|10|||
124525893|NCT04051944|447876554|FG000|Overall Study|Study ending|1|||
124525894|NCT04051944|447876555|FG001|Overall Study|Study ending|1|||
124525895|NCT04051944|447876554|FG000|Overall Study|Early study termination by participant|1|||
124525896|NCT04051944|447876555|FG001|Overall Study|Early study termination by participant|0|||
124525897|NCT04051944|447876554|FG000|Overall Study|Withdrawal by Subject|2|||
124525898|NCT04051944|447876555|FG001|Overall Study|Withdrawal by Subject|2|||
124525899|NCT04051944|447876554|FG000|Overall Study|Lack of Efficacy|3|||
124525900|NCT04051944|447876555|FG001|Overall Study|Lack of Efficacy|0|||
124525901|NCT04051944|447876554|FG000|Overall Study|Adverse event, non- fatal|1|||
124525902|NCT04051944|447876555|FG001|Overall Study|Adverse event, non- fatal|1|||
124525903|NCT02139280|447876556|FG000|Overall Study|No longer eligible|2|||
124525904|NCT02139280|447876557|FG001|Overall Study|No longer eligible|0|||
124525905|NCT00422903|447876574|FG000|Overall Study|Disease Progression|3|||
124525906|NCT00422903|447876575|FG001|Overall Study|Disease Progression|1|||
124525907|NCT00422903|447876574|FG000|Overall Study|Adverse Event|0|||
124525908|NCT00422903|447876575|FG001|Overall Study|Adverse Event|2|||
124525909|NCT00422903|447876574|FG000|Overall Study|Informed Consent Withdrawn|1|||
124525910|NCT00422903|447876575|FG001|Overall Study|Informed Consent Withdrawn|2|||
124525911|NCT01302691|447876580|FG000|Overall Study|Adverse Event|2|||
124525912|NCT01302691|447876581|FG001|Overall Study|Adverse Event|0|||
124525913|NCT01302691|447876580|FG000|Overall Study|Death|0|||
124525914|NCT01302691|447876581|FG001|Overall Study|Death|1|||
124525915|NCT01302691|447876580|FG000|Overall Study|Lost to Follow-up|1|||
124525916|NCT01302691|447876581|FG001|Overall Study|Lost to Follow-up|0|||
124525917|NCT01302691|447876580|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
124525918|NCT01302691|447876581|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
124525919|NCT01302691|447876580|FG000|Overall Study|Physician Decision|0|||
124525920|NCT01302691|447876581|FG001|Overall Study|Physician Decision|1|||
124525921|NCT01302691|447876580|FG000|Overall Study|Protocol Violation|1|||
124525922|NCT01302691|447876581|FG001|Overall Study|Protocol Violation|0|||
124525923|NCT00441480|447876582|FG000|Overall Study|Protocol Violation|1|||
124525924|NCT00441480|447876583|FG001|Overall Study|Protocol Violation|1|||
124525925|NCT00441480|447876582|FG000|Overall Study|Withdrawal by Subject|2|||
124525926|NCT00441480|447876583|FG001|Overall Study|Withdrawal by Subject|3|||
124525927|NCT00441012|447876584|FG000|Overall Study|Adverse Event|0|||
124525928|NCT00441012|447876585|FG001|Overall Study|Adverse Event|1|||
124525929|NCT00441012|447876584|FG000|Overall Study|Lost to Follow-up|3|||
124525930|NCT00441012|447876585|FG001|Overall Study|Lost to Follow-up|3|||
124525931|NCT00441012|447876584|FG000|Overall Study|Protocol Violation|10|||
124525932|NCT00441012|447876585|FG001|Overall Study|Protocol Violation|9|||
124525933|NCT00441012|447876584|FG000|Overall Study|Withdrawal by Subject|4|||
124525934|NCT00441012|447876585|FG001|Overall Study|Withdrawal by Subject|0|||
124525935|NCT00441012|447876584|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
124525936|NCT00441012|447876585|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
124525937|NCT02201472|447876586|FG000|Overall Study|Lack of Efficacy|2|||
124525938|NCT00262314|447876589|FG000|Overall Study|Changing physicians|38|||
124525939|NCT00262314|447876589|FG000|Overall Study|Death|12|||
124525940|NCT00262314|447876589|FG000|Overall Study|Patient's decision|92|||
124525941|NCT00262314|447876589|FG000|Overall Study|Other|95|||
124525942|NCT00262314|447876589|FG000|Overall Study|Lost to Follow-up|70|||
124525943|NCT00262314|447876589|FG000|Overall Study|Administrative withdrawal|30|||
124525944|NCT05104749|447876590|FG000|Overall Study|Lost to Follow-up|2|||
124525945|NCT05104749|447876591|FG001|Overall Study|Lost to Follow-up|3|||
124525946|NCT01300767|447876592|FG000|Overall Study|Discomfort|2|||
124525947|NCT01300767|447876592|FG000|Overall Study|Biomicroscopy|1|||
124525948|NCT01300767|447876592|FG000|Overall Study|Unacceptable fit|1|||
124525949|NCT00117572|447876593|FG000|Overall Study|Site withdrew before starting treatment|2|||
124525950|NCT00117572|447876594|FG001|Overall Study|Site withdrew before starting treatment|3|||
124525951|NCT00117572|447876593|FG000|Overall Study|Withdrawal by Subject|3|||
124525952|NCT00117572|447876594|FG001|Overall Study|Withdrawal by Subject|3|||
124525953|NCT00117572|447876593|FG000|Overall Study|Protocol Violation|1|||
124525954|NCT00117572|447876594|FG001|Overall Study|Protocol Violation|0|||
124525955|NCT04973085|447876599|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
124525956|NCT04973085|447876600|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
124525957|NCT00887068|447876601|FG000|Overall Study|Withdrawal by Subject|2|||
124525958|NCT00887068|447876602|FG001|Overall Study|Withdrawal by Subject|0|||
124525959|NCT00887068|447876601|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
124525960|NCT00887068|447876602|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
124578811|NCT01597245|448076624|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
124578812|NCT01597245|448076625|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124578813|NCT01597245|448076626|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
124578814|NCT01597245|448076627|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
124578815|NCT01597245|448076628|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
124578816|NCT01597245|448076608|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578817|NCT01597245|448076609|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578818|NCT01597245|448076610|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578819|NCT01597245|448076611|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578820|NCT01597245|448076612|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578821|NCT01597245|448076613|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578822|NCT01597245|448076614|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578823|NCT01597245|448076615|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578824|NCT01597245|448076616|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578825|NCT01597245|448076617|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578826|NCT01597245|448076618|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578827|NCT01597245|448076619|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578828|NCT01597245|448076620|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578829|NCT01597245|448076621|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578830|NCT01597245|448076622|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578831|NCT01597245|448076623|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578832|NCT01597245|448076624|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578833|NCT01597245|448076625|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
124578834|NCT01597245|448076626|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
124578835|NCT01597245|448076627|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
124578836|NCT01597245|448076628|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
124578837|NCT01597245|448076608|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124578838|NCT01597245|448076609|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124578839|NCT01597245|448076610|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124578840|NCT01597245|448076611|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124578841|NCT01597245|448076612|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124578842|NCT01597245|448076613|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124578843|NCT01597245|448076614|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124578844|NCT01597245|448076615|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124578845|NCT01597245|448076616|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124578846|NCT01597245|448076617|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124578847|NCT01597245|448076618|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124578848|NCT01597245|448076619|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124578849|NCT01597245|448076620|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124578850|NCT01597245|448076621|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124578851|NCT01597245|448076622|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124578852|NCT01597245|448076623|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124578853|NCT01597245|448076624|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
124578854|NCT01597245|448076625|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124578855|NCT01597245|448076626|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
124726320|NCT00734604|448620250|FG000|Overall Study|Adverse Event|0|||
124578856|NCT01597245|448076627|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
124578857|NCT01597245|448076628|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
124578858|NCT01597245|448076608|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124578859|NCT01597245|448076609|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124578860|NCT01597245|448076610|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124578861|NCT01597245|448076611|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124578862|NCT01597245|448076612|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124578863|NCT01597245|448076613|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124726321|NCT00734604|448620251|FG001|Overall Study|Adverse Event|2|||
124726322|NCT00734604|448620252|FG002|Overall Study|Adverse Event|0|||
124726323|NCT00734604|448620253|FG003|Overall Study|Adverse Event|2|||
124726324|NCT00734604|448620254|FG004|Overall Study|Adverse Event|1|||
124726325|NCT00734604|448620255|FG005|Overall Study|Adverse Event|1|||
124726326|NCT00734604|448620250|FG000|Overall Study|Serious Adverse Event|1|||
124726327|NCT00734604|448620251|FG001|Overall Study|Serious Adverse Event|0|||
124726328|NCT00734604|448620252|FG002|Overall Study|Serious Adverse Event|1|||
124726329|NCT00734604|448620253|FG003|Overall Study|Serious Adverse Event|2|||
124726330|NCT00734604|448620254|FG004|Overall Study|Serious Adverse Event|0|||
124525961|NCT04195750|447876608|FG000|Overall Study|Death|245|||
124525962|NCT04195750|447876609|FG001|Overall Study|Death|253|||
124525963|NCT04195750|447876610|FG002|Overall Study|Death|5|||
124525964|NCT04195750|447876608|FG000|Overall Study|Physician Decision|0|||
124525965|NCT04195750|447876609|FG001|Overall Study|Physician Decision|1|||
124525966|NCT04195750|447876610|FG002|Overall Study|Physician Decision|0|||
124525967|NCT04195750|447876608|FG000|Overall Study|Withdrawal by Subject|9|||
124525968|NCT04195750|447876609|FG001|Overall Study|Withdrawal by Subject|8|||
124525969|NCT04195750|447876610|FG002|Overall Study|Withdrawal by Subject|0|||
124525970|NCT04195750|447876608|FG000|Overall Study|Ongoing|120|||
124525971|NCT04195750|447876609|FG001|Overall Study|Ongoing|110|||
124525972|NCT04195750|447876610|FG002|Overall Study|Ongoing|4|||
124525973|NCT03782376|447876611|FG000|Overall Study|Lost to Follow-up|2|||
124525974|NCT03782376|447876612|FG001|Overall Study|Lost to Follow-up|2|||
124525975|NCT03782376|447876611|FG000|Overall Study|Withdrawal by Subject|7|||
124525976|NCT03782376|447876612|FG001|Overall Study|Withdrawal by Subject|11|||
124525977|NCT03782376|447876611|FG000|Overall Study|Death|1|||
124525978|NCT03782376|447876612|FG001|Overall Study|Death|0|||
124525979|NCT03782376|447876611|FG000|Overall Study|Other|16|||
124525980|NCT03782376|447876612|FG001|Overall Study|Other|17|||
124525981|NCT00952419|447876613|FG000|Overall Study|Adverse Event|2|||
124525982|NCT00952419|447876614|FG001|Overall Study|Adverse Event|0|||
124525983|NCT00952419|447876615|FG002|Overall Study|Adverse Event|0|||
124525984|NCT00952419|447876613|FG000|Overall Study|Protocol Violation|3|||
124525985|NCT00952419|447876614|FG001|Overall Study|Protocol Violation|7|||
124525986|NCT00952419|447876615|FG002|Overall Study|Protocol Violation|0|||
124525987|NCT00952419|447876613|FG000|Overall Study|Withdrawal by Subject|1|||
124525988|NCT00952419|447876614|FG001|Overall Study|Withdrawal by Subject|3|||
124525989|NCT00952419|447876615|FG002|Overall Study|Withdrawal by Subject|0|||
124525990|NCT04507360|447878057|FG000|Week 1|Lost to Follow-up|0|||
124525991|NCT04507360|447878058|FG001|Week 1|Lost to Follow-up|0|||
124525992|NCT04507360|447878059|FG002|Week 1|Lost to Follow-up|0|||
124525993|NCT04507360|447878060|FG003|Week 1|Lost to Follow-up|0|||
124525994|NCT04507360|447878061|FG004|Week 1|Lost to Follow-up|0|||
124525995|NCT04507360|447878062|FG005|Week 1|Lost to Follow-up|0|||
124525996|NCT04507360|447878063|FG006|Week 1|Lost to Follow-up|0|||
124525997|NCT04507360|447878064|FG007|Week 1|Lost to Follow-up|0|||
124525998|NCT04507360|447878065|FG008|Week 1|Lost to Follow-up|72|||
124525999|NCT04507360|447878066|FG009|Week 1|Lost to Follow-up|22|||
124526000|NCT04507360|447878067|FG010|Week 1|Lost to Follow-up|10|||
124526001|NCT04507360|447878057|FG000|Week 2|Lost to Follow-up|0|||
124526002|NCT04507360|447878058|FG001|Week 2|Lost to Follow-up|0|||
124526003|NCT04507360|447878059|FG002|Week 2|Lost to Follow-up|0|||
124526004|NCT04507360|447878060|FG003|Week 2|Lost to Follow-up|0|||
124526005|NCT04507360|447878061|FG004|Week 2|Lost to Follow-up|0|||
124526006|NCT04507360|447878062|FG005|Week 2|Lost to Follow-up|0|||
124526007|NCT04507360|447878063|FG006|Week 2|Lost to Follow-up|0|||
124526008|NCT04507360|447878064|FG007|Week 2|Lost to Follow-up|0|||
124526009|NCT04507360|447878065|FG008|Week 2|Lost to Follow-up|121|||
124526010|NCT04507360|447878066|FG009|Week 2|Lost to Follow-up|85|||
124526011|NCT04507360|447878067|FG010|Week 2|Lost to Follow-up|82|||
124526012|NCT04507360|447878057|FG000|Week 3|Lost to Follow-up|0|||
124526013|NCT04507360|447878058|FG001|Week 3|Lost to Follow-up|0|||
124526014|NCT04507360|447878059|FG002|Week 3|Lost to Follow-up|0|||
124526015|NCT04507360|447878060|FG003|Week 3|Lost to Follow-up|0|||
124526016|NCT04507360|447878061|FG004|Week 3|Lost to Follow-up|0|||
124526017|NCT04507360|447878062|FG005|Week 3|Lost to Follow-up|0|||
124526018|NCT04507360|447878063|FG006|Week 3|Lost to Follow-up|0|||
124526019|NCT04507360|447878064|FG007|Week 3|Lost to Follow-up|0|||
124526020|NCT04507360|447878065|FG008|Week 3|Lost to Follow-up|123|||
124526021|NCT04507360|447878066|FG009|Week 3|Lost to Follow-up|92|||
124526022|NCT04507360|447878067|FG010|Week 3|Lost to Follow-up|84|||
124526023|NCT04507360|447878057|FG000|Week 4|Lost to Follow-up|0|||
124526024|NCT04507360|447878058|FG001|Week 4|Lost to Follow-up|0|||
124526025|NCT04507360|447878059|FG002|Week 4|Lost to Follow-up|0|||
124526026|NCT04507360|447878060|FG003|Week 4|Lost to Follow-up|0|||
124526027|NCT04507360|447878061|FG004|Week 4|Lost to Follow-up|0|||
124526028|NCT04507360|447878062|FG005|Week 4|Lost to Follow-up|0|||
124526029|NCT04507360|447878063|FG006|Week 4|Lost to Follow-up|0|||
124526030|NCT04507360|447878064|FG007|Week 4|Lost to Follow-up|0|||
124526031|NCT04507360|447878065|FG008|Week 4|Lost to Follow-up|131|||
124526032|NCT04507360|447878066|FG009|Week 4|Lost to Follow-up|115|||
124526033|NCT04507360|447878067|FG010|Week 4|Lost to Follow-up|102|||
124526034|NCT04507360|447878057|FG000|Week 5|Lost to Follow-up|0|||
124526035|NCT04507360|447878058|FG001|Week 5|Lost to Follow-up|0|||
124526036|NCT04507360|447878059|FG002|Week 5|Lost to Follow-up|0|||
124526037|NCT04507360|447878060|FG003|Week 5|Lost to Follow-up|0|||
124526038|NCT04507360|447878061|FG004|Week 5|Lost to Follow-up|0|||
124526039|NCT04507360|447878062|FG005|Week 5|Lost to Follow-up|0|||
124526040|NCT04507360|447878063|FG006|Week 5|Lost to Follow-up|0|||
124526041|NCT04507360|447878064|FG007|Week 5|Lost to Follow-up|0|||
124526042|NCT04507360|447878065|FG008|Week 5|Lost to Follow-up|103|||
124526043|NCT04507360|447878066|FG009|Week 5|Lost to Follow-up|135|||
124526044|NCT04507360|447878067|FG010|Week 5|Lost to Follow-up|143|||
124526045|NCT04507360|447878057|FG000|Week 8|Lost to Follow-up|0|||
124578864|NCT01597245|448076614|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124578865|NCT01597245|448076615|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124578866|NCT01597245|448076616|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124578867|NCT01597245|448076617|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124578868|NCT01597245|448076618|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124578869|NCT01597245|448076619|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124578870|NCT01597245|448076620|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124578871|NCT01597245|448076621|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124578872|NCT01597245|448076622|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124578873|NCT01597245|448076623|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124578874|NCT01597245|448076624|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
124578875|NCT01597245|448076625|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124578876|NCT01597245|448076626|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
124578877|NCT01597245|448076627|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
124578878|NCT01597245|448076628|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
124578879|NCT01597245|448076608|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578880|NCT01597245|448076609|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578881|NCT01597245|448076610|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578882|NCT01597245|448076611|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578883|NCT01597245|448076612|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124726331|NCT00734604|448620255|FG005|Overall Study|Serious Adverse Event|1|||
124726332|NCT00734604|448620250|FG000|Overall Study|Lost to Follow-up|1|||
124726333|NCT00734604|448620251|FG001|Overall Study|Lost to Follow-up|2|||
124726334|NCT00734604|448620252|FG002|Overall Study|Lost to Follow-up|2|||
124726335|NCT00734604|448620253|FG003|Overall Study|Lost to Follow-up|4|||
124726336|NCT00734604|448620254|FG004|Overall Study|Lost to Follow-up|2|||
124726337|NCT00734604|448620255|FG005|Overall Study|Lost to Follow-up|3|||
124578884|NCT01597245|448076613|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578885|NCT01597245|448076614|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578886|NCT01597245|448076615|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578887|NCT01597245|448076616|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578888|NCT01597245|448076617|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578889|NCT01597245|448076618|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578890|NCT01597245|448076619|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578891|NCT01597245|448076620|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578892|NCT01597245|448076621|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578893|NCT01597245|448076622|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578894|NCT01597245|448076623|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578895|NCT01597245|448076624|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
124578896|NCT01597245|448076625|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578897|NCT01597245|448076626|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578898|NCT01597245|448076627|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
124726338|NCT00734604|448620250|FG000|Overall Study|Physician Decision|0|||
124726339|NCT00734604|448620251|FG001|Overall Study|Physician Decision|1|||
124726340|NCT00734604|448620252|FG002|Overall Study|Physician Decision|1|||
124726341|NCT00734604|448620253|FG003|Overall Study|Physician Decision|0|||
124726342|NCT00734604|448620254|FG004|Overall Study|Physician Decision|0|||
124726343|NCT00734604|448620255|FG005|Overall Study|Physician Decision|0|||
124726344|NCT00734604|448620250|FG000|Overall Study|Protocol Violation|0|||
124726345|NCT00734604|448620251|FG001|Overall Study|Protocol Violation|2|||
124726346|NCT00734604|448620252|FG002|Overall Study|Protocol Violation|0|||
124726347|NCT00734604|448620253|FG003|Overall Study|Protocol Violation|0|||
124726348|NCT00734604|448620254|FG004|Overall Study|Protocol Violation|1|||
124726349|NCT00734604|448620255|FG005|Overall Study|Protocol Violation|0|||
124726350|NCT00734604|448620250|FG000|Overall Study|Sponsor Decision|1|||
124726351|NCT00734604|448620251|FG001|Overall Study|Sponsor Decision|2|||
124726352|NCT00734604|448620252|FG002|Overall Study|Sponsor Decision|1|||
124726353|NCT00734604|448620253|FG003|Overall Study|Sponsor Decision|0|||
124726354|NCT00734604|448620254|FG004|Overall Study|Sponsor Decision|2|||
124726355|NCT00734604|448620255|FG005|Overall Study|Sponsor Decision|0|||
124726356|NCT00734604|448620250|FG000|Overall Study|Withdrawal by Subject|0|||
124726357|NCT00734604|448620251|FG001|Overall Study|Withdrawal by Subject|2|||
124726358|NCT00734604|448620252|FG002|Overall Study|Withdrawal by Subject|0|||
124726359|NCT00734604|448620253|FG003|Overall Study|Withdrawal by Subject|1|||
124726360|NCT00734604|448620254|FG004|Overall Study|Withdrawal by Subject|2|||
124726361|NCT00734604|448620255|FG005|Overall Study|Withdrawal by Subject|1|||
124726362|NCT00734604|448620250|FG000|Overall Study|Lack of Efficacy|0|||
124726363|NCT00734604|448620251|FG001|Overall Study|Lack of Efficacy|1|||
124726364|NCT00734604|448620252|FG002|Overall Study|Lack of Efficacy|1|||
124726365|NCT00734604|448620253|FG003|Overall Study|Lack of Efficacy|0|||
124726366|NCT00734604|448620254|FG004|Overall Study|Lack of Efficacy|0|||
124726367|NCT00734604|448620255|FG005|Overall Study|Lack of Efficacy|0|||
124726368|NCT02589665|448620256|FG000|Induction Period|Did not receive drug|0|||
124726369|NCT02589665|448620257|FG001|Induction Period|Did not receive drug|0|||
124726370|NCT02589665|448620258|FG002|Induction Period|Did not receive drug|0|||
124726371|NCT02589665|448620259|FG003|Induction Period|Did not receive drug|1|||
124726372|NCT02589665|448620260|FG004|Induction Period|Did not receive drug|0|||
124726373|NCT02589665|448620261|FG005|Induction Period|Did not receive drug|0|||
124726374|NCT02589665|448620262|FG006|Induction Period|Did not receive drug|0|||
124726375|NCT02589665|448620263|FG007|Induction Period|Did not receive drug|0|||
124726376|NCT02589665|448620264|FG008|Induction Period|Did not receive drug|0|||
124726377|NCT02589665|448620265|FG009|Induction Period|Did not receive drug|0|||
124726378|NCT02589665|448620256|FG000|Induction Period|Adverse Event|3|||
124726379|NCT02589665|448620257|FG001|Induction Period|Adverse Event|0|||
124726380|NCT02589665|448620258|FG002|Induction Period|Adverse Event|2|||
124726381|NCT02589665|448620259|FG003|Induction Period|Adverse Event|2|||
124726382|NCT02589665|448620260|FG004|Induction Period|Adverse Event|0|||
124726383|NCT02589665|448620261|FG005|Induction Period|Adverse Event|0|||
124726384|NCT02589665|448620262|FG006|Induction Period|Adverse Event|0|||
124726385|NCT02589665|448620263|FG007|Induction Period|Adverse Event|0|||
124726386|NCT02589665|448620264|FG008|Induction Period|Adverse Event|0|||
124726387|NCT02589665|448620265|FG009|Induction Period|Adverse Event|0|||
124726388|NCT02589665|448620256|FG000|Induction Period|Withdrawal by Subject|0|||
124726389|NCT02589665|448620257|FG001|Induction Period|Withdrawal by Subject|1|||
124726390|NCT02589665|448620258|FG002|Induction Period|Withdrawal by Subject|0|||
124726391|NCT02589665|448620259|FG003|Induction Period|Withdrawal by Subject|1|||
124726392|NCT02589665|448620260|FG004|Induction Period|Withdrawal by Subject|0|||
124526046|NCT04507360|447878058|FG001|Week 8|Lost to Follow-up|0|||
124526047|NCT04507360|447878059|FG002|Week 8|Lost to Follow-up|0|||
124526048|NCT04507360|447878060|FG003|Week 8|Lost to Follow-up|0|||
124526049|NCT04507360|447878061|FG004|Week 8|Lost to Follow-up|0|||
124526050|NCT04507360|447878062|FG005|Week 8|Lost to Follow-up|0|||
124526051|NCT04507360|447878063|FG006|Week 8|Lost to Follow-up|0|||
124526052|NCT04507360|447878064|FG007|Week 8|Lost to Follow-up|0|||
124526053|NCT04507360|447878065|FG008|Week 8|Lost to Follow-up|139|||
124526054|NCT04507360|447878066|FG009|Week 8|Lost to Follow-up|145|||
124526055|NCT04507360|447878067|FG010|Week 8|Lost to Follow-up|152|||
124526056|NCT00636155|447878068|FG000|Overall Study|Adverse Event|8|||
124526057|NCT00636155|447878068|FG000|Overall Study|Lack of Efficacy|1|||
124526058|NCT00636155|447878068|FG000|Overall Study|Withdrawal by Subject|3|||
124526059|NCT00636155|447878068|FG000|Overall Study|Stem cell transplant|1|||
124526060|NCT00636155|447878068|FG000|Overall Study|Physician Decision|5|||
124526061|NCT05643170|447878069|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
124526062|NCT05643170|447878069|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
124526063|NCT01432756|447878070|FG000|Overall Study|Lost to Follow-up|1|||
124526064|NCT01432756|447878071|FG001|Overall Study|Lost to Follow-up|0|||
124526065|NCT01432756|447878072|FG002|Overall Study|Lost to Follow-up|2|||
124526066|NCT01432756|447878073|FG003|Overall Study|Lost to Follow-up|1|||
124526067|NCT01004159|447878081|FG000|Overall Study|Adverse Event|2|||
124526068|NCT01004159|447878081|FG000|Overall Study|Disease Progression|18|||
124526069|NCT02973997|447878082|FG000|Overall Study|Withdrawal by Subject|4|||
124526070|NCT02973997|447878083|FG001|Overall Study|Withdrawal by Subject|0|||
124526071|NCT02973997|447878082|FG000|Overall Study|Adverse Event|4|||
124526072|NCT02973997|447878083|FG001|Overall Study|Adverse Event|1|||
124526073|NCT02973997|447878082|FG000|Overall Study|Disease Progression|11|||
124526074|NCT02973997|447878083|FG001|Overall Study|Disease Progression|20|||
124526075|NCT02973997|447878082|FG000|Overall Study|Alternative Therapy|3|||
124526076|NCT02973997|447878083|FG001|Overall Study|Alternative Therapy|0|||
124526077|NCT02973997|447878082|FG000|Overall Study|Other complicating disease|0|||
124526078|NCT02973997|447878083|FG001|Overall Study|Other complicating disease|1|||
124526079|NCT02973997|447878082|FG000|Overall Study|Death|0|||
124526080|NCT02973997|447878083|FG001|Overall Study|Death|1|||
124526081|NCT01431521|447878084|FG000|Overall Study|Withdrawal by Subject|0|||
124726393|NCT02589665|448620261|FG005|Induction Period|Withdrawal by Subject|0|||
124726394|NCT02589665|448620262|FG006|Induction Period|Withdrawal by Subject|0|||
124526082|NCT01431521|447878085|FG001|Overall Study|Withdrawal by Subject|0|||
124526083|NCT01431521|447878086|FG002|Overall Study|Withdrawal by Subject|1|||
124526084|NCT01431521|447878087|FG003|Overall Study|Withdrawal by Subject|0|||
124526085|NCT00444951|447878088|FG000|Overall Study|Lost to Follow-up|1|||
124526086|NCT00444951|447878089|FG001|Overall Study|Lost to Follow-up|1|||
124526087|NCT00444951|447878090|FG002|Overall Study|Lost to Follow-up|0|||
124526088|NCT00444951|447878088|FG000|Overall Study|Withdrawal by Subject|4|||
124526089|NCT00444951|447878089|FG001|Overall Study|Withdrawal by Subject|5|||
124726395|NCT02589665|448620263|FG007|Induction Period|Withdrawal by Subject|0|||
124726396|NCT02589665|448620264|FG008|Induction Period|Withdrawal by Subject|0|||
124726397|NCT02589665|448620265|FG009|Induction Period|Withdrawal by Subject|0|||
124726398|NCT02589665|448620256|FG000|Induction Period|Protocol Violation|0|||
124526090|NCT00444951|447878090|FG002|Overall Study|Withdrawal by Subject|3|||
124526091|NCT00366444|447878092|FG000|Overall Study|Withdrawal by Subject|1|||
124726399|NCT02589665|448620257|FG001|Induction Period|Protocol Violation|1|||
124726400|NCT02589665|448620258|FG002|Induction Period|Protocol Violation|0|||
124726401|NCT02589665|448620259|FG003|Induction Period|Protocol Violation|0|||
124726402|NCT02589665|448620260|FG004|Induction Period|Protocol Violation|0|||
124726403|NCT02589665|448620261|FG005|Induction Period|Protocol Violation|0|||
124726404|NCT02589665|448620262|FG006|Induction Period|Protocol Violation|0|||
124726405|NCT02589665|448620263|FG007|Induction Period|Protocol Violation|0|||
124726406|NCT02589665|448620264|FG008|Induction Period|Protocol Violation|0|||
124726407|NCT02589665|448620265|FG009|Induction Period|Protocol Violation|0|||
124726408|NCT02589665|448620256|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
124726409|NCT02589665|448620257|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
124726410|NCT02589665|448620258|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
124726411|NCT02589665|448620259|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
124726412|NCT02589665|448620260|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
124726413|NCT02589665|448620261|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
124726414|NCT02589665|448620262|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
124726415|NCT02589665|448620263|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
124726416|NCT02589665|448620264|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
124526092|NCT00366444|447878093|FG001|Overall Study|Withdrawal by Subject|1|||
124526093|NCT00366444|447878092|FG000|Overall Study|Lack of Efficacy|0|||
124526094|NCT00366444|447878093|FG001|Overall Study|Lack of Efficacy|1|||
124526095|NCT01320033|447878102|FG000|Overall Study|Lack of Efficacy|0|||
124526096|NCT01320033|447878103|FG001|Overall Study|Lack of Efficacy|0|||
124526097|NCT01320033|447878104|FG002|Overall Study|Lack of Efficacy|1|||
124526098|NCT01320033|447878102|FG000|Overall Study|Adverse Event|9|||
124526099|NCT01320033|447878103|FG001|Overall Study|Adverse Event|7|||
124526100|NCT01320033|447878104|FG002|Overall Study|Adverse Event|8|||
124526101|NCT01320033|447878102|FG000|Overall Study|Withdrawal by Subject|22|||
124526102|NCT01320033|447878103|FG001|Overall Study|Withdrawal by Subject|23|||
124526103|NCT01320033|447878104|FG002|Overall Study|Withdrawal by Subject|23|||
124526104|NCT01320033|447878102|FG000|Overall Study|Protocol Violation|3|||
124526105|NCT01320033|447878103|FG001|Overall Study|Protocol Violation|5|||
124526106|NCT01320033|447878104|FG002|Overall Study|Protocol Violation|3|||
124526107|NCT01320033|447878102|FG000|Overall Study|Lost to Follow-up|22|||
124526108|NCT01320033|447878103|FG001|Overall Study|Lost to Follow-up|26|||
124526109|NCT01320033|447878104|FG002|Overall Study|Lost to Follow-up|17|||
124526110|NCT01320033|447878102|FG000|Overall Study|Other|2|||
124526111|NCT01320033|447878103|FG001|Overall Study|Other|3|||
124526112|NCT01320033|447878104|FG002|Overall Study|Other|1|||
124526113|NCT00963469|447878105|FG000|Overall Study|Adverse Event|15|||
124526114|NCT00963469|447878106|FG001|Overall Study|Adverse Event|11|||
124526115|NCT00963469|447878107|FG002|Overall Study|Adverse Event|1|||
124526116|NCT00963469|447878105|FG000|Overall Study|Lack of Efficacy|10|||
124526117|NCT00963469|447878106|FG001|Overall Study|Lack of Efficacy|7|||
124526118|NCT00963469|447878107|FG002|Overall Study|Lack of Efficacy|2|||
124526119|NCT00963469|447878105|FG000|Overall Study|Lost to Follow-up|1|||
124526120|NCT00963469|447878106|FG001|Overall Study|Lost to Follow-up|1|||
124526121|NCT00963469|447878107|FG002|Overall Study|Lost to Follow-up|0|||
124526122|NCT00963469|447878105|FG000|Overall Study|Protocol Violation|5|||
124526123|NCT00963469|447878106|FG001|Overall Study|Protocol Violation|5|||
124526124|NCT00963469|447878107|FG002|Overall Study|Protocol Violation|3|||
124526125|NCT00963469|447878105|FG000|Overall Study|Withdrawal by Subject|4|||
124526126|NCT00963469|447878106|FG001|Overall Study|Withdrawal by Subject|1|||
124526127|NCT00963469|447878107|FG002|Overall Study|Withdrawal by Subject|1|||
124526128|NCT00963469|447878105|FG000|Overall Study|Pre-randomization Adverse Event|1|||
124526129|NCT00963469|447878106|FG001|Overall Study|Pre-randomization Adverse Event|2|||
124526130|NCT00963469|447878107|FG002|Overall Study|Pre-randomization Adverse Event|0|||
124526131|NCT00963469|447878105|FG000|Overall Study|Moved|1|||
124526132|NCT00963469|447878106|FG001|Overall Study|Moved|0|||
124526133|NCT00963469|447878107|FG002|Overall Study|Moved|0|||
124526134|NCT00963469|447878105|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
124526135|NCT00963469|447878106|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
124526136|NCT00963469|447878107|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
124526137|NCT01938391|447878115|FG000|6 Month Follow up|Withdrawal by Subject|1|||
124526138|NCT01938391|447878115|FG000|12 Month Follow up|Physician Decision|1|||
124526139|NCT01938391|447878115|FG000|12 Month Follow up|Withdrawal by Subject|1|||
124526140|NCT01536418|447878117|FG000|Overall Study|Protocol Violation|2|||
124526141|NCT01536418|447878118|FG001|Overall Study|Protocol Violation|3|||
124526142|NCT01536418|447878117|FG000|Overall Study|Physician Decision|1|||
124526143|NCT01536418|447878118|FG001|Overall Study|Physician Decision|3|||
124526144|NCT01536418|447878117|FG000|Overall Study|Study closed/terminated|41|||
124526145|NCT01536418|447878118|FG001|Overall Study|Study closed/terminated|37|||
124526146|NCT01536418|447878117|FG000|Overall Study|Lack of Efficacy|10|||
124578899|NCT01597245|448076628|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
124578900|NCT01597245|448076608|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578901|NCT01597245|448076609|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578902|NCT01597245|448076610|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578903|NCT01597245|448076611|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578904|NCT01597245|448076612|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578905|NCT01597245|448076613|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578906|NCT01597245|448076614|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578907|NCT01597245|448076615|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578908|NCT01597245|448076616|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578909|NCT01597245|448076617|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578910|NCT01597245|448076618|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578911|NCT01597245|448076619|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578912|NCT01597245|448076620|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578913|NCT01597245|448076621|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578914|NCT01597245|448076622|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578915|NCT01597245|448076623|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578916|NCT01597245|448076624|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
124578917|NCT01597245|448076625|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578918|NCT01597245|448076626|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578919|NCT01597245|448076627|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
124578920|NCT01597245|448076628|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
124578921|NCT01597245|448076608|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578922|NCT01597245|448076609|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578923|NCT01597245|448076610|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578924|NCT01597245|448076611|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578925|NCT01597245|448076612|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578926|NCT01597245|448076613|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578927|NCT01597245|448076614|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578928|NCT01597245|448076615|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578929|NCT01597245|448076616|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578930|NCT01597245|448076617|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578931|NCT01597245|448076618|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578932|NCT01597245|448076619|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578933|NCT01597245|448076620|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578934|NCT01597245|448076621|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578935|NCT01597245|448076622|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578936|NCT01597245|448076623|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578937|NCT01597245|448076624|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578938|NCT01597245|448076625|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578939|NCT01597245|448076626|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578940|NCT01597245|448076627|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
124578941|NCT01597245|448076628|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
124578942|NCT00583453|448078498|FG000|Overall Study|discontinued intervention|0|||
124578943|NCT00583453|448078499|FG001|Overall Study|discontinued intervention|2|||
124578944|NCT00794963|448078500|FG000|Overall Study|Withdrawal by Subject|1|||
124578945|NCT00794963|448078501|FG001|Overall Study|Withdrawal by Subject|4|||
124578946|NCT01527006|448078507|FG000|Core Study|Adverse Event|0|||
124578947|NCT01527006|448078508|FG001|Core Study|Adverse Event|2|||
124578948|NCT01527006|448078507|FG000|Core Study|Lost to Follow-up|0|||
124578949|NCT01527006|448078508|FG001|Core Study|Lost to Follow-up|1|||
124578950|NCT01527006|448078507|FG000|Core Study|Subject Choice|1|||
124578951|NCT01527006|448078508|FG001|Core Study|Subject Choice|0|||
124578952|NCT01527006|448078507|FG000|Core Study|Inadequate Therapeutic Effect|1|||
124726417|NCT02589665|448620265|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
124726418|NCT02589665|448620256|FG000|Maintenance Period|Withdrawal by Subject|0|||
124726419|NCT02589665|448620257|FG001|Maintenance Period|Withdrawal by Subject|0|||
124726420|NCT02589665|448620258|FG002|Maintenance Period|Withdrawal by Subject|0|||
124726421|NCT02589665|448620259|FG003|Maintenance Period|Withdrawal by Subject|0|||
124726422|NCT02589665|448620260|FG004|Maintenance Period|Withdrawal by Subject|4|||
124726423|NCT02589665|448620261|FG005|Maintenance Period|Withdrawal by Subject|2|||
124726424|NCT02589665|448620262|FG006|Maintenance Period|Withdrawal by Subject|4|||
124726425|NCT02589665|448620263|FG007|Maintenance Period|Withdrawal by Subject|0|||
124726426|NCT02589665|448620264|FG008|Maintenance Period|Withdrawal by Subject|0|||
124726427|NCT02589665|448620265|FG009|Maintenance Period|Withdrawal by Subject|0|||
124726428|NCT02589665|448620256|FG000|Maintenance Period|Lack of Efficacy|0|||
124726429|NCT02589665|448620257|FG001|Maintenance Period|Lack of Efficacy|0|||
124578953|NCT01527006|448078508|FG001|Core Study|Inadequate Therapeutic Effect|0|||
124726430|NCT02589665|448620258|FG002|Maintenance Period|Lack of Efficacy|0|||
124726431|NCT02589665|448620259|FG003|Maintenance Period|Lack of Efficacy|0|||
124526147|NCT01536418|447878118|FG001|Overall Study|Lack of Efficacy|16|||
124526148|NCT01536418|447878117|FG000|Overall Study|Adverse Event|9|||
124526149|NCT01536418|447878118|FG001|Overall Study|Adverse Event|4|||
124526150|NCT01536418|447878117|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
124526151|NCT01536418|447878118|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
124526152|NCT01536418|447878117|FG000|Overall Study|Withdrawal by Subject|5|||
124526153|NCT01536418|447878118|FG001|Overall Study|Withdrawal by Subject|3|||
124526154|NCT02234050|447878119|FG000|Overall Study|Lack of Efficacy|38|||
124526155|NCT02234050|447878120|FG001|Overall Study|Lack of Efficacy|22|||
124526156|NCT02234050|447878119|FG000|Overall Study|Adverse Event|13|||
124526157|NCT02234050|447878120|FG001|Overall Study|Adverse Event|1|||
124526158|NCT02234050|447878119|FG000|Overall Study|Withdrawal by Subject|4|||
124526159|NCT02234050|447878120|FG001|Overall Study|Withdrawal by Subject|2|||
124526160|NCT02234050|447878119|FG000|Overall Study|Sponsor's decision|6|||
124726432|NCT02589665|448620260|FG004|Maintenance Period|Lack of Efficacy|2|||
124726433|NCT02589665|448620261|FG005|Maintenance Period|Lack of Efficacy|1|||
124726434|NCT02589665|448620262|FG006|Maintenance Period|Lack of Efficacy|0|||
124726435|NCT02589665|448620263|FG007|Maintenance Period|Lack of Efficacy|0|||
124726436|NCT02589665|448620264|FG008|Maintenance Period|Lack of Efficacy|0|||
124726437|NCT02589665|448620265|FG009|Maintenance Period|Lack of Efficacy|0|||
124726438|NCT02589665|448620256|FG000|Maintenance Period|Adverse Event|0|||
124726439|NCT02589665|448620257|FG001|Maintenance Period|Adverse Event|0|||
124726440|NCT02589665|448620258|FG002|Maintenance Period|Adverse Event|0|||
124726441|NCT02589665|448620259|FG003|Maintenance Period|Adverse Event|0|||
124726442|NCT02589665|448620260|FG004|Maintenance Period|Adverse Event|0|||
124726443|NCT02589665|448620261|FG005|Maintenance Period|Adverse Event|0|||
124726444|NCT02589665|448620262|FG006|Maintenance Period|Adverse Event|2|||
124726445|NCT02589665|448620263|FG007|Maintenance Period|Adverse Event|0|||
124726446|NCT02589665|448620264|FG008|Maintenance Period|Adverse Event|0|||
124726447|NCT02589665|448620265|FG009|Maintenance Period|Adverse Event|0|||
124726448|NCT02589665|448620256|FG000|Maintenance Period|Lost to Follow-up|0|||
124726449|NCT02589665|448620257|FG001|Maintenance Period|Lost to Follow-up|0|||
124726450|NCT02589665|448620258|FG002|Maintenance Period|Lost to Follow-up|0|||
124726451|NCT02589665|448620259|FG003|Maintenance Period|Lost to Follow-up|0|||
124726452|NCT02589665|448620260|FG004|Maintenance Period|Lost to Follow-up|0|||
124726453|NCT02589665|448620261|FG005|Maintenance Period|Lost to Follow-up|1|||
124726454|NCT02589665|448620262|FG006|Maintenance Period|Lost to Follow-up|0|||
124726455|NCT02589665|448620263|FG007|Maintenance Period|Lost to Follow-up|0|||
124726456|NCT02589665|448620264|FG008|Maintenance Period|Lost to Follow-up|0|||
124726457|NCT02589665|448620265|FG009|Maintenance Period|Lost to Follow-up|0|||
124726458|NCT02589665|448620256|FG000|Maintenance Period|Physician Decision|0|||
124726459|NCT02589665|448620257|FG001|Maintenance Period|Physician Decision|0|||
124726460|NCT02589665|448620258|FG002|Maintenance Period|Physician Decision|0|||
124726461|NCT02589665|448620259|FG003|Maintenance Period|Physician Decision|0|||
124726462|NCT02589665|448620260|FG004|Maintenance Period|Physician Decision|0|||
124726463|NCT02589665|448620261|FG005|Maintenance Period|Physician Decision|1|||
124726464|NCT02589665|448620262|FG006|Maintenance Period|Physician Decision|0|||
124726465|NCT02589665|448620263|FG007|Maintenance Period|Physician Decision|0|||
124726466|NCT02589665|448620264|FG008|Maintenance Period|Physician Decision|0|||
124726467|NCT02589665|448620265|FG009|Maintenance Period|Physician Decision|0|||
124726468|NCT02589665|448620256|FG000|Maintenance Period|Reason Not Collected|0|||
124726469|NCT02589665|448620257|FG001|Maintenance Period|Reason Not Collected|0|||
124726470|NCT02589665|448620258|FG002|Maintenance Period|Reason Not Collected|0|||
124526161|NCT02234050|447878120|FG001|Overall Study|Sponsor's decision|0|||
124526162|NCT02365506|447878121|FG000|Overall Study|Investigator's Discretion|0|||
124526163|NCT02365506|447878122|FG001|Overall Study|Investigator's Discretion|0|||
124526164|NCT02365506|447878123|FG002|Overall Study|Investigator's Discretion|1|||
124526165|NCT01680991|447878125|FG000|Overall Study|Adverse Event|1|||
124526166|NCT01680991|447878126|FG001|Overall Study|Adverse Event|0|||
124526167|NCT01680991|447878127|FG002|Overall Study|Adverse Event|0|||
124526168|NCT01680991|447878125|FG000|Overall Study|Death|1|||
124526169|NCT01680991|447878126|FG001|Overall Study|Death|0|||
124526170|NCT01680991|447878127|FG002|Overall Study|Death|1|||
124526171|NCT01680991|447878125|FG000|Overall Study|Protocol Violation|0|||
124526172|NCT01680991|447878126|FG001|Overall Study|Protocol Violation|1|||
124726471|NCT02589665|448620259|FG003|Maintenance Period|Reason Not Collected|0|||
124726472|NCT02589665|448620260|FG004|Maintenance Period|Reason Not Collected|0|||
124726473|NCT02589665|448620261|FG005|Maintenance Period|Reason Not Collected|1|||
124526173|NCT01680991|447878127|FG002|Overall Study|Protocol Violation|0|||
124526174|NCT01680991|447878125|FG000|Overall Study|Withdrawal by Subject|5|||
124526175|NCT01680991|447878126|FG001|Overall Study|Withdrawal by Subject|1|||
124726474|NCT02589665|448620262|FG006|Maintenance Period|Reason Not Collected|1|||
124726475|NCT02589665|448620263|FG007|Maintenance Period|Reason Not Collected|0|||
124726476|NCT02589665|448620264|FG008|Maintenance Period|Reason Not Collected|0|||
124726477|NCT02589665|448620265|FG009|Maintenance Period|Reason Not Collected|0|||
124726478|NCT02589665|448620256|FG000|Induction Extension Period|Adverse Event|0|||
124726479|NCT02589665|448620257|FG001|Induction Extension Period|Adverse Event|0|||
124726480|NCT02589665|448620258|FG002|Induction Extension Period|Adverse Event|0|||
124726481|NCT02589665|448620259|FG003|Induction Extension Period|Adverse Event|0|||
124526176|NCT01680991|447878127|FG002|Overall Study|Withdrawal by Subject|0|||
124526177|NCT01680991|447878125|FG000|Overall Study|Progressive disease (PD)|0|||
124526178|NCT01680991|447878126|FG001|Overall Study|Progressive disease (PD)|10|||
124526179|NCT01680991|447878127|FG002|Overall Study|Progressive disease (PD)|0|||
124526180|NCT01680991|447878125|FG000|Overall Study|Physician Decision|0|||
124526181|NCT01680991|447878126|FG001|Overall Study|Physician Decision|7|||
124526182|NCT01680991|447878127|FG002|Overall Study|Physician Decision|2|||
124526183|NCT01680991|447878125|FG000|Overall Study|Bad physical condition|0|||
124526184|NCT01680991|447878126|FG001|Overall Study|Bad physical condition|0|||
124526185|NCT01680991|447878127|FG002|Overall Study|Bad physical condition|1|||
124526186|NCT01680991|447878125|FG000|Overall Study|PD confirmed in other hospital|1|||
124526187|NCT01680991|447878126|FG001|Overall Study|PD confirmed in other hospital|0|||
124526188|NCT01680991|447878127|FG002|Overall Study|PD confirmed in other hospital|0|||
124526189|NCT01852591|447878128|FG000|Overall Study|Withdrawal by Subject|2|||
124526190|NCT01852591|447878128|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
124526191|NCT06073054|447878129|FG000|Overall Study|Withdrawal by Subject|2|||
124526192|NCT00413777|447878133|FG000|Fixed-dose Period|Lost to Follow-up|1|||
124526193|NCT00413777|447878134|FG001|Fixed-dose Period|Lost to Follow-up|1|||
124526194|NCT00413777|447878133|FG000|Fixed-dose Period|Adverse Event|2|||
124526195|NCT00413777|447878134|FG001|Fixed-dose Period|Adverse Event|1|||
124526196|NCT00413777|447878133|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
124526197|NCT00413777|447878134|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
124526198|NCT00413777|447878133|FG000|Fixed-dose Period|Withdrew Consent|0|||
124526199|NCT00413777|447878134|FG001|Fixed-dose Period|Withdrew Consent|1|||
124526200|NCT05505734|447878139|FG000|Overall Study|Withdrawal by Subject|51|||
124526201|NCT05505734|447878140|FG001|Overall Study|Withdrawal by Subject|64|||
124526202|NCT05505734|447878139|FG000|Overall Study|Adverse Event|6|||
124526203|NCT05505734|447878140|FG001|Overall Study|Adverse Event|20|||
124526204|NCT05505734|447878139|FG000|Overall Study|Protocol Violation|8|||
124526205|NCT05505734|447878140|FG001|Overall Study|Protocol Violation|15|||
124526206|NCT05505734|447878139|FG000|Overall Study|Lack of therapeutic response|0|||
124526207|NCT05505734|447878140|FG001|Overall Study|Lack of therapeutic response|1|||
124526208|NCT05505734|447878139|FG000|Overall Study|Lost to Follow-up|247|||
124526209|NCT05505734|447878140|FG001|Overall Study|Lost to Follow-up|237|||
124526210|NCT05505734|447878139|FG000|Overall Study|Physician Decision|22|||
124526211|NCT05505734|447878140|FG001|Overall Study|Physician Decision|13|||
124526212|NCT05505734|447878139|FG000|Overall Study|Death|2|||
124526213|NCT05505734|447878140|FG001|Overall Study|Death|1|||
124526214|NCT05505734|447878139|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124526215|NCT05505734|447878140|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124526216|NCT05505734|447878139|FG000|Overall Study|Pregnancy|1|||
124526217|NCT05505734|447878140|FG001|Overall Study|Pregnancy|0|||
124526218|NCT05505734|447878139|FG000|Overall Study|Other|17|||
124526219|NCT05505734|447878140|FG001|Overall Study|Other|13|||
124526220|NCT00764322|447878141|FG000|Overall Study|Withdrawal by Subject|11|||
124526221|NCT00764322|447878141|FG000|Overall Study|No CYP2D6 genotyping|9|||
124526222|NCT00976963|447878147|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
124526223|NCT00976963|447878148|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
124526224|NCT00976963|447878147|FG000|Overall Study|administrative error|1|||
124526225|NCT00976963|447878148|FG001|Overall Study|administrative error|0|||
124526226|NCT00976963|447878147|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
124526227|NCT00976963|447878148|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
124526228|NCT02768103|447878153|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
124526229|NCT03369704|447878154|FG000|Treatment Epoch|technical problems|1|||
124526230|NCT03369704|447878155|FG001|Treatment Epoch|technical problems|0|||
124526231|NCT03369704|447878154|FG000|Treatment Epoch|Protocol Violation|1|||
124526232|NCT03369704|447878155|FG001|Treatment Epoch|Protocol Violation|0|||
124526233|NCT03369704|447878154|FG000|Treatment Epoch|Lost to Follow-up|0|||
124526234|NCT03369704|447878155|FG001|Treatment Epoch|Lost to Follow-up|1|||
124526235|NCT03369704|447878154|FG000|Treatment Epoch|Lack of Efficacy|0|||
124526236|NCT03369704|447878155|FG001|Treatment Epoch|Lack of Efficacy|2|||
124526237|NCT03369704|447878154|FG000|Treatment Epoch|Adverse Event|2|||
124526238|NCT03369704|447878155|FG001|Treatment Epoch|Adverse Event|0|||
124526239|NCT03369704|447878154|FG000|Follow-up Epoch|Lost to Follow-up|1|||
124526240|NCT03369704|447878155|FG001|Follow-up Epoch|Lost to Follow-up|0|||
124526241|NCT02348840|447878159|FG000|Overall Study|Withdrawal by Subject|2|||
124526242|NCT02348840|447878160|FG001|Overall Study|Withdrawal by Subject|1|||
124526243|NCT02348840|447878161|FG002|Overall Study|Withdrawal by Subject|0|||
124526244|NCT02348840|447878162|FG003|Overall Study|Withdrawal by Subject|0|||
124526245|NCT01263444|447878163|FG000|Overall Study|Adverse Event|8|||
124526246|NCT01263444|447878163|FG000|Overall Study|Withdrawal by Subject|1|||
124526247|NCT01263444|447878163|FG000|Overall Study|Protocol Violation|1|||
124526248|NCT03236506|447878165|FG000|Overall Study|Death|1|||
124526249|NCT03236506|447878166|FG001|Overall Study|Death|1|||
124578954|NCT01527006|448078507|FG000|Core Study|Withdrawal by Subject|0|||
124578955|NCT01527006|448078508|FG001|Core Study|Withdrawal by Subject|1|||
124578956|NCT01527006|448078507|FG000|Core Study|Other|0|||
124578957|NCT01527006|448078508|FG001|Core Study|Other|2|||
124578958|NCT01527006|448078507|FG000|Extension Phase|Adverse Event|4|||
124578959|NCT01527006|448078508|FG001|Extension Phase|Adverse Event|2|||
124578960|NCT01527006|448078507|FG000|Extension Phase|Lost to Follow-up|0|||
124578961|NCT01527006|448078508|FG001|Extension Phase|Lost to Follow-up|1|||
124578962|NCT01527006|448078507|FG000|Extension Phase|Subject Choice|1|||
124578963|NCT01527006|448078508|FG001|Extension Phase|Subject Choice|1|||
124578964|NCT01527006|448078507|FG000|Extension Phase|Inadequate therapeutic effect|1|||
124578965|NCT01527006|448078508|FG001|Extension Phase|Inadequate therapeutic effect|1|||
124578966|NCT01527006|448078507|FG000|Extension Phase|Other|0|||
124578967|NCT01527006|448078508|FG001|Extension Phase|Other|3|||
124578968|NCT00834340|448078513|FG000|Washout|Adverse Event|1|||
124578969|NCT00834340|448078514|FG001|Washout|Adverse Event|0|||
124578970|NCT00834340|448078513|FG000|Washout|Withdrawal by Subject|1|||
124578971|NCT00834340|448078514|FG001|Washout|Withdrawal by Subject|0|||
124578972|NCT02849457|448078517|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
124578973|NCT02849457|448078518|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
124578974|NCT02849457|448078519|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
124578975|NCT02849457|448078520|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
124578976|NCT03673670|448078524|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
124578977|NCT03673670|448078525|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
124578978|NCT03673670|448078526|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
124578979|NCT03673670|448078527|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
124578980|NCT03673670|448078528|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
124578981|NCT03673670|448078529|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
124578982|NCT03673670|448078524|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
124578983|NCT03673670|448078525|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
124578984|NCT03673670|448078526|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
124578985|NCT03673670|448078527|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
124578986|NCT03673670|448078528|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
124578987|NCT03673670|448078529|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
124578988|NCT03673670|448078524|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
124578989|NCT03673670|448078525|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
124578990|NCT03673670|448078526|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
124578991|NCT03673670|448078527|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
124578992|NCT03673670|448078528|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
124578993|NCT03673670|448078529|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
124578994|NCT03673670|448078524|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
124578995|NCT03673670|448078525|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
124578996|NCT03673670|448078526|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
124578997|NCT03673670|448078527|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
124578998|NCT03673670|448078528|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
124578999|NCT03673670|448078529|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
124579000|NCT03673670|448078524|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
124579001|NCT03673670|448078525|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
124579002|NCT03673670|448078526|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
124579003|NCT03673670|448078527|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
124579004|NCT03673670|448078528|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
124579005|NCT03673670|448078529|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
124579006|NCT03673670|448078524|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
124579007|NCT03673670|448078525|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
124579008|NCT03673670|448078526|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
124579009|NCT03673670|448078527|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
124579010|NCT03673670|448078528|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
124579011|NCT03673670|448078529|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
124579012|NCT03673670|448078524|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
124579013|NCT03673670|448078525|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
124579014|NCT03673670|448078526|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
124579015|NCT03673670|448078527|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
124579016|NCT03673670|448078528|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
124579017|NCT03673670|448078529|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
124579018|NCT04408794|448078530|FG000|Overall Study|Adverse Event|43|||
124579019|NCT04408794|448078530|FG000|Overall Study|Infrequent study drug usage|43|||
124579020|NCT04408794|448078530|FG000|Overall Study|Lack of Efficacy|61|||
124579021|NCT04408794|448078530|FG000|Overall Study|Lost to Follow-up|33|||
124579022|NCT04408794|448078530|FG000|Overall Study|Non-compliance|6|||
124579023|NCT04408794|448078530|FG000|Overall Study|Physician Decision|1|||
124579024|NCT04408794|448078530|FG000|Overall Study|Pregnancy|6|||
124579025|NCT04408794|448078530|FG000|Overall Study|Protocol Deviation|9|||
124579026|NCT04408794|448078530|FG000|Overall Study|Sheehan-STS Result|1|||
124579027|NCT04408794|448078530|FG000|Overall Study|Withdrawal by Subject|57|||
124579028|NCT04408794|448078530|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
124579029|NCT04408794|448078530|FG000|Overall Study|Never Treated Migraine|5|||
124579030|NCT04238754|448078533|FG000|Washout - 1 Week|Lost to Follow-up|1|||
124579031|NCT04238754|448078534|FG001|Washout - 1 Week|Lost to Follow-up|0|||
124579032|NCT01518972|448078538|FG000|Overall Study|Lost to Follow-up|2|||
124579033|NCT01518972|448078539|FG001|Overall Study|Lost to Follow-up|1|||
124579034|NCT01518972|448078538|FG000|Overall Study|Withdrawal by Subject|1|||
124579035|NCT01518972|448078539|FG001|Overall Study|Withdrawal by Subject|0|||
124579036|NCT01518972|448078538|FG000|Overall Study|Moved from area|1|||
124579037|NCT01518972|448078539|FG001|Overall Study|Moved from area|0|||
124579038|NCT01518972|448078538|FG000|Overall Study|Transportation problems|1|||
124579039|NCT01518972|448078539|FG001|Overall Study|Transportation problems|0|||
124579040|NCT01518972|448078538|FG000|Overall Study|Exclusionary medical condition|1|||
124579041|NCT01518972|448078539|FG001|Overall Study|Exclusionary medical condition|0|||
124579042|NCT01518972|448078538|FG000|Overall Study|Missed safety visits|0|||
124726482|NCT02589665|448620260|FG004|Induction Extension Period|Adverse Event|0|||
124726483|NCT02589665|448620261|FG005|Induction Extension Period|Adverse Event|0|||
124726484|NCT02589665|448620262|FG006|Induction Extension Period|Adverse Event|0|||
124726485|NCT02589665|448620263|FG007|Induction Extension Period|Adverse Event|0|||
124526250|NCT03236506|447878167|FG002|Overall Study|Death|1|||
124526251|NCT03236506|447878165|FG000|Overall Study|Withdrawal by Subject|3|||
124526252|NCT03236506|447878166|FG001|Overall Study|Withdrawal by Subject|3|||
124526253|NCT03236506|447878167|FG002|Overall Study|Withdrawal by Subject|4|||
124526254|NCT03236506|447878165|FG000|Overall Study|Did not initiate treatment|2|||
124526255|NCT03236506|447878166|FG001|Overall Study|Did not initiate treatment|1|||
124526256|NCT03236506|447878167|FG002|Overall Study|Did not initiate treatment|2|||
124526257|NCT01466062|447878168|FG000|Overall Study|Adverse Event|1|||
124526258|NCT01466062|447878168|FG000|Overall Study|Withdrawal by Subject|1|||
124526259|NCT02865928|447878169|FG000|Overall Study|Withdrawal by Subject|1|||
124526260|NCT02865928|447878170|FG001|Overall Study|Withdrawal by Subject|0|||
124526261|NCT02865928|447878169|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
124526262|NCT02865928|447878170|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
124526263|NCT02865928|447878169|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
124526264|NCT02865928|447878170|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
124526265|NCT03152110|447878171|FG000|Overall Study|Withdrawal by Subject|3|||
124526266|NCT00085644|447878173|FG000|Double-Blind Period|Adverse Event|5|||
124526267|NCT00085644|447878174|FG001|Double-Blind Period|Adverse Event|2|||
124526268|NCT00085644|447878175|FG002|Double-Blind Period|Adverse Event|0|||
124526269|NCT00085644|447878173|FG000|Double-Blind Period|Withdrawal by Subject|3|||
124526270|NCT00085644|447878174|FG001|Double-Blind Period|Withdrawal by Subject|0|||
124526271|NCT00085644|447878175|FG002|Double-Blind Period|Withdrawal by Subject|0|||
124526272|NCT00085644|447878173|FG000|Double-Blind Period|Lost to Follow-up|2|||
124526273|NCT00085644|447878174|FG001|Double-Blind Period|Lost to Follow-up|1|||
124526274|NCT00085644|447878175|FG002|Double-Blind Period|Lost to Follow-up|0|||
124526275|NCT00085644|447878173|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
124526276|NCT00085644|447878174|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
124526277|NCT00085644|447878175|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
124526278|NCT00085644|447878173|FG000|Double-Blind Period|Contemplating pregnancy|1|||
124526279|NCT00085644|447878174|FG001|Double-Blind Period|Contemplating pregnancy|0|||
124526280|NCT00085644|447878175|FG002|Double-Blind Period|Contemplating pregnancy|0|||
124526281|NCT00085644|447878173|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
124526282|NCT00085644|447878174|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
124526283|NCT00085644|447878175|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
124526284|NCT00085644|447878173|FG000|Open-Label Period|Adverse Event|0|||
124526285|NCT00085644|447878174|FG001|Open-Label Period|Adverse Event|0|||
124526286|NCT00085644|447878175|FG002|Open-Label Period|Adverse Event|38|||
124526287|NCT00085644|447878173|FG000|Open-Label Period|Withdrawal by Subject|0|||
124526288|NCT00085644|447878174|FG001|Open-Label Period|Withdrawal by Subject|0|||
124526289|NCT00085644|447878175|FG002|Open-Label Period|Withdrawal by Subject|29|||
124526290|NCT00085644|447878173|FG000|Open-Label Period|Lost to Follow-up|0|||
124526291|NCT00085644|447878174|FG001|Open-Label Period|Lost to Follow-up|0|||
124526292|NCT00085644|447878175|FG002|Open-Label Period|Lost to Follow-up|13|||
124526293|NCT00085644|447878173|FG000|Open-Label Period|Lack of Efficacy|0|||
124526294|NCT00085644|447878174|FG001|Open-Label Period|Lack of Efficacy|0|||
124526295|NCT00085644|447878175|FG002|Open-Label Period|Lack of Efficacy|15|||
124579043|NCT01518972|448078539|FG001|Overall Study|Missed safety visits|1|||
124579044|NCT01518972|448078538|FG000|Overall Study|Exclusionary medication|0|||
124579045|NCT01518972|448078539|FG001|Overall Study|Exclusionary medication|1|||
124579046|NCT01518972|448078538|FG000|Overall Study|Declined medication starting on day 12|0|||
124579047|NCT01518972|448078539|FG001|Overall Study|Declined medication starting on day 12|1|||
124579048|NCT01175018|448078540|FG000|Overall Study|Adverse Event|3|||
124579049|NCT01175018|448078541|FG001|Overall Study|Adverse Event|1|||
124579050|NCT04022954|448078543|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
124579051|NCT04022954|448078543|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
124579052|NCT04022954|448078543|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
124579053|NCT03872128|448078546|FG000|Overall Study|Dropped out before treatment|1|||
124579054|NCT03872128|448078547|FG001|Overall Study|Dropped out before treatment|0|||
124579055|NCT03872128|448078548|FG002|Overall Study|Dropped out before treatment|4|||
124579056|NCT03872128|448078546|FG000|Overall Study|Lost to Follow-up|2|||
124579057|NCT03872128|448078547|FG001|Overall Study|Lost to Follow-up|5|||
124579058|NCT03872128|448078548|FG002|Overall Study|Lost to Follow-up|8|||
124579059|NCT03733444|448078549|FG000|Overall Study|Adverse Event|8|||
124579060|NCT03733444|448078550|FG001|Overall Study|Adverse Event|10|||
124579061|NCT03733444|448078551|FG002|Overall Study|Adverse Event|5|||
124579062|NCT03733444|448078549|FG000|Overall Study|Death|20|||
124579063|NCT03733444|448078550|FG001|Overall Study|Death|19|||
124579064|NCT03733444|448078551|FG002|Overall Study|Death|11|||
124579065|NCT03733444|448078549|FG000|Overall Study|Lost to Follow-up|3|||
124579066|NCT03733444|448078550|FG001|Overall Study|Lost to Follow-up|0|||
124579067|NCT03733444|448078551|FG002|Overall Study|Lost to Follow-up|1|||
124579068|NCT03733444|448078549|FG000|Overall Study|Lack of Efficacy|0|||
124579069|NCT03733444|448078550|FG001|Overall Study|Lack of Efficacy|1|||
124579070|NCT03733444|448078551|FG002|Overall Study|Lack of Efficacy|1|||
124579071|NCT03733444|448078549|FG000|Overall Study|Physician Decision|2|||
124579072|NCT03733444|448078550|FG001|Overall Study|Physician Decision|1|||
124579073|NCT03733444|448078551|FG002|Overall Study|Physician Decision|0|||
124579074|NCT03733444|448078549|FG000|Overall Study|Protocol Violation|2|||
124579075|NCT03733444|448078550|FG001|Overall Study|Protocol Violation|1|||
124579076|NCT03733444|448078551|FG002|Overall Study|Protocol Violation|0|||
124579077|NCT03733444|448078549|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
124579078|NCT03733444|448078550|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
124579079|NCT03733444|448078551|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
124579080|NCT03733444|448078549|FG000|Overall Study|Study Terminated by Sponsor|203|||
124579081|NCT03733444|448078550|FG001|Overall Study|Study Terminated by Sponsor|209|||
124579082|NCT03733444|448078551|FG002|Overall Study|Study Terminated by Sponsor|221|||
124579083|NCT03733444|448078549|FG000|Overall Study|Withdrawal by Subject|19|||
124579084|NCT03733444|448078550|FG001|Overall Study|Withdrawal by Subject|18|||
124579085|NCT03733444|448078551|FG002|Overall Study|Withdrawal by Subject|16|||
124579086|NCT03733444|448078549|FG000|Overall Study|Miscellaneous|1|||
124579087|NCT03733444|448078550|FG001|Overall Study|Miscellaneous|0|||
124579088|NCT03733444|448078551|FG002|Overall Study|Miscellaneous|1|||
124579089|NCT03733444|448078549|FG000|Overall Study|Not Treated|1|||
124579090|NCT03733444|448078550|FG001|Overall Study|Not Treated|2|||
124579091|NCT03733444|448078551|FG002|Overall Study|Not Treated|1|||
124579092|NCT00556322|448078552|FG000|Overall Study|Insufficient therapeutic response|158|||
124579093|NCT00556322|448078553|FG001|Overall Study|Insufficient therapeutic response|168|||
124579094|NCT00556322|448078552|FG000|Overall Study|Adverse Event|7|||
124579095|NCT00556322|448078553|FG001|Overall Study|Adverse Event|4|||
124579096|NCT00556322|448078552|FG000|Overall Study|Other|4|||
124579097|NCT00556322|448078553|FG001|Overall Study|Other|1|||
124579098|NCT00556322|448078552|FG000|Overall Study|Lost to Follow-up|5|||
124526296|NCT00085644|447878173|FG000|Open-Label Period|Pregnancy|0|||
124526297|NCT00085644|447878174|FG001|Open-Label Period|Pregnancy|0|||
124526298|NCT00085644|447878175|FG002|Open-Label Period|Pregnancy|3|||
124526299|NCT00085644|447878173|FG000|Open-Label Period|Contemplating pregnancy|0|||
124526300|NCT00085644|447878174|FG001|Open-Label Period|Contemplating pregnancy|0|||
124526301|NCT00085644|447878175|FG002|Open-Label Period|Contemplating pregnancy|3|||
124526302|NCT00085644|447878173|FG000|Open-Label Period|Protocol Violation|0|||
124526303|NCT00085644|447878174|FG001|Open-Label Period|Protocol Violation|0|||
124526304|NCT00085644|447878175|FG002|Open-Label Period|Protocol Violation|4|||
124579099|NCT00556322|448078553|FG001|Overall Study|Lost to Follow-up|3|||
124579100|NCT00556322|448078552|FG000|Overall Study|Withdrawal by Subject|19|||
124579101|NCT00556322|448078553|FG001|Overall Study|Withdrawal by Subject|7|||
124579102|NCT00556322|448078552|FG000|Overall Study|Protocol Violation|5|||
124579103|NCT00556322|448078553|FG001|Overall Study|Protocol Violation|1|||
124579104|NCT00556322|448078552|FG000|Overall Study|Ongoing at data cutoff|3|||
124579105|NCT00556322|448078553|FG001|Overall Study|Ongoing at data cutoff|5|||
124579106|NCT00556322|448078552|FG000|Overall Study|Death|20|||
124579107|NCT00556322|448078553|FG001|Overall Study|Death|14|||
124579108|NCT01788423|448078554|FG000|Overall Study|See Comments in Completed (above)|0|||
124579109|NCT01788423|448078555|FG001|Overall Study|See Comments in Completed (above)|4|||
124579110|NCT01788423|448078556|FG002|Overall Study|See Comments in Completed (above)|5|||
124579111|NCT03637764|448078557|FG000|Overall Study|Adverse Event|2|||
124579112|NCT03637764|448078558|FG001|Overall Study|Adverse Event|0|||
124579113|NCT03637764|448078559|FG002|Overall Study|Adverse Event|0|||
124579114|NCT03637764|448078560|FG003|Overall Study|Adverse Event|1|||
124579115|NCT03637764|448078557|FG000|Overall Study|Progressive Disease|23|||
124579116|NCT03637764|448078558|FG001|Overall Study|Progressive Disease|23|||
124579117|NCT03637764|448078559|FG002|Overall Study|Progressive Disease|18|||
124579118|NCT03637764|448078560|FG003|Overall Study|Progressive Disease|31|||
124579119|NCT03637764|448078557|FG000|Overall Study|Withdrawal by Subject|1|||
124579120|NCT03637764|448078558|FG001|Overall Study|Withdrawal by Subject|3|||
124579121|NCT03637764|448078559|FG002|Overall Study|Withdrawal by Subject|0|||
124579122|NCT03637764|448078560|FG003|Overall Study|Withdrawal by Subject|1|||
124579123|NCT02760927|448078561|FG000|Overall Study|Tube Slippage from Device|1|||
124579124|NCT01940341|448078565|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
124579125|NCT01940341|448078566|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
124579126|NCT01940341|448078567|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
124579127|NCT01940341|448078568|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
124579128|NCT01940341|448078565|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
124579129|NCT01940341|448078566|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
124579130|NCT01940341|448078567|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
124579131|NCT01940341|448078568|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
124579132|NCT01940341|448078565|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
124579133|NCT01940341|448078566|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
124579134|NCT01940341|448078567|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
124579135|NCT01940341|448078568|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
124579136|NCT01940341|448078565|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
124579137|NCT01940341|448078566|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
124579138|NCT01940341|448078567|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
124579139|NCT01940341|448078568|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
124579140|NCT01940341|448078565|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
124579141|NCT01940341|448078566|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
124579142|NCT01940341|448078567|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
124579143|NCT01940341|448078568|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
124579144|NCT01940341|448078565|FG000|Period 1: Double-blind Phase|Death|0|||
124579145|NCT01940341|448078566|FG001|Period 1: Double-blind Phase|Death|1|||
124579146|NCT01940341|448078567|FG002|Period 1: Double-blind Phase|Death|0|||
124579147|NCT01940341|448078568|FG003|Period 1: Double-blind Phase|Death|0|||
124579148|NCT01940341|448078565|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
124579149|NCT01940341|448078566|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
124579150|NCT01940341|448078567|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
124579151|NCT01940341|448078568|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
124579152|NCT01940341|448078565|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
124579153|NCT01940341|448078566|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
124579154|NCT01940341|448078567|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
124579155|NCT01940341|448078568|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
124579156|NCT01940341|448078565|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
124579157|NCT01940341|448078566|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
124579158|NCT01940341|448078567|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
124579159|NCT01940341|448078568|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
124579160|NCT01940341|448078565|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
124579161|NCT01940341|448078566|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
124579162|NCT01940341|448078567|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
124579163|NCT01940341|448078568|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
124579164|NCT01940341|448078565|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
124579165|NCT01940341|448078566|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
124579166|NCT01940341|448078567|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
124579167|NCT01940341|448078568|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
124579168|NCT01940341|448078565|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
124579169|NCT01940341|448078566|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
124579170|NCT01940341|448078567|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
124579171|NCT01940341|448078568|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
124579172|NCT01940341|448078565|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
124579173|NCT01940341|448078566|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
124579174|NCT01940341|448078567|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
124579175|NCT01940341|448078568|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
124579176|NCT01940341|448078565|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
124726486|NCT02589665|448620264|FG008|Induction Extension Period|Adverse Event|4|||
124726487|NCT02589665|448620265|FG009|Induction Extension Period|Adverse Event|0|||
124579177|NCT01940341|448078566|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
124579178|NCT01940341|448078567|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
124726488|NCT02589665|448620256|FG000|Induction Extension Period|Lack of Efficacy|0|||
124726489|NCT02589665|448620257|FG001|Induction Extension Period|Lack of Efficacy|0|||
124726490|NCT02589665|448620258|FG002|Induction Extension Period|Lack of Efficacy|0|||
124726491|NCT02589665|448620259|FG003|Induction Extension Period|Lack of Efficacy|0|||
124726492|NCT02589665|448620260|FG004|Induction Extension Period|Lack of Efficacy|0|||
124726493|NCT02589665|448620261|FG005|Induction Extension Period|Lack of Efficacy|0|||
124726494|NCT02589665|448620262|FG006|Induction Extension Period|Lack of Efficacy|0|||
124726495|NCT02589665|448620263|FG007|Induction Extension Period|Lack of Efficacy|0|||
124726496|NCT02589665|448620264|FG008|Induction Extension Period|Lack of Efficacy|3|||
124726497|NCT02589665|448620265|FG009|Induction Extension Period|Lack of Efficacy|0|||
124726498|NCT02589665|448620256|FG000|Induction Extension Period|Withdrawal by Subject|0|||
124726499|NCT02589665|448620257|FG001|Induction Extension Period|Withdrawal by Subject|0|||
124726500|NCT02589665|448620258|FG002|Induction Extension Period|Withdrawal by Subject|0|||
124526305|NCT00085644|447878173|FG000|Open-Label Period|Personal reason|0|||
124526306|NCT00085644|447878174|FG001|Open-Label Period|Personal reason|0|||
124526307|NCT00085644|447878175|FG002|Open-Label Period|Personal reason|4|||
124526308|NCT04259346|447878176|FG000|Overall Study|Lost to Follow-up|1|||
124526309|NCT04259346|447878177|FG001|Overall Study|Lost to Follow-up|3|||
124526310|NCT04259346|447878176|FG000|Overall Study|Protocol Violation|1|||
124526311|NCT04259346|447878177|FG001|Overall Study|Protocol Violation|0|||
124526312|NCT04259346|447878176|FG000|Overall Study|Withdrawal by Subject|1|||
124526313|NCT04259346|447878177|FG001|Overall Study|Withdrawal by Subject|0|||
124526314|NCT04259346|447878176|FG000|Overall Study|Adverse Event|1|||
124526315|NCT04259346|447878177|FG001|Overall Study|Adverse Event|1|||
124526316|NCT03330106|447878178|FG000|Part A|Withdrawal by Subject|1|||
124526317|NCT03330106|447878179|FG001|Part A|Withdrawal by Subject|1|||
124526318|NCT03330106|447878180|FG002|Part A|Withdrawal by Subject|0|||
124526319|NCT03330106|447878181|FG003|Part A|Withdrawal by Subject|0|||
124526320|NCT03330106|447878178|FG000|Part A|Death|2|||
124526321|NCT03330106|447878179|FG001|Part A|Death|1|||
124526322|NCT03330106|447878180|FG002|Part A|Death|0|||
124526323|NCT03330106|447878181|FG003|Part A|Death|0|||
124526324|NCT03330106|447878178|FG000|Part A|Adverse Event|0|||
124526325|NCT03330106|447878179|FG001|Part A|Adverse Event|1|||
124526326|NCT03330106|447878180|FG002|Part A|Adverse Event|0|||
124526327|NCT03330106|447878181|FG003|Part A|Adverse Event|0|||
124526328|NCT03330106|447878178|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
124526329|NCT03330106|447878179|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
124526330|NCT03330106|447878180|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
124526331|NCT03330106|447878181|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
124526332|NCT03330106|447878178|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
124526333|NCT03330106|447878179|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
124526334|NCT03330106|447878180|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
124526335|NCT03330106|447878181|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
124526336|NCT03330106|447878178|FG000|Part A|Progressive Disease|0|||
124526337|NCT03330106|447878179|FG001|Part A|Progressive Disease|1|||
124526338|NCT03330106|447878180|FG002|Part A|Progressive Disease|0|||
124526339|NCT03330106|447878181|FG003|Part A|Progressive Disease|0|||
124526340|NCT03330106|447878178|FG000|Part B|Lost to Follow-up|0|||
124526341|NCT03330106|447878179|FG001|Part B|Lost to Follow-up|0|||
124526342|NCT03330106|447878180|FG002|Part B|Lost to Follow-up|0|||
124526343|NCT03330106|447878181|FG003|Part B|Lost to Follow-up|1|||
124526344|NCT03330106|447878178|FG000|Part B|Withdrawal by Subject|0|||
124526345|NCT03330106|447878179|FG001|Part B|Withdrawal by Subject|0|||
124526346|NCT03330106|447878180|FG002|Part B|Withdrawal by Subject|4|||
124526347|NCT03330106|447878181|FG003|Part B|Withdrawal by Subject|0|||
124526348|NCT03330106|447878178|FG000|Part B|Death|0|||
124526349|NCT03330106|447878179|FG001|Part B|Death|0|||
124526350|NCT03330106|447878180|FG002|Part B|Death|2|||
124526351|NCT03330106|447878181|FG003|Part B|Death|0|||
124526352|NCT03330106|447878178|FG000|Part B|Clinical Progression|0|||
124526353|NCT03330106|447878179|FG001|Part B|Clinical Progression|0|||
124526354|NCT03330106|447878180|FG002|Part B|Clinical Progression|1|||
124526355|NCT03330106|447878181|FG003|Part B|Clinical Progression|1|||
124526356|NCT03330106|447878178|FG000|Part B|Symptomatic Deterioration|0|||
124526357|NCT03330106|447878179|FG001|Part B|Symptomatic Deterioration|0|||
124526358|NCT03330106|447878180|FG002|Part B|Symptomatic Deterioration|0|||
124526359|NCT03330106|447878181|FG003|Part B|Symptomatic Deterioration|1|||
124526360|NCT03330106|447878178|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
124526361|NCT03330106|447878179|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
124526362|NCT03330106|447878180|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
124526363|NCT03330106|447878181|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
124526364|NCT03330106|447878178|FG000|Part B|Progressive Disease|0|||
124526365|NCT03330106|447878179|FG001|Part B|Progressive Disease|0|||
124526366|NCT03330106|447878180|FG002|Part B|Progressive Disease|11|||
124526367|NCT03330106|447878181|FG003|Part B|Progressive Disease|4|||
124526368|NCT00623766|447878183|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
124579179|NCT01940341|448078568|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
124579180|NCT01940341|448078565|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
124579181|NCT01940341|448078566|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
124579182|NCT01940341|448078567|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
124579183|NCT01940341|448078568|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
124579184|NCT01940341|448078565|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
124579185|NCT01940341|448078566|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
124579186|NCT01940341|448078567|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
124579187|NCT01940341|448078568|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
124579188|NCT01940341|448078565|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
124579189|NCT01940341|448078566|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
124579190|NCT01940341|448078567|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
124579191|NCT01940341|448078568|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
124579192|NCT01940341|448078565|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
124579193|NCT01940341|448078566|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
124579194|NCT01940341|448078567|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
124579195|NCT01940341|448078568|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
124579196|NCT01940341|448078565|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
124579197|NCT01940341|448078566|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
124579198|NCT01940341|448078567|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
124579199|NCT01940341|448078568|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
124579200|NCT00841698|448078573|FG000|First Intervention|Withdrawal by Subject|1|||
124579201|NCT00841698|448078574|FG001|First Intervention|Withdrawal by Subject|0|||
124579202|NCT00185458|448078575|FG000|Contraception Phase|Adverse Event|37|||
124579203|NCT00185458|448078575|FG000|Contraception Phase|Lost to Follow-up|10|||
124579204|NCT00185458|448078575|FG000|Contraception Phase|Protocol Violation|2|||
124579205|NCT00185458|448078575|FG000|Contraception Phase|Physician Decision|2|||
124579206|NCT00185458|448078575|FG000|Contraception Phase|Withdrawal by Subject|7|||
124579207|NCT00185458|448078575|FG000|HRT Phase|Adverse Event|18|||
124579208|NCT00185458|448078575|FG000|HRT Phase|Lost to Follow-up|4|||
124579209|NCT00185458|448078575|FG000|HRT Phase|Protocol Violation|2|||
124579210|NCT00185458|448078575|FG000|HRT Phase|Withdrawal by Subject|3|||
124579211|NCT00251979|448078576|FG000|Overall Study|Protocol Violation|3|||
124579212|NCT00251979|448078577|FG001|Overall Study|Protocol Violation|5|||
124579213|NCT00251979|448078576|FG000|Overall Study|Adverse Event|11|||
124579214|NCT00251979|448078577|FG001|Overall Study|Adverse Event|17|||
124579215|NCT00251979|448078576|FG000|Overall Study|Withdrawal by Subject|13|||
124579216|NCT00251979|448078577|FG001|Overall Study|Withdrawal by Subject|7|||
124579217|NCT00251979|448078576|FG000|Overall Study|Lost to Follow-up|8|||
124579218|NCT00251979|448078577|FG001|Overall Study|Lost to Follow-up|6|||
124579219|NCT00251979|448078576|FG000|Overall Study|Death|3|||
124579220|NCT00251979|448078577|FG001|Overall Study|Death|5|||
124579221|NCT01576042|448078578|FG000|Overall Study|Physician Decision|2|||
124579222|NCT01576042|448078579|FG001|Overall Study|Physician Decision|0|||
124579223|NCT00835536|448078586|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
124579224|NCT00835536|448078587|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
124579225|NCT00657553|448078588|FG000|Overall Study|low accrual, no analysis run|5|||
124579226|NCT00657553|448078589|FG001|Overall Study|low accrual, no analysis run|5|||
124579227|NCT03173547|448078590|FG000|Overall Study|Adverse Event|2|||
124579228|NCT03173547|448078591|FG001|Overall Study|Adverse Event|0|||
124579229|NCT03173547|448078590|FG000|Overall Study|Withdrawal by Subject|2|||
124579230|NCT03173547|448078591|FG001|Overall Study|Withdrawal by Subject|2|||
124579231|NCT00446563|448078592|FG000|Overall Study|Adverse Event|4|||
124579232|NCT00446563|448078593|FG001|Overall Study|Adverse Event|3|||
124579233|NCT00446563|448078592|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124579234|NCT00446563|448078593|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124579235|NCT00446563|448078592|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124579236|NCT00446563|448078593|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124776814|NCT05006573|448810019|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
124579237|NCT00446563|448078592|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124579238|NCT00446563|448078593|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
124579239|NCT00446563|448078592|FG000|Overall Study|Withdrawal by Subject|2|||
124579240|NCT00446563|448078593|FG001|Overall Study|Withdrawal by Subject|1|||
124579241|NCT00446563|448078592|FG000|Overall Study|Administrative problems|0|||
124579242|NCT00446563|448078593|FG001|Overall Study|Administrative problems|1|||
124579243|NCT03769025|448078594|FG000|Overall Study|Withdrawal by Subject|1|||
124579244|NCT03769025|448078595|FG001|Overall Study|Withdrawal by Subject|1|||
124579245|NCT03769025|448078594|FG000|Overall Study|Lost to Follow-up|4|||
124579246|NCT03769025|448078595|FG001|Overall Study|Lost to Follow-up|3|||
124579247|NCT01169558|448078596|FG000|Overall Study|Disease progression|98|||
124579248|NCT01169558|448078596|FG000|Overall Study|Adverse Event|25|||
124776815|NCT05006573|448810020|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
124526369|NCT00623766|447878184|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
124526370|NCT00623766|447878183|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
124526371|NCT00623766|447878184|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
124526372|NCT00623766|447878183|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
124526373|NCT00623766|447878184|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
124526374|NCT00623766|447878183|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
124526375|NCT00623766|447878184|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
124526376|NCT00623766|447878183|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
124526377|NCT00623766|447878184|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
124526378|NCT00486889|447878188|FG000|Overall Study|Death|3|||
124526379|NCT00486889|447878188|FG000|Overall Study|Non-compliant|2|||
124526380|NCT00486889|447878188|FG000|Overall Study|Withdrawal by Subject|6|||
124526381|NCT00893763|447878189|FG000|Overall Study|extubated|110|||
124526382|NCT00893763|447878190|FG001|Overall Study|extubated|110|||
124526383|NCT02324049|447878191|FG000|Part C|Study terminated|11|||
124526384|NCT00736450|447878193|FG000|Overall Study|Not ABC gene eligible|19|||
124526385|NCT00736450|447878193|FG000|Overall Study|Withdrawal by Subject|5|||
124526386|NCT00736450|447878193|FG000|Overall Study|Physician Decision|1|||
124526387|NCT04157751|447878194|FG000|Overall Study|Withdrawal by Subject|12|||
124526388|NCT04157751|447878195|FG001|Overall Study|Withdrawal by Subject|17|||
124526389|NCT04157751|447878194|FG000|Overall Study|Lost to Follow-up|6|||
124526390|NCT04157751|447878195|FG001|Overall Study|Lost to Follow-up|2|||
124526391|NCT04157751|447878194|FG000|Overall Study|Adverse Event|34|||
124526392|NCT04157751|447878195|FG001|Overall Study|Adverse Event|23|||
124526393|NCT04157751|447878194|FG000|Overall Study|Not treated|1|||
124526394|NCT04157751|447878195|FG001|Overall Study|Not treated|5|||
124526395|NCT04157751|447878194|FG000|Overall Study|Other reason not stated above|10|||
124526396|NCT04157751|447878195|FG001|Overall Study|Other reason not stated above|10|||
124526397|NCT02829775|447878197|FG000|Overall Study|Death|1|||
124526398|NCT02829775|447878197|FG000|Overall Study|Withdrawal by Subject|3|||
124526399|NCT02829775|447878197|FG000|Overall Study|Disease remission|1|||
124526400|NCT01249157|447878198|FG000|Overall Study|Withdrawal by Subject|1|||
124526401|NCT00062647|447878199|FG000|Overall Study|Death|2|||
124526402|NCT00062647|447878200|FG001|Overall Study|Death|2|||
124526403|NCT00062647|447878199|FG000|Overall Study|Adverse Event|1|||
124526404|NCT00062647|447878200|FG001|Overall Study|Adverse Event|1|||
124526405|NCT00062647|447878199|FG000|Overall Study|Withdrawal by Subject|2|||
124526406|NCT00062647|447878200|FG001|Overall Study|Withdrawal by Subject|1|||
124526407|NCT00062647|447878199|FG000|Overall Study|Protocol Violation|1|||
124526408|NCT00062647|447878200|FG001|Overall Study|Protocol Violation|0|||
124526409|NCT00062647|447878199|FG000|Overall Study|Lost to Follow-up|1|||
124526410|NCT00062647|447878200|FG001|Overall Study|Lost to Follow-up|2|||
124526411|NCT00062647|447878199|FG000|Overall Study|Failed continuation criteria|4|||
124526412|NCT00062647|447878200|FG001|Overall Study|Failed continuation criteria|2|||
124526413|NCT00062647|447878199|FG000|Overall Study|Other|4|||
124526414|NCT00062647|447878200|FG001|Overall Study|Other|4|||
124526415|NCT00062647|447878199|FG000|Overall Study|Never received study treatment|1|||
124526416|NCT00062647|447878200|FG001|Overall Study|Never received study treatment|1|||
124526417|NCT04445051|447878201|FG000|Overall Study|Adverse Event|0|||
124526418|NCT04445051|447878202|FG001|Overall Study|Adverse Event|0|||
124526419|NCT04445051|447878203|FG002|Overall Study|Adverse Event|1|||
124526420|NCT04445051|447878204|FG003|Overall Study|Adverse Event|0|||
124526421|NCT04445051|447878205|FG004|Overall Study|Adverse Event|0|||
124526422|NCT04445051|447878206|FG005|Overall Study|Adverse Event|0|||
124526423|NCT02392468|447878215|FG000|Overall Study|Adverse Event|0|||
124526424|NCT02392468|447878216|FG001|Overall Study|Adverse Event|1|||
124526425|NCT02392468|447878217|FG002|Overall Study|Adverse Event|0|||
124526426|NCT02392468|447878218|FG003|Overall Study|Adverse Event|0|||
124526427|NCT02392468|447878219|FG004|Overall Study|Adverse Event|0|||
124526428|NCT02392468|447878220|FG005|Overall Study|Adverse Event|1|||
124526429|NCT01313039|447878221|FG000|Overall Study|Physician Decision|1|||
124526430|NCT01313039|447878221|FG000|Overall Study|Adverse Event|1|||
124526431|NCT05083949|447878222|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
124526432|NCT05083949|447878223|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
124526433|NCT05083949|447878222|FG000|Period 1|Adverse Event|1|||
124579249|NCT01169558|448078596|FG000|Overall Study|Withdrawal of Consent|8|||
124526434|NCT05083949|447878223|FG001|Period 1|Adverse Event|1|||
124526435|NCT05083949|447878222|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
124526436|NCT05083949|447878223|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
124526437|NCT05083949|447878222|FG000|Period 2|Adverse Event|0|||
124526438|NCT05083949|447878223|FG001|Period 2|Adverse Event|2|||
124526439|NCT00901394|447878230|FG000|Overall Study|Physician Decision|1|||
124526440|NCT00901394|447878231|FG001|Overall Study|Physician Decision|1|||
124526441|NCT00901394|447878232|FG002|Overall Study|Physician Decision|2|||
124526442|NCT02422186|447878233|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
124579250|NCT01169558|448078596|FG000|Overall Study|Medical Decision|7|||
124526443|NCT02422186|447878234|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
124526444|NCT02422186|447878233|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
124526445|NCT02422186|447878234|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
124526446|NCT02422186|447878233|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
124526447|NCT02422186|447878234|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
124526448|NCT02422186|447878233|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
124526449|NCT02422186|447878234|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
124526450|NCT02422186|447878233|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
124526451|NCT02422186|447878234|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
124526452|NCT02422186|447878233|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
124526453|NCT02422186|447878234|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
124526454|NCT02422186|447878233|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
124526455|NCT02422186|447878234|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
124526456|NCT02422186|447878233|FG000|Follow-up Phase (2 Weeks)|Other|3|||
124526457|NCT02422186|447878234|FG001|Follow-up Phase (2 Weeks)|Other|0|||
124526458|NCT03039569|447878235|FG000|Overall Study|Lost to Follow-up|5|||
124526459|NCT03039569|447878236|FG001|Overall Study|Lost to Follow-up|4|||
124526460|NCT02254304|447878237|FG000|Overall Study|Adverse Event|2|||
124526461|NCT02254304|447878238|FG001|Overall Study|Adverse Event|1|||
124526462|NCT02254304|447878237|FG000|Overall Study|Lost to Follow-up|2|||
124526463|NCT02254304|447878238|FG001|Overall Study|Lost to Follow-up|2|||
124526464|NCT02254304|447878237|FG000|Overall Study|Protocol Violation|1|||
124526465|NCT02254304|447878238|FG001|Overall Study|Protocol Violation|0|||
124526466|NCT02254304|447878237|FG000|Overall Study|Withdrawal by Subject|3|||
124526467|NCT02254304|447878238|FG001|Overall Study|Withdrawal by Subject|0|||
124526468|NCT02254304|447878237|FG000|Overall Study|Injection site pain and Injection fear|1|||
124526469|NCT02254304|447878238|FG001|Overall Study|Injection site pain and Injection fear|0|||
124526470|NCT02254304|447878237|FG000|Overall Study|Personal causes|4|||
124526471|NCT02254304|447878238|FG001|Overall Study|Personal causes|1|||
124526472|NCT02254304|447878237|FG000|Overall Study|Personal decision|1|||
124526473|NCT02254304|447878238|FG001|Overall Study|Personal decision|0|||
124526474|NCT04888507|447880445|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
124526475|NCT00400946|447880446|FG000|Overall Study|Ineligible|0|||
124526476|NCT00400946|447880447|FG001|Overall Study|Ineligible|0|||
124526477|NCT00400946|447880448|FG002|Overall Study|Ineligible|0|||
124526478|NCT00400946|447880449|FG003|Overall Study|Ineligible|5|||
124526479|NCT00400946|447880450|FG004|Overall Study|Ineligible|1|||
124526480|NCT00400946|447880446|FG000|Overall Study|Induction Failure|0|||
124526481|NCT00400946|447880447|FG001|Overall Study|Induction Failure|0|||
124526482|NCT00400946|447880448|FG002|Overall Study|Induction Failure|0|||
124526483|NCT00400946|447880449|FG003|Overall Study|Induction Failure|11|||
124526484|NCT00400946|447880450|FG004|Overall Study|Induction Failure|8|||
124526485|NCT00400946|447880446|FG000|Overall Study|Induction Death|0|||
124526486|NCT00400946|447880447|FG001|Overall Study|Induction Death|0|||
124526487|NCT00400946|447880448|FG002|Overall Study|Induction Death|0|||
124526488|NCT00400946|447880449|FG003|Overall Study|Induction Death|13|||
124526489|NCT00400946|447880450|FG004|Overall Study|Induction Death|3|||
124526490|NCT00400946|447880446|FG000|Overall Study|Lost to Follow-up|1|||
124526491|NCT00400946|447880447|FG001|Overall Study|Lost to Follow-up|1|||
124526492|NCT00400946|447880448|FG002|Overall Study|Lost to Follow-up|0|||
124526493|NCT00400946|447880449|FG003|Overall Study|Lost to Follow-up|0|||
124526494|NCT00400946|447880450|FG004|Overall Study|Lost to Follow-up|1|||
124526495|NCT00400946|447880446|FG000|Overall Study|Remission Death|1|||
124526496|NCT00400946|447880447|FG001|Overall Study|Remission Death|1|||
124526497|NCT00400946|447880448|FG002|Overall Study|Remission Death|0|||
124526498|NCT00400946|447880449|FG003|Overall Study|Remission Death|0|||
124526499|NCT00400946|447880450|FG004|Overall Study|Remission Death|1|||
124526500|NCT00400946|447880446|FG000|Overall Study|Relapse|9|||
124526501|NCT00400946|447880447|FG001|Overall Study|Relapse|2|||
124526502|NCT00400946|447880448|FG002|Overall Study|Relapse|1|||
124526503|NCT00400946|447880449|FG003|Overall Study|Relapse|1|||
124526504|NCT00400946|447880450|FG004|Overall Study|Relapse|5|||
124526505|NCT00400946|447880446|FG000|Overall Study|Transplant in CR1|0|||
124526506|NCT00400946|447880447|FG001|Overall Study|Transplant in CR1|0|||
124526507|NCT00400946|447880448|FG002|Overall Study|Transplant in CR1|0|||
124526508|NCT00400946|447880449|FG003|Overall Study|Transplant in CR1|10|||
124526509|NCT00400946|447880450|FG004|Overall Study|Transplant in CR1|1|||
124526510|NCT00400946|447880446|FG000|Overall Study|Withdrawal by Subject|2|||
124526511|NCT00400946|447880447|FG001|Overall Study|Withdrawal by Subject|5|||
124526512|NCT00400946|447880448|FG002|Overall Study|Withdrawal by Subject|1|||
124526513|NCT00400946|447880449|FG003|Overall Study|Withdrawal by Subject|5|||
124526514|NCT00400946|447880450|FG004|Overall Study|Withdrawal by Subject|8|||
124526515|NCT00400946|447880446|FG000|Overall Study|Clinical|1|||
124526516|NCT00400946|447880447|FG001|Overall Study|Clinical|2|||
124526517|NCT00400946|447880448|FG002|Overall Study|Clinical|0|||
124526518|NCT00400946|447880449|FG003|Overall Study|Clinical|2|||
124526519|NCT00400946|447880450|FG004|Overall Study|Clinical|9|||
124526520|NCT00400946|447880446|FG000|Overall Study|Other|0|||
124579251|NCT01169558|448078596|FG000|Overall Study|Stable Disease|4|||
124579252|NCT01169558|448078596|FG000|Overall Study|Lost to Follow-up|4|||
124579253|NCT01169558|448078596|FG000|Overall Study|Need for Surgery|4|||
124579254|NCT01169558|448078596|FG000|Overall Study|Non-compliance|2|||
124579255|NCT01169558|448078596|FG000|Overall Study|Protocol Violation|2|||
124579256|NCT01169558|448078596|FG000|Overall Study|Partial response|2|||
124579257|NCT02409355|448078602|FG000|Overall Study|Withdrawal by Subject|1|||
124579258|NCT02409355|448078603|FG001|Overall Study|Withdrawal by Subject|0|||
124579259|NCT02409355|448078602|FG000|Overall Study|Death|1|||
124579260|NCT02409355|448078603|FG001|Overall Study|Death|1|||
124579261|NCT02409355|448078602|FG000|Overall Study|Study terminated by Sponsor|2|||
124579262|NCT02409355|448078603|FG001|Overall Study|Study terminated by Sponsor|3|||
124579263|NCT00838539|448078604|FG000|Overall Study|Disease Progression|2|||
124579264|NCT00838539|448078605|FG001|Overall Study|Disease Progression|4|||
124579265|NCT00838539|448078606|FG002|Overall Study|Disease Progression|3|||
124579266|NCT00838539|448078607|FG003|Overall Study|Disease Progression|2|||
124579267|NCT00838539|448078608|FG004|Overall Study|Disease Progression|4|||
124579268|NCT00838539|448078609|FG005|Overall Study|Disease Progression|2|||
124579269|NCT00838539|448078610|FG006|Overall Study|Disease Progression|3|||
124579270|NCT00838539|448078611|FG007|Overall Study|Disease Progression|4|||
124579271|NCT00838539|448078612|FG008|Overall Study|Disease Progression|4|||
124579272|NCT00838539|448078613|FG009|Overall Study|Disease Progression|5|||
124579273|NCT00838539|448078614|FG010|Overall Study|Disease Progression|1|||
124579274|NCT00838539|448078615|FG011|Overall Study|Disease Progression|4|||
124579275|NCT00838539|448078604|FG000|Overall Study|Adverse Event|1|||
124579276|NCT00838539|448078605|FG001|Overall Study|Adverse Event|1|||
124579277|NCT00838539|448078606|FG002|Overall Study|Adverse Event|1|||
124579278|NCT00838539|448078607|FG003|Overall Study|Adverse Event|1|||
124579279|NCT00838539|448078608|FG004|Overall Study|Adverse Event|2|||
124579280|NCT00838539|448078609|FG005|Overall Study|Adverse Event|1|||
124579281|NCT00838539|448078610|FG006|Overall Study|Adverse Event|0|||
124579282|NCT00838539|448078611|FG007|Overall Study|Adverse Event|2|||
124579283|NCT00838539|448078612|FG008|Overall Study|Adverse Event|0|||
124579284|NCT00838539|448078613|FG009|Overall Study|Adverse Event|1|||
124579285|NCT00838539|448078614|FG010|Overall Study|Adverse Event|2|||
124579286|NCT00838539|448078615|FG011|Overall Study|Adverse Event|0|||
124579287|NCT00838539|448078604|FG000|Overall Study|Withdrawal by Subject|0|||
124579288|NCT00838539|448078605|FG001|Overall Study|Withdrawal by Subject|1|||
124579289|NCT00838539|448078606|FG002|Overall Study|Withdrawal by Subject|0|||
124579290|NCT00838539|448078607|FG003|Overall Study|Withdrawal by Subject|0|||
124579291|NCT00838539|448078608|FG004|Overall Study|Withdrawal by Subject|0|||
124579292|NCT00838539|448078609|FG005|Overall Study|Withdrawal by Subject|0|||
124579293|NCT00838539|448078610|FG006|Overall Study|Withdrawal by Subject|0|||
124579294|NCT00838539|448078611|FG007|Overall Study|Withdrawal by Subject|0|||
124579295|NCT00838539|448078612|FG008|Overall Study|Withdrawal by Subject|0|||
124579296|NCT00838539|448078613|FG009|Overall Study|Withdrawal by Subject|1|||
124579297|NCT00838539|448078614|FG010|Overall Study|Withdrawal by Subject|2|||
124579298|NCT00838539|448078615|FG011|Overall Study|Withdrawal by Subject|0|||
124579299|NCT00838539|448078604|FG000|Overall Study|Death|0|||
124579300|NCT00838539|448078605|FG001|Overall Study|Death|0|||
124579301|NCT00838539|448078606|FG002|Overall Study|Death|0|||
124579302|NCT00838539|448078607|FG003|Overall Study|Death|0|||
124579303|NCT00838539|448078608|FG004|Overall Study|Death|0|||
124579304|NCT00838539|448078609|FG005|Overall Study|Death|0|||
124579305|NCT00838539|448078610|FG006|Overall Study|Death|1|||
124579306|NCT00838539|448078611|FG007|Overall Study|Death|0|||
124579307|NCT00838539|448078612|FG008|Overall Study|Death|0|||
124579308|NCT00838539|448078613|FG009|Overall Study|Death|0|||
124579309|NCT00838539|448078614|FG010|Overall Study|Death|0|||
124579310|NCT00838539|448078615|FG011|Overall Study|Death|0|||
124579311|NCT00838539|448078604|FG000|Overall Study|Physician Decision|0|||
124579312|NCT00838539|448078605|FG001|Overall Study|Physician Decision|0|||
124579313|NCT00838539|448078606|FG002|Overall Study|Physician Decision|0|||
124579314|NCT00838539|448078607|FG003|Overall Study|Physician Decision|0|||
124579315|NCT00838539|448078608|FG004|Overall Study|Physician Decision|0|||
124579316|NCT00838539|448078609|FG005|Overall Study|Physician Decision|0|||
124579317|NCT00838539|448078610|FG006|Overall Study|Physician Decision|0|||
124579318|NCT00838539|448078611|FG007|Overall Study|Physician Decision|0|||
124579319|NCT00838539|448078612|FG008|Overall Study|Physician Decision|1|||
124579320|NCT00838539|448078613|FG009|Overall Study|Physician Decision|0|||
124579321|NCT00838539|448078614|FG010|Overall Study|Physician Decision|0|||
124579322|NCT00838539|448078615|FG011|Overall Study|Physician Decision|0|||
124579323|NCT00838539|448078604|FG000|Overall Study|Clinical Progression|0|||
124726501|NCT02589665|448620259|FG003|Induction Extension Period|Withdrawal by Subject|0|||
124579324|NCT00838539|448078605|FG001|Overall Study|Clinical Progression|0|||
124579325|NCT00838539|448078606|FG002|Overall Study|Clinical Progression|0|||
124579326|NCT00838539|448078607|FG003|Overall Study|Clinical Progression|0|||
124579327|NCT00838539|448078608|FG004|Overall Study|Clinical Progression|0|||
124579328|NCT00838539|448078609|FG005|Overall Study|Clinical Progression|0|||
124579329|NCT00838539|448078610|FG006|Overall Study|Clinical Progression|1|||
124526521|NCT00400946|447880447|FG001|Overall Study|Other|0|||
124526522|NCT00400946|447880448|FG002|Overall Study|Other|0|||
124526523|NCT00400946|447880449|FG003|Overall Study|Other|0|||
124526524|NCT00400946|447880450|FG004|Overall Study|Other|1|||
124526525|NCT01673373|447880452|FG000|Overall Study|Death|2|||
124526526|NCT05426460|447880453|FG000|Overall Study|Protocol Violation|1|||
124526527|NCT05426460|447880454|FG001|Overall Study|Protocol Violation|1|||
124526528|NCT05426460|447880455|FG002|Overall Study|Protocol Violation|1|||
124526529|NCT05426460|447880456|FG003|Overall Study|Protocol Violation|0|||
124526530|NCT02531633|447880462|FG000|Part A (52 Weeks)|Sponsor request|24|||
124526531|NCT02531633|447880463|FG001|Part A (52 Weeks)|Sponsor request|24|||
124526532|NCT02531633|447880464|FG002|Part A (52 Weeks)|Sponsor request|18|||
124526533|NCT02531633|447880465|FG003|Part A (52 Weeks)|Sponsor request|18|||
124526534|NCT02531633|447880466|FG004|Part A (52 Weeks)|Sponsor request|19|||
124526535|NCT02531633|447880467|FG005|Part A (52 Weeks)|Sponsor request|0|||
124526536|NCT02531633|447880468|FG006|Part A (52 Weeks)|Sponsor request|0|||
124526537|NCT02531633|447880469|FG007|Part A (52 Weeks)|Sponsor request|0|||
124526538|NCT02531633|447880470|FG008|Part A (52 Weeks)|Sponsor request|0|||
124526539|NCT02531633|447880471|FG009|Part A (52 Weeks)|Sponsor request|0|||
124526540|NCT02531633|447880462|FG000|Part A (52 Weeks)|Protocol Violation|1|||
124526541|NCT02531633|447880463|FG001|Part A (52 Weeks)|Protocol Violation|0|||
124526542|NCT02531633|447880464|FG002|Part A (52 Weeks)|Protocol Violation|0|||
124526543|NCT02531633|447880465|FG003|Part A (52 Weeks)|Protocol Violation|0|||
124526544|NCT02531633|447880466|FG004|Part A (52 Weeks)|Protocol Violation|0|||
124526545|NCT02531633|447880467|FG005|Part A (52 Weeks)|Protocol Violation|0|||
124526546|NCT02531633|447880468|FG006|Part A (52 Weeks)|Protocol Violation|0|||
124526547|NCT02531633|447880469|FG007|Part A (52 Weeks)|Protocol Violation|0|||
124526548|NCT02531633|447880470|FG008|Part A (52 Weeks)|Protocol Violation|0|||
124526549|NCT02531633|447880471|FG009|Part A (52 Weeks)|Protocol Violation|0|||
124526550|NCT02531633|447880462|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
124526551|NCT02531633|447880463|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
124526552|NCT02531633|447880464|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
124526553|NCT02531633|447880465|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
124526554|NCT02531633|447880466|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
124526555|NCT02531633|447880467|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
124526556|NCT02531633|447880468|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
124526557|NCT02531633|447880469|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
124526558|NCT02531633|447880470|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
124526559|NCT02531633|447880471|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
124526560|NCT02531633|447880462|FG000|Part A (52 Weeks)|Physician Decision|1|||
124526561|NCT02531633|447880463|FG001|Part A (52 Weeks)|Physician Decision|4|||
124526562|NCT02531633|447880464|FG002|Part A (52 Weeks)|Physician Decision|3|||
124526563|NCT02531633|447880465|FG003|Part A (52 Weeks)|Physician Decision|1|||
124526564|NCT02531633|447880466|FG004|Part A (52 Weeks)|Physician Decision|0|||
124526565|NCT02531633|447880467|FG005|Part A (52 Weeks)|Physician Decision|0|||
124526566|NCT02531633|447880468|FG006|Part A (52 Weeks)|Physician Decision|0|||
124526567|NCT02531633|447880469|FG007|Part A (52 Weeks)|Physician Decision|0|||
124526568|NCT02531633|447880470|FG008|Part A (52 Weeks)|Physician Decision|0|||
124526569|NCT02531633|447880471|FG009|Part A (52 Weeks)|Physician Decision|0|||
124526570|NCT02531633|447880462|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
124526571|NCT02531633|447880463|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
124526572|NCT02531633|447880464|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
124526573|NCT02531633|447880465|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
124526574|NCT02531633|447880466|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
124526575|NCT02531633|447880467|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
124526576|NCT02531633|447880468|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
124526577|NCT02531633|447880469|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
124526578|NCT02531633|447880470|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
124526579|NCT02531633|447880471|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
124526580|NCT02531633|447880462|FG000|Part A (52 Weeks)|Other|2|||
124526581|NCT02531633|447880463|FG001|Part A (52 Weeks)|Other|0|||
124526582|NCT02531633|447880464|FG002|Part A (52 Weeks)|Other|0|||
124526583|NCT02531633|447880465|FG003|Part A (52 Weeks)|Other|0|||
124526584|NCT02531633|447880466|FG004|Part A (52 Weeks)|Other|0|||
124526585|NCT02531633|447880467|FG005|Part A (52 Weeks)|Other|0|||
124526586|NCT02531633|447880468|FG006|Part A (52 Weeks)|Other|0|||
124526587|NCT02531633|447880469|FG007|Part A (52 Weeks)|Other|0|||
124526588|NCT02531633|447880470|FG008|Part A (52 Weeks)|Other|0|||
124526589|NCT02531633|447880471|FG009|Part A (52 Weeks)|Other|0|||
124526590|NCT02531633|447880462|FG000|Part B (104 Weeks)|Sponsor request|0|||
124526591|NCT02531633|447880463|FG001|Part B (104 Weeks)|Sponsor request|0|||
124526592|NCT02531633|447880464|FG002|Part B (104 Weeks)|Sponsor request|0|||
124526593|NCT02531633|447880465|FG003|Part B (104 Weeks)|Sponsor request|0|||
124526594|NCT02531633|447880466|FG004|Part B (104 Weeks)|Sponsor request|0|||
124526595|NCT02531633|447880467|FG005|Part B (104 Weeks)|Sponsor request|8|||
124526596|NCT02531633|447880468|FG006|Part B (104 Weeks)|Sponsor request|5|||
124526597|NCT02531633|447880469|FG007|Part B (104 Weeks)|Sponsor request|3|||
124526598|NCT02531633|447880470|FG008|Part B (104 Weeks)|Sponsor request|5|||
124579330|NCT00838539|448078611|FG007|Overall Study|Clinical Progression|0|||
124579331|NCT00838539|448078612|FG008|Overall Study|Clinical Progression|0|||
124579332|NCT00838539|448078613|FG009|Overall Study|Clinical Progression|0|||
124579333|NCT00838539|448078614|FG010|Overall Study|Clinical Progression|0|||
124579334|NCT00838539|448078615|FG011|Overall Study|Clinical Progression|0|||
124579335|NCT00838539|448078604|FG000|Overall Study|Symptomatic Deterioration|0|||
124579336|NCT00838539|448078605|FG001|Overall Study|Symptomatic Deterioration|0|||
124579337|NCT00838539|448078606|FG002|Overall Study|Symptomatic Deterioration|1|||
124579338|NCT00838539|448078607|FG003|Overall Study|Symptomatic Deterioration|1|||
124579339|NCT00838539|448078608|FG004|Overall Study|Symptomatic Deterioration|0|||
124579340|NCT00838539|448078609|FG005|Overall Study|Symptomatic Deterioration|1|||
124579341|NCT00838539|448078610|FG006|Overall Study|Symptomatic Deterioration|0|||
124579342|NCT00838539|448078611|FG007|Overall Study|Symptomatic Deterioration|0|||
124579343|NCT00838539|448078612|FG008|Overall Study|Symptomatic Deterioration|0|||
124579344|NCT00838539|448078613|FG009|Overall Study|Symptomatic Deterioration|1|||
124579345|NCT00838539|448078614|FG010|Overall Study|Symptomatic Deterioration|0|||
124579346|NCT00838539|448078615|FG011|Overall Study|Symptomatic Deterioration|0|||
124526599|NCT02531633|447880471|FG009|Part B (104 Weeks)|Sponsor request|4|||
124526600|NCT02531633|447880462|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
124526601|NCT02531633|447880463|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
124526602|NCT02531633|447880464|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
124526603|NCT02531633|447880465|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
124526604|NCT02531633|447880466|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
124526605|NCT02531633|447880467|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
124526606|NCT02531633|447880468|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
124526607|NCT02531633|447880469|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
124526608|NCT02531633|447880470|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
124526609|NCT02531633|447880471|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
124526610|NCT01572844|447880472|FG000|Overall Study|Physician Decision|1|||
124526611|NCT01572844|447880473|FG001|Overall Study|Physician Decision|1|||
124526612|NCT05171816|447880474|FG000|Overall Study|Death|18|||
124526613|NCT05171816|447880475|FG001|Overall Study|Death|16|||
124526614|NCT04667949|447880476|FG000|Overall Study|Adverse Event|0|||
124526615|NCT04667949|447880477|FG001|Overall Study|Adverse Event|2|||
124526616|NCT04667949|447880476|FG000|Overall Study|Lost to Follow-up|0|||
124526617|NCT04667949|447880477|FG001|Overall Study|Lost to Follow-up|1|||
124526618|NCT04667949|447880476|FG000|Overall Study|Physician Decision|0|||
124526619|NCT04667949|447880477|FG001|Overall Study|Physician Decision|2|||
124526620|NCT04667949|447880476|FG000|Overall Study|Subject decision|1|||
124526621|NCT04667949|447880477|FG001|Overall Study|Subject decision|7|||
124526622|NCT02000622|447880478|FG000|Overall Study|Withdrawal by Subject|5|||
124526623|NCT02000622|447880479|FG001|Overall Study|Withdrawal by Subject|7|||
124526624|NCT02000622|447880478|FG000|Overall Study|Lost to Follow-up|4|||
124526625|NCT02000622|447880479|FG001|Overall Study|Lost to Follow-up|0|||
124526626|NCT02000622|447880478|FG000|Overall Study|Death|159|||
124526627|NCT02000622|447880479|FG001|Overall Study|Death|73|||
124526628|NCT02000622|447880478|FG000|Overall Study|Withdrawn due to site closure|1|||
124526629|NCT02000622|447880479|FG001|Overall Study|Withdrawn due to site closure|0|||
124526630|NCT01405027|447880480|FG000|Overall Study|Withdrawn consent|3|||
124526631|NCT01405027|447880481|FG001|Overall Study|Withdrawn consent|0|||
124526632|NCT01405027|447880480|FG000|Overall Study|Lost to Follow-up|16|||
124526633|NCT01405027|447880481|FG001|Overall Study|Lost to Follow-up|24|||
124526634|NCT01405027|447880480|FG000|Overall Study|Investigator judgement|0|||
124526635|NCT01405027|447880481|FG001|Overall Study|Investigator judgement|2|||
124526636|NCT01405027|447880480|FG000|Overall Study|Death|1|||
124526637|NCT01405027|447880481|FG001|Overall Study|Death|0|||
124579347|NCT03482882|448078616|FG000|Overall Study|Adverse Event|3|||
124579348|NCT03482882|448078616|FG000|Overall Study|Lost to Follow-up|1|||
124579349|NCT03482882|448078616|FG000|Overall Study|Protocol Violation|2|||
124579350|NCT03482882|448078616|FG000|Overall Study|Not further specified|1|||
124579351|NCT03123471|448078623|FG000|Placebo-controlled Phase|Adverse Event|3|||
124526638|NCT01405027|447880480|FG000|Overall Study|Other or Unknown|12|||
124526639|NCT01405027|447880481|FG001|Overall Study|Other or Unknown|25|||
124526640|NCT04924114|447880497|FG000|Overall Study|Withdrawal by Subject|0|||
124526641|NCT04924114|447880498|FG001|Overall Study|Withdrawal by Subject|2|||
124526642|NCT04924114|447880499|FG002|Overall Study|Withdrawal by Subject|2|||
124526643|NCT04924114|447880500|FG003|Overall Study|Withdrawal by Subject|0|||
124526644|NCT04924114|447880501|FG004|Overall Study|Withdrawal by Subject|2|||
124526645|NCT04960202|447880502|FG000|Overall Study|Other|5|||
124526646|NCT04960202|447880503|FG001|Overall Study|Other|0|||
124526647|NCT04960202|447880502|FG000|Overall Study|Withdrawal by Subject|37|||
124526648|NCT04960202|447880503|FG001|Overall Study|Withdrawal by Subject|43|||
124526649|NCT04960202|447880502|FG000|Overall Study|Lost to Follow-up|20|||
124526650|NCT04960202|447880503|FG001|Overall Study|Lost to Follow-up|16|||
124526651|NCT04960202|447880502|FG000|Overall Study|Death|0|||
124526652|NCT04960202|447880503|FG001|Overall Study|Death|15|||
124526653|NCT03558828|447880506|FG000|Overall Study|Lost to Follow-up|4|||
124579352|NCT03123471|448078624|FG001|Placebo-controlled Phase|Adverse Event|8|||
124526654|NCT03558828|447880507|FG001|Overall Study|Lost to Follow-up|3|||
124526655|NCT03558828|447880508|FG002|Overall Study|Lost to Follow-up|3|||
124526656|NCT03558828|447880509|FG003|Overall Study|Lost to Follow-up|5|||
124526657|NCT03558828|447880510|FG004|Overall Study|Lost to Follow-up|2|||
124526658|NCT03558828|447880511|FG005|Overall Study|Lost to Follow-up|3|||
124526659|NCT03558828|447880506|FG000|Overall Study|dropped before the intervention|1|||
124579353|NCT03123471|448078623|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
124579354|NCT03123471|448078624|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
124579355|NCT03123471|448078623|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
124579356|NCT03123471|448078624|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
124579357|NCT03123471|448078623|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
124579358|NCT03123471|448078624|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
124579359|NCT03123471|448078623|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
124579360|NCT03123471|448078624|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
124579361|NCT03123471|448078623|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
124579362|NCT03123471|448078624|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
124579363|NCT03123471|448078623|FG000|Placebo-controlled Phase|Miscellaneous|0|||
124579364|NCT03123471|448078624|FG001|Placebo-controlled Phase|Miscellaneous|1|||
124579365|NCT03123471|448078623|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
124579366|NCT03123471|448078624|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
124579367|NCT03123471|448078623|FG000|Apremilast Extension Phase|Adverse Event|1|||
124579368|NCT03123471|448078624|FG001|Apremilast Extension Phase|Adverse Event|5|||
124579369|NCT03123471|448078623|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
124579370|NCT03123471|448078624|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
124579371|NCT03123471|448078623|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
124579372|NCT03123471|448078624|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
124579373|NCT02957942|448078625|FG000|Overall Study|Withdrawal by Subject|0|||
124579374|NCT02957942|448078626|FG001|Overall Study|Withdrawal by Subject|1|||
124579375|NCT02957942|448078625|FG000|Overall Study|Practicing experiment protocol|0|||
124579376|NCT02957942|448078626|FG001|Overall Study|Practicing experiment protocol|6|||
124579377|NCT03238781|448078627|FG000|Overall Study|Adverse Event|1|||
124579378|NCT03238781|448078628|FG001|Overall Study|Adverse Event|1|||
124579379|NCT03238781|448078629|FG002|Overall Study|Adverse Event|2|||
124526660|NCT03558828|447880507|FG001|Overall Study|dropped before the intervention|1|||
124579380|NCT03238781|448078627|FG000|Overall Study|Lost to Follow-up|2|||
124579381|NCT03238781|448078628|FG001|Overall Study|Lost to Follow-up|1|||
124579382|NCT03238781|448078629|FG002|Overall Study|Lost to Follow-up|2|||
124579383|NCT03238781|448078627|FG000|Overall Study|Withdrawal by Subject|23|||
124579384|NCT03238781|448078628|FG001|Overall Study|Withdrawal by Subject|14|||
124579385|NCT03238781|448078629|FG002|Overall Study|Withdrawal by Subject|16|||
124579386|NCT03238781|448078627|FG000|Overall Study|Decision by sponsor|0|||
124579387|NCT03238781|448078628|FG001|Overall Study|Decision by sponsor|1|||
124579388|NCT03238781|448078629|FG002|Overall Study|Decision by sponsor|0|||
124579389|NCT01249651|448078631|FG000|Overall Study|Withdrawal by Subject|4|||
124579390|NCT01249651|448078631|FG000|Overall Study|Adverse Event|1|||
124579391|NCT01249651|448078631|FG000|Overall Study|Protocol Violation|1|||
124579392|NCT01249651|448078631|FG000|Overall Study|Sponsor Decision|1|||
124579393|NCT00813592|448078637|FG000|Overall Study|Disease assessment was not completed per|2|||
124579394|NCT00811655|448078638|FG000|Overall Study|Physician Decision|1|||
124579395|NCT03801707|448078643|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
124579396|NCT03873272|448078644|FG000|Overall Study|Withdrawal by Subject|2|||
124579397|NCT03873272|448078645|FG001|Overall Study|Withdrawal by Subject|0|||
124579398|NCT03873272|448078646|FG002|Overall Study|Withdrawal by Subject|1|||
124579399|NCT03873272|448078644|FG000|Overall Study|Death|0|||
124579400|NCT03873272|448078645|FG001|Overall Study|Death|2|||
124726502|NCT02589665|448620260|FG004|Induction Extension Period|Withdrawal by Subject|0|||
124726503|NCT02589665|448620261|FG005|Induction Extension Period|Withdrawal by Subject|0|||
124726504|NCT02589665|448620262|FG006|Induction Extension Period|Withdrawal by Subject|0|||
124726505|NCT02589665|448620263|FG007|Induction Extension Period|Withdrawal by Subject|2|||
124726506|NCT02589665|448620264|FG008|Induction Extension Period|Withdrawal by Subject|3|||
124526661|NCT03558828|447880508|FG002|Overall Study|dropped before the intervention|0|||
124726507|NCT02589665|448620265|FG009|Induction Extension Period|Withdrawal by Subject|0|||
124726508|NCT02589665|448620256|FG000|Induction Extension Period|Physician Decision|0|||
124776816|NCT05006573|448810019|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
124776817|NCT05006573|448810020|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
124526662|NCT03558828|447880509|FG003|Overall Study|dropped before the intervention|0|||
124579401|NCT03873272|448078646|FG002|Overall Study|Death|1|||
124579402|NCT00787254|448078647|FG000|Overall Study|Adverse Event|24|||
124579403|NCT00787254|448078648|FG001|Overall Study|Adverse Event|23|||
124579404|NCT00787254|448078647|FG000|Overall Study|Protocol Violation|26|||
124579405|NCT00787254|448078648|FG001|Overall Study|Protocol Violation|23|||
124579406|NCT00787254|448078647|FG000|Overall Study|Withdrawal by Subject|16|||
124579407|NCT00787254|448078648|FG001|Overall Study|Withdrawal by Subject|11|||
124579408|NCT00787254|448078647|FG000|Overall Study|Lack of Efficacy|4|||
124579409|NCT00787254|448078648|FG001|Overall Study|Lack of Efficacy|15|||
124579410|NCT00787254|448078647|FG000|Overall Study|NSAIDs discontinuation|1|||
124579411|NCT00787254|448078648|FG001|Overall Study|NSAIDs discontinuation|2|||
124579412|NCT00787254|448078647|FG000|Overall Study|Institution closed|1|||
124579413|NCT00787254|448078648|FG001|Overall Study|Institution closed|0|||
124579414|NCT00787254|448078647|FG000|Overall Study|Physician Decision|4|||
124579415|NCT00787254|448078648|FG001|Overall Study|Physician Decision|8|||
124579416|NCT00316186|448078651|FG000|Overall Study|Adverse Event|6|||
124579417|NCT00316186|448078651|FG000|Overall Study|Disease Progression|4|||
124579418|NCT00316186|448078651|FG000|Overall Study|Lost to Follow-up|1|||
124579419|NCT00316186|448078651|FG000|Overall Study|Other|1|||
124579420|NCT03071575|448080236|FG000|Overall Study|Death|0|||
124579421|NCT03071575|448080237|FG001|Overall Study|Death|1|||
124579422|NCT03071575|448080236|FG000|Overall Study|Lost to Follow-up|5|||
124579423|NCT03071575|448080237|FG001|Overall Study|Lost to Follow-up|11|||
124579424|NCT03071575|448080236|FG000|Overall Study|Withdrawal by Subject|4|||
124579425|NCT03071575|448080237|FG001|Overall Study|Withdrawal by Subject|2|||
124579426|NCT03255733|448080241|FG000|Overall Study|Lost to Follow-up|4|||
124579427|NCT04299087|448080242|FG000|Overall Study|Lost to Follow-up|2|||
124579428|NCT04299087|448080243|FG001|Overall Study|Lost to Follow-up|1|||
124579429|NCT00594035|448080244|FG000|Overall Study|Lost to Follow-up|1|||
124579430|NCT00594035|448080245|FG001|Overall Study|Lost to Follow-up|1|||
124579431|NCT00594035|448080244|FG000|Overall Study|Withdrawal by Subject|1|||
124579432|NCT00594035|448080245|FG001|Overall Study|Withdrawal by Subject|0|||
124579433|NCT00594035|448080244|FG000|Overall Study|Subject transferred to nursing home|0|||
124579434|NCT00594035|448080245|FG001|Overall Study|Subject transferred to nursing home|1|||
124579435|NCT00594035|448080244|FG000|Overall Study|Subject couldn't return due to job|0|||
124579436|NCT00594035|448080245|FG001|Overall Study|Subject couldn't return due to job|1|||
124579437|NCT00795821|448080246|FG000|Acute Treatment Phase|Adverse Event|23|||
124579438|NCT00795821|448080247|FG001|Acute Treatment Phase|Adverse Event|4|||
124579439|NCT00795821|448080246|FG000|Acute Treatment Phase|Death|1|||
124579440|NCT00795821|448080247|FG001|Acute Treatment Phase|Death|0|||
124579441|NCT00795821|448080246|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
124579442|NCT00795821|448080247|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
124579443|NCT00795821|448080246|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
124579444|NCT00795821|448080247|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
124579445|NCT00795821|448080246|FG000|Acute Treatment Phase|Physician Decision|1|||
124579446|NCT00795821|448080247|FG001|Acute Treatment Phase|Physician Decision|1|||
124579447|NCT00795821|448080246|FG000|Acute Treatment Phase|Protocol Violation|1|||
124579448|NCT00795821|448080247|FG001|Acute Treatment Phase|Protocol Violation|2|||
124579449|NCT00795821|448080246|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
124579450|NCT00795821|448080247|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
124579451|NCT00795821|448080246|FG000|Long-term Extension Phase|Adverse Event|25|||
124579452|NCT00795821|448080247|FG001|Long-term Extension Phase|Adverse Event|32|||
124579453|NCT00795821|448080246|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
124579454|NCT00795821|448080247|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
124579455|NCT00795821|448080246|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
124579456|NCT00795821|448080247|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
124579457|NCT00795821|448080246|FG000|Long-term Extension Phase|Physician Decision|1|||
124579458|NCT00795821|448080247|FG001|Long-term Extension Phase|Physician Decision|2|||
124579459|NCT00795821|448080246|FG000|Long-term Extension Phase|Protocol Violation|3|||
124579460|NCT00795821|448080247|FG001|Long-term Extension Phase|Protocol Violation|5|||
124579461|NCT00795821|448080246|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
124579462|NCT00795821|448080247|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
124579463|NCT00795821|448080246|FG000|Taper Phase|Adverse Event|2|||
124579464|NCT00795821|448080247|FG001|Taper Phase|Adverse Event|0|||
124579465|NCT00795821|448080246|FG000|Taper Phase|Lost to Follow-up|1|||
124579466|NCT00795821|448080247|FG001|Taper Phase|Lost to Follow-up|0|||
124579467|NCT00795821|448080246|FG000|Taper Phase|Physician Decision|2|||
124726509|NCT02589665|448620257|FG001|Induction Extension Period|Physician Decision|0|||
124726510|NCT02589665|448620258|FG002|Induction Extension Period|Physician Decision|0|||
124726511|NCT02589665|448620259|FG003|Induction Extension Period|Physician Decision|0|||
124726512|NCT02589665|448620260|FG004|Induction Extension Period|Physician Decision|0|||
124579468|NCT00795821|448080247|FG001|Taper Phase|Physician Decision|0|||
124579469|NCT00795821|448080246|FG000|Taper Phase|Withdrawal by Subject|4|||
124579470|NCT00795821|448080247|FG001|Taper Phase|Withdrawal by Subject|0|||
124579471|NCT02301975|448080256|FG000|Overall Study|Adverse Event|8|||
124579472|NCT02301975|448080257|FG001|Overall Study|Adverse Event|3|||
124726513|NCT02589665|448620261|FG005|Induction Extension Period|Physician Decision|0|||
124579473|NCT02301975|448080258|FG002|Overall Study|Adverse Event|2|||
124579474|NCT02301975|448080256|FG000|Overall Study|Lack of Efficacy|1|||
124579475|NCT02301975|448080257|FG001|Overall Study|Lack of Efficacy|1|||
124579476|NCT02301975|448080258|FG002|Overall Study|Lack of Efficacy|1|||
124579477|NCT02301975|448080256|FG000|Overall Study|Protocol Violation|3|||
124579478|NCT02301975|448080257|FG001|Overall Study|Protocol Violation|5|||
124579479|NCT02301975|448080258|FG002|Overall Study|Protocol Violation|3|||
124726514|NCT02589665|448620262|FG006|Induction Extension Period|Physician Decision|0|||
124579480|NCT02301975|448080256|FG000|Overall Study|Lost to Follow-up|0|||
124579481|NCT02301975|448080257|FG001|Overall Study|Lost to Follow-up|2|||
124579482|NCT02301975|448080258|FG002|Overall Study|Lost to Follow-up|2|||
124579483|NCT02301975|448080256|FG000|Overall Study|Physician Decision|4|||
124579484|NCT02301975|448080257|FG001|Overall Study|Physician Decision|2|||
124579485|NCT02301975|448080258|FG002|Overall Study|Physician Decision|3|||
124579486|NCT02301975|448080256|FG000|Overall Study|Withdrawal by Subject|15|||
124579487|NCT02301975|448080257|FG001|Overall Study|Withdrawal by Subject|12|||
124579488|NCT02301975|448080258|FG002|Overall Study|Withdrawal by Subject|11|||
124579489|NCT01440803|448080259|FG000|Overall Study|Met study stopping rule|2|||
124579490|NCT01440803|448080260|FG001|Overall Study|Met study stopping rule|1|||
124579491|NCT01440803|448080259|FG000|Overall Study|Lost to Follow-up|0|||
124579492|NCT01440803|448080260|FG001|Overall Study|Lost to Follow-up|2|||
124579493|NCT01440803|448080259|FG000|Overall Study|Withdrawal by Subject|0|||
124579494|NCT01440803|448080260|FG001|Overall Study|Withdrawal by Subject|1|||
124579495|NCT01609257|448080263|FG000|Overall Study|Lost to Follow-up|2|||
124579496|NCT01609257|448080264|FG001|Overall Study|Lost to Follow-up|1|||
124579497|NCT01609257|448080263|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
124579498|NCT01609257|448080264|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
124579499|NCT01609257|448080263|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
124579500|NCT01609257|448080264|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
124579501|NCT02125461|448080265|FG000|Overall Study|Withdrawal by Subject|30|||
124579502|NCT02125461|448080266|FG001|Overall Study|Withdrawal by Subject|16|||
124579503|NCT02125461|448080265|FG000|Overall Study|Lost to Follow-up|8|||
124579504|NCT02125461|448080266|FG001|Overall Study|Lost to Follow-up|3|||
124579505|NCT02125461|448080265|FG000|Overall Study|Death|260|||
124579506|NCT02125461|448080266|FG001|Overall Study|Death|149|||
124579507|NCT02125461|448080265|FG000|Overall Study|Missing Termination Reason|0|||
124579508|NCT02125461|448080266|FG001|Overall Study|Missing Termination Reason|1|||
124579509|NCT03049748|448080267|FG000|Overall Study|Lost to Follow-up|1|||
124579510|NCT03049748|448080268|FG001|Overall Study|Lost to Follow-up|0|||
124579511|NCT03049748|448080267|FG000|Overall Study|Death|3|||
124579512|NCT03049748|448080268|FG001|Overall Study|Death|0|||
124579513|NCT03049748|448080267|FG000|Overall Study|Withdrawal by Subject|0|||
124579514|NCT03049748|448080268|FG001|Overall Study|Withdrawal by Subject|3|||
124579515|NCT03049748|448080267|FG000|Overall Study|Protocol Violation|0|||
124579516|NCT03049748|448080268|FG001|Overall Study|Protocol Violation|2|||
124579517|NCT03049748|448080267|FG000|Overall Study|Moved out of state (relocation)|0|||
124579518|NCT03049748|448080268|FG001|Overall Study|Moved out of state (relocation)|1|||
124579519|NCT01158118|448080272|FG000|Overall Study|Screen failure|1|||
124579520|NCT01158118|448080273|FG001|Overall Study|Screen failure|0|||
124579521|NCT01158118|448080272|FG000|Overall Study|Donor match was a screen failure|0|||
124579522|NCT01158118|448080273|FG001|Overall Study|Donor match was a screen failure|1|||
124579523|NCT01158118|448080272|FG000|Overall Study|Suffered stroke prior to transplant|0|||
124579524|NCT01158118|448080273|FG001|Overall Study|Suffered stroke prior to transplant|1|||
124579525|NCT01158118|448080272|FG000|Overall Study|Death|0|||
124579526|NCT01158118|448080273|FG001|Overall Study|Death|1|||
124579527|NCT04994535|448080274|FG000|Overall Study|Lost to Follow-up|7|||
124579528|NCT04994535|448080275|FG001|Overall Study|Lost to Follow-up|7|||
124579529|NCT04994535|448080274|FG000|Overall Study|Withdrawal by Subject|10|||
124579530|NCT04994535|448080275|FG001|Overall Study|Withdrawal by Subject|7|||
124579531|NCT04994535|448080274|FG000|Overall Study|Other|1|||
124579532|NCT04994535|448080275|FG001|Overall Study|Other|1|||
124579533|NCT00604162|448080276|FG000|Overall Study|Physician Decision|3|||
124579534|NCT00604162|448080276|FG000|Overall Study|Withdrawal by Subject|1|||
124726515|NCT02589665|448620263|FG007|Induction Extension Period|Physician Decision|0|||
124726516|NCT02589665|448620264|FG008|Induction Extension Period|Physician Decision|1|||
124726517|NCT02589665|448620265|FG009|Induction Extension Period|Physician Decision|0|||
124726518|NCT02589665|448620256|FG000|Induction Extension Period|Reason Not Collected|0|||
124726519|NCT02589665|448620257|FG001|Induction Extension Period|Reason Not Collected|0|||
124726520|NCT02589665|448620258|FG002|Induction Extension Period|Reason Not Collected|0|||
124726521|NCT02589665|448620259|FG003|Induction Extension Period|Reason Not Collected|0|||
124579535|NCT01015287|448080279|FG000|Overall Study|Death|21|||
124579536|NCT01015287|448080280|FG001|Overall Study|Death|16|||
124579537|NCT01015287|448080279|FG000|Overall Study|Adverse Event|1|||
124579538|NCT01015287|448080280|FG001|Overall Study|Adverse Event|0|||
124579539|NCT01015287|448080279|FG000|Overall Study|Sponsor Decision|3|||
124579540|NCT01015287|448080280|FG001|Overall Study|Sponsor Decision|7|||
124726522|NCT02589665|448620260|FG004|Induction Extension Period|Reason Not Collected|0|||
124776818|NCT05006573|448810019|FG000|Double-blind Treatment Period|Protocol Violation|2|||
124579541|NCT01015287|448080279|FG000|Overall Study|Physician Decision|19|||
124579542|NCT01015287|448080280|FG001|Overall Study|Physician Decision|21|||
124579543|NCT01015287|448080279|FG000|Overall Study|Withdrawal by Subject|14|||
124579544|NCT01015287|448080280|FG001|Overall Study|Withdrawal by Subject|19|||
124579545|NCT01015287|448080279|FG000|Overall Study|Entry Criteria not Met|11|||
124579546|NCT01015287|448080280|FG001|Overall Study|Entry Criteria not Met|14|||
124579547|NCT01015287|448080279|FG000|Overall Study|Lost to Follow-up|2|||
124526663|NCT03558828|447880510|FG004|Overall Study|dropped before the intervention|0|||
124526664|NCT03558828|447880511|FG005|Overall Study|dropped before the intervention|0|||
124526665|NCT00378534|447880512|FG000|Overall Study|Participants did not receive transplant|3|||
124526666|NCT00378534|447880513|FG001|Overall Study|Participants did not receive transplant|0|||
124526667|NCT03657576|447880517|FG000|Overall Study|Death|0|||
124526668|NCT03657576|447880518|FG001|Overall Study|Death|1|||
124526669|NCT03657576|447880519|FG002|Overall Study|Death|1|||
124526670|NCT03657576|447880520|FG003|Overall Study|Death|0|||
124526671|NCT03657576|447880521|FG004|Overall Study|Death|0|||
124526672|NCT03657576|447880522|FG005|Overall Study|Death|0|||
124526673|NCT03657576|447880517|FG000|Overall Study|Withdrawal by Subject|0|||
124526674|NCT03657576|447880518|FG001|Overall Study|Withdrawal by Subject|0|||
124526675|NCT03657576|447880519|FG002|Overall Study|Withdrawal by Subject|0|||
124526676|NCT03657576|447880520|FG003|Overall Study|Withdrawal by Subject|1|||
124526677|NCT03657576|447880521|FG004|Overall Study|Withdrawal by Subject|0|||
124526678|NCT03657576|447880522|FG005|Overall Study|Withdrawal by Subject|0|||
124526679|NCT03657576|447880517|FG000|Overall Study|Screen Fail|0|||
124526680|NCT03657576|447880518|FG001|Overall Study|Screen Fail|0|||
124526681|NCT03657576|447880519|FG002|Overall Study|Screen Fail|0|||
124526682|NCT03657576|447880520|FG003|Overall Study|Screen Fail|0|||
124526683|NCT03657576|447880521|FG004|Overall Study|Screen Fail|0|||
124526684|NCT03657576|447880522|FG005|Overall Study|Screen Fail|5|||
124526685|NCT03657576|447880517|FG000|Overall Study|Disease Progression|1|||
124526686|NCT03657576|447880518|FG001|Overall Study|Disease Progression|1|||
124526687|NCT03657576|447880519|FG002|Overall Study|Disease Progression|0|||
124526688|NCT03657576|447880520|FG003|Overall Study|Disease Progression|5|||
124526689|NCT03657576|447880521|FG004|Overall Study|Disease Progression|0|||
124526690|NCT03657576|447880522|FG005|Overall Study|Disease Progression|0|||
124526691|NCT03657576|447880517|FG000|Overall Study|Insurance Coverage|0|||
124526692|NCT03657576|447880518|FG001|Overall Study|Insurance Coverage|0|||
124526693|NCT03657576|447880519|FG002|Overall Study|Insurance Coverage|0|||
124526694|NCT03657576|447880520|FG003|Overall Study|Insurance Coverage|1|||
124526695|NCT03657576|447880521|FG004|Overall Study|Insurance Coverage|0|||
124526696|NCT03657576|447880522|FG005|Overall Study|Insurance Coverage|0|||
124526697|NCT05618808|447880523|FG000|Overall Study|Withdrawal by Subject|3|||
124526698|NCT05618808|447880524|FG001|Overall Study|Withdrawal by Subject|1|||
124526699|NCT05618808|447880525|FG002|Overall Study|Withdrawal by Subject|3|||
124526700|NCT04284787|447880526|FG000|Overall Study|Disease Progression|9|||
124526701|NCT04284787|447880527|FG001|Overall Study|Disease Progression|12|||
124526702|NCT04284787|447880526|FG000|Overall Study|Physician Decision|12|||
124526703|NCT04284787|447880527|FG001|Overall Study|Physician Decision|7|||
124526704|NCT04284787|447880526|FG000|Overall Study|Transplant|5|||
124526705|NCT04284787|447880527|FG001|Overall Study|Transplant|4|||
124526706|NCT04284787|447880526|FG000|Overall Study|Death|1|||
124526707|NCT04284787|447880527|FG001|Overall Study|Death|2|||
124526708|NCT04284787|447880526|FG000|Overall Study|Adverse Event|0|||
124526709|NCT04284787|447880527|FG001|Overall Study|Adverse Event|4|||
124526710|NCT04284787|447880526|FG000|Overall Study|Non-adherence|2|||
124526711|NCT04284787|447880527|FG001|Overall Study|Non-adherence|0|||
124526712|NCT04284787|447880526|FG000|Overall Study|Lack of Efficacy|2|||
124526713|NCT04284787|447880527|FG001|Overall Study|Lack of Efficacy|0|||
124526714|NCT01874353|447880528|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
124526715|NCT01874353|447880529|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
124526716|NCT01874353|447880530|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
124526717|NCT01874353|447880531|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
124526718|NCT01874353|447880528|FG000|Overall Study|Lost to Follow-up|2|||
124526719|NCT01874353|447880529|FG001|Overall Study|Lost to Follow-up|2|||
124526720|NCT01874353|447880530|FG002|Overall Study|Lost to Follow-up|2|||
124526721|NCT01874353|447880531|FG003|Overall Study|Lost to Follow-up|0|||
124526722|NCT01874353|447880528|FG000|Overall Study|Death|110|||
124526723|NCT01874353|447880529|FG001|Overall Study|Death|60|||
124526724|NCT01874353|447880530|FG002|Overall Study|Death|13|||
124526725|NCT01874353|447880531|FG003|Overall Study|Death|7|||
124526726|NCT01874353|447880528|FG000|Overall Study|Withdrawal by Subject|13|||
124526727|NCT01874353|447880529|FG001|Overall Study|Withdrawal by Subject|11|||
124526728|NCT01874353|447880530|FG002|Overall Study|Withdrawal by Subject|0|||
124526729|NCT01874353|447880531|FG003|Overall Study|Withdrawal by Subject|0|||
124526730|NCT04392154|447880532|FG000|Overall Study|Adverse Event|3|||
124526731|NCT04392154|447880533|FG001|Overall Study|Adverse Event|46|||
124526732|NCT04392154|447880532|FG000|Overall Study|Due to epidemic/pandemic|0|||
124526733|NCT04392154|447880533|FG001|Overall Study|Due to epidemic/pandemic|1|||
124526734|NCT04392154|447880532|FG000|Overall Study|Lack of Efficacy|1|||
124579548|NCT01015287|448080280|FG001|Overall Study|Lost to Follow-up|1|||
124526735|NCT04392154|447880533|FG001|Overall Study|Lack of Efficacy|47|||
124526736|NCT04392154|447880532|FG000|Overall Study|Lost to Follow-up|11|||
124526737|NCT04392154|447880533|FG001|Overall Study|Lost to Follow-up|61|||
124526738|NCT04392154|447880532|FG000|Overall Study|Geopolitical conflict|1|||
124526739|NCT04392154|447880533|FG001|Overall Study|Geopolitical conflict|1|||
124526740|NCT04392154|447880532|FG000|Overall Study|Physician Decision|1|||
124579549|NCT01015287|448080279|FG000|Overall Study|Protocol Violation|1|||
124579550|NCT01015287|448080280|FG001|Overall Study|Protocol Violation|1|||
124579551|NCT00905840|448080281|FG000|Overall Study|Lost to Follow-up|11|||
124579552|NCT00905840|448080281|FG000|Overall Study|Death|3|||
124579553|NCT00905840|448080281|FG000|Overall Study|Withdrawal by Subject|1|||
124579554|NCT00905840|448080281|FG000|Overall Study|Adverse Event|1|||
124579555|NCT01370317|448080282|FG000|Overall Study|Participant withdrew consent|1|||
124579556|NCT01370317|448080283|FG001|Overall Study|Participant withdrew consent|0|||
124579557|NCT01370317|448080282|FG000|Overall Study|Protocol deviation|0|||
124579558|NCT01370317|448080283|FG001|Overall Study|Protocol deviation|1|||
124579559|NCT02105272|448080291|FG000|Overall Study|Adverse Event|1|||
124579560|NCT02105272|448080292|FG001|Overall Study|Adverse Event|2|||
124579561|NCT02105272|448080291|FG000|Overall Study|Physician Decision|0|||
124579562|NCT02105272|448080292|FG001|Overall Study|Physician Decision|1|||
124579563|NCT02105272|448080291|FG000|Overall Study|Protocol Violation|2|||
124579564|NCT02105272|448080292|FG001|Overall Study|Protocol Violation|0|||
124579565|NCT02105272|448080291|FG000|Overall Study|Withdrawal by Subject|2|||
124579566|NCT02105272|448080292|FG001|Overall Study|Withdrawal by Subject|0|||
124579567|NCT03190915|448080294|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
124579568|NCT03190915|448080294|FG000|Overall Study|Progressive Disease|3|||
124579569|NCT02964039|448080295|FG000|Overall Study|Medical reason unrelated to study participation|1|||
124579570|NCT02964039|448080296|FG001|Overall Study|Medical reason unrelated to study participation|0|||
124579571|NCT02964039|448080297|FG002|Overall Study|Medical reason unrelated to study participation|3|||
124579572|NCT02964039|448080295|FG000|Overall Study|Research shutdown due to pandemic|2|||
124579573|NCT02964039|448080296|FG001|Overall Study|Research shutdown due to pandemic|0|||
124579574|NCT02964039|448080297|FG002|Overall Study|Research shutdown due to pandemic|1|||
124579575|NCT02964039|448080295|FG000|Overall Study|Withdrawal by Subject|0|||
124579576|NCT02964039|448080296|FG001|Overall Study|Withdrawal by Subject|1|||
124579577|NCT02964039|448080297|FG002|Overall Study|Withdrawal by Subject|0|||
124579578|NCT02964039|448080295|FG000|Overall Study|Lost to Follow-up|1|||
124579579|NCT02964039|448080296|FG001|Overall Study|Lost to Follow-up|0|||
124579580|NCT02964039|448080297|FG002|Overall Study|Lost to Follow-up|1|||
124579581|NCT01103713|448080298|FG000|Overall Study|Lost to Follow-up|2|||
124579582|NCT01103713|448080298|FG000|Overall Study|Withdrawal by Subject|8|||
124579583|NCT01103713|448080298|FG000|Overall Study|Study terminated by sponsor|2|||
124579584|NCT01103713|448080298|FG000|Overall Study|Other|1|||
124579585|NCT00505622|448080303|FG000|Overall Study|Adverse Event|5|||
124579586|NCT00505622|448080304|FG001|Overall Study|Adverse Event|6|||
124579587|NCT00505622|448080305|FG002|Overall Study|Adverse Event|4|||
124579588|NCT00505622|448080303|FG000|Overall Study|Protocol Violation|1|||
124579589|NCT00505622|448080304|FG001|Overall Study|Protocol Violation|1|||
124579590|NCT00505622|448080305|FG002|Overall Study|Protocol Violation|0|||
124579591|NCT00505622|448080303|FG000|Overall Study|Withdrawal by Subject|0|||
124579592|NCT00505622|448080304|FG001|Overall Study|Withdrawal by Subject|3|||
124579593|NCT00505622|448080305|FG002|Overall Study|Withdrawal by Subject|2|||
124579594|NCT00505622|448080303|FG000|Overall Study|Study termination by sponsor|115|||
124579595|NCT00505622|448080304|FG001|Overall Study|Study termination by sponsor|98|||
124579596|NCT00505622|448080305|FG002|Overall Study|Study termination by sponsor|90|||
124579597|NCT03084471|448080306|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
124579598|NCT03084471|448080306|FG000|Overall Study|Condition under investigation worsened|84|||
124579599|NCT03084471|448080306|FG000|Overall Study|Lack of therapeutic response|2|||
124579600|NCT03084471|448080306|FG000|Overall Study|Protocol Violation|1|||
124579601|NCT03084471|448080306|FG000|Overall Study|Adverse Event|73|||
124579602|NCT03084471|448080306|FG000|Overall Study|Withdrawal by Subject|12|||
124726523|NCT02589665|448620261|FG005|Induction Extension Period|Reason Not Collected|0|||
124726524|NCT02589665|448620262|FG006|Induction Extension Period|Reason Not Collected|0|||
124579603|NCT03084471|448080306|FG000|Overall Study|Disease relapse|181|||
124579604|NCT03084471|448080306|FG000|Overall Study|Subjective disease progression|359|||
124579605|NCT03084471|448080306|FG000|Overall Study|Other (as recorded)|33|||
124579606|NCT03084471|448080306|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
124579607|NCT01848938|448080313|FG000|Overall Study|Lost to Follow-up|1|||
124579608|NCT01848938|448080314|FG001|Overall Study|Lost to Follow-up|1|||
124579609|NCT01757392|448080315|FG000|Overall Study|Withdrawal by Subject|1|||
124579610|NCT01757392|448080315|FG000|Overall Study|Screen Fail|3|||
124579611|NCT00651820|448080324|FG000|Overall Study|Lost to Follow-up|2|||
124579612|NCT01878292|448080325|FG000|Randomized|Protocol Violation|1|||
124726525|NCT02589665|448620263|FG007|Induction Extension Period|Reason Not Collected|0|||
124726526|NCT02589665|448620264|FG008|Induction Extension Period|Reason Not Collected|1|||
124579613|NCT01878292|448080326|FG001|Randomized|Protocol Violation|0|||
124579614|NCT01878292|448080327|FG002|Randomized|Protocol Violation|0|||
124579615|NCT01878292|448080325|FG000|Randomized|Lost to Follow-up|1|||
124579616|NCT01878292|448080326|FG001|Randomized|Lost to Follow-up|0|||
124579617|NCT01878292|448080327|FG002|Randomized|Lost to Follow-up|0|||
124579618|NCT01878292|448080325|FG000|Randomized|Adverse Event|1|||
124579619|NCT01878292|448080326|FG001|Randomized|Adverse Event|0|||
124579620|NCT01878292|448080327|FG002|Randomized|Adverse Event|0|||
124579621|NCT01878292|448080325|FG000|Double-blind Treatment Period|Other Reasons|2|||
124579622|NCT01878292|448080326|FG001|Double-blind Treatment Period|Other Reasons|0|||
124579623|NCT01878292|448080327|FG002|Double-blind Treatment Period|Other Reasons|0|||
124579624|NCT01878292|448080325|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
124579625|NCT01878292|448080326|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
124579626|NCT01878292|448080327|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
124579627|NCT01878292|448080325|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
124579628|NCT01878292|448080326|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
124579629|NCT01878292|448080327|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
124579630|NCT01878292|448080325|FG000|Double-blind Treatment Period|Protocol Violation|3|||
124579631|NCT01878292|448080326|FG001|Double-blind Treatment Period|Protocol Violation|4|||
124579632|NCT01878292|448080327|FG002|Double-blind Treatment Period|Protocol Violation|2|||
124579633|NCT01878292|448080325|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
124579634|NCT01878292|448080326|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
124579635|NCT01878292|448080327|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
124579636|NCT01878292|448080325|FG000|Double-blind Treatment Period|Adverse Event|4|||
124579637|NCT01878292|448080326|FG001|Double-blind Treatment Period|Adverse Event|9|||
124579638|NCT01878292|448080327|FG002|Double-blind Treatment Period|Adverse Event|8|||
124579639|NCT01878292|448080325|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
124579640|NCT01878292|448080326|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
124579641|NCT01878292|448080327|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
124579642|NCT01302548|448080328|FG000|Overall Study|Lost to Follow-up|2|||
124579643|NCT01302548|448080329|FG001|Overall Study|Lost to Follow-up|1|||
124579644|NCT00950989|448080330|FG000|Overall Study|Death|0|||
124579645|NCT00950989|448080331|FG001|Overall Study|Death|0|||
124579646|NCT00950989|448080332|FG002|Overall Study|Death|1|||
124579647|NCT00950989|448080333|FG003|Overall Study|Death|0|||
124579648|NCT00950989|448080330|FG000|Overall Study|Administrative Decision|0|||
124579649|NCT00950989|448080331|FG001|Overall Study|Administrative Decision|1|||
124579650|NCT00950989|448080332|FG002|Overall Study|Administrative Decision|0|||
124579651|NCT00950989|448080333|FG003|Overall Study|Administrative Decision|0|||
124579652|NCT00950989|448080330|FG000|Overall Study|Disease Progression|0|||
124579653|NCT00950989|448080331|FG001|Overall Study|Disease Progression|0|||
124579654|NCT00950989|448080332|FG002|Overall Study|Disease Progression|1|||
124579655|NCT00950989|448080333|FG003|Overall Study|Disease Progression|0|||
124579656|NCT00950989|448080330|FG000|Overall Study|Withdrawal by Subject|2|||
124579657|NCT00950989|448080331|FG001|Overall Study|Withdrawal by Subject|1|||
124579658|NCT00950989|448080332|FG002|Overall Study|Withdrawal by Subject|0|||
124579659|NCT00950989|448080333|FG003|Overall Study|Withdrawal by Subject|0|||
124579660|NCT00950989|448080330|FG000|Overall Study|Adverse Event|2|||
124579661|NCT00950989|448080331|FG001|Overall Study|Adverse Event|1|||
124579662|NCT00950989|448080332|FG002|Overall Study|Adverse Event|1|||
124579663|NCT00950989|448080333|FG003|Overall Study|Adverse Event|0|||
124579664|NCT00730691|448080336|FG000|Overall Study|Adverse Event|4|||
124579665|NCT00730691|448080337|FG001|Overall Study|Adverse Event|8|||
124579666|NCT00730691|448080338|FG002|Overall Study|Adverse Event|11|||
124579667|NCT00730691|448080339|FG003|Overall Study|Adverse Event|11|||
124579668|NCT00730691|448080340|FG004|Overall Study|Adverse Event|23|||
124579669|NCT00730691|448080336|FG000|Overall Study|Lack of Efficacy|4|||
124579670|NCT00730691|448080337|FG001|Overall Study|Lack of Efficacy|4|||
124579671|NCT00730691|448080338|FG002|Overall Study|Lack of Efficacy|2|||
124579672|NCT00730691|448080339|FG003|Overall Study|Lack of Efficacy|1|||
124579673|NCT00730691|448080340|FG004|Overall Study|Lack of Efficacy|1|||
124579674|NCT00730691|448080336|FG000|Overall Study|Non-compliance with Study Drug|6|||
124579675|NCT00730691|448080337|FG001|Overall Study|Non-compliance with Study Drug|1|||
124579676|NCT00730691|448080338|FG002|Overall Study|Non-compliance with Study Drug|6|||
124579677|NCT00730691|448080339|FG003|Overall Study|Non-compliance with Study Drug|3|||
124579678|NCT00730691|448080340|FG004|Overall Study|Non-compliance with Study Drug|3|||
124579679|NCT00730691|448080336|FG000|Overall Study|Protocol Deviations|3|||
124579680|NCT00730691|448080337|FG001|Overall Study|Protocol Deviations|5|||
124579681|NCT00730691|448080338|FG002|Overall Study|Protocol Deviations|3|||
124579682|NCT00730691|448080339|FG003|Overall Study|Protocol Deviations|7|||
124579683|NCT00730691|448080340|FG004|Overall Study|Protocol Deviations|5|||
124579684|NCT00730691|448080336|FG000|Overall Study|Withdrawal of Consent|7|||
124579685|NCT00730691|448080337|FG001|Overall Study|Withdrawal of Consent|9|||
124579686|NCT00730691|448080338|FG002|Overall Study|Withdrawal of Consent|3|||
124579687|NCT00730691|448080339|FG003|Overall Study|Withdrawal of Consent|6|||
124579688|NCT00730691|448080340|FG004|Overall Study|Withdrawal of Consent|3|||
124579689|NCT00730691|448080336|FG000|Overall Study|Lost to Follow-up|11|||
124579690|NCT00730691|448080337|FG001|Overall Study|Lost to Follow-up|8|||
124579691|NCT00730691|448080338|FG002|Overall Study|Lost to Follow-up|13|||
124579692|NCT00730691|448080339|FG003|Overall Study|Lost to Follow-up|15|||
124579693|NCT00730691|448080340|FG004|Overall Study|Lost to Follow-up|13|||
124579694|NCT00730691|448080336|FG000|Overall Study|Other|1|||
124579695|NCT00730691|448080337|FG001|Overall Study|Other|1|||
124579696|NCT00730691|448080338|FG002|Overall Study|Other|1|||
124579697|NCT00730691|448080339|FG003|Overall Study|Other|2|||
124579698|NCT00730691|448080340|FG004|Overall Study|Other|2|||
124579699|NCT02178787|448080341|FG000|Overall Study|Lost to Follow-up|1|||
124579700|NCT02178787|448080342|FG001|Overall Study|Lost to Follow-up|0|||
124579701|NCT02178787|448080341|FG000|Overall Study|Withdrawal by Subject|0|||
124579702|NCT02178787|448080342|FG001|Overall Study|Withdrawal by Subject|2|||
124579703|NCT02178787|448080341|FG000|Overall Study|No TCD window|3|||
124579704|NCT02178787|448080342|FG001|Overall Study|No TCD window|7|||
124579705|NCT02178787|448080341|FG000|Overall Study|Physician Decision|1|||
124579706|NCT02178787|448080342|FG001|Overall Study|Physician Decision|0|||
124579707|NCT02554890|448080343|FG000|Double-blind|Adverse Event|45|||
124579708|NCT02554890|448080344|FG001|Double-blind|Adverse Event|51|||
124579709|NCT02554890|448080343|FG000|Double-blind|Death|6|||
124579710|NCT02554890|448080344|FG001|Double-blind|Death|4|||
124579711|NCT02554890|448080343|FG000|Double-blind|Protocol Violation|1|||
124579712|NCT02554890|448080344|FG001|Double-blind|Protocol Violation|1|||
124579713|NCT02554890|448080343|FG000|Double-blind|Physician Decision|4|||
124579714|NCT02554890|448080344|FG001|Double-blind|Physician Decision|3|||
124579715|NCT02554890|448080343|FG000|Double-blind|Subject/Guardian decision|21|||
124579716|NCT02554890|448080344|FG001|Double-blind|Subject/Guardian decision|16|||
124579717|NCT02554890|448080343|FG000|Double-blind|Lost to Follow-up|7|||
124579718|NCT02554890|448080344|FG001|Double-blind|Lost to Follow-up|5|||
124579719|NCT02554890|448080343|FG000|Double-blind|Technical problems|1|||
124579720|NCT02554890|448080344|FG001|Double-blind|Technical problems|0|||
124579721|NCT02554890|448080343|FG000|Double-blind|Withdrawal by Subject|5|||
124579722|NCT02554890|448080344|FG001|Double-blind|Withdrawal by Subject|6|||
124579723|NCT02554890|448080343|FG000|Double-blind|Noncompliance with study treatment|6|||
124579724|NCT02554890|448080344|FG001|Double-blind|Noncompliance with study treatment|5|||
124579725|NCT02554890|448080343|FG000|Open-label|Adverse Event|0|||
124579726|NCT02554890|448080344|FG001|Open-label|Adverse Event|30|||
124579727|NCT02554890|448080343|FG000|Open-label|Death|0|||
124579728|NCT02554890|448080344|FG001|Open-label|Death|1|||
124579729|NCT02554890|448080343|FG000|Open-label|Physician Decision|0|||
124579730|NCT02554890|448080344|FG001|Open-label|Physician Decision|1|||
124579731|NCT02554890|448080343|FG000|Open-label|Subject/Guardian decision|0|||
124579732|NCT02554890|448080344|FG001|Open-label|Subject/Guardian decision|11|||
124579733|NCT02554890|448080343|FG000|Open-label|Lost to Follow-up|0|||
124579734|NCT02554890|448080344|FG001|Open-label|Lost to Follow-up|7|||
124579735|NCT02554890|448080343|FG000|Open-label|Technical problems|0|||
124579736|NCT02554890|448080344|FG001|Open-label|Technical problems|1|||
124579737|NCT02554890|448080343|FG000|Open-label|Withdrawal by Subject|0|||
124579738|NCT02554890|448080344|FG001|Open-label|Withdrawal by Subject|1|||
124579739|NCT03043872|448080348|FG000|Overall Study|Withdrawal by Subject|6|||
124579740|NCT03043872|448080349|FG001|Overall Study|Withdrawal by Subject|6|||
124579741|NCT03043872|448080350|FG002|Overall Study|Withdrawal by Subject|15|||
124579742|NCT03043872|448080348|FG000|Overall Study|Lost to Follow-up|2|||
124579743|NCT03043872|448080349|FG001|Overall Study|Lost to Follow-up|1|||
124579744|NCT03043872|448080350|FG002|Overall Study|Lost to Follow-up|1|||
124579745|NCT03043872|448080348|FG000|Overall Study|Death|270|||
124579746|NCT03043872|448080349|FG001|Overall Study|Death|269|||
124579747|NCT03043872|448080350|FG002|Overall Study|Death|296|||
124579748|NCT03649477|448080351|FG000|Overall Study|Adverse Event|2|||
124579749|NCT03649477|448080352|FG001|Overall Study|Adverse Event|0|||
124579750|NCT03649477|448080353|FG002|Overall Study|Adverse Event|0|||
124579751|NCT02430480|448080354|FG000|Overall Study|Death|1|||
124579752|NCT02430480|448080354|FG000|Overall Study|Anesthesia concerns|1|||
124579753|NCT02430480|448080354|FG000|Overall Study|Progressed on treatment|1|||
124579754|NCT01154231|448080355|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
124579755|NCT01154231|448080355|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
124579756|NCT04852978|448080361|FG000|Overall Study|Physician Decision|0|||
124579757|NCT04852978|448080362|FG001|Overall Study|Physician Decision|1|||
124579758|NCT04852978|448080363|FG002|Overall Study|Physician Decision|0|||
124579759|NCT04852978|448080364|FG003|Overall Study|Physician Decision|0|||
124579760|NCT04852978|448080365|FG004|Overall Study|Physician Decision|0|||
124579761|NCT04852978|448080366|FG005|Overall Study|Physician Decision|0|||
124579762|NCT04852978|448080367|FG006|Overall Study|Physician Decision|0|||
124579763|NCT04852978|448080368|FG007|Overall Study|Physician Decision|2|||
124579764|NCT04852978|448080369|FG008|Overall Study|Physician Decision|0|||
124579765|NCT04852978|448080361|FG000|Overall Study|Sponsor request|0|||
124579766|NCT04852978|448080362|FG001|Overall Study|Sponsor request|0|||
124579767|NCT04852978|448080363|FG002|Overall Study|Sponsor request|1|||
124579768|NCT04852978|448080364|FG003|Overall Study|Sponsor request|0|||
124579769|NCT04852978|448080365|FG004|Overall Study|Sponsor request|0|||
124579770|NCT04852978|448080366|FG005|Overall Study|Sponsor request|0|||
124579771|NCT04852978|448080367|FG006|Overall Study|Sponsor request|0|||
124579772|NCT04852978|448080368|FG007|Overall Study|Sponsor request|0|||
124579773|NCT04852978|448080369|FG008|Overall Study|Sponsor request|0|||
124579774|NCT04852978|448080361|FG000|Overall Study|Death|0|||
124579775|NCT04852978|448080362|FG001|Overall Study|Death|0|||
124579776|NCT04852978|448080363|FG002|Overall Study|Death|0|||
124579777|NCT04852978|448080364|FG003|Overall Study|Death|0|||
124579778|NCT04852978|448080365|FG004|Overall Study|Death|0|||
124579779|NCT04852978|448080366|FG005|Overall Study|Death|0|||
124579780|NCT04852978|448080367|FG006|Overall Study|Death|1|||
124579781|NCT04852978|448080368|FG007|Overall Study|Death|0|||
124579782|NCT04852978|448080369|FG008|Overall Study|Death|0|||
124579783|NCT04852978|448080361|FG000|Overall Study|Lost to Follow-up|3|||
124579784|NCT04852978|448080362|FG001|Overall Study|Lost to Follow-up|2|||
124579785|NCT04852978|448080363|FG002|Overall Study|Lost to Follow-up|2|||
124579786|NCT04852978|448080364|FG003|Overall Study|Lost to Follow-up|0|||
124579787|NCT04852978|448080365|FG004|Overall Study|Lost to Follow-up|2|||
124579788|NCT04852978|448080366|FG005|Overall Study|Lost to Follow-up|4|||
124579789|NCT04852978|448080367|FG006|Overall Study|Lost to Follow-up|1|||
124579790|NCT04852978|448080368|FG007|Overall Study|Lost to Follow-up|2|||
124579791|NCT04852978|448080369|FG008|Overall Study|Lost to Follow-up|2|||
124579792|NCT04852978|448080361|FG000|Overall Study|Withdrawal by Subject|4|||
124579793|NCT04852978|448080362|FG001|Overall Study|Withdrawal by Subject|2|||
124579794|NCT04852978|448080363|FG002|Overall Study|Withdrawal by Subject|2|||
124579795|NCT04852978|448080364|FG003|Overall Study|Withdrawal by Subject|1|||
124579796|NCT04852978|448080365|FG004|Overall Study|Withdrawal by Subject|5|||
124579797|NCT04852978|448080366|FG005|Overall Study|Withdrawal by Subject|3|||
124579798|NCT04852978|448080367|FG006|Overall Study|Withdrawal by Subject|2|||
124579799|NCT04852978|448080368|FG007|Overall Study|Withdrawal by Subject|2|||
124579800|NCT04852978|448080369|FG008|Overall Study|Withdrawal by Subject|1|||
124579801|NCT00859430|448080370|FG000|First Intervention|Withdrawal by Subject|0|||
124579802|NCT00859430|448080371|FG001|First Intervention|Withdrawal by Subject|1|||
124579803|NCT00001703|448082849|FG000|Overall Study|progressed disease|2|||
124579804|NCT00001703|448082849|FG000|Overall Study|No evidence of disease|1|||
124579805|NCT00001703|448082849|FG000|Overall Study|recurrent disease|2|||
124579806|NCT03733730|448082852|FG000|Overall Study|Lost to Follow-up|1|||
124579807|NCT03733730|448082853|FG001|Overall Study|Lost to Follow-up|32|||
124579808|NCT03733730|448082852|FG000|Overall Study|Other|1|||
124579809|NCT03733730|448082853|FG001|Overall Study|Other|0|||
124579810|NCT03733730|448082852|FG000|Overall Study|Adverse Event|0|||
124579811|NCT03733730|448082853|FG001|Overall Study|Adverse Event|4|||
124579812|NCT03733730|448082852|FG000|Overall Study|Death|0|||
124579813|NCT03733730|448082853|FG001|Overall Study|Death|5|||
124579814|NCT03733730|448082852|FG000|Overall Study|Withdrawal by Subject|0|||
124579815|NCT03733730|448082853|FG001|Overall Study|Withdrawal by Subject|8|||
124579816|NCT01531894|448082854|FG000|Overall Study|Physician Decision|8|||
124579817|NCT01531894|448082854|FG000|Overall Study|Death|1|||
124526741|NCT04392154|447880533|FG001|Overall Study|Physician Decision|5|||
124526742|NCT04392154|447880532|FG000|Overall Study|Pregnancy|1|||
124526743|NCT04392154|447880533|FG001|Overall Study|Pregnancy|8|||
124526744|NCT04392154|447880532|FG000|Overall Study|Protocol deviation|1|||
124526745|NCT04392154|447880533|FG001|Overall Study|Protocol deviation|12|||
124526746|NCT04392154|447880532|FG000|Overall Study|Withdrawal by Subject|18|||
124526747|NCT04392154|447880533|FG001|Overall Study|Withdrawal by Subject|138|||
124526748|NCT04392154|447880532|FG000|Overall Study|Sponsor Decision|1|||
124526749|NCT04392154|447880533|FG001|Overall Study|Sponsor Decision|14|||
124526750|NCT04392154|447880532|FG000|Overall Study|Site Closure|0|||
124526751|NCT04392154|447880533|FG001|Overall Study|Site Closure|4|||
124526752|NCT04992507|447880534|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
124526753|NCT04992507|447880535|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
124526754|NCT04992507|447880534|FG000|Overall Study|Death|0|||
124526755|NCT04992507|447880535|FG001|Overall Study|Death|1|||
124526756|NCT03728881|447880536|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
124526757|NCT03728881|447880537|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
124579818|NCT06195579|448082855|FG000|Overall Study|Withdrawal by Subject|1|||
124579819|NCT02545283|448082856|FG000|Overall Study|Lost to Follow-up|2|||
124579820|NCT02545283|448082857|FG001|Overall Study|Lost to Follow-up|4|||
124579821|NCT02545283|448082856|FG000|Overall Study|Withdrawal by Subject|5|||
124579822|NCT02545283|448082857|FG001|Overall Study|Withdrawal by Subject|9|||
124526758|NCT03728881|447880536|FG000|Enrolled and Received 1st Vaccination|Death|1|||
124579823|NCT02545283|448082856|FG000|Overall Study|Death|109|||
124579824|NCT02545283|448082857|FG001|Overall Study|Death|211|||
124579825|NCT02545283|448082856|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
124579826|NCT02545283|448082857|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
124579827|NCT02545283|448082856|FG000|Overall Study|Study Terminated By Sponsor|33|||
124579828|NCT02545283|448082857|FG001|Overall Study|Study Terminated By Sponsor|71|||
124526759|NCT03728881|447880537|FG001|Enrolled and Received 1st Vaccination|Death|1|||
124526760|NCT03728881|447880536|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
124526761|NCT03728881|447880537|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
124579829|NCT03635320|448082859|FG000|Overall Study|not implanted the device|1|||
124579830|NCT03635320|448082860|FG001|Overall Study|not implanted the device|2|||
124579831|NCT03635320|448082859|FG000|Overall Study|Withdrawal by Subject|11|||
124776819|NCT05006573|448810020|FG001|Double-blind Treatment Period|Protocol Violation|0|||
124526762|NCT03728881|447880536|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
124526763|NCT03728881|447880537|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
124526764|NCT03728881|447880536|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
124526765|NCT03728881|447880537|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
124526766|NCT03728881|447880536|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
124526767|NCT03728881|447880537|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
124526768|NCT03728881|447880536|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
124526769|NCT03728881|447880537|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
124526770|NCT03728881|447880536|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
124526771|NCT03728881|447880537|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
124526772|NCT03728881|447880536|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
124526773|NCT03728881|447880537|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
124526774|NCT03728881|447880536|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
124526775|NCT03728881|447880537|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
124526776|NCT03728881|447880536|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
124526777|NCT03728881|447880537|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
124526778|NCT04088331|447880538|FG000|Overall Study|Lost to Follow-up|3|||
124526779|NCT04088331|447880538|FG000|Overall Study|Withdrawal by Subject|7|||
124526780|NCT04088331|447880538|FG000|Overall Study|Adverse Event|4|||
124526781|NCT02155712|447880541|FG000|Overall Study|Death|12|||
124526782|NCT02155712|447880542|FG001|Overall Study|Death|0|||
124526783|NCT02155712|447880541|FG000|Overall Study|Lost to Follow-up|37|||
124526784|NCT02155712|447880542|FG001|Overall Study|Lost to Follow-up|22|||
124526785|NCT02155712|447880541|FG000|Overall Study|Revision of device|4|||
124526786|NCT02155712|447880542|FG001|Overall Study|Revision of device|3|||
124526787|NCT02155712|447880541|FG000|Overall Study|Withdrawal by Subject|39|||
124526788|NCT02155712|447880542|FG001|Overall Study|Withdrawal by Subject|21|||
124526789|NCT02155712|447880541|FG000|Overall Study|Site termination|77|||
124526790|NCT02155712|447880542|FG001|Overall Study|Site termination|19|||
124526791|NCT02155712|447880541|FG000|Overall Study|Sponsor terminated study early|150|||
124526792|NCT02155712|447880542|FG001|Overall Study|Sponsor terminated study early|0|||
124526793|NCT02155712|447880541|FG000|Overall Study|Missed final 5-year protocol visit|0|||
124526794|NCT02155712|447880542|FG001|Overall Study|Missed final 5-year protocol visit|32|||
124526795|NCT02155712|447880541|FG000|Overall Study|Censored because surgery cancelled|6|||
124526796|NCT02155712|447880542|FG001|Overall Study|Censored because surgery cancelled|10|||
124726527|NCT02589665|448620265|FG009|Induction Extension Period|Reason Not Collected|0|||
124726528|NCT02589665|448620256|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
124726529|NCT02589665|448620257|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
124726530|NCT02589665|448620258|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
124526797|NCT02155712|447880541|FG000|Overall Study|Censored because study device was not implanted|61|||
124526798|NCT02155712|447880542|FG001|Overall Study|Censored because study device was not implanted|66|||
124526799|NCT02155712|447880541|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
124526800|NCT02155712|447880542|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
124526801|NCT02756845|447880546|FG000|Overall Study|Death|12|||
124526802|NCT02756845|447880547|FG001|Overall Study|Death|2|||
124526803|NCT02756845|447880546|FG000|Overall Study|Withdrawal by Subject|1|||
124526804|NCT02756845|447880547|FG001|Overall Study|Withdrawal by Subject|0|||
124526805|NCT01688999|447880548|FG000|Overall Study|Withdrawal by Subject|5|||
124526806|NCT01688999|447880549|FG001|Overall Study|Withdrawal by Subject|1|||
124526807|NCT01688999|447880550|FG002|Overall Study|Withdrawal by Subject|1|||
124526808|NCT01688999|447880548|FG000|Overall Study|Adverse Event|2|||
124526809|NCT01688999|447880549|FG001|Overall Study|Adverse Event|0|||
124526810|NCT01688999|447880550|FG002|Overall Study|Adverse Event|2|||
124526811|NCT01688999|447880548|FG000|Overall Study|Ineligible/Not treated|1|||
124526812|NCT01688999|447880549|FG001|Overall Study|Ineligible/Not treated|0|||
124526813|NCT01688999|447880550|FG002|Overall Study|Ineligible/Not treated|0|||
124526814|NCT01025232|447880567|FG000|Overall Study|Study drug no longer available|3|||
124526815|NCT01025232|447880568|FG001|Overall Study|Study drug no longer available|6|||
124526816|NCT04228445|447880574|FG000|Overall Study|Lost to Follow-up|1|||
124526817|NCT04228445|447880575|FG001|Overall Study|Lost to Follow-up|1|||
124526818|NCT04228445|447880574|FG000|Overall Study|Physician Decision|1|||
124526819|NCT04228445|447880575|FG001|Overall Study|Physician Decision|2|||
124526820|NCT04228445|447880574|FG000|Overall Study|Withdrawal by Subject|0|||
124526821|NCT04228445|447880575|FG001|Overall Study|Withdrawal by Subject|1|||
124526822|NCT04228445|447880574|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
124526823|NCT04228445|447880575|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
124526824|NCT01316380|447880580|FG000|Overall Study|Adverse Event|0|||
124526825|NCT01316380|447880581|FG001|Overall Study|Adverse Event|2|||
124526826|NCT01316380|447880582|FG002|Overall Study|Adverse Event|1|||
124526827|NCT01316380|447880580|FG000|Overall Study|Protocol Violation|0|||
124526828|NCT01316380|447880581|FG001|Overall Study|Protocol Violation|0|||
124526829|NCT01316380|447880582|FG002|Overall Study|Protocol Violation|1|||
124526830|NCT01316380|447880580|FG000|Overall Study|Withdrawal by Subject|1|||
124526831|NCT01316380|447880581|FG001|Overall Study|Withdrawal by Subject|2|||
124526832|NCT01316380|447880582|FG002|Overall Study|Withdrawal by Subject|0|||
124526833|NCT01316380|447880580|FG000|Overall Study|Other|0|||
124526834|NCT01316380|447880581|FG001|Overall Study|Other|1|||
124526835|NCT01316380|447880582|FG002|Overall Study|Other|1|||
124526836|NCT01316380|447880580|FG000|Overall Study|Not treated|1|||
124526837|NCT01316380|447880581|FG001|Overall Study|Not treated|0|||
124526838|NCT01316380|447880582|FG002|Overall Study|Not treated|0|||
124526839|NCT01894776|447880586|FG000|Overall Study|Withdrawal by Subject|1|||
124526840|NCT03512275|447880587|FG000|Overall Study|Withdrawal by Subject|1|||
124526841|NCT03512275|447880588|FG001|Overall Study|Withdrawal by Subject|3|||
124526842|NCT03512275|447880587|FG000|Overall Study|Physician Decision|0|||
124526843|NCT03512275|447880588|FG001|Overall Study|Physician Decision|1|||
124526844|NCT03512275|447880587|FG000|Overall Study|Lost to Follow-up|0|||
124526845|NCT03512275|447880588|FG001|Overall Study|Lost to Follow-up|3|||
124526846|NCT03512275|447880587|FG000|Overall Study|Other|1|||
124526847|NCT03512275|447880588|FG001|Overall Study|Other|0|||
124526848|NCT01307046|447880589|FG000|Overall Study|Adverse Event|3|||
124526849|NCT01307046|447880590|FG001|Overall Study|Adverse Event|3|||
124526850|NCT01307046|447880589|FG000|Overall Study|Lack of Efficacy|0|||
124526851|NCT01307046|447880590|FG001|Overall Study|Lack of Efficacy|2|||
124526852|NCT01307046|447880589|FG000|Overall Study|Physician Decision|2|||
124526853|NCT01307046|447880590|FG001|Overall Study|Physician Decision|0|||
124526854|NCT01307046|447880589|FG000|Overall Study|Withdrawal by Subject|1|||
124526855|NCT01307046|447880590|FG001|Overall Study|Withdrawal by Subject|1|||
124526856|NCT01307046|447880589|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
124526857|NCT01307046|447880590|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
124526858|NCT01307046|447880589|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
124526859|NCT01307046|447880590|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
124526860|NCT00609167|447880591|FG000|Overall Study|Withdrawal by Subject|1|||
124526861|NCT00609167|447880592|FG001|Overall Study|Withdrawal by Subject|0|||
124526862|NCT00609167|447880591|FG000|Overall Study|Lack of Efficacy|1|||
124526863|NCT00609167|447880592|FG001|Overall Study|Lack of Efficacy|0|||
124526864|NCT00609167|447880591|FG000|Overall Study|Adverse Event|5|||
124526865|NCT00609167|447880592|FG001|Overall Study|Adverse Event|1|||
124526866|NCT00609167|447880591|FG000|Overall Study|Disease Progression|1|||
124526867|NCT00609167|447880592|FG001|Overall Study|Disease Progression|0|||
124526868|NCT00609167|447880591|FG000|Overall Study|Stem Cell Transplant|0|||
124526869|NCT00609167|447880592|FG001|Overall Study|Stem Cell Transplant|6|||
124526870|NCT02574520|447880593|FG000|Overall Study|Not dosed|2|||
124526871|NCT02574520|447880594|FG001|Overall Study|Not dosed|0|||
124526872|NCT02574520|447880595|FG002|Overall Study|Not dosed|5|||
124526873|NCT02574520|447880596|FG003|Overall Study|Not dosed|4|||
124526874|NCT02574520|447880593|FG000|Overall Study|Adverse Event|0|||
124526875|NCT02574520|447880594|FG001|Overall Study|Adverse Event|0|||
124526876|NCT02574520|447880595|FG002|Overall Study|Adverse Event|0|||
124526877|NCT02574520|447880596|FG003|Overall Study|Adverse Event|1|||
124526878|NCT02574520|447880593|FG000|Overall Study|Withdrawal by Subject|0|||
124526879|NCT02574520|447880594|FG001|Overall Study|Withdrawal by Subject|0|||
124526880|NCT02574520|447880595|FG002|Overall Study|Withdrawal by Subject|0|||
124579832|NCT03635320|448082860|FG001|Overall Study|Withdrawal by Subject|6|||
124526881|NCT02574520|447880596|FG003|Overall Study|Withdrawal by Subject|1|||
124526882|NCT02574520|447880593|FG000|Overall Study|Other|0|||
124526883|NCT02574520|447880594|FG001|Overall Study|Other|0|||
124526884|NCT02574520|447880595|FG002|Overall Study|Other|0|||
124526885|NCT02574520|447880596|FG003|Overall Study|Other|2|||
124526886|NCT01365091|447880599|FG000|Period 1|Adverse Event|1|||
124526887|NCT01365091|447880600|FG001|Period 1|Adverse Event|0|||
124526888|NCT01365091|447880601|FG002|Period 1|Adverse Event|2|||
124526889|NCT01365091|447880602|FG003|Period 1|Adverse Event|3|||
124526890|NCT01365091|447880599|FG000|Period 1|Positive test result for drugs of abuse|1|||
124526891|NCT01365091|447880600|FG001|Period 1|Positive test result for drugs of abuse|0|||
124526892|NCT01365091|447880601|FG002|Period 1|Positive test result for drugs of abuse|0|||
124526893|NCT01365091|447880602|FG003|Period 1|Positive test result for drugs of abuse|0|||
124526894|NCT01365091|447880599|FG000|Period 1|No longer met study criteria|0|||
124526895|NCT01365091|447880600|FG001|Period 1|No longer met study criteria|1|||
124526896|NCT01365091|447880601|FG002|Period 1|No longer met study criteria|0|||
124526897|NCT01365091|447880602|FG003|Period 1|No longer met study criteria|0|||
124526898|NCT01365091|447880599|FG000|Period 1|Withdrawal by Subject|0|||
124526899|NCT01365091|447880600|FG001|Period 1|Withdrawal by Subject|1|||
124526900|NCT01365091|447880601|FG002|Period 1|Withdrawal by Subject|0|||
124526901|NCT01365091|447880602|FG003|Period 1|Withdrawal by Subject|0|||
124526902|NCT01365091|447880599|FG000|Period 1|Personal reasons|0|||
124526903|NCT01365091|447880600|FG001|Period 1|Personal reasons|0|||
124526904|NCT01365091|447880601|FG002|Period 1|Personal reasons|1|||
124526905|NCT01365091|447880602|FG003|Period 1|Personal reasons|0|||
124526906|NCT01365091|447880599|FG000|Period 2|Withdrawal by Subject|1|||
124526907|NCT01365091|447880600|FG001|Period 2|Withdrawal by Subject|0|||
124526908|NCT01365091|447880601|FG002|Period 2|Withdrawal by Subject|0|||
124526909|NCT01365091|447880602|FG003|Period 2|Withdrawal by Subject|0|||
124526910|NCT01365091|447880599|FG000|Period 2|Adverse Event|0|||
124526911|NCT01365091|447880600|FG001|Period 2|Adverse Event|0|||
124526912|NCT01365091|447880601|FG002|Period 2|Adverse Event|1|||
124526913|NCT01365091|447880602|FG003|Period 2|Adverse Event|0|||
124526914|NCT05116683|447880603|FG000|Overall Study|Physician Decision|4|||
124526915|NCT01474889|447880605|FG000|Overall Study|Physician Decision|1|||
124526916|NCT01474889|447880606|FG001|Overall Study|Physician Decision|0|||
124526917|NCT01474889|447880607|FG002|Overall Study|Physician Decision|0|||
124526918|NCT01474889|447880605|FG000|Overall Study|Did not meet inclusion|1|||
124526919|NCT01474889|447880606|FG001|Overall Study|Did not meet inclusion|0|||
124526920|NCT01474889|447880607|FG002|Overall Study|Did not meet inclusion|0|||
124526921|NCT01474889|447880605|FG000|Overall Study|Withdrawal by Subject|0|||
124526922|NCT01474889|447880606|FG001|Overall Study|Withdrawal by Subject|1|||
124526923|NCT01474889|447880607|FG002|Overall Study|Withdrawal by Subject|0|||
124526924|NCT03935594|447880611|FG000|Overall Study|Physician Decision|3|||
124526925|NCT01435122|447880612|FG000|Overall Study|Early withdrawal due to toxicity|8|||
124526926|NCT04412668|447880613|FG000|Overall Study|Death - multiple comorbidities|2|||
124526927|NCT04412668|447880614|FG001|Overall Study|Death - multiple comorbidities|0|||
124526928|NCT04412668|447880615|FG002|Overall Study|Death - multiple comorbidities|0|||
124526929|NCT04412668|447880613|FG000|Overall Study|Withdrawal by Subject|3|||
124526930|NCT04412668|447880614|FG001|Overall Study|Withdrawal by Subject|0|||
124526931|NCT04412668|447880615|FG002|Overall Study|Withdrawal by Subject|0|||
124526932|NCT04412668|447880613|FG000|Overall Study|Other than Specified|2|||
124526933|NCT04412668|447880614|FG001|Overall Study|Other than Specified|0|||
124526934|NCT04412668|447880615|FG002|Overall Study|Other than Specified|0|||
124526935|NCT03864627|447880617|FG000|Overall Study|Adverse Event|0|||
124526936|NCT03864627|447880618|FG001|Overall Study|Adverse Event|1|||
124526937|NCT03864627|447880617|FG000|Overall Study|Lack of Efficacy|0|||
124526938|NCT03864627|447880618|FG001|Overall Study|Lack of Efficacy|1|||
124526939|NCT03864627|447880617|FG000|Overall Study|Lost to Follow-up|0|||
124526940|NCT03864627|447880618|FG001|Overall Study|Lost to Follow-up|1|||
124526941|NCT03864627|447880617|FG000|Overall Study|Withdrawal by Subject|4|||
124526942|NCT03864627|447880618|FG001|Overall Study|Withdrawal by Subject|8|||
124526943|NCT03864627|447880617|FG000|Overall Study|Study terminated by sponsor|0|||
124526944|NCT03864627|447880618|FG001|Overall Study|Study terminated by sponsor|1|||
124526945|NCT01388491|447880619|FG000|Overall Study|Adverse Event|10|||
124526946|NCT01388491|447880620|FG001|Overall Study|Adverse Event|9|||
124526947|NCT01388491|447880619|FG000|Overall Study|Sponsor Request|9|||
124526948|NCT01388491|447880620|FG001|Overall Study|Sponsor Request|7|||
124526949|NCT01388491|447880619|FG000|Overall Study|Withdrawal by Subject|6|||
124526950|NCT01388491|447880620|FG001|Overall Study|Withdrawal by Subject|10|||
124526951|NCT01388491|447880619|FG000|Overall Study|Lost to Follow-up|4|||
124526952|NCT01388491|447880620|FG001|Overall Study|Lost to Follow-up|3|||
124526953|NCT01388491|447880619|FG000|Overall Study|Protocol Violation|2|||
124526954|NCT01388491|447880620|FG001|Overall Study|Protocol Violation|0|||
124526955|NCT01388491|447880619|FG000|Overall Study|Noncompliance|2|||
124526956|NCT01388491|447880620|FG001|Overall Study|Noncompliance|0|||
124526957|NCT01388491|447880619|FG000|Overall Study|Pregnancy|1|||
124526958|NCT01388491|447880620|FG001|Overall Study|Pregnancy|0|||
124526959|NCT00397891|447880621|FG000|Overall Study|Withdrawal by Subject|1|||
124526960|NCT00397891|447880622|FG001|Overall Study|Withdrawal by Subject|0|||
124526961|NCT00397891|447880623|FG002|Overall Study|Withdrawal by Subject|0|||
124526962|NCT00397891|447880624|FG003|Overall Study|Withdrawal by Subject|0|||
124526963|NCT00397891|447880625|FG004|Overall Study|Withdrawal by Subject|1|||
124526964|NCT04964557|447880626|FG000|Overall Study|Withdrawal by Subject|3|||
124526965|NCT04964557|447880627|FG001|Overall Study|Withdrawal by Subject|2|||
124526966|NCT04964557|447880626|FG000|Overall Study|Lost to Follow-up|1|||
124526967|NCT04964557|447880627|FG001|Overall Study|Lost to Follow-up|2|||
124526968|NCT04964557|447880626|FG000|Overall Study|Physician Decision|2|||
124526969|NCT04964557|447880627|FG001|Overall Study|Physician Decision|0|||
124526970|NCT04964557|447880626|FG000|Overall Study|Death|3|||
124526971|NCT04964557|447880627|FG001|Overall Study|Death|0|||
124526972|NCT04964557|447880626|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
124526973|NCT04964557|447880627|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
124526974|NCT03695471|447882310|FG000|Overall Study|Cancellation|1|||
124526975|NCT02859558|447882311|FG000|Step 1|Not Eligible|0|||
124526976|NCT02859558|447882312|FG001|Step 1|Not Eligible|0|||
124526977|NCT02859558|447882313|FG002|Step 1|Not Eligible|0|||
124526978|NCT02859558|447882314|FG003|Step 1|Not Eligible|0|||
124526979|NCT02859558|447882315|FG004|Step 1|Not Eligible|3|||
124526980|NCT02859558|447882311|FG000|Step 1|Lost to Follow-up|1|||
124526981|NCT02859558|447882312|FG001|Step 1|Lost to Follow-up|3|||
124526982|NCT02859558|447882313|FG002|Step 1|Lost to Follow-up|3|||
124526983|NCT02859558|447882314|FG003|Step 1|Lost to Follow-up|0|||
124526984|NCT02859558|447882315|FG004|Step 1|Lost to Follow-up|0|||
124526985|NCT02859558|447882311|FG000|Step 1|Did Not Return to Clinic|2|||
124526986|NCT02859558|447882312|FG001|Step 1|Did Not Return to Clinic|3|||
124526987|NCT02859558|447882313|FG002|Step 1|Did Not Return to Clinic|4|||
124526988|NCT02859558|447882314|FG003|Step 1|Did Not Return to Clinic|0|||
124526989|NCT02859558|447882315|FG004|Step 1|Did Not Return to Clinic|0|||
124526990|NCT02859558|447882311|FG000|Step 1|Moved|0|||
124526991|NCT02859558|447882312|FG001|Step 1|Moved|1|||
124526992|NCT02859558|447882313|FG002|Step 1|Moved|1|||
124526993|NCT02859558|447882314|FG003|Step 1|Moved|0|||
124526994|NCT02859558|447882315|FG004|Step 1|Moved|0|||
124526995|NCT02859558|447882311|FG000|Step 1|Withdrawal By Participant|1|||
124526996|NCT02859558|447882312|FG001|Step 1|Withdrawal By Participant|2|||
124526997|NCT02859558|447882313|FG002|Step 1|Withdrawal By Participant|1|||
124526998|NCT02859558|447882314|FG003|Step 1|Withdrawal By Participant|0|||
124526999|NCT02859558|447882315|FG004|Step 1|Withdrawal By Participant|0|||
124527000|NCT02859558|447882311|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
124527001|NCT02859558|447882312|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
124527002|NCT02859558|447882313|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
124527003|NCT02859558|447882314|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
124527004|NCT02859558|447882315|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
124527005|NCT02859558|447882311|FG000|Step 1|Incarceration|0|||
124527006|NCT02859558|447882312|FG001|Step 1|Incarceration|1|||
124527007|NCT02859558|447882313|FG002|Step 1|Incarceration|0|||
124527008|NCT02859558|447882314|FG003|Step 1|Incarceration|0|||
124527009|NCT02859558|447882315|FG004|Step 1|Incarceration|0|||
124527010|NCT02859558|447882311|FG000|Step 1|Non-Adherence to Study Drug|2|||
124527011|NCT02859558|447882312|FG001|Step 1|Non-Adherence to Study Drug|0|||
124527012|NCT02859558|447882313|FG002|Step 1|Non-Adherence to Study Drug|1|||
124527013|NCT02859558|447882314|FG003|Step 1|Non-Adherence to Study Drug|0|||
124527014|NCT02859558|447882315|FG004|Step 1|Non-Adherence to Study Drug|0|||
124527015|NCT02859558|447882311|FG000|Step 1|Non-Adherence to Study Requirements|3|||
124527016|NCT02859558|447882312|FG001|Step 1|Non-Adherence to Study Requirements|1|||
124527017|NCT02859558|447882313|FG002|Step 1|Non-Adherence to Study Requirements|0|||
124527018|NCT02859558|447882314|FG003|Step 1|Non-Adherence to Study Requirements|0|||
124527019|NCT02859558|447882315|FG004|Step 1|Non-Adherence to Study Requirements|0|||
124527020|NCT02859558|447882311|FG000|Step 1|Virologic Failure|2|||
124527021|NCT02859558|447882312|FG001|Step 1|Virologic Failure|1|||
124527022|NCT02859558|447882313|FG002|Step 1|Virologic Failure|1|||
124527023|NCT02859558|447882314|FG003|Step 1|Virologic Failure|0|||
124527024|NCT02859558|447882315|FG004|Step 1|Virologic Failure|0|||
124527025|NCT02859558|447882311|FG000|Step 2|Lost to Follow-up|3|||
124527026|NCT02859558|447882312|FG001|Step 2|Lost to Follow-up|3|||
124527027|NCT02859558|447882313|FG002|Step 2|Lost to Follow-up|1|||
124527028|NCT02859558|447882314|FG003|Step 2|Lost to Follow-up|0|||
124527029|NCT02859558|447882315|FG004|Step 2|Lost to Follow-up|0|||
124527030|NCT02859558|447882311|FG000|Step 2|Withdrawal by Subject|0|||
124527031|NCT02859558|447882312|FG001|Step 2|Withdrawal by Subject|1|||
124527032|NCT02859558|447882313|FG002|Step 2|Withdrawal by Subject|1|||
124527033|NCT02859558|447882314|FG003|Step 2|Withdrawal by Subject|0|||
124527034|NCT02859558|447882315|FG004|Step 2|Withdrawal by Subject|0|||
124527035|NCT02859558|447882311|FG000|Step 2|Unexpected Closure of Site|0|||
124527036|NCT02859558|447882312|FG001|Step 2|Unexpected Closure of Site|1|||
124527037|NCT02859558|447882313|FG002|Step 2|Unexpected Closure of Site|1|||
124527038|NCT02859558|447882314|FG003|Step 2|Unexpected Closure of Site|0|||
124527039|NCT02859558|447882315|FG004|Step 2|Unexpected Closure of Site|0|||
124527040|NCT02859558|447882311|FG000|Step 2|Death|1|||
124527041|NCT02859558|447882312|FG001|Step 2|Death|0|||
124527042|NCT02859558|447882313|FG002|Step 2|Death|0|||
124527043|NCT02859558|447882314|FG003|Step 2|Death|0|||
124527044|NCT02859558|447882315|FG004|Step 2|Death|0|||
124527045|NCT02859558|447882311|FG000|Step 2|Incarceration|0|||
124527046|NCT02859558|447882312|FG001|Step 2|Incarceration|0|||
124527047|NCT02859558|447882313|FG002|Step 2|Incarceration|1|||
124527048|NCT02859558|447882314|FG003|Step 2|Incarceration|0|||
124527049|NCT02859558|447882315|FG004|Step 2|Incarceration|0|||
124527050|NCT05665595|447882316|FG000|Overall Study|Ongoing|692|||
124527051|NCT05665595|447882317|FG001|Overall Study|Ongoing|698|||
124527052|NCT05665595|447882316|FG000|Overall Study|Withdrawal by Subject|2|||
124527053|NCT05665595|447882317|FG001|Overall Study|Withdrawal by Subject|2|||
124527054|NCT05665595|447882316|FG000|Overall Study|Lost to Follow-up|1|||
124527055|NCT05665595|447882317|FG001|Overall Study|Lost to Follow-up|0|||
124527056|NCT05665595|447882316|FG000|Overall Study|Death|6|||
124527057|NCT05665595|447882317|FG001|Overall Study|Death|1|||
124527058|NCT02358863|447882318|FG000|Overall Study|Physician Decision|3|||
124527059|NCT04969900|447882324|FG000|Overall Study|Physician Decision|1|||
124527060|NCT04969900|447882325|FG001|Overall Study|Physician Decision|1|||
124527061|NCT04969900|447882324|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
124527062|NCT04969900|447882325|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
124527063|NCT03671148|447882331|FG000|Overall Study|Adverse Event|3|||
124527064|NCT03671148|447882332|FG001|Overall Study|Adverse Event|2|||
124527065|NCT03671148|447882331|FG000|Overall Study|Withdrawal by Subject|8|||
124527066|NCT03671148|447882332|FG001|Overall Study|Withdrawal by Subject|2|||
124726531|NCT02589665|448620259|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
124726532|NCT02589665|448620260|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
124726533|NCT02589665|448620261|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
124726534|NCT02589665|448620262|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
124726535|NCT02589665|448620263|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
124726536|NCT02589665|448620264|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
124726537|NCT02589665|448620265|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
124726538|NCT02589665|448620256|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
124726539|NCT02589665|448620257|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
124726540|NCT02589665|448620258|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
124726541|NCT02589665|448620259|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
124527067|NCT03671148|447882331|FG000|Overall Study|Lost to Follow-up|1|||
124527068|NCT03671148|447882332|FG001|Overall Study|Lost to Follow-up|2|||
124527069|NCT03671148|447882331|FG000|Overall Study|Lack of Efficacy|7|||
124527070|NCT03671148|447882332|FG001|Overall Study|Lack of Efficacy|2|||
124527071|NCT03671148|447882331|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
124527072|NCT03671148|447882332|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
124527073|NCT03671148|447882331|FG000|Overall Study|Other|1|||
124527074|NCT03671148|447882332|FG001|Overall Study|Other|0|||
124527075|NCT03671148|447882331|FG000|Overall Study|Incomplete Randomization Visit|1|||
124527076|NCT03671148|447882332|FG001|Overall Study|Incomplete Randomization Visit|0|||
124527077|NCT04423718|447882333|FG000|Main Study|Adverse Event|9|||
124527078|NCT04423718|447882334|FG001|Main Study|Adverse Event|5|||
124527079|NCT04423718|447882335|FG002|Main Study|Adverse Event|8|||
124527080|NCT04423718|447882333|FG000|Main Study|Physician Decision|3|||
124527081|NCT04423718|447882334|FG001|Main Study|Physician Decision|3|||
124527082|NCT04423718|447882335|FG002|Main Study|Physician Decision|2|||
124527083|NCT04423718|447882333|FG000|Main Study|Protocol Violation|0|||
124527084|NCT04423718|447882334|FG001|Main Study|Protocol Violation|0|||
124527085|NCT04423718|447882335|FG002|Main Study|Protocol Violation|1|||
124527086|NCT04423718|447882333|FG000|Main Study|Lost to Follow-up|3|||
124527087|NCT04423718|447882334|FG001|Main Study|Lost to Follow-up|3|||
124527088|NCT04423718|447882335|FG002|Main Study|Lost to Follow-up|4|||
124527089|NCT04423718|447882333|FG000|Main Study|Lack of Efficacy|2|||
124527090|NCT04423718|447882334|FG001|Main Study|Lack of Efficacy|1|||
124527091|NCT04423718|447882335|FG002|Main Study|Lack of Efficacy|0|||
124527092|NCT04423718|447882333|FG000|Main Study|Withdrawal by Subject|14|||
124527093|NCT04423718|447882334|FG001|Main Study|Withdrawal by Subject|20|||
124527094|NCT04423718|447882335|FG002|Main Study|Withdrawal by Subject|20|||
124527095|NCT04423718|447882333|FG000|Main Study|Death|10|||
124527096|NCT04423718|447882334|FG001|Main Study|Death|7|||
124527097|NCT04423718|447882335|FG002|Main Study|Death|7|||
124527098|NCT04423718|447882333|FG000|Main Study|COVID-19 pandemic|2|||
124527099|NCT04423718|447882334|FG001|Main Study|COVID-19 pandemic|2|||
124527100|NCT04423718|447882335|FG002|Main Study|COVID-19 pandemic|2|||
124527101|NCT04423718|447882333|FG000|Main Study|Other|7|||
124527102|NCT04423718|447882334|FG001|Main Study|Other|3|||
124527103|NCT04423718|447882335|FG002|Main Study|Other|2|||
124527104|NCT04423718|447882333|FG000|Extension Phase|Other|1|||
124527105|NCT04423718|447882334|FG001|Extension Phase|Other|0|||
124527106|NCT04423718|447882335|FG002|Extension Phase|Other|0|||
124527107|NCT04423718|447882333|FG000|Extension Phase|Logistical problems|0|||
124527108|NCT04423718|447882334|FG001|Extension Phase|Logistical problems|1|||
124527109|NCT04423718|447882335|FG002|Extension Phase|Logistical problems|1|||
124527110|NCT04423718|447882333|FG000|Extension Phase|Physician Decision|1|||
124527111|NCT04423718|447882334|FG001|Extension Phase|Physician Decision|0|||
124527112|NCT04423718|447882335|FG002|Extension Phase|Physician Decision|1|||
124527113|NCT04423718|447882333|FG000|Extension Phase|Lack of Efficacy|2|||
124527114|NCT04423718|447882334|FG001|Extension Phase|Lack of Efficacy|0|||
124527115|NCT04423718|447882335|FG002|Extension Phase|Lack of Efficacy|1|||
124527116|NCT04423718|447882333|FG000|Extension Phase|Lost to Follow-up|0|||
124527117|NCT04423718|447882334|FG001|Extension Phase|Lost to Follow-up|2|||
124527118|NCT04423718|447882335|FG002|Extension Phase|Lost to Follow-up|3|||
124527119|NCT04423718|447882333|FG000|Extension Phase|Adverse Event|2|||
124527120|NCT04423718|447882334|FG001|Extension Phase|Adverse Event|3|||
124527121|NCT04423718|447882335|FG002|Extension Phase|Adverse Event|1|||
124527122|NCT04423718|447882333|FG000|Extension Phase|Death|4|||
124527123|NCT04423718|447882334|FG001|Extension Phase|Death|7|||
124527124|NCT04423718|447882335|FG002|Extension Phase|Death|2|||
124527125|NCT04423718|447882333|FG000|Extension Phase|Withdrawal by Subject|11|||
124527126|NCT04423718|447882334|FG001|Extension Phase|Withdrawal by Subject|11|||
124527127|NCT04423718|447882335|FG002|Extension Phase|Withdrawal by Subject|7|||
124527128|NCT00425945|447882336|FG000|Overall Study|Concern about Supplement|2|||
124527129|NCT00425945|447882337|FG001|Overall Study|Concern about Supplement|0|||
124527130|NCT00425945|447882336|FG000|Overall Study|Inconvenience|0|||
124527131|NCT00425945|447882337|FG001|Overall Study|Inconvenience|2|||
124527132|NCT00425945|447882336|FG000|Overall Study|Lost to Follow-up|0|||
124579833|NCT00835575|448082863|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
124579834|NCT00835575|448082864|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
124579835|NCT00443651|448082865|FG000|Overall Study|Death|1|||
124579836|NCT00443651|448082866|FG001|Overall Study|Death|5|||
124579837|NCT00443651|448082865|FG000|Overall Study|Adverse Event|5|||
124579838|NCT00443651|448082866|FG001|Overall Study|Adverse Event|6|||
124579839|NCT00443651|448082865|FG000|Overall Study|Lost to Follow-up|18|||
124579840|NCT00443651|448082866|FG001|Overall Study|Lost to Follow-up|12|||
124579841|NCT00443651|448082865|FG000|Overall Study|Patient's/Guardian's Decision|58|||
124579842|NCT00443651|448082866|FG001|Overall Study|Patient's/Guardian's Decision|30|||
124579843|NCT00443651|448082865|FG000|Overall Study|Physician Decision|13|||
124579844|NCT00443651|448082866|FG001|Overall Study|Physician Decision|4|||
124579845|NCT00443651|448082865|FG000|Overall Study|Pregnancy|0|||
124579846|NCT00443651|448082866|FG001|Overall Study|Pregnancy|1|||
124579847|NCT03606174|448082867|FG000|Overall Study|Death|37|||
124579848|NCT03606174|448082868|FG001|Overall Study|Death|15|||
124579849|NCT03606174|448082869|FG002|Overall Study|Death|15|||
124579850|NCT03606174|448082870|FG003|Overall Study|Death|7|||
124579851|NCT03606174|448082871|FG004|Overall Study|Death|35|||
124579852|NCT03606174|448082872|FG005|Overall Study|Death|12|||
124579853|NCT03606174|448082873|FG006|Overall Study|Death|35|||
124579854|NCT03606174|448082874|FG007|Overall Study|Death|8|||
124579855|NCT03606174|448082875|FG008|Overall Study|Death|5|||
124579856|NCT03606174|448082876|FG009|Overall Study|Death|3|||
124579857|NCT03606174|448082877|FG010|Overall Study|Death|0|||
124527133|NCT00425945|447882337|FG001|Overall Study|Lost to Follow-up|2|||
124527134|NCT00425945|447882336|FG000|Overall Study|Began hypertension medication|1|||
124527135|NCT00425945|447882337|FG001|Overall Study|Began hypertension medication|0|||
124527136|NCT00425945|447882336|FG000|Overall Study|Began cancer treatments|1|||
124527137|NCT00425945|447882337|FG001|Overall Study|Began cancer treatments|0|||
124527138|NCT00425945|447882336|FG000|Overall Study|Moved from area|0|||
124527139|NCT00425945|447882337|FG001|Overall Study|Moved from area|1|||
124527140|NCT03774875|447882343|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
124527141|NCT03774875|447882344|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
124527142|NCT03774875|447882343|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
124527143|NCT03774875|447882344|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
124527144|NCT03774875|447882343|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
124527145|NCT03774875|447882344|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
124527146|NCT03774875|447882343|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
124527147|NCT03774875|447882344|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
124527148|NCT03774875|447882343|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
124527149|NCT03774875|447882344|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
124527150|NCT03774875|447882343|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
124527151|NCT03774875|447882344|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
124527152|NCT03774875|447882343|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
124527153|NCT03774875|447882344|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
124527154|NCT03774875|447882343|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
124527155|NCT03774875|447882344|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
124527156|NCT03774875|447882343|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
124527157|NCT03774875|447882344|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
124527158|NCT03774875|447882343|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
124527159|NCT03774875|447882344|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
124527160|NCT03774875|447882343|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
124527161|NCT03774875|447882344|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
124527162|NCT03774875|447882343|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
124527163|NCT03774875|447882344|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
124527164|NCT03774875|447882343|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
124527165|NCT03774875|447882344|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
124527166|NCT03149029|447882347|FG000|Overall Study|Adverse Event|2|||
124527167|NCT03149029|447882348|FG001|Overall Study|Adverse Event|0|||
124579858|NCT03606174|448082867|FG000|Overall Study|Lost to Follow-up|0|||
124527168|NCT03233308|447882349|FG000|Overall Study|Adverse Event|1|||
124527169|NCT03233308|447882349|FG000|Overall Study|Protocol Violation|1|||
124527170|NCT03287830|447882350|FG000|Overall Study|Withdrawal by Subject|1|||
124527171|NCT03287830|447882351|FG001|Overall Study|Withdrawal by Subject|1|||
124527172|NCT03287830|447882350|FG000|Overall Study|not meeting inclusion criteria|5|||
124527173|NCT03287830|447882351|FG001|Overall Study|not meeting inclusion criteria|12|||
124579859|NCT03606174|448082868|FG001|Overall Study|Lost to Follow-up|0|||
124579860|NCT03606174|448082869|FG002|Overall Study|Lost to Follow-up|0|||
124579861|NCT03606174|448082870|FG003|Overall Study|Lost to Follow-up|0|||
124579862|NCT03606174|448082871|FG004|Overall Study|Lost to Follow-up|1|||
124579863|NCT03606174|448082872|FG005|Overall Study|Lost to Follow-up|1|||
124579864|NCT03606174|448082873|FG006|Overall Study|Lost to Follow-up|0|||
124579865|NCT03606174|448082874|FG007|Overall Study|Lost to Follow-up|0|||
124579866|NCT03606174|448082875|FG008|Overall Study|Lost to Follow-up|0|||
124579867|NCT03606174|448082876|FG009|Overall Study|Lost to Follow-up|0|||
124579868|NCT03606174|448082877|FG010|Overall Study|Lost to Follow-up|0|||
124579869|NCT03606174|448082867|FG000|Overall Study|Withdrawal by Subject|6|||
124579870|NCT03606174|448082868|FG001|Overall Study|Withdrawal by Subject|0|||
124579871|NCT03606174|448082869|FG002|Overall Study|Withdrawal by Subject|0|||
124579872|NCT03606174|448082870|FG003|Overall Study|Withdrawal by Subject|1|||
124579873|NCT03606174|448082871|FG004|Overall Study|Withdrawal by Subject|2|||
124579874|NCT03606174|448082872|FG005|Overall Study|Withdrawal by Subject|1|||
124579875|NCT03606174|448082873|FG006|Overall Study|Withdrawal by Subject|4|||
124579876|NCT03606174|448082874|FG007|Overall Study|Withdrawal by Subject|0|||
124579877|NCT03606174|448082875|FG008|Overall Study|Withdrawal by Subject|0|||
124579878|NCT03606174|448082876|FG009|Overall Study|Withdrawal by Subject|0|||
124579879|NCT03606174|448082877|FG010|Overall Study|Withdrawal by Subject|1|||
124579880|NCT03606174|448082867|FG000|Overall Study|Study Terminated by Sponsor|5|||
124579881|NCT03606174|448082868|FG001|Overall Study|Study Terminated by Sponsor|7|||
124579882|NCT03606174|448082869|FG002|Overall Study|Study Terminated by Sponsor|3|||
124579883|NCT03606174|448082870|FG003|Overall Study|Study Terminated by Sponsor|0|||
124579884|NCT03606174|448082871|FG004|Overall Study|Study Terminated by Sponsor|11|||
124579885|NCT03606174|448082872|FG005|Overall Study|Study Terminated by Sponsor|6|||
124579886|NCT03606174|448082873|FG006|Overall Study|Study Terminated by Sponsor|12|||
124579887|NCT03606174|448082874|FG007|Overall Study|Study Terminated by Sponsor|1|||
124579888|NCT03606174|448082875|FG008|Overall Study|Study Terminated by Sponsor|3|||
124579889|NCT03606174|448082876|FG009|Overall Study|Study Terminated by Sponsor|1|||
124579890|NCT03606174|448082877|FG010|Overall Study|Study Terminated by Sponsor|2|||
124579891|NCT03606174|448082867|FG000|Overall Study|Miscellaneous|1|||
124579892|NCT03606174|448082868|FG001|Overall Study|Miscellaneous|1|||
124579893|NCT03606174|448082869|FG002|Overall Study|Miscellaneous|0|||
124579894|NCT03606174|448082870|FG003|Overall Study|Miscellaneous|1|||
124579895|NCT03606174|448082871|FG004|Overall Study|Miscellaneous|4|||
124579896|NCT03606174|448082872|FG005|Overall Study|Miscellaneous|7|||
124579897|NCT03606174|448082873|FG006|Overall Study|Miscellaneous|5|||
124579898|NCT03606174|448082874|FG007|Overall Study|Miscellaneous|0|||
124579899|NCT03606174|448082875|FG008|Overall Study|Miscellaneous|0|||
124579900|NCT03606174|448082876|FG009|Overall Study|Miscellaneous|0|||
124579901|NCT03606174|448082877|FG010|Overall Study|Miscellaneous|1|||
124579902|NCT02241551|448082880|FG000|Overall Study|Adverse Event|1|||
124579903|NCT02241551|448082881|FG001|Overall Study|Adverse Event|0|||
124579904|NCT00469898|448082882|FG000|Overall Study|Adverse Event|7|||
124579905|NCT00469898|448082882|FG000|Overall Study|Withdrawal by Subject|4|||
124579906|NCT00469898|448082882|FG000|Overall Study|Death|4|||
124579907|NCT00469898|448082882|FG000|Overall Study|Disease progression|9|||
124579908|NCT00469898|448082882|FG000|Overall Study|Decreased performance status|1|||
124579909|NCT01205035|448082883|FG000|Overall Study|Withdrawal by Subject|1|||
124579910|NCT01205035|448082884|FG001|Overall Study|Withdrawal by Subject|0|||
124579911|NCT01205035|448082883|FG000|Overall Study|Physician Decision|1|||
124579912|NCT01205035|448082884|FG001|Overall Study|Physician Decision|0|||
124579913|NCT01667679|448082886|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
124726542|NCT02589665|448620260|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
124726543|NCT02589665|448620261|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
124726544|NCT02589665|448620262|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
124726545|NCT02589665|448620263|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
124726546|NCT02589665|448620264|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
124726547|NCT02589665|448620265|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
124726548|NCT02589665|448620256|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
124726549|NCT02589665|448620257|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
124726550|NCT02589665|448620258|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
124726551|NCT02589665|448620259|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
124726552|NCT02589665|448620260|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
124726553|NCT02589665|448620261|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
124726554|NCT02589665|448620262|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
124726555|NCT02589665|448620263|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
124726556|NCT02589665|448620264|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
124579914|NCT01667679|448082887|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
124579915|NCT01667679|448082886|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
124579916|NCT01667679|448082887|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
124579917|NCT01667679|448082886|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
124579918|NCT01667679|448082887|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
124579919|NCT01667679|448082886|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
124579920|NCT01667679|448082887|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
124579921|NCT01667679|448082886|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
124579922|NCT01667679|448082887|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
124579923|NCT01667679|448082886|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
124527174|NCT02974621|447882352|FG000|Overall Study|Didn't receive study treatment|1|||
124527175|NCT02974621|447882353|FG001|Overall Study|Didn't receive study treatment|10|||
124527176|NCT00557323|447882355|FG000|Overall Study|Death|3|||
124527177|NCT00557323|447882355|FG000|Overall Study|Withdrawal by Subject|2|||
124527178|NCT00557323|447882355|FG000|Overall Study|Administrative change|2|||
124527179|NCT01196091|447882360|FG000|Overall Study|Adverse Event|22|||
124527180|NCT01196091|447882361|FG001|Overall Study|Adverse Event|27|||
124527181|NCT01196091|447882362|FG002|Overall Study|Adverse Event|26|||
124527182|NCT01196091|447882360|FG000|Overall Study|Death|3|||
124527183|NCT01196091|447882361|FG001|Overall Study|Death|2|||
124527184|NCT01196091|447882362|FG002|Overall Study|Death|2|||
124527185|NCT01196091|447882360|FG000|Overall Study|Entry Criteria Not Met|11|||
124527186|NCT01196091|447882361|FG001|Overall Study|Entry Criteria Not Met|11|||
124527187|NCT01196091|447882362|FG002|Overall Study|Entry Criteria Not Met|10|||
124726557|NCT02589665|448620265|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
124726558|NCT02589665|448620256|FG000|Maintenance Extension Period|Adverse Event|0|||
124726559|NCT02589665|448620257|FG001|Maintenance Extension Period|Adverse Event|0|||
124726560|NCT02589665|448620258|FG002|Maintenance Extension Period|Adverse Event|0|||
124726561|NCT02589665|448620259|FG003|Maintenance Extension Period|Adverse Event|0|||
124726562|NCT02589665|448620260|FG004|Maintenance Extension Period|Adverse Event|0|||
124726563|NCT02589665|448620261|FG005|Maintenance Extension Period|Adverse Event|0|||
124726564|NCT02589665|448620262|FG006|Maintenance Extension Period|Adverse Event|0|||
124726565|NCT02589665|448620263|FG007|Maintenance Extension Period|Adverse Event|0|||
124726566|NCT02589665|448620264|FG008|Maintenance Extension Period|Adverse Event|0|||
124726567|NCT02589665|448620265|FG009|Maintenance Extension Period|Adverse Event|2|||
124726568|NCT02589665|448620256|FG000|Maintenance Extension Period|Non-responder|0|||
124726569|NCT02589665|448620257|FG001|Maintenance Extension Period|Non-responder|0|||
124726570|NCT02589665|448620258|FG002|Maintenance Extension Period|Non-responder|0|||
124726571|NCT02589665|448620259|FG003|Maintenance Extension Period|Non-responder|0|||
124726572|NCT02589665|448620260|FG004|Maintenance Extension Period|Non-responder|0|||
124726573|NCT02589665|448620261|FG005|Maintenance Extension Period|Non-responder|0|||
124726574|NCT02589665|448620262|FG006|Maintenance Extension Period|Non-responder|0|||
124726575|NCT02589665|448620263|FG007|Maintenance Extension Period|Non-responder|0|||
124726576|NCT02589665|448620264|FG008|Maintenance Extension Period|Non-responder|0|||
124726577|NCT02589665|448620265|FG009|Maintenance Extension Period|Non-responder|1|||
124726578|NCT00978380|448620266|FG000|Overall Study|Protocol Violation|2|||
124726579|NCT00978380|448620266|FG000|Overall Study|Withdrawal criteria|9|||
124726580|NCT00978380|448620266|FG000|Overall Study|Unclassified|8|||
124726581|NCT00327015|448620267|FG000|Overall Study|Lack of Efficacy|18|||
124726582|NCT00327015|448620268|FG001|Overall Study|Lack of Efficacy|18|||
124726583|NCT00327015|448620269|FG002|Overall Study|Lack of Efficacy|35|||
124726584|NCT00327015|448620270|FG003|Overall Study|Lack of Efficacy|29|||
124726585|NCT00327015|448620267|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
124527188|NCT01196091|447882360|FG000|Overall Study|Lack of Efficacy|15|||
124527189|NCT01196091|447882361|FG001|Overall Study|Lack of Efficacy|12|||
124527190|NCT01196091|447882362|FG002|Overall Study|Lack of Efficacy|17|||
124527191|NCT01196091|447882360|FG000|Overall Study|Lost to Follow-up|5|||
124527192|NCT01196091|447882361|FG001|Overall Study|Lost to Follow-up|5|||
124527193|NCT01196091|447882362|FG002|Overall Study|Lost to Follow-up|6|||
124527194|NCT01196091|447882360|FG000|Overall Study|Parent/Caregiver Decision|0|||
124527195|NCT01196091|447882361|FG001|Overall Study|Parent/Caregiver Decision|0|||
124527196|NCT01196091|447882362|FG002|Overall Study|Parent/Caregiver Decision|1|||
124527197|NCT01196091|447882360|FG000|Overall Study|Withdrawal by Subject|16|||
124527198|NCT01196091|447882361|FG001|Overall Study|Withdrawal by Subject|19|||
124527199|NCT01196091|447882362|FG002|Overall Study|Withdrawal by Subject|22|||
124527200|NCT01196091|447882360|FG000|Overall Study|Physician Decision|3|||
124527201|NCT01196091|447882361|FG001|Overall Study|Physician Decision|3|||
124527202|NCT01196091|447882362|FG002|Overall Study|Physician Decision|4|||
124527203|NCT01196091|447882360|FG000|Overall Study|Protocol Violation|1|||
124527204|NCT01196091|447882361|FG001|Overall Study|Protocol Violation|3|||
124527205|NCT01196091|447882362|FG002|Overall Study|Protocol Violation|3|||
124527206|NCT01196091|447882360|FG000|Overall Study|Sponsor Decision|6|||
124527207|NCT01196091|447882361|FG001|Overall Study|Sponsor Decision|5|||
124726586|NCT00327015|448620268|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
124726587|NCT00327015|448620269|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
124726588|NCT00327015|448620270|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
124726589|NCT00327015|448620267|FG000|Overall Study|Lost to Follow-up|22|||
124527208|NCT01196091|447882362|FG002|Overall Study|Sponsor Decision|4|||
124527209|NCT01196091|447882360|FG000|Overall Study|Excluded Site|5|||
124527210|NCT01196091|447882361|FG001|Overall Study|Excluded Site|11|||
124527211|NCT01196091|447882362|FG002|Overall Study|Excluded Site|8|||
124527212|NCT01196091|447882360|FG000|Overall Study|Randomized, No Study Drug Received|1|||
124527213|NCT01196091|447882361|FG001|Overall Study|Randomized, No Study Drug Received|0|||
124527214|NCT01196091|447882362|FG002|Overall Study|Randomized, No Study Drug Received|1|||
124527215|NCT03797144|447882363|FG000|Enrollment|Protocol Violation|4|||
124527216|NCT03797144|447882364|FG001|Enrollment|Protocol Violation|1|||
124726590|NCT00327015|448620268|FG001|Overall Study|Lost to Follow-up|23|||
124726591|NCT00327015|448620269|FG002|Overall Study|Lost to Follow-up|29|||
124726592|NCT00327015|448620270|FG003|Overall Study|Lost to Follow-up|22|||
124726593|NCT00327015|448620267|FG000|Overall Study|Adverse Event|14|||
124726594|NCT00327015|448620268|FG001|Overall Study|Adverse Event|10|||
124726595|NCT00327015|448620269|FG002|Overall Study|Adverse Event|14|||
124726596|NCT00327015|448620270|FG003|Overall Study|Adverse Event|14|||
124726597|NCT00327015|448620267|FG000|Overall Study|Subject no longer meets study criteria|4|||
124726598|NCT00327015|448620268|FG001|Overall Study|Subject no longer meets study criteria|2|||
124726599|NCT00327015|448620269|FG002|Overall Study|Subject no longer meets study criteria|8|||
124726600|NCT00327015|448620270|FG003|Overall Study|Subject no longer meets study criteria|7|||
124726601|NCT00327015|448620267|FG000|Overall Study|Poor/Noncompliance|11|||
124726602|NCT00327015|448620268|FG001|Overall Study|Poor/Noncompliance|8|||
124726603|NCT00327015|448620269|FG002|Overall Study|Poor/Noncompliance|4|||
124726604|NCT00327015|448620270|FG003|Overall Study|Poor/Noncompliance|5|||
124726605|NCT00327015|448620267|FG000|Overall Study|Physician Decision|0|||
124726606|NCT00327015|448620268|FG001|Overall Study|Physician Decision|1|||
124726607|NCT00327015|448620269|FG002|Overall Study|Physician Decision|3|||
124726608|NCT00327015|448620270|FG003|Overall Study|Physician Decision|2|||
124726609|NCT00327015|448620267|FG000|Overall Study|Death|1|||
124726610|NCT00327015|448620268|FG001|Overall Study|Death|2|||
124726611|NCT00327015|448620269|FG002|Overall Study|Death|2|||
124726612|NCT00327015|448620270|FG003|Overall Study|Death|3|||
124726613|NCT00327015|448620267|FG000|Overall Study|Pregnancy|0|||
124726614|NCT00327015|448620268|FG001|Overall Study|Pregnancy|2|||
124726615|NCT00327015|448620269|FG002|Overall Study|Pregnancy|1|||
124726616|NCT00327015|448620270|FG003|Overall Study|Pregnancy|1|||
124726617|NCT00327015|448620267|FG000|Overall Study|Administrative Reason by Sponsor|1|||
124726618|NCT00327015|448620268|FG001|Overall Study|Administrative Reason by Sponsor|2|||
124776820|NCT05006573|448810019|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
124776821|NCT05006573|448810020|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
124776822|NCT05006573|448810019|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
124776823|NCT05006573|448810020|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
124527217|NCT03797144|447882363|FG000|Surgery|Protocol Violation|1|||
124527218|NCT03797144|447882364|FG001|Surgery|Protocol Violation|0|||
124527219|NCT03797144|447882363|FG000|3 Month|Early termination cut-off date|2|||
124579924|NCT01667679|448082887|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
124579925|NCT01667679|448082886|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
124579926|NCT01667679|448082887|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
124579927|NCT01667679|448082886|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
124579928|NCT01667679|448082887|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
124579929|NCT01667679|448082886|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
124579930|NCT01667679|448082887|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
124579931|NCT01667679|448082886|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
124579932|NCT01667679|448082887|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
124579933|NCT01667679|448082886|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
124579934|NCT01667679|448082887|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
124527220|NCT03797144|447882364|FG001|3 Month|Early termination cut-off date|0|||
124527221|NCT03797144|447882363|FG000|12 Month|Early termination cut-off date|8|||
124527222|NCT03797144|447882364|FG001|12 Month|Early termination cut-off date|9|||
124527223|NCT03797144|447882363|FG000|24 Month|Early termination cut-off date|1|||
124527224|NCT03797144|447882364|FG001|24 Month|Early termination cut-off date|1|||
124527225|NCT03077711|447882365|FG000|Overall Study|Lost to Follow-up|2|||
124527226|NCT03077711|447882366|FG001|Overall Study|Lost to Follow-up|2|||
124527227|NCT03077711|447882365|FG000|Overall Study|noncompliant taking medication|2|||
124527228|NCT03077711|447882366|FG001|Overall Study|noncompliant taking medication|0|||
124527229|NCT00376675|447882367|FG000|Overall Study|Withdrawal by Subject|9|||
124527230|NCT00376675|447882368|FG001|Overall Study|Withdrawal by Subject|2|||
124527231|NCT00376675|447882367|FG000|Overall Study|Adverse Event|10|||
124527232|NCT00376675|447882368|FG001|Overall Study|Adverse Event|5|||
124527233|NCT00376675|447882367|FG000|Overall Study|Other Reason|1|||
124527234|NCT00376675|447882368|FG001|Overall Study|Other Reason|7|||
124579935|NCT01667679|448082886|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
124579936|NCT01667679|448082887|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
124579937|NCT01667679|448082886|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
124776824|NCT01967238|448810021|FG000|Overall Study|Adverse Event|1|||
124527235|NCT02943668|447882370|FG000|Overall Study|Disease Progression|1|||
124726619|NCT00327015|448620269|FG002|Overall Study|Administrative Reason by Sponsor|2|||
124726620|NCT00327015|448620270|FG003|Overall Study|Administrative Reason by Sponsor|1|||
124527236|NCT02201251|447882371|FG000|Overall Study|Adverse Event|1|||
124527237|NCT02201251|447882372|FG001|Overall Study|Adverse Event|1|||
124527238|NCT02201251|447882371|FG000|Overall Study|Protocol Violation|1|||
124726621|NCT01519791|448620271|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
124726622|NCT01519791|448620272|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
124726623|NCT01519791|448620271|FG000|Overall Study|Protocol Violation|6|||
124726624|NCT01519791|448620272|FG001|Overall Study|Protocol Violation|19|||
124726625|NCT01519791|448620271|FG000|Overall Study|Other Reason|87|||
124726626|NCT01519791|448620272|FG001|Overall Study|Other Reason|222|||
124726627|NCT01519791|448620271|FG000|Overall Study|subjects randomized in error|2|||
124726628|NCT01519791|448620272|FG001|Overall Study|subjects randomized in error|0|||
124726629|NCT01519791|448620271|FG000|Overall Study|Lack of Efficacy|16|||
124726630|NCT01519791|448620272|FG001|Overall Study|Lack of Efficacy|20|||
124726631|NCT01519791|448620271|FG000|Overall Study|SAE, non-fatal|6|||
124726632|NCT01519791|448620272|FG001|Overall Study|SAE, non-fatal|22|||
124726633|NCT01519791|448620271|FG000|Overall Study|AE, serious fatal|0|||
124726634|NCT01519791|448620272|FG001|Overall Study|AE, serious fatal|1|||
124726635|NCT01519791|448620271|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
124726636|NCT01519791|448620272|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
124726637|NCT01519791|448620271|FG000|Overall Study|AE, non-serious non-fatal|12|||
124726638|NCT01519791|448620272|FG001|Overall Study|AE, non-serious non-fatal|31|||
124726639|NCT01519791|448620271|FG000|Overall Study|Withdrawal by Subject|15|||
124726640|NCT01519791|448620272|FG001|Overall Study|Withdrawal by Subject|37|||
124726641|NCT01519791|448620271|FG000|Overall Study|Lost to Follow-up|6|||
124726642|NCT01519791|448620272|FG001|Overall Study|Lost to Follow-up|14|||
124726643|NCT00837265|448620273|FG000|Pilot Phase|Withdrawal by Subject|0|||
124726644|NCT00837265|448620274|FG001|Pilot Phase|Withdrawal by Subject|2|||
124726645|NCT00837265|448620275|FG002|Pilot Phase|Withdrawal by Subject|3|||
124726646|NCT00837265|448620276|FG003|Pilot Phase|Withdrawal by Subject|2|||
124726647|NCT00837265|448620277|FG004|Pilot Phase|Withdrawal by Subject|0|||
124726648|NCT00837265|448620278|FG005|Pilot Phase|Withdrawal by Subject|0|||
124726649|NCT00837265|448620279|FG006|Pilot Phase|Withdrawal by Subject|0|||
124726650|NCT00837265|448620273|FG000|Pilot Phase|Decision of the investigator|2|||
124726651|NCT00837265|448620274|FG001|Pilot Phase|Decision of the investigator|1|||
124726652|NCT00837265|448620275|FG002|Pilot Phase|Decision of the investigator|0|||
124726653|NCT00837265|448620276|FG003|Pilot Phase|Decision of the investigator|0|||
124726654|NCT00837265|448620277|FG004|Pilot Phase|Decision of the investigator|0|||
124726655|NCT00837265|448620278|FG005|Pilot Phase|Decision of the investigator|0|||
124726656|NCT00837265|448620279|FG006|Pilot Phase|Decision of the investigator|0|||
124726657|NCT00837265|448620273|FG000|Pilot Phase|Adverse Event|1|||
124726658|NCT00837265|448620274|FG001|Pilot Phase|Adverse Event|0|||
124726659|NCT00837265|448620275|FG002|Pilot Phase|Adverse Event|0|||
124726660|NCT00837265|448620276|FG003|Pilot Phase|Adverse Event|0|||
124726661|NCT00837265|448620277|FG004|Pilot Phase|Adverse Event|0|||
124726662|NCT00837265|448620278|FG005|Pilot Phase|Adverse Event|0|||
124726663|NCT00837265|448620279|FG006|Pilot Phase|Adverse Event|0|||
124726664|NCT00837265|448620273|FG000|Pilot Phase|Disease progression|0|||
124726665|NCT00837265|448620274|FG001|Pilot Phase|Disease progression|0|||
124726666|NCT00837265|448620275|FG002|Pilot Phase|Disease progression|0|||
124726667|NCT00837265|448620276|FG003|Pilot Phase|Disease progression|1|||
124726668|NCT00837265|448620277|FG004|Pilot Phase|Disease progression|0|||
124726669|NCT00837265|448620278|FG005|Pilot Phase|Disease progression|0|||
124726670|NCT00837265|448620279|FG006|Pilot Phase|Disease progression|0|||
124527239|NCT02201251|447882372|FG001|Overall Study|Protocol Violation|0|||
124527240|NCT02201251|447882371|FG000|Overall Study|Noncompliance with Study Drug|0|||
124527241|NCT02201251|447882372|FG001|Overall Study|Noncompliance with Study Drug|1|||
124527242|NCT02201251|447882371|FG000|Overall Study|Withdrawal by Subject|2|||
124527243|NCT02201251|447882372|FG001|Overall Study|Withdrawal by Subject|1|||
124527244|NCT01332851|447882373|FG000|Overall Study|Withdrawal by Subject|4|||
124527245|NCT01332851|447882374|FG001|Overall Study|Withdrawal by Subject|2|||
124527246|NCT01332851|447882373|FG000|Overall Study|Lost to Follow-up|7|||
124527247|NCT01332851|447882374|FG001|Overall Study|Lost to Follow-up|11|||
124527248|NCT01947894|447882376|FG000|Overall Study|Other|3|||
124527249|NCT01947894|447882377|FG001|Overall Study|Other|4|||
124527250|NCT01947894|447882378|FG002|Overall Study|Other|3|||
124726671|NCT00837265|448620273|FG000|Pilot Phase|Participant left the city|0|||
124726672|NCT00837265|448620274|FG001|Pilot Phase|Participant left the city|0|||
124726673|NCT00837265|448620275|FG002|Pilot Phase|Participant left the city|0|||
124726674|NCT00837265|448620276|FG003|Pilot Phase|Participant left the city|1|||
124726675|NCT00837265|448620277|FG004|Pilot Phase|Participant left the city|0|||
124726676|NCT00837265|448620278|FG005|Pilot Phase|Participant left the city|0|||
124726677|NCT00837265|448620279|FG006|Pilot Phase|Participant left the city|0|||
124726678|NCT00837265|448620273|FG000|Main Phase|Withdrawal by Subject|0|||
124726679|NCT00837265|448620274|FG001|Main Phase|Withdrawal by Subject|0|||
124527251|NCT01947894|447882376|FG000|Overall Study|Withdrawal by Subject|12|||
124527252|NCT01947894|447882377|FG001|Overall Study|Withdrawal by Subject|4|||
124527253|NCT01947894|447882378|FG002|Overall Study|Withdrawal by Subject|1|||
124527254|NCT01947894|447882376|FG000|Overall Study|Death|12|||
124527255|NCT01947894|447882377|FG001|Overall Study|Death|1|||
124726680|NCT00837265|448620275|FG002|Main Phase|Withdrawal by Subject|0|||
124726681|NCT00837265|448620276|FG003|Main Phase|Withdrawal by Subject|0|||
124726682|NCT00837265|448620277|FG004|Main Phase|Withdrawal by Subject|4|||
124726683|NCT00837265|448620278|FG005|Main Phase|Withdrawal by Subject|2|||
124726684|NCT00837265|448620279|FG006|Main Phase|Withdrawal by Subject|1|||
124579938|NCT01667679|448082887|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
124579939|NCT01667679|448082886|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
124579940|NCT01667679|448082887|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
124579941|NCT01667679|448082886|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
124527256|NCT01947894|447882378|FG002|Overall Study|Death|0|||
124527257|NCT01947894|447882376|FG000|Overall Study|Physician Decision|2|||
124527258|NCT01947894|447882377|FG001|Overall Study|Physician Decision|0|||
124527259|NCT01947894|447882378|FG002|Overall Study|Physician Decision|0|||
124527260|NCT01947894|447882376|FG000|Overall Study|Adverse Event|5|||
124527261|NCT01947894|447882377|FG001|Overall Study|Adverse Event|1|||
124527262|NCT01947894|447882378|FG002|Overall Study|Adverse Event|0|||
124527263|NCT01947894|447882376|FG000|Overall Study|Switched to other growth hormone brand|53|||
124527264|NCT01947894|447882377|FG001|Overall Study|Switched to other growth hormone brand|8|||
124527265|NCT01947894|447882378|FG002|Overall Study|Switched to other growth hormone brand|23|||
124527266|NCT00333970|447882379|FG000|Overall Study|Withdrawal by Subject|13|||
124527267|NCT00333970|447882380|FG001|Overall Study|Withdrawal by Subject|7|||
124527268|NCT01678560|447882386|FG000|Overall Study|Physician Decision|4|||
124527269|NCT01678560|447882387|FG001|Overall Study|Physician Decision|4|||
124527270|NCT01678560|447882386|FG000|Overall Study|Death|0|||
124527271|NCT01678560|447882387|FG001|Overall Study|Death|1|||
124527272|NCT01678560|447882386|FG000|Overall Study|Withdrawal by Subject|0|||
124527273|NCT01678560|447882387|FG001|Overall Study|Withdrawal by Subject|1|||
124527274|NCT00322387|447882391|FG000|Treatment Period|Adverse Event|0|||
124527275|NCT00322387|447882392|FG001|Treatment Period|Adverse Event|1|||
124527276|NCT00322387|447882391|FG000|Follow-up Period|Final assessment not done|1|||
124527277|NCT00322387|447882392|FG001|Follow-up Period|Final assessment not done|3|||
124579942|NCT01667679|448082887|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
124579943|NCT01667679|448082886|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
124579944|NCT01667679|448082887|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
124579945|NCT01667679|448082886|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
124579946|NCT01667679|448082887|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
124579947|NCT01667679|448082886|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
124579948|NCT01667679|448082887|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
124579949|NCT01667679|448082886|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
124579950|NCT01667679|448082887|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
124579951|NCT01667679|448082886|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
124579952|NCT01667679|448082887|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
124579953|NCT01667679|448082886|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
124579954|NCT01667679|448082887|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
124579955|NCT02159183|448082888|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
124579956|NCT02159183|448082889|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
124579957|NCT02159183|448082888|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
124579958|NCT02159183|448082889|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
124579959|NCT02159183|448082888|FG000|Analysis After the 36 Months Follow-up|Death|0|||
124579960|NCT02159183|448082889|FG001|Analysis After the 36 Months Follow-up|Death|1|||
124579961|NCT02159183|448082888|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
124579962|NCT02159183|448082889|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
124579963|NCT02159183|448082888|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
124579964|NCT02159183|448082889|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
124579965|NCT01294917|448082893|FG000|Overall Study|Relocation|5|||
124579966|NCT01294917|448082893|FG000|Overall Study|Inconvenience|1|||
124579967|NCT02519348|448082894|FG000|Overall Study|Death|31|||
124579968|NCT02519348|448082895|FG001|Overall Study|Death|74|||
124579969|NCT02519348|448082896|FG002|Overall Study|Death|47|||
124579970|NCT02519348|448082897|FG003|Overall Study|Death|54|||
124579971|NCT02519348|448082898|FG004|Overall Study|Death|63|||
124579972|NCT02519348|448082899|FG005|Overall Study|Death|18|||
124579973|NCT02519348|448082900|FG006|Overall Study|Death|2|||
124579974|NCT02519348|448082901|FG007|Overall Study|Death|5|||
124579975|NCT02519348|448082902|FG008|Overall Study|Death|5|||
124579976|NCT02519348|448082894|FG000|Overall Study|Withdrawal by Subject|4|||
124579977|NCT02519348|448082895|FG001|Overall Study|Withdrawal by Subject|7|||
124527278|NCT00322387|447882391|FG000|Follow-up Period|Death|1|||
124527279|NCT00322387|447882392|FG001|Follow-up Period|Death|0|||
124527280|NCT01828567|447882395|FG000|Overall Study|Lost to Follow-up|27|||
124527281|NCT01828567|447882396|FG001|Overall Study|Lost to Follow-up|9|||
124527282|NCT01828567|447882395|FG000|Overall Study|Excluded - did not meet criteria|4|||
124579978|NCT02519348|448082896|FG002|Overall Study|Withdrawal by Subject|4|||
124579979|NCT02519348|448082897|FG003|Overall Study|Withdrawal by Subject|3|||
124579980|NCT02519348|448082898|FG004|Overall Study|Withdrawal by Subject|3|||
124579981|NCT02519348|448082899|FG005|Overall Study|Withdrawal by Subject|2|||
124776825|NCT01967238|448810022|FG001|Overall Study|Adverse Event|1|||
124527283|NCT01828567|447882396|FG001|Overall Study|Excluded - did not meet criteria|1|||
124726685|NCT00837265|448620273|FG000|Main Phase|Decision of the investigator|0|||
124726686|NCT00837265|448620274|FG001|Main Phase|Decision of the investigator|0|||
124726687|NCT00837265|448620275|FG002|Main Phase|Decision of the investigator|0|||
124726688|NCT00837265|448620276|FG003|Main Phase|Decision of the investigator|0|||
124726689|NCT00837265|448620277|FG004|Main Phase|Decision of the investigator|0|||
124726690|NCT00837265|448620278|FG005|Main Phase|Decision of the investigator|2|||
124726691|NCT00837265|448620279|FG006|Main Phase|Decision of the investigator|1|||
124726692|NCT00837265|448620273|FG000|Main Phase|Adverse Event|0|||
124527284|NCT00090766|447882399|FG000|Overall Study|Nephrectomy Planned|0|||
124527285|NCT00090766|447882400|FG001|Overall Study|Nephrectomy Planned|0|||
124527286|NCT00090766|447882401|FG002|Overall Study|Nephrectomy Planned|1|||
124527287|NCT00090766|447882399|FG000|Overall Study|Death|1|||
124527288|NCT00090766|447882400|FG001|Overall Study|Death|0|||
124527289|NCT00090766|447882401|FG002|Overall Study|Death|0|||
124527290|NCT00090766|447882399|FG000|Overall Study|Admin|0|||
124527291|NCT00090766|447882400|FG001|Overall Study|Admin|2|||
124527292|NCT00090766|447882401|FG002|Overall Study|Admin|0|||
124527293|NCT00090766|447882399|FG000|Overall Study|Lost to Follow-up|2|||
124527294|NCT00090766|447882400|FG001|Overall Study|Lost to Follow-up|0|||
124527295|NCT00090766|447882401|FG002|Overall Study|Lost to Follow-up|2|||
124527296|NCT00707486|447882402|FG000|Overall Study|Withdrawal by Subject|1|||
124527297|NCT00654368|447882409|FG000|Overall Study|Ineligibility determined|6|||
124527298|NCT00654368|447882410|FG001|Overall Study|Ineligibility determined|0|||
124527299|NCT00654368|447882411|FG002|Overall Study|Ineligibility determined|0|||
124527300|NCT00654368|447882409|FG000|Overall Study|Protocol deviation|3|||
124527301|NCT00654368|447882410|FG001|Overall Study|Protocol deviation|2|||
124527302|NCT00654368|447882411|FG002|Overall Study|Protocol deviation|1|||
124527303|NCT00654368|447882409|FG000|Overall Study|Non-compliance|2|||
124527304|NCT00654368|447882410|FG001|Overall Study|Non-compliance|1|||
124527305|NCT00654368|447882411|FG002|Overall Study|Non-compliance|2|||
124527306|NCT00654368|447882409|FG000|Overall Study|Withdrawal by Subject|5|||
124527307|NCT00654368|447882410|FG001|Overall Study|Withdrawal by Subject|2|||
124527308|NCT00654368|447882411|FG002|Overall Study|Withdrawal by Subject|2|||
124527309|NCT00654368|447882409|FG000|Overall Study|Disease progression|21|||
124527310|NCT00654368|447882410|FG001|Overall Study|Disease progression|31|||
124527311|NCT00654368|447882411|FG002|Overall Study|Disease progression|13|||
124527312|NCT00654368|447882409|FG000|Overall Study|Requirement for alternative therapy|1|||
124527313|NCT00654368|447882410|FG001|Overall Study|Requirement for alternative therapy|1|||
124527314|NCT00654368|447882411|FG002|Overall Study|Requirement for alternative therapy|1|||
124527315|NCT00654368|447882409|FG000|Overall Study|Physician Decision|0|||
124527316|NCT00654368|447882410|FG001|Overall Study|Physician Decision|0|||
124527317|NCT00654368|447882411|FG002|Overall Study|Physician Decision|2|||
124527318|NCT00654368|447882409|FG000|Overall Study|Death|1|||
124527319|NCT00654368|447882410|FG001|Overall Study|Death|0|||
124527320|NCT00654368|447882411|FG002|Overall Study|Death|0|||
124527321|NCT00654368|447882409|FG000|Overall Study|Pregnancy|0|||
124527322|NCT00654368|447882410|FG001|Overall Study|Pregnancy|0|||
124527323|NCT00654368|447882411|FG002|Overall Study|Pregnancy|2|||
124527324|NCT00654368|447882409|FG000|Overall Study|Other|0|||
124527325|NCT00654368|447882410|FG001|Overall Study|Other|2|||
124527326|NCT00654368|447882411|FG002|Overall Study|Other|3|||
124527327|NCT00654368|447882409|FG000|Overall Study|Adverse Event|14|||
124527328|NCT00654368|447882410|FG001|Overall Study|Adverse Event|9|||
124527329|NCT00654368|447882411|FG002|Overall Study|Adverse Event|6|||
124527330|NCT00804986|447882412|FG000|Overall Study|Adverse Event|0|||
124527331|NCT00804986|447882413|FG001|Overall Study|Adverse Event|1|||
124527332|NCT00804986|447882414|FG002|Overall Study|Adverse Event|2|||
124527333|NCT00804986|447882415|FG003|Overall Study|Adverse Event|1|||
124527334|NCT00804986|447882416|FG004|Overall Study|Adverse Event|3|||
124527335|NCT00804986|447882417|FG005|Overall Study|Adverse Event|0|||
124527336|NCT00804986|447882412|FG000|Overall Study|Lack of Efficacy|0|||
124527337|NCT00804986|447882413|FG001|Overall Study|Lack of Efficacy|0|||
124527338|NCT00804986|447882414|FG002|Overall Study|Lack of Efficacy|0|||
124527339|NCT00804986|447882415|FG003|Overall Study|Lack of Efficacy|1|||
124527340|NCT00804986|447882416|FG004|Overall Study|Lack of Efficacy|0|||
124527341|NCT00804986|447882417|FG005|Overall Study|Lack of Efficacy|3|||
124527342|NCT00804986|447882412|FG000|Overall Study|Lost to Follow-up|0|||
124527343|NCT00804986|447882413|FG001|Overall Study|Lost to Follow-up|0|||
124527344|NCT00804986|447882414|FG002|Overall Study|Lost to Follow-up|0|||
124527345|NCT00804986|447882415|FG003|Overall Study|Lost to Follow-up|1|||
124527346|NCT00804986|447882416|FG004|Overall Study|Lost to Follow-up|1|||
124527347|NCT00804986|447882417|FG005|Overall Study|Lost to Follow-up|3|||
124527348|NCT00804986|447882412|FG000|Overall Study|Protocol Violation|0|||
124527349|NCT00804986|447882413|FG001|Overall Study|Protocol Violation|1|||
124527350|NCT00804986|447882414|FG002|Overall Study|Protocol Violation|0|||
124527351|NCT00804986|447882415|FG003|Overall Study|Protocol Violation|1|||
124527352|NCT00804986|447882416|FG004|Overall Study|Protocol Violation|0|||
124527353|NCT00804986|447882417|FG005|Overall Study|Protocol Violation|0|||
124527354|NCT00804986|447882412|FG000|Overall Study|Withdrawal by Subject|0|||
124726693|NCT00837265|448620274|FG001|Main Phase|Adverse Event|0|||
124726694|NCT00837265|448620275|FG002|Main Phase|Adverse Event|0|||
124726695|NCT00837265|448620276|FG003|Main Phase|Adverse Event|0|||
124726696|NCT00837265|448620277|FG004|Main Phase|Adverse Event|0|||
124726697|NCT00837265|448620278|FG005|Main Phase|Adverse Event|1|||
124726698|NCT00837265|448620279|FG006|Main Phase|Adverse Event|0|||
124726699|NCT00837265|448620273|FG000|Main Phase|Death|0|||
124726700|NCT00837265|448620274|FG001|Main Phase|Death|0|||
124726701|NCT00837265|448620275|FG002|Main Phase|Death|0|||
124726702|NCT00837265|448620276|FG003|Main Phase|Death|0|||
124726703|NCT00837265|448620277|FG004|Main Phase|Death|2|||
124726704|NCT00837265|448620278|FG005|Main Phase|Death|0|||
124726705|NCT00837265|448620279|FG006|Main Phase|Death|1|||
124726706|NCT00837265|448620273|FG000|Main Phase|Lost to Follow-up|0|||
124726707|NCT00837265|448620274|FG001|Main Phase|Lost to Follow-up|0|||
124776826|NCT01967238|448810023|FG002|Overall Study|Adverse Event|0|||
124527355|NCT00804986|447882413|FG001|Overall Study|Withdrawal by Subject|3|||
124527356|NCT00804986|447882414|FG002|Overall Study|Withdrawal by Subject|0|||
124527357|NCT00804986|447882415|FG003|Overall Study|Withdrawal by Subject|3|||
124527358|NCT00804986|447882416|FG004|Overall Study|Withdrawal by Subject|5|||
124527359|NCT00804986|447882417|FG005|Overall Study|Withdrawal by Subject|3|||
124527360|NCT00804986|447882412|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
124527361|NCT00804986|447882413|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
124527362|NCT00804986|447882414|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
124527363|NCT00804986|447882415|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
124527364|NCT00804986|447882416|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
124527365|NCT00804986|447882417|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
124527366|NCT00804986|447882412|FG000|Overall Study|Sponsor Decision|0|||
124527367|NCT00804986|447882413|FG001|Overall Study|Sponsor Decision|1|||
124527368|NCT00804986|447882414|FG002|Overall Study|Sponsor Decision|0|||
124527369|NCT00804986|447882415|FG003|Overall Study|Sponsor Decision|0|||
124527370|NCT00804986|447882416|FG004|Overall Study|Sponsor Decision|0|||
124527371|NCT00804986|447882417|FG005|Overall Study|Sponsor Decision|0|||
124527372|NCT00804986|447882412|FG000|Overall Study|Physician Decision|1|||
124527373|NCT00804986|447882413|FG001|Overall Study|Physician Decision|0|||
124527374|NCT00804986|447882414|FG002|Overall Study|Physician Decision|0|||
124527375|NCT00804986|447882415|FG003|Overall Study|Physician Decision|0|||
124527376|NCT00804986|447882416|FG004|Overall Study|Physician Decision|0|||
124527377|NCT00804986|447882417|FG005|Overall Study|Physician Decision|0|||
124527378|NCT00959699|447882418|FG000|Treatment Period|Adverse Event|3|||
124527379|NCT00959699|447882419|FG001|Treatment Period|Adverse Event|13|||
124527380|NCT00959699|447882418|FG000|Treatment Period|Lack of Efficacy|15|||
124527381|NCT00959699|447882419|FG001|Treatment Period|Lack of Efficacy|6|||
124527382|NCT00959699|447882418|FG000|Treatment Period|Lost to Follow-up|0|||
124527383|NCT00959699|447882419|FG001|Treatment Period|Lost to Follow-up|1|||
124527384|NCT00959699|447882418|FG000|Treatment Period|Withdrawal by Subject|1|||
124527385|NCT00959699|447882419|FG001|Treatment Period|Withdrawal by Subject|3|||
124527386|NCT00959699|447882418|FG000|Treatment Period|Non-Compliance with Protocol|0|||
124527387|NCT00959699|447882419|FG001|Treatment Period|Non-Compliance with Protocol|1|||
124527388|NCT00959699|447882418|FG000|Treatment Period|Did not receive treatment|0|||
124527389|NCT00959699|447882419|FG001|Treatment Period|Did not receive treatment|1|||
124527390|NCT00959699|447882418|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
124527391|NCT00959699|447882419|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
124527392|NCT00959699|447882418|FG000|Follow-up Period|Lost to Follow-up|3|||
124527393|NCT00959699|447882419|FG001|Follow-up Period|Lost to Follow-up|2|||
124527394|NCT00959699|447882418|FG000|Follow-up Period|Withdrawal by Subject|3|||
124527395|NCT00959699|447882419|FG001|Follow-up Period|Withdrawal by Subject|4|||
124527396|NCT00606294|447882420|FG000|Overall Study|Withdrawal by Subject|36|||
124527397|NCT00606294|447882421|FG001|Overall Study|Withdrawal by Subject|0|||
124527398|NCT03924427|447882426|FG000|Overall Study|Adverse Event|4|||
124527399|NCT03924427|447882426|FG000|Overall Study|Lack of Efficacy|1|||
124527400|NCT03924427|447882426|FG000|Overall Study|Withdrawal by Subject|1|||
124527401|NCT02774291|447882430|FG000|Overall Study|Lost to Follow-up|1|||
124527402|NCT00126425|447882431|FG000|Overall Study|Withdrawal by Subject|17|||
124527403|NCT00126425|447882432|FG001|Overall Study|Withdrawal by Subject|1|||
124527404|NCT00126425|447882431|FG000|Overall Study|Lost to Follow-up|8|||
124527405|NCT00126425|447882432|FG001|Overall Study|Lost to Follow-up|4|||
124527406|NCT00126425|447882431|FG000|Overall Study|Protocol Violation|9|||
124527407|NCT00126425|447882432|FG001|Overall Study|Protocol Violation|6|||
124527408|NCT00126425|447882431|FG000|Overall Study|Adverse Event|1|||
124527409|NCT00126425|447882432|FG001|Overall Study|Adverse Event|0|||
124527410|NCT00126425|447882431|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
124527411|NCT00126425|447882432|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
124527412|NCT00126425|447882431|FG000|Overall Study|Other|5|||
124527413|NCT00126425|447882432|FG001|Overall Study|Other|0|||
124527414|NCT00149890|447882433|FG000|Overall Study|Adverse Event|1|||
124726708|NCT00837265|448620275|FG002|Main Phase|Lost to Follow-up|0|||
124726709|NCT00837265|448620276|FG003|Main Phase|Lost to Follow-up|0|||
124726710|NCT00837265|448620277|FG004|Main Phase|Lost to Follow-up|1|||
124726711|NCT00837265|448620278|FG005|Main Phase|Lost to Follow-up|0|||
124726712|NCT00837265|448620279|FG006|Main Phase|Lost to Follow-up|0|||
124726713|NCT00837265|448620273|FG000|Main Phase|Principal investigator resignation|0|||
124726714|NCT00837265|448620274|FG001|Main Phase|Principal investigator resignation|0|||
124726715|NCT00837265|448620275|FG002|Main Phase|Principal investigator resignation|0|||
124726716|NCT00837265|448620276|FG003|Main Phase|Principal investigator resignation|0|||
124527415|NCT00149890|447882434|FG001|Overall Study|Adverse Event|8|||
124527416|NCT00149890|447882433|FG000|Overall Study|Lack of Efficacy|8|||
124527417|NCT00149890|447882434|FG001|Overall Study|Lack of Efficacy|9|||
124527418|NCT00149890|447882433|FG000|Overall Study|Protocol Violation|1|||
124527419|NCT00149890|447882434|FG001|Overall Study|Protocol Violation|0|||
124527420|NCT00149890|447882433|FG000|Overall Study|Lost to Follow-up|1|||
124527421|NCT00149890|447882434|FG001|Overall Study|Lost to Follow-up|0|||
124527422|NCT00149890|447882433|FG000|Overall Study|Graft Loss|2|||
124527423|NCT00149890|447882434|FG001|Overall Study|Graft Loss|1|||
124527424|NCT02332876|447882435|FG000|Overall Study|Lost to Follow-up|1|||
124527425|NCT02332876|447882436|FG001|Overall Study|Lost to Follow-up|1|||
124527426|NCT02415595|447882438|FG000|Overall Study|Administrative reason by sponsor|39|||
124527427|NCT02415595|447882439|FG001|Overall Study|Administrative reason by sponsor|40|||
124527428|NCT02415595|447882440|FG002|Overall Study|Administrative reason by sponsor|41|||
124527429|NCT02415595|447882441|FG003|Overall Study|Administrative reason by sponsor|39|||
124527430|NCT02415595|447882438|FG000|Overall Study|Adverse Event|1|||
124527431|NCT02415595|447882439|FG001|Overall Study|Adverse Event|3|||
124527432|NCT02415595|447882440|FG002|Overall Study|Adverse Event|5|||
124527433|NCT02415595|447882441|FG003|Overall Study|Adverse Event|10|||
124527434|NCT02415595|447882438|FG000|Overall Study|Lack of Efficacy|4|||
124527435|NCT02415595|447882439|FG001|Overall Study|Lack of Efficacy|4|||
124527436|NCT02415595|447882440|FG002|Overall Study|Lack of Efficacy|0|||
124527437|NCT02415595|447882441|FG003|Overall Study|Lack of Efficacy|0|||
124527438|NCT02415595|447882438|FG000|Overall Study|Lost to Follow-up|1|||
124527439|NCT02415595|447882439|FG001|Overall Study|Lost to Follow-up|3|||
124527440|NCT02415595|447882440|FG002|Overall Study|Lost to Follow-up|1|||
124527441|NCT02415595|447882441|FG003|Overall Study|Lost to Follow-up|1|||
124527442|NCT02415595|447882438|FG000|Overall Study|Poor/Non-compliance|1|||
124527443|NCT02415595|447882439|FG001|Overall Study|Poor/Non-compliance|0|||
124527444|NCT02415595|447882440|FG002|Overall Study|Poor/Non-compliance|1|||
124527445|NCT02415595|447882441|FG003|Overall Study|Poor/Non-compliance|0|||
124527446|NCT02415595|447882438|FG000|Overall Study|Reached stopping criteria|0|||
124527447|NCT02415595|447882439|FG001|Overall Study|Reached stopping criteria|1|||
124527448|NCT02415595|447882440|FG002|Overall Study|Reached stopping criteria|1|||
124527449|NCT02415595|447882441|FG003|Overall Study|Reached stopping criteria|0|||
124527450|NCT02415595|447882438|FG000|Overall Study|Withdrawal by Subject|4|||
124527451|NCT02415595|447882439|FG001|Overall Study|Withdrawal by Subject|0|||
124527452|NCT02415595|447882440|FG002|Overall Study|Withdrawal by Subject|1|||
124527453|NCT02415595|447882441|FG003|Overall Study|Withdrawal by Subject|3|||
124527454|NCT02415595|447882438|FG000|Overall Study|Other|0|||
124527455|NCT02415595|447882439|FG001|Overall Study|Other|1|||
124527456|NCT02415595|447882440|FG002|Overall Study|Other|1|||
124527457|NCT02415595|447882441|FG003|Overall Study|Other|0|||
124527458|NCT02614261|447882442|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
124527459|NCT02614261|447882443|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
124527460|NCT02614261|447882444|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
124527461|NCT02614261|447882445|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
124527462|NCT02614261|447882442|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
124527463|NCT02614261|447882443|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
124527464|NCT02614261|447882444|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
124527465|NCT02614261|447882445|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
124527466|NCT02614261|447882442|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
124527467|NCT02614261|447882443|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
124527468|NCT02614261|447882444|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
124527469|NCT02614261|447882445|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
124527470|NCT02614261|447882442|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
124527471|NCT02614261|447882443|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
124527472|NCT02614261|447882444|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
124527473|NCT02614261|447882445|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
124527474|NCT02614261|447882442|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
124527475|NCT02614261|447882443|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
124527476|NCT02614261|447882444|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
124527477|NCT02614261|447882445|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
124527478|NCT02614261|447882442|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
124726717|NCT00837265|448620277|FG004|Main Phase|Principal investigator resignation|2|||
124776827|NCT01967238|448810021|FG000|Overall Study|Lost to Follow-up|1|||
124527479|NCT02614261|447882443|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
124527480|NCT02614261|447882444|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
124527481|NCT02614261|447882445|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
124527482|NCT02614261|447882442|FG000|Double-Blind Treatment Phase|Screen failure|0|||
124527483|NCT02614261|447882443|FG001|Double-Blind Treatment Phase|Screen failure|1|||
124726718|NCT00837265|448620278|FG005|Main Phase|Principal investigator resignation|0|||
124726719|NCT00837265|448620279|FG006|Main Phase|Principal investigator resignation|0|||
124726720|NCT00837265|448620273|FG000|Main Phase|Participant's personal reason|0|||
124726721|NCT00837265|448620274|FG001|Main Phase|Participant's personal reason|0|||
124726722|NCT00837265|448620275|FG002|Main Phase|Participant's personal reason|0|||
124726723|NCT00837265|448620276|FG003|Main Phase|Participant's personal reason|0|||
124726724|NCT00837265|448620277|FG004|Main Phase|Participant's personal reason|1|||
124726725|NCT00837265|448620278|FG005|Main Phase|Participant's personal reason|0|||
124726726|NCT00837265|448620279|FG006|Main Phase|Participant's personal reason|0|||
124726727|NCT01289353|448620280|FG000|Overall Study|Lost to Follow-up|2|||
124726728|NCT02226562|448620281|FG000|Overall Study|Lost to Follow-up|0|||
124726729|NCT02226562|448620282|FG001|Overall Study|Lost to Follow-up|1|||
124726730|NCT01474772|448620284|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
124726731|NCT01474772|448620285|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
124726732|NCT01474772|448620284|FG000|Period 1|AE not Related to Study Drug|1|||
124726733|NCT01474772|448620285|FG001|Period 1|AE not Related to Study Drug|0|||
124726734|NCT01474772|448620284|FG000|Period 1|Withdrawal by Subject|3|||
124726735|NCT01474772|448620285|FG001|Period 1|Withdrawal by Subject|1|||
124726736|NCT01474772|448620284|FG000|Period 1|Lost to Follow-up|1|||
124726737|NCT01474772|448620285|FG001|Period 1|Lost to Follow-up|0|||
124726738|NCT01474772|448620284|FG000|Period 1|Reason not Specified|1|||
124726739|NCT01474772|448620285|FG001|Period 1|Reason not Specified|1|||
124726740|NCT01474772|448620284|FG000|Washout|AE not Related to Study Drug|2|||
124726741|NCT01474772|448620285|FG001|Washout|AE not Related to Study Drug|0|||
124726742|NCT01474772|448620284|FG000|Washout|Withdrawal by Subject|1|||
124726743|NCT01474772|448620285|FG001|Washout|Withdrawal by Subject|0|||
124726744|NCT01474772|448620284|FG000|Washout|Lost to Follow-up|0|||
124726745|NCT01474772|448620285|FG001|Washout|Lost to Follow-up|1|||
124726746|NCT01474772|448620284|FG000|Washout|Reason not Specified|0|||
124726747|NCT01474772|448620285|FG001|Washout|Reason not Specified|1|||
124726748|NCT01474772|448620284|FG000|Period 2|Death|0|||
124726749|NCT01474772|448620285|FG001|Period 2|Death|1|||
124726750|NCT01474772|448620284|FG000|Period 2|AE Related to Study Drug|0|||
124726751|NCT01474772|448620285|FG001|Period 2|AE Related to Study Drug|1|||
124726752|NCT01474772|448620284|FG000|Period 2|AE not Related to Study Drug|4|||
124726753|NCT01474772|448620285|FG001|Period 2|AE not Related to Study Drug|1|||
124726754|NCT01474772|448620284|FG000|Period 2|Lack of Efficacy|1|||
124726755|NCT01474772|448620285|FG001|Period 2|Lack of Efficacy|0|||
124527484|NCT02614261|447882444|FG002|Double-Blind Treatment Phase|Screen failure|2|||
124527485|NCT02614261|447882445|FG003|Double-Blind Treatment Phase|Screen failure|0|||
124527486|NCT02614261|447882442|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
124527487|NCT02614261|447882443|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
124527488|NCT02614261|447882444|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
124527489|NCT02614261|447882445|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
124527490|NCT02614261|447882442|FG000|Open-Label Extension Phase|Adverse Event|23|||
124527491|NCT02614261|447882443|FG001|Open-Label Extension Phase|Adverse Event|12|||
124527492|NCT02614261|447882444|FG002|Open-Label Extension Phase|Adverse Event|11|||
124527493|NCT02614261|447882445|FG003|Open-Label Extension Phase|Adverse Event|0|||
124527494|NCT02614261|447882442|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
124527495|NCT02614261|447882443|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
124527496|NCT02614261|447882444|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
124527497|NCT02614261|447882445|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
124527498|NCT02614261|447882442|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
124527499|NCT02614261|447882443|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
124527500|NCT02614261|447882444|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
124527501|NCT02614261|447882445|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
124527502|NCT02614261|447882442|FG000|Open-Label Extension Phase|Physician Decision|2|||
124527503|NCT02614261|447882443|FG001|Open-Label Extension Phase|Physician Decision|0|||
124527504|NCT02614261|447882444|FG002|Open-Label Extension Phase|Physician Decision|0|||
124527505|NCT02614261|447882445|FG003|Open-Label Extension Phase|Physician Decision|0|||
124527506|NCT02614261|447882442|FG000|Open-Label Extension Phase|Pregnancy|1|||
124527507|NCT02614261|447882443|FG001|Open-Label Extension Phase|Pregnancy|2|||
124527508|NCT02614261|447882444|FG002|Open-Label Extension Phase|Pregnancy|1|||
124527509|NCT02614261|447882445|FG003|Open-Label Extension Phase|Pregnancy|0|||
124527510|NCT02614261|447882442|FG000|Open-Label Extension Phase|Protocol Violation|3|||
124527511|NCT02614261|447882443|FG001|Open-Label Extension Phase|Protocol Violation|4|||
124527512|NCT02614261|447882444|FG002|Open-Label Extension Phase|Protocol Violation|1|||
124527513|NCT02614261|447882445|FG003|Open-Label Extension Phase|Protocol Violation|0|||
124527514|NCT02614261|447882442|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
124527515|NCT02614261|447882443|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
124527516|NCT02614261|447882444|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
124726756|NCT01474772|448620284|FG000|Period 2|Withdrawal by Subject|3|||
124726757|NCT01474772|448620285|FG001|Period 2|Withdrawal by Subject|4|||
124726758|NCT01474772|448620284|FG000|Period 2|Lost to Follow-up|1|||
124726759|NCT01474772|448620285|FG001|Period 2|Lost to Follow-up|1|||
124726760|NCT01474772|448620284|FG000|Period 2|Reason not Specified|0|||
124527517|NCT02614261|447882445|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
124527518|NCT02614261|447882442|FG000|Follow-up Phase|Adverse Event|2|||
124527519|NCT02614261|447882443|FG001|Follow-up Phase|Adverse Event|0|||
124527520|NCT02614261|447882444|FG002|Follow-up Phase|Adverse Event|1|||
124527521|NCT02614261|447882445|FG003|Follow-up Phase|Adverse Event|0|||
124527522|NCT02614261|447882442|FG000|Follow-up Phase|Lost to Follow-up|12|||
124527523|NCT02614261|447882443|FG001|Follow-up Phase|Lost to Follow-up|5|||
124527524|NCT02614261|447882444|FG002|Follow-up Phase|Lost to Follow-up|2|||
124527525|NCT02614261|447882445|FG003|Follow-up Phase|Lost to Follow-up|0|||
124527526|NCT02614261|447882442|FG000|Follow-up Phase|Physician Decision|5|||
124527527|NCT02614261|447882443|FG001|Follow-up Phase|Physician Decision|1|||
124527528|NCT02614261|447882444|FG002|Follow-up Phase|Physician Decision|0|||
124527529|NCT02614261|447882445|FG003|Follow-up Phase|Physician Decision|0|||
124527530|NCT02614261|447882442|FG000|Follow-up Phase|Pregnancy|0|||
124527531|NCT02614261|447882443|FG001|Follow-up Phase|Pregnancy|1|||
124527532|NCT02614261|447882444|FG002|Follow-up Phase|Pregnancy|0|||
124527533|NCT02614261|447882445|FG003|Follow-up Phase|Pregnancy|0|||
124527534|NCT02614261|447882442|FG000|Follow-up Phase|Protocol Violation|1|||
124527535|NCT02614261|447882443|FG001|Follow-up Phase|Protocol Violation|0|||
124527536|NCT02614261|447882444|FG002|Follow-up Phase|Protocol Violation|0|||
124527537|NCT02614261|447882445|FG003|Follow-up Phase|Protocol Violation|0|||
124527538|NCT02614261|447882442|FG000|Follow-up Phase|Withdrawal by Subject|12|||
124527539|NCT02614261|447882443|FG001|Follow-up Phase|Withdrawal by Subject|4|||
124527540|NCT02614261|447882444|FG002|Follow-up Phase|Withdrawal by Subject|11|||
124527541|NCT02614261|447882445|FG003|Follow-up Phase|Withdrawal by Subject|0|||
124527542|NCT02614261|447882442|FG000|Israel Addendum|Withdrawal by Subject|0|||
124527543|NCT02614261|447882443|FG001|Israel Addendum|Withdrawal by Subject|0|||
124527544|NCT02614261|447882444|FG002|Israel Addendum|Withdrawal by Subject|0|||
124527545|NCT02614261|447882445|FG003|Israel Addendum|Withdrawal by Subject|4|||
124527546|NCT00471315|447882446|FG000|Overall Study|Adverse Event|7|||
124527547|NCT00471315|447882446|FG000|Overall Study|Withdrawal by Subject|1|||
124527548|NCT02875366|447882455|FG000|Overall Study|Adverse Event|0|||
124527549|NCT02875366|447882456|FG001|Overall Study|Adverse Event|2|||
124527550|NCT02875366|447882455|FG000|Overall Study|Noncompliance|0|||
124527551|NCT02875366|447882456|FG001|Overall Study|Noncompliance|1|||
124527552|NCT02141854|447882459|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
124527553|NCT02141854|447882460|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124527554|NCT02141854|447882461|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124527555|NCT02141854|447882462|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124527556|NCT02141854|447882463|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124527557|NCT02141854|447882464|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124527558|NCT02141854|447882459|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
124527559|NCT02141854|447882460|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124527560|NCT02141854|447882461|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124527561|NCT02141854|447882462|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124527562|NCT02141854|447882463|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124527563|NCT02141854|447882464|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124527564|NCT02141854|447882459|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
124527565|NCT02141854|447882460|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124527566|NCT02141854|447882461|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124527567|NCT02141854|447882462|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124527568|NCT02141854|447882463|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124527569|NCT02141854|447882464|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124527570|NCT02141854|447882459|FG000|Run-In Period (Pre-assignment)|Other|14|||
124527571|NCT02141854|447882460|FG001|Run-In Period (Pre-assignment)|Other|0|||
124527572|NCT02141854|447882461|FG002|Run-In Period (Pre-assignment)|Other|0|||
124527573|NCT02141854|447882462|FG003|Run-In Period (Pre-assignment)|Other|0|||
124527574|NCT02141854|447882463|FG004|Run-In Period (Pre-assignment)|Other|0|||
124527575|NCT02141854|447882464|FG005|Run-In Period (Pre-assignment)|Other|0|||
124527576|NCT02141854|447882459|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
124527577|NCT02141854|447882460|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
124527578|NCT02141854|447882461|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
124527579|NCT02141854|447882462|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
124527580|NCT02141854|447882463|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
124527581|NCT02141854|447882464|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
124527582|NCT02141854|447882459|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
124527583|NCT02141854|447882460|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124527584|NCT02141854|447882461|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124527585|NCT02141854|447882462|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124527586|NCT02141854|447882463|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124527587|NCT02141854|447882464|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124527588|NCT02141854|447882459|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
124527589|NCT02141854|447882460|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124527590|NCT02141854|447882461|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124527591|NCT02141854|447882462|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124527592|NCT02141854|447882463|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124527593|NCT02141854|447882464|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124527594|NCT02141854|447882459|FG000|Treatment Period|Protocol Violation|0|||
124527595|NCT02141854|447882460|FG001|Treatment Period|Protocol Violation|1|||
124527596|NCT02141854|447882461|FG002|Treatment Period|Protocol Violation|0|||
124527597|NCT02141854|447882462|FG003|Treatment Period|Protocol Violation|2|||
124527598|NCT02141854|447882463|FG004|Treatment Period|Protocol Violation|2|||
124527599|NCT02141854|447882464|FG005|Treatment Period|Protocol Violation|1|||
124527600|NCT02141854|447882459|FG000|Treatment Period|Noncompliance|0|||
124527601|NCT02141854|447882460|FG001|Treatment Period|Noncompliance|0|||
124527602|NCT02141854|447882461|FG002|Treatment Period|Noncompliance|0|||
124527603|NCT02141854|447882462|FG003|Treatment Period|Noncompliance|1|||
124527604|NCT02141854|447882463|FG004|Treatment Period|Noncompliance|0|||
124527605|NCT02141854|447882464|FG005|Treatment Period|Noncompliance|0|||
124527606|NCT02141854|447882459|FG000|Treatment Period|Lack of Efficacy|0|||
124527607|NCT02141854|447882460|FG001|Treatment Period|Lack of Efficacy|0|||
124527608|NCT02141854|447882461|FG002|Treatment Period|Lack of Efficacy|0|||
124527609|NCT02141854|447882462|FG003|Treatment Period|Lack of Efficacy|1|||
124527610|NCT02141854|447882463|FG004|Treatment Period|Lack of Efficacy|1|||
124527611|NCT02141854|447882464|FG005|Treatment Period|Lack of Efficacy|7|||
124527612|NCT02141854|447882459|FG000|Treatment Period|Pregnancy|0|||
124527613|NCT02141854|447882460|FG001|Treatment Period|Pregnancy|1|||
124527614|NCT02141854|447882461|FG002|Treatment Period|Pregnancy|0|||
124527615|NCT02141854|447882462|FG003|Treatment Period|Pregnancy|0|||
124527616|NCT02141854|447882463|FG004|Treatment Period|Pregnancy|0|||
124527617|NCT02141854|447882464|FG005|Treatment Period|Pregnancy|0|||
124527618|NCT02141854|447882459|FG000|Treatment Period|Other|0|||
124527619|NCT02141854|447882460|FG001|Treatment Period|Other|1|||
124527620|NCT02141854|447882461|FG002|Treatment Period|Other|2|||
124527621|NCT02141854|447882462|FG003|Treatment Period|Other|0|||
124527622|NCT02141854|447882463|FG004|Treatment Period|Other|1|||
124527623|NCT02141854|447882464|FG005|Treatment Period|Other|2|||
124527624|NCT02141854|447882459|FG000|Treatment Period|Adverse Event|0|||
124527625|NCT02141854|447882460|FG001|Treatment Period|Adverse Event|2|||
124527626|NCT02141854|447882461|FG002|Treatment Period|Adverse Event|2|||
124527627|NCT02141854|447882462|FG003|Treatment Period|Adverse Event|0|||
124527628|NCT02141854|447882463|FG004|Treatment Period|Adverse Event|2|||
124527629|NCT02141854|447882464|FG005|Treatment Period|Adverse Event|2|||
124527630|NCT02141854|447882459|FG000|Treatment Period|Withdrawal by Subject|0|||
124527631|NCT02141854|447882460|FG001|Treatment Period|Withdrawal by Subject|2|||
124527632|NCT02141854|447882461|FG002|Treatment Period|Withdrawal by Subject|3|||
124527633|NCT02141854|447882462|FG003|Treatment Period|Withdrawal by Subject|3|||
124527634|NCT02141854|447882463|FG004|Treatment Period|Withdrawal by Subject|4|||
124527635|NCT02141854|447882464|FG005|Treatment Period|Withdrawal by Subject|7|||
124527636|NCT02141854|447882459|FG000|Treatment Period|Disease progression|0|||
124527637|NCT02141854|447882460|FG001|Treatment Period|Disease progression|2|||
124527638|NCT02141854|447882461|FG002|Treatment Period|Disease progression|1|||
124527639|NCT02141854|447882462|FG003|Treatment Period|Disease progression|3|||
124527640|NCT02141854|447882463|FG004|Treatment Period|Disease progression|0|||
124527641|NCT02141854|447882464|FG005|Treatment Period|Disease progression|18|||
124527642|NCT02141854|447882459|FG000|Treatment Period|Lost to Follow-up|0|||
124527643|NCT02141854|447882460|FG001|Treatment Period|Lost to Follow-up|1|||
124527644|NCT02141854|447882461|FG002|Treatment Period|Lost to Follow-up|1|||
124527645|NCT02141854|447882462|FG003|Treatment Period|Lost to Follow-up|1|||
124527646|NCT02141854|447882463|FG004|Treatment Period|Lost to Follow-up|0|||
124527647|NCT02141854|447882464|FG005|Treatment Period|Lost to Follow-up|1|||
124527648|NCT02659098|447882465|FG000|Overall Study|Withdrawal by Subject|7|||
124527649|NCT04363944|447882466|FG000|Overall Study|Withdrawal by Subject|2|||
124527650|NCT04363944|447882467|FG001|Overall Study|Withdrawal by Subject|0|||
124527651|NCT00766142|447884113|FG000|Overall Study|Protocol Violation|4|||
124579982|NCT02519348|448082900|FG006|Overall Study|Withdrawal by Subject|0|||
124579983|NCT02519348|448082901|FG007|Overall Study|Withdrawal by Subject|0|||
124579984|NCT02519348|448082902|FG008|Overall Study|Withdrawal by Subject|1|||
124527652|NCT03793010|447884120|FG000|Overall Study|Withdrawal by Subject|5|||
124527653|NCT03793010|447884121|FG001|Overall Study|Withdrawal by Subject|7|||
124527654|NCT03793010|447884120|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
124527655|NCT03793010|447884121|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
124527656|NCT03793010|447884120|FG000|Overall Study|Lost to Follow-up|1|||
124527657|NCT03793010|447884121|FG001|Overall Study|Lost to Follow-up|2|||
124527658|NCT03793010|447884120|FG000|Overall Study|Patient couldn't sit still for injection|1|||
124579985|NCT02519348|448082894|FG000|Overall Study|Lost to Follow-up|0|||
124527659|NCT03793010|447884121|FG001|Overall Study|Patient couldn't sit still for injection|0|||
124527660|NCT03793010|447884120|FG000|Overall Study|Withdrew to pursue other treatment|1|||
124527661|NCT03793010|447884121|FG001|Overall Study|Withdrew to pursue other treatment|0|||
124579986|NCT02519348|448082895|FG001|Overall Study|Lost to Follow-up|0|||
124579987|NCT02519348|448082896|FG002|Overall Study|Lost to Follow-up|1|||
124579988|NCT02519348|448082897|FG003|Overall Study|Lost to Follow-up|0|||
124579989|NCT02519348|448082898|FG004|Overall Study|Lost to Follow-up|2|||
124579990|NCT02519348|448082899|FG005|Overall Study|Lost to Follow-up|1|||
124579991|NCT02519348|448082900|FG006|Overall Study|Lost to Follow-up|1|||
124579992|NCT02519348|448082901|FG007|Overall Study|Lost to Follow-up|0|||
124579993|NCT02519348|448082902|FG008|Overall Study|Lost to Follow-up|0|||
124579994|NCT02519348|448082894|FG000|Overall Study|Other|0|||
124579995|NCT02519348|448082895|FG001|Overall Study|Other|3|||
124579996|NCT02519348|448082896|FG002|Overall Study|Other|0|||
124579997|NCT02519348|448082897|FG003|Overall Study|Other|0|||
124579998|NCT02519348|448082898|FG004|Overall Study|Other|1|||
124579999|NCT02519348|448082899|FG005|Overall Study|Other|0|||
124580000|NCT02519348|448082900|FG006|Overall Study|Other|0|||
124580001|NCT02519348|448082901|FG007|Overall Study|Other|0|||
124580002|NCT02519348|448082902|FG008|Overall Study|Other|0|||
124580003|NCT02519348|448082894|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
124580004|NCT02519348|448082895|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
124580005|NCT02519348|448082896|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
124580006|NCT02519348|448082897|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
124580007|NCT02519348|448082898|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
124580008|NCT02519348|448082899|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
124580009|NCT02519348|448082900|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
124580010|NCT02519348|448082901|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
124580011|NCT02519348|448082902|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
124580012|NCT01444378|448082903|FG000|Overall Study|Lost to Follow-up|1|||
124580013|NCT01444378|448082903|FG000|Overall Study|Withdrawal by Subject|1|||
124580014|NCT01444378|448082903|FG000|Overall Study|Death|3|||
124580015|NCT01444378|448082903|FG000|Overall Study|Administrative Closure Of The Study|2|||
124580016|NCT01444378|448082903|FG000|Overall Study|Missed Visits|10|||
124580017|NCT02911792|448082904|FG000|Overall Study|Lost to Follow-up|3|||
124580018|NCT02911792|448082905|FG001|Overall Study|Lost to Follow-up|3|||
124580019|NCT02911792|448082906|FG002|Overall Study|Lost to Follow-up|3|||
124580020|NCT02911792|448082907|FG003|Overall Study|Lost to Follow-up|3|||
124580021|NCT01244620|448082908|FG000|Overall Study|Study terminated|4|||
124580022|NCT01244620|448082909|FG001|Overall Study|Study terminated|4|||
124580023|NCT01244620|448082910|FG002|Overall Study|Study terminated|4|||
124580024|NCT01244620|448082911|FG003|Overall Study|Study terminated|4|||
124580025|NCT02321098|448082913|FG000|12 Weeks Treament|Lost to Follow-up|1|||
124580026|NCT02321098|448082914|FG001|12 Weeks Treament|Lost to Follow-up|1|||
124580027|NCT02321098|448082915|FG002|12 Weeks Treament|Lost to Follow-up|0|||
124580028|NCT02321098|448082913|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
124580029|NCT02321098|448082914|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
124580030|NCT02321098|448082915|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
124580031|NCT02321098|448082913|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
124580032|NCT02321098|448082914|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
124580033|NCT02321098|448082915|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
124580034|NCT02321098|448082913|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
124580035|NCT02321098|448082914|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
124580036|NCT02321098|448082915|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
124580037|NCT01663233|448082916|FG000|Overall Study|Withdrawal by Subject|3|||
124580038|NCT01663233|448082917|FG001|Overall Study|Withdrawal by Subject|2|||
124580039|NCT01663233|448082916|FG000|Overall Study|Protocol Deviation|1|||
124580040|NCT01663233|448082917|FG001|Overall Study|Protocol Deviation|4|||
124580041|NCT01663233|448082916|FG000|Overall Study|Lost to Follow-up|0|||
124580042|NCT01663233|448082917|FG001|Overall Study|Lost to Follow-up|1|||
124580043|NCT05630885|448082918|FG000|Study Completion|Took prohibited medications|2|||
124580044|NCT05630885|448082919|FG001|Study Completion|Took prohibited medications|0|||
124580045|NCT05630885|448082918|FG000|Study Completion|Non-compliance with study drug|1|||
124580046|NCT05630885|448082919|FG001|Study Completion|Non-compliance with study drug|0|||
124580047|NCT05630885|448082918|FG000|Study Completion|Adverse Event|1|||
124776828|NCT01967238|448810022|FG001|Overall Study|Lost to Follow-up|0|||
124580048|NCT05630885|448082919|FG001|Study Completion|Adverse Event|0|||
124580049|NCT05630885|448082918|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
124580050|NCT05630885|448082919|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
124580051|NCT05630885|448082918|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
124580052|NCT05630885|448082919|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
124580053|NCT01370733|448082920|FG000|Overall Study|Withdrawal by Subject|8|||
124580054|NCT01370733|448082921|FG001|Overall Study|Withdrawal by Subject|8|||
124580055|NCT01370733|448082920|FG000|Overall Study|Lost to Follow-up|3|||
124580056|NCT01370733|448082921|FG001|Overall Study|Lost to Follow-up|0|||
124580057|NCT01370733|448082920|FG000|Overall Study|Adverse Event|2|||
124580058|NCT01370733|448082921|FG001|Overall Study|Adverse Event|4|||
124580059|NCT01370733|448082920|FG000|Overall Study|Lack of Efficacy|3|||
124580060|NCT01370733|448082921|FG001|Overall Study|Lack of Efficacy|5|||
124580061|NCT01370733|448082920|FG000|Overall Study|Physician Decision|0|||
124580062|NCT01370733|448082921|FG001|Overall Study|Physician Decision|2|||
124580063|NCT01370733|448082920|FG000|Overall Study|Protocol Violation|1|||
124580064|NCT01370733|448082921|FG001|Overall Study|Protocol Violation|3|||
124580065|NCT06539676|448082922|FG000|Overall Study|Early study termination|1|||
124580066|NCT06539676|448082923|FG001|Overall Study|Early study termination|0|||
124580067|NCT06539676|448082924|FG002|Overall Study|Early study termination|6|||
124580068|NCT02645409|448082925|FG000|Overall Study|Withdrawal by Subject|3|||
124580069|NCT02645409|448082926|FG001|Overall Study|Withdrawal by Subject|0|||
124580070|NCT02645409|448082925|FG000|Overall Study|Physician Decision|1|||
124580071|NCT02645409|448082926|FG001|Overall Study|Physician Decision|0|||
124580072|NCT03419403|448082927|FG000|Overall Study|Withdrawal by Subject|5|||
124580073|NCT03419403|448082928|FG001|Overall Study|Withdrawal by Subject|2|||
124580074|NCT03419403|448082929|FG002|Overall Study|Withdrawal by Subject|5|||
124580075|NCT03419403|448082930|FG003|Overall Study|Withdrawal by Subject|1|||
124580076|NCT03419403|448082927|FG000|Overall Study|Progressive disease (per protocol)|0|||
124580077|NCT03419403|448082928|FG001|Overall Study|Progressive disease (per protocol)|2|||
124580078|NCT03419403|448082929|FG002|Overall Study|Progressive disease (per protocol)|2|||
124580079|NCT03419403|448082930|FG003|Overall Study|Progressive disease (per protocol)|0|||
124580080|NCT03419403|448082927|FG000|Overall Study|Other, not specified|6|||
124580081|NCT03419403|448082928|FG001|Overall Study|Other, not specified|4|||
124580082|NCT03419403|448082929|FG002|Overall Study|Other, not specified|5|||
124580083|NCT03419403|448082930|FG003|Overall Study|Other, not specified|1|||
124580084|NCT03419403|448082927|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
124580085|NCT03419403|448082928|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
124580086|NCT03419403|448082929|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
124580087|NCT03419403|448082930|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
124580088|NCT02089685|448082935|FG000|Overall Study|Adverse Event|1|||
124580089|NCT02089685|448082936|FG001|Overall Study|Adverse Event|0|||
124580090|NCT02089685|448082937|FG002|Overall Study|Adverse Event|0|||
124580091|NCT02089685|448082938|FG003|Overall Study|Adverse Event|0|||
124580092|NCT02089685|448082939|FG004|Overall Study|Adverse Event|1|||
124580093|NCT02089685|448082940|FG005|Overall Study|Adverse Event|0|||
124580094|NCT02089685|448082935|FG000|Overall Study|Clinical Progression|4|||
124580095|NCT02089685|448082936|FG001|Overall Study|Clinical Progression|0|||
124580096|NCT02089685|448082937|FG002|Overall Study|Clinical Progression|0|||
124580097|NCT02089685|448082938|FG003|Overall Study|Clinical Progression|5|||
124580098|NCT02089685|448082939|FG004|Overall Study|Clinical Progression|1|||
124580099|NCT02089685|448082940|FG005|Overall Study|Clinical Progression|2|||
124580100|NCT02089685|448082935|FG000|Overall Study|Excluded Medication|1|||
124580101|NCT02089685|448082936|FG001|Overall Study|Excluded Medication|0|||
124580102|NCT02089685|448082937|FG002|Overall Study|Excluded Medication|0|||
124580103|NCT02089685|448082938|FG003|Overall Study|Excluded Medication|11|||
124580104|NCT02089685|448082939|FG004|Overall Study|Excluded Medication|2|||
124580105|NCT02089685|448082940|FG005|Overall Study|Excluded Medication|1|||
124580106|NCT02089685|448082935|FG000|Overall Study|Progressive disease|13|||
124580107|NCT02089685|448082936|FG001|Overall Study|Progressive disease|10|||
124580108|NCT02089685|448082937|FG002|Overall Study|Progressive disease|3|||
124580109|NCT02089685|448082938|FG003|Overall Study|Progressive disease|51|||
124580110|NCT02089685|448082939|FG004|Overall Study|Progressive disease|17|||
124580111|NCT02089685|448082940|FG005|Overall Study|Progressive disease|12|||
124580112|NCT02089685|448082935|FG000|Overall Study|Follow up ended by sponsor|2|||
124580113|NCT02089685|448082936|FG001|Overall Study|Follow up ended by sponsor|2|||
124580114|NCT02089685|448082937|FG002|Overall Study|Follow up ended by sponsor|0|||
124580115|NCT02089685|448082938|FG003|Overall Study|Follow up ended by sponsor|70|||
124580116|NCT02089685|448082939|FG004|Overall Study|Follow up ended by sponsor|26|||
124580117|NCT02089685|448082940|FG005|Overall Study|Follow up ended by sponsor|26|||
124580118|NCT02089685|448082935|FG000|Overall Study|Withdrawal by Subject|0|||
124580119|NCT02089685|448082936|FG001|Overall Study|Withdrawal by Subject|2|||
124580120|NCT02089685|448082937|FG002|Overall Study|Withdrawal by Subject|0|||
124580121|NCT02089685|448082938|FG003|Overall Study|Withdrawal by Subject|8|||
124580122|NCT02089685|448082939|FG004|Overall Study|Withdrawal by Subject|1|||
124580123|NCT02089685|448082940|FG005|Overall Study|Withdrawal by Subject|1|||
124580124|NCT02089685|448082935|FG000|Overall Study|Status not recorded|1|||
124580125|NCT02089685|448082936|FG001|Overall Study|Status not recorded|0|||
124580126|NCT02089685|448082937|FG002|Overall Study|Status not recorded|0|||
124580127|NCT02089685|448082938|FG003|Overall Study|Status not recorded|0|||
124580128|NCT02089685|448082939|FG004|Overall Study|Status not recorded|1|||
124580129|NCT02089685|448082940|FG005|Overall Study|Status not recorded|0|||
124580130|NCT02089685|448082935|FG000|Overall Study|Death|0|||
124580131|NCT02089685|448082936|FG001|Overall Study|Death|0|||
124580132|NCT02089685|448082937|FG002|Overall Study|Death|0|||
124580133|NCT02089685|448082938|FG003|Overall Study|Death|7|||
124580134|NCT02089685|448082939|FG004|Overall Study|Death|2|||
124580135|NCT02089685|448082940|FG005|Overall Study|Death|5|||
124580136|NCT02089685|448082935|FG000|Overall Study|Lost to Follow-up|0|||
124580137|NCT02089685|448082936|FG001|Overall Study|Lost to Follow-up|0|||
124527662|NCT03793010|447884120|FG000|Overall Study|Did not meet eligibility criteria|1|||
124527663|NCT03793010|447884121|FG001|Overall Study|Did not meet eligibility criteria|0|||
124527664|NCT05016037|447884122|FG000|Overall Study|Lost to Follow-up|2|||
124527665|NCT00129376|447884127|FG000|Overall Study|Adverse Event|1|||
124527666|NCT00129376|447884127|FG000|Overall Study|Lack of Efficacy|1|||
124527667|NCT03218826|447884129|FG000|Overall Study|Non-compliance with protocol|1|||
124527668|NCT03218826|447884130|FG001|Overall Study|Non-compliance with protocol|0|||
124527669|NCT03218826|447884131|FG002|Overall Study|Non-compliance with protocol|2|||
124527670|NCT03218826|447884132|FG003|Overall Study|Non-compliance with protocol|1|||
124527671|NCT03218826|447884133|FG004|Overall Study|Non-compliance with protocol|1|||
124527672|NCT01426009|447884134|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
124527673|NCT01426009|447884134|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
124580138|NCT02089685|448082937|FG002|Overall Study|Lost to Follow-up|0|||
124580139|NCT02089685|448082938|FG003|Overall Study|Lost to Follow-up|1|||
124580140|NCT02089685|448082939|FG004|Overall Study|Lost to Follow-up|0|||
124580141|NCT02089685|448082940|FG005|Overall Study|Lost to Follow-up|0|||
124580142|NCT02089685|448082935|FG000|Overall Study|Physician Decision|0|||
124580143|NCT02089685|448082936|FG001|Overall Study|Physician Decision|0|||
124580144|NCT02089685|448082937|FG002|Overall Study|Physician Decision|0|||
124580145|NCT02089685|448082938|FG003|Overall Study|Physician Decision|0|||
124580146|NCT02089685|448082939|FG004|Overall Study|Physician Decision|0|||
124580147|NCT02089685|448082940|FG005|Overall Study|Physician Decision|4|||
124580148|NCT02089685|448082935|FG000|Overall Study|Screen failure|1|||
124580149|NCT02089685|448082936|FG001|Overall Study|Screen failure|0|||
124527674|NCT01426009|447884134|FG000|Washout 1|Withdrawal by Subject|1|||
124527675|NCT01426009|447884134|FG000|Washout 1|Personal Reasons|1|||
124527676|NCT01426009|447884134|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
124527677|NCT01426009|447884134|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
124527678|NCT01426009|447884134|FG000|Washout 2|electrive surgery|1|||
124527679|NCT01426009|447884134|FG000|Washout 3|personal reasons|1|||
124527680|NCT01426009|447884134|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
124527681|NCT01426009|447884134|FG000|Washout 4|Lost to Follow-up|1|||
124527682|NCT00796549|447884144|FG000|Overall Study|Adverse Event|11|||
124527683|NCT00796549|447884144|FG000|Overall Study|not entered|149|||
124527684|NCT00796549|447884144|FG000|Overall Study|Other|2|||
124527685|NCT00796549|447884144|FG000|Overall Study|Progressive disease|56|||
124527686|NCT01878175|447884146|FG000|Overall Study|Developed contraindicated health problem|2|||
124527687|NCT03083470|447884147|FG000|Overall Study|Lost to Follow-up|0|||
124580150|NCT02089685|448082937|FG002|Overall Study|Screen failure|0|||
124580151|NCT02089685|448082938|FG003|Overall Study|Screen failure|0|||
124580152|NCT02089685|448082939|FG004|Overall Study|Screen failure|0|||
124580153|NCT02089685|448082940|FG005|Overall Study|Screen failure|0|||
124580154|NCT00318461|448082941|FG000|Double-Blind, 6 Months|Adverse Event|11|||
124580155|NCT00318461|448082942|FG001|Double-Blind, 6 Months|Adverse Event|23|||
124580156|NCT00318461|448082943|FG002|Double-Blind, 6 Months|Adverse Event|29|||
124580157|NCT00318461|448082944|FG003|Double-Blind, 6 Months|Adverse Event|2|||
124580158|NCT00318461|448082945|FG004|Double-Blind, 6 Months|Adverse Event|8|||
124580159|NCT00318461|448082941|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
124580160|NCT00318461|448082942|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
124580161|NCT00318461|448082943|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
124580162|NCT00318461|448082944|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
124580163|NCT00318461|448082945|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
124580164|NCT00318461|448082941|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
124580165|NCT00318461|448082942|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
124580166|NCT00318461|448082943|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
124580167|NCT00318461|448082944|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
124580168|NCT00318461|448082945|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
124580169|NCT00318461|448082941|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
124580170|NCT00318461|448082942|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
124580171|NCT00318461|448082943|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
124580172|NCT00318461|448082944|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
124527688|NCT03083470|447884148|FG001|Overall Study|Lost to Follow-up|0|||
124580173|NCT00318461|448082945|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
124580174|NCT00318461|448082941|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
124580175|NCT00318461|448082942|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
124580176|NCT00318461|448082943|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
124726761|NCT01474772|448620285|FG001|Period 2|Reason not Specified|2|||
124726762|NCT01474772|448620284|FG000|Follow-up|AE not Related to Study Drug|0|||
124527689|NCT03083470|447884149|FG002|Overall Study|Lost to Follow-up|0|||
124527690|NCT03083470|447884150|FG003|Overall Study|Lost to Follow-up|0|||
124527691|NCT03083470|447884151|FG004|Overall Study|Lost to Follow-up|1|||
124527692|NCT03083470|447884147|FG000|Overall Study|Withdrawal by Subject|0|||
124527693|NCT03083470|447884148|FG001|Overall Study|Withdrawal by Subject|0|||
124726763|NCT01474772|448620285|FG001|Follow-up|AE not Related to Study Drug|1|||
124726764|NCT00223808|448620286|FG000|Overall Study|<5 hrs therapy before discharge|3|||
124726765|NCT00223808|448620287|FG001|Overall Study|<5 hrs therapy before discharge|5|||
124580177|NCT00318461|448082944|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
124580178|NCT00318461|448082945|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
124580179|NCT00318461|448082941|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
124580180|NCT00318461|448082942|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
124580181|NCT00318461|448082943|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
124580182|NCT00318461|448082944|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
124580183|NCT00318461|448082945|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
124580184|NCT00318461|448082941|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
124580185|NCT00318461|448082942|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
124580186|NCT00318461|448082943|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
124580187|NCT00318461|448082944|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
124580188|NCT00318461|448082945|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
124580189|NCT00318461|448082941|FG000|Double-Blind, 6 Months|Move|0|||
124580190|NCT00318461|448082942|FG001|Double-Blind, 6 Months|Move|1|||
124580191|NCT00318461|448082943|FG002|Double-Blind, 6 Months|Move|0|||
124580192|NCT00318461|448082944|FG003|Double-Blind, 6 Months|Move|0|||
124580193|NCT00318461|448082945|FG004|Double-Blind, 6 Months|Move|0|||
124580194|NCT00318461|448082941|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
124580195|NCT00318461|448082942|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
124580196|NCT00318461|448082943|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
124580197|NCT00318461|448082944|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
124580198|NCT00318461|448082945|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
124580199|NCT00318461|448082941|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
124580200|NCT00318461|448082942|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
124580201|NCT00318461|448082943|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
124580202|NCT00318461|448082944|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
124580203|NCT00318461|448082945|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
124580204|NCT00318461|448082941|FG000|Double-Blind, 6 Months|Work commitment|0|||
124580205|NCT00318461|448082942|FG001|Double-Blind, 6 Months|Work commitment|0|||
124580206|NCT00318461|448082943|FG002|Double-Blind, 6 Months|Work commitment|0|||
124580207|NCT00318461|448082944|FG003|Double-Blind, 6 Months|Work commitment|0|||
124580208|NCT00318461|448082945|FG004|Double-Blind, 6 Months|Work commitment|1|||
124580209|NCT00318461|448082941|FG000|Double-Blind, 6 Months|Investigator decision|0|||
124580210|NCT00318461|448082942|FG001|Double-Blind, 6 Months|Investigator decision|0|||
124580211|NCT00318461|448082943|FG002|Double-Blind, 6 Months|Investigator decision|0|||
124580212|NCT00318461|448082944|FG003|Double-Blind, 6 Months|Investigator decision|0|||
124580213|NCT00318461|448082945|FG004|Double-Blind, 6 Months|Investigator decision|1|||
124580214|NCT00318461|448082941|FG000|Double-Blind, 6 Months|Lack of time|1|||
124580215|NCT00318461|448082942|FG001|Double-Blind, 6 Months|Lack of time|0|||
124580216|NCT00318461|448082943|FG002|Double-Blind, 6 Months|Lack of time|0|||
124580217|NCT00318461|448082944|FG003|Double-Blind, 6 Months|Lack of time|0|||
124580218|NCT00318461|448082945|FG004|Double-Blind, 6 Months|Lack of time|0|||
124580219|NCT00318461|448082941|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
124580220|NCT00318461|448082942|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
124580221|NCT00318461|448082943|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
124580222|NCT00318461|448082944|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
124580223|NCT00318461|448082945|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
124580224|NCT00318461|448082941|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
124580225|NCT00318461|448082942|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
124580226|NCT00318461|448082943|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
124580227|NCT00318461|448082944|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
124580228|NCT00318461|448082945|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
124580229|NCT00318461|448082941|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
124580230|NCT00318461|448082942|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
124580231|NCT00318461|448082943|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
124580232|NCT00318461|448082944|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
124580233|NCT00318461|448082945|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
124580234|NCT00318461|448082941|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
124580235|NCT00318461|448082942|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
124580236|NCT00318461|448082943|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
124580237|NCT00318461|448082944|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
124580238|NCT00318461|448082945|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
124580239|NCT00318461|448082941|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
124580240|NCT00318461|448082942|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
124580241|NCT00318461|448082943|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
124580242|NCT00318461|448082944|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
124580243|NCT00318461|448082945|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
124580244|NCT00318461|448082941|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
124580245|NCT00318461|448082942|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
124580246|NCT00318461|448082943|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
124580247|NCT00318461|448082944|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
124580248|NCT00318461|448082945|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
124580249|NCT00318461|448082941|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
124580250|NCT00318461|448082942|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
124580251|NCT00318461|448082943|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
124580252|NCT00318461|448082944|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
124580253|NCT00318461|448082945|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
124580254|NCT00318461|448082941|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
124580255|NCT00318461|448082942|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
124580256|NCT00318461|448082943|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
124580257|NCT00318461|448082944|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
124580258|NCT00318461|448082945|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
124580259|NCT00796653|448082949|FG000|Overall Study|Adverse Event|19|||
124580260|NCT00796653|448082950|FG001|Overall Study|Adverse Event|16|||
124580261|NCT00796653|448082951|FG002|Overall Study|Adverse Event|16|||
124580262|NCT00796653|448082952|FG003|Overall Study|Adverse Event|16|||
124580263|NCT00796653|448082949|FG000|Overall Study|Lost to Follow-up|2|||
124580264|NCT00796653|448082950|FG001|Overall Study|Lost to Follow-up|1|||
124580265|NCT00796653|448082951|FG002|Overall Study|Lost to Follow-up|2|||
124580266|NCT00796653|448082952|FG003|Overall Study|Lost to Follow-up|3|||
124580267|NCT00796653|448082949|FG000|Overall Study|Withdrawal by Subject|16|||
124580268|NCT00796653|448082950|FG001|Overall Study|Withdrawal by Subject|8|||
124580269|NCT00796653|448082951|FG002|Overall Study|Withdrawal by Subject|8|||
124580270|NCT00796653|448082952|FG003|Overall Study|Withdrawal by Subject|13|||
124580271|NCT00796653|448082949|FG000|Overall Study|Lack of Efficacy|8|||
124580272|NCT00796653|448082950|FG001|Overall Study|Lack of Efficacy|1|||
124580273|NCT00796653|448082951|FG002|Overall Study|Lack of Efficacy|3|||
124580274|NCT00796653|448082952|FG003|Overall Study|Lack of Efficacy|2|||
124580275|NCT00796653|448082949|FG000|Overall Study|Non compliance with protocol|2|||
124580276|NCT00796653|448082950|FG001|Overall Study|Non compliance with protocol|2|||
124580277|NCT00796653|448082951|FG002|Overall Study|Non compliance with protocol|0|||
124580278|NCT00796653|448082952|FG003|Overall Study|Non compliance with protocol|2|||
124580279|NCT00796653|448082949|FG000|Overall Study|Other reason not described above|4|||
124580280|NCT00796653|448082950|FG001|Overall Study|Other reason not described above|9|||
124580281|NCT00796653|448082951|FG002|Overall Study|Other reason not described above|7|||
124580282|NCT00796653|448082952|FG003|Overall Study|Other reason not described above|4|||
124580283|NCT00207090|448082959|FG000|Overall Study|Study drug toxicity|3|||
124580284|NCT00207090|448082959|FG000|Overall Study|Chest wall mass larger|1|||
124580285|NCT00207090|448082959|FG000|Overall Study|Disease progression/relapse|2|||
124580286|NCT00207090|448082959|FG000|Overall Study|Physician Decision|1|||
124580287|NCT01911676|448082962|FG000|Period 1 of Study|Withdrawal by Subject|4|||
124527694|NCT03083470|447884149|FG002|Overall Study|Withdrawal by Subject|0|||
124527695|NCT03083470|447884150|FG003|Overall Study|Withdrawal by Subject|0|||
124527696|NCT03083470|447884151|FG004|Overall Study|Withdrawal by Subject|1|||
124527697|NCT00606229|447884152|FG000|Overall Study|Adverse Event|11|||
124527698|NCT00606229|447884152|FG000|Overall Study|Lack of Efficacy|1|||
124527699|NCT00606229|447884152|FG000|Overall Study|Withdrawal by Subject|4|||
124527700|NCT00606229|447884152|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
124527701|NCT00606229|447884152|FG000|Overall Study|change of residence or other commitments|2|||
124527702|NCT01526928|447884153|FG000|Overall Study|Progressive Disease|35|||
124527703|NCT01526928|447884154|FG001|Overall Study|Progressive Disease|17|||
124527704|NCT01526928|447884155|FG002|Overall Study|Progressive Disease|150|||
124527705|NCT01526928|447884156|FG003|Overall Study|Progressive Disease|182|||
124527706|NCT01526928|447884157|FG004|Overall Study|Progressive Disease|76|||
124527707|NCT01526928|447884158|FG005|Overall Study|Progressive Disease|4|||
124527708|NCT01526928|447884153|FG000|Overall Study|Adverse Event|2|||
124527709|NCT01526928|447884154|FG001|Overall Study|Adverse Event|1|||
124527710|NCT01526928|447884155|FG002|Overall Study|Adverse Event|29|||
124527711|NCT01526928|447884156|FG003|Overall Study|Adverse Event|40|||
124580288|NCT01911676|448082963|FG001|Period 1 of Study|Withdrawal by Subject|2|||
124580289|NCT01911676|448082964|FG002|Period 1 of Study|Withdrawal by Subject|1|||
124580290|NCT01911676|448082965|FG003|Period 1 of Study|Withdrawal by Subject|2|||
124580291|NCT01911676|448082962|FG000|Period 1 of Study|Physician Decision|2|||
124580292|NCT01911676|448082963|FG001|Period 1 of Study|Physician Decision|0|||
124580293|NCT01911676|448082964|FG002|Period 1 of Study|Physician Decision|0|||
124580294|NCT01911676|448082965|FG003|Period 1 of Study|Physician Decision|1|||
124580295|NCT01911676|448082962|FG000|Period 2 of Study|Physician Decision|2|||
124580296|NCT01911676|448082963|FG001|Period 2 of Study|Physician Decision|0|||
124527712|NCT01526928|447884157|FG004|Overall Study|Adverse Event|13|||
124527713|NCT01526928|447884158|FG005|Overall Study|Adverse Event|2|||
124527714|NCT01526928|447884153|FG000|Overall Study|Death|0|||
124527715|NCT01526928|447884154|FG001|Overall Study|Death|0|||
124527716|NCT01526928|447884155|FG002|Overall Study|Death|3|||
124580297|NCT01911676|448082964|FG002|Period 2 of Study|Physician Decision|0|||
124580298|NCT01911676|448082965|FG003|Period 2 of Study|Physician Decision|1|||
124580299|NCT01911676|448082962|FG000|Period 2 of Study|Lost to Follow-up|0|||
124580300|NCT01911676|448082963|FG001|Period 2 of Study|Lost to Follow-up|0|||
124580301|NCT01911676|448082964|FG002|Period 2 of Study|Lost to Follow-up|0|||
124580302|NCT01911676|448082965|FG003|Period 2 of Study|Lost to Follow-up|1|||
124580303|NCT00773253|448082966|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
124580304|NCT00773253|448082967|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
124580305|NCT01566721|448082968|FG000|Treatment Period|Withdrawal by Subject|35|||
124580306|NCT01566721|448082969|FG001|Treatment Period|Withdrawal by Subject|9|||
124580307|NCT01566721|448082968|FG000|Treatment Period|Disease Progression/Recurrence|37|||
124580308|NCT01566721|448082969|FG001|Treatment Period|Disease Progression/Recurrence|13|||
124580309|NCT01566721|448082968|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
124580310|NCT01566721|448082969|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
124580311|NCT01566721|448082968|FG000|Treatment Period|Other|13|||
124580312|NCT01566721|448082969|FG001|Treatment Period|Other|2|||
124580313|NCT01566721|448082968|FG000|Treatment Period|Lack of Compliance|5|||
124580314|NCT01566721|448082969|FG001|Treatment Period|Lack of Compliance|1|||
124580315|NCT01566721|448082968|FG000|Treatment Period|Adverse Event|100|||
124580316|NCT01566721|448082969|FG001|Treatment Period|Adverse Event|30|||
124580317|NCT01566721|448082968|FG000|Treatment Period|Pregnancy|1|||
124580318|NCT01566721|448082969|FG001|Treatment Period|Pregnancy|0|||
124580319|NCT01566721|448082968|FG000|Safety Follow-up|Physician Decision|6|||
124580320|NCT01566721|448082969|FG001|Safety Follow-up|Physician Decision|4|||
124580321|NCT01566721|448082968|FG000|Safety Follow-up|Lost to Follow-up|101|||
124580322|NCT01566721|448082969|FG001|Safety Follow-up|Lost to Follow-up|48|||
124580323|NCT01566721|448082968|FG000|Safety Follow-up|Withdrawal by Subject|155|||
124580324|NCT01566721|448082969|FG001|Safety Follow-up|Withdrawal by Subject|49|||
124580325|NCT01566721|448082968|FG000|Safety Follow-up|Death|28|||
124580326|NCT01566721|448082969|FG001|Safety Follow-up|Death|4|||
124580327|NCT01566721|448082968|FG000|Safety Follow-up|Non-compliance|7|||
124580328|NCT01566721|448082969|FG001|Safety Follow-up|Non-compliance|3|||
124580329|NCT01566721|448082968|FG000|Safety Follow-up|Protocol Violation|7|||
124580330|NCT01566721|448082969|FG001|Safety Follow-up|Protocol Violation|0|||
124580331|NCT01566721|448082968|FG000|Safety Follow-up|Site closure|2|||
124580332|NCT01566721|448082969|FG001|Safety Follow-up|Site closure|3|||
124580333|NCT01566721|448082968|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
124580334|NCT01566721|448082969|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
124580335|NCT01566721|448082968|FG000|Safety Follow-up|Missing|7|||
124580336|NCT01566721|448082969|FG001|Safety Follow-up|Missing|2|||
124580337|NCT01566721|448082968|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
124580338|NCT01566721|448082969|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
124580339|NCT01566721|448082968|FG000|Safety Follow-up|Sponsor decision|1|||
124580340|NCT01566721|448082969|FG001|Safety Follow-up|Sponsor decision|0|||
124580341|NCT01566721|448082968|FG000|Safety Follow-up|Adverse Event|8|||
124580342|NCT01566721|448082969|FG001|Safety Follow-up|Adverse Event|4|||
124580343|NCT02911701|448082974|FG000|Overall Study|Withdrawal by Subject|2|||
124580344|NCT02911701|448082975|FG001|Overall Study|Withdrawal by Subject|4|||
124580345|NCT02911701|448082974|FG000|Overall Study|Adverse Event|1|||
124580346|NCT02911701|448082975|FG001|Overall Study|Adverse Event|0|||
124580347|NCT01237054|448082976|FG000|Overall Study|imaging 10C0096|1|||
124580348|NCT01983969|448082977|FG000|Overall Study|Disease Progression|0|||
124580349|NCT01983969|448082978|FG001|Overall Study|Disease Progression|1|||
124580350|NCT01983969|448082979|FG002|Overall Study|Disease Progression|0|||
124580351|NCT02619682|448082980|FG000|Overall Study|Withdrawal by Subject|3|||
124580352|NCT02619682|448082980|FG000|Overall Study|Lack of Efficacy|8|||
124580353|NCT02619682|448082980|FG000|Overall Study|new secondary cancer|1|||
124580354|NCT02619682|448082980|FG000|Overall Study|post surgery complications|2|||
124580355|NCT00268203|448082983|FG000|Overall Study|Lost to Follow-up|92|||
124580356|NCT00268203|448082983|FG000|Overall Study|Withdrawal by Subject|9|||
124580357|NCT00268203|448082983|FG000|Overall Study|Received Other NHL Therapy|7|||
124580358|NCT00268203|448082983|FG000|Overall Study|Progressive Disease|359|||
124580359|NCT00268203|448082983|FG000|Overall Study|Death|84|||
124580360|NCT00268203|448082983|FG000|Overall Study|Reason Not Specified|34|||
124580361|NCT00268203|448082983|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
124580362|NCT01841554|448082985|FG000|Overall Study|Death|7|||
124580363|NCT01841554|448082985|FG000|Overall Study|No Implantation|1|||
124580364|NCT01841554|448082985|FG000|Overall Study|Discontinued Follow Up|5|||
124580365|NCT01841554|448082985|FG000|Overall Study|Study exit due to secondary intervention|6|||
124580366|NCT03804983|448082989|FG000|Overall Study|Adverse Event|0|||
124580367|NCT03804983|448082990|FG001|Overall Study|Adverse Event|1|||
124580368|NCT03804983|448082989|FG000|Overall Study|Family Obligation|1|||
124580369|NCT03804983|448082990|FG001|Overall Study|Family Obligation|0|||
124580370|NCT03600376|448082991|FG000|Overall Study|Adverse Event|1|||
124726766|NCT00223808|448620288|FG002|Overall Study|<5 hrs therapy before discharge|5|||
124580371|NCT03600376|448082992|FG001|Overall Study|Adverse Event|1|||
124580372|NCT03600376|448082991|FG000|Overall Study|Transferred to other facility|1|||
124527717|NCT01526928|447884156|FG003|Overall Study|Death|0|||
124527718|NCT01526928|447884157|FG004|Overall Study|Death|0|||
124527719|NCT01526928|447884158|FG005|Overall Study|Death|0|||
124527720|NCT01526928|447884153|FG000|Overall Study|Withdrawal by Subject|1|||
124527721|NCT01526928|447884154|FG001|Overall Study|Withdrawal by Subject|0|||
124527722|NCT01526928|447884155|FG002|Overall Study|Withdrawal by Subject|13|||
124527723|NCT01526928|447884156|FG003|Overall Study|Withdrawal by Subject|11|||
124527724|NCT01526928|447884157|FG004|Overall Study|Withdrawal by Subject|3|||
124527725|NCT01526928|447884158|FG005|Overall Study|Withdrawal by Subject|0|||
124527726|NCT01526928|447884153|FG000|Overall Study|Physician Decision|0|||
124726767|NCT00152477|448620289|FG000|Chemotherapy Period|Adverse Event|9|||
124527727|NCT01526928|447884154|FG001|Overall Study|Physician Decision|0|||
124527728|NCT01526928|447884155|FG002|Overall Study|Physician Decision|2|||
124527729|NCT01526928|447884156|FG003|Overall Study|Physician Decision|5|||
124527730|NCT01526928|447884157|FG004|Overall Study|Physician Decision|0|||
124527731|NCT01526928|447884158|FG005|Overall Study|Physician Decision|0|||
124527732|NCT01526928|447884153|FG000|Overall Study|Other Reason|0|||
124527733|NCT01526928|447884154|FG001|Overall Study|Other Reason|1|||
124527734|NCT01526928|447884155|FG002|Overall Study|Other Reason|11|||
124527735|NCT01526928|447884156|FG003|Overall Study|Other Reason|4|||
124527736|NCT01526928|447884157|FG004|Overall Study|Other Reason|1|||
124527737|NCT01526928|447884158|FG005|Overall Study|Other Reason|0|||
124527738|NCT01526928|447884153|FG000|Overall Study|Lost to Follow-up|0|||
124527739|NCT01526928|447884154|FG001|Overall Study|Lost to Follow-up|0|||
124527740|NCT01526928|447884155|FG002|Overall Study|Lost to Follow-up|0|||
124527741|NCT01526928|447884156|FG003|Overall Study|Lost to Follow-up|1|||
124527742|NCT01526928|447884157|FG004|Overall Study|Lost to Follow-up|0|||
124527743|NCT01526928|447884158|FG005|Overall Study|Lost to Follow-up|0|||
124527744|NCT01526928|447884153|FG000|Overall Study|Protocol Deviation|0|||
124527745|NCT01526928|447884154|FG001|Overall Study|Protocol Deviation|0|||
124527746|NCT01526928|447884155|FG002|Overall Study|Protocol Deviation|0|||
124527747|NCT01526928|447884156|FG003|Overall Study|Protocol Deviation|2|||
124527748|NCT01526928|447884157|FG004|Overall Study|Protocol Deviation|0|||
124527749|NCT01526928|447884158|FG005|Overall Study|Protocol Deviation|0|||
124527750|NCT01526928|447884153|FG000|Overall Study|Missing|0|||
124527751|NCT01526928|447884154|FG001|Overall Study|Missing|0|||
124527752|NCT01526928|447884155|FG002|Overall Study|Missing|1|||
124527753|NCT01526928|447884156|FG003|Overall Study|Missing|0|||
124527754|NCT01526928|447884157|FG004|Overall Study|Missing|2|||
124527755|NCT01526928|447884158|FG005|Overall Study|Missing|0|||
124527756|NCT01108068|447884159|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
124527757|NCT01108068|447884160|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
124527758|NCT00836953|447884161|FG000|Overall Study|Withdrawal by Subject|1|||
124527759|NCT00836953|447884161|FG000|Overall Study|Lost to Follow-up|1|||
124527760|NCT02877134|447884165|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
124527761|NCT02877134|447884166|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
124527762|NCT02877134|447884167|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
124527763|NCT02877134|447884168|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
124527764|NCT02877134|447884169|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
124527765|NCT02877134|447884170|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
124527766|NCT02877134|447884171|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
124527767|NCT02877134|447884172|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
124527768|NCT02877134|447884173|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
124527769|NCT02877134|447884174|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
124527770|NCT02877134|447884175|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
124527771|NCT02877134|447884176|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
124527772|NCT02877134|447884165|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
124527773|NCT02877134|447884166|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
124527774|NCT02877134|447884167|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
124527775|NCT02877134|447884168|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
124527776|NCT02877134|447884169|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
124527777|NCT02877134|447884170|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
124527778|NCT02877134|447884171|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
124527779|NCT02877134|447884172|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
124527780|NCT02877134|447884173|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
124527781|NCT02877134|447884174|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
124527782|NCT02877134|447884175|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
124527783|NCT02877134|447884176|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
124527784|NCT02877134|447884165|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
124527785|NCT02877134|447884166|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
124527786|NCT02877134|447884167|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
124527787|NCT02877134|447884168|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
124527788|NCT02877134|447884169|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
124527789|NCT02877134|447884170|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
124527790|NCT02877134|447884171|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
124527791|NCT02877134|447884172|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
124527792|NCT02877134|447884173|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
124527793|NCT02877134|447884174|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
124527794|NCT02877134|447884175|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
124527795|NCT02877134|447884176|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
124527796|NCT02877134|447884165|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
124527797|NCT02877134|447884166|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
124527798|NCT02877134|447884167|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
124527799|NCT02877134|447884168|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
124527800|NCT02877134|447884169|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
124527801|NCT02877134|447884170|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
124527802|NCT02877134|447884171|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
124527803|NCT02877134|447884172|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
124527804|NCT02877134|447884173|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
124527805|NCT02877134|447884174|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
124527806|NCT02877134|447884175|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
124527807|NCT02877134|447884176|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
124527808|NCT02877134|447884165|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
124527809|NCT02877134|447884166|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
124527810|NCT02877134|447884167|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
124527811|NCT02877134|447884168|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
124527812|NCT02877134|447884169|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
124527813|NCT02877134|447884170|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
124527814|NCT02877134|447884171|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
124527815|NCT02877134|447884172|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
124527816|NCT02877134|447884173|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
124527817|NCT02877134|447884174|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
124527818|NCT02877134|447884175|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
124527819|NCT02877134|447884176|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
124527820|NCT02877134|447884165|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
124527821|NCT02877134|447884166|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
124527822|NCT02877134|447884167|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
124527823|NCT02877134|447884168|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
124527824|NCT02877134|447884169|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
124527825|NCT02877134|447884170|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
124527826|NCT02877134|447884171|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
124527827|NCT02877134|447884172|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
124527828|NCT02877134|447884173|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
124527829|NCT02877134|447884174|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
124527830|NCT02877134|447884175|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
124527831|NCT02877134|447884176|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
124527832|NCT02877134|447884165|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
124527833|NCT02877134|447884166|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
124527834|NCT02877134|447884167|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
124527835|NCT02877134|447884168|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
124527836|NCT02877134|447884169|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
124527837|NCT02877134|447884170|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
124527838|NCT02877134|447884171|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
124527839|NCT02877134|447884172|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
124527840|NCT02877134|447884173|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
124527841|NCT02877134|447884174|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
124527842|NCT02877134|447884175|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
124527843|NCT02877134|447884176|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
124527844|NCT02877134|447884165|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
124527845|NCT02877134|447884166|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
124527846|NCT02877134|447884167|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
124527847|NCT02877134|447884168|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
124527848|NCT02877134|447884169|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
124527849|NCT02877134|447884170|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
124527850|NCT02877134|447884171|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
124527851|NCT02877134|447884172|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
124527852|NCT02877134|447884173|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
124527853|NCT02877134|447884174|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
124726768|NCT00152477|448620290|FG001|Chemotherapy Period|Adverse Event|4|||
124726769|NCT00152477|448620291|FG002|Chemotherapy Period|Adverse Event|5|||
124726770|NCT00152477|448620289|FG000|Chemotherapy Period|Death|1|||
124726771|NCT00152477|448620290|FG001|Chemotherapy Period|Death|3|||
124726772|NCT00152477|448620291|FG002|Chemotherapy Period|Death|3|||
124726773|NCT00152477|448620289|FG000|Chemotherapy Period|Lack of Efficacy|4|||
124726774|NCT00152477|448620290|FG001|Chemotherapy Period|Lack of Efficacy|5|||
124726775|NCT00152477|448620291|FG002|Chemotherapy Period|Lack of Efficacy|6|||
124726776|NCT00152477|448620289|FG000|Chemotherapy Period|Lost to Follow-up|1|||
124726777|NCT00152477|448620290|FG001|Chemotherapy Period|Lost to Follow-up|0|||
124726778|NCT00152477|448620291|FG002|Chemotherapy Period|Lost to Follow-up|1|||
124726779|NCT00152477|448620289|FG000|Chemotherapy Period|Protocol Violation|1|||
124726780|NCT00152477|448620290|FG001|Chemotherapy Period|Protocol Violation|1|||
124726781|NCT00152477|448620291|FG002|Chemotherapy Period|Protocol Violation|0|||
124726782|NCT00152477|448620289|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
124726783|NCT00152477|448620290|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
124726784|NCT00152477|448620291|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
124726785|NCT00152477|448620289|FG000|Chemotherapy Period|Progression of Disease|6|||
124726786|NCT00152477|448620290|FG001|Chemotherapy Period|Progression of Disease|8|||
124726787|NCT00152477|448620291|FG002|Chemotherapy Period|Progression of Disease|4|||
124726788|NCT00152477|448620289|FG000|Chemotherapy Period|Investigator decision|0|||
124726789|NCT00152477|448620290|FG001|Chemotherapy Period|Investigator decision|0|||
124726790|NCT00152477|448620291|FG002|Chemotherapy Period|Investigator decision|1|||
124726791|NCT00152477|448620289|FG000|Chemotherapy Period|Patient condition worsened|1|||
124726792|NCT00152477|448620290|FG001|Chemotherapy Period|Patient condition worsened|0|||
124726793|NCT00152477|448620291|FG002|Chemotherapy Period|Patient condition worsened|0|||
124726794|NCT00152477|448620289|FG000|Monotherapy Period|Adverse Event|1|||
124726795|NCT00152477|448620290|FG001|Monotherapy Period|Adverse Event|0|||
124726796|NCT00152477|448620291|FG002|Monotherapy Period|Adverse Event|5|||
124726797|NCT00152477|448620289|FG000|Monotherapy Period|Death|2|||
124726798|NCT00152477|448620290|FG001|Monotherapy Period|Death|0|||
124726799|NCT00152477|448620291|FG002|Monotherapy Period|Death|1|||
124726800|NCT00152477|448620289|FG000|Monotherapy Period|Lack of Efficacy|7|||
124726801|NCT00152477|448620290|FG001|Monotherapy Period|Lack of Efficacy|16|||
124726802|NCT00152477|448620291|FG002|Monotherapy Period|Lack of Efficacy|10|||
124726803|NCT00152477|448620289|FG000|Monotherapy Period|Protocol Violation|0|||
124726804|NCT00152477|448620290|FG001|Monotherapy Period|Protocol Violation|1|||
124726805|NCT00152477|448620291|FG002|Monotherapy Period|Protocol Violation|0|||
124726806|NCT00152477|448620289|FG000|Monotherapy Period|Withdrawal by Subject|0|||
124726807|NCT00152477|448620290|FG001|Monotherapy Period|Withdrawal by Subject|0|||
124726808|NCT00152477|448620291|FG002|Monotherapy Period|Withdrawal by Subject|4|||
124726809|NCT00152477|448620289|FG000|Monotherapy Period|Progression of Disease|5|||
124726810|NCT00152477|448620290|FG001|Monotherapy Period|Progression of Disease|11|||
124726811|NCT00152477|448620291|FG002|Monotherapy Period|Progression of Disease|12|||
124726812|NCT00152477|448620289|FG000|Monotherapy Period|Patient decision|0|||
124726813|NCT00152477|448620290|FG001|Monotherapy Period|Patient decision|1|||
124726814|NCT00152477|448620291|FG002|Monotherapy Period|Patient decision|1|||
124726815|NCT00152477|448620289|FG000|Monotherapy Period|Study personel decision|0|||
124726816|NCT00152477|448620290|FG001|Monotherapy Period|Study personel decision|0|||
124726817|NCT00152477|448620291|FG002|Monotherapy Period|Study personel decision|1|||
124726818|NCT01626118|448620297|FG000|Overall Study|Lack of Efficacy|1|||
124726819|NCT01626118|448620298|FG001|Overall Study|Lack of Efficacy|0|||
124726820|NCT01626118|448620299|FG002|Overall Study|Lack of Efficacy|1|||
124726821|NCT01626118|448620300|FG003|Overall Study|Lack of Efficacy|3|||
124726822|NCT01626118|448620297|FG000|Overall Study|Lost to Follow-up|1|||
124726823|NCT01626118|448620298|FG001|Overall Study|Lost to Follow-up|0|||
124726824|NCT01626118|448620299|FG002|Overall Study|Lost to Follow-up|0|||
124726825|NCT01626118|448620300|FG003|Overall Study|Lost to Follow-up|0|||
124726826|NCT01626118|448620297|FG000|Overall Study|Adverse Event|0|||
124726827|NCT01626118|448620298|FG001|Overall Study|Adverse Event|1|||
124726828|NCT01626118|448620299|FG002|Overall Study|Adverse Event|1|||
124776829|NCT01967238|448810023|FG002|Overall Study|Lost to Follow-up|1|||
124776830|NCT01967238|448810021|FG000|Overall Study|Withdrawal by Subject|0|||
124726829|NCT01626118|448620300|FG003|Overall Study|Adverse Event|0|||
124726830|NCT01626118|448620297|FG000|Overall Study|Investigator Decision|0|||
124726831|NCT01626118|448620298|FG001|Overall Study|Investigator Decision|1|||
124726832|NCT01626118|448620299|FG002|Overall Study|Investigator Decision|0|||
124726833|NCT01626118|448620300|FG003|Overall Study|Investigator Decision|0|||
124776831|NCT01967238|448810022|FG001|Overall Study|Withdrawal by Subject|0|||
124776832|NCT01967238|448810023|FG002|Overall Study|Withdrawal by Subject|1|||
124776833|NCT05232682|448810024|FG000|Overall Study|Lost to Follow-up|2|||
124726834|NCT00888329|448620301|FG000|Overall Study|Physician Decision|6|||
124726835|NCT00888329|448620302|FG001|Overall Study|Physician Decision|9|||
124726836|NCT00939029|448620303|FG000|Overall Study|Withdrawal by Subject|3|||
124726837|NCT00939029|448620304|FG001|Overall Study|Withdrawal by Subject|7|||
124726838|NCT00939029|448620303|FG000|Overall Study|Lost to Follow-up|3|||
124726839|NCT00939029|448620304|FG001|Overall Study|Lost to Follow-up|4|||
124726840|NCT00939029|448620303|FG000|Overall Study|Adverse Event|0|||
124776834|NCT03387085|448810025|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
124776835|NCT01442103|448811310|FG000|Overall Study|Lost to Follow-up|2|||
124726841|NCT00939029|448620304|FG001|Overall Study|Adverse Event|1|||
124726842|NCT01421303|448620306|FG000|Overall Study|Lost to Follow-up|13|||
124726843|NCT01421303|448620306|FG000|Overall Study|Non compliance with study procedure|1|||
124726844|NCT01421303|448620306|FG000|Overall Study|Other|7|||
124726845|NCT01421303|448620306|FG000|Overall Study|Withdrawal by Subject|1|||
124726846|NCT06003777|448620307|FG000|Period 1|Adverse Event|0|||
124726847|NCT06003777|448620308|FG001|Period 1|Adverse Event|0|||
124726848|NCT06003777|448620309|FG002|Period 1|Adverse Event|1|||
124726849|NCT06003777|448620310|FG003|Period 1|Adverse Event|0|||
124726850|NCT06003777|448620311|FG004|Period 1|Adverse Event|0|||
124726851|NCT06003777|448620312|FG005|Period 1|Adverse Event|0|||
124726852|NCT06003777|448620313|FG006|Period 1|Adverse Event|0|||
124726853|NCT06003777|448620314|FG007|Period 1|Adverse Event|0|||
124726854|NCT06003777|448620315|FG008|Period 1|Adverse Event|0|||
124726855|NCT06003777|448620316|FG009|Period 1|Adverse Event|0|||
124726856|NCT06003777|448620317|FG010|Period 1|Adverse Event|0|||
124726857|NCT06003777|448620318|FG011|Period 1|Adverse Event|0|||
124527854|NCT02877134|447884175|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
124527855|NCT02877134|447884176|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
124527856|NCT01197794|447884179|FG000|Overall Study|Adverse Event|3|||
124527857|NCT01197794|447884180|FG001|Overall Study|Adverse Event|2|||
124527858|NCT01197794|447884181|FG002|Overall Study|Adverse Event|4|||
124527859|NCT01197794|447884182|FG003|Overall Study|Adverse Event|4|||
124527860|NCT01197794|447884183|FG004|Overall Study|Adverse Event|4|||
124527861|NCT01197794|447884184|FG005|Overall Study|Adverse Event|2|||
124527862|NCT01197794|447884185|FG006|Overall Study|Adverse Event|3|||
124726858|NCT06003777|448620307|FG000|Period 1|Withdrawal by Subject|0|||
124726859|NCT06003777|448620308|FG001|Period 1|Withdrawal by Subject|0|||
124726860|NCT06003777|448620309|FG002|Period 1|Withdrawal by Subject|0|||
124726861|NCT06003777|448620310|FG003|Period 1|Withdrawal by Subject|0|||
124726862|NCT06003777|448620311|FG004|Period 1|Withdrawal by Subject|1|||
124726863|NCT06003777|448620312|FG005|Period 1|Withdrawal by Subject|0|||
124726864|NCT06003777|448620313|FG006|Period 1|Withdrawal by Subject|0|||
124527863|NCT01197794|447884179|FG000|Overall Study|Protocol Violation|0|||
124527864|NCT01197794|447884180|FG001|Overall Study|Protocol Violation|0|||
124527865|NCT01197794|447884181|FG002|Overall Study|Protocol Violation|0|||
124527866|NCT01197794|447884182|FG003|Overall Study|Protocol Violation|0|||
124527867|NCT01197794|447884183|FG004|Overall Study|Protocol Violation|2|||
124527868|NCT01197794|447884184|FG005|Overall Study|Protocol Violation|0|||
124527869|NCT01197794|447884185|FG006|Overall Study|Protocol Violation|1|||
124527870|NCT01197794|447884179|FG000|Overall Study|Development of study withdrawal criteria|3|||
124527871|NCT01197794|447884180|FG001|Overall Study|Development of study withdrawal criteria|0|||
124527872|NCT01197794|447884181|FG002|Overall Study|Development of study withdrawal criteria|0|||
124527873|NCT01197794|447884182|FG003|Overall Study|Development of study withdrawal criteria|1|||
124527874|NCT01197794|447884183|FG004|Overall Study|Development of study withdrawal criteria|0|||
124527875|NCT01197794|447884184|FG005|Overall Study|Development of study withdrawal criteria|0|||
124527876|NCT01197794|447884185|FG006|Overall Study|Development of study withdrawal criteria|1|||
124527877|NCT01197794|447884179|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
124527878|NCT01197794|447884180|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
124527879|NCT01197794|447884181|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
124527880|NCT01197794|447884182|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
124527881|NCT01197794|447884183|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
124527882|NCT01197794|447884184|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
124527883|NCT01197794|447884185|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
124527884|NCT01197794|447884179|FG000|Overall Study|Withdrawal by Subject|3|||
124527885|NCT01197794|447884180|FG001|Overall Study|Withdrawal by Subject|3|||
124527886|NCT01197794|447884181|FG002|Overall Study|Withdrawal by Subject|4|||
124527887|NCT01197794|447884182|FG003|Overall Study|Withdrawal by Subject|1|||
124527888|NCT01197794|447884183|FG004|Overall Study|Withdrawal by Subject|1|||
124527889|NCT01197794|447884184|FG005|Overall Study|Withdrawal by Subject|5|||
124527890|NCT01197794|447884185|FG006|Overall Study|Withdrawal by Subject|6|||
124527891|NCT01197794|447884179|FG000|Overall Study|Lost to Follow-up|1|||
124527892|NCT01197794|447884180|FG001|Overall Study|Lost to Follow-up|1|||
124527893|NCT01197794|447884181|FG002|Overall Study|Lost to Follow-up|0|||
124527894|NCT01197794|447884182|FG003|Overall Study|Lost to Follow-up|1|||
124527895|NCT01197794|447884183|FG004|Overall Study|Lost to Follow-up|0|||
124527896|NCT01197794|447884184|FG005|Overall Study|Lost to Follow-up|1|||
124527897|NCT01197794|447884185|FG006|Overall Study|Lost to Follow-up|0|||
124527898|NCT01197794|447884179|FG000|Overall Study|Other|1|||
124527899|NCT01197794|447884180|FG001|Overall Study|Other|1|||
124726865|NCT06003777|448620314|FG007|Period 1|Withdrawal by Subject|0|||
124726866|NCT06003777|448620315|FG008|Period 1|Withdrawal by Subject|0|||
124726867|NCT06003777|448620316|FG009|Period 1|Withdrawal by Subject|0|||
124726868|NCT06003777|448620317|FG010|Period 1|Withdrawal by Subject|0|||
124726869|NCT06003777|448620318|FG011|Period 1|Withdrawal by Subject|0|||
124726870|NCT06003777|448620307|FG000|Period 2|Withdrawal by Subject|0|||
124527900|NCT01197794|447884181|FG002|Overall Study|Other|3|||
124527901|NCT01197794|447884182|FG003|Overall Study|Other|0|||
124726871|NCT06003777|448620308|FG001|Period 2|Withdrawal by Subject|0|||
124580373|NCT03600376|448082992|FG001|Overall Study|Transferred to other facility|0|||
124580374|NCT03600376|448082991|FG000|Overall Study|Investigator Decision|0|||
124580375|NCT03600376|448082992|FG001|Overall Study|Investigator Decision|4|||
124580376|NCT03600376|448082991|FG000|Overall Study|Determined to be ineligible for study|0|||
124580377|NCT03600376|448082992|FG001|Overall Study|Determined to be ineligible for study|1|||
124580378|NCT02152163|448082993|FG000|Overall Study|Physician Decision|12|||
124580379|NCT02152163|448082994|FG001|Overall Study|Physician Decision|13|||
124580380|NCT00796562|448082998|FG000|Overall Study|Death|49|||
124580381|NCT00424047|448082999|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
124580382|NCT00424047|448083000|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
124580383|NCT00424047|448082999|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
124580384|NCT00424047|448083000|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
124580385|NCT00424047|448082999|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
124580386|NCT00424047|448083000|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
124580387|NCT00424047|448082999|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
124580388|NCT00424047|448083000|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
124580389|NCT00424047|448082999|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
124580390|NCT00424047|448083000|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
124580391|NCT00424047|448082999|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
124580392|NCT00424047|448083000|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
124580393|NCT00424047|448082999|FG000|On Study at Time of Unblinding|Adverse Event|22|||
124580394|NCT00424047|448083000|FG001|On Study at Time of Unblinding|Adverse Event|12|||
124580395|NCT00424047|448082999|FG000|On Study at Time of Unblinding|Progression of disease|92|||
124580396|NCT00424047|448083000|FG001|On Study at Time of Unblinding|Progression of disease|128|||
124527902|NCT01197794|447884183|FG004|Overall Study|Other|2|||
124527903|NCT01197794|447884184|FG005|Overall Study|Other|2|||
124527904|NCT01197794|447884185|FG006|Overall Study|Other|4|||
124527905|NCT01055457|447884186|FG000|Overall Study|Lost to Follow-up|0|||
124527906|NCT01055457|447884187|FG001|Overall Study|Lost to Follow-up|1|||
124527907|NCT01055457|447884188|FG002|Overall Study|Lost to Follow-up|0|||
124527908|NCT01055457|447884189|FG003|Overall Study|Lost to Follow-up|0|||
124527909|NCT01055457|447884190|FG004|Overall Study|Lost to Follow-up|0|||
124527910|NCT01055457|447884191|FG005|Overall Study|Lost to Follow-up|1|||
124527911|NCT01055457|447884192|FG006|Overall Study|Lost to Follow-up|0|||
124527912|NCT01055457|447884193|FG007|Overall Study|Lost to Follow-up|0|||
124527913|NCT01055457|447884194|FG008|Overall Study|Lost to Follow-up|0|||
124527914|NCT01055457|447884195|FG009|Overall Study|Lost to Follow-up|0|||
124527915|NCT01055457|447884186|FG000|Overall Study|Protocol Violation|0|||
124527916|NCT01055457|447884187|FG001|Overall Study|Protocol Violation|0|||
124527917|NCT01055457|447884188|FG002|Overall Study|Protocol Violation|1|||
124527918|NCT01055457|447884189|FG003|Overall Study|Protocol Violation|1|||
124527919|NCT01055457|447884190|FG004|Overall Study|Protocol Violation|1|||
124527920|NCT01055457|447884191|FG005|Overall Study|Protocol Violation|2|||
124527921|NCT01055457|447884192|FG006|Overall Study|Protocol Violation|1|||
124527922|NCT01055457|447884193|FG007|Overall Study|Protocol Violation|0|||
124527923|NCT01055457|447884194|FG008|Overall Study|Protocol Violation|0|||
124527924|NCT01055457|447884195|FG009|Overall Study|Protocol Violation|1|||
124527925|NCT01055457|447884186|FG000|Overall Study|Subject Disinterest|0|||
124527926|NCT01055457|447884187|FG001|Overall Study|Subject Disinterest|0|||
124527927|NCT01055457|447884188|FG002|Overall Study|Subject Disinterest|0|||
124527928|NCT01055457|447884189|FG003|Overall Study|Subject Disinterest|0|||
124527929|NCT01055457|447884190|FG004|Overall Study|Subject Disinterest|0|||
124527930|NCT01055457|447884191|FG005|Overall Study|Subject Disinterest|0|||
124527931|NCT01055457|447884192|FG006|Overall Study|Subject Disinterest|0|||
124527932|NCT01055457|447884193|FG007|Overall Study|Subject Disinterest|1|||
124527933|NCT01055457|447884194|FG008|Overall Study|Subject Disinterest|0|||
124527934|NCT01055457|447884195|FG009|Overall Study|Subject Disinterest|0|||
124527935|NCT01055457|447884186|FG000|Overall Study|Subject Ineligible|1|||
124527936|NCT01055457|447884187|FG001|Overall Study|Subject Ineligible|0|||
124527937|NCT01055457|447884188|FG002|Overall Study|Subject Ineligible|1|||
124527938|NCT01055457|447884189|FG003|Overall Study|Subject Ineligible|0|||
124527939|NCT01055457|447884190|FG004|Overall Study|Subject Ineligible|1|||
124527940|NCT01055457|447884191|FG005|Overall Study|Subject Ineligible|0|||
124527941|NCT01055457|447884192|FG006|Overall Study|Subject Ineligible|0|||
124527942|NCT01055457|447884193|FG007|Overall Study|Subject Ineligible|0|||
124580397|NCT00424047|448082999|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
124580398|NCT00424047|448083000|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
124726872|NCT06003777|448620309|FG002|Period 2|Withdrawal by Subject|0|||
124527943|NCT01055457|447884194|FG008|Overall Study|Subject Ineligible|0|||
124726873|NCT06003777|448620310|FG003|Period 2|Withdrawal by Subject|0|||
124726874|NCT06003777|448620311|FG004|Period 2|Withdrawal by Subject|0|||
124726875|NCT06003777|448620312|FG005|Period 2|Withdrawal by Subject|0|||
124726876|NCT06003777|448620313|FG006|Period 2|Withdrawal by Subject|0|||
124726877|NCT06003777|448620314|FG007|Period 2|Withdrawal by Subject|0|||
124726878|NCT06003777|448620315|FG008|Period 2|Withdrawal by Subject|1|||
124726879|NCT06003777|448620316|FG009|Period 2|Withdrawal by Subject|0|||
124580399|NCT00424047|448082999|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
124580400|NCT00424047|448083000|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
124580401|NCT00424047|448082999|FG000|On Study at Time of Unblinding|Death|11|||
124580402|NCT00424047|448083000|FG001|On Study at Time of Unblinding|Death|11|||
124580403|NCT00424047|448082999|FG000|On Study at Time of Unblinding|Other|5|||
124580404|NCT00424047|448083000|FG001|On Study at Time of Unblinding|Other|4|||
124580405|NCT00424047|448082999|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
124580406|NCT00424047|448083000|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
124580407|NCT00424047|448082999|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
124580408|NCT00424047|448083000|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
124580409|NCT00424047|448082999|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
124580410|NCT00424047|448083000|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
124580411|NCT00424047|448082999|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
124580412|NCT00424047|448083000|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
124580413|NCT00424047|448082999|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
124580414|NCT00424047|448083000|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
124580415|NCT00312897|448083002|FG000|Overall Study|Adverse Event|1|||
124580416|NCT00312897|448083003|FG001|Overall Study|Adverse Event|0|||
124580417|NCT00312897|448083002|FG000|Overall Study|Lost to Follow-up|2|||
124580418|NCT00312897|448083003|FG001|Overall Study|Lost to Follow-up|0|||
124580419|NCT00312897|448083002|FG000|Overall Study|Physician Decision|1|||
124580420|NCT00312897|448083003|FG001|Overall Study|Physician Decision|0|||
124580421|NCT00312897|448083002|FG000|Overall Study|Withdrawal by Subject|1|||
124580422|NCT00312897|448083003|FG001|Overall Study|Withdrawal by Subject|3|||
124580423|NCT00312897|448083002|FG000|Overall Study|Pregnancy|1|||
124580424|NCT00312897|448083003|FG001|Overall Study|Pregnancy|0|||
124580425|NCT00312897|448083002|FG000|Overall Study|discontinued prior to getting treatment|0|||
124580426|NCT00312897|448083003|FG001|Overall Study|discontinued prior to getting treatment|3|||
124580427|NCT04633564|448083004|FG000|Period 1|Adverse Event|28|||
124580428|NCT04633564|448083005|FG001|Period 1|Adverse Event|19|||
124580429|NCT04633564|448083004|FG000|Period 1|Death|8|||
124580430|NCT04633564|448083005|FG001|Period 1|Death|7|||
124580431|NCT04633564|448083004|FG000|Period 1|Lost to Follow-up|3|||
124580432|NCT04633564|448083005|FG001|Period 1|Lost to Follow-up|5|||
124580433|NCT04633564|448083004|FG000|Period 1|Physician Decision|4|||
124580434|NCT04633564|448083005|FG001|Period 1|Physician Decision|12|||
124580435|NCT04633564|448083004|FG000|Period 1|Protocol Violation|0|||
124580436|NCT04633564|448083005|FG001|Period 1|Protocol Violation|1|||
124580437|NCT04633564|448083004|FG000|Period 1|Withdrawal by Subject|10|||
124580438|NCT04633564|448083005|FG001|Period 1|Withdrawal by Subject|8|||
124580439|NCT04633564|448083004|FG000|Period 1|Progressive disease|47|||
124580440|NCT04633564|448083005|FG001|Period 1|Progressive disease|51|||
124580441|NCT04633564|448083004|FG000|Period 1|Terminated by Sponsor|8|||
124580442|NCT04633564|448083005|FG001|Period 1|Terminated by Sponsor|6|||
124580443|NCT04633564|448083004|FG000|Period 2|Adverse Event|3|||
124580444|NCT04633564|448083005|FG001|Period 2|Adverse Event|4|||
124580445|NCT04633564|448083004|FG000|Period 2|Death|0|||
124580446|NCT04633564|448083005|FG001|Period 2|Death|2|||
124580447|NCT04633564|448083004|FG000|Period 2|Lost to Follow-up|0|||
124580448|NCT04633564|448083005|FG001|Period 2|Lost to Follow-up|1|||
124580449|NCT04633564|448083004|FG000|Period 2|Physician Decision|2|||
124580450|NCT04633564|448083005|FG001|Period 2|Physician Decision|4|||
124580451|NCT04633564|448083004|FG000|Period 2|Withdrawal by Subject|5|||
124580452|NCT04633564|448083005|FG001|Period 2|Withdrawal by Subject|1|||
124580453|NCT04633564|448083004|FG000|Period 2|Progressive Disease|74|||
124580454|NCT04633564|448083005|FG001|Period 2|Progressive Disease|82|||
124580455|NCT04633564|448083004|FG000|Period 2|Terminated by Sponsor|9|||
124580456|NCT04633564|448083005|FG001|Period 2|Terminated by Sponsor|3|||
124580457|NCT01010503|448083006|FG000|Overall Study|Adverse Event|1|||
124580458|NCT01010503|448083006|FG000|Overall Study|Death|1|||
124580459|NCT01097577|448083007|FG000|Overall Study|Adverse Event|0|||
124580460|NCT01097577|448083008|FG001|Overall Study|Adverse Event|1|||
124580461|NCT04493684|448083011|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
124580462|NCT04493684|448083012|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
124580463|NCT04493684|448083013|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
124580464|NCT04493684|448083014|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
124580465|NCT04493684|448083015|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
124580466|NCT04493684|448083016|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
124580467|NCT04493684|448083017|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
124580468|NCT04493684|448083018|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
124580469|NCT04493684|448083019|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
124580470|NCT04493684|448083020|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
124580471|NCT04493684|448083021|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
124580472|NCT04493684|448083022|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
124726880|NCT06003777|448620317|FG010|Period 2|Withdrawal by Subject|0|||
124527944|NCT01055457|447884195|FG009|Overall Study|Subject Ineligible|0|||
124580473|NCT04493684|448083023|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
124580474|NCT04493684|448083024|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
124580475|NCT04493684|448083025|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
124527945|NCT01055457|447884186|FG000|Overall Study|Discomfort|0|||
124527946|NCT01055457|447884187|FG001|Overall Study|Discomfort|0|||
124527947|NCT01055457|447884188|FG002|Overall Study|Discomfort|0|||
124527948|NCT01055457|447884189|FG003|Overall Study|Discomfort|0|||
124527949|NCT01055457|447884190|FG004|Overall Study|Discomfort|1|||
124527950|NCT01055457|447884191|FG005|Overall Study|Discomfort|0|||
124527951|NCT01055457|447884192|FG006|Overall Study|Discomfort|0|||
124527952|NCT01055457|447884193|FG007|Overall Study|Discomfort|0|||
124527953|NCT01055457|447884194|FG008|Overall Study|Discomfort|0|||
124580476|NCT04493684|448083026|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
124580477|NCT04493684|448083027|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
124580478|NCT04493684|448083011|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
124580479|NCT04493684|448083012|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
124580480|NCT04493684|448083013|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
124580481|NCT04493684|448083014|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
124580482|NCT04493684|448083015|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
124580483|NCT04493684|448083016|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
124580484|NCT04493684|448083017|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
124580485|NCT04493684|448083018|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
124580486|NCT04493684|448083019|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
124580487|NCT04493684|448083020|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
124580488|NCT04493684|448083021|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
124580489|NCT04493684|448083022|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
124580490|NCT04493684|448083023|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
124580491|NCT04493684|448083024|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
124580492|NCT04493684|448083025|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
124580493|NCT04493684|448083026|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
124580494|NCT04493684|448083027|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
124580495|NCT04493684|448083011|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
124580496|NCT04493684|448083012|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
124580497|NCT04493684|448083013|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
124580498|NCT04493684|448083014|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
124580499|NCT04493684|448083015|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
124580500|NCT04493684|448083016|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
124580501|NCT04493684|448083017|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
124580502|NCT04493684|448083018|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
124580503|NCT04493684|448083019|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
124580504|NCT04493684|448083020|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
124580505|NCT04493684|448083021|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
124580506|NCT04493684|448083022|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
124580507|NCT04493684|448083023|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
124580508|NCT04493684|448083024|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
124580509|NCT04493684|448083025|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
124580510|NCT04493684|448083026|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
124580511|NCT04493684|448083027|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
124580512|NCT04493684|448083011|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
124580513|NCT04493684|448083012|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
124580514|NCT04493684|448083013|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
124580515|NCT04493684|448083014|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
124580516|NCT04493684|448083015|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
124580517|NCT04493684|448083016|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
124726881|NCT06003777|448620318|FG011|Period 2|Withdrawal by Subject|0|||
124726882|NCT06003777|448620307|FG000|Period 3|Adverse Event|0|||
124527954|NCT01055457|447884195|FG009|Overall Study|Discomfort|0|||
124527955|NCT01055457|447884186|FG000|Overall Study|Pregnancy|0|||
124527956|NCT01055457|447884187|FG001|Overall Study|Pregnancy|0|||
124527957|NCT01055457|447884188|FG002|Overall Study|Pregnancy|0|||
124527958|NCT01055457|447884189|FG003|Overall Study|Pregnancy|1|||
124527959|NCT01055457|447884190|FG004|Overall Study|Pregnancy|0|||
124527960|NCT01055457|447884191|FG005|Overall Study|Pregnancy|0|||
124527961|NCT01055457|447884192|FG006|Overall Study|Pregnancy|0|||
124527962|NCT01055457|447884193|FG007|Overall Study|Pregnancy|0|||
124527963|NCT01055457|447884194|FG008|Overall Study|Pregnancy|0|||
124527964|NCT01055457|447884195|FG009|Overall Study|Pregnancy|0|||
124527965|NCT01055457|447884186|FG000|Overall Study|Adverse Event|0|||
124580518|NCT04493684|448083017|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
124580519|NCT04493684|448083018|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
124580520|NCT04493684|448083019|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
124580521|NCT04493684|448083020|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
124580522|NCT04493684|448083021|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
124580523|NCT04493684|448083022|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
124580524|NCT04493684|448083023|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
124580525|NCT04493684|448083024|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
124580526|NCT04493684|448083025|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
124580527|NCT04493684|448083026|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
124580528|NCT04493684|448083027|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
124580529|NCT04493684|448083011|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
124580530|NCT04493684|448083012|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
124580531|NCT04493684|448083013|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
124580532|NCT04493684|448083014|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
124580533|NCT04493684|448083015|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
124580534|NCT04493684|448083016|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
124580535|NCT04493684|448083017|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
124580536|NCT04493684|448083018|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
124580537|NCT04493684|448083019|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
124580538|NCT04493684|448083020|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
124580539|NCT04493684|448083021|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
124580540|NCT04493684|448083022|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
124580541|NCT04493684|448083023|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
124580542|NCT04493684|448083024|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
124580543|NCT04493684|448083025|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
124580544|NCT04493684|448083026|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
124580545|NCT04493684|448083027|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
124580546|NCT04493684|448083011|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
124580547|NCT04493684|448083012|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
124580548|NCT04493684|448083013|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
124580549|NCT04493684|448083014|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
124580550|NCT04493684|448083015|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
124580551|NCT04493684|448083016|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
124580552|NCT04493684|448083017|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
124580553|NCT04493684|448083018|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
124580554|NCT04493684|448083019|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
124580555|NCT04493684|448083020|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
124580556|NCT04493684|448083021|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
124580557|NCT04493684|448083022|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
124580558|NCT04493684|448083023|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
124580559|NCT04493684|448083024|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
124580560|NCT04493684|448083025|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
124580561|NCT04493684|448083026|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
124580562|NCT04493684|448083027|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
124580563|NCT04493684|448083011|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
124580564|NCT04493684|448083012|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
124580565|NCT04493684|448083013|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
124580566|NCT04493684|448083014|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
124580567|NCT04493684|448083015|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
124580568|NCT04493684|448083016|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
124580569|NCT04493684|448083017|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
124580570|NCT04493684|448083018|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
124580571|NCT04493684|448083019|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
124580572|NCT04493684|448083020|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
124580573|NCT04493684|448083021|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
124580574|NCT04493684|448083022|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
124580575|NCT04493684|448083023|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
124580576|NCT04493684|448083024|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
124580577|NCT04493684|448083025|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
124580578|NCT04493684|448083026|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
124580579|NCT04493684|448083027|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
124726883|NCT06003777|448620308|FG001|Period 3|Adverse Event|0|||
124726884|NCT06003777|448620309|FG002|Period 3|Adverse Event|0|||
124726885|NCT06003777|448620310|FG003|Period 3|Adverse Event|0|||
124726886|NCT06003777|448620311|FG004|Period 3|Adverse Event|0|||
124726887|NCT06003777|448620312|FG005|Period 3|Adverse Event|0|||
124726888|NCT06003777|448620313|FG006|Period 3|Adverse Event|1|||
124726889|NCT06003777|448620314|FG007|Period 3|Adverse Event|0|||
124726890|NCT06003777|448620315|FG008|Period 3|Adverse Event|0|||
124726891|NCT06003777|448620316|FG009|Period 3|Adverse Event|0|||
124726892|NCT06003777|448620317|FG010|Period 3|Adverse Event|0|||
124726893|NCT06003777|448620318|FG011|Period 3|Adverse Event|0|||
124726894|NCT06003777|448620307|FG000|Period 4|No longer met eligibility criteria|0|||
124726895|NCT06003777|448620308|FG001|Period 4|No longer met eligibility criteria|0|||
124726896|NCT06003777|448620309|FG002|Period 4|No longer met eligibility criteria|1|||
124726897|NCT06003777|448620310|FG003|Period 4|No longer met eligibility criteria|0|||
124726898|NCT06003777|448620311|FG004|Period 4|No longer met eligibility criteria|0|||
124726899|NCT06003777|448620312|FG005|Period 4|No longer met eligibility criteria|0|||
124726900|NCT06003777|448620313|FG006|Period 4|No longer met eligibility criteria|0|||
124726901|NCT06003777|448620314|FG007|Period 4|No longer met eligibility criteria|0|||
124726902|NCT06003777|448620315|FG008|Period 4|No longer met eligibility criteria|0|||
124726903|NCT06003777|448620316|FG009|Period 4|No longer met eligibility criteria|0|||
124726904|NCT06003777|448620317|FG010|Period 4|No longer met eligibility criteria|0|||
124726905|NCT06003777|448620318|FG011|Period 4|No longer met eligibility criteria|0|||
124726906|NCT06003777|448620307|FG000|Period 4|Withdrawal by Subject|0|||
124527966|NCT01055457|447884187|FG001|Overall Study|Adverse Event|0|||
124726907|NCT06003777|448620308|FG001|Period 4|Withdrawal by Subject|1|||
124726908|NCT06003777|448620309|FG002|Period 4|Withdrawal by Subject|0|||
124527967|NCT01055457|447884188|FG002|Overall Study|Adverse Event|0|||
124527968|NCT01055457|447884189|FG003|Overall Study|Adverse Event|1|||
124527969|NCT01055457|447884190|FG004|Overall Study|Adverse Event|0|||
124527970|NCT01055457|447884191|FG005|Overall Study|Adverse Event|0|||
124527971|NCT01055457|447884192|FG006|Overall Study|Adverse Event|0|||
124527972|NCT01055457|447884193|FG007|Overall Study|Adverse Event|0|||
124527973|NCT01055457|447884194|FG008|Overall Study|Adverse Event|0|||
124527974|NCT01055457|447884195|FG009|Overall Study|Adverse Event|0|||
124527975|NCT04055844|447884196|FG000|Overall Study|Adverse Event|12|||
124527976|NCT04055844|447884196|FG000|Overall Study|Poor Performance|1|||
124527977|NCT04055844|447884196|FG000|Overall Study|Death|1|||
124527978|NCT03630016|447884205|FG000|Overall Study|Poor Sensor Placement|1|||
124527979|NCT00255008|447884206|FG000|Overall Study|Adverse Event|1|||
124527980|NCT00255008|447884207|FG001|Overall Study|Adverse Event|1|||
124527981|NCT00255008|447884208|FG002|Overall Study|Adverse Event|2|||
124527982|NCT00255008|447884209|FG003|Overall Study|Adverse Event|0|||
124527983|NCT00255008|447884206|FG000|Overall Study|Lost to Follow-up|1|||
124527984|NCT00255008|447884207|FG001|Overall Study|Lost to Follow-up|0|||
124527985|NCT00255008|447884208|FG002|Overall Study|Lost to Follow-up|1|||
124527986|NCT00255008|447884209|FG003|Overall Study|Lost to Follow-up|2|||
124527987|NCT00255008|447884206|FG000|Overall Study|Did not meet viral reduction criteria|4|||
124527988|NCT00255008|447884207|FG001|Overall Study|Did not meet viral reduction criteria|5|||
124527989|NCT00255008|447884208|FG002|Overall Study|Did not meet viral reduction criteria|0|||
124527990|NCT00255008|447884209|FG003|Overall Study|Did not meet viral reduction criteria|1|||
124527991|NCT00255008|447884206|FG000|Overall Study|Withdrew consent|0|||
124527992|NCT00255008|447884207|FG001|Overall Study|Withdrew consent|0|||
124527993|NCT00255008|447884208|FG002|Overall Study|Withdrew consent|2|||
124527994|NCT00255008|447884209|FG003|Overall Study|Withdrew consent|0|||
124527995|NCT00255008|447884206|FG000|Overall Study|Sponsor request|18|||
124527996|NCT00255008|447884207|FG001|Overall Study|Sponsor request|3|||
124527997|NCT00255008|447884208|FG002|Overall Study|Sponsor request|8|||
124527998|NCT00255008|447884209|FG003|Overall Study|Sponsor request|17|||
124527999|NCT00255008|447884206|FG000|Overall Study|Adverse lab experience|1|||
124528000|NCT00255008|447884207|FG001|Overall Study|Adverse lab experience|0|||
124528001|NCT00255008|447884208|FG002|Overall Study|Adverse lab experience|0|||
124528002|NCT00255008|447884209|FG003|Overall Study|Adverse lab experience|0|||
124528003|NCT00255008|447884206|FG000|Overall Study|Other|7|||
124528004|NCT00255008|447884207|FG001|Overall Study|Other|0|||
124528005|NCT00255008|447884208|FG002|Overall Study|Other|3|||
124528006|NCT00255008|447884209|FG003|Overall Study|Other|2|||
124528007|NCT01833806|447884210|FG000|Overall Study|Alternative treatment|2|||
124528008|NCT01833806|447884210|FG000|Overall Study|Death|5|||
124528009|NCT01833806|447884210|FG000|Overall Study|Physician Decision|1|||
124528010|NCT01833806|447884210|FG000|Overall Study|Lost to Follow-up|1|||
124528011|NCT02724111|447884211|FG000|Overall Study|Protocol Violation|2|||
124528012|NCT02724111|447884212|FG001|Overall Study|Protocol Violation|5|||
124528013|NCT02996500|447884213|FG000|Overall Study|Adverse Event|1|||
124726909|NCT06003777|448620310|FG003|Period 4|Withdrawal by Subject|0|||
124726910|NCT06003777|448620311|FG004|Period 4|Withdrawal by Subject|0|||
124726911|NCT06003777|448620312|FG005|Period 4|Withdrawal by Subject|0|||
124726912|NCT06003777|448620313|FG006|Period 4|Withdrawal by Subject|0|||
124726913|NCT06003777|448620314|FG007|Period 4|Withdrawal by Subject|0|||
124726914|NCT06003777|448620315|FG008|Period 4|Withdrawal by Subject|0|||
124726915|NCT06003777|448620316|FG009|Period 4|Withdrawal by Subject|0|||
124726916|NCT06003777|448620317|FG010|Period 4|Withdrawal by Subject|0|||
124528014|NCT02996500|447884214|FG001|Overall Study|Adverse Event|1|||
124528015|NCT02996500|447884215|FG002|Overall Study|Adverse Event|4|||
124528016|NCT02996500|447884216|FG003|Overall Study|Adverse Event|3|||
124528017|NCT02996500|447884217|FG004|Overall Study|Adverse Event|1|||
124528018|NCT02996500|447884218|FG005|Overall Study|Adverse Event|2|||
124528019|NCT02996500|447884213|FG000|Overall Study|Lack of Efficacy|0|||
124528020|NCT02996500|447884214|FG001|Overall Study|Lack of Efficacy|0|||
124528021|NCT02996500|447884215|FG002|Overall Study|Lack of Efficacy|0|||
124528022|NCT02996500|447884216|FG003|Overall Study|Lack of Efficacy|0|||
124528023|NCT02996500|447884217|FG004|Overall Study|Lack of Efficacy|2|||
124528024|NCT02996500|447884218|FG005|Overall Study|Lack of Efficacy|0|||
124528025|NCT02996500|447884213|FG000|Overall Study|Lost to Follow-up|1|||
124528026|NCT02996500|447884214|FG001|Overall Study|Lost to Follow-up|0|||
124528027|NCT02996500|447884215|FG002|Overall Study|Lost to Follow-up|0|||
124528028|NCT02996500|447884216|FG003|Overall Study|Lost to Follow-up|0|||
124528029|NCT02996500|447884217|FG004|Overall Study|Lost to Follow-up|0|||
124528030|NCT02996500|447884218|FG005|Overall Study|Lost to Follow-up|1|||
124528031|NCT02996500|447884213|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
124528032|NCT02996500|447884214|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
124528033|NCT02996500|447884215|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
124528034|NCT02996500|447884216|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
124528035|NCT02996500|447884217|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
124528036|NCT02996500|447884218|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
124528037|NCT02996500|447884213|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124528038|NCT02996500|447884214|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124528039|NCT02996500|447884215|FG002|Overall Study|Non-Compliance With Study Drug|0|||
124528040|NCT02996500|447884216|FG003|Overall Study|Non-Compliance With Study Drug|0|||
124528041|NCT02996500|447884217|FG004|Overall Study|Non-Compliance With Study Drug|0|||
124528042|NCT02996500|447884218|FG005|Overall Study|Non-Compliance With Study Drug|1|||
124528043|NCT02996500|447884213|FG000|Overall Study|Progressive Disease|1|||
124528044|NCT02996500|447884214|FG001|Overall Study|Progressive Disease|0|||
124528045|NCT02996500|447884215|FG002|Overall Study|Progressive Disease|0|||
124528046|NCT02996500|447884216|FG003|Overall Study|Progressive Disease|0|||
124528047|NCT02996500|447884217|FG004|Overall Study|Progressive Disease|0|||
124528048|NCT02996500|447884218|FG005|Overall Study|Progressive Disease|0|||
124528049|NCT02996500|447884213|FG000|Overall Study|Other|2|||
124528050|NCT02996500|447884214|FG001|Overall Study|Other|0|||
124528051|NCT02996500|447884215|FG002|Overall Study|Other|2|||
124528052|NCT02996500|447884216|FG003|Overall Study|Other|0|||
124528053|NCT02996500|447884217|FG004|Overall Study|Other|0|||
124528054|NCT02996500|447884218|FG005|Overall Study|Other|0|||
124528055|NCT02996500|447884213|FG000|Overall Study|Protocol Violation|0|||
124528056|NCT02996500|447884214|FG001|Overall Study|Protocol Violation|0|||
124528057|NCT02996500|447884215|FG002|Overall Study|Protocol Violation|0|||
124528058|NCT02996500|447884216|FG003|Overall Study|Protocol Violation|1|||
124528059|NCT02996500|447884217|FG004|Overall Study|Protocol Violation|0|||
124528060|NCT02996500|447884218|FG005|Overall Study|Protocol Violation|0|||
124528061|NCT02996500|447884213|FG000|Overall Study|Withdrawal by Subject|3|||
124528062|NCT02996500|447884214|FG001|Overall Study|Withdrawal by Subject|0|||
124528063|NCT02996500|447884215|FG002|Overall Study|Withdrawal by Subject|3|||
124528064|NCT02996500|447884216|FG003|Overall Study|Withdrawal by Subject|0|||
124528065|NCT02996500|447884217|FG004|Overall Study|Withdrawal by Subject|2|||
124528066|NCT02996500|447884218|FG005|Overall Study|Withdrawal by Subject|0|||
124528067|NCT02485860|447884219|FG000|Overall Study|Lost to Follow-up|4|||
124528068|NCT02485860|447884220|FG001|Overall Study|Lost to Follow-up|1|||
124528069|NCT02485860|447884219|FG000|Overall Study|Physician Decision|1|||
124528070|NCT02485860|447884220|FG001|Overall Study|Physician Decision|2|||
124528071|NCT02485860|447884219|FG000|Overall Study|Health context (COVID-19)|1|||
124528072|NCT02485860|447884220|FG001|Overall Study|Health context (COVID-19)|0|||
124528073|NCT03325010|447884223|FG000|Overall Study|Adverse Event|3|||
124528074|NCT03325010|447884224|FG001|Overall Study|Adverse Event|8|||
124528075|NCT03325010|447884223|FG000|Overall Study|Protocol Violation|1|||
124528076|NCT03325010|447884224|FG001|Overall Study|Protocol Violation|8|||
124528077|NCT03325010|447884223|FG000|Overall Study|Withdrawal by Subject|1|||
124528078|NCT03325010|447884224|FG001|Overall Study|Withdrawal by Subject|3|||
124528079|NCT03325010|447884223|FG000|Overall Study|Lost to Follow-up|1|||
124528080|NCT03325010|447884224|FG001|Overall Study|Lost to Follow-up|0|||
124528081|NCT03325010|447884223|FG000|Overall Study|Physician Decision|1|||
124528082|NCT03325010|447884224|FG001|Overall Study|Physician Decision|1|||
124726917|NCT06003777|448620318|FG011|Period 4|Withdrawal by Subject|0|||
124528083|NCT03325010|447884223|FG000|Overall Study|Lack of Efficacy|2|||
124528084|NCT03325010|447884224|FG001|Overall Study|Lack of Efficacy|0|||
124528085|NCT03073200|447884231|FG000|Double Blind Treatment Period|Protocol Violation|1|||
124528086|NCT03073200|447884232|FG001|Double Blind Treatment Period|Protocol Violation|0|||
124528087|NCT03073200|447884233|FG002|Double Blind Treatment Period|Protocol Violation|0|||
124528088|NCT03073200|447884234|FG003|Double Blind Treatment Period|Protocol Violation|0|||
124528089|NCT03073200|447884235|FG004|Double Blind Treatment Period|Protocol Violation|0|||
124528090|NCT03073200|447884236|FG005|Double Blind Treatment Period|Protocol Violation|0|||
124528091|NCT03073200|447884237|FG006|Double Blind Treatment Period|Protocol Violation|0|||
124528092|NCT03073200|447884238|FG007|Double Blind Treatment Period|Protocol Violation|0|||
124528093|NCT03073200|447884239|FG008|Double Blind Treatment Period|Protocol Violation|0|||
124528094|NCT03073200|447884240|FG009|Double Blind Treatment Period|Protocol Violation|0|||
124580580|NCT04493684|448083011|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
124580581|NCT04493684|448083012|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
124580582|NCT04493684|448083013|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
124580583|NCT04493684|448083014|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
124580584|NCT04493684|448083015|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
124580585|NCT04493684|448083016|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
124580586|NCT04493684|448083017|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
124580587|NCT04493684|448083018|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
124580588|NCT04493684|448083019|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
124580589|NCT04493684|448083020|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
124580590|NCT04493684|448083021|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
124580591|NCT04493684|448083022|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
124580592|NCT04493684|448083023|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
124580593|NCT04493684|448083024|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
124580594|NCT04493684|448083025|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
124580595|NCT04493684|448083026|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
124580596|NCT04493684|448083027|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
124580597|NCT01963728|448083028|FG000|Overall Study|Study terminated early|0|||
124580598|NCT01963728|448083029|FG001|Overall Study|Study terminated early|1|||
124580599|NCT05152576|448083030|FG000|Overall Study|Lost to Follow-up|3|||
124580600|NCT05152576|448083031|FG001|Overall Study|Lost to Follow-up|0|||
124580601|NCT05152576|448083032|FG002|Overall Study|Lost to Follow-up|0|||
124580602|NCT05152576|448083033|FG003|Overall Study|Lost to Follow-up|1|||
124580603|NCT05152576|448083030|FG000|Overall Study|Withdrawal by Subject|0|||
124580604|NCT05152576|448083031|FG001|Overall Study|Withdrawal by Subject|1|||
124580605|NCT05152576|448083032|FG002|Overall Study|Withdrawal by Subject|0|||
124580606|NCT05152576|448083033|FG003|Overall Study|Withdrawal by Subject|1|||
124580607|NCT05152576|448083030|FG000|Overall Study|Other|2|||
124580608|NCT05152576|448083031|FG001|Overall Study|Other|0|||
124580609|NCT05152576|448083032|FG002|Overall Study|Other|0|||
124580610|NCT05152576|448083033|FG003|Overall Study|Other|0|||
124580611|NCT04115293|448084714|FG000|Overall Study|Adverse Event|0|||
124580612|NCT04115293|448084715|FG001|Overall Study|Adverse Event|2|||
124580613|NCT04115293|448084714|FG000|Overall Study|Withdrawal by Subject|2|||
124580614|NCT04115293|448084715|FG001|Overall Study|Withdrawal by Subject|1|||
124580615|NCT04115293|448084714|FG000|Overall Study|Physician Decision|1|||
124580616|NCT04115293|448084715|FG001|Overall Study|Physician Decision|0|||
124580617|NCT04115293|448084714|FG000|Overall Study|Death|1|||
124580618|NCT04115293|448084715|FG001|Overall Study|Death|1|||
124580619|NCT00712959|448084723|FG000|Overall Study|Protocol Violation|3|||
124580620|NCT00712959|448084724|FG001|Overall Study|Protocol Violation|1|||
124580621|NCT00712959|448084723|FG000|Overall Study|Lost to Follow-up|13|||
124580622|NCT00712959|448084724|FG001|Overall Study|Lost to Follow-up|2|||
124580623|NCT00712959|448084723|FG000|Overall Study|Withdrawal by Subject|3|||
124580624|NCT00712959|448084724|FG001|Overall Study|Withdrawal by Subject|0|||
124580625|NCT01376037|448084734|FG000|Overall Study|Lost to Follow-up|0|||
124580626|NCT01376037|448084735|FG001|Overall Study|Lost to Follow-up|2|||
124580627|NCT02328040|448084736|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
124580628|NCT02328040|448084737|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
124580629|NCT04278560|448084742|FG000|Overall Study|Adverse Event|1|||
124580630|NCT04278560|448084743|FG001|Overall Study|Adverse Event|2|||
124580631|NCT04278560|448084742|FG000|Overall Study|Withdrawal by Subject|0|||
124580632|NCT04278560|448084743|FG001|Overall Study|Withdrawal by Subject|1|||
124580633|NCT02832063|448084744|FG000|Overall Study|Adverse Event|2|||
124580634|NCT02832063|448084745|FG001|Overall Study|Adverse Event|1|||
124580635|NCT02832063|448084744|FG000|Overall Study|Physician Decision|5|||
124580636|NCT02832063|448084745|FG001|Overall Study|Physician Decision|7|||
124580637|NCT02832063|448084744|FG000|Overall Study|Lost to Follow-up|15|||
124580638|NCT02832063|448084745|FG001|Overall Study|Lost to Follow-up|8|||
124580639|NCT02832063|448084744|FG000|Overall Study|Withdrawal by Subject|10|||
124580640|NCT02832063|448084745|FG001|Overall Study|Withdrawal by Subject|21|||
124580641|NCT02832063|448084744|FG000|Overall Study|Other|2|||
124580642|NCT02832063|448084745|FG001|Overall Study|Other|1|||
124580643|NCT03086460|448084750|FG000|Study Participants|Lost to Follow-up|2|||
124580644|NCT03086460|448084750|FG000|Study Participants|Protocol Violation|1|||
124580645|NCT03086460|448084750|FG000|Study Participants|Withdrawal by Subject|6|||
124580646|NCT03086460|448084750|FG000|Treatment A|Lost to Follow-up|1|||
124726918|NCT01106651|448620319|FG000|Overall Study|Adverse Event|17|||
124726919|NCT01106651|448620320|FG001|Overall Study|Adverse Event|9|||
124726920|NCT01106651|448620321|FG002|Overall Study|Adverse Event|23|||
124726921|NCT01106651|448620319|FG000|Overall Study|Lost to Follow-up|8|||
124726922|NCT01106651|448620320|FG001|Overall Study|Lost to Follow-up|2|||
124726923|NCT01106651|448620321|FG002|Overall Study|Lost to Follow-up|6|||
124726924|NCT01106651|448620319|FG000|Overall Study|Physician Decision|4|||
124726925|NCT01106651|448620320|FG001|Overall Study|Physician Decision|3|||
124726926|NCT01106651|448620321|FG002|Overall Study|Physician Decision|1|||
124726927|NCT01106651|448620319|FG000|Overall Study|Protocol Violation|1|||
124726928|NCT01106651|448620320|FG001|Overall Study|Protocol Violation|2|||
124726929|NCT01106651|448620321|FG002|Overall Study|Protocol Violation|1|||
124726930|NCT01106651|448620319|FG000|Overall Study|Withdrawal by Subject|14|||
124726931|NCT01106651|448620320|FG001|Overall Study|Withdrawal by Subject|7|||
124726932|NCT01106651|448620321|FG002|Overall Study|Withdrawal by Subject|4|||
124726933|NCT01106651|448620319|FG000|Overall Study|Noncompliance with study drug|1|||
124726934|NCT01106651|448620320|FG001|Overall Study|Noncompliance with study drug|0|||
124726935|NCT01106651|448620321|FG002|Overall Study|Noncompliance with study drug|2|||
124726936|NCT01106651|448620319|FG000|Overall Study|Other|34|||
124726937|NCT01106651|448620320|FG001|Overall Study|Other|31|||
124726938|NCT01106651|448620321|FG002|Overall Study|Other|21|||
124726939|NCT01106651|448620319|FG000|Overall Study|Death|0|||
124726940|NCT01106651|448620320|FG001|Overall Study|Death|3|||
124726941|NCT01106651|448620321|FG002|Overall Study|Death|0|||
124726942|NCT00613327|448620325|FG000|Overall Study|Adverse Event|38|||
124726943|NCT00613327|448620325|FG000|Overall Study|Lost to Follow-up|8|||
124726944|NCT00613327|448620325|FG000|Overall Study|Withdrawal by Subject|6|||
124726945|NCT00613327|448620325|FG000|Overall Study|Protocol Violation|2|||
124726946|NCT00613327|448620325|FG000|Overall Study|Other|47|||
124726947|NCT00290771|448620332|FG000|Overall Study|Disease progression|95|||
124726948|NCT00290771|448620333|FG001|Overall Study|Disease progression|73|||
124726949|NCT00290771|448620332|FG000|Overall Study|Death|11|||
124726950|NCT00290771|448620333|FG001|Overall Study|Death|10|||
124726951|NCT00290771|448620332|FG000|Overall Study|Adverse Event|12|||
124726952|NCT00290771|448620333|FG001|Overall Study|Adverse Event|6|||
124726953|NCT00290771|448620332|FG000|Overall Study|Withdrawal by Subject|5|||
124726954|NCT00290771|448620333|FG001|Overall Study|Withdrawal by Subject|6|||
124726955|NCT00290771|448620332|FG000|Overall Study|Administrative problems|2|||
124726956|NCT00290771|448620333|FG001|Overall Study|Administrative problems|1|||
124726957|NCT00290771|448620332|FG000|Overall Study|Protocol Violation|2|||
124726958|NCT00290771|448620333|FG001|Overall Study|Protocol Violation|0|||
124726959|NCT00290771|448620332|FG000|Overall Study|Lost to Follow-up|0|||
124726960|NCT00290771|448620333|FG001|Overall Study|Lost to Follow-up|1|||
124726961|NCT03403361|448620337|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
124726962|NCT02247011|448620339|FG000|Overall Study|Poor quality of radiological results|125|||
124726963|NCT00656058|448620340|FG000|Overall Study|Withdrawal by Subject|2|||
124726964|NCT00656058|448620340|FG000|Overall Study|Withdrawal by Subject|4|||
124726965|NCT03718884|448620341|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
124726966|NCT03718884|448620342|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
124726967|NCT03718884|448620341|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
124726968|NCT03718884|448620342|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
124726969|NCT04700540|448620343|FG000|Overall Study|Withdrawal by Subject|12|||
124726970|NCT04700540|448620344|FG001|Overall Study|Withdrawal by Subject|8|||
124726971|NCT04700540|448620343|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
124726972|NCT04700540|448620344|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
124726973|NCT03515551|448620345|FG000|Overall Study|Death|4|||
124726974|NCT03515551|448620346|FG001|Overall Study|Death|1|||
124726975|NCT03515551|448620347|FG002|Overall Study|Death|2|||
124726976|NCT03515551|448620348|FG003|Overall Study|Death|2|||
124726977|NCT03515551|448620349|FG004|Overall Study|Death|2|||
124726978|NCT03515551|448620350|FG005|Overall Study|Death|4|||
124528095|NCT03073200|447884241|FG010|Double Blind Treatment Period|Protocol Violation|0|||
124528096|NCT03073200|447884242|FG011|Double Blind Treatment Period|Protocol Violation|0|||
124726979|NCT03515551|448620351|FG006|Overall Study|Death|1|||
124726980|NCT03515551|448620345|FG000|Overall Study|Lost to Follow-up|0|||
124726981|NCT03515551|448620346|FG001|Overall Study|Lost to Follow-up|0|||
124726982|NCT03515551|448620347|FG002|Overall Study|Lost to Follow-up|1|||
124726983|NCT03515551|448620348|FG003|Overall Study|Lost to Follow-up|0|||
124726984|NCT03515551|448620349|FG004|Overall Study|Lost to Follow-up|0|||
124726985|NCT03515551|448620350|FG005|Overall Study|Lost to Follow-up|0|||
124726986|NCT03515551|448620351|FG006|Overall Study|Lost to Follow-up|0|||
124726987|NCT03515551|448620345|FG000|Overall Study|Withdrawal by Subject|0|||
124726988|NCT03515551|448620346|FG001|Overall Study|Withdrawal by Subject|1|||
124726989|NCT03515551|448620347|FG002|Overall Study|Withdrawal by Subject|0|||
124726990|NCT03515551|448620348|FG003|Overall Study|Withdrawal by Subject|0|||
124726991|NCT03515551|448620349|FG004|Overall Study|Withdrawal by Subject|0|||
124726992|NCT03515551|448620350|FG005|Overall Study|Withdrawal by Subject|0|||
124580647|NCT03086460|448084750|FG000|Treatment A|Protocol Violation|1|||
124580648|NCT03086460|448084750|FG000|Treatment A|Withdrawal by Subject|2|||
124580649|NCT03086460|448084750|FG000|Treatment C|Withdrawal by Subject|2|||
124580650|NCT03086460|448084750|FG000|Treatment E|Lost to Follow-up|1|||
124580651|NCT03086460|448084750|FG000|Treatment E|Withdrawal by Subject|3|||
124580652|NCT03600805|448084751|FG000|Overall Study|Adverse Event|2|||
124580653|NCT03600805|448084752|FG001|Overall Study|Adverse Event|1|||
124580654|NCT03600805|448084753|FG002|Overall Study|Adverse Event|1|||
124580655|NCT03600805|448084754|FG003|Overall Study|Adverse Event|7|||
124580656|NCT03600805|448084751|FG000|Overall Study|Lack of Efficacy|2|||
124580657|NCT03600805|448084752|FG001|Overall Study|Lack of Efficacy|1|||
124580658|NCT03600805|448084753|FG002|Overall Study|Lack of Efficacy|0|||
124580659|NCT03600805|448084754|FG003|Overall Study|Lack of Efficacy|0|||
124580660|NCT03600805|448084751|FG000|Overall Study|Withdrawal by Subject|1|||
124580661|NCT03600805|448084752|FG001|Overall Study|Withdrawal by Subject|0|||
124580662|NCT03600805|448084753|FG002|Overall Study|Withdrawal by Subject|0|||
124580663|NCT03600805|448084754|FG003|Overall Study|Withdrawal by Subject|1|||
124580664|NCT03600805|448084751|FG000|Overall Study|Other unspecified|14|||
124580665|NCT03600805|448084752|FG001|Overall Study|Other unspecified|6|||
124580666|NCT03600805|448084753|FG002|Overall Study|Other unspecified|7|||
124580667|NCT03600805|448084754|FG003|Overall Study|Other unspecified|11|||
124580668|NCT03415308|448084757|FG000|Overall Study|Lost to Follow-up|0|||
124580669|NCT03415308|448084758|FG001|Overall Study|Lost to Follow-up|0|||
124580670|NCT03415308|448084759|FG002|Overall Study|Lost to Follow-up|1|||
124580671|NCT03415308|448084757|FG000|Overall Study|Scheduling Conflicts|0|||
124580672|NCT03415308|448084758|FG001|Overall Study|Scheduling Conflicts|0|||
124580673|NCT03415308|448084759|FG002|Overall Study|Scheduling Conflicts|7|||
124580674|NCT01471353|448084761|FG000|Overall Study|remain on study|3|||
124580675|NCT00836472|448084762|FG000|Washout|Adverse Event|1|||
124580676|NCT00836472|448084763|FG001|Washout|Adverse Event|2|||
124580677|NCT00836472|448084762|FG000|Washout|Withdrawal by Subject|1|||
124580678|NCT00836472|448084763|FG001|Washout|Withdrawal by Subject|1|||
124580679|NCT01695239|448084764|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
124580680|NCT01695239|448084765|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
124580681|NCT01695239|448084766|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
124580682|NCT01695239|448084767|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
124580683|NCT01695239|448084768|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
124580684|NCT01695239|448084769|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
124580685|NCT01695239|448084770|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
124580686|NCT01695239|448084771|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
124580687|NCT01695239|448084772|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
124580688|NCT01695239|448084773|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
124580689|NCT01695239|448084774|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
124580690|NCT01695239|448084775|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
124580691|NCT01695239|448084776|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
124580692|NCT01695239|448084777|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
124580693|NCT01695239|448084764|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
124580694|NCT01695239|448084765|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
124580695|NCT01695239|448084766|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
124580696|NCT01695239|448084767|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
124580697|NCT01695239|448084768|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
124580698|NCT01695239|448084769|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
124580699|NCT01695239|448084770|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
124580700|NCT01695239|448084771|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
124580701|NCT01695239|448084772|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
124580702|NCT01695239|448084773|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
124580703|NCT01695239|448084774|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
124580704|NCT01695239|448084775|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
124580705|NCT01695239|448084776|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
124580706|NCT01695239|448084777|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
124580707|NCT01695239|448084764|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
124580708|NCT01695239|448084765|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
124580709|NCT01695239|448084766|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
124580710|NCT01695239|448084767|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
124580711|NCT01695239|448084768|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
124580712|NCT01695239|448084769|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
124580713|NCT01695239|448084770|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
124580714|NCT01695239|448084771|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
124580715|NCT01695239|448084772|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
124580716|NCT01695239|448084773|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
124580717|NCT01695239|448084774|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
124580718|NCT01695239|448084775|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
124726993|NCT03515551|448620351|FG006|Overall Study|Withdrawal by Subject|1|||
124726994|NCT03515551|448620345|FG000|Overall Study|Study ended by sponsor|0|||
124726995|NCT03515551|448620346|FG001|Overall Study|Study ended by sponsor|0|||
124726996|NCT03515551|448620347|FG002|Overall Study|Study ended by sponsor|2|||
124726997|NCT03515551|448620348|FG003|Overall Study|Study ended by sponsor|1|||
124726998|NCT03515551|448620349|FG004|Overall Study|Study ended by sponsor|3|||
124726999|NCT03515551|448620350|FG005|Overall Study|Study ended by sponsor|0|||
124580719|NCT01695239|448084776|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
124580720|NCT01695239|448084777|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
124580721|NCT01695239|448084764|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
124580722|NCT01695239|448084765|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
124580723|NCT01695239|448084766|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
124580724|NCT01695239|448084767|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
124580725|NCT01695239|448084768|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
124580726|NCT01695239|448084769|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
124580727|NCT01695239|448084770|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
124580728|NCT01695239|448084771|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
124580729|NCT01695239|448084772|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
124727000|NCT03515551|448620351|FG006|Overall Study|Study ended by sponsor|3|||
124727001|NCT03515551|448620345|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
124528097|NCT03073200|447884243|FG012|Double Blind Treatment Period|Protocol Violation|0|||
124528098|NCT03073200|447884244|FG013|Double Blind Treatment Period|Protocol Violation|0|||
124528099|NCT03073200|447884245|FG014|Double Blind Treatment Period|Protocol Violation|0|||
124528100|NCT03073200|447884231|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
124528101|NCT03073200|447884232|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
124528102|NCT03073200|447884233|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
124528103|NCT03073200|447884234|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
124528104|NCT03073200|447884235|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
124528105|NCT03073200|447884236|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
124528106|NCT03073200|447884237|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
124528107|NCT03073200|447884238|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
124528108|NCT03073200|447884239|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
124528109|NCT03073200|447884240|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
124528110|NCT03073200|447884241|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
124528111|NCT03073200|447884242|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
124528112|NCT03073200|447884243|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
124528113|NCT03073200|447884244|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
124528114|NCT03073200|447884245|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
124528115|NCT03073200|447884231|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
124528116|NCT03073200|447884232|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
124528117|NCT03073200|447884233|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
124528118|NCT03073200|447884234|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
124528119|NCT03073200|447884235|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
124528120|NCT03073200|447884236|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
124528121|NCT03073200|447884237|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
124528122|NCT03073200|447884238|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
124528123|NCT03073200|447884239|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
124528124|NCT03073200|447884240|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
124528125|NCT03073200|447884241|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
124528126|NCT03073200|447884242|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
124528127|NCT03073200|447884243|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
124528128|NCT03073200|447884244|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
124528129|NCT03073200|447884245|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
124528130|NCT03073200|447884231|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
124528131|NCT03073200|447884232|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
124528132|NCT03073200|447884233|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
124528133|NCT03073200|447884234|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
124528134|NCT03073200|447884235|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
124528135|NCT03073200|447884236|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
124528136|NCT03073200|447884237|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
124528137|NCT03073200|447884238|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
124528138|NCT03073200|447884239|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
124528139|NCT03073200|447884240|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
124528140|NCT03073200|447884241|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
124580730|NCT01695239|448084773|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
124727002|NCT03515551|448620346|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
124528141|NCT03073200|447884242|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
124528142|NCT03073200|447884243|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
124528143|NCT03073200|447884244|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
124528144|NCT03073200|447884245|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
124528145|NCT03073200|447884231|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
124528146|NCT03073200|447884232|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
124528147|NCT03073200|447884233|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
124528148|NCT03073200|447884234|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
124528149|NCT03073200|447884235|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
124528150|NCT03073200|447884236|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
124776836|NCT02202759|448811311|FG000|Overall Study|Study Terminated by Sponsor|3|||
124776837|NCT02202759|448811312|FG001|Overall Study|Study Terminated by Sponsor|3|||
124528151|NCT03073200|447884237|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
124528152|NCT03073200|447884238|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
124528153|NCT03073200|447884239|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
124528154|NCT03073200|447884240|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
124528155|NCT03073200|447884241|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
124528156|NCT03073200|447884242|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
124528157|NCT03073200|447884243|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
124528158|NCT03073200|447884244|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
124528159|NCT03073200|447884245|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
124528160|NCT03073200|447884231|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
124528161|NCT03073200|447884232|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
124528162|NCT03073200|447884233|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
124528163|NCT03073200|447884234|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
124528164|NCT03073200|447884235|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
124528165|NCT03073200|447884236|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
124528166|NCT03073200|447884237|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
124528167|NCT03073200|447884238|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
124528168|NCT03073200|447884239|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
124528169|NCT03073200|447884240|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
124528170|NCT03073200|447884241|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
124528171|NCT03073200|447884242|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
124528172|NCT03073200|447884243|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
124528173|NCT03073200|447884244|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
124528174|NCT03073200|447884245|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
124528175|NCT03073200|447884231|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
124528176|NCT03073200|447884232|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
124528177|NCT03073200|447884233|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
124528178|NCT03073200|447884234|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
124528179|NCT03073200|447884235|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
124528180|NCT03073200|447884236|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
124528181|NCT03073200|447884237|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
124528182|NCT03073200|447884238|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
124528183|NCT03073200|447884239|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
124528184|NCT03073200|447884240|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
124528185|NCT03073200|447884241|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
124528186|NCT03073200|447884242|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
124528187|NCT03073200|447884243|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
124528188|NCT03073200|447884244|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
124528189|NCT03073200|447884245|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
124528190|NCT03073200|447884231|FG000|Extension Period|Lost to Follow-up|0|||
124528191|NCT03073200|447884232|FG001|Extension Period|Lost to Follow-up|0|||
124528192|NCT03073200|447884233|FG002|Extension Period|Lost to Follow-up|0|||
124528193|NCT03073200|447884234|FG003|Extension Period|Lost to Follow-up|0|||
124528194|NCT03073200|447884235|FG004|Extension Period|Lost to Follow-up|0|||
124528195|NCT03073200|447884236|FG005|Extension Period|Lost to Follow-up|0|||
124528196|NCT03073200|447884237|FG006|Extension Period|Lost to Follow-up|1|||
124528197|NCT03073200|447884238|FG007|Extension Period|Lost to Follow-up|1|||
124528198|NCT03073200|447884239|FG008|Extension Period|Lost to Follow-up|0|||
124776838|NCT02202759|448811313|FG002|Overall Study|Study Terminated by Sponsor|3|||
124528199|NCT03073200|447884240|FG009|Extension Period|Lost to Follow-up|0|||
124528200|NCT03073200|447884241|FG010|Extension Period|Lost to Follow-up|0|||
124528201|NCT03073200|447884242|FG011|Extension Period|Lost to Follow-up|0|||
124528202|NCT03073200|447884243|FG012|Extension Period|Lost to Follow-up|0|||
124528203|NCT03073200|447884244|FG013|Extension Period|Lost to Follow-up|0|||
124528204|NCT03073200|447884245|FG014|Extension Period|Lost to Follow-up|0|||
124528205|NCT03073200|447884231|FG000|Extension Period|Sponsor Decision|0|||
124528206|NCT03073200|447884232|FG001|Extension Period|Sponsor Decision|0|||
124528207|NCT03073200|447884233|FG002|Extension Period|Sponsor Decision|0|||
124528208|NCT03073200|447884234|FG003|Extension Period|Sponsor Decision|0|||
124528209|NCT03073200|447884235|FG004|Extension Period|Sponsor Decision|0|||
124528210|NCT03073200|447884236|FG005|Extension Period|Sponsor Decision|0|||
124528211|NCT03073200|447884237|FG006|Extension Period|Sponsor Decision|0|||
124528212|NCT03073200|447884238|FG007|Extension Period|Sponsor Decision|0|||
124528213|NCT03073200|447884239|FG008|Extension Period|Sponsor Decision|1|||
124528214|NCT03073200|447884240|FG009|Extension Period|Sponsor Decision|0|||
124528215|NCT03073200|447884241|FG010|Extension Period|Sponsor Decision|0|||
124528216|NCT03073200|447884242|FG011|Extension Period|Sponsor Decision|0|||
124528217|NCT03073200|447884243|FG012|Extension Period|Sponsor Decision|0|||
124528218|NCT03073200|447884244|FG013|Extension Period|Sponsor Decision|0|||
124528219|NCT03073200|447884245|FG014|Extension Period|Sponsor Decision|0|||
124528220|NCT03073200|447884231|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
124528221|NCT03073200|447884232|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
124528222|NCT03073200|447884233|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
124528223|NCT03073200|447884234|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
124528224|NCT03073200|447884235|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
124528225|NCT03073200|447884236|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
124528226|NCT03073200|447884237|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
124528227|NCT03073200|447884238|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
124528228|NCT03073200|447884239|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
124528229|NCT03073200|447884240|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
124528230|NCT03073200|447884241|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
124528231|NCT03073200|447884242|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
124528232|NCT03073200|447884243|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
124528233|NCT03073200|447884244|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
124528234|NCT03073200|447884245|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
124528235|NCT03073200|447884231|FG000|Extension Period|Withdrawal by Subject|0|||
124528236|NCT03073200|447884232|FG001|Extension Period|Withdrawal by Subject|0|||
124528237|NCT03073200|447884233|FG002|Extension Period|Withdrawal by Subject|0|||
124528238|NCT03073200|447884234|FG003|Extension Period|Withdrawal by Subject|0|||
124528239|NCT03073200|447884235|FG004|Extension Period|Withdrawal by Subject|0|||
124528240|NCT03073200|447884236|FG005|Extension Period|Withdrawal by Subject|0|||
124528241|NCT03073200|447884237|FG006|Extension Period|Withdrawal by Subject|1|||
124528242|NCT03073200|447884238|FG007|Extension Period|Withdrawal by Subject|2|||
124528243|NCT03073200|447884239|FG008|Extension Period|Withdrawal by Subject|0|||
124528244|NCT03073200|447884240|FG009|Extension Period|Withdrawal by Subject|0|||
124528245|NCT03073200|447884241|FG010|Extension Period|Withdrawal by Subject|0|||
124528246|NCT03073200|447884242|FG011|Extension Period|Withdrawal by Subject|0|||
124528247|NCT03073200|447884243|FG012|Extension Period|Withdrawal by Subject|0|||
124528248|NCT03073200|447884244|FG013|Extension Period|Withdrawal by Subject|0|||
124528249|NCT03073200|447884245|FG014|Extension Period|Withdrawal by Subject|0|||
124528250|NCT03073200|447884231|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
124528251|NCT03073200|447884232|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
124528252|NCT03073200|447884233|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
124528253|NCT03073200|447884234|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
124528254|NCT03073200|447884235|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
124528255|NCT03073200|447884236|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
124528256|NCT03073200|447884237|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
124528257|NCT03073200|447884238|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
124528258|NCT03073200|447884239|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
124528259|NCT03073200|447884240|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
124528260|NCT03073200|447884241|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
124528261|NCT03073200|447884242|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
124528262|NCT03073200|447884243|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
124528263|NCT03073200|447884244|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
124528264|NCT03073200|447884245|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
124528265|NCT03073200|447884231|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
124528266|NCT03073200|447884232|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
124528267|NCT03073200|447884233|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
124528268|NCT03073200|447884234|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
124528269|NCT03073200|447884235|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
124528270|NCT03073200|447884236|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
124528271|NCT03073200|447884237|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
124528272|NCT03073200|447884238|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
124528273|NCT03073200|447884239|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
124528274|NCT03073200|447884240|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
124528275|NCT03073200|447884241|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
124528276|NCT03073200|447884242|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
124580731|NCT01695239|448084774|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
124580732|NCT01695239|448084775|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
124580733|NCT01695239|448084776|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
124580734|NCT01695239|448084777|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
124580735|NCT01695239|448084764|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
124580736|NCT01695239|448084765|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
124580737|NCT01695239|448084766|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
124580738|NCT01695239|448084767|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
124580739|NCT01695239|448084768|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
124580740|NCT01695239|448084769|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
124580741|NCT01695239|448084770|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
124580742|NCT01695239|448084771|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
124580743|NCT01695239|448084772|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
124580744|NCT01695239|448084773|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
124580745|NCT01695239|448084774|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
124580746|NCT01695239|448084775|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
124580747|NCT01695239|448084776|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
124580748|NCT01695239|448084777|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
124580749|NCT01695239|448084764|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
124580750|NCT01695239|448084765|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
124580751|NCT01695239|448084766|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
124580752|NCT01695239|448084767|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
124580753|NCT01695239|448084768|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
124580754|NCT01695239|448084769|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
124580755|NCT01695239|448084770|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
124580756|NCT01695239|448084771|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
124580757|NCT01695239|448084772|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
124580758|NCT01695239|448084773|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
124580759|NCT01695239|448084774|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
124580760|NCT01695239|448084775|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
124580761|NCT01695239|448084776|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
124580762|NCT01695239|448084777|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
124580763|NCT01695239|448084764|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
124580764|NCT01695239|448084765|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
124580765|NCT01695239|448084766|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
124580766|NCT01695239|448084767|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
124580767|NCT01695239|448084768|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
124580768|NCT01695239|448084769|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
124580769|NCT01695239|448084770|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
124580770|NCT01695239|448084771|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
124580771|NCT01695239|448084772|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
124580772|NCT01695239|448084773|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
124580773|NCT01695239|448084774|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
124580774|NCT01695239|448084775|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
124580775|NCT01695239|448084776|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
124580776|NCT01695239|448084777|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
124580777|NCT01695239|448084764|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
124580778|NCT01695239|448084765|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
124580779|NCT01695239|448084766|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
124580780|NCT01695239|448084767|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
124580781|NCT01695239|448084768|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
124580782|NCT01695239|448084769|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
124580783|NCT01695239|448084770|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
124727003|NCT03515551|448620347|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
124727004|NCT03515551|448620348|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
124727005|NCT03515551|448620349|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
124727006|NCT03515551|448620350|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
124727007|NCT03515551|448620351|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
124727008|NCT02265536|448620358|FG000|Overall Study|Adverse Event|1|||
124580784|NCT01695239|448084771|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
124580785|NCT01695239|448084772|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
124580786|NCT01695239|448084773|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
124580787|NCT01695239|448084774|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
124727009|NCT02265536|448620359|FG001|Overall Study|Adverse Event|0|||
124727010|NCT02265536|448620360|FG002|Overall Study|Adverse Event|0|||
124727011|NCT02265536|448620361|FG003|Overall Study|Adverse Event|0|||
124727012|NCT02265536|448620362|FG004|Overall Study|Adverse Event|1|||
124528277|NCT03073200|447884243|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
124528278|NCT03073200|447884244|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
124528279|NCT03073200|447884245|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
124528280|NCT03073200|447884231|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124528281|NCT03073200|447884232|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124528282|NCT03073200|447884233|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124528283|NCT03073200|447884234|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124528284|NCT03073200|447884235|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124528285|NCT03073200|447884236|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124528286|NCT03073200|447884237|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124528287|NCT03073200|447884238|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124528288|NCT03073200|447884239|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124528289|NCT03073200|447884240|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124528290|NCT03073200|447884241|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
124528291|NCT03073200|447884242|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
124528292|NCT03073200|447884243|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124528293|NCT03073200|447884244|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124528294|NCT03073200|447884245|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
124528295|NCT03073200|447884231|FG000|Randomized Withdrawal Period|Adverse Event|0|||
124528296|NCT03073200|447884232|FG001|Randomized Withdrawal Period|Adverse Event|0|||
124528297|NCT03073200|447884233|FG002|Randomized Withdrawal Period|Adverse Event|0|||
124528298|NCT03073200|447884234|FG003|Randomized Withdrawal Period|Adverse Event|0|||
124528299|NCT03073200|447884235|FG004|Randomized Withdrawal Period|Adverse Event|0|||
124528300|NCT03073200|447884236|FG005|Randomized Withdrawal Period|Adverse Event|0|||
124528301|NCT03073200|447884237|FG006|Randomized Withdrawal Period|Adverse Event|0|||
124528302|NCT03073200|447884238|FG007|Randomized Withdrawal Period|Adverse Event|0|||
124528303|NCT03073200|447884239|FG008|Randomized Withdrawal Period|Adverse Event|0|||
124528304|NCT03073200|447884240|FG009|Randomized Withdrawal Period|Adverse Event|0|||
124528305|NCT03073200|447884241|FG010|Randomized Withdrawal Period|Adverse Event|1|||
124528306|NCT03073200|447884242|FG011|Randomized Withdrawal Period|Adverse Event|0|||
124528307|NCT03073200|447884243|FG012|Randomized Withdrawal Period|Adverse Event|0|||
124528308|NCT03073200|447884244|FG013|Randomized Withdrawal Period|Adverse Event|0|||
124528309|NCT03073200|447884245|FG014|Randomized Withdrawal Period|Adverse Event|0|||
124528310|NCT03073200|447884231|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
124528311|NCT03073200|447884232|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
124528312|NCT03073200|447884233|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
124528313|NCT03073200|447884234|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
124528314|NCT03073200|447884235|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
124528315|NCT03073200|447884236|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
124528316|NCT03073200|447884237|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
124528317|NCT03073200|447884238|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
124528318|NCT03073200|447884239|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
124528319|NCT03073200|447884240|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
124528320|NCT03073200|447884241|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
124528321|NCT03073200|447884242|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
124528322|NCT03073200|447884243|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
124528323|NCT03073200|447884244|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
124528324|NCT03073200|447884245|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
124528325|NCT03073200|447884231|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124528326|NCT03073200|447884232|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124528327|NCT03073200|447884233|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124528328|NCT03073200|447884234|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124528329|NCT03073200|447884235|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124528330|NCT03073200|447884236|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124727013|NCT02265536|448620363|FG005|Overall Study|Adverse Event|0|||
124727014|NCT02265536|448620358|FG000|Overall Study|Physician Decision|0|||
124528331|NCT03073200|447884237|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124528332|NCT03073200|447884238|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124528333|NCT03073200|447884239|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124528334|NCT03073200|447884240|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124528335|NCT03073200|447884241|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124528336|NCT03073200|447884242|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124528337|NCT03073200|447884243|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124528338|NCT03073200|447884244|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
124528339|NCT03073200|447884245|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124528340|NCT03073200|447884231|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
124727015|NCT02265536|448620359|FG001|Overall Study|Physician Decision|0|||
124727016|NCT02265536|448620360|FG002|Overall Study|Physician Decision|0|||
124727017|NCT02265536|448620361|FG003|Overall Study|Physician Decision|0|||
124727018|NCT02265536|448620362|FG004|Overall Study|Physician Decision|2|||
124727019|NCT02265536|448620363|FG005|Overall Study|Physician Decision|0|||
124727020|NCT02265536|448620358|FG000|Overall Study|Withdrawal by Subject|0|||
124727021|NCT02265536|448620359|FG001|Overall Study|Withdrawal by Subject|3|||
124727022|NCT02265536|448620360|FG002|Overall Study|Withdrawal by Subject|0|||
124727023|NCT02265536|448620361|FG003|Overall Study|Withdrawal by Subject|0|||
124727024|NCT02265536|448620362|FG004|Overall Study|Withdrawal by Subject|0|||
124727025|NCT02265536|448620363|FG005|Overall Study|Withdrawal by Subject|0|||
124727026|NCT03268954|448620364|FG000|Overall Study|Ongoing|23|||
124727027|NCT03268954|448620365|FG001|Overall Study|Ongoing|31|||
124727028|NCT03268954|448620364|FG000|Overall Study|Adverse Event|53|||
124727029|NCT03268954|448620365|FG001|Overall Study|Adverse Event|62|||
124727030|NCT03268954|448620364|FG000|Overall Study|Withdrawal by Subject|25|||
124727031|NCT03268954|448620365|FG001|Overall Study|Withdrawal by Subject|16|||
124776839|NCT02202759|448811311|FG000|Overall Study|Withdrawal by Subject|2|||
124776840|NCT02202759|448811312|FG001|Overall Study|Withdrawal by Subject|1|||
124776841|NCT02202759|448811313|FG002|Overall Study|Withdrawal by Subject|1|||
124776842|NCT02202759|448811311|FG000|Overall Study|Reason not Specified|4|||
124776843|NCT02202759|448811312|FG001|Overall Study|Reason not Specified|11|||
124776844|NCT02202759|448811313|FG002|Overall Study|Reason not Specified|10|||
124776845|NCT01987453|448811314|FG000|Overall Study|Death|0|||
124776846|NCT01987453|448811315|FG001|Overall Study|Death|0|||
124776847|NCT01987453|448811316|FG002|Overall Study|Death|1|||
124776848|NCT01987453|448811314|FG000|Overall Study|Lack of Efficacy|1|||
124776849|NCT01987453|448811315|FG001|Overall Study|Lack of Efficacy|12|||
124776850|NCT01987453|448811316|FG002|Overall Study|Lack of Efficacy|0|||
124776851|NCT01590888|448811318|FG000|Overall Study|Adverse Event|3|||
124776852|NCT01590888|448811319|FG001|Overall Study|Adverse Event|0|||
124776853|NCT01590888|448811320|FG002|Overall Study|Adverse Event|1|||
124776854|NCT01590888|448811318|FG000|Overall Study|Lost to Follow-up|1|||
124776855|NCT01590888|448811319|FG001|Overall Study|Lost to Follow-up|0|||
124776856|NCT01590888|448811320|FG002|Overall Study|Lost to Follow-up|0|||
124776857|NCT01646125|448811321|FG000|Overall Study|Untreated|2|||
124776858|NCT01646125|448811322|FG001|Overall Study|Untreated|5|||
124776859|NCT01646125|448811321|FG000|Overall Study|Adverse Event|2|||
124776860|NCT01646125|448811322|FG001|Overall Study|Adverse Event|1|||
124776861|NCT01646125|448811321|FG000|Overall Study|Death|1|||
124776862|NCT01646125|448811322|FG001|Overall Study|Death|1|||
124776863|NCT01646125|448811321|FG000|Overall Study|Physician Decision|1|||
124776864|NCT01646125|448811322|FG001|Overall Study|Physician Decision|3|||
124776865|NCT01646125|448811321|FG000|Overall Study|Progressive disease|22|||
124776866|NCT01646125|448811322|FG001|Overall Study|Progressive disease|16|||
124776867|NCT01646125|448811321|FG000|Overall Study|Study terminated by sponsor|2|||
124776868|NCT01646125|448811322|FG001|Overall Study|Study terminated by sponsor|1|||
124776869|NCT01646125|448811321|FG000|Overall Study|Subject/Guardian decision|1|||
124776870|NCT01646125|448811322|FG001|Overall Study|Subject/Guardian decision|1|||
124776871|NCT05462756|448811325|FG000|Treatment Period|Adverse Event|3|||
124776872|NCT05462756|448811326|FG001|Treatment Period|Adverse Event|0|||
124776873|NCT05462756|448811325|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
124776874|NCT05462756|448811326|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
124776875|NCT05462756|448811325|FG000|Treatment Period|Death|0|||
124776876|NCT05462756|448811326|FG001|Treatment Period|Death|1|||
124776877|NCT05462756|448811325|FG000|Treatment Period|Lost to Follow-up|2|||
124776878|NCT05462756|448811326|FG001|Treatment Period|Lost to Follow-up|1|||
124776879|NCT05462756|448811325|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
124776880|NCT05462756|448811326|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
124776881|NCT05462756|448811325|FG000|Treatment Period|Physician Decision|2|||
124776882|NCT05462756|448811326|FG001|Treatment Period|Physician Decision|0|||
124776883|NCT05462756|448811325|FG000|Treatment Period|Protocol Violation|0|||
124776884|NCT05462756|448811326|FG001|Treatment Period|Protocol Violation|1|||
124776885|NCT05462756|448811325|FG000|Treatment Period|Withdrawal by Subject|5|||
124776886|NCT05462756|448811326|FG001|Treatment Period|Withdrawal by Subject|12|||
124776887|NCT05462756|448811325|FG000|Follow-Up Period|Adverse Event|1|||
124776888|NCT05462756|448811326|FG001|Follow-Up Period|Adverse Event|0|||
124776889|NCT05462756|448811325|FG000|Follow-Up Period|Death|1|||
124776890|NCT05462756|448811326|FG001|Follow-Up Period|Death|0|||
124776891|NCT05462756|448811325|FG000|Follow-Up Period|Lost to Follow-up|3|||
124776892|NCT05462756|448811326|FG001|Follow-Up Period|Lost to Follow-up|1|||
124776893|NCT05462756|448811325|FG000|Follow-Up Period|Withdrawal by Subject|0|||
124776894|NCT05462756|448811326|FG001|Follow-Up Period|Withdrawal by Subject|4|||
124776895|NCT04040933|448811328|FG000|Overall Study|Protocol Violation|1|||
124776896|NCT04040933|448811328|FG000|Overall Study|Withdrawal by Subject|2|||
124776897|NCT01705509|448811333|FG000|Inclusion CPET|Screen Failure|5|||
124776898|NCT01705509|448811333|FG000|Inclusion CPET|Withdrawal by Subject|2|||
124776899|NCT01705509|448811333|FG000|CPET w/ Ranexa|Screen Failure|2|||
124776900|NCT01528969|448811336|FG000|Overall Study|absent from the school at baseline|2|||
124776901|NCT01528969|448811337|FG001|Overall Study|absent from the school at baseline|0|||
124776902|NCT01662102|448811338|FG000|Overall Study|Sponsor's decision|1|||
124580788|NCT01695239|448084775|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
124580789|NCT01695239|448084776|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
124580790|NCT01695239|448084777|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
124580791|NCT01695239|448084764|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
124580792|NCT01695239|448084765|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
124580793|NCT01695239|448084766|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
124580794|NCT01695239|448084767|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
124580795|NCT01695239|448084768|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
124580796|NCT01695239|448084769|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
124580797|NCT01695239|448084770|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
124580798|NCT01695239|448084771|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
124580799|NCT01695239|448084772|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
124580800|NCT01695239|448084773|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
124580801|NCT01695239|448084774|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
124580802|NCT01695239|448084775|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
124580803|NCT01695239|448084776|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
124580804|NCT01695239|448084777|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
124580805|NCT01695239|448084764|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
124580806|NCT01695239|448084765|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
124580807|NCT01695239|448084766|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
124580808|NCT01695239|448084767|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
124580809|NCT01695239|448084768|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
124580810|NCT01695239|448084769|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
124580811|NCT01695239|448084770|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
124580812|NCT01695239|448084771|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
124580813|NCT01695239|448084772|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
124580814|NCT01695239|448084773|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
124580815|NCT01695239|448084774|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
124580816|NCT01695239|448084775|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
124580817|NCT01695239|448084776|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
124580818|NCT01695239|448084777|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
124580819|NCT01695239|448084764|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
124580820|NCT01695239|448084765|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
124580821|NCT01695239|448084766|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
124580822|NCT01695239|448084767|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
124580823|NCT01695239|448084768|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
124580824|NCT01695239|448084769|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
124580825|NCT01695239|448084770|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
124580826|NCT01695239|448084771|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
124580827|NCT01695239|448084772|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
124580828|NCT01695239|448084773|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
124580829|NCT01695239|448084774|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
124580830|NCT01695239|448084775|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
124580831|NCT01695239|448084776|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
124580832|NCT01695239|448084777|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
124580833|NCT01695239|448084764|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
124580834|NCT01695239|448084765|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
124580835|NCT01695239|448084766|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
124580836|NCT01695239|448084767|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
124528341|NCT03073200|447884232|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
124528342|NCT03073200|447884233|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
124528343|NCT03073200|447884234|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
124528344|NCT03073200|447884235|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
124528345|NCT03073200|447884236|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
124528346|NCT03073200|447884237|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
124528347|NCT03073200|447884238|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
124528348|NCT03073200|447884239|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
124528349|NCT03073200|447884240|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
124528350|NCT03073200|447884241|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
124528351|NCT03073200|447884242|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
124528352|NCT03073200|447884243|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
124528353|NCT03073200|447884244|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
124528354|NCT03073200|447884245|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
124528355|NCT03073200|447884231|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124727032|NCT03268954|448620364|FG000|Overall Study|Progressive Disease|61|||
124727033|NCT03268954|448620365|FG001|Overall Study|Progressive Disease|48|||
124727034|NCT03268954|448620364|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
124727035|NCT03268954|448620365|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
124727036|NCT03268954|448620364|FG000|Overall Study|Reason not Specified|40|||
124727037|NCT03268954|448620365|FG001|Overall Study|Reason not Specified|40|||
124727038|NCT03802630|448620366|FG000|Overall Study|Study terminated by sponsor|130|||
124727039|NCT03802630|448620367|FG001|Overall Study|Study terminated by sponsor|134|||
124727040|NCT03802630|448620366|FG000|Overall Study|Subject decision|16|||
124727041|NCT03802630|448620367|FG001|Overall Study|Subject decision|9|||
124727042|NCT03802630|448620366|FG000|Overall Study|Adverse Event|3|||
124727043|NCT03802630|448620367|FG001|Overall Study|Adverse Event|1|||
124727044|NCT03802630|448620366|FG000|Overall Study|Lost to Follow-up|2|||
124727045|NCT03802630|448620367|FG001|Overall Study|Lost to Follow-up|2|||
124727046|NCT03802630|448620366|FG000|Overall Study|Physician Decision|2|||
124727047|NCT03802630|448620367|FG001|Overall Study|Physician Decision|0|||
124727048|NCT03802630|448620366|FG000|Overall Study|Death|0|||
124727049|NCT03802630|448620367|FG001|Overall Study|Death|2|||
124727050|NCT05005013|448620368|FG000|Overall Study|Withdrawal by Subject|5|||
124727051|NCT05005013|448620369|FG001|Overall Study|Withdrawal by Subject|1|||
124727052|NCT05005013|448620368|FG000|Overall Study|Lost to Follow-up|3|||
124727053|NCT05005013|448620369|FG001|Overall Study|Lost to Follow-up|1|||
124727054|NCT05005013|448620368|FG000|Overall Study|Ineligibility|1|||
124727055|NCT05005013|448620369|FG001|Overall Study|Ineligibility|1|||
124727056|NCT06099223|448620370|FG000|Overall Study|Preoperative surveys missed|0|||
124727057|NCT06099223|448620371|FG001|Overall Study|Preoperative surveys missed|1|||
124727058|NCT01802580|448620374|FG000|Overall Study|Physician Decision|1|||
124727059|NCT01802580|448620375|FG001|Overall Study|Physician Decision|0|||
124727060|NCT01802580|448620374|FG000|Overall Study|Protocol Violation|2|||
124727061|NCT01802580|448620375|FG001|Overall Study|Protocol Violation|0|||
124727062|NCT01802580|448620374|FG000|Overall Study|Withdrawal by Subject|5|||
124727063|NCT01802580|448620375|FG001|Overall Study|Withdrawal by Subject|6|||
124727064|NCT01802580|448620374|FG000|Overall Study|Other|1|||
124727065|NCT01802580|448620375|FG001|Overall Study|Other|3|||
124727066|NCT01802580|448620374|FG000|Overall Study|Lack of Efficacy|0|||
124727067|NCT01802580|448620375|FG001|Overall Study|Lack of Efficacy|2|||
124727068|NCT00211757|448620376|FG000|Overall Study|Withdrawal by Subject|1|||
124727069|NCT00211757|448620377|FG001|Overall Study|Withdrawal by Subject|1|||
124727070|NCT00211757|448620376|FG000|Overall Study|Lack of Efficacy|0|||
124727071|NCT00211757|448620377|FG001|Overall Study|Lack of Efficacy|1|||
124727072|NCT04091581|448620378|FG000|Overall Study|Lost to Follow-up|0|||
124727073|NCT04091581|448620379|FG001|Overall Study|Lost to Follow-up|1|||
124727074|NCT03724981|448622346|FG000|First Device|Protocol Violation|1|||
124727075|NCT03724981|448622347|FG001|First Device|Protocol Violation|1|||
124727076|NCT04439539|448622351|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
124727077|NCT04439539|448622352|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
124727078|NCT04439539|448622353|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
124727079|NCT04439539|448622351|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
124727080|NCT04439539|448622352|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
124727081|NCT04439539|448622353|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
124727082|NCT04439539|448622351|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
124727083|NCT04439539|448622352|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
124727084|NCT04439539|448622353|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
124727085|NCT03116828|448622354|FG000|Overall Study|Adverse Event|1|||
124727086|NCT03116828|448622355|FG001|Overall Study|Adverse Event|10|||
124727087|NCT03116828|448622354|FG000|Overall Study|Withdrawal by Subject|4|||
124727088|NCT03116828|448622355|FG001|Overall Study|Withdrawal by Subject|8|||
124727089|NCT03116828|448622354|FG000|Overall Study|OTHER|3|||
124727090|NCT03116828|448622355|FG001|Overall Study|OTHER|3|||
124727091|NCT03596047|448622357|FG000|Overall Study|Withdrawal by Subject|7|||
124727092|NCT03596047|448622358|FG001|Overall Study|Withdrawal by Subject|4|||
124727093|NCT03596047|448622357|FG000|Overall Study|Lost to Follow-up|0|||
124727094|NCT03596047|448622358|FG001|Overall Study|Lost to Follow-up|2|||
124727095|NCT03727646|448622359|FG000|Overall Study|Adverse Event|1|||
124727096|NCT03727646|448622360|FG001|Overall Study|Adverse Event|0|||
124727097|NCT02290691|448622363|FG000|Overall Study|Noncompliance|0|||
124727098|NCT02290691|448622364|FG001|Overall Study|Noncompliance|1|||
124727099|NCT02290691|448622363|FG000|Overall Study|Withdrawal by Subject|1|||
124727100|NCT02290691|448622364|FG001|Overall Study|Withdrawal by Subject|1|||
124727101|NCT02290691|448622363|FG000|Overall Study|Lost to Follow-up|7|||
124727102|NCT02290691|448622364|FG001|Overall Study|Lost to Follow-up|7|||
124727103|NCT00923975|448622369|FG000|Overall Study|Did not meet inclusion criteria|1|||
124727104|NCT01328535|448622370|FG000|Overall Study|Ineligible|1|||
124727105|NCT01005316|448622371|FG000|Overall Study|Adverse Event|0|||
124727106|NCT01005316|448622372|FG001|Overall Study|Adverse Event|0|||
124727107|NCT01005316|448622373|FG002|Overall Study|Adverse Event|0|||
124727108|NCT01005316|448622374|FG003|Overall Study|Adverse Event|1|||
124727109|NCT01005316|448622371|FG000|Overall Study|Death|20|||
124727110|NCT01005316|448622372|FG001|Overall Study|Death|5|||
124727111|NCT01005316|448622373|FG002|Overall Study|Death|1|||
124727112|NCT01005316|448622374|FG003|Overall Study|Death|15|||
124727113|NCT01005316|448622371|FG000|Overall Study|Study Termination|5|||
124727114|NCT01005316|448622372|FG001|Overall Study|Study Termination|63|||
124727115|NCT01005316|448622373|FG002|Overall Study|Study Termination|9|||
124727116|NCT01005316|448622374|FG003|Overall Study|Study Termination|85|||
124727117|NCT01005316|448622371|FG000|Overall Study|Lost to Follow-up|1|||
124727118|NCT01005316|448622372|FG001|Overall Study|Lost to Follow-up|3|||
124727119|NCT01005316|448622373|FG002|Overall Study|Lost to Follow-up|0|||
124727120|NCT01005316|448622374|FG003|Overall Study|Lost to Follow-up|2|||
124727121|NCT01005316|448622371|FG000|Overall Study|Physician Decision|6|||
124727122|NCT01005316|448622372|FG001|Overall Study|Physician Decision|0|||
124727123|NCT01005316|448622373|FG002|Overall Study|Physician Decision|0|||
124727124|NCT01005316|448622374|FG003|Overall Study|Physician Decision|0|||
124727125|NCT01005316|448622371|FG000|Overall Study|Sponsor Decision|6|||
124727126|NCT01005316|448622372|FG001|Overall Study|Sponsor Decision|3|||
124580837|NCT01695239|448084768|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
124580838|NCT01695239|448084769|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
124580839|NCT01695239|448084770|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
124580840|NCT01695239|448084771|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
124580841|NCT01695239|448084772|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
124580842|NCT01695239|448084773|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
124580843|NCT01695239|448084774|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
124580844|NCT01695239|448084775|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
124580845|NCT01695239|448084776|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
124580846|NCT01695239|448084777|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
124580847|NCT01695239|448084764|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
124580848|NCT01695239|448084765|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
124580849|NCT01695239|448084766|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
124580850|NCT01695239|448084767|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
124580851|NCT01695239|448084768|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
124580852|NCT01695239|448084769|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
124580853|NCT01695239|448084770|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
124580854|NCT01695239|448084771|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
124580855|NCT01695239|448084772|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
124580856|NCT01695239|448084773|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
124580857|NCT01695239|448084774|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
124580858|NCT01695239|448084775|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
124580859|NCT01695239|448084776|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
124580860|NCT01695239|448084777|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
124580861|NCT01695239|448084764|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
124580862|NCT01695239|448084765|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
124580863|NCT01695239|448084766|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
124580864|NCT01695239|448084767|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
124580865|NCT01695239|448084768|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
124580866|NCT01695239|448084769|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
124580867|NCT01695239|448084770|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
124580868|NCT01695239|448084771|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
124580869|NCT01695239|448084772|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
124580870|NCT01695239|448084773|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
124580871|NCT01695239|448084774|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
124580872|NCT01695239|448084775|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
124580873|NCT01695239|448084776|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
124580874|NCT01695239|448084777|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
124580875|NCT01695239|448084764|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
124580876|NCT01695239|448084765|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
124580877|NCT01695239|448084766|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
124580878|NCT01695239|448084767|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
124580879|NCT01695239|448084768|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
124580880|NCT01695239|448084769|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
124580881|NCT01695239|448084770|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
124580882|NCT01695239|448084771|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
124727127|NCT01005316|448622373|FG002|Overall Study|Sponsor Decision|0|||
124727128|NCT01005316|448622374|FG003|Overall Study|Sponsor Decision|0|||
124727129|NCT01005316|448622371|FG000|Overall Study|Withdrawal by Subject|1|||
124727130|NCT01005316|448622372|FG001|Overall Study|Withdrawal by Subject|1|||
124727131|NCT01005316|448622373|FG002|Overall Study|Withdrawal by Subject|0|||
124727132|NCT01005316|448622374|FG003|Overall Study|Withdrawal by Subject|2|||
124727133|NCT01005316|448622371|FG000|Overall Study|Consented to Another Study|2|||
124727134|NCT01005316|448622372|FG001|Overall Study|Consented to Another Study|0|||
124727135|NCT01005316|448622373|FG002|Overall Study|Consented to Another Study|0|||
124727136|NCT01005316|448622374|FG003|Overall Study|Consented to Another Study|0|||
124727137|NCT01005316|448622371|FG000|Overall Study|Delisted|8|||
124727138|NCT01005316|448622372|FG001|Overall Study|Delisted|0|||
124727139|NCT01005316|448622373|FG002|Overall Study|Delisted|0|||
124727140|NCT01005316|448622374|FG003|Overall Study|Delisted|0|||
124727141|NCT01005316|448622371|FG000|Overall Study|Transferred Care|1|||
124727142|NCT01005316|448622372|FG001|Overall Study|Transferred Care|0|||
124727143|NCT01005316|448622373|FG002|Overall Study|Transferred Care|1|||
124727144|NCT01005316|448622374|FG003|Overall Study|Transferred Care|3|||
124727145|NCT01005316|448622371|FG000|Overall Study|Retransplanted|0|||
124727146|NCT01005316|448622372|FG001|Overall Study|Retransplanted|1|||
124528356|NCT03073200|447884232|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124528357|NCT03073200|447884233|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124528358|NCT03073200|447884234|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124528359|NCT03073200|447884235|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124528360|NCT03073200|447884236|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124528361|NCT03073200|447884237|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124528362|NCT03073200|447884238|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124528363|NCT03073200|447884239|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124528364|NCT03073200|447884240|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124528365|NCT03073200|447884241|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124528366|NCT03073200|447884242|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124528367|NCT03073200|447884243|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124528368|NCT03073200|447884244|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
124528369|NCT03073200|447884245|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124528370|NCT03073200|447884231|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
124528371|NCT03073200|447884232|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
124528372|NCT03073200|447884233|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
124528373|NCT03073200|447884234|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
124528374|NCT03073200|447884235|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
124528375|NCT03073200|447884236|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
124528376|NCT03073200|447884237|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
124528377|NCT03073200|447884238|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
124528378|NCT03073200|447884239|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
124528379|NCT03073200|447884240|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
124528380|NCT03073200|447884241|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
124528381|NCT03073200|447884242|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
124528382|NCT03073200|447884243|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
124528383|NCT03073200|447884244|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
124528384|NCT03073200|447884245|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
124528385|NCT03073200|447884231|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
124528386|NCT03073200|447884232|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
124528387|NCT03073200|447884233|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
124528388|NCT03073200|447884234|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
124528389|NCT03073200|447884235|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
124528390|NCT03073200|447884236|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
124528391|NCT03073200|447884237|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
124528392|NCT03073200|447884238|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
124528393|NCT03073200|447884239|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
124528394|NCT03073200|447884240|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
124528395|NCT03073200|447884241|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
124528396|NCT03073200|447884242|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
124528397|NCT03073200|447884243|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
124528398|NCT03073200|447884244|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
124528399|NCT03073200|447884245|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
124528400|NCT03073200|447884231|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124528401|NCT03073200|447884232|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124528402|NCT03073200|447884233|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124528403|NCT03073200|447884234|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124727147|NCT01005316|448622373|FG002|Overall Study|Retransplanted|0|||
124727148|NCT01005316|448622374|FG003|Overall Study|Retransplanted|0|||
124727149|NCT04417218|448622375|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
124727150|NCT04417218|448622376|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
124727151|NCT02516098|448622379|FG000|Period 1|Protocol Violation|1|||
124727152|NCT02516098|448622380|FG001|Period 1|Protocol Violation|0|||
124727153|NCT02516098|448622379|FG000|Washout After Period 1|Adverse Event|0|||
124727154|NCT02516098|448622380|FG001|Washout After Period 1|Adverse Event|1|||
124727155|NCT02516098|448622379|FG000|Period 2|Withdrawal by Subject|0|||
124727156|NCT02516098|448622380|FG001|Period 2|Withdrawal by Subject|1|||
124727157|NCT00873041|448622381|FG000|Core Study|Adverse Event|2|||
124727158|NCT00873041|448622382|FG001|Core Study|Adverse Event|3|||
124727159|NCT00873041|448622383|FG002|Core Study|Adverse Event|1|||
124727160|NCT00873041|448622381|FG000|Core Study|Withdrawal by Subject|1|||
124727161|NCT00873041|448622382|FG001|Core Study|Withdrawal by Subject|2|||
124727162|NCT00873041|448622383|FG002|Core Study|Withdrawal by Subject|2|||
124727163|NCT00873041|448622381|FG000|Core Study|Lost to Follow-up|3|||
124727164|NCT00873041|448622382|FG001|Core Study|Lost to Follow-up|1|||
124727165|NCT00873041|448622383|FG002|Core Study|Lost to Follow-up|0|||
124727166|NCT00873041|448622381|FG000|Core Study|Abnormal laboratory value|0|||
124727167|NCT00873041|448622382|FG001|Core Study|Abnormal laboratory value|0|||
124727168|NCT00873041|448622383|FG002|Core Study|Abnormal laboratory value|1|||
124727169|NCT00873041|448622381|FG000|Core Study|Protocol deviation|1|||
124727170|NCT00873041|448622382|FG001|Core Study|Protocol deviation|0|||
124727171|NCT00873041|448622383|FG002|Core Study|Protocol deviation|1|||
124727172|NCT00873041|448622381|FG000|Extension Study|Adverse Event|1|||
124727173|NCT00873041|448622382|FG001|Extension Study|Adverse Event|0|||
124727174|NCT00873041|448622383|FG002|Extension Study|Adverse Event|1|||
124727175|NCT00873041|448622381|FG000|Extension Study|Administrative reasons|0|||
124727176|NCT00873041|448622382|FG001|Extension Study|Administrative reasons|0|||
124727177|NCT00873041|448622383|FG002|Extension Study|Administrative reasons|1|||
124727178|NCT01734395|448622386|FG000|Overall Study|Other|65|||
124727179|NCT01734395|448622386|FG000|Overall Study|Lost to Follow-up|287|||
124727180|NCT01734395|448622386|FG000|Overall Study|Lack of Efficacy|5|||
124727181|NCT01734395|448622386|FG000|Overall Study|Adverse Event|40|||
124727182|NCT01734395|448622386|FG000|Overall Study|Withdrawal by Subject|10|||
124727183|NCT01734395|448622386|FG000|Overall Study|Missing the reasons for not completed|3|||
124727184|NCT01032291|448622387|FG000|Safety Lead-in|Adverse Event|1|||
124727185|NCT01032291|448622388|FG001|Safety Lead-in|Adverse Event|0|||
124727186|NCT01032291|448622389|FG002|Safety Lead-in|Adverse Event|0|||
124727187|NCT01032291|448622387|FG000|Safety Lead-in|Death|1|||
124727188|NCT01032291|448622388|FG001|Safety Lead-in|Death|0|||
124727189|NCT01032291|448622389|FG002|Safety Lead-in|Death|0|||
124727190|NCT01032291|448622387|FG000|Proof of Concept|Adverse Event|0|||
124727191|NCT01032291|448622388|FG001|Proof of Concept|Adverse Event|5|||
124727192|NCT01032291|448622389|FG002|Proof of Concept|Adverse Event|1|||
124727193|NCT01032291|448622387|FG000|Proof of Concept|Death|0|||
124727194|NCT01032291|448622388|FG001|Proof of Concept|Death|1|||
124727195|NCT01032291|448622389|FG002|Proof of Concept|Death|2|||
124727196|NCT01032291|448622387|FG000|Proof of Concept|Lack of Efficacy|0|||
124727197|NCT01032291|448622388|FG001|Proof of Concept|Lack of Efficacy|1|||
124727198|NCT01032291|448622389|FG002|Proof of Concept|Lack of Efficacy|0|||
124727199|NCT01032291|448622387|FG000|Proof of Concept|Never Received Study Drug|0|||
124727200|NCT01032291|448622388|FG001|Proof of Concept|Never Received Study Drug|1|||
124528404|NCT03073200|447884235|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124528405|NCT03073200|447884236|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124528406|NCT03073200|447884237|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124528407|NCT03073200|447884238|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124528408|NCT03073200|447884239|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124528409|NCT03073200|447884240|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124528410|NCT03073200|447884241|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124528411|NCT03073200|447884242|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124528412|NCT03073200|447884243|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124528413|NCT03073200|447884244|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
124528414|NCT03073200|447884245|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124727201|NCT01032291|448622389|FG002|Proof of Concept|Never Received Study Drug|0|||
124727202|NCT00313313|448622390|FG000|Overall Study|Lack of Efficacy|14|||
124727203|NCT00313313|448622391|FG001|Overall Study|Lack of Efficacy|9|||
124727204|NCT00313313|448622392|FG002|Overall Study|Lack of Efficacy|20|||
124727205|NCT00313313|448622390|FG000|Overall Study|Withdrawal of consent by subject|18|||
124776903|NCT01662102|448811339|FG001|Overall Study|Sponsor's decision|0|||
124727206|NCT00313313|448622391|FG001|Overall Study|Withdrawal of consent by subject|17|||
124727207|NCT00313313|448622392|FG002|Overall Study|Withdrawal of consent by subject|31|||
124727208|NCT00313313|448622390|FG000|Overall Study|Lost to Follow-up|10|||
124727209|NCT00313313|448622391|FG001|Overall Study|Lost to Follow-up|7|||
124727210|NCT00313313|448622392|FG002|Overall Study|Lost to Follow-up|9|||
124727211|NCT00313313|448622390|FG000|Overall Study|Adverse Event|15|||
124727212|NCT00313313|448622391|FG001|Overall Study|Adverse Event|16|||
124727213|NCT00313313|448622392|FG002|Overall Study|Adverse Event|12|||
124727214|NCT00313313|448622390|FG000|Overall Study|Physician Decision|2|||
124727215|NCT00313313|448622391|FG001|Overall Study|Physician Decision|6|||
124727216|NCT00313313|448622392|FG002|Overall Study|Physician Decision|4|||
124727217|NCT00313313|448622390|FG000|Overall Study|Poor/Noncompliance|3|||
124727218|NCT00313313|448622391|FG001|Overall Study|Poor/Noncompliance|6|||
124727219|NCT00313313|448622392|FG002|Overall Study|Poor/Noncompliance|2|||
124727220|NCT00313313|448622390|FG000|Overall Study|Pregnancy|1|||
124727221|NCT00313313|448622391|FG001|Overall Study|Pregnancy|2|||
124727222|NCT00313313|448622392|FG002|Overall Study|Pregnancy|0|||
124727223|NCT00313313|448622390|FG000|Overall Study|Death|0|||
124727224|NCT00313313|448622391|FG001|Overall Study|Death|0|||
124727225|NCT00313313|448622392|FG002|Overall Study|Death|2|||
124528415|NCT03073200|447884231|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
124528416|NCT03073200|447884232|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
124528417|NCT03073200|447884233|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
124528418|NCT03073200|447884234|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
124528419|NCT03073200|447884235|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
124528420|NCT03073200|447884236|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
124528421|NCT03073200|447884237|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
124528422|NCT03073200|447884238|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
124528423|NCT03073200|447884239|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
124528424|NCT03073200|447884240|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
124528425|NCT03073200|447884241|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
124528426|NCT03073200|447884242|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
124528427|NCT03073200|447884243|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
124528428|NCT03073200|447884244|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
124528429|NCT03073200|447884245|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
124528430|NCT04757376|447884246|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
124528431|NCT04757376|447884247|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
124528432|NCT04757376|447884248|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
124528433|NCT04757376|447884249|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
124528434|NCT04757376|447884250|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
124528435|NCT04757376|447884246|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
124528436|NCT04757376|447884247|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
124580883|NCT01695239|448084772|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
124580884|NCT01695239|448084773|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
124580885|NCT01695239|448084774|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
124580886|NCT01695239|448084775|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
124580887|NCT01695239|448084776|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
124580888|NCT01695239|448084777|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
124580889|NCT01695239|448084764|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
124580890|NCT01695239|448084765|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
124580891|NCT01695239|448084766|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
124580892|NCT01695239|448084767|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
124580893|NCT01695239|448084768|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
124580894|NCT01695239|448084769|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
124580895|NCT01695239|448084770|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
124580896|NCT01695239|448084771|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
124580897|NCT01695239|448084772|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
124580898|NCT01695239|448084773|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
124580899|NCT01695239|448084774|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
124580900|NCT01695239|448084775|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
124580901|NCT01695239|448084776|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
124580902|NCT01695239|448084777|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
124580903|NCT01695239|448084764|FG000|Extension Long-Term Extension Periods|Death|0|||
124580904|NCT01695239|448084765|FG001|Extension Long-Term Extension Periods|Death|0|||
124580905|NCT01695239|448084766|FG002|Extension Long-Term Extension Periods|Death|0|||
124580906|NCT01695239|448084767|FG003|Extension Long-Term Extension Periods|Death|0|||
124580907|NCT01695239|448084768|FG004|Extension Long-Term Extension Periods|Death|0|||
124580908|NCT01695239|448084769|FG005|Extension Long-Term Extension Periods|Death|0|||
124580909|NCT01695239|448084770|FG006|Extension Long-Term Extension Periods|Death|0|||
124580910|NCT01695239|448084771|FG007|Extension Long-Term Extension Periods|Death|0|||
124580911|NCT01695239|448084772|FG008|Extension Long-Term Extension Periods|Death|1|||
124727226|NCT00313313|448622390|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
124580912|NCT01695239|448084773|FG009|Extension Long-Term Extension Periods|Death|0|||
124580913|NCT01695239|448084774|FG010|Extension Long-Term Extension Periods|Death|0|||
124580914|NCT01695239|448084775|FG011|Extension Long-Term Extension Periods|Death|0|||
124580915|NCT01695239|448084776|FG012|Extension Long-Term Extension Periods|Death|0|||
124580916|NCT01695239|448084777|FG013|Extension Long-Term Extension Periods|Death|0|||
124727227|NCT00313313|448622391|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
124727228|NCT00313313|448622392|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
124727229|NCT00758264|448622395|FG000|Active Phase|Withdrawal by Subject|0|||
124727230|NCT00758264|448622396|FG001|Active Phase|Withdrawal by Subject|0|||
124727231|NCT00758264|448622397|FG002|Active Phase|Withdrawal by Subject|1|||
124727232|NCT00758264|448622395|FG000|Active Phase|Lost to Follow-up|1|||
124727233|NCT00758264|448622396|FG001|Active Phase|Lost to Follow-up|0|||
124727234|NCT00758264|448622397|FG002|Active Phase|Lost to Follow-up|0|||
124727235|NCT00758264|448622395|FG000|Active Phase|Other|0|||
124727236|NCT00758264|448622396|FG001|Active Phase|Other|0|||
124727237|NCT00758264|448622397|FG002|Active Phase|Other|4|||
124727238|NCT03425006|448622398|FG000|Overall Study|Withdrawal by Subject|1|||
124727239|NCT03425006|448622398|FG000|Overall Study|Physician Decision|1|||
124727240|NCT03425006|448622398|FG000|Overall Study|Death|1|||
124727243|NCT03831191|448622404|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
124528437|NCT04757376|447884248|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
124528438|NCT04757376|447884249|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
124528439|NCT04757376|447884250|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
124528440|NCT04757376|447884246|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
124528441|NCT04757376|447884247|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
124528442|NCT04757376|447884248|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
124528443|NCT04757376|447884249|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
124528444|NCT04757376|447884250|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
124528445|NCT04757376|447884246|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
124528446|NCT04757376|447884247|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
124528447|NCT04757376|447884248|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
124528448|NCT04757376|447884249|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
124528449|NCT04757376|447884250|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
124528450|NCT04757376|447884246|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
124528451|NCT04757376|447884247|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
124727244|NCT03831191|448622405|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
124727245|NCT03831191|448622406|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
124727246|NCT03831191|448622407|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
124727247|NCT03831191|448622408|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
124727248|NCT03831191|448622409|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
124528452|NCT04757376|447884248|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
124528453|NCT04757376|447884249|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
124528454|NCT04757376|447884250|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
124528455|NCT04757376|447884246|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
124528456|NCT04757376|447884247|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
124528457|NCT04757376|447884248|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
124528458|NCT04757376|447884249|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
124528459|NCT04757376|447884250|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
124528460|NCT04757376|447884246|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
124528461|NCT04757376|447884247|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
124528462|NCT04757376|447884248|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
124528463|NCT04757376|447884249|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
124528464|NCT04757376|447884250|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
124528465|NCT04757376|447884246|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
124528466|NCT04757376|447884247|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
124528467|NCT04757376|447884248|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
124528468|NCT04757376|447884249|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
124528469|NCT04757376|447884250|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
124528470|NCT04474366|447884251|FG000|Overall Study|Lost to Follow-up|2|||
124528471|NCT04474366|447884252|FG001|Overall Study|Lost to Follow-up|5|||
124528472|NCT04063865|447884253|FG000|Overall Study|Physician Decision|1|||
124528473|NCT04063865|447884254|FG001|Overall Study|Physician Decision|3|||
124528474|NCT04063865|447884253|FG000|Overall Study|Study Closed Prior to Completion|4|||
124528475|NCT04063865|447884254|FG001|Overall Study|Study Closed Prior to Completion|4|||
124528476|NCT04063865|447884253|FG000|Overall Study|Withdrawal by Subject|1|||
124528477|NCT04063865|447884254|FG001|Overall Study|Withdrawal by Subject|1|||
124727249|NCT03831191|448622410|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
124727250|NCT03831191|448622411|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
124727251|NCT03831191|448622412|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
124727252|NCT03831191|448622413|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
124727253|NCT03831191|448622414|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
124727254|NCT03831191|448622415|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
124727255|NCT03831191|448622416|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
124727256|NCT03831191|448622417|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
124727257|NCT03831191|448622418|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
124727258|NCT03831191|448622404|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
124727259|NCT03831191|448622405|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
124727260|NCT03831191|448622406|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124727261|NCT03831191|448622407|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124727262|NCT03831191|448622408|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124727263|NCT03831191|448622409|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124727264|NCT03831191|448622410|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124727265|NCT03831191|448622411|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124727266|NCT03831191|448622412|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124727267|NCT03831191|448622413|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124727268|NCT03831191|448622414|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124727269|NCT03831191|448622415|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124727270|NCT03831191|448622416|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124727271|NCT03831191|448622417|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124727272|NCT03831191|448622418|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
124727273|NCT03831191|448622404|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
124727274|NCT03831191|448622405|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
124727275|NCT03831191|448622406|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
124727276|NCT03831191|448622407|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
124727277|NCT03831191|448622408|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
124727278|NCT03831191|448622409|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
124580917|NCT01695239|448084764|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124580918|NCT01695239|448084765|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124580919|NCT01695239|448084766|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124580920|NCT01695239|448084767|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124580921|NCT01695239|448084768|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124580922|NCT01695239|448084769|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124580923|NCT01695239|448084770|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124580924|NCT01695239|448084771|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124580925|NCT01695239|448084772|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124580926|NCT01695239|448084773|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124580927|NCT01695239|448084774|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124580928|NCT01695239|448084775|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
124580929|NCT01695239|448084776|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
124580930|NCT01695239|448084777|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
124580931|NCT01695239|448084764|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124580932|NCT01695239|448084765|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124580933|NCT01695239|448084766|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124580934|NCT01695239|448084767|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124580935|NCT01695239|448084768|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124580936|NCT01695239|448084769|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124580937|NCT01695239|448084770|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124580938|NCT01695239|448084771|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124580939|NCT01695239|448084772|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124580940|NCT01695239|448084773|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124580941|NCT01695239|448084774|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124580942|NCT01695239|448084775|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124580943|NCT01695239|448084776|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
124580944|NCT01695239|448084777|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
124580945|NCT01695239|448084764|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
124580946|NCT01695239|448084765|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
124580947|NCT01695239|448084766|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
124580948|NCT01695239|448084767|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
124580949|NCT01695239|448084768|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
124727279|NCT03831191|448622410|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
124580950|NCT01695239|448084769|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
124580951|NCT01695239|448084770|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
124727280|NCT03831191|448622411|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
124580952|NCT01695239|448084771|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
124727281|NCT03831191|448622412|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
124727282|NCT03831191|448622413|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
124727283|NCT03831191|448622414|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
124727284|NCT03831191|448622415|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
124727285|NCT03831191|448622416|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
124727286|NCT03831191|448622417|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
124727287|NCT03831191|448622418|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
124727288|NCT03831191|448622404|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
124727289|NCT03831191|448622405|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
124727290|NCT03831191|448622406|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
124727291|NCT03831191|448622407|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
124727292|NCT03831191|448622408|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
124727293|NCT03831191|448622409|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
124727294|NCT03831191|448622410|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
124727295|NCT03831191|448622411|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
124727296|NCT03831191|448622412|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
124528478|NCT03898323|447884255|FG000|Overall Study|Physician Decision|1|||
124528479|NCT00320190|447884256|FG000|First 12 Months|Completed but did not enter extension|5|||
124528480|NCT00320190|447884257|FG001|First 12 Months|Completed but did not enter extension|3|||
124528481|NCT00320190|447884256|FG000|First 12 Months|Sponsor terminated study|2|||
124528482|NCT00320190|447884257|FG001|First 12 Months|Sponsor terminated study|2|||
124528483|NCT00320190|447884256|FG000|First 12 Months|Lost to Follow-up|0|||
124528484|NCT00320190|447884257|FG001|First 12 Months|Lost to Follow-up|1|||
124528485|NCT00320190|447884256|FG000|First 12 Months|Enrollment failure|0|||
124528486|NCT00320190|447884257|FG001|First 12 Months|Enrollment failure|1|||
124528487|NCT00320190|447884256|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
124528488|NCT00320190|447884257|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
124528489|NCT00320190|447884256|FG000|First 12 Months|Investigator request|0|||
124528490|NCT00320190|447884257|FG001|First 12 Months|Investigator request|1|||
124528491|NCT00320190|447884256|FG000|First 12 Months|Study drug toxicity|0|||
124528492|NCT00320190|447884257|FG001|First 12 Months|Study drug toxicity|1|||
124528493|NCT00320190|447884256|FG000|First 12 Months|Withdrawal by Subject|0|||
124528494|NCT00320190|447884257|FG001|First 12 Months|Withdrawal by Subject|1|||
124528495|NCT00320190|447884256|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
124528496|NCT00320190|447884257|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
124528497|NCT00320190|447884256|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
124528498|NCT00320190|447884257|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
124528499|NCT00320190|447884256|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
124528500|NCT00320190|447884257|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
124528501|NCT00712270|447884259|FG000|Overall Study|Withdrawal by Subject|11|||
124528502|NCT00712270|447884259|FG000|Overall Study|Screen Failure|3|||
124528503|NCT00683774|447884267|FG000|Overall Study|Withdrawal by Subject|0|||
124528504|NCT00683774|447884268|FG001|Overall Study|Withdrawal by Subject|1|||
124528505|NCT00683774|447884267|FG000|Overall Study|Physician Decision|3|||
124528506|NCT00683774|447884268|FG001|Overall Study|Physician Decision|0|||
124528507|NCT03595176|447884269|FG000|Overall Study|Death|0|||
124528508|NCT03595176|447884270|FG001|Overall Study|Death|2|||
124528509|NCT03595176|447884269|FG000|Overall Study|Lost to Follow-up|0|||
124528510|NCT03595176|447884270|FG001|Overall Study|Lost to Follow-up|1|||
124528511|NCT01201967|447884275|FG000|Overall Study|Lost to Follow-up|6|||
124528512|NCT01201967|447884276|FG001|Overall Study|Lost to Follow-up|5|||
124528513|NCT03128307|447884281|FG000|Overall Study|Lost to Follow-up|29|||
124528514|NCT03128307|447884281|FG000|Overall Study|Withdrawal by Subject|5|||
124528515|NCT02632344|447885851|FG000|Overall Study|Adverse Event|3|||
124528516|NCT02632344|447885851|FG000|Overall Study|Lack of Efficacy|3|||
124528517|NCT02632344|447885851|FG000|Overall Study|Withdrawal by Subject|2|||
124528518|NCT01693562|447885852|FG000|Escalation Phase|Withdrawal by Subject|0|||
124528519|NCT01693562|447885853|FG001|Escalation Phase|Withdrawal by Subject|1|||
124528520|NCT01693562|447885854|FG002|Escalation Phase|Withdrawal by Subject|0|||
124528521|NCT01693562|447885855|FG003|Escalation Phase|Withdrawal by Subject|0|||
124528522|NCT01693562|447885856|FG004|Escalation Phase|Withdrawal by Subject|0|||
124528523|NCT01693562|447885857|FG005|Escalation Phase|Withdrawal by Subject|2|||
124528524|NCT01693562|447885858|FG006|Escalation Phase|Withdrawal by Subject|0|||
124528525|NCT01693562|447885859|FG007|Escalation Phase|Withdrawal by Subject|0|||
124528526|NCT01693562|447885860|FG008|Escalation Phase|Withdrawal by Subject|0|||
124727297|NCT03831191|448622413|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
124727298|NCT03831191|448622414|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
124727299|NCT03831191|448622415|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
124528527|NCT01693562|447885861|FG009|Escalation Phase|Withdrawal by Subject|0|||
124528528|NCT01693562|447885862|FG010|Escalation Phase|Withdrawal by Subject|0|||
124528529|NCT01693562|447885863|FG011|Escalation Phase|Withdrawal by Subject|0|||
124528530|NCT01693562|447885864|FG012|Escalation Phase|Withdrawal by Subject|0|||
124528531|NCT01693562|447885865|FG013|Escalation Phase|Withdrawal by Subject|0|||
124528532|NCT01693562|447885866|FG014|Escalation Phase|Withdrawal by Subject|0|||
124528533|NCT01693562|447885867|FG015|Escalation Phase|Withdrawal by Subject|0|||
124528534|NCT01693562|447885868|FG016|Escalation Phase|Withdrawal by Subject|0|||
124528535|NCT01693562|447885869|FG017|Escalation Phase|Withdrawal by Subject|0|||
124580953|NCT01695239|448084772|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
124580954|NCT01695239|448084773|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
124580955|NCT01695239|448084774|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
124580956|NCT01695239|448084775|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
124580957|NCT01695239|448084776|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
124580958|NCT01695239|448084777|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
124580959|NCT01695239|448084764|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124580960|NCT01695239|448084765|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124580961|NCT01695239|448084766|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124580962|NCT01695239|448084767|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124580963|NCT01695239|448084768|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124580964|NCT01695239|448084769|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124580965|NCT01695239|448084770|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124580966|NCT01695239|448084771|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124580967|NCT01695239|448084772|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124580968|NCT01695239|448084773|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124580969|NCT01695239|448084774|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124580970|NCT01695239|448084775|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124580971|NCT01695239|448084776|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
124580972|NCT01695239|448084777|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
124580973|NCT03502811|448084779|FG000|Overall Study|Death|157|||
124580974|NCT03502811|448084779|FG000|Overall Study|Withdrawal by Subject|105|||
124580975|NCT03502811|448084779|FG000|Overall Study|Lost to Follow-up|26|||
124580976|NCT03502811|448084779|FG000|Overall Study|No Visits (Missed)|31|||
124580977|NCT01735994|448084780|FG000|Overall Study|Withdrawal by Subject|6|||
124580978|NCT01735994|448084781|FG001|Overall Study|Withdrawal by Subject|4|||
124580979|NCT01735994|448084780|FG000|Overall Study|Injury|2|||
124580980|NCT01735994|448084781|FG001|Overall Study|Injury|0|||
124580981|NCT01735994|448084780|FG000|Overall Study|Kicked off team|5|||
124580982|NCT01735994|448084781|FG001|Overall Study|Kicked off team|0|||
124580983|NCT01735994|448084780|FG000|Overall Study|Lost to Follow-up|50|||
124580984|NCT01735994|448084781|FG001|Overall Study|Lost to Follow-up|62|||
124580985|NCT05239195|448084782|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
124580986|NCT05239195|448084783|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
124580987|NCT03552484|448084786|FG000|Overall Study|Death|6|||
124580988|NCT03552484|448084787|FG001|Overall Study|Death|4|||
124580989|NCT03552484|448084786|FG000|Overall Study|Lost to Follow-up|0|||
124580990|NCT03552484|448084787|FG001|Overall Study|Lost to Follow-up|16|||
124580991|NCT02663349|448084796|FG000|Overall Study|Withdrawal by Subject|6|||
124580992|NCT01204294|448084797|FG000|Overall Study|Adverse Event|2|||
124580993|NCT01204294|448084798|FG001|Overall Study|Adverse Event|6|||
124580994|NCT01204294|448084799|FG002|Overall Study|Adverse Event|0|||
124580995|NCT01204294|448084800|FG003|Overall Study|Adverse Event|7|||
124580996|NCT01204294|448084801|FG004|Overall Study|Adverse Event|1|||
124580997|NCT01204294|448084802|FG005|Overall Study|Adverse Event|4|||
124580998|NCT01204294|448084803|FG006|Overall Study|Adverse Event|0|||
124580999|NCT01204294|448084797|FG000|Overall Study|Protocol Violation|1|||
124581000|NCT01204294|448084798|FG001|Overall Study|Protocol Violation|0|||
124581001|NCT01204294|448084799|FG002|Overall Study|Protocol Violation|2|||
124581002|NCT01204294|448084800|FG003|Overall Study|Protocol Violation|1|||
124581003|NCT01204294|448084801|FG004|Overall Study|Protocol Violation|0|||
124581004|NCT01204294|448084802|FG005|Overall Study|Protocol Violation|0|||
124581005|NCT01204294|448084803|FG006|Overall Study|Protocol Violation|0|||
124581006|NCT01204294|448084797|FG000|Overall Study|Withdrawal by Subject|0|||
124581007|NCT01204294|448084798|FG001|Overall Study|Withdrawal by Subject|2|||
124581008|NCT01204294|448084799|FG002|Overall Study|Withdrawal by Subject|2|||
124581009|NCT01204294|448084800|FG003|Overall Study|Withdrawal by Subject|1|||
124581010|NCT01204294|448084801|FG004|Overall Study|Withdrawal by Subject|1|||
124581011|NCT01204294|448084802|FG005|Overall Study|Withdrawal by Subject|1|||
124581012|NCT01204294|448084803|FG006|Overall Study|Withdrawal by Subject|2|||
124581013|NCT01204294|448084797|FG000|Overall Study|Lack of Efficacy|0|||
124581014|NCT01204294|448084798|FG001|Overall Study|Lack of Efficacy|0|||
124727300|NCT03831191|448622416|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
124581015|NCT01204294|448084799|FG002|Overall Study|Lack of Efficacy|0|||
124581016|NCT01204294|448084800|FG003|Overall Study|Lack of Efficacy|2|||
124581017|NCT01204294|448084801|FG004|Overall Study|Lack of Efficacy|0|||
124581018|NCT01204294|448084802|FG005|Overall Study|Lack of Efficacy|0|||
124581019|NCT01204294|448084803|FG006|Overall Study|Lack of Efficacy|0|||
124581020|NCT01204294|448084797|FG000|Overall Study|Other (house moving)|0|||
124581021|NCT01204294|448084798|FG001|Overall Study|Other (house moving)|0|||
124581022|NCT01204294|448084799|FG002|Overall Study|Other (house moving)|1|||
124581023|NCT01204294|448084800|FG003|Overall Study|Other (house moving)|0|||
124581024|NCT01204294|448084801|FG004|Overall Study|Other (house moving)|0|||
124581025|NCT01204294|448084802|FG005|Overall Study|Other (house moving)|0|||
124528536|NCT01693562|447885870|FG018|Escalation Phase|Withdrawal by Subject|0|||
124528537|NCT01693562|447885871|FG019|Escalation Phase|Withdrawal by Subject|0|||
124727301|NCT03831191|448622417|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
124727302|NCT03831191|448622418|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
124727303|NCT03831191|448622404|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
124727304|NCT03831191|448622405|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
124727305|NCT03831191|448622406|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
124727306|NCT03831191|448622407|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
124727307|NCT03831191|448622408|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124727308|NCT03831191|448622409|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124727309|NCT03831191|448622410|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124727310|NCT03831191|448622411|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124727311|NCT03831191|448622412|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124727312|NCT03831191|448622413|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124727313|NCT03831191|448622414|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124727314|NCT03831191|448622415|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124727315|NCT03831191|448622416|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124727316|NCT03831191|448622417|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124776904|NCT00275509|448811342|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
124776905|NCT00275509|448811343|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
124776906|NCT03388164|448811344|FG000|Overall Study|Withdrawal by Subject|3|||
124776907|NCT03388164|448811345|FG001|Overall Study|Withdrawal by Subject|1|||
124776908|NCT03967444|448811346|FG000|Overall Study|Lost to Follow-up|1|||
124776909|NCT03967444|448811347|FG001|Overall Study|Lost to Follow-up|2|||
124776910|NCT01821118|448811349|FG000|Overall Study|Death|0|||
124776911|NCT01821118|448811350|FG001|Overall Study|Death|1|||
124776912|NCT01605799|448811351|FG000|Overall Study|Withdrawal by Subject|2|||
124776913|NCT01605799|448811352|FG001|Overall Study|Withdrawal by Subject|1|||
124776914|NCT00345358|448811353|FG000|Primary Vaccination Phase|Other|0|||
124776915|NCT00345358|448811354|FG001|Primary Vaccination Phase|Other|1|||
124776916|NCT00345358|448811355|FG002|Primary Vaccination Phase|Other|1|||
124776917|NCT00345358|448811356|FG003|Primary Vaccination Phase|Other|0|||
124776918|NCT00345358|448811353|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
124776919|NCT00345358|448811354|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
124776920|NCT00345358|448811355|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
124776921|NCT00345358|448811356|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
124776922|NCT00345358|448811353|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
124528538|NCT01693562|447885872|FG020|Escalation Phase|Withdrawal by Subject|0|||
124528539|NCT01693562|447885873|FG021|Escalation Phase|Withdrawal by Subject|0|||
124528540|NCT01693562|447885874|FG022|Escalation Phase|Withdrawal by Subject|0|||
124528541|NCT01693562|447885852|FG000|Escalation Phase|Death|4|||
124528542|NCT01693562|447885853|FG001|Escalation Phase|Death|2|||
124528543|NCT01693562|447885854|FG002|Escalation Phase|Death|0|||
124528544|NCT01693562|447885855|FG003|Escalation Phase|Death|3|||
124528545|NCT01693562|447885856|FG004|Escalation Phase|Death|6|||
124528546|NCT01693562|447885857|FG005|Escalation Phase|Death|4|||
124528547|NCT01693562|447885858|FG006|Escalation Phase|Death|0|||
124528548|NCT01693562|447885859|FG007|Escalation Phase|Death|0|||
124528549|NCT01693562|447885860|FG008|Escalation Phase|Death|0|||
124528550|NCT01693562|447885861|FG009|Escalation Phase|Death|0|||
124528551|NCT01693562|447885862|FG010|Escalation Phase|Death|0|||
124528552|NCT01693562|447885863|FG011|Escalation Phase|Death|0|||
124528553|NCT01693562|447885864|FG012|Escalation Phase|Death|0|||
124528554|NCT01693562|447885865|FG013|Escalation Phase|Death|0|||
124528555|NCT01693562|447885866|FG014|Escalation Phase|Death|0|||
124528556|NCT01693562|447885867|FG015|Escalation Phase|Death|0|||
124528557|NCT01693562|447885868|FG016|Escalation Phase|Death|0|||
124528558|NCT01693562|447885869|FG017|Escalation Phase|Death|0|||
124528559|NCT01693562|447885870|FG018|Escalation Phase|Death|0|||
124528560|NCT01693562|447885871|FG019|Escalation Phase|Death|0|||
124528561|NCT01693562|447885872|FG020|Escalation Phase|Death|0|||
124528562|NCT01693562|447885873|FG021|Escalation Phase|Death|0|||
124528563|NCT01693562|447885874|FG022|Escalation Phase|Death|0|||
124776923|NCT00345358|448811354|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
124776924|NCT00345358|448811355|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
124776925|NCT00345358|448811356|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
124776926|NCT00345358|448811353|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
124776927|NCT00345358|448811354|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
124776928|NCT00345358|448811355|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
124528564|NCT01693562|447885852|FG000|Escalation Phase|Lost to Follow-up|0|||
124528565|NCT01693562|447885853|FG001|Escalation Phase|Lost to Follow-up|1|||
124528566|NCT01693562|447885854|FG002|Escalation Phase|Lost to Follow-up|1|||
124528567|NCT01693562|447885855|FG003|Escalation Phase|Lost to Follow-up|0|||
124528568|NCT01693562|447885856|FG004|Escalation Phase|Lost to Follow-up|0|||
124528569|NCT01693562|447885857|FG005|Escalation Phase|Lost to Follow-up|0|||
124528570|NCT01693562|447885858|FG006|Escalation Phase|Lost to Follow-up|0|||
124528571|NCT01693562|447885859|FG007|Escalation Phase|Lost to Follow-up|0|||
124528572|NCT01693562|447885860|FG008|Escalation Phase|Lost to Follow-up|0|||
124528573|NCT01693562|447885861|FG009|Escalation Phase|Lost to Follow-up|0|||
124528574|NCT01693562|447885862|FG010|Escalation Phase|Lost to Follow-up|0|||
124528575|NCT01693562|447885863|FG011|Escalation Phase|Lost to Follow-up|0|||
124528576|NCT01693562|447885864|FG012|Escalation Phase|Lost to Follow-up|0|||
124528577|NCT01693562|447885865|FG013|Escalation Phase|Lost to Follow-up|0|||
124528578|NCT01693562|447885866|FG014|Escalation Phase|Lost to Follow-up|0|||
124528579|NCT01693562|447885867|FG015|Escalation Phase|Lost to Follow-up|0|||
124528580|NCT01693562|447885868|FG016|Escalation Phase|Lost to Follow-up|0|||
124528581|NCT01693562|447885869|FG017|Escalation Phase|Lost to Follow-up|0|||
124528582|NCT01693562|447885870|FG018|Escalation Phase|Lost to Follow-up|0|||
124528583|NCT01693562|447885871|FG019|Escalation Phase|Lost to Follow-up|0|||
124528584|NCT01693562|447885872|FG020|Escalation Phase|Lost to Follow-up|0|||
124528585|NCT01693562|447885873|FG021|Escalation Phase|Lost to Follow-up|0|||
124528586|NCT01693562|447885874|FG022|Escalation Phase|Lost to Follow-up|0|||
124528587|NCT01693562|447885852|FG000|Escalation Phase|Other|0|||
124528588|NCT01693562|447885853|FG001|Escalation Phase|Other|0|||
124528589|NCT01693562|447885854|FG002|Escalation Phase|Other|2|||
124528590|NCT01693562|447885855|FG003|Escalation Phase|Other|0|||
124581026|NCT01204294|448084803|FG006|Overall Study|Other (house moving)|0|||
124581027|NCT03128723|448084806|FG000|Overall Study|Withdrawal by Subject|2|||
124581028|NCT00673660|448084807|FG000|Overall Study|Lost to Follow-up|107|||
124581029|NCT01383486|448084808|FG000|Overall Study|Lost to Follow-up|10|||
124581030|NCT01383486|448084808|FG000|Overall Study|Incomplete information for analysis|2|||
124581031|NCT01383486|448084808|FG000|Overall Study|Did not take any product|6|||
124581032|NCT01929863|448084822|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
124581033|NCT01929863|448084823|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
124581034|NCT01929863|448084822|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
124581035|NCT01929863|448084823|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
124581036|NCT01929863|448084822|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
124581037|NCT01929863|448084823|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
124581038|NCT00323882|448084824|FG000|Overall Study|Adverse Event|2|||
124581039|NCT00323882|448084825|FG001|Overall Study|Adverse Event|1|||
124581040|NCT00323882|448084826|FG002|Overall Study|Adverse Event|1|||
124581041|NCT00323882|448084827|FG003|Overall Study|Adverse Event|1|||
124581042|NCT00323882|448084828|FG004|Overall Study|Adverse Event|3|||
124581043|NCT00323882|448084824|FG000|Overall Study|Disease Progression|6|||
124581044|NCT00323882|448084825|FG001|Overall Study|Disease Progression|4|||
124581045|NCT00323882|448084826|FG002|Overall Study|Disease Progression|10|||
124581046|NCT00323882|448084827|FG003|Overall Study|Disease Progression|5|||
124581047|NCT00323882|448084828|FG004|Overall Study|Disease Progression|22|||
124581048|NCT00323882|448084824|FG000|Overall Study|Death|0|||
124581049|NCT00323882|448084825|FG001|Overall Study|Death|1|||
124581050|NCT00323882|448084826|FG002|Overall Study|Death|1|||
124581051|NCT00323882|448084827|FG003|Overall Study|Death|0|||
124581052|NCT00323882|448084828|FG004|Overall Study|Death|5|||
124581053|NCT00323882|448084824|FG000|Overall Study|Lost to Follow-up|0|||
124581054|NCT00323882|448084825|FG001|Overall Study|Lost to Follow-up|0|||
124581055|NCT00323882|448084826|FG002|Overall Study|Lost to Follow-up|1|||
124581056|NCT00323882|448084827|FG003|Overall Study|Lost to Follow-up|0|||
124528591|NCT01693562|447885856|FG004|Escalation Phase|Other|0|||
124528592|NCT01693562|447885857|FG005|Escalation Phase|Other|1|||
124528593|NCT01693562|447885858|FG006|Escalation Phase|Other|0|||
124528594|NCT01693562|447885859|FG007|Escalation Phase|Other|0|||
124581057|NCT00323882|448084828|FG004|Overall Study|Lost to Follow-up|1|||
124581058|NCT00323882|448084824|FG000|Overall Study|Other|0|||
124581059|NCT00323882|448084825|FG001|Overall Study|Other|0|||
124581060|NCT00323882|448084826|FG002|Overall Study|Other|0|||
124581061|NCT00323882|448084827|FG003|Overall Study|Other|1|||
124581062|NCT00323882|448084828|FG004|Overall Study|Other|1|||
124528595|NCT01693562|447885860|FG008|Escalation Phase|Other|0|||
124528596|NCT01693562|447885861|FG009|Escalation Phase|Other|0|||
124528597|NCT01693562|447885862|FG010|Escalation Phase|Other|0|||
124528598|NCT01693562|447885863|FG011|Escalation Phase|Other|0|||
124528599|NCT01693562|447885864|FG012|Escalation Phase|Other|0|||
124581063|NCT00830024|448084830|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
124581064|NCT00830024|448084831|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
124581065|NCT01456221|448084832|FG000|Overall Study|Withdrawal by Subject|56|||
124581066|NCT01456221|448084833|FG001|Overall Study|Withdrawal by Subject|49|||
124581067|NCT01456221|448084832|FG000|Overall Study|Lost to Follow-up|1|||
124581068|NCT01456221|448084833|FG001|Overall Study|Lost to Follow-up|4|||
124581069|NCT01456221|448084832|FG000|Overall Study|Received medication|3|||
124581070|NCT01456221|448084833|FG001|Overall Study|Received medication|2|||
124581071|NCT01456221|448084832|FG000|Overall Study|Incomplete data|4|||
124581072|NCT01456221|448084833|FG001|Overall Study|Incomplete data|2|||
124581073|NCT00436163|448084834|FG000|Overall Study|Lost to Follow-up|2|||
124528600|NCT01693562|447885865|FG013|Escalation Phase|Other|0|||
124528601|NCT01693562|447885866|FG014|Escalation Phase|Other|0|||
124528602|NCT01693562|447885867|FG015|Escalation Phase|Other|0|||
124727317|NCT03831191|448622418|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124727318|NCT03831191|448622404|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
124727319|NCT03831191|448622405|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
124727320|NCT03831191|448622406|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
124727321|NCT03831191|448622407|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
124727322|NCT03831191|448622408|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
124727323|NCT03831191|448622409|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
124727324|NCT03831191|448622410|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
124727325|NCT03831191|448622411|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
124727326|NCT03831191|448622412|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
124727327|NCT03831191|448622413|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
124727328|NCT03831191|448622414|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
124727329|NCT03831191|448622415|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
124727330|NCT03831191|448622416|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
124727331|NCT03831191|448622417|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
124727332|NCT03831191|448622418|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
124727333|NCT03831191|448622404|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
124727334|NCT03831191|448622405|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
124727335|NCT03831191|448622406|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
124727336|NCT03831191|448622407|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
124727337|NCT03831191|448622408|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
124727338|NCT03831191|448622409|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
124727339|NCT03831191|448622410|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
124528603|NCT01693562|447885868|FG016|Escalation Phase|Other|0|||
124528604|NCT01693562|447885869|FG017|Escalation Phase|Other|0|||
124528605|NCT01693562|447885870|FG018|Escalation Phase|Other|0|||
124528606|NCT01693562|447885871|FG019|Escalation Phase|Other|0|||
124528607|NCT01693562|447885872|FG020|Escalation Phase|Other|0|||
124528608|NCT01693562|447885873|FG021|Escalation Phase|Other|0|||
124528609|NCT01693562|447885874|FG022|Escalation Phase|Other|0|||
124528610|NCT01693562|447885852|FG000|Exploration Phase|Withdrawal by Subject|0|||
124528611|NCT01693562|447885853|FG001|Exploration Phase|Withdrawal by Subject|0|||
124528612|NCT01693562|447885854|FG002|Exploration Phase|Withdrawal by Subject|0|||
124528613|NCT01693562|447885855|FG003|Exploration Phase|Withdrawal by Subject|0|||
124528614|NCT01693562|447885856|FG004|Exploration Phase|Withdrawal by Subject|0|||
124528615|NCT01693562|447885857|FG005|Exploration Phase|Withdrawal by Subject|0|||
124528616|NCT01693562|447885858|FG006|Exploration Phase|Withdrawal by Subject|2|||
124528617|NCT01693562|447885859|FG007|Exploration Phase|Withdrawal by Subject|0|||
124528618|NCT01693562|447885860|FG008|Exploration Phase|Withdrawal by Subject|0|||
124528619|NCT01693562|447885861|FG009|Exploration Phase|Withdrawal by Subject|0|||
124528620|NCT01693562|447885862|FG010|Exploration Phase|Withdrawal by Subject|0|||
124528621|NCT01693562|447885863|FG011|Exploration Phase|Withdrawal by Subject|0|||
124528622|NCT01693562|447885864|FG012|Exploration Phase|Withdrawal by Subject|0|||
124528623|NCT01693562|447885865|FG013|Exploration Phase|Withdrawal by Subject|0|||
124528624|NCT01693562|447885866|FG014|Exploration Phase|Withdrawal by Subject|0|||
124528625|NCT01693562|447885867|FG015|Exploration Phase|Withdrawal by Subject|0|||
124528626|NCT01693562|447885868|FG016|Exploration Phase|Withdrawal by Subject|0|||
124528627|NCT01693562|447885869|FG017|Exploration Phase|Withdrawal by Subject|0|||
124528628|NCT01693562|447885870|FG018|Exploration Phase|Withdrawal by Subject|0|||
124528629|NCT01693562|447885871|FG019|Exploration Phase|Withdrawal by Subject|0|||
124528630|NCT01693562|447885872|FG020|Exploration Phase|Withdrawal by Subject|0|||
124528631|NCT01693562|447885873|FG021|Exploration Phase|Withdrawal by Subject|0|||
124528632|NCT01693562|447885874|FG022|Exploration Phase|Withdrawal by Subject|0|||
124528633|NCT01693562|447885852|FG000|Exploration Phase|Death|0|||
124528634|NCT01693562|447885853|FG001|Exploration Phase|Death|0|||
124528635|NCT01693562|447885854|FG002|Exploration Phase|Death|0|||
124528636|NCT01693562|447885855|FG003|Exploration Phase|Death|0|||
124528637|NCT01693562|447885856|FG004|Exploration Phase|Death|0|||
124528638|NCT01693562|447885857|FG005|Exploration Phase|Death|0|||
124528639|NCT01693562|447885858|FG006|Exploration Phase|Death|17|||
124776929|NCT00345358|448811356|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
124776930|NCT00345358|448811353|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
124528640|NCT01693562|447885859|FG007|Exploration Phase|Death|0|||
124528641|NCT01693562|447885860|FG008|Exploration Phase|Death|0|||
124528642|NCT01693562|447885861|FG009|Exploration Phase|Death|0|||
124528643|NCT01693562|447885862|FG010|Exploration Phase|Death|0|||
124528644|NCT01693562|447885863|FG011|Exploration Phase|Death|0|||
124776931|NCT00345358|448811354|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
124528645|NCT01693562|447885864|FG012|Exploration Phase|Death|0|||
124528646|NCT01693562|447885865|FG013|Exploration Phase|Death|0|||
124528647|NCT01693562|447885866|FG014|Exploration Phase|Death|0|||
124528648|NCT01693562|447885867|FG015|Exploration Phase|Death|0|||
124528649|NCT01693562|447885868|FG016|Exploration Phase|Death|0|||
124528650|NCT01693562|447885869|FG017|Exploration Phase|Death|0|||
124528651|NCT01693562|447885870|FG018|Exploration Phase|Death|0|||
124528652|NCT01693562|447885871|FG019|Exploration Phase|Death|0|||
124581074|NCT00436163|448084834|FG000|Overall Study|Adverse Event|1|||
124581075|NCT06647173|448084837|FG000|Overall Study|Lost to Follow-up|24|||
124581076|NCT02530905|448084838|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
124581077|NCT02530905|448084839|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
124581078|NCT02530905|448084840|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
124581079|NCT01473953|448084843|FG000|Overall Study|Other|1|||
124581080|NCT01473953|448084844|FG001|Overall Study|Other|0|||
124581081|NCT01473953|448084845|FG002|Overall Study|Other|0|||
124581082|NCT01473953|448084846|FG003|Overall Study|Other|0|||
124581083|NCT01473953|448084847|FG004|Overall Study|Other|0|||
124581084|NCT03100344|448084848|FG000|Overall Study|Adverse Event|0|||
124581085|NCT03100344|448084849|FG001|Overall Study|Adverse Event|3|||
124581086|NCT03100344|448084850|FG002|Overall Study|Adverse Event|2|||
124581087|NCT03100344|448084851|FG003|Overall Study|Adverse Event|3|||
124581088|NCT03100344|448084848|FG000|Overall Study|Lack of Efficacy|2|||
124581089|NCT03100344|448084849|FG001|Overall Study|Lack of Efficacy|0|||
124581090|NCT03100344|448084850|FG002|Overall Study|Lack of Efficacy|0|||
124581091|NCT03100344|448084851|FG003|Overall Study|Lack of Efficacy|0|||
124581092|NCT03100344|448084848|FG000|Overall Study|Protocol Violation|1|||
124528653|NCT01693562|447885872|FG020|Exploration Phase|Death|0|||
124528654|NCT01693562|447885873|FG021|Exploration Phase|Death|0|||
124528655|NCT01693562|447885874|FG022|Exploration Phase|Death|0|||
124528656|NCT01693562|447885852|FG000|Exploration Phase|Other|0|||
124528657|NCT01693562|447885853|FG001|Exploration Phase|Other|0|||
124528658|NCT01693562|447885854|FG002|Exploration Phase|Other|0|||
124528659|NCT01693562|447885855|FG003|Exploration Phase|Other|0|||
124528660|NCT01693562|447885856|FG004|Exploration Phase|Other|0|||
124528661|NCT01693562|447885857|FG005|Exploration Phase|Other|0|||
124528662|NCT01693562|447885858|FG006|Exploration Phase|Other|2|||
124581093|NCT03100344|448084849|FG001|Overall Study|Protocol Violation|0|||
124528663|NCT01693562|447885859|FG007|Exploration Phase|Other|0|||
124528664|NCT01693562|447885860|FG008|Exploration Phase|Other|0|||
124528665|NCT01693562|447885861|FG009|Exploration Phase|Other|0|||
124528666|NCT01693562|447885862|FG010|Exploration Phase|Other|0|||
124528667|NCT01693562|447885863|FG011|Exploration Phase|Other|0|||
124528668|NCT01693562|447885864|FG012|Exploration Phase|Other|0|||
124528669|NCT01693562|447885865|FG013|Exploration Phase|Other|0|||
124528670|NCT01693562|447885866|FG014|Exploration Phase|Other|0|||
124528671|NCT01693562|447885867|FG015|Exploration Phase|Other|0|||
124528672|NCT01693562|447885868|FG016|Exploration Phase|Other|0|||
124528673|NCT01693562|447885869|FG017|Exploration Phase|Other|0|||
124528674|NCT01693562|447885870|FG018|Exploration Phase|Other|0|||
124528675|NCT01693562|447885871|FG019|Exploration Phase|Other|0|||
124528676|NCT01693562|447885872|FG020|Exploration Phase|Other|0|||
124528677|NCT01693562|447885873|FG021|Exploration Phase|Other|0|||
124528678|NCT01693562|447885874|FG022|Exploration Phase|Other|0|||
124528679|NCT01693562|447885852|FG000|Expansion Phase|Withdrawal by Subject|0|||
124528680|NCT01693562|447885853|FG001|Expansion Phase|Withdrawal by Subject|0|||
124528681|NCT01693562|447885854|FG002|Expansion Phase|Withdrawal by Subject|0|||
124528682|NCT01693562|447885855|FG003|Expansion Phase|Withdrawal by Subject|0|||
124528683|NCT01693562|447885856|FG004|Expansion Phase|Withdrawal by Subject|0|||
124528684|NCT01693562|447885857|FG005|Expansion Phase|Withdrawal by Subject|0|||
124528685|NCT01693562|447885858|FG006|Expansion Phase|Withdrawal by Subject|0|||
124528686|NCT01693562|447885859|FG007|Expansion Phase|Withdrawal by Subject|16|||
124528687|NCT01693562|447885860|FG008|Expansion Phase|Withdrawal by Subject|2|||
124528688|NCT01693562|447885861|FG009|Expansion Phase|Withdrawal by Subject|54|||
124528689|NCT01693562|447885862|FG010|Expansion Phase|Withdrawal by Subject|2|||
124528690|NCT01693562|447885863|FG011|Expansion Phase|Withdrawal by Subject|2|||
124528691|NCT01693562|447885864|FG012|Expansion Phase|Withdrawal by Subject|3|||
124528692|NCT01693562|447885865|FG013|Expansion Phase|Withdrawal by Subject|5|||
124528693|NCT01693562|447885866|FG014|Expansion Phase|Withdrawal by Subject|16|||
124528694|NCT01693562|447885867|FG015|Expansion Phase|Withdrawal by Subject|7|||
124581094|NCT03100344|448084850|FG002|Overall Study|Protocol Violation|0|||
124581095|NCT03100344|448084851|FG003|Overall Study|Protocol Violation|0|||
124581096|NCT03100344|448084848|FG000|Overall Study|Withdrawal by Subject|10|||
124581097|NCT03100344|448084849|FG001|Overall Study|Withdrawal by Subject|7|||
124581098|NCT03100344|448084850|FG002|Overall Study|Withdrawal by Subject|4|||
124581099|NCT03100344|448084851|FG003|Overall Study|Withdrawal by Subject|8|||
124581100|NCT03100344|448084848|FG000|Overall Study|Lost to Follow-up|1|||
124581101|NCT03100344|448084849|FG001|Overall Study|Lost to Follow-up|1|||
124581102|NCT03100344|448084850|FG002|Overall Study|Lost to Follow-up|1|||
124581103|NCT03100344|448084851|FG003|Overall Study|Lost to Follow-up|1|||
124581104|NCT02358538|448084852|FG000|Through Week 26|Adverse Event|0|||
124528695|NCT01693562|447885868|FG016|Expansion Phase|Withdrawal by Subject|40|||
124528696|NCT01693562|447885869|FG017|Expansion Phase|Withdrawal by Subject|4|||
124528697|NCT01693562|447885870|FG018|Expansion Phase|Withdrawal by Subject|8|||
124528698|NCT01693562|447885871|FG019|Expansion Phase|Withdrawal by Subject|3|||
124528699|NCT01693562|447885872|FG020|Expansion Phase|Withdrawal by Subject|1|||
124528700|NCT01693562|447885873|FG021|Expansion Phase|Withdrawal by Subject|8|||
124528701|NCT01693562|447885874|FG022|Expansion Phase|Withdrawal by Subject|1|||
124528702|NCT01693562|447885852|FG000|Expansion Phase|Death|0|||
124727340|NCT03831191|448622411|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
124727341|NCT03831191|448622412|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
124727342|NCT03831191|448622413|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
124727343|NCT03831191|448622414|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
124727344|NCT03831191|448622415|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
124727345|NCT03831191|448622416|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
124727346|NCT03831191|448622417|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
124727347|NCT03831191|448622418|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
124727348|NCT03831191|448622404|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
124528703|NCT01693562|447885853|FG001|Expansion Phase|Death|0|||
124581105|NCT02358538|448084853|FG001|Through Week 26|Adverse Event|1|||
124581106|NCT02358538|448084854|FG002|Through Week 26|Adverse Event|1|||
124581107|NCT02358538|448084855|FG003|Through Week 26|Adverse Event|2|||
124581108|NCT02358538|448084852|FG000|Through Week 26|Lack of Efficacy|1|||
124581109|NCT02358538|448084853|FG001|Through Week 26|Lack of Efficacy|1|||
124581110|NCT02358538|448084854|FG002|Through Week 26|Lack of Efficacy|3|||
124581111|NCT02358538|448084855|FG003|Through Week 26|Lack of Efficacy|3|||
124581112|NCT02358538|448084852|FG000|Through Week 26|Withdrawal by Subject|1|||
124581113|NCT02358538|448084853|FG001|Through Week 26|Withdrawal by Subject|0|||
124581114|NCT02358538|448084854|FG002|Through Week 26|Withdrawal by Subject|0|||
124581115|NCT02358538|448084855|FG003|Through Week 26|Withdrawal by Subject|0|||
124581116|NCT02358538|448084852|FG000|Through Week 26|Non-Compliance|0|||
124581117|NCT02358538|448084853|FG001|Through Week 26|Non-Compliance|0|||
124581118|NCT02358538|448084854|FG002|Through Week 26|Non-Compliance|1|||
124581119|NCT02358538|448084855|FG003|Through Week 26|Non-Compliance|0|||
124581120|NCT02358538|448084852|FG000|Through Week 26|Family did not see benefit from IP|1|||
124581121|NCT02358538|448084853|FG001|Through Week 26|Family did not see benefit from IP|0|||
124581122|NCT02358538|448084854|FG002|Through Week 26|Family did not see benefit from IP|0|||
124581123|NCT02358538|448084855|FG003|Through Week 26|Family did not see benefit from IP|0|||
124581124|NCT02358538|448084852|FG000|52 Week Extension Period|Lack of Efficacy|0|||
124528704|NCT01693562|447885854|FG002|Expansion Phase|Death|0|||
124528705|NCT01693562|447885855|FG003|Expansion Phase|Death|0|||
124528706|NCT01693562|447885856|FG004|Expansion Phase|Death|0|||
124581125|NCT02358538|448084853|FG001|52 Week Extension Period|Lack of Efficacy|0|||
124581126|NCT02358538|448084854|FG002|52 Week Extension Period|Lack of Efficacy|2|||
124581127|NCT02358538|448084855|FG003|52 Week Extension Period|Lack of Efficacy|4|||
124581128|NCT01494532|448084858|FG000|Overall Study|Adverse Event|4|||
124581129|NCT01494532|448084859|FG001|Overall Study|Adverse Event|1|||
124581130|NCT01494532|448084860|FG002|Overall Study|Adverse Event|8|||
124528707|NCT01693562|447885857|FG005|Expansion Phase|Death|0|||
124528708|NCT01693562|447885858|FG006|Expansion Phase|Death|0|||
124528709|NCT01693562|447885859|FG007|Expansion Phase|Death|42|||
124528710|NCT01693562|447885860|FG008|Expansion Phase|Death|17|||
124528711|NCT01693562|447885861|FG009|Expansion Phase|Death|208|||
124528712|NCT01693562|447885862|FG010|Expansion Phase|Death|30|||
124528713|NCT01693562|447885863|FG011|Expansion Phase|Death|8|||
124528714|NCT01693562|447885864|FG012|Expansion Phase|Death|19|||
124528715|NCT01693562|447885865|FG013|Expansion Phase|Death|42|||
124528716|NCT01693562|447885866|FG014|Expansion Phase|Death|23|||
124528717|NCT01693562|447885867|FG015|Expansion Phase|Death|23|||
124528718|NCT01693562|447885868|FG016|Expansion Phase|Death|128|||
124528719|NCT01693562|447885869|FG017|Expansion Phase|Death|16|||
124528720|NCT01693562|447885870|FG018|Expansion Phase|Death|36|||
124528721|NCT01693562|447885871|FG019|Expansion Phase|Death|16|||
124528722|NCT01693562|447885872|FG020|Expansion Phase|Death|17|||
124528723|NCT01693562|447885873|FG021|Expansion Phase|Death|35|||
124528724|NCT01693562|447885874|FG022|Expansion Phase|Death|7|||
124528725|NCT01693562|447885852|FG000|Expansion Phase|Lost to Follow-up|0|||
124528726|NCT01693562|447885853|FG001|Expansion Phase|Lost to Follow-up|0|||
124528727|NCT01693562|447885854|FG002|Expansion Phase|Lost to Follow-up|0|||
124528728|NCT01693562|447885855|FG003|Expansion Phase|Lost to Follow-up|0|||
124528729|NCT01693562|447885856|FG004|Expansion Phase|Lost to Follow-up|0|||
124528730|NCT01693562|447885857|FG005|Expansion Phase|Lost to Follow-up|0|||
124528731|NCT01693562|447885858|FG006|Expansion Phase|Lost to Follow-up|0|||
124528732|NCT01693562|447885859|FG007|Expansion Phase|Lost to Follow-up|1|||
124528733|NCT01693562|447885860|FG008|Expansion Phase|Lost to Follow-up|2|||
124581131|NCT01494532|448084861|FG003|Overall Study|Adverse Event|6|||
124581132|NCT01494532|448084862|FG004|Overall Study|Adverse Event|5|||
124581133|NCT01494532|448084863|FG005|Overall Study|Adverse Event|0|||
124581134|NCT01494532|448084858|FG000|Overall Study|Lack of Efficacy|0|||
124581135|NCT01494532|448084859|FG001|Overall Study|Lack of Efficacy|0|||
124581136|NCT01494532|448084860|FG002|Overall Study|Lack of Efficacy|0|||
124727349|NCT03831191|448622405|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
124528734|NCT01693562|447885861|FG009|Expansion Phase|Lost to Follow-up|10|||
124528735|NCT01693562|447885862|FG010|Expansion Phase|Lost to Follow-up|4|||
124528736|NCT01693562|447885863|FG011|Expansion Phase|Lost to Follow-up|4|||
124528737|NCT01693562|447885864|FG012|Expansion Phase|Lost to Follow-up|1|||
124528738|NCT01693562|447885865|FG013|Expansion Phase|Lost to Follow-up|3|||
124528739|NCT01693562|447885866|FG014|Expansion Phase|Lost to Follow-up|0|||
124528740|NCT01693562|447885867|FG015|Expansion Phase|Lost to Follow-up|1|||
124528741|NCT01693562|447885868|FG016|Expansion Phase|Lost to Follow-up|1|||
124528742|NCT01693562|447885869|FG017|Expansion Phase|Lost to Follow-up|0|||
124528743|NCT01693562|447885870|FG018|Expansion Phase|Lost to Follow-up|2|||
124528744|NCT01693562|447885871|FG019|Expansion Phase|Lost to Follow-up|1|||
124528745|NCT01693562|447885872|FG020|Expansion Phase|Lost to Follow-up|2|||
124528746|NCT01693562|447885873|FG021|Expansion Phase|Lost to Follow-up|2|||
124528747|NCT01693562|447885874|FG022|Expansion Phase|Lost to Follow-up|1|||
124528748|NCT01693562|447885852|FG000|Expansion Phase|Other|0|||
124528749|NCT01693562|447885853|FG001|Expansion Phase|Other|0|||
124528750|NCT01693562|447885854|FG002|Expansion Phase|Other|0|||
124528751|NCT01693562|447885855|FG003|Expansion Phase|Other|0|||
124528752|NCT01693562|447885856|FG004|Expansion Phase|Other|0|||
124528753|NCT01693562|447885857|FG005|Expansion Phase|Other|0|||
124727350|NCT03831191|448622406|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
124528754|NCT01693562|447885858|FG006|Expansion Phase|Other|0|||
124528755|NCT01693562|447885859|FG007|Expansion Phase|Other|3|||
124528756|NCT01693562|447885860|FG008|Expansion Phase|Other|1|||
124528757|NCT01693562|447885861|FG009|Expansion Phase|Other|28|||
124528758|NCT01693562|447885862|FG010|Expansion Phase|Other|4|||
124528759|NCT01693562|447885863|FG011|Expansion Phase|Other|7|||
124528760|NCT01693562|447885864|FG012|Expansion Phase|Other|0|||
124581137|NCT01494532|448084861|FG003|Overall Study|Lack of Efficacy|0|||
124581138|NCT01494532|448084862|FG004|Overall Study|Lack of Efficacy|2|||
124581139|NCT01494532|448084863|FG005|Overall Study|Lack of Efficacy|0|||
124581140|NCT01494532|448084858|FG000|Overall Study|Protocol deviation|2|||
124581141|NCT01494532|448084859|FG001|Overall Study|Protocol deviation|1|||
124581142|NCT01494532|448084860|FG002|Overall Study|Protocol deviation|3|||
124581143|NCT01494532|448084861|FG003|Overall Study|Protocol deviation|2|||
124727351|NCT03831191|448622407|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
124727352|NCT03831191|448622408|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
124727353|NCT03831191|448622409|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
124727354|NCT03831191|448622410|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
124727355|NCT03831191|448622411|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
124727356|NCT03831191|448622412|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
124727357|NCT03831191|448622413|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
124727358|NCT03831191|448622414|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
124727359|NCT03831191|448622415|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
124727360|NCT03831191|448622416|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
124727361|NCT03831191|448622417|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
124727362|NCT03831191|448622418|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
124727363|NCT03831191|448622404|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124727364|NCT03831191|448622405|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124727365|NCT03831191|448622406|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124727366|NCT03831191|448622407|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124727367|NCT03831191|448622408|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124727368|NCT03831191|448622409|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124727369|NCT03831191|448622410|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124727370|NCT03831191|448622411|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124727371|NCT03831191|448622412|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124727372|NCT03831191|448622413|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124727373|NCT03831191|448622414|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124727374|NCT03831191|448622415|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124727375|NCT03831191|448622416|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124727376|NCT03831191|448622417|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124727377|NCT03831191|448622418|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
124581144|NCT01494532|448084862|FG004|Overall Study|Protocol deviation|3|||
124581145|NCT01494532|448084863|FG005|Overall Study|Protocol deviation|0|||
124581146|NCT01494532|448084858|FG000|Overall Study|Protocol-defined stopping criteria|0|||
124581147|NCT01494532|448084859|FG001|Overall Study|Protocol-defined stopping criteria|0|||
124581148|NCT01494532|448084860|FG002|Overall Study|Protocol-defined stopping criteria|1|||
124727378|NCT03831191|448622404|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124581149|NCT01494532|448084861|FG003|Overall Study|Protocol-defined stopping criteria|0|||
124581150|NCT01494532|448084862|FG004|Overall Study|Protocol-defined stopping criteria|0|||
124727379|NCT03831191|448622405|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124727380|NCT03831191|448622406|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124528761|NCT01693562|447885865|FG013|Expansion Phase|Other|1|||
124528762|NCT01693562|447885866|FG014|Expansion Phase|Other|1|||
124528763|NCT01693562|447885867|FG015|Expansion Phase|Other|0|||
124528764|NCT01693562|447885868|FG016|Expansion Phase|Other|28|||
124528765|NCT01693562|447885869|FG017|Expansion Phase|Other|0|||
124528766|NCT01693562|447885870|FG018|Expansion Phase|Other|1|||
124528767|NCT01693562|447885871|FG019|Expansion Phase|Other|0|||
124581151|NCT01494532|448084863|FG005|Overall Study|Protocol-defined stopping criteria|0|||
124581152|NCT01494532|448084858|FG000|Overall Study|Lost to Follow-up|1|||
124528768|NCT01693562|447885872|FG020|Expansion Phase|Other|1|||
124528769|NCT01693562|447885873|FG021|Expansion Phase|Other|17|||
124727381|NCT03831191|448622407|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124727382|NCT03831191|448622408|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124727383|NCT03831191|448622409|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124727384|NCT03831191|448622410|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124727385|NCT03831191|448622411|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124727386|NCT03831191|448622412|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124727387|NCT03831191|448622413|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124727388|NCT03831191|448622414|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124727389|NCT03831191|448622415|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124727390|NCT03831191|448622416|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124727391|NCT03831191|448622417|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124727392|NCT03831191|448622418|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
124727393|NCT02300558|448622419|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
124727394|NCT02300558|448622419|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
124727395|NCT02300558|448622419|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
124727396|NCT02300558|448622419|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
124727397|NCT00695955|448622420|FG000|Cohort 1|Adverse Event|26|||
124727398|NCT00695955|448622420|FG000|Cohort 1|Protocol Violation|2|||
124727399|NCT00695955|448622420|FG000|Cohort 1|Lost to Follow-up|30|||
124727400|NCT00695955|448622420|FG000|Cohort 1|Withdrawal by Subject|25|||
124727401|NCT00695955|448622420|FG000|Cohort 1|Lack of Efficacy|3|||
124727402|NCT00695955|448622420|FG000|Cohort 1|Other|16|||
124727403|NCT00695955|448622420|FG000|Cohort 2|Adverse Event|24|||
124727404|NCT00695955|448622420|FG000|Cohort 2|Protocol Violation|5|||
124727405|NCT00695955|448622420|FG000|Cohort 2|Lost to Follow-up|38|||
124727406|NCT00695955|448622420|FG000|Cohort 2|Withdrawal by Subject|28|||
124727407|NCT00695955|448622420|FG000|Cohort 2|Lack of Efficacy|4|||
124727408|NCT00695955|448622420|FG000|Cohort 2|Other|5|||
124727409|NCT03888235|448622423|FG000|Overall Study|Lost to Follow-up|1|||
124727410|NCT03888235|448622424|FG001|Overall Study|Lost to Follow-up|1|||
124727411|NCT03888235|448622425|FG002|Overall Study|Lost to Follow-up|0|||
124727412|NCT01054560|448622426|FG000|Overall Study|Death|10|||
124727413|NCT01054560|448622427|FG001|Overall Study|Death|21|||
124727414|NCT01054560|448622426|FG000|Overall Study|Lost to Follow-up|2|||
124727415|NCT01054560|448622427|FG001|Overall Study|Lost to Follow-up|5|||
124727416|NCT01054560|448622426|FG000|Overall Study|Withdrawal by Subject|0|||
124727417|NCT01054560|448622427|FG001|Overall Study|Withdrawal by Subject|2|||
124727418|NCT01054560|448622426|FG000|Overall Study|Physician Decision|1|||
124727419|NCT01054560|448622427|FG001|Overall Study|Physician Decision|0|||
124727420|NCT00712725|448622428|FG000|Overall Study|Adverse Event|1|||
124727421|NCT00712725|448622429|FG001|Overall Study|Adverse Event|0|||
124727422|NCT00712725|448622430|FG002|Overall Study|Adverse Event|0|||
124727423|NCT00712725|448622431|FG003|Overall Study|Adverse Event|1|||
124727424|NCT00712725|448622432|FG004|Overall Study|Adverse Event|0|||
124727425|NCT00712725|448622433|FG005|Overall Study|Adverse Event|0|||
124727426|NCT00712725|448622434|FG006|Overall Study|Adverse Event|0|||
124727427|NCT00712725|448622435|FG007|Overall Study|Adverse Event|0|||
124727428|NCT00712725|448622428|FG000|Overall Study|Lost to Follow-up|3|||
124727429|NCT00712725|448622429|FG001|Overall Study|Lost to Follow-up|2|||
124727430|NCT00712725|448622430|FG002|Overall Study|Lost to Follow-up|1|||
124727431|NCT00712725|448622431|FG003|Overall Study|Lost to Follow-up|1|||
124727432|NCT00712725|448622432|FG004|Overall Study|Lost to Follow-up|2|||
124727433|NCT00712725|448622433|FG005|Overall Study|Lost to Follow-up|2|||
124727434|NCT00712725|448622434|FG006|Overall Study|Lost to Follow-up|3|||
124727435|NCT00712725|448622435|FG007|Overall Study|Lost to Follow-up|1|||
124727436|NCT00712725|448622428|FG000|Overall Study|Physician Decision|2|||
124727437|NCT00712725|448622429|FG001|Overall Study|Physician Decision|0|||
124727438|NCT00712725|448622430|FG002|Overall Study|Physician Decision|0|||
124528770|NCT01693562|447885874|FG022|Expansion Phase|Other|1|||
124528771|NCT02903966|447885875|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
124528772|NCT02903966|447885876|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
124528773|NCT02903966|447885875|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
124727439|NCT00712725|448622431|FG003|Overall Study|Physician Decision|0|||
124727440|NCT00712725|448622432|FG004|Overall Study|Physician Decision|1|||
124727441|NCT00712725|448622433|FG005|Overall Study|Physician Decision|0|||
124727442|NCT00712725|448622434|FG006|Overall Study|Physician Decision|2|||
124727443|NCT00712725|448622435|FG007|Overall Study|Physician Decision|0|||
124727444|NCT00712725|448622428|FG000|Overall Study|Pregnancy|0|||
124528774|NCT02903966|447885876|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
124727445|NCT00712725|448622429|FG001|Overall Study|Pregnancy|1|||
124727446|NCT00712725|448622430|FG002|Overall Study|Pregnancy|0|||
124727447|NCT00712725|448622431|FG003|Overall Study|Pregnancy|0|||
124727448|NCT00712725|448622432|FG004|Overall Study|Pregnancy|1|||
124727449|NCT00712725|448622433|FG005|Overall Study|Pregnancy|0|||
124727450|NCT00712725|448622434|FG006|Overall Study|Pregnancy|2|||
124727451|NCT00712725|448622435|FG007|Overall Study|Pregnancy|0|||
124528775|NCT02903966|447885875|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
124727452|NCT00712725|448622428|FG000|Overall Study|Protocol Violation|2|||
124727453|NCT00712725|448622429|FG001|Overall Study|Protocol Violation|0|||
124727454|NCT00712725|448622430|FG002|Overall Study|Protocol Violation|1|||
124727455|NCT00712725|448622431|FG003|Overall Study|Protocol Violation|3|||
124727456|NCT00712725|448622432|FG004|Overall Study|Protocol Violation|2|||
124727457|NCT00712725|448622433|FG005|Overall Study|Protocol Violation|0|||
124727458|NCT00712725|448622434|FG006|Overall Study|Protocol Violation|1|||
124727459|NCT00712725|448622435|FG007|Overall Study|Protocol Violation|1|||
124727460|NCT00712725|448622428|FG000|Overall Study|Withdrawal by Subject|2|||
124727461|NCT00712725|448622429|FG001|Overall Study|Withdrawal by Subject|1|||
124727462|NCT00712725|448622430|FG002|Overall Study|Withdrawal by Subject|1|||
124727463|NCT00712725|448622431|FG003|Overall Study|Withdrawal by Subject|2|||
124727464|NCT00712725|448622432|FG004|Overall Study|Withdrawal by Subject|1|||
124727465|NCT00712725|448622433|FG005|Overall Study|Withdrawal by Subject|1|||
124727466|NCT00712725|448622434|FG006|Overall Study|Withdrawal by Subject|1|||
124727467|NCT00712725|448622435|FG007|Overall Study|Withdrawal by Subject|2|||
124727468|NCT00712725|448622428|FG000|Overall Study|Lack of Qualifying Event|16|||
124727469|NCT00712725|448622429|FG001|Overall Study|Lack of Qualifying Event|2|||
124727470|NCT00712725|448622430|FG002|Overall Study|Lack of Qualifying Event|6|||
124727471|NCT00712725|448622431|FG003|Overall Study|Lack of Qualifying Event|8|||
124727472|NCT00712725|448622432|FG004|Overall Study|Lack of Qualifying Event|11|||
124727473|NCT00712725|448622433|FG005|Overall Study|Lack of Qualifying Event|13|||
124727474|NCT00712725|448622434|FG006|Overall Study|Lack of Qualifying Event|11|||
124727475|NCT00712725|448622435|FG007|Overall Study|Lack of Qualifying Event|6|||
124727476|NCT00712725|448622428|FG000|Overall Study|Protocol Specified Criteria|3|||
124727477|NCT00712725|448622429|FG001|Overall Study|Protocol Specified Criteria|0|||
124727478|NCT00712725|448622430|FG002|Overall Study|Protocol Specified Criteria|1|||
124727479|NCT00712725|448622431|FG003|Overall Study|Protocol Specified Criteria|2|||
124727480|NCT00712725|448622432|FG004|Overall Study|Protocol Specified Criteria|1|||
124727481|NCT00712725|448622433|FG005|Overall Study|Protocol Specified Criteria|0|||
124528776|NCT02903966|447885876|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
124528777|NCT02987205|447885877|FG000|Overall Study|Adverse Event|1|||
124727482|NCT00712725|448622434|FG006|Overall Study|Protocol Specified Criteria|2|||
124727483|NCT00712725|448622435|FG007|Overall Study|Protocol Specified Criteria|1|||
124727484|NCT03466099|448622436|FG000|Overall Study|Adverse Event|1|||
124727485|NCT03466099|448622437|FG001|Overall Study|Adverse Event|1|||
124727486|NCT03466099|448622438|FG002|Overall Study|Adverse Event|1|||
124727487|NCT03466099|448622436|FG000|Overall Study|Withdrawal by Subject|2|||
124727488|NCT03466099|448622437|FG001|Overall Study|Withdrawal by Subject|3|||
124727489|NCT03466099|448622438|FG002|Overall Study|Withdrawal by Subject|1|||
124727490|NCT03466099|448622436|FG000|Overall Study|Use of rescue medication|8|||
124727491|NCT03466099|448622437|FG001|Overall Study|Use of rescue medication|9|||
124727492|NCT03466099|448622438|FG002|Overall Study|Use of rescue medication|13|||
124727493|NCT03466099|448622436|FG000|Overall Study|Rescued without meeting criteria|4|||
124727494|NCT03466099|448622437|FG001|Overall Study|Rescued without meeting criteria|1|||
124727495|NCT03466099|448622438|FG002|Overall Study|Rescued without meeting criteria|1|||
124727496|NCT03466099|448622436|FG000|Overall Study|Subject compliance|2|||
124727497|NCT03466099|448622437|FG001|Overall Study|Subject compliance|0|||
124727498|NCT03466099|448622438|FG002|Overall Study|Subject compliance|0|||
124727499|NCT03466099|448622436|FG000|Overall Study|Worsening disease|0|||
124727500|NCT03466099|448622437|FG001|Overall Study|Worsening disease|0|||
124727501|NCT03466099|448622438|FG002|Overall Study|Worsening disease|1|||
124727502|NCT00344318|448622441|FG000|Overall Study|Adverse Event|0|||
124727503|NCT00344318|448622442|FG001|Overall Study|Adverse Event|3|||
124727504|NCT00344318|448622443|FG002|Overall Study|Adverse Event|0|||
124727505|NCT00344318|448622444|FG003|Overall Study|Adverse Event|1|||
124727506|NCT00344318|448622441|FG000|Overall Study|Withdrawal by Subject|2|||
124727507|NCT00344318|448622442|FG001|Overall Study|Withdrawal by Subject|2|||
124528778|NCT02987205|447885877|FG000|Overall Study|Withdrawal by Subject|3|||
124528779|NCT03381274|447885880|FG000|Overall Study|Death|2|||
124528780|NCT03381274|447885881|FG001|Overall Study|Death|9|||
124528781|NCT03381274|447885882|FG002|Overall Study|Death|3|||
124528782|NCT03381274|447885883|FG003|Overall Study|Death|2|||
124528783|NCT03381274|447885884|FG004|Overall Study|Death|3|||
124528784|NCT03381274|447885880|FG000|Overall Study|Lost to Follow-up|0|||
124528785|NCT03381274|447885881|FG001|Overall Study|Lost to Follow-up|0|||
124727508|NCT00344318|448622443|FG002|Overall Study|Withdrawal by Subject|0|||
124727509|NCT00344318|448622444|FG003|Overall Study|Withdrawal by Subject|2|||
124727510|NCT00344318|448622441|FG000|Overall Study|Lost to Follow-up|2|||
124528786|NCT03381274|447885882|FG002|Overall Study|Lost to Follow-up|0|||
124528787|NCT03381274|447885883|FG003|Overall Study|Lost to Follow-up|1|||
124528788|NCT03381274|447885884|FG004|Overall Study|Lost to Follow-up|0|||
124727511|NCT00344318|448622442|FG001|Overall Study|Lost to Follow-up|0|||
124727512|NCT00344318|448622443|FG002|Overall Study|Lost to Follow-up|1|||
124727513|NCT00344318|448622444|FG003|Overall Study|Lost to Follow-up|0|||
124727514|NCT03832322|448622445|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
124727515|NCT03832322|448622446|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
124727516|NCT01923363|448622447|FG000|Overall Study|Protocol Violation|1|||
124727517|NCT00616018|448622448|FG000|Overall Study|Protocol Violation|3|||
124727518|NCT00404755|448622450|FG000|Phase I (Bupropion)|Adverse Event|3|||
124727519|NCT00404755|448622450|FG000|Phase I (Bupropion)|Other|1|||
124727520|NCT00404755|448622450|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
124727521|NCT00350870|448622451|FG000|Overall Study|Withdrawal by Subject|21|||
124727522|NCT00350870|448622452|FG001|Overall Study|Withdrawal by Subject|17|||
124727523|NCT00350870|448622453|FG002|Overall Study|Withdrawal by Subject|15|||
124727524|NCT00350870|448622454|FG003|Overall Study|Withdrawal by Subject|14|||
124727525|NCT00350870|448622451|FG000|Overall Study|Physician Decision|1|||
124727526|NCT00350870|448622452|FG001|Overall Study|Physician Decision|0|||
124727527|NCT00350870|448622453|FG002|Overall Study|Physician Decision|1|||
124727528|NCT00350870|448622454|FG003|Overall Study|Physician Decision|1|||
124727529|NCT03194568|448622455|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
124727530|NCT05248997|448622456|FG000|Overall Study|Lost to Follow-up|1|||
124727531|NCT05248997|448622457|FG001|Overall Study|Lost to Follow-up|1|||
124727532|NCT05248997|448622456|FG000|Overall Study|Randomized but not treated|32|||
124727533|NCT05248997|448622457|FG001|Overall Study|Randomized but not treated|25|||
124727534|NCT01453205|448622458|FG000|Overall Study|Lost to Follow-up|3|||
124727535|NCT01453205|448622459|FG001|Overall Study|Lost to Follow-up|0|||
124727536|NCT01453205|448622460|FG002|Overall Study|Lost to Follow-up|1|||
124727537|NCT01453205|448622458|FG000|Overall Study|Withdrawal by Subject|8|||
124727538|NCT01453205|448622459|FG001|Overall Study|Withdrawal by Subject|3|||
124727539|NCT01453205|448622460|FG002|Overall Study|Withdrawal by Subject|0|||
124727540|NCT01453205|448622458|FG000|Overall Study|Death|24|||
124727541|NCT01453205|448622459|FG001|Overall Study|Death|22|||
124727542|NCT01453205|448622460|FG002|Overall Study|Death|18|||
124727543|NCT01453205|448622458|FG000|Overall Study|Other|45|||
124727544|NCT01453205|448622459|FG001|Overall Study|Other|27|||
124727545|NCT01453205|448622460|FG002|Overall Study|Other|35|||
124727546|NCT02602275|448622468|FG000|Day 1|Physician Decision|0|||
124727547|NCT02602275|448622469|FG001|Day 1|Physician Decision|1|||
124727548|NCT04262882|448622470|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
124727549|NCT04262882|448622471|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
124727550|NCT04262882|448622470|FG000|Overall Study|Lost to Follow-up|1|||
124727551|NCT04262882|448622471|FG001|Overall Study|Lost to Follow-up|0|||
124727552|NCT01301066|448622472|FG000|Overall Study|Lost to Follow-up|5|||
124727553|NCT01301066|448622473|FG001|Overall Study|Lost to Follow-up|11|||
124727554|NCT01301066|448622472|FG000|Overall Study|Protocol Violation|8|||
124727555|NCT01301066|448622473|FG001|Overall Study|Protocol Violation|7|||
124727556|NCT01301066|448622472|FG000|Overall Study|Withdrawal by Subject|4|||
124727557|NCT01301066|448622473|FG001|Overall Study|Withdrawal by Subject|9|||
124727558|NCT01301066|448622472|FG000|Overall Study|Adverse Event|6|||
124727559|NCT01301066|448622473|FG001|Overall Study|Adverse Event|6|||
124727560|NCT01301066|448622472|FG000|Overall Study|Sponsor Decision|2|||
124727561|NCT01301066|448622473|FG001|Overall Study|Sponsor Decision|1|||
124727562|NCT01301066|448622472|FG000|Overall Study|Physician Decision|0|||
124727563|NCT01301066|448622473|FG001|Overall Study|Physician Decision|1|||
124581153|NCT01494532|448084859|FG001|Overall Study|Lost to Follow-up|0|||
124581154|NCT01494532|448084860|FG002|Overall Study|Lost to Follow-up|0|||
124581155|NCT01494532|448084861|FG003|Overall Study|Lost to Follow-up|2|||
124581156|NCT01494532|448084862|FG004|Overall Study|Lost to Follow-up|0|||
124581157|NCT01494532|448084863|FG005|Overall Study|Lost to Follow-up|0|||
124581158|NCT01494532|448084858|FG000|Overall Study|Physician Decision|0|||
124581159|NCT01494532|448084859|FG001|Overall Study|Physician Decision|1|||
124581160|NCT01494532|448084860|FG002|Overall Study|Physician Decision|1|||
124581161|NCT01494532|448084861|FG003|Overall Study|Physician Decision|2|||
124581162|NCT01494532|448084862|FG004|Overall Study|Physician Decision|0|||
124581163|NCT01494532|448084863|FG005|Overall Study|Physician Decision|0|||
124727564|NCT01301066|448622472|FG000|Overall Study|Other|2|||
124727565|NCT01301066|448622473|FG001|Overall Study|Other|0|||
124727566|NCT01108731|448622480|FG000|Overall Study|Withdrawal by Subject|1|||
124727567|NCT01108731|448622481|FG001|Overall Study|Withdrawal by Subject|1|||
124727568|NCT01108731|448622480|FG000|Overall Study|Adverse Event|3|||
124727569|NCT01108731|448622481|FG001|Overall Study|Adverse Event|3|||
124581164|NCT01494532|448084858|FG000|Overall Study|Withdrawal by Subject|3|||
124581165|NCT01494532|448084859|FG001|Overall Study|Withdrawal by Subject|1|||
124581166|NCT01494532|448084860|FG002|Overall Study|Withdrawal by Subject|4|||
124581167|NCT01494532|448084861|FG003|Overall Study|Withdrawal by Subject|3|||
124727570|NCT04210245|448622482|FG000|Overall Study|Adverse Event|0|||
124727571|NCT04210245|448622483|FG001|Overall Study|Adverse Event|3|||
124727572|NCT04210245|448622484|FG002|Overall Study|Adverse Event|6|||
124727573|NCT04210245|448622485|FG003|Overall Study|Adverse Event|0|||
124727574|NCT04210245|448622482|FG000|Overall Study|Withdrawal by Subject|0|||
124727575|NCT04210245|448622483|FG001|Overall Study|Withdrawal by Subject|1|||
124727576|NCT04210245|448622484|FG002|Overall Study|Withdrawal by Subject|4|||
124727577|NCT04210245|448622485|FG003|Overall Study|Withdrawal by Subject|4|||
124727578|NCT04210245|448622482|FG000|Overall Study|Lost to Follow-up|0|||
124727579|NCT04210245|448622483|FG001|Overall Study|Lost to Follow-up|1|||
124528789|NCT03381274|447885880|FG000|Overall Study|Withdrawal by Subject|2|||
124528790|NCT03381274|447885881|FG001|Overall Study|Withdrawal by Subject|1|||
124528791|NCT03381274|447885882|FG002|Overall Study|Withdrawal by Subject|3|||
124528792|NCT03381274|447885883|FG003|Overall Study|Withdrawal by Subject|1|||
124528793|NCT03381274|447885884|FG004|Overall Study|Withdrawal by Subject|0|||
124528794|NCT03381274|447885880|FG000|Overall Study|Other|1|||
124528795|NCT03381274|447885881|FG001|Overall Study|Other|11|||
124528796|NCT03381274|447885882|FG002|Overall Study|Other|0|||
124528797|NCT03381274|447885883|FG003|Overall Study|Other|2|||
124727580|NCT04210245|448622484|FG002|Overall Study|Lost to Follow-up|1|||
124528798|NCT03381274|447885884|FG004|Overall Study|Other|2|||
124528799|NCT05298774|447885885|FG000|Overall Study|Physician Decision|3|||
124528800|NCT05298774|447885885|FG000|Overall Study|Withdrawal by Subject|2|||
124528801|NCT05298774|447885885|FG000|Overall Study|Lost to Follow-up|3|||
124528802|NCT05298774|447885885|FG000|Overall Study|Screen failure|1|||
124528803|NCT06048367|447885888|FG000|Overall Study|Withdrawal by Subject|0|||
124528804|NCT06048367|447885889|FG001|Overall Study|Withdrawal by Subject|1|||
124528805|NCT06048367|447885890|FG002|Overall Study|Withdrawal by Subject|0|||
124528806|NCT06048367|447885891|FG003|Overall Study|Withdrawal by Subject|0|||
124528807|NCT06048367|447885892|FG004|Overall Study|Withdrawal by Subject|0|||
124528808|NCT06048367|447885888|FG000|Overall Study|Withdrawal by Subject|0|||
124528809|NCT06048367|447885889|FG001|Overall Study|Withdrawal by Subject|0|||
124528810|NCT06048367|447885890|FG002|Overall Study|Withdrawal by Subject|1|||
124528811|NCT06048367|447885891|FG003|Overall Study|Withdrawal by Subject|0|||
124528812|NCT06048367|447885892|FG004|Overall Study|Withdrawal by Subject|0|||
124528813|NCT06048367|447885888|FG000|Overall Study|Withdrawal by Subject|0|||
124528814|NCT06048367|447885889|FG001|Overall Study|Withdrawal by Subject|0|||
124528815|NCT06048367|447885890|FG002|Overall Study|Withdrawal by Subject|0|||
124528816|NCT06048367|447885891|FG003|Overall Study|Withdrawal by Subject|1|||
124528817|NCT06048367|447885892|FG004|Overall Study|Withdrawal by Subject|0|||
124528818|NCT06048367|447885888|FG000|Overall Study|Withdrawal by Subject|0|||
124528819|NCT06048367|447885889|FG001|Overall Study|Withdrawal by Subject|0|||
124528820|NCT06048367|447885890|FG002|Overall Study|Withdrawal by Subject|0|||
124528821|NCT06048367|447885891|FG003|Overall Study|Withdrawal by Subject|1|||
124528822|NCT06048367|447885892|FG004|Overall Study|Withdrawal by Subject|0|||
124528823|NCT02136134|447885893|FG000|Overall Study|Death|170|||
124528824|NCT02136134|447885894|FG001|Overall Study|Death|148|||
124528825|NCT02136134|447885893|FG000|Overall Study|Withdrawal by Subject|19|||
124528826|NCT02136134|447885894|FG001|Overall Study|Withdrawal by Subject|10|||
124528827|NCT02136134|447885893|FG000|Overall Study|Lost to Follow-up|3|||
124528828|NCT02136134|447885894|FG001|Overall Study|Lost to Follow-up|3|||
124528829|NCT02136134|447885893|FG000|Overall Study|Uspecified|55|||
124528830|NCT02136134|447885894|FG001|Overall Study|Uspecified|90|||
124528831|NCT03070119|447885895|FG000|Overall Study|Adverse Event|0|||
124528832|NCT03070119|447885896|FG001|Overall Study|Adverse Event|0|||
124528833|NCT03070119|447885897|FG002|Overall Study|Adverse Event|1|||
124528834|NCT03070119|447885895|FG000|Overall Study|Lost to Follow-up|0|||
124528835|NCT03070119|447885896|FG001|Overall Study|Lost to Follow-up|1|||
124528836|NCT03070119|447885897|FG002|Overall Study|Lost to Follow-up|0|||
124528837|NCT03070119|447885895|FG000|Overall Study|Consent Withdrawn|6|||
124528838|NCT03070119|447885896|FG001|Overall Study|Consent Withdrawn|5|||
124528839|NCT03070119|447885897|FG002|Overall Study|Consent Withdrawn|3|||
124528840|NCT03070119|447885895|FG000|Overall Study|Investigator Decision|0|||
124528841|NCT03070119|447885896|FG001|Overall Study|Investigator Decision|0|||
124528842|NCT03070119|447885897|FG002|Overall Study|Investigator Decision|1|||
124528843|NCT03070119|447885895|FG000|Overall Study|Death|7|||
124528844|NCT03070119|447885896|FG001|Overall Study|Death|14|||
124528845|NCT03070119|447885897|FG002|Overall Study|Death|5|||
124528846|NCT03070119|447885895|FG000|Overall Study|Disease Progression|5|||
124528847|NCT03070119|447885896|FG001|Overall Study|Disease Progression|7|||
124528848|NCT03070119|447885897|FG002|Overall Study|Disease Progression|7|||
124528849|NCT03070119|447885895|FG000|Overall Study|Reason not Specified|2|||
124528850|NCT03070119|447885896|FG001|Overall Study|Reason not Specified|2|||
124528851|NCT03070119|447885897|FG002|Overall Study|Reason not Specified|1|||
124528852|NCT00732472|447885898|FG000|Overall Study|Adverse Event|0|||
124528853|NCT00732472|447885899|FG001|Overall Study|Adverse Event|1|||
124528854|NCT00732472|447885900|FG002|Overall Study|Adverse Event|1|||
124528855|NCT00732472|447885901|FG003|Overall Study|Adverse Event|1|||
124581168|NCT01494532|448084862|FG004|Overall Study|Withdrawal by Subject|2|||
124528856|NCT00732472|447885898|FG000|Overall Study|Protocol Violation|0|||
124528857|NCT00732472|447885899|FG001|Overall Study|Protocol Violation|0|||
124528858|NCT00732472|447885900|FG002|Overall Study|Protocol Violation|0|||
124581169|NCT01494532|448084863|FG005|Overall Study|Withdrawal by Subject|0|||
124528859|NCT00732472|447885901|FG003|Overall Study|Protocol Violation|1|||
124528860|NCT00732472|447885898|FG000|Overall Study|Withdrawal by Subject|0|||
124528861|NCT00732472|447885899|FG001|Overall Study|Withdrawal by Subject|2|||
124528862|NCT00732472|447885900|FG002|Overall Study|Withdrawal by Subject|0|||
124528863|NCT00732472|447885901|FG003|Overall Study|Withdrawal by Subject|1|||
124581170|NCT02057835|448086360|FG000|Overall Study|Withdrawal by Subject|0|||
124727581|NCT04210245|448622485|FG003|Overall Study|Lost to Follow-up|1|||
124727582|NCT04210245|448622482|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
124727583|NCT04210245|448622483|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
124727584|NCT04210245|448622484|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
124727585|NCT04210245|448622485|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
124727586|NCT01892722|448622486|FG000|Overall Study|Protocol deviation|0|||
124727587|NCT01892722|448622487|FG001|Overall Study|Protocol deviation|1|||
124727588|NCT01892722|448622486|FG000|Overall Study|Administrative problems|0|||
124727589|NCT01892722|448622487|FG001|Overall Study|Administrative problems|1|||
124727590|NCT01892722|448622486|FG000|Overall Study|Patient/guardian decision|0|||
124727591|NCT01892722|448622487|FG001|Overall Study|Patient/guardian decision|2|||
124727592|NCT01892722|448622486|FG000|Overall Study|Physician Decision|1|||
124727593|NCT01892722|448622487|FG001|Overall Study|Physician Decision|2|||
124727594|NCT01892722|448622486|FG000|Overall Study|Adverse Event|3|||
124727595|NCT01892722|448622487|FG001|Overall Study|Adverse Event|2|||
124727596|NCT01892722|448622486|FG000|Overall Study|Lack of Efficacy|0|||
124727597|NCT01892722|448622487|FG001|Overall Study|Lack of Efficacy|7|||
124727598|NCT01892722|448622486|FG000|Overall Study|Withdrawal by Subject|3|||
124727599|NCT01892722|448622487|FG001|Overall Study|Withdrawal by Subject|5|||
124727600|NCT01252186|448622488|FG000|Overall Study|Adverse Event|9|||
124727601|NCT01252186|448622489|FG001|Overall Study|Adverse Event|6|||
124727602|NCT01252186|448622490|FG002|Overall Study|Adverse Event|8|||
124727603|NCT01252186|448622488|FG000|Overall Study|Withdrawal by Subject|2|||
124727604|NCT01252186|448622489|FG001|Overall Study|Withdrawal by Subject|5|||
124727605|NCT01252186|448622490|FG002|Overall Study|Withdrawal by Subject|2|||
124727606|NCT01252186|448622488|FG000|Overall Study|Physician Decision|0|||
124727607|NCT01252186|448622489|FG001|Overall Study|Physician Decision|0|||
124727608|NCT01252186|448622490|FG002|Overall Study|Physician Decision|1|||
124727609|NCT01252186|448622488|FG000|Overall Study|Non-compliance|0|||
124727610|NCT01252186|448622489|FG001|Overall Study|Non-compliance|3|||
124727611|NCT01252186|448622490|FG002|Overall Study|Non-compliance|4|||
124727612|NCT01252186|448622488|FG000|Overall Study|Protocol Violation|0|||
124727613|NCT01252186|448622489|FG001|Overall Study|Protocol Violation|0|||
124727614|NCT01252186|448622490|FG002|Overall Study|Protocol Violation|1|||
124727615|NCT01252186|448622488|FG000|Overall Study|Pregnancy|2|||
124727616|NCT01252186|448622489|FG001|Overall Study|Pregnancy|2|||
124727617|NCT01252186|448622490|FG002|Overall Study|Pregnancy|0|||
124727618|NCT01252186|448622488|FG000|Overall Study|Sponsor Request|2|||
124727619|NCT01252186|448622489|FG001|Overall Study|Sponsor Request|1|||
124727620|NCT01252186|448622490|FG002|Overall Study|Sponsor Request|0|||
124727621|NCT01252186|448622488|FG000|Overall Study|Lost to Follow-up|10|||
124727622|NCT01252186|448622489|FG001|Overall Study|Lost to Follow-up|10|||
124727623|NCT01252186|448622490|FG002|Overall Study|Lost to Follow-up|11|||
124727624|NCT01252186|448622488|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
124727625|NCT01252186|448622489|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
124727626|NCT01252186|448622490|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
124727627|NCT04283994|448622497|FG000|Overall Study|Death|11|||
124727628|NCT04283994|448622498|FG001|Overall Study|Death|20|||
124727629|NCT04283994|448622499|FG002|Overall Study|Death|11|||
124727630|NCT04283994|448622500|FG003|Overall Study|Death|0|||
124727631|NCT04283994|448622501|FG004|Overall Study|Death|0|||
124727632|NCT04283994|448622502|FG005|Overall Study|Death|0|||
124727633|NCT04283994|448622503|FG006|Overall Study|Death|0|||
124727634|NCT04283994|448622497|FG000|Overall Study|Withdrawal by Subject|16|||
124727635|NCT04283994|448622498|FG001|Overall Study|Withdrawal by Subject|4|||
124727636|NCT04283994|448622499|FG002|Overall Study|Withdrawal by Subject|6|||
124727637|NCT04283994|448622500|FG003|Overall Study|Withdrawal by Subject|1|||
124727638|NCT04283994|448622501|FG004|Overall Study|Withdrawal by Subject|0|||
124727639|NCT04283994|448622502|FG005|Overall Study|Withdrawal by Subject|1|||
124727640|NCT04283994|448622503|FG006|Overall Study|Withdrawal by Subject|0|||
124727641|NCT03763656|448622504|FG000|Overall Study|Physician Decision|1|||
124727642|NCT03763656|448622504|FG000|Overall Study|Protocol Violation|1|||
124727643|NCT03763656|448622504|FG000|Overall Study|Withdrawal by Subject|7|||
124727644|NCT00487942|448622505|FG000|Overall Study|Adverse Event|1|||
124727645|NCT00487942|448622506|FG001|Overall Study|Adverse Event|1|||
124727646|NCT00487942|448622507|FG002|Overall Study|Adverse Event|1|||
124727647|NCT00487942|448622508|FG003|Overall Study|Adverse Event|1|||
124727648|NCT00487942|448622505|FG000|Overall Study|Lost to Follow-up|1|||
124727649|NCT00487942|448622506|FG001|Overall Study|Lost to Follow-up|0|||
124727650|NCT00487942|448622507|FG002|Overall Study|Lost to Follow-up|0|||
124727651|NCT00487942|448622508|FG003|Overall Study|Lost to Follow-up|1|||
124727652|NCT00487942|448622505|FG000|Overall Study|Protocol Violation|1|||
124727653|NCT00487942|448622506|FG001|Overall Study|Protocol Violation|1|||
124727654|NCT00487942|448622507|FG002|Overall Study|Protocol Violation|0|||
124727655|NCT00487942|448622508|FG003|Overall Study|Protocol Violation|0|||
124727656|NCT00487942|448622505|FG000|Overall Study|Withdrawal by Subject|0|||
124727657|NCT00487942|448622506|FG001|Overall Study|Withdrawal by Subject|1|||
124727658|NCT00487942|448622507|FG002|Overall Study|Withdrawal by Subject|2|||
124727659|NCT00487942|448622508|FG003|Overall Study|Withdrawal by Subject|0|||
124727660|NCT00197145|448623807|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
124727661|NCT00197145|448623808|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
124727662|NCT00197145|448623807|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
124727663|NCT00197145|448623808|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
124727664|NCT00197145|448623807|FG000|Period 1: Randomized Treatment Phase|Other|2|||
124727665|NCT00197145|448623808|FG001|Period 1: Randomized Treatment Phase|Other|2|||
124727666|NCT00197145|448623807|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
124727667|NCT00197145|448623808|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
124727668|NCT00197145|448623807|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
124727669|NCT00197145|448623808|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
124727670|NCT00197145|448623807|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
124727671|NCT00197145|448623808|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
124727672|NCT00197145|448623807|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
124727673|NCT00197145|448623808|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
124727674|NCT00197145|448623807|FG000|Period 2 : Open Label Phase|Other|1|||
124727675|NCT00197145|448623808|FG001|Period 2 : Open Label Phase|Other|0|||
124727676|NCT03372551|448623815|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
124727677|NCT03372551|448623816|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
124727678|NCT03285958|448623821|FG000|Overall Study|Lost to Follow-up|1|||
124727679|NCT03285958|448623822|FG001|Overall Study|Lost to Follow-up|1|||
124727680|NCT03285958|448623821|FG000|Overall Study|Withdrawal by Subject|1|||
124727681|NCT03285958|448623822|FG001|Overall Study|Withdrawal by Subject|0|||
124727682|NCT03285958|448623821|FG000|Overall Study|Not able to attend required orientation|3|||
124727683|NCT03285958|448623822|FG001|Overall Study|Not able to attend required orientation|0|||
124727684|NCT02578680|448623823|FG000|Overall Study|Death|329|||
124727685|NCT02578680|448623824|FG001|Overall Study|Death|181|||
124727686|NCT02578680|448623823|FG000|Overall Study|Lost to Follow-up|3|||
124727687|NCT02578680|448623824|FG001|Overall Study|Lost to Follow-up|1|||
124727688|NCT02578680|448623823|FG000|Overall Study|Physician Decision|0|||
124727689|NCT02578680|448623824|FG001|Overall Study|Physician Decision|1|||
124727690|NCT02578680|448623823|FG000|Overall Study|Protocol Violation|1|||
124727691|NCT02578680|448623824|FG001|Overall Study|Protocol Violation|1|||
124727692|NCT02578680|448623823|FG000|Overall Study|Sponsor Decision|64|||
124727693|NCT02578680|448623824|FG001|Overall Study|Sponsor Decision|13|||
124727694|NCT02578680|448623823|FG000|Overall Study|Withdrawal by Subject|13|||
124727695|NCT02578680|448623824|FG001|Overall Study|Withdrawal by Subject|9|||
124727696|NCT00218634|448623825|FG000|Overall Study|Lost to Follow-up|8|||
124727697|NCT00218634|448623826|FG001|Overall Study|Lost to Follow-up|15|||
124727698|NCT00176488|448623827|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
124727699|NCT00664560|448623849|FG000|Overall Study|Adverse Event|19|||
124727700|NCT00664560|448623850|FG001|Overall Study|Adverse Event|16|||
124727701|NCT00664560|448623851|FG002|Overall Study|Adverse Event|7|||
124727702|NCT00664560|448623849|FG000|Overall Study|Withdrawal by Subject|9|||
124727703|NCT00664560|448623850|FG001|Overall Study|Withdrawal by Subject|13|||
124727704|NCT00664560|448623851|FG002|Overall Study|Withdrawal by Subject|7|||
124727705|NCT00664560|448623849|FG000|Overall Study|Lost to Follow-up|0|||
124727706|NCT00664560|448623850|FG001|Overall Study|Lost to Follow-up|2|||
124727707|NCT00664560|448623851|FG002|Overall Study|Lost to Follow-up|0|||
124727708|NCT00664560|448623849|FG000|Overall Study|Other|11|||
124727709|NCT00664560|448623850|FG001|Overall Study|Other|4|||
124727710|NCT00664560|448623851|FG002|Overall Study|Other|5|||
124727711|NCT03350035|448623852|FG000|Overall Study|Lack of Efficacy|2|||
124727712|NCT03350035|448623853|FG001|Overall Study|Lack of Efficacy|0|||
124727713|NCT03350035|448623854|FG002|Overall Study|Lack of Efficacy|0|||
124727714|NCT03350035|448623852|FG000|Overall Study|Subject discharged to hospice|0|||
124727715|NCT03350035|448623853|FG001|Overall Study|Subject discharged to hospice|0|||
124727716|NCT03350035|448623854|FG002|Overall Study|Subject discharged to hospice|1|||
124727717|NCT03576066|448623855|FG000|Overall Study|Noncompliance with study drug|0|||
124727718|NCT03576066|448623856|FG001|Overall Study|Noncompliance with study drug|1|||
124727719|NCT00006164|448623857|FG000|Overall Study|Withdrew or lost to follow-up|70|||
124727720|NCT00006164|448623858|FG001|Overall Study|Withdrew or lost to follow-up|81|||
124727721|NCT00633074|448623861|FG000|Overall Study|Adverse Event|1|||
124727722|NCT00633074|448623862|FG001|Overall Study|Adverse Event|0|||
124727723|NCT00365105|448623863|FG000|Overall Study|Protocol Violation|5|||
124727724|NCT00365105|448623864|FG001|Overall Study|Protocol Violation|8|||
124727725|NCT06422364|448623865|FG000|Overall Study|Withdrawn due to study closure|0|||
124727726|NCT06422364|448623866|FG001|Overall Study|Withdrawn due to study closure|2|||
124727727|NCT01681069|448623867|FG000|Overall Study|Withdrawal by Subject|4|||
124727728|NCT01681069|448623868|FG001|Overall Study|Withdrawal by Subject|5|||
124727729|NCT01681069|448623867|FG000|Overall Study|Protocol Violation|1|||
124727730|NCT01681069|448623868|FG001|Overall Study|Protocol Violation|1|||
124727731|NCT01681069|448623867|FG000|Overall Study|Adverse Event|0|||
124727732|NCT01681069|448623868|FG001|Overall Study|Adverse Event|1|||
124727733|NCT01463696|448623869|FG000|Overall Study|Adverse Event|0|||
124727734|NCT01463696|448623870|FG001|Overall Study|Adverse Event|1|||
124727735|NCT01463696|448623871|FG002|Overall Study|Adverse Event|0|||
124727736|NCT01463696|448623872|FG003|Overall Study|Adverse Event|2|||
124727737|NCT01463696|448623873|FG004|Overall Study|Adverse Event|0|||
124727738|NCT01463696|448623874|FG005|Overall Study|Adverse Event|1|||
124727739|NCT01463696|448623875|FG006|Overall Study|Adverse Event|3|||
124727740|NCT01463696|448623876|FG007|Overall Study|Adverse Event|2|||
124727741|NCT01463696|448623869|FG000|Overall Study|Lost to Follow-up|0|||
124727742|NCT01463696|448623870|FG001|Overall Study|Lost to Follow-up|0|||
124727743|NCT01463696|448623871|FG002|Overall Study|Lost to Follow-up|1|||
124727744|NCT01463696|448623872|FG003|Overall Study|Lost to Follow-up|0|||
124727745|NCT01463696|448623873|FG004|Overall Study|Lost to Follow-up|0|||
124727746|NCT01463696|448623874|FG005|Overall Study|Lost to Follow-up|0|||
124727747|NCT01463696|448623875|FG006|Overall Study|Lost to Follow-up|0|||
124727748|NCT01463696|448623876|FG007|Overall Study|Lost to Follow-up|0|||
124727749|NCT01463696|448623869|FG000|Overall Study|Progressive Disease|0|||
124727750|NCT01463696|448623870|FG001|Overall Study|Progressive Disease|1|||
124581171|NCT02057835|448086361|FG001|Overall Study|Withdrawal by Subject|2|||
124581172|NCT02057835|448086362|FG002|Overall Study|Withdrawal by Subject|0|||
124581173|NCT02057835|448086363|FG003|Overall Study|Withdrawal by Subject|0|||
124581174|NCT02057835|448086364|FG004|Overall Study|Withdrawal by Subject|0|||
124581175|NCT02057835|448086365|FG005|Overall Study|Withdrawal by Subject|0|||
124581176|NCT02057835|448086366|FG006|Overall Study|Withdrawal by Subject|0|||
124581177|NCT02057835|448086367|FG007|Overall Study|Withdrawal by Subject|0|||
124581178|NCT02057835|448086368|FG008|Overall Study|Withdrawal by Subject|0|||
124581179|NCT02057835|448086369|FG009|Overall Study|Withdrawal by Subject|0|||
124581180|NCT00834717|448086372|FG000|First Intervention|Adverse Event|1|||
124581181|NCT00834717|448086373|FG001|First Intervention|Adverse Event|0|||
124581182|NCT00834717|448086372|FG000|First Intervention|Withdrawal by Subject|0|||
124581183|NCT00834717|448086373|FG001|First Intervention|Withdrawal by Subject|1|||
124581184|NCT02222818|448086374|FG000|Period 1|Eligibility criteria not met|0|||
124581185|NCT02222818|448086375|FG001|Period 1|Eligibility criteria not met|3|||
124581186|NCT01660243|448086376|FG000|Overall Study|Adverse Event|1|||
124581187|NCT01660243|448086377|FG001|Overall Study|Adverse Event|0|||
124581188|NCT01660243|448086378|FG002|Overall Study|Adverse Event|1|||
124581189|NCT01660243|448086379|FG003|Overall Study|Adverse Event|0|||
124581190|NCT01660243|448086376|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
124581191|NCT01660243|448086377|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
124581192|NCT01660243|448086378|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
124581193|NCT01660243|448086379|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
124581194|NCT01660243|448086376|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
124581195|NCT01660243|448086377|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
124581196|NCT01660243|448086378|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
124581197|NCT01660243|448086379|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
124581198|NCT01660243|448086376|FG000|Overall Study|Randomization error|0|||
124581199|NCT01660243|448086377|FG001|Overall Study|Randomization error|0|||
124581200|NCT01660243|448086378|FG002|Overall Study|Randomization error|0|||
124581201|NCT01660243|448086379|FG003|Overall Study|Randomization error|1|||
124581202|NCT03025087|448086380|FG000|Overall Study|Physician Decision|3|||
124581203|NCT03025087|448086381|FG001|Overall Study|Physician Decision|3|||
124581204|NCT03025087|448086382|FG002|Overall Study|Physician Decision|0|||
124581205|NCT03025087|448086383|FG003|Overall Study|Physician Decision|0|||
124581206|NCT03025087|448086384|FG004|Overall Study|Physician Decision|0|||
124581207|NCT03025087|448086380|FG000|Overall Study|Withdrawal by Subject|1|||
124581208|NCT03025087|448086381|FG001|Overall Study|Withdrawal by Subject|1|||
124581209|NCT03025087|448086382|FG002|Overall Study|Withdrawal by Subject|0|||
124581210|NCT03025087|448086383|FG003|Overall Study|Withdrawal by Subject|0|||
124727751|NCT01463696|448623871|FG002|Overall Study|Progressive Disease|0|||
124727752|NCT01463696|448623872|FG003|Overall Study|Progressive Disease|1|||
124581211|NCT03025087|448086384|FG004|Overall Study|Withdrawal by Subject|0|||
124581212|NCT03025087|448086380|FG000|Overall Study|Unable to complete MRI|2|||
124581213|NCT03025087|448086381|FG001|Overall Study|Unable to complete MRI|2|||
124581214|NCT03025087|448086382|FG002|Overall Study|Unable to complete MRI|0|||
124581215|NCT03025087|448086383|FG003|Overall Study|Unable to complete MRI|0|||
124727753|NCT01463696|448623873|FG004|Overall Study|Progressive Disease|0|||
124727754|NCT01463696|448623874|FG005|Overall Study|Progressive Disease|1|||
124727755|NCT01463696|448623875|FG006|Overall Study|Progressive Disease|4|||
124727756|NCT01463696|448623876|FG007|Overall Study|Progressive Disease|2|||
124727757|NCT01463696|448623869|FG000|Overall Study|Withdrawal by Subject|0|||
124727758|NCT01463696|448623870|FG001|Overall Study|Withdrawal by Subject|0|||
124727759|NCT01463696|448623871|FG002|Overall Study|Withdrawal by Subject|0|||
124727760|NCT01463696|448623872|FG003|Overall Study|Withdrawal by Subject|1|||
124581216|NCT03025087|448086384|FG004|Overall Study|Unable to complete MRI|0|||
124581217|NCT00508651|448086387|FG000|Overall Study|Lost to Follow-up|3|||
124581218|NCT00508651|448086388|FG001|Overall Study|Lost to Follow-up|1|||
124581219|NCT00508651|448086387|FG000|Overall Study|Withdrawal by Subject|1|||
124581220|NCT00508651|448086388|FG001|Overall Study|Withdrawal by Subject|1|||
124581221|NCT05710718|448086394|FG000|Overall Study|Withdrawal by Subject|5|||
124581222|NCT05710718|448086395|FG001|Overall Study|Withdrawal by Subject|1|||
124581223|NCT05710718|448086394|FG000|Overall Study|Lost to Follow-up|0|||
124581224|NCT05710718|448086395|FG001|Overall Study|Lost to Follow-up|1|||
124581225|NCT05710718|448086394|FG000|Overall Study|Death|0|||
124581226|NCT05710718|448086395|FG001|Overall Study|Death|1|||
124581227|NCT06381102|448086396|FG000|Washout 5 Days|Withdrawal by Subject|0|||
124581228|NCT06381102|448086397|FG001|Washout 5 Days|Withdrawal by Subject|2|||
124581229|NCT01319383|448086398|FG000|Overall Study|No ex vivo or in vivo response|4|||
124581230|NCT01319383|448086399|FG001|Overall Study|No ex vivo or in vivo response|0|||
124581231|NCT01319383|448086398|FG000|Overall Study|Physician Decision|3|||
124581232|NCT01319383|448086399|FG001|Overall Study|Physician Decision|0|||
124581233|NCT01319383|448086398|FG000|Overall Study|Lack of Efficacy|5|||
124581234|NCT01319383|448086399|FG001|Overall Study|Lack of Efficacy|9|||
124581235|NCT01319383|448086398|FG000|Overall Study|No in vivo response to interval doses|0|||
124581236|NCT01319383|448086399|FG001|Overall Study|No in vivo response to interval doses|1|||
124581237|NCT01987765|448086400|FG000|Overall Study|Protocol Violation|65|||
124581238|NCT01987765|448086400|FG000|Overall Study|Lost to Follow-up|37|||
124581239|NCT00772603|448086401|FG000|Overall Study|Withdrawal by Subject|11|||
124581240|NCT00772603|448086402|FG001|Overall Study|Withdrawal by Subject|10|||
124581241|NCT00772603|448086403|FG002|Overall Study|Withdrawal by Subject|6|||
124581242|NCT00772603|448086401|FG000|Overall Study|Adverse Event|37|||
124581243|NCT00772603|448086402|FG001|Overall Study|Adverse Event|18|||
124581244|NCT00772603|448086403|FG002|Overall Study|Adverse Event|10|||
124581245|NCT00772603|448086401|FG000|Overall Study|Subject Non-compliance|1|||
124581246|NCT00772603|448086402|FG001|Overall Study|Subject Non-compliance|6|||
124581247|NCT00772603|448086403|FG002|Overall Study|Subject Non-compliance|4|||
124581248|NCT00772603|448086401|FG000|Overall Study|Protocol Violation|0|||
124581249|NCT00772603|448086402|FG001|Overall Study|Protocol Violation|1|||
124581250|NCT00772603|448086403|FG002|Overall Study|Protocol Violation|1|||
124581251|NCT00772603|448086401|FG000|Overall Study|Lost to Follow-up|1|||
124581252|NCT00772603|448086402|FG001|Overall Study|Lost to Follow-up|5|||
124581253|NCT00772603|448086403|FG002|Overall Study|Lost to Follow-up|2|||
124581254|NCT00772603|448086401|FG000|Overall Study|Physician Decision|0|||
124581255|NCT00772603|448086402|FG001|Overall Study|Physician Decision|0|||
124581256|NCT00772603|448086403|FG002|Overall Study|Physician Decision|1|||
124581257|NCT00772603|448086401|FG000|Overall Study|Other|2|||
124581258|NCT00772603|448086402|FG001|Overall Study|Other|0|||
124581259|NCT00772603|448086403|FG002|Overall Study|Other|2|||
124581260|NCT01528696|448086414|FG000|Overall Study|See detailed description|18|||
124581261|NCT01528696|448086415|FG001|Overall Study|See detailed description|19|||
124581262|NCT01056484|448086416|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
124581263|NCT01056484|448086417|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
124581264|NCT01056484|448086416|FG000|Randomized Controlled Trial|Physician Decision|1|||
124581265|NCT01056484|448086417|FG001|Randomized Controlled Trial|Physician Decision|0|||
124581266|NCT01056484|448086416|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
124581267|NCT01056484|448086417|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
124581268|NCT00446966|448086420|FG000|Overall Study|Lost to Follow-up|10|||
124581269|NCT00446966|448086421|FG001|Overall Study|Lost to Follow-up|7|||
124581270|NCT01564394|448086424|FG000|Overall Study|Withdrawal by Subject|6|||
124581271|NCT01564394|448086425|FG001|Overall Study|Withdrawal by Subject|10|||
124581272|NCT00859521|448086426|FG000|Washout|Withdrawal by Subject|0|||
124581273|NCT00859521|448086427|FG001|Washout|Withdrawal by Subject|1|||
124776932|NCT00345358|448811355|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
124581274|NCT02888756|448086431|FG000|Analytical Treatment Interruption|Physician Decision|10|||
124581275|NCT02888756|448086432|FG001|Analytical Treatment Interruption|Physician Decision|6|||
124581276|NCT02888756|448086433|FG002|Analytical Treatment Interruption|Physician Decision|5|||
124581277|NCT01547286|448086438|FG000|Overall Study|Did not meet all eligibility criteria|1|||
124581278|NCT01547286|448086438|FG000|Overall Study|Physician Decision|1|||
124581279|NCT00488774|448086441|FG000|Overall Study|Withdrawal of consent|2|||
124581280|NCT00488774|448086442|FG001|Overall Study|Withdrawal of consent|2|||
124581281|NCT00488774|448086443|FG002|Overall Study|Withdrawal of consent|2|||
124581282|NCT00488774|448086444|FG003|Overall Study|Withdrawal of consent|0|||
124581283|NCT00488774|448086441|FG000|Overall Study|Other|6|||
124581284|NCT00488774|448086442|FG001|Overall Study|Other|3|||
124581285|NCT00488774|448086443|FG002|Overall Study|Other|2|||
124581286|NCT00488774|448086444|FG003|Overall Study|Other|2|||
124581287|NCT00488774|448086441|FG000|Overall Study|Lost to Follow-up|0|||
124581288|NCT00488774|448086442|FG001|Overall Study|Lost to Follow-up|0|||
124581289|NCT00488774|448086443|FG002|Overall Study|Lost to Follow-up|1|||
124581290|NCT00488774|448086444|FG003|Overall Study|Lost to Follow-up|1|||
124581291|NCT02682238|448086445|FG000|Overall Study|Lost to Follow-up|0|||
124581292|NCT02682238|448086446|FG001|Overall Study|Lost to Follow-up|2|||
124581293|NCT02682238|448086445|FG000|Overall Study|Withdrawal by Subject|1|||
124581294|NCT02682238|448086446|FG001|Overall Study|Withdrawal by Subject|0|||
124581295|NCT02682238|448086445|FG000|Overall Study|Adverse Event|1|||
124581296|NCT02682238|448086446|FG001|Overall Study|Adverse Event|0|||
124581297|NCT02682238|448086445|FG000|Overall Study|Non-compliance with Study Drug|1|||
124581298|NCT02682238|448086446|FG001|Overall Study|Non-compliance with Study Drug|0|||
124581299|NCT02682238|448086445|FG000|Overall Study|Non-compliance with Protocol|0|||
124581300|NCT02682238|448086446|FG001|Overall Study|Non-compliance with Protocol|2|||
124581301|NCT00075478|448086447|FG000|Overall Study|not eligible|1|||
124581302|NCT00075478|448086448|FG001|Overall Study|not eligible|0|||
124581303|NCT00075478|448086447|FG000|Overall Study|Physician Decision|0|||
124581304|NCT00075478|448086448|FG001|Overall Study|Physician Decision|1|||
124581305|NCT02075463|448086450|FG000|Overall Study|Adverse Event|3|||
124581306|NCT02075463|448086450|FG000|Overall Study|Par. reached stopping criteria|4|||
124581307|NCT02075463|448086450|FG000|Overall Study|Withdrawal by Subject|1|||
124581308|NCT00245063|448086452|FG000|Overall Study|Adverse Event|6|||
124581309|NCT00245063|448086453|FG001|Overall Study|Adverse Event|5|||
124581310|NCT00245063|448086452|FG000|Overall Study|Death|1|||
124581311|NCT00245063|448086453|FG001|Overall Study|Death|0|||
124581312|NCT05099380|448086455|FG000|Overall Study|Subject enrolled in error|1|||
124581313|NCT05099380|448086456|FG001|Overall Study|Subject enrolled in error|0|||
124581314|NCT05099380|448086455|FG000|Overall Study|Study Procedure|1|||
124581315|NCT05099380|448086456|FG001|Overall Study|Study Procedure|0|||
124581316|NCT05099380|448086455|FG000|Overall Study|Protocol Violation|1|||
124581317|NCT05099380|448086456|FG001|Overall Study|Protocol Violation|0|||
124581318|NCT05099380|448086455|FG000|Overall Study|Adverse Event|1|||
124581319|NCT05099380|448086456|FG001|Overall Study|Adverse Event|1|||
124581320|NCT05099380|448086455|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
124581321|NCT05099380|448086456|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
124581322|NCT02294786|448086459|FG000|Overall Study|Withdrawal by Subject|0|||
124581323|NCT02294786|448086460|FG001|Overall Study|Withdrawal by Subject|1|||
124581324|NCT02294786|448086459|FG000|Overall Study|Physician Decision|6|||
124581325|NCT02294786|448086460|FG001|Overall Study|Physician Decision|7|||
124581326|NCT02294786|448086459|FG000|Overall Study|Lost to Follow-up|1|||
124581327|NCT02294786|448086460|FG001|Overall Study|Lost to Follow-up|2|||
124581328|NCT02294786|448086459|FG000|Overall Study|Protocol Violation|1|||
124581329|NCT02294786|448086460|FG001|Overall Study|Protocol Violation|0|||
124581330|NCT02294786|448086459|FG000|Overall Study|Adverse Event|1|||
124581331|NCT02294786|448086460|FG001|Overall Study|Adverse Event|1|||
124581332|NCT02294786|448086459|FG000|Overall Study|Death|2|||
124581333|NCT02294786|448086460|FG001|Overall Study|Death|3|||
124581334|NCT01778010|448086461|FG000|Overall Study|Withdrawal by Subject|2|||
124581335|NCT01778010|448086461|FG000|Overall Study|abnormal ECG before meds|1|||
124581336|NCT01778010|448086461|FG000|Overall Study|Arrested|1|||
124581337|NCT01778010|448086461|FG000|Overall Study|rash while on placebo|1|||
124581338|NCT00927069|448086463|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
124581339|NCT00927069|448086464|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
124581340|NCT00927069|448086465|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
124581341|NCT00927069|448086466|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
124581342|NCT00927069|448086463|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
124581343|NCT00927069|448086464|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
124581344|NCT00927069|448086465|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
124581345|NCT00927069|448086466|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
124581346|NCT00927069|448086463|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
124581347|NCT00927069|448086464|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
124581348|NCT00927069|448086465|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
124581349|NCT00927069|448086466|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
124581350|NCT00927069|448086463|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
124581351|NCT00927069|448086464|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
124581352|NCT00927069|448086465|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
124581353|NCT00927069|448086466|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
124727761|NCT01463696|448623873|FG004|Overall Study|Withdrawal by Subject|1|||
124581354|NCT00927069|448086463|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
124581355|NCT00927069|448086464|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
124581356|NCT00927069|448086465|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
124581357|NCT00927069|448086466|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
124581358|NCT02558491|448086467|FG000|First Invention|Withdrawal by Subject|3|||
124581359|NCT02558491|448086468|FG001|First Invention|Withdrawal by Subject|1|||
124581360|NCT02558491|448086467|FG000|First Invention|Data collection issues|1|||
124581361|NCT02558491|448086468|FG001|First Invention|Data collection issues|0|||
124581362|NCT02558491|448086467|FG000|First Invention|Stopping criteria|0|||
124581363|NCT02558491|448086468|FG001|First Invention|Stopping criteria|1|||
124581364|NCT02558491|448086467|FG000|First Invention|Changed parameters during trial|1|||
124581365|NCT02558491|448086468|FG001|First Invention|Changed parameters during trial|0|||
124581366|NCT02558491|448086467|FG000|Second Intervention|Withdrawal by Subject|1|||
124581367|NCT02558491|448086468|FG001|Second Intervention|Withdrawal by Subject|0|||
124581368|NCT02558491|448086467|FG000|Second Intervention|Stopping Criteria|1|||
124581369|NCT02558491|448086468|FG001|Second Intervention|Stopping Criteria|0|||
124581370|NCT00834431|448086469|FG000|First Intervention|Adverse Event|0|||
124581371|NCT00834431|448086470|FG001|First Intervention|Adverse Event|1|||
124581372|NCT00834431|448086469|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
124581373|NCT00834431|448086470|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
124581374|NCT00835263|448086473|FG000|Second Intervention|Adverse Event|1|||
124581375|NCT00835263|448086474|FG001|Second Intervention|Adverse Event|0|||
124581376|NCT03249454|448086475|FG000|Overall Study|Withdrawal by Subject|0|||
124581377|NCT03249454|448086476|FG001|Overall Study|Withdrawal by Subject|0|||
124581378|NCT03249454|448086477|FG002|Overall Study|Withdrawal by Subject|0|||
124581379|NCT03249454|448086478|FG003|Overall Study|Withdrawal by Subject|0|||
124581380|NCT03249454|448086479|FG004|Overall Study|Withdrawal by Subject|0|||
124581381|NCT03249454|448086480|FG005|Overall Study|Withdrawal by Subject|0|||
124581382|NCT03249454|448086481|FG006|Overall Study|Withdrawal by Subject|0|||
124581383|NCT03249454|448086482|FG007|Overall Study|Withdrawal by Subject|0|||
124581384|NCT03249454|448086483|FG008|Overall Study|Withdrawal by Subject|0|||
124581385|NCT03249454|448086484|FG009|Overall Study|Withdrawal by Subject|1|||
124581386|NCT03249454|448086485|FG010|Overall Study|Withdrawal by Subject|1|||
124581387|NCT01913405|448086486|FG000|Overall Study|Withdrawal by Subject|1|||
124581388|NCT01913405|448086486|FG000|Overall Study|Adverse Event|1|||
124581389|NCT03987191|448086489|FG000|Overall Study|COVID-19 related research disruption|0|||
124581390|NCT03987191|448086490|FG001|Overall Study|COVID-19 related research disruption|2|||
124581391|NCT01020474|448086491|FG000|Overall Study|Adverse Event|4|||
124581392|NCT01020474|448086492|FG001|Overall Study|Adverse Event|4|||
124581393|NCT01020474|448086491|FG000|Overall Study|Protocol Violation|0|||
124581394|NCT01020474|448086492|FG001|Overall Study|Protocol Violation|2|||
124581395|NCT01020474|448086491|FG000|Overall Study|Withdrawal by Subject|5|||
124581396|NCT01020474|448086492|FG001|Overall Study|Withdrawal by Subject|7|||
124581397|NCT01020474|448086491|FG000|Overall Study|Other Reasons|1|||
124581398|NCT01020474|448086492|FG001|Overall Study|Other Reasons|1|||
124581399|NCT01020474|448086491|FG000|Overall Study|Insufficient Clinical Response|0|||
124581400|NCT01020474|448086492|FG001|Overall Study|Insufficient Clinical Response|3|||
124727762|NCT01463696|448623874|FG005|Overall Study|Withdrawal by Subject|1|||
124727763|NCT01463696|448623875|FG006|Overall Study|Withdrawal by Subject|2|||
124727764|NCT01463696|448623876|FG007|Overall Study|Withdrawal by Subject|0|||
124727765|NCT01463696|448623869|FG000|Overall Study|Not Treated|0|||
124727766|NCT01463696|448623870|FG001|Overall Study|Not Treated|0|||
124727767|NCT01463696|448623871|FG002|Overall Study|Not Treated|0|||
124727768|NCT01463696|448623872|FG003|Overall Study|Not Treated|0|||
124727769|NCT01463696|448623873|FG004|Overall Study|Not Treated|0|||
124727770|NCT01463696|448623874|FG005|Overall Study|Not Treated|0|||
124727771|NCT01463696|448623875|FG006|Overall Study|Not Treated|1|||
124727772|NCT01463696|448623876|FG007|Overall Study|Not Treated|0|||
124727773|NCT03883165|448623878|FG000|Overall Study|Withdrawal by Subject|4|||
124727774|NCT03883165|448623879|FG001|Overall Study|Withdrawal by Subject|3|||
124727775|NCT00245050|448623883|FG000|Overall Study|Adverse Event|3|||
124727776|NCT00245050|448623884|FG001|Overall Study|Adverse Event|2|||
124727777|NCT01843673|448623885|FG000|Overall Study|Lack of Efficacy|2|||
124727778|NCT01843673|448623885|FG000|Overall Study|Withdrawal by Subject|4|||
124727779|NCT00425698|448623886|FG000|Overall Study|Adverse Event|3|||
124727780|NCT00425698|448623887|FG001|Overall Study|Adverse Event|1|||
124727781|NCT00425698|448623886|FG000|Overall Study|Withdrawal by Subject|0|||
124528864|NCT01266876|447885903|FG000|Overall Study|Adverse Event|0|||
124528865|NCT01266876|447885904|FG001|Overall Study|Adverse Event|0|||
124528866|NCT01266876|447885905|FG002|Overall Study|Adverse Event|0|||
124528867|NCT01266876|447885906|FG003|Overall Study|Adverse Event|1|||
124528868|NCT01266876|447885907|FG004|Overall Study|Adverse Event|0|||
124528869|NCT05180721|447885908|FG000|Overall Study|Lost to Follow-up|4|||
124528870|NCT01996865|447885910|FG000|Induction Period|Protocol Violation|1|||
124528871|NCT01996865|447885911|FG001|Induction Period|Protocol Violation|0|||
124528872|NCT01996865|447885912|FG002|Induction Period|Protocol Violation|0|||
124528873|NCT01996865|447885910|FG000|Induction Period|Progressive Disease|4|||
124581401|NCT03261167|448086493|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
124727782|NCT00425698|448623887|FG001|Overall Study|Withdrawal by Subject|1|||
124727783|NCT03275246|448623896|FG000|Overall Study|Protocol Violation|5|||
124727784|NCT03275246|448623896|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
124528874|NCT01996865|447885911|FG001|Induction Period|Progressive Disease|0|||
124528875|NCT01996865|447885912|FG002|Induction Period|Progressive Disease|0|||
124581402|NCT03261167|448086494|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
124581403|NCT03261167|448086493|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
124581404|NCT03261167|448086494|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
124581405|NCT03261167|448086493|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
124581406|NCT03261167|448086494|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
124727785|NCT03905265|448623899|FG000|Overall Study|Withdrawal by Subject|1|||
124528876|NCT01996865|447885910|FG000|Induction Period|Lost to Follow-up|10|||
124727786|NCT03905265|448623900|FG001|Overall Study|Withdrawal by Subject|1|||
124727787|NCT03905265|448623901|FG002|Overall Study|Withdrawal by Subject|0|||
124727788|NCT03905265|448623902|FG003|Overall Study|Withdrawal by Subject|0|||
124727789|NCT01973387|448623903|FG000|Overall Study|Adverse Event|14|||
124727790|NCT01973387|448623904|FG001|Overall Study|Adverse Event|4|||
124727791|NCT01973387|448623903|FG000|Overall Study|Withdrawal by Subject|7|||
124727792|NCT01973387|448623904|FG001|Overall Study|Withdrawal by Subject|4|||
124727793|NCT01973387|448623903|FG000|Overall Study|Study terminated by sponsor|63|||
124727794|NCT01973387|448623904|FG001|Overall Study|Study terminated by sponsor|0|||
124727795|NCT01973387|448623903|FG000|Overall Study|Progressive disease or relapse|16|||
124727796|NCT01973387|448623904|FG001|Overall Study|Progressive disease or relapse|5|||
124727797|NCT01973387|448623903|FG000|Overall Study|Death|4|||
124727798|NCT01973387|448623904|FG001|Overall Study|Death|3|||
124776933|NCT00345358|448811356|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
124776934|NCT00345358|448811353|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
124528877|NCT01996865|447885911|FG001|Induction Period|Lost to Follow-up|0|||
124528878|NCT01996865|447885912|FG002|Induction Period|Lost to Follow-up|0|||
124528879|NCT01996865|447885910|FG000|Induction Period|Other Reasons|13|||
124528880|NCT01996865|447885911|FG001|Induction Period|Other Reasons|0|||
124528881|NCT01996865|447885912|FG002|Induction Period|Other Reasons|0|||
124528882|NCT01996865|447885910|FG000|Induction Period|Adverse Event|20|||
124528883|NCT01996865|447885911|FG001|Induction Period|Adverse Event|0|||
124528884|NCT01996865|447885912|FG002|Induction Period|Adverse Event|0|||
124528885|NCT01996865|447885910|FG000|Induction Period|Withdrawal by Subject|60|||
124528886|NCT01996865|447885911|FG001|Induction Period|Withdrawal by Subject|0|||
124528887|NCT01996865|447885912|FG002|Induction Period|Withdrawal by Subject|0|||
124528888|NCT01996865|447885910|FG000|Induction Period|Death|111|||
124528889|NCT01996865|447885911|FG001|Induction Period|Death|0|||
124528890|NCT01996865|447885912|FG002|Induction Period|Death|0|||
124528891|NCT01996865|447885910|FG000|Maintenance Period|Protocol Violation|0|||
124528892|NCT01996865|447885911|FG001|Maintenance Period|Protocol Violation|1|||
124528893|NCT01996865|447885912|FG002|Maintenance Period|Protocol Violation|1|||
124528894|NCT01996865|447885910|FG000|Maintenance Period|Other reasons|0|||
124528895|NCT01996865|447885911|FG001|Maintenance Period|Other reasons|8|||
124528896|NCT01996865|447885912|FG002|Maintenance Period|Other reasons|5|||
124528897|NCT01996865|447885910|FG000|Maintenance Period|Progressive Disease|0|||
124528898|NCT01996865|447885911|FG001|Maintenance Period|Progressive Disease|6|||
124528899|NCT01996865|447885912|FG002|Maintenance Period|Progressive Disease|23|||
124528900|NCT01996865|447885910|FG000|Maintenance Period|Withdrawal by Subject|0|||
124528901|NCT01996865|447885911|FG001|Maintenance Period|Withdrawal by Subject|18|||
124528902|NCT01996865|447885912|FG002|Maintenance Period|Withdrawal by Subject|4|||
124528903|NCT01996865|447885910|FG000|Maintenance Period|Adverse Event|0|||
124528904|NCT01996865|447885911|FG001|Maintenance Period|Adverse Event|7|||
124528905|NCT01996865|447885912|FG002|Maintenance Period|Adverse Event|7|||
124528906|NCT01996865|447885910|FG000|Maintenance Period|Death|0|||
124528907|NCT01996865|447885911|FG001|Maintenance Period|Death|15|||
124528908|NCT01996865|447885912|FG002|Maintenance Period|Death|3|||
124528909|NCT01996865|447885910|FG000|Maintenance Period|Lost to Follow-up|0|||
124528910|NCT01996865|447885911|FG001|Maintenance Period|Lost to Follow-up|2|||
124528911|NCT01996865|447885912|FG002|Maintenance Period|Lost to Follow-up|0|||
124528912|NCT03575351|447885913|FG000|Overall Study|Adverse Event|1|||
124528913|NCT03575351|447885914|FG001|Overall Study|Adverse Event|0|||
124528914|NCT03575351|447885913|FG000|Overall Study|Death|2|||
124528915|NCT03575351|447885914|FG001|Overall Study|Death|2|||
124528916|NCT03575351|447885913|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
124528917|NCT03575351|447885914|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
124528918|NCT03575351|447885913|FG000|Overall Study|Lack of Efficacy|28|||
124528919|NCT03575351|447885914|FG001|Overall Study|Lack of Efficacy|0|||
124528920|NCT03575351|447885913|FG000|Overall Study|Withdrawal by Subject|1|||
124528921|NCT03575351|447885914|FG001|Overall Study|Withdrawal by Subject|1|||
124528922|NCT03575351|447885913|FG000|Overall Study|Physician Decision|3|||
124528923|NCT03575351|447885914|FG001|Overall Study|Physician Decision|0|||
124528924|NCT03575351|447885913|FG000|Overall Study|Disease relapse|15|||
124528925|NCT03575351|447885914|FG001|Overall Study|Disease relapse|6|||
124528926|NCT03575351|447885913|FG000|Overall Study|Study drug manufacturing failure|0|||
124528927|NCT03575351|447885914|FG001|Overall Study|Study drug manufacturing failure|1|||
124727799|NCT01973387|448623903|FG000|Overall Study|Randomized, not treated|2|||
124528928|NCT03575351|447885913|FG000|Overall Study|other reasons|5|||
124528929|NCT03575351|447885914|FG001|Overall Study|other reasons|0|||
124528930|NCT04288089|447885915|FG000|Overall Study|Ongoing Treatment|2|||
124528931|NCT04288089|447885916|FG001|Overall Study|Ongoing Treatment|1|||
124528932|NCT04288089|447885917|FG002|Overall Study|Ongoing Treatment|1|||
124727800|NCT01973387|448623904|FG001|Overall Study|Randomized, not treated|2|||
124528933|NCT04288089|447885918|FG003|Overall Study|Ongoing Treatment|4|||
124528934|NCT03715205|447885919|FG000|Overall Study|Death|13|||
124528935|NCT03715205|447885919|FG000|Overall Study|Lost to Follow-up|2|||
124528936|NCT03715205|447885919|FG000|Overall Study|Physician Decision|93|||
124528937|NCT03715205|447885919|FG000|Overall Study|Withdrawal by Subject|26|||
124528938|NCT02286089|447885922|FG000|Overall Study|Ongoing in Study|1|||
124528939|NCT02286089|447885923|FG001|Overall Study|Ongoing in Study|1|||
124528940|NCT02286089|447885924|FG002|Overall Study|Ongoing in Study|4|||
124528941|NCT02286089|447885925|FG003|Overall Study|Ongoing in Study|10|||
124528942|NCT02286089|447885922|FG000|Overall Study|Withdrawal by Subject|0|||
124528943|NCT02286089|447885923|FG001|Overall Study|Withdrawal by Subject|0|||
124528944|NCT02286089|447885924|FG002|Overall Study|Withdrawal by Subject|2|||
124528945|NCT02286089|447885925|FG003|Overall Study|Withdrawal by Subject|2|||
124528946|NCT03733249|447885926|FG000|Overall Study|Death|7|||
124528947|NCT03733249|447885926|FG000|Overall Study|Disease relapse|16|||
124528948|NCT03733249|447885926|FG000|Overall Study|Lost to Follow-up|4|||
124528949|NCT03733249|447885926|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
124528950|NCT03733249|447885926|FG000|Overall Study|Withdrawal by Subject|1|||
124528951|NCT04247828|447885927|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
124528952|NCT03299166|447885928|FG000|Overall Study|Adverse Event|9|||
124528953|NCT03299166|447885929|FG001|Overall Study|Adverse Event|4|||
124528954|NCT03299166|447885928|FG000|Overall Study|Withdrawal by Subject|6|||
124528955|NCT03299166|447885929|FG001|Overall Study|Withdrawal by Subject|5|||
124528956|NCT03299166|447885928|FG000|Overall Study|Physician Decision|1|||
124528957|NCT03299166|447885929|FG001|Overall Study|Physician Decision|1|||
124528958|NCT03299166|447885928|FG000|Overall Study|Sponsor Decision|3|||
124528959|NCT03299166|447885929|FG001|Overall Study|Sponsor Decision|0|||
124528960|NCT03299166|447885928|FG000|Overall Study|Lost to Follow-up|2|||
124528961|NCT03299166|447885929|FG001|Overall Study|Lost to Follow-up|4|||
124528962|NCT03299166|447885928|FG000|Overall Study|Randomization Error|0|||
124528963|NCT03299166|447885929|FG001|Overall Study|Randomization Error|1|||
124528964|NCT03299166|447885928|FG000|Overall Study|Subject unable to return due to COVID|1|||
124528965|NCT03299166|447885929|FG001|Overall Study|Subject unable to return due to COVID|0|||
124528966|NCT03299166|447885928|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
124528967|NCT03299166|447885929|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
124528968|NCT00572728|447885930|FG000|Overall Study|Withdrawal by Subject|10|||
124528969|NCT00572728|447885930|FG000|Overall Study|Ineligible|3|||
124528970|NCT00572728|447885930|FG000|Overall Study|Enrolled under Amendment 4|5|||
124528971|NCT00572728|447885930|FG000|Overall Study|Offstudy due to complicating disease|1|||
124528972|NCT00572728|447885930|FG000|Overall Study|FLT1 not completed|4|||
124528973|NCT00572728|447885930|FG000|Overall Study|First Chemotherapy not initiated|2|||
124528974|NCT00572728|447885930|FG000|Overall Study|FLT2 not completed|5|||
124528975|NCT00572728|447885930|FG000|Overall Study|Second chemotherapy not initiated|1|||
124528976|NCT00572728|447885930|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
124528977|NCT00572728|447885930|FG000|Overall Study|Pathology missing|1|||
124528978|NCT00002981|447885931|FG000|Overall Study|Inevaluable|6|||
124528979|NCT03457636|447885934|FG000|Overall Study|Lost to Follow-up|2|||
124528980|NCT00113555|447885936|FG000|Overall Study|Baseline Failure|59|||
124528981|NCT00113555|447885936|FG000|Overall Study|Permanently Explanted|7|||
124528982|NCT00113555|447885936|FG000|Overall Study|Death|1|||
124528983|NCT00113555|447885936|FG000|Overall Study|Missed Followup|4|||
124528984|NCT00113555|447885936|FG000|Overall Study|Lost to Follow-up|8|||
124528985|NCT01060124|447885937|FG000|Overall Study|Other|16|||
124528986|NCT01060124|447885937|FG000|Overall Study|Adverse Event|14|||
124528987|NCT01060124|447885937|FG000|Overall Study|Withdrawal by Subject|7|||
124528988|NCT03858686|447885945|FG000|Period 1|Adverse Event|1|||
124528989|NCT03858686|447885946|FG001|Period 1|Adverse Event|1|||
124528990|NCT03858686|447885945|FG000|Period 1|Lack of compliance|0|||
124528991|NCT03858686|447885946|FG001|Period 1|Lack of compliance|1|||
124528992|NCT03858686|447885945|FG000|Period 1|Adverse Event|0|||
124528993|NCT03858686|447885946|FG001|Period 1|Adverse Event|1|||
124528994|NCT03858686|447885945|FG000|Period 2|Adverse Event|0|||
124528995|NCT03858686|447885946|FG001|Period 2|Adverse Event|1|||
124528996|NCT03954704|447885947|FG000|Overall Study|Death|1|||
124528997|NCT03954704|447885948|FG001|Overall Study|Death|1|||
124528998|NCT03954704|447885949|FG002|Overall Study|Death|1|||
124528999|NCT03954704|447885950|FG003|Overall Study|Death|3|||
124529000|NCT03954704|447885951|FG004|Overall Study|Death|2|||
124529001|NCT03954704|447885952|FG005|Overall Study|Death|2|||
124529002|NCT03954704|447885953|FG006|Overall Study|Death|0|||
124529003|NCT03954704|447885947|FG000|Overall Study|Withdrew Consent|0|||
124529004|NCT03954704|447885948|FG001|Overall Study|Withdrew Consent|0|||
124529005|NCT03954704|447885949|FG002|Overall Study|Withdrew Consent|1|||
124529006|NCT03954704|447885950|FG003|Overall Study|Withdrew Consent|0|||
124529007|NCT03954704|447885951|FG004|Overall Study|Withdrew Consent|0|||
124529008|NCT03954704|447885952|FG005|Overall Study|Withdrew Consent|1|||
124529009|NCT03954704|447885953|FG006|Overall Study|Withdrew Consent|0|||
124529010|NCT03954704|447885947|FG000|Overall Study|Lost to Follow-up|0|||
124529011|NCT03954704|447885948|FG001|Overall Study|Lost to Follow-up|0|||
124529012|NCT03954704|447885949|FG002|Overall Study|Lost to Follow-up|0|||
124529013|NCT03954704|447885950|FG003|Overall Study|Lost to Follow-up|0|||
124529014|NCT03954704|447885951|FG004|Overall Study|Lost to Follow-up|0|||
124529015|NCT03954704|447885952|FG005|Overall Study|Lost to Follow-up|0|||
124581407|NCT03261167|448086493|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
124581408|NCT03261167|448086494|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
124581409|NCT03261167|448086493|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
124581410|NCT03261167|448086494|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
124581411|NCT03199963|448086497|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
124581412|NCT03199963|448086498|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
124581413|NCT03199963|448086497|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
124581414|NCT03199963|448086498|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
124581415|NCT03199963|448086497|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
124581416|NCT03199963|448086498|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
124581417|NCT03199963|448086497|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
124581418|NCT03199963|448086498|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
124581419|NCT03199963|448086497|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
124581420|NCT03199963|448086498|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
124581421|NCT03199963|448086497|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
124581422|NCT03199963|448086498|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
124581423|NCT00466167|448086499|FG000|Overall Study|Adverse Event|8|||
124581424|NCT00466167|448086500|FG001|Overall Study|Adverse Event|8|||
124581425|NCT00466167|448086501|FG002|Overall Study|Adverse Event|7|||
124581426|NCT00466167|448086499|FG000|Overall Study|Lack of Efficacy|2|||
124581427|NCT00466167|448086500|FG001|Overall Study|Lack of Efficacy|0|||
124581428|NCT00466167|448086501|FG002|Overall Study|Lack of Efficacy|3|||
124581429|NCT00466167|448086499|FG000|Overall Study|Protocol Violation|1|||
124581430|NCT00466167|448086500|FG001|Overall Study|Protocol Violation|1|||
124581431|NCT00466167|448086501|FG002|Overall Study|Protocol Violation|2|||
124581432|NCT00466167|448086499|FG000|Overall Study|Lost to Follow-up|3|||
124581433|NCT00466167|448086500|FG001|Overall Study|Lost to Follow-up|2|||
124581434|NCT00466167|448086501|FG002|Overall Study|Lost to Follow-up|2|||
124581435|NCT00466167|448086499|FG000|Overall Study|Withdrawal by Subject|4|||
124581436|NCT00466167|448086500|FG001|Overall Study|Withdrawal by Subject|1|||
124581437|NCT00466167|448086501|FG002|Overall Study|Withdrawal by Subject|6|||
124581438|NCT00466167|448086499|FG000|Overall Study|patient did not meet inclusion criteria|1|||
124581439|NCT00466167|448086500|FG001|Overall Study|patient did not meet inclusion criteria|0|||
124581440|NCT00466167|448086501|FG002|Overall Study|patient did not meet inclusion criteria|1|||
124581441|NCT00466167|448086499|FG000|Overall Study|Not treated|1|||
124581442|NCT00466167|448086500|FG001|Overall Study|Not treated|0|||
124581443|NCT00466167|448086501|FG002|Overall Study|Not treated|0|||
124581444|NCT03366792|448086508|FG000|Overall Study|Withdrawal by Subject|7|||
124581445|NCT03366792|448086508|FG000|Overall Study|Lost to Follow-up|2|||
124581446|NCT03366792|448086508|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
124581447|NCT03366792|448086508|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
124581448|NCT02450539|448086509|FG000|Overall Study|Withdrawal by Subject|12|||
124581449|NCT02450539|448086510|FG001|Overall Study|Withdrawal by Subject|6|||
124581450|NCT02450539|448086509|FG000|Overall Study|Lost to Follow-up|4|||
124581451|NCT02450539|448086510|FG001|Overall Study|Lost to Follow-up|1|||
124581452|NCT00402103|448086513|FG000|Overall Study|Adverse Event|60|||
124581453|NCT00402103|448086514|FG001|Overall Study|Adverse Event|7|||
124581454|NCT00402103|448086513|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124581455|NCT00402103|448086514|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124581456|NCT00402103|448086513|FG000|Overall Study|Condition no longer requires study drug|2|||
124581457|NCT00402103|448086514|FG001|Overall Study|Condition no longer requires study drug|0|||
124581458|NCT00402103|448086513|FG000|Overall Study|Protocol Deviation|8|||
124581459|NCT00402103|448086514|FG001|Overall Study|Protocol Deviation|0|||
124581460|NCT00402103|448086513|FG000|Overall Study|Patient withdrew consent|12|||
124581461|NCT00402103|448086514|FG001|Overall Study|Patient withdrew consent|1|||
124581462|NCT00402103|448086513|FG000|Overall Study|Lost to Follow-up|6|||
124581463|NCT00402103|448086514|FG001|Overall Study|Lost to Follow-up|3|||
124581464|NCT00402103|448086513|FG000|Overall Study|Administrative problems|2|||
124581465|NCT00402103|448086514|FG001|Overall Study|Administrative problems|0|||
124581466|NCT04078022|448086515|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
124776935|NCT00345358|448811354|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
124776936|NCT00345358|448811355|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
124776937|NCT00345358|448811356|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
124581467|NCT04078022|448086516|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
124581468|NCT01895335|448086521|FG000|Overall Study|Adverse Event|106|||
124581469|NCT01895335|448086521|FG000|Overall Study|Lack of Efficacy|53|||
124581470|NCT01895335|448086521|FG000|Overall Study|Poor Compliance to Protocol|11|||
124581471|NCT01895335|448086521|FG000|Overall Study|Included But Not treated|1|||
124581472|NCT01895335|448086521|FG000|Overall Study|Other than Specified Above|44|||
124581473|NCT00418938|448086522|FG000|Overall Study|Reimbursement|1|||
124581474|NCT00418938|448086523|FG001|Overall Study|Reimbursement|0|||
124529016|NCT03954704|447885953|FG006|Overall Study|Lost to Follow-up|1|||
124529017|NCT03954704|447885947|FG000|Overall Study|Study Terminated by Sponsor|0|||
124529018|NCT03954704|447885948|FG001|Overall Study|Study Terminated by Sponsor|0|||
124529019|NCT03954704|447885949|FG002|Overall Study|Study Terminated by Sponsor|1|||
124529020|NCT03954704|447885950|FG003|Overall Study|Study Terminated by Sponsor|0|||
124529021|NCT03954704|447885951|FG004|Overall Study|Study Terminated by Sponsor|1|||
124529022|NCT03954704|447885952|FG005|Overall Study|Study Terminated by Sponsor|4|||
124529023|NCT03954704|447885953|FG006|Overall Study|Study Terminated by Sponsor|2|||
124529024|NCT03954704|447885947|FG000|Overall Study|Enrolled but not Treated|0|||
124529025|NCT03954704|447885948|FG001|Overall Study|Enrolled but not Treated|0|||
124529026|NCT03954704|447885949|FG002|Overall Study|Enrolled but not Treated|0|||
124529027|NCT03954704|447885950|FG003|Overall Study|Enrolled but not Treated|0|||
124529028|NCT03954704|447885951|FG004|Overall Study|Enrolled but not Treated|0|||
124529029|NCT03954704|447885952|FG005|Overall Study|Enrolled but not Treated|1|||
124529030|NCT03954704|447885953|FG006|Overall Study|Enrolled but not Treated|0|||
124529031|NCT00102804|447885954|FG000|Overall Study|Progressive Disease (PD)|307|||
124529032|NCT00102804|447885955|FG001|Overall Study|Progressive Disease (PD)|196|||
124727801|NCT01562314|448623905|FG000|Overall Study|Adverse Event|10|||
124727802|NCT01562314|448623906|FG001|Overall Study|Adverse Event|5|||
124727803|NCT01562314|448623905|FG000|Overall Study|Met Withdrawal Criteria|3|||
124727804|NCT01562314|448623906|FG001|Overall Study|Met Withdrawal Criteria|2|||
124727805|NCT01562314|448623905|FG000|Overall Study|Withdrawal by Subject|0|||
124727806|NCT01562314|448623906|FG001|Overall Study|Withdrawal by Subject|1|||
124727807|NCT03655054|448623907|FG000|Overall Study|Lost to Follow-up|1|||
124727808|NCT02256384|448623914|FG000|Overall Study|Withdrawal by Subject|12|||
124727809|NCT02256384|448623914|FG000|Overall Study|Equipment not capturing data|2|||
124529033|NCT00102804|447885954|FG000|Overall Study|Withdrawal by Subject|46|||
124529034|NCT00102804|447885955|FG001|Overall Study|Withdrawal by Subject|7|||
124529035|NCT00102804|447885954|FG000|Overall Study|Adverse Event|37|||
124529036|NCT00102804|447885955|FG001|Overall Study|Adverse Event|3|||
124529037|NCT00102804|447885954|FG000|Overall Study|Physician Decision|24|||
124581475|NCT00418938|448086522|FG000|Overall Study|Administrative decision|3|||
124581476|NCT00418938|448086523|FG001|Overall Study|Administrative decision|3|||
124581477|NCT00418938|448086522|FG000|Overall Study|Withdrawal by Subject|16|||
124581478|NCT00418938|448086523|FG001|Overall Study|Withdrawal by Subject|15|||
124581479|NCT00418938|448086522|FG000|Overall Study|Lost to Follow-up|1|||
124581480|NCT00418938|448086523|FG001|Overall Study|Lost to Follow-up|3|||
124581481|NCT00418938|448086522|FG000|Overall Study|Adverse Event|1|||
124581482|NCT00418938|448086523|FG001|Overall Study|Adverse Event|1|||
124581483|NCT00418938|448086522|FG000|Overall Study|On-going|1|||
124581484|NCT00418938|448086523|FG001|Overall Study|On-going|1|||
124581485|NCT00418938|448086522|FG000|Overall Study|Ineligibility Determined|1|||
124581486|NCT00418938|448086523|FG001|Overall Study|Ineligibility Determined|0|||
124581487|NCT00463684|448086524|FG000|Overall Study|Withdrawal by Subject|1|||
124581488|NCT00463684|448086524|FG000|Overall Study|Lost to Follow-up|3|||
124581489|NCT00115063|448086525|FG000|Overall Study|Lost to Follow-up|98|||
124581490|NCT00115063|448086526|FG001|Overall Study|Lost to Follow-up|104|||
124581491|NCT00115063|448086525|FG000|Overall Study|Death|1|||
124581492|NCT00115063|448086526|FG001|Overall Study|Death|0|||
124581493|NCT00191815|448086527|FG000|Overall Study|Adverse Event|2|||
124581494|NCT00191815|448086527|FG000|Overall Study|Disease progression or relapse|24|||
124581495|NCT00191815|448086527|FG000|Overall Study|Death|2|||
124581496|NCT00191815|448086527|FG000|Overall Study|Protocol Violation|3|||
124581497|NCT00191815|448086527|FG000|Overall Study|Physician Decision|2|||
124581498|NCT00191815|448086527|FG000|Overall Study|Withdrawal by Subject|7|||
124727810|NCT00244933|448623922|FG000|Overall Study|Not response evaluable|2|||
124727811|NCT00349921|448623923|FG000|First Spinal Injection|Physician Decision|1|||
124581499|NCT01075282|448086528|FG000|Overall Study|Withdrawal by Subject|11|||
124581500|NCT01075282|448086529|FG001|Overall Study|Withdrawal by Subject|7|||
124581501|NCT01075282|448086530|FG002|Overall Study|Withdrawal by Subject|11|||
124581502|NCT01075282|448086528|FG000|Overall Study|Adverse Event|9|||
124581503|NCT01075282|448086529|FG001|Overall Study|Adverse Event|8|||
124581504|NCT01075282|448086530|FG002|Overall Study|Adverse Event|5|||
124727812|NCT00349921|448623924|FG001|First Spinal Injection|Physician Decision|0|||
124727813|NCT00349921|448623925|FG002|First Spinal Injection|Physician Decision|0|||
124727814|NCT00349921|448623926|FG003|First Spinal Injection|Physician Decision|0|||
124529038|NCT00102804|447885955|FG001|Overall Study|Physician Decision|6|||
124529039|NCT00102804|447885954|FG000|Overall Study|Death|5|||
124529040|NCT00102804|447885955|FG001|Overall Study|Death|6|||
124529041|NCT00102804|447885954|FG000|Overall Study|Enrollment Criteria Not Met|6|||
124529042|NCT00102804|447885955|FG001|Overall Study|Enrollment Criteria Not Met|0|||
124529043|NCT00102804|447885954|FG000|Overall Study|Lost to Follow-up|4|||
124529044|NCT00102804|447885955|FG001|Overall Study|Lost to Follow-up|1|||
124529045|NCT00102804|447885954|FG000|Overall Study|Protocol Violation|2|||
124581505|NCT01075282|448086528|FG000|Overall Study|Entry Criteria Not Met|3|||
124581506|NCT01075282|448086529|FG001|Overall Study|Entry Criteria Not Met|2|||
124581507|NCT01075282|448086530|FG002|Overall Study|Entry Criteria Not Met|0|||
124581508|NCT01075282|448086528|FG000|Overall Study|Lost to Follow-up|3|||
124581509|NCT01075282|448086529|FG001|Overall Study|Lost to Follow-up|3|||
124581510|NCT01075282|448086530|FG002|Overall Study|Lost to Follow-up|3|||
124581511|NCT01075282|448086528|FG000|Overall Study|Physician Decision|3|||
124581512|NCT01075282|448086529|FG001|Overall Study|Physician Decision|3|||
124581513|NCT01075282|448086530|FG002|Overall Study|Physician Decision|3|||
124581514|NCT01075282|448086528|FG000|Overall Study|Lack of Efficacy|1|||
124581515|NCT01075282|448086529|FG001|Overall Study|Lack of Efficacy|1|||
124581516|NCT01075282|448086530|FG002|Overall Study|Lack of Efficacy|0|||
124581517|NCT01075282|448086528|FG000|Overall Study|Treatment Non-compliance|1|||
124581518|NCT01075282|448086529|FG001|Overall Study|Treatment Non-compliance|2|||
124581519|NCT01075282|448086530|FG002|Overall Study|Treatment Non-compliance|2|||
124581520|NCT01075282|448086528|FG000|Overall Study|Protocol Violation|0|||
124581521|NCT01075282|448086529|FG001|Overall Study|Protocol Violation|2|||
124581522|NCT01075282|448086530|FG002|Overall Study|Protocol Violation|1|||
124581523|NCT01075282|448086528|FG000|Overall Study|Death|0|||
124581524|NCT01075282|448086529|FG001|Overall Study|Death|1|||
124581525|NCT01075282|448086530|FG002|Overall Study|Death|2|||
124581526|NCT01794845|448086531|FG000|Overall Study|Withdrawal by Subject|1|||
124581527|NCT02139826|448086532|FG000|Overall Study|Adverse Event|1|||
124581528|NCT00429416|448086533|FG000|Overall Study|Death|1|||
124581529|NCT06999265|448086534|FG000|Overall Study|Lost to Follow-up|1|||
124581530|NCT06999265|448086535|FG001|Overall Study|Lost to Follow-up|1|||
124581531|NCT02316548|448087547|FG000|Overall Study|Protocol Violation|0|||
124581532|NCT02316548|448087548|FG001|Overall Study|Protocol Violation|1|||
124581533|NCT02571907|448087549|FG000|Overall Study|Death|4|||
124581534|NCT02571907|448087549|FG000|Overall Study|Lost to Follow-up|3|||
124581535|NCT02571907|448087549|FG000|Overall Study|Withdrawal by Subject|3|||
124581536|NCT02286739|448087555|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
124581537|NCT02286739|448087556|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
124581538|NCT02286739|448087555|FG000|Overall Study|No Verasense type documented|0|||
124581539|NCT02286739|448087556|FG001|Overall Study|No Verasense type documented|23|||
124581540|NCT02286739|448087555|FG000|Overall Study|Adverse Event|1|||
124581541|NCT02286739|448087556|FG001|Overall Study|Adverse Event|2|||
124581542|NCT02286739|448087555|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
124581543|NCT02286739|448087556|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
124581544|NCT02566850|448087557|FG000|Overall Study|Protocol Violation|1|||
124581545|NCT03447353|448087561|FG000|Overall Study|Failure at Screening Visit|2|||
124581546|NCT03447353|448087561|FG000|Overall Study|Lost to Follow-up|4|||
124581547|NCT03447353|448087561|FG000|Overall Study|Scheduling Conflicts|3|||
124581548|NCT03447353|448087561|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
124581549|NCT02642653|448087566|FG000|Overall Study|Adverse Event|2|||
124581550|NCT02642653|448087567|FG001|Overall Study|Adverse Event|0|||
124581551|NCT00830258|448087568|FG000|First Intervention|Adverse Event|1|||
124581552|NCT00830258|448087569|FG001|First Intervention|Adverse Event|0|||
124581553|NCT00830258|448087568|FG000|Washout: 7 Days|Protocol Violation|1|||
124581554|NCT00830258|448087569|FG001|Washout: 7 Days|Protocol Violation|0|||
124581555|NCT00682461|448087573|FG000|Overall Study|Adverse Event|5|||
124581556|NCT00682461|448087574|FG001|Overall Study|Adverse Event|7|||
124581557|NCT00682461|448087573|FG000|Overall Study|Lost to Follow-up|8|||
124581558|NCT00682461|448087574|FG001|Overall Study|Lost to Follow-up|5|||
124581559|NCT00682461|448087573|FG000|Overall Study|Withdrawal by Subject|12|||
124581560|NCT00682461|448087574|FG001|Overall Study|Withdrawal by Subject|19|||
124581561|NCT02267187|448087575|FG000|Overall Study|Physician Decision|2|||
124581562|NCT02267187|448087575|FG000|Overall Study|Screen fail|3|||
124581563|NCT04035187|448087578|FG000|Overall Study|Withdrawal by Subject|2|||
124581564|NCT04035187|448087579|FG001|Overall Study|Withdrawal by Subject|1|||
124581565|NCT04035187|448087580|FG002|Overall Study|Withdrawal by Subject|0|||
124581566|NCT04035187|448087581|FG003|Overall Study|Withdrawal by Subject|0|||
124581567|NCT04035187|448087578|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
124581568|NCT04035187|448087579|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
124581569|NCT04035187|448087580|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
124581570|NCT04035187|448087581|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
124581571|NCT01116739|448087588|FG000|Overall Study|Child had 2 years of HS|110|||
124581572|NCT01116739|448087589|FG001|Overall Study|Child had 2 years of HS|128|||
124581573|NCT01116739|448087588|FG000|Overall Study|Withdrawal by Subject|6|||
124581574|NCT01116739|448087589|FG001|Overall Study|Withdrawal by Subject|0|||
124727815|NCT00349921|448623923|FG000|First Spinal Injection|Adverse Event|0|||
124727816|NCT00349921|448623924|FG001|First Spinal Injection|Adverse Event|0|||
124581575|NCT01116739|448087588|FG000|Overall Study|child too young|2|||
124581576|NCT01116739|448087589|FG001|Overall Study|child too young|6|||
124581577|NCT01116739|448087588|FG000|Overall Study|child not enrolled in head start|10|||
124581578|NCT01116739|448087589|FG001|Overall Study|child not enrolled in head start|2|||
124581579|NCT01116739|448087588|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
124581580|NCT01116739|448087589|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
124529046|NCT00102804|447885955|FG001|Overall Study|Protocol Violation|1|||
124529047|NCT00102804|447885954|FG000|Overall Study|Satisfactory Response|2|||
124529048|NCT00102804|447885955|FG001|Overall Study|Satisfactory Response|0|||
124529049|NCT00102804|447885954|FG000|Overall Study|Sponsor Decision|1|||
124529050|NCT00102804|447885955|FG001|Overall Study|Sponsor Decision|0|||
124529051|NCT00102804|447885954|FG000|Overall Study|Alive, Receiving Treatment|7|||
124529052|NCT00102804|447885955|FG001|Overall Study|Alive, Receiving Treatment|2|||
124529053|NCT01432938|447885958|FG000|First Intervention|Protocol Violation|1|||
124529054|NCT01432938|447885959|FG001|First Intervention|Protocol Violation|0|||
124529055|NCT01432938|447885958|FG000|First Intervention|Physician Decision|1|||
124529056|NCT01432938|447885959|FG001|First Intervention|Physician Decision|0|||
124529057|NCT01432938|447885958|FG000|Second Intervention|Adverse Event|1|||
124529058|NCT01432938|447885959|FG001|Second Intervention|Adverse Event|0|||
124529059|NCT00374127|447885960|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
124529060|NCT00374127|447885960|FG000|Overall Study|Blood could not be drawn.|2|||
124529061|NCT00374127|447885960|FG000|Overall Study|Protocol Violation|5|||
124529062|NCT00374127|447885960|FG000|Overall Study|Pregnancy|1|||
124529063|NCT04035473|447885965|FG000|Screening/Baseline|Death|0|||
124529064|NCT04035473|447885966|FG001|Screening/Baseline|Death|1|||
124529065|NCT04035473|447885965|FG000|Screening/Baseline|Adverse Event|0|||
124529066|NCT04035473|447885966|FG001|Screening/Baseline|Adverse Event|1|||
124529067|NCT04035473|447885965|FG000|Follow-up Period|Adverse Event|2|||
124529068|NCT04035473|447885966|FG001|Follow-up Period|Adverse Event|0|||
124529069|NCT00112840|447885967|FG000|Overall Study|Physician Decision|1|||
124529070|NCT00112840|447885968|FG001|Overall Study|Physician Decision|0|||
124529071|NCT00112840|447885969|FG002|Overall Study|Physician Decision|0|||
124529072|NCT00112840|447885967|FG000|Overall Study|Withdrawal by Subject|1|||
124529073|NCT00112840|447885968|FG001|Overall Study|Withdrawal by Subject|0|||
124529074|NCT00112840|447885969|FG002|Overall Study|Withdrawal by Subject|1|||
124529075|NCT00112840|447885967|FG000|Overall Study|Protocol Violation|0|||
124529076|NCT00112840|447885968|FG001|Overall Study|Protocol Violation|0|||
124529077|NCT00112840|447885969|FG002|Overall Study|Protocol Violation|5|||
124529078|NCT02299206|447885970|FG000|Overall Study|Lost to Follow-up|1|||
124529079|NCT02299206|447885970|FG000|Overall Study|Withdrawal by Subject|1|||
124529080|NCT00691054|447885971|FG000|Overall Study|Withdrawal by Subject|1|||
124529081|NCT02735044|447885973|FG000|Overall Study|Adverse Event|3|||
124529082|NCT02735044|447885974|FG001|Overall Study|Adverse Event|3|||
124529083|NCT02735044|447885973|FG000|Overall Study|Lack of Efficacy|1|||
124529084|NCT02735044|447885974|FG001|Overall Study|Lack of Efficacy|0|||
124529085|NCT02735044|447885973|FG000|Overall Study|Poor compliance to protocol|7|||
124529086|NCT02735044|447885974|FG001|Overall Study|Poor compliance to protocol|7|||
124529087|NCT02735044|447885973|FG000|Overall Study|Randomized and not treated|0|||
124529088|NCT02735044|447885974|FG001|Overall Study|Randomized and not treated|2|||
124529089|NCT02735044|447885973|FG000|Overall Study|Other, not specified above|5|||
124529090|NCT02735044|447885974|FG001|Overall Study|Other, not specified above|11|||
124529091|NCT01682759|447885976|FG000|Overall Study|Death|2|||
124529092|NCT01682759|447885977|FG001|Overall Study|Death|1|||
124529093|NCT01682759|447885976|FG000|Overall Study|Lost to Follow-up|10|||
124529094|NCT01682759|447885977|FG001|Overall Study|Lost to Follow-up|13|||
124529095|NCT01682759|447885976|FG000|Overall Study|Physician Decision|1|||
124529096|NCT01682759|447885977|FG001|Overall Study|Physician Decision|1|||
124529097|NCT01682759|447885976|FG000|Overall Study|Withdrawal by Subject|56|||
124529098|NCT01682759|447885977|FG001|Overall Study|Withdrawal by Subject|55|||
124529099|NCT01868594|447885978|FG000|Overall Study|Do not meet inclusion criteria|4|||
124529100|NCT01868594|447885979|FG001|Overall Study|Do not meet inclusion criteria|3|||
124529101|NCT04076579|447887779|FG000|Overall Study|Adverse Event|2|||
124529102|NCT04076579|447887780|FG001|Overall Study|Adverse Event|0|||
124529103|NCT04076579|447887779|FG000|Overall Study|discontinued due to toxicity|1|||
124529104|NCT04076579|447887780|FG001|Overall Study|discontinued due to toxicity|0|||
124529105|NCT04076579|447887779|FG000|Overall Study|Physician Decision|1|||
124529106|NCT04076579|447887780|FG001|Overall Study|Physician Decision|0|||
124529107|NCT04076579|447887779|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
124529108|NCT04076579|447887780|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
124529109|NCT04076579|447887779|FG000|Overall Study|Noncompliance|0|||
124529110|NCT04076579|447887780|FG001|Overall Study|Noncompliance|1|||
124529111|NCT04076579|447887779|FG000|Overall Study|Withdrawal by Subject|0|||
124529112|NCT04076579|447887780|FG001|Overall Study|Withdrawal by Subject|2|||
124529113|NCT05815758|447887785|FG000|Overall Study|Adverse Event|6|||
124529114|NCT05815758|447887786|FG001|Overall Study|Adverse Event|2|||
124529115|NCT05815758|447887785|FG000|Overall Study|Lost to Follow-up|14|||
124529116|NCT05815758|447887786|FG001|Overall Study|Lost to Follow-up|1|||
124529117|NCT05815758|447887785|FG000|Overall Study|Withdrawal by Subject|6|||
124529118|NCT05815758|447887786|FG001|Overall Study|Withdrawal by Subject|6|||
124529119|NCT05815758|447887785|FG000|Overall Study|Protocol Violation|1|||
124529120|NCT05815758|447887786|FG001|Overall Study|Protocol Violation|1|||
124529121|NCT05815758|447887785|FG000|Overall Study|Discontinued|4|||
124529122|NCT05815758|447887786|FG001|Overall Study|Discontinued|4|||
124529123|NCT04167514|447887789|FG000|Overall Study|Adverse event, not serious|0|||
124529124|NCT04167514|447887790|FG001|Overall Study|Adverse event, not serious|1|||
124529125|NCT04167514|447887789|FG000|Overall Study|Lost to Follow-up|1|||
124529126|NCT04167514|447887790|FG001|Overall Study|Lost to Follow-up|0|||
124529127|NCT04167514|447887789|FG000|Overall Study|Participant Decision|2|||
124529128|NCT04167514|447887790|FG001|Overall Study|Participant Decision|4|||
124529129|NCT04167514|447887789|FG000|Overall Study|Physician Decision|3|||
124529130|NCT04167514|447887790|FG001|Overall Study|Physician Decision|2|||
124529131|NCT04167514|447887789|FG000|Overall Study|Death|14|||
124529132|NCT04167514|447887790|FG001|Overall Study|Death|18|||
124529133|NCT04167514|447887789|FG000|Overall Study|Enrolled but treatment not administered|2|||
124529134|NCT04167514|447887790|FG001|Overall Study|Enrolled but treatment not administered|0|||
124529135|NCT04167514|447887789|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
124529136|NCT04167514|447887790|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
124529137|NCT04167514|447887789|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
124529138|NCT04167514|447887790|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
124529139|NCT03991936|447887791|FG000|Overall Study|Lost to Follow-up|1|||
124529140|NCT03991936|447887792|FG001|Overall Study|Lost to Follow-up|1|||
124529141|NCT03991936|447887793|FG002|Overall Study|Lost to Follow-up|1|||
124529142|NCT03991936|447887794|FG003|Overall Study|Lost to Follow-up|1|||
124529143|NCT03991936|447887795|FG004|Overall Study|Lost to Follow-up|1|||
124529144|NCT00939055|447887796|FG000|Overall Study|Discontinuation prior to procedure|4|||
124529145|NCT00939055|447887797|FG001|Overall Study|Discontinuation prior to procedure|0|||
124529146|NCT00584987|447887800|FG000|Overall Study|Protocol Violation|1|||
124529147|NCT00584987|447887801|FG001|Overall Study|Protocol Violation|1|||
124529148|NCT00584987|447887802|FG002|Overall Study|Protocol Violation|1|||
124529149|NCT00584987|447887803|FG003|Overall Study|Protocol Violation|0|||
124529150|NCT00584987|447887800|FG000|Overall Study|Adverse Event|0|||
124529151|NCT00584987|447887801|FG001|Overall Study|Adverse Event|0|||
124529152|NCT00584987|447887802|FG002|Overall Study|Adverse Event|0|||
124529153|NCT00584987|447887803|FG003|Overall Study|Adverse Event|1|||
124529154|NCT03225833|447887804|FG000|Overall Study|Adverse Event|0|||
124529155|NCT03225833|447887805|FG001|Overall Study|Adverse Event|1|||
124529156|NCT03225833|447887806|FG002|Overall Study|Adverse Event|2|||
124529157|NCT03225833|447887807|FG003|Overall Study|Adverse Event|0|||
124529158|NCT03225833|447887808|FG004|Overall Study|Adverse Event|0|||
124529159|NCT03225833|447887809|FG005|Overall Study|Adverse Event|2|||
124529160|NCT03225833|447887804|FG000|Overall Study|Withdrawal by Subject|1|||
124529161|NCT03225833|447887805|FG001|Overall Study|Withdrawal by Subject|0|||
124529162|NCT03225833|447887806|FG002|Overall Study|Withdrawal by Subject|0|||
124529163|NCT03225833|447887807|FG003|Overall Study|Withdrawal by Subject|0|||
124529164|NCT03225833|447887808|FG004|Overall Study|Withdrawal by Subject|1|||
124529165|NCT03225833|447887809|FG005|Overall Study|Withdrawal by Subject|0|||
124529166|NCT03225833|447887804|FG000|Overall Study|Termination of Study by Sponsor|4|||
124529167|NCT03225833|447887805|FG001|Overall Study|Termination of Study by Sponsor|0|||
124529168|NCT03225833|447887806|FG002|Overall Study|Termination of Study by Sponsor|0|||
124529169|NCT03225833|447887807|FG003|Overall Study|Termination of Study by Sponsor|0|||
124529170|NCT03225833|447887808|FG004|Overall Study|Termination of Study by Sponsor|0|||
124529171|NCT03225833|447887809|FG005|Overall Study|Termination of Study by Sponsor|7|||
124529172|NCT03225833|447887804|FG000|Overall Study|Sponsor Decision|0|||
124529173|NCT03225833|447887805|FG001|Overall Study|Sponsor Decision|0|||
124529174|NCT03225833|447887806|FG002|Overall Study|Sponsor Decision|0|||
124529175|NCT03225833|447887807|FG003|Overall Study|Sponsor Decision|0|||
124529176|NCT03225833|447887808|FG004|Overall Study|Sponsor Decision|0|||
124529177|NCT03225833|447887809|FG005|Overall Study|Sponsor Decision|1|||
124529178|NCT02881151|447887810|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
124529179|NCT03258593|447887811|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
124529180|NCT03258593|447887812|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
124529181|NCT03258593|447887813|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
124529182|NCT03258593|447887814|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
124529183|NCT03258593|447887811|FG000|Run-In Maintenance Phase|Disease progression|3|||
124529184|NCT03258593|447887812|FG001|Run-In Maintenance Phase|Disease progression|0|||
124529185|NCT03258593|447887813|FG002|Run-In Maintenance Phase|Disease progression|0|||
124529186|NCT03258593|447887814|FG003|Run-In Maintenance Phase|Disease progression|0|||
124529187|NCT03258593|447887811|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
124529188|NCT03258593|447887812|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
124529189|NCT03258593|447887813|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
124529190|NCT03258593|447887814|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
124529191|NCT03258593|447887811|FG000|Expansion Maintenance Phase|Physician Decision|0|||
124529192|NCT03258593|447887812|FG001|Expansion Maintenance Phase|Physician Decision|1|||
124529193|NCT03258593|447887813|FG002|Expansion Maintenance Phase|Physician Decision|0|||
124727817|NCT00349921|448623925|FG002|First Spinal Injection|Adverse Event|1|||
124529194|NCT03258593|447887814|FG003|Expansion Maintenance Phase|Physician Decision|0|||
124727818|NCT00349921|448623926|FG003|First Spinal Injection|Adverse Event|0|||
124581581|NCT02255149|448087590|FG000|Overall Study|Lost to Follow-up|2|||
124581582|NCT02255149|448087590|FG000|Overall Study|Withdrawal by Subject|1|||
124581583|NCT02255149|448087590|FG000|Overall Study|Withdrawal by PI|1|||
124581584|NCT02255149|448087590|FG000|Overall Study|Implant Failure|1|||
124581585|NCT03121586|448087594|FG000|Overall Study|Study terminated by sponsor|0|||
124581586|NCT03121586|448087595|FG001|Overall Study|Study terminated by sponsor|0|||
124581587|NCT03121586|448087596|FG002|Overall Study|Study terminated by sponsor|99|||
124581588|NCT03121586|448087594|FG000|Overall Study|Withdrawal by Subject|37|||
124581589|NCT03121586|448087595|FG001|Overall Study|Withdrawal by Subject|14|||
124581590|NCT03121586|448087596|FG002|Overall Study|Withdrawal by Subject|9|||
124581591|NCT03121586|448087594|FG000|Overall Study|Not further specified|6|||
124581592|NCT03121586|448087595|FG001|Overall Study|Not further specified|11|||
124581593|NCT03121586|448087596|FG002|Overall Study|Not further specified|10|||
124581594|NCT03121586|448087594|FG000|Overall Study|Adverse Event|16|||
124581595|NCT03121586|448087595|FG001|Overall Study|Adverse Event|5|||
124581596|NCT03121586|448087596|FG002|Overall Study|Adverse Event|6|||
124581597|NCT03121586|448087594|FG000|Overall Study|Protocol Violation|0|||
124581598|NCT03121586|448087595|FG001|Overall Study|Protocol Violation|5|||
124581599|NCT03121586|448087596|FG002|Overall Study|Protocol Violation|0|||
124581600|NCT03121586|448087594|FG000|Overall Study|Lack of Efficacy|3|||
124581601|NCT03121586|448087595|FG001|Overall Study|Lack of Efficacy|3|||
124581602|NCT03121586|448087596|FG002|Overall Study|Lack of Efficacy|1|||
124581603|NCT03121586|448087594|FG000|Overall Study|Physician Decision|2|||
124581604|NCT03121586|448087595|FG001|Overall Study|Physician Decision|2|||
124581605|NCT03121586|448087596|FG002|Overall Study|Physician Decision|0|||
124581606|NCT03121586|448087594|FG000|Overall Study|Noncompliance with study drug|5|||
124581607|NCT03121586|448087595|FG001|Overall Study|Noncompliance with study drug|3|||
124581608|NCT03121586|448087596|FG002|Overall Study|Noncompliance with study drug|5|||
124581609|NCT03121586|448087594|FG000|Overall Study|Lost to Follow-up|4|||
124581610|NCT03121586|448087595|FG001|Overall Study|Lost to Follow-up|2|||
124581611|NCT03121586|448087596|FG002|Overall Study|Lost to Follow-up|0|||
124581612|NCT03121586|448087594|FG000|Overall Study|Death|2|||
124581613|NCT03121586|448087595|FG001|Overall Study|Death|0|||
124581614|NCT03121586|448087596|FG002|Overall Study|Death|0|||
124581615|NCT02909907|448087597|FG000|Overall Study|Withdrawal by Subject|0|||
124581616|NCT02909907|448087598|FG001|Overall Study|Withdrawal by Subject|1|||
124581617|NCT01839279|448087600|FG000|Overall Study|Adverse Event|4|||
124581618|NCT01839279|448087601|FG001|Overall Study|Adverse Event|1|||
124581619|NCT01839279|448087602|FG002|Overall Study|Adverse Event|1|||
124581620|NCT01839279|448087600|FG000|Overall Study|Withdrawal by Subject|4|||
124581621|NCT01839279|448087601|FG001|Overall Study|Withdrawal by Subject|1|||
124581622|NCT01839279|448087602|FG002|Overall Study|Withdrawal by Subject|1|||
124581623|NCT01839279|448087600|FG000|Overall Study|Classified as 'Other'|5|||
124581624|NCT01839279|448087601|FG001|Overall Study|Classified as 'Other'|0|||
124581625|NCT01839279|448087602|FG002|Overall Study|Classified as 'Other'|0|||
124581626|NCT00392665|448087603|FG000|Overall Study|Death|16|||
124581627|NCT00392665|448087604|FG001|Overall Study|Death|14|||
124581628|NCT00392665|448087603|FG000|Overall Study|Lost to Follow-up|1|||
124581629|NCT00392665|448087604|FG001|Overall Study|Lost to Follow-up|1|||
124581630|NCT03276754|448087605|FG000|Overall Study|Withdrawal of informed consent|4|||
124581631|NCT03276754|448087605|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
124581632|NCT03276754|448087605|FG000|Overall Study|Lost to Follow-up|27|||
124581633|NCT03276754|448087605|FG000|Overall Study|No data reported at Month 24|31|||
124581634|NCT03276754|448087605|FG000|Overall Study|Death|39|||
124581635|NCT03437265|448087606|FG000|Overall Study|Protocol Violation|6|||
124581636|NCT00316277|448087607|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
124581637|NCT00316277|448087608|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
124581638|NCT00316277|448087607|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
124581639|NCT00316277|448087608|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
124581640|NCT00316277|448087607|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
124581641|NCT00316277|448087608|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
124581642|NCT00316277|448087607|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
124581643|NCT00316277|448087608|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
124581644|NCT00316277|448087607|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
124581645|NCT00316277|448087608|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
124581646|NCT01572662|448087619|FG000|Overall Study|Withdrawal by Subject|1|||
124727819|NCT00920387|448623927|FG000|Stage 1|Adverse Event|1|||
124727820|NCT00920387|448623928|FG001|Stage 1|Adverse Event|0|||
124727821|NCT00920387|448623929|FG002|Stage 1|Adverse Event|0|||
124727822|NCT00157196|448623930|FG000|Overall Study|Ongoing at data cut-off|9|||
124581647|NCT01572662|448087620|FG001|Overall Study|Withdrawal by Subject|0|||
124581648|NCT01572662|448087619|FG000|Overall Study|Physician Decision|0|||
124581649|NCT01572662|448087620|FG001|Overall Study|Physician Decision|1|||
124581650|NCT03364192|448087621|FG000|Overall Study|Ineligible|10|||
124581651|NCT03364192|448087621|FG000|Overall Study|Withdrawal by Subject|5|||
124581652|NCT03364192|448087621|FG000|Overall Study|Lost to Follow-up|1|||
124581653|NCT00918645|448087622|FG000|Overall Study|Withdrawal by Subject|1|||
124776938|NCT00499083|448811357|FG000|Overall Study|Not evaluable|3|||
124776939|NCT00686686|448811358|FG000|Overall Study|Non-compliance|1|||
124776940|NCT00686686|448811358|FG000|Overall Study|Adverse Event|2|||
124776941|NCT00686686|448811358|FG000|Overall Study|Lost to Follow-up|3|||
124776942|NCT00131248|448811362|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
124776943|NCT00131248|448811363|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
124776944|NCT00477386|448811364|FG000|Overall Study|Adverse Event|4|||
124776945|NCT00477386|448811365|FG001|Overall Study|Adverse Event|8|||
124776946|NCT00477386|448811364|FG000|Overall Study|Disease progression, relapse|3|||
124776947|NCT00477386|448811365|FG001|Overall Study|Disease progression, relapse|4|||
124776948|NCT00477386|448811364|FG000|Overall Study|Disease progression, refractory|1|||
124776949|NCT00477386|448811365|FG001|Overall Study|Disease progression, refractory|3|||
124776950|NCT00477386|448811364|FG000|Overall Study|Other|1|||
124776951|NCT00477386|448811365|FG001|Overall Study|Other|2|||
124776952|NCT00477386|448811364|FG000|Overall Study|Physician Decision|1|||
124776953|NCT00477386|448811365|FG001|Overall Study|Physician Decision|0|||
124776954|NCT00477386|448811364|FG000|Overall Study|Withdrawal by Subject|1|||
124727823|NCT02524275|448623931|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
124727824|NCT00778258|448623932|FG000|Overall Study|Adverse Event|1|||
124727825|NCT00778258|448623933|FG001|Overall Study|Adverse Event|0|||
124727826|NCT00778258|448623934|FG002|Overall Study|Adverse Event|0|||
124727827|NCT00778258|448623935|FG003|Overall Study|Adverse Event|0|||
124727828|NCT00778258|448623936|FG004|Overall Study|Adverse Event|0|||
124727829|NCT00778258|448623937|FG005|Overall Study|Adverse Event|1|||
124727830|NCT00778258|448623938|FG006|Overall Study|Adverse Event|0|||
124727831|NCT00778258|448623939|FG007|Overall Study|Adverse Event|0|||
124727832|NCT00778258|448623940|FG008|Overall Study|Adverse Event|0|||
124727833|NCT00778258|448623932|FG000|Overall Study|Lost to Follow-up|0|||
124727834|NCT00778258|448623933|FG001|Overall Study|Lost to Follow-up|0|||
124727835|NCT00778258|448623934|FG002|Overall Study|Lost to Follow-up|2|||
124727836|NCT00778258|448623935|FG003|Overall Study|Lost to Follow-up|0|||
124727837|NCT00778258|448623936|FG004|Overall Study|Lost to Follow-up|0|||
124727838|NCT00778258|448623937|FG005|Overall Study|Lost to Follow-up|3|||
124727839|NCT00778258|448623938|FG006|Overall Study|Lost to Follow-up|2|||
124727840|NCT00778258|448623939|FG007|Overall Study|Lost to Follow-up|2|||
124727841|NCT00778258|448623940|FG008|Overall Study|Lost to Follow-up|0|||
124727842|NCT00778258|448623932|FG000|Overall Study|Withdrawal by Subject|6|||
124581654|NCT03446768|448087623|FG000|Overall Study|Withdrawal by Subject|0|||
124581655|NCT03446768|448087624|FG001|Overall Study|Withdrawal by Subject|1|||
124581656|NCT05133180|448087625|FG000|Overall Study|Withdrawal of consent|1|||
124581657|NCT05133180|448087626|FG001|Overall Study|Withdrawal of consent|1|||
124581658|NCT05133180|448087625|FG000|Overall Study|Lost to Follow-up|1|||
124581659|NCT05133180|448087626|FG001|Overall Study|Lost to Follow-up|1|||
124581660|NCT05133180|448087625|FG000|Overall Study|Documented disease progression|0|||
124581661|NCT05133180|448087626|FG001|Overall Study|Documented disease progression|1|||
124581662|NCT00107991|448087627|FG000|Eligibility Assessment|Disease not severe enough|7|||
124581663|NCT00107991|448087627|FG000|Eligibility Assessment|Unwilling to participate|7|||
124581664|NCT00107991|448087627|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
124581665|NCT00107991|448087627|FG000|Eligibility Assessment|Abnormal labs|2|||
124581666|NCT00107991|448087627|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
124581667|NCT00107991|448087627|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
124581668|NCT00107991|448087627|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
124581669|NCT00107991|448087627|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
124581670|NCT00107991|448087627|FG000|12 Week Treatment Period|Adverse Event|1|||
124581671|NCT00107991|448087627|FG000|12 Week Treatment Period|Protocol Violation|1|||
124581672|NCT00107991|448087627|FG000|12 Week Treatment Period|Incarcerated|1|||
124727843|NCT00778258|448623933|FG001|Overall Study|Withdrawal by Subject|2|||
124727844|NCT00778258|448623934|FG002|Overall Study|Withdrawal by Subject|8|||
124727845|NCT00778258|448623935|FG003|Overall Study|Withdrawal by Subject|2|||
124727846|NCT00778258|448623936|FG004|Overall Study|Withdrawal by Subject|0|||
124727847|NCT00778258|448623937|FG005|Overall Study|Withdrawal by Subject|6|||
124727848|NCT00778258|448623938|FG006|Overall Study|Withdrawal by Subject|12|||
124727849|NCT00778258|448623939|FG007|Overall Study|Withdrawal by Subject|12|||
124581673|NCT00107991|448087627|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
124581674|NCT01535222|448087628|FG000|Overall Study|Inclusion/exclusion|0|||
124727850|NCT00778258|448623940|FG008|Overall Study|Withdrawal by Subject|4|||
124727851|NCT00778258|448623932|FG000|Overall Study|New Contraindication|0|||
124727852|NCT00778258|448623933|FG001|Overall Study|New Contraindication|0|||
124727853|NCT00778258|448623934|FG002|Overall Study|New Contraindication|0|||
124727854|NCT00778258|448623935|FG003|Overall Study|New Contraindication|0|||
124727855|NCT00778258|448623936|FG004|Overall Study|New Contraindication|0|||
124727856|NCT00778258|448623937|FG005|Overall Study|New Contraindication|0|||
124727857|NCT00778258|448623938|FG006|Overall Study|New Contraindication|0|||
124776955|NCT00477386|448811365|FG001|Overall Study|Withdrawal by Subject|0|||
124776956|NCT01254422|448811366|FG000|Overall Study|Protocol Violation|1|||
124776957|NCT01254422|448811367|FG001|Overall Study|Protocol Violation|0|||
124727858|NCT00778258|448623939|FG007|Overall Study|New Contraindication|1|||
124727859|NCT00778258|448623940|FG008|Overall Study|New Contraindication|0|||
124727860|NCT00778258|448623932|FG000|Overall Study|Non-compliance|0|||
124727861|NCT00778258|448623933|FG001|Overall Study|Non-compliance|0|||
124727862|NCT00778258|448623934|FG002|Overall Study|Non-compliance|0|||
124727863|NCT00778258|448623935|FG003|Overall Study|Non-compliance|1|||
124529195|NCT05318183|447887815|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
124529196|NCT05318183|447887816|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
124529197|NCT05318183|447887815|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
124529198|NCT05318183|447887816|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
124529199|NCT04437511|447887817|FG000|Overall Study|Adverse Event|50|||
124529200|NCT04437511|447887818|FG001|Overall Study|Adverse Event|21|||
124529201|NCT04437511|447887817|FG000|Overall Study|Death|15|||
124529202|NCT04437511|447887818|FG001|Overall Study|Death|10|||
124529203|NCT04437511|447887817|FG000|Overall Study|Lost to Follow-up|11|||
124529204|NCT04437511|447887818|FG001|Overall Study|Lost to Follow-up|11|||
124529205|NCT04437511|447887817|FG000|Overall Study|Physician Decision|19|||
124529206|NCT04437511|447887818|FG001|Overall Study|Physician Decision|10|||
124529207|NCT04437511|447887817|FG000|Overall Study|Progressive Disease|4|||
124529208|NCT04437511|447887818|FG001|Overall Study|Progressive Disease|7|||
124529209|NCT04437511|447887817|FG000|Overall Study|Withdrawal by Subject|111|||
124529210|NCT04437511|447887818|FG001|Overall Study|Withdrawal by Subject|94|||
124529211|NCT04437511|447887817|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
124529212|NCT04437511|447887818|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
124529213|NCT04437511|447887817|FG000|Overall Study|Continuing Study|7|||
124529214|NCT04437511|447887818|FG001|Overall Study|Continuing Study|5|||
124529215|NCT00777036|447887847|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
124529216|NCT00777036|447887848|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
124529217|NCT00777036|447887849|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
124529218|NCT00777036|447887850|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
124529219|NCT00777036|447887847|FG000|On Treatment|Administrative Reason By Sponsor|1|||
124529220|NCT00777036|447887848|FG001|On Treatment|Administrative Reason By Sponsor|0|||
124529221|NCT00777036|447887849|FG002|On Treatment|Administrative Reason By Sponsor|9|||
124529222|NCT00777036|447887850|FG003|On Treatment|Administrative Reason By Sponsor|0|||
124529223|NCT00777036|447887847|FG000|On Treatment|Failure to Meet Study Criteria|0|||
124529224|NCT00777036|447887848|FG001|On Treatment|Failure to Meet Study Criteria|1|||
124529225|NCT00777036|447887849|FG002|On Treatment|Failure to Meet Study Criteria|4|||
124529226|NCT00777036|447887850|FG003|On Treatment|Failure to Meet Study Criteria|0|||
124529227|NCT00777036|447887847|FG000|On Treatment|Pregnancy|1|||
124529228|NCT00777036|447887848|FG001|On Treatment|Pregnancy|0|||
124529229|NCT00777036|447887849|FG002|On Treatment|Pregnancy|1|||
124529230|NCT00777036|447887850|FG003|On Treatment|Pregnancy|0|||
124529231|NCT00777036|447887847|FG000|On Treatment|Non-compliance with Study Drug|1|||
124529232|NCT00777036|447887848|FG001|On Treatment|Non-compliance with Study Drug|0|||
124529233|NCT00777036|447887849|FG002|On Treatment|Non-compliance with Study Drug|1|||
124529234|NCT00777036|447887850|FG003|On Treatment|Non-compliance with Study Drug|0|||
124529235|NCT00777036|447887847|FG000|On Treatment|Maximum Clinical Benefit|2|||
124529236|NCT00777036|447887848|FG001|On Treatment|Maximum Clinical Benefit|0|||
124529237|NCT00777036|447887849|FG002|On Treatment|Maximum Clinical Benefit|5|||
124529238|NCT00777036|447887850|FG003|On Treatment|Maximum Clinical Benefit|0|||
124529239|NCT00777036|447887847|FG000|On Treatment|Withdrawal by Subject|0|||
124529240|NCT00777036|447887848|FG001|On Treatment|Withdrawal by Subject|2|||
124529241|NCT00777036|447887849|FG002|On Treatment|Withdrawal by Subject|2|||
124529242|NCT00777036|447887850|FG003|On Treatment|Withdrawal by Subject|0|||
124529243|NCT00777036|447887847|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
124529244|NCT00777036|447887848|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
124529245|NCT00777036|447887849|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
124529246|NCT00777036|447887850|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
124529247|NCT00777036|447887847|FG000|On Treatment|Death|0|||
124529248|NCT00777036|447887848|FG001|On Treatment|Death|2|||
124529249|NCT00777036|447887849|FG002|On Treatment|Death|0|||
124529250|NCT00777036|447887850|FG003|On Treatment|Death|0|||
124529251|NCT00777036|447887847|FG000|On Treatment|Study Drug Toxicity|1|||
124529252|NCT00777036|447887848|FG001|On Treatment|Study Drug Toxicity|0|||
124529253|NCT00777036|447887849|FG002|On Treatment|Study Drug Toxicity|4|||
124529254|NCT00777036|447887850|FG003|On Treatment|Study Drug Toxicity|0|||
124529255|NCT00777036|447887847|FG000|On Treatment|Progressive Disease|6|||
124529256|NCT00777036|447887848|FG001|On Treatment|Progressive Disease|4|||
124529257|NCT00777036|447887849|FG002|On Treatment|Progressive Disease|7|||
124529258|NCT00777036|447887850|FG003|On Treatment|Progressive Disease|0|||
124529259|NCT00777036|447887847|FG000|On Treatment|Not Reported|0|||
124529260|NCT00777036|447887848|FG001|On Treatment|Not Reported|0|||
124727864|NCT00778258|448623936|FG004|Overall Study|Non-compliance|0|||
124727865|NCT00778258|448623937|FG005|Overall Study|Non-compliance|0|||
124727866|NCT00778258|448623938|FG006|Overall Study|Non-compliance|0|||
124727867|NCT00778258|448623939|FG007|Overall Study|Non-compliance|0|||
124727868|NCT00778258|448623940|FG008|Overall Study|Non-compliance|0|||
124727869|NCT00778258|448623932|FG000|Overall Study|Other|0|||
124727870|NCT00778258|448623933|FG001|Overall Study|Other|0|||
124727871|NCT00778258|448623934|FG002|Overall Study|Other|0|||
124727872|NCT00778258|448623935|FG003|Overall Study|Other|0|||
124727873|NCT00778258|448623936|FG004|Overall Study|Other|0|||
124727874|NCT00778258|448623937|FG005|Overall Study|Other|0|||
124727875|NCT00778258|448623938|FG006|Overall Study|Other|1|||
124727876|NCT00778258|448623939|FG007|Overall Study|Other|0|||
124727877|NCT00778258|448623940|FG008|Overall Study|Other|0|||
124727878|NCT00780143|448623949|FG000|Overall Study|Progressive disease|1|||
124727879|NCT00780143|448623949|FG000|Overall Study|Toxicity|1|||
124727880|NCT00780143|448623949|FG000|Overall Study|Adverse Event|1|||
124727881|NCT00082368|448623952|FG000|Overall Study|Not treated-pt had poor IV access|1|||
124727882|NCT00322452|448623953|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124727883|NCT00322452|448623954|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
124727884|NCT00322452|448623953|FG000|Overall Study|Lost to Follow-up|5|||
124727885|NCT00322452|448623954|FG001|Overall Study|Lost to Follow-up|2|||
124727886|NCT00322452|448623953|FG000|Overall Study|Withdrawal by Subject|19|||
124727887|NCT00322452|448623954|FG001|Overall Study|Withdrawal by Subject|46|||
124727888|NCT00322452|448623953|FG000|Overall Study|Death|223|||
124727889|NCT00322452|448623954|FG001|Overall Study|Death|227|||
124727890|NCT00882583|448625788|FG000|Overall Study|Physician Decision|1|||
124581675|NCT01535222|448087629|FG001|Overall Study|Inclusion/exclusion|0|||
124581676|NCT01535222|448087630|FG002|Overall Study|Inclusion/exclusion|1|||
124581677|NCT01535222|448087631|FG003|Overall Study|Inclusion/exclusion|0|||
124581678|NCT01535222|448087632|FG004|Overall Study|Inclusion/exclusion|0|||
124581679|NCT01535222|448087633|FG005|Overall Study|Inclusion/exclusion|0|||
124581680|NCT00935012|448087634|FG000|Overall Study|Death|19|||
124581681|NCT00935012|448087634|FG000|Overall Study|Withdrawal by Subject|3|||
124581682|NCT00935012|448087634|FG000|Overall Study|Other|5|||
124581683|NCT00935012|448087634|FG000|Overall Study|Adverse Event|2|||
124581684|NCT01442155|448087635|FG000|Overall Study|Complete remission|35|||
124581685|NCT01442155|448087635|FG000|Overall Study|Recurrence|26|||
124581686|NCT01442155|448087635|FG000|Overall Study|Adverse Event|2|||
124581687|NCT01442155|448087635|FG000|Overall Study|Lost to Follow-up|2|||
124581688|NCT03669861|448087636|FG000|Overall Study|Disease Flare|5|||
124581689|NCT03669861|448087636|FG000|Overall Study|Lack of Efficacy|2|||
124581690|NCT00705666|448087638|FG000|Overall Study|No post-treatment questionnaire|279|||
124581691|NCT00705666|448087638|FG000|Overall Study|Withdrawal by Subject|21|||
124581692|NCT00705666|448087638|FG000|Overall Study|Physician Decision|7|||
124581693|NCT00705666|448087638|FG000|Overall Study|Lost to Follow-up|5|||
124581694|NCT00705666|448087638|FG000|Overall Study|Death|1|||
124581695|NCT00705666|448087638|FG000|Overall Study|Adverse Event|4|||
124581696|NCT00705666|448087638|FG000|Overall Study|Other|12|||
124581697|NCT00705666|448087638|FG000|Overall Study|Other|2|||
124581698|NCT00705666|448087638|FG000|Overall Study|Lack of data|3|||
124581699|NCT00705666|448087638|FG000|Overall Study|Untreated|5|||
124581700|NCT01590563|448087648|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
124581701|NCT03256695|448087649|FG000|Overall Study|Adverse Event|8|||
124581702|NCT03256695|448087649|FG000|Overall Study|Death|2|||
124581703|NCT03256695|448087649|FG000|Overall Study|Withdrawal by Subject|14|||
124581704|NCT03256695|448087649|FG000|Overall Study|Non-compliance with study drug|1|||
124581705|NCT03256695|448087649|FG000|Overall Study|Lost to Follow-up|3|||
124581706|NCT03256695|448087649|FG000|Overall Study|Lack of Efficacy|3|||
124581707|NCT03256695|448087649|FG000|Overall Study|Protocol Violation|5|||
124581708|NCT03256695|448087649|FG000|Overall Study|Other than specified|3|||
124581709|NCT01604941|448087650|FG000|Overall Study|Adverse Event|1|||
124581710|NCT01604941|448087651|FG001|Overall Study|Adverse Event|2|||
124581711|NCT01604941|448087652|FG002|Overall Study|Adverse Event|0|||
124581712|NCT01604941|448087653|FG003|Overall Study|Adverse Event|0|||
124581713|NCT01604941|448087654|FG004|Overall Study|Adverse Event|1|||
124581714|NCT01604941|448087655|FG005|Overall Study|Adverse Event|5|||
124581715|NCT01604941|448087650|FG000|Overall Study|Non-compliance|1|||
124581716|NCT01604941|448087651|FG001|Overall Study|Non-compliance|0|||
124581717|NCT01604941|448087652|FG002|Overall Study|Non-compliance|0|||
124581718|NCT01604941|448087653|FG003|Overall Study|Non-compliance|0|||
124581719|NCT01604941|448087654|FG004|Overall Study|Non-compliance|0|||
124581720|NCT01604941|448087655|FG005|Overall Study|Non-compliance|0|||
124581721|NCT01604941|448087650|FG000|Overall Study|Participant Decision|0|||
124581722|NCT01604941|448087651|FG001|Overall Study|Participant Decision|0|||
124727891|NCT00882583|448625789|FG001|Overall Study|Physician Decision|0|||
124727892|NCT00882583|448625788|FG000|Overall Study|Adverse Event|0|||
124727893|NCT00882583|448625789|FG001|Overall Study|Adverse Event|1|||
124727894|NCT04753658|448625790|FG000|Overall Study|Progressive disease|7|||
124581723|NCT01604941|448087652|FG002|Overall Study|Participant Decision|0|||
124727895|NCT04753658|448625790|FG000|Overall Study|Other|7|||
124727896|NCT04753658|448625790|FG000|Overall Study|Adverse Event|1|||
124727897|NCT05243745|448625791|FG000|Overall Study|Withdrawal by Subject|0|||
124581724|NCT01604941|448087653|FG003|Overall Study|Participant Decision|0|||
124529261|NCT00777036|447887849|FG002|On Treatment|Not Reported|2|||
124529262|NCT00777036|447887850|FG003|On Treatment|Not Reported|0|||
124529263|NCT00777036|447887847|FG000|On Treatment|Site Closed|0|||
124529264|NCT00777036|447887848|FG001|On Treatment|Site Closed|1|||
124529265|NCT00777036|447887849|FG002|On Treatment|Site Closed|1|||
124529266|NCT00777036|447887850|FG003|On Treatment|Site Closed|0|||
124529267|NCT00777036|447887847|FG000|Follow-Up|Withdrawal by Subject|0|||
124529268|NCT00777036|447887848|FG001|Follow-Up|Withdrawal by Subject|0|||
124529269|NCT00777036|447887849|FG002|Follow-Up|Withdrawal by Subject|5|||
124529270|NCT00777036|447887850|FG003|Follow-Up|Withdrawal by Subject|0|||
124529271|NCT00777036|447887847|FG000|Follow-Up|Death|1|||
124529272|NCT00777036|447887848|FG001|Follow-Up|Death|9|||
124529273|NCT00777036|447887849|FG002|Follow-Up|Death|0|||
124529274|NCT00777036|447887850|FG003|Follow-Up|Death|0|||
124529275|NCT00777036|447887847|FG000|Follow-Up|Lost to Follow-up|3|||
124529276|NCT00777036|447887848|FG001|Follow-Up|Lost to Follow-up|0|||
124529277|NCT00777036|447887849|FG002|Follow-Up|Lost to Follow-up|0|||
124529278|NCT00777036|447887850|FG003|Follow-Up|Lost to Follow-up|0|||
124529279|NCT00777036|447887847|FG000|Follow-Up|Reason Not Specified|4|||
124529280|NCT00777036|447887848|FG001|Follow-Up|Reason Not Specified|0|||
124529281|NCT00777036|447887849|FG002|Follow-Up|Reason Not Specified|13|||
124529282|NCT00777036|447887850|FG003|Follow-Up|Reason Not Specified|0|||
124529283|NCT00777036|447887847|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
124529284|NCT00777036|447887848|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
124529285|NCT00777036|447887849|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
124529286|NCT00777036|447887850|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
124529287|NCT01267955|447887851|FG000|Stage 1 (6 Months)|Death|3|||
124529288|NCT01267955|447887851|FG000|Stage 2 (6 Months)|Death|5|||
124529289|NCT01267955|447887851|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
124529290|NCT02421939|447887856|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
124529291|NCT02421939|447887857|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
124529292|NCT02421939|447887856|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
124529293|NCT02421939|447887857|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
124529294|NCT02421939|447887856|FG000|Randomization Period: Up to 3 Years|Death|38|||
124529295|NCT02421939|447887857|FG001|Randomization Period: Up to 3 Years|Death|10|||
124529296|NCT02421939|447887856|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
124529297|NCT02421939|447887857|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
124529298|NCT02421939|447887856|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
124529299|NCT02421939|447887857|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
124529300|NCT02421939|447887856|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
124529301|NCT02421939|447887857|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
124529302|NCT02421939|447887856|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
124529303|NCT02421939|447887857|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
124529304|NCT02421939|447887856|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
124529305|NCT02421939|447887857|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
124529306|NCT02421939|447887856|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
124529307|NCT02421939|447887857|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
124529308|NCT02421939|447887856|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
124529309|NCT02421939|447887857|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
124529310|NCT02421939|447887856|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
124529311|NCT02421939|447887857|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
124581725|NCT01604941|448087654|FG004|Overall Study|Participant Decision|0|||
124581726|NCT01604941|448087655|FG005|Overall Study|Participant Decision|2|||
124581727|NCT01604941|448087650|FG000|Overall Study|Early Study Termination|9|||
124581728|NCT01604941|448087651|FG001|Overall Study|Early Study Termination|2|||
124581729|NCT01604941|448087652|FG002|Overall Study|Early Study Termination|3|||
124581730|NCT01604941|448087653|FG003|Overall Study|Early Study Termination|3|||
124581731|NCT01604941|448087654|FG004|Overall Study|Early Study Termination|0|||
124581732|NCT01604941|448087655|FG005|Overall Study|Early Study Termination|0|||
124581733|NCT03930732|448087656|FG000|Overall Study|Adverse Event|9|||
124529312|NCT02421939|447887856|FG000|Long Term Follow up: up to 3 Years|Death|118|||
124529313|NCT02421939|447887857|FG001|Long Term Follow up: up to 3 Years|Death|65|||
124529314|NCT02421939|447887856|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
124529315|NCT02421939|447887857|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
124529316|NCT01263470|447887860|FG000|Overall Study|Adverse Event|2|||
124529317|NCT01263470|447887861|FG001|Overall Study|Adverse Event|2|||
124529318|NCT01263470|447887862|FG002|Overall Study|Adverse Event|1|||
124581734|NCT03930732|448087657|FG001|Overall Study|Adverse Event|7|||
124581735|NCT03930732|448087656|FG000|Overall Study|Poor compliance to protocol|0|||
124581736|NCT03930732|448087657|FG001|Overall Study|Poor compliance to protocol|1|||
124529319|NCT01263470|447887863|FG003|Overall Study|Adverse Event|1|||
124529320|NCT01263470|447887864|FG004|Overall Study|Adverse Event|2|||
124529321|NCT01263470|447887865|FG005|Overall Study|Adverse Event|2|||
124529322|NCT01263470|447887860|FG000|Overall Study|Protocol Violation|0|||
124581737|NCT03930732|448087656|FG000|Overall Study|Withdrawal by Subject|23|||
124581738|NCT03930732|448087657|FG001|Overall Study|Withdrawal by Subject|11|||
124581739|NCT03930732|448087656|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
124581740|NCT03930732|448087657|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
124581741|NCT03930732|448087656|FG000|Overall Study|Other reason not related to COVID-19|5|||
124581742|NCT03930732|448087657|FG001|Overall Study|Other reason not related to COVID-19|8|||
124581743|NCT03406156|448087658|FG000|Overall Study|Death|9|||
124581744|NCT03406156|448087659|FG001|Overall Study|Death|3|||
124581745|NCT03406156|448087658|FG000|Overall Study|Withdrawal by Subject|1|||
124581746|NCT03406156|448087659|FG001|Overall Study|Withdrawal by Subject|2|||
124581747|NCT03406156|448087658|FG000|Overall Study|COVID-19 infection|1|||
124581748|NCT03406156|448087659|FG001|Overall Study|COVID-19 infection|0|||
124581749|NCT03406156|448087658|FG000|Overall Study|Non-compliance with study procedures|1|||
124581750|NCT03406156|448087659|FG001|Overall Study|Non-compliance with study procedures|1|||
124581751|NCT03406156|448087658|FG000|Overall Study|Lost to Follow-up|0|||
124581752|NCT03406156|448087659|FG001|Overall Study|Lost to Follow-up|2|||
124581753|NCT03406156|448087658|FG000|Overall Study|Other, not specified|72|||
124581754|NCT03406156|448087659|FG001|Overall Study|Other, not specified|28|||
124581755|NCT02699463|448087662|FG000|Overall Study|Lost to Follow-up|11|||
124581756|NCT02699463|448087663|FG001|Overall Study|Lost to Follow-up|8|||
124581757|NCT02699463|448087662|FG000|Overall Study|Withdrawal by Subject|4|||
124581758|NCT02699463|448087663|FG001|Overall Study|Withdrawal by Subject|1|||
124529323|NCT01263470|447887861|FG001|Overall Study|Protocol Violation|1|||
124529324|NCT01263470|447887862|FG002|Overall Study|Protocol Violation|0|||
124529325|NCT01263470|447887863|FG003|Overall Study|Protocol Violation|0|||
124529326|NCT01263470|447887864|FG004|Overall Study|Protocol Violation|0|||
124529327|NCT01263470|447887865|FG005|Overall Study|Protocol Violation|1|||
124529328|NCT01263470|447887860|FG000|Overall Study|Withdrawal by Subject|0|||
124529329|NCT01263470|447887861|FG001|Overall Study|Withdrawal by Subject|1|||
124529330|NCT01263470|447887862|FG002|Overall Study|Withdrawal by Subject|1|||
124529331|NCT01263470|447887863|FG003|Overall Study|Withdrawal by Subject|2|||
124529332|NCT01263470|447887864|FG004|Overall Study|Withdrawal by Subject|0|||
124529333|NCT01263470|447887865|FG005|Overall Study|Withdrawal by Subject|2|||
124529334|NCT01263470|447887860|FG000|Overall Study|Lack of Efficacy|0|||
124529335|NCT01263470|447887861|FG001|Overall Study|Lack of Efficacy|0|||
124529336|NCT01263470|447887862|FG002|Overall Study|Lack of Efficacy|2|||
124529337|NCT01263470|447887863|FG003|Overall Study|Lack of Efficacy|0|||
124529338|NCT01263470|447887864|FG004|Overall Study|Lack of Efficacy|0|||
124529339|NCT01263470|447887865|FG005|Overall Study|Lack of Efficacy|0|||
124529340|NCT01263470|447887860|FG000|Overall Study|Participant Unavailability|0|||
124529341|NCT01263470|447887861|FG001|Overall Study|Participant Unavailability|1|||
124529342|NCT01263470|447887862|FG002|Overall Study|Participant Unavailability|0|||
124529343|NCT01263470|447887863|FG003|Overall Study|Participant Unavailability|0|||
124529344|NCT01263470|447887864|FG004|Overall Study|Participant Unavailability|0|||
124529345|NCT01263470|447887865|FG005|Overall Study|Participant Unavailability|0|||
124529346|NCT01263470|447887860|FG000|Overall Study|Study Drug Non-compliance|0|||
124529347|NCT01263470|447887861|FG001|Overall Study|Study Drug Non-compliance|0|||
124529348|NCT01263470|447887862|FG002|Overall Study|Study Drug Non-compliance|0|||
124529349|NCT01263470|447887863|FG003|Overall Study|Study Drug Non-compliance|0|||
124529350|NCT01263470|447887864|FG004|Overall Study|Study Drug Non-compliance|1|||
124529351|NCT01263470|447887865|FG005|Overall Study|Study Drug Non-compliance|0|||
124529352|NCT00610714|447887866|FG000|Overall Study|Adverse Event|3|||
124529353|NCT00610714|447887867|FG001|Overall Study|Adverse Event|1|||
124529354|NCT00610714|447887866|FG000|Overall Study|Death|12|||
124529355|NCT00610714|447887867|FG001|Overall Study|Death|18|||
124529356|NCT00610714|447887866|FG000|Overall Study|Withdrawal by Subject|9|||
124529357|NCT00610714|447887867|FG001|Overall Study|Withdrawal by Subject|3|||
124529358|NCT00610714|447887866|FG000|Overall Study|Study completion at 120 PFS events|2|||
124529359|NCT00610714|447887867|FG001|Overall Study|Study completion at 120 PFS events|2|||
124529360|NCT01327573|447887868|FG000|Overall Study|Physician Decision|3|||
124529361|NCT01327573|447887869|FG001|Overall Study|Physician Decision|1|||
124529362|NCT00712712|447887870|FG000|Overall Study|Protocol Violation|11|||
124529363|NCT00712712|447887870|FG000|Overall Study|Radiofrequency not done|3|||
124529364|NCT00712712|447887870|FG000|Overall Study|Death|8|||
124529365|NCT00712712|447887870|FG000|Overall Study|Withdrawal by Subject|1|||
124581759|NCT00585286|448087667|FG000|Overall Study|Lost to Follow-up|1|||
124581760|NCT01316055|448087673|FG000|Overall Study|Lost to Follow-up|1|||
124727898|NCT05243745|448625792|FG001|Overall Study|Withdrawal by Subject|0|||
124529366|NCT01058395|447887874|FG000|Overall Study|Death|2|||
124529367|NCT01058395|447887875|FG001|Overall Study|Death|1|||
124529368|NCT01058395|447887874|FG000|Overall Study|Lost to Follow-up|1|||
124529369|NCT01058395|447887875|FG001|Overall Study|Lost to Follow-up|0|||
124529370|NCT04083781|447887876|FG000|Main Part|Physician Decision|0|||
124529371|NCT04083781|447887877|FG001|Main Part|Physician Decision|1|||
124529372|NCT04083781|447887878|FG002|Main Part|Physician Decision|2|||
124581761|NCT01316055|448087674|FG001|Overall Study|Lost to Follow-up|0|||
124529373|NCT04083781|447887879|FG003|Main Part|Physician Decision|0|||
124529374|NCT04083781|447887876|FG000|Main Part|Death|1|||
124529375|NCT04083781|447887877|FG001|Main Part|Death|3|||
124529376|NCT04083781|447887878|FG002|Main Part|Death|1|||
124529377|NCT04083781|447887879|FG003|Main Part|Death|0|||
124529378|NCT04083781|447887876|FG000|Main Part|Withdrawal by Subject|5|||
124529379|NCT04083781|447887877|FG001|Main Part|Withdrawal by Subject|2|||
124529380|NCT04083781|447887878|FG002|Main Part|Withdrawal by Subject|3|||
124529381|NCT04083781|447887879|FG003|Main Part|Withdrawal by Subject|7|||
124529382|NCT04083781|447887876|FG000|Extension Part|Physician Decision|0|||
124529383|NCT04083781|447887877|FG001|Extension Part|Physician Decision|0|||
124529384|NCT04083781|447887878|FG002|Extension Part|Physician Decision|0|||
124529385|NCT04083781|447887879|FG003|Extension Part|Physician Decision|1|||
124529386|NCT04083781|447887876|FG000|Extension Part|Death|0|||
124529387|NCT04083781|447887877|FG001|Extension Part|Death|1|||
124529388|NCT04083781|447887878|FG002|Extension Part|Death|0|||
124529389|NCT04083781|447887879|FG003|Extension Part|Death|1|||
124529390|NCT04083781|447887876|FG000|Extension Part|Withdrawal by Subject|0|||
124529391|NCT04083781|447887877|FG001|Extension Part|Withdrawal by Subject|1|||
124529392|NCT04083781|447887878|FG002|Extension Part|Withdrawal by Subject|0|||
124529393|NCT04083781|447887879|FG003|Extension Part|Withdrawal by Subject|0|||
124529394|NCT04083781|447887876|FG000|Extension Part|Ongoing|13|||
124529395|NCT04083781|447887877|FG001|Extension Part|Ongoing|25|||
124529396|NCT04083781|447887878|FG002|Extension Part|Ongoing|15|||
124529397|NCT04083781|447887879|FG003|Extension Part|Ongoing|51|||
124529398|NCT04556175|447887888|FG000|Overall Study|Study terminated due to COVID-19|8|||
124529399|NCT04556175|447887889|FG001|Overall Study|Study terminated due to COVID-19|8|||
124529400|NCT05549505|447887891|FG000|Overall Study|Lost to Follow-up|2|||
124529401|NCT05549505|447887892|FG001|Overall Study|Lost to Follow-up|0|||
124529402|NCT05549505|447887891|FG000|Overall Study|Withdrawal by Subject|3|||
124529403|NCT05549505|447887892|FG001|Overall Study|Withdrawal by Subject|3|||
124529404|NCT05549505|447887891|FG000|Overall Study|Other: Miscellaneous|3|||
124529405|NCT05549505|447887892|FG001|Overall Study|Other: Miscellaneous|6|||
124529406|NCT01602822|447887893|FG000|Overall Study|Adverse Event|11|||
124529407|NCT05492877|447887895|FG000|Overall Study|Adverse Event|11|||
124529408|NCT05492877|447887896|FG001|Overall Study|Adverse Event|7|||
124529409|NCT05492877|447887895|FG000|Overall Study|Death|1|||
124529410|NCT05492877|447887896|FG001|Overall Study|Death|0|||
124529411|NCT05492877|447887895|FG000|Overall Study|Lost to Follow-up|1|||
124529412|NCT05492877|447887896|FG001|Overall Study|Lost to Follow-up|1|||
124529413|NCT05492877|447887895|FG000|Overall Study|Physician Decision|1|||
124529414|NCT05492877|447887896|FG001|Overall Study|Physician Decision|2|||
124529415|NCT05492877|447887895|FG000|Overall Study|Protocol Violation|1|||
124529416|NCT05492877|447887896|FG001|Overall Study|Protocol Violation|1|||
124529417|NCT05492877|447887895|FG000|Overall Study|Withdrawal by Subject|3|||
124529418|NCT05492877|447887896|FG001|Overall Study|Withdrawal by Subject|7|||
124529419|NCT05492877|447887895|FG000|Overall Study|Reason not specified|6|||
124529420|NCT05492877|447887896|FG001|Overall Study|Reason not specified|4|||
124529421|NCT02871791|447887897|FG000|Phase 1b|Death|0|||
124529422|NCT02871791|447887898|FG001|Phase 1b|Death|1|||
124529423|NCT02871791|447887897|FG000|Phase 1b|progressive disease|6|||
124529424|NCT02871791|447887898|FG001|Phase 1b|progressive disease|2|||
124529425|NCT02871791|447887897|FG000|Phase 2|Death|1|||
124529426|NCT02871791|447887898|FG001|Phase 2|Death|0|||
124529427|NCT02871791|447887897|FG000|Phase 2|Lost to Follow-up|2|||
124529428|NCT02871791|447887898|FG001|Phase 2|Lost to Follow-up|0|||
124529429|NCT05333289|447887907|FG000|Overall Study|Other|1|||
124529430|NCT05333289|447887908|FG001|Overall Study|Other|0|||
124529431|NCT05333289|447887909|FG002|Overall Study|Other|0|||
124529432|NCT05333289|447887910|FG003|Overall Study|Other|1|||
124529433|NCT05333289|447887911|FG004|Overall Study|Other|1|||
124529434|NCT05333289|447887912|FG005|Overall Study|Other|2|||
124529435|NCT05333289|447887913|FG006|Overall Study|Other|2|||
124529436|NCT05333289|447887914|FG007|Overall Study|Other|0|||
124529437|NCT05333289|447887907|FG000|Overall Study|Withdrawal by Subject|1|||
124529438|NCT05333289|447887908|FG001|Overall Study|Withdrawal by Subject|2|||
124529439|NCT05333289|447887909|FG002|Overall Study|Withdrawal by Subject|2|||
124529440|NCT05333289|447887910|FG003|Overall Study|Withdrawal by Subject|1|||
124529441|NCT05333289|447887911|FG004|Overall Study|Withdrawal by Subject|1|||
124529442|NCT05333289|447887912|FG005|Overall Study|Withdrawal by Subject|2|||
124529443|NCT05333289|447887913|FG006|Overall Study|Withdrawal by Subject|1|||
124529444|NCT05333289|447887914|FG007|Overall Study|Withdrawal by Subject|3|||
124529445|NCT05333289|447887907|FG000|Overall Study|Protocol Violation|1|||
124529446|NCT05333289|447887908|FG001|Overall Study|Protocol Violation|0|||
124529447|NCT05333289|447887909|FG002|Overall Study|Protocol Violation|0|||
124529448|NCT05333289|447887910|FG003|Overall Study|Protocol Violation|0|||
124529449|NCT05333289|447887911|FG004|Overall Study|Protocol Violation|0|||
124529450|NCT05333289|447887912|FG005|Overall Study|Protocol Violation|0|||
124529451|NCT05333289|447887913|FG006|Overall Study|Protocol Violation|0|||
124529452|NCT05333289|447887914|FG007|Overall Study|Protocol Violation|0|||
124529453|NCT05333289|447887907|FG000|Overall Study|Physician Decision|0|||
124529454|NCT05333289|447887908|FG001|Overall Study|Physician Decision|0|||
124529455|NCT05333289|447887909|FG002|Overall Study|Physician Decision|1|||
124529456|NCT05333289|447887910|FG003|Overall Study|Physician Decision|0|||
124529457|NCT05333289|447887911|FG004|Overall Study|Physician Decision|0|||
124529458|NCT05333289|447887912|FG005|Overall Study|Physician Decision|2|||
124529459|NCT05333289|447887913|FG006|Overall Study|Physician Decision|0|||
124529460|NCT05333289|447887914|FG007|Overall Study|Physician Decision|0|||
124529461|NCT05333289|447887907|FG000|Overall Study|Lost to Follow-up|6|||
124581762|NCT01316055|448087675|FG002|Overall Study|Lost to Follow-up|0|||
124581763|NCT00003470|448087676|FG000|Overall Study|Not evaluable|6|||
124581764|NCT01825798|448087677|FG000|Overall Study|Adverse Event|1|||
124581765|NCT01825798|448087678|FG001|Overall Study|Adverse Event|5|||
124581766|NCT01825798|448087677|FG000|Overall Study|Lost to Follow-up|1|||
124581767|NCT01825798|448087678|FG001|Overall Study|Lost to Follow-up|0|||
124581768|NCT03500094|448087683|FG000|Overall Study|Withdrawal by Subject|1|||
124581769|NCT03500094|448087683|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
124581770|NCT03500094|448087683|FG000|Overall Study|Lost to Follow-up|1|||
124581771|NCT01030133|448087684|FG000|Overall Study|failed to experience pain at level 7/10|2|||
124581772|NCT01030133|448087685|FG001|Overall Study|failed to experience pain at level 7/10|2|||
124581773|NCT04025229|448089048|FG000|Overall Study|Adverse Event|1|||
124581774|NCT04025229|448089049|FG001|Overall Study|Adverse Event|0|||
124581775|NCT04025229|448089048|FG000|Overall Study|Withdrawal by Subject|0|||
124581776|NCT04025229|448089049|FG001|Overall Study|Withdrawal by Subject|2|||
124581777|NCT04025229|448089048|FG000|Overall Study|Death|0|||
124581778|NCT04025229|448089049|FG001|Overall Study|Death|1|||
124581779|NCT04025229|448089048|FG000|Overall Study|Physician Decision|0|||
124581780|NCT04025229|448089049|FG001|Overall Study|Physician Decision|1|||
124581781|NCT01958294|448089052|FG000|Overall Study|Clinical Circumstances|2|||
124581782|NCT05511935|448089053|FG000|Overall Study|Lost to Follow-up|9|||
124581783|NCT05511935|448089054|FG001|Overall Study|Lost to Follow-up|27|||
124581784|NCT05090839|448089055|FG000|Overall Study|Lost to Follow-up|2|||
124581785|NCT05090839|448089056|FG001|Overall Study|Lost to Follow-up|3|||
124581786|NCT05090839|448089057|FG002|Overall Study|Lost to Follow-up|1|||
124581787|NCT05090839|448089058|FG003|Overall Study|Lost to Follow-up|1|||
124581788|NCT03913377|448089059|FG000|Period 1|Test Article no longer available|0|||
124727899|NCT05243745|448625793|FG002|Overall Study|Withdrawal by Subject|0|||
124727900|NCT05243745|448625794|FG003|Overall Study|Withdrawal by Subject|1|||
124727901|NCT05243745|448625791|FG000|Overall Study|Unable to Attend Visit 6|0|||
124727902|NCT05243745|448625792|FG001|Overall Study|Unable to Attend Visit 6|0|||
124727903|NCT05243745|448625793|FG002|Overall Study|Unable to Attend Visit 6|1|||
124727904|NCT05243745|448625794|FG003|Overall Study|Unable to Attend Visit 6|0|||
124727905|NCT03842969|448625805|FG000|Overall Study|Participant declined follow-up visit|0|||
124727906|NCT03842969|448625806|FG001|Overall Study|Participant declined follow-up visit|1|||
124727907|NCT03842969|448625807|FG002|Overall Study|Participant declined follow-up visit|0|||
124727908|NCT03842969|448625805|FG000|Overall Study|Sponsor's decision|12|||
124727909|NCT03842969|448625806|FG001|Overall Study|Sponsor's decision|99|||
124727910|NCT03842969|448625807|FG002|Overall Study|Sponsor's decision|61|||
124727911|NCT03842969|448625805|FG000|Overall Study|Pregnancy|0|||
124727912|NCT03842969|448625806|FG001|Overall Study|Pregnancy|0|||
124727913|NCT03842969|448625807|FG002|Overall Study|Pregnancy|1|||
124727914|NCT03842969|448625805|FG000|Overall Study|Death|1|||
124727915|NCT03842969|448625806|FG001|Overall Study|Death|0|||
124727916|NCT03842969|448625807|FG002|Overall Study|Death|1|||
124727917|NCT03842969|448625805|FG000|Overall Study|Withdrawal by Subject|3|||
124727918|NCT03842969|448625806|FG001|Overall Study|Withdrawal by Subject|30|||
124727919|NCT03842969|448625807|FG002|Overall Study|Withdrawal by Subject|18|||
124727920|NCT03842969|448625805|FG000|Overall Study|Protocol Violation|1|||
124727921|NCT03842969|448625806|FG001|Overall Study|Protocol Violation|1|||
124727922|NCT03842969|448625807|FG002|Overall Study|Protocol Violation|0|||
124727923|NCT03842969|448625805|FG000|Overall Study|Physician Decision|0|||
124727924|NCT03842969|448625806|FG001|Overall Study|Physician Decision|3|||
124529462|NCT05333289|447887908|FG001|Overall Study|Lost to Follow-up|0|||
124529463|NCT05333289|447887909|FG002|Overall Study|Lost to Follow-up|1|||
124529464|NCT05333289|447887910|FG003|Overall Study|Lost to Follow-up|6|||
124529465|NCT05333289|447887911|FG004|Overall Study|Lost to Follow-up|3|||
124581789|NCT03913377|448089060|FG001|Period 1|Test Article no longer available|1|||
124529466|NCT05333289|447887912|FG005|Overall Study|Lost to Follow-up|3|||
124581790|NCT03913377|448089061|FG002|Period 1|Test Article no longer available|0|||
124581791|NCT03913377|448089059|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
124581792|NCT03913377|448089060|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
124727925|NCT03842969|448625807|FG002|Overall Study|Physician Decision|0|||
124727926|NCT03842969|448625805|FG000|Overall Study|Lost to Follow-up|0|||
124727927|NCT03842969|448625806|FG001|Overall Study|Lost to Follow-up|2|||
124727928|NCT03842969|448625807|FG002|Overall Study|Lost to Follow-up|0|||
124727929|NCT03842969|448625805|FG000|Overall Study|Adverse Event|0|||
124727930|NCT03842969|448625806|FG001|Overall Study|Adverse Event|2|||
124727931|NCT03842969|448625807|FG002|Overall Study|Adverse Event|0|||
124529467|NCT05333289|447887913|FG006|Overall Study|Lost to Follow-up|2|||
124581793|NCT03913377|448089061|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
124581794|NCT03499353|448089062|FG000|Treatment|Adverse Event|3|||
124727932|NCT01044745|448625808|FG000|Overall Study|Ineiligible|2|||
124529468|NCT05333289|447887914|FG007|Overall Study|Lost to Follow-up|1|||
124727933|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Adverse Event|76|||
124727934|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Adverse Event|0|||
124727935|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Adverse Event|0|||
124727936|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Death|3|||
124727937|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Death|0|||
124727938|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Death|0|||
124727939|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
124727940|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
124727941|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
124727942|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Physician Decision|9|||
124727943|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Physician Decision|0|||
124727944|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Physician Decision|0|||
124727945|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
124727946|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
124727947|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
124727948|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Disease progression|45|||
124727949|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Disease progression|0|||
124727950|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Disease progression|0|||
124727951|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
124727952|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
124727953|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
124727954|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
124727955|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
124727956|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
124727957|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
124727958|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
124727959|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
124727960|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
124727961|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
124727962|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
124727963|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
124727964|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
124727965|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
124727966|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
124727967|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
124727968|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
124727969|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
124727970|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
124727971|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
124727972|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
124727973|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
124727974|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
124727975|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
124727976|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
124727977|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
124727978|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Promotor request|1|||
124727979|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Promotor request|0|||
124727980|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Promotor request|0|||
124727981|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
124727982|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
124727983|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
124727984|NCT01461928|448625812|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
124727985|NCT01461928|448625813|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
124727986|NCT01461928|448625814|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
124727987|NCT01461928|448625812|FG000|Maintenance I (24 Months)|Death|3|||
124529469|NCT05333289|447887907|FG000|Overall Study|Death|1|||
124529470|NCT05333289|447887908|FG001|Overall Study|Death|0|||
124529471|NCT05333289|447887909|FG002|Overall Study|Death|0|||
124529472|NCT05333289|447887910|FG003|Overall Study|Death|0|||
124529473|NCT05333289|447887911|FG004|Overall Study|Death|0|||
124529474|NCT05333289|447887912|FG005|Overall Study|Death|0|||
124529475|NCT05333289|447887913|FG006|Overall Study|Death|0|||
124529476|NCT05333289|447887914|FG007|Overall Study|Death|0|||
124529477|NCT04476108|447887915|FG000|Overall Study|Adverse Event|4|||
124529478|NCT04476108|447887916|FG001|Overall Study|Adverse Event|1|||
124529479|NCT04476108|447887915|FG000|Overall Study|Lost to Follow-up|1|||
124529480|NCT04476108|447887916|FG001|Overall Study|Lost to Follow-up|0|||
124529481|NCT04476108|447887915|FG000|Overall Study|Inadvertent Enrollment|1|||
124529482|NCT04476108|447887916|FG001|Overall Study|Inadvertent Enrollment|0|||
124581795|NCT03499353|448089062|FG000|Treatment|Progressive Disease|10|||
124581796|NCT03499353|448089062|FG000|Treatment|Other|1|||
124581797|NCT03499353|448089062|FG000|Treatment|Withdrawal by Subject|2|||
124581798|NCT03499353|448089062|FG000|Long-Term Follow-up|Death|2|||
124529483|NCT04476108|447887915|FG000|Overall Study|Protocol Violation|1|||
124581799|NCT03499353|448089062|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
124581800|NCT03499353|448089062|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
124581801|NCT01117623|448089063|FG000|Overall Study|Adverse Event|0|||
124581802|NCT01117623|448089064|FG001|Overall Study|Adverse Event|2|||
124581803|NCT01117623|448089065|FG002|Overall Study|Adverse Event|4|||
124581804|NCT01117623|448089066|FG003|Overall Study|Adverse Event|0|||
124581805|NCT01117623|448089067|FG004|Overall Study|Adverse Event|2|||
124581806|NCT01117623|448089068|FG005|Overall Study|Adverse Event|0|||
124581807|NCT01117623|448089069|FG006|Overall Study|Adverse Event|0|||
124581808|NCT01117623|448089070|FG007|Overall Study|Adverse Event|2|||
124581809|NCT01117623|448089063|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
124581810|NCT01117623|448089064|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
124581811|NCT01117623|448089065|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
124529484|NCT04476108|447887916|FG001|Overall Study|Protocol Violation|1|||
124529485|NCT04476108|447887915|FG000|Overall Study|Withdrawal by Subject|1|||
124529486|NCT04476108|447887916|FG001|Overall Study|Withdrawal by Subject|1|||
124529487|NCT02253992|447887917|FG000|Overall Study|Study drug toxicity|1|||
124529488|NCT02253992|447887918|FG001|Overall Study|Study drug toxicity|0|||
124529489|NCT02253992|447887919|FG002|Overall Study|Study drug toxicity|10|||
124529490|NCT02253992|447887917|FG000|Overall Study|Disease progression|4|||
124529491|NCT02253992|447887918|FG001|Overall Study|Disease progression|3|||
124529492|NCT02253992|447887919|FG002|Overall Study|Disease progression|98|||
124529493|NCT02253992|447887917|FG000|Overall Study|Withdrawal by Subject|0|||
124529494|NCT02253992|447887918|FG001|Overall Study|Withdrawal by Subject|0|||
124529495|NCT02253992|447887919|FG002|Overall Study|Withdrawal by Subject|3|||
124529496|NCT02253992|447887917|FG000|Overall Study|Adverse Event|0|||
124529497|NCT02253992|447887918|FG001|Overall Study|Adverse Event|0|||
124529498|NCT02253992|447887919|FG002|Overall Study|Adverse Event|8|||
124529499|NCT02253992|447887917|FG000|Overall Study|Death|0|||
124529500|NCT02253992|447887918|FG001|Overall Study|Death|0|||
124529501|NCT02253992|447887919|FG002|Overall Study|Death|1|||
124529502|NCT02253992|447887917|FG000|Overall Study|Subject discontinued study drug|1|||
124529503|NCT02253992|447887918|FG001|Overall Study|Subject discontinued study drug|0|||
124529504|NCT02253992|447887919|FG002|Overall Study|Subject discontinued study drug|1|||
124529505|NCT02253992|447887917|FG000|Overall Study|Completed treatment as per protocol|0|||
124529506|NCT02253992|447887918|FG001|Overall Study|Completed treatment as per protocol|1|||
124529507|NCT02253992|447887919|FG002|Overall Study|Completed treatment as per protocol|22|||
124529508|NCT02253992|447887917|FG000|Overall Study|Other|0|||
124529509|NCT02253992|447887918|FG001|Overall Study|Other|0|||
124529510|NCT02253992|447887919|FG002|Overall Study|Other|1|||
124529511|NCT00772889|447887920|FG000|Overall Study|Adverse Event|7|||
124529512|NCT00772889|447887921|FG001|Overall Study|Adverse Event|4|||
124581812|NCT01117623|448089066|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
124581813|NCT01117623|448089067|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
124581814|NCT01117623|448089068|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
124581815|NCT01117623|448089069|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
124581816|NCT01117623|448089070|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
124581817|NCT01117623|448089063|FG000|Overall Study|Withdrawal by Subject|0|||
124581818|NCT01117623|448089064|FG001|Overall Study|Withdrawal by Subject|0|||
124581819|NCT01117623|448089065|FG002|Overall Study|Withdrawal by Subject|2|||
124581820|NCT01117623|448089066|FG003|Overall Study|Withdrawal by Subject|0|||
124581821|NCT01117623|448089067|FG004|Overall Study|Withdrawal by Subject|0|||
124581822|NCT01117623|448089068|FG005|Overall Study|Withdrawal by Subject|1|||
124581823|NCT01117623|448089069|FG006|Overall Study|Withdrawal by Subject|1|||
124581824|NCT01117623|448089070|FG007|Overall Study|Withdrawal by Subject|1|||
124581825|NCT01117623|448089063|FG000|Overall Study|Non-compliance with study medication|0|||
124529513|NCT00772889|447887922|FG002|Overall Study|Adverse Event|0|||
124529514|NCT00772889|447887920|FG000|Overall Study|Withdrawal by Subject|9|||
124529515|NCT00772889|447887921|FG001|Overall Study|Withdrawal by Subject|8|||
124529516|NCT00772889|447887922|FG002|Overall Study|Withdrawal by Subject|9|||
124581826|NCT01117623|448089064|FG001|Overall Study|Non-compliance with study medication|0|||
124581827|NCT01117623|448089065|FG002|Overall Study|Non-compliance with study medication|0|||
124581828|NCT01117623|448089066|FG003|Overall Study|Non-compliance with study medication|0|||
124581829|NCT01117623|448089067|FG004|Overall Study|Non-compliance with study medication|0|||
124581830|NCT01117623|448089068|FG005|Overall Study|Non-compliance with study medication|0|||
124581831|NCT01117623|448089069|FG006|Overall Study|Non-compliance with study medication|0|||
124581832|NCT01117623|448089070|FG007|Overall Study|Non-compliance with study medication|1|||
124727988|NCT01461928|448625813|FG001|Maintenance I (24 Months)|Death|0|||
124529517|NCT00772889|447887920|FG000|Overall Study|Lost to Follow-up|6|||
124529518|NCT00772889|447887921|FG001|Overall Study|Lost to Follow-up|6|||
124529519|NCT00772889|447887922|FG002|Overall Study|Lost to Follow-up|7|||
124529520|NCT03323086|447887923|FG000|Overall Study|Lost to Follow-up|3|||
124529521|NCT03323086|447887924|FG001|Overall Study|Lost to Follow-up|2|||
124529522|NCT00355615|447887925|FG000|Randomized Double Blind Period|Adverse Event|1|||
124529523|NCT00355615|447887926|FG001|Randomized Double Blind Period|Adverse Event|0|||
124581833|NCT01117623|448089063|FG000|Overall Study|Invest. text: completed all planned txs|0|||
124581834|NCT01117623|448089064|FG001|Overall Study|Invest. text: completed all planned txs|0|||
124581835|NCT01117623|448089065|FG002|Overall Study|Invest. text: completed all planned txs|0|||
124581836|NCT01117623|448089066|FG003|Overall Study|Invest. text: completed all planned txs|0|||
124581837|NCT01117623|448089067|FG004|Overall Study|Invest. text: completed all planned txs|0|||
124581838|NCT01117623|448089068|FG005|Overall Study|Invest. text: completed all planned txs|1|||
124581839|NCT01117623|448089069|FG006|Overall Study|Invest. text: completed all planned txs|0|||
124581840|NCT01117623|448089070|FG007|Overall Study|Invest. text: completed all planned txs|0|||
124581841|NCT00736190|448089075|FG000|Overall Study|Pregnancy|1|||
124581842|NCT00736190|448089075|FG000|Overall Study|Withdrawal by Subject|1|||
124581843|NCT00736190|448089075|FG000|Overall Study|Adverse Event|1|||
124581844|NCT01896934|448089077|FG000|Overall Study|Adverse Event|1|||
124581845|NCT01896934|448089077|FG000|Overall Study|Withdrawal by Subject|1|||
124581846|NCT04590027|448089078|FG000|Overall Study|Lost to Follow-up|17|||
124581847|NCT04590027|448089079|FG001|Overall Study|Lost to Follow-up|14|||
124581848|NCT04590027|448089078|FG000|Overall Study|Protocol Violation|0|||
124581849|NCT04590027|448089079|FG001|Overall Study|Protocol Violation|3|||
124581850|NCT00933686|448089080|FG000|Overall Study|Protocol Violation|0|||
124581851|NCT00933686|448089081|FG001|Overall Study|Protocol Violation|1|||
124581852|NCT00933686|448089080|FG000|Overall Study|Lost to Follow-up|2|||
124581853|NCT00933686|448089081|FG001|Overall Study|Lost to Follow-up|2|||
124581854|NCT00933686|448089080|FG000|Overall Study|Withdrawal by Subject|6|||
124529524|NCT00355615|447887927|FG002|Randomized Double Blind Period|Adverse Event|0|||
124581855|NCT00933686|448089081|FG001|Overall Study|Withdrawal by Subject|5|||
124581856|NCT00933686|448089080|FG000|Overall Study|Adverse Event|1|||
124581857|NCT00933686|448089081|FG001|Overall Study|Adverse Event|1|||
124581858|NCT00933686|448089080|FG000|Overall Study|Physician Decision|1|||
124581859|NCT00933686|448089081|FG001|Overall Study|Physician Decision|0|||
124581860|NCT00933686|448089080|FG000|Overall Study|Failure to show up at endpoint visits|0|||
124581861|NCT00933686|448089081|FG001|Overall Study|Failure to show up at endpoint visits|2|||
124581862|NCT00840216|448089085|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
124529525|NCT00355615|447887928|FG003|Randomized Double Blind Period|Adverse Event|0|||
124529526|NCT00355615|447887929|FG004|Randomized Double Blind Period|Adverse Event|0|||
124529527|NCT00355615|447887925|FG000|Randomized Double Blind Period|Protocol Violation|0|||
124529528|NCT00355615|447887926|FG001|Randomized Double Blind Period|Protocol Violation|0|||
124529529|NCT00355615|447887927|FG002|Randomized Double Blind Period|Protocol Violation|1|||
124529530|NCT00355615|447887928|FG003|Randomized Double Blind Period|Protocol Violation|1|||
124529531|NCT00355615|447887929|FG004|Randomized Double Blind Period|Protocol Violation|0|||
124529532|NCT00355615|447887925|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
124529533|NCT00355615|447887926|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
124529534|NCT00355615|447887927|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
124529535|NCT00355615|447887928|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
124529536|NCT00355615|447887929|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
124581863|NCT00840216|448089086|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
124581864|NCT05041361|448089087|FG000|Overall Study|Lost to Follow-up|1|||
124581865|NCT05041361|448089088|FG001|Overall Study|Lost to Follow-up|3|||
124581866|NCT01642277|448089089|FG000|Overall Study|Adverse Event|10|||
124581867|NCT01642277|448089090|FG001|Overall Study|Adverse Event|0|||
124581868|NCT01642277|448089089|FG000|Overall Study|Physician Decision|2|||
124581869|NCT01642277|448089090|FG001|Overall Study|Physician Decision|0|||
124581870|NCT01642277|448089089|FG000|Overall Study|Protocol Violation|1|||
124581871|NCT01642277|448089090|FG001|Overall Study|Protocol Violation|0|||
124581872|NCT01642277|448089089|FG000|Overall Study|Withdrawal by Subject|11|||
124581873|NCT01642277|448089090|FG001|Overall Study|Withdrawal by Subject|0|||
124529537|NCT00355615|447887925|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
124581874|NCT03605342|448089093|FG000|Overall Study|Withdrawal by Subject|9|||
124581875|NCT03605342|448089094|FG001|Overall Study|Withdrawal by Subject|7|||
124529538|NCT00355615|447887926|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
124581876|NCT03605342|448089093|FG000|Overall Study|Lost to Follow-up|1|||
124581877|NCT03605342|448089094|FG001|Overall Study|Lost to Follow-up|1|||
124581878|NCT00848536|448089095|FG000|Overall Study|Adverse Event|2|||
124581879|NCT00848536|448089096|FG001|Overall Study|Adverse Event|2|||
124581880|NCT00848536|448089095|FG000|Overall Study|Withdrawal by Subject|0|||
124581881|NCT00848536|448089096|FG001|Overall Study|Withdrawal by Subject|1|||
124581882|NCT00848536|448089095|FG000|Overall Study|Protocol Violation|0|||
124581883|NCT00848536|448089096|FG001|Overall Study|Protocol Violation|1|||
124581884|NCT00848536|448089095|FG000|Overall Study|Noncompliance|1|||
124581885|NCT00848536|448089096|FG001|Overall Study|Noncompliance|0|||
124581886|NCT00848536|448089095|FG000|Overall Study|Inadequate Control of IOP|1|||
124581887|NCT00848536|448089096|FG001|Overall Study|Inadequate Control of IOP|1|||
124727989|NCT01461928|448625814|FG002|Maintenance I (24 Months)|Death|0|||
124727990|NCT01461928|448625812|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
124727991|NCT01461928|448625813|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
124727992|NCT01461928|448625814|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
124727993|NCT01461928|448625812|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
124727994|NCT01461928|448625813|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
124727995|NCT01461928|448625814|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
124727996|NCT01461928|448625812|FG000|Maintenance I (24 Months)|Diseases progression|91|||
124727997|NCT01461928|448625813|FG001|Maintenance I (24 Months)|Diseases progression|0|||
124727998|NCT01461928|448625814|FG002|Maintenance I (24 Months)|Diseases progression|0|||
124727999|NCT01461928|448625812|FG000|Maintenance I (24 Months)|Adverse Event|70|||
124728000|NCT01461928|448625813|FG001|Maintenance I (24 Months)|Adverse Event|0|||
124728001|NCT01461928|448625814|FG002|Maintenance I (24 Months)|Adverse Event|0|||
124728002|NCT01461928|448625812|FG000|Maintenance I (24 Months)|Physician Decision|9|||
124728003|NCT01461928|448625813|FG001|Maintenance I (24 Months)|Physician Decision|0|||
124728004|NCT01461928|448625814|FG002|Maintenance I (24 Months)|Physician Decision|0|||
124728005|NCT01461928|448625812|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
124728006|NCT01461928|448625813|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
124529539|NCT00355615|447887927|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
124529540|NCT00355615|447887928|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
124529541|NCT00355615|447887929|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
124529542|NCT00355615|447887925|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
124529543|NCT00355615|447887926|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
124529544|NCT00355615|447887927|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
124529545|NCT00355615|447887928|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
124529546|NCT00355615|447887929|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
124529547|NCT00355615|447887925|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
124529548|NCT00355615|447887926|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
124529549|NCT00355615|447887927|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
124529550|NCT00355615|447887928|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
124529551|NCT00355615|447887929|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
124529552|NCT03685643|447887933|FG000|Overall Study|Lost to Follow-up|14|||
124529553|NCT03685643|447887934|FG001|Overall Study|Lost to Follow-up|22|||
124529554|NCT02159365|447887935|FG000|Overall Study|Disease Progression|23|||
124529555|NCT02159365|447887935|FG000|Overall Study|Other reasons|11|||
124529556|NCT02159365|447887935|FG000|Overall Study|Administrative reason by Sponsor|9|||
124529557|NCT02159365|447887935|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
124529558|NCT02159365|447887935|FG000|Overall Study|Study drug toxicity|7|||
124529559|NCT02159365|447887935|FG000|Overall Study|Maximum clinical benefit|3|||
124529560|NCT02159365|447887935|FG000|Overall Study|Subject request to discontinue treatment|3|||
124529561|NCT02159365|447887935|FG000|Overall Study|Subject withdrew consent|3|||
124529562|NCT02159365|447887935|FG000|Overall Study|Death|1|||
124529563|NCT02159365|447887935|FG000|Overall Study|Lost to Follow-up|1|||
124529564|NCT03523715|447887936|FG000|Overall Study|Lost to Follow-up|11|||
124529565|NCT03523715|447887937|FG001|Overall Study|Lost to Follow-up|14|||
124529566|NCT03523715|447887936|FG000|Overall Study|Did not meet inclusion criteria|1|||
124529567|NCT03523715|447887937|FG001|Overall Study|Did not meet inclusion criteria|0|||
124529568|NCT03523715|447887936|FG000|Overall Study|Internally inconsistent reporting|0|||
124529569|NCT03523715|447887937|FG001|Overall Study|Internally inconsistent reporting|2|||
124529570|NCT04430036|447887938|FG000|Safety Run in Phase|Progression of disease|2|||
124529571|NCT01842334|447887939|FG000|Overall Study|Withdrawal by Subject|3|||
124529572|NCT01842334|447887940|FG001|Overall Study|Withdrawal by Subject|3|||
124529573|NCT01842334|447887939|FG000|Overall Study|Moved away mid-study|0|||
124529574|NCT01842334|447887940|FG001|Overall Study|Moved away mid-study|1|||
124529575|NCT01885104|447887944|FG000|Overall Study|Withdrawal of Consent|1|||
124529576|NCT01885104|447887945|FG001|Overall Study|Withdrawal of Consent|0|||
124529577|NCT01885104|447887944|FG000|Overall Study|Lost to Follow-up|0|||
124529578|NCT01885104|447887945|FG001|Overall Study|Lost to Follow-up|1|||
124529579|NCT01885104|447887944|FG000|Overall Study|Physician Decision|1|||
124529580|NCT01885104|447887945|FG001|Overall Study|Physician Decision|0|||
124529581|NCT04191096|447887947|FG000|Overall Study|Death|102|||
124529582|NCT04191096|447887948|FG001|Overall Study|Death|89|||
124529583|NCT04191096|447887947|FG000|Overall Study|Lost to Follow-up|1|||
124529584|NCT04191096|447887948|FG001|Overall Study|Lost to Follow-up|1|||
124529585|NCT04191096|447887947|FG000|Overall Study|Withdrawal by Subject|5|||
124529586|NCT04191096|447887948|FG001|Overall Study|Withdrawal by Subject|5|||
124529587|NCT04191096|447887947|FG000|Overall Study|Participants Ongoing|518|||
124529588|NCT04191096|447887948|FG001|Overall Study|Participants Ongoing|530|||
124529589|NCT02683668|447887950|FG000|Period 2|Withdrawal by Subject|0|||
124776958|NCT01254422|448811366|FG000|Overall Study|Adverse Event|1|||
124529590|NCT02683668|447887951|FG001|Period 2|Withdrawal by Subject|1|||
124529591|NCT02683668|447887952|FG002|Period 2|Withdrawal by Subject|0|||
124529592|NCT04418427|447889594|FG000|Overall Study|Death|0|||
124529593|NCT04418427|447889595|FG001|Overall Study|Death|1|||
124529594|NCT04418427|447889596|FG002|Overall Study|Death|0|||
124529595|NCT04418427|447889594|FG000|Overall Study|Lost to Follow-up|0|||
124529596|NCT04418427|447889595|FG001|Overall Study|Lost to Follow-up|2|||
124529597|NCT04418427|447889596|FG002|Overall Study|Lost to Follow-up|2|||
124529598|NCT04418427|447889594|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
124529599|NCT04418427|447889595|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
124529600|NCT04418427|447889596|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
124529601|NCT04418427|447889594|FG000|Overall Study|Pre-existing medical condition|0|||
124529602|NCT04418427|447889595|FG001|Overall Study|Pre-existing medical condition|1|||
124529603|NCT04418427|447889596|FG002|Overall Study|Pre-existing medical condition|0|||
124581888|NCT00848536|448089095|FG000|Overall Study|Patient Moved|0|||
124581889|NCT00848536|448089096|FG001|Overall Study|Patient Moved|2|||
124581890|NCT00796328|448089097|FG000|Overall Study|experienced hypotension requiring tx|6|||
124581891|NCT00506831|448089105|FG000|Overall Study|Death|1|||
124581892|NCT00506831|448089105|FG000|Overall Study|Withdrawal by Subject|1|||
124581893|NCT02488239|448089106|FG000|Overall Study|Death|3|||
124581894|NCT02488239|448089106|FG000|Overall Study|Withdrawal by Subject|3|||
124581895|NCT02488239|448089106|FG000|Overall Study|Physician Decision|2|||
124581896|NCT02488239|448089106|FG000|Overall Study|Consent ineligible|1|||
124581897|NCT02488239|448089106|FG000|Overall Study|Did not undergo implant procedure|1|||
124581898|NCT00263588|448089113|FG000|Overall Study|Death|54|||
124581899|NCT00263588|448089114|FG001|Overall Study|Death|90|||
124581900|NCT00263588|448089113|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
124581901|NCT00263588|448089114|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
124581902|NCT00263588|448089113|FG000|Overall Study|Lost to Follow-up|7|||
124581903|NCT00263588|448089114|FG001|Overall Study|Lost to Follow-up|10|||
124581904|NCT00263588|448089113|FG000|Overall Study|Withdrawal by Subject|3|||
124581905|NCT00263588|448089114|FG001|Overall Study|Withdrawal by Subject|4|||
124581906|NCT00263588|448089113|FG000|Overall Study|Protocol Violation|0|||
124581907|NCT00263588|448089114|FG001|Overall Study|Protocol Violation|1|||
124581908|NCT00263588|448089113|FG000|Overall Study|Investigator decision|7|||
124581909|NCT00263588|448089114|FG001|Overall Study|Investigator decision|15|||
124581910|NCT00263588|448089113|FG000|Overall Study|Sponsor terminated study|0|||
124581911|NCT00263588|448089114|FG001|Overall Study|Sponsor terminated study|1|||
124581912|NCT00918684|448089115|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
124581913|NCT00918684|448089115|FG000|Treatment Phase|Lack of Efficacy|6|||
124581914|NCT00918684|448089115|FG000|Treatment Phase|Lost to Follow-up|2|||
124581915|NCT00918684|448089115|FG000|Treatment Phase|Physician Decision|8|||
124581916|NCT00918684|448089115|FG000|Treatment Phase|Protocol Violation|1|||
124581917|NCT00918684|448089115|FG000|Treatment Phase|Withdrawal by Subject|8|||
124728007|NCT01461928|448625814|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
124728008|NCT01461928|448625812|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
124728009|NCT01461928|448625813|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
124728010|NCT01461928|448625814|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
124728011|NCT01461928|448625812|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
124728012|NCT01461928|448625813|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
124728013|NCT01461928|448625814|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
124728014|NCT01461928|448625812|FG000|Maintenance I (24 Months)|Not compliant|1|||
124728015|NCT01461928|448625813|FG001|Maintenance I (24 Months)|Not compliant|0|||
124728016|NCT01461928|448625814|FG002|Maintenance I (24 Months)|Not compliant|0|||
124728017|NCT01461928|448625812|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
124728018|NCT01461928|448625813|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
124728019|NCT01461928|448625814|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
124728020|NCT01461928|448625812|FG000|Maintenance II (15 Months)|Adverse Event|0|||
124728021|NCT01461928|448625813|FG001|Maintenance II (15 Months)|Adverse Event|2|||
124728022|NCT01461928|448625814|FG002|Maintenance II (15 Months)|Adverse Event|0|||
124728023|NCT01461928|448625812|FG000|Maintenance II (15 Months)|Death|0|||
124728024|NCT01461928|448625813|FG001|Maintenance II (15 Months)|Death|10|||
124728025|NCT01461928|448625814|FG002|Maintenance II (15 Months)|Death|8|||
124529604|NCT02554721|447889601|FG000|Overall Study|Adverse Event|1|||
124581918|NCT00909038|448089116|FG000|Overall Study|Protocol Violation|187|||
124529605|NCT02554721|447889602|FG001|Overall Study|Adverse Event|0|||
124529606|NCT02554721|447889603|FG002|Overall Study|Adverse Event|0|||
124529607|NCT02554721|447889604|FG003|Overall Study|Adverse Event|0|||
124581919|NCT00909038|448089116|FG000|Overall Study|Non-evaluable Subjects|230|||
124728026|NCT01461928|448625812|FG000|Maintenance II (15 Months)|Physician Decision|0|||
124728027|NCT01461928|448625813|FG001|Maintenance II (15 Months)|Physician Decision|0|||
124529608|NCT02554721|447889605|FG004|Overall Study|Adverse Event|1|||
124529609|NCT02554721|447889601|FG000|Overall Study|Noncompliance|0|||
124581920|NCT00484679|448089117|FG000|Overall Study|Withdrawal by Subject|3|||
124581921|NCT00835692|448089118|FG000|First Intervention|Withdrawal by Subject|1|||
124581922|NCT00835692|448089119|FG001|First Intervention|Withdrawal by Subject|0|||
124581923|NCT04345653|448089122|FG000|Overall Study|Withdrawal by Subject|2|||
124728028|NCT01461928|448625814|FG002|Maintenance II (15 Months)|Physician Decision|4|||
124728029|NCT01461928|448625812|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
124728030|NCT01461928|448625813|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
124728031|NCT01461928|448625814|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
124728032|NCT01461928|448625812|FG000|Maintenance II (15 Months)|Moved to another town|0|||
124728033|NCT01461928|448625813|FG001|Maintenance II (15 Months)|Moved to another town|1|||
124728034|NCT01461928|448625814|FG002|Maintenance II (15 Months)|Moved to another town|0|||
124728035|NCT01461928|448625812|FG000|Maintenance II (15 Months)|Disease progression|0|||
124728036|NCT01461928|448625813|FG001|Maintenance II (15 Months)|Disease progression|0|||
124776959|NCT01254422|448811367|FG001|Overall Study|Adverse Event|0|||
124776960|NCT01254422|448811366|FG000|Overall Study|Serious adverse event|0|||
124776961|NCT01254422|448811367|FG001|Overall Study|Serious adverse event|1|||
124776962|NCT01254422|448811366|FG000|Overall Study|Lost to Follow-up|1|||
124776963|NCT01254422|448811367|FG001|Overall Study|Lost to Follow-up|0|||
124776964|NCT02207088|448811368|FG000|Overall Study|Adverse Event|2|||
124776965|NCT00643162|448811369|FG000|Overall Study|Withdrawal by Subject|1|||
124776966|NCT00643162|448811370|FG001|Overall Study|Withdrawal by Subject|1|||
124776967|NCT02284243|448811371|FG000|Overall Study|Lack of Efficacy|3|||
124776968|NCT02284243|448811372|FG001|Overall Study|Lack of Efficacy|3|||
124776969|NCT02284243|448811371|FG000|Overall Study|Adverse Event|1|||
124776970|NCT02284243|448811372|FG001|Overall Study|Adverse Event|0|||
124776971|NCT02699749|448811377|FG000|Overall Study|Other|0|||
124776972|NCT02699749|448811378|FG001|Overall Study|Other|0|||
124776973|NCT02699749|448811379|FG002|Overall Study|Other|2|||
124776974|NCT02699749|448811380|FG003|Overall Study|Other|0|||
124776975|NCT02699749|448811381|FG004|Overall Study|Other|0|||
124776976|NCT02699749|448811382|FG005|Overall Study|Other|1|||
124776977|NCT02699749|448811383|FG006|Overall Study|Other|1|||
124776978|NCT02699749|448811384|FG007|Overall Study|Other|0|||
124776979|NCT02699749|448811385|FG008|Overall Study|Other|0|||
124776980|NCT02699749|448811386|FG009|Overall Study|Other|0|||
124776981|NCT02699749|448811387|FG010|Overall Study|Other|1|||
124776982|NCT02699749|448811388|FG011|Overall Study|Other|0|||
124776983|NCT02699749|448811389|FG012|Overall Study|Other|0|||
124776984|NCT02699749|448811390|FG013|Overall Study|Other|0|||
124776985|NCT02699749|448811377|FG000|Overall Study|Progressive Disease|3|||
124776986|NCT02699749|448811378|FG001|Overall Study|Progressive Disease|3|||
124776987|NCT02699749|448811379|FG002|Overall Study|Progressive Disease|14|||
124776988|NCT02699749|448811380|FG003|Overall Study|Progressive Disease|3|||
124776989|NCT02699749|448811381|FG004|Overall Study|Progressive Disease|3|||
124776990|NCT02699749|448811382|FG005|Overall Study|Progressive Disease|7|||
124776991|NCT02699749|448811383|FG006|Overall Study|Progressive Disease|5|||
124776992|NCT02699749|448811384|FG007|Overall Study|Progressive Disease|5|||
124776993|NCT02699749|448811385|FG008|Overall Study|Progressive Disease|6|||
124776994|NCT02699749|448811386|FG009|Overall Study|Progressive Disease|6|||
124776995|NCT02699749|448811387|FG010|Overall Study|Progressive Disease|5|||
124776996|NCT02699749|448811388|FG011|Overall Study|Progressive Disease|4|||
124776997|NCT02699749|448811389|FG012|Overall Study|Progressive Disease|3|||
124776998|NCT02699749|448811390|FG013|Overall Study|Progressive Disease|5|||
124776999|NCT02699749|448811377|FG000|Overall Study|Death|0|||
124777000|NCT02699749|448811378|FG001|Overall Study|Death|0|||
124777001|NCT02699749|448811379|FG002|Overall Study|Death|0|||
124777002|NCT02699749|448811380|FG003|Overall Study|Death|0|||
124777003|NCT02699749|448811381|FG004|Overall Study|Death|0|||
124777004|NCT02699749|448811382|FG005|Overall Study|Death|0|||
124777005|NCT02699749|448811383|FG006|Overall Study|Death|0|||
124777006|NCT02699749|448811384|FG007|Overall Study|Death|0|||
124777007|NCT02699749|448811385|FG008|Overall Study|Death|0|||
124777008|NCT02699749|448811386|FG009|Overall Study|Death|0|||
124777009|NCT02699749|448811387|FG010|Overall Study|Death|0|||
124777010|NCT02699749|448811388|FG011|Overall Study|Death|0|||
124777011|NCT02699749|448811389|FG012|Overall Study|Death|0|||
124777012|NCT02699749|448811390|FG013|Overall Study|Death|1|||
124777013|NCT02699749|448811377|FG000|Overall Study|Lost to Follow-up|0|||
124777014|NCT02699749|448811378|FG001|Overall Study|Lost to Follow-up|0|||
124777015|NCT02699749|448811379|FG002|Overall Study|Lost to Follow-up|0|||
124728037|NCT01461928|448625814|FG002|Maintenance II (15 Months)|Disease progression|3|||
124777016|NCT02699749|448811380|FG003|Overall Study|Lost to Follow-up|0|||
124728038|NCT01461928|448625812|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
124777017|NCT02699749|448811381|FG004|Overall Study|Lost to Follow-up|0|||
124777018|NCT02699749|448811382|FG005|Overall Study|Lost to Follow-up|1|||
124777019|NCT02699749|448811383|FG006|Overall Study|Lost to Follow-up|0|||
124777020|NCT02699749|448811384|FG007|Overall Study|Lost to Follow-up|1|||
124529610|NCT02554721|447889602|FG001|Overall Study|Noncompliance|0|||
124529611|NCT02554721|447889603|FG002|Overall Study|Noncompliance|0|||
124777021|NCT02699749|448811385|FG008|Overall Study|Lost to Follow-up|0|||
124777022|NCT02699749|448811386|FG009|Overall Study|Lost to Follow-up|0|||
124777023|NCT02699749|448811387|FG010|Overall Study|Lost to Follow-up|0|||
124777024|NCT02699749|448811388|FG011|Overall Study|Lost to Follow-up|0|||
124777025|NCT02699749|448811389|FG012|Overall Study|Lost to Follow-up|0|||
124777026|NCT02699749|448811390|FG013|Overall Study|Lost to Follow-up|0|||
124728039|NCT01461928|448625813|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
124728040|NCT01461928|448625814|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
124728041|NCT01461928|448625812|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
124728042|NCT01461928|448625813|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
124728043|NCT01461928|448625814|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
124728044|NCT01461928|448625812|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
124728045|NCT01461928|448625813|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
124728046|NCT01461928|448625814|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
124728047|NCT01461928|448625812|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
124728048|NCT01461928|448625813|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
124728049|NCT01461928|448625814|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
124728050|NCT01461928|448625812|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
124728051|NCT01461928|448625813|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
124529612|NCT02554721|447889604|FG003|Overall Study|Noncompliance|0|||
124529613|NCT02554721|447889605|FG004|Overall Study|Noncompliance|1|||
124529614|NCT01888965|447889607|FG000|Overall Study|Adverse Event|5|||
124529615|NCT01888965|447889607|FG000|Overall Study|Lack of Efficacy|4|||
124529616|NCT00908895|447889608|FG000|Overall Study|Lost to Follow-up|1|||
124529617|NCT00908895|447889609|FG001|Overall Study|Lost to Follow-up|3|||
124529618|NCT00908895|447889608|FG000|Overall Study|algodystrophy|2|||
124529619|NCT00908895|447889609|FG001|Overall Study|algodystrophy|2|||
124529620|NCT00908895|447889608|FG000|Overall Study|Adverse Event|1|||
124529621|NCT00908895|447889609|FG001|Overall Study|Adverse Event|1|||
124529622|NCT04124952|447889611|FG000|Overall Study|Lost to Follow-up|1|||
124529623|NCT01654224|447889612|FG000|Overall Study|Lost to Follow-up|2|||
124529624|NCT01654224|447889613|FG001|Overall Study|Lost to Follow-up|2|||
124529625|NCT01654224|447889612|FG000|Overall Study|Did not receive allocation|1|||
124529626|NCT01654224|447889613|FG001|Overall Study|Did not receive allocation|8|||
124529627|NCT01654224|447889612|FG000|Overall Study|Insufficient blood sample|3|||
124529628|NCT01654224|447889613|FG001|Overall Study|Insufficient blood sample|2|||
124529629|NCT02094612|447889614|FG000|Overall Study|Lost to Follow-up|47|||
124529630|NCT02094612|447889615|FG001|Overall Study|Lost to Follow-up|47|||
124529631|NCT02094612|447889614|FG000|Overall Study|Never started ADHD medication|32|||
124529632|NCT02094612|447889615|FG001|Overall Study|Never started ADHD medication|23|||
124529633|NCT03345849|447889616|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
124529634|NCT03345849|447889617|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
124529635|NCT03345849|447889618|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
124529636|NCT03345849|447889619|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
124529637|NCT03345849|447889616|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
124529638|NCT03345849|447889617|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
124529639|NCT03345849|447889618|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
124529640|NCT03345849|447889619|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
124529641|NCT03345849|447889616|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
124529642|NCT03345849|447889617|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
124529643|NCT03345849|447889618|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
124529644|NCT03345849|447889619|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
124529645|NCT03345849|447889616|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
124529646|NCT03345849|447889617|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
124529647|NCT03345849|447889618|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
124529648|NCT03345849|447889619|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
124529649|NCT03345849|447889616|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
124529650|NCT03345849|447889617|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
124529651|NCT03345849|447889618|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
124529652|NCT03345849|447889619|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
124529653|NCT03345849|447889616|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
124529654|NCT03345849|447889617|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
124529655|NCT03345849|447889618|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
124529656|NCT03345849|447889619|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
124529657|NCT03345849|447889616|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
124529658|NCT03345849|447889617|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
124529659|NCT03345849|447889618|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
124529660|NCT03345849|447889619|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
124529661|NCT03345849|447889616|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
124529662|NCT03345849|447889617|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
124529663|NCT03345849|447889618|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
124529664|NCT03345849|447889619|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
124529665|NCT03345849|447889616|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
124529666|NCT03345849|447889617|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
124581924|NCT03808376|448089123|FG000|Overall Study|Withdrawal by Subject|10|||
124581925|NCT03644550|448089124|FG000|Overall Study|Withdrawal by Subject|3|||
124581926|NCT03644550|448089124|FG000|Overall Study|Progressive disease|15|||
124581927|NCT00700739|448089125|FG000|Overall Study|Lost to Follow-up|4|||
124581928|NCT00700739|448089126|FG001|Overall Study|Lost to Follow-up|4|||
124581929|NCT03488108|448089135|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
124581930|NCT03488108|448089136|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
124581931|NCT03488108|448089135|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
124581932|NCT03488108|448089136|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
124581933|NCT03602339|448089140|FG000|Overall Study|Withdrawal by Subject|9|||
124581934|NCT03602339|448089140|FG000|Overall Study|Physician Decision|2|||
124581935|NCT03602339|448089140|FG000|Overall Study|Other reason|4|||
124581936|NCT01297504|448089141|FG000|Overall Study|Invalid Consent|1|||
124581937|NCT01297504|448089141|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
124581938|NCT01297504|448089141|FG000|Overall Study|No Study Visits|4|||
124581939|NCT01297504|448089141|FG000|Overall Study|Death|3|||
124581940|NCT01297504|448089141|FG000|Overall Study|Lost to Follow-up|43|||
124581941|NCT01297504|448089141|FG000|Overall Study|Withdrawal by Subject|9|||
124728052|NCT01461928|448625814|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
124529667|NCT03345849|447889618|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
124529668|NCT03345849|447889619|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
124529669|NCT03345849|447889616|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
124529670|NCT03345849|447889617|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
124529671|NCT03345849|447889618|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
124529672|NCT03345849|447889619|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
124529673|NCT03345849|447889616|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
124529674|NCT03345849|447889617|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
124529675|NCT03345849|447889618|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
124529676|NCT03345849|447889619|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
124529677|NCT03261037|447889620|FG000|Overall Study|Withdrawal by Subject|2|||
124529678|NCT03261037|447889621|FG001|Overall Study|Withdrawal by Subject|13|||
124529679|NCT03261037|447889622|FG002|Overall Study|Withdrawal by Subject|0|||
124529680|NCT03261037|447889623|FG003|Overall Study|Withdrawal by Subject|18|||
124529681|NCT03261037|447889620|FG000|Overall Study|Non-compliance with study procedures|0|||
124529682|NCT03261037|447889621|FG001|Overall Study|Non-compliance with study procedures|2|||
124529683|NCT03261037|447889622|FG002|Overall Study|Non-compliance with study procedures|0|||
124529684|NCT03261037|447889623|FG003|Overall Study|Non-compliance with study procedures|6|||
124529685|NCT03261037|447889620|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
124529686|NCT03261037|447889621|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
124529687|NCT03261037|447889622|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
124529688|NCT03261037|447889623|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
124529689|NCT03261037|447889620|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
124529690|NCT03261037|447889621|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
124529691|NCT03261037|447889622|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
124529692|NCT03261037|447889623|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
124529693|NCT03261037|447889620|FG000|Overall Study|Diagnosed but protocol deviation|1|||
124529694|NCT03261037|447889621|FG001|Overall Study|Diagnosed but protocol deviation|0|||
124529695|NCT03261037|447889622|FG002|Overall Study|Diagnosed but protocol deviation|0|||
124529696|NCT03261037|447889623|FG003|Overall Study|Diagnosed but protocol deviation|0|||
124529697|NCT03261037|447889620|FG000|Overall Study|Participant did not want to continue the study|0|||
124529698|NCT03261037|447889621|FG001|Overall Study|Participant did not want to continue the study|1|||
124529699|NCT03261037|447889622|FG002|Overall Study|Participant did not want to continue the study|0|||
124529700|NCT03261037|447889623|FG003|Overall Study|Participant did not want to continue the study|0|||
124529701|NCT03261037|447889620|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
124529702|NCT03261037|447889621|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
124529703|NCT03261037|447889622|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
124529704|NCT03261037|447889623|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
124529705|NCT03261037|447889620|FG000|Overall Study|Participant presented clinical improvement|0|||
124529706|NCT03261037|447889621|FG001|Overall Study|Participant presented clinical improvement|2|||
124529707|NCT03261037|447889622|FG002|Overall Study|Participant presented clinical improvement|0|||
124529708|NCT03261037|447889623|FG003|Overall Study|Participant presented clinical improvement|0|||
124581942|NCT01297504|448089141|FG000|Overall Study|Site Closure|3|||
124581943|NCT01297504|448089141|FG000|Overall Study|Protocol Violation|3|||
124581944|NCT01348789|448089142|FG000|Overall Study|Protocol Violation|2|||
124581945|NCT01348789|448089142|FG000|Overall Study|Withdrawal by Subject|2|||
124581946|NCT03503318|448089145|FG000|Overall Study|Death|1|||
124581947|NCT03503318|448089146|FG001|Overall Study|Death|0|||
124581948|NCT03503318|448089147|FG002|Overall Study|Death|4|||
124581949|NCT03503318|448089145|FG000|Overall Study|Adverse Event|3|||
124581950|NCT03503318|448089146|FG001|Overall Study|Adverse Event|4|||
124581951|NCT03503318|448089147|FG002|Overall Study|Adverse Event|2|||
124581952|NCT03503318|448089145|FG000|Overall Study|Withdrawal by Subject|12|||
124581953|NCT03503318|448089146|FG001|Overall Study|Withdrawal by Subject|17|||
124581954|NCT03503318|448089147|FG002|Overall Study|Withdrawal by Subject|16|||
124581955|NCT03503318|448089145|FG000|Overall Study|Protocol Violation|5|||
124581956|NCT03503318|448089146|FG001|Overall Study|Protocol Violation|0|||
124581957|NCT03503318|448089147|FG002|Overall Study|Protocol Violation|3|||
124581958|NCT03503318|448089145|FG000|Overall Study|Lost to Follow-up|17|||
124581959|NCT03503318|448089146|FG001|Overall Study|Lost to Follow-up|15|||
124581960|NCT03503318|448089147|FG002|Overall Study|Lost to Follow-up|12|||
124581961|NCT03503318|448089145|FG000|Overall Study|Other than specified|1|||
124581962|NCT03503318|448089146|FG001|Overall Study|Other than specified|3|||
124581963|NCT03503318|448089147|FG002|Overall Study|Other than specified|3|||
124581964|NCT00834873|448089154|FG000|First Intervention|Adverse Event|0|||
124581965|NCT00834873|448089155|FG001|First Intervention|Adverse Event|1|||
124581966|NCT04827394|448089157|FG000|Overall Study|Physician Decision|0|||
124581967|NCT04827394|448089158|FG001|Overall Study|Physician Decision|2|||
124581968|NCT04594252|448089159|FG000|Overall Study|Adverse Event|0|||
124581969|NCT04594252|448089160|FG001|Overall Study|Adverse Event|2|||
124581970|NCT00477594|448089165|FG000|Year 1 and Year 2|Adverse Event|4|||
124581971|NCT00477594|448089166|FG001|Year 1 and Year 2|Adverse Event|2|||
124581972|NCT00477594|448089165|FG000|Year 1 and Year 2|Physician Decision|2|||
124581973|NCT00477594|448089166|FG001|Year 1 and Year 2|Physician Decision|1|||
124581974|NCT00477594|448089165|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
124581975|NCT00477594|448089166|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
124581976|NCT00477594|448089165|FG000|Year 1 and Year 2|Other|1|||
124581977|NCT00477594|448089166|FG001|Year 1 and Year 2|Other|0|||
124581978|NCT00477594|448089165|FG000|Year 3|Adverse Event|1|||
124581979|NCT00477594|448089166|FG001|Year 3|Adverse Event|0|||
124581980|NCT00477594|448089165|FG000|Year 3|Withdrawal by Subject|1|||
124581981|NCT00477594|448089166|FG001|Year 3|Withdrawal by Subject|0|||
124581982|NCT00477594|448089165|FG000|Follow-up Period|Withdrawal by Subject|2|||
124581983|NCT00477594|448089166|FG001|Follow-up Period|Withdrawal by Subject|1|||
124581984|NCT00477594|448089165|FG000|Follow-up Period|Other|1|||
124581985|NCT00477594|448089166|FG001|Follow-up Period|Other|0|||
124581986|NCT03114891|448089167|FG000|First Treatment Round|Lost to Follow-up|0|||
124581987|NCT03114891|448089168|FG001|First Treatment Round|Lost to Follow-up|1|||
124581988|NCT03114891|448089169|FG002|First Treatment Round|Lost to Follow-up|1|||
124581989|NCT03114891|448089170|FG003|First Treatment Round|Lost to Follow-up|0|||
124581990|NCT03114891|448089167|FG000|First Treatment Round|Withdrawal by Subject|0|||
124581991|NCT03114891|448089168|FG001|First Treatment Round|Withdrawal by Subject|2|||
124581992|NCT03114891|448089169|FG002|First Treatment Round|Withdrawal by Subject|0|||
124581993|NCT03114891|448089170|FG003|First Treatment Round|Withdrawal by Subject|1|||
124581994|NCT03114891|448089167|FG000|3 Week Break|Lost to Follow-up|1|||
124581995|NCT03114891|448089168|FG001|3 Week Break|Lost to Follow-up|0|||
124581996|NCT03114891|448089169|FG002|3 Week Break|Lost to Follow-up|0|||
124581997|NCT03114891|448089170|FG003|3 Week Break|Lost to Follow-up|1|||
124581998|NCT03114891|448089167|FG000|3 Week Break|Withdrawal by Subject|0|||
124581999|NCT03114891|448089168|FG001|3 Week Break|Withdrawal by Subject|1|||
124582000|NCT03114891|448089169|FG002|3 Week Break|Withdrawal by Subject|0|||
124582001|NCT03114891|448089170|FG003|3 Week Break|Withdrawal by Subject|0|||
124582002|NCT03114891|448089167|FG000|Second Treatment Round|Lost to Follow-up|1|||
124582003|NCT03114891|448089168|FG001|Second Treatment Round|Lost to Follow-up|0|||
124582004|NCT03114891|448089169|FG002|Second Treatment Round|Lost to Follow-up|0|||
124582005|NCT03114891|448089170|FG003|Second Treatment Round|Lost to Follow-up|0|||
124582006|NCT03114891|448089167|FG000|Second Treatment Round|Physician Decision|1|||
124582007|NCT03114891|448089168|FG001|Second Treatment Round|Physician Decision|0|||
124582008|NCT03114891|448089169|FG002|Second Treatment Round|Physician Decision|0|||
124582009|NCT03114891|448089170|FG003|Second Treatment Round|Physician Decision|0|||
124582010|NCT02068794|448090995|FG000|Overall Study|Withdrawal by Subject|0|||
124582011|NCT02068794|448090996|FG001|Overall Study|Withdrawal by Subject|1|||
124582012|NCT02068794|448090997|FG002|Overall Study|Withdrawal by Subject|2|||
124582013|NCT02068794|448090995|FG000|Overall Study|Early Progression|1|||
124582014|NCT02068794|448090996|FG001|Overall Study|Early Progression|0|||
124582015|NCT02068794|448090997|FG002|Overall Study|Early Progression|1|||
124582016|NCT02068794|448090995|FG000|Overall Study|Ineligible|0|||
124582017|NCT02068794|448090996|FG001|Overall Study|Ineligible|0|||
124582018|NCT02068794|448090997|FG002|Overall Study|Ineligible|1|||
124582019|NCT02635750|448090998|FG000|Part 1, Period 2|Adverse Event|1|||
124582020|NCT02635750|448090999|FG001|Part 1, Period 2|Adverse Event|0|||
124582021|NCT02635750|448091000|FG002|Part 1, Period 2|Adverse Event|0|||
124582022|NCT02875392|448091002|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
124582023|NCT02875392|448091003|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
124529709|NCT03261037|447889620|FG000|Overall Study|Technical difficulties|0|||
124529710|NCT03261037|447889621|FG001|Overall Study|Technical difficulties|0|||
124529711|NCT03261037|447889622|FG002|Overall Study|Technical difficulties|0|||
124529712|NCT03261037|447889623|FG003|Overall Study|Technical difficulties|1|||
124529713|NCT03261037|447889620|FG000|Overall Study|Equipment failed to work|0|||
124529714|NCT03261037|447889621|FG001|Overall Study|Equipment failed to work|0|||
124529715|NCT03261037|447889622|FG002|Overall Study|Equipment failed to work|0|||
124529716|NCT03261037|447889623|FG003|Overall Study|Equipment failed to work|1|||
124529717|NCT03261037|447889620|FG000|Overall Study|End of study for participant and no follow up|0|||
124529718|NCT03261037|447889621|FG001|Overall Study|End of study for participant and no follow up|0|||
124529719|NCT03261037|447889622|FG002|Overall Study|End of study for participant and no follow up|0|||
124529720|NCT03261037|447889623|FG003|Overall Study|End of study for participant and no follow up|1|||
124529721|NCT03261037|447889620|FG000|Overall Study|Participant was too weak to continue in study|1|||
124529722|NCT03261037|447889621|FG001|Overall Study|Participant was too weak to continue in study|0|||
124529723|NCT03261037|447889622|FG002|Overall Study|Participant was too weak to continue in study|0|||
124529724|NCT03261037|447889623|FG003|Overall Study|Participant was too weak to continue in study|0|||
124529725|NCT02943577|447889624|FG000|Overall Study|Protocol Violation|0|||
124529726|NCT02943577|447889625|FG001|Overall Study|Protocol Violation|1|||
124529727|NCT02943577|447889624|FG000|Overall Study|Adverse Event|3|||
124529728|NCT02943577|447889625|FG001|Overall Study|Adverse Event|2|||
124529729|NCT02943577|447889624|FG000|Overall Study|Lost to Follow-up|0|||
124529730|NCT02943577|447889625|FG001|Overall Study|Lost to Follow-up|1|||
124529731|NCT02943577|447889624|FG000|Overall Study|Withdrawal by Subject|1|||
124529732|NCT02943577|447889625|FG001|Overall Study|Withdrawal by Subject|1|||
124529733|NCT02943577|447889624|FG000|Overall Study|Pregnancy|1|||
124529734|NCT02943577|447889625|FG001|Overall Study|Pregnancy|0|||
124529735|NCT04654468|447889632|FG000|Overall Study|Death|1|||
124529736|NCT04654468|447889632|FG000|Overall Study|Ongoing in the Study|50|||
124529737|NCT03093350|447889637|FG000|Overall Study|Death|1|||
124529738|NCT03093350|447889637|FG000|Overall Study|Signed consent, never began treartment|1|||
124529739|NCT04564027|447889639|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
124529740|NCT04564027|447889640|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
124529741|NCT04564027|447889641|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
124529742|NCT04564027|447889642|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
124529743|NCT05564039|447889645|FG000|Overall Study|Adverse Event|1|||
124529744|NCT05564039|447889646|FG001|Overall Study|Adverse Event|0|||
124529745|NCT05564039|447889645|FG000|Overall Study|Death|1|||
124529746|NCT05564039|447889646|FG001|Overall Study|Death|1|||
124529747|NCT05564039|447889645|FG000|Overall Study|Lost to Follow-up|3|||
124529748|NCT05564039|447889646|FG001|Overall Study|Lost to Follow-up|2|||
124529749|NCT05564039|447889645|FG000|Overall Study|Withdrawal by Subject|2|||
124529750|NCT05564039|447889646|FG001|Overall Study|Withdrawal by Subject|0|||
124529751|NCT05564039|447889645|FG000|Overall Study|Inadvertent enrollment|3|||
124529752|NCT05564039|447889646|FG001|Overall Study|Inadvertent enrollment|6|||
124529753|NCT04651777|447889647|FG000|Overall Study|Adverse Event|1|||
124529754|NCT04651777|447889647|FG000|Overall Study|Withdrawal by Subject|2|||
124529755|NCT04566445|447889648|FG000|Overall Study|Death|4|||
124529756|NCT04566445|447889649|FG001|Overall Study|Death|1|||
124529757|NCT04566445|447889650|FG002|Overall Study|Death|1|||
124529758|NCT04566445|447889648|FG000|Overall Study|Lost to Follow-up|3|||
124529759|NCT04566445|447889649|FG001|Overall Study|Lost to Follow-up|1|||
124529760|NCT04566445|447889650|FG002|Overall Study|Lost to Follow-up|1|||
124529761|NCT04566445|447889648|FG000|Overall Study|Study terminated by sponsor|11|||
124529762|NCT04566445|447889649|FG001|Overall Study|Study terminated by sponsor|17|||
124529763|NCT04566445|447889650|FG002|Overall Study|Study terminated by sponsor|32|||
124529764|NCT04566445|447889648|FG000|Overall Study|Withdrawal by Subject|12|||
124529765|NCT04566445|447889649|FG001|Overall Study|Withdrawal by Subject|14|||
124529766|NCT04566445|447889650|FG002|Overall Study|Withdrawal by Subject|13|||
124529767|NCT04566445|447889648|FG000|Overall Study|Randomized but not treated due to AE|2|||
124529768|NCT04566445|447889649|FG001|Overall Study|Randomized but not treated due to AE|1|||
124529769|NCT04566445|447889650|FG002|Overall Study|Randomized but not treated due to AE|0|||
124529770|NCT04566445|447889648|FG000|Overall Study|Adverse Event|1|||
124529771|NCT04566445|447889649|FG001|Overall Study|Adverse Event|1|||
124529772|NCT04566445|447889650|FG002|Overall Study|Adverse Event|0|||
124529773|NCT04785144|447889651|FG000|Overall Study|Withdrawal by Subject|4|||
124529774|NCT04785144|447889652|FG001|Overall Study|Withdrawal by Subject|1|||
124529775|NCT04785144|447889653|FG002|Overall Study|Withdrawal by Subject|0|||
124529776|NCT04785144|447889654|FG003|Overall Study|Withdrawal by Subject|0|||
124529777|NCT04785144|447889655|FG004|Overall Study|Withdrawal by Subject|0|||
124529778|NCT04785144|447889656|FG005|Overall Study|Withdrawal by Subject|2|||
124529779|NCT04785144|447889657|FG006|Overall Study|Withdrawal by Subject|2|||
124529780|NCT04785144|447889658|FG007|Overall Study|Withdrawal by Subject|0|||
124529781|NCT04785144|447889659|FG008|Overall Study|Withdrawal by Subject|1|||
124529782|NCT04785144|447889660|FG009|Overall Study|Withdrawal by Subject|0|||
124529783|NCT04785144|447889651|FG000|Overall Study|Lost to Follow-up|1|||
124728053|NCT01159171|448625815|FG000|Overall Study|Adverse Event|11|||
124582024|NCT03599193|448091004|FG000|Overall Study|Adverse Event|0|||
124582025|NCT03599193|448091005|FG001|Overall Study|Adverse Event|2|||
124582026|NCT03599193|448091004|FG000|Overall Study|Withdrawal by Subject|1|||
124582027|NCT03599193|448091005|FG001|Overall Study|Withdrawal by Subject|0|||
124582028|NCT03599193|448091004|FG000|Overall Study|Protocol Violation|1|||
124582029|NCT03599193|448091005|FG001|Overall Study|Protocol Violation|0|||
124728054|NCT01159171|448625815|FG000|Overall Study|Progression of Disease|28|||
124728055|NCT01159171|448625815|FG000|Overall Study|Protocol Violation|1|||
124728056|NCT01159171|448625815|FG000|Overall Study|Need for Surgery|5|||
124728057|NCT01159171|448625815|FG000|Overall Study|Medical Decision|4|||
124529784|NCT04785144|447889652|FG001|Overall Study|Lost to Follow-up|0|||
124529785|NCT04785144|447889653|FG002|Overall Study|Lost to Follow-up|0|||
124529786|NCT04785144|447889654|FG003|Overall Study|Lost to Follow-up|0|||
124529787|NCT04785144|447889655|FG004|Overall Study|Lost to Follow-up|1|||
124529788|NCT04785144|447889656|FG005|Overall Study|Lost to Follow-up|2|||
124529789|NCT04785144|447889657|FG006|Overall Study|Lost to Follow-up|1|||
124529790|NCT04785144|447889658|FG007|Overall Study|Lost to Follow-up|2|||
124529791|NCT04785144|447889659|FG008|Overall Study|Lost to Follow-up|4|||
124529792|NCT04785144|447889660|FG009|Overall Study|Lost to Follow-up|1|||
124529793|NCT04785144|447889651|FG000|Overall Study|Protocol Violation|0|||
124529794|NCT04785144|447889652|FG001|Overall Study|Protocol Violation|0|||
124529795|NCT04785144|447889653|FG002|Overall Study|Protocol Violation|0|||
124529796|NCT04785144|447889654|FG003|Overall Study|Protocol Violation|0|||
124529797|NCT04785144|447889655|FG004|Overall Study|Protocol Violation|0|||
124529798|NCT04785144|447889656|FG005|Overall Study|Protocol Violation|0|||
124529799|NCT04785144|447889657|FG006|Overall Study|Protocol Violation|1|||
124529800|NCT04785144|447889658|FG007|Overall Study|Protocol Violation|0|||
124529801|NCT04785144|447889659|FG008|Overall Study|Protocol Violation|0|||
124529802|NCT04785144|447889660|FG009|Overall Study|Protocol Violation|0|||
124529803|NCT04785144|447889651|FG000|Overall Study|Physician Decision|0|||
124529804|NCT04785144|447889652|FG001|Overall Study|Physician Decision|0|||
124529805|NCT04785144|447889653|FG002|Overall Study|Physician Decision|0|||
124529806|NCT04785144|447889654|FG003|Overall Study|Physician Decision|0|||
124529807|NCT04785144|447889655|FG004|Overall Study|Physician Decision|0|||
124529808|NCT04785144|447889656|FG005|Overall Study|Physician Decision|0|||
124529809|NCT04785144|447889657|FG006|Overall Study|Physician Decision|0|||
124529810|NCT04785144|447889658|FG007|Overall Study|Physician Decision|0|||
124529811|NCT04785144|447889659|FG008|Overall Study|Physician Decision|0|||
124529812|NCT04785144|447889660|FG009|Overall Study|Physician Decision|1|||
124529813|NCT04785144|447889651|FG000|Overall Study|Unable to continue due to work schedule|0|||
124529814|NCT04785144|447889652|FG001|Overall Study|Unable to continue due to work schedule|0|||
124529815|NCT04785144|447889653|FG002|Overall Study|Unable to continue due to work schedule|0|||
124529816|NCT04785144|447889654|FG003|Overall Study|Unable to continue due to work schedule|0|||
124529817|NCT04785144|447889655|FG004|Overall Study|Unable to continue due to work schedule|0|||
124529818|NCT04785144|447889656|FG005|Overall Study|Unable to continue due to work schedule|0|||
124529819|NCT04785144|447889657|FG006|Overall Study|Unable to continue due to work schedule|0|||
124529820|NCT04785144|447889658|FG007|Overall Study|Unable to continue due to work schedule|0|||
124529821|NCT04785144|447889659|FG008|Overall Study|Unable to continue due to work schedule|0|||
124529822|NCT04785144|447889660|FG009|Overall Study|Unable to continue due to work schedule|1|||
124529823|NCT03598140|447889661|FG000|Overall Study|enrolled but didn't start|1|||
124529824|NCT03598140|447889662|FG001|Overall Study|enrolled but didn't start|0|||
124529825|NCT02559115|447889663|FG000|Overall Study|Withdrawal by Subject|3|||
124529826|NCT05245071|447889666|FG000|Overall Study|Progressive disease|18|||
124529827|NCT05245071|447889666|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
124529828|NCT05245071|447889666|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
124529829|NCT05304611|447889667|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
124529830|NCT05304611|447889668|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
124529831|NCT05304611|447889669|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
124529832|NCT05304611|447889670|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
124529833|NCT05304611|447889671|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
124529834|NCT05304611|447889672|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
124529835|NCT05304611|447889673|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
124529836|NCT05304611|447889674|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
124529837|NCT05304611|447889675|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
124529838|NCT05304611|447889676|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
124529839|NCT05304611|447889677|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
124529840|NCT05304611|447889678|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
124529841|NCT05304611|447889667|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
124529842|NCT05304611|447889668|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
124529843|NCT05304611|447889669|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
124529844|NCT05304611|447889670|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
124529845|NCT05304611|447889671|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
124529846|NCT05304611|447889672|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
124529847|NCT05304611|447889673|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
124582030|NCT03599193|448091004|FG000|Overall Study|Lost to Follow-up|0|||
124582031|NCT03599193|448091005|FG001|Overall Study|Lost to Follow-up|1|||
124582032|NCT00835705|448091006|FG000|First Intervention|Difficulty with vein|1|||
124582033|NCT00835705|448091007|FG001|First Intervention|Difficulty with vein|0|||
124582034|NCT00835705|448091006|FG000|Second Intervention|Difficulty with vein|1|||
124582035|NCT00835705|448091007|FG001|Second Intervention|Difficulty with vein|0|||
124582036|NCT01592240|448091008|FG000|Overall Study|Adverse Event|1|||
124582037|NCT01592240|448091009|FG001|Overall Study|Adverse Event|0|||
124582038|NCT01592240|448091010|FG002|Overall Study|Adverse Event|0|||
124582039|NCT01592240|448091011|FG003|Overall Study|Adverse Event|1|||
124582040|NCT01592240|448091012|FG004|Overall Study|Adverse Event|1|||
124582041|NCT01592240|448091013|FG005|Overall Study|Adverse Event|0|||
124582042|NCT01592240|448091014|FG006|Overall Study|Adverse Event|0|||
124582043|NCT01592240|448091008|FG000|Overall Study|Death|0|||
124582044|NCT01592240|448091009|FG001|Overall Study|Death|1|||
124582045|NCT01592240|448091010|FG002|Overall Study|Death|0|||
124582046|NCT01592240|448091011|FG003|Overall Study|Death|0|||
124582047|NCT01592240|448091012|FG004|Overall Study|Death|0|||
124582048|NCT01592240|448091013|FG005|Overall Study|Death|0|||
124582049|NCT01592240|448091014|FG006|Overall Study|Death|0|||
124582050|NCT01592240|448091008|FG000|Overall Study|Lost to Follow-up|1|||
124582051|NCT01592240|448091009|FG001|Overall Study|Lost to Follow-up|3|||
124582052|NCT01592240|448091010|FG002|Overall Study|Lost to Follow-up|1|||
124582053|NCT01592240|448091011|FG003|Overall Study|Lost to Follow-up|0|||
124582054|NCT01592240|448091012|FG004|Overall Study|Lost to Follow-up|3|||
124582055|NCT01592240|448091013|FG005|Overall Study|Lost to Follow-up|2|||
124582056|NCT01592240|448091014|FG006|Overall Study|Lost to Follow-up|0|||
124582057|NCT01592240|448091008|FG000|Overall Study|Protocol Violation|0|||
124582058|NCT01592240|448091009|FG001|Overall Study|Protocol Violation|0|||
124582059|NCT01592240|448091010|FG002|Overall Study|Protocol Violation|0|||
124582060|NCT01592240|448091011|FG003|Overall Study|Protocol Violation|0|||
124582061|NCT01592240|448091012|FG004|Overall Study|Protocol Violation|0|||
124582062|NCT01592240|448091013|FG005|Overall Study|Protocol Violation|1|||
124582063|NCT01592240|448091014|FG006|Overall Study|Protocol Violation|0|||
124582064|NCT01592240|448091008|FG000|Overall Study|Withdrawal by Subject|0|||
124582065|NCT01592240|448091009|FG001|Overall Study|Withdrawal by Subject|4|||
124582066|NCT01592240|448091010|FG002|Overall Study|Withdrawal by Subject|4|||
124582067|NCT01592240|448091011|FG003|Overall Study|Withdrawal by Subject|1|||
124582068|NCT01592240|448091012|FG004|Overall Study|Withdrawal by Subject|3|||
124582069|NCT01592240|448091013|FG005|Overall Study|Withdrawal by Subject|0|||
124582070|NCT01592240|448091014|FG006|Overall Study|Withdrawal by Subject|2|||
124582071|NCT01592240|448091008|FG000|Overall Study|Other|0|||
124582072|NCT01592240|448091009|FG001|Overall Study|Other|3|||
124582073|NCT01592240|448091010|FG002|Overall Study|Other|1|||
124582074|NCT01592240|448091011|FG003|Overall Study|Other|1|||
124582075|NCT01592240|448091012|FG004|Overall Study|Other|0|||
124582076|NCT01592240|448091013|FG005|Overall Study|Other|0|||
124582077|NCT01592240|448091014|FG006|Overall Study|Other|1|||
124582078|NCT01592240|448091008|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
124582079|NCT01592240|448091009|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
124582080|NCT01592240|448091010|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
124582081|NCT01592240|448091011|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
124582082|NCT01592240|448091012|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
124582083|NCT01592240|448091013|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
124582084|NCT01592240|448091014|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
124582085|NCT03246503|448091018|FG000|Overall Study|Lost to Follow-up|23|||
124582086|NCT03246503|448091018|FG000|Overall Study|Withdrawal by Subject|20|||
124582087|NCT03246503|448091018|FG000|Overall Study|Physician Decision|5|||
124582088|NCT03246503|448091018|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
124582089|NCT02751424|448091019|FG000|Part 2|Adverse Event|0|||
124582090|NCT02751424|448091020|FG001|Part 2|Adverse Event|0|||
124582091|NCT02751424|448091021|FG002|Part 2|Adverse Event|0|||
124582092|NCT02751424|448091022|FG003|Part 2|Adverse Event|0|||
124582093|NCT02751424|448091023|FG004|Part 2|Adverse Event|0|||
124582094|NCT02751424|448091024|FG005|Part 2|Adverse Event|0|||
124582095|NCT02751424|448091025|FG006|Part 2|Adverse Event|0|||
124582096|NCT02751424|448091026|FG007|Part 2|Adverse Event|5|||
124582097|NCT02751424|448091027|FG008|Part 2|Adverse Event|0|||
124582098|NCT03206749|448091028|FG000|Overall Study|Withdrawal of consent|5|||
124582099|NCT03206749|448091029|FG001|Overall Study|Withdrawal of consent|3|||
124582100|NCT03206749|448091030|FG002|Overall Study|Withdrawal of consent|6|||
124582101|NCT03206749|448091028|FG000|Overall Study|Lost to Follow-up|0|||
124582102|NCT03206749|448091029|FG001|Overall Study|Lost to Follow-up|0|||
124582103|NCT03206749|448091030|FG002|Overall Study|Lost to Follow-up|1|||
124582104|NCT01492439|448091031|FG000|Overall Study|Withdrew from RTE|4|||
124582105|NCT01492439|448091032|FG001|Overall Study|Withdrew from RTE|9|||
124582106|NCT00716625|448091033|FG000|Overall Study|Safety was not Assessable|1|||
124582107|NCT05523895|448091034|FG000|Overall Study|Adverse Event|2|||
124582108|NCT05523895|448091035|FG001|Overall Study|Adverse Event|1|||
124582109|NCT05523895|448091036|FG002|Overall Study|Adverse Event|1|||
124582110|NCT05523895|448091034|FG000|Overall Study|Lost to Follow-up|0|||
124582111|NCT05523895|448091035|FG001|Overall Study|Lost to Follow-up|1|||
124582112|NCT05523895|448091036|FG002|Overall Study|Lost to Follow-up|2|||
124582113|NCT05523895|448091034|FG000|Overall Study|Noncompliance with study drug|1|||
124582114|NCT05523895|448091035|FG001|Overall Study|Noncompliance with study drug|1|||
124582115|NCT05523895|448091036|FG002|Overall Study|Noncompliance with study drug|1|||
124582116|NCT05523895|448091034|FG000|Overall Study|Protocol Violation|0|||
124582117|NCT05523895|448091035|FG001|Overall Study|Protocol Violation|2|||
124582118|NCT05523895|448091036|FG002|Overall Study|Protocol Violation|0|||
124582119|NCT05523895|448091034|FG000|Overall Study|Withdrawal by Subject|1|||
124582120|NCT05523895|448091035|FG001|Overall Study|Withdrawal by Subject|3|||
124582121|NCT05523895|448091036|FG002|Overall Study|Withdrawal by Subject|1|||
124582122|NCT05523895|448091034|FG000|Overall Study|Not further specified|0|||
124582123|NCT05523895|448091035|FG001|Overall Study|Not further specified|3|||
124582124|NCT05523895|448091036|FG002|Overall Study|Not further specified|1|||
124582125|NCT03674892|448091037|FG000|Overall Study|Lack of Efficacy|5|||
124582126|NCT03674892|448091037|FG000|Overall Study|Lost to Follow-up|3|||
124582127|NCT03674892|448091037|FG000|Overall Study|Migraine|2|||
124582128|NCT03674892|448091037|FG000|Overall Study|Excessive Tearing|1|||
124582129|NCT03674892|448091037|FG000|Overall Study|Increased Eye Pain|1|||
124582130|NCT03674892|448091037|FG000|Overall Study|Increased Facial Pain|1|||
124582131|NCT03674892|448091037|FG000|Overall Study|Sinus Irritation|1|||
124582132|NCT03674892|448091037|FG000|Overall Study|Sinus Infection|1|||
124582133|NCT00824291|448091038|FG000|Overall Study|Adverse Event|15|||
124582134|NCT00824291|448091039|FG001|Overall Study|Adverse Event|6|||
124582135|NCT00824291|448091038|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
124582136|NCT00824291|448091039|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
124582137|NCT00824291|448091038|FG000|Overall Study|Lost to Follow-up|11|||
124582138|NCT00824291|448091039|FG001|Overall Study|Lost to Follow-up|9|||
124582139|NCT00824291|448091038|FG000|Overall Study|Non-compliance|1|||
124582140|NCT00824291|448091039|FG001|Overall Study|Non-compliance|1|||
124582141|NCT00824291|448091038|FG000|Overall Study|Protocol Violation|4|||
124582142|NCT00824291|448091039|FG001|Overall Study|Protocol Violation|1|||
124582143|NCT00824291|448091038|FG000|Overall Study|Withdrawal by Subject|14|||
124582144|NCT00824291|448091039|FG001|Overall Study|Withdrawal by Subject|8|||
124582145|NCT00824291|448091038|FG000|Overall Study|Lack of Efficacy|7|||
124582146|NCT00824291|448091039|FG001|Overall Study|Lack of Efficacy|8|||
124582147|NCT00824291|448091038|FG000|Overall Study|Participant on prohibited medication|1|||
124582148|NCT00824291|448091039|FG001|Overall Study|Participant on prohibited medication|0|||
124582149|NCT00395694|448091043|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
124582150|NCT00395694|448091044|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
124582151|NCT00395694|448091043|FG000|Continuation Phase|Adverse Event|1|||
124582152|NCT00395694|448091044|FG001|Continuation Phase|Adverse Event|0|||
124582153|NCT00395694|448091043|FG000|Continuation Phase|Lack of Efficacy|12|||
124582154|NCT00395694|448091044|FG001|Continuation Phase|Lack of Efficacy|11|||
124582155|NCT00395694|448091043|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
124582156|NCT00395694|448091044|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
124582157|NCT00395694|448091043|FG000|Continuation Phase|Poor Compliance|1|||
124582158|NCT00395694|448091044|FG001|Continuation Phase|Poor Compliance|0|||
124582159|NCT00395694|448091043|FG000|Continuation Phase|Withdrawal by Subject|0|||
124582160|NCT00395694|448091044|FG001|Continuation Phase|Withdrawal by Subject|2|||
124582161|NCT01648582|448091045|FG000|Overall Study|Adverse Event|6|||
124529848|NCT05304611|447889674|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
124529849|NCT05304611|447889675|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
124529850|NCT05304611|447889676|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
124529851|NCT05304611|447889677|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
124529852|NCT05304611|447889678|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
124529853|NCT05304611|447889667|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
124529854|NCT05304611|447889668|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
124529855|NCT05304611|447889669|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
124529856|NCT05304611|447889670|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
124529857|NCT05304611|447889671|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
124529858|NCT05304611|447889672|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
124529859|NCT05304611|447889673|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
124529860|NCT05304611|447889674|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
124529861|NCT05304611|447889675|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
124529862|NCT05304611|447889676|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
124529863|NCT05304611|447889677|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
124529864|NCT05304611|447889678|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
124582162|NCT01648582|448091046|FG001|Overall Study|Adverse Event|11|||
124582163|NCT01648582|448091047|FG002|Overall Study|Adverse Event|2|||
124582164|NCT01648582|448091045|FG000|Overall Study|Lost to Follow-up|9|||
124582165|NCT01648582|448091046|FG001|Overall Study|Lost to Follow-up|6|||
124582166|NCT01648582|448091047|FG002|Overall Study|Lost to Follow-up|8|||
124582167|NCT01648582|448091045|FG000|Overall Study|Protocol Violation|1|||
124582168|NCT01648582|448091046|FG001|Overall Study|Protocol Violation|2|||
124529865|NCT00963820|447889683|FG000|Dose Escalation Phase|Progressive Disease|3|||
124529866|NCT00963820|447889684|FG001|Dose Escalation Phase|Progressive Disease|3|||
124529867|NCT00963820|447889685|FG002|Dose Escalation Phase|Progressive Disease|3|||
124529868|NCT00963820|447889686|FG003|Dose Escalation Phase|Progressive Disease|3|||
124529869|NCT00963820|447889687|FG004|Dose Escalation Phase|Progressive Disease|4|||
124529870|NCT00963820|447889688|FG005|Dose Escalation Phase|Progressive Disease|3|||
124529871|NCT00963820|447889689|FG006|Dose Escalation Phase|Progressive Disease|3|||
124529872|NCT00963820|447889690|FG007|Dose Escalation Phase|Progressive Disease|2|||
124529873|NCT00963820|447889691|FG008|Dose Escalation Phase|Progressive Disease|0|||
124529874|NCT00963820|447889692|FG009|Dose Escalation Phase|Progressive Disease|0|||
124529875|NCT00963820|447889693|FG010|Dose Escalation Phase|Progressive Disease|0|||
124529876|NCT00963820|447889694|FG011|Dose Escalation Phase|Progressive Disease|0|||
124529877|NCT00963820|447889683|FG000|Dose Escalation Phase|Adverse Event|0|||
124529878|NCT00963820|447889684|FG001|Dose Escalation Phase|Adverse Event|0|||
124529879|NCT00963820|447889685|FG002|Dose Escalation Phase|Adverse Event|0|||
124529880|NCT00963820|447889686|FG003|Dose Escalation Phase|Adverse Event|0|||
124529881|NCT00963820|447889687|FG004|Dose Escalation Phase|Adverse Event|0|||
124529882|NCT00963820|447889688|FG005|Dose Escalation Phase|Adverse Event|0|||
124529883|NCT00963820|447889689|FG006|Dose Escalation Phase|Adverse Event|3|||
124582169|NCT01648582|448091047|FG002|Overall Study|Protocol Violation|1|||
124582170|NCT01648582|448091045|FG000|Overall Study|Withdrawal by Subject|15|||
124582171|NCT01648582|448091046|FG001|Overall Study|Withdrawal by Subject|17|||
124582172|NCT01648582|448091047|FG002|Overall Study|Withdrawal by Subject|17|||
124582173|NCT01648582|448091045|FG000|Overall Study|Physician Decision|0|||
124582174|NCT01648582|448091046|FG001|Overall Study|Physician Decision|1|||
124582175|NCT01648582|448091047|FG002|Overall Study|Physician Decision|3|||
124582176|NCT01648582|448091045|FG000|Overall Study|Death|1|||
124582177|NCT01648582|448091046|FG001|Overall Study|Death|0|||
124582178|NCT01648582|448091047|FG002|Overall Study|Death|0|||
124582179|NCT01648582|448091045|FG000|Overall Study|Sponsor Decision|0|||
124582180|NCT01648582|448091046|FG001|Overall Study|Sponsor Decision|1|||
124582181|NCT01648582|448091047|FG002|Overall Study|Sponsor Decision|1|||
124582182|NCT02699866|448091048|FG000|Overall Study|Withdrawal by Subject|3|||
124582183|NCT02699866|448091048|FG000|Overall Study|Physician Decision|2|||
124582184|NCT02699866|448091048|FG000|Overall Study|Adverse Event|3|||
124582185|NCT01959672|448091049|FG000|Overall Study|Death|1|||
124582186|NCT01058668|448091050|FG000|Double-blind Treatment Phase|Adverse Event|8|||
124582187|NCT01058668|448091051|FG001|Double-blind Treatment Phase|Adverse Event|15|||
124582188|NCT01058668|448091052|FG002|Double-blind Treatment Phase|Adverse Event|25|||
124582189|NCT01058668|448091050|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
124582190|NCT01058668|448091051|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
124582191|NCT01058668|448091052|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
124582192|NCT01058668|448091050|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
124582193|NCT01058668|448091051|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
124582194|NCT01058668|448091052|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
124582195|NCT01058668|448091050|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
124582196|NCT01058668|448091051|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
124582197|NCT01058668|448091052|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
124582198|NCT01058668|448091050|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
124582199|NCT01058668|448091051|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
124582200|NCT01058668|448091052|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
124582201|NCT01058668|448091050|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
124582202|NCT01058668|448091051|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
124582203|NCT01058668|448091052|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
124582204|NCT02842853|448091061|FG000|Overall Study|Non-compliance with the protocol|3|||
124582205|NCT02842853|448091062|FG001|Overall Study|Non-compliance with the protocol|7|||
124582206|NCT02842853|448091063|FG002|Overall Study|Non-compliance with the protocol|2|||
124582207|NCT02842853|448091064|FG003|Overall Study|Non-compliance with the protocol|5|||
124582208|NCT02842853|448091061|FG000|Overall Study|Subject met exclusion criteria|0|||
124582209|NCT02842853|448091062|FG001|Overall Study|Subject met exclusion criteria|1|||
124582210|NCT02842853|448091063|FG002|Overall Study|Subject met exclusion criteria|0|||
124582211|NCT02842853|448091064|FG003|Overall Study|Subject met exclusion criteria|0|||
124582212|NCT02842853|448091061|FG000|Overall Study|Withdrawal by Subject|11|||
124582213|NCT02842853|448091062|FG001|Overall Study|Withdrawal by Subject|13|||
124582214|NCT02842853|448091063|FG002|Overall Study|Withdrawal by Subject|9|||
124582215|NCT02842853|448091064|FG003|Overall Study|Withdrawal by Subject|8|||
124582216|NCT02842853|448091061|FG000|Overall Study|Lost to Follow-up|9|||
124529884|NCT00963820|447889690|FG007|Dose Escalation Phase|Adverse Event|1|||
124529885|NCT00963820|447889691|FG008|Dose Escalation Phase|Adverse Event|0|||
124529886|NCT00963820|447889692|FG009|Dose Escalation Phase|Adverse Event|0|||
124529887|NCT00963820|447889693|FG010|Dose Escalation Phase|Adverse Event|0|||
124529888|NCT00963820|447889694|FG011|Dose Escalation Phase|Adverse Event|0|||
124529889|NCT00963820|447889683|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
124582217|NCT02842853|448091062|FG001|Overall Study|Lost to Follow-up|13|||
124529890|NCT00963820|447889684|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
124529891|NCT00963820|447889685|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
124529892|NCT00963820|447889686|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
124529893|NCT00963820|447889687|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
124529894|NCT00963820|447889688|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
124529895|NCT00963820|447889689|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
124529896|NCT00963820|447889690|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
124529897|NCT00963820|447889691|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
124529898|NCT00963820|447889692|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
124529899|NCT00963820|447889693|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
124529900|NCT00963820|447889694|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
124529901|NCT00963820|447889683|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124529902|NCT00963820|447889684|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124529903|NCT00963820|447889685|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124529904|NCT00963820|447889686|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124529905|NCT00963820|447889687|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124529906|NCT00963820|447889688|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124529907|NCT00963820|447889689|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
124529908|NCT00963820|447889690|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124529909|NCT00963820|447889691|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124529910|NCT00963820|447889692|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124529911|NCT00963820|447889693|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124529912|NCT00963820|447889694|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
124529913|NCT00963820|447889683|FG000|Expansion Phase|Progressive Disease|0|||
124529914|NCT00963820|447889684|FG001|Expansion Phase|Progressive Disease|0|||
124529915|NCT00963820|447889685|FG002|Expansion Phase|Progressive Disease|0|||
124529916|NCT00963820|447889686|FG003|Expansion Phase|Progressive Disease|0|||
124529917|NCT00963820|447889687|FG004|Expansion Phase|Progressive Disease|0|||
124529918|NCT00963820|447889688|FG005|Expansion Phase|Progressive Disease|0|||
124529919|NCT00963820|447889689|FG006|Expansion Phase|Progressive Disease|0|||
124529920|NCT00963820|447889690|FG007|Expansion Phase|Progressive Disease|0|||
124529921|NCT00963820|447889691|FG008|Expansion Phase|Progressive Disease|8|||
124529922|NCT00963820|447889692|FG009|Expansion Phase|Progressive Disease|6|||
124529923|NCT00963820|447889693|FG010|Expansion Phase|Progressive Disease|4|||
124529924|NCT00963820|447889694|FG011|Expansion Phase|Progressive Disease|2|||
124529925|NCT00963820|447889683|FG000|Expansion Phase|Adverse Event|0|||
124529926|NCT00963820|447889684|FG001|Expansion Phase|Adverse Event|0|||
124728058|NCT01159171|448625815|FG000|Overall Study|Death|1|||
124728059|NCT01892436|448625816|FG000|Overall Study|Withdrawal by Subject|8|||
124728060|NCT01892436|448625817|FG001|Overall Study|Withdrawal by Subject|15|||
124728061|NCT01892436|448625818|FG002|Overall Study|Withdrawal by Subject|4|||
124728062|NCT01892436|448625819|FG003|Overall Study|Withdrawal by Subject|4|||
124728063|NCT01892436|448625816|FG000|Overall Study|Death|1|||
124728064|NCT01892436|448625817|FG001|Overall Study|Death|1|||
124728065|NCT01892436|448625818|FG002|Overall Study|Death|0|||
124728066|NCT01892436|448625819|FG003|Overall Study|Death|0|||
124728067|NCT01892436|448625816|FG000|Overall Study|Physician Decision|2|||
124728068|NCT01892436|448625817|FG001|Overall Study|Physician Decision|1|||
124728069|NCT01892436|448625818|FG002|Overall Study|Physician Decision|0|||
124728070|NCT01892436|448625819|FG003|Overall Study|Physician Decision|1|||
124728071|NCT01892436|448625816|FG000|Overall Study|Pregnancy|0|||
124529927|NCT00963820|447889685|FG002|Expansion Phase|Adverse Event|0|||
124529928|NCT00963820|447889686|FG003|Expansion Phase|Adverse Event|0|||
124529929|NCT00963820|447889687|FG004|Expansion Phase|Adverse Event|0|||
124529930|NCT00963820|447889688|FG005|Expansion Phase|Adverse Event|0|||
124529931|NCT00963820|447889689|FG006|Expansion Phase|Adverse Event|0|||
124529932|NCT00963820|447889690|FG007|Expansion Phase|Adverse Event|0|||
124529933|NCT00963820|447889691|FG008|Expansion Phase|Adverse Event|1|||
124529934|NCT00963820|447889692|FG009|Expansion Phase|Adverse Event|3|||
124529935|NCT00963820|447889693|FG010|Expansion Phase|Adverse Event|0|||
124728072|NCT01892436|448625817|FG001|Overall Study|Pregnancy|2|||
124529936|NCT00963820|447889694|FG011|Expansion Phase|Adverse Event|0|||
124529937|NCT00963820|447889683|FG000|Expansion Phase|Withdrawal by Subject|0|||
124529938|NCT00963820|447889684|FG001|Expansion Phase|Withdrawal by Subject|0|||
124529939|NCT00963820|447889685|FG002|Expansion Phase|Withdrawal by Subject|0|||
124529940|NCT00963820|447889686|FG003|Expansion Phase|Withdrawal by Subject|0|||
124529941|NCT00963820|447889687|FG004|Expansion Phase|Withdrawal by Subject|0|||
124529942|NCT00963820|447889688|FG005|Expansion Phase|Withdrawal by Subject|0|||
124529943|NCT00963820|447889689|FG006|Expansion Phase|Withdrawal by Subject|0|||
124529944|NCT00963820|447889690|FG007|Expansion Phase|Withdrawal by Subject|0|||
124529945|NCT00963820|447889691|FG008|Expansion Phase|Withdrawal by Subject|1|||
124728073|NCT01892436|448625818|FG002|Overall Study|Pregnancy|1|||
124728074|NCT01892436|448625819|FG003|Overall Study|Pregnancy|0|||
124728075|NCT01892436|448625816|FG000|Overall Study|Technical problems|2|||
124728076|NCT01892436|448625817|FG001|Overall Study|Technical problems|1|||
124582218|NCT02842853|448091063|FG002|Overall Study|Lost to Follow-up|10|||
124582219|NCT02842853|448091064|FG003|Overall Study|Lost to Follow-up|11|||
124582220|NCT04089553|448091065|FG000|Overall Study|Death|1|||
124582221|NCT04089553|448091066|FG001|Overall Study|Death|1|||
124582222|NCT04089553|448091065|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
124582223|NCT04089553|448091066|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
124582224|NCT04089553|448091065|FG000|Overall Study|Withdrawal by Subject|3|||
124582225|NCT04089553|448091066|FG001|Overall Study|Withdrawal by Subject|3|||
124582226|NCT04089553|448091065|FG000|Overall Study|Physician Decision|1|||
124582227|NCT04089553|448091066|FG001|Overall Study|Physician Decision|0|||
124582228|NCT04089553|448091065|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
124582229|NCT04089553|448091066|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
124582230|NCT04089553|448091065|FG000|Overall Study|Other|1|||
124582231|NCT04089553|448091066|FG001|Overall Study|Other|0|||
124582232|NCT04089553|448091065|FG000|Overall Study|Adverse Event|1|||
124582233|NCT04089553|448091066|FG001|Overall Study|Adverse Event|1|||
124582234|NCT01403194|448091067|FG000|Overall Study|Screen Failure|2|||
124582235|NCT01403194|448091067|FG000|Overall Study|Lost to Follow-up|8|||
124582236|NCT01808651|448091077|FG000|Study Period 1|Lost to Follow-up|1|||
124582237|NCT01808651|448091078|FG001|Study Period 1|Lost to Follow-up|3|||
124582238|NCT01808651|448091079|FG002|Study Period 1|Lost to Follow-up|0|||
124582239|NCT01808651|448091077|FG000|Study Period 1|Protocol Violation|1|||
124582240|NCT01808651|448091078|FG001|Study Period 1|Protocol Violation|0|||
124582241|NCT01808651|448091079|FG002|Study Period 1|Protocol Violation|1|||
124582242|NCT01808651|448091077|FG000|Study Period 1|Physician Decision|3|||
124582243|NCT01808651|448091078|FG001|Study Period 1|Physician Decision|2|||
124582244|NCT01808651|448091079|FG002|Study Period 1|Physician Decision|0|||
124582245|NCT01808651|448091077|FG000|Study Period 1|Lack of Efficacy|2|||
124582246|NCT01808651|448091078|FG001|Study Period 1|Lack of Efficacy|1|||
124529946|NCT00963820|447889692|FG009|Expansion Phase|Withdrawal by Subject|0|||
124529947|NCT00963820|447889693|FG010|Expansion Phase|Withdrawal by Subject|1|||
124529948|NCT00963820|447889694|FG011|Expansion Phase|Withdrawal by Subject|1|||
124529949|NCT00963820|447889683|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124529950|NCT00963820|447889684|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124529951|NCT00963820|447889685|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124529952|NCT00963820|447889686|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124529953|NCT00963820|447889687|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124529954|NCT00963820|447889688|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124529955|NCT00963820|447889689|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124529956|NCT00963820|447889690|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124529957|NCT00963820|447889691|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124529958|NCT00963820|447889692|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124529959|NCT00963820|447889693|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
124529960|NCT00963820|447889694|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
124529961|NCT02354690|447889695|FG000|Overall Study|Physician Decision|1|||
124529962|NCT04005755|447889705|FG000|Overall Study|Adverse Event|6|||
124529963|NCT04005755|447889705|FG000|Overall Study|Physician Decision|3|||
124529964|NCT04005755|447889705|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
124529965|NCT04005755|447889705|FG000|Overall Study|Withdrawal by Subject|3|||
124529966|NCT04005755|447889705|FG000|Overall Study|Lost to Follow-up|1|||
124529967|NCT02723019|447889706|FG000|Overall Study|Death|17|||
124529968|NCT02723019|447889707|FG001|Overall Study|Death|13|||
124529969|NCT02723019|447889706|FG000|Overall Study|Withdrawal by Subject|11|||
124529970|NCT02723019|447889707|FG001|Overall Study|Withdrawal by Subject|7|||
124529971|NCT02723019|447889706|FG000|Overall Study|Lost to Follow-up|57|||
124529972|NCT02723019|447889707|FG001|Overall Study|Lost to Follow-up|70|||
124529973|NCT00515099|447889709|FG000|Overall Study|Lost to Follow-up|0|||
124529974|NCT00515099|447889710|FG001|Overall Study|Lost to Follow-up|4|||
124529975|NCT00515099|447889709|FG000|Overall Study|Withdrawal by Subject|2|||
124529976|NCT00515099|447889710|FG001|Overall Study|Withdrawal by Subject|0|||
124529977|NCT00515099|447889709|FG000|Overall Study|IRB Recommendation|1|||
124529978|NCT00515099|447889710|FG001|Overall Study|IRB Recommendation|0|||
124529979|NCT00592072|447889711|FG000|Wash Out Period|Lost to Follow-up|1|||
124529980|NCT00592072|447889712|FG001|Wash Out Period|Lost to Follow-up|1|||
124529981|NCT02750501|447889718|FG000|Overall Study|Adverse Event|4|||
124529982|NCT02750501|447889718|FG000|Overall Study|Physician Decision|1|||
124529983|NCT02750501|447889718|FG000|Overall Study|Protocol Violation|1|||
124529984|NCT02750501|447889718|FG000|Overall Study|G-tube came out|1|||
124582247|NCT01808651|448091079|FG002|Study Period 1|Lack of Efficacy|0|||
124582248|NCT01808651|448091077|FG000|Study Period 1|Adverse Event|10|||
124582249|NCT01808651|448091078|FG001|Study Period 1|Adverse Event|4|||
124582250|NCT01808651|448091079|FG002|Study Period 1|Adverse Event|1|||
124529985|NCT02750501|447889718|FG000|Overall Study|Non-compliant use of PERT|1|||
124529986|NCT01738594|447889719|FG000|Registration and Treatment Start|Adverse Event|0|||
124582251|NCT01808651|448091077|FG000|Study Period 1|Participant Decision|9|||
124582252|NCT01808651|448091078|FG001|Study Period 1|Participant Decision|7|||
124582253|NCT01808651|448091079|FG002|Study Period 1|Participant Decision|3|||
124582254|NCT00608322|448091082|FG000|Overall Study|Death|2|||
124582255|NCT00608322|448091083|FG001|Overall Study|Death|1|||
124582256|NCT05479058|448091084|FG000|Overall Study|Withdrawal by Subject|1|||
124582257|NCT05479058|448091085|FG001|Overall Study|Withdrawal by Subject|1|||
124582258|NCT05479058|448091084|FG000|Overall Study|Study terminated by sponsor|10|||
124582259|NCT05479058|448091085|FG001|Overall Study|Study terminated by sponsor|10|||
124582260|NCT00834444|448091086|FG000|First Intervention|Adverse Event|1|||
124582261|NCT00834444|448091087|FG001|First Intervention|Adverse Event|0|||
124582262|NCT00834444|448091086|FG000|First Intervention|Intolerance to Venopuncture|0|||
124582263|NCT00834444|448091087|FG001|First Intervention|Intolerance to Venopuncture|1|||
124582264|NCT00834444|448091086|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
124582265|NCT00834444|448091087|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
124582266|NCT00834444|448091086|FG000|Second Intervention|Adverse Event|1|||
124582267|NCT00834444|448091087|FG001|Second Intervention|Adverse Event|0|||
124582268|NCT03325881|448091090|FG000|Overall Study|Protocol Violation|0|||
124582269|NCT03325881|448091091|FG001|Overall Study|Protocol Violation|1|||
124582270|NCT03325881|448091090|FG000|Overall Study|Withdrawal by Subject|0|||
124582271|NCT03325881|448091091|FG001|Overall Study|Withdrawal by Subject|2|||
124582272|NCT03325881|448091090|FG000|Overall Study|Lack of Efficacy|2|||
124582273|NCT03325881|448091091|FG001|Overall Study|Lack of Efficacy|0|||
124582274|NCT03325881|448091090|FG000|Overall Study|Not treated|1|||
124582275|NCT03325881|448091091|FG001|Overall Study|Not treated|0|||
124582276|NCT02294981|448091096|FG000|Overall Study|Lost to Follow-up|1|||
124582277|NCT00829712|448091097|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
124582278|NCT00829712|448091098|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
124582279|NCT00606281|448091099|FG000|Overall Study|Adverse Event|11|||
124582280|NCT00606281|448091100|FG001|Overall Study|Adverse Event|12|||
124582281|NCT00606281|448091099|FG000|Overall Study|Death|1|||
124582282|NCT00606281|448091100|FG001|Overall Study|Death|0|||
124582283|NCT00606281|448091099|FG000|Overall Study|Lack of Efficacy|28|||
124582284|NCT00606281|448091100|FG001|Overall Study|Lack of Efficacy|35|||
124582285|NCT00606281|448091099|FG000|Overall Study|Physician Decision|0|||
124582286|NCT00606281|448091100|FG001|Overall Study|Physician Decision|1|||
124582287|NCT00606281|448091099|FG000|Overall Study|Protocol Violation|3|||
124582288|NCT00606281|448091100|FG001|Overall Study|Protocol Violation|3|||
124582289|NCT00606281|448091099|FG000|Overall Study|Withdrawal by Subject|11|||
124582290|NCT00606281|448091100|FG001|Overall Study|Withdrawal by Subject|13|||
124582291|NCT00606281|448091099|FG000|Overall Study|Progression to depressive phase|1|||
124582292|NCT00606281|448091100|FG001|Overall Study|Progression to depressive phase|1|||
124582293|NCT00606281|448091099|FG000|Overall Study|Change of residence or other commitments|1|||
124582294|NCT00606281|448091100|FG001|Overall Study|Change of residence or other commitments|1|||
124582295|NCT05752721|448091104|FG000|Overall Study|Lost to Follow-up|22|||
124582296|NCT05752721|448091105|FG001|Overall Study|Lost to Follow-up|20|||
124582297|NCT05752721|448091104|FG000|Overall Study|Withdrawal by Subject|15|||
124582298|NCT05752721|448091105|FG001|Overall Study|Withdrawal by Subject|12|||
124582299|NCT01188681|448091106|FG000|Overall Study|bladder cancer|0|||
124582300|NCT01188681|448091107|FG001|Overall Study|bladder cancer|0|||
124582301|NCT01188681|448091108|FG002|Overall Study|bladder cancer|1|||
124582302|NCT01188681|448091109|FG003|Overall Study|bladder cancer|0|||
124582303|NCT01188681|448091106|FG000|Overall Study|Withdrawal by Subject|0|||
124582304|NCT01188681|448091107|FG001|Overall Study|Withdrawal by Subject|0|||
124582305|NCT01188681|448091108|FG002|Overall Study|Withdrawal by Subject|0|||
124582306|NCT01188681|448091109|FG003|Overall Study|Withdrawal by Subject|1|||
124582307|NCT02280863|448091110|FG000|Integrated Platform|Met stopping criteria|0|||
124582308|NCT02280863|448091111|FG001|Integrated Platform|Met stopping criteria|1|||
124582309|NCT03236311|448091112|FG000|Overall Study|Study terminated by sponsor|0|||
124582310|NCT03236311|448091113|FG001|Overall Study|Study terminated by sponsor|2|||
124582311|NCT03236311|448091112|FG000|Overall Study|Adverse Event|0|||
124582312|NCT03236311|448091113|FG001|Overall Study|Adverse Event|1|||
124582313|NCT00909753|448091114|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
124582314|NCT00909753|448091115|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
124582315|NCT00909753|448091114|FG000|Period: Second Intervention|Protocol Violation|1|||
124582316|NCT00909753|448091115|FG001|Period: Second Intervention|Protocol Violation|0|||
124582317|NCT02336074|448091118|FG000|Overall Study|Adverse Event|0|||
124582318|NCT02336074|448091119|FG001|Overall Study|Adverse Event|2|||
124728077|NCT01892436|448625818|FG002|Overall Study|Technical problems|1|||
124728078|NCT01892436|448625819|FG003|Overall Study|Technical problems|1|||
124582319|NCT02679729|448091120|FG000|Overall Study|Lost to Follow-up|0|||
124582320|NCT02679729|448091121|FG001|Overall Study|Lost to Follow-up|1|||
124728079|NCT01892436|448625816|FG000|Overall Study|Lack of Efficacy|1|||
124582321|NCT02679729|448091122|FG002|Overall Study|Lost to Follow-up|0|||
124582322|NCT02679729|448091123|FG003|Overall Study|Lost to Follow-up|0|||
124582323|NCT02679729|448091124|FG004|Overall Study|Lost to Follow-up|1|||
124582324|NCT02679729|448091125|FG005|Overall Study|Lost to Follow-up|0|||
124582325|NCT02679729|448091126|FG006|Overall Study|Lost to Follow-up|0|||
124582326|NCT02679729|448091127|FG007|Overall Study|Lost to Follow-up|0|||
124582327|NCT02679729|448091128|FG008|Overall Study|Lost to Follow-up|0|||
124529987|NCT01738594|447889720|FG001|Registration and Treatment Start|Adverse Event|1|||
124529988|NCT01738594|447889721|FG002|Registration and Treatment Start|Adverse Event|0|||
124529989|NCT01738594|447889722|FG003|Registration and Treatment Start|Adverse Event|0|||
124529990|NCT01738594|447889723|FG004|Registration and Treatment Start|Adverse Event|0|||
124529991|NCT01738594|447889724|FG005|Registration and Treatment Start|Adverse Event|0|||
124529992|NCT01738594|447889725|FG006|Registration and Treatment Start|Adverse Event|0|||
124529993|NCT01738594|447889726|FG007|Registration and Treatment Start|Adverse Event|0|||
124529994|NCT01738594|447889719|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
124529995|NCT01738594|447889720|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
124529996|NCT01738594|447889721|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
124529997|NCT01738594|447889722|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
124582328|NCT02679729|448091120|FG000|Overall Study|Participant decision|0|||
124582329|NCT02679729|448091121|FG001|Overall Study|Participant decision|1|||
124582330|NCT02679729|448091122|FG002|Overall Study|Participant decision|0|||
124582331|NCT02679729|448091123|FG003|Overall Study|Participant decision|0|||
124582332|NCT02679729|448091124|FG004|Overall Study|Participant decision|0|||
124582333|NCT02679729|448091125|FG005|Overall Study|Participant decision|0|||
124582334|NCT02679729|448091126|FG006|Overall Study|Participant decision|1|||
124582335|NCT02679729|448091127|FG007|Overall Study|Participant decision|0|||
124582336|NCT02679729|448091128|FG008|Overall Study|Participant decision|0|||
124582337|NCT00906399|448091130|FG000|Year 1|Randomized But Not Treated|0|||
124582338|NCT00906399|448091131|FG001|Year 1|Randomized But Not Treated|1|||
124582339|NCT00906399|448091132|FG002|Year 1|Randomized But Not Treated|3|||
124582340|NCT00906399|448091133|FG003|Year 1|Randomized But Not Treated|0|||
124582341|NCT00906399|448091134|FG004|Year 1|Randomized But Not Treated|0|||
124582342|NCT00906399|448091135|FG005|Year 1|Randomized But Not Treated|0|||
124582343|NCT00906399|448091136|FG006|Year 1|Randomized But Not Treated|0|||
124582344|NCT00906399|448091130|FG000|Year 1|Adverse Event|4|||
124582345|NCT00906399|448091131|FG001|Year 1|Adverse Event|22|||
124582346|NCT00906399|448091132|FG002|Year 1|Adverse Event|24|||
124582347|NCT00906399|448091133|FG003|Year 1|Adverse Event|0|||
124582348|NCT00906399|448091134|FG004|Year 1|Adverse Event|0|||
124582349|NCT00906399|448091135|FG005|Year 1|Adverse Event|0|||
124582350|NCT00906399|448091136|FG006|Year 1|Adverse Event|0|||
124582351|NCT00906399|448091130|FG000|Year 1|Lost to Follow-up|4|||
124582352|NCT00906399|448091131|FG001|Year 1|Lost to Follow-up|4|||
124582353|NCT00906399|448091132|FG002|Year 1|Lost to Follow-up|2|||
124582354|NCT00906399|448091133|FG003|Year 1|Lost to Follow-up|0|||
124582355|NCT00906399|448091134|FG004|Year 1|Lost to Follow-up|0|||
124582356|NCT00906399|448091135|FG005|Year 1|Lost to Follow-up|0|||
124582357|NCT00906399|448091136|FG006|Year 1|Lost to Follow-up|0|||
124582358|NCT00906399|448091130|FG000|Year 1|Withdrawal by Subject|30|||
124582359|NCT00906399|448091131|FG001|Year 1|Withdrawal by Subject|32|||
124582360|NCT00906399|448091132|FG002|Year 1|Withdrawal by Subject|36|||
124582361|NCT00906399|448091133|FG003|Year 1|Withdrawal by Subject|0|||
124582362|NCT00906399|448091134|FG004|Year 1|Withdrawal by Subject|0|||
124582363|NCT00906399|448091135|FG005|Year 1|Withdrawal by Subject|0|||
124582364|NCT00906399|448091136|FG006|Year 1|Withdrawal by Subject|0|||
124582365|NCT00906399|448091130|FG000|Year 1|Physician Decision|0|||
124582366|NCT00906399|448091131|FG001|Year 1|Physician Decision|1|||
124582367|NCT00906399|448091132|FG002|Year 1|Physician Decision|3|||
124582368|NCT00906399|448091133|FG003|Year 1|Physician Decision|0|||
124582369|NCT00906399|448091134|FG004|Year 1|Physician Decision|0|||
124582370|NCT00906399|448091135|FG005|Year 1|Physician Decision|0|||
124582371|NCT00906399|448091136|FG006|Year 1|Physician Decision|0|||
124582372|NCT00906399|448091130|FG000|Year 1|Death|2|||
124582373|NCT00906399|448091131|FG001|Year 1|Death|1|||
124582374|NCT00906399|448091132|FG002|Year 1|Death|1|||
124582375|NCT00906399|448091133|FG003|Year 1|Death|0|||
124582376|NCT00906399|448091134|FG004|Year 1|Death|0|||
124728080|NCT01892436|448625817|FG001|Overall Study|Lack of Efficacy|2|||
124529998|NCT01738594|447889723|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
124582377|NCT00906399|448091135|FG005|Year 1|Death|0|||
124582378|NCT00906399|448091136|FG006|Year 1|Death|0|||
124582379|NCT00906399|448091130|FG000|Year 1|Other|4|||
124582380|NCT00906399|448091131|FG001|Year 1|Other|2|||
124582381|NCT00906399|448091132|FG002|Year 1|Other|7|||
124582382|NCT00906399|448091133|FG003|Year 1|Other|0|||
124582383|NCT00906399|448091134|FG004|Year 1|Other|0|||
124728081|NCT01892436|448625818|FG002|Overall Study|Lack of Efficacy|2|||
124582384|NCT00906399|448091135|FG005|Year 1|Other|0|||
124582385|NCT00906399|448091136|FG006|Year 1|Other|0|||
124582386|NCT00906399|448091130|FG000|Year 2|Adverse Event|0|||
124582387|NCT00906399|448091131|FG001|Year 2|Adverse Event|0|||
124582388|NCT00906399|448091132|FG002|Year 2|Adverse Event|0|||
124582389|NCT00906399|448091133|FG003|Year 2|Adverse Event|9|||
124582390|NCT00906399|448091134|FG004|Year 2|Adverse Event|8|||
124582391|NCT00906399|448091135|FG005|Year 2|Adverse Event|11|||
124582392|NCT00906399|448091136|FG006|Year 2|Adverse Event|6|||
124582393|NCT00906399|448091130|FG000|Year 2|Lost to Follow-up|0|||
124582394|NCT00906399|448091131|FG001|Year 2|Lost to Follow-up|0|||
124582395|NCT00906399|448091132|FG002|Year 2|Lost to Follow-up|0|||
124582396|NCT00906399|448091133|FG003|Year 2|Lost to Follow-up|1|||
124582397|NCT00906399|448091134|FG004|Year 2|Lost to Follow-up|4|||
124582398|NCT00906399|448091135|FG005|Year 2|Lost to Follow-up|2|||
124582399|NCT00906399|448091136|FG006|Year 2|Lost to Follow-up|4|||
124582400|NCT00906399|448091130|FG000|Year 2|Withdrawal by Subject|0|||
124582401|NCT00906399|448091131|FG001|Year 2|Withdrawal by Subject|0|||
124582402|NCT00906399|448091132|FG002|Year 2|Withdrawal by Subject|0|||
124582403|NCT00906399|448091133|FG003|Year 2|Withdrawal by Subject|17|||
124582404|NCT00906399|448091134|FG004|Year 2|Withdrawal by Subject|18|||
124582405|NCT00906399|448091135|FG005|Year 2|Withdrawal by Subject|27|||
124582406|NCT00906399|448091136|FG006|Year 2|Withdrawal by Subject|13|||
124582407|NCT00906399|448091130|FG000|Year 2|Physician Decision|0|||
124582408|NCT00906399|448091131|FG001|Year 2|Physician Decision|0|||
124582409|NCT00906399|448091132|FG002|Year 2|Physician Decision|0|||
124582410|NCT00906399|448091133|FG003|Year 2|Physician Decision|0|||
124582411|NCT00906399|448091134|FG004|Year 2|Physician Decision|2|||
124582412|NCT00906399|448091135|FG005|Year 2|Physician Decision|6|||
124582413|NCT00906399|448091136|FG006|Year 2|Physician Decision|3|||
124582414|NCT00906399|448091130|FG000|Year 2|Death|0|||
124582415|NCT00906399|448091131|FG001|Year 2|Death|0|||
124582416|NCT00906399|448091132|FG002|Year 2|Death|0|||
124582417|NCT00906399|448091133|FG003|Year 2|Death|1|||
124582418|NCT00906399|448091134|FG004|Year 2|Death|0|||
124582419|NCT00906399|448091135|FG005|Year 2|Death|0|||
124582420|NCT00906399|448091136|FG006|Year 2|Death|3|||
124582421|NCT00906399|448091130|FG000|Year 2|Other|0|||
124582422|NCT00906399|448091131|FG001|Year 2|Other|0|||
124582423|NCT00906399|448091132|FG002|Year 2|Other|0|||
124582424|NCT00906399|448091133|FG003|Year 2|Other|2|||
124582425|NCT00906399|448091134|FG004|Year 2|Other|3|||
124582426|NCT00906399|448091135|FG005|Year 2|Other|1|||
124582427|NCT00906399|448091136|FG006|Year 2|Other|0|||
124582428|NCT00574847|448091142|FG000|Overall Study|Adverse Event|2|||
124582429|NCT00574847|448091143|FG001|Overall Study|Adverse Event|0|||
124582430|NCT00574847|448091142|FG000|Overall Study|Death|1|||
124582431|NCT00574847|448091143|FG001|Overall Study|Death|0|||
124582432|NCT00574847|448091142|FG000|Overall Study|Withdrawal by Subject|2|||
124582433|NCT00574847|448091143|FG001|Overall Study|Withdrawal by Subject|2|||
124582434|NCT00574847|448091142|FG000|Overall Study|Physician Decision|1|||
124582435|NCT00574847|448091143|FG001|Overall Study|Physician Decision|0|||
124582436|NCT00574847|448091142|FG000|Overall Study|Did not receive medication (declined)|2|||
124582437|NCT00574847|448091143|FG001|Overall Study|Did not receive medication (declined)|5|||
124582438|NCT02055547|448091145|FG000|Overall Study|Protocol Violation|0|||
124582439|NCT02055547|448091146|FG001|Overall Study|Protocol Violation|0|||
124582440|NCT02055547|448091147|FG002|Overall Study|Protocol Violation|1|||
124582441|NCT02055547|448091148|FG003|Overall Study|Protocol Violation|0|||
124582442|NCT02055547|448091149|FG004|Overall Study|Protocol Violation|0|||
124582443|NCT02055547|448091150|FG005|Overall Study|Protocol Violation|0|||
124582444|NCT02055547|448091151|FG006|Overall Study|Protocol Violation|1|||
124582445|NCT02055547|448091152|FG007|Overall Study|Protocol Violation|0|||
124582446|NCT02055547|448091153|FG008|Overall Study|Protocol Violation|0|||
124582447|NCT02055547|448091154|FG009|Overall Study|Protocol Violation|0|||
124582448|NCT02055547|448091155|FG010|Overall Study|Protocol Violation|0|||
124582449|NCT02055547|448091156|FG011|Overall Study|Protocol Violation|0|||
124582450|NCT02055547|448091157|FG012|Overall Study|Protocol Violation|0|||
124582451|NCT02055547|448091158|FG013|Overall Study|Protocol Violation|0|||
124582452|NCT02055547|448091159|FG014|Overall Study|Protocol Violation|0|||
124582453|NCT02055547|448091160|FG015|Overall Study|Protocol Violation|0|||
124582454|NCT02055547|448091161|FG016|Overall Study|Protocol Violation|0|||
124582455|NCT02055547|448091162|FG017|Overall Study|Protocol Violation|0|||
124582456|NCT02055547|448091163|FG018|Overall Study|Protocol Violation|0|||
124582457|NCT02055547|448091145|FG000|Overall Study|Physician Decision|0|||
124582458|NCT02055547|448091146|FG001|Overall Study|Physician Decision|1|||
124582459|NCT02055547|448091147|FG002|Overall Study|Physician Decision|1|||
124582460|NCT02055547|448091148|FG003|Overall Study|Physician Decision|0|||
124582461|NCT02055547|448091149|FG004|Overall Study|Physician Decision|1|||
124582462|NCT02055547|448091150|FG005|Overall Study|Physician Decision|0|||
124582463|NCT02055547|448091151|FG006|Overall Study|Physician Decision|0|||
124582464|NCT02055547|448091152|FG007|Overall Study|Physician Decision|0|||
124582465|NCT02055547|448091153|FG008|Overall Study|Physician Decision|0|||
124582466|NCT02055547|448091154|FG009|Overall Study|Physician Decision|1|||
124582467|NCT02055547|448091155|FG010|Overall Study|Physician Decision|1|||
124582468|NCT02055547|448091156|FG011|Overall Study|Physician Decision|0|||
124582469|NCT02055547|448091157|FG012|Overall Study|Physician Decision|0|||
124582470|NCT02055547|448091158|FG013|Overall Study|Physician Decision|0|||
124582471|NCT02055547|448091159|FG014|Overall Study|Physician Decision|0|||
124582472|NCT02055547|448091160|FG015|Overall Study|Physician Decision|0|||
124582473|NCT02055547|448091161|FG016|Overall Study|Physician Decision|0|||
124582474|NCT02055547|448091162|FG017|Overall Study|Physician Decision|0|||
124582475|NCT02055547|448091163|FG018|Overall Study|Physician Decision|0|||
124582476|NCT02055547|448091145|FG000|Overall Study|Adverse Event|0|||
124582477|NCT02055547|448091146|FG001|Overall Study|Adverse Event|0|||
124582478|NCT02055547|448091147|FG002|Overall Study|Adverse Event|0|||
124582479|NCT02055547|448091148|FG003|Overall Study|Adverse Event|0|||
124582480|NCT02055547|448091149|FG004|Overall Study|Adverse Event|0|||
124582481|NCT02055547|448091150|FG005|Overall Study|Adverse Event|0|||
124582482|NCT02055547|448091151|FG006|Overall Study|Adverse Event|1|||
124582483|NCT02055547|448091152|FG007|Overall Study|Adverse Event|0|||
124582484|NCT02055547|448091153|FG008|Overall Study|Adverse Event|1|||
124582485|NCT02055547|448091154|FG009|Overall Study|Adverse Event|0|||
124582486|NCT02055547|448091155|FG010|Overall Study|Adverse Event|0|||
124582487|NCT02055547|448091156|FG011|Overall Study|Adverse Event|0|||
124582488|NCT02055547|448091157|FG012|Overall Study|Adverse Event|0|||
124582489|NCT02055547|448091158|FG013|Overall Study|Adverse Event|0|||
124582490|NCT02055547|448091159|FG014|Overall Study|Adverse Event|0|||
124582491|NCT02055547|448091160|FG015|Overall Study|Adverse Event|0|||
124582492|NCT02055547|448091161|FG016|Overall Study|Adverse Event|0|||
124582493|NCT02055547|448091162|FG017|Overall Study|Adverse Event|0|||
124582494|NCT02055547|448091163|FG018|Overall Study|Adverse Event|0|||
124582495|NCT02055547|448091145|FG000|Overall Study|Withdrawal by Subject|0|||
124582496|NCT02055547|448091146|FG001|Overall Study|Withdrawal by Subject|0|||
124582497|NCT02055547|448091147|FG002|Overall Study|Withdrawal by Subject|0|||
124582498|NCT02055547|448091148|FG003|Overall Study|Withdrawal by Subject|0|||
124582499|NCT02055547|448091149|FG004|Overall Study|Withdrawal by Subject|0|||
124582500|NCT02055547|448091150|FG005|Overall Study|Withdrawal by Subject|1|||
124582501|NCT02055547|448091151|FG006|Overall Study|Withdrawal by Subject|0|||
124582502|NCT02055547|448091152|FG007|Overall Study|Withdrawal by Subject|0|||
124582503|NCT02055547|448091153|FG008|Overall Study|Withdrawal by Subject|1|||
124582504|NCT02055547|448091154|FG009|Overall Study|Withdrawal by Subject|0|||
124582505|NCT02055547|448091155|FG010|Overall Study|Withdrawal by Subject|0|||
124582506|NCT02055547|448091156|FG011|Overall Study|Withdrawal by Subject|0|||
124582507|NCT02055547|448091157|FG012|Overall Study|Withdrawal by Subject|0|||
124582508|NCT02055547|448091158|FG013|Overall Study|Withdrawal by Subject|1|||
124582509|NCT02055547|448091159|FG014|Overall Study|Withdrawal by Subject|0|||
124582510|NCT02055547|448091160|FG015|Overall Study|Withdrawal by Subject|1|||
124582511|NCT02055547|448091161|FG016|Overall Study|Withdrawal by Subject|0|||
124582512|NCT02055547|448091162|FG017|Overall Study|Withdrawal by Subject|0|||
124582513|NCT02055547|448091163|FG018|Overall Study|Withdrawal by Subject|0|||
124582514|NCT02055547|448091145|FG000|Overall Study|Lost to Follow-up|0|||
124582515|NCT02055547|448091146|FG001|Overall Study|Lost to Follow-up|0|||
124582516|NCT02055547|448091147|FG002|Overall Study|Lost to Follow-up|1|||
124582517|NCT02055547|448091148|FG003|Overall Study|Lost to Follow-up|0|||
124582518|NCT02055547|448091149|FG004|Overall Study|Lost to Follow-up|0|||
124582519|NCT02055547|448091150|FG005|Overall Study|Lost to Follow-up|0|||
124582520|NCT02055547|448091151|FG006|Overall Study|Lost to Follow-up|0|||
124582521|NCT02055547|448091152|FG007|Overall Study|Lost to Follow-up|0|||
124582522|NCT02055547|448091153|FG008|Overall Study|Lost to Follow-up|0|||
124582523|NCT02055547|448091154|FG009|Overall Study|Lost to Follow-up|0|||
124582524|NCT02055547|448091155|FG010|Overall Study|Lost to Follow-up|0|||
124582525|NCT02055547|448091156|FG011|Overall Study|Lost to Follow-up|0|||
124582526|NCT02055547|448091157|FG012|Overall Study|Lost to Follow-up|0|||
124582527|NCT02055547|448091158|FG013|Overall Study|Lost to Follow-up|0|||
124582528|NCT02055547|448091159|FG014|Overall Study|Lost to Follow-up|0|||
124582529|NCT02055547|448091160|FG015|Overall Study|Lost to Follow-up|0|||
124582530|NCT02055547|448091161|FG016|Overall Study|Lost to Follow-up|0|||
124582531|NCT02055547|448091162|FG017|Overall Study|Lost to Follow-up|0|||
124582532|NCT02055547|448091163|FG018|Overall Study|Lost to Follow-up|0|||
124582533|NCT01279486|448091164|FG000|Overall Study|Lost to Follow-up|1|||
124582534|NCT03067987|448091165|FG000|Overall Study|Lost to Follow-up|7|||
124582535|NCT03067987|448091166|FG001|Overall Study|Lost to Follow-up|10|||
124582536|NCT03067987|448091165|FG000|Overall Study|Protocol Violation|1|||
124582537|NCT03067987|448091166|FG001|Overall Study|Protocol Violation|2|||
124582538|NCT03067987|448091165|FG000|Overall Study|Withdrawal by Subject|2|||
124728082|NCT01892436|448625819|FG003|Overall Study|Lack of Efficacy|2|||
124728083|NCT01892436|448625816|FG000|Overall Study|Lost to Follow-up|1|||
124728084|NCT01892436|448625817|FG001|Overall Study|Lost to Follow-up|1|||
124728085|NCT01892436|448625818|FG002|Overall Study|Lost to Follow-up|1|||
124728086|NCT01892436|448625819|FG003|Overall Study|Lost to Follow-up|3|||
124582539|NCT03067987|448091166|FG001|Overall Study|Withdrawal by Subject|1|||
124582540|NCT00829764|448091169|FG000|First Intervention|Adverse Event|1|||
124582541|NCT00829764|448091170|FG001|First Intervention|Adverse Event|0|||
124582542|NCT00829764|448091169|FG000|First Intervention|Withdrawal by Subject|1|||
124582543|NCT00829764|448091170|FG001|First Intervention|Withdrawal by Subject|1|||
124582544|NCT01750294|448093497|FG000|Overall Study|Withdrawal by Subject|1|||
124582545|NCT01750294|448093497|FG000|Overall Study|Safety Endpoint|1|||
124582546|NCT00665925|448093498|FG000|Overall Study|Lack of Efficacy|10|||
124582547|NCT00665925|448093499|FG001|Overall Study|Lack of Efficacy|8|||
124582548|NCT00665925|448093500|FG002|Overall Study|Lack of Efficacy|9|||
124582549|NCT00665925|448093501|FG003|Overall Study|Lack of Efficacy|8|||
124582550|NCT00665925|448093498|FG000|Overall Study|Lost to Follow-up|1|||
124582551|NCT00665925|448093499|FG001|Overall Study|Lost to Follow-up|2|||
124728087|NCT01892436|448625816|FG000|Overall Study|non-compliance with treatment|1|||
124728088|NCT01892436|448625817|FG001|Overall Study|non-compliance with treatment|0|||
124582552|NCT00665925|448093500|FG002|Overall Study|Lost to Follow-up|2|||
124728089|NCT01892436|448625818|FG002|Overall Study|non-compliance with treatment|0|||
124728090|NCT01892436|448625819|FG003|Overall Study|non-compliance with treatment|0|||
124728091|NCT01892436|448625816|FG000|Overall Study|Adverse Event|7|||
124728092|NCT01892436|448625817|FG001|Overall Study|Adverse Event|6|||
124728093|NCT01892436|448625818|FG002|Overall Study|Adverse Event|2|||
124728094|NCT01892436|448625819|FG003|Overall Study|Adverse Event|3|||
124529999|NCT01738594|447889724|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
124530000|NCT01738594|447889725|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
124530001|NCT01738594|447889726|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
124530002|NCT01738594|447889719|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
124530003|NCT01738594|447889720|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
124530004|NCT01738594|447889721|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
124530005|NCT01738594|447889722|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
124530006|NCT01738594|447889723|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
124530007|NCT01738594|447889724|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
124530008|NCT01738594|447889725|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
124530009|NCT01738594|447889726|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
124530010|NCT01738594|447889719|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
124530011|NCT01738594|447889720|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
124530012|NCT01738594|447889721|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
124530013|NCT01738594|447889722|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
124530014|NCT01738594|447889723|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
124530015|NCT01738594|447889724|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
124530016|NCT01738594|447889725|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
124530017|NCT01738594|447889726|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
124530018|NCT01738594|447889719|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
124530019|NCT01738594|447889720|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
124530020|NCT01738594|447889721|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
124530021|NCT01738594|447889722|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
124530022|NCT01738594|447889723|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
124530023|NCT01738594|447889724|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
124530024|NCT01738594|447889725|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
124530025|NCT01738594|447889726|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
124530026|NCT01738594|447889719|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
124530027|NCT01738594|447889720|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
124530028|NCT01738594|447889721|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
124530029|NCT01738594|447889722|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
124530030|NCT01738594|447889723|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
124530031|NCT01738594|447889724|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
124530032|NCT01738594|447889725|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
124530033|NCT01738594|447889726|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
124530034|NCT01738594|447889719|FG000|Follow up for 1 Year|Death|0|||
124530035|NCT01738594|447889720|FG001|Follow up for 1 Year|Death|0|||
124530036|NCT01738594|447889721|FG002|Follow up for 1 Year|Death|0|||
124530037|NCT01738594|447889722|FG003|Follow up for 1 Year|Death|0|||
124530038|NCT01738594|447889723|FG004|Follow up for 1 Year|Death|0|||
124530039|NCT01738594|447889724|FG005|Follow up for 1 Year|Death|1|||
124530040|NCT01738594|447889725|FG006|Follow up for 1 Year|Death|0|||
124530041|NCT01738594|447889726|FG007|Follow up for 1 Year|Death|0|||
124530042|NCT01738594|447889719|FG000|Follow up for 1 Year|Other|0|||
124530043|NCT01738594|447889720|FG001|Follow up for 1 Year|Other|0|||
124530044|NCT01738594|447889721|FG002|Follow up for 1 Year|Other|0|||
124530045|NCT01738594|447889722|FG003|Follow up for 1 Year|Other|0|||
124530046|NCT01738594|447889723|FG004|Follow up for 1 Year|Other|0|||
124530047|NCT01738594|447889724|FG005|Follow up for 1 Year|Other|2|||
124530048|NCT01738594|447889725|FG006|Follow up for 1 Year|Other|0|||
124530049|NCT01738594|447889726|FG007|Follow up for 1 Year|Other|0|||
124530050|NCT00403390|447889727|FG000|Overall Study|Withdrawal by Subject|1|||
124530051|NCT00403390|447889728|FG001|Overall Study|Withdrawal by Subject|0|||
124530052|NCT00403390|447889727|FG000|Overall Study|samples lost|1|||
124530053|NCT00403390|447889728|FG001|Overall Study|samples lost|0|||
124728095|NCT00733291|448625821|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
124777027|NCT02721966|448811392|FG000|Overall Study|Protocol Violation|1|||
124530054|NCT00403390|447889727|FG000|Overall Study|non-compliant|1|||
124530055|NCT00403390|447889728|FG001|Overall Study|non-compliant|0|||
124530056|NCT05307523|447889737|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
124530057|NCT05307523|447889738|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
124530058|NCT05307523|447889737|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
124728096|NCT00733291|448625822|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
124777028|NCT02721966|448811393|FG001|Overall Study|Protocol Violation|0|||
124582553|NCT00665925|448093501|FG003|Overall Study|Lost to Follow-up|2|||
124582554|NCT00665925|448093498|FG000|Overall Study|Withdrawal by Subject|2|||
124582555|NCT00665925|448093499|FG001|Overall Study|Withdrawal by Subject|2|||
124582556|NCT00665925|448093500|FG002|Overall Study|Withdrawal by Subject|3|||
124582557|NCT00665925|448093501|FG003|Overall Study|Withdrawal by Subject|2|||
124582558|NCT00665925|448093498|FG000|Overall Study|Physician Decision|0|||
124582559|NCT00665925|448093499|FG001|Overall Study|Physician Decision|0|||
124582560|NCT00665925|448093500|FG002|Overall Study|Physician Decision|1|||
124582561|NCT00665925|448093501|FG003|Overall Study|Physician Decision|2|||
124582562|NCT00665925|448093498|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
124582563|NCT00665925|448093499|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
124582564|NCT00665925|448093500|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
124582565|NCT00665925|448093501|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
124582566|NCT00665925|448093498|FG000|Overall Study|Adverse Event|1|||
124582567|NCT00665925|448093499|FG001|Overall Study|Adverse Event|5|||
124582568|NCT00665925|448093500|FG002|Overall Study|Adverse Event|10|||
124582569|NCT00665925|448093501|FG003|Overall Study|Adverse Event|5|||
124582570|NCT00665925|448093498|FG000|Overall Study|Enrolled by mistake|0|||
124582571|NCT00665925|448093499|FG001|Overall Study|Enrolled by mistake|0|||
124582572|NCT00665925|448093500|FG002|Overall Study|Enrolled by mistake|0|||
124582573|NCT00665925|448093501|FG003|Overall Study|Enrolled by mistake|1|||
124582574|NCT00665925|448093498|FG000|Overall Study|Due to exclusion criteria|1|||
124582575|NCT00665925|448093499|FG001|Overall Study|Due to exclusion criteria|0|||
124582576|NCT00665925|448093500|FG002|Overall Study|Due to exclusion criteria|0|||
124582577|NCT00665925|448093501|FG003|Overall Study|Due to exclusion criteria|0|||
124582582|NCT00334815|448093506|FG000|Overall Study|Adverse Event|3|||
124582583|NCT00334815|448093507|FG001|Overall Study|Adverse Event|2|||
124582584|NCT00334815|448093506|FG000|Overall Study|Death|0|||
124582585|NCT00334815|448093507|FG001|Overall Study|Death|2|||
124582586|NCT00334815|448093506|FG000|Overall Study|Progression|1|||
124582587|NCT00334815|448093507|FG001|Overall Study|Progression|0|||
124582588|NCT00334815|448093506|FG000|Overall Study|ineligible|1|||
124582589|NCT00334815|448093507|FG001|Overall Study|ineligible|1|||
124582590|NCT00334815|448093506|FG000|Overall Study|patient refused treatment|0|||
124582591|NCT00334815|448093507|FG001|Overall Study|patient refused treatment|1|||
124582592|NCT00334815|448093506|FG000|Overall Study|Physician Decision|2|||
124582593|NCT00334815|448093507|FG001|Overall Study|Physician Decision|4|||
124582594|NCT02197416|448093508|FG000|Overall Study|Other reasons|0|||
124582595|NCT02197416|448093509|FG001|Overall Study|Other reasons|2|||
124582596|NCT02197416|448093510|FG002|Overall Study|Other reasons|5|||
124582597|NCT02197416|448093508|FG000|Overall Study|Withdrawal by Subject|0|||
124582598|NCT02197416|448093509|FG001|Overall Study|Withdrawal by Subject|2|||
124582599|NCT02197416|448093510|FG002|Overall Study|Withdrawal by Subject|1|||
124582600|NCT02197416|448093508|FG000|Overall Study|Protocol Violation|1|||
124582601|NCT02197416|448093509|FG001|Overall Study|Protocol Violation|0|||
124582602|NCT02197416|448093510|FG002|Overall Study|Protocol Violation|1|||
124582603|NCT02197416|448093508|FG000|Overall Study|Adverse Event|0|||
124582604|NCT02197416|448093509|FG001|Overall Study|Adverse Event|0|||
124582605|NCT02197416|448093510|FG002|Overall Study|Adverse Event|1|||
124582606|NCT02451696|448093511|FG000|Overall Study|Surgery postponed|1|||
124582607|NCT02451696|448093512|FG001|Overall Study|Surgery postponed|0|||
124582608|NCT05014828|448093513|FG000|Overall Study|Study Completed by Sponsor|16|||
124582609|NCT05014828|448093514|FG001|Overall Study|Study Completed by Sponsor|16|||
124582610|NCT05014828|448093515|FG002|Overall Study|Study Completed by Sponsor|3|||
124582611|NCT05014828|448093516|FG003|Overall Study|Study Completed by Sponsor|3|||
124582612|NCT05014828|448093513|FG000|Overall Study|Death|11|||
124582613|NCT05014828|448093514|FG001|Overall Study|Death|6|||
124582614|NCT05014828|448093515|FG002|Overall Study|Death|0|||
124582615|NCT05014828|448093516|FG003|Overall Study|Death|0|||
124582616|NCT05014828|448093513|FG000|Overall Study|Lost to Follow-up|0|||
124582617|NCT05014828|448093514|FG001|Overall Study|Lost to Follow-up|0|||
124582618|NCT05014828|448093515|FG002|Overall Study|Lost to Follow-up|2|||
124582619|NCT05014828|448093516|FG003|Overall Study|Lost to Follow-up|0|||
124582620|NCT05014828|448093513|FG000|Overall Study|Miscellaneous.|0|||
124582621|NCT05014828|448093514|FG001|Overall Study|Miscellaneous.|1|||
124582622|NCT05014828|448093515|FG002|Overall Study|Miscellaneous.|0|||
124582623|NCT05014828|448093516|FG003|Overall Study|Miscellaneous.|0|||
124582624|NCT02392195|448093520|FG000|Overall Study|Lost to Follow-up|4|||
124582625|NCT02392195|448093520|FG000|Overall Study|Withdrawal by Subject|4|||
124582626|NCT00545792|448093523|FG000|Overall Study|Withdrawal by Subject|1|||
124582627|NCT03679598|448093525|FG000|Overall Study|Adverse Event|2|||
124582628|NCT03679598|448093526|FG001|Overall Study|Adverse Event|0|||
124582629|NCT03779334|448093529|FG000|Overall Study|Withdrawal by Subject|3|||
124582630|NCT03779334|448093530|FG001|Overall Study|Withdrawal by Subject|0|||
124582631|NCT03779334|448093531|FG002|Overall Study|Withdrawal by Subject|0|||
124728097|NCT00733291|448625823|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
124728098|NCT00733291|448625824|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
124728099|NCT02242435|448625829|FG000|Overall Study|Lost to Follow-up|3|||
124728100|NCT02242435|448625830|FG001|Overall Study|Lost to Follow-up|4|||
124728101|NCT02242435|448625829|FG000|Overall Study|Adverse Event|3|||
124728102|NCT02242435|448625830|FG001|Overall Study|Adverse Event|2|||
124728103|NCT02242435|448625829|FG000|Overall Study|Withdrawal by Subject|13|||
124728104|NCT02242435|448625830|FG001|Overall Study|Withdrawal by Subject|8|||
124728105|NCT02242435|448625829|FG000|Overall Study|Death|0|||
124728106|NCT02242435|448625830|FG001|Overall Study|Death|1|||
124728107|NCT02242435|448625829|FG000|Overall Study|Protocol Violation|1|||
124728108|NCT02242435|448625830|FG001|Overall Study|Protocol Violation|0|||
124728109|NCT02242435|448625829|FG000|Overall Study|Physician Decision|0|||
124728110|NCT02242435|448625830|FG001|Overall Study|Physician Decision|1|||
124728111|NCT03895086|448625832|FG000|Overall Study|Early termination study|1|||
124728112|NCT03895086|448625833|FG001|Overall Study|Early termination study|0|||
124728113|NCT01089413|448625837|FG000|Overall Study|Lost to Follow-up|1|||
124728114|NCT01089413|448625837|FG000|Overall Study|Progressive Disease|93|||
124728115|NCT01089413|448625837|FG000|Overall Study|Participant Withdrew Consent|1|||
124728116|NCT01089413|448625837|FG000|Overall Study|Unacceptable Toxicity|12|||
124728117|NCT01089413|448625837|FG000|Overall Study|Death|10|||
124728118|NCT01089413|448625837|FG000|Overall Study|Metastasectomy|13|||
124728119|NCT01089413|448625837|FG000|Overall Study|Other|71|||
124728120|NCT02513485|448625841|FG000|Overall Study|Adverse Event|1|||
124728121|NCT02513485|448625842|FG001|Overall Study|Adverse Event|0|||
124728122|NCT00420004|448625853|FG000|Overall Study|Adverse Event|4|||
124728123|NCT00420004|448625854|FG001|Overall Study|Adverse Event|1|||
124728124|NCT00420004|448625855|FG002|Overall Study|Adverse Event|1|||
124728125|NCT00420004|448625853|FG000|Overall Study|Lack of Efficacy|5|||
124728126|NCT00420004|448625854|FG001|Overall Study|Lack of Efficacy|4|||
124728127|NCT00420004|448625855|FG002|Overall Study|Lack of Efficacy|1|||
124728128|NCT00420004|448625853|FG000|Overall Study|Lost to Follow-up|31|||
124728129|NCT00420004|448625854|FG001|Overall Study|Lost to Follow-up|12|||
124728130|NCT00420004|448625855|FG002|Overall Study|Lost to Follow-up|10|||
124728131|NCT00420004|448625853|FG000|Overall Study|Entry Criteria Not Met|0|||
124728132|NCT00420004|448625854|FG001|Overall Study|Entry Criteria Not Met|1|||
124728133|NCT00420004|448625855|FG002|Overall Study|Entry Criteria Not Met|0|||
124728134|NCT00420004|448625853|FG000|Overall Study|Physician Decision|14|||
124728135|NCT00420004|448625854|FG001|Overall Study|Physician Decision|4|||
124728136|NCT00420004|448625855|FG002|Overall Study|Physician Decision|2|||
124728137|NCT00420004|448625853|FG000|Overall Study|Protocol Violation|5|||
124728138|NCT00420004|448625854|FG001|Overall Study|Protocol Violation|4|||
124728139|NCT00420004|448625855|FG002|Overall Study|Protocol Violation|3|||
124728140|NCT00420004|448625853|FG000|Overall Study|Withdrawal by Subject|67|||
124728141|NCT00420004|448625854|FG001|Overall Study|Withdrawal by Subject|42|||
124728142|NCT00420004|448625855|FG002|Overall Study|Withdrawal by Subject|14|||
124728143|NCT00420004|448625853|FG000|Overall Study|Sponsor Decision|3|||
124728144|NCT00420004|448625854|FG001|Overall Study|Sponsor Decision|3|||
124728145|NCT00420004|448625855|FG002|Overall Study|Sponsor Decision|1|||
124728146|NCT00591149|448625856|FG000|Overall Study|Adverse Event|4|||
124530059|NCT05307523|447889738|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
124728147|NCT00591149|448625856|FG000|Overall Study|Withdrawal by Subject|1|||
124728148|NCT00470093|448625857|FG000|Overall Study|Adverse Event|2|||
124728149|NCT02456636|448625858|FG000|Overall Study|Death|0|||
124728150|NCT02456636|448625859|FG001|Overall Study|Death|3|||
124728151|NCT02456636|448625860|FG002|Overall Study|Death|0|||
124728152|NCT02456636|448625858|FG000|Overall Study|Pregnancy|1|||
124728153|NCT02456636|448625859|FG001|Overall Study|Pregnancy|3|||
124728154|NCT02456636|448625860|FG002|Overall Study|Pregnancy|5|||
124728155|NCT02456636|448625858|FG000|Overall Study|Physician Decision|4|||
124728156|NCT02456636|448625859|FG001|Overall Study|Physician Decision|5|||
124728157|NCT02456636|448625860|FG002|Overall Study|Physician Decision|4|||
124728158|NCT02456636|448625858|FG000|Overall Study|Withdrawal by Subject|13|||
124728159|NCT02456636|448625859|FG001|Overall Study|Withdrawal by Subject|14|||
124728160|NCT02456636|448625860|FG002|Overall Study|Withdrawal by Subject|16|||
124530060|NCT01708915|447889740|FG000|Overall Study|Adverse Event|1|||
124530061|NCT01708915|447889741|FG001|Overall Study|Adverse Event|0|||
124530062|NCT01708915|447889742|FG002|Overall Study|Adverse Event|9|||
124728161|NCT02456636|448625858|FG000|Overall Study|Lost to Follow-up|50|||
124530063|NCT01708915|447889743|FG003|Overall Study|Adverse Event|13|||
124530064|NCT01708915|447889740|FG000|Overall Study|Lack of Efficacy|84|||
124728162|NCT02456636|448625859|FG001|Overall Study|Lost to Follow-up|44|||
124728163|NCT02456636|448625860|FG002|Overall Study|Lost to Follow-up|50|||
124728164|NCT05312632|448625863|FG000|Overall Study|Adverse Event|12|||
124728165|NCT05312632|448625863|FG000|Overall Study|Withdrawal by Subject|10|||
124728166|NCT05312632|448625863|FG000|Overall Study|Lack of Efficacy|4|||
124728167|NCT05312632|448625863|FG000|Overall Study|Non-compliance with study procedures|9|||
124728168|NCT05312632|448625863|FG000|Overall Study|Other|4|||
124728169|NCT02379221|448625864|FG000|Overall Study|Lost to Follow-up|1|||
124582632|NCT03779334|448093529|FG000|Overall Study|Ongoing in Study|5|||
124582633|NCT03779334|448093530|FG001|Overall Study|Ongoing in Study|13|||
124582634|NCT03779334|448093531|FG002|Overall Study|Ongoing in Study|5|||
124582635|NCT03957551|448093535|FG000|Overall Study|Adverse Event|2|||
124582636|NCT03957551|448093536|FG001|Overall Study|Adverse Event|2|||
124582637|NCT03957551|448093537|FG002|Overall Study|Adverse Event|6|||
124582638|NCT03957551|448093535|FG000|Overall Study|Physician Decision|1|||
124582639|NCT03957551|448093536|FG001|Overall Study|Physician Decision|0|||
124582640|NCT03957551|448093537|FG002|Overall Study|Physician Decision|2|||
124582641|NCT03957551|448093535|FG000|Overall Study|Withdrawal by Subject|1|||
124582642|NCT03957551|448093536|FG001|Overall Study|Withdrawal by Subject|0|||
124582643|NCT03957551|448093537|FG002|Overall Study|Withdrawal by Subject|2|||
124582644|NCT03957551|448093535|FG000|Overall Study|Disease progression|1|||
124582645|NCT03957551|448093536|FG001|Overall Study|Disease progression|0|||
124582646|NCT03957551|448093537|FG002|Overall Study|Disease progression|8|||
124582647|NCT03676634|448093540|FG000|Overall Study|Red blood cell loss|1|||
124728170|NCT01610557|448625865|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
124728171|NCT01610557|448625866|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
124728172|NCT01610557|448625867|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
124582648|NCT03676634|448093540|FG000|Overall Study|Out-of-limit pulse|2|||
124582649|NCT03131895|448093546|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
124582650|NCT03131895|448093547|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
124582651|NCT03131895|448093548|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
124582652|NCT03131895|448093549|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
124582653|NCT03131895|448093546|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
124582654|NCT03131895|448093547|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
124582655|NCT03131895|448093548|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
124582656|NCT03131895|448093549|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
124582657|NCT03131895|448093546|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
124582658|NCT03131895|448093547|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
124582659|NCT03131895|448093548|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
124582660|NCT03131895|448093549|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
124582661|NCT03131895|448093546|FG000|Washout Period (at Least 5 Days)|Other|0|||
124582662|NCT03131895|448093547|FG001|Washout Period (at Least 5 Days)|Other|0|||
124582663|NCT03131895|448093548|FG002|Washout Period (at Least 5 Days)|Other|2|||
124582664|NCT03131895|448093549|FG003|Washout Period (at Least 5 Days)|Other|0|||
124582665|NCT03131895|448093546|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
124582666|NCT03131895|448093547|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
124582667|NCT03131895|448093548|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
124582668|NCT03131895|448093549|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
124582669|NCT03131895|448093546|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
124582670|NCT03131895|448093547|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
124582671|NCT03131895|448093548|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
124582672|NCT03131895|448093549|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
124582673|NCT00540423|448093550|FG000|Double-Blind Treatment Period|Adverse Event|0|||
124582674|NCT00540423|448093551|FG001|Double-Blind Treatment Period|Adverse Event|1|||
124582675|NCT00540423|448093552|FG002|Double-Blind Treatment Period|Adverse Event|0|||
124582676|NCT00540423|448093550|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
124582677|NCT00540423|448093551|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
124582678|NCT00540423|448093552|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
124582679|NCT02213263|448093556|FG000|Overall Study|Insufficient clinical response|4|||
124582680|NCT02213263|448093557|FG001|Overall Study|Insufficient clinical response|3|||
124582681|NCT02213263|448093556|FG000|Overall Study|Lost to Follow-up|0|||
124582682|NCT02213263|448093557|FG001|Overall Study|Lost to Follow-up|1|||
124582683|NCT02213263|448093556|FG000|Overall Study|No longer willing to participate|3|||
124582684|NCT02213263|448093557|FG001|Overall Study|No longer willing to participate|4|||
124582685|NCT02213263|448093556|FG000|Overall Study|Progressive disease|20|||
124582686|NCT02213263|448093557|FG001|Overall Study|Progressive disease|14|||
124582687|NCT02213263|448093556|FG000|Overall Study|Protocol Violation|0|||
124582688|NCT02213263|448093557|FG001|Overall Study|Protocol Violation|1|||
124582689|NCT02213263|448093556|FG000|Overall Study|Adverse Event|1|||
124582690|NCT02213263|448093557|FG001|Overall Study|Adverse Event|3|||
124582691|NCT00216736|448093563|FG000|Overall Study|Lost to Follow-up|1|||
124582692|NCT00216736|448093564|FG001|Overall Study|Lost to Follow-up|1|||
124582693|NCT00418145|448093565|FG000|Overall Study|study terminated|6|||
124582694|NCT03214588|448093566|FG000|Overall Study|Adverse Event|1|||
124582695|NCT03214588|448093567|FG001|Overall Study|Adverse Event|0|||
124582696|NCT03214588|448093568|FG002|Overall Study|Adverse Event|2|||
124582697|NCT03214588|448093566|FG000|Overall Study|Reason Not Specified|0|||
124582698|NCT03214588|448093567|FG001|Overall Study|Reason Not Specified|1|||
124582699|NCT03214588|448093568|FG002|Overall Study|Reason Not Specified|0|||
124582700|NCT03480763|448093573|FG000|Overall Study|Withdrawal by Subject|18|||
124728173|NCT01610557|448625868|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
124777029|NCT02721966|448811394|FG002|Overall Study|Protocol Violation|0|||
124582701|NCT03480763|448093574|FG001|Overall Study|Withdrawal by Subject|10|||
124582702|NCT03480763|448093573|FG000|Overall Study|Lost to Follow-up|4|||
124582703|NCT03480763|448093574|FG001|Overall Study|Lost to Follow-up|7|||
124582704|NCT03480763|448093573|FG000|Overall Study|non-study pneumococcal vaccine|1|||
124582705|NCT03480763|448093574|FG001|Overall Study|non-study pneumococcal vaccine|0|||
124582706|NCT03480763|448093573|FG000|Overall Study|oncological treatment|0|||
124582707|NCT03480763|448093574|FG001|Overall Study|oncological treatment|2|||
124582708|NCT03480763|448093573|FG000|Overall Study|pain with vaccination|1|||
124582709|NCT03480763|448093574|FG001|Overall Study|pain with vaccination|0|||
124582710|NCT03629054|448093578|FG000|Period 2 (4 Days)|Not treated|0|||
124582711|NCT03629054|448093579|FG001|Period 2 (4 Days)|Not treated|1|||
124582712|NCT00205777|448093580|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
124582713|NCT00205777|448093581|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
124582714|NCT00205777|448093582|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
124582715|NCT00205777|448093583|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
124582716|NCT00205777|448093584|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
124582717|NCT00205777|448093585|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
124582718|NCT00205777|448093580|FG000|Core Study (Up to 3 Years)|Death|9|||
124582719|NCT00205777|448093581|FG001|Core Study (Up to 3 Years)|Death|7|||
124582720|NCT00205777|448093582|FG002|Core Study (Up to 3 Years)|Death|14|||
124582721|NCT00205777|448093583|FG003|Core Study (Up to 3 Years)|Death|7|||
124582722|NCT00205777|448093584|FG004|Core Study (Up to 3 Years)|Death|0|||
124582723|NCT00205777|448093585|FG005|Core Study (Up to 3 Years)|Death|0|||
124582724|NCT00205777|448093580|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
124582725|NCT00205777|448093581|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
124582726|NCT00205777|448093582|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
124582727|NCT00205777|448093583|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
124582728|NCT00205777|448093584|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
124582729|NCT00205777|448093585|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
124582730|NCT00205777|448093580|FG000|Core Study (Up to 3 Years)|Other Event|49|||
124582731|NCT00205777|448093581|FG001|Core Study (Up to 3 Years)|Other Event|52|||
124728174|NCT01610557|448625869|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
124728175|NCT01610557|448625865|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
124728176|NCT01610557|448625866|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
124728177|NCT01610557|448625867|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
124728178|NCT01610557|448625868|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
124728179|NCT01610557|448625869|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
124728180|NCT00519376|448625872|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
124728181|NCT00519376|448625873|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
124728182|NCT00519376|448625874|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
124728183|NCT00519376|448625875|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
124728184|NCT00519376|448625876|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
124728185|NCT00519376|448625877|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
124728186|NCT00519376|448625878|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
124728187|NCT00519376|448625879|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
124728188|NCT00519376|448625880|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
124728189|NCT00519376|448625881|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
124728190|NCT00519376|448625882|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
124728191|NCT00519376|448625883|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
124728192|NCT00519376|448625884|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
124728193|NCT00519376|448625885|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
124728194|NCT00519376|448625886|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
124728195|NCT00519376|448625887|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
124728196|NCT00519376|448625872|FG000|Treatment Period 4|Lost to Follow-up|0|||
124728197|NCT00519376|448625873|FG001|Treatment Period 4|Lost to Follow-up|0|||
124728198|NCT00519376|448625874|FG002|Treatment Period 4|Lost to Follow-up|1|||
124728199|NCT00519376|448625875|FG003|Treatment Period 4|Lost to Follow-up|0|||
124728200|NCT00519376|448625876|FG004|Treatment Period 4|Lost to Follow-up|0|||
124728201|NCT00519376|448625877|FG005|Treatment Period 4|Lost to Follow-up|0|||
124728202|NCT00519376|448625878|FG006|Treatment Period 4|Lost to Follow-up|0|||
124728203|NCT00519376|448625879|FG007|Treatment Period 4|Lost to Follow-up|0|||
124728204|NCT00519376|448625880|FG008|Treatment Period 4|Lost to Follow-up|0|||
124728205|NCT00519376|448625881|FG009|Treatment Period 4|Lost to Follow-up|0|||
124728206|NCT00519376|448625882|FG010|Treatment Period 4|Lost to Follow-up|0|||
124777030|NCT02721966|448811395|FG003|Overall Study|Protocol Violation|0|||
124582732|NCT00205777|448093582|FG002|Core Study (Up to 3 Years)|Other Event|41|||
124582733|NCT00205777|448093583|FG003|Core Study (Up to 3 Years)|Other Event|58|||
124582734|NCT00205777|448093584|FG004|Core Study (Up to 3 Years)|Other Event|0|||
124582735|NCT00205777|448093585|FG005|Core Study (Up to 3 Years)|Other Event|0|||
124582736|NCT00205777|448093580|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
124582737|NCT00205777|448093581|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
124530065|NCT01708915|447889741|FG001|Overall Study|Lack of Efficacy|60|||
124530066|NCT01708915|447889742|FG002|Overall Study|Lack of Efficacy|35|||
124530067|NCT01708915|447889743|FG003|Overall Study|Lack of Efficacy|15|||
124530068|NCT01708915|447889740|FG000|Overall Study|Protocol Violation|0|||
124530069|NCT01708915|447889741|FG001|Overall Study|Protocol Violation|0|||
124530070|NCT01708915|447889742|FG002|Overall Study|Protocol Violation|0|||
124530071|NCT01708915|447889743|FG003|Overall Study|Protocol Violation|1|||
124530072|NCT01708915|447889740|FG000|Overall Study|Withdrawal by Subject|0|||
124530073|NCT01708915|447889741|FG001|Overall Study|Withdrawal by Subject|1|||
124530074|NCT01708915|447889742|FG002|Overall Study|Withdrawal by Subject|2|||
124530075|NCT01708915|447889743|FG003|Overall Study|Withdrawal by Subject|2|||
124530076|NCT01708915|447889740|FG000|Overall Study|Other reasons than stated above|1|||
124530077|NCT01708915|447889741|FG001|Overall Study|Other reasons than stated above|1|||
124530078|NCT01708915|447889742|FG002|Overall Study|Other reasons than stated above|0|||
124530079|NCT01708915|447889743|FG003|Overall Study|Other reasons than stated above|2|||
124530080|NCT03231228|447889744|FG000|Overall Study|Lost to Follow-up|2|||
124530081|NCT03231228|447889745|FG001|Overall Study|Lost to Follow-up|0|||
124530082|NCT03231228|447889744|FG000|Overall Study|Physician Decision|1|||
124530083|NCT03231228|447889745|FG001|Overall Study|Physician Decision|0|||
124530084|NCT03661983|447891184|FG000|Open Label Stabilization Phase|Adverse Event|5|||
124530085|NCT03661983|447891185|FG001|Open Label Stabilization Phase|Adverse Event|0|||
124530086|NCT03661983|447891186|FG002|Open Label Stabilization Phase|Adverse Event|0|||
124530087|NCT03661983|447891187|FG003|Open Label Stabilization Phase|Adverse Event|0|||
124530088|NCT03661983|447891184|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
124530089|NCT03661983|447891185|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
124530090|NCT03661983|447891186|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
124530091|NCT03661983|447891187|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
124530092|NCT03661983|447891184|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
124530093|NCT03661983|447891185|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
124530094|NCT03661983|447891186|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
124530095|NCT03661983|447891187|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
124530096|NCT03661983|447891184|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
124530097|NCT03661983|447891185|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
124530098|NCT03661983|447891186|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
124530099|NCT03661983|447891187|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
124530100|NCT03661983|447891184|FG000|Double-blind Randomized Phase|Adverse Event|0|||
124530101|NCT03661983|447891185|FG001|Double-blind Randomized Phase|Adverse Event|1|||
124530102|NCT03661983|447891186|FG002|Double-blind Randomized Phase|Adverse Event|0|||
124530103|NCT03661983|447891187|FG003|Double-blind Randomized Phase|Adverse Event|0|||
124530104|NCT03661983|447891184|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
124530105|NCT03661983|447891185|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
124530106|NCT03661983|447891186|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
124582738|NCT00205777|448093582|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
124582739|NCT00205777|448093583|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
124582740|NCT00205777|448093584|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
124582741|NCT00205777|448093585|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
124582742|NCT00205777|448093580|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
124582743|NCT00205777|448093581|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
124582744|NCT00205777|448093582|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
124582745|NCT00205777|448093583|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
124582746|NCT00205777|448093584|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
124582747|NCT00205777|448093585|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
124582748|NCT00205777|448093580|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
124582749|NCT00205777|448093581|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
124582750|NCT00205777|448093582|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
124582751|NCT00205777|448093583|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
124582752|NCT00205777|448093584|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
124582753|NCT00205777|448093585|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
124582754|NCT00205777|448093580|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
124582755|NCT00205777|448093581|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
124582756|NCT00205777|448093582|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
124582757|NCT00205777|448093583|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
124728207|NCT00519376|448625883|FG011|Treatment Period 4|Lost to Follow-up|0|||
124728208|NCT00519376|448625884|FG012|Treatment Period 4|Lost to Follow-up|0|||
124728209|NCT00519376|448625885|FG013|Treatment Period 4|Lost to Follow-up|0|||
124530107|NCT03661983|447891187|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
124530108|NCT03661983|447891184|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
124530109|NCT03661983|447891185|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
124530110|NCT03661983|447891186|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
124530111|NCT03661983|447891187|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
124728210|NCT00519376|448625886|FG014|Treatment Period 4|Lost to Follow-up|0|||
124728211|NCT00519376|448625887|FG015|Treatment Period 4|Lost to Follow-up|0|||
124728212|NCT02039219|448625888|FG000|Treatment|Withdrawal by Subject|1|||
124728213|NCT02039219|448625889|FG001|Treatment|Withdrawal by Subject|0|||
124728214|NCT02039219|448625888|FG000|Treatment|Adverse Event|0|||
124728215|NCT02039219|448625889|FG001|Treatment|Adverse Event|1|||
124728216|NCT02039219|448625888|FG000|Treatment|Physician Decision|1|||
124728217|NCT02039219|448625889|FG001|Treatment|Physician Decision|0|||
124728218|NCT02039219|448625888|FG000|Treatment|Lost to Follow-up|0|||
124728219|NCT02039219|448625889|FG001|Treatment|Lost to Follow-up|1|||
124728220|NCT02039219|448625888|FG000|Treatment|Protocol Violation|1|||
124728221|NCT02039219|448625889|FG001|Treatment|Protocol Violation|0|||
124728222|NCT02039219|448625888|FG000|Treatment|Death|1|||
124728223|NCT02039219|448625889|FG001|Treatment|Death|0|||
124728224|NCT02039219|448625888|FG000|Follow up|Adverse Event|0|||
124728225|NCT02039219|448625889|FG001|Follow up|Adverse Event|1|||
124728226|NCT02974855|448625890|FG000|Overall Study|Adverse Event|0|||
124728227|NCT02974855|448625891|FG001|Overall Study|Adverse Event|1|||
124728228|NCT02974855|448625892|FG002|Overall Study|Adverse Event|0|||
124728229|NCT02974855|448625893|FG003|Overall Study|Adverse Event|1|||
124728230|NCT00129701|448625894|FG000|Overall Study|Withdrawal by Subject|33|||
124728231|NCT02750345|448625895|FG000|Intervention 1|Adverse Event|0|||
124728232|NCT02750345|448625896|FG001|Intervention 1|Adverse Event|0|||
124728233|NCT02750345|448625897|FG002|Intervention 1|Adverse Event|0|||
124728234|NCT02750345|448625898|FG003|Intervention 1|Adverse Event|0|||
124728235|NCT02750345|448625899|FG004|Intervention 1|Adverse Event|1|||
124728236|NCT02750345|448625900|FG005|Intervention 1|Adverse Event|0|||
124728237|NCT02650128|448625901|FG000|Overall Study|Death|2|||
124728238|NCT00608023|448625904|FG000|Overall Study|Withdrawal by Subject|8|||
124728239|NCT00608023|448625905|FG001|Overall Study|Withdrawal by Subject|10|||
124728240|NCT00608023|448625906|FG002|Overall Study|Withdrawal by Subject|7|||
124728241|NCT00608023|448625904|FG000|Overall Study|Adverse Event|1|||
124728242|NCT00608023|448625905|FG001|Overall Study|Adverse Event|4|||
124728243|NCT00608023|448625906|FG002|Overall Study|Adverse Event|5|||
124728244|NCT00608023|448625904|FG000|Overall Study|Lost to Follow-up|2|||
124728245|NCT00608023|448625905|FG001|Overall Study|Lost to Follow-up|2|||
124728246|NCT00608023|448625906|FG002|Overall Study|Lost to Follow-up|1|||
124728247|NCT00608023|448625904|FG000|Overall Study|Protocol Violation|1|||
124728248|NCT00608023|448625905|FG001|Overall Study|Protocol Violation|3|||
124728249|NCT00608023|448625906|FG002|Overall Study|Protocol Violation|1|||
124728250|NCT00608023|448625904|FG000|Overall Study|Unknown reason|0|||
124728251|NCT00608023|448625905|FG001|Overall Study|Unknown reason|3|||
124728252|NCT00608023|448625906|FG002|Overall Study|Unknown reason|0|||
124728253|NCT01801436|448625924|FG000|Overall Study|Withdrawal by Subject|3|||
124728254|NCT01801436|448625924|FG000|Overall Study|Adverse Event|2|||
124728255|NCT01801436|448625924|FG000|Overall Study|Progressive disease|4|||
124728256|NCT01126437|448625929|FG000|Overall Study|Not treated|11|||
124728257|NCT01126437|448625930|FG001|Overall Study|Not treated|18|||
124728258|NCT01126437|448625931|FG002|Overall Study|Not treated|19|||
124728259|NCT01126437|448625929|FG000|Overall Study|Sites with data irregularities/fraud|6|||
124728260|NCT01126437|448625930|FG001|Overall Study|Sites with data irregularities/fraud|6|||
124728261|NCT01126437|448625931|FG002|Overall Study|Sites with data irregularities/fraud|7|||
124728262|NCT01126437|448625929|FG000|Overall Study|Adverse Event|602|||
124728263|NCT01126437|448625930|FG001|Overall Study|Adverse Event|606|||
124728264|NCT01126437|448625931|FG002|Overall Study|Adverse Event|635|||
124728265|NCT01126437|448625929|FG000|Overall Study|Lack of Efficacy|65|||
124728266|NCT01126437|448625930|FG001|Overall Study|Lack of Efficacy|60|||
124728267|NCT01126437|448625931|FG002|Overall Study|Lack of Efficacy|59|||
124728268|NCT01126437|448625929|FG000|Overall Study|Protocol Violation|64|||
124728269|NCT01126437|448625930|FG001|Overall Study|Protocol Violation|66|||
124728270|NCT01126437|448625931|FG002|Overall Study|Protocol Violation|41|||
124728271|NCT01126437|448625929|FG000|Overall Study|Lost to Follow-up|52|||
124728272|NCT01126437|448625930|FG001|Overall Study|Lost to Follow-up|63|||
124728273|NCT01126437|448625931|FG002|Overall Study|Lost to Follow-up|55|||
124728274|NCT01126437|448625929|FG000|Overall Study|Withdrawal by Subject|331|||
124728275|NCT01126437|448625930|FG001|Overall Study|Withdrawal by Subject|335|||
124728276|NCT01126437|448625931|FG002|Overall Study|Withdrawal by Subject|319|||
124728277|NCT01126437|448625929|FG000|Overall Study|Other reason not specified|210|||
124728278|NCT01126437|448625930|FG001|Overall Study|Other reason not specified|176|||
124728279|NCT01126437|448625931|FG002|Overall Study|Other reason not specified|178|||
124728280|NCT01846663|448625938|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
124728281|NCT01846663|448625939|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
124728282|NCT01846663|448625938|FG000|Overall Study|Withdrawal by Subject|1|||
124728283|NCT01846663|448625939|FG001|Overall Study|Withdrawal by Subject|0|||
124728284|NCT01846663|448625938|FG000|Overall Study|Adverse Event|1|||
124728285|NCT01846663|448625939|FG001|Overall Study|Adverse Event|2|||
124728286|NCT00813865|448625945|FG000|Overall Study|Failure to Respond|3|||
124728287|NCT00813865|448625945|FG000|Overall Study|Lost to Follow-up|3|||
124728288|NCT00813865|448625945|FG000|Overall Study|Withdrawal by Subject|1|||
124728289|NCT03525600|448625946|FG000|Overall Study|Adverse Event|9|||
124582758|NCT00205777|448093584|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
124582759|NCT00205777|448093585|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
124582760|NCT00205777|448093580|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
124582761|NCT00205777|448093581|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
124582762|NCT00205777|448093582|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
124582763|NCT00205777|448093583|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
124582764|NCT00205777|448093584|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
124582765|NCT00205777|448093585|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
124582766|NCT00205777|448093580|FG000|Completed Core Study, Entered SE I|Other Event|52|||
124582767|NCT00205777|448093581|FG001|Completed Core Study, Entered SE I|Other Event|46|||
124582768|NCT00205777|448093582|FG002|Completed Core Study, Entered SE I|Other Event|47|||
124582769|NCT00205777|448093583|FG003|Completed Core Study, Entered SE I|Other Event|50|||
124582770|NCT00205777|448093584|FG004|Completed Core Study, Entered SE I|Other Event|0|||
124582771|NCT00205777|448093585|FG005|Completed Core Study, Entered SE I|Other Event|0|||
124582772|NCT00205777|448093580|FG000|Study Extension I|Adverse Event|57|||
124582773|NCT00205777|448093581|FG001|Study Extension I|Adverse Event|0|||
124582774|NCT00205777|448093582|FG002|Study Extension I|Adverse Event|0|||
124582775|NCT00205777|448093583|FG003|Study Extension I|Adverse Event|61|||
124582776|NCT00205777|448093584|FG004|Study Extension I|Adverse Event|58|||
124582777|NCT00205777|448093585|FG005|Study Extension I|Adverse Event|0|||
124582778|NCT00205777|448093580|FG000|Study Extension I|Death|5|||
124582779|NCT00205777|448093581|FG001|Study Extension I|Death|0|||
124582780|NCT00205777|448093582|FG002|Study Extension I|Death|0|||
124582781|NCT00205777|448093583|FG003|Study Extension I|Death|1|||
124582782|NCT00205777|448093584|FG004|Study Extension I|Death|2|||
124582783|NCT00205777|448093585|FG005|Study Extension I|Death|0|||
124582784|NCT00205777|448093580|FG000|Study Extension I|Withdrawal by Subject|99|||
124582785|NCT00205777|448093581|FG001|Study Extension I|Withdrawal by Subject|0|||
124582786|NCT00205777|448093582|FG002|Study Extension I|Withdrawal by Subject|0|||
124582787|NCT00205777|448093583|FG003|Study Extension I|Withdrawal by Subject|106|||
124582788|NCT00205777|448093584|FG004|Study Extension I|Withdrawal by Subject|89|||
124582789|NCT00205777|448093585|FG005|Study Extension I|Withdrawal by Subject|0|||
124582790|NCT00205777|448093580|FG000|Study Extension I|Protocol Violation|4|||
124582791|NCT00205777|448093581|FG001|Study Extension I|Protocol Violation|0|||
124582792|NCT00205777|448093582|FG002|Study Extension I|Protocol Violation|0|||
124582793|NCT00205777|448093583|FG003|Study Extension I|Protocol Violation|8|||
124582794|NCT00205777|448093584|FG004|Study Extension I|Protocol Violation|8|||
124582795|NCT00205777|448093585|FG005|Study Extension I|Protocol Violation|0|||
124582796|NCT00205777|448093580|FG000|Study Extension I|Lack of Efficacy|0|||
124582797|NCT00205777|448093581|FG001|Study Extension I|Lack of Efficacy|0|||
124582798|NCT00205777|448093582|FG002|Study Extension I|Lack of Efficacy|0|||
124582799|NCT00205777|448093583|FG003|Study Extension I|Lack of Efficacy|1|||
124582800|NCT00205777|448093584|FG004|Study Extension I|Lack of Efficacy|2|||
124582801|NCT00205777|448093585|FG005|Study Extension I|Lack of Efficacy|0|||
124582802|NCT00205777|448093580|FG000|Study Extension I|Failed to return|15|||
124582803|NCT00205777|448093581|FG001|Study Extension I|Failed to return|0|||
124582804|NCT00205777|448093582|FG002|Study Extension I|Failed to return|0|||
124582805|NCT00205777|448093583|FG003|Study Extension I|Failed to return|17|||
124582806|NCT00205777|448093584|FG004|Study Extension I|Failed to return|13|||
124582807|NCT00205777|448093585|FG005|Study Extension I|Failed to return|0|||
124582808|NCT00205777|448093580|FG000|Study Extension I|Other Event|34|||
124582809|NCT00205777|448093581|FG001|Study Extension I|Other Event|0|||
124582810|NCT00205777|448093582|FG002|Study Extension I|Other Event|0|||
124582811|NCT00205777|448093583|FG003|Study Extension I|Other Event|34|||
124582812|NCT00205777|448093584|FG004|Study Extension I|Other Event|29|||
124582813|NCT00205777|448093585|FG005|Study Extension I|Other Event|0|||
124582814|NCT00205777|448093580|FG000|Study Extension I|Withdrawn as per protocol|0|||
124582815|NCT00205777|448093581|FG001|Study Extension I|Withdrawn as per protocol|0|||
124582816|NCT00205777|448093582|FG002|Study Extension I|Withdrawn as per protocol|1070|||
124582817|NCT00205777|448093583|FG003|Study Extension I|Withdrawn as per protocol|0|||
124582818|NCT00205777|448093584|FG004|Study Extension I|Withdrawn as per protocol|0|||
124582819|NCT00205777|448093585|FG005|Study Extension I|Withdrawn as per protocol|0|||
124582820|NCT00205777|448093580|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
124582821|NCT00205777|448093581|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
124582822|NCT00205777|448093582|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
124582823|NCT00205777|448093583|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
124582824|NCT00205777|448093584|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
124582825|NCT00205777|448093585|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
124582826|NCT00205777|448093580|FG000|Study Extension II|Adverse Event|0|||
124582827|NCT00205777|448093581|FG001|Study Extension II|Adverse Event|0|||
124582828|NCT00205777|448093582|FG002|Study Extension II|Adverse Event|0|||
124582829|NCT00205777|448093583|FG003|Study Extension II|Adverse Event|14|||
124582830|NCT00205777|448093584|FG004|Study Extension II|Adverse Event|0|||
124530112|NCT03661983|447891184|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
124530113|NCT03661983|447891185|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
124530114|NCT03661983|447891186|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
124530115|NCT03661983|447891187|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
124530116|NCT00166504|447891191|FG000|Overall Study|Adverse Event|3|||
124530117|NCT00166504|447891192|FG001|Overall Study|Adverse Event|3|||
124530118|NCT00166504|447891191|FG000|Overall Study|Lost to Follow-up|1|||
124530119|NCT00166504|447891192|FG001|Overall Study|Lost to Follow-up|1|||
124530120|NCT00166504|447891191|FG000|Overall Study|Withdrawal by Subject|1|||
124530121|NCT00166504|447891192|FG001|Overall Study|Withdrawal by Subject|0|||
124530122|NCT01222767|447891193|FG000|Overall Study|Progressive disease|13|||
124530123|NCT01222767|447891193|FG000|Overall Study|Adverse Event|2|||
124530124|NCT01222767|447891193|FG000|Overall Study|Surgical resection|1|||
124582831|NCT00205777|448093585|FG005|Study Extension II|Adverse Event|30|||
124582832|NCT00205777|448093580|FG000|Study Extension II|Death|0|||
124582833|NCT00205777|448093581|FG001|Study Extension II|Death|0|||
124582834|NCT00205777|448093582|FG002|Study Extension II|Death|0|||
124582835|NCT00205777|448093583|FG003|Study Extension II|Death|2|||
124582836|NCT00205777|448093584|FG004|Study Extension II|Death|0|||
124582837|NCT00205777|448093585|FG005|Study Extension II|Death|5|||
124582838|NCT00205777|448093580|FG000|Study Extension II|Withdrawal by Subject|0|||
124582839|NCT00205777|448093581|FG001|Study Extension II|Withdrawal by Subject|0|||
124582840|NCT00205777|448093582|FG002|Study Extension II|Withdrawal by Subject|0|||
124582841|NCT00205777|448093583|FG003|Study Extension II|Withdrawal by Subject|35|||
124582842|NCT00205777|448093584|FG004|Study Extension II|Withdrawal by Subject|0|||
124582843|NCT00205777|448093585|FG005|Study Extension II|Withdrawal by Subject|59|||
124582844|NCT00205777|448093580|FG000|Study Extension II|Protocol Violation|0|||
124582845|NCT00205777|448093581|FG001|Study Extension II|Protocol Violation|0|||
124582846|NCT00205777|448093582|FG002|Study Extension II|Protocol Violation|0|||
124582847|NCT00205777|448093583|FG003|Study Extension II|Protocol Violation|1|||
124582848|NCT00205777|448093584|FG004|Study Extension II|Protocol Violation|0|||
124582849|NCT00205777|448093585|FG005|Study Extension II|Protocol Violation|10|||
124582850|NCT00205777|448093580|FG000|Study Extension II|Lack of Efficacy|0|||
124582851|NCT00205777|448093581|FG001|Study Extension II|Lack of Efficacy|0|||
124582852|NCT00205777|448093582|FG002|Study Extension II|Lack of Efficacy|0|||
124582853|NCT00205777|448093583|FG003|Study Extension II|Lack of Efficacy|0|||
124582854|NCT00205777|448093584|FG004|Study Extension II|Lack of Efficacy|0|||
124582855|NCT00205777|448093585|FG005|Study Extension II|Lack of Efficacy|1|||
124582856|NCT00205777|448093580|FG000|Study Extension II|Failed to return|0|||
124582857|NCT00205777|448093581|FG001|Study Extension II|Failed to return|0|||
124582858|NCT00205777|448093582|FG002|Study Extension II|Failed to return|0|||
124582859|NCT00205777|448093583|FG003|Study Extension II|Failed to return|14|||
124582860|NCT00205777|448093584|FG004|Study Extension II|Failed to return|0|||
124582861|NCT00205777|448093585|FG005|Study Extension II|Failed to return|26|||
124582862|NCT00205777|448093580|FG000|Study Extension II|Other Event|0|||
124582863|NCT00205777|448093581|FG001|Study Extension II|Other Event|0|||
124582864|NCT00205777|448093582|FG002|Study Extension II|Other Event|0|||
124582865|NCT00205777|448093583|FG003|Study Extension II|Other Event|12|||
124582866|NCT00205777|448093584|FG004|Study Extension II|Other Event|0|||
124582867|NCT00205777|448093585|FG005|Study Extension II|Other Event|20|||
124582868|NCT00205777|448093580|FG000|Study Extension II|Enrolled but not treated|0|||
124582869|NCT00205777|448093581|FG001|Study Extension II|Enrolled but not treated|0|||
124582870|NCT00205777|448093582|FG002|Study Extension II|Enrolled but not treated|0|||
124582871|NCT00205777|448093583|FG003|Study Extension II|Enrolled but not treated|71|||
124582872|NCT00205777|448093584|FG004|Study Extension II|Enrolled but not treated|0|||
124530125|NCT01222767|447891193|FG000|Overall Study|Never treated|1|||
124530126|NCT00723489|447891194|FG000|Overall Study|Physician Decision|0|||
124530127|NCT00723489|447891195|FG001|Overall Study|Physician Decision|1|||
124530128|NCT00723489|447891196|FG002|Overall Study|Physician Decision|0|||
124530129|NCT00723489|447891197|FG003|Overall Study|Physician Decision|0|||
124530130|NCT00723489|447891194|FG000|Overall Study|Pregnancy|0|||
124530131|NCT00723489|447891195|FG001|Overall Study|Pregnancy|0|||
124582873|NCT00205777|448093585|FG005|Study Extension II|Enrolled but not treated|131|||
124582874|NCT00367133|448093588|FG000|2 Years|Death|20|||
124582875|NCT00367133|448093589|FG001|2 Years|Death|12|||
124582876|NCT00367133|448093590|FG002|2 Years|Death|12|||
124582877|NCT00367133|448093588|FG000|2 Years|Dropped|34|||
124582878|NCT00367133|448093589|FG001|2 Years|Dropped|19|||
124582879|NCT00367133|448093590|FG002|2 Years|Dropped|33|||
124582880|NCT00367133|448093588|FG000|2 Years|Missed visit|4|||
124530132|NCT00723489|447891196|FG002|Overall Study|Pregnancy|0|||
124582881|NCT00367133|448093589|FG001|2 Years|Missed visit|5|||
124582882|NCT00367133|448093590|FG002|2 Years|Missed visit|4|||
124582883|NCT01252953|448093592|FG000|Overall Study|Withdrawal by Subject|16|||
124582884|NCT01252953|448093593|FG001|Overall Study|Withdrawal by Subject|17|||
124582885|NCT01252953|448093592|FG000|Overall Study|Lost to Follow-up|22|||
124582886|NCT01252953|448093593|FG001|Overall Study|Lost to Follow-up|21|||
124582887|NCT00858780|448093603|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
124530133|NCT00723489|447891197|FG003|Overall Study|Pregnancy|1|||
124530134|NCT00723489|447891194|FG000|Overall Study|Withdrawal by Subject|0|||
124530135|NCT00723489|447891195|FG001|Overall Study|Withdrawal by Subject|0|||
124530136|NCT00723489|447891196|FG002|Overall Study|Withdrawal by Subject|0|||
124530137|NCT00723489|447891197|FG003|Overall Study|Withdrawal by Subject|1|||
124530138|NCT00723489|447891194|FG000|Overall Study|Seropositive at baseline|1|||
124530139|NCT00723489|447891195|FG001|Overall Study|Seropositive at baseline|0|||
124530140|NCT00723489|447891196|FG002|Overall Study|Seropositive at baseline|0|||
124530141|NCT00723489|447891197|FG003|Overall Study|Seropositive at baseline|0|||
124582888|NCT00858780|448093604|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
124582889|NCT00858780|448093605|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
124582890|NCT00858780|448093606|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
124582891|NCT00858780|448093607|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
124582892|NCT00858780|448093603|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
124582893|NCT00858780|448093604|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
124582894|NCT00858780|448093605|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
124582895|NCT00858780|448093606|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
124582896|NCT00858780|448093607|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
124582897|NCT00858780|448093603|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
124582898|NCT00858780|448093604|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
124582899|NCT00858780|448093605|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
124582900|NCT00858780|448093606|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
124582901|NCT00858780|448093607|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
124582902|NCT00858780|448093603|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
124582903|NCT00858780|448093604|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
124582904|NCT00858780|448093605|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
124582905|NCT00858780|448093606|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
124582906|NCT00858780|448093607|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
124582907|NCT00858780|448093603|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
124582908|NCT00858780|448093604|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
124582909|NCT00858780|448093605|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
124582910|NCT00858780|448093606|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
124582911|NCT00858780|448093607|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
124582912|NCT00858780|448093603|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
124582913|NCT00858780|448093604|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
124582914|NCT00858780|448093605|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
124582915|NCT00858780|448093606|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
124582916|NCT00858780|448093607|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
124582917|NCT00863330|448093608|FG000|Overall Study|study terminated early due to administra|6|||
124582918|NCT02615249|448093609|FG000|Overall Study|Withdrawal by Subject|1|||
124582919|NCT05098743|448093610|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
124582920|NCT05098743|448093611|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
124582921|NCT05098743|448093610|FG000|Overall Study|Lost to Follow-up|1|||
124582922|NCT05098743|448093611|FG001|Overall Study|Lost to Follow-up|2|||
124582923|NCT00842309|448093621|FG000|Overall Study|Withdrawal by Subject|3|||
124582924|NCT00842309|448093622|FG001|Overall Study|Withdrawal by Subject|1|||
124582925|NCT02911025|448093623|FG000|Overall Study|Lost to Follow-up|3|||
124582926|NCT03218787|448093624|FG000|Overall Study|Lost to Follow-up|12|||
124582927|NCT03218787|448093624|FG000|Overall Study|Withdrawal by Subject|72|||
124582928|NCT03218787|448093624|FG000|Overall Study|Physician Decision|11|||
124582929|NCT03218787|448093624|FG000|Overall Study|Death|111|||
124582930|NCT03719040|448093625|FG000|Overall Study|Withdrawal by Subject|177|||
124582931|NCT03719040|448093625|FG000|Overall Study|Lost to Follow-up|26|||
124582932|NCT02264977|448093626|FG000|Overall Study|Death|3|||
124582933|NCT02264977|448093626|FG000|Overall Study|Physician Decision|1|||
124582934|NCT02264977|448093626|FG000|Overall Study|Refuse to return|1|||
124582935|NCT02923349|448093627|FG000|Overall Study|Other|1|||
124582936|NCT02923349|448093628|FG001|Overall Study|Other|2|||
124582937|NCT02923349|448093629|FG002|Overall Study|Other|4|||
124582938|NCT02923349|448093630|FG003|Overall Study|Other|1|||
124582939|NCT02923349|448093631|FG004|Overall Study|Other|3|||
124582940|NCT02923349|448093632|FG005|Overall Study|Other|0|||
124582941|NCT02923349|448093633|FG006|Overall Study|Other|1|||
124582942|NCT02923349|448093627|FG000|Overall Study|Withdrawal by Subject|2|||
124582943|NCT02923349|448093628|FG001|Overall Study|Withdrawal by Subject|2|||
124530142|NCT00723489|447891194|FG000|Overall Study|Prohibited Medication|0|||
124530143|NCT00723489|447891195|FG001|Overall Study|Prohibited Medication|0|||
124530144|NCT00723489|447891196|FG002|Overall Study|Prohibited Medication|0|||
124582944|NCT02923349|448093629|FG002|Overall Study|Withdrawal by Subject|8|||
124582945|NCT02923349|448093630|FG003|Overall Study|Withdrawal by Subject|10|||
124582946|NCT02923349|448093631|FG004|Overall Study|Withdrawal by Subject|12|||
124530145|NCT00723489|447891197|FG003|Overall Study|Prohibited Medication|1|||
124530146|NCT00723489|447891194|FG000|Overall Study|Samples Collected Out of Window|0|||
124530147|NCT00723489|447891195|FG001|Overall Study|Samples Collected Out of Window|3|||
124530148|NCT00723489|447891196|FG002|Overall Study|Samples Collected Out of Window|0|||
124530149|NCT00723489|447891197|FG003|Overall Study|Samples Collected Out of Window|0|||
124530150|NCT00081263|447891198|FG000|Overall Study|clerical error|1|||
124530151|NCT00081263|447891199|FG001|Overall Study|clerical error|0|||
124530152|NCT00081263|447891198|FG000|Overall Study|wrong cell type|7|||
124530153|NCT00081263|447891199|FG001|Overall Study|wrong cell type|5|||
124530154|NCT00081263|447891198|FG000|Overall Study|improper pre-protocol therapy|0|||
124530155|NCT00081263|447891199|FG001|Overall Study|improper pre-protocol therapy|1|||
124530156|NCT00081263|447891198|FG000|Overall Study|Inadequate pathology|0|||
124530157|NCT00081263|447891199|FG001|Overall Study|Inadequate pathology|1|||
124530158|NCT00081263|447891198|FG000|Overall Study|Never treated|4|||
124530159|NCT00081263|447891199|FG001|Overall Study|Never treated|5|||
124530160|NCT00081263|447891198|FG000|Overall Study|Inadequate data|5|||
124530161|NCT00081263|447891199|FG001|Overall Study|Inadequate data|10|||
124530162|NCT04517253|447891200|FG000|Primary Treatment Period|Adverse Event|1|||
124530163|NCT04517253|447891201|FG001|Primary Treatment Period|Adverse Event|0|||
124530164|NCT04517253|447891202|FG002|Primary Treatment Period|Adverse Event|0|||
124530165|NCT04517253|447891200|FG000|Primary Treatment Period|Death|0|||
124530166|NCT04517253|447891201|FG001|Primary Treatment Period|Death|1|||
124530167|NCT04517253|447891202|FG002|Primary Treatment Period|Death|0|||
124530168|NCT04517253|447891200|FG000|Maintenance Period|Withdrawal by Subject|1|||
124530169|NCT04517253|447891201|FG001|Maintenance Period|Withdrawal by Subject|0|||
124530170|NCT04517253|447891202|FG002|Maintenance Period|Withdrawal by Subject|0|||
124530171|NCT04517253|447891200|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
124530172|NCT04517253|447891201|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
124530173|NCT04517253|447891202|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
124530174|NCT02060903|447891203|FG000|Overall Study|Lost to Follow-up|4|||
124530175|NCT02060903|447891204|FG001|Overall Study|Lost to Follow-up|0|||
124530176|NCT02060903|447891203|FG000|Overall Study|Withdrawal by Subject|0|||
124530177|NCT02060903|447891204|FG001|Overall Study|Withdrawal by Subject|7|||
124530178|NCT00958191|447891209|FG000|Overall Study|Death|4|||
124530179|NCT00958191|447891209|FG000|Overall Study|Lost to Follow-up|5|||
124530180|NCT00958191|447891209|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
124530181|NCT00958191|447891209|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
124530182|NCT00958191|447891209|FG000|Overall Study|Revision of study device|4|||
124530183|NCT00958191|447891209|FG000|Overall Study|Site termination|11|||
124530184|NCT00958191|447891209|FG000|Overall Study|No 5 yr x-rays|56|||
124530185|NCT00611767|447891210|FG000|Overall Study|Withdrawal by Subject|4|||
124530186|NCT00611767|447891211|FG001|Overall Study|Withdrawal by Subject|1|||
124530187|NCT00611767|447891210|FG000|Overall Study|Thiopental not available|3|||
124530188|NCT00611767|447891211|FG001|Overall Study|Thiopental not available|0|||
124530189|NCT00611767|447891210|FG000|Overall Study|didn't like the medication|1|||
124530190|NCT00611767|447891211|FG001|Overall Study|didn't like the medication|1|||
124530191|NCT00611767|447891210|FG000|Overall Study|Physician Decision|1|||
124530192|NCT00611767|447891211|FG001|Overall Study|Physician Decision|0|||
124530193|NCT02010567|447891212|FG000|Overall Study|Adverse Event|0|||
124530194|NCT02010567|447891213|FG001|Overall Study|Adverse Event|0|||
124530195|NCT02010567|447891214|FG002|Overall Study|Adverse Event|1|||
124530196|NCT02010567|447891215|FG003|Overall Study|Adverse Event|0|||
124530197|NCT02010567|447891216|FG004|Overall Study|Adverse Event|1|||
124530198|NCT00118040|447891217|FG000|Overall Study|Adverse Event|0|||
124530199|NCT00118040|447891218|FG001|Overall Study|Adverse Event|1|||
124530200|NCT00118040|447891219|FG002|Overall Study|Adverse Event|0|||
124530201|NCT00118040|447891217|FG000|Overall Study|Withdrawal by Subject|0|||
124530202|NCT00118040|447891218|FG001|Overall Study|Withdrawal by Subject|0|||
124530203|NCT00118040|447891219|FG002|Overall Study|Withdrawal by Subject|2|||
124530204|NCT00118040|447891217|FG000|Overall Study|Medical Contraindication|0|||
124530205|NCT00118040|447891218|FG001|Overall Study|Medical Contraindication|0|||
124530206|NCT00118040|447891219|FG002|Overall Study|Medical Contraindication|1|||
124530207|NCT00118040|447891217|FG000|Overall Study|Non-Compliant Participant|1|||
124530208|NCT00118040|447891218|FG001|Overall Study|Non-Compliant Participant|1|||
124530209|NCT00118040|447891219|FG002|Overall Study|Non-Compliant Participant|2|||
124530210|NCT00118040|447891217|FG000|Overall Study|Other|0|||
124530211|NCT00118040|447891218|FG001|Overall Study|Other|0|||
124530212|NCT00118040|447891219|FG002|Overall Study|Other|1|||
124530213|NCT05559203|447891222|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
124530214|NCT03117309|447891223|FG000|Overall Study|Not meeting inclusion criteria|0|||
124530215|NCT03117309|447891224|FG001|Overall Study|Not meeting inclusion criteria|1|||
124530216|NCT04048876|447891225|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
124530217|NCT04048876|447891226|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
124530218|NCT04048876|447891227|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
124530219|NCT04048876|447891228|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
124530220|NCT04048876|447891225|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
124582947|NCT02923349|448093632|FG005|Overall Study|Withdrawal by Subject|3|||
124582948|NCT02923349|448093633|FG006|Overall Study|Withdrawal by Subject|0|||
124582949|NCT02923349|448093627|FG000|Overall Study|Physician Decision|0|||
124582950|NCT02923349|448093628|FG001|Overall Study|Physician Decision|0|||
124582951|NCT02923349|448093629|FG002|Overall Study|Physician Decision|0|||
124582952|NCT02923349|448093630|FG003|Overall Study|Physician Decision|1|||
124582953|NCT02923349|448093631|FG004|Overall Study|Physician Decision|1|||
124582954|NCT02923349|448093632|FG005|Overall Study|Physician Decision|0|||
124582955|NCT02923349|448093633|FG006|Overall Study|Physician Decision|2|||
124582956|NCT02923349|448093627|FG000|Overall Study|Lost to Follow-up|0|||
124582957|NCT02923349|448093628|FG001|Overall Study|Lost to Follow-up|0|||
124582958|NCT02923349|448093629|FG002|Overall Study|Lost to Follow-up|3|||
124582959|NCT02923349|448093630|FG003|Overall Study|Lost to Follow-up|0|||
124582960|NCT02923349|448093631|FG004|Overall Study|Lost to Follow-up|1|||
124582961|NCT02923349|448093632|FG005|Overall Study|Lost to Follow-up|1|||
124582962|NCT02923349|448093633|FG006|Overall Study|Lost to Follow-up|0|||
124582963|NCT02923349|448093627|FG000|Overall Study|Death|1|||
124582964|NCT02923349|448093628|FG001|Overall Study|Death|0|||
124582965|NCT02923349|448093629|FG002|Overall Study|Death|2|||
124582966|NCT02923349|448093630|FG003|Overall Study|Death|4|||
124582967|NCT02923349|448093631|FG004|Overall Study|Death|2|||
124582968|NCT02923349|448093632|FG005|Overall Study|Death|3|||
124582969|NCT02923349|448093633|FG006|Overall Study|Death|0|||
124582970|NCT04063878|448093636|FG000|Overall Study|Withdrawal by Subject|2|||
124582971|NCT04063878|448093636|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
124582972|NCT02751827|448093637|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
124582973|NCT02751827|448093638|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
124582974|NCT02751827|448093639|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
124582975|NCT01248728|448093640|FG000|Overall Study|Adverse Event|1|||
124582976|NCT01248728|448093641|FG001|Overall Study|Adverse Event|1|||
124582977|NCT01248728|448093640|FG000|Overall Study|Withdrawal by Subject|2|||
124582978|NCT01248728|448093641|FG001|Overall Study|Withdrawal by Subject|1|||
124582979|NCT01248728|448093640|FG000|Overall Study|Lack of Efficacy|1|||
124582980|NCT01248728|448093641|FG001|Overall Study|Lack of Efficacy|0|||
124582981|NCT00147498|448093642|FG000|Overall Study|Adverse Event|1|||
124582982|NCT00147498|448093643|FG001|Overall Study|Adverse Event|6|||
124582983|NCT00147498|448093644|FG002|Overall Study|Adverse Event|7|||
124582984|NCT00147498|448093645|FG003|Overall Study|Adverse Event|3|||
124582985|NCT00147498|448093642|FG000|Overall Study|Lack of Efficacy|1|||
124582986|NCT00147498|448093643|FG001|Overall Study|Lack of Efficacy|1|||
124582987|NCT00147498|448093644|FG002|Overall Study|Lack of Efficacy|1|||
124582988|NCT00147498|448093645|FG003|Overall Study|Lack of Efficacy|8|||
124582989|NCT00147498|448093642|FG000|Overall Study|Laboratory abnormality|0|||
124582990|NCT00147498|448093643|FG001|Overall Study|Laboratory abnormality|0|||
124582991|NCT00147498|448093644|FG002|Overall Study|Laboratory abnormality|2|||
124582992|NCT00147498|448093645|FG003|Overall Study|Laboratory abnormality|0|||
124582993|NCT00147498|448093642|FG000|Overall Study|Participant defaulted|0|||
124582994|NCT00147498|448093643|FG001|Overall Study|Participant defaulted|1|||
124582995|NCT00147498|448093644|FG002|Overall Study|Participant defaulted|4|||
124582996|NCT00147498|448093645|FG003|Overall Study|Participant defaulted|3|||
124582997|NCT00147498|448093642|FG000|Overall Study|Other|1|||
124582998|NCT00147498|448093643|FG001|Overall Study|Other|1|||
124582999|NCT00147498|448093644|FG002|Overall Study|Other|3|||
124583000|NCT00147498|448093645|FG003|Overall Study|Other|3|||
124583001|NCT01838681|448093646|FG000|Period A|Adverse Event|39|||
124583002|NCT01838681|448093647|FG001|Period A|Adverse Event|0|||
124583003|NCT01838681|448093648|FG002|Period A|Adverse Event|0|||
124583004|NCT01838681|448093649|FG003|Period A|Adverse Event|0|||
124583005|NCT01838681|448093646|FG000|Period A|Lack of Efficacy|21|||
124583006|NCT01838681|448093647|FG001|Period A|Lack of Efficacy|0|||
124583007|NCT01838681|448093648|FG002|Period A|Lack of Efficacy|0|||
124583008|NCT01838681|448093649|FG003|Period A|Lack of Efficacy|0|||
124583009|NCT01838681|448093646|FG000|Period A|Early response|148|||
124728290|NCT03525600|448625947|FG001|Overall Study|Adverse Event|6|||
124728291|NCT03525600|448625948|FG002|Overall Study|Adverse Event|5|||
124583010|NCT01838681|448093647|FG001|Period A|Early response|0|||
124583011|NCT01838681|448093648|FG002|Period A|Early response|0|||
124583012|NCT01838681|448093649|FG003|Period A|Early response|0|||
124583013|NCT01838681|448093646|FG000|Period A|Withdrawal by Subject|70|||
124583014|NCT01838681|448093647|FG001|Period A|Withdrawal by Subject|0|||
124728292|NCT03525600|448625949|FG003|Overall Study|Adverse Event|3|||
124728293|NCT03525600|448625946|FG000|Overall Study|Lost to Follow-up|2|||
124583015|NCT01838681|448093648|FG002|Period A|Withdrawal by Subject|0|||
124583016|NCT01838681|448093649|FG003|Period A|Withdrawal by Subject|0|||
124583017|NCT01838681|448093646|FG000|Period A|Protocol Violation|16|||
124583018|NCT01838681|448093647|FG001|Period A|Protocol Violation|0|||
124583019|NCT01838681|448093648|FG002|Period A|Protocol Violation|0|||
124583020|NCT01838681|448093649|FG003|Period A|Protocol Violation|0|||
124583021|NCT01838681|448093646|FG000|Period A|Non-compliance with IMP|6|||
124583022|NCT01838681|448093647|FG001|Period A|Non-compliance with IMP|0|||
124583023|NCT01838681|448093648|FG002|Period A|Non-compliance with IMP|0|||
124583024|NCT01838681|448093649|FG003|Period A|Non-compliance with IMP|0|||
124583025|NCT01838681|448093646|FG000|Period A|Lost to Follow-up|4|||
124583026|NCT01838681|448093647|FG001|Period A|Lost to Follow-up|0|||
124583027|NCT01838681|448093648|FG002|Period A|Lost to Follow-up|0|||
124583028|NCT01838681|448093649|FG003|Period A|Lost to Follow-up|0|||
124583029|NCT01838681|448093646|FG000|Period A|Withdrawal before treatment|4|||
124583030|NCT01838681|448093647|FG001|Period A|Withdrawal before treatment|0|||
124583031|NCT01838681|448093648|FG002|Period A|Withdrawal before treatment|0|||
124583032|NCT01838681|448093649|FG003|Period A|Withdrawal before treatment|0|||
124583033|NCT01838681|448093646|FG000|Period A|Administrative or other reasons|17|||
124583034|NCT01838681|448093647|FG001|Period A|Administrative or other reasons|0|||
124583035|NCT01838681|448093648|FG002|Period A|Administrative or other reasons|0|||
124583036|NCT01838681|448093649|FG003|Period A|Administrative or other reasons|0|||
124583037|NCT01838681|448093646|FG000|Period B/A+|Adverse Event|0|||
124583038|NCT01838681|448093647|FG001|Period B/A+|Adverse Event|13|||
124583039|NCT01838681|448093648|FG002|Period B/A+|Adverse Event|27|||
124583040|NCT01838681|448093649|FG003|Period B/A+|Adverse Event|16|||
124583041|NCT01838681|448093646|FG000|Period B/A+|Lack of Efficacy|0|||
124583042|NCT01838681|448093647|FG001|Period B/A+|Lack of Efficacy|9|||
124583043|NCT01838681|448093648|FG002|Period B/A+|Lack of Efficacy|11|||
124583044|NCT01838681|448093649|FG003|Period B/A+|Lack of Efficacy|6|||
124583045|NCT01838681|448093646|FG000|Period B/A+|Withdrawal by Subject|0|||
124583046|NCT01838681|448093647|FG001|Period B/A+|Withdrawal by Subject|28|||
124583047|NCT01838681|448093648|FG002|Period B/A+|Withdrawal by Subject|35|||
124583048|NCT01838681|448093649|FG003|Period B/A+|Withdrawal by Subject|47|||
124583049|NCT01838681|448093646|FG000|Period B/A+|Protocol Violation|0|||
124583050|NCT01838681|448093647|FG001|Period B/A+|Protocol Violation|1|||
124583051|NCT01838681|448093648|FG002|Period B/A+|Protocol Violation|4|||
124583052|NCT01838681|448093649|FG003|Period B/A+|Protocol Violation|6|||
124728294|NCT03525600|448625947|FG001|Overall Study|Lost to Follow-up|4|||
124728295|NCT03525600|448625948|FG002|Overall Study|Lost to Follow-up|4|||
124728296|NCT03525600|448625949|FG003|Overall Study|Lost to Follow-up|0|||
124728297|NCT03525600|448625946|FG000|Overall Study|Physician Decision|1|||
124728298|NCT03525600|448625947|FG001|Overall Study|Physician Decision|0|||
124728299|NCT03525600|448625948|FG002|Overall Study|Physician Decision|2|||
124728300|NCT03525600|448625949|FG003|Overall Study|Physician Decision|0|||
124728301|NCT03525600|448625946|FG000|Overall Study|Consent withdrawal|36|||
124728302|NCT03525600|448625947|FG001|Overall Study|Consent withdrawal|20|||
124728303|NCT03525600|448625948|FG002|Overall Study|Consent withdrawal|6|||
124728304|NCT03525600|448625949|FG003|Overall Study|Consent withdrawal|13|||
124728305|NCT03525600|448625946|FG000|Overall Study|Death|7|||
124728306|NCT03525600|448625947|FG001|Overall Study|Death|6|||
124728307|NCT03525600|448625948|FG002|Overall Study|Death|4|||
124728308|NCT03525600|448625949|FG003|Overall Study|Death|3|||
124728309|NCT03525600|448625946|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
124728310|NCT03525600|448625947|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
124728311|NCT03525600|448625948|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
124728312|NCT03525600|448625949|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
124728313|NCT03525600|448625946|FG000|Overall Study|Other|0|||
124728314|NCT03525600|448625947|FG001|Overall Study|Other|1|||
124728315|NCT03525600|448625948|FG002|Overall Study|Other|0|||
124728316|NCT03525600|448625949|FG003|Overall Study|Other|0|||
124728317|NCT03703817|448625957|FG000|Overall Study|Not meeting eligibility criteria|7|||
124728318|NCT03703817|448625958|FG001|Overall Study|Not meeting eligibility criteria|4|||
124728319|NCT03255967|448625961|FG000|Overall Study|Adverse Event|26|||
124728320|NCT03255967|448625962|FG001|Overall Study|Adverse Event|30|||
124728321|NCT03255967|448625961|FG000|Overall Study|Withdrawal by Subject|6|||
124728322|NCT03255967|448625962|FG001|Overall Study|Withdrawal by Subject|6|||
124728323|NCT03255967|448625961|FG000|Overall Study|Schedule conflict|6|||
124728324|NCT03255967|448625962|FG001|Overall Study|Schedule conflict|4|||
124728325|NCT03255967|448625961|FG000|Overall Study|POA did not sign consent form|2|||
124728326|NCT03255967|448625962|FG001|Overall Study|POA did not sign consent form|0|||
124728327|NCT01202188|448625963|FG000|Overall Study|Protocol deviation|14|||
124728328|NCT01202188|448625964|FG001|Overall Study|Protocol deviation|8|||
124728329|NCT01202188|448625965|FG002|Overall Study|Protocol deviation|12|||
124728330|NCT01202188|448625966|FG003|Overall Study|Protocol deviation|10|||
124583053|NCT01838681|448093646|FG000|Period B/A+|Non-compliance with IMP|0|||
124583054|NCT01838681|448093647|FG001|Period B/A+|Non-compliance with IMP|2|||
124583055|NCT01838681|448093648|FG002|Period B/A+|Non-compliance with IMP|3|||
124583056|NCT01838681|448093649|FG003|Period B/A+|Non-compliance with IMP|3|||
124583057|NCT01838681|448093646|FG000|Period B/A+|Lost to Follow-up|0|||
124583058|NCT01838681|448093647|FG001|Period B/A+|Lost to Follow-up|2|||
124583059|NCT01838681|448093648|FG002|Period B/A+|Lost to Follow-up|5|||
124583060|NCT01838681|448093649|FG003|Period B/A+|Lost to Follow-up|11|||
124583061|NCT01838681|448093646|FG000|Period B/A+|Withdrawal before treatment|0|||
124728331|NCT01202188|448625967|FG004|Overall Study|Protocol deviation|11|||
124728332|NCT01202188|448625963|FG000|Overall Study|Subject withdrew consent|12|||
124583062|NCT01838681|448093647|FG001|Period B/A+|Withdrawal before treatment|1|||
124583063|NCT01838681|448093648|FG002|Period B/A+|Withdrawal before treatment|0|||
124583064|NCT01838681|448093649|FG003|Period B/A+|Withdrawal before treatment|0|||
124583065|NCT01838681|448093646|FG000|Period B/A+|Administrative or other reasons|0|||
124583066|NCT01838681|448093647|FG001|Period B/A+|Administrative or other reasons|6|||
124583067|NCT01838681|448093648|FG002|Period B/A+|Administrative or other reasons|10|||
124583068|NCT01838681|448093649|FG003|Period B/A+|Administrative or other reasons|28|||
124583069|NCT01229150|448093652|FG000|Overall Study|Toxicity|2|||
124583070|NCT01229150|448093653|FG001|Overall Study|Toxicity|2|||
124583071|NCT01229150|448093654|FG002|Overall Study|Toxicity|0|||
124583072|NCT01229150|448093655|FG003|Overall Study|Toxicity|0|||
124583073|NCT02011945|448093656|FG000|Overall Study|Participant requested to Discontinue|0|||
124583074|NCT02011945|448093657|FG001|Overall Study|Participant requested to Discontinue|1|||
124583075|NCT02011945|448093658|FG002|Overall Study|Participant requested to Discontinue|1|||
124583076|NCT02011945|448093656|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
124583077|NCT02011945|448093657|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
124583078|NCT02011945|448093658|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
124583079|NCT02011945|448093656|FG000|Overall Study|Study Drug Toxicity|0|||
124583080|NCT02011945|448093657|FG001|Overall Study|Study Drug Toxicity|0|||
124583081|NCT02011945|448093658|FG002|Overall Study|Study Drug Toxicity|1|||
124583082|NCT02011945|448093656|FG000|Overall Study|Treatment Failure|0|||
124583083|NCT02011945|448093657|FG001|Overall Study|Treatment Failure|7|||
124583084|NCT02011945|448093658|FG002|Overall Study|Treatment Failure|6|||
124583085|NCT02011945|448093656|FG000|Overall Study|No Longer Meets Study Criteria|1|||
124583086|NCT02011945|448093657|FG001|Overall Study|No Longer Meets Study Criteria|0|||
124583087|NCT02011945|448093658|FG002|Overall Study|No Longer Meets Study Criteria|0|||
124583088|NCT02011945|448093656|FG000|Overall Study|Proceeded to stem cell transplant|0|||
124583089|NCT02011945|448093657|FG001|Overall Study|Proceeded to stem cell transplant|0|||
124583090|NCT02011945|448093658|FG002|Overall Study|Proceeded to stem cell transplant|1|||
124583091|NCT02011945|448093656|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
124583092|NCT02011945|448093657|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
124583093|NCT02011945|448093658|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
124583094|NCT03531827|448093659|FG000|Overall Study|Adverse Event|2|||
124583095|NCT03531827|448093660|FG001|Overall Study|Adverse Event|0|||
124583096|NCT03531827|448093659|FG000|Overall Study|Progressive disease|1|||
124583097|NCT03531827|448093660|FG001|Overall Study|Progressive disease|0|||
124583098|NCT00849797|448093661|FG000|First Intervention|bad veins|1|||
124583099|NCT00849797|448093662|FG001|First Intervention|bad veins|0|||
124583100|NCT00849797|448093661|FG000|First Intervention|Adverse Event|0|||
124583101|NCT00849797|448093662|FG001|First Intervention|Adverse Event|1|||
124583102|NCT00849797|448093661|FG000|Washout: One Week|Withdrawal by Subject|0|||
124583103|NCT00849797|448093662|FG001|Washout: One Week|Withdrawal by Subject|2|||
124583104|NCT00679081|448093663|FG000|Overall Study|Lost to Follow-up|1|||
124583105|NCT04198363|448093665|FG000|Overall Study|Adverse Event|1|||
124583106|NCT04198363|448093666|FG001|Overall Study|Adverse Event|1|||
124583107|NCT04198363|448093665|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
124583108|NCT04198363|448093666|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
124583109|NCT04198363|448093665|FG000|Overall Study|Reason not Specified|1|||
124583110|NCT04198363|448093666|FG001|Overall Study|Reason not Specified|0|||
124583111|NCT01404988|448093670|FG000|Overall Study|Death|2|||
124583112|NCT01404988|448093671|FG001|Overall Study|Death|0|||
124583113|NCT01404988|448093672|FG002|Overall Study|Death|2|||
124583114|NCT01404988|448093670|FG000|Overall Study|Adverse Event|1|||
124583115|NCT01404988|448093671|FG001|Overall Study|Adverse Event|0|||
124583116|NCT01404988|448093672|FG002|Overall Study|Adverse Event|0|||
124583117|NCT01404988|448093670|FG000|Overall Study|Withdrawal by Subject|2|||
124583118|NCT01404988|448093671|FG001|Overall Study|Withdrawal by Subject|2|||
124583119|NCT01404988|448093672|FG002|Overall Study|Withdrawal by Subject|0|||
124583120|NCT01404988|448093670|FG000|Overall Study|Lost to Follow-up|1|||
124583121|NCT01404988|448093671|FG001|Overall Study|Lost to Follow-up|2|||
124583122|NCT01404988|448093672|FG002|Overall Study|Lost to Follow-up|1|||
124583123|NCT02588339|448093673|FG000|Overall Study|Withdrawal by Subject|1|||
124583124|NCT02588339|448093673|FG000|Overall Study|GVHD Progression prior to treatment|2|||
124583125|NCT03578809|448095735|FG000|Overall Study|Death|0|||
124583126|NCT03578809|448095736|FG001|Overall Study|Death|2|||
124583127|NCT03578809|448095737|FG002|Overall Study|Death|0|||
124583128|NCT03578809|448095738|FG003|Overall Study|Death|1|||
124583129|NCT03578809|448095735|FG000|Overall Study|Lost to Follow-up|0|||
124583130|NCT03578809|448095736|FG001|Overall Study|Lost to Follow-up|1|||
124583131|NCT03578809|448095737|FG002|Overall Study|Lost to Follow-up|0|||
124583132|NCT03578809|448095738|FG003|Overall Study|Lost to Follow-up|0|||
124583133|NCT03578809|448095735|FG000|Overall Study|Withdrawal by Subject|3|||
124583134|NCT03578809|448095736|FG001|Overall Study|Withdrawal by Subject|5|||
124583135|NCT03578809|448095737|FG002|Overall Study|Withdrawal by Subject|2|||
124583136|NCT03578809|448095738|FG003|Overall Study|Withdrawal by Subject|0|||
124583137|NCT03578809|448095735|FG000|Overall Study|Other|3|||
124583138|NCT03578809|448095736|FG001|Overall Study|Other|6|||
124583139|NCT03578809|448095737|FG002|Overall Study|Other|2|||
124583140|NCT03578809|448095738|FG003|Overall Study|Other|8|||
124583141|NCT02997176|448095741|FG000|Overall Study|Adverse Event|0|||
124583142|NCT02997176|448095742|FG001|Overall Study|Adverse Event|0|||
124583143|NCT02997176|448095743|FG002|Overall Study|Adverse Event|0|||
124583144|NCT02997176|448095744|FG003|Overall Study|Adverse Event|8|||
124583145|NCT02997176|448095741|FG000|Overall Study|Progressive Disease|1|||
124583146|NCT02997176|448095742|FG001|Overall Study|Progressive Disease|0|||
124583147|NCT02997176|448095743|FG002|Overall Study|Progressive Disease|1|||
124583148|NCT02997176|448095744|FG003|Overall Study|Progressive Disease|1|||
124583149|NCT02997176|448095741|FG000|Overall Study|Death|0|||
124583150|NCT02997176|448095742|FG001|Overall Study|Death|0|||
124583151|NCT02997176|448095743|FG002|Overall Study|Death|1|||
124583152|NCT02997176|448095744|FG003|Overall Study|Death|1|||
124583153|NCT02997176|448095741|FG000|Overall Study|Withdrawal by Subject|0|||
124583154|NCT02997176|448095742|FG001|Overall Study|Withdrawal by Subject|2|||
124583155|NCT02997176|448095743|FG002|Overall Study|Withdrawal by Subject|0|||
124583156|NCT02997176|448095744|FG003|Overall Study|Withdrawal by Subject|1|||
124583157|NCT01624233|448095747|FG000|Period 2 - Induction|Adverse Event|1|||
124583158|NCT01624233|448095747|FG000|Period 3 - Maintenance|Adverse Event|2|||
124583159|NCT01624233|448095747|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
124583160|NCT01624233|448095747|FG000|Period 3 - Maintenance|Physician Decision|2|||
124583161|NCT01624233|448095747|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
124583162|NCT01624233|448095747|FG000|Period 4 - Drug Free Period|Relapsed|61|||
124583163|NCT01624233|448095747|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
124583164|NCT01624233|448095747|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
124583165|NCT01624233|448095747|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
124583166|NCT01624233|448095747|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
124583167|NCT01624233|448095747|FG000|Period 6: Follow-up|Adverse Event|3|||
124583168|NCT01624233|448095747|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
124583169|NCT01624233|448095747|FG000|Period 6: Follow-up|Physician Decision|1|||
124583170|NCT01624233|448095747|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
124583171|NCT00373256|448095748|FG000|Overall Study|Adverse Event (AE)|1|||
124583172|NCT00373256|448095749|FG001|Overall Study|Adverse Event (AE)|5|||
124583173|NCT00373256|448095748|FG000|Overall Study|Lost to Follow-up|2|||
124583174|NCT00373256|448095749|FG001|Overall Study|Lost to Follow-up|1|||
124583175|NCT00373256|448095748|FG000|Overall Study|Death|9|||
124583176|NCT00373256|448095749|FG001|Overall Study|Death|8|||
124583177|NCT00373256|448095748|FG000|Overall Study|Objective Progression or Relapse|111|||
124583178|NCT00373256|448095749|FG001|Overall Study|Objective Progression or Relapse|104|||
124583179|NCT00373256|448095748|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
124583180|NCT00373256|448095749|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
124583181|NCT00373256|448095748|FG000|Overall Study|Other|73|||
124583182|NCT00373256|448095749|FG001|Overall Study|Other|107|||
124583183|NCT00373256|448095748|FG000|Overall Study|Protocol Violation|0|||
124583184|NCT00373256|448095749|FG001|Overall Study|Protocol Violation|2|||
124583185|NCT00373256|448095748|FG000|Overall Study|Study Terminated by Sponsor|41|||
124583186|NCT00373256|448095749|FG001|Overall Study|Study Terminated by Sponsor|13|||
124583187|NCT04372238|448095750|FG000|Overall Study|Duplicate|3|||
124583188|NCT04372238|448095751|FG001|Overall Study|Duplicate|3|||
124583189|NCT04372238|448095750|FG000|Overall Study|Did not consent for data linkage|6|||
124583190|NCT04372238|448095751|FG001|Overall Study|Did not consent for data linkage|10|||
124583191|NCT04241458|448095752|FG000|Overall Study|Withdrawal by Subject|0|||
124583192|NCT04241458|448095753|FG001|Overall Study|Withdrawal by Subject|0|||
124583193|NCT04241458|448095754|FG002|Overall Study|Withdrawal by Subject|0|||
124583194|NCT04241458|448095755|FG003|Overall Study|Withdrawal by Subject|0|||
124583195|NCT04241458|448095756|FG004|Overall Study|Withdrawal by Subject|1|||
124583196|NCT06144424|448095757|FG000|Overall Study|Withdrawal by Subject|2|||
124583197|NCT06144424|448095758|FG001|Overall Study|Withdrawal by Subject|0|||
124583198|NCT06144424|448095757|FG000|Overall Study|Incarceration|1|||
124583199|NCT06144424|448095758|FG001|Overall Study|Incarceration|0|||
124583200|NCT02752074|448095770|FG000|Overall Study|Lost to Follow-up|1|||
124583201|NCT02752074|448095771|FG001|Overall Study|Lost to Follow-up|4|||
124583202|NCT02752074|448095770|FG000|Overall Study|Death|146|||
124583203|NCT02752074|448095771|FG001|Overall Study|Death|129|||
124583204|NCT02752074|448095770|FG000|Overall Study|Withdrawal by Subject|9|||
124583205|NCT02752074|448095771|FG001|Overall Study|Withdrawal by Subject|10|||
124583206|NCT01175135|448095774|FG000|Overall Study|Adverse Event|2|||
124583207|NCT01175135|448095775|FG001|Overall Study|Adverse Event|5|||
124583208|NCT01175135|448095776|FG002|Overall Study|Adverse Event|3|||
124583209|NCT01175135|448095777|FG003|Overall Study|Adverse Event|4|||
124583210|NCT01175135|448095774|FG000|Overall Study|Death|1|||
124583211|NCT01175135|448095775|FG001|Overall Study|Death|0|||
124583212|NCT01175135|448095776|FG002|Overall Study|Death|0|||
124583213|NCT01175135|448095777|FG003|Overall Study|Death|0|||
124583214|NCT01175135|448095774|FG000|Overall Study|Lack of Efficacy|4|||
124583215|NCT01175135|448095775|FG001|Overall Study|Lack of Efficacy|5|||
124583216|NCT01175135|448095776|FG002|Overall Study|Lack of Efficacy|0|||
124583217|NCT01175135|448095777|FG003|Overall Study|Lack of Efficacy|5|||
124583218|NCT01175135|448095774|FG000|Overall Study|Lost to Follow-up|1|||
124583219|NCT01175135|448095775|FG001|Overall Study|Lost to Follow-up|2|||
124583220|NCT01175135|448095776|FG002|Overall Study|Lost to Follow-up|0|||
124583221|NCT01175135|448095777|FG003|Overall Study|Lost to Follow-up|0|||
124583222|NCT01175135|448095774|FG000|Overall Study|Protocol Violation|1|||
124583223|NCT01175135|448095775|FG001|Overall Study|Protocol Violation|1|||
124583224|NCT01175135|448095776|FG002|Overall Study|Protocol Violation|0|||
124583225|NCT01175135|448095777|FG003|Overall Study|Protocol Violation|0|||
124583226|NCT01175135|448095774|FG000|Overall Study|Withdrawal by Subject|4|||
124583227|NCT01175135|448095775|FG001|Overall Study|Withdrawal by Subject|8|||
124583228|NCT01175135|448095776|FG002|Overall Study|Withdrawal by Subject|5|||
124583229|NCT01175135|448095777|FG003|Overall Study|Withdrawal by Subject|5|||
124583230|NCT01175135|448095774|FG000|Overall Study|Other|3|||
124583231|NCT01175135|448095775|FG001|Overall Study|Other|1|||
124583232|NCT01175135|448095776|FG002|Overall Study|Other|3|||
124583233|NCT01175135|448095777|FG003|Overall Study|Other|0|||
124583234|NCT01175135|448095774|FG000|Overall Study|Randomized But Not Treated|0|||
124583235|NCT01175135|448095775|FG001|Overall Study|Randomized But Not Treated|0|||
124583236|NCT01175135|448095776|FG002|Overall Study|Randomized But Not Treated|1|||
124583237|NCT01175135|448095777|FG003|Overall Study|Randomized But Not Treated|0|||
124583238|NCT01701063|448095778|FG000|Overall Study|Lost to Follow-up|0|||
124583239|NCT01701063|448095779|FG001|Overall Study|Lost to Follow-up|1|||
124583240|NCT01701063|448095780|FG002|Overall Study|Lost to Follow-up|0|||
124583241|NCT01701063|448095778|FG000|Overall Study|Withdrawal by Subject|0|||
124583242|NCT01701063|448095779|FG001|Overall Study|Withdrawal by Subject|0|||
124583243|NCT01701063|448095780|FG002|Overall Study|Withdrawal by Subject|1|||
124583244|NCT01701063|448095778|FG000|Overall Study|Other|0|||
124583245|NCT01701063|448095779|FG001|Overall Study|Other|0|||
124583246|NCT01701063|448095780|FG002|Overall Study|Other|1|||
124583247|NCT04692155|448095781|FG000|Overall Study|Death|1|||
124583248|NCT02554877|448095782|FG000|Overall Study|Adverse Event|2|||
124583249|NCT02554877|448095783|FG001|Overall Study|Adverse Event|0|||
124583250|NCT02554877|448095784|FG002|Overall Study|Adverse Event|0|||
124583251|NCT02554877|448095785|FG003|Overall Study|Adverse Event|1|||
124583252|NCT02554877|448095782|FG000|Overall Study|Lost to Follow-up|1|||
124583253|NCT02554877|448095783|FG001|Overall Study|Lost to Follow-up|1|||
124583254|NCT02554877|448095784|FG002|Overall Study|Lost to Follow-up|1|||
124583255|NCT02554877|448095785|FG003|Overall Study|Lost to Follow-up|2|||
124583256|NCT02554877|448095782|FG000|Overall Study|Did not meet entrance criteria|0|||
124583257|NCT02554877|448095783|FG001|Overall Study|Did not meet entrance criteria|0|||
124583258|NCT02554877|448095784|FG002|Overall Study|Did not meet entrance criteria|1|||
124583259|NCT02554877|448095785|FG003|Overall Study|Did not meet entrance criteria|0|||
124583260|NCT02554877|448095782|FG000|Overall Study|No longer met eligibility criteria|1|||
124583261|NCT02554877|448095783|FG001|Overall Study|No longer met eligibility criteria|0|||
124583262|NCT02554877|448095784|FG002|Overall Study|No longer met eligibility criteria|1|||
124583263|NCT02554877|448095785|FG003|Overall Study|No longer met eligibility criteria|1|||
124583264|NCT02554877|448095782|FG000|Overall Study|Protocol Violation|3|||
124583265|NCT02554877|448095783|FG001|Overall Study|Protocol Violation|1|||
124583266|NCT02554877|448095784|FG002|Overall Study|Protocol Violation|1|||
124583267|NCT02554877|448095785|FG003|Overall Study|Protocol Violation|0|||
124583268|NCT02554877|448095782|FG000|Overall Study|Other|1|||
124583269|NCT02554877|448095783|FG001|Overall Study|Other|3|||
124583270|NCT02554877|448095784|FG002|Overall Study|Other|0|||
124583271|NCT02554877|448095785|FG003|Overall Study|Other|3|||
124583272|NCT02554877|448095782|FG000|Overall Study|Insufficient clinical response|4|||
124583273|NCT02554877|448095783|FG001|Overall Study|Insufficient clinical response|0|||
124583274|NCT02554877|448095784|FG002|Overall Study|Insufficient clinical response|0|||
124583275|NCT02554877|448095785|FG003|Overall Study|Insufficient clinical response|0|||
124583276|NCT02554877|448095782|FG000|Overall Study|No longer willing to participate|0|||
124583277|NCT02554877|448095783|FG001|Overall Study|No longer willing to participate|2|||
124583278|NCT02554877|448095784|FG002|Overall Study|No longer willing to participate|2|||
124583279|NCT02554877|448095785|FG003|Overall Study|No longer willing to participate|0|||
124583280|NCT00274651|448095786|FG000|Overall Study|Adverse Event|6|||
124583281|NCT00274651|448095787|FG001|Overall Study|Adverse Event|3|||
124583282|NCT00274651|448095786|FG000|Overall Study|Lack of Efficacy|13|||
124583283|NCT00274651|448095787|FG001|Overall Study|Lack of Efficacy|6|||
124583284|NCT00274651|448095786|FG000|Overall Study|Death|1|||
124583285|NCT00274651|448095787|FG001|Overall Study|Death|3|||
124583286|NCT00274651|448095786|FG000|Overall Study|Withdrawal by Subject|0|||
124583287|NCT00274651|448095787|FG001|Overall Study|Withdrawal by Subject|1|||
124583288|NCT00274651|448095786|FG000|Overall Study|Physician Decision|8|||
124583289|NCT00274651|448095787|FG001|Overall Study|Physician Decision|7|||
124583290|NCT04474405|448095788|FG000|Overall Study|Withdrawal by Subject|0|||
124583291|NCT04474405|448095789|FG001|Overall Study|Withdrawal by Subject|0|||
124583292|NCT04474405|448095790|FG002|Overall Study|Withdrawal by Subject|1|||
124583293|NCT04474405|448095791|FG003|Overall Study|Withdrawal by Subject|0|||
124583294|NCT04474405|448095792|FG004|Overall Study|Withdrawal by Subject|1|||
124583295|NCT04474405|448095793|FG005|Overall Study|Withdrawal by Subject|0|||
124583296|NCT04474405|448095788|FG000|Overall Study|Other|0|||
124583297|NCT04474405|448095789|FG001|Overall Study|Other|0|||
124583298|NCT04474405|448095790|FG002|Overall Study|Other|0|||
124583299|NCT04474405|448095791|FG003|Overall Study|Other|0|||
124583300|NCT04474405|448095792|FG004|Overall Study|Other|3|||
124583301|NCT04474405|448095793|FG005|Overall Study|Other|0|||
124728333|NCT01202188|448625964|FG001|Overall Study|Subject withdrew consent|13|||
124728334|NCT01202188|448625965|FG002|Overall Study|Subject withdrew consent|22|||
124728335|NCT01202188|448625966|FG003|Overall Study|Subject withdrew consent|11|||
124728336|NCT01202188|448625967|FG004|Overall Study|Subject withdrew consent|13|||
124728337|NCT01202188|448625963|FG000|Overall Study|Adverse Event|5|||
124728338|NCT01202188|448625964|FG001|Overall Study|Adverse Event|23|||
124728339|NCT01202188|448625965|FG002|Overall Study|Adverse Event|13|||
124728340|NCT01202188|448625966|FG003|Overall Study|Adverse Event|10|||
124530221|NCT04048876|447891226|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
124530222|NCT04048876|447891227|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
124530223|NCT04048876|447891228|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
124530224|NCT04048876|447891225|FG000|Placebo Controlled Phase|Adverse Event|0|||
124530225|NCT04048876|447891226|FG001|Placebo Controlled Phase|Adverse Event|1|||
124530226|NCT04048876|447891227|FG002|Placebo Controlled Phase|Adverse Event|0|||
124530227|NCT04048876|447891228|FG003|Placebo Controlled Phase|Adverse Event|0|||
124530228|NCT04048876|447891225|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
124530229|NCT04048876|447891226|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
124530230|NCT04048876|447891227|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
124530231|NCT04048876|447891228|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
124530232|NCT01347840|447891237|FG000|Overall Study|Withdrawal by Subject|1|||
124530233|NCT01010776|447891240|FG000|Main Phase|Withdrawal by Subject|14|||
124530234|NCT01010776|447891240|FG000|Main Phase|Lack of Efficacy|8|||
124530235|NCT01010776|447891240|FG000|Main Phase|Adverse Event|7|||
124530236|NCT01010776|447891240|FG000|Main Phase|Lost to Follow-up|6|||
124530237|NCT01010776|447891240|FG000|Main Phase|Non-compliance to study medication|5|||
124530238|NCT01010776|447891240|FG000|Main Phase|Selection failure|2|||
124530239|NCT01010776|447891240|FG000|Main Phase|Inform consent withdrawal|1|||
124530240|NCT01010776|447891240|FG000|Main Phase|Other|1|||
124530241|NCT01010776|447891240|FG000|Main Phase|Did not received study medication|5|||
124530242|NCT01010776|447891240|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
124530243|NCT01010776|447891240|FG000|Extension Phase|Other|3|||
124530244|NCT02583711|447891242|FG000|Overall Study|Withdrawal by Subject|0|||
124583302|NCT04547192|448095794|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
124583303|NCT04547192|448095795|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
124583304|NCT04547192|448095796|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
124583305|NCT04547192|448095797|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
124583306|NCT04547192|448095794|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
124583307|NCT04547192|448095795|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
124583308|NCT04547192|448095796|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
124583309|NCT04547192|448095797|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
124583310|NCT04547192|448095794|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
124583311|NCT04547192|448095795|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
124583312|NCT04547192|448095796|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
124583313|NCT04547192|448095797|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
124583314|NCT04547192|448095794|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
124583315|NCT04547192|448095795|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
124583316|NCT04547192|448095796|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
124583317|NCT04547192|448095797|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
124583318|NCT04547192|448095794|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
124583319|NCT04547192|448095795|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
124583320|NCT04547192|448095796|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
124583321|NCT04547192|448095797|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
124583322|NCT04723693|448095798|FG000|Overall Study|Withdrawal by Subject|2|||
124583323|NCT01410227|448095801|FG000|Overall Study|Adverse Event|1|||
124583324|NCT01410227|448095802|FG001|Overall Study|Adverse Event|0|||
124583325|NCT01410227|448095803|FG002|Overall Study|Adverse Event|0|||
124583326|NCT01410227|448095804|FG003|Overall Study|Adverse Event|0|||
124583327|NCT01410227|448095801|FG000|Overall Study|Withdrawal by Subject|3|||
124728341|NCT01202188|448625967|FG004|Overall Study|Adverse Event|10|||
124728342|NCT01202188|448625963|FG000|Overall Study|Administrative problems|3|||
124530245|NCT02583711|447891243|FG001|Overall Study|Withdrawal by Subject|10|||
124583328|NCT01410227|448095802|FG001|Overall Study|Withdrawal by Subject|0|||
124583329|NCT01410227|448095803|FG002|Overall Study|Withdrawal by Subject|1|||
124583330|NCT01410227|448095804|FG003|Overall Study|Withdrawal by Subject|0|||
124583331|NCT01410227|448095801|FG000|Overall Study|Pregnancy|0|||
124583332|NCT01410227|448095802|FG001|Overall Study|Pregnancy|0|||
124728343|NCT01202188|448625964|FG001|Overall Study|Administrative problems|2|||
124530246|NCT02583711|447891244|FG002|Overall Study|Withdrawal by Subject|0|||
124530247|NCT01012037|447891245|FG000|Overall Study|Adverse Event|0|||
124530248|NCT01012037|447891246|FG001|Overall Study|Adverse Event|8|||
124583333|NCT01410227|448095803|FG002|Overall Study|Pregnancy|0|||
124728344|NCT01202188|448625965|FG002|Overall Study|Administrative problems|1|||
124728345|NCT01202188|448625966|FG003|Overall Study|Administrative problems|1|||
124728346|NCT01202188|448625967|FG004|Overall Study|Administrative problems|2|||
124728347|NCT01202188|448625963|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124728348|NCT01202188|448625964|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
124728349|NCT01202188|448625965|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
124728350|NCT01202188|448625966|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
124728351|NCT01202188|448625967|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
124728352|NCT01202188|448625963|FG000|Overall Study|Lost to Follow-up|1|||
124728353|NCT01202188|448625964|FG001|Overall Study|Lost to Follow-up|1|||
124728354|NCT01202188|448625965|FG002|Overall Study|Lost to Follow-up|0|||
124728355|NCT01202188|448625966|FG003|Overall Study|Lost to Follow-up|4|||
124728356|NCT01202188|448625967|FG004|Overall Study|Lost to Follow-up|1|||
124728357|NCT01202188|448625963|FG000|Overall Study|Death|1|||
124728358|NCT01202188|448625964|FG001|Overall Study|Death|1|||
124728359|NCT01202188|448625965|FG002|Overall Study|Death|1|||
124728360|NCT01202188|448625966|FG003|Overall Study|Death|1|||
124728361|NCT01202188|448625967|FG004|Overall Study|Death|0|||
124728362|NCT01202188|448625963|FG000|Overall Study|Abnormal test procedure result (s)|0|||
124728363|NCT01202188|448625964|FG001|Overall Study|Abnormal test procedure result (s)|0|||
124728364|NCT01202188|448625965|FG002|Overall Study|Abnormal test procedure result (s)|2|||
124728365|NCT01202188|448625966|FG003|Overall Study|Abnormal test procedure result (s)|0|||
124728366|NCT01202188|448625967|FG004|Overall Study|Abnormal test procedure result (s)|0|||
124728367|NCT03319953|448625970|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
124728368|NCT03319953|448625971|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
124728369|NCT03319953|448625972|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
124728370|NCT03319953|448625973|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
124728371|NCT03319953|448625970|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
124728372|NCT03319953|448625971|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
124728373|NCT03319953|448625972|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
124728374|NCT03319953|448625973|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
124728375|NCT02438384|448625974|FG000|Overall Study|Lost to Follow-up|8|||
124728376|NCT02438384|448625975|FG001|Overall Study|Lost to Follow-up|6|||
124728377|NCT02438384|448625976|FG002|Overall Study|Lost to Follow-up|4|||
124728378|NCT03315793|448625977|FG000|Overall Study|Adverse Event|4|||
124728379|NCT03315793|448625978|FG001|Overall Study|Adverse Event|2|||
124728380|NCT03315793|448625977|FG000|Overall Study|Protocol Deviation|1|||
124728381|NCT03315793|448625978|FG001|Overall Study|Protocol Deviation|0|||
124728382|NCT03315793|448625977|FG000|Overall Study|Difficult for regular visit|0|||
124728383|NCT03315793|448625978|FG001|Overall Study|Difficult for regular visit|1|||
124728384|NCT01331837|448625979|FG000|Overall Study|Death|30|||
124728385|NCT01331837|448625980|FG001|Overall Study|Death|34|||
124728386|NCT01331837|448625979|FG000|Overall Study|Lost to Follow-up|3|||
124728387|NCT01331837|448625980|FG001|Overall Study|Lost to Follow-up|1|||
124728388|NCT01331837|448625979|FG000|Overall Study|Info not recorded|10|||
124728389|NCT01331837|448625980|FG001|Overall Study|Info not recorded|16|||
124728390|NCT01331837|448625979|FG000|Overall Study|Withdrawal by Subject|13|||
124728391|NCT01331837|448625980|FG001|Overall Study|Withdrawal by Subject|16|||
124752798|NCT04427072|448716839|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
124752799|NCT04427072|448716840|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
124752800|NCT04427072|448716839|FG000|Randomized Treatment Phase|Death|0|||
124752801|NCT04427072|448716840|FG001|Randomized Treatment Phase|Death|1|||
124752802|NCT04427072|448716839|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
124752803|NCT04427072|448716840|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
124752804|NCT04427072|448716839|FG000|Extension Treatment Phase|Progressive disease|0|||
124752805|NCT04427072|448716840|FG001|Extension Treatment Phase|Progressive disease|5|||
124752806|NCT02104947|448716846|FG000|Overall Study|Withdrawal by Subject|10|||
124752807|NCT02104947|448716847|FG001|Overall Study|Withdrawal by Subject|3|||
124752808|NCT02104947|448716846|FG000|Overall Study|Lost to Follow-up|4|||
124752809|NCT02104947|448716847|FG001|Overall Study|Lost to Follow-up|4|||
124752810|NCT02104947|448716846|FG000|Overall Study|Protocol Violation|6|||
124752811|NCT02104947|448716847|FG001|Overall Study|Protocol Violation|8|||
124752812|NCT02104947|448716846|FG000|Overall Study|Adverse Event|57|||
124752813|NCT02104947|448716847|FG001|Overall Study|Adverse Event|38|||
124752814|NCT02104947|448716846|FG000|Overall Study|Other than stated above|2|||
124752815|NCT02104947|448716847|FG001|Overall Study|Other than stated above|3|||
124752816|NCT04698993|448716852|FG000|Overall Study|PCR results not accessible|2|||
124752817|NCT04698993|448716853|FG001|Overall Study|PCR results not accessible|7|||
124752818|NCT04698993|448716852|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
124752819|NCT04698993|448716853|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
124752820|NCT00635882|448716857|FG000|Overall Study|Protocol Violation|1|||
124752821|NCT00635882|448716858|FG001|Overall Study|Protocol Violation|0|||
124752822|NCT00635882|448716859|FG002|Overall Study|Protocol Violation|0|||
124752823|NCT00635882|448716860|FG003|Overall Study|Protocol Violation|0|||
124752824|NCT00635882|448716861|FG004|Overall Study|Protocol Violation|0|||
124752825|NCT00635882|448716862|FG005|Overall Study|Protocol Violation|0|||
124583334|NCT01410227|448095804|FG003|Overall Study|Pregnancy|1|||
124583335|NCT01410227|448095801|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
124583336|NCT01410227|448095802|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
124583337|NCT01410227|448095803|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
124583338|NCT01410227|448095804|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
124583339|NCT03497130|448095805|FG000|Overall Study|Lost to Follow-up|1|||
124583340|NCT03497130|448095806|FG001|Overall Study|Lost to Follow-up|1|||
124583341|NCT04002648|448095807|FG000|Overall Study|Lost to Follow-up|2|||
124583342|NCT04002648|448095808|FG001|Overall Study|Lost to Follow-up|0|||
124583343|NCT01484912|448095809|FG000|Overall Study|Withdrawal by Subject|1|||
124583344|NCT01484912|448095810|FG001|Overall Study|Withdrawal by Subject|0|||
124583345|NCT01484912|448095809|FG000|Overall Study|Physician Decision|0|||
124583346|NCT01484912|448095810|FG001|Overall Study|Physician Decision|1|||
124583347|NCT02622386|448095811|FG000|First Assignment|Withdrawal by Subject|3|||
124583348|NCT02622386|448095812|FG001|First Assignment|Withdrawal by Subject|2|||
124583349|NCT02622386|448095811|FG000|Washout|Withdrawal by Subject|4|||
124583350|NCT02622386|448095812|FG001|Washout|Withdrawal by Subject|4|||
124583351|NCT02622386|448095811|FG000|Second Assignment|Withdrawal by Subject|0|||
124583352|NCT02622386|448095812|FG001|Second Assignment|Withdrawal by Subject|2|||
124583353|NCT02890992|448095813|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
124583354|NCT02890992|448095814|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
124583355|NCT02890992|448095815|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
124583356|NCT02890992|448095816|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
124583357|NCT02890992|448095817|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
124583358|NCT02890992|448095818|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
124583359|NCT02890992|448095819|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
124583360|NCT02890992|448095820|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
124583361|NCT02890992|448095813|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
124583362|NCT02890992|448095814|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
124583363|NCT02890992|448095815|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
124583364|NCT02890992|448095816|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
124583365|NCT02890992|448095817|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
124583366|NCT02890992|448095818|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
124583367|NCT02890992|448095819|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
124583368|NCT02890992|448095820|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
124583369|NCT02890992|448095813|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
124583370|NCT02890992|448095814|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
124583371|NCT02890992|448095815|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
124583372|NCT02890992|448095816|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
124583373|NCT02890992|448095817|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
124583374|NCT02890992|448095818|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
124583375|NCT02890992|448095819|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
124583376|NCT02890992|448095820|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
124583377|NCT03158727|448095821|FG000|Overall Study|Withdrawal by Subject|2|||
124530249|NCT01012037|447891247|FG002|Overall Study|Adverse Event|3|||
124530250|NCT01012037|447891245|FG000|Overall Study|Protocol Violation|0|||
124530251|NCT01012037|447891246|FG001|Overall Study|Protocol Violation|3|||
124530252|NCT01012037|447891247|FG002|Overall Study|Protocol Violation|5|||
124530253|NCT01012037|447891245|FG000|Overall Study|Withdrawal by Subject|0|||
124530254|NCT01012037|447891246|FG001|Overall Study|Withdrawal by Subject|4|||
124530255|NCT01012037|447891247|FG002|Overall Study|Withdrawal by Subject|1|||
124530256|NCT01012037|447891245|FG000|Overall Study|Other reason (not specified)|1|||
124530257|NCT01012037|447891246|FG001|Overall Study|Other reason (not specified)|1|||
124530258|NCT01012037|447891247|FG002|Overall Study|Other reason (not specified)|1|||
124530259|NCT01700140|447891249|FG000|Overall Study|Use of rescue drugs|3|||
124530260|NCT01700140|447891250|FG001|Overall Study|Use of rescue drugs|3|||
124530261|NCT01700140|447891251|FG002|Overall Study|Use of rescue drugs|1|||
124530262|NCT01700140|447891249|FG000|Overall Study|Discontinuation of radiotherapy|1|||
124530263|NCT01700140|447891250|FG001|Overall Study|Discontinuation of radiotherapy|0|||
124530264|NCT01700140|447891251|FG002|Overall Study|Discontinuation of radiotherapy|0|||
124530265|NCT01700140|447891249|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
124530266|NCT01700140|447891250|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
124530267|NCT01700140|447891251|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
124530268|NCT01700140|447891249|FG000|Overall Study|Aggravation of symptoms|1|||
124530269|NCT01700140|447891250|FG001|Overall Study|Aggravation of symptoms|0|||
124530270|NCT01700140|447891251|FG002|Overall Study|Aggravation of symptoms|0|||
124530271|NCT01700140|447891249|FG000|Overall Study|Adverse Event|0|||
124530272|NCT01700140|447891250|FG001|Overall Study|Adverse Event|1|||
124530273|NCT01700140|447891251|FG002|Overall Study|Adverse Event|0|||
124530274|NCT01700140|447891249|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
124583378|NCT03158727|448095822|FG001|Overall Study|Withdrawal by Subject|6|||
124583379|NCT03158727|448095821|FG000|Overall Study|Death|11|||
124583380|NCT03158727|448095822|FG001|Overall Study|Death|12|||
124583381|NCT03158727|448095821|FG000|Overall Study|Lost to Follow-up|1|||
124583382|NCT03158727|448095822|FG001|Overall Study|Lost to Follow-up|0|||
124583383|NCT03158727|448095821|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
124583384|NCT03158727|448095822|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
124583385|NCT03158727|448095821|FG000|Overall Study|Visit 11 not done by mistake|0|||
124583386|NCT03158727|448095822|FG001|Overall Study|Visit 11 not done by mistake|1|||
124530275|NCT01700140|447891250|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
124583387|NCT03158727|448095821|FG000|Overall Study|Enrolled, not treated|1|||
124583388|NCT03158727|448095822|FG001|Overall Study|Enrolled, not treated|0|||
124583389|NCT00669162|448095823|FG000|Overall Study|Withdrawal by Subject|1|||
124583390|NCT00807495|448095827|FG000|Overall Study|Adverse Event|6|||
124583391|NCT00807495|448095828|FG001|Overall Study|Adverse Event|3|||
124583392|NCT00807495|448095829|FG002|Overall Study|Adverse Event|1|||
124583393|NCT00807495|448095830|FG003|Overall Study|Adverse Event|1|||
124583394|NCT00807495|448095831|FG004|Overall Study|Adverse Event|2|||
124583395|NCT00807495|448095827|FG000|Overall Study|Withdrawal by Patient|2|||
124583396|NCT00807495|448095828|FG001|Overall Study|Withdrawal by Patient|0|||
124583397|NCT00807495|448095829|FG002|Overall Study|Withdrawal by Patient|1|||
124583398|NCT00807495|448095830|FG003|Overall Study|Withdrawal by Patient|0|||
124583399|NCT00807495|448095831|FG004|Overall Study|Withdrawal by Patient|0|||
124583400|NCT00807495|448095827|FG000|Overall Study|Reason Not Specified|0|||
124583401|NCT00807495|448095828|FG001|Overall Study|Reason Not Specified|3|||
124583402|NCT00807495|448095829|FG002|Overall Study|Reason Not Specified|2|||
124583403|NCT00807495|448095830|FG003|Overall Study|Reason Not Specified|0|||
124583404|NCT00807495|448095831|FG004|Overall Study|Reason Not Specified|3|||
124583405|NCT02412852|448095832|FG000|Overall Study|Withdrawal by Subject|0|||
124583406|NCT02412852|448095833|FG001|Overall Study|Withdrawal by Subject|1|||
124583407|NCT02412852|448095834|FG002|Overall Study|Withdrawal by Subject|0|||
124583408|NCT02412852|448095835|FG003|Overall Study|Withdrawal by Subject|0|||
124583409|NCT02412852|448095832|FG000|Overall Study|Physician Decision|0|||
124583410|NCT02412852|448095833|FG001|Overall Study|Physician Decision|0|||
124583411|NCT02412852|448095834|FG002|Overall Study|Physician Decision|0|||
124530276|NCT01700140|447891251|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
124530277|NCT00415623|447891252|FG000|Overall Study|Adverse Event|3|||
124530278|NCT00415623|447891253|FG001|Overall Study|Adverse Event|4|||
124530279|NCT00415623|447891252|FG000|Overall Study|Death|1|||
124530280|NCT00415623|447891253|FG001|Overall Study|Death|0|||
124530281|NCT00415623|447891252|FG000|Overall Study|Withdrawal by Subject|1|||
124530282|NCT00415623|447891253|FG001|Overall Study|Withdrawal by Subject|1|||
124530283|NCT00542425|447891259|FG000|Initial 24 Weeks|Administrative reasons|0|||
124530284|NCT00542425|447891260|FG001|Initial 24 Weeks|Administrative reasons|0|||
124530285|NCT00542425|447891261|FG002|Initial 24 Weeks|Administrative reasons|1|||
124530286|NCT00542425|447891262|FG003|Initial 24 Weeks|Administrative reasons|1|||
124530287|NCT00542425|447891263|FG004|Initial 24 Weeks|Administrative reasons|0|||
124530288|NCT00542425|447891259|FG000|Initial 24 Weeks|Adverse Event|0|||
124530289|NCT00542425|447891260|FG001|Initial 24 Weeks|Adverse Event|1|||
124530290|NCT00542425|447891261|FG002|Initial 24 Weeks|Adverse Event|1|||
124530291|NCT00542425|447891262|FG003|Initial 24 Weeks|Adverse Event|3|||
124530292|NCT00542425|447891263|FG004|Initial 24 Weeks|Adverse Event|2|||
124530293|NCT00542425|447891259|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
124530294|NCT00542425|447891260|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
124530295|NCT00542425|447891261|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
124530296|NCT00542425|447891262|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
124530297|NCT00542425|447891263|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
124530298|NCT00542425|447891259|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
124530299|NCT00542425|447891260|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
124530300|NCT00542425|447891261|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
124530301|NCT00542425|447891262|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
124530302|NCT00542425|447891263|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
124530303|NCT00542425|447891259|FG000|Initial 24 Weeks|Non-compliance|0|||
124583412|NCT02412852|448095835|FG003|Overall Study|Physician Decision|1|||
124583413|NCT00841542|448095836|FG000|Period 1|Adverse Event|1|||
124583414|NCT00841542|448095837|FG001|Period 1|Adverse Event|0|||
124583415|NCT00924638|448095843|FG000|Overall Study|Death|3|||
124583416|NCT00924638|448095844|FG001|Overall Study|Death|2|||
124583417|NCT00924638|448095843|FG000|Overall Study|Lost to Follow-up|1|||
124777031|NCT02721966|448811396|FG004|Overall Study|Protocol Violation|0|||
124530304|NCT00542425|447891260|FG001|Initial 24 Weeks|Non-compliance|0|||
124530305|NCT00542425|447891261|FG002|Initial 24 Weeks|Non-compliance|0|||
124530306|NCT00542425|447891262|FG003|Initial 24 Weeks|Non-compliance|1|||
124530307|NCT00542425|447891263|FG004|Initial 24 Weeks|Non-compliance|1|||
124530308|NCT00542425|447891259|FG000|Initial 24 Weeks|Protocol Violation|0|||
124583418|NCT00924638|448095844|FG001|Overall Study|Lost to Follow-up|1|||
124583419|NCT00924638|448095843|FG000|Overall Study|Withdrawal by Subject|5|||
124728392|NCT02640625|448627899|FG000|Overall Study|Adverse Event|1|||
124728393|NCT00511433|448627900|FG000|Overall Study|Adverse Event|5|||
124728394|NCT00511433|448627901|FG001|Overall Study|Adverse Event|0|||
124728395|NCT00511433|448627900|FG000|Overall Study|Other Reason|1|||
124728396|NCT00511433|448627901|FG001|Overall Study|Other Reason|1|||
124728397|NCT01740089|448627902|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
124728398|NCT01740089|448627903|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
124728399|NCT01740089|448627904|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
124728400|NCT01740089|448627902|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
124728401|NCT01740089|448627903|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
124728402|NCT01740089|448627904|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
124728403|NCT01740089|448627902|FG000|After 12 Weeks|Lack of Efficacy|3|||
124728404|NCT01740089|448627903|FG001|After 12 Weeks|Lack of Efficacy|1|||
124728405|NCT01740089|448627904|FG002|After 12 Weeks|Lack of Efficacy|4|||
124728406|NCT01740089|448627902|FG000|After 12 Weeks|Adverse Event|2|||
124728407|NCT01740089|448627903|FG001|After 12 Weeks|Adverse Event|0|||
124728408|NCT01740089|448627904|FG002|After 12 Weeks|Adverse Event|5|||
124728409|NCT01740089|448627902|FG000|After 12 Weeks|Protocol Violation|1|||
124728410|NCT01740089|448627903|FG001|After 12 Weeks|Protocol Violation|1|||
124728411|NCT01740089|448627904|FG002|After 12 Weeks|Protocol Violation|1|||
124728412|NCT01740089|448627902|FG000|After 12 Weeks|Withdrawal by Subject|1|||
124728413|NCT01740089|448627903|FG001|After 12 Weeks|Withdrawal by Subject|1|||
124728414|NCT01740089|448627904|FG002|After 12 Weeks|Withdrawal by Subject|1|||
124728415|NCT00790868|448627905|FG000|Overall Study|Withdrawal by Subject|4|||
124728416|NCT00790868|448627906|FG001|Overall Study|Withdrawal by Subject|5|||
124728417|NCT00790868|448627905|FG000|Overall Study|Lost to Follow-up|2|||
124728418|NCT00790868|448627906|FG001|Overall Study|Lost to Follow-up|12|||
124530309|NCT00542425|447891260|FG001|Initial 24 Weeks|Protocol Violation|0|||
124530310|NCT00542425|447891261|FG002|Initial 24 Weeks|Protocol Violation|0|||
124728419|NCT01380535|448627907|FG000|Overall Study|Adverse Event|3|||
124728420|NCT01380535|448627908|FG001|Overall Study|Adverse Event|3|||
124728421|NCT01380535|448627907|FG000|Overall Study|Death|3|||
124728422|NCT01380535|448627908|FG001|Overall Study|Death|0|||
124728423|NCT01380535|448627907|FG000|Overall Study|Study site closed|0|||
124728424|NCT01380535|448627908|FG001|Overall Study|Study site closed|5|||
124728425|NCT01380535|448627907|FG000|Overall Study|Withdrawal by Subject|1|||
124728426|NCT01380535|448627908|FG001|Overall Study|Withdrawal by Subject|2|||
124728427|NCT01380535|448627907|FG000|Overall Study|Protocol Violation|0|||
124728428|NCT01380535|448627908|FG001|Overall Study|Protocol Violation|2|||
124728429|NCT01380535|448627907|FG000|Overall Study|Lack of Efficacy|0|||
124728430|NCT01380535|448627908|FG001|Overall Study|Lack of Efficacy|3|||
124728431|NCT02013206|448627909|FG000|Overall Study|Progressive disease (PD)|14|||
124728432|NCT02013206|448627910|FG001|Overall Study|Progressive disease (PD)|17|||
124728433|NCT02013206|448627909|FG000|Overall Study|Symptomatic deterioration|3|||
124728434|NCT02013206|448627910|FG001|Overall Study|Symptomatic deterioration|1|||
124728435|NCT02013206|448627909|FG000|Overall Study|Adverse Event|1|||
124728436|NCT02013206|448627910|FG001|Overall Study|Adverse Event|0|||
124728437|NCT02013206|448627909|FG000|Overall Study|Patient refusal|2|||
124728438|NCT02013206|448627910|FG001|Overall Study|Patient refusal|0|||
124728439|NCT02013206|448627909|FG000|Overall Study|Patient non-compliance|1|||
124728440|NCT02013206|448627910|FG001|Overall Study|Patient non-compliance|0|||
124728441|NCT02013206|448627909|FG000|Overall Study|Death|1|||
124728442|NCT02013206|448627910|FG001|Overall Study|Death|2|||
124728443|NCT02013206|448627909|FG000|Overall Study|Other reasons off treatment|5|||
124728444|NCT02013206|448627910|FG001|Overall Study|Other reasons off treatment|2|||
124728445|NCT02791191|448627911|FG000|Overall Study|Adverse Event|2|||
124728446|NCT02791191|448627912|FG001|Overall Study|Adverse Event|4|||
124728447|NCT02791191|448627913|FG002|Overall Study|Adverse Event|5|||
124728448|NCT02791191|448627911|FG000|Overall Study|Lack of Efficacy|0|||
124728449|NCT02791191|448627912|FG001|Overall Study|Lack of Efficacy|1|||
124728450|NCT02791191|448627913|FG002|Overall Study|Lack of Efficacy|0|||
124728451|NCT02791191|448627911|FG000|Overall Study|Study Drug Non-Compliance|0|||
124728452|NCT02791191|448627912|FG001|Overall Study|Study Drug Non-Compliance|2|||
124728453|NCT02791191|448627913|FG002|Overall Study|Study Drug Non-Compliance|0|||
124728454|NCT02791191|448627911|FG000|Overall Study|Site Closed by Sponsor|1|||
124728455|NCT02791191|448627912|FG001|Overall Study|Site Closed by Sponsor|1|||
124728456|NCT02791191|448627913|FG002|Overall Study|Site Closed by Sponsor|3|||
124728457|NCT02791191|448627911|FG000|Overall Study|Progressive Disease|1|||
124728458|NCT02791191|448627912|FG001|Overall Study|Progressive Disease|0|||
124728459|NCT02791191|448627913|FG002|Overall Study|Progressive Disease|0|||
124530311|NCT00542425|447891262|FG003|Initial 24 Weeks|Protocol Violation|1|||
124728460|NCT02791191|448627911|FG000|Overall Study|Study Terminated by Sponsor|29|||
124728461|NCT02791191|448627912|FG001|Overall Study|Study Terminated by Sponsor|101|||
124728462|NCT02791191|448627913|FG002|Overall Study|Study Terminated by Sponsor|109|||
124530312|NCT00542425|447891263|FG004|Initial 24 Weeks|Protocol Violation|0|||
124728463|NCT02791191|448627911|FG000|Overall Study|Withdrawal by Subject|3|||
124728464|NCT02791191|448627912|FG001|Overall Study|Withdrawal by Subject|1|||
124728465|NCT02791191|448627913|FG002|Overall Study|Withdrawal by Subject|3|||
124583420|NCT00924638|448095844|FG001|Overall Study|Withdrawal by Subject|7|||
124583421|NCT00924638|448095843|FG000|Overall Study|Physician Decision|3|||
124583422|NCT00924638|448095844|FG001|Overall Study|Physician Decision|3|||
124583423|NCT04411680|448095848|FG000|Treatment Period|Adverse Event|3|||
124583424|NCT04411680|448095849|FG001|Treatment Period|Adverse Event|0|||
124583425|NCT04411680|448095848|FG000|Treatment Period|Discharged from hospital|18|||
124583426|NCT04411680|448095849|FG001|Treatment Period|Discharged from hospital|7|||
124583427|NCT04411680|448095848|FG000|Treatment Period|Missed 1 or more doses|8|||
124583428|NCT04411680|448095849|FG001|Treatment Period|Missed 1 or more doses|0|||
124583429|NCT04411680|448095848|FG000|Treatment Period|Transferred to another hospital|0|||
124583430|NCT04411680|448095849|FG001|Treatment Period|Transferred to another hospital|1|||
124583431|NCT04411680|448095848|FG000|Follow up Period|Withdrawal by Subject|2|||
124583432|NCT04411680|448095849|FG001|Follow up Period|Withdrawal by Subject|0|||
124583433|NCT04411680|448095848|FG000|Follow up Period|Lost to Follow-up|5|||
124583434|NCT04411680|448095849|FG001|Follow up Period|Lost to Follow-up|6|||
124583435|NCT04411680|448095848|FG000|Follow up Period|Death|11|||
124583436|NCT04411680|448095849|FG001|Follow up Period|Death|8|||
124583437|NCT00748566|448095850|FG000|Overall Study|Adverse Event|49|||
124583438|NCT00748566|448095850|FG000|Overall Study|Death|1|||
124583439|NCT00748566|448095850|FG000|Overall Study|Lack of Efficacy|12|||
124583440|NCT00748566|448095850|FG000|Overall Study|Lost to Follow-up|1|||
124583441|NCT00748566|448095850|FG000|Overall Study|Protocol Violation|13|||
124583442|NCT00748566|448095850|FG000|Overall Study|Withdrawal by Subject|22|||
124583443|NCT00748566|448095850|FG000|Overall Study|Study terminated by sponsor|5|||
124583444|NCT00748566|448095850|FG000|Overall Study|Other|9|||
124583445|NCT00624286|448095851|FG000|Overall Study|Protocol Deviation|7|||
124583446|NCT00624286|448095852|FG001|Overall Study|Protocol Deviation|9|||
124583447|NCT00624286|448095851|FG000|Overall Study|Adverse Event|6|||
124583448|NCT00624286|448095852|FG001|Overall Study|Adverse Event|3|||
124583449|NCT00624286|448095851|FG000|Overall Study|Withdrawal by Subject|5|||
124728466|NCT02791191|448627911|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
124728467|NCT02791191|448627912|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
124728468|NCT02791191|448627913|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
124728469|NCT01952665|448627914|FG000|Overall Study|Physician Decision|3|||
124728470|NCT01952665|448627915|FG001|Overall Study|Physician Decision|2|||
124728471|NCT01952665|448627914|FG000|Overall Study|Lost to Follow-up|1|||
124728472|NCT01952665|448627915|FG001|Overall Study|Lost to Follow-up|2|||
124728473|NCT01952665|448627914|FG000|Overall Study|Adverse Event|2|||
124728474|NCT01952665|448627915|FG001|Overall Study|Adverse Event|1|||
124728475|NCT01952665|448627914|FG000|Overall Study|Protocol Violation|0|||
124728476|NCT01952665|448627915|FG001|Overall Study|Protocol Violation|1|||
124728477|NCT01537081|448627917|FG000|Overall Study|Adverse Event|5|||
124728478|NCT01537081|448627918|FG001|Overall Study|Adverse Event|2|||
124728479|NCT01537081|448627919|FG002|Overall Study|Adverse Event|2|||
124728480|NCT01537081|448627917|FG000|Overall Study|Lack of Efficacy|2|||
124728481|NCT01537081|448627918|FG001|Overall Study|Lack of Efficacy|1|||
124728482|NCT01537081|448627919|FG002|Overall Study|Lack of Efficacy|0|||
124530313|NCT00542425|447891259|FG000|Initial 24 Weeks|Refusal of treatment|2|||
124530314|NCT00542425|447891260|FG001|Initial 24 Weeks|Refusal of treatment|2|||
124530315|NCT00542425|447891261|FG002|Initial 24 Weeks|Refusal of treatment|1|||
124530316|NCT00542425|447891262|FG003|Initial 24 Weeks|Refusal of treatment|4|||
124530317|NCT00542425|447891263|FG004|Initial 24 Weeks|Refusal of treatment|1|||
124530318|NCT00542425|447891259|FG000|Initial 24 Weeks|Other|0|||
124530319|NCT00542425|447891260|FG001|Initial 24 Weeks|Other|2|||
124530320|NCT00542425|447891261|FG002|Initial 24 Weeks|Other|1|||
124530321|NCT00542425|447891262|FG003|Initial 24 Weeks|Other|0|||
124530322|NCT00542425|447891263|FG004|Initial 24 Weeks|Other|0|||
124530323|NCT00542425|447891259|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
124530324|NCT00542425|447891260|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
124530325|NCT00542425|447891261|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
124530326|NCT00542425|447891262|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
124530327|NCT00542425|447891263|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
124530328|NCT00542425|447891259|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
124530329|NCT00542425|447891260|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
124583450|NCT00624286|448095852|FG001|Overall Study|Withdrawal by Subject|4|||
124583451|NCT00624286|448095851|FG000|Overall Study|Lost to Follow-up|3|||
124583452|NCT00624286|448095852|FG001|Overall Study|Lost to Follow-up|2|||
124583453|NCT00624286|448095851|FG000|Overall Study|Administrative problems|3|||
124583454|NCT00624286|448095852|FG001|Overall Study|Administrative problems|0|||
124583455|NCT00624286|448095851|FG000|Overall Study|Lack of Efficacy|1|||
124583456|NCT00624286|448095852|FG001|Overall Study|Lack of Efficacy|6|||
124583457|NCT00624286|448095851|FG000|Overall Study|Not stated|0|||
124530330|NCT00542425|447891261|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
124530331|NCT00542425|447891262|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
124530332|NCT00542425|447891263|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
124583458|NCT00624286|448095852|FG001|Overall Study|Not stated|1|||
124728483|NCT01537081|448627917|FG000|Overall Study|Lost to Follow-up|17|||
124728484|NCT01537081|448627918|FG001|Overall Study|Lost to Follow-up|15|||
124530333|NCT00542425|447891259|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
124530334|NCT00542425|447891260|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
124530335|NCT00542425|447891261|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
124530336|NCT00542425|447891262|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
124530337|NCT00542425|447891263|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
124530338|NCT00542425|447891259|FG000|Extended 24 Weeks of Treatment|Other|1|||
124530339|NCT00542425|447891260|FG001|Extended 24 Weeks of Treatment|Other|1|||
124530340|NCT00542425|447891261|FG002|Extended 24 Weeks of Treatment|Other|0|||
124530341|NCT00542425|447891262|FG003|Extended 24 Weeks of Treatment|Other|0|||
124530342|NCT00542425|447891263|FG004|Extended 24 Weeks of Treatment|Other|1|||
124530343|NCT02096471|447891264|FG000|Overall Study|Adverse Event|1|||
124530344|NCT02096471|447891264|FG000|Overall Study|Lack of Efficacy|7|||
124530345|NCT02096471|447891264|FG000|Overall Study|Withdrawal by Subject|3|||
124530346|NCT02096471|447891264|FG000|Overall Study|Non-Compliant|2|||
124530347|NCT01610414|447891265|FG000|Study Start - Month 13|Serious Adverse Event|65|||
124530348|NCT01610414|447891266|FG001|Study Start - Month 13|Serious Adverse Event|67|||
124530349|NCT01610414|447891265|FG000|Study Start - Month 13|Adverse Event|14|||
124530350|NCT01610414|447891266|FG001|Study Start - Month 13|Adverse Event|14|||
124530351|NCT01610414|447891265|FG000|Study Start - Month 13|Protocol Violation|3|||
124530352|NCT01610414|447891266|FG001|Study Start - Month 13|Protocol Violation|1|||
124530353|NCT01610414|447891265|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
124530354|NCT01610414|447891266|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
124530355|NCT01610414|447891265|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
124530356|NCT01610414|447891266|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
124530357|NCT01610414|447891265|FG000|Study Start - Month 13|Lost to Follow-up|4|||
124530358|NCT01610414|447891266|FG001|Study Start - Month 13|Lost to Follow-up|6|||
124530359|NCT01610414|447891265|FG000|Study Start - Month 13|Suspected HZ episode|1|||
124530360|NCT01610414|447891266|FG001|Study Start - Month 13|Suspected HZ episode|3|||
124530361|NCT01610414|447891265|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
124530362|NCT01610414|447891266|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
124530363|NCT01610414|447891265|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
124530364|NCT01610414|447891266|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
124530365|NCT01610414|447891265|FG000|Month 13 - Month 25|Adverse Event|8|||
124530366|NCT01610414|447891266|FG001|Month 13 - Month 25|Adverse Event|4|||
124530367|NCT01610414|447891265|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
124530368|NCT01610414|447891266|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
124530369|NCT01610414|447891265|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
124530370|NCT01610414|447891266|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
124530371|NCT01610414|447891265|FG000|Month 13 - Month 25|Protocol Violation|0|||
124530372|NCT01610414|447891266|FG001|Month 13 - Month 25|Protocol Violation|2|||
124530373|NCT01610414|447891265|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
124530374|NCT01610414|447891266|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
124530375|NCT01610414|447891265|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
124530376|NCT01610414|447891266|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
124530377|NCT01610414|447891265|FG000|After Month 25|Study end not reached|48|||
124530378|NCT01610414|447891266|FG001|After Month 25|Study end not reached|53|||
124530379|NCT02736474|447891267|FG000|Overall Study|Lost to Follow-up|0|||
124530380|NCT02736474|447891268|FG001|Overall Study|Lost to Follow-up|1|||
124530381|NCT02483611|447891269|FG000|Overall Study|Protocol Violation|0|||
124530382|NCT02483611|447891270|FG001|Overall Study|Protocol Violation|0|||
124530383|NCT02483611|447891271|FG002|Overall Study|Protocol Violation|1|||
124530384|NCT02382276|447891272|FG000|Overall Study|Withdrawal by Subject|4|||
124530385|NCT02382276|447891273|FG001|Overall Study|Withdrawal by Subject|8|||
124530386|NCT02382276|447891274|FG002|Overall Study|Withdrawal by Subject|5|||
124530387|NCT02382276|447891272|FG000|Overall Study|Adverse Event|7|||
124530388|NCT02382276|447891273|FG001|Overall Study|Adverse Event|2|||
124530389|NCT02382276|447891274|FG002|Overall Study|Adverse Event|32|||
124530390|NCT02382276|447891272|FG000|Overall Study|Physician Decision|0|||
124530391|NCT02382276|447891273|FG001|Overall Study|Physician Decision|0|||
124530392|NCT02382276|447891274|FG002|Overall Study|Physician Decision|2|||
124530393|NCT04223778|447891277|FG000|Overall Study|Death|1|||
124530394|NCT04223778|447891278|FG001|Overall Study|Death|1|||
124530395|NCT04223778|447891277|FG000|Overall Study|Lost to Follow-up|4|||
124530396|NCT04223778|447891278|FG001|Overall Study|Lost to Follow-up|5|||
124530397|NCT04223778|447891277|FG000|Overall Study|Physician Decision|10|||
124530398|NCT04223778|447891278|FG001|Overall Study|Physician Decision|6|||
124530399|NCT04223778|447891277|FG000|Overall Study|Withdrawal by Subject|35|||
124530400|NCT04223778|447891278|FG001|Overall Study|Withdrawal by Subject|17|||
124530401|NCT04223778|447891277|FG000|Overall Study|Not Reported|7|||
124530402|NCT04223778|447891278|FG001|Overall Study|Not Reported|8|||
124530403|NCT03893630|447891281|FG000|Overall Study|Lost to Follow-up|5|||
124728485|NCT01537081|448627919|FG002|Overall Study|Lost to Follow-up|9|||
124728486|NCT01537081|448627917|FG000|Overall Study|Protocol Violation|3|||
124728487|NCT01537081|448627918|FG001|Overall Study|Protocol Violation|2|||
124530404|NCT03893630|447891282|FG001|Overall Study|Lost to Follow-up|4|||
124530405|NCT03893630|447891283|FG002|Overall Study|Lost to Follow-up|2|||
124530406|NCT03893630|447891281|FG000|Overall Study|Withdrawal by Subject|3|||
124728488|NCT01537081|448627919|FG002|Overall Study|Protocol Violation|2|||
124728489|NCT01537081|448627917|FG000|Overall Study|Withdrawal by Subject|6|||
124728490|NCT01537081|448627918|FG001|Overall Study|Withdrawal by Subject|11|||
124728491|NCT01537081|448627919|FG002|Overall Study|Withdrawal by Subject|3|||
124728492|NCT01537081|448627917|FG000|Overall Study|Physician Decision|5|||
124728493|NCT01537081|448627918|FG001|Overall Study|Physician Decision|6|||
124728494|NCT01537081|448627919|FG002|Overall Study|Physician Decision|0|||
124728495|NCT01537081|448627917|FG000|Overall Study|Sponsor decision|0|||
124728496|NCT01537081|448627918|FG001|Overall Study|Sponsor decision|1|||
124728497|NCT01537081|448627919|FG002|Overall Study|Sponsor decision|0|||
124728498|NCT01537081|448627917|FG000|Overall Study|Assigned but never dosed|1|||
124728499|NCT01537081|448627918|FG001|Overall Study|Assigned but never dosed|0|||
124728500|NCT01537081|448627919|FG002|Overall Study|Assigned but never dosed|0|||
124728501|NCT01463111|448627922|FG000|Overall Study|Withdrawal by Subject|2|||
124728502|NCT01463111|448627922|FG000|Overall Study|Lost to Follow-up|5|||
124728503|NCT01463111|448627922|FG000|Overall Study|Physician Decision|2|||
124728504|NCT02596958|448627933|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
124728505|NCT02596958|448627933|FG000|Overall Study|Cancer Progression|441|||
124728506|NCT02596958|448627933|FG000|Overall Study|Death From Cancer|112|||
124728507|NCT02596958|448627933|FG000|Overall Study|Death From Other Cause|33|||
124728508|NCT02596958|448627933|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
124728509|NCT02596958|448627933|FG000|Overall Study|Administrative Reasons/Other|231|||
124728510|NCT02596958|448627933|FG000|Overall Study|Lost to Follow-up|33|||
124728511|NCT02596958|448627933|FG000|Overall Study|Missing|32|||
124728512|NCT02596958|448627933|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
124728513|NCT01559259|448627934|FG000|Overall Study|Withdrawal by Subject|0|||
124728514|NCT01559259|448627935|FG001|Overall Study|Withdrawal by Subject|0|||
124728515|NCT01559259|448627936|FG002|Overall Study|Withdrawal by Subject|0|||
124728516|NCT01559259|448627937|FG003|Overall Study|Withdrawal by Subject|1|||
124728517|NCT01559259|448627938|FG004|Overall Study|Withdrawal by Subject|0|||
124728518|NCT01559259|448627934|FG000|Overall Study|Adverse Event|0|||
124728519|NCT01559259|448627935|FG001|Overall Study|Adverse Event|1|||
124728520|NCT01559259|448627936|FG002|Overall Study|Adverse Event|1|||
124728521|NCT01559259|448627937|FG003|Overall Study|Adverse Event|0|||
124728522|NCT01559259|448627938|FG004|Overall Study|Adverse Event|0|||
124728523|NCT01995669|448627939|FG000|Overall Study|Progression|2|||
124728524|NCT01995669|448627940|FG001|Overall Study|Progression|1|||
124728525|NCT01995669|448627941|FG002|Overall Study|Progression|1|||
124728526|NCT01995669|448627942|FG003|Overall Study|Progression|13|||
124728527|NCT01995669|448627939|FG000|Overall Study|Adverse Event|0|||
124728528|NCT01995669|448627940|FG001|Overall Study|Adverse Event|0|||
124728529|NCT01995669|448627941|FG002|Overall Study|Adverse Event|0|||
124728530|NCT01995669|448627942|FG003|Overall Study|Adverse Event|3|||
124728531|NCT01995669|448627939|FG000|Overall Study|Death|0|||
124728532|NCT01995669|448627940|FG001|Overall Study|Death|0|||
124728533|NCT01995669|448627941|FG002|Overall Study|Death|0|||
124728534|NCT01995669|448627942|FG003|Overall Study|Death|6|||
124728535|NCT01995669|448627939|FG000|Overall Study|Withdrawal by Subject|0|||
124728536|NCT01995669|448627940|FG001|Overall Study|Withdrawal by Subject|0|||
124728537|NCT01995669|448627941|FG002|Overall Study|Withdrawal by Subject|0|||
124728538|NCT01995669|448627942|FG003|Overall Study|Withdrawal by Subject|6|||
124728539|NCT01995669|448627939|FG000|Overall Study|Insurance Expired|0|||
124728540|NCT01995669|448627940|FG001|Overall Study|Insurance Expired|0|||
124728541|NCT01995669|448627941|FG002|Overall Study|Insurance Expired|0|||
124728542|NCT01995669|448627942|FG003|Overall Study|Insurance Expired|1|||
124728543|NCT05425732|448627943|FG000|Overall Study|Death|4|||
124728544|NCT05425732|448627944|FG001|Overall Study|Death|2|||
124728545|NCT05425732|448627945|FG002|Overall Study|Death|0|||
124728546|NCT05425732|448627946|FG003|Overall Study|Death|0|||
124728547|NCT05425732|448627943|FG000|Overall Study|Lost to Follow-up|10|||
124728548|NCT05425732|448627944|FG001|Overall Study|Lost to Follow-up|15|||
124728549|NCT05425732|448627945|FG002|Overall Study|Lost to Follow-up|5|||
124728550|NCT05425732|448627946|FG003|Overall Study|Lost to Follow-up|3|||
124530407|NCT03893630|447891282|FG001|Overall Study|Withdrawal by Subject|6|||
124530408|NCT03893630|447891283|FG002|Overall Study|Withdrawal by Subject|3|||
124728551|NCT05425732|448627943|FG000|Overall Study|Physician Decision|0|||
124728552|NCT05425732|448627944|FG001|Overall Study|Physician Decision|2|||
124728553|NCT05425732|448627945|FG002|Overall Study|Physician Decision|0|||
124728554|NCT05425732|448627946|FG003|Overall Study|Physician Decision|0|||
124728555|NCT05425732|448627943|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
124728556|NCT05425732|448627944|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
124728557|NCT05425732|448627945|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124728558|NCT05425732|448627946|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124728559|NCT05425732|448627943|FG000|Overall Study|Withdrawal by Subject|4|||
124728560|NCT05425732|448627944|FG001|Overall Study|Withdrawal by Subject|8|||
124728561|NCT05425732|448627945|FG002|Overall Study|Withdrawal by Subject|1|||
124583459|NCT00624286|448095851|FG000|Overall Study|Abnormal test procedure result(s)|0|||
124583460|NCT00624286|448095852|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124583461|NCT00624286|448095851|FG000|Overall Study|Death|0|||
124583462|NCT00624286|448095852|FG001|Overall Study|Death|1|||
124583463|NCT00841659|448095853|FG000|Washout: 2 Weeks|Protocol Violation|1|||
124583464|NCT00841659|448095854|FG001|Washout: 2 Weeks|Protocol Violation|0|||
124583465|NCT00073307|448095856|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
124583466|NCT00073307|448095857|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
124583467|NCT00073307|448095858|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
124583468|NCT00073307|448095856|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
124583469|NCT00073307|448095857|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
124583470|NCT00073307|448095858|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
124583471|NCT00073307|448095856|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
124583472|NCT00073307|448095857|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
124583473|NCT00073307|448095858|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
124583474|NCT00073307|448095856|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
124583475|NCT00073307|448095857|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
124583476|NCT00073307|448095858|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
124583477|NCT00073307|448095856|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
124583478|NCT00073307|448095857|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
124583479|NCT00073307|448095858|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
124583480|NCT00073307|448095856|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
124583481|NCT00073307|448095857|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
124583482|NCT00073307|448095858|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
124583483|NCT00073307|448095856|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
124583484|NCT00073307|448095857|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
124583485|NCT00073307|448095858|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
124583486|NCT00073307|448095856|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
124583487|NCT00073307|448095857|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
124583488|NCT00073307|448095858|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
124583489|NCT00073307|448095856|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
124728562|NCT05425732|448627946|FG003|Overall Study|Withdrawal by Subject|1|||
124728563|NCT05425732|448627943|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
124728564|NCT05425732|448627944|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
124728565|NCT05425732|448627945|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
124728566|NCT05425732|448627946|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
124728567|NCT00306293|448627948|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
124728568|NCT00306293|448627949|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
124728569|NCT00306293|448627948|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
124728570|NCT00306293|448627949|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
124728571|NCT00306293|448627948|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
124728572|NCT00306293|448627949|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
124728573|NCT00306293|448627948|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
124728574|NCT00306293|448627949|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
124728575|NCT00306293|448627948|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
124728576|NCT00306293|448627949|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
124728577|NCT00306293|448627948|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
124728578|NCT00306293|448627949|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
124728579|NCT00306293|448627948|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
124728580|NCT00306293|448627949|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
124728581|NCT00306293|448627948|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
124728582|NCT00306293|448627949|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
124728583|NCT00185380|448627950|FG000|Overall Study|Adverse Event|41|||
124728584|NCT00185380|448627951|FG001|Overall Study|Adverse Event|43|||
124728585|NCT00185380|448627952|FG002|Overall Study|Adverse Event|48|||
124728586|NCT00185380|448627950|FG000|Overall Study|Lost to Follow-up|0|||
124728587|NCT00185380|448627951|FG001|Overall Study|Lost to Follow-up|4|||
124728588|NCT00185380|448627952|FG002|Overall Study|Lost to Follow-up|3|||
124728589|NCT00185380|448627950|FG000|Overall Study|Pregnancy|1|||
124583490|NCT00073307|448095857|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
124583491|NCT00073307|448095858|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
124728590|NCT00185380|448627951|FG001|Overall Study|Pregnancy|4|||
124728591|NCT00185380|448627952|FG002|Overall Study|Pregnancy|0|||
124728592|NCT00185380|448627950|FG000|Overall Study|Protocol Violation|2|||
124728593|NCT00185380|448627951|FG001|Overall Study|Protocol Violation|2|||
124728594|NCT00185380|448627952|FG002|Overall Study|Protocol Violation|1|||
124728595|NCT00185380|448627950|FG000|Overall Study|Withdrawal by Subject|1|||
124530409|NCT03893630|447891281|FG000|Overall Study|Discontinued Intervention|0|||
124530410|NCT03893630|447891282|FG001|Overall Study|Discontinued Intervention|4|||
124530411|NCT03893630|447891283|FG002|Overall Study|Discontinued Intervention|2|||
124530412|NCT01569568|447892867|FG000|Overall Study|Physician Decision|0|||
124530413|NCT01569568|447892868|FG001|Overall Study|Physician Decision|2|||
124530414|NCT01370499|447892869|FG000|Overall Study|Adverse Event|38|||
124530415|NCT01370499|447892870|FG001|Overall Study|Adverse Event|12|||
124530416|NCT01370499|447892869|FG000|Overall Study|Lack of Efficacy|4|||
124530417|NCT01370499|447892870|FG001|Overall Study|Lack of Efficacy|2|||
124530418|NCT01370499|447892869|FG000|Overall Study|Lost to Follow-up|2|||
124530419|NCT01370499|447892870|FG001|Overall Study|Lost to Follow-up|1|||
124530420|NCT01370499|447892869|FG000|Overall Study|Physician Decision|3|||
124530421|NCT01370499|447892870|FG001|Overall Study|Physician Decision|3|||
124530422|NCT01370499|447892869|FG000|Overall Study|Protocol Violation|5|||
124530423|NCT01370499|447892870|FG001|Overall Study|Protocol Violation|4|||
124530424|NCT01370499|447892869|FG000|Overall Study|Withdrawal by Subject|18|||
124530425|NCT01370499|447892870|FG001|Overall Study|Withdrawal by Subject|7|||
124530426|NCT01370499|447892869|FG000|Overall Study|Sponsor Decision|41|||
124530427|NCT01370499|447892870|FG001|Overall Study|Sponsor Decision|15|||
124530428|NCT00887822|447892871|FG000|Overall Study|Insufficient therapeutic response|53|||
124530429|NCT00887822|447892872|FG001|Overall Study|Insufficient therapeutic response|55|||
124530430|NCT00887822|447892871|FG000|Overall Study|Adverse Event|14|||
124530431|NCT00887822|447892872|FG001|Overall Study|Adverse Event|17|||
124530432|NCT00887822|447892871|FG000|Overall Study|Failure to return|11|||
124530433|NCT00887822|447892872|FG001|Overall Study|Failure to return|11|||
124530434|NCT00887822|447892871|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
124530435|NCT00887822|447892872|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
124530436|NCT00887822|447892871|FG000|Overall Study|Administrative/Other than specified|5|||
124530437|NCT00887822|447892872|FG001|Overall Study|Administrative/Other than specified|4|||
124530438|NCT00887822|447892871|FG000|Overall Study|Death|2|||
124530439|NCT00887822|447892872|FG001|Overall Study|Death|3|||
124530440|NCT00887822|447892871|FG000|Overall Study|Protocol Violation|0|||
124530441|NCT00887822|447892872|FG001|Overall Study|Protocol Violation|1|||
124530442|NCT00887822|447892871|FG000|Overall Study|Randomized but not treated|0|||
124530443|NCT00887822|447892872|FG001|Overall Study|Randomized but not treated|1|||
124530444|NCT02045979|447892873|FG000|Overall Study|Informed Consent Withdrawn|2|||
124530445|NCT02045979|447892874|FG001|Overall Study|Informed Consent Withdrawn|0|||
124530446|NCT02045979|447892875|FG002|Overall Study|Informed Consent Withdrawn|1|||
124530447|NCT02045979|447892873|FG000|Overall Study|not specified above|0|||
124530448|NCT02045979|447892874|FG001|Overall Study|not specified above|1|||
124530449|NCT02045979|447892875|FG002|Overall Study|not specified above|0|||
124530450|NCT02425891|447892876|FG000|Overall Study|Death|333|||
124530451|NCT02425891|447892877|FG001|Overall Study|Death|314|||
124530452|NCT02425891|447892876|FG000|Overall Study|Lost to Follow-up|4|||
124530453|NCT02425891|447892877|FG001|Overall Study|Lost to Follow-up|6|||
124530454|NCT02425891|447892876|FG000|Overall Study|Non-Compliance|1|||
124530455|NCT02425891|447892877|FG001|Overall Study|Non-Compliance|1|||
124530456|NCT02425891|447892876|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
124530457|NCT02425891|447892877|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
124530458|NCT02425891|447892876|FG000|Overall Study|Physician Decision|0|||
124530459|NCT02425891|447892877|FG001|Overall Study|Physician Decision|1|||
124530460|NCT02425891|447892876|FG000|Overall Study|Protocol Violation|1|||
124530461|NCT02425891|447892877|FG001|Overall Study|Protocol Violation|1|||
124530462|NCT02425891|447892876|FG000|Overall Study|Study Terminated By Sponsor|85|||
124530463|NCT02425891|447892877|FG001|Overall Study|Study Terminated By Sponsor|95|||
124530464|NCT02425891|447892876|FG000|Overall Study|Withdrawal by Subject|27|||
124530465|NCT02425891|447892877|FG001|Overall Study|Withdrawal by Subject|32|||
124530466|NCT01944462|447892879|FG000|PPPP Educational Program|Lost to Follow-up|60|||
124530467|NCT01599585|447892880|FG000|Overall Study|Withdrawal by Subject|16|||
124530468|NCT01599585|447892881|FG001|Overall Study|Withdrawal by Subject|9|||
124530469|NCT01599585|447892880|FG000|Overall Study|Lost to Follow-up|3|||
124530470|NCT01599585|447892881|FG001|Overall Study|Lost to Follow-up|5|||
124530471|NCT01599585|447892880|FG000|Overall Study|randomized did not start treatment|3|||
124530472|NCT01599585|447892881|FG001|Overall Study|randomized did not start treatment|3|||
124530473|NCT05827978|447892882|FG000|Overall Study|Adverse Event|1|||
124530474|NCT05827978|447892883|FG001|Overall Study|Adverse Event|0|||
124530475|NCT05827978|447892884|FG002|Overall Study|Adverse Event|0|||
124530476|NCT05827978|447892885|FG003|Overall Study|Adverse Event|1|||
124530477|NCT05827978|447892886|FG004|Overall Study|Adverse Event|0|||
124530478|NCT05827978|447892887|FG005|Overall Study|Adverse Event|0|||
124530479|NCT05827978|447892882|FG000|Overall Study|Death|1|||
124530480|NCT05827978|447892883|FG001|Overall Study|Death|5|||
124530481|NCT05827978|447892884|FG002|Overall Study|Death|2|||
124530482|NCT05827978|447892885|FG003|Overall Study|Death|3|||
124530483|NCT05827978|447892886|FG004|Overall Study|Death|1|||
124530484|NCT05827978|447892887|FG005|Overall Study|Death|3|||
124530485|NCT05827978|447892882|FG000|Overall Study|Lost to Follow-up|57|||
124530486|NCT05827978|447892883|FG001|Overall Study|Lost to Follow-up|88|||
124530487|NCT05827978|447892884|FG002|Overall Study|Lost to Follow-up|54|||
124583492|NCT00073307|448095856|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
124583493|NCT00073307|448095857|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
124583494|NCT00073307|448095858|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
124583495|NCT00073307|448095856|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
124583496|NCT00073307|448095857|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
124583497|NCT00073307|448095858|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
124583498|NCT00073307|448095856|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
124583499|NCT00073307|448095857|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
124583500|NCT00073307|448095858|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
124583501|NCT00073307|448095856|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
124583502|NCT00073307|448095857|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
124583503|NCT00073307|448095858|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
124583504|NCT00073307|448095856|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
124583505|NCT00073307|448095857|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
124583506|NCT00073307|448095858|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
124583507|NCT00073307|448095856|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
124583508|NCT00073307|448095857|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
124583509|NCT00073307|448095858|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
124583510|NCT00073307|448095856|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
124583511|NCT00073307|448095857|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
124583512|NCT00073307|448095858|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
124583513|NCT00073307|448095856|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
124583514|NCT00073307|448095857|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
124583515|NCT00073307|448095858|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
124583516|NCT00073307|448095856|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
124583517|NCT00073307|448095857|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
124583518|NCT00073307|448095858|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
124583519|NCT00073307|448095856|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
124583520|NCT00073307|448095857|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
124583521|NCT00073307|448095858|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
124583522|NCT01190865|448095872|FG000|Overall Study|Withdrawal by Subject|1|||
124583523|NCT01190865|448095872|FG000|Overall Study|Non-compliance|2|||
124583524|NCT02436200|448095874|FG000|Overall Study|Significant outlier|1|||
124583525|NCT00957021|448095877|FG000|Overall Study|Death|5|||
124583526|NCT00957021|448095877|FG000|Overall Study|Lost to Follow-up|8|||
124583527|NCT00957021|448095877|FG000|Overall Study|Withdrawal by Subject|34|||
124583528|NCT00957021|448095877|FG000|Overall Study|No 2 yr ROM data|35|||
124583529|NCT00957021|448095877|FG000|Overall Study|Revised study component by 2 yr visit|8|||
124583530|NCT00957021|448095877|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
124583531|NCT00957021|448095877|FG000|Overall Study|Surgery Cancelled|9|||
124583532|NCT00957021|448095877|FG000|Overall Study|Termination due to language issue|2|||
124583533|NCT01483820|448095879|FG000|Overall Study|Lack of Efficacy|6|||
124583534|NCT01483820|448095879|FG000|Overall Study|Adverse Event|1|||
124583535|NCT01483820|448095879|FG000|Overall Study|Death|1|||
124583536|NCT00867360|448095880|FG000|Overall Study|Withdrawal by Subject|1|||
124583537|NCT00867360|448095881|FG001|Overall Study|Withdrawal by Subject|0|||
124583538|NCT00867360|448095880|FG000|Overall Study|Physician Decision|0|||
124583539|NCT00867360|448095881|FG001|Overall Study|Physician Decision|1|||
124583540|NCT00112437|448095885|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
124583541|NCT00112437|448095886|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
124583542|NCT00112437|448095887|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
124583543|NCT00112437|448095888|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
124583544|NCT00112437|448095889|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
124583545|NCT00112437|448095890|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583546|NCT00112437|448095891|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583547|NCT00112437|448095892|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583548|NCT00112437|448095893|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583549|NCT00112437|448095894|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583550|NCT00112437|448095895|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583551|NCT00112437|448095896|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583552|NCT00112437|448095897|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583553|NCT00112437|448095898|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583554|NCT00112437|448095899|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583555|NCT00112437|448095900|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583556|NCT00112437|448095901|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583557|NCT00112437|448095902|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583558|NCT00112437|448095903|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
124530488|NCT05827978|447892885|FG003|Overall Study|Lost to Follow-up|47|||
124530489|NCT05827978|447892886|FG004|Overall Study|Lost to Follow-up|25|||
124530490|NCT05827978|447892887|FG005|Overall Study|Lost to Follow-up|10|||
124530491|NCT05827978|447892882|FG000|Overall Study|Noncompliance with Study Procedures|0|||
124530492|NCT05827978|447892883|FG001|Overall Study|Noncompliance with Study Procedures|1|||
124530493|NCT05827978|447892884|FG002|Overall Study|Noncompliance with Study Procedures|1|||
124530494|NCT05827978|447892885|FG003|Overall Study|Noncompliance with Study Procedures|1|||
124530495|NCT05827978|447892886|FG004|Overall Study|Noncompliance with Study Procedures|1|||
124530496|NCT05827978|447892887|FG005|Overall Study|Noncompliance with Study Procedures|0|||
124530497|NCT05827978|447892882|FG000|Overall Study|Physician Decision|2|||
124530498|NCT05827978|447892883|FG001|Overall Study|Physician Decision|0|||
124530499|NCT05827978|447892884|FG002|Overall Study|Physician Decision|1|||
124530500|NCT05827978|447892885|FG003|Overall Study|Physician Decision|2|||
124530501|NCT05827978|447892886|FG004|Overall Study|Physician Decision|1|||
124530502|NCT05827978|447892887|FG005|Overall Study|Physician Decision|1|||
124530503|NCT05827978|447892882|FG000|Overall Study|Protocol Violation|5|||
124530504|NCT05827978|447892883|FG001|Overall Study|Protocol Violation|2|||
124530505|NCT05827978|447892884|FG002|Overall Study|Protocol Violation|0|||
124530506|NCT05827978|447892885|FG003|Overall Study|Protocol Violation|0|||
124530507|NCT05827978|447892886|FG004|Overall Study|Protocol Violation|0|||
124530508|NCT05827978|447892887|FG005|Overall Study|Protocol Violation|0|||
124530509|NCT05827978|447892882|FG000|Overall Study|Withdrawal by Subject|17|||
124530510|NCT05827978|447892883|FG001|Overall Study|Withdrawal by Subject|16|||
124530511|NCT05827978|447892884|FG002|Overall Study|Withdrawal by Subject|10|||
124530512|NCT05827978|447892885|FG003|Overall Study|Withdrawal by Subject|12|||
124530513|NCT05827978|447892886|FG004|Overall Study|Withdrawal by Subject|10|||
124530514|NCT05827978|447892887|FG005|Overall Study|Withdrawal by Subject|9|||
124530515|NCT05827978|447892882|FG000|Overall Study|Other Than Specified|0|||
124530516|NCT05827978|447892883|FG001|Overall Study|Other Than Specified|0|||
124530517|NCT05827978|447892884|FG002|Overall Study|Other Than Specified|1|||
124530518|NCT05827978|447892885|FG003|Overall Study|Other Than Specified|0|||
124530519|NCT05827978|447892886|FG004|Overall Study|Other Than Specified|2|||
124530520|NCT05827978|447892887|FG005|Overall Study|Other Than Specified|0|||
124530521|NCT00729560|447892888|FG000|Overall Study|Withdrawal by Subject|3|||
124530522|NCT00103207|447892889|FG000|Overall Study|Adverse Event|3|||
124530523|NCT00103207|447892889|FG000|Overall Study|Death|1|||
124530524|NCT00103207|447892889|FG000|Overall Study|Withdrawal by Subject|2|||
124530525|NCT00103207|447892889|FG000|Overall Study|Other complicating disease|1|||
124530526|NCT00103207|447892889|FG000|Overall Study|Ineligible|4|||
124530527|NCT00103207|447892889|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
124530528|NCT03662789|447892890|FG000|Overall Study|Lost to Follow-up|1|||
124530529|NCT03662789|447892891|FG001|Overall Study|Lost to Follow-up|2|||
124530530|NCT03662789|447892890|FG000|Overall Study|Could not perform treadmill test|4|||
124530531|NCT03662789|447892891|FG001|Overall Study|Could not perform treadmill test|4|||
124530532|NCT03662789|447892890|FG000|Overall Study|Death|0|||
124530533|NCT03662789|447892891|FG001|Overall Study|Death|1|||
124530534|NCT01029691|447892892|FG000|Continued APAP to Delivery|Death|0|||
124530535|NCT01029691|447892893|FG001|Continued APAP to Delivery|Death|0|||
124530536|NCT01029691|447892894|FG002|Continued APAP to Delivery|Death|1|||
124530537|NCT01023516|447892895|FG000|Overall Study|Voluntary discontinuation|7|||
124530538|NCT01023516|447892896|FG001|Overall Study|Voluntary discontinuation|5|||
124530539|NCT01023516|447892895|FG000|Overall Study|Adverse Event|9|||
124530540|NCT01023516|447892896|FG001|Overall Study|Adverse Event|6|||
124530541|NCT01023516|447892895|FG000|Overall Study|Safety reason|0|||
124530542|NCT01023516|447892896|FG001|Overall Study|Safety reason|3|||
124530543|NCT01023516|447892895|FG000|Overall Study|Study-specific criteria|4|||
124530544|NCT01023516|447892896|FG001|Overall Study|Study-specific criteria|2|||
124530545|NCT01023516|447892895|FG000|Overall Study|Incorrect enrolment|4|||
124530546|NCT01023516|447892896|FG001|Overall Study|Incorrect enrolment|2|||
124530547|NCT00137267|447892899|FG000|Overall Study|Lost to Follow-up|15|||
124530548|NCT00137267|447892900|FG001|Overall Study|Lost to Follow-up|21|||
124530549|NCT00638989|447892902|FG000|Overall Study|Lost to Follow-up|0|||
124530550|NCT00638989|447892903|FG001|Overall Study|Lost to Follow-up|0|||
124530551|NCT00638989|447892904|FG002|Overall Study|Lost to Follow-up|1|||
124530552|NCT00853112|447892905|FG000|Overall Study|Randomized but not treated|0|||
124583559|NCT00112437|448095904|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
124728596|NCT00185380|448627951|FG001|Overall Study|Withdrawal by Subject|2|||
124728597|NCT00185380|448627952|FG002|Overall Study|Withdrawal by Subject|0|||
124728598|NCT00185380|448627950|FG000|Overall Study|Failed insertion|1|||
124530553|NCT00853112|447892906|FG001|Overall Study|Randomized but not treated|1|||
124530554|NCT00853112|447892907|FG002|Overall Study|Randomized but not treated|0|||
124530555|NCT00853112|447892908|FG003|Overall Study|Randomized but not treated|2|||
124530556|NCT00853112|447892909|FG004|Overall Study|Randomized but not treated|0|||
124530557|NCT00853112|447892910|FG005|Overall Study|Randomized but not treated|0|||
124530558|NCT00853112|447892911|FG006|Overall Study|Randomized but not treated|1|||
124530559|NCT01553591|447892912|FG000|Overall Study|Voluntarily withdrew|94|||
124728599|NCT00185380|448627951|FG001|Overall Study|Failed insertion|1|||
124728600|NCT00185380|448627952|FG002|Overall Study|Failed insertion|2|||
124530560|NCT01553591|447892913|FG001|Overall Study|Voluntarily withdrew|79|||
124530561|NCT01553591|447892914|FG002|Overall Study|Voluntarily withdrew|96|||
124530562|NCT01553591|447892912|FG000|Overall Study|Adverse Event|36|||
124530563|NCT01553591|447892913|FG001|Overall Study|Adverse Event|45|||
124530564|NCT01553591|447892914|FG002|Overall Study|Adverse Event|16|||
124530565|NCT01553591|447892912|FG000|Overall Study|Lost to Follow-up|25|||
124530566|NCT01553591|447892913|FG001|Overall Study|Lost to Follow-up|23|||
124530567|NCT01553591|447892914|FG002|Overall Study|Lost to Follow-up|16|||
124530568|NCT01553591|447892912|FG000|Overall Study|Physician decision: other|11|||
124530569|NCT01553591|447892913|FG001|Overall Study|Physician decision: other|14|||
124530570|NCT01553591|447892914|FG002|Overall Study|Physician decision: other|16|||
124530571|NCT01553591|447892912|FG000|Overall Study|Physician decision: lack of efficacy|2|||
124530572|NCT01553591|447892913|FG001|Overall Study|Physician decision: lack of efficacy|3|||
124530573|NCT01553591|447892914|FG002|Overall Study|Physician decision: lack of efficacy|7|||
124530574|NCT01553591|447892912|FG000|Overall Study|Protocol Violation|3|||
124530575|NCT01553591|447892913|FG001|Overall Study|Protocol Violation|4|||
124530576|NCT01553591|447892914|FG002|Overall Study|Protocol Violation|4|||
124530577|NCT01553591|447892912|FG000|Overall Study|Sponsor decision|1|||
124530578|NCT01553591|447892913|FG001|Overall Study|Sponsor decision|0|||
124530579|NCT01553591|447892914|FG002|Overall Study|Sponsor decision|3|||
124530580|NCT01553591|447892912|FG000|Overall Study|Randomized and never dispensed drug|0|||
124530581|NCT01553591|447892913|FG001|Overall Study|Randomized and never dispensed drug|1|||
124530582|NCT01553591|447892914|FG002|Overall Study|Randomized and never dispensed drug|0|||
124530583|NCT01818765|447892915|FG000|Overall Study|Death|2|||
124530584|NCT00170846|447892916|FG000|Overall Study|Subject withdrew Informed Consent|5|||
124530585|NCT00170846|447892917|FG001|Overall Study|Subject withdrew Informed Consent|12|||
124530586|NCT00170846|447892918|FG002|Overall Study|Subject withdrew Informed Consent|8|||
124530587|NCT00170846|447892916|FG000|Overall Study|Lost to Follow-up|6|||
124530588|NCT00170846|447892917|FG001|Overall Study|Lost to Follow-up|3|||
124530589|NCT00170846|447892918|FG002|Overall Study|Lost to Follow-up|2|||
124530590|NCT00170846|447892916|FG000|Overall Study|Death|0|||
124530591|NCT00170846|447892917|FG001|Overall Study|Death|3|||
124530592|NCT00170846|447892918|FG002|Overall Study|Death|3|||
124530593|NCT00170846|447892916|FG000|Overall Study|Reason Missing|0|||
124530594|NCT00170846|447892917|FG001|Overall Study|Reason Missing|1|||
124530595|NCT00170846|447892918|FG002|Overall Study|Reason Missing|0|||
124530596|NCT02005211|447892919|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
124530597|NCT02005211|447892920|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
124530598|NCT02005211|447892921|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
124530599|NCT02005211|447892922|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
124530600|NCT02005211|447892923|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
124530601|NCT02005211|447892924|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
124530602|NCT02005211|447892925|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
124530603|NCT00397631|447892927|FG000|Overall Study|Adverse Event|5|||
124530604|NCT00397631|447892928|FG001|Overall Study|Adverse Event|6|||
124530605|NCT00397631|447892927|FG000|Overall Study|Lack of Efficacy|7|||
124530606|NCT00397631|447892928|FG001|Overall Study|Lack of Efficacy|10|||
124530607|NCT00397631|447892927|FG000|Overall Study|Lost to Follow-up|8|||
124530608|NCT00397631|447892928|FG001|Overall Study|Lost to Follow-up|9|||
124530609|NCT00397631|447892927|FG000|Overall Study|Physician Decision|2|||
124530610|NCT00397631|447892928|FG001|Overall Study|Physician Decision|0|||
124530611|NCT00397631|447892927|FG000|Overall Study|Protocol Violation|0|||
124530612|NCT00397631|447892928|FG001|Overall Study|Protocol Violation|1|||
124530613|NCT00397631|447892927|FG000|Overall Study|Withdrawal by Subject|7|||
124530614|NCT00397631|447892928|FG001|Overall Study|Withdrawal by Subject|14|||
124530615|NCT00397631|447892927|FG000|Overall Study|protocol discontinuation criteria|1|||
124530616|NCT00397631|447892928|FG001|Overall Study|protocol discontinuation criteria|4|||
124530617|NCT02202161|447892929|FG000|Overall Study|Adverse Event|1|||
124530618|NCT02202161|447892930|FG001|Overall Study|Adverse Event|1|||
124530619|NCT02202161|447892931|FG002|Overall Study|Adverse Event|0|||
124530620|NCT02202161|447892932|FG003|Overall Study|Adverse Event|0|||
124530621|NCT02202161|447892933|FG004|Overall Study|Adverse Event|0|||
124530622|NCT02202161|447892934|FG005|Overall Study|Adverse Event|1|||
124530623|NCT02202161|447892935|FG006|Overall Study|Adverse Event|0|||
124530624|NCT02202161|447892936|FG007|Overall Study|Adverse Event|0|||
124530625|NCT02202161|447892929|FG000|Overall Study|Did not meet continuation criteria|0|||
124583560|NCT00112437|448095905|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583561|NCT00112437|448095906|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
124530626|NCT02202161|447892930|FG001|Overall Study|Did not meet continuation criteria|0|||
124530627|NCT02202161|447892931|FG002|Overall Study|Did not meet continuation criteria|0|||
124530628|NCT02202161|447892932|FG003|Overall Study|Did not meet continuation criteria|0|||
124530629|NCT02202161|447892933|FG004|Overall Study|Did not meet continuation criteria|0|||
124530630|NCT02202161|447892934|FG005|Overall Study|Did not meet continuation criteria|0|||
124530631|NCT02202161|447892935|FG006|Overall Study|Did not meet continuation criteria|0|||
124530632|NCT02202161|447892936|FG007|Overall Study|Did not meet continuation criteria|3|||
124728601|NCT00185380|448627950|FG000|Overall Study|Planned pregnancy|9|||
124728602|NCT00185380|448627951|FG001|Overall Study|Planned pregnancy|12|||
124728603|NCT00185380|448627952|FG002|Overall Study|Planned pregnancy|12|||
124728604|NCT00185380|448627950|FG000|Overall Study|No need for contraception|3|||
124728605|NCT00185380|448627951|FG001|Overall Study|No need for contraception|3|||
124728606|NCT00185380|448627952|FG002|Overall Study|No need for contraception|3|||
124728607|NCT00185380|448627950|FG000|Overall Study|Could not attend visits|2|||
124728608|NCT00185380|448627951|FG001|Overall Study|Could not attend visits|0|||
124728609|NCT00185380|448627952|FG002|Overall Study|Could not attend visits|4|||
124728610|NCT00185380|448627950|FG000|Overall Study|personal reason|6|||
124728611|NCT00185380|448627951|FG001|Overall Study|personal reason|1|||
124728612|NCT00185380|448627952|FG002|Overall Study|personal reason|1|||
124728613|NCT02998203|448627953|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
124728614|NCT02998203|448627954|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
124728615|NCT02998203|448627953|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
124728616|NCT02998203|448627954|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
124728617|NCT02199314|448627957|FG000|Overall Study|Withdrawal by Subject|6|||
124728618|NCT02199314|448627957|FG000|Overall Study|Physician Decision|10|||
124728619|NCT04187144|448627958|FG000|Overall Study|Lost to Follow-up|12|||
124728620|NCT04187144|448627959|FG001|Overall Study|Lost to Follow-up|11|||
124728621|NCT04187144|448627958|FG000|Overall Study|Withdrawal by Subject|20|||
124728622|NCT04187144|448627959|FG001|Overall Study|Withdrawal by Subject|18|||
124728623|NCT04187144|448627958|FG000|Overall Study|Adverse Event|19|||
124728624|NCT04187144|448627959|FG001|Overall Study|Adverse Event|4|||
124728625|NCT04187144|448627958|FG000|Overall Study|Physician Decision|5|||
124728626|NCT04187144|448627959|FG001|Overall Study|Physician Decision|3|||
124728627|NCT04187144|448627958|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
124777032|NCT02721966|448811392|FG000|Overall Study|Withdrawal by Subject|9|||
124777033|NCT02721966|448811393|FG001|Overall Study|Withdrawal by Subject|2|||
124777034|NCT02721966|448811394|FG002|Overall Study|Withdrawal by Subject|3|||
124777035|NCT02721966|448811395|FG003|Overall Study|Withdrawal by Subject|7|||
124777036|NCT02721966|448811396|FG004|Overall Study|Withdrawal by Subject|0|||
124777037|NCT02721966|448811392|FG000|Overall Study|Adverse Event|4|||
124777038|NCT02721966|448811393|FG001|Overall Study|Adverse Event|4|||
124777039|NCT02721966|448811394|FG002|Overall Study|Adverse Event|3|||
124777040|NCT02721966|448811395|FG003|Overall Study|Adverse Event|0|||
124777041|NCT02721966|448811396|FG004|Overall Study|Adverse Event|0|||
124777042|NCT02721966|448811392|FG000|Overall Study|Death|1|||
124777043|NCT02721966|448811393|FG001|Overall Study|Death|0|||
124777044|NCT02721966|448811394|FG002|Overall Study|Death|0|||
124777045|NCT02721966|448811395|FG003|Overall Study|Death|0|||
124777046|NCT02721966|448811396|FG004|Overall Study|Death|0|||
124777047|NCT02721966|448811392|FG000|Overall Study|Lack of Efficacy|7|||
124777048|NCT02721966|448811393|FG001|Overall Study|Lack of Efficacy|4|||
124777049|NCT02721966|448811394|FG002|Overall Study|Lack of Efficacy|0|||
124777050|NCT02721966|448811395|FG003|Overall Study|Lack of Efficacy|0|||
124777051|NCT02721966|448811396|FG004|Overall Study|Lack of Efficacy|0|||
124777052|NCT02721966|448811392|FG000|Overall Study|Lost to Follow-up|0|||
124777053|NCT02721966|448811393|FG001|Overall Study|Lost to Follow-up|0|||
124777054|NCT02721966|448811394|FG002|Overall Study|Lost to Follow-up|3|||
124777055|NCT02721966|448811395|FG003|Overall Study|Lost to Follow-up|0|||
124777056|NCT02721966|448811396|FG004|Overall Study|Lost to Follow-up|0|||
124777057|NCT02721966|448811392|FG000|Overall Study|Physician Decision|1|||
124777058|NCT02721966|448811393|FG001|Overall Study|Physician Decision|1|||
124777059|NCT02721966|448811394|FG002|Overall Study|Physician Decision|0|||
124777060|NCT02721966|448811395|FG003|Overall Study|Physician Decision|0|||
124777061|NCT02721966|448811396|FG004|Overall Study|Physician Decision|0|||
124777062|NCT02721966|448811392|FG000|Overall Study|Pregnancy|1|||
124777063|NCT02721966|448811393|FG001|Overall Study|Pregnancy|0|||
124777064|NCT02721966|448811394|FG002|Overall Study|Pregnancy|0|||
124777065|NCT02721966|448811395|FG003|Overall Study|Pregnancy|0|||
124777066|NCT02721966|448811396|FG004|Overall Study|Pregnancy|0|||
124777067|NCT02721966|448811392|FG000|Overall Study|Did not continue to period 2|5|||
124777068|NCT02721966|448811393|FG001|Overall Study|Did not continue to period 2|12|||
124777069|NCT02721966|448811394|FG002|Overall Study|Did not continue to period 2|0|||
124777070|NCT02721966|448811395|FG003|Overall Study|Did not continue to period 2|0|||
124777071|NCT02721966|448811396|FG004|Overall Study|Did not continue to period 2|5|||
124777072|NCT03857867|448811397|FG000|Overall Study|Physician Decision|1|||
124777073|NCT02157883|448811398|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
124777074|NCT02157883|448811398|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
124777075|NCT02157883|448811398|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
124777076|NCT02157883|448811398|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
124777077|NCT02157883|448811398|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
124777078|NCT00888940|448811399|FG000|Overall Study|Adverse Event|12|||
124777079|NCT00888940|448811400|FG001|Overall Study|Adverse Event|3|||
124728628|NCT04187144|448627959|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
124728629|NCT04187144|448627958|FG000|Overall Study|Protocol Deviation|1|||
124728630|NCT04187144|448627959|FG001|Overall Study|Protocol Deviation|4|||
124728631|NCT02650804|448627960|FG000|Overall Study|Adverse Event|3|||
124728632|NCT02650804|448627961|FG001|Overall Study|Adverse Event|2|||
124728633|NCT02650804|448627960|FG000|Overall Study|Death|1|||
124728634|NCT02650804|448627961|FG001|Overall Study|Death|2|||
124728635|NCT02650804|448627960|FG000|Overall Study|Progressive Disease|7|||
124728636|NCT02650804|448627961|FG001|Overall Study|Progressive Disease|10|||
124728637|NCT02650804|448627960|FG000|Overall Study|Physician Decision|0|||
124728638|NCT02650804|448627961|FG001|Overall Study|Physician Decision|2|||
124728639|NCT02650804|448627960|FG000|Overall Study|Withdrawal by Subject|1|||
124728640|NCT02650804|448627961|FG001|Overall Study|Withdrawal by Subject|4|||
124728641|NCT02650804|448627960|FG000|Overall Study|Symptomatic deterioration|5|||
124728642|NCT02650804|448627961|FG001|Overall Study|Symptomatic deterioration|7|||
124728643|NCT02650804|448627960|FG000|Overall Study|Protocol Violation|0|||
124728644|NCT02650804|448627961|FG001|Overall Study|Protocol Violation|1|||
124728645|NCT02759107|448627962|FG000|Overall Study|Adverse Event|0|||
124728646|NCT02759107|448627963|FG001|Overall Study|Adverse Event|0|||
124728647|NCT02759107|448627964|FG002|Overall Study|Adverse Event|0|||
124728648|NCT02759107|448627965|FG003|Overall Study|Adverse Event|0|||
124728649|NCT02759107|448627966|FG004|Overall Study|Adverse Event|0|||
124728650|NCT02759107|448627967|FG005|Overall Study|Adverse Event|0|||
124728651|NCT02759107|448627968|FG006|Overall Study|Adverse Event|0|||
124728652|NCT02759107|448627969|FG007|Overall Study|Adverse Event|0|||
124728653|NCT02759107|448627970|FG008|Overall Study|Adverse Event|0|||
124728654|NCT02759107|448627971|FG009|Overall Study|Adverse Event|0|||
124728655|NCT02759107|448627972|FG010|Overall Study|Adverse Event|0|||
124728656|NCT02759107|448627973|FG011|Overall Study|Adverse Event|0|||
124728657|NCT02759107|448627974|FG012|Overall Study|Adverse Event|2|||
124728658|NCT02759107|448627975|FG013|Overall Study|Adverse Event|0|||
124728659|NCT02759107|448627976|FG014|Overall Study|Adverse Event|0|||
124728660|NCT02759107|448627977|FG015|Overall Study|Adverse Event|1|||
124728661|NCT02759107|448627978|FG016|Overall Study|Adverse Event|0|||
124728662|NCT02759107|448627979|FG017|Overall Study|Adverse Event|2|||
124728663|NCT02759107|448627962|FG000|Overall Study|Scheduling Conflict|0|||
124728664|NCT02759107|448627963|FG001|Overall Study|Scheduling Conflict|0|||
124728665|NCT02759107|448627964|FG002|Overall Study|Scheduling Conflict|0|||
124728666|NCT02759107|448627965|FG003|Overall Study|Scheduling Conflict|0|||
124728667|NCT02759107|448627966|FG004|Overall Study|Scheduling Conflict|0|||
124728668|NCT02759107|448627967|FG005|Overall Study|Scheduling Conflict|0|||
124728669|NCT02759107|448627968|FG006|Overall Study|Scheduling Conflict|0|||
124728670|NCT02759107|448627969|FG007|Overall Study|Scheduling Conflict|0|||
124728671|NCT02759107|448627970|FG008|Overall Study|Scheduling Conflict|0|||
124728672|NCT02759107|448627971|FG009|Overall Study|Scheduling Conflict|1|||
124530633|NCT02202161|447892929|FG000|Overall Study|Physician Decision|0|||
124530634|NCT02202161|447892930|FG001|Overall Study|Physician Decision|0|||
124530635|NCT02202161|447892931|FG002|Overall Study|Physician Decision|0|||
124530636|NCT02202161|447892932|FG003|Overall Study|Physician Decision|0|||
124530637|NCT02202161|447892933|FG004|Overall Study|Physician Decision|0|||
124530638|NCT02202161|447892934|FG005|Overall Study|Physician Decision|0|||
124530639|NCT02202161|447892935|FG006|Overall Study|Physician Decision|0|||
124530640|NCT02202161|447892936|FG007|Overall Study|Physician Decision|3|||
124530641|NCT02202161|447892929|FG000|Overall Study|Withdrawal by Subject|0|||
124530642|NCT02202161|447892930|FG001|Overall Study|Withdrawal by Subject|0|||
124530643|NCT02202161|447892931|FG002|Overall Study|Withdrawal by Subject|0|||
124530644|NCT02202161|447892932|FG003|Overall Study|Withdrawal by Subject|0|||
124530645|NCT02202161|447892933|FG004|Overall Study|Withdrawal by Subject|1|||
124530646|NCT02202161|447892934|FG005|Overall Study|Withdrawal by Subject|0|||
124530647|NCT02202161|447892935|FG006|Overall Study|Withdrawal by Subject|0|||
124530648|NCT02202161|447892936|FG007|Overall Study|Withdrawal by Subject|0|||
124530649|NCT00832091|447892937|FG000|Overall Study|Adverse Event|1|||
124530650|NCT00832091|447892938|FG001|Overall Study|Adverse Event|1|||
124530651|NCT00832091|447892937|FG000|Overall Study|Protocol Violation|1|||
124530652|NCT00832091|447892938|FG001|Overall Study|Protocol Violation|0|||
124530653|NCT00832091|447892937|FG000|Overall Study|Withdrawal by Subject|2|||
124530654|NCT00832091|447892938|FG001|Overall Study|Withdrawal by Subject|1|||
124530655|NCT00832091|447892937|FG000|Overall Study|Prohibited Medication|1|||
124530656|NCT00832091|447892938|FG001|Overall Study|Prohibited Medication|0|||
124530657|NCT00942422|447892944|FG000|Overall Study|Withdrawal by Subject|1|||
124530658|NCT00942422|447892944|FG000|Overall Study|Death|1|||
124530659|NCT00942422|447892944|FG000|Overall Study|Progressive diease|1|||
124530660|NCT02711553|447892945|FG000|Overall Study|Withdrawal by Subject|2|||
124530661|NCT02711553|447892946|FG001|Overall Study|Withdrawal by Subject|1|||
124530662|NCT02711553|447892947|FG002|Overall Study|Withdrawal by Subject|1|||
124530663|NCT02711553|447892948|FG003|Overall Study|Withdrawal by Subject|0|||
124530664|NCT02711553|447892945|FG000|Overall Study|Lost to Follow-up|3|||
124530665|NCT02711553|447892946|FG001|Overall Study|Lost to Follow-up|3|||
124530666|NCT02711553|447892947|FG002|Overall Study|Lost to Follow-up|6|||
124530667|NCT02711553|447892948|FG003|Overall Study|Lost to Follow-up|3|||
124583562|NCT00112437|448095907|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583563|NCT00112437|448095908|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583564|NCT00112437|448095909|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583565|NCT00112437|448095910|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
124583566|NCT00112437|448095885|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583567|NCT00112437|448095886|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
124583568|NCT00112437|448095887|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583569|NCT00112437|448095888|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583570|NCT00112437|448095889|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583571|NCT00112437|448095890|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583572|NCT00112437|448095891|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583573|NCT00112437|448095892|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583574|NCT00112437|448095893|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583575|NCT00112437|448095894|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583576|NCT00112437|448095895|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583577|NCT00112437|448095896|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583578|NCT00112437|448095897|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583579|NCT00112437|448095898|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583580|NCT00112437|448095899|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583581|NCT00112437|448095900|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583582|NCT00112437|448095901|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583583|NCT00112437|448095902|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583584|NCT00112437|448095903|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583585|NCT00112437|448095904|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583586|NCT00112437|448095905|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583587|NCT00112437|448095906|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583588|NCT00112437|448095907|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583589|NCT00112437|448095908|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583590|NCT00112437|448095909|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583591|NCT00112437|448095910|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
124583592|NCT00112437|448095885|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583593|NCT00112437|448095886|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
124583594|NCT00112437|448095887|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583595|NCT00112437|448095888|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583596|NCT00112437|448095889|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583597|NCT00112437|448095890|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583598|NCT00112437|448095891|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583599|NCT00112437|448095892|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583600|NCT00112437|448095893|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583601|NCT00112437|448095894|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583602|NCT00112437|448095895|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583603|NCT00112437|448095896|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583604|NCT00112437|448095897|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583605|NCT00112437|448095898|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583606|NCT00112437|448095899|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583607|NCT00112437|448095900|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583608|NCT00112437|448095901|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583609|NCT00112437|448095902|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583610|NCT00112437|448095903|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583611|NCT00112437|448095904|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583612|NCT00112437|448095905|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583613|NCT00112437|448095906|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583614|NCT00112437|448095907|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583615|NCT00112437|448095908|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583616|NCT00112437|448095909|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124583617|NCT00112437|448095910|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
124728673|NCT02759107|448627972|FG010|Overall Study|Scheduling Conflict|0|||
124728674|NCT02759107|448627973|FG011|Overall Study|Scheduling Conflict|0|||
124728675|NCT02759107|448627974|FG012|Overall Study|Scheduling Conflict|0|||
124728676|NCT02759107|448627975|FG013|Overall Study|Scheduling Conflict|0|||
124728677|NCT02759107|448627976|FG014|Overall Study|Scheduling Conflict|0|||
124728678|NCT02759107|448627977|FG015|Overall Study|Scheduling Conflict|0|||
124728679|NCT02759107|448627978|FG016|Overall Study|Scheduling Conflict|0|||
124583618|NCT00112437|448095885|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
124583619|NCT00112437|448095886|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583620|NCT00112437|448095887|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
124583621|NCT00112437|448095888|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
124583622|NCT00112437|448095889|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
124583623|NCT00112437|448095890|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583624|NCT00112437|448095891|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124728680|NCT02759107|448627979|FG017|Overall Study|Scheduling Conflict|0|||
124583625|NCT00112437|448095892|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583626|NCT00112437|448095893|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583627|NCT00112437|448095894|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583628|NCT00112437|448095895|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583629|NCT00112437|448095896|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583630|NCT00112437|448095897|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583631|NCT00112437|448095898|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583632|NCT00112437|448095899|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583633|NCT00112437|448095900|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583634|NCT00112437|448095901|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583635|NCT00112437|448095902|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583636|NCT00112437|448095903|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583637|NCT00112437|448095904|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583638|NCT00112437|448095905|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583639|NCT00112437|448095906|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583640|NCT00112437|448095907|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583641|NCT00112437|448095908|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583642|NCT00112437|448095909|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583643|NCT00112437|448095910|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
124583644|NCT00112437|448095885|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
124583645|NCT00112437|448095886|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
124583646|NCT00112437|448095887|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
124583647|NCT00112437|448095888|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
124583648|NCT00112437|448095889|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
124583649|NCT00112437|448095890|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583650|NCT00112437|448095891|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583651|NCT00112437|448095892|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583652|NCT00112437|448095893|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583653|NCT00112437|448095894|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583654|NCT00112437|448095895|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583655|NCT00112437|448095896|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583656|NCT00112437|448095897|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583657|NCT00112437|448095898|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583658|NCT00112437|448095899|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583659|NCT00112437|448095900|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583660|NCT00112437|448095901|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583661|NCT00112437|448095902|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583662|NCT00112437|448095903|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583663|NCT00112437|448095904|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583664|NCT00112437|448095905|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583665|NCT00112437|448095906|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583666|NCT00112437|448095907|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583667|NCT00112437|448095908|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583668|NCT00112437|448095909|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583669|NCT00112437|448095910|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
124583670|NCT00112437|448095885|FG000|Year 1 (12-Month Base Study)|moved|0|||
124583671|NCT00112437|448095886|FG001|Year 1 (12-Month Base Study)|moved|1|||
124583672|NCT00112437|448095887|FG002|Year 1 (12-Month Base Study)|moved|1|||
124583673|NCT00112437|448095888|FG003|Year 1 (12-Month Base Study)|moved|0|||
124583674|NCT00112437|448095889|FG004|Year 1 (12-Month Base Study)|moved|0|||
124728681|NCT02526524|448627980|FG000|Overall Study|Withdrawal by Subject|3|||
124530668|NCT02711553|447892945|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
124530669|NCT02711553|447892946|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
124530670|NCT02711553|447892947|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
124530671|NCT02711553|447892948|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
124530672|NCT02187224|447892949|FG000|Overall Study|Did not show up for test day|1|||
124530673|NCT02187224|447892950|FG001|Overall Study|Did not show up for test day|0|||
124530674|NCT00998985|447892953|FG000|Overall Study|Withdrawal by Subject|0|||
124530675|NCT00998985|447892954|FG001|Overall Study|Withdrawal by Subject|0|||
124530676|NCT00998985|447892955|FG002|Overall Study|Withdrawal by Subject|0|||
124530677|NCT00998985|447892956|FG003|Overall Study|Withdrawal by Subject|0|||
124530678|NCT00998985|447892957|FG004|Overall Study|Withdrawal by Subject|0|||
124530679|NCT00998985|447892958|FG005|Overall Study|Withdrawal by Subject|0|||
124583675|NCT00112437|448095890|FG005|Year 1 (12-Month Base Study)|moved|0|||
124583676|NCT00112437|448095891|FG006|Year 1 (12-Month Base Study)|moved|0|||
124583677|NCT00112437|448095892|FG007|Year 1 (12-Month Base Study)|moved|0|||
124583678|NCT00112437|448095893|FG008|Year 1 (12-Month Base Study)|moved|0|||
124583679|NCT00112437|448095894|FG009|Year 1 (12-Month Base Study)|moved|0|||
124728682|NCT02526524|448627981|FG001|Overall Study|Withdrawal by Subject|3|||
124583680|NCT00112437|448095895|FG010|Year 1 (12-Month Base Study)|moved|0|||
124583681|NCT00112437|448095896|FG011|Year 1 (12-Month Base Study)|moved|0|||
124583682|NCT00112437|448095897|FG012|Year 1 (12-Month Base Study)|moved|0|||
124583683|NCT00112437|448095898|FG013|Year 1 (12-Month Base Study)|moved|0|||
124583684|NCT00112437|448095899|FG014|Year 1 (12-Month Base Study)|moved|0|||
124583685|NCT00112437|448095900|FG015|Year 1 (12-Month Base Study)|moved|0|||
124583686|NCT00112437|448095901|FG016|Year 1 (12-Month Base Study)|moved|0|||
124583687|NCT00112437|448095902|FG017|Year 1 (12-Month Base Study)|moved|0|||
124583688|NCT00112437|448095903|FG018|Year 1 (12-Month Base Study)|moved|0|||
124583689|NCT00112437|448095904|FG019|Year 1 (12-Month Base Study)|moved|0|||
124583690|NCT00112437|448095905|FG020|Year 1 (12-Month Base Study)|moved|0|||
124583691|NCT00112437|448095906|FG021|Year 1 (12-Month Base Study)|moved|0|||
124583692|NCT00112437|448095907|FG022|Year 1 (12-Month Base Study)|moved|0|||
124583693|NCT00112437|448095908|FG023|Year 1 (12-Month Base Study)|moved|0|||
124583694|NCT00112437|448095909|FG024|Year 1 (12-Month Base Study)|moved|0|||
124583695|NCT00112437|448095910|FG025|Year 1 (12-Month Base Study)|moved|0|||
124583696|NCT00112437|448095885|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583697|NCT00112437|448095886|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583698|NCT00112437|448095887|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583699|NCT00112437|448095888|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
124583700|NCT00112437|448095889|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583701|NCT00112437|448095890|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583702|NCT00112437|448095891|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583703|NCT00112437|448095892|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583704|NCT00112437|448095893|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583705|NCT00112437|448095894|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583706|NCT00112437|448095895|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583707|NCT00112437|448095896|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583708|NCT00112437|448095897|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583709|NCT00112437|448095898|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583710|NCT00112437|448095899|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583711|NCT00112437|448095900|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583712|NCT00112437|448095901|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583713|NCT00112437|448095902|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583714|NCT00112437|448095903|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583715|NCT00112437|448095904|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583716|NCT00112437|448095905|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583717|NCT00112437|448095906|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583718|NCT00112437|448095907|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583719|NCT00112437|448095908|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583720|NCT00112437|448095909|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583721|NCT00112437|448095910|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
124583722|NCT00112437|448095885|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583723|NCT00112437|448095886|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583724|NCT00112437|448095887|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583725|NCT00112437|448095888|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583726|NCT00112437|448095889|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
124583727|NCT00112437|448095890|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583728|NCT00112437|448095891|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583729|NCT00112437|448095892|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583730|NCT00112437|448095893|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124728683|NCT02526524|448627982|FG002|Overall Study|Withdrawal by Subject|6|||
124728684|NCT02526524|448627983|FG003|Overall Study|Withdrawal by Subject|1|||
124728685|NCT02526524|448627984|FG004|Overall Study|Withdrawal by Subject|9|||
124728686|NCT02526524|448627985|FG005|Overall Study|Withdrawal by Subject|5|||
124530680|NCT00998985|447892959|FG006|Overall Study|Withdrawal by Subject|0|||
124530681|NCT00998985|447892960|FG007|Overall Study|Withdrawal by Subject|0|||
124530682|NCT00998985|447892961|FG008|Overall Study|Withdrawal by Subject|1|||
124530683|NCT00998985|447892962|FG009|Overall Study|Withdrawal by Subject|0|||
124530684|NCT00998985|447892963|FG010|Overall Study|Withdrawal by Subject|0|||
124530685|NCT00998985|447892964|FG011|Overall Study|Withdrawal by Subject|0|||
124530686|NCT00998985|447892965|FG012|Overall Study|Withdrawal by Subject|0|||
124530687|NCT00998985|447892966|FG013|Overall Study|Withdrawal by Subject|0|||
124530688|NCT00998985|447892953|FG000|Overall Study|Protocol Violation|0|||
124530689|NCT00998985|447892954|FG001|Overall Study|Protocol Violation|0|||
124530690|NCT00998985|447892955|FG002|Overall Study|Protocol Violation|0|||
124583731|NCT00112437|448095894|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583732|NCT00112437|448095895|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583733|NCT00112437|448095896|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124530691|NCT00998985|447892956|FG003|Overall Study|Protocol Violation|0|||
124583734|NCT00112437|448095897|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583735|NCT00112437|448095898|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583736|NCT00112437|448095899|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583737|NCT00112437|448095900|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583738|NCT00112437|448095901|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583739|NCT00112437|448095902|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583740|NCT00112437|448095903|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583741|NCT00112437|448095904|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124728687|NCT02526524|448627980|FG000|Overall Study|Adverse Event|3|||
124530692|NCT00998985|447892957|FG004|Overall Study|Protocol Violation|0|||
124530693|NCT00998985|447892958|FG005|Overall Study|Protocol Violation|1|||
124530694|NCT00998985|447892959|FG006|Overall Study|Protocol Violation|0|||
124530695|NCT00998985|447892960|FG007|Overall Study|Protocol Violation|0|||
124530696|NCT00998985|447892961|FG008|Overall Study|Protocol Violation|0|||
124530697|NCT00998985|447892962|FG009|Overall Study|Protocol Violation|0|||
124530698|NCT00998985|447892963|FG010|Overall Study|Protocol Violation|0|||
124530699|NCT00998985|447892964|FG011|Overall Study|Protocol Violation|0|||
124530700|NCT00998985|447892965|FG012|Overall Study|Protocol Violation|0|||
124530701|NCT00998985|447892966|FG013|Overall Study|Protocol Violation|0|||
124530702|NCT02573012|447892969|FG000|Overall Study|Adverse Event|5|||
124530703|NCT02573012|447892970|FG001|Overall Study|Adverse Event|5|||
124530704|NCT02573012|447892969|FG000|Overall Study|Lack of Efficacy|5|||
124530705|NCT02573012|447892970|FG001|Overall Study|Lack of Efficacy|4|||
124530706|NCT02573012|447892969|FG000|Overall Study|Non-compliance|1|||
124530707|NCT02573012|447892970|FG001|Overall Study|Non-compliance|2|||
124530708|NCT02573012|447892969|FG000|Overall Study|Withdrawal by Subject|2|||
124530709|NCT02573012|447892970|FG001|Overall Study|Withdrawal by Subject|2|||
124530710|NCT02573012|447892969|FG000|Overall Study|Study Ended per Protocol|1|||
124530711|NCT02573012|447892970|FG001|Overall Study|Study Ended per Protocol|0|||
124530712|NCT02573012|447892969|FG000|Overall Study|Physician Decision|1|||
124530713|NCT02573012|447892970|FG001|Overall Study|Physician Decision|2|||
124530714|NCT01222416|447892980|FG000|Overall Study|ineligible;metastasis|3|||
124530715|NCT01222416|447892981|FG001|Overall Study|ineligible;metastasis|0|||
124530716|NCT01222416|447892980|FG000|Overall Study|Adverse Event|4|||
124530717|NCT01222416|447892981|FG001|Overall Study|Adverse Event|0|||
124530718|NCT01222416|447892980|FG000|Overall Study|Withdrawal by Subject|5|||
124530719|NCT01222416|447892981|FG001|Overall Study|Withdrawal by Subject|0|||
124530720|NCT01222416|447892980|FG000|Overall Study|scheduling|6|||
124530721|NCT01222416|447892981|FG001|Overall Study|scheduling|0|||
124530722|NCT01222416|447892980|FG000|Overall Study|missed view/scan|1|||
124530723|NCT01222416|447892981|FG001|Overall Study|missed view/scan|0|||
124530724|NCT01222416|447892980|FG000|Overall Study|Death|1|||
124530725|NCT01222416|447892981|FG001|Overall Study|Death|0|||
124530726|NCT02178592|447892982|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
124530727|NCT02178592|447892983|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
124530728|NCT02178592|447892982|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
124530729|NCT02178592|447892983|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
124530730|NCT02178592|447892982|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
124530731|NCT02178592|447892983|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
124530732|NCT02178592|447892982|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
124530733|NCT02178592|447892983|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
124530734|NCT02178592|447892982|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
124530735|NCT02178592|447892983|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
124530736|NCT02178592|447892982|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
124530737|NCT02178592|447892983|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
124530738|NCT02178592|447892982|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
124530739|NCT02178592|447892983|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
124530740|NCT02178592|447892982|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
124530741|NCT02178592|447892983|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
124530742|NCT02178592|447892982|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
124530743|NCT02178592|447892983|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
124530744|NCT02178592|447892982|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
124530745|NCT02178592|447892983|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
124530746|NCT02178592|447892982|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
124530747|NCT02178592|447892983|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
124530748|NCT02178592|447892982|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
124728688|NCT02526524|448627981|FG001|Overall Study|Adverse Event|2|||
124728689|NCT02526524|448627982|FG002|Overall Study|Adverse Event|4|||
124728690|NCT02526524|448627983|FG003|Overall Study|Adverse Event|2|||
124728691|NCT02526524|448627984|FG004|Overall Study|Adverse Event|6|||
124530749|NCT02178592|447892983|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
124530750|NCT00518336|447892986|FG000|Year 7|Lost to Follow-up|2|||
124530751|NCT00518336|447892987|FG001|Year 7|Lost to Follow-up|0|||
124530752|NCT00518336|447892986|FG000|Year 7|Could not attend in time|0|||
124530753|NCT00518336|447892987|FG001|Year 7|Could not attend in time|3|||
124530754|NCT00518336|447892986|FG000|Year 8|Lost to Follow-up|1|||
124530755|NCT00518336|447892987|FG001|Year 8|Lost to Follow-up|1|||
124530756|NCT00518336|447892986|FG000|Year 8|Could not attend in time|0|||
124530757|NCT00518336|447892987|FG001|Year 8|Could not attend in time|1|||
124530758|NCT00518336|447892986|FG000|Year 9|Migrated/moved from study area|1|||
124530759|NCT00518336|447892987|FG001|Year 9|Migrated/moved from study area|1|||
124530760|NCT00518336|447892986|FG000|Year 9|Lost to Follow-up|3|||
124530761|NCT00518336|447892987|FG001|Year 9|Lost to Follow-up|0|||
124530762|NCT00518336|447892986|FG000|Year 9|Personal reasons|1|||
124530763|NCT00518336|447892987|FG001|Year 9|Personal reasons|0|||
124530764|NCT00125268|447892988|FG000|Overall Study|Withdrawal by Subject|1|||
124530765|NCT00125268|447892989|FG001|Overall Study|Withdrawal by Subject|1|||
124530766|NCT00286156|447892991|FG000|Overall Study|Missed 12 month visit|0|||
124530767|NCT00286156|447892992|FG001|Overall Study|Missed 12 month visit|0|||
124530768|NCT00286156|447892993|FG002|Overall Study|Missed 12 month visit|1|||
124530769|NCT00286156|447892991|FG000|Overall Study|AE: pulmonary embolus|0|||
124530770|NCT00286156|447892992|FG001|Overall Study|AE: pulmonary embolus|1|||
124530771|NCT00286156|447892993|FG002|Overall Study|AE: pulmonary embolus|0|||
124530772|NCT00286156|447892991|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
124530773|NCT00286156|447892992|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
124530774|NCT00286156|447892993|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
124530775|NCT00286156|447892991|FG000|Overall Study|AE: pneumonia|1|||
124530776|NCT00286156|447892992|FG001|Overall Study|AE: pneumonia|0|||
124530777|NCT00286156|447892993|FG002|Overall Study|AE: pneumonia|0|||
124530778|NCT02449915|447892995|FG000|Overall Study|Exclusion criteria - drug use|1|||
124530779|NCT02449915|447892996|FG001|Overall Study|Exclusion criteria - drug use|0|||
124530780|NCT02449915|447892995|FG000|Overall Study|Withdrawal by Subject|0|||
124530781|NCT02449915|447892996|FG001|Overall Study|Withdrawal by Subject|2|||
124530782|NCT02449915|447892995|FG000|Overall Study|Intraoperative surgical findings|1|||
124530783|NCT02449915|447892996|FG001|Overall Study|Intraoperative surgical findings|1|||
124530784|NCT02449915|447892995|FG000|Overall Study|Abnormal preop lab|0|||
124530785|NCT02449915|447892996|FG001|Overall Study|Abnormal preop lab|1|||
124530786|NCT02059174|447894213|FG000|Period 1|Withdrawal by Subject|0|||
124530787|NCT02059174|447894214|FG001|Period 1|Withdrawal by Subject|2|||
124530788|NCT02059174|447894213|FG000|Period 2|Withdrawal by Subject|0|||
124530789|NCT02059174|447894214|FG001|Period 2|Withdrawal by Subject|2|||
124530790|NCT02059174|447894213|FG000|Period 2|Protocol Violation|1|||
124530791|NCT02059174|447894214|FG001|Period 2|Protocol Violation|0|||
124530792|NCT02059174|447894213|FG000|Period 3|Physician Decision|1|||
124530793|NCT02059174|447894214|FG001|Period 3|Physician Decision|0|||
124530794|NCT02306148|447894215|FG000|Overall Study|Adverse Event|12|||
124530795|NCT02306148|447894216|FG001|Overall Study|Adverse Event|6|||
124530796|NCT02306148|447894215|FG000|Overall Study|Lost to Follow-up|1|||
124530797|NCT02306148|447894216|FG001|Overall Study|Lost to Follow-up|4|||
124530798|NCT00087594|447894221|FG000|Overall Study|Adverse Event|2|||
124530799|NCT00087594|447894222|FG001|Overall Study|Adverse Event|3|||
124530800|NCT00087594|447894221|FG000|Overall Study|Lost to Follow-up|0|||
124530801|NCT00087594|447894222|FG001|Overall Study|Lost to Follow-up|2|||
124530802|NCT00087594|447894221|FG000|Overall Study|Withdrawal by Subject|4|||
124530803|NCT00087594|447894222|FG001|Overall Study|Withdrawal by Subject|2|||
124530804|NCT00087594|447894221|FG000|Overall Study|Lack of Efficacy|2|||
124530805|NCT00087594|447894222|FG001|Overall Study|Lack of Efficacy|5|||
124530806|NCT01952041|447894225|FG000|Overall Study|Lost to Follow-up|9|||
124530807|NCT01952041|447894226|FG001|Overall Study|Lost to Follow-up|16|||
124530808|NCT01952041|447894225|FG000|Overall Study|Withdrawal by Subject|7|||
124530809|NCT01952041|447894226|FG001|Overall Study|Withdrawal by Subject|5|||
124530810|NCT01952041|447894225|FG000|Overall Study|Death|1|||
124530811|NCT01952041|447894226|FG001|Overall Study|Death|0|||
124530812|NCT01736176|447894227|FG000|Overall Study|Adverse Event|3|||
124530813|NCT01736176|447894227|FG000|Overall Study|Withdrawal by Subject|4|||
124530814|NCT01736176|447894227|FG000|Overall Study|Lack of Efficacy|3|||
124530815|NCT01736176|447894227|FG000|Overall Study|Unable to Complete PEG Placement|1|||
124530816|NCT00186121|447894228|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
124530817|NCT00186121|447894228|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
124530818|NCT00186121|447894228|FG000|Overall Study|Not eligible (no treatment)|1|||
124530819|NCT03650387|447894229|FG000|Overall Study|Withdrawal by Subject|13|||
124530820|NCT03650387|447894229|FG000|Overall Study|Lost to Follow-up|12|||
124530821|NCT03650387|447894229|FG000|Overall Study|Adverse Event (Not related)|1|||
124728692|NCT02526524|448627985|FG005|Overall Study|Adverse Event|8|||
124530822|NCT03650387|447894229|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
124530823|NCT00934791|447894230|FG000|Overall Study|Withdrawal by Subject|1|||
124530824|NCT00934791|447894231|FG001|Overall Study|Withdrawal by Subject|0|||
124530825|NCT03763942|447894233|FG000|Overall Study|Lost to Follow-up|114|||
124530826|NCT03763942|447894234|FG001|Overall Study|Lost to Follow-up|54|||
124530827|NCT03763942|447894233|FG000|Overall Study|Protocol Violation|1|||
124530828|NCT03763942|447894234|FG001|Overall Study|Protocol Violation|0|||
124530829|NCT03763942|447894233|FG000|Overall Study|Withdrawal by Subject|2|||
124530830|NCT03763942|447894234|FG001|Overall Study|Withdrawal by Subject|0|||
124530831|NCT03763942|447894233|FG000|Overall Study|Other|2|||
124530832|NCT03763942|447894234|FG001|Overall Study|Other|3|||
124530833|NCT03558503|447894235|FG000|Overall Study|Adverse Event|1|||
124530834|NCT03558503|447894235|FG000|Overall Study|Death|1|||
124530835|NCT03558503|447894235|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
124530836|NCT02145429|447894236|FG000|Overall Study|Death|4|||
124530837|NCT02145429|447894237|FG001|Overall Study|Death|5|||
124530838|NCT02145429|447894236|FG000|Overall Study|Lost to Follow-up|4|||
124530839|NCT02145429|447894237|FG001|Overall Study|Lost to Follow-up|3|||
124530840|NCT02145429|447894236|FG000|Overall Study|Withdrawal by Subject|8|||
124530841|NCT02145429|447894237|FG001|Overall Study|Withdrawal by Subject|3|||
124530842|NCT02646891|447894238|FG000|Overall Study|Adverse Event|0|||
124530843|NCT02646891|447894239|FG001|Overall Study|Adverse Event|1|||
124530844|NCT02646891|447894240|FG002|Overall Study|Adverse Event|0|||
124530845|NCT02646891|447894241|FG003|Overall Study|Adverse Event|0|||
124530846|NCT02646891|447894242|FG004|Overall Study|Adverse Event|0|||
124530847|NCT02646891|447894243|FG005|Overall Study|Adverse Event|0|||
124530848|NCT02646891|447894244|FG006|Overall Study|Adverse Event|0|||
124530849|NCT02646891|447894245|FG007|Overall Study|Adverse Event|0|||
124530850|NCT02646891|447894246|FG008|Overall Study|Adverse Event|0|||
124530851|NCT02646891|447894247|FG009|Overall Study|Adverse Event|0|||
124530852|NCT02646891|447894238|FG000|Overall Study|Lost to Follow-up|0|||
124530853|NCT02646891|447894239|FG001|Overall Study|Lost to Follow-up|0|||
124530854|NCT02646891|447894240|FG002|Overall Study|Lost to Follow-up|0|||
124530855|NCT02646891|447894241|FG003|Overall Study|Lost to Follow-up|0|||
124530856|NCT02646891|447894242|FG004|Overall Study|Lost to Follow-up|0|||
124530857|NCT02646891|447894243|FG005|Overall Study|Lost to Follow-up|0|||
124530858|NCT02646891|447894244|FG006|Overall Study|Lost to Follow-up|2|||
124530859|NCT02646891|447894245|FG007|Overall Study|Lost to Follow-up|2|||
124530860|NCT02646891|447894246|FG008|Overall Study|Lost to Follow-up|2|||
124530861|NCT02646891|447894247|FG009|Overall Study|Lost to Follow-up|2|||
124530862|NCT02646891|447894238|FG000|Overall Study|Protocol Violation|0|||
124530863|NCT02646891|447894239|FG001|Overall Study|Protocol Violation|0|||
124530864|NCT02646891|447894240|FG002|Overall Study|Protocol Violation|0|||
124530865|NCT02646891|447894241|FG003|Overall Study|Protocol Violation|0|||
124530866|NCT02646891|447894242|FG004|Overall Study|Protocol Violation|0|||
124530867|NCT02646891|447894243|FG005|Overall Study|Protocol Violation|0|||
124530868|NCT02646891|447894244|FG006|Overall Study|Protocol Violation|1|||
124530869|NCT02646891|447894245|FG007|Overall Study|Protocol Violation|1|||
124530870|NCT02646891|447894246|FG008|Overall Study|Protocol Violation|0|||
124530871|NCT02646891|447894247|FG009|Overall Study|Protocol Violation|0|||
124530872|NCT02646891|447894238|FG000|Overall Study|Withdrawal by Subject|2|||
124530873|NCT02646891|447894239|FG001|Overall Study|Withdrawal by Subject|0|||
124530874|NCT02646891|447894240|FG002|Overall Study|Withdrawal by Subject|1|||
124530875|NCT02646891|447894241|FG003|Overall Study|Withdrawal by Subject|0|||
124530876|NCT02646891|447894242|FG004|Overall Study|Withdrawal by Subject|0|||
124530877|NCT02646891|447894243|FG005|Overall Study|Withdrawal by Subject|0|||
124530878|NCT02646891|447894244|FG006|Overall Study|Withdrawal by Subject|5|||
124530879|NCT02646891|447894245|FG007|Overall Study|Withdrawal by Subject|9|||
124530880|NCT02646891|447894246|FG008|Overall Study|Withdrawal by Subject|7|||
124530881|NCT02646891|447894247|FG009|Overall Study|Withdrawal by Subject|3|||
124530882|NCT02646891|447894238|FG000|Overall Study|Death|0|||
124530883|NCT02646891|447894239|FG001|Overall Study|Death|0|||
124530884|NCT02646891|447894240|FG002|Overall Study|Death|0|||
124530885|NCT02646891|447894241|FG003|Overall Study|Death|0|||
124530886|NCT02646891|447894242|FG004|Overall Study|Death|0|||
124530887|NCT02646891|447894243|FG005|Overall Study|Death|0|||
124530888|NCT02646891|447894244|FG006|Overall Study|Death|1|||
124530889|NCT02646891|447894245|FG007|Overall Study|Death|1|||
124530890|NCT02646891|447894246|FG008|Overall Study|Death|1|||
124530891|NCT02646891|447894247|FG009|Overall Study|Death|0|||
124530892|NCT02274311|447894248|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
124530893|NCT02477800|447894249|FG000|Placebo-Controlled Period|Adverse Event|16|||
124530894|NCT02477800|447894250|FG001|Placebo-Controlled Period|Adverse Event|25|||
124530895|NCT02477800|447894251|FG002|Placebo-Controlled Period|Adverse Event|28|||
124530896|NCT02477800|447894252|FG003|Placebo-Controlled Period|Adverse Event|0|||
124530897|NCT02477800|447894253|FG004|Placebo-Controlled Period|Adverse Event|0|||
124530898|NCT02477800|447894254|FG005|Placebo-Controlled Period|Adverse Event|0|||
124530899|NCT02477800|447894255|FG006|Placebo-Controlled Period|Adverse Event|0|||
124530900|NCT02477800|447894249|FG000|Placebo-Controlled Period|Change of Treatment|1|||
124530901|NCT02477800|447894250|FG001|Placebo-Controlled Period|Change of Treatment|2|||
124530902|NCT02477800|447894251|FG002|Placebo-Controlled Period|Change of Treatment|1|||
124583742|NCT00112437|448095905|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583743|NCT00112437|448095906|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583744|NCT00112437|448095907|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583745|NCT00112437|448095908|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583746|NCT00112437|448095909|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583747|NCT00112437|448095910|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
124583748|NCT00112437|448095885|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
124583749|NCT00112437|448095886|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
124583750|NCT00112437|448095887|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
124583751|NCT00112437|448095888|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
124583752|NCT00112437|448095889|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
124583753|NCT00112437|448095890|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
124583754|NCT00112437|448095891|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
124583755|NCT00112437|448095892|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
124583756|NCT00112437|448095893|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
124583757|NCT00112437|448095894|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
124583758|NCT00112437|448095895|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
124583759|NCT00112437|448095896|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
124583760|NCT00112437|448095897|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
124583761|NCT00112437|448095898|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
124583762|NCT00112437|448095899|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
124583763|NCT00112437|448095900|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
124583764|NCT00112437|448095901|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
124583765|NCT00112437|448095902|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
124583766|NCT00112437|448095903|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
124583767|NCT00112437|448095904|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
124583768|NCT00112437|448095905|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
124583769|NCT00112437|448095906|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
124583770|NCT00112437|448095907|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
124583771|NCT00112437|448095908|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
124583772|NCT00112437|448095909|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
124583773|NCT00112437|448095910|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
124583774|NCT00112437|448095885|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583775|NCT00112437|448095886|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583776|NCT00112437|448095887|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583777|NCT00112437|448095888|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583778|NCT00112437|448095889|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583779|NCT00112437|448095890|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
124583780|NCT00112437|448095891|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
124583781|NCT00112437|448095892|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583782|NCT00112437|448095893|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583783|NCT00112437|448095894|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
124583784|NCT00112437|448095895|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583785|NCT00112437|448095896|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583786|NCT00112437|448095897|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583787|NCT00112437|448095898|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583788|NCT00112437|448095899|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583789|NCT00112437|448095900|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583790|NCT00112437|448095901|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583791|NCT00112437|448095902|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583792|NCT00112437|448095903|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583793|NCT00112437|448095904|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583794|NCT00112437|448095905|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583795|NCT00112437|448095906|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583796|NCT00112437|448095907|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583797|NCT00112437|448095908|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583798|NCT00112437|448095909|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583799|NCT00112437|448095910|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
124583800|NCT00112437|448095885|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583801|NCT00112437|448095886|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583802|NCT00112437|448095887|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583803|NCT00112437|448095888|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583804|NCT00112437|448095889|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583805|NCT00112437|448095890|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583806|NCT00112437|448095891|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583807|NCT00112437|448095892|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583808|NCT00112437|448095893|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
124583809|NCT00112437|448095894|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583810|NCT00112437|448095895|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583811|NCT00112437|448095896|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583812|NCT00112437|448095897|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583813|NCT00112437|448095898|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583814|NCT00112437|448095899|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583815|NCT00112437|448095900|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583816|NCT00112437|448095901|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583817|NCT00112437|448095902|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583818|NCT00112437|448095903|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583819|NCT00112437|448095904|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583820|NCT00112437|448095905|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583821|NCT00112437|448095906|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583822|NCT00112437|448095907|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583823|NCT00112437|448095908|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583824|NCT00112437|448095909|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583825|NCT00112437|448095910|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
124583826|NCT00112437|448095885|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583827|NCT00112437|448095886|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583828|NCT00112437|448095887|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583829|NCT00112437|448095888|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583830|NCT00112437|448095889|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583831|NCT00112437|448095890|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583832|NCT00112437|448095891|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583833|NCT00112437|448095892|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583834|NCT00112437|448095893|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
124583835|NCT00112437|448095894|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583836|NCT00112437|448095895|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583837|NCT00112437|448095896|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583838|NCT00112437|448095897|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583839|NCT00112437|448095898|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583840|NCT00112437|448095899|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583841|NCT00112437|448095900|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583842|NCT00112437|448095901|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583843|NCT00112437|448095902|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583844|NCT00112437|448095903|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583845|NCT00112437|448095904|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583846|NCT00112437|448095905|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583847|NCT00112437|448095906|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583848|NCT00112437|448095907|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583849|NCT00112437|448095908|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583850|NCT00112437|448095909|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583851|NCT00112437|448095910|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
124583852|NCT00112437|448095885|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583853|NCT00112437|448095886|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583854|NCT00112437|448095887|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583855|NCT00112437|448095888|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583856|NCT00112437|448095889|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583857|NCT00112437|448095890|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
124583858|NCT00112437|448095891|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
124583859|NCT00112437|448095892|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
124583860|NCT00112437|448095893|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
124583861|NCT00112437|448095894|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
124583862|NCT00112437|448095895|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583863|NCT00112437|448095896|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583864|NCT00112437|448095897|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583865|NCT00112437|448095898|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583866|NCT00112437|448095899|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583867|NCT00112437|448095900|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583868|NCT00112437|448095901|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583869|NCT00112437|448095902|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583870|NCT00112437|448095903|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583871|NCT00112437|448095904|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583872|NCT00112437|448095905|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583873|NCT00112437|448095906|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583874|NCT00112437|448095907|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583875|NCT00112437|448095908|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583876|NCT00112437|448095909|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583877|NCT00112437|448095910|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
124583878|NCT00112437|448095885|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583879|NCT00112437|448095886|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583880|NCT00112437|448095887|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583881|NCT00112437|448095888|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124728693|NCT02526524|448627980|FG000|Overall Study|Lost to Follow-up|2|||
124728694|NCT02526524|448627981|FG001|Overall Study|Lost to Follow-up|3|||
124728695|NCT02526524|448627982|FG002|Overall Study|Lost to Follow-up|8|||
124728696|NCT02526524|448627983|FG003|Overall Study|Lost to Follow-up|1|||
124728697|NCT02526524|448627984|FG004|Overall Study|Lost to Follow-up|2|||
124728698|NCT02526524|448627985|FG005|Overall Study|Lost to Follow-up|5|||
124728699|NCT02526524|448627980|FG000|Overall Study|Protocol Violation|3|||
124728700|NCT02526524|448627981|FG001|Overall Study|Protocol Violation|1|||
124728701|NCT02526524|448627982|FG002|Overall Study|Protocol Violation|5|||
124728702|NCT02526524|448627983|FG003|Overall Study|Protocol Violation|3|||
124583882|NCT00112437|448095889|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583883|NCT00112437|448095890|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583884|NCT00112437|448095891|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583885|NCT00112437|448095892|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583886|NCT00112437|448095893|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583887|NCT00112437|448095894|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
124583888|NCT00112437|448095895|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583889|NCT00112437|448095896|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583890|NCT00112437|448095897|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583891|NCT00112437|448095898|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583892|NCT00112437|448095899|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583893|NCT00112437|448095900|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583894|NCT00112437|448095901|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583895|NCT00112437|448095902|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583896|NCT00112437|448095903|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583897|NCT00112437|448095904|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583898|NCT00112437|448095905|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583899|NCT00112437|448095906|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583900|NCT00112437|448095907|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583901|NCT00112437|448095908|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583902|NCT00112437|448095909|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583903|NCT00112437|448095910|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
124583904|NCT00112437|448095885|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583905|NCT00112437|448095886|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583906|NCT00112437|448095887|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583907|NCT00112437|448095888|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583908|NCT00112437|448095889|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583909|NCT00112437|448095890|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583910|NCT00112437|448095891|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583911|NCT00112437|448095892|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583912|NCT00112437|448095893|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583913|NCT00112437|448095894|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
124583914|NCT00112437|448095895|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583915|NCT00112437|448095896|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583916|NCT00112437|448095897|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583917|NCT00112437|448095898|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583918|NCT00112437|448095899|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583919|NCT00112437|448095900|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583920|NCT00112437|448095901|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583921|NCT00112437|448095902|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583922|NCT00112437|448095903|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583923|NCT00112437|448095904|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583924|NCT00112437|448095905|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583925|NCT00112437|448095906|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583926|NCT00112437|448095907|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
124777080|NCT00888940|448811399|FG000|Overall Study|Lost to Follow-up|5|||
124583927|NCT00112437|448095908|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583928|NCT00112437|448095909|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583929|NCT00112437|448095910|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
124583930|NCT00112437|448095885|FG000|Year 2 (12-Month Extension)|Moved|0|||
124583931|NCT00112437|448095886|FG001|Year 2 (12-Month Extension)|Moved|0|||
124583932|NCT00112437|448095887|FG002|Year 2 (12-Month Extension)|Moved|0|||
124583933|NCT00112437|448095888|FG003|Year 2 (12-Month Extension)|Moved|0|||
124583934|NCT00112437|448095889|FG004|Year 2 (12-Month Extension)|Moved|0|||
124583935|NCT00112437|448095890|FG005|Year 2 (12-Month Extension)|Moved|0|||
124583936|NCT00112437|448095891|FG006|Year 2 (12-Month Extension)|Moved|0|||
124728703|NCT02526524|448627984|FG004|Overall Study|Protocol Violation|4|||
124728704|NCT02526524|448627985|FG005|Overall Study|Protocol Violation|3|||
124728705|NCT02526524|448627980|FG000|Overall Study|Loss of Glucose Control|0|||
124583937|NCT00112437|448095892|FG007|Year 2 (12-Month Extension)|Moved|0|||
124583938|NCT00112437|448095893|FG008|Year 2 (12-Month Extension)|Moved|0|||
124583939|NCT00112437|448095894|FG009|Year 2 (12-Month Extension)|Moved|1|||
124583940|NCT00112437|448095895|FG010|Year 2 (12-Month Extension)|Moved|0|||
124583941|NCT00112437|448095896|FG011|Year 2 (12-Month Extension)|Moved|0|||
124583942|NCT00112437|448095897|FG012|Year 2 (12-Month Extension)|Moved|0|||
124583943|NCT00112437|448095898|FG013|Year 2 (12-Month Extension)|Moved|0|||
124583944|NCT00112437|448095899|FG014|Year 2 (12-Month Extension)|Moved|0|||
124583945|NCT00112437|448095900|FG015|Year 2 (12-Month Extension)|Moved|0|||
124583946|NCT00112437|448095901|FG016|Year 2 (12-Month Extension)|Moved|0|||
124583947|NCT00112437|448095902|FG017|Year 2 (12-Month Extension)|Moved|0|||
124583948|NCT00112437|448095903|FG018|Year 2 (12-Month Extension)|Moved|0|||
124583949|NCT00112437|448095904|FG019|Year 2 (12-Month Extension)|Moved|0|||
124583950|NCT00112437|448095905|FG020|Year 2 (12-Month Extension)|Moved|0|||
124530903|NCT02477800|447894252|FG003|Placebo-Controlled Period|Change of Treatment|0|||
124583951|NCT00112437|448095906|FG021|Year 2 (12-Month Extension)|Moved|0|||
124583952|NCT00112437|448095907|FG022|Year 2 (12-Month Extension)|Moved|0|||
124583953|NCT00112437|448095908|FG023|Year 2 (12-Month Extension)|Moved|0|||
124583954|NCT00112437|448095909|FG024|Year 2 (12-Month Extension)|Moved|0|||
124583955|NCT00112437|448095910|FG025|Year 2 (12-Month Extension)|Moved|0|||
124583956|NCT00112437|448095885|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
124583957|NCT00112437|448095886|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
124583958|NCT00112437|448095887|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
124583959|NCT00112437|448095888|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
124583960|NCT00112437|448095889|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
124583961|NCT00112437|448095890|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
124583962|NCT00112437|448095891|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
124583963|NCT00112437|448095892|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
124530904|NCT02477800|447894253|FG004|Placebo-Controlled Period|Change of Treatment|0|||
124530905|NCT02477800|447894254|FG005|Placebo-Controlled Period|Change of Treatment|0|||
124530906|NCT02477800|447894255|FG006|Placebo-Controlled Period|Change of Treatment|0|||
124530907|NCT02477800|447894249|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
124530908|NCT02477800|447894250|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
124530909|NCT02477800|447894251|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
124530910|NCT02477800|447894252|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
124530911|NCT02477800|447894253|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
124530912|NCT02477800|447894254|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
124530913|NCT02477800|447894255|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
124530914|NCT02477800|447894249|FG000|Placebo-Controlled Period|Death|0|||
124530915|NCT02477800|447894250|FG001|Placebo-Controlled Period|Death|3|||
124530916|NCT02477800|447894251|FG002|Placebo-Controlled Period|Death|2|||
124530917|NCT02477800|447894252|FG003|Placebo-Controlled Period|Death|0|||
124530918|NCT02477800|447894253|FG004|Placebo-Controlled Period|Death|0|||
124530919|NCT02477800|447894254|FG005|Placebo-Controlled Period|Death|0|||
124530920|NCT02477800|447894255|FG006|Placebo-Controlled Period|Death|0|||
124530921|NCT02477800|447894249|FG000|Placebo-Controlled Period|Disease Progression|1|||
124530922|NCT02477800|447894250|FG001|Placebo-Controlled Period|Disease Progression|0|||
124530923|NCT02477800|447894251|FG002|Placebo-Controlled Period|Disease Progression|1|||
124530924|NCT02477800|447894252|FG003|Placebo-Controlled Period|Disease Progression|0|||
124530925|NCT02477800|447894253|FG004|Placebo-Controlled Period|Disease Progression|0|||
124530926|NCT02477800|447894254|FG005|Placebo-Controlled Period|Disease Progression|0|||
124530927|NCT02477800|447894255|FG006|Placebo-Controlled Period|Disease Progression|0|||
124530928|NCT02477800|447894249|FG000|Placebo-Controlled Period|Investigator Decision|3|||
124530929|NCT02477800|447894250|FG001|Placebo-Controlled Period|Investigator Decision|2|||
124530930|NCT02477800|447894251|FG002|Placebo-Controlled Period|Investigator Decision|1|||
124530931|NCT02477800|447894252|FG003|Placebo-Controlled Period|Investigator Decision|0|||
124530932|NCT02477800|447894253|FG004|Placebo-Controlled Period|Investigator Decision|0|||
124530933|NCT02477800|447894254|FG005|Placebo-Controlled Period|Investigator Decision|0|||
124530934|NCT02477800|447894255|FG006|Placebo-Controlled Period|Investigator Decision|0|||
124530935|NCT02477800|447894249|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
124530936|NCT02477800|447894250|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
124530937|NCT02477800|447894251|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
124530938|NCT02477800|447894252|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
124530939|NCT02477800|447894253|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
124530940|NCT02477800|447894254|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
124530941|NCT02477800|447894255|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
124583964|NCT00112437|448095893|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
124583965|NCT00112437|448095894|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
124583966|NCT00112437|448095895|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
124583967|NCT00112437|448095896|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
124583968|NCT00112437|448095897|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
124530942|NCT02477800|447894249|FG000|Placebo-Controlled Period|Relocation|2|||
124530943|NCT02477800|447894250|FG001|Placebo-Controlled Period|Relocation|0|||
124530944|NCT02477800|447894251|FG002|Placebo-Controlled Period|Relocation|0|||
124583969|NCT00112437|448095898|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
124728706|NCT02526524|448627981|FG001|Overall Study|Loss of Glucose Control|0|||
124728707|NCT02526524|448627982|FG002|Overall Study|Loss of Glucose Control|3|||
124728708|NCT02526524|448627983|FG003|Overall Study|Loss of Glucose Control|0|||
124728709|NCT02526524|448627984|FG004|Overall Study|Loss of Glucose Control|2|||
124728710|NCT02526524|448627985|FG005|Overall Study|Loss of Glucose Control|0|||
124728711|NCT02526524|448627980|FG000|Overall Study|Physician Decision|0|||
124728712|NCT02526524|448627981|FG001|Overall Study|Physician Decision|0|||
124728713|NCT02526524|448627982|FG002|Overall Study|Physician Decision|0|||
124728714|NCT02526524|448627983|FG003|Overall Study|Physician Decision|0|||
124728715|NCT02526524|448627984|FG004|Overall Study|Physician Decision|1|||
124728716|NCT02526524|448627985|FG005|Overall Study|Physician Decision|0|||
124728717|NCT02526524|448627980|FG000|Overall Study|Sponsor Decision|1|||
124728718|NCT02526524|448627981|FG001|Overall Study|Sponsor Decision|0|||
124728719|NCT02526524|448627982|FG002|Overall Study|Sponsor Decision|0|||
124728720|NCT02526524|448627983|FG003|Overall Study|Sponsor Decision|0|||
124728721|NCT02526524|448627984|FG004|Overall Study|Sponsor Decision|0|||
124728722|NCT02526524|448627985|FG005|Overall Study|Sponsor Decision|0|||
124728723|NCT02019108|448627988|FG000|Overall Study|Lost to Follow-up|5|||
124728724|NCT02019108|448627989|FG001|Overall Study|Lost to Follow-up|7|||
124728725|NCT04569136|448627995|FG000|Overall Study|Lost to Follow-up|2|||
124728726|NCT04569136|448627996|FG001|Overall Study|Lost to Follow-up|0|||
124728727|NCT04569136|448627997|FG002|Overall Study|Lost to Follow-up|1|||
124728728|NCT01466660|448628002|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
124728729|NCT01466660|448628003|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
124728730|NCT01466660|448628002|FG000|Overall Study|Worsening of underlying cancer disease|5|||
124728731|NCT01466660|448628003|FG001|Overall Study|Worsening of underlying cancer disease|2|||
124728732|NCT01466660|448628002|FG000|Overall Study|Other adverse event|19|||
124728733|NCT01466660|448628003|FG001|Overall Study|Other adverse event|18|||
124728734|NCT01466660|448628002|FG000|Overall Study|Protocol Violation|2|||
124728735|NCT01466660|448628003|FG001|Overall Study|Protocol Violation|1|||
124728736|NCT01466660|448628002|FG000|Overall Study|Refused continuation of trial medication|4|||
124728737|NCT01466660|448628003|FG001|Overall Study|Refused continuation of trial medication|3|||
124728738|NCT01466660|448628002|FG000|Overall Study|Other reason not defined above|10|||
124728739|NCT01466660|448628003|FG001|Overall Study|Other reason not defined above|8|||
124728740|NCT00191724|448628004|FG000|Overall Study|Adverse Event|0|||
124728741|NCT00191724|448628005|FG001|Overall Study|Adverse Event|0|||
124728742|NCT00191724|448628006|FG002|Overall Study|Adverse Event|1|||
124728743|NCT00191724|448628007|FG003|Overall Study|Adverse Event|0|||
124728744|NCT00191724|448628008|FG004|Overall Study|Adverse Event|0|||
124728745|NCT00191724|448628004|FG000|Overall Study|Lost to Follow-up|1|||
124728746|NCT00191724|448628005|FG001|Overall Study|Lost to Follow-up|1|||
124728747|NCT00191724|448628006|FG002|Overall Study|Lost to Follow-up|0|||
124728748|NCT00191724|448628007|FG003|Overall Study|Lost to Follow-up|2|||
124728749|NCT00191724|448628008|FG004|Overall Study|Lost to Follow-up|3|||
124728750|NCT00191724|448628004|FG000|Overall Study|Withdrawal by Subject|0|||
124728751|NCT00191724|448628005|FG001|Overall Study|Withdrawal by Subject|0|||
124728752|NCT00191724|448628006|FG002|Overall Study|Withdrawal by Subject|0|||
124530945|NCT02477800|447894252|FG003|Placebo-Controlled Period|Relocation|0|||
124530946|NCT02477800|447894253|FG004|Placebo-Controlled Period|Relocation|0|||
124530947|NCT02477800|447894254|FG005|Placebo-Controlled Period|Relocation|0|||
124530948|NCT02477800|447894255|FG006|Placebo-Controlled Period|Relocation|0|||
124530949|NCT02477800|447894249|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
124530950|NCT02477800|447894250|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
124530951|NCT02477800|447894251|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
124530952|NCT02477800|447894252|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
124530953|NCT02477800|447894253|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
124530954|NCT02477800|447894254|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
124530955|NCT02477800|447894255|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
124530956|NCT02477800|447894249|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
124530957|NCT02477800|447894250|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
124530958|NCT02477800|447894251|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
124530959|NCT02477800|447894252|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
124530960|NCT02477800|447894253|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
124530961|NCT02477800|447894254|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
124530962|NCT02477800|447894255|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
124530963|NCT02477800|447894249|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
124530964|NCT02477800|447894250|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
124530965|NCT02477800|447894251|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
124530966|NCT02477800|447894252|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
124530967|NCT02477800|447894253|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
124728753|NCT00191724|448628007|FG003|Overall Study|Withdrawal by Subject|1|||
124728754|NCT00191724|448628008|FG004|Overall Study|Withdrawal by Subject|0|||
124728755|NCT02301546|448628009|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
124728756|NCT02301546|448628010|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
124583970|NCT00112437|448095899|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
124583971|NCT00112437|448095900|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
124583972|NCT00112437|448095901|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
124583973|NCT00112437|448095902|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
124583974|NCT00112437|448095903|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
124583975|NCT00112437|448095904|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
124583976|NCT00112437|448095905|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
124583977|NCT00112437|448095906|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
124583978|NCT00112437|448095907|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
124583979|NCT00112437|448095908|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
124583980|NCT00112437|448095909|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
124583981|NCT00112437|448095910|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
124583982|NCT00112437|448095885|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124583983|NCT00112437|448095886|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124583984|NCT00112437|448095887|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124583985|NCT00112437|448095888|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124583986|NCT00112437|448095889|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124583987|NCT00112437|448095890|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124583988|NCT00112437|448095891|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124583989|NCT00112437|448095892|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124583990|NCT00112437|448095893|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124583991|NCT00112437|448095894|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124583992|NCT00112437|448095895|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124583993|NCT00112437|448095896|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
124583994|NCT00112437|448095897|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124583995|NCT00112437|448095898|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
124583996|NCT00112437|448095899|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124583997|NCT00112437|448095900|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
124583998|NCT00112437|448095901|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124583999|NCT00112437|448095902|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124584000|NCT00112437|448095903|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
124584001|NCT00112437|448095904|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124584002|NCT00112437|448095905|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124584003|NCT00112437|448095906|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124584004|NCT00112437|448095907|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124584005|NCT00112437|448095908|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124584006|NCT00112437|448095909|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124584007|NCT00112437|448095910|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
124584008|NCT00112437|448095885|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584009|NCT00112437|448095886|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584010|NCT00112437|448095887|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584011|NCT00112437|448095888|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584012|NCT00112437|448095889|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584013|NCT00112437|448095890|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584014|NCT00112437|448095891|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584015|NCT00112437|448095892|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584016|NCT00112437|448095893|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584017|NCT00112437|448095894|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584018|NCT00112437|448095895|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584019|NCT00112437|448095896|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584020|NCT00112437|448095897|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584021|NCT00112437|448095898|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584022|NCT00112437|448095899|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584023|NCT00112437|448095900|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
124584024|NCT00112437|448095901|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584025|NCT00112437|448095902|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584026|NCT00112437|448095903|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584027|NCT00112437|448095904|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584028|NCT00112437|448095905|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584029|NCT00112437|448095906|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584030|NCT00112437|448095907|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584031|NCT00112437|448095908|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584032|NCT00112437|448095909|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584033|NCT00112437|448095910|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
124584034|NCT00112437|448095885|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584035|NCT00112437|448095886|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584036|NCT00112437|448095887|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584037|NCT00112437|448095888|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
124728757|NCT02301546|448628009|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
124728758|NCT02301546|448628010|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
124728759|NCT02301546|448628009|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
124777081|NCT00888940|448811400|FG001|Overall Study|Lost to Follow-up|5|||
124777082|NCT00888940|448811399|FG000|Overall Study|Randomized Not Treated|11|||
124777083|NCT00888940|448811400|FG001|Overall Study|Randomized Not Treated|13|||
124777084|NCT00607373|448811401|FG000|Treatment Period|Adverse Event|0|||
124777085|NCT00607373|448811402|FG001|Treatment Period|Adverse Event|4|||
124777086|NCT00607373|448811401|FG000|Treatment Period|Physician Decision|0|||
124777087|NCT00607373|448811402|FG001|Treatment Period|Physician Decision|1|||
124777088|NCT00607373|448811401|FG000|Treatment Period|Withdrawal by Subject|0|||
124777089|NCT00607373|448811402|FG001|Treatment Period|Withdrawal by Subject|1|||
124777090|NCT00607373|448811401|FG000|Follow-up Period|Other|0|||
124777091|NCT00607373|448811402|FG001|Follow-up Period|Other|1|||
124777092|NCT00607373|448811401|FG000|Follow-up Period|Protocol Violation|0|||
124777093|NCT00607373|448811402|FG001|Follow-up Period|Protocol Violation|1|||
124777094|NCT00607373|448811401|FG000|Follow-up Period|Withdrawal by Subject|1|||
124777095|NCT00607373|448811402|FG001|Follow-up Period|Withdrawal by Subject|3|||
124777096|NCT01918306|448811403|FG000|Overall Study|progresive disease|4|||
124777097|NCT01918306|448811404|FG001|Overall Study|progresive disease|0|||
124777098|NCT01918306|448811405|FG002|Overall Study|progresive disease|1|||
124777099|NCT01918306|448811406|FG003|Overall Study|progresive disease|1|||
124777100|NCT01918306|448811403|FG000|Overall Study|Withdrawal by Subject|0|||
124777101|NCT01918306|448811404|FG001|Overall Study|Withdrawal by Subject|0|||
124777102|NCT01918306|448811405|FG002|Overall Study|Withdrawal by Subject|0|||
124777103|NCT01918306|448811406|FG003|Overall Study|Withdrawal by Subject|2|||
124777104|NCT01918306|448811403|FG000|Overall Study|neutropenia|1|||
124777105|NCT01918306|448811404|FG001|Overall Study|neutropenia|0|||
124777106|NCT01918306|448811405|FG002|Overall Study|neutropenia|0|||
124777107|NCT01918306|448811406|FG003|Overall Study|neutropenia|0|||
124777108|NCT01918306|448811403|FG000|Overall Study|Lack of Efficacy|1|||
124777109|NCT01918306|448811404|FG001|Overall Study|Lack of Efficacy|0|||
124777110|NCT01918306|448811405|FG002|Overall Study|Lack of Efficacy|0|||
124777111|NCT01918306|448811406|FG003|Overall Study|Lack of Efficacy|0|||
124777112|NCT01918306|448811403|FG000|Overall Study|progress disease, crossover|0|||
124777113|NCT01918306|448811404|FG001|Overall Study|progress disease, crossover|0|||
124777114|NCT01918306|448811405|FG002|Overall Study|progress disease, crossover|1|||
124777115|NCT01918306|448811406|FG003|Overall Study|progress disease, crossover|0|||
124777116|NCT02170077|448811407|FG000|Overall Study|Withdrawal by Subject|3|||
124777117|NCT02170077|448811408|FG001|Overall Study|Withdrawal by Subject|4|||
124777118|NCT02170077|448811409|FG002|Overall Study|Withdrawal by Subject|2|||
124777119|NCT02170077|448811407|FG000|Overall Study|Adverse Event|4|||
124777120|NCT02170077|448811408|FG001|Overall Study|Adverse Event|4|||
124777121|NCT02170077|448811409|FG002|Overall Study|Adverse Event|4|||
124777122|NCT02170077|448811407|FG000|Overall Study|Lost to Follow-up|0|||
124777123|NCT02170077|448811408|FG001|Overall Study|Lost to Follow-up|1|||
124777124|NCT02170077|448811409|FG002|Overall Study|Lost to Follow-up|0|||
124777125|NCT02170077|448811407|FG000|Overall Study|Exclusion criteria|2|||
124777126|NCT02170077|448811408|FG001|Overall Study|Exclusion criteria|2|||
124777127|NCT02170077|448811409|FG002|Overall Study|Exclusion criteria|5|||
124777128|NCT02170077|448811407|FG000|Overall Study|Exacerbation of seizures|0|||
124777129|NCT02170077|448811408|FG001|Overall Study|Exacerbation of seizures|2|||
124777130|NCT02170077|448811409|FG002|Overall Study|Exacerbation of seizures|1|||
124530968|NCT02477800|447894254|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
124530969|NCT02477800|447894255|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
124530970|NCT02477800|447894249|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
124530971|NCT02477800|447894250|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
124530972|NCT02477800|447894251|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
124530973|NCT02477800|447894252|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
124530974|NCT02477800|447894253|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
124530975|NCT02477800|447894254|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
124530976|NCT02477800|447894255|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
124530977|NCT02477800|447894249|FG000|Placebo-Controlled Period|Reason not Specified|161|||
124530978|NCT02477800|447894250|FG001|Placebo-Controlled Period|Reason not Specified|161|||
124530979|NCT02477800|447894251|FG002|Placebo-Controlled Period|Reason not Specified|189|||
124530980|NCT02477800|447894252|FG003|Placebo-Controlled Period|Reason not Specified|0|||
124530981|NCT02477800|447894253|FG004|Placebo-Controlled Period|Reason not Specified|0|||
124530982|NCT02477800|447894254|FG005|Placebo-Controlled Period|Reason not Specified|0|||
124530983|NCT02477800|447894255|FG006|Placebo-Controlled Period|Reason not Specified|0|||
124530984|NCT02477800|447894249|FG000|Long Term Extension Period|Adverse Event|0|||
124530985|NCT02477800|447894250|FG001|Long Term Extension Period|Adverse Event|0|||
124530986|NCT02477800|447894251|FG002|Long Term Extension Period|Adverse Event|0|||
124530987|NCT02477800|447894252|FG003|Long Term Extension Period|Adverse Event|6|||
124530988|NCT02477800|447894253|FG004|Long Term Extension Period|Adverse Event|2|||
124530989|NCT02477800|447894254|FG005|Long Term Extension Period|Adverse Event|4|||
124530990|NCT02477800|447894255|FG006|Long Term Extension Period|Adverse Event|3|||
124530991|NCT02477800|447894249|FG000|Long Term Extension Period|Death|0|||
124777131|NCT01780974|448811410|FG000|Overall Study|Death|1|||
124777132|NCT01780974|448811411|FG001|Overall Study|Death|0|||
124584038|NCT00112437|448095889|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584039|NCT00112437|448095890|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
124728760|NCT02301546|448628010|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
124728761|NCT02301546|448628009|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
124728762|NCT02301546|448628010|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
124728763|NCT02301546|448628009|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
124728764|NCT02301546|448628010|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
124728765|NCT02301546|448628009|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
124728766|NCT02301546|448628010|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
124728767|NCT02301546|448628009|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
124728768|NCT02301546|448628010|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
124728769|NCT02447250|448628013|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
124728770|NCT02447250|448628013|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
124728771|NCT02447250|448628013|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
124728772|NCT01885208|448628014|FG000|Overall Study|Unclassified|32|||
124728773|NCT01885208|448628015|FG001|Overall Study|Unclassified|38|||
124728774|NCT01498575|448628018|FG000|Overall Sample|Withdrawal by Subject|60|||
124728775|NCT01498575|448628019|FG001|Overall Sample|Withdrawal by Subject|14|||
124728776|NCT01498575|448628018|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
124728777|NCT01498575|448628019|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
124728778|NCT01498575|448628018|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
124728779|NCT01498575|448628019|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
124728780|NCT01972308|448628021|FG000|Overall Study|Withdrawal by Subject|0|||
124728781|NCT01972308|448628022|FG001|Overall Study|Withdrawal by Subject|1|||
124728782|NCT01972308|448628021|FG000|Overall Study|Lost to Follow-up|4|||
124728783|NCT01972308|448628022|FG001|Overall Study|Lost to Follow-up|6|||
124728784|NCT01972308|448628021|FG000|Overall Study|Death|4|||
124728785|NCT01972308|448628022|FG001|Overall Study|Death|1|||
124728786|NCT02851797|448628027|FG000|Overall Study|Withdrawal by Subject|4|||
124728787|NCT02851797|448628028|FG001|Overall Study|Withdrawal by Subject|2|||
124728788|NCT02851797|448628027|FG000|Overall Study|Adverse Event|3|||
124728789|NCT02851797|448628028|FG001|Overall Study|Adverse Event|0|||
124728790|NCT00543803|448628029|FG000|Overall Study|Adverse Event|14|||
124728791|NCT00543803|448628029|FG000|Overall Study|Lack of Efficacy|22|||
124728792|NCT00543803|448628029|FG000|Overall Study|Lost to Follow-up|20|||
124728793|NCT00543803|448628029|FG000|Overall Study|Other|86|||
124728794|NCT04295681|448628039|FG000|Overall Study|Eligibility error|1|||
124728795|NCT04295681|448628040|FG001|Overall Study|Eligibility error|3|||
124728796|NCT02135029|448628049|FG000|Overall Study|Adverse Event|2|||
124728797|NCT02135029|448628050|FG001|Overall Study|Adverse Event|2|||
124728798|NCT02135029|448628051|FG002|Overall Study|Adverse Event|2|||
124728799|NCT02135029|448628049|FG000|Overall Study|Lost to Follow-up|0|||
124728800|NCT02135029|448628050|FG001|Overall Study|Lost to Follow-up|1|||
124584040|NCT00112437|448095891|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584041|NCT00112437|448095892|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584042|NCT00112437|448095893|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584043|NCT00112437|448095894|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584044|NCT00112437|448095895|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584045|NCT00112437|448095896|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584046|NCT00112437|448095897|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584047|NCT00112437|448095898|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584048|NCT00112437|448095899|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584049|NCT00112437|448095900|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
124584050|NCT00112437|448095901|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584051|NCT00112437|448095902|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584052|NCT00112437|448095903|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584053|NCT00112437|448095904|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
124728801|NCT02135029|448628051|FG002|Overall Study|Lost to Follow-up|0|||
124728802|NCT02135029|448628049|FG000|Overall Study|Withdrawal by Subject|2|||
124728803|NCT02135029|448628050|FG001|Overall Study|Withdrawal by Subject|0|||
124584054|NCT00112437|448095905|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
124728804|NCT02135029|448628051|FG002|Overall Study|Withdrawal by Subject|1|||
124728805|NCT02135029|448628049|FG000|Overall Study|Other|0|||
124728806|NCT02135029|448628050|FG001|Overall Study|Other|1|||
124728807|NCT02135029|448628051|FG002|Overall Study|Other|0|||
124728808|NCT02135029|448628049|FG000|Overall Study|Death|0|||
124728809|NCT02135029|448628050|FG001|Overall Study|Death|1|||
124584055|NCT00112437|448095906|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584056|NCT00112437|448095907|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
124728810|NCT02135029|448628051|FG002|Overall Study|Death|0|||
124728811|NCT05129449|448628056|FG000|Overall Study|Protocol Violation|1|||
124728812|NCT02839720|448628059|FG000|Overall Study|Adverse Event|2|||
124728813|NCT02839720|448628059|FG000|Overall Study|Non-compliance|2|||
124728814|NCT02839720|448628059|FG000|Overall Study|Intercurrent Illness|1|||
124584057|NCT00112437|448095908|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584058|NCT00112437|448095909|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584059|NCT00112437|448095910|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
124584060|NCT00112437|448095885|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584061|NCT00112437|448095886|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584062|NCT00112437|448095887|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584063|NCT00112437|448095888|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584064|NCT00112437|448095889|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584065|NCT00112437|448095890|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584066|NCT00112437|448095891|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584067|NCT00112437|448095892|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584068|NCT00112437|448095893|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584069|NCT00112437|448095894|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124530992|NCT02477800|447894250|FG001|Long Term Extension Period|Death|0|||
124530993|NCT02477800|447894251|FG002|Long Term Extension Period|Death|0|||
124530994|NCT02477800|447894252|FG003|Long Term Extension Period|Death|1|||
124530995|NCT02477800|447894253|FG004|Long Term Extension Period|Death|1|||
124530996|NCT02477800|447894254|FG005|Long Term Extension Period|Death|1|||
124530997|NCT02477800|447894255|FG006|Long Term Extension Period|Death|2|||
124530998|NCT02477800|447894249|FG000|Long Term Extension Period|Consent Withdrawn|0|||
124530999|NCT02477800|447894250|FG001|Long Term Extension Period|Consent Withdrawn|0|||
124531000|NCT02477800|447894251|FG002|Long Term Extension Period|Consent Withdrawn|0|||
124531001|NCT02477800|447894252|FG003|Long Term Extension Period|Consent Withdrawn|10|||
124531002|NCT02477800|447894253|FG004|Long Term Extension Period|Consent Withdrawn|4|||
124531003|NCT02477800|447894254|FG005|Long Term Extension Period|Consent Withdrawn|13|||
124531004|NCT02477800|447894255|FG006|Long Term Extension Period|Consent Withdrawn|16|||
124531005|NCT02477800|447894249|FG000|Long Term Extension Period|Disease Progression|0|||
124531006|NCT02477800|447894250|FG001|Long Term Extension Period|Disease Progression|0|||
124531007|NCT02477800|447894251|FG002|Long Term Extension Period|Disease Progression|0|||
124531008|NCT02477800|447894252|FG003|Long Term Extension Period|Disease Progression|3|||
124531009|NCT02477800|447894253|FG004|Long Term Extension Period|Disease Progression|1|||
124531010|NCT02477800|447894254|FG005|Long Term Extension Period|Disease Progression|1|||
124531011|NCT02477800|447894255|FG006|Long Term Extension Period|Disease Progression|0|||
124531012|NCT02477800|447894249|FG000|Long Term Extension Period|Investigator Decision|0|||
124531013|NCT02477800|447894250|FG001|Long Term Extension Period|Investigator Decision|0|||
124531014|NCT02477800|447894251|FG002|Long Term Extension Period|Investigator Decision|0|||
124531015|NCT02477800|447894252|FG003|Long Term Extension Period|Investigator Decision|0|||
124531016|NCT02477800|447894253|FG004|Long Term Extension Period|Investigator Decision|0|||
124531017|NCT02477800|447894254|FG005|Long Term Extension Period|Investigator Decision|0|||
124531018|NCT02477800|447894255|FG006|Long Term Extension Period|Investigator Decision|2|||
124531019|NCT02477800|447894249|FG000|Long Term Extension Period|Lost to Follow-up|0|||
124531020|NCT02477800|447894250|FG001|Long Term Extension Period|Lost to Follow-up|0|||
124531021|NCT02477800|447894251|FG002|Long Term Extension Period|Lost to Follow-up|0|||
124531022|NCT02477800|447894252|FG003|Long Term Extension Period|Lost to Follow-up|0|||
124531023|NCT02477800|447894253|FG004|Long Term Extension Period|Lost to Follow-up|1|||
124531024|NCT02477800|447894254|FG005|Long Term Extension Period|Lost to Follow-up|3|||
124531025|NCT02477800|447894255|FG006|Long Term Extension Period|Lost to Follow-up|0|||
124531026|NCT02477800|447894249|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
124531027|NCT02477800|447894250|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
124531028|NCT02477800|447894251|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
124531029|NCT02477800|447894252|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
124531030|NCT02477800|447894253|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
124531031|NCT02477800|447894254|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
124531032|NCT02477800|447894255|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
124531033|NCT02477800|447894249|FG000|Long Term Extension Period|Study Visit Burden|0|||
124531034|NCT02477800|447894250|FG001|Long Term Extension Period|Study Visit Burden|0|||
124531035|NCT02477800|447894251|FG002|Long Term Extension Period|Study Visit Burden|0|||
124531036|NCT02477800|447894252|FG003|Long Term Extension Period|Study Visit Burden|3|||
124531037|NCT02477800|447894253|FG004|Long Term Extension Period|Study Visit Burden|0|||
124531038|NCT02477800|447894254|FG005|Long Term Extension Period|Study Visit Burden|2|||
124531039|NCT02477800|447894255|FG006|Long Term Extension Period|Study Visit Burden|2|||
124531040|NCT02477800|447894249|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
124584070|NCT00112437|448095895|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584071|NCT00112437|448095896|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
124531041|NCT02477800|447894250|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
124531042|NCT02477800|447894251|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
124531043|NCT02477800|447894252|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
124531044|NCT02477800|447894253|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
124531045|NCT02477800|447894254|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
124531046|NCT02477800|447894255|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
124777133|NCT01780974|448811410|FG000|Overall Study|Adverse Event|1|||
124777134|NCT01780974|448811411|FG001|Overall Study|Adverse Event|3|||
124777135|NCT01724346|448811412|FG000|Overall Study|Death|42|||
124777136|NCT01724346|448811413|FG001|Overall Study|Death|42|||
124777137|NCT01724346|448811412|FG000|Overall Study|Lost to Follow-up|5|||
124777138|NCT01724346|448811413|FG001|Overall Study|Lost to Follow-up|1|||
124777139|NCT01724346|448811412|FG000|Overall Study|Withdrawal by Subject|27|||
124777140|NCT01724346|448811413|FG001|Overall Study|Withdrawal by Subject|19|||
124777141|NCT01724346|448811412|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
124777142|NCT01724346|448811413|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
124777143|NCT02876601|448811414|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
124777144|NCT02876601|448811415|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
124777145|NCT02876601|448811416|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
124777146|NCT02876601|448811417|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
124777147|NCT00256997|448811418|FG000|Overall Study|Protocol Violation|1|||
124777148|NCT00256997|448811419|FG001|Overall Study|Protocol Violation|4|||
124777149|NCT00256997|448811418|FG000|Overall Study|Lack of Efficacy|1|||
124777150|NCT00256997|448811419|FG001|Overall Study|Lack of Efficacy|4|||
124777151|NCT00256997|448811418|FG000|Overall Study|Death|2|||
124777152|NCT00256997|448811419|FG001|Overall Study|Death|0|||
124777153|NCT00256997|448811418|FG000|Overall Study|Adverse Event|4|||
124777154|NCT00256997|448811419|FG001|Overall Study|Adverse Event|0|||
124777155|NCT00256997|448811418|FG000|Overall Study|Lost to Follow-up|3|||
124777156|NCT00256997|448811419|FG001|Overall Study|Lost to Follow-up|5|||
124777157|NCT00256997|448811418|FG000|Overall Study|Withdrawal by Subject|13|||
124777158|NCT00256997|448811419|FG001|Overall Study|Withdrawal by Subject|3|||
124777159|NCT00256997|448811418|FG000|Overall Study|Started but not treated|2|||
124777160|NCT00256997|448811419|FG001|Overall Study|Started but not treated|0|||
124777161|NCT00256997|448811418|FG000|Overall Study|Other|5|||
124777162|NCT00256997|448811419|FG001|Overall Study|Other|8|||
124777163|NCT00256997|448811418|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
124777164|NCT00256997|448811419|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
124777165|NCT00256997|448811418|FG000|Overall Study|Participant Non-compliant|3|||
124777166|NCT00256997|448811419|FG001|Overall Study|Participant Non-compliant|6|||
124777167|NCT00256997|448811418|FG000|Overall Study|Investigator Withdrew Participant|2|||
124777168|NCT00256997|448811419|FG001|Overall Study|Investigator Withdrew Participant|1|||
124777169|NCT00354432|448811420|FG000|Overall Study|Adverse Event|3|||
124777170|NCT00354432|448811421|FG001|Overall Study|Adverse Event|1|||
124777171|NCT00354432|448811422|FG002|Overall Study|Adverse Event|5|||
124777172|NCT00354432|448811423|FG003|Overall Study|Adverse Event|5|||
124777173|NCT00354432|448811420|FG000|Overall Study|Off/Toxicity|3|||
124777174|NCT00354432|448811421|FG001|Overall Study|Off/Toxicity|7|||
124777175|NCT00354432|448811422|FG002|Overall Study|Off/Toxicity|5|||
124777176|NCT00354432|448811423|FG003|Overall Study|Off/Toxicity|5|||
124777177|NCT02736578|448811424|FG000|Overall Study|Adverse Event|1|||
124777178|NCT02736578|448811425|FG001|Overall Study|Adverse Event|0|||
124777179|NCT02827877|448811426|FG000|Overall Study|Withdrawal by Subject|1|||
124777180|NCT04953728|448812977|FG000|Overall Study|Withdrawal by Subject|3|||
124777181|NCT04953728|448812977|FG000|Overall Study|Physician Decision|1|||
124777182|NCT02105662|448812980|FG000|Overall Study|Lost to Follow-up|5|||
124777183|NCT02105662|448812980|FG000|Overall Study|Withdrawal by Subject|1|||
124777184|NCT02331277|448812981|FG000|Overall Study|Withdrawal by Subject|1|||
124777185|NCT02331277|448812982|FG001|Overall Study|Withdrawal by Subject|0|||
124777186|NCT03978117|448812983|FG000|Overall Study|Non-Compliance|26|||
124777187|NCT03978117|448812984|FG001|Overall Study|Non-Compliance|26|||
124777188|NCT03978117|448812983|FG000|Overall Study|Lost to Follow-up|4|||
124777189|NCT03978117|448812984|FG001|Overall Study|Lost to Follow-up|4|||
124777190|NCT00990704|448812986|FG000|Overall Study|Adverse Event|1|||
124777191|NCT00990704|448812987|FG001|Overall Study|Adverse Event|1|||
124777192|NCT00990704|448812986|FG000|Overall Study|Physician Decision|0|||
124777193|NCT00990704|448812987|FG001|Overall Study|Physician Decision|1|||
124777194|NCT01354899|448812991|FG000|Overall Study|discharge from the hospital|2|||
124777195|NCT01354899|448812991|FG000|Overall Study|Protocol Violation|1|||
124584072|NCT00112437|448095897|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584073|NCT00112437|448095898|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584074|NCT00112437|448095899|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
124584075|NCT00112437|448095900|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584076|NCT00112437|448095901|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124777196|NCT00641667|448812992|FG000|Overall Study|Withdrawal by Subject|1|||
124777197|NCT00641667|448812992|FG000|Overall Study|Adverse Event|1|||
124777198|NCT00641667|448812992|FG000|Overall Study|Physician Decision|1|||
124777199|NCT00641667|448812992|FG000|Overall Study|Worsening of underlying disease|3|||
124777200|NCT01235741|448812993|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
124777201|NCT01235741|448812994|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
124777202|NCT01235741|448812995|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
124777203|NCT01235741|448812993|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
124728815|NCT02839720|448628059|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
124728816|NCT00516906|448628060|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
124728817|NCT00516906|448628061|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
124728818|NCT01974206|448628062|FG000|Overall Study|Did Not Take Study Drug|0|||
124728819|NCT01974206|448628063|FG001|Overall Study|Did Not Take Study Drug|1|||
124728820|NCT01974206|448628062|FG000|Overall Study|Physician Decision|1|||
124728821|NCT01974206|448628063|FG001|Overall Study|Physician Decision|0|||
124728822|NCT01974206|448628062|FG000|Overall Study|Withdrawal by Subject|3|||
124728823|NCT01974206|448628063|FG001|Overall Study|Withdrawal by Subject|0|||
124728824|NCT01974206|448628062|FG000|Overall Study|Lost to Follow-up|1|||
124728825|NCT01974206|448628063|FG001|Overall Study|Lost to Follow-up|0|||
124728826|NCT01974206|448628062|FG000|Overall Study|Death|1|||
124728827|NCT01974206|448628063|FG001|Overall Study|Death|0|||
124728828|NCT05463744|448628076|FG000|Treatment Period|Withdrawal by Subject|19|||
124728829|NCT05463744|448628077|FG001|Treatment Period|Withdrawal by Subject|16|||
124728830|NCT05463744|448628076|FG000|Treatment Period|Adverse Event|4|||
124728831|NCT05463744|448628077|FG001|Treatment Period|Adverse Event|4|||
124728832|NCT05463744|448628076|FG000|Treatment Period|Pregnancy|0|||
124728833|NCT05463744|448628077|FG001|Treatment Period|Pregnancy|3|||
124728834|NCT05463744|448628076|FG000|Treatment Period|Lost to Follow-up|1|||
124728835|NCT05463744|448628077|FG001|Treatment Period|Lost to Follow-up|3|||
124728836|NCT05463744|448628076|FG000|Treatment Period|Inadvertent enrollment|2|||
124728837|NCT05463744|448628077|FG001|Treatment Period|Inadvertent enrollment|1|||
124728838|NCT05463744|448628076|FG000|Treatment Period|Death|0|||
124728839|NCT05463744|448628077|FG001|Treatment Period|Death|1|||
124728840|NCT05463744|448628076|FG000|Treatment Period|Non-compliance with Study Drug|1|||
124728841|NCT05463744|448628077|FG001|Treatment Period|Non-compliance with Study Drug|0|||
124728842|NCT05463744|448628076|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
124728843|NCT05463744|448628077|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
124728844|NCT05463744|448628076|FG000|Treatment Period|Physician Decision|0|||
124728845|NCT05463744|448628077|FG001|Treatment Period|Physician Decision|1|||
124728846|NCT05463744|448628076|FG000|Follow-Up Period|Withdrawal by Subject|3|||
124728847|NCT05463744|448628077|FG001|Follow-Up Period|Withdrawal by Subject|1|||
124728848|NCT05463744|448628076|FG000|Follow-Up Period|Lost to Follow-up|1|||
124728849|NCT05463744|448628077|FG001|Follow-Up Period|Lost to Follow-up|1|||
124728850|NCT01795495|448628078|FG000|Overall Study|Protocol Violation|1|||
124728851|NCT01795495|448628079|FG001|Overall Study|Protocol Violation|0|||
124728852|NCT01795495|448628080|FG002|Overall Study|Protocol Violation|1|||
124728853|NCT01795495|448628078|FG000|Overall Study|Physician Decision|0|||
124728854|NCT01795495|448628079|FG001|Overall Study|Physician Decision|0|||
124728855|NCT01795495|448628080|FG002|Overall Study|Physician Decision|1|||
124728856|NCT01579565|448630083|FG000|Randomized|Adverse Event|1|||
124728857|NCT01579565|448630084|FG001|Randomized|Adverse Event|3|||
124728858|NCT01579565|448630083|FG000|Randomized|Withdrawal by Subject|3|||
124728859|NCT01579565|448630084|FG001|Randomized|Withdrawal by Subject|0|||
124728860|NCT01579565|448630083|FG000|Randomized|inadequate preoperative pupil dilation|0|||
124728861|NCT01579565|448630084|FG001|Randomized|inadequate preoperative pupil dilation|1|||
124728862|NCT01579565|448630083|FG000|Randomized|prohibited preoperative eating|1|||
124728863|NCT01579565|448630084|FG001|Randomized|prohibited preoperative eating|0|||
124728864|NCT01579565|448630083|FG000|Randomized|prohibited preoperative medication|0|||
124728865|NCT01579565|448630084|FG001|Randomized|prohibited preoperative medication|1|||
124728866|NCT01579565|448630083|FG000|Treated|Physician Decision|0|||
124728867|NCT01579565|448630084|FG001|Treated|Physician Decision|1|||
124728868|NCT01579565|448630083|FG000|Treated|Lost to Follow-up|2|||
124728869|NCT01579565|448630084|FG001|Treated|Lost to Follow-up|1|||
124728870|NCT01579565|448630083|FG000|Treated|declined to return for final visit|0|||
124728871|NCT01579565|448630084|FG001|Treated|declined to return for final visit|1|||
124728872|NCT02867813|448630085|FG000|Overall Study|Withdrawal by Subject|57|||
124728873|NCT02867813|448630086|FG001|Overall Study|Withdrawal by Subject|56|||
124728874|NCT02867813|448630085|FG000|Overall Study|Decision by Sponsor|7|||
124728875|NCT02867813|448630086|FG001|Overall Study|Decision by Sponsor|7|||
124728876|NCT02867813|448630085|FG000|Overall Study|Lost to Follow-up|91|||
124728877|NCT02867813|448630086|FG001|Overall Study|Lost to Follow-up|78|||
124728878|NCT02867813|448630085|FG000|Overall Study|Missing|2|||
124728879|NCT02867813|448630086|FG001|Overall Study|Missing|1|||
124728880|NCT02867813|448630085|FG000|Overall Study|Death|294|||
124728881|NCT02867813|448630086|FG001|Overall Study|Death|268|||
124728882|NCT01448824|448630087|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
124728883|NCT01448824|448630088|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
124728884|NCT01448824|448630089|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
124728885|NCT01448824|448630090|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
124728886|NCT01448824|448630091|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
124728887|NCT01448824|448630092|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
124728888|NCT01448824|448630093|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
124728889|NCT01448824|448630094|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
124728890|NCT01448824|448630087|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
124728891|NCT01448824|448630088|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
124728892|NCT01448824|448630089|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
124728893|NCT01448824|448630090|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
124728894|NCT01448824|448630091|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
124728895|NCT01448824|448630092|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
124728896|NCT01448824|448630093|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
124728897|NCT01448824|448630094|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
124728898|NCT01448824|448630087|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
124728899|NCT01448824|448630088|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
124728900|NCT01448824|448630089|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
124728901|NCT01448824|448630090|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
124728902|NCT01448824|448630091|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
124728903|NCT01448824|448630092|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
124728904|NCT01448824|448630093|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
124728905|NCT01448824|448630094|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
124728906|NCT01448824|448630087|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
124728907|NCT01448824|448630088|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
124728908|NCT01448824|448630089|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
124728909|NCT01448824|448630090|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
124728910|NCT01448824|448630091|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
124728911|NCT01448824|448630092|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
124728912|NCT01448824|448630093|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
124728913|NCT01448824|448630094|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
124728914|NCT01448824|448630087|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
124728915|NCT01448824|448630088|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
124728916|NCT01448824|448630089|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
124728917|NCT01448824|448630090|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
124728918|NCT01448824|448630091|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
124728919|NCT01448824|448630092|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
124728920|NCT01448824|448630093|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
124728921|NCT01448824|448630094|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
124728922|NCT01448824|448630087|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
124728923|NCT01448824|448630088|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
124728924|NCT01448824|448630089|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
124728925|NCT01448824|448630090|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
124728926|NCT01448824|448630091|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
124728927|NCT01448824|448630092|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
124728928|NCT01448824|448630093|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
124728929|NCT01448824|448630094|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
124728930|NCT01448824|448630087|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
124728931|NCT01448824|448630088|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
124728932|NCT01448824|448630089|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
124728933|NCT01448824|448630090|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
124728934|NCT01448824|448630091|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
124728935|NCT01448824|448630092|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
124728936|NCT01448824|448630093|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
124728937|NCT01448824|448630094|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
124728938|NCT01448824|448630087|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
124728939|NCT01448824|448630088|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
124728940|NCT01448824|448630089|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
124728941|NCT01448824|448630090|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
124728942|NCT01448824|448630091|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
124728943|NCT01448824|448630092|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
124728944|NCT01448824|448630093|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
124728945|NCT01448824|448630094|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
124728946|NCT03389555|448630097|FG000|Overall Study|Protocol Violation|1|||
124728947|NCT03389555|448630098|FG001|Overall Study|Protocol Violation|3|||
124728948|NCT03389555|448630097|FG000|Overall Study|Death|1|||
124728949|NCT03389555|448630098|FG001|Overall Study|Death|0|||
124728950|NCT00920218|448630101|FG000|Overall Study|Serious Adverse Event|2|||
124728951|NCT00920218|448630102|FG001|Overall Study|Serious Adverse Event|0|||
124728952|NCT00920218|448630103|FG002|Overall Study|Serious Adverse Event|2|||
124728953|NCT00920218|448630104|FG003|Overall Study|Serious Adverse Event|1|||
124728954|NCT00920218|448630101|FG000|Overall Study|Withdrawal by Subject|0|||
124728955|NCT00920218|448630102|FG001|Overall Study|Withdrawal by Subject|3|||
124728956|NCT00920218|448630103|FG002|Overall Study|Withdrawal by Subject|2|||
124728957|NCT00920218|448630104|FG003|Overall Study|Withdrawal by Subject|0|||
124728958|NCT00920218|448630101|FG000|Overall Study|Migrated/moved from study area|0|||
124728959|NCT00920218|448630102|FG001|Overall Study|Migrated/moved from study area|0|||
124531047|NCT02477800|447894249|FG000|Long Term Extension Period|Reason not Specified|0|||
124531048|NCT02477800|447894250|FG001|Long Term Extension Period|Reason not Specified|0|||
124531049|NCT02477800|447894251|FG002|Long Term Extension Period|Reason not Specified|0|||
124531050|NCT02477800|447894252|FG003|Long Term Extension Period|Reason not Specified|126|||
124531051|NCT02477800|447894253|FG004|Long Term Extension Period|Reason not Specified|140|||
124531052|NCT02477800|447894254|FG005|Long Term Extension Period|Reason not Specified|270|||
124531053|NCT02477800|447894255|FG006|Long Term Extension Period|Reason not Specified|224|||
124531054|NCT02607865|447894260|FG000|Overall Study|Lost to Follow-up|9|||
124531055|NCT02607865|447894261|FG001|Overall Study|Lost to Follow-up|7|||
124531056|NCT02607865|447894262|FG002|Overall Study|Lost to Follow-up|7|||
124531057|NCT02607865|447894263|FG003|Overall Study|Lost to Follow-up|5|||
124531058|NCT02607865|447894260|FG000|Overall Study|Withdrawal by Subject|18|||
124531059|NCT02607865|447894261|FG001|Overall Study|Withdrawal by Subject|18|||
124531060|NCT02607865|447894262|FG002|Overall Study|Withdrawal by Subject|17|||
124531061|NCT02607865|447894263|FG003|Overall Study|Withdrawal by Subject|8|||
124531062|NCT02607865|447894260|FG000|Overall Study|Death|5|||
124531063|NCT02607865|447894261|FG001|Overall Study|Death|4|||
124531064|NCT02607865|447894262|FG002|Overall Study|Death|1|||
124531065|NCT02607865|447894263|FG003|Overall Study|Death|3|||
124531066|NCT02607865|447894260|FG000|Overall Study|Unclassified|1|||
124531067|NCT02607865|447894261|FG001|Overall Study|Unclassified|1|||
124531068|NCT02607865|447894262|FG002|Overall Study|Unclassified|2|||
124531069|NCT02607865|447894263|FG003|Overall Study|Unclassified|0|||
124531070|NCT02447952|447894264|FG000|Overall Study|Adverse Event|2|||
124531071|NCT02447952|447894264|FG000|Overall Study|Physician Decision|1|||
124531072|NCT02447952|447894264|FG000|Overall Study|Withdrawal by Subject|4|||
124531073|NCT01756833|447894268|FG000|Overall Study|Withdrawal by Subject|4|||
124531074|NCT01756833|447894269|FG001|Overall Study|Withdrawal by Subject|3|||
124531075|NCT01766401|447894270|FG000|Overall Study|Adverse Event|7|||
124531076|NCT01766401|447894271|FG001|Overall Study|Adverse Event|22|||
124531077|NCT01766401|447894270|FG000|Overall Study|Lack of Efficacy|1|||
124531078|NCT01766401|447894271|FG001|Overall Study|Lack of Efficacy|2|||
124531079|NCT01766401|447894270|FG000|Overall Study|Protocol Violation|3|||
124531080|NCT01766401|447894271|FG001|Overall Study|Protocol Violation|8|||
124531081|NCT01766401|447894270|FG000|Overall Study|Withdrawal by Subject|15|||
124531082|NCT01766401|447894271|FG001|Overall Study|Withdrawal by Subject|12|||
124531083|NCT01766401|447894270|FG000|Overall Study|Lost to Follow-up|10|||
124531084|NCT01766401|447894271|FG001|Overall Study|Lost to Follow-up|11|||
124531085|NCT01766401|447894270|FG000|Overall Study|Pregnancy|1|||
124531086|NCT01766401|447894271|FG001|Overall Study|Pregnancy|1|||
124531087|NCT01040728|447894276|FG000|Overall Study|Adverse Event|4|||
124531088|NCT01040728|447894277|FG001|Overall Study|Adverse Event|8|||
124531089|NCT01040728|447894278|FG002|Overall Study|Adverse Event|0|||
124531090|NCT01040728|447894279|FG003|Overall Study|Adverse Event|4|||
124531091|NCT01040728|447894276|FG000|Overall Study|Withdrawal by Subject|0|||
124531092|NCT01040728|447894277|FG001|Overall Study|Withdrawal by Subject|1|||
124531093|NCT01040728|447894278|FG002|Overall Study|Withdrawal by Subject|1|||
124531094|NCT01040728|447894279|FG003|Overall Study|Withdrawal by Subject|0|||
124531095|NCT01040728|447894276|FG000|Overall Study|Protocol Violation|0|||
124531096|NCT01040728|447894277|FG001|Overall Study|Protocol Violation|0|||
124531097|NCT01040728|447894278|FG002|Overall Study|Protocol Violation|0|||
124531098|NCT01040728|447894279|FG003|Overall Study|Protocol Violation|1|||
124531099|NCT01040728|447894276|FG000|Overall Study|Lack of Efficacy|0|||
124531100|NCT01040728|447894277|FG001|Overall Study|Lack of Efficacy|1|||
124531101|NCT01040728|447894278|FG002|Overall Study|Lack of Efficacy|0|||
124531102|NCT01040728|447894279|FG003|Overall Study|Lack of Efficacy|1|||
124531103|NCT01040728|447894276|FG000|Overall Study|Other reasons not listed above|0|||
124531104|NCT01040728|447894277|FG001|Overall Study|Other reasons not listed above|1|||
124531105|NCT01040728|447894278|FG002|Overall Study|Other reasons not listed above|0|||
124531106|NCT01040728|447894279|FG003|Overall Study|Other reasons not listed above|0|||
124531107|NCT01875874|447894281|FG000|Overall Study|Death|3|||
124531108|NCT00590031|447894282|FG000|Overall Study|Adverse Event|3|||
124531109|NCT00590031|447894282|FG000|Overall Study|Withdrawal by Subject|1|||
124531110|NCT00590031|447894282|FG000|Overall Study|Metastatic Disease|1|||
124531111|NCT00590031|447894282|FG000|Overall Study|Admin Hold|1|||
124531112|NCT01601873|447894283|FG000|Overall Study|Lost to Follow-up|2|||
124728960|NCT00920218|448630103|FG002|Overall Study|Migrated/moved from study area|1|||
124728961|NCT00920218|448630104|FG003|Overall Study|Migrated/moved from study area|0|||
124728962|NCT00920218|448630101|FG000|Overall Study|Lost to Follow-up|0|||
124728963|NCT00920218|448630102|FG001|Overall Study|Lost to Follow-up|1|||
124531113|NCT01601873|447894284|FG001|Overall Study|Lost to Follow-up|3|||
124531114|NCT00826540|447894289|FG000|Overall Study|ineligible|3|||
124531115|NCT00826540|447894289|FG000|Overall Study|Withdrawal by Subject|1|||
124531116|NCT02520141|447894292|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
124531117|NCT00703781|447894293|FG000|Overall Study|Withdrawal by Subject|1|||
124531118|NCT00703781|447894294|FG001|Overall Study|Withdrawal by Subject|2|||
124531119|NCT00703781|447894293|FG000|Overall Study|Cancelled surgery|1|||
124531120|NCT00703781|447894294|FG001|Overall Study|Cancelled surgery|0|||
124531121|NCT03452397|447894295|FG000|Overall Study|Adverse Event|1|||
124531122|NCT03452397|447894296|FG001|Overall Study|Adverse Event|0|||
124531123|NCT03452397|447894297|FG002|Overall Study|Adverse Event|0|||
124531124|NCT03452397|447894298|FG003|Overall Study|Adverse Event|0|||
124531125|NCT03452397|447894295|FG000|Overall Study|Administrative reason|0|||
124531126|NCT03452397|447894296|FG001|Overall Study|Administrative reason|0|||
124531127|NCT03452397|447894297|FG002|Overall Study|Administrative reason|1|||
124531128|NCT03452397|447894298|FG003|Overall Study|Administrative reason|1|||
124531129|NCT03452397|447894295|FG000|Overall Study|Withdrawal by Subject|0|||
124531130|NCT03452397|447894296|FG001|Overall Study|Withdrawal by Subject|0|||
124531131|NCT03452397|447894297|FG002|Overall Study|Withdrawal by Subject|1|||
124531132|NCT03452397|447894298|FG003|Overall Study|Withdrawal by Subject|0|||
124531133|NCT02691468|447894299|FG000|Overall Study|Bronchial blocker use|2|||
124531134|NCT02691468|447894300|FG001|Overall Study|Bronchial blocker use|1|||
124531135|NCT02691468|447894299|FG000|Overall Study|Lost to Follow-up|2|||
124531136|NCT02691468|447894300|FG001|Overall Study|Lost to Follow-up|1|||
124531137|NCT02691468|447894299|FG000|Overall Study|Failure to advance FOB|2|||
124531138|NCT02691468|447894300|FG001|Overall Study|Failure to advance FOB|0|||
124531139|NCT06334055|447894301|FG000|Overall Study|Adverse Event|4|||
124531140|NCT06334055|447894301|FG000|Overall Study|Disqualified|72|||
124531141|NCT02545049|447894302|FG000|Overall Study|Withdrawal by Subject|1|||
124531142|NCT02545049|447894303|FG001|Overall Study|Withdrawal by Subject|7|||
124531143|NCT02545049|447894302|FG000|Overall Study|Lost to Follow-up|4|||
124531144|NCT02545049|447894303|FG001|Overall Study|Lost to Follow-up|6|||
124531145|NCT02545049|447894302|FG000|Overall Study|GCP violations|37|||
124531146|NCT02545049|447894303|FG001|Overall Study|GCP violations|48|||
124531147|NCT01855919|447896303|FG000|Overall Study|Adverse Event|16|||
124531148|NCT01855919|447896304|FG001|Overall Study|Adverse Event|8|||
124531149|NCT01855919|447896303|FG000|Overall Study|Lack of Efficacy|1|||
124531150|NCT01855919|447896304|FG001|Overall Study|Lack of Efficacy|3|||
124531151|NCT01855919|447896303|FG000|Overall Study|Withdrawal by Subject|4|||
124531152|NCT01855919|447896304|FG001|Overall Study|Withdrawal by Subject|10|||
124531153|NCT01855919|447896303|FG000|Overall Study|Entry Criteria Not Met|1|||
124531154|NCT01855919|447896304|FG001|Overall Study|Entry Criteria Not Met|1|||
124531155|NCT01855919|447896303|FG000|Overall Study|Protocol Violation|1|||
124531156|NCT01855919|447896304|FG001|Overall Study|Protocol Violation|4|||
124531157|NCT04459416|447896305|FG000|Overall Study|Lost to Follow-up|2|||
124531158|NCT04459416|447896306|FG001|Overall Study|Lost to Follow-up|0|||
124531159|NCT04459416|447896305|FG000|Overall Study|Withdrawal by Subject|8|||
124531160|NCT04459416|447896306|FG001|Overall Study|Withdrawal by Subject|10|||
124531161|NCT04459416|447896305|FG000|Overall Study|Disease progression|0|||
124531162|NCT04459416|447896306|FG001|Overall Study|Disease progression|3|||
124531163|NCT03455530|447896307|FG000|Overall Study|Withdrawal by Subject|9|||
124531164|NCT03455530|447896308|FG001|Overall Study|Withdrawal by Subject|1|||
124531165|NCT03455530|447896309|FG002|Overall Study|Withdrawal by Subject|3|||
124531166|NCT03455530|447896310|FG003|Overall Study|Withdrawal by Subject|3|||
124531167|NCT01592773|447896311|FG000|Overall Study|Study Terminated by Sponsor|582|||
124531168|NCT01592773|447896311|FG000|Overall Study|Withdrawal by Subject|35|||
124531169|NCT01592773|447896311|FG000|Overall Study|Lost to Follow-up|19|||
124531170|NCT01592773|447896311|FG000|Overall Study|Adverse Event|17|||
124531171|NCT01592773|447896311|FG000|Overall Study|Lack of Efficacy|9|||
124531172|NCT01592773|447896311|FG000|Overall Study|Protocol Violation|2|||
124531173|NCT01592773|447896311|FG000|Overall Study|Inclusion/exclusion not meet|1|||
124531174|NCT01592773|447896311|FG000|Overall Study|Other Reason|1|||
124531175|NCT00740116|447896315|FG000|Overall Study|Withdrawal by Subject|1|||
124531176|NCT00740116|447896316|FG001|Overall Study|Withdrawal by Subject|1|||
124531177|NCT00740116|447896315|FG000|Overall Study|Protocol Violation|1|||
124531178|NCT00740116|447896316|FG001|Overall Study|Protocol Violation|4|||
124531179|NCT03037489|447896317|FG000|Overall Study|Adverse Event|4|||
124531180|NCT03037489|447896318|FG001|Overall Study|Adverse Event|0|||
124531181|NCT03037489|447896317|FG000|Overall Study|Withdrawal by Subject|3|||
124531182|NCT03037489|447896318|FG001|Overall Study|Withdrawal by Subject|0|||
124531183|NCT00621764|447896320|FG000|Overall Study|Protocol Violation|0|||
124531184|NCT00621764|447896321|FG001|Overall Study|Protocol Violation|0|||
124531185|NCT00621764|447896322|FG002|Overall Study|Protocol Violation|0|||
124531186|NCT00621764|447896323|FG003|Overall Study|Protocol Violation|1|||
124531187|NCT01293123|447896324|FG000|Overall Study|Lost to Follow-up|0|||
124531188|NCT01293123|447896325|FG001|Overall Study|Lost to Follow-up|1|||
124531189|NCT00121485|447896326|FG000|Overall Study|Not implanted|1|||
124531190|NCT00121485|447896327|FG001|Overall Study|Not implanted|5|||
124531191|NCT00121485|447896326|FG000|Overall Study|Crossover|0|||
124531192|NCT00121485|447896327|FG001|Overall Study|Crossover|2|||
124531193|NCT00724243|447896330|FG000|Overall Study|Lack of Efficacy|10|||
124531194|NCT00724243|447896330|FG000|Overall Study|Adverse Event|5|||
124531195|NCT03031327|447896333|FG000|Overall Study|Withdrawal by Subject|0|||
124531196|NCT03031327|447896334|FG001|Overall Study|Withdrawal by Subject|1|||
124531197|NCT03031327|447896335|FG002|Overall Study|Withdrawal by Subject|1|||
124584077|NCT00112437|448095902|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584078|NCT00112437|448095903|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584079|NCT00112437|448095904|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584080|NCT00112437|448095905|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584081|NCT00112437|448095906|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584082|NCT00112437|448095907|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584083|NCT00112437|448095908|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584084|NCT00112437|448095909|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124531198|NCT00211536|447896336|FG000|Overall Study|Withdrawal by Subject|2|||
124531199|NCT00211536|447896337|FG001|Overall Study|Withdrawal by Subject|2|||
124531200|NCT00211536|447896336|FG000|Overall Study|Physician Decision|0|||
124531201|NCT00211536|447896337|FG001|Overall Study|Physician Decision|5|||
124531202|NCT00211536|447896336|FG000|Overall Study|Adverse Event|2|||
124531203|NCT00211536|447896337|FG001|Overall Study|Adverse Event|0|||
124531204|NCT01004861|447896338|FG000|Overall Study|Disease progression|3|||
124531205|NCT01004861|447896339|FG001|Overall Study|Disease progression|4|||
124531206|NCT01004861|447896340|FG002|Overall Study|Disease progression|5|||
124531207|NCT01004861|447896341|FG003|Overall Study|Disease progression|4|||
124531208|NCT01004861|447896342|FG004|Overall Study|Disease progression|4|||
124531209|NCT01004861|447896343|FG005|Overall Study|Disease progression|4|||
124531210|NCT01004861|447896344|FG006|Overall Study|Disease progression|5|||
124531211|NCT01004861|447896345|FG007|Overall Study|Disease progression|1|||
124531212|NCT01004861|447896346|FG008|Overall Study|Disease progression|4|||
124531213|NCT01004861|447896347|FG009|Overall Study|Disease progression|7|||
124531214|NCT01004861|447896348|FG010|Overall Study|Disease progression|6|||
124531215|NCT01004861|447896349|FG011|Overall Study|Disease progression|3|||
124531216|NCT01004861|447896350|FG012|Overall Study|Disease progression|8|||
124531217|NCT01004861|447896338|FG000|Overall Study|Physician Decision|0|||
124531218|NCT01004861|447896339|FG001|Overall Study|Physician Decision|2|||
124531219|NCT01004861|447896340|FG002|Overall Study|Physician Decision|1|||
124531220|NCT01004861|447896341|FG003|Overall Study|Physician Decision|1|||
124531221|NCT01004861|447896342|FG004|Overall Study|Physician Decision|1|||
124531222|NCT01004861|447896343|FG005|Overall Study|Physician Decision|0|||
124531223|NCT01004861|447896344|FG006|Overall Study|Physician Decision|0|||
124531224|NCT01004861|447896345|FG007|Overall Study|Physician Decision|1|||
124531225|NCT01004861|447896346|FG008|Overall Study|Physician Decision|0|||
124531226|NCT01004861|447896347|FG009|Overall Study|Physician Decision|0|||
124531227|NCT01004861|447896348|FG010|Overall Study|Physician Decision|0|||
124531228|NCT01004861|447896349|FG011|Overall Study|Physician Decision|0|||
124531229|NCT01004861|447896350|FG012|Overall Study|Physician Decision|3|||
124531230|NCT01004861|447896338|FG000|Overall Study|Adverse Event|0|||
124531231|NCT01004861|447896339|FG001|Overall Study|Adverse Event|0|||
124531232|NCT01004861|447896340|FG002|Overall Study|Adverse Event|0|||
124531233|NCT01004861|447896341|FG003|Overall Study|Adverse Event|1|||
124531234|NCT01004861|447896342|FG004|Overall Study|Adverse Event|0|||
124531235|NCT01004861|447896343|FG005|Overall Study|Adverse Event|2|||
124531236|NCT01004861|447896344|FG006|Overall Study|Adverse Event|1|||
124531237|NCT01004861|447896345|FG007|Overall Study|Adverse Event|1|||
124531238|NCT01004861|447896346|FG008|Overall Study|Adverse Event|13|||
124531239|NCT01004861|447896347|FG009|Overall Study|Adverse Event|1|||
124531240|NCT01004861|447896348|FG010|Overall Study|Adverse Event|1|||
124531241|NCT01004861|447896349|FG011|Overall Study|Adverse Event|0|||
124531242|NCT01004861|447896350|FG012|Overall Study|Adverse Event|2|||
124531243|NCT01004861|447896338|FG000|Overall Study|Protocol Violation|0|||
124531244|NCT01004861|447896339|FG001|Overall Study|Protocol Violation|0|||
124531245|NCT01004861|447896340|FG002|Overall Study|Protocol Violation|0|||
124531246|NCT01004861|447896341|FG003|Overall Study|Protocol Violation|0|||
124531247|NCT01004861|447896342|FG004|Overall Study|Protocol Violation|1|||
124531248|NCT01004861|447896343|FG005|Overall Study|Protocol Violation|0|||
124531249|NCT01004861|447896344|FG006|Overall Study|Protocol Violation|0|||
124531250|NCT01004861|447896345|FG007|Overall Study|Protocol Violation|0|||
124531251|NCT01004861|447896346|FG008|Overall Study|Protocol Violation|0|||
124531252|NCT01004861|447896347|FG009|Overall Study|Protocol Violation|0|||
124531253|NCT01004861|447896348|FG010|Overall Study|Protocol Violation|0|||
124531254|NCT01004861|447896349|FG011|Overall Study|Protocol Violation|0|||
124531255|NCT01004861|447896350|FG012|Overall Study|Protocol Violation|0|||
124531256|NCT01004861|447896338|FG000|Overall Study|Lost to Follow-up|0|||
124584085|NCT00112437|448095910|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
124584086|NCT00112437|448095885|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124728964|NCT00920218|448630103|FG002|Overall Study|Lost to Follow-up|0|||
124531257|NCT01004861|447896339|FG001|Overall Study|Lost to Follow-up|0|||
124531258|NCT01004861|447896340|FG002|Overall Study|Lost to Follow-up|0|||
124531259|NCT01004861|447896341|FG003|Overall Study|Lost to Follow-up|0|||
124531260|NCT01004861|447896342|FG004|Overall Study|Lost to Follow-up|0|||
124531261|NCT01004861|447896343|FG005|Overall Study|Lost to Follow-up|0|||
124531262|NCT01004861|447896344|FG006|Overall Study|Lost to Follow-up|0|||
124531263|NCT01004861|447896345|FG007|Overall Study|Lost to Follow-up|1|||
124531264|NCT01004861|447896346|FG008|Overall Study|Lost to Follow-up|3|||
124531265|NCT01004861|447896347|FG009|Overall Study|Lost to Follow-up|0|||
124777204|NCT01235741|448812994|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
124777205|NCT01235741|448812995|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
124777206|NCT01235741|448812993|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
124777207|NCT01235741|448812994|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
124777208|NCT01235741|448812995|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
124777209|NCT01235741|448812993|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
124777210|NCT01235741|448812994|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
124777211|NCT01235741|448812995|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
124777212|NCT01235741|448812993|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
124777213|NCT01235741|448812994|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
124777214|NCT01235741|448812995|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
124777215|NCT01235741|448812993|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
124584087|NCT00112437|448095886|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584088|NCT00112437|448095887|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584089|NCT00112437|448095888|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584090|NCT00112437|448095889|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124777216|NCT01235741|448812994|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
124777217|NCT01235741|448812995|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
124777218|NCT01235741|448812993|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
124777219|NCT01235741|448812994|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
124777220|NCT01235741|448812995|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
124777221|NCT01235741|448812993|FG000|Randomized to Treatment|Adverse Event|0|||
124777222|NCT01235741|448812994|FG001|Randomized to Treatment|Adverse Event|1|||
124777223|NCT01235741|448812995|FG002|Randomized to Treatment|Adverse Event|1|||
124777224|NCT01235741|448812993|FG000|Randomized to Treatment|Sponsor terminated study|0|||
124777225|NCT01235741|448812994|FG001|Randomized to Treatment|Sponsor terminated study|35|||
124777226|NCT01235741|448812995|FG002|Randomized to Treatment|Sponsor terminated study|34|||
124777227|NCT01235741|448812993|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
124777228|NCT01235741|448812994|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
124777229|NCT01235741|448812995|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
124777230|NCT01235741|448812993|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
124777231|NCT01235741|448812994|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
124777232|NCT01235741|448812995|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
124777233|NCT01235741|448812993|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
124777234|NCT01235741|448812994|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
124777235|NCT01235741|448812995|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
124777236|NCT01106690|448812996|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
124777237|NCT01106690|448812997|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
124777238|NCT01106690|448812998|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
124777239|NCT01106690|448812996|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
124777240|NCT01106690|448812997|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
124777241|NCT01106690|448812998|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
124777242|NCT01106690|448812996|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
124777243|NCT01106690|448812997|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
124777244|NCT01106690|448812998|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
124777245|NCT01106690|448812996|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
124777246|NCT01106690|448812997|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
124777247|NCT01106690|448812998|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
124777248|NCT01106690|448812996|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
124777249|NCT01106690|448812997|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
124777250|NCT01106690|448812998|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
124777251|NCT01106690|448812996|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
124777252|NCT01106690|448812997|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
124777253|NCT01106690|448812998|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
124777254|NCT01106690|448812996|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
124777255|NCT01106690|448812997|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
124777256|NCT01106690|448812998|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
124777257|NCT01106690|448812996|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
124777258|NCT01106690|448812997|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
124777259|NCT01106690|448812998|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
124777260|NCT01106690|448812996|FG000|Core Period: Baseline to Week 26|Other|10|||
124777261|NCT01106690|448812997|FG001|Core Period: Baseline to Week 26|Other|2|||
124777262|NCT01106690|448812998|FG002|Core Period: Baseline to Week 26|Other|6|||
124777263|NCT01106690|448812996|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
124728965|NCT00920218|448630104|FG003|Overall Study|Lost to Follow-up|3|||
124728966|NCT00920218|448630101|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
124728967|NCT00920218|448630102|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
124728968|NCT00920218|448630103|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
124728969|NCT00920218|448630104|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
124728970|NCT00920218|448630101|FG000|Overall Study|Other|0|||
124728971|NCT00920218|448630102|FG001|Overall Study|Other|0|||
124728972|NCT00920218|448630103|FG002|Overall Study|Other|1|||
124531266|NCT01004861|447896348|FG010|Overall Study|Lost to Follow-up|0|||
124531267|NCT01004861|447896349|FG011|Overall Study|Lost to Follow-up|1|||
124531268|NCT01004861|447896350|FG012|Overall Study|Lost to Follow-up|0|||
124531269|NCT01004861|447896338|FG000|Overall Study|Non-compliance|0|||
124531270|NCT01004861|447896339|FG001|Overall Study|Non-compliance|0|||
124728973|NCT00920218|448630104|FG003|Overall Study|Other|0|||
124728974|NCT03224507|448630108|FG000|Overall Study|Death|3|||
124728975|NCT03224507|448630109|FG001|Overall Study|Death|0|||
124728976|NCT03224507|448630108|FG000|Overall Study|Lack of Efficacy|6|||
124728977|NCT03224507|448630109|FG001|Overall Study|Lack of Efficacy|0|||
124728978|NCT03224507|448630108|FG000|Overall Study|Withdrawal by Subject|6|||
124728979|NCT03224507|448630109|FG001|Overall Study|Withdrawal by Subject|0|||
124728980|NCT01007435|448630110|FG000|Overall Study|Adverse Event|16|||
124728981|NCT01007435|448630111|FG001|Overall Study|Adverse Event|25|||
124728982|NCT01007435|448630112|FG002|Overall Study|Adverse Event|47|||
124728983|NCT01007435|448630113|FG003|Overall Study|Adverse Event|31|||
124728984|NCT01007435|448630110|FG000|Overall Study|Death|2|||
124728985|NCT01007435|448630111|FG001|Overall Study|Death|4|||
124728986|NCT01007435|448630112|FG002|Overall Study|Death|2|||
124728987|NCT01007435|448630113|FG003|Overall Study|Death|1|||
124728988|NCT01007435|448630110|FG000|Overall Study|Insufficient Therapeutic Response|21|||
124728989|NCT01007435|448630111|FG001|Overall Study|Insufficient Therapeutic Response|7|||
124728990|NCT01007435|448630112|FG002|Overall Study|Insufficient Therapeutic Response|2|||
124728991|NCT01007435|448630113|FG003|Overall Study|Insufficient Therapeutic Response|9|||
124728992|NCT01007435|448630110|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
124728993|NCT01007435|448630111|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
124728994|NCT01007435|448630112|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
124728995|NCT01007435|448630113|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
124728996|NCT01007435|448630110|FG000|Overall Study|Other Protocol Violation|2|||
124728997|NCT01007435|448630111|FG001|Overall Study|Other Protocol Violation|0|||
124728998|NCT01007435|448630112|FG002|Overall Study|Other Protocol Violation|1|||
124728999|NCT01007435|448630113|FG003|Overall Study|Other Protocol Violation|0|||
124729000|NCT01007435|448630110|FG000|Overall Study|Refused Treatment|13|||
124729001|NCT01007435|448630111|FG001|Overall Study|Refused Treatment|13|||
124729002|NCT01007435|448630112|FG002|Overall Study|Refused Treatment|5|||
124729003|NCT01007435|448630113|FG003|Overall Study|Refused Treatment|8|||
124729004|NCT01007435|448630110|FG000|Overall Study|Failure to Return|5|||
124729005|NCT01007435|448630111|FG001|Overall Study|Failure to Return|4|||
124729006|NCT01007435|448630112|FG002|Overall Study|Failure to Return|3|||
124729007|NCT01007435|448630113|FG003|Overall Study|Failure to Return|6|||
124729008|NCT01007435|448630110|FG000|Overall Study|Reason not Specified|1|||
124729009|NCT01007435|448630111|FG001|Overall Study|Reason not Specified|1|||
124729010|NCT01007435|448630112|FG002|Overall Study|Reason not Specified|2|||
124729011|NCT01007435|448630113|FG003|Overall Study|Reason not Specified|1|||
124729012|NCT01345591|448630116|FG000|Overall Study|Lost to Follow-up|1|||
124729013|NCT00847665|448630123|FG000|Overall Study|Withdrawal by Subject|1|||
124729014|NCT00847665|448630124|FG001|Overall Study|Withdrawal by Subject|0|||
124729015|NCT00624585|448630125|FG000|Overall Study|Death|3|||
124729016|NCT00624585|448630125|FG000|Overall Study|Disease Progression|6|||
124729017|NCT00624585|448630125|FG000|Overall Study|Adverse Event|3|||
124729018|NCT00676520|448630129|FG000|Overall Study|Withdrawal by Subject|163|||
124729019|NCT00676520|448630129|FG000|Overall Study|Lost to Follow-up|162|||
124729020|NCT00676520|448630129|FG000|Overall Study|Death|159|||
124531271|NCT01004861|447896340|FG002|Overall Study|Non-compliance|0|||
124531272|NCT01004861|447896341|FG003|Overall Study|Non-compliance|0|||
124531273|NCT01004861|447896342|FG004|Overall Study|Non-compliance|0|||
124531274|NCT01004861|447896343|FG005|Overall Study|Non-compliance|0|||
124531275|NCT01004861|447896344|FG006|Overall Study|Non-compliance|0|||
124531276|NCT01004861|447896345|FG007|Overall Study|Non-compliance|0|||
124531277|NCT01004861|447896346|FG008|Overall Study|Non-compliance|5|||
124531278|NCT01004861|447896347|FG009|Overall Study|Non-compliance|0|||
124531279|NCT01004861|447896348|FG010|Overall Study|Non-compliance|0|||
124531280|NCT01004861|447896349|FG011|Overall Study|Non-compliance|0|||
124531281|NCT01004861|447896350|FG012|Overall Study|Non-compliance|1|||
124729021|NCT00676520|448630129|FG000|Overall Study|Physician Decision|20|||
124729022|NCT00676520|448630129|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
124777264|NCT01106690|448812997|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
124777265|NCT01106690|448812998|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
124531282|NCT01004861|447896338|FG000|Overall Study|Other|0|||
124729023|NCT00676520|448630129|FG000|Overall Study|Other Reason|18|||
124584091|NCT00112437|448095890|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584092|NCT00112437|448095891|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584093|NCT00112437|448095892|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584094|NCT00112437|448095893|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584095|NCT00112437|448095894|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584096|NCT00112437|448095895|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
124584097|NCT00112437|448095896|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
124584098|NCT00112437|448095897|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584099|NCT00112437|448095898|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584100|NCT00112437|448095899|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584101|NCT00112437|448095900|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584102|NCT00112437|448095901|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584103|NCT00112437|448095902|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584104|NCT00112437|448095903|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584105|NCT00112437|448095904|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584106|NCT00112437|448095905|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584107|NCT00112437|448095906|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584108|NCT00112437|448095907|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584109|NCT00112437|448095908|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584110|NCT00112437|448095909|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584111|NCT00112437|448095910|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
124584112|NCT00112437|448095885|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584113|NCT00112437|448095886|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584114|NCT00112437|448095887|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584115|NCT00112437|448095888|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584116|NCT00112437|448095889|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584117|NCT00112437|448095890|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584118|NCT00112437|448095891|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584119|NCT00112437|448095892|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584120|NCT00112437|448095893|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584121|NCT00112437|448095894|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584122|NCT00112437|448095895|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584123|NCT00112437|448095896|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584124|NCT00112437|448095897|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584125|NCT00112437|448095898|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584126|NCT00112437|448095899|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584127|NCT00112437|448095900|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584128|NCT00112437|448095901|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584129|NCT00112437|448095902|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584130|NCT00112437|448095903|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584131|NCT00112437|448095904|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584132|NCT00112437|448095905|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
124584133|NCT00112437|448095906|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
124584134|NCT00112437|448095907|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124531283|NCT01004861|447896339|FG001|Overall Study|Other|0|||
124531284|NCT01004861|447896340|FG002|Overall Study|Other|0|||
124531285|NCT01004861|447896341|FG003|Overall Study|Other|0|||
124531286|NCT01004861|447896342|FG004|Overall Study|Other|0|||
124531287|NCT01004861|447896343|FG005|Overall Study|Other|0|||
124531288|NCT01004861|447896344|FG006|Overall Study|Other|0|||
124531289|NCT01004861|447896345|FG007|Overall Study|Other|0|||
124531290|NCT01004861|447896346|FG008|Overall Study|Other|0|||
124531291|NCT01004861|447896347|FG009|Overall Study|Other|2|||
124531292|NCT01004861|447896348|FG010|Overall Study|Other|1|||
124531293|NCT01004861|447896349|FG011|Overall Study|Other|2|||
124531294|NCT01004861|447896350|FG012|Overall Study|Other|3|||
124531295|NCT01004861|447896338|FG000|Overall Study|Patient decision|0|||
124531296|NCT01004861|447896339|FG001|Overall Study|Patient decision|0|||
124531297|NCT01004861|447896340|FG002|Overall Study|Patient decision|0|||
124531298|NCT01004861|447896341|FG003|Overall Study|Patient decision|0|||
124531299|NCT01004861|447896342|FG004|Overall Study|Patient decision|1|||
124531300|NCT01004861|447896343|FG005|Overall Study|Patient decision|0|||
124531301|NCT01004861|447896344|FG006|Overall Study|Patient decision|1|||
124531302|NCT01004861|447896345|FG007|Overall Study|Patient decision|0|||
124531303|NCT01004861|447896346|FG008|Overall Study|Patient decision|7|||
124531304|NCT01004861|447896347|FG009|Overall Study|Patient decision|1|||
124531305|NCT01004861|447896348|FG010|Overall Study|Patient decision|1|||
124531306|NCT01004861|447896349|FG011|Overall Study|Patient decision|2|||
124531307|NCT01004861|447896350|FG012|Overall Study|Patient decision|3|||
124531308|NCT01004861|447896338|FG000|Overall Study|Transitioned to Phase 4 study|0|||
124531309|NCT01004861|447896339|FG001|Overall Study|Transitioned to Phase 4 study|0|||
124777266|NCT01106690|448812996|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
124777267|NCT01106690|448812997|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
124729024|NCT01425359|448630130|FG000|Overall Study|Randomized but Not Treated|2|||
124729025|NCT01425359|448630131|FG001|Overall Study|Randomized but Not Treated|3|||
124729026|NCT01425359|448630130|FG000|Overall Study|Adverse Event|9|||
124729027|NCT01425359|448630131|FG001|Overall Study|Adverse Event|8|||
124729028|NCT01425359|448630130|FG000|Overall Study|Revascularization|0|||
124729029|NCT01425359|448630131|FG001|Overall Study|Revascularization|1|||
124729030|NCT01425359|448630130|FG000|Overall Study|Death|0|||
124729031|NCT01425359|448630131|FG001|Overall Study|Death|1|||
124729032|NCT01425359|448630130|FG000|Overall Study|Unsatisfactory Response|1|||
124729033|NCT01425359|448630131|FG001|Overall Study|Unsatisfactory Response|0|||
124729034|NCT01425359|448630130|FG000|Overall Study|Protocol Violation|1|||
124729035|NCT01425359|448630131|FG001|Overall Study|Protocol Violation|2|||
124729036|NCT01425359|448630130|FG000|Overall Study|Subject Withdrew Consent|1|||
124729037|NCT01425359|448630131|FG001|Overall Study|Subject Withdrew Consent|2|||
124729038|NCT01425359|448630130|FG000|Overall Study|Investigator's Discretion|2|||
124729039|NCT01425359|448630131|FG001|Overall Study|Investigator's Discretion|0|||
124729040|NCT01425359|448630130|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
124729041|NCT01425359|448630131|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
124729042|NCT03172325|448630132|FG000|Overall Study|Adverse Event|2|||
124729043|NCT03172325|448630133|FG001|Overall Study|Adverse Event|3|||
124729044|NCT03172325|448630132|FG000|Overall Study|Positive PPD|1|||
124729045|NCT03172325|448630133|FG001|Overall Study|Positive PPD|0|||
124729046|NCT03172325|448630132|FG000|Overall Study|Poor Compliance|1|||
124729047|NCT03172325|448630133|FG001|Overall Study|Poor Compliance|1|||
124729048|NCT03305419|448630138|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
124729049|NCT03305419|448630139|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
124729050|NCT03305419|448630140|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
124729051|NCT03305419|448630141|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
124729052|NCT03305419|448630142|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
124729053|NCT03305419|448630143|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
124729054|NCT03305419|448630144|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
124729055|NCT03305419|448630145|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
124729056|NCT03305419|448630138|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
124729057|NCT03305419|448630139|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
124729058|NCT03305419|448630140|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
124729059|NCT03305419|448630141|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
124729060|NCT03305419|448630142|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
124729061|NCT03305419|448630143|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
124729062|NCT03305419|448630144|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
124729063|NCT03305419|448630145|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
124729064|NCT03305419|448630138|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
124729065|NCT03305419|448630139|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
124729066|NCT03305419|448630140|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
124729067|NCT03305419|448630141|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
124729068|NCT03305419|448630142|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
124729069|NCT03305419|448630143|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
124729070|NCT03305419|448630144|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
124729071|NCT03305419|448630145|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
124729072|NCT03305419|448630138|FG000|Part B (14 Days)|Adverse Event|0|||
124729073|NCT03305419|448630139|FG001|Part B (14 Days)|Adverse Event|0|||
124729074|NCT03305419|448630140|FG002|Part B (14 Days)|Adverse Event|0|||
124729075|NCT03305419|448630141|FG003|Part B (14 Days)|Adverse Event|0|||
124729076|NCT03305419|448630142|FG004|Part B (14 Days)|Adverse Event|1|||
124729077|NCT03305419|448630143|FG005|Part B (14 Days)|Adverse Event|2|||
124729078|NCT03305419|448630144|FG006|Part B (14 Days)|Adverse Event|4|||
124729079|NCT03305419|448630145|FG007|Part B (14 Days)|Adverse Event|0|||
124729080|NCT03305419|448630138|FG000|Part B (14 Days)|Physician Decision|0|||
124777268|NCT01106690|448812998|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
124531310|NCT01004861|447896340|FG002|Overall Study|Transitioned to Phase 4 study|0|||
124729081|NCT03305419|448630139|FG001|Part B (14 Days)|Physician Decision|0|||
124729082|NCT03305419|448630140|FG002|Part B (14 Days)|Physician Decision|0|||
124729083|NCT03305419|448630141|FG003|Part B (14 Days)|Physician Decision|0|||
124729084|NCT03305419|448630142|FG004|Part B (14 Days)|Physician Decision|2|||
124729085|NCT03305419|448630143|FG005|Part B (14 Days)|Physician Decision|8|||
124729086|NCT03305419|448630144|FG006|Part B (14 Days)|Physician Decision|1|||
124729087|NCT03305419|448630145|FG007|Part B (14 Days)|Physician Decision|0|||
124729088|NCT00075946|448630146|FG000|Overall Study|Path ineligible: undetermined histology|0|||
124729089|NCT00075946|448630147|FG001|Overall Study|Path ineligible: undetermined histology|0|||
124777269|NCT01106690|448812996|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
124584135|NCT00112437|448095908|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584136|NCT00112437|448095909|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584137|NCT00112437|448095910|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
124584138|NCT00112437|448095885|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584139|NCT00112437|448095886|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584140|NCT00112437|448095887|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584141|NCT00112437|448095888|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584142|NCT00112437|448095889|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584143|NCT00112437|448095890|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584144|NCT00112437|448095891|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584145|NCT00112437|448095892|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584146|NCT00112437|448095893|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584147|NCT00112437|448095894|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584148|NCT00112437|448095895|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584149|NCT00112437|448095896|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584150|NCT00112437|448095897|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584151|NCT00112437|448095898|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584152|NCT00112437|448095899|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584153|NCT00112437|448095900|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584154|NCT00112437|448095901|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584155|NCT00112437|448095902|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584156|NCT00112437|448095903|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584157|NCT00112437|448095904|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584158|NCT00112437|448095905|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
124584159|NCT00112437|448095906|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584160|NCT00112437|448095907|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584161|NCT00112437|448095908|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584162|NCT00112437|448095909|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584163|NCT00112437|448095910|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
124584164|NCT00112437|448095885|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584165|NCT00112437|448095886|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584166|NCT00112437|448095887|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584167|NCT00112437|448095888|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584168|NCT00112437|448095889|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584169|NCT00112437|448095890|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584170|NCT00112437|448095891|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584171|NCT00112437|448095892|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584172|NCT00112437|448095893|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584173|NCT00112437|448095894|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584174|NCT00112437|448095895|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584175|NCT00112437|448095896|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584176|NCT00112437|448095897|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584177|NCT00112437|448095898|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584178|NCT00112437|448095899|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584179|NCT00112437|448095900|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584180|NCT00112437|448095901|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584181|NCT00112437|448095902|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584182|NCT00112437|448095903|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584183|NCT00112437|448095904|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584184|NCT00112437|448095905|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584185|NCT00112437|448095906|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
124584186|NCT00112437|448095907|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584187|NCT00112437|448095908|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584188|NCT00112437|448095909|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584189|NCT00112437|448095910|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
124584190|NCT00112437|448095885|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584191|NCT00112437|448095886|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584192|NCT00112437|448095887|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584193|NCT00112437|448095888|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584194|NCT00112437|448095889|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584195|NCT00112437|448095890|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584196|NCT00112437|448095891|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584197|NCT00112437|448095892|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584198|NCT00112437|448095893|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
124729090|NCT00075946|448630148|FG002|Overall Study|Path ineligible: undetermined histology|0|||
124729091|NCT00075946|448630149|FG003|Overall Study|Path ineligible: undetermined histology|0|||
124729092|NCT00075946|448630150|FG004|Overall Study|Path ineligible: undetermined histology|6|||
124729093|NCT00075946|448630146|FG000|Overall Study|Did not achieve response after induction|0|||
124729094|NCT00075946|448630147|FG001|Overall Study|Did not achieve response after induction|0|||
124729095|NCT00075946|448630148|FG002|Overall Study|Did not achieve response after induction|0|||
124729096|NCT00075946|448630149|FG003|Overall Study|Did not achieve response after induction|0|||
124729097|NCT00075946|448630150|FG004|Overall Study|Did not achieve response after induction|182|||
124729098|NCT00075946|448630146|FG000|Overall Study|Incorrectly randomized (no response)|5|||
124729099|NCT00075946|448630147|FG001|Overall Study|Incorrectly randomized (no response)|5|||
124729100|NCT00075946|448630148|FG002|Overall Study|Incorrectly randomized (no response)|5|||
124729101|NCT00075946|448630149|FG003|Overall Study|Incorrectly randomized (no response)|1|||
124729102|NCT00075946|448630150|FG004|Overall Study|Incorrectly randomized (no response)|0|||
124729103|NCT00075946|448630146|FG000|Overall Study|Adverse Event|2|||
124729104|NCT00075946|448630147|FG001|Overall Study|Adverse Event|10|||
124729105|NCT00075946|448630148|FG002|Overall Study|Adverse Event|0|||
124729106|NCT00075946|448630149|FG003|Overall Study|Adverse Event|2|||
124729107|NCT00075946|448630150|FG004|Overall Study|Adverse Event|0|||
124729108|NCT00075946|448630146|FG000|Overall Study|Death|0|||
124729109|NCT00075946|448630147|FG001|Overall Study|Death|1|||
124729110|NCT00075946|448630148|FG002|Overall Study|Death|0|||
124729111|NCT00075946|448630149|FG003|Overall Study|Death|0|||
124729112|NCT00075946|448630150|FG004|Overall Study|Death|0|||
124729113|NCT00075946|448630146|FG000|Overall Study|Withdrawal by Subject|23|||
124729114|NCT00075946|448630147|FG001|Overall Study|Withdrawal by Subject|58|||
124729115|NCT00075946|448630148|FG002|Overall Study|Withdrawal by Subject|4|||
124729116|NCT00075946|448630149|FG003|Overall Study|Withdrawal by Subject|9|||
124729117|NCT00075946|448630150|FG004|Overall Study|Withdrawal by Subject|0|||
124729118|NCT00075946|448630146|FG000|Overall Study|Alternative therapy|16|||
124729119|NCT00075946|448630147|FG001|Overall Study|Alternative therapy|2|||
124729120|NCT00075946|448630148|FG002|Overall Study|Alternative therapy|5|||
124729121|NCT00075946|448630149|FG003|Overall Study|Alternative therapy|0|||
124729122|NCT00075946|448630150|FG004|Overall Study|Alternative therapy|0|||
124729123|NCT00075946|448630146|FG000|Overall Study|Other complicating disease|7|||
124729124|NCT00075946|448630147|FG001|Overall Study|Other complicating disease|13|||
124729125|NCT00075946|448630148|FG002|Overall Study|Other complicating disease|1|||
124729126|NCT00075946|448630149|FG003|Overall Study|Other complicating disease|4|||
124729127|NCT00075946|448630150|FG004|Overall Study|Other complicating disease|0|||
124729128|NCT00075946|448630146|FG000|Overall Study|No response to retreatment|23|||
124729129|NCT00075946|448630147|FG001|Overall Study|No response to retreatment|0|||
124729130|NCT00075946|448630148|FG002|Overall Study|No response to retreatment|2|||
124729131|NCT00075946|448630149|FG003|Overall Study|No response to retreatment|0|||
124729132|NCT00075946|448630150|FG004|Overall Study|No response to retreatment|0|||
124729133|NCT00075946|448630146|FG000|Overall Study|Time to progression less than 6 months|15|||
124729134|NCT00075946|448630147|FG001|Overall Study|Time to progression less than 6 months|30|||
124729135|NCT00075946|448630148|FG002|Overall Study|Time to progression less than 6 months|8|||
124729136|NCT00075946|448630149|FG003|Overall Study|Time to progression less than 6 months|3|||
124729137|NCT00075946|448630150|FG004|Overall Study|Time to progression less than 6 months|0|||
124729138|NCT00075946|448630146|FG000|Overall Study|Other|57|||
124729139|NCT00075946|448630147|FG001|Overall Study|Other|32|||
124729140|NCT00075946|448630148|FG002|Overall Study|Other|3|||
124729141|NCT00075946|448630149|FG003|Overall Study|Other|11|||
124729142|NCT00075946|448630150|FG004|Overall Study|Other|0|||
124729143|NCT00889603|448630153|FG000|Overall Study|Adverse Event|7|||
124729144|NCT00889603|448630153|FG000|Overall Study|Death|3|||
124729145|NCT00889603|448630153|FG000|Overall Study|Lost to Follow-up|19|||
124729146|NCT00889603|448630153|FG000|Overall Study|No longer willing to participant in stud|4|||
124729147|NCT00889603|448630153|FG000|Overall Study|Other|4|||
124729148|NCT01229254|448630154|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
124729149|NCT01229254|448630155|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
124729150|NCT01229254|448630156|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
124729151|NCT01229254|448630154|FG000|Overall Study|Adverse Event|4|||
124729152|NCT01229254|448630155|FG001|Overall Study|Adverse Event|5|||
124729153|NCT01229254|448630156|FG002|Overall Study|Adverse Event|3|||
124729154|NCT01229254|448630154|FG000|Overall Study|Lost to Follow-up|3|||
124729155|NCT01229254|448630155|FG001|Overall Study|Lost to Follow-up|0|||
124729156|NCT01229254|448630156|FG002|Overall Study|Lost to Follow-up|1|||
124729157|NCT01229254|448630154|FG000|Overall Study|Physician Decision|0|||
124729158|NCT01229254|448630155|FG001|Overall Study|Physician Decision|3|||
124729159|NCT01229254|448630156|FG002|Overall Study|Physician Decision|0|||
124729160|NCT01229254|448630154|FG000|Overall Study|Protocol Violation|4|||
124729161|NCT01229254|448630155|FG001|Overall Study|Protocol Violation|6|||
124729162|NCT01229254|448630156|FG002|Overall Study|Protocol Violation|5|||
124729163|NCT01229254|448630154|FG000|Overall Study|Withdrawal by Subject|1|||
124729164|NCT01229254|448630155|FG001|Overall Study|Withdrawal by Subject|0|||
124729165|NCT01229254|448630156|FG002|Overall Study|Withdrawal by Subject|1|||
124729166|NCT01229254|448630154|FG000|Overall Study|Non-compliance with Study Drug|0|||
124729167|NCT01229254|448630155|FG001|Overall Study|Non-compliance with Study Drug|1|||
124584199|NCT00112437|448095894|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584200|NCT00112437|448095895|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584201|NCT00112437|448095896|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584202|NCT00112437|448095897|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584203|NCT00112437|448095898|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584204|NCT00112437|448095899|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584205|NCT00112437|448095900|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584206|NCT00112437|448095901|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584207|NCT00112437|448095902|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584208|NCT00112437|448095903|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584209|NCT00112437|448095904|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584210|NCT00112437|448095905|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584211|NCT00112437|448095906|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
124584212|NCT00112437|448095907|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584213|NCT00112437|448095908|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584214|NCT00112437|448095909|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584215|NCT00112437|448095910|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
124584216|NCT00112437|448095885|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584217|NCT00112437|448095886|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584218|NCT00112437|448095887|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584219|NCT00112437|448095888|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584220|NCT00112437|448095889|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584221|NCT00112437|448095890|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584222|NCT00112437|448095891|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584223|NCT00112437|448095892|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584224|NCT00112437|448095893|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584225|NCT00112437|448095894|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584226|NCT00112437|448095895|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584227|NCT00112437|448095896|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584228|NCT00112437|448095897|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584229|NCT00112437|448095898|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584230|NCT00112437|448095899|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584231|NCT00112437|448095900|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584232|NCT00112437|448095901|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584233|NCT00112437|448095902|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584234|NCT00112437|448095903|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584235|NCT00112437|448095904|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584236|NCT00112437|448095905|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
124584237|NCT00112437|448095906|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
124584238|NCT00112437|448095907|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584239|NCT00112437|448095908|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584240|NCT00112437|448095909|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584241|NCT00112437|448095910|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
124584242|NCT00112437|448095885|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584243|NCT00112437|448095886|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584244|NCT00112437|448095887|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584245|NCT00112437|448095888|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584246|NCT00112437|448095889|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584247|NCT00112437|448095890|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584248|NCT00112437|448095891|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584249|NCT00112437|448095892|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584250|NCT00112437|448095893|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584251|NCT00112437|448095894|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584252|NCT00112437|448095895|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584253|NCT00112437|448095896|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584254|NCT00112437|448095897|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584255|NCT00112437|448095898|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584256|NCT00112437|448095899|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584257|NCT00112437|448095900|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584258|NCT00112437|448095901|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584259|NCT00112437|448095902|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584260|NCT00112437|448095903|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584261|NCT00112437|448095904|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584262|NCT00112437|448095905|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584263|NCT00112437|448095906|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124584264|NCT00112437|448095907|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
124584265|NCT00112437|448095908|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
124584266|NCT00112437|448095909|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
124777270|NCT01106690|448812997|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
124777271|NCT01106690|448812998|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
124777272|NCT01106690|448812996|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
124777273|NCT01106690|448812997|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
124531311|NCT01004861|447896341|FG003|Overall Study|Transitioned to Phase 4 study|0|||
124531312|NCT01004861|447896342|FG004|Overall Study|Transitioned to Phase 4 study|0|||
124531313|NCT01004861|447896343|FG005|Overall Study|Transitioned to Phase 4 study|0|||
124531314|NCT01004861|447896344|FG006|Overall Study|Transitioned to Phase 4 study|0|||
124531315|NCT01004861|447896345|FG007|Overall Study|Transitioned to Phase 4 study|0|||
124531316|NCT01004861|447896346|FG008|Overall Study|Transitioned to Phase 4 study|2|||
124531317|NCT01004861|447896347|FG009|Overall Study|Transitioned to Phase 4 study|0|||
124531318|NCT01004861|447896348|FG010|Overall Study|Transitioned to Phase 4 study|0|||
124531319|NCT01004861|447896349|FG011|Overall Study|Transitioned to Phase 4 study|0|||
124531320|NCT01004861|447896350|FG012|Overall Study|Transitioned to Phase 4 study|0|||
124531321|NCT01004861|447896338|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
124531322|NCT01004861|447896339|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
124531323|NCT01004861|447896340|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
124531324|NCT01004861|447896341|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
124531325|NCT01004861|447896342|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
124531326|NCT01004861|447896343|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
124531327|NCT01004861|447896344|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
124531328|NCT01004861|447896345|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
124531329|NCT01004861|447896346|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
124531330|NCT01004861|447896347|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
124531331|NCT01004861|447896348|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
124531332|NCT01004861|447896349|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
124531333|NCT01004861|447896350|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
124531334|NCT01004861|447896338|FG000|Overall Study|Patient withdrew|0|||
124531335|NCT01004861|447896339|FG001|Overall Study|Patient withdrew|0|||
124531336|NCT01004861|447896340|FG002|Overall Study|Patient withdrew|0|||
124531337|NCT01004861|447896341|FG003|Overall Study|Patient withdrew|0|||
124531338|NCT01004861|447896342|FG004|Overall Study|Patient withdrew|0|||
124531339|NCT01004861|447896343|FG005|Overall Study|Patient withdrew|0|||
124531340|NCT01004861|447896344|FG006|Overall Study|Patient withdrew|0|||
124531341|NCT01004861|447896345|FG007|Overall Study|Patient withdrew|0|||
124531342|NCT01004861|447896346|FG008|Overall Study|Patient withdrew|1|||
124531343|NCT01004861|447896347|FG009|Overall Study|Patient withdrew|0|||
124531344|NCT01004861|447896348|FG010|Overall Study|Patient withdrew|0|||
124531345|NCT01004861|447896349|FG011|Overall Study|Patient withdrew|0|||
124531346|NCT01004861|447896350|FG012|Overall Study|Patient withdrew|0|||
124531347|NCT01004861|447896338|FG000|Overall Study|Surgical resection|0|||
124531348|NCT01004861|447896339|FG001|Overall Study|Surgical resection|0|||
124531349|NCT01004861|447896340|FG002|Overall Study|Surgical resection|0|||
124531350|NCT01004861|447896341|FG003|Overall Study|Surgical resection|0|||
124531351|NCT01004861|447896342|FG004|Overall Study|Surgical resection|0|||
124531352|NCT01004861|447896343|FG005|Overall Study|Surgical resection|0|||
124531353|NCT01004861|447896344|FG006|Overall Study|Surgical resection|0|||
124531354|NCT01004861|447896345|FG007|Overall Study|Surgical resection|0|||
124531355|NCT01004861|447896346|FG008|Overall Study|Surgical resection|1|||
124531356|NCT01004861|447896347|FG009|Overall Study|Surgical resection|0|||
124531357|NCT01004861|447896348|FG010|Overall Study|Surgical resection|0|||
124531358|NCT01004861|447896349|FG011|Overall Study|Surgical resection|0|||
124531359|NCT01004861|447896350|FG012|Overall Study|Surgical resection|0|||
124531360|NCT01004861|447896338|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
124531361|NCT01004861|447896339|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
124531362|NCT01004861|447896340|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
124531363|NCT01004861|447896341|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
124531364|NCT01004861|447896342|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
124531365|NCT01004861|447896343|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
124531366|NCT01004861|447896344|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
124531367|NCT01004861|447896345|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
124531368|NCT01004861|447896346|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
124531369|NCT01004861|447896347|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
124531370|NCT01004861|447896348|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
124584267|NCT00112437|448095910|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
124584268|NCT00112437|448095885|FG000|Years 6-10 (60-Month Extension)|Death|0|||
124584269|NCT00112437|448095886|FG001|Years 6-10 (60-Month Extension)|Death|0|||
124584270|NCT00112437|448095887|FG002|Years 6-10 (60-Month Extension)|Death|0|||
124584271|NCT00112437|448095888|FG003|Years 6-10 (60-Month Extension)|Death|0|||
124584272|NCT00112437|448095889|FG004|Years 6-10 (60-Month Extension)|Death|0|||
124584273|NCT00112437|448095890|FG005|Years 6-10 (60-Month Extension)|Death|0|||
124584274|NCT00112437|448095891|FG006|Years 6-10 (60-Month Extension)|Death|0|||
124584275|NCT00112437|448095892|FG007|Years 6-10 (60-Month Extension)|Death|0|||
124584276|NCT00112437|448095893|FG008|Years 6-10 (60-Month Extension)|Death|0|||
124584277|NCT00112437|448095894|FG009|Years 6-10 (60-Month Extension)|Death|0|||
124584278|NCT00112437|448095895|FG010|Years 6-10 (60-Month Extension)|Death|0|||
124584279|NCT00112437|448095896|FG011|Years 6-10 (60-Month Extension)|Death|0|||
124584280|NCT00112437|448095897|FG012|Years 6-10 (60-Month Extension)|Death|0|||
124584281|NCT00112437|448095898|FG013|Years 6-10 (60-Month Extension)|Death|0|||
124531371|NCT01004861|447896349|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
124531372|NCT01004861|447896350|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
124584282|NCT00112437|448095899|FG014|Years 6-10 (60-Month Extension)|Death|0|||
124584283|NCT00112437|448095900|FG015|Years 6-10 (60-Month Extension)|Death|0|||
124584284|NCT00112437|448095901|FG016|Years 6-10 (60-Month Extension)|Death|0|||
124584285|NCT00112437|448095902|FG017|Years 6-10 (60-Month Extension)|Death|0|||
124584286|NCT00112437|448095903|FG018|Years 6-10 (60-Month Extension)|Death|0|||
124584287|NCT00112437|448095904|FG019|Years 6-10 (60-Month Extension)|Death|0|||
124584288|NCT00112437|448095905|FG020|Years 6-10 (60-Month Extension)|Death|0|||
124584289|NCT00112437|448095906|FG021|Years 6-10 (60-Month Extension)|Death|0|||
124584290|NCT00112437|448095907|FG022|Years 6-10 (60-Month Extension)|Death|0|||
124584291|NCT00112437|448095908|FG023|Years 6-10 (60-Month Extension)|Death|2|||
124584292|NCT00112437|448095909|FG024|Years 6-10 (60-Month Extension)|Death|0|||
124584293|NCT00112437|448095910|FG025|Years 6-10 (60-Month Extension)|Death|0|||
124584294|NCT00112437|448095885|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584295|NCT00112437|448095886|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584296|NCT00112437|448095887|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584297|NCT00112437|448095888|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584298|NCT00112437|448095889|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584299|NCT00112437|448095890|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584300|NCT00112437|448095891|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584301|NCT00112437|448095892|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584302|NCT00112437|448095893|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584303|NCT00112437|448095894|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584304|NCT00112437|448095895|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584305|NCT00112437|448095896|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584306|NCT00112437|448095897|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584307|NCT00112437|448095898|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584308|NCT00112437|448095899|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584309|NCT00112437|448095900|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584310|NCT00112437|448095901|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584311|NCT00112437|448095902|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584312|NCT00112437|448095903|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584313|NCT00112437|448095904|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584314|NCT00112437|448095905|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584315|NCT00112437|448095906|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584316|NCT00112437|448095907|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584317|NCT00112437|448095908|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584318|NCT00112437|448095909|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
124584319|NCT00112437|448095910|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
124584320|NCT00112437|448095885|FG000|Years 6-10 (60-Month Extension)|Other|0|||
124729168|NCT01229254|448630156|FG002|Overall Study|Non-compliance with Study Drug|1|||
124729169|NCT02231892|448630157|FG000|Overall Study|Lost to Follow-up|1|||
124729170|NCT02231892|448630158|FG001|Overall Study|Lost to Follow-up|0|||
124729171|NCT02231892|448630159|FG002|Overall Study|Lost to Follow-up|3|||
124531373|NCT01004861|447896338|FG000|Overall Study|Study termination by Sponsor|0|||
124531374|NCT01004861|447896339|FG001|Overall Study|Study termination by Sponsor|0|||
124531375|NCT01004861|447896340|FG002|Overall Study|Study termination by Sponsor|0|||
124531376|NCT01004861|447896341|FG003|Overall Study|Study termination by Sponsor|0|||
124531377|NCT01004861|447896342|FG004|Overall Study|Study termination by Sponsor|0|||
124531378|NCT01004861|447896343|FG005|Overall Study|Study termination by Sponsor|0|||
124531379|NCT01004861|447896344|FG006|Overall Study|Study termination by Sponsor|0|||
124531380|NCT01004861|447896345|FG007|Overall Study|Study termination by Sponsor|0|||
124531381|NCT01004861|447896346|FG008|Overall Study|Study termination by Sponsor|1|||
124584321|NCT00112437|448095886|FG001|Years 6-10 (60-Month Extension)|Other|0|||
124584322|NCT00112437|448095887|FG002|Years 6-10 (60-Month Extension)|Other|0|||
124584323|NCT00112437|448095888|FG003|Years 6-10 (60-Month Extension)|Other|0|||
124584324|NCT00112437|448095889|FG004|Years 6-10 (60-Month Extension)|Other|0|||
124531382|NCT01004861|447896347|FG009|Overall Study|Study termination by Sponsor|0|||
124531383|NCT01004861|447896348|FG010|Overall Study|Study termination by Sponsor|0|||
124531384|NCT01004861|447896349|FG011|Overall Study|Study termination by Sponsor|0|||
124531385|NCT01004861|447896350|FG012|Overall Study|Study termination by Sponsor|0|||
124531386|NCT00003389|447896351|FG000|Overall Study|Disease progression|6|||
124531387|NCT00003389|447896352|FG001|Overall Study|Disease progression|1|||
124531388|NCT00003389|447896351|FG000|Overall Study|Adverse Event|13|||
124531389|NCT00003389|447896352|FG001|Overall Study|Adverse Event|2|||
124531390|NCT00003389|447896351|FG000|Overall Study|Death|0|||
124531391|NCT00003389|447896352|FG001|Overall Study|Death|3|||
124531392|NCT00003389|447896351|FG000|Overall Study|Withdrawal by Subject|12|||
124531393|NCT00003389|447896352|FG001|Overall Study|Withdrawal by Subject|5|||
124531394|NCT00003389|447896351|FG000|Overall Study|Alternative therapy|2|||
124531395|NCT00003389|447896352|FG001|Overall Study|Alternative therapy|1|||
124531396|NCT00003389|447896351|FG000|Overall Study|Complicating disease|1|||
124531397|NCT00003389|447896352|FG001|Overall Study|Complicating disease|0|||
124531398|NCT00003389|447896351|FG000|Overall Study|Off-treatment reason missing|31|||
124531399|NCT00003389|447896352|FG001|Overall Study|Off-treatment reason missing|21|||
124531400|NCT00003389|447896351|FG000|Overall Study|Ineligible|33|||
124531401|NCT00003389|447896352|FG001|Overall Study|Ineligible|27|||
124531402|NCT00686699|447896353|FG000|Treatment Period 1|Adverse Event|0|||
124531403|NCT00686699|447896354|FG001|Treatment Period 1|Adverse Event|2|||
124531404|NCT04610827|447896355|FG000|Overall Study|Withdrawal by Subject|1|||
124531405|NCT04610827|447896356|FG001|Overall Study|Withdrawal by Subject|1|||
124531406|NCT04610827|447896357|FG002|Overall Study|Withdrawal by Subject|0|||
124531407|NCT01997892|447896361|FG000|Overall Study|Physician Decision|2|||
124531408|NCT01997892|447896361|FG000|Overall Study|Lost to Follow-up|6|||
124531409|NCT01997892|447896361|FG000|Overall Study|Death|14|||
124531410|NCT01997892|447896361|FG000|Overall Study|Renal transplant|8|||
124531411|NCT01997892|447896361|FG000|Overall Study|Other|3|||
124531412|NCT01997892|447896361|FG000|Overall Study|Study completion data not recorded|35|||
124531413|NCT02710422|447896362|FG000|Overall Study|Termination of study|9|||
124531414|NCT02710422|447896363|FG001|Overall Study|Termination of study|9|||
124531415|NCT02608099|447896367|FG000|Overall Study|Ablation procedure not initiated|3|||
124531416|NCT02608099|447896368|FG001|Overall Study|Ablation procedure not initiated|2|||
124531417|NCT04657003|447896372|FG000|Overall Study|Adverse Event|5|||
124531418|NCT04657003|447896373|FG001|Overall Study|Adverse Event|1|||
124531419|NCT04657003|447896374|FG002|Overall Study|Adverse Event|5|||
124531420|NCT04657003|447896372|FG000|Overall Study|Death|0|||
124531421|NCT04657003|447896373|FG001|Overall Study|Death|2|||
124531422|NCT04657003|447896374|FG002|Overall Study|Death|0|||
124531423|NCT04657003|447896372|FG000|Overall Study|Lost to Follow-up|8|||
124531424|NCT04657003|447896373|FG001|Overall Study|Lost to Follow-up|4|||
124531425|NCT04657003|447896374|FG002|Overall Study|Lost to Follow-up|10|||
124531426|NCT04657003|447896372|FG000|Overall Study|Other - As Reported by Investigator|3|||
124531427|NCT04657003|447896373|FG001|Overall Study|Other - As Reported by Investigator|2|||
124531428|NCT04657003|447896374|FG002|Overall Study|Other - As Reported by Investigator|2|||
124531429|NCT04657003|447896372|FG000|Overall Study|Pregnancy|2|||
124531430|NCT04657003|447896373|FG001|Overall Study|Pregnancy|0|||
124531431|NCT04657003|447896374|FG002|Overall Study|Pregnancy|2|||
124531432|NCT04657003|447896372|FG000|Overall Study|Withdrawal by Subject|16|||
124531433|NCT04657003|447896373|FG001|Overall Study|Withdrawal by Subject|7|||
124531434|NCT04657003|447896374|FG002|Overall Study|Withdrawal by Subject|10|||
124584325|NCT00112437|448095890|FG005|Years 6-10 (60-Month Extension)|Other|0|||
124584326|NCT00112437|448095891|FG006|Years 6-10 (60-Month Extension)|Other|0|||
124584327|NCT00112437|448095892|FG007|Years 6-10 (60-Month Extension)|Other|0|||
124584328|NCT00112437|448095893|FG008|Years 6-10 (60-Month Extension)|Other|0|||
124584329|NCT00112437|448095894|FG009|Years 6-10 (60-Month Extension)|Other|0|||
124584330|NCT00112437|448095895|FG010|Years 6-10 (60-Month Extension)|Other|0|||
124584331|NCT00112437|448095896|FG011|Years 6-10 (60-Month Extension)|Other|0|||
124584332|NCT00112437|448095897|FG012|Years 6-10 (60-Month Extension)|Other|0|||
124584333|NCT00112437|448095898|FG013|Years 6-10 (60-Month Extension)|Other|0|||
124584334|NCT00112437|448095899|FG014|Years 6-10 (60-Month Extension)|Other|0|||
124584335|NCT00112437|448095900|FG015|Years 6-10 (60-Month Extension)|Other|0|||
124584336|NCT00112437|448095901|FG016|Years 6-10 (60-Month Extension)|Other|0|||
124584337|NCT00112437|448095902|FG017|Years 6-10 (60-Month Extension)|Other|0|||
124584338|NCT00112437|448095903|FG018|Years 6-10 (60-Month Extension)|Other|0|||
124584339|NCT00112437|448095904|FG019|Years 6-10 (60-Month Extension)|Other|0|||
124531435|NCT00768040|447896377|FG000|Overall Study|Adverse Event|3|||
124531436|NCT00768040|447896378|FG001|Overall Study|Adverse Event|2|||
124531437|NCT00768040|447896377|FG000|Overall Study|Abnormal laboratory value|1|||
124531438|NCT00768040|447896378|FG001|Overall Study|Abnormal laboratory value|1|||
124531439|NCT00417248|447896380|FG000|Overall Study|Study Terminated|6|||
124531440|NCT00417248|447896380|FG000|Overall Study|Death|1|||
124584340|NCT00112437|448095905|FG020|Years 6-10 (60-Month Extension)|Other|0|||
124584341|NCT00112437|448095906|FG021|Years 6-10 (60-Month Extension)|Other|0|||
124584342|NCT00112437|448095907|FG022|Years 6-10 (60-Month Extension)|Other|0|||
124584343|NCT00112437|448095908|FG023|Years 6-10 (60-Month Extension)|Other|0|||
124777274|NCT01106690|448812998|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
124777275|NCT01106690|448812996|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
124777276|NCT01106690|448812997|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
124777277|NCT01106690|448812998|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
124777278|NCT01106690|448812996|FG000|Extension Period: Week 26 to Week 52|Other|8|||
124777279|NCT01106690|448812997|FG001|Extension Period: Week 26 to Week 52|Other|3|||
124777280|NCT01106690|448812998|FG002|Extension Period: Week 26 to Week 52|Other|4|||
124777281|NCT01106690|448812996|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
124777282|NCT01106690|448812997|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
124777283|NCT01106690|448812998|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
124777284|NCT02863419|448812999|FG000|Overall Study|Lost to Follow-up|0|||
124777285|NCT02863419|448813000|FG001|Overall Study|Lost to Follow-up|1|||
124777286|NCT02863419|448813001|FG002|Overall Study|Lost to Follow-up|4|||
124777287|NCT02863419|448812999|FG000|Overall Study|Withdrawal by Subject|5|||
124777288|NCT02863419|448813000|FG001|Overall Study|Withdrawal by Subject|5|||
124777289|NCT02863419|448813001|FG002|Overall Study|Withdrawal by Subject|3|||
124777290|NCT02863419|448812999|FG000|Overall Study|Died|3|||
124777291|NCT02863419|448813000|FG001|Overall Study|Died|4|||
124777292|NCT02863419|448813001|FG002|Overall Study|Died|1|||
124777293|NCT02454517|448813015|FG000|Overall Study|Withdrawal by Subject|3|||
124777294|NCT02454517|448813016|FG001|Overall Study|Withdrawal by Subject|0|||
124777295|NCT02454517|448813015|FG000|Overall Study|Lost to Follow-up|4|||
124777296|NCT02454517|448813016|FG001|Overall Study|Lost to Follow-up|7|||
124777297|NCT02454517|448813015|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
124777298|NCT02454517|448813016|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
124777299|NCT01189032|448813017|FG000|Overall Study|Adverse Event|1|||
124777300|NCT01189032|448813018|FG001|Overall Study|Adverse Event|3|||
124777301|NCT01189032|448813019|FG002|Overall Study|Adverse Event|4|||
124777302|NCT01189032|448813017|FG000|Overall Study|Lack of Efficacy|2|||
124777303|NCT01189032|448813018|FG001|Overall Study|Lack of Efficacy|3|||
124777304|NCT01189032|448813019|FG002|Overall Study|Lack of Efficacy|0|||
124777305|NCT01189032|448813017|FG000|Overall Study|Withdrawal by Subject|1|||
124777306|NCT01189032|448813018|FG001|Overall Study|Withdrawal by Subject|0|||
124777307|NCT01189032|448813019|FG002|Overall Study|Withdrawal by Subject|1|||
124777308|NCT01189032|448813017|FG000|Overall Study|Protocol Violation|1|||
124777309|NCT01189032|448813018|FG001|Overall Study|Protocol Violation|1|||
124777310|NCT01189032|448813019|FG002|Overall Study|Protocol Violation|1|||
124777311|NCT00473382|448813020|FG000|Core Study|Adverse Event|3|||
124777312|NCT00473382|448813021|FG001|Core Study|Adverse Event|1|||
124777313|NCT00473382|448813022|FG002|Core Study|Adverse Event|1|||
124777314|NCT00473382|448813020|FG000|Core Study|Death|3|||
124777315|NCT00473382|448813021|FG001|Core Study|Death|5|||
124777316|NCT00473382|448813022|FG002|Core Study|Death|10|||
124531441|NCT00417248|447896380|FG000|Overall Study|Lack of Efficacy|1|||
124777317|NCT00473382|448813020|FG000|Core Study|Lost to Follow-up|3|||
124777318|NCT00473382|448813021|FG001|Core Study|Lost to Follow-up|3|||
124777319|NCT00473382|448813022|FG002|Core Study|Lost to Follow-up|3|||
124777320|NCT00473382|448813020|FG000|Core Study|Physician Decision|1|||
124777321|NCT00473382|448813021|FG001|Core Study|Physician Decision|2|||
124777322|NCT00473382|448813022|FG002|Core Study|Physician Decision|2|||
124531442|NCT02185040|447896381|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
124531443|NCT02185040|447896382|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
124531444|NCT02185040|447896383|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
124531445|NCT02185040|447896384|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
124531446|NCT02185040|447896385|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
124531447|NCT02185040|447896386|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
124531448|NCT02185040|447896387|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
124531449|NCT02185040|447896381|FG000|Part 1 Treatment Phase|Adverse Event|1|||
124531450|NCT02185040|447896382|FG001|Part 1 Treatment Phase|Adverse Event|0|||
124531451|NCT02185040|447896383|FG002|Part 1 Treatment Phase|Adverse Event|0|||
124531452|NCT02185040|447896384|FG003|Part 1 Treatment Phase|Adverse Event|2|||
124531453|NCT02185040|447896385|FG004|Part 1 Treatment Phase|Adverse Event|3|||
124531454|NCT02185040|447896386|FG005|Part 1 Treatment Phase|Adverse Event|0|||
124531455|NCT02185040|447896387|FG006|Part 1 Treatment Phase|Adverse Event|0|||
124531456|NCT02185040|447896381|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
124531457|NCT02185040|447896382|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
124531458|NCT02185040|447896383|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
124531459|NCT02185040|447896384|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
124531460|NCT02185040|447896385|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
124777323|NCT00473382|448813020|FG000|Core Study|Subject non-compliance|5|||
124531461|NCT02185040|447896386|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
124531462|NCT02185040|447896387|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
124777324|NCT00473382|448813021|FG001|Core Study|Subject non-compliance|2|||
124777325|NCT00473382|448813022|FG002|Core Study|Subject non-compliance|1|||
124777326|NCT00473382|448813020|FG000|Core Study|Subject needed other treatment|1|||
124777327|NCT00473382|448813021|FG001|Core Study|Subject needed other treatment|3|||
124777328|NCT00473382|448813022|FG002|Core Study|Subject needed other treatment|2|||
124777329|NCT00473382|448813020|FG000|Core Study|Subject's decision|12|||
124777330|NCT00473382|448813021|FG001|Core Study|Subject's decision|11|||
124777331|NCT00473382|448813022|FG002|Core Study|Subject's decision|10|||
124531463|NCT02185040|447896381|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
124531464|NCT02185040|447896382|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
124531465|NCT02185040|447896383|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
124531466|NCT02185040|447896384|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
124531467|NCT02185040|447896385|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
124531468|NCT02185040|447896386|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
124531469|NCT02185040|447896387|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
124531470|NCT02185040|447896381|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
124531471|NCT02185040|447896382|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
124531472|NCT02185040|447896383|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
124531473|NCT02185040|447896384|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
124531474|NCT02185040|447896385|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
124531475|NCT02185040|447896386|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
124531476|NCT02185040|447896387|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
124531477|NCT02185040|447896381|FG000|Active Treatment Extension Phase|Adverse Event|0|||
124531478|NCT02185040|447896382|FG001|Active Treatment Extension Phase|Adverse Event|0|||
124531479|NCT02185040|447896383|FG002|Active Treatment Extension Phase|Adverse Event|0|||
124531480|NCT02185040|447896384|FG003|Active Treatment Extension Phase|Adverse Event|0|||
124531481|NCT02185040|447896385|FG004|Active Treatment Extension Phase|Adverse Event|0|||
124531482|NCT02185040|447896386|FG005|Active Treatment Extension Phase|Adverse Event|1|||
124531483|NCT02185040|447896387|FG006|Active Treatment Extension Phase|Adverse Event|4|||
124531484|NCT02185040|447896381|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
124531485|NCT02185040|447896382|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
124531486|NCT02185040|447896383|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
124531487|NCT02185040|447896384|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
124531488|NCT02185040|447896385|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
124531489|NCT02185040|447896386|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
124531490|NCT02185040|447896387|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
124531491|NCT02185040|447896381|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
124531492|NCT02185040|447896382|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
124531493|NCT02185040|447896383|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
124531494|NCT02185040|447896384|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
124531495|NCT02185040|447896385|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
124531496|NCT02185040|447896386|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
124531497|NCT02185040|447896387|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
124531498|NCT03347279|447896388|FG000|Overall Study|Withdrawal by Subject|8|||
124531499|NCT03347279|447896389|FG001|Overall Study|Withdrawal by Subject|15|||
124531500|NCT03347279|447896388|FG000|Overall Study|Death|0|||
124531501|NCT03347279|447896389|FG001|Overall Study|Death|2|||
124531502|NCT03347279|447896388|FG000|Overall Study|Lost to Follow-up|5|||
124531503|NCT03347279|447896389|FG001|Overall Study|Lost to Follow-up|2|||
124531504|NCT03347279|447896388|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
124531505|NCT03347279|447896389|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
124531506|NCT03818399|447896394|FG000|Overall Study|Lost to Follow-up|11|||
124531507|NCT03818399|447896394|FG000|Overall Study|Withdrawal by Subject|1|||
124531508|NCT03818399|447896394|FG000|Overall Study|Protocol Violation|2|||
124531509|NCT03557801|447896397|FG000|Overall Study|Protocol Violation|1|||
124531510|NCT03557801|447896398|FG001|Overall Study|Protocol Violation|0|||
124531511|NCT03557801|447896399|FG002|Overall Study|Protocol Violation|0|||
124531512|NCT03557801|447896397|FG000|Overall Study|Withdrawal by Subject|1|||
124531513|NCT03557801|447896398|FG001|Overall Study|Withdrawal by Subject|0|||
124531514|NCT03557801|447896399|FG002|Overall Study|Withdrawal by Subject|3|||
124531515|NCT03557801|447896397|FG000|Overall Study|Lost to Follow-up|0|||
124531516|NCT03557801|447896398|FG001|Overall Study|Lost to Follow-up|1|||
124531517|NCT03557801|447896399|FG002|Overall Study|Lost to Follow-up|0|||
124531518|NCT00535236|447896400|FG000|Overall Study|Adverse Event|1|||
124531519|NCT00535236|447896401|FG001|Overall Study|Adverse Event|0|||
124531520|NCT00535236|447896402|FG002|Overall Study|Adverse Event|9|||
124531521|NCT00535236|447896403|FG003|Overall Study|Adverse Event|3|||
124531522|NCT00535236|447896404|FG004|Overall Study|Adverse Event|3|||
124531523|NCT00535236|447896405|FG005|Overall Study|Adverse Event|0|||
124531524|NCT00535236|447896406|FG006|Overall Study|Adverse Event|5|||
124531525|NCT00535236|447896407|FG007|Overall Study|Adverse Event|1|||
124531526|NCT00535236|447896408|FG008|Overall Study|Adverse Event|2|||
124531527|NCT00535236|447896409|FG009|Overall Study|Adverse Event|1|||
124531528|NCT00535236|447896400|FG000|Overall Study|Lost to Follow-up|1|||
124531529|NCT00535236|447896401|FG001|Overall Study|Lost to Follow-up|2|||
124531530|NCT00535236|447896402|FG002|Overall Study|Lost to Follow-up|0|||
124531531|NCT00535236|447896403|FG003|Overall Study|Lost to Follow-up|0|||
124777332|NCT00473382|448813020|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
124777333|NCT00473382|448813021|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
124777334|NCT00473382|448813022|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
124777335|NCT00473382|448813020|FG000|Open-label Extension Through Month 48|Death|1|||
124777336|NCT00473382|448813021|FG001|Open-label Extension Through Month 48|Death|3|||
124777337|NCT00473382|448813022|FG002|Open-label Extension Through Month 48|Death|3|||
124777338|NCT00473382|448813020|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
124777339|NCT00473382|448813021|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
124777340|NCT00473382|448813022|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
124777341|NCT00473382|448813020|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
124777342|NCT00473382|448813021|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
124777343|NCT00473382|448813022|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
124531532|NCT00535236|447896404|FG004|Overall Study|Lost to Follow-up|2|||
124531533|NCT00535236|447896405|FG005|Overall Study|Lost to Follow-up|0|||
124584344|NCT00112437|448095909|FG024|Years 6-10 (60-Month Extension)|Other|1|||
124531534|NCT00535236|447896406|FG006|Overall Study|Lost to Follow-up|0|||
124531535|NCT00535236|447896407|FG007|Overall Study|Lost to Follow-up|0|||
124531536|NCT00535236|447896408|FG008|Overall Study|Lost to Follow-up|6|||
124531537|NCT00535236|447896409|FG009|Overall Study|Lost to Follow-up|1|||
124531538|NCT00535236|447896400|FG000|Overall Study|Physician Decision|0|||
124531539|NCT00535236|447896401|FG001|Overall Study|Physician Decision|0|||
124531540|NCT00535236|447896402|FG002|Overall Study|Physician Decision|0|||
124531541|NCT00535236|447896403|FG003|Overall Study|Physician Decision|0|||
124531542|NCT00535236|447896404|FG004|Overall Study|Physician Decision|1|||
124531543|NCT00535236|447896405|FG005|Overall Study|Physician Decision|0|||
124531544|NCT00535236|447896406|FG006|Overall Study|Physician Decision|1|||
124531545|NCT00535236|447896407|FG007|Overall Study|Physician Decision|0|||
124531546|NCT00535236|447896408|FG008|Overall Study|Physician Decision|0|||
124531547|NCT00535236|447896409|FG009|Overall Study|Physician Decision|0|||
124531548|NCT00535236|447896400|FG000|Overall Study|Protocol Violation|2|||
124531549|NCT00535236|447896401|FG001|Overall Study|Protocol Violation|0|||
124531550|NCT00535236|447896402|FG002|Overall Study|Protocol Violation|1|||
124531551|NCT00535236|447896403|FG003|Overall Study|Protocol Violation|0|||
124531552|NCT00535236|447896404|FG004|Overall Study|Protocol Violation|0|||
124531553|NCT00535236|447896405|FG005|Overall Study|Protocol Violation|0|||
124531554|NCT00535236|447896406|FG006|Overall Study|Protocol Violation|0|||
124531555|NCT00535236|447896407|FG007|Overall Study|Protocol Violation|0|||
124531556|NCT00535236|447896408|FG008|Overall Study|Protocol Violation|1|||
124531557|NCT00535236|447896409|FG009|Overall Study|Protocol Violation|0|||
124531558|NCT00535236|447896400|FG000|Overall Study|Withdrawal by Subject|3|||
124531559|NCT00535236|447896401|FG001|Overall Study|Withdrawal by Subject|0|||
124531560|NCT00535236|447896402|FG002|Overall Study|Withdrawal by Subject|2|||
124531561|NCT00535236|447896403|FG003|Overall Study|Withdrawal by Subject|1|||
124531562|NCT00535236|447896404|FG004|Overall Study|Withdrawal by Subject|6|||
124531563|NCT00535236|447896405|FG005|Overall Study|Withdrawal by Subject|1|||
124531564|NCT00535236|447896406|FG006|Overall Study|Withdrawal by Subject|5|||
124531565|NCT00535236|447896407|FG007|Overall Study|Withdrawal by Subject|0|||
124531566|NCT00535236|447896408|FG008|Overall Study|Withdrawal by Subject|4|||
124531567|NCT00535236|447896409|FG009|Overall Study|Withdrawal by Subject|2|||
124531568|NCT00141297|447896411|FG000|Overall Study|Adverse Event|0|||
124531569|NCT00141297|447896412|FG001|Overall Study|Adverse Event|0|||
124531570|NCT00141297|447896413|FG002|Overall Study|Adverse Event|1|||
124531571|NCT00141297|447896414|FG003|Overall Study|Adverse Event|0|||
124531572|NCT00141297|447896415|FG004|Overall Study|Adverse Event|1|||
124531573|NCT00141297|447896416|FG005|Overall Study|Adverse Event|1|||
124531574|NCT00141297|447896417|FG006|Overall Study|Adverse Event|0|||
124531575|NCT00141297|447896418|FG007|Overall Study|Adverse Event|1|||
124531576|NCT00141297|447896419|FG008|Overall Study|Adverse Event|1|||
124531577|NCT00141297|447896420|FG009|Overall Study|Adverse Event|0|||
124531578|NCT00141297|447896411|FG000|Overall Study|Death|1|||
124531579|NCT00141297|447896412|FG001|Overall Study|Death|0|||
124531580|NCT00141297|447896413|FG002|Overall Study|Death|0|||
124531581|NCT00141297|447896414|FG003|Overall Study|Death|0|||
124531582|NCT00141297|447896415|FG004|Overall Study|Death|0|||
124531583|NCT00141297|447896416|FG005|Overall Study|Death|0|||
124584345|NCT00112437|448095910|FG025|Years 6-10 (60-Month Extension)|Other|0|||
124531584|NCT00141297|447896417|FG006|Overall Study|Death|0|||
124531585|NCT00141297|447896418|FG007|Overall Study|Death|0|||
124584346|NCT00112437|448095885|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124531586|NCT00141297|447896419|FG008|Overall Study|Death|1|||
124531587|NCT00141297|447896420|FG009|Overall Study|Death|0|||
124531588|NCT00141297|447896411|FG000|Overall Study|Withdrawal by Subject|0|||
124531589|NCT00141297|447896412|FG001|Overall Study|Withdrawal by Subject|0|||
124531590|NCT00141297|447896413|FG002|Overall Study|Withdrawal by Subject|0|||
124531591|NCT00141297|447896414|FG003|Overall Study|Withdrawal by Subject|0|||
124531592|NCT00141297|447896415|FG004|Overall Study|Withdrawal by Subject|0|||
124531593|NCT00141297|447896416|FG005|Overall Study|Withdrawal by Subject|0|||
124777344|NCT00473382|448813020|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
124777345|NCT00473382|448813021|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
124777346|NCT00473382|448813022|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
124777347|NCT00473382|448813020|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
124777348|NCT00473382|448813021|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
124777349|NCT00473382|448813022|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
124777350|NCT00473382|448813020|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
124777351|NCT00473382|448813021|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
124777352|NCT00473382|448813022|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
124777353|NCT00473382|448813020|FG000|Open-label Extension Through Month 60|Death|1|||
124777354|NCT00473382|448813021|FG001|Open-label Extension Through Month 60|Death|7|||
124584347|NCT00112437|448095886|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584348|NCT00112437|448095887|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584349|NCT00112437|448095888|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584350|NCT00112437|448095889|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584351|NCT00112437|448095890|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584352|NCT00112437|448095891|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584353|NCT00112437|448095892|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584354|NCT00112437|448095893|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584355|NCT00112437|448095894|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584356|NCT00112437|448095895|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584357|NCT00112437|448095896|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584358|NCT00112437|448095897|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584359|NCT00112437|448095898|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584360|NCT00112437|448095899|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584361|NCT00112437|448095900|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584362|NCT00112437|448095901|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584363|NCT00112437|448095902|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584364|NCT00112437|448095903|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584365|NCT00112437|448095904|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584366|NCT00112437|448095905|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584367|NCT00112437|448095906|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584368|NCT00112437|448095907|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584369|NCT00112437|448095908|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
124584370|NCT00112437|448095909|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584371|NCT00112437|448095910|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
124584372|NCT00112437|448095885|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584373|NCT00112437|448095886|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584374|NCT00112437|448095887|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584375|NCT00112437|448095888|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584376|NCT00112437|448095889|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584377|NCT00112437|448095890|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584378|NCT00112437|448095891|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584379|NCT00112437|448095892|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584380|NCT00112437|448095893|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584381|NCT00112437|448095894|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584382|NCT00112437|448095895|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584383|NCT00112437|448095896|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584384|NCT00112437|448095897|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584385|NCT00112437|448095898|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584386|NCT00112437|448095899|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584387|NCT00112437|448095900|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124777355|NCT00473382|448813022|FG002|Open-label Extension Through Month 60|Death|4|||
124777356|NCT00473382|448813020|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
124777357|NCT00473382|448813021|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
124777358|NCT00473382|448813022|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
124777359|NCT00473382|448813020|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
124584388|NCT00112437|448095901|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584389|NCT00112437|448095902|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584390|NCT00112437|448095903|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584391|NCT00112437|448095904|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584392|NCT00112437|448095905|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584393|NCT00112437|448095906|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584394|NCT00112437|448095907|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
124584395|NCT00112437|448095908|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
124584396|NCT00112437|448095909|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
124584397|NCT00112437|448095910|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
124584398|NCT01960296|448095911|FG000|Overall Study|Postponed surgery|1|||
124584399|NCT01960296|448095912|FG001|Overall Study|Postponed surgery|0|||
124584400|NCT01960296|448095911|FG000|Overall Study|Received different procedure|1|||
124584401|NCT01960296|448095912|FG001|Overall Study|Received different procedure|3|||
124584402|NCT02003391|448095913|FG000|Overall Study|Withdrawal by Subject|2|||
124584403|NCT02003391|448095914|FG001|Overall Study|Withdrawal by Subject|1|||
124584404|NCT02003391|448095913|FG000|Overall Study|Protocol Violation|0|||
124584405|NCT02003391|448095914|FG001|Overall Study|Protocol Violation|1|||
124584406|NCT02003391|448095913|FG000|Overall Study|Adverse Event|1|||
124584407|NCT02003391|448095914|FG001|Overall Study|Adverse Event|0|||
124584408|NCT02272803|448095915|FG000|Overall Study|Disease progression|16|||
124584409|NCT02272803|448095916|FG001|Overall Study|Disease progression|8|||
124584410|NCT02272803|448095915|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
124584411|NCT02272803|448095916|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
124584412|NCT02272803|448095915|FG000|Overall Study|Study drug toxicity|4|||
124584413|NCT02272803|448095916|FG001|Overall Study|Study drug toxicity|9|||
124584414|NCT02272803|448095915|FG000|Overall Study|Participant request to discontinue study treatment|3|||
124584415|NCT02272803|448095916|FG001|Overall Study|Participant request to discontinue study treatment|7|||
124584416|NCT02272803|448095915|FG000|Overall Study|Maximum clinical benefit|4|||
124584417|NCT02272803|448095916|FG001|Overall Study|Maximum clinical benefit|2|||
124584418|NCT02272803|448095915|FG000|Overall Study|Poor/non-compliance|2|||
124584419|NCT02272803|448095916|FG001|Overall Study|Poor/non-compliance|2|||
124584420|NCT02272803|448095915|FG000|Overall Study|Withdrawal by Subject|2|||
124584421|NCT02272803|448095916|FG001|Overall Study|Withdrawal by Subject|1|||
124584422|NCT02272803|448095915|FG000|Overall Study|Death|0|||
124584423|NCT02272803|448095916|FG001|Overall Study|Death|1|||
124584424|NCT02272803|448095915|FG000|Overall Study|Other reasons|1|||
124584425|NCT02272803|448095916|FG001|Overall Study|Other reasons|3|||
124584426|NCT02272803|448095915|FG000|Overall Study|Administrative reason by sponsor|5|||
124584427|NCT02272803|448095916|FG001|Overall Study|Administrative reason by sponsor|4|||
124584428|NCT03573544|448095917|FG000|Overall Study|Adverse Event|0|||
124584429|NCT03573544|448095918|FG001|Overall Study|Adverse Event|0|||
124584430|NCT03573544|448095919|FG002|Overall Study|Adverse Event|0|||
124584431|NCT03573544|448095920|FG003|Overall Study|Adverse Event|3|||
124584432|NCT03573544|448095921|FG004|Overall Study|Adverse Event|1|||
124584433|NCT03573544|448095922|FG005|Overall Study|Adverse Event|0|||
124584434|NCT03573544|448095923|FG006|Overall Study|Adverse Event|2|||
124584435|NCT03573544|448095924|FG007|Overall Study|Adverse Event|0|||
124584436|NCT03573544|448095917|FG000|Overall Study|Physician Decision|0|||
124584437|NCT03573544|448095918|FG001|Overall Study|Physician Decision|0|||
124584438|NCT03573544|448095919|FG002|Overall Study|Physician Decision|0|||
124584439|NCT03573544|448095920|FG003|Overall Study|Physician Decision|0|||
124584440|NCT03573544|448095921|FG004|Overall Study|Physician Decision|0|||
124584441|NCT03573544|448095922|FG005|Overall Study|Physician Decision|0|||
124584442|NCT03573544|448095923|FG006|Overall Study|Physician Decision|1|||
124584443|NCT03573544|448095924|FG007|Overall Study|Physician Decision|0|||
124584444|NCT03573544|448095917|FG000|Overall Study|Withdrawal by Subject|2|||
124584445|NCT03573544|448095918|FG001|Overall Study|Withdrawal by Subject|0|||
124584446|NCT03573544|448095919|FG002|Overall Study|Withdrawal by Subject|0|||
124584447|NCT03573544|448095920|FG003|Overall Study|Withdrawal by Subject|1|||
124584448|NCT03573544|448095921|FG004|Overall Study|Withdrawal by Subject|1|||
124584449|NCT03573544|448095922|FG005|Overall Study|Withdrawal by Subject|1|||
124584450|NCT03573544|448095923|FG006|Overall Study|Withdrawal by Subject|0|||
124584451|NCT03573544|448095924|FG007|Overall Study|Withdrawal by Subject|1|||
124584452|NCT03573544|448095917|FG000|Overall Study|Disease progression|3|||
124584453|NCT03573544|448095918|FG001|Overall Study|Disease progression|3|||
124584454|NCT03573544|448095919|FG002|Overall Study|Disease progression|6|||
124584455|NCT03573544|448095920|FG003|Overall Study|Disease progression|4|||
124584456|NCT03573544|448095921|FG004|Overall Study|Disease progression|5|||
124584457|NCT03573544|448095922|FG005|Overall Study|Disease progression|7|||
124584458|NCT03573544|448095923|FG006|Overall Study|Disease progression|6|||
124584459|NCT03573544|448095924|FG007|Overall Study|Disease progression|7|||
124584460|NCT00227370|448095926|FG000|Overall Study|Withdrawal by Subject|1|||
124584461|NCT00227370|448095927|FG001|Overall Study|Withdrawal by Subject|2|||
124584462|NCT00227370|448095926|FG000|Overall Study|Death|3|||
124584463|NCT00227370|448095927|FG001|Overall Study|Death|4|||
124584464|NCT00227370|448095926|FG000|Overall Study|Adverse Event|6|||
124584465|NCT00227370|448095927|FG001|Overall Study|Adverse Event|11|||
124584466|NCT00227370|448095926|FG000|Overall Study|Physician Decision|9|||
124584467|NCT00227370|448095927|FG001|Overall Study|Physician Decision|6|||
124584468|NCT00227370|448095926|FG000|Overall Study|Other reasons|2|||
124584469|NCT00227370|448095927|FG001|Overall Study|Other reasons|1|||
124584470|NCT03846193|448095928|FG000|Overall Study|Physician Decision|0|||
124584471|NCT03846193|448095929|FG001|Overall Study|Physician Decision|0|||
124584472|NCT03846193|448095930|FG002|Overall Study|Physician Decision|1|||
124777360|NCT00473382|448813021|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
124777361|NCT00473382|448813022|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
124777362|NCT00473382|448813020|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
124777363|NCT00473382|448813021|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
124777364|NCT00473382|448813022|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
124777365|NCT00473382|448813020|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
124777366|NCT00473382|448813021|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
124777367|NCT00473382|448813022|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
124777368|NCT01470326|448813023|FG000|Overall Study|Protocol Violation|32|||
124777369|NCT01470326|448813023|FG000|Overall Study|No Drug Administration Information|2|||
124777370|NCT01470326|448813023|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
124777371|NCT01166282|448813024|FG000|Open-label Period|Adverse Event|0|||
124777372|NCT01166282|448813025|FG001|Open-label Period|Adverse Event|0|||
124777373|NCT01166282|448813026|FG002|Open-label Period|Adverse Event|6|||
124777374|NCT01166282|448813024|FG000|Open-label Period|Withdrawal by Subject|0|||
124777375|NCT01166282|448813025|FG001|Open-label Period|Withdrawal by Subject|0|||
124777376|NCT01166282|448813026|FG002|Open-label Period|Withdrawal by Subject|4|||
124777377|NCT01166282|448813024|FG000|Open-label Period|Lack of Efficacy|0|||
124777378|NCT01166282|448813025|FG001|Open-label Period|Lack of Efficacy|0|||
124777379|NCT01166282|448813026|FG002|Open-label Period|Lack of Efficacy|2|||
124777380|NCT01166282|448813024|FG000|Open-label Period|Remission|0|||
124777381|NCT01166282|448813025|FG001|Open-label Period|Remission|0|||
124777382|NCT01166282|448813026|FG002|Open-label Period|Remission|4|||
124777383|NCT01166282|448813024|FG000|Open-label Period|Irregular Compliance|0|||
124777384|NCT01166282|448813025|FG001|Open-label Period|Irregular Compliance|0|||
124777385|NCT01166282|448813026|FG002|Open-label Period|Irregular Compliance|1|||
124777386|NCT02577718|448813027|FG000|Overall Study|Death|6|||
124777387|NCT02577718|448813027|FG000|Overall Study|Withdrawal by Subject|2|||
124777388|NCT01995838|448813028|FG000|Overall Study|Lost to Follow-up|0|||
124777389|NCT01995838|448813029|FG001|Overall Study|Lost to Follow-up|1|||
124777390|NCT01995838|448813030|FG002|Overall Study|Lost to Follow-up|0|||
124777391|NCT01995838|448813031|FG003|Overall Study|Lost to Follow-up|0|||
124777392|NCT01995838|448813032|FG004|Overall Study|Lost to Follow-up|0|||
124777393|NCT01995838|448813033|FG005|Overall Study|Lost to Follow-up|0|||
124777394|NCT01995838|448813034|FG006|Overall Study|Lost to Follow-up|1|||
124777395|NCT01995838|448813028|FG000|Overall Study|Participant choice|2|||
124777396|NCT01995838|448813029|FG001|Overall Study|Participant choice|0|||
124777397|NCT01995838|448813030|FG002|Overall Study|Participant choice|0|||
124777398|NCT01995838|448813031|FG003|Overall Study|Participant choice|0|||
124777399|NCT01995838|448813032|FG004|Overall Study|Participant choice|0|||
124777400|NCT01995838|448813033|FG005|Overall Study|Participant choice|1|||
124777401|NCT01995838|448813034|FG006|Overall Study|Participant choice|1|||
124777402|NCT01995838|448813028|FG000|Overall Study|Adverse Event|0|||
124777403|NCT01995838|448813029|FG001|Overall Study|Adverse Event|0|||
124777404|NCT01995838|448813030|FG002|Overall Study|Adverse Event|0|||
124777405|NCT01995838|448813031|FG003|Overall Study|Adverse Event|0|||
124777406|NCT01995838|448813032|FG004|Overall Study|Adverse Event|0|||
124777407|NCT01995838|448813033|FG005|Overall Study|Adverse Event|0|||
124777408|NCT01995838|448813034|FG006|Overall Study|Adverse Event|1|||
124777409|NCT01995838|448813028|FG000|Overall Study|Withdrawal by Subject|0|||
124777410|NCT01995838|448813029|FG001|Overall Study|Withdrawal by Subject|0|||
124777411|NCT01995838|448813030|FG002|Overall Study|Withdrawal by Subject|0|||
124777412|NCT01995838|448813031|FG003|Overall Study|Withdrawal by Subject|0|||
124777413|NCT01995838|448813032|FG004|Overall Study|Withdrawal by Subject|1|||
124777414|NCT01995838|448813033|FG005|Overall Study|Withdrawal by Subject|0|||
124777415|NCT01995838|448813034|FG006|Overall Study|Withdrawal by Subject|0|||
124777416|NCT01995838|448813028|FG000|Overall Study|Other|3|||
124777417|NCT01995838|448813029|FG001|Overall Study|Other|1|||
124777418|NCT01995838|448813030|FG002|Overall Study|Other|0|||
124777419|NCT01995838|448813031|FG003|Overall Study|Other|2|||
124777420|NCT01995838|448813032|FG004|Overall Study|Other|1|||
124777421|NCT01995838|448813033|FG005|Overall Study|Other|1|||
124777422|NCT01995838|448813034|FG006|Overall Study|Other|2|||
124777423|NCT01967576|448813035|FG000|Overall Study|Withdrawal by Subject|3|||
124584473|NCT03846193|448095931|FG003|Overall Study|Physician Decision|0|||
124777424|NCT01967576|448813035|FG000|Overall Study|Progressed/Removed from treatment|1|||
124777425|NCT01967576|448813035|FG000|Overall Study|Study closing at site|1|||
124777426|NCT01967576|448813035|FG000|Overall Study|Adverse Event|1|||
124777427|NCT01967576|448813035|FG000|Overall Study|Refused further treatment|1|||
124777428|NCT00380367|448813038|FG000|Overall Study|Lost to Follow-up|1|||
124777429|NCT00380367|448813038|FG000|Overall Study|Withdrawal by Subject|1|||
124777430|NCT00392769|448813042|FG000|Overall Study|Clinical Deterioration|9|||
124777431|NCT00392769|448813042|FG000|Overall Study|Adverse Event|1|||
124777432|NCT00060840|448813051|FG000|Overall Study|Change in surgical plan|2|||
124777433|NCT00060840|448813052|FG001|Overall Study|Change in surgical plan|6|||
124584474|NCT03846193|448095932|FG004|Overall Study|Physician Decision|0|||
124584475|NCT03846193|448095928|FG000|Overall Study|Lost to Follow-up|0|||
124584476|NCT03846193|448095929|FG001|Overall Study|Lost to Follow-up|0|||
124584477|NCT03846193|448095930|FG002|Overall Study|Lost to Follow-up|0|||
124584478|NCT03846193|448095931|FG003|Overall Study|Lost to Follow-up|0|||
124584479|NCT03846193|448095932|FG004|Overall Study|Lost to Follow-up|1|||
124584480|NCT03846193|448095928|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
124584481|NCT03846193|448095929|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
124584482|NCT03846193|448095930|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
124584483|NCT03846193|448095931|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
124584484|NCT03846193|448095932|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
124584485|NCT00902538|448095934|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
124584486|NCT00902538|448095935|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
124584487|NCT00902538|448095936|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
124584488|NCT00902538|448095937|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
124584489|NCT00902538|448095938|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
124584490|NCT00902538|448095939|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
124584491|NCT00902538|448095934|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
124584492|NCT00902538|448095935|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
124584493|NCT00902538|448095936|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
124584494|NCT00902538|448095937|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
124584495|NCT00902538|448095938|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
124584496|NCT00902538|448095939|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
124584497|NCT00902538|448095934|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
124584498|NCT00902538|448095935|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
124584499|NCT00902538|448095936|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
124584500|NCT00902538|448095937|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
124584501|NCT00902538|448095938|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
124584502|NCT00902538|448095939|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
124584503|NCT00902538|448095934|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
124584504|NCT00902538|448095935|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
124584505|NCT00902538|448095936|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
124584506|NCT00902538|448095937|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
124584507|NCT00902538|448095938|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
124584508|NCT00902538|448095939|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
124584509|NCT00902538|448095934|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
124584510|NCT00902538|448095935|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
124584511|NCT00902538|448095936|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
124584512|NCT00902538|448095937|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
124584513|NCT00902538|448095938|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
124584514|NCT00902538|448095939|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
124584515|NCT00902538|448095934|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
124584516|NCT00902538|448095935|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
124584517|NCT00902538|448095936|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
124584518|NCT00902538|448095937|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
124584519|NCT00902538|448095938|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
124584520|NCT00902538|448095939|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
124584521|NCT00902538|448095934|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
124584522|NCT00902538|448095935|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
124584523|NCT00902538|448095936|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
124584524|NCT00902538|448095937|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
124584525|NCT00902538|448095938|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
124584526|NCT00902538|448095939|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
124584527|NCT00902538|448095934|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
124584528|NCT00902538|448095935|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
124584529|NCT00902538|448095936|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
124584530|NCT00902538|448095937|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
124584531|NCT00902538|448095938|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
124584532|NCT00902538|448095939|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
124584533|NCT00902538|448095934|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
124584534|NCT00902538|448095935|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
124584535|NCT00902538|448095936|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
124584536|NCT00902538|448095937|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
124584537|NCT00902538|448095938|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
124584538|NCT00902538|448095939|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
124584539|NCT00902538|448095934|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
124584540|NCT00902538|448095935|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
124584541|NCT00902538|448095936|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
124584542|NCT00902538|448095937|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
124584543|NCT00902538|448095938|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
124584544|NCT00902538|448095939|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
124584545|NCT00902538|448095934|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
124584546|NCT00902538|448095935|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
124584547|NCT00902538|448095936|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
124584548|NCT00902538|448095937|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
124584549|NCT00902538|448095938|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
124584550|NCT00902538|448095939|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
124584551|NCT00902538|448095934|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
124584552|NCT00902538|448095935|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
124584553|NCT00902538|448095936|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
124584554|NCT00902538|448095937|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
124584555|NCT00902538|448095938|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
124584556|NCT00902538|448095939|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
124584557|NCT00902538|448095934|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
124584558|NCT00902538|448095935|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
124584559|NCT00902538|448095936|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
124584560|NCT00902538|448095937|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
124584561|NCT00902538|448095938|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
124584562|NCT00902538|448095939|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
124584563|NCT00902538|448095934|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
124584564|NCT00902538|448095935|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
124584565|NCT00902538|448095936|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
124584566|NCT00902538|448095937|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
124584567|NCT00902538|448095938|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
124584568|NCT00902538|448095939|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
124584569|NCT00902538|448095934|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
124584570|NCT00902538|448095935|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
124584571|NCT00902538|448095936|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
124584572|NCT00902538|448095937|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
124584573|NCT00902538|448095938|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
124584574|NCT00902538|448095939|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
124584575|NCT00902538|448095934|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
124584576|NCT00902538|448095935|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
124584577|NCT00902538|448095936|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
124584578|NCT00902538|448095937|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
124584579|NCT00902538|448095938|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
124584580|NCT00902538|448095939|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
124584581|NCT00902538|448095934|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
124584582|NCT00902538|448095935|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
124584583|NCT00902538|448095936|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
124584584|NCT00902538|448095937|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
124584585|NCT00902538|448095938|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
124584586|NCT00902538|448095939|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
124584587|NCT00725322|448095940|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
124584588|NCT00725322|448095941|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
124584589|NCT00725322|448095940|FG000|Washout (28 Days)|Protocol Violation|0|||
124584590|NCT00725322|448095941|FG001|Washout (28 Days)|Protocol Violation|1|||
124584591|NCT00660660|448097557|FG000|Overall Study|Adverse Event|1|||
124584592|NCT00660660|448097558|FG001|Overall Study|Adverse Event|0|||
124584593|NCT00660660|448097557|FG000|Overall Study|Lost to Follow-up|0|||
124584594|NCT00660660|448097558|FG001|Overall Study|Lost to Follow-up|6|||
124584595|NCT00660660|448097557|FG000|Overall Study|Lack of Efficacy|0|||
124584596|NCT00660660|448097558|FG001|Overall Study|Lack of Efficacy|2|||
124584597|NCT00660660|448097557|FG000|Overall Study|Withdrawal by Subject|3|||
124584598|NCT00660660|448097558|FG001|Overall Study|Withdrawal by Subject|0|||
124584599|NCT00660660|448097557|FG000|Overall Study|Incorrect enrollment and other|0|||
124584600|NCT00660660|448097558|FG001|Overall Study|Incorrect enrollment and other|1|||
124584601|NCT00660660|448097557|FG000|Overall Study|New medication after randomization|1|||
124584602|NCT00660660|448097558|FG001|Overall Study|New medication after randomization|0|||
124584603|NCT00081653|448097568|FG000|Overall Study|Adverse Event|23|||
124584604|NCT00081653|448097569|FG001|Overall Study|Adverse Event|17|||
124584605|NCT00081653|448097568|FG000|Overall Study|Lost to Follow-up|2|||
124584606|NCT00081653|448097569|FG001|Overall Study|Lost to Follow-up|4|||
124584607|NCT00081653|448097568|FG000|Overall Study|Refused Treatment|18|||
124584608|NCT00081653|448097569|FG001|Overall Study|Refused Treatment|14|||
124777434|NCT00060840|448813051|FG000|Overall Study|Death|0|||
124777435|NCT00060840|448813052|FG001|Overall Study|Death|1|||
124777436|NCT00060840|448813051|FG000|Overall Study|Withdrawal by Subject|0|||
124584609|NCT00081653|448097568|FG000|Overall Study|Low bone mineral density|1|||
124584610|NCT00081653|448097569|FG001|Overall Study|Low bone mineral density|0|||
124584611|NCT00081653|448097568|FG000|Overall Study|Bone loss|2|||
124584612|NCT00081653|448097569|FG001|Overall Study|Bone loss|0|||
124584613|NCT00081653|448097568|FG000|Overall Study|Participant leaving country|1|||
124584614|NCT00081653|448097569|FG001|Overall Study|Participant leaving country|0|||
124584615|NCT00081653|448097568|FG000|Overall Study|Loss of bone mass|0|||
124584616|NCT00081653|448097569|FG001|Overall Study|Loss of bone mass|2|||
124584617|NCT02694536|448097577|FG000|Overall Study|Progressive Disease|40|||
124584618|NCT02694536|448097577|FG000|Overall Study|Lost to Follow-up|1|||
124584619|NCT02694536|448097577|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
124584620|NCT02694536|448097577|FG000|Overall Study|Withdrawal by Subject|8|||
124584621|NCT02694536|448097577|FG000|Overall Study|Death|8|||
124584622|NCT02694536|448097577|FG000|Overall Study|Other|22|||
124584623|NCT00385736|448097578|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
124584624|NCT00385736|448097579|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
124584625|NCT00385736|448097580|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
124584626|NCT00385736|448097578|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
124584627|NCT00385736|448097579|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
124584628|NCT00385736|448097580|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
124584629|NCT00385736|448097578|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
124584630|NCT00385736|448097579|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
124584631|NCT00385736|448097580|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
124584632|NCT00385736|448097578|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
124584633|NCT00385736|448097579|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
124584634|NCT00385736|448097580|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
124584635|NCT00385736|448097578|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
124584636|NCT00385736|448097579|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
124584637|NCT00385736|448097580|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
124584638|NCT00385736|448097578|FG000|Efficacy Analysis Set - Induction|Other|0|||
124584639|NCT00385736|448097579|FG001|Efficacy Analysis Set - Induction|Other|0|||
124584640|NCT00385736|448097580|FG002|Efficacy Analysis Set - Induction|Other|1|||
124584641|NCT00385736|448097578|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
124584642|NCT00385736|448097579|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
124584643|NCT00385736|448097580|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
124584644|NCT00385736|448097578|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
124584645|NCT00385736|448097579|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
124584646|NCT00385736|448097580|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
124584647|NCT00385736|448097578|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
124584648|NCT00385736|448097579|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
124584649|NCT00385736|448097580|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
124584650|NCT00385736|448097578|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
124584651|NCT00385736|448097579|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
124584652|NCT00385736|448097580|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
124584653|NCT00385736|448097578|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
124584654|NCT00385736|448097579|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
124584655|NCT00385736|448097580|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
124584656|NCT00385736|448097578|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
124584657|NCT00385736|448097579|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
124584658|NCT00385736|448097580|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
124584659|NCT00385736|448097578|FG000|Safety Analysis Set|Adverse Event|23|||
124584660|NCT00385736|448097579|FG001|Safety Analysis Set|Adverse Event|15|||
124584661|NCT00385736|448097580|FG002|Safety Analysis Set|Adverse Event|23|||
124584662|NCT00385736|448097578|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
124584663|NCT00385736|448097579|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
124584664|NCT00385736|448097580|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
124584665|NCT00385736|448097578|FG000|Safety Analysis Set|Lost to Follow-up|0|||
124584666|NCT00385736|448097579|FG001|Safety Analysis Set|Lost to Follow-up|2|||
124584667|NCT00385736|448097580|FG002|Safety Analysis Set|Lost to Follow-up|2|||
124584668|NCT00385736|448097578|FG000|Safety Analysis Set|Lack of Efficacy|38|||
124584669|NCT00385736|448097579|FG001|Safety Analysis Set|Lack of Efficacy|16|||
124584670|NCT00385736|448097580|FG002|Safety Analysis Set|Lack of Efficacy|31|||
124584671|NCT00385736|448097578|FG000|Safety Analysis Set|Protocol Violation|2|||
124584672|NCT00385736|448097579|FG001|Safety Analysis Set|Protocol Violation|1|||
124584673|NCT00385736|448097580|FG002|Safety Analysis Set|Protocol Violation|6|||
124777437|NCT00060840|448813052|FG001|Overall Study|Withdrawal by Subject|1|||
124777438|NCT00060840|448813051|FG000|Overall Study|Subinvestigator unavailable|0|||
124584674|NCT00385736|448097578|FG000|Safety Analysis Set|Other|1|||
124584675|NCT00385736|448097579|FG001|Safety Analysis Set|Other|4|||
124777439|NCT00060840|448813052|FG001|Overall Study|Subinvestigator unavailable|1|||
124531594|NCT00141297|447896417|FG006|Overall Study|Withdrawal by Subject|0|||
124531595|NCT00141297|447896418|FG007|Overall Study|Withdrawal by Subject|0|||
124531596|NCT00141297|447896419|FG008|Overall Study|Withdrawal by Subject|1|||
124531597|NCT00141297|447896420|FG009|Overall Study|Withdrawal by Subject|0|||
124531598|NCT00141297|447896411|FG000|Overall Study|Other|0|||
124531599|NCT00141297|447896412|FG001|Overall Study|Other|0|||
124531600|NCT00141297|447896413|FG002|Overall Study|Other|0|||
124531601|NCT00141297|447896414|FG003|Overall Study|Other|1|||
124531602|NCT00141297|447896415|FG004|Overall Study|Other|5|||
124531603|NCT00141297|447896416|FG005|Overall Study|Other|0|||
124531604|NCT00141297|447896417|FG006|Overall Study|Other|0|||
124531605|NCT00141297|447896418|FG007|Overall Study|Other|0|||
124531606|NCT00141297|447896419|FG008|Overall Study|Other|2|||
124531607|NCT00141297|447896420|FG009|Overall Study|Other|0|||
124531608|NCT00141297|447896411|FG000|Overall Study|Progressive Disease|2|||
124531609|NCT00141297|447896412|FG001|Overall Study|Progressive Disease|3|||
124531610|NCT00141297|447896413|FG002|Overall Study|Progressive Disease|6|||
124531611|NCT00141297|447896414|FG003|Overall Study|Progressive Disease|2|||
124531612|NCT00141297|447896415|FG004|Overall Study|Progressive Disease|15|||
124531613|NCT00141297|447896416|FG005|Overall Study|Progressive Disease|2|||
124531614|NCT00141297|447896417|FG006|Overall Study|Progressive Disease|3|||
124531615|NCT00141297|447896418|FG007|Overall Study|Progressive Disease|3|||
124531616|NCT00141297|447896419|FG008|Overall Study|Progressive Disease|15|||
124531617|NCT00141297|447896420|FG009|Overall Study|Progressive Disease|6|||
124531618|NCT00141297|447896411|FG000|Overall Study|Transitioned|0|||
124531619|NCT00141297|447896412|FG001|Overall Study|Transitioned|0|||
124531620|NCT00141297|447896413|FG002|Overall Study|Transitioned|0|||
124531621|NCT00141297|447896414|FG003|Overall Study|Transitioned|0|||
124531622|NCT00141297|447896415|FG004|Overall Study|Transitioned|1|||
124531623|NCT00141297|447896416|FG005|Overall Study|Transitioned|0|||
124531624|NCT00141297|447896417|FG006|Overall Study|Transitioned|0|||
124531625|NCT00141297|447896418|FG007|Overall Study|Transitioned|0|||
124531626|NCT00141297|447896419|FG008|Overall Study|Transitioned|0|||
124531627|NCT00141297|447896420|FG009|Overall Study|Transitioned|0|||
124531628|NCT02200510|447896421|FG000|Overall Study|Death|1|||
124531629|NCT02200510|447896422|FG001|Overall Study|Death|1|||
124531630|NCT02200510|447896421|FG000|Overall Study|Protocol Violation|0|||
124531631|NCT02200510|447896422|FG001|Overall Study|Protocol Violation|1|||
124531632|NCT02200510|447896421|FG000|Overall Study|Lost to Follow-up|7|||
124531633|NCT02200510|447896422|FG001|Overall Study|Lost to Follow-up|1|||
124531634|NCT02200510|447896421|FG000|Overall Study|potential COI - joined study team|1|||
124531635|NCT02200510|447896422|FG001|Overall Study|potential COI - joined study team|0|||
124531636|NCT00290355|447896423|FG000|Overall Study|Serious adverse event|7|||
124531637|NCT00290355|447896424|FG001|Overall Study|Serious adverse event|4|||
124531638|NCT00290355|447896423|FG000|Overall Study|Study product reactogenicity|1|||
124531639|NCT00290355|447896424|FG001|Overall Study|Study product reactogenicity|0|||
124531640|NCT00290355|447896423|FG000|Overall Study|Protocol Violation|1|||
124531641|NCT00290355|447896424|FG001|Overall Study|Protocol Violation|0|||
124531642|NCT00290355|447896423|FG000|Overall Study|Withdrawal by Subject|2|||
124531643|NCT00290355|447896424|FG001|Overall Study|Withdrawal by Subject|0|||
124531644|NCT00290355|447896423|FG000|Overall Study|Migrated / moved from the study area|1|||
124531645|NCT00290355|447896424|FG001|Overall Study|Migrated / moved from the study area|0|||
124531646|NCT00290355|447896423|FG000|Overall Study|Lost to Follow-up|3|||
124531647|NCT00290355|447896424|FG001|Overall Study|Lost to Follow-up|1|||
124531648|NCT00290355|447896423|FG000|Overall Study|Other|2|||
124531649|NCT00290355|447896424|FG001|Overall Study|Other|0|||
124531650|NCT01542632|447896425|FG000|Overall Study|Withdrawal of Consent|0|||
124531651|NCT01542632|447896426|FG001|Overall Study|Withdrawal of Consent|0|||
124531652|NCT01542632|447896427|FG002|Overall Study|Withdrawal of Consent|0|||
124531653|NCT01542632|447896428|FG003|Overall Study|Withdrawal of Consent|2|||
124531654|NCT01542632|447896429|FG004|Overall Study|Withdrawal of Consent|3|||
124531655|NCT01542632|447896430|FG005|Overall Study|Withdrawal of Consent|0|||
124531656|NCT01542632|447896425|FG000|Overall Study|Adverse Event|0|||
124531657|NCT01542632|447896426|FG001|Overall Study|Adverse Event|0|||
124531658|NCT01542632|447896427|FG002|Overall Study|Adverse Event|1|||
124531659|NCT01542632|447896428|FG003|Overall Study|Adverse Event|0|||
124531660|NCT01542632|447896429|FG004|Overall Study|Adverse Event|0|||
124531661|NCT01542632|447896430|FG005|Overall Study|Adverse Event|0|||
124531662|NCT01542632|447896425|FG000|Overall Study|Lost to Follow-up|0|||
124531663|NCT01542632|447896426|FG001|Overall Study|Lost to Follow-up|1|||
124531664|NCT01542632|447896427|FG002|Overall Study|Lost to Follow-up|0|||
124531665|NCT01542632|447896428|FG003|Overall Study|Lost to Follow-up|0|||
124531666|NCT01542632|447896429|FG004|Overall Study|Lost to Follow-up|0|||
124531667|NCT01542632|447896430|FG005|Overall Study|Lost to Follow-up|0|||
124531668|NCT01542632|447896425|FG000|Overall Study|Sponsor/Investigator Decision|0|||
124531669|NCT01542632|447896426|FG001|Overall Study|Sponsor/Investigator Decision|0|||
124531670|NCT01542632|447896427|FG002|Overall Study|Sponsor/Investigator Decision|0|||
124531671|NCT01542632|447896428|FG003|Overall Study|Sponsor/Investigator Decision|0|||
124584676|NCT00385736|448097580|FG002|Safety Analysis Set|Other|4|||
124584677|NCT02727192|448097588|FG000|Overall Study|Lost to Follow-up|1|||
124584678|NCT02727192|448097589|FG001|Overall Study|Lost to Follow-up|0|||
124584679|NCT02727192|448097590|FG002|Overall Study|Lost to Follow-up|0|||
124584680|NCT00928057|448097591|FG000|Overall Study|Adverse Event|1|||
124584681|NCT00928057|448097592|FG001|Overall Study|Adverse Event|2|||
124584682|NCT00928057|448097591|FG000|Overall Study|Withdrawal by Subject|1|||
124584683|NCT00928057|448097592|FG001|Overall Study|Withdrawal by Subject|0|||
124584684|NCT00928057|448097591|FG000|Overall Study|Lost to Follow-up|0|||
124584685|NCT00928057|448097592|FG001|Overall Study|Lost to Follow-up|1|||
124584686|NCT00928057|448097591|FG000|Overall Study|Protocol Violation|0|||
124584687|NCT00928057|448097592|FG001|Overall Study|Protocol Violation|1|||
124584688|NCT05497557|448097595|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
124584689|NCT05497557|448097596|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
124584690|NCT05497557|448097597|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
124584691|NCT01380782|448097602|FG000|Overall Study|Adverse Event|0|||
124584692|NCT01380782|448097603|FG001|Overall Study|Adverse Event|1|||
124584693|NCT01380782|448097604|FG002|Overall Study|Adverse Event|0|||
124584694|NCT01380782|448097605|FG003|Overall Study|Adverse Event|0|||
124584695|NCT01380782|448097602|FG000|Overall Study|Death|1|||
124584696|NCT01380782|448097603|FG001|Overall Study|Death|0|||
124584697|NCT01380782|448097604|FG002|Overall Study|Death|0|||
124584698|NCT01380782|448097605|FG003|Overall Study|Death|0|||
124584699|NCT01380782|448097602|FG000|Overall Study|Lack of Efficacy|10|||
124584700|NCT01380782|448097603|FG001|Overall Study|Lack of Efficacy|9|||
124584701|NCT01380782|448097604|FG002|Overall Study|Lack of Efficacy|10|||
124584702|NCT01380782|448097605|FG003|Overall Study|Lack of Efficacy|3|||
124584703|NCT01380782|448097602|FG000|Overall Study|Physician Decision|1|||
124584704|NCT01380782|448097603|FG001|Overall Study|Physician Decision|0|||
124584705|NCT01380782|448097604|FG002|Overall Study|Physician Decision|0|||
124584706|NCT01380782|448097605|FG003|Overall Study|Physician Decision|0|||
124584707|NCT01380782|448097602|FG000|Overall Study|Withdrawal by Subject|0|||
124584708|NCT01380782|448097603|FG001|Overall Study|Withdrawal by Subject|0|||
124584709|NCT01380782|448097604|FG002|Overall Study|Withdrawal by Subject|1|||
124584710|NCT01380782|448097605|FG003|Overall Study|Withdrawal by Subject|1|||
124584711|NCT05387408|448097606|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
124584712|NCT03428750|448097607|FG000|Overall Study|Withdrawal by Subject|11|||
124584713|NCT03428750|448097608|FG001|Overall Study|Withdrawal by Subject|10|||
124584714|NCT03428750|448097607|FG000|Overall Study|Lost to Follow-up|3|||
124584715|NCT03428750|448097608|FG001|Overall Study|Lost to Follow-up|9|||
124584716|NCT03428750|448097607|FG000|Overall Study|Adverse Event|9|||
124584717|NCT03428750|448097608|FG001|Overall Study|Adverse Event|1|||
124584718|NCT03428750|448097607|FG000|Overall Study|Protocol Violation|1|||
124584719|NCT03428750|448097608|FG001|Overall Study|Protocol Violation|0|||
124584720|NCT03428750|448097607|FG000|Overall Study|Administrative|0|||
124584721|NCT03428750|448097608|FG001|Overall Study|Administrative|1|||
124584722|NCT01919112|448097609|FG000|Secondary Analysis-day 30|Death|1|||
124584723|NCT01919112|448097610|FG001|Secondary Analysis-day 30|Death|1|||
124584724|NCT01919112|448097611|FG002|Secondary Analysis-day 30|Death|1|||
124584725|NCT01919112|448097609|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
124584726|NCT01919112|448097610|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
124584727|NCT01919112|448097611|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
124584728|NCT00635648|448097612|FG000|Overall Study|Adverse Event|12|||
124584729|NCT00635648|448097612|FG000|Overall Study|Withdrawal by Subject|9|||
124584730|NCT00635648|448097612|FG000|Overall Study|Physician Decision|4|||
124584731|NCT00635648|448097612|FG000|Overall Study|Rapid progression of baseline disease|4|||
124584732|NCT00635648|448097612|FG000|Overall Study|Use of other antifungal agent needed|1|||
124584733|NCT00635648|448097612|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
124584734|NCT00635648|448097612|FG000|Overall Study|Noncompliance with protocol|1|||
124584735|NCT00635648|448097612|FG000|Overall Study|Other reason|2|||
124584736|NCT04194801|448097613|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
124584737|NCT04194801|448097614|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
124584738|NCT04194801|448097615|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
124584739|NCT04194801|448097613|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
124584740|NCT04194801|448097614|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
124584741|NCT04194801|448097615|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
124584742|NCT04194801|448097613|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
124584743|NCT04194801|448097614|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
124584744|NCT04194801|448097615|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
124584745|NCT04194801|448097613|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
124584746|NCT04194801|448097614|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
124584747|NCT04194801|448097615|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
124584748|NCT04194801|448097613|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
124637316|NCT00507455|448290463|FG001|Overall Study|Other - miscellaneous reason|0|||
124777440|NCT00060840|448813051|FG000|Overall Study|Physician Decision|1|||
124637317|NCT00507455|448290464|FG002|Overall Study|Other - miscellaneous reason|1|||
124584749|NCT04194801|448097614|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
124584750|NCT04194801|448097615|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
124584751|NCT04194801|448097613|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
124584752|NCT04194801|448097614|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
124584753|NCT04194801|448097615|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
124584754|NCT04194801|448097613|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
124584755|NCT04194801|448097614|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
124584756|NCT04194801|448097615|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
124584757|NCT04194801|448097613|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
124584758|NCT04194801|448097614|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
124584759|NCT04194801|448097615|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
124584760|NCT04194801|448097613|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
124584761|NCT04194801|448097614|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
124584762|NCT04194801|448097615|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
124584763|NCT04194801|448097613|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
124584764|NCT04194801|448097614|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
124584765|NCT04194801|448097615|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
124584766|NCT04194801|448097613|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
124584767|NCT04194801|448097614|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
124584768|NCT04194801|448097615|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
124584769|NCT04194801|448097613|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
124584770|NCT04194801|448097614|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
124584771|NCT04194801|448097615|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
124584772|NCT04194801|448097613|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
124584773|NCT04194801|448097614|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
124584774|NCT04194801|448097615|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
124584775|NCT04194801|448097613|FG000|Part Ib/II End of Study|Death|2|||
124584776|NCT04194801|448097614|FG001|Part Ib/II End of Study|Death|3|||
124584777|NCT04194801|448097615|FG002|Part Ib/II End of Study|Death|3|||
124584778|NCT04194801|448097613|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
124584779|NCT04194801|448097614|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
124584780|NCT04194801|448097615|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
124584781|NCT04194801|448097613|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
124584782|NCT04194801|448097614|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
124584783|NCT04194801|448097615|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
124584784|NCT04194801|448097613|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
124584785|NCT04194801|448097614|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
124584786|NCT04194801|448097615|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
124584787|NCT04194801|448097613|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
124584788|NCT04194801|448097614|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
124584789|NCT04194801|448097615|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
124584790|NCT00294047|448097616|FG000|Month 48|Adverse Event|28|||
124584791|NCT00294047|448097617|FG001|Month 48|Adverse Event|13|||
124584792|NCT00294047|448097616|FG000|Month 48|Protocol Violation|4|||
124584793|NCT00294047|448097617|FG001|Month 48|Protocol Violation|4|||
124584794|NCT00294047|448097616|FG000|Month 48|Withdrawal by Subject|111|||
124584795|NCT00294047|448097617|FG001|Month 48|Withdrawal by Subject|115|||
124584796|NCT00294047|448097616|FG000|Month 48|Lost to Follow-up|272|||
124584797|NCT00294047|448097617|FG001|Month 48|Lost to Follow-up|287|||
124584798|NCT00294047|448097616|FG000|Month 48|Other|10|||
124584799|NCT00294047|448097617|FG001|Month 48|Other|14|||
124584800|NCT00294047|448097616|FG000|Month 84|Adverse Event|4|||
124584801|NCT00294047|448097617|FG001|Month 84|Adverse Event|2|||
124584802|NCT00294047|448097616|FG000|Month 84|Protocol Violation|1|||
124584803|NCT00294047|448097617|FG001|Month 84|Protocol Violation|1|||
124584804|NCT00294047|448097616|FG000|Month 84|Withdrawal by Subject|33|||
124584805|NCT00294047|448097617|FG001|Month 84|Withdrawal by Subject|31|||
124584806|NCT00294047|448097616|FG000|Month 84|Lost to Follow-up|187|||
124584807|NCT00294047|448097617|FG001|Month 84|Lost to Follow-up|190|||
124584808|NCT00294047|448097616|FG000|Month 84|Absent Cervix|2|||
124584809|NCT00294047|448097617|FG001|Month 84|Absent Cervix|0|||
124584810|NCT00294047|448097616|FG000|Month 84|Work related reasons|4|||
124584811|NCT00294047|448097617|FG001|Month 84|Work related reasons|2|||
124584812|NCT00294047|448097616|FG000|Month 84|Center closed, subject did not transfer|1|||
124584813|NCT00294047|448097617|FG001|Month 84|Center closed, subject did not transfer|0|||
124584814|NCT00294047|448097616|FG000|Month 84|Family problems|2|||
124584815|NCT00294047|448097617|FG001|Month 84|Family problems|2|||
124584816|NCT00294047|448097616|FG000|Month 84|Lack of time|3|||
124584817|NCT00294047|448097617|FG001|Month 84|Lack of time|1|||
124584818|NCT00294047|448097616|FG000|Month 84|Personal reason|2|||
124584819|NCT00294047|448097617|FG001|Month 84|Personal reason|4|||
124584820|NCT00294047|448097616|FG000|Month 84|Subject does not want male physician|1|||
124584821|NCT00294047|448097617|FG001|Month 84|Subject does not want male physician|0|||
124584822|NCT00294047|448097616|FG000|Month 84|Transport reimbursement delayed|0|||
124584823|NCT00294047|448097617|FG001|Month 84|Transport reimbursement delayed|1|||
124584824|NCT00294047|448097616|FG000|Month 84|Unable to reach study site|1|||
124584825|NCT00294047|448097617|FG001|Month 84|Unable to reach study site|0|||
124584826|NCT00294047|448097616|FG000|Month 84|Under investigation locally|1|||
124584827|NCT00294047|448097617|FG001|Month 84|Under investigation locally|0|||
124584828|NCT00294047|448097616|FG000|Month 84|Visit missed|0|||
124584829|NCT00294047|448097617|FG001|Month 84|Visit missed|1|||
124584830|NCT00294047|448097616|FG000|Month 84|No consent for Month 84 Follow-up|731|||
124584831|NCT00294047|448097617|FG001|Month 84|No consent for Month 84 Follow-up|754|||
124584832|NCT02157974|448097618|FG000|Overall Study|Withdrawal by Subject|0|||
124584833|NCT02157974|448097619|FG001|Overall Study|Withdrawal by Subject|1|||
124729172|NCT02231892|448630157|FG000|Overall Study|Withdrawal by Subject|4|||
124729173|NCT02231892|448630158|FG001|Overall Study|Withdrawal by Subject|3|||
124729174|NCT02231892|448630159|FG002|Overall Study|Withdrawal by Subject|15|||
124729175|NCT02231892|448630157|FG000|Overall Study|Physician Decision|0|||
124729176|NCT02231892|448630158|FG001|Overall Study|Physician Decision|2|||
124729177|NCT02231892|448630159|FG002|Overall Study|Physician Decision|4|||
124729178|NCT02231892|448630157|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
124729179|NCT02231892|448630158|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
124729180|NCT02231892|448630159|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
124729181|NCT02231892|448630157|FG000|Overall Study|Participant motor threshold was >83%|0|||
124729182|NCT02231892|448630158|FG001|Overall Study|Participant motor threshold was >83%|0|||
124729183|NCT02231892|448630159|FG002|Overall Study|Participant motor threshold was >83%|9|||
124729184|NCT02231892|448630157|FG000|Overall Study|Could not find motor threshold|2|||
124729185|NCT02231892|448630158|FG001|Overall Study|Could not find motor threshold|0|||
124729186|NCT02231892|448630159|FG002|Overall Study|Could not find motor threshold|1|||
124729187|NCT02231892|448630157|FG000|Overall Study|Could not find reliable motor hotspot|0|||
124729188|NCT02231892|448630158|FG001|Overall Study|Could not find reliable motor hotspot|0|||
124729189|NCT02231892|448630159|FG002|Overall Study|Could not find reliable motor hotspot|1|||
124729190|NCT01694121|448630162|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
124729191|NCT01694121|448630163|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
124729192|NCT02680041|448630164|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
124729193|NCT02680041|448630164|FG000|Overall Study|Lost to Follow-up|2|||
124729194|NCT00521599|448630165|FG000|Overall Study|Adverse Event|5|||
124729195|NCT00521599|448630166|FG001|Overall Study|Adverse Event|7|||
124729196|NCT00521599|448630167|FG002|Overall Study|Adverse Event|6|||
124729197|NCT00521599|448630165|FG000|Overall Study|Treatment Failure|8|||
124729198|NCT00521599|448630166|FG001|Overall Study|Treatment Failure|9|||
124729199|NCT00521599|448630167|FG002|Overall Study|Treatment Failure|22|||
124729200|NCT00521599|448630165|FG000|Overall Study|Lost to Follow-up|2|||
124729201|NCT00521599|448630166|FG001|Overall Study|Lost to Follow-up|1|||
124729202|NCT00521599|448630167|FG002|Overall Study|Lost to Follow-up|2|||
124729203|NCT00521599|448630165|FG000|Overall Study|Withdrawal by Subject|3|||
124729204|NCT00521599|448630166|FG001|Overall Study|Withdrawal by Subject|5|||
124729205|NCT00521599|448630167|FG002|Overall Study|Withdrawal by Subject|1|||
124729206|NCT00521599|448630165|FG000|Overall Study|Withdrawal by subject treatment related|3|||
124729207|NCT00521599|448630166|FG001|Overall Study|Withdrawal by subject treatment related|1|||
124729208|NCT00521599|448630167|FG002|Overall Study|Withdrawal by subject treatment related|2|||
124729209|NCT00521599|448630165|FG000|Overall Study|Protocol Violation|2|||
124729210|NCT00521599|448630166|FG001|Overall Study|Protocol Violation|4|||
124729211|NCT00521599|448630167|FG002|Overall Study|Protocol Violation|2|||
124729212|NCT00521599|448630165|FG000|Overall Study|Did not meet protocol eligibility|2|||
124729213|NCT00521599|448630166|FG001|Overall Study|Did not meet protocol eligibility|2|||
124729214|NCT00521599|448630167|FG002|Overall Study|Did not meet protocol eligibility|1|||
124729215|NCT02186652|448630168|FG000|Overall Study|Lost to Follow-up|2|||
124729216|NCT02186652|448630169|FG001|Overall Study|Lost to Follow-up|0|||
124729217|NCT00744978|448630173|FG000|Period 1|Lost to Follow-up|1|||
124729218|NCT00744978|448630174|FG001|Period 1|Lost to Follow-up|0|||
124729219|NCT00744978|448630173|FG000|Period 1|Withdrawal by Subject|0|||
124729220|NCT00744978|448630174|FG001|Period 1|Withdrawal by Subject|2|||
124729221|NCT00744978|448630173|FG000|Period 1|Other|0|||
124729222|NCT00744978|448630174|FG001|Period 1|Other|2|||
124729223|NCT00744978|448630173|FG000|Period 1|Adverse Event|4|||
124729224|NCT00744978|448630174|FG001|Period 1|Adverse Event|0|||
124729225|NCT00744978|448630173|FG000|Period 1|Randomized but not Treated|1|||
124729226|NCT00744978|448630174|FG001|Period 1|Randomized but not Treated|1|||
124729227|NCT00744978|448630173|FG000|Period 2|Adverse Event|0|||
124729228|NCT00744978|448630174|FG001|Period 2|Adverse Event|1|||
124729229|NCT00866047|448630175|FG000|Treatment Period|Progressive disease|13|||
124729230|NCT00866047|448630175|FG000|Treatment Period|Adverse Event|16|||
124729231|NCT00866047|448630175|FG000|Treatment Period|Physician Decision|14|||
124729232|NCT00866047|448630175|FG000|Treatment Period|Withdrawal by Subject|5|||
124729233|NCT00866047|448630175|FG000|Follow-up Period|Lost to Follow-up|5|||
124729234|NCT02928029|448630176|FG000|Overall Study|Withdrawal by Subject|0|||
124729235|NCT02928029|448630177|FG001|Overall Study|Withdrawal by Subject|1|||
124729236|NCT02928029|448630176|FG000|Overall Study|Radiological progression|1|||
124729237|NCT02928029|448630177|FG001|Overall Study|Radiological progression|0|||
124729238|NCT02928029|448630176|FG000|Overall Study|Clinical progression|1|||
124729239|NCT02928029|448630177|FG001|Overall Study|Clinical progression|2|||
124729240|NCT02928029|448630176|FG000|Overall Study|AE not related to clinical progression|1|||
124729241|NCT02928029|448630177|FG001|Overall Study|AE not related to clinical progression|1|||
124729242|NCT00515294|448630178|FG000|Overall Study|Lost to Follow-up|3|||
124729243|NCT00515294|448630179|FG001|Overall Study|Lost to Follow-up|2|||
124729244|NCT00515294|448630180|FG002|Overall Study|Lost to Follow-up|3|||
124729245|NCT00515294|448630181|FG003|Overall Study|Lost to Follow-up|1|||
124729246|NCT00515294|448630178|FG000|Overall Study|Driver simulator problems|1|||
124729247|NCT00515294|448630179|FG001|Overall Study|Driver simulator problems|1|||
124729248|NCT00515294|448630180|FG002|Overall Study|Driver simulator problems|1|||
124729249|NCT00515294|448630181|FG003|Overall Study|Driver simulator problems|3|||
124729250|NCT00515294|448630178|FG000|Overall Study|Caffeine amount inaccurate|5|||
124729251|NCT00515294|448630179|FG001|Overall Study|Caffeine amount inaccurate|0|||
124729252|NCT00515294|448630180|FG002|Overall Study|Caffeine amount inaccurate|7|||
124729253|NCT00515294|448630181|FG003|Overall Study|Caffeine amount inaccurate|0|||
124729254|NCT02778555|448630182|FG000|Overall Study|Withdrawal by Subject|55|||
124729255|NCT02778555|448630183|FG001|Overall Study|Withdrawal by Subject|32|||
124729256|NCT02778555|448630184|FG002|Overall Study|Withdrawal by Subject|107|||
124729257|NCT04659174|448630189|FG000|Overall Study|Sponsor decision to discontinue study|0|||
124729258|NCT04659174|448630190|FG001|Overall Study|Sponsor decision to discontinue study|2|||
124729259|NCT04659174|448630189|FG000|Overall Study|Lost to Follow-up|9|||
124729260|NCT04659174|448630190|FG001|Overall Study|Lost to Follow-up|11|||
124729261|NCT04659174|448630189|FG000|Overall Study|Adverse Event|8|||
124729262|NCT04659174|448630190|FG001|Overall Study|Adverse Event|5|||
124729263|NCT04659174|448630189|FG000|Overall Study|Withdrawal by Subject|17|||
124729264|NCT04659174|448630190|FG001|Overall Study|Withdrawal by Subject|33|||
124729265|NCT04659174|448630189|FG000|Overall Study|Progressive disease|0|||
124729266|NCT04659174|448630190|FG001|Overall Study|Progressive disease|2|||
124729267|NCT04659174|448630189|FG000|Overall Study|Other reasons|0|||
124729268|NCT04659174|448630190|FG001|Overall Study|Other reasons|2|||
124729269|NCT04659174|448630189|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
124729270|NCT04659174|448630190|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
124729271|NCT04659174|448630189|FG000|Overall Study|Alcohol or illegal drug use|0|||
124729272|NCT04659174|448630190|FG001|Overall Study|Alcohol or illegal drug use|3|||
124729273|NCT04659174|448630189|FG000|Overall Study|Violation of entry criteria|1|||
124729274|NCT04659174|448630190|FG001|Overall Study|Violation of entry criteria|0|||
124729275|NCT04659174|448630189|FG000|Overall Study|Death|0|||
124729276|NCT04659174|448630190|FG001|Overall Study|Death|1|||
124729277|NCT01639339|448630196|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
124729278|NCT01639339|448630197|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
124729279|NCT01639339|448630196|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
124729280|NCT01639339|448630197|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
124729281|NCT01639339|448630196|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
124729282|NCT01639339|448630197|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
124729283|NCT01639339|448630196|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
124729284|NCT01639339|448630197|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
124729285|NCT01639339|448630196|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
124729286|NCT01639339|448630197|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
124729287|NCT01639339|448630196|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
124729288|NCT01639339|448630197|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
124729289|NCT01639339|448630196|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
124729290|NCT01639339|448630197|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
124729291|NCT01639339|448630196|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
124729292|NCT01639339|448630197|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
124729293|NCT01639339|448630196|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
124729294|NCT01639339|448630197|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
124729295|NCT01639339|448630196|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
124729296|NCT01639339|448630197|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
124729297|NCT03022097|448630198|FG000|Overall Study|Adverse Event|3|||
124729298|NCT03022097|448630199|FG001|Overall Study|Adverse Event|4|||
124729299|NCT03022097|448630200|FG002|Overall Study|Adverse Event|1|||
124729300|NCT03022097|448630201|FG003|Overall Study|Adverse Event|3|||
124729301|NCT03022097|448630198|FG000|Overall Study|Progressive Disease|2|||
124729302|NCT03022097|448630199|FG001|Overall Study|Progressive Disease|0|||
124729303|NCT03022097|448630200|FG002|Overall Study|Progressive Disease|5|||
124729304|NCT03022097|448630201|FG003|Overall Study|Progressive Disease|2|||
124729305|NCT03022097|448630198|FG000|Overall Study|Lack of Efficacy|0|||
124729306|NCT03022097|448630199|FG001|Overall Study|Lack of Efficacy|0|||
124777441|NCT00060840|448813052|FG001|Overall Study|Physician Decision|0|||
124584834|NCT02157974|448097620|FG002|Overall Study|Withdrawal by Subject|0|||
124584835|NCT02157974|448097621|FG003|Overall Study|Withdrawal by Subject|0|||
124584836|NCT02157974|448097622|FG004|Overall Study|Withdrawal by Subject|0|||
124584837|NCT02157974|448097618|FG000|Overall Study|Screen Failure|0|||
124584838|NCT02157974|448097619|FG001|Overall Study|Screen Failure|1|||
124584839|NCT02157974|448097620|FG002|Overall Study|Screen Failure|0|||
124584840|NCT02157974|448097621|FG003|Overall Study|Screen Failure|0|||
124584841|NCT02157974|448097622|FG004|Overall Study|Screen Failure|0|||
124584842|NCT02157974|448097618|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
124584843|NCT02157974|448097619|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
124584844|NCT02157974|448097620|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
124584845|NCT02157974|448097621|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
124584846|NCT02157974|448097622|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
124584847|NCT00985439|448097625|FG000|Overall Study|Adverse Event|0|||
124584848|NCT00985439|448097626|FG001|Overall Study|Adverse Event|0|||
124584849|NCT00985439|448097627|FG002|Overall Study|Adverse Event|1|||
124584850|NCT00985439|448097628|FG003|Overall Study|Adverse Event|0|||
124584851|NCT05274763|448097629|FG000|Overall Study|Lost to Follow-up|1|||
124584852|NCT01174186|448097630|FG000|Overall Study|Lost to Follow-up|0|||
124584853|NCT01174186|448097631|FG001|Overall Study|Lost to Follow-up|1|||
124584854|NCT01174186|448097630|FG000|Overall Study|Withdrawal by Subject|0|||
124584855|NCT01174186|448097631|FG001|Overall Study|Withdrawal by Subject|2|||
124584856|NCT01051349|448097633|FG000|Overall Study|Adverse Event|88|||
124584857|NCT01051349|448097633|FG000|Overall Study|Consent Withdrawn|54|||
124584858|NCT01051349|448097633|FG000|Overall Study|Investigator Decision|6|||
124584859|NCT01051349|448097633|FG000|Overall Study|Lost to Follow-up|6|||
124584860|NCT01051349|448097633|FG000|Overall Study|Subject non-compliance|7|||
124584861|NCT01051349|448097633|FG000|Overall Study|Reason not Specified|12|||
124584862|NCT01647828|448097634|FG000|Overall Study|Death|3|||
124584863|NCT01647828|448097635|FG001|Overall Study|Death|4|||
124584864|NCT01647828|448097636|FG002|Overall Study|Death|4|||
124584865|NCT01647828|448097637|FG003|Overall Study|Death|5|||
124584866|NCT01647828|448097638|FG004|Overall Study|Death|6|||
124584867|NCT01647828|448097639|FG005|Overall Study|Death|3|||
124584868|NCT01647828|448097640|FG006|Overall Study|Death|10|||
124584869|NCT01647828|448097641|FG007|Overall Study|Death|60|||
124584870|NCT01647828|448097642|FG008|Overall Study|Death|71|||
124584871|NCT01647828|448097634|FG000|Overall Study|Withdrawal by Subject|2|||
124584872|NCT01647828|448097635|FG001|Overall Study|Withdrawal by Subject|0|||
124584873|NCT01647828|448097636|FG002|Overall Study|Withdrawal by Subject|0|||
124584874|NCT01647828|448097637|FG003|Overall Study|Withdrawal by Subject|1|||
124584875|NCT01647828|448097638|FG004|Overall Study|Withdrawal by Subject|0|||
124584876|NCT01647828|448097639|FG005|Overall Study|Withdrawal by Subject|0|||
124584877|NCT01647828|448097640|FG006|Overall Study|Withdrawal by Subject|1|||
124584878|NCT01647828|448097641|FG007|Overall Study|Withdrawal by Subject|0|||
124584879|NCT01647828|448097642|FG008|Overall Study|Withdrawal by Subject|2|||
124584880|NCT01647828|448097634|FG000|Overall Study|Study terminated by Sponsor|0|||
124584881|NCT01647828|448097635|FG001|Overall Study|Study terminated by Sponsor|0|||
124584882|NCT01647828|448097636|FG002|Overall Study|Study terminated by Sponsor|0|||
124584883|NCT01647828|448097637|FG003|Overall Study|Study terminated by Sponsor|0|||
124584884|NCT01647828|448097638|FG004|Overall Study|Study terminated by Sponsor|0|||
124584885|NCT01647828|448097639|FG005|Overall Study|Study terminated by Sponsor|0|||
124584886|NCT01647828|448097640|FG006|Overall Study|Study terminated by Sponsor|1|||
124584887|NCT01647828|448097641|FG007|Overall Study|Study terminated by Sponsor|26|||
124584888|NCT01647828|448097642|FG008|Overall Study|Study terminated by Sponsor|16|||
124584889|NCT01647828|448097634|FG000|Overall Study|Lost to Follow-up|0|||
124584890|NCT01647828|448097635|FG001|Overall Study|Lost to Follow-up|0|||
124584891|NCT01647828|448097636|FG002|Overall Study|Lost to Follow-up|0|||
124584892|NCT01647828|448097637|FG003|Overall Study|Lost to Follow-up|0|||
124584893|NCT01647828|448097638|FG004|Overall Study|Lost to Follow-up|0|||
124584894|NCT01647828|448097639|FG005|Overall Study|Lost to Follow-up|0|||
124777442|NCT00060840|448813051|FG000|Overall Study|Other|1|||
124584895|NCT01647828|448097640|FG006|Overall Study|Lost to Follow-up|0|||
124584896|NCT01647828|448097641|FG007|Overall Study|Lost to Follow-up|2|||
124584897|NCT01647828|448097642|FG008|Overall Study|Lost to Follow-up|0|||
124584898|NCT01906372|448097643|FG000|Overall Study|Withdrawal by Subject|2|||
124584899|NCT00847535|448097647|FG000|Overall Study|Withdrawal by Subject|2|||
124777443|NCT00060840|448813052|FG001|Overall Study|Other|0|||
124584900|NCT00847535|448097648|FG001|Overall Study|Withdrawal by Subject|1|||
124584901|NCT00847535|448097649|FG002|Overall Study|Withdrawal by Subject|1|||
124584902|NCT00847535|448097647|FG000|Overall Study|Lost to Follow-up|0|||
124584903|NCT00847535|448097648|FG001|Overall Study|Lost to Follow-up|1|||
124584904|NCT00847535|448097649|FG002|Overall Study|Lost to Follow-up|0|||
124584905|NCT05604014|448097650|FG000|Overall Study|Lost to Follow-up|13|||
124584906|NCT02054715|448097662|FG000|Baseline/Follow-up 1|Refused|1|||
124584907|NCT02054715|448097663|FG001|Baseline/Follow-up 1|Refused|3|||
124584908|NCT02054715|448097662|FG000|Baseline/Follow-up 1|Medical|0|||
124777444|NCT03710161|448813054|FG000|Overall Study|Study halted due to COVID pandemic|3|||
124531672|NCT01542632|447896429|FG004|Overall Study|Sponsor/Investigator Decision|1|||
124531673|NCT01542632|447896430|FG005|Overall Study|Sponsor/Investigator Decision|0|||
124531674|NCT00033514|447896431|FG000|Overall Study|Lost to Follow-up|1|||
124531675|NCT00033514|447896432|FG001|Overall Study|Lost to Follow-up|1|||
124531676|NCT00033514|447896431|FG000|Overall Study|Withdrawal by Subject|0|||
124531677|NCT00033514|447896432|FG001|Overall Study|Withdrawal by Subject|3|||
124531678|NCT01108263|447896438|FG000|Overall Study|Adverse Event|0|||
124531679|NCT01108263|447896439|FG001|Overall Study|Adverse Event|1|||
124531680|NCT01685372|447896440|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
124531681|NCT01685372|447896441|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
124531682|NCT01072500|447896442|FG000|Overall Study|Death|2|||
124531683|NCT01072500|447896443|FG001|Overall Study|Death|2|||
124531684|NCT01072500|447896442|FG000|Overall Study|Lost to Follow-up|5|||
124531685|NCT01072500|447896443|FG001|Overall Study|Lost to Follow-up|2|||
124531686|NCT01072500|447896442|FG000|Overall Study|Withdrawal by Subject|17|||
124531687|NCT01072500|447896443|FG001|Overall Study|Withdrawal by Subject|10|||
124531688|NCT00829010|447896444|FG000|Overall Study|Adverse Event|1|||
124531689|NCT00829010|447896445|FG001|Overall Study|Adverse Event|0|||
124531690|NCT00829010|447896446|FG002|Overall Study|Adverse Event|0|||
124531691|NCT00829010|447896447|FG003|Overall Study|Adverse Event|0|||
124531692|NCT00829010|447896448|FG004|Overall Study|Adverse Event|0|||
124531693|NCT00829010|447896444|FG000|Overall Study|Withdrawal by Subject|0|||
124531694|NCT00829010|447896445|FG001|Overall Study|Withdrawal by Subject|1|||
124531695|NCT00829010|447896446|FG002|Overall Study|Withdrawal by Subject|1|||
124531696|NCT00829010|447896447|FG003|Overall Study|Withdrawal by Subject|0|||
124531697|NCT00829010|447896448|FG004|Overall Study|Withdrawal by Subject|2|||
124531698|NCT00829010|447896444|FG000|Overall Study|Lost to Follow-up|1|||
124531699|NCT00829010|447896445|FG001|Overall Study|Lost to Follow-up|0|||
124531700|NCT00829010|447896446|FG002|Overall Study|Lost to Follow-up|2|||
124531701|NCT00829010|447896447|FG003|Overall Study|Lost to Follow-up|0|||
124531702|NCT00829010|447896448|FG004|Overall Study|Lost to Follow-up|0|||
124531703|NCT00829010|447896444|FG000|Overall Study|Fatality|5|||
124531704|NCT00829010|447896445|FG001|Overall Study|Fatality|4|||
124531705|NCT00829010|447896446|FG002|Overall Study|Fatality|0|||
124531706|NCT00829010|447896447|FG003|Overall Study|Fatality|3|||
124531707|NCT00829010|447896448|FG004|Overall Study|Fatality|0|||
124531708|NCT00829010|447896444|FG000|Overall Study|Migrated/Moved from study area|3|||
124531709|NCT00829010|447896445|FG001|Overall Study|Migrated/Moved from study area|4|||
124531710|NCT00829010|447896446|FG002|Overall Study|Migrated/Moved from study area|0|||
124531711|NCT00829010|447896447|FG003|Overall Study|Migrated/Moved from study area|5|||
124531712|NCT00829010|447896448|FG004|Overall Study|Migrated/Moved from study area|0|||
124531713|NCT02061540|447896449|FG000|Overall Study|Adverse Event|2|||
124531714|NCT02061540|447896449|FG000|Overall Study|Withdrawal by Subject|2|||
124531715|NCT02289833|447896451|FG000|Overall Study|Study discontinuation|0|||
124531716|NCT02289833|447896452|FG001|Overall Study|Study discontinuation|1|||
124531717|NCT02289833|447896451|FG000|Overall Study|Lost to Follow-up|4|||
124531718|NCT02289833|447896452|FG001|Overall Study|Lost to Follow-up|0|||
124531719|NCT02289833|447896451|FG000|Overall Study|Death|23|||
124531720|NCT02289833|447896452|FG001|Overall Study|Death|16|||
124531721|NCT03442595|447896459|FG000|Overall Study|Lost to Follow-up|94|||
124531722|NCT03442595|447896460|FG001|Overall Study|Lost to Follow-up|0|||
124531723|NCT01642004|447896461|FG000|Randomization|Adverse Event unrelated to study drug|1|||
124531724|NCT01642004|447896462|FG001|Randomization|Adverse Event unrelated to study drug|0|||
124531725|NCT01642004|447896461|FG000|Randomization|Participant withdrew consent|1|||
124531726|NCT01642004|447896462|FG001|Randomization|Participant withdrew consent|6|||
124531727|NCT01642004|447896461|FG000|Randomization|No longer meets study criteria|2|||
124531728|NCT01642004|447896462|FG001|Randomization|No longer meets study criteria|2|||
124531729|NCT01642004|447896461|FG000|Treatment|Disease progression|95|||
124531730|NCT01642004|447896462|FG001|Treatment|Disease progression|79|||
124531731|NCT01642004|447896461|FG000|Treatment|Study drug toxicity|10|||
124531732|NCT01642004|447896462|FG001|Treatment|Study drug toxicity|13|||
124531733|NCT01642004|447896461|FG000|Treatment|Death|1|||
124531734|NCT01642004|447896462|FG001|Treatment|Death|1|||
124531735|NCT01642004|447896461|FG000|Treatment|Adverse event unrelated to study drug|9|||
124531736|NCT01642004|447896462|FG001|Treatment|Adverse event unrelated to study drug|13|||
124531737|NCT01642004|447896461|FG000|Treatment|Maximum clinical benefit|1|||
124531738|NCT01642004|447896462|FG001|Treatment|Maximum clinical benefit|9|||
124531739|NCT01642004|447896461|FG000|Treatment|Poor/non-compliance|1|||
124531740|NCT01642004|447896462|FG001|Treatment|Poor/non-compliance|0|||
124531741|NCT01642004|447896461|FG000|Treatment|No longer meets study criteria|1|||
124531742|NCT01642004|447896462|FG001|Treatment|No longer meets study criteria|2|||
124531743|NCT01642004|447896461|FG000|Treatment|Other reasons|2|||
124531744|NCT01642004|447896462|FG001|Treatment|Other reasons|0|||
124777445|NCT03710161|448813055|FG001|Overall Study|Study halted due to COVID pandemic|2|||
124531745|NCT01642004|447896461|FG000|Treatment|Not reported|0|||
124531746|NCT01642004|447896462|FG001|Treatment|Not reported|3|||
124531747|NCT01642004|447896461|FG000|Treatment|Participant request to discontinue study treatment|6|||
124584909|NCT02054715|448097663|FG001|Baseline/Follow-up 1|Medical|1|||
124584910|NCT02054715|448097662|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
124584911|NCT02054715|448097663|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
124584912|NCT02054715|448097662|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
124584913|NCT02054715|448097663|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
124584914|NCT02054715|448097662|FG000|Baseline/Follow-up 1|No Reason|0|||
124584915|NCT02054715|448097663|FG001|Baseline/Follow-up 1|No Reason|1|||
124584916|NCT02054715|448097662|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
124584917|NCT02054715|448097663|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
124584918|NCT02054715|448097662|FG000|Baseline/Follow-up 1|Ineligible|3|||
124584919|NCT02054715|448097663|FG001|Baseline/Follow-up 1|Ineligible|0|||
124584920|NCT02054715|448097662|FG000|Baseline/Follow-up 1|Hospitalization|1|||
124584921|NCT02054715|448097663|FG001|Baseline/Follow-up 1|Hospitalization|0|||
124584922|NCT02054715|448097662|FG000|Baseline/Follow-up 1|Changed Mind|1|||
124584923|NCT02054715|448097663|FG001|Baseline/Follow-up 1|Changed Mind|0|||
124584924|NCT02054715|448097662|FG000|Follow-up 2|Lost to Followup|3|||
124584925|NCT02054715|448097663|FG001|Follow-up 2|Lost to Followup|1|||
124584926|NCT02054715|448097662|FG000|Follow-up 2|Refused|3|||
124584927|NCT02054715|448097663|FG001|Follow-up 2|Refused|2|||
124584928|NCT02054715|448097662|FG000|Follow-up 2|Followup Not Completed|3|||
124584929|NCT02054715|448097663|FG001|Follow-up 2|Followup Not Completed|4|||
124584930|NCT02054715|448097662|FG000|Follow-up 2|Ineligible|4|||
124584931|NCT02054715|448097663|FG001|Follow-up 2|Ineligible|5|||
124584932|NCT02054715|448097662|FG000|Follow-up 2|Death|3|||
124584933|NCT02054715|448097663|FG001|Follow-up 2|Death|3|||
124584934|NCT02054715|448097662|FG000|Follow-up 2|Hospitalization|0|||
124584935|NCT02054715|448097663|FG001|Follow-up 2|Hospitalization|2|||
124584936|NCT02054715|448097662|FG000|Follow-up 2|Changed MD/Facility|0|||
124584937|NCT02054715|448097663|FG001|Follow-up 2|Changed MD/Facility|1|||
124584938|NCT02054715|448097662|FG000|Follow-up 2|Changed Mind|0|||
124584939|NCT02054715|448097663|FG001|Follow-up 2|Changed Mind|1|||
124584940|NCT02054715|448097662|FG000|Follow-up 2|No Reason|2|||
124584941|NCT02054715|448097663|FG001|Follow-up 2|No Reason|0|||
124584942|NCT02054715|448097662|FG000|Follow-up 2|Treatment Change or Delay|1|||
124584943|NCT02054715|448097663|FG001|Follow-up 2|Treatment Change or Delay|0|||
124584944|NCT01438060|448097664|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
124584945|NCT01438060|448097665|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
124584946|NCT01438060|448097664|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
124584947|NCT01438060|448097665|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
124584948|NCT01438060|448097664|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
124584949|NCT01438060|448097665|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
124584950|NCT01438060|448097664|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
124584951|NCT01438060|448097665|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
124584952|NCT01438060|448097664|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
124584953|NCT01438060|448097665|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
124584954|NCT01438060|448097664|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
124584955|NCT01438060|448097665|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
124584956|NCT01438060|448097664|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
124584957|NCT01438060|448097665|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
124584958|NCT01438060|448097664|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
124584959|NCT01438060|448097665|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
124584960|NCT01438060|448097664|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
124584961|NCT01438060|448097665|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
124584962|NCT01438060|448097664|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
124584963|NCT01438060|448097665|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
124584964|NCT01438060|448097664|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
124584965|NCT01438060|448097665|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
124584966|NCT01438060|448097664|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
124584967|NCT01438060|448097665|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
124584968|NCT01438060|448097664|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
124584969|NCT01438060|448097665|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
124584970|NCT01438060|448097664|FG000|On Study Beyond Week 140|Adverse Event|0|||
124584971|NCT01438060|448097665|FG001|On Study Beyond Week 140|Adverse Event|2|||
124584972|NCT01438060|448097664|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
124584973|NCT01438060|448097665|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
124584974|NCT01438060|448097664|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
124584975|NCT01438060|448097665|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
124584976|NCT01438060|448097664|FG000|On Study Beyond Week 140|Death|0|||
124584977|NCT01438060|448097665|FG001|On Study Beyond Week 140|Death|1|||
124584978|NCT01438060|448097664|FG000|On Study Beyond Week 140|Other Reason|0|||
124584979|NCT01438060|448097665|FG001|On Study Beyond Week 140|Other Reason|3|||
124584980|NCT01442376|448097667|FG000|Overall Study|Adverse Event|0|||
124584981|NCT01442376|448097668|FG001|Overall Study|Adverse Event|3|||
124584982|NCT01442376|448097669|FG002|Overall Study|Adverse Event|2|||
124584983|NCT01442376|448097667|FG000|Overall Study|Death|0|||
124584984|NCT01442376|448097668|FG001|Overall Study|Death|1|||
124584985|NCT01442376|448097669|FG002|Overall Study|Death|1|||
124584986|NCT01442376|448097667|FG000|Overall Study|Withdrawal of consent|0|||
124584987|NCT01442376|448097668|FG001|Overall Study|Withdrawal of consent|0|||
124584988|NCT01442376|448097669|FG002|Overall Study|Withdrawal of consent|1|||
124584989|NCT01442376|448097667|FG000|Overall Study|Patients not treated|2|||
124584990|NCT01442376|448097668|FG001|Overall Study|Patients not treated|3|||
124584991|NCT01442376|448097669|FG002|Overall Study|Patients not treated|1|||
124584992|NCT01442376|448097667|FG000|Overall Study|Not eligible for subsequent cycles|1|||
124584993|NCT01442376|448097668|FG001|Overall Study|Not eligible for subsequent cycles|2|||
124584994|NCT01442376|448097669|FG002|Overall Study|Not eligible for subsequent cycles|0|||
124584995|NCT03499873|448097670|FG000|Overall Study|Withdrawal by Subject|4|||
124584996|NCT03499873|448097671|FG001|Overall Study|Withdrawal by Subject|6|||
124584997|NCT03499873|448097672|FG002|Overall Study|Withdrawal by Subject|1|||
124584998|NCT03499873|448097670|FG000|Overall Study|Subjects condition worsened|0|||
124584999|NCT03499873|448097671|FG001|Overall Study|Subjects condition worsened|3|||
124585000|NCT03499873|448097672|FG002|Overall Study|Subjects condition worsened|11|||
124585001|NCT03499873|448097670|FG000|Overall Study|Adverse Event|8|||
124585002|NCT03499873|448097671|FG001|Overall Study|Adverse Event|3|||
124585003|NCT03499873|448097672|FG002|Overall Study|Adverse Event|6|||
124585004|NCT03499873|448097670|FG000|Overall Study|Physician Decision|1|||
124585005|NCT03499873|448097671|FG001|Overall Study|Physician Decision|0|||
124585006|NCT03499873|448097672|FG002|Overall Study|Physician Decision|0|||
124585007|NCT03499873|448097670|FG000|Overall Study|Administrative reasons|0|||
124585008|NCT03499873|448097671|FG001|Overall Study|Administrative reasons|1|||
124585009|NCT03499873|448097672|FG002|Overall Study|Administrative reasons|0|||
124585010|NCT03499873|448097670|FG000|Overall Study|Concomitant therapy|5|||
124585011|NCT03499873|448097671|FG001|Overall Study|Concomitant therapy|4|||
124585012|NCT03499873|448097672|FG002|Overall Study|Concomitant therapy|7|||
124585013|NCT03499873|448097670|FG000|Overall Study|Miscellaneous|1|||
124585014|NCT03499873|448097671|FG001|Overall Study|Miscellaneous|2|||
124585015|NCT03499873|448097672|FG002|Overall Study|Miscellaneous|2|||
124585016|NCT03499873|448097670|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
124585017|NCT03499873|448097671|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
124585018|NCT03499873|448097672|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
124585019|NCT01964950|448097673|FG000|Overall Study|Protocol Violation|25|||
124585020|NCT04404725|448097674|FG000|First Intervention|Withdrawal by Subject|0|||
124585021|NCT04404725|448097675|FG001|First Intervention|Withdrawal by Subject|2|||
124585022|NCT04404725|448097674|FG000|Second Intervention|Adverse Event|1|||
124585023|NCT04404725|448097675|FG001|Second Intervention|Adverse Event|1|||
124585024|NCT04404725|448097674|FG000|Second Intervention|Withdrawal by Subject|0|||
124585025|NCT04404725|448097675|FG001|Second Intervention|Withdrawal by Subject|1|||
124585026|NCT01075516|448097676|FG000|Overall Study|Death|5|||
124585027|NCT01075516|448097677|FG001|Overall Study|Death|9|||
124585028|NCT01075516|448097676|FG000|Overall Study|Lost to Follow-up|10|||
124585029|NCT01075516|448097677|FG001|Overall Study|Lost to Follow-up|2|||
124585030|NCT01075516|448097676|FG000|Overall Study|Withdrawal by Subject|3|||
124585031|NCT01075516|448097677|FG001|Overall Study|Withdrawal by Subject|5|||
124585032|NCT02252016|448097680|FG000|Overall Study|Lost to Follow-up|2|||
124585033|NCT02252016|448097681|FG001|Overall Study|Lost to Follow-up|1|||
124585034|NCT02252016|448097680|FG000|Overall Study|Physician Decision|1|||
124585035|NCT02252016|448097681|FG001|Overall Study|Physician Decision|0|||
124585036|NCT02252016|448097680|FG000|Overall Study|Withdrawal by Subject|0|||
124585037|NCT02252016|448097681|FG001|Overall Study|Withdrawal by Subject|2|||
124585038|NCT04631562|448097684|FG000|Overall Study|Withdrawal by Subject|0|||
124585039|NCT04631562|448097685|FG001|Overall Study|Withdrawal by Subject|0|||
124585040|NCT04631562|448097686|FG002|Overall Study|Withdrawal by Subject|0|||
124585041|NCT04631562|448097687|FG003|Overall Study|Withdrawal by Subject|0|||
124585042|NCT04631562|448097688|FG004|Overall Study|Withdrawal by Subject|0|||
124585043|NCT04631562|448097689|FG005|Overall Study|Withdrawal by Subject|0|||
124585044|NCT04631562|448097690|FG006|Overall Study|Withdrawal by Subject|0|||
124585045|NCT04631562|448097691|FG007|Overall Study|Withdrawal by Subject|1|||
124729307|NCT03022097|448630200|FG002|Overall Study|Lack of Efficacy|3|||
124729308|NCT03022097|448630201|FG003|Overall Study|Lack of Efficacy|3|||
124729309|NCT03022097|448630198|FG000|Overall Study|Protocol Violation|1|||
124585046|NCT04631562|448097692|FG008|Overall Study|Withdrawal by Subject|0|||
124585047|NCT04631562|448097684|FG000|Overall Study|Other|0|||
124585048|NCT04631562|448097685|FG001|Overall Study|Other|0|||
124585049|NCT04631562|448097686|FG002|Overall Study|Other|0|||
124585050|NCT04631562|448097687|FG003|Overall Study|Other|0|||
124585051|NCT04631562|448097688|FG004|Overall Study|Other|0|||
124585052|NCT04631562|448097689|FG005|Overall Study|Other|0|||
124585053|NCT04631562|448097690|FG006|Overall Study|Other|0|||
124585054|NCT04631562|448097691|FG007|Overall Study|Other|0|||
124585055|NCT04631562|448097692|FG008|Overall Study|Other|1|||
124585056|NCT04631562|448097684|FG000|Overall Study|Lost to Follow-up|0|||
124585057|NCT04631562|448097685|FG001|Overall Study|Lost to Follow-up|0|||
124585058|NCT04631562|448097686|FG002|Overall Study|Lost to Follow-up|0|||
124729310|NCT03022097|448630199|FG001|Overall Study|Protocol Violation|0|||
124585059|NCT04631562|448097687|FG003|Overall Study|Lost to Follow-up|1|||
124585060|NCT04631562|448097688|FG004|Overall Study|Lost to Follow-up|0|||
124585061|NCT04631562|448097689|FG005|Overall Study|Lost to Follow-up|0|||
124585062|NCT04631562|448097690|FG006|Overall Study|Lost to Follow-up|0|||
124585063|NCT04631562|448097691|FG007|Overall Study|Lost to Follow-up|0|||
124585064|NCT04631562|448097692|FG008|Overall Study|Lost to Follow-up|0|||
124585065|NCT04631562|448097684|FG000|Overall Study|Adverse Event|0|||
124585066|NCT04631562|448097685|FG001|Overall Study|Adverse Event|0|||
124585067|NCT04631562|448097686|FG002|Overall Study|Adverse Event|0|||
124585068|NCT04631562|448097687|FG003|Overall Study|Adverse Event|0|||
124585069|NCT04631562|448097688|FG004|Overall Study|Adverse Event|0|||
124585070|NCT04631562|448097689|FG005|Overall Study|Adverse Event|0|||
124585071|NCT04631562|448097690|FG006|Overall Study|Adverse Event|1|||
124585072|NCT04631562|448097691|FG007|Overall Study|Adverse Event|0|||
124585073|NCT04631562|448097692|FG008|Overall Study|Adverse Event|0|||
124585074|NCT02471807|448097698|FG000|Overall Study|Death|14|||
124585075|NCT02471807|448097698|FG000|Overall Study|Withdrawal by Subject|2|||
124585076|NCT02471807|448097698|FG000|Overall Study|Explant|5|||
124585077|NCT02471807|448097698|FG000|Overall Study|Lost to Follow-up|1|||
124585078|NCT02227238|448097710|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
124585079|NCT02227238|448097711|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
124585080|NCT02227238|448097712|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
124585081|NCT02227238|448097710|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
124585082|NCT02227238|448097711|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
124585083|NCT02227238|448097712|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
124585084|NCT02227238|448097710|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
124585085|NCT02227238|448097711|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
124585086|NCT02227238|448097712|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
124585087|NCT02227238|448097710|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
124585088|NCT02227238|448097711|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
124585089|NCT02227238|448097712|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
124585090|NCT02227238|448097710|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
124585091|NCT02227238|448097711|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
124585092|NCT02227238|448097712|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
124585093|NCT02227238|448097710|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
124585094|NCT02227238|448097711|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
124585095|NCT02227238|448097712|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
124585096|NCT02227238|448097710|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
124585097|NCT02227238|448097711|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
124585098|NCT02227238|448097712|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
124585099|NCT02227238|448097710|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
124585100|NCT02227238|448097711|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
124585101|NCT02227238|448097712|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
124585102|NCT02227238|448097710|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
124585103|NCT02227238|448097711|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
124585104|NCT02227238|448097712|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
124585105|NCT02227238|448097710|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
124585106|NCT02227238|448097711|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
124585107|NCT02227238|448097712|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
124585108|NCT02227238|448097710|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
124585109|NCT02227238|448097711|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
124585110|NCT02227238|448097712|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
124585111|NCT02227238|448097710|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
124585112|NCT02227238|448097711|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
124585113|NCT02227238|448097712|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
124585114|NCT02227238|448097710|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
124585115|NCT02227238|448097711|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
124585116|NCT02227238|448097712|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
124585117|NCT02227238|448097710|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
124585118|NCT02227238|448097711|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
124585119|NCT02227238|448097712|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
124585120|NCT04025021|448097713|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
124777446|NCT00541385|448813057|FG000|Overall Study|Adverse Event|6|||
124585121|NCT04025021|448097714|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
124585122|NCT03966911|448097715|FG000|Overall Study|Adverse Event|1|||
124585123|NCT03966911|448097716|FG001|Overall Study|Adverse Event|1|||
124585124|NCT03966911|448097715|FG000|Overall Study|Withdrawal by Subject|8|||
124585125|NCT03966911|448097716|FG001|Overall Study|Withdrawal by Subject|2|||
124637318|NCT06110494|448290467|FG000|Overall Study|Protocol Violation|2|||
124585126|NCT03966911|448097715|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
124585127|NCT03966911|448097716|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
124585128|NCT01986647|448097717|FG000|Overall Study|Lost to Follow-up|4|||
124585129|NCT01986647|448097718|FG001|Overall Study|Lost to Follow-up|1|||
124585130|NCT01986647|448097719|FG002|Overall Study|Lost to Follow-up|4|||
124585131|NCT01986647|448097720|FG003|Overall Study|Lost to Follow-up|4|||
124585132|NCT01986647|448097717|FG000|Overall Study|Withdrawal by Subject|1|||
124585133|NCT01986647|448097718|FG001|Overall Study|Withdrawal by Subject|3|||
124585134|NCT01986647|448097719|FG002|Overall Study|Withdrawal by Subject|2|||
124585135|NCT01986647|448097720|FG003|Overall Study|Withdrawal by Subject|3|||
124585136|NCT01986647|448097717|FG000|Overall Study|Health|5|||
124585137|NCT01986647|448097718|FG001|Overall Study|Health|3|||
124585138|NCT01986647|448097719|FG002|Overall Study|Health|6|||
124585139|NCT01986647|448097720|FG003|Overall Study|Health|4|||
124585140|NCT00868998|448097721|FG000|Overall Study|Screen Failure|1|||
124585141|NCT00868998|448097721|FG000|Overall Study|Withdrawal by Subject|1|||
124585142|NCT00868998|448097721|FG000|Overall Study|Progression of disease|2|||
124585143|NCT00868998|448097721|FG000|Overall Study|Death|1|||
124585144|NCT03498560|448097725|FG000|Overall Study|Found Ineligible|2|||
124585145|NCT03498560|448097725|FG000|Overall Study|Withdrawal by Subject|14|||
124585146|NCT03498560|448097725|FG000|Overall Study|Lost to Follow-up|4|||
124585147|NCT03498560|448097725|FG000|Overall Study|Death|1|||
124585148|NCT01004510|448097730|FG000|Overall Study|Adverse Event|1|||
124585149|NCT00474188|448097733|FG000|Overall Study|Withdrawal by Subject|1|||
124585150|NCT00474188|448097733|FG000|Overall Study|Study discontinued by sponsor|5|||
124585151|NCT01952691|448099016|FG000|Overall Study|Lost to Follow-up|2|||
124585152|NCT00199901|448099017|FG000|Overall Study|Protocol Violation|2|||
124585153|NCT00199901|448099018|FG001|Overall Study|Protocol Violation|0|||
124585154|NCT00199901|448099017|FG000|Overall Study|Withdrawal by Subject|1|||
124585155|NCT00199901|448099018|FG001|Overall Study|Withdrawal by Subject|0|||
124585156|NCT00199901|448099017|FG000|Overall Study|Progressive Disease|24|||
124585157|NCT00199901|448099018|FG001|Overall Study|Progressive Disease|24|||
124585158|NCT05776901|448099021|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
124585159|NCT02302716|448099024|FG000|Overall Study|Adverse Event|1|||
124585160|NCT02302716|448099025|FG001|Overall Study|Adverse Event|1|||
124585161|NCT02302716|448099024|FG000|Overall Study|Death|0|||
124585162|NCT02302716|448099025|FG001|Overall Study|Death|1|||
124585163|NCT02302716|448099024|FG000|Overall Study|Lack of Efficacy|0|||
124585164|NCT02302716|448099025|FG001|Overall Study|Lack of Efficacy|1|||
124585165|NCT02302716|448099024|FG000|Overall Study|Lost to Follow-up|2|||
124585166|NCT02302716|448099025|FG001|Overall Study|Lost to Follow-up|4|||
124585167|NCT02302716|448099024|FG000|Overall Study|Physician Decision|3|||
124585168|NCT02302716|448099025|FG001|Overall Study|Physician Decision|4|||
124585169|NCT02302716|448099024|FG000|Overall Study|Withdrawal by Subject|13|||
124585170|NCT02302716|448099025|FG001|Overall Study|Withdrawal by Subject|7|||
124585171|NCT02302716|448099024|FG000|Overall Study|Protocol Violation|0|||
124585172|NCT02302716|448099025|FG001|Overall Study|Protocol Violation|1|||
124585173|NCT04523480|448099026|FG000|Overall Study|Lost to Follow-up|30|||
124585174|NCT04523480|448099027|FG001|Overall Study|Lost to Follow-up|35|||
124585175|NCT04523480|448099028|FG002|Overall Study|Lost to Follow-up|0|||
124585176|NCT01911429|448099031|FG000|Overall Study|Adverse Event|5|||
124585177|NCT01911429|448099032|FG001|Overall Study|Adverse Event|3|||
124585178|NCT01911429|448099033|FG002|Overall Study|Adverse Event|9|||
124585179|NCT01911429|448099031|FG000|Overall Study|Lack of Efficacy|1|||
124585180|NCT01911429|448099032|FG001|Overall Study|Lack of Efficacy|2|||
124585181|NCT01911429|448099033|FG002|Overall Study|Lack of Efficacy|4|||
124585182|NCT01911429|448099031|FG000|Overall Study|Lost to Follow-up|0|||
124585183|NCT01911429|448099032|FG001|Overall Study|Lost to Follow-up|0|||
124585184|NCT01911429|448099033|FG002|Overall Study|Lost to Follow-up|1|||
124585185|NCT01911429|448099031|FG000|Overall Study|Protocol Violation|0|||
124585186|NCT01911429|448099032|FG001|Overall Study|Protocol Violation|0|||
124585187|NCT01911429|448099033|FG002|Overall Study|Protocol Violation|1|||
124585188|NCT01911429|448099031|FG000|Overall Study|Withdrawal by Subject|5|||
124585189|NCT01911429|448099032|FG001|Overall Study|Withdrawal by Subject|5|||
124585190|NCT01911429|448099033|FG002|Overall Study|Withdrawal by Subject|4|||
124585191|NCT01911429|448099031|FG000|Overall Study|Accidental randomization|0|||
124585192|NCT01911429|448099032|FG001|Overall Study|Accidental randomization|0|||
124585193|NCT01911429|448099033|FG002|Overall Study|Accidental randomization|1|||
124585194|NCT01911429|448099031|FG000|Overall Study|subject left study|1|||
124585195|NCT01911429|448099032|FG001|Overall Study|subject left study|0|||
124585196|NCT01911429|448099033|FG002|Overall Study|subject left study|0|||
124585197|NCT01557751|448099034|FG000|Overall Study|Physician Decision|3|||
124585198|NCT02043132|448099035|FG000|Overall Study|Lost to Follow-up|1|||
124585199|NCT02043132|448099036|FG001|Overall Study|Lost to Follow-up|1|||
124585200|NCT02043132|448099035|FG000|Overall Study|screen failures|4|||
124585201|NCT02043132|448099036|FG001|Overall Study|screen failures|8|||
124585202|NCT01923740|448099037|FG000|Overall Study|Lost to Follow-up|4|||
124585203|NCT01923740|448099038|FG001|Overall Study|Lost to Follow-up|9|||
124585204|NCT01923740|448099037|FG000|Overall Study|Withdrawal by Subject|2|||
124531748|NCT01642004|447896462|FG001|Treatment|Participant request to discontinue study treatment|4|||
124585205|NCT01923740|448099038|FG001|Overall Study|Withdrawal by Subject|0|||
124585206|NCT00472212|448099040|FG000|Overall Study|Lost to Follow-up|6|||
124585207|NCT00472212|448099041|FG001|Overall Study|Lost to Follow-up|4|||
124585208|NCT02462837|448099042|FG000|Overall Study|pt developed hives|1|||
124585209|NCT02462837|448099043|FG001|Overall Study|pt developed hives|0|||
124585210|NCT02462837|448099042|FG000|Overall Study|Withdrawal by Subject|1|||
124585211|NCT02462837|448099043|FG001|Overall Study|Withdrawal by Subject|0|||
124585212|NCT00958724|448099046|FG000|Overall Study|Disease Progression|6|||
124585213|NCT02121184|448099064|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
124585214|NCT02121184|448099065|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
124585215|NCT02121184|448099064|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
124585216|NCT02121184|448099065|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
124585217|NCT02121184|448099064|FG000|Overall Study|Emergency cesarean section required|0|||
124585218|NCT02121184|448099065|FG001|Overall Study|Emergency cesarean section required|2|||
124637319|NCT06110494|448290468|FG001|Overall Study|Protocol Violation|0|||
124531749|NCT01642004|447896461|FG000|Treatment|Participant withdrew consent|5|||
124531750|NCT01642004|447896462|FG001|Treatment|Participant withdrew consent|5|||
124531751|NCT00811395|447896465|FG000|Extension Treatment|Adverse Event|1|||
124531752|NCT00811395|447896466|FG001|Extension Treatment|Adverse Event|2|||
124531753|NCT00811395|447896467|FG002|Extension Treatment|Adverse Event|2|||
124531754|NCT00811395|447896468|FG003|Extension Treatment|Adverse Event|2|||
124531755|NCT00811395|447896469|FG004|Extension Treatment|Adverse Event|0|||
124531756|NCT00811395|447896470|FG005|Extension Treatment|Adverse Event|1|||
124531757|NCT00811395|447896465|FG000|Extension Treatment|Progressive disease|1|||
124531758|NCT00811395|447896466|FG001|Extension Treatment|Progressive disease|1|||
124531759|NCT00811395|447896467|FG002|Extension Treatment|Progressive disease|0|||
124531760|NCT00811395|447896468|FG003|Extension Treatment|Progressive disease|0|||
124531761|NCT00811395|447896469|FG004|Extension Treatment|Progressive disease|0|||
124531762|NCT00811395|447896470|FG005|Extension Treatment|Progressive disease|0|||
124531763|NCT00811395|447896465|FG000|Extension Treatment|Participant did not wish to continue|0|||
124531764|NCT00811395|447896466|FG001|Extension Treatment|Participant did not wish to continue|3|||
124531765|NCT00811395|447896467|FG002|Extension Treatment|Participant did not wish to continue|0|||
124531766|NCT00811395|447896468|FG003|Extension Treatment|Participant did not wish to continue|1|||
124531767|NCT00811395|447896469|FG004|Extension Treatment|Participant did not wish to continue|0|||
124531768|NCT00811395|447896470|FG005|Extension Treatment|Participant did not wish to continue|1|||
124531769|NCT00811395|447896465|FG000|Extension Treatment|Other than above|0|||
124637320|NCT06110494|448290469|FG002|Overall Study|Protocol Violation|1|||
124637321|NCT06110494|448290467|FG000|Overall Study|Dixon's test for outlier analysis|1|||
124637322|NCT06110494|448290468|FG001|Overall Study|Dixon's test for outlier analysis|1|||
124637323|NCT06110494|448290469|FG002|Overall Study|Dixon's test for outlier analysis|0|||
124637324|NCT02914613|448290474|FG000|Overall Study|Withdrawal by Subject|1|||
124637325|NCT02914613|448290475|FG001|Overall Study|Withdrawal by Subject|2|||
124637326|NCT02914613|448290474|FG000|Overall Study|Adverse Event|1|||
124637327|NCT02914613|448290475|FG001|Overall Study|Adverse Event|0|||
124637328|NCT03850496|448290484|FG000|Overall Study|Withdrawal by Subject|1|||
124637329|NCT03850496|448290485|FG001|Overall Study|Withdrawal by Subject|0|||
124637330|NCT03850496|448290486|FG002|Overall Study|Withdrawal by Subject|0|||
124637331|NCT03850496|448290484|FG000|Overall Study|Lost to Follow-up|0|||
124637332|NCT03850496|448290485|FG001|Overall Study|Lost to Follow-up|1|||
124637333|NCT03850496|448290486|FG002|Overall Study|Lost to Follow-up|4|||
124637334|NCT02861807|448290488|FG000|Overall Study|Lost to Follow-up|7|||
124637335|NCT02861807|448290489|FG001|Overall Study|Lost to Follow-up|6|||
124637336|NCT02861807|448290488|FG000|Overall Study|Withdrawal by Subject|5|||
124637337|NCT02861807|448290489|FG001|Overall Study|Withdrawal by Subject|8|||
124637338|NCT05310071|448290490|FG000|Overall Study|Death|0|||
124637339|NCT05310071|448290491|FG001|Overall Study|Death|3|||
124637340|NCT05310071|448290490|FG000|Overall Study|Adverse Event|4|||
124637341|NCT05310071|448290491|FG001|Overall Study|Adverse Event|31|||
124637342|NCT05310071|448290490|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
124637343|NCT05310071|448290491|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
124637344|NCT05310071|448290490|FG000|Overall Study|Protocol Deviation|2|||
124637345|NCT05310071|448290491|FG001|Overall Study|Protocol Deviation|0|||
124637346|NCT05310071|448290490|FG000|Overall Study|Randomized by Mistake|0|||
124637347|NCT05310071|448290491|FG001|Overall Study|Randomized by Mistake|1|||
124637348|NCT05310071|448290490|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
124637349|NCT05310071|448290491|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
124637350|NCT05310071|448290490|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
124637351|NCT05310071|448290491|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
124637352|NCT05310071|448290490|FG000|Overall Study|Site Terminated by Sponsor|0|||
124637353|NCT05310071|448290491|FG001|Overall Study|Site Terminated by Sponsor|2|||
124585219|NCT02121184|448099064|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
124585220|NCT02121184|448099065|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
124585221|NCT00840203|448099066|FG000|First Intervention|Protocol Violation|1|||
124585222|NCT00840203|448099067|FG001|First Intervention|Protocol Violation|1|||
124585223|NCT00840203|448099066|FG000|Washout|Protocol Violation|1|||
124585224|NCT00840203|448099067|FG001|Washout|Protocol Violation|0|||
124585225|NCT05562011|448099071|FG000|Overall Study|Withdrawal by Subject|3|||
124585226|NCT05562011|448099071|FG000|Overall Study|Lost to Follow-up|1|||
124585227|NCT05562011|448099071|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
124585228|NCT05562011|448099071|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
124585229|NCT05562011|448099071|FG000|Overall Study|Device malfunction|13|||
124585230|NCT00487435|448099080|FG000|Overall Study|Adverse Event|146|||
124585231|NCT00487435|448099080|FG000|Overall Study|Death|2|||
124585232|NCT00487435|448099080|FG000|Overall Study|Lack of Efficacy|33|||
124585233|NCT00487435|448099080|FG000|Overall Study|Lost to Follow-up|54|||
124585234|NCT00487435|448099080|FG000|Overall Study|Pregnancy|2|||
124585235|NCT00487435|448099080|FG000|Overall Study|Withdrawal by Subject|132|||
124585236|NCT00487435|448099080|FG000|Overall Study|Resolution Of Pain|1|||
124585237|NCT00487435|448099080|FG000|Overall Study|Study Medication Non-Compliant|32|||
124585238|NCT00487435|448099080|FG000|Overall Study|Other|83|||
124585239|NCT02705716|448099081|FG000|Overall Study|Adverse Event|0|||
124585240|NCT02705716|448099082|FG001|Overall Study|Adverse Event|1|||
124585241|NCT02705716|448099081|FG000|Overall Study|Protocol Violation|3|||
124585242|NCT02705716|448099082|FG001|Overall Study|Protocol Violation|0|||
124585243|NCT02705716|448099081|FG000|Overall Study|Withdrawal of Consent|1|||
124585244|NCT02705716|448099082|FG001|Overall Study|Withdrawal of Consent|1|||
124585245|NCT00562718|448099083|FG000|Overall Study|Death|1|||
124585246|NCT00562718|448099083|FG000|Overall Study|Withdrawal by Subject|3|||
124585247|NCT00562718|448099083|FG000|Overall Study|Adverse Event|4|||
124585248|NCT00562718|448099083|FG000|Overall Study|Lack of Efficacy|2|||
124585249|NCT00562718|448099083|FG000|Overall Study|not stated|1|||
124585250|NCT01868243|448099084|FG000|Overall Study|Death|0|||
124585251|NCT01868243|448099085|FG001|Overall Study|Death|1|||
124585252|NCT02905435|448099087|FG000|Overall Study|Death|2|||
124585253|NCT02905435|448099087|FG000|Overall Study|Physician Decision|1|||
124585254|NCT02905435|448099087|FG000|Overall Study|Lost to Follow-up|4|||
124585255|NCT01507662|448099088|FG000|Overall Study|Death|26|||
124585256|NCT01507662|448099089|FG001|Overall Study|Death|18|||
124585257|NCT01507662|448099088|FG000|Overall Study|Withdrawal by Subject|290|||
124585258|NCT01507662|448099089|FG001|Overall Study|Withdrawal by Subject|287|||
124585259|NCT01507662|448099088|FG000|Overall Study|Lost to Follow-up|498|||
124585260|NCT01507662|448099089|FG001|Overall Study|Lost to Follow-up|523|||
124585261|NCT01507662|448099088|FG000|Overall Study|Proxy interview done|2|||
124585262|NCT01507662|448099089|FG001|Overall Study|Proxy interview done|3|||
124585263|NCT01395017|448099090|FG000|Overall Study|Lost to Follow-up|1|||
124585264|NCT01395017|448099091|FG001|Overall Study|Lost to Follow-up|0|||
124585265|NCT01395017|448099090|FG000|Overall Study|Adverse Event|26|||
124585266|NCT01395017|448099091|FG001|Overall Study|Adverse Event|12|||
124585267|NCT01395017|448099090|FG000|Overall Study|Physician Decision|11|||
124585268|NCT01395017|448099091|FG001|Overall Study|Physician Decision|15|||
124585269|NCT01395017|448099090|FG000|Overall Study|Withdrawal by Subject|14|||
124585270|NCT01395017|448099091|FG001|Overall Study|Withdrawal by Subject|8|||
124585271|NCT01395017|448099090|FG000|Overall Study|Protocol deviation|1|||
124585272|NCT01395017|448099091|FG001|Overall Study|Protocol deviation|2|||
124585273|NCT01395017|448099090|FG000|Overall Study|Death|4|||
124585274|NCT01395017|448099091|FG001|Overall Study|Death|3|||
124585275|NCT01395017|448099090|FG000|Overall Study|Disease progression|42|||
124585276|NCT01395017|448099091|FG001|Overall Study|Disease progression|58|||
124585277|NCT01395017|448099090|FG000|Overall Study|Sponsor discontinued study|1|||
124585278|NCT01395017|448099091|FG001|Overall Study|Sponsor discontinued study|4|||
124585279|NCT03541252|448099092|FG000|Overall Study|Withdrawal by Subject|1|||
124585280|NCT03961204|448099095|FG000|Overall Study|Withdrawal by Subject|2|||
124585281|NCT03961204|448099095|FG000|Overall Study|Lost to Follow-up|3|||
124585282|NCT03961204|448099095|FG000|Overall Study|Other|1|||
124585283|NCT03961204|448099095|FG000|Overall Study|Missing|1|||
124585284|NCT01566435|448099097|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
124585285|NCT03733145|448099103|FG000|Overall Study|screenfail|3|||
124585286|NCT03733145|448099104|FG001|Overall Study|screenfail|3|||
124585287|NCT03733145|448099105|FG002|Overall Study|screenfail|2|||
124585288|NCT04236596|448099106|FG000|Overall Study|Withdrawal by Subject|1|||
124585289|NCT04236596|448099106|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
124585290|NCT04236596|448099106|FG000|Overall Study|Participants did not receive implant at all|4|||
124585291|NCT00798603|448100499|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
124585292|NCT00798603|448100499|FG000|Overall Study|Withdrawal by Subject|10|||
124585293|NCT00798603|448100499|FG000|Overall Study|Adverse Event|22|||
124585294|NCT00798603|448100499|FG000|Overall Study|Physician Decision|1|||
124585295|NCT00798603|448100499|FG000|Overall Study|Lack of insurance coverage|1|||
124729311|NCT03022097|448630200|FG002|Overall Study|Protocol Violation|1|||
124729312|NCT03022097|448630201|FG003|Overall Study|Protocol Violation|0|||
124729313|NCT03022097|448630198|FG000|Overall Study|Withdrawal by Subject|11|||
124729314|NCT03022097|448630199|FG001|Overall Study|Withdrawal by Subject|13|||
124729315|NCT03022097|448630200|FG002|Overall Study|Withdrawal by Subject|15|||
124729316|NCT03022097|448630201|FG003|Overall Study|Withdrawal by Subject|21|||
124729317|NCT03022097|448630198|FG000|Overall Study|Lost to Follow-up|0|||
124729318|NCT03022097|448630199|FG001|Overall Study|Lost to Follow-up|0|||
124729319|NCT03022097|448630200|FG002|Overall Study|Lost to Follow-up|1|||
124729320|NCT03022097|448630201|FG003|Overall Study|Lost to Follow-up|1|||
124729321|NCT03022097|448630198|FG000|Overall Study|Other|4|||
124729322|NCT03022097|448630199|FG001|Overall Study|Other|1|||
124729323|NCT03022097|448630200|FG002|Overall Study|Other|6|||
124729324|NCT03022097|448630201|FG003|Overall Study|Other|4|||
124729325|NCT03022097|448630198|FG000|Overall Study|Due to COVID-19 pandemic|0|||
124729326|NCT03022097|448630199|FG001|Overall Study|Due to COVID-19 pandemic|1|||
124729327|NCT03022097|448630200|FG002|Overall Study|Due to COVID-19 pandemic|0|||
124729328|NCT03022097|448630201|FG003|Overall Study|Due to COVID-19 pandemic|0|||
124729329|NCT01451931|448630204|FG000|Overall Study|Lost to Follow-up|17|||
124729330|NCT01451931|448630205|FG001|Overall Study|Lost to Follow-up|36|||
124729331|NCT01451931|448630206|FG002|Overall Study|Lost to Follow-up|21|||
124729332|NCT01451931|448630204|FG000|Overall Study|Withdrawal by Subject|16|||
124729333|NCT01451931|448630205|FG001|Overall Study|Withdrawal by Subject|22|||
124729334|NCT01451931|448630206|FG002|Overall Study|Withdrawal by Subject|22|||
124729335|NCT00503581|448630207|FG000|Overall Study|Study closed|3|||
124729336|NCT00503581|448630208|FG001|Overall Study|Study closed|4|||
124729337|NCT00503581|448630209|FG002|Overall Study|Study closed|2|||
124729338|NCT04470908|448630210|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
124729339|NCT06107803|448630216|FG000|Overall Study|Adverse Event|1|||
124729340|NCT06107803|448630216|FG000|Overall Study|Withdrawal by Subject|2|||
124729341|NCT06107803|448630216|FG000|Overall Study|Protocol Violation|1|||
124729342|NCT02378298|448630218|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
124729343|NCT02378298|448630219|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
124729344|NCT02378298|448630220|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
124729345|NCT02378298|448630218|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
124729346|NCT02378298|448630219|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
124729347|NCT02378298|448630220|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
124729348|NCT02378298|448630218|FG000|Surveillance (19-68 Weeks)|Death|1|||
124729349|NCT02378298|448630219|FG001|Surveillance (19-68 Weeks)|Death|0|||
124729350|NCT02378298|448630220|FG002|Surveillance (19-68 Weeks)|Death|0|||
124729351|NCT04730635|448630221|FG000|Overall Study|Lost to Follow-up|1|||
124729352|NCT04730635|448630222|FG001|Overall Study|Lost to Follow-up|0|||
124729353|NCT04730635|448630221|FG000|Overall Study|Withdrawal by Subject|0|||
124729354|NCT04730635|448630222|FG001|Overall Study|Withdrawal by Subject|1|||
124729355|NCT04934800|448630223|FG000|Overall Study|Other|1|||
124729356|NCT04934800|448630223|FG000|Overall Study|Withdrawal by Subject|5|||
124729357|NCT04934800|448630223|FG000|Overall Study|Lack of Efficacy|1|||
124729358|NCT04934800|448630223|FG000|Overall Study|Adverse Event|9|||
124729359|NCT04934800|448630223|FG000|Overall Study|Lost to Follow-up|5|||
124729360|NCT04934800|448630223|FG000|Overall Study|Enrolled but not treated|1|||
124729361|NCT02118766|448630226|FG000|Overall Study|Adverse Event|7|||
124729362|NCT02118766|448630227|FG001|Overall Study|Adverse Event|2|||
124729363|NCT02118766|448630226|FG000|Overall Study|Withdrawal by Subject|3|||
124729364|NCT02118766|448630227|FG001|Overall Study|Withdrawal by Subject|6|||
124729365|NCT02118766|448630226|FG000|Overall Study|Lost to Follow-up|5|||
124585296|NCT02316223|448100502|FG000|Overall Study|Lack of Efficacy|0|||
124585297|NCT02316223|448100503|FG001|Overall Study|Lack of Efficacy|1|||
124585298|NCT02316223|448100504|FG002|Overall Study|Lack of Efficacy|1|||
124585299|NCT02316223|448100502|FG000|Overall Study|Lost to Follow-up|27|||
124585300|NCT02316223|448100503|FG001|Overall Study|Lost to Follow-up|34|||
124585301|NCT02316223|448100504|FG002|Overall Study|Lost to Follow-up|36|||
124585302|NCT02316223|448100502|FG000|Overall Study|COPD Diagnosis|3|||
124585303|NCT02316223|448100503|FG001|Overall Study|COPD Diagnosis|2|||
124585304|NCT02316223|448100504|FG002|Overall Study|COPD Diagnosis|3|||
124585305|NCT02316223|448100502|FG000|Overall Study|Reside outside study area|1|||
124585306|NCT02316223|448100503|FG001|Overall Study|Reside outside study area|1|||
124729366|NCT02118766|448630227|FG001|Overall Study|Lost to Follow-up|4|||
124729367|NCT02118766|448630226|FG000|Overall Study|Withdrawal by parent/guardian|12|||
124729368|NCT02118766|448630227|FG001|Overall Study|Withdrawal by parent/guardian|18|||
124729369|NCT02118766|448630226|FG000|Overall Study|Other|3|||
124729370|NCT02118766|448630227|FG001|Overall Study|Other|1|||
124585307|NCT02316223|448100504|FG002|Overall Study|Reside outside study area|1|||
124585308|NCT02316223|448100502|FG000|Overall Study|No asthma|2|||
124585309|NCT02316223|448100503|FG001|Overall Study|No asthma|0|||
124729371|NCT03941964|448630231|FG000|Overall Study|Adverse Event|1|||
124585310|NCT02316223|448100504|FG002|Overall Study|No asthma|0|||
124585311|NCT02316223|448100502|FG000|Overall Study|Discontinued by PI|11|||
124585312|NCT02316223|448100503|FG001|Overall Study|Discontinued by PI|19|||
124585313|NCT02316223|448100504|FG002|Overall Study|Discontinued by PI|3|||
124585314|NCT00521586|448100506|FG000|Initial Vaccination (Year 0)|Subject request|8|||
124585315|NCT00521586|448100507|FG001|Initial Vaccination (Year 0)|Subject request|11|||
124585316|NCT00521586|448100506|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
124585317|NCT00521586|448100507|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
124585318|NCT00521586|448100506|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
124585319|NCT00521586|448100507|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
124585320|NCT00521586|448100506|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
124585321|NCT00521586|448100507|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
124585322|NCT00521586|448100506|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
124585323|NCT00521586|448100507|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
124585324|NCT00521586|448100506|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
124585325|NCT00521586|448100507|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
124585326|NCT00521586|448100506|FG000|Initial Vaccination (Year 0)|Death|1|||
124585327|NCT00521586|448100507|FG001|Initial Vaccination (Year 0)|Death|0|||
124585328|NCT00521586|448100506|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
124585329|NCT00521586|448100507|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
124585330|NCT00521586|448100506|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
124585331|NCT00521586|448100507|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
124777447|NCT00541385|448813058|FG001|Overall Study|Adverse Event|3|||
124777448|NCT00541385|448813057|FG000|Overall Study|Withdrawal by Subject|2|||
124777449|NCT00541385|448813058|FG001|Overall Study|Withdrawal by Subject|2|||
124777450|NCT00541385|448813057|FG000|Overall Study|Lost to Follow-up|6|||
124777451|NCT00541385|448813058|FG001|Overall Study|Lost to Follow-up|1|||
124777452|NCT00541385|448813057|FG000|Overall Study|Parasite reappearance/malaria|67|||
124777453|NCT00541385|448813058|FG001|Overall Study|Parasite reappearance/malaria|32|||
124777454|NCT01499355|448813061|FG000|Run-In Period|Study Termination|15|||
124777455|NCT01499355|448813062|FG001|Run-In Period|Study Termination|0|||
124777456|NCT01499355|448813063|FG002|Run-In Period|Study Termination|0|||
124777457|NCT01499355|448813064|FG003|Run-In Period|Study Termination|0|||
124777458|NCT01499355|448813061|FG000|Run-In Period|Other|3|||
124777459|NCT01499355|448813062|FG001|Run-In Period|Other|0|||
124777460|NCT01499355|448813063|FG002|Run-In Period|Other|0|||
124777461|NCT01499355|448813064|FG003|Run-In Period|Other|0|||
124777462|NCT01499355|448813061|FG000|Run-In Period|Death|2|||
124777463|NCT01499355|448813062|FG001|Run-In Period|Death|0|||
124777464|NCT01499355|448813063|FG002|Run-In Period|Death|0|||
124777465|NCT01499355|448813064|FG003|Run-In Period|Death|0|||
124777466|NCT01499355|448813061|FG000|Run-In Period|Investigator Decision|2|||
124777467|NCT01499355|448813062|FG001|Run-In Period|Investigator Decision|0|||
124777468|NCT01499355|448813063|FG002|Run-In Period|Investigator Decision|0|||
124777469|NCT01499355|448813064|FG003|Run-In Period|Investigator Decision|0|||
124777470|NCT01499355|448813061|FG000|Run-In Period|Consent Withdrawn|1|||
124585332|NCT00521586|448100506|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
124585333|NCT00521586|448100507|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
124585334|NCT00521586|448100506|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
124585335|NCT00521586|448100507|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
124585336|NCT00521586|448100506|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
124585337|NCT00521586|448100507|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
124585338|NCT00521586|448100506|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
124585339|NCT00521586|448100507|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
124585340|NCT00521586|448100506|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
124585341|NCT00521586|448100507|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
124585342|NCT00521586|448100506|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
124585343|NCT00521586|448100507|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
124585344|NCT00521586|448100506|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
124585345|NCT00521586|448100507|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
124585346|NCT00521586|448100506|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
124585347|NCT00521586|448100507|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
124585348|NCT00521586|448100506|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
124585349|NCT00521586|448100507|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
124585350|NCT00521586|448100506|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
124585351|NCT00521586|448100507|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
124585352|NCT00529763|448100508|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
124585353|NCT00529763|448100509|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
124585354|NCT00529763|448100510|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
124777471|NCT01499355|448813062|FG001|Run-In Period|Consent Withdrawn|0|||
124777472|NCT01499355|448813063|FG002|Run-In Period|Consent Withdrawn|0|||
124777473|NCT01499355|448813064|FG003|Run-In Period|Consent Withdrawn|0|||
124777474|NCT01499355|448813061|FG000|Run-In Period|Adverse Event|8|||
124777475|NCT01499355|448813062|FG001|Run-In Period|Adverse Event|0|||
124585355|NCT00529763|448100508|FG000|Overall Study|Death|1|||
124585356|NCT00529763|448100509|FG001|Overall Study|Death|1|||
124585357|NCT00529763|448100510|FG002|Overall Study|Death|1|||
124585358|NCT00529763|448100508|FG000|Overall Study|Disease Progression|10|||
124585359|NCT00529763|448100509|FG001|Overall Study|Disease Progression|16|||
124585360|NCT00529763|448100510|FG002|Overall Study|Disease Progression|11|||
124585361|NCT00529763|448100508|FG000|Overall Study|Lost to Follow-up|1|||
124585362|NCT00529763|448100509|FG001|Overall Study|Lost to Follow-up|2|||
124585363|NCT00529763|448100510|FG002|Overall Study|Lost to Follow-up|3|||
124585364|NCT00529763|448100508|FG000|Overall Study|Stem Cell Transplant|0|||
124585365|NCT00529763|448100509|FG001|Overall Study|Stem Cell Transplant|3|||
124585366|NCT00529763|448100510|FG002|Overall Study|Stem Cell Transplant|1|||
124585367|NCT00529763|448100508|FG000|Overall Study|Study Drug Toxicity|3|||
124585368|NCT00529763|448100509|FG001|Overall Study|Study Drug Toxicity|6|||
124585369|NCT00529763|448100510|FG002|Overall Study|Study Drug Toxicity|4|||
124585370|NCT00529763|448100508|FG000|Overall Study|Participant Withdrew Consent|2|||
124585371|NCT00529763|448100509|FG001|Overall Study|Participant Withdrew Consent|3|||
124585372|NCT00529763|448100510|FG002|Overall Study|Participant Withdrew Consent|4|||
124585373|NCT00529763|448100508|FG000|Overall Study|Other reasons|2|||
124585374|NCT00529763|448100509|FG001|Overall Study|Other reasons|0|||
124585375|NCT00529763|448100510|FG002|Overall Study|Other reasons|2|||
124585376|NCT00529763|448100508|FG000|Overall Study|Participant request to discontinue treatment|1|||
124585377|NCT00529763|448100509|FG001|Overall Study|Participant request to discontinue treatment|1|||
124585378|NCT00529763|448100510|FG002|Overall Study|Participant request to discontinue treatment|3|||
124585379|NCT03669250|448100511|FG000|Overall Study|Adverse Event|0|||
124585380|NCT03669250|448100512|FG001|Overall Study|Adverse Event|0|||
124585381|NCT03669250|448100513|FG002|Overall Study|Adverse Event|0|||
124585382|NCT03669250|448100514|FG003|Overall Study|Adverse Event|0|||
124585383|NCT03669250|448100515|FG004|Overall Study|Adverse Event|1|||
124585384|NCT03669250|448100516|FG005|Overall Study|Adverse Event|0|||
124585385|NCT03669250|448100511|FG000|Overall Study|Withdrawal by Subject|0|||
124585386|NCT03669250|448100512|FG001|Overall Study|Withdrawal by Subject|1|||
124585387|NCT03669250|448100513|FG002|Overall Study|Withdrawal by Subject|0|||
124585388|NCT03669250|448100514|FG003|Overall Study|Withdrawal by Subject|1|||
124585389|NCT03669250|448100515|FG004|Overall Study|Withdrawal by Subject|0|||
124585390|NCT03669250|448100516|FG005|Overall Study|Withdrawal by Subject|0|||
124585391|NCT00828321|448100517|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
124585392|NCT00828321|448100518|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
124585393|NCT00828321|448100517|FG000|Second Intervention|Protocol Violation|0|||
124585394|NCT00828321|448100518|FG001|Second Intervention|Protocol Violation|1|||
124585395|NCT03234907|448100519|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
124585396|NCT03234907|448100520|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
124585397|NCT03234907|448100521|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
124585398|NCT03234907|448100522|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
124585399|NCT03234907|448100523|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
124585400|NCT03234907|448100524|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
124585401|NCT03234907|448100519|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
124585402|NCT03234907|448100520|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
124585403|NCT03234907|448100521|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
124585404|NCT03234907|448100522|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
124585405|NCT03234907|448100523|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
124585406|NCT03234907|448100524|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
124585407|NCT03234907|448100519|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
124585408|NCT03234907|448100520|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
124585409|NCT03234907|448100521|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
124585410|NCT03234907|448100522|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
124585411|NCT03234907|448100523|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
124585412|NCT03234907|448100524|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
124585413|NCT03234907|448100519|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
124585414|NCT03234907|448100520|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
124585415|NCT03234907|448100521|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
124585416|NCT03234907|448100522|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
124585417|NCT03234907|448100523|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
124585418|NCT03234907|448100524|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
124585419|NCT03234907|448100519|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
124585420|NCT03234907|448100520|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
124585421|NCT03234907|448100521|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
124585422|NCT03234907|448100522|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
124585423|NCT03234907|448100523|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
124777476|NCT01499355|448813063|FG002|Run-In Period|Adverse Event|0|||
124777477|NCT01499355|448813064|FG003|Run-In Period|Adverse Event|0|||
124585424|NCT03234907|448100524|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
124585425|NCT03234907|448100519|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
124585426|NCT03234907|448100520|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
124585427|NCT03234907|448100521|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
124585428|NCT03234907|448100522|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
124585429|NCT03234907|448100523|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
124585430|NCT03234907|448100524|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
124585431|NCT03234907|448100519|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
124585432|NCT03234907|448100520|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
124585433|NCT03234907|448100521|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
124585434|NCT03234907|448100522|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
124585435|NCT03234907|448100523|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
124585436|NCT03234907|448100524|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
124585437|NCT02664415|448100525|FG000|Overall Study|Adverse Event|1|||
124585438|NCT02664415|448100526|FG001|Overall Study|Adverse Event|0|||
124585439|NCT02107196|448100531|FG000|12-week Treatment Period|Adverse Event|6|||
124585440|NCT02107196|448100532|FG001|12-week Treatment Period|Adverse Event|3|||
124585441|NCT02107196|448100531|FG000|12-week Treatment Period|Lack of Efficacy|2|||
124585442|NCT02107196|448100532|FG001|12-week Treatment Period|Lack of Efficacy|1|||
124585443|NCT02107196|448100531|FG000|12-week Treatment Period|Lost to Follow-up|3|||
124585444|NCT02107196|448100532|FG001|12-week Treatment Period|Lost to Follow-up|6|||
124585445|NCT02107196|448100531|FG000|12-week Treatment Period|Physician Decision|0|||
124585446|NCT02107196|448100532|FG001|12-week Treatment Period|Physician Decision|1|||
124585447|NCT02107196|448100531|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
124585448|NCT02107196|448100532|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
124585449|NCT02107196|448100531|FG000|12-week Treatment Period|Protocol Violation|7|||
124585450|NCT02107196|448100532|FG001|12-week Treatment Period|Protocol Violation|8|||
124585451|NCT02107196|448100531|FG000|12-week Treatment Period|Reason Missing|11|||
124585452|NCT02107196|448100532|FG001|12-week Treatment Period|Reason Missing|8|||
124585453|NCT02107196|448100531|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
124585454|NCT02107196|448100532|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
124585455|NCT02107196|448100531|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
124585456|NCT02107196|448100532|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
124585457|NCT02107196|448100531|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
124585458|NCT02107196|448100532|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
124585459|NCT02107196|448100531|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
124585460|NCT02107196|448100532|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
124585461|NCT00516295|448100533|FG000|Overall Study|Lack of Efficacy|2|||
124585462|NCT00516295|448100534|FG001|Overall Study|Lack of Efficacy|0|||
124585463|NCT00516295|448100535|FG002|Overall Study|Lack of Efficacy|0|||
124585464|NCT00516295|448100533|FG000|Overall Study|Ineligible|1|||
124585465|NCT00516295|448100534|FG001|Overall Study|Ineligible|0|||
124585466|NCT00516295|448100535|FG002|Overall Study|Ineligible|0|||
124585467|NCT01243151|448100536|FG000|Overall Study|Adverse Event|0|||
124585468|NCT01243151|448100537|FG001|Overall Study|Adverse Event|1|||
124585469|NCT01243151|448100538|FG002|Overall Study|Adverse Event|0|||
124585470|NCT01243151|448100539|FG003|Overall Study|Adverse Event|0|||
124585471|NCT01243151|448100540|FG004|Overall Study|Adverse Event|0|||
124585472|NCT01243151|448100536|FG000|Overall Study|Protocol Violation|0|||
124585473|NCT01243151|448100537|FG001|Overall Study|Protocol Violation|0|||
124585474|NCT01243151|448100538|FG002|Overall Study|Protocol Violation|1|||
124585475|NCT01243151|448100539|FG003|Overall Study|Protocol Violation|0|||
124585476|NCT01243151|448100540|FG004|Overall Study|Protocol Violation|0|||
124585477|NCT01243151|448100536|FG000|Overall Study|Other|0|||
124585478|NCT01243151|448100537|FG001|Overall Study|Other|0|||
124585479|NCT01243151|448100538|FG002|Overall Study|Other|0|||
124585480|NCT01243151|448100539|FG003|Overall Study|Other|1|||
124585481|NCT01243151|448100540|FG004|Overall Study|Other|0|||
124585482|NCT01243151|448100536|FG000|Overall Study|Randomized but not treated|0|||
124585483|NCT01243151|448100537|FG001|Overall Study|Randomized but not treated|0|||
124585484|NCT01243151|448100538|FG002|Overall Study|Randomized but not treated|0|||
124585485|NCT01243151|448100539|FG003|Overall Study|Randomized but not treated|1|||
124585486|NCT01243151|448100540|FG004|Overall Study|Randomized but not treated|0|||
124585487|NCT03119662|448100541|FG000|Overall Study|Withdrawal by Subject|0|||
124585488|NCT03119662|448100542|FG001|Overall Study|Withdrawal by Subject|1|||
124585489|NCT01630616|448100546|FG000|Overall Study|Adverse Event|0|||
124729372|NCT03941964|448630232|FG001|Overall Study|Adverse Event|8|||
124729373|NCT03941964|448630231|FG000|Overall Study|Progressive disease|7|||
124729374|NCT03941964|448630232|FG001|Overall Study|Progressive disease|3|||
124729375|NCT03941964|448630231|FG000|Overall Study|Lack of Efficacy|0|||
124729376|NCT03941964|448630232|FG001|Overall Study|Lack of Efficacy|1|||
124729377|NCT03941964|448630231|FG000|Overall Study|Death|3|||
124729378|NCT03941964|448630232|FG001|Overall Study|Death|1|||
124729379|NCT03941964|448630231|FG000|Overall Study|Withdrew consent|1|||
124585490|NCT01630616|448100547|FG001|Overall Study|Adverse Event|0|||
124585491|NCT01630616|448100548|FG002|Overall Study|Adverse Event|0|||
124585492|NCT01630616|448100549|FG003|Overall Study|Adverse Event|1|||
124585493|NCT01630616|448100550|FG004|Overall Study|Adverse Event|0|||
124585494|NCT01630616|448100551|FG005|Overall Study|Adverse Event|0|||
124585495|NCT01630616|448100546|FG000|Overall Study|Withdrawal by Subject|0|||
124585496|NCT01630616|448100547|FG001|Overall Study|Withdrawal by Subject|0|||
124585497|NCT01630616|448100548|FG002|Overall Study|Withdrawal by Subject|0|||
124585498|NCT01630616|448100549|FG003|Overall Study|Withdrawal by Subject|2|||
124585499|NCT01630616|448100550|FG004|Overall Study|Withdrawal by Subject|0|||
124585500|NCT01630616|448100551|FG005|Overall Study|Withdrawal by Subject|0|||
124585501|NCT02218541|448100552|FG000|Overall Study|Lost to Follow-up|2|||
124585502|NCT02218541|448100553|FG001|Overall Study|Lost to Follow-up|1|||
124585503|NCT02218541|448100552|FG000|Overall Study|Implant Failure|4|||
124585504|NCT02218541|448100553|FG001|Overall Study|Implant Failure|1|||
124585505|NCT01993186|448100555|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
124585506|NCT01993186|448100556|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
124585507|NCT01993186|448100555|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
124585508|NCT01993186|448100556|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
124585509|NCT01993186|448100555|FG000|Open-Label Extension Period|Other, Not Specified|0|||
124585510|NCT01993186|448100556|FG001|Open-Label Extension Period|Other, Not Specified|1|||
124585511|NCT01993186|448100555|FG000|Open-Label Extension Period|Adverse Event|1|||
124585512|NCT01993186|448100556|FG001|Open-Label Extension Period|Adverse Event|0|||
124585513|NCT01993186|448100555|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
124585514|NCT01993186|448100556|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
124585515|NCT01993186|448100555|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
124585516|NCT01993186|448100556|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
124585517|NCT01993186|448100555|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
124585518|NCT01993186|448100556|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
124585519|NCT01853176|448100557|FG000|Overall Study|Study terminated|4|||
124585520|NCT01853176|448100558|FG001|Overall Study|Study terminated|0|||
124585521|NCT00198133|448100559|FG000|Overall Study|Disease progression|2|||
124585522|NCT00198133|448100560|FG001|Overall Study|Disease progression|5|||
124585523|NCT00198133|448100559|FG000|Overall Study|Adverse Event|1|||
124585524|NCT00198133|448100560|FG001|Overall Study|Adverse Event|3|||
124585525|NCT00198133|448100559|FG000|Overall Study|Withdrawal by Subject|1|||
124585526|NCT00198133|448100560|FG001|Overall Study|Withdrawal by Subject|0|||
124585527|NCT00198133|448100559|FG000|Overall Study|Physician Decision|1|||
124585528|NCT00198133|448100560|FG001|Overall Study|Physician Decision|0|||
124585529|NCT03827395|448100561|FG000|Overall Study|Lost to Follow-up|1|||
124585530|NCT03827395|448100562|FG001|Overall Study|Lost to Follow-up|0|||
124585531|NCT03827395|448100561|FG000|Overall Study|Protocol Violation|1|||
124585532|NCT03827395|448100562|FG001|Overall Study|Protocol Violation|0|||
124585533|NCT03827395|448100561|FG000|Overall Study|Became ineligible after enrollment|1|||
124585534|NCT03827395|448100562|FG001|Overall Study|Became ineligible after enrollment|2|||
124585535|NCT00731939|448100563|FG000|Overall Study|Adverse Event|6|||
124585536|NCT00731939|448100563|FG000|Overall Study|Lost to Follow-up|15|||
124585537|NCT00731939|448100563|FG000|Overall Study|Not implanted with study device|9|||
124585538|NCT00731939|448100563|FG000|Overall Study|Withdrawal by Subject|2|||
124585539|NCT00731939|448100563|FG000|Overall Study|Did not meet enrollment criteria|2|||
124585540|NCT02072096|448100570|FG000|Overall Study|Lack of Efficacy|18|||
124585541|NCT02072096|448100571|FG001|Overall Study|Lack of Efficacy|29|||
124585542|NCT02072096|448100570|FG000|Overall Study|Protocol Violation|7|||
124585543|NCT02072096|448100571|FG001|Overall Study|Protocol Violation|7|||
124585544|NCT02072096|448100570|FG000|Overall Study|Withdrawal by Subject|5|||
124585545|NCT02072096|448100571|FG001|Overall Study|Withdrawal by Subject|7|||
124585546|NCT02072096|448100570|FG000|Overall Study|Adverse Event|5|||
124585547|NCT02072096|448100571|FG001|Overall Study|Adverse Event|2|||
124585548|NCT02072096|448100570|FG000|Overall Study|No Reason Provided|4|||
124585549|NCT02072096|448100571|FG001|Overall Study|No Reason Provided|2|||
124585550|NCT02072096|448100570|FG000|Overall Study|Death|2|||
124585551|NCT02072096|448100571|FG001|Overall Study|Death|0|||
124585552|NCT02072096|448100570|FG000|Overall Study|Physician Decision|0|||
124585553|NCT02072096|448100571|FG001|Overall Study|Physician Decision|1|||
124585554|NCT02072096|448100570|FG000|Overall Study|Study Terminated by Sponsor|43|||
124777478|NCT01499355|448813061|FG000|Double-Blind Period|Adverse Event|0|||
124585555|NCT02072096|448100571|FG001|Overall Study|Study Terminated by Sponsor|30|||
124585556|NCT02072096|448100570|FG000|Overall Study|Lost to Follow-up|1|||
124585557|NCT02072096|448100571|FG001|Overall Study|Lost to Follow-up|0|||
124585558|NCT01634139|448100572|FG000|Overall Study|Non compliant with protocol|1|||
124585559|NCT01634139|448100573|FG001|Overall Study|Non compliant with protocol|0|||
124585560|NCT01634139|448100574|FG002|Overall Study|Non compliant with protocol|0|||
124585561|NCT01634139|448100572|FG000|Overall Study|Consent withdrawn not due to AE|4|||
124585562|NCT01634139|448100573|FG001|Overall Study|Consent withdrawn not due to AE|3|||
124585563|NCT01634139|448100574|FG002|Overall Study|Consent withdrawn not due to AE|2|||
124585564|NCT01634139|448100572|FG000|Overall Study|Other|4|||
124585565|NCT01634139|448100573|FG001|Overall Study|Other|0|||
124585566|NCT01634139|448100574|FG002|Overall Study|Other|3|||
124585567|NCT01634139|448100572|FG000|Overall Study|Lost to Follow-up|0|||
124585568|NCT01634139|448100573|FG001|Overall Study|Lost to Follow-up|2|||
124585569|NCT01634139|448100574|FG002|Overall Study|Lost to Follow-up|0|||
124585570|NCT01634139|448100572|FG000|Overall Study|Not treated|1|||
124585571|NCT01634139|448100573|FG001|Overall Study|Not treated|1|||
124585572|NCT01634139|448100574|FG002|Overall Study|Not treated|0|||
124585573|NCT01168856|448100576|FG000|Overall Study|Lost to Follow-up|4|||
124531770|NCT00811395|447896466|FG001|Extension Treatment|Other than above|0|||
124531771|NCT00811395|447896467|FG002|Extension Treatment|Other than above|1|||
124531772|NCT00811395|447896468|FG003|Extension Treatment|Other than above|0|||
124531773|NCT00811395|447896469|FG004|Extension Treatment|Other than above|0|||
124531774|NCT00811395|447896470|FG005|Extension Treatment|Other than above|0|||
124531775|NCT00528840|447896475|FG000|Overall Study|Lost to Follow-up|10|||
124531776|NCT00528840|447896475|FG000|Overall Study|Adverse Event|1|||
124531777|NCT00528840|447896475|FG000|Overall Study|Withdrawal by Subject|17|||
124531778|NCT00528840|447896475|FG000|Overall Study|Death|2|||
124531779|NCT00528840|447896475|FG000|Overall Study|Administrative Reasons|1|||
124531780|NCT00528840|447896475|FG000|Overall Study|Other|2|||
124531781|NCT00398086|447896481|FG000|Overall Study|Unacceptable Toxicity|2|||
124531782|NCT00398086|447896482|FG001|Overall Study|Unacceptable Toxicity|8|||
124531783|NCT00398086|447896483|FG002|Overall Study|Unacceptable Toxicity|2|||
124531784|NCT00398086|447896481|FG000|Overall Study|Adverse Event|1|||
124531785|NCT00398086|447896482|FG001|Overall Study|Adverse Event|4|||
124531786|NCT00398086|447896483|FG002|Overall Study|Adverse Event|0|||
124531787|NCT00398086|447896481|FG000|Overall Study|Physician Decision|1|||
124531788|NCT00398086|447896482|FG001|Overall Study|Physician Decision|4|||
124531789|NCT00398086|447896483|FG002|Overall Study|Physician Decision|0|||
124531790|NCT00398086|447896481|FG000|Overall Study|Withdrawal by Subject|5|||
124531791|NCT00398086|447896482|FG001|Overall Study|Withdrawal by Subject|7|||
124531792|NCT00398086|447896483|FG002|Overall Study|Withdrawal by Subject|0|||
124531793|NCT01950364|447896484|FG000|Overall Study|Adverse Event|3|||
124531794|NCT01950364|447896485|FG001|Overall Study|Adverse Event|0|||
124531795|NCT01950364|447896484|FG000|Overall Study|Stem Cell Transplant|2|||
124531796|NCT01950364|447896485|FG001|Overall Study|Stem Cell Transplant|6|||
124531797|NCT01950364|447896484|FG000|Overall Study|Disease Progression|5|||
124531798|NCT01950364|447896485|FG001|Overall Study|Disease Progression|2|||
124531799|NCT01950364|447896484|FG000|Overall Study|Withdrawal by Subject|0|||
124531800|NCT01950364|447896485|FG001|Overall Study|Withdrawal by Subject|1|||
124531801|NCT01950364|447896484|FG000|Overall Study|Protocol Violation|0|||
124531802|NCT01950364|447896485|FG001|Overall Study|Protocol Violation|1|||
124531803|NCT01166386|447896487|FG000|Overall Study|Withdrawal by Subject|3|||
124531804|NCT01166386|447896488|FG001|Overall Study|Withdrawal by Subject|5|||
124531805|NCT02972658|447897945|FG000|Overall Study|Adverse Event|0|||
124531806|NCT02972658|447897946|FG001|Overall Study|Adverse Event|3|||
124531807|NCT02972658|447897947|FG002|Overall Study|Adverse Event|0|||
124531808|NCT02972658|447897948|FG003|Overall Study|Adverse Event|2|||
124531809|NCT02972658|447897945|FG000|Overall Study|Other-determined by Investigator|1|||
124531810|NCT02972658|447897946|FG001|Overall Study|Other-determined by Investigator|1|||
124531811|NCT02972658|447897947|FG002|Overall Study|Other-determined by Investigator|0|||
124531812|NCT02972658|447897948|FG003|Overall Study|Other-determined by Investigator|0|||
124531813|NCT02972658|447897945|FG000|Overall Study|Death|0|||
124531814|NCT02972658|447897946|FG001|Overall Study|Death|0|||
124531815|NCT02972658|447897947|FG002|Overall Study|Death|0|||
124531816|NCT02972658|447897948|FG003|Overall Study|Death|1|||
124531817|NCT02972658|447897945|FG000|Overall Study|Lost to Follow-up|0|||
124531818|NCT02972658|447897946|FG001|Overall Study|Lost to Follow-up|1|||
124531819|NCT02972658|447897947|FG002|Overall Study|Lost to Follow-up|1|||
124531820|NCT02972658|447897948|FG003|Overall Study|Lost to Follow-up|2|||
124531821|NCT02972658|447897945|FG000|Overall Study|Progressive Disease|0|||
124531822|NCT02972658|447897946|FG001|Overall Study|Progressive Disease|1|||
124531823|NCT02972658|447897947|FG002|Overall Study|Progressive Disease|0|||
124531824|NCT02972658|447897948|FG003|Overall Study|Progressive Disease|1|||
124531825|NCT02972658|447897945|FG000|Overall Study|Withdrawal by Subject|4|||
124531826|NCT02972658|447897946|FG001|Overall Study|Withdrawal by Subject|4|||
124585574|NCT01168856|448100577|FG001|Overall Study|Lost to Follow-up|34|||
124729380|NCT03941964|448630232|FG001|Overall Study|Withdrew consent|3|||
124729381|NCT03941964|448630231|FG000|Overall Study|Physician Decision|9|||
124729382|NCT03941964|448630232|FG001|Overall Study|Physician Decision|2|||
124729383|NCT03941964|448630231|FG000|Overall Study|Other, not specified|2|||
124729384|NCT03941964|448630232|FG001|Overall Study|Other, not specified|1|||
124729385|NCT03219034|448630233|FG000|Overall Study|Lost to Follow-up|9|||
124729386|NCT03219034|448630234|FG001|Overall Study|Lost to Follow-up|13|||
124531827|NCT02972658|447897947|FG002|Overall Study|Withdrawal by Subject|1|||
124531828|NCT02972658|447897948|FG003|Overall Study|Withdrawal by Subject|6|||
124531829|NCT02972658|447897945|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
124585575|NCT01168856|448100576|FG000|Overall Study|Withdrawal by Subject|6|||
124585576|NCT01168856|448100577|FG001|Overall Study|Withdrawal by Subject|8|||
124585577|NCT01168856|448100576|FG000|Overall Study|Physician Decision|2|||
124585578|NCT01168856|448100577|FG001|Overall Study|Physician Decision|1|||
124585579|NCT01168856|448100576|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
124585580|NCT01168856|448100577|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
124585581|NCT01168856|448100576|FG000|Overall Study|Participant received anti-HCV treatment|1|||
124585582|NCT01168856|448100577|FG001|Overall Study|Participant received anti-HCV treatment|0|||
124585583|NCT01168856|448100576|FG000|Overall Study|Death|0|||
124585584|NCT01168856|448100577|FG001|Overall Study|Death|2|||
124585585|NCT01168856|448100576|FG000|Overall Study|Other|1|||
124585586|NCT01168856|448100577|FG001|Overall Study|Other|291|||
124585587|NCT01168856|448100576|FG000|Overall Study|Protocol Violation|4|||
124585588|NCT01168856|448100577|FG001|Overall Study|Protocol Violation|6|||
124585589|NCT01266902|448100578|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
124585590|NCT01266902|448100579|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
124585591|NCT01266902|448100580|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
124585592|NCT01266902|448100578|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
124585593|NCT01266902|448100579|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
124585594|NCT01266902|448100580|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
124585595|NCT01266902|448100578|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
124585596|NCT01266902|448100579|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
124585597|NCT01266902|448100580|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
124585598|NCT01266902|448100578|FG000|Period 1 (Main Study)|Adverse Event|3|||
124585599|NCT01266902|448100579|FG001|Period 1 (Main Study)|Adverse Event|11|||
124585600|NCT01266902|448100580|FG002|Period 1 (Main Study)|Adverse Event|0|||
124585601|NCT01266902|448100578|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
124585602|NCT01266902|448100579|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
124585603|NCT01266902|448100580|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
124585604|NCT01266902|448100578|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
124585605|NCT01266902|448100579|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
124585606|NCT01266902|448100580|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
124585607|NCT01266902|448100578|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
124585608|NCT01266902|448100579|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
124585609|NCT01266902|448100580|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
124585610|NCT01266902|448100578|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
124585611|NCT01266902|448100579|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
124585612|NCT01266902|448100580|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
124585613|NCT01266902|448100578|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
124585614|NCT01266902|448100579|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
124585615|NCT01266902|448100580|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
124585616|NCT01266902|448100578|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
124585617|NCT01266902|448100579|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
124585618|NCT01266902|448100580|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
124585619|NCT00387153|448100585|FG000|Overall Study|Adverse Event|1|||
124585620|NCT00387153|448100585|FG000|Overall Study|Disease Progression|3|||
124585621|NCT00387153|448100585|FG000|Overall Study|Lack of Response|4|||
124585622|NCT04567329|448100586|FG000|Overall Study|Withdrawal by Subject|5|||
124585623|NCT04567329|448100587|FG001|Overall Study|Withdrawal by Subject|6|||
124585624|NCT04567329|448100586|FG000|Overall Study|Protocol Violation|2|||
124585625|NCT04567329|448100587|FG001|Overall Study|Protocol Violation|3|||
124585626|NCT04567329|448100586|FG000|Overall Study|Discontinued|2|||
124585627|NCT04567329|448100587|FG001|Overall Study|Discontinued|2|||
124585628|NCT04567329|448100586|FG000|Overall Study|Lost to Follow-up|0|||
124585629|NCT04567329|448100587|FG001|Overall Study|Lost to Follow-up|1|||
124585630|NCT04567329|448100586|FG000|Overall Study|Lack of Efficacy|0|||
124585631|NCT04567329|448100587|FG001|Overall Study|Lack of Efficacy|1|||
124585632|NCT01087502|448100588|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
124585633|NCT01087502|448100589|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
124585634|NCT01087502|448100588|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
124585635|NCT01087502|448100589|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
124585636|NCT01087502|448100588|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
124585637|NCT01087502|448100589|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
124585638|NCT01087502|448100588|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
124585639|NCT01087502|448100589|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
124585640|NCT01087502|448100588|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
124585641|NCT01087502|448100589|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
124585642|NCT01087502|448100588|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
124585643|NCT01087502|448100589|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
124585644|NCT01087502|448100588|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
124585645|NCT01087502|448100589|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
124585646|NCT01087502|448100588|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
124777479|NCT01499355|448813062|FG001|Double-Blind Period|Adverse Event|2|||
124777480|NCT01499355|448813063|FG002|Double-Blind Period|Adverse Event|3|||
124585647|NCT01087502|448100589|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
124585648|NCT01087502|448100588|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
124585649|NCT01087502|448100589|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
124585650|NCT01087502|448100588|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
124585651|NCT01087502|448100589|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
124585652|NCT01087502|448100588|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
124585653|NCT01087502|448100589|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
124585654|NCT01087502|448100588|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
124585655|NCT01087502|448100589|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
124585656|NCT00985751|448100591|FG000|Overall Study|Adverse Event|0|||
124585657|NCT00985751|448100592|FG001|Overall Study|Adverse Event|0|||
124585658|NCT00985751|448100593|FG002|Overall Study|Adverse Event|0|||
124585659|NCT00985751|448100594|FG003|Overall Study|Adverse Event|0|||
124585660|NCT00985751|448100595|FG004|Overall Study|Adverse Event|1|||
124585661|NCT00380588|448100596|FG000|Overall Study|Unequivocal Disease Progression|25|||
124585662|NCT00380588|448100597|FG001|Overall Study|Unequivocal Disease Progression|34|||
124585663|NCT00380588|448100596|FG000|Overall Study|Next Cycle Not Started|4|||
124585664|NCT00380588|448100597|FG001|Overall Study|Next Cycle Not Started|0|||
124585665|NCT00380588|448100596|FG000|Overall Study|Adverse Event|7|||
124585666|NCT00380588|448100597|FG001|Overall Study|Adverse Event|3|||
124585667|NCT00380588|448100596|FG000|Overall Study|Withdrawal by Subject|1|||
124585668|NCT00380588|448100597|FG001|Overall Study|Withdrawal by Subject|3|||
124585669|NCT00380588|448100596|FG000|Overall Study|Physician Decision|2|||
124585670|NCT00380588|448100597|FG001|Overall Study|Physician Decision|0|||
124585671|NCT01451541|448100599|FG000|Overall Study|Adverse Event|4|||
124585672|NCT01451541|448100600|FG001|Overall Study|Adverse Event|3|||
124585673|NCT01451541|448100601|FG002|Overall Study|Adverse Event|6|||
124585674|NCT01451541|448100599|FG000|Overall Study|Lack of Efficacy|2|||
124585675|NCT01451541|448100600|FG001|Overall Study|Lack of Efficacy|0|||
124585676|NCT01451541|448100601|FG002|Overall Study|Lack of Efficacy|0|||
124585677|NCT01451541|448100599|FG000|Overall Study|Lost to Follow-up|4|||
124585678|NCT01451541|448100600|FG001|Overall Study|Lost to Follow-up|4|||
124585679|NCT01451541|448100601|FG002|Overall Study|Lost to Follow-up|7|||
124585680|NCT01451541|448100599|FG000|Overall Study|Withdrawal by Subject|15|||
124585681|NCT01451541|448100600|FG001|Overall Study|Withdrawal by Subject|8|||
124585682|NCT01451541|448100601|FG002|Overall Study|Withdrawal by Subject|6|||
124585683|NCT01451541|448100599|FG000|Overall Study|randomization error, noncompliance|11|||
124585684|NCT01451541|448100600|FG001|Overall Study|randomization error, noncompliance|10|||
124585685|NCT01451541|448100601|FG002|Overall Study|randomization error, noncompliance|8|||
124585686|NCT03366428|448100603|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
124585687|NCT03366428|448100603|FG000|Overall Study|Adverse Event|12|||
124585688|NCT03366428|448100603|FG000|Overall Study|Clinical progression|2|||
124585689|NCT03366428|448100603|FG000|Overall Study|Withdrawal by Subject|4|||
124585690|NCT00999687|448100610|FG000|First Intervention|Withdrawal by Subject|1|||
124585691|NCT00999687|448100610|FG000|Second Intervention|Withdrawal by Subject|2|||
124585692|NCT00999687|448100610|FG000|Second Intervention|Lack of Efficacy|1|||
124585693|NCT01120028|448100612|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
124585694|NCT01120028|448100613|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
124585695|NCT01120028|448100614|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
124585696|NCT01120028|448100615|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
124585697|NCT01120028|448100612|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
124585698|NCT01120028|448100613|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
124585699|NCT01120028|448100614|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
124585700|NCT01120028|448100615|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
124585701|NCT03684928|448100618|FG000|First Intervention|Lost to Follow-up|0|||
124585702|NCT03684928|448100619|FG001|First Intervention|Lost to Follow-up|1|||
124585703|NCT03684928|448100618|FG000|First Intervention|Withdrawal by Subject|0|||
124585704|NCT03684928|448100619|FG001|First Intervention|Withdrawal by Subject|2|||
124585705|NCT03684928|448100618|FG000|Second Intervention|Soft Tissue Injury|1|||
124585706|NCT03684928|448100619|FG001|Second Intervention|Soft Tissue Injury|0|||
124585707|NCT01253564|448100621|FG000|Overall Study|Disease Progression|22|||
124585708|NCT01253564|448100621|FG000|Overall Study|Withdrawal by Subject|1|||
124585709|NCT01253564|448100621|FG000|Overall Study|Serious Adverse Event|1|||
124585710|NCT00557245|448102219|FG000|Overall Study|Lost to Follow-up|7|||
124585711|NCT00557245|448102220|FG001|Overall Study|Lost to Follow-up|8|||
124585712|NCT00557245|448102221|FG002|Overall Study|Lost to Follow-up|10|||
124585713|NCT00557245|448102219|FG000|Overall Study|Ineligible|5|||
124585714|NCT00557245|448102220|FG001|Overall Study|Ineligible|4|||
124585715|NCT00557245|448102221|FG002|Overall Study|Ineligible|2|||
124585716|NCT00642993|448102222|FG000|Overall Study|Adverse Event|85|||
124585717|NCT00642993|448102223|FG001|Overall Study|Adverse Event|4|||
124585718|NCT00642993|448102222|FG000|Overall Study|Lost to Follow-up|8|||
124585719|NCT00642993|448102223|FG001|Overall Study|Lost to Follow-up|4|||
124585720|NCT00642993|448102222|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
124585721|NCT00642993|448102223|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
124585722|NCT00642993|448102222|FG000|Overall Study|Protocol Violation|1|||
124585723|NCT00642993|448102223|FG001|Overall Study|Protocol Violation|4|||
124585724|NCT00642993|448102222|FG000|Overall Study|Did not meet protocol eligibility|0|||
124585725|NCT00642993|448102223|FG001|Overall Study|Did not meet protocol eligibility|1|||
124585726|NCT00642993|448102222|FG000|Overall Study|Administrative|1|||
124585727|NCT00642993|448102223|FG001|Overall Study|Administrative|0|||
124585728|NCT02986139|448102224|FG000|Overall Study|Sponsor Decision|1|||
124585729|NCT02986139|448102225|FG001|Overall Study|Sponsor Decision|2|||
124585730|NCT02986139|448102224|FG000|Overall Study|Withdrawal by Subject|0|||
124585731|NCT02986139|448102225|FG001|Overall Study|Withdrawal by Subject|1|||
124585732|NCT02986139|448102224|FG000|Overall Study|Lost to Follow-up|0|||
124585733|NCT02986139|448102225|FG001|Overall Study|Lost to Follow-up|1|||
124585734|NCT00414726|448102226|FG000|Overall Study|Withdrawal by Subject|0|||
124585735|NCT00414726|448102227|FG001|Overall Study|Withdrawal by Subject|1|||
124585736|NCT02034513|448102228|FG000|Overall Study|Adverse Event|11|||
124585737|NCT02034513|448102229|FG001|Overall Study|Adverse Event|10|||
124585738|NCT02034513|448102228|FG000|Overall Study|Lack of Efficacy|0|||
124585739|NCT02034513|448102229|FG001|Overall Study|Lack of Efficacy|1|||
124585740|NCT02034513|448102228|FG000|Overall Study|Lost to Follow-up|6|||
124585741|NCT02034513|448102229|FG001|Overall Study|Lost to Follow-up|7|||
124585742|NCT02034513|448102228|FG000|Overall Study|Pregnancy|0|||
124585743|NCT02034513|448102229|FG001|Overall Study|Pregnancy|3|||
124585744|NCT02034513|448102228|FG000|Overall Study|Protocol Violation|7|||
124585745|NCT02034513|448102229|FG001|Overall Study|Protocol Violation|10|||
124585746|NCT02034513|448102228|FG000|Overall Study|Withdrawal by Subject|25|||
124585747|NCT02034513|448102229|FG001|Overall Study|Withdrawal by Subject|25|||
124585748|NCT02034513|448102228|FG000|Overall Study|Unclassified|0|||
124585749|NCT02034513|448102229|FG001|Overall Study|Unclassified|1|||
124585750|NCT02308241|448102232|FG000|Overall Study|Withdrawal by Subject|3|||
124585751|NCT04408924|448102233|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
124585752|NCT04408924|448102233|FG000|Overall Study|Lost to Follow-up|3|||
124585753|NCT04408924|448102233|FG000|Overall Study|Withdrawal by Subject|5|||
124585754|NCT04408924|448102233|FG000|Overall Study|Sponsor Decision|2|||
124585755|NCT00691704|448102234|FG000|Induction Therapy|Disease Progression|1|||
124585756|NCT00691704|448102234|FG000|Induction Therapy|Active Hepatitis|1|||
124585757|NCT00691704|448102234|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
124585758|NCT00691704|448102234|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
124585759|NCT00691704|448102234|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
124585760|NCT04661202|448102235|FG000|Overall Study|Withdrawal by Subject|1|||
124585761|NCT04661202|448102236|FG001|Overall Study|Withdrawal by Subject|1|||
124585762|NCT04661202|448102235|FG000|Overall Study|Lack of Efficacy|2|||
124585763|NCT04661202|448102236|FG001|Overall Study|Lack of Efficacy|0|||
124585764|NCT04158687|448102237|FG000|Overall Study|Adverse Event|2|||
124585765|NCT04158687|448102238|FG001|Overall Study|Adverse Event|3|||
124585766|NCT04158687|448102239|FG002|Overall Study|Adverse Event|0|||
124585767|NCT04158687|448102240|FG003|Overall Study|Adverse Event|3|||
124585768|NCT04158687|448102237|FG000|Overall Study|Lost to Follow-up|5|||
124585769|NCT04158687|448102238|FG001|Overall Study|Lost to Follow-up|12|||
124585770|NCT04158687|448102239|FG002|Overall Study|Lost to Follow-up|4|||
124585771|NCT04158687|448102240|FG003|Overall Study|Lost to Follow-up|5|||
124585772|NCT04158687|448102237|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
124585773|NCT04158687|448102238|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
124585774|NCT04158687|448102239|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
124585775|NCT04158687|448102240|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
124585776|NCT04158687|448102237|FG000|Overall Study|Non-Compliance with Study Medication|2|||
124585777|NCT04158687|448102238|FG001|Overall Study|Non-Compliance with Study Medication|2|||
124585778|NCT04158687|448102239|FG002|Overall Study|Non-Compliance with Study Medication|3|||
124585779|NCT04158687|448102240|FG003|Overall Study|Non-Compliance with Study Medication|0|||
124585780|NCT04158687|448102237|FG000|Overall Study|Investigator Decision|0|||
124585781|NCT04158687|448102238|FG001|Overall Study|Investigator Decision|0|||
124585782|NCT04158687|448102239|FG002|Overall Study|Investigator Decision|2|||
124585783|NCT04158687|448102240|FG003|Overall Study|Investigator Decision|0|||
124585784|NCT04158687|448102237|FG000|Overall Study|Protocol Violation|0|||
124585785|NCT04158687|448102238|FG001|Overall Study|Protocol Violation|2|||
124585786|NCT04158687|448102239|FG002|Overall Study|Protocol Violation|1|||
124585787|NCT04158687|448102240|FG003|Overall Study|Protocol Violation|0|||
124585788|NCT04158687|448102237|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
124585789|NCT04158687|448102238|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
124585790|NCT04158687|448102239|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
124585791|NCT04158687|448102240|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
124585792|NCT04158687|448102237|FG000|Overall Study|Reason not Specified|3|||
124585793|NCT04158687|448102238|FG001|Overall Study|Reason not Specified|2|||
124585794|NCT04158687|448102239|FG002|Overall Study|Reason not Specified|4|||
124585795|NCT04158687|448102240|FG003|Overall Study|Reason not Specified|4|||
124585796|NCT04102345|448102243|FG000|Overall Study|Withdrawal by Subject|1|||
124585797|NCT04102345|448102244|FG001|Overall Study|Withdrawal by Subject|0|||
124585798|NCT00835666|448102250|FG000|Washout|Protocol Violation|1|||
124585799|NCT00835666|448102251|FG001|Washout|Protocol Violation|0|||
124585800|NCT00835666|448102250|FG000|Washout|Withdrawal by Subject|1|||
124585801|NCT00835666|448102251|FG001|Washout|Withdrawal by Subject|0|||
124585802|NCT03599362|448102252|FG000|Overall Study|Screen Failure|3|||
124585803|NCT03707587|448102256|FG000|Overall Study|Death|0|||
124585804|NCT03707587|448102257|FG001|Overall Study|Death|1|||
124585805|NCT01537887|448102258|FG000|Period 1|Physician Decision|0|||
124585806|NCT01537887|448102259|FG001|Period 1|Physician Decision|0|||
124585807|NCT01537887|448102260|FG002|Period 1|Physician Decision|0|||
124585808|NCT01537887|448102261|FG003|Period 1|Physician Decision|0|||
124585809|NCT01537887|448102262|FG004|Period 1|Physician Decision|1|||
124585810|NCT01537887|448102263|FG005|Period 1|Physician Decision|1|||
124585811|NCT01537887|448102258|FG000|Period 1|Did not receive treatment|0|||
124585812|NCT01537887|448102259|FG001|Period 1|Did not receive treatment|0|||
124585813|NCT01537887|448102260|FG002|Period 1|Did not receive treatment|1|||
124585814|NCT01537887|448102261|FG003|Period 1|Did not receive treatment|0|||
124585815|NCT01537887|448102262|FG004|Period 1|Did not receive treatment|0|||
124585816|NCT01537887|448102263|FG005|Period 1|Did not receive treatment|0|||
124585817|NCT01537887|448102258|FG000|Period 2|Withdrawal by Subject|0|||
124585818|NCT01537887|448102259|FG001|Period 2|Withdrawal by Subject|1|||
124585819|NCT01537887|448102260|FG002|Period 2|Withdrawal by Subject|0|||
124585820|NCT01537887|448102261|FG003|Period 2|Withdrawal by Subject|0|||
124585821|NCT01537887|448102262|FG004|Period 2|Withdrawal by Subject|0|||
124585822|NCT01537887|448102263|FG005|Period 2|Withdrawal by Subject|0|||
124585823|NCT01537887|448102258|FG000|Period 3|Adverse Event|0|||
124585824|NCT01537887|448102259|FG001|Period 3|Adverse Event|0|||
124585825|NCT01537887|448102260|FG002|Period 3|Adverse Event|1|||
124585826|NCT01537887|448102261|FG003|Period 3|Adverse Event|0|||
124585827|NCT01537887|448102262|FG004|Period 3|Adverse Event|0|||
124585828|NCT01537887|448102263|FG005|Period 3|Adverse Event|0|||
124585829|NCT01537887|448102258|FG000|Period 3|Withdrawal by Subject|0|||
124585830|NCT01537887|448102259|FG001|Period 3|Withdrawal by Subject|1|||
124585831|NCT01537887|448102260|FG002|Period 3|Withdrawal by Subject|0|||
124585832|NCT01537887|448102261|FG003|Period 3|Withdrawal by Subject|0|||
124585833|NCT01537887|448102262|FG004|Period 3|Withdrawal by Subject|0|||
124585834|NCT01537887|448102263|FG005|Period 3|Withdrawal by Subject|0|||
124585835|NCT01370083|448102265|FG000|Overall Study|Lost to Follow-up|2|||
124585836|NCT01370083|448102266|FG001|Overall Study|Lost to Follow-up|0|||
124585837|NCT01370083|448102265|FG000|Overall Study|Adverse Event|0|||
124585838|NCT01370083|448102266|FG001|Overall Study|Adverse Event|1|||
124585839|NCT03358147|448102268|FG000|Overall Study|Withdrawal by Subject|13|||
124585840|NCT03358147|448102269|FG001|Overall Study|Withdrawal by Subject|19|||
124585841|NCT03358147|448102270|FG002|Overall Study|Withdrawal by Subject|16|||
124585842|NCT03358147|448102271|FG003|Overall Study|Withdrawal by Subject|10|||
124585843|NCT03358147|448102272|FG004|Overall Study|Withdrawal by Subject|5|||
124585844|NCT03358147|448102268|FG000|Overall Study|Adverse Event|3|||
124585845|NCT03358147|448102269|FG001|Overall Study|Adverse Event|9|||
124585846|NCT03358147|448102270|FG002|Overall Study|Adverse Event|7|||
124585847|NCT03358147|448102271|FG003|Overall Study|Adverse Event|5|||
124585848|NCT03358147|448102272|FG004|Overall Study|Adverse Event|2|||
124585849|NCT03358147|448102268|FG000|Overall Study|Lost to Follow-up|4|||
124585850|NCT03358147|448102269|FG001|Overall Study|Lost to Follow-up|3|||
124585851|NCT03358147|448102270|FG002|Overall Study|Lost to Follow-up|7|||
124585852|NCT03358147|448102271|FG003|Overall Study|Lost to Follow-up|6|||
124585853|NCT03358147|448102272|FG004|Overall Study|Lost to Follow-up|4|||
124585854|NCT03358147|448102268|FG000|Overall Study|Major Protocol Deviation|11|||
124585855|NCT03358147|448102269|FG001|Overall Study|Major Protocol Deviation|3|||
124585856|NCT03358147|448102270|FG002|Overall Study|Major Protocol Deviation|2|||
124585857|NCT03358147|448102271|FG003|Overall Study|Major Protocol Deviation|3|||
124585858|NCT03358147|448102272|FG004|Overall Study|Major Protocol Deviation|1|||
124585859|NCT03358147|448102268|FG000|Overall Study|Protocol specified criteria|2|||
124585860|NCT03358147|448102269|FG001|Overall Study|Protocol specified criteria|3|||
124585861|NCT03358147|448102270|FG002|Overall Study|Protocol specified criteria|0|||
124585862|NCT03358147|448102271|FG003|Overall Study|Protocol specified criteria|3|||
124585863|NCT03358147|448102272|FG004|Overall Study|Protocol specified criteria|1|||
124585864|NCT03358147|448102268|FG000|Overall Study|Physician Decision|1|||
124585865|NCT03358147|448102269|FG001|Overall Study|Physician Decision|0|||
124585866|NCT03358147|448102270|FG002|Overall Study|Physician Decision|1|||
124585867|NCT03358147|448102271|FG003|Overall Study|Physician Decision|6|||
124585868|NCT03358147|448102272|FG004|Overall Study|Physician Decision|1|||
124585869|NCT03358147|448102268|FG000|Overall Study|Administrative reasons|0|||
124585870|NCT03358147|448102269|FG001|Overall Study|Administrative reasons|1|||
124585871|NCT03358147|448102270|FG002|Overall Study|Administrative reasons|0|||
124585872|NCT03358147|448102271|FG003|Overall Study|Administrative reasons|3|||
124585873|NCT03358147|448102272|FG004|Overall Study|Administrative reasons|0|||
124585874|NCT03358147|448102268|FG000|Overall Study|Lack of Efficacy|0|||
124585875|NCT03358147|448102269|FG001|Overall Study|Lack of Efficacy|1|||
124585876|NCT03358147|448102270|FG002|Overall Study|Lack of Efficacy|1|||
124585877|NCT03358147|448102271|FG003|Overall Study|Lack of Efficacy|0|||
124585878|NCT03358147|448102272|FG004|Overall Study|Lack of Efficacy|0|||
124585879|NCT00425308|448102280|FG000|Overall Study|Adverse Event|2|||
124585880|NCT00425308|448102281|FG001|Overall Study|Adverse Event|1|||
124585881|NCT00425308|448102280|FG000|Overall Study|Withdrawal by Subject|1|||
124585882|NCT00425308|448102281|FG001|Overall Study|Withdrawal by Subject|0|||
124585883|NCT00425308|448102280|FG000|Overall Study|Death|1|||
124585884|NCT00425308|448102281|FG001|Overall Study|Death|0|||
124585885|NCT04442503|448102282|FG000|Overall Study|Adverse Event|1|||
124585886|NCT04442503|448102283|FG001|Overall Study|Adverse Event|1|||
124585887|NCT04442503|448102282|FG000|Overall Study|Lost to Follow-up|8|||
124585888|NCT04442503|448102283|FG001|Overall Study|Lost to Follow-up|6|||
124585889|NCT04442503|448102282|FG000|Overall Study|Physician Decision|0|||
124585890|NCT04442503|448102283|FG001|Overall Study|Physician Decision|2|||
124585891|NCT04442503|448102282|FG000|Overall Study|Withdrawal by Subject|3|||
124585892|NCT04442503|448102283|FG001|Overall Study|Withdrawal by Subject|4|||
124585893|NCT04442503|448102282|FG000|Overall Study|Reason not Specified|0|||
124585894|NCT04442503|448102283|FG001|Overall Study|Reason not Specified|1|||
124585895|NCT04442503|448102282|FG000|Overall Study|Randomized but not Treated|3|||
124585896|NCT04442503|448102283|FG001|Overall Study|Randomized but not Treated|1|||
124585897|NCT02933060|448102287|FG000|Overall Study|Withdrawal by Subject|0|||
124585898|NCT02933060|448102288|FG001|Overall Study|Withdrawal by Subject|1|||
124585899|NCT01945580|448102289|FG000|Overall Study|Withdrawal by Subject|13|||
124585900|NCT01945580|448102290|FG001|Overall Study|Withdrawal by Subject|35|||
124585901|NCT01945580|448102289|FG000|Overall Study|Physician Decision|3|||
124585902|NCT01945580|448102290|FG001|Overall Study|Physician Decision|2|||
124585903|NCT01945580|448102289|FG000|Overall Study|Lost to Follow-up|26|||
124585904|NCT01945580|448102290|FG001|Overall Study|Lost to Follow-up|39|||
124585905|NCT01945580|448102289|FG000|Overall Study|Death|7|||
124585906|NCT01945580|448102290|FG001|Overall Study|Death|2|||
124585907|NCT01945580|448102289|FG000|Overall Study|Patient moved out of state|0|||
124585908|NCT01945580|448102290|FG001|Overall Study|Patient moved out of state|1|||
124585909|NCT01945580|448102289|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
124585910|NCT01945580|448102290|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
124585911|NCT01945580|448102289|FG000|Overall Study|Family illness - unable to return|0|||
124585912|NCT01945580|448102290|FG001|Overall Study|Family illness - unable to return|1|||
124585913|NCT01945580|448102289|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
124585914|NCT01945580|448102290|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
124585915|NCT01945580|448102289|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
124585916|NCT01945580|448102290|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
124585917|NCT01945580|448102289|FG000|Overall Study|Noncompliance with 36 month visit|1|||
124585918|NCT01945580|448102290|FG001|Overall Study|Noncompliance with 36 month visit|0|||
124585919|NCT01945580|448102289|FG000|Overall Study|The patient moved.|1|||
124585920|NCT01945580|448102290|FG001|Overall Study|The patient moved.|0|||
124585921|NCT01945580|448102289|FG000|Overall Study|No data available|0|||
124585922|NCT01945580|448102290|FG001|Overall Study|No data available|2|||
124585923|NCT05034874|448102295|FG000|Overall Study|Withdrawal by Subject|6|||
124585924|NCT05034874|448102296|FG001|Overall Study|Withdrawal by Subject|6|||
124585925|NCT05034874|448102295|FG000|Overall Study|Lost to Follow-up|18|||
124585926|NCT05034874|448102296|FG001|Overall Study|Lost to Follow-up|8|||
124585927|NCT05034874|448102295|FG000|Overall Study|Physician Decision|0|||
124585928|NCT05034874|448102296|FG001|Overall Study|Physician Decision|1|||
124585929|NCT05034874|448102295|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
124585930|NCT05034874|448102296|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
124585931|NCT00989950|448102297|FG000|Randomized Phase|Protocol Violation|1|||
124585932|NCT00989950|448102298|FG001|Randomized Phase|Protocol Violation|0|||
124585933|NCT00989950|448102299|FG002|Randomized Phase|Protocol Violation|0|||
124585934|NCT00989950|448102300|FG003|Randomized Phase|Protocol Violation|0|||
124585935|NCT00989950|448102297|FG000|Randomized Phase|Adverse Event|0|||
124585936|NCT00989950|448102298|FG001|Randomized Phase|Adverse Event|1|||
124585937|NCT00989950|448102299|FG002|Randomized Phase|Adverse Event|0|||
124585938|NCT00989950|448102300|FG003|Randomized Phase|Adverse Event|0|||
124585939|NCT00101439|448102301|FG000|Period 2|Withdrawal by Subject|0|||
124585940|NCT00101439|448102302|FG001|Period 2|Withdrawal by Subject|2|||
124585941|NCT00840658|448102304|FG000|Overall Study|Death|2|||
124585942|NCT00840658|448102305|FG001|Overall Study|Death|2|||
124585943|NCT00840658|448102306|FG002|Overall Study|Death|3|||
124585944|NCT00840658|448102307|FG003|Overall Study|Death|3|||
124585945|NCT00840658|448102304|FG000|Overall Study|Lost to Follow-up|3|||
124585946|NCT00840658|448102305|FG001|Overall Study|Lost to Follow-up|1|||
124585947|NCT00840658|448102306|FG002|Overall Study|Lost to Follow-up|2|||
124585948|NCT00840658|448102307|FG003|Overall Study|Lost to Follow-up|1|||
124585949|NCT01867658|448102308|FG000|Overall Study|Withdrawal by Subject|6|||
124585950|NCT01867658|448102308|FG000|Overall Study|Death|2|||
124585951|NCT01867658|448102308|FG000|Overall Study|Subject could not be contacted|1|||
124585952|NCT00474058|448102309|FG000|Overall Study|Adverse Event|11|||
124585953|NCT00474058|448102310|FG001|Overall Study|Adverse Event|6|||
124585954|NCT00474058|448102309|FG000|Overall Study|Lack of Efficacy|0|||
124585955|NCT00474058|448102310|FG001|Overall Study|Lack of Efficacy|4|||
124585956|NCT00474058|448102309|FG000|Overall Study|Withdrawal by Subject|11|||
124585957|NCT00474058|448102310|FG001|Overall Study|Withdrawal by Subject|7|||
124585958|NCT00474058|448102309|FG000|Overall Study|Other|2|||
124585959|NCT00474058|448102310|FG001|Overall Study|Other|0|||
124585960|NCT03101358|448102311|FG000|Overall Study|Non-compliance with study schedule|1|||
124585961|NCT03101358|448102312|FG001|Overall Study|Non-compliance with study schedule|0|||
124585962|NCT03101358|448102313|FG002|Overall Study|Non-compliance with study schedule|0|||
124585963|NCT03101358|448102314|FG003|Overall Study|Non-compliance with study schedule|1|||
124585964|NCT03101358|448102311|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
124585965|NCT03101358|448102312|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
124585966|NCT03101358|448102313|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
124585967|NCT03101358|448102314|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
124585968|NCT03101358|448102311|FG000|Overall Study|Physician Decision|1|||
124585969|NCT03101358|448102312|FG001|Overall Study|Physician Decision|0|||
124585970|NCT03101358|448102313|FG002|Overall Study|Physician Decision|0|||
124585971|NCT03101358|448102314|FG003|Overall Study|Physician Decision|3|||
124585972|NCT03101358|448102311|FG000|Overall Study|Adverse Event|0|||
124585973|NCT03101358|448102312|FG001|Overall Study|Adverse Event|0|||
124585974|NCT03101358|448102313|FG002|Overall Study|Adverse Event|1|||
124585975|NCT03101358|448102314|FG003|Overall Study|Adverse Event|0|||
124585976|NCT03101358|448102311|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
124585977|NCT03101358|448102312|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
124585978|NCT03101358|448102313|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
124585979|NCT03101358|448102314|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
124585980|NCT03101358|448102311|FG000|Overall Study|Lost to Follow-up|1|||
124585981|NCT03101358|448102312|FG001|Overall Study|Lost to Follow-up|0|||
124585982|NCT03101358|448102313|FG002|Overall Study|Lost to Follow-up|0|||
124585983|NCT03101358|448102314|FG003|Overall Study|Lost to Follow-up|1|||
124585984|NCT02426918|448102319|FG000|Overall Study|Adverse Event|2|||
124585985|NCT02426918|448102320|FG001|Overall Study|Adverse Event|2|||
124585986|NCT02426918|448102321|FG002|Overall Study|Adverse Event|0|||
124585987|NCT02426918|448102319|FG000|Overall Study|Physician Decision|1|||
124585988|NCT02426918|448102320|FG001|Overall Study|Physician Decision|1|||
124585989|NCT02426918|448102321|FG002|Overall Study|Physician Decision|1|||
124585990|NCT02426918|448102319|FG000|Overall Study|Withdrawal by Subject|5|||
124585991|NCT02426918|448102320|FG001|Overall Study|Withdrawal by Subject|5|||
124585992|NCT02426918|448102321|FG002|Overall Study|Withdrawal by Subject|4|||
124585993|NCT02426918|448102319|FG000|Overall Study|Other|9|||
124585994|NCT02426918|448102320|FG001|Overall Study|Other|11|||
124585995|NCT02426918|448102321|FG002|Overall Study|Other|9|||
124585996|NCT02845336|448102322|FG000|Overall Study|Lost to Follow-up|3|||
124585997|NCT02845336|448102323|FG001|Overall Study|Lost to Follow-up|1|||
124585998|NCT02845336|448102322|FG000|Overall Study|Inability to get medication|2|||
124585999|NCT02845336|448102323|FG001|Overall Study|Inability to get medication|0|||
124586000|NCT00654186|448102330|FG000|Overall Study|Withdrawal by Subject|5|||
124586001|NCT05616728|448102331|FG000|Overall Study|Lost to Follow-up|0|||
124586002|NCT05616728|448102332|FG001|Overall Study|Lost to Follow-up|0|||
124586003|NCT05616728|448102333|FG002|Overall Study|Lost to Follow-up|1|||
124586004|NCT05616728|448102331|FG000|Overall Study|Withdrawal by Subject|1|||
124586005|NCT05616728|448102332|FG001|Overall Study|Withdrawal by Subject|1|||
124586006|NCT05616728|448102333|FG002|Overall Study|Withdrawal by Subject|0|||
124586007|NCT05616728|448102331|FG000|Overall Study|Physician Decision|1|||
124586008|NCT05616728|448102332|FG001|Overall Study|Physician Decision|1|||
124586009|NCT05616728|448102333|FG002|Overall Study|Physician Decision|1|||
124586010|NCT05616728|448102331|FG000|Overall Study|Other|0|||
124586011|NCT05616728|448102332|FG001|Overall Study|Other|2|||
124586012|NCT05616728|448102333|FG002|Overall Study|Other|0|||
124586013|NCT01024855|448102336|FG000|Overall Study|Inclusion/exclusion criteria|1|||
124586014|NCT00674128|448102343|FG000|Overall Study|Withdrawal by Subject|25|||
124586015|NCT00674128|448102344|FG001|Overall Study|Withdrawal by Subject|23|||
124586016|NCT03306277|448102345|FG000|Overall Study|Death|1|||
124586017|NCT03306277|448102345|FG000|Overall Study|Adverse Event|1|||
124586018|NCT03306277|448102345|FG000|Overall Study|Withdrawal by Subject|1|||
124586019|NCT00829452|448102349|FG000|First Intervention|Withdrawal by Subject|0|||
124586020|NCT00829452|448102350|FG001|First Intervention|Withdrawal by Subject|1|||
124586021|NCT00829452|448102349|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
124586022|NCT00829452|448102350|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
124586023|NCT00829452|448102349|FG000|Second Intervention|Physician Decision|0|||
124586024|NCT00829452|448102350|FG001|Second Intervention|Physician Decision|1|||
124586025|NCT00881751|448102361|FG000|Overall Study|Physician Decision|0|||
124586026|NCT00881751|448102362|FG001|Overall Study|Physician Decision|1|||
124586027|NCT00881751|448102361|FG000|Overall Study|Adverse Event|0|||
124586028|NCT00881751|448102362|FG001|Overall Study|Adverse Event|2|||
124586029|NCT00881751|448102361|FG000|Overall Study|Withdrawal by Subject|0|||
124586030|NCT00881751|448102362|FG001|Overall Study|Withdrawal by Subject|2|||
124586031|NCT00301964|448102363|FG000|Overall Study|Second primary|2|||
124586032|NCT00301964|448102363|FG000|Overall Study|Wrong primary|1|||
124586033|NCT00301964|448102363|FG000|Overall Study|Inadequate pathology|1|||
124586034|NCT02385708|448102364|FG000|Overall Study|Withdrawal by Subject|0|||
124586035|NCT02385708|448102365|FG001|Overall Study|Withdrawal by Subject|2|||
124586036|NCT02385708|448102364|FG000|Overall Study|Withdrawn - surgery canceled|2|||
124586037|NCT02385708|448102365|FG001|Overall Study|Withdrawn - surgery canceled|5|||
124586038|NCT02385708|448102364|FG000|Overall Study|Investigator decision|5|||
124586039|NCT02385708|448102365|FG001|Overall Study|Investigator decision|7|||
124586040|NCT02385708|448102364|FG000|Overall Study|Protocol Violation|1|||
124586041|NCT02385708|448102365|FG001|Overall Study|Protocol Violation|1|||
124586042|NCT01559363|448102373|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
124586043|NCT01559363|448102374|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
124586044|NCT01559363|448102375|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
124586045|NCT01559363|448102376|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
124586046|NCT01559363|448102377|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
124586047|NCT01559363|448102378|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
124586048|NCT01559363|448102373|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
124586049|NCT01559363|448102374|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
124586050|NCT01559363|448102375|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
124586051|NCT01559363|448102376|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
124586052|NCT01559363|448102377|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
124586053|NCT01559363|448102378|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
124586054|NCT01559363|448102373|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
124586055|NCT01559363|448102374|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
124586056|NCT01559363|448102375|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
124586057|NCT01559363|448102376|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
124586058|NCT01559363|448102377|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
124586059|NCT01559363|448102378|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
124586060|NCT01559363|448102373|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
124586061|NCT01559363|448102374|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
124586062|NCT01559363|448102375|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
124586063|NCT01559363|448102376|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
124586064|NCT01559363|448102377|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
124586065|NCT01559363|448102378|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
124586066|NCT01559363|448102373|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
124586067|NCT01559363|448102374|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
124586068|NCT01559363|448102375|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
124586069|NCT01559363|448102376|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
124586070|NCT01559363|448102377|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
124586071|NCT01559363|448102378|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
124586072|NCT01559363|448102373|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
124586073|NCT01559363|448102374|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
124586074|NCT01559363|448102375|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
124586075|NCT01559363|448102376|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
124586076|NCT01559363|448102377|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
124586077|NCT01559363|448102378|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
124586078|NCT01559363|448102373|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
124586079|NCT01559363|448102374|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
124586080|NCT01559363|448102375|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
124586081|NCT01559363|448102376|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
124586082|NCT01559363|448102377|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
124586083|NCT01559363|448102378|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
124586084|NCT00672984|448102379|FG000|First Intervention|Adverse Event|5|||
124586085|NCT00672984|448102380|FG001|First Intervention|Adverse Event|0|||
124586086|NCT00672984|448102381|FG002|First Intervention|Adverse Event|0|||
124586087|NCT00672984|448102379|FG000|First Intervention|Withdrawal by Subject|1|||
124586088|NCT00672984|448102380|FG001|First Intervention|Withdrawal by Subject|2|||
124586089|NCT00672984|448102381|FG002|First Intervention|Withdrawal by Subject|2|||
124586090|NCT00672984|448102379|FG000|First Intervention|Sponsor decision|3|||
124586091|NCT00672984|448102380|FG001|First Intervention|Sponsor decision|0|||
124586092|NCT00672984|448102381|FG002|First Intervention|Sponsor decision|0|||
124586093|NCT00672984|448102379|FG000|Second Intervention|Non-compliance with facility policies|0|||
124586094|NCT00672984|448102380|FG001|Second Intervention|Non-compliance with facility policies|2|||
124586095|NCT00672984|448102381|FG002|Second Intervention|Non-compliance with facility policies|0|||
124586096|NCT00672984|448102379|FG000|Second Intervention|Withdrawal by Subject|0|||
124586097|NCT00672984|448102380|FG001|Second Intervention|Withdrawal by Subject|3|||
124586098|NCT00672984|448102381|FG002|Second Intervention|Withdrawal by Subject|0|||
124586099|NCT00672984|448102379|FG000|Second Intervention|Protocol Violation|0|||
124586100|NCT00672984|448102380|FG001|Second Intervention|Protocol Violation|1|||
124586101|NCT00672984|448102381|FG002|Second Intervention|Protocol Violation|1|||
124586102|NCT00672984|448102379|FG000|Third Intervention|Adverse Event|1|||
124586103|NCT00672984|448102380|FG001|Third Intervention|Adverse Event|0|||
124586104|NCT00672984|448102381|FG002|Third Intervention|Adverse Event|1|||
124586105|NCT00645853|448102382|FG000|Overall Study|Adverse Event|18|||
124586106|NCT00645853|448102383|FG001|Overall Study|Adverse Event|7|||
124586107|NCT00645853|448102382|FG000|Overall Study|AZ study closure in Hungary|60|||
124586108|NCT00645853|448102383|FG001|Overall Study|AZ study closure in Hungary|40|||
124586109|NCT00645853|448102382|FG000|Overall Study|Withdrawal by Subject|5|||
124586110|NCT00645853|448102383|FG001|Overall Study|Withdrawal by Subject|2|||
124586111|NCT00645853|448102382|FG000|Overall Study|Protocol Violation|0|||
124586112|NCT00645853|448102383|FG001|Overall Study|Protocol Violation|2|||
124586113|NCT00645853|448102382|FG000|Overall Study|Discontinuation criteria|2|||
124586114|NCT00645853|448102383|FG001|Overall Study|Discontinuation criteria|2|||
124586115|NCT00645853|448102382|FG000|Overall Study|recall of ICF, planned operation, death|7|||
124586116|NCT00645853|448102383|FG001|Overall Study|recall of ICF, planned operation, death|4|||
124586117|NCT04060251|448102384|FG000|Overall Study|Study terminated due to low enrollment.|7|||
124586118|NCT04060251|448102385|FG001|Overall Study|Study terminated due to low enrollment.|5|||
124586119|NCT04060251|448102386|FG002|Overall Study|Study terminated due to low enrollment.|7|||
124586120|NCT04060251|448102384|FG000|Overall Study|Adverse Event|1|||
124586121|NCT04060251|448102385|FG001|Overall Study|Adverse Event|1|||
124586122|NCT04060251|448102386|FG002|Overall Study|Adverse Event|0|||
124586123|NCT01151618|448102387|FG000|Overall Study|Adverse Event|2|||
124586124|NCT01151618|448102387|FG000|Overall Study|Withdrawal by Subject|7|||
124586125|NCT01632306|448102388|FG000|Overall Study|Protocol Violation|1|||
124586126|NCT01632306|448102389|FG001|Overall Study|Protocol Violation|0|||
124586127|NCT01632306|448102390|FG002|Overall Study|Protocol Violation|0|||
124586128|NCT03867760|448102397|FG000|Overall Study|Lost to Follow-up|2|||
124586129|NCT03867760|448102398|FG001|Overall Study|Lost to Follow-up|3|||
124586130|NCT03867760|448102397|FG000|Overall Study|Withdrawal by Subject|1|||
124586131|NCT03867760|448102398|FG001|Overall Study|Withdrawal by Subject|2|||
124586132|NCT03867760|448102397|FG000|Overall Study|subject could not meet study logistics|3|||
124777481|NCT01499355|448813064|FG003|Double-Blind Period|Adverse Event|2|||
124777482|NCT01499355|448813061|FG000|Double-Blind Period|Study Termination|0|||
124586133|NCT03867760|448102398|FG001|Overall Study|subject could not meet study logistics|3|||
124586134|NCT02286466|448102399|FG000|Overall Study|Death|1|||
124586135|NCT02286466|448102400|FG001|Overall Study|Death|3|||
124586136|NCT02286466|448102399|FG000|Overall Study|Withdrawal by Subject|5|||
124586137|NCT02286466|448102400|FG001|Overall Study|Withdrawal by Subject|2|||
124531830|NCT02972658|447897946|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
124531831|NCT02972658|447897947|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
124531832|NCT02972658|447897948|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
124531833|NCT02972658|447897945|FG000|Overall Study|Sponsor Decision|70|||
124531834|NCT02972658|447897946|FG001|Overall Study|Sponsor Decision|127|||
124531835|NCT02972658|447897947|FG002|Overall Study|Sponsor Decision|72|||
124531836|NCT02972658|447897948|FG003|Overall Study|Sponsor Decision|119|||
124531837|NCT03958149|447897949|FG000|Overall Study|Withdrawal by Subject|0|||
124531838|NCT03958149|447897950|FG001|Overall Study|Withdrawal by Subject|1|||
124531839|NCT02785588|447897951|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
124531840|NCT02785588|447897951|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
124531841|NCT02499172|447897952|FG000|Overall Study|Financial reason|0|||
124531842|NCT02499172|447897953|FG001|Overall Study|Financial reason|0|||
124531843|NCT02499172|447897954|FG002|Overall Study|Financial reason|523|||
124531844|NCT02499172|447897955|FG003|Overall Study|Financial reason|436|||
124531845|NCT02499172|447897952|FG000|Overall Study|Lost to Follow-up|65|||
124531846|NCT02499172|447897953|FG001|Overall Study|Lost to Follow-up|64|||
124531847|NCT02499172|447897954|FG002|Overall Study|Lost to Follow-up|0|||
124531848|NCT02499172|447897955|FG003|Overall Study|Lost to Follow-up|0|||
124531849|NCT01488994|447897964|FG000|Overall Study|Withdrawal by Subject|0|||
124531850|NCT01488994|447897965|FG001|Overall Study|Withdrawal by Subject|1|||
124531851|NCT03798366|447897966|FG000|Overall Study|Lost to Follow-up|0|||
124586138|NCT02286466|448102399|FG000|Overall Study|Lost to Follow-up|1|||
124586139|NCT02286466|448102400|FG001|Overall Study|Lost to Follow-up|4|||
124586140|NCT02286466|448102399|FG000|Overall Study|Declined Clinician Assessment|0|||
124586141|NCT02286466|448102400|FG001|Overall Study|Declined Clinician Assessment|1|||
124586142|NCT00874276|448102404|FG000|Overall Study|Withdrawal by Subject|1|||
124586143|NCT00874276|448102405|FG001|Overall Study|Withdrawal by Subject|1|||
124586144|NCT03694197|448102408|FG000|Overall Study|Adverse Event|9|||
124586145|NCT03694197|448102408|FG000|Overall Study|Protocol became inconvenient to participate|1|||
124586146|NCT03694197|448102408|FG000|Overall Study|Physician Decision|4|||
124586147|NCT03694197|448102408|FG000|Overall Study|Study terminated by sponsor|1350|||
124586148|NCT03694197|448102408|FG000|Overall Study|Participant moved|5|||
124586149|NCT03694197|448102408|FG000|Overall Study|Participant withdrew consent|10|||
124586150|NCT03694197|448102408|FG000|Overall Study|Related to IMP administration|1|||
124586151|NCT03694197|448102408|FG000|Overall Study|Not disclosed|5|||
124586152|NCT02957331|448102409|FG000|Overall Study|Protocol Violation|1|||
124586153|NCT02957331|448102410|FG001|Overall Study|Protocol Violation|0|||
124586154|NCT03247686|448104221|FG000|Overall Study|Withdrawal by Subject|1|||
124586155|NCT03247686|448104222|FG001|Overall Study|Withdrawal by Subject|2|||
124586156|NCT02583048|448104233|FG000|Overall Study|Withdrawal by Subject|0|||
124586157|NCT02583048|448104234|FG001|Overall Study|Withdrawal by Subject|1|||
124586158|NCT02583048|448104235|FG002|Overall Study|Withdrawal by Subject|0|||
124586159|NCT02583048|448104233|FG000|Overall Study|Failed to meet eligibility criterion|0|||
124586160|NCT02583048|448104234|FG001|Overall Study|Failed to meet eligibility criterion|0|||
124586161|NCT02583048|448104235|FG002|Overall Study|Failed to meet eligibility criterion|1|||
124586162|NCT01151280|448104238|FG000|Overall Study|Adverse Event|1|||
124586163|NCT01151280|448104238|FG000|Overall Study|Lack of Efficacy|3|||
124586164|NCT00757705|448104239|FG000|Overall Study|Adverse Event|19|||
124586165|NCT00757705|448104239|FG000|Overall Study|Lost to Follow-up|16|||
124586166|NCT00757705|448104239|FG000|Overall Study|Withdrawal by Subject|25|||
124586167|NCT00757705|448104239|FG000|Overall Study|Insufficient Response|26|||
124586168|NCT00757705|448104239|FG000|Overall Study|Ineligible to continue|8|||
124586169|NCT00757705|448104239|FG000|Overall Study|Non-compliant|9|||
124586170|NCT00757705|448104239|FG000|Overall Study|Other|18|||
124586171|NCT02578641|448104243|FG000|Overall Study|Adverse Event|5|||
124586172|NCT02578641|448104244|FG001|Overall Study|Adverse Event|15|||
124586173|NCT02578641|448104243|FG000|Overall Study|Death|16|||
124586174|NCT02578641|448104244|FG001|Overall Study|Death|8|||
124586175|NCT02578641|448104243|FG000|Overall Study|Lost to Follow-up|0|||
124586176|NCT02578641|448104244|FG001|Overall Study|Lost to Follow-up|1|||
124586177|NCT02578641|448104243|FG000|Overall Study|Withdrawal by Subject|14|||
124586178|NCT02578641|448104244|FG001|Overall Study|Withdrawal by Subject|7|||
124586179|NCT02578641|448104243|FG000|Overall Study|Progressive Disease|69|||
124586180|NCT02578641|448104244|FG001|Overall Study|Progressive Disease|21|||
124586181|NCT02578641|448104243|FG000|Overall Study|No Study Drug|2|||
124586182|NCT02578641|448104244|FG001|Overall Study|No Study Drug|0|||
124586183|NCT02578641|448104243|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
124586184|NCT02578641|448104244|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
124586185|NCT02578641|448104243|FG000|Overall Study|Non-compliance with Study Schedule|1|||
124586186|NCT02578641|448104244|FG001|Overall Study|Non-compliance with Study Schedule|0|||
124586187|NCT02578641|448104243|FG000|Overall Study|Other|1|||
124586188|NCT02578641|448104244|FG001|Overall Study|Other|10|||
124586189|NCT02578641|448104243|FG000|Overall Study|Not treated|1|||
124586190|NCT02578641|448104244|FG001|Overall Study|Not treated|4|||
124586191|NCT02313558|448104245|FG000|Overall Study|Withdrawal by Subject|2|||
124586192|NCT02313558|448104246|FG001|Overall Study|Withdrawal by Subject|0|||
124586193|NCT02313558|448104245|FG000|Overall Study|Lost to Follow-up|4|||
124586194|NCT02313558|448104246|FG001|Overall Study|Lost to Follow-up|4|||
124586195|NCT01710358|448104248|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
124586196|NCT01710358|448104249|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
124586197|NCT01710358|448104250|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
124586198|NCT01710358|448104248|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
124586199|NCT01710358|448104249|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
124586200|NCT01710358|448104250|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
124586201|NCT01710358|448104248|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
124586202|NCT01710358|448104249|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
124586203|NCT01710358|448104250|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
124586204|NCT01710358|448104248|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
124586205|NCT01710358|448104249|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
124586206|NCT01710358|448104250|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
124586207|NCT01710358|448104248|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
124586208|NCT01710358|448104249|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
124586209|NCT01710358|448104250|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
124586210|NCT01710358|448104248|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
124586211|NCT01710358|448104249|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
124586212|NCT01710358|448104250|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
124586213|NCT01710358|448104248|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
124586214|NCT01710358|448104249|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
124586215|NCT01710358|448104250|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
124586216|NCT01710358|448104248|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
124586217|NCT01710358|448104249|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
124586218|NCT01710358|448104250|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
124586219|NCT01710358|448104248|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
124586220|NCT01710358|448104249|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
124586221|NCT01710358|448104250|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
124586222|NCT01710358|448104248|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
124586223|NCT01710358|448104249|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
124586224|NCT01710358|448104250|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
124586225|NCT01710358|448104248|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
124586226|NCT01710358|448104249|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
124586227|NCT01710358|448104250|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
124586228|NCT01710358|448104248|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
124586229|NCT01710358|448104249|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
124586230|NCT01710358|448104250|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
124586231|NCT01710358|448104248|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
124586232|NCT01710358|448104249|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
124586233|NCT01710358|448104250|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
124586234|NCT01710358|448104248|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
124586235|NCT01710358|448104249|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
124586236|NCT01710358|448104250|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
124586237|NCT01710358|448104248|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
124586238|NCT01710358|448104249|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
124586239|NCT01710358|448104250|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
124586240|NCT01710358|448104248|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
124586241|NCT01710358|448104249|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
124586242|NCT01710358|448104250|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
124586243|NCT01710358|448104248|FG000|Rescue Period|Adverse Event|0|||
124586244|NCT01710358|448104249|FG001|Rescue Period|Adverse Event|15|||
124586245|NCT01710358|448104250|FG002|Rescue Period|Adverse Event|0|||
124531852|NCT03798366|447897967|FG001|Overall Study|Lost to Follow-up|1|||
124531853|NCT00474539|447897970|FG000|Infant Series|Withdrawal by Subject|3|||
124531854|NCT00474539|447897971|FG001|Infant Series|Withdrawal by Subject|4|||
124531855|NCT00474539|447897970|FG000|Infant Series|Randomization error|5|||
124531856|NCT00474539|447897971|FG001|Infant Series|Randomization error|0|||
124531857|NCT00474539|447897970|FG000|Infant Series|Lost to Follow-up|2|||
124531858|NCT00474539|447897971|FG001|Infant Series|Lost to Follow-up|1|||
124531859|NCT00474539|447897970|FG000|Infant Series|Protocol Violation|0|||
124531860|NCT00474539|447897971|FG001|Infant Series|Protocol Violation|1|||
124531861|NCT00474539|447897970|FG000|After Infant Series|Lost to Follow-up|3|||
124531862|NCT00474539|447897971|FG001|After Infant Series|Lost to Follow-up|0|||
124531863|NCT00474539|447897970|FG000|After Infant Series|Withdrawal by Subject|1|||
124531864|NCT00474539|447897971|FG001|After Infant Series|Withdrawal by Subject|0|||
124531865|NCT00474539|447897970|FG000|Toddler Dose|Protocol Violation|1|||
124531866|NCT00474539|447897971|FG001|Toddler Dose|Protocol Violation|0|||
124531867|NCT01227252|447897972|FG000|Overall Study|Sponsor Decision|0|||
124531868|NCT01227252|447897973|FG001|Overall Study|Sponsor Decision|1|||
124531869|NCT01227252|447897974|FG002|Overall Study|Sponsor Decision|0|||
124531870|NCT01227252|447897975|FG003|Overall Study|Sponsor Decision|0|||
124531871|NCT01227252|447897972|FG000|Overall Study|Lost to Follow-up|0|||
124531872|NCT01227252|447897973|FG001|Overall Study|Lost to Follow-up|1|||
124531873|NCT01227252|447897974|FG002|Overall Study|Lost to Follow-up|0|||
124531874|NCT01227252|447897975|FG003|Overall Study|Lost to Follow-up|0|||
124531875|NCT01227252|447897972|FG000|Overall Study|Withdrawal by Subject|0|||
124531876|NCT01227252|447897973|FG001|Overall Study|Withdrawal by Subject|1|||
124531877|NCT01227252|447897974|FG002|Overall Study|Withdrawal by Subject|0|||
124531878|NCT01227252|447897975|FG003|Overall Study|Withdrawal by Subject|0|||
124531879|NCT02561273|447897976|FG000|Overall Study|Protocol Violation|1|||
124531880|NCT02561273|447897977|FG001|Overall Study|Protocol Violation|0|||
124531881|NCT02192190|447897987|FG000|Overall Study|Adverse Event|1|||
124586246|NCT01710358|448104248|FG000|Rescue Period|Death|0|||
124586247|NCT01710358|448104249|FG001|Rescue Period|Death|1|||
124586248|NCT01710358|448104250|FG002|Rescue Period|Death|0|||
124586249|NCT01710358|448104248|FG000|Rescue Period|Lack of Efficacy|0|||
124586250|NCT01710358|448104249|FG001|Rescue Period|Lack of Efficacy|7|||
124586251|NCT01710358|448104250|FG002|Rescue Period|Lack of Efficacy|0|||
124586252|NCT01710358|448104248|FG000|Rescue Period|Withdrawal by Subject|0|||
124586253|NCT01710358|448104249|FG001|Rescue Period|Withdrawal by Subject|8|||
124586254|NCT01710358|448104250|FG002|Rescue Period|Withdrawal by Subject|0|||
124586255|NCT00735696|448104257|FG000|Overall Study|Withdrawal by Subject|1|||
124586256|NCT00735696|448104257|FG000|Overall Study|Enrolled but never Treated|1|||
124586257|NCT00084864|448104258|FG000|Overall Study|Adverse Event|1|||
124586258|NCT00084864|448104259|FG001|Overall Study|Adverse Event|0|||
124586259|NCT00084864|448104260|FG002|Overall Study|Adverse Event|0|||
124531882|NCT02192190|447897988|FG001|Overall Study|Adverse Event|1|||
124531883|NCT02192190|447897989|FG002|Overall Study|Adverse Event|0|||
124531884|NCT02192190|447897990|FG003|Overall Study|Adverse Event|0|||
124531885|NCT02192190|447897991|FG004|Overall Study|Adverse Event|0|||
124586260|NCT00084864|448104261|FG003|Overall Study|Adverse Event|0|||
124586261|NCT04406194|448104262|FG000|Period 1|Withdrawal by Subject|0|||
124586262|NCT04406194|448104263|FG001|Period 1|Withdrawal by Subject|1|||
124586263|NCT01741545|448104264|FG000|Treatment Period|Lack of Efficacy|0|||
124586264|NCT01741545|448104265|FG001|Treatment Period|Lack of Efficacy|1|||
124586265|NCT01741545|448104264|FG000|Treatment Period|Adverse event, non-fatal|1|||
124586266|NCT01741545|448104265|FG001|Treatment Period|Adverse event, non-fatal|3|||
124586267|NCT01741545|448104264|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
124586268|NCT01741545|448104265|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
124586269|NCT01741545|448104264|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
124586270|NCT01741545|448104265|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
124586271|NCT01456962|448104266|FG000|Overall Study|Lost to Follow-up|2|||
124586272|NCT01456962|448104267|FG001|Overall Study|Lost to Follow-up|1|||
124586273|NCT02704091|448104270|FG000|Overall Study|Adverse Event|4|||
124586274|NCT02704091|448104271|FG001|Overall Study|Adverse Event|3|||
124586275|NCT02704091|448104270|FG000|Overall Study|Protocol Violation|5|||
124586276|NCT02704091|448104271|FG001|Overall Study|Protocol Violation|3|||
124586277|NCT02704091|448104270|FG000|Overall Study|Consent withdrawn|4|||
124586278|NCT02704091|448104271|FG001|Overall Study|Consent withdrawn|4|||
124586279|NCT02704091|448104270|FG000|Overall Study|Lost to Follow-up|13|||
124586280|NCT02704091|448104271|FG001|Overall Study|Lost to Follow-up|5|||
124586281|NCT02704091|448104270|FG000|Overall Study|Other|2|||
124586282|NCT02704091|448104271|FG001|Overall Study|Other|8|||
124586283|NCT03073798|448104272|FG000|Overall Study|Adverse Event|1|||
124586284|NCT03073798|448104272|FG000|Overall Study|Withdrawal by Subject|1|||
124586285|NCT01186458|448104273|FG000|Overall Study|Adverse Event|1|||
124586286|NCT01496118|448104274|FG000|Overall Study|Disease progression|3|||
124586287|NCT01496118|448104275|FG001|Overall Study|Disease progression|2|||
124586288|NCT01496118|448104276|FG002|Overall Study|Disease progression|3|||
124586289|NCT01496118|448104277|FG003|Overall Study|Disease progression|1|||
124586290|NCT01496118|448104278|FG004|Overall Study|Disease progression|2|||
124586291|NCT01496118|448104279|FG005|Overall Study|Disease progression|2|||
124586292|NCT01496118|448104280|FG006|Overall Study|Disease progression|14|||
124586293|NCT01496118|448104281|FG007|Overall Study|Disease progression|10|||
124586294|NCT01496118|448104274|FG000|Overall Study|Physician Decision|0|||
124586295|NCT01496118|448104275|FG001|Overall Study|Physician Decision|0|||
124586296|NCT01496118|448104276|FG002|Overall Study|Physician Decision|0|||
124586297|NCT01496118|448104277|FG003|Overall Study|Physician Decision|0|||
124586298|NCT01496118|448104278|FG004|Overall Study|Physician Decision|1|||
124586299|NCT01496118|448104279|FG005|Overall Study|Physician Decision|0|||
124586300|NCT01496118|448104280|FG006|Overall Study|Physician Decision|3|||
124586301|NCT01496118|448104281|FG007|Overall Study|Physician Decision|6|||
124586302|NCT01496118|448104274|FG000|Overall Study|Adverse Event|1|||
124586303|NCT01496118|448104275|FG001|Overall Study|Adverse Event|1|||
124586304|NCT01496118|448104276|FG002|Overall Study|Adverse Event|0|||
124586305|NCT01496118|448104277|FG003|Overall Study|Adverse Event|0|||
124586306|NCT01496118|448104278|FG004|Overall Study|Adverse Event|0|||
124586307|NCT01496118|448104279|FG005|Overall Study|Adverse Event|0|||
124586308|NCT01496118|448104280|FG006|Overall Study|Adverse Event|6|||
124531886|NCT02192190|447897992|FG005|Overall Study|Adverse Event|0|||
124531887|NCT02192190|447897987|FG000|Overall Study|Lost to Follow-up|3|||
124531888|NCT02192190|447897988|FG001|Overall Study|Lost to Follow-up|3|||
124531889|NCT02192190|447897989|FG002|Overall Study|Lost to Follow-up|2|||
124531890|NCT02192190|447897990|FG003|Overall Study|Lost to Follow-up|1|||
124531891|NCT02192190|447897991|FG004|Overall Study|Lost to Follow-up|4|||
124531892|NCT02192190|447897992|FG005|Overall Study|Lost to Follow-up|3|||
124531893|NCT02192190|447897987|FG000|Overall Study|Physician Decision|2|||
124531894|NCT02192190|447897988|FG001|Overall Study|Physician Decision|0|||
124531895|NCT02192190|447897989|FG002|Overall Study|Physician Decision|0|||
124531896|NCT02192190|447897990|FG003|Overall Study|Physician Decision|0|||
124531897|NCT02192190|447897991|FG004|Overall Study|Physician Decision|0|||
124586309|NCT01496118|448104281|FG007|Overall Study|Adverse Event|10|||
124586310|NCT01496118|448104274|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
124586311|NCT01496118|448104275|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
124586312|NCT01496118|448104276|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
124531898|NCT02192190|447897992|FG005|Overall Study|Physician Decision|0|||
124531899|NCT02192190|447897987|FG000|Overall Study|Terminated by Sponsor|43|||
124531900|NCT02192190|447897988|FG001|Overall Study|Terminated by Sponsor|23|||
124586313|NCT01496118|448104277|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
124586314|NCT01496118|448104278|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
124586315|NCT01496118|448104279|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
124586316|NCT01496118|448104280|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
124586317|NCT01496118|448104281|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
124586318|NCT01496118|448104274|FG000|Overall Study|Death|0|||
124586319|NCT01496118|448104275|FG001|Overall Study|Death|0|||
124586320|NCT01496118|448104276|FG002|Overall Study|Death|0|||
124531901|NCT02192190|447897989|FG002|Overall Study|Terminated by Sponsor|20|||
124586321|NCT01496118|448104277|FG003|Overall Study|Death|0|||
124586322|NCT01496118|448104278|FG004|Overall Study|Death|0|||
124586323|NCT01496118|448104279|FG005|Overall Study|Death|0|||
124586324|NCT01496118|448104280|FG006|Overall Study|Death|1|||
124586325|NCT01496118|448104281|FG007|Overall Study|Death|1|||
124586326|NCT01496118|448104274|FG000|Overall Study|Withdrawal by Subject|0|||
124586327|NCT01496118|448104275|FG001|Overall Study|Withdrawal by Subject|0|||
124586328|NCT01496118|448104276|FG002|Overall Study|Withdrawal by Subject|0|||
124586329|NCT01496118|448104277|FG003|Overall Study|Withdrawal by Subject|2|||
124586330|NCT01496118|448104278|FG004|Overall Study|Withdrawal by Subject|0|||
124586331|NCT01496118|448104279|FG005|Overall Study|Withdrawal by Subject|1|||
124586332|NCT01496118|448104280|FG006|Overall Study|Withdrawal by Subject|6|||
124586333|NCT01496118|448104281|FG007|Overall Study|Withdrawal by Subject|3|||
124586334|NCT02420353|448104282|FG000|Overall Study|Withdrawal by Subject|0|||
124586335|NCT02420353|448104283|FG001|Overall Study|Withdrawal by Subject|1|||
124586336|NCT04608448|448104284|FG000|Overall Study|Withdrawal by Subject|1|||
124586337|NCT04608448|448104284|FG000|Overall Study|Adverse Event|1|||
124586338|NCT01149057|448104285|FG000|Overall Study|Lack of Efficacy|16|||
124586339|NCT01149057|448104285|FG000|Overall Study|Adverse Event|13|||
124586340|NCT01149057|448104285|FG000|Overall Study|Withdrawal by Subject|9|||
124586341|NCT01149057|448104285|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
124586342|NCT01149057|448104285|FG000|Overall Study|B Cell Depletion|4|||
124586343|NCT01149057|448104285|FG000|Overall Study|Participant Non-Compliance|2|||
124586344|NCT01149057|448104285|FG000|Overall Study|Lost to Follow-up|1|||
124586345|NCT01149057|448104285|FG000|Overall Study|High Parathyroid Hormone Value|1|||
124586346|NCT01149057|448104285|FG000|Overall Study|Other|6|||
124586347|NCT00577655|448104286|FG000|Overall Study|Patient Request|0|||
124586348|NCT00577655|448104287|FG001|Overall Study|Patient Request|2|||
124586349|NCT00577655|448104286|FG000|Overall Study|Protocol Violation|0|||
124586350|NCT00577655|448104287|FG001|Overall Study|Protocol Violation|1|||
124586351|NCT00577655|448104286|FG000|Overall Study|Lost to Follow-up|1|||
124586352|NCT00577655|448104287|FG001|Overall Study|Lost to Follow-up|1|||
124586353|NCT00875524|448104288|FG000|Overall Study|Serious adverse event|0|||
124586354|NCT00875524|448104289|FG001|Overall Study|Serious adverse event|1|||
124586355|NCT00875524|448104288|FG000|Overall Study|Protocol Violation|4|||
124586356|NCT00875524|448104289|FG001|Overall Study|Protocol Violation|0|||
124586357|NCT00875524|448104288|FG000|Overall Study|Lost to Follow-up|1|||
124586358|NCT00875524|448104289|FG001|Overall Study|Lost to Follow-up|0|||
124586359|NCT00875524|448104288|FG000|Overall Study|Withdrawal by Subject|3|||
124586360|NCT00875524|448104289|FG001|Overall Study|Withdrawal by Subject|5|||
124586361|NCT01370863|448104290|FG000|Overall Study|Adverse Event|1|||
124586362|NCT01370863|448104291|FG001|Overall Study|Adverse Event|1|||
124586363|NCT01370863|448104290|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
124586364|NCT01370863|448104291|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
124586365|NCT01370863|448104290|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
124586366|NCT01370863|448104291|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
124586367|NCT02761915|448104292|FG000|Overall Study|Death|3|||
124586368|NCT02761915|448104293|FG001|Overall Study|Death|1|||
124586369|NCT02761915|448104294|FG002|Overall Study|Death|1|||
124586370|NCT02761915|448104295|FG003|Overall Study|Death|1|||
124586371|NCT02761915|448104296|FG004|Overall Study|Death|0|||
124586372|NCT02761915|448104297|FG005|Overall Study|Death|1|||
124586373|NCT02761915|448104292|FG000|Overall Study|Withdrawal by Subject|1|||
124531902|NCT02192190|447897990|FG003|Overall Study|Terminated by Sponsor|23|||
124531903|NCT02192190|447897991|FG004|Overall Study|Terminated by Sponsor|21|||
124531904|NCT02192190|447897992|FG005|Overall Study|Terminated by Sponsor|23|||
124531905|NCT02192190|447897987|FG000|Overall Study|Withdrawal by Subject|4|||
124531906|NCT02192190|447897988|FG001|Overall Study|Withdrawal by Subject|1|||
124531907|NCT02192190|447897989|FG002|Overall Study|Withdrawal by Subject|2|||
124531908|NCT02192190|447897990|FG003|Overall Study|Withdrawal by Subject|1|||
124531909|NCT02192190|447897991|FG004|Overall Study|Withdrawal by Subject|5|||
124531910|NCT02192190|447897992|FG005|Overall Study|Withdrawal by Subject|3|||
124531911|NCT02192190|447897987|FG000|Overall Study|Could not Keep Visit Schedule|1|||
124531912|NCT02192190|447897988|FG001|Overall Study|Could not Keep Visit Schedule|0|||
124531913|NCT02192190|447897989|FG002|Overall Study|Could not Keep Visit Schedule|0|||
124531914|NCT02192190|447897990|FG003|Overall Study|Could not Keep Visit Schedule|0|||
124531915|NCT02192190|447897991|FG004|Overall Study|Could not Keep Visit Schedule|0|||
124531916|NCT02192190|447897992|FG005|Overall Study|Could not Keep Visit Schedule|0|||
124531917|NCT02192190|447897987|FG000|Overall Study|Positive Drug Screen|0|||
124586374|NCT02761915|448104293|FG001|Overall Study|Withdrawal by Subject|0|||
124586375|NCT02761915|448104294|FG002|Overall Study|Withdrawal by Subject|0|||
124586376|NCT02761915|448104295|FG003|Overall Study|Withdrawal by Subject|0|||
124586377|NCT02761915|448104296|FG004|Overall Study|Withdrawal by Subject|1|||
124531918|NCT02192190|447897988|FG001|Overall Study|Positive Drug Screen|0|||
124586378|NCT02761915|448104297|FG005|Overall Study|Withdrawal by Subject|2|||
124586379|NCT02761915|448104292|FG000|Overall Study|Disease Progression|0|||
124586380|NCT02761915|448104293|FG001|Overall Study|Disease Progression|0|||
124777483|NCT01499355|448813062|FG001|Double-Blind Period|Study Termination|18|||
124777484|NCT01499355|448813063|FG002|Double-Blind Period|Study Termination|16|||
124777485|NCT01499355|448813064|FG003|Double-Blind Period|Study Termination|14|||
124777486|NCT01499355|448813061|FG000|Double-Blind Period|Other|0|||
124777487|NCT01499355|448813062|FG001|Double-Blind Period|Other|1|||
124777488|NCT01499355|448813063|FG002|Double-Blind Period|Other|2|||
124777489|NCT01499355|448813064|FG003|Double-Blind Period|Other|2|||
124777490|NCT01499355|448813061|FG000|Double-Blind Period|Death|0|||
124777491|NCT01499355|448813062|FG001|Double-Blind Period|Death|1|||
124777492|NCT01499355|448813063|FG002|Double-Blind Period|Death|0|||
124777493|NCT01499355|448813064|FG003|Double-Blind Period|Death|0|||
124777494|NCT01499355|448813061|FG000|Double-Blind Period|Investigator Decision|0|||
124777495|NCT01499355|448813062|FG001|Double-Blind Period|Investigator Decision|0|||
124777496|NCT01499355|448813063|FG002|Double-Blind Period|Investigator Decision|3|||
124777497|NCT01499355|448813064|FG003|Double-Blind Period|Investigator Decision|3|||
124777498|NCT01499355|448813061|FG000|Double-Blind Period|Consent Withdrawn|0|||
124777499|NCT01499355|448813062|FG001|Double-Blind Period|Consent Withdrawn|0|||
124777500|NCT01499355|448813063|FG002|Double-Blind Period|Consent Withdrawn|1|||
124777501|NCT01499355|448813064|FG003|Double-Blind Period|Consent Withdrawn|2|||
124777502|NCT01499355|448813061|FG000|Double-Blind Period|Lost to Follow-up|0|||
124777503|NCT01499355|448813062|FG001|Double-Blind Period|Lost to Follow-up|1|||
124777504|NCT01499355|448813063|FG002|Double-Blind Period|Lost to Follow-up|0|||
124777505|NCT01499355|448813064|FG003|Double-Blind Period|Lost to Follow-up|0|||
124777506|NCT01526733|448813065|FG000|Phase 1|Protocol Violation|1|||
124777507|NCT01526733|448813066|FG001|Phase 1|Protocol Violation|0|||
124777508|NCT01526733|448813065|FG000|Phase 1|Withdrawal by Subject|1|||
124777509|NCT01526733|448813066|FG001|Phase 1|Withdrawal by Subject|1|||
124586381|NCT02761915|448104294|FG002|Overall Study|Disease Progression|0|||
124586382|NCT02761915|448104295|FG003|Overall Study|Disease Progression|2|||
124586383|NCT02761915|448104296|FG004|Overall Study|Disease Progression|2|||
124586384|NCT02761915|448104297|FG005|Overall Study|Disease Progression|2|||
124586385|NCT01143337|448104298|FG000|Overall Study|Adverse Event|3|||
124586386|NCT01143337|448104299|FG001|Overall Study|Adverse Event|9|||
124586387|NCT01143337|448104300|FG002|Overall Study|Adverse Event|5|||
124586388|NCT01143337|448104298|FG000|Overall Study|Lack of Efficacy|6|||
124586389|NCT01143337|448104299|FG001|Overall Study|Lack of Efficacy|2|||
124586390|NCT01143337|448104300|FG002|Overall Study|Lack of Efficacy|1|||
124586391|NCT01143337|448104298|FG000|Overall Study|Protocol Violation|1|||
124586392|NCT01143337|448104299|FG001|Overall Study|Protocol Violation|0|||
124586393|NCT01143337|448104300|FG002|Overall Study|Protocol Violation|0|||
124586394|NCT01143337|448104298|FG000|Overall Study|Withdrawal by Subject|0|||
124586395|NCT01143337|448104299|FG001|Overall Study|Withdrawal by Subject|0|||
124586396|NCT01143337|448104300|FG002|Overall Study|Withdrawal by Subject|1|||
124586397|NCT01143337|448104298|FG000|Overall Study|Other reason|0|||
124586398|NCT01143337|448104299|FG001|Overall Study|Other reason|0|||
124586399|NCT01143337|448104300|FG002|Overall Study|Other reason|5|||
124586400|NCT00819169|448104309|FG000|Overall Study|Withdrawal by Subject|2|||
124586401|NCT00819169|448104310|FG001|Overall Study|Withdrawal by Subject|0|||
124586402|NCT00819169|448104311|FG002|Overall Study|Withdrawal by Subject|0|||
124586403|NCT00819169|448104312|FG003|Overall Study|Withdrawal by Subject|1|||
124586404|NCT00819169|448104313|FG004|Overall Study|Withdrawal by Subject|1|||
124586405|NCT00819169|448104314|FG005|Overall Study|Withdrawal by Subject|1|||
124586406|NCT00819169|448104315|FG006|Overall Study|Withdrawal by Subject|5|||
124586407|NCT00819169|448104316|FG007|Overall Study|Withdrawal by Subject|1|||
124586408|NCT00819169|448104317|FG008|Overall Study|Withdrawal by Subject|4|||
124586409|NCT00819169|448104309|FG000|Overall Study|Lost to Follow-up|0|||
124586410|NCT00819169|448104310|FG001|Overall Study|Lost to Follow-up|2|||
124586411|NCT00819169|448104311|FG002|Overall Study|Lost to Follow-up|0|||
124586412|NCT00819169|448104312|FG003|Overall Study|Lost to Follow-up|1|||
124586413|NCT00819169|448104313|FG004|Overall Study|Lost to Follow-up|0|||
124586414|NCT00819169|448104314|FG005|Overall Study|Lost to Follow-up|6|||
124586415|NCT00819169|448104315|FG006|Overall Study|Lost to Follow-up|2|||
124586416|NCT00819169|448104316|FG007|Overall Study|Lost to Follow-up|2|||
124586417|NCT00819169|448104317|FG008|Overall Study|Lost to Follow-up|1|||
124586418|NCT00819169|448104309|FG000|Overall Study|Death|1|||
124586419|NCT00819169|448104310|FG001|Overall Study|Death|1|||
124586420|NCT00819169|448104311|FG002|Overall Study|Death|3|||
124586421|NCT00819169|448104312|FG003|Overall Study|Death|8|||
124586422|NCT00819169|448104313|FG004|Overall Study|Death|5|||
124777510|NCT01599637|448813067|FG000|Overall Study|administrative problems|0|||
124586423|NCT00819169|448104314|FG005|Overall Study|Death|7|||
124586424|NCT00819169|448104315|FG006|Overall Study|Death|9|||
124586425|NCT00819169|448104316|FG007|Overall Study|Death|4|||
124586426|NCT00819169|448104317|FG008|Overall Study|Death|7|||
124586427|NCT00819169|448104309|FG000|Overall Study|Ineligibility determined|0|||
124586428|NCT00819169|448104310|FG001|Overall Study|Ineligibility determined|0|||
124586429|NCT00819169|448104311|FG002|Overall Study|Ineligibility determined|0|||
124586430|NCT00819169|448104312|FG003|Overall Study|Ineligibility determined|2|||
124777511|NCT01599637|448813068|FG001|Overall Study|administrative problems|2|||
124777512|NCT01599637|448813069|FG002|Overall Study|administrative problems|0|||
124586431|NCT00819169|448104313|FG004|Overall Study|Ineligibility determined|0|||
124586432|NCT00819169|448104314|FG005|Overall Study|Ineligibility determined|0|||
124586433|NCT00819169|448104315|FG006|Overall Study|Ineligibility determined|0|||
124586434|NCT00819169|448104316|FG007|Overall Study|Ineligibility determined|0|||
124586435|NCT00819169|448104317|FG008|Overall Study|Ineligibility determined|1|||
124586436|NCT00819169|448104309|FG000|Overall Study|Adverse Event|0|||
124586437|NCT00819169|448104310|FG001|Overall Study|Adverse Event|0|||
124586438|NCT00819169|448104311|FG002|Overall Study|Adverse Event|0|||
124586439|NCT00819169|448104312|FG003|Overall Study|Adverse Event|0|||
124586440|NCT00819169|448104313|FG004|Overall Study|Adverse Event|1|||
124586441|NCT00819169|448104314|FG005|Overall Study|Adverse Event|0|||
124586442|NCT00819169|448104315|FG006|Overall Study|Adverse Event|0|||
124586443|NCT00819169|448104316|FG007|Overall Study|Adverse Event|0|||
124586444|NCT00819169|448104317|FG008|Overall Study|Adverse Event|0|||
124586445|NCT00819169|448104309|FG000|Overall Study|Administrative Decision|0|||
124586446|NCT00819169|448104310|FG001|Overall Study|Administrative Decision|0|||
124586447|NCT00819169|448104311|FG002|Overall Study|Administrative Decision|0|||
124586448|NCT00819169|448104312|FG003|Overall Study|Administrative Decision|0|||
124586449|NCT00819169|448104313|FG004|Overall Study|Administrative Decision|1|||
124586450|NCT00819169|448104314|FG005|Overall Study|Administrative Decision|2|||
124777513|NCT01599637|448813067|FG000|Overall Study|Adverse Event|1|||
124777514|NCT01599637|448813068|FG001|Overall Study|Adverse Event|0|||
124777515|NCT01599637|448813069|FG002|Overall Study|Adverse Event|0|||
124777516|NCT02565108|448813070|FG000|Overall Study|Adverse Event|1|||
124777517|NCT02565108|448813071|FG001|Overall Study|Adverse Event|0|||
124777518|NCT02565108|448813070|FG000|Overall Study|Withdrew Consent|1|||
124777519|NCT02565108|448813071|FG001|Overall Study|Withdrew Consent|0|||
124777520|NCT01310075|448813072|FG000|Overall Study|Lost to Follow-up|1|||
124777521|NCT01310075|448813073|FG001|Overall Study|Lost to Follow-up|0|||
124777522|NCT01310075|448813072|FG000|Overall Study|Physician Decision|10|||
124777523|NCT01310075|448813073|FG001|Overall Study|Physician Decision|7|||
124586451|NCT00819169|448104315|FG006|Overall Study|Administrative Decision|0|||
124586452|NCT00819169|448104316|FG007|Overall Study|Administrative Decision|2|||
124586453|NCT00819169|448104317|FG008|Overall Study|Administrative Decision|0|||
124586454|NCT00406393|448104318|FG000|Overall Study|Did not undergo transplantation|2|||
124586455|NCT00406393|448104319|FG001|Overall Study|Did not undergo transplantation|1|||
124586456|NCT03277248|448104322|FG000|Overall Study|Adverse Event|3|||
124586457|NCT03277248|448104323|FG001|Overall Study|Adverse Event|1|||
124586458|NCT03277248|448104322|FG000|Overall Study|Subject Withdrawal of Consent|6|||
124586459|NCT03277248|448104323|FG001|Overall Study|Subject Withdrawal of Consent|23|||
124586460|NCT03277248|448104322|FG000|Overall Study|Investigator/Sponsor Decision|2|||
124586461|NCT03277248|448104323|FG001|Overall Study|Investigator/Sponsor Decision|2|||
124586462|NCT03277248|448104322|FG000|Overall Study|Pregnancy|4|||
124586463|NCT03277248|448104323|FG001|Overall Study|Pregnancy|1|||
124586464|NCT03277248|448104322|FG000|Overall Study|Lost to Follow-up|0|||
124586465|NCT03277248|448104323|FG001|Overall Study|Lost to Follow-up|2|||
124586466|NCT03277248|448104322|FG000|Overall Study|Lack of Efficacy|0|||
124586467|NCT03277248|448104323|FG001|Overall Study|Lack of Efficacy|2|||
124586468|NCT03277248|448104322|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
124586469|NCT03277248|448104323|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
124586470|NCT01663896|448104324|FG000|Overall Study|Various reasons|43|||
124586471|NCT03614728|448104328|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
124586472|NCT03614728|448104329|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
124586473|NCT03614728|448104330|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
124586474|NCT03614728|448104331|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
124586475|NCT03614728|448104328|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
124586476|NCT03614728|448104329|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
124586477|NCT03614728|448104330|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
124586478|NCT03614728|448104331|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
124586479|NCT00379353|448104332|FG000|Overall Study|Hospitalization|3|||
124586480|NCT00379353|448104333|FG001|Overall Study|Hospitalization|3|||
124586481|NCT00379353|448104332|FG000|Overall Study|Withdrawal by Subject|5|||
124586482|NCT00379353|448104333|FG001|Overall Study|Withdrawal by Subject|2|||
124586483|NCT00379353|448104332|FG000|Overall Study|Death|1|||
124586484|NCT00379353|448104333|FG001|Overall Study|Death|0|||
124586485|NCT00379353|448104332|FG000|Overall Study|Cardiac Tamponade|1|||
124586486|NCT00379353|448104333|FG001|Overall Study|Cardiac Tamponade|0|||
124586487|NCT00379353|448104332|FG000|Overall Study|Non-compliance|1|||
124586488|NCT00379353|448104333|FG001|Overall Study|Non-compliance|0|||
124777524|NCT01310075|448813072|FG000|Overall Study|Protocol Violation|2|||
124777525|NCT01310075|448813073|FG001|Overall Study|Protocol Violation|2|||
124777526|NCT01310075|448813072|FG000|Overall Study|Withdrawal by Subject|1|||
124777527|NCT01310075|448813073|FG001|Overall Study|Withdrawal by Subject|1|||
124777528|NCT02395081|448813074|FG000|Overall Study|Withdrawal by Subject|1|||
124777529|NCT02395081|448813075|FG001|Overall Study|Withdrawal by Subject|1|||
124777530|NCT02395081|448813076|FG002|Overall Study|Withdrawal by Subject|0|||
124777531|NCT02395081|448813074|FG000|Overall Study|Moved where blood couldn't be collected|4|||
124777532|NCT02395081|448813075|FG001|Overall Study|Moved where blood couldn't be collected|1|||
124777533|NCT02395081|448813076|FG002|Overall Study|Moved where blood couldn't be collected|3|||
124777534|NCT02395081|448813074|FG000|Overall Study|Fetal Loss|2|||
124777535|NCT02395081|448813075|FG001|Overall Study|Fetal Loss|3|||
124777536|NCT02395081|448813076|FG002|Overall Study|Fetal Loss|1|||
124777537|NCT02991040|448813077|FG000|Overall Study|Withdrawal by Subject|2|||
124777538|NCT02991040|448813077|FG000|Overall Study|Lost to Follow-up|2|||
124777539|NCT00467753|448813078|FG000|Overall Study|Lost to Follow-up|1|||
124777540|NCT00467753|448813079|FG001|Overall Study|Lost to Follow-up|2|||
124777541|NCT00467753|448813078|FG000|Overall Study|Adverse Event|2|||
124777542|NCT00467753|448813079|FG001|Overall Study|Adverse Event|0|||
124777543|NCT01869764|448813080|FG000|Overall Study|Withdrawal by Subject|0|||
124777544|NCT01869764|448813081|FG001|Overall Study|Withdrawal by Subject|2|||
124777545|NCT01286480|448813082|FG000|Overall Study|Withdrawal by Subject|5|||
124777546|NCT01286480|448813083|FG001|Overall Study|Withdrawal by Subject|3|||
124777547|NCT02536963|448813084|FG000|Overall Study|Withdrawal by Subject|18|||
124777548|NCT02668393|448813086|FG000|Overall Study|Progressive disease|6|||
124777549|NCT02668393|448813087|FG001|Overall Study|Progressive disease|3|||
124777550|NCT02668393|448813086|FG000|Overall Study|Adverse Event|0|||
124777551|NCT02668393|448813087|FG001|Overall Study|Adverse Event|2|||
124777552|NCT02668393|448813086|FG000|Overall Study|Withdrawal from the trial|0|||
124777553|NCT02668393|448813087|FG001|Overall Study|Withdrawal from the trial|1|||
124777554|NCT02668393|448813086|FG000|Overall Study|Lack of benefit and side effects|1|||
124777555|NCT02668393|448813087|FG001|Overall Study|Lack of benefit and side effects|0|||
124777556|NCT02141204|448813088|FG000|Overall Study|Lost to Follow-up|2|||
124777557|NCT02141204|448813089|FG001|Overall Study|Lost to Follow-up|1|||
124777558|NCT02141204|448813088|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
124777559|NCT02141204|448813089|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
124777560|NCT02141204|448813088|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
124777561|NCT02141204|448813089|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
124777562|NCT02141204|448813088|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
124777563|NCT02141204|448813089|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
124777564|NCT02963506|448813091|FG000|Double-Blind Period|Adverse Event|0|||
124777565|NCT02963506|448813092|FG001|Double-Blind Period|Adverse Event|0|||
124586489|NCT00379353|448104332|FG000|Overall Study|Conflicting drug treatment|0|||
124586490|NCT00379353|448104333|FG001|Overall Study|Conflicting drug treatment|1|||
124586491|NCT01824576|448104334|FG000|Overall Study|Device deficiency|2|||
124586492|NCT01691612|448104339|FG000|Overall Study|deemed ineligible after 1st visit|6|||
124586493|NCT01691612|448104339|FG000|Overall Study|Adverse Event|1|||
124586494|NCT00858403|448104340|FG000|Overall Study|Withdrawal by Subject|1|||
124586495|NCT00858403|448104340|FG000|Overall Study|Death|3|||
124586496|NCT00858403|448104340|FG000|Overall Study|Disease Progression|1|||
124586497|NCT05315713|448104343|FG000|Overall Study|Death|5|||
124586498|NCT05315713|448104343|FG000|Overall Study|Progressive disease|1|||
124586499|NCT05315713|448104343|FG000|Overall Study|Withdrawal by Subject|1|||
124586500|NCT05315713|448104343|FG000|Overall Study|Study terminated by sponsor|1|||
124586501|NCT00556673|448104345|FG000|Overall Study|Protocol deviation|3|||
124586502|NCT00556673|448104346|FG001|Overall Study|Protocol deviation|2|||
124586503|NCT01131260|448104347|FG000|Overall Study|Randomization error|5|||
124586504|NCT01131260|448104348|FG001|Overall Study|Randomization error|1|||
124777566|NCT02963506|448813093|FG002|Double-Blind Period|Adverse Event|1|||
124777567|NCT02963506|448813094|FG003|Double-Blind Period|Adverse Event|0|||
124586505|NCT01131260|448104347|FG000|Overall Study|Declined to continue participation|8|||
124586506|NCT01131260|448104348|FG001|Overall Study|Declined to continue participation|13|||
124586507|NCT01131260|448104347|FG000|Overall Study|Physician Decision|22|||
124586508|NCT01131260|448104348|FG001|Overall Study|Physician Decision|24|||
124586509|NCT01131260|448104347|FG000|Overall Study|Technical problems|7|||
124586510|NCT01131260|448104348|FG001|Overall Study|Technical problems|6|||
124586511|NCT01131260|448104347|FG000|Overall Study|Staff error|2|||
124586512|NCT01131260|448104348|FG001|Overall Study|Staff error|1|||
124586513|NCT01131260|448104347|FG000|Overall Study|Ineligible|0|||
124586514|NCT01131260|448104348|FG001|Overall Study|Ineligible|2|||
124586515|NCT00835081|448104349|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
124586516|NCT00835081|448104350|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
124586517|NCT00421304|448104351|FG000|Overall Study|Lost to Follow-up|5|||
124586518|NCT00421304|448104352|FG001|Overall Study|Lost to Follow-up|2|||
124586519|NCT00421304|448104353|FG002|Overall Study|Lost to Follow-up|5|||
124777568|NCT02963506|448813095|FG004|Double-Blind Period|Adverse Event|0|||
124777569|NCT02963506|448813096|FG005|Double-Blind Period|Adverse Event|0|||
124777570|NCT02963506|448813097|FG006|Double-Blind Period|Adverse Event|0|||
124777571|NCT02963506|448813098|FG007|Double-Blind Period|Adverse Event|0|||
124777572|NCT02963506|448813099|FG008|Double-Blind Period|Adverse Event|0|||
124586520|NCT00421304|448104351|FG000|Overall Study|Withdrawal by Subject|2|||
124586521|NCT00421304|448104352|FG001|Overall Study|Withdrawal by Subject|2|||
124777573|NCT02963506|448813100|FG009|Double-Blind Period|Adverse Event|0|||
124777574|NCT02963506|448813101|FG010|Double-Blind Period|Adverse Event|0|||
124777575|NCT02963506|448813102|FG011|Double-Blind Period|Adverse Event|0|||
124586522|NCT00421304|448104353|FG002|Overall Study|Withdrawal by Subject|2|||
124586523|NCT00421304|448104351|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
124586524|NCT00421304|448104352|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
124586525|NCT00421304|448104353|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
124586526|NCT00421304|448104351|FG000|Overall Study|Did not attend Day 360 visit|0|||
124586527|NCT00421304|448104352|FG001|Overall Study|Did not attend Day 360 visit|0|||
124586528|NCT00421304|448104353|FG002|Overall Study|Did not attend Day 360 visit|1|||
124586529|NCT03196284|448104354|FG000|Main Part|Withdrawal by Subject|0|||
124586530|NCT03196284|448104355|FG001|Main Part|Withdrawal by Subject|1|||
124586531|NCT03196284|448104356|FG002|Main Part|Withdrawal by Subject|0|||
124586532|NCT03196284|448104354|FG000|Extension Part|Lack of Efficacy|0|||
124586533|NCT03196284|448104355|FG001|Extension Part|Lack of Efficacy|0|||
124586534|NCT03196284|448104356|FG002|Extension Part|Lack of Efficacy|1|||
124586535|NCT03196284|448104354|FG000|Extension Part|Withdrawal by Subject|0|||
124586536|NCT03196284|448104355|FG001|Extension Part|Withdrawal by Subject|0|||
124586537|NCT03196284|448104356|FG002|Extension Part|Withdrawal by Subject|1|||
124586538|NCT03196284|448104354|FG000|Extension Part|Physician Decision|0|||
124586539|NCT03196284|448104355|FG001|Extension Part|Physician Decision|0|||
124586540|NCT03196284|448104356|FG002|Extension Part|Physician Decision|1|||
124586541|NCT02535923|448104361|FG000|Overall Study|Lost to Follow-up|5|||
124586542|NCT02535923|448104362|FG001|Overall Study|Lost to Follow-up|5|||
124586543|NCT02535923|448104361|FG000|Overall Study|Withdrawal by Subject|4|||
124586544|NCT02535923|448104362|FG001|Overall Study|Withdrawal by Subject|3|||
124586545|NCT01018862|448104363|FG000|Overall Study|Adverse Event|2|||
124586546|NCT01018862|448104364|FG001|Overall Study|Adverse Event|0|||
124586547|NCT01018862|448104365|FG002|Overall Study|Adverse Event|6|||
124586548|NCT01018862|448104363|FG000|Overall Study|Lack of Efficacy|1|||
124586549|NCT01018862|448104364|FG001|Overall Study|Lack of Efficacy|0|||
124586550|NCT01018862|448104365|FG002|Overall Study|Lack of Efficacy|2|||
124586551|NCT01018862|448104363|FG000|Overall Study|Lost to Follow-up|3|||
124586552|NCT01018862|448104364|FG001|Overall Study|Lost to Follow-up|1|||
124586553|NCT01018862|448104365|FG002|Overall Study|Lost to Follow-up|0|||
124586554|NCT01018862|448104363|FG000|Overall Study|Protocol Violation|1|||
124586555|NCT01018862|448104364|FG001|Overall Study|Protocol Violation|3|||
124586556|NCT01018862|448104365|FG002|Overall Study|Protocol Violation|3|||
124586557|NCT01018862|448104363|FG000|Overall Study|Withdrawal by Subject|1|||
124586558|NCT01018862|448104364|FG001|Overall Study|Withdrawal by Subject|2|||
124777576|NCT02963506|448813103|FG012|Double-Blind Period|Adverse Event|0|||
124777577|NCT02963506|448813091|FG000|Double-Blind Period|Death|0|||
124777578|NCT02963506|448813092|FG001|Double-Blind Period|Death|0|||
124777579|NCT02963506|448813093|FG002|Double-Blind Period|Death|0|||
124777580|NCT02963506|448813094|FG003|Double-Blind Period|Death|1|||
124777581|NCT02963506|448813095|FG004|Double-Blind Period|Death|0|||
124777582|NCT02963506|448813096|FG005|Double-Blind Period|Death|0|||
124777583|NCT02963506|448813097|FG006|Double-Blind Period|Death|0|||
124777584|NCT02963506|448813098|FG007|Double-Blind Period|Death|0|||
124777585|NCT02963506|448813099|FG008|Double-Blind Period|Death|0|||
124777586|NCT02963506|448813100|FG009|Double-Blind Period|Death|0|||
124777587|NCT02963506|448813101|FG010|Double-Blind Period|Death|0|||
124777588|NCT02963506|448813102|FG011|Double-Blind Period|Death|0|||
124777589|NCT02963506|448813103|FG012|Double-Blind Period|Death|0|||
124777590|NCT02963506|448813091|FG000|Double-Blind Period|Lost to Follow-up|0|||
124777591|NCT02963506|448813092|FG001|Double-Blind Period|Lost to Follow-up|1|||
124777592|NCT02963506|448813093|FG002|Double-Blind Period|Lost to Follow-up|0|||
124777593|NCT02963506|448813094|FG003|Double-Blind Period|Lost to Follow-up|0|||
124777594|NCT02963506|448813095|FG004|Double-Blind Period|Lost to Follow-up|0|||
124777595|NCT02963506|448813096|FG005|Double-Blind Period|Lost to Follow-up|0|||
124777596|NCT02963506|448813097|FG006|Double-Blind Period|Lost to Follow-up|0|||
124777597|NCT02963506|448813098|FG007|Double-Blind Period|Lost to Follow-up|0|||
124777598|NCT02963506|448813099|FG008|Double-Blind Period|Lost to Follow-up|0|||
124777599|NCT02963506|448813100|FG009|Double-Blind Period|Lost to Follow-up|0|||
124777600|NCT02963506|448813101|FG010|Double-Blind Period|Lost to Follow-up|0|||
124777601|NCT02963506|448813102|FG011|Double-Blind Period|Lost to Follow-up|0|||
124586559|NCT01018862|448104365|FG002|Overall Study|Withdrawal by Subject|1|||
124586560|NCT01018862|448104363|FG000|Overall Study|administrative problems|5|||
124777602|NCT02963506|448813103|FG012|Double-Blind Period|Lost to Follow-up|0|||
124777603|NCT02963506|448813091|FG000|Double-Blind Period|Withdrawal by Subject|0|||
124777604|NCT02963506|448813092|FG001|Double-Blind Period|Withdrawal by Subject|0|||
124777605|NCT02963506|448813093|FG002|Double-Blind Period|Withdrawal by Subject|1|||
124777606|NCT02963506|448813094|FG003|Double-Blind Period|Withdrawal by Subject|1|||
124777607|NCT02963506|448813095|FG004|Double-Blind Period|Withdrawal by Subject|0|||
124586561|NCT01018862|448104364|FG001|Overall Study|administrative problems|4|||
124586562|NCT01018862|448104365|FG002|Overall Study|administrative problems|4|||
124586563|NCT00840879|448104371|FG000|Second Intervention|Withdrawal by Subject|1|||
124586564|NCT00840879|448104372|FG001|Second Intervention|Withdrawal by Subject|0|||
124777608|NCT02963506|448813096|FG005|Double-Blind Period|Withdrawal by Subject|0|||
124777609|NCT02963506|448813097|FG006|Double-Blind Period|Withdrawal by Subject|0|||
124777610|NCT02963506|448813098|FG007|Double-Blind Period|Withdrawal by Subject|0|||
124777611|NCT02963506|448813099|FG008|Double-Blind Period|Withdrawal by Subject|0|||
124777612|NCT02963506|448813100|FG009|Double-Blind Period|Withdrawal by Subject|0|||
124777613|NCT02963506|448813101|FG010|Double-Blind Period|Withdrawal by Subject|0|||
124777614|NCT02963506|448813102|FG011|Double-Blind Period|Withdrawal by Subject|0|||
124777615|NCT02963506|448813103|FG012|Double-Blind Period|Withdrawal by Subject|0|||
124777616|NCT02963506|448813091|FG000|Double-Blind Period|No compliance|0|||
124777617|NCT02963506|448813092|FG001|Double-Blind Period|No compliance|1|||
124777618|NCT02963506|448813093|FG002|Double-Blind Period|No compliance|0|||
124777619|NCT02963506|448813094|FG003|Double-Blind Period|No compliance|0|||
124777620|NCT02963506|448813095|FG004|Double-Blind Period|No compliance|0|||
124777621|NCT02963506|448813096|FG005|Double-Blind Period|No compliance|0|||
124777622|NCT02963506|448813097|FG006|Double-Blind Period|No compliance|0|||
124777623|NCT02963506|448813098|FG007|Double-Blind Period|No compliance|0|||
124777624|NCT02963506|448813099|FG008|Double-Blind Period|No compliance|0|||
124777625|NCT02963506|448813100|FG009|Double-Blind Period|No compliance|0|||
124777626|NCT02963506|448813101|FG010|Double-Blind Period|No compliance|0|||
124777627|NCT02963506|448813102|FG011|Double-Blind Period|No compliance|0|||
124586565|NCT01109849|448105594|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
124586566|NCT01109849|448105595|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
124586567|NCT01109849|448105596|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
124586568|NCT01109849|448105597|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
124586569|NCT01109849|448105598|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
124586570|NCT01109849|448105594|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
124586571|NCT01109849|448105595|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
124586572|NCT01109849|448105596|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
124586573|NCT01109849|448105597|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
124586574|NCT01109849|448105598|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
124586575|NCT01109849|448105594|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
124586576|NCT01109849|448105595|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
124586577|NCT01109849|448105596|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
124586578|NCT01109849|448105597|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
124586579|NCT01109849|448105598|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
124586580|NCT01109849|448105594|FG000|Initial Randomization: ADHD Treatment|move away|2|||
124586581|NCT01109849|448105595|FG001|Initial Randomization: ADHD Treatment|move away|7|||
124586582|NCT01109849|448105596|FG002|Initial Randomization: ADHD Treatment|move away|0|||
124586583|NCT01109849|448105597|FG003|Initial Randomization: ADHD Treatment|move away|0|||
124586584|NCT01109849|448105598|FG004|Initial Randomization: ADHD Treatment|move away|0|||
124586585|NCT01109849|448105594|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
124586586|NCT01109849|448105595|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
124586587|NCT01109849|448105596|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
124586588|NCT01109849|448105597|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
124586589|NCT01109849|448105598|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
124586590|NCT01109849|448105594|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
124586591|NCT01109849|448105595|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
124586592|NCT01109849|448105596|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
124586593|NCT01109849|448105597|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
124586594|NCT01109849|448105598|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
124586595|NCT00754052|448105605|FG000|Overall Study|Study terminated by Sponsor|5|||
124586596|NCT00754052|448105606|FG001|Overall Study|Study terminated by Sponsor|3|||
124586597|NCT04364854|448105610|FG000|Overall Study|Withdrawal by Subject|1|||
124586598|NCT04364854|448105611|FG001|Overall Study|Withdrawal by Subject|0|||
124586599|NCT04364854|448105612|FG002|Overall Study|Withdrawal by Subject|1|||
124586600|NCT04364854|448105613|FG003|Overall Study|Withdrawal by Subject|3|||
124586601|NCT04364854|448105610|FG000|Overall Study|Death|1|||
124586602|NCT04364854|448105611|FG001|Overall Study|Death|0|||
124586603|NCT04364854|448105612|FG002|Overall Study|Death|0|||
124586604|NCT04364854|448105613|FG003|Overall Study|Death|0|||
124777628|NCT02963506|448813103|FG012|Double-Blind Period|No compliance|0|||
124777629|NCT02963506|448813091|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
124777630|NCT02963506|448813092|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
124777631|NCT02963506|448813093|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
124586605|NCT04364854|448105610|FG000|Overall Study|Lost to Follow-up|0|||
124586606|NCT04364854|448105611|FG001|Overall Study|Lost to Follow-up|0|||
124586607|NCT04364854|448105612|FG002|Overall Study|Lost to Follow-up|0|||
124586608|NCT04364854|448105613|FG003|Overall Study|Lost to Follow-up|1|||
124586609|NCT02435433|448105614|FG000|Overall Study|Withdrawal by Subject|2|||
124586610|NCT02435433|448105615|FG001|Overall Study|Withdrawal by Subject|3|||
124586611|NCT02435433|448105616|FG002|Overall Study|Withdrawal by Subject|1|||
124777632|NCT02963506|448813094|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
124777633|NCT02963506|448813095|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
124586612|NCT02435433|448105617|FG003|Overall Study|Withdrawal by Subject|0|||
124586613|NCT02435433|448105618|FG004|Overall Study|Withdrawal by Subject|0|||
124586614|NCT02435433|448105614|FG000|Overall Study|Lost to Follow-up|2|||
124586615|NCT02435433|448105615|FG001|Overall Study|Lost to Follow-up|2|||
124586616|NCT02435433|448105616|FG002|Overall Study|Lost to Follow-up|4|||
124586617|NCT02435433|448105617|FG003|Overall Study|Lost to Follow-up|1|||
124531919|NCT02192190|447897989|FG002|Overall Study|Positive Drug Screen|0|||
124531920|NCT02192190|447897990|FG003|Overall Study|Positive Drug Screen|1|||
124531921|NCT02192190|447897991|FG004|Overall Study|Positive Drug Screen|0|||
124531922|NCT02192190|447897992|FG005|Overall Study|Positive Drug Screen|0|||
124531923|NCT02192190|447897987|FG000|Overall Study|Inadequate Pain Relief|0|||
124531924|NCT02192190|447897988|FG001|Overall Study|Inadequate Pain Relief|1|||
124531925|NCT02192190|447897989|FG002|Overall Study|Inadequate Pain Relief|1|||
124531926|NCT02192190|447897990|FG003|Overall Study|Inadequate Pain Relief|0|||
124531927|NCT02192190|447897991|FG004|Overall Study|Inadequate Pain Relief|0|||
124531928|NCT02192190|447897992|FG005|Overall Study|Inadequate Pain Relief|0|||
124531929|NCT03227692|447897993|FG000|Overall Study|Protocol Violation|1|||
124531930|NCT03227692|447897994|FG001|Overall Study|Protocol Violation|1|||
124531931|NCT03227692|447897993|FG000|Overall Study|Lost to Follow-up|4|||
124531932|NCT03227692|447897994|FG001|Overall Study|Lost to Follow-up|2|||
124531933|NCT03227692|447897993|FG000|Overall Study|Adverse Event|0|||
124531934|NCT03227692|447897994|FG001|Overall Study|Adverse Event|2|||
124531935|NCT01657253|447897995|FG000|Overall Study|Lost to Follow-up|6|||
124531936|NCT01657253|447897996|FG001|Overall Study|Lost to Follow-up|5|||
124531937|NCT01657253|447897995|FG000|Overall Study|Withdrawal by Subject|11|||
124531938|NCT01657253|447897996|FG001|Overall Study|Withdrawal by Subject|12|||
124531939|NCT01657253|447897995|FG000|Overall Study|Adverse Event|0|||
124531940|NCT01657253|447897996|FG001|Overall Study|Adverse Event|1|||
124531941|NCT01970540|447897999|FG000|Overall Study|Non-treatment-related AE|0|||
124531942|NCT01970540|447898000|FG001|Overall Study|Non-treatment-related AE|0|||
124531943|NCT01970540|447898001|FG002|Overall Study|Non-treatment-related AE|1|||
124531944|NCT01970540|447897999|FG000|Overall Study|Progressive disease|55|||
124531945|NCT01970540|447898000|FG001|Overall Study|Progressive disease|23|||
124531946|NCT01970540|447898001|FG002|Overall Study|Progressive disease|10|||
124531947|NCT01970540|447897999|FG000|Overall Study|Treatment delay over protocol|0|||
124531948|NCT01970540|447898000|FG001|Overall Study|Treatment delay over protocol|0|||
124531949|NCT01970540|447898001|FG002|Overall Study|Treatment delay over protocol|1|||
124531950|NCT01970540|447897999|FG000|Overall Study|Physician Decision|7|||
124531951|NCT01970540|447898000|FG001|Overall Study|Physician Decision|2|||
124531952|NCT01970540|447898001|FG002|Overall Study|Physician Decision|0|||
124531953|NCT01970540|447897999|FG000|Overall Study|Clinical progression|0|||
124531954|NCT01970540|447898000|FG001|Overall Study|Clinical progression|1|||
124531955|NCT01970540|447898001|FG002|Overall Study|Clinical progression|1|||
124531956|NCT01970540|447897999|FG000|Overall Study|End of study|2|||
124531957|NCT01970540|447898000|FG001|Overall Study|End of study|0|||
124531958|NCT01970540|447898001|FG002|Overall Study|End of study|2|||
124531959|NCT01970540|447897999|FG000|Overall Study|Adverse Event|0|||
124531960|NCT01970540|447898000|FG001|Overall Study|Adverse Event|2|||
124531961|NCT01970540|447898001|FG002|Overall Study|Adverse Event|1|||
124531962|NCT01970540|447897999|FG000|Overall Study|Treatment-related AE|4|||
124531963|NCT01970540|447898000|FG001|Overall Study|Treatment-related AE|0|||
124531964|NCT01970540|447898001|FG002|Overall Study|Treatment-related AE|2|||
124531965|NCT01970540|447897999|FG000|Overall Study|Withdrawal by Subject|4|||
124531966|NCT01970540|447898000|FG001|Overall Study|Withdrawal by Subject|0|||
124531967|NCT01970540|447898001|FG002|Overall Study|Withdrawal by Subject|1|||
124531968|NCT01970540|447897999|FG000|Overall Study|Clinical deterioration|1|||
124531969|NCT01970540|447898000|FG001|Overall Study|Clinical deterioration|0|||
124531970|NCT01970540|447898001|FG002|Overall Study|Clinical deterioration|0|||
124531971|NCT01603628|447898002|FG000|Overall Study|Personal Reasons|1|||
124531972|NCT01603628|447898003|FG001|Overall Study|Personal Reasons|1|||
124531973|NCT01603628|447898004|FG002|Overall Study|Personal Reasons|2|||
124531974|NCT01603628|447898002|FG000|Overall Study|Protocol Violation|1|||
124531975|NCT01603628|447898003|FG001|Overall Study|Protocol Violation|1|||
124531976|NCT01603628|447898004|FG002|Overall Study|Protocol Violation|0|||
124531977|NCT01603628|447898002|FG000|Overall Study|Lost to Follow-up|0|||
124531978|NCT01603628|447898003|FG001|Overall Study|Lost to Follow-up|1|||
124586618|NCT02435433|448105618|FG004|Overall Study|Lost to Follow-up|0|||
124531979|NCT01603628|447898004|FG002|Overall Study|Lost to Follow-up|0|||
124531980|NCT01603628|447898002|FG000|Overall Study|Other Miscellaneous Reason|1|||
124531981|NCT01603628|447898003|FG001|Overall Study|Other Miscellaneous Reason|0|||
124531982|NCT01603628|447898004|FG002|Overall Study|Other Miscellaneous Reason|0|||
124531983|NCT00952588|447898006|FG000|Overall Study|Death|28|||
124531984|NCT00952588|447898007|FG001|Overall Study|Death|13|||
124531985|NCT00952588|447898006|FG000|Overall Study|Withdrawal by Subject|2|||
124531986|NCT00952588|447898007|FG001|Overall Study|Withdrawal by Subject|5|||
124531987|NCT00952588|447898006|FG000|Overall Study|Adverse Event|2|||
124531988|NCT00952588|447898007|FG001|Overall Study|Adverse Event|3|||
124531989|NCT00952588|447898006|FG000|Overall Study|Lost to Follow-up|2|||
124531990|NCT00952588|447898007|FG001|Overall Study|Lost to Follow-up|0|||
124531991|NCT00952588|447898006|FG000|Overall Study|Physician Decision|0|||
124586619|NCT00659815|448105619|FG000|Overall Study|Study related symptoms and complaints|2|||
124586620|NCT00659815|448105620|FG001|Overall Study|Study related symptoms and complaints|1|||
124586621|NCT00659815|448105619|FG000|Overall Study|Inability to maintain wearing schedule|1|||
124586622|NCT00659815|448105620|FG001|Overall Study|Inability to maintain wearing schedule|2|||
124586623|NCT00659815|448105619|FG000|Overall Study|Withdrawal by Subject|1|||
124586624|NCT00659815|448105620|FG001|Overall Study|Withdrawal by Subject|1|||
124729387|NCT03219034|448630233|FG000|Overall Study|Additional dental work needed|1|||
124729388|NCT03219034|448630234|FG001|Overall Study|Additional dental work needed|0|||
124531992|NCT00952588|447898007|FG001|Overall Study|Physician Decision|1|||
124531993|NCT00952588|447898006|FG000|Overall Study|Lack of Efficacy|2|||
124531994|NCT00952588|447898007|FG001|Overall Study|Lack of Efficacy|2|||
124531995|NCT01796106|447898008|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
124531996|NCT01796106|447898009|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
124531997|NCT02795182|447898010|FG000|Overall Study|Death|5|||
124531998|NCT02795182|447898011|FG001|Overall Study|Death|4|||
124531999|NCT02795182|447898012|FG002|Overall Study|Death|4|||
124532000|NCT02795182|447898013|FG003|Overall Study|Death|18|||
124532001|NCT02795182|447898010|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
124532002|NCT02795182|447898011|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
124532003|NCT02795182|447898012|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
124532004|NCT02795182|447898013|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
124532005|NCT02795182|447898010|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
124532006|NCT02795182|447898011|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
124532007|NCT02795182|447898012|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
124532008|NCT02795182|447898013|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
124532009|NCT02795182|447898010|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
124532010|NCT02795182|447898011|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
124532011|NCT02795182|447898012|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
124532012|NCT02795182|447898013|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
124532013|NCT02795182|447898010|FG000|Overall Study|Withdrawal by Subject|4|||
124532014|NCT02795182|447898011|FG001|Overall Study|Withdrawal by Subject|0|||
124532015|NCT02795182|447898012|FG002|Overall Study|Withdrawal by Subject|0|||
124532016|NCT02795182|447898013|FG003|Overall Study|Withdrawal by Subject|3|||
124532017|NCT02795182|447898010|FG000|Overall Study|Lost to Follow-up|0|||
124532018|NCT02795182|447898011|FG001|Overall Study|Lost to Follow-up|0|||
124532019|NCT02795182|447898012|FG002|Overall Study|Lost to Follow-up|1|||
124532020|NCT02795182|447898013|FG003|Overall Study|Lost to Follow-up|1|||
124532021|NCT02795182|447898010|FG000|Overall Study|Roll Over to Long Term Extension|3|||
124532022|NCT02795182|447898011|FG001|Overall Study|Roll Over to Long Term Extension|3|||
124532023|NCT02795182|447898012|FG002|Overall Study|Roll Over to Long Term Extension|2|||
124532024|NCT02795182|447898013|FG003|Overall Study|Roll Over to Long Term Extension|5|||
124532025|NCT02795182|447898010|FG000|Overall Study|Progressive Disease|0|||
124532026|NCT02795182|447898011|FG001|Overall Study|Progressive Disease|1|||
124532027|NCT02795182|447898012|FG002|Overall Study|Progressive Disease|0|||
124532028|NCT02795182|447898013|FG003|Overall Study|Progressive Disease|4|||
124532029|NCT02795182|447898010|FG000|Overall Study|Physician Decision|0|||
124532030|NCT02795182|447898011|FG001|Overall Study|Physician Decision|0|||
124532031|NCT02795182|447898012|FG002|Overall Study|Physician Decision|0|||
124532032|NCT02795182|447898013|FG003|Overall Study|Physician Decision|1|||
124532033|NCT04107935|447898014|FG000|Overall Study|Death|1|||
124532034|NCT04107935|447898015|FG001|Overall Study|Death|0|||
124532035|NCT01021553|447898016|FG000|Overall Study|Adverse Event|1|||
124532036|NCT01021553|447898017|FG001|Overall Study|Adverse Event|0|||
124532037|NCT01021553|447898018|FG002|Overall Study|Adverse Event|0|||
124532038|NCT01021553|447898016|FG000|Overall Study|Lack of Efficacy|2|||
124532039|NCT01021553|447898017|FG001|Overall Study|Lack of Efficacy|2|||
124532040|NCT01021553|447898018|FG002|Overall Study|Lack of Efficacy|0|||
124532041|NCT01021553|447898016|FG000|Overall Study|Protocol Violation|0|||
124532042|NCT01021553|447898017|FG001|Overall Study|Protocol Violation|2|||
124532043|NCT01021553|447898018|FG002|Overall Study|Protocol Violation|2|||
124532044|NCT01021553|447898016|FG000|Overall Study|Lost to Follow-up|0|||
124532045|NCT01021553|447898017|FG001|Overall Study|Lost to Follow-up|0|||
124532046|NCT01021553|447898018|FG002|Overall Study|Lost to Follow-up|1|||
124532047|NCT01021553|447898016|FG000|Overall Study|Withdrawal by Subject|1|||
124532048|NCT01021553|447898017|FG001|Overall Study|Withdrawal by Subject|1|||
124532049|NCT01021553|447898018|FG002|Overall Study|Withdrawal by Subject|0|||
124532050|NCT00890201|447898019|FG000|Overall Study|Protocol Violation|5|||
124532051|NCT00890201|447898020|FG001|Overall Study|Protocol Violation|56|||
124532052|NCT00033293|447898021|FG000|Overall Study|Death|0|||
124532053|NCT00033293|447898022|FG001|Overall Study|Death|1|||
124532054|NCT00033293|447898021|FG000|Overall Study|Lack of Efficacy|5|||
124729389|NCT03219034|448630233|FG000|Overall Study|UPPP Surgery|1|||
124586625|NCT02651987|448105621|FG000|Overall Study|Adverse Event|2|||
124586626|NCT02651987|448105622|FG001|Overall Study|Adverse Event|2|||
124586627|NCT02651987|448105621|FG000|Overall Study|Consent Withdrawn|2|||
124586628|NCT02651987|448105622|FG001|Overall Study|Consent Withdrawn|0|||
124586629|NCT02651987|448105621|FG000|Overall Study|Local PD|0|||
124586630|NCT02651987|448105622|FG001|Overall Study|Local PD|2|||
124586631|NCT02651987|448105621|FG000|Overall Study|Investigator Decision|1|||
124586632|NCT02651987|448105622|FG001|Overall Study|Investigator Decision|1|||
124586633|NCT00522041|448105623|FG000|Overall Study|Adverse Event|9|||
124586634|NCT00522041|448105624|FG001|Overall Study|Adverse Event|3|||
124586635|NCT00522041|448105623|FG000|Overall Study|Protocol Violation|2|||
124586636|NCT00522041|448105624|FG001|Overall Study|Protocol Violation|0|||
124586637|NCT00522041|448105623|FG000|Overall Study|Lost to Follow-up|1|||
124586638|NCT00522041|448105624|FG001|Overall Study|Lost to Follow-up|4|||
124586639|NCT00522041|448105623|FG000|Overall Study|Voluntary withdrawal|5|||
124586640|NCT00522041|448105624|FG001|Overall Study|Voluntary withdrawal|4|||
124586641|NCT00522041|448105623|FG000|Overall Study|Did not receive treatment|0|||
124586642|NCT00522041|448105624|FG001|Overall Study|Did not receive treatment|1|||
124586643|NCT03540160|448105625|FG000|Overall Study|Protocol Violation|1|||
124586644|NCT03540160|448105625|FG000|Overall Study|Physician Decision|8|||
124586645|NCT03540160|448105625|FG000|Overall Study|Lack of Efficacy|60|||
124586646|NCT03540160|448105625|FG000|Overall Study|Pregnancy|1|||
124586647|NCT03540160|448105625|FG000|Overall Study|Adverse Event|20|||
124586648|NCT03540160|448105625|FG000|Overall Study|Withdrawal by Subject|68|||
124586649|NCT03540160|448105625|FG000|Overall Study|COVID-19|2|||
124586650|NCT03540160|448105625|FG000|Overall Study|Study Closure|10|||
124586651|NCT03540160|448105625|FG000|Overall Study|Lost to Follow-up|18|||
124586652|NCT03540160|448105625|FG000|Overall Study|Sponsor decision|191|||
124586653|NCT01664039|448105626|FG000|Overall Study|Adverse Event|3|||
124586654|NCT01664039|448105627|FG001|Overall Study|Adverse Event|4|||
124586655|NCT01664039|448105626|FG000|Overall Study|Lost to Follow-up|1|||
124586656|NCT01664039|448105627|FG001|Overall Study|Lost to Follow-up|1|||
124586657|NCT01664039|448105626|FG000|Overall Study|Withdrawal by Subject|1|||
124586658|NCT01664039|448105627|FG001|Overall Study|Withdrawal by Subject|3|||
124586659|NCT01664039|448105626|FG000|Overall Study|Noncompliance|1|||
124586660|NCT01664039|448105627|FG001|Overall Study|Noncompliance|1|||
124586661|NCT02640235|448105633|FG000|Overall Study|Withdrawal by Subject|7|||
124586662|NCT02640235|448105634|FG001|Overall Study|Withdrawal by Subject|6|||
124586663|NCT02640235|448105633|FG000|Overall Study|Lost to Follow-up|4|||
124586664|NCT02640235|448105634|FG001|Overall Study|Lost to Follow-up|3|||
124586665|NCT02640235|448105633|FG000|Overall Study|Death|2|||
124586666|NCT02640235|448105634|FG001|Overall Study|Death|3|||
124586667|NCT02640235|448105633|FG000|Overall Study|Other|1|||
124586668|NCT02640235|448105634|FG001|Overall Study|Other|2|||
124586669|NCT02372006|448105638|FG000|Overall Study|Progressive disease|8|||
124586670|NCT02372006|448105639|FG001|Overall Study|Progressive disease|7|||
124586671|NCT02372006|448105640|FG002|Overall Study|Progressive disease|34|||
124586672|NCT02372006|448105638|FG000|Overall Study|Dose limiting toxicity|0|||
124586673|NCT02372006|448105639|FG001|Overall Study|Dose limiting toxicity|1|||
124586674|NCT02372006|448105640|FG002|Overall Study|Dose limiting toxicity|0|||
124586675|NCT02372006|448105638|FG000|Overall Study|Adverse Event|0|||
124586676|NCT02372006|448105639|FG001|Overall Study|Adverse Event|0|||
124586677|NCT02372006|448105640|FG002|Overall Study|Adverse Event|3|||
124586678|NCT02372006|448105638|FG000|Overall Study|Withdrawal by Subject|0|||
124586679|NCT02372006|448105639|FG001|Overall Study|Withdrawal by Subject|1|||
124586680|NCT02372006|448105640|FG002|Overall Study|Withdrawal by Subject|1|||
124586681|NCT02372006|448105638|FG000|Overall Study|Other reason for not completing|0|||
124586682|NCT02372006|448105639|FG001|Overall Study|Other reason for not completing|0|||
124586683|NCT02372006|448105640|FG002|Overall Study|Other reason for not completing|1|||
124586684|NCT00467597|448105648|FG000|Overall Study|Withdrawal by Subject|2|||
124586685|NCT00467597|448105649|FG001|Overall Study|Withdrawal by Subject|0|||
124586686|NCT01046084|448105652|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
124586687|NCT01046084|448105653|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
124586688|NCT02166606|448105654|FG000|Overall Study|Adverse Event|3|||
124586689|NCT02166606|448105654|FG000|Overall Study|Death|31|||
124586690|NCT02166606|448105654|FG000|Overall Study|Protocol Violation|7|||
124586691|NCT02166606|448105654|FG000|Overall Study|Lost to Follow-up|30|||
124586692|NCT02166606|448105654|FG000|Overall Study|Withdrawal by Subject|1|||
124586693|NCT02166606|448105654|FG000|Overall Study|Physician Decision|1|||
124586694|NCT02166606|448105654|FG000|Overall Study|Device upgrade|1|||
124586695|NCT02166606|448105654|FG000|Overall Study|Enrolled after End of Enrollment|4|||
124586696|NCT01958476|448105655|FG000|Overall Study|Parent requested exclusion from analysis|1|||
124586697|NCT01958476|448105656|FG001|Overall Study|Parent requested exclusion from analysis|0|||
124586698|NCT04476277|448105659|FG000|Overall Study|Withdrawal by Subject|0|||
124586699|NCT04476277|448105660|FG001|Overall Study|Withdrawal by Subject|0|||
124586700|NCT04476277|448105661|FG002|Overall Study|Withdrawal by Subject|1|||
124586701|NCT04476277|448105662|FG003|Overall Study|Withdrawal by Subject|0|||
124586702|NCT01971645|448105663|FG000|Overall Study|Adverse Event|1|||
124586703|NCT01971645|448105664|FG001|Overall Study|Adverse Event|0|||
124586704|NCT01971645|448105665|FG002|Overall Study|Adverse Event|0|||
124586705|NCT01971645|448105663|FG000|Overall Study|Lost to Follow-up|1|||
124586706|NCT01971645|448105664|FG001|Overall Study|Lost to Follow-up|0|||
124586707|NCT01971645|448105665|FG002|Overall Study|Lost to Follow-up|1|||
124586708|NCT01971645|448105663|FG000|Overall Study|Protocol Violation|0|||
124586709|NCT01971645|448105664|FG001|Overall Study|Protocol Violation|0|||
124586710|NCT01971645|448105665|FG002|Overall Study|Protocol Violation|1|||
124586711|NCT01962298|448105666|FG000|Overall Study|Protocol Violation|1|||
124586712|NCT01962298|448105667|FG001|Overall Study|Protocol Violation|0|||
124586713|NCT01962298|448105668|FG002|Overall Study|Protocol Violation|1|||
124586714|NCT01962298|448105669|FG003|Overall Study|Protocol Violation|1|||
124586715|NCT01962298|448105670|FG004|Overall Study|Protocol Violation|0|||
124586716|NCT01962298|448105666|FG000|Overall Study|Data quality insufficient|2|||
124586717|NCT01962298|448105667|FG001|Overall Study|Data quality insufficient|0|||
124586718|NCT01962298|448105668|FG002|Overall Study|Data quality insufficient|3|||
124586719|NCT01962298|448105669|FG003|Overall Study|Data quality insufficient|1|||
124586720|NCT01962298|448105670|FG004|Overall Study|Data quality insufficient|4|||
124586721|NCT01962298|448105666|FG000|Overall Study|Insufficient data|0|||
124586722|NCT01962298|448105667|FG001|Overall Study|Insufficient data|2|||
124586723|NCT01962298|448105668|FG002|Overall Study|Insufficient data|1|||
124586724|NCT01962298|448105669|FG003|Overall Study|Insufficient data|0|||
124586725|NCT01962298|448105670|FG004|Overall Study|Insufficient data|1|||
124586726|NCT01962298|448105666|FG000|Overall Study|Incorrect data recorded|0|||
124586727|NCT01962298|448105667|FG001|Overall Study|Incorrect data recorded|1|||
124532055|NCT00033293|447898022|FG001|Overall Study|Lack of Efficacy|8|||
124532056|NCT00033293|447898021|FG000|Overall Study|Lost to Follow-up|0|||
124532057|NCT00033293|447898022|FG001|Overall Study|Lost to Follow-up|1|||
124532058|NCT00033293|447898021|FG000|Overall Study|Physician Decision|3|||
124532059|NCT00033293|447898022|FG001|Overall Study|Physician Decision|1|||
124532060|NCT00033293|447898021|FG000|Overall Study|Withdrawal by Subject|1|||
124532061|NCT00033293|447898022|FG001|Overall Study|Withdrawal by Subject|0|||
124532062|NCT00033293|447898021|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
124532063|NCT00033293|447898022|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
124532064|NCT00033293|447898021|FG000|Overall Study|Treatment refused|0|||
124532065|NCT00033293|447898022|FG001|Overall Study|Treatment refused|6|||
124532066|NCT00935701|447898023|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
124532067|NCT02087241|447898024|FG000|Overall Study|Death|2|||
124532068|NCT02087241|447898025|FG001|Overall Study|Death|1|||
124532069|NCT02087241|447898026|FG002|Overall Study|Death|1|||
124532070|NCT02087241|447898027|FG003|Overall Study|Death|1|||
124532071|NCT02087241|447898024|FG000|Overall Study|Withdrawal by Subject|1|||
124532072|NCT02087241|447898025|FG001|Overall Study|Withdrawal by Subject|0|||
124532073|NCT02087241|447898026|FG002|Overall Study|Withdrawal by Subject|0|||
124532074|NCT02087241|447898027|FG003|Overall Study|Withdrawal by Subject|1|||
124532075|NCT02087241|447898024|FG000|Overall Study|Progressive Disease|0|||
124532076|NCT02087241|447898025|FG001|Overall Study|Progressive Disease|0|||
124532077|NCT02087241|447898026|FG002|Overall Study|Progressive Disease|0|||
124532078|NCT02087241|447898027|FG003|Overall Study|Progressive Disease|1|||
124532079|NCT02087241|447898024|FG000|Overall Study|Study Terminated by Sponsor|0|||
124532080|NCT02087241|447898025|FG001|Overall Study|Study Terminated by Sponsor|2|||
124532081|NCT02087241|447898026|FG002|Overall Study|Study Terminated by Sponsor|0|||
124532082|NCT02087241|447898027|FG003|Overall Study|Study Terminated by Sponsor|4|||
124532083|NCT02181504|447898028|FG000|Overall Study|Adverse Event|1|||
124532084|NCT02181504|447898029|FG001|Overall Study|Adverse Event|1|||
124532085|NCT02181504|447898030|FG002|Overall Study|Adverse Event|1|||
124532086|NCT00545584|447898031|FG000|Overall Study|Only one reason for discontinuation|62|||
124532087|NCT00545584|447898032|FG001|Overall Study|Only one reason for discontinuation|61|||
124532088|NCT00545584|447898033|FG002|Overall Study|Only one reason for discontinuation|48|||
124532089|NCT00545584|447898031|FG000|Overall Study|Two or more reasons for discontinuation|17|||
124532090|NCT00545584|447898032|FG001|Overall Study|Two or more reasons for discontinuation|19|||
124532091|NCT00545584|447898033|FG002|Overall Study|Two or more reasons for discontinuation|8|||
124532092|NCT03525613|447898034|FG000|Overall Study|Adverse Event|11|||
124532093|NCT03525613|447898035|FG001|Overall Study|Adverse Event|8|||
124532094|NCT03525613|447898036|FG002|Overall Study|Adverse Event|3|||
124532095|NCT03525613|447898037|FG003|Overall Study|Adverse Event|3|||
124532096|NCT03525613|447898034|FG000|Overall Study|Lost to Follow-up|4|||
124532097|NCT03525613|447898035|FG001|Overall Study|Lost to Follow-up|5|||
124777634|NCT02963506|448813096|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
124532098|NCT03525613|447898036|FG002|Overall Study|Lost to Follow-up|3|||
124532099|NCT03525613|447898037|FG003|Overall Study|Lost to Follow-up|2|||
124532100|NCT03525613|447898034|FG000|Overall Study|Physician Decision|0|||
124532101|NCT03525613|447898035|FG001|Overall Study|Physician Decision|1|||
124532102|NCT03525613|447898036|FG002|Overall Study|Physician Decision|0|||
124532103|NCT03525613|447898037|FG003|Overall Study|Physician Decision|1|||
124586728|NCT01962298|448105668|FG002|Overall Study|Incorrect data recorded|0|||
124586729|NCT01962298|448105669|FG003|Overall Study|Incorrect data recorded|0|||
124586730|NCT01962298|448105670|FG004|Overall Study|Incorrect data recorded|0|||
124586731|NCT01962298|448105666|FG000|Overall Study|Physician Decision|0|||
124586732|NCT01962298|448105667|FG001|Overall Study|Physician Decision|1|||
124586733|NCT01962298|448105668|FG002|Overall Study|Physician Decision|0|||
124586734|NCT01962298|448105669|FG003|Overall Study|Physician Decision|0|||
124586735|NCT01962298|448105670|FG004|Overall Study|Physician Decision|1|||
124586736|NCT00537095|448105671|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
124586737|NCT00537095|448105672|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
124586738|NCT00537095|448105671|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
124586739|NCT00537095|448105672|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
124586740|NCT00537095|448105671|FG000|Randomized Treatment Period (433 Days)|Death|3|||
124586741|NCT00537095|448105672|FG001|Randomized Treatment Period (433 Days)|Death|1|||
124586742|NCT00537095|448105671|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
124586743|NCT00537095|448105672|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
124586744|NCT00537095|448105671|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
124586745|NCT00537095|448105672|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
124586746|NCT00537095|448105671|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
124586747|NCT00537095|448105672|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
124586748|NCT00537095|448105671|FG000|Open-label Period (590 Days)|Adverse Event|2|||
124586749|NCT00537095|448105672|FG001|Open-label Period (590 Days)|Adverse Event|11|||
124586750|NCT00537095|448105671|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
124586751|NCT00537095|448105672|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
124586752|NCT00537095|448105671|FG000|Open-label Period (590 Days)|Death|2|||
124586753|NCT00537095|448105672|FG001|Open-label Period (590 Days)|Death|2|||
124586754|NCT00537095|448105671|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
124586755|NCT00537095|448105672|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
124586756|NCT00537095|448105671|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
124586757|NCT00537095|448105672|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
124586758|NCT00533507|448105673|FG000|Overall Study|Withdrawal by Subject|1|||
124586759|NCT01576705|448105674|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
124586760|NCT01576705|448105675|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
124586761|NCT01576705|448105676|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
124586762|NCT01576705|448105677|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
124586763|NCT01576705|448105674|FG000|Overall Study|invalid ICF|0|||
124586764|NCT01576705|448105675|FG001|Overall Study|invalid ICF|1|||
124586765|NCT01576705|448105676|FG002|Overall Study|invalid ICF|0|||
124586766|NCT01576705|448105677|FG003|Overall Study|invalid ICF|0|||
124586767|NCT03727139|448105678|FG000|Overall Study|Protocol Violation|60|||
124586768|NCT00566722|448105679|FG000|Overall Study|Adverse Event|0|||
124586769|NCT00566722|448105680|FG001|Overall Study|Adverse Event|1|||
124586770|NCT00566722|448105681|FG002|Overall Study|Adverse Event|0|||
124586771|NCT00566722|448105679|FG000|Overall Study|Withdrawal by Subject|0|||
124586772|NCT00566722|448105680|FG001|Overall Study|Withdrawal by Subject|0|||
124586773|NCT00566722|448105681|FG002|Overall Study|Withdrawal by Subject|1|||
124586774|NCT00566722|448105679|FG000|Overall Study|Lost to Follow-up|1|||
124586775|NCT00566722|448105680|FG001|Overall Study|Lost to Follow-up|1|||
124586776|NCT00566722|448105681|FG002|Overall Study|Lost to Follow-up|1|||
124586777|NCT00566722|448105679|FG000|Overall Study|Lack of Efficacy|1|||
124586778|NCT00566722|448105680|FG001|Overall Study|Lack of Efficacy|2|||
124586779|NCT00566722|448105681|FG002|Overall Study|Lack of Efficacy|4|||
124586780|NCT00566722|448105679|FG000|Overall Study|Did not meet exclusion criteria|0|||
124586781|NCT00566722|448105680|FG001|Overall Study|Did not meet exclusion criteria|0|||
124586782|NCT00566722|448105681|FG002|Overall Study|Did not meet exclusion criteria|2|||
124586783|NCT00566722|448105679|FG000|Overall Study|Serious adverse event|0|||
124586784|NCT00566722|448105680|FG001|Overall Study|Serious adverse event|1|||
124586785|NCT00566722|448105681|FG002|Overall Study|Serious adverse event|0|||
124586786|NCT00566722|448105679|FG000|Overall Study|Noncompliant with drug administration|0|||
124586787|NCT00566722|448105680|FG001|Overall Study|Noncompliant with drug administration|0|||
124586788|NCT00566722|448105681|FG002|Overall Study|Noncompliant with drug administration|1|||
124586789|NCT02896296|448105682|FG000|Overall Study|Adverse Event|1|||
124586790|NCT02896296|448105682|FG000|Overall Study|Lost to Follow-up|19|||
124586791|NCT02896296|448105682|FG000|Overall Study|Pregnancy|1|||
124586792|NCT02896296|448105682|FG000|Overall Study|Physician Decision|2|||
124586793|NCT02896296|448105682|FG000|Overall Study|Withdrawal by Subject|10|||
124586794|NCT02896296|448105682|FG000|Overall Study|Site closing|7|||
124586795|NCT02896296|448105682|FG000|Overall Study|Incarceration|1|||
124586796|NCT02896296|448105682|FG000|Overall Study|Relocation|1|||
124586797|NCT01874535|448105683|FG000|Overall Study|Lost to Follow-up|10|||
124586798|NCT01874535|448105684|FG001|Overall Study|Lost to Follow-up|9|||
124586799|NCT01874535|448105683|FG000|Overall Study|incomplete symptom resolution|45|||
124586800|NCT01874535|448105684|FG001|Overall Study|incomplete symptom resolution|35|||
124586801|NCT02597049|448105685|FG000|Overall Study|Lost to Follow-up|0|||
124586802|NCT02597049|448105686|FG001|Overall Study|Lost to Follow-up|3|||
124586803|NCT02597049|448105687|FG002|Overall Study|Lost to Follow-up|2|||
124586804|NCT02597049|448105685|FG000|Overall Study|Withdrawal by Subject|2|||
124586805|NCT02597049|448105686|FG001|Overall Study|Withdrawal by Subject|2|||
124586806|NCT02597049|448105687|FG002|Overall Study|Withdrawal by Subject|1|||
124586807|NCT02597049|448105685|FG000|Overall Study|Adverse Event|2|||
124586808|NCT02597049|448105686|FG001|Overall Study|Adverse Event|0|||
124586809|NCT02597049|448105687|FG002|Overall Study|Adverse Event|0|||
124586810|NCT02597049|448105685|FG000|Overall Study|Death|2|||
124586811|NCT02597049|448105686|FG001|Overall Study|Death|0|||
124586812|NCT02597049|448105687|FG002|Overall Study|Death|0|||
124586813|NCT02597049|448105685|FG000|Overall Study|Noncompliant with Study Visits|1|||
124586814|NCT02597049|448105686|FG001|Overall Study|Noncompliant with Study Visits|0|||
124586815|NCT02597049|448105687|FG002|Overall Study|Noncompliant with Study Visits|0|||
124586816|NCT00243347|448105690|FG000|Overall Study|Lack of Efficacy|4|||
124586817|NCT00243347|448105690|FG000|Overall Study|Adverse Event|2|||
124586818|NCT00243347|448105690|FG000|Overall Study|Death|1|||
124586819|NCT00243347|448105690|FG000|Overall Study|Withdrawal by Subject|5|||
124586820|NCT00243347|448105690|FG000|Overall Study|Condition worsened|7|||
124532104|NCT03525613|447898034|FG000|Overall Study|Consent Withdrawal|25|||
124532105|NCT03525613|447898035|FG001|Overall Study|Consent Withdrawal|16|||
124532106|NCT03525613|447898036|FG002|Overall Study|Consent Withdrawal|12|||
124532107|NCT03525613|447898037|FG003|Overall Study|Consent Withdrawal|9|||
124532108|NCT03525613|447898034|FG000|Overall Study|Death|20|||
124532109|NCT03525613|447898035|FG001|Overall Study|Death|9|||
124532110|NCT03525613|447898036|FG002|Overall Study|Death|7|||
124532111|NCT03525613|447898037|FG003|Overall Study|Death|1|||
124532112|NCT03525613|447898034|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
124532113|NCT03525613|447898035|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
124532114|NCT03525613|447898036|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
124532115|NCT03525613|447898037|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
124532116|NCT02584660|447898038|FG000|Overall Study|Adverse Event|4|||
124532117|NCT02584660|447898039|FG001|Overall Study|Adverse Event|0|||
124532118|NCT02584660|447898038|FG000|Overall Study|Lost to Follow-up|3|||
124532119|NCT02584660|447898039|FG001|Overall Study|Lost to Follow-up|4|||
124532120|NCT02584660|447898038|FG000|Overall Study|Protocol Violation|0|||
124532121|NCT02584660|447898039|FG001|Overall Study|Protocol Violation|1|||
124532122|NCT02584660|447898038|FG000|Overall Study|Withdrawal by Subject|0|||
124532123|NCT02584660|447898039|FG001|Overall Study|Withdrawal by Subject|2|||
124532124|NCT02584660|447898038|FG000|Overall Study|Other|0|||
124532125|NCT02584660|447898039|FG001|Overall Study|Other|1|||
124532126|NCT00461552|447898042|FG000|Overall Study|Drug Dispensing error|0|||
124532127|NCT00461552|447898043|FG001|Overall Study|Drug Dispensing error|2|||
124532128|NCT01289028|447898047|FG000|Overall Study|Progressive Disease|49|||
124532129|NCT01289028|447898047|FG000|Overall Study|Adverse Event|14|||
124532130|NCT01289028|447898047|FG000|Overall Study|Withdrawal by Subject|6|||
124532131|NCT01289028|447898047|FG000|Overall Study|Death|4|||
124532132|NCT01289028|447898047|FG000|Overall Study|Lack of Efficacy|2|||
124532133|NCT01289028|447898047|FG000|Overall Study|No longer required|2|||
124532134|NCT01289028|447898047|FG000|Overall Study|Lost to Follow-up|2|||
124532135|NCT01289028|447898047|FG000|Overall Study|New Cancer Therapy|2|||
124532136|NCT01289028|447898047|FG000|Overall Study|Abnormal Lab Value|1|||
124532137|NCT01289028|447898047|FG000|Overall Study|Missing reason for discon|1|||
124532138|NCT02120469|447898048|FG000|Overall Study|HER-2/neu-amplified|1|||
124532139|NCT02120469|447898049|FG001|Overall Study|HER-2/neu-amplified|0|||
124532140|NCT02120469|447898050|FG002|Overall Study|HER-2/neu-amplified|1|||
124532141|NCT03267576|447898055|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
124532142|NCT03267576|447898056|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
124532143|NCT03267576|447898055|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
124532144|NCT03267576|447898056|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
124532145|NCT01369069|447898057|FG000|Overall Study|Lost to Follow-up|8|||
124532146|NCT01369069|447898058|FG001|Overall Study|Lost to Follow-up|9|||
124532147|NCT01369069|447898057|FG000|Overall Study|Withdrawal by Subject|9|||
124532148|NCT01369069|447898058|FG001|Overall Study|Withdrawal by Subject|7|||
124532149|NCT00882362|447898059|FG000|Overall Study|Adverse Event|13|||
124532150|NCT00882362|447898060|FG001|Overall Study|Adverse Event|10|||
124532151|NCT00882362|447898059|FG000|Overall Study|Withdrawal by Subject|13|||
124532152|NCT00882362|447898060|FG001|Overall Study|Withdrawal by Subject|10|||
124532153|NCT00882362|447898059|FG000|Overall Study|Lack of Efficacy|3|||
124532154|NCT00882362|447898060|FG001|Overall Study|Lack of Efficacy|0|||
124532155|NCT00882362|447898059|FG000|Overall Study|Protocol Violation|7|||
124532156|NCT00882362|447898060|FG001|Overall Study|Protocol Violation|2|||
124532157|NCT00882362|447898059|FG000|Overall Study|Pregnancy|1|||
124532158|NCT00882362|447898060|FG001|Overall Study|Pregnancy|0|||
124532159|NCT00882362|447898059|FG000|Overall Study|Physician Decision|5|||
124532160|NCT00882362|447898060|FG001|Overall Study|Physician Decision|1|||
124532161|NCT00882362|447898059|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
124532162|NCT00882362|447898060|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
124586821|NCT01044433|448105692|FG000|Overall Study|Lost to Follow-up|3|||
124586822|NCT01044433|448105692|FG000|Overall Study|Withdrawal by Subject|3|||
124586823|NCT05065619|448105694|FG000|Up to Day 42|Lost to Follow-up|1|||
124586824|NCT05065619|448105695|FG001|Up to Day 42|Lost to Follow-up|0|||
124586825|NCT05065619|448105694|FG000|Up to Day 42|Withdrawal by Subject|1|||
124586826|NCT05065619|448105695|FG001|Up to Day 42|Withdrawal by Subject|0|||
124586827|NCT05065619|448105694|FG000|After Day 43|Lost to Follow-up|1|||
124586828|NCT05065619|448105695|FG001|After Day 43|Lost to Follow-up|0|||
124586829|NCT05065619|448105694|FG000|After Day 43|Physician Decision|3|||
124586830|NCT05065619|448105695|FG001|After Day 43|Physician Decision|0|||
124586831|NCT05065619|448105694|FG000|After Day 43|Withdrawal by Subject|1|||
124586832|NCT05065619|448105695|FG001|After Day 43|Withdrawal by Subject|2|||
124586833|NCT05065619|448105694|FG000|After Day 43|Public vaccination|6|||
124586834|NCT05065619|448105695|FG001|After Day 43|Public vaccination|8|||
124586835|NCT05065619|448105694|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
124586836|NCT05065619|448105695|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
124586837|NCT05065619|448105694|FG000|After Day 43|Study Terminated by Sponsor|88|||
124586838|NCT05065619|448105695|FG001|After Day 43|Study Terminated by Sponsor|16|||
124586839|NCT01390948|448105696|FG000|Overall Study|End of Study|1|||
124586840|NCT01390948|448105697|FG001|Overall Study|End of Study|0|||
124586841|NCT01390948|448105698|FG002|Overall Study|End of Study|0|||
124586842|NCT01390948|448105696|FG000|Overall Study|Withdrew consent|2|||
124586843|NCT01390948|448105697|FG001|Overall Study|Withdrew consent|2|||
124586844|NCT01390948|448105698|FG002|Overall Study|Withdrew consent|0|||
124586845|NCT01390948|448105696|FG000|Overall Study|Progressive Disease|2|||
124586846|NCT01390948|448105697|FG001|Overall Study|Progressive Disease|5|||
124586847|NCT01390948|448105698|FG002|Overall Study|Progressive Disease|0|||
124586848|NCT01390948|448105696|FG000|Overall Study|Death during follow-up|10|||
124586849|NCT01390948|448105697|FG001|Overall Study|Death during follow-up|11|||
124586850|NCT01390948|448105698|FG002|Overall Study|Death during follow-up|1|||
124586851|NCT02452463|448105701|FG000|Overall Study|Death|1|||
124586852|NCT02452463|448105702|FG001|Overall Study|Death|0|||
124586853|NCT02452463|448105703|FG002|Overall Study|Death|0|||
124586854|NCT02452463|448105701|FG000|Overall Study|Study Suspended|1|||
124586855|NCT02452463|448105702|FG001|Overall Study|Study Suspended|0|||
124586856|NCT02452463|448105703|FG002|Overall Study|Study Suspended|0|||
124586857|NCT02452463|448105701|FG000|Overall Study|Recommended by DSMB|0|||
124586858|NCT02452463|448105702|FG001|Overall Study|Recommended by DSMB|1|||
124586859|NCT02452463|448105703|FG002|Overall Study|Recommended by DSMB|0|||
124586860|NCT02452463|448105701|FG000|Overall Study|Withdrawal by Subject|0|||
124586861|NCT02452463|448105702|FG001|Overall Study|Withdrawal by Subject|1|||
124586862|NCT02452463|448105703|FG002|Overall Study|Withdrawal by Subject|0|||
124586863|NCT05740098|448105704|FG000|Overall Study|Lost to Follow-up|26|||
124586864|NCT05740098|448105705|FG001|Overall Study|Lost to Follow-up|17|||
124586865|NCT05740098|448105706|FG002|Overall Study|Lost to Follow-up|21|||
124586866|NCT01528735|448105707|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
124586867|NCT01528735|448105708|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
124586868|NCT01528735|448105707|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
124586869|NCT01528735|448105708|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
124586870|NCT01401062|448105709|FG000|Overall Study|Death|9|||
124586871|NCT01401062|448105710|FG001|Overall Study|Death|7|||
124586872|NCT01401062|448105709|FG000|Overall Study|Physician Decision|1|||
124586873|NCT01401062|448105710|FG001|Overall Study|Physician Decision|0|||
124586874|NCT01401062|448105709|FG000|Overall Study|Withdrawal by Subject|1|||
124586875|NCT01401062|448105710|FG001|Overall Study|Withdrawal by Subject|1|||
124586876|NCT00757172|448105713|FG000|Overall Study|Withdrawal by Subject|4|||
124586877|NCT00757172|448105713|FG000|Overall Study|Physician Decision|3|||
124586878|NCT00757172|448105713|FG000|Overall Study|Progression|4|||
124586879|NCT03555695|448105714|FG000|Overall Study|Withdrawal by Subject|1|||
124586880|NCT03555695|448105714|FG000|Overall Study|Lost to Follow-up|1|||
124586881|NCT03555695|448105714|FG000|Overall Study|appendicitis (unrelated)|1|||
124586882|NCT03555695|448105714|FG000|Overall Study|pre-existing sciatica|1|||
124586883|NCT04194151|448105717|FG000|Overall Study|Physician Decision|1|||
124586884|NCT04194151|448105718|FG001|Overall Study|Physician Decision|1|||
124586885|NCT04194151|448105719|FG002|Overall Study|Physician Decision|1|||
124586886|NCT04194151|448105720|FG003|Overall Study|Physician Decision|1|||
124586887|NCT04194151|448105721|FG004|Overall Study|Physician Decision|0|||
124586888|NCT04194151|448105722|FG005|Overall Study|Physician Decision|1|||
124586889|NCT04194151|448105717|FG000|Overall Study|Monitorization problem|0|||
124586890|NCT04194151|448105718|FG001|Overall Study|Monitorization problem|1|||
124586891|NCT04194151|448105719|FG002|Overall Study|Monitorization problem|0|||
124586892|NCT04194151|448105720|FG003|Overall Study|Monitorization problem|0|||
124586893|NCT04194151|448105721|FG004|Overall Study|Monitorization problem|0|||
124586894|NCT04194151|448105722|FG005|Overall Study|Monitorization problem|0|||
124586895|NCT01499043|448105723|FG000|Overall Study|Progressive disease (radiographic)|2|||
124586896|NCT01499043|448105723|FG000|Overall Study|Progressive disease (clinical)|1|||
124586897|NCT01499043|448105723|FG000|Overall Study|Withdrawal by Subject|2|||
124586898|NCT01499043|448105723|FG000|Overall Study|Adverse Event|1|||
124586899|NCT04203823|448105725|FG000|Overall Study|Withdrawal by Subject|2|||
124586900|NCT04203823|448105726|FG001|Overall Study|Withdrawal by Subject|2|||
124586901|NCT04203823|448105725|FG000|Overall Study|Adverse Event|1|||
124586902|NCT04203823|448105726|FG001|Overall Study|Adverse Event|1|||
124586903|NCT04203823|448105725|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124586904|NCT04203823|448105726|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
124586905|NCT00438633|448105727|FG000|Overall Study|Withdrawal by Subject|1|||
124586906|NCT00438633|448105728|FG001|Overall Study|Withdrawal by Subject|0|||
124586907|NCT00438633|448105727|FG000|Overall Study|Lost to Follow-up|15|||
124586908|NCT00438633|448105728|FG001|Overall Study|Lost to Follow-up|17|||
124586909|NCT01912807|448105729|FG000|Overall Study|Did not meet elegibility criteria|6|||
124586910|NCT01912807|448105730|FG001|Overall Study|Did not meet elegibility criteria|4|||
124586911|NCT01912807|448105729|FG000|Overall Study|Lost to Follow-up|36|||
124586912|NCT01912807|448105730|FG001|Overall Study|Lost to Follow-up|37|||
124586913|NCT01968031|448105731|FG000|Overall Study|Adverse Event|13|||
124586914|NCT01968031|448105732|FG001|Overall Study|Adverse Event|10|||
124586915|NCT01968031|448105733|FG002|Overall Study|Adverse Event|22|||
124586916|NCT01968031|448105731|FG000|Overall Study|Withdrawal by Subject|3|||
124586917|NCT01968031|448105732|FG001|Overall Study|Withdrawal by Subject|7|||
124586918|NCT01968031|448105733|FG002|Overall Study|Withdrawal by Subject|3|||
124586919|NCT01968031|448105731|FG000|Overall Study|Did not meet entry criteria|1|||
124586920|NCT01968031|448105732|FG001|Overall Study|Did not meet entry criteria|1|||
124586921|NCT01968031|448105733|FG002|Overall Study|Did not meet entry criteria|1|||
124586922|NCT01968031|448105731|FG000|Overall Study|Noncompliance|0|||
124586923|NCT01968031|448105732|FG001|Overall Study|Noncompliance|0|||
124586924|NCT01968031|448105733|FG002|Overall Study|Noncompliance|2|||
124586925|NCT01968031|448105731|FG000|Overall Study|Failed inclusion criteria|0|||
124586926|NCT01968031|448105732|FG001|Overall Study|Failed inclusion criteria|2|||
124586927|NCT01968031|448105733|FG002|Overall Study|Failed inclusion criteria|0|||
124586928|NCT01968031|448105731|FG000|Overall Study|Death|0|||
124586929|NCT01968031|448105732|FG001|Overall Study|Death|0|||
124586930|NCT01968031|448105733|FG002|Overall Study|Death|1|||
124586931|NCT01968031|448105731|FG000|Overall Study|Prohibited concomitant medication|1|||
124586932|NCT01968031|448105732|FG001|Overall Study|Prohibited concomitant medication|0|||
124586933|NCT01968031|448105733|FG002|Overall Study|Prohibited concomitant medication|0|||
124586934|NCT03506633|448107721|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
124586935|NCT03506633|448107722|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
124586936|NCT01894230|448107723|FG000|Overall Study|Lost to Follow-up|2|||
124586937|NCT01894230|448107724|FG001|Overall Study|Lost to Follow-up|2|||
124586938|NCT01894230|448107723|FG000|Overall Study|Withdrawal by Subject|4|||
124586939|NCT01894230|448107724|FG001|Overall Study|Withdrawal by Subject|4|||
124586940|NCT01894230|448107723|FG000|Overall Study|Non-adherent|0|||
124586941|NCT01894230|448107724|FG001|Overall Study|Non-adherent|1|||
124586942|NCT01894230|448107723|FG000|Overall Study|Death|1|||
124586943|NCT01894230|448107724|FG001|Overall Study|Death|0|||
124586944|NCT00640393|448107726|FG000|Part 1|Lost to Follow-up|2|||
124586945|NCT00640393|448107727|FG001|Part 1|Lost to Follow-up|0|||
124586946|NCT00640393|448107728|FG002|Part 1|Lost to Follow-up|0|||
124586947|NCT00640393|448107726|FG000|Part 1|Withdrawal by Subject|3|||
124586948|NCT00640393|448107727|FG001|Part 1|Withdrawal by Subject|0|||
124586949|NCT00640393|448107728|FG002|Part 1|Withdrawal by Subject|0|||
124586950|NCT00640393|448107726|FG000|Randomization|Withdrawn per protocol|17|||
124586951|NCT00640393|448107727|FG001|Randomization|Withdrawn per protocol|0|||
124586952|NCT00640393|448107728|FG002|Randomization|Withdrawn per protocol|0|||
124586953|NCT00640393|448107726|FG000|Randomization|Never randomized by site|2|||
124532163|NCT00882362|447898059|FG000|Overall Study|change of residence or other commitments|5|||
124532164|NCT00882362|447898060|FG001|Overall Study|change of residence or other commitments|0|||
124532165|NCT01268514|447898061|FG000|Overall Study|Adverse Event|20|||
124532166|NCT01268514|447898061|FG000|Overall Study|Death|8|||
124532167|NCT01268514|447898061|FG000|Overall Study|Lost to Follow-up|5|||
124532168|NCT01268514|447898061|FG000|Overall Study|Withdrawal by Subject|3|||
124532169|NCT01268514|447898061|FG000|Overall Study|Withdrawal by Surgeon|5|||
124586954|NCT00640393|448107727|FG001|Randomization|Never randomized by site|0|||
124532170|NCT01846208|447898062|FG000|Overall Study|Withdrew prior to treatment|1|||
124532171|NCT01846208|447898063|FG001|Overall Study|Withdrew prior to treatment|1|||
124532172|NCT01846208|447898064|FG002|Overall Study|Withdrew prior to treatment|1|||
124586955|NCT00640393|448107728|FG002|Randomization|Never randomized by site|0|||
124586956|NCT00640393|448107726|FG000|Part 2|Lost to Follow-up|0|||
124586957|NCT00640393|448107727|FG001|Part 2|Lost to Follow-up|2|||
124586958|NCT00640393|448107728|FG002|Part 2|Lost to Follow-up|2|||
124586959|NCT00640393|448107726|FG000|Part 2|Withdrawal by Subject|0|||
124586960|NCT00640393|448107727|FG001|Part 2|Withdrawal by Subject|6|||
124586961|NCT00640393|448107728|FG002|Part 2|Withdrawal by Subject|1|||
124586962|NCT00640393|448107726|FG000|Part 2|Non-adherence|0|||
124586963|NCT00640393|448107727|FG001|Part 2|Non-adherence|1|||
124586964|NCT00640393|448107728|FG002|Part 2|Non-adherence|0|||
124586965|NCT00640393|448107726|FG000|Part 2|Adverse Event|0|||
124586966|NCT00640393|448107727|FG001|Part 2|Adverse Event|1|||
124586967|NCT00640393|448107728|FG002|Part 2|Adverse Event|0|||
124532173|NCT01846208|447898062|FG000|Overall Study|Dosing Symptoms|1|||
124532174|NCT01846208|447898063|FG001|Overall Study|Dosing Symptoms|2|||
124532175|NCT01846208|447898064|FG002|Overall Study|Dosing Symptoms|6|||
124532176|NCT01846208|447898062|FG000|Overall Study|Withdrawal by Subject|5|||
124532177|NCT01846208|447898063|FG001|Overall Study|Withdrawal by Subject|0|||
124532178|NCT01846208|447898064|FG002|Overall Study|Withdrawal by Subject|0|||
124532179|NCT01846208|447898062|FG000|Overall Study|Non-compliance|1|||
124532180|NCT01846208|447898063|FG001|Overall Study|Non-compliance|1|||
124532181|NCT01846208|447898064|FG002|Overall Study|Non-compliance|0|||
124532182|NCT01846208|447898062|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
124532183|NCT01846208|447898063|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
124532184|NCT01846208|447898064|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
124532185|NCT01846208|447898062|FG000|Overall Study|Refused SU OFC|0|||
124532186|NCT01846208|447898063|FG001|Overall Study|Refused SU OFC|0|||
124532187|NCT01846208|447898064|FG002|Overall Study|Refused SU OFC|1|||
124532188|NCT01424306|447898065|FG000|Overall Study|Protocol Violation|0|||
124532189|NCT01424306|447898066|FG001|Overall Study|Protocol Violation|0|||
124532190|NCT01424306|447898067|FG002|Overall Study|Protocol Violation|0|||
124532191|NCT01424306|447898068|FG003|Overall Study|Protocol Violation|0|||
124532192|NCT01424306|447898069|FG004|Overall Study|Protocol Violation|1|||
124532193|NCT01424306|447898070|FG005|Overall Study|Protocol Violation|0|||
124532194|NCT03344562|447898076|FG000|Overall Study|Withdrawal by Subject|2|||
124532195|NCT03344562|447898077|FG001|Overall Study|Withdrawal by Subject|0|||
124532196|NCT02463331|447898082|FG000|Overall Study|Adverse Event|4|||
124532197|NCT02463331|447898083|FG001|Overall Study|Adverse Event|2|||
124532198|NCT02463331|447898082|FG000|Overall Study|Lost to Follow-up|1|||
124532199|NCT02463331|447898083|FG001|Overall Study|Lost to Follow-up|1|||
124532200|NCT02463331|447898082|FG000|Overall Study|Pregnancy|2|||
124532201|NCT02463331|447898083|FG001|Overall Study|Pregnancy|3|||
124532202|NCT02463331|447898082|FG000|Overall Study|Lack of Efficacy|6|||
124532203|NCT02463331|447898083|FG001|Overall Study|Lack of Efficacy|0|||
124532204|NCT02463331|447898082|FG000|Overall Study|Physician Decision|3|||
124532205|NCT02463331|447898083|FG001|Overall Study|Physician Decision|0|||
124532206|NCT02274766|447898084|FG000|Overall Study|Withdrawal by Subject|3|||
124532207|NCT02274766|447898085|FG001|Overall Study|Withdrawal by Subject|6|||
124532208|NCT02274766|447898084|FG000|Overall Study|Did Not Receive Study Drug|1|||
124532209|NCT02274766|447898085|FG001|Overall Study|Did Not Receive Study Drug|1|||
124532210|NCT02274766|447898084|FG000|Overall Study|Subject Unwilling to Proceed|0|||
124532211|NCT02274766|447898085|FG001|Overall Study|Subject Unwilling to Proceed|1|||
124532212|NCT02274766|447898084|FG000|Overall Study|Adverse Event|0|||
124532213|NCT02274766|447898085|FG001|Overall Study|Adverse Event|1|||
124532214|NCT02608892|447898095|FG000|Overall Study|Lost to Follow-up|1|||
124532215|NCT02608892|447898096|FG001|Overall Study|Lost to Follow-up|0|||
124532216|NCT02590406|447898097|FG000|Overall Study|Adverse Event|1|||
124532217|NCT02590406|447898098|FG001|Overall Study|Adverse Event|0|||
124586968|NCT00396162|448107734|FG000|Overall Study|Withdrawal by Subject|2|||
124586969|NCT00396162|448107735|FG001|Overall Study|Withdrawal by Subject|3|||
124586970|NCT03387462|448107738|FG000|Overall Study|Lost to Follow-up|1|||
124586971|NCT01460628|448107741|FG000|Overall Study|Adverse Event|3|||
124586972|NCT01460628|448107741|FG000|Overall Study|Withdrawal by Subject|2|||
124586973|NCT01944722|448107743|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
124586974|NCT01944722|448107743|FG000|Overall Study|Specimen Shipping Issues|34|||
124586975|NCT01944722|448107743|FG000|Overall Study|Improper Storage/Transport|5|||
124586976|NCT01944722|448107743|FG000|Overall Study|Insufficient Volume for Test|1|||
124586977|NCT01944722|448107743|FG000|Overall Study|Missing Specimens|3|||
124586978|NCT01944722|448107743|FG000|Overall Study|Specimens Mislabeled|2|||
124586979|NCT01944722|448107743|FG000|Overall Study|Withdrawal by Subject|8|||
124532218|NCT02590406|447898097|FG000|Overall Study|Saturometer malfunction|0|||
124532219|NCT02590406|447898098|FG001|Overall Study|Saturometer malfunction|1|||
124532220|NCT00984009|447898099|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
124532221|NCT02036476|447898102|FG000|Overall Study|Withdrawal by Subject|2|||
124532222|NCT02036476|447898102|FG000|Overall Study|Progressive Disease|4|||
124586980|NCT01944722|448107743|FG000|Overall Study|NILM Subjects <30 years old|8106|||
124586981|NCT01944722|448107743|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
124532223|NCT02036476|447898102|FG000|Overall Study|Unacceptable Toxicity|2|||
124532224|NCT02168816|447898103|FG000|Overall Study|Lost to Follow-up|2|||
124532225|NCT02168816|447898104|FG001|Overall Study|Lost to Follow-up|2|||
124532226|NCT02985684|447898105|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
124532227|NCT02985684|447898105|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
124532228|NCT02985684|447898105|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
124532229|NCT01436357|447898106|FG000|Overall Study|Death|5|||
124532230|NCT01436357|447898107|FG001|Overall Study|Death|1|||
124532231|NCT01436357|447898106|FG000|Overall Study|Enrolled but not vaccinated|1|||
124532232|NCT01436357|447898107|FG001|Overall Study|Enrolled but not vaccinated|1|||
124532233|NCT01436357|447898106|FG000|Overall Study|Incarceration|18|||
124586982|NCT01944722|448107743|FG000|Overall Study|>ASCUS Cytology|1122|||
124586983|NCT00210639|448107744|FG000|Overall Study|Lost to Follow-up|37|||
124532234|NCT01436357|447898107|FG001|Overall Study|Incarceration|20|||
124532235|NCT01436357|447898106|FG000|Overall Study|Lost to Follow-up|67|||
124532236|NCT01436357|447898107|FG001|Overall Study|Lost to Follow-up|61|||
124532237|NCT01436357|447898106|FG000|Overall Study|Protocol Violation|1|||
124532238|NCT01436357|447898107|FG001|Overall Study|Protocol Violation|0|||
124532239|NCT01436357|447898106|FG000|Overall Study|Withdrawal by Subject|26|||
124532240|NCT01436357|447898107|FG001|Overall Study|Withdrawal by Subject|38|||
124532241|NCT01436357|447898106|FG000|Overall Study|Physician Decision|3|||
124532242|NCT01436357|447898107|FG001|Overall Study|Physician Decision|4|||
124532243|NCT01436357|447898106|FG000|Overall Study|Moved out of area|1|||
124532244|NCT01436357|447898107|FG001|Overall Study|Moved out of area|2|||
124532245|NCT01436357|447898106|FG000|Overall Study|Subject in rehab|0|||
124532246|NCT01436357|447898107|FG001|Overall Study|Subject in rehab|1|||
124532247|NCT05281094|447898108|FG000|Overall Study|Adverse Event|1|||
124532248|NCT05281094|447898109|FG001|Overall Study|Adverse Event|0|||
124532249|NCT05281094|447898108|FG000|Overall Study|Lost to Follow-up|29|||
124532250|NCT05281094|447898109|FG001|Overall Study|Lost to Follow-up|22|||
124532251|NCT05281094|447898108|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
124532252|NCT05281094|447898109|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
124532253|NCT05281094|447898108|FG000|Overall Study|Death|1|||
124532254|NCT05281094|447898109|FG001|Overall Study|Death|2|||
124532255|NCT05281094|447898108|FG000|Overall Study|Not pre-specified reason|8|||
124532256|NCT05281094|447898109|FG001|Overall Study|Not pre-specified reason|5|||
124532257|NCT05315297|447898110|FG000|Overall Study|Lost to Follow-up|6|||
124532258|NCT05315297|447898111|FG001|Overall Study|Lost to Follow-up|4|||
124532259|NCT05315297|447898110|FG000|Overall Study|Withdrawal by Subject|0|||
124532260|NCT05315297|447898111|FG001|Overall Study|Withdrawal by Subject|1|||
124532261|NCT02583399|447900075|FG000|Overall Study|Able to be discharged|3|||
124532262|NCT02583399|447900075|FG000|Overall Study|Wanted to use a restricted medication|3|||
124532263|NCT02759939|447900083|FG000|Overall Study|Missing data on first outcome assessed|11|||
124532264|NCT02759939|447900084|FG001|Overall Study|Missing data on first outcome assessed|2|||
124532265|NCT02759939|447900085|FG002|Overall Study|Missing data on first outcome assessed|5|||
124532266|NCT02759939|447900086|FG003|Overall Study|Missing data on first outcome assessed|2|||
124532267|NCT02759939|447900083|FG000|Overall Study|Ineligible for T2 and T3|310|||
124532268|NCT02759939|447900084|FG001|Overall Study|Ineligible for T2 and T3|179|||
124532269|NCT02759939|447900085|FG002|Overall Study|Ineligible for T2 and T3|366|||
124532270|NCT02759939|447900086|FG003|Overall Study|Ineligible for T2 and T3|391|||
124532271|NCT02759939|447900083|FG000|Overall Study|Lost to Follow-up|735|||
124532272|NCT02759939|447900084|FG001|Overall Study|Lost to Follow-up|791|||
124532273|NCT02759939|447900085|FG002|Overall Study|Lost to Follow-up|783|||
124532274|NCT02759939|447900086|FG003|Overall Study|Lost to Follow-up|650|||
124532275|NCT03288987|447900091|FG000|Overall Study|Protocol Violation|10|||
124532276|NCT03288987|447900092|FG001|Overall Study|Protocol Violation|4|||
124532277|NCT02807376|447900095|FG000|Overall Study|Intra-operative exclusion criteria|3|||
124532278|NCT02807376|447900096|FG001|Overall Study|Intra-operative exclusion criteria|0|||
124532279|NCT02807376|447900095|FG000|Overall Study|Lost to Follow-up|0|||
124532280|NCT02807376|447900096|FG001|Overall Study|Lost to Follow-up|1|||
124532281|NCT00846027|447900097|FG000|Overall Study|Death|3|||
124532282|NCT00846027|447900097|FG000|Overall Study|Disease Progression|30|||
124532283|NCT00846027|447900097|FG000|Overall Study|Toxicity|12|||
124532284|NCT00846027|447900097|FG000|Overall Study|Patient Decision|7|||
124532285|NCT00846027|447900097|FG000|Overall Study|Investigator Discretion|29|||
124532286|NCT00846027|447900097|FG000|Overall Study|Protocol Violation|2|||
124532287|NCT00846027|447900097|FG000|Overall Study|Subject Not Treated|7|||
124532288|NCT04905563|447900100|FG000|Overall Study|Withdrawal by Subject|1|||
124532289|NCT04905563|447900101|FG001|Overall Study|Withdrawal by Subject|0|||
124532290|NCT04905563|447900100|FG000|Overall Study|Standard of care orders entered by resident|1|||
124532291|NCT04905563|447900101|FG001|Overall Study|Standard of care orders entered by resident|0|||
124532292|NCT04905563|447900100|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
124532293|NCT04905563|447900101|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
124532294|NCT04905563|447900100|FG000|Overall Study|Withdrawal by Subject|0|||
124532295|NCT04905563|447900101|FG001|Overall Study|Withdrawal by Subject|1|||
124532296|NCT01797302|447900102|FG000|Overall Study|Lost to Follow-up|16|||
124532297|NCT01797302|447900103|FG001|Overall Study|Lost to Follow-up|23|||
124532298|NCT01797302|447900104|FG002|Overall Study|Lost to Follow-up|22|||
124532299|NCT01797302|447900102|FG000|Overall Study|Withdrawal by Subject|1|||
124532300|NCT01797302|447900103|FG001|Overall Study|Withdrawal by Subject|3|||
124532301|NCT01797302|447900104|FG002|Overall Study|Withdrawal by Subject|4|||
124532302|NCT03228836|447900106|FG000|Overall Study|Adverse Event|3|||
124532303|NCT03228836|447900106|FG000|Overall Study|Withdrawal by Subject|1|||
124532304|NCT03228836|447900106|FG000|Overall Study|Death|1|||
124532305|NCT03228836|447900106|FG000|Overall Study|Physician Decision|1|||
124532306|NCT03228836|447900106|FG000|Overall Study|Disease Progression|7|||
124532307|NCT03228836|447900106|FG000|Overall Study|Other|4|||
124532308|NCT02908841|447900111|FG000|Overall Study|Physician Decision|4|||
124532309|NCT02908841|447900112|FG001|Overall Study|Physician Decision|0|||
124532310|NCT01611558|447900113|FG000|Induction Phase|Study drug toxicity|15|||
124532311|NCT01611558|447900113|FG000|Induction Phase|Disease progression|18|||
124532312|NCT01611558|447900113|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
124586984|NCT00210639|448107745|FG001|Overall Study|Lost to Follow-up|29|||
124586985|NCT00210639|448107744|FG000|Overall Study|Withdrawal by Subject|8|||
124586986|NCT00210639|448107745|FG001|Overall Study|Withdrawal by Subject|1|||
124586987|NCT00210639|448107744|FG000|Overall Study|Other|18|||
124586988|NCT00210639|448107745|FG001|Overall Study|Other|12|||
124586989|NCT02854800|448107747|FG000|Overall Study|Protocol Violation|16|||
124586990|NCT02854800|448107748|FG001|Overall Study|Protocol Violation|11|||
124586991|NCT02854800|448107749|FG002|Overall Study|Protocol Violation|3|||
124586992|NCT02854800|448107747|FG000|Overall Study|Withdrawal by Subject|4|||
124586993|NCT02854800|448107748|FG001|Overall Study|Withdrawal by Subject|2|||
124586994|NCT02854800|448107749|FG002|Overall Study|Withdrawal by Subject|3|||
124586995|NCT02627963|448107755|FG000|Overall Study|Randomized but not treated|2|||
124586996|NCT02627963|448107756|FG001|Overall Study|Randomized but not treated|6|||
124586997|NCT00152451|448107759|FG000|Overall Study|Adverse Event|4|||
124586998|NCT00503867|448107762|FG000|Overall Study|Lost to Follow-up|1|||
124586999|NCT00503867|448107762|FG000|Overall Study|Adverse Event|1|||
124587000|NCT04697173|448107765|FG000|Overall Study|Withdrawal by Subject|34|||
124587001|NCT04697173|448107766|FG001|Overall Study|Withdrawal by Subject|38|||
124587002|NCT03807440|448107767|FG000|Overall Study|No documentation of index date 2|320|||
124587003|NCT03807440|448107767|FG000|Overall Study|No informed consent for index date 2|117|||
124587004|NCT00323258|448107768|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
124587005|NCT00323258|448107769|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
124587006|NCT00323258|448107768|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
124587007|NCT00323258|448107769|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
124587008|NCT00323258|448107768|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
124587009|NCT00323258|448107769|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
124587010|NCT00323258|448107768|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
124587011|NCT00323258|448107769|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
124587012|NCT00323258|448107768|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
124587013|NCT00323258|448107769|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
124587014|NCT00323258|448107768|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
124587015|NCT00323258|448107769|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
124587016|NCT00323258|448107768|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
124587017|NCT00323258|448107769|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
124587018|NCT01859598|448107782|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
124587019|NCT00354835|448107783|FG000|Overall Study|Death|1|||
124587020|NCT00354835|448107784|FG001|Overall Study|Death|1|||
124587021|NCT00354835|448107783|FG000|Overall Study|Physician Decision|8|||
124532313|NCT01611558|447900113|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
124532314|NCT01611558|447900113|FG000|Induction Phase|Death|1|||
124532315|NCT01611558|447900113|FG000|Maintenance Phase|Withdrawal by Subject|1|||
124532316|NCT01611558|447900113|FG000|Maintenance Phase|Elevated Uric acid|1|||
124532317|NCT04005885|447900124|FG000|First Intervention|Withdrawal by Subject|1|||
124532318|NCT04005885|447900125|FG001|First Intervention|Withdrawal by Subject|1|||
124532319|NCT04005885|447900124|FG000|Second Intervention|Withdrawal by Subject|0|||
124532320|NCT04005885|447900125|FG001|Second Intervention|Withdrawal by Subject|2|||
124532321|NCT04652102|447900127|FG000|Overall Study|Adverse Event|14|||
124532322|NCT04652102|447900128|FG001|Overall Study|Adverse Event|13|||
124532323|NCT04652102|447900127|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
124532324|NCT04652102|447900128|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
124532325|NCT04652102|447900127|FG000|Overall Study|Physician Decision|78|||
124532326|NCT04652102|447900128|FG001|Overall Study|Physician Decision|40|||
124532327|NCT04652102|447900127|FG000|Overall Study|Study Ended by Sponsor|64|||
124532328|NCT04652102|447900128|FG001|Overall Study|Study Ended by Sponsor|17|||
124532329|NCT04652102|447900127|FG000|Overall Study|Withdrawal by Subject|4625|||
124532330|NCT04652102|447900128|FG001|Overall Study|Withdrawal by Subject|5594|||
124532331|NCT04652102|447900127|FG000|Overall Study|Lost to Follow-up|2019|||
124532332|NCT04652102|447900128|FG001|Overall Study|Lost to Follow-up|1082|||
124532333|NCT04652102|447900127|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
124532334|NCT04652102|447900128|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
124532335|NCT04652102|447900127|FG000|Overall Study|Miscellaneous|80|||
124532336|NCT04652102|447900128|FG001|Overall Study|Miscellaneous|64|||
124532337|NCT00696774|447900134|FG000|Period II|Adverse Event|0|||
124532338|NCT00696774|447900135|FG001|Period II|Adverse Event|0|||
124532339|NCT00696774|447900136|FG002|Period II|Adverse Event|15|||
124532340|NCT00696774|447900134|FG000|Period II|Lost to Follow-up|0|||
124532341|NCT00696774|447900135|FG001|Period II|Lost to Follow-up|0|||
124532342|NCT00696774|447900136|FG002|Period II|Lost to Follow-up|4|||
124532343|NCT00696774|447900134|FG000|Period II|Protocol Violation|0|||
124587022|NCT00354835|448107784|FG001|Overall Study|Physician Decision|13|||
124587023|NCT00354835|448107783|FG000|Overall Study|Withdrawal by Subject|2|||
124532344|NCT00696774|447900135|FG001|Period II|Protocol Violation|0|||
124532345|NCT00696774|447900136|FG002|Period II|Protocol Violation|11|||
124532346|NCT00696774|447900134|FG000|Period II|Withdrawal by Subject|0|||
124532347|NCT00696774|447900135|FG001|Period II|Withdrawal by Subject|0|||
124532348|NCT00696774|447900136|FG002|Period II|Withdrawal by Subject|4|||
124532349|NCT00696774|447900134|FG000|Period II|Sponsor Decision|0|||
124532350|NCT00696774|447900135|FG001|Period II|Sponsor Decision|0|||
124532351|NCT00696774|447900136|FG002|Period II|Sponsor Decision|0|||
124532352|NCT00696774|447900134|FG000|Period II|Lack of Efficacy|0|||
124532353|NCT00696774|447900135|FG001|Period II|Lack of Efficacy|0|||
124532354|NCT00696774|447900136|FG002|Period II|Lack of Efficacy|2|||
124532355|NCT00696774|447900134|FG000|Period III|Adverse Event|1|||
124532356|NCT00696774|447900135|FG001|Period III|Adverse Event|1|||
124532357|NCT00696774|447900136|FG002|Period III|Adverse Event|0|||
124532358|NCT00696774|447900134|FG000|Period III|Lost to Follow-up|2|||
124532359|NCT00696774|447900135|FG001|Period III|Lost to Follow-up|1|||
124532360|NCT00696774|447900136|FG002|Period III|Lost to Follow-up|0|||
124532361|NCT00696774|447900134|FG000|Period III|Protocol Violation|1|||
124532362|NCT00696774|447900135|FG001|Period III|Protocol Violation|1|||
124532363|NCT00696774|447900136|FG002|Period III|Protocol Violation|0|||
124532364|NCT00696774|447900134|FG000|Period III|Withdrawal by Subject|1|||
124532365|NCT00696774|447900135|FG001|Period III|Withdrawal by Subject|2|||
124532366|NCT00696774|447900136|FG002|Period III|Withdrawal by Subject|0|||
124532367|NCT00696774|447900134|FG000|Period III|Sponsor Decision|2|||
124532368|NCT00696774|447900135|FG001|Period III|Sponsor Decision|0|||
124532369|NCT00696774|447900136|FG002|Period III|Sponsor Decision|0|||
124532370|NCT00696774|447900134|FG000|Period III|Lack of Efficacy|0|||
124532371|NCT00696774|447900135|FG001|Period III|Lack of Efficacy|2|||
124532372|NCT00696774|447900136|FG002|Period III|Lack of Efficacy|0|||
124532373|NCT02442765|447900146|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
124532374|NCT02442765|447900147|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
124532375|NCT02442765|447900148|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
124532376|NCT02442765|447900149|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
124532377|NCT02442765|447900150|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
124532378|NCT02442765|447900151|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
124532379|NCT02442765|447900152|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
124532380|NCT02442765|447900153|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
124532381|NCT02442765|447900146|FG000|Stage 2- (Days 43 to 85)|Death|0|||
124532382|NCT02442765|447900147|FG001|Stage 2- (Days 43 to 85)|Death|0|||
124532383|NCT02442765|447900148|FG002|Stage 2- (Days 43 to 85)|Death|0|||
124532384|NCT02442765|447900149|FG003|Stage 2- (Days 43 to 85)|Death|1|||
124532385|NCT02442765|447900150|FG004|Stage 2- (Days 43 to 85)|Death|1|||
124532386|NCT02442765|447900151|FG005|Stage 2- (Days 43 to 85)|Death|0|||
124532387|NCT02442765|447900152|FG006|Stage 2- (Days 43 to 85)|Death|2|||
124532388|NCT02442765|447900153|FG007|Stage 2- (Days 43 to 85)|Death|0|||
124532389|NCT02442765|447900146|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
124532390|NCT02442765|447900147|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
124532391|NCT02442765|447900148|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
124532392|NCT02442765|447900149|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
124532393|NCT02442765|447900150|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
124532394|NCT02442765|447900151|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
124587024|NCT00354835|448107784|FG001|Overall Study|Withdrawal by Subject|1|||
124587025|NCT00354835|448107783|FG000|Overall Study|Ineligible|17|||
124587026|NCT00354835|448107784|FG001|Overall Study|Ineligible|16|||
124587027|NCT00354835|448107783|FG000|Overall Study|Disease progression or relapse|15|||
124532395|NCT02442765|447900152|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
124532396|NCT02442765|447900153|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
124532397|NCT02442765|447900146|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
124532398|NCT02442765|447900147|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
124532399|NCT02442765|447900148|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
124532400|NCT02442765|447900149|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
124587028|NCT00354835|448107784|FG001|Overall Study|Disease progression or relapse|22|||
124587029|NCT00354835|448107783|FG000|Overall Study|Adverse Event|6|||
124587030|NCT00354835|448107784|FG001|Overall Study|Adverse Event|0|||
124532401|NCT02442765|447900150|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
124587031|NCT00354835|448107783|FG000|Overall Study|Refusal of further therapy|3|||
124587032|NCT00354835|448107784|FG001|Overall Study|Refusal of further therapy|8|||
124587033|NCT01968551|448107785|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
124587034|NCT01968551|448107786|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
124587035|NCT01968551|448107787|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
124532402|NCT02442765|447900151|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
124532403|NCT02442765|447900152|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
124532404|NCT02442765|447900153|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
124532405|NCT02442765|447900146|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
124532406|NCT02442765|447900147|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
124532407|NCT02442765|447900148|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
124587036|NCT01968551|448107785|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
124587037|NCT01968551|448107786|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
124587038|NCT01968551|448107787|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
124587039|NCT01968551|448107785|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
124587040|NCT01968551|448107786|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
124587041|NCT01968551|448107787|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
124587042|NCT01968551|448107785|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
124587043|NCT01968551|448107786|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
124587044|NCT01968551|448107787|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
124587045|NCT01968551|448107785|FG000|Extension Phase|Adverse Event|0|||
124587046|NCT01968551|448107786|FG001|Extension Phase|Adverse Event|0|||
124587047|NCT01968551|448107787|FG002|Extension Phase|Adverse Event|2|||
124587048|NCT01968551|448107785|FG000|Extension Phase|Death|0|||
124587049|NCT01968551|448107786|FG001|Extension Phase|Death|1|||
124587050|NCT01968551|448107787|FG002|Extension Phase|Death|0|||
124587051|NCT01968551|448107785|FG000|Extension Phase|Withdrew Consent|0|||
124587052|NCT01968551|448107786|FG001|Extension Phase|Withdrew Consent|0|||
124587053|NCT01968551|448107787|FG002|Extension Phase|Withdrew Consent|1|||
124587054|NCT01968551|448107785|FG000|Extension Phase|Lost to Follow-up|1|||
124587055|NCT01968551|448107786|FG001|Extension Phase|Lost to Follow-up|0|||
124587056|NCT01968551|448107787|FG002|Extension Phase|Lost to Follow-up|1|||
124587057|NCT00573313|448107788|FG000|Overall Study|Protocol Violation|5|||
124587058|NCT00573313|448107789|FG001|Overall Study|Protocol Violation|0|||
124587059|NCT00573313|448107790|FG002|Overall Study|Protocol Violation|6|||
124532408|NCT02442765|447900149|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
124532409|NCT02442765|447900150|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
124532410|NCT02442765|447900151|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
124532411|NCT02442765|447900152|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
124532412|NCT02442765|447900153|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
124532413|NCT02442765|447900146|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
124532414|NCT02442765|447900147|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
124532415|NCT02442765|447900148|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
124532416|NCT02442765|447900149|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
124532417|NCT02442765|447900150|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
124532418|NCT02442765|447900151|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
124532419|NCT02442765|447900152|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
124532420|NCT02442765|447900153|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
124532421|NCT02442765|447900146|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
124532422|NCT02442765|447900147|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
124532423|NCT02442765|447900148|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
124532424|NCT02442765|447900149|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
124532425|NCT02442765|447900150|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
124532426|NCT02442765|447900151|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
124532427|NCT02442765|447900152|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
124532428|NCT02442765|447900153|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
124532429|NCT02442765|447900146|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
124532430|NCT02442765|447900147|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
124532431|NCT02442765|447900148|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
124532432|NCT02442765|447900149|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
124532433|NCT02442765|447900150|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
124532434|NCT02442765|447900151|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
124532435|NCT02442765|447900152|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
124532436|NCT02442765|447900153|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
124532437|NCT00887913|447900154|FG000|Overall Study|Withdrawal by Subject|6|||
124532438|NCT01371721|447900155|FG000|Overall Study|Adverse Event|5|||
124532439|NCT01371721|447900156|FG001|Overall Study|Adverse Event|4|||
124532440|NCT01371721|447900157|FG002|Overall Study|Adverse Event|5|||
124532441|NCT01371721|447900155|FG000|Overall Study|Protocol Violation|6|||
124532442|NCT01371721|447900156|FG001|Overall Study|Protocol Violation|4|||
124532443|NCT01371721|447900157|FG002|Overall Study|Protocol Violation|5|||
124532444|NCT01371721|447900155|FG000|Overall Study|Lost to Follow-up|8|||
124532445|NCT01371721|447900156|FG001|Overall Study|Lost to Follow-up|2|||
124532446|NCT01371721|447900157|FG002|Overall Study|Lost to Follow-up|6|||
124532447|NCT01371721|447900155|FG000|Overall Study|Withdrawal by Subject|5|||
124532448|NCT01371721|447900156|FG001|Overall Study|Withdrawal by Subject|7|||
124532449|NCT01371721|447900157|FG002|Overall Study|Withdrawal by Subject|11|||
124587060|NCT00573313|448107791|FG003|Overall Study|Protocol Violation|0|||
124587061|NCT03255980|448107794|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
124587062|NCT03255980|448107795|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
124587063|NCT03255980|448107796|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
124587064|NCT03255980|448107797|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
124587065|NCT03255980|448107794|FG000|Overall Study|Adverse Event|1|||
124587066|NCT03255980|448107795|FG001|Overall Study|Adverse Event|1|||
124587067|NCT03255980|448107796|FG002|Overall Study|Adverse Event|0|||
124532450|NCT01371721|447900155|FG000|Overall Study|Other|2|||
124532451|NCT01371721|447900156|FG001|Overall Study|Other|3|||
124532452|NCT01371721|447900157|FG002|Overall Study|Other|0|||
124532453|NCT01371721|447900155|FG000|Overall Study|Lack of Efficacy|2|||
124532454|NCT01371721|447900156|FG001|Overall Study|Lack of Efficacy|4|||
124532455|NCT01371721|447900157|FG002|Overall Study|Lack of Efficacy|3|||
124532456|NCT01371721|447900155|FG000|Overall Study|Randomized but not treated|1|||
124532457|NCT01371721|447900156|FG001|Overall Study|Randomized but not treated|0|||
124532458|NCT01371721|447900157|FG002|Overall Study|Randomized but not treated|0|||
124532459|NCT01200758|447900158|FG000|Stage I|Death|0|||
124532460|NCT01200758|447900159|FG001|Stage I|Death|1|||
124532461|NCT01200758|447900160|FG002|Stage I|Death|0|||
124532462|NCT01200758|447900161|FG003|Stage I|Death|0|||
124532463|NCT01200758|447900158|FG000|Stage I|Physician Decision|1|||
124532464|NCT01200758|447900159|FG001|Stage I|Physician Decision|1|||
124532465|NCT01200758|447900160|FG002|Stage I|Physician Decision|0|||
124532466|NCT01200758|447900161|FG003|Stage I|Physician Decision|0|||
124532467|NCT01200758|447900158|FG000|Stage I|Lack of Efficacy|2|||
124532468|NCT01200758|447900159|FG001|Stage I|Lack of Efficacy|1|||
124532469|NCT01200758|447900160|FG002|Stage I|Lack of Efficacy|0|||
124532470|NCT01200758|447900161|FG003|Stage I|Lack of Efficacy|0|||
124532471|NCT01200758|447900158|FG000|Stage I|Adverse Event|5|||
124532472|NCT01200758|447900159|FG001|Stage I|Adverse Event|5|||
124532473|NCT01200758|447900160|FG002|Stage I|Adverse Event|0|||
124532474|NCT01200758|447900161|FG003|Stage I|Adverse Event|0|||
124532475|NCT01200758|447900158|FG000|Stage I|Withdrawal by Subject|1|||
124532476|NCT01200758|447900159|FG001|Stage I|Withdrawal by Subject|2|||
124532477|NCT01200758|447900160|FG002|Stage I|Withdrawal by Subject|0|||
124532478|NCT01200758|447900161|FG003|Stage I|Withdrawal by Subject|0|||
124532479|NCT01200758|447900158|FG000|Stage I|Disease Progression|9|||
124532480|NCT01200758|447900159|FG001|Stage I|Disease Progression|7|||
124532481|NCT01200758|447900160|FG002|Stage I|Disease Progression|0|||
124532482|NCT01200758|447900161|FG003|Stage I|Disease Progression|0|||
124532483|NCT01200758|447900158|FG000|Stage 2|Disease Progression|0|||
124532484|NCT01200758|447900159|FG001|Stage 2|Disease Progression|0|||
124532485|NCT01200758|447900160|FG002|Stage 2|Disease Progression|16|||
124532486|NCT01200758|447900161|FG003|Stage 2|Disease Progression|21|||
124532487|NCT01200758|447900158|FG000|Stage 2|Lack of Efficacy|0|||
124532488|NCT01200758|447900159|FG001|Stage 2|Lack of Efficacy|0|||
124532489|NCT01200758|447900160|FG002|Stage 2|Lack of Efficacy|4|||
124532490|NCT01200758|447900161|FG003|Stage 2|Lack of Efficacy|2|||
124532491|NCT01200758|447900158|FG000|Stage 2|Physician Decision|0|||
124532492|NCT01200758|447900159|FG001|Stage 2|Physician Decision|0|||
124532493|NCT01200758|447900160|FG002|Stage 2|Physician Decision|5|||
124532494|NCT01200758|447900161|FG003|Stage 2|Physician Decision|7|||
124532495|NCT01200758|447900158|FG000|Stage 2|Adverse Event|0|||
124532496|NCT01200758|447900159|FG001|Stage 2|Adverse Event|0|||
124532497|NCT01200758|447900160|FG002|Stage 2|Adverse Event|5|||
124532498|NCT01200758|447900161|FG003|Stage 2|Adverse Event|9|||
124532499|NCT01200758|447900158|FG000|Stage 2|Withdrawal by Subject|0|||
124532500|NCT01200758|447900159|FG001|Stage 2|Withdrawal by Subject|0|||
124532501|NCT01200758|447900160|FG002|Stage 2|Withdrawal by Subject|4|||
124532502|NCT01200758|447900161|FG003|Stage 2|Withdrawal by Subject|1|||
124532503|NCT01200758|447900158|FG000|Stage 2|Lost to Follow-up|0|||
124532504|NCT01200758|447900159|FG001|Stage 2|Lost to Follow-up|0|||
124532505|NCT01200758|447900160|FG002|Stage 2|Lost to Follow-up|3|||
124532506|NCT01200758|447900161|FG003|Stage 2|Lost to Follow-up|1|||
124587068|NCT03255980|448107797|FG003|Overall Study|Adverse Event|1|||
124587069|NCT03255980|448107794|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
124587070|NCT03255980|448107795|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
124587071|NCT03255980|448107796|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
124587072|NCT03255980|448107797|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
124587073|NCT03255980|448107794|FG000|Overall Study|Lost to Follow-up|1|||
124587074|NCT03255980|448107795|FG001|Overall Study|Lost to Follow-up|1|||
124532507|NCT01200758|447900158|FG000|Stage 2|Protocol Violation|0|||
124532508|NCT01200758|447900159|FG001|Stage 2|Protocol Violation|0|||
124532509|NCT01200758|447900160|FG002|Stage 2|Protocol Violation|1|||
124532510|NCT01200758|447900161|FG003|Stage 2|Protocol Violation|4|||
124532511|NCT01200758|447900158|FG000|Stage 2|Death|0|||
124532512|NCT01200758|447900159|FG001|Stage 2|Death|0|||
124532513|NCT01200758|447900160|FG002|Stage 2|Death|3|||
124532514|NCT01200758|447900161|FG003|Stage 2|Death|5|||
124532515|NCT03196973|447900166|FG000|Overall Study|Adverse Event|1|||
124532516|NCT03196973|447900167|FG001|Overall Study|Adverse Event|1|||
124532517|NCT03196973|447900168|FG002|Overall Study|Adverse Event|2|||
124532518|NCT03196973|447900166|FG000|Overall Study|Lack of Efficacy|2|||
124532519|NCT03196973|447900167|FG001|Overall Study|Lack of Efficacy|6|||
124532520|NCT03196973|447900168|FG002|Overall Study|Lack of Efficacy|1|||
124532521|NCT03196973|447900166|FG000|Overall Study|Lost to Follow-up|4|||
124532522|NCT03196973|447900167|FG001|Overall Study|Lost to Follow-up|3|||
124532523|NCT03196973|447900168|FG002|Overall Study|Lost to Follow-up|2|||
124532524|NCT03196973|447900166|FG000|Overall Study|Consent withdrawn|2|||
124587075|NCT03255980|448107796|FG002|Overall Study|Lost to Follow-up|0|||
124777635|NCT02963506|448813097|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
124532525|NCT03196973|447900167|FG001|Overall Study|Consent withdrawn|1|||
124532526|NCT03196973|447900168|FG002|Overall Study|Consent withdrawn|0|||
124532527|NCT03196973|447900166|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
124532528|NCT03196973|447900167|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
124532529|NCT03196973|447900168|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
124532530|NCT01809327|447900169|FG000|Overall Study|Lost to Follow-up|5|||
124532531|NCT01809327|447900170|FG001|Overall Study|Lost to Follow-up|2|||
124532532|NCT01809327|447900171|FG002|Overall Study|Lost to Follow-up|4|||
124532533|NCT01809327|447900172|FG003|Overall Study|Lost to Follow-up|2|||
124532534|NCT01809327|447900173|FG004|Overall Study|Lost to Follow-up|3|||
124532535|NCT01809327|447900169|FG000|Overall Study|Withdrawal by Subject|6|||
124532536|NCT01809327|447900170|FG001|Overall Study|Withdrawal by Subject|4|||
124532537|NCT01809327|447900171|FG002|Overall Study|Withdrawal by Subject|4|||
124532538|NCT01809327|447900172|FG003|Overall Study|Withdrawal by Subject|2|||
124532539|NCT01809327|447900173|FG004|Overall Study|Withdrawal by Subject|5|||
124532540|NCT01809327|447900169|FG000|Overall Study|Adverse Event|4|||
124532541|NCT01809327|447900170|FG001|Overall Study|Adverse Event|3|||
124532542|NCT01809327|447900171|FG002|Overall Study|Adverse Event|7|||
124532543|NCT01809327|447900172|FG003|Overall Study|Adverse Event|4|||
124532544|NCT01809327|447900173|FG004|Overall Study|Adverse Event|8|||
124532545|NCT01809327|447900169|FG000|Overall Study|Death|1|||
124532546|NCT01809327|447900170|FG001|Overall Study|Death|0|||
124532547|NCT01809327|447900171|FG002|Overall Study|Death|0|||
124532548|NCT01809327|447900172|FG003|Overall Study|Death|0|||
124532549|NCT01809327|447900173|FG004|Overall Study|Death|0|||
124532550|NCT01809327|447900169|FG000|Overall Study|Protocol Violation|0|||
124532551|NCT01809327|447900170|FG001|Overall Study|Protocol Violation|1|||
124532552|NCT01809327|447900171|FG002|Overall Study|Protocol Violation|0|||
124532553|NCT01809327|447900172|FG003|Overall Study|Protocol Violation|0|||
124532554|NCT01809327|447900173|FG004|Overall Study|Protocol Violation|0|||
124532555|NCT01809327|447900169|FG000|Overall Study|Physician Decision|1|||
124532556|NCT01809327|447900170|FG001|Overall Study|Physician Decision|1|||
124532557|NCT01809327|447900171|FG002|Overall Study|Physician Decision|0|||
124532558|NCT01809327|447900172|FG003|Overall Study|Physician Decision|0|||
124532559|NCT01809327|447900173|FG004|Overall Study|Physician Decision|0|||
124532560|NCT01809327|447900169|FG000|Overall Study|Pregnancy|1|||
124532561|NCT01809327|447900170|FG001|Overall Study|Pregnancy|0|||
124532562|NCT01809327|447900171|FG002|Overall Study|Pregnancy|0|||
124532563|NCT01809327|447900172|FG003|Overall Study|Pregnancy|0|||
124532564|NCT01809327|447900173|FG004|Overall Study|Pregnancy|0|||
124532565|NCT01809327|447900169|FG000|Overall Study|Other|14|||
124532566|NCT01809327|447900170|FG001|Overall Study|Other|15|||
124532567|NCT01809327|447900171|FG002|Overall Study|Other|7|||
124532568|NCT01809327|447900172|FG003|Overall Study|Other|4|||
124532569|NCT01809327|447900173|FG004|Overall Study|Other|9|||
124532570|NCT02390362|447900176|FG000|Overall Study|Withdrawal by Subject|0|||
124532571|NCT02390362|447900177|FG001|Overall Study|Withdrawal by Subject|1|||
124532572|NCT04009824|447900178|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
124532573|NCT04009824|447900179|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
124532574|NCT04009824|447900180|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
124532575|NCT04009824|447900181|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
124532576|NCT04009824|447900182|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
124532577|NCT01142791|447900185|FG000|Overall Study|Alternative Treatment|1|||
124532578|NCT01142791|447900186|FG001|Overall Study|Alternative Treatment|0|||
124532579|NCT01142791|447900185|FG000|Overall Study|Lost to Follow-up|1|||
124532580|NCT01142791|447900186|FG001|Overall Study|Lost to Follow-up|0|||
124532581|NCT01142791|447900185|FG000|Overall Study|Withdrawal by Subject|5|||
124532582|NCT01142791|447900186|FG001|Overall Study|Withdrawal by Subject|0|||
124532583|NCT01142791|447900185|FG000|Overall Study|Received only 1 sonication|0|||
124532584|NCT01142791|447900186|FG001|Overall Study|Received only 1 sonication|6|||
124532585|NCT03032523|447900189|FG000|Overall Study|Withdrawal by Subject|2|||
124532586|NCT03032523|447900190|FG001|Overall Study|Withdrawal by Subject|2|||
124532587|NCT03032523|447900189|FG000|Overall Study|Physician Decision|1|||
124532588|NCT03032523|447900190|FG001|Overall Study|Physician Decision|0|||
124532589|NCT00957723|447900191|FG000|Overall Study|Death|3|||
124532590|NCT00957723|447900191|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
124532591|NCT00957723|447900191|FG000|Overall Study|Lost to Follow-up|8|||
124587076|NCT03255980|448107797|FG003|Overall Study|Lost to Follow-up|3|||
124532592|NCT00957723|447900191|FG000|Overall Study|Withdrawal by Subject|24|||
124532593|NCT00957723|447900191|FG000|Overall Study|Investigative Site Terminated|61|||
124532594|NCT00957723|447900191|FG000|Overall Study|Intercurrent Illness|2|||
124532595|NCT00957723|447900191|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
124532596|NCT00281528|447900192|FG000|Overall Study|Progressive Disease|28|||
124532597|NCT00281528|447900193|FG001|Overall Study|Progressive Disease|18|||
124532598|NCT00281528|447900194|FG002|Overall Study|Progressive Disease|27|||
124532599|NCT00281528|447900192|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
124532600|NCT00281528|447900193|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
124532601|NCT00281528|447900194|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
124532602|NCT00281528|447900192|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
124532603|NCT00281528|447900193|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
124532604|NCT00281528|447900194|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
124532605|NCT00281528|447900192|FG000|Overall Study|Physician Decision|11|||
124532606|NCT00281528|447900193|FG001|Overall Study|Physician Decision|4|||
124532607|NCT00281528|447900194|FG002|Overall Study|Physician Decision|5|||
124532608|NCT00281528|447900192|FG000|Overall Study|Protocol Violation|1|||
124532609|NCT00281528|447900193|FG001|Overall Study|Protocol Violation|0|||
124532610|NCT00281528|447900194|FG002|Overall Study|Protocol Violation|1|||
124532611|NCT00281528|447900192|FG000|Overall Study|Withdrawal by Subject|5|||
124532612|NCT00281528|447900193|FG001|Overall Study|Withdrawal by Subject|5|||
124532613|NCT00281528|447900194|FG002|Overall Study|Withdrawal by Subject|7|||
124532614|NCT00281528|447900192|FG000|Overall Study|Other|6|||
124532615|NCT00281528|447900193|FG001|Overall Study|Other|3|||
124532616|NCT00281528|447900194|FG002|Overall Study|Other|5|||
124532617|NCT01984294|447900202|FG000|Overall Study|Randomized but Never Treated|0|||
124532618|NCT01984294|447900203|FG001|Overall Study|Randomized but Never Treated|0|||
124532619|NCT01984294|447900204|FG002|Overall Study|Randomized but Never Treated|1|||
124532620|NCT01984294|447900202|FG000|Overall Study|Lack of Efficacy|4|||
124532621|NCT01984294|447900203|FG001|Overall Study|Lack of Efficacy|2|||
124532622|NCT01984294|447900204|FG002|Overall Study|Lack of Efficacy|6|||
124532623|NCT01984294|447900202|FG000|Overall Study|Adverse Event|0|||
124532624|NCT01984294|447900203|FG001|Overall Study|Adverse Event|1|||
124532625|NCT01984294|447900204|FG002|Overall Study|Adverse Event|0|||
124532626|NCT01987609|447900205|FG000|Overall Study|Adverse Event|1|||
124532627|NCT00806494|447900206|FG000|Overall Study|Adverse Event|29|||
124532628|NCT00806494|447900206|FG000|Overall Study|Lack of Efficacy|6|||
124532629|NCT00806494|447900206|FG000|Overall Study|Lost to Follow-up|10|||
124532630|NCT00806494|447900206|FG000|Overall Study|Other|30|||
124532631|NCT00806494|447900206|FG000|Overall Study|Withdrawal by Subject|5|||
124532632|NCT02610231|447900207|FG000|Overall Study|Withdrawal by Subject|27|||
124532633|NCT02610231|447900207|FG000|Overall Study|Adverse Event|20|||
124532634|NCT02610231|447900207|FG000|Overall Study|Death|5|||
124532635|NCT02610231|447900207|FG000|Overall Study|Surgery|2|||
124532636|NCT02610231|447900207|FG000|Overall Study|Physician Decision|1|||
124532637|NCT02610231|447900207|FG000|Overall Study|Non Compliance|2|||
124532638|NCT02610231|447900207|FG000|Overall Study|Other|3|||
124532639|NCT01279954|447900208|FG000|Overall Study|Lack of Efficacy|3|||
124532640|NCT01279954|447900209|FG001|Overall Study|Lack of Efficacy|4|||
124532641|NCT02709889|447900210|FG000|Overall Study|Withdrawal by Subject|11|||
124532642|NCT02709889|447900211|FG001|Overall Study|Withdrawal by Subject|10|||
124532643|NCT02709889|447900212|FG002|Overall Study|Withdrawal by Subject|2|||
124532644|NCT02709889|447900213|FG003|Overall Study|Withdrawal by Subject|12|||
124532645|NCT02709889|447900210|FG000|Overall Study|Death|25|||
124532646|NCT02709889|447900211|FG001|Overall Study|Death|38|||
124532647|NCT02709889|447900212|FG002|Overall Study|Death|4|||
124532648|NCT02709889|447900213|FG003|Overall Study|Death|44|||
124532649|NCT02709889|447900210|FG000|Overall Study|Physician Decision|1|||
124532650|NCT02709889|447900211|FG001|Overall Study|Physician Decision|2|||
124532651|NCT02709889|447900212|FG002|Overall Study|Physician Decision|3|||
124532652|NCT02709889|447900213|FG003|Overall Study|Physician Decision|5|||
124532653|NCT02709889|447900210|FG000|Overall Study|Lost to Follow-up|2|||
124532654|NCT02709889|447900211|FG001|Overall Study|Lost to Follow-up|0|||
124532655|NCT02709889|447900212|FG002|Overall Study|Lost to Follow-up|0|||
124532656|NCT02709889|447900213|FG003|Overall Study|Lost to Follow-up|4|||
124532657|NCT02709889|447900210|FG000|Overall Study|Study Terminated by Sponsor|4|||
124532658|NCT02709889|447900211|FG001|Overall Study|Study Terminated by Sponsor|6|||
124532659|NCT02709889|447900212|FG002|Overall Study|Study Terminated by Sponsor|2|||
124532660|NCT02709889|447900213|FG003|Overall Study|Study Terminated by Sponsor|17|||
124532661|NCT02709889|447900210|FG000|Overall Study|Other, Not Specified|0|||
124532662|NCT02709889|447900211|FG001|Overall Study|Other, Not Specified|1|||
124532663|NCT02709889|447900212|FG002|Overall Study|Other, Not Specified|1|||
124532664|NCT02709889|447900213|FG003|Overall Study|Other, Not Specified|6|||
124532665|NCT00537810|447900214|FG000|Overall Study|Withdrawal by Subject|4|||
124532666|NCT00537810|447900215|FG001|Overall Study|Withdrawal by Subject|11|||
124532667|NCT00537810|447900216|FG002|Overall Study|Withdrawal by Subject|4|||
124532668|NCT00537810|447900217|FG003|Overall Study|Withdrawal by Subject|3|||
124532669|NCT00537810|447900214|FG000|Overall Study|Medically withdrawn|2|||
124532670|NCT00537810|447900215|FG001|Overall Study|Medically withdrawn|2|||
124532671|NCT00537810|447900216|FG002|Overall Study|Medically withdrawn|0|||
124532672|NCT00537810|447900217|FG003|Overall Study|Medically withdrawn|1|||
124532673|NCT01066546|447900218|FG000|Overall Study|Study terminated by sponsor|5|||
124532674|NCT03258762|447900219|FG000|Overall Study|Lost to Follow-up|0|||
124532675|NCT03258762|447900220|FG001|Overall Study|Lost to Follow-up|1|||
124532676|NCT01711359|447900221|FG000|Treatment Period|Withdrawal by Subject|18|||
124532677|NCT01711359|447900222|FG001|Treatment Period|Withdrawal by Subject|7|||
124532678|NCT01711359|447900223|FG002|Treatment Period|Withdrawal by Subject|13|||
124532679|NCT01711359|447900221|FG000|Treatment Period|Lack of Efficacy|13|||
124532680|NCT01711359|447900222|FG001|Treatment Period|Lack of Efficacy|2|||
124532681|NCT01711359|447900223|FG002|Treatment Period|Lack of Efficacy|2|||
124532682|NCT01711359|447900221|FG000|Treatment Period|Adverse Event|8|||
124532683|NCT01711359|447900222|FG001|Treatment Period|Adverse Event|10|||
124532684|NCT01711359|447900223|FG002|Treatment Period|Adverse Event|24|||
124532685|NCT01711359|447900221|FG000|Treatment Period|Physician Decision|4|||
124532686|NCT01711359|447900222|FG001|Treatment Period|Physician Decision|3|||
124532687|NCT01711359|447900223|FG002|Treatment Period|Physician Decision|2|||
124532688|NCT01711359|447900221|FG000|Treatment Period|Death|3|||
124532689|NCT01711359|447900222|FG001|Treatment Period|Death|0|||
124532690|NCT01711359|447900223|FG002|Treatment Period|Death|0|||
124532691|NCT01711359|447900221|FG000|Treatment Period|Entry Criteria Not Met|1|||
124532692|NCT01711359|447900222|FG001|Treatment Period|Entry Criteria Not Met|0|||
124532693|NCT01711359|447900223|FG002|Treatment Period|Entry Criteria Not Met|0|||
124532694|NCT01711359|447900221|FG000|Treatment Period|Sponsor Decision|1|||
124532695|NCT01711359|447900222|FG001|Treatment Period|Sponsor Decision|0|||
124532696|NCT01711359|447900223|FG002|Treatment Period|Sponsor Decision|0|||
124532697|NCT01711359|447900221|FG000|Treatment Period|Lost to Follow-up|1|||
124532698|NCT01711359|447900222|FG001|Treatment Period|Lost to Follow-up|1|||
124532699|NCT01711359|447900223|FG002|Treatment Period|Lost to Follow-up|1|||
124532700|NCT01711359|447900221|FG000|Treatment Period|Randomized, Not Treated|3|||
124532701|NCT01711359|447900222|FG001|Treatment Period|Randomized, Not Treated|1|||
124532702|NCT01711359|447900223|FG002|Treatment Period|Randomized, Not Treated|0|||
124532703|NCT02698176|447900224|FG000|Overall Study|Progressive disease|4|||
124532704|NCT02698176|447900225|FG001|Overall Study|Progressive disease|3|||
124532705|NCT02698176|447900226|FG002|Overall Study|Progressive disease|1|||
124532706|NCT02698176|447900227|FG003|Overall Study|Progressive disease|0|||
124532707|NCT02698176|447900224|FG000|Overall Study|Adverse Event|2|||
124532708|NCT02698176|447900225|FG001|Overall Study|Adverse Event|0|||
124532709|NCT02698176|447900226|FG002|Overall Study|Adverse Event|0|||
124532710|NCT02698176|447900227|FG003|Overall Study|Adverse Event|0|||
124532711|NCT02698176|447900224|FG000|Overall Study|Clinical progression|3|||
124532712|NCT02698176|447900225|FG001|Overall Study|Clinical progression|0|||
124532713|NCT02698176|447900226|FG002|Overall Study|Clinical progression|0|||
124532714|NCT02698176|447900227|FG003|Overall Study|Clinical progression|0|||
124532715|NCT02561572|447900234|FG000|Overall Study|Inadequate time before surgery|2|||
124532716|NCT02561572|447900235|FG001|Overall Study|Inadequate time before surgery|1|||
124532717|NCT02561572|447900234|FG000|Overall Study|Protocol Violation|0|||
124532718|NCT02561572|447900235|FG001|Overall Study|Protocol Violation|1|||
124532719|NCT00795717|447900236|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
124532720|NCT00795717|447900237|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
124532721|NCT00795717|447900236|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
124532722|NCT00795717|447900237|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
124532723|NCT00795717|447900236|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
124532724|NCT00795717|447900237|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
124532725|NCT00795717|447900236|FG000|Phase II|too busy|0|||
124532726|NCT00795717|447900237|FG001|Phase II|too busy|1|||
124532727|NCT00424463|447900244|FG000|Overall Study|Adverse Event|2|||
124532728|NCT00424463|447900245|FG001|Overall Study|Adverse Event|3|||
124532729|NCT00424463|447900246|FG002|Overall Study|Adverse Event|2|||
124532730|NCT00424463|447900244|FG000|Overall Study|Physician Decision|0|||
124532731|NCT00424463|447900245|FG001|Overall Study|Physician Decision|2|||
124532732|NCT00424463|447900246|FG002|Overall Study|Physician Decision|2|||
124532733|NCT00424463|447900244|FG000|Overall Study|Withdrawal by Subject|4|||
124532734|NCT00424463|447900245|FG001|Overall Study|Withdrawal by Subject|2|||
124532735|NCT00424463|447900246|FG002|Overall Study|Withdrawal by Subject|5|||
124532736|NCT00424463|447900244|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
124532737|NCT00424463|447900245|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
124532738|NCT00424463|447900246|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
124532739|NCT00424463|447900244|FG000|Overall Study|Patient's convenience|0|||
124532740|NCT00424463|447900245|FG001|Overall Study|Patient's convenience|0|||
124532741|NCT00424463|447900246|FG002|Overall Study|Patient's convenience|1|||
124532742|NCT04728815|447900254|FG000|Overall Study|Lost to Follow-up|3|||
124532743|NCT04728815|447900255|FG001|Overall Study|Lost to Follow-up|0|||
124532744|NCT04728815|447900256|FG002|Overall Study|Lost to Follow-up|0|||
124532745|NCT04728815|447900257|FG003|Overall Study|Lost to Follow-up|1|||
124532746|NCT04728815|447900258|FG004|Overall Study|Lost to Follow-up|1|||
124532747|NCT04728815|447900259|FG005|Overall Study|Lost to Follow-up|0|||
124532748|NCT04728815|447900260|FG006|Overall Study|Lost to Follow-up|2|||
124532749|NCT04728815|447900261|FG007|Overall Study|Lost to Follow-up|0|||
124532750|NCT04728815|447900254|FG000|Overall Study|Physician Decision|0|||
124532751|NCT04728815|447900255|FG001|Overall Study|Physician Decision|0|||
124532752|NCT04728815|447900256|FG002|Overall Study|Physician Decision|1|||
124532753|NCT04728815|447900257|FG003|Overall Study|Physician Decision|0|||
124532754|NCT04728815|447900258|FG004|Overall Study|Physician Decision|0|||
124532755|NCT04728815|447900259|FG005|Overall Study|Physician Decision|0|||
124532756|NCT04728815|447900260|FG006|Overall Study|Physician Decision|0|||
124587077|NCT03255980|448107794|FG000|Overall Study|Withdrawal by Subject|0|||
124587078|NCT03255980|448107795|FG001|Overall Study|Withdrawal by Subject|1|||
124587079|NCT03255980|448107796|FG002|Overall Study|Withdrawal by Subject|0|||
124587080|NCT03255980|448107797|FG003|Overall Study|Withdrawal by Subject|3|||
124587081|NCT01597791|448107798|FG000|Overall Study|Physician Decision|2|||
124587082|NCT01597791|448107799|FG001|Overall Study|Physician Decision|1|||
124587083|NCT01597791|448107798|FG000|Overall Study|Cesarean Section|6|||
124587084|NCT01597791|448107799|FG001|Overall Study|Cesarean Section|7|||
124587085|NCT01597791|448107798|FG000|Overall Study|Subject withdrawal|0|||
124587086|NCT01597791|448107799|FG001|Overall Study|Subject withdrawal|1|||
124532757|NCT04728815|447900261|FG007|Overall Study|Physician Decision|0|||
124532758|NCT04728815|447900254|FG000|Overall Study|Treatment drop|0|||
124532759|NCT04728815|447900255|FG001|Overall Study|Treatment drop|2|||
124532760|NCT04728815|447900256|FG002|Overall Study|Treatment drop|1|||
124532761|NCT04728815|447900257|FG003|Overall Study|Treatment drop|0|||
124532762|NCT04728815|447900258|FG004|Overall Study|Treatment drop|3|||
124532763|NCT04728815|447900259|FG005|Overall Study|Treatment drop|1|||
124532764|NCT04728815|447900260|FG006|Overall Study|Treatment drop|3|||
124532765|NCT04728815|447900261|FG007|Overall Study|Treatment drop|0|||
124532766|NCT04728815|447900254|FG000|Overall Study|Study drop|0|||
124532767|NCT04728815|447900255|FG001|Overall Study|Study drop|3|||
124532768|NCT04728815|447900256|FG002|Overall Study|Study drop|3|||
124532769|NCT04728815|447900257|FG003|Overall Study|Study drop|0|||
124532770|NCT04728815|447900258|FG004|Overall Study|Study drop|0|||
124532771|NCT04728815|447900259|FG005|Overall Study|Study drop|0|||
124532772|NCT04728815|447900260|FG006|Overall Study|Study drop|7|||
124532773|NCT04728815|447900261|FG007|Overall Study|Study drop|0|||
124532774|NCT00631969|447900262|FG000|Overall Study|Adverse Event|3|||
124532775|NCT00631969|447900263|FG001|Overall Study|Adverse Event|1|||
124532776|NCT00631969|447900262|FG000|Overall Study|Lack of Efficacy|2|||
124532777|NCT00631969|447900263|FG001|Overall Study|Lack of Efficacy|8|||
124532778|NCT00631969|447900262|FG000|Overall Study|Lost to Follow-up|2|||
124532779|NCT00631969|447900263|FG001|Overall Study|Lost to Follow-up|1|||
124532780|NCT00631969|447900262|FG000|Overall Study|Protocol Violation|1|||
124532781|NCT00631969|447900263|FG001|Overall Study|Protocol Violation|1|||
124532782|NCT00631969|447900262|FG000|Overall Study|Consent Withdrawn|5|||
124532783|NCT00631969|447900263|FG001|Overall Study|Consent Withdrawn|7|||
124532784|NCT00631969|447900262|FG000|Overall Study|Noncompliant With Study Medication|0|||
124532785|NCT00631969|447900263|FG001|Overall Study|Noncompliant With Study Medication|1|||
124532786|NCT00631969|447900262|FG000|Overall Study|No Drug Exposure|2|||
124532787|NCT00631969|447900263|FG001|Overall Study|No Drug Exposure|2|||
124532788|NCT00957034|447900264|FG000|Overall Study|Adverse Event|0|||
124532789|NCT00957034|447900265|FG001|Overall Study|Adverse Event|1|||
124532790|NCT00957034|447900266|FG002|Overall Study|Adverse Event|1|||
124532791|NCT00957034|447900264|FG000|Overall Study|Sponsor Terminated Study|6|||
124532792|NCT00957034|447900265|FG001|Overall Study|Sponsor Terminated Study|1|||
124532793|NCT00957034|447900266|FG002|Overall Study|Sponsor Terminated Study|5|||
124532794|NCT00957034|447900264|FG000|Overall Study|Withdrawal by Subject|0|||
124532795|NCT00957034|447900265|FG001|Overall Study|Withdrawal by Subject|2|||
124532796|NCT00957034|447900266|FG002|Overall Study|Withdrawal by Subject|0|||
124587087|NCT01597791|448107798|FG000|Overall Study|Protocol Violation|0|||
124587088|NCT01597791|448107799|FG001|Overall Study|Protocol Violation|1|||
124587089|NCT02096705|448107804|FG000|Treatment|Adverse Event|6|||
124587090|NCT02096705|448107805|FG001|Treatment|Adverse Event|3|||
124587091|NCT02096705|448107804|FG000|Treatment|Subject request to discontinue treatment|1|||
124587092|NCT02096705|448107805|FG001|Treatment|Subject request to discontinue treatment|1|||
124587093|NCT02096705|448107804|FG000|Treatment|Withdrawal by Subject|1|||
124587094|NCT02096705|448107805|FG001|Treatment|Withdrawal by Subject|0|||
124587095|NCT02096705|448107804|FG000|Treatment|Other|1|||
124587096|NCT02096705|448107805|FG001|Treatment|Other|1|||
124587097|NCT02096705|448107804|FG000|Follow-up|Withdrawal by Subject|1|||
124587098|NCT02096705|448107805|FG001|Follow-up|Withdrawal by Subject|0|||
124587099|NCT02096705|448107804|FG000|Follow-up|Adverse Event|2|||
124587100|NCT02096705|448107805|FG001|Follow-up|Adverse Event|2|||
124587101|NCT02096705|448107804|FG000|Follow-up|Subjects not reporting status|1|||
124587102|NCT02096705|448107805|FG001|Follow-up|Subjects not reporting status|2|||
124587103|NCT01949532|448107806|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
124587104|NCT01949532|448107807|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
124587105|NCT00884390|448107808|FG000|Overall Study|Adverse Event|0|||
124587106|NCT00884390|448107809|FG001|Overall Study|Adverse Event|1|||
124587107|NCT00884390|448107808|FG000|Overall Study|Lost to Follow-up|0|||
124587108|NCT00884390|448107809|FG001|Overall Study|Lost to Follow-up|1|||
124587109|NCT00884390|448107808|FG000|Overall Study|Physician Decision|2|||
124587110|NCT00884390|448107809|FG001|Overall Study|Physician Decision|1|||
124587111|NCT00884390|448107808|FG000|Overall Study|Protocol Violation|4|||
124587112|NCT00884390|448107809|FG001|Overall Study|Protocol Violation|1|||
124587113|NCT00884390|448107808|FG000|Overall Study|Withdrawal by Subject|4|||
124587114|NCT00884390|448107809|FG001|Overall Study|Withdrawal by Subject|1|||
124587115|NCT00884390|448107808|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
124587116|NCT00884390|448107809|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
124587117|NCT00884390|448107808|FG000|Overall Study|Other|11|||
124587118|NCT00884390|448107809|FG001|Overall Study|Other|1|||
124587119|NCT05412121|448107810|FG000|Overall Study|Withdrawal by Subject|4|||
124587120|NCT05412121|448107810|FG000|Overall Study|Physician Decision|1|||
124587121|NCT05412121|448107810|FG000|Overall Study|Lost to Follow-up|5|||
124587122|NCT02670551|448107814|FG000|Overall Study|Adverse Event|4|||
124587123|NCT02670551|448107815|FG001|Overall Study|Adverse Event|7|||
124777636|NCT02963506|448813098|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
124587124|NCT02670551|448107816|FG002|Overall Study|Adverse Event|9|||
124587125|NCT02670551|448107814|FG000|Overall Study|Lack of Efficacy|2|||
124587126|NCT02670551|448107815|FG001|Overall Study|Lack of Efficacy|0|||
124587127|NCT02670551|448107816|FG002|Overall Study|Lack of Efficacy|3|||
124587128|NCT02670551|448107814|FG000|Overall Study|Withdrawal of Consent|6|||
124587129|NCT02670551|448107815|FG001|Overall Study|Withdrawal of Consent|3|||
124587130|NCT02670551|448107816|FG002|Overall Study|Withdrawal of Consent|8|||
124587131|NCT02670551|448107814|FG000|Overall Study|Lost to Follow-up|5|||
124587132|NCT02670551|448107815|FG001|Overall Study|Lost to Follow-up|7|||
124587133|NCT02670551|448107816|FG002|Overall Study|Lost to Follow-up|6|||
124587134|NCT02670551|448107814|FG000|Overall Study|Protocol Violation|1|||
124587135|NCT02670551|448107815|FG001|Overall Study|Protocol Violation|0|||
124587136|NCT02670551|448107816|FG002|Overall Study|Protocol Violation|0|||
124587137|NCT02670551|448107814|FG000|Overall Study|Noncompliance with study drug|3|||
124587138|NCT02670551|448107815|FG001|Overall Study|Noncompliance with study drug|3|||
124587139|NCT02670551|448107816|FG002|Overall Study|Noncompliance with study drug|2|||
124587140|NCT02670551|448107814|FG000|Overall Study|Other Miscellaneous Reasons|2|||
124587141|NCT02670551|448107815|FG001|Overall Study|Other Miscellaneous Reasons|3|||
124587142|NCT02670551|448107816|FG002|Overall Study|Other Miscellaneous Reasons|3|||
124587143|NCT02670551|448107814|FG000|Overall Study|Did Not Receive Treatment|5|||
124587144|NCT02670551|448107815|FG001|Overall Study|Did Not Receive Treatment|3|||
124587145|NCT02670551|448107816|FG002|Overall Study|Did Not Receive Treatment|0|||
124587146|NCT02611323|448107817|FG000|Overall Study|Death|3|||
124587147|NCT02611323|448107818|FG001|Overall Study|Death|1|||
124587148|NCT02611323|448107819|FG002|Overall Study|Death|0|||
124587149|NCT02611323|448107820|FG003|Overall Study|Death|0|||
124587150|NCT02611323|448107821|FG004|Overall Study|Death|1|||
124587151|NCT02611323|448107822|FG005|Overall Study|Death|1|||
124587152|NCT02611323|448107823|FG006|Overall Study|Death|8|||
124587153|NCT02611323|448107824|FG007|Overall Study|Death|0|||
124587154|NCT02611323|448107825|FG008|Overall Study|Death|4|||
124587155|NCT02611323|448107826|FG009|Overall Study|Death|6|||
124587156|NCT02611323|448107827|FG010|Overall Study|Death|26|||
124587157|NCT02611323|448107817|FG000|Overall Study|Lost to Follow-up|1|||
124587158|NCT02611323|448107818|FG001|Overall Study|Lost to Follow-up|0|||
124587159|NCT02611323|448107819|FG002|Overall Study|Lost to Follow-up|0|||
124587160|NCT02611323|448107820|FG003|Overall Study|Lost to Follow-up|0|||
124587161|NCT02611323|448107821|FG004|Overall Study|Lost to Follow-up|0|||
124587162|NCT02611323|448107822|FG005|Overall Study|Lost to Follow-up|0|||
124587163|NCT02611323|448107823|FG006|Overall Study|Lost to Follow-up|3|||
124587164|NCT02611323|448107824|FG007|Overall Study|Lost to Follow-up|0|||
124587165|NCT02611323|448107825|FG008|Overall Study|Lost to Follow-up|0|||
124587166|NCT02611323|448107826|FG009|Overall Study|Lost to Follow-up|0|||
124587167|NCT02611323|448107827|FG010|Overall Study|Lost to Follow-up|2|||
124587168|NCT02611323|448107817|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
124587169|NCT02611323|448107818|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
124587170|NCT02611323|448107819|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
124587171|NCT02611323|448107820|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
124587172|NCT02611323|448107821|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
124587173|NCT02611323|448107822|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
124587174|NCT02611323|448107823|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
124587175|NCT02611323|448107824|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
124587176|NCT02611323|448107825|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
124777637|NCT02963506|448813099|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
124587177|NCT02611323|448107826|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
124777638|NCT02963506|448813100|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
124777639|NCT02963506|448813101|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
124777640|NCT02963506|448813102|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
124587178|NCT02611323|448107827|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
124587179|NCT02611323|448107817|FG000|Overall Study|Progressive Disease|0|||
124587180|NCT02611323|448107818|FG001|Overall Study|Progressive Disease|0|||
124587181|NCT02611323|448107819|FG002|Overall Study|Progressive Disease|0|||
124587182|NCT02611323|448107820|FG003|Overall Study|Progressive Disease|0|||
124587183|NCT02611323|448107821|FG004|Overall Study|Progressive Disease|0|||
124587184|NCT02611323|448107822|FG005|Overall Study|Progressive Disease|0|||
124587185|NCT02611323|448107823|FG006|Overall Study|Progressive Disease|0|||
124587186|NCT02611323|448107824|FG007|Overall Study|Progressive Disease|0|||
124587187|NCT02611323|448107825|FG008|Overall Study|Progressive Disease|0|||
124587188|NCT02611323|448107826|FG009|Overall Study|Progressive Disease|0|||
124587189|NCT02611323|448107827|FG010|Overall Study|Progressive Disease|1|||
124587190|NCT02611323|448107817|FG000|Overall Study|Withdrawal by Subject|1|||
124587191|NCT02611323|448107818|FG001|Overall Study|Withdrawal by Subject|0|||
124587192|NCT02611323|448107819|FG002|Overall Study|Withdrawal by Subject|0|||
124587193|NCT02611323|448107820|FG003|Overall Study|Withdrawal by Subject|0|||
124587194|NCT02611323|448107821|FG004|Overall Study|Withdrawal by Subject|0|||
124587195|NCT02611323|448107822|FG005|Overall Study|Withdrawal by Subject|0|||
124587196|NCT02611323|448107823|FG006|Overall Study|Withdrawal by Subject|0|||
124587197|NCT02611323|448107824|FG007|Overall Study|Withdrawal by Subject|1|||
124587198|NCT02611323|448107825|FG008|Overall Study|Withdrawal by Subject|0|||
124587199|NCT02611323|448107826|FG009|Overall Study|Withdrawal by Subject|1|||
124587200|NCT02611323|448107827|FG010|Overall Study|Withdrawal by Subject|0|||
124587201|NCT01215721|448107828|FG000|Overall Study|Adverse Event|2|||
124587202|NCT00045162|448107829|FG000|Overall Study|Ineligible|12|||
124587203|NCT00045162|448107830|FG001|Overall Study|Ineligible|8|||
124587204|NCT00045162|448107829|FG000|Overall Study|Not treated|7|||
124587205|NCT00045162|448107830|FG001|Overall Study|Not treated|2|||
124587206|NCT00045162|448107829|FG000|Overall Study|Adverse Event|55|||
124587207|NCT00045162|448107830|FG001|Overall Study|Adverse Event|50|||
124587208|NCT00045162|448107829|FG000|Overall Study|Lack of Efficacy|32|||
124587209|NCT00045162|448107830|FG001|Overall Study|Lack of Efficacy|29|||
124587210|NCT00045162|448107829|FG000|Overall Study|Death|10|||
124587211|NCT00045162|448107830|FG001|Overall Study|Death|10|||
124587212|NCT00045162|448107829|FG000|Overall Study|Withdrawal by Subject|5|||
124587213|NCT00045162|448107830|FG001|Overall Study|Withdrawal by Subject|3|||
124587214|NCT00045162|448107829|FG000|Overall Study|Other|21|||
124587215|NCT00045162|448107830|FG001|Overall Study|Other|16|||
124587216|NCT01899053|448107831|FG000|Overall Study|Progressive Disease|4|||
124587217|NCT01899053|448107832|FG001|Overall Study|Progressive Disease|0|||
124587218|NCT01899053|448107833|FG002|Overall Study|Progressive Disease|3|||
124587219|NCT01899053|448107834|FG003|Overall Study|Progressive Disease|0|||
124587220|NCT01899053|448107835|FG004|Overall Study|Progressive Disease|3|||
124587221|NCT01899053|448107836|FG005|Overall Study|Progressive Disease|1|||
124587222|NCT01899053|448107837|FG006|Overall Study|Progressive Disease|1|||
124587223|NCT01899053|448107838|FG007|Overall Study|Progressive Disease|1|||
124587224|NCT01899053|448107839|FG008|Overall Study|Progressive Disease|4|||
124587225|NCT01899053|448107840|FG009|Overall Study|Progressive Disease|3|||
124587226|NCT01899053|448107841|FG010|Overall Study|Progressive Disease|12|||
124587227|NCT01899053|448107842|FG011|Overall Study|Progressive Disease|5|||
124587228|NCT01899053|448107843|FG012|Overall Study|Progressive Disease|8|||
124587229|NCT01899053|448107844|FG013|Overall Study|Progressive Disease|17|||
124587230|NCT01899053|448107831|FG000|Overall Study|Adverse Event|1|||
124587231|NCT01899053|448107832|FG001|Overall Study|Adverse Event|1|||
124587232|NCT01899053|448107833|FG002|Overall Study|Adverse Event|1|||
124587233|NCT01899053|448107834|FG003|Overall Study|Adverse Event|3|||
124587234|NCT01899053|448107835|FG004|Overall Study|Adverse Event|1|||
124587235|NCT01899053|448107836|FG005|Overall Study|Adverse Event|1|||
124587236|NCT01899053|448107837|FG006|Overall Study|Adverse Event|1|||
124587237|NCT01899053|448107838|FG007|Overall Study|Adverse Event|0|||
124587238|NCT01899053|448107839|FG008|Overall Study|Adverse Event|2|||
124587239|NCT01899053|448107840|FG009|Overall Study|Adverse Event|0|||
124777641|NCT02963506|448813103|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
124587240|NCT01899053|448107841|FG010|Overall Study|Adverse Event|3|||
124587241|NCT01899053|448107842|FG011|Overall Study|Adverse Event|1|||
124587242|NCT01899053|448107843|FG012|Overall Study|Adverse Event|2|||
124587243|NCT01899053|448107844|FG013|Overall Study|Adverse Event|2|||
124587244|NCT01899053|448107831|FG000|Overall Study|Reason Not Specified|0|||
124587245|NCT01899053|448107832|FG001|Overall Study|Reason Not Specified|0|||
124587246|NCT01899053|448107833|FG002|Overall Study|Reason Not Specified|0|||
124587247|NCT01899053|448107834|FG003|Overall Study|Reason Not Specified|0|||
124587248|NCT01899053|448107835|FG004|Overall Study|Reason Not Specified|0|||
124587249|NCT01899053|448107836|FG005|Overall Study|Reason Not Specified|0|||
124587250|NCT01899053|448107837|FG006|Overall Study|Reason Not Specified|1|||
124587251|NCT01899053|448107838|FG007|Overall Study|Reason Not Specified|0|||
124587252|NCT01899053|448107839|FG008|Overall Study|Reason Not Specified|0|||
124587253|NCT01899053|448107840|FG009|Overall Study|Reason Not Specified|0|||
124587254|NCT01899053|448107841|FG010|Overall Study|Reason Not Specified|0|||
124587255|NCT01899053|448107842|FG011|Overall Study|Reason Not Specified|0|||
124587256|NCT01899053|448107843|FG012|Overall Study|Reason Not Specified|1|||
124587257|NCT01899053|448107844|FG013|Overall Study|Reason Not Specified|0|||
124777642|NCT02963506|448813091|FG000|Dose-Blind Period|Adverse Event|0|||
124587258|NCT01899053|448107831|FG000|Overall Study|Withdrawal by Subject|1|||
124587259|NCT01899053|448107832|FG001|Overall Study|Withdrawal by Subject|1|||
124587260|NCT01899053|448107833|FG002|Overall Study|Withdrawal by Subject|2|||
124587261|NCT01899053|448107834|FG003|Overall Study|Withdrawal by Subject|0|||
124587262|NCT01899053|448107835|FG004|Overall Study|Withdrawal by Subject|2|||
124587263|NCT01899053|448107836|FG005|Overall Study|Withdrawal by Subject|0|||
124587264|NCT01899053|448107837|FG006|Overall Study|Withdrawal by Subject|0|||
124587265|NCT01899053|448107838|FG007|Overall Study|Withdrawal by Subject|1|||
124587266|NCT01899053|448107839|FG008|Overall Study|Withdrawal by Subject|0|||
124587267|NCT01899053|448107840|FG009|Overall Study|Withdrawal by Subject|0|||
124587268|NCT01899053|448107841|FG010|Overall Study|Withdrawal by Subject|0|||
124587269|NCT01899053|448107842|FG011|Overall Study|Withdrawal by Subject|0|||
124587270|NCT01899053|448107843|FG012|Overall Study|Withdrawal by Subject|1|||
124587271|NCT01899053|448107844|FG013|Overall Study|Withdrawal by Subject|1|||
124587272|NCT01899053|448107831|FG000|Overall Study|Protocol Violation|0|||
124587273|NCT01899053|448107832|FG001|Overall Study|Protocol Violation|0|||
124587274|NCT01899053|448107833|FG002|Overall Study|Protocol Violation|1|||
124587275|NCT01899053|448107834|FG003|Overall Study|Protocol Violation|0|||
124587276|NCT01899053|448107835|FG004|Overall Study|Protocol Violation|0|||
124587277|NCT01899053|448107836|FG005|Overall Study|Protocol Violation|0|||
124587278|NCT01899053|448107837|FG006|Overall Study|Protocol Violation|0|||
124587279|NCT01899053|448107838|FG007|Overall Study|Protocol Violation|0|||
124587280|NCT01899053|448107839|FG008|Overall Study|Protocol Violation|0|||
124587281|NCT01899053|448107840|FG009|Overall Study|Protocol Violation|0|||
124587282|NCT01899053|448107841|FG010|Overall Study|Protocol Violation|0|||
124587283|NCT01899053|448107842|FG011|Overall Study|Protocol Violation|0|||
124587284|NCT01899053|448107843|FG012|Overall Study|Protocol Violation|0|||
124587285|NCT01899053|448107844|FG013|Overall Study|Protocol Violation|0|||
124587286|NCT01899053|448107831|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
124587287|NCT01899053|448107832|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
124587288|NCT01899053|448107833|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
124587289|NCT01899053|448107834|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
124587290|NCT01899053|448107835|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
124587291|NCT01899053|448107836|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
124587292|NCT01899053|448107837|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
124587293|NCT01899053|448107838|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
124587294|NCT01899053|448107839|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
124587295|NCT01899053|448107840|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
124587296|NCT01899053|448107841|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
124587297|NCT01899053|448107842|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
124587298|NCT01899053|448107843|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
124587299|NCT01899053|448107844|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
124587300|NCT01899053|448107831|FG000|Overall Study|Symptomatic Deterioration|0|||
124587301|NCT01899053|448107832|FG001|Overall Study|Symptomatic Deterioration|0|||
124587302|NCT01899053|448107833|FG002|Overall Study|Symptomatic Deterioration|0|||
124587303|NCT01899053|448107834|FG003|Overall Study|Symptomatic Deterioration|0|||
124587304|NCT01899053|448107835|FG004|Overall Study|Symptomatic Deterioration|0|||
124587305|NCT01899053|448107836|FG005|Overall Study|Symptomatic Deterioration|1|||
124587306|NCT01899053|448107837|FG006|Overall Study|Symptomatic Deterioration|0|||
124587307|NCT01899053|448107838|FG007|Overall Study|Symptomatic Deterioration|1|||
124587308|NCT01899053|448107839|FG008|Overall Study|Symptomatic Deterioration|0|||
124587309|NCT01899053|448107840|FG009|Overall Study|Symptomatic Deterioration|0|||
124587310|NCT01899053|448107841|FG010|Overall Study|Symptomatic Deterioration|0|||
124587311|NCT01899053|448107842|FG011|Overall Study|Symptomatic Deterioration|1|||
124587312|NCT01899053|448107843|FG012|Overall Study|Symptomatic Deterioration|2|||
124587313|NCT01899053|448107844|FG013|Overall Study|Symptomatic Deterioration|0|||
124587314|NCT03105297|448107845|FG000|Baseline Phase (Day 1)|Other|21|||
124587315|NCT03105297|448107845|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
124587316|NCT03105297|448107845|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
124587317|NCT00714051|448107850|FG000|Overall Study|Withdrawal by Subject|1|||
124587318|NCT00714051|448107851|FG001|Overall Study|Withdrawal by Subject|0|||
124587319|NCT00714051|448107850|FG000|Overall Study|Death|0|||
124587320|NCT00714051|448107851|FG001|Overall Study|Death|1|||
124587321|NCT01929681|448107854|FG000|Overall Study|Withdrawal by Subject|1|||
124587322|NCT01929681|448107855|FG001|Overall Study|Withdrawal by Subject|0|||
124587323|NCT01929681|448107854|FG000|Overall Study|Physician Decision|1|||
124587324|NCT01929681|448107855|FG001|Overall Study|Physician Decision|1|||
124587325|NCT03250117|448107856|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
124587326|NCT03250117|448107857|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
124587327|NCT03250117|448107858|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
124587328|NCT03250117|448107859|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
124587329|NCT01073631|448107862|FG000|Overall Study|Death|82|||
124587330|NCT01073631|448107862|FG000|Overall Study|Adverse Event|24|||
124587331|NCT01073631|448107862|FG000|Overall Study|Other|63|||
124587332|NCT01971554|448107863|FG000|Overall Study|Lost to Follow-up|1|||
124587333|NCT01971554|448107864|FG001|Overall Study|Lost to Follow-up|0|||
124587334|NCT01971554|448107865|FG002|Overall Study|Lost to Follow-up|0|||
124587335|NCT01971554|448107866|FG003|Overall Study|Lost to Follow-up|0|||
124587336|NCT01426854|448107869|FG000|Overall Study|Adverse Event|1|||
124587337|NCT01426854|448107870|FG001|Overall Study|Adverse Event|5|||
124587338|NCT01426854|448107869|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
124587339|NCT01426854|448107870|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
124587340|NCT01426854|448107869|FG000|Overall Study|Lost to Follow-up|3|||
124587341|NCT01426854|448107870|FG001|Overall Study|Lost to Follow-up|0|||
124587342|NCT01426854|448107869|FG000|Overall Study|Noncompliance|0|||
124587343|NCT01426854|448107870|FG001|Overall Study|Noncompliance|1|||
124587344|NCT01426854|448107869|FG000|Overall Study|Treatment Failure|0|||
124587345|NCT01426854|448107870|FG001|Overall Study|Treatment Failure|16|||
124587346|NCT01426854|448107869|FG000|Overall Study|Protocol Deviation|0|||
124587347|NCT01426854|448107870|FG001|Overall Study|Protocol Deviation|1|||
124587348|NCT01426854|448107869|FG000|Overall Study|Other|3|||
124587349|NCT01426854|448107870|FG001|Overall Study|Other|2|||
124587350|NCT01942135|448107874|FG000|Overall Study|Adverse Event|21|||
124587351|NCT01942135|448107875|FG001|Overall Study|Adverse Event|7|||
124587352|NCT01942135|448107874|FG000|Overall Study|Global Deterioration of Health Status|9|||
124587353|NCT01942135|448107875|FG001|Overall Study|Global Deterioration of Health Status|6|||
124587354|NCT01942135|448107874|FG000|Overall Study|Randomized Not Treated|2|||
124587355|NCT01942135|448107875|FG001|Overall Study|Randomized Not Treated|2|||
124587356|NCT01942135|448107874|FG000|Overall Study|Death|2|||
124587357|NCT01942135|448107875|FG001|Overall Study|Death|1|||
124587358|NCT01942135|448107874|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
124587359|NCT01942135|448107875|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
124587360|NCT01942135|448107874|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
124587361|NCT01942135|448107875|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
124587362|NCT01942135|448107874|FG000|Overall Study|Withdrawal by Subject|4|||
124587363|NCT01942135|448107875|FG001|Overall Study|Withdrawal by Subject|3|||
124587364|NCT01942135|448107874|FG000|Overall Study|Protocol Violation|1|||
124587365|NCT01942135|448107875|FG001|Overall Study|Protocol Violation|0|||
124587366|NCT01942135|448107874|FG000|Overall Study|Other|19|||
124587367|NCT01942135|448107875|FG001|Overall Study|Other|4|||
124587368|NCT00950300|448107876|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
124587369|NCT00950300|448107877|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
124587370|NCT00950300|448107876|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
124587371|NCT00950300|448107877|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
124587372|NCT00950300|448107876|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
124587373|NCT00950300|448107877|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
124587374|NCT00950300|448107876|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
124587375|NCT00950300|448107877|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
124587376|NCT00950300|448107876|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
124587377|NCT00950300|448107877|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
124587378|NCT00950300|448107876|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
124587379|NCT00950300|448107877|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
124587380|NCT00950300|448107876|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
124587381|NCT00950300|448107877|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
124587382|NCT00950300|448107876|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
124587383|NCT00950300|448107877|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
124587384|NCT00950300|448107876|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
124587385|NCT00950300|448107877|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
124587386|NCT00950300|448107876|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
124587387|NCT00950300|448107877|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
124587388|NCT00950300|448107876|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
124587389|NCT00950300|448107877|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
124587390|NCT00950300|448107876|FG000|TFFU Period|Death|4|||
124587391|NCT00950300|448107877|FG001|TFFU Period|Death|1|||
124587392|NCT00950300|448107876|FG000|TFFU Period|Refused Treatment|10|||
124587393|NCT00950300|448107877|FG001|TFFU Period|Refused Treatment|11|||
124587394|NCT00950300|448107876|FG000|TFFU Period|Failure to Return|16|||
124587395|NCT00950300|448107877|FG001|TFFU Period|Failure to Return|16|||
124587396|NCT00950300|448107876|FG000|TFFU Period|Recurrence of Disease|63|||
124587397|NCT00950300|448107877|FG001|TFFU Period|Recurrence of Disease|72|||
124587398|NCT00950300|448107876|FG000|TFFU Period|Other|4|||
124587399|NCT00950300|448107877|FG001|TFFU Period|Other|3|||
124587400|NCT00950300|448107876|FG000|SFU Period|Death|44|||
124587401|NCT00950300|448107877|FG001|SFU Period|Death|42|||
124587402|NCT00950300|448107876|FG000|SFU Period|Lost to Follow-up|30|||
124587403|NCT00950300|448107877|FG001|SFU Period|Lost to Follow-up|28|||
124587404|NCT00950300|448107876|FG000|SFU Period|Withdrawal by Subject|4|||
124587405|NCT00950300|448107877|FG001|SFU Period|Withdrawal by Subject|8|||
124587406|NCT01717040|448107878|FG000|Overall Study|Lost to Follow-up|2|||
124587407|NCT01717040|448107879|FG001|Overall Study|Lost to Follow-up|3|||
124587408|NCT01717040|448107878|FG000|Overall Study|Lack of Efficacy|1|||
124587409|NCT01717040|448107879|FG001|Overall Study|Lack of Efficacy|1|||
124587410|NCT01717040|448107878|FG000|Overall Study|Adverse Event|1|||
124587411|NCT01717040|448107879|FG001|Overall Study|Adverse Event|0|||
124587412|NCT01717040|448107878|FG000|Overall Study|Required Medication Change|0|||
124587413|NCT01717040|448107879|FG001|Overall Study|Required Medication Change|1|||
124587414|NCT01717040|448107878|FG000|Overall Study|New Substance Use Disorder|1|||
124587415|NCT01717040|448107879|FG001|Overall Study|New Substance Use Disorder|0|||
124587416|NCT00494013|448107880|FG000|Overall Study|Adverse Event|0|||
124587417|NCT00494013|448107881|FG001|Overall Study|Adverse Event|1|||
124587418|NCT00494013|448107880|FG000|Overall Study|Entry Criteria Not Met|1|||
124587419|NCT00494013|448107881|FG001|Overall Study|Entry Criteria Not Met|4|||
124587420|NCT00494013|448107880|FG000|Overall Study|Lost to Follow-up|5|||
124587421|NCT00494013|448107881|FG001|Overall Study|Lost to Follow-up|6|||
124587422|NCT00494013|448107880|FG000|Overall Study|Physician Decision|3|||
124587423|NCT00494013|448107881|FG001|Overall Study|Physician Decision|5|||
124587424|NCT00494013|448107880|FG000|Overall Study|Protocol Violation|8|||
124587425|NCT00494013|448107881|FG001|Overall Study|Protocol Violation|5|||
124587426|NCT00494013|448107880|FG000|Overall Study|Withdrawal by Subject|13|||
124587427|NCT00494013|448107881|FG001|Overall Study|Withdrawal by Subject|14|||
124587428|NCT00494013|448107880|FG000|Overall Study|Sponsor Decision|0|||
124587429|NCT00494013|448107881|FG001|Overall Study|Sponsor Decision|1|||
124587430|NCT04750239|448107882|FG000|Overall Study|Withdrawal by Subject|2|||
124587431|NCT04750239|448107882|FG000|Overall Study|Trial terminated by sponsor|1|||
124587432|NCT00919711|448107883|FG000|Overall Study|Withdrawal by Subject|15|||
124587433|NCT00919711|448107884|FG001|Overall Study|Withdrawal by Subject|7|||
124587434|NCT00919711|448107883|FG000|Overall Study|Adverse Event|13|||
124587435|NCT00919711|448107884|FG001|Overall Study|Adverse Event|3|||
124587436|NCT00919711|448107883|FG000|Overall Study|Other|1|||
124587437|NCT00919711|448107884|FG001|Overall Study|Other|2|||
124587438|NCT00919711|448107883|FG000|Overall Study|Administrative Decision|0|||
124587439|NCT00919711|448107884|FG001|Overall Study|Administrative Decision|1|||
124587440|NCT00919711|448107883|FG000|Overall Study|Lost to Follow-up|2|||
124587441|NCT00919711|448107884|FG001|Overall Study|Lost to Follow-up|0|||
124587442|NCT00919711|448107883|FG000|Overall Study|Death|1|||
124587443|NCT00919711|448107884|FG001|Overall Study|Death|0|||
124587444|NCT00919711|448107883|FG000|Overall Study|Noncompliance|1|||
124587445|NCT00919711|448107884|FG001|Overall Study|Noncompliance|0|||
124587446|NCT00903877|448107885|FG000|Overall Study|Did not meet study criteria|33|||
124587447|NCT00903877|448107885|FG000|Overall Study|Withdrawal by Subject|3|||
124587448|NCT00903877|448107885|FG000|Overall Study|Adverse Event|2|||
124587449|NCT00903877|448107885|FG000|Overall Study|Lost to Follow-up|1|||
124587450|NCT00903877|448107885|FG000|Overall Study|Participation put on hold|4|||
124587451|NCT00087529|448107886|FG000|Overall Study|Death|1|||
124587452|NCT00087529|448107887|FG001|Overall Study|Death|0|||
124587453|NCT00087529|448107886|FG000|Overall Study|Adverse Event|0|||
124587454|NCT00087529|448107887|FG001|Overall Study|Adverse Event|8|||
124587455|NCT00087529|448107886|FG000|Overall Study|Pregnancy|0|||
124587456|NCT00087529|448107887|FG001|Overall Study|Pregnancy|1|||
124587457|NCT00087529|448107886|FG000|Overall Study|Lost to Follow-up|2|||
124587458|NCT00087529|448107887|FG001|Overall Study|Lost to Follow-up|3|||
124587459|NCT00087529|448107886|FG000|Overall Study|Participant Decision|14|||
124587460|NCT00087529|448107887|FG001|Overall Study|Participant Decision|37|||
124587461|NCT00087529|448107886|FG000|Overall Study|Physician Decision|4|||
124587462|NCT00087529|448107887|FG001|Overall Study|Physician Decision|8|||
124587463|NCT00087529|448107886|FG000|Overall Study|Initiation of Excluded Therapy|0|||
124587464|NCT00087529|448107887|FG001|Overall Study|Initiation of Excluded Therapy|1|||
124587465|NCT00087529|448107886|FG000|Overall Study|Participant Noncompliance|0|||
124587466|NCT00087529|448107887|FG001|Overall Study|Participant Noncompliance|1|||
124587467|NCT00087529|448107886|FG000|Overall Study|Disease Progression|5|||
124587468|NCT00087529|448107887|FG001|Overall Study|Disease Progression|4|||
124587469|NCT00087529|448107886|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
124587470|NCT00087529|448107887|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
124587471|NCT00685334|448107888|FG000|Overall Study|Withdrawal by Subject|5|||
124587472|NCT00685334|448107889|FG001|Overall Study|Withdrawal by Subject|6|||
124587473|NCT00685334|448107888|FG000|Overall Study|Lost to Follow-up|4|||
124587474|NCT00685334|448107889|FG001|Overall Study|Lost to Follow-up|0|||
124587475|NCT00685334|448107888|FG000|Overall Study|Chose to enter hospital|1|||
124587476|NCT00685334|448107889|FG001|Overall Study|Chose to enter hospital|1|||
124587477|NCT01891357|448107890|FG000|Overall Study|Protocol Violation|3|||
124587478|NCT04573309|448109104|FG000|Overall Study|Protocol Violation|1|||
124587479|NCT04573309|448109105|FG001|Overall Study|Protocol Violation|0|||
124587480|NCT02300987|448109106|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
124729390|NCT03219034|448630234|FG001|Overall Study|UPPP Surgery|0|||
124729391|NCT03219034|448630233|FG000|Overall Study|Dental sensitivity|0|||
124729392|NCT03219034|448630234|FG001|Overall Study|Dental sensitivity|1|||
124729393|NCT03219034|448630233|FG000|Overall Study|Death in family|0|||
124729394|NCT03219034|448630234|FG001|Overall Study|Death in family|1|||
124729395|NCT02438683|448630236|FG000|Overall Study|Adverse Event|1|||
124729396|NCT02438683|448630237|FG001|Overall Study|Adverse Event|0|||
124587481|NCT02300987|448109107|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
124587482|NCT02300987|448109106|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
124777643|NCT02963506|448813092|FG001|Dose-Blind Period|Adverse Event|0|||
124587483|NCT02300987|448109107|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
124587484|NCT02300987|448109106|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
124587485|NCT02300987|448109107|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
124587486|NCT02300987|448109106|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
124587487|NCT02300987|448109107|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
124587488|NCT02300987|448109106|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
124587489|NCT02300987|448109107|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
124587490|NCT02488109|448109108|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
124587491|NCT02488109|448109109|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
124587492|NCT02488109|448109108|FG000|12-month Follow-Up|Lost to Follow-up|4|||
124587493|NCT02488109|448109109|FG001|12-month Follow-Up|Lost to Follow-up|7|||
124587494|NCT03969641|448109110|FG000|Overall Study|Lost to Follow-up|5|||
124587495|NCT03969641|448109111|FG001|Overall Study|Lost to Follow-up|3|||
124587496|NCT03969641|448109110|FG000|Overall Study|Withdrawal by Subject|1|||
124587497|NCT03969641|448109111|FG001|Overall Study|Withdrawal by Subject|2|||
124587498|NCT03969641|448109110|FG000|Overall Study|Found to be ineligible|1|||
124587499|NCT03969641|448109111|FG001|Overall Study|Found to be ineligible|1|||
124587500|NCT03969641|448109110|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
124587501|NCT03969641|448109111|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
124587502|NCT03969641|448109110|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
124587503|NCT03969641|448109111|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
124587504|NCT03969641|448109110|FG000|Overall Study|Elective termination|0|||
124587505|NCT03969641|448109111|FG001|Overall Study|Elective termination|1|||
124587506|NCT01541215|448109112|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
124587507|NCT01541215|448109113|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
124587508|NCT01541215|448109112|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
124587509|NCT01541215|448109113|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
124587510|NCT01541215|448109112|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
124587511|NCT01541215|448109113|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
124587512|NCT01541215|448109112|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
124587513|NCT01541215|448109113|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
124587514|NCT01541215|448109112|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
124587515|NCT01541215|448109113|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
124587516|NCT01541215|448109112|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
124587517|NCT01541215|448109113|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
124587518|NCT02658019|448109122|FG000|Overall Study|Adverse Event|1|||
124587519|NCT00820599|448109123|FG000|Overall Study|Death|129|||
124587520|NCT00820599|448109123|FG000|Overall Study|Withdrawal by Subject|2|||
124587521|NCT01098851|448109124|FG000|Overall Study|Equipment failure|1|||
124587522|NCT01098851|448109125|FG001|Overall Study|Equipment failure|0|||
124587523|NCT00452348|448109127|FG000|Overall Study|Adverse Event|6|||
124587524|NCT00452348|448109128|FG001|Overall Study|Adverse Event|9|||
124587525|NCT00452348|448109127|FG000|Overall Study|Lack of Efficacy|10|||
124587526|NCT00452348|448109128|FG001|Overall Study|Lack of Efficacy|9|||
124587527|NCT00452348|448109127|FG000|Overall Study|Lost to Follow-up|14|||
124587528|NCT00452348|448109128|FG001|Overall Study|Lost to Follow-up|8|||
124587529|NCT00452348|448109127|FG000|Overall Study|Protocol Violation|22|||
124587530|NCT00452348|448109128|FG001|Overall Study|Protocol Violation|28|||
124587531|NCT00452348|448109127|FG000|Overall Study|Withdrawal by Subject|18|||
124587532|NCT00452348|448109128|FG001|Overall Study|Withdrawal by Subject|21|||
124587533|NCT00452348|448109127|FG000|Overall Study|Other|9|||
124587534|NCT00452348|448109128|FG001|Overall Study|Other|9|||
124587535|NCT00960154|448109129|FG000|Overall Study|Study termination|25|||
124587536|NCT00960154|448109130|FG001|Overall Study|Study termination|25|||
124587537|NCT00486434|448109131|FG000|Overall Study|Withdrawal by Subject|34|||
124587538|NCT00486434|448109132|FG001|Overall Study|Withdrawal by Subject|39|||
124587539|NCT00486434|448109131|FG000|Overall Study|Adverse Event|118|||
124587540|NCT00486434|448109132|FG001|Overall Study|Adverse Event|44|||
124587541|NCT00486434|448109131|FG000|Overall Study|Protocol Violation|22|||
124587542|NCT00486434|448109132|FG001|Overall Study|Protocol Violation|21|||
124587543|NCT00486434|448109131|FG000|Overall Study|Lack of Efficacy|12|||
124587544|NCT00486434|448109132|FG001|Overall Study|Lack of Efficacy|19|||
124587545|NCT00486434|448109131|FG000|Overall Study|Lost to Follow-up|2|||
124587546|NCT00486434|448109132|FG001|Overall Study|Lost to Follow-up|3|||
124587547|NCT00486434|448109131|FG000|Overall Study|Death|1|||
124587548|NCT00486434|448109132|FG001|Overall Study|Death|2|||
124587549|NCT00486434|448109131|FG000|Overall Study|Personal reasons|5|||
124587550|NCT00486434|448109132|FG001|Overall Study|Personal reasons|6|||
124587551|NCT00544167|448109133|FG000|Overall Study|Adverse Event|21|||
124587552|NCT00544167|448109133|FG000|Overall Study|Physician Decision|8|||
124587553|NCT02725515|448109134|FG000|Overall Study|Refused infusion (no study treatment)|1|||
124587554|NCT02725515|448109135|FG001|Overall Study|Refused infusion (no study treatment)|0|||
124587555|NCT02725515|448109134|FG000|Overall Study|Loss of Improvement per Protocol|14|||
124587556|NCT02725515|448109135|FG001|Overall Study|Loss of Improvement per Protocol|25|||
124587557|NCT02725515|448109134|FG000|Overall Study|Withdrawal by Subject|2|||
124587558|NCT02725515|448109135|FG001|Overall Study|Withdrawal by Subject|1|||
124587559|NCT02725515|448109134|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124587560|NCT02725515|448109135|FG001|Overall Study|Non-Compliance With Study Drug|3|||
124587561|NCT02725515|448109134|FG000|Overall Study|Lost to Follow-up|1|||
124587562|NCT02725515|448109135|FG001|Overall Study|Lost to Follow-up|1|||
124587563|NCT02725515|448109134|FG000|Overall Study|Adverse Event|7|||
124587564|NCT02725515|448109135|FG001|Overall Study|Adverse Event|2|||
124587565|NCT02725515|448109134|FG000|Overall Study|No Documented Disease Improvement|0|||
124587566|NCT02725515|448109135|FG001|Overall Study|No Documented Disease Improvement|1|||
124587567|NCT02725515|448109134|FG000|Overall Study|Completed Study Under Original Protocol|0|||
124587568|NCT02725515|448109135|FG001|Overall Study|Completed Study Under Original Protocol|1|||
124587569|NCT02725515|448109134|FG000|Overall Study|Lack of Response|0|||
124587570|NCT02725515|448109135|FG001|Overall Study|Lack of Response|1|||
124587571|NCT00874549|448109136|FG000|Overall Study|Adverse Event|0|||
124587572|NCT00874549|448109137|FG001|Overall Study|Adverse Event|0|||
124587573|NCT00874549|448109138|FG002|Overall Study|Adverse Event|1|||
124587574|NCT00874549|448109139|FG003|Overall Study|Adverse Event|0|||
124587575|NCT00874549|448109136|FG000|Overall Study|Protocol Violation|1|||
124587576|NCT00874549|448109137|FG001|Overall Study|Protocol Violation|0|||
124587577|NCT00874549|448109138|FG002|Overall Study|Protocol Violation|2|||
124587578|NCT00874549|448109139|FG003|Overall Study|Protocol Violation|1|||
124587579|NCT00874549|448109136|FG000|Overall Study|Lost to Follow-up|0|||
124587580|NCT00874549|448109137|FG001|Overall Study|Lost to Follow-up|0|||
124587581|NCT00874549|448109138|FG002|Overall Study|Lost to Follow-up|1|||
124587582|NCT00874549|448109139|FG003|Overall Study|Lost to Follow-up|0|||
124587583|NCT00874549|448109136|FG000|Overall Study|Withdrawal by Subject|0|||
124587584|NCT00874549|448109137|FG001|Overall Study|Withdrawal by Subject|1|||
124587585|NCT00874549|448109138|FG002|Overall Study|Withdrawal by Subject|0|||
124587586|NCT00874549|448109139|FG003|Overall Study|Withdrawal by Subject|1|||
124587587|NCT02998541|448109149|FG000|Overall Study|Adverse Event|4|||
124587588|NCT02998541|448109150|FG001|Overall Study|Adverse Event|5|||
124587589|NCT02998541|448109151|FG002|Overall Study|Adverse Event|1|||
124587590|NCT02998541|448109149|FG000|Overall Study|Protocol Violation|1|||
124587591|NCT02998541|448109150|FG001|Overall Study|Protocol Violation|0|||
124587592|NCT02998541|448109151|FG002|Overall Study|Protocol Violation|0|||
124587593|NCT02998541|448109149|FG000|Overall Study|Withdrawal by Subject|3|||
124587594|NCT02998541|448109150|FG001|Overall Study|Withdrawal by Subject|1|||
124587595|NCT02998541|448109151|FG002|Overall Study|Withdrawal by Subject|0|||
124587596|NCT02998541|448109149|FG000|Overall Study|Lost to Follow-up|0|||
124587597|NCT02998541|448109150|FG001|Overall Study|Lost to Follow-up|3|||
124587598|NCT02998541|448109151|FG002|Overall Study|Lost to Follow-up|1|||
124587599|NCT02998541|448109149|FG000|Overall Study|Physician Decision|0|||
124587600|NCT02998541|448109150|FG001|Overall Study|Physician Decision|0|||
124587601|NCT02998541|448109151|FG002|Overall Study|Physician Decision|3|||
124587602|NCT02998541|448109149|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124587603|NCT02998541|448109150|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124587604|NCT02998541|448109151|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
124587605|NCT01513239|448109152|FG000|Period 1: Main Phase|Adverse Event|1|||
124587606|NCT01513239|448109153|FG001|Period 1: Main Phase|Adverse Event|1|||
124587607|NCT01513239|448109154|FG002|Period 1: Main Phase|Adverse Event|2|||
124587608|NCT01513239|448109155|FG003|Period 1: Main Phase|Adverse Event|0|||
124587609|NCT01513239|448109156|FG004|Period 1: Main Phase|Adverse Event|0|||
124587610|NCT01513239|448109157|FG005|Period 1: Main Phase|Adverse Event|0|||
124587611|NCT01513239|448109152|FG000|Period 1: Main Phase|Death|29|||
124587612|NCT01513239|448109153|FG001|Period 1: Main Phase|Death|22|||
124587613|NCT01513239|448109154|FG002|Period 1: Main Phase|Death|32|||
124587614|NCT01513239|448109155|FG003|Period 1: Main Phase|Death|0|||
124587615|NCT01513239|448109156|FG004|Period 1: Main Phase|Death|0|||
124587616|NCT01513239|448109157|FG005|Period 1: Main Phase|Death|0|||
124587617|NCT01513239|448109152|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
124587618|NCT01513239|448109153|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
124587619|NCT01513239|448109154|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
124587620|NCT01513239|448109155|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
124587621|NCT01513239|448109156|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
124587622|NCT01513239|448109157|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
124587623|NCT01513239|448109152|FG000|Period 1: Main Phase|Physician Decision|4|||
124587624|NCT01513239|448109153|FG001|Period 1: Main Phase|Physician Decision|4|||
124587625|NCT01513239|448109154|FG002|Period 1: Main Phase|Physician Decision|4|||
124587626|NCT01513239|448109155|FG003|Period 1: Main Phase|Physician Decision|0|||
124587627|NCT01513239|448109156|FG004|Period 1: Main Phase|Physician Decision|0|||
124587628|NCT01513239|448109157|FG005|Period 1: Main Phase|Physician Decision|0|||
124587629|NCT01513239|448109152|FG000|Period 1: Main Phase|Protocol Violation|2|||
124587630|NCT01513239|448109153|FG001|Period 1: Main Phase|Protocol Violation|2|||
124587631|NCT01513239|448109154|FG002|Period 1: Main Phase|Protocol Violation|2|||
124587632|NCT01513239|448109155|FG003|Period 1: Main Phase|Protocol Violation|0|||
124587633|NCT01513239|448109156|FG004|Period 1: Main Phase|Protocol Violation|0|||
124587634|NCT01513239|448109157|FG005|Period 1: Main Phase|Protocol Violation|0|||
124587635|NCT01513239|448109152|FG000|Period 1: Main Phase|Technical Problems|1|||
124587636|NCT01513239|448109153|FG001|Period 1: Main Phase|Technical Problems|2|||
124587637|NCT01513239|448109154|FG002|Period 1: Main Phase|Technical Problems|0|||
124587638|NCT01513239|448109155|FG003|Period 1: Main Phase|Technical Problems|0|||
124587639|NCT01513239|448109156|FG004|Period 1: Main Phase|Technical Problems|0|||
124587640|NCT01513239|448109157|FG005|Period 1: Main Phase|Technical Problems|0|||
124587641|NCT01513239|448109152|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
124587642|NCT01513239|448109153|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
124587643|NCT01513239|448109154|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
124587644|NCT01513239|448109155|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
124587645|NCT01513239|448109156|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
124587646|NCT01513239|448109157|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
124587647|NCT01513239|448109152|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
124587648|NCT01513239|448109153|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
124587649|NCT01513239|448109154|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
124587650|NCT01513239|448109155|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
124587651|NCT01513239|448109156|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
124587652|NCT01513239|448109157|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
124587653|NCT01513239|448109152|FG000|Period 2: 9 Month Extension Phase|Death|0|||
124587654|NCT01513239|448109153|FG001|Period 2: 9 Month Extension Phase|Death|0|||
124587655|NCT01513239|448109154|FG002|Period 2: 9 Month Extension Phase|Death|0|||
124587656|NCT01513239|448109155|FG003|Period 2: 9 Month Extension Phase|Death|2|||
124587657|NCT01513239|448109156|FG004|Period 2: 9 Month Extension Phase|Death|5|||
124587658|NCT01513239|448109157|FG005|Period 2: 9 Month Extension Phase|Death|2|||
124587659|NCT01513239|448109152|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
124587660|NCT01513239|448109153|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
124587661|NCT01513239|448109154|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
124587662|NCT01513239|448109155|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
124587663|NCT01513239|448109156|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
124587664|NCT01513239|448109157|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
124587665|NCT01513239|448109152|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
124587666|NCT01513239|448109153|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
124587667|NCT01513239|448109154|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
124587668|NCT01513239|448109155|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
124587669|NCT01513239|448109156|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
124587670|NCT01513239|448109157|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
124587671|NCT01513239|448109152|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
124587672|NCT01513239|448109153|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
124587673|NCT01513239|448109154|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
124587674|NCT01513239|448109155|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
124587675|NCT01513239|448109156|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
124587676|NCT01513239|448109157|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
124587677|NCT03167606|448109160|FG000|Overall Study|Lost to Follow-up|73|||
124587678|NCT03167606|448109161|FG001|Overall Study|Lost to Follow-up|64|||
124587679|NCT03167606|448109160|FG000|Overall Study|Withdrawal by Subject|6|||
124587680|NCT03167606|448109161|FG001|Overall Study|Withdrawal by Subject|5|||
124587681|NCT03167606|448109160|FG000|Overall Study|Withdrawal by Investigator|0|||
124587682|NCT03167606|448109161|FG001|Overall Study|Withdrawal by Investigator|2|||
124587683|NCT00059332|448109162|FG000|Overall Study|Withdrawal by Subject|2|||
124587684|NCT00059332|448109163|FG001|Overall Study|Withdrawal by Subject|1|||
124587685|NCT00059332|448109162|FG000|Overall Study|Lost to Follow-up|1|||
124587686|NCT00059332|448109163|FG001|Overall Study|Lost to Follow-up|1|||
124587687|NCT00413049|448109164|FG000|Overall Study|Adverse Event|10|||
124587688|NCT00413049|448109165|FG001|Overall Study|Adverse Event|8|||
124587689|NCT00413049|448109164|FG000|Overall Study|Withdrawal by Subject|7|||
124587690|NCT00413049|448109165|FG001|Overall Study|Withdrawal by Subject|5|||
124587691|NCT00413049|448109164|FG000|Overall Study|Lost to Follow-up|2|||
124587692|NCT00413049|448109165|FG001|Overall Study|Lost to Follow-up|3|||
124587693|NCT00413049|448109164|FG000|Overall Study|Protocol Violation|3|||
124587694|NCT00413049|448109165|FG001|Overall Study|Protocol Violation|1|||
124587695|NCT00413049|448109164|FG000|Overall Study|Subject no longer requires study drug|0|||
124587696|NCT00413049|448109165|FG001|Overall Study|Subject no longer requires study drug|1|||
124587697|NCT00413049|448109164|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124587698|NCT00413049|448109165|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124587699|NCT00413049|448109164|FG000|Overall Study|Lack of Efficacy|1|||
124587700|NCT00413049|448109165|FG001|Overall Study|Lack of Efficacy|0|||
124587701|NCT02587143|448109166|FG000|Overall Study|Adverse Event|1|||
124587702|NCT02587143|448109167|FG001|Overall Study|Adverse Event|0|||
124587703|NCT03314857|448109172|FG000|Overall Study|Death|4|||
124587704|NCT03314857|448109172|FG000|Overall Study|Physician Decision|1|||
124587705|NCT02906917|448109173|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
124587706|NCT02906917|448109174|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
124587707|NCT02906917|448109173|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
124587708|NCT02906917|448109174|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
124587709|NCT02906917|448109173|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
124587710|NCT02906917|448109174|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
124587711|NCT02906917|448109173|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
124587712|NCT02906917|448109174|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
124587713|NCT02906917|448109173|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
124587714|NCT02906917|448109174|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
124587715|NCT02906917|448109173|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
124587716|NCT02906917|448109174|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
124587717|NCT02906917|448109173|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
124587718|NCT02906917|448109174|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
124587719|NCT02906917|448109173|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
124587720|NCT02906917|448109174|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
124587721|NCT00874822|448109177|FG000|Overall Study|excluded by criteria|8|||
124587722|NCT04281472|448109179|FG000|Stage A|Lack of Efficacy|8|||
124587723|NCT04281472|448109180|FG001|Stage A|Lack of Efficacy|0|||
124587724|NCT04281472|448109181|FG002|Stage A|Lack of Efficacy|0|||
124587725|NCT04281472|448109179|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
124587726|NCT04281472|448109180|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
124587727|NCT04281472|448109181|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
124587728|NCT04281472|448109179|FG000|Stage A|Adverse Event|20|||
124587729|NCT04281472|448109180|FG001|Stage A|Adverse Event|0|||
124587730|NCT04281472|448109181|FG002|Stage A|Adverse Event|0|||
124587731|NCT04281472|448109179|FG000|Stage A|Death|1|||
124587732|NCT04281472|448109180|FG001|Stage A|Death|0|||
124587733|NCT04281472|448109181|FG002|Stage A|Death|0|||
124587734|NCT04281472|448109179|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
124587735|NCT04281472|448109180|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
124587736|NCT04281472|448109181|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
124587737|NCT04281472|448109179|FG000|Stage A|Lost to Follow-up|2|||
124587738|NCT04281472|448109180|FG001|Stage A|Lost to Follow-up|0|||
124587739|NCT04281472|448109181|FG002|Stage A|Lost to Follow-up|0|||
124587740|NCT04281472|448109179|FG000|Stage A|Non-compliance with study drug|1|||
124587741|NCT04281472|448109180|FG001|Stage A|Non-compliance with study drug|0|||
124587742|NCT04281472|448109181|FG002|Stage A|Non-compliance with study drug|0|||
124587743|NCT04281472|448109179|FG000|Stage A|Physician Decision|1|||
124587744|NCT04281472|448109180|FG001|Stage A|Physician Decision|0|||
124587745|NCT04281472|448109181|FG002|Stage A|Physician Decision|0|||
124587746|NCT04281472|448109179|FG000|Stage A|Prohibited medications|2|||
124587747|NCT04281472|448109180|FG001|Stage A|Prohibited medications|0|||
124587748|NCT04281472|448109181|FG002|Stage A|Prohibited medications|0|||
124587749|NCT04281472|448109179|FG000|Stage A|Withdrawal by Subject|11|||
124587750|NCT04281472|448109180|FG001|Stage A|Withdrawal by Subject|0|||
124587751|NCT04281472|448109181|FG002|Stage A|Withdrawal by Subject|0|||
124587752|NCT04281472|448109179|FG000|Stage A|Other|5|||
124587753|NCT04281472|448109180|FG001|Stage A|Other|0|||
124587754|NCT04281472|448109181|FG002|Stage A|Other|0|||
124587755|NCT04281472|448109179|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
124587756|NCT04281472|448109180|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
124587757|NCT04281472|448109181|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
124587758|NCT04281472|448109179|FG000|Stage B|Adverse Event|0|||
124587759|NCT04281472|448109180|FG001|Stage B|Adverse Event|3|||
124587760|NCT04281472|448109181|FG002|Stage B|Adverse Event|0|||
124587761|NCT04281472|448109179|FG000|Stage B|Death|0|||
124587762|NCT04281472|448109180|FG001|Stage B|Death|0|||
124587763|NCT04281472|448109181|FG002|Stage B|Death|1|||
124587764|NCT04281472|448109179|FG000|Stage B|Lack of Efficacy|0|||
124587765|NCT04281472|448109180|FG001|Stage B|Lack of Efficacy|0|||
124587766|NCT04281472|448109181|FG002|Stage B|Lack of Efficacy|1|||
124587767|NCT04281472|448109179|FG000|Stage B|Lost to Follow-up|0|||
124587768|NCT04281472|448109180|FG001|Stage B|Lost to Follow-up|0|||
124587769|NCT04281472|448109181|FG002|Stage B|Lost to Follow-up|2|||
124587770|NCT04281472|448109179|FG000|Stage B|Prohibited medications|0|||
124587771|NCT04281472|448109180|FG001|Stage B|Prohibited medications|2|||
124587772|NCT04281472|448109181|FG002|Stage B|Prohibited medications|1|||
124587773|NCT04281472|448109179|FG000|Stage B|Protocol Violation|0|||
124587774|NCT04281472|448109180|FG001|Stage B|Protocol Violation|1|||
124587775|NCT04281472|448109181|FG002|Stage B|Protocol Violation|1|||
124587776|NCT04281472|448109179|FG000|Stage B|Sponsor decision|0|||
124587777|NCT04281472|448109180|FG001|Stage B|Sponsor decision|0|||
124587778|NCT04281472|448109181|FG002|Stage B|Sponsor decision|1|||
124587779|NCT04281472|448109179|FG000|Stage B|Withdrawal by Subject|0|||
124587780|NCT04281472|448109180|FG001|Stage B|Withdrawal by Subject|3|||
124587781|NCT04281472|448109181|FG002|Stage B|Withdrawal by Subject|3|||
124587782|NCT04281472|448109179|FG000|Stage B|Other|0|||
124587783|NCT04281472|448109180|FG001|Stage B|Other|3|||
124587784|NCT04281472|448109181|FG002|Stage B|Other|0|||
124587785|NCT05278858|448109182|FG000|Overall Study|Withdrawal by Subject|1|||
124587786|NCT03504085|448109185|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
124587787|NCT03504085|448109186|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
124587788|NCT03504085|448109185|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
124587789|NCT03504085|448109186|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
124587790|NCT04133311|448109187|FG000|Period 1 Double Masked Treatment Period|Death|1|||
124587791|NCT04133311|448109188|FG001|Period 1 Double Masked Treatment Period|Death|0|||
124587792|NCT04133311|448109189|FG002|Period 1 Double Masked Treatment Period|Death|0|||
124587793|NCT04133311|448109190|FG003|Period 1 Double Masked Treatment Period|Death|0|||
124587794|NCT04133311|448109187|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
124587795|NCT04133311|448109188|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
124587796|NCT04133311|448109189|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
124587797|NCT04133311|448109190|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
124587798|NCT04133311|448109187|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
124587799|NCT04133311|448109188|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
124587800|NCT04133311|448109189|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
124587801|NCT04133311|448109190|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
124587802|NCT04133311|448109187|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
124587803|NCT04133311|448109188|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
124587804|NCT04133311|448109189|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
124587805|NCT04133311|448109190|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
124587806|NCT04133311|448109187|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
124587807|NCT04133311|448109188|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
124587808|NCT04133311|448109189|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
124587809|NCT04133311|448109190|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
124587810|NCT04133311|448109187|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
124587811|NCT04133311|448109188|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
124587812|NCT04133311|448109189|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
124587813|NCT04133311|448109190|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
124587814|NCT04133311|448109187|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
124587815|NCT04133311|448109188|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
124587816|NCT04133311|448109189|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
124587817|NCT04133311|448109190|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
124587818|NCT04133311|448109187|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
124587819|NCT04133311|448109188|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
124587820|NCT04133311|448109189|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
124587821|NCT04133311|448109190|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
124587822|NCT00728754|448109193|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
124587823|NCT00728754|448109194|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
124587824|NCT00728754|448109193|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
124587825|NCT00728754|448109194|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
124587826|NCT00728754|448109193|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
124587827|NCT00728754|448109194|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
124587828|NCT01926119|448109195|FG000|Overall Study|Withdrawal by Subject|1|||
124587829|NCT00009945|448109198|FG000|Overall Study|no follow up data|7|||
124587830|NCT00009945|448109199|FG001|Overall Study|no follow up data|5|||
124587831|NCT00295490|448109202|FG000|Overall Study|Protocol Violation|0|||
124587832|NCT00295490|448109203|FG001|Overall Study|Protocol Violation|0|||
124587833|NCT00295490|448109204|FG002|Overall Study|Protocol Violation|3|||
124587834|NCT00295490|448109205|FG003|Overall Study|Protocol Violation|3|||
124587835|NCT00295490|448109202|FG000|Overall Study|Withdrawal by Subject|0|||
124587836|NCT00295490|448109203|FG001|Overall Study|Withdrawal by Subject|2|||
124587837|NCT00295490|448109204|FG002|Overall Study|Withdrawal by Subject|0|||
124587838|NCT00295490|448109205|FG003|Overall Study|Withdrawal by Subject|1|||
124587839|NCT00295490|448109202|FG000|Overall Study|Lost to Follow-up|0|||
124587840|NCT00295490|448109203|FG001|Overall Study|Lost to Follow-up|0|||
124587841|NCT00295490|448109204|FG002|Overall Study|Lost to Follow-up|1|||
124587842|NCT00295490|448109205|FG003|Overall Study|Lost to Follow-up|0|||
124587843|NCT00295490|448109202|FG000|Overall Study|Adverse Event|1|||
124587844|NCT00295490|448109203|FG001|Overall Study|Adverse Event|0|||
124587845|NCT00295490|448109204|FG002|Overall Study|Adverse Event|0|||
124587846|NCT00295490|448109205|FG003|Overall Study|Adverse Event|0|||
124587847|NCT00295490|448109202|FG000|Overall Study|Other|0|||
124587848|NCT00295490|448109203|FG001|Overall Study|Other|2|||
124587849|NCT00295490|448109204|FG002|Overall Study|Other|0|||
124587850|NCT00295490|448109205|FG003|Overall Study|Other|1|||
124587851|NCT03868631|448109206|FG000|Baseline to Week 6|Adverse Event|0|||
124587852|NCT03868631|448109207|FG001|Baseline to Week 6|Adverse Event|3|||
124587853|NCT03868631|448109206|FG000|Baseline to Week 6|Protocol Violation|1|||
124587854|NCT03868631|448109207|FG001|Baseline to Week 6|Protocol Violation|1|||
124587855|NCT03868631|448109206|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
124729397|NCT02438683|448630238|FG002|Overall Study|Adverse Event|0|||
124729398|NCT02438683|448630239|FG003|Overall Study|Adverse Event|0|||
124729399|NCT02438683|448630240|FG004|Overall Study|Adverse Event|0|||
124729400|NCT02438683|448630241|FG005|Overall Study|Adverse Event|0|||
124729401|NCT04669262|448630244|FG000|Overall Study|Withdrawal by Subject|0|||
124729402|NCT04669262|448630245|FG001|Overall Study|Withdrawal by Subject|0|||
124729403|NCT04669262|448630246|FG002|Overall Study|Withdrawal by Subject|0|||
124729404|NCT04669262|448630247|FG003|Overall Study|Withdrawal by Subject|1|||
124729405|NCT04669262|448630244|FG000|Overall Study|Randomized but Not Treated|0|||
124729406|NCT04669262|448630245|FG001|Overall Study|Randomized but Not Treated|1|||
124729407|NCT04669262|448630246|FG002|Overall Study|Randomized but Not Treated|0|||
124729408|NCT04669262|448630247|FG003|Overall Study|Randomized but Not Treated|0|||
124729409|NCT01638013|448630248|FG000|Overall Study|Adverse Event|36|||
124729410|NCT01638013|448630249|FG001|Overall Study|Adverse Event|29|||
124729411|NCT01638013|448630250|FG002|Overall Study|Adverse Event|48|||
124729412|NCT01638013|448630248|FG000|Overall Study|Lack of Efficacy|39|||
124729413|NCT01638013|448630249|FG001|Overall Study|Lack of Efficacy|11|||
124729414|NCT01638013|448630250|FG002|Overall Study|Lack of Efficacy|14|||
124729415|NCT01638013|448630248|FG000|Overall Study|Protocol Violation|10|||
124729416|NCT01638013|448630249|FG001|Overall Study|Protocol Violation|7|||
124729417|NCT01638013|448630250|FG002|Overall Study|Protocol Violation|11|||
124729418|NCT01638013|448630248|FG000|Overall Study|Met discontinuation criteria|4|||
124729419|NCT01638013|448630249|FG001|Overall Study|Met discontinuation criteria|0|||
124729420|NCT01638013|448630250|FG002|Overall Study|Met discontinuation criteria|7|||
124729421|NCT01638013|448630248|FG000|Overall Study|Subject Lost to Follow up|1|||
124729422|NCT01638013|448630249|FG001|Overall Study|Subject Lost to Follow up|0|||
124729423|NCT01638013|448630250|FG002|Overall Study|Subject Lost to Follow up|1|||
124729424|NCT01638013|448630248|FG000|Overall Study|Miscellaneous|25|||
124729425|NCT01638013|448630249|FG001|Overall Study|Miscellaneous|19|||
124729426|NCT01638013|448630250|FG002|Overall Study|Miscellaneous|23|||
124729427|NCT01638013|448630248|FG000|Overall Study|Withdrawal of Consent|16|||
124729428|NCT01638013|448630249|FG001|Overall Study|Withdrawal of Consent|12|||
124729429|NCT01638013|448630250|FG002|Overall Study|Withdrawal of Consent|16|||
124729430|NCT01638013|448630248|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
124729431|NCT01638013|448630249|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
124729432|NCT01638013|448630250|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
124729433|NCT01846299|448630253|FG000|Overall Study|Physician Decision|4|||
124729434|NCT01846299|448630254|FG001|Overall Study|Physician Decision|2|||
124729435|NCT01846299|448630253|FG000|Overall Study|Protocol deviation|1|||
124729436|NCT01846299|448630254|FG001|Overall Study|Protocol deviation|0|||
124729437|NCT01846299|448630253|FG000|Overall Study|Death|1|||
124729438|NCT01846299|448630254|FG001|Overall Study|Death|2|||
124729439|NCT01846299|448630253|FG000|Overall Study|Lost to Follow-up|3|||
124729440|NCT01846299|448630254|FG001|Overall Study|Lost to Follow-up|0|||
124729441|NCT01846299|448630253|FG000|Overall Study|Withdrawal by Subject|1|||
124729442|NCT01846299|448630254|FG001|Overall Study|Withdrawal by Subject|6|||
124729443|NCT01846299|448630253|FG000|Overall Study|Adverse Event|2|||
124729444|NCT01846299|448630254|FG001|Overall Study|Adverse Event|0|||
124729445|NCT03559517|448630255|FG000|Overall Study|Withdrawal by Subject|1|||
124729446|NCT03559517|448630256|FG001|Overall Study|Withdrawal by Subject|0|||
124729447|NCT03559517|448630257|FG002|Overall Study|Withdrawal by Subject|0|||
124729448|NCT00496483|448632445|FG000|Overall Study|Not dosed|9|||
124729449|NCT00496483|448632445|FG000|Overall Study|Adverse Event|2|||
124729450|NCT00496483|448632445|FG000|Overall Study|Lack of Efficacy|1|||
124729451|NCT03095027|448632448|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
124729452|NCT03095027|448632449|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
124729453|NCT04021524|448632450|FG000|Overall Study|Change in surgical intervention|0|||
124729454|NCT04021524|448632451|FG001|Overall Study|Change in surgical intervention|1|||
124729455|NCT05275010|448632452|FG000|Overall Study|Reason Not Specified|4|||
124729456|NCT05275010|448632453|FG001|Overall Study|Reason Not Specified|1|||
124729457|NCT05275010|448632452|FG000|Overall Study|Withdrawal by Subject|1|||
124729458|NCT05275010|448632453|FG001|Overall Study|Withdrawal by Subject|0|||
124729459|NCT05275010|448632452|FG000|Overall Study|Lost to Follow-up|0|||
124729460|NCT05275010|448632453|FG001|Overall Study|Lost to Follow-up|1|||
124729461|NCT00730041|448632454|FG000|Overall Study|Lost to Follow-up|0|||
124729462|NCT00730041|448632455|FG001|Overall Study|Lost to Follow-up|2|||
124729463|NCT05526781|448632456|FG000|Overall Study|Lost to Follow-up|1|||
124729464|NCT04085458|448632457|FG000|Overall Study|Other|1|||
124729465|NCT04085458|448632457|FG000|Overall Study|Withdrawal by Subject|2|||
124729466|NCT04085458|448632457|FG000|Overall Study|Adverse Event|2|||
124729467|NCT03632993|448632458|FG000|Overall Study|Withdrawal by Subject|1|||
124729468|NCT03632993|448632459|FG001|Overall Study|Withdrawal by Subject|0|||
124729469|NCT03632993|448632460|FG002|Overall Study|Withdrawal by Subject|0|||
124729470|NCT03632993|448632461|FG003|Overall Study|Withdrawal by Subject|0|||
124587856|NCT03868631|448109207|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
124587857|NCT03868631|448109206|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
124587858|NCT03868631|448109207|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
124587859|NCT03868631|448109206|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
124587860|NCT03868631|448109207|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
124587861|NCT03868631|448109206|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
124587862|NCT03868631|448109207|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
124587863|NCT01691430|448110664|FG000|Overall Study|Death|17|||
124587864|NCT01691430|448110665|FG001|Overall Study|Death|16|||
124587865|NCT01691430|448110664|FG000|Overall Study|Withdrawal by Subject|5|||
124587866|NCT01691430|448110665|FG001|Overall Study|Withdrawal by Subject|1|||
124587867|NCT01691430|448110664|FG000|Overall Study|Lost to Follow-up|0|||
124587868|NCT01691430|448110665|FG001|Overall Study|Lost to Follow-up|3|||
124587869|NCT00660387|448110671|FG000|Overall Study|Adverse Event|1|||
124587870|NCT00660387|448110672|FG001|Overall Study|Adverse Event|2|||
124587871|NCT00660387|448110671|FG000|Overall Study|Lack of Efficacy|0|||
124587872|NCT00660387|448110672|FG001|Overall Study|Lack of Efficacy|1|||
124587873|NCT00660387|448110671|FG000|Overall Study|Protocol Violation|1|||
124587874|NCT00660387|448110672|FG001|Overall Study|Protocol Violation|0|||
124587875|NCT04729101|448110673|FG000|Overall Study|Adverse Event|1|||
124587876|NCT04729101|448110674|FG001|Overall Study|Adverse Event|0|||
124587877|NCT04729101|448110673|FG000|Overall Study|Physician Decision|1|||
124587878|NCT04729101|448110674|FG001|Overall Study|Physician Decision|0|||
124587879|NCT04729101|448110673|FG000|Overall Study|Withdrawal by Subject|1|||
124587880|NCT04729101|448110674|FG001|Overall Study|Withdrawal by Subject|0|||
124587881|NCT03086135|448110675|FG000|Overall Study|Adverse Event|1|||
124587882|NCT03086135|448110675|FG000|Overall Study|Lost to Follow-up|2|||
124587883|NCT01023061|448110678|FG000|Overall Study|Withdrawal prior to treatment|2|||
124587884|NCT00762411|448110679|FG000|Initial Treatment|Death|7|||
124587885|NCT00762411|448110680|FG001|Initial Treatment|Death|6|||
124587886|NCT00762411|448110679|FG000|Initial Treatment|Adverse Event|132|||
124587887|NCT00762411|448110680|FG001|Initial Treatment|Adverse Event|40|||
124587888|NCT00762411|448110679|FG000|Initial Treatment|Protocol Violation|4|||
124587889|NCT00762411|448110680|FG001|Initial Treatment|Protocol Violation|1|||
124587890|NCT00762411|448110679|FG000|Initial Treatment|Withdrawal by Subject|65|||
124587891|NCT00762411|448110680|FG001|Initial Treatment|Withdrawal by Subject|52|||
124587892|NCT00762411|448110679|FG000|Initial Treatment|Physician Decision|1|||
124587893|NCT00762411|448110680|FG001|Initial Treatment|Physician Decision|0|||
124587894|NCT00762411|448110679|FG000|Initial Treatment|Sponsor Decision|293|||
124587895|NCT00762411|448110680|FG001|Initial Treatment|Sponsor Decision|401|||
124587896|NCT00762411|448110679|FG000|Initial Treatment|Lost to Follow-up|5|||
124587897|NCT00762411|448110680|FG001|Initial Treatment|Lost to Follow-up|0|||
124587898|NCT00762411|448110679|FG000|Initial Treatment|Caregiver Decision|21|||
124587899|NCT00762411|448110680|FG001|Initial Treatment|Caregiver Decision|16|||
124587900|NCT00762411|448110679|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
124587901|NCT00762411|448110680|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
124587902|NCT00762411|448110679|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
124587903|NCT00762411|448110680|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
124587904|NCT00762411|448110679|FG000|Delayed Start|Adverse Event|0|||
124587905|NCT00762411|448110680|FG001|Delayed Start|Adverse Event|4|||
124587906|NCT00762411|448110679|FG000|Delayed Start|Protocol Violation|0|||
124587907|NCT00762411|448110680|FG001|Delayed Start|Protocol Violation|1|||
124587908|NCT00762411|448110679|FG000|Delayed Start|Sponsor Decision|16|||
124587909|NCT00762411|448110680|FG001|Delayed Start|Sponsor Decision|20|||
124587910|NCT00762411|448110679|FG000|Delayed Start|Caregiver Decision|1|||
124587911|NCT00762411|448110680|FG001|Delayed Start|Caregiver Decision|1|||
124587912|NCT00762411|448110679|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
124587913|NCT00762411|448110680|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
124587914|NCT00762411|448110679|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
124587915|NCT00762411|448110680|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
124587916|NCT00762411|448110679|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
124587917|NCT00762411|448110680|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
124587918|NCT00762411|448110679|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
124587919|NCT00762411|448110680|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
124587920|NCT00762411|448110679|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
124587921|NCT00762411|448110680|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
124587922|NCT00762411|448110679|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
124587923|NCT00762411|448110680|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
124587924|NCT02259348|448110684|FG000|Overall Study|Donors|6|||
124587925|NCT02259348|448110684|FG000|Overall Study|Death|4|||
124587926|NCT04812548|448110685|FG000|Overall Study|Adverse Event|2|||
124587927|NCT04812548|448110686|FG001|Overall Study|Adverse Event|7|||
124587928|NCT04812548|448110685|FG000|Overall Study|HSCT Planned|2|||
124587929|NCT04812548|448110686|FG001|Overall Study|HSCT Planned|3|||
124777644|NCT02963506|448813093|FG002|Dose-Blind Period|Adverse Event|0|||
124587930|NCT04812548|448110685|FG000|Overall Study|Progressive Disease|0|||
124587931|NCT04812548|448110686|FG001|Overall Study|Progressive Disease|2|||
124587932|NCT04812548|448110685|FG000|Overall Study|Death|0|||
124587933|NCT04812548|448110686|FG001|Overall Study|Death|1|||
124587934|NCT04812548|448110685|FG000|Overall Study|Post Study Access to Treatment|0|||
124587935|NCT04812548|448110686|FG001|Overall Study|Post Study Access to Treatment|1|||
124587936|NCT04812548|448110685|FG000|Overall Study|Withdrawal by Subject|0|||
124587937|NCT04812548|448110686|FG001|Overall Study|Withdrawal by Subject|1|||
124587938|NCT04812548|448110685|FG000|Overall Study|Physician Decision|1|||
124587939|NCT04812548|448110686|FG001|Overall Study|Physician Decision|0|||
124587940|NCT04211766|448110687|FG000|Overall Study|Withdrawal by Subject|5|||
124587941|NCT04211766|448110688|FG001|Overall Study|Withdrawal by Subject|1|||
124587942|NCT03686215|448110689|FG000|Overall Study|Adverse Event|0|||
124587943|NCT03686215|448110690|FG001|Overall Study|Adverse Event|0|||
124587944|NCT03686215|448110691|FG002|Overall Study|Adverse Event|7|||
124587945|NCT03686215|448110689|FG000|Overall Study|Physician Decision|0|||
124587946|NCT03686215|448110690|FG001|Overall Study|Physician Decision|0|||
124587947|NCT03686215|448110691|FG002|Overall Study|Physician Decision|1|||
124587948|NCT03686215|448110689|FG000|Overall Study|Protocol Violation|0|||
124587949|NCT03686215|448110690|FG001|Overall Study|Protocol Violation|0|||
124587950|NCT03686215|448110691|FG002|Overall Study|Protocol Violation|4|||
124587951|NCT03686215|448110689|FG000|Overall Study|Device issue|1|||
124587952|NCT03686215|448110690|FG001|Overall Study|Device issue|0|||
124587953|NCT03686215|448110691|FG002|Overall Study|Device issue|2|||
124587954|NCT02485158|448110692|FG000|Overall Study|Withdrawal by Subject|3|||
124587955|NCT02485158|448110692|FG000|Overall Study|expected drug side effect|1|||
124587956|NCT01813435|448110695|FG000|Overall Study|did not finish experimental regimen|1902|||
124587957|NCT01813435|448110696|FG001|Overall Study|did not finish experimental regimen|770|||
124587958|NCT01813435|448110695|FG000|Overall Study|Lost to Follow-up|268|||
124587959|NCT01813435|448110696|FG001|Overall Study|Lost to Follow-up|237|||
124587960|NCT03035890|448110697|FG000|Overall Study|Death|1|||
124587961|NCT01490190|448110698|FG000|Overall Study|Withdrawal by Subject|9|||
124587962|NCT01490190|448110698|FG000|Overall Study|Adverse Event|17|||
124587963|NCT01490190|448110698|FG000|Overall Study|Protocol Violation|5|||
124587964|NCT01490190|448110698|FG000|Overall Study|Lost to Follow-up|13|||
124587965|NCT01490190|448110698|FG000|Overall Study|Relocation|1|||
124587966|NCT01490190|448110698|FG000|Overall Study|Inconvenience|1|||
124587967|NCT01490190|448110698|FG000|Overall Study|Ring expulsion|2|||
124587968|NCT02817828|448110704|FG000|Overall Study|Lost to Follow-up|41|||
124587969|NCT02817828|448110704|FG000|Overall Study|Adverse event not related to bleeding|104|||
124587970|NCT02817828|448110704|FG000|Overall Study|Adverse event related to bleeding|53|||
124587971|NCT02817828|448110704|FG000|Overall Study|Protocol Violation|11|||
124587972|NCT02817828|448110704|FG000|Overall Study|Pregnancy|7|||
124587973|NCT02817828|448110704|FG000|Overall Study|Pregnancy wish|15|||
124587974|NCT02817828|448110704|FG000|Overall Study|Withdrawal by Subject|78|||
124587975|NCT02817828|448110704|FG000|Overall Study|Other|26|||
124587976|NCT00856349|448110708|FG000|Overall Study|Death|418|||
124587977|NCT00856349|448110708|FG000|Overall Study|Withdrawal by Subject|116|||
124587978|NCT00856349|448110708|FG000|Overall Study|Lost to Follow-up|91|||
124587979|NCT00856349|448110708|FG000|Overall Study|Protocol Violation|38|||
124587980|NCT00856349|448110708|FG000|Overall Study|Physician Decision|13|||
124587981|NCT00856349|448110708|FG000|Overall Study|Subject relocation|104|||
124587982|NCT00856349|448110708|FG000|Overall Study|Device explant|33|||
124587983|NCT00856349|448110708|FG000|Overall Study|Site closure|78|||
124587984|NCT00856349|448110708|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
124587985|NCT05061992|448110709|FG000|Overall Study|Excess bowel movements|1|||
124587986|NCT05061992|448110710|FG001|Overall Study|Excess bowel movements|0|||
124587987|NCT05061992|448110709|FG000|Overall Study|Complications of Medical Care|1|||
124587988|NCT05061992|448110710|FG001|Overall Study|Complications of Medical Care|0|||
124587989|NCT05061992|448110709|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
124587990|NCT05061992|448110710|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
124587991|NCT05061992|448110709|FG000|Overall Study|Withdrawal by Subject|0|||
124587992|NCT05061992|448110710|FG001|Overall Study|Withdrawal by Subject|1|||
124587993|NCT01157234|448110711|FG000|Overall Study|Withdrawal by Subject|1|||
124587994|NCT01157234|448110712|FG001|Overall Study|Withdrawal by Subject|0|||
124587995|NCT00397254|448110721|FG000|Overall Study|Lost to Follow-up|2|||
124587996|NCT00397254|448110722|FG001|Overall Study|Lost to Follow-up|2|||
124587997|NCT02340780|448110723|FG000|Overall Study|Ineligible|1|||
124587998|NCT01055834|448110728|FG000|Treatment Period I|Adverse Event|1|||
124587999|NCT01055834|448110729|FG001|Treatment Period I|Adverse Event|0|||
124588000|NCT01717313|448110730|FG000|Phase A (Weeks 0 to 24)|Death|0|||
124588001|NCT01717313|448110731|FG001|Phase A (Weeks 0 to 24)|Death|1|||
124588002|NCT01717313|448110730|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
124588003|NCT01717313|448110731|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
124588004|NCT01717313|448110730|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
124588005|NCT01717313|448110731|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
124588006|NCT01717313|448110730|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
124588007|NCT01717313|448110731|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
124588008|NCT01717313|448110730|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
124777645|NCT02963506|448813094|FG003|Dose-Blind Period|Adverse Event|0|||
124777646|NCT02963506|448813095|FG004|Dose-Blind Period|Adverse Event|0|||
124777647|NCT02963506|448813096|FG005|Dose-Blind Period|Adverse Event|1|||
124777648|NCT02963506|448813097|FG006|Dose-Blind Period|Adverse Event|3|||
124777649|NCT02963506|448813098|FG007|Dose-Blind Period|Adverse Event|2|||
124777650|NCT02963506|448813099|FG008|Dose-Blind Period|Adverse Event|2|||
124777651|NCT02963506|448813100|FG009|Dose-Blind Period|Adverse Event|2|||
124777652|NCT02963506|448813101|FG010|Dose-Blind Period|Adverse Event|1|||
124777653|NCT02963506|448813102|FG011|Dose-Blind Period|Adverse Event|1|||
124777654|NCT02963506|448813103|FG012|Dose-Blind Period|Adverse Event|6|||
124777655|NCT02963506|448813091|FG000|Dose-Blind Period|Lack of Efficacy|0|||
124777656|NCT02963506|448813092|FG001|Dose-Blind Period|Lack of Efficacy|0|||
124777657|NCT02963506|448813093|FG002|Dose-Blind Period|Lack of Efficacy|0|||
124777658|NCT02963506|448813094|FG003|Dose-Blind Period|Lack of Efficacy|0|||
124777659|NCT02963506|448813095|FG004|Dose-Blind Period|Lack of Efficacy|0|||
124777660|NCT02963506|448813096|FG005|Dose-Blind Period|Lack of Efficacy|0|||
124777661|NCT02963506|448813097|FG006|Dose-Blind Period|Lack of Efficacy|0|||
124777662|NCT02963506|448813098|FG007|Dose-Blind Period|Lack of Efficacy|1|||
124777663|NCT02963506|448813099|FG008|Dose-Blind Period|Lack of Efficacy|0|||
124777664|NCT02963506|448813100|FG009|Dose-Blind Period|Lack of Efficacy|1|||
124777665|NCT02963506|448813101|FG010|Dose-Blind Period|Lack of Efficacy|0|||
124777666|NCT02963506|448813102|FG011|Dose-Blind Period|Lack of Efficacy|0|||
124777667|NCT02963506|448813103|FG012|Dose-Blind Period|Lack of Efficacy|0|||
124777668|NCT02963506|448813091|FG000|Dose-Blind Period|Lost to Follow-up|0|||
124777669|NCT02963506|448813092|FG001|Dose-Blind Period|Lost to Follow-up|0|||
124777670|NCT02963506|448813093|FG002|Dose-Blind Period|Lost to Follow-up|0|||
124777671|NCT02963506|448813094|FG003|Dose-Blind Period|Lost to Follow-up|0|||
124777672|NCT02963506|448813095|FG004|Dose-Blind Period|Lost to Follow-up|0|||
124777673|NCT02963506|448813096|FG005|Dose-Blind Period|Lost to Follow-up|1|||
124777674|NCT02963506|448813097|FG006|Dose-Blind Period|Lost to Follow-up|0|||
124777675|NCT02963506|448813098|FG007|Dose-Blind Period|Lost to Follow-up|0|||
124777676|NCT02963506|448813099|FG008|Dose-Blind Period|Lost to Follow-up|1|||
124777677|NCT02963506|448813100|FG009|Dose-Blind Period|Lost to Follow-up|0|||
124777678|NCT02963506|448813101|FG010|Dose-Blind Period|Lost to Follow-up|0|||
124777679|NCT02963506|448813102|FG011|Dose-Blind Period|Lost to Follow-up|1|||
124777680|NCT02963506|448813103|FG012|Dose-Blind Period|Lost to Follow-up|0|||
124777681|NCT02963506|448813091|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
124777682|NCT02963506|448813092|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
124777683|NCT02963506|448813093|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
124777684|NCT02963506|448813094|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
124777685|NCT02963506|448813095|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
124777686|NCT02963506|448813096|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
124777687|NCT02963506|448813097|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
124777688|NCT02963506|448813098|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
124777689|NCT02963506|448813099|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
124777690|NCT02963506|448813100|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
124777691|NCT02963506|448813101|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
124777692|NCT02963506|448813102|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
124777693|NCT02963506|448813103|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
124777694|NCT02963506|448813091|FG000|Dose-Blind Period|Sponsor decision|0|||
124777695|NCT02963506|448813092|FG001|Dose-Blind Period|Sponsor decision|0|||
124777696|NCT02963506|448813093|FG002|Dose-Blind Period|Sponsor decision|0|||
124777697|NCT02963506|448813094|FG003|Dose-Blind Period|Sponsor decision|0|||
124777698|NCT02963506|448813095|FG004|Dose-Blind Period|Sponsor decision|0|||
124777699|NCT02963506|448813096|FG005|Dose-Blind Period|Sponsor decision|1|||
124777700|NCT02963506|448813097|FG006|Dose-Blind Period|Sponsor decision|0|||
124777701|NCT02963506|448813098|FG007|Dose-Blind Period|Sponsor decision|0|||
124777702|NCT02963506|448813099|FG008|Dose-Blind Period|Sponsor decision|0|||
124777703|NCT02963506|448813100|FG009|Dose-Blind Period|Sponsor decision|0|||
124777704|NCT02963506|448813101|FG010|Dose-Blind Period|Sponsor decision|0|||
124777705|NCT02963506|448813102|FG011|Dose-Blind Period|Sponsor decision|0|||
124777706|NCT02963506|448813103|FG012|Dose-Blind Period|Sponsor decision|0|||
124588009|NCT01717313|448110731|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
124588010|NCT01717313|448110730|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
124588011|NCT01717313|448110731|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
124588012|NCT01717313|448110730|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
124777707|NCT02963506|448813091|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
124777708|NCT02963506|448813092|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
124777709|NCT02963506|448813093|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
124777710|NCT02963506|448813094|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
124777711|NCT02963506|448813095|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
124777712|NCT02963506|448813096|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
124777713|NCT02963506|448813097|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
124777714|NCT02963506|448813098|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
124777715|NCT02963506|448813099|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
124588013|NCT01717313|448110731|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
124588014|NCT01717313|448110730|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
124588015|NCT01717313|448110731|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
124588016|NCT01717313|448110730|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
124588017|NCT01717313|448110731|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
124588018|NCT01617096|448110742|FG000|Overall Study|Withdrawal by Subject|96|||
124588019|NCT01617096|448110743|FG001|Overall Study|Withdrawal by Subject|81|||
124588020|NCT01617096|448110742|FG000|Overall Study|Lost to Follow-up|37|||
124588021|NCT01617096|448110743|FG001|Overall Study|Lost to Follow-up|32|||
124588022|NCT01617096|448110742|FG000|Overall Study|Physician Decision|10|||
124588023|NCT01617096|448110743|FG001|Overall Study|Physician Decision|18|||
124588024|NCT01617096|448110742|FG000|Overall Study|Death|4|||
124588025|NCT01617096|448110743|FG001|Overall Study|Death|3|||
124588026|NCT01617096|448110742|FG000|Overall Study|Other|1|||
124588027|NCT01617096|448110743|FG001|Overall Study|Other|3|||
124588028|NCT04473326|448110746|FG000|Overall Study|Death|0|||
124588029|NCT04473326|448110747|FG001|Overall Study|Death|1|||
124588030|NCT04473326|448110746|FG000|Overall Study|Withdrawal by Subject|1|||
124588031|NCT04473326|448110747|FG001|Overall Study|Withdrawal by Subject|2|||
124588032|NCT02611362|448110748|FG000|Overall Study|Withdrawal by Subject|7|||
124588033|NCT02611362|448110749|FG001|Overall Study|Withdrawal by Subject|2|||
124588034|NCT02611362|448110748|FG000|Overall Study|Lost to Follow-up|2|||
124588035|NCT02611362|448110749|FG001|Overall Study|Lost to Follow-up|4|||
124588036|NCT01155531|448110750|FG000|Overall Study|Adverse Event|0|||
124588037|NCT01155531|448110751|FG001|Overall Study|Adverse Event|0|||
124588038|NCT01155531|448110752|FG002|Overall Study|Adverse Event|1|||
124588039|NCT01155531|448110753|FG003|Overall Study|Adverse Event|0|||
124588040|NCT01155531|448110750|FG000|Overall Study|Lost to Follow-up|0|||
124588041|NCT01155531|448110751|FG001|Overall Study|Lost to Follow-up|0|||
124588042|NCT01155531|448110752|FG002|Overall Study|Lost to Follow-up|0|||
124588043|NCT01155531|448110753|FG003|Overall Study|Lost to Follow-up|1|||
124588044|NCT01155531|448110750|FG000|Overall Study|Withdrawal by Subject|1|||
124588045|NCT01155531|448110751|FG001|Overall Study|Withdrawal by Subject|0|||
124588046|NCT01155531|448110752|FG002|Overall Study|Withdrawal by Subject|1|||
124588047|NCT01155531|448110753|FG003|Overall Study|Withdrawal by Subject|0|||
124588048|NCT00354159|448110754|FG000|Randomized Study Period|Withdrawal by Subject|5|||
124588049|NCT00354159|448110755|FG001|Randomized Study Period|Withdrawal by Subject|3|||
124588050|NCT00354159|448110754|FG000|Randomized Study Period|Physician Decision|6|||
124588051|NCT00354159|448110755|FG001|Randomized Study Period|Physician Decision|10|||
124588052|NCT00354159|448110754|FG000|Randomized Study Period|Lost to Follow-up|4|||
124588053|NCT00354159|448110755|FG001|Randomized Study Period|Lost to Follow-up|0|||
124588054|NCT00354159|448110754|FG000|Randomized Study Period|Death|7|||
124588055|NCT00354159|448110755|FG001|Randomized Study Period|Death|9|||
124588056|NCT00354159|448110754|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
124588057|NCT00354159|448110755|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
124588058|NCT00354159|448110754|FG000|Long-term Follow-up|Physician Decision|127|||
124588059|NCT00354159|448110755|FG001|Long-term Follow-up|Physician Decision|122|||
124588060|NCT00354159|448110754|FG000|Long-term Follow-up|Lost to Follow-up|1|||
124588061|NCT00354159|448110755|FG001|Long-term Follow-up|Lost to Follow-up|0|||
124588062|NCT00354159|448110754|FG000|Long-term Follow-up|Death|14|||
124588063|NCT00354159|448110755|FG001|Long-term Follow-up|Death|11|||
124588064|NCT00354159|448110754|FG000|Long-term Follow-up|Study Closed|29|||
124588065|NCT00354159|448110755|FG001|Long-term Follow-up|Study Closed|34|||
124588066|NCT02046122|448110756|FG000|Overall Study|Physician Decision|8|||
124588067|NCT02046122|448110756|FG000|Overall Study|Withdrawal by Subject|1|||
124588068|NCT01653704|448110757|FG000|Overall Study|Technical failure during recording|1|||
124588069|NCT01653704|448110758|FG001|Overall Study|Technical failure during recording|1|||
124588070|NCT01653704|448110757|FG000|Overall Study|Performance not reflective of training|1|||
124588071|NCT01653704|448110758|FG001|Overall Study|Performance not reflective of training|0|||
124588072|NCT01728116|448110759|FG000|Overall Study|Sponsor Terminated Study|106|||
124588073|NCT01728116|448110760|FG001|Overall Study|Sponsor Terminated Study|35|||
124588074|NCT01728116|448110759|FG000|Overall Study|Withdrawal by Subject|16|||
124588075|NCT01728116|448110760|FG001|Overall Study|Withdrawal by Subject|9|||
124588076|NCT01728116|448110759|FG000|Overall Study|Adverse Event|13|||
124588077|NCT01728116|448110760|FG001|Overall Study|Adverse Event|0|||
124588078|NCT01728116|448110759|FG000|Overall Study|Procedure/device failure|7|||
124588079|NCT01728116|448110760|FG001|Overall Study|Procedure/device failure|0|||
124588080|NCT01728116|448110759|FG000|Overall Study|Lost to Follow-up|9|||
124588081|NCT01728116|448110760|FG001|Overall Study|Lost to Follow-up|2|||
124588082|NCT01728116|448110759|FG000|Overall Study|Physician Decision|2|||
124588083|NCT01728116|448110760|FG001|Overall Study|Physician Decision|0|||
124588084|NCT01728116|448110759|FG000|Overall Study|Subject Non-Compliance|2|||
124588085|NCT01728116|448110760|FG001|Overall Study|Subject Non-Compliance|0|||
124588086|NCT01728116|448110759|FG000|Overall Study|Inter-current finding at procedure|1|||
124588087|NCT01728116|448110760|FG001|Overall Study|Inter-current finding at procedure|0|||
124588088|NCT01728116|448110759|FG000|Overall Study|Incorrectly enrolled in Study|0|||
124588089|NCT01728116|448110760|FG001|Overall Study|Incorrectly enrolled in Study|1|||
124777716|NCT02963506|448813100|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
124777717|NCT02963506|448813101|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
124777718|NCT02963506|448813102|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
124588090|NCT01728116|448110759|FG000|Overall Study|various not noted previously|5|||
124588091|NCT01728116|448110760|FG001|Overall Study|various not noted previously|0|||
124588092|NCT01532908|448110763|FG000|Overall Study|Not Transplanted|1|||
124588093|NCT01532908|448110764|FG001|Overall Study|Not Transplanted|0|||
124588094|NCT01196390|448110765|FG000|Overall Study|Protocol Violation|4|||
124588095|NCT01196390|448110766|FG001|Overall Study|Protocol Violation|5|||
124588096|NCT03141151|448110767|FG000|Overall Study|Lost to Follow-up|3|||
124588097|NCT03141151|448110768|FG001|Overall Study|Lost to Follow-up|2|||
124588098|NCT03141151|448110767|FG000|Overall Study|Withdrawal by Subject|3|||
124588099|NCT03141151|448110768|FG001|Overall Study|Withdrawal by Subject|2|||
124588100|NCT04610580|448110775|FG000|Two-way Crossover Period|Adverse Event|1|||
124588101|NCT04610580|448110776|FG001|Two-way Crossover Period|Adverse Event|0|||
124588102|NCT04610580|448110777|FG002|Two-way Crossover Period|Adverse Event|0|||
124588103|NCT04610580|448110778|FG003|Two-way Crossover Period|Adverse Event|0|||
124588104|NCT04610580|448110779|FG004|Two-way Crossover Period|Adverse Event|0|||
124588105|NCT04610580|448110780|FG005|Two-way Crossover Period|Adverse Event|0|||
124588106|NCT04610580|448110775|FG000|Two-way Crossover Period|Physician Decision|1|||
124588107|NCT04610580|448110776|FG001|Two-way Crossover Period|Physician Decision|0|||
124588108|NCT04610580|448110777|FG002|Two-way Crossover Period|Physician Decision|0|||
124588109|NCT04610580|448110778|FG003|Two-way Crossover Period|Physician Decision|0|||
124588110|NCT04610580|448110779|FG004|Two-way Crossover Period|Physician Decision|0|||
124588111|NCT04610580|448110780|FG005|Two-way Crossover Period|Physician Decision|0|||
124588112|NCT04610580|448110775|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
124588113|NCT04610580|448110776|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
124588114|NCT04610580|448110777|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
124588115|NCT04610580|448110778|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
124588116|NCT04610580|448110779|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
124588117|NCT04610580|448110780|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
124588118|NCT04610580|448110775|FG000|Two-way Crossover Period|Other than specified|0|||
124588119|NCT04610580|448110776|FG001|Two-way Crossover Period|Other than specified|1|||
124588120|NCT04610580|448110777|FG002|Two-way Crossover Period|Other than specified|0|||
124588121|NCT04610580|448110778|FG003|Two-way Crossover Period|Other than specified|0|||
124588122|NCT04610580|448110779|FG004|Two-way Crossover Period|Other than specified|0|||
124588123|NCT04610580|448110780|FG005|Two-way Crossover Period|Other than specified|0|||
124588124|NCT04610580|448110775|FG000|Washout Before Extension Period|Other than specified|0|||
124588125|NCT04610580|448110776|FG001|Washout Before Extension Period|Other than specified|1|||
124588126|NCT04610580|448110777|FG002|Washout Before Extension Period|Other than specified|0|||
124588127|NCT04610580|448110778|FG003|Washout Before Extension Period|Other than specified|0|||
124588128|NCT04610580|448110779|FG004|Washout Before Extension Period|Other than specified|0|||
124588129|NCT04610580|448110780|FG005|Washout Before Extension Period|Other than specified|0|||
124588130|NCT04610580|448110775|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
124588131|NCT04610580|448110776|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
124588132|NCT04610580|448110777|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
124588133|NCT04610580|448110778|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
124588134|NCT04610580|448110779|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
124588135|NCT04610580|448110780|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
124588136|NCT04610580|448110775|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
124588137|NCT04610580|448110776|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
124588138|NCT04610580|448110777|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
124588139|NCT04610580|448110778|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
124588140|NCT04610580|448110779|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
124588141|NCT04610580|448110780|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
124588142|NCT01097694|448110781|FG000|Overall Study|Adverse Event|5|||
124588143|NCT01097694|448110782|FG001|Overall Study|Adverse Event|0|||
124588144|NCT01097694|448110781|FG000|Overall Study|Lost to Follow-up|0|||
124588145|NCT01097694|448110782|FG001|Overall Study|Lost to Follow-up|3|||
124588146|NCT01097694|448110781|FG000|Overall Study|Withdrawal by Subject|3|||
124588147|NCT01097694|448110782|FG001|Overall Study|Withdrawal by Subject|1|||
124588148|NCT04320745|448110783|FG000|Overall Study|Adverse Event|26|||
124588149|NCT04320745|448110783|FG000|Overall Study|Withdrawal by Subject|4|||
124588150|NCT04320745|448110783|FG000|Overall Study|Lost to Follow-up|12|||
124588151|NCT04320745|448110783|FG000|Overall Study|Protocol Deviation|2|||
124588152|NCT04320745|448110783|FG000|Overall Study|Non-compliance With Study Drug|2|||
124588153|NCT04320745|448110783|FG000|Overall Study|Reason Not Specified|1|||
124588154|NCT02004691|448110784|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
124588155|NCT02004691|448110785|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
124588156|NCT02004691|448110784|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
124588157|NCT02004691|448110785|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
124588158|NCT02004691|448110784|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
124588159|NCT02004691|448110785|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
124588160|NCT02004691|448110784|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
124588161|NCT02004691|448110785|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
124588162|NCT02004691|448110784|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
124588163|NCT02004691|448110785|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
124588164|NCT02004691|448110784|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
124588165|NCT02004691|448110785|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
124588166|NCT01320722|448110786|FG000|Overall Study|Did not Receive Intervention|3|||
124588167|NCT01320722|448110787|FG001|Overall Study|Did not Receive Intervention|2|||
124588168|NCT01320722|448110788|FG002|Overall Study|Did not Receive Intervention|1|||
124588169|NCT01320722|448110789|FG003|Overall Study|Did not Receive Intervention|1|||
124588170|NCT01320722|448110790|FG004|Overall Study|Did not Receive Intervention|2|||
124588171|NCT01320722|448110786|FG000|Overall Study|Lost to Follow-up|0|||
124588172|NCT01320722|448110787|FG001|Overall Study|Lost to Follow-up|1|||
124588173|NCT01320722|448110788|FG002|Overall Study|Lost to Follow-up|0|||
124588174|NCT01320722|448110789|FG003|Overall Study|Lost to Follow-up|1|||
124588175|NCT01320722|448110790|FG004|Overall Study|Lost to Follow-up|3|||
124588176|NCT01320722|448110786|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
124588177|NCT01320722|448110787|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
124588178|NCT01320722|448110788|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
124588179|NCT01320722|448110789|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
124588180|NCT01320722|448110790|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
124588181|NCT01320722|448110786|FG000|Overall Study|Participant Developed a Rash|0|||
124588182|NCT01320722|448110787|FG001|Overall Study|Participant Developed a Rash|0|||
124588183|NCT01320722|448110788|FG002|Overall Study|Participant Developed a Rash|2|||
124588184|NCT01320722|448110789|FG003|Overall Study|Participant Developed a Rash|1|||
124588185|NCT01320722|448110790|FG004|Overall Study|Participant Developed a Rash|1|||
124588186|NCT01320722|448110786|FG000|Overall Study|Non-compliant with Medication|0|||
124588187|NCT01320722|448110787|FG001|Overall Study|Non-compliant with Medication|0|||
124588188|NCT01320722|448110788|FG002|Overall Study|Non-compliant with Medication|1|||
124588189|NCT01320722|448110789|FG003|Overall Study|Non-compliant with Medication|0|||
124588190|NCT01320722|448110790|FG004|Overall Study|Non-compliant with Medication|0|||
124588191|NCT01320722|448110786|FG000|Overall Study|Adverse Event|0|||
124588192|NCT01320722|448110787|FG001|Overall Study|Adverse Event|0|||
124588193|NCT01320722|448110788|FG002|Overall Study|Adverse Event|3|||
124588194|NCT01320722|448110789|FG003|Overall Study|Adverse Event|6|||
124588195|NCT01320722|448110790|FG004|Overall Study|Adverse Event|0|||
124588196|NCT01320722|448110786|FG000|Overall Study|Not Compliant with Study Procedures|0|||
124588197|NCT01320722|448110787|FG001|Overall Study|Not Compliant with Study Procedures|0|||
124588198|NCT01320722|448110788|FG002|Overall Study|Not Compliant with Study Procedures|0|||
124588199|NCT01320722|448110789|FG003|Overall Study|Not Compliant with Study Procedures|4|||
124588200|NCT01320722|448110790|FG004|Overall Study|Not Compliant with Study Procedures|0|||
124588201|NCT01320722|448110786|FG000|Overall Study|Pregnancy|0|||
124588202|NCT01320722|448110787|FG001|Overall Study|Pregnancy|0|||
124588203|NCT01320722|448110788|FG002|Overall Study|Pregnancy|0|||
124588204|NCT01320722|448110789|FG003|Overall Study|Pregnancy|1|||
124588205|NCT01320722|448110790|FG004|Overall Study|Pregnancy|0|||
124588206|NCT01320722|448110786|FG000|Overall Study|Started an Exclusionary Medication|0|||
124588207|NCT01320722|448110787|FG001|Overall Study|Started an Exclusionary Medication|0|||
124588208|NCT01320722|448110788|FG002|Overall Study|Started an Exclusionary Medication|0|||
124588209|NCT01320722|448110789|FG003|Overall Study|Started an Exclusionary Medication|0|||
124588210|NCT01320722|448110790|FG004|Overall Study|Started an Exclusionary Medication|1|||
124588211|NCT01320722|448110786|FG000|Overall Study|Withdrew due to Health Condition|0|||
124588212|NCT01320722|448110787|FG001|Overall Study|Withdrew due to Health Condition|0|||
124588213|NCT01320722|448110788|FG002|Overall Study|Withdrew due to Health Condition|0|||
124588214|NCT01320722|448110789|FG003|Overall Study|Withdrew due to Health Condition|0|||
124588215|NCT01320722|448110790|FG004|Overall Study|Withdrew due to Health Condition|1|||
124588216|NCT00021541|448110791|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
124588217|NCT00021541|448110792|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
124588218|NCT00021541|448110791|FG000|Period 1-First Treatment|Adverse Event|2|||
124588219|NCT00021541|448110792|FG001|Period 1-First Treatment|Adverse Event|1|||
124588220|NCT00021541|448110791|FG000|Period 1-First Treatment|non-adherence|3|||
124588221|NCT00021541|448110792|FG001|Period 1-First Treatment|non-adherence|0|||
124588222|NCT00021541|448110791|FG000|Period 1-First Treatment|Death|1|||
124588223|NCT00021541|448110792|FG001|Period 1-First Treatment|Death|0|||
124588224|NCT00021541|448110791|FG000|Period 1-First Treatment|Pts that did not progress|2|||
124588225|NCT00021541|448110792|FG001|Period 1-First Treatment|Pts that did not progress|2|||
124588226|NCT00021541|448110791|FG000|Period 1-First Treatment|Ineligible|0|||
124588227|NCT00021541|448110792|FG001|Period 1-First Treatment|Ineligible|2|||
124588228|NCT00021541|448110791|FG000|Period 2-crossover|refused phase B|2|||
124588229|NCT00021541|448110792|FG001|Period 2-crossover|refused phase B|2|||
124588230|NCT00021541|448110791|FG000|Period 2-crossover|Withdrawal by Subject|3|||
124588231|NCT00021541|448110792|FG001|Period 2-crossover|Withdrawal by Subject|4|||
124588232|NCT00021541|448110791|FG000|Period 2-crossover|Adverse Event|2|||
124588233|NCT00021541|448110792|FG001|Period 2-crossover|Adverse Event|2|||
124588234|NCT00021541|448110791|FG000|Period 2-crossover|non-adherence|1|||
124588235|NCT00021541|448110792|FG001|Period 2-crossover|non-adherence|0|||
124729471|NCT03632993|448632462|FG004|Overall Study|Withdrawal by Subject|0|||
124729472|NCT03632993|448632463|FG005|Overall Study|Withdrawal by Subject|0|||
124729473|NCT03632993|448632464|FG006|Overall Study|Withdrawal by Subject|0|||
124729474|NCT03632993|448632465|FG007|Overall Study|Withdrawal by Subject|0|||
124729475|NCT03632993|448632466|FG008|Overall Study|Withdrawal by Subject|0|||
124729476|NCT03632993|448632467|FG009|Overall Study|Withdrawal by Subject|1|||
124729477|NCT03632993|448632458|FG000|Overall Study|Protocol Non-compliance|0|||
124729478|NCT03632993|448632459|FG001|Overall Study|Protocol Non-compliance|1|||
124729479|NCT03632993|448632460|FG002|Overall Study|Protocol Non-compliance|0|||
124729480|NCT03632993|448632461|FG003|Overall Study|Protocol Non-compliance|0|||
124729481|NCT03632993|448632462|FG004|Overall Study|Protocol Non-compliance|0|||
124729482|NCT03632993|448632463|FG005|Overall Study|Protocol Non-compliance|0|||
124729483|NCT03632993|448632464|FG006|Overall Study|Protocol Non-compliance|0|||
124729484|NCT03632993|448632465|FG007|Overall Study|Protocol Non-compliance|0|||
124729485|NCT03632993|448632466|FG008|Overall Study|Protocol Non-compliance|0|||
124729486|NCT03632993|448632467|FG009|Overall Study|Protocol Non-compliance|0|||
124729487|NCT03632993|448632458|FG000|Overall Study|Lost to Follow-up|0|||
124729488|NCT03632993|448632459|FG001|Overall Study|Lost to Follow-up|0|||
124729489|NCT03632993|448632460|FG002|Overall Study|Lost to Follow-up|0|||
124729490|NCT03632993|448632461|FG003|Overall Study|Lost to Follow-up|0|||
124729491|NCT03632993|448632462|FG004|Overall Study|Lost to Follow-up|0|||
124729492|NCT03632993|448632463|FG005|Overall Study|Lost to Follow-up|1|||
124729493|NCT03632993|448632464|FG006|Overall Study|Lost to Follow-up|0|||
124729494|NCT03632993|448632465|FG007|Overall Study|Lost to Follow-up|1|||
124729495|NCT03632993|448632466|FG008|Overall Study|Lost to Follow-up|0|||
124729496|NCT03632993|448632467|FG009|Overall Study|Lost to Follow-up|0|||
124729497|NCT03632993|448632458|FG000|Overall Study|Adverse Event|0|||
124729498|NCT03632993|448632459|FG001|Overall Study|Adverse Event|0|||
124729499|NCT03632993|448632460|FG002|Overall Study|Adverse Event|0|||
124729500|NCT03632993|448632461|FG003|Overall Study|Adverse Event|0|||
124729501|NCT03632993|448632462|FG004|Overall Study|Adverse Event|0|||
124729502|NCT03632993|448632463|FG005|Overall Study|Adverse Event|1|||
124729503|NCT03632993|448632464|FG006|Overall Study|Adverse Event|0|||
124729504|NCT03632993|448632465|FG007|Overall Study|Adverse Event|1|||
124729505|NCT03632993|448632466|FG008|Overall Study|Adverse Event|0|||
124729506|NCT03632993|448632467|FG009|Overall Study|Adverse Event|0|||
124729507|NCT02743949|448632468|FG000|Overall Study|Adverse Event|0|||
124729508|NCT02743949|448632469|FG001|Overall Study|Adverse Event|0|||
124729509|NCT02743949|448632470|FG002|Overall Study|Adverse Event|2|||
124729510|NCT02743949|448632468|FG000|Overall Study|Significant Protocol Deviation|2|||
124729511|NCT02743949|448632469|FG001|Overall Study|Significant Protocol Deviation|0|||
124729512|NCT02743949|448632470|FG002|Overall Study|Significant Protocol Deviation|1|||
124729513|NCT02743949|448632468|FG000|Overall Study|Voluntary Withdrawal|2|||
124729514|NCT02743949|448632469|FG001|Overall Study|Voluntary Withdrawal|1|||
124729515|NCT02743949|448632470|FG002|Overall Study|Voluntary Withdrawal|0|||
124729516|NCT03327220|448632471|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
124729517|NCT03327220|448632472|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
124729518|NCT03327220|448632471|FG000|Overall Study|Investigator Decision|2|||
124729519|NCT03327220|448632472|FG001|Overall Study|Investigator Decision|0|||
124729520|NCT03327220|448632471|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
124729521|NCT03327220|448632472|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
124729522|NCT03327220|448632471|FG000|Overall Study|Fungal infection|1|||
124729523|NCT03327220|448632472|FG001|Overall Study|Fungal infection|0|||
124729524|NCT03327220|448632471|FG000|Overall Study|Discharged to Rehabilitation|0|||
124729525|NCT03327220|448632472|FG001|Overall Study|Discharged to Rehabilitation|1|||
124729526|NCT03327220|448632471|FG000|Overall Study|Missing|1|||
124729527|NCT03327220|448632472|FG001|Overall Study|Missing|0|||
124729528|NCT00523705|448632475|FG000|Overall Study|No time for study.|0|||
124729529|NCT00523705|448632476|FG001|Overall Study|No time for study.|1|||
124729530|NCT00368836|448632477|FG000|Phase II|Screen Failure|1|||
124729531|NCT00368836|448632477|FG000|Phase II|Withdrawal by Subject|1|||
124729532|NCT00368836|448632477|FG000|Phase II|unable to collect blood and/or breath|17|||
124729533|NCT00368836|448632477|FG000|Phase II|Protocol Violation|2|||
124729534|NCT00090142|448632479|FG000|Treatment Period I|Lost to Follow-up|1|||
124729535|NCT00090142|448632480|FG001|Treatment Period I|Lost to Follow-up|2|||
124729536|NCT00090142|448632479|FG000|Treatment Period I|Protocol Violation|2|||
124729537|NCT00090142|448632480|FG001|Treatment Period I|Protocol Violation|0|||
124729538|NCT00090142|448632479|FG000|Treatment Period I|Withdrawal by Subject|2|||
124729539|NCT00090142|448632480|FG001|Treatment Period I|Withdrawal by Subject|0|||
124729540|NCT00090142|448632479|FG000|Treatment Period I|Other|0|||
124729541|NCT00090142|448632480|FG001|Treatment Period I|Other|1|||
124729542|NCT00090142|448632479|FG000|Treatment Period II|Other|1|||
124729543|NCT00090142|448632480|FG001|Treatment Period II|Other|0|||
124588236|NCT00021541|448110791|FG000|Period 2-crossover|Pts that did not progress|2|||
124588237|NCT00021541|448110792|FG001|Period 2-crossover|Pts that did not progress|3|||
124588238|NCT03407729|448110793|FG000|Overall Study|Lost to Follow-up|2|||
124588239|NCT03407729|448110794|FG001|Overall Study|Lost to Follow-up|0|||
124588240|NCT03407729|448110793|FG000|Overall Study|Unable to schedule|0|||
124588241|NCT03407729|448110794|FG001|Overall Study|Unable to schedule|3|||
124588242|NCT02943096|448110795|FG000|Overall Study|Lack of Efficacy|0|||
124588243|NCT02943096|448110796|FG001|Overall Study|Lack of Efficacy|1|||
124588244|NCT04142658|448110797|FG000|Overall Study|Death|2|||
124588245|NCT04142658|448110798|FG001|Overall Study|Death|1|||
124588246|NCT04142658|448110797|FG000|Overall Study|Lost to Follow-up|4|||
124588247|NCT04142658|448110798|FG001|Overall Study|Lost to Follow-up|13|||
124588248|NCT04142658|448110797|FG000|Overall Study|Withdrawal by Subject|9|||
124588249|NCT04142658|448110798|FG001|Overall Study|Withdrawal by Subject|16|||
124588250|NCT00939523|448110803|FG000|Overall Study|Lack of Efficacy|1|||
124588251|NCT00939523|448110803|FG000|Overall Study|Physician Decision|2|||
124588252|NCT00024258|448110804|FG000|Overall Study|Withdrawal by Subject|1|||
124588253|NCT00024258|448110804|FG000|Overall Study|Disease Progression|8|||
124588254|NCT01050764|448110805|FG000|Overall Study|Death, before HSCT|1|||
124588255|NCT01050764|448110805|FG000|Overall Study|Donor mobilization failure, death|1|||
124588256|NCT01050764|448110805|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
124588257|NCT02119936|448110815|FG000|Overall Study|Lost to Follow-up|10|||
124588258|NCT00570128|448110816|FG000|Overall Study|Adverse Event|1|||
124588259|NCT00570128|448110817|FG001|Overall Study|Adverse Event|0|||
124588260|NCT00570128|448110816|FG000|Overall Study|Lost to Follow-up|1|||
124588261|NCT00570128|448110817|FG001|Overall Study|Lost to Follow-up|0|||
124588262|NCT00570128|448110816|FG000|Overall Study|Withdrawal by Subject|2|||
124588263|NCT00570128|448110817|FG001|Overall Study|Withdrawal by Subject|0|||
124588264|NCT04194008|448110820|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
124588265|NCT04194008|448110820|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
124588266|NCT04194008|448110820|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
124588267|NCT04194008|448110820|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
124588268|NCT04194008|448110820|FG000|Treatment Phase With Nerivio|Missing data|4|||
124588269|NCT04194008|448110820|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
124588270|NCT02218216|448110821|FG000|Overall Study|Study terminated before completed|6|||
124588271|NCT02218216|448110822|FG001|Overall Study|Study terminated before completed|0|||
124588272|NCT02218216|448110823|FG002|Overall Study|Study terminated before completed|0|||
124588273|NCT00640341|448112440|FG000|Overall Study|Adverse Event|0|||
124588274|NCT00640341|448112441|FG001|Overall Study|Adverse Event|0|||
124588275|NCT00640341|448112442|FG002|Overall Study|Adverse Event|1|||
124588276|NCT00640341|448112440|FG000|Overall Study|Positive Slit Lamp Findings|0|||
124588277|NCT00640341|448112441|FG001|Overall Study|Positive Slit Lamp Findings|0|||
124588278|NCT00640341|448112442|FG002|Overall Study|Positive Slit Lamp Findings|1|||
124588279|NCT00640341|448112440|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
124588280|NCT00640341|448112441|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
124588281|NCT00640341|448112442|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
124588282|NCT00640341|448112440|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
124588283|NCT00640341|448112441|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
124588284|NCT00640341|448112442|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
124588285|NCT00640341|448112440|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
124588286|NCT00640341|448112441|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
124588287|NCT00640341|448112442|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
124588288|NCT00640341|448112440|FG000|Overall Study|Lost to Follow-up|2|||
124588289|NCT00640341|448112441|FG001|Overall Study|Lost to Follow-up|0|||
124588290|NCT00640341|448112442|FG002|Overall Study|Lost to Follow-up|0|||
124588291|NCT00640341|448112440|FG000|Overall Study|Withdrawal by Subject|4|||
124588292|NCT00640341|448112441|FG001|Overall Study|Withdrawal by Subject|0|||
124588293|NCT00640341|448112442|FG002|Overall Study|Withdrawal by Subject|1|||
124588294|NCT00640341|448112440|FG000|Overall Study|Unacceptable Lens Movement|1|||
124588295|NCT00640341|448112441|FG001|Overall Study|Unacceptable Lens Movement|0|||
124588296|NCT00640341|448112442|FG002|Overall Study|Unacceptable Lens Movement|0|||
124588297|NCT00640341|448112440|FG000|Overall Study|Poor fit/Uncomfortable|4|||
124588298|NCT00640341|448112441|FG001|Overall Study|Poor fit/Uncomfortable|0|||
124588299|NCT00640341|448112442|FG002|Overall Study|Poor fit/Uncomfortable|0|||
124588300|NCT00640341|448112440|FG000|Overall Study|Ineligable at Baseline|5|||
124588301|NCT00640341|448112441|FG001|Overall Study|Ineligable at Baseline|3|||
124588302|NCT00640341|448112442|FG002|Overall Study|Ineligable at Baseline|2|||
124588303|NCT00640341|448112440|FG000|Overall Study|Adverse event and positive slit lamp|1|||
124588304|NCT00640341|448112441|FG001|Overall Study|Adverse event and positive slit lamp|0|||
124588305|NCT00640341|448112442|FG002|Overall Study|Adverse event and positive slit lamp|0|||
124588306|NCT01520987|448112445|FG000|Overall Study|Withdrawal by Subject|1|||
124588307|NCT01520987|448112446|FG001|Overall Study|Withdrawal by Subject|0|||
124588308|NCT01520987|448112447|FG002|Overall Study|Withdrawal by Subject|0|||
124588309|NCT01520987|448112448|FG003|Overall Study|Withdrawal by Subject|0|||
124729544|NCT02442310|448632481|FG000|Overall Study|Adverse Event|2|||
124588310|NCT01520987|448112449|FG004|Overall Study|Withdrawal by Subject|0|||
124588311|NCT01520987|448112450|FG005|Overall Study|Withdrawal by Subject|1|||
124588312|NCT01520987|448112451|FG006|Overall Study|Withdrawal by Subject|0|||
124588313|NCT01520987|448112452|FG007|Overall Study|Withdrawal by Subject|0|||
124588314|NCT02005562|448112453|FG000|Overall Study|Death|2|||
124588315|NCT02005562|448112454|FG001|Overall Study|Death|2|||
124588316|NCT02005562|448112453|FG000|Overall Study|Graft loss|7|||
124588317|NCT02005562|448112454|FG001|Overall Study|Graft loss|6|||
124588318|NCT02005562|448112453|FG000|Overall Study|Withdrawal by Subject|2|||
124588319|NCT02005562|448112454|FG001|Overall Study|Withdrawal by Subject|2|||
124588320|NCT02005562|448112453|FG000|Overall Study|No transplant|1|||
124588321|NCT02005562|448112454|FG001|Overall Study|No transplant|4|||
124588322|NCT02005562|448112453|FG000|Overall Study|Physician Decision|0|||
124588323|NCT02005562|448112454|FG001|Overall Study|Physician Decision|1|||
124588324|NCT02966340|448112457|FG000|Overall Study|Adverse Event|0|||
124588325|NCT02966340|448112458|FG001|Overall Study|Adverse Event|1|||
124588326|NCT02966340|448112457|FG000|Overall Study|Lost to Follow-up|0|||
124588327|NCT02966340|448112458|FG001|Overall Study|Lost to Follow-up|1|||
124588328|NCT02966340|448112457|FG000|Overall Study|Withdrawal by Subject|1|||
124588329|NCT02966340|448112458|FG001|Overall Study|Withdrawal by Subject|0|||
124588330|NCT02966340|448112457|FG000|Overall Study|data acquisition error|1|||
124588331|NCT02966340|448112458|FG001|Overall Study|data acquisition error|0|||
124588332|NCT02966340|448112457|FG000|Overall Study|startle non-responder|1|||
124588333|NCT02966340|448112458|FG001|Overall Study|startle non-responder|1|||
124588334|NCT01622660|448112459|FG000|Overall Study|Adverse Event|1|||
124588335|NCT04590781|448112460|FG000|Overall Study|Death|0|||
124588336|NCT04590781|448112461|FG001|Overall Study|Death|2|||
124588337|NCT04590781|448112460|FG000|Overall Study|Withdrawal by Subject|2|||
124588338|NCT04590781|448112461|FG001|Overall Study|Withdrawal by Subject|0|||
124588339|NCT01680016|448112462|FG000|Overall Study|Adverse Event|0|||
124588340|NCT01680016|448112463|FG001|Overall Study|Adverse Event|0|||
124588341|NCT01680016|448112464|FG002|Overall Study|Adverse Event|1|||
124588342|NCT01680016|448112465|FG003|Overall Study|Adverse Event|4|||
124588343|NCT01680016|448112462|FG000|Overall Study|The Subject went out of The Trial|1|||
124588344|NCT01680016|448112463|FG001|Overall Study|The Subject went out of The Trial|0|||
124588345|NCT01680016|448112464|FG002|Overall Study|The Subject went out of The Trial|3|||
124588346|NCT01680016|448112465|FG003|Overall Study|The Subject went out of The Trial|0|||
124588347|NCT01680016|448112462|FG000|Overall Study|Protocol Violation|0|||
124588348|NCT01680016|448112463|FG001|Overall Study|Protocol Violation|1|||
124588349|NCT01680016|448112464|FG002|Overall Study|Protocol Violation|0|||
124588350|NCT01680016|448112465|FG003|Overall Study|Protocol Violation|0|||
124588351|NCT01680016|448112462|FG000|Overall Study|Withdrawal by Subject|5|||
124588352|NCT01680016|448112463|FG001|Overall Study|Withdrawal by Subject|7|||
124588353|NCT01680016|448112464|FG002|Overall Study|Withdrawal by Subject|1|||
124588354|NCT01680016|448112465|FG003|Overall Study|Withdrawal by Subject|1|||
124588355|NCT01120899|448112466|FG000|Overall Study|Withdrawal by Subject|3|||
124588356|NCT00202839|448112469|FG000|Overall Study|Adverse Event|1|||
124588357|NCT00202839|448112470|FG001|Overall Study|Adverse Event|5|||
124588358|NCT00202839|448112469|FG000|Overall Study|Physician Decision|12|||
124588359|NCT00202839|448112470|FG001|Overall Study|Physician Decision|0|||
124588360|NCT00202839|448112469|FG000|Overall Study|Withdrawal by Subject|6|||
124588361|NCT00202839|448112470|FG001|Overall Study|Withdrawal by Subject|2|||
124588362|NCT00202839|448112469|FG000|Overall Study|Protocol Violation|2|||
124588363|NCT00202839|448112470|FG001|Overall Study|Protocol Violation|1|||
124588364|NCT00202839|448112469|FG000|Overall Study|Lost to Follow-up|3|||
124588365|NCT00202839|448112470|FG001|Overall Study|Lost to Follow-up|2|||
124588366|NCT00442351|448112471|FG000|Overall Study|Administrative|6|||
124588367|NCT00442351|448112472|FG001|Overall Study|Administrative|5|||
124588368|NCT00442351|448112471|FG000|Overall Study|Did not meet protocol eligibility|1|||
124588369|NCT00442351|448112472|FG001|Overall Study|Did not meet protocol eligibility|0|||
124588370|NCT00442351|448112471|FG000|Overall Study|Other|0|||
124588371|NCT00442351|448112472|FG001|Overall Study|Other|1|||
124588372|NCT00377156|448112477|FG000|Overall Study|Death|23|||
124588373|NCT00377156|448112478|FG001|Overall Study|Death|19|||
124588374|NCT00377156|448112477|FG000|Overall Study|Withdrawal by Subject|16|||
124588375|NCT00377156|448112478|FG001|Overall Study|Withdrawal by Subject|24|||
124588376|NCT00377156|448112477|FG000|Overall Study|Had follow-up <90 d|3|||
124588377|NCT00377156|448112478|FG001|Overall Study|Had follow-up <90 d|6|||
124588378|NCT00377156|448112477|FG000|Overall Study|Cancellation|1|||
124588379|NCT00377156|448112478|FG001|Overall Study|Cancellation|0|||
124588380|NCT00377156|448112477|FG000|Overall Study|Refused testing|0|||
124588381|NCT00377156|448112478|FG001|Overall Study|Refused testing|1|||
124588382|NCT00377156|448112477|FG000|Overall Study|Ineligible|0|||
124588383|NCT00377156|448112478|FG001|Overall Study|Ineligible|1|||
124588384|NCT00377156|448112477|FG000|Overall Study|Disability or language problem|0|||
124588385|NCT00377156|448112478|FG001|Overall Study|Disability or language problem|1|||
124588386|NCT00377156|448112477|FG000|Overall Study|Other|5|||
124588387|NCT00377156|448112478|FG001|Overall Study|Other|2|||
124588388|NCT00288704|448112479|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
124588389|NCT00288704|448112480|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
124588390|NCT00288704|448112481|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
124588391|NCT00288704|448112479|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
124588392|NCT00288704|448112480|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
124588393|NCT00288704|448112481|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
124588394|NCT00288704|448112479|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
124588395|NCT00288704|448112480|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
124588396|NCT00288704|448112481|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
124588397|NCT00288704|448112479|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
124588398|NCT00288704|448112480|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
124588399|NCT00288704|448112481|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
124588400|NCT00288704|448112479|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
124588401|NCT00288704|448112480|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
124588402|NCT00288704|448112481|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
124588403|NCT00288704|448112479|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
124588404|NCT00288704|448112480|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
124588405|NCT00288704|448112481|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
124588406|NCT00288704|448112479|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
124588407|NCT00288704|448112480|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
124588408|NCT00288704|448112481|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
124588409|NCT01579006|448112482|FG000|Overall Study|Lack of Efficacy|10|||
124588410|NCT01579006|448112482|FG000|Overall Study|Adverse Event|13|||
124588411|NCT01579006|448112482|FG000|Overall Study|Withdrawal by Subject|5|||
124588412|NCT01579006|448112482|FG000|Overall Study|Non-compliance|3|||
124588413|NCT01579006|448112482|FG000|Overall Study|Due to participant's health fund|1|||
124588414|NCT01579006|448112482|FG000|Overall Study|Scheduled surgery|1|||
124588415|NCT02473393|448112485|FG000|Overall Study|Adverse Event|0|||
124588416|NCT02473393|448112486|FG001|Overall Study|Adverse Event|0|||
124588417|NCT02473393|448112487|FG002|Overall Study|Adverse Event|1|||
124588418|NCT02473393|448112488|FG003|Overall Study|Adverse Event|0|||
124777719|NCT02963506|448813103|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
124588419|NCT02473393|448112485|FG000|Overall Study|Withdrawal by Subject|0|||
124588420|NCT02473393|448112486|FG001|Overall Study|Withdrawal by Subject|0|||
124588421|NCT02473393|448112487|FG002|Overall Study|Withdrawal by Subject|1|||
124588422|NCT02473393|448112488|FG003|Overall Study|Withdrawal by Subject|1|||
124588423|NCT02697617|448112489|FG000|Overall Study|Withdrawal by Subject|0|||
124588424|NCT02697617|448112490|FG001|Overall Study|Withdrawal by Subject|2|||
124588425|NCT02697617|448112489|FG000|Overall Study|Pregnancy|1|||
124588426|NCT02697617|448112490|FG001|Overall Study|Pregnancy|0|||
124588427|NCT02460835|448112491|FG000|Overall Study|Disease progression prior to treatment|3|||
124588428|NCT02460835|448112491|FG000|Overall Study|Unable to complete planning scans|2|||
124588429|NCT02460835|448112491|FG000|Overall Study|Decrease in performance status|1|||
124588430|NCT02460835|448112491|FG000|Overall Study|Withdrawal by Subject|3|||
124588431|NCT02460835|448112491|FG000|Overall Study|Underwent fractionated RT|10|||
124588432|NCT02460835|448112491|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
124588433|NCT00517192|448112495|FG000|Overall Study|Adverse Event|1|||
124588434|NCT00517192|448112496|FG001|Overall Study|Adverse Event|1|||
124588435|NCT00517192|448112495|FG000|Overall Study|Lost to Follow-up|1|||
124588436|NCT00517192|448112496|FG001|Overall Study|Lost to Follow-up|1|||
124588437|NCT00517192|448112495|FG000|Overall Study|Withdrawal by Subject|1|||
124588438|NCT00517192|448112496|FG001|Overall Study|Withdrawal by Subject|0|||
124588439|NCT00517192|448112495|FG000|Overall Study|Early termination of the trial|16|||
124588440|NCT00517192|448112496|FG001|Overall Study|Early termination of the trial|18|||
124588441|NCT02733627|448112498|FG000|Overall Study|Adverse Event|0|||
124588442|NCT02733627|448112499|FG001|Overall Study|Adverse Event|1|||
124588443|NCT02733627|448112500|FG002|Overall Study|Adverse Event|1|||
124588444|NCT02733627|448112501|FG003|Overall Study|Adverse Event|0|||
124588445|NCT02733627|448112498|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
124588446|NCT02733627|448112499|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
124588447|NCT02733627|448112500|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
124588448|NCT02733627|448112501|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
124588449|NCT00183196|448112502|FG000|Overall Study|Withdrawal by Subject|18|||
124588450|NCT00183196|448112503|FG001|Overall Study|Withdrawal by Subject|11|||
124588451|NCT00183196|448112504|FG002|Overall Study|Withdrawal by Subject|13|||
124588452|NCT00183196|448112502|FG000|Overall Study|Adverse Event|1|||
124588453|NCT00183196|448112503|FG001|Overall Study|Adverse Event|2|||
124588454|NCT00183196|448112504|FG002|Overall Study|Adverse Event|2|||
124777720|NCT00750438|448813104|FG000|Overall Study|Protocol Violation|4|||
124777721|NCT00750438|448813105|FG001|Overall Study|Protocol Violation|1|||
124588455|NCT00183196|448112502|FG000|Overall Study|Legal event|1|||
124588456|NCT00183196|448112503|FG001|Overall Study|Legal event|1|||
124588457|NCT00183196|448112504|FG002|Overall Study|Legal event|1|||
124588458|NCT00183196|448112502|FG000|Overall Study|Required more intensive care|0|||
124588459|NCT00183196|448112503|FG001|Overall Study|Required more intensive care|1|||
124588460|NCT00183196|448112504|FG002|Overall Study|Required more intensive care|2|||
124588461|NCT01119625|448112505|FG000|Overall Study|Lost to Follow-up|1|||
124588462|NCT01119625|448112506|FG001|Overall Study|Lost to Follow-up|2|||
124588463|NCT01119625|448112505|FG000|Overall Study|Withdrawal by Subject|2|||
124588464|NCT01119625|448112506|FG001|Overall Study|Withdrawal by Subject|1|||
124588465|NCT01119625|448112505|FG000|Overall Study|Other|0|||
124588466|NCT01119625|448112506|FG001|Overall Study|Other|1|||
124588467|NCT01721772|448112511|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
124588468|NCT01721772|448112512|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
124588469|NCT01721772|448112511|FG000|Pre-Treatment|Poor/non-compliance|0|||
124588470|NCT01721772|448112512|FG001|Pre-Treatment|Poor/non-compliance|1|||
124588471|NCT01721772|448112511|FG000|Pre-Treatment|Participant withdrew consent|0|||
124588472|NCT01721772|448112512|FG001|Pre-Treatment|Participant withdrew consent|1|||
124588473|NCT01721772|448112511|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
124588474|NCT01721772|448112512|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
124588475|NCT01721772|448112511|FG000|Treatment|Disease progression|119|||
124588476|NCT01721772|448112512|FG001|Treatment|Disease progression|168|||
124588477|NCT01721772|448112511|FG000|Treatment|Study drug toxicity|19|||
124588478|NCT01721772|448112512|FG001|Treatment|Study drug toxicity|10|||
124588479|NCT01721772|448112511|FG000|Treatment|Adverse event unrelated to study drug|7|||
124588480|NCT01721772|448112512|FG001|Treatment|Adverse event unrelated to study drug|7|||
124588481|NCT01721772|448112511|FG000|Treatment|Maximum clinical benefit|16|||
124588482|NCT01721772|448112512|FG001|Treatment|Maximum clinical benefit|4|||
124588483|NCT01721772|448112511|FG000|Treatment|Other|19|||
124588484|NCT01721772|448112512|FG001|Treatment|Other|2|||
124588485|NCT01721772|448112511|FG000|Treatment|Participant withdrew consent|2|||
124588486|NCT01721772|448112512|FG001|Treatment|Participant withdrew consent|5|||
124588487|NCT01721772|448112511|FG000|Treatment|Participant request to discontinue study treatment|21|||
124588488|NCT01721772|448112512|FG001|Treatment|Participant request to discontinue study treatment|8|||
124588489|NCT01721772|448112511|FG000|Treatment|Death|1|||
124588490|NCT01721772|448112512|FG001|Treatment|Death|0|||
124588491|NCT01721772|448112511|FG000|Treatment|Not reported|1|||
124588492|NCT01721772|448112512|FG001|Treatment|Not reported|0|||
124588493|NCT01721772|448112511|FG000|Treatment|Poor/non-compliance|1|||
124588494|NCT01721772|448112512|FG001|Treatment|Poor/non-compliance|0|||
124588495|NCT01721772|448112511|FG000|Treatment|Lost to Follow-up|0|||
124588496|NCT01721772|448112512|FG001|Treatment|Lost to Follow-up|1|||
124588497|NCT05004649|448112518|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
124588498|NCT05004649|448112518|FG000|Overall Study|Lost to Follow-up|1|||
124588499|NCT05004649|448112518|FG000|Overall Study|Withdrawal by Subject|2|||
124588500|NCT05004649|448112518|FG000|Overall Study|COVID-19|1|||
124588501|NCT01698554|448112519|FG000|Overall Study|Adverse Event|2|||
124588502|NCT01698554|448112520|FG001|Overall Study|Adverse Event|5|||
124588503|NCT01698554|448112521|FG002|Overall Study|Adverse Event|0|||
124588504|NCT01698554|448112522|FG003|Overall Study|Adverse Event|1|||
124588505|NCT01698554|448112519|FG000|Overall Study|Lost to Follow-up|1|||
124588506|NCT01698554|448112520|FG001|Overall Study|Lost to Follow-up|0|||
124588507|NCT01698554|448112521|FG002|Overall Study|Lost to Follow-up|0|||
124588508|NCT01698554|448112522|FG003|Overall Study|Lost to Follow-up|0|||
124588509|NCT01698554|448112519|FG000|Overall Study|Personal Reasons|0|||
124588510|NCT01698554|448112520|FG001|Overall Study|Personal Reasons|5|||
124588511|NCT01698554|448112521|FG002|Overall Study|Personal Reasons|1|||
124588512|NCT01698554|448112522|FG003|Overall Study|Personal Reasons|1|||
124588513|NCT01698554|448112519|FG000|Overall Study|Protocol Violation|2|||
124588514|NCT01698554|448112520|FG001|Overall Study|Protocol Violation|0|||
124588515|NCT01698554|448112521|FG002|Overall Study|Protocol Violation|1|||
124588516|NCT01698554|448112522|FG003|Overall Study|Protocol Violation|0|||
124588517|NCT01698554|448112519|FG000|Overall Study|Other Miscellaneous Reasons|1|||
124588518|NCT01698554|448112520|FG001|Overall Study|Other Miscellaneous Reasons|0|||
124588519|NCT01698554|448112521|FG002|Overall Study|Other Miscellaneous Reasons|0|||
124588520|NCT01698554|448112522|FG003|Overall Study|Other Miscellaneous Reasons|0|||
124588521|NCT02654145|448112523|FG000|Overall Study|Lack of Efficacy|1|||
124588522|NCT02654145|448112523|FG000|Overall Study|Protocol Violation|1|||
124588523|NCT02654145|448112523|FG000|Overall Study|Withdrawal by Subject|5|||
124588524|NCT02637141|448112524|FG000|Overall Study|Adverse Event|1|||
124588525|NCT02637141|448112525|FG001|Overall Study|Adverse Event|1|||
124588526|NCT02637141|448112526|FG002|Overall Study|Adverse Event|0|||
124588527|NCT02637141|448112524|FG000|Overall Study|Withdrawal by Subject|1|||
124588528|NCT02637141|448112525|FG001|Overall Study|Withdrawal by Subject|1|||
124588529|NCT02637141|448112526|FG002|Overall Study|Withdrawal by Subject|1|||
124588530|NCT01943435|448112528|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
124588531|NCT01943435|448112529|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
124588532|NCT01943435|448112530|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
124588533|NCT01943435|448112528|FG000|Intervention Period|Withdrawal by Subject|3|||
124588534|NCT01943435|448112529|FG001|Intervention Period|Withdrawal by Subject|3|||
124588535|NCT01943435|448112530|FG002|Intervention Period|Withdrawal by Subject|4|||
124588536|NCT01943435|448112528|FG000|2 Month Follow up|Lost to Follow-up|2|||
124588537|NCT01943435|448112529|FG001|2 Month Follow up|Lost to Follow-up|3|||
124588538|NCT01943435|448112530|FG002|2 Month Follow up|Lost to Follow-up|0|||
124588539|NCT01943435|448112528|FG000|6 Month Follow up|Lost to Follow-up|12|||
124588540|NCT01943435|448112529|FG001|6 Month Follow up|Lost to Follow-up|7|||
124588541|NCT01943435|448112530|FG002|6 Month Follow up|Lost to Follow-up|15|||
124588542|NCT03885934|448112531|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
124588543|NCT03885934|448112532|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
124588544|NCT03885934|448112533|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
124588545|NCT03885934|448112534|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
124588546|NCT03885934|448112535|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
124588547|NCT03885934|448112536|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
124588548|NCT04535986|448112541|FG000|Overall Study|Death|4|||
124588549|NCT04535986|448112542|FG001|Overall Study|Death|5|||
124588550|NCT04535986|448112541|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
124588551|NCT04535986|448112542|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
124588552|NCT04535986|448112541|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
124588553|NCT04535986|448112542|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
124588554|NCT04535986|448112541|FG000|Overall Study|Adverse Event|10|||
124588555|NCT04535986|448112542|FG001|Overall Study|Adverse Event|1|||
124588556|NCT04535986|448112541|FG000|Overall Study|Lack of Efficacy|3|||
124588557|NCT04535986|448112542|FG001|Overall Study|Lack of Efficacy|2|||
124588558|NCT04535986|448112541|FG000|Overall Study|Investigator discretion|3|||
124588559|NCT04535986|448112542|FG001|Overall Study|Investigator discretion|0|||
124588560|NCT04535986|448112541|FG000|Overall Study|Withdrawal by Subject|32|||
124588561|NCT04535986|448112542|FG001|Overall Study|Withdrawal by Subject|14|||
124588562|NCT04535986|448112541|FG000|Overall Study|Lost to Follow-up|5|||
124588563|NCT04535986|448112542|FG001|Overall Study|Lost to Follow-up|3|||
124588564|NCT04535986|448112541|FG000|Overall Study|Other|7|||
124588565|NCT04535986|448112542|FG001|Overall Study|Other|3|||
124588566|NCT01559116|448112548|FG000|Overall Study|Adverse Event|10|||
124588567|NCT01559116|448112548|FG000|Overall Study|Lack of Efficacy|1|||
124588568|NCT01559116|448112548|FG000|Overall Study|Lost to Follow-up|1|||
124588569|NCT01559116|448112548|FG000|Overall Study|Protocol Violation|1|||
124588570|NCT01559116|448112548|FG000|Overall Study|Withdrawal by Subject|4|||
124588571|NCT01559116|448112548|FG000|Overall Study|other than stated above|9|||
124588572|NCT02377349|448112549|FG000|Overall Study|Serious Adverse Event|1|||
124588573|NCT02377349|448112550|FG001|Overall Study|Serious Adverse Event|0|||
124588574|NCT02377349|448112549|FG000|Overall Study|Protocol Violation|3|||
124588575|NCT02377349|448112550|FG001|Overall Study|Protocol Violation|2|||
124588576|NCT02377349|448112549|FG000|Overall Study|Withdrawal by Subject|5|||
124588577|NCT02377349|448112550|FG001|Overall Study|Withdrawal by Subject|3|||
124588578|NCT02377349|448112549|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
124588579|NCT02377349|448112550|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
124588580|NCT02377349|448112549|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
124588581|NCT02377349|448112550|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
124588582|NCT02377349|448112549|FG000|Overall Study|Other|0|||
124588583|NCT02377349|448112550|FG001|Overall Study|Other|1|||
124588584|NCT03259165|448112551|FG000|Overall Study|COVID 19 pandemic|1|||
124588585|NCT03259165|448112552|FG001|Overall Study|COVID 19 pandemic|1|||
124588586|NCT00550147|448112555|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
124588587|NCT00550147|448112555|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
124588588|NCT00550147|448112555|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
124588589|NCT00550147|448112555|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
124588590|NCT00550147|448112555|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
124588591|NCT01824498|448112556|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
124588592|NCT01824498|448112557|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
124588593|NCT01824498|448112558|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
124588594|NCT01824498|448112559|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
124588595|NCT01824498|448112560|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
124777722|NCT00750438|448813104|FG000|Overall Study|Physician Decision|2|||
124777723|NCT00750438|448813105|FG001|Overall Study|Physician Decision|2|||
124777724|NCT00750438|448813104|FG000|Overall Study|Withdrawal by Subject|1|||
124777725|NCT00750438|448813105|FG001|Overall Study|Withdrawal by Subject|1|||
124777726|NCT00928408|448813110|FG000|Overall Study|Other|2|||
124588596|NCT01824498|448112561|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
124588597|NCT01567527|448112562|FG000|Conversion Phase.|Protocol deviation|3|||
124588598|NCT01567527|448112563|FG001|Conversion Phase.|Protocol deviation|0|||
124588599|NCT01567527|448112564|FG002|Conversion Phase.|Protocol deviation|0|||
124588600|NCT01567527|448112565|FG003|Conversion Phase.|Protocol deviation|0|||
124588601|NCT01567527|448112566|FG004|Conversion Phase.|Protocol deviation|0|||
124588602|NCT01567527|448112562|FG000|Conversion Phase.|Met withdrawal criteria|10|||
124588603|NCT01567527|448112563|FG001|Conversion Phase.|Met withdrawal criteria|0|||
124588604|NCT01567527|448112564|FG002|Conversion Phase.|Met withdrawal criteria|0|||
124588605|NCT01567527|448112565|FG003|Conversion Phase.|Met withdrawal criteria|0|||
124588606|NCT01567527|448112566|FG004|Conversion Phase.|Met withdrawal criteria|0|||
124588607|NCT01567527|448112562|FG000|Conversion Phase.|Withdrawal by Subject|32|||
124588608|NCT01567527|448112563|FG001|Conversion Phase.|Withdrawal by Subject|0|||
124588609|NCT01567527|448112564|FG002|Conversion Phase.|Withdrawal by Subject|0|||
124588610|NCT01567527|448112565|FG003|Conversion Phase.|Withdrawal by Subject|0|||
124588611|NCT01567527|448112566|FG004|Conversion Phase.|Withdrawal by Subject|0|||
124588612|NCT01567527|448112562|FG000|Conversion Phase.|Lost to Follow-up|16|||
124588613|NCT01567527|448112563|FG001|Conversion Phase.|Lost to Follow-up|0|||
124588614|NCT01567527|448112564|FG002|Conversion Phase.|Lost to Follow-up|0|||
124588615|NCT01567527|448112565|FG003|Conversion Phase.|Lost to Follow-up|0|||
124588616|NCT01567527|448112566|FG004|Conversion Phase.|Lost to Follow-up|0|||
124588617|NCT01567527|448112562|FG000|Conversion Phase.|Lack of Efficacy|2|||
124588618|NCT01567527|448112563|FG001|Conversion Phase.|Lack of Efficacy|0|||
124588619|NCT01567527|448112564|FG002|Conversion Phase.|Lack of Efficacy|0|||
124588620|NCT01567527|448112565|FG003|Conversion Phase.|Lack of Efficacy|0|||
124588621|NCT01567527|448112566|FG004|Conversion Phase.|Lack of Efficacy|0|||
124588622|NCT01567527|448112562|FG000|Conversion Phase.|Adverse Event|33|||
124588623|NCT01567527|448112563|FG001|Conversion Phase.|Adverse Event|0|||
124588624|NCT01567527|448112564|FG002|Conversion Phase.|Adverse Event|0|||
124588625|NCT01567527|448112565|FG003|Conversion Phase.|Adverse Event|0|||
124588626|NCT01567527|448112566|FG004|Conversion Phase.|Adverse Event|0|||
124588627|NCT01567527|448112562|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
124588628|NCT01567527|448112563|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
124588629|NCT01567527|448112564|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
124588630|NCT01567527|448112565|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
124588631|NCT01567527|448112566|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
124588632|NCT01567527|448112562|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
124588633|NCT01567527|448112563|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
124588634|NCT01567527|448112564|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
124588635|NCT01567527|448112565|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
124588636|NCT01567527|448112566|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
124588637|NCT01567527|448112562|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
124588638|NCT01567527|448112563|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
124588639|NCT01567527|448112564|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
124588640|NCT01567527|448112565|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
124588641|NCT01567527|448112566|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
124588642|NCT01567527|448112562|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
124588643|NCT01567527|448112563|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
124588644|NCT01567527|448112564|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
124588645|NCT01567527|448112565|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
124588646|NCT01567527|448112566|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
124588647|NCT01567527|448112562|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
124588648|NCT01567527|448112563|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
124588649|NCT01567527|448112564|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
124588650|NCT01567527|448112565|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
124588651|NCT01567527|448112566|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
124588652|NCT01567527|448112562|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
124588653|NCT01567527|448112563|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
124588654|NCT01567527|448112564|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
124588655|NCT01567527|448112565|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
124588656|NCT01567527|448112566|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
124588657|NCT01567527|448112562|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
124588658|NCT01567527|448112563|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
124588659|NCT01567527|448112564|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
124588660|NCT01567527|448112565|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
124588661|NCT01567527|448112566|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
124588662|NCT01567527|448112562|FG000|IM Depot Stabilization.|Protocol deviation|0|||
124588663|NCT01567527|448112563|FG001|IM Depot Stabilization.|Protocol deviation|0|||
124588664|NCT01567527|448112564|FG002|IM Depot Stabilization.|Protocol deviation|5|||
124588665|NCT01567527|448112565|FG003|IM Depot Stabilization.|Protocol deviation|0|||
124588666|NCT01567527|448112566|FG004|IM Depot Stabilization.|Protocol deviation|0|||
124588667|NCT01567527|448112562|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
124588668|NCT01567527|448112563|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
124588669|NCT01567527|448112564|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
124588670|NCT01567527|448112565|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
124588671|NCT01567527|448112566|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
124588672|NCT01567527|448112562|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
124588673|NCT01567527|448112563|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
124588674|NCT01567527|448112564|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
124588675|NCT01567527|448112565|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
124588676|NCT01567527|448112566|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
124588677|NCT01567527|448112562|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
124588678|NCT01567527|448112563|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
124588679|NCT01567527|448112564|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
124588680|NCT01567527|448112565|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
124588681|NCT01567527|448112566|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
124588682|NCT01567527|448112562|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
124588683|NCT01567527|448112563|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
124588684|NCT01567527|448112564|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
124588685|NCT01567527|448112565|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
124588686|NCT01567527|448112566|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
124588687|NCT01567527|448112562|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
124588688|NCT01567527|448112563|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
124588689|NCT01567527|448112564|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
124588690|NCT01567527|448112565|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
124588691|NCT01567527|448112566|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
124588692|NCT01567527|448112562|FG000|IM Depot Stabilization.|Adverse Event|0|||
124588693|NCT01567527|448112563|FG001|IM Depot Stabilization.|Adverse Event|0|||
124588694|NCT01567527|448112564|FG002|IM Depot Stabilization.|Adverse Event|37|||
124588695|NCT01567527|448112565|FG003|IM Depot Stabilization.|Adverse Event|0|||
124588696|NCT01567527|448112566|FG004|IM Depot Stabilization.|Adverse Event|0|||
124588697|NCT01567527|448112562|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
124588698|NCT01567527|448112563|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
124588699|NCT01567527|448112564|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
124588700|NCT01567527|448112565|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
124588701|NCT01567527|448112566|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
124588702|NCT01567527|448112562|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
124588703|NCT01567527|448112563|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
124588704|NCT01567527|448112564|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
124588705|NCT01567527|448112565|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
124588706|NCT01567527|448112566|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
124588707|NCT01567527|448112562|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
124588708|NCT01567527|448112563|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
124588709|NCT01567527|448112564|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
124588710|NCT01567527|448112565|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
124588711|NCT01567527|448112566|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
124588712|NCT01567527|448112562|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
124588713|NCT01567527|448112563|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
124588714|NCT01567527|448112564|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
124588715|NCT01567527|448112565|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
124588716|NCT01567527|448112566|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
124588717|NCT01567527|448112562|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
124588718|NCT01567527|448112563|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
124588719|NCT01567527|448112564|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
124588720|NCT01567527|448112565|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
124588721|NCT01567527|448112566|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
124588722|NCT01567527|448112562|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
124588723|NCT01567527|448112563|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
124588724|NCT01567527|448112564|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
124588725|NCT01567527|448112565|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
124588726|NCT01567527|448112566|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
124588727|NCT01567527|448112562|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
124588728|NCT01567527|448112563|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
124588729|NCT01567527|448112564|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
124588730|NCT01567527|448112565|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
124588731|NCT01567527|448112566|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
124588732|NCT01567527|448112562|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
124588733|NCT01567527|448112563|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
124588734|NCT01567527|448112564|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
124588735|NCT01567527|448112565|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
124588736|NCT01567527|448112566|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
124588737|NCT01567527|448112562|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
124588738|NCT01567527|448112563|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
124588739|NCT01567527|448112564|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
124588740|NCT01567527|448112565|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
124588741|NCT01567527|448112566|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
124588742|NCT02623218|448112567|FG000|Overall Study|Lost to Follow-up|0|||
124588743|NCT02623218|448112568|FG001|Overall Study|Lost to Follow-up|1|||
124588744|NCT02623218|448112569|FG002|Overall Study|Lost to Follow-up|0|||
124588745|NCT02623218|448112570|FG003|Overall Study|Lost to Follow-up|0|||
124588746|NCT02623218|448112571|FG004|Overall Study|Lost to Follow-up|0|||
124588747|NCT01726803|448112572|FG000|Overall Study|Lost to Follow-up|6|||
124588748|NCT01726803|448112573|FG001|Overall Study|Lost to Follow-up|1|||
124588749|NCT01726803|448112572|FG000|Overall Study|Withdrawal by Subject|1|||
124588750|NCT01726803|448112573|FG001|Overall Study|Withdrawal by Subject|0|||
124588751|NCT01547728|448112579|FG000|Overall Study|Change in procedure and equipment|1|||
124588752|NCT01547728|448112579|FG000|Overall Study|Drug not ready for subject|1|||
124588753|NCT01547728|448112579|FG000|Overall Study|Screen failure|39|||
124588754|NCT03828539|448112580|FG000|Overall Study|Adverse Event|3|||
124588755|NCT03828539|448112581|FG001|Overall Study|Adverse Event|12|||
124588756|NCT03828539|448112580|FG000|Overall Study|Patient's/guardian's decision|3|||
124588757|NCT03828539|448112581|FG001|Overall Study|Patient's/guardian's decision|5|||
124588758|NCT03828539|448112580|FG000|Overall Study|Lost to Follow-up|4|||
124588759|NCT03828539|448112581|FG001|Overall Study|Lost to Follow-up|2|||
124588760|NCT03828539|448112580|FG000|Overall Study|Protocol Violation|3|||
124588761|NCT03828539|448112581|FG001|Overall Study|Protocol Violation|2|||
124588762|NCT03828539|448112580|FG000|Overall Study|Withdrawal of informed consent|2|||
124588763|NCT03828539|448112581|FG001|Overall Study|Withdrawal of informed consent|1|||
124588764|NCT03828539|448112580|FG000|Overall Study|New therapy for study indication|1|||
124588765|NCT03828539|448112581|FG001|Overall Study|New therapy for study indication|0|||
124588766|NCT01341405|448112582|FG000|Overall Study|Adverse Event|0|||
124588767|NCT01341405|448112583|FG001|Overall Study|Adverse Event|1|||
124588768|NCT01341405|448112584|FG002|Overall Study|Adverse Event|1|||
124588769|NCT01341405|448112582|FG000|Overall Study|Withdrawal by Subject|3|||
124588770|NCT01341405|448112583|FG001|Overall Study|Withdrawal by Subject|2|||
124588771|NCT01341405|448112584|FG002|Overall Study|Withdrawal by Subject|1|||
124588772|NCT02616380|448112585|FG000|Overall Study|Lost to Follow-up|1|||
124588773|NCT02616380|448112585|FG000|Overall Study|Other|2|||
124588774|NCT00826241|448112586|FG000|Overall Study|Withdrawal from Follow-up|1|||
124588775|NCT00826241|448112586|FG000|Overall Study|Withdrew consent|2|||
124588776|NCT00826241|448112586|FG000|Overall Study|Death|4|||
124588777|NCT00826241|448112586|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
124588778|NCT00826241|448112586|FG000|Overall Study|Non-compliance|1|||
124588779|NCT00826241|448112586|FG000|Overall Study|Progression of disease|1|||
124588780|NCT00826241|448112586|FG000|Overall Study|Patient refused follow-up|3|||
124588781|NCT00826241|448112586|FG000|Overall Study|Lost to Follow-up|9|||
124588782|NCT00826241|448112586|FG000|Overall Study|Could not obtain records|1|||
124588783|NCT00826241|448112586|FG000|Overall Study|Screen failure|2|||
124588784|NCT00826241|448112586|FG000|Overall Study|Pt unable to proceed to registration|1|||
124588785|NCT00826241|448112586|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
124588786|NCT03950674|448112591|FG000|Overall Study|Death|16|||
124588787|NCT03950674|448112592|FG001|Overall Study|Death|15|||
124588788|NCT03950674|448112591|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
124588789|NCT03950674|448112592|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
124588790|NCT00830167|448112595|FG000|Overall Study|Lack of Efficacy|26|||
124588791|NCT00830167|448112596|FG001|Overall Study|Lack of Efficacy|10|||
124588792|NCT00830167|448112595|FG000|Overall Study|Adverse Event|8|||
124588793|NCT00830167|448112596|FG001|Overall Study|Adverse Event|24|||
124588794|NCT00830167|448112595|FG000|Overall Study|Not meeting entrance criteria|2|||
124588795|NCT00830167|448112596|FG001|Overall Study|Not meeting entrance criteria|5|||
124588796|NCT00830167|448112595|FG000|Overall Study|Withdrawal by Subject|2|||
124588797|NCT00830167|448112596|FG001|Overall Study|Withdrawal by Subject|0|||
124588798|NCT00830167|448112595|FG000|Overall Study|Lost to Follow-up|0|||
124588799|NCT00830167|448112596|FG001|Overall Study|Lost to Follow-up|1|||
124588800|NCT00830167|448112595|FG000|Overall Study|Protocol Violation|0|||
124588801|NCT00830167|448112596|FG001|Overall Study|Protocol Violation|1|||
124588802|NCT00830167|448112595|FG000|Overall Study|Other|2|||
124588803|NCT00830167|448112596|FG001|Overall Study|Other|2|||
124588804|NCT02224053|448112597|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
124588805|NCT02224053|448112597|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
124588806|NCT02224053|448112597|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
124588807|NCT02224053|448112597|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
124588808|NCT02224053|448112597|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
124588809|NCT00609154|448112598|FG000|Overall Study|Protocol Violation|1|||
124588810|NCT00609154|448112599|FG001|Overall Study|Protocol Violation|2|||
124588811|NCT00609154|448112598|FG000|Overall Study|Unable to establish IV access|0|||
124588812|NCT00609154|448112599|FG001|Overall Study|Unable to establish IV access|4|||
124588813|NCT00609154|448112598|FG000|Overall Study|Adverse Event|0|||
124588814|NCT00609154|448112599|FG001|Overall Study|Adverse Event|2|||
124588815|NCT00124618|448112604|FG000|Overall Study|Ineligible|1|||
124588816|NCT03193021|448112605|FG000|Overall Study|Lost to Follow-up|1|||
124588817|NCT03193021|448112606|FG001|Overall Study|Lost to Follow-up|1|||
124588818|NCT01139762|448112607|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
124588819|NCT01139762|448112608|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
124588820|NCT01139762|448112609|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
124588821|NCT01139762|448112607|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
124588822|NCT01139762|448112608|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
124588823|NCT01139762|448112609|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
124588824|NCT01139762|448112607|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
124588825|NCT01139762|448112608|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
124588826|NCT01139762|448112609|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
124588827|NCT01139762|448112607|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
124588828|NCT01139762|448112608|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
124588829|NCT01139762|448112609|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
124588830|NCT01139762|448112607|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
124588831|NCT01139762|448112608|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
124588832|NCT01139762|448112609|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
124588833|NCT01139762|448112607|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
124588834|NCT01139762|448112608|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
124588835|NCT01139762|448112609|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
124588836|NCT01139762|448112607|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
124588837|NCT01139762|448112608|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
124588838|NCT01139762|448112609|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
124588839|NCT01139762|448112607|FG000|Double-Blind Randomized Active Treatment|Death|0|||
124588840|NCT01139762|448112608|FG001|Double-Blind Randomized Active Treatment|Death|1|||
124588841|NCT01139762|448112609|FG002|Double-Blind Randomized Active Treatment|Death|1|||
124588842|NCT01139762|448112607|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
124588843|NCT01139762|448112608|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
124588844|NCT01139762|448112609|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
124588845|NCT01139762|448112607|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
124588846|NCT01139762|448112608|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
124588847|NCT01139762|448112609|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
124588848|NCT01139762|448112607|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
124588849|NCT01139762|448112608|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
124588850|NCT01139762|448112609|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
124588851|NCT01139762|448112607|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
124588852|NCT01139762|448112608|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
124588853|NCT01139762|448112609|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
124588854|NCT01139762|448112607|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
124588855|NCT01139762|448112608|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
124588856|NCT01139762|448112609|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
124588857|NCT01139762|448112607|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
124588858|NCT01139762|448112608|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
124588859|NCT01139762|448112609|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
124588860|NCT01139762|448112607|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
124588861|NCT01139762|448112608|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
124588862|NCT01139762|448112609|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
124588863|NCT01675596|448112610|FG000|Overall Study|Death|6|||
124588864|NCT01675596|448112610|FG000|Overall Study|Exit with other reason|1|||
124588865|NCT01675596|448112610|FG000|Overall Study|Missed Visit|1|||
124588866|NCT02614196|448112611|FG000|Double Blind Treatment Phase|Adverse Event|8|||
124588867|NCT02614196|448112612|FG001|Double Blind Treatment Phase|Adverse Event|5|||
124588868|NCT02614196|448112613|FG002|Double Blind Treatment Phase|Adverse Event|9|||
124588869|NCT02614196|448112614|FG003|Double Blind Treatment Phase|Adverse Event|0|||
124588870|NCT02614196|448112615|FG004|Double Blind Treatment Phase|Adverse Event|0|||
124588871|NCT02614196|448112616|FG005|Double Blind Treatment Phase|Adverse Event|0|||
124588872|NCT02614196|448112611|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
124588873|NCT02614196|448112612|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
124588874|NCT02614196|448112613|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
124588875|NCT02614196|448112614|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
124588876|NCT02614196|448112615|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
124588877|NCT02614196|448112616|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
124588878|NCT02614196|448112611|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
124588879|NCT02614196|448112612|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
124588880|NCT02614196|448112613|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
124588881|NCT02614196|448112614|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
124588882|NCT02614196|448112615|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
124588883|NCT02614196|448112616|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
124588884|NCT02614196|448112611|FG000|Double Blind Treatment Phase|Physician Decision|4|||
124588885|NCT02614196|448112612|FG001|Double Blind Treatment Phase|Physician Decision|0|||
124588886|NCT02614196|448112613|FG002|Double Blind Treatment Phase|Physician Decision|2|||
124588887|NCT02614196|448112614|FG003|Double Blind Treatment Phase|Physician Decision|0|||
124588888|NCT02614196|448112615|FG004|Double Blind Treatment Phase|Physician Decision|0|||
124588889|NCT02614196|448112616|FG005|Double Blind Treatment Phase|Physician Decision|0|||
124588890|NCT02614196|448112611|FG000|Double Blind Treatment Phase|Pregnancy|1|||
124588891|NCT02614196|448112612|FG001|Double Blind Treatment Phase|Pregnancy|2|||
124588892|NCT02614196|448112613|FG002|Double Blind Treatment Phase|Pregnancy|0|||
124588893|NCT02614196|448112614|FG003|Double Blind Treatment Phase|Pregnancy|0|||
124588894|NCT02614196|448112615|FG004|Double Blind Treatment Phase|Pregnancy|0|||
124588895|NCT02614196|448112616|FG005|Double Blind Treatment Phase|Pregnancy|0|||
124588896|NCT02614196|448112611|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
124588897|NCT02614196|448112612|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
124588898|NCT02614196|448112613|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
124588899|NCT02614196|448112614|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
124588900|NCT02614196|448112615|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
124588901|NCT02614196|448112616|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
124588902|NCT02614196|448112611|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
124588903|NCT02614196|448112612|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
124588904|NCT02614196|448112613|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
124588905|NCT02614196|448112614|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
124588906|NCT02614196|448112615|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
124588907|NCT02614196|448112616|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
124588908|NCT02614196|448112611|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
124588909|NCT02614196|448112612|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
124588910|NCT02614196|448112613|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
124588911|NCT02614196|448112614|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
124588912|NCT02614196|448112615|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
124588913|NCT02614196|448112616|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
124588914|NCT02614196|448112611|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
124588915|NCT02614196|448112612|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
124588916|NCT02614196|448112613|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
124588917|NCT02614196|448112614|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
124588918|NCT02614196|448112615|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
124588919|NCT02614196|448112616|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
124588920|NCT02614196|448112611|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
124588921|NCT02614196|448112612|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
124588922|NCT02614196|448112613|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
124588923|NCT02614196|448112614|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
124588924|NCT02614196|448112615|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
124588925|NCT02614196|448112616|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
124588926|NCT02614196|448112611|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
124588927|NCT02614196|448112612|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
124588928|NCT02614196|448112613|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
124588929|NCT02614196|448112614|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
124588930|NCT02614196|448112615|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
124588931|NCT02614196|448112616|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
124588932|NCT02614196|448112611|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
124588933|NCT02614196|448112612|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
124588934|NCT02614196|448112613|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
124588935|NCT02614196|448112614|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
124588936|NCT02614196|448112615|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
124588937|NCT02614196|448112616|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
124588938|NCT02614196|448112611|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
124588939|NCT02614196|448112612|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
124588940|NCT02614196|448112613|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
124588941|NCT02614196|448112614|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
124588942|NCT02614196|448112615|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
124588943|NCT02614196|448112616|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
124588944|NCT01539239|448112617|FG000|Overall Study|Death|5|||
124588945|NCT01539239|448112618|FG001|Overall Study|Death|5|||
124588946|NCT01539239|448112617|FG000|Overall Study|Lost to Follow-up|7|||
124588947|NCT01539239|448112618|FG001|Overall Study|Lost to Follow-up|12|||
124637354|NCT05310071|448290490|FG000|Overall Study|Study Terminated by Sponsor|282|||
124588948|NCT02219009|448114179|FG000|Overall Study|Withdrawal by Subject|5|||
124588949|NCT02219009|448114180|FG001|Overall Study|Withdrawal by Subject|1|||
124588950|NCT02219009|448114179|FG000|Overall Study|Adverse Event|2|||
124588951|NCT02219009|448114180|FG001|Overall Study|Adverse Event|4|||
124588952|NCT02219009|448114179|FG000|Overall Study|Lost to Follow-up|2|||
124588953|NCT02219009|448114180|FG001|Overall Study|Lost to Follow-up|2|||
124588954|NCT02219009|448114179|FG000|Overall Study|Protocol deviation|1|||
124588955|NCT02219009|448114180|FG001|Overall Study|Protocol deviation|0|||
124588956|NCT02219009|448114179|FG000|Overall Study|Physician Decision|0|||
124588957|NCT02219009|448114180|FG001|Overall Study|Physician Decision|1|||
124588958|NCT00274625|448114181|FG000|Overall Study|Lost to Follow-up|46|||
124588959|NCT00274625|448114182|FG001|Overall Study|Lost to Follow-up|54|||
124588960|NCT00274625|448114181|FG000|Overall Study|Excluded from analysis|14|||
124588961|NCT00274625|448114182|FG001|Overall Study|Excluded from analysis|8|||
124588962|NCT03087786|448114184|FG000|Overall Study|Withdrawal by Subject|2|||
124588963|NCT03087786|448114185|FG001|Overall Study|Withdrawal by Subject|0|||
124588964|NCT00880334|448114186|FG000|Randomized Phase|Physician Decision|1|||
124588965|NCT00880334|448114187|FG001|Randomized Phase|Physician Decision|0|||
124588966|NCT00880334|448114186|FG000|Randomized Phase|Withdrawal by Subject|2|||
124588967|NCT00880334|448114187|FG001|Randomized Phase|Withdrawal by Subject|1|||
124588968|NCT00880334|448114186|FG000|Randomized Phase|Inadequate Labs|1|||
124588969|NCT00880334|448114187|FG001|Randomized Phase|Inadequate Labs|1|||
124588970|NCT00880334|448114186|FG000|Randomized Phase|Brain Metastasis|0|||
124588971|NCT00880334|448114187|FG001|Randomized Phase|Brain Metastasis|1|||
124588972|NCT00880334|448114186|FG000|Randomized Phase|Crossover Participants|0|||
124588973|NCT00880334|448114187|FG001|Randomized Phase|Crossover Participants|37|||
124588974|NCT02419573|448114195|FG000|Overall Study|Lost to Follow-up|3|||
124588975|NCT02419573|448114196|FG001|Overall Study|Lost to Follow-up|0|||
124588976|NCT02419573|448114195|FG000|Overall Study|Withdrawal by Subject|1|||
124588977|NCT02419573|448114196|FG001|Overall Study|Withdrawal by Subject|0|||
124588978|NCT02229084|448114197|FG000|Overall Study|Adverse Event|1|||
124588979|NCT02229084|448114198|FG001|Overall Study|Adverse Event|0|||
124588980|NCT02229084|448114199|FG002|Overall Study|Adverse Event|0|||
124588981|NCT02229084|448114200|FG003|Overall Study|Adverse Event|0|||
124588982|NCT02229084|448114201|FG004|Overall Study|Adverse Event|0|||
124588983|NCT02229084|448114202|FG005|Overall Study|Adverse Event|0|||
124588984|NCT02229084|448114203|FG006|Overall Study|Adverse Event|0|||
124588985|NCT02229084|448114197|FG000|Overall Study|Lost to Follow-up|0|||
124588986|NCT02229084|448114198|FG001|Overall Study|Lost to Follow-up|0|||
124588987|NCT02229084|448114199|FG002|Overall Study|Lost to Follow-up|1|||
124588988|NCT02229084|448114200|FG003|Overall Study|Lost to Follow-up|1|||
124588989|NCT02229084|448114201|FG004|Overall Study|Lost to Follow-up|0|||
124588990|NCT02229084|448114202|FG005|Overall Study|Lost to Follow-up|0|||
124588991|NCT02229084|448114203|FG006|Overall Study|Lost to Follow-up|1|||
124588992|NCT02229084|448114197|FG000|Overall Study|Physician Decision|0|||
124588993|NCT02229084|448114198|FG001|Overall Study|Physician Decision|0|||
124588994|NCT02229084|448114199|FG002|Overall Study|Physician Decision|0|||
124588995|NCT02229084|448114200|FG003|Overall Study|Physician Decision|1|||
124588996|NCT02229084|448114201|FG004|Overall Study|Physician Decision|3|||
124588997|NCT02229084|448114202|FG005|Overall Study|Physician Decision|0|||
124588998|NCT02229084|448114203|FG006|Overall Study|Physician Decision|1|||
124588999|NCT02229084|448114197|FG000|Overall Study|Withdrawal by Subject|0|||
124589000|NCT02229084|448114198|FG001|Overall Study|Withdrawal by Subject|0|||
124589001|NCT02229084|448114199|FG002|Overall Study|Withdrawal by Subject|1|||
124589002|NCT02229084|448114200|FG003|Overall Study|Withdrawal by Subject|0|||
124589003|NCT02229084|448114201|FG004|Overall Study|Withdrawal by Subject|1|||
124589004|NCT02229084|448114202|FG005|Overall Study|Withdrawal by Subject|1|||
124589005|NCT02229084|448114203|FG006|Overall Study|Withdrawal by Subject|1|||
124589006|NCT02229084|448114197|FG000|Overall Study|Death|0|||
124589007|NCT02229084|448114198|FG001|Overall Study|Death|0|||
124589008|NCT02229084|448114199|FG002|Overall Study|Death|0|||
124589009|NCT02229084|448114200|FG003|Overall Study|Death|0|||
124589010|NCT02229084|448114201|FG004|Overall Study|Death|0|||
124589011|NCT02229084|448114202|FG005|Overall Study|Death|0|||
124589012|NCT02229084|448114203|FG006|Overall Study|Death|1|||
124589013|NCT02179190|448114207|FG000|Enrollment|Exit Prior to Device Attempt|11|||
124589014|NCT02179190|448114207|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
124589015|NCT02179190|448114207|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
124589016|NCT02179190|448114207|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
124589017|NCT02179190|448114207|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
124589018|NCT02179190|448114207|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
124589019|NCT00881569|448114210|FG000|Overall Study|Disease progression|1|||
124589020|NCT00881569|448114211|FG001|Overall Study|Disease progression|1|||
124589021|NCT01993940|448114222|FG000|Overall Study|Adverse Event|16|||
124589022|NCT01993940|448114223|FG001|Overall Study|Adverse Event|11|||
124589023|NCT01993940|448114222|FG000|Overall Study|Withdrawal by Subject|15|||
124589024|NCT01993940|448114223|FG001|Overall Study|Withdrawal by Subject|19|||
124589025|NCT01993940|448114222|FG000|Overall Study|Lost to Follow-up|2|||
124589026|NCT01993940|448114223|FG001|Overall Study|Lost to Follow-up|5|||
124589027|NCT01993940|448114222|FG000|Overall Study|Protocol Violation|5|||
124589028|NCT01993940|448114223|FG001|Overall Study|Protocol Violation|8|||
124589029|NCT01993940|448114222|FG000|Overall Study|Death|1|||
124589030|NCT01993940|448114223|FG001|Overall Study|Death|0|||
124589031|NCT01993940|448114222|FG000|Overall Study|Other - Miscellaneous|1|||
124589032|NCT01993940|448114223|FG001|Overall Study|Other - Miscellaneous|1|||
124589033|NCT04164758|448114224|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
124589034|NCT04164758|448114225|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
124589035|NCT04164758|448114226|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
124589036|NCT04164758|448114224|FG000|Overall Study|Adverse Event|0|||
124589037|NCT04164758|448114225|FG001|Overall Study|Adverse Event|1|||
124589038|NCT04164758|448114226|FG002|Overall Study|Adverse Event|0|||
124589039|NCT02858037|448114231|FG000|Overall Study|Death|1|||
124589040|NCT02858037|448114231|FG000|Overall Study|Withdrawal by Subject|18|||
124589041|NCT02858037|448114231|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
124589042|NCT02858037|448114231|FG000|Overall Study|Lost to Follow-up|3|||
124589043|NCT02858037|448114231|FG000|Overall Study|Other|4|||
124589044|NCT01670097|448114234|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
124589045|NCT01670097|448114235|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
124589046|NCT01670097|448114234|FG000|Overall Study|Study burden|1|||
124589047|NCT01670097|448114235|FG001|Overall Study|Study burden|0|||
124589048|NCT01670097|448114234|FG000|Overall Study|COPD exacerbation|0|||
124589049|NCT01670097|448114235|FG001|Overall Study|COPD exacerbation|1|||
124589050|NCT01670097|448114234|FG000|Overall Study|Neutropenia|0|||
124589051|NCT01670097|448114235|FG001|Overall Study|Neutropenia|1|||
124589052|NCT01670097|448114234|FG000|Overall Study|Clinical deterioration|0|||
124589053|NCT01670097|448114235|FG001|Overall Study|Clinical deterioration|1|||
124589054|NCT01670097|448114234|FG000|Overall Study|Disease progression|0|||
124589055|NCT01670097|448114235|FG001|Overall Study|Disease progression|1|||
124589056|NCT00697827|448114236|FG000|Overall Study|enrolled but not treated|2|||
124589057|NCT00697827|448114237|FG001|Overall Study|enrolled but not treated|1|||
124589058|NCT03732833|448114238|FG000|Overall Study|Adverse Event|0|||
124589059|NCT03732833|448114239|FG001|Overall Study|Adverse Event|3|||
124589060|NCT03732833|448114240|FG002|Overall Study|Adverse Event|1|||
124589061|NCT03732833|448114238|FG000|Overall Study|Withdrawal by Subject|11|||
124589062|NCT03732833|448114239|FG001|Overall Study|Withdrawal by Subject|13|||
124589063|NCT03732833|448114240|FG002|Overall Study|Withdrawal by Subject|8|||
124589064|NCT03732833|448114238|FG000|Overall Study|Lost to Follow-up|3|||
124589065|NCT03732833|448114239|FG001|Overall Study|Lost to Follow-up|5|||
124589066|NCT03732833|448114240|FG002|Overall Study|Lost to Follow-up|4|||
124589067|NCT03732833|448114238|FG000|Overall Study|Pregnancy|0|||
124589068|NCT03732833|448114239|FG001|Overall Study|Pregnancy|2|||
124589069|NCT03732833|448114240|FG002|Overall Study|Pregnancy|0|||
124589070|NCT03732833|448114238|FG000|Overall Study|Physician Decision|2|||
124589071|NCT03732833|448114239|FG001|Overall Study|Physician Decision|3|||
124589072|NCT03732833|448114240|FG002|Overall Study|Physician Decision|1|||
124589073|NCT03732833|448114238|FG000|Overall Study|Covid-19 related and other reasons|2|||
124589074|NCT03732833|448114239|FG001|Overall Study|Covid-19 related and other reasons|7|||
124589075|NCT03732833|448114240|FG002|Overall Study|Covid-19 related and other reasons|3|||
124589076|NCT02311894|448114242|FG000|Overall Study|Discontinued in error|1|||
124589077|NCT02311894|448114242|FG000|Overall Study|Lost to Follow-up|1|||
124589078|NCT02311894|448114242|FG000|Overall Study|Adverse Event|1|||
124589079|NCT02311894|448114242|FG000|Overall Study|Withdrawal by Subject|1|||
124589080|NCT00702507|448114245|FG000|Initial Treatment Phase|Adverse Event|2|||
124589081|NCT00702507|448114245|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
124589082|NCT00702507|448114245|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
124589083|NCT00702507|448114245|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
124589084|NCT00702507|448114245|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
124589085|NCT00702507|448114245|FG000|Follow-up Phase|Protocol Violation|2|||
124589086|NCT00702507|448114245|FG000|Follow-up Phase|Lost to Follow-up|23|||
124589087|NCT00702507|448114245|FG000|Follow-up Phase|Late Enrollment|1|||
124589088|NCT01277510|448114246|FG000|Double-blind Phase|Non-compliance|0|||
124589089|NCT01277510|448114247|FG001|Double-blind Phase|Non-compliance|1|||
124589090|NCT01277510|448114246|FG000|Double-blind Phase|Adverse Event|1|||
124589091|NCT01277510|448114247|FG001|Double-blind Phase|Adverse Event|0|||
124589092|NCT01277510|448114246|FG000|Double-blind Phase|Withdrawal by Subject|2|||
124589093|NCT01277510|448114247|FG001|Double-blind Phase|Withdrawal by Subject|0|||
124589094|NCT01277510|448114246|FG000|Double-blind Phase|Administrative decision|7|||
124589095|NCT01277510|448114247|FG001|Double-blind Phase|Administrative decision|9|||
124589096|NCT01277510|448114246|FG000|Double-blind Phase|Death|0|||
124589097|NCT01277510|448114247|FG001|Double-blind Phase|Death|1|||
124589098|NCT01277510|448114246|FG000|Double-blind Phase|Protocol-specified criteria|2|||
124589099|NCT01277510|448114247|FG001|Double-blind Phase|Protocol-specified criteria|6|||
124589100|NCT01277510|448114246|FG000|Double-blind Phase|Other|1|||
124589101|NCT01277510|448114247|FG001|Double-blind Phase|Other|1|||
124589102|NCT01277510|448114246|FG000|Open-label Phase|Administrative decision|4|||
124589103|NCT01277510|448114247|FG001|Open-label Phase|Administrative decision|3|||
124589104|NCT01277510|448114246|FG000|Open-label Phase|Protocol-specified criteria|1|||
124589105|NCT01277510|448114247|FG001|Open-label Phase|Protocol-specified criteria|0|||
124589106|NCT01277510|448114246|FG000|Open-label Phase|Never received investigational product|2|||
124589107|NCT01277510|448114247|FG001|Open-label Phase|Never received investigational product|0|||
124589108|NCT01685008|448114248|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
124589109|NCT01685008|448114249|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
124589110|NCT01685008|448114250|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
124589111|NCT01685008|448114251|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
124589112|NCT01685008|448114248|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
124589113|NCT01685008|448114249|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
124589114|NCT01685008|448114250|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
124589115|NCT01685008|448114251|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
124589116|NCT01685008|448114248|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
124589117|NCT01685008|448114249|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
124589118|NCT01685008|448114250|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
124589119|NCT01685008|448114251|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
124589120|NCT01685008|448114248|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
124589121|NCT01685008|448114249|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
124589122|NCT01685008|448114250|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
124589123|NCT01685008|448114251|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
124589124|NCT01685008|448114248|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
124589125|NCT01685008|448114249|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
124589126|NCT01685008|448114250|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
124589127|NCT01685008|448114251|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
124589128|NCT00057941|448114262|FG000|Overall Study|Death|1|||
124589129|NCT00057941|448114263|FG001|Overall Study|Death|2|||
124589130|NCT00057941|448114262|FG000|Overall Study|Adverse Event|7|||
124589131|NCT00057941|448114263|FG001|Overall Study|Adverse Event|9|||
124589132|NCT00057941|448114262|FG000|Overall Study|Lack of Efficacy|54|||
124589133|NCT00057941|448114263|FG001|Overall Study|Lack of Efficacy|53|||
124589134|NCT00057941|448114262|FG000|Overall Study|Withdrawal by Subject|6|||
124589135|NCT00057941|448114263|FG001|Overall Study|Withdrawal by Subject|1|||
124589136|NCT00057941|448114262|FG000|Overall Study|still on treatment|3|||
124589137|NCT00057941|448114263|FG001|Overall Study|still on treatment|1|||
124589138|NCT00057941|448114262|FG000|Overall Study|insurance, symptomatic deterioration|1|||
124589139|NCT00057941|448114263|FG001|Overall Study|insurance, symptomatic deterioration|3|||
124589140|NCT00057941|448114262|FG000|Overall Study|Ineligible|2|||
124589141|NCT00057941|448114263|FG001|Overall Study|Ineligible|5|||
124589142|NCT01898598|448114265|FG000|Overall Study|Adverse Event|1|||
124589143|NCT01898598|448114266|FG001|Overall Study|Adverse Event|0|||
124589144|NCT01898598|448114265|FG000|Overall Study|Withdrawal by Subject|3|||
124589145|NCT01898598|448114266|FG001|Overall Study|Withdrawal by Subject|0|||
124589146|NCT01898598|448114265|FG000|Overall Study|Lost to Follow-up|0|||
124589147|NCT01898598|448114266|FG001|Overall Study|Lost to Follow-up|1|||
124589148|NCT01898598|448114265|FG000|Overall Study|Other|0|||
124589149|NCT01898598|448114266|FG001|Overall Study|Other|1|||
124589150|NCT03833427|448114267|FG000|Overall Study|Death|4|||
124589151|NCT03833427|448114268|FG001|Overall Study|Death|2|||
124589152|NCT03833427|448114269|FG002|Overall Study|Death|9|||
124589153|NCT03833427|448114270|FG003|Overall Study|Death|11|||
124589154|NCT03833427|448114271|FG004|Overall Study|Death|0|||
124589155|NCT03833427|448114272|FG005|Overall Study|Death|0|||
124589156|NCT03833427|448114273|FG006|Overall Study|Death|0|||
124589157|NCT03833427|448114267|FG000|Overall Study|Withdrawal by Subject|0|||
124589158|NCT03833427|448114268|FG001|Overall Study|Withdrawal by Subject|1|||
124589159|NCT03833427|448114269|FG002|Overall Study|Withdrawal by Subject|1|||
124589160|NCT03833427|448114270|FG003|Overall Study|Withdrawal by Subject|0|||
124589161|NCT03833427|448114271|FG004|Overall Study|Withdrawal by Subject|0|||
124589162|NCT03833427|448114272|FG005|Overall Study|Withdrawal by Subject|0|||
124589163|NCT03833427|448114273|FG006|Overall Study|Withdrawal by Subject|0|||
124589164|NCT03833427|448114267|FG000|Overall Study|Sponsor Decision|0|||
124589165|NCT03833427|448114268|FG001|Overall Study|Sponsor Decision|0|||
124777727|NCT00928408|448813110|FG000|Overall Study|Withdrawal by Subject|4|||
124777728|NCT00928408|448813110|FG000|Overall Study|Death|5|||
124589166|NCT03833427|448114269|FG002|Overall Study|Sponsor Decision|1|||
124589167|NCT03833427|448114270|FG003|Overall Study|Sponsor Decision|3|||
124589168|NCT03833427|448114271|FG004|Overall Study|Sponsor Decision|0|||
124589169|NCT03833427|448114272|FG005|Overall Study|Sponsor Decision|0|||
124589170|NCT03833427|448114273|FG006|Overall Study|Sponsor Decision|0|||
124589171|NCT01499160|448114275|FG000|Overall Study|Adverse Event|1|||
124589172|NCT01499160|448114275|FG000|Overall Study|Withdrawal by Subject|1|||
124589173|NCT00860262|448114278|FG000|Overall Study|Adverse Event|9|||
124589174|NCT00860262|448114279|FG001|Overall Study|Adverse Event|6|||
124589175|NCT00860262|448114280|FG002|Overall Study|Adverse Event|7|||
124589176|NCT00860262|448114278|FG000|Overall Study|Protocol Violation|0|||
124589177|NCT00860262|448114279|FG001|Overall Study|Protocol Violation|1|||
124589178|NCT00860262|448114280|FG002|Overall Study|Protocol Violation|0|||
124777729|NCT00928408|448813110|FG000|Overall Study|Lost to Follow-up|12|||
124777730|NCT00536744|448813111|FG000|Overall Study|Adverse Event|13|||
124777731|NCT00536744|448813112|FG001|Overall Study|Adverse Event|10|||
124777732|NCT00536744|448813111|FG000|Overall Study|Death|2|||
124777733|NCT00536744|448813112|FG001|Overall Study|Death|1|||
124777734|NCT00536744|448813111|FG000|Overall Study|Physician Decision|3|||
124777735|NCT00536744|448813112|FG001|Overall Study|Physician Decision|1|||
124777736|NCT00536744|448813111|FG000|Overall Study|Lost to Follow-up|3|||
124777737|NCT00536744|448813112|FG001|Overall Study|Lost to Follow-up|5|||
124777738|NCT00536744|448813111|FG000|Overall Study|Withdrawal by Subject|7|||
124777739|NCT00536744|448813112|FG001|Overall Study|Withdrawal by Subject|8|||
124777740|NCT00536744|448813111|FG000|Overall Study|PI tried alternative treatment|1|||
124777741|NCT00536744|448813112|FG001|Overall Study|PI tried alternative treatment|3|||
124777742|NCT00787644|448813113|FG000|Overall Study|Lost to Follow-up|1|||
124777743|NCT00787644|448813114|FG001|Overall Study|Lost to Follow-up|1|||
124777744|NCT00787644|448813113|FG000|Overall Study|Withdrawal by Subject|1|||
124777745|NCT00787644|448813114|FG001|Overall Study|Withdrawal by Subject|1|||
124777746|NCT02908672|448813115|FG000|Run-in Period|Death|12|||
124777747|NCT02908672|448813116|FG001|Run-in Period|Death|10|||
124777748|NCT02908672|448813117|FG002|Run-in Period|Death|0|||
124777749|NCT02908672|448813118|FG003|Run-in Period|Death|0|||
124777750|NCT02908672|448813115|FG000|Run-in Period|Lost to Follow-up|1|||
124777751|NCT02908672|448813116|FG001|Run-in Period|Lost to Follow-up|1|||
124777752|NCT02908672|448813117|FG002|Run-in Period|Lost to Follow-up|0|||
124777753|NCT02908672|448813118|FG003|Run-in Period|Lost to Follow-up|0|||
124777754|NCT02908672|448813115|FG000|Run-in Period|Reason Not Specified|2|||
124777755|NCT02908672|448813116|FG001|Run-in Period|Reason Not Specified|0|||
124777756|NCT02908672|448813117|FG002|Run-in Period|Reason Not Specified|0|||
124777757|NCT02908672|448813118|FG003|Run-in Period|Reason Not Specified|0|||
124777758|NCT02908672|448813115|FG000|Run-in Period|Protocol Violation|1|||
124777759|NCT02908672|448813116|FG001|Run-in Period|Protocol Violation|1|||
124777760|NCT02908672|448813117|FG002|Run-in Period|Protocol Violation|0|||
124777761|NCT02908672|448813118|FG003|Run-in Period|Protocol Violation|0|||
124777762|NCT02908672|448813115|FG000|Run-in Period|Study Ended by Sponsor|5|||
124777763|NCT02908672|448813116|FG001|Run-in Period|Study Ended by Sponsor|1|||
124777764|NCT02908672|448813117|FG002|Run-in Period|Study Ended by Sponsor|0|||
124777765|NCT02908672|448813118|FG003|Run-in Period|Study Ended by Sponsor|0|||
124777766|NCT02908672|448813115|FG000|Run-in Period|Withdrawal by Subject|3|||
124777767|NCT02908672|448813116|FG001|Run-in Period|Withdrawal by Subject|9|||
124777768|NCT02908672|448813117|FG002|Run-in Period|Withdrawal by Subject|0|||
124777769|NCT02908672|448813118|FG003|Run-in Period|Withdrawal by Subject|0|||
124777770|NCT02908672|448813115|FG000|Triple Combination Period|Death|0|||
124777771|NCT02908672|448813116|FG001|Triple Combination Period|Death|0|||
124777772|NCT02908672|448813117|FG002|Triple Combination Period|Death|150|||
124777773|NCT02908672|448813118|FG003|Triple Combination Period|Death|127|||
124777774|NCT02908672|448813115|FG000|Triple Combination Period|Lost to Follow-up|0|||
124777775|NCT02908672|448813116|FG001|Triple Combination Period|Lost to Follow-up|0|||
124777776|NCT02908672|448813117|FG002|Triple Combination Period|Lost to Follow-up|6|||
124777777|NCT02908672|448813118|FG003|Triple Combination Period|Lost to Follow-up|8|||
124777778|NCT02908672|448813115|FG000|Triple Combination Period|Reason Not Specified|0|||
124777779|NCT02908672|448813116|FG001|Triple Combination Period|Reason Not Specified|0|||
124777780|NCT02908672|448813117|FG002|Triple Combination Period|Reason Not Specified|0|||
124777781|NCT02908672|448813118|FG003|Triple Combination Period|Reason Not Specified|1|||
124777782|NCT02908672|448813115|FG000|Triple Combination Period|Physician Decision|0|||
124777783|NCT02908672|448813116|FG001|Triple Combination Period|Physician Decision|0|||
124777784|NCT02908672|448813117|FG002|Triple Combination Period|Physician Decision|1|||
124777785|NCT02908672|448813118|FG003|Triple Combination Period|Physician Decision|1|||
124777786|NCT02908672|448813115|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
124589179|NCT00860262|448114278|FG000|Overall Study|Lost to Follow-up|2|||
124777787|NCT02908672|448813116|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
124777788|NCT02908672|448813117|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
124777789|NCT02908672|448813118|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
124777790|NCT02908672|448813115|FG000|Triple Combination Period|Withdrawal by Subject|0|||
124777791|NCT02908672|448813116|FG001|Triple Combination Period|Withdrawal by Subject|0|||
124777792|NCT02908672|448813117|FG002|Triple Combination Period|Withdrawal by Subject|13|||
124777793|NCT02908672|448813118|FG003|Triple Combination Period|Withdrawal by Subject|16|||
124777794|NCT04163016|448813119|FG000|Enrollment|Adverse Event|1|||
124777795|NCT04163016|448813120|FG001|Enrollment|Adverse Event|0|||
124777796|NCT04163016|448813121|FG002|Enrollment|Adverse Event|0|||
124777797|NCT04163016|448813122|FG003|Enrollment|Adverse Event|0|||
124777798|NCT04163016|448813119|FG000|Treatment|Adverse Event|0|||
124777799|NCT04163016|448813120|FG001|Treatment|Adverse Event|1|||
124777800|NCT04163016|448813121|FG002|Treatment|Adverse Event|0|||
124777801|NCT04163016|448813122|FG003|Treatment|Adverse Event|0|||
124777802|NCT04163016|448813119|FG000|Treatment|Withdrawal by Subject|0|||
124777803|NCT04163016|448813120|FG001|Treatment|Withdrawal by Subject|2|||
124589180|NCT00860262|448114279|FG001|Overall Study|Lost to Follow-up|0|||
124589181|NCT00860262|448114280|FG002|Overall Study|Lost to Follow-up|1|||
124589182|NCT00860262|448114278|FG000|Overall Study|Withdrawal by Subject|4|||
124589183|NCT00860262|448114279|FG001|Overall Study|Withdrawal by Subject|8|||
124589184|NCT00860262|448114280|FG002|Overall Study|Withdrawal by Subject|6|||
124589185|NCT00860262|448114278|FG000|Overall Study|Lack of Efficacy|0|||
124589186|NCT00860262|448114279|FG001|Overall Study|Lack of Efficacy|4|||
124589187|NCT00860262|448114280|FG002|Overall Study|Lack of Efficacy|3|||
124589188|NCT00860262|448114278|FG000|Overall Study|Other|5|||
124589189|NCT00860262|448114279|FG001|Overall Study|Other|3|||
124589190|NCT00860262|448114280|FG002|Overall Study|Other|1|||
124589191|NCT02387762|448114281|FG000|Overall Study|Withdrawal by Subject|1|||
124589192|NCT02387762|448114282|FG001|Overall Study|Withdrawal by Subject|0|||
124589193|NCT00593827|448114283|FG000|Overall Study|On Active Treatment/Pending|0|||
124589194|NCT00593827|448114284|FG001|Overall Study|On Active Treatment/Pending|2|||
124589195|NCT01596127|448114285|FG000|Overall Study|Patient Ineligible|1|||
124589196|NCT00688844|448114287|FG000|Overall Study|Lost to Follow-up|10|||
124589197|NCT01374451|448114288|FG000|Overall Study|Administrative problems|1|||
124589198|NCT01374451|448114289|FG001|Overall Study|Administrative problems|0|||
124589199|NCT01223027|448114290|FG000|Overall Study|Adverse Event|20|||
124589200|NCT01223027|448114291|FG001|Overall Study|Adverse Event|10|||
124589201|NCT01223027|448114290|FG000|Overall Study|Death|42|||
124589202|NCT01223027|448114291|FG001|Overall Study|Death|42|||
124589203|NCT01223027|448114290|FG000|Overall Study|Lost to Follow-up|2|||
124589204|NCT01223027|448114291|FG001|Overall Study|Lost to Follow-up|1|||
124589205|NCT01223027|448114290|FG000|Overall Study|Physician Decision|4|||
124589206|NCT01223027|448114291|FG001|Overall Study|Physician Decision|8|||
124589207|NCT01223027|448114290|FG000|Overall Study|Progressive Disease|167|||
124589208|NCT01223027|448114291|FG001|Overall Study|Progressive Disease|183|||
124589209|NCT01223027|448114290|FG000|Overall Study|Protocol Violation|2|||
124589210|NCT01223027|448114291|FG001|Overall Study|Protocol Violation|1|||
124589211|NCT01223027|448114290|FG000|Overall Study|Subject/guardian decicion|18|||
124589212|NCT01223027|448114291|FG001|Overall Study|Subject/guardian decicion|16|||
124589213|NCT01223027|448114290|FG000|Overall Study|New therapy for study indication|17|||
124589214|NCT01223027|448114291|FG001|Overall Study|New therapy for study indication|8|||
124589215|NCT01223027|448114290|FG000|Overall Study|Study terminated by sponsor|2|||
124589216|NCT01223027|448114291|FG001|Overall Study|Study terminated by sponsor|8|||
124589217|NCT03201003|448114295|FG000|Overall Study|Adverse Event|14|||
124589218|NCT03201003|448114296|FG001|Overall Study|Adverse Event|1|||
124589219|NCT03201003|448114295|FG000|Overall Study|Other reasons|5|||
124589220|NCT03201003|448114296|FG001|Overall Study|Other reasons|1|||
124589221|NCT03201003|448114295|FG000|Overall Study|Withdrawal by Subject|4|||
124589222|NCT03201003|448114296|FG001|Overall Study|Withdrawal by Subject|1|||
124589223|NCT03201003|448114295|FG000|Overall Study|Lost to Follow-up|2|||
124589224|NCT03201003|448114296|FG001|Overall Study|Lost to Follow-up|0|||
124589225|NCT03201003|448114295|FG000|Overall Study|Protocol Violation|1|||
124589226|NCT03201003|448114296|FG001|Overall Study|Protocol Violation|0|||
124589227|NCT00834613|448114297|FG000|First Intervention|Protocol Violation|1|||
124589228|NCT00834613|448114298|FG001|First Intervention|Protocol Violation|0|||
124589229|NCT00663234|448114299|FG000|Overall Study|Not willing to adhere to requirements|1|||
124589230|NCT01709903|448114302|FG000|Overall Study|administrative problems|2|||
124589231|NCT01709903|448114303|FG001|Overall Study|administrative problems|6|||
124589232|NCT01709903|448114302|FG000|Overall Study|Abnormal test procedure results|1|||
124589233|NCT01709903|448114303|FG001|Overall Study|Abnormal test procedure results|0|||
124589234|NCT01709903|448114302|FG000|Overall Study|In ability to use device|1|||
124589235|NCT01709903|448114303|FG001|Overall Study|In ability to use device|1|||
124589236|NCT01709903|448114302|FG000|Overall Study|no longer needed study drug|0|||
124589237|NCT01709903|448114303|FG001|Overall Study|no longer needed study drug|1|||
124589238|NCT01709903|448114302|FG000|Overall Study|Lost to Follow-up|0|||
124589239|NCT01709903|448114303|FG001|Overall Study|Lost to Follow-up|2|||
124589240|NCT01709903|448114302|FG000|Overall Study|Death|2|||
124589241|NCT01709903|448114303|FG001|Overall Study|Death|0|||
124589242|NCT01709903|448114302|FG000|Overall Study|Protocol Violation|3|||
124589243|NCT01709903|448114303|FG001|Overall Study|Protocol Violation|2|||
124589244|NCT01709903|448114302|FG000|Overall Study|Lack of Efficacy|3|||
124589245|NCT01709903|448114303|FG001|Overall Study|Lack of Efficacy|3|||
124589246|NCT01709903|448114302|FG000|Overall Study|Withdrawal by Subject|6|||
124589247|NCT01709903|448114303|FG001|Overall Study|Withdrawal by Subject|6|||
124589248|NCT01709903|448114302|FG000|Overall Study|Adverse Event|11|||
124589249|NCT01709903|448114303|FG001|Overall Study|Adverse Event|18|||
124589250|NCT02061280|448114304|FG000|Overall Study|Protocol Violation|12|||
124589251|NCT02061280|448114305|FG001|Overall Study|Protocol Violation|8|||
124589252|NCT02061280|448114304|FG000|Overall Study|moved out of state|0|||
124589253|NCT02061280|448114305|FG001|Overall Study|moved out of state|1|||
124589254|NCT02061280|448114304|FG000|Overall Study|Withdrawal by Subject|1|||
124589255|NCT02061280|448114305|FG001|Overall Study|Withdrawal by Subject|2|||
124589256|NCT02061280|448114304|FG000|Overall Study|Lost to Follow-up|5|||
124589257|NCT02061280|448114305|FG001|Overall Study|Lost to Follow-up|1|||
124589258|NCT01751087|448114308|FG000|Overall Study|Withdrawal by Subject|1|||
124589259|NCT01751087|448114309|FG001|Overall Study|Withdrawal by Subject|0|||
124777804|NCT04163016|448813121|FG002|Treatment|Withdrawal by Subject|0|||
124777805|NCT04163016|448813122|FG003|Treatment|Withdrawal by Subject|0|||
124777806|NCT04163016|448813119|FG000|Treatment|Indeterminate TB-test|0|||
124777807|NCT04163016|448813120|FG001|Treatment|Indeterminate TB-test|0|||
124777808|NCT04163016|448813121|FG002|Treatment|Indeterminate TB-test|0|||
124777809|NCT04163016|448813122|FG003|Treatment|Indeterminate TB-test|1|||
124777810|NCT04163016|448813119|FG000|Treatment|Participant did not want to continue in study|0|||
124777811|NCT04163016|448813120|FG001|Treatment|Participant did not want to continue in study|0|||
124777812|NCT04163016|448813121|FG002|Treatment|Participant did not want to continue in study|0|||
124777813|NCT04163016|448813122|FG003|Treatment|Participant did not want to continue in study|1|||
124777814|NCT01071798|448814315|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
124777815|NCT01071798|448814315|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
124777816|NCT01071798|448814315|FG000|Participants Who Received One Cycle|Patient requirement|20|||
124777817|NCT01071798|448814315|FG000|Participants Who Received One Cycle|Death|5|||
124777818|NCT01071798|448814315|FG000|Participants Who Received One Cycle|Change of therapy|6|||
124777819|NCT01071798|448814315|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
124777820|NCT01071798|448814315|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
124777821|NCT01071798|448814315|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
124777822|NCT01071798|448814315|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
124777823|NCT01071798|448814315|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
124777824|NCT00145158|448814318|FG000|Overall Study|premature withdrawal|2|||
124777825|NCT00145158|448814319|FG001|Overall Study|premature withdrawal|3|||
124777826|NCT01227018|448814323|FG000|Overall Study|Disease progression|9|||
124777827|NCT01227018|448814323|FG000|Overall Study|Toxicity|2|||
124777828|NCT01227018|448814323|FG000|Overall Study|Withdrew after beginning treatment|4|||
124777829|NCT00753649|448814324|FG000|Overall Study|Migrated/moved from study area|1|||
124777830|NCT00753649|448814325|FG001|Overall Study|Migrated/moved from study area|0|||
124777831|NCT00753649|448814324|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
124777832|NCT00753649|448814325|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
124777833|NCT00753649|448814324|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
124777834|NCT00753649|448814325|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
124777835|NCT00753649|448814324|FG000|Overall Study|Protocol Violation|2|||
124777836|NCT00753649|448814325|FG001|Overall Study|Protocol Violation|0|||
124777837|NCT00499616|448814326|FG000|Overall Study|Death|1|||
124777838|NCT00499616|448814327|FG001|Overall Study|Death|5|||
124777839|NCT00499616|448814328|FG002|Overall Study|Death|3|||
124777840|NCT00499616|448814329|FG003|Overall Study|Death|1|||
124777841|NCT00499616|448814326|FG000|Overall Study|Lack of Efficacy|5|||
124777842|NCT00499616|448814327|FG001|Overall Study|Lack of Efficacy|0|||
124777843|NCT00499616|448814328|FG002|Overall Study|Lack of Efficacy|19|||
124777844|NCT00499616|448814329|FG003|Overall Study|Lack of Efficacy|0|||
124777845|NCT00499616|448814326|FG000|Overall Study|Lost to Follow-up|0|||
124777846|NCT00499616|448814327|FG001|Overall Study|Lost to Follow-up|0|||
124777847|NCT00499616|448814328|FG002|Overall Study|Lost to Follow-up|1|||
124777848|NCT00499616|448814329|FG003|Overall Study|Lost to Follow-up|0|||
124777849|NCT00499616|448814326|FG000|Overall Study|Physician Decision|6|||
124777850|NCT00499616|448814327|FG001|Overall Study|Physician Decision|16|||
124777851|NCT00499616|448814328|FG002|Overall Study|Physician Decision|9|||
124777852|NCT00499616|448814329|FG003|Overall Study|Physician Decision|0|||
124777853|NCT00499616|448814326|FG000|Overall Study|Withdrawal by Subject|1|||
124777854|NCT00499616|448814327|FG001|Overall Study|Withdrawal by Subject|0|||
124777855|NCT00499616|448814328|FG002|Overall Study|Withdrawal by Subject|1|||
124777856|NCT00499616|448814329|FG003|Overall Study|Withdrawal by Subject|0|||
124777857|NCT00499616|448814326|FG000|Overall Study|Ineligible|1|||
124777858|NCT00499616|448814327|FG001|Overall Study|Ineligible|2|||
124777859|NCT00499616|448814328|FG002|Overall Study|Ineligible|0|||
124777860|NCT00499616|448814329|FG003|Overall Study|Ineligible|15|||
124777861|NCT00499616|448814326|FG000|Overall Study|Not evaluable|0|||
124777862|NCT00499616|448814327|FG001|Overall Study|Not evaluable|0|||
124777863|NCT00499616|448814328|FG002|Overall Study|Not evaluable|0|||
124777864|NCT00499616|448814329|FG003|Overall Study|Not evaluable|41|||
124777865|NCT00499616|448814326|FG000|Overall Study|Patient/Parent Refusal|1|||
124777866|NCT00499616|448814327|FG001|Overall Study|Patient/Parent Refusal|5|||
124777867|NCT00499616|448814328|FG002|Overall Study|Patient/Parent Refusal|3|||
124777868|NCT00499616|448814329|FG003|Overall Study|Patient/Parent Refusal|0|||
124777869|NCT01938716|448814337|FG000|Overall Study|Physician Decision|2|||
124777870|NCT01938716|448814337|FG000|Overall Study|Withdrawal by Subject|2|||
124777871|NCT00098813|448814338|FG000|Overall Study|Death|8|||
124777872|NCT00098813|448814338|FG000|Overall Study|Protocol Violation|1|||
124777873|NCT00098813|448814338|FG000|Overall Study|Withdrawal by Subject|7|||
124777874|NCT00098813|448814338|FG000|Overall Study|Progression of Disease|1|||
124777875|NCT00098813|448814338|FG000|Overall Study|Other complicating disease|1|||
124777876|NCT00098813|448814338|FG000|Overall Study|Reversal of RAI resistance|1|||
124777877|NCT00433004|448814341|FG000|Overall Study|Lost to Follow-up|5|||
124777878|NCT00433004|448814342|FG001|Overall Study|Lost to Follow-up|7|||
124777879|NCT00220636|448814343|FG000|Overall Study|Withdrawal by Subject|4|||
124589260|NCT01751087|448114310|FG002|Overall Study|Withdrawal by Subject|0|||
124589261|NCT01751087|448114308|FG000|Overall Study|Physician Decision|0|||
124589262|NCT01751087|448114309|FG001|Overall Study|Physician Decision|0|||
124589263|NCT01751087|448114310|FG002|Overall Study|Physician Decision|1|||
124589264|NCT00724958|448114322|FG000|Overall Study|Adverse Event|28|||
124589265|NCT00724958|448114322|FG000|Overall Study|Loss of Response|40|||
124589266|NCT00724958|448114322|FG000|Overall Study|No Response|18|||
124589267|NCT00724958|448114322|FG000|Overall Study|Remission|7|||
124589268|NCT00724958|448114322|FG000|Overall Study|Other Reason|76|||
124589269|NCT00724958|448114322|FG000|Overall Study|No documentation for end of therapy|13|||
124589270|NCT00697619|448114323|FG000|Overall Study|Lack of Efficacy|2|||
124589271|NCT00697619|448114324|FG001|Overall Study|Lack of Efficacy|2|||
124589272|NCT00697619|448114323|FG000|Overall Study|Adverse Event|4|||
124589273|NCT00697619|448114324|FG001|Overall Study|Adverse Event|6|||
124589274|NCT00258856|448116021|FG000|Overall Study|Lost to Follow-up|1|||
124589275|NCT00258856|448116022|FG001|Overall Study|Lost to Follow-up|0|||
124589276|NCT00258856|448116023|FG002|Overall Study|Lost to Follow-up|2|||
124589277|NCT00258856|448116024|FG003|Overall Study|Lost to Follow-up|0|||
124589278|NCT00258856|448116021|FG000|Overall Study|Non-compliance|2|||
124589279|NCT00258856|448116022|FG001|Overall Study|Non-compliance|0|||
124589280|NCT00258856|448116023|FG002|Overall Study|Non-compliance|0|||
124589281|NCT00258856|448116024|FG003|Overall Study|Non-compliance|1|||
124589282|NCT01754376|448116027|FG000|Overall Study|Adverse Event|1|||
124589283|NCT01754376|448116027|FG000|Overall Study|Lack of Efficacy|2|||
124589284|NCT04556734|448116028|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
124589285|NCT04556734|448116029|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
124589286|NCT04556734|448116030|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
124589287|NCT04556734|448116031|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124589288|NCT04556734|448116032|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124589289|NCT04556734|448116033|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124589290|NCT04556734|448116034|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124589291|NCT04556734|448116035|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
124589292|NCT04556734|448116028|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
124589293|NCT04556734|448116029|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
124589294|NCT04556734|448116030|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
124589295|NCT04556734|448116031|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
124589296|NCT04556734|448116032|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
124589297|NCT04556734|448116033|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
124589298|NCT04556734|448116034|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
124589299|NCT04556734|448116035|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
124589300|NCT04556734|448116028|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
124589301|NCT04556734|448116029|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124589302|NCT04556734|448116030|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
124589303|NCT04556734|448116031|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124589304|NCT04556734|448116032|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124589305|NCT04556734|448116033|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124589306|NCT04556734|448116034|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124589307|NCT04556734|448116035|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
124589308|NCT04556734|448116028|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
124589309|NCT04556734|448116029|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
124589310|NCT04556734|448116030|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
124777880|NCT00330967|448814344|FG000|Overall Study|Withdrawal by Subject|0|||
124589311|NCT04556734|448116031|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
124589312|NCT04556734|448116032|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
124589313|NCT04556734|448116033|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
124589314|NCT04556734|448116034|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
124589315|NCT04556734|448116035|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
124589316|NCT04556734|448116028|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
124589317|NCT04556734|448116029|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
124589318|NCT04556734|448116030|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
124777881|NCT00330967|448814345|FG001|Overall Study|Withdrawal by Subject|5|||
124777882|NCT00330967|448814344|FG000|Overall Study|Physician Decision|0|||
124589319|NCT04556734|448116031|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
124589320|NCT04556734|448116032|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
124777883|NCT00330967|448814345|FG001|Overall Study|Physician Decision|9|||
124589321|NCT04556734|448116033|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
124589322|NCT04556734|448116034|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
124589323|NCT04556734|448116035|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
124589324|NCT04556734|448116028|FG000|OLE Period (28 Weeks)|Not reported|0|||
124589325|NCT04556734|448116029|FG001|OLE Period (28 Weeks)|Not reported|0|||
124589326|NCT04556734|448116030|FG002|OLE Period (28 Weeks)|Not reported|0|||
124589327|NCT04556734|448116031|FG003|OLE Period (28 Weeks)|Not reported|0|||
124777884|NCT00790088|448814348|FG000|Overall Study|Protocol Violation|11|||
124777885|NCT00790088|448814348|FG000|Overall Study|Withdrawal by Subject|17|||
124777886|NCT00790088|448814348|FG000|Overall Study|Lost to Follow-up|7|||
124777887|NCT00790088|448814348|FG000|Overall Study|Physician Decision|4|||
124777888|NCT04329806|448814349|FG000|Overall Study|Physician Decision|3|||
124777889|NCT04329806|448814350|FG001|Overall Study|Physician Decision|4|||
124777890|NCT02636595|448814353|FG000|Overall Study|Lost to Follow-up|1|||
124777891|NCT02636595|448814353|FG000|Overall Study|Other|1|||
124777892|NCT02578706|448814357|FG000|Overall Study|Withdrawal by Subject|1|||
124777893|NCT02578706|448814358|FG001|Overall Study|Withdrawal by Subject|0|||
124777894|NCT02578706|448814359|FG002|Overall Study|Withdrawal by Subject|0|||
124777895|NCT02578706|448814357|FG000|Overall Study|Lost to Follow-up|0|||
124777896|NCT02578706|448814358|FG001|Overall Study|Lost to Follow-up|4|||
124777897|NCT02578706|448814359|FG002|Overall Study|Lost to Follow-up|0|||
124777898|NCT02578706|448814357|FG000|Overall Study|Physician Decision|0|||
124777899|NCT02578706|448814358|FG001|Overall Study|Physician Decision|1|||
124777900|NCT02578706|448814359|FG002|Overall Study|Physician Decision|0|||
124777901|NCT02015637|448814363|FG000|Overall Study|Lost to Follow-up|3|||
124777902|NCT02015637|448814364|FG001|Overall Study|Lost to Follow-up|5|||
124777903|NCT02015637|448814363|FG000|Overall Study|Adverse Event|3|||
124777904|NCT02015637|448814364|FG001|Overall Study|Adverse Event|0|||
124777905|NCT02015637|448814363|FG000|Overall Study|Did not take study drug|2|||
124777906|NCT02015637|448814364|FG001|Overall Study|Did not take study drug|0|||
124777907|NCT04455815|448814369|FG000|Randomisation Phase|Adverse Event|1|||
124777908|NCT04455815|448814370|FG001|Randomisation Phase|Adverse Event|0|||
124777909|NCT04455815|448814369|FG000|Treatment Phase|Adverse Event|0|||
124777910|NCT04455815|448814370|FG001|Treatment Phase|Adverse Event|1|||
124777911|NCT04455815|448814369|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
124777912|NCT04455815|448814370|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
124777913|NCT04455815|448814369|FG000|Treatment Phase|Withdrawal by Subject|1|||
124777914|NCT04455815|448814370|FG001|Treatment Phase|Withdrawal by Subject|1|||
124777915|NCT02106390|448814371|FG000|Overall Study|Withdrawal by Subject|15|||
124777916|NCT02106390|448814372|FG001|Overall Study|Withdrawal by Subject|16|||
124777917|NCT02106390|448814373|FG002|Overall Study|Withdrawal by Subject|15|||
124777918|NCT02106390|448814371|FG000|Overall Study|Lost to Follow-up|25|||
124777919|NCT02106390|448814372|FG001|Overall Study|Lost to Follow-up|20|||
124777920|NCT02106390|448814373|FG002|Overall Study|Lost to Follow-up|13|||
124777921|NCT02106390|448814371|FG000|Overall Study|Other: Administrative Reason|8|||
124777922|NCT02106390|448814372|FG001|Overall Study|Other: Administrative Reason|5|||
124777923|NCT02106390|448814373|FG002|Overall Study|Other: Administrative Reason|12|||
124777924|NCT02106390|448814371|FG000|Overall Study|Other: Unspecified|1|||
124777925|NCT02106390|448814372|FG001|Overall Study|Other: Unspecified|4|||
124777926|NCT02106390|448814373|FG002|Overall Study|Other: Unspecified|2|||
124777927|NCT02106390|448814371|FG000|Overall Study|Adverse Event|0|||
124777928|NCT02106390|448814372|FG001|Overall Study|Adverse Event|2|||
124777929|NCT02106390|448814373|FG002|Overall Study|Adverse Event|1|||
124777930|NCT02106390|448814371|FG000|Overall Study|Protocol Violation|0|||
124777931|NCT02106390|448814372|FG001|Overall Study|Protocol Violation|1|||
124777932|NCT02106390|448814373|FG002|Overall Study|Protocol Violation|0|||
124777933|NCT03198507|448814374|FG000|Overall Study|Withdrawal by Subject|1|||
124777934|NCT03198507|448814375|FG001|Overall Study|Withdrawal by Subject|0|||
124777935|NCT00241839|448814380|FG000|Overall Study|Withdrawal by Subject|18|||
124777936|NCT00241839|448814381|FG001|Overall Study|Withdrawal by Subject|17|||
124777937|NCT00241839|448814380|FG000|Overall Study|Adverse Event|1|||
124777938|NCT00241839|448814381|FG001|Overall Study|Adverse Event|1|||
124777939|NCT00439517|448814382|FG000|Overall Study|Subject on treatment|1|||
124777940|NCT00439517|448814383|FG001|Overall Study|Subject on treatment|0|||
124777941|NCT00439517|448814382|FG000|Overall Study|Subject in survival follow-up|1|||
124777942|NCT00439517|448814383|FG001|Overall Study|Subject in survival follow-up|0|||
124777943|NCT02304367|448814384|FG000|Overall Study|Lack of Response to Bruosumab|1|||
124777944|NCT02304367|448814384|FG000|Overall Study|Sponsor Decision|3|||
124589328|NCT04556734|448116032|FG004|OLE Period (28 Weeks)|Not reported|0|||
124589329|NCT04556734|448116033|FG005|OLE Period (28 Weeks)|Not reported|1|||
124589330|NCT04556734|448116034|FG006|OLE Period (28 Weeks)|Not reported|0|||
124777945|NCT02304367|448814384|FG000|Overall Study|Death|2|||
124777946|NCT02304367|448814384|FG000|Overall Study|Physician Decision|1|||
124777947|NCT02304367|448814384|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
124777948|NCT00526071|448814385|FG000|Overall Study|Adverse Event|1|||
124777949|NCT00526071|448814385|FG000|Overall Study|Withdrawal by Subject|1|||
124777950|NCT00526071|448814385|FG000|Overall Study|Lack of Response to Study Drug|4|||
124777951|NCT01626872|448814386|FG000|Overall Study|Physician Decision|13|||
124777952|NCT01626872|448814387|FG001|Overall Study|Physician Decision|9|||
124777953|NCT01626872|448814388|FG002|Overall Study|Physician Decision|6|||
124777954|NCT01626872|448814386|FG000|Overall Study|Withdrawal by Subject|19|||
124777955|NCT01626872|448814387|FG001|Overall Study|Withdrawal by Subject|27|||
124777956|NCT01626872|448814388|FG002|Overall Study|Withdrawal by Subject|8|||
124777957|NCT01626872|448814386|FG000|Overall Study|Adverse Event (including Death)|20|||
124777958|NCT01626872|448814387|FG001|Overall Study|Adverse Event (including Death)|28|||
124589331|NCT04556734|448116035|FG007|OLE Period (28 Weeks)|Not reported|0|||
124589332|NCT04556734|448116028|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
124589333|NCT04556734|448116029|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
124589334|NCT04556734|448116030|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
124589335|NCT04556734|448116031|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
124589336|NCT04556734|448116032|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
124589337|NCT04556734|448116033|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
124589338|NCT04556734|448116034|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
124589339|NCT04556734|448116035|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
124589340|NCT04556734|448116028|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
124589341|NCT04556734|448116029|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
124589342|NCT04556734|448116030|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
124589343|NCT04556734|448116031|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
124589344|NCT04556734|448116032|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
124589345|NCT04556734|448116033|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
124589346|NCT04556734|448116034|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
124589347|NCT04556734|448116035|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
124589348|NCT04556734|448116028|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
124589349|NCT04556734|448116029|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
124589350|NCT04556734|448116030|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
124589351|NCT04556734|448116031|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
124589352|NCT04556734|448116032|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
124589353|NCT04556734|448116033|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
124589354|NCT04556734|448116034|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
124589355|NCT04556734|448116035|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
124589356|NCT04264819|448116036|FG000|Overall Study|Physician Decision|19|||
124589357|NCT04264819|448116036|FG000|Overall Study|Adverse Event|12|||
124589358|NCT04264819|448116036|FG000|Overall Study|Withdrawal by Subject|11|||
124589359|NCT04264819|448116036|FG000|Overall Study|Lost to Follow-up|2|||
124589360|NCT04264819|448116036|FG000|Overall Study|Death|2|||
124589361|NCT01705717|448116042|FG000|Overall Study|Adverse Event|2|||
124589362|NCT01705717|448116043|FG001|Overall Study|Adverse Event|2|||
124589363|NCT01705717|448116042|FG000|Overall Study|Lack of Efficacy|0|||
124589364|NCT01705717|448116043|FG001|Overall Study|Lack of Efficacy|1|||
124589365|NCT01705717|448116042|FG000|Overall Study|Other|0|||
124589366|NCT01705717|448116043|FG001|Overall Study|Other|2|||
124589367|NCT01662024|448116047|FG000|Overall Study|Pregnancy|2|||
124589368|NCT01662024|448116047|FG000|Overall Study|Withdrawal by Subject|3|||
124589369|NCT02846883|448116048|FG000|Overall Study|Death|0|||
124589370|NCT02846883|448116049|FG001|Overall Study|Death|1|||
124589371|NCT02846883|448116050|FG002|Overall Study|Death|1|||
124589372|NCT02846883|448116048|FG000|Overall Study|Lost to Follow-up|0|||
124589373|NCT02846883|448116049|FG001|Overall Study|Lost to Follow-up|0|||
124589374|NCT02846883|448116050|FG002|Overall Study|Lost to Follow-up|1|||
124589375|NCT02846883|448116048|FG000|Overall Study|Withdrawal by Subject|1|||
124589376|NCT02846883|448116049|FG001|Overall Study|Withdrawal by Subject|0|||
124589377|NCT02846883|448116050|FG002|Overall Study|Withdrawal by Subject|0|||
124589378|NCT02846883|448116048|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
124589379|NCT02846883|448116049|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
124589380|NCT02846883|448116050|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
124589381|NCT02846883|448116048|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
124589382|NCT02846883|448116049|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
124589383|NCT02846883|448116050|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
124589384|NCT04768296|448116051|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
124589385|NCT04768296|448116052|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
124589386|NCT01453153|448116059|FG000|Overall Study|Physician Decision|0|||
124589387|NCT01453153|448116060|FG001|Overall Study|Physician Decision|0|||
124589388|NCT01453153|448116061|FG002|Overall Study|Physician Decision|1|||
124589389|NCT01453153|448116059|FG000|Overall Study|Progressive Disease|3|||
124589390|NCT01453153|448116060|FG001|Overall Study|Progressive Disease|2|||
124589391|NCT01453153|448116061|FG002|Overall Study|Progressive Disease|16|||
124589392|NCT01453153|448116059|FG000|Overall Study|Withdrawal by Subject|0|||
124777959|NCT01626872|448814388|FG002|Overall Study|Adverse Event (including Death)|8|||
124777960|NCT01626872|448814386|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
124589393|NCT01453153|448116060|FG001|Overall Study|Withdrawal by Subject|1|||
124589394|NCT01453153|448116061|FG002|Overall Study|Withdrawal by Subject|2|||
124589395|NCT01453153|448116059|FG000|Overall Study|Adverse Event|1|||
124589396|NCT01453153|448116060|FG001|Overall Study|Adverse Event|1|||
124589397|NCT01453153|448116061|FG002|Overall Study|Adverse Event|1|||
124589398|NCT00799708|448116064|FG000|Overall Study|non-compliance|1|||
124589399|NCT00799708|448116065|FG001|Overall Study|non-compliance|0|||
124589400|NCT00799708|448116066|FG002|Overall Study|non-compliance|0|||
124589401|NCT03343639|448116067|FG000|Overall Study|Withdrawal by Subject|10|||
124589402|NCT03343639|448116068|FG001|Overall Study|Withdrawal by Subject|6|||
124589403|NCT03343639|448116067|FG000|Overall Study|Lost to Follow-up|4|||
124589404|NCT03343639|448116068|FG001|Overall Study|Lost to Follow-up|5|||
124589405|NCT03343639|448116067|FG000|Overall Study|Protocol Violation|0|||
124589406|NCT03343639|448116068|FG001|Overall Study|Protocol Violation|1|||
124589407|NCT02274558|448116074|FG000|Overall Study|Adverse Event|2|||
124589408|NCT02274558|448116075|FG001|Overall Study|Adverse Event|4|||
124589409|NCT02274558|448116076|FG002|Overall Study|Adverse Event|2|||
124589410|NCT02274558|448116074|FG000|Overall Study|Non-compliance|2|||
124589411|NCT02274558|448116075|FG001|Overall Study|Non-compliance|1|||
124589412|NCT02274558|448116076|FG002|Overall Study|Non-compliance|0|||
124589413|NCT02274558|448116074|FG000|Overall Study|Withdrawal by Subject|1|||
124589414|NCT02274558|448116075|FG001|Overall Study|Withdrawal by Subject|5|||
124589415|NCT02274558|448116076|FG002|Overall Study|Withdrawal by Subject|4|||
124589416|NCT02274558|448116074|FG000|Overall Study|Death|0|||
124589417|NCT02274558|448116075|FG001|Overall Study|Death|0|||
124589418|NCT02274558|448116076|FG002|Overall Study|Death|1|||
124589419|NCT02274558|448116074|FG000|Overall Study|Lost to Follow-up|2|||
124589420|NCT02274558|448116075|FG001|Overall Study|Lost to Follow-up|1|||
124589421|NCT02274558|448116076|FG002|Overall Study|Lost to Follow-up|1|||
124589422|NCT02274558|448116074|FG000|Overall Study|Physician Decision|0|||
124589423|NCT02274558|448116075|FG001|Overall Study|Physician Decision|2|||
124589424|NCT02274558|448116076|FG002|Overall Study|Physician Decision|1|||
124589425|NCT02655224|448116077|FG000|Overall Study|Adverse Event|1|||
124589426|NCT02655224|448116078|FG001|Overall Study|Adverse Event|1|||
124589427|NCT04592419|448116081|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
124589428|NCT04592419|448116082|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
124589429|NCT04592419|448116081|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
124589430|NCT04592419|448116082|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
124589431|NCT04592419|448116081|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
124589432|NCT04592419|448116082|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
124589433|NCT04592419|448116081|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
124589434|NCT04592419|448116082|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
124589435|NCT04592419|448116081|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
124589436|NCT04592419|448116082|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
124589437|NCT04592419|448116081|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
124589438|NCT04592419|448116082|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
124589439|NCT04592419|448116081|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
124589440|NCT04592419|448116082|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
124589441|NCT04592419|448116081|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
124589442|NCT04592419|448116082|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
124589443|NCT04592419|448116081|FG000|Open-Label Extension Period|Adverse Event|1|||
124589444|NCT04592419|448116082|FG001|Open-Label Extension Period|Adverse Event|2|||
124589445|NCT04592419|448116081|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
124589446|NCT04592419|448116082|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
124589447|NCT04592419|448116081|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
124589448|NCT04592419|448116082|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
124589449|NCT04592419|448116081|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
124589450|NCT04592419|448116082|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
124589451|NCT04592419|448116081|FG000|Open-Label Extension Period|Sponsor Request|73|||
124589452|NCT04592419|448116082|FG001|Open-Label Extension Period|Sponsor Request|84|||
124589453|NCT05393271|448116087|FG000|Overall Study|Physician Decision|0|||
124589454|NCT05393271|448116088|FG001|Overall Study|Physician Decision|0|||
124589455|NCT05393271|448116089|FG002|Overall Study|Physician Decision|0|||
124589456|NCT05393271|448116090|FG003|Overall Study|Physician Decision|0|||
124589457|NCT05393271|448116091|FG004|Overall Study|Physician Decision|0|||
124589458|NCT05393271|448116092|FG005|Overall Study|Physician Decision|0|||
124589459|NCT05393271|448116093|FG006|Overall Study|Physician Decision|1|||
124589460|NCT05393271|448116094|FG007|Overall Study|Physician Decision|0|||
124589461|NCT05393271|448116095|FG008|Overall Study|Physician Decision|0|||
124589462|NCT05393271|448116096|FG009|Overall Study|Physician Decision|0|||
124589463|NCT05393271|448116097|FG010|Overall Study|Physician Decision|0|||
124589464|NCT02943993|448116098|FG000|Overall Study|Withdrawal by Subject|52|||
124589465|NCT02943993|448116098|FG000|Overall Study|Transfer to another institution|6|||
124589466|NCT02943993|448116098|FG000|Overall Study|Lost to Follow-up|135|||
124589467|NCT02943993|448116098|FG000|Overall Study|Death|98|||
124589468|NCT02943993|448116098|FG000|Overall Study|Other reason for premature termination|32|||
124589469|NCT02943993|448116098|FG000|Overall Study|Missing reason for termination|7|||
124589470|NCT02483416|448116099|FG000|Overall Study|Other reason|0|||
124589471|NCT02483416|448116100|FG001|Overall Study|Other reason|1|||
124589472|NCT02483416|448116099|FG000|Overall Study|Treatment stop|3|||
124589473|NCT02483416|448116100|FG001|Overall Study|Treatment stop|0|||
124589474|NCT04968925|448116101|FG000|Phase I- Period 1|COVID-19 related|0|||
124589475|NCT04968925|448116102|FG001|Phase I- Period 1|COVID-19 related|1|||
124589476|NCT04968925|448116103|FG002|Phase I- Period 1|COVID-19 related|0|||
124589477|NCT04968925|448116104|FG003|Phase I- Period 1|COVID-19 related|0|||
124777961|NCT01626872|448814387|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
124777962|NCT01626872|448814388|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
124777963|NCT01696188|448814389|FG000|Overall Study|Protocol Violation|1|||
124777964|NCT01696188|448814390|FG001|Overall Study|Protocol Violation|1|||
124777965|NCT00960999|448814391|FG000|Overall Study|Withdrawal by Subject|1|||
124777966|NCT00960999|448814392|FG001|Overall Study|Withdrawal by Subject|0|||
124777967|NCT00960999|448814391|FG000|Overall Study|Protocol Violation|5|||
124777968|NCT00960999|448814392|FG001|Overall Study|Protocol Violation|2|||
124777969|NCT00960999|448814391|FG000|Overall Study|RT dose constraints not met|2|||
124777970|NCT00960999|448814392|FG001|Overall Study|RT dose constraints not met|0|||
124777971|NCT01578486|448814393|FG000|Overall Study|Physician Decision|3|||
124777972|NCT01578486|448814393|FG000|Overall Study|Withdrawal by Subject|2|||
124777973|NCT01958164|448814394|FG000|Overall Study|Adverse Event|0|||
124777974|NCT01958164|448814395|FG001|Overall Study|Adverse Event|2|||
124777975|NCT01958164|448814394|FG000|Overall Study|Lost to Follow-up|2|||
124777976|NCT01958164|448814395|FG001|Overall Study|Lost to Follow-up|3|||
124777977|NCT00828204|448814398|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
124777978|NCT00828204|448814399|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
124777979|NCT00828204|448814398|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
124777980|NCT00828204|448814399|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
124777981|NCT00828204|448814398|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
124777982|NCT00828204|448814399|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
124777983|NCT00828204|448814398|FG000|Main Study: After Study Restart|Adverse Event|0|||
124777984|NCT00828204|448814399|FG001|Main Study: After Study Restart|Adverse Event|2|||
124777985|NCT00828204|448814398|FG000|Main Study: After Study Restart|Noncompliance|0|||
124589478|NCT04968925|448116101|FG000|Phase I- Period 1|Subject enrolled in error|1|||
124589479|NCT04968925|448116102|FG001|Phase I- Period 1|Subject enrolled in error|1|||
124589480|NCT04968925|448116103|FG002|Phase I- Period 1|Subject enrolled in error|0|||
124589481|NCT04968925|448116104|FG003|Phase I- Period 1|Subject enrolled in error|0|||
124589482|NCT04968925|448116101|FG000|Phase II- Period 1|COVID-19 Related|0|||
124589483|NCT04968925|448116102|FG001|Phase II- Period 1|COVID-19 Related|0|||
124589484|NCT04968925|448116103|FG002|Phase II- Period 1|COVID-19 Related|6|||
124589485|NCT04968925|448116104|FG003|Phase II- Period 1|COVID-19 Related|6|||
124589486|NCT04968925|448116101|FG000|Phase II- Period 1|Subject enrolled in error|0|||
124589487|NCT04968925|448116102|FG001|Phase II- Period 1|Subject enrolled in error|0|||
124589488|NCT04968925|448116103|FG002|Phase II- Period 1|Subject enrolled in error|1|||
124589489|NCT04968925|448116104|FG003|Phase II- Period 1|Subject enrolled in error|0|||
124589490|NCT04968925|448116101|FG000|Phase II -Period 2|COVID-19 related|0|||
124589491|NCT04968925|448116102|FG001|Phase II -Period 2|COVID-19 related|0|||
124589492|NCT04968925|448116103|FG002|Phase II -Period 2|COVID-19 related|4|||
124589493|NCT04968925|448116104|FG003|Phase II -Period 2|COVID-19 related|3|||
124589494|NCT04968925|448116101|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
124589495|NCT04968925|448116102|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
124589496|NCT04968925|448116103|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
124589497|NCT04968925|448116104|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
124589498|NCT00876265|448116109|FG000|Overall Study|Miscellaneous reasons|4|||
124589499|NCT00876265|448116109|FG000|Overall Study|Lost to Follow-up|6|||
124589500|NCT00876265|448116109|FG000|Overall Study|Withdrawal by Subject|2|||
124589501|NCT02754492|448116110|FG000|Overall Study|Protocol Violation|2|||
124589502|NCT02754492|448116111|FG001|Overall Study|Protocol Violation|2|||
124589503|NCT02754492|448116112|FG002|Overall Study|Protocol Violation|0|||
124589504|NCT02754492|448116113|FG003|Overall Study|Protocol Violation|1|||
124589505|NCT02754492|448116110|FG000|Overall Study|Withdrawal by Subject|2|||
124589506|NCT02754492|448116111|FG001|Overall Study|Withdrawal by Subject|0|||
124589507|NCT02754492|448116112|FG002|Overall Study|Withdrawal by Subject|0|||
124589508|NCT02754492|448116113|FG003|Overall Study|Withdrawal by Subject|0|||
124589509|NCT02754492|448116110|FG000|Overall Study|Equipment malfuntion|0|||
124589510|NCT02754492|448116111|FG001|Overall Study|Equipment malfuntion|0|||
124589511|NCT02754492|448116112|FG002|Overall Study|Equipment malfuntion|2|||
124589512|NCT02754492|448116113|FG003|Overall Study|Equipment malfuntion|5|||
124589513|NCT02754492|448116110|FG000|Overall Study|Adverse Event|0|||
124777986|NCT00828204|448814399|FG001|Main Study: After Study Restart|Noncompliance|1|||
124777987|NCT00828204|448814398|FG000|Extension Study|Lost to Follow-up|0|||
124777988|NCT00828204|448814399|FG001|Extension Study|Lost to Follow-up|1|||
124777989|NCT00828204|448814398|FG000|Extension Study|Physician Decision|0|||
124777990|NCT00828204|448814399|FG001|Extension Study|Physician Decision|2|||
124777991|NCT02302339|448814402|FG000|Overall Study|Lost to Follow-up|1|||
124589514|NCT02754492|448116111|FG001|Overall Study|Adverse Event|0|||
124589515|NCT02754492|448116112|FG002|Overall Study|Adverse Event|0|||
124777992|NCT02302339|448814403|FG001|Overall Study|Lost to Follow-up|0|||
124589516|NCT02754492|448116113|FG003|Overall Study|Adverse Event|13|||
124589517|NCT02754492|448116110|FG000|Overall Study|Venous access issues not resulting in AE|0|||
124589518|NCT02754492|448116111|FG001|Overall Study|Venous access issues not resulting in AE|0|||
124589519|NCT02754492|448116112|FG002|Overall Study|Venous access issues not resulting in AE|0|||
124589520|NCT02754492|448116113|FG003|Overall Study|Venous access issues not resulting in AE|4|||
124589521|NCT01408888|448116114|FG000|First Intervention|Adverse Event|0|||
124589522|NCT01408888|448116115|FG001|First Intervention|Adverse Event|1|||
124589523|NCT01408888|448116114|FG000|First Intervention|Withdrawal by Subject|0|||
124589524|NCT01408888|448116115|FG001|First Intervention|Withdrawal by Subject|2|||
124589525|NCT01408888|448116114|FG000|Second Intervention|Withdrawal by Subject|1|||
124589526|NCT01408888|448116115|FG001|Second Intervention|Withdrawal by Subject|0|||
124589527|NCT01408888|448116114|FG000|Second Intervention|Adverse Event|1|||
124589528|NCT01408888|448116115|FG001|Second Intervention|Adverse Event|0|||
124589529|NCT00487695|448116116|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
124589530|NCT00487695|448116117|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
124589531|NCT00487695|448116116|FG000|First Procedure|active wheezing (did not have procedure)|1|||
124589532|NCT00487695|448116117|FG001|First Procedure|active wheezing (did not have procedure)|0|||
124589533|NCT00487695|448116116|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
124589534|NCT00487695|448116117|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
124589535|NCT00487695|448116116|FG000|Second Procedure|active wheezing|0|||
124589536|NCT00487695|448116117|FG001|Second Procedure|active wheezing|1|||
124589537|NCT00487695|448116116|FG000|Second Procedure|Withdrawal by Subject|1|||
124589538|NCT00487695|448116117|FG001|Second Procedure|Withdrawal by Subject|2|||
124589539|NCT00695110|448116120|FG000|Treatment Period 1|Adverse Event|1|||
124589540|NCT00695110|448116120|FG000|Treatment Period 1|Withdrawal by Subject|2|||
124589541|NCT00695110|448116120|FG000|Treatment Period 3|Withdrawal by Subject|1|||
124589542|NCT00695110|448116120|FG000|Treatment Period 4|Adverse Event|1|||
124589543|NCT04542694|448116121|FG000|Overall Study|The need for prohibited therapy|2|||
124589544|NCT04542694|448116122|FG001|Overall Study|The need for prohibited therapy|0|||
124589545|NCT04542694|448116121|FG000|Overall Study|Adverse Event|1|||
124589546|NCT04542694|448116122|FG001|Overall Study|Adverse Event|0|||
124589547|NCT04542694|448116121|FG000|Overall Study|Protocol Violation|1|||
124589548|NCT04542694|448116122|FG001|Overall Study|Protocol Violation|0|||
124589549|NCT02167594|448116123|FG000|Overall Study|Withdrawal by Subject|2|||
124589550|NCT02167594|448116124|FG001|Overall Study|Withdrawal by Subject|0|||
124589551|NCT02167594|448116125|FG002|Overall Study|Withdrawal by Subject|0|||
124589552|NCT02167594|448116123|FG000|Overall Study|Death|0|||
124589553|NCT02167594|448116124|FG001|Overall Study|Death|1|||
124589554|NCT02167594|448116125|FG002|Overall Study|Death|0|||
124589555|NCT01957150|448116126|FG000|Overall Study|Adverse Event|23|||
124589556|NCT01957150|448116127|FG001|Overall Study|Adverse Event|20|||
124589557|NCT01957150|448116126|FG000|Overall Study|Withdrawal by Subject|13|||
124589558|NCT01957150|448116127|FG001|Overall Study|Withdrawal by Subject|17|||
124589559|NCT01957150|448116126|FG000|Overall Study|Physician Decision|3|||
124589560|NCT01957150|448116127|FG001|Overall Study|Physician Decision|6|||
124589561|NCT01957150|448116126|FG000|Overall Study|Lost to Follow-up|4|||
124589562|NCT01957150|448116127|FG001|Overall Study|Lost to Follow-up|4|||
124589563|NCT01957150|448116126|FG000|Overall Study|Protocol Violation|1|||
124589564|NCT01957150|448116127|FG001|Overall Study|Protocol Violation|0|||
124589565|NCT01957150|448116126|FG000|Overall Study|Lack of Efficacy|11|||
124589566|NCT01957150|448116127|FG001|Overall Study|Lack of Efficacy|11|||
124589567|NCT02786953|448116132|FG000|Overall Study|Withdrawal by Subject|3|||
124589568|NCT02786953|448116133|FG001|Overall Study|Withdrawal by Subject|0|||
124589569|NCT02786953|448116132|FG000|Overall Study|Physician Decision|0|||
124589570|NCT02786953|448116133|FG001|Overall Study|Physician Decision|1|||
124589571|NCT01745094|448116136|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
124589572|NCT01745094|448116137|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
124589573|NCT01745094|448116138|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
124589574|NCT01745094|448116139|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
124589575|NCT01745094|448116136|FG000|Overall Study|Adverse Event|0|||
124589576|NCT01745094|448116137|FG001|Overall Study|Adverse Event|0|||
124589577|NCT01745094|448116138|FG002|Overall Study|Adverse Event|3|||
124589578|NCT01745094|448116139|FG003|Overall Study|Adverse Event|0|||
124589579|NCT01745094|448116136|FG000|Overall Study|Withdrawal by Subject|2|||
124589580|NCT01745094|448116137|FG001|Overall Study|Withdrawal by Subject|0|||
124589581|NCT01745094|448116138|FG002|Overall Study|Withdrawal by Subject|1|||
124589582|NCT01745094|448116139|FG003|Overall Study|Withdrawal by Subject|2|||
124589583|NCT01745094|448116136|FG000|Overall Study|Protocol Violation|1|||
124589584|NCT01745094|448116137|FG001|Overall Study|Protocol Violation|0|||
124589585|NCT01745094|448116138|FG002|Overall Study|Protocol Violation|3|||
124589586|NCT01745094|448116139|FG003|Overall Study|Protocol Violation|1|||
124589587|NCT01745094|448116136|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
124589588|NCT01745094|448116137|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
124589589|NCT01745094|448116138|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
124589590|NCT01745094|448116139|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
124589591|NCT01745094|448116136|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
124589592|NCT01745094|448116137|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
124589593|NCT01745094|448116138|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
124589594|NCT01745094|448116139|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
124777993|NCT02302339|448814404|FG002|Overall Study|Lost to Follow-up|0|||
124777994|NCT02302339|448814405|FG003|Overall Study|Lost to Follow-up|0|||
124777995|NCT02302339|448814402|FG000|Overall Study|Withdrawal by Subject|0|||
124777996|NCT02302339|448814403|FG001|Overall Study|Withdrawal by Subject|2|||
124777997|NCT02302339|448814404|FG002|Overall Study|Withdrawal by Subject|1|||
124777998|NCT02302339|448814405|FG003|Overall Study|Withdrawal by Subject|0|||
124777999|NCT01642589|448814409|FG000|Overall Study|Withdrawal by Subject|1|||
124778000|NCT01642589|448814410|FG001|Overall Study|Withdrawal by Subject|1|||
124778001|NCT01185080|448814415|FG000|Overall Study|Adverse Event|1|||
124778002|NCT01185080|448814416|FG001|Overall Study|Adverse Event|1|||
124778003|NCT01185080|448814417|FG002|Overall Study|Adverse Event|0|||
124778004|NCT01185080|448814415|FG000|Overall Study|Personal reasons|0|||
124778005|NCT01185080|448814416|FG001|Overall Study|Personal reasons|0|||
124778006|NCT01185080|448814417|FG002|Overall Study|Personal reasons|1|||
124778007|NCT01104311|448814422|FG000|Overall Study|Withdrawal by Subject|6|||
124778008|NCT01104311|448814423|FG001|Overall Study|Withdrawal by Subject|6|||
124778009|NCT01104311|448814422|FG000|Overall Study|Protocol Violation|0|||
124778010|NCT01104311|448814423|FG001|Overall Study|Protocol Violation|1|||
124778011|NCT01104311|448814422|FG000|Overall Study|Physician Decision|2|||
124778012|NCT01104311|448814423|FG001|Overall Study|Physician Decision|2|||
124778013|NCT01104311|448814422|FG000|Overall Study|low compliance|1|||
124778014|NCT01104311|448814423|FG001|Overall Study|low compliance|1|||
124778015|NCT01104311|448814422|FG000|Overall Study|Adverse Event|1|||
124778016|NCT01104311|448814423|FG001|Overall Study|Adverse Event|2|||
124778017|NCT01255436|448816275|FG000|Overall Study|Lost to Follow-up|178|||
124778018|NCT01255436|448816276|FG001|Overall Study|Lost to Follow-up|191|||
124778019|NCT01255436|448816275|FG000|Overall Study|Death, stroke, or MI|4|||
124778020|NCT01255436|448816276|FG001|Overall Study|Death, stroke, or MI|3|||
124778021|NCT00372593|448816277|FG000|Overall Study|Adverse Event|43|||
124778022|NCT00372593|448816278|FG001|Overall Study|Adverse Event|45|||
124778023|NCT00372593|448816279|FG002|Overall Study|Adverse Event|0|||
124778024|NCT00372593|448816277|FG000|Overall Study|Death|16|||
124778025|NCT00372593|448816278|FG001|Overall Study|Death|20|||
124778026|NCT00372593|448816279|FG002|Overall Study|Death|1|||
124778027|NCT00372593|448816277|FG000|Overall Study|Lack of Efficacy|82|||
124778028|NCT00372593|448816278|FG001|Overall Study|Lack of Efficacy|71|||
124778029|NCT00372593|448816279|FG002|Overall Study|Lack of Efficacy|2|||
124778030|NCT00372593|448816277|FG000|Overall Study|Lost to Follow-up|1|||
124778031|NCT00372593|448816278|FG001|Overall Study|Lost to Follow-up|0|||
124778032|NCT00372593|448816279|FG002|Overall Study|Lost to Follow-up|0|||
124778033|NCT00372593|448816277|FG000|Overall Study|Physician Decision|42|||
124778034|NCT00372593|448816278|FG001|Overall Study|Physician Decision|41|||
124778035|NCT00372593|448816279|FG002|Overall Study|Physician Decision|0|||
124778036|NCT00372593|448816277|FG000|Overall Study|Ineligible|20|||
124778037|NCT00372593|448816278|FG001|Overall Study|Ineligible|21|||
124778038|NCT00372593|448816279|FG002|Overall Study|Ineligible|1|||
124778039|NCT03534180|448816280|FG000|Overall Study|Withdrawal by Subject|1|||
124778040|NCT04439136|448816281|FG000|Overall Study|Ineligible|1|||
124778041|NCT04439136|448816281|FG000|Overall Study|Never Started Treatment|2|||
124778042|NCT04439136|448816281|FG000|Overall Study|Adverse Event|4|||
124778043|NCT04439136|448816281|FG000|Overall Study|Death|3|||
124778044|NCT04439136|448816281|FG000|Overall Study|Disease Progression|27|||
124778045|NCT04439136|448816281|FG000|Overall Study|Alternative Therapy|1|||
124778046|NCT04439136|448816281|FG000|Overall Study|Increased Tumor Burden|1|||
124778047|NCT04439136|448816281|FG000|Overall Study|Symptomatic Detrioration|1|||
124778048|NCT02223858|448816282|FG000|Overall Study|Death|1|||
124778049|NCT02223858|448816283|FG001|Overall Study|Death|1|||
124778050|NCT02223858|448816282|FG000|Overall Study|Lost to Follow-up|6|||
124778051|NCT02223858|448816283|FG001|Overall Study|Lost to Follow-up|11|||
124589595|NCT01745094|448116136|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
124589596|NCT01745094|448116137|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
124589597|NCT01745094|448116138|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
124589598|NCT01745094|448116139|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
124589599|NCT03414034|448116140|FG000|Overall Study|Adverse Event|6|||
124778052|NCT02223858|448816282|FG000|Overall Study|Withdrawal by Subject|8|||
124778053|NCT02223858|448816283|FG001|Overall Study|Withdrawal by Subject|5|||
124778054|NCT02223858|448816282|FG000|Overall Study|Refused|9|||
124778055|NCT02223858|448816283|FG001|Overall Study|Refused|9|||
124778056|NCT03682770|448816286|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
124778057|NCT03682770|448816287|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
124778058|NCT03682770|448816288|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
124778059|NCT03682770|448816289|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
124778060|NCT03682770|448816290|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
124589600|NCT03414034|448116141|FG001|Overall Study|Adverse Event|1|||
124589601|NCT03414034|448116142|FG002|Overall Study|Adverse Event|1|||
124778061|NCT03682770|448816291|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
124778062|NCT03682770|448816292|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
124778063|NCT03682770|448816286|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
124589602|NCT03414034|448116140|FG000|Overall Study|Death|0|||
124589603|NCT03414034|448116141|FG001|Overall Study|Death|0|||
124589604|NCT03414034|448116142|FG002|Overall Study|Death|1|||
124589605|NCT03414034|448116140|FG000|Overall Study|Non-compliance With Study Drug|0|||
124589606|NCT03414034|448116141|FG001|Overall Study|Non-compliance With Study Drug|0|||
124589607|NCT03414034|448116142|FG002|Overall Study|Non-compliance With Study Drug|1|||
124589608|NCT03414034|448116140|FG000|Overall Study|Physician Decision|1|||
124589609|NCT03414034|448116141|FG001|Overall Study|Physician Decision|3|||
124589610|NCT03414034|448116142|FG002|Overall Study|Physician Decision|2|||
124589611|NCT03414034|448116140|FG000|Overall Study|Withdrawal of Informed Consent|2|||
124589612|NCT03414034|448116141|FG001|Overall Study|Withdrawal of Informed Consent|1|||
124589613|NCT03414034|448116142|FG002|Overall Study|Withdrawal of Informed Consent|4|||
124589614|NCT03414034|448116140|FG000|Overall Study|Progressive Disease|15|||
124589615|NCT03414034|448116141|FG001|Overall Study|Progressive Disease|15|||
124589616|NCT03414034|448116142|FG002|Overall Study|Progressive Disease|17|||
124589617|NCT03414034|448116140|FG000|Overall Study|Miscellaneous|0|||
124589618|NCT03414034|448116141|FG001|Overall Study|Miscellaneous|0|||
124589619|NCT03414034|448116142|FG002|Overall Study|Miscellaneous|2|||
124589620|NCT04010227|448116144|FG000|Overall Study|Death|1|||
124589621|NCT04010227|448116145|FG001|Overall Study|Death|2|||
124589622|NCT04010227|448116144|FG000|Overall Study|Medical Reasons|4|||
124589623|NCT04010227|448116145|FG001|Overall Study|Medical Reasons|3|||
124589624|NCT04010227|448116144|FG000|Overall Study|Withdrawal by Subject|2|||
124589625|NCT04010227|448116145|FG001|Overall Study|Withdrawal by Subject|0|||
124589626|NCT04010227|448116144|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
124589627|NCT04010227|448116145|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
124589628|NCT00640926|448116146|FG000|Overall Study|Adverse Event|2|||
124589629|NCT00640926|448116147|FG001|Overall Study|Adverse Event|3|||
124589630|NCT00640926|448116148|FG002|Overall Study|Adverse Event|2|||
124589631|NCT00640926|448116146|FG000|Overall Study|Lack of Efficacy|0|||
124589632|NCT00640926|448116147|FG001|Overall Study|Lack of Efficacy|2|||
124589633|NCT00640926|448116148|FG002|Overall Study|Lack of Efficacy|1|||
124589634|NCT00640926|448116146|FG000|Overall Study|Protocol Violation|2|||
124589635|NCT00640926|448116147|FG001|Overall Study|Protocol Violation|0|||
124589636|NCT00640926|448116148|FG002|Overall Study|Protocol Violation|2|||
124589637|NCT00640926|448116146|FG000|Overall Study|Lost to Follow-up|3|||
124589638|NCT00640926|448116147|FG001|Overall Study|Lost to Follow-up|1|||
124589639|NCT00640926|448116148|FG002|Overall Study|Lost to Follow-up|2|||
124589640|NCT00640926|448116146|FG000|Overall Study|Withdrawal by Subject|1|||
124589641|NCT00640926|448116147|FG001|Overall Study|Withdrawal by Subject|0|||
124589642|NCT00640926|448116148|FG002|Overall Study|Withdrawal by Subject|1|||
124589643|NCT03922750|448116149|FG000|Overall Study|Unclassified|0|||
124589644|NCT03922750|448116150|FG001|Overall Study|Unclassified|0|||
124589645|NCT03922750|448116151|FG002|Overall Study|Unclassified|1|||
124589646|NCT03922750|448116149|FG000|Overall Study|Adverse Event|0|||
124589647|NCT03922750|448116150|FG001|Overall Study|Adverse Event|1|||
124589648|NCT03922750|448116151|FG002|Overall Study|Adverse Event|0|||
124589649|NCT02985398|448116152|FG000|Overall Study|Adverse Event|1|||
124589650|NCT02985398|448116152|FG000|Overall Study|Lost to Follow-up|4|||
124589651|NCT02985398|448116152|FG000|Overall Study|Withdrawal by Subject|8|||
124589652|NCT02985398|448116152|FG000|Overall Study|Study Burden|9|||
124589653|NCT01841073|448116153|FG000|Overall Study|Adverse Event|1|||
124589654|NCT01841073|448116154|FG001|Overall Study|Adverse Event|1|||
124589655|NCT01841073|448116153|FG000|Overall Study|Physician Decision|1|||
124589656|NCT01841073|448116154|FG001|Overall Study|Physician Decision|0|||
124589657|NCT01841073|448116153|FG000|Overall Study|Lost to Follow-up|0|||
124589658|NCT01841073|448116154|FG001|Overall Study|Lost to Follow-up|2|||
124589659|NCT00668395|448116155|FG000|Overall Study|Withdrawal by Subject|4|||
124589660|NCT00668395|448116156|FG001|Overall Study|Withdrawal by Subject|4|||
124589661|NCT00668395|448116157|FG002|Overall Study|Withdrawal by Subject|1|||
124589662|NCT00668395|448116155|FG000|Overall Study|Adverse Event|1|||
124589663|NCT00668395|448116156|FG001|Overall Study|Adverse Event|1|||
124589664|NCT00668395|448116157|FG002|Overall Study|Adverse Event|0|||
124589665|NCT00668395|448116155|FG000|Overall Study|Physician Decision|1|||
124589666|NCT00668395|448116156|FG001|Overall Study|Physician Decision|1|||
124589667|NCT00668395|448116157|FG002|Overall Study|Physician Decision|0|||
124589668|NCT05665387|448116162|FG000|Overall Study|Withdrawal by Subject|1|||
124778064|NCT03682770|448816287|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
124589669|NCT05665387|448116163|FG001|Overall Study|Withdrawal by Subject|0|||
124589670|NCT05665387|448116164|FG002|Overall Study|Withdrawal by Subject|1|||
124589671|NCT01211262|448116167|FG000|Overall Study|Progressive Disease|18|||
124589672|NCT01211262|448116168|FG001|Overall Study|Progressive Disease|9|||
124589673|NCT01211262|448116167|FG000|Overall Study|Adverse Event|4|||
124589674|NCT01211262|448116168|FG001|Overall Study|Adverse Event|0|||
124589675|NCT01211262|448116167|FG000|Overall Study|Withdrawal of Consent|1|||
124589676|NCT01211262|448116168|FG001|Overall Study|Withdrawal of Consent|0|||
124589677|NCT01211262|448116167|FG000|Overall Study|Other|0|||
124589678|NCT01211262|448116168|FG001|Overall Study|Other|1|||
124589679|NCT04049097|448116169|FG000|Overall Study|Adverse Event|18|||
124589680|NCT04049097|448116169|FG000|Overall Study|Death|2|||
124589681|NCT04049097|448116169|FG000|Overall Study|Lost to Follow-up|1|||
124589682|NCT04049097|448116169|FG000|Overall Study|Physician Decision|2|||
124589683|NCT04049097|448116169|FG000|Overall Study|Withdrawal by Subject|9|||
124589684|NCT04049097|448116169|FG000|Overall Study|Protocol Violation|2|||
124589685|NCT04049097|448116169|FG000|Overall Study|Other|1|||
124589686|NCT04049097|448116169|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
124589687|NCT01970592|448116172|FG000|Overall Study|Withdrawal by Subject|4|||
124589688|NCT01970592|448116172|FG000|Overall Study|Physician Decision|1|||
124589689|NCT01970592|448116172|FG000|Overall Study|Adverse Event|1|||
124589690|NCT00160524|448116175|FG000|Overall Study|Adverse Event|119|||
124589691|NCT00160524|448116175|FG000|Overall Study|Adverse Event and Other|94|||
124589692|NCT00160524|448116175|FG000|Overall Study|Protocol Violation|16|||
124589693|NCT00160524|448116175|FG000|Overall Study|Protocol Violation and Other|2|||
124589694|NCT00160524|448116175|FG000|Overall Study|Withdrawal by Subject|141|||
124589695|NCT00160524|448116175|FG000|Overall Study|Withdrawal by Subject and Other|17|||
124589696|NCT00160524|448116175|FG000|Overall Study|Physician Decision|27|||
124589697|NCT00160524|448116175|FG000|Overall Study|Physician Decision and Other|6|||
124589698|NCT00160524|448116175|FG000|Overall Study|Lost to Follow-up|13|||
124589699|NCT00160524|448116175|FG000|Overall Study|Lost to Follow-up and Other|1|||
124589700|NCT00160524|448116175|FG000|Overall Study|Lack of Efficacy|21|||
124589701|NCT00160524|448116175|FG000|Overall Study|Lack of Efficacy and Other|1|||
124589702|NCT00160524|448116175|FG000|Overall Study|Other|20|||
124589703|NCT02661022|448116176|FG000|Overall Study|Withdrawal by Subject|3|||
124589704|NCT02661022|448116177|FG001|Overall Study|Withdrawal by Subject|0|||
124589705|NCT02661022|448116176|FG000|Overall Study|Adverse Event|1|||
124589706|NCT02661022|448116177|FG001|Overall Study|Adverse Event|1|||
124589707|NCT02661022|448116176|FG000|Overall Study|Physician Decision|1|||
124589708|NCT02661022|448116177|FG001|Overall Study|Physician Decision|0|||
124589709|NCT02661022|448116176|FG000|Overall Study|Progressive Disease|2|||
124589710|NCT02661022|448116177|FG001|Overall Study|Progressive Disease|1|||
124589711|NCT03448692|448116178|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
124589712|NCT03448692|448116179|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
124589713|NCT03448692|448116178|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
124589714|NCT03448692|448116179|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
124589715|NCT03448692|448116178|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
124589716|NCT03448692|448116179|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
124589717|NCT03448692|448116178|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
124589718|NCT03448692|448116179|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
124589719|NCT03448692|448116178|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
124589720|NCT03448692|448116179|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
124589721|NCT01598896|448116188|FG000|Overall Study|Withdrawal by Subject|0|||
124589722|NCT01598896|448116189|FG001|Overall Study|Withdrawal by Subject|1|||
124589723|NCT01598896|448116188|FG000|Overall Study|Lack of Efficacy|0|||
124589724|NCT01598896|448116189|FG001|Overall Study|Lack of Efficacy|1|||
124589725|NCT04553406|448116192|FG000|Overall Study|Study Discontinuation|0|||
124589726|NCT04553406|448116193|FG001|Overall Study|Study Discontinuation|1|||
124589727|NCT00633022|448116196|FG000|Overall Study|Adverse Event|1|||
124589728|NCT00633022|448116197|FG001|Overall Study|Adverse Event|0|||
124589729|NCT00633022|448116198|FG002|Overall Study|Adverse Event|5|||
124589730|NCT00633022|448116196|FG000|Overall Study|Physician Decision|0|||
124589731|NCT00633022|448116197|FG001|Overall Study|Physician Decision|1|||
124589732|NCT00633022|448116198|FG002|Overall Study|Physician Decision|0|||
124589733|NCT03573336|448116199|FG000|Overall Study|Study terminated|2|||
124589734|NCT03573336|448116200|FG001|Overall Study|Study terminated|4|||
124589735|NCT03573336|448116201|FG002|Overall Study|Study terminated|2|||
124589736|NCT04388787|448116202|FG000|Blinded Period|Patient could not follow instructions|1|||
124589737|NCT04388787|448116202|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
124589738|NCT02940522|448117677|FG000|Overall Study|Lost to Follow-up|1|||
124589739|NCT02940522|448117678|FG001|Overall Study|Lost to Follow-up|2|||
124589740|NCT02940522|448117677|FG000|Overall Study|Withdrawal by Subject|1|||
124589741|NCT02940522|448117678|FG001|Overall Study|Withdrawal by Subject|0|||
124589742|NCT02710214|448117679|FG000|Overall Study|Lost to Follow-up|1|||
124589743|NCT02710214|448117680|FG001|Overall Study|Lost to Follow-up|0|||
124589744|NCT02710214|448117679|FG000|Overall Study|Lack of Efficacy|0|||
124589745|NCT02710214|448117680|FG001|Overall Study|Lack of Efficacy|1|||
124589746|NCT02710214|448117679|FG000|Overall Study|Death|0|||
124589747|NCT02710214|448117680|FG001|Overall Study|Death|1|||
124589748|NCT01188226|448117687|FG000|Overall Study|Withdrawal by Subject|4|||
124589749|NCT04832971|448117688|FG000|Overall Study|Death|1|||
124589750|NCT04832971|448117689|FG001|Overall Study|Death|0|||
124589751|NCT04832971|448117690|FG002|Overall Study|Death|0|||
124589752|NCT04832971|448117691|FG003|Overall Study|Death|0|||
124589753|NCT04832971|448117688|FG000|Overall Study|Lost to Follow-up|1|||
124589754|NCT04832971|448117689|FG001|Overall Study|Lost to Follow-up|1|||
124589755|NCT04832971|448117690|FG002|Overall Study|Lost to Follow-up|1|||
124589756|NCT04832971|448117691|FG003|Overall Study|Lost to Follow-up|0|||
124589757|NCT04832971|448117688|FG000|Overall Study|Withdrawal by Subject|1|||
124589758|NCT04832971|448117689|FG001|Overall Study|Withdrawal by Subject|3|||
124589759|NCT04832971|448117690|FG002|Overall Study|Withdrawal by Subject|2|||
124589760|NCT04832971|448117691|FG003|Overall Study|Withdrawal by Subject|2|||
124589761|NCT04832971|448117688|FG000|Overall Study|Other, Not Specified|0|||
124589762|NCT04832971|448117689|FG001|Overall Study|Other, Not Specified|0|||
124589763|NCT04832971|448117690|FG002|Overall Study|Other, Not Specified|1|||
124589764|NCT04832971|448117691|FG003|Overall Study|Other, Not Specified|0|||
124589765|NCT04980456|448117692|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
124589766|NCT04980456|448117693|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
124589767|NCT04980456|448117692|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
124589768|NCT04980456|448117693|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
124589769|NCT04980456|448117692|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
124589770|NCT04980456|448117693|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
124589771|NCT04980456|448117692|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
124589772|NCT04980456|448117693|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
124589773|NCT00927251|448117694|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
124589774|NCT03687242|448117696|FG000|Overall Study|Adverse Event|1|||
124589775|NCT01802216|448117699|FG000|4 Month Visit|Participant did not show to visit|3|||
124589776|NCT01802216|448117700|FG001|4 Month Visit|Participant did not show to visit|4|||
124589777|NCT01802216|448117699|FG000|8 Month Visit|Participant did not show to visit|3|||
124589778|NCT01802216|448117700|FG001|8 Month Visit|Participant did not show to visit|5|||
124589779|NCT01802216|448117699|FG000|12 Month Visit|Participant did not show to visit|3|||
124589780|NCT01802216|448117700|FG001|12 Month Visit|Participant did not show to visit|4|||
124589781|NCT00969124|448117710|FG000|Overall Study|Protocol Violation|2|||
124589782|NCT00969124|448117710|FG000|Overall Study|Inadequate bowel preparation|15|||
124589783|NCT00969124|448117710|FG000|Overall Study|Inability to reach cecum|9|||
124589784|NCT00969124|448117710|FG000|Overall Study|Previously unrecognized disease|3|||
124589785|NCT00969124|448117710|FG000|Overall Study|Technical error|1|||
124589786|NCT02575339|448117711|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
124589787|NCT02575339|448117712|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
124589788|NCT02575339|448117713|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
124589789|NCT02575339|448117711|FG000|Study Treatment|Disease Progression|5|||
124589790|NCT02575339|448117712|FG001|Study Treatment|Disease Progression|2|||
124589791|NCT02575339|448117713|FG002|Study Treatment|Disease Progression|0|||
124589792|NCT02575339|448117711|FG000|Study Treatment|Adverse Event|1|||
124589793|NCT02575339|448117712|FG001|Study Treatment|Adverse Event|2|||
124589794|NCT02575339|448117713|FG002|Study Treatment|Adverse Event|0|||
124589795|NCT02575339|448117711|FG000|Follow up|Death|6|||
124589796|NCT02575339|448117712|FG001|Follow up|Death|2|||
124589797|NCT02575339|448117713|FG002|Follow up|Death|0|||
124589798|NCT02575339|448117711|FG000|Follow up|Study Terminated|0|||
124589799|NCT02575339|448117712|FG001|Follow up|Study Terminated|2|||
124589800|NCT02575339|448117713|FG002|Follow up|Study Terminated|0|||
124589801|NCT02575339|448117711|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
124589802|NCT02575339|448117712|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
124589803|NCT02575339|448117713|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
124589804|NCT04675775|448117714|FG000|Overall Study|Withdrawal by Subject|7|||
124589805|NCT04633642|448117715|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
124589806|NCT04633642|448117716|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
124589807|NCT03433703|448117718|FG000|Overall Study|Study terminated by Sponsor|2|||
124589808|NCT02451358|448117722|FG000|Overall Study|Withdrawal by Subject|1|||
124589809|NCT02451358|448117723|FG001|Overall Study|Withdrawal by Subject|1|||
124589810|NCT02451358|448117724|FG002|Overall Study|Withdrawal by Subject|0|||
124589811|NCT02451358|448117725|FG003|Overall Study|Withdrawal by Subject|0|||
124589812|NCT02451358|448117722|FG000|Overall Study|Protocol Violation|0|||
124589813|NCT02451358|448117723|FG001|Overall Study|Protocol Violation|1|||
124589814|NCT02451358|448117724|FG002|Overall Study|Protocol Violation|1|||
124589815|NCT02451358|448117725|FG003|Overall Study|Protocol Violation|0|||
124589816|NCT01344018|448117732|FG000|Overall Study|Death|22|||
124589817|NCT01344018|448117733|FG001|Overall Study|Death|25|||
124589818|NCT01344018|448117732|FG000|Overall Study|Lost to Follow-up|4|||
124589819|NCT01344018|448117733|FG001|Overall Study|Lost to Follow-up|7|||
124589820|NCT05070754|448117734|FG000|Overall Study|Withdrawal by Subject|0|||
124589821|NCT05070754|448117735|FG001|Overall Study|Withdrawal by Subject|0|||
124589822|NCT05070754|448117736|FG002|Overall Study|Withdrawal by Subject|0|||
124589823|NCT05070754|448117737|FG003|Overall Study|Withdrawal by Subject|1|||
124589824|NCT05070754|448117734|FG000|Overall Study|Protocol Violation|0|||
124589825|NCT05070754|448117735|FG001|Overall Study|Protocol Violation|0|||
124589826|NCT05070754|448117736|FG002|Overall Study|Protocol Violation|0|||
124589827|NCT05070754|448117737|FG003|Overall Study|Protocol Violation|1|||
124589828|NCT00252564|448117738|FG000|Overall Study|Adverse Event|17|||
124778065|NCT03682770|448816288|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
124778066|NCT03682770|448816289|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
124778067|NCT03682770|448816290|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
124778068|NCT03682770|448816291|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
124778069|NCT03682770|448816292|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
124778070|NCT03682770|448816286|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
124778071|NCT03682770|448816287|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
124778072|NCT03682770|448816288|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
124778073|NCT03682770|448816289|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
124778074|NCT03682770|448816290|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
124778075|NCT03682770|448816291|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
124778076|NCT03682770|448816292|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
124778077|NCT03682770|448816286|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
124778078|NCT03682770|448816287|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
124778079|NCT03682770|448816288|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
124778080|NCT03682770|448816289|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
124778081|NCT03682770|448816290|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
124778082|NCT03682770|448816291|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
124778083|NCT03682770|448816292|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
124778084|NCT03682770|448816286|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
124778085|NCT03682770|448816287|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
124778086|NCT03682770|448816288|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
124778087|NCT03682770|448816289|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
124778088|NCT03682770|448816290|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
124778089|NCT03682770|448816291|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
124778090|NCT03682770|448816292|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
124778091|NCT03682770|448816286|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
124778092|NCT03682770|448816287|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
124778093|NCT03682770|448816288|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
124778094|NCT03682770|448816289|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
124778095|NCT03682770|448816290|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
124778096|NCT03682770|448816291|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
124778097|NCT03682770|448816292|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
124778098|NCT03682770|448816286|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
124778099|NCT03682770|448816287|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
124778100|NCT03682770|448816288|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
124778101|NCT03682770|448816289|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
124589829|NCT00252564|448117739|FG001|Overall Study|Adverse Event|13|||
124589830|NCT00252564|448117738|FG000|Overall Study|Unrelated Complication|2|||
124589831|NCT00252564|448117739|FG001|Overall Study|Unrelated Complication|1|||
124589832|NCT00252564|448117738|FG000|Overall Study|Disease Progression|14|||
124589833|NCT00252564|448117739|FG001|Overall Study|Disease Progression|20|||
124589834|NCT00252564|448117738|FG000|Overall Study|Death|0|||
124589835|NCT00252564|448117739|FG001|Overall Study|Death|3|||
124589836|NCT00252564|448117738|FG000|Overall Study|Physician Decision|1|||
124589837|NCT00252564|448117739|FG001|Overall Study|Physician Decision|0|||
124589838|NCT00252564|448117738|FG000|Overall Study|Lost to Follow-up|1|||
124589839|NCT00252564|448117739|FG001|Overall Study|Lost to Follow-up|0|||
124589840|NCT00252564|448117738|FG000|Overall Study|Patient Request|4|||
124589841|NCT00252564|448117739|FG001|Overall Study|Patient Request|5|||
124589842|NCT00252564|448117738|FG000|Overall Study|Withdrawal by Subject|0|||
124589843|NCT00252564|448117739|FG001|Overall Study|Withdrawal by Subject|2|||
124589844|NCT04561115|448117741|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
124589845|NCT04561115|448117742|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
124589846|NCT04561115|448117741|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
124589847|NCT04561115|448117742|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
124589848|NCT04561115|448117741|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
124589849|NCT04561115|448117742|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
124778102|NCT03682770|448816290|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
124778103|NCT03682770|448816291|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
124778104|NCT03682770|448816292|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
124589850|NCT00743145|448117743|FG000|Overall Study|Withdrawal by Subject|1|||
124589851|NCT00743145|448117743|FG000|Overall Study|Adverse Event|2|||
124589852|NCT00743145|448117743|FG000|Overall Study|Pregnancy|1|||
124589853|NCT01583530|448117744|FG000|Overall Study|Adverse Event|0|||
124589854|NCT01583530|448117745|FG001|Overall Study|Adverse Event|0|||
124589855|NCT01583530|448117746|FG002|Overall Study|Adverse Event|0|||
124589856|NCT01583530|448117747|FG003|Overall Study|Adverse Event|0|||
124589857|NCT01583530|448117748|FG004|Overall Study|Adverse Event|0|||
124589858|NCT01583530|448117749|FG005|Overall Study|Adverse Event|1|||
124589859|NCT01583530|448117744|FG000|Overall Study|Withdrawal by Subject|0|||
124589860|NCT01583530|448117745|FG001|Overall Study|Withdrawal by Subject|3|||
124589861|NCT01583530|448117746|FG002|Overall Study|Withdrawal by Subject|0|||
124589862|NCT01583530|448117747|FG003|Overall Study|Withdrawal by Subject|1|||
124589863|NCT01583530|448117748|FG004|Overall Study|Withdrawal by Subject|1|||
124589864|NCT01583530|448117749|FG005|Overall Study|Withdrawal by Subject|2|||
124589865|NCT01583530|448117744|FG000|Overall Study|Lost to Follow-up|0|||
124589866|NCT01583530|448117745|FG001|Overall Study|Lost to Follow-up|0|||
124589867|NCT01583530|448117746|FG002|Overall Study|Lost to Follow-up|0|||
124589868|NCT01583530|448117747|FG003|Overall Study|Lost to Follow-up|0|||
124589869|NCT01583530|448117748|FG004|Overall Study|Lost to Follow-up|3|||
124589870|NCT01583530|448117749|FG005|Overall Study|Lost to Follow-up|0|||
124589871|NCT01583530|448117744|FG000|Overall Study|Lack of compliance|0|||
124589872|NCT01583530|448117745|FG001|Overall Study|Lack of compliance|0|||
124589873|NCT01583530|448117746|FG002|Overall Study|Lack of compliance|0|||
124589874|NCT01583530|448117747|FG003|Overall Study|Lack of compliance|0|||
124589875|NCT01583530|448117748|FG004|Overall Study|Lack of compliance|1|||
124589876|NCT01583530|448117749|FG005|Overall Study|Lack of compliance|0|||
124589877|NCT02416180|448117750|FG000|Overall Study|Withdrawal by Subject|1|||
124589878|NCT03480022|448117755|FG000|Overall Study|Pregnancy|2|||
124589879|NCT03480022|448117756|FG001|Overall Study|Pregnancy|0|||
124589880|NCT03480022|448117755|FG000|Overall Study|Adverse Event|6|||
124589881|NCT03480022|448117756|FG001|Overall Study|Adverse Event|0|||
124589882|NCT03480022|448117755|FG000|Overall Study|Lack of Efficacy|0|||
124589883|NCT03480022|448117756|FG001|Overall Study|Lack of Efficacy|2|||
124589884|NCT03480022|448117755|FG000|Overall Study|Physician Decision|0|||
124589885|NCT03480022|448117756|FG001|Overall Study|Physician Decision|1|||
124589886|NCT03480022|448117755|FG000|Overall Study|Withdrawal by Subject|2|||
124589887|NCT03480022|448117756|FG001|Overall Study|Withdrawal by Subject|0|||
124589888|NCT03480022|448117755|FG000|Overall Study|Medication concerns|1|||
124589889|NCT03480022|448117756|FG001|Overall Study|Medication concerns|0|||
124589890|NCT03480022|448117755|FG000|Overall Study|Family member COVID exposure|0|||
124729545|NCT02442310|448632481|FG000|Overall Study|Withdrawal by Subject|1|||
124729546|NCT04154345|448632482|FG000|Overall Study|Covid-19 pandemic|4|||
124729547|NCT03622112|448632495|FG000|Overall Study|Withdrawal by Subject|6|||
124729548|NCT03622112|448632496|FG001|Overall Study|Withdrawal by Subject|2|||
124729549|NCT03622112|448632497|FG002|Overall Study|Withdrawal by Subject|4|||
124729550|NCT03622112|448632498|FG003|Overall Study|Withdrawal by Subject|2|||
124729551|NCT03622112|448632499|FG004|Overall Study|Withdrawal by Subject|1|||
124778105|NCT03682770|448816286|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
124778106|NCT03682770|448816287|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
124778107|NCT03682770|448816288|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
124589891|NCT03480022|448117756|FG001|Overall Study|Family member COVID exposure|1|||
124589892|NCT00283842|448117757|FG000|Overall Study|Adverse Event|8|||
124589893|NCT00283842|448117758|FG001|Overall Study|Adverse Event|7|||
124589894|NCT00283842|448117759|FG002|Overall Study|Adverse Event|21|||
124589895|NCT00283842|448117760|FG003|Overall Study|Adverse Event|21|||
124589896|NCT00283842|448117761|FG004|Overall Study|Adverse Event|5|||
124589897|NCT00283842|448117757|FG000|Overall Study|Protocol Violation|1|||
124589898|NCT00283842|448117758|FG001|Overall Study|Protocol Violation|5|||
124589899|NCT00283842|448117759|FG002|Overall Study|Protocol Violation|4|||
124589900|NCT00283842|448117760|FG003|Overall Study|Protocol Violation|0|||
124589901|NCT00283842|448117761|FG004|Overall Study|Protocol Violation|0|||
124589902|NCT00283842|448117757|FG000|Overall Study|Protocol deviation|0|||
124589903|NCT00283842|448117758|FG001|Overall Study|Protocol deviation|0|||
124589904|NCT00283842|448117759|FG002|Overall Study|Protocol deviation|0|||
124589905|NCT00283842|448117760|FG003|Overall Study|Protocol deviation|0|||
124589906|NCT00283842|448117761|FG004|Overall Study|Protocol deviation|2|||
124589907|NCT00283842|448117757|FG000|Overall Study|Withdrawal by Subject|2|||
124589908|NCT00283842|448117758|FG001|Overall Study|Withdrawal by Subject|1|||
124589909|NCT00283842|448117759|FG002|Overall Study|Withdrawal by Subject|1|||
124589910|NCT00283842|448117760|FG003|Overall Study|Withdrawal by Subject|5|||
124589911|NCT00283842|448117761|FG004|Overall Study|Withdrawal by Subject|4|||
124589912|NCT00283842|448117757|FG000|Overall Study|Lack of Efficacy|1|||
124589913|NCT00283842|448117758|FG001|Overall Study|Lack of Efficacy|3|||
124589914|NCT00283842|448117759|FG002|Overall Study|Lack of Efficacy|1|||
124589915|NCT00283842|448117760|FG003|Overall Study|Lack of Efficacy|0|||
124589916|NCT00283842|448117761|FG004|Overall Study|Lack of Efficacy|3|||
124589917|NCT00283842|448117757|FG000|Overall Study|Lost to Follow-up|0|||
124589918|NCT00283842|448117758|FG001|Overall Study|Lost to Follow-up|2|||
124589919|NCT00283842|448117759|FG002|Overall Study|Lost to Follow-up|4|||
124589920|NCT00283842|448117760|FG003|Overall Study|Lost to Follow-up|1|||
124589921|NCT00283842|448117761|FG004|Overall Study|Lost to Follow-up|1|||
124729552|NCT03622112|448632500|FG005|Overall Study|Withdrawal by Subject|2|||
124589922|NCT02472639|448117764|FG000|Overall Study|Physician Decision|4|||
124589923|NCT02472639|448117765|FG001|Overall Study|Physician Decision|3|||
124589924|NCT00751023|448117767|FG000|Overall Study|Lost to Follow-up|11|||
124589925|NCT00751023|448117768|FG001|Overall Study|Lost to Follow-up|7|||
124589926|NCT02308696|448117770|FG000|Overall Study|Lost to Follow-up|28|||
124589927|NCT02308696|448117771|FG001|Overall Study|Lost to Follow-up|21|||
124589928|NCT02308696|448117770|FG000|Overall Study|Death|8|||
124589929|NCT02308696|448117771|FG001|Overall Study|Death|4|||
124589930|NCT02308696|448117770|FG000|Overall Study|Moved to a Higher Level of Care|17|||
124589931|NCT02308696|448117771|FG001|Overall Study|Moved to a Higher Level of Care|6|||
124589932|NCT04768114|448117772|FG000|Overall Study|Lost to Follow-up|5|||
124589933|NCT04768114|448117773|FG001|Overall Study|Lost to Follow-up|10|||
124589934|NCT04768114|448117772|FG000|Overall Study|Withdrawal by Subject|0|||
124589935|NCT04768114|448117773|FG001|Overall Study|Withdrawal by Subject|1|||
124589936|NCT03980522|448117780|FG000|Treatment Period|Adverse Event|1|||
124589937|NCT03980522|448117781|FG001|Treatment Period|Adverse Event|0|||
124589938|NCT03980522|448117782|FG002|Treatment Period|Adverse Event|0|||
124589939|NCT03980522|448117783|FG003|Treatment Period|Adverse Event|0|||
124589940|NCT03980522|448117784|FG004|Treatment Period|Adverse Event|0|||
124589941|NCT04892147|448117785|FG000|Overall Study|Withdrawal by Subject|2|||
124589942|NCT04892147|448117786|FG001|Overall Study|Withdrawal by Subject|0|||
124589943|NCT05263505|448117787|FG000|Overall Study|Adverse Event|0|||
124589944|NCT05263505|448117788|FG001|Overall Study|Adverse Event|1|||
124589945|NCT01785615|448117795|FG000|Dietary Phase|Lost to Follow-up|0|||
124589946|NCT01785615|448117796|FG001|Dietary Phase|Lost to Follow-up|0|||
124589947|NCT01785615|448117797|FG002|Dietary Phase|Lost to Follow-up|0|||
124589948|NCT01785615|448117798|FG003|Dietary Phase|Lost to Follow-up|24|||
124589949|NCT00360490|448117801|FG000|Overall Study|Adverse Event|4|||
124589950|NCT00360490|448117802|FG001|Overall Study|Adverse Event|2|||
124589951|NCT00360490|448117801|FG000|Overall Study|Lost to Follow-up|2|||
124589952|NCT00360490|448117802|FG001|Overall Study|Lost to Follow-up|1|||
124589953|NCT00360490|448117801|FG000|Overall Study|Physician Decision|2|||
124589954|NCT00360490|448117802|FG001|Overall Study|Physician Decision|1|||
124589955|NCT00360490|448117801|FG000|Overall Study|Protocol Violation|0|||
124589956|NCT00360490|448117802|FG001|Overall Study|Protocol Violation|4|||
124589957|NCT00360490|448117801|FG000|Overall Study|Withdrawal by Subject|1|||
124589958|NCT00360490|448117802|FG001|Overall Study|Withdrawal by Subject|3|||
124589959|NCT03294317|448117803|FG000|Overall Study|Physician Decision|1|||
124589960|NCT03294317|448117803|FG000|Overall Study|Withdrawal by Subject|6|||
124589961|NCT03294317|448117803|FG000|Overall Study|Lost to Follow-up|1|||
124589962|NCT03294317|448117803|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
124589963|NCT03294317|448117803|FG000|Overall Study|Failed HB lead implant|8|||
124589964|NCT03294317|448117803|FG000|Overall Study|Received CRT instead|1|||
124589965|NCT03294317|448117803|FG000|Overall Study|Exited after lead revision|2|||
124589966|NCT01160640|448117804|FG000|Overall Study|Physician Decision|3|||
124589967|NCT01160640|448117805|FG001|Overall Study|Physician Decision|3|||
124589968|NCT01160640|448117804|FG000|Overall Study|Incarceration|1|||
124589969|NCT01160640|448117805|FG001|Overall Study|Incarceration|0|||
124589970|NCT01160640|448117804|FG000|Overall Study|Withdrawal by Subject|0|||
124589971|NCT01160640|448117805|FG001|Overall Study|Withdrawal by Subject|3|||
124589972|NCT00642811|448117810|FG000|Overall Study|Adverse Event|2|||
124589973|NCT00642811|448117811|FG001|Overall Study|Adverse Event|3|||
124589974|NCT00642811|448117812|FG002|Overall Study|Adverse Event|0|||
124589975|NCT00642811|448117813|FG003|Overall Study|Adverse Event|0|||
124589976|NCT00642811|448117814|FG004|Overall Study|Adverse Event|0|||
124589977|NCT00642811|448117815|FG005|Overall Study|Adverse Event|1|||
124589978|NCT00642811|448117810|FG000|Overall Study|Developement of discontinuation criteria|0|||
124589979|NCT00642811|448117811|FG001|Overall Study|Developement of discontinuation criteria|0|||
124589980|NCT00642811|448117812|FG002|Overall Study|Developement of discontinuation criteria|0|||
124589981|NCT00642811|448117813|FG003|Overall Study|Developement of discontinuation criteria|0|||
124589982|NCT00642811|448117814|FG004|Overall Study|Developement of discontinuation criteria|1|||
124589983|NCT00642811|448117815|FG005|Overall Study|Developement of discontinuation criteria|0|||
124589984|NCT00642811|448117810|FG000|Overall Study|Severe Non-compliance to protocol|1|||
124589985|NCT00642811|448117811|FG001|Overall Study|Severe Non-compliance to protocol|0|||
124589986|NCT00642811|448117812|FG002|Overall Study|Severe Non-compliance to protocol|0|||
124589987|NCT00642811|448117813|FG003|Overall Study|Severe Non-compliance to protocol|0|||
124589988|NCT00642811|448117814|FG004|Overall Study|Severe Non-compliance to protocol|0|||
124589989|NCT00642811|448117815|FG005|Overall Study|Severe Non-compliance to protocol|0|||
124589990|NCT00642811|448117810|FG000|Overall Study|Other|0|||
124589991|NCT00642811|448117811|FG001|Overall Study|Other|1|||
124589992|NCT00642811|448117812|FG002|Overall Study|Other|0|||
124589993|NCT00642811|448117813|FG003|Overall Study|Other|1|||
124589994|NCT00642811|448117814|FG004|Overall Study|Other|0|||
124589995|NCT00642811|448117815|FG005|Overall Study|Other|0|||
124589996|NCT00772148|448117817|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
124589997|NCT00772148|448117818|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
124589998|NCT00772148|448117817|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
124778108|NCT03682770|448816289|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
124778109|NCT03682770|448816290|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
124778110|NCT03682770|448816291|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
124778111|NCT03682770|448816292|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
124778112|NCT03682770|448816286|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
124778113|NCT03682770|448816287|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
124778114|NCT03682770|448816288|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
124778115|NCT03682770|448816289|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
124778116|NCT03682770|448816290|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
124778117|NCT03682770|448816291|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
124778118|NCT03682770|448816292|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
124778119|NCT03682770|448816286|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
124778120|NCT03682770|448816287|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
124778121|NCT03682770|448816288|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
124778122|NCT03682770|448816289|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
124778123|NCT03682770|448816290|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
124778124|NCT03682770|448816291|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
124778125|NCT03682770|448816292|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
124778126|NCT03682770|448816286|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
124778127|NCT03682770|448816287|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
124778128|NCT03682770|448816288|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
124778129|NCT03682770|448816289|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
124778130|NCT03682770|448816290|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
124778131|NCT03682770|448816291|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
124778132|NCT03682770|448816292|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
124778133|NCT03682770|448816286|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
124778134|NCT03682770|448816287|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
124778135|NCT03682770|448816288|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
124778136|NCT03682770|448816289|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
124778137|NCT03682770|448816290|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
124778138|NCT03682770|448816291|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
124778139|NCT03682770|448816292|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
124778140|NCT02362282|448816293|FG000|Overall Study|Withdrawal by Subject|1|||
124778141|NCT02362282|448816294|FG001|Overall Study|Withdrawal by Subject|0|||
124778142|NCT03599089|448816301|FG000|Overall Study|Lost to Follow-up|1|||
124778143|NCT03599089|448816302|FG001|Overall Study|Lost to Follow-up|0|||
124778144|NCT03599089|448816303|FG002|Overall Study|Lost to Follow-up|0|||
124778145|NCT03599089|448816304|FG003|Overall Study|Lost to Follow-up|0|||
124778146|NCT03599089|448816301|FG000|Overall Study|Withdrawal by Subject|2|||
124778147|NCT03599089|448816302|FG001|Overall Study|Withdrawal by Subject|1|||
124778148|NCT03599089|448816303|FG002|Overall Study|Withdrawal by Subject|0|||
124778149|NCT03599089|448816304|FG003|Overall Study|Withdrawal by Subject|0|||
124778150|NCT03599089|448816301|FG000|Overall Study|Lack of Efficacy|0|||
124778151|NCT03599089|448816302|FG001|Overall Study|Lack of Efficacy|0|||
124589999|NCT00772148|448117818|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
124590000|NCT00772148|448117817|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
124590001|NCT00772148|448117818|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
124590002|NCT00772148|448117817|FG000|Maintenance Phase (Week 52)|Death|2|||
124590003|NCT00772148|448117818|FG001|Maintenance Phase (Week 52)|Death|2|||
124590004|NCT00772148|448117817|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
124590005|NCT00772148|448117818|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
124590006|NCT00772148|448117817|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
124590007|NCT00772148|448117818|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
124590008|NCT00772148|448117817|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
124590009|NCT00772148|448117818|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
124590010|NCT01562613|448117819|FG000|Overall Study|Lost to Follow-up|2|||
124590011|NCT01562613|448117819|FG000|Overall Study|Withdrawal by Subject|2|||
124590012|NCT00239005|448117820|FG000|Overall Study|Adverse Event|6|||
124590013|NCT00239005|448117821|FG001|Overall Study|Adverse Event|6|||
124590014|NCT00239005|448117820|FG000|Overall Study|Withdrawal by Subject|3|||
124590015|NCT00239005|448117821|FG001|Overall Study|Withdrawal by Subject|4|||
124590016|NCT00239005|448117820|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
124590017|NCT00239005|448117821|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
124778152|NCT03599089|448816303|FG002|Overall Study|Lack of Efficacy|1|||
124778153|NCT03599089|448816304|FG003|Overall Study|Lack of Efficacy|2|||
124778154|NCT03214666|448816305|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
124778155|NCT03214666|448816306|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
124778156|NCT03214666|448816307|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
124778157|NCT03214666|448816308|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
124778158|NCT03214666|448816309|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
124778159|NCT03214666|448816310|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
124778160|NCT00470275|448816311|FG000|Overall Study|Death|1|||
124778161|NCT00470275|448816311|FG000|Overall Study|Lack of Efficacy|7|||
124778162|NCT00470275|448816311|FG000|Overall Study|Withdrawal by Subject|2|||
124778163|NCT00318643|448816317|FG000|Overall Study|Adverse Event|0|||
124778164|NCT00318643|448816318|FG001|Overall Study|Adverse Event|0|||
124778165|NCT00318643|448816319|FG002|Overall Study|Adverse Event|0|||
124778166|NCT00318643|448816320|FG003|Overall Study|Adverse Event|0|||
124778167|NCT00318643|448816321|FG004|Overall Study|Adverse Event|1|||
124778168|NCT00318643|448816317|FG000|Overall Study|Participant's Decision|0|||
124778169|NCT00318643|448816318|FG001|Overall Study|Participant's Decision|0|||
124778170|NCT00318643|448816319|FG002|Overall Study|Participant's Decision|0|||
124778171|NCT00318643|448816320|FG003|Overall Study|Participant's Decision|0|||
124778172|NCT00318643|448816321|FG004|Overall Study|Participant's Decision|1|||
124778173|NCT00318643|448816317|FG000|Overall Study|Investigator's Decision|0|||
124778174|NCT00318643|448816318|FG001|Overall Study|Investigator's Decision|0|||
124778175|NCT00318643|448816319|FG002|Overall Study|Investigator's Decision|0|||
124778176|NCT00318643|448816320|FG003|Overall Study|Investigator's Decision|0|||
124778177|NCT00318643|448816321|FG004|Overall Study|Investigator's Decision|1|||
124778178|NCT01519921|448816324|FG000|Overall Study|Adverse Event|10|||
124778179|NCT01519921|448816325|FG001|Overall Study|Adverse Event|9|||
124778180|NCT01519921|448816324|FG000|Overall Study|Lack of Efficacy|4|||
124778181|NCT01519921|448816325|FG001|Overall Study|Lack of Efficacy|3|||
124778182|NCT01519921|448816324|FG000|Overall Study|Withdrawal by Subject|3|||
124778183|NCT01519921|448816325|FG001|Overall Study|Withdrawal by Subject|0|||
124778184|NCT01519921|448816324|FG000|Overall Study|Lost to Follow-up|2|||
124778185|NCT01519921|448816325|FG001|Overall Study|Lost to Follow-up|1|||
124778186|NCT01519921|448816324|FG000|Overall Study|Treatment refusal|2|||
124778187|NCT01519921|448816325|FG001|Overall Study|Treatment refusal|1|||
124778188|NCT01519921|448816324|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
124778189|NCT01519921|448816325|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
124778190|NCT02500797|448816326|FG000|Overall Study|Cancel (rapid disease progression)|0|||
124778191|NCT02500797|448816327|FG001|Overall Study|Cancel (rapid disease progression)|0|||
124778192|NCT02500797|448816328|FG002|Overall Study|Cancel (rapid disease progression)|0|||
124778193|NCT02500797|448816329|FG003|Overall Study|Cancel (rapid disease progression)|0|||
124778194|NCT02500797|448816330|FG004|Overall Study|Cancel (rapid disease progression)|1|||
124778195|NCT02500797|448816331|FG005|Overall Study|Cancel (rapid disease progression)|1|||
124778196|NCT02500797|448816332|FG006|Overall Study|Cancel (rapid disease progression)|0|||
124778197|NCT02500797|448816333|FG007|Overall Study|Cancel (rapid disease progression)|0|||
124778198|NCT02500797|448816326|FG000|Overall Study|Withdrawal by Subject|1|||
124778199|NCT02500797|448816327|FG001|Overall Study|Withdrawal by Subject|0|||
124778200|NCT02500797|448816328|FG002|Overall Study|Withdrawal by Subject|0|||
124590018|NCT00239005|448117820|FG000|Overall Study|Protocol Violation|1|||
124590019|NCT00239005|448117821|FG001|Overall Study|Protocol Violation|0|||
124590020|NCT00239005|448117820|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
124590021|NCT00239005|448117821|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
124590022|NCT00239005|448117820|FG000|Overall Study|Lost to Follow-up|0|||
124590023|NCT00239005|448117821|FG001|Overall Study|Lost to Follow-up|1|||
124590024|NCT02614898|448117822|FG000|Overall Study|Participated until study termination|10|||
124590025|NCT02614898|448117823|FG001|Overall Study|Participated until study termination|26|||
124590026|NCT02614898|448117822|FG000|Overall Study|Lost to Follow-up|0|||
124590027|NCT02614898|448117823|FG001|Overall Study|Lost to Follow-up|2|||
124590028|NCT02614898|448117822|FG000|Overall Study|Physician Decision|1|||
124590029|NCT02614898|448117823|FG001|Overall Study|Physician Decision|8|||
124590030|NCT02614898|448117822|FG000|Overall Study|Study Terminated by Sponsor|3|||
124590031|NCT02614898|448117823|FG001|Overall Study|Study Terminated by Sponsor|0|||
124590032|NCT02614898|448117822|FG000|Overall Study|Withdrawal by Subject|0|||
124590033|NCT02614898|448117823|FG001|Overall Study|Withdrawal by Subject|2|||
124590034|NCT02614898|448117822|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
124590035|NCT02614898|448117823|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
124590036|NCT02614898|448117822|FG000|Overall Study|Other-Additional Information Unavailable|0|||
124590037|NCT02614898|448117823|FG001|Overall Study|Other-Additional Information Unavailable|11|||
124778201|NCT02500797|448816329|FG003|Overall Study|Withdrawal by Subject|0|||
124778202|NCT02500797|448816330|FG004|Overall Study|Withdrawal by Subject|0|||
124778203|NCT02500797|448816331|FG005|Overall Study|Withdrawal by Subject|0|||
124778204|NCT02500797|448816332|FG006|Overall Study|Withdrawal by Subject|0|||
124778205|NCT02500797|448816333|FG007|Overall Study|Withdrawal by Subject|0|||
124778206|NCT01415882|448816336|FG000|Overall Study|Ineligible|1|||
124590038|NCT02614898|448117822|FG000|Overall Study|Missing|0|||
124590039|NCT02614898|448117823|FG001|Overall Study|Missing|1|||
124778207|NCT01415882|448816337|FG001|Overall Study|Ineligible|0|||
124778208|NCT01415882|448816338|FG002|Overall Study|Ineligible|0|||
124778209|NCT01415882|448816339|FG003|Overall Study|Ineligible|3|||
124778210|NCT01415882|448816340|FG004|Overall Study|Ineligible|0|||
124778211|NCT01415882|448816336|FG000|Overall Study|Withdrawal by Subject|0|||
124778212|NCT01415882|448816337|FG001|Overall Study|Withdrawal by Subject|1|||
124778213|NCT01415882|448816338|FG002|Overall Study|Withdrawal by Subject|0|||
124778214|NCT01415882|448816339|FG003|Overall Study|Withdrawal by Subject|1|||
124778215|NCT01415882|448816340|FG004|Overall Study|Withdrawal by Subject|0|||
124778216|NCT00357006|448816345|FG000|Overall Study|Lost to Follow-up|1|||
124778217|NCT00357006|448816346|FG001|Overall Study|Lost to Follow-up|2|||
124778218|NCT00357006|448816347|FG002|Overall Study|Lost to Follow-up|1|||
124778219|NCT00357006|448816345|FG000|Overall Study|Withdrawal by Subject|1|||
124778220|NCT00357006|448816346|FG001|Overall Study|Withdrawal by Subject|3|||
124778221|NCT00357006|448816347|FG002|Overall Study|Withdrawal by Subject|2|||
124778222|NCT00976560|448816348|FG000|Overall Study|Adverse Event|5|||
124590040|NCT03108820|448117824|FG000|Overall Study|Lost to Follow-up|30|||
124590041|NCT03108820|448117825|FG001|Overall Study|Lost to Follow-up|28|||
124590042|NCT03108820|448117824|FG000|Overall Study|Withdrawal by Subject|32|||
124590043|NCT03108820|448117825|FG001|Overall Study|Withdrawal by Subject|24|||
124590044|NCT03108820|448117824|FG000|Overall Study|Death|6|||
124590045|NCT03108820|448117825|FG001|Overall Study|Death|11|||
124590046|NCT00787605|448117826|FG000|Overall Study|Administrative Problems|3|||
124590047|NCT00787605|448117827|FG001|Overall Study|Administrative Problems|0|||
124590048|NCT00787605|448117826|FG000|Overall Study|Adverse Event|14|||
124590049|NCT00787605|448117827|FG001|Overall Study|Adverse Event|25|||
124590050|NCT00787605|448117826|FG000|Overall Study|Lost to Follow-up|3|||
124590051|NCT00787605|448117827|FG001|Overall Study|Lost to Follow-up|6|||
124590052|NCT00787605|448117826|FG000|Overall Study|Protocol Violation|7|||
124590053|NCT00787605|448117827|FG001|Overall Study|Protocol Violation|3|||
124590054|NCT00787605|448117826|FG000|Overall Study|Withdrawal by Subject|6|||
124590055|NCT00787605|448117827|FG001|Overall Study|Withdrawal by Subject|13|||
124590056|NCT00787605|448117826|FG000|Overall Study|Lack of Efficacy|13|||
124590057|NCT00787605|448117827|FG001|Overall Study|Lack of Efficacy|9|||
124590058|NCT03382041|448117828|FG000|Overall Study|Consent Form Lost|2|||
124590059|NCT03382041|448117829|FG001|Overall Study|Consent Form Lost|1|||
124590060|NCT03382041|448117828|FG000|Overall Study|Withdrawal by Subject|1|||
124590061|NCT03382041|448117829|FG001|Overall Study|Withdrawal by Subject|4|||
124590062|NCT03382041|448117828|FG000|Overall Study|Lost to Follow-up|1|||
124590063|NCT03382041|448117829|FG001|Overall Study|Lost to Follow-up|4|||
124590064|NCT03493919|448117834|FG000|Overall Study|Other|2|||
124590065|NCT03493919|448117835|FG001|Overall Study|Other|0|||
124590066|NCT03493919|448117836|FG002|Overall Study|Other|1|||
124590067|NCT03493919|448117837|FG003|Overall Study|Other|0|||
124590068|NCT03493919|448117834|FG000|Overall Study|Withdrawal by Subject|9|||
124590069|NCT03493919|448117835|FG001|Overall Study|Withdrawal by Subject|3|||
124590070|NCT03493919|448117836|FG002|Overall Study|Withdrawal by Subject|1|||
124590071|NCT03493919|448117837|FG003|Overall Study|Withdrawal by Subject|1|||
124590072|NCT03493919|448117834|FG000|Overall Study|Lost to Follow-up|5|||
124590073|NCT03493919|448117835|FG001|Overall Study|Lost to Follow-up|0|||
124590074|NCT03493919|448117836|FG002|Overall Study|Lost to Follow-up|0|||
124590075|NCT03493919|448117837|FG003|Overall Study|Lost to Follow-up|3|||
124590076|NCT03493919|448117834|FG000|Overall Study|Adverse Event|0|||
124590077|NCT03493919|448117835|FG001|Overall Study|Adverse Event|1|||
124590078|NCT03493919|448117836|FG002|Overall Study|Adverse Event|0|||
124590079|NCT03493919|448117837|FG003|Overall Study|Adverse Event|0|||
124590080|NCT04640194|448117838|FG000|Overall Study|Adverse Event|3|||
124590081|NCT04640194|448117839|FG001|Overall Study|Adverse Event|7|||
124590082|NCT04640194|448117840|FG002|Overall Study|Adverse Event|0|||
124590083|NCT04640194|448117841|FG003|Overall Study|Adverse Event|5|||
124590084|NCT04640194|448117842|FG004|Overall Study|Adverse Event|0|||
124590085|NCT04640194|448117843|FG005|Overall Study|Adverse Event|4|||
124590086|NCT04640194|448117844|FG006|Overall Study|Adverse Event|0|||
124590087|NCT04640194|448117838|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
124590088|NCT04640194|448117839|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
124590089|NCT04640194|448117840|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
124590090|NCT04640194|448117841|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
124590091|NCT04640194|448117842|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
124590092|NCT04640194|448117843|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
124590093|NCT04640194|448117844|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
124778223|NCT00976560|448816349|FG001|Overall Study|Adverse Event|5|||
124778224|NCT00976560|448816348|FG000|Overall Study|Lack of Efficacy|3|||
124778225|NCT00976560|448816349|FG001|Overall Study|Lack of Efficacy|5|||
124590094|NCT04640194|448117838|FG000|Overall Study|fibrinogen level too low|0|||
124590095|NCT04640194|448117839|FG001|Overall Study|fibrinogen level too low|0|||
124590096|NCT04640194|448117840|FG002|Overall Study|fibrinogen level too low|0|||
124590097|NCT04640194|448117841|FG003|Overall Study|fibrinogen level too low|1|||
124590098|NCT04640194|448117842|FG004|Overall Study|fibrinogen level too low|0|||
124778226|NCT00976560|448816348|FG000|Overall Study|Protocol Violation|1|||
124778227|NCT00976560|448816349|FG001|Overall Study|Protocol Violation|0|||
124590099|NCT04640194|448117843|FG005|Overall Study|fibrinogen level too low|0|||
124590100|NCT04640194|448117844|FG006|Overall Study|fibrinogen level too low|0|||
124590101|NCT04640194|448117838|FG000|Overall Study|mild bleeding|0|||
124590102|NCT04640194|448117839|FG001|Overall Study|mild bleeding|0|||
124590103|NCT04640194|448117840|FG002|Overall Study|mild bleeding|0|||
124590104|NCT04640194|448117841|FG003|Overall Study|mild bleeding|1|||
124590105|NCT04640194|448117842|FG004|Overall Study|mild bleeding|0|||
124590106|NCT04640194|448117843|FG005|Overall Study|mild bleeding|0|||
124590107|NCT04640194|448117844|FG006|Overall Study|mild bleeding|0|||
124590108|NCT04640194|448117838|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
124590109|NCT04640194|448117839|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
124590110|NCT04640194|448117840|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
124590111|NCT04640194|448117841|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
124590112|NCT04640194|448117842|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
124590113|NCT04640194|448117843|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
124590114|NCT04640194|448117844|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
124590115|NCT04428645|448117845|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
124590116|NCT04773600|448117847|FG000|Overall Study|Withdrawal by Subject|15|||
124590117|NCT04773600|448117848|FG001|Overall Study|Withdrawal by Subject|9|||
124590118|NCT04773600|448117847|FG000|Overall Study|Lost to Follow-up|10|||
124590119|NCT04773600|448117848|FG001|Overall Study|Lost to Follow-up|6|||
124590120|NCT04773600|448117847|FG000|Overall Study|Adverse Event|8|||
124590121|NCT04773600|448117848|FG001|Overall Study|Adverse Event|2|||
124590122|NCT04773600|448117847|FG000|Overall Study|Lack of Efficacy|2|||
124590123|NCT04773600|448117848|FG001|Overall Study|Lack of Efficacy|3|||
124590124|NCT04773600|448117847|FG000|Overall Study|Noncompliance|2|||
124590125|NCT04773600|448117848|FG001|Overall Study|Noncompliance|0|||
124590126|NCT04773600|448117847|FG000|Overall Study|Protocol Violation|2|||
124590127|NCT04773600|448117848|FG001|Overall Study|Protocol Violation|0|||
124590128|NCT04773600|448117847|FG000|Overall Study|Physician Decision|0|||
124590129|NCT04773600|448117848|FG001|Overall Study|Physician Decision|1|||
124590130|NCT04773600|448117847|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
124590131|NCT04773600|448117848|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
124590132|NCT04773600|448117847|FG000|Overall Study|Emergency Travel Out of Country|1|||
124590133|NCT04773600|448117848|FG001|Overall Study|Emergency Travel Out of Country|0|||
124590134|NCT00500318|448120353|FG000|Overall Study|Adverse Event|3|||
124590135|NCT00500318|448120354|FG001|Overall Study|Adverse Event|8|||
124590136|NCT00500318|448120353|FG000|Overall Study|Protocol Violation|1|||
124590137|NCT00500318|448120354|FG001|Overall Study|Protocol Violation|3|||
124590138|NCT00500318|448120353|FG000|Overall Study|Withdrawal by Subject|1|||
124590139|NCT00500318|448120354|FG001|Overall Study|Withdrawal by Subject|2|||
124590140|NCT00500318|448120353|FG000|Overall Study|Lack of Efficacy|0|||
124590141|NCT00500318|448120354|FG001|Overall Study|Lack of Efficacy|3|||
124590142|NCT00500318|448120353|FG000|Overall Study|Other Reason|0|||
124590143|NCT00500318|448120354|FG001|Overall Study|Other Reason|1|||
124590144|NCT03243396|448120358|FG000|Overall Study|Lost to Follow-up|2|||
124590145|NCT03243396|448120359|FG001|Overall Study|Lost to Follow-up|3|||
124590146|NCT03243396|448120360|FG002|Overall Study|Lost to Follow-up|15|||
124590147|NCT03243396|448120361|FG003|Overall Study|Lost to Follow-up|8|||
124590148|NCT03243396|448120362|FG004|Overall Study|Lost to Follow-up|1|||
124590149|NCT03243396|448120363|FG005|Overall Study|Lost to Follow-up|4|||
124590150|NCT03243396|448120364|FG006|Overall Study|Lost to Follow-up|9|||
124590151|NCT01257581|448120365|FG000|Overall Study|Early Termination|3|||
124590152|NCT01257581|448120366|FG001|Overall Study|Early Termination|1|||
124590153|NCT01257581|448120367|FG002|Overall Study|Early Termination|2|||
124590154|NCT01257581|448120365|FG000|Overall Study|Death|2|||
124590155|NCT01257581|448120366|FG001|Overall Study|Death|2|||
124590156|NCT01257581|448120367|FG002|Overall Study|Death|4|||
124590157|NCT02246764|448120383|FG000|Overall Study|Adverse Event|15|||
124590158|NCT02246764|448120384|FG001|Overall Study|Adverse Event|29|||
124590159|NCT02246764|448120385|FG002|Overall Study|Adverse Event|1|||
124590160|NCT02246764|448120383|FG000|Overall Study|Withdrawal by Subject|0|||
124590161|NCT02246764|448120384|FG001|Overall Study|Withdrawal by Subject|0|||
124590162|NCT02246764|448120385|FG002|Overall Study|Withdrawal by Subject|1|||
124590163|NCT02246764|448120383|FG000|Overall Study|Disallowed Concomitant Medication|1|||
124778228|NCT00976560|448816348|FG000|Overall Study|Lost to Follow-up|1|||
124590164|NCT02246764|448120384|FG001|Overall Study|Disallowed Concomitant Medication|0|||
124590165|NCT02246764|448120385|FG002|Overall Study|Disallowed Concomitant Medication|0|||
124590166|NCT02246764|448120383|FG000|Overall Study|Physician Decision|0|||
124590167|NCT02246764|448120384|FG001|Overall Study|Physician Decision|2|||
124590168|NCT02246764|448120385|FG002|Overall Study|Physician Decision|1|||
124590169|NCT02246764|448120383|FG000|Overall Study|Protocol Violation|2|||
124590170|NCT02246764|448120384|FG001|Overall Study|Protocol Violation|1|||
124590171|NCT02246764|448120385|FG002|Overall Study|Protocol Violation|1|||
124590172|NCT04982445|448120386|FG000|Overall Study|Protocol Violation|1|||
124590173|NCT04982445|448120386|FG000|Overall Study|Withdrawal by Subject|4|||
124590174|NCT04982445|448120386|FG000|Overall Study|Lost to Follow-up|1|||
124590175|NCT02161549|448120392|FG000|Overall Study|Physician Decision|6|||
124590176|NCT02161549|448120393|FG001|Overall Study|Physician Decision|2|||
124590177|NCT03223909|448120394|FG000|Overall Study|Protocol Violation|48|||
124590178|NCT03223909|448120395|FG001|Overall Study|Protocol Violation|45|||
124590179|NCT03223909|448120396|FG002|Overall Study|Protocol Violation|16|||
124590180|NCT01628549|448120399|FG000|Overall Study|Adverse Event|1|||
124590181|NCT01628549|448120400|FG001|Overall Study|Adverse Event|1|||
124590182|NCT01628549|448120401|FG002|Overall Study|Adverse Event|0|||
124590183|NCT01628549|448120402|FG003|Overall Study|Adverse Event|4|||
124590184|NCT01628549|448120399|FG000|Overall Study|Lost to Follow-up|3|||
124590185|NCT01628549|448120400|FG001|Overall Study|Lost to Follow-up|4|||
124590186|NCT01628549|448120401|FG002|Overall Study|Lost to Follow-up|3|||
124590187|NCT01628549|448120402|FG003|Overall Study|Lost to Follow-up|3|||
124590188|NCT01628549|448120399|FG000|Overall Study|Withdrawal by Subject|3|||
124590189|NCT01628549|448120400|FG001|Overall Study|Withdrawal by Subject|4|||
124590190|NCT01628549|448120401|FG002|Overall Study|Withdrawal by Subject|4|||
124590191|NCT01628549|448120402|FG003|Overall Study|Withdrawal by Subject|1|||
124590192|NCT01628549|448120399|FG000|Overall Study|Protocol Violation|2|||
124590193|NCT01628549|448120400|FG001|Overall Study|Protocol Violation|1|||
124590194|NCT01628549|448120401|FG002|Overall Study|Protocol Violation|1|||
124590195|NCT01628549|448120402|FG003|Overall Study|Protocol Violation|0|||
124590196|NCT01628549|448120399|FG000|Overall Study|withdrawn for noncompliance|0|||
124590197|NCT01628549|448120400|FG001|Overall Study|withdrawn for noncompliance|2|||
124590198|NCT01628549|448120401|FG002|Overall Study|withdrawn for noncompliance|1|||
124590199|NCT01628549|448120402|FG003|Overall Study|withdrawn for noncompliance|0|||
124590200|NCT01628549|448120399|FG000|Overall Study|abnormal laboratory test results|0|||
124590201|NCT01628549|448120400|FG001|Overall Study|abnormal laboratory test results|0|||
124590202|NCT01628549|448120401|FG002|Overall Study|abnormal laboratory test results|1|||
124590203|NCT01628549|448120402|FG003|Overall Study|abnormal laboratory test results|0|||
124590204|NCT01628549|448120399|FG000|Overall Study|positive pregnancy test|0|||
124590205|NCT01628549|448120400|FG001|Overall Study|positive pregnancy test|0|||
124590206|NCT01628549|448120401|FG002|Overall Study|positive pregnancy test|0|||
124590207|NCT01628549|448120402|FG003|Overall Study|positive pregnancy test|1|||
124590208|NCT00177164|448120403|FG000|Overall Study|Protocol Violation|0|||
124590209|NCT00177164|448120404|FG001|Overall Study|Protocol Violation|7|||
124590210|NCT00177164|448120403|FG000|Overall Study|Lost to Follow-up|4|||
124590211|NCT00177164|448120404|FG001|Overall Study|Lost to Follow-up|5|||
124590212|NCT00177164|448120403|FG000|Overall Study|increase in alcohol and drug use|1|||
124590213|NCT00177164|448120404|FG001|Overall Study|increase in alcohol and drug use|2|||
124590214|NCT00177164|448120403|FG000|Overall Study|Adverse Event|1|||
124590215|NCT00177164|448120404|FG001|Overall Study|Adverse Event|0|||
124590216|NCT00177164|448120403|FG000|Overall Study|discharge from hospital|1|||
124590217|NCT00177164|448120404|FG001|Overall Study|discharge from hospital|0|||
124590218|NCT00177164|448120403|FG000|Overall Study|Lack of Efficacy|2|||
124590219|NCT00177164|448120404|FG001|Overall Study|Lack of Efficacy|1|||
124590220|NCT00177164|448120403|FG000|Overall Study|Pregnancy|0|||
124590221|NCT00177164|448120404|FG001|Overall Study|Pregnancy|1|||
124590222|NCT00965757|448120405|FG000|Double-blind Phase|Progression of concomitant disease|1|||
124590223|NCT00965757|448120406|FG001|Double-blind Phase|Progression of concomitant disease|2|||
124590224|NCT00965757|448120407|FG002|Double-blind Phase|Progression of concomitant disease|0|||
124590225|NCT00965757|448120408|FG003|Double-blind Phase|Progression of concomitant disease|0|||
124590226|NCT00965757|448120405|FG000|Double-blind Phase|Adverse drug reaction|2|||
124590227|NCT00965757|448120406|FG001|Double-blind Phase|Adverse drug reaction|1|||
124590228|NCT00965757|448120407|FG002|Double-blind Phase|Adverse drug reaction|0|||
124590229|NCT00965757|448120408|FG003|Double-blind Phase|Adverse drug reaction|0|||
124590230|NCT00965757|448120405|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
124590231|NCT00965757|448120406|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
124590232|NCT00965757|448120407|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
124590233|NCT00965757|448120408|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
124590234|NCT00965757|448120405|FG000|Double-blind Phase|Lack of Efficacy|7|||
124590235|NCT00965757|448120406|FG001|Double-blind Phase|Lack of Efficacy|11|||
124590236|NCT00965757|448120407|FG002|Double-blind Phase|Lack of Efficacy|0|||
124590237|NCT00965757|448120408|FG003|Double-blind Phase|Lack of Efficacy|0|||
124590238|NCT00965757|448120405|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
124590239|NCT00965757|448120406|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
124590240|NCT00965757|448120407|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
124590241|NCT00965757|448120408|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
124590242|NCT00965757|448120405|FG000|Double-blind Phase|Lost to Follow-up|0|||
124590243|NCT00965757|448120406|FG001|Double-blind Phase|Lost to Follow-up|1|||
124729553|NCT03622112|448632501|FG006|Overall Study|Withdrawal by Subject|2|||
124590244|NCT00965757|448120407|FG002|Double-blind Phase|Lost to Follow-up|0|||
124590245|NCT00965757|448120408|FG003|Double-blind Phase|Lost to Follow-up|0|||
124590246|NCT00965757|448120405|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
124590247|NCT00965757|448120406|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
124590248|NCT00965757|448120407|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
124590249|NCT00965757|448120408|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
124590250|NCT00965757|448120405|FG000|Double-blind Phase|Other|1|||
124590251|NCT00965757|448120406|FG001|Double-blind Phase|Other|0|||
124590252|NCT00965757|448120407|FG002|Double-blind Phase|Other|0|||
124590253|NCT00965757|448120408|FG003|Double-blind Phase|Other|0|||
124590254|NCT00965757|448120405|FG000|Extension Phase|Progression of concomitant disease|0|||
124590255|NCT00965757|448120406|FG001|Extension Phase|Progression of concomitant disease|0|||
124590256|NCT00965757|448120407|FG002|Extension Phase|Progression of concomitant disease|4|||
124590257|NCT00965757|448120408|FG003|Extension Phase|Progression of concomitant disease|2|||
124590258|NCT00965757|448120405|FG000|Extension Phase|Adverse drug reaction|0|||
124590259|NCT00965757|448120406|FG001|Extension Phase|Adverse drug reaction|0|||
124590260|NCT00965757|448120407|FG002|Extension Phase|Adverse drug reaction|6|||
124590261|NCT00965757|448120408|FG003|Extension Phase|Adverse drug reaction|3|||
124590262|NCT00965757|448120405|FG000|Extension Phase|Abnormal Laboratory Value|0|||
124590263|NCT00965757|448120406|FG001|Extension Phase|Abnormal Laboratory Value|0|||
124590264|NCT00965757|448120407|FG002|Extension Phase|Abnormal Laboratory Value|6|||
124590265|NCT00965757|448120408|FG003|Extension Phase|Abnormal Laboratory Value|1|||
124590266|NCT00965757|448120405|FG000|Extension Phase|Lack of Efficacy|0|||
124590267|NCT00965757|448120406|FG001|Extension Phase|Lack of Efficacy|0|||
124590268|NCT00965757|448120407|FG002|Extension Phase|Lack of Efficacy|8|||
124590269|NCT00965757|448120408|FG003|Extension Phase|Lack of Efficacy|12|||
124590270|NCT00965757|448120405|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
124590271|NCT00965757|448120406|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
124590272|NCT00965757|448120407|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
124590273|NCT00965757|448120408|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
124590274|NCT00965757|448120405|FG000|Extension Phase|Lost to Follow-up|0|||
124590275|NCT00965757|448120406|FG001|Extension Phase|Lost to Follow-up|0|||
124590276|NCT00965757|448120407|FG002|Extension Phase|Lost to Follow-up|0|||
124590277|NCT00965757|448120408|FG003|Extension Phase|Lost to Follow-up|1|||
124590278|NCT00965757|448120405|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
124590279|NCT00965757|448120406|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
124590280|NCT00965757|448120407|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
124590281|NCT00965757|448120408|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
124590282|NCT00965757|448120405|FG000|Extension Phase|Protocol Violation|0|||
124590283|NCT00965757|448120406|FG001|Extension Phase|Protocol Violation|0|||
124590284|NCT00965757|448120407|FG002|Extension Phase|Protocol Violation|0|||
124590285|NCT00965757|448120408|FG003|Extension Phase|Protocol Violation|1|||
124590286|NCT00965757|448120405|FG000|Extension Phase|Other|0|||
124590287|NCT00965757|448120406|FG001|Extension Phase|Other|0|||
124590288|NCT00965757|448120407|FG002|Extension Phase|Other|2|||
124590289|NCT00965757|448120408|FG003|Extension Phase|Other|1|||
124590290|NCT01398787|448120413|FG000|Overall Study|Adverse Event|1|||
124590291|NCT01332968|448120414|FG000|Induction Period|Adverse Event|23|||
124590292|NCT01332968|448120415|FG001|Induction Period|Adverse Event|26|||
124590293|NCT01332968|448120416|FG002|Induction Period|Adverse Event|0|||
124590294|NCT01332968|448120417|FG003|Induction Period|Adverse Event|0|||
124590295|NCT01332968|448120418|FG004|Induction Period|Adverse Event|0|||
124590296|NCT01332968|448120419|FG005|Induction Period|Adverse Event|0|||
124590297|NCT01332968|448120420|FG006|Induction Period|Adverse Event|0|||
124590298|NCT01332968|448120421|FG007|Induction Period|Adverse Event|0|||
124590299|NCT01332968|448120414|FG000|Induction Period|Death|1|||
124590300|NCT01332968|448120415|FG001|Induction Period|Death|4|||
124590301|NCT01332968|448120416|FG002|Induction Period|Death|0|||
124590302|NCT01332968|448120417|FG003|Induction Period|Death|0|||
124590303|NCT01332968|448120418|FG004|Induction Period|Death|0|||
124590304|NCT01332968|448120419|FG005|Induction Period|Death|0|||
124590305|NCT01332968|448120420|FG006|Induction Period|Death|0|||
124590306|NCT01332968|448120421|FG007|Induction Period|Death|0|||
124590307|NCT01332968|448120414|FG000|Induction Period|Non-compliance|1|||
124590308|NCT01332968|448120415|FG001|Induction Period|Non-compliance|0|||
124590309|NCT01332968|448120416|FG002|Induction Period|Non-compliance|0|||
124590310|NCT01332968|448120417|FG003|Induction Period|Non-compliance|0|||
124590311|NCT01332968|448120418|FG004|Induction Period|Non-compliance|0|||
124590312|NCT01332968|448120419|FG005|Induction Period|Non-compliance|0|||
124590313|NCT01332968|448120420|FG006|Induction Period|Non-compliance|0|||
124590314|NCT01332968|448120421|FG007|Induction Period|Non-compliance|0|||
124590315|NCT01332968|448120414|FG000|Induction Period|Other|2|||
124590316|NCT01332968|448120415|FG001|Induction Period|Other|2|||
124590317|NCT01332968|448120416|FG002|Induction Period|Other|0|||
124590318|NCT01332968|448120417|FG003|Induction Period|Other|0|||
124590319|NCT01332968|448120418|FG004|Induction Period|Other|0|||
124590320|NCT01332968|448120419|FG005|Induction Period|Other|0|||
124590321|NCT01332968|448120420|FG006|Induction Period|Other|0|||
124590322|NCT01332968|448120421|FG007|Induction Period|Other|0|||
124590323|NCT01332968|448120414|FG000|Induction Period|Physician Decision|6|||
124590324|NCT01332968|448120415|FG001|Induction Period|Physician Decision|1|||
124590325|NCT01332968|448120416|FG002|Induction Period|Physician Decision|0|||
124590326|NCT01332968|448120417|FG003|Induction Period|Physician Decision|0|||
124590327|NCT01332968|448120418|FG004|Induction Period|Physician Decision|0|||
124590328|NCT01332968|448120419|FG005|Induction Period|Physician Decision|0|||
124590329|NCT01332968|448120420|FG006|Induction Period|Physician Decision|0|||
124590330|NCT01332968|448120421|FG007|Induction Period|Physician Decision|0|||
124590331|NCT01332968|448120414|FG000|Induction Period|Progressive Disease|15|||
124590332|NCT01332968|448120415|FG001|Induction Period|Progressive Disease|7|||
124590333|NCT01332968|448120416|FG002|Induction Period|Progressive Disease|0|||
124590334|NCT01332968|448120417|FG003|Induction Period|Progressive Disease|0|||
124590335|NCT01332968|448120418|FG004|Induction Period|Progressive Disease|0|||
124729554|NCT03622112|448632495|FG000|Overall Study|Death|0|||
124729555|NCT03622112|448632496|FG001|Overall Study|Death|0|||
124729556|NCT03622112|448632497|FG002|Overall Study|Death|0|||
124729557|NCT03622112|448632498|FG003|Overall Study|Death|1|||
124729558|NCT03622112|448632499|FG004|Overall Study|Death|0|||
124729559|NCT03622112|448632500|FG005|Overall Study|Death|0|||
124729560|NCT03622112|448632501|FG006|Overall Study|Death|0|||
124729561|NCT03622112|448632495|FG000|Overall Study|Lost to Follow-up|1|||
124729562|NCT03622112|448632496|FG001|Overall Study|Lost to Follow-up|1|||
124729563|NCT03622112|448632497|FG002|Overall Study|Lost to Follow-up|0|||
124729564|NCT03622112|448632498|FG003|Overall Study|Lost to Follow-up|0|||
124729565|NCT03622112|448632499|FG004|Overall Study|Lost to Follow-up|0|||
124729566|NCT03622112|448632500|FG005|Overall Study|Lost to Follow-up|0|||
124729567|NCT03622112|448632501|FG006|Overall Study|Lost to Follow-up|0|||
124729568|NCT03622112|448632495|FG000|Overall Study|Study-specific withdrawal criteria|10|||
124729569|NCT03622112|448632496|FG001|Overall Study|Study-specific withdrawal criteria|8|||
124729570|NCT03622112|448632497|FG002|Overall Study|Study-specific withdrawal criteria|7|||
124729571|NCT03622112|448632498|FG003|Overall Study|Study-specific withdrawal criteria|6|||
124729572|NCT03622112|448632499|FG004|Overall Study|Study-specific withdrawal criteria|4|||
124729573|NCT03622112|448632500|FG005|Overall Study|Study-specific withdrawal criteria|18|||
124729574|NCT03622112|448632501|FG006|Overall Study|Study-specific withdrawal criteria|4|||
124729575|NCT03622112|448632495|FG000|Overall Study|Protocol Violation|2|||
124729576|NCT03622112|448632496|FG001|Overall Study|Protocol Violation|0|||
124729577|NCT03622112|448632497|FG002|Overall Study|Protocol Violation|1|||
124729578|NCT03622112|448632498|FG003|Overall Study|Protocol Violation|1|||
124729579|NCT03622112|448632499|FG004|Overall Study|Protocol Violation|0|||
124778229|NCT00976560|448816349|FG001|Overall Study|Lost to Follow-up|0|||
124590336|NCT01332968|448120419|FG005|Induction Period|Progressive Disease|0|||
124590337|NCT01332968|448120420|FG006|Induction Period|Progressive Disease|0|||
124590338|NCT01332968|448120421|FG007|Induction Period|Progressive Disease|0|||
124590339|NCT01332968|448120414|FG000|Induction Period|Protocol Violation|3|||
124590340|NCT01332968|448120415|FG001|Induction Period|Protocol Violation|4|||
124590341|NCT01332968|448120416|FG002|Induction Period|Protocol Violation|0|||
124590342|NCT01332968|448120417|FG003|Induction Period|Protocol Violation|0|||
124590343|NCT01332968|448120418|FG004|Induction Period|Protocol Violation|0|||
124590344|NCT01332968|448120419|FG005|Induction Period|Protocol Violation|0|||
124590345|NCT01332968|448120420|FG006|Induction Period|Protocol Violation|0|||
124590346|NCT01332968|448120421|FG007|Induction Period|Protocol Violation|0|||
124590347|NCT01332968|448120414|FG000|Induction Period|Withdrawal by Subject|3|||
124590348|NCT01332968|448120415|FG001|Induction Period|Withdrawal by Subject|5|||
124590349|NCT01332968|448120416|FG002|Induction Period|Withdrawal by Subject|0|||
124590350|NCT01332968|448120417|FG003|Induction Period|Withdrawal by Subject|0|||
124590351|NCT01332968|448120418|FG004|Induction Period|Withdrawal by Subject|0|||
124590352|NCT01332968|448120419|FG005|Induction Period|Withdrawal by Subject|0|||
124590353|NCT01332968|448120420|FG006|Induction Period|Withdrawal by Subject|0|||
124590354|NCT01332968|448120421|FG007|Induction Period|Withdrawal by Subject|0|||
124590355|NCT01332968|448120414|FG000|Induction Period|Randomised but not treated|4|||
124590356|NCT01332968|448120415|FG001|Induction Period|Randomised but not treated|7|||
124590357|NCT01332968|448120416|FG002|Induction Period|Randomised but not treated|0|||
124590358|NCT01332968|448120417|FG003|Induction Period|Randomised but not treated|0|||
124590359|NCT01332968|448120418|FG004|Induction Period|Randomised but not treated|0|||
124590360|NCT01332968|448120419|FG005|Induction Period|Randomised but not treated|0|||
124590361|NCT01332968|448120420|FG006|Induction Period|Randomised but not treated|0|||
124590362|NCT01332968|448120421|FG007|Induction Period|Randomised but not treated|0|||
124590363|NCT01332968|448120414|FG000|Maintenance/Observation Period|Adverse Event|0|||
124590364|NCT01332968|448120415|FG001|Maintenance/Observation Period|Adverse Event|0|||
124590365|NCT01332968|448120416|FG002|Maintenance/Observation Period|Adverse Event|53|||
124590366|NCT01332968|448120417|FG003|Maintenance/Observation Period|Adverse Event|66|||
124590367|NCT01332968|448120418|FG004|Maintenance/Observation Period|Adverse Event|0|||
124590368|NCT01332968|448120419|FG005|Maintenance/Observation Period|Adverse Event|0|||
124590369|NCT01332968|448120420|FG006|Maintenance/Observation Period|Adverse Event|0|||
124590370|NCT01332968|448120421|FG007|Maintenance/Observation Period|Adverse Event|0|||
124729580|NCT03622112|448632500|FG005|Overall Study|Protocol Violation|0|||
124729581|NCT03622112|448632501|FG006|Overall Study|Protocol Violation|0|||
124729582|NCT03622112|448632495|FG000|Overall Study|Adverse Event|6|||
124729583|NCT03622112|448632496|FG001|Overall Study|Adverse Event|8|||
124729584|NCT03622112|448632497|FG002|Overall Study|Adverse Event|4|||
124729585|NCT03622112|448632498|FG003|Overall Study|Adverse Event|11|||
124778230|NCT00976560|448816348|FG000|Overall Study|Physician Decision|2|||
124590371|NCT01332968|448120414|FG000|Maintenance/Observation Period|Death|0|||
124729586|NCT03622112|448632499|FG004|Overall Study|Adverse Event|4|||
124778231|NCT00976560|448816349|FG001|Overall Study|Physician Decision|0|||
124778232|NCT00976560|448816348|FG000|Overall Study|Withdrawal by Subject|2|||
124778233|NCT00976560|448816349|FG001|Overall Study|Withdrawal by Subject|3|||
124778234|NCT01216189|448816350|FG000|Overall Study|Lost to Follow-up|21|||
124590372|NCT01332968|448120415|FG001|Maintenance/Observation Period|Death|0|||
124590373|NCT01332968|448120416|FG002|Maintenance/Observation Period|Death|5|||
124590374|NCT01332968|448120417|FG003|Maintenance/Observation Period|Death|6|||
124590375|NCT01332968|448120418|FG004|Maintenance/Observation Period|Death|0|||
124590376|NCT01332968|448120419|FG005|Maintenance/Observation Period|Death|0|||
124590377|NCT01332968|448120420|FG006|Maintenance/Observation Period|Death|0|||
124590378|NCT01332968|448120421|FG007|Maintenance/Observation Period|Death|0|||
124590379|NCT01332968|448120414|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
124590380|NCT01332968|448120415|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
124590381|NCT01332968|448120416|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
124590382|NCT01332968|448120417|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
124590383|NCT01332968|448120418|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
124590384|NCT01332968|448120419|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
124590385|NCT01332968|448120420|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
124590386|NCT01332968|448120421|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
124590387|NCT01332968|448120414|FG000|Maintenance/Observation Period|Non-compliance|0|||
124590388|NCT01332968|448120415|FG001|Maintenance/Observation Period|Non-compliance|0|||
124590389|NCT01332968|448120416|FG002|Maintenance/Observation Period|Non-compliance|4|||
124590390|NCT01332968|448120417|FG003|Maintenance/Observation Period|Non-compliance|3|||
124590391|NCT01332968|448120418|FG004|Maintenance/Observation Period|Non-compliance|0|||
124590392|NCT01332968|448120419|FG005|Maintenance/Observation Period|Non-compliance|0|||
124590393|NCT01332968|448120420|FG006|Maintenance/Observation Period|Non-compliance|0|||
124590394|NCT01332968|448120421|FG007|Maintenance/Observation Period|Non-compliance|0|||
124590395|NCT01332968|448120414|FG000|Maintenance/Observation Period|Other|0|||
124590396|NCT01332968|448120415|FG001|Maintenance/Observation Period|Other|0|||
124590397|NCT01332968|448120416|FG002|Maintenance/Observation Period|Other|4|||
124590398|NCT01332968|448120417|FG003|Maintenance/Observation Period|Other|7|||
124590399|NCT01332968|448120418|FG004|Maintenance/Observation Period|Other|0|||
124590400|NCT01332968|448120419|FG005|Maintenance/Observation Period|Other|0|||
124590401|NCT01332968|448120420|FG006|Maintenance/Observation Period|Other|0|||
124590402|NCT01332968|448120421|FG007|Maintenance/Observation Period|Other|0|||
124590403|NCT01332968|448120414|FG000|Maintenance/Observation Period|Physician Decision|0|||
124590404|NCT01332968|448120415|FG001|Maintenance/Observation Period|Physician Decision|0|||
124590405|NCT01332968|448120416|FG002|Maintenance/Observation Period|Physician Decision|14|||
124590406|NCT01332968|448120417|FG003|Maintenance/Observation Period|Physician Decision|19|||
124590407|NCT01332968|448120418|FG004|Maintenance/Observation Period|Physician Decision|0|||
124590408|NCT01332968|448120419|FG005|Maintenance/Observation Period|Physician Decision|1|||
124590409|NCT01332968|448120420|FG006|Maintenance/Observation Period|Physician Decision|0|||
124590410|NCT01332968|448120421|FG007|Maintenance/Observation Period|Physician Decision|0|||
124590411|NCT01332968|448120414|FG000|Maintenance/Observation Period|Progressive Disease|0|||
124590412|NCT01332968|448120415|FG001|Maintenance/Observation Period|Progressive Disease|0|||
124590413|NCT01332968|448120416|FG002|Maintenance/Observation Period|Progressive Disease|72|||
124590414|NCT01332968|448120417|FG003|Maintenance/Observation Period|Progressive Disease|40|||
124590415|NCT01332968|448120418|FG004|Maintenance/Observation Period|Progressive Disease|0|||
124590416|NCT01332968|448120419|FG005|Maintenance/Observation Period|Progressive Disease|0|||
124590417|NCT01332968|448120420|FG006|Maintenance/Observation Period|Progressive Disease|0|||
124590418|NCT01332968|448120421|FG007|Maintenance/Observation Period|Progressive Disease|0|||
124590419|NCT01332968|448120414|FG000|Maintenance/Observation Period|Protocol Violation|0|||
124590420|NCT01332968|448120415|FG001|Maintenance/Observation Period|Protocol Violation|0|||
124590421|NCT01332968|448120416|FG002|Maintenance/Observation Period|Protocol Violation|1|||
124590422|NCT01332968|448120417|FG003|Maintenance/Observation Period|Protocol Violation|1|||
124590423|NCT01332968|448120418|FG004|Maintenance/Observation Period|Protocol Violation|0|||
124590424|NCT01332968|448120419|FG005|Maintenance/Observation Period|Protocol Violation|0|||
124590425|NCT01332968|448120420|FG006|Maintenance/Observation Period|Protocol Violation|0|||
124590426|NCT01332968|448120421|FG007|Maintenance/Observation Period|Protocol Violation|0|||
124590427|NCT01332968|448120414|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
124729587|NCT03622112|448632500|FG005|Overall Study|Adverse Event|20|||
124729588|NCT03622112|448632501|FG006|Overall Study|Adverse Event|2|||
124729589|NCT03622112|448632495|FG000|Overall Study|Reason not specified|0|||
124729590|NCT03622112|448632496|FG001|Overall Study|Reason not specified|1|||
124729591|NCT03622112|448632497|FG002|Overall Study|Reason not specified|0|||
124590428|NCT01332968|448120415|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
124729592|NCT03622112|448632498|FG003|Overall Study|Reason not specified|1|||
124729593|NCT03622112|448632499|FG004|Overall Study|Reason not specified|1|||
124729594|NCT03622112|448632500|FG005|Overall Study|Reason not specified|2|||
124729595|NCT03622112|448632501|FG006|Overall Study|Reason not specified|1|||
124729596|NCT03773133|448632502|FG000|Overall Study|Screen Failure|8|||
124729597|NCT01610713|448632503|FG000|Overall Study|Adverse Event|3|||
124590429|NCT01332968|448120416|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
124590430|NCT01332968|448120417|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
124590431|NCT01332968|448120418|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
124590432|NCT01332968|448120419|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
124590433|NCT01332968|448120420|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
124590434|NCT01332968|448120421|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
124590435|NCT01332968|448120414|FG000|Follow-Up Period|Adverse Event|0|||
124590436|NCT01332968|448120415|FG001|Follow-Up Period|Adverse Event|0|||
124590437|NCT01332968|448120416|FG002|Follow-Up Period|Adverse Event|0|||
124590438|NCT01332968|448120417|FG003|Follow-Up Period|Adverse Event|0|||
124590439|NCT01332968|448120418|FG004|Follow-Up Period|Adverse Event|0|||
124590440|NCT01332968|448120419|FG005|Follow-Up Period|Adverse Event|0|||
124590441|NCT01332968|448120420|FG006|Follow-Up Period|Adverse Event|0|||
124590442|NCT01332968|448120421|FG007|Follow-Up Period|Adverse Event|4|||
124590443|NCT01332968|448120414|FG000|Follow-Up Period|Death|0|||
124590444|NCT01332968|448120415|FG001|Follow-Up Period|Death|0|||
124590445|NCT01332968|448120416|FG002|Follow-Up Period|Death|0|||
124590446|NCT01332968|448120417|FG003|Follow-Up Period|Death|0|||
124590447|NCT01332968|448120418|FG004|Follow-Up Period|Death|0|||
124590448|NCT01332968|448120419|FG005|Follow-Up Period|Death|0|||
124590449|NCT01332968|448120420|FG006|Follow-Up Period|Death|27|||
124590450|NCT01332968|448120421|FG007|Follow-Up Period|Death|30|||
124590451|NCT01332968|448120414|FG000|Follow-Up Period|Lost to Follow-up|0|||
124590452|NCT01332968|448120415|FG001|Follow-Up Period|Lost to Follow-up|0|||
124590453|NCT01332968|448120416|FG002|Follow-Up Period|Lost to Follow-up|0|||
124590454|NCT01332968|448120417|FG003|Follow-Up Period|Lost to Follow-up|0|||
124590455|NCT01332968|448120418|FG004|Follow-Up Period|Lost to Follow-up|0|||
124590456|NCT01332968|448120419|FG005|Follow-Up Period|Lost to Follow-up|0|||
124590457|NCT01332968|448120420|FG006|Follow-Up Period|Lost to Follow-up|11|||
124590458|NCT01332968|448120421|FG007|Follow-Up Period|Lost to Follow-up|15|||
124590459|NCT01332968|448120414|FG000|Follow-Up Period|Non-compliance|0|||
124590460|NCT01332968|448120415|FG001|Follow-Up Period|Non-compliance|0|||
124590461|NCT01332968|448120416|FG002|Follow-Up Period|Non-compliance|0|||
124590462|NCT01332968|448120417|FG003|Follow-Up Period|Non-compliance|0|||
124590463|NCT01332968|448120418|FG004|Follow-Up Period|Non-compliance|0|||
124590464|NCT01332968|448120419|FG005|Follow-Up Period|Non-compliance|0|||
124590465|NCT01332968|448120420|FG006|Follow-Up Period|Non-compliance|4|||
124590466|NCT01332968|448120421|FG007|Follow-Up Period|Non-compliance|9|||
124590467|NCT01332968|448120414|FG000|Follow-Up Period|Other|0|||
124590468|NCT01332968|448120415|FG001|Follow-Up Period|Other|0|||
124590469|NCT01332968|448120416|FG002|Follow-Up Period|Other|0|||
124590470|NCT01332968|448120417|FG003|Follow-Up Period|Other|0|||
124590471|NCT01332968|448120418|FG004|Follow-Up Period|Other|0|||
124590472|NCT01332968|448120419|FG005|Follow-Up Period|Other|0|||
124590473|NCT01332968|448120420|FG006|Follow-Up Period|Other|18|||
124590474|NCT01332968|448120421|FG007|Follow-Up Period|Other|21|||
124590475|NCT01332968|448120414|FG000|Follow-Up Period|Physician Decision|0|||
124590476|NCT01332968|448120415|FG001|Follow-Up Period|Physician Decision|0|||
124590477|NCT01332968|448120416|FG002|Follow-Up Period|Physician Decision|0|||
124590478|NCT01332968|448120417|FG003|Follow-Up Period|Physician Decision|0|||
124590479|NCT01332968|448120418|FG004|Follow-Up Period|Physician Decision|0|||
124590480|NCT01332968|448120419|FG005|Follow-Up Period|Physician Decision|0|||
124590481|NCT01332968|448120420|FG006|Follow-Up Period|Physician Decision|12|||
124590482|NCT01332968|448120421|FG007|Follow-Up Period|Physician Decision|15|||
124590483|NCT01332968|448120414|FG000|Follow-Up Period|Progressive Disease|0|||
124590484|NCT01332968|448120415|FG001|Follow-Up Period|Progressive Disease|0|||
124590485|NCT01332968|448120416|FG002|Follow-Up Period|Progressive Disease|0|||
124590486|NCT01332968|448120417|FG003|Follow-Up Period|Progressive Disease|0|||
124590487|NCT01332968|448120418|FG004|Follow-Up Period|Progressive Disease|0|||
124590488|NCT01332968|448120419|FG005|Follow-Up Period|Progressive Disease|0|||
124590489|NCT01332968|448120420|FG006|Follow-Up Period|Progressive Disease|126|||
124729598|NCT01610713|448632504|FG001|Overall Study|Adverse Event|0|||
124729599|NCT01610713|448632503|FG000|Overall Study|Lack of Efficacy|1|||
124729600|NCT01610713|448632504|FG001|Overall Study|Lack of Efficacy|0|||
124590490|NCT01332968|448120421|FG007|Follow-Up Period|Progressive Disease|106|||
124590491|NCT01332968|448120414|FG000|Follow-Up Period|Protocol Violation|0|||
124590492|NCT01332968|448120415|FG001|Follow-Up Period|Protocol Violation|0|||
124590493|NCT01332968|448120416|FG002|Follow-Up Period|Protocol Violation|0|||
124590494|NCT01332968|448120417|FG003|Follow-Up Period|Protocol Violation|0|||
124590495|NCT01332968|448120418|FG004|Follow-Up Period|Protocol Violation|0|||
124590496|NCT01332968|448120419|FG005|Follow-Up Period|Protocol Violation|0|||
124590497|NCT01332968|448120420|FG006|Follow-Up Period|Protocol Violation|1|||
124590498|NCT01332968|448120421|FG007|Follow-Up Period|Protocol Violation|0|||
124590499|NCT01332968|448120414|FG000|Follow-Up Period|Withdrawal by Subject|0|||
124590500|NCT01332968|448120415|FG001|Follow-Up Period|Withdrawal by Subject|0|||
124590501|NCT01332968|448120416|FG002|Follow-Up Period|Withdrawal by Subject|0|||
124590502|NCT01332968|448120417|FG003|Follow-Up Period|Withdrawal by Subject|0|||
124729601|NCT01610713|448632503|FG000|Overall Study|low mood and poor motivation|1|||
124778235|NCT01216189|448816351|FG001|Overall Study|Lost to Follow-up|3|||
124778236|NCT01216189|448816350|FG000|Overall Study|Death|4|||
124778237|NCT01216189|448816351|FG001|Overall Study|Death|2|||
124778238|NCT00125164|448816354|FG000|Overall Study|Adverse Event|0|||
124778239|NCT00125164|448816355|FG001|Overall Study|Adverse Event|0|||
124778240|NCT00125164|448816356|FG002|Overall Study|Adverse Event|2|||
124778241|NCT00125164|448816357|FG003|Overall Study|Adverse Event|4|||
124778242|NCT00125164|448816354|FG000|Overall Study|Lost to Follow-up|0|||
124778243|NCT00125164|448816355|FG001|Overall Study|Lost to Follow-up|0|||
124778244|NCT00125164|448816356|FG002|Overall Study|Lost to Follow-up|1|||
124778245|NCT00125164|448816357|FG003|Overall Study|Lost to Follow-up|1|||
124778246|NCT00125164|448816354|FG000|Overall Study|Withdrawal by Subject|2|||
124778247|NCT00125164|448816355|FG001|Overall Study|Withdrawal by Subject|0|||
124778248|NCT00125164|448816356|FG002|Overall Study|Withdrawal by Subject|1|||
124778249|NCT00125164|448816357|FG003|Overall Study|Withdrawal by Subject|1|||
124778250|NCT01339052|448816358|FG000|Overall Study|Disease progression|13|||
124778251|NCT01339052|448816359|FG001|Overall Study|Disease progression|46|||
124778252|NCT01339052|448816358|FG000|Overall Study|Adverse Event|1|||
124778253|NCT01339052|448816359|FG001|Overall Study|Adverse Event|1|||
124778254|NCT01339052|448816358|FG000|Overall Study|Withdrawal by Subject|0|||
124778255|NCT01339052|448816359|FG001|Overall Study|Withdrawal by Subject|3|||
124778256|NCT01339052|448816358|FG000|Overall Study|Physician Decision|1|||
124778257|NCT01339052|448816359|FG001|Overall Study|Physician Decision|0|||
124778258|NCT02637037|448816360|FG000|Overall Study|Positive drug screen at admission|1|||
124778259|NCT02637037|448816361|FG001|Overall Study|Positive drug screen at admission|0|||
124778260|NCT02637037|448816360|FG000|Overall Study|Withdrawal by Subject|2|||
124778261|NCT02637037|448816361|FG001|Overall Study|Withdrawal by Subject|1|||
124778262|NCT02637037|448816360|FG000|Overall Study|Adverse Event|1|||
124778263|NCT02637037|448816361|FG001|Overall Study|Adverse Event|0|||
124778264|NCT03339219|448816362|FG000|Overall Study|Death|12|||
124778265|NCT03339219|448816362|FG000|Overall Study|Site Terminated by Sponsor|22|||
124778266|NCT03339219|448816362|FG000|Overall Study|Withdrawal by Subject|1|||
124778267|NCT01469377|448816364|FG000|Overall Study|Protocol Deviation|7|||
124778268|NCT01469377|448816365|FG001|Overall Study|Protocol Deviation|10|||
124778269|NCT01469377|448816366|FG002|Overall Study|Protocol Deviation|10|||
124778270|NCT01469377|448816364|FG000|Overall Study|Lost to Follow-up|3|||
124778271|NCT01469377|448816365|FG001|Overall Study|Lost to Follow-up|2|||
124778272|NCT01469377|448816366|FG002|Overall Study|Lost to Follow-up|5|||
124778273|NCT01469377|448816364|FG000|Overall Study|Withdrawal of Consent|12|||
124778274|NCT01469377|448816365|FG001|Overall Study|Withdrawal of Consent|14|||
124778275|NCT01469377|448816366|FG002|Overall Study|Withdrawal of Consent|15|||
124778276|NCT01469377|448816364|FG000|Overall Study|Adverse Event|8|||
124778277|NCT01469377|448816365|FG001|Overall Study|Adverse Event|18|||
124778278|NCT01469377|448816366|FG002|Overall Study|Adverse Event|36|||
124778279|NCT01469377|448816364|FG000|Overall Study|Insufficient Therapeutic Response|3|||
124778280|NCT01469377|448816365|FG001|Overall Study|Insufficient Therapeutic Response|4|||
124778281|NCT01469377|448816366|FG002|Overall Study|Insufficient Therapeutic Response|0|||
124778282|NCT01469377|448816364|FG000|Overall Study|Other Miscellaneous Reasons|2|||
124778283|NCT01469377|448816365|FG001|Overall Study|Other Miscellaneous Reasons|0|||
124778284|NCT01469377|448816366|FG002|Overall Study|Other Miscellaneous Reasons|0|||
124778285|NCT01733680|448816367|FG000|Overall Study|Withdrawal by Subject|0|||
124778286|NCT01733680|448816368|FG001|Overall Study|Withdrawal by Subject|1|||
124778287|NCT04139798|448816373|FG000|Overall Study|Withdrawal by Subject|6|||
124778288|NCT04139798|448816374|FG001|Overall Study|Withdrawal by Subject|5|||
124729602|NCT01610713|448632504|FG001|Overall Study|low mood and poor motivation|0|||
124729603|NCT01610713|448632503|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
124729604|NCT01610713|448632504|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
124729605|NCT01610713|448632503|FG000|Overall Study|Lost to Follow-up|0|||
124729606|NCT01610713|448632504|FG001|Overall Study|Lost to Follow-up|1|||
124729607|NCT00503776|448632506|FG000|Overall Study|Withdrawal by Subject|1|||
124729608|NCT00503776|448632507|FG001|Overall Study|Withdrawal by Subject|0|||
124729609|NCT00503776|448632508|FG002|Overall Study|Withdrawal by Subject|1|||
124729610|NCT00503776|448632509|FG003|Overall Study|Withdrawal by Subject|1|||
124729611|NCT00503776|448632506|FG000|Overall Study|Physician Decision|0|||
124729612|NCT00503776|448632507|FG001|Overall Study|Physician Decision|0|||
124729613|NCT00503776|448632508|FG002|Overall Study|Physician Decision|1|||
124729614|NCT00503776|448632509|FG003|Overall Study|Physician Decision|1|||
124729615|NCT03943550|448632512|FG000|Overall Study|Adverse Event|0|||
124729616|NCT03943550|448632513|FG001|Overall Study|Adverse Event|0|||
124729617|NCT03943550|448632514|FG002|Overall Study|Adverse Event|1|||
124729618|NCT03943550|448632512|FG000|Overall Study|Lost to Follow-up|0|||
124729619|NCT03943550|448632513|FG001|Overall Study|Lost to Follow-up|0|||
124729620|NCT03943550|448632514|FG002|Overall Study|Lost to Follow-up|1|||
124729621|NCT03943550|448632512|FG000|Overall Study|Progressive Disease|0|||
124729622|NCT03943550|448632513|FG001|Overall Study|Progressive Disease|0|||
124778289|NCT04139798|448816373|FG000|Overall Study|Lost to Follow-up|2|||
124778290|NCT04139798|448816374|FG001|Overall Study|Lost to Follow-up|5|||
124778291|NCT04139798|448816373|FG000|Overall Study|Discontinued|4|||
124590503|NCT01332968|448120418|FG004|Follow-Up Period|Withdrawal by Subject|0|||
124590504|NCT01332968|448120419|FG005|Follow-Up Period|Withdrawal by Subject|0|||
124590505|NCT01332968|448120420|FG006|Follow-Up Period|Withdrawal by Subject|29|||
124590506|NCT01332968|448120421|FG007|Follow-Up Period|Withdrawal by Subject|32|||
124590507|NCT01332968|448120414|FG000|Follow-Up Period|No reason provided|0|||
124590508|NCT01332968|448120415|FG001|Follow-Up Period|No reason provided|0|||
124590509|NCT01332968|448120416|FG002|Follow-Up Period|No reason provided|0|||
124590510|NCT01332968|448120417|FG003|Follow-Up Period|No reason provided|0|||
124590511|NCT01332968|448120418|FG004|Follow-Up Period|No reason provided|0|||
124590512|NCT01332968|448120419|FG005|Follow-Up Period|No reason provided|0|||
124590513|NCT01332968|448120420|FG006|Follow-Up Period|No reason provided|2|||
124590514|NCT01332968|448120421|FG007|Follow-Up Period|No reason provided|3|||
124590515|NCT02351167|448120422|FG000|Overall Study|Withdrawal by Subject|19|||
124590516|NCT02351167|448120423|FG001|Overall Study|Withdrawal by Subject|18|||
124590517|NCT02351167|448120424|FG002|Overall Study|Withdrawal by Subject|21|||
124590518|NCT00113919|448120431|FG000|Overall Study|Physician Decision|8|||
124590519|NCT00113919|448120431|FG000|Overall Study|Death|6|||
124590520|NCT00715676|448120435|FG000|Overall Study|Adverse Event|3|||
124590521|NCT00715676|448120436|FG001|Overall Study|Adverse Event|5|||
124590522|NCT00715676|448120437|FG002|Overall Study|Adverse Event|21|||
124590523|NCT00715676|448120435|FG000|Overall Study|Withdrawal by Subject|1|||
124590524|NCT00715676|448120436|FG001|Overall Study|Withdrawal by Subject|3|||
124590525|NCT00715676|448120437|FG002|Overall Study|Withdrawal by Subject|8|||
124590526|NCT00715676|448120435|FG000|Overall Study|Lost to Follow-up|1|||
124590527|NCT00715676|448120436|FG001|Overall Study|Lost to Follow-up|2|||
124590528|NCT00715676|448120437|FG002|Overall Study|Lost to Follow-up|1|||
124590529|NCT00715676|448120435|FG000|Overall Study|Terminated by Sponsor|1|||
124729623|NCT03943550|448632514|FG002|Overall Study|Progressive Disease|2|||
124729624|NCT03943550|448632512|FG000|Overall Study|Participant Moved Out of the Country|0|||
124729625|NCT03943550|448632513|FG001|Overall Study|Participant Moved Out of the Country|1|||
124590530|NCT00715676|448120436|FG001|Overall Study|Terminated by Sponsor|0|||
124590531|NCT00715676|448120437|FG002|Overall Study|Terminated by Sponsor|0|||
124590532|NCT00715676|448120435|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
124590533|NCT00715676|448120436|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
124590534|NCT00715676|448120437|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
124590535|NCT00715676|448120435|FG000|Overall Study|Use of Exclusionary Medication|0|||
124590536|NCT00715676|448120436|FG001|Overall Study|Use of Exclusionary Medication|0|||
124590537|NCT00715676|448120437|FG002|Overall Study|Use of Exclusionary Medication|1|||
124590538|NCT00715676|448120435|FG000|Overall Study|Elevated Blood Glucose|0|||
124590539|NCT00715676|448120436|FG001|Overall Study|Elevated Blood Glucose|1|||
124590540|NCT00715676|448120437|FG002|Overall Study|Elevated Blood Glucose|0|||
124590541|NCT00372996|448120438|FG000|Overall Study|Death|11|||
124590542|NCT00372996|448120439|FG001|Overall Study|Death|4|||
124590543|NCT00372996|448120440|FG002|Overall Study|Death|8|||
124590544|NCT00372996|448120441|FG003|Overall Study|Death|7|||
124590545|NCT00372996|448120438|FG000|Overall Study|Lost to Follow-up|0|||
124590546|NCT00372996|448120439|FG001|Overall Study|Lost to Follow-up|2|||
124590547|NCT00372996|448120440|FG002|Overall Study|Lost to Follow-up|0|||
124729626|NCT03943550|448632514|FG002|Overall Study|Participant Moved Out of the Country|0|||
124729627|NCT03359785|448632515|FG000|Overall Study|Protocol Violation|0|||
124729628|NCT03359785|448632516|FG001|Overall Study|Protocol Violation|1|||
124729629|NCT03359785|448632517|FG002|Overall Study|Protocol Violation|0|||
124729630|NCT03359785|448632518|FG003|Overall Study|Protocol Violation|0|||
124729631|NCT03359785|448632515|FG000|Overall Study|Early study termination due to study pause|0|||
124729632|NCT03359785|448632516|FG001|Overall Study|Early study termination due to study pause|0|||
124729633|NCT03359785|448632517|FG002|Overall Study|Early study termination due to study pause|2|||
124729634|NCT03359785|448632518|FG003|Overall Study|Early study termination due to study pause|0|||
124729635|NCT03359785|448632515|FG000|Overall Study|Withdrawal by Subject|2|||
124729636|NCT03359785|448632516|FG001|Overall Study|Withdrawal by Subject|2|||
124729637|NCT03359785|448632517|FG002|Overall Study|Withdrawal by Subject|0|||
124729638|NCT03359785|448632518|FG003|Overall Study|Withdrawal by Subject|0|||
124729639|NCT03276026|448632521|FG000|Overall Study|Protocol Violation|1|||
124729640|NCT03276026|448632522|FG001|Overall Study|Protocol Violation|0|||
124729641|NCT03650803|448632524|FG000|Overall Study|Lost to Follow-up|6|||
124729642|NCT04049266|448632527|FG000|Overall Study|Adverse Event|16|||
124729643|NCT04049266|448632528|FG001|Overall Study|Adverse Event|9|||
124729644|NCT04049266|448632527|FG000|Overall Study|Non-compliance with study drug|0|||
124729645|NCT04049266|448632528|FG001|Overall Study|Non-compliance with study drug|3|||
124778292|NCT04139798|448816374|FG001|Overall Study|Discontinued|2|||
124778293|NCT04139798|448816373|FG000|Overall Study|Adverse Event|1|||
124590548|NCT00372996|448120441|FG003|Overall Study|Lost to Follow-up|1|||
124590549|NCT00372996|448120438|FG000|Overall Study|Withdrawal by Subject|12|||
124590550|NCT00372996|448120439|FG001|Overall Study|Withdrawal by Subject|6|||
124590551|NCT00372996|448120440|FG002|Overall Study|Withdrawal by Subject|9|||
124590552|NCT00372996|448120441|FG003|Overall Study|Withdrawal by Subject|5|||
124729646|NCT04049266|448632527|FG000|Overall Study|Withdrawal by Subject|6|||
124590553|NCT00372996|448120438|FG000|Overall Study|Study Terminated by Sponsor|4|||
124590554|NCT00372996|448120439|FG001|Overall Study|Study Terminated by Sponsor|0|||
124590555|NCT00372996|448120440|FG002|Overall Study|Study Terminated by Sponsor|4|||
124590556|NCT00372996|448120441|FG003|Overall Study|Study Terminated by Sponsor|0|||
124590557|NCT00372996|448120438|FG000|Overall Study|Other|10|||
124590558|NCT00372996|448120439|FG001|Overall Study|Other|2|||
124590559|NCT00372996|448120440|FG002|Overall Study|Other|7|||
124590560|NCT00372996|448120441|FG003|Overall Study|Other|7|||
124590561|NCT01091363|448120442|FG000|Overall Study|Withdrawal by Subject|11|||
124590562|NCT01091363|448120443|FG001|Overall Study|Withdrawal by Subject|15|||
124590563|NCT01091363|448120442|FG000|Overall Study|Lost to Follow-up|2|||
124590564|NCT01091363|448120443|FG001|Overall Study|Lost to Follow-up|2|||
124590565|NCT02760433|448120446|FG000|Overall Study|Lost to Follow-up|1|||
124590566|NCT02760433|448120447|FG001|Overall Study|Lost to Follow-up|0|||
124590567|NCT02760433|448120448|FG002|Overall Study|Lost to Follow-up|1|||
124590568|NCT02760433|448120449|FG003|Overall Study|Lost to Follow-up|0|||
124590569|NCT02760433|448120450|FG004|Overall Study|Lost to Follow-up|0|||
124590570|NCT02760433|448120446|FG000|Overall Study|Withdrawal by Subject|23|||
124590571|NCT02760433|448120447|FG001|Overall Study|Withdrawal by Subject|9|||
124590572|NCT02760433|448120448|FG002|Overall Study|Withdrawal by Subject|0|||
124590573|NCT02760433|448120449|FG003|Overall Study|Withdrawal by Subject|2|||
124590574|NCT02760433|448120450|FG004|Overall Study|Withdrawal by Subject|9|||
124590575|NCT02760433|448120446|FG000|Overall Study|Lack of Response At Week 14|0|||
124590576|NCT02760433|448120447|FG001|Overall Study|Lack of Response At Week 14|0|||
124590577|NCT02760433|448120448|FG002|Overall Study|Lack of Response At Week 14|0|||
124590578|NCT02760433|448120449|FG003|Overall Study|Lack of Response At Week 14|0|||
124590579|NCT02760433|448120450|FG004|Overall Study|Lack of Response At Week 14|1|||
124590580|NCT02760433|448120446|FG000|Overall Study|Subject refused to continue the study|1|||
124590581|NCT02760433|448120447|FG001|Overall Study|Subject refused to continue the study|0|||
124590582|NCT02760433|448120448|FG002|Overall Study|Subject refused to continue the study|0|||
124590583|NCT02760433|448120449|FG003|Overall Study|Subject refused to continue the study|0|||
124590584|NCT02760433|448120450|FG004|Overall Study|Subject refused to continue the study|0|||
124590585|NCT02760433|448120446|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
124590586|NCT02760433|448120447|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
124590587|NCT02760433|448120448|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
124590588|NCT02760433|448120449|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
124590589|NCT02760433|448120450|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
124590590|NCT02760433|448120446|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
124590591|NCT02760433|448120447|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
124590592|NCT02760433|448120448|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
124590593|NCT02760433|448120449|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
124590594|NCT02760433|448120450|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
124590595|NCT02151149|448120451|FG000|Treatment Period|Death|2|||
124590596|NCT02151149|448120452|FG001|Treatment Period|Death|3|||
124590597|NCT02151149|448120451|FG000|Treatment Period|Adverse Event|17|||
124590598|NCT02151149|448120452|FG001|Treatment Period|Adverse Event|14|||
124590599|NCT02151149|448120451|FG000|Treatment Period|Progressive Disease|25|||
124590600|NCT02151149|448120452|FG001|Treatment Period|Progressive Disease|24|||
124590601|NCT02151149|448120451|FG000|Treatment Period|Symptomatic Deterioration|2|||
124590602|NCT02151149|448120452|FG001|Treatment Period|Symptomatic Deterioration|10|||
124590603|NCT02151149|448120451|FG000|Treatment Period|Withdrawal by Subject|13|||
124590604|NCT02151149|448120452|FG001|Treatment Period|Withdrawal by Subject|11|||
124590605|NCT02151149|448120451|FG000|Treatment Period|Miscellaneous|8|||
124590606|NCT02151149|448120452|FG001|Treatment Period|Miscellaneous|7|||
124590607|NCT02151149|448120451|FG000|Treatment Period|Participants randomized but not treated|3|||
124590608|NCT02151149|448120452|FG001|Treatment Period|Participants randomized but not treated|2|||
124590609|NCT02151149|448120451|FG000|Follow-Up Period|Lost to Follow-up|2|||
124590610|NCT02151149|448120452|FG001|Follow-Up Period|Lost to Follow-up|3|||
124590611|NCT02151149|448120451|FG000|Follow-Up Period|Death|37|||
124590612|NCT02151149|448120452|FG001|Follow-Up Period|Death|34|||
124590613|NCT05889039|448120458|FG000|Overall Study|error in completing survey|0|||
124590614|NCT05889039|448120459|FG001|Overall Study|error in completing survey|2|||
124590615|NCT05889039|448120460|FG002|Overall Study|error in completing survey|0|||
124590616|NCT05889039|448120461|FG003|Overall Study|error in completing survey|0|||
124590617|NCT05889039|448120458|FG000|Overall Study|Lost to Follow-up|4|||
124590618|NCT05889039|448120459|FG001|Overall Study|Lost to Follow-up|0|||
124590619|NCT05889039|448120460|FG002|Overall Study|Lost to Follow-up|0|||
124729647|NCT04049266|448632528|FG001|Overall Study|Withdrawal by Subject|10|||
124590620|NCT05889039|448120461|FG003|Overall Study|Lost to Follow-up|0|||
124590621|NCT03428945|448120462|FG000|Overall Study|Lost to Follow-up|5|||
124729648|NCT04049266|448632527|FG000|Overall Study|Lost to Follow-up|2|||
124590622|NCT03428945|448120463|FG001|Overall Study|Lost to Follow-up|3|||
124590623|NCT03428945|448120462|FG000|Overall Study|Withdrawal by Subject|10|||
124590624|NCT03428945|448120463|FG001|Overall Study|Withdrawal by Subject|10|||
124590625|NCT00982228|448120464|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
124590626|NCT00982228|448120465|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
124590627|NCT00982228|448120464|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
124590628|NCT00982228|448120465|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
124729649|NCT04049266|448632528|FG001|Overall Study|Lost to Follow-up|2|||
124729650|NCT04049266|448632527|FG000|Overall Study|Progressive disease|11|||
124729651|NCT04049266|448632528|FG001|Overall Study|Progressive disease|2|||
124729652|NCT04049266|448632527|FG000|Overall Study|Physician Decision|1|||
124729653|NCT04049266|448632528|FG001|Overall Study|Physician Decision|0|||
124729654|NCT04049266|448632527|FG000|Overall Study|Patient moved out of state|1|||
124729655|NCT04049266|448632528|FG001|Overall Study|Patient moved out of state|0|||
124729656|NCT02901054|448632529|FG000|Overall Study|Physician Decision|1|||
124729657|NCT02901054|448632529|FG000|Overall Study|Withdrawal by Subject|3|||
124729658|NCT01534260|448632530|FG000|Overall Study|Adverse Event|1|||
124729659|NCT01534260|448632531|FG001|Overall Study|Adverse Event|8|||
124729660|NCT01534260|448632530|FG000|Overall Study|Death|2|||
124729661|NCT01534260|448632531|FG001|Overall Study|Death|0|||
124729662|NCT01534260|448632530|FG000|Overall Study|Lack of Efficacy|1|||
124729663|NCT01534260|448632531|FG001|Overall Study|Lack of Efficacy|1|||
124729664|NCT01534260|448632530|FG000|Overall Study|Withdrawal by Subject|1|||
124729665|NCT01534260|448632531|FG001|Overall Study|Withdrawal by Subject|3|||
124729666|NCT01534260|448632530|FG000|Overall Study|Disease Progression|8|||
124729667|NCT01534260|448632531|FG001|Overall Study|Disease Progression|6|||
124729668|NCT01534260|448632530|FG000|Overall Study|Physician Decision|3|||
124729669|NCT01534260|448632531|FG001|Overall Study|Physician Decision|1|||
124729670|NCT01534260|448632530|FG000|Overall Study|No treatment, per protocol|0|||
124729671|NCT01534260|448632531|FG001|Overall Study|No treatment, per protocol|1|||
124729672|NCT01818258|448632535|FG000|Overall Study|Death|3|||
124729673|NCT01818258|448632536|FG001|Overall Study|Death|0|||
124729674|NCT01818258|448632535|FG000|Overall Study|Withdrawal by Subject|0|||
124729675|NCT01818258|448632536|FG001|Overall Study|Withdrawal by Subject|1|||
124729676|NCT01818258|448632535|FG000|Overall Study|Lost to Follow-up|0|||
124729677|NCT01818258|448632536|FG001|Overall Study|Lost to Follow-up|1|||
124729678|NCT01818258|448632535|FG000|Overall Study|Unable to Travel to Clinic|0|||
124729679|NCT01818258|448632536|FG001|Overall Study|Unable to Travel to Clinic|1|||
124729680|NCT02649218|448632545|FG000|Overall Study|Adverse Event|8|||
124729681|NCT02649218|448632545|FG000|Overall Study|Lack of Efficacy|8|||
124729682|NCT02649218|448632545|FG000|Overall Study|Pregnancy|3|||
124729683|NCT02649218|448632545|FG000|Overall Study|Protocol Violation|3|||
124729684|NCT02649218|448632545|FG000|Overall Study|Physician Decision|1|||
124729685|NCT02649218|448632545|FG000|Overall Study|Withdrawal by Subject|2|||
124729686|NCT05145322|448632547|FG000|Overall Study|Lost to Follow-up|4|||
124729687|NCT05145322|448632548|FG001|Overall Study|Lost to Follow-up|5|||
124729688|NCT01349322|448632549|FG000|Overall Study|Protocol Violation|45|||
124729689|NCT01349322|448632550|FG001|Overall Study|Protocol Violation|47|||
124729690|NCT04376684|448632555|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
124729691|NCT04376684|448632556|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
124729692|NCT04376684|448632557|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
124729693|NCT04376684|448632558|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
124729694|NCT04376684|448632555|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
124729695|NCT04376684|448632556|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
124729696|NCT04376684|448632557|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
124729697|NCT04376684|448632558|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
124729698|NCT04376684|448632555|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
124729699|NCT04376684|448632556|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
124729700|NCT04376684|448632557|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
124729701|NCT04376684|448632558|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
124729702|NCT04376684|448632555|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
124729703|NCT04376684|448632556|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
124590629|NCT00982228|448120464|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
124729704|NCT04376684|448632557|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
124729705|NCT04376684|448632558|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
124729706|NCT04376684|448632555|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
124590630|NCT00982228|448120465|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
124729707|NCT04376684|448632556|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
124729708|NCT04376684|448632557|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
124729709|NCT04376684|448632558|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
124729710|NCT04376684|448632555|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
124729711|NCT04376684|448632556|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
124729712|NCT04376684|448632557|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
124729713|NCT04376684|448632558|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
124729714|NCT04376684|448632555|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
124729715|NCT04376684|448632556|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
124729716|NCT04376684|448632557|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
124778294|NCT04139798|448816374|FG001|Overall Study|Adverse Event|3|||
124778295|NCT04139798|448816373|FG000|Overall Study|Protocol Violation|1|||
124778296|NCT04139798|448816374|FG001|Overall Study|Protocol Violation|0|||
124778297|NCT04269889|448816375|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
124778298|NCT04308291|448816378|FG000|Run-In Phase|Withdrawal by Subject|4|||
124778299|NCT04308291|448816378|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
124778300|NCT04308291|448816378|FG000|Study Phase 6-M|Physician Decision|2|||
124778301|NCT04308291|448816378|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
124778302|NCT04308291|448816378|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
124778303|NCT04308291|448816378|FG000|Study Phase 12-M|Physician Decision|2|||
124778304|NCT04308291|448816378|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
124778305|NCT03610269|448816380|FG000|Overall Study|Physician Decision|10|||
124778306|NCT03610269|448816380|FG000|Overall Study|Protocol Violation|1|||
124778307|NCT03610269|448816380|FG000|Overall Study|Unable to draw blood|1|||
124778308|NCT03610269|448816380|FG000|Overall Study|Screen fail|4|||
124778309|NCT04411667|448816383|FG000|Overall Study|Physician Decision|1|||
124778310|NCT04411667|448816384|FG001|Overall Study|Physician Decision|0|||
124778311|NCT00067002|448816385|FG000|Overall Study|Early Death|1|||
124778312|NCT00067002|448816386|FG001|Overall Study|Early Death|2|||
124778313|NCT00067002|448816385|FG000|Overall Study|Delayed|1|||
124778314|NCT00067002|448816386|FG001|Overall Study|Delayed|1|||
124778315|NCT00067002|448816385|FG000|Overall Study|Graft Failure|5|||
124778316|NCT00067002|448816386|FG001|Overall Study|Graft Failure|6|||
124778317|NCT01354314|448816391|FG000|Overall Study|Lost to Follow-up|1|||
124778318|NCT01354314|448816392|FG001|Overall Study|Lost to Follow-up|0|||
124778319|NCT01354314|448816393|FG002|Overall Study|Lost to Follow-up|1|||
124778320|NCT01354314|448816394|FG003|Overall Study|Lost to Follow-up|1|||
124778321|NCT01354314|448816391|FG000|Overall Study|Withdrawal by Subject|0|||
124778322|NCT01354314|448816392|FG001|Overall Study|Withdrawal by Subject|0|||
124778323|NCT01354314|448816393|FG002|Overall Study|Withdrawal by Subject|1|||
124778324|NCT01354314|448816394|FG003|Overall Study|Withdrawal by Subject|0|||
124778325|NCT01354314|448816391|FG000|Overall Study|Adverse Event|0|||
124778326|NCT01354314|448816392|FG001|Overall Study|Adverse Event|0|||
124778327|NCT01354314|448816393|FG002|Overall Study|Adverse Event|0|||
124778328|NCT01354314|448816394|FG003|Overall Study|Adverse Event|1|||
124778329|NCT01354314|448816391|FG000|Overall Study|Protocol Violation|1|||
124778330|NCT01354314|448816392|FG001|Overall Study|Protocol Violation|1|||
124778331|NCT01354314|448816393|FG002|Overall Study|Protocol Violation|0|||
124778332|NCT01354314|448816394|FG003|Overall Study|Protocol Violation|0|||
124778333|NCT01354314|448816391|FG000|Overall Study|Less than 90% Adherence|4|||
124778334|NCT01354314|448816392|FG001|Overall Study|Less than 90% Adherence|2|||
124778335|NCT01354314|448816393|FG002|Overall Study|Less than 90% Adherence|6|||
124778336|NCT01354314|448816394|FG003|Overall Study|Less than 90% Adherence|4|||
124778337|NCT00478023|448816396|FG000|Overall Study|Adverse Event|11|||
124778338|NCT00478023|448816397|FG001|Overall Study|Adverse Event|7|||
124778339|NCT00478023|448816398|FG002|Overall Study|Adverse Event|8|||
124778340|NCT00478023|448816399|FG003|Overall Study|Adverse Event|14|||
124778341|NCT00478023|448816400|FG004|Overall Study|Adverse Event|6|||
124778342|NCT00478023|448816396|FG000|Overall Study|Death|1|||
124778343|NCT00478023|448816397|FG001|Overall Study|Death|0|||
124778344|NCT00478023|448816398|FG002|Overall Study|Death|0|||
124778345|NCT00478023|448816399|FG003|Overall Study|Death|0|||
124778346|NCT00478023|448816400|FG004|Overall Study|Death|0|||
124778347|NCT00478023|448816396|FG000|Overall Study|Lack of Efficacy|11|||
124778348|NCT00478023|448816397|FG001|Overall Study|Lack of Efficacy|10|||
124778349|NCT00478023|448816398|FG002|Overall Study|Lack of Efficacy|4|||
124778350|NCT00478023|448816399|FG003|Overall Study|Lack of Efficacy|5|||
124778351|NCT00478023|448816400|FG004|Overall Study|Lack of Efficacy|41|||
124778352|NCT00478023|448816396|FG000|Overall Study|Lost to Follow-up|3|||
124778353|NCT00478023|448816397|FG001|Overall Study|Lost to Follow-up|1|||
124778354|NCT00478023|448816398|FG002|Overall Study|Lost to Follow-up|1|||
124778355|NCT00478023|448816399|FG003|Overall Study|Lost to Follow-up|1|||
124778356|NCT00478023|448816400|FG004|Overall Study|Lost to Follow-up|0|||
124778357|NCT00478023|448816396|FG000|Overall Study|Withdrawal by Subject|2|||
124778358|NCT00478023|448816397|FG001|Overall Study|Withdrawal by Subject|3|||
124778359|NCT00478023|448816398|FG002|Overall Study|Withdrawal by Subject|2|||
124778360|NCT00478023|448816399|FG003|Overall Study|Withdrawal by Subject|4|||
124778361|NCT00478023|448816400|FG004|Overall Study|Withdrawal by Subject|5|||
124778362|NCT00478023|448816396|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
124778363|NCT00478023|448816397|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
124778364|NCT00478023|448816398|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
124778365|NCT00478023|448816399|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
124778366|NCT00478023|448816400|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
124778367|NCT00714870|448816402|FG000|Overall Study|Lost to Follow-up|22|||
124778368|NCT00714870|448816403|FG001|Overall Study|Lost to Follow-up|5|||
124778369|NCT00714870|448816402|FG000|Overall Study|patient unable to come b/c back pain|1|||
124778370|NCT00714870|448816403|FG001|Overall Study|patient unable to come b/c back pain|0|||
124778371|NCT00714870|448816402|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
124778372|NCT00714870|448816403|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
124590631|NCT00982228|448120464|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
124590632|NCT00982228|448120465|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
124590633|NCT00982228|448120464|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
124590634|NCT00982228|448120465|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
124590635|NCT00982228|448120464|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
124590636|NCT00982228|448120465|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
124778373|NCT02357368|448816404|FG000|Overall Study|Lost to Follow-up|0|||
124778374|NCT02357368|448816405|FG001|Overall Study|Lost to Follow-up|0|||
124590637|NCT00982228|448120464|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
124590638|NCT00982228|448120465|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
124590639|NCT00982228|448120464|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
124590640|NCT00982228|448120465|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
124590641|NCT00982228|448120464|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
124590642|NCT00982228|448120465|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
124590643|NCT00982228|448120464|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
124590644|NCT00982228|448120465|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
124590645|NCT01438476|448120466|FG000|Overall Study|Protocol Violation|1|||
124590646|NCT01438476|448120467|FG001|Overall Study|Protocol Violation|0|||
124590647|NCT01438476|448120466|FG000|Overall Study|Withdrawal by Subject|1|||
124590648|NCT01438476|448120467|FG001|Overall Study|Withdrawal by Subject|0|||
124590649|NCT01438476|448120466|FG000|Overall Study|No Surgery- Disease|8|||
124590650|NCT01438476|448120467|FG001|Overall Study|No Surgery- Disease|10|||
124590651|NCT01438476|448120466|FG000|Overall Study|Communication barrier|0|||
124590652|NCT01438476|448120467|FG001|Overall Study|Communication barrier|1|||
124590653|NCT02058160|448120468|FG000|Overall Study|Randomized but not treated|2|||
124590654|NCT02058160|448120469|FG001|Overall Study|Randomized but not treated|4|||
124590655|NCT02058160|448120468|FG000|Overall Study|Poor compliance to protocol|4|||
124590656|NCT02058160|448120469|FG001|Overall Study|Poor compliance to protocol|1|||
124590657|NCT02058160|448120468|FG000|Overall Study|Adverse Event|12|||
124590658|NCT02058160|448120469|FG001|Overall Study|Adverse Event|3|||
124590659|NCT02058160|448120468|FG000|Overall Study|Lost to Follow-up|1|||
124590660|NCT02058160|448120469|FG001|Overall Study|Lost to Follow-up|0|||
124590661|NCT02058160|448120468|FG000|Overall Study|Other than specified above|12|||
124590662|NCT02058160|448120469|FG001|Overall Study|Other than specified above|6|||
124590663|NCT01115933|448120470|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
124590664|NCT00926367|448120471|FG000|Overall Study|Withdrawal by Subject|0|||
124590665|NCT00926367|448120472|FG001|Overall Study|Withdrawal by Subject|1|||
124590666|NCT00926367|448120471|FG000|Overall Study|Lost to Follow-up|1|||
124590667|NCT00926367|448120472|FG001|Overall Study|Lost to Follow-up|0|||
124590668|NCT00926367|448120471|FG000|Overall Study|Skin Irritation|1|||
124590669|NCT00926367|448120472|FG001|Overall Study|Skin Irritation|2|||
124590670|NCT01266603|448120473|FG000|Overall Study|Adverse Event|1|||
124590671|NCT01266603|448120473|FG000|Overall Study|Lack of Efficacy|14|||
124590672|NCT01266603|448120473|FG000|Overall Study|Withdrawal by Subject|1|||
124590673|NCT01266603|448120473|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
124590674|NCT02725411|448120474|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
124590675|NCT02725411|448120475|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
124590676|NCT02725411|448120476|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
124590677|NCT02725411|448120474|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
124590678|NCT02725411|448120475|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
124590679|NCT02725411|448120476|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
124590680|NCT02725411|448120474|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
124590681|NCT02725411|448120475|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
124590682|NCT02725411|448120476|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
124590683|NCT02725411|448120474|FG000|Treatment Period (56 Weeks)|Other|1|||
124590684|NCT02725411|448120475|FG001|Treatment Period (56 Weeks)|Other|4|||
124590685|NCT02725411|448120476|FG002|Treatment Period (56 Weeks)|Other|5|||
124590686|NCT02725411|448120474|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
124590687|NCT02725411|448120475|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
124590688|NCT02725411|448120476|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
124590689|NCT02725411|448120474|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
124590690|NCT02725411|448120475|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
124590691|NCT02725411|448120476|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
124590692|NCT02725411|448120474|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
124590693|NCT02725411|448120475|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
124590694|NCT02725411|448120476|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
124590695|NCT02725411|448120474|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
124590696|NCT02725411|448120475|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
124590697|NCT02725411|448120476|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
124590698|NCT02725411|448120474|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
124778375|NCT02357368|448816406|FG002|Overall Study|Lost to Follow-up|0|||
124778376|NCT02357368|448816407|FG003|Overall Study|Lost to Follow-up|1|||
124590699|NCT02725411|448120475|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
124590700|NCT02725411|448120476|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
124729717|NCT04376684|448632558|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
124729718|NCT03099174|448632562|FG000|Overall Study|Withdrawal by Subject|0|||
124729719|NCT03099174|448632563|FG001|Overall Study|Withdrawal by Subject|0|||
124729720|NCT03099174|448632564|FG002|Overall Study|Withdrawal by Subject|1|||
124729721|NCT03099174|448632565|FG003|Overall Study|Withdrawal by Subject|0|||
124729722|NCT03099174|448632566|FG004|Overall Study|Withdrawal by Subject|2|||
124729723|NCT03099174|448632567|FG005|Overall Study|Withdrawal by Subject|2|||
124729724|NCT03099174|448632568|FG006|Overall Study|Withdrawal by Subject|1|||
124729725|NCT03099174|448632569|FG007|Overall Study|Withdrawal by Subject|4|||
124729726|NCT03099174|448632562|FG000|Overall Study|Adverse Event|0|||
124729727|NCT03099174|448632563|FG001|Overall Study|Adverse Event|1|||
124729728|NCT03099174|448632564|FG002|Overall Study|Adverse Event|1|||
124729729|NCT03099174|448632565|FG003|Overall Study|Adverse Event|2|||
124729730|NCT03099174|448632566|FG004|Overall Study|Adverse Event|5|||
124729731|NCT03099174|448632567|FG005|Overall Study|Adverse Event|3|||
124729732|NCT03099174|448632568|FG006|Overall Study|Adverse Event|6|||
124729733|NCT03099174|448632569|FG007|Overall Study|Adverse Event|4|||
124729734|NCT03099174|448632562|FG000|Overall Study|Other than listed|6|||
124729735|NCT03099174|448632563|FG001|Overall Study|Other than listed|6|||
124729736|NCT03099174|448632564|FG002|Overall Study|Other than listed|5|||
124729737|NCT03099174|448632565|FG003|Overall Study|Other than listed|6|||
124729738|NCT03099174|448632566|FG004|Overall Study|Other than listed|19|||
124729739|NCT03099174|448632567|FG005|Overall Study|Other than listed|10|||
124729740|NCT03099174|448632568|FG006|Overall Study|Other than listed|26|||
124729741|NCT03099174|448632569|FG007|Overall Study|Other than listed|23|||
124729742|NCT04173260|448632570|FG000|Overall Study|Early termination|4|||
124729743|NCT02308163|448632571|FG000|Overall Study|Not fulfill eligible criteria|1|||
124729744|NCT02308163|448632572|FG001|Overall Study|Not fulfill eligible criteria|2|||
124729745|NCT02308163|448632573|FG002|Overall Study|Not fulfill eligible criteria|0|||
124729746|NCT02308163|448632574|FG003|Overall Study|Not fulfill eligible criteria|1|||
124729747|NCT02308163|448632575|FG004|Overall Study|Not fulfill eligible criteria|1|||
124729748|NCT02308163|448632571|FG000|Overall Study|Adverse Event|9|||
124729749|NCT02308163|448632572|FG001|Overall Study|Adverse Event|5|||
124729750|NCT02308163|448632573|FG002|Overall Study|Adverse Event|2|||
124729751|NCT02308163|448632574|FG003|Overall Study|Adverse Event|2|||
124729752|NCT02308163|448632575|FG004|Overall Study|Adverse Event|11|||
124729753|NCT02308163|448632571|FG000|Overall Study|Lack of Efficacy|11|||
124729754|NCT02308163|448632572|FG001|Overall Study|Lack of Efficacy|3|||
124729755|NCT02308163|448632573|FG002|Overall Study|Lack of Efficacy|8|||
124729756|NCT02308163|448632574|FG003|Overall Study|Lack of Efficacy|4|||
124729757|NCT02308163|448632575|FG004|Overall Study|Lack of Efficacy|6|||
124729758|NCT02308163|448632571|FG000|Overall Study|Withdrawal of consent|2|||
124729759|NCT02308163|448632572|FG001|Overall Study|Withdrawal of consent|3|||
124729760|NCT02308163|448632573|FG002|Overall Study|Withdrawal of consent|0|||
124729761|NCT02308163|448632574|FG003|Overall Study|Withdrawal of consent|2|||
124729762|NCT02308163|448632575|FG004|Overall Study|Withdrawal of consent|6|||
124729763|NCT02308163|448632571|FG000|Overall Study|Protocol Violation|3|||
124729764|NCT02308163|448632572|FG001|Overall Study|Protocol Violation|3|||
124729765|NCT02308163|448632573|FG002|Overall Study|Protocol Violation|3|||
124729766|NCT02308163|448632574|FG003|Overall Study|Protocol Violation|2|||
124729767|NCT02308163|448632575|FG004|Overall Study|Protocol Violation|5|||
124729768|NCT02308163|448632571|FG000|Overall Study|Lab data met discontinuation criteria|3|||
124729769|NCT02308163|448632572|FG001|Overall Study|Lab data met discontinuation criteria|0|||
124729770|NCT02308163|448632573|FG002|Overall Study|Lab data met discontinuation criteria|0|||
124729771|NCT02308163|448632574|FG003|Overall Study|Lab data met discontinuation criteria|2|||
124729772|NCT02308163|448632575|FG004|Overall Study|Lab data met discontinuation criteria|0|||
124729773|NCT02308163|448632571|FG000|Overall Study|Miscellaneous|2|||
124729774|NCT02308163|448632572|FG001|Overall Study|Miscellaneous|2|||
124729775|NCT02308163|448632573|FG002|Overall Study|Miscellaneous|1|||
124729776|NCT02308163|448632574|FG003|Overall Study|Miscellaneous|0|||
124729777|NCT02308163|448632575|FG004|Overall Study|Miscellaneous|5|||
124729778|NCT02684058|448632576|FG000|Treatment Period|Progressive disease|4|||
124729779|NCT02684058|448632577|FG001|Treatment Period|Progressive disease|10|||
124729780|NCT02684058|448632578|FG002|Treatment Period|Progressive disease|19|||
124729781|NCT02684058|448632576|FG000|Treatment Period|Adverse Event|3|||
124729782|NCT02684058|448632577|FG001|Treatment Period|Adverse Event|8|||
124729783|NCT02684058|448632578|FG002|Treatment Period|Adverse Event|1|||
124729784|NCT02684058|448632576|FG000|Treatment Period|Physician Decision|5|||
124729785|NCT02684058|448632577|FG001|Treatment Period|Physician Decision|1|||
124729786|NCT02684058|448632578|FG002|Treatment Period|Physician Decision|2|||
124729787|NCT02684058|448632576|FG000|Treatment Period|New therapy for study indication|1|||
124729788|NCT02684058|448632577|FG001|Treatment Period|New therapy for study indication|0|||
124729789|NCT02684058|448632578|FG002|Treatment Period|New therapy for study indication|0|||
124729790|NCT02684058|448632576|FG000|Treatment Period|Protocol deviation|0|||
124729791|NCT02684058|448632577|FG001|Treatment Period|Protocol deviation|1|||
124778377|NCT02357368|448816404|FG000|Overall Study|Pregnancy|3|||
124778378|NCT02357368|448816405|FG001|Overall Study|Pregnancy|2|||
124778379|NCT02357368|448816406|FG002|Overall Study|Pregnancy|0|||
124778380|NCT02357368|448816407|FG003|Overall Study|Pregnancy|0|||
124778381|NCT02357368|448816404|FG000|Overall Study|Withdrawal by Subject|3|||
124590701|NCT02725411|448120474|FG000|Follow-up Period (24 Weeks)|Other|1|||
124590702|NCT02725411|448120475|FG001|Follow-up Period (24 Weeks)|Other|4|||
124590703|NCT02725411|448120476|FG002|Follow-up Period (24 Weeks)|Other|2|||
124590704|NCT02725411|448120474|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
124590705|NCT02725411|448120475|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
124590706|NCT02725411|448120476|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
124590707|NCT02911935|448120485|FG000|Overall Study|Lost to Follow-up|5|||
124590708|NCT02911935|448120486|FG001|Overall Study|Lost to Follow-up|7|||
124590709|NCT00603512|448120487|FG000|Overall Study|Adverse Event|0|||
124590710|NCT00603512|448120488|FG001|Overall Study|Adverse Event|2|||
124590711|NCT00603512|448120489|FG002|Overall Study|Adverse Event|4|||
124590712|NCT00603512|448120490|FG003|Overall Study|Adverse Event|4|||
124590713|NCT00603512|448120491|FG004|Overall Study|Adverse Event|2|||
124590714|NCT00603512|448120487|FG000|Overall Study|Lack of Efficacy|0|||
124590715|NCT00603512|448120488|FG001|Overall Study|Lack of Efficacy|1|||
124590716|NCT00603512|448120489|FG002|Overall Study|Lack of Efficacy|0|||
124590717|NCT00603512|448120490|FG003|Overall Study|Lack of Efficacy|0|||
124590718|NCT00603512|448120491|FG004|Overall Study|Lack of Efficacy|1|||
124590719|NCT00603512|448120487|FG000|Overall Study|Other|2|||
124590720|NCT00603512|448120488|FG001|Overall Study|Other|1|||
124590721|NCT00603512|448120489|FG002|Overall Study|Other|0|||
124590722|NCT00603512|448120490|FG003|Overall Study|Other|1|||
124590723|NCT00603512|448120491|FG004|Overall Study|Other|1|||
124590724|NCT00603512|448120487|FG000|Overall Study|Withdrawal by Subject|0|||
124590725|NCT00603512|448120488|FG001|Overall Study|Withdrawal by Subject|0|||
124590726|NCT00603512|448120489|FG002|Overall Study|Withdrawal by Subject|0|||
124590727|NCT00603512|448120490|FG003|Overall Study|Withdrawal by Subject|0|||
124590728|NCT00603512|448120491|FG004|Overall Study|Withdrawal by Subject|1|||
124590729|NCT00603512|448120487|FG000|Overall Study|Randomized but not treated|0|||
124590730|NCT00603512|448120488|FG001|Overall Study|Randomized but not treated|1|||
124590731|NCT00603512|448120489|FG002|Overall Study|Randomized but not treated|1|||
124590732|NCT00603512|448120490|FG003|Overall Study|Randomized but not treated|2|||
124590733|NCT00603512|448120491|FG004|Overall Study|Randomized but not treated|0|||
124590734|NCT00685750|448120492|FG000|Overall Study|Tumor sampling failure|0|||
124590735|NCT00685750|448120493|FG001|Overall Study|Tumor sampling failure|0|||
124590736|NCT00685750|448120494|FG002|Overall Study|Tumor sampling failure|1|||
124590737|NCT00685750|448120495|FG003|Overall Study|Tumor sampling failure|0|||
124590738|NCT00685750|448120496|FG004|Overall Study|Tumor sampling failure|0|||
124590739|NCT00685750|448120497|FG005|Overall Study|Tumor sampling failure|0|||
124590740|NCT00685750|448120498|FG006|Overall Study|Tumor sampling failure|0|||
124590741|NCT00685750|448120492|FG000|Overall Study|Patient didn't receive the treatment|0|||
124590742|NCT00685750|448120493|FG001|Overall Study|Patient didn't receive the treatment|0|||
124590743|NCT00685750|448120494|FG002|Overall Study|Patient didn't receive the treatment|0|||
124590744|NCT00685750|448120495|FG003|Overall Study|Patient didn't receive the treatment|0|||
124590745|NCT00685750|448120496|FG004|Overall Study|Patient didn't receive the treatment|0|||
124590746|NCT00685750|448120497|FG005|Overall Study|Patient didn't receive the treatment|0|||
124590747|NCT00685750|448120498|FG006|Overall Study|Patient didn't receive the treatment|1|||
124590748|NCT00685750|448120492|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124590749|NCT00685750|448120493|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124590750|NCT00685750|448120494|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
124590751|NCT00685750|448120495|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
124590752|NCT00685750|448120496|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
124590753|NCT00685750|448120497|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
124590754|NCT00685750|448120498|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
124590755|NCT04979858|448120499|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
124590756|NCT04979858|448120500|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
124590757|NCT02654015|448120501|FG000|Overall Study|Death|12|||
124590758|NCT02654015|448120501|FG000|Overall Study|Lost to Follow-up|3|||
124590759|NCT01896505|448120504|FG000|Overall Study|Adverse Event|1|||
124590760|NCT01896505|448120505|FG001|Overall Study|Adverse Event|0|||
124590761|NCT01896505|448120506|FG002|Overall Study|Adverse Event|2|||
124590762|NCT01896505|448120507|FG003|Overall Study|Adverse Event|1|||
124590763|NCT01896505|448120508|FG004|Overall Study|Adverse Event|1|||
124590764|NCT01896505|448120509|FG005|Overall Study|Adverse Event|0|||
124590765|NCT01896505|448120504|FG000|Overall Study|Physician Decision|1|||
124590766|NCT01896505|448120505|FG001|Overall Study|Physician Decision|3|||
124590767|NCT01896505|448120506|FG002|Overall Study|Physician Decision|2|||
124590768|NCT01896505|448120507|FG003|Overall Study|Physician Decision|0|||
124590769|NCT01896505|448120508|FG004|Overall Study|Physician Decision|0|||
124590770|NCT01896505|448120509|FG005|Overall Study|Physician Decision|1|||
124778382|NCT02357368|448816405|FG001|Overall Study|Withdrawal by Subject|1|||
124590771|NCT01896505|448120504|FG000|Overall Study|Withdrawal by Subject|1|||
124590772|NCT01896505|448120505|FG001|Overall Study|Withdrawal by Subject|0|||
124590773|NCT01896505|448120506|FG002|Overall Study|Withdrawal by Subject|3|||
124590774|NCT01896505|448120507|FG003|Overall Study|Withdrawal by Subject|1|||
124590775|NCT01896505|448120508|FG004|Overall Study|Withdrawal by Subject|0|||
124590776|NCT01896505|448120509|FG005|Overall Study|Withdrawal by Subject|0|||
124590777|NCT01896505|448120504|FG000|Overall Study|Disease Progression|7|||
124590778|NCT01896505|448120505|FG001|Overall Study|Disease Progression|5|||
124590779|NCT01896505|448120506|FG002|Overall Study|Disease Progression|8|||
124590780|NCT01896505|448120507|FG003|Overall Study|Disease Progression|4|||
124590781|NCT01896505|448120508|FG004|Overall Study|Disease Progression|4|||
124590782|NCT01896505|448120509|FG005|Overall Study|Disease Progression|4|||
124590783|NCT01896505|448120504|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
124590784|NCT01896505|448120505|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
124590785|NCT01896505|448120506|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
124590786|NCT01896505|448120507|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
124590787|NCT01896505|448120508|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
124590788|NCT01896505|448120509|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
124590789|NCT01896505|448120504|FG000|Overall Study|Intercurrent illness|0|||
124590790|NCT01896505|448120505|FG001|Overall Study|Intercurrent illness|1|||
124590791|NCT01896505|448120506|FG002|Overall Study|Intercurrent illness|0|||
124590792|NCT01896505|448120507|FG003|Overall Study|Intercurrent illness|0|||
124590793|NCT01896505|448120508|FG004|Overall Study|Intercurrent illness|0|||
124590794|NCT01896505|448120509|FG005|Overall Study|Intercurrent illness|0|||
124590795|NCT01896505|448120504|FG000|Overall Study|Death|0|||
124590796|NCT01896505|448120505|FG001|Overall Study|Death|0|||
124590797|NCT01896505|448120506|FG002|Overall Study|Death|1|||
124590798|NCT01896505|448120507|FG003|Overall Study|Death|1|||
124590799|NCT01896505|448120508|FG004|Overall Study|Death|0|||
124590800|NCT01896505|448120509|FG005|Overall Study|Death|1|||
124590801|NCT05317195|448120515|FG000|Randomization|Withdrawal by Subject|1|||
124590802|NCT05317195|448120515|FG000|Randomization|Discontinued|6|||
124590803|NCT05317195|448120515|FG000|Admission|Withdrawal by Subject|2|||
124590804|NCT03919695|448120516|FG000|3-month Follow-up|Death|1|||
124590805|NCT03919695|448120517|FG001|3-month Follow-up|Death|1|||
124590806|NCT03919695|448120516|FG000|3-month Follow-up|unable to contact|0|||
124590807|NCT03919695|448120517|FG001|3-month Follow-up|unable to contact|3|||
124590808|NCT03919695|448120516|FG000|3-month Follow-up|in prison|0|||
124590809|NCT03919695|448120517|FG001|3-month Follow-up|in prison|1|||
124590810|NCT03919695|448120516|FG000|6-month Follow-up|Death|0|||
124590811|NCT03919695|448120517|FG001|6-month Follow-up|Death|1|||
124590812|NCT03919695|448120516|FG000|6-month Follow-up|Lost to Follow-up|1|||
124590813|NCT03919695|448120517|FG001|6-month Follow-up|Lost to Follow-up|2|||
124590814|NCT03919695|448120516|FG000|6-month Follow-up|in prison|0|||
124590815|NCT03919695|448120517|FG001|6-month Follow-up|in prison|2|||
124590816|NCT03919695|448120516|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
124590817|NCT03919695|448120517|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
124590818|NCT03919695|448120516|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
124590819|NCT03919695|448120517|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
124590820|NCT02063217|448120519|FG000|Overall Study|Withdrawal by Subject|1|||
124590821|NCT02063217|448120520|FG001|Overall Study|Withdrawal by Subject|0|||
124590822|NCT02063217|448120521|FG002|Overall Study|Withdrawal by Subject|0|||
124590823|NCT01020526|448120522|FG000|Overall Study|Withdrawal by Subject|5|||
124590824|NCT01020526|448120522|FG000|Overall Study|Other reasons|3|||
124590825|NCT01020526|448120522|FG000|Overall Study|Insufficient clinical response|3|||
124590826|NCT01020526|448120522|FG000|Overall Study|Lost to Follow-up|1|||
124590827|NCT01020526|448120522|FG000|Overall Study|Adverse Event|2|||
124590828|NCT02212457|448120528|FG000|Overall Study|Adverse Event|1|||
124590829|NCT02212457|448120529|FG001|Overall Study|Adverse Event|2|||
124590830|NCT02212457|448120530|FG002|Overall Study|Adverse Event|2|||
124590831|NCT02212457|448120531|FG003|Overall Study|Adverse Event|2|||
124590832|NCT02212457|448120532|FG004|Overall Study|Adverse Event|0|||
124590833|NCT02212457|448120533|FG005|Overall Study|Adverse Event|1|||
124590834|NCT02212457|448120528|FG000|Overall Study|Withdrawal by Subject|8|||
124590835|NCT02212457|448120529|FG001|Overall Study|Withdrawal by Subject|10|||
124590836|NCT02212457|448120530|FG002|Overall Study|Withdrawal by Subject|8|||
124590837|NCT02212457|448120531|FG003|Overall Study|Withdrawal by Subject|6|||
124590838|NCT02212457|448120532|FG004|Overall Study|Withdrawal by Subject|5|||
124590839|NCT02212457|448120533|FG005|Overall Study|Withdrawal by Subject|4|||
124590840|NCT02212457|448120528|FG000|Overall Study|Lost to Follow-up|6|||
124590841|NCT02212457|448120529|FG001|Overall Study|Lost to Follow-up|7|||
124590842|NCT02212457|448120530|FG002|Overall Study|Lost to Follow-up|4|||
124590843|NCT02212457|448120531|FG003|Overall Study|Lost to Follow-up|1|||
124590844|NCT02212457|448120532|FG004|Overall Study|Lost to Follow-up|8|||
124590845|NCT02212457|448120533|FG005|Overall Study|Lost to Follow-up|4|||
124590846|NCT02212457|448120528|FG000|Overall Study|Protocol Violation|2|||
124590847|NCT02212457|448120529|FG001|Overall Study|Protocol Violation|1|||
124590848|NCT02212457|448120530|FG002|Overall Study|Protocol Violation|0|||
124590849|NCT02212457|448120531|FG003|Overall Study|Protocol Violation|1|||
124590850|NCT02212457|448120532|FG004|Overall Study|Protocol Violation|2|||
124590851|NCT02212457|448120533|FG005|Overall Study|Protocol Violation|3|||
124590852|NCT02212457|448120528|FG000|Overall Study|Other|2|||
124590853|NCT02212457|448120529|FG001|Overall Study|Other|1|||
124590854|NCT02212457|448120530|FG002|Overall Study|Other|2|||
124590855|NCT02212457|448120531|FG003|Overall Study|Other|1|||
124590856|NCT02212457|448120532|FG004|Overall Study|Other|0|||
124590857|NCT02212457|448120533|FG005|Overall Study|Other|1|||
124590858|NCT01120691|448120534|FG000|Overall Study|Adverse Event|59|||
124590859|NCT01120691|448120535|FG001|Overall Study|Adverse Event|67|||
124590860|NCT01120691|448120536|FG002|Overall Study|Adverse Event|47|||
124590861|NCT01120691|448120534|FG000|Overall Study|Subject withdrew consent|33|||
124590862|NCT01120691|448120535|FG001|Overall Study|Subject withdrew consent|50|||
124590863|NCT01120691|448120536|FG002|Overall Study|Subject withdrew consent|44|||
124590864|NCT01120691|448120534|FG000|Overall Study|Death|21|||
124590865|NCT01120691|448120535|FG001|Overall Study|Death|22|||
124590866|NCT01120691|448120536|FG002|Overall Study|Death|24|||
124590867|NCT01120691|448120534|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
124590868|NCT01120691|448120535|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
124590869|NCT01120691|448120536|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
124590870|NCT01120691|448120534|FG000|Overall Study|Administrative problems|15|||
124590871|NCT01120691|448120535|FG001|Overall Study|Administrative problems|8|||
124590872|NCT01120691|448120536|FG002|Overall Study|Administrative problems|9|||
124590873|NCT01120691|448120534|FG000|Overall Study|Protocol deviation|13|||
124590874|NCT01120691|448120535|FG001|Overall Study|Protocol deviation|12|||
124590875|NCT01120691|448120536|FG002|Overall Study|Protocol deviation|12|||
124590876|NCT01120691|448120534|FG000|Overall Study|Lost to Follow-up|5|||
124590877|NCT01120691|448120535|FG001|Overall Study|Lost to Follow-up|6|||
124590878|NCT01120691|448120536|FG002|Overall Study|Lost to Follow-up|4|||
124590879|NCT01120691|448120534|FG000|Overall Study|Abnormal test procedure result(s)|3|||
124590880|NCT01120691|448120535|FG001|Overall Study|Abnormal test procedure result(s)|2|||
124590881|NCT01120691|448120536|FG002|Overall Study|Abnormal test procedure result(s)|1|||
124590882|NCT01120691|448120534|FG000|Overall Study|Patient's inability to use the device|3|||
124590883|NCT01120691|448120535|FG001|Overall Study|Patient's inability to use the device|1|||
124590884|NCT01120691|448120536|FG002|Overall Study|Patient's inability to use the device|0|||
124590885|NCT01120691|448120534|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124590886|NCT01120691|448120535|FG001|Overall Study|Abnormal laboratory value(s)|3|||
124590887|NCT01120691|448120536|FG002|Overall Study|Abnormal laboratory value(s)|4|||
124590888|NCT03370510|448120539|FG000|Overall Study|COVID-19|2|||
124590889|NCT03370510|448120540|FG001|Overall Study|COVID-19|0|||
124590890|NCT01525628|448120545|FG000|Overall Study|Adverse Event|1|||
124590891|NCT01525628|448120546|FG001|Overall Study|Adverse Event|1|||
124590892|NCT01525628|448120547|FG002|Overall Study|Adverse Event|2|||
124590893|NCT01525628|448120548|FG003|Overall Study|Adverse Event|0|||
124590894|NCT01525628|448120549|FG004|Overall Study|Adverse Event|1|||
124590895|NCT01525628|448120545|FG000|Overall Study|Lack of Efficacy|0|||
124590896|NCT01525628|448120546|FG001|Overall Study|Lack of Efficacy|2|||
124590897|NCT01525628|448120547|FG002|Overall Study|Lack of Efficacy|2|||
124590898|NCT01525628|448120548|FG003|Overall Study|Lack of Efficacy|1|||
124590899|NCT01525628|448120549|FG004|Overall Study|Lack of Efficacy|2|||
124590900|NCT01525628|448120545|FG000|Overall Study|Protocol Violation|0|||
124590901|NCT01525628|448120546|FG001|Overall Study|Protocol Violation|0|||
124590902|NCT01525628|448120547|FG002|Overall Study|Protocol Violation|1|||
124590903|NCT01525628|448120548|FG003|Overall Study|Protocol Violation|0|||
124729792|NCT02684058|448632578|FG002|Treatment Period|Protocol deviation|0|||
124729793|NCT02684058|448632576|FG000|Treatment Period|Subject/guardian decision|4|||
124729794|NCT02684058|448632577|FG001|Treatment Period|Subject/guardian decision|3|||
124729795|NCT02684058|448632578|FG002|Treatment Period|Subject/guardian decision|0|||
124729796|NCT02684058|448632576|FG000|Treatment Period|Death|0|||
124729797|NCT02684058|448632577|FG001|Treatment Period|Death|0|||
124729798|NCT02684058|448632578|FG002|Treatment Period|Death|2|||
124590904|NCT01525628|448120549|FG004|Overall Study|Protocol Violation|0|||
124590905|NCT01525628|448120545|FG000|Overall Study|Lost to Follow-up|1|||
124590906|NCT01525628|448120546|FG001|Overall Study|Lost to Follow-up|1|||
124590907|NCT01525628|448120547|FG002|Overall Study|Lost to Follow-up|0|||
124590908|NCT01525628|448120548|FG003|Overall Study|Lost to Follow-up|0|||
124590909|NCT01525628|448120549|FG004|Overall Study|Lost to Follow-up|0|||
124590910|NCT01525628|448120545|FG000|Overall Study|Withdrawal by Subject|0|||
124590911|NCT01525628|448120546|FG001|Overall Study|Withdrawal by Subject|1|||
124590912|NCT01525628|448120547|FG002|Overall Study|Withdrawal by Subject|0|||
124590913|NCT01525628|448120548|FG003|Overall Study|Withdrawal by Subject|0|||
124590914|NCT01525628|448120549|FG004|Overall Study|Withdrawal by Subject|0|||
124590915|NCT01525628|448120545|FG000|Overall Study|Other reason not defined above|0|||
124590916|NCT01525628|448120546|FG001|Overall Study|Other reason not defined above|0|||
124729799|NCT02684058|448632576|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
124729800|NCT02684058|448632577|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
124590917|NCT01525628|448120547|FG002|Overall Study|Other reason not defined above|0|||
124729801|NCT02684058|448632578|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
124729802|NCT02684058|448632576|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
124590918|NCT01525628|448120548|FG003|Overall Study|Other reason not defined above|3|||
124590919|NCT01525628|448120549|FG004|Overall Study|Other reason not defined above|0|||
124590920|NCT00089973|448120550|FG000|Overall Study|Adverse Event|3|||
124590921|NCT00089973|448120550|FG000|Overall Study|Withdrawal by Subject|1|||
124590922|NCT00089973|448120550|FG000|Overall Study|Disease progression|45|||
124590923|NCT00089973|448120550|FG000|Overall Study|Death|1|||
124590924|NCT01992094|448120551|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
124590925|NCT01992094|448120552|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
124590926|NCT01992094|448120553|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
124590927|NCT01992094|448120551|FG000|Overall Study|Adverse Event|1|||
124590928|NCT01992094|448120552|FG001|Overall Study|Adverse Event|0|||
124590929|NCT01992094|448120553|FG002|Overall Study|Adverse Event|0|||
124590930|NCT01992094|448120551|FG000|Overall Study|Death|5|||
124590931|NCT01992094|448120552|FG001|Overall Study|Death|5|||
124590932|NCT01992094|448120553|FG002|Overall Study|Death|2|||
124590933|NCT01992094|448120551|FG000|Overall Study|Lost to Follow-up|26|||
124590934|NCT01992094|448120552|FG001|Overall Study|Lost to Follow-up|9|||
124590935|NCT01992094|448120553|FG002|Overall Study|Lost to Follow-up|13|||
124590936|NCT01992094|448120551|FG000|Overall Study|OTHER|4|||
124590937|NCT01992094|448120552|FG001|Overall Study|OTHER|0|||
124590938|NCT01992094|448120553|FG002|Overall Study|OTHER|0|||
124590939|NCT01992094|448120551|FG000|Overall Study|Protocol Violation|1|||
124590940|NCT01992094|448120552|FG001|Overall Study|Protocol Violation|0|||
124590941|NCT01992094|448120553|FG002|Overall Study|Protocol Violation|1|||
124590942|NCT01992094|448120551|FG000|Overall Study|Withdrawal by Subject|7|||
124590943|NCT01992094|448120552|FG001|Overall Study|Withdrawal by Subject|3|||
124590944|NCT01992094|448120553|FG002|Overall Study|Withdrawal by Subject|4|||
124590945|NCT01214239|448120554|FG000|Overall Study|Adverse Event|3|||
124590946|NCT01214239|448120555|FG001|Overall Study|Adverse Event|4|||
124590947|NCT01214239|448120554|FG000|Overall Study|Protocol Violation|2|||
124590948|NCT01214239|448120555|FG001|Overall Study|Protocol Violation|1|||
124590949|NCT01214239|448120554|FG000|Overall Study|Lost to Follow-up|1|||
124590950|NCT01214239|448120555|FG001|Overall Study|Lost to Follow-up|1|||
124590951|NCT01214239|448120554|FG000|Overall Study|Withdrawal by Subject|4|||
124590952|NCT01214239|448120555|FG001|Overall Study|Withdrawal by Subject|9|||
124590953|NCT01214239|448120554|FG000|Overall Study|Lack of Efficacy|1|||
124590954|NCT01214239|448120555|FG001|Overall Study|Lack of Efficacy|2|||
124590955|NCT01214239|448120554|FG000|Overall Study|patient's private reason|1|||
124590956|NCT01214239|448120555|FG001|Overall Study|patient's private reason|1|||
124590957|NCT01049581|448120556|FG000|Overall Study|Lost to Follow-up|2|||
124590958|NCT01049581|448120557|FG001|Overall Study|Lost to Follow-up|1|||
124590959|NCT05068284|448120571|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
124590960|NCT05068284|448120572|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
124590961|NCT05068284|448120573|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
124590962|NCT05068284|448120574|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
124590963|NCT05068284|448120575|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
124590964|NCT05068284|448120576|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
124590965|NCT05068284|448120577|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
124590966|NCT05068284|448120578|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
124590967|NCT05068284|448120571|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
124590968|NCT05068284|448120572|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
124590969|NCT05068284|448120573|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
124590970|NCT05068284|448120574|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
124590971|NCT05068284|448120575|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
124590972|NCT05068284|448120576|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
124590973|NCT05068284|448120577|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
124590974|NCT05068284|448120578|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
124590975|NCT05068284|448120571|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
124590976|NCT05068284|448120572|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
124590977|NCT05068284|448120573|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
124590978|NCT05068284|448120574|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
124590979|NCT05068284|448120575|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
124590980|NCT05068284|448120576|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
124729803|NCT02684058|448632577|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
124729804|NCT02684058|448632578|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
124590981|NCT05068284|448120577|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
124590982|NCT05068284|448120578|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
124590983|NCT05068284|448120571|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
124590984|NCT05068284|448120572|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
124590985|NCT05068284|448120573|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
124590986|NCT05068284|448120574|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
124590987|NCT05068284|448120575|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
124590988|NCT05068284|448120576|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
124590989|NCT05068284|448120577|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
124590990|NCT05068284|448120578|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
124590991|NCT05068284|448120571|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
124590992|NCT05068284|448120572|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
124590993|NCT05068284|448120573|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
124590994|NCT05068284|448120574|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
124590995|NCT05068284|448120575|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
124590996|NCT05068284|448120576|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
124590997|NCT05068284|448120577|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
124590998|NCT05068284|448120578|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
124590999|NCT05068284|448120571|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
124591000|NCT05068284|448120572|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
124591001|NCT05068284|448120573|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
124591002|NCT05068284|448120574|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
124591003|NCT05068284|448120575|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
124591004|NCT05068284|448120576|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
124591005|NCT05068284|448120577|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
124591006|NCT05068284|448120578|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
124591007|NCT05068284|448120571|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
124591008|NCT05068284|448120572|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
124591009|NCT05068284|448120573|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
124591010|NCT05068284|448120574|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
124591011|NCT05068284|448120575|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
124591012|NCT05068284|448120576|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
124591013|NCT05068284|448120577|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
124591014|NCT05068284|448120578|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
124591015|NCT05068284|448120571|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
124591016|NCT05068284|448120572|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
124591017|NCT05068284|448120573|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
124591018|NCT05068284|448120574|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
124591019|NCT05068284|448120575|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
124591020|NCT05068284|448120576|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
124591021|NCT05068284|448120577|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
124591022|NCT05068284|448120578|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
124591023|NCT05068284|448120571|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
124591024|NCT05068284|448120572|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
124591025|NCT05068284|448120573|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
124591026|NCT05068284|448120574|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
124591027|NCT05068284|448120575|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
124591028|NCT05068284|448120576|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
124591029|NCT05068284|448120577|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
124591030|NCT05068284|448120578|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
124591031|NCT05068284|448120571|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
124591032|NCT05068284|448120572|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
124591033|NCT05068284|448120573|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
124591034|NCT05068284|448120574|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
124591035|NCT05068284|448120575|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
124591036|NCT05068284|448120576|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
124591037|NCT05068284|448120577|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
124591038|NCT05068284|448120578|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
124591039|NCT05068284|448120571|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
124591040|NCT05068284|448120572|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
124591041|NCT05068284|448120573|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
124591042|NCT05068284|448120574|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
124591043|NCT05068284|448120575|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
124591044|NCT05068284|448120576|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
124591045|NCT05068284|448120577|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
124591046|NCT05068284|448120578|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
124591047|NCT05068284|448120571|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
124591048|NCT05068284|448120572|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
124591049|NCT05068284|448120573|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
124591050|NCT05068284|448120574|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
124591051|NCT05068284|448120575|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
124591052|NCT05068284|448120576|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
124591053|NCT05068284|448120577|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
124591054|NCT05068284|448120578|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
124591055|NCT05068284|448120571|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
124591056|NCT05068284|448120572|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
124591057|NCT05068284|448120573|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
124591058|NCT05068284|448120574|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
124591059|NCT05068284|448120575|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
124591060|NCT05068284|448120576|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
124591061|NCT05068284|448120577|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
124591062|NCT05068284|448120578|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
124591063|NCT05068284|448120571|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
124591064|NCT05068284|448120572|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
124591065|NCT05068284|448120573|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
124591066|NCT05068284|448120574|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
124591067|NCT05068284|448120575|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
124591068|NCT05068284|448120576|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
124591069|NCT05068284|448120577|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
124591070|NCT05068284|448120578|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
124591071|NCT00965731|448120579|FG000|Overall Study|Death|0|||
124591072|NCT00965731|448120580|FG001|Overall Study|Death|4|||
124591073|NCT00965731|448120579|FG000|Overall Study|Withdrawal by Subject|0|||
124591074|NCT00965731|448120580|FG001|Overall Study|Withdrawal by Subject|1|||
124591075|NCT00965731|448120579|FG000|Overall Study|Other|7|||
124591076|NCT00965731|448120580|FG001|Overall Study|Other|15|||
124591077|NCT05135273|448122581|FG000|Overall Study|Recruited into the army|0|||
124591078|NCT05135273|448122582|FG001|Overall Study|Recruited into the army|0|||
124591079|NCT05135273|448122583|FG002|Overall Study|Recruited into the army|0|||
124591080|NCT05135273|448122584|FG003|Overall Study|Recruited into the army|0|||
124591081|NCT05135273|448122585|FG004|Overall Study|Recruited into the army|1|||
124591082|NCT05135273|448122586|FG005|Overall Study|Recruited into the army|0|||
124591083|NCT05135273|448122587|FG006|Overall Study|Recruited into the army|0|||
124591084|NCT05135273|448122588|FG007|Overall Study|Recruited into the army|0|||
124591085|NCT05135273|448122581|FG000|Overall Study|Moved away from study site|0|||
124591086|NCT05135273|448122582|FG001|Overall Study|Moved away from study site|0|||
124591087|NCT05135273|448122583|FG002|Overall Study|Moved away from study site|0|||
124591088|NCT05135273|448122584|FG003|Overall Study|Moved away from study site|0|||
124591089|NCT05135273|448122585|FG004|Overall Study|Moved away from study site|0|||
124591090|NCT05135273|448122586|FG005|Overall Study|Moved away from study site|1|||
124591091|NCT05135273|448122587|FG006|Overall Study|Moved away from study site|1|||
124591092|NCT05135273|448122588|FG007|Overall Study|Moved away from study site|0|||
124591093|NCT05135273|448122581|FG000|Overall Study|Travel|0|||
124591094|NCT05135273|448122582|FG001|Overall Study|Travel|0|||
124591095|NCT05135273|448122583|FG002|Overall Study|Travel|0|||
124591096|NCT05135273|448122584|FG003|Overall Study|Travel|0|||
124591097|NCT05135273|448122585|FG004|Overall Study|Travel|0|||
124591098|NCT05135273|448122586|FG005|Overall Study|Travel|0|||
124591099|NCT05135273|448122587|FG006|Overall Study|Travel|0|||
124591100|NCT05135273|448122588|FG007|Overall Study|Travel|1|||
124591101|NCT04129944|448122590|FG000|Overall Study|Death|0|||
124591102|NCT04129944|448122591|FG001|Overall Study|Death|0|||
124591103|NCT04129944|448122592|FG002|Overall Study|Death|0|||
124591104|NCT04129944|448122593|FG003|Overall Study|Death|1|||
124591105|NCT04129944|448122590|FG000|Overall Study|Lost to Follow-up|1|||
124591106|NCT04129944|448122591|FG001|Overall Study|Lost to Follow-up|0|||
124591107|NCT04129944|448122592|FG002|Overall Study|Lost to Follow-up|0|||
124729805|NCT02684058|448632576|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
124591108|NCT04129944|448122593|FG003|Overall Study|Lost to Follow-up|0|||
124591109|NCT04129944|448122590|FG000|Overall Study|Withdrawal by Subject|1|||
124591110|NCT04129944|448122591|FG001|Overall Study|Withdrawal by Subject|0|||
124591111|NCT04129944|448122592|FG002|Overall Study|Withdrawal by Subject|1|||
124591112|NCT04129944|448122593|FG003|Overall Study|Withdrawal by Subject|2|||
124591113|NCT00493792|448122594|FG000|Overall Study|Death|55|||
124591114|NCT00493792|448122595|FG001|Overall Study|Death|50|||
124591115|NCT00493792|448122594|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
124591116|NCT00493792|448122595|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
124591117|NCT04241133|448122596|FG000|Overall Study|COVID19 Precautions|14|||
124591118|NCT04241133|448122597|FG001|Overall Study|COVID19 Precautions|34|||
124591119|NCT00348816|448122598|FG000|Overall Study|Noncompliance with radiation treatment|1|||
124591120|NCT01190930|448122599|FG000|Induction|Adverse Event|17|||
124591121|NCT01190930|448122600|FG001|Induction|Adverse Event|0|||
124591122|NCT01190930|448122601|FG002|Induction|Adverse Event|0|||
124591123|NCT01190930|448122602|FG003|Induction|Adverse Event|0|||
124591124|NCT01190930|448122603|FG004|Induction|Adverse Event|0|||
124591125|NCT01190930|448122604|FG005|Induction|Adverse Event|0|||
124591126|NCT01190930|448122605|FG006|Induction|Adverse Event|0|||
124591127|NCT01190930|448122606|FG007|Induction|Adverse Event|0|||
124591128|NCT01190930|448122607|FG008|Induction|Adverse Event|0|||
124591129|NCT01190930|448122608|FG009|Induction|Adverse Event|0|||
124591130|NCT01190930|448122599|FG000|Induction|Death|34|||
124591131|NCT01190930|448122600|FG001|Induction|Death|0|||
124591132|NCT01190930|448122601|FG002|Induction|Death|0|||
124591133|NCT01190930|448122602|FG003|Induction|Death|0|||
124591134|NCT01190930|448122603|FG004|Induction|Death|0|||
124591135|NCT01190930|448122604|FG005|Induction|Death|0|||
124591136|NCT01190930|448122605|FG006|Induction|Death|0|||
124591137|NCT01190930|448122606|FG007|Induction|Death|0|||
124591138|NCT01190930|448122607|FG008|Induction|Death|0|||
124591139|NCT01190930|448122608|FG009|Induction|Death|0|||
124591140|NCT01190930|448122599|FG000|Induction|Lost to Follow-up|1|||
124591141|NCT01190930|448122600|FG001|Induction|Lost to Follow-up|0|||
124591142|NCT01190930|448122601|FG002|Induction|Lost to Follow-up|0|||
124591143|NCT01190930|448122602|FG003|Induction|Lost to Follow-up|0|||
124591144|NCT01190930|448122603|FG004|Induction|Lost to Follow-up|0|||
124591145|NCT01190930|448122604|FG005|Induction|Lost to Follow-up|0|||
124591146|NCT01190930|448122605|FG006|Induction|Lost to Follow-up|0|||
124591147|NCT01190930|448122606|FG007|Induction|Lost to Follow-up|0|||
124591148|NCT01190930|448122607|FG008|Induction|Lost to Follow-up|0|||
124591149|NCT01190930|448122608|FG009|Induction|Lost to Follow-up|0|||
124591150|NCT01190930|448122599|FG000|Induction|Physician Decision|125|||
124591151|NCT01190930|448122600|FG001|Induction|Physician Decision|3|||
124591152|NCT01190930|448122601|FG002|Induction|Physician Decision|0|||
124591153|NCT01190930|448122602|FG003|Induction|Physician Decision|0|||
124591154|NCT01190930|448122603|FG004|Induction|Physician Decision|0|||
124591155|NCT01190930|448122604|FG005|Induction|Physician Decision|0|||
124591156|NCT01190930|448122605|FG006|Induction|Physician Decision|0|||
124591157|NCT01190930|448122606|FG007|Induction|Physician Decision|0|||
124591158|NCT01190930|448122607|FG008|Induction|Physician Decision|0|||
124591159|NCT01190930|448122608|FG009|Induction|Physician Decision|0|||
124591160|NCT01190930|448122599|FG000|Induction|Withdrawal by Subject|9|||
124591161|NCT01190930|448122600|FG001|Induction|Withdrawal by Subject|0|||
124591162|NCT01190930|448122601|FG002|Induction|Withdrawal by Subject|0|||
124591163|NCT01190930|448122602|FG003|Induction|Withdrawal by Subject|0|||
124591164|NCT01190930|448122603|FG004|Induction|Withdrawal by Subject|0|||
124591165|NCT01190930|448122604|FG005|Induction|Withdrawal by Subject|0|||
124591166|NCT01190930|448122605|FG006|Induction|Withdrawal by Subject|0|||
124591167|NCT01190930|448122606|FG007|Induction|Withdrawal by Subject|0|||
124591168|NCT01190930|448122607|FG008|Induction|Withdrawal by Subject|0|||
124591169|NCT01190930|448122608|FG009|Induction|Withdrawal by Subject|0|||
124591170|NCT01190930|448122599|FG000|Induction|Refusal|235|||
124591171|NCT01190930|448122600|FG001|Induction|Refusal|0|||
124591172|NCT01190930|448122601|FG002|Induction|Refusal|0|||
124591173|NCT01190930|448122602|FG003|Induction|Refusal|0|||
124591174|NCT01190930|448122603|FG004|Induction|Refusal|0|||
124591175|NCT01190930|448122604|FG005|Induction|Refusal|0|||
124591176|NCT01190930|448122605|FG006|Induction|Refusal|0|||
124591177|NCT01190930|448122606|FG007|Induction|Refusal|0|||
124591178|NCT01190930|448122607|FG008|Induction|Refusal|0|||
124591179|NCT01190930|448122608|FG009|Induction|Refusal|0|||
124591180|NCT01190930|448122599|FG000|Induction|Inevaluable|23|||
124591181|NCT01190930|448122600|FG001|Induction|Inevaluable|1|||
124591182|NCT01190930|448122601|FG002|Induction|Inevaluable|0|||
124591183|NCT01190930|448122602|FG003|Induction|Inevaluable|0|||
124591184|NCT01190930|448122603|FG004|Induction|Inevaluable|0|||
124591185|NCT01190930|448122604|FG005|Induction|Inevaluable|0|||
124591186|NCT01190930|448122605|FG006|Induction|Inevaluable|0|||
124591187|NCT01190930|448122606|FG007|Induction|Inevaluable|0|||
124591188|NCT01190930|448122607|FG008|Induction|Inevaluable|0|||
124591189|NCT01190930|448122608|FG009|Induction|Inevaluable|0|||
124591190|NCT01190930|448122599|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
124591191|NCT01190930|448122600|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
124591192|NCT01190930|448122601|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
124591193|NCT01190930|448122602|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
124591194|NCT01190930|448122603|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
124591195|NCT01190930|448122604|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
124591196|NCT01190930|448122605|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
124591197|NCT01190930|448122606|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
124591198|NCT01190930|448122607|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
124778383|NCT02357368|448816406|FG002|Overall Study|Withdrawal by Subject|1|||
124778384|NCT02357368|448816407|FG003|Overall Study|Withdrawal by Subject|2|||
124778385|NCT02377817|448816408|FG000|Overall Study|Transportation/childcare barriers.|2|||
124778386|NCT02377817|448816409|FG001|Overall Study|Transportation/childcare barriers.|0|||
124778387|NCT02377817|448816408|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
124778388|NCT02377817|448816409|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
124778389|NCT03895840|448816410|FG000|Overall Study|Withdrawal by Subject|21|||
124778390|NCT01147874|448816413|FG000|Overall Study|Adverse Event|5|||
124778391|NCT01147874|448816413|FG000|Overall Study|Investigator's Request|1|||
124778392|NCT01147874|448816413|FG000|Overall Study|Lost to Follow-up|25|||
124778393|NCT01147874|448816413|FG000|Overall Study|Other|5|||
124778394|NCT01147874|448816413|FG000|Overall Study|Protocol Violation|5|||
124778395|NCT01147874|448816413|FG000|Overall Study|Sponsor's Decision|2|||
124778396|NCT01147874|448816413|FG000|Overall Study|Withdrawal by Subject|24|||
124778397|NCT02175030|448816415|FG000|Overall Study|Failed screen after consent|7|||
124778398|NCT02175030|448816416|FG001|Overall Study|Failed screen after consent|6|||
124778399|NCT02175030|448816415|FG000|Overall Study|Failed IUD Insertion|20|||
124778400|NCT02175030|448816416|FG001|Overall Study|Failed IUD Insertion|21|||
124778401|NCT02175030|448816415|FG000|Overall Study|Physician Decision|1|||
124778402|NCT02175030|448816416|FG001|Overall Study|Physician Decision|1|||
124778403|NCT02175030|448816415|FG000|Overall Study|Lost to Follow-up|6|||
124778404|NCT02175030|448816416|FG001|Overall Study|Lost to Follow-up|6|||
124778405|NCT02175030|448816415|FG000|Overall Study|Withdrawal by Subject|1|||
124778406|NCT02175030|448816416|FG001|Overall Study|Withdrawal by Subject|4|||
124778407|NCT02817464|448816417|FG000|Overall Study|Lost to Follow-up|1|||
124778408|NCT02817464|448816418|FG001|Overall Study|Lost to Follow-up|0|||
124778409|NCT02817464|448816417|FG000|Overall Study|Discontinued early due to personal decision|1|||
124778410|NCT02817464|448816418|FG001|Overall Study|Discontinued early due to personal decision|1|||
124778411|NCT00885534|448816419|FG000|Overall Study|Patient deemed ineligible|1|||
124778412|NCT02453711|448816420|FG000|Overall Study|Withdrawal by Subject|5|||
124778413|NCT02453711|448816421|FG001|Overall Study|Withdrawal by Subject|4|||
124778414|NCT02453711|448816422|FG002|Overall Study|Withdrawal by Subject|6|||
124778415|NCT02453711|448816423|FG003|Overall Study|Withdrawal by Subject|4|||
124778416|NCT02453711|448816424|FG004|Overall Study|Withdrawal by Subject|1|||
124778417|NCT02453711|448816425|FG005|Overall Study|Withdrawal by Subject|1|||
124778418|NCT02453711|448816426|FG006|Overall Study|Withdrawal by Subject|0|||
124778419|NCT02453711|448816427|FG007|Overall Study|Withdrawal by Subject|1|||
124778420|NCT02453711|448816428|FG008|Overall Study|Withdrawal by Subject|7|||
124778421|NCT02453711|448816420|FG000|Overall Study|Lost to Follow-up|5|||
124778422|NCT02453711|448816421|FG001|Overall Study|Lost to Follow-up|3|||
124778423|NCT02453711|448816422|FG002|Overall Study|Lost to Follow-up|2|||
124778424|NCT02453711|448816423|FG003|Overall Study|Lost to Follow-up|3|||
124778425|NCT02453711|448816424|FG004|Overall Study|Lost to Follow-up|1|||
124778426|NCT02453711|448816425|FG005|Overall Study|Lost to Follow-up|5|||
124778427|NCT02453711|448816426|FG006|Overall Study|Lost to Follow-up|2|||
124778428|NCT02453711|448816427|FG007|Overall Study|Lost to Follow-up|6|||
124778429|NCT02453711|448816428|FG008|Overall Study|Lost to Follow-up|6|||
124778430|NCT02453711|448816420|FG000|Overall Study|Death|0|||
124778431|NCT02453711|448816421|FG001|Overall Study|Death|0|||
124778432|NCT02453711|448816422|FG002|Overall Study|Death|0|||
124778433|NCT02453711|448816423|FG003|Overall Study|Death|0|||
124778434|NCT02453711|448816424|FG004|Overall Study|Death|0|||
124778435|NCT02453711|448816425|FG005|Overall Study|Death|0|||
124778436|NCT02453711|448816426|FG006|Overall Study|Death|1|||
124778437|NCT02453711|448816427|FG007|Overall Study|Death|0|||
124778438|NCT02453711|448816428|FG008|Overall Study|Death|0|||
124778439|NCT02453711|448816420|FG000|Overall Study|Unclassified|1|||
124778440|NCT02453711|448816421|FG001|Overall Study|Unclassified|0|||
124778441|NCT02453711|448816422|FG002|Overall Study|Unclassified|1|||
124778442|NCT02453711|448816423|FG003|Overall Study|Unclassified|0|||
124778443|NCT02453711|448816424|FG004|Overall Study|Unclassified|0|||
124778444|NCT02453711|448816425|FG005|Overall Study|Unclassified|0|||
124778445|NCT02453711|448816426|FG006|Overall Study|Unclassified|0|||
124778446|NCT02453711|448816427|FG007|Overall Study|Unclassified|0|||
124778447|NCT02453711|448816428|FG008|Overall Study|Unclassified|0|||
124778448|NCT01273519|448816431|FG000|Overall Study|Adverse Event|3|||
124778449|NCT01273519|448816432|FG001|Overall Study|Adverse Event|0|||
124778450|NCT01273519|448816433|FG002|Overall Study|Adverse Event|0|||
124778451|NCT01273519|448816431|FG000|Overall Study|Lost to Follow-up|2|||
124778452|NCT01273519|448816432|FG001|Overall Study|Lost to Follow-up|1|||
124778453|NCT01273519|448816433|FG002|Overall Study|Lost to Follow-up|3|||
124778454|NCT01273519|448816431|FG000|Overall Study|Lack of Efficacy|8|||
124778455|NCT01273519|448816432|FG001|Overall Study|Lack of Efficacy|3|||
124778456|NCT01273519|448816433|FG002|Overall Study|Lack of Efficacy|4|||
124778457|NCT01273519|448816431|FG000|Overall Study|Other|6|||
124778458|NCT01273519|448816432|FG001|Overall Study|Other|1|||
124778459|NCT01273519|448816433|FG002|Overall Study|Other|1|||
124778460|NCT04292899|448816434|FG000|Overall Study|Death|21|||
124778461|NCT04292899|448816435|FG001|Overall Study|Death|28|||
124778462|NCT04292899|448816436|FG002|Overall Study|Death|188|||
124591199|NCT01190930|448122608|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
124591200|NCT01190930|448122599|FG000|Induction|High Risk Downs|80|||
124591201|NCT01190930|448122600|FG001|Induction|High Risk Downs|0|||
124591202|NCT01190930|448122601|FG002|Induction|High Risk Downs|0|||
124591203|NCT01190930|448122602|FG003|Induction|High Risk Downs|0|||
124591204|NCT01190930|448122603|FG004|Induction|High Risk Downs|0|||
124591205|NCT01190930|448122604|FG005|Induction|High Risk Downs|0|||
124591206|NCT01190930|448122605|FG006|Induction|High Risk Downs|0|||
124591207|NCT01190930|448122606|FG007|Induction|High Risk Downs|0|||
124591208|NCT01190930|448122607|FG008|Induction|High Risk Downs|0|||
124591209|NCT01190930|448122608|FG009|Induction|High Risk Downs|0|||
124591210|NCT01190930|448122599|FG000|Induction|Enrollment onto another COG Protocol|1|||
124591211|NCT01190930|448122600|FG001|Induction|Enrollment onto another COG Protocol|0|||
124591212|NCT01190930|448122601|FG002|Induction|Enrollment onto another COG Protocol|0|||
124591213|NCT01190930|448122602|FG003|Induction|Enrollment onto another COG Protocol|0|||
124591214|NCT01190930|448122603|FG004|Induction|Enrollment onto another COG Protocol|0|||
124591215|NCT01190930|448122604|FG005|Induction|Enrollment onto another COG Protocol|0|||
124591216|NCT01190930|448122605|FG006|Induction|Enrollment onto another COG Protocol|0|||
124591217|NCT01190930|448122606|FG007|Induction|Enrollment onto another COG Protocol|0|||
124591218|NCT01190930|448122607|FG008|Induction|Enrollment onto another COG Protocol|0|||
124591219|NCT01190930|448122608|FG009|Induction|Enrollment onto another COG Protocol|0|||
124591220|NCT01190930|448122599|FG000|Induction|Average Risk|1847|||
124591221|NCT01190930|448122600|FG001|Induction|Average Risk|0|||
124591222|NCT01190930|448122601|FG002|Induction|Average Risk|0|||
124591223|NCT01190930|448122602|FG003|Induction|Average Risk|0|||
124591224|NCT01190930|448122603|FG004|Induction|Average Risk|0|||
124591225|NCT01190930|448122604|FG005|Induction|Average Risk|0|||
124591226|NCT01190930|448122605|FG006|Induction|Average Risk|0|||
124591227|NCT01190930|448122606|FG007|Induction|Average Risk|0|||
124591228|NCT01190930|448122607|FG008|Induction|Average Risk|0|||
124591229|NCT01190930|448122608|FG009|Induction|Average Risk|0|||
124591230|NCT01190930|448122599|FG000|Induction|High Risk|1227|||
124591231|NCT01190930|448122600|FG001|Induction|High Risk|0|||
124591232|NCT01190930|448122601|FG002|Induction|High Risk|0|||
124591233|NCT01190930|448122602|FG003|Induction|High Risk|0|||
124591234|NCT01190930|448122603|FG004|Induction|High Risk|0|||
124591235|NCT01190930|448122604|FG005|Induction|High Risk|0|||
124591236|NCT01190930|448122605|FG006|Induction|High Risk|0|||
124591237|NCT01190930|448122606|FG007|Induction|High Risk|0|||
124591238|NCT01190930|448122607|FG008|Induction|High Risk|0|||
124591239|NCT01190930|448122608|FG009|Induction|High Risk|0|||
124591240|NCT01190930|448122599|FG000|Induction|Low Risk|443|||
124591241|NCT01190930|448122600|FG001|Induction|Low Risk|0|||
124591242|NCT01190930|448122601|FG002|Induction|Low Risk|0|||
124591243|NCT01190930|448122602|FG003|Induction|Low Risk|0|||
124591244|NCT01190930|448122603|FG004|Induction|Low Risk|0|||
124729806|NCT02684058|448632577|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
124729807|NCT02684058|448632578|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
124729808|NCT02684058|448632576|FG000|Post-treatment Efficacy Follow-up|Death|0|||
124729809|NCT02684058|448632577|FG001|Post-treatment Efficacy Follow-up|Death|0|||
124729810|NCT02684058|448632578|FG002|Post-treatment Efficacy Follow-up|Death|3|||
124729811|NCT02684058|448632576|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
124729812|NCT02684058|448632577|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
124729813|NCT02684058|448632578|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
124729814|NCT02684058|448632576|FG000|Post-treatment Survival Follow-up|Death|0|||
124729815|NCT02684058|448632577|FG001|Post-treatment Survival Follow-up|Death|0|||
124729816|NCT02684058|448632578|FG002|Post-treatment Survival Follow-up|Death|7|||
124729817|NCT02684058|448632576|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
124729818|NCT02684058|448632577|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
124729819|NCT02684058|448632578|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
124729820|NCT02684058|448632576|FG000|Crossover Treatment Period|Progressive disease|0|||
124729821|NCT02684058|448632577|FG001|Crossover Treatment Period|Progressive disease|1|||
124729822|NCT02684058|448632578|FG002|Crossover Treatment Period|Progressive disease|0|||
124729823|NCT00443053|448632579|FG000|Overall Study|Adverse Event|2|||
124729824|NCT00443053|448632580|FG001|Overall Study|Adverse Event|1|||
124729825|NCT00443053|448632579|FG000|Overall Study|Withdrawal by Subject|9|||
124729826|NCT00443053|448632580|FG001|Overall Study|Withdrawal by Subject|18|||
124729827|NCT00443053|448632579|FG000|Overall Study|Lost to Follow-up|4|||
124729828|NCT00443053|448632580|FG001|Overall Study|Lost to Follow-up|5|||
124729829|NCT00443053|448632579|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
124729830|NCT00443053|448632580|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
124729831|NCT00443053|448632579|FG000|Overall Study|Noncompliance|2|||
124729832|NCT00443053|448632580|FG001|Overall Study|Noncompliance|1|||
124591245|NCT01190930|448122604|FG005|Induction|Low Risk|0|||
124591246|NCT01190930|448122605|FG006|Induction|Low Risk|0|||
124591247|NCT01190930|448122606|FG007|Induction|Low Risk|0|||
124591248|NCT01190930|448122607|FG008|Induction|Low Risk|0|||
124591249|NCT01190930|448122608|FG009|Induction|Low Risk|0|||
124591250|NCT01190930|448122599|FG000|Induction|Very High Risk|1012|||
124778463|NCT04292899|448816437|FG003|Overall Study|Death|371|||
124778464|NCT04292899|448816434|FG000|Overall Study|Lost to Follow-up|8|||
124778465|NCT04292899|448816435|FG001|Overall Study|Lost to Follow-up|4|||
124778466|NCT04292899|448816436|FG002|Overall Study|Lost to Follow-up|22|||
124778467|NCT04292899|448816437|FG003|Overall Study|Lost to Follow-up|235|||
124778468|NCT04292899|448816434|FG000|Overall Study|Withdrew consent|1|||
124778469|NCT04292899|448816435|FG001|Overall Study|Withdrew consent|0|||
124778470|NCT04292899|448816436|FG002|Overall Study|Withdrew consent|11|||
124778471|NCT04292899|448816437|FG003|Overall Study|Withdrew consent|32|||
124778472|NCT04292899|448816434|FG000|Overall Study|Adverse Event|2|||
124778473|NCT04292899|448816435|FG001|Overall Study|Adverse Event|1|||
124778474|NCT04292899|448816436|FG002|Overall Study|Adverse Event|2|||
124778475|NCT04292899|448816437|FG003|Overall Study|Adverse Event|2|||
124591251|NCT01190930|448122600|FG001|Induction|Very High Risk|0|||
124591252|NCT01190930|448122601|FG002|Induction|Very High Risk|0|||
124591253|NCT01190930|448122602|FG003|Induction|Very High Risk|0|||
124729833|NCT00443053|448632579|FG000|Overall Study|Other|3|||
124729834|NCT00443053|448632580|FG001|Overall Study|Other|4|||
124729835|NCT00443053|448632579|FG000|Overall Study|Physician Decision|0|||
124729836|NCT00443053|448632580|FG001|Overall Study|Physician Decision|4|||
124729837|NCT02136680|448632584|FG000|Overall Study|No Longer Interested|1|||
124729838|NCT02136680|448632585|FG001|Overall Study|No Longer Interested|1|||
124729839|NCT02136680|448632584|FG000|Overall Study|No longer receiving care at clinic|3|||
124729840|NCT02136680|448632585|FG001|Overall Study|No longer receiving care at clinic|5|||
124729841|NCT02136680|448632584|FG000|Overall Study|Moved away|5|||
124729842|NCT02136680|448632585|FG001|Overall Study|Moved away|4|||
124729843|NCT02136680|448632584|FG000|Overall Study|Unable to schedule|17|||
124729844|NCT02136680|448632585|FG001|Overall Study|Unable to schedule|16|||
124729845|NCT02136680|448632584|FG000|Overall Study|Study ended before interview due|6|||
124729846|NCT02136680|448632585|FG001|Overall Study|Study ended before interview due|3|||
124729847|NCT05151445|448632586|FG000|Overall Study|Withdrawal by Subject|3|||
124729848|NCT02298179|448632587|FG000|Overall Study|Lost to Follow-up|0|||
124729849|NCT02298179|448632588|FG001|Overall Study|Lost to Follow-up|0|||
124729850|NCT02298179|448632589|FG002|Overall Study|Lost to Follow-up|1|||
124729851|NCT02298179|448632590|FG003|Overall Study|Lost to Follow-up|0|||
124729852|NCT02298179|448632591|FG004|Overall Study|Lost to Follow-up|0|||
124729853|NCT02298179|448632592|FG005|Overall Study|Lost to Follow-up|0|||
124729854|NCT02298179|448632593|FG006|Overall Study|Lost to Follow-up|0|||
124729855|NCT02298179|448632594|FG007|Overall Study|Lost to Follow-up|1|||
124729856|NCT02298179|448632595|FG008|Overall Study|Lost to Follow-up|0|||
124729857|NCT02298179|448632596|FG009|Overall Study|Lost to Follow-up|0|||
124729858|NCT02298179|448632597|FG010|Overall Study|Lost to Follow-up|0|||
124729859|NCT02298179|448632598|FG011|Overall Study|Lost to Follow-up|0|||
124729860|NCT01457014|448632599|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
124729861|NCT01457014|448632600|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
124729862|NCT01457014|448632601|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
124729863|NCT01457014|448632602|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
124729864|NCT01457014|448632599|FG000|First Night|Withdrawal by Subject|3|||
124729865|NCT01457014|448632600|FG001|First Night|Withdrawal by Subject|0|||
124729866|NCT01457014|448632601|FG002|First Night|Withdrawal by Subject|0|||
124729867|NCT01457014|448632602|FG003|First Night|Withdrawal by Subject|0|||
124729868|NCT01357161|448632603|FG000|Part 1 (Open Label Run-in)|Death|5|||
124729869|NCT01357161|448632604|FG001|Part 1 (Open Label Run-in)|Death|0|||
124729870|NCT01357161|448632605|FG002|Part 1 (Open Label Run-in)|Death|0|||
124729871|NCT01357161|448632603|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
124729872|NCT01357161|448632604|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
124729873|NCT01357161|448632605|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
124729874|NCT01357161|448632603|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
124729875|NCT01357161|448632604|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
124729876|NCT01357161|448632605|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
124729877|NCT01357161|448632603|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
124729878|NCT01357161|448632604|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
124729879|NCT01357161|448632605|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
124729880|NCT01357161|448632603|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
124729881|NCT01357161|448632604|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
124729882|NCT01357161|448632605|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
124729883|NCT01357161|448632603|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
124729884|NCT01357161|448632604|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
124729885|NCT01357161|448632605|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
124729886|NCT01357161|448632603|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
124729887|NCT01357161|448632604|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
124729888|NCT01357161|448632605|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
124778476|NCT04292899|448816434|FG000|Overall Study|Investigator's Discretion|0|||
124778477|NCT04292899|448816435|FG001|Overall Study|Investigator's Discretion|0|||
124778478|NCT04292899|448816436|FG002|Overall Study|Investigator's Discretion|0|||
124778479|NCT04292899|448816437|FG003|Overall Study|Investigator's Discretion|3|||
124591254|NCT01190930|448122603|FG004|Induction|Very High Risk|0|||
124591255|NCT01190930|448122604|FG005|Induction|Very High Risk|0|||
124591256|NCT01190930|448122605|FG006|Induction|Very High Risk|0|||
124591257|NCT01190930|448122606|FG007|Induction|Very High Risk|0|||
124591258|NCT01190930|448122607|FG008|Induction|Very High Risk|0|||
124591259|NCT01190930|448122608|FG009|Induction|Very High Risk|0|||
124591260|NCT01190930|448122599|FG000|Induction|Philadelphia chromosome-positive|99|||
124591261|NCT01190930|448122600|FG001|Induction|Philadelphia chromosome-positive|0|||
124591262|NCT01190930|448122601|FG002|Induction|Philadelphia chromosome-positive|0|||
124591263|NCT01190930|448122602|FG003|Induction|Philadelphia chromosome-positive|0|||
124591264|NCT01190930|448122603|FG004|Induction|Philadelphia chromosome-positive|0|||
124591265|NCT01190930|448122604|FG005|Induction|Philadelphia chromosome-positive|0|||
124591266|NCT01190930|448122605|FG006|Induction|Philadelphia chromosome-positive|0|||
124591267|NCT01190930|448122606|FG007|Induction|Philadelphia chromosome-positive|0|||
124591268|NCT01190930|448122607|FG008|Induction|Philadelphia chromosome-positive|0|||
124591269|NCT01190930|448122608|FG009|Induction|Philadelphia chromosome-positive|0|||
124591270|NCT01190930|448122599|FG000|Induction|Incomplete Induction data|63|||
124591271|NCT01190930|448122600|FG001|Induction|Incomplete Induction data|0|||
124591272|NCT01190930|448122601|FG002|Induction|Incomplete Induction data|0|||
124591273|NCT01190930|448122602|FG003|Induction|Incomplete Induction data|0|||
124591274|NCT01190930|448122603|FG004|Induction|Incomplete Induction data|0|||
124591275|NCT01190930|448122604|FG005|Induction|Incomplete Induction data|0|||
124591276|NCT01190930|448122605|FG006|Induction|Incomplete Induction data|0|||
124591277|NCT01190930|448122606|FG007|Induction|Incomplete Induction data|0|||
124591278|NCT01190930|448122607|FG008|Induction|Incomplete Induction data|0|||
124591279|NCT01190930|448122608|FG009|Induction|Incomplete Induction data|0|||
124591280|NCT01190930|448122599|FG000|Induction|Progressive disease|0|||
124591281|NCT01190930|448122600|FG001|Induction|Progressive disease|1|||
124591282|NCT01190930|448122601|FG002|Induction|Progressive disease|0|||
124591283|NCT01190930|448122602|FG003|Induction|Progressive disease|0|||
124591284|NCT01190930|448122603|FG004|Induction|Progressive disease|0|||
124591285|NCT01190930|448122604|FG005|Induction|Progressive disease|0|||
124591286|NCT01190930|448122605|FG006|Induction|Progressive disease|0|||
124591287|NCT01190930|448122606|FG007|Induction|Progressive disease|0|||
124591288|NCT01190930|448122607|FG008|Induction|Progressive disease|0|||
124591289|NCT01190930|448122608|FG009|Induction|Progressive disease|0|||
124591290|NCT01190930|448122599|FG000|Induction|No treatment|3|||
124591291|NCT01190930|448122600|FG001|Induction|No treatment|0|||
124591292|NCT01190930|448122601|FG002|Induction|No treatment|0|||
124591293|NCT01190930|448122602|FG003|Induction|No treatment|0|||
124591294|NCT01190930|448122603|FG004|Induction|No treatment|0|||
124591295|NCT01190930|448122604|FG005|Induction|No treatment|0|||
124591296|NCT01190930|448122605|FG006|Induction|No treatment|0|||
124591297|NCT01190930|448122606|FG007|Induction|No treatment|0|||
124591298|NCT01190930|448122607|FG008|Induction|No treatment|0|||
124591299|NCT01190930|448122608|FG009|Induction|No treatment|0|||
124591300|NCT01190930|448122599|FG000|Induction|Ineligible|69|||
124591301|NCT01190930|448122600|FG001|Induction|Ineligible|4|||
124591302|NCT01190930|448122601|FG002|Induction|Ineligible|0|||
124591303|NCT01190930|448122602|FG003|Induction|Ineligible|0|||
124591304|NCT01190930|448122603|FG004|Induction|Ineligible|0|||
124591305|NCT01190930|448122604|FG005|Induction|Ineligible|0|||
124591306|NCT01190930|448122605|FG006|Induction|Ineligible|0|||
124591307|NCT01190930|448122606|FG007|Induction|Ineligible|0|||
124591308|NCT01190930|448122607|FG008|Induction|Ineligible|0|||
124591309|NCT01190930|448122608|FG009|Induction|Ineligible|0|||
124591310|NCT01190930|448122599|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
124591311|NCT01190930|448122600|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
124591312|NCT01190930|448122601|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
124591313|NCT01190930|448122602|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
124591314|NCT01190930|448122603|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
124591315|NCT01190930|448122604|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
124591316|NCT01190930|448122605|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
124591317|NCT01190930|448122606|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
124591318|NCT01190930|448122607|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
124591319|NCT01190930|448122608|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
124591320|NCT01190930|448122599|FG000|Post Induction Pre-Maintenance|Death|0|||
124591321|NCT01190930|448122600|FG001|Post Induction Pre-Maintenance|Death|0|||
124591322|NCT01190930|448122601|FG002|Post Induction Pre-Maintenance|Death|8|||
124591323|NCT01190930|448122602|FG003|Post Induction Pre-Maintenance|Death|4|||
124591324|NCT01190930|448122603|FG004|Post Induction Pre-Maintenance|Death|0|||
124591325|NCT01190930|448122604|FG005|Post Induction Pre-Maintenance|Death|0|||
124591326|NCT01190930|448122605|FG006|Post Induction Pre-Maintenance|Death|0|||
124591327|NCT01190930|448122606|FG007|Post Induction Pre-Maintenance|Death|0|||
124591328|NCT01190930|448122607|FG008|Post Induction Pre-Maintenance|Death|0|||
124591329|NCT01190930|448122608|FG009|Post Induction Pre-Maintenance|Death|0|||
124591330|NCT01190930|448122599|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
124591331|NCT01190930|448122600|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
124591332|NCT01190930|448122601|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
124591333|NCT01190930|448122602|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
124591334|NCT01190930|448122603|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
124591335|NCT01190930|448122604|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
124591336|NCT01190930|448122605|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
124591337|NCT01190930|448122606|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
124591338|NCT01190930|448122607|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
124591339|NCT01190930|448122608|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
124591340|NCT01190930|448122599|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
124591341|NCT01190930|448122600|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
124591342|NCT01190930|448122601|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
124591343|NCT01190930|448122602|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
124591344|NCT01190930|448122603|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
124591345|NCT01190930|448122604|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
124591346|NCT01190930|448122605|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
124591347|NCT01190930|448122606|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
124591348|NCT01190930|448122607|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
124591349|NCT01190930|448122608|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
124591350|NCT01190930|448122599|FG000|Post Induction Pre-Maintenance|Refusal|0|||
124591351|NCT01190930|448122600|FG001|Post Induction Pre-Maintenance|Refusal|2|||
124591352|NCT01190930|448122601|FG002|Post Induction Pre-Maintenance|Refusal|694|||
124591353|NCT01190930|448122602|FG003|Post Induction Pre-Maintenance|Refusal|4|||
124591354|NCT01190930|448122603|FG004|Post Induction Pre-Maintenance|Refusal|0|||
124591355|NCT01190930|448122604|FG005|Post Induction Pre-Maintenance|Refusal|3|||
124591356|NCT01190930|448122605|FG006|Post Induction Pre-Maintenance|Refusal|0|||
124591357|NCT01190930|448122606|FG007|Post Induction Pre-Maintenance|Refusal|0|||
124591358|NCT01190930|448122607|FG008|Post Induction Pre-Maintenance|Refusal|0|||
124591359|NCT01190930|448122608|FG009|Post Induction Pre-Maintenance|Refusal|0|||
124591360|NCT01190930|448122599|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
124591361|NCT01190930|448122600|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
124591362|NCT01190930|448122601|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
124591363|NCT01190930|448122602|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
124591364|NCT01190930|448122603|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
124591365|NCT01190930|448122604|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
124591366|NCT01190930|448122605|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
124591367|NCT01190930|448122606|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
124591368|NCT01190930|448122607|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
124591369|NCT01190930|448122608|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
124591370|NCT01190930|448122599|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
124591371|NCT01190930|448122600|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
124591372|NCT01190930|448122601|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
124591373|NCT01190930|448122602|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
124591374|NCT01190930|448122603|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
124591375|NCT01190930|448122604|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
124591376|NCT01190930|448122605|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
124591377|NCT01190930|448122606|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
124591378|NCT01190930|448122607|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
124591379|NCT01190930|448122608|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
124591380|NCT01190930|448122599|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
124591381|NCT01190930|448122600|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
124591382|NCT01190930|448122601|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
124591383|NCT01190930|448122602|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
124591384|NCT01190930|448122603|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
124591385|NCT01190930|448122604|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
124591386|NCT01190930|448122605|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
124591387|NCT01190930|448122606|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
124591388|NCT01190930|448122607|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
124591389|NCT01190930|448122608|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
124591390|NCT01190930|448122599|FG000|Post Induction Pre-Maintenance|Relapse|0|||
124591391|NCT01190930|448122600|FG001|Post Induction Pre-Maintenance|Relapse|0|||
124591392|NCT01190930|448122601|FG002|Post Induction Pre-Maintenance|Relapse|1|||
124591393|NCT01190930|448122602|FG003|Post Induction Pre-Maintenance|Relapse|0|||
124591394|NCT01190930|448122603|FG004|Post Induction Pre-Maintenance|Relapse|0|||
124591395|NCT01190930|448122604|FG005|Post Induction Pre-Maintenance|Relapse|0|||
124591396|NCT01190930|448122605|FG006|Post Induction Pre-Maintenance|Relapse|0|||
124591397|NCT01190930|448122606|FG007|Post Induction Pre-Maintenance|Relapse|0|||
124591398|NCT01190930|448122607|FG008|Post Induction Pre-Maintenance|Relapse|0|||
124591399|NCT01190930|448122608|FG009|Post Induction Pre-Maintenance|Relapse|0|||
124591400|NCT01190930|448122599|FG000|Maintenance|Adverse Event|0|||
124591401|NCT01190930|448122600|FG001|Maintenance|Adverse Event|0|||
124591402|NCT01190930|448122601|FG002|Maintenance|Adverse Event|0|||
124591403|NCT01190930|448122602|FG003|Maintenance|Adverse Event|0|||
124591404|NCT01190930|448122603|FG004|Maintenance|Adverse Event|0|||
124591405|NCT01190930|448122604|FG005|Maintenance|Adverse Event|1|||
124591406|NCT01190930|448122605|FG006|Maintenance|Adverse Event|1|||
124591407|NCT01190930|448122606|FG007|Maintenance|Adverse Event|3|||
124591408|NCT01190930|448122607|FG008|Maintenance|Adverse Event|3|||
124591409|NCT01190930|448122608|FG009|Maintenance|Adverse Event|0|||
124591410|NCT01190930|448122599|FG000|Maintenance|Death|0|||
124591411|NCT01190930|448122600|FG001|Maintenance|Death|0|||
124591412|NCT01190930|448122601|FG002|Maintenance|Death|0|||
124591413|NCT01190930|448122602|FG003|Maintenance|Death|1|||
124591414|NCT01190930|448122603|FG004|Maintenance|Death|0|||
124591415|NCT01190930|448122604|FG005|Maintenance|Death|0|||
124591416|NCT01190930|448122605|FG006|Maintenance|Death|2|||
124591417|NCT01190930|448122606|FG007|Maintenance|Death|2|||
124591418|NCT01190930|448122607|FG008|Maintenance|Death|2|||
124591419|NCT01190930|448122608|FG009|Maintenance|Death|2|||
124591420|NCT01190930|448122599|FG000|Maintenance|Lost to Follow-up|0|||
124591421|NCT01190930|448122600|FG001|Maintenance|Lost to Follow-up|0|||
124591422|NCT01190930|448122601|FG002|Maintenance|Lost to Follow-up|0|||
124591423|NCT01190930|448122602|FG003|Maintenance|Lost to Follow-up|0|||
124591424|NCT01190930|448122603|FG004|Maintenance|Lost to Follow-up|0|||
124591425|NCT01190930|448122604|FG005|Maintenance|Lost to Follow-up|0|||
124591426|NCT01190930|448122605|FG006|Maintenance|Lost to Follow-up|1|||
124591427|NCT01190930|448122606|FG007|Maintenance|Lost to Follow-up|1|||
124591428|NCT01190930|448122607|FG008|Maintenance|Lost to Follow-up|1|||
124591429|NCT01190930|448122608|FG009|Maintenance|Lost to Follow-up|0|||
124591430|NCT01190930|448122599|FG000|Maintenance|Physician Decision|0|||
124591431|NCT01190930|448122600|FG001|Maintenance|Physician Decision|1|||
124591432|NCT01190930|448122601|FG002|Maintenance|Physician Decision|0|||
124591433|NCT01190930|448122602|FG003|Maintenance|Physician Decision|5|||
124591434|NCT01190930|448122603|FG004|Maintenance|Physician Decision|9|||
124591435|NCT01190930|448122604|FG005|Maintenance|Physician Decision|4|||
124591436|NCT01190930|448122605|FG006|Maintenance|Physician Decision|8|||
124591437|NCT01190930|448122606|FG007|Maintenance|Physician Decision|8|||
124591438|NCT01190930|448122607|FG008|Maintenance|Physician Decision|10|||
124591439|NCT01190930|448122608|FG009|Maintenance|Physician Decision|17|||
124591440|NCT01190930|448122599|FG000|Maintenance|Withdrawal by Subject|0|||
124591441|NCT01190930|448122600|FG001|Maintenance|Withdrawal by Subject|0|||
124591442|NCT01190930|448122601|FG002|Maintenance|Withdrawal by Subject|0|||
124591443|NCT01190930|448122602|FG003|Maintenance|Withdrawal by Subject|0|||
124591444|NCT01190930|448122603|FG004|Maintenance|Withdrawal by Subject|0|||
124591445|NCT01190930|448122604|FG005|Maintenance|Withdrawal by Subject|0|||
124591446|NCT01190930|448122605|FG006|Maintenance|Withdrawal by Subject|2|||
124591447|NCT01190930|448122606|FG007|Maintenance|Withdrawal by Subject|1|||
124591448|NCT01190930|448122607|FG008|Maintenance|Withdrawal by Subject|4|||
124591449|NCT01190930|448122608|FG009|Maintenance|Withdrawal by Subject|1|||
124591450|NCT01190930|448122599|FG000|Maintenance|Refusal|0|||
124591451|NCT01190930|448122600|FG001|Maintenance|Refusal|1|||
124591452|NCT01190930|448122601|FG002|Maintenance|Refusal|0|||
124591453|NCT01190930|448122602|FG003|Maintenance|Refusal|2|||
124591454|NCT01190930|448122603|FG004|Maintenance|Refusal|0|||
124591455|NCT01190930|448122604|FG005|Maintenance|Refusal|4|||
124591456|NCT01190930|448122605|FG006|Maintenance|Refusal|5|||
124591457|NCT01190930|448122606|FG007|Maintenance|Refusal|17|||
124591458|NCT01190930|448122607|FG008|Maintenance|Refusal|13|||
124591459|NCT01190930|448122608|FG009|Maintenance|Refusal|6|||
124591460|NCT01190930|448122599|FG000|Maintenance|second malignant neoplasm|0|||
124591461|NCT01190930|448122600|FG001|Maintenance|second malignant neoplasm|0|||
124591462|NCT01190930|448122601|FG002|Maintenance|second malignant neoplasm|0|||
124591463|NCT01190930|448122602|FG003|Maintenance|second malignant neoplasm|1|||
124591464|NCT01190930|448122603|FG004|Maintenance|second malignant neoplasm|0|||
124591465|NCT01190930|448122604|FG005|Maintenance|second malignant neoplasm|1|||
124591466|NCT01190930|448122605|FG006|Maintenance|second malignant neoplasm|0|||
124591467|NCT01190930|448122606|FG007|Maintenance|second malignant neoplasm|0|||
124591468|NCT01190930|448122607|FG008|Maintenance|second malignant neoplasm|1|||
124591469|NCT01190930|448122608|FG009|Maintenance|second malignant neoplasm|0|||
124591470|NCT01190930|448122599|FG000|Maintenance|Inevaluable|0|||
124591471|NCT01190930|448122600|FG001|Maintenance|Inevaluable|0|||
124591472|NCT01190930|448122601|FG002|Maintenance|Inevaluable|0|||
124591473|NCT01190930|448122602|FG003|Maintenance|Inevaluable|0|||
124591474|NCT01190930|448122603|FG004|Maintenance|Inevaluable|0|||
124591475|NCT01190930|448122604|FG005|Maintenance|Inevaluable|1|||
124591476|NCT01190930|448122605|FG006|Maintenance|Inevaluable|1|||
124591477|NCT01190930|448122606|FG007|Maintenance|Inevaluable|1|||
124591478|NCT01190930|448122607|FG008|Maintenance|Inevaluable|0|||
124591479|NCT01190930|448122608|FG009|Maintenance|Inevaluable|0|||
124591480|NCT01190930|448122599|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
124591481|NCT01190930|448122600|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
124591482|NCT01190930|448122601|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
124591483|NCT01190930|448122602|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
124778480|NCT04292899|448816434|FG000|Overall Study|Non-compliance With Study Drug|0|||
124778481|NCT04292899|448816435|FG001|Overall Study|Non-compliance With Study Drug|0|||
124778482|NCT04292899|448816436|FG002|Overall Study|Non-compliance With Study Drug|0|||
124778483|NCT04292899|448816437|FG003|Overall Study|Non-compliance With Study Drug|1|||
124778484|NCT04292899|448816434|FG000|Overall Study|Protocol Violation|0|||
124778485|NCT04292899|448816435|FG001|Overall Study|Protocol Violation|0|||
124778486|NCT04292899|448816436|FG002|Overall Study|Protocol Violation|0|||
124778487|NCT04292899|448816437|FG003|Overall Study|Protocol Violation|1|||
124778488|NCT03695367|448816438|FG000|Overall Study|Missed the Day 28 visit.|1|||
124778489|NCT03695367|448816439|FG001|Overall Study|Missed the Day 28 visit.|0|||
124778490|NCT03695367|448816438|FG000|Overall Study|Lost to Follow-up|0|||
124778491|NCT03695367|448816439|FG001|Overall Study|Lost to Follow-up|1|||
124778492|NCT03695367|448816438|FG000|Overall Study|Withdrawal by Subject|0|||
124778493|NCT03695367|448816439|FG001|Overall Study|Withdrawal by Subject|1|||
124778494|NCT03695367|448816438|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
124778495|NCT03695367|448816439|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
124778496|NCT01209325|448816443|FG000|Overall Study|Lost to Follow-up|24|||
124778497|NCT01209325|448816443|FG000|Overall Study|Adverse Event|1|||
124778498|NCT01209325|448816443|FG000|Overall Study|Relocated|3|||
124778499|NCT01209325|448816443|FG000|Overall Study|Refusal after starting therapy|8|||
124778500|NCT01209325|448816443|FG000|Overall Study|Protocol Violation|4|||
124778501|NCT01209325|448816443|FG000|Overall Study|Refusal prior to therapy|1|||
124778502|NCT01209325|448816443|FG000|Overall Study|Incarceration|2|||
124778503|NCT00396253|448816444|FG000|Overall Study|Protocol Violation|1|||
124778504|NCT00396253|448816444|FG000|Overall Study|Withdrawal by Subject|7|||
124778505|NCT00396253|448816444|FG000|Overall Study|Death|3|||
124778506|NCT00396253|448816444|FG000|Overall Study|Physician Decision|1|||
124778507|NCT00396253|448816444|FG000|Overall Study|Change in eligibility status|1|||
124778508|NCT05340478|448816448|FG000|Overall Study|Scheduling Issues|10|||
124778509|NCT05340478|448816449|FG001|Overall Study|Scheduling Issues|4|||
124778510|NCT05340478|448816448|FG000|Overall Study|Neither member of dyad started treatment|2|||
124778511|NCT05340478|448816449|FG001|Overall Study|Neither member of dyad started treatment|2|||
124778512|NCT05340478|448816448|FG000|Overall Study|Withdrawn from study|2|||
124778513|NCT05340478|448816449|FG001|Overall Study|Withdrawn from study|2|||
124778514|NCT05340478|448816448|FG000|Overall Study|Lost to Follow-up|1|||
124778515|NCT05340478|448816449|FG001|Overall Study|Lost to Follow-up|4|||
124591484|NCT01190930|448122603|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
124591485|NCT01190930|448122604|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
124778516|NCT00092443|448816450|FG000|Overall Study|Adverse Event|9|||
124778517|NCT00092443|448816451|FG001|Overall Study|Adverse Event|13|||
124778518|NCT00092443|448816450|FG000|Overall Study|Lost to Follow-up|7|||
124778519|NCT00092443|448816451|FG001|Overall Study|Lost to Follow-up|3|||
124778520|NCT00092443|448816450|FG000|Overall Study|Protocol Violation|11|||
124778521|NCT00092443|448816451|FG001|Overall Study|Protocol Violation|9|||
124778522|NCT00092443|448816450|FG000|Overall Study|Withdrawal by Subject|9|||
124778523|NCT00092443|448816451|FG001|Overall Study|Withdrawal by Subject|11|||
124778524|NCT00092443|448816450|FG000|Overall Study|Moved|5|||
124778525|NCT00092443|448816451|FG001|Overall Study|Moved|5|||
124778526|NCT00092443|448816450|FG000|Overall Study|Other|17|||
124778527|NCT00092443|448816451|FG001|Overall Study|Other|13|||
124778528|NCT03207763|448817832|FG000|Overall Study|Lost to Follow-up|1|||
124778529|NCT03207763|448817833|FG001|Overall Study|Lost to Follow-up|0|||
124778530|NCT02605122|448817834|FG000|Overall Study|Withdrawal by Subject|4|||
124778531|NCT02605122|448817835|FG001|Overall Study|Withdrawal by Subject|1|||
124778532|NCT02605122|448817834|FG000|Overall Study|Lost to Follow-up|1|||
124778533|NCT02605122|448817835|FG001|Overall Study|Lost to Follow-up|1|||
124778534|NCT00807001|448817837|FG000|Overall Study|Non-compliance|0|||
124778535|NCT00807001|448817838|FG001|Overall Study|Non-compliance|1|||
124591486|NCT01190930|448122605|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
124591487|NCT01190930|448122606|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
124591488|NCT01190930|448122607|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
124778536|NCT00807001|448817839|FG002|Overall Study|Non-compliance|0|||
124778537|NCT00807001|448817840|FG003|Overall Study|Non-compliance|0|||
124778538|NCT00807001|448817841|FG004|Overall Study|Non-compliance|0|||
124778539|NCT00854113|448817842|FG000|Overall Study|Adverse Event|0|||
124778540|NCT00854113|448817843|FG001|Overall Study|Adverse Event|0|||
124778541|NCT00854113|448817844|FG002|Overall Study|Adverse Event|0|||
124591489|NCT01190930|448122608|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
124591490|NCT01190930|448122599|FG000|Maintenance|Relapse|0|||
124778542|NCT00854113|448817845|FG003|Overall Study|Adverse Event|0|||
124778543|NCT00854113|448817846|FG004|Overall Study|Adverse Event|0|||
124778544|NCT00854113|448817847|FG005|Overall Study|Adverse Event|0|||
124778545|NCT00854113|448817848|FG006|Overall Study|Adverse Event|0|||
124778546|NCT00854113|448817849|FG007|Overall Study|Adverse Event|2|||
124778547|NCT00854113|448817850|FG008|Overall Study|Adverse Event|0|||
124778548|NCT00854113|448817851|FG009|Overall Study|Adverse Event|0|||
124778549|NCT00854113|448817852|FG010|Overall Study|Adverse Event|0|||
124591491|NCT01190930|448122600|FG001|Maintenance|Relapse|0|||
124591492|NCT01190930|448122601|FG002|Maintenance|Relapse|0|||
124591493|NCT01190930|448122602|FG003|Maintenance|Relapse|2|||
124591494|NCT01190930|448122603|FG004|Maintenance|Relapse|0|||
124591495|NCT01190930|448122604|FG005|Maintenance|Relapse|1|||
124591496|NCT01190930|448122605|FG006|Maintenance|Relapse|6|||
124591497|NCT01190930|448122606|FG007|Maintenance|Relapse|13|||
124591498|NCT01190930|448122607|FG008|Maintenance|Relapse|11|||
124591499|NCT01190930|448122608|FG009|Maintenance|Relapse|11|||
124591500|NCT01190930|448122599|FG000|Maintenance|Still on therapy|0|||
124729889|NCT01357161|448632603|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
124729890|NCT01357161|448632604|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
124729891|NCT01357161|448632605|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
124729892|NCT01357161|448632603|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
124729893|NCT01357161|448632604|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
124729894|NCT01357161|448632605|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
124591501|NCT01190930|448122600|FG001|Maintenance|Still on therapy|8|||
124591502|NCT01190930|448122601|FG002|Maintenance|Still on therapy|0|||
124591503|NCT01190930|448122602|FG003|Maintenance|Still on therapy|29|||
124591504|NCT01190930|448122603|FG004|Maintenance|Still on therapy|0|||
124591505|NCT01190930|448122604|FG005|Maintenance|Still on therapy|0|||
124591506|NCT01190930|448122605|FG006|Maintenance|Still on therapy|0|||
124591507|NCT01190930|448122606|FG007|Maintenance|Still on therapy|0|||
124591508|NCT01190930|448122607|FG008|Maintenance|Still on therapy|0|||
124591509|NCT01190930|448122608|FG009|Maintenance|Still on therapy|0|||
124591510|NCT00046839|448122611|FG000|Overall Study|Ineligible / No protocol treatment|0|||
124591511|NCT00046839|448122612|FG001|Overall Study|Ineligible / No protocol treatment|2|||
124591512|NCT00046839|448122611|FG000|Overall Study|Withdrawal of consent|1|||
124591513|NCT00046839|448122612|FG001|Overall Study|Withdrawal of consent|0|||
124591514|NCT02050321|448122613|FG000|Overall Study|Withdrawal by Subject|1|||
124591515|NCT02050321|448122613|FG000|Overall Study|Adverse Event|1|||
124591516|NCT00766493|448122614|FG000|30 Days Post-Procedure|Discontinued|7|||
124591517|NCT00766493|448122614|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
124591518|NCT00766493|448122614|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
124591519|NCT00721955|448122617|FG000|Overall Study|Adverse Event|0|||
124591520|NCT00721955|448122618|FG001|Overall Study|Adverse Event|0|||
124591521|NCT00721955|448122619|FG002|Overall Study|Adverse Event|2|||
124591522|NCT01292837|448122620|FG000|Overall Study|Adverse Event|1|||
124591523|NCT01292837|448122620|FG000|Overall Study|Further treatment determined|1|||
124591524|NCT04531527|448122623|FG000|Overall Study|Found to be Ineligible|3|||
124591525|NCT01077258|448122632|FG000|Overall Study|Lost to Follow-up|1390|||
124591526|NCT01077258|448122632|FG000|Overall Study|Adverse drug reaction|218|||
124591527|NCT01077258|448122632|FG000|Overall Study|Lack of Efficacy|663|||
124591528|NCT01077258|448122632|FG000|Overall Study|Clinical remission|37|||
124591529|NCT01077258|448122632|FG000|Overall Study|Other reasons|260|||
124591530|NCT00434837|448122633|FG000|Overall Study|Lost to Follow-up|20|||
124591531|NCT00434837|448122634|FG001|Overall Study|Lost to Follow-up|23|||
124591532|NCT00434837|448122635|FG002|Overall Study|Lost to Follow-up|30|||
124591533|NCT00726895|448122637|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
124591534|NCT00726895|448122638|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
124591535|NCT01881737|448122643|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
124591536|NCT01881737|448122643|FG000|Overall Study|Withdrawal by Subject|1|||
124591537|NCT01881737|448122643|FG000|Overall Study|Worsening of baseline behavior|1|||
124591538|NCT02250651|448122654|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
124591539|NCT02250651|448122655|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
124591540|NCT02250651|448122656|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
124729895|NCT01357161|448632603|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
124729896|NCT01357161|448632604|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
124729897|NCT01357161|448632605|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
124729898|NCT01357161|448632603|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
124729899|NCT01357161|448632604|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
124729900|NCT01357161|448632605|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
124729901|NCT02825420|448632607|FG000|Overall Study|Death|30|||
124729902|NCT02825420|448632608|FG001|Overall Study|Death|12|||
124729903|NCT02825420|448632607|FG000|Overall Study|Progressive disease|6|||
124729904|NCT02825420|448632608|FG001|Overall Study|Progressive disease|1|||
124729905|NCT02825420|448632607|FG000|Overall Study|Lost to Follow-up|2|||
124591541|NCT02250651|448122654|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
124591542|NCT02250651|448122655|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
124591543|NCT02250651|448122656|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
124591544|NCT02250651|448122654|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
124729906|NCT02825420|448632608|FG001|Overall Study|Lost to Follow-up|2|||
124729907|NCT02825420|448632607|FG000|Overall Study|Withdrawal by Subject|1|||
124729908|NCT02825420|448632608|FG001|Overall Study|Withdrawal by Subject|1|||
124729909|NCT02825420|448632607|FG000|Overall Study|Protocol amendment not signed|1|||
124729910|NCT02825420|448632608|FG001|Overall Study|Protocol amendment not signed|1|||
124729911|NCT02825420|448632607|FG000|Overall Study|Physician Decision|1|||
124729912|NCT02825420|448632608|FG001|Overall Study|Physician Decision|0|||
124591545|NCT02250651|448122655|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
124591546|NCT02250651|448122656|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
124591547|NCT02250651|448122654|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
124591548|NCT02250651|448122655|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
124591549|NCT02250651|448122656|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
124591550|NCT02250651|448122654|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
124591551|NCT02250651|448122655|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
124591552|NCT02250651|448122656|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
124591553|NCT02250651|448122654|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
124591554|NCT02250651|448122655|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
124591555|NCT02250651|448122656|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
124591556|NCT02250651|448122654|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
124591557|NCT02250651|448122655|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
124591558|NCT02250651|448122656|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
124591559|NCT02250651|448122654|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
124591560|NCT02250651|448122655|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
124591561|NCT02250651|448122656|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
124591562|NCT02250651|448122654|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
124591563|NCT02250651|448122655|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
124591564|NCT02250651|448122656|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
124591565|NCT02250651|448122654|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
124591566|NCT02250651|448122655|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
124591567|NCT02250651|448122656|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
124591568|NCT02250651|448122654|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
124591569|NCT02250651|448122655|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
124591570|NCT02250651|448122656|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
124591571|NCT02250651|448122654|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
124591572|NCT02250651|448122655|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
124591573|NCT02250651|448122656|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
124591574|NCT02250651|448122654|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
124591575|NCT02250651|448122655|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
124591576|NCT02250651|448122656|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
124591577|NCT02250651|448122654|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
124591578|NCT02250651|448122655|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
124591579|NCT02250651|448122656|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
124591580|NCT02250651|448122654|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
124591581|NCT02250651|448122655|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
124591582|NCT02250651|448122656|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
124591583|NCT03496298|448122657|FG000|Overall Study|Adverse Event|49|||
124591584|NCT03496298|448122658|FG001|Overall Study|Adverse Event|68|||
124591585|NCT03496298|448122659|FG002|Overall Study|Adverse Event|79|||
124591586|NCT03496298|448122657|FG000|Overall Study|Study terminated by Sponsor|1050|||
124591587|NCT03496298|448122658|FG001|Overall Study|Study terminated by Sponsor|1063|||
124591588|NCT03496298|448122659|FG002|Overall Study|Study terminated by Sponsor|1071|||
124591589|NCT03496298|448122657|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
124591590|NCT03496298|448122658|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
124591591|NCT03496298|448122659|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
124729913|NCT02825420|448632607|FG000|Overall Study|Did not receive PLD|2|||
124591592|NCT03496298|448122657|FG000|Overall Study|Withdrawal by Subject|176|||
124591593|NCT03496298|448122658|FG001|Overall Study|Withdrawal by Subject|154|||
124591594|NCT03496298|448122659|FG002|Overall Study|Withdrawal by Subject|151|||
124591595|NCT03496298|448122657|FG000|Overall Study|Other|29|||
124591596|NCT03496298|448122658|FG001|Overall Study|Other|20|||
124591597|NCT03496298|448122659|FG002|Overall Study|Other|23|||
124591598|NCT03496298|448122657|FG000|Overall Study|Randomized and not treated|1|||
124591599|NCT03496298|448122658|FG001|Overall Study|Randomized and not treated|1|||
124591600|NCT03496298|448122659|FG002|Overall Study|Randomized and not treated|1|||
124591601|NCT02522780|448122666|FG000|Overall Study|Consent withdrawn by subject|5|||
124591602|NCT02522780|448122667|FG001|Overall Study|Consent withdrawn by subject|7|||
124591603|NCT02522780|448122666|FG000|Overall Study|Protocol deviation|1|||
124591604|NCT02522780|448122667|FG001|Overall Study|Protocol deviation|3|||
124591605|NCT02522780|448122666|FG000|Overall Study|Subject refused endoscopic procedure|0|||
124729914|NCT02825420|448632608|FG001|Overall Study|Did not receive PLD|0|||
124729915|NCT04027049|448632609|FG000|Overall Study|Withdrawn by family|1|||
124729916|NCT04027049|448632610|FG001|Overall Study|Withdrawn by family|0|||
124729917|NCT04027049|448632609|FG000|Overall Study|Participant safety|1|||
124591606|NCT02522780|448122667|FG001|Overall Study|Subject refused endoscopic procedure|1|||
124591607|NCT02522780|448122666|FG000|Overall Study|Adverse event, non-fatal|11|||
124591608|NCT02522780|448122667|FG001|Overall Study|Adverse event, non-fatal|16|||
124591609|NCT04106817|448122668|FG000|Overall Study|Lost to Follow-up|1|||
124591610|NCT04106817|448122669|FG001|Overall Study|Lost to Follow-up|0|||
124591611|NCT04106817|448122670|FG002|Overall Study|Lost to Follow-up|0|||
124591612|NCT02260635|448122671|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
124591613|NCT02260635|448122672|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
124591614|NCT02260635|448122671|FG000|Open-Label Extension|Study Termination|25|||
124591615|NCT02260635|448122672|FG001|Open-Label Extension|Study Termination|25|||
124591616|NCT02260635|448122671|FG000|Open-Label Extension|Withdrawal by Subject|1|||
124591617|NCT02260635|448122672|FG001|Open-Label Extension|Withdrawal by Subject|0|||
124591618|NCT03310619|448122673|FG000|Pre-Treatment Period|Death|1|||
124591619|NCT03310619|448122674|FG001|Pre-Treatment Period|Death|0|||
124591620|NCT03310619|448122675|FG002|Pre-Treatment Period|Death|0|||
124591621|NCT03310619|448122676|FG003|Pre-Treatment Period|Death|0|||
124591622|NCT03310619|448122677|FG004|Pre-Treatment Period|Death|1|||
124591623|NCT03310619|448122678|FG005|Pre-Treatment Period|Death|0|||
124591624|NCT03310619|448122679|FG006|Pre-Treatment Period|Death|0|||
124591625|NCT03310619|448122680|FG007|Pre-Treatment Period|Death|0|||
124591626|NCT03310619|448122673|FG000|Pre-Treatment Period|Other reasons|2|||
124591627|NCT03310619|448122674|FG001|Pre-Treatment Period|Other reasons|1|||
124591628|NCT03310619|448122675|FG002|Pre-Treatment Period|Other reasons|2|||
124591629|NCT03310619|448122676|FG003|Pre-Treatment Period|Other reasons|0|||
124591630|NCT03310619|448122677|FG004|Pre-Treatment Period|Other reasons|0|||
124591631|NCT03310619|448122678|FG005|Pre-Treatment Period|Other reasons|0|||
124591632|NCT03310619|448122679|FG006|Pre-Treatment Period|Other reasons|2|||
124591633|NCT03310619|448122680|FG007|Pre-Treatment Period|Other reasons|0|||
124591634|NCT03310619|448122673|FG000|Treatment Period|Death|1|||
124591635|NCT03310619|448122674|FG001|Treatment Period|Death|2|||
124591636|NCT03310619|448122675|FG002|Treatment Period|Death|0|||
124591637|NCT03310619|448122676|FG003|Treatment Period|Death|0|||
124591638|NCT03310619|448122677|FG004|Treatment Period|Death|1|||
124591639|NCT03310619|448122678|FG005|Treatment Period|Death|0|||
124591640|NCT03310619|448122679|FG006|Treatment Period|Death|2|||
124591641|NCT03310619|448122680|FG007|Treatment Period|Death|0|||
124591642|NCT03310619|448122673|FG000|Treatment Period|Adverse Event|0|||
124591643|NCT03310619|448122674|FG001|Treatment Period|Adverse Event|1|||
124591644|NCT03310619|448122675|FG002|Treatment Period|Adverse Event|4|||
124591645|NCT03310619|448122676|FG003|Treatment Period|Adverse Event|1|||
124591646|NCT03310619|448122677|FG004|Treatment Period|Adverse Event|0|||
124591647|NCT03310619|448122678|FG005|Treatment Period|Adverse Event|0|||
124591648|NCT03310619|448122679|FG006|Treatment Period|Adverse Event|0|||
124591649|NCT03310619|448122680|FG007|Treatment Period|Adverse Event|0|||
124591650|NCT03310619|448122673|FG000|Treatment Period|Withdrawal by participant|0|||
124591651|NCT03310619|448122674|FG001|Treatment Period|Withdrawal by participant|0|||
124591652|NCT03310619|448122675|FG002|Treatment Period|Withdrawal by participant|1|||
124591653|NCT03310619|448122676|FG003|Treatment Period|Withdrawal by participant|0|||
124591654|NCT03310619|448122677|FG004|Treatment Period|Withdrawal by participant|0|||
124591655|NCT03310619|448122678|FG005|Treatment Period|Withdrawal by participant|0|||
124591656|NCT03310619|448122679|FG006|Treatment Period|Withdrawal by participant|0|||
124591657|NCT03310619|448122680|FG007|Treatment Period|Withdrawal by participant|0|||
124591658|NCT03310619|448122673|FG000|Treatment Period|Lost to Follow-up|0|||
124591659|NCT03310619|448122674|FG001|Treatment Period|Lost to Follow-up|0|||
124591660|NCT03310619|448122675|FG002|Treatment Period|Lost to Follow-up|0|||
124591661|NCT03310619|448122676|FG003|Treatment Period|Lost to Follow-up|0|||
124591662|NCT03310619|448122677|FG004|Treatment Period|Lost to Follow-up|0|||
124591663|NCT03310619|448122678|FG005|Treatment Period|Lost to Follow-up|0|||
124591664|NCT03310619|448122679|FG006|Treatment Period|Lost to Follow-up|0|||
124591665|NCT03310619|448122680|FG007|Treatment Period|Lost to Follow-up|1|||
124591666|NCT03310619|448122673|FG000|Treatment Period|Study terminated by sponsor|0|||
124591667|NCT03310619|448122674|FG001|Treatment Period|Study terminated by sponsor|0|||
124591668|NCT03310619|448122675|FG002|Treatment Period|Study terminated by sponsor|0|||
124591669|NCT03310619|448122676|FG003|Treatment Period|Study terminated by sponsor|0|||
124591670|NCT03310619|448122677|FG004|Treatment Period|Study terminated by sponsor|0|||
124591671|NCT03310619|448122678|FG005|Treatment Period|Study terminated by sponsor|0|||
124591672|NCT03310619|448122679|FG006|Treatment Period|Study terminated by sponsor|0|||
124591673|NCT03310619|448122680|FG007|Treatment Period|Study terminated by sponsor|1|||
124591674|NCT03310619|448122673|FG000|Treatment Period|Physician Decision|0|||
124591675|NCT03310619|448122674|FG001|Treatment Period|Physician Decision|0|||
124591676|NCT03310619|448122675|FG002|Treatment Period|Physician Decision|0|||
124591677|NCT03310619|448122676|FG003|Treatment Period|Physician Decision|0|||
124591678|NCT03310619|448122677|FG004|Treatment Period|Physician Decision|3|||
124591679|NCT03310619|448122678|FG005|Treatment Period|Physician Decision|0|||
124591680|NCT03310619|448122679|FG006|Treatment Period|Physician Decision|0|||
124591681|NCT03310619|448122680|FG007|Treatment Period|Physician Decision|0|||
124591682|NCT03310619|448122673|FG000|Treatment Period|Other reasons|1|||
124591683|NCT03310619|448122674|FG001|Treatment Period|Other reasons|0|||
124591684|NCT03310619|448122675|FG002|Treatment Period|Other reasons|2|||
124591685|NCT03310619|448122676|FG003|Treatment Period|Other reasons|0|||
124591686|NCT03310619|448122677|FG004|Treatment Period|Other reasons|0|||
124591687|NCT03310619|448122678|FG005|Treatment Period|Other reasons|0|||
124591688|NCT03310619|448122679|FG006|Treatment Period|Other reasons|0|||
124591689|NCT03310619|448122680|FG007|Treatment Period|Other reasons|0|||
124591690|NCT00152516|448122681|FG000|Overall Study|Adverse Event|18|||
124591691|NCT00152516|448122681|FG000|Overall Study|Lack and Loss of Efficacy|30|||
124591692|NCT00152516|448122681|FG000|Overall Study|Lost to Follow-up|5|||
124591693|NCT00152516|448122681|FG000|Overall Study|Withdrawal by Subject|8|||
124591694|NCT00152516|448122681|FG000|Overall Study|Protocol Violation|3|||
124591695|NCT00152516|448122681|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
124591696|NCT00152516|448122681|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
124591697|NCT00152516|448122681|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
124591698|NCT00152516|448122681|FG000|Overall Study|Other: Non-Compliance|2|||
124591699|NCT00152516|448122681|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
124591700|NCT00152516|448122681|FG000|Overall Study|Other: Moved Out Of State|1|||
124591701|NCT00152516|448122681|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
124591702|NCT00152516|448122681|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
124591703|NCT02427399|448122682|FG000|Overall Study|Protocol Violation|14|||
124591704|NCT02427399|448122683|FG001|Overall Study|Protocol Violation|16|||
124591705|NCT02427399|448122684|FG002|Overall Study|Protocol Violation|12|||
124591706|NCT02427399|448122685|FG003|Overall Study|Protocol Violation|18|||
124591707|NCT02427399|448122686|FG004|Overall Study|Protocol Violation|15|||
124591708|NCT02289820|448122688|FG000|Overall Study|Withdrawal by Subject|2|||
124591709|NCT02289820|448122689|FG001|Overall Study|Withdrawal by Subject|1|||
124591710|NCT02289820|448122690|FG002|Overall Study|Withdrawal by Subject|2|||
124591711|NCT02289820|448122691|FG003|Overall Study|Withdrawal by Subject|1|||
124591712|NCT02289820|448122692|FG004|Overall Study|Withdrawal by Subject|0|||
124591713|NCT02289820|448122693|FG005|Overall Study|Withdrawal by Subject|0|||
124591714|NCT02289820|448122694|FG006|Overall Study|Withdrawal by Subject|1|||
124591715|NCT02289820|448122688|FG000|Overall Study|Death|0|||
124591716|NCT02289820|448122689|FG001|Overall Study|Death|0|||
124591717|NCT02289820|448122690|FG002|Overall Study|Death|1|||
124591718|NCT02289820|448122691|FG003|Overall Study|Death|0|||
124591719|NCT02289820|448122692|FG004|Overall Study|Death|0|||
124591720|NCT02289820|448122693|FG005|Overall Study|Death|0|||
124729918|NCT04027049|448632610|FG001|Overall Study|Participant safety|0|||
124729919|NCT01730339|448633940|FG000|Overall Study|Withdrawal by Subject|3|||
124729920|NCT01730339|448633941|FG001|Overall Study|Withdrawal by Subject|2|||
124729921|NCT01730339|448633940|FG000|Overall Study|Lost to Follow-up|1|||
124729922|NCT01730339|448633941|FG001|Overall Study|Lost to Follow-up|1|||
124729923|NCT01730339|448633940|FG000|Overall Study|Un-specified|1|||
124729924|NCT01730339|448633941|FG001|Overall Study|Un-specified|0|||
124729925|NCT01145352|448633942|FG000|Overall Study|Found to have been registered twice|6|||
124729926|NCT01145352|448633942|FG000|Overall Study|Treated before marketing approval|4|||
124729927|NCT01145352|448633942|FG000|Overall Study|Syringe formulation was used|1|||
124729928|NCT04143217|448633943|FG000|Overall Study|Withdrawal by Subject|42|||
124729929|NCT04143217|448633943|FG000|Overall Study|Adverse Event|29|||
124729930|NCT04143217|448633943|FG000|Overall Study|Lost to Follow-up|29|||
124729931|NCT04143217|448633943|FG000|Overall Study|Lack of Efficacy|15|||
124729932|NCT04143217|448633943|FG000|Overall Study|Physician Decision|1|||
124729933|NCT04143217|448633943|FG000|Overall Study|Non-Compliance With Study Drug|6|||
124591721|NCT02289820|448122694|FG006|Overall Study|Death|0|||
124591722|NCT02289820|448122688|FG000|Overall Study|Lost to Follow-up|0|||
124591723|NCT02289820|448122689|FG001|Overall Study|Lost to Follow-up|0|||
124591724|NCT02289820|448122690|FG002|Overall Study|Lost to Follow-up|3|||
124591725|NCT02289820|448122691|FG003|Overall Study|Lost to Follow-up|1|||
124591726|NCT02289820|448122692|FG004|Overall Study|Lost to Follow-up|0|||
124591727|NCT02289820|448122693|FG005|Overall Study|Lost to Follow-up|1|||
124591728|NCT02289820|448122694|FG006|Overall Study|Lost to Follow-up|1|||
124591729|NCT02289820|448122688|FG000|Overall Study|withdrawal of consent|0|||
124591730|NCT02289820|448122689|FG001|Overall Study|withdrawal of consent|1|||
124591731|NCT02289820|448122690|FG002|Overall Study|withdrawal of consent|0|||
124591732|NCT02289820|448122691|FG003|Overall Study|withdrawal of consent|0|||
124591733|NCT02289820|448122692|FG004|Overall Study|withdrawal of consent|0|||
124591734|NCT02289820|448122693|FG005|Overall Study|withdrawal of consent|0|||
124591735|NCT02289820|448122694|FG006|Overall Study|withdrawal of consent|0|||
124591736|NCT01517867|448122697|FG000|Overall Study|never started treatment|29|||
124591737|NCT01517867|448122698|FG001|Overall Study|never started treatment|32|||
124591738|NCT01517867|448122697|FG000|Overall Study|Withdrawal by Subject|34|||
124591739|NCT01517867|448122698|FG001|Overall Study|Withdrawal by Subject|30|||
124729934|NCT04143217|448633943|FG000|Overall Study|Other, Multiple Categories|11|||
124729935|NCT02264665|448633944|FG000|Overall Study|Other|0|||
124729936|NCT02264665|448633945|FG001|Overall Study|Other|0|||
124729937|NCT02264665|448633946|FG002|Overall Study|Other|3|||
124591740|NCT01517867|448122697|FG000|Overall Study|Still in treatment at study end|0|||
124591741|NCT01517867|448122698|FG001|Overall Study|Still in treatment at study end|3|||
124591742|NCT03847974|448122700|FG000|Overall Study|relocated out of region|3|||
124591743|NCT03847974|448122700|FG000|Overall Study|Withdrawal by Subject|2|||
124591744|NCT03847974|448122700|FG000|Overall Study|Adverse Event|1|||
124591745|NCT01924364|448122701|FG000|Overall Study|Physician Decision|3|||
124591746|NCT01685216|448122702|FG000|Overall Study|Did not receive study drug|1|||
124591747|NCT00756717|448122703|FG000|Overall Study|Withdrawal by Subject|2|||
124591748|NCT02418754|448122704|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
124591749|NCT02418754|448122705|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
124591750|NCT02418754|448122706|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
124591751|NCT02418754|448122707|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
124591752|NCT02418754|448122708|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
124591753|NCT02418754|448122704|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
124591754|NCT02418754|448122705|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
124591755|NCT02418754|448122706|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
124591756|NCT02418754|448122707|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
124591757|NCT02418754|448122708|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
124591758|NCT02418754|448122704|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
124591759|NCT02418754|448122705|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
124591760|NCT02418754|448122706|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
124591761|NCT02418754|448122707|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
124591762|NCT02418754|448122708|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
124591763|NCT02418754|448122704|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
124591764|NCT02418754|448122705|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
124591765|NCT02418754|448122706|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
124591766|NCT02418754|448122707|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
124591767|NCT02418754|448122708|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
124591768|NCT02418754|448122704|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
124591769|NCT02418754|448122705|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
124591770|NCT02418754|448122706|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
124591771|NCT02418754|448122707|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
124591772|NCT02418754|448122708|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
124591773|NCT02418754|448122704|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
124591774|NCT02418754|448122705|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
124591775|NCT02418754|448122706|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
124591776|NCT02418754|448122707|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
124591777|NCT02418754|448122708|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
124591778|NCT02418754|448122704|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
124591779|NCT02418754|448122705|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
124591780|NCT02418754|448122706|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
124591781|NCT02418754|448122707|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
124591782|NCT02418754|448122708|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
124591783|NCT02418754|448122704|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
124591784|NCT02418754|448122705|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
124591785|NCT02418754|448122706|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
124591786|NCT02418754|448122707|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
124591787|NCT02418754|448122708|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
124591788|NCT02418754|448122704|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
124591789|NCT02418754|448122705|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
124591790|NCT02418754|448122706|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
124591791|NCT02418754|448122707|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
124591792|NCT02418754|448122708|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
124591793|NCT02418754|448122704|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
124591794|NCT02418754|448122705|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
124591795|NCT02418754|448122706|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
124591796|NCT02418754|448122707|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
124591797|NCT02418754|448122708|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
124591798|NCT02418754|448122704|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
124591799|NCT02418754|448122705|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
124591800|NCT02418754|448122706|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
124591801|NCT02418754|448122707|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
124591802|NCT02418754|448122708|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
124591803|NCT04974580|448122709|FG000|Overall Study|Lost to Follow-up|33|||
124591804|NCT04974580|448122710|FG001|Overall Study|Lost to Follow-up|39|||
124591805|NCT04974580|448122711|FG002|Overall Study|Lost to Follow-up|30|||
124591806|NCT04974580|448122712|FG003|Overall Study|Lost to Follow-up|29|||
124591807|NCT00250705|448122713|FG000|Overall Study|Lack of Efficacy|2|||
124591808|NCT02466386|448122721|FG000|Overall Study|Adverse Event|5|||
124591809|NCT02466386|448122721|FG000|Overall Study|Protocol Violation|2|||
124591810|NCT02466386|448122721|FG000|Overall Study|Withdrawal by Subject|14|||
124591811|NCT02466386|448122721|FG000|Overall Study|Lost to Follow-up|5|||
124591812|NCT02466386|448122721|FG000|Overall Study|Lack of Efficacy|8|||
124591813|NCT02466386|448122721|FG000|Overall Study|Other|10|||
124591814|NCT01688882|448122724|FG000|Overall Study|Adverse Event|1|||
124591815|NCT01688882|448122725|FG001|Overall Study|Adverse Event|0|||
124591816|NCT01688882|448122724|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124591817|NCT01688882|448122725|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124591818|NCT01688882|448122724|FG000|Overall Study|Administrative problems|1|||
124591819|NCT01688882|448122725|FG001|Overall Study|Administrative problems|0|||
124591820|NCT03259789|448122726|FG000|Overall Study|Adverse Event|3|||
124591821|NCT03259789|448122727|FG001|Overall Study|Adverse Event|2|||
124591822|NCT03259789|448122728|FG002|Overall Study|Adverse Event|1|||
124591823|NCT03259789|448122726|FG000|Overall Study|Withdrawal by Subject|9|||
124591824|NCT03259789|448122727|FG001|Overall Study|Withdrawal by Subject|5|||
124591825|NCT03259789|448122728|FG002|Overall Study|Withdrawal by Subject|1|||
124591826|NCT03259789|448122726|FG000|Overall Study|Lost to Follow-up|5|||
124591827|NCT03259789|448122727|FG001|Overall Study|Lost to Follow-up|9|||
124591828|NCT03259789|448122728|FG002|Overall Study|Lost to Follow-up|4|||
124591829|NCT03259789|448122726|FG000|Overall Study|Physician Decision|0|||
124591830|NCT03259789|448122727|FG001|Overall Study|Physician Decision|1|||
124591831|NCT03259789|448122728|FG002|Overall Study|Physician Decision|0|||
124591832|NCT00889252|448122729|FG000|Overall Study|Adverse Event|2|||
124591833|NCT00889252|448122730|FG001|Overall Study|Adverse Event|4|||
124591834|NCT00889252|448122729|FG000|Overall Study|Withdrawal by Subject|3|||
124591835|NCT00889252|448122730|FG001|Overall Study|Withdrawal by Subject|0|||
124591836|NCT00889252|448122729|FG000|Overall Study|Protocol Violation|2|||
124591837|NCT00889252|448122730|FG001|Overall Study|Protocol Violation|0|||
124591838|NCT02416934|448122731|FG000|Overall Study|given steroids|1|||
124591839|NCT02416934|448122732|FG001|Overall Study|given steroids|2|||
124591840|NCT02416934|448122731|FG000|Overall Study|Lost to Follow-up|0|||
124591841|NCT02416934|448122732|FG001|Overall Study|Lost to Follow-up|2|||
124591842|NCT02416934|448122731|FG000|Overall Study|Withdrawal by Subject|1|||
124591843|NCT02416934|448122732|FG001|Overall Study|Withdrawal by Subject|0|||
124591844|NCT02416934|448122731|FG000|Overall Study|recruited during continuing renewal proc|0|||
124591845|NCT02416934|448122732|FG001|Overall Study|recruited during continuing renewal proc|1|||
124591846|NCT02416934|448122731|FG000|Overall Study|Protocol Violation|0|||
124591847|NCT02416934|448122732|FG001|Overall Study|Protocol Violation|1|||
124591848|NCT02416934|448122731|FG000|Overall Study|surgery started late|0|||
124591849|NCT02416934|448122732|FG001|Overall Study|surgery started late|1|||
124591850|NCT02416934|448122731|FG000|Overall Study|re-operation|1|||
124591851|NCT02416934|448122732|FG001|Overall Study|re-operation|0|||
124591852|NCT00398073|448122733|FG000|Overall Study|Withdrawal by Subject|1|||
124591853|NCT00398073|448122734|FG001|Overall Study|Withdrawal by Subject|0|||
124591854|NCT01833169|448122739|FG000|Overall Study|Disease Progression|99|||
124591855|NCT01833169|448122739|FG000|Overall Study|Adverse Event|33|||
124591856|NCT01833169|448122739|FG000|Overall Study|Withdrawal by Subject|9|||
124591857|NCT01833169|448122739|FG000|Overall Study|Death|3|||
124591858|NCT01833169|448122739|FG000|Overall Study|Physician Decision|2|||
124591859|NCT00879684|448122743|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
124591860|NCT00879684|448122744|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
124591861|NCT00879684|448122745|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
124591862|NCT00879684|448122746|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
124591863|NCT00879684|448122747|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
124591864|NCT00879684|448122748|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
124591865|NCT00879684|448122749|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
124591866|NCT00879684|448122743|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
124591867|NCT00879684|448122744|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
124591868|NCT00879684|448122745|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
124591869|NCT00879684|448122746|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
124591870|NCT00879684|448122747|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
124591871|NCT00879684|448122748|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
124591872|NCT00879684|448122749|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
124591873|NCT00879684|448122743|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
124591874|NCT00879684|448122744|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
124729938|NCT02264665|448633947|FG003|Overall Study|Other|0|||
124591875|NCT00879684|448122745|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
124729939|NCT02264665|448633948|FG004|Overall Study|Other|0|||
124729940|NCT02264665|448633949|FG005|Overall Study|Other|0|||
124729941|NCT02264665|448633950|FG006|Overall Study|Other|0|||
124729942|NCT02264665|448633944|FG000|Overall Study|Death|9|||
124729943|NCT02264665|448633945|FG001|Overall Study|Death|8|||
124729944|NCT02264665|448633946|FG002|Overall Study|Death|13|||
124729945|NCT02264665|448633947|FG003|Overall Study|Death|5|||
124729946|NCT02264665|448633948|FG004|Overall Study|Death|0|||
124591876|NCT00879684|448122746|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
124591877|NCT00879684|448122747|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
124591878|NCT00879684|448122748|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
124591879|NCT00879684|448122749|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
124591880|NCT00879684|448122743|FG000|Stage 1: Dose Escalation|Death|0|||
124591881|NCT00879684|448122744|FG001|Stage 1: Dose Escalation|Death|0|||
124591882|NCT00879684|448122745|FG002|Stage 1: Dose Escalation|Death|1|||
124591883|NCT00879684|448122746|FG003|Stage 1: Dose Escalation|Death|0|||
124591884|NCT00879684|448122747|FG004|Stage 1: Dose Escalation|Death|0|||
124591885|NCT00879684|448122748|FG005|Stage 1: Dose Escalation|Death|0|||
124591886|NCT00879684|448122749|FG006|Stage 1: Dose Escalation|Death|0|||
124591887|NCT00879684|448122743|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
124591888|NCT00879684|448122744|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
124591889|NCT00879684|448122745|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
124591890|NCT00879684|448122746|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
124591891|NCT00879684|448122747|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
124591892|NCT00879684|448122748|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
124591893|NCT00879684|448122749|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
124591894|NCT00879684|448122743|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
124591895|NCT00879684|448122744|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
124591896|NCT00879684|448122745|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
124591897|NCT00879684|448122746|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
124591898|NCT00879684|448122747|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
124591899|NCT00879684|448122748|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
124591900|NCT00879684|448122749|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
124591901|NCT00879684|448122743|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
124591902|NCT00879684|448122744|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
124591903|NCT00879684|448122745|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
124591904|NCT00879684|448122746|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
124591905|NCT00879684|448122747|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
124591906|NCT00879684|448122748|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
124591907|NCT00879684|448122749|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
124591908|NCT00105157|448122750|FG000|Double-Blind (DB)|Never Treated|1|||
124591909|NCT00105157|448122751|FG001|Double-Blind (DB)|Never Treated|0|||
124591910|NCT00105157|448122752|FG002|Double-Blind (DB)|Never Treated|0|||
124591911|NCT00105157|448122753|FG003|Double-Blind (DB)|Never Treated|0|||
124591912|NCT00105157|448122750|FG000|Double-Blind (DB)|Adverse Event|2|||
124591913|NCT00105157|448122751|FG001|Double-Blind (DB)|Adverse Event|0|||
124591914|NCT00105157|448122752|FG002|Double-Blind (DB)|Adverse Event|1|||
124591915|NCT00105157|448122753|FG003|Double-Blind (DB)|Adverse Event|1|||
124591916|NCT00105157|448122750|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
124591917|NCT00105157|448122751|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
124591918|NCT00105157|448122752|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
124591919|NCT00105157|448122753|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
124591920|NCT00105157|448122750|FG000|Open-Label Continuation of DB|Adverse Event|3|||
124591921|NCT00105157|448122751|FG001|Open-Label Continuation of DB|Adverse Event|1|||
124591922|NCT00105157|448122752|FG002|Open-Label Continuation of DB|Adverse Event|0|||
124591923|NCT00105157|448122753|FG003|Open-Label Continuation of DB|Adverse Event|0|||
124591924|NCT00105157|448122750|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
124591925|NCT00105157|448122751|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
124591926|NCT00105157|448122752|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
124591927|NCT00105157|448122753|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
124591928|NCT00105157|448122750|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
124591929|NCT00105157|448122751|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
124591930|NCT00105157|448122752|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
124591931|NCT00105157|448122753|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
124591932|NCT00105157|448122750|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
124591933|NCT00105157|448122751|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
124591934|NCT00105157|448122752|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
124591935|NCT00105157|448122753|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
124591936|NCT00105157|448122750|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
124591937|NCT00105157|448122751|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
124591938|NCT00105157|448122752|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
124729947|NCT02264665|448633949|FG005|Overall Study|Death|0|||
124729948|NCT02264665|448633950|FG006|Overall Study|Death|1|||
124729949|NCT02264665|448633944|FG000|Overall Study|Lost to Follow-up|1|||
124729950|NCT02264665|448633945|FG001|Overall Study|Lost to Follow-up|0|||
124729951|NCT02264665|448633946|FG002|Overall Study|Lost to Follow-up|2|||
124729952|NCT02264665|448633947|FG003|Overall Study|Lost to Follow-up|1|||
124729953|NCT02264665|448633948|FG004|Overall Study|Lost to Follow-up|0|||
124729954|NCT02264665|448633949|FG005|Overall Study|Lost to Follow-up|0|||
124729955|NCT02264665|448633950|FG006|Overall Study|Lost to Follow-up|0|||
124591939|NCT00105157|448122753|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
124591940|NCT00105157|448122750|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
124591941|NCT00105157|448122751|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
124591942|NCT00105157|448122752|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
124591943|NCT00105157|448122753|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
124591944|NCT00105157|448122750|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
124591945|NCT00105157|448122751|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
124591946|NCT00105157|448122752|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
124591947|NCT00105157|448122753|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
124591948|NCT00105157|448122750|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
124591949|NCT00105157|448122751|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
124591950|NCT00105157|448122752|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
124591951|NCT00105157|448122753|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
124591952|NCT00105157|448122750|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
124591953|NCT00105157|448122751|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
124591954|NCT00105157|448122752|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
124591955|NCT00105157|448122753|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
124591956|NCT00105157|448122750|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
124591957|NCT00105157|448122751|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
124591958|NCT00105157|448122752|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
124591959|NCT00105157|448122753|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
124591960|NCT00105157|448122750|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
124591961|NCT00105157|448122751|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
124591962|NCT00105157|448122752|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
124591963|NCT00105157|448122753|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
124591964|NCT00127166|448122754|FG000|Period I|Protocol Violation|0|||
124591965|NCT00127166|448122755|FG001|Period I|Protocol Violation|2|||
124591966|NCT00127166|448122754|FG000|Period I|Withdrawal by Subject|2|||
124591967|NCT00127166|448122755|FG001|Period I|Withdrawal by Subject|0|||
124591968|NCT00127166|448122754|FG000|Period I|Patient did not meet inclusion criteria|1|||
124591969|NCT00127166|448122755|FG001|Period I|Patient did not meet inclusion criteria|0|||
124591970|NCT00127166|448122754|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
124591971|NCT00127166|448122755|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
124591972|NCT00127166|448122754|FG000|Period II|Withdrawal by Subject|2|||
124591973|NCT00127166|448122755|FG001|Period II|Withdrawal by Subject|0|||
124591974|NCT00127166|448122754|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
124591975|NCT00127166|448122755|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
124591976|NCT02169336|448122758|FG000|Overall Study|Lack of Efficacy|1|||
124591977|NCT02169336|448122759|FG001|Overall Study|Lack of Efficacy|1|||
124591978|NCT02169336|448122760|FG002|Overall Study|Lack of Efficacy|0|||
124591979|NCT02169336|448122758|FG000|Overall Study|Adverse Event|2|||
124591980|NCT02169336|448122759|FG001|Overall Study|Adverse Event|3|||
124591981|NCT02169336|448122760|FG002|Overall Study|Adverse Event|1|||
124591982|NCT02169336|448122758|FG000|Overall Study|Withdrawal by Subject|1|||
124591983|NCT02169336|448122759|FG001|Overall Study|Withdrawal by Subject|0|||
124591984|NCT02169336|448122760|FG002|Overall Study|Withdrawal by Subject|0|||
124591985|NCT02169336|448122758|FG000|Overall Study|Physician Decision|0|||
124591986|NCT02169336|448122759|FG001|Overall Study|Physician Decision|0|||
124591987|NCT02169336|448122760|FG002|Overall Study|Physician Decision|1|||
124591988|NCT02169336|448122758|FG000|Overall Study|Subject declined to continue dosing|0|||
124591989|NCT02169336|448122759|FG001|Overall Study|Subject declined to continue dosing|0|||
124591990|NCT02169336|448122760|FG002|Overall Study|Subject declined to continue dosing|1|||
124591991|NCT01148225|448122761|FG000|Overall Study|Other|185|||
124591992|NCT00393705|448122762|FG000|Overall Study|Adverse Event|0|||
124591993|NCT00393705|448122763|FG001|Overall Study|Adverse Event|2|||
124591994|NCT00393705|448122762|FG000|Overall Study|Death|0|||
124591995|NCT00393705|448122763|FG001|Overall Study|Death|1|||
124591996|NCT00393705|448122762|FG000|Overall Study|Lost to Follow-up|2|||
124591997|NCT00393705|448122763|FG001|Overall Study|Lost to Follow-up|2|||
124591998|NCT00393705|448122762|FG000|Overall Study|Entry Criteria Not Met|10|||
124591999|NCT00393705|448122763|FG001|Overall Study|Entry Criteria Not Met|10|||
124592000|NCT00393705|448122762|FG000|Overall Study|Protocol Violation|4|||
124592001|NCT00393705|448122763|FG001|Overall Study|Protocol Violation|3|||
124592002|NCT00393705|448122762|FG000|Overall Study|Withdrawal by Subject|5|||
124592003|NCT00393705|448122763|FG001|Overall Study|Withdrawal by Subject|3|||
124729956|NCT02264665|448633944|FG000|Overall Study|Participant decision|0|||
124729957|NCT02264665|448633945|FG001|Overall Study|Participant decision|0|||
124729958|NCT02264665|448633946|FG002|Overall Study|Participant decision|0|||
124729959|NCT02264665|448633947|FG003|Overall Study|Participant decision|1|||
124729960|NCT02264665|448633948|FG004|Overall Study|Participant decision|0|||
124729961|NCT02264665|448633949|FG005|Overall Study|Participant decision|0|||
124592004|NCT00393705|448122762|FG000|Overall Study|Physician Decision|2|||
124592005|NCT00393705|448122763|FG001|Overall Study|Physician Decision|2|||
124592006|NCT02490800|448122764|FG000|Overall Study|Adverse Event|0|||
124592007|NCT02490800|448122765|FG001|Overall Study|Adverse Event|0|||
124592008|NCT02490800|448122766|FG002|Overall Study|Adverse Event|0|||
124592009|NCT02490800|448122767|FG003|Overall Study|Adverse Event|2|||
124592010|NCT02490800|448122768|FG004|Overall Study|Adverse Event|3|||
124592011|NCT02490800|448122769|FG005|Overall Study|Adverse Event|2|||
124592012|NCT02490800|448122770|FG006|Overall Study|Adverse Event|0|||
124592013|NCT02490800|448122771|FG007|Overall Study|Adverse Event|0|||
124592014|NCT02490800|448122772|FG008|Overall Study|Adverse Event|0|||
124592015|NCT02490800|448122773|FG009|Overall Study|Adverse Event|0|||
124592016|NCT02490800|448122774|FG010|Overall Study|Adverse Event|0|||
124592017|NCT02490800|448122775|FG011|Overall Study|Adverse Event|2|||
124592018|NCT02490800|448122776|FG012|Overall Study|Adverse Event|2|||
124592019|NCT02490800|448122764|FG000|Overall Study|Withdrawal by Subject|0|||
124592020|NCT02490800|448122765|FG001|Overall Study|Withdrawal by Subject|0|||
124592021|NCT02490800|448122766|FG002|Overall Study|Withdrawal by Subject|0|||
124592022|NCT02490800|448122767|FG003|Overall Study|Withdrawal by Subject|1|||
124592023|NCT02490800|448122768|FG004|Overall Study|Withdrawal by Subject|0|||
124592024|NCT02490800|448122769|FG005|Overall Study|Withdrawal by Subject|0|||
124592025|NCT02490800|448122770|FG006|Overall Study|Withdrawal by Subject|0|||
124592026|NCT02490800|448122771|FG007|Overall Study|Withdrawal by Subject|0|||
124592027|NCT02490800|448122772|FG008|Overall Study|Withdrawal by Subject|1|||
124592028|NCT02490800|448122773|FG009|Overall Study|Withdrawal by Subject|0|||
124592029|NCT02490800|448122774|FG010|Overall Study|Withdrawal by Subject|0|||
124592030|NCT02490800|448122775|FG011|Overall Study|Withdrawal by Subject|0|||
124592031|NCT02490800|448122776|FG012|Overall Study|Withdrawal by Subject|0|||
124592032|NCT02490800|448122764|FG000|Overall Study|Progressive disease|3|||
124592033|NCT02490800|448122765|FG001|Overall Study|Progressive disease|3|||
124592034|NCT02490800|448122766|FG002|Overall Study|Progressive disease|3|||
124592035|NCT02490800|448122767|FG003|Overall Study|Progressive disease|4|||
124592036|NCT02490800|448122768|FG004|Overall Study|Progressive disease|4|||
124592037|NCT02490800|448122769|FG005|Overall Study|Progressive disease|1|||
124592038|NCT02490800|448122770|FG006|Overall Study|Progressive disease|4|||
124592039|NCT02490800|448122771|FG007|Overall Study|Progressive disease|3|||
124592040|NCT02490800|448122772|FG008|Overall Study|Progressive disease|6|||
124592041|NCT02490800|448122773|FG009|Overall Study|Progressive disease|2|||
124592042|NCT02490800|448122774|FG010|Overall Study|Progressive disease|7|||
124592043|NCT02490800|448122775|FG011|Overall Study|Progressive disease|1|||
124592044|NCT02490800|448122776|FG012|Overall Study|Progressive disease|10|||
124592045|NCT02490800|448122764|FG000|Overall Study|Patient enrolled in post-trial access|0|||
124592046|NCT02490800|448122765|FG001|Overall Study|Patient enrolled in post-trial access|0|||
124592047|NCT02490800|448122766|FG002|Overall Study|Patient enrolled in post-trial access|0|||
124592048|NCT02490800|448122767|FG003|Overall Study|Patient enrolled in post-trial access|0|||
124592049|NCT02490800|448122768|FG004|Overall Study|Patient enrolled in post-trial access|0|||
124592050|NCT02490800|448122769|FG005|Overall Study|Patient enrolled in post-trial access|0|||
124592051|NCT02490800|448122770|FG006|Overall Study|Patient enrolled in post-trial access|0|||
124592052|NCT02490800|448122771|FG007|Overall Study|Patient enrolled in post-trial access|0|||
124592053|NCT02490800|448122772|FG008|Overall Study|Patient enrolled in post-trial access|0|||
124592054|NCT02490800|448122773|FG009|Overall Study|Patient enrolled in post-trial access|1|||
124592055|NCT02490800|448122774|FG010|Overall Study|Patient enrolled in post-trial access|1|||
124592056|NCT02490800|448122775|FG011|Overall Study|Patient enrolled in post-trial access|0|||
124592057|NCT02490800|448122776|FG012|Overall Study|Patient enrolled in post-trial access|6|||
124592058|NCT03365791|448122777|FG000|Overall Study|Adverse Event|5|||
124592059|NCT03365791|448122777|FG000|Overall Study|Death|1|||
124592060|NCT03365791|448122777|FG000|Overall Study|Lost to Follow-up|1|||
124592061|NCT03365791|448122777|FG000|Overall Study|Physician Decision|9|||
124592062|NCT03365791|448122777|FG000|Overall Study|Progressive disease|51|||
124592063|NCT03365791|448122777|FG000|Overall Study|Subject/guardian decision|5|||
124592064|NCT03693950|448122778|FG000|Overall Study|Withdrawal by Subject|1|||
124592065|NCT03693950|448122779|FG001|Overall Study|Withdrawal by Subject|0|||
124592066|NCT01475487|448122780|FG000|Overall Study|had to leave early for personal reasons|2|||
124592067|NCT01475487|448122781|FG001|Overall Study|had to leave early for personal reasons|1|||
124592068|NCT03203642|448122782|FG000|Overall Study|Adverse Event|3|||
124592069|NCT03203642|448122783|FG001|Overall Study|Adverse Event|1|||
124592070|NCT03203642|448122782|FG000|Overall Study|Withdrawal by Subject|6|||
124592071|NCT03203642|448122783|FG001|Overall Study|Withdrawal by Subject|6|||
124592072|NCT03203642|448122782|FG000|Overall Study|Lost to Follow-up|2|||
124592073|NCT03203642|448122783|FG001|Overall Study|Lost to Follow-up|1|||
124592074|NCT03203642|448122782|FG000|Overall Study|Termination of the study by sponsor|1|||
124592075|NCT03203642|448122783|FG001|Overall Study|Termination of the study by sponsor|1|||
124592076|NCT03203642|448122782|FG000|Overall Study|Participant moved|0|||
124592077|NCT03203642|448122783|FG001|Overall Study|Participant moved|1|||
124592078|NCT03203642|448122782|FG000|Overall Study|Investigator's decision|3|||
124592079|NCT03203642|448122783|FG001|Overall Study|Investigator's decision|0|||
124778550|NCT00854113|448817842|FG000|Overall Study|Withdrawal by Subject|0|||
124778551|NCT00854113|448817843|FG001|Overall Study|Withdrawal by Subject|0|||
124778552|NCT00854113|448817844|FG002|Overall Study|Withdrawal by Subject|0|||
124778553|NCT00854113|448817845|FG003|Overall Study|Withdrawal by Subject|0|||
124778554|NCT00854113|448817846|FG004|Overall Study|Withdrawal by Subject|0|||
124778555|NCT00854113|448817847|FG005|Overall Study|Withdrawal by Subject|0|||
124778556|NCT00854113|448817848|FG006|Overall Study|Withdrawal by Subject|0|||
124778557|NCT00854113|448817849|FG007|Overall Study|Withdrawal by Subject|1|||
124778558|NCT00854113|448817850|FG008|Overall Study|Withdrawal by Subject|1|||
124778559|NCT00854113|448817851|FG009|Overall Study|Withdrawal by Subject|0|||
124778560|NCT00854113|448817852|FG010|Overall Study|Withdrawal by Subject|0|||
124778561|NCT02273596|448817856|FG000|24-Week Treatment Period|Adverse Event|3|||
124778562|NCT02273596|448817856|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
124778563|NCT02273596|448817856|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
124778564|NCT02273596|448817856|FG000|24-Week Treatment Period|Physician Decision|1|||
124778565|NCT02273596|448817856|FG000|24-Week Treatment Period|Protocol Deviation|1|||
124778566|NCT02273596|448817856|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
124778567|NCT02273596|448817856|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
124778568|NCT02273596|448817856|FG000|Extension Period|Lost to Follow-up|1|||
124778569|NCT02273596|448817856|FG000|Extension Period|Protocol Deviation|1|||
124778570|NCT02604160|448817857|FG000|Overall Study|Protocol Violation|0|||
124778571|NCT02604160|448817858|FG001|Overall Study|Protocol Violation|1|||
124778572|NCT02604160|448817857|FG000|Overall Study|Physician Decision|0|||
124778573|NCT02604160|448817858|FG001|Overall Study|Physician Decision|1|||
124778574|NCT01596062|448817859|FG000|Overall Study|Adverse Event|1|||
124778575|NCT01596062|448817860|FG001|Overall Study|Adverse Event|0|||
124778576|NCT01596062|448817861|FG002|Overall Study|Adverse Event|2|||
124778577|NCT01596062|448817859|FG000|Overall Study|Lack of Efficacy|0|||
124778578|NCT01596062|448817860|FG001|Overall Study|Lack of Efficacy|0|||
124778579|NCT01596062|448817861|FG002|Overall Study|Lack of Efficacy|1|||
124778580|NCT02139592|448817862|FG000|Overall Study|Case Report Forms Uncollected|8|||
124778581|NCT03180840|448817863|FG000|Overall Study|Withdrawal by Subject|1|||
124778582|NCT01413204|448817873|FG000|Overall Study|Adverse Event|1|||
124778583|NCT01413204|448817874|FG001|Overall Study|Adverse Event|2|||
124778584|NCT01413204|448817875|FG002|Overall Study|Adverse Event|2|||
124778585|NCT01413204|448817873|FG000|Overall Study|Physician Decision|3|||
124778586|NCT01413204|448817874|FG001|Overall Study|Physician Decision|0|||
124778587|NCT01413204|448817875|FG002|Overall Study|Physician Decision|2|||
124778588|NCT01413204|448817873|FG000|Overall Study|Withdrawal by Subject|1|||
124778589|NCT01413204|448817874|FG001|Overall Study|Withdrawal by Subject|4|||
124778590|NCT01413204|448817875|FG002|Overall Study|Withdrawal by Subject|4|||
124778591|NCT01413204|448817873|FG000|Overall Study|Clearly not eligible for the study|0|||
124778592|NCT01413204|448817874|FG001|Overall Study|Clearly not eligible for the study|0|||
124778593|NCT01413204|448817875|FG002|Overall Study|Clearly not eligible for the study|1|||
124778594|NCT01413204|448817873|FG000|Overall Study|Fasting plasma glucose level increased|1|||
124778595|NCT01413204|448817874|FG001|Overall Study|Fasting plasma glucose level increased|0|||
124778596|NCT01413204|448817875|FG002|Overall Study|Fasting plasma glucose level increased|10|||
124778597|NCT00123422|448817876|FG000|Overall Study|Physician Decision|2|||
124778598|NCT00123422|448817877|FG001|Overall Study|Physician Decision|2|||
124778599|NCT00123422|448817878|FG002|Overall Study|Physician Decision|6|||
124778600|NCT00123422|448817876|FG000|Overall Study|Withdrawal by Subject|1|||
124778601|NCT00123422|448817877|FG001|Overall Study|Withdrawal by Subject|2|||
124778602|NCT00123422|448817878|FG002|Overall Study|Withdrawal by Subject|2|||
124778603|NCT00123422|448817876|FG000|Overall Study|Lost to Follow-up|1|||
124778604|NCT00123422|448817877|FG001|Overall Study|Lost to Follow-up|2|||
124778605|NCT00123422|448817878|FG002|Overall Study|Lost to Follow-up|2|||
124778606|NCT04555616|448817881|FG000|Overall Study|Death|1|||
124778607|NCT04555616|448817882|FG001|Overall Study|Death|0|||
124778608|NCT04555616|448817883|FG002|Overall Study|Death|1|||
124778609|NCT04555616|448817881|FG000|Overall Study|Withdrawal by Subject|2|||
124778610|NCT04555616|448817882|FG001|Overall Study|Withdrawal by Subject|1|||
124592080|NCT03203642|448122782|FG000|Overall Study|Other than above specified|0|||
124592081|NCT03203642|448122783|FG001|Overall Study|Other than above specified|1|||
124592082|NCT00559637|448124416|FG000|Overall Study|Adverse Event|22|||
124778611|NCT04555616|448817883|FG002|Overall Study|Withdrawal by Subject|0|||
124778612|NCT04816669|448817884|FG000|Part 1|Adverse Event|1|||
124592083|NCT00559637|448124416|FG000|Overall Study|Withdrawal by Subject|4|||
124778613|NCT04816669|448817885|FG001|Part 1|Adverse Event|1|||
124778614|NCT04816669|448817886|FG002|Part 1|Adverse Event|0|||
124778615|NCT04816669|448817887|FG003|Part 1|Adverse Event|0|||
124778616|NCT04816669|448817884|FG000|Part 1|Lost to Follow-up|2|||
124778617|NCT04816669|448817885|FG001|Part 1|Lost to Follow-up|2|||
124778618|NCT04816669|448817886|FG002|Part 1|Lost to Follow-up|0|||
124778619|NCT04816669|448817887|FG003|Part 1|Lost to Follow-up|0|||
124778620|NCT04816669|448817884|FG000|Part 1|Protocol Violation|0|||
124778621|NCT04816669|448817885|FG001|Part 1|Protocol Violation|1|||
124778622|NCT04816669|448817886|FG002|Part 1|Protocol Violation|0|||
124729962|NCT02264665|448633950|FG006|Overall Study|Participant decision|0|||
124729963|NCT02264665|448633944|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
124729964|NCT02264665|448633945|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
124729965|NCT02264665|448633946|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
124729966|NCT02264665|448633947|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
124729967|NCT02264665|448633948|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
124729968|NCT02264665|448633949|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
124729969|NCT02264665|448633950|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
124729970|NCT02264665|448633944|FG000|Overall Study|Data Missing|0|||
124729971|NCT02264665|448633945|FG001|Overall Study|Data Missing|0|||
124729972|NCT02264665|448633946|FG002|Overall Study|Data Missing|1|||
124729973|NCT02264665|448633947|FG003|Overall Study|Data Missing|0|||
124729974|NCT02264665|448633948|FG004|Overall Study|Data Missing|0|||
124729975|NCT02264665|448633949|FG005|Overall Study|Data Missing|0|||
124729976|NCT02264665|448633950|FG006|Overall Study|Data Missing|0|||
124729977|NCT01962987|448633951|FG000|Overall Study|Adverse Event|4|||
124729978|NCT01962987|448633952|FG001|Overall Study|Adverse Event|4|||
124729979|NCT01962987|448633953|FG002|Overall Study|Adverse Event|0|||
124729980|NCT01962987|448633951|FG000|Overall Study|Lost to Follow-up|0|||
124729981|NCT01962987|448633952|FG001|Overall Study|Lost to Follow-up|0|||
124729982|NCT01962987|448633953|FG002|Overall Study|Lost to Follow-up|1|||
124729983|NCT01962987|448633951|FG000|Overall Study|Non compliance with dosing requirements|4|||
124729984|NCT01962987|448633952|FG001|Overall Study|Non compliance with dosing requirements|2|||
124729985|NCT01962987|448633953|FG002|Overall Study|Non compliance with dosing requirements|0|||
124729986|NCT01962987|448633951|FG000|Overall Study|Miscellaneous|1|||
124729987|NCT01962987|448633952|FG001|Overall Study|Miscellaneous|9|||
124729988|NCT01962987|448633953|FG002|Overall Study|Miscellaneous|2|||
124729989|NCT01962987|448633951|FG000|Overall Study|Restricted medication|5|||
124729990|NCT01962987|448633952|FG001|Overall Study|Restricted medication|1|||
124729991|NCT01962987|448633953|FG002|Overall Study|Restricted medication|1|||
124729992|NCT01962987|448633951|FG000|Overall Study|Serious Adverse Event|1|||
124729993|NCT01962987|448633952|FG001|Overall Study|Serious Adverse Event|0|||
124729994|NCT01962987|448633953|FG002|Overall Study|Serious Adverse Event|0|||
124729995|NCT01962987|448633951|FG000|Overall Study|Withdrawal by Subject|11|||
124729996|NCT01962987|448633952|FG001|Overall Study|Withdrawal by Subject|10|||
124729997|NCT01962987|448633953|FG002|Overall Study|Withdrawal by Subject|6|||
124729998|NCT01962987|448633951|FG000|Overall Study|Randomized in Error|4|||
124729999|NCT01962987|448633952|FG001|Overall Study|Randomized in Error|2|||
124730000|NCT01962987|448633953|FG002|Overall Study|Randomized in Error|2|||
124730001|NCT02688088|448633962|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
124730002|NCT02688088|448633963|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
124730003|NCT02688088|448633964|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
124730004|NCT02688088|448633965|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
124730005|NCT02688088|448633966|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
124730006|NCT02688088|448633962|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
124730007|NCT02688088|448633963|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
124730008|NCT02688088|448633964|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
124730009|NCT02688088|448633965|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
124730010|NCT02688088|448633966|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
124730011|NCT02688088|448633962|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
124730012|NCT02688088|448633963|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
124730013|NCT02688088|448633964|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
124730014|NCT02688088|448633965|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
124730015|NCT02688088|448633966|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
124730016|NCT02688088|448633962|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
124730017|NCT02688088|448633963|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
124730018|NCT02688088|448633964|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
124730019|NCT02688088|448633965|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
124730020|NCT02688088|448633966|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
124730021|NCT02688088|448633962|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
124730022|NCT02688088|448633963|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
124730023|NCT02688088|448633964|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
124730024|NCT02688088|448633965|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
124730025|NCT02688088|448633966|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
124730026|NCT02688088|448633962|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
124730027|NCT02688088|448633963|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
124730028|NCT02688088|448633964|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
124730029|NCT02688088|448633965|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
124730030|NCT02688088|448633966|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
124730031|NCT02688088|448633962|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
124592084|NCT00559637|448124416|FG000|Overall Study|Protocol Violation|6|||
124592085|NCT00559637|448124416|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
124592086|NCT00559637|448124416|FG000|Overall Study|Failure to return|6|||
124592087|NCT00559637|448124416|FG000|Overall Study|Insufficient response|3|||
124592088|NCT00559637|448124416|FG000|Overall Study|Started requiring dialysis after month 7|2|||
124592089|NCT00559637|448124416|FG000|Overall Study|Suspected lung cancer|1|||
124592090|NCT00559637|448124416|FG000|Overall Study|Participation in another study|1|||
124592091|NCT00559637|448124416|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
124592092|NCT00559637|448124416|FG000|Overall Study|Change of center|1|||
124592093|NCT00559637|448124416|FG000|Overall Study|Change of home|1|||
124592094|NCT00559637|448124416|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
124592095|NCT02832167|448124417|FG000|Treatment Period 1|Disease progression|90|||
124592096|NCT02832167|448124417|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
124592097|NCT02832167|448124417|FG000|Treatment Period 1|Death|2|||
124592098|NCT02832167|448124417|FG000|Treatment Period 1|Study Drug Toxicity|6|||
124592099|NCT02832167|448124417|FG000|Treatment Period 1|Participant request to discontinue|9|||
124592100|NCT02832167|448124417|FG000|Treatment Period 1|No longer meet study criteria|1|||
124592101|NCT02832167|448124417|FG000|Treatment Period 1|Participant withdrew consent|3|||
124592102|NCT02832167|448124417|FG000|Treatment Period 1|Other reasons|6|||
124592103|NCT02832167|448124417|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
124592104|NCT02832167|448124417|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
124592105|NCT02832167|448124417|FG000|Transition From Period 1 to Period 2|Death|2|||
124592106|NCT02832167|448124417|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
124592107|NCT02832167|448124417|FG000|Treatment Period 2|Disease progression|69|||
124592108|NCT02832167|448124417|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
124592109|NCT02832167|448124417|FG000|Treatment Period 2|Maximum clinical benefit|1|||
124592110|NCT02832167|448124417|FG000|Treatment Period 2|Study Drug Toxicity|5|||
124592111|NCT02832167|448124417|FG000|Treatment Period 2|Participant request to discontinue|2|||
124592112|NCT02832167|448124417|FG000|Treatment Period 2|Participant withdrew consent|3|||
124592113|NCT02832167|448124417|FG000|Treatment Period 2|Other reasons|3|||
124592114|NCT01958060|448124420|FG000|Overall Study|Not treated|2|||
124592115|NCT01958060|448124421|FG001|Overall Study|Not treated|0|||
124592116|NCT01958060|448124422|FG002|Overall Study|Not treated|0|||
124592117|NCT01958060|448124423|FG003|Overall Study|Not treated|0|||
124592118|NCT01958060|448124424|FG004|Overall Study|Not treated|1|||
124592119|NCT01958060|448124425|FG005|Overall Study|Not treated|0|||
124592120|NCT02293460|448124427|FG000|Overall Study|Protocol Violation|1|||
124592121|NCT02293460|448124427|FG000|Overall Study|Lack of Efficacy|2|||
124592122|NCT02293460|448124427|FG000|Overall Study|Adverse Event|2|||
124592123|NCT02293460|448124427|FG000|Overall Study|Withdrawal by Subject|1|||
124592124|NCT01074008|448124447|FG000|Overall Study|Adverse Event|0|||
124592125|NCT01074008|448124448|FG001|Overall Study|Adverse Event|1|||
124592126|NCT01074008|448124449|FG002|Overall Study|Adverse Event|0|||
124592127|NCT01074008|448124450|FG003|Overall Study|Adverse Event|0|||
124592128|NCT01074008|448124451|FG004|Overall Study|Adverse Event|0|||
124592129|NCT01074008|448124452|FG005|Overall Study|Adverse Event|0|||
124592130|NCT01074008|448124453|FG006|Overall Study|Adverse Event|0|||
124592131|NCT01074008|448124454|FG007|Overall Study|Adverse Event|0|||
124592132|NCT01074008|448124455|FG008|Overall Study|Adverse Event|0|||
124592133|NCT01074008|448124447|FG000|Overall Study|Withdrawal by Subject|1|||
124592134|NCT01074008|448124448|FG001|Overall Study|Withdrawal by Subject|1|||
124592135|NCT01074008|448124449|FG002|Overall Study|Withdrawal by Subject|1|||
124592136|NCT01074008|448124450|FG003|Overall Study|Withdrawal by Subject|0|||
124592137|NCT01074008|448124451|FG004|Overall Study|Withdrawal by Subject|1|||
124592138|NCT01074008|448124452|FG005|Overall Study|Withdrawal by Subject|0|||
124592139|NCT01074008|448124453|FG006|Overall Study|Withdrawal by Subject|0|||
124592140|NCT01074008|448124454|FG007|Overall Study|Withdrawal by Subject|0|||
124592141|NCT01074008|448124455|FG008|Overall Study|Withdrawal by Subject|0|||
124592142|NCT01074008|448124447|FG000|Overall Study|Lost to Follow-up|0|||
124592143|NCT01074008|448124448|FG001|Overall Study|Lost to Follow-up|1|||
124592144|NCT01074008|448124449|FG002|Overall Study|Lost to Follow-up|1|||
124592145|NCT01074008|448124450|FG003|Overall Study|Lost to Follow-up|1|||
124592146|NCT01074008|448124451|FG004|Overall Study|Lost to Follow-up|1|||
124592147|NCT01074008|448124452|FG005|Overall Study|Lost to Follow-up|0|||
124592148|NCT01074008|448124453|FG006|Overall Study|Lost to Follow-up|1|||
124592149|NCT01074008|448124454|FG007|Overall Study|Lost to Follow-up|0|||
124592150|NCT01074008|448124455|FG008|Overall Study|Lost to Follow-up|4|||
124592151|NCT00224484|448124456|FG000|Overall Study|Serious Adverse Event|1|||
124592152|NCT00224484|448124457|FG001|Overall Study|Serious Adverse Event|1|||
124592153|NCT00224484|448124458|FG002|Overall Study|Serious Adverse Event|0|||
124592154|NCT00224484|448124456|FG000|Overall Study|Non-Serious Adverse Event|5|||
124592155|NCT00224484|448124457|FG001|Overall Study|Non-Serious Adverse Event|7|||
124592156|NCT00224484|448124458|FG002|Overall Study|Non-Serious Adverse Event|3|||
124592157|NCT00224484|448124456|FG000|Overall Study|Protocol Violation|2|||
124592158|NCT00224484|448124457|FG001|Overall Study|Protocol Violation|2|||
124592159|NCT00224484|448124458|FG002|Overall Study|Protocol Violation|0|||
124778623|NCT04816669|448817887|FG003|Part 1|Protocol Violation|0|||
124778624|NCT04816669|448817884|FG000|Part 1|Withdrawal by Subject|1|||
124778625|NCT04816669|448817885|FG001|Part 1|Withdrawal by Subject|2|||
124778626|NCT04816669|448817886|FG002|Part 1|Withdrawal by Subject|0|||
124778627|NCT04816669|448817887|FG003|Part 1|Withdrawal by Subject|0|||
124778628|NCT04816669|448817884|FG000|Part 2|Other|0|||
124778629|NCT04816669|448817885|FG001|Part 2|Other|0|||
124778630|NCT04816669|448817886|FG002|Part 2|Other|1|||
124778631|NCT04816669|448817887|FG003|Part 2|Other|0|||
124778632|NCT04816669|448817884|FG000|Part 2|Withdrawal by Subject|0|||
124778633|NCT04816669|448817885|FG001|Part 2|Withdrawal by Subject|0|||
124778634|NCT04816669|448817886|FG002|Part 2|Withdrawal by Subject|0|||
124778635|NCT04816669|448817887|FG003|Part 2|Withdrawal by Subject|1|||
124778636|NCT04816669|448817884|FG000|Part 2|Lost to Follow-up|0|||
124778637|NCT04816669|448817885|FG001|Part 2|Lost to Follow-up|0|||
124778638|NCT04816669|448817886|FG002|Part 2|Lost to Follow-up|1|||
124778639|NCT04816669|448817887|FG003|Part 2|Lost to Follow-up|0|||
124778640|NCT01229267|448817888|FG000|Overall Study|Adverse Event|4|||
124778641|NCT01229267|448817889|FG001|Overall Study|Adverse Event|6|||
124778642|NCT01229267|448817890|FG002|Overall Study|Adverse Event|3|||
124778643|NCT01229267|448817891|FG003|Overall Study|Adverse Event|2|||
124778644|NCT01229267|448817892|FG004|Overall Study|Adverse Event|10|||
124778645|NCT01229267|448817888|FG000|Overall Study|Death|40|||
124778646|NCT01229267|448817889|FG001|Overall Study|Death|37|||
124778647|NCT01229267|448817890|FG002|Overall Study|Death|35|||
124778648|NCT01229267|448817891|FG003|Overall Study|Death|13|||
124778649|NCT01229267|448817892|FG004|Overall Study|Death|103|||
124778650|NCT01229267|448817888|FG000|Overall Study|Withdrawal by Subject|23|||
124778651|NCT01229267|448817889|FG001|Overall Study|Withdrawal by Subject|22|||
124778652|NCT01229267|448817890|FG002|Overall Study|Withdrawal by Subject|32|||
124778653|NCT01229267|448817891|FG003|Overall Study|Withdrawal by Subject|14|||
124778654|NCT01229267|448817892|FG004|Overall Study|Withdrawal by Subject|59|||
124778655|NCT01229267|448817888|FG000|Overall Study|Protocol Violation|0|||
124778656|NCT01229267|448817889|FG001|Overall Study|Protocol Violation|1|||
124778657|NCT01229267|448817890|FG002|Overall Study|Protocol Violation|0|||
124778658|NCT01229267|448817891|FG003|Overall Study|Protocol Violation|0|||
124778659|NCT01229267|448817892|FG004|Overall Study|Protocol Violation|0|||
124778660|NCT01229267|448817888|FG000|Overall Study|Progressive disease|0|||
124778661|NCT01229267|448817889|FG001|Overall Study|Progressive disease|0|||
124778662|NCT01229267|448817890|FG002|Overall Study|Progressive disease|0|||
124778663|NCT01229267|448817891|FG003|Overall Study|Progressive disease|0|||
124778664|NCT01229267|448817892|FG004|Overall Study|Progressive disease|1|||
124778665|NCT01229267|448817888|FG000|Overall Study|Physician Decision|8|||
124778666|NCT01229267|448817889|FG001|Overall Study|Physician Decision|11|||
124778667|NCT01229267|448817890|FG002|Overall Study|Physician Decision|8|||
124778668|NCT01229267|448817891|FG003|Overall Study|Physician Decision|3|||
124778669|NCT01229267|448817892|FG004|Overall Study|Physician Decision|25|||
124778670|NCT01229267|448817888|FG000|Overall Study|Lost to Follow-up|6|||
124778671|NCT01229267|448817889|FG001|Overall Study|Lost to Follow-up|5|||
124778672|NCT01229267|448817890|FG002|Overall Study|Lost to Follow-up|8|||
124778673|NCT01229267|448817891|FG003|Overall Study|Lost to Follow-up|3|||
124778674|NCT01229267|448817892|FG004|Overall Study|Lost to Follow-up|22|||
124778675|NCT01358721|448817895|FG000|Overall Study|Withdrawal by Subject|0|||
124778676|NCT01358721|448817896|FG001|Overall Study|Withdrawal by Subject|0|||
124778677|NCT01358721|448817897|FG002|Overall Study|Withdrawal by Subject|0|||
124778678|NCT01358721|448817898|FG003|Overall Study|Withdrawal by Subject|1|||
124778679|NCT01358721|448817895|FG000|Overall Study|Death|0|||
124778680|NCT01358721|448817896|FG001|Overall Study|Death|2|||
124778681|NCT01358721|448817897|FG002|Overall Study|Death|0|||
124778682|NCT01358721|448817898|FG003|Overall Study|Death|0|||
124778683|NCT01358721|448817895|FG000|Overall Study|Study Drug Toxicity|1|||
124778684|NCT01358721|448817896|FG001|Overall Study|Study Drug Toxicity|3|||
124778685|NCT01358721|448817897|FG002|Overall Study|Study Drug Toxicity|4|||
124778686|NCT01358721|448817898|FG003|Overall Study|Study Drug Toxicity|5|||
124778687|NCT01358721|448817895|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
124778688|NCT01358721|448817896|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
124778689|NCT01358721|448817897|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
124778690|NCT01358721|448817898|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
124778691|NCT01358721|448817895|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
124778692|NCT01358721|448817896|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
124778693|NCT01358721|448817897|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
124778694|NCT01358721|448817898|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
124778695|NCT01358721|448817895|FG000|Overall Study|Adverse Event related to study drug|1|||
124778696|NCT01358721|448817896|FG001|Overall Study|Adverse Event related to study drug|0|||
124778697|NCT01358721|448817897|FG002|Overall Study|Adverse Event related to study drug|0|||
124778698|NCT01358721|448817898|FG003|Overall Study|Adverse Event related to study drug|1|||
124778699|NCT01358721|448817895|FG000|Overall Study|Disease Progression|19|||
124778700|NCT01358721|448817896|FG001|Overall Study|Disease Progression|15|||
124778701|NCT01358721|448817897|FG002|Overall Study|Disease Progression|17|||
124778702|NCT01358721|448817898|FG003|Overall Study|Disease Progression|15|||
124778703|NCT01358721|448817895|FG000|Overall Study|Out of State/Unmet Criteria|0|||
124778704|NCT01358721|448817896|FG001|Overall Study|Out of State/Unmet Criteria|0|||
124778705|NCT01358721|448817897|FG002|Overall Study|Out of State/Unmet Criteria|1|||
124778706|NCT01358721|448817898|FG003|Overall Study|Out of State/Unmet Criteria|0|||
124778707|NCT01908803|448817899|FG000|Overall Study|Adverse Event|1|||
124778708|NCT01908803|448817900|FG001|Overall Study|Adverse Event|0|||
124778709|NCT01908803|448817899|FG000|Overall Study|Physician Decision|0|||
124778710|NCT01908803|448817900|FG001|Overall Study|Physician Decision|1|||
124778711|NCT01908803|448817899|FG000|Overall Study|Withdrawal by Subject|1|||
124778712|NCT01908803|448817900|FG001|Overall Study|Withdrawal by Subject|0|||
124778713|NCT01908803|448817899|FG000|Overall Study|Randomization Error|1|||
124778714|NCT01908803|448817900|FG001|Overall Study|Randomization Error|0|||
124778715|NCT01908803|448817899|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
124778716|NCT01908803|448817900|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
124778717|NCT00867815|448817901|FG000|Overall Study|Lost to Follow-up|1|||
124778718|NCT01864603|448817902|FG000|Stage 2|DSMB design modification|86056|||
124778719|NCT01864603|448817903|FG001|Stage 2|DSMB design modification|92558|||
124778720|NCT02446899|448817904|FG000|Overall Study|Adverse Event|4|||
124778721|NCT02446899|448817905|FG001|Overall Study|Adverse Event|7|||
124778722|NCT02446899|448817904|FG000|Overall Study|Condition Under Investigation Worsened|1|||
124778723|NCT02446899|448817905|FG001|Overall Study|Condition Under Investigation Worsened|4|||
124778724|NCT02446899|448817904|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
124778725|NCT02446899|448817905|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
124778726|NCT02446899|448817904|FG000|Overall Study|Lack of Efficacy|2|||
124778727|NCT02446899|448817905|FG001|Overall Study|Lack of Efficacy|8|||
124778728|NCT02446899|448817904|FG000|Overall Study|Lost to Follow-up|1|||
124778729|NCT02446899|448817905|FG001|Overall Study|Lost to Follow-up|3|||
124778730|NCT02446899|448817904|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
124778731|NCT02446899|448817905|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
124730032|NCT02688088|448633963|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
124730033|NCT02688088|448633964|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
124730034|NCT02688088|448633965|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
124730035|NCT02688088|448633966|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
124730036|NCT02688088|448633962|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
124730037|NCT02688088|448633963|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
124730038|NCT02688088|448633964|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
124730039|NCT02688088|448633965|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
124730040|NCT02688088|448633966|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
124730041|NCT02688088|448633962|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
124730042|NCT02688088|448633963|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
124730043|NCT02688088|448633964|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
124730044|NCT02688088|448633965|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
124730045|NCT02688088|448633966|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
124730046|NCT01921218|448633969|FG000|Overall Study|Death|2|||
124730047|NCT01921218|448633970|FG001|Overall Study|Death|1|||
124730048|NCT01921218|448633969|FG000|Overall Study|Withdrawal by Subject|0|||
124730049|NCT01921218|448633970|FG001|Overall Study|Withdrawal by Subject|2|||
124730050|NCT01921218|448633969|FG000|Overall Study|Kidney transplant|1|||
124730051|NCT01921218|448633970|FG001|Overall Study|Kidney transplant|1|||
124730052|NCT02449889|448633971|FG000|Overall Study|Adverse Event|1|||
124730053|NCT02449889|448633972|FG001|Overall Study|Adverse Event|2|||
124730054|NCT02449889|448633973|FG002|Overall Study|Adverse Event|0|||
124730055|NCT02449889|448633971|FG000|Overall Study|Protocol Violation|0|||
124730056|NCT02449889|448633972|FG001|Overall Study|Protocol Violation|4|||
124730057|NCT02449889|448633973|FG002|Overall Study|Protocol Violation|1|||
124730058|NCT00688324|448633974|FG000|Overall Study|Withdrawal by Subject|2|||
124730059|NCT00688324|448633974|FG000|Overall Study|Physician Decision|5|||
124730060|NCT00688324|448633974|FG000|Overall Study|Lost to Follow-up|1|||
124730061|NCT00006046|448633975|FG000|Overall Study|Adverse Event|3|||
124730062|NCT00006046|448633976|FG001|Overall Study|Adverse Event|0|||
124730063|NCT00006046|448633977|FG002|Overall Study|Adverse Event|0|||
124730064|NCT00006046|448633978|FG003|Overall Study|Adverse Event|0|||
124730065|NCT00006046|448633979|FG004|Overall Study|Adverse Event|0|||
124730066|NCT00006046|448633975|FG000|Overall Study|Disease Progression|2|||
124730067|NCT00006046|448633976|FG001|Overall Study|Disease Progression|0|||
124730068|NCT00006046|448633977|FG002|Overall Study|Disease Progression|0|||
124730069|NCT00006046|448633978|FG003|Overall Study|Disease Progression|0|||
124730070|NCT00006046|448633979|FG004|Overall Study|Disease Progression|0|||
124730071|NCT03176472|448633980|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
124778732|NCT02446899|448817904|FG000|Overall Study|Withdrawal by Subject|11|||
124592160|NCT00224484|448124456|FG000|Overall Study|Withdrawal by Subject|49|||
124778733|NCT02446899|448817905|FG001|Overall Study|Withdrawal by Subject|19|||
124778734|NCT02446899|448817904|FG000|Overall Study|Miscellaneous|5|||
124778735|NCT02446899|448817905|FG001|Overall Study|Miscellaneous|4|||
124778736|NCT02446899|448817904|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
124778737|NCT02446899|448817905|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
124778738|NCT04050202|448817906|FG000|Overall Study|Lost to Follow-up|2|||
124778739|NCT00001213|448817907|FG000|Overall Study|Death|18|||
124778740|NCT01554241|448817909|FG000|Overall Study|Death|3|||
124778741|NCT01554241|448817910|FG001|Overall Study|Death|1|||
124778742|NCT01554241|448817911|FG002|Overall Study|Death|1|||
124778743|NCT01554241|448817912|FG003|Overall Study|Death|0|||
124778744|NCT01554241|448817909|FG000|Overall Study|protocol specified renal stone|0|||
124778745|NCT01554241|448817910|FG001|Overall Study|protocol specified renal stone|0|||
124778746|NCT01554241|448817911|FG002|Overall Study|protocol specified renal stone|0|||
124778747|NCT01554241|448817912|FG003|Overall Study|protocol specified renal stone|1|||
124778748|NCT01554241|448817909|FG000|Overall Study|protocol specified change in eGFR|0|||
124778749|NCT01554241|448817910|FG001|Overall Study|protocol specified change in eGFR|0|||
124778750|NCT01554241|448817911|FG002|Overall Study|protocol specified change in eGFR|1|||
124778751|NCT01554241|448817912|FG003|Overall Study|protocol specified change in eGFR|0|||
124778752|NCT01554241|448817909|FG000|Overall Study|Withdrawal by Subject|0|||
124778753|NCT01554241|448817910|FG001|Overall Study|Withdrawal by Subject|0|||
124778754|NCT01554241|448817911|FG002|Overall Study|Withdrawal by Subject|2|||
124778755|NCT01554241|448817912|FG003|Overall Study|Withdrawal by Subject|0|||
124778756|NCT02974543|448817917|FG000|Overall Study|Withdrawal by Subject|1|||
124778757|NCT02974543|448817918|FG001|Overall Study|Withdrawal by Subject|0|||
124778758|NCT00742235|448817919|FG000|Overall Study|Lost to Follow-up|0|||
124778759|NCT00742235|448817920|FG001|Overall Study|Lost to Follow-up|31|||
124778760|NCT01237899|448817921|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
124778761|NCT01237899|448817922|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
124778762|NCT01237899|448817923|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
124778763|NCT01237899|448817924|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
124778764|NCT01237899|448817925|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
124778765|NCT01237899|448817926|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
124778766|NCT01237899|448817927|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
124778767|NCT01237899|448817928|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
124778768|NCT01237899|448817929|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
124778769|NCT01237899|448817930|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
124778770|NCT01237899|448817931|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
124778771|NCT02141438|448817933|FG000|Overall Study|Death|1308|||
124778772|NCT02141438|448817933|FG000|Overall Study|Lost to Follow-up|84|||
124778773|NCT02141438|448817933|FG000|Overall Study|Withdrawal by Subject|52|||
124778774|NCT02141438|448817933|FG000|Overall Study|Physician Decision|1|||
124778775|NCT02141438|448817933|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
124778776|NCT05661409|448817934|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
124778777|NCT05661409|448817935|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
124592161|NCT00224484|448124457|FG001|Overall Study|Withdrawal by Subject|18|||
124592162|NCT00224484|448124458|FG002|Overall Study|Withdrawal by Subject|16|||
124592163|NCT00224484|448124456|FG000|Overall Study|Migrated/moved from study area|18|||
124778778|NCT05661409|448817936|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
124778779|NCT05661409|448817937|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
124778780|NCT05661409|448817938|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
124778781|NCT05661409|448817939|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
124778782|NCT05661409|448817934|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
124778783|NCT05661409|448817935|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
124778784|NCT05661409|448817936|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
124778785|NCT05661409|448817937|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
124778786|NCT05661409|448817938|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
124778787|NCT05661409|448817939|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
124778788|NCT05661409|448817934|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
124778789|NCT05661409|448817935|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
124778790|NCT05661409|448817936|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
124778791|NCT05661409|448817937|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
124778792|NCT05661409|448817938|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
124778793|NCT05661409|448817939|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
124778794|NCT05661409|448817934|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
124778795|NCT05661409|448817935|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
124778796|NCT05661409|448817936|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
124778797|NCT05661409|448817937|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
124778798|NCT05661409|448817938|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
124778799|NCT05661409|448817939|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
124592164|NCT00224484|448124457|FG001|Overall Study|Migrated/moved from study area|5|||
124592165|NCT00224484|448124458|FG002|Overall Study|Migrated/moved from study area|5|||
124592166|NCT00224484|448124456|FG000|Overall Study|Lost to Follow-up|66|||
124592167|NCT00224484|448124457|FG001|Overall Study|Lost to Follow-up|28|||
124778800|NCT05661409|448817934|FG000|Overall Study|Miscommu-nication about administration|0|||
124778801|NCT05661409|448817935|FG001|Overall Study|Miscommu-nication about administration|0|||
124778802|NCT05661409|448817936|FG002|Overall Study|Miscommu-nication about administration|0|||
124778803|NCT05661409|448817937|FG003|Overall Study|Miscommu-nication about administration|0|||
124778804|NCT05661409|448817938|FG004|Overall Study|Miscommu-nication about administration|0|||
124778805|NCT05661409|448817939|FG005|Overall Study|Miscommu-nication about administration|1|||
124778806|NCT05782179|448817940|FG000|Overall Study|Adverse Event|0|||
124778807|NCT05782179|448817941|FG001|Overall Study|Adverse Event|0|||
124592168|NCT00224484|448124458|FG002|Overall Study|Lost to Follow-up|36|||
124592169|NCT00224484|448124456|FG000|Overall Study|Reason not specified|5|||
124592170|NCT00224484|448124457|FG001|Overall Study|Reason not specified|4|||
124592171|NCT00224484|448124458|FG002|Overall Study|Reason not specified|2|||
124592172|NCT02805309|448124461|FG000|Overall Study|Lost to Follow-up|2|||
124592173|NCT02805309|448124462|FG001|Overall Study|Lost to Follow-up|2|||
124592174|NCT02805309|448124463|FG002|Overall Study|Lost to Follow-up|2|||
124592175|NCT02805309|448124461|FG000|Overall Study|Post-Randomization Exclusion|0|||
124592176|NCT02805309|448124462|FG001|Overall Study|Post-Randomization Exclusion|2|||
124592177|NCT02805309|448124463|FG002|Overall Study|Post-Randomization Exclusion|1|||
124592178|NCT01350934|448124470|FG000|Base Study|Adverse Event|6|||
124592179|NCT01350934|448124471|FG001|Base Study|Adverse Event|0|||
124592180|NCT01350934|448124470|FG000|Base Study|Lost to Follow-up|1|||
124592181|NCT01350934|448124471|FG001|Base Study|Lost to Follow-up|0|||
124592182|NCT01350934|448124470|FG000|Base Study|Protocol Violation|1|||
124592183|NCT01350934|448124471|FG001|Base Study|Protocol Violation|1|||
124592184|NCT01350934|448124470|FG000|Base Study|Withdrawal by Subject|1|||
124592185|NCT01350934|448124471|FG001|Base Study|Withdrawal by Subject|2|||
124592186|NCT01350934|448124470|FG000|Base Study|Non-Compliance With Study Drug|2|||
124592187|NCT01350934|448124471|FG001|Base Study|Non-Compliance With Study Drug|0|||
124592188|NCT01350934|448124470|FG000|Extension Study|Adverse Event|2|||
124592189|NCT01350934|448124471|FG001|Extension Study|Adverse Event|1|||
124592190|NCT01350934|448124470|FG000|Extension Study|Lost to Follow-up|2|||
124592191|NCT01350934|448124471|FG001|Extension Study|Lost to Follow-up|0|||
124592192|NCT01350934|448124470|FG000|Extension Study|Protocol Violation|1|||
124592193|NCT01350934|448124471|FG001|Extension Study|Protocol Violation|1|||
124592194|NCT01350934|448124470|FG000|Extension Study|Lack of Efficacy|0|||
124592195|NCT01350934|448124471|FG001|Extension Study|Lack of Efficacy|1|||
124592196|NCT01350934|448124470|FG000|Extension Study|Withdrawal by Subject|0|||
124592197|NCT01350934|448124471|FG001|Extension Study|Withdrawal by Subject|1|||
124592198|NCT03547635|448124472|FG000|Overall Study|Adverse Event|5|||
124592199|NCT03547635|448124473|FG001|Overall Study|Adverse Event|2|||
124592200|NCT03547635|448124474|FG002|Overall Study|Adverse Event|3|||
124592201|NCT03547635|448124472|FG000|Overall Study|Lost to Follow-up|1|||
124592202|NCT03547635|448124473|FG001|Overall Study|Lost to Follow-up|3|||
124592203|NCT03547635|448124474|FG002|Overall Study|Lost to Follow-up|4|||
124592204|NCT03547635|448124472|FG000|Overall Study|Withdrawal by Subject|1|||
124592205|NCT03547635|448124473|FG001|Overall Study|Withdrawal by Subject|0|||
124592206|NCT03547635|448124474|FG002|Overall Study|Withdrawal by Subject|0|||
124778808|NCT05782179|448817942|FG002|Overall Study|Adverse Event|2|||
124778809|NCT05782179|448817943|FG003|Overall Study|Adverse Event|0|||
124592207|NCT03547635|448124472|FG000|Overall Study|Withdrawal By PI|0|||
124592208|NCT03547635|448124473|FG001|Overall Study|Withdrawal By PI|1|||
124592209|NCT03547635|448124474|FG002|Overall Study|Withdrawal By PI|0|||
124592210|NCT03547635|448124472|FG000|Overall Study|Withdrawal by Sponsor|0|||
124592211|NCT03547635|448124473|FG001|Overall Study|Withdrawal by Sponsor|0|||
124592212|NCT03547635|448124474|FG002|Overall Study|Withdrawal by Sponsor|1|||
124592213|NCT03547635|448124472|FG000|Overall Study|Errant Randomization before Treatment|0|||
124592214|NCT03547635|448124473|FG001|Overall Study|Errant Randomization before Treatment|1|||
124592215|NCT03547635|448124474|FG002|Overall Study|Errant Randomization before Treatment|0|||
124592216|NCT03547635|448124472|FG000|Overall Study|Withdrawal by Subject|1|||
124592217|NCT03547635|448124473|FG001|Overall Study|Withdrawal by Subject|0|||
124778810|NCT05782179|448817944|FG004|Overall Study|Adverse Event|0|||
124778811|NCT05782179|448817945|FG005|Overall Study|Adverse Event|0|||
124778812|NCT03675321|448817946|FG000|Overall Study|Lack of Efficacy|2|||
124592218|NCT03547635|448124474|FG002|Overall Study|Withdrawal by Subject|0|||
124592219|NCT02415387|448124484|FG000|Overall Study|Withdrawal by Subject|6|||
124592220|NCT02415387|448124485|FG001|Overall Study|Withdrawal by Subject|1|||
124592221|NCT02415387|448124484|FG000|Overall Study|blood draw problem|0|||
124592222|NCT02415387|448124485|FG001|Overall Study|blood draw problem|1|||
124592223|NCT02415387|448124484|FG000|Overall Study|Protocol Violation|1|||
124592224|NCT02415387|448124485|FG001|Overall Study|Protocol Violation|0|||
124592225|NCT00676650|448124489|FG000|Overall Study|Death|45|||
124592226|NCT00676650|448124490|FG001|Overall Study|Death|14|||
124592227|NCT00676650|448124489|FG000|Overall Study|Adverse Event|159|||
124592228|NCT00676650|448124490|FG001|Overall Study|Adverse Event|21|||
124592229|NCT00676650|448124489|FG000|Overall Study|Global deterioration of health status|66|||
124592230|NCT00676650|448124490|FG001|Overall Study|Global deterioration of health status|31|||
124592231|NCT00676650|448124489|FG000|Overall Study|Lost to Follow-up|0|||
124592232|NCT00676650|448124490|FG001|Overall Study|Lost to Follow-up|1|||
124592233|NCT00676650|448124489|FG000|Overall Study|Objective progression or relapse|189|||
124592234|NCT00676650|448124490|FG001|Overall Study|Objective progression or relapse|140|||
124592235|NCT00676650|448124489|FG000|Overall Study|Other|14|||
124592236|NCT00676650|448124490|FG001|Overall Study|Other|10|||
124592237|NCT00676650|448124489|FG000|Overall Study|Protocol Violation|3|||
124592238|NCT00676650|448124490|FG001|Overall Study|Protocol Violation|1|||
124592239|NCT00676650|448124489|FG000|Overall Study|Study terminated by sponsor|57|||
124592240|NCT00676650|448124490|FG001|Overall Study|Study terminated by sponsor|43|||
124592241|NCT00676650|448124489|FG000|Overall Study|Withdrawal by Subject|48|||
124592242|NCT00676650|448124490|FG001|Overall Study|Withdrawal by Subject|24|||
124592243|NCT00676650|448124489|FG000|Overall Study|Randomized but not treated|3|||
124592244|NCT00676650|448124490|FG001|Overall Study|Randomized but not treated|4|||
124592245|NCT00683592|448124491|FG000|Overall Study|Adverse Event|12|||
124592246|NCT00683592|448124492|FG001|Overall Study|Adverse Event|4|||
124592247|NCT00683592|448124491|FG000|Overall Study|Withdrawal by Subject|11|||
124592248|NCT00683592|448124492|FG001|Overall Study|Withdrawal by Subject|11|||
124592249|NCT00683592|448124491|FG000|Overall Study|Lost to Follow-up|17|||
124592250|NCT00683592|448124492|FG001|Overall Study|Lost to Follow-up|17|||
124592251|NCT00683592|448124491|FG000|Overall Study|Lack of Efficacy|3|||
124592252|NCT00683592|448124492|FG001|Overall Study|Lack of Efficacy|7|||
124592253|NCT00683592|448124491|FG000|Overall Study|Physician Decision|0|||
124592254|NCT00683592|448124492|FG001|Overall Study|Physician Decision|1|||
124592255|NCT00683592|448124491|FG000|Overall Study|Non-compliance|3|||
124592256|NCT00683592|448124492|FG001|Overall Study|Non-compliance|5|||
124592257|NCT00683592|448124491|FG000|Overall Study|Other|1|||
124592258|NCT00683592|448124492|FG001|Overall Study|Other|1|||
124592259|NCT00685035|448124493|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
124592260|NCT00685035|448124494|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
124592261|NCT03653026|448124495|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
124592262|NCT03653026|448124496|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
124592263|NCT03653026|448124497|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
124592264|NCT03653026|448124498|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
124592265|NCT03653026|448124495|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
124592266|NCT03653026|448124496|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
124592267|NCT03653026|448124497|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
124592268|NCT03653026|448124498|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
124592269|NCT03653026|448124495|FG000|Part 1: Placebo-controlled Period|Other|0|||
124592270|NCT03653026|448124496|FG001|Part 1: Placebo-controlled Period|Other|3|||
124592271|NCT03653026|448124497|FG002|Part 1: Placebo-controlled Period|Other|0|||
124592272|NCT03653026|448124498|FG003|Part 1: Placebo-controlled Period|Other|0|||
124592273|NCT03653026|448124495|FG000|Part 2: Open-label Extension|Adverse Event|0|||
124592274|NCT03653026|448124496|FG001|Part 2: Open-label Extension|Adverse Event|0|||
124592275|NCT03653026|448124497|FG002|Part 2: Open-label Extension|Adverse Event|1|||
124592276|NCT03653026|448124498|FG003|Part 2: Open-label Extension|Adverse Event|1|||
124592277|NCT03653026|448124495|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
124592278|NCT03653026|448124496|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
124592279|NCT03653026|448124497|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
124592280|NCT03653026|448124498|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
124592281|NCT03653026|448124495|FG000|Part 2: Open-label Extension|Other|0|||
124592282|NCT03653026|448124496|FG001|Part 2: Open-label Extension|Other|0|||
124592283|NCT03653026|448124497|FG002|Part 2: Open-label Extension|Other|1|||
124592284|NCT03653026|448124498|FG003|Part 2: Open-label Extension|Other|2|||
124592285|NCT02104817|448124499|FG000|Overall Study|Death|363|||
124592286|NCT02104817|448124500|FG001|Overall Study|Death|330|||
124592287|NCT02104817|448124499|FG000|Overall Study|Lost to Follow-up|3|||
124592288|NCT02104817|448124500|FG001|Overall Study|Lost to Follow-up|2|||
124592289|NCT02104817|448124499|FG000|Overall Study|Protocol Violation|0|||
124592290|NCT02104817|448124500|FG001|Overall Study|Protocol Violation|1|||
124592291|NCT02104817|448124499|FG000|Overall Study|Study terminated by sponsor|5854|||
124592292|NCT02104817|448124500|FG001|Overall Study|Study terminated by sponsor|5901|||
124592293|NCT02104817|448124499|FG000|Overall Study|Withdrawal by Subject|111|||
124592294|NCT02104817|448124500|FG001|Overall Study|Withdrawal by Subject|78|||
124592295|NCT02104817|448124499|FG000|Overall Study|Other reasons|128|||
124592296|NCT02104817|448124500|FG001|Overall Study|Other reasons|135|||
124592297|NCT00611884|448124505|FG000|Overall Study|Adverse Event|1|||
124592298|NCT00611884|448124506|FG001|Overall Study|Adverse Event|0|||
124592299|NCT00611884|448124507|FG002|Overall Study|Adverse Event|0|||
124592300|NCT00611884|448124508|FG003|Overall Study|Adverse Event|1|||
124592301|NCT00611884|448124505|FG000|Overall Study|Non-Compliance|1|||
124592302|NCT00611884|448124506|FG001|Overall Study|Non-Compliance|4|||
124592303|NCT00611884|448124507|FG002|Overall Study|Non-Compliance|2|||
124592304|NCT00611884|448124508|FG003|Overall Study|Non-Compliance|2|||
124592305|NCT00611884|448124505|FG000|Overall Study|Lack of Efficacy|0|||
124592306|NCT00611884|448124506|FG001|Overall Study|Lack of Efficacy|1|||
124592307|NCT00611884|448124507|FG002|Overall Study|Lack of Efficacy|0|||
124592308|NCT00611884|448124508|FG003|Overall Study|Lack of Efficacy|0|||
124592309|NCT00611884|448124505|FG000|Overall Study|Unclassified|7|||
124592310|NCT00611884|448124506|FG001|Overall Study|Unclassified|4|||
124592311|NCT00611884|448124507|FG002|Overall Study|Unclassified|2|||
124592312|NCT00611884|448124508|FG003|Overall Study|Unclassified|3|||
124592313|NCT00981799|448124509|FG000|Overall Study|Adverse Event|1|||
124592314|NCT00981799|448124510|FG001|Overall Study|Adverse Event|1|||
124592315|NCT00981799|448124511|FG002|Overall Study|Adverse Event|0|||
124592316|NCT00981799|448124512|FG003|Overall Study|Adverse Event|0|||
124592317|NCT01201759|448124513|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
124592318|NCT01201759|448124514|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
124592319|NCT01201759|448124513|FG000|Visit 3 - Washout|Adverse Event|0|||
124592320|NCT01201759|448124514|FG001|Visit 3 - Washout|Adverse Event|3|||
124592321|NCT01201759|448124513|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
124592322|NCT01201759|448124514|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
124592323|NCT01201759|448124513|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
124592324|NCT01201759|448124514|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
124592325|NCT00687739|448124515|FG000|Overall Study|Lost to Follow-up|2|||
124592326|NCT00687739|448124516|FG001|Overall Study|Lost to Follow-up|2|||
124592327|NCT00687739|448124517|FG002|Overall Study|Lost to Follow-up|1|||
124592328|NCT00687739|448124518|FG003|Overall Study|Lost to Follow-up|2|||
124592329|NCT00687739|448124515|FG000|Overall Study|Adverse Event|0|||
124592330|NCT00687739|448124516|FG001|Overall Study|Adverse Event|1|||
124592331|NCT00687739|448124517|FG002|Overall Study|Adverse Event|1|||
124592332|NCT00687739|448124518|FG003|Overall Study|Adverse Event|0|||
124592333|NCT02005276|448124525|FG000|Overall Study|No longer interested|5|||
124592334|NCT02005276|448124526|FG001|Overall Study|No longer interested|2|||
124592335|NCT02005276|448124527|FG002|Overall Study|No longer interested|3|||
124592336|NCT02005276|448124528|FG003|Overall Study|No longer interested|3|||
124592337|NCT01963260|448124529|FG000|Overall Study|Withdrawal by Subject|2|||
124592338|NCT01963260|448124530|FG001|Overall Study|Withdrawal by Subject|0|||
124592339|NCT01963260|448124531|FG002|Overall Study|Withdrawal by Subject|0|||
124592340|NCT01963260|448124532|FG003|Overall Study|Withdrawal by Subject|1|||
124592341|NCT01963260|448124533|FG004|Overall Study|Withdrawal by Subject|2|||
124592342|NCT01963260|448124534|FG005|Overall Study|Withdrawal by Subject|0|||
124592343|NCT01963260|448124535|FG006|Overall Study|Withdrawal by Subject|0|||
124592344|NCT01963260|448124536|FG007|Overall Study|Withdrawal by Subject|0|||
124592345|NCT01963260|448124537|FG008|Overall Study|Withdrawal by Subject|0|||
124592346|NCT01963260|448124538|FG009|Overall Study|Withdrawal by Subject|0|||
124592347|NCT04994431|448124539|FG000|Overall Study|Adverse Event|1|||
124592348|NCT04994431|448124540|FG001|Overall Study|Adverse Event|0|||
124592349|NCT01067521|448124543|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
124592350|NCT01067521|448124544|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
124592351|NCT01067521|448124543|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
124592352|NCT01067521|448124544|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
124592353|NCT01067521|448124543|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
124592354|NCT01067521|448124544|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
124592355|NCT01067521|448124543|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
124592356|NCT01067521|448124544|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
124592357|NCT01067521|448124543|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
124592358|NCT01067521|448124544|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
124592359|NCT01067521|448124543|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
124592360|NCT01067521|448124544|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
124592361|NCT01067521|448124543|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
124592362|NCT01067521|448124544|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
124592363|NCT01067521|448124543|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
124592364|NCT01067521|448124544|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
124592365|NCT01067521|448124543|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
124592366|NCT01067521|448124544|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
124592367|NCT01067521|448124543|FG000|Open-Label Period|Death|3|||
124592368|NCT01067521|448124544|FG001|Open-Label Period|Death|1|||
124592369|NCT01067521|448124543|FG000|Open-Label Period|Adverse Event|30|||
124592370|NCT01067521|448124544|FG001|Open-Label Period|Adverse Event|28|||
124592371|NCT01067521|448124543|FG000|Open-Label Period|Withdrawal by Subject|160|||
124592372|NCT01067521|448124544|FG001|Open-Label Period|Withdrawal by Subject|88|||
124592373|NCT01067521|448124543|FG000|Open-Label Period|Physician Decision|13|||
124592374|NCT01067521|448124544|FG001|Open-Label Period|Physician Decision|11|||
124592375|NCT01067521|448124543|FG000|Open-Label Period|Non-compliance with study drug|5|||
124592376|NCT01067521|448124544|FG001|Open-Label Period|Non-compliance with study drug|0|||
124592377|NCT01067521|448124543|FG000|Open-Label Period|Protocol Violation|3|||
124592378|NCT01067521|448124544|FG001|Open-Label Period|Protocol Violation|0|||
124592379|NCT01067521|448124543|FG000|Open-Label Period|Pregnancy|14|||
124592380|NCT01067521|448124544|FG001|Open-Label Period|Pregnancy|8|||
124592381|NCT01067521|448124543|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
124592382|NCT01067521|448124544|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
124778813|NCT03675321|448817947|FG001|Overall Study|Lack of Efficacy|2|||
124778814|NCT03675321|448817946|FG000|Overall Study|Withdrawal by Subject|1|||
124778815|NCT03675321|448817947|FG001|Overall Study|Withdrawal by Subject|3|||
124778816|NCT02999672|448817953|FG000|Overall Study|Death|0|||
124778817|NCT02999672|448817954|FG001|Overall Study|Death|1|||
124778818|NCT02999672|448817953|FG000|Overall Study|Study Terminated by Sponsor|0|||
124778819|NCT02999672|448817954|FG001|Overall Study|Study Terminated by Sponsor|1|||
124778820|NCT02999672|448817953|FG000|Overall Study|Progressive Disease|9|||
124778821|NCT02999672|448817954|FG001|Overall Study|Progressive Disease|5|||
124778822|NCT02999672|448817953|FG000|Overall Study|Adverse Event|4|||
124778823|NCT02999672|448817954|FG001|Overall Study|Adverse Event|0|||
124778824|NCT03565497|448817955|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
124778825|NCT03565497|448817956|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
124778826|NCT03565497|448817957|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
124778827|NCT03565497|448817955|FG000|Overall Study|Lost to Follow-up|1|||
124778828|NCT03565497|448817956|FG001|Overall Study|Lost to Follow-up|1|||
124778829|NCT03565497|448817957|FG002|Overall Study|Lost to Follow-up|2|||
124778830|NCT03565497|448817955|FG000|Overall Study|Withdrawal by Subject|1|||
124778831|NCT03565497|448817956|FG001|Overall Study|Withdrawal by Subject|1|||
124778832|NCT03565497|448817957|FG002|Overall Study|Withdrawal by Subject|1|||
124778833|NCT02194985|448817960|FG000|Overall Study|Adverse Event|1|||
124778834|NCT02194985|448817960|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
124778835|NCT02194985|448817960|FG000|Overall Study|Physician Decision|4|||
124778836|NCT02194985|448817960|FG000|Overall Study|Lost to Follow-up|1|||
124778837|NCT02194985|448817960|FG000|Overall Study|Withdrawal by Subject|2|||
124778838|NCT02561832|448817961|FG000|Overall Study|Withdrawal by Subject|1|||
124778839|NCT02561832|448817962|FG001|Overall Study|Withdrawal by Subject|1|||
124778840|NCT02561832|448817961|FG000|Overall Study|Adverse Event|3|||
124778841|NCT02561832|448817962|FG001|Overall Study|Adverse Event|0|||
124778842|NCT02561832|448817961|FG000|Overall Study|Disease progression|3|||
124778843|NCT02561832|448817962|FG001|Overall Study|Disease progression|3|||
124778844|NCT03048578|448817964|FG000|Overall Study|Withdrawal by Subject|5|||
124778845|NCT03048578|448817965|FG001|Overall Study|Withdrawal by Subject|6|||
124778846|NCT03048578|448817964|FG000|Overall Study|Lost to Follow-up|22|||
124778847|NCT03048578|448817965|FG001|Overall Study|Lost to Follow-up|10|||
124778848|NCT03048578|448817964|FG000|Overall Study|Adverse Event|1|||
124778849|NCT03048578|448817965|FG001|Overall Study|Adverse Event|2|||
124778850|NCT03048578|448817964|FG000|Overall Study|Terminated|3|||
124778851|NCT03048578|448817965|FG001|Overall Study|Terminated|2|||
124778852|NCT00996333|448817970|FG000|Overall Study|Screen failure|1|||
124778853|NCT00996333|448817970|FG000|Overall Study|Withdrawal by Subject|1|||
124778854|NCT00996333|448817970|FG000|Overall Study|Death|4|||
124778855|NCT00996333|448817970|FG000|Overall Study|Adverse Event|1|||
124778856|NCT00996333|448817970|FG000|Overall Study|Physician Decision|1|||
124778857|NCT00996333|448817970|FG000|Overall Study|Other|5|||
124778858|NCT01301027|448817972|FG000|Overall Study|Physician Decision|2|||
124778859|NCT01301027|448817973|FG001|Overall Study|Physician Decision|0|||
124778860|NCT01301027|448817972|FG000|Overall Study|Withdrawal by Subject|2|||
124778861|NCT01301027|448817973|FG001|Overall Study|Withdrawal by Subject|3|||
124778862|NCT01301027|448817972|FG000|Overall Study|Adverse Event|0|||
124778863|NCT01301027|448817973|FG001|Overall Study|Adverse Event|2|||
124778864|NCT01301027|448817972|FG000|Overall Study|Fracture|1|||
124778865|NCT01301027|448817973|FG001|Overall Study|Fracture|3|||
124778866|NCT01301027|448817972|FG000|Overall Study|Transplant|0|||
124778867|NCT01301027|448817973|FG001|Overall Study|Transplant|2|||
124778868|NCT01301027|448817972|FG000|Overall Study|Volume Overload|3|||
124778869|NCT01301027|448817973|FG001|Overall Study|Volume Overload|0|||
124778870|NCT00074490|448817974|FG000|Overall Study|Progressive malignancy|0|||
124778871|NCT00074490|448817975|FG001|Overall Study|Progressive malignancy|7|||
124778872|NCT00074490|448817976|FG002|Overall Study|Progressive malignancy|0|||
124778873|NCT00074490|448817977|FG003|Overall Study|Progressive malignancy|0|||
124778874|NCT00074490|448817978|FG004|Overall Study|Progressive malignancy|3|||
124778875|NCT00074490|448817979|FG005|Overall Study|Progressive malignancy|0|||
124778876|NCT02722499|448817980|FG000|Overall Study|Lost to Follow-up|2|||
124778877|NCT02722499|448817981|FG001|Overall Study|Lost to Follow-up|0|||
124778878|NCT02722499|448817982|FG002|Overall Study|Lost to Follow-up|1|||
124778879|NCT03566485|448817984|FG000|Overall Study|Disease progression|5|||
124778880|NCT03566485|448817985|FG001|Overall Study|Disease progression|4|||
124778881|NCT03566485|448817984|FG000|Overall Study|Clinical progression|0|||
124778882|NCT03566485|448817985|FG001|Overall Study|Clinical progression|1|||
124778883|NCT03566485|448817984|FG000|Overall Study|Toxicity|0|||
124778884|NCT03566485|448817985|FG001|Overall Study|Toxicity|2|||
124778885|NCT04999852|448817986|FG000|Overall Study|Withdrawal by Subject|11|||
124778886|NCT04999852|448817987|FG001|Overall Study|Withdrawal by Subject|1|||
124778887|NCT04999852|448817986|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
124778888|NCT04999852|448817987|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
124778889|NCT02506244|448817988|FG000|Overall Study|Did not undergo active monitoring|458|||
124778890|NCT02506244|448817989|FG001|Overall Study|Did not undergo active monitoring|459|||
124778891|NCT02506244|448817990|FG002|Overall Study|Did not undergo active monitoring|0|||
124592383|NCT01067521|448124543|FG000|Open-Label Period|Lost to Follow-up|21|||
124592384|NCT01067521|448124544|FG001|Open-Label Period|Lost to Follow-up|20|||
124592385|NCT03419962|448124545|FG000|Overall Study|Change to other medication|1|||
124592386|NCT03419962|448124545|FG000|Overall Study|Refusal of continuing with trial drug|1|||
124592387|NCT03419962|448124545|FG000|Overall Study|Lost to Follow-up|3|||
124592388|NCT03419962|448124545|FG000|Overall Study|Difficulty in inhaling the doses|1|||
124592389|NCT03419962|448124545|FG000|Overall Study|Missing completion data|31|||
124592390|NCT02914457|448124548|FG000|Overall Study|Withdrawal by Subject|1|||
124592391|NCT02914457|448124548|FG000|Overall Study|Physician Decision|1|||
124592392|NCT02914457|448124548|FG000|Overall Study|No veins available for lead placement|1|||
124592393|NCT02914457|448124548|FG000|Overall Study|Electrical instability of patient|1|||
124592394|NCT02914457|448124548|FG000|Overall Study|ECG acquisition error due to sweating|1|||
124592395|NCT02914457|448124548|FG000|Overall Study|Protocol Violation|1|||
124592396|NCT01098539|448124551|FG000|Overall Study|Adverse Event|26|||
124592397|NCT01098539|448124552|FG001|Overall Study|Adverse Event|26|||
124592398|NCT01098539|448124551|FG000|Overall Study|Protocol Violation|1|||
124592399|NCT01098539|448124552|FG001|Overall Study|Protocol Violation|4|||
124592400|NCT01098539|448124551|FG000|Overall Study|Noncompliance|3|||
124592401|NCT01098539|448124552|FG001|Overall Study|Noncompliance|5|||
124592402|NCT01098539|448124551|FG000|Overall Study|Lost to Follow-up|4|||
124592403|NCT01098539|448124552|FG001|Overall Study|Lost to Follow-up|4|||
124592404|NCT01098539|448124551|FG000|Overall Study|Withdrawal by Subject|12|||
124592405|NCT01098539|448124552|FG001|Overall Study|Withdrawal by Subject|26|||
124592406|NCT01098539|448124551|FG000|Overall Study|Physician Decision|5|||
124592407|NCT01098539|448124552|FG001|Overall Study|Physician Decision|3|||
124592408|NCT01849458|448124553|FG000|Overall Study|Lost to Follow-up|4|||
124592409|NCT01781234|448124554|FG000|Overall Study|Adverse Event|2|||
124592410|NCT01781234|448124555|FG001|Overall Study|Adverse Event|0|||
124592411|NCT01781234|448124554|FG000|Overall Study|Protocol Violation|3|||
124592412|NCT01781234|448124555|FG001|Overall Study|Protocol Violation|0|||
124592413|NCT01781234|448124554|FG000|Overall Study|Withdrawal by Subject|4|||
124592414|NCT01781234|448124555|FG001|Overall Study|Withdrawal by Subject|3|||
124592415|NCT03439085|448124556|FG000|Overall Study|Death|2|||
124592416|NCT03439085|448124556|FG000|Overall Study|Screen Failure|20|||
124592417|NCT01863433|448124557|FG000|Overall Study|Protocol Violation|1|||
124592418|NCT02174276|448124558|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
124592419|NCT02174276|448124559|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
124592420|NCT02174276|448124560|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
124592421|NCT02174276|448124561|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
124592422|NCT02174276|448124558|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
124592423|NCT02174276|448124559|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
124592424|NCT02174276|448124560|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
124592425|NCT02174276|448124561|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
124592426|NCT02174276|448124558|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
124592427|NCT02174276|448124559|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
124592428|NCT02174276|448124560|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
124592429|NCT02174276|448124561|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
124592430|NCT02174276|448124558|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
124592431|NCT02174276|448124559|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
124592432|NCT02174276|448124560|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
124592433|NCT02174276|448124561|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
124592434|NCT02174276|448124558|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
124730072|NCT03176472|448633981|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
124730073|NCT03176472|448633980|FG000|Double Blind Treatment Period|Adverse Event|0|||
124730074|NCT03176472|448633981|FG001|Double Blind Treatment Period|Adverse Event|5|||
124730075|NCT03176472|448633980|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
124730076|NCT03176472|448633981|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
124730077|NCT03176472|448633980|FG000|Double Blind Treatment Period|Physician Decision|0|||
124730078|NCT03176472|448633981|FG001|Double Blind Treatment Period|Physician Decision|1|||
124730079|NCT03176472|448633980|FG000|Double Blind Treatment Period|Protocol Violation|1|||
124730080|NCT03176472|448633981|FG001|Double Blind Treatment Period|Protocol Violation|0|||
124730081|NCT03176472|448633980|FG000|Double Blind Treatment Period|Not Provided|1|||
124730082|NCT03176472|448633981|FG001|Double Blind Treatment Period|Not Provided|0|||
124778892|NCT02840461|448817999|FG000|Overall Study|Adverse Event|1|||
124592435|NCT02174276|448124559|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
124592436|NCT02174276|448124560|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
124592437|NCT02174276|448124561|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
124592438|NCT02174276|448124558|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
124592439|NCT02174276|448124559|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
124592440|NCT02174276|448124560|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
124592441|NCT02174276|448124561|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
124730083|NCT03176472|448633980|FG000|Open Label Extension|Withdrawal by Subject|3|||
124778893|NCT02840461|448818000|FG001|Overall Study|Adverse Event|5|||
124778894|NCT02840461|448818001|FG002|Overall Study|Adverse Event|3|||
124778895|NCT02840461|448817999|FG000|Overall Study|Lost to Follow-up|10|||
124778896|NCT02840461|448818000|FG001|Overall Study|Lost to Follow-up|7|||
124778897|NCT02840461|448818001|FG002|Overall Study|Lost to Follow-up|6|||
124778898|NCT02840461|448817999|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
124778899|NCT02840461|448818000|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
124778900|NCT02840461|448818001|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
124778901|NCT02840461|448817999|FG000|Overall Study|Protocol Violation|2|||
124778902|NCT02840461|448818000|FG001|Overall Study|Protocol Violation|3|||
124778903|NCT02840461|448818001|FG002|Overall Study|Protocol Violation|1|||
124778904|NCT02840461|448817999|FG000|Overall Study|Withdrawal by Subject|10|||
124778905|NCT02840461|448818000|FG001|Overall Study|Withdrawal by Subject|6|||
124778906|NCT02840461|448818001|FG002|Overall Study|Withdrawal by Subject|2|||
124778907|NCT02840461|448817999|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
124778908|NCT02840461|448818000|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
124778909|NCT02840461|448818001|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
124778910|NCT01737502|448818002|FG000|Phase I|Disease progression|2|||
124778911|NCT01737502|448818003|FG001|Phase I|Disease progression|3|||
124778912|NCT01737502|448818002|FG000|Phase I|Complicating disease|1|||
124778913|NCT01737502|448818003|FG001|Phase I|Complicating disease|0|||
124778914|NCT01737502|448818002|FG000|Phase II|Adverse Event|0|||
124778915|NCT01737502|448818003|FG001|Phase II|Adverse Event|3|||
124778916|NCT01737502|448818002|FG000|Phase II|Disease progression|0|||
124778917|NCT01737502|448818003|FG001|Phase II|Disease progression|18|||
124778918|NCT01737502|448818002|FG000|Phase II|Death|0|||
124778919|NCT01737502|448818003|FG001|Phase II|Death|1|||
124778920|NCT01737502|448818002|FG000|Phase II|Transition to hospice care|0|||
124778921|NCT01737502|448818003|FG001|Phase II|Transition to hospice care|1|||
124778922|NCT04672655|448818007|FG000|Overall Study|Lost to Follow-up|12|||
124778923|NCT04672655|448818008|FG001|Overall Study|Lost to Follow-up|17|||
124778924|NCT04672655|448818007|FG000|Overall Study|Withdrawal by Subject|1|||
124778925|NCT04672655|448818008|FG001|Overall Study|Withdrawal by Subject|0|||
124592442|NCT01206439|448124562|FG000|Overall Study|subject did not meet inclusion criteria|1|||
124730084|NCT03176472|448633981|FG001|Open Label Extension|Withdrawal by Subject|4|||
124730085|NCT03176472|448633980|FG000|Open Label Extension|Adverse Event|2|||
124730086|NCT03176472|448633981|FG001|Open Label Extension|Adverse Event|4|||
124730087|NCT03176472|448633980|FG000|Open Label Extension|Lost to Follow-up|1|||
124730088|NCT03176472|448633981|FG001|Open Label Extension|Lost to Follow-up|2|||
124730089|NCT03176472|448633980|FG000|Open Label Extension|Protocol Violation|0|||
124730090|NCT03176472|448633981|FG001|Open Label Extension|Protocol Violation|1|||
124730091|NCT03176472|448633980|FG000|Open Label Extension|Not Provided|2|||
124730092|NCT03176472|448633981|FG001|Open Label Extension|Not Provided|1|||
124730093|NCT00596154|448633982|FG000|Overall Study|Not Evaluable|2|||
124730094|NCT00642369|448633984|FG000|Overall Study|Adverse Event|2|||
124730095|NCT00642369|448633985|FG001|Overall Study|Adverse Event|3|||
124730096|NCT00642369|448633984|FG000|Overall Study|Withdrawal by Subject|1|||
124730097|NCT00642369|448633985|FG001|Overall Study|Withdrawal by Subject|0|||
124730098|NCT00642369|448633984|FG000|Overall Study|misdiagnosis|0|||
124730099|NCT00642369|448633985|FG001|Overall Study|misdiagnosis|1|||
124730100|NCT00642369|448633984|FG000|Overall Study|Lack of Efficacy|2|||
124730101|NCT00642369|448633985|FG001|Overall Study|Lack of Efficacy|2|||
124730102|NCT00585546|448633992|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
124730103|NCT00585546|448633992|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
124730104|NCT03077438|448633993|FG000|Overall Study|Protocol Violation|3|||
124730105|NCT03077438|448633994|FG001|Overall Study|Protocol Violation|5|||
124730106|NCT03077438|448633993|FG000|Overall Study|Withdrawal by Subject|3|||
124730107|NCT03077438|448633994|FG001|Overall Study|Withdrawal by Subject|6|||
124730108|NCT03077438|448633993|FG000|Overall Study|Lost to Follow-up|6|||
124730109|NCT03077438|448633994|FG001|Overall Study|Lost to Follow-up|3|||
124730110|NCT01190475|448633999|FG000|Overall Study|Withdrawal by Subject|0|||
124730111|NCT01190475|448634000|FG001|Overall Study|Withdrawal by Subject|0|||
124730112|NCT01190475|448634001|FG002|Overall Study|Withdrawal by Subject|1|||
124730113|NCT01535599|448634004|FG000|Overall Study|Adverse Event|6|||
124730114|NCT01535599|448634005|FG001|Overall Study|Adverse Event|15|||
124730115|NCT01535599|448634004|FG000|Overall Study|Lost to Follow-up|3|||
124730116|NCT01535599|448634005|FG001|Overall Study|Lost to Follow-up|4|||
124730117|NCT01535599|448634004|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
124730118|NCT01535599|448634005|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
124730119|NCT01535599|448634004|FG000|Overall Study|Treatment Failure|33|||
124730120|NCT01535599|448634005|FG001|Overall Study|Treatment Failure|66|||
124730121|NCT01535599|448634004|FG000|Overall Study|BL Culture + for Group A Strep|0|||
124730122|NCT01535599|448634005|FG001|Overall Study|BL Culture + for Group A Strep|1|||
124730123|NCT01535599|448634004|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
124730124|NCT01535599|448634005|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
124730125|NCT01535599|448634004|FG000|Overall Study|Randomized in Error|2|||
124730126|NCT01535599|448634005|FG001|Overall Study|Randomized in Error|4|||
124730127|NCT01535599|448634004|FG000|Overall Study|Did not use product|1|||
124778926|NCT04672655|448818007|FG000|Overall Study|Withdrawal by Study|1|||
124778927|NCT04672655|448818008|FG001|Overall Study|Withdrawal by Study|0|||
124778928|NCT00494676|448818009|FG000|Allocation|Withdrawal by Subject|2|||
124778929|NCT00494676|448818010|FG001|Allocation|Withdrawal by Subject|4|||
124778930|NCT00494676|448818009|FG000|First Intervention|Withdrawal by Subject|1|||
124778931|NCT00494676|448818010|FG001|First Intervention|Withdrawal by Subject|3|||
124778932|NCT00494676|448818009|FG000|Second Intervention|Withdrawal by Subject|1|||
124778933|NCT00494676|448818010|FG001|Second Intervention|Withdrawal by Subject|1|||
124778934|NCT01932437|448819428|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
124778935|NCT01932437|448819429|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
124778936|NCT01932437|448819430|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
124778937|NCT01932437|448819431|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
124778938|NCT01932437|448819432|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
124778939|NCT01932437|448819433|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
124778940|NCT04638660|448819443|FG000|Overall Study|Withdrawal by Subject|2|||
124778941|NCT04638660|448819444|FG001|Overall Study|Withdrawal by Subject|0|||
124778942|NCT04638660|448819443|FG000|Overall Study|Lost to Follow-up|1|||
124778943|NCT04638660|448819444|FG001|Overall Study|Lost to Follow-up|0|||
124778944|NCT04939415|448819445|FG000|Overall Study|Withdrawal by Subject|1|||
124778945|NCT04939415|448819446|FG001|Overall Study|Withdrawal by Subject|3|||
124778946|NCT04939415|448819445|FG000|Overall Study|Lost to Follow-up|0|||
124778947|NCT04939415|448819446|FG001|Overall Study|Lost to Follow-up|2|||
124778948|NCT03399552|448819448|FG000|Overall Study|No evidence of disease|1|||
124778949|NCT03399552|448819448|FG000|Overall Study|Unevaluable|1|||
124778950|NCT01931566|448819449|FG000|Overall Study|Randomized But Not Treated|6|||
124778951|NCT01931566|448819450|FG001|Overall Study|Randomized But Not Treated|9|||
124778952|NCT01931566|448819451|FG002|Overall Study|Randomized But Not Treated|14|||
124778953|NCT01931566|448819449|FG000|Overall Study|Adverse Event|37|||
124778954|NCT01931566|448819450|FG001|Overall Study|Adverse Event|167|||
124778955|NCT01931566|448819451|FG002|Overall Study|Adverse Event|132|||
124778956|NCT01931566|448819449|FG000|Overall Study|Major Protocol Deviation|5|||
124778957|NCT01931566|448819450|FG001|Overall Study|Major Protocol Deviation|14|||
124778958|NCT01931566|448819451|FG002|Overall Study|Major Protocol Deviation|21|||
124778959|NCT01931566|448819449|FG000|Overall Study|Lost to Follow-up|3|||
124778960|NCT01931566|448819450|FG001|Overall Study|Lost to Follow-up|26|||
124778961|NCT01931566|448819451|FG002|Overall Study|Lost to Follow-up|23|||
124778962|NCT01931566|448819449|FG000|Overall Study|Voluntary Withdrawal|78|||
124778963|NCT01931566|448819450|FG001|Overall Study|Voluntary Withdrawal|245|||
124778964|NCT01931566|448819451|FG002|Overall Study|Voluntary Withdrawal|225|||
124778965|NCT01931566|448819449|FG000|Overall Study|Study Termination|289|||
124778966|NCT01931566|448819450|FG001|Overall Study|Study Termination|968|||
124778967|NCT01931566|448819451|FG002|Overall Study|Study Termination|1037|||
124778968|NCT01931566|448819449|FG000|Overall Study|Reason Not Specified|11|||
124778969|NCT01931566|448819450|FG001|Overall Study|Reason Not Specified|47|||
124778970|NCT01931566|448819451|FG002|Overall Study|Reason Not Specified|53|||
124778971|NCT01931566|448819449|FG000|Overall Study|Missing|0|||
124778972|NCT01931566|448819450|FG001|Overall Study|Missing|0|||
124778973|NCT01931566|448819451|FG002|Overall Study|Missing|1|||
124778974|NCT00611026|448819455|FG000|Randomized to Double-blind Treatment|Not treated|2|||
124778975|NCT00611026|448819456|FG001|Randomized to Double-blind Treatment|Not treated|1|||
124778976|NCT00611026|448819457|FG002|Randomized to Double-blind Treatment|Not treated|3|||
124778977|NCT00611026|448819455|FG000|Double-blind Treatment Period|Death|1|||
124778978|NCT00611026|448819456|FG001|Double-blind Treatment Period|Death|0|||
124778979|NCT00611026|448819457|FG002|Double-blind Treatment Period|Death|0|||
124778980|NCT00611026|448819455|FG000|Double-blind Treatment Period|Adverse Event|9|||
124778981|NCT00611026|448819456|FG001|Double-blind Treatment Period|Adverse Event|28|||
124778982|NCT00611026|448819457|FG002|Double-blind Treatment Period|Adverse Event|46|||
124778983|NCT00611026|448819455|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
124778984|NCT00611026|448819456|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
124778985|NCT00611026|448819457|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
124778986|NCT00611026|448819455|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
124778987|NCT00611026|448819456|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
124778988|NCT00611026|448819457|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
124778989|NCT00611026|448819455|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
124778990|NCT00611026|448819456|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
124778991|NCT00611026|448819457|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
124778992|NCT00611026|448819455|FG000|Double-blind Treatment Period|Other|13|||
124778993|NCT00611026|448819456|FG001|Double-blind Treatment Period|Other|20|||
124778994|NCT00611026|448819457|FG002|Double-blind Treatment Period|Other|18|||
124778995|NCT05019521|448819458|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
124778996|NCT05019521|448819459|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
124778997|NCT05019521|448819460|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
124778998|NCT05019521|448819461|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
124778999|NCT05019521|448819462|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
124592443|NCT00515216|448124565|FG000|Overall Study|Withdrawal by Subject|1|||
124592444|NCT02786927|448124566|FG000|Overall Study|Adverse Event|1|||
124592445|NCT02786927|448124566|FG000|Overall Study|Protocol Violation|4|||
124592446|NCT01801917|448124567|FG000|Period 1 - Randomized|Adverse Event|1|||
124592447|NCT01801917|448124568|FG001|Period 1 - Randomized|Adverse Event|0|||
124592448|NCT01801917|448124569|FG002|Period 1 - Randomized|Adverse Event|1|||
124592449|NCT01801917|448124570|FG003|Period 1 - Randomized|Adverse Event|0|||
124592450|NCT04307849|448124571|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
124592451|NCT04307849|448124572|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
124592452|NCT04307849|448124573|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
124592453|NCT04307849|448124574|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
124592454|NCT04307849|448124575|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
124592455|NCT04307849|448124576|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
124592456|NCT04307849|448124571|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
124592457|NCT04307849|448124572|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
124592458|NCT04307849|448124573|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
124592459|NCT04307849|448124574|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
124592460|NCT04307849|448124575|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
124592461|NCT04307849|448124576|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
124592462|NCT04307849|448124571|FG000|Overall Study|Family member did not want them to continue|0|||
124592463|NCT04307849|448124572|FG001|Overall Study|Family member did not want them to continue|0|||
124592464|NCT04307849|448124573|FG002|Overall Study|Family member did not want them to continue|1|||
124592465|NCT04307849|448124574|FG003|Overall Study|Family member did not want them to continue|0|||
124592466|NCT04307849|448124575|FG004|Overall Study|Family member did not want them to continue|0|||
124592467|NCT04307849|448124576|FG005|Overall Study|Family member did not want them to continue|0|||
124592468|NCT04307849|448124571|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
124592469|NCT04307849|448124572|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
124592470|NCT04307849|448124573|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
124592471|NCT04307849|448124574|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
124592472|NCT04307849|448124575|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
124592473|NCT04307849|448124576|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
124592474|NCT05467982|448124577|FG000|Overall Study|Death|0|||
124592475|NCT05467982|448124578|FG001|Overall Study|Death|1|||
124592476|NCT05467982|448124577|FG000|Overall Study|Lost to Follow-up|3|||
124592477|NCT05467982|448124578|FG001|Overall Study|Lost to Follow-up|1|||
124592478|NCT00708682|448124593|FG000|Infant Series|Adverse Event|1|||
124592479|NCT00708682|448124593|FG000|Infant Series|Lost to Follow-up|4|||
124592480|NCT00708682|448124593|FG000|Infant Series|Protocol Violation|1|||
124592481|NCT00708682|448124593|FG000|Infant Series|Parent/legal guardian request|6|||
124592482|NCT00708682|448124593|FG000|Infant Series|Failed to return|2|||
124592483|NCT00708682|448124593|FG000|Infant Series|Other|19|||
124592484|NCT00708682|448124593|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
124592485|NCT00708682|448124593|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
124592486|NCT00708682|448124593|FG000|Toddler Dose|Lost to Follow-up|3|||
124592487|NCT00708682|448124593|FG000|Toddler Dose|Failed to Return|4|||
124592488|NCT03185741|448124598|FG000|Baseline|Withdrawal by Subject|1|||
124592489|NCT03185741|448124599|FG001|Baseline|Withdrawal by Subject|3|||
124592490|NCT03185741|448124600|FG002|Baseline|Withdrawal by Subject|2|||
124592491|NCT03185741|448124598|FG000|Baseline|Lost to Follow-up|1|||
124592492|NCT03185741|448124599|FG001|Baseline|Lost to Follow-up|2|||
124592493|NCT03185741|448124600|FG002|Baseline|Lost to Follow-up|3|||
124592494|NCT03185741|448124598|FG000|3Month|Death|1|||
124592495|NCT03185741|448124599|FG001|3Month|Death|1|||
124592496|NCT03185741|448124600|FG002|3Month|Death|2|||
124592497|NCT03185741|448124598|FG000|3Month|Withdrawal by Subject|1|||
124592498|NCT03185741|448124599|FG001|3Month|Withdrawal by Subject|5|||
124592499|NCT03185741|448124600|FG002|3Month|Withdrawal by Subject|1|||
124592500|NCT03185741|448124598|FG000|3Month|Lost to Follow-up|7|||
124592501|NCT03185741|448124599|FG001|3Month|Lost to Follow-up|9|||
124592502|NCT03185741|448124600|FG002|3Month|Lost to Follow-up|8|||
124779000|NCT05019521|448819463|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
124779001|NCT05019521|448819464|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
124592503|NCT03185741|448124598|FG000|3Month|Unavailable for 3Month|11|||
124592504|NCT03185741|448124599|FG001|3Month|Unavailable for 3Month|10|||
124592505|NCT03185741|448124600|FG002|3Month|Unavailable for 3Month|11|||
124592506|NCT03185741|448124598|FG000|3Month|Protocol Violation|0|||
124592507|NCT03185741|448124599|FG001|3Month|Protocol Violation|0|||
124592508|NCT03185741|448124600|FG002|3Month|Protocol Violation|3|||
124592509|NCT03185741|448124598|FG000|6Month|Death|1|||
124592510|NCT03185741|448124599|FG001|6Month|Death|1|||
124592511|NCT03185741|448124600|FG002|6Month|Death|2|||
124592512|NCT03185741|448124598|FG000|6Month|Withdrawal by Subject|2|||
124592513|NCT03185741|448124599|FG001|6Month|Withdrawal by Subject|3|||
124592514|NCT03185741|448124600|FG002|6Month|Withdrawal by Subject|1|||
124592515|NCT03185741|448124598|FG000|6Month|Lost to Follow-up|16|||
124592516|NCT03185741|448124599|FG001|6Month|Lost to Follow-up|15|||
124592517|NCT03185741|448124600|FG002|6Month|Lost to Follow-up|16|||
124592518|NCT01634854|448124601|FG000|Overall Study|Cesarean delivery|2|||
124592519|NCT01634854|448124602|FG001|Overall Study|Cesarean delivery|7|||
124592520|NCT01337596|448124603|FG000|Overall Study|Withdrawal by Subject|0|||
124592521|NCT01337596|448124604|FG001|Overall Study|Withdrawal by Subject|0|||
124592522|NCT01337596|448124605|FG002|Overall Study|Withdrawal by Subject|0|||
124592523|NCT01337596|448124606|FG003|Overall Study|Withdrawal by Subject|0|||
124592524|NCT01337596|448124607|FG004|Overall Study|Withdrawal by Subject|2|||
124592525|NCT01337596|448124608|FG005|Overall Study|Withdrawal by Subject|0|||
124592526|NCT01337596|448124609|FG006|Overall Study|Withdrawal by Subject|0|||
124592527|NCT01337596|448124610|FG007|Overall Study|Withdrawal by Subject|0|||
124592528|NCT01337596|448124611|FG008|Overall Study|Withdrawal by Subject|0|||
124592529|NCT00108628|448125920|FG000|Overall Study|Withdrawal by Subject|17|||
124592530|NCT00108628|448125921|FG001|Overall Study|Withdrawal by Subject|9|||
124592531|NCT00108628|448125920|FG000|Overall Study|Lack of Efficacy|2|||
124592532|NCT00108628|448125921|FG001|Overall Study|Lack of Efficacy|1|||
124592533|NCT00108628|448125920|FG000|Overall Study|Death|1|||
124592534|NCT00108628|448125921|FG001|Overall Study|Death|0|||
124592535|NCT01636934|448125922|FG000|Overall Study|Withdrawal by Subject|3|||
124592536|NCT01636934|448125923|FG001|Overall Study|Withdrawal by Subject|2|||
124592537|NCT01636934|448125922|FG000|Overall Study|Chemo cancel|1|||
124592538|NCT01636934|448125923|FG001|Overall Study|Chemo cancel|0|||
124592539|NCT01636934|448125922|FG000|Overall Study|Too ill to continue|1|||
124592540|NCT01636934|448125923|FG001|Overall Study|Too ill to continue|0|||
124592541|NCT01636934|448125922|FG000|Overall Study|Never started study medication|1|||
124592542|NCT01636934|448125923|FG001|Overall Study|Never started study medication|1|||
124592543|NCT02297841|448125927|FG000|Overall Study|Withdrawal by Subject|1|||
124592544|NCT02297841|448125927|FG000|Overall Study|Protocol Violation|7|||
124592545|NCT03429049|448125928|FG000|Overall Study|Adverse Event|2|||
124592546|NCT03429049|448125929|FG001|Overall Study|Adverse Event|3|||
124592547|NCT03429049|448125928|FG000|Overall Study|Death|0|||
124592548|NCT03429049|448125929|FG001|Overall Study|Death|1|||
124592549|NCT03429049|448125928|FG000|Overall Study|Lack of Efficacy|4|||
124592550|NCT03429049|448125929|FG001|Overall Study|Lack of Efficacy|2|||
124592551|NCT03429049|448125928|FG000|Overall Study|Lost to Follow-up|9|||
124592552|NCT03429049|448125929|FG001|Overall Study|Lost to Follow-up|8|||
124592553|NCT03429049|448125928|FG000|Overall Study|Physician Decision|1|||
124592554|NCT03429049|448125929|FG001|Overall Study|Physician Decision|0|||
124592555|NCT03429049|448125928|FG000|Overall Study|Protocol Violation|3|||
124592556|NCT03429049|448125929|FG001|Overall Study|Protocol Violation|0|||
124592557|NCT03429049|448125928|FG000|Overall Study|Sponsor Decision|2|||
124592558|NCT03429049|448125929|FG001|Overall Study|Sponsor Decision|0|||
124592559|NCT03429049|448125928|FG000|Overall Study|Withdrawal by Subject|4|||
124592560|NCT03429049|448125929|FG001|Overall Study|Withdrawal by Subject|20|||
124592561|NCT03429049|448125928|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
124592562|NCT03429049|448125929|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
124592563|NCT01841060|448125933|FG000|Overall Study|Protocol Violation|10|||
124592564|NCT01872715|448125937|FG000|Overall Study|Adverse Event|1|||
124592565|NCT01872715|448125937|FG000|Overall Study|Protocol Violation|1|||
124592566|NCT01872715|448125937|FG000|Overall Study|Withdrawal by Subject|2|||
124592567|NCT01765270|448125947|FG000|Overall Study|Physician Decision|1|||
124592568|NCT01765270|448125948|FG001|Overall Study|Physician Decision|0|||
124592569|NCT01765270|448125947|FG000|Overall Study|Withdrawal by Subject|0|||
124592570|NCT01765270|448125948|FG001|Overall Study|Withdrawal by Subject|1|||
124592571|NCT03431337|448125951|FG000|Overall Study|Lost to Follow-up|21|||
124592572|NCT03431337|448125952|FG001|Overall Study|Lost to Follow-up|19|||
124592573|NCT03431337|448125951|FG000|Overall Study|Withdrawal by Subject|8|||
124592574|NCT03431337|448125952|FG001|Overall Study|Withdrawal by Subject|3|||
124592575|NCT00329160|448125953|FG000|Overall Study|Adverse Event|27|||
124592576|NCT00329160|448125953|FG000|Overall Study|Withdrawal by Subject|13|||
124592577|NCT00329160|448125953|FG000|Overall Study|Protocol Violation|2|||
124592578|NCT00329160|448125953|FG000|Overall Study|Did not Receive Study Drug|1|||
124592579|NCT00329160|448125953|FG000|Overall Study|Incomplete IVUS|45|||
124592580|NCT04501094|448125954|FG000|Overall Study|Death (unrelated to research)|1|||
124592581|NCT04501094|448125955|FG001|Overall Study|Death (unrelated to research)|0|||
124592582|NCT00063258|448125959|FG000|Overall Study|Physician Decision|2|||
124592583|NCT00063258|448125960|FG001|Overall Study|Physician Decision|0|||
124592584|NCT00063258|448125959|FG000|Overall Study|Lack of Efficacy|2|||
124592585|NCT00063258|448125960|FG001|Overall Study|Lack of Efficacy|0|||
124592586|NCT00784979|448125963|FG000|Overall Study|incomplete data|6|||
124592587|NCT00894933|448125964|FG000|Overall Study|Lost to Follow-up|2|||
124592588|NCT00894933|448125964|FG000|Overall Study|Cancelled Procedure|1|||
124592589|NCT00894933|448125964|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
124592590|NCT01235715|448125969|FG000|Overall Study|Physician Decision|0|||
124592591|NCT01235715|448125970|FG001|Overall Study|Physician Decision|2|||
124592592|NCT03619876|448125971|FG000|Overall Study|Withdrawal by Subject|1|||
124592593|NCT03619876|448125972|FG001|Overall Study|Withdrawal by Subject|2|||
124592594|NCT03619876|448125971|FG000|Overall Study|Withdrawal due to incidental finding|0|||
124592595|NCT03619876|448125972|FG001|Overall Study|Withdrawal due to incidental finding|2|||
124592596|NCT00396630|448125975|FG000|Overall Study|Lost to Follow-up|1|||
124592597|NCT00396630|448125976|FG001|Overall Study|Lost to Follow-up|1|||
124592598|NCT00396630|448125975|FG000|Overall Study|Withdrawal by Subject|1|||
124592599|NCT00396630|448125976|FG001|Overall Study|Withdrawal by Subject|1|||
124592600|NCT00396630|448125975|FG000|Overall Study|Not vaccinated at Visit 3|3|||
124592601|NCT00396630|448125976|FG001|Overall Study|Not vaccinated at Visit 3|3|||
124592602|NCT00996437|448125981|FG000|Overall Study|Death|1|||
124592603|NCT00996437|448125982|FG001|Overall Study|Death|0|||
124592604|NCT00996437|448125981|FG000|Overall Study|Dropped|2|||
124592605|NCT00996437|448125982|FG001|Overall Study|Dropped|2|||
124592606|NCT00996437|448125981|FG000|Overall Study|Missed|2|||
124592607|NCT00996437|448125982|FG001|Overall Study|Missed|5|||
124592608|NCT02576717|448125983|FG000|Overall Study|Other Reasons|16|||
124592609|NCT02576717|448125984|FG001|Overall Study|Other Reasons|18|||
124592610|NCT02576717|448125985|FG002|Overall Study|Other Reasons|15|||
124592611|NCT02576717|448125983|FG000|Overall Study|Covid-19 Pandemic|0|||
124592612|NCT02576717|448125984|FG001|Overall Study|Covid-19 Pandemic|1|||
124592613|NCT02576717|448125985|FG002|Overall Study|Covid-19 Pandemic|1|||
124592614|NCT02576717|448125983|FG000|Overall Study|Sponsor Decision|0|||
124592615|NCT02576717|448125984|FG001|Overall Study|Sponsor Decision|0|||
124592616|NCT02576717|448125985|FG002|Overall Study|Sponsor Decision|1|||
124592617|NCT02576717|448125983|FG000|Overall Study|Physician Decision|3|||
124592618|NCT02576717|448125984|FG001|Overall Study|Physician Decision|8|||
124592619|NCT02576717|448125985|FG002|Overall Study|Physician Decision|9|||
124592620|NCT02576717|448125983|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
124592621|NCT02576717|448125984|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
124592622|NCT02576717|448125985|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
124592623|NCT02576717|448125983|FG000|Overall Study|Death|3|||
124592624|NCT02576717|448125984|FG001|Overall Study|Death|5|||
124592625|NCT02576717|448125985|FG002|Overall Study|Death|3|||
124592626|NCT02576717|448125983|FG000|Overall Study|Lost to Follow-up|9|||
124592627|NCT02576717|448125984|FG001|Overall Study|Lost to Follow-up|10|||
124592628|NCT02576717|448125985|FG002|Overall Study|Lost to Follow-up|19|||
124592629|NCT02576717|448125983|FG000|Overall Study|Protocol Violation|4|||
124592630|NCT02576717|448125984|FG001|Overall Study|Protocol Violation|0|||
124592631|NCT02576717|448125985|FG002|Overall Study|Protocol Violation|5|||
124592632|NCT02576717|448125983|FG000|Overall Study|Lack of Efficacy|24|||
124592633|NCT02576717|448125984|FG001|Overall Study|Lack of Efficacy|28|||
124592634|NCT02576717|448125985|FG002|Overall Study|Lack of Efficacy|20|||
124592635|NCT02576717|448125983|FG000|Overall Study|Adverse Event|26|||
124592636|NCT02576717|448125984|FG001|Overall Study|Adverse Event|32|||
124592637|NCT02576717|448125985|FG002|Overall Study|Adverse Event|26|||
124592638|NCT01755975|448125986|FG000|Overall Study|Adverse Event|0|||
124592639|NCT01755975|448125987|FG001|Overall Study|Adverse Event|0|||
124592640|NCT01755975|448125988|FG002|Overall Study|Adverse Event|1|||
124592641|NCT01755975|448125989|FG003|Overall Study|Adverse Event|0|||
124592642|NCT01755975|448125990|FG004|Overall Study|Adverse Event|2|||
124592643|NCT00399893|448125991|FG000|Overall Study|Withdrawal by Subject|1|||
124592644|NCT00399893|448125992|FG001|Overall Study|Withdrawal by Subject|0|||
124779002|NCT05019521|448819458|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
124592645|NCT01729026|448125994|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
124592646|NCT01729026|448125995|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
124592647|NCT01729026|448125994|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
124592648|NCT01729026|448125995|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
124592649|NCT00906373|448125996|FG000|Overall Study|Withdrawal by Subject|0|||
124592650|NCT00906373|448125997|FG001|Overall Study|Withdrawal by Subject|5|||
124592651|NCT00906373|448125996|FG000|Overall Study|Other|0|||
124592652|NCT00906373|448125997|FG001|Overall Study|Other|1|||
124779003|NCT05019521|448819459|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
124592653|NCT00906373|448125996|FG000|Overall Study|Still on treatment at cutoff date|0|||
124592654|NCT00906373|448125997|FG001|Overall Study|Still on treatment at cutoff date|2|||
124592655|NCT01597479|448125998|FG000|Overall Study|Protocol Violation|1|||
124592656|NCT01597479|448125999|FG001|Overall Study|Protocol Violation|0|||
124592657|NCT01597479|448125998|FG000|Overall Study|Lost to Follow-up|1|||
124592658|NCT01597479|448125999|FG001|Overall Study|Lost to Follow-up|0|||
124592659|NCT00848042|448126000|FG000|Overall Study|Death|1|||
124592660|NCT00848042|448126001|FG001|Overall Study|Death|2|||
124592661|NCT00848042|448126002|FG002|Overall Study|Death|0|||
124592662|NCT00848042|448126000|FG000|Overall Study|Other Therapy|3|||
124592663|NCT00848042|448126001|FG001|Overall Study|Other Therapy|0|||
124592664|NCT00848042|448126002|FG002|Overall Study|Other Therapy|0|||
124592665|NCT00979212|448126005|FG000|Overall Study|Protocol Violation|1|||
124592666|NCT00979212|448126006|FG001|Overall Study|Protocol Violation|8|||
124592667|NCT00979212|448126005|FG000|Overall Study|No protocol therapy received|1|||
124779004|NCT05019521|448819460|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
124779005|NCT05019521|448819461|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
124779006|NCT05019521|448819462|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
124779007|NCT05019521|448819463|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
124779008|NCT05019521|448819464|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
124779009|NCT05019521|448819458|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
124779010|NCT05019521|448819459|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
124779011|NCT05019521|448819460|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
124779012|NCT05019521|448819461|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
124779013|NCT05019521|448819462|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
124779014|NCT05019521|448819463|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
124779015|NCT05019521|448819464|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
124779016|NCT05019521|448819458|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
124779017|NCT05019521|448819459|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
124779018|NCT05019521|448819460|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
124779019|NCT05019521|448819461|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
124779020|NCT05019521|448819462|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
124779021|NCT05019521|448819463|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
124779022|NCT05019521|448819464|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
124779023|NCT05019521|448819458|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
124779024|NCT05019521|448819459|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
124779025|NCT05019521|448819460|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
124779026|NCT05019521|448819461|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
124779027|NCT05019521|448819462|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
124779028|NCT05019521|448819463|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
124779029|NCT05019521|448819464|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
124779030|NCT05019521|448819458|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
124779031|NCT05019521|448819459|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
124779032|NCT05019521|448819460|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
124779033|NCT05019521|448819461|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
124779034|NCT05019521|448819462|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
124779035|NCT05019521|448819463|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
124779036|NCT05019521|448819464|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
124779037|NCT05019521|448819458|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
124779038|NCT05019521|448819459|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
124779039|NCT05019521|448819460|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
124779040|NCT05019521|448819461|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
124779041|NCT05019521|448819462|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
124779042|NCT05019521|448819463|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
124779043|NCT05019521|448819464|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
124779044|NCT05019521|448819458|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
124779045|NCT05019521|448819459|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
124779046|NCT05019521|448819460|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
124779047|NCT05019521|448819461|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
124779048|NCT05019521|448819462|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
124779049|NCT05019521|448819463|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
124779050|NCT05019521|448819464|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
124779051|NCT05019521|448819458|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
124779052|NCT05019521|448819459|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
124779053|NCT05019521|448819460|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
124779054|NCT05019521|448819461|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
124592668|NCT00979212|448126006|FG001|Overall Study|No protocol therapy received|0|||
124592669|NCT04886063|448126009|FG000|Overall Study|Adverse Event|50|||
124592670|NCT04886063|448126009|FG000|Overall Study|Lack of Efficacy|31|||
124592671|NCT04886063|448126009|FG000|Overall Study|Withdrawal by Subject|45|||
124592672|NCT04886063|448126009|FG000|Overall Study|Physician Decision|3|||
124592673|NCT04886063|448126009|FG000|Overall Study|Protocol Violation|3|||
124592674|NCT04886063|448126009|FG000|Overall Study|Site closure|4|||
124592675|NCT04886063|448126009|FG000|Overall Study|Nursing home replacement|3|||
124592676|NCT04886063|448126009|FG000|Overall Study|Lost to Follow-up|5|||
124592677|NCT04886063|448126009|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
124592678|NCT04886063|448126009|FG000|Overall Study|>1 reason|20|||
124592679|NCT00309985|448126010|FG000|Overall Study|Disease progression|12|||
124592680|NCT00309985|448126011|FG001|Overall Study|Disease progression|0|||
124592681|NCT00309985|448126010|FG000|Overall Study|Adverse Event|30|||
124592682|NCT00309985|448126011|FG001|Overall Study|Adverse Event|0|||
124592683|NCT00309985|448126010|FG000|Overall Study|Death|2|||
124592684|NCT00309985|448126011|FG001|Overall Study|Death|0|||
124592685|NCT00309985|448126010|FG000|Overall Study|Withdrawal by Subject|5|||
124592686|NCT00309985|448126011|FG001|Overall Study|Withdrawal by Subject|1|||
124592687|NCT00309985|448126010|FG000|Overall Study|Physician Decision|3|||
124592688|NCT00309985|448126011|FG001|Overall Study|Physician Decision|0|||
124592689|NCT00309985|448126010|FG000|Overall Study|Never started treatment|7|||
124592690|NCT00309985|448126011|FG001|Overall Study|Never started treatment|0|||
124592691|NCT00309985|448126010|FG000|Overall Study|Complicating disease|1|||
124592692|NCT00309985|448126011|FG001|Overall Study|Complicating disease|0|||
124592693|NCT00309985|448126010|FG000|Overall Study|Non-compliance|1|||
124592694|NCT00309985|448126011|FG001|Overall Study|Non-compliance|0|||
124592695|NCT00309985|448126010|FG000|Overall Study|Chemotherapy discontinued only|1|||
124592696|NCT00309985|448126011|FG001|Overall Study|Chemotherapy discontinued only|0|||
124592697|NCT02448563|448126012|FG000|Overall Study|Lost to Follow-up|16|||
124592698|NCT02448563|448126013|FG001|Overall Study|Lost to Follow-up|10|||
124592699|NCT02448563|448126012|FG000|Overall Study|Withdrawal by Subject|0|||
124592700|NCT02448563|448126013|FG001|Overall Study|Withdrawal by Subject|1|||
124592701|NCT02340962|448126015|FG000|Overall Study|Lost to Follow-up|1|||
124592702|NCT02340962|448126016|FG001|Overall Study|Lost to Follow-up|0|||
124592703|NCT01450800|448126017|FG000|Overall Study|Protocol Violation|1|||
124592704|NCT01450800|448126018|FG001|Overall Study|Protocol Violation|3|||
124592705|NCT00265785|448126019|FG000|Overall Study|Adverse Event|4|||
124592706|NCT00265785|448126019|FG000|Overall Study|Withdrawal by Subject|3|||
124592707|NCT00265785|448126019|FG000|Overall Study|Progression/Relapse|15|||
124592708|NCT00265785|448126019|FG000|Overall Study|Not protocol specified|2|||
124592709|NCT00265785|448126019|FG000|Overall Study|Ineligible|1|||
124592710|NCT00265785|448126019|FG000|Overall Study|Did not receive protocol treatment|2|||
124592711|NCT01294449|448126022|FG000|Overall Study|Death|11|||
124592712|NCT01294449|448126023|FG001|Overall Study|Death|12|||
124592713|NCT01294449|448126022|FG000|Overall Study|Withdrawal by Subject|1|||
124592714|NCT01294449|448126023|FG001|Overall Study|Withdrawal by Subject|3|||
124592715|NCT00420095|448126031|FG000|Overall Study|Adverse Event|1|||
124592716|NCT00420095|448126032|FG001|Overall Study|Adverse Event|0|||
124592717|NCT00420095|448126031|FG000|Overall Study|Protocol Violation|1|||
124592718|NCT00420095|448126032|FG001|Overall Study|Protocol Violation|1|||
124592719|NCT00420095|448126031|FG000|Overall Study|Lost to Follow-up|1|||
124592720|NCT00420095|448126032|FG001|Overall Study|Lost to Follow-up|0|||
124592721|NCT00654641|448126033|FG000|Overall Study|Lost to Follow-up|2|||
124592722|NCT00654641|448126034|FG001|Overall Study|Lost to Follow-up|3|||
124592723|NCT02625974|448126035|FG000|Part 1|Lost to Follow-up|9|||
124592724|NCT02625974|448126036|FG001|Part 1|Lost to Follow-up|3|||
124592725|NCT02625974|448126035|FG000|Part 2|Lost to Follow-up|4|||
124730128|NCT01535599|448634005|FG001|Overall Study|Did not use product|0|||
124730129|NCT01535599|448634004|FG000|Overall Study|Other|1|||
124730130|NCT01535599|448634005|FG001|Overall Study|Other|0|||
124730131|NCT01535599|448634004|FG000|Overall Study|Stopped medication|0|||
124730132|NCT01535599|448634005|FG001|Overall Study|Stopped medication|1|||
124730133|NCT01535599|448634004|FG000|Overall Study|Noncompliance|0|||
124730134|NCT01535599|448634005|FG001|Overall Study|Noncompliance|1|||
124730135|NCT04043234|448634008|FG000|Overall Study|Lost to Follow-up|1|||
124730136|NCT04043234|448634008|FG000|Overall Study|Withdrawal by Subject|1|||
124730137|NCT01165320|448634009|FG000|Overall Study|Clinical adverse experience|2|||
124730138|NCT01165320|448634010|FG001|Overall Study|Clinical adverse experience|1|||
124730139|NCT01165320|448634011|FG002|Overall Study|Clinical adverse experience|0|||
124730140|NCT01165320|448634009|FG000|Overall Study|Laboratory adverse experience|1|||
124730141|NCT01165320|448634010|FG001|Overall Study|Laboratory adverse experience|0|||
124730142|NCT01165320|448634011|FG002|Overall Study|Laboratory adverse experience|0|||
124730143|NCT01165320|448634009|FG000|Overall Study|Lack of Efficacy|0|||
124730144|NCT01165320|448634010|FG001|Overall Study|Lack of Efficacy|2|||
124730145|NCT01165320|448634011|FG002|Overall Study|Lack of Efficacy|0|||
124592726|NCT02625974|448126036|FG001|Part 2|Lost to Follow-up|6|||
124592727|NCT02625974|448126035|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
124730146|NCT01165320|448634009|FG000|Overall Study|Reason unknown|0|||
124592728|NCT02625974|448126036|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
124592729|NCT01977456|448126037|FG000|Overall Study|Death|5|||
124592730|NCT01142661|448126038|FG000|Overall Study|Adverse Event|2|||
124592731|NCT01142661|448126038|FG000|Overall Study|Withdrawal by Subject|1|||
124730147|NCT01165320|448634010|FG001|Overall Study|Reason unknown|1|||
124592732|NCT01142661|448126038|FG000|Overall Study|Physician Decision|1|||
124592733|NCT00434590|448126039|FG000|Overall Study|Administrative problems|5|||
124592734|NCT00434590|448126040|FG001|Overall Study|Administrative problems|5|||
124592735|NCT02129062|448127540|FG000|Overall Study|Death|1|||
124592736|NCT02129062|448127540|FG000|Overall Study|Disease Progression|2|||
124592737|NCT02722616|448127541|FG000|Overall Study|Sponsor closed study after one month|2|||
124592738|NCT02722616|448127542|FG001|Overall Study|Sponsor closed study after one month|0|||
124592739|NCT02722616|448127543|FG002|Overall Study|Sponsor closed study after one month|0|||
124730148|NCT01165320|448634011|FG002|Overall Study|Reason unknown|0|||
124592740|NCT01923311|448127546|FG000|Overall Study|Pregnancy|1|||
124592741|NCT01923311|448127547|FG001|Overall Study|Pregnancy|0|||
124592742|NCT01923311|448127546|FG000|Overall Study|Investigator's Discretion|1|||
124592743|NCT01923311|448127547|FG001|Overall Study|Investigator's Discretion|0|||
124592744|NCT01923311|448127546|FG000|Overall Study|Non-Compliance with Study Drug|2|||
124592745|NCT01923311|448127547|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124592746|NCT01923311|448127546|FG000|Overall Study|Withdrew Consent|1|||
124592747|NCT01923311|448127547|FG001|Overall Study|Withdrew Consent|0|||
124592748|NCT01923311|448127546|FG000|Overall Study|Study Terminated by Sponsor|12|||
124592749|NCT01923311|448127547|FG001|Overall Study|Study Terminated by Sponsor|0|||
124592750|NCT02031237|448127548|FG000|Overall Study|Death|1|||
124592751|NCT02031237|448127549|FG001|Overall Study|Death|5|||
124592752|NCT02031237|448127550|FG002|Overall Study|Death|0|||
124592753|NCT02031237|448127548|FG000|Overall Study|Physician Decision|0|||
124592754|NCT02031237|448127549|FG001|Overall Study|Physician Decision|1|||
124592755|NCT02031237|448127550|FG002|Overall Study|Physician Decision|0|||
124592756|NCT02031237|448127548|FG000|Overall Study|Withdrawal by Subject|2|||
124592757|NCT02031237|448127549|FG001|Overall Study|Withdrawal by Subject|2|||
124592758|NCT02031237|448127550|FG002|Overall Study|Withdrawal by Subject|0|||
124592759|NCT02031237|448127548|FG000|Overall Study|Protocol Violation|2|||
124592760|NCT02031237|448127549|FG001|Overall Study|Protocol Violation|6|||
124592761|NCT02031237|448127550|FG002|Overall Study|Protocol Violation|0|||
124592762|NCT02031237|448127548|FG000|Overall Study|Alternate Treatment Given|0|||
124592763|NCT02031237|448127549|FG001|Overall Study|Alternate Treatment Given|0|||
124592764|NCT02031237|448127550|FG002|Overall Study|Alternate Treatment Given|3|||
124592765|NCT01011335|448127553|FG000|Overall Study|Lost to Follow-up|0|||
124592766|NCT01011335|448127554|FG001|Overall Study|Lost to Follow-up|0|||
124592767|NCT01011335|448127555|FG002|Overall Study|Lost to Follow-up|1|||
124592768|NCT01011335|448127556|FG003|Overall Study|Lost to Follow-up|1|||
124592769|NCT01011335|448127557|FG004|Overall Study|Lost to Follow-up|1|||
124592770|NCT01011335|448127558|FG005|Overall Study|Lost to Follow-up|1|||
124592771|NCT01011335|448127559|FG006|Overall Study|Lost to Follow-up|2|||
124592772|NCT01011335|448127560|FG007|Overall Study|Lost to Follow-up|2|||
124592773|NCT01011335|448127561|FG008|Overall Study|Lost to Follow-up|1|||
124592774|NCT01011335|448127562|FG009|Overall Study|Lost to Follow-up|0|||
124592775|NCT01011335|448127563|FG010|Overall Study|Lost to Follow-up|0|||
124592776|NCT01011335|448127564|FG011|Overall Study|Lost to Follow-up|1|||
124592777|NCT01011335|448127565|FG012|Overall Study|Lost to Follow-up|2|||
124592778|NCT01011335|448127553|FG000|Overall Study|Protocol Violation|0|||
124592779|NCT01011335|448127554|FG001|Overall Study|Protocol Violation|1|||
124592780|NCT01011335|448127555|FG002|Overall Study|Protocol Violation|0|||
124592781|NCT01011335|448127556|FG003|Overall Study|Protocol Violation|0|||
124592782|NCT01011335|448127557|FG004|Overall Study|Protocol Violation|0|||
124592783|NCT01011335|448127558|FG005|Overall Study|Protocol Violation|0|||
124592784|NCT01011335|448127559|FG006|Overall Study|Protocol Violation|0|||
124592785|NCT01011335|448127560|FG007|Overall Study|Protocol Violation|0|||
124592786|NCT01011335|448127561|FG008|Overall Study|Protocol Violation|0|||
124592787|NCT01011335|448127562|FG009|Overall Study|Protocol Violation|0|||
124592788|NCT01011335|448127563|FG010|Overall Study|Protocol Violation|0|||
124592789|NCT01011335|448127564|FG011|Overall Study|Protocol Violation|0|||
124592790|NCT01011335|448127565|FG012|Overall Study|Protocol Violation|0|||
124592791|NCT01011335|448127553|FG000|Overall Study|Moved/deployed or no booster|1|||
124592792|NCT01011335|448127554|FG001|Overall Study|Moved/deployed or no booster|0|||
124592793|NCT01011335|448127555|FG002|Overall Study|Moved/deployed or no booster|0|||
124592794|NCT01011335|448127556|FG003|Overall Study|Moved/deployed or no booster|1|||
124592795|NCT01011335|448127557|FG004|Overall Study|Moved/deployed or no booster|0|||
124592796|NCT01011335|448127558|FG005|Overall Study|Moved/deployed or no booster|0|||
124592797|NCT01011335|448127559|FG006|Overall Study|Moved/deployed or no booster|1|||
124592798|NCT01011335|448127560|FG007|Overall Study|Moved/deployed or no booster|0|||
124592799|NCT01011335|448127561|FG008|Overall Study|Moved/deployed or no booster|1|||
124592800|NCT01011335|448127562|FG009|Overall Study|Moved/deployed or no booster|0|||
124779055|NCT05019521|448819462|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
124779056|NCT05019521|448819463|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
124779057|NCT05019521|448819464|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
124779058|NCT05019521|448819458|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
124592801|NCT01011335|448127563|FG010|Overall Study|Moved/deployed or no booster|2|||
124592802|NCT01011335|448127564|FG011|Overall Study|Moved/deployed or no booster|0|||
124592803|NCT01011335|448127565|FG012|Overall Study|Moved/deployed or no booster|0|||
124592804|NCT01011335|448127553|FG000|Overall Study|Adverse Event|0|||
124592805|NCT01011335|448127554|FG001|Overall Study|Adverse Event|0|||
124592806|NCT01011335|448127555|FG002|Overall Study|Adverse Event|0|||
124592807|NCT01011335|448127556|FG003|Overall Study|Adverse Event|0|||
124592808|NCT01011335|448127557|FG004|Overall Study|Adverse Event|0|||
124592809|NCT01011335|448127558|FG005|Overall Study|Adverse Event|0|||
124592810|NCT01011335|448127559|FG006|Overall Study|Adverse Event|0|||
124592811|NCT01011335|448127560|FG007|Overall Study|Adverse Event|0|||
124592812|NCT01011335|448127561|FG008|Overall Study|Adverse Event|0|||
124592813|NCT01011335|448127562|FG009|Overall Study|Adverse Event|0|||
124779059|NCT05019521|448819459|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
124779060|NCT05019521|448819460|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
124779061|NCT05019521|448819461|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
124779062|NCT05019521|448819462|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
124779063|NCT05019521|448819463|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
124779064|NCT05019521|448819464|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
124779065|NCT05019521|448819458|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
124779066|NCT05019521|448819459|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
124779067|NCT05019521|448819460|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
124779068|NCT05019521|448819461|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
124779069|NCT05019521|448819462|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
124779070|NCT05019521|448819463|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
124779071|NCT05019521|448819464|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
124779072|NCT05019521|448819458|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
124779073|NCT05019521|448819459|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
124779074|NCT05019521|448819460|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
124779075|NCT05019521|448819461|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
124779076|NCT05019521|448819462|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
124779077|NCT05019521|448819463|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
124779078|NCT05019521|448819464|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
124779079|NCT05019521|448819458|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
124779080|NCT05019521|448819459|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
124779081|NCT05019521|448819460|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
124779082|NCT05019521|448819461|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
124779083|NCT05019521|448819462|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
124779084|NCT05019521|448819463|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
124779085|NCT05019521|448819464|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
124779086|NCT05019521|448819458|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
124779087|NCT05019521|448819459|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
124779088|NCT05019521|448819460|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
124779089|NCT05019521|448819461|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
124779090|NCT05019521|448819462|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
124779091|NCT05019521|448819463|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
124779092|NCT05019521|448819464|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
124779093|NCT05019521|448819458|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
124779094|NCT05019521|448819459|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
124779095|NCT05019521|448819460|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
124779096|NCT05019521|448819461|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
124779097|NCT05019521|448819462|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
124779098|NCT05019521|448819463|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
124779099|NCT05019521|448819464|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
124779100|NCT00760617|448819465|FG000|Overall Study|Adverse Event|5|||
124779101|NCT00760617|448819466|FG001|Overall Study|Adverse Event|2|||
124779102|NCT00760617|448819467|FG002|Overall Study|Adverse Event|0|||
124779103|NCT00760617|448819465|FG000|Overall Study|Lost to Follow-up|0|||
124592814|NCT01011335|448127563|FG010|Overall Study|Adverse Event|4|||
124592815|NCT01011335|448127564|FG011|Overall Study|Adverse Event|0|||
124592816|NCT01011335|448127565|FG012|Overall Study|Adverse Event|1|||
124592817|NCT01765751|448127572|FG000|Overall Study|Lost to Follow-up|0|||
124592818|NCT01765751|448127573|FG001|Overall Study|Lost to Follow-up|2|||
124592819|NCT01765751|448127574|FG002|Overall Study|Lost to Follow-up|1|||
124592820|NCT05258630|448127575|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
124592821|NCT05258630|448127576|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
124592822|NCT05258630|448127575|FG000|Overall Study|Lost to Follow-up|0|||
124592823|NCT05258630|448127576|FG001|Overall Study|Lost to Follow-up|2|||
124592824|NCT03303417|448127577|FG000|Overall Study|Withdrawal by Subject|1|||
124592825|NCT03303417|448127578|FG001|Overall Study|Withdrawal by Subject|1|||
124779104|NCT00760617|448819466|FG001|Overall Study|Lost to Follow-up|0|||
124779105|NCT00760617|448819467|FG002|Overall Study|Lost to Follow-up|5|||
124779106|NCT04625101|448819468|FG000|Overall Study|Withdrawal by Subject|0|||
124592826|NCT01848210|448127579|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
124592827|NCT01848210|448127580|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
124592828|NCT01848210|448127579|FG000|Overall Study|Lost to Follow-up|24|||
124592829|NCT01848210|448127580|FG001|Overall Study|Lost to Follow-up|12|||
124592830|NCT01848210|448127579|FG000|Overall Study|Protocol Violation|3|||
124592831|NCT01848210|448127580|FG001|Overall Study|Protocol Violation|5|||
124592832|NCT01848210|448127579|FG000|Overall Study|Use of Forbidden Drugs|9|||
124592833|NCT01848210|448127580|FG001|Overall Study|Use of Forbidden Drugs|10|||
124592834|NCT01848210|448127579|FG000|Overall Study|Impedition Condition|5|||
124592835|NCT01848210|448127580|FG001|Overall Study|Impedition Condition|9|||
124592836|NCT01848210|448127579|FG000|Overall Study|Adverse Event|7|||
124592837|NCT01848210|448127580|FG001|Overall Study|Adverse Event|9|||
124592838|NCT01848210|448127579|FG000|Overall Study|Discontinuation Criterion|5|||
124592839|NCT01848210|448127580|FG001|Overall Study|Discontinuation Criterion|7|||
124592840|NCT01848210|448127579|FG000|Overall Study|Hypesensitivity|1|||
124592841|NCT01848210|448127580|FG001|Overall Study|Hypesensitivity|0|||
124592842|NCT01848210|448127579|FG000|Overall Study|Hepatic Function Alteration|4|||
124592843|NCT01848210|448127580|FG001|Overall Study|Hepatic Function Alteration|0|||
124592844|NCT01848210|448127579|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
124592845|NCT01848210|448127580|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
124592846|NCT01848210|448127579|FG000|Overall Study|Administrative|1|||
124592847|NCT01848210|448127580|FG001|Overall Study|Administrative|0|||
124592848|NCT02426541|448127584|FG000|Overall Study|Protocol Violation|1|||
124592849|NCT02426541|448127585|FG001|Overall Study|Protocol Violation|0|||
124592850|NCT00631007|448127588|FG000|Overall Study|Adverse Event|0|||
124592851|NCT00631007|448127589|FG001|Overall Study|Adverse Event|2|||
124592852|NCT00631007|448127590|FG002|Overall Study|Adverse Event|0|||
124592853|NCT00631007|448127591|FG003|Overall Study|Adverse Event|2|||
124592854|NCT00631007|448127592|FG004|Overall Study|Adverse Event|3|||
124592855|NCT00631007|448127593|FG005|Overall Study|Adverse Event|2|||
124592856|NCT00631007|448127588|FG000|Overall Study|Lost to Follow-up|2|||
124592857|NCT00631007|448127589|FG001|Overall Study|Lost to Follow-up|1|||
124592858|NCT00631007|448127590|FG002|Overall Study|Lost to Follow-up|2|||
124592859|NCT00631007|448127591|FG003|Overall Study|Lost to Follow-up|4|||
124592860|NCT00631007|448127592|FG004|Overall Study|Lost to Follow-up|5|||
124592861|NCT00631007|448127593|FG005|Overall Study|Lost to Follow-up|3|||
124592862|NCT00631007|448127588|FG000|Overall Study|Physician Decision|1|||
124592863|NCT00631007|448127589|FG001|Overall Study|Physician Decision|0|||
124592864|NCT00631007|448127590|FG002|Overall Study|Physician Decision|1|||
124592865|NCT00631007|448127591|FG003|Overall Study|Physician Decision|0|||
124592866|NCT00631007|448127592|FG004|Overall Study|Physician Decision|0|||
124592867|NCT00631007|448127593|FG005|Overall Study|Physician Decision|2|||
124592868|NCT00631007|448127588|FG000|Overall Study|Persistent Hyperglycemia|2|||
124592869|NCT00631007|448127589|FG001|Overall Study|Persistent Hyperglycemia|2|||
124592870|NCT00631007|448127590|FG002|Overall Study|Persistent Hyperglycemia|5|||
124592871|NCT00631007|448127591|FG003|Overall Study|Persistent Hyperglycemia|1|||
124592872|NCT00631007|448127592|FG004|Overall Study|Persistent Hyperglycemia|2|||
124592873|NCT00631007|448127593|FG005|Overall Study|Persistent Hyperglycemia|5|||
124592874|NCT00631007|448127588|FG000|Overall Study|Withdrawal by Subject|4|||
124592875|NCT00631007|448127589|FG001|Overall Study|Withdrawal by Subject|5|||
124592876|NCT00631007|448127590|FG002|Overall Study|Withdrawal by Subject|2|||
124592877|NCT00631007|448127591|FG003|Overall Study|Withdrawal by Subject|2|||
124592878|NCT00631007|448127592|FG004|Overall Study|Withdrawal by Subject|1|||
124592879|NCT00631007|448127593|FG005|Overall Study|Withdrawal by Subject|3|||
124592880|NCT00631007|448127588|FG000|Overall Study|Other|2|||
124592881|NCT00631007|448127589|FG001|Overall Study|Other|1|||
124592882|NCT00631007|448127590|FG002|Overall Study|Other|0|||
124592883|NCT00631007|448127591|FG003|Overall Study|Other|0|||
124592884|NCT00631007|448127592|FG004|Overall Study|Other|1|||
124592885|NCT00631007|448127593|FG005|Overall Study|Other|0|||
124592886|NCT02674633|448127594|FG000|Overall Study|Lost to Follow-up|3|||
124592887|NCT02674633|448127595|FG001|Overall Study|Lost to Follow-up|2|||
124592888|NCT02674633|448127594|FG000|Overall Study|Physician Decision|1|||
124592889|NCT02674633|448127595|FG001|Overall Study|Physician Decision|0|||
124592890|NCT02674633|448127594|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
124592891|NCT02674633|448127595|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
124592892|NCT00683787|448127596|FG000|Overall Study|Progression|3|||
124592893|NCT00683787|448127597|FG001|Overall Study|Progression|3|||
124592894|NCT00683787|448127598|FG002|Overall Study|Progression|0|||
124592895|NCT00683787|448127596|FG000|Overall Study|Adverse Event|0|||
124592896|NCT00683787|448127597|FG001|Overall Study|Adverse Event|0|||
124592897|NCT00683787|448127598|FG002|Overall Study|Adverse Event|2|||
124592898|NCT00460109|448127599|FG000|Overall Study|Death|1|||
124592899|NCT02994394|448127600|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
124592900|NCT02994394|448127601|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
124592901|NCT02994394|448127602|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
124592902|NCT02994394|448127603|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
124592903|NCT02994394|448127604|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
124592904|NCT02994394|448127605|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
124592905|NCT02994394|448127600|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
124592906|NCT02994394|448127601|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
124592907|NCT02994394|448127602|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
124592908|NCT02994394|448127603|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
124592909|NCT02994394|448127604|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
124592910|NCT02994394|448127605|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
124592911|NCT02327325|448127606|FG000|Overall Study|Withdrawal by Subject|1|||
124592912|NCT02327325|448127607|FG001|Overall Study|Withdrawal by Subject|4|||
124592913|NCT02327325|448127608|FG002|Overall Study|Withdrawal by Subject|4|||
124592914|NCT02327325|448127606|FG000|Overall Study|Excluded by Study Team|0|||
124592915|NCT02327325|448127607|FG001|Overall Study|Excluded by Study Team|0|||
124592916|NCT02327325|448127608|FG002|Overall Study|Excluded by Study Team|1|||
124592917|NCT02457819|448127613|FG000|Overall Study|reason not given|8|||
124592918|NCT02457819|448127613|FG000|Overall Study|Withdrawal by Subject|24|||
124592919|NCT02457819|448127613|FG000|Overall Study|Protocol Violation|1|||
124592920|NCT02457819|448127613|FG000|Overall Study|non compliance with study drug|4|||
124592921|NCT02457819|448127613|FG000|Overall Study|Lost to Follow-up|10|||
124592922|NCT02457819|448127613|FG000|Overall Study|Lack of Efficacy|19|||
124592923|NCT02457819|448127613|FG000|Overall Study|Adverse Event|33|||
124592924|NCT03330236|448127615|FG000|Overall Study|Death|2|||
124592925|NCT03330236|448127616|FG001|Overall Study|Death|1|||
124592926|NCT03330236|448127615|FG000|Overall Study|Withdrawal by Subject|2|||
124592927|NCT03330236|448127616|FG001|Overall Study|Withdrawal by Subject|4|||
124592928|NCT03330236|448127615|FG000|Overall Study|Lost to Follow-up|0|||
124592929|NCT03330236|448127616|FG001|Overall Study|Lost to Follow-up|2|||
124592930|NCT03330236|448127615|FG000|Overall Study|Physician Decision|2|||
124592931|NCT03330236|448127616|FG001|Overall Study|Physician Decision|0|||
124592932|NCT03330236|448127615|FG000|Overall Study|Protocol Violation|4|||
124592933|NCT03330236|448127616|FG001|Overall Study|Protocol Violation|3|||
124592934|NCT03330236|448127615|FG000|Overall Study|SedLine malfunction/blinding|19|||
124592935|NCT03330236|448127616|FG001|Overall Study|SedLine malfunction/blinding|14|||
124592936|NCT03330236|448127615|FG000|Overall Study|Volatile anesthetics used|11|||
124592937|NCT03330236|448127616|FG001|Overall Study|Volatile anesthetics used|8|||
124592938|NCT03330236|448127615|FG000|Overall Study|Surgery aborted/converted to open|60|||
124592939|NCT03330236|448127616|FG001|Overall Study|Surgery aborted/converted to open|52|||
124592940|NCT01901848|448127620|FG000|Randomized and Treated|Lost to Follow-up|3|||
124592941|NCT01901848|448127621|FG001|Randomized and Treated|Lost to Follow-up|6|||
124592942|NCT01901848|448127620|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
124592943|NCT01901848|448127621|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
124592944|NCT00763555|448127622|FG000|Overall Study|Adverse Event|2|||
124592945|NCT00763555|448127623|FG001|Overall Study|Adverse Event|1|||
124592946|NCT00763555|448127622|FG000|Overall Study|Withdrawal by Subject|2|||
124592947|NCT00763555|448127623|FG001|Overall Study|Withdrawal by Subject|6|||
124592948|NCT00763555|448127622|FG000|Overall Study|Lost to Follow-up|0|||
124592949|NCT00763555|448127623|FG001|Overall Study|Lost to Follow-up|3|||
124592950|NCT00852917|448127624|FG000|Overall Study|Adverse Event|13|||
124592951|NCT00852917|448127625|FG001|Overall Study|Adverse Event|20|||
124592952|NCT00852917|448127626|FG002|Overall Study|Adverse Event|35|||
124592953|NCT00852917|448127627|FG003|Overall Study|Adverse Event|17|||
124592954|NCT00852917|448127624|FG000|Overall Study|Lack of Efficacy|21|||
124592955|NCT00852917|448127625|FG001|Overall Study|Lack of Efficacy|11|||
124592956|NCT00852917|448127626|FG002|Overall Study|Lack of Efficacy|11|||
124592957|NCT00852917|448127627|FG003|Overall Study|Lack of Efficacy|47|||
124592958|NCT00852917|448127624|FG000|Overall Study|Withdrawal by Subject|4|||
124592959|NCT00852917|448127625|FG001|Overall Study|Withdrawal by Subject|8|||
124592960|NCT00852917|448127626|FG002|Overall Study|Withdrawal by Subject|10|||
124592961|NCT00852917|448127627|FG003|Overall Study|Withdrawal by Subject|9|||
124592962|NCT00852917|448127624|FG000|Overall Study|Physician Decision|6|||
124592963|NCT00852917|448127625|FG001|Overall Study|Physician Decision|7|||
124592964|NCT00852917|448127626|FG002|Overall Study|Physician Decision|2|||
124592965|NCT00852917|448127627|FG003|Overall Study|Physician Decision|19|||
124592966|NCT00852917|448127624|FG000|Overall Study|Death|0|||
124592967|NCT00852917|448127625|FG001|Overall Study|Death|0|||
124592968|NCT00852917|448127626|FG002|Overall Study|Death|0|||
124592969|NCT00852917|448127627|FG003|Overall Study|Death|1|||
124592970|NCT02488824|448127628|FG000|Overall Study|Adverse Event|1|||
124592971|NCT02488824|448127629|FG001|Overall Study|Adverse Event|1|||
124592972|NCT04317599|448127631|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
124592973|NCT04317599|448127631|FG000|Overall Study|treatment outside standard of care|4|||
124592974|NCT00809965|448127632|FG000|Overall Study|Death|194|||
124592975|NCT00809965|448127633|FG001|Overall Study|Death|147|||
124592976|NCT00809965|448127634|FG002|Overall Study|Death|196|||
124730149|NCT00385944|448634015|FG000|1st Maintenance Dose Period|Physician Decision|1|||
124592977|NCT00809965|448127632|FG000|Overall Study|Lost to Follow-up|17|||
124592978|NCT00809965|448127633|FG001|Overall Study|Lost to Follow-up|10|||
124592979|NCT00809965|448127634|FG002|Overall Study|Lost to Follow-up|18|||
124592980|NCT00809965|448127632|FG000|Overall Study|Withdrawal by Subject|405|||
124592981|NCT00809965|448127633|FG001|Overall Study|Withdrawal by Subject|448|||
124592982|NCT00809965|448127634|FG002|Overall Study|Withdrawal by Subject|441|||
124592983|NCT00809965|448127632|FG000|Overall Study|Other Reason|167|||
124730150|NCT00385944|448634016|FG001|1st Maintenance Dose Period|Physician Decision|0|||
124592984|NCT00809965|448127633|FG001|Overall Study|Other Reason|170|||
124592985|NCT00809965|448127634|FG002|Overall Study|Other Reason|189|||
124779107|NCT04625101|448819469|FG001|Overall Study|Withdrawal by Subject|1|||
124779108|NCT04625101|448819468|FG000|Overall Study|Protocol Deviation|1|||
124779109|NCT04625101|448819469|FG001|Overall Study|Protocol Deviation|0|||
124779110|NCT02533453|448819477|FG000|Overall Study|Adverse Event|6|||
124779111|NCT02533453|448819477|FG000|Overall Study|Protocol Violation|1|||
124779112|NCT02533453|448819477|FG000|Overall Study|Withdrawal by Subject|2|||
124779113|NCT02039843|448819487|FG000|Randomization and Observation Period|Adverse Event|2|||
124779114|NCT02039843|448819488|FG001|Randomization and Observation Period|Adverse Event|0|||
124779115|NCT02039843|448819487|FG000|Randomization and Observation Period|Death|1|||
124779116|NCT02039843|448819488|FG001|Randomization and Observation Period|Death|0|||
124779117|NCT02039843|448819487|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
124779118|NCT02039843|448819488|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
124779119|NCT02039843|448819487|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
124779120|NCT02039843|448819488|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
124779121|NCT02039843|448819487|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
124779122|NCT02039843|448819488|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
124779123|NCT02039843|448819487|FG000|Pairing With a Study Dog|Death|1|||
124779124|NCT02039843|448819488|FG001|Pairing With a Study Dog|Death|0|||
124779125|NCT02039843|448819487|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
124779126|NCT02039843|448819488|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
124779127|NCT02039843|448819487|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
124779128|NCT02039843|448819488|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
124779129|NCT02039843|448819487|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
124779130|NCT02039843|448819488|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
124779131|NCT00806819|448819493|FG000|Overall Study|progressive disease (modified RECIST )|217|||
124779132|NCT00806819|448819494|FG001|Overall Study|progressive disease (modified RECIST )|216|||
124779133|NCT00806819|448819493|FG000|Overall Study|Worsening or AE of underlying disease|18|||
124779134|NCT00806819|448819494|FG001|Overall Study|Worsening or AE of underlying disease|25|||
124779135|NCT00806819|448819493|FG000|Overall Study|Other AE|38|||
124779136|NCT00806819|448819494|FG001|Overall Study|Other AE|40|||
124779137|NCT00806819|448819493|FG000|Overall Study|Protocol Violation|9|||
124779138|NCT00806819|448819494|FG001|Overall Study|Protocol Violation|4|||
124779139|NCT00806819|448819493|FG000|Overall Study|Lost to Follow-up|1|||
124779140|NCT00806819|448819494|FG001|Overall Study|Lost to Follow-up|0|||
124779141|NCT00806819|448819493|FG000|Overall Study|Withdrawal by Subject|32|||
124779142|NCT00806819|448819494|FG001|Overall Study|Withdrawal by Subject|29|||
124779143|NCT00806819|448819493|FG000|Overall Study|Not treated|6|||
124779144|NCT00806819|448819494|FG001|Overall Study|Not treated|3|||
124779145|NCT00806819|448819493|FG000|Overall Study|Reasons other than stated above|25|||
124779146|NCT00806819|448819494|FG001|Overall Study|Reasons other than stated above|41|||
124779147|NCT02752165|448819500|FG000|Overall Study|Withdrawal by Subject|6|||
124779148|NCT02752165|448819501|FG001|Overall Study|Withdrawal by Subject|6|||
124779149|NCT02752165|448819500|FG000|Overall Study|Protocol Violation|6|||
124779150|NCT02752165|448819501|FG001|Overall Study|Protocol Violation|5|||
124779151|NCT02752165|448819500|FG000|Overall Study|Lost to Follow-up|33|||
124779152|NCT02752165|448819501|FG001|Overall Study|Lost to Follow-up|38|||
124779153|NCT01704599|448819502|FG000|Overall Study|Adverse Event|1|||
124779154|NCT03843541|448819510|FG000|Overall Study|Adverse Event|4|||
124779155|NCT03843541|448819511|FG001|Overall Study|Adverse Event|2|||
124779156|NCT03843541|448819512|FG002|Overall Study|Adverse Event|3|||
124779157|NCT03843541|448819510|FG000|Overall Study|Death|1|||
124779158|NCT03843541|448819511|FG001|Overall Study|Death|0|||
124779159|NCT03843541|448819512|FG002|Overall Study|Death|0|||
124779160|NCT03843541|448819510|FG000|Overall Study|Lack of adherence to study medication|0|||
124779161|NCT03843541|448819511|FG001|Overall Study|Lack of adherence to study medication|0|||
124779162|NCT03843541|448819512|FG002|Overall Study|Lack of adherence to study medication|1|||
124779163|NCT03843541|448819510|FG000|Overall Study|Physician Decision|1|||
124779164|NCT03843541|448819511|FG001|Overall Study|Physician Decision|2|||
124779165|NCT03843541|448819512|FG002|Overall Study|Physician Decision|2|||
124779166|NCT03843541|448819510|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
124779167|NCT03843541|448819511|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
124779168|NCT03843541|448819512|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
124779169|NCT03843541|448819510|FG000|Overall Study|Withdrawal by Subject|6|||
124779170|NCT03843541|448819511|FG001|Overall Study|Withdrawal by Subject|9|||
124779171|NCT03843541|448819512|FG002|Overall Study|Withdrawal by Subject|7|||
124779172|NCT03843541|448819510|FG000|Overall Study|Administration of rescue mucolytic|0|||
124779173|NCT03843541|448819511|FG001|Overall Study|Administration of rescue mucolytic|0|||
124779174|NCT03843541|448819512|FG002|Overall Study|Administration of rescue mucolytic|1|||
124779175|NCT03843541|448819510|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
124779176|NCT03843541|448819511|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
124779177|NCT03843541|448819512|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
124592986|NCT02315066|448127635|FG000|Overall Study|Lost to Follow-up|0|||
124592987|NCT02315066|448127636|FG001|Overall Study|Lost to Follow-up|1|||
124592988|NCT02315066|448127637|FG002|Overall Study|Lost to Follow-up|1|||
124592989|NCT02315066|448127638|FG003|Overall Study|Lost to Follow-up|0|||
124592990|NCT02315066|448127639|FG004|Overall Study|Lost to Follow-up|1|||
124592991|NCT02315066|448127640|FG005|Overall Study|Lost to Follow-up|0|||
124592992|NCT02315066|448127641|FG006|Overall Study|Lost to Follow-up|2|||
124592993|NCT02315066|448127642|FG007|Overall Study|Lost to Follow-up|1|||
124592994|NCT02315066|448127643|FG008|Overall Study|Lost to Follow-up|0|||
124592995|NCT02315066|448127644|FG009|Overall Study|Lost to Follow-up|0|||
124592996|NCT02315066|448127645|FG010|Overall Study|Lost to Follow-up|1|||
124592997|NCT02315066|448127646|FG011|Overall Study|Lost to Follow-up|2|||
124592998|NCT02315066|448127647|FG012|Overall Study|Lost to Follow-up|0|||
124592999|NCT02315066|448127648|FG013|Overall Study|Lost to Follow-up|4|||
124593000|NCT02315066|448127635|FG000|Overall Study|Death|2|||
124593001|NCT02315066|448127636|FG001|Overall Study|Death|7|||
124593002|NCT02315066|448127637|FG002|Overall Study|Death|6|||
124593003|NCT02315066|448127638|FG003|Overall Study|Death|11|||
124593004|NCT02315066|448127639|FG004|Overall Study|Death|10|||
124593005|NCT02315066|448127640|FG005|Overall Study|Death|3|||
124593006|NCT02315066|448127641|FG006|Overall Study|Death|9|||
124593007|NCT02315066|448127642|FG007|Overall Study|Death|9|||
124593008|NCT02315066|448127643|FG008|Overall Study|Death|10|||
124593009|NCT02315066|448127644|FG009|Overall Study|Death|8|||
124593010|NCT02315066|448127645|FG010|Overall Study|Death|10|||
124593011|NCT02315066|448127646|FG011|Overall Study|Death|7|||
124593012|NCT02315066|448127647|FG012|Overall Study|Death|8|||
124593013|NCT02315066|448127648|FG013|Overall Study|Death|21|||
124593014|NCT02315066|448127635|FG000|Overall Study|Other|0|||
124593015|NCT02315066|448127636|FG001|Overall Study|Other|0|||
124593016|NCT02315066|448127637|FG002|Overall Study|Other|0|||
124593017|NCT02315066|448127638|FG003|Overall Study|Other|0|||
124593018|NCT02315066|448127639|FG004|Overall Study|Other|0|||
124593019|NCT02315066|448127640|FG005|Overall Study|Other|0|||
124593020|NCT02315066|448127641|FG006|Overall Study|Other|0|||
124593021|NCT02315066|448127642|FG007|Overall Study|Other|1|||
124593022|NCT02315066|448127643|FG008|Overall Study|Other|1|||
124593023|NCT02315066|448127644|FG009|Overall Study|Other|2|||
124593024|NCT02315066|448127645|FG010|Overall Study|Other|0|||
124593025|NCT02315066|448127646|FG011|Overall Study|Other|0|||
124593026|NCT02315066|448127647|FG012|Overall Study|Other|0|||
124593027|NCT02315066|448127648|FG013|Overall Study|Other|0|||
124593028|NCT02315066|448127635|FG000|Overall Study|Subject refused further follow-up|0|||
124593029|NCT02315066|448127636|FG001|Overall Study|Subject refused further follow-up|2|||
124593030|NCT02315066|448127637|FG002|Overall Study|Subject refused further follow-up|2|||
124593031|NCT02315066|448127638|FG003|Overall Study|Subject refused further follow-up|0|||
124593032|NCT02315066|448127639|FG004|Overall Study|Subject refused further follow-up|0|||
124593033|NCT02315066|448127640|FG005|Overall Study|Subject refused further follow-up|0|||
124593034|NCT02315066|448127641|FG006|Overall Study|Subject refused further follow-up|2|||
124593035|NCT02315066|448127642|FG007|Overall Study|Subject refused further follow-up|3|||
124593036|NCT02315066|448127643|FG008|Overall Study|Subject refused further follow-up|0|||
124593037|NCT02315066|448127644|FG009|Overall Study|Subject refused further follow-up|1|||
124593038|NCT02315066|448127645|FG010|Overall Study|Subject refused further follow-up|1|||
124593039|NCT02315066|448127646|FG011|Overall Study|Subject refused further follow-up|2|||
124593040|NCT02315066|448127647|FG012|Overall Study|Subject refused further follow-up|2|||
124593041|NCT02315066|448127648|FG013|Overall Study|Subject refused further follow-up|4|||
124593042|NCT02315066|448127635|FG000|Overall Study|Study ongoing at date of cut-off|0|||
124593043|NCT02315066|448127636|FG001|Overall Study|Study ongoing at date of cut-off|0|||
124593044|NCT02315066|448127637|FG002|Overall Study|Study ongoing at date of cut-off|0|||
124593045|NCT02315066|448127638|FG003|Overall Study|Study ongoing at date of cut-off|0|||
124593046|NCT02315066|448127639|FG004|Overall Study|Study ongoing at date of cut-off|0|||
124593047|NCT02315066|448127640|FG005|Overall Study|Study ongoing at date of cut-off|0|||
124593048|NCT02315066|448127641|FG006|Overall Study|Study ongoing at date of cut-off|0|||
124593049|NCT02315066|448127642|FG007|Overall Study|Study ongoing at date of cut-off|0|||
124593050|NCT02315066|448127643|FG008|Overall Study|Study ongoing at date of cut-off|0|||
124779178|NCT05767749|448819521|FG000|Overall Study|Withdrawal by Subject|0|||
124593051|NCT02315066|448127644|FG009|Overall Study|Study ongoing at date of cut-off|0|||
124593052|NCT02315066|448127645|FG010|Overall Study|Study ongoing at date of cut-off|0|||
124593053|NCT02315066|448127646|FG011|Overall Study|Study ongoing at date of cut-off|0|||
124593054|NCT02315066|448127647|FG012|Overall Study|Study ongoing at date of cut-off|0|||
124593055|NCT02315066|448127648|FG013|Overall Study|Study ongoing at date of cut-off|1|||
124593056|NCT00112294|448127649|FG000|Overall Study|Still on study|5|||
124593057|NCT00112294|448127650|FG001|Overall Study|Still on study|0|||
124593058|NCT01142908|448127651|FG000|Overall Study|Lost to Follow-up|19|||
124593059|NCT01142908|448127652|FG001|Overall Study|Lost to Follow-up|13|||
124593060|NCT01142908|448127651|FG000|Overall Study|Death|1|||
124593061|NCT01142908|448127652|FG001|Overall Study|Death|4|||
124593062|NCT01142908|448127651|FG000|Overall Study|Excluded - did not meet criteria|9|||
124779179|NCT05767749|448819522|FG001|Overall Study|Withdrawal by Subject|0|||
124593063|NCT01142908|448127652|FG001|Overall Study|Excluded - did not meet criteria|5|||
124593064|NCT01142908|448127651|FG000|Overall Study|Withdrawal by Subject|3|||
124593065|NCT01142908|448127652|FG001|Overall Study|Withdrawal by Subject|0|||
124593066|NCT01186016|448127655|FG000|Overall Study|Withdrawal by Subject|46|||
124593067|NCT01186016|448127656|FG001|Overall Study|Withdrawal by Subject|29|||
124593068|NCT01055886|448127658|FG000|Overall Study|Withdrawal by Subject|4|||
124593069|NCT01055886|448127659|FG001|Overall Study|Withdrawal by Subject|9|||
124593070|NCT01055886|448127658|FG000|Overall Study|Lost to Follow-up|1|||
124593071|NCT01055886|448127659|FG001|Overall Study|Lost to Follow-up|1|||
124593072|NCT01055886|448127658|FG000|Overall Study|Withdrawal by PI|0|||
124593073|NCT01055886|448127659|FG001|Overall Study|Withdrawal by PI|1|||
124593074|NCT02972515|448127662|FG000|Overall Study|Lost to Follow-up|78|||
124593075|NCT01086969|448127663|FG000|Overall Study|Withdrawal by Subject|1|||
124593076|NCT01086969|448127664|FG001|Overall Study|Withdrawal by Subject|2|||
124593077|NCT01086969|448127665|FG002|Overall Study|Withdrawal by Subject|0|||
124593078|NCT00585312|448127676|FG000|Overall Study|Adverse Event|3|||
124593079|NCT00585312|448127677|FG001|Overall Study|Adverse Event|0|||
124593080|NCT00585312|448127676|FG000|Overall Study|Lack of Efficacy|6|||
124593081|NCT00585312|448127677|FG001|Overall Study|Lack of Efficacy|11|||
124593082|NCT00585312|448127676|FG000|Overall Study|Lost to Follow-up|1|||
124593083|NCT00585312|448127677|FG001|Overall Study|Lost to Follow-up|1|||
124593084|NCT00585312|448127676|FG000|Overall Study|Reason not specified|2|||
124593085|NCT00585312|448127677|FG001|Overall Study|Reason not specified|0|||
124593086|NCT00585312|448127676|FG000|Overall Study|Withdrawal by Subject|5|||
124593087|NCT00585312|448127677|FG001|Overall Study|Withdrawal by Subject|1|||
124593088|NCT00585312|448127676|FG000|Overall Study|Study terminated by the sponsor|34|||
124593089|NCT00585312|448127677|FG001|Overall Study|Study terminated by the sponsor|31|||
124593090|NCT04291508|448127680|FG000|Overall Study|Withdrawal by Subject|1|||
124593091|NCT04291508|448127681|FG001|Overall Study|Withdrawal by Subject|0|||
124593092|NCT04291508|448127682|FG002|Overall Study|Withdrawal by Subject|1|||
124593093|NCT04291508|448127683|FG003|Overall Study|Withdrawal by Subject|0|||
124593094|NCT04291508|448127680|FG000|Overall Study|lost to follow up|4|||
124593095|NCT04291508|448127681|FG001|Overall Study|lost to follow up|0|||
124593096|NCT04291508|448127682|FG002|Overall Study|lost to follow up|1|||
124593097|NCT04291508|448127683|FG003|Overall Study|lost to follow up|0|||
124593098|NCT04203667|448127684|FG000|Overall Study|Withdrawal by Subject|1|||
124593099|NCT04203667|448127684|FG000|Overall Study|Lost to Follow-up|1|||
124593100|NCT04203667|448127684|FG000|Overall Study|Death|1|||
124593101|NCT04203667|448127684|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
124593102|NCT02329431|448127685|FG000|Overall Study|Lost to Follow-up|20|||
124593103|NCT02329431|448127686|FG001|Overall Study|Lost to Follow-up|13|||
124593104|NCT01362296|448127687|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
124593105|NCT01362296|448127688|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
124593106|NCT01362296|448127689|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
124593107|NCT01362296|448127690|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
124593108|NCT01362296|448127687|FG000|Randomized Phase (RP)|Physician Decision|1|||
124593109|NCT01362296|448127688|FG001|Randomized Phase (RP)|Physician Decision|9|||
124593110|NCT01362296|448127689|FG002|Randomized Phase (RP)|Physician Decision|0|||
124593111|NCT01362296|448127690|FG003|Randomized Phase (RP)|Physician Decision|0|||
124593112|NCT01362296|448127687|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
124593113|NCT01362296|448127688|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
124593114|NCT01362296|448127689|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
124730151|NCT00385944|448634017|FG002|1st Maintenance Dose Period|Physician Decision|0|||
124730152|NCT00385944|448634015|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
124730153|NCT00385944|448634016|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
124730154|NCT00385944|448634017|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
124730155|NCT00385944|448634015|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
124730156|NCT00385944|448634016|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
124730157|NCT00385944|448634017|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
124593115|NCT01362296|448127690|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
124593116|NCT01362296|448127687|FG000|Randomized Phase (RP)|Adverse Event|20|||
124593117|NCT01362296|448127688|FG001|Randomized Phase (RP)|Adverse Event|4|||
124730158|NCT00385944|448634015|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
124730159|NCT00385944|448634016|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
124730160|NCT00385944|448634017|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
124730161|NCT00590824|448634018|FG000|Overall Study|Disease could not be resected|0|||
124593118|NCT01362296|448127689|FG002|Randomized Phase (RP)|Adverse Event|0|||
124593119|NCT01362296|448127690|FG003|Randomized Phase (RP)|Adverse Event|0|||
124593120|NCT01362296|448127687|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
124593121|NCT01362296|448127688|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
124593122|NCT01362296|448127689|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
124730162|NCT00590824|448634019|FG001|Overall Study|Disease could not be resected|2|||
124730163|NCT00590824|448634020|FG002|Overall Study|Disease could not be resected|1|||
124730164|NCT00590824|448634021|FG003|Overall Study|Disease could not be resected|0|||
124593123|NCT01362296|448127690|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
124593124|NCT01362296|448127687|FG000|Crossover Phase|PD including Death due to PD|0|||
124593125|NCT01362296|448127688|FG001|Crossover Phase|PD including Death due to PD|0|||
124593126|NCT01362296|448127689|FG002|Crossover Phase|PD including Death due to PD|16|||
124593127|NCT01362296|448127690|FG003|Crossover Phase|PD including Death due to PD|1|||
124593128|NCT01362296|448127687|FG000|Crossover Phase|Withdrawal by Subject|0|||
124593129|NCT01362296|448127688|FG001|Crossover Phase|Withdrawal by Subject|0|||
124593130|NCT01362296|448127689|FG002|Crossover Phase|Withdrawal by Subject|2|||
124593131|NCT01362296|448127690|FG003|Crossover Phase|Withdrawal by Subject|1|||
124593132|NCT01362296|448127687|FG000|Crossover Phase|Adverse Event|0|||
124593133|NCT01362296|448127688|FG001|Crossover Phase|Adverse Event|0|||
124593134|NCT01362296|448127689|FG002|Crossover Phase|Adverse Event|4|||
124593135|NCT01362296|448127690|FG003|Crossover Phase|Adverse Event|0|||
124593136|NCT01362296|448127687|FG000|Crossover Phase|Study Closed/Terminated|0|||
124593137|NCT01362296|448127688|FG001|Crossover Phase|Study Closed/Terminated|0|||
124593138|NCT01362296|448127689|FG002|Crossover Phase|Study Closed/Terminated|1|||
124593139|NCT01362296|448127690|FG003|Crossover Phase|Study Closed/Terminated|0|||
124593140|NCT02459418|448129027|FG000|Overall Study|Exclusion Criteria|4|||
124593141|NCT02459418|448129028|FG001|Overall Study|Exclusion Criteria|0|||
124593142|NCT02459418|448129027|FG000|Overall Study|Protocol Violation|0|||
124593143|NCT02459418|448129028|FG001|Overall Study|Protocol Violation|2|||
124593144|NCT02459418|448129027|FG000|Overall Study|Physician Decision|0|||
124593145|NCT02459418|448129028|FG001|Overall Study|Physician Decision|2|||
124593146|NCT02459418|448129027|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
124593147|NCT02459418|448129028|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
124593148|NCT02459418|448129027|FG000|Overall Study|Adverse Event|0|||
124593149|NCT02459418|448129028|FG001|Overall Study|Adverse Event|1|||
124593150|NCT02459418|448129027|FG000|Overall Study|Withdrawal by Subject|1|||
124593151|NCT02459418|448129028|FG001|Overall Study|Withdrawal by Subject|1|||
124593152|NCT02459418|448129027|FG000|Overall Study|Elevated Creatine Kinase|1|||
124593153|NCT02459418|448129028|FG001|Overall Study|Elevated Creatine Kinase|0|||
124593154|NCT02459418|448129027|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
124593155|NCT02459418|448129028|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
124593156|NCT00653159|448129029|FG000|Overall Study|Adverse Event|4|||
124593157|NCT00653159|448129030|FG001|Overall Study|Adverse Event|1|||
124593158|NCT00653159|448129029|FG000|Overall Study|Lost to Follow-up|1|||
124593159|NCT00653159|448129030|FG001|Overall Study|Lost to Follow-up|2|||
124593160|NCT00109837|448129031|FG000|Overall Study|Adverse Event|2|||
124593161|NCT00109837|448129031|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
124593162|NCT00109837|448129031|FG000|Overall Study|Death|1|||
124593163|NCT00109837|448129031|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
124593164|NCT00109837|448129031|FG000|Overall Study|Not treated|1|||
124593165|NCT00109837|448129031|FG000|Overall Study|Ineligible|1|||
124593166|NCT00381849|448129032|FG000|Wash Out|Withdrawal by Subject|0|||
124593167|NCT00381849|448129033|FG001|Wash Out|Withdrawal by Subject|1|||
124593168|NCT04167618|448129034|FG000|Overall Study|Trial terminated by sponsor|1|||
124593169|NCT04167618|448129035|FG001|Overall Study|Trial terminated by sponsor|1|||
124593170|NCT05996198|448129036|FG000|Overall Study|Withdrawal by Subject|1|||
124593171|NCT05996198|448129037|FG001|Overall Study|Withdrawal by Subject|0|||
124593172|NCT00835796|448129039|FG000|First Intervention|Withdrawal by Subject|0|||
124593173|NCT00835796|448129040|FG001|First Intervention|Withdrawal by Subject|1|||
124593174|NCT00651183|448129043|FG000|Overall Study|Lack of Efficacy|1|||
124593175|NCT00651183|448129044|FG001|Overall Study|Lack of Efficacy|0|||
124593176|NCT00651183|448129043|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
124593177|NCT00651183|448129044|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
124593178|NCT00651183|448129043|FG000|Overall Study|Tolerability insufficient|5|||
124593179|NCT00651183|448129044|FG001|Overall Study|Tolerability insufficient|2|||
124593180|NCT00651183|448129043|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
124593181|NCT00651183|448129044|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
124593182|NCT00651183|448129043|FG000|Overall Study|Withdrawal by Subject|6|||
124593183|NCT00651183|448129044|FG001|Overall Study|Withdrawal by Subject|3|||
124593184|NCT00651183|448129043|FG000|Overall Study|Lost to Follow-up|3|||
124593185|NCT00651183|448129044|FG001|Overall Study|Lost to Follow-up|1|||
124593186|NCT00651183|448129043|FG000|Overall Study|Other reasons|4|||
124593187|NCT00651183|448129044|FG001|Overall Study|Other reasons|2|||
124593188|NCT00651183|448129043|FG000|Overall Study|missing|1|||
124593189|NCT00651183|448129044|FG001|Overall Study|missing|0|||
124593190|NCT01363011|448129046|FG000|Main Study|Adverse Event|2|||
124593191|NCT01363011|448129047|FG001|Main Study|Adverse Event|3|||
124593192|NCT01363011|448129046|FG000|Main Study|Investigator's Discretion|1|||
124593193|NCT01363011|448129047|FG001|Main Study|Investigator's Discretion|1|||
124593194|NCT01363011|448129046|FG000|Main Study|Withdrew Consent|1|||
124593195|NCT01363011|448129047|FG001|Main Study|Withdrew Consent|4|||
124593196|NCT01363011|448129046|FG000|Main Study|Protocol Violation|0|||
124593197|NCT01363011|448129047|FG001|Main Study|Protocol Violation|1|||
124593198|NCT01363011|448129046|FG000|Extension Phase|Adverse Event|1|||
124779180|NCT05767749|448819523|FG002|Overall Study|Withdrawal by Subject|2|||
124593199|NCT01363011|448129047|FG001|Extension Phase|Adverse Event|1|||
124593200|NCT01363011|448129046|FG000|Extension Phase|Lack of Efficacy|0|||
124593201|NCT01363011|448129047|FG001|Extension Phase|Lack of Efficacy|1|||
124593202|NCT01363011|448129046|FG000|Extension Phase|Investigator's Discretion|2|||
124593203|NCT01363011|448129047|FG001|Extension Phase|Investigator's Discretion|2|||
124593204|NCT01363011|448129046|FG000|Extension Phase|Withdrew Consent|0|||
124593205|NCT01363011|448129047|FG001|Extension Phase|Withdrew Consent|1|||
124593206|NCT01363011|448129046|FG000|Extension Phase|Lost to Follow-up|0|||
124593207|NCT01363011|448129047|FG001|Extension Phase|Lost to Follow-up|2|||
124593208|NCT01363011|448129046|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
124593209|NCT01363011|448129047|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
124593210|NCT04412057|448129048|FG000|Overall Study|Death|3|||
124593211|NCT04412057|448129049|FG001|Overall Study|Death|7|||
124593212|NCT04412057|448129048|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
124593213|NCT04412057|448129049|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
124593214|NCT01961882|448129053|FG000|Overall Study|Adverse Event|3|||
124593215|NCT01961882|448129054|FG001|Overall Study|Adverse Event|2|||
124593216|NCT01961882|448129053|FG000|Overall Study|Physician Decision|1|||
124593217|NCT01961882|448129054|FG001|Overall Study|Physician Decision|0|||
124593218|NCT01961882|448129053|FG000|Overall Study|Withdrawal by Subject|4|||
124593219|NCT01961882|448129054|FG001|Overall Study|Withdrawal by Subject|1|||
124593220|NCT01961882|448129053|FG000|Overall Study|Relapse of AML|39|||
124593221|NCT01961882|448129054|FG001|Overall Study|Relapse of AML|37|||
124593222|NCT01961882|448129053|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
124593223|NCT01961882|448129054|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
124593224|NCT01961882|448129053|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
124593225|NCT01961882|448129054|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
124593226|NCT03710590|448129055|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
124593227|NCT03710590|448129056|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
124593228|NCT00407745|448129057|FG000|Overall Study|Lack of Efficacy|1|||
124593229|NCT00407745|448129058|FG001|Overall Study|Lack of Efficacy|2|||
124593230|NCT00407745|448129057|FG000|Overall Study|Withdrawal by Subject|3|||
124593231|NCT00407745|448129058|FG001|Overall Study|Withdrawal by Subject|3|||
124593232|NCT00407745|448129057|FG000|Overall Study|Protocol Violation|5|||
124593233|NCT00407745|448129058|FG001|Overall Study|Protocol Violation|3|||
124593234|NCT00407745|448129057|FG000|Overall Study|Adverse Event|8|||
124593235|NCT00407745|448129058|FG001|Overall Study|Adverse Event|8|||
124593236|NCT00407745|448129057|FG000|Overall Study|Other|2|||
124593237|NCT00407745|448129058|FG001|Overall Study|Other|0|||
124593238|NCT00407745|448129057|FG000|Overall Study|Randomized, unknown if treated|0|||
124593239|NCT00407745|448129058|FG001|Overall Study|Randomized, unknown if treated|1|||
124593240|NCT00108082|448129059|FG000|Overall Study|Adverse Event|14|||
124593241|NCT00108082|448129060|FG001|Overall Study|Adverse Event|12|||
124593242|NCT00108082|448129061|FG002|Overall Study|Adverse Event|17|||
124593243|NCT00108082|448129059|FG000|Overall Study|Lost to Follow-up|6|||
124593244|NCT00108082|448129060|FG001|Overall Study|Lost to Follow-up|3|||
124593245|NCT00108082|448129061|FG002|Overall Study|Lost to Follow-up|7|||
124593246|NCT00108082|448129059|FG000|Overall Study|Consent Withdrawn|3|||
124593247|NCT00108082|448129060|FG001|Overall Study|Consent Withdrawn|3|||
124593248|NCT00108082|448129061|FG002|Overall Study|Consent Withdrawn|5|||
124593249|NCT00108082|448129059|FG000|Overall Study|Protocol Violation|1|||
124593250|NCT00108082|448129060|FG001|Overall Study|Protocol Violation|2|||
124593251|NCT00108082|448129061|FG002|Overall Study|Protocol Violation|0|||
124593252|NCT00108082|448129059|FG000|Overall Study|Lack of Efficacy|3|||
124593253|NCT00108082|448129060|FG001|Overall Study|Lack of Efficacy|1|||
124593254|NCT00108082|448129061|FG002|Overall Study|Lack of Efficacy|2|||
124593255|NCT00108082|448129059|FG000|Overall Study|Amendment 4: > Month 12|5|||
124593256|NCT00108082|448129060|FG001|Overall Study|Amendment 4: > Month 12|7|||
124593257|NCT00108082|448129061|FG002|Overall Study|Amendment 4: > Month 12|5|||
124593258|NCT00108082|448129059|FG000|Overall Study|Woman of Child-bearing Potential|2|||
124593259|NCT00108082|448129060|FG001|Overall Study|Woman of Child-bearing Potential|0|||
124730165|NCT00590824|448634018|FG000|Overall Study|Adverse Event|0|||
124593260|NCT00108082|448129061|FG002|Overall Study|Woman of Child-bearing Potential|2|||
124593261|NCT00108082|448129059|FG000|Overall Study|Incorrectly Randomized|0|||
124593262|NCT00108082|448129060|FG001|Overall Study|Incorrectly Randomized|0|||
124593263|NCT00108082|448129061|FG002|Overall Study|Incorrectly Randomized|2|||
124593264|NCT00108082|448129059|FG000|Overall Study|Non-compliance|1|||
124593265|NCT00108082|448129060|FG001|Overall Study|Non-compliance|0|||
124593266|NCT00108082|448129061|FG002|Overall Study|Non-compliance|2|||
124593267|NCT00108082|448129059|FG000|Overall Study|Stopped Study Medication|0|||
124593268|NCT00108082|448129060|FG001|Overall Study|Stopped Study Medication|0|||
124593269|NCT00108082|448129061|FG002|Overall Study|Stopped Study Medication|1|||
124593270|NCT00108082|448129059|FG000|Overall Study|Site Closed Study|0|||
124593271|NCT00108082|448129060|FG001|Overall Study|Site Closed Study|2|||
124593272|NCT00108082|448129061|FG002|Overall Study|Site Closed Study|0|||
124593273|NCT00108082|448129059|FG000|Overall Study|Protocol Amendment|0|||
124593274|NCT00108082|448129060|FG001|Overall Study|Protocol Amendment|1|||
124593275|NCT00108082|448129061|FG002|Overall Study|Protocol Amendment|0|||
124593276|NCT00108082|448129059|FG000|Overall Study|Study Medication Not Tapered|0|||
124593277|NCT00108082|448129060|FG001|Overall Study|Study Medication Not Tapered|1|||
124593278|NCT00108082|448129061|FG002|Overall Study|Study Medication Not Tapered|0|||
124593279|NCT00108082|448129059|FG000|Overall Study|Subject Left Site Location|1|||
124593280|NCT00108082|448129060|FG001|Overall Study|Subject Left Site Location|0|||
124593281|NCT00108082|448129061|FG002|Overall Study|Subject Left Site Location|0|||
124593282|NCT00108082|448129059|FG000|Overall Study|Investigator Not at Site|1|||
124593283|NCT00108082|448129060|FG001|Overall Study|Investigator Not at Site|0|||
124593284|NCT00108082|448129061|FG002|Overall Study|Investigator Not at Site|0|||
124593285|NCT00108082|448129059|FG000|Overall Study|Blood Pressure Not Controlled|1|||
124593286|NCT00108082|448129060|FG001|Overall Study|Blood Pressure Not Controlled|0|||
124593287|NCT00108082|448129061|FG002|Overall Study|Blood Pressure Not Controlled|0|||
124593288|NCT01563237|448129062|FG000|Overall Study|Lost to Follow-up|6|||
124593289|NCT01563237|448129063|FG001|Overall Study|Lost to Follow-up|0|||
124593290|NCT01563237|448129062|FG000|Overall Study|Withdrawal by Subject|1|||
124593291|NCT01563237|448129063|FG001|Overall Study|Withdrawal by Subject|0|||
124593292|NCT01563237|448129062|FG000|Overall Study|Adverse Event|1|||
124593293|NCT01563237|448129063|FG001|Overall Study|Adverse Event|0|||
124593294|NCT01563237|448129062|FG000|Overall Study|Medical Reasons|1|||
124593295|NCT01563237|448129063|FG001|Overall Study|Medical Reasons|0|||
124593296|NCT01563237|448129062|FG000|Overall Study|Death|1|||
124593297|NCT01563237|448129063|FG001|Overall Study|Death|0|||
124593298|NCT02940730|448129069|FG000|Intervention 2|Physician Decision|7|||
124593299|NCT02940730|448129070|FG001|Intervention 2|Physician Decision|0|||
124593300|NCT03036839|448129072|FG000|Overall Study|Adverse Event|0|||
124593301|NCT03036839|448129073|FG001|Overall Study|Adverse Event|0|||
124593302|NCT03036839|448129074|FG002|Overall Study|Adverse Event|1|||
124593303|NCT03036839|448129072|FG000|Overall Study|Death|3|||
124593304|NCT03036839|448129073|FG001|Overall Study|Death|0|||
124593305|NCT03036839|448129074|FG002|Overall Study|Death|3|||
124593306|NCT03036839|448129072|FG000|Overall Study|Withdrew Consent|0|||
124593307|NCT03036839|448129073|FG001|Overall Study|Withdrew Consent|0|||
124593308|NCT03036839|448129074|FG002|Overall Study|Withdrew Consent|1|||
124593309|NCT00412737|448129075|FG000|Overall Study|Death|1|||
124593310|NCT00412737|448129076|FG001|Overall Study|Death|0|||
124593311|NCT00412737|448129075|FG000|Overall Study|Adverse Event|3|||
124593312|NCT00412737|448129076|FG001|Overall Study|Adverse Event|2|||
124593313|NCT00412737|448129075|FG000|Overall Study|Refused Treatment|6|||
124593314|NCT00412737|448129076|FG001|Overall Study|Refused Treatment|2|||
124593315|NCT00412737|448129075|FG000|Overall Study|Failure to Return|6|||
124593316|NCT00412737|448129076|FG001|Overall Study|Failure to Return|2|||
124593317|NCT01064531|448129079|FG000|Overall Study|Lost to Follow-up|0|||
124593318|NCT01064531|448129080|FG001|Overall Study|Lost to Follow-up|2|||
124593319|NCT01064531|448129079|FG000|Overall Study|Physician Decision|0|||
124593320|NCT01064531|448129080|FG001|Overall Study|Physician Decision|1|||
124593321|NCT01064531|448129079|FG000|Overall Study|Withdrawal by Subject|2|||
124593322|NCT01064531|448129080|FG001|Overall Study|Withdrawal by Subject|2|||
124593323|NCT01064531|448129079|FG000|Overall Study|Revision due to femoral stem loosening|1|||
124593324|NCT01064531|448129080|FG001|Overall Study|Revision due to femoral stem loosening|0|||
124593325|NCT01064531|448129079|FG000|Overall Study|Revision due to dislocation|0|||
124593326|NCT01064531|448129080|FG001|Overall Study|Revision due to dislocation|1|||
124593327|NCT01064531|448129079|FG000|Overall Study|Death|0|||
124593328|NCT01064531|448129080|FG001|Overall Study|Death|1|||
124593329|NCT03449199|448129084|FG000|Overall Study|Lost to Follow-up|1|||
124593330|NCT03449199|448129085|FG001|Overall Study|Lost to Follow-up|1|||
124593331|NCT03449199|448129086|FG002|Overall Study|Lost to Follow-up|0|||
124593332|NCT03449199|448129084|FG000|Overall Study|Protocol Deviation|0|||
124593333|NCT03449199|448129085|FG001|Overall Study|Protocol Deviation|0|||
124593334|NCT03449199|448129086|FG002|Overall Study|Protocol Deviation|1|||
124593335|NCT03449199|448129084|FG000|Overall Study|Withdrawal by Subject|0|||
124593336|NCT03449199|448129085|FG001|Overall Study|Withdrawal by Subject|0|||
124593337|NCT03449199|448129086|FG002|Overall Study|Withdrawal by Subject|1|||
124593338|NCT01091103|448129087|FG000|Overall Study|Adverse Event|1|||
124593339|NCT01091103|448129087|FG000|Overall Study|Progressive Disease|3|||
124593340|NCT01270620|448129088|FG000|Overall Study|Withdrawal by Subject|1|||
124593341|NCT01270620|448129089|FG001|Overall Study|Withdrawal by Subject|3|||
124593342|NCT00684567|448129090|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
124593343|NCT00684567|448129090|FG000|Monotherapy Period|Adverse Event|2|||
124593344|NCT00684567|448129090|FG000|Monotherapy Period|Death|1|||
124593345|NCT00684567|448129090|FG000|Monotherapy Period|Progression of primary disease|11|||
124593346|NCT03136406|448129091|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
124593347|NCT00988208|448129094|FG000|Overall Study|Adverse Event|71|||
124593348|NCT00988208|448129095|FG001|Overall Study|Adverse Event|122|||
124593349|NCT00988208|448129094|FG000|Overall Study|Disease Progression|103|||
124593350|NCT00988208|448129095|FG001|Overall Study|Disease Progression|89|||
124593351|NCT00988208|448129094|FG000|Overall Study|Withdrawal by Subject|50|||
124593352|NCT00988208|448129095|FG001|Overall Study|Withdrawal by Subject|57|||
124593353|NCT00988208|448129094|FG000|Overall Study|Death|9|||
124593354|NCT00988208|448129095|FG001|Overall Study|Death|15|||
124593355|NCT00988208|448129094|FG000|Overall Study|Lost to Follow-up|2|||
124593356|NCT00988208|448129095|FG001|Overall Study|Lost to Follow-up|3|||
124593357|NCT00988208|448129094|FG000|Overall Study|Protocol Violation|9|||
124593358|NCT00988208|448129095|FG001|Overall Study|Protocol Violation|2|||
124593359|NCT00988208|448129094|FG000|Overall Study|Sponsor Decision|102|||
124593360|NCT00988208|448129095|FG001|Overall Study|Sponsor Decision|78|||
124593361|NCT00988208|448129094|FG000|Overall Study|Clinical Progression|17|||
124593362|NCT00988208|448129095|FG001|Overall Study|Clinical Progression|16|||
124593363|NCT00988208|448129094|FG000|Overall Study|Biochemical Progression|21|||
124593364|NCT00988208|448129095|FG001|Overall Study|Biochemical Progression|7|||
124593365|NCT00988208|448129094|FG000|Overall Study|Clinical Deterioration|7|||
124593366|NCT00988208|448129095|FG001|Overall Study|Clinical Deterioration|14|||
124593367|NCT00988208|448129094|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
124593368|NCT00988208|448129095|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
124593369|NCT00988208|448129094|FG000|Overall Study|Other|8|||
124593370|NCT00988208|448129095|FG001|Overall Study|Other|3|||
124593371|NCT01045707|448129101|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
124593372|NCT01045707|448129102|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
124593373|NCT01045707|448129101|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
124593374|NCT01045707|448129102|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
124593375|NCT01045707|448129101|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
124593376|NCT01045707|448129102|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
124593377|NCT01045707|448129101|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
124593378|NCT01045707|448129102|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
124593379|NCT01045707|448129101|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
124593380|NCT01045707|448129102|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
124593381|NCT01045707|448129101|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
124593382|NCT01045707|448129102|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
124593383|NCT01045707|448129101|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
124593384|NCT01045707|448129102|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
124593385|NCT01045707|448129101|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
124593386|NCT01045707|448129102|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
124593387|NCT01045707|448129101|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
124593388|NCT01045707|448129102|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
124593389|NCT00035555|448129109|FG000|Overall Study|Adverse Event|5|||
124593390|NCT00035555|448129110|FG001|Overall Study|Adverse Event|8|||
124593391|NCT00035555|448129111|FG002|Overall Study|Adverse Event|9|||
124593392|NCT00035555|448129109|FG000|Overall Study|Allograft loss|1|||
124593393|NCT00035555|448129110|FG001|Overall Study|Allograft loss|1|||
124593394|NCT00035555|448129111|FG002|Overall Study|Allograft loss|2|||
124593395|NCT00035555|448129109|FG000|Overall Study|Death|0|||
124593396|NCT00035555|448129110|FG001|Overall Study|Death|0|||
124593397|NCT00035555|448129111|FG002|Overall Study|Death|2|||
124593398|NCT00035555|448129109|FG000|Overall Study|Lost to Follow-up|0|||
124593399|NCT00035555|448129110|FG001|Overall Study|Lost to Follow-up|0|||
124593400|NCT00035555|448129111|FG002|Overall Study|Lost to Follow-up|1|||
124593401|NCT00035555|448129109|FG000|Overall Study|Noncompliance|0|||
124593402|NCT00035555|448129110|FG001|Overall Study|Noncompliance|1|||
124593403|NCT00035555|448129111|FG002|Overall Study|Noncompliance|1|||
124593404|NCT00035555|448129109|FG000|Overall Study|Prohibited medication|1|||
124593405|NCT00035555|448129110|FG001|Overall Study|Prohibited medication|1|||
124593406|NCT00035555|448129111|FG002|Overall Study|Prohibited medication|0|||
124593407|NCT00035555|448129109|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
124593408|NCT00035555|448129110|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
124593409|NCT00035555|448129111|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
124593410|NCT00035555|448129109|FG000|Overall Study|Withdrawal by Subject|2|||
124593411|NCT00035555|448129110|FG001|Overall Study|Withdrawal by Subject|0|||
124593412|NCT00035555|448129111|FG002|Overall Study|Withdrawal by Subject|2|||
124593413|NCT00035555|448129109|FG000|Overall Study|Investigator deemed not a good candidate|0|||
124593414|NCT00035555|448129110|FG001|Overall Study|Investigator deemed not a good candidate|0|||
124593415|NCT00035555|448129111|FG002|Overall Study|Investigator deemed not a good candidate|1|||
124593416|NCT00035555|448129109|FG000|Overall Study|Received cyclosporin in error|0|||
124593417|NCT00035555|448129110|FG001|Overall Study|Received cyclosporin in error|0|||
124593418|NCT00035555|448129111|FG002|Overall Study|Received cyclosporin in error|1|||
124593419|NCT02618382|448129112|FG000|Overall Study|Physician Decision|1|||
124593420|NCT02618382|448129112|FG000|Overall Study|Withdrawal by Subject|1|||
124593421|NCT02618382|448129112|FG000|Overall Study|Protocol Violation|1|||
124593422|NCT03843125|448129113|FG000|Overall Study|Adverse Event|17|||
124593423|NCT03843125|448129114|FG001|Overall Study|Adverse Event|13|||
124593424|NCT03843125|448129115|FG002|Overall Study|Adverse Event|5|||
124593425|NCT03843125|448129116|FG003|Overall Study|Adverse Event|9|||
124593426|NCT03843125|448129113|FG000|Overall Study|Death|0|||
124593427|NCT03843125|448129114|FG001|Overall Study|Death|6|||
124593428|NCT03843125|448129115|FG002|Overall Study|Death|2|||
124593429|NCT03843125|448129116|FG003|Overall Study|Death|0|||
124593430|NCT03843125|448129113|FG000|Overall Study|Lack of Efficacy|14|||
124593431|NCT03843125|448129114|FG001|Overall Study|Lack of Efficacy|11|||
124593432|NCT03843125|448129115|FG002|Overall Study|Lack of Efficacy|9|||
124593433|NCT03843125|448129116|FG003|Overall Study|Lack of Efficacy|4|||
124593434|NCT03843125|448129113|FG000|Overall Study|Lost to Follow-up|3|||
124593435|NCT03843125|448129114|FG001|Overall Study|Lost to Follow-up|4|||
124593436|NCT03843125|448129115|FG002|Overall Study|Lost to Follow-up|0|||
124593437|NCT03843125|448129116|FG003|Overall Study|Lost to Follow-up|2|||
124593438|NCT03843125|448129113|FG000|Overall Study|Other|12|||
124593439|NCT03843125|448129114|FG001|Overall Study|Other|14|||
124593440|NCT03843125|448129115|FG002|Overall Study|Other|3|||
124593441|NCT03843125|448129116|FG003|Overall Study|Other|4|||
124593442|NCT03843125|448129113|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
124593443|NCT03843125|448129114|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
124593444|NCT03843125|448129115|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
124593445|NCT03843125|448129116|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
124593446|NCT03843125|448129113|FG000|Overall Study|Study Terminated by Sponsor|318|||
124593447|NCT03843125|448129114|FG001|Overall Study|Study Terminated by Sponsor|318|||
124593448|NCT03843125|448129115|FG002|Overall Study|Study Terminated by Sponsor|163|||
124593449|NCT03843125|448129116|FG003|Overall Study|Study Terminated by Sponsor|163|||
124593450|NCT03843125|448129113|FG000|Overall Study|Withdrawal by Subject|23|||
124593451|NCT03843125|448129114|FG001|Overall Study|Withdrawal by Subject|12|||
124593452|NCT03843125|448129115|FG002|Overall Study|Withdrawal by Subject|6|||
124593453|NCT03843125|448129116|FG003|Overall Study|Withdrawal by Subject|9|||
124593454|NCT03843125|448129113|FG000|Overall Study|Missing data|0|||
124593455|NCT03843125|448129114|FG001|Overall Study|Missing data|1|||
124593456|NCT03843125|448129115|FG002|Overall Study|Missing data|1|||
124593457|NCT03843125|448129116|FG003|Overall Study|Missing data|0|||
124593458|NCT03173560|448129117|FG000|Overall Study|Death|70|||
124593459|NCT03173560|448129118|FG001|Overall Study|Death|60|||
124593460|NCT03173560|448129117|FG000|Overall Study|Lost to Follow-up|1|||
124593461|NCT03173560|448129118|FG001|Overall Study|Lost to Follow-up|4|||
124593462|NCT03173560|448129117|FG000|Overall Study|Withdrawal by Subject|10|||
124593463|NCT03173560|448129118|FG001|Overall Study|Withdrawal by Subject|5|||
124593464|NCT03173560|448129117|FG000|Overall Study|Other|0|||
124593465|NCT03173560|448129118|FG001|Overall Study|Other|1|||
124593466|NCT04254809|448129119|FG000|Overall Study|Lost to Follow-up|5|||
124593467|NCT04254809|448129120|FG001|Overall Study|Lost to Follow-up|10|||
124593468|NCT03023137|448129121|FG000|Overall Study|Multiple pregnancy|2|||
124593469|NCT03023137|448129122|FG001|Overall Study|Multiple pregnancy|4|||
124593470|NCT03023137|448129121|FG000|Overall Study|Lost to Follow-up|1|||
124593471|NCT03023137|448129122|FG001|Overall Study|Lost to Follow-up|1|||
124593472|NCT03023137|448129121|FG000|Overall Study|Protocol Violation|0|||
124593473|NCT03023137|448129122|FG001|Overall Study|Protocol Violation|4|||
124593474|NCT03023137|448129121|FG000|Overall Study|Lost the baby in a car accident|1|||
124593475|NCT03023137|448129122|FG001|Overall Study|Lost the baby in a car accident|0|||
124593476|NCT02608476|448129123|FG000|Overall Study|Withdrawal by Subject|30|||
124593477|NCT02608476|448129124|FG001|Overall Study|Withdrawal by Subject|37|||
124593478|NCT02608476|448129123|FG000|Overall Study|Lost to Follow-up|24|||
124593479|NCT02608476|448129124|FG001|Overall Study|Lost to Follow-up|24|||
124593480|NCT02608476|448129123|FG000|Overall Study|Adverse Event|2|||
124593481|NCT02608476|448129124|FG001|Overall Study|Adverse Event|8|||
124593482|NCT02608476|448129123|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
124593483|NCT02608476|448129124|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
124593484|NCT02608476|448129123|FG000|Overall Study|Noncompliance with treatment|1|||
124593485|NCT02608476|448129124|FG001|Overall Study|Noncompliance with treatment|5|||
124593486|NCT02608476|448129123|FG000|Overall Study|Lack of Efficacy|3|||
124593487|NCT02608476|448129124|FG001|Overall Study|Lack of Efficacy|1|||
124593488|NCT02608476|448129123|FG000|Overall Study|Other|0|||
124593489|NCT02608476|448129124|FG001|Overall Study|Other|1|||
124593490|NCT02608476|448129123|FG000|Overall Study|Physician Decision|1|||
124593491|NCT02608476|448129124|FG001|Overall Study|Physician Decision|0|||
124593492|NCT02608476|448129123|FG000|Overall Study|Pregnancy|0|||
124593493|NCT02608476|448129124|FG001|Overall Study|Pregnancy|1|||
124593494|NCT02608476|448129123|FG000|Overall Study|Progressive disease|1|||
124593495|NCT02608476|448129124|FG001|Overall Study|Progressive disease|0|||
124593496|NCT02795676|448129125|FG000|Overall Study|Adverse Event|2|||
124593497|NCT02795676|448129126|FG001|Overall Study|Adverse Event|0|||
124593498|NCT02795676|448129125|FG000|Overall Study|Withdrawal by Subject|3|||
124593499|NCT02795676|448129126|FG001|Overall Study|Withdrawal by Subject|1|||
124593500|NCT00605176|448129127|FG000|Overall Study|Adverse Event|2|||
124593501|NCT00605176|448129128|FG001|Overall Study|Adverse Event|1|||
124593502|NCT00605176|448129129|FG002|Overall Study|Adverse Event|3|||
124593503|NCT00605176|448129127|FG000|Overall Study|Withdrawal by Subject|4|||
124593504|NCT00605176|448129128|FG001|Overall Study|Withdrawal by Subject|2|||
124593505|NCT00605176|448129129|FG002|Overall Study|Withdrawal by Subject|4|||
124593506|NCT00605176|448129127|FG000|Overall Study|Lost to Follow-up|2|||
124730166|NCT00590824|448634019|FG001|Overall Study|Adverse Event|0|||
124730167|NCT00590824|448634020|FG002|Overall Study|Adverse Event|0|||
124593507|NCT00605176|448129128|FG001|Overall Study|Lost to Follow-up|2|||
124593508|NCT00605176|448129129|FG002|Overall Study|Lost to Follow-up|1|||
124593509|NCT00605176|448129127|FG000|Overall Study|Non-complicance with study procedures|1|||
124593510|NCT00605176|448129128|FG001|Overall Study|Non-complicance with study procedures|0|||
124593511|NCT00605176|448129129|FG002|Overall Study|Non-complicance with study procedures|0|||
124593512|NCT00605176|448129127|FG000|Overall Study|Use of concomitant therapy|1|||
124593513|NCT00605176|448129128|FG001|Overall Study|Use of concomitant therapy|0|||
124593514|NCT00605176|448129129|FG002|Overall Study|Use of concomitant therapy|1|||
124593515|NCT00605176|448129127|FG000|Overall Study|Other (not due to AE)|1|||
124593516|NCT00605176|448129128|FG001|Overall Study|Other (not due to AE)|1|||
124593517|NCT00605176|448129129|FG002|Overall Study|Other (not due to AE)|0|||
124593518|NCT04253236|448129137|FG000|Overall Study|Adverse Event|1|||
124593519|NCT04253236|448129138|FG001|Overall Study|Adverse Event|0|||
124593520|NCT04253236|448129137|FG000|Overall Study|Safety Concerns|1|||
124593521|NCT04253236|448129138|FG001|Overall Study|Safety Concerns|0|||
124593522|NCT04253236|448129137|FG000|Overall Study|Study Terminated by Sponsor|1|||
124593523|NCT04253236|448129138|FG001|Overall Study|Study Terminated by Sponsor|0|||
124593524|NCT00587431|448129139|FG000|Overall Study|Adverse Event|1|||
124593525|NCT00587431|448129140|FG001|Overall Study|Adverse Event|0|||
124593526|NCT00587431|448129139|FG000|Overall Study|Withdrawal by Subject|0|||
124593527|NCT00587431|448129140|FG001|Overall Study|Withdrawal by Subject|1|||
124593528|NCT03566238|448129141|FG000|Overall Study|Adverse Event|0|||
124593529|NCT03566238|448129142|FG001|Overall Study|Adverse Event|1|||
124593530|NCT03566238|448129143|FG002|Overall Study|Adverse Event|0|||
124593531|NCT03566238|448129141|FG000|Overall Study|Lack of Efficacy|4|||
124593532|NCT03566238|448129142|FG001|Overall Study|Lack of Efficacy|2|||
124593533|NCT03566238|448129143|FG002|Overall Study|Lack of Efficacy|5|||
124593534|NCT03566238|448129141|FG000|Overall Study|Other|1|||
124593535|NCT03566238|448129142|FG001|Overall Study|Other|0|||
124593536|NCT03566238|448129143|FG002|Overall Study|Other|0|||
124593537|NCT00373425|448129150|FG000|Overall Study|Relapse of NSCLC|116|||
124593538|NCT00373425|448129151|FG001|Overall Study|Relapse of NSCLC|104|||
124593539|NCT00373425|448129152|FG002|Overall Study|Relapse of NSCLC|19|||
124593540|NCT00373425|448129153|FG003|Overall Study|Relapse of NSCLC|2|||
124593541|NCT00373425|448129154|FG004|Overall Study|Relapse of NSCLC|26|||
124593542|NCT00373425|448129150|FG000|Overall Study|Adverse Event|191|||
124593543|NCT00373425|448129151|FG001|Overall Study|Adverse Event|22|||
124593544|NCT00373425|448129152|FG002|Overall Study|Adverse Event|59|||
124593545|NCT00373425|448129153|FG003|Overall Study|Adverse Event|0|||
124593546|NCT00373425|448129154|FG004|Overall Study|Adverse Event|34|||
124593547|NCT00373425|448129150|FG000|Overall Study|Patient request|35|||
124593548|NCT00373425|448129151|FG001|Overall Study|Patient request|18|||
124593549|NCT00373425|448129152|FG002|Overall Study|Patient request|43|||
124593550|NCT00373425|448129153|FG003|Overall Study|Patient request|6|||
124593551|NCT00373425|448129154|FG004|Overall Study|Patient request|7|||
124593552|NCT00373425|448129150|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
124593553|NCT00373425|448129151|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
124593554|NCT00373425|448129152|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
124593555|NCT00373425|448129153|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
124593556|NCT00373425|448129154|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
124593557|NCT00373425|448129150|FG000|Overall Study|Death|7|||
124593558|NCT00373425|448129151|FG001|Overall Study|Death|0|||
124593559|NCT00373425|448129152|FG002|Overall Study|Death|3|||
124593560|NCT00373425|448129153|FG003|Overall Study|Death|1|||
124593561|NCT00373425|448129154|FG004|Overall Study|Death|0|||
124593562|NCT03942211|448129157|FG000|Overall Study|Death|1|||
124730168|NCT00590824|448634021|FG003|Overall Study|Adverse Event|1|||
124730169|NCT00791479|448634027|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
124593563|NCT03942211|448129158|FG001|Overall Study|Death|0|||
124593564|NCT03942211|448129157|FG000|Overall Study|Study terminated by sponsor|5|||
124593565|NCT03942211|448129158|FG001|Overall Study|Study terminated by sponsor|3|||
124593566|NCT03942211|448129157|FG000|Overall Study|Adverse Event|0|||
124593567|NCT03942211|448129158|FG001|Overall Study|Adverse Event|1|||
124593568|NCT01183884|448129159|FG000|Overall Study|Progressive Disease|26|||
124593569|NCT01183884|448129159|FG000|Overall Study|Adverse Event|3|||
124593570|NCT01183884|448129159|FG000|Overall Study|Withdrawal by Subject|1|||
124593571|NCT01183884|448129159|FG000|Overall Study|Other Complicating Disease|3|||
124593572|NCT01183884|448129159|FG000|Overall Study|Not Treated|1|||
124593573|NCT01183884|448129159|FG000|Overall Study|Other|4|||
124593574|NCT01835548|448129165|FG000|Dose Optimization Period|Adverse Event|0|||
124593575|NCT01835548|448129166|FG001|Dose Optimization Period|Adverse Event|0|||
124593576|NCT01835548|448129167|FG002|Dose Optimization Period|Adverse Event|1|||
124593577|NCT01835548|448129165|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
124593578|NCT01835548|448129166|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
124593579|NCT01835548|448129167|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
124593580|NCT01835548|448129165|FG000|Double-Blind Treatment Period|Adverse Event|0|||
124593581|NCT01835548|448129166|FG001|Double-Blind Treatment Period|Adverse Event|1|||
124593582|NCT01835548|448129167|FG002|Double-Blind Treatment Period|Adverse Event|0|||
124593583|NCT01835548|448129165|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124593584|NCT01835548|448129166|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
124593585|NCT01835548|448129167|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124593586|NCT01169038|448129168|FG000|Overall Study|Death|1|||
124593587|NCT01169038|448129168|FG000|Overall Study|Adverse Event|5|||
124593588|NCT01169038|448129168|FG000|Overall Study|Required antibiotic administration|1|||
124593589|NCT01488448|448129169|FG000|Overall Study|Withdrawal by Subject|3|||
124593590|NCT01488448|448129170|FG001|Overall Study|Withdrawal by Subject|1|||
124593591|NCT01488448|448129169|FG000|Overall Study|Adverse Event|9|||
124593592|NCT01488448|448129170|FG001|Overall Study|Adverse Event|4|||
124593593|NCT01488448|448129169|FG000|Overall Study|Physician Decision|4|||
124593594|NCT01488448|448129170|FG001|Overall Study|Physician Decision|9|||
124593595|NCT01488448|448129169|FG000|Overall Study|Protocol Violation|4|||
124593596|NCT01488448|448129170|FG001|Overall Study|Protocol Violation|3|||
124593597|NCT00537017|448129171|FG000|Treatment Phase|Adverse Event|19|||
124593598|NCT00537017|448129171|FG000|Treatment Phase|Withdrawal by Subject|13|||
124593599|NCT00537017|448129171|FG000|Treatment Phase|Protocol Violation|2|||
124593600|NCT00537017|448129171|FG000|Follow-up Phase|Withdrawal by Subject|9|||
124593601|NCT03168906|448129174|FG000|Overall Study|Lack of Efficacy|6|||
124593602|NCT03168906|448129175|FG001|Overall Study|Lack of Efficacy|6|||
124593603|NCT02219308|448129176|FG000|Overall Study|Withdrawal by Subject|1|||
124593604|NCT02219308|448129177|FG001|Overall Study|Withdrawal by Subject|2|||
124593605|NCT02447887|448131055|FG000|Overall Study|Study was terminated|3|||
124593606|NCT02839798|448131056|FG000|Overall Study|Withdrawal by Subject|2|||
124593607|NCT00401245|448131057|FG000|Double Blind Titration Phase|Adverse Event|3|||
124593608|NCT00401245|448131058|FG001|Double Blind Titration Phase|Adverse Event|2|||
124593609|NCT00401245|448131059|FG002|Double Blind Titration Phase|Adverse Event|5|||
124593610|NCT00401245|448131060|FG003|Double Blind Titration Phase|Adverse Event|12|||
124593611|NCT00401245|448131061|FG004|Double Blind Titration Phase|Adverse Event|0|||
124593612|NCT00401245|448131062|FG005|Double Blind Titration Phase|Adverse Event|0|||
124593613|NCT00401245|448131063|FG006|Double Blind Titration Phase|Adverse Event|0|||
124593614|NCT00401245|448131064|FG007|Double Blind Titration Phase|Adverse Event|0|||
124593615|NCT00401245|448131057|FG000|Double Blind Titration Phase|Other|0|||
124593616|NCT00401245|448131058|FG001|Double Blind Titration Phase|Other|0|||
124593617|NCT00401245|448131059|FG002|Double Blind Titration Phase|Other|1|||
124593618|NCT00401245|448131060|FG003|Double Blind Titration Phase|Other|0|||
124593619|NCT00401245|448131061|FG004|Double Blind Titration Phase|Other|0|||
124593620|NCT00401245|448131062|FG005|Double Blind Titration Phase|Other|0|||
124593621|NCT00401245|448131063|FG006|Double Blind Titration Phase|Other|0|||
124593622|NCT00401245|448131064|FG007|Double Blind Titration Phase|Other|0|||
124593623|NCT00401245|448131057|FG000|Double Blind Titration Phase|Protocol Violation|0|||
124593624|NCT00401245|448131058|FG001|Double Blind Titration Phase|Protocol Violation|0|||
124593625|NCT00401245|448131059|FG002|Double Blind Titration Phase|Protocol Violation|0|||
124593626|NCT00401245|448131060|FG003|Double Blind Titration Phase|Protocol Violation|1|||
124593627|NCT00401245|448131061|FG004|Double Blind Titration Phase|Protocol Violation|0|||
124593628|NCT00401245|448131062|FG005|Double Blind Titration Phase|Protocol Violation|0|||
124593629|NCT00401245|448131063|FG006|Double Blind Titration Phase|Protocol Violation|0|||
124593630|NCT00401245|448131064|FG007|Double Blind Titration Phase|Protocol Violation|0|||
124593631|NCT00401245|448131057|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
124593632|NCT00401245|448131058|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
124593633|NCT00401245|448131059|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
124593634|NCT00401245|448131060|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
124593635|NCT00401245|448131061|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
124593636|NCT00401245|448131062|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
124593637|NCT00401245|448131063|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
124730170|NCT00791479|448634028|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
124593638|NCT00401245|448131064|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
124593639|NCT00401245|448131057|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
124593640|NCT00401245|448131058|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
124593641|NCT00401245|448131059|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
124593642|NCT00401245|448131060|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
124593643|NCT00401245|448131061|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
124593644|NCT00401245|448131062|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
124593645|NCT00401245|448131063|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
124593646|NCT00401245|448131064|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
124593647|NCT00401245|448131057|FG000|Open Label Phase|Adverse Event|5|||
124593648|NCT00401245|448131058|FG001|Open Label Phase|Adverse Event|14|||
124593649|NCT00401245|448131059|FG002|Open Label Phase|Adverse Event|6|||
124593650|NCT00401245|448131060|FG003|Open Label Phase|Adverse Event|7|||
124730171|NCT00791479|448634029|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
124730172|NCT00791479|448634030|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
124730173|NCT00791479|448634031|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
124730174|NCT00791479|448634032|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
124730175|NCT00791479|448634027|FG000|Overall Study|Adverse Event|0|||
124730176|NCT00791479|448634028|FG001|Overall Study|Adverse Event|1|||
124730177|NCT00791479|448634029|FG002|Overall Study|Adverse Event|0|||
124730178|NCT00791479|448634030|FG003|Overall Study|Adverse Event|2|||
124730179|NCT00791479|448634031|FG004|Overall Study|Adverse Event|0|||
124730180|NCT00791479|448634032|FG005|Overall Study|Adverse Event|1|||
124730181|NCT00791479|448634027|FG000|Overall Study|Lost to Follow-up|0|||
124730182|NCT00791479|448634028|FG001|Overall Study|Lost to Follow-up|1|||
124730183|NCT00791479|448634029|FG002|Overall Study|Lost to Follow-up|0|||
124730184|NCT00791479|448634030|FG003|Overall Study|Lost to Follow-up|0|||
124730185|NCT00791479|448634031|FG004|Overall Study|Lost to Follow-up|0|||
124730186|NCT00791479|448634032|FG005|Overall Study|Lost to Follow-up|1|||
124730187|NCT00791479|448634027|FG000|Overall Study|Protocol Violation|2|||
124730188|NCT00791479|448634028|FG001|Overall Study|Protocol Violation|1|||
124730189|NCT00791479|448634029|FG002|Overall Study|Protocol Violation|0|||
124730190|NCT00791479|448634030|FG003|Overall Study|Protocol Violation|1|||
124730191|NCT00791479|448634031|FG004|Overall Study|Protocol Violation|0|||
124730192|NCT00791479|448634032|FG005|Overall Study|Protocol Violation|0|||
124730193|NCT00791479|448634027|FG000|Overall Study|Withdrawal by Subject|0|||
124730194|NCT00791479|448634028|FG001|Overall Study|Withdrawal by Subject|0|||
124730195|NCT00791479|448634029|FG002|Overall Study|Withdrawal by Subject|0|||
124730196|NCT00791479|448634030|FG003|Overall Study|Withdrawal by Subject|1|||
124730197|NCT00791479|448634031|FG004|Overall Study|Withdrawal by Subject|0|||
124730198|NCT00791479|448634032|FG005|Overall Study|Withdrawal by Subject|1|||
124730199|NCT01778049|448634033|FG000|Open Label Treatment Period|Adverse Event|5|||
124730200|NCT01778049|448634034|FG001|Open Label Treatment Period|Adverse Event|15|||
124730201|NCT01778049|448634035|FG002|Open Label Treatment Period|Adverse Event|0|||
124730202|NCT01778049|448634036|FG003|Open Label Treatment Period|Adverse Event|0|||
124730203|NCT01778049|448634037|FG004|Open Label Treatment Period|Adverse Event|0|||
124730204|NCT01778049|448634038|FG005|Open Label Treatment Period|Adverse Event|0|||
124730205|NCT01778049|448634033|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
124730206|NCT01778049|448634034|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
124730207|NCT01778049|448634035|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
124730208|NCT01778049|448634036|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
124730209|NCT01778049|448634037|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
124730210|NCT01778049|448634038|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
124730211|NCT01778049|448634033|FG000|Open Label Treatment Period|Protocol Violation|5|||
124730212|NCT01778049|448634034|FG001|Open Label Treatment Period|Protocol Violation|5|||
124730213|NCT01778049|448634035|FG002|Open Label Treatment Period|Protocol Violation|0|||
124730214|NCT01778049|448634036|FG003|Open Label Treatment Period|Protocol Violation|0|||
124730215|NCT01778049|448634037|FG004|Open Label Treatment Period|Protocol Violation|0|||
124730216|NCT01778049|448634038|FG005|Open Label Treatment Period|Protocol Violation|0|||
124730217|NCT01778049|448634033|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
124730218|NCT01778049|448634034|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
124730219|NCT01778049|448634035|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
124730220|NCT01778049|448634036|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
124730221|NCT01778049|448634037|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
124730222|NCT01778049|448634038|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
124730223|NCT01778049|448634033|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
124730224|NCT01778049|448634034|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
124730225|NCT01778049|448634035|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
124730226|NCT01778049|448634036|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
124730227|NCT01778049|448634037|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
124730228|NCT01778049|448634038|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
124730229|NCT01778049|448634033|FG000|Open Label Treatment Period|Not treated|2|||
124730230|NCT01778049|448634034|FG001|Open Label Treatment Period|Not treated|1|||
124730231|NCT01778049|448634035|FG002|Open Label Treatment Period|Not treated|0|||
124730232|NCT01778049|448634036|FG003|Open Label Treatment Period|Not treated|0|||
124730233|NCT01778049|448634037|FG004|Open Label Treatment Period|Not treated|0|||
124730234|NCT01778049|448634038|FG005|Open Label Treatment Period|Not treated|0|||
124730235|NCT01778049|448634033|FG000|Open Label Treatment Period|Other reason not defined above|77|||
124730236|NCT01778049|448634034|FG001|Open Label Treatment Period|Other reason not defined above|94|||
124730237|NCT01778049|448634035|FG002|Open Label Treatment Period|Other reason not defined above|0|||
124730238|NCT01778049|448634036|FG003|Open Label Treatment Period|Other reason not defined above|0|||
124730239|NCT01778049|448634037|FG004|Open Label Treatment Period|Other reason not defined above|0|||
124730240|NCT01778049|448634038|FG005|Open Label Treatment Period|Other reason not defined above|0|||
124730241|NCT01778049|448634033|FG000|Double Blind Treatment Period|Adverse Event|0|||
124730242|NCT01778049|448634034|FG001|Double Blind Treatment Period|Adverse Event|0|||
124730243|NCT01778049|448634035|FG002|Double Blind Treatment Period|Adverse Event|4|||
124730244|NCT01778049|448634036|FG003|Double Blind Treatment Period|Adverse Event|5|||
124730245|NCT01778049|448634037|FG004|Double Blind Treatment Period|Adverse Event|3|||
124730246|NCT01778049|448634038|FG005|Double Blind Treatment Period|Adverse Event|2|||
124730247|NCT01778049|448634033|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
124730248|NCT01778049|448634034|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
124730249|NCT01778049|448634035|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
124730250|NCT01778049|448634036|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
124730251|NCT01778049|448634037|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
124730252|NCT01778049|448634038|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
124730253|NCT01778049|448634033|FG000|Double Blind Treatment Period|Protocol Violation|0|||
124730254|NCT01778049|448634034|FG001|Double Blind Treatment Period|Protocol Violation|0|||
124730255|NCT01778049|448634035|FG002|Double Blind Treatment Period|Protocol Violation|2|||
124730256|NCT01778049|448634036|FG003|Double Blind Treatment Period|Protocol Violation|0|||
124730257|NCT01778049|448634037|FG004|Double Blind Treatment Period|Protocol Violation|0|||
124730258|NCT01778049|448634038|FG005|Double Blind Treatment Period|Protocol Violation|0|||
124730259|NCT01778049|448634033|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
124730260|NCT01778049|448634034|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
124730261|NCT01778049|448634035|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
124730262|NCT01778049|448634036|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
124730263|NCT01778049|448634037|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
124730264|NCT01778049|448634038|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
124730265|NCT01778049|448634033|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
124730266|NCT01778049|448634034|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
124730267|NCT01778049|448634035|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
124730268|NCT01778049|448634036|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
124730269|NCT01778049|448634037|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
124730270|NCT01778049|448634038|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
124730271|NCT01778049|448634033|FG000|Double Blind Treatment Period|Not treated|0|||
124730272|NCT01778049|448634034|FG001|Double Blind Treatment Period|Not treated|0|||
124730273|NCT01778049|448634035|FG002|Double Blind Treatment Period|Not treated|0|||
124730274|NCT01778049|448634036|FG003|Double Blind Treatment Period|Not treated|2|||
124730275|NCT01778049|448634037|FG004|Double Blind Treatment Period|Not treated|2|||
124730276|NCT01778049|448634038|FG005|Double Blind Treatment Period|Not treated|0|||
124730277|NCT01778049|448634033|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
124730278|NCT01778049|448634034|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
124730279|NCT01778049|448634035|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
124730280|NCT01778049|448634036|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
124730281|NCT01778049|448634037|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
124730282|NCT01778049|448634038|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
124730283|NCT03770728|448634042|FG000|Overall Study|Adverse Event|1|||
124730284|NCT03770728|448634043|FG001|Overall Study|Adverse Event|0|||
124730285|NCT03770728|448634044|FG002|Overall Study|Adverse Event|1|||
124730286|NCT03770728|448634045|FG003|Overall Study|Adverse Event|0|||
124730287|NCT03770728|448634042|FG000|Overall Study|Poor compliance to protocol|0|||
124730288|NCT03770728|448634043|FG001|Overall Study|Poor compliance to protocol|0|||
124730289|NCT03770728|448634044|FG002|Overall Study|Poor compliance to protocol|1|||
124730290|NCT03770728|448634045|FG003|Overall Study|Poor compliance to protocol|0|||
124730291|NCT03770728|448634042|FG000|Overall Study|Withdrawal by Subject|13|||
124730292|NCT03770728|448634043|FG001|Overall Study|Withdrawal by Subject|8|||
124730293|NCT03770728|448634044|FG002|Overall Study|Withdrawal by Subject|9|||
124730294|NCT03770728|448634045|FG003|Overall Study|Withdrawal by Subject|13|||
124730295|NCT03770728|448634042|FG000|Overall Study|Other than specified|24|||
124730296|NCT03770728|448634043|FG001|Overall Study|Other than specified|23|||
124730297|NCT03770728|448634044|FG002|Overall Study|Other than specified|21|||
124730298|NCT03770728|448634045|FG003|Overall Study|Other than specified|22|||
124730299|NCT02379988|448634049|FG000|Overall Study|Not eligible|1|||
124730300|NCT00107315|448634050|FG000|Overall Study|Disease Progression|9|||
124730301|NCT00107315|448634050|FG000|Overall Study|Adverse Event|4|||
124730302|NCT00107315|448634050|FG000|Overall Study|Withdrawal by Subject|2|||
124730303|NCT02509039|448634053|FG000|Overall Study|Adverse Event|0|||
124730304|NCT02509039|448634054|FG001|Overall Study|Adverse Event|1|||
124730305|NCT02509039|448634055|FG002|Overall Study|Adverse Event|1|||
124730306|NCT02509039|448634056|FG003|Overall Study|Adverse Event|1|||
124730307|NCT02509039|448634053|FG000|Overall Study|Withdrawal by Subject|0|||
124730308|NCT02509039|448634054|FG001|Overall Study|Withdrawal by Subject|0|||
124593651|NCT00401245|448131061|FG004|Open Label Phase|Adverse Event|0|||
124593652|NCT00401245|448131062|FG005|Open Label Phase|Adverse Event|0|||
124593653|NCT00401245|448131063|FG006|Open Label Phase|Adverse Event|0|||
124593654|NCT00401245|448131064|FG007|Open Label Phase|Adverse Event|0|||
124730309|NCT02509039|448634055|FG002|Overall Study|Withdrawal by Subject|1|||
124593655|NCT00401245|448131057|FG000|Open Label Phase|Lost to Follow-up|5|||
124593656|NCT00401245|448131058|FG001|Open Label Phase|Lost to Follow-up|7|||
124593657|NCT00401245|448131059|FG002|Open Label Phase|Lost to Follow-up|5|||
124593658|NCT00401245|448131060|FG003|Open Label Phase|Lost to Follow-up|4|||
124593659|NCT00401245|448131061|FG004|Open Label Phase|Lost to Follow-up|0|||
124593660|NCT00401245|448131062|FG005|Open Label Phase|Lost to Follow-up|0|||
124593661|NCT00401245|448131063|FG006|Open Label Phase|Lost to Follow-up|0|||
124593662|NCT00401245|448131064|FG007|Open Label Phase|Lost to Follow-up|0|||
124593663|NCT00401245|448131057|FG000|Open Label Phase|Other|4|||
124593664|NCT00401245|448131058|FG001|Open Label Phase|Other|8|||
124593665|NCT00401245|448131059|FG002|Open Label Phase|Other|7|||
124593666|NCT00401245|448131060|FG003|Open Label Phase|Other|8|||
124593667|NCT00401245|448131061|FG004|Open Label Phase|Other|0|||
124593668|NCT00401245|448131062|FG005|Open Label Phase|Other|0|||
124593669|NCT00401245|448131063|FG006|Open Label Phase|Other|0|||
124593670|NCT00401245|448131064|FG007|Open Label Phase|Other|0|||
124593671|NCT00401245|448131057|FG000|Open Label Phase|Protocol Violation|0|||
124593672|NCT00401245|448131058|FG001|Open Label Phase|Protocol Violation|1|||
124593673|NCT00401245|448131059|FG002|Open Label Phase|Protocol Violation|0|||
124593674|NCT00401245|448131060|FG003|Open Label Phase|Protocol Violation|1|||
124593675|NCT00401245|448131061|FG004|Open Label Phase|Protocol Violation|0|||
124593676|NCT00401245|448131062|FG005|Open Label Phase|Protocol Violation|0|||
124593677|NCT00401245|448131063|FG006|Open Label Phase|Protocol Violation|0|||
124593678|NCT00401245|448131064|FG007|Open Label Phase|Protocol Violation|0|||
124593679|NCT00401245|448131057|FG000|Open Label Phase|Withdrawal by Subject|3|||
124593680|NCT00401245|448131058|FG001|Open Label Phase|Withdrawal by Subject|3|||
124593681|NCT00401245|448131059|FG002|Open Label Phase|Withdrawal by Subject|2|||
124593682|NCT00401245|448131060|FG003|Open Label Phase|Withdrawal by Subject|1|||
124593683|NCT00401245|448131061|FG004|Open Label Phase|Withdrawal by Subject|0|||
124593684|NCT00401245|448131062|FG005|Open Label Phase|Withdrawal by Subject|0|||
124593685|NCT00401245|448131063|FG006|Open Label Phase|Withdrawal by Subject|0|||
124593686|NCT00401245|448131064|FG007|Open Label Phase|Withdrawal by Subject|0|||
124593687|NCT00401245|448131057|FG000|Open Label Phase|Lack of Efficacy|4|||
124593688|NCT00401245|448131058|FG001|Open Label Phase|Lack of Efficacy|2|||
124593689|NCT00401245|448131059|FG002|Open Label Phase|Lack of Efficacy|3|||
124593690|NCT00401245|448131060|FG003|Open Label Phase|Lack of Efficacy|0|||
124593691|NCT00401245|448131061|FG004|Open Label Phase|Lack of Efficacy|0|||
124593692|NCT00401245|448131062|FG005|Open Label Phase|Lack of Efficacy|0|||
124593693|NCT00401245|448131063|FG006|Open Label Phase|Lack of Efficacy|0|||
124593694|NCT00401245|448131064|FG007|Open Label Phase|Lack of Efficacy|0|||
124593695|NCT00401245|448131057|FG000|Double Blind Tapering Phase|Adverse Event|0|||
124593696|NCT00401245|448131058|FG001|Double Blind Tapering Phase|Adverse Event|0|||
124593697|NCT00401245|448131059|FG002|Double Blind Tapering Phase|Adverse Event|0|||
124593698|NCT00401245|448131060|FG003|Double Blind Tapering Phase|Adverse Event|0|||
124593699|NCT00401245|448131061|FG004|Double Blind Tapering Phase|Adverse Event|1|||
124593700|NCT00401245|448131062|FG005|Double Blind Tapering Phase|Adverse Event|1|||
124593701|NCT00401245|448131063|FG006|Double Blind Tapering Phase|Adverse Event|2|||
124593702|NCT00401245|448131064|FG007|Double Blind Tapering Phase|Adverse Event|4|||
124593703|NCT00401245|448131057|FG000|Double Blind Tapering Phase|Investigator request|0|||
124593704|NCT00401245|448131058|FG001|Double Blind Tapering Phase|Investigator request|0|||
124593705|NCT00401245|448131059|FG002|Double Blind Tapering Phase|Investigator request|0|||
124593706|NCT00401245|448131060|FG003|Double Blind Tapering Phase|Investigator request|0|||
124593707|NCT00401245|448131061|FG004|Double Blind Tapering Phase|Investigator request|0|||
124593708|NCT00401245|448131062|FG005|Double Blind Tapering Phase|Investigator request|0|||
124593709|NCT00401245|448131063|FG006|Double Blind Tapering Phase|Investigator request|0|||
124593710|NCT00401245|448131064|FG007|Double Blind Tapering Phase|Investigator request|1|||
124593711|NCT00401245|448131057|FG000|Double Blind Tapering Phase|Other|0|||
124593712|NCT00401245|448131058|FG001|Double Blind Tapering Phase|Other|0|||
124593713|NCT00401245|448131059|FG002|Double Blind Tapering Phase|Other|0|||
124593714|NCT00401245|448131060|FG003|Double Blind Tapering Phase|Other|0|||
124593715|NCT00401245|448131061|FG004|Double Blind Tapering Phase|Other|1|||
124593716|NCT00401245|448131062|FG005|Double Blind Tapering Phase|Other|0|||
124593717|NCT00401245|448131063|FG006|Double Blind Tapering Phase|Other|2|||
124593718|NCT00401245|448131064|FG007|Double Blind Tapering Phase|Other|2|||
124593719|NCT00401245|448131057|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
124593720|NCT00401245|448131058|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
124593721|NCT00401245|448131059|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
124593722|NCT00401245|448131060|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
124593723|NCT00401245|448131061|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
124593724|NCT00401245|448131062|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
124593725|NCT00401245|448131063|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
124593726|NCT00401245|448131064|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
124593727|NCT00401245|448131057|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
124593728|NCT00401245|448131058|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
124593729|NCT00401245|448131059|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
124593730|NCT00401245|448131060|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
124593731|NCT00401245|448131061|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
124593732|NCT00401245|448131062|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
124779181|NCT05767749|448819524|FG003|Overall Study|Withdrawal by Subject|2|||
124593733|NCT00401245|448131063|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
124593734|NCT00401245|448131064|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
124593735|NCT02344745|448131065|FG000|Overall Study|Data collection sheets were lost|2|||
124593736|NCT02344745|448131066|FG001|Overall Study|Data collection sheets were lost|0|||
124593737|NCT02788513|448131067|FG000|Overall Study|Withdrawal by Subject|3|||
124593738|NCT02788513|448131068|FG001|Overall Study|Withdrawal by Subject|0|||
124593739|NCT02788513|448131069|FG002|Overall Study|Withdrawal by Subject|2|||
124779182|NCT05767749|448819525|FG004|Overall Study|Withdrawal by Subject|2|||
124593740|NCT02788513|448131070|FG003|Overall Study|Withdrawal by Subject|3|||
124593741|NCT02788513|448131071|FG004|Overall Study|Withdrawal by Subject|1|||
124593742|NCT02788513|448131067|FG000|Overall Study|Lost to Follow-up|1|||
124593743|NCT02788513|448131068|FG001|Overall Study|Lost to Follow-up|0|||
124593744|NCT02788513|448131069|FG002|Overall Study|Lost to Follow-up|0|||
124593745|NCT02788513|448131070|FG003|Overall Study|Lost to Follow-up|0|||
124593746|NCT02788513|448131071|FG004|Overall Study|Lost to Follow-up|1|||
124593747|NCT02788513|448131067|FG000|Overall Study|Adverse Event|5|||
124593748|NCT02788513|448131068|FG001|Overall Study|Adverse Event|8|||
124593749|NCT02788513|448131069|FG002|Overall Study|Adverse Event|4|||
124593750|NCT02788513|448131070|FG003|Overall Study|Adverse Event|2|||
124593751|NCT02788513|448131071|FG004|Overall Study|Adverse Event|2|||
124593752|NCT02788513|448131067|FG000|Overall Study|Protocol Violation|0|||
124593753|NCT02788513|448131068|FG001|Overall Study|Protocol Violation|0|||
124593754|NCT02788513|448131069|FG002|Overall Study|Protocol Violation|1|||
124593755|NCT02788513|448131070|FG003|Overall Study|Protocol Violation|1|||
124593756|NCT02788513|448131071|FG004|Overall Study|Protocol Violation|0|||
124593757|NCT02788513|448131067|FG000|Overall Study|Subject decided to stop taking treatment|0|||
124593758|NCT02788513|448131068|FG001|Overall Study|Subject decided to stop taking treatment|0|||
124593759|NCT02788513|448131069|FG002|Overall Study|Subject decided to stop taking treatment|1|||
124593760|NCT02788513|448131070|FG003|Overall Study|Subject decided to stop taking treatment|0|||
124593761|NCT02788513|448131071|FG004|Overall Study|Subject decided to stop taking treatment|0|||
124593762|NCT02788513|448131067|FG000|Overall Study|Decision by the study team|0|||
124593763|NCT02788513|448131068|FG001|Overall Study|Decision by the study team|0|||
124593764|NCT02788513|448131069|FG002|Overall Study|Decision by the study team|0|||
124593765|NCT02788513|448131070|FG003|Overall Study|Decision by the study team|0|||
124593766|NCT02788513|448131071|FG004|Overall Study|Decision by the study team|1|||
124593767|NCT02014441|448131073|FG000|Overall Study|Withdrawal by Subject|12|||
124593768|NCT01933919|448131074|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
124593769|NCT01933919|448131075|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
124593770|NCT01933919|448131074|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
124593771|NCT01933919|448131075|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
124593772|NCT01933919|448131074|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
124593773|NCT01933919|448131075|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
124593774|NCT01933919|448131074|FG000|Open-label Long-term Phase|Adverse Event|2|||
124593775|NCT01933919|448131075|FG001|Open-label Long-term Phase|Adverse Event|0|||
124593776|NCT01933919|448131074|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
124593777|NCT01933919|448131075|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
124593778|NCT01933919|448131074|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
124593779|NCT01933919|448131075|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
124593780|NCT01933919|448131074|FG000|Open-label Long-term Phase|Other|1|||
124593781|NCT01933919|448131075|FG001|Open-label Long-term Phase|Other|2|||
124593782|NCT00991510|448131076|FG000|Period I (Days 1-14)|Adverse Event|1|||
124593783|NCT00991510|448131077|FG001|Period I (Days 1-14)|Adverse Event|0|||
124593784|NCT00991510|448131076|FG000|Period III (Days 29-112)|Adverse Event|1|||
124593785|NCT00991510|448131077|FG001|Period III (Days 29-112)|Adverse Event|1|||
124593786|NCT02356211|448131082|FG000|Overall Study|Withdrawal by Subject|2|||
124593787|NCT02356211|448131083|FG001|Overall Study|Withdrawal by Subject|2|||
124593788|NCT02356211|448131082|FG000|Overall Study|ineligible|1|||
124593789|NCT02356211|448131083|FG001|Overall Study|ineligible|8|||
124593790|NCT02510261|448131088|FG000|Overall Study|Adverse Event|5|||
124593791|NCT02510261|448131089|FG001|Overall Study|Adverse Event|8|||
124593792|NCT02510261|448131090|FG002|Overall Study|Adverse Event|0|||
124593793|NCT02510261|448131088|FG000|Overall Study|Physician Decision|1|||
124593794|NCT02510261|448131089|FG001|Overall Study|Physician Decision|5|||
124593795|NCT02510261|448131090|FG002|Overall Study|Physician Decision|0|||
124593796|NCT02510261|448131088|FG000|Overall Study|Death|19|||
124593797|NCT02510261|448131089|FG001|Overall Study|Death|19|||
124593798|NCT02510261|448131090|FG002|Overall Study|Death|0|||
124593799|NCT02510261|448131088|FG000|Overall Study|Withdrawal by Subject|3|||
124593800|NCT02510261|448131089|FG001|Overall Study|Withdrawal by Subject|10|||
124593801|NCT02510261|448131090|FG002|Overall Study|Withdrawal by Subject|3|||
124593802|NCT02443324|448131094|FG000|Overall Study|Death|4|||
124593803|NCT02443324|448131095|FG001|Overall Study|Death|1|||
124593804|NCT02443324|448131096|FG002|Overall Study|Death|0|||
124593805|NCT02443324|448131097|FG003|Overall Study|Death|3|||
124593806|NCT02443324|448131098|FG004|Overall Study|Death|1|||
124593807|NCT02443324|448131099|FG005|Overall Study|Death|3|||
124593808|NCT02443324|448131100|FG006|Overall Study|Death|2|||
124593809|NCT02443324|448131094|FG000|Overall Study|Lost to Follow-up|0|||
124593810|NCT02443324|448131095|FG001|Overall Study|Lost to Follow-up|0|||
124593811|NCT02443324|448131096|FG002|Overall Study|Lost to Follow-up|0|||
124593812|NCT02443324|448131097|FG003|Overall Study|Lost to Follow-up|1|||
124593813|NCT02443324|448131098|FG004|Overall Study|Lost to Follow-up|0|||
124593814|NCT02443324|448131099|FG005|Overall Study|Lost to Follow-up|1|||
124593815|NCT02443324|448131100|FG006|Overall Study|Lost to Follow-up|0|||
124593816|NCT02443324|448131094|FG000|Overall Study|Physician Decision|0|||
124593817|NCT02443324|448131095|FG001|Overall Study|Physician Decision|3|||
124593818|NCT02443324|448131096|FG002|Overall Study|Physician Decision|5|||
124593819|NCT02443324|448131097|FG003|Overall Study|Physician Decision|1|||
124593820|NCT02443324|448131098|FG004|Overall Study|Physician Decision|1|||
124593821|NCT02443324|448131099|FG005|Overall Study|Physician Decision|0|||
124593822|NCT02443324|448131100|FG006|Overall Study|Physician Decision|2|||
124593823|NCT02443324|448131094|FG000|Overall Study|Progressive Disease|20|||
124593824|NCT02443324|448131095|FG001|Overall Study|Progressive Disease|20|||
124593825|NCT02443324|448131096|FG002|Overall Study|Progressive Disease|13|||
124593826|NCT02443324|448131097|FG003|Overall Study|Progressive Disease|10|||
124593827|NCT02443324|448131098|FG004|Overall Study|Progressive Disease|13|||
124593828|NCT02443324|448131099|FG005|Overall Study|Progressive Disease|17|||
124593829|NCT02443324|448131100|FG006|Overall Study|Progressive Disease|10|||
124593830|NCT02443324|448131094|FG000|Overall Study|Withdrawal by Subject|0|||
124593831|NCT02443324|448131095|FG001|Overall Study|Withdrawal by Subject|0|||
124593832|NCT02443324|448131096|FG002|Overall Study|Withdrawal by Subject|3|||
124593833|NCT02443324|448131097|FG003|Overall Study|Withdrawal by Subject|1|||
124593834|NCT02443324|448131098|FG004|Overall Study|Withdrawal by Subject|1|||
124593835|NCT02443324|448131099|FG005|Overall Study|Withdrawal by Subject|0|||
124593836|NCT02443324|448131100|FG006|Overall Study|Withdrawal by Subject|1|||
124593837|NCT02443324|448131094|FG000|Overall Study|Adverse Event|0|||
124593838|NCT02443324|448131095|FG001|Overall Study|Adverse Event|1|||
124593839|NCT02443324|448131096|FG002|Overall Study|Adverse Event|3|||
124593840|NCT02443324|448131097|FG003|Overall Study|Adverse Event|0|||
124593841|NCT02443324|448131098|FG004|Overall Study|Adverse Event|4|||
124593842|NCT02443324|448131099|FG005|Overall Study|Adverse Event|3|||
124593843|NCT02443324|448131100|FG006|Overall Study|Adverse Event|3|||
124593844|NCT02443324|448131094|FG000|Overall Study|Enrolled but Never Treated|0|||
124593845|NCT02443324|448131095|FG001|Overall Study|Enrolled but Never Treated|0|||
124593846|NCT02443324|448131096|FG002|Overall Study|Enrolled but Never Treated|1|||
124593847|NCT02443324|448131097|FG003|Overall Study|Enrolled but Never Treated|0|||
124593848|NCT02443324|448131098|FG004|Overall Study|Enrolled but Never Treated|1|||
124593849|NCT02443324|448131099|FG005|Overall Study|Enrolled but Never Treated|0|||
124593850|NCT02443324|448131100|FG006|Overall Study|Enrolled but Never Treated|1|||
124593851|NCT02780167|448131107|FG000|Overall Study|Adverse Event|9|||
124593852|NCT02780167|448131108|FG001|Overall Study|Adverse Event|8|||
124593853|NCT02780167|448131109|FG002|Overall Study|Adverse Event|8|||
124593854|NCT02780167|448131110|FG003|Overall Study|Adverse Event|12|||
124593855|NCT02780167|448131111|FG004|Overall Study|Adverse Event|8|||
124593856|NCT02780167|448131107|FG000|Overall Study|Lack of Efficacy|6|||
124593857|NCT02780167|448131108|FG001|Overall Study|Lack of Efficacy|5|||
124593858|NCT02780167|448131109|FG002|Overall Study|Lack of Efficacy|6|||
124593859|NCT02780167|448131110|FG003|Overall Study|Lack of Efficacy|1|||
124593860|NCT02780167|448131111|FG004|Overall Study|Lack of Efficacy|0|||
124593861|NCT02780167|448131107|FG000|Overall Study|Lost to Follow-up|2|||
124593862|NCT02780167|448131108|FG001|Overall Study|Lost to Follow-up|0|||
124593863|NCT02780167|448131109|FG002|Overall Study|Lost to Follow-up|1|||
124593864|NCT02780167|448131110|FG003|Overall Study|Lost to Follow-up|0|||
124593865|NCT02780167|448131111|FG004|Overall Study|Lost to Follow-up|0|||
124593866|NCT02780167|448131107|FG000|Overall Study|Does not meet entrance criteria|0|||
124593867|NCT02780167|448131108|FG001|Overall Study|Does not meet entrance criteria|0|||
124593868|NCT02780167|448131109|FG002|Overall Study|Does not meet entrance criteria|1|||
124593869|NCT02780167|448131110|FG003|Overall Study|Does not meet entrance criteria|0|||
124593870|NCT02780167|448131111|FG004|Overall Study|Does not meet entrance criteria|0|||
124593871|NCT02780167|448131107|FG000|Overall Study|No longer meets eligibility criteria|0|||
124593872|NCT02780167|448131108|FG001|Overall Study|No longer meets eligibility criteria|0|||
124593873|NCT02780167|448131109|FG002|Overall Study|No longer meets eligibility criteria|0|||
124730310|NCT02509039|448634056|FG003|Overall Study|Withdrawal by Subject|0|||
124730311|NCT02509039|448634053|FG000|Overall Study|Progressive disease|2|||
124730312|NCT02509039|448634054|FG001|Overall Study|Progressive disease|2|||
124730313|NCT02509039|448634055|FG002|Overall Study|Progressive disease|1|||
124593874|NCT02780167|448131110|FG003|Overall Study|No longer meets eligibility criteria|1|||
124593875|NCT02780167|448131111|FG004|Overall Study|No longer meets eligibility criteria|1|||
124593876|NCT02780167|448131107|FG000|Overall Study|Protocol Violation|5|||
124593877|NCT02780167|448131108|FG001|Overall Study|Protocol Violation|5|||
124593878|NCT02780167|448131109|FG002|Overall Study|Protocol Violation|1|||
124593879|NCT02780167|448131110|FG003|Overall Study|Protocol Violation|1|||
124593880|NCT02780167|448131111|FG004|Overall Study|Protocol Violation|2|||
124593881|NCT02780167|448131107|FG000|Overall Study|Withdrawal by Subject|6|||
124593882|NCT02780167|448131108|FG001|Overall Study|Withdrawal by Subject|4|||
124593883|NCT02780167|448131109|FG002|Overall Study|Withdrawal by Subject|4|||
124593884|NCT02780167|448131110|FG003|Overall Study|Withdrawal by Subject|3|||
124593885|NCT02780167|448131111|FG004|Overall Study|Withdrawal by Subject|4|||
124593886|NCT02780167|448131107|FG000|Overall Study|Other|0|||
124593887|NCT02780167|448131108|FG001|Overall Study|Other|0|||
124593888|NCT02780167|448131109|FG002|Overall Study|Other|3|||
124593889|NCT02780167|448131110|FG003|Overall Study|Other|1|||
124593890|NCT02780167|448131111|FG004|Overall Study|Other|2|||
124593891|NCT03110380|448131123|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
124593892|NCT03110380|448131124|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
124593893|NCT03110380|448131125|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
124593894|NCT03110380|448131126|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
124593895|NCT03110380|448131123|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
124593896|NCT03110380|448131124|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
124593897|NCT03110380|448131125|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
124593898|NCT03110380|448131126|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
124593899|NCT03110380|448131123|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
124593900|NCT03110380|448131124|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
124593901|NCT03110380|448131125|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
124593902|NCT03110380|448131126|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
124593903|NCT03110380|448131123|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
124593904|NCT03110380|448131124|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
124593905|NCT03110380|448131125|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
124593906|NCT03110380|448131126|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
124593907|NCT03110380|448131123|FG000|Double-Blind Treatment Phase|Death|2|||
124593908|NCT03110380|448131124|FG001|Double-Blind Treatment Phase|Death|1|||
124593909|NCT03110380|448131125|FG002|Double-Blind Treatment Phase|Death|0|||
124593910|NCT03110380|448131126|FG003|Double-Blind Treatment Phase|Death|0|||
124593911|NCT03110380|448131123|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
124593912|NCT03110380|448131124|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
124593913|NCT03110380|448131125|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
124593914|NCT03110380|448131126|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
124593915|NCT03110380|448131123|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
124593916|NCT03110380|448131124|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
124593917|NCT03110380|448131125|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
124593918|NCT03110380|448131126|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
124593919|NCT03110380|448131123|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
124593920|NCT03110380|448131124|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
124593921|NCT03110380|448131125|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
124593922|NCT03110380|448131126|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
124593923|NCT03110380|448131123|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
124593924|NCT03110380|448131124|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
124593925|NCT03110380|448131125|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
124593926|NCT03110380|448131126|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
124593927|NCT03110380|448131123|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
124593928|NCT03110380|448131124|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
124593929|NCT03110380|448131125|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
124593930|NCT03110380|448131126|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
124593931|NCT03110380|448131123|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
124593932|NCT03110380|448131124|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
124593933|NCT03110380|448131125|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
124593934|NCT03110380|448131126|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
124593935|NCT01355302|448131129|FG000|Phase 1b|Death|4|||
124593936|NCT01355302|448131130|FG001|Phase 1b|Death|0|||
124593937|NCT01355302|448131131|FG002|Phase 1b|Death|0|||
124593938|NCT01355302|448131129|FG000|Phase 1b|Study terminated by sponsor|2|||
124593939|NCT01355302|448131130|FG001|Phase 1b|Study terminated by sponsor|0|||
124593940|NCT01355302|448131131|FG002|Phase 1b|Study terminated by sponsor|0|||
124593941|NCT02531594|448131132|FG000|Overall Study|Withdrawal by Subject|7|||
124593942|NCT02531594|448131133|FG001|Overall Study|Withdrawal by Subject|8|||
124593943|NCT03750695|448131134|FG000|Overall Study|Lost to Follow-up|0|||
124593944|NCT03750695|448131135|FG001|Overall Study|Lost to Follow-up|1|||
124593945|NCT04480307|448131138|FG000|Overall Study|Withdrawal by Subject|0|||
124593946|NCT04480307|448131139|FG001|Overall Study|Withdrawal by Subject|1|||
124593947|NCT04480307|448131140|FG002|Overall Study|Withdrawal by Subject|0|||
124593948|NCT04480307|448131141|FG003|Overall Study|Withdrawal by Subject|0|||
124593949|NCT04480307|448131138|FG000|Overall Study|Adverse Event|0|||
124593950|NCT04480307|448131139|FG001|Overall Study|Adverse Event|0|||
124593951|NCT04480307|448131140|FG002|Overall Study|Adverse Event|0|||
124593952|NCT04480307|448131141|FG003|Overall Study|Adverse Event|1|||
124779183|NCT05767749|448819526|FG005|Overall Study|Withdrawal by Subject|2|||
124779184|NCT01077050|448821324|FG000|Overall Study|Subjects signed ICF could not be located|1|||
124779185|NCT01077050|448821324|FG000|Overall Study|Screen failure|8|||
124779186|NCT03894813|448821325|FG000|Overall Study|Adverse Event|1|||
124779187|NCT03894813|448821326|FG001|Overall Study|Adverse Event|1|||
124779188|NCT03894813|448821325|FG000|Overall Study|Lack of Efficacy|3|||
124779189|NCT03894813|448821326|FG001|Overall Study|Lack of Efficacy|3|||
124779190|NCT03894813|448821325|FG000|Overall Study|Lost to Follow-up|1|||
124779191|NCT03894813|448821326|FG001|Overall Study|Lost to Follow-up|0|||
124779192|NCT03894813|448821325|FG000|Overall Study|Pregnancy|2|||
124779193|NCT03894813|448821326|FG001|Overall Study|Pregnancy|1|||
124779194|NCT03894813|448821325|FG000|Overall Study|Protocol Violation|3|||
124779195|NCT03894813|448821326|FG001|Overall Study|Protocol Violation|7|||
124779196|NCT03894813|448821325|FG000|Overall Study|Withdrawal by Subject|1|||
124779197|NCT03894813|448821326|FG001|Overall Study|Withdrawal by Subject|3|||
124779198|NCT03894813|448821325|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
124779199|NCT03894813|448821326|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
124779200|NCT03083873|448821328|FG000|Overall Study|Death|6|||
124779201|NCT03083873|448821329|FG001|Overall Study|Death|15|||
124779202|NCT03083873|448821330|FG002|Overall Study|Death|13|||
124779203|NCT03083873|448821331|FG003|Overall Study|Death|9|||
124593953|NCT01264835|448131143|FG000|Overall Study|Lost to Follow-up|1|||
124593954|NCT01203917|448131144|FG000|Overall Study|Death|29|||
124593955|NCT01203917|448131144|FG000|Overall Study|Lost to Follow-up|2|||
124593956|NCT01203917|448131144|FG000|Overall Study|Withdrawal by Subject|3|||
124593957|NCT01203917|448131144|FG000|Overall Study|Due to objective disease progression|1|||
124593958|NCT01203917|448131144|FG000|Overall Study|Due to EGFR M+I patient|1|||
124593959|NCT04660032|448131147|FG000|Overall Study|Protocol Violation|1|||
124593960|NCT04660032|448131148|FG001|Overall Study|Protocol Violation|1|||
124593961|NCT01609582|448131163|FG000|Overall Study|Adverse Event|20|||
124593962|NCT01609582|448131164|FG001|Overall Study|Adverse Event|18|||
124593963|NCT01609582|448131163|FG000|Overall Study|Lost to Follow-up|10|||
124593964|NCT01609582|448131164|FG001|Overall Study|Lost to Follow-up|10|||
124593965|NCT01609582|448131163|FG000|Overall Study|Withdrawal by Subject|21|||
124593966|NCT01609582|448131164|FG001|Overall Study|Withdrawal by Subject|15|||
124593967|NCT01609582|448131163|FG000|Overall Study|Study Terminated by Sponsor|1543|||
124593968|NCT01609582|448131164|FG001|Overall Study|Study Terminated by Sponsor|1548|||
124593969|NCT01609582|448131163|FG000|Overall Study|Other|9|||
124593970|NCT01609582|448131164|FG001|Overall Study|Other|10|||
124593971|NCT01609582|448131163|FG000|Overall Study|Randomized, but not treated|0|||
124593972|NCT01609582|448131164|FG001|Overall Study|Randomized, but not treated|3|||
124593973|NCT00819767|448131165|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124593974|NCT00819767|448131166|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124593975|NCT00808509|448131172|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
124593976|NCT00808509|448131173|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
124593977|NCT00808509|448131172|FG000|Randomized Phase|Reduced methotrexate dose|1|||
124593978|NCT00808509|448131173|FG001|Randomized Phase|Reduced methotrexate dose|2|||
124593979|NCT00808509|448131172|FG000|Randomized Phase|Patient refused rescue therapy|0|||
124593980|NCT00808509|448131173|FG001|Randomized Phase|Patient refused rescue therapy|3|||
124593981|NCT02169791|448131174|FG000|Overall Study|Death|6|||
124593982|NCT02169791|448131174|FG000|Overall Study|patient withdrew consent|1|||
124593983|NCT02762994|448131179|FG000|Overall Study|Withdrawal by Subject|0|||
124593984|NCT02762994|448131180|FG001|Overall Study|Withdrawal by Subject|1|||
124593985|NCT02762994|448131181|FG002|Overall Study|Withdrawal by Subject|2|||
124593986|NCT02762994|448131182|FG003|Overall Study|Withdrawal by Subject|0|||
124593987|NCT02762994|448131179|FG000|Overall Study|Protocol Violation|1|||
124593988|NCT02762994|448131180|FG001|Overall Study|Protocol Violation|0|||
124593989|NCT02762994|448131181|FG002|Overall Study|Protocol Violation|0|||
124593990|NCT02762994|448131182|FG003|Overall Study|Protocol Violation|2|||
124593991|NCT05103657|448131183|FG000|Overall Study|Other reasons than listed|9|||
124593992|NCT05103657|448131184|FG001|Overall Study|Other reasons than listed|8|||
124593993|NCT05103657|448131183|FG000|Overall Study|Protocol deviation|2|||
124593994|NCT05103657|448131184|FG001|Overall Study|Protocol deviation|2|||
124593995|NCT05103657|448131183|FG000|Overall Study|No reason available|5|||
124593996|NCT05103657|448131184|FG001|Overall Study|No reason available|4|||
124593997|NCT05103657|448131183|FG000|Overall Study|Burden of study procedures|3|||
124593998|NCT05103657|448131184|FG001|Overall Study|Burden of study procedures|1|||
124593999|NCT05103657|448131183|FG000|Overall Study|Perceived lack of efficacy|1|||
124594000|NCT05103657|448131184|FG001|Overall Study|Perceived lack of efficacy|1|||
124594001|NCT05103657|448131183|FG000|Overall Study|Adverse Event|6|||
124594002|NCT05103657|448131184|FG001|Overall Study|Adverse Event|14|||
124594003|NCT05103657|448131183|FG000|Overall Study|Not Treated|1|||
124779204|NCT03083873|448821332|FG004|Overall Study|Death|0|||
124779205|NCT03083873|448821328|FG000|Overall Study|Sponsor Terminated Study|0|||
124779206|NCT03083873|448821329|FG001|Overall Study|Sponsor Terminated Study|1|||
124779207|NCT03083873|448821330|FG002|Overall Study|Sponsor Terminated Study|2|||
124779208|NCT03083873|448821331|FG003|Overall Study|Sponsor Terminated Study|3|||
124594004|NCT05103657|448131184|FG001|Overall Study|Not Treated|1|||
124594005|NCT04234464|448131188|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
124594006|NCT04234464|448131189|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
124594007|NCT03635983|448131190|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
124594008|NCT03635983|448131191|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
124594009|NCT03635983|448131190|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
124594010|NCT03635983|448131191|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124594011|NCT03635983|448131190|FG000|Pre-Treatment Period|Other reasons|0|||
124594012|NCT03635983|448131191|FG001|Pre-Treatment Period|Other reasons|1|||
124594013|NCT03635983|448131190|FG000|Pre-Treatment Period|Disease Progression|0|||
124594014|NCT03635983|448131191|FG001|Pre-Treatment Period|Disease Progression|1|||
124594015|NCT03635983|448131190|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
124594016|NCT03635983|448131191|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
124594017|NCT03635983|448131190|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
124594018|NCT03635983|448131191|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
124594019|NCT03635983|448131190|FG000|Treatment Period|Withdrawal by Subject|3|||
124594020|NCT03635983|448131191|FG001|Treatment Period|Withdrawal by Subject|5|||
124594021|NCT03635983|448131190|FG000|Treatment Period|Death|3|||
124594022|NCT03635983|448131191|FG001|Treatment Period|Death|5|||
124594023|NCT03635983|448131190|FG000|Treatment Period|Poor/Non-compliance|2|||
124594024|NCT03635983|448131191|FG001|Treatment Period|Poor/Non-compliance|1|||
124594025|NCT03635983|448131190|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
124594026|NCT03635983|448131191|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
124594027|NCT03635983|448131190|FG000|Treatment Period|Other reasons|7|||
124594028|NCT03635983|448131191|FG001|Treatment Period|Other reasons|4|||
124594029|NCT03635983|448131190|FG000|Treatment Period|Disease progression|230|||
124594030|NCT03635983|448131191|FG001|Treatment Period|Disease progression|201|||
124594031|NCT03635983|448131190|FG000|Treatment Period|Study drug toxicity|35|||
124594032|NCT03635983|448131191|FG001|Treatment Period|Study drug toxicity|36|||
124594033|NCT03635983|448131190|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
124594034|NCT03635983|448131191|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
124594035|NCT03635983|448131190|FG000|Treatment Period|Maximum clinical benefit|3|||
124594036|NCT03635983|448131191|FG001|Treatment Period|Maximum clinical benefit|5|||
124594037|NCT03635983|448131190|FG000|Treatment Period|Administrative reason by the sponsor|1|||
124594038|NCT03635983|448131191|FG001|Treatment Period|Administrative reason by the sponsor|2|||
124594039|NCT03635983|448131190|FG000|Treatment Period|Lost to Follow-up|0|||
124594040|NCT03635983|448131191|FG001|Treatment Period|Lost to Follow-up|1|||
124594041|NCT01235442|448131193|FG000|Overall Study|Lost to Follow-up|12|||
124594042|NCT01235442|448131194|FG001|Overall Study|Lost to Follow-up|10|||
124594043|NCT01235442|448131193|FG000|Overall Study|Death|0|||
124594044|NCT01235442|448131194|FG001|Overall Study|Death|2|||
124594045|NCT01235442|448131193|FG000|Overall Study|Pregnancy|1|||
124594046|NCT01235442|448131194|FG001|Overall Study|Pregnancy|1|||
124594047|NCT01235442|448131193|FG000|Overall Study|Ineligibility determined|5|||
124594048|NCT01235442|448131194|FG001|Overall Study|Ineligibility determined|4|||
124594049|NCT01235442|448131193|FG000|Overall Study|Protocol Violation|3|||
124594050|NCT01235442|448131194|FG001|Overall Study|Protocol Violation|3|||
124594051|NCT01235442|448131193|FG000|Overall Study|Adverse Event|4|||
124594052|NCT01235442|448131194|FG001|Overall Study|Adverse Event|6|||
124594053|NCT01235442|448131193|FG000|Overall Study|Withdrawal by Subject|15|||
124594054|NCT01235442|448131194|FG001|Overall Study|Withdrawal by Subject|9|||
124594055|NCT01235442|448131193|FG000|Overall Study|Lack of Efficacy|1|||
124594056|NCT01235442|448131194|FG001|Overall Study|Lack of Efficacy|3|||
124594057|NCT01235442|448131193|FG000|Overall Study|Noncompliance|1|||
124594058|NCT01235442|448131194|FG001|Overall Study|Noncompliance|2|||
124594059|NCT01235442|448131193|FG000|Overall Study|Administrative decision|1|||
124594060|NCT01235442|448131194|FG001|Overall Study|Administrative decision|2|||
124594061|NCT01235442|448131193|FG000|Overall Study|Other unspecified|1|||
124594062|NCT01235442|448131194|FG001|Overall Study|Other unspecified|2|||
124594063|NCT01701973|448131197|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
124594064|NCT01701973|448131198|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
124594065|NCT01701973|448131199|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
124594066|NCT01701973|448131200|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
124594067|NCT01701973|448131201|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
124594068|NCT01701973|448131202|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
124594069|NCT01701973|448131203|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
124594070|NCT01701973|448131204|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
124594071|NCT02412722|448131207|FG000|Overall Study|Adverse Event|0|||
124594072|NCT02412722|448131208|FG001|Overall Study|Adverse Event|2|||
124594073|NCT02412722|448131209|FG002|Overall Study|Adverse Event|0|||
124594074|NCT02412722|448131210|FG003|Overall Study|Adverse Event|3|||
124594075|NCT02412722|448131211|FG004|Overall Study|Adverse Event|0|||
124594076|NCT02412722|448131212|FG005|Overall Study|Adverse Event|3|||
124594077|NCT02412722|448131207|FG000|Overall Study|Progressive Disease|6|||
124594078|NCT02412722|448131208|FG001|Overall Study|Progressive Disease|4|||
124594079|NCT02412722|448131209|FG002|Overall Study|Progressive Disease|4|||
124594080|NCT02412722|448131210|FG003|Overall Study|Progressive Disease|9|||
124594081|NCT02412722|448131211|FG004|Overall Study|Progressive Disease|3|||
124594082|NCT02412722|448131212|FG005|Overall Study|Progressive Disease|3|||
124594083|NCT02412722|448131207|FG000|Overall Study|Withdrawal by Subject|2|||
124594084|NCT02412722|448131208|FG001|Overall Study|Withdrawal by Subject|0|||
124594085|NCT02412722|448131209|FG002|Overall Study|Withdrawal by Subject|1|||
124594086|NCT02412722|448131210|FG003|Overall Study|Withdrawal by Subject|2|||
124594087|NCT02412722|448131211|FG004|Overall Study|Withdrawal by Subject|1|||
124594088|NCT02412722|448131212|FG005|Overall Study|Withdrawal by Subject|1|||
124594089|NCT02412722|448131207|FG000|Overall Study|Lost to Follow-up|0|||
124594090|NCT02412722|448131208|FG001|Overall Study|Lost to Follow-up|0|||
124594091|NCT02412722|448131209|FG002|Overall Study|Lost to Follow-up|0|||
124594092|NCT02412722|448131210|FG003|Overall Study|Lost to Follow-up|0|||
124594093|NCT02412722|448131211|FG004|Overall Study|Lost to Follow-up|1|||
124594094|NCT02412722|448131212|FG005|Overall Study|Lost to Follow-up|0|||
124594095|NCT02412722|448131207|FG000|Overall Study|Received drug in run-in and discontinued|0|||
124594096|NCT02412722|448131208|FG001|Overall Study|Received drug in run-in and discontinued|2|||
124594097|NCT02412722|448131209|FG002|Overall Study|Received drug in run-in and discontinued|0|||
124594098|NCT02412722|448131210|FG003|Overall Study|Received drug in run-in and discontinued|0|||
124594099|NCT02412722|448131211|FG004|Overall Study|Received drug in run-in and discontinued|0|||
124594100|NCT02412722|448131212|FG005|Overall Study|Received drug in run-in and discontinued|0|||
124594101|NCT02412722|448131207|FG000|Overall Study|Reason not Specified|3|||
124594102|NCT02412722|448131208|FG001|Overall Study|Reason not Specified|0|||
124594103|NCT02412722|448131209|FG002|Overall Study|Reason not Specified|2|||
124594104|NCT02412722|448131210|FG003|Overall Study|Reason not Specified|1|||
124594105|NCT02412722|448131211|FG004|Overall Study|Reason not Specified|2|||
124594106|NCT02412722|448131212|FG005|Overall Study|Reason not Specified|6|||
124594107|NCT02941523|448131213|FG000|Monotherapy|Withdrawal by Subject|0|||
124594108|NCT02941523|448131214|FG001|Monotherapy|Withdrawal by Subject|1|||
124594109|NCT02941523|448131213|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
124594110|NCT02941523|448131214|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
124594111|NCT02941523|448131213|FG000|Carboplatin Combination Therapy|Death|1|||
124594112|NCT02941523|448131214|FG001|Carboplatin Combination Therapy|Death|2|||
124594113|NCT02941523|448131213|FG000|Carboplatin Combination Therapy|Disease progression|2|||
124594114|NCT02941523|448131214|FG001|Carboplatin Combination Therapy|Disease progression|0|||
124594115|NCT02941523|448131213|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
124594116|NCT02941523|448131214|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
124594117|NCT04449341|448131215|FG000|Overall Study|Protocol Violation|1|||
124594118|NCT04449341|448131216|FG001|Overall Study|Protocol Violation|0|||
124594119|NCT04330157|448131217|FG000|Overall Study|Protocol Violation|4|||
124594120|NCT04330157|448131217|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
124594121|NCT04499482|448131218|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
124594122|NCT01899326|448131220|FG000|Overall Study|Withdrawal by Subject|1|||
124594123|NCT01899326|448131220|FG000|Overall Study|Adverse Event|2|||
124594124|NCT01899326|448131220|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
124594125|NCT01263561|448131221|FG000|Overall Study|Death|1|||
124594126|NCT01263561|448131222|FG001|Overall Study|Death|2|||
124594127|NCT01396421|448131223|FG000|Overall Study|Lost to Follow-up|0|||
124594128|NCT01396421|448131224|FG001|Overall Study|Lost to Follow-up|0|||
124594129|NCT01396421|448131225|FG002|Overall Study|Lost to Follow-up|0|||
124594130|NCT01396421|448131226|FG003|Overall Study|Lost to Follow-up|1|||
124594131|NCT01396421|448131223|FG000|Overall Study|Adverse Event|17|||
124594132|NCT01396421|448131224|FG001|Overall Study|Adverse Event|15|||
124594133|NCT01396421|448131225|FG002|Overall Study|Adverse Event|12|||
124594134|NCT01396421|448131226|FG003|Overall Study|Adverse Event|32|||
124594135|NCT01396421|448131223|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
124594136|NCT01396421|448131224|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
124594137|NCT01396421|448131225|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
124594138|NCT01396421|448131226|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
124594139|NCT01396421|448131223|FG000|Overall Study|Physician Decision|1|||
124594140|NCT01396421|448131224|FG001|Overall Study|Physician Decision|1|||
124594141|NCT01396421|448131225|FG002|Overall Study|Physician Decision|0|||
124594142|NCT01396421|448131226|FG003|Overall Study|Physician Decision|3|||
124594143|NCT01396421|448131223|FG000|Overall Study|Withdrawal by Subject|31|||
124594144|NCT01396421|448131224|FG001|Overall Study|Withdrawal by Subject|24|||
124594145|NCT01396421|448131225|FG002|Overall Study|Withdrawal by Subject|13|||
124594146|NCT01396421|448131226|FG003|Overall Study|Withdrawal by Subject|21|||
124594147|NCT01396421|448131223|FG000|Overall Study|Protocol Deviation|2|||
124594148|NCT01396421|448131224|FG001|Overall Study|Protocol Deviation|1|||
124594149|NCT01396421|448131225|FG002|Overall Study|Protocol Deviation|1|||
124594150|NCT01396421|448131226|FG003|Overall Study|Protocol Deviation|0|||
124594151|NCT01396421|448131223|FG000|Overall Study|Lack of Efficacy|7|||
124594152|NCT01396421|448131224|FG001|Overall Study|Lack of Efficacy|17|||
124594153|NCT01396421|448131225|FG002|Overall Study|Lack of Efficacy|7|||
124594154|NCT01396421|448131226|FG003|Overall Study|Lack of Efficacy|18|||
124594155|NCT03689894|448131231|FG000|Overall Study|Adverse Event|1|||
124594156|NCT01321697|448131237|FG000|Overall Study|Study Terminated|7|||
124594157|NCT04149535|448131242|FG000|Overall Study|Death|11|||
124594158|NCT04149535|448131243|FG001|Overall Study|Death|7|||
124594159|NCT04149535|448131242|FG000|Overall Study|Physician Decision|10|||
124594160|NCT04149535|448131243|FG001|Overall Study|Physician Decision|4|||
124730314|NCT02509039|448634056|FG003|Overall Study|Progressive disease|5|||
124730315|NCT02509039|448634053|FG000|Overall Study|Study terminated by Sponsor|1|||
124730316|NCT02509039|448634054|FG001|Overall Study|Study terminated by Sponsor|0|||
124730317|NCT02509039|448634055|FG002|Overall Study|Study terminated by Sponsor|0|||
124730318|NCT02509039|448634056|FG003|Overall Study|Study terminated by Sponsor|0|||
124730319|NCT05427539|448634059|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
124730320|NCT05427539|448634060|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
124730321|NCT05427539|448634059|FG000|Period 1|Withdrawal by Subject|1|||
124730322|NCT05427539|448634060|FG001|Period 1|Withdrawal by Subject|0|||
124730323|NCT01895543|448634063|FG000|Overall Study|Withdrawal by Subject|43|||
124730324|NCT01895543|448634063|FG000|Overall Study|Lost to Follow-up|25|||
124730325|NCT01895543|448634063|FG000|Overall Study|Adverse Event|28|||
124730326|NCT01895543|448634063|FG000|Overall Study|Subject's substantial non-compliance|6|||
124730327|NCT01895543|448634063|FG000|Overall Study|Protocol Violation|1|||
124730328|NCT01895543|448634063|FG000|Overall Study|Physician Decision|2|||
124730329|NCT01895543|448634063|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
124730330|NCT00543296|448634064|FG000|Overall Study|Physician Decision|7|||
124730331|NCT00934947|448634065|FG000|Overall Study|Adverse Event|0|||
124730332|NCT00934947|448634066|FG001|Overall Study|Adverse Event|2|||
124730333|NCT01703208|448634069|FG000|Overall Study|Death|61|||
124730334|NCT01703208|448634070|FG001|Overall Study|Death|48|||
124730335|NCT01703208|448634069|FG000|Overall Study|Lack of Efficacy|1|||
124730336|NCT01703208|448634070|FG001|Overall Study|Lack of Efficacy|2|||
124730337|NCT01703208|448634069|FG000|Overall Study|Lost to Follow-up|68|||
124730338|NCT01703208|448634070|FG001|Overall Study|Lost to Follow-up|62|||
124730339|NCT01703208|448634069|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124730340|NCT01703208|448634070|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124730341|NCT01703208|448634069|FG000|Overall Study|Excluded Medication|1|||
124730342|NCT01703208|448634070|FG001|Overall Study|Excluded Medication|2|||
124730343|NCT01703208|448634069|FG000|Overall Study|Site Discontinued Study Participation|23|||
124730344|NCT01703208|448634070|FG001|Overall Study|Site Discontinued Study Participation|27|||
124730345|NCT01703208|448634069|FG000|Overall Study|Physician Decision|11|||
124730346|NCT01703208|448634070|FG001|Overall Study|Physician Decision|13|||
124730347|NCT01703208|448634069|FG000|Overall Study|Progressive disease|2|||
124730348|NCT01703208|448634070|FG001|Overall Study|Progressive disease|2|||
124730349|NCT01703208|448634069|FG000|Overall Study|Protocol Violation|1|||
124730350|NCT01703208|448634070|FG001|Overall Study|Protocol Violation|1|||
124730351|NCT01703208|448634069|FG000|Overall Study|Study Terminated by Sponsor|1710|||
124730352|NCT01703208|448634070|FG001|Overall Study|Study Terminated by Sponsor|1716|||
124730353|NCT01703208|448634069|FG000|Overall Study|Withdrawal by Subject|205|||
124730354|NCT01703208|448634070|FG001|Overall Study|Withdrawal by Subject|209|||
124730355|NCT01703208|448634069|FG000|Overall Study|Adverse Event|14|||
124730356|NCT01703208|448634070|FG001|Overall Study|Adverse Event|19|||
124730357|NCT01703208|448634069|FG000|Overall Study|Technical Problems|0|||
124730358|NCT01703208|448634070|FG001|Overall Study|Technical Problems|1|||
124730359|NCT01703208|448634069|FG000|Overall Study|Protocol Deviation|2|||
124730360|NCT01703208|448634070|FG001|Overall Study|Protocol Deviation|0|||
124730361|NCT02099344|448634071|FG000|Overall Study|Physician Decision|1|||
124730362|NCT02099344|448634072|FG001|Overall Study|Physician Decision|0|||
124730363|NCT05593913|448634077|FG000|Overall Study|Insufficient image quality|39|||
124730364|NCT02979093|448634080|FG000|First Scan Session|Scanning data problems|1|||
124730365|NCT02979093|448634081|FG001|First Scan Session|Scanning data problems|2|||
124730366|NCT02979093|448634082|FG002|First Scan Session|Scanning data problems|2|||
124730367|NCT02979093|448634083|FG003|First Scan Session|Scanning data problems|0|||
124730368|NCT02979093|448634080|FG000|Second Scan Session|Scanning data problems|3|||
124730369|NCT02979093|448634081|FG001|Second Scan Session|Scanning data problems|0|||
124594161|NCT04149535|448131242|FG000|Overall Study|Withdrawal by Subject|6|||
124730370|NCT02979093|448634082|FG002|Second Scan Session|Scanning data problems|1|||
124730371|NCT02979093|448634083|FG003|Second Scan Session|Scanning data problems|3|||
124730372|NCT01096368|448634084|FG000|Overall Study|Death|0|||
124730373|NCT01096368|448634085|FG001|Overall Study|Death|1|||
124730374|NCT01096368|448634086|FG002|Overall Study|Death|0|||
124730375|NCT01096368|448634087|FG003|Overall Study|Death|0|||
124730376|NCT01096368|448634088|FG004|Overall Study|Death|0|||
124730377|NCT01096368|448634084|FG000|Overall Study|Physician Decision|0|||
124730378|NCT01096368|448634085|FG001|Overall Study|Physician Decision|13|||
124730379|NCT01096368|448634086|FG002|Overall Study|Physician Decision|2|||
124730380|NCT01096368|448634087|FG003|Overall Study|Physician Decision|4|||
124730381|NCT01096368|448634088|FG004|Overall Study|Physician Decision|6|||
124779209|NCT03083873|448821332|FG004|Overall Study|Sponsor Terminated Study|0|||
124779210|NCT03083873|448821328|FG000|Overall Study|Lost to Follow-up|0|||
124594162|NCT04149535|448131243|FG001|Overall Study|Withdrawal by Subject|7|||
124594163|NCT04149535|448131242|FG000|Overall Study|Not described|2|||
124594164|NCT04149535|448131243|FG001|Overall Study|Not described|0|||
124594165|NCT02875028|448131244|FG000|Washout Period|Withdrawal by Subject|0|||
124594166|NCT02875028|448131245|FG001|Washout Period|Withdrawal by Subject|1|||
124594167|NCT03180528|448132665|FG000|Overall Study|Adverse Event|1|||
124594168|NCT03180528|448132665|FG000|Overall Study|Withdrawal by Subject|1|||
124594169|NCT03180528|448132665|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
124594170|NCT04703855|448132666|FG000|Overall Study|Heart Transplant|1|||
124594171|NCT01989676|448132669|FG000|Overall Study|Death|52|||
124594172|NCT01989676|448132670|FG001|Overall Study|Death|60|||
124594173|NCT01989676|448132669|FG000|Overall Study|Protocol Violation|2|||
124594174|NCT01989676|448132670|FG001|Overall Study|Protocol Violation|1|||
124594175|NCT01989676|448132669|FG000|Overall Study|Lost to Follow-up|8|||
124594176|NCT01989676|448132670|FG001|Overall Study|Lost to Follow-up|18|||
124594177|NCT01989676|448132669|FG000|Overall Study|No longer willing to participate in study|26|||
124594178|NCT01989676|448132670|FG001|Overall Study|No longer willing to participate in study|26|||
124594179|NCT01989676|448132669|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
124594180|NCT01989676|448132670|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
124594181|NCT01989676|448132669|FG000|Overall Study|Other|4|||
124594182|NCT01989676|448132670|FG001|Overall Study|Other|3|||
124594183|NCT00114231|448132674|FG000|Overall Study|No consent|2|||
124594184|NCT00114231|448132675|FG001|Overall Study|No consent|0|||
124594185|NCT00114231|448132674|FG000|Overall Study|QARC requirement not met|1|||
124594186|NCT00114231|448132675|FG001|Overall Study|QARC requirement not met|0|||
124594187|NCT00114231|448132674|FG000|Overall Study|Suspected metastatic disease|1|||
124594188|NCT00114231|448132675|FG001|Overall Study|Suspected metastatic disease|0|||
124594189|NCT00114231|448132674|FG000|Overall Study|No adenocarcinoma|1|||
124594190|NCT00114231|448132675|FG001|Overall Study|No adenocarcinoma|0|||
124594191|NCT00114231|448132674|FG000|Overall Study|Low creatinine clearance|0|||
124594192|NCT00114231|448132675|FG001|Overall Study|Low creatinine clearance|1|||
124594193|NCT00114231|448132674|FG000|Overall Study|Tumor size > 4cm|1|||
124594194|NCT00114231|448132675|FG001|Overall Study|Tumor size > 4cm|0|||
124594195|NCT00114231|448132674|FG000|Overall Study|Tumor fixed on digital exam|0|||
124594196|NCT00114231|448132675|FG001|Overall Study|Tumor fixed on digital exam|1|||
124594197|NCT00114231|448132674|FG000|Overall Study|No Absolute Neutrophil Count|2|||
124594198|NCT00114231|448132675|FG001|Overall Study|No Absolute Neutrophil Count|0|||
124594199|NCT00114231|448132674|FG000|Overall Study|Biopsy done after registration|1|||
124594200|NCT00114231|448132675|FG001|Overall Study|Biopsy done after registration|0|||
124594201|NCT01976728|448132678|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
124594202|NCT01976728|448132679|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
124594203|NCT01976728|448132680|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
124594204|NCT01976728|448132681|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
124594205|NCT00966381|448132683|FG000|Overall Study|Withdrawal by Subject|2|||
124594206|NCT00966381|448132684|FG001|Overall Study|Withdrawal by Subject|2|||
124594207|NCT01124695|448132688|FG000|Overall Study|Disease progression|77|||
124594208|NCT01124695|448132688|FG000|Overall Study|Adverse Event|11|||
124594209|NCT01124695|448132688|FG000|Overall Study|Death|1|||
124594210|NCT01124695|448132688|FG000|Overall Study|Withdrawal by Subject|7|||
124594211|NCT01124695|448132688|FG000|Overall Study|Physician Decision|3|||
124594212|NCT01124695|448132688|FG000|Overall Study|Alternative therapy|9|||
124594213|NCT01124695|448132688|FG000|Overall Study|No documentation that patient went off treatment|4|||
124594214|NCT01124695|448132688|FG000|Overall Study|Ineligible|9|||
124594215|NCT01124695|448132688|FG000|Overall Study|Ineligible and never start treatment|2|||
124594216|NCT02668822|448132689|FG000|Overall Study|Protocol Violation|2|||
124594217|NCT02668822|448132690|FG001|Overall Study|Protocol Violation|0|||
124594218|NCT02668822|448132689|FG000|Overall Study|Study Terminated by Sponsor|7|||
124594219|NCT02668822|448132690|FG001|Overall Study|Study Terminated by Sponsor|9|||
124594220|NCT01522950|448132691|FG000|Overall Study|Withdrawal by Subject|3|||
124594221|NCT01522950|448132692|FG001|Overall Study|Withdrawal by Subject|2|||
124594222|NCT01522950|448132693|FG002|Overall Study|Withdrawal by Subject|1|||
124594223|NCT01522950|448132691|FG000|Overall Study|Adverse Event|3|||
124779211|NCT03083873|448821329|FG001|Overall Study|Lost to Follow-up|1|||
124779212|NCT03083873|448821330|FG002|Overall Study|Lost to Follow-up|1|||
124779213|NCT03083873|448821331|FG003|Overall Study|Lost to Follow-up|0|||
124594224|NCT01522950|448132692|FG001|Overall Study|Adverse Event|1|||
124594225|NCT01522950|448132693|FG002|Overall Study|Adverse Event|1|||
124594226|NCT01522950|448132691|FG000|Overall Study|Protocol Violation|0|||
124594227|NCT01522950|448132692|FG001|Overall Study|Protocol Violation|0|||
124594228|NCT01522950|448132693|FG002|Overall Study|Protocol Violation|2|||
124594229|NCT01522950|448132691|FG000|Overall Study|Death|0|||
124594230|NCT01522950|448132692|FG001|Overall Study|Death|1|||
124594231|NCT01522950|448132693|FG002|Overall Study|Death|1|||
124779214|NCT03083873|448821332|FG004|Overall Study|Lost to Follow-up|0|||
124594232|NCT01522950|448132691|FG000|Overall Study|Study Medication Sensitivity|0|||
124594233|NCT01522950|448132692|FG001|Overall Study|Study Medication Sensitivity|1|||
124594234|NCT01522950|448132693|FG002|Overall Study|Study Medication Sensitivity|0|||
124594235|NCT00298740|448132698|FG000|Overall Study|Lack of Efficacy|6|||
124594236|NCT00298740|448132698|FG000|Overall Study|Withdrawal by Subject|3|||
124594237|NCT01345318|448132702|FG000|Overall Study|Adverse Event|16|||
124594238|NCT01345318|448132702|FG000|Overall Study|Lack of Efficacy|17|||
124594239|NCT01345318|448132702|FG000|Overall Study|Lost to Follow-up|2|||
124594240|NCT01345318|448132702|FG000|Overall Study|Protocol Violation|1|||
124594241|NCT01345318|448132702|FG000|Overall Study|Withdrawal by Subject|41|||
124594242|NCT01345318|448132702|FG000|Overall Study|Other|3|||
124594243|NCT00317642|448132703|FG000|Overall Study|Not Received Either Study Drug|1|||
124594244|NCT00317642|448132704|FG001|Overall Study|Not Received Either Study Drug|3|||
124594245|NCT00317642|448132703|FG000|Overall Study|Physician Decision|15|||
124594246|NCT00317642|448132704|FG001|Overall Study|Physician Decision|7|||
124594247|NCT00317642|448132703|FG000|Overall Study|Participant declined treatment|14|||
124594248|NCT00317642|448132704|FG001|Overall Study|Participant declined treatment|3|||
124594249|NCT00317642|448132703|FG000|Overall Study|Adverse Event|17|||
124594250|NCT00317642|448132704|FG001|Overall Study|Adverse Event|5|||
124594251|NCT00317642|448132703|FG000|Overall Study|Treatment Failure|56|||
124594252|NCT00317642|448132704|FG001|Overall Study|Treatment Failure|102|||
124594253|NCT00317642|448132703|FG000|Overall Study|Disease Recurrence|1|||
124594254|NCT00317642|448132704|FG001|Overall Study|Disease Recurrence|2|||
124594255|NCT00317642|448132703|FG000|Overall Study|Death|14|||
124594256|NCT00317642|448132704|FG001|Overall Study|Death|7|||
124594257|NCT00317642|448132703|FG000|Overall Study|Not Continue to Consolidation|2|||
124594258|NCT00317642|448132704|FG001|Overall Study|Not Continue to Consolidation|0|||
124594259|NCT00317642|448132703|FG000|Overall Study|Withdrawal by Subject|0|||
124594260|NCT00317642|448132704|FG001|Overall Study|Withdrawal by Subject|1|||
124594261|NCT00317642|448132703|FG000|Overall Study|Referred For Transplantation|1|||
124594262|NCT00317642|448132704|FG001|Overall Study|Referred For Transplantation|0|||
124594263|NCT00317642|448132703|FG000|Overall Study|AML Not Centrally Confirmed|1|||
124594264|NCT00317642|448132704|FG001|Overall Study|AML Not Centrally Confirmed|5|||
124594265|NCT03180801|448132706|FG000|Overall Study|Physician Decision|3|||
124594266|NCT03180801|448132707|FG001|Overall Study|Physician Decision|3|||
124594267|NCT03180801|448132708|FG002|Overall Study|Physician Decision|1|||
124594268|NCT03180801|448132706|FG000|Overall Study|Non-compliance|1|||
124594269|NCT03180801|448132707|FG001|Overall Study|Non-compliance|4|||
124594270|NCT03180801|448132708|FG002|Overall Study|Non-compliance|0|||
124594271|NCT03180801|448132706|FG000|Overall Study|Inoculation Target Reached|1|||
124594272|NCT03180801|448132707|FG001|Overall Study|Inoculation Target Reached|1|||
124594273|NCT03180801|448132708|FG002|Overall Study|Inoculation Target Reached|3|||
124594274|NCT03180801|448132706|FG000|Overall Study|Adverse Event|1|||
124594275|NCT03180801|448132707|FG001|Overall Study|Adverse Event|0|||
124594276|NCT03180801|448132708|FG002|Overall Study|Adverse Event|2|||
124594277|NCT03180801|448132706|FG000|Overall Study|Withdrawal by Subject|2|||
124594278|NCT03180801|448132707|FG001|Overall Study|Withdrawal by Subject|2|||
124594279|NCT03180801|448132708|FG002|Overall Study|Withdrawal by Subject|1|||
124594280|NCT03180801|448132706|FG000|Overall Study|Lost to Follow-up|0|||
124594281|NCT03180801|448132707|FG001|Overall Study|Lost to Follow-up|2|||
124594282|NCT03180801|448132708|FG002|Overall Study|Lost to Follow-up|3|||
124594283|NCT01049412|448132709|FG000|Period I|Withdrawal by Subject|4|||
124594284|NCT01049412|448132710|FG001|Period I|Withdrawal by Subject|6|||
124594285|NCT01049412|448132709|FG000|Period I|Lost to Follow-up|2|||
124594286|NCT01049412|448132710|FG001|Period I|Lost to Follow-up|2|||
124594287|NCT01049412|448132709|FG000|Period I|Physician Decision|0|||
124594288|NCT01049412|448132710|FG001|Period I|Physician Decision|3|||
124730382|NCT01096368|448634084|FG000|Overall Study|Withdrawal by Subject|0|||
124730383|NCT01096368|448634085|FG001|Overall Study|Withdrawal by Subject|52|||
124730384|NCT01096368|448634086|FG002|Overall Study|Withdrawal by Subject|0|||
124594289|NCT01049412|448132709|FG000|Period I|Protocol Violation|1|||
124594290|NCT01049412|448132710|FG001|Period I|Protocol Violation|2|||
124594291|NCT01049412|448132709|FG000|Period I|Adverse Event|1|||
124594292|NCT01049412|448132710|FG001|Period I|Adverse Event|0|||
124730385|NCT01096368|448634087|FG003|Overall Study|Withdrawal by Subject|10|||
124730386|NCT01096368|448634088|FG004|Overall Study|Withdrawal by Subject|14|||
124594293|NCT01049412|448132709|FG000|Period II|Withdrawal by Subject|2|||
124594294|NCT01049412|448132710|FG001|Period II|Withdrawal by Subject|3|||
124594295|NCT01049412|448132709|FG000|Period II|Adverse Event|1|||
124594296|NCT01049412|448132710|FG001|Period II|Adverse Event|0|||
124594297|NCT01049412|448132709|FG000|Period II|Lost to Follow-up|1|||
124594298|NCT01049412|448132710|FG001|Period II|Lost to Follow-up|0|||
124594299|NCT03756883|448132711|FG000|Overall Study|Adverse Event|2|||
124594300|NCT03756883|448132712|FG001|Overall Study|Adverse Event|2|||
124594301|NCT03756883|448132713|FG002|Overall Study|Adverse Event|2|||
124594302|NCT03756883|448132711|FG000|Overall Study|Lack of Efficacy|0|||
124594303|NCT03756883|448132712|FG001|Overall Study|Lack of Efficacy|1|||
124594304|NCT03756883|448132713|FG002|Overall Study|Lack of Efficacy|2|||
124730387|NCT01096368|448634084|FG000|Overall Study|Ineligible|0|||
124594305|NCT03756883|448132711|FG000|Overall Study|Lost to Follow-up|3|||
124594306|NCT03756883|448132712|FG001|Overall Study|Lost to Follow-up|3|||
124594307|NCT03756883|448132713|FG002|Overall Study|Lost to Follow-up|0|||
124594308|NCT03756883|448132711|FG000|Overall Study|Protocol Violation|2|||
124594309|NCT03756883|448132712|FG001|Overall Study|Protocol Violation|0|||
124594310|NCT03756883|448132713|FG002|Overall Study|Protocol Violation|1|||
124594311|NCT03756883|448132711|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
124594312|NCT03756883|448132712|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
124594313|NCT03756883|448132713|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
124594314|NCT03756883|448132711|FG000|Overall Study|Withdrawal by Subject|4|||
124594315|NCT03756883|448132712|FG001|Overall Study|Withdrawal by Subject|1|||
124594316|NCT03756883|448132713|FG002|Overall Study|Withdrawal by Subject|0|||
124594317|NCT03756883|448132711|FG000|Overall Study|Other Reasons|2|||
124594318|NCT03756883|448132712|FG001|Overall Study|Other Reasons|4|||
124594319|NCT03756883|448132713|FG002|Overall Study|Other Reasons|0|||
124594320|NCT03235479|448132716|FG000|Overall Study|Lost to Follow-up|8|||
124594321|NCT03235479|448132717|FG001|Overall Study|Lost to Follow-up|11|||
124594322|NCT03235479|448132716|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
124594323|NCT03235479|448132717|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
124594324|NCT03235479|448132716|FG000|Overall Study|Pregnancy|1|||
124594325|NCT03235479|448132717|FG001|Overall Study|Pregnancy|0|||
124594326|NCT03235479|448132716|FG000|Overall Study|Protocol Deviation|1|||
124594327|NCT03235479|448132717|FG001|Overall Study|Protocol Deviation|3|||
124594328|NCT03235479|448132716|FG000|Overall Study|Technical Problems|3|||
124594329|NCT03235479|448132717|FG001|Overall Study|Technical Problems|2|||
124594330|NCT03235479|448132716|FG000|Overall Study|Withdrawal by Subject|2|||
124594331|NCT03235479|448132717|FG001|Overall Study|Withdrawal by Subject|2|||
124594332|NCT03235479|448132716|FG000|Overall Study|Other Reasons|3|||
124594333|NCT03235479|448132717|FG001|Overall Study|Other Reasons|5|||
124594334|NCT04205162|448132718|FG000|Overall Study|Lost to Follow-up|1|||
124594335|NCT04205162|448132719|FG001|Overall Study|Lost to Follow-up|0|||
124594336|NCT04205162|448132718|FG000|Overall Study|Withdrawal by Subject|2|||
124594337|NCT04205162|448132719|FG001|Overall Study|Withdrawal by Subject|0|||
124594338|NCT04205162|448132718|FG000|Overall Study|University closure due to COVID-19|1|||
124594339|NCT04205162|448132719|FG001|Overall Study|University closure due to COVID-19|0|||
124594340|NCT01011556|448132720|FG000|Overall Study|Adverse Event|1|||
124594341|NCT01011556|448132721|FG001|Overall Study|Adverse Event|3|||
124594342|NCT01011556|448132722|FG002|Overall Study|Adverse Event|2|||
124594343|NCT01011556|448132723|FG003|Overall Study|Adverse Event|1|||
124594344|NCT01011556|448132720|FG000|Overall Study|Lost to Follow-up|1|||
124594345|NCT01011556|448132721|FG001|Overall Study|Lost to Follow-up|0|||
124594346|NCT01011556|448132722|FG002|Overall Study|Lost to Follow-up|0|||
124594347|NCT01011556|448132723|FG003|Overall Study|Lost to Follow-up|0|||
124594348|NCT01011556|448132720|FG000|Overall Study|Physician Decision|1|||
124594349|NCT01011556|448132721|FG001|Overall Study|Physician Decision|0|||
124594350|NCT01011556|448132722|FG002|Overall Study|Physician Decision|0|||
124594351|NCT01011556|448132723|FG003|Overall Study|Physician Decision|1|||
124594352|NCT01011556|448132720|FG000|Overall Study|Protocol Violation|0|||
124594353|NCT01011556|448132721|FG001|Overall Study|Protocol Violation|1|||
124594354|NCT01011556|448132722|FG002|Overall Study|Protocol Violation|0|||
124594355|NCT01011556|448132723|FG003|Overall Study|Protocol Violation|0|||
124594356|NCT01011556|448132720|FG000|Overall Study|Withdrawal by Subject|1|||
124594357|NCT01011556|448132721|FG001|Overall Study|Withdrawal by Subject|2|||
124594358|NCT01011556|448132722|FG002|Overall Study|Withdrawal by Subject|4|||
124594359|NCT01011556|448132723|FG003|Overall Study|Withdrawal by Subject|4|||
124594360|NCT01011556|448132720|FG000|Overall Study|Sponsor decision|0|||
124594361|NCT01011556|448132721|FG001|Overall Study|Sponsor decision|1|||
124594362|NCT01011556|448132722|FG002|Overall Study|Sponsor decision|1|||
124594363|NCT01011556|448132723|FG003|Overall Study|Sponsor decision|2|||
124594364|NCT01011556|448132720|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
124594365|NCT01011556|448132721|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
124594366|NCT01011556|448132722|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
124594367|NCT01011556|448132723|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
124594368|NCT00263887|448132724|FG000|Overall Study|Withdrawal by Subject|1|||
124594369|NCT00263887|448132725|FG001|Overall Study|Withdrawal by Subject|1|||
124594370|NCT00263887|448132724|FG000|Overall Study|Lung transplantation|1|||
124730388|NCT01096368|448634085|FG001|Overall Study|Ineligible|3|||
124730389|NCT01096368|448634086|FG002|Overall Study|Ineligible|2|||
124730390|NCT01096368|448634087|FG003|Overall Study|Ineligible|0|||
124594371|NCT00263887|448132725|FG001|Overall Study|Lung transplantation|2|||
124594372|NCT00263887|448132724|FG000|Overall Study|Too ill to attend visit|1|||
124594373|NCT00263887|448132725|FG001|Overall Study|Too ill to attend visit|0|||
124594374|NCT00263887|448132724|FG000|Overall Study|Adverse Event|0|||
124594375|NCT00263887|448132725|FG001|Overall Study|Adverse Event|2|||
124594376|NCT00263887|448132724|FG000|Overall Study|Disease progression|0|||
124594377|NCT00263887|448132725|FG001|Overall Study|Disease progression|1|||
124730391|NCT01096368|448634088|FG004|Overall Study|Ineligible|25|||
124779215|NCT03083873|448821328|FG000|Overall Study|Withdrawal by Subject|2|||
124779216|NCT03083873|448821329|FG001|Overall Study|Withdrawal by Subject|0|||
124779217|NCT03083873|448821330|FG002|Overall Study|Withdrawal by Subject|0|||
124779218|NCT03083873|448821331|FG003|Overall Study|Withdrawal by Subject|0|||
124779219|NCT03083873|448821332|FG004|Overall Study|Withdrawal by Subject|0|||
124779220|NCT03083873|448821328|FG000|Overall Study|Did Not Receive TIL|2|||
124779221|NCT03083873|448821329|FG001|Overall Study|Did Not Receive TIL|5|||
124779222|NCT03083873|448821330|FG002|Overall Study|Did Not Receive TIL|3|||
124779223|NCT03083873|448821331|FG003|Overall Study|Did Not Receive TIL|1|||
124779224|NCT03083873|448821332|FG004|Overall Study|Did Not Receive TIL|0|||
124779225|NCT01677377|448821333|FG000|Overall Study|Protocol Violation|1|||
124779226|NCT01677377|448821334|FG001|Overall Study|Protocol Violation|0|||
124779227|NCT01677377|448821335|FG002|Overall Study|Protocol Violation|0|||
124779228|NCT01677377|448821333|FG000|Overall Study|Lost to Follow-up|0|||
124779229|NCT01677377|448821334|FG001|Overall Study|Lost to Follow-up|1|||
124779230|NCT01677377|448821335|FG002|Overall Study|Lost to Follow-up|1|||
124779231|NCT01677377|448821333|FG000|Overall Study|Withdrawal by Subject|0|||
124779232|NCT01677377|448821334|FG001|Overall Study|Withdrawal by Subject|0|||
124779233|NCT01677377|448821335|FG002|Overall Study|Withdrawal by Subject|3|||
124779234|NCT01677377|448821333|FG000|Overall Study|Lack of Efficacy|0|||
124779235|NCT01677377|448821334|FG001|Overall Study|Lack of Efficacy|0|||
124779236|NCT01677377|448821335|FG002|Overall Study|Lack of Efficacy|1|||
124779237|NCT01677377|448821333|FG000|Overall Study|Pregnancy|0|||
124779238|NCT01677377|448821334|FG001|Overall Study|Pregnancy|0|||
124779239|NCT01677377|448821335|FG002|Overall Study|Pregnancy|1|||
124779240|NCT02656693|448821349|FG000|Overall Study|Pregnancy|1|||
124779241|NCT02656693|448821350|FG001|Overall Study|Pregnancy|1|||
124779242|NCT02656693|448821351|FG002|Overall Study|Pregnancy|1|||
124779243|NCT02656693|448821349|FG000|Overall Study|Bariatric surgery|0|||
124779244|NCT02656693|448821350|FG001|Overall Study|Bariatric surgery|1|||
124779245|NCT02656693|448821351|FG002|Overall Study|Bariatric surgery|2|||
124779246|NCT02269267|448821353|FG000|Overall Study|Death|5|||
124779247|NCT03773796|448821354|FG000|Overall Study|Adverse Event|1|||
124779248|NCT03773796|448821354|FG000|Overall Study|Withdrawal by Subject|1|||
124779249|NCT03773796|448821354|FG000|Overall Study|Lack of Efficacy|1|||
124779250|NCT03805659|448821356|FG000|Overall Study|Withdrawal by Subject|0|||
124779251|NCT03805659|448821357|FG001|Overall Study|Withdrawal by Subject|1|||
124779252|NCT00796419|448821358|FG000|Overall Study|Death|0|||
124779253|NCT00796419|448821359|FG001|Overall Study|Death|1|||
124779254|NCT01250145|448821360|FG000|Overall Study|Adverse Event|2|||
124779255|NCT01250145|448821361|FG001|Overall Study|Adverse Event|1|||
124779256|NCT01250145|448821360|FG000|Overall Study|Withdrawal by Subject|0|||
124779257|NCT01250145|448821361|FG001|Overall Study|Withdrawal by Subject|4|||
124779258|NCT01069900|448821363|FG000|Overall Study|Technical problems|0|||
124779259|NCT01069900|448821364|FG001|Overall Study|Technical problems|1|||
124779260|NCT01069900|448821363|FG000|Overall Study|Lost to Follow-up|7|||
124779261|NCT01069900|448821364|FG001|Overall Study|Lost to Follow-up|1|||
124779262|NCT01069900|448821363|FG000|Overall Study|Withdrawal by Subject|6|||
124779263|NCT01069900|448821364|FG001|Overall Study|Withdrawal by Subject|1|||
124779264|NCT01069900|448821363|FG000|Overall Study|Protocol Violation|4|||
124779265|NCT01069900|448821364|FG001|Overall Study|Protocol Violation|1|||
124779266|NCT01069900|448821363|FG000|Overall Study|Insufficient Therapeutic effect|1|||
124779267|NCT01069900|448821364|FG001|Overall Study|Insufficient Therapeutic effect|0|||
124779268|NCT02687191|448821366|FG000|Overall Study|Death|0|||
124779269|NCT02687191|448821367|FG001|Overall Study|Death|1|||
124779270|NCT02687191|448821368|FG002|Overall Study|Death|1|||
124779271|NCT02687191|448821369|FG003|Overall Study|Death|0|||
124779272|NCT02687191|448821370|FG004|Overall Study|Death|1|||
124779273|NCT02687191|448821371|FG005|Overall Study|Death|1|||
124779274|NCT02687191|448821366|FG000|Overall Study|Withdrawal by Subject|0|||
124779275|NCT02687191|448821367|FG001|Overall Study|Withdrawal by Subject|0|||
124779276|NCT02687191|448821368|FG002|Overall Study|Withdrawal by Subject|0|||
124779277|NCT02687191|448821369|FG003|Overall Study|Withdrawal by Subject|1|||
124779278|NCT02687191|448821370|FG004|Overall Study|Withdrawal by Subject|0|||
124779279|NCT02687191|448821371|FG005|Overall Study|Withdrawal by Subject|0|||
124779280|NCT01788358|448821377|FG000|Overall Study|Other|11|||
124779281|NCT01788358|448821377|FG000|Overall Study|Logistical difficulties|1|||
124779282|NCT01788358|448821377|FG000|Overall Study|Lost to Follow-up|5|||
124779283|NCT01788358|448821377|FG000|Overall Study|Protocol Violation|3|||
124779284|NCT01788358|448821377|FG000|Overall Study|Withdrawal by Subject|26|||
124779285|NCT01788358|448821377|FG000|Overall Study|Lack of Efficacy|1|||
124779286|NCT01788358|448821377|FG000|Overall Study|Adverse Event|51|||
124779287|NCT01168219|448821378|FG000|Overall Study|off study before starting treatment|2|||
124779288|NCT01168219|448821378|FG000|Overall Study|withdrew before transplant|1|||
124779289|NCT01168219|448821378|FG000|Overall Study|ineligible due to CML|2|||
124779290|NCT02736890|448821381|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
124779291|NCT02736890|448821382|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
124779292|NCT02736890|448821381|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
124779293|NCT02736890|448821382|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
124594378|NCT00263887|448132724|FG000|Overall Study|Lack of Efficacy|0|||
124594379|NCT00263887|448132725|FG001|Overall Study|Lack of Efficacy|1|||
124594380|NCT00779402|448132726|FG000|Treatment Phase 1|Disease Progression|1|||
124594381|NCT00779402|448132727|FG001|Treatment Phase 1|Disease Progression|0|||
124594382|NCT00779402|448132726|FG000|Treatment Phase 1|Adverse Event|2|||
124594383|NCT00779402|448132727|FG001|Treatment Phase 1|Adverse Event|0|||
124594384|NCT00779402|448132726|FG000|Treatment Phase 1|Protocol Violation|1|||
124594385|NCT00779402|448132727|FG001|Treatment Phase 1|Protocol Violation|0|||
124594386|NCT00779402|448132726|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
124594387|NCT00779402|448132727|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
124594388|NCT00779402|448132726|FG000|Treatment Phase 1|Lost to Follow-up|0|||
124730392|NCT01096368|448634084|FG000|Overall Study|Did not start treatment|0|||
124730393|NCT01096368|448634085|FG001|Overall Study|Did not start treatment|4|||
124730394|NCT01096368|448634086|FG002|Overall Study|Did not start treatment|4|||
124730395|NCT01096368|448634087|FG003|Overall Study|Did not start treatment|0|||
124730396|NCT01096368|448634088|FG004|Overall Study|Did not start treatment|0|||
124730397|NCT01096368|448634084|FG000|Overall Study|Progressive disease|0|||
124730398|NCT01096368|448634085|FG001|Overall Study|Progressive disease|6|||
124730399|NCT01096368|448634086|FG002|Overall Study|Progressive disease|0|||
124730400|NCT01096368|448634087|FG003|Overall Study|Progressive disease|10|||
124730401|NCT01096368|448634088|FG004|Overall Study|Progressive disease|3|||
124730402|NCT01096368|448634084|FG000|Overall Study|Other|0|||
124730403|NCT01096368|448634085|FG001|Overall Study|Other|0|||
124730404|NCT01096368|448634086|FG002|Overall Study|Other|1|||
124730405|NCT01096368|448634087|FG003|Overall Study|Other|0|||
124730406|NCT01096368|448634088|FG004|Overall Study|Other|0|||
124730407|NCT01096368|448634084|FG000|Overall Study|Treated with institutional review|0|||
124730408|NCT01096368|448634085|FG001|Overall Study|Treated with institutional review|0|||
124730409|NCT01096368|448634086|FG002|Overall Study|Treated with institutional review|0|||
124730410|NCT01096368|448634087|FG003|Overall Study|Treated with institutional review|0|||
124730411|NCT01096368|448634088|FG004|Overall Study|Treated with institutional review|1|||
124730412|NCT03070223|448634089|FG000|Overall Study|Lost to Follow-up|34|||
124730413|NCT03070223|448634090|FG001|Overall Study|Lost to Follow-up|27|||
124730414|NCT03070223|448634089|FG000|Overall Study|Withdrawal by Subject|12|||
124730415|NCT03070223|448634090|FG001|Overall Study|Withdrawal by Subject|22|||
124730416|NCT03070223|448634089|FG000|Overall Study|Protocol Violation|0|||
124730417|NCT03070223|448634090|FG001|Overall Study|Protocol Violation|1|||
124730418|NCT00118846|448634094|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
124730419|NCT00118846|448634095|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
124730420|NCT00118846|448634094|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
124730421|NCT00118846|448634095|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
124730422|NCT00118846|448634094|FG000|Overall Study|Physician Decision|1|||
124730423|NCT00118846|448634095|FG001|Overall Study|Physician Decision|0|||
124730424|NCT00118846|448634094|FG000|Overall Study|Medical condition|2|||
124730425|NCT00118846|448634095|FG001|Overall Study|Medical condition|2|||
124730426|NCT00118846|448634094|FG000|Overall Study|Lost to Follow-up|0|||
124730427|NCT00118846|448634095|FG001|Overall Study|Lost to Follow-up|2|||
124730428|NCT00118846|448634094|FG000|Overall Study|Personal reason|4|||
124730429|NCT00118846|448634095|FG001|Overall Study|Personal reason|5|||
124730430|NCT00350272|448634099|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
124730431|NCT00350272|448634100|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
124730432|NCT00350272|448634099|FG000|Blinded 12-Week Treatment|Death|1|||
124730433|NCT00350272|448634100|FG001|Blinded 12-Week Treatment|Death|0|||
124730434|NCT00350272|448634099|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
124730435|NCT00350272|448634100|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
124730436|NCT00350272|448634099|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
124730437|NCT00350272|448634100|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
124730438|NCT00350272|448634099|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
124730439|NCT00350272|448634100|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
124730440|NCT00350272|448634099|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
124730441|NCT00350272|448634100|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
124730442|NCT00350272|448634099|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
124730443|NCT00350272|448634100|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
124730444|NCT00350272|448634099|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
124730445|NCT00350272|448634100|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
124730446|NCT00350272|448634099|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
124730447|NCT00350272|448634100|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
124730448|NCT00350272|448634099|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
124730449|NCT00350272|448634100|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
124730450|NCT00350272|448634099|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
124594389|NCT00779402|448132727|FG001|Treatment Phase 1|Lost to Follow-up|1|||
124594390|NCT00779402|448132726|FG000|Treatment Phase 1|Death|0|||
124594391|NCT00779402|448132727|FG001|Treatment Phase 1|Death|1|||
124730451|NCT00350272|448634100|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
124730452|NCT02226198|448635487|FG000|Lead-in Phase|Protocol Violation|1|||
124594392|NCT00779402|448132726|FG000|Treatment Phase 1|Intercurrent Illness|1|||
124594393|NCT00779402|448132727|FG001|Treatment Phase 1|Intercurrent Illness|1|||
124594394|NCT00779402|448132726|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
124594395|NCT00779402|448132727|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
124594396|NCT00779402|448132726|FG000|Treatment Phase 1|Other|4|||
124594397|NCT00779402|448132727|FG001|Treatment Phase 1|Other|2|||
124594398|NCT00779402|448132726|FG000|Treatment Phase 1|Closure of Study|3|||
124594399|NCT00779402|448132727|FG001|Treatment Phase 1|Closure of Study|2|||
124594400|NCT00779402|448132726|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
124594401|NCT00779402|448132727|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
124594402|NCT00779402|448132726|FG000|Surveillance Phase|Protocol Violation|0|||
124594403|NCT00779402|448132727|FG001|Surveillance Phase|Protocol Violation|1|||
124594404|NCT00779402|448132726|FG000|Surveillance Phase|Patient refused to continue|22|||
124594405|NCT00779402|448132727|FG001|Surveillance Phase|Patient refused to continue|14|||
124594406|NCT00779402|448132726|FG000|Surveillance Phase|Lost to Follow-up|2|||
124594407|NCT00779402|448132727|FG001|Surveillance Phase|Lost to Follow-up|1|||
124594408|NCT00779402|448132726|FG000|Surveillance Phase|Death|0|||
124594409|NCT00779402|448132727|FG001|Surveillance Phase|Death|1|||
124594410|NCT00779402|448132726|FG000|Surveillance Phase|Intercurrent Illness|2|||
124594411|NCT00779402|448132727|FG001|Surveillance Phase|Intercurrent Illness|0|||
124594412|NCT00779402|448132726|FG000|Surveillance Phase|Other|5|||
124594413|NCT00779402|448132727|FG001|Surveillance Phase|Other|5|||
124594414|NCT00779402|448132726|FG000|Surveillance Phase|Withdrawal by Subject|4|||
124594415|NCT00779402|448132727|FG001|Surveillance Phase|Withdrawal by Subject|1|||
124594416|NCT00779402|448132726|FG000|Surveillance Phase|Closure of study|5|||
124594417|NCT00779402|448132727|FG001|Surveillance Phase|Closure of study|6|||
124594418|NCT00779402|448132726|FG000|Surveillance Phase|Completed Protocol Visits|3|||
124594419|NCT00779402|448132727|FG001|Surveillance Phase|Completed Protocol Visits|2|||
124594420|NCT00779402|448132726|FG000|Long-term Follow-up|Patient refused to continue|2|||
124594421|NCT00779402|448132727|FG001|Long-term Follow-up|Patient refused to continue|0|||
124594422|NCT00779402|448132726|FG000|Long-term Follow-up|Other|5|||
124594423|NCT00779402|448132727|FG001|Long-term Follow-up|Other|0|||
124594424|NCT00779402|448132726|FG000|Long-term Follow-up|Closure of Study|8|||
124594425|NCT00779402|448132727|FG001|Long-term Follow-up|Closure of Study|4|||
124594426|NCT00779402|448132726|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
124594427|NCT00779402|448132727|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
124594428|NCT00693225|448132728|FG000|Overall Study|Lost to Follow-up|1|||
124594429|NCT00693225|448132729|FG001|Overall Study|Lost to Follow-up|2|||
124594430|NCT00693225|448132728|FG000|Overall Study|Adverse Event|1|||
124594431|NCT00693225|448132729|FG001|Overall Study|Adverse Event|3|||
124594432|NCT01315028|448132730|FG000|Overall Study|Lost to Follow-up|1|||
124594433|NCT01315028|448132731|FG001|Overall Study|Lost to Follow-up|0|||
124594434|NCT01315028|448132730|FG000|Overall Study|Death|0|||
124594435|NCT01315028|448132731|FG001|Overall Study|Death|1|||
124594436|NCT02359864|448132732|FG000|Overall Study|Withdrawal by Subject|1|||
124594437|NCT02359864|448132733|FG001|Overall Study|Withdrawal by Subject|0|||
124594438|NCT00725764|448132734|FG000|Overall Study|Withdrawal by Subject|2|||
124594439|NCT00725764|448132734|FG000|Overall Study|Physician Decision|1|||
124594440|NCT00725764|448132734|FG000|Overall Study|Progressive Disease|7|||
124594441|NCT00725764|448132734|FG000|Overall Study|Lost to Follow-up|1|||
124594442|NCT00725764|448132734|FG000|Overall Study|Death|1|||
124594443|NCT00725764|448132734|FG000|Overall Study|Participant non compliant with protocol|1|||
124594444|NCT00725764|448132734|FG000|Overall Study|Decline in performance status|1|||
124594445|NCT01928615|448132735|FG000|Overall Study|Study Terminated by Sponsor|2|||
124594446|NCT00090753|448132736|FG000|First Treatment Period|Adverse Event|20|||
124594447|NCT00090753|448132737|FG001|First Treatment Period|Adverse Event|8|||
124594448|NCT00090753|448132736|FG000|First Treatment Period|Death|88|||
124594449|NCT00090753|448132737|FG001|First Treatment Period|Death|62|||
124594450|NCT00090753|448132736|FG000|First Treatment Period|Lack of Efficacy|2|||
124594451|NCT00090753|448132737|FG001|First Treatment Period|Lack of Efficacy|1|||
124594452|NCT00090753|448132736|FG000|First Treatment Period|Refused Treatment|32|||
124594453|NCT00090753|448132737|FG001|First Treatment Period|Refused Treatment|25|||
124594454|NCT00090753|448132736|FG000|First Treatment Period|Lost to Follow-up|4|||
124594455|NCT00090753|448132737|FG001|First Treatment Period|Lost to Follow-up|4|||
124594456|NCT00090753|448132736|FG000|First Treatment Period|Renal Transplant|70|||
124594457|NCT00090753|448132737|FG001|First Treatment Period|Renal Transplant|50|||
124594458|NCT00090753|448132736|FG000|First Treatment Period|Mircera Commercialization|1|||
124594459|NCT00090753|448132737|FG001|First Treatment Period|Mircera Commercialization|0|||
124594460|NCT00090753|448132736|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
124594461|NCT00090753|448132737|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
124594462|NCT00090753|448132736|FG000|Extended Treatment Period|Adverse Event|11|||
124594463|NCT00090753|448132737|FG001|Extended Treatment Period|Adverse Event|0|||
124594464|NCT00090753|448132736|FG000|Extended Treatment Period|Death|58|||
124594465|NCT00090753|448132737|FG001|Extended Treatment Period|Death|30|||
124594466|NCT00090753|448132736|FG000|Extended Treatment Period|Lack of Efficacy|1|||
124594467|NCT00090753|448132737|FG001|Extended Treatment Period|Lack of Efficacy|0|||
124594468|NCT00090753|448132736|FG000|Extended Treatment Period|Refused Treatment|18|||
124594469|NCT00090753|448132737|FG001|Extended Treatment Period|Refused Treatment|12|||
124594470|NCT00090753|448132736|FG000|Extended Treatment Period|Lost to Follow-up|3|||
124594471|NCT00090753|448132737|FG001|Extended Treatment Period|Lost to Follow-up|1|||
124594472|NCT00090753|448132736|FG000|Extended Treatment Period|Renal Transplant|15|||
124594473|NCT00090753|448132737|FG001|Extended Treatment Period|Renal Transplant|12|||
124594474|NCT00090753|448132736|FG000|Extended Treatment Period|Mircera Commercialization|188|||
124594475|NCT00090753|448132737|FG001|Extended Treatment Period|Mircera Commercialization|93|||
124594476|NCT00090753|448132736|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
124594477|NCT00090753|448132737|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
124594478|NCT01256060|448132740|FG000|Overall Study|Lost to Follow-up|0|||
124594479|NCT01256060|448132741|FG001|Overall Study|Lost to Follow-up|1|||
124594480|NCT01256060|448132742|FG002|Overall Study|Lost to Follow-up|0|||
124594481|NCT01256060|448132743|FG003|Overall Study|Lost to Follow-up|0|||
124594482|NCT01466036|448132744|FG000|Overall Study|Death|1|||
124594483|NCT01466036|448132745|FG001|Overall Study|Death|1|||
124594484|NCT01466036|448132744|FG000|Overall Study|Physician Decision|0|||
124594485|NCT01466036|448132745|FG001|Overall Study|Physician Decision|4|||
124594486|NCT01466036|448132744|FG000|Overall Study|Adverse Event|2|||
124594487|NCT01466036|448132745|FG001|Overall Study|Adverse Event|6|||
124594488|NCT01466036|448132744|FG000|Overall Study|Withdrawal by Subject|2|||
124594489|NCT01466036|448132745|FG001|Overall Study|Withdrawal by Subject|8|||
124594490|NCT01466036|448132744|FG000|Overall Study|progression/relapse|14|||
124594491|NCT01466036|448132745|FG001|Overall Study|progression/relapse|21|||
124594492|NCT01466036|448132744|FG000|Overall Study|prolonged treatment delay|1|||
124594493|NCT01466036|448132745|FG001|Overall Study|prolonged treatment delay|1|||
124594494|NCT01808248|448132746|FG000|Overall Study|Lack of Efficacy|3|||
124594495|NCT01808248|448132746|FG000|Overall Study|Withdrawal by Subject|1|||
124594496|NCT01808248|448132746|FG000|Overall Study|Lost to Follow-up|1|||
124594497|NCT00761176|448132747|FG000|Overall Study|Death|1|||
124594498|NCT00761176|448132748|FG001|Overall Study|Death|0|||
124594499|NCT00761176|448132747|FG000|Overall Study|Withdrawal by Subject|1|||
124594500|NCT00761176|448132748|FG001|Overall Study|Withdrawal by Subject|1|||
124594501|NCT00109850|448132749|FG000|Overall Study|Adverse Event|1|||
124594502|NCT00109850|448132749|FG000|Overall Study|Death|2|||
124594503|NCT00109850|448132749|FG000|Overall Study|Ineligible|1|||
124594504|NCT00476593|448132750|FG000|Overall Study|Lost to Follow-up|10|||
124594505|NCT00476593|448132751|FG001|Overall Study|Lost to Follow-up|2|||
124594506|NCT00476593|448132752|FG002|Overall Study|Lost to Follow-up|8|||
124594507|NCT00476593|448132753|FG003|Overall Study|Lost to Follow-up|22|||
124594508|NCT03430011|448132754|FG000|Pre-Treatment|Death|1|||
124594509|NCT03430011|448132755|FG001|Pre-Treatment|Death|0|||
124594510|NCT03430011|448132756|FG002|Pre-Treatment|Death|0|||
124594511|NCT03430011|448132757|FG003|Pre-Treatment|Death|0|||
124594512|NCT03430011|448132758|FG004|Pre-Treatment|Death|1|||
124594513|NCT03430011|448132759|FG005|Pre-Treatment|Death|0|||
124594514|NCT03430011|448132760|FG006|Pre-Treatment|Death|1|||
124594515|NCT03430011|448132761|FG007|Pre-Treatment|Death|0|||
124594516|NCT03430011|448132754|FG000|Pre-Treatment|Screen Fail|0|||
124594517|NCT03430011|448132755|FG001|Pre-Treatment|Screen Fail|0|||
124594518|NCT03430011|448132756|FG002|Pre-Treatment|Screen Fail|0|||
124594519|NCT03430011|448132757|FG003|Pre-Treatment|Screen Fail|0|||
124594520|NCT03430011|448132758|FG004|Pre-Treatment|Screen Fail|1|||
124594521|NCT03430011|448132759|FG005|Pre-Treatment|Screen Fail|0|||
124594522|NCT03430011|448132760|FG006|Pre-Treatment|Screen Fail|0|||
124594523|NCT03430011|448132761|FG007|Pre-Treatment|Screen Fail|0|||
124594524|NCT03430011|448132754|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
124594525|NCT03430011|448132755|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
124594526|NCT03430011|448132756|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
124594527|NCT03430011|448132757|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
124594528|NCT03430011|448132758|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
124594529|NCT03430011|448132759|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
124594530|NCT03430011|448132760|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
124594531|NCT03430011|448132761|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
124594532|NCT03430011|448132754|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
124594533|NCT03430011|448132755|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
124594534|NCT03430011|448132756|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
124594535|NCT03430011|448132757|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
124594536|NCT03430011|448132758|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
124594537|NCT03430011|448132759|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
124594538|NCT03430011|448132760|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
124594539|NCT03430011|448132761|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
124594540|NCT03430011|448132754|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
124594541|NCT03430011|448132755|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
124594542|NCT03430011|448132756|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
124594543|NCT03430011|448132757|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
124594544|NCT03430011|448132758|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
124594545|NCT03430011|448132759|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
124594546|NCT03430011|448132760|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
124594547|NCT03430011|448132761|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
124594548|NCT03430011|448132754|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
124594549|NCT03430011|448132755|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
124594550|NCT03430011|448132756|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
124594551|NCT03430011|448132757|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
124594552|NCT03430011|448132758|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
124594553|NCT03430011|448132759|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
124594554|NCT03430011|448132760|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
124594555|NCT03430011|448132761|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
124594556|NCT03430011|448132754|FG000|JCARH125 Treatment|Death|4|||
124594557|NCT03430011|448132755|FG001|JCARH125 Treatment|Death|19|||
124594558|NCT03430011|448132756|FG002|JCARH125 Treatment|Death|10|||
124594559|NCT03430011|448132757|FG003|JCARH125 Treatment|Death|8|||
124594560|NCT03430011|448132758|FG004|JCARH125 Treatment|Death|5|||
124594561|NCT03430011|448132759|FG005|JCARH125 Treatment|Death|3|||
124594562|NCT03430011|448132760|FG006|JCARH125 Treatment|Death|4|||
124594563|NCT03430011|448132761|FG007|JCARH125 Treatment|Death|2|||
124594564|NCT03430011|448132754|FG000|JCARH125 Treatment|Other reasons|1|||
124594565|NCT03430011|448132755|FG001|JCARH125 Treatment|Other reasons|0|||
124594566|NCT03430011|448132756|FG002|JCARH125 Treatment|Other reasons|4|||
124594567|NCT03430011|448132757|FG003|JCARH125 Treatment|Other reasons|2|||
124594568|NCT03430011|448132758|FG004|JCARH125 Treatment|Other reasons|2|||
124594569|NCT03430011|448132759|FG005|JCARH125 Treatment|Other reasons|1|||
124594570|NCT03430011|448132760|FG006|JCARH125 Treatment|Other reasons|3|||
124594571|NCT03430011|448132761|FG007|JCARH125 Treatment|Other reasons|2|||
124594572|NCT04126343|448132762|FG000|Overall Study|Adverse Event|0|||
124594573|NCT04126343|448132763|FG001|Overall Study|Adverse Event|0|||
124594574|NCT04126343|448132764|FG002|Overall Study|Adverse Event|0|||
124594575|NCT04126343|448132765|FG003|Overall Study|Adverse Event|0|||
124594576|NCT04126343|448132766|FG004|Overall Study|Adverse Event|0|||
124594577|NCT04126343|448132767|FG005|Overall Study|Adverse Event|1|||
124594578|NCT04126343|448132762|FG000|Overall Study|Withdrawal by Subject|0|||
124594579|NCT04126343|448132763|FG001|Overall Study|Withdrawal by Subject|0|||
124594580|NCT04126343|448132764|FG002|Overall Study|Withdrawal by Subject|0|||
124594581|NCT04126343|448132765|FG003|Overall Study|Withdrawal by Subject|1|||
124594582|NCT04126343|448132766|FG004|Overall Study|Withdrawal by Subject|0|||
124594583|NCT04126343|448132767|FG005|Overall Study|Withdrawal by Subject|0|||
124594584|NCT04126343|448132762|FG000|Overall Study|Related to COVID-19 pandemic|3|||
124594585|NCT04126343|448132763|FG001|Overall Study|Related to COVID-19 pandemic|4|||
124594586|NCT04126343|448132764|FG002|Overall Study|Related to COVID-19 pandemic|3|||
124594587|NCT04126343|448132765|FG003|Overall Study|Related to COVID-19 pandemic|3|||
124594588|NCT04126343|448132766|FG004|Overall Study|Related to COVID-19 pandemic|3|||
124594589|NCT04126343|448132767|FG005|Overall Study|Related to COVID-19 pandemic|3|||
124594590|NCT00084799|448132768|FG000|Overall Study|Disease Progression|1|||
124594591|NCT00084799|448132769|FG001|Overall Study|Disease Progression|0|||
124594592|NCT03712124|448132770|FG000|Overall Study|Protocol Violation|1|||
124594593|NCT03712124|448132771|FG001|Overall Study|Protocol Violation|0|||
124594594|NCT04314843|448132773|FG000|Overall Study|Death|2|||
124594595|NCT04314843|448132774|FG001|Overall Study|Death|2|||
124594596|NCT04314843|448132773|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
124594597|NCT04314843|448132774|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
124594598|NCT00551616|448132775|FG000|Overall Study|Lost to Follow-up|48|||
124594599|NCT00551616|448132776|FG001|Overall Study|Lost to Follow-up|40|||
124594600|NCT00569777|448132777|FG000|Overall Study|Withdrawal by Subject|4|||
124594601|NCT00569777|448132778|FG001|Overall Study|Withdrawal by Subject|0|||
124594602|NCT00569777|448132777|FG000|Overall Study|Adverse Event|3|||
124594603|NCT00569777|448132778|FG001|Overall Study|Adverse Event|0|||
124594604|NCT00569777|448132777|FG000|Overall Study|Lost to Follow-up|1|||
124594605|NCT00569777|448132778|FG001|Overall Study|Lost to Follow-up|0|||
124594606|NCT00569777|448132777|FG000|Overall Study|scheduled eye surgery|0|||
124594607|NCT00569777|448132778|FG001|Overall Study|scheduled eye surgery|1|||
124594608|NCT00569777|448132777|FG000|Overall Study|did not meet exclusion criteria|1|||
124594609|NCT00569777|448132778|FG001|Overall Study|did not meet exclusion criteria|2|||
124594610|NCT00569777|448132777|FG000|Overall Study|pregnant|1|||
124594611|NCT00569777|448132778|FG001|Overall Study|pregnant|0|||
124594612|NCT04718129|448132783|FG000|Overall Study|Lost to Follow-up|6|||
124594613|NCT04718129|448132784|FG001|Overall Study|Lost to Follow-up|7|||
124594614|NCT01378962|448132785|FG000|Overall Study|Death|14|||
124594615|NCT01378962|448132785|FG000|Overall Study|Lost to Follow-up|1|||
124594616|NCT01378962|448132785|FG000|Overall Study|Other|2|||
124594617|NCT02030535|448132786|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
124594618|NCT01588548|448132787|FG000|Overall Study|Withdrawal by Subject|0|||
124594619|NCT01588548|448132788|FG001|Overall Study|Withdrawal by Subject|1|||
124594620|NCT01588548|448132789|FG002|Overall Study|Withdrawal by Subject|1|||
124594621|NCT01588548|448132790|FG003|Overall Study|Withdrawal by Subject|1|||
124594622|NCT01588548|448132791|FG004|Overall Study|Withdrawal by Subject|2|||
124594623|NCT01588548|448132792|FG005|Overall Study|Withdrawal by Subject|3|||
124594624|NCT01588548|448132787|FG000|Overall Study|Adverse Event|0|||
124594625|NCT01588548|448132788|FG001|Overall Study|Adverse Event|0|||
124594626|NCT01588548|448132789|FG002|Overall Study|Adverse Event|1|||
124594627|NCT01588548|448132790|FG003|Overall Study|Adverse Event|2|||
124594628|NCT01588548|448132791|FG004|Overall Study|Adverse Event|1|||
124594629|NCT01588548|448132792|FG005|Overall Study|Adverse Event|0|||
124594630|NCT01588548|448132787|FG000|Overall Study|Condition Under Investigation Worsened|3|||
124594631|NCT01588548|448132788|FG001|Overall Study|Condition Under Investigation Worsened|6|||
124594632|NCT01588548|448132789|FG002|Overall Study|Condition Under Investigation Worsened|4|||
124594633|NCT01588548|448132790|FG003|Overall Study|Condition Under Investigation Worsened|4|||
124594634|NCT01588548|448132791|FG004|Overall Study|Condition Under Investigation Worsened|3|||
124594635|NCT01588548|448132792|FG005|Overall Study|Condition Under Investigation Worsened|3|||
124594636|NCT00292227|448132793|FG000|Patch Period|Adverse Event|1|||
124594637|NCT00292227|448132794|FG001|Patch Period|Adverse Event|0|||
124594638|NCT00292227|448132795|FG002|Patch Period|Adverse Event|2|||
124594639|NCT00292227|448132793|FG000|Patch Period|Withdrawal by Subject|0|||
124594640|NCT00292227|448132794|FG001|Patch Period|Withdrawal by Subject|0|||
124594641|NCT00292227|448132795|FG002|Patch Period|Withdrawal by Subject|1|||
124594642|NCT03257254|448132796|FG000|Overall Study|Withdrawal by Subject|7|||
124594643|NCT03257254|448132796|FG000|Overall Study|Lost to Follow-up|9|||
124594644|NCT03257254|448132796|FG000|Overall Study|Study discontinued by sponsor|5|||
124594645|NCT00857818|448132797|FG000|Overall Study|Lack of Efficacy|1|||
124594646|NCT00857818|448132798|FG001|Overall Study|Lack of Efficacy|0|||
124594647|NCT00857818|448132797|FG000|Overall Study|Adverse Event|3|||
124594648|NCT00857818|448132798|FG001|Overall Study|Adverse Event|0|||
124594649|NCT00857818|448132797|FG000|Overall Study|Withdrawal by Subject|0|||
124594650|NCT00857818|448132798|FG001|Overall Study|Withdrawal by Subject|4|||
124594651|NCT00857818|448132797|FG000|Overall Study|Sponsor terminated study|6|||
124594652|NCT00857818|448132798|FG001|Overall Study|Sponsor terminated study|4|||
124594653|NCT00857818|448132797|FG000|Overall Study|Investigator decision|1|||
124594654|NCT00857818|448132798|FG001|Overall Study|Investigator decision|0|||
124594655|NCT03840382|448132799|FG000|Overall Study|Lost to Follow-up|11|||
124594656|NCT02175368|448132800|FG000|Overall Study|Lost to Follow-up|1|||
124594657|NCT03941834|448133892|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
124594658|NCT03941834|448133893|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
124594659|NCT03941834|448133894|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
124594660|NCT03941834|448133892|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
124594661|NCT03941834|448133893|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
124594662|NCT03941834|448133894|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
124594663|NCT03941834|448133892|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
124594664|NCT03941834|448133893|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
124594665|NCT03941834|448133894|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
124594666|NCT03941834|448133892|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
124594667|NCT03941834|448133893|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
124594668|NCT03941834|448133894|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
124594669|NCT03941834|448133892|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
124594670|NCT03941834|448133893|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
124594671|NCT03941834|448133894|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
124594672|NCT03941834|448133892|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
124594673|NCT03941834|448133893|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
124594674|NCT03941834|448133894|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
124594675|NCT01560819|448133897|FG000|Overall Study|Physician Decision|1|||
124594676|NCT01560819|448133898|FG001|Overall Study|Physician Decision|0|||
124594677|NCT00802178|448133899|FG000|Overall Study|Lack of Efficacy|36|||
124594678|NCT00802178|448133899|FG000|Overall Study|Insufficient tolerability (IT)|17|||
124594679|NCT00802178|448133899|FG000|Overall Study|Withdrawal by Subject|18|||
124594680|NCT00802178|448133899|FG000|Overall Study|Other|32|||
124594681|NCT00802178|448133899|FG000|Overall Study|Lack of efficacy and patient wish|1|||
124594682|NCT00802178|448133899|FG000|Overall Study|IT and patient wish|8|||
124594683|NCT00802178|448133899|FG000|Overall Study|Patients wish and other reason|1|||
124594684|NCT00097786|448133900|FG000|Overall Study|lost to follow-up for all-cause death|296|||
124594685|NCT00097786|448133901|FG001|Overall Study|lost to follow-up for all-cause death|292|||
124594686|NCT00097786|448133902|FG002|Overall Study|lost to follow-up for all-cause death|313|||
124594687|NCT00097786|448133903|FG003|Overall Study|lost to follow-up for all-cause death|310|||
124594688|NCT02000531|448133904|FG000|Overall Study|Lost to Follow-up|1|||
124594689|NCT02000531|448133905|FG001|Overall Study|Lost to Follow-up|0|||
124594690|NCT02000531|448133904|FG000|Overall Study|Discontinued due to data cut-off|3|||
124594691|NCT02000531|448133905|FG001|Overall Study|Discontinued due to data cut-off|8|||
124594692|NCT01239472|448133908|FG000|Overall Study|Withdrawal by Subject|5|||
124594693|NCT01239472|448133909|FG001|Overall Study|Withdrawal by Subject|1|||
124779294|NCT02873702|448821383|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
124779295|NCT02873702|448821384|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
124779296|NCT02873702|448821385|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
124779297|NCT02873702|448821386|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
124779298|NCT02873702|448821383|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
124779299|NCT02873702|448821384|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
124779300|NCT02873702|448821385|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
124779301|NCT02873702|448821386|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
124779302|NCT02873702|448821383|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
124779303|NCT02873702|448821384|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
124779304|NCT02873702|448821385|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
124779305|NCT02873702|448821386|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
124779306|NCT02873702|448821383|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
124779307|NCT02873702|448821384|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
124779308|NCT02873702|448821385|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
124779309|NCT02873702|448821386|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
124779310|NCT02873702|448821383|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
124779311|NCT02873702|448821384|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
124779312|NCT02873702|448821385|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
124779313|NCT02873702|448821386|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
124779314|NCT01039376|448821389|FG000|Overall Study|Lost to Follow-up|5|||
124779315|NCT01039376|448821390|FG001|Overall Study|Lost to Follow-up|12|||
124779316|NCT01039376|448821389|FG000|Overall Study|Physician Decision|15|||
124779317|NCT01039376|448821390|FG001|Overall Study|Physician Decision|10|||
124779318|NCT01039376|448821389|FG000|Overall Study|Withdrawal by Subject|20|||
124779319|NCT01039376|448821390|FG001|Overall Study|Withdrawal by Subject|32|||
124779320|NCT01039376|448821389|FG000|Overall Study|Study terminated by Sponsor|90|||
124779321|NCT01039376|448821390|FG001|Overall Study|Study terminated by Sponsor|72|||
124779322|NCT03252925|448821391|FG000|Overall Study|Withdrawal by Subject|1|||
124779323|NCT03252925|448821392|FG001|Overall Study|Withdrawal by Subject|0|||
124779324|NCT03252925|448821391|FG000|Overall Study|Protocol Violation|6|||
124779325|NCT03252925|448821392|FG001|Overall Study|Protocol Violation|0|||
124779326|NCT03252925|448821391|FG000|Overall Study|Adverse Event|1|||
124779327|NCT03252925|448821392|FG001|Overall Study|Adverse Event|0|||
124779328|NCT03252925|448821391|FG000|Overall Study|Lost to Follow-up|6|||
124779329|NCT03252925|448821392|FG001|Overall Study|Lost to Follow-up|6|||
124779330|NCT03830892|448821400|FG000|Overall Study|Physician Decision|2|||
124779331|NCT03830892|448821401|FG001|Overall Study|Physician Decision|3|||
124779332|NCT03830892|448821400|FG000|Overall Study|Study terminated due to COVID|4|||
124779333|NCT03830892|448821401|FG001|Overall Study|Study terminated due to COVID|0|||
124779334|NCT03830892|448821400|FG000|Overall Study|Protocol Violation|0|||
124594694|NCT01239472|448133908|FG000|Overall Study|Adverse Event|0|||
124594695|NCT01239472|448133909|FG001|Overall Study|Adverse Event|1|||
124594696|NCT01239472|448133908|FG000|Overall Study|Lack of Efficacy|0|||
124779335|NCT03830892|448821401|FG001|Overall Study|Protocol Violation|1|||
124779336|NCT03830892|448821400|FG000|Overall Study|Withdrawal by Subject|0|||
124779337|NCT03830892|448821401|FG001|Overall Study|Withdrawal by Subject|2|||
124779338|NCT01499277|448821402|FG000|Overall Study|Adverse Event|3|||
124779339|NCT01499277|448821403|FG001|Overall Study|Adverse Event|6|||
124779340|NCT01499277|448821402|FG000|Overall Study|Death|3|||
124779341|NCT01499277|448821403|FG001|Overall Study|Death|2|||
124779342|NCT01499277|448821402|FG000|Overall Study|Lost to Follow-up|15|||
124779343|NCT01499277|448821403|FG001|Overall Study|Lost to Follow-up|8|||
124779344|NCT01499277|448821402|FG000|Overall Study|Protocol Violation|2|||
124779345|NCT01499277|448821403|FG001|Overall Study|Protocol Violation|3|||
124779346|NCT01499277|448821402|FG000|Overall Study|Withdrawal by Subject|16|||
124779347|NCT01499277|448821403|FG001|Overall Study|Withdrawal by Subject|6|||
124779348|NCT01499277|448821402|FG000|Overall Study|Lack of therapeutic response and other|8|||
124779349|NCT01499277|448821403|FG001|Overall Study|Lack of therapeutic response and other|7|||
124779350|NCT04661579|448821404|FG000|Overall Study|Lost to Follow-up|19|||
124594697|NCT01239472|448133909|FG001|Overall Study|Lack of Efficacy|1|||
124594698|NCT01280617|448133910|FG000|Overall Study|Adverse Event|0|||
124594699|NCT01280617|448133911|FG001|Overall Study|Adverse Event|1|||
124594700|NCT05966090|448133912|FG000|Overall Study|Lost to Follow-up|6|||
124779351|NCT04661579|448821405|FG001|Overall Study|Lost to Follow-up|10|||
124594701|NCT05966090|448133913|FG001|Overall Study|Lost to Follow-up|6|||
124594702|NCT05966090|448133912|FG000|Overall Study|Adverse Event|1|||
124594703|NCT05966090|448133913|FG001|Overall Study|Adverse Event|1|||
124594704|NCT05966090|448133912|FG000|Overall Study|Withdrawal by Subject|1|||
124779352|NCT04661579|448821406|FG002|Overall Study|Lost to Follow-up|2|||
124779353|NCT04661579|448821407|FG003|Overall Study|Lost to Follow-up|7|||
124779354|NCT04661579|448821408|FG004|Overall Study|Lost to Follow-up|11|||
124779355|NCT04661579|448821404|FG000|Overall Study|Physician Decision|2|||
124779356|NCT04661579|448821405|FG001|Overall Study|Physician Decision|0|||
124779357|NCT04661579|448821406|FG002|Overall Study|Physician Decision|0|||
124779358|NCT04661579|448821407|FG003|Overall Study|Physician Decision|1|||
124779359|NCT04661579|448821408|FG004|Overall Study|Physician Decision|0|||
124594705|NCT05966090|448133913|FG001|Overall Study|Withdrawal by Subject|1|||
124594706|NCT05966090|448133912|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
124594707|NCT05966090|448133913|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
124594708|NCT05966090|448133912|FG000|Overall Study|Other|1|||
124594709|NCT05966090|448133913|FG001|Overall Study|Other|1|||
124594710|NCT02001051|448133916|FG000|Overall Study|Deemed not eligible following enrollment|0|||
124594711|NCT02001051|448133917|FG001|Overall Study|Deemed not eligible following enrollment|1|||
124594712|NCT00529217|448133927|FG000|Overall Study|Lack of Efficacy|2|||
124594713|NCT00529217|448133927|FG000|Overall Study|Unable to adhere to study schedule|2|||
124594714|NCT01098110|448133929|FG000|Overall Study|Withdrawal by Subject|14|||
124594715|NCT01098110|448133930|FG001|Overall Study|Withdrawal by Subject|24|||
124594716|NCT01098110|448133931|FG002|Overall Study|Withdrawal by Subject|19|||
124594717|NCT01098110|448133929|FG000|Overall Study|Adverse Event|30|||
124594718|NCT01098110|448133930|FG001|Overall Study|Adverse Event|32|||
124594719|NCT01098110|448133931|FG002|Overall Study|Adverse Event|43|||
124594720|NCT01098110|448133929|FG000|Overall Study|Lack of Efficacy|13|||
124594721|NCT01098110|448133930|FG001|Overall Study|Lack of Efficacy|9|||
124594722|NCT01098110|448133931|FG002|Overall Study|Lack of Efficacy|27|||
124594723|NCT01098110|448133929|FG000|Overall Study|Other|4|||
124594724|NCT01098110|448133930|FG001|Overall Study|Other|7|||
124594725|NCT01098110|448133931|FG002|Overall Study|Other|5|||
124594726|NCT01098110|448133929|FG000|Overall Study|Untreated|1|||
124594727|NCT01098110|448133930|FG001|Overall Study|Untreated|1|||
124594728|NCT01098110|448133931|FG002|Overall Study|Untreated|0|||
124594729|NCT02147587|448133932|FG000|Overall Study|Adverse Event|9|||
124594730|NCT02147587|448133933|FG001|Overall Study|Adverse Event|4|||
124594731|NCT02147587|448133932|FG000|Overall Study|Lack of Efficacy|2|||
124594732|NCT02147587|448133933|FG001|Overall Study|Lack of Efficacy|1|||
124594733|NCT01546519|448133936|FG000|Overall Study|Adverse Event|0|||
124594734|NCT01546519|448133937|FG001|Overall Study|Adverse Event|0|||
124594735|NCT01546519|448133938|FG002|Overall Study|Adverse Event|1|||
124594736|NCT01546519|448133939|FG003|Overall Study|Adverse Event|1|||
124594737|NCT01546519|448133936|FG000|Overall Study|Death|0|||
124594738|NCT01546519|448133937|FG001|Overall Study|Death|1|||
124594739|NCT01546519|448133938|FG002|Overall Study|Death|3|||
124594740|NCT01546519|448133939|FG003|Overall Study|Death|1|||
124594741|NCT01546519|448133936|FG000|Overall Study|related to disease progression|2|||
124594742|NCT01546519|448133937|FG001|Overall Study|related to disease progression|2|||
124594743|NCT01546519|448133938|FG002|Overall Study|related to disease progression|2|||
124594744|NCT01546519|448133939|FG003|Overall Study|related to disease progression|1|||
124594745|NCT01546519|448133936|FG000|Overall Study|Physician Decision|6|||
124594746|NCT01546519|448133937|FG001|Overall Study|Physician Decision|5|||
124594747|NCT01546519|448133938|FG002|Overall Study|Physician Decision|2|||
124594748|NCT01546519|448133939|FG003|Overall Study|Physician Decision|3|||
124594749|NCT01546519|448133936|FG000|Overall Study|Withdrawal by Subject|1|||
124594750|NCT01546519|448133937|FG001|Overall Study|Withdrawal by Subject|0|||
124594751|NCT01546519|448133938|FG002|Overall Study|Withdrawal by Subject|0|||
124594752|NCT01546519|448133939|FG003|Overall Study|Withdrawal by Subject|0|||
124594753|NCT01519947|448133944|FG000|Overall Study|Death|0|||
124594754|NCT01519947|448133945|FG001|Overall Study|Death|0|||
124594755|NCT01519947|448133946|FG002|Overall Study|Death|0|||
124594756|NCT01519947|448133947|FG003|Overall Study|Death|1|||
124594757|NCT01519947|448133944|FG000|Overall Study|Protocol Violation|0|||
124594758|NCT01519947|448133945|FG001|Overall Study|Protocol Violation|0|||
124594759|NCT01519947|448133946|FG002|Overall Study|Protocol Violation|2|||
124594760|NCT01519947|448133947|FG003|Overall Study|Protocol Violation|1|||
124594761|NCT01519947|448133944|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
124730453|NCT02226198|448635488|FG001|Lead-in Phase|Protocol Violation|0|||
124730454|NCT02226198|448635489|FG002|Lead-in Phase|Protocol Violation|0|||
124730455|NCT02226198|448635487|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
124730456|NCT02226198|448635488|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
124730457|NCT02226198|448635489|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
124730458|NCT01288612|448635491|FG000|Overall Study|Unable to contact|11|||
124730459|NCT01288612|448635492|FG001|Overall Study|Unable to contact|16|||
124730460|NCT01288612|448635493|FG002|Overall Study|Unable to contact|20|||
124730461|NCT01288612|448635491|FG000|Overall Study|Declined|78|||
124594762|NCT01519947|448133945|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
124594763|NCT01519947|448133946|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
124594764|NCT01519947|448133947|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
124594765|NCT01519947|448133944|FG000|Overall Study|Development of Anemia|0|||
124594766|NCT01519947|448133945|FG001|Overall Study|Development of Anemia|1|||
124594767|NCT01519947|448133946|FG002|Overall Study|Development of Anemia|0|||
124594768|NCT01519947|448133947|FG003|Overall Study|Development of Anemia|1|||
124594769|NCT01519947|448133944|FG000|Overall Study|Blood Transfusion|0|||
124594770|NCT01519947|448133945|FG001|Overall Study|Blood Transfusion|1|||
124594771|NCT01519947|448133946|FG002|Overall Study|Blood Transfusion|1|||
124594772|NCT01519947|448133947|FG003|Overall Study|Blood Transfusion|0|||
124594773|NCT01519947|448133944|FG000|Overall Study|Withdrawal by Subject|0|||
124594774|NCT01519947|448133945|FG001|Overall Study|Withdrawal by Subject|1|||
124594775|NCT01519947|448133946|FG002|Overall Study|Withdrawal by Subject|0|||
124594776|NCT01519947|448133947|FG003|Overall Study|Withdrawal by Subject|1|||
124594777|NCT01519947|448133944|FG000|Overall Study|Lost to Follow-up|0|||
124594778|NCT01519947|448133945|FG001|Overall Study|Lost to Follow-up|0|||
124594779|NCT01519947|448133946|FG002|Overall Study|Lost to Follow-up|3|||
124594780|NCT01519947|448133947|FG003|Overall Study|Lost to Follow-up|2|||
124594781|NCT01519947|448133944|FG000|Overall Study|Poor Response|1|||
124594782|NCT01519947|448133945|FG001|Overall Study|Poor Response|0|||
124594783|NCT01519947|448133946|FG002|Overall Study|Poor Response|0|||
124594784|NCT01519947|448133947|FG003|Overall Study|Poor Response|1|||
124594785|NCT01519947|448133944|FG000|Overall Study|Adverse Event|1|||
124594786|NCT01519947|448133945|FG001|Overall Study|Adverse Event|0|||
124594787|NCT01519947|448133946|FG002|Overall Study|Adverse Event|1|||
124594788|NCT01519947|448133947|FG003|Overall Study|Adverse Event|1|||
124594789|NCT02274948|448133954|FG000|Overall Study|Lost to Follow-up|28|||
124594790|NCT02274948|448133955|FG001|Overall Study|Lost to Follow-up|25|||
124594791|NCT02274948|448133954|FG000|Overall Study|Withdrawal by Subject|64|||
124594792|NCT02274948|448133955|FG001|Overall Study|Withdrawal by Subject|58|||
124594793|NCT02274948|448133954|FG000|Overall Study|Stopped on family Practitioner advice|2|||
124594794|NCT02274948|448133955|FG001|Overall Study|Stopped on family Practitioner advice|5|||
124594795|NCT02274948|448133954|FG000|Overall Study|Left the area|4|||
124594796|NCT02274948|448133955|FG001|Overall Study|Left the area|3|||
124594797|NCT00707434|448133956|FG000|Overall Study|Adverse Event|1|||
124594798|NCT00530348|448133958|FG000|Overall Study|Adverse Event|5|||
124594799|NCT00530348|448133959|FG001|Overall Study|Adverse Event|1|||
124594800|NCT00530348|448133958|FG000|Overall Study|Death|0|||
124594801|NCT00530348|448133959|FG001|Overall Study|Death|1|||
124594802|NCT00530348|448133958|FG000|Overall Study|Lack of Efficacy|2|||
124594803|NCT00530348|448133959|FG001|Overall Study|Lack of Efficacy|0|||
124594804|NCT00530348|448133958|FG000|Overall Study|Lost to Follow-up|0|||
124594805|NCT00530348|448133959|FG001|Overall Study|Lost to Follow-up|2|||
124594806|NCT00530348|448133958|FG000|Overall Study|Physician Decision|1|||
124594807|NCT00530348|448133959|FG001|Overall Study|Physician Decision|2|||
124594808|NCT00530348|448133958|FG000|Overall Study|Pregnancy|1|||
124594809|NCT00530348|448133959|FG001|Overall Study|Pregnancy|0|||
124594810|NCT00530348|448133958|FG000|Overall Study|Withdrawal by Subject|12|||
124594811|NCT00530348|448133959|FG001|Overall Study|Withdrawal by Subject|12|||
124594812|NCT00530348|448133958|FG000|Overall Study|Randomised in error|1|||
124594813|NCT00530348|448133959|FG001|Overall Study|Randomised in error|0|||
124594814|NCT00530348|448133958|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
124594815|NCT00530348|448133959|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
124594816|NCT04364763|448133960|FG000|Overall Study|Death|1|||
124594817|NCT04364763|448133961|FG001|Overall Study|Death|2|||
124594818|NCT04364763|448133960|FG000|Overall Study|Lost to Follow-up|1|||
124594819|NCT04364763|448133961|FG001|Overall Study|Lost to Follow-up|0|||
124594820|NCT01386125|448133962|FG000|Overall Study|Lost to Follow-up|3|||
124594821|NCT01386125|448133963|FG001|Overall Study|Lost to Follow-up|9|||
124594822|NCT01386125|448133962|FG000|Overall Study|Physician Decision|0|||
124594823|NCT01386125|448133963|FG001|Overall Study|Physician Decision|1|||
124594824|NCT01386125|448133962|FG000|Overall Study|Protocol Violation|5|||
124594825|NCT01386125|448133963|FG001|Overall Study|Protocol Violation|7|||
124594826|NCT01386125|448133962|FG000|Overall Study|Disease Progress|1|||
124594827|NCT01386125|448133963|FG001|Overall Study|Disease Progress|2|||
124594828|NCT01386125|448133962|FG000|Overall Study|Withdrawal by Subject|13|||
124594829|NCT01386125|448133963|FG001|Overall Study|Withdrawal by Subject|12|||
124594830|NCT01386125|448133962|FG000|Overall Study|Adverse Event|2|||
124594831|NCT01386125|448133963|FG001|Overall Study|Adverse Event|5|||
124594832|NCT01386125|448133962|FG000|Overall Study|Lack of Efficacy|0|||
124594833|NCT01386125|448133963|FG001|Overall Study|Lack of Efficacy|1|||
124594834|NCT01386125|448133962|FG000|Overall Study|Participant Leaving Country|1|||
124594835|NCT01386125|448133963|FG001|Overall Study|Participant Leaving Country|0|||
124594836|NCT00676494|448133968|FG000|Overall Study|Missed Visit|8|||
124594837|NCT00676494|448133968|FG000|Overall Study|Withdrawal by Subject|6|||
124594838|NCT00732160|448133969|FG000|Overall Study|Adverse Event|1|||
124594839|NCT00732160|448133970|FG001|Overall Study|Adverse Event|0|||
124594840|NCT00732160|448133971|FG002|Overall Study|Adverse Event|1|||
124594841|NCT00732160|448133972|FG003|Overall Study|Adverse Event|1|||
124594842|NCT00732160|448133969|FG000|Overall Study|scheduling|4|||
124594843|NCT00732160|448133970|FG001|Overall Study|scheduling|4|||
124594844|NCT00732160|448133971|FG002|Overall Study|scheduling|2|||
124594845|NCT00732160|448133972|FG003|Overall Study|scheduling|1|||
124594846|NCT00985231|448133993|FG000|Overall Study|ineligible|1|||
124594847|NCT00985231|448133994|FG001|Overall Study|ineligible|0|||
124594848|NCT00985231|448133993|FG000|Overall Study|Protocol Violation|1|||
124594849|NCT00985231|448133994|FG001|Overall Study|Protocol Violation|0|||
124594850|NCT00985231|448133993|FG000|Overall Study|Withdrawal by Subject|1|||
124594851|NCT00985231|448133994|FG001|Overall Study|Withdrawal by Subject|0|||
124594852|NCT00985231|448133993|FG000|Overall Study|Lost to Follow-up|0|||
124594853|NCT00985231|448133994|FG001|Overall Study|Lost to Follow-up|1|||
124594854|NCT00985231|448133993|FG000|Overall Study|Study related symptoms & complaints|0|||
124594855|NCT00985231|448133994|FG001|Overall Study|Study related symptoms & complaints|2|||
124594856|NCT01463982|448133995|FG000|Overall Study|Withdrawal by Subject|0|||
124594857|NCT01463982|448133996|FG001|Overall Study|Withdrawal by Subject|1|||
124594858|NCT01463982|448133997|FG002|Overall Study|Withdrawal by Subject|1|||
124594859|NCT01463982|448133998|FG003|Overall Study|Withdrawal by Subject|0|||
124594860|NCT01463982|448133995|FG000|Overall Study|Treatment delay over 5 week|0|||
124594861|NCT01463982|448133996|FG001|Overall Study|Treatment delay over 5 week|0|||
124594862|NCT01463982|448133997|FG002|Overall Study|Treatment delay over 5 week|1|||
124594863|NCT01463982|448133998|FG003|Overall Study|Treatment delay over 5 week|0|||
124594864|NCT04220775|448133999|FG000|Overall Study|Adverse Event|1|||
124594865|NCT04220775|448134000|FG001|Overall Study|Adverse Event|0|||
124594866|NCT04220775|448133999|FG000|Overall Study|Disease Progression|1|||
124594867|NCT04220775|448134000|FG001|Overall Study|Disease Progression|0|||
124594868|NCT00436917|448134001|FG000|Overall Study|Withdrawal by Subject|13|||
124594869|NCT00436917|448134001|FG000|Overall Study|Adverse Event|2|||
124594870|NCT00436917|448134001|FG000|Overall Study|Physician Decision|1|||
124594871|NCT00436917|448134001|FG000|Overall Study|Death|1|||
124594872|NCT00436917|448134001|FG000|Overall Study|Lost to Follow-up|1|||
124594873|NCT00436917|448134001|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
124594874|NCT00436917|448134001|FG000|Overall Study|Increased creatinine|1|||
124594875|NCT00436917|448134001|FG000|Overall Study|Personal conflicts of patient|1|||
124594876|NCT00931463|448134002|FG000|Overall Study|Death|8|||
124594877|NCT00931463|448134003|FG001|Overall Study|Death|4|||
124594878|NCT00931463|448134002|FG000|Overall Study|Withdrawal by Subject|5|||
124594879|NCT00931463|448134003|FG001|Overall Study|Withdrawal by Subject|0|||
124594880|NCT00931463|448134002|FG000|Overall Study|Lost to Follow-up|4|||
124594881|NCT00931463|448134003|FG001|Overall Study|Lost to Follow-up|1|||
124594882|NCT01083680|448134008|FG000|Overall Study|Lost to Follow-up|2758|||
124594883|NCT01083680|448134008|FG000|Overall Study|Withdrawal by Subject|1086|||
124594884|NCT05766787|448134009|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
124594885|NCT05766787|448134010|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
124594886|NCT05766787|448134009|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
124594887|NCT05766787|448134010|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
124594888|NCT05766787|448134009|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
124594889|NCT05766787|448134010|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
124594890|NCT01435928|448134011|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
124594891|NCT01435928|448134012|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
124594892|NCT01435928|448134013|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
124594893|NCT01435928|448134011|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
124594894|NCT01435928|448134012|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
124594895|NCT01435928|448134013|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
124594896|NCT01435928|448134011|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
124594897|NCT01435928|448134012|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
124594898|NCT01435928|448134013|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
124594899|NCT01435928|448134011|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
124594900|NCT01435928|448134012|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
124594901|NCT01435928|448134013|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
124594902|NCT01435928|448134011|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
124594903|NCT01435928|448134012|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
124594904|NCT01435928|448134013|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
124594905|NCT01435928|448134011|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
124594906|NCT01435928|448134012|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
124594907|NCT01435928|448134013|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
124594908|NCT01435928|448134011|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
124594909|NCT01435928|448134012|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
124594910|NCT01435928|448134013|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
124594911|NCT01435928|448134011|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
124594912|NCT01435928|448134012|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
124594913|NCT01435928|448134013|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
124594914|NCT01435928|448134011|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
124594915|NCT01435928|448134012|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
124730462|NCT01288612|448635492|FG001|Overall Study|Declined|63|||
124730463|NCT01288612|448635493|FG002|Overall Study|Declined|62|||
124730464|NCT01288612|448635491|FG000|Overall Study|Unable to intubate|0|||
124730465|NCT01288612|448635492|FG001|Overall Study|Unable to intubate|3|||
124594916|NCT01435928|448134013|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
124594917|NCT01435928|448134011|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
124594918|NCT01435928|448134012|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
124594919|NCT01435928|448134013|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
124730466|NCT01288612|448635493|FG002|Overall Study|Unable to intubate|0|||
124730467|NCT00871923|448635494|FG000|Overall Study|Death|1|||
124779360|NCT04661579|448821404|FG000|Overall Study|Withdrawal by Subject|1|||
124779361|NCT04661579|448821405|FG001|Overall Study|Withdrawal by Subject|4|||
124779362|NCT04661579|448821406|FG002|Overall Study|Withdrawal by Subject|0|||
124779363|NCT04661579|448821407|FG003|Overall Study|Withdrawal by Subject|2|||
124779364|NCT04661579|448821408|FG004|Overall Study|Withdrawal by Subject|0|||
124779365|NCT04661579|448821404|FG000|Overall Study|Death|1|||
124779366|NCT04661579|448821405|FG001|Overall Study|Death|0|||
124779367|NCT04661579|448821406|FG002|Overall Study|Death|0|||
124779368|NCT04661579|448821407|FG003|Overall Study|Death|0|||
124779369|NCT04661579|448821408|FG004|Overall Study|Death|0|||
124594920|NCT01435928|448134011|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
124594921|NCT01435928|448134012|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
124594922|NCT01435928|448134013|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
124594923|NCT01435928|448134011|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
124594924|NCT01435928|448134012|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
124594925|NCT01435928|448134013|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
124594926|NCT01435928|448134011|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
124594927|NCT01435928|448134012|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
124594928|NCT01435928|448134013|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
124594929|NCT01435928|448134011|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
124594930|NCT01435928|448134012|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
124730468|NCT00871923|448635494|FG000|Overall Study|Withdrawal by Subject|1|||
124730469|NCT05599451|448635495|FG000|Overall Study|Not randomized|11|||
124730470|NCT05599451|448635496|FG001|Overall Study|Not randomized|0|||
124730471|NCT05599451|448635497|FG002|Overall Study|Not randomized|0|||
124730472|NCT05599451|448635498|FG003|Overall Study|Not randomized|0|||
124730473|NCT05599451|448635499|FG004|Overall Study|Not randomized|0|||
124730474|NCT05599451|448635495|FG000|Overall Study|Physician Decision|0|||
124730475|NCT05599451|448635496|FG001|Overall Study|Physician Decision|0|||
124730476|NCT05599451|448635497|FG002|Overall Study|Physician Decision|0|||
124730477|NCT05599451|448635498|FG003|Overall Study|Physician Decision|1|||
124730478|NCT05599451|448635499|FG004|Overall Study|Physician Decision|0|||
124730479|NCT00789581|448635502|FG000|AC Therapy|Adverse Event|2|||
124730480|NCT00789581|448635503|FG001|AC Therapy|Adverse Event|3|||
124730481|NCT00789581|448635502|FG000|AC Therapy|Withdrawal by Subject|4|||
124730482|NCT00789581|448635503|FG001|AC Therapy|Withdrawal by Subject|7|||
124730483|NCT00789581|448635502|FG000|AC Therapy|Disease recurrence|3|||
124730484|NCT00789581|448635503|FG001|AC Therapy|Disease recurrence|1|||
124779370|NCT04661579|448821404|FG000|Overall Study|Other|1|||
124779371|NCT04661579|448821405|FG001|Overall Study|Other|2|||
124594931|NCT01435928|448134013|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
124594932|NCT01435928|448134011|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
124594933|NCT01435928|448134012|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
124594934|NCT01435928|448134013|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
124594935|NCT01435928|448134011|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
124594936|NCT01435928|448134012|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
124594937|NCT01435928|448134013|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
124594938|NCT00442546|448134015|FG000|Overall Study|Adverse Event|11|||
124594939|NCT00442546|448134016|FG001|Overall Study|Adverse Event|17|||
124594940|NCT00442546|448134017|FG002|Overall Study|Adverse Event|13|||
124594941|NCT00442546|448134015|FG000|Overall Study|Lost to Follow-up|1|||
124594942|NCT00442546|448134016|FG001|Overall Study|Lost to Follow-up|2|||
124594943|NCT00442546|448134017|FG002|Overall Study|Lost to Follow-up|1|||
124594944|NCT00442546|448134015|FG000|Overall Study|Other|4|||
124594945|NCT00442546|448134016|FG001|Overall Study|Other|9|||
124594946|NCT00442546|448134017|FG002|Overall Study|Other|6|||
124594947|NCT00442546|448134015|FG000|Overall Study|Withdrawal by Subject|5|||
124594948|NCT00442546|448134016|FG001|Overall Study|Withdrawal by Subject|5|||
124594949|NCT00442546|448134017|FG002|Overall Study|Withdrawal by Subject|7|||
124594950|NCT00442546|448134015|FG000|Overall Study|Randomized But Not Treated|5|||
124594951|NCT00442546|448134016|FG001|Overall Study|Randomized But Not Treated|4|||
124730485|NCT00789581|448635502|FG000|AC Therapy|Intercurrent Illness|1|||
124730486|NCT00789581|448635503|FG001|AC Therapy|Intercurrent Illness|0|||
124730487|NCT00789581|448635502|FG000|AC Therapy|Never Treated|1|||
124594952|NCT00442546|448134017|FG002|Overall Study|Randomized But Not Treated|6|||
124594953|NCT01619579|448135818|FG000|Overall Study|Withdrawal by Subject|0|||
124594954|NCT01619579|448135819|FG001|Overall Study|Withdrawal by Subject|3|||
124594955|NCT02124902|448135820|FG000|Overall Study|Adverse Event|7|||
124594956|NCT02124902|448135821|FG001|Overall Study|Adverse Event|2|||
124594957|NCT02124902|448135820|FG000|Overall Study|Went to alternative treatment|4|||
124730488|NCT00789581|448635503|FG001|AC Therapy|Never Treated|4|||
124730489|NCT00789581|448635502|FG000|AC Therapy|Other|0|||
124730490|NCT00789581|448635503|FG001|AC Therapy|Other|2|||
124779372|NCT04661579|448821406|FG002|Overall Study|Other|1|||
124779373|NCT04661579|448821407|FG003|Overall Study|Other|1|||
124779374|NCT04661579|448821408|FG004|Overall Study|Other|1|||
124779375|NCT04661579|448821404|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
124594958|NCT02124902|448135821|FG001|Overall Study|Went to alternative treatment|0|||
124594959|NCT02124902|448135820|FG000|Overall Study|Withdrawal by Subject|2|||
124594960|NCT02124902|448135821|FG001|Overall Study|Withdrawal by Subject|1|||
124594961|NCT02124902|448135820|FG000|Overall Study|Physician Decision|2|||
124594962|NCT02124902|448135821|FG001|Overall Study|Physician Decision|0|||
124594963|NCT02124902|448135820|FG000|Overall Study|Not eligible|1|||
124594964|NCT02124902|448135821|FG001|Overall Study|Not eligible|0|||
124594965|NCT02124902|448135820|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
124594966|NCT02124902|448135821|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
124594967|NCT02938442|448135822|FG000|Overall Study|Death|0|||
124594968|NCT02938442|448135823|FG001|Overall Study|Death|1|||
124594969|NCT02938442|448135822|FG000|Overall Study|Lost to Follow-up|0|||
124594970|NCT02938442|448135823|FG001|Overall Study|Lost to Follow-up|1|||
124594971|NCT02938442|448135822|FG000|Overall Study|Physician Decision|0|||
124594972|NCT02938442|448135823|FG001|Overall Study|Physician Decision|1|||
124594973|NCT02938442|448135822|FG000|Overall Study|Withdrawal by Subject|2|||
124594974|NCT02938442|448135823|FG001|Overall Study|Withdrawal by Subject|0|||
124594975|NCT04100096|448135826|FG000|Overall Study|Adverse Event|19|||
124594976|NCT04100096|448135827|FG001|Overall Study|Adverse Event|7|||
124594977|NCT04100096|448135826|FG000|Overall Study|Lack of Efficacy|0|||
124594978|NCT04100096|448135827|FG001|Overall Study|Lack of Efficacy|1|||
124594979|NCT04100096|448135826|FG000|Overall Study|Lost to Follow-up|13|||
124594980|NCT04100096|448135827|FG001|Overall Study|Lost to Follow-up|11|||
124594981|NCT04100096|448135826|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124594982|NCT04100096|448135827|FG001|Overall Study|Non-Compliance With Study Drug|3|||
124594983|NCT04100096|448135826|FG000|Overall Study|Protocol Deviation|1|||
124594984|NCT04100096|448135827|FG001|Overall Study|Protocol Deviation|1|||
124594985|NCT04100096|448135826|FG000|Overall Study|Withdrawal by Participant|13|||
124594986|NCT04100096|448135827|FG001|Overall Study|Withdrawal by Participant|15|||
124594987|NCT00831233|448135831|FG000|Overall Study|Adverse Event|0|||
124594988|NCT00831233|448135832|FG001|Overall Study|Adverse Event|1|||
124594989|NCT00831233|448135831|FG000|Overall Study|Protocol Violation|1|||
124594990|NCT00831233|448135832|FG001|Overall Study|Protocol Violation|0|||
124594991|NCT00831233|448135831|FG000|Overall Study|Selection Criteria Not Met|2|||
124594992|NCT00831233|448135832|FG001|Overall Study|Selection Criteria Not Met|0|||
124594993|NCT02211014|448135833|FG000|Overall Study|Adverse Event|0|||
124594994|NCT02211014|448135834|FG001|Overall Study|Adverse Event|2|||
124594995|NCT02211014|448135833|FG000|Overall Study|Physician Decision|1|||
124594996|NCT02211014|448135834|FG001|Overall Study|Physician Decision|2|||
124594997|NCT02211014|448135833|FG000|Overall Study|Started another cancer therapy|1|||
124594998|NCT02211014|448135834|FG001|Overall Study|Started another cancer therapy|0|||
124594999|NCT02211014|448135833|FG000|Overall Study|Withdrawal by Subject|0|||
124595000|NCT02211014|448135834|FG001|Overall Study|Withdrawal by Subject|1|||
124595001|NCT02211014|448135833|FG000|Overall Study|In agreement with patient, no benefit|0|||
124595002|NCT02211014|448135834|FG001|Overall Study|In agreement with patient, no benefit|1|||
124595003|NCT01915940|448135835|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
124595004|NCT01915940|448135836|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
124595005|NCT01915940|448135837|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
124595006|NCT01915940|448135835|FG000|Treatment Period|Decision of Participant|0|||
124595007|NCT01915940|448135836|FG001|Treatment Period|Decision of Participant|1|||
124595008|NCT01915940|448135837|FG002|Treatment Period|Decision of Participant|3|||
124595009|NCT01915940|448135835|FG000|Treatment Period|Adverse Event|0|||
124595010|NCT01915940|448135836|FG001|Treatment Period|Adverse Event|9|||
124595011|NCT01915940|448135837|FG002|Treatment Period|Adverse Event|1|||
124595012|NCT01915940|448135835|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
124595013|NCT01915940|448135836|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
124595014|NCT01915940|448135837|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
124595015|NCT02960438|448135838|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
124595016|NCT02960438|448135839|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
124595017|NCT02960438|448135840|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
124595018|NCT02960438|448135841|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
124595019|NCT02960438|448135838|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
124595020|NCT02960438|448135839|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
124595021|NCT02960438|448135840|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
124595022|NCT02960438|448135841|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
124595023|NCT02960438|448135838|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
124595024|NCT02960438|448135839|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
124595025|NCT02960438|448135840|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
124595026|NCT02960438|448135841|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
124595027|NCT02960438|448135838|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
124595028|NCT02960438|448135839|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
124595029|NCT02960438|448135840|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
124595030|NCT02960438|448135841|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
124595031|NCT02960438|448135838|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
124595032|NCT02960438|448135839|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
124595033|NCT02960438|448135840|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
124595034|NCT02960438|448135841|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
124595035|NCT02960438|448135838|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
124595036|NCT02960438|448135839|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
124595037|NCT02960438|448135840|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
124595038|NCT02960438|448135841|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
124595039|NCT02960438|448135838|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
124595040|NCT02960438|448135839|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
124595041|NCT02960438|448135840|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
124595042|NCT02960438|448135841|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
124595043|NCT02960438|448135838|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
124595044|NCT02960438|448135839|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
124595045|NCT02960438|448135840|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
124595046|NCT02960438|448135841|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
124595047|NCT02960438|448135838|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
124595048|NCT02960438|448135839|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
124595049|NCT02960438|448135840|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
124595050|NCT02960438|448135841|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
124595051|NCT02960438|448135838|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
124595052|NCT02960438|448135839|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
124595053|NCT02960438|448135840|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
124595054|NCT02960438|448135841|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
124595055|NCT02960438|448135838|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
124595056|NCT02960438|448135839|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
124595057|NCT02960438|448135840|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
124595058|NCT02960438|448135841|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
124595059|NCT02960438|448135838|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
124595060|NCT02960438|448135839|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
124595061|NCT02960438|448135840|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
124595062|NCT02960438|448135841|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
124595063|NCT01647711|448135843|FG000|Overall Study|Progressive disease|6|||
124595064|NCT01647711|448135844|FG001|Overall Study|Progressive disease|2|||
124595065|NCT01647711|448135845|FG002|Overall Study|Progressive disease|6|||
124595066|NCT01647711|448135846|FG003|Overall Study|Progressive disease|8|||
124595067|NCT01647711|448135847|FG004|Overall Study|Progressive disease|2|||
124595068|NCT01647711|448135843|FG000|Overall Study|Other adverse event|0|||
124595069|NCT01647711|448135844|FG001|Overall Study|Other adverse event|0|||
124595070|NCT01647711|448135845|FG002|Overall Study|Other adverse event|2|||
124595071|NCT01647711|448135846|FG003|Overall Study|Other adverse event|0|||
124595072|NCT01647711|448135847|FG004|Overall Study|Other adverse event|2|||
124595073|NCT01647711|448135843|FG000|Overall Study|Protocol Violation|0|||
124595074|NCT01647711|448135844|FG001|Overall Study|Protocol Violation|0|||
124595075|NCT01647711|448135845|FG002|Overall Study|Protocol Violation|0|||
124595076|NCT01647711|448135846|FG003|Overall Study|Protocol Violation|0|||
124595077|NCT01647711|448135847|FG004|Overall Study|Protocol Violation|1|||
124595078|NCT01647711|448135843|FG000|Overall Study|Refused to continue taking medication|0|||
124595079|NCT01647711|448135844|FG001|Overall Study|Refused to continue taking medication|0|||
124595080|NCT01647711|448135845|FG002|Overall Study|Refused to continue taking medication|0|||
124595081|NCT01647711|448135846|FG003|Overall Study|Refused to continue taking medication|2|||
124595082|NCT01647711|448135847|FG004|Overall Study|Refused to continue taking medication|1|||
124595083|NCT01647711|448135843|FG000|Overall Study|Other reason not defined|0|||
124595084|NCT01647711|448135844|FG001|Overall Study|Other reason not defined|1|||
124595085|NCT01647711|448135845|FG002|Overall Study|Other reason not defined|1|||
124595086|NCT01647711|448135846|FG003|Overall Study|Other reason not defined|1|||
124595087|NCT01647711|448135847|FG004|Overall Study|Other reason not defined|0|||
124595088|NCT01796964|448135865|FG000|Overall Study|Adverse Event|1|||
124595089|NCT01796964|448135866|FG001|Overall Study|Adverse Event|1|||
124595090|NCT01796964|448135865|FG000|Overall Study|Death|1|||
124595091|NCT01796964|448135866|FG001|Overall Study|Death|0|||
124595092|NCT01796964|448135865|FG000|Overall Study|Protocol Violation|0|||
124595093|NCT01796964|448135866|FG001|Overall Study|Protocol Violation|1|||
124779376|NCT04661579|448821405|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
124779377|NCT04661579|448821406|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
124595094|NCT01796964|448135865|FG000|Overall Study|Withdrawal by Subject|1|||
124595095|NCT01796964|448135866|FG001|Overall Study|Withdrawal by Subject|1|||
124595096|NCT04025684|448135867|FG000|Overall Study|Withdrawal by Subject|1|||
124595097|NCT04025684|448135868|FG001|Overall Study|Withdrawal by Subject|1|||
124595098|NCT04025684|448135869|FG002|Overall Study|Withdrawal by Subject|0|||
124595099|NCT04025684|448135870|FG003|Overall Study|Withdrawal by Subject|0|||
124595100|NCT04025684|448135867|FG000|Overall Study|Multiple reasons|1|||
124595101|NCT04025684|448135868|FG001|Overall Study|Multiple reasons|3|||
124595102|NCT04025684|448135869|FG002|Overall Study|Multiple reasons|0|||
124595103|NCT04025684|448135870|FG003|Overall Study|Multiple reasons|1|||
124595104|NCT01844531|448135871|FG000|Overall Study|Withdrawal by Subject|0|||
124595105|NCT01844531|448135872|FG001|Overall Study|Withdrawal by Subject|1|||
124595106|NCT01844531|448135873|FG002|Overall Study|Withdrawal by Subject|0|||
124595107|NCT01844531|448135874|FG003|Overall Study|Withdrawal by Subject|0|||
124595108|NCT02744755|448135875|FG000|Study Period 1|Protocol Violation|2|||
124595109|NCT02744755|448135876|FG001|Study Period 1|Protocol Violation|1|||
124595110|NCT02744755|448135875|FG000|Study Period 1|not defined|0|||
124595111|NCT02744755|448135876|FG001|Study Period 1|not defined|1|||
124595112|NCT02744755|448135875|FG000|Study Period 1|Pregnancy|1|||
124595113|NCT02744755|448135876|FG001|Study Period 1|Pregnancy|0|||
124595114|NCT02744755|448135875|FG000|Study Period 1|Adverse Event|1|||
124595115|NCT02744755|448135876|FG001|Study Period 1|Adverse Event|1|||
124595116|NCT02744755|448135875|FG000|Study Period 1|Lost to Follow-up|1|||
124595117|NCT02744755|448135876|FG001|Study Period 1|Lost to Follow-up|1|||
124595118|NCT02744755|448135875|FG000|Study Period 1|Lack of Efficacy|1|||
124595119|NCT02744755|448135876|FG001|Study Period 1|Lack of Efficacy|0|||
124595120|NCT02744755|448135875|FG000|Study Period 1|Withdrawal by Subject|8|||
124595121|NCT02744755|448135876|FG001|Study Period 1|Withdrawal by Subject|4|||
124595122|NCT02744755|448135875|FG000|Study Period 2|Adverse Event|5|||
124595123|NCT02744755|448135876|FG001|Study Period 2|Adverse Event|0|||
124595124|NCT02744755|448135875|FG000|Study Period 2|Protocol Violation|1|||
124595125|NCT02744755|448135876|FG001|Study Period 2|Protocol Violation|0|||
124595126|NCT02744755|448135875|FG000|Study Period 2|not defined|3|||
124595127|NCT02744755|448135876|FG001|Study Period 2|not defined|2|||
124595128|NCT02744755|448135875|FG000|Study Period 2|Lost to Follow-up|0|||
124595129|NCT02744755|448135876|FG001|Study Period 2|Lost to Follow-up|2|||
124595130|NCT02744755|448135875|FG000|Study Period 2|Withdrawal by Subject|2|||
124595131|NCT02744755|448135876|FG001|Study Period 2|Withdrawal by Subject|2|||
124595132|NCT02744755|448135875|FG000|Study Period 2|Lack of Efficacy|3|||
124595133|NCT02744755|448135876|FG001|Study Period 2|Lack of Efficacy|2|||
124595134|NCT02916693|448135880|FG000|Overall Study|Lost to Follow-up|7|||
124595135|NCT00337428|448135882|FG000|Overall Study|Withdrawal by Subject|1|||
124595136|NCT00337428|448135883|FG001|Overall Study|Withdrawal by Subject|2|||
124595137|NCT00337428|448135882|FG000|Overall Study|Lack of Time|1|||
124595138|NCT00337428|448135883|FG001|Overall Study|Lack of Time|1|||
124595139|NCT00337428|448135882|FG000|Overall Study|Unwilling to Continue|1|||
124595140|NCT00337428|448135883|FG001|Overall Study|Unwilling to Continue|0|||
124595141|NCT00337428|448135882|FG000|Overall Study|Anorexia|1|||
124595142|NCT00337428|448135883|FG001|Overall Study|Anorexia|0|||
124595143|NCT01999894|448135884|FG000|Overall Study|Adverse Event|9|||
124595144|NCT01999894|448135884|FG000|Overall Study|Lack of Efficacy|5|||
124595145|NCT01999894|448135884|FG000|Overall Study|Protocol Violation|1|||
124595146|NCT01999894|448135884|FG000|Overall Study|Withdrawal by Subject|7|||
124595147|NCT01999894|448135884|FG000|Overall Study|Lost to Follow-up|10|||
124595148|NCT01999894|448135884|FG000|Overall Study|Other Reason|3|||
124595149|NCT01999894|448135884|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
124595150|NCT01740791|448135886|FG000|Overall Study|Randomized but never treated|5|||
124595151|NCT01740791|448135887|FG001|Overall Study|Randomized but never treated|3|||
124595152|NCT01740791|448135888|FG002|Overall Study|Randomized but never treated|2|||
124595153|NCT01740791|448135889|FG003|Overall Study|Randomized but never treated|2|||
124595154|NCT01740791|448135890|FG004|Overall Study|Randomized but never treated|1|||
124595155|NCT01740791|448135891|FG005|Overall Study|Randomized but never treated|3|||
124595156|NCT01740791|448135886|FG000|Overall Study|Lost to Follow-up|2|||
124595157|NCT01740791|448135887|FG001|Overall Study|Lost to Follow-up|0|||
124595158|NCT01740791|448135888|FG002|Overall Study|Lost to Follow-up|2|||
124595159|NCT01740791|448135889|FG003|Overall Study|Lost to Follow-up|3|||
124595160|NCT01740791|448135890|FG004|Overall Study|Lost to Follow-up|2|||
124595161|NCT01740791|448135891|FG005|Overall Study|Lost to Follow-up|3|||
124595162|NCT01740791|448135886|FG000|Overall Study|Withdrew Consent|4|||
124595163|NCT01740791|448135887|FG001|Overall Study|Withdrew Consent|0|||
124595164|NCT01740791|448135888|FG002|Overall Study|Withdrew Consent|1|||
124595165|NCT01740791|448135889|FG003|Overall Study|Withdrew Consent|2|||
124779378|NCT04661579|448821407|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
124595166|NCT01740791|448135890|FG004|Overall Study|Withdrew Consent|0|||
124595167|NCT01740791|448135891|FG005|Overall Study|Withdrew Consent|3|||
124595168|NCT01740791|448135886|FG000|Overall Study|Investigator's discretion|1|||
124595169|NCT01740791|448135887|FG001|Overall Study|Investigator's discretion|0|||
124595170|NCT01740791|448135888|FG002|Overall Study|Investigator's discretion|1|||
124595171|NCT01740791|448135889|FG003|Overall Study|Investigator's discretion|0|||
124595172|NCT01740791|448135890|FG004|Overall Study|Investigator's discretion|0|||
124595173|NCT01740791|448135891|FG005|Overall Study|Investigator's discretion|1|||
124595174|NCT01740791|448135886|FG000|Overall Study|Adverse Event|0|||
124595175|NCT01740791|448135887|FG001|Overall Study|Adverse Event|0|||
124595176|NCT01740791|448135888|FG002|Overall Study|Adverse Event|0|||
124595177|NCT01740791|448135889|FG003|Overall Study|Adverse Event|0|||
124595178|NCT01740791|448135890|FG004|Overall Study|Adverse Event|0|||
124595179|NCT01740791|448135891|FG005|Overall Study|Adverse Event|1|||
124595180|NCT03170869|448135892|FG000|Overall Study|Protocol Violation|5|||
124595181|NCT03170869|448135892|FG000|Overall Study|Early study termination|3|||
124595182|NCT00220727|448135895|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
124595183|NCT00220727|448135896|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
124595184|NCT02020967|448135897|FG000|Overall Study|Withdrawal by Subject|51|||
124595185|NCT03507686|448135898|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
124595186|NCT03507686|448135899|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
124595187|NCT03507686|448135898|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
124595188|NCT03507686|448135899|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
124595189|NCT03507686|448135898|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
124595190|NCT03507686|448135899|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
124595191|NCT03507686|448135898|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
124595192|NCT03507686|448135899|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
124595193|NCT03507686|448135898|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
124595194|NCT03507686|448135899|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
124595195|NCT03507686|448135898|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
124595196|NCT03507686|448135899|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
124595197|NCT02508116|448135900|FG000|Overall Study|Lost to Follow-up|2|||
124595198|NCT02508116|448135901|FG001|Overall Study|Lost to Follow-up|3|||
124595199|NCT02508116|448135900|FG000|Overall Study|Withdrawal by Subject|3|||
124595200|NCT02508116|448135901|FG001|Overall Study|Withdrawal by Subject|2|||
124595201|NCT02508116|448135900|FG000|Overall Study|Protocol Violation|1|||
124595202|NCT02508116|448135901|FG001|Overall Study|Protocol Violation|2|||
124595203|NCT02508116|448135900|FG000|Overall Study|Physician Decision|2|||
124595204|NCT02508116|448135901|FG001|Overall Study|Physician Decision|0|||
124595205|NCT00983528|448135904|FG000|Overall Study|Death|4|||
124595206|NCT00983528|448135904|FG000|Overall Study|Lost to Follow-up|1|||
124595207|NCT00983528|448135904|FG000|Overall Study|Study Terminated|1|||
124595208|NCT00575380|448135905|FG000|Overall Study|Withdrawal by Subject|1|||
124595209|NCT00575380|448135906|FG001|Overall Study|Withdrawal by Subject|0|||
124595210|NCT00575380|448135905|FG000|Overall Study|Adverse Event|0|||
124595211|NCT00575380|448135906|FG001|Overall Study|Adverse Event|1|||
124595212|NCT00575380|448135905|FG000|Overall Study|Various|0|||
124595213|NCT00575380|448135906|FG001|Overall Study|Various|2|||
124595214|NCT00559364|448135907|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
124595215|NCT00559364|448135908|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
124595216|NCT02663882|448135913|FG000|Overall Study|Lost to Follow-up|4|||
124595217|NCT02663882|448135914|FG001|Overall Study|Lost to Follow-up|2|||
124595218|NCT00869440|448135921|FG000|Overall Study|Withdrawal by Subject|1|||
124595219|NCT00869440|448135922|FG001|Overall Study|Withdrawal by Subject|0|||
124595220|NCT00869440|448135923|FG002|Overall Study|Withdrawal by Subject|0|||
124595221|NCT00869440|448135924|FG003|Overall Study|Withdrawal by Subject|0|||
124595222|NCT00869440|448135921|FG000|Overall Study|Physician Decision|1|||
124595223|NCT00869440|448135922|FG001|Overall Study|Physician Decision|1|||
124595224|NCT00869440|448135923|FG002|Overall Study|Physician Decision|0|||
124595225|NCT00869440|448135924|FG003|Overall Study|Physician Decision|0|||
124595226|NCT03558139|448135926|FG000|Overall Study|Consent Withdrawn|1|||
124595227|NCT03558139|448135927|FG001|Overall Study|Consent Withdrawn|1|||
124595228|NCT03558139|448135928|FG002|Overall Study|Consent Withdrawn|4|||
124595229|NCT03558139|448135926|FG000|Overall Study|Death|5|||
124595230|NCT03558139|448135927|FG001|Overall Study|Death|3|||
124595231|NCT03558139|448135928|FG002|Overall Study|Death|8|||
124595232|NCT03558139|448135926|FG000|Overall Study|Lost to Follow-up|0|||
124595233|NCT03558139|448135927|FG001|Overall Study|Lost to Follow-up|0|||
124595234|NCT03558139|448135928|FG002|Overall Study|Lost to Follow-up|3|||
124595235|NCT03558139|448135926|FG000|Overall Study|Study Ended Per Protocol|0|||
124730491|NCT00789581|448635502|FG000|Adjuvant Therapy|Never treated|2|||
124730492|NCT00789581|448635503|FG001|Adjuvant Therapy|Never treated|2|||
124730493|NCT00789581|448635502|FG000|Adjuvant Therapy|Adverse Event|20|||
124595236|NCT03558139|448135927|FG001|Overall Study|Study Ended Per Protocol|3|||
124595237|NCT03558139|448135928|FG002|Overall Study|Study Ended Per Protocol|6|||
124595238|NCT02808819|448135929|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
124595239|NCT02808819|448135930|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
124595240|NCT02808819|448135929|FG000|Overall Study|Withdrawal by Subject|10|||
124595241|NCT02808819|448135930|FG001|Overall Study|Withdrawal by Subject|13|||
124595242|NCT02808819|448135929|FG000|Overall Study|Site terminated by sponsor|2|||
124595243|NCT02808819|448135930|FG001|Overall Study|Site terminated by sponsor|0|||
124595244|NCT02808819|448135929|FG000|Overall Study|Pregnancy|1|||
124595245|NCT02808819|448135930|FG001|Overall Study|Pregnancy|0|||
124595246|NCT02808819|448135929|FG000|Overall Study|Lost to Follow-up|1|||
124595247|NCT02808819|448135930|FG001|Overall Study|Lost to Follow-up|6|||
124595248|NCT02808819|448135929|FG000|Overall Study|Protocol Violation|0|||
124595249|NCT02808819|448135930|FG001|Overall Study|Protocol Violation|1|||
124595250|NCT02808819|448135929|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
124595251|NCT02808819|448135930|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
124595252|NCT02808819|448135929|FG000|Overall Study|Death|1|||
124595253|NCT02808819|448135930|FG001|Overall Study|Death|0|||
124595254|NCT02808819|448135929|FG000|Overall Study|Adverse Event|3|||
124595255|NCT02808819|448135930|FG001|Overall Study|Adverse Event|4|||
124595256|NCT03573817|448135931|FG000|Overall Study|Adverse Event|0|||
124595257|NCT03573817|448135932|FG001|Overall Study|Adverse Event|2|||
124595258|NCT03573817|448135931|FG000|Overall Study|Protocol Violation|0|||
124595259|NCT03573817|448135932|FG001|Overall Study|Protocol Violation|1|||
124595260|NCT03573817|448135931|FG000|Overall Study|Withdrawal by Subject|1|||
124595261|NCT03573817|448135932|FG001|Overall Study|Withdrawal by Subject|1|||
124595262|NCT02013531|448135933|FG000|Overall Study|Lost to Follow-up|3|||
124595263|NCT02013531|448135933|FG000|Overall Study|Met Withdrawal Criteria|1|||
124595264|NCT02013531|448135933|FG000|Overall Study|Withdrawal by Subject|1|||
124595265|NCT03546647|448135934|FG000|Overall Study|Adverse Event|1|||
124595266|NCT03546647|448135935|FG001|Overall Study|Adverse Event|0|||
124595267|NCT02400476|448135936|FG000|Overall Study|Adverse Event|57|||
124595268|NCT02400476|448135937|FG001|Overall Study|Adverse Event|10|||
124595269|NCT02400476|448135938|FG002|Overall Study|Adverse Event|22|||
124595270|NCT02400476|448135939|FG003|Overall Study|Adverse Event|19|||
124595271|NCT02400476|448135940|FG004|Overall Study|Adverse Event|5|||
124595272|NCT02400476|448135941|FG005|Overall Study|Adverse Event|8|||
124595273|NCT02400476|448135936|FG000|Overall Study|Withdrawal by Subject|4|||
124595274|NCT02400476|448135937|FG001|Overall Study|Withdrawal by Subject|1|||
124595275|NCT02400476|448135938|FG002|Overall Study|Withdrawal by Subject|12|||
124595276|NCT02400476|448135939|FG003|Overall Study|Withdrawal by Subject|7|||
124595277|NCT02400476|448135940|FG004|Overall Study|Withdrawal by Subject|5|||
124595278|NCT02400476|448135941|FG005|Overall Study|Withdrawal by Subject|5|||
124595279|NCT02400476|448135936|FG000|Overall Study|Lost to Follow-up|0|||
124595280|NCT02400476|448135937|FG001|Overall Study|Lost to Follow-up|0|||
124595281|NCT02400476|448135938|FG002|Overall Study|Lost to Follow-up|0|||
124595282|NCT02400476|448135939|FG003|Overall Study|Lost to Follow-up|1|||
124595283|NCT02400476|448135940|FG004|Overall Study|Lost to Follow-up|3|||
124595284|NCT02400476|448135941|FG005|Overall Study|Lost to Follow-up|1|||
124595285|NCT02400476|448135936|FG000|Overall Study|Physician Decision|0|||
124595286|NCT02400476|448135937|FG001|Overall Study|Physician Decision|0|||
124595287|NCT02400476|448135938|FG002|Overall Study|Physician Decision|1|||
124595288|NCT02400476|448135939|FG003|Overall Study|Physician Decision|1|||
124595289|NCT02400476|448135940|FG004|Overall Study|Physician Decision|0|||
124595290|NCT02400476|448135941|FG005|Overall Study|Physician Decision|1|||
124595291|NCT02400476|448135936|FG000|Overall Study|Other, Disease Progression|0|||
124595292|NCT02400476|448135937|FG001|Overall Study|Other, Disease Progression|1|||
124595293|NCT02400476|448135938|FG002|Overall Study|Other, Disease Progression|2|||
124595294|NCT02400476|448135939|FG003|Overall Study|Other, Disease Progression|1|||
124595295|NCT02400476|448135940|FG004|Overall Study|Other, Disease Progression|2|||
124595296|NCT02400476|448135941|FG005|Overall Study|Other, Disease Progression|1|||
124595297|NCT02400476|448135936|FG000|Overall Study|Other, Decreased Quality of Life|0|||
124595298|NCT02400476|448135937|FG001|Overall Study|Other, Decreased Quality of Life|0|||
124595299|NCT02400476|448135938|FG002|Overall Study|Other, Decreased Quality of Life|2|||
124595300|NCT02400476|448135939|FG003|Overall Study|Other, Decreased Quality of Life|0|||
124595301|NCT02400476|448135940|FG004|Overall Study|Other, Decreased Quality of Life|0|||
124595302|NCT02400476|448135941|FG005|Overall Study|Other, Decreased Quality of Life|0|||
124595303|NCT02400476|448135936|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
124595304|NCT02400476|448135937|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
124595305|NCT02400476|448135938|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
124595306|NCT02400476|448135939|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
124595307|NCT02400476|448135940|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
124595308|NCT02400476|448135941|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
124595309|NCT00588731|448135944|FG000|Overall Study|Withdrawal by Subject|3|||
124595310|NCT00588731|448135945|FG001|Overall Study|Withdrawal by Subject|2|||
124595311|NCT00613730|448135946|FG000|Overall Study|Disease progression|2|||
124595312|NCT00613730|448135946|FG000|Overall Study|Administrative decision|1|||
124595313|NCT02056652|448135949|FG000|Overall Study|Withdrawal by Subject|1|||
124595314|NCT02056652|448135950|FG001|Overall Study|Withdrawal by Subject|0|||
124595315|NCT02056652|448135949|FG000|Overall Study|Lost to Follow-up|0|||
124595316|NCT02056652|448135950|FG001|Overall Study|Lost to Follow-up|3|||
124595317|NCT02093923|448135953|FG000|Overall Study|Lost to Follow-up|0|||
124595318|NCT02093923|448135954|FG001|Overall Study|Lost to Follow-up|0|||
124595319|NCT02093923|448135955|FG002|Overall Study|Lost to Follow-up|0|||
124595320|NCT02093923|448135956|FG003|Overall Study|Lost to Follow-up|1|||
124595321|NCT02093923|448135957|FG004|Overall Study|Lost to Follow-up|0|||
124595322|NCT02093923|448135953|FG000|Overall Study|Screen failure after randomization|0|||
124595323|NCT02093923|448135954|FG001|Overall Study|Screen failure after randomization|0|||
124595324|NCT02093923|448135955|FG002|Overall Study|Screen failure after randomization|0|||
124595325|NCT02093923|448135956|FG003|Overall Study|Screen failure after randomization|1|||
124595326|NCT02093923|448135957|FG004|Overall Study|Screen failure after randomization|0|||
124595327|NCT03253094|448135958|FG000|Overall Study|Adverse Event|2|||
124595328|NCT03253094|448135959|FG001|Overall Study|Adverse Event|0|||
124595329|NCT03253094|448135960|FG002|Overall Study|Adverse Event|0|||
124595330|NCT03253094|448135961|FG003|Overall Study|Adverse Event|0|||
124595331|NCT03253094|448135962|FG004|Overall Study|Adverse Event|0|||
124595332|NCT03253094|448135963|FG005|Overall Study|Adverse Event|0|||
124595333|NCT03253094|448135958|FG000|Overall Study|Lack of Efficacy|0|||
124595334|NCT03253094|448135959|FG001|Overall Study|Lack of Efficacy|0|||
124595335|NCT03253094|448135960|FG002|Overall Study|Lack of Efficacy|2|||
124595336|NCT03253094|448135961|FG003|Overall Study|Lack of Efficacy|1|||
124595337|NCT03253094|448135962|FG004|Overall Study|Lack of Efficacy|2|||
124595338|NCT03253094|448135963|FG005|Overall Study|Lack of Efficacy|1|||
124595339|NCT03253094|448135958|FG000|Overall Study|Lost to Follow-up|0|||
124595340|NCT03253094|448135959|FG001|Overall Study|Lost to Follow-up|0|||
124595341|NCT03253094|448135960|FG002|Overall Study|Lost to Follow-up|1|||
124595342|NCT03253094|448135961|FG003|Overall Study|Lost to Follow-up|1|||
124595343|NCT03253094|448135962|FG004|Overall Study|Lost to Follow-up|0|||
124595344|NCT03253094|448135963|FG005|Overall Study|Lost to Follow-up|1|||
124595345|NCT03253094|448135958|FG000|Overall Study|Physician Decision|1|||
124595346|NCT03253094|448135959|FG001|Overall Study|Physician Decision|0|||
124595347|NCT03253094|448135960|FG002|Overall Study|Physician Decision|0|||
124595348|NCT03253094|448135961|FG003|Overall Study|Physician Decision|1|||
124595349|NCT03253094|448135962|FG004|Overall Study|Physician Decision|0|||
124595350|NCT03253094|448135963|FG005|Overall Study|Physician Decision|2|||
124595351|NCT03253094|448135958|FG000|Overall Study|Withdrawal by Subject|1|||
124595352|NCT03253094|448135959|FG001|Overall Study|Withdrawal by Subject|2|||
124595353|NCT03253094|448135960|FG002|Overall Study|Withdrawal by Subject|1|||
124595354|NCT03253094|448135961|FG003|Overall Study|Withdrawal by Subject|0|||
124595355|NCT03253094|448135962|FG004|Overall Study|Withdrawal by Subject|3|||
124595356|NCT03253094|448135963|FG005|Overall Study|Withdrawal by Subject|0|||
124595357|NCT03253094|448135958|FG000|Overall Study|Other|0|||
124595358|NCT03253094|448135959|FG001|Overall Study|Other|1|||
124595359|NCT03253094|448135960|FG002|Overall Study|Other|2|||
124595360|NCT03253094|448135961|FG003|Overall Study|Other|1|||
124595361|NCT03253094|448135962|FG004|Overall Study|Other|0|||
124595362|NCT03253094|448135963|FG005|Overall Study|Other|0|||
124595363|NCT00248170|448135964|FG000|Overall Study|Withdrawal by Subject|71|||
124595364|NCT00248170|448135965|FG001|Overall Study|Withdrawal by Subject|79|||
124595365|NCT00248170|448135964|FG000|Overall Study|Protocol Violation|35|||
124595366|NCT00248170|448135965|FG001|Overall Study|Protocol Violation|30|||
124595367|NCT00248170|448135964|FG000|Overall Study|Lost to Follow-up|28|||
124595368|NCT00248170|448135965|FG001|Overall Study|Lost to Follow-up|35|||
124595369|NCT00248170|448135964|FG000|Overall Study|Disease progression|196|||
124595370|NCT00248170|448135965|FG001|Overall Study|Disease progression|216|||
124595371|NCT00248170|448135964|FG000|Overall Study|Death|28|||
124595372|NCT00248170|448135965|FG001|Overall Study|Death|47|||
124595373|NCT00248170|448135964|FG000|Overall Study|Adverse Event|311|||
124595374|NCT00248170|448135965|FG001|Overall Study|Adverse Event|296|||
124595375|NCT00248170|448135964|FG000|Overall Study|Administrative problems|22|||
124595376|NCT00248170|448135965|FG001|Overall Study|Administrative problems|25|||
124595377|NCT00248170|448135964|FG000|Overall Study|Abnormal test procedure(s) result|49|||
124595378|NCT00248170|448135965|FG001|Overall Study|Abnormal test procedure(s) result|61|||
124595379|NCT00248170|448135964|FG000|Overall Study|Abnormal laboratory values|4|||
124595380|NCT00248170|448135965|FG001|Overall Study|Abnormal laboratory values|0|||
124595381|NCT00248170|448135964|FG000|Overall Study|Protocol deviation|17|||
124595382|NCT00248170|448135965|FG001|Overall Study|Protocol deviation|19|||
124595383|NCT01557582|448135966|FG000|Overall Study|Protocol Violation|4|||
124595384|NCT01557582|448135966|FG000|Overall Study|Operator error|2|||
124779379|NCT04661579|448821408|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
124779380|NCT04730271|448821410|FG000|Overall Study|Adverse Event|0|||
124779381|NCT04730271|448821411|FG001|Overall Study|Adverse Event|2|||
124595385|NCT02843659|448135967|FG000|Overall Study|Subject Withdrew Consent|0|||
124595386|NCT02843659|448135968|FG001|Overall Study|Subject Withdrew Consent|0|||
124595387|NCT02843659|448135969|FG002|Overall Study|Subject Withdrew Consent|1|||
124595388|NCT02843659|448135967|FG000|Overall Study|Administrative Reason by Sponsor|4|||
124595389|NCT02843659|448135968|FG001|Overall Study|Administrative Reason by Sponsor|5|||
124595390|NCT02843659|448135969|FG002|Overall Study|Administrative Reason by Sponsor|4|||
124595391|NCT02843659|448135967|FG000|Overall Study|Adverse Event|0|||
124595392|NCT02843659|448135968|FG001|Overall Study|Adverse Event|1|||
124595393|NCT02843659|448135969|FG002|Overall Study|Adverse Event|0|||
124595394|NCT02413294|448135973|FG000|Overall Study|Withdrawal by Subject|1|||
124595395|NCT01253317|448135980|FG000|Overall Study|Adverse Event|2|||
124595396|NCT02012452|448139025|FG000|Overall Study|Lost to Follow-up|2|||
124595397|NCT02012452|448139026|FG001|Overall Study|Lost to Follow-up|1|||
124779382|NCT04730271|448821410|FG000|Overall Study|Withdrawal by Subject|1|||
124595398|NCT02012452|448139025|FG000|Overall Study|Withdrawal by Subject|4|||
124595399|NCT02012452|448139026|FG001|Overall Study|Withdrawal by Subject|0|||
124595400|NCT02688387|448139027|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595401|NCT02688387|448139028|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595402|NCT02688387|448139029|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
124595403|NCT02688387|448139030|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595404|NCT02688387|448139031|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595405|NCT02688387|448139032|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595406|NCT02688387|448139033|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595407|NCT02688387|448139034|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595408|NCT02688387|448139035|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595409|NCT02688387|448139036|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595410|NCT02688387|448139037|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595411|NCT02688387|448139038|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595412|NCT02688387|448139039|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595413|NCT02688387|448139040|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595414|NCT02688387|448139041|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595415|NCT02688387|448139042|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595416|NCT02688387|448139043|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595417|NCT02688387|448139044|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595418|NCT02688387|448139045|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595419|NCT02688387|448139046|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595420|NCT02688387|448139047|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595421|NCT02688387|448139048|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
124595422|NCT02688387|448139027|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595423|NCT02688387|448139028|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595424|NCT02688387|448139029|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595425|NCT02688387|448139030|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
124595426|NCT02688387|448139031|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595427|NCT02688387|448139032|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595428|NCT02688387|448139033|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595429|NCT02688387|448139034|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595430|NCT02688387|448139035|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595431|NCT02688387|448139036|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595432|NCT02688387|448139037|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595433|NCT02688387|448139038|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595434|NCT02688387|448139039|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595435|NCT02688387|448139040|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595436|NCT02688387|448139041|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595437|NCT02688387|448139042|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595438|NCT02688387|448139043|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595439|NCT02688387|448139044|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595440|NCT02688387|448139045|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124730494|NCT00789581|448635503|FG001|Adjuvant Therapy|Adverse Event|44|||
124730495|NCT00789581|448635502|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
124730496|NCT00789581|448635503|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
124730497|NCT00789581|448635502|FG000|Adjuvant Therapy|Disease recurrence|2|||
124730498|NCT00789581|448635503|FG001|Adjuvant Therapy|Disease recurrence|1|||
124730499|NCT00789581|448635502|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
124730500|NCT00789581|448635503|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
124730501|NCT00789581|448635502|FG000|Adjuvant Therapy|Protocol Violation|1|||
124730502|NCT00789581|448635503|FG001|Adjuvant Therapy|Protocol Violation|1|||
124730503|NCT00789581|448635502|FG000|Adjuvant Therapy|Other|0|||
124730504|NCT00789581|448635503|FG001|Adjuvant Therapy|Other|1|||
124730505|NCT01468207|448635504|FG000|Treatment Period 1|Adverse Event|1|||
124730506|NCT01468207|448635505|FG001|Treatment Period 1|Adverse Event|0|||
124730507|NCT01468207|448635506|FG002|Treatment Period 1|Adverse Event|0|||
124730508|NCT01468207|448635507|FG003|Treatment Period 1|Adverse Event|0|||
124730509|NCT01468207|448635508|FG004|Treatment Period 1|Adverse Event|0|||
124730510|NCT01468207|448635509|FG005|Treatment Period 1|Adverse Event|0|||
124730511|NCT01468207|448635504|FG000|Treatment Period 1|Protocol Violation|1|||
124730512|NCT01468207|448635505|FG001|Treatment Period 1|Protocol Violation|1|||
124730513|NCT01468207|448635506|FG002|Treatment Period 1|Protocol Violation|0|||
124730514|NCT01468207|448635507|FG003|Treatment Period 1|Protocol Violation|0|||
124730515|NCT01468207|448635508|FG004|Treatment Period 1|Protocol Violation|0|||
124730516|NCT01468207|448635509|FG005|Treatment Period 1|Protocol Violation|0|||
124730517|NCT01468207|448635504|FG000|Treatment Period 1|Withdrawal by Subject|5|||
124730518|NCT01468207|448635505|FG001|Treatment Period 1|Withdrawal by Subject|4|||
124730519|NCT01468207|448635506|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124730520|NCT01468207|448635507|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124730521|NCT01468207|448635508|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124595441|NCT02688387|448139046|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595442|NCT02688387|448139047|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595443|NCT02688387|448139048|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595444|NCT02688387|448139027|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595445|NCT02688387|448139028|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
124595446|NCT02688387|448139029|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595447|NCT02688387|448139030|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595448|NCT02688387|448139031|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595449|NCT02688387|448139032|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595450|NCT02688387|448139033|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595451|NCT02688387|448139034|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595452|NCT02688387|448139035|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595453|NCT02688387|448139036|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595454|NCT02688387|448139037|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595455|NCT02688387|448139038|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595456|NCT02688387|448139039|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595457|NCT02688387|448139040|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595458|NCT02688387|448139041|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595459|NCT02688387|448139042|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595460|NCT02688387|448139043|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595461|NCT02688387|448139044|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595462|NCT02688387|448139045|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595463|NCT02688387|448139046|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595464|NCT02688387|448139047|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595465|NCT02688387|448139048|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
124595466|NCT02688387|448139027|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595467|NCT02688387|448139028|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595468|NCT02688387|448139029|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
124595469|NCT02688387|448139030|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595470|NCT02688387|448139031|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
124595471|NCT02688387|448139032|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595472|NCT02688387|448139033|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595473|NCT02688387|448139034|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595474|NCT02688387|448139035|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595475|NCT02688387|448139036|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595476|NCT02688387|448139037|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595477|NCT02688387|448139038|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595478|NCT02688387|448139039|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595479|NCT02688387|448139040|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595480|NCT02688387|448139041|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595481|NCT02688387|448139042|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595482|NCT02688387|448139043|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595483|NCT02688387|448139044|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595484|NCT02688387|448139045|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595485|NCT02688387|448139046|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595486|NCT02688387|448139047|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595487|NCT02688387|448139048|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
124595488|NCT02688387|448139027|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
124595489|NCT02688387|448139028|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595490|NCT02688387|448139029|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595491|NCT02688387|448139030|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595492|NCT02688387|448139031|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595493|NCT02688387|448139032|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595494|NCT02688387|448139033|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595495|NCT02688387|448139034|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595496|NCT02688387|448139035|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595497|NCT02688387|448139036|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595498|NCT02688387|448139037|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595499|NCT02688387|448139038|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595500|NCT02688387|448139039|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595501|NCT02688387|448139040|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595502|NCT02688387|448139041|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595503|NCT02688387|448139042|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595504|NCT02688387|448139043|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595505|NCT02688387|448139044|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595506|NCT02688387|448139045|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595507|NCT02688387|448139046|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595508|NCT02688387|448139047|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595509|NCT02688387|448139048|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
124595510|NCT02688387|448139027|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595511|NCT02688387|448139028|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595512|NCT02688387|448139029|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595513|NCT02688387|448139030|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595514|NCT02688387|448139031|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595515|NCT02688387|448139032|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595516|NCT02688387|448139033|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595517|NCT02688387|448139034|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595518|NCT02688387|448139035|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595519|NCT02688387|448139036|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595520|NCT02688387|448139037|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
124595521|NCT02688387|448139038|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595522|NCT02688387|448139039|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595523|NCT02688387|448139040|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595524|NCT02688387|448139041|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595525|NCT02688387|448139042|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595526|NCT02688387|448139043|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595527|NCT02688387|448139044|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595528|NCT02688387|448139045|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595529|NCT02688387|448139046|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595530|NCT02688387|448139047|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595531|NCT02688387|448139048|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
124595532|NCT02688387|448139027|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595533|NCT02688387|448139028|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595534|NCT02688387|448139029|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595535|NCT02688387|448139030|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595536|NCT02688387|448139031|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595537|NCT02688387|448139032|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595538|NCT02688387|448139033|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595539|NCT02688387|448139034|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595540|NCT02688387|448139035|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595541|NCT02688387|448139036|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595542|NCT02688387|448139037|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595543|NCT02688387|448139038|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595544|NCT02688387|448139039|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595545|NCT02688387|448139040|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595546|NCT02688387|448139041|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
124595547|NCT02688387|448139042|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595548|NCT02688387|448139043|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595549|NCT02688387|448139044|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595550|NCT02688387|448139045|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595551|NCT02688387|448139046|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595552|NCT02688387|448139047|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595553|NCT02688387|448139048|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
124595554|NCT02688387|448139027|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595555|NCT02688387|448139028|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595556|NCT02688387|448139029|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595557|NCT02688387|448139030|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595558|NCT02688387|448139031|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595559|NCT02688387|448139032|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595560|NCT02688387|448139033|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595561|NCT02688387|448139034|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595562|NCT02688387|448139035|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595563|NCT02688387|448139036|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595564|NCT02688387|448139037|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595565|NCT02688387|448139038|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595566|NCT02688387|448139039|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595567|NCT02688387|448139040|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595568|NCT02688387|448139041|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595569|NCT02688387|448139042|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595570|NCT02688387|448139043|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595571|NCT02688387|448139044|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595572|NCT02688387|448139045|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595573|NCT02688387|448139046|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595574|NCT02688387|448139047|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
124595575|NCT02688387|448139048|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
124595576|NCT02688387|448139027|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595577|NCT02688387|448139028|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595578|NCT02688387|448139029|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595579|NCT02688387|448139030|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595580|NCT02688387|448139031|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595581|NCT02688387|448139032|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595582|NCT02688387|448139033|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595583|NCT02688387|448139034|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595584|NCT02688387|448139035|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595585|NCT02688387|448139036|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595586|NCT02688387|448139037|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595587|NCT02688387|448139038|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595588|NCT02688387|448139039|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595589|NCT02688387|448139040|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595590|NCT02688387|448139041|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595591|NCT02688387|448139042|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595592|NCT02688387|448139043|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595593|NCT02688387|448139044|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595594|NCT02688387|448139045|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
124730522|NCT01468207|448635509|FG005|Treatment Period 1|Withdrawal by Subject|0|||
124730523|NCT01468207|448635504|FG000|Treatment Period 1|Lost to Follow-up|2|||
124730524|NCT01468207|448635505|FG001|Treatment Period 1|Lost to Follow-up|1|||
124730525|NCT01468207|448635506|FG002|Treatment Period 1|Lost to Follow-up|0|||
124730526|NCT01468207|448635507|FG003|Treatment Period 1|Lost to Follow-up|0|||
124730527|NCT01468207|448635508|FG004|Treatment Period 1|Lost to Follow-up|0|||
124730528|NCT01468207|448635509|FG005|Treatment Period 1|Lost to Follow-up|0|||
124730529|NCT01468207|448635504|FG000|Treatment Period 1|Other|0|||
124730530|NCT01468207|448635505|FG001|Treatment Period 1|Other|2|||
124730531|NCT01468207|448635506|FG002|Treatment Period 1|Other|0|||
124730532|NCT01468207|448635507|FG003|Treatment Period 1|Other|0|||
124730533|NCT01468207|448635508|FG004|Treatment Period 1|Other|0|||
124730534|NCT01468207|448635509|FG005|Treatment Period 1|Other|0|||
124730535|NCT01468207|448635504|FG000|Treatment Period 2|Adverse Event|0|||
124730536|NCT01468207|448635505|FG001|Treatment Period 2|Adverse Event|0|||
124730537|NCT01468207|448635506|FG002|Treatment Period 2|Adverse Event|6|||
124730538|NCT01468207|448635507|FG003|Treatment Period 2|Adverse Event|1|||
124730539|NCT01468207|448635508|FG004|Treatment Period 2|Adverse Event|2|||
124730540|NCT01468207|448635509|FG005|Treatment Period 2|Adverse Event|1|||
124730541|NCT01468207|448635504|FG000|Treatment Period 2|Lack of Efficacy|0|||
124730542|NCT01468207|448635505|FG001|Treatment Period 2|Lack of Efficacy|0|||
124730543|NCT01468207|448635506|FG002|Treatment Period 2|Lack of Efficacy|1|||
124730544|NCT01468207|448635507|FG003|Treatment Period 2|Lack of Efficacy|1|||
124730545|NCT01468207|448635508|FG004|Treatment Period 2|Lack of Efficacy|0|||
124730546|NCT01468207|448635509|FG005|Treatment Period 2|Lack of Efficacy|2|||
124730547|NCT01468207|448635504|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124730548|NCT01468207|448635505|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124730549|NCT01468207|448635506|FG002|Treatment Period 2|Withdrawal by Subject|5|||
124730550|NCT01468207|448635507|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124730551|NCT01468207|448635508|FG004|Treatment Period 2|Withdrawal by Subject|0|||
124730552|NCT01468207|448635509|FG005|Treatment Period 2|Withdrawal by Subject|2|||
124730553|NCT01468207|448635504|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
124730554|NCT01468207|448635505|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
124730555|NCT01468207|448635506|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
124730556|NCT01468207|448635507|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
124730557|NCT01468207|448635508|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
124730558|NCT01468207|448635509|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
124730559|NCT01468207|448635504|FG000|Treatment Period 2|Lost to Follow-up|0|||
124730560|NCT01468207|448635505|FG001|Treatment Period 2|Lost to Follow-up|0|||
124730561|NCT01468207|448635506|FG002|Treatment Period 2|Lost to Follow-up|5|||
124730562|NCT01468207|448635507|FG003|Treatment Period 2|Lost to Follow-up|1|||
124730563|NCT01468207|448635508|FG004|Treatment Period 2|Lost to Follow-up|0|||
124730564|NCT01468207|448635509|FG005|Treatment Period 2|Lost to Follow-up|0|||
124730565|NCT01468207|448635504|FG000|Treatment Period 2|Other|0|||
124730566|NCT01468207|448635505|FG001|Treatment Period 2|Other|0|||
124730567|NCT01468207|448635506|FG002|Treatment Period 2|Other|5|||
124595595|NCT02688387|448139046|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595596|NCT02688387|448139047|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
124595597|NCT02688387|448139048|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
124595598|NCT02688387|448139027|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595599|NCT02688387|448139028|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595600|NCT02688387|448139029|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595601|NCT02688387|448139030|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595602|NCT02688387|448139031|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595603|NCT02688387|448139032|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595604|NCT02688387|448139033|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595605|NCT02688387|448139034|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595606|NCT02688387|448139035|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595607|NCT02688387|448139036|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595608|NCT02688387|448139037|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595609|NCT02688387|448139038|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595610|NCT02688387|448139039|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595611|NCT02688387|448139040|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595612|NCT02688387|448139041|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595613|NCT02688387|448139042|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595614|NCT02688387|448139043|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595615|NCT02688387|448139044|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595616|NCT02688387|448139045|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595617|NCT02688387|448139046|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
124595618|NCT02688387|448139047|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595619|NCT02688387|448139048|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
124595620|NCT04403399|448139051|FG000|Period 2|Physician Decision|0|||
124595621|NCT04403399|448139052|FG001|Period 2|Physician Decision|1|||
124595622|NCT01606228|448139053|FG000|Overall Study|Lost to Follow-up|20|||
124595623|NCT01606228|448139053|FG000|Overall Study|Withdrawal by Subject|3|||
124595624|NCT01606228|448139053|FG000|Overall Study|Non-compliant|3|||
124595625|NCT01606228|448139053|FG000|Overall Study|Lack of Efficacy|2|||
124595626|NCT01606228|448139053|FG000|Overall Study|Adverse Event|1|||
124595627|NCT00546910|448139054|FG000|Overall Study|Adverse Event|2|||
124595628|NCT00546910|448139055|FG001|Overall Study|Adverse Event|3|||
124595629|NCT00546910|448139054|FG000|Overall Study|Lack of Efficacy|5|||
124595630|NCT00546910|448139055|FG001|Overall Study|Lack of Efficacy|7|||
124595631|NCT00546910|448139054|FG000|Overall Study|Physician Decision|0|||
124595632|NCT00546910|448139055|FG001|Overall Study|Physician Decision|1|||
124595633|NCT00546910|448139054|FG000|Overall Study|Withdrawal by Subject|2|||
124595634|NCT00546910|448139055|FG001|Overall Study|Withdrawal by Subject|0|||
124595635|NCT01115855|448139056|FG000|Overall Study|Adverse Event|16|||
124595636|NCT01115855|448139057|FG001|Overall Study|Adverse Event|18|||
124595637|NCT01115855|448139056|FG000|Overall Study|Death|6|||
124595638|NCT01115855|448139057|FG001|Overall Study|Death|5|||
124595639|NCT01115855|448139056|FG000|Overall Study|Lab Abnormality|1|||
124595640|NCT01115855|448139057|FG001|Overall Study|Lab Abnormality|1|||
124595641|NCT01115855|448139056|FG000|Overall Study|Protocol Violation|0|||
124595642|NCT01115855|448139057|FG001|Overall Study|Protocol Violation|1|||
124595643|NCT01115855|448139056|FG000|Overall Study|Withdrawal by Subject|5|||
124595644|NCT01115855|448139057|FG001|Overall Study|Withdrawal by Subject|5|||
124595645|NCT01115855|448139056|FG000|Overall Study|Other|8|||
124779383|NCT04730271|448821411|FG001|Overall Study|Withdrawal by Subject|1|||
124779384|NCT04730271|448821410|FG000|Overall Study|Protocol Violation|7|||
124779385|NCT04730271|448821411|FG001|Overall Study|Protocol Violation|13|||
124779386|NCT04730271|448821410|FG000|Overall Study|Lost to Follow-up|3|||
124779387|NCT04730271|448821411|FG001|Overall Study|Lost to Follow-up|3|||
124779388|NCT04730271|448821410|FG000|Overall Study|Death|1|||
124595646|NCT01115855|448139057|FG001|Overall Study|Other|6|||
124595647|NCT01009515|448139080|FG000|Overall Study|Withdrawal by Subject|3|||
124595648|NCT00330460|448139085|FG000|Overall Study|Physician Decision|1|||
124595649|NCT00330460|448139086|FG001|Overall Study|Physician Decision|0|||
124595650|NCT00330460|448139085|FG000|Overall Study|Adverse Event|10|||
124779389|NCT04730271|448821411|FG001|Overall Study|Death|0|||
124595651|NCT00330460|448139086|FG001|Overall Study|Adverse Event|8|||
124595652|NCT00330460|448139085|FG000|Overall Study|Withdrawal by Subject|18|||
124595653|NCT00330460|448139086|FG001|Overall Study|Withdrawal by Subject|17|||
124595654|NCT00330460|448139085|FG000|Overall Study|Death|1|||
124595655|NCT00330460|448139086|FG001|Overall Study|Death|1|||
124595656|NCT00330460|448139085|FG000|Overall Study|Ineligibility determined|1|||
124595657|NCT00330460|448139086|FG001|Overall Study|Ineligibility determined|3|||
124595658|NCT00330460|448139085|FG000|Overall Study|Lost to Follow-up|8|||
124595659|NCT00330460|448139086|FG001|Overall Study|Lost to Follow-up|3|||
124595660|NCT00330460|448139085|FG000|Overall Study|Noncompliance|2|||
124595661|NCT00330460|448139086|FG001|Overall Study|Noncompliance|1|||
124779390|NCT02023697|448821416|FG000|Treatment Period|Radiological progression|13|||
124779391|NCT02023697|448821417|FG001|Treatment Period|Radiological progression|17|||
124779392|NCT02023697|448821418|FG002|Treatment Period|Radiological progression|26|||
124779393|NCT02023697|448821416|FG000|Treatment Period|Never Treated|5|||
124779394|NCT02023697|448821417|FG001|Treatment Period|Never Treated|6|||
124779395|NCT02023697|448821418|FG002|Treatment Period|Never Treated|10|||
124779396|NCT02023697|448821416|FG000|Treatment Period|Adverse Event|13|||
124779397|NCT02023697|448821417|FG001|Treatment Period|Adverse Event|25|||
124779398|NCT02023697|448821418|FG002|Treatment Period|Adverse Event|23|||
124779399|NCT02023697|448821416|FG000|Treatment Period|Logistical difficulties|1|||
124779400|NCT02023697|448821417|FG001|Treatment Period|Logistical difficulties|1|||
124779401|NCT02023697|448821418|FG002|Treatment Period|Logistical difficulties|1|||
124779402|NCT02023697|448821416|FG000|Treatment Period|Clinical progression|10|||
124779403|NCT02023697|448821417|FG001|Treatment Period|Clinical progression|8|||
124779404|NCT02023697|448821418|FG002|Treatment Period|Clinical progression|28|||
124779405|NCT02023697|448821416|FG000|Treatment Period|Withdrawal by Subject|4|||
124779406|NCT02023697|448821417|FG001|Treatment Period|Withdrawal by Subject|5|||
124779407|NCT02023697|448821418|FG002|Treatment Period|Withdrawal by Subject|13|||
124779408|NCT02023697|448821416|FG000|Treatment Period|Safety outcome reached|0|||
124779409|NCT02023697|448821417|FG001|Treatment Period|Safety outcome reached|1|||
124779410|NCT02023697|448821418|FG002|Treatment Period|Safety outcome reached|0|||
124779411|NCT02023697|448821416|FG000|Treatment Period|Physician Decision|0|||
124779412|NCT02023697|448821417|FG001|Treatment Period|Physician Decision|0|||
124779413|NCT02023697|448821418|FG002|Treatment Period|Physician Decision|1|||
124779414|NCT02023697|448821416|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
124779415|NCT02023697|448821417|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
124779416|NCT02023697|448821418|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
124779417|NCT02023697|448821416|FG000|Active Follow-up Period|Lost to Follow-up|1|||
124779418|NCT02023697|448821417|FG001|Active Follow-up Period|Lost to Follow-up|1|||
124779419|NCT02023697|448821418|FG002|Active Follow-up Period|Lost to Follow-up|1|||
124779420|NCT02023697|448821416|FG000|Active Follow-up Period|Deterioration of general condition|1|||
124779421|NCT02023697|448821417|FG001|Active Follow-up Period|Deterioration of general condition|1|||
124779422|NCT02023697|448821418|FG002|Active Follow-up Period|Deterioration of general condition|1|||
124779423|NCT02023697|448821416|FG000|Active Follow-up Period|Other unspecified|2|||
124779424|NCT02023697|448821417|FG001|Active Follow-up Period|Other unspecified|0|||
124779425|NCT02023697|448821418|FG002|Active Follow-up Period|Other unspecified|1|||
124779426|NCT02023697|448821416|FG000|Active Follow-up Period|Clinical progression|0|||
124779427|NCT02023697|448821417|FG001|Active Follow-up Period|Clinical progression|2|||
124779428|NCT02023697|448821418|FG002|Active Follow-up Period|Clinical progression|1|||
124779429|NCT02023697|448821416|FG000|Active Follow-up Period|Radiological progression|0|||
124779430|NCT02023697|448821417|FG001|Active Follow-up Period|Radiological progression|0|||
124779431|NCT02023697|448821418|FG002|Active Follow-up Period|Radiological progression|1|||
124779432|NCT02023697|448821416|FG000|Active Follow-up Period|Death|83|||
124779433|NCT02023697|448821417|FG001|Active Follow-up Period|Death|82|||
124779434|NCT02023697|448821418|FG002|Active Follow-up Period|Death|87|||
124779435|NCT02023697|448821416|FG000|Long-term Follow-up Period|Death|9|||
124779436|NCT02023697|448821417|FG001|Long-term Follow-up Period|Death|6|||
124779437|NCT02023697|448821418|FG002|Long-term Follow-up Period|Death|4|||
124779438|NCT02023697|448821416|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
124779439|NCT02023697|448821417|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
124779440|NCT02023697|448821418|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
124779441|NCT02023697|448821416|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
124779442|NCT02023697|448821417|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
124779443|NCT02023697|448821418|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
124779444|NCT02023697|448821416|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
124779445|NCT02023697|448821417|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
124779446|NCT02023697|448821418|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
124779447|NCT02023697|448821416|FG000|Long-term Follow-up Period|Technical problems|0|||
124779448|NCT02023697|448821417|FG001|Long-term Follow-up Period|Technical problems|0|||
124779449|NCT02023697|448821418|FG002|Long-term Follow-up Period|Technical problems|1|||
124779450|NCT02023697|448821416|FG000|Long-term Follow-up Period|Other unspecified|6|||
124779451|NCT02023697|448821417|FG001|Long-term Follow-up Period|Other unspecified|3|||
124779452|NCT02023697|448821418|FG002|Long-term Follow-up Period|Other unspecified|5|||
124779453|NCT00845897|448821419|FG000|Overall Study|Lost to Follow-up|1|||
124779454|NCT00845897|448821420|FG001|Overall Study|Lost to Follow-up|1|||
124779455|NCT00845897|448821421|FG002|Overall Study|Lost to Follow-up|0|||
124779456|NCT00845897|448821419|FG000|Overall Study|Withdrawal by Subject|0|||
124779457|NCT00845897|448821420|FG001|Overall Study|Withdrawal by Subject|3|||
124779458|NCT00845897|448821421|FG002|Overall Study|Withdrawal by Subject|2|||
124779459|NCT00845897|448821419|FG000|Overall Study|Ulcer did not heal|1|||
124779460|NCT00845897|448821420|FG001|Overall Study|Ulcer did not heal|0|||
124779461|NCT00845897|448821421|FG002|Overall Study|Ulcer did not heal|1|||
124779462|NCT00845897|448821419|FG000|Overall Study|Too ill to participate|0|||
124779463|NCT00845897|448821420|FG001|Overall Study|Too ill to participate|1|||
124779464|NCT00845897|448821421|FG002|Overall Study|Too ill to participate|0|||
124595662|NCT00330460|448139085|FG000|Overall Study|Other|1|||
124730568|NCT01468207|448635507|FG003|Treatment Period 2|Other|1|||
124730569|NCT01468207|448635508|FG004|Treatment Period 2|Other|1|||
124730570|NCT01468207|448635509|FG005|Treatment Period 2|Other|2|||
124730571|NCT01328041|448635512|FG000|Overall Study|Adverse Event|7|||
124730572|NCT01328041|448635512|FG000|Overall Study|Lack of Efficacy|27|||
124730573|NCT01328041|448635512|FG000|Overall Study|Protocol Violation|7|||
124730574|NCT01328041|448635512|FG000|Overall Study|Lost to Follow-up|7|||
124730575|NCT01328041|448635512|FG000|Overall Study|Physician Decision|2|||
124730576|NCT01328041|448635512|FG000|Overall Study|Withdrawal by Subject|7|||
124730577|NCT00908115|448635513|FG000|Overall Study|Other|14|||
124730578|NCT01728077|448635514|FG000|Overall Study|Lack of Efficacy|3|||
124730579|NCT01728077|448635515|FG001|Overall Study|Lack of Efficacy|1|||
124730580|NCT01728077|448635514|FG000|Overall Study|Lost to Follow-up|1|||
124730581|NCT01728077|448635515|FG001|Overall Study|Lost to Follow-up|0|||
124730582|NCT01728077|448635514|FG000|Overall Study|Subject choice|2|||
124730583|NCT01728077|448635515|FG001|Overall Study|Subject choice|3|||
124730584|NCT01728077|448635514|FG000|Overall Study|Death|0|||
124730585|NCT01728077|448635515|FG001|Overall Study|Death|1|||
124730586|NCT01728077|448635514|FG000|Overall Study|Patient moving|1|||
124730587|NCT01728077|448635515|FG001|Overall Study|Patient moving|0|||
124730588|NCT01728077|448635514|FG000|Overall Study|Non compliance|1|||
124730589|NCT01728077|448635515|FG001|Overall Study|Non compliance|0|||
124730590|NCT00347438|448635520|FG000|Overall Study|Withdrawal by Subject|1|||
124730591|NCT00347438|448635520|FG000|Overall Study|Physician Decision|1|||
124730592|NCT00322023|448635521|FG000|Overall Study|various|0|||
124730593|NCT00322023|448635522|FG001|Overall Study|various|2|||
124730594|NCT00322023|448635523|FG002|Overall Study|various|6|||
124730595|NCT00693017|448635524|FG000|Overall Study|Sponsor Decision|2|||
124730596|NCT00693017|448635525|FG001|Overall Study|Sponsor Decision|1|||
124730597|NCT00693017|448635524|FG000|Overall Study|Death|0|||
124730598|NCT00693017|448635525|FG001|Overall Study|Death|1|||
124730599|NCT01082874|448635526|FG000|Overall Study|Lost to Follow-up|10|||
124730600|NCT01082874|448635527|FG001|Overall Study|Lost to Follow-up|10|||
124730601|NCT01082874|448635528|FG002|Overall Study|Lost to Follow-up|6|||
124730602|NCT01082874|448635529|FG003|Overall Study|Lost to Follow-up|10|||
124730603|NCT01082874|448635526|FG000|Overall Study|Withdrawal by Subject|1|||
124730604|NCT01082874|448635527|FG001|Overall Study|Withdrawal by Subject|2|||
124730605|NCT01082874|448635528|FG002|Overall Study|Withdrawal by Subject|5|||
124730606|NCT01082874|448635529|FG003|Overall Study|Withdrawal by Subject|3|||
124730607|NCT00354107|448635536|FG000|Overall Study|Adverse Event|2|||
124730608|NCT00354107|448635536|FG000|Overall Study|Physician Decision|2|||
124730609|NCT00354107|448635536|FG000|Overall Study|Withdrawal by Subject|1|||
124730610|NCT01685801|448635541|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
124730611|NCT01685801|448635542|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
124730612|NCT01685801|448635543|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
124730613|NCT01685801|448635544|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
124730614|NCT01685801|448635541|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
124730615|NCT01685801|448635542|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
124730616|NCT01685801|448635543|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
124730617|NCT01685801|448635544|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
124730618|NCT00113399|448635545|FG000|Overall Study|Death|1|||
124730619|NCT00113399|448635546|FG001|Overall Study|Death|1|||
124730620|NCT00113399|448635545|FG000|Overall Study|Withdrawal by Subject|1|||
124730621|NCT00113399|448635546|FG001|Overall Study|Withdrawal by Subject|2|||
124730622|NCT00113399|448635545|FG000|Overall Study|Complete Response|0|||
124730623|NCT00113399|448635546|FG001|Overall Study|Complete Response|1|||
124730624|NCT00113399|448635545|FG000|Overall Study|Other|0|||
124730625|NCT00113399|448635546|FG001|Overall Study|Other|1|||
124730626|NCT00396136|448635547|FG000|Overall Study|Death|43|||
124730627|NCT00396136|448635547|FG000|Overall Study|Withdrawal by Subject|59|||
124730628|NCT00396136|448635547|FG000|Overall Study|Lost to Follow-up|15|||
124730629|NCT00396136|448635547|FG000|Overall Study|Study device explanted|8|||
124730630|NCT04686084|448635549|FG000|Overall Study|Lost to Follow-up|1|||
124730631|NCT01779856|448635551|FG000|Overall Study|Withdrawal by Subject|15|||
124730632|NCT01779856|448635551|FG000|Overall Study|Death|3|||
124730633|NCT01779856|448635551|FG000|Overall Study|Physician Decision|1|||
124730634|NCT01779856|448635551|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
124730635|NCT01779856|448635551|FG000|Overall Study|Delays in scheduling implant|1|||
124730636|NCT01779856|448635551|FG000|Overall Study|Subject ineligible for Implant|2|||
124730637|NCT03350256|448635552|FG000|Overall Study|Inclusion/exclusion violation|4|||
124730638|NCT03350256|448635552|FG000|Overall Study|Recommended for other therapies|2|||
124730639|NCT03350256|448635552|FG000|Overall Study|Protocol Violation|3|||
124730640|NCT03350256|448635552|FG000|Overall Study|Non compliance|2|||
124730641|NCT03350256|448635552|FG000|Overall Study|Denial by insurance|1|||
124730642|NCT03350256|448635552|FG000|Overall Study|Adverse Event|2|||
124595663|NCT00330460|448139086|FG001|Overall Study|Other|0|||
124730643|NCT03350256|448635552|FG000|Overall Study|Trial failure|12|||
124730644|NCT03350256|448635552|FG000|Overall Study|Did not proceed to permanent implant|3|||
124779465|NCT03904693|448821422|FG000|Overall Study|Death|0|||
124595664|NCT01857973|448139087|FG000|Overall Study|Subject did not meet required BG range|3|||
124595665|NCT01857973|448139087|FG000|Overall Study|drop out after 3 failed attempts|1|||
124595666|NCT01857973|448139087|FG000|Overall Study|Physician Decision|1|||
124595667|NCT01731886|448139096|FG000|Overall Study|Death|1|||
124595668|NCT01731886|448139097|FG001|Overall Study|Death|0|||
124595669|NCT01731886|448139096|FG000|Overall Study|Never started treatment|0|||
124595670|NCT01731886|448139097|FG001|Overall Study|Never started treatment|1|||
124595671|NCT01731886|448139096|FG000|Overall Study|Non-compliant|1|||
124730645|NCT03350256|448635552|FG000|Overall Study|Withdrawal by Subject|3|||
124730646|NCT03350256|448635552|FG000|Overall Study|Subject moving out of state|1|||
124730647|NCT03350256|448635552|FG000|Overall Study|Lost to Follow-up|1|||
124730648|NCT03350256|448635552|FG000|Overall Study|Lack of Efficacy|2|||
124730649|NCT03960580|448635553|FG000|Overall Study|Adverse Event|2|||
124730650|NCT03960580|448635554|FG001|Overall Study|Adverse Event|1|||
124730651|NCT03960580|448635555|FG002|Overall Study|Adverse Event|1|||
124730652|NCT03960580|448635553|FG000|Overall Study|Lost to Follow-up|1|||
124730653|NCT03960580|448635554|FG001|Overall Study|Lost to Follow-up|0|||
124730654|NCT03960580|448635555|FG002|Overall Study|Lost to Follow-up|0|||
124730655|NCT03960580|448635553|FG000|Overall Study|Lack of Efficacy|2|||
124730656|NCT03960580|448635554|FG001|Overall Study|Lack of Efficacy|1|||
124730657|NCT03960580|448635555|FG002|Overall Study|Lack of Efficacy|0|||
124730658|NCT03960580|448635553|FG000|Overall Study|Protocol Violation|0|||
124730659|NCT03960580|448635554|FG001|Overall Study|Protocol Violation|0|||
124730660|NCT03960580|448635555|FG002|Overall Study|Protocol Violation|1|||
124730661|NCT03960580|448635553|FG000|Overall Study|Withdrawal by Subject|1|||
124730662|NCT03960580|448635554|FG001|Overall Study|Withdrawal by Subject|1|||
124730663|NCT03960580|448635555|FG002|Overall Study|Withdrawal by Subject|1|||
124730664|NCT03960580|448635553|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
124730665|NCT03960580|448635554|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
124730666|NCT03960580|448635555|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
124730667|NCT01155466|448635558|FG000|Overall Study|Adverse Event|13|||
124730668|NCT01155466|448635559|FG001|Overall Study|Adverse Event|15|||
124730669|NCT01155466|448635560|FG002|Overall Study|Adverse Event|6|||
124730670|NCT01155466|448635561|FG003|Overall Study|Adverse Event|17|||
124730671|NCT01155466|448635562|FG004|Overall Study|Adverse Event|18|||
124730672|NCT01155466|448635558|FG000|Overall Study|Lost to Follow-up|0|||
124730673|NCT01155466|448635559|FG001|Overall Study|Lost to Follow-up|0|||
124730674|NCT01155466|448635560|FG002|Overall Study|Lost to Follow-up|0|||
124730675|NCT01155466|448635561|FG003|Overall Study|Lost to Follow-up|0|||
124730676|NCT01155466|448635562|FG004|Overall Study|Lost to Follow-up|2|||
124730677|NCT01155466|448635558|FG000|Overall Study|Withdrawal by Subject|7|||
124730678|NCT01155466|448635559|FG001|Overall Study|Withdrawal by Subject|5|||
124730679|NCT01155466|448635560|FG002|Overall Study|Withdrawal by Subject|9|||
124730680|NCT01155466|448635561|FG003|Overall Study|Withdrawal by Subject|4|||
124730681|NCT01155466|448635562|FG004|Overall Study|Withdrawal by Subject|4|||
124730682|NCT01155466|448635558|FG000|Overall Study|Protocol Violation|0|||
124730683|NCT01155466|448635559|FG001|Overall Study|Protocol Violation|0|||
124730684|NCT01155466|448635560|FG002|Overall Study|Protocol Violation|2|||
124730685|NCT01155466|448635561|FG003|Overall Study|Protocol Violation|0|||
124730686|NCT01155466|448635562|FG004|Overall Study|Protocol Violation|1|||
124730687|NCT01155466|448635558|FG000|Overall Study|Administrative|0|||
124730688|NCT01155466|448635559|FG001|Overall Study|Administrative|3|||
124730689|NCT01155466|448635560|FG002|Overall Study|Administrative|0|||
124730690|NCT01155466|448635561|FG003|Overall Study|Administrative|0|||
124730691|NCT01155466|448635562|FG004|Overall Study|Administrative|0|||
124730692|NCT01155466|448635558|FG000|Overall Study|Randomized not treated|2|||
124730693|NCT01155466|448635559|FG001|Overall Study|Randomized not treated|2|||
124730694|NCT01155466|448635560|FG002|Overall Study|Randomized not treated|3|||
124730695|NCT01155466|448635561|FG003|Overall Study|Randomized not treated|0|||
124730696|NCT01155466|448635562|FG004|Overall Study|Randomized not treated|2|||
124730697|NCT02210689|448635563|FG000|Overall Study|Withdrawal by Subject|7|||
124730698|NCT02210689|448635564|FG001|Overall Study|Withdrawal by Subject|4|||
124730699|NCT02210689|448635565|FG002|Overall Study|Withdrawal by Subject|2|||
124730700|NCT02210689|448635563|FG000|Overall Study|Adverse Event|0|||
124730701|NCT02210689|448635564|FG001|Overall Study|Adverse Event|1|||
124730702|NCT02210689|448635565|FG002|Overall Study|Adverse Event|0|||
124730703|NCT02210689|448635563|FG000|Overall Study|Protocol Violation|1|||
124730704|NCT02210689|448635564|FG001|Overall Study|Protocol Violation|0|||
124595672|NCT01731886|448139097|FG001|Overall Study|Non-compliant|0|||
124730705|NCT02210689|448635565|FG002|Overall Study|Protocol Violation|0|||
124730706|NCT02210689|448635563|FG000|Overall Study|Lost to Follow-up|11|||
124730707|NCT02210689|448635564|FG001|Overall Study|Lost to Follow-up|9|||
124730708|NCT02210689|448635565|FG002|Overall Study|Lost to Follow-up|5|||
124730709|NCT02210689|448635563|FG000|Overall Study|Pregnancy|0|||
124730710|NCT02210689|448635564|FG001|Overall Study|Pregnancy|1|||
124730711|NCT02210689|448635565|FG002|Overall Study|Pregnancy|0|||
124730712|NCT02210689|448635563|FG000|Overall Study|Lack of Efficacy|0|||
124730713|NCT02210689|448635564|FG001|Overall Study|Lack of Efficacy|1|||
124595673|NCT00129116|448139098|FG000|Primary Phase|Lost to Follow-up|1|||
124595674|NCT00129116|448139099|FG001|Primary Phase|Lost to Follow-up|1|||
124595675|NCT00129116|448139100|FG002|Primary Phase|Lost to Follow-up|0|||
124595676|NCT00129116|448139101|FG003|Primary Phase|Lost to Follow-up|1|||
124595677|NCT00129116|448139102|FG004|Primary Phase|Lost to Follow-up|1|||
124595678|NCT00129116|448139098|FG000|Primary Phase|Protocol Violation|0|||
124595679|NCT00129116|448139099|FG001|Primary Phase|Protocol Violation|1|||
124595680|NCT00129116|448139100|FG002|Primary Phase|Protocol Violation|0|||
124595681|NCT00129116|448139101|FG003|Primary Phase|Protocol Violation|0|||
124595682|NCT00129116|448139102|FG004|Primary Phase|Protocol Violation|0|||
124595683|NCT00129116|448139098|FG000|Primary Phase|Adverse Event|1|||
124595684|NCT00129116|448139099|FG001|Primary Phase|Adverse Event|1|||
124595685|NCT00129116|448139100|FG002|Primary Phase|Adverse Event|0|||
124595686|NCT00129116|448139101|FG003|Primary Phase|Adverse Event|0|||
124595687|NCT00129116|448139102|FG004|Primary Phase|Adverse Event|0|||
124595688|NCT00129116|448139098|FG000|Primary Phase|Withdrawal by Subject|0|||
124595689|NCT00129116|448139099|FG001|Primary Phase|Withdrawal by Subject|1|||
124595690|NCT00129116|448139100|FG002|Primary Phase|Withdrawal by Subject|0|||
124595691|NCT00129116|448139101|FG003|Primary Phase|Withdrawal by Subject|0|||
124595692|NCT00129116|448139102|FG004|Primary Phase|Withdrawal by Subject|0|||
124595693|NCT00129116|448139098|FG000|Primary Phase|Other|0|||
124595694|NCT00129116|448139099|FG001|Primary Phase|Other|0|||
124595695|NCT00129116|448139100|FG002|Primary Phase|Other|1|||
124595696|NCT00129116|448139101|FG003|Primary Phase|Other|0|||
124595697|NCT00129116|448139102|FG004|Primary Phase|Other|0|||
124595698|NCT00129116|448139098|FG000|Booster Phase|Lost to Follow-up|2|||
124595699|NCT00129116|448139099|FG001|Booster Phase|Lost to Follow-up|0|||
124595700|NCT00129116|448139100|FG002|Booster Phase|Lost to Follow-up|0|||
124730714|NCT02210689|448635565|FG002|Overall Study|Lack of Efficacy|5|||
124730715|NCT02210689|448635563|FG000|Overall Study|Prohibited medication|2|||
124730716|NCT02210689|448635564|FG001|Overall Study|Prohibited medication|8|||
124730717|NCT02210689|448635565|FG002|Overall Study|Prohibited medication|1|||
124730718|NCT02210689|448635563|FG000|Overall Study|Negative Nugent score at baseline|6|||
124730719|NCT02210689|448635564|FG001|Overall Study|Negative Nugent score at baseline|2|||
124730720|NCT02210689|448635565|FG002|Overall Study|Negative Nugent score at baseline|2|||
124730721|NCT02210689|448635563|FG000|Overall Study|Other|25|||
124730722|NCT02210689|448635564|FG001|Overall Study|Other|21|||
124730723|NCT02210689|448635565|FG002|Overall Study|Other|8|||
124730724|NCT00223977|448635566|FG000|Overall Study|Adverse Event|7|||
124730725|NCT00223977|448635567|FG001|Overall Study|Adverse Event|10|||
124730726|NCT00223977|448635568|FG002|Overall Study|Adverse Event|0|||
124730727|NCT00223977|448635566|FG000|Overall Study|Protocol Violation|0|||
124730728|NCT00223977|448635567|FG001|Overall Study|Protocol Violation|0|||
124730729|NCT00223977|448635568|FG002|Overall Study|Protocol Violation|1|||
124730730|NCT00223977|448635566|FG000|Overall Study|Withdrawal by Subject|1|||
124730731|NCT00223977|448635567|FG001|Overall Study|Withdrawal by Subject|1|||
124730732|NCT00223977|448635568|FG002|Overall Study|Withdrawal by Subject|2|||
124730733|NCT00223977|448635566|FG000|Overall Study|Other|1|||
124730734|NCT00223977|448635567|FG001|Overall Study|Other|0|||
124730735|NCT00223977|448635568|FG002|Overall Study|Other|0|||
124730736|NCT03136497|448635569|FG000|Overall Study|Screen Failure|1|||
124730737|NCT03136497|448635570|FG001|Overall Study|Screen Failure|0|||
124730738|NCT03136497|448635571|FG002|Overall Study|Screen Failure|0|||
124730739|NCT00557310|448635574|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
124730740|NCT00557310|448635574|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
124730741|NCT00557310|448635574|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
124730742|NCT00557310|448635574|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
124730743|NCT00557310|448635574|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
124730744|NCT00557310|448635574|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
124730745|NCT00367744|448635577|FG000|Overall Study|Lost to Follow-up|4|||
124730746|NCT00367744|448635578|FG001|Overall Study|Lost to Follow-up|5|||
124730747|NCT01271712|448635581|FG000|Double Blind Treatment|Death|2|||
124730748|NCT01271712|448635582|FG001|Double Blind Treatment|Death|0|||
124730749|NCT01271712|448635581|FG000|Double Blind Treatment|Lack of Efficacy|1|||
124730750|NCT01271712|448635582|FG001|Double Blind Treatment|Lack of Efficacy|0|||
124730751|NCT01271712|448635581|FG000|Double Blind Treatment|Adverse Event|9|||
124730752|NCT01271712|448635582|FG001|Double Blind Treatment|Adverse Event|4|||
124730753|NCT01271712|448635581|FG000|Double Blind Treatment|Progressive disease|23|||
124730754|NCT01271712|448635582|FG001|Double Blind Treatment|Progressive disease|3|||
124730755|NCT01271712|448635581|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
124730756|NCT01271712|448635582|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
124595701|NCT00129116|448139101|FG003|Booster Phase|Lost to Follow-up|0|||
124595702|NCT00129116|448139102|FG004|Booster Phase|Lost to Follow-up|1|||
124595703|NCT00271024|448139103|FG000|Overall Study|Lost Interest|3|||
124595704|NCT00271024|448139104|FG001|Overall Study|Lost Interest|4|||
124595705|NCT00271024|448139105|FG002|Overall Study|Lost Interest|2|||
124595706|NCT00271024|448139106|FG003|Overall Study|Lost Interest|3|||
124595707|NCT00271024|448139103|FG000|Overall Study|Unknown/Unspecified|11|||
124779466|NCT03904693|448821423|FG001|Overall Study|Death|0|||
124779467|NCT03904693|448821424|FG002|Overall Study|Death|3|||
124779468|NCT03904693|448821422|FG000|Overall Study|Physician Decision|0|||
124779469|NCT03904693|448821423|FG001|Overall Study|Physician Decision|0|||
124779470|NCT03904693|448821424|FG002|Overall Study|Physician Decision|2|||
124779471|NCT03904693|448821422|FG000|Overall Study|Withdrawal by Subject|0|||
124779472|NCT03904693|448821423|FG001|Overall Study|Withdrawal by Subject|1|||
124779473|NCT03904693|448821424|FG002|Overall Study|Withdrawal by Subject|4|||
124779474|NCT00068419|448821425|FG000|Overall Study|Adverse Event|3|||
124779475|NCT00068419|448821425|FG000|Overall Study|Lack of Efficacy|24|||
124779476|NCT00068419|448821425|FG000|Overall Study|Lost to Follow-up|1|||
124779477|NCT00068419|448821425|FG000|Overall Study|Physician Decision|7|||
124779478|NCT00068419|448821425|FG000|Overall Study|Withdrawal by Subject|14|||
124779479|NCT00068419|448821425|FG000|Overall Study|Ineligible|11|||
124779480|NCT01160822|448821432|FG000|Overall Study|Adverse Event|0|||
124779481|NCT01160822|448821433|FG001|Overall Study|Adverse Event|0|||
124779482|NCT01160822|448821434|FG002|Overall Study|Adverse Event|0|||
124779483|NCT01160822|448821435|FG003|Overall Study|Adverse Event|0|||
124779484|NCT01160822|448821436|FG004|Overall Study|Adverse Event|1|||
124779485|NCT01160822|448821437|FG005|Overall Study|Adverse Event|2|||
124779486|NCT01160822|448821438|FG006|Overall Study|Adverse Event|5|||
124779487|NCT01160822|448821432|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124779488|NCT01160822|448821433|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124779489|NCT01160822|448821434|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
124779490|NCT01160822|448821435|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
124779491|NCT01160822|448821436|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
124779492|NCT01160822|448821437|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
124779493|NCT01160822|448821438|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
124779494|NCT01160822|448821432|FG000|Overall Study|Withdrawal by Subject|0|||
124779495|NCT01160822|448821433|FG001|Overall Study|Withdrawal by Subject|0|||
124779496|NCT01160822|448821434|FG002|Overall Study|Withdrawal by Subject|0|||
124779497|NCT01160822|448821435|FG003|Overall Study|Withdrawal by Subject|0|||
124779498|NCT01160822|448821436|FG004|Overall Study|Withdrawal by Subject|0|||
124779499|NCT01160822|448821437|FG005|Overall Study|Withdrawal by Subject|0|||
124779500|NCT01160822|448821438|FG006|Overall Study|Withdrawal by Subject|1|||
124779501|NCT01160822|448821432|FG000|Overall Study|Lost to Follow-up|0|||
124779502|NCT01160822|448821433|FG001|Overall Study|Lost to Follow-up|0|||
124779503|NCT01160822|448821434|FG002|Overall Study|Lost to Follow-up|0|||
124779504|NCT01160822|448821435|FG003|Overall Study|Lost to Follow-up|0|||
124779505|NCT01160822|448821436|FG004|Overall Study|Lost to Follow-up|1|||
124779506|NCT01160822|448821437|FG005|Overall Study|Lost to Follow-up|0|||
124779507|NCT01160822|448821438|FG006|Overall Study|Lost to Follow-up|0|||
124779508|NCT01160822|448821432|FG000|Overall Study|Administrative problems|0|||
124595708|NCT00271024|448139104|FG001|Overall Study|Unknown/Unspecified|11|||
124595709|NCT00271024|448139105|FG002|Overall Study|Unknown/Unspecified|8|||
124595710|NCT00271024|448139106|FG003|Overall Study|Unknown/Unspecified|4|||
124595711|NCT00271024|448139103|FG000|Overall Study|Protocol Violation|1|||
124595712|NCT00271024|448139104|FG001|Overall Study|Protocol Violation|6|||
124595713|NCT00271024|448139105|FG002|Overall Study|Protocol Violation|5|||
124595714|NCT00271024|448139106|FG003|Overall Study|Protocol Violation|11|||
124595715|NCT00271024|448139103|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
124595716|NCT00271024|448139104|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
124595717|NCT00271024|448139105|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
124595718|NCT00271024|448139106|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
124595719|NCT00271024|448139103|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
124595720|NCT00271024|448139104|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
124595721|NCT00271024|448139105|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
124595722|NCT00271024|448139106|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
124595723|NCT00388037|448139107|FG000|Overall Study|Protocol Violation|1|||
124595724|NCT00602537|448139110|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
124595725|NCT00602537|448139111|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
124595726|NCT00602537|448139110|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
124595727|NCT00602537|448139111|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
124595728|NCT00602537|448139110|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
124779509|NCT01160822|448821433|FG001|Overall Study|Administrative problems|0|||
124779510|NCT01160822|448821434|FG002|Overall Study|Administrative problems|0|||
124779511|NCT01160822|448821435|FG003|Overall Study|Administrative problems|0|||
124779512|NCT01160822|448821436|FG004|Overall Study|Administrative problems|1|||
124779513|NCT01160822|448821437|FG005|Overall Study|Administrative problems|0|||
124595729|NCT00602537|448139111|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
124595730|NCT00602537|448139110|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
124595731|NCT00602537|448139111|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
124595732|NCT00602537|448139110|FG000|Follow Up Study Comparison|Adverse Event|1|||
124779514|NCT01160822|448821438|FG006|Overall Study|Administrative problems|0|||
124779515|NCT01160822|448821432|FG000|Overall Study|Protocol deviation|0|||
124779516|NCT01160822|448821433|FG001|Overall Study|Protocol deviation|0|||
124779517|NCT01160822|448821434|FG002|Overall Study|Protocol deviation|0|||
124595733|NCT00602537|448139111|FG001|Follow Up Study Comparison|Adverse Event|0|||
124595734|NCT00602537|448139110|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
124595735|NCT00602537|448139111|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
124595736|NCT00602537|448139110|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
124595737|NCT00602537|448139111|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
124595738|NCT02539368|448139112|FG000|Overall Study|Death|4|||
124595739|NCT02539368|448139113|FG001|Overall Study|Death|2|||
124595740|NCT02539368|448139114|FG002|Overall Study|Death|1|||
124595741|NCT02539368|448139115|FG003|Overall Study|Death|0|||
124595742|NCT02539368|448139116|FG004|Overall Study|Death|0|||
124595743|NCT02539368|448139112|FG000|Overall Study|Withdrawal by Subject|44|||
124595744|NCT02539368|448139113|FG001|Overall Study|Withdrawal by Subject|35|||
124595745|NCT02539368|448139114|FG002|Overall Study|Withdrawal by Subject|9|||
124595746|NCT02539368|448139115|FG003|Overall Study|Withdrawal by Subject|1|||
124595747|NCT02539368|448139116|FG004|Overall Study|Withdrawal by Subject|3|||
124595748|NCT02539368|448139112|FG000|Overall Study|Physician Decision|49|||
124595749|NCT02539368|448139113|FG001|Overall Study|Physician Decision|15|||
124595750|NCT02539368|448139114|FG002|Overall Study|Physician Decision|7|||
124595751|NCT02539368|448139115|FG003|Overall Study|Physician Decision|0|||
124595752|NCT02539368|448139116|FG004|Overall Study|Physician Decision|2|||
124595753|NCT02539368|448139112|FG000|Overall Study|Lost to Follow-up|96|||
124595754|NCT02539368|448139113|FG001|Overall Study|Lost to Follow-up|21|||
124595755|NCT02539368|448139114|FG002|Overall Study|Lost to Follow-up|16|||
124595756|NCT02539368|448139115|FG003|Overall Study|Lost to Follow-up|4|||
124595757|NCT02539368|448139116|FG004|Overall Study|Lost to Follow-up|3|||
124595758|NCT02539368|448139112|FG000|Overall Study|Adverse Event|44|||
124595759|NCT02539368|448139113|FG001|Overall Study|Adverse Event|5|||
124595760|NCT02539368|448139114|FG002|Overall Study|Adverse Event|9|||
124595761|NCT02539368|448139115|FG003|Overall Study|Adverse Event|0|||
124595762|NCT02539368|448139116|FG004|Overall Study|Adverse Event|3|||
124595763|NCT02539368|448139112|FG000|Overall Study|Participant Non-compliant|13|||
124595764|NCT02539368|448139113|FG001|Overall Study|Participant Non-compliant|2|||
124595765|NCT02539368|448139114|FG002|Overall Study|Participant Non-compliant|1|||
124595766|NCT02539368|448139115|FG003|Overall Study|Participant Non-compliant|1|||
124595767|NCT02539368|448139116|FG004|Overall Study|Participant Non-compliant|0|||
124595768|NCT02539368|448139112|FG000|Overall Study|Other|145|||
124595769|NCT02539368|448139113|FG001|Overall Study|Other|18|||
124595770|NCT02539368|448139114|FG002|Overall Study|Other|24|||
124595771|NCT02539368|448139115|FG003|Overall Study|Other|1|||
124595772|NCT02539368|448139116|FG004|Overall Study|Other|3|||
124595773|NCT02539368|448139112|FG000|Overall Study|Missing|10|||
124595774|NCT02539368|448139113|FG001|Overall Study|Missing|3|||
124595775|NCT02539368|448139114|FG002|Overall Study|Missing|0|||
124595776|NCT02539368|448139115|FG003|Overall Study|Missing|0|||
124595777|NCT02539368|448139116|FG004|Overall Study|Missing|0|||
124595778|NCT02752802|448139118|FG000|Overall Study|Contrast Volume Not Collected|1|||
124595779|NCT02752802|448139119|FG001|Overall Study|Contrast Volume Not Collected|0|||
124595780|NCT00612677|448139122|FG000|Overall Study|study closed before treatment started|1|||
124595781|NCT00268892|448139125|FG000|Overall Study|Adverse Event|14|||
124595782|NCT00268892|448139126|FG001|Overall Study|Adverse Event|17|||
124595783|NCT00268892|448139127|FG002|Overall Study|Adverse Event|20|||
124595784|NCT00268892|448139125|FG000|Overall Study|Lack of Efficacy|1|||
124595785|NCT00268892|448139126|FG001|Overall Study|Lack of Efficacy|3|||
124595786|NCT00268892|448139127|FG002|Overall Study|Lack of Efficacy|0|||
124595787|NCT00268892|448139125|FG000|Overall Study|Withdrawal by Subject|14|||
124595788|NCT00268892|448139126|FG001|Overall Study|Withdrawal by Subject|15|||
124595789|NCT00268892|448139127|FG002|Overall Study|Withdrawal by Subject|13|||
124595790|NCT00268892|448139125|FG000|Overall Study|Physician Decision|0|||
124595791|NCT00268892|448139126|FG001|Overall Study|Physician Decision|1|||
124595792|NCT00268892|448139127|FG002|Overall Study|Physician Decision|0|||
124595793|NCT00268892|448139125|FG000|Overall Study|Lost to Follow-up|5|||
124595794|NCT00268892|448139126|FG001|Overall Study|Lost to Follow-up|2|||
124595795|NCT00268892|448139127|FG002|Overall Study|Lost to Follow-up|4|||
124595796|NCT00268892|448139125|FG000|Overall Study|Protocol Violation|0|||
124595797|NCT00268892|448139126|FG001|Overall Study|Protocol Violation|1|||
124730757|NCT01271712|448635581|FG000|Double Blind Treatment|Non compliance with study drug|2|||
124595798|NCT00268892|448139127|FG002|Overall Study|Protocol Violation|0|||
124595799|NCT00268892|448139125|FG000|Overall Study|Disease Progression|1|||
124595800|NCT00268892|448139126|FG001|Overall Study|Disease Progression|1|||
124595801|NCT00268892|448139127|FG002|Overall Study|Disease Progression|0|||
124595802|NCT00268892|448139125|FG000|Overall Study|Trial Site Closed|4|||
124595803|NCT00268892|448139126|FG001|Overall Study|Trial Site Closed|2|||
124595804|NCT00268892|448139127|FG002|Overall Study|Trial Site Closed|2|||
124595805|NCT01640184|448139134|FG000|Overall Study|Death|1|||
124595806|NCT01640184|448139135|FG001|Overall Study|Death|0|||
124595807|NCT01640184|448139136|FG002|Overall Study|Death|0|||
124595808|NCT01640184|448139134|FG000|Overall Study|Lost to Follow-up|4|||
124595809|NCT01640184|448139135|FG001|Overall Study|Lost to Follow-up|1|||
124595810|NCT01640184|448139136|FG002|Overall Study|Lost to Follow-up|0|||
124595811|NCT01640184|448139134|FG000|Overall Study|Physician Decision|3|||
124595812|NCT01640184|448139135|FG001|Overall Study|Physician Decision|0|||
124595813|NCT01640184|448139136|FG002|Overall Study|Physician Decision|0|||
124595814|NCT01640184|448139134|FG000|Overall Study|Withdrawal by Subject|0|||
124595815|NCT01640184|448139135|FG001|Overall Study|Withdrawal by Subject|1|||
124595816|NCT01640184|448139136|FG002|Overall Study|Withdrawal by Subject|1|||
124595817|NCT01640184|448139134|FG000|Overall Study|Protocol Violation|0|||
124595818|NCT01640184|448139135|FG001|Overall Study|Protocol Violation|0|||
124595819|NCT01640184|448139136|FG002|Overall Study|Protocol Violation|1|||
124595820|NCT02927834|448139137|FG000|Overall Study|Lost to Follow-up|1|||
124595821|NCT02927834|448139138|FG001|Overall Study|Lost to Follow-up|2|||
124595822|NCT02927834|448139139|FG002|Overall Study|Lost to Follow-up|2|||
124595823|NCT00479388|448139140|FG000|Overall Study|Adverse Event|90|||
124595824|NCT00479388|448139141|FG001|Overall Study|Adverse Event|45|||
124595825|NCT00479388|448139140|FG000|Overall Study|Lost to Follow-up|0|||
124595826|NCT00479388|448139141|FG001|Overall Study|Lost to Follow-up|2|||
124595827|NCT00479388|448139140|FG000|Overall Study|Protocol Violation|10|||
124595828|NCT00479388|448139141|FG001|Overall Study|Protocol Violation|9|||
124595829|NCT00479388|448139140|FG000|Overall Study|Withdrawal by Subject|32|||
124595830|NCT00479388|448139141|FG001|Overall Study|Withdrawal by Subject|17|||
124595831|NCT01876368|448139144|FG000|Overall Study|Adverse Event|2|||
124595832|NCT01876368|448139145|FG001|Overall Study|Adverse Event|5|||
124595833|NCT01876368|448139144|FG000|Overall Study|Lack of Efficacy|1|||
124595834|NCT01876368|448139145|FG001|Overall Study|Lack of Efficacy|0|||
124595835|NCT01876368|448139144|FG000|Overall Study|Lost to Follow-up|0|||
124595836|NCT01876368|448139145|FG001|Overall Study|Lost to Follow-up|1|||
124595837|NCT01876368|448139144|FG000|Overall Study|Non-compliance with study treatment|0|||
124595838|NCT01876368|448139145|FG001|Overall Study|Non-compliance with study treatment|1|||
124595839|NCT01876368|448139144|FG000|Overall Study|Physician Decision|0|||
124595840|NCT01876368|448139145|FG001|Overall Study|Physician Decision|2|||
124595841|NCT01876368|448139144|FG000|Overall Study|Protocol deviation|3|||
124595842|NCT01876368|448139145|FG001|Overall Study|Protocol deviation|3|||
124595843|NCT01876368|448139144|FG000|Overall Study|Subject/guardian decision|3|||
124595844|NCT01876368|448139145|FG001|Overall Study|Subject/guardian decision|1|||
124595845|NCT01955044|448139146|FG000|Overall Study|Death|1|||
124595846|NCT01955044|448139147|FG001|Overall Study|Death|1|||
124595847|NCT01955044|448139148|FG002|Overall Study|Death|0|||
124595848|NCT02260258|448139149|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
124595849|NCT02260258|448139150|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
124595850|NCT01644149|448139151|FG000|Overall Study|Withdrawal by Subject|1|||
124595851|NCT01644149|448139152|FG001|Overall Study|Withdrawal by Subject|0|||
124595852|NCT01644149|448139151|FG000|Overall Study|Lost to Follow-up|3|||
124595853|NCT01644149|448139152|FG001|Overall Study|Lost to Follow-up|1|||
124595854|NCT01610063|448139155|FG000|Overall Study|Lost to Follow-up|42|||
124595855|NCT01610063|448139156|FG001|Overall Study|Lost to Follow-up|20|||
124595856|NCT04405739|448139157|FG000|Overall Study|Adverse Event|0|||
124595857|NCT04405739|448139158|FG001|Overall Study|Adverse Event|1|||
124595858|NCT04405739|448139159|FG002|Overall Study|Adverse Event|0|||
124595859|NCT04405739|448139160|FG003|Overall Study|Adverse Event|0|||
124595860|NCT04405739|448139157|FG000|Overall Study|Lost to Follow-up|0|||
124595861|NCT04405739|448139158|FG001|Overall Study|Lost to Follow-up|2|||
124595862|NCT04405739|448139159|FG002|Overall Study|Lost to Follow-up|1|||
124595863|NCT04405739|448139160|FG003|Overall Study|Lost to Follow-up|3|||
124595864|NCT04405739|448139157|FG000|Overall Study|Withdrawal by Subject|0|||
124595865|NCT04405739|448139158|FG001|Overall Study|Withdrawal by Subject|2|||
124595866|NCT04405739|448139159|FG002|Overall Study|Withdrawal by Subject|1|||
124595867|NCT04405739|448139160|FG003|Overall Study|Withdrawal by Subject|1|||
124595868|NCT04405739|448139157|FG000|Overall Study|Death|0|||
124595869|NCT04405739|448139158|FG001|Overall Study|Death|0|||
124595870|NCT04405739|448139159|FG002|Overall Study|Death|1|||
124730758|NCT01271712|448635582|FG001|Double Blind Treatment|Non compliance with study drug|0|||
124730759|NCT01271712|448635581|FG000|Double Blind Treatment|receive no study drug|1|||
124595871|NCT04405739|448139160|FG003|Overall Study|Death|0|||
124730760|NCT01271712|448635582|FG001|Double Blind Treatment|receive no study drug|0|||
124730761|NCT01271712|448635581|FG000|Open Label Treatment|Death|6|||
124595872|NCT04405739|448139157|FG000|Overall Study|Transferred to rehab|0|||
124595873|NCT04405739|448139158|FG001|Overall Study|Transferred to rehab|0|||
124595874|NCT04405739|448139159|FG002|Overall Study|Transferred to rehab|0|||
124595875|NCT04405739|448139160|FG003|Overall Study|Transferred to rehab|1|||
124595876|NCT04405739|448139157|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
124595877|NCT04405739|448139158|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
124595878|NCT04405739|448139159|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
124595879|NCT04405739|448139160|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
124595880|NCT01436643|448139161|FG000|2-week Pre-treatment|Abnormal test result|0|||
124595881|NCT01436643|448139162|FG001|2-week Pre-treatment|Abnormal test result|0|||
124595882|NCT01436643|448139163|FG002|2-week Pre-treatment|Abnormal test result|0|||
124595883|NCT01436643|448139164|FG003|2-week Pre-treatment|Abnormal test result|1|||
124595884|NCT01436643|448139161|FG000|2-week Pre-treatment|Adverse Event|0|||
124595885|NCT01436643|448139162|FG001|2-week Pre-treatment|Adverse Event|0|||
124595886|NCT01436643|448139163|FG002|2-week Pre-treatment|Adverse Event|0|||
124595887|NCT01436643|448139164|FG003|2-week Pre-treatment|Adverse Event|5|||
124595888|NCT01436643|448139161|FG000|2-week Pre-treatment|Protocol Violation|0|||
124595889|NCT01436643|448139162|FG001|2-week Pre-treatment|Protocol Violation|0|||
124595890|NCT01436643|448139163|FG002|2-week Pre-treatment|Protocol Violation|0|||
124595891|NCT01436643|448139164|FG003|2-week Pre-treatment|Protocol Violation|4|||
124595892|NCT01436643|448139161|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
124595893|NCT01436643|448139162|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
124595894|NCT01436643|448139163|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
124595895|NCT01436643|448139164|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
124595896|NCT01436643|448139161|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
124595897|NCT01436643|448139162|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
124595898|NCT01436643|448139163|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
124595899|NCT01436643|448139164|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
124595900|NCT01436643|448139161|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
124595901|NCT01436643|448139162|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
124595902|NCT01436643|448139163|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
124595903|NCT01436643|448139164|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
124595904|NCT03718117|448139165|FG000|Overall Study|Death|12|||
124595905|NCT03718117|448139166|FG001|Overall Study|Death|11|||
124595906|NCT03718117|448139167|FG002|Overall Study|Death|0|||
124595907|NCT03718117|448139165|FG000|Overall Study|Other|0|||
124595908|NCT03718117|448139166|FG001|Overall Study|Other|1|||
124595909|NCT03718117|448139167|FG002|Overall Study|Other|0|||
124595910|NCT03718117|448139165|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
124595911|NCT03718117|448139166|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
124595912|NCT03718117|448139167|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
124595913|NCT03718117|448139165|FG000|Overall Study|Participant not met eligibility criteria|0|||
124595914|NCT03718117|448139166|FG001|Overall Study|Participant not met eligibility criteria|0|||
124595915|NCT03718117|448139167|FG002|Overall Study|Participant not met eligibility criteria|2|||
124595916|NCT03069417|448139168|FG000|Overall Study|Lost to Follow-up|2|||
124595917|NCT03069417|448139169|FG001|Overall Study|Lost to Follow-up|0|||
124595918|NCT03069417|448139168|FG000|Overall Study|Reason Unknown|4|||
124595919|NCT03069417|448139169|FG001|Overall Study|Reason Unknown|7|||
124595920|NCT01867606|448139170|FG000|Overall Study|Withdrawal by Subject|10|||
124595921|NCT01867606|448139171|FG001|Overall Study|Withdrawal by Subject|14|||
124595922|NCT01867606|448139170|FG000|Overall Study|Protocol Violation|0|||
124595923|NCT01867606|448139171|FG001|Overall Study|Protocol Violation|1|||
124595924|NCT00402025|448139177|FG000|Overall Study|Adverse Event|0|||
124595925|NCT00402025|448139178|FG001|Overall Study|Adverse Event|0|||
124595926|NCT00402025|448139179|FG002|Overall Study|Adverse Event|2|||
124595927|NCT00402025|448139177|FG000|Overall Study|Death|0|||
124595928|NCT00402025|448139178|FG001|Overall Study|Death|1|||
124595929|NCT00402025|448139179|FG002|Overall Study|Death|5|||
124595930|NCT00402025|448139177|FG000|Overall Study|Disease Progression|1|||
124595931|NCT00402025|448139178|FG001|Overall Study|Disease Progression|1|||
124595932|NCT00402025|448139179|FG002|Overall Study|Disease Progression|2|||
124595933|NCT00402025|448139177|FG000|Overall Study|Physician Decision|1|||
124595934|NCT00402025|448139178|FG001|Overall Study|Physician Decision|1|||
124595935|NCT00402025|448139179|FG002|Overall Study|Physician Decision|0|||
124595936|NCT00402025|448139177|FG000|Overall Study|Participant Decision|0|||
124595937|NCT00402025|448139178|FG001|Overall Study|Participant Decision|0|||
124595938|NCT00402025|448139179|FG002|Overall Study|Participant Decision|1|||
124595939|NCT02105701|448139185|FG000|Overall Study|Lost to Follow-up|1|||
124595940|NCT02105701|448139186|FG001|Overall Study|Lost to Follow-up|0|||
124595941|NCT02105701|448139187|FG002|Overall Study|Lost to Follow-up|2|||
124595942|NCT02105701|448139188|FG003|Overall Study|Lost to Follow-up|1|||
124595943|NCT02105701|448139185|FG000|Overall Study|Protocol Violation|0|||
124595944|NCT02105701|448139186|FG001|Overall Study|Protocol Violation|0|||
124595945|NCT02105701|448139187|FG002|Overall Study|Protocol Violation|1|||
124730762|NCT01271712|448635582|FG001|Open Label Treatment|Death|5|||
124730763|NCT01271712|448635581|FG000|Open Label Treatment|Withdrawal by Subject|6|||
124730764|NCT01271712|448635582|FG001|Open Label Treatment|Withdrawal by Subject|11|||
124730765|NCT01271712|448635581|FG000|Open Label Treatment|Physician Decision|2|||
124595946|NCT02105701|448139188|FG003|Overall Study|Protocol Violation|0|||
124595947|NCT02105701|448139185|FG000|Overall Study|Withdrawal by Subject|2|||
124595948|NCT02105701|448139186|FG001|Overall Study|Withdrawal by Subject|1|||
124595949|NCT02105701|448139187|FG002|Overall Study|Withdrawal by Subject|0|||
124595950|NCT02105701|448139188|FG003|Overall Study|Withdrawal by Subject|1|||
124595951|NCT02105701|448139185|FG000|Overall Study|Death|1|||
124595952|NCT02105701|448139186|FG001|Overall Study|Death|0|||
124595953|NCT02105701|448139187|FG002|Overall Study|Death|0|||
124595954|NCT02105701|448139188|FG003|Overall Study|Death|0|||
124595955|NCT03234608|448139189|FG000|Overall Study|Lost to Follow-up|23|||
124730766|NCT01271712|448635582|FG001|Open Label Treatment|Physician Decision|0|||
124595956|NCT03234608|448139190|FG001|Overall Study|Lost to Follow-up|21|||
124595957|NCT02148445|448139191|FG000|Overall Study|Death|1|||
124595958|NCT02148445|448139192|FG001|Overall Study|Death|3|||
124595959|NCT03450629|448139193|FG000|Overall Study|Adverse Event|15|||
124595960|NCT03450629|448139194|FG001|Overall Study|Adverse Event|14|||
124595961|NCT03450629|448139193|FG000|Overall Study|Physician Decision|2|||
124595962|NCT03450629|448139194|FG001|Overall Study|Physician Decision|2|||
124595963|NCT03450629|448139193|FG000|Overall Study|Lack of Efficacy|2|||
124595964|NCT03450629|448139194|FG001|Overall Study|Lack of Efficacy|0|||
124595965|NCT03450629|448139193|FG000|Overall Study|Lost to Follow-up|4|||
124595966|NCT03450629|448139194|FG001|Overall Study|Lost to Follow-up|2|||
124595967|NCT03450629|448139193|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
124595968|NCT03450629|448139194|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
124595969|NCT03450629|448139193|FG000|Overall Study|Non-Compliance With Study Drug|2|||
124595970|NCT03450629|448139194|FG001|Overall Study|Non-Compliance With Study Drug|1|||
124595971|NCT03450629|448139193|FG000|Overall Study|Protocol Violation|11|||
124595972|NCT03450629|448139194|FG001|Overall Study|Protocol Violation|8|||
124595973|NCT03450629|448139193|FG000|Overall Study|Withdrawal by Subject|12|||
124595974|NCT03450629|448139194|FG001|Overall Study|Withdrawal by Subject|6|||
124595975|NCT04230876|448139195|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
124595976|NCT04230876|448139196|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
124595977|NCT00739973|448139198|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
124595978|NCT00739973|448139199|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
124595979|NCT00739973|448139200|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
124595980|NCT00739973|448139201|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
124595981|NCT00739973|448139202|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
124595982|NCT00739973|448139203|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
124595983|NCT00739973|448139204|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
124595984|NCT00739973|448139205|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
124595985|NCT00739973|448139206|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
124595986|NCT00739973|448139198|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
124595987|NCT00739973|448139199|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
124595988|NCT00739973|448139200|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
124595989|NCT00739973|448139201|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
124595990|NCT00739973|448139202|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
124595991|NCT00739973|448139203|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
124595992|NCT00739973|448139204|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
124595993|NCT00739973|448139205|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
124595994|NCT00739973|448139206|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
124595995|NCT00739973|448139198|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
124595996|NCT00739973|448139199|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
124595997|NCT00739973|448139200|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
124595998|NCT00739973|448139201|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
124595999|NCT00739973|448139202|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
124596000|NCT00739973|448139203|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
124596001|NCT00739973|448139204|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
124596002|NCT00739973|448139205|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
124596003|NCT00739973|448139206|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
124596004|NCT00739973|448139198|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
124596005|NCT00739973|448139199|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
124596006|NCT00739973|448139200|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
124596007|NCT00739973|448139201|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
124596008|NCT00739973|448139202|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
124596009|NCT00739973|448139203|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
124596010|NCT00739973|448139204|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
124596011|NCT00739973|448139205|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
124596012|NCT00739973|448139206|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
124596013|NCT00739973|448139198|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
124596014|NCT00739973|448139199|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
124596015|NCT00739973|448139200|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
124596016|NCT00739973|448139201|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
124596017|NCT00739973|448139202|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
124596018|NCT00739973|448139203|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
124596019|NCT00739973|448139204|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
124596020|NCT00739973|448139205|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
124596021|NCT00739973|448139206|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
124596022|NCT00739973|448139198|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
124596023|NCT00739973|448139199|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
124779518|NCT01160822|448821435|FG003|Overall Study|Protocol deviation|0|||
124779519|NCT01160822|448821436|FG004|Overall Study|Protocol deviation|2|||
124779520|NCT01160822|448821437|FG005|Overall Study|Protocol deviation|0|||
124779521|NCT01160822|448821438|FG006|Overall Study|Protocol deviation|0|||
124779522|NCT04717336|448821441|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
124779523|NCT04717336|448821442|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
124779524|NCT04717336|448821441|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
124779525|NCT04717336|448821442|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
124779526|NCT01500720|448821443|FG000|Overall Study|Randomized But Not Treated|1|||
124779527|NCT01500720|448821444|FG001|Overall Study|Randomized But Not Treated|1|||
124779528|NCT01500720|448821443|FG000|Overall Study|Other|4|||
124779529|NCT01500720|448821444|FG001|Overall Study|Other|8|||
124779530|NCT02624986|448821445|FG000|Overall Study|Death|0|||
124779531|NCT02624986|448821446|FG001|Overall Study|Death|1|||
124779532|NCT02624986|448821447|FG002|Overall Study|Death|2|||
124779533|NCT02624986|448821448|FG003|Overall Study|Death|2|||
124779534|NCT02624986|448821449|FG004|Overall Study|Death|2|||
124596024|NCT00739973|448139200|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
124596025|NCT00739973|448139201|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
124596026|NCT00739973|448139202|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
124596027|NCT00739973|448139203|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
124596028|NCT00739973|448139204|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
124596029|NCT00739973|448139205|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
124596030|NCT00739973|448139206|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
124596031|NCT00739973|448139198|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
124596032|NCT00739973|448139199|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
124596033|NCT00739973|448139200|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
124596034|NCT00739973|448139201|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
124596035|NCT00739973|448139202|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
124596036|NCT00739973|448139203|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
124596037|NCT00739973|448139204|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
124596038|NCT00739973|448139205|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
124596039|NCT00739973|448139206|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
124596040|NCT00739973|448139198|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
124596041|NCT00739973|448139199|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
124596042|NCT00739973|448139200|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
124596043|NCT00739973|448139201|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
124596044|NCT00739973|448139202|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
124596045|NCT00739973|448139203|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
124596046|NCT00739973|448139204|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
124596047|NCT00739973|448139205|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
124596048|NCT00739973|448139206|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
124596049|NCT00739973|448139198|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
124596050|NCT00739973|448139199|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
124596051|NCT00739973|448139200|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
124596052|NCT00739973|448139201|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
124596053|NCT00739973|448139202|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
124596054|NCT00739973|448139203|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
124596055|NCT00739973|448139204|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
124596056|NCT00739973|448139205|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
124596057|NCT00739973|448139206|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
124596058|NCT00739973|448139198|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
124596059|NCT00739973|448139199|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
124596060|NCT00739973|448139200|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
124596061|NCT00739973|448139201|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
124596062|NCT00739973|448139202|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
124596063|NCT00739973|448139203|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
124596064|NCT00739973|448139204|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
124596065|NCT00739973|448139205|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
124596066|NCT00739973|448139206|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
124596067|NCT00739973|448139198|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
124596068|NCT00739973|448139199|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
124779535|NCT02624986|448821450|FG005|Overall Study|Death|0|||
124779536|NCT02624986|448821451|FG006|Overall Study|Death|0|||
124779537|NCT02624986|448821452|FG007|Overall Study|Death|1|||
124779538|NCT02624986|448821445|FG000|Overall Study|Study Terminated by Sponsor|1|||
124596069|NCT00739973|448139200|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
124596070|NCT00739973|448139201|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
124596071|NCT00739973|448139202|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
124596072|NCT00739973|448139203|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
124596073|NCT00739973|448139204|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
124596074|NCT00739973|448139205|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
124596075|NCT00739973|448139206|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
124596076|NCT00739973|448139198|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
124596077|NCT00739973|448139199|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
124596078|NCT00739973|448139200|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
124596079|NCT00739973|448139201|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
124596080|NCT00739973|448139202|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
124596081|NCT00739973|448139203|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
124596082|NCT00739973|448139204|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
124596083|NCT00739973|448139205|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
124596084|NCT00739973|448139206|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
124596085|NCT00739973|448139198|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
124596086|NCT00739973|448139199|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
124596087|NCT00739973|448139200|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
124596088|NCT00739973|448139201|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
124596089|NCT00739973|448139202|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
124596090|NCT00739973|448139203|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
124596091|NCT00739973|448139204|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
124596092|NCT00739973|448139205|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
124596093|NCT00739973|448139206|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
124596094|NCT00739973|448139198|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
124596095|NCT00739973|448139199|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
124596096|NCT00739973|448139200|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
124596097|NCT00739973|448139201|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
124596098|NCT00739973|448139202|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
124596099|NCT00739973|448139203|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
124596100|NCT00739973|448139204|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
124596101|NCT00739973|448139205|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
124596102|NCT00739973|448139206|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
124596103|NCT00739973|448139198|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
124596104|NCT00739973|448139199|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
124596105|NCT00739973|448139200|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
124596106|NCT00739973|448139201|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
124596107|NCT00739973|448139202|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
124596108|NCT00739973|448139203|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
124596109|NCT00739973|448139204|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
124596110|NCT00739973|448139205|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
124596111|NCT00739973|448139206|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
124730767|NCT01271712|448635581|FG000|Open Label Treatment|Adverse Event|14|||
124730768|NCT01271712|448635582|FG001|Open Label Treatment|Adverse Event|8|||
124730769|NCT01271712|448635581|FG000|Open Label Treatment|Progressive disease|59|||
124730770|NCT01271712|448635582|FG001|Open Label Treatment|Progressive disease|32|||
124730771|NCT01271712|448635581|FG000|Open Label Treatment|transferred to rollover study|1|||
124730772|NCT01271712|448635582|FG001|Open Label Treatment|transferred to rollover study|0|||
124730773|NCT01271712|448635581|FG000|Open Label Treatment|Non-compliance with study drug|1|||
124730774|NCT01271712|448635582|FG001|Open Label Treatment|Non-compliance with study drug|0|||
124730775|NCT01271712|448635581|FG000|Open Label Treatment|Protocol Violation|0|||
124730776|NCT01271712|448635582|FG001|Open Label Treatment|Protocol Violation|1|||
124730777|NCT01271712|448635581|FG000|Open Label Treatment|Switching to other therapy|2|||
124730778|NCT01271712|448635582|FG001|Open Label Treatment|Switching to other therapy|1|||
124730779|NCT01271712|448635581|FG000|Safety Follow-up|Death|11|||
124730780|NCT01271712|448635582|FG001|Safety Follow-up|Death|7|||
124730781|NCT01271712|448635581|FG000|Safety Follow-up|Withdrawal by Subject|4|||
124730782|NCT01271712|448635582|FG001|Safety Follow-up|Withdrawal by Subject|2|||
124730783|NCT01271712|448635581|FG000|Safety Follow-up|Protocol Violation|1|||
124730784|NCT01271712|448635582|FG001|Safety Follow-up|Protocol Violation|1|||
124730785|NCT01271712|448635581|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
124596112|NCT00739973|448139198|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
124596113|NCT00739973|448139199|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
124596114|NCT00739973|448139200|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
124596115|NCT00739973|448139201|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
124596116|NCT00739973|448139202|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
124596117|NCT00739973|448139203|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
124596118|NCT00739973|448139204|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
124596119|NCT00739973|448139205|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
124596120|NCT00739973|448139206|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
124596121|NCT00739973|448139198|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
124596122|NCT00739973|448139199|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
124596123|NCT00739973|448139200|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
124596124|NCT00739973|448139201|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
124596125|NCT00739973|448139202|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
124596126|NCT00739973|448139203|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
124596127|NCT00739973|448139204|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
124596128|NCT00739973|448139205|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
124596129|NCT00739973|448139206|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
124596130|NCT01662362|448139207|FG000|Overall Study|Lost to Follow-up|38|||
124596131|NCT01181531|448139208|FG000|Overall Study|Other|17|||
124596132|NCT01181531|448139209|FG001|Overall Study|Other|12|||
124596133|NCT01181531|448139208|FG000|Overall Study|Partial consent by subject withdrawn|0|||
124596134|NCT01181531|448139209|FG001|Overall Study|Partial consent by subject withdrawn|1|||
124596135|NCT01181531|448139208|FG000|Overall Study|Physician Decision|3|||
124596136|NCT01181531|448139209|FG001|Overall Study|Physician Decision|1|||
124596137|NCT01181531|448139208|FG000|Overall Study|Noncompliance|2|||
124596138|NCT01181531|448139209|FG001|Overall Study|Noncompliance|2|||
124596139|NCT01181531|448139208|FG000|Overall Study|Ineligibility determined|1|||
124596140|NCT01181531|448139209|FG001|Overall Study|Ineligibility determined|2|||
124596141|NCT01181531|448139208|FG000|Overall Study|Protocol Specified Criteria|15|||
124596142|NCT01181531|448139209|FG001|Overall Study|Protocol Specified Criteria|8|||
124596143|NCT01181531|448139208|FG000|Overall Study|Pregnancy|0|||
124596144|NCT01181531|448139209|FG001|Overall Study|Pregnancy|1|||
124596145|NCT01181531|448139208|FG000|Overall Study|Withdrawal by Subject|8|||
124596146|NCT01181531|448139209|FG001|Overall Study|Withdrawal by Subject|7|||
124596147|NCT01181531|448139208|FG000|Overall Study|Protocol Violation|6|||
124596148|NCT01181531|448139209|FG001|Overall Study|Protocol Violation|6|||
124596149|NCT01181531|448139208|FG000|Overall Study|Death|9|||
124596150|NCT01181531|448139209|FG001|Overall Study|Death|12|||
124596151|NCT01181531|448139208|FG000|Overall Study|Adverse Event|0|||
124596152|NCT01181531|448139209|FG001|Overall Study|Adverse Event|1|||
124596153|NCT00987831|448139210|FG000|Overall Study|Never flared in 12 months|1|||
124596154|NCT00987831|448139211|FG001|Overall Study|Never flared in 12 months|0|||
124596155|NCT00987831|448139212|FG002|Overall Study|Never flared in 12 months|0|||
124596156|NCT00987831|448139210|FG000|Overall Study|Lost to Follow-up|0|||
124596157|NCT00987831|448139211|FG001|Overall Study|Lost to Follow-up|3|||
124596158|NCT00987831|448139212|FG002|Overall Study|Lost to Follow-up|0|||
124596159|NCT00576303|448139213|FG000|Dose Titration Period|Early withdrawal|17|||
124596160|NCT00576303|448139213|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
124596161|NCT00576303|448139213|FG000|Long Term Safety Period|Early withdrawal|16|||
124596162|NCT02792218|448139214|FG000|Overall Study|Patient/guardian decision|15|||
124596163|NCT02792218|448139215|FG001|Overall Study|Patient/guardian decision|42|||
124596164|NCT02792218|448139214|FG000|Overall Study|Adverse Event|15|||
124596165|NCT02792218|448139215|FG001|Overall Study|Adverse Event|14|||
124596166|NCT02792218|448139214|FG000|Overall Study|Lost to Follow-up|10|||
124596167|NCT02792218|448139215|FG001|Overall Study|Lost to Follow-up|5|||
124596168|NCT02792218|448139214|FG000|Overall Study|Lack of Efficacy|1|||
124596169|NCT02792218|448139215|FG001|Overall Study|Lack of Efficacy|12|||
124596170|NCT02792218|448139214|FG000|Overall Study|Physician Decision|4|||
124596171|NCT02792218|448139215|FG001|Overall Study|Physician Decision|4|||
124596172|NCT02792218|448139214|FG000|Overall Study|Protocol deviation|3|||
124596173|NCT02792218|448139215|FG001|Overall Study|Protocol deviation|2|||
124596174|NCT02792218|448139214|FG000|Overall Study|New therapy for study indication|0|||
124596175|NCT02792218|448139215|FG001|Overall Study|New therapy for study indication|1|||
124596176|NCT02792218|448139214|FG000|Overall Study|Non-compliance with study treatment|0|||
124596177|NCT02792218|448139215|FG001|Overall Study|Non-compliance with study treatment|1|||
124596178|NCT02792218|448139214|FG000|Overall Study|Pregnancy|1|||
124596179|NCT02792218|448139215|FG001|Overall Study|Pregnancy|0|||
124596180|NCT00810602|448139216|FG000|Overall Study|Withdrawal by Subject|8|||
124596181|NCT00810602|448139217|FG001|Overall Study|Withdrawal by Subject|3|||
124596182|NCT00824369|448139221|FG000|Overall Study|Nolonger willing to participate in study|1|||
124596183|NCT00824369|448139222|FG001|Overall Study|Nolonger willing to participate in study|0|||
124596184|NCT00824369|448139223|FG002|Overall Study|Nolonger willing to participate in study|1|||
124596185|NCT00824369|448139224|FG003|Overall Study|Nolonger willing to participate in study|2|||
124596186|NCT00824369|448139225|FG004|Overall Study|Nolonger willing to participate in study|0|||
124596187|NCT00824369|448139226|FG005|Overall Study|Nolonger willing to participate in study|1|||
124596188|NCT00824369|448139221|FG000|Overall Study|Lost to Follow-up|0|||
124596189|NCT00824369|448139222|FG001|Overall Study|Lost to Follow-up|0|||
124596190|NCT00824369|448139223|FG002|Overall Study|Lost to Follow-up|0|||
124596191|NCT00824369|448139224|FG003|Overall Study|Lost to Follow-up|0|||
124596192|NCT00824369|448139225|FG004|Overall Study|Lost to Follow-up|1|||
124596193|NCT00824369|448139226|FG005|Overall Study|Lost to Follow-up|0|||
124596194|NCT00749411|448139233|FG000|Overall Study|Adverse Event|0|||
124596195|NCT00749411|448139234|FG001|Overall Study|Adverse Event|2|||
124596196|NCT00749411|448139233|FG000|Overall Study|Lack of Efficacy|0|||
124596197|NCT00749411|448139234|FG001|Overall Study|Lack of Efficacy|1|||
124596198|NCT00749411|448139233|FG000|Overall Study|Protocol Violation|1|||
124596199|NCT00749411|448139234|FG001|Overall Study|Protocol Violation|1|||
124596200|NCT00749411|448139233|FG000|Overall Study|Protocol-defined stopping criteria|0|||
124596201|NCT00749411|448139234|FG001|Overall Study|Protocol-defined stopping criteria|1|||
124596202|NCT03183141|448139236|FG000|Overall Study|Withdrawal by Subject|2|||
124596203|NCT03183141|448139237|FG001|Overall Study|Withdrawal by Subject|4|||
124596204|NCT03183141|448139236|FG000|Overall Study|Death|0|||
124596205|NCT03183141|448139237|FG001|Overall Study|Death|8|||
124596206|NCT02756637|448139239|FG000|Overall Study|Not eligible for initial SWOG study|10|||
124596207|NCT02756637|448139240|FG001|Overall Study|Not eligible for initial SWOG study|10|||
124596208|NCT02756637|448139239|FG000|Overall Study|No available NLR value|44|||
124596209|NCT02756637|448139240|FG001|Overall Study|No available NLR value|44|||
124596210|NCT02756637|448139239|FG000|Overall Study|Did not complete curative therapy|33|||
124596211|NCT02756637|448139240|FG001|Overall Study|Did not complete curative therapy|0|||
124596212|NCT01507090|448139241|FG000|Overall Study|incomplete dataset|18|||
124596213|NCT04034355|448139260|FG000|Overall Study|Study terminated by Sponsor|10|||
124596214|NCT04034355|448139261|FG001|Overall Study|Study terminated by Sponsor|17|||
124596215|NCT04034355|448139260|FG000|Overall Study|Withdrawal by Subject|12|||
124596216|NCT04034355|448139261|FG001|Overall Study|Withdrawal by Subject|11|||
124596217|NCT04034355|448139260|FG000|Overall Study|Site terminated by Sponsor|4|||
124596218|NCT04034355|448139261|FG001|Overall Study|Site terminated by Sponsor|5|||
124596219|NCT04034355|448139260|FG000|Overall Study|Adverse Event|2|||
124596220|NCT04034355|448139261|FG001|Overall Study|Adverse Event|0|||
124596221|NCT04034355|448139260|FG000|Overall Study|Death|1|||
124596222|NCT04034355|448139261|FG001|Overall Study|Death|1|||
124596223|NCT04034355|448139260|FG000|Overall Study|Not reported|2|||
124596224|NCT04034355|448139261|FG001|Overall Study|Not reported|0|||
124596225|NCT04034355|448139260|FG000|Overall Study|Lost to Follow-up|1|||
124596226|NCT04034355|448139261|FG001|Overall Study|Lost to Follow-up|0|||
124596227|NCT04034355|448139260|FG000|Overall Study|Physician Decision|1|||
124596228|NCT04034355|448139261|FG001|Overall Study|Physician Decision|0|||
124596229|NCT04034355|448139260|FG000|Overall Study|Protocol Violation|0|||
124596230|NCT04034355|448139261|FG001|Overall Study|Protocol Violation|1|||
124596231|NCT04034355|448139260|FG000|Overall Study|Progressive disease|1|||
124596232|NCT04034355|448139261|FG001|Overall Study|Progressive disease|0|||
124596233|NCT02190279|448141069|FG000|Overall Study|Withdrawal consent|1|||
124596234|NCT02190279|448141070|FG001|Overall Study|Withdrawal consent|0|||
124596235|NCT02190279|448141071|FG002|Overall Study|Withdrawal consent|1|||
124596236|NCT02190279|448141069|FG000|Overall Study|Lost to Follow-up|2|||
124730786|NCT01271712|448635582|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
124730787|NCT01271712|448635581|FG000|Safety Follow-up|No follow-up|1|||
124730788|NCT01271712|448635582|FG001|Safety Follow-up|No follow-up|1|||
124730789|NCT01271712|448635581|FG000|Safety Follow-up|Progressive disease|1|||
124730790|NCT01271712|448635582|FG001|Safety Follow-up|Progressive disease|0|||
124730791|NCT01271712|448635581|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
124730792|NCT01271712|448635582|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
124730793|NCT00096226|448635585|FG000|Overall Study|Ineligible|2|||
124730794|NCT00096226|448635585|FG000|Overall Study|Protocol treatment not started|1|||
124596237|NCT02190279|448141070|FG001|Overall Study|Lost to Follow-up|0|||
124596238|NCT02190279|448141071|FG002|Overall Study|Lost to Follow-up|0|||
124596239|NCT02190279|448141069|FG000|Overall Study|Refused further treatment|0|||
124596240|NCT02190279|448141070|FG001|Overall Study|Refused further treatment|0|||
124596241|NCT02190279|448141071|FG002|Overall Study|Refused further treatment|1|||
124596242|NCT02190279|448141069|FG000|Overall Study|Screening failure|0|||
124596243|NCT02190279|448141070|FG001|Overall Study|Screening failure|0|||
124596244|NCT02190279|448141071|FG002|Overall Study|Screening failure|1|||
124596245|NCT01467479|448141072|FG000|Overall Study|No Study Medication|1|||
124596246|NCT01467479|448141073|FG001|Overall Study|No Study Medication|0|||
124730795|NCT01666119|448635586|FG000|Overall Study|Adverse Event|6|||
124596247|NCT01467479|448141074|FG002|Overall Study|No Study Medication|2|||
124596248|NCT01467479|448141072|FG000|Overall Study|Adverse Event|1|||
124596249|NCT01467479|448141073|FG001|Overall Study|Adverse Event|2|||
124596250|NCT01467479|448141074|FG002|Overall Study|Adverse Event|0|||
124779539|NCT02624986|448821446|FG001|Overall Study|Study Terminated by Sponsor|1|||
124779540|NCT02624986|448821447|FG002|Overall Study|Study Terminated by Sponsor|0|||
124779541|NCT02624986|448821448|FG003|Overall Study|Study Terminated by Sponsor|1|||
124779542|NCT02624986|448821449|FG004|Overall Study|Study Terminated by Sponsor|2|||
124779543|NCT02624986|448821450|FG005|Overall Study|Study Terminated by Sponsor|2|||
124779544|NCT02624986|448821451|FG006|Overall Study|Study Terminated by Sponsor|4|||
124779545|NCT02624986|448821452|FG007|Overall Study|Study Terminated by Sponsor|3|||
124779546|NCT02624986|448821445|FG000|Overall Study|Progressive Disease|0|||
124779547|NCT02624986|448821446|FG001|Overall Study|Progressive Disease|1|||
124779548|NCT02624986|448821447|FG002|Overall Study|Progressive Disease|0|||
124779549|NCT02624986|448821448|FG003|Overall Study|Progressive Disease|0|||
124779550|NCT02624986|448821449|FG004|Overall Study|Progressive Disease|0|||
124779551|NCT02624986|448821450|FG005|Overall Study|Progressive Disease|0|||
124779552|NCT02624986|448821451|FG006|Overall Study|Progressive Disease|0|||
124779553|NCT02624986|448821452|FG007|Overall Study|Progressive Disease|0|||
124779554|NCT02624986|448821445|FG000|Overall Study|Protocol Violation|1|||
124779555|NCT02624986|448821446|FG001|Overall Study|Protocol Violation|0|||
124779556|NCT02624986|448821447|FG002|Overall Study|Protocol Violation|0|||
124779557|NCT02624986|448821448|FG003|Overall Study|Protocol Violation|0|||
124779558|NCT02624986|448821449|FG004|Overall Study|Protocol Violation|0|||
124779559|NCT02624986|448821450|FG005|Overall Study|Protocol Violation|0|||
124779560|NCT02624986|448821451|FG006|Overall Study|Protocol Violation|0|||
124779561|NCT02624986|448821452|FG007|Overall Study|Protocol Violation|0|||
124779562|NCT02624986|448821445|FG000|Overall Study|Withdrawal by Subject|0|||
124779563|NCT02624986|448821446|FG001|Overall Study|Withdrawal by Subject|0|||
124779564|NCT02624986|448821447|FG002|Overall Study|Withdrawal by Subject|0|||
124779565|NCT02624986|448821448|FG003|Overall Study|Withdrawal by Subject|0|||
124779566|NCT02624986|448821449|FG004|Overall Study|Withdrawal by Subject|0|||
124779567|NCT02624986|448821450|FG005|Overall Study|Withdrawal by Subject|0|||
124779568|NCT02624986|448821451|FG006|Overall Study|Withdrawal by Subject|0|||
124779569|NCT02624986|448821452|FG007|Overall Study|Withdrawal by Subject|1|||
124779570|NCT02527421|448821453|FG000|Overall Study|Withdrawal by Subject|1|||
124779571|NCT02527421|448821454|FG001|Overall Study|Withdrawal by Subject|0|||
124779572|NCT02116205|448821455|FG000|Overall Study|Withdrawal by Subject|2|||
124779573|NCT02116205|448821456|FG001|Overall Study|Withdrawal by Subject|4|||
124779574|NCT02116205|448821457|FG002|Overall Study|Withdrawal by Subject|1|||
124779575|NCT02116205|448821458|FG003|Overall Study|Withdrawal by Subject|3|||
124779576|NCT02116205|448821455|FG000|Overall Study|Lost to Follow-up|0|||
124779577|NCT02116205|448821456|FG001|Overall Study|Lost to Follow-up|2|||
124779578|NCT02116205|448821457|FG002|Overall Study|Lost to Follow-up|1|||
124779579|NCT02116205|448821458|FG003|Overall Study|Lost to Follow-up|2|||
124779580|NCT02116205|448821455|FG000|Overall Study|Physician Decision|0|||
124779581|NCT02116205|448821456|FG001|Overall Study|Physician Decision|1|||
124779582|NCT02116205|448821457|FG002|Overall Study|Physician Decision|1|||
124779583|NCT02116205|448821458|FG003|Overall Study|Physician Decision|1|||
124779584|NCT02116205|448821455|FG000|Overall Study|Exclusion criteria|0|||
124779585|NCT02116205|448821456|FG001|Overall Study|Exclusion criteria|0|||
124779586|NCT02116205|448821457|FG002|Overall Study|Exclusion criteria|1|||
124779587|NCT02116205|448821458|FG003|Overall Study|Exclusion criteria|0|||
124779588|NCT02541604|448821459|FG000|Overall Study|Death|6|||
124779589|NCT02541604|448821460|FG001|Overall Study|Death|5|||
124779590|NCT02541604|448821461|FG002|Overall Study|Death|7|||
124779591|NCT02541604|448821462|FG003|Overall Study|Death|2|||
124779592|NCT02541604|448821463|FG004|Overall Study|Death|9|||
124779593|NCT02541604|448821464|FG005|Overall Study|Death|8|||
124779594|NCT02541604|448821465|FG006|Overall Study|Death|9|||
124779595|NCT02541604|448821466|FG007|Overall Study|Death|9|||
124779596|NCT02541604|448821467|FG008|Overall Study|Death|3|||
124779597|NCT02541604|448821468|FG009|Overall Study|Death|4|||
124779598|NCT02541604|448821469|FG010|Overall Study|Death|2|||
124779599|NCT02541604|448821470|FG011|Overall Study|Death|3|||
124779600|NCT02541604|448821459|FG000|Overall Study|Lost to Follow-up|2|||
124779601|NCT02541604|448821460|FG001|Overall Study|Lost to Follow-up|0|||
124779602|NCT02541604|448821461|FG002|Overall Study|Lost to Follow-up|1|||
124779603|NCT02541604|448821462|FG003|Overall Study|Lost to Follow-up|0|||
124779604|NCT02541604|448821463|FG004|Overall Study|Lost to Follow-up|0|||
124779605|NCT02541604|448821464|FG005|Overall Study|Lost to Follow-up|1|||
124779606|NCT02541604|448821465|FG006|Overall Study|Lost to Follow-up|1|||
124779607|NCT02541604|448821466|FG007|Overall Study|Lost to Follow-up|0|||
124779608|NCT02541604|448821467|FG008|Overall Study|Lost to Follow-up|0|||
124779609|NCT02541604|448821468|FG009|Overall Study|Lost to Follow-up|0|||
124779610|NCT02541604|448821469|FG010|Overall Study|Lost to Follow-up|0|||
124779611|NCT02541604|448821470|FG011|Overall Study|Lost to Follow-up|0|||
124779612|NCT02541604|448821459|FG000|Overall Study|Withdrawal by Subject|2|||
124779613|NCT02541604|448821460|FG001|Overall Study|Withdrawal by Subject|0|||
124779614|NCT02541604|448821461|FG002|Overall Study|Withdrawal by Subject|1|||
124779615|NCT02541604|448821462|FG003|Overall Study|Withdrawal by Subject|0|||
124779616|NCT02541604|448821463|FG004|Overall Study|Withdrawal by Subject|1|||
124779617|NCT02541604|448821464|FG005|Overall Study|Withdrawal by Subject|1|||
124779618|NCT02541604|448821465|FG006|Overall Study|Withdrawal by Subject|0|||
124779619|NCT02541604|448821466|FG007|Overall Study|Withdrawal by Subject|0|||
124779620|NCT02541604|448821467|FG008|Overall Study|Withdrawal by Subject|1|||
124779621|NCT02541604|448821468|FG009|Overall Study|Withdrawal by Subject|0|||
124779622|NCT02541604|448821469|FG010|Overall Study|Withdrawal by Subject|0|||
124779623|NCT02541604|448821470|FG011|Overall Study|Withdrawal by Subject|0|||
124779624|NCT02541604|448821459|FG000|Overall Study|Study Terminated by Sponsor|1|||
124596251|NCT01467479|448141072|FG000|Overall Study|Death|0|||
124596252|NCT01467479|448141073|FG001|Overall Study|Death|0|||
124779625|NCT02541604|448821460|FG001|Overall Study|Study Terminated by Sponsor|4|||
124779626|NCT02541604|448821461|FG002|Overall Study|Study Terminated by Sponsor|2|||
124779627|NCT02541604|448821462|FG003|Overall Study|Study Terminated by Sponsor|1|||
124779628|NCT02541604|448821463|FG004|Overall Study|Study Terminated by Sponsor|0|||
124779629|NCT02541604|448821464|FG005|Overall Study|Study Terminated by Sponsor|0|||
124596253|NCT01467479|448141074|FG002|Overall Study|Death|1|||
124596254|NCT01467479|448141072|FG000|Overall Study|Lost to Follow-up|2|||
124596255|NCT01467479|448141073|FG001|Overall Study|Lost to Follow-up|5|||
124596256|NCT01467479|448141074|FG002|Overall Study|Lost to Follow-up|3|||
124596257|NCT01467479|448141072|FG000|Overall Study|Withdrawal of Consent|3|||
124596258|NCT01467479|448141073|FG001|Overall Study|Withdrawal of Consent|7|||
124596259|NCT01467479|448141074|FG002|Overall Study|Withdrawal of Consent|7|||
124596260|NCT01467479|448141072|FG000|Overall Study|Study Terminated by Sponsor|1|||
124596261|NCT01467479|448141073|FG001|Overall Study|Study Terminated by Sponsor|3|||
124596262|NCT01467479|448141074|FG002|Overall Study|Study Terminated by Sponsor|3|||
124596263|NCT01467479|448141072|FG000|Overall Study|Other|1|||
124596264|NCT01467479|448141073|FG001|Overall Study|Other|0|||
124596265|NCT01467479|448141074|FG002|Overall Study|Other|0|||
124596266|NCT01197417|448141080|FG000|Overall Study|Physician Decision|3|||
124596267|NCT01197417|448141081|FG001|Overall Study|Physician Decision|2|||
124596268|NCT01197417|448141080|FG000|Overall Study|Withdrawal by Subject|2|||
124596269|NCT01197417|448141081|FG001|Overall Study|Withdrawal by Subject|4|||
124596270|NCT01197417|448141080|FG000|Overall Study|Site miscommunication|0|||
124596271|NCT01197417|448141081|FG001|Overall Study|Site miscommunication|1|||
124596272|NCT01197417|448141080|FG000|Overall Study|Subject transferred to intensive care|0|||
124596273|NCT01197417|448141081|FG001|Overall Study|Subject transferred to intensive care|1|||
124596274|NCT01197417|448141080|FG000|Overall Study|Not consented in time to receive drug|0|||
124596275|NCT01197417|448141081|FG001|Overall Study|Not consented in time to receive drug|1|||
124596276|NCT01197417|448141080|FG000|Overall Study|Hypotension|1|||
124596277|NCT01197417|448141081|FG001|Overall Study|Hypotension|2|||
124596278|NCT01197417|448141080|FG000|Overall Study|Found to be ineligible|2|||
124596279|NCT01197417|448141081|FG001|Overall Study|Found to be ineligible|5|||
124779630|NCT02541604|448821465|FG006|Overall Study|Study Terminated by Sponsor|0|||
124779631|NCT02541604|448821466|FG007|Overall Study|Study Terminated by Sponsor|0|||
124779632|NCT02541604|448821467|FG008|Overall Study|Study Terminated by Sponsor|0|||
124596280|NCT01197417|448141080|FG000|Overall Study|No 25-hour magnesium level|0|||
124596281|NCT01197417|448141081|FG001|Overall Study|No 25-hour magnesium level|2|||
124596282|NCT01652729|448141082|FG000|Overall Study|Withdrawal by Subject|14|||
124596283|NCT01652729|448141083|FG001|Overall Study|Withdrawal by Subject|7|||
124596284|NCT01652729|448141084|FG002|Overall Study|Withdrawal by Subject|7|||
124596285|NCT01652729|448141082|FG000|Overall Study|Adverse Event|4|||
124596286|NCT01652729|448141083|FG001|Overall Study|Adverse Event|0|||
124596287|NCT01652729|448141084|FG002|Overall Study|Adverse Event|3|||
124596288|NCT01652729|448141082|FG000|Overall Study|Physician Decision|1|||
124596289|NCT01652729|448141083|FG001|Overall Study|Physician Decision|0|||
124596290|NCT01652729|448141084|FG002|Overall Study|Physician Decision|1|||
124596291|NCT01652729|448141082|FG000|Overall Study|Protocol Violation|1|||
124596292|NCT01652729|448141083|FG001|Overall Study|Protocol Violation|0|||
124596293|NCT01652729|448141084|FG002|Overall Study|Protocol Violation|0|||
124596294|NCT01652729|448141082|FG000|Overall Study|Lost to Follow-up|6|||
124596295|NCT01652729|448141083|FG001|Overall Study|Lost to Follow-up|6|||
124596296|NCT01652729|448141084|FG002|Overall Study|Lost to Follow-up|3|||
124596297|NCT01652729|448141082|FG000|Overall Study|Administrative|1|||
124596298|NCT01652729|448141083|FG001|Overall Study|Administrative|0|||
124596299|NCT01652729|448141084|FG002|Overall Study|Administrative|0|||
124596300|NCT01311557|448141085|FG000|Overall Study|Serious adverse event|0|||
124596301|NCT01311557|448141086|FG001|Overall Study|Serious adverse event|1|||
124596302|NCT01311557|448141085|FG000|Overall Study|Protocol Violation|4|||
124596303|NCT01311557|448141086|FG001|Overall Study|Protocol Violation|2|||
124596304|NCT01311557|448141085|FG000|Overall Study|Lost to Follow-up|0|||
124596305|NCT01311557|448141086|FG001|Overall Study|Lost to Follow-up|1|||
124596306|NCT01311557|448141085|FG000|Overall Study|Withdrawal by Subject|1|||
124596307|NCT01311557|448141086|FG001|Overall Study|Withdrawal by Subject|2|||
124596308|NCT02418455|448141087|FG000|48-Week Treatment Period|Other- Not Specified|1|||
124596309|NCT02418455|448141087|FG000|Continuation Period|Sponsor Decision|7|||
124596310|NCT02973321|448141088|FG000|Overall Study|Other than specified|0|||
124779633|NCT02541604|448821468|FG009|Overall Study|Study Terminated by Sponsor|0|||
124779634|NCT02541604|448821469|FG010|Overall Study|Study Terminated by Sponsor|0|||
124596311|NCT02973321|448141089|FG001|Overall Study|Other than specified|5|||
124596312|NCT02973321|448141090|FG002|Overall Study|Other than specified|3|||
124596313|NCT02973321|448141091|FG003|Overall Study|Other than specified|3|||
124596314|NCT02973321|448141092|FG004|Overall Study|Other than specified|1|||
124596315|NCT02973321|448141088|FG000|Overall Study|Lack of Efficacy|0|||
124596316|NCT02973321|448141089|FG001|Overall Study|Lack of Efficacy|0|||
124596317|NCT02973321|448141090|FG002|Overall Study|Lack of Efficacy|0|||
124596318|NCT02973321|448141091|FG003|Overall Study|Lack of Efficacy|0|||
124596319|NCT02973321|448141092|FG004|Overall Study|Lack of Efficacy|1|||
124596320|NCT02973321|448141088|FG000|Overall Study|Adverse Event|1|||
124596321|NCT02973321|448141089|FG001|Overall Study|Adverse Event|10|||
124596322|NCT02973321|448141090|FG002|Overall Study|Adverse Event|11|||
124596323|NCT02973321|448141091|FG003|Overall Study|Adverse Event|13|||
124596324|NCT02973321|448141092|FG004|Overall Study|Adverse Event|3|||
124596325|NCT00865514|448141099|FG000|Overall Study|Infusion cost exceeded funding|2|||
124596326|NCT03920280|448141100|FG000|Overall Study|Adverse Event|2|||
124596327|NCT03920280|448141101|FG001|Overall Study|Adverse Event|3|||
124596328|NCT03920280|448141100|FG000|Overall Study|Lost to Follow-up|0|||
124596329|NCT03920280|448141101|FG001|Overall Study|Lost to Follow-up|1|||
124596330|NCT03920280|448141100|FG000|Overall Study|Withdrawal by Subject|1|||
124596331|NCT03920280|448141101|FG001|Overall Study|Withdrawal by Subject|1|||
124596332|NCT03920280|448141100|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
124596333|NCT03920280|448141101|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
124596334|NCT01557920|448141102|FG000|Overall Study|Withdrawal by Subject|2|||
124596335|NCT01557920|448141103|FG001|Overall Study|Withdrawal by Subject|3|||
124596336|NCT01557920|448141102|FG000|Overall Study|Lack of Efficacy|1|||
124596337|NCT01557920|448141103|FG001|Overall Study|Lack of Efficacy|0|||
124596338|NCT00089076|448141106|FG000|Overall Study|Alternate Therapy|1|||
124596339|NCT00089076|448141106|FG000|Overall Study|Withdrawal by Subject|2|||
124596340|NCT00089076|448141106|FG000|Overall Study|Progression|7|||
124596341|NCT00983476|448141110|FG000|Overall Study|Did not receive intervention|17|||
124596342|NCT00983476|448141111|FG001|Overall Study|Did not receive intervention|22|||
124596343|NCT00983476|448141112|FG002|Overall Study|Did not receive intervention|0|||
124596344|NCT01175473|448141114|FG000|Overall Study|Adverse Event|2|||
124596345|NCT01175473|448141115|FG001|Overall Study|Adverse Event|2|||
124596346|NCT01857206|448141119|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
124596347|NCT01857206|448141120|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
124596348|NCT01857206|448141119|FG000|Overall Study|Lost to Follow-up|9|||
124596349|NCT01857206|448141120|FG001|Overall Study|Lost to Follow-up|6|||
124596350|NCT01857206|448141119|FG000|Overall Study|Unclassified|3|||
124596351|NCT01857206|448141120|FG001|Overall Study|Unclassified|3|||
124596352|NCT01857206|448141119|FG000|Overall Study|Withdrawal by Subject|1|||
124596353|NCT01857206|448141120|FG001|Overall Study|Withdrawal by Subject|0|||
124596354|NCT00003531|448141124|FG000|Overall Study|Not evaluable|10|||
124596355|NCT02487082|448141125|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
124596356|NCT02487082|448141126|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
124596357|NCT02487082|448141125|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
124596358|NCT02487082|448141126|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
124596359|NCT00251316|448141127|FG000|Overall Study|Physician Decision|2|||
124596360|NCT00251316|448141128|FG001|Overall Study|Physician Decision|3|||
124596361|NCT00346164|448141129|FG000|Overall Study|Adverse Event|0|||
124596362|NCT00346164|448141130|FG001|Overall Study|Adverse Event|0|||
124596363|NCT00346164|448141131|FG002|Overall Study|Adverse Event|0|||
124596364|NCT00346164|448141132|FG003|Overall Study|Adverse Event|1|||
124596365|NCT00346164|448141129|FG000|Overall Study|Lack of Efficacy|0|||
124596366|NCT00346164|448141130|FG001|Overall Study|Lack of Efficacy|1|||
124596367|NCT00346164|448141131|FG002|Overall Study|Lack of Efficacy|7|||
124596368|NCT00346164|448141132|FG003|Overall Study|Lack of Efficacy|25|||
124596369|NCT00346164|448141129|FG000|Overall Study|Physician Decision|0|||
124596370|NCT00346164|448141130|FG001|Overall Study|Physician Decision|1|||
124596371|NCT00346164|448141131|FG002|Overall Study|Physician Decision|2|||
124596372|NCT00346164|448141132|FG003|Overall Study|Physician Decision|27|||
124596373|NCT00346164|448141129|FG000|Overall Study|Protocol Violation|6|||
124596374|NCT00346164|448141130|FG001|Overall Study|Protocol Violation|2|||
124596375|NCT00346164|448141131|FG002|Overall Study|Protocol Violation|10|||
124596376|NCT00346164|448141132|FG003|Overall Study|Protocol Violation|4|||
124596377|NCT00346164|448141129|FG000|Overall Study|Withdrawal by Subject|0|||
124596378|NCT00346164|448141130|FG001|Overall Study|Withdrawal by Subject|0|||
124596379|NCT00346164|448141131|FG002|Overall Study|Withdrawal by Subject|2|||
124596380|NCT00346164|448141132|FG003|Overall Study|Withdrawal by Subject|0|||
124596381|NCT00346164|448141129|FG000|Overall Study|Ineligible|11|||
124596382|NCT00346164|448141130|FG001|Overall Study|Ineligible|2|||
124596383|NCT00346164|448141131|FG002|Overall Study|Ineligible|2|||
124596384|NCT00346164|448141132|FG003|Overall Study|Ineligible|23|||
124596385|NCT00346164|448141129|FG000|Overall Study|Refusal of further protocol therapy|0|||
124596386|NCT00346164|448141130|FG001|Overall Study|Refusal of further protocol therapy|1|||
124596387|NCT00346164|448141131|FG002|Overall Study|Refusal of further protocol therapy|3|||
124596388|NCT00346164|448141132|FG003|Overall Study|Refusal of further protocol therapy|15|||
124596389|NCT00346164|448141129|FG000|Overall Study|Inability to start week 16 tx on time|0|||
124596390|NCT00346164|448141130|FG001|Overall Study|Inability to start week 16 tx on time|0|||
124596391|NCT00346164|448141131|FG002|Overall Study|Inability to start week 16 tx on time|0|||
124596392|NCT00346164|448141132|FG003|Overall Study|Inability to start week 16 tx on time|11|||
124596393|NCT02039063|448141133|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
124596394|NCT02039063|448141134|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
124596395|NCT02039063|448141135|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
124596396|NCT02039063|448141136|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
124596397|NCT02039063|448141133|FG000|Treatment Phase|Progression of disease|0|||
124596398|NCT02039063|448141134|FG001|Treatment Phase|Progression of disease|0|||
124596399|NCT02039063|448141135|FG002|Treatment Phase|Progression of disease|1|||
124596400|NCT02039063|448141136|FG003|Treatment Phase|Progression of disease|1|||
124596401|NCT02039063|448141133|FG000|Extension Phase|Inadequate therapeutic effect|0|||
124596402|NCT02039063|448141134|FG001|Extension Phase|Inadequate therapeutic effect|1|||
124596403|NCT02039063|448141135|FG002|Extension Phase|Inadequate therapeutic effect|2|||
124596404|NCT02039063|448141136|FG003|Extension Phase|Inadequate therapeutic effect|0|||
124596405|NCT02039063|448141133|FG000|Extension Phase|Progression of disease|0|||
124596406|NCT02039063|448141134|FG001|Extension Phase|Progression of disease|0|||
124596407|NCT02039063|448141135|FG002|Extension Phase|Progression of disease|0|||
124596408|NCT02039063|448141136|FG003|Extension Phase|Progression of disease|1|||
124596409|NCT02039063|448141133|FG000|Extension Phase|Adverse Event|0|||
124596410|NCT02039063|448141134|FG001|Extension Phase|Adverse Event|0|||
124596411|NCT02039063|448141135|FG002|Extension Phase|Adverse Event|1|||
124596412|NCT02039063|448141136|FG003|Extension Phase|Adverse Event|0|||
124596413|NCT00467831|448141138|FG000|Overall Study|Death|2|||
124596414|NCT00467831|448141138|FG000|Overall Study|Withdrawal by Subject|1|||
124596415|NCT01198873|448141139|FG000|Overall Study|Adverse Event|4|||
124596416|NCT01198873|448141140|FG001|Overall Study|Adverse Event|7|||
124596417|NCT01198873|448141139|FG000|Overall Study|Study closure|29|||
124596418|NCT01198873|448141140|FG001|Overall Study|Study closure|23|||
124596419|NCT01198873|448141139|FG000|Overall Study|Other than above|4|||
124596420|NCT01198873|448141140|FG001|Overall Study|Other than above|2|||
124596421|NCT03139240|448141141|FG000|Overall Study|Lost to Follow-up|0|||
124596422|NCT03139240|448141142|FG001|Overall Study|Lost to Follow-up|1|||
124596423|NCT03139240|448141143|FG002|Overall Study|Lost to Follow-up|1|||
124596424|NCT03139240|448141144|FG003|Overall Study|Lost to Follow-up|0|||
124596425|NCT03417830|448141145|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
124596426|NCT03417830|448141146|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
124596427|NCT00823199|448141147|FG000|Overall Study|Withdrawal by Subject|2|||
124596428|NCT00171340|448141148|FG000|Overall Study|Adverse Event|46|||
124596429|NCT00171340|448141149|FG001|Overall Study|Adverse Event|42|||
124596430|NCT00171340|448141148|FG000|Overall Study|Lack of Efficacy|29|||
124596431|NCT00171340|448141149|FG001|Overall Study|Lack of Efficacy|41|||
124596432|NCT00171340|448141148|FG000|Overall Study|Protocol Violation|7|||
124596433|NCT00171340|448141149|FG001|Overall Study|Protocol Violation|8|||
124596434|NCT00171340|448141148|FG000|Overall Study|Withdrawal by Subject|22|||
124596435|NCT00171340|448141149|FG001|Overall Study|Withdrawal by Subject|19|||
124596436|NCT00171340|448141148|FG000|Overall Study|Lost to Follow-up|0|||
124596437|NCT00171340|448141149|FG001|Overall Study|Lost to Follow-up|5|||
124596438|NCT00171340|448141148|FG000|Overall Study|Abnormal Laboratory Results|2|||
124596439|NCT00171340|448141149|FG001|Overall Study|Abnormal Laboratory Results|0|||
124596440|NCT00171340|448141148|FG000|Overall Study|Abnormal Test Procedure Results|6|||
124596441|NCT00171340|448141149|FG001|Overall Study|Abnormal Test Procedure Results|11|||
124596442|NCT00171340|448141148|FG000|Overall Study|No Longer Required Study Drug|1|||
124596443|NCT00171340|448141149|FG001|Overall Study|No Longer Required Study Drug|1|||
124596444|NCT00171340|448141148|FG000|Overall Study|Administrative Problems|5|||
124596445|NCT00171340|448141149|FG001|Overall Study|Administrative Problems|2|||
124596446|NCT00171340|448141148|FG000|Overall Study|Death|6|||
124596447|NCT00171340|448141149|FG001|Overall Study|Death|6|||
124596448|NCT01998243|448141150|FG000|Overall Study|Pregnancy|0|||
124596449|NCT01998243|448141151|FG001|Overall Study|Pregnancy|1|||
124596450|NCT01998243|448141150|FG000|Overall Study|Protocol Violation|5|||
124596451|NCT01998243|448141151|FG001|Overall Study|Protocol Violation|2|||
124596452|NCT01998243|448141150|FG000|Overall Study|Withdrawal by Subject|3|||
124596453|NCT01998243|448141151|FG001|Overall Study|Withdrawal by Subject|4|||
124730796|NCT01666119|448635586|FG000|Overall Study|Withdrawal by Subject|16|||
124596454|NCT01056640|448141152|FG000|Overall Study|Withdrawal by Subject|11|||
124596455|NCT01056640|448141153|FG001|Overall Study|Withdrawal by Subject|8|||
124596456|NCT01056640|448141152|FG000|Overall Study|Death|15|||
124596457|NCT01056640|448141153|FG001|Overall Study|Death|4|||
124596458|NCT04569786|448141154|FG000|Overall Study|Lost to Follow-up|1|||
124596459|NCT04569786|448141155|FG001|Overall Study|Lost to Follow-up|0|||
124730797|NCT01666119|448635586|FG000|Overall Study|Lost to Follow-up|7|||
124596460|NCT04569786|448141156|FG002|Overall Study|Lost to Follow-up|4|||
124596461|NCT04569786|448141157|FG003|Overall Study|Lost to Follow-up|1|||
124596462|NCT04569786|448141158|FG004|Overall Study|Lost to Follow-up|0|||
124596463|NCT04569786|448141154|FG000|Overall Study|Withdrawal by Subject|0|||
124596464|NCT04569786|448141155|FG001|Overall Study|Withdrawal by Subject|0|||
124596465|NCT04569786|448141156|FG002|Overall Study|Withdrawal by Subject|0|||
124596466|NCT04569786|448141157|FG003|Overall Study|Withdrawal by Subject|5|||
124596467|NCT04569786|448141158|FG004|Overall Study|Withdrawal by Subject|1|||
124596468|NCT04569786|448141154|FG000|Overall Study|Physician Decision|0|||
124596469|NCT04569786|448141155|FG001|Overall Study|Physician Decision|0|||
124596470|NCT04569786|448141156|FG002|Overall Study|Physician Decision|0|||
124596471|NCT04569786|448141157|FG003|Overall Study|Physician Decision|1|||
124596472|NCT04569786|448141158|FG004|Overall Study|Physician Decision|0|||
124596473|NCT01684878|448141162|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
124596474|NCT01684878|448141163|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
124596475|NCT01684878|448141164|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
124596476|NCT01684878|448141165|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
124596477|NCT01684878|448141162|FG000|Part 1: Safety Run in Phase|Death|15|||
124596478|NCT01684878|448141163|FG001|Part 1: Safety Run in Phase|Death|20|||
124596479|NCT01684878|448141164|FG002|Part 1: Safety Run in Phase|Death|0|||
124596480|NCT01684878|448141165|FG003|Part 1: Safety Run in Phase|Death|0|||
124596481|NCT01684878|448141162|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
124596482|NCT01684878|448141163|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
124596483|NCT01684878|448141164|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
124596484|NCT01684878|448141165|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
124596485|NCT01684878|448141162|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
124596486|NCT01684878|448141163|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
124596487|NCT01684878|448141164|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
124596488|NCT01684878|448141165|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
124596489|NCT01684878|448141162|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
124596490|NCT01684878|448141163|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
124596491|NCT01684878|448141164|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
124596492|NCT01684878|448141165|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
124596493|NCT01684878|448141162|FG000|Part 2: Randomized Phase|Death|0|||
124596494|NCT01684878|448141163|FG001|Part 2: Randomized Phase|Death|0|||
124596495|NCT01684878|448141164|FG002|Part 2: Randomized Phase|Death|62|||
124596496|NCT01684878|448141165|FG003|Part 2: Randomized Phase|Death|68|||
124596497|NCT01684878|448141162|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
124596498|NCT01684878|448141163|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
124596499|NCT01684878|448141164|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
124596500|NCT01684878|448141165|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
124596501|NCT01684878|448141162|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
124596502|NCT01684878|448141163|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
124596503|NCT01684878|448141164|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
124596504|NCT01684878|448141165|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
124596505|NCT02692482|448141166|FG000|Overall Study|Death|2|||
124596506|NCT02692482|448141167|FG001|Overall Study|Death|2|||
124596507|NCT02692482|448141166|FG000|Overall Study|Withdrawal by Subject|1|||
124596508|NCT02692482|448141167|FG001|Overall Study|Withdrawal by Subject|2|||
124596509|NCT01435031|448141168|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
124596510|NCT01435031|448141168|FG000|ITT at 1 Month|Death|1|||
124596511|NCT01435031|448141168|FG000|ITT at 1 Month|Lost to Follow-up|4|||
124596512|NCT01435031|448141168|FG000|ITT at 6 Months|Death|2|||
124596513|NCT01435031|448141168|FG000|ITT at 6 Months|Lost to Follow-up|3|||
124596514|NCT01435031|448141168|FG000|ITT at 1 Year|Death|1|||
124596515|NCT01435031|448141168|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
124596516|NCT01435031|448141168|FG000|ITT at 1 Year|Lost to Follow-up|6|||
124596517|NCT01435031|448141168|FG000|ITT at 2 Years|Death|7|||
124596518|NCT01435031|448141168|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
124596519|NCT01435031|448141168|FG000|ITT at 2 Years|Lost to Follow-up|4|||
124596520|NCT01435031|448141168|FG000|ITT at 3 Years|Death|5|||
124596521|NCT01435031|448141168|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
124596522|NCT01435031|448141168|FG000|ITT at 3 Years|Lost to Follow-up|4|||
124596523|NCT01435031|448141168|FG000|ITT at 4 Years|Death|4|||
124596524|NCT01435031|448141168|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
124596525|NCT01435031|448141168|FG000|ITT at 4 Years|Lost to Follow-up|1|||
124596526|NCT02492841|448141169|FG000|Overall Study|Lost to Follow-up|34|||
124596527|NCT02492841|448141170|FG001|Overall Study|Lost to Follow-up|31|||
124596528|NCT02492841|448141171|FG002|Overall Study|Lost to Follow-up|35|||
124596529|NCT02563769|448141179|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
124596530|NCT02563769|448141180|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
124596531|NCT02563769|448141181|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
124596532|NCT00690482|448141184|FG000|Overall Study|Adverse Event|2|||
124596533|NCT00690482|448141185|FG001|Overall Study|Adverse Event|1|||
124596534|NCT00690482|448141184|FG000|Overall Study|Incorrect enrolment|0|||
124596535|NCT00690482|448141185|FG001|Overall Study|Incorrect enrolment|1|||
124596536|NCT00690482|448141184|FG000|Overall Study|Study-specific discontinuation criteria|1|||
124596537|NCT00690482|448141185|FG001|Overall Study|Study-specific discontinuation criteria|0|||
124596538|NCT00690482|448141184|FG000|Overall Study|Intake of prohibited medicine|1|||
124779635|NCT02541604|448821470|FG011|Overall Study|Study Terminated by Sponsor|0|||
124779636|NCT02541604|448821459|FG000|Overall Study|Medical condition may jeopardize safety|0|||
124779637|NCT02541604|448821460|FG001|Overall Study|Medical condition may jeopardize safety|0|||
124779638|NCT02541604|448821461|FG002|Overall Study|Medical condition may jeopardize safety|0|||
124779639|NCT02541604|448821462|FG003|Overall Study|Medical condition may jeopardize safety|0|||
124779640|NCT02541604|448821463|FG004|Overall Study|Medical condition may jeopardize safety|0|||
124779641|NCT02541604|448821464|FG005|Overall Study|Medical condition may jeopardize safety|0|||
124779642|NCT02541604|448821465|FG006|Overall Study|Medical condition may jeopardize safety|0|||
124779643|NCT02541604|448821466|FG007|Overall Study|Medical condition may jeopardize safety|1|||
124779644|NCT02541604|448821467|FG008|Overall Study|Medical condition may jeopardize safety|0|||
124779645|NCT02541604|448821468|FG009|Overall Study|Medical condition may jeopardize safety|0|||
124779646|NCT02541604|448821469|FG010|Overall Study|Medical condition may jeopardize safety|0|||
124596539|NCT00690482|448141185|FG001|Overall Study|Intake of prohibited medicine|0|||
124596540|NCT00690482|448141184|FG000|Overall Study|withdrew consent at rand.day|0|||
124596541|NCT00690482|448141185|FG001|Overall Study|withdrew consent at rand.day|1|||
124779647|NCT02541604|448821470|FG011|Overall Study|Medical condition may jeopardize safety|0|||
124779648|NCT00560352|448821473|FG000|Overall Study|Adverse event unrelated to study drug|2|||
124779649|NCT00560352|448821474|FG001|Overall Study|Adverse event unrelated to study drug|1|||
124779650|NCT00560352|448821475|FG002|Overall Study|Adverse event unrelated to study drug|1|||
124779651|NCT00560352|448821473|FG000|Overall Study|Study drug toxicity|3|||
124779652|NCT00560352|448821474|FG001|Overall Study|Study drug toxicity|0|||
124779653|NCT00560352|448821475|FG002|Overall Study|Study drug toxicity|1|||
124779654|NCT00560352|448821473|FG000|Overall Study|Disease progression|0|||
124779655|NCT00560352|448821474|FG001|Overall Study|Disease progression|1|||
124779656|NCT00560352|448821475|FG002|Overall Study|Disease progression|1|||
124779657|NCT00560352|448821473|FG000|Overall Study|Withdrawal by Subject|1|||
124779658|NCT00560352|448821474|FG001|Overall Study|Withdrawal by Subject|1|||
124779659|NCT00560352|448821475|FG002|Overall Study|Withdrawal by Subject|1|||
124596542|NCT02820740|448141186|FG000|Overall Study|Did not have procedure|2|||
124596543|NCT00925301|448141190|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
124596544|NCT00925301|448141191|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
124596545|NCT00925301|448141192|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
124596546|NCT00925301|448141193|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
124596547|NCT00925301|448141190|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
124596548|NCT00925301|448141191|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
124596549|NCT00925301|448141192|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
124596550|NCT00925301|448141193|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
124596551|NCT00925301|448141190|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
124596552|NCT00925301|448141191|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
124596553|NCT00925301|448141192|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
124596554|NCT00925301|448141193|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
124596555|NCT00925301|448141190|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
124596556|NCT00925301|448141191|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
124596557|NCT00925301|448141192|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
124596558|NCT00925301|448141193|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
124596559|NCT00925301|448141190|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
124596560|NCT00925301|448141191|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
124596561|NCT00925301|448141192|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
124596562|NCT00925301|448141193|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
124596563|NCT00925301|448141190|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
124596564|NCT00925301|448141191|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
124779660|NCT00560352|448821473|FG000|Overall Study|Maximum clinical benefit|1|||
124779661|NCT00560352|448821474|FG001|Overall Study|Maximum clinical benefit|0|||
124779662|NCT00560352|448821475|FG002|Overall Study|Maximum clinical benefit|0|||
124779663|NCT04434937|448821476|FG000|Overall Study|Death|4|||
124779664|NCT04434937|448821476|FG000|Overall Study|Withdrawal by Subject|1|||
124779665|NCT04434937|448821476|FG000|Overall Study|Transitioned to Rollover Study|19|||
124779666|NCT04434937|448821476|FG000|Overall Study|Progressive Disease|18|||
124779667|NCT00924027|448821477|FG000|Overall Study|Lost to Further Follow-Up|4|||
124779668|NCT00924027|448821478|FG001|Overall Study|Lost to Further Follow-Up|0|||
124596565|NCT00925301|448141192|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
124596566|NCT00925301|448141193|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
124596567|NCT00925301|448141190|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
124596568|NCT00925301|448141191|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
124596569|NCT00925301|448141192|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
124596570|NCT00925301|448141193|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
124596571|NCT01117987|448141194|FG000|Overall Study|Protocol deviation|0|||
124596572|NCT01117987|448141195|FG001|Overall Study|Protocol deviation|1|||
124596573|NCT01117987|448141194|FG000|Overall Study|Subject no longer requires study drug|1|||
124779669|NCT00924027|448821479|FG002|Overall Study|Lost to Further Follow-Up|0|||
124779670|NCT00924027|448821480|FG003|Overall Study|Lost to Further Follow-Up|0|||
124779671|NCT00924027|448821477|FG000|Overall Study|Physician Decision|1|||
124779672|NCT00924027|448821478|FG001|Overall Study|Physician Decision|0|||
124779673|NCT00924027|448821479|FG002|Overall Study|Physician Decision|0|||
124779674|NCT00924027|448821480|FG003|Overall Study|Physician Decision|1|||
124779675|NCT00924027|448821477|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
124779676|NCT00924027|448821478|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
124779677|NCT00924027|448821479|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
124779678|NCT00924027|448821480|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
124779679|NCT00924027|448821477|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
124779680|NCT00924027|448821478|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
124779681|NCT00924027|448821479|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
124779682|NCT00924027|448821480|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
124779683|NCT00924027|448821477|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
124596574|NCT01117987|448141195|FG001|Overall Study|Subject no longer requires study drug|0|||
124596575|NCT01117987|448141194|FG000|Overall Study|Lost to Follow-up|1|||
124596576|NCT01117987|448141195|FG001|Overall Study|Lost to Follow-up|1|||
124596577|NCT01117987|448141194|FG000|Overall Study|Abnormal test procedure result|2|||
124596578|NCT01117987|448141195|FG001|Overall Study|Abnormal test procedure result|0|||
124779684|NCT00924027|448821478|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
124779685|NCT00924027|448821479|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
124779686|NCT00924027|448821480|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
124779687|NCT04695977|448821481|FG000|Overall Study|Sponsor Decision|9|||
124779688|NCT04695977|448821482|FG001|Overall Study|Sponsor Decision|4|||
124779689|NCT04695977|448821481|FG000|Overall Study|Death|2|||
124779690|NCT04695977|448821482|FG001|Overall Study|Death|5|||
124779691|NCT03474965|448821483|FG000|Overall Study|Pregnancy|1|||
124779692|NCT03474965|448821484|FG001|Overall Study|Pregnancy|0|||
124779693|NCT03474965|448821485|FG002|Overall Study|Pregnancy|0|||
124779694|NCT03474965|448821486|FG003|Overall Study|Pregnancy|0|||
124779695|NCT03474965|448821483|FG000|Overall Study|Lost to Follow-up|0|||
124779696|NCT03474965|448821484|FG001|Overall Study|Lost to Follow-up|0|||
124779697|NCT03474965|448821485|FG002|Overall Study|Lost to Follow-up|1|||
124779698|NCT03474965|448821486|FG003|Overall Study|Lost to Follow-up|0|||
124779699|NCT03474965|448821483|FG000|Overall Study|Death|1|||
124779700|NCT03474965|448821484|FG001|Overall Study|Death|0|||
124779701|NCT03474965|448821485|FG002|Overall Study|Death|0|||
124779702|NCT03474965|448821486|FG003|Overall Study|Death|0|||
124779703|NCT03474965|448821483|FG000|Overall Study|Adverse Event|1|||
124779704|NCT03474965|448821484|FG001|Overall Study|Adverse Event|0|||
124779705|NCT03474965|448821485|FG002|Overall Study|Adverse Event|0|||
124779706|NCT03474965|448821486|FG003|Overall Study|Adverse Event|1|||
124779707|NCT03474965|448821483|FG000|Overall Study|Physician Decision|3|||
124779708|NCT03474965|448821484|FG001|Overall Study|Physician Decision|1|||
124779709|NCT03474965|448821485|FG002|Overall Study|Physician Decision|2|||
124779710|NCT03474965|448821486|FG003|Overall Study|Physician Decision|0|||
124779711|NCT03474965|448821483|FG000|Overall Study|Participant Decision|7|||
124779712|NCT03474965|448821484|FG001|Overall Study|Participant Decision|0|||
124779713|NCT03474965|448821485|FG002|Overall Study|Participant Decision|1|||
124779714|NCT03474965|448821486|FG003|Overall Study|Participant Decision|0|||
124779715|NCT03474965|448821483|FG000|Overall Study|Guardian Decision|4|||
124779716|NCT03474965|448821484|FG001|Overall Study|Guardian Decision|2|||
124779717|NCT03474965|448821485|FG002|Overall Study|Guardian Decision|7|||
124779718|NCT03474965|448821486|FG003|Overall Study|Guardian Decision|2|||
124779719|NCT03751657|448823337|FG000|Overall Study|Physician Decision|0|||
124779720|NCT03751657|448823338|FG001|Overall Study|Physician Decision|1|||
124779721|NCT03751657|448823337|FG000|Overall Study|Withdrawal by Subject|1|||
124596579|NCT01117987|448141194|FG000|Overall Study|Lack of Efficacy|3|||
124779722|NCT03751657|448823338|FG001|Overall Study|Withdrawal by Subject|1|||
124779723|NCT03751657|448823337|FG000|Overall Study|Lost to Follow-up|2|||
124779724|NCT03751657|448823338|FG001|Overall Study|Lost to Follow-up|1|||
124779725|NCT02600819|448823339|FG000|GEN Phase|Adverse Event|2|||
124779726|NCT02600819|448823340|FG001|GEN Phase|Adverse Event|0|||
124779727|NCT02600819|448823339|FG000|GEN Phase|Death|2|||
124596580|NCT01117987|448141195|FG001|Overall Study|Lack of Efficacy|4|||
124596581|NCT01117987|448141194|FG000|Overall Study|Death|5|||
124779728|NCT02600819|448823340|FG001|GEN Phase|Death|0|||
124779729|NCT02600819|448823339|FG000|GEN Phase|Investigator's Discretion|4|||
124596582|NCT01117987|448141195|FG001|Overall Study|Death|10|||
124596583|NCT01117987|448141194|FG000|Overall Study|Withdrawal by Subject|5|||
124779730|NCT02600819|448823340|FG001|GEN Phase|Investigator's Discretion|0|||
124779731|NCT02600819|448823339|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
124779732|NCT02600819|448823340|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
124779733|NCT02600819|448823339|FG000|GEN Phase|Withdrew Consent|5|||
124779734|NCT02600819|448823340|FG001|GEN Phase|Withdrew Consent|0|||
124779735|NCT02600819|448823339|FG000|GEN Phase|Lost to Follow-up|2|||
124779736|NCT02600819|448823340|FG001|GEN Phase|Lost to Follow-up|0|||
124779737|NCT01027273|448823341|FG000|Overall Study|Lost to Follow-up|57|||
124779738|NCT01027273|448823342|FG001|Overall Study|Lost to Follow-up|31|||
124779739|NCT01027273|448823341|FG000|Overall Study|Death|2|||
124779740|NCT01027273|448823342|FG001|Overall Study|Death|2|||
124779741|NCT02904954|448823344|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
124779742|NCT02904954|448823345|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
124779743|NCT02904954|448823344|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
124779744|NCT02904954|448823345|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
124779745|NCT02904954|448823344|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
124779746|NCT02904954|448823345|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
124779747|NCT02904954|448823344|FG000|Adjuvant Durvalumab|Recurrence|2|||
124779748|NCT02904954|448823345|FG001|Adjuvant Durvalumab|Recurrence|0|||
124779749|NCT02904954|448823344|FG000|Adjuvant Durvalumab|Adverse Event|2|||
124779750|NCT02904954|448823345|FG001|Adjuvant Durvalumab|Adverse Event|6|||
124779751|NCT02904954|448823344|FG000|Adjuvant Durvalumab|Participant wishes|12|||
124779752|NCT02904954|448823345|FG001|Adjuvant Durvalumab|Participant wishes|7|||
124779753|NCT02904954|448823344|FG000|Adjuvant Durvalumab|Physician Decision|2|||
124779754|NCT02904954|448823345|FG001|Adjuvant Durvalumab|Physician Decision|1|||
124779755|NCT02904954|448823344|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
124779756|NCT02904954|448823345|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
124779757|NCT02904954|448823344|FG000|Adjuvant Durvalumab|Death|0|||
124779758|NCT02904954|448823345|FG001|Adjuvant Durvalumab|Death|1|||
124779759|NCT02904954|448823344|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
124779760|NCT02904954|448823345|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
124779761|NCT05097963|448823346|FG000|Overall Study|Protocol Violation|13|||
124779762|NCT05097963|448823346|FG000|Overall Study|Withdrawal by Subject|21|||
124779763|NCT00337675|448823347|FG000|Overall Study|Adverse Event|10|||
124779764|NCT00337675|448823348|FG001|Overall Study|Adverse Event|9|||
124779765|NCT00337675|448823349|FG002|Overall Study|Adverse Event|19|||
124779766|NCT00337675|448823347|FG000|Overall Study|Lack of Efficacy|10|||
124779767|NCT00337675|448823348|FG001|Overall Study|Lack of Efficacy|7|||
124779768|NCT00337675|448823349|FG002|Overall Study|Lack of Efficacy|9|||
124779769|NCT00337675|448823347|FG000|Overall Study|Lost to Follow-up|22|||
124779770|NCT00337675|448823348|FG001|Overall Study|Lost to Follow-up|19|||
124779771|NCT00337675|448823349|FG002|Overall Study|Lost to Follow-up|17|||
124779772|NCT00337675|448823347|FG000|Overall Study|Physician Decision|9|||
124779773|NCT00337675|448823348|FG001|Overall Study|Physician Decision|17|||
124779774|NCT00337675|448823349|FG002|Overall Study|Physician Decision|14|||
124779775|NCT00337675|448823347|FG000|Overall Study|Protocol Violation|21|||
124779776|NCT00337675|448823348|FG001|Overall Study|Protocol Violation|24|||
124779777|NCT00337675|448823349|FG002|Overall Study|Protocol Violation|19|||
124779778|NCT00337675|448823347|FG000|Overall Study|Withdrawal by Subject|25|||
124779779|NCT00337675|448823348|FG001|Overall Study|Withdrawal by Subject|25|||
124779780|NCT00337675|448823349|FG002|Overall Study|Withdrawal by Subject|19|||
124779781|NCT00337675|448823347|FG000|Overall Study|Progressive Disease|0|||
124779782|NCT00337675|448823348|FG001|Overall Study|Progressive Disease|2|||
124779783|NCT00337675|448823349|FG002|Overall Study|Progressive Disease|0|||
124779784|NCT00337675|448823347|FG000|Overall Study|Trial Terminated|0|||
124779785|NCT00337675|448823348|FG001|Overall Study|Trial Terminated|0|||
124779786|NCT00337675|448823349|FG002|Overall Study|Trial Terminated|2|||
124779787|NCT00859456|448823350|FG000|Overall Study|Adverse Event|3|||
124779788|NCT00859456|448823350|FG000|Overall Study|Progressive disease|2|||
124779789|NCT00859456|448823350|FG000|Overall Study|Non-compliance|3|||
124779790|NCT01491607|448823355|FG000|Overall Study|Lost to Follow-up|7|||
124779791|NCT01491607|448823355|FG000|Overall Study|Withdrawal by Subject|3|||
124779792|NCT01317277|448823356|FG000|Overall Study|Lost to Follow-up|3|||
124596584|NCT01117987|448141195|FG001|Overall Study|Withdrawal by Subject|10|||
124596585|NCT01117987|448141194|FG000|Overall Study|Adverse Event|19|||
124596586|NCT01117987|448141195|FG001|Overall Study|Adverse Event|26|||
124596587|NCT01117987|448141194|FG000|Overall Study|Administrative problems|25|||
124596588|NCT01117987|448141195|FG001|Overall Study|Administrative problems|22|||
124779793|NCT01317277|448823357|FG001|Overall Study|Lost to Follow-up|1|||
124779794|NCT01317277|448823356|FG000|Overall Study|Lost MEMS|1|||
124779795|NCT01317277|448823357|FG001|Overall Study|Lost MEMS|1|||
124779796|NCT01317277|448823356|FG000|Overall Study|Unable to comply with intervention|1|||
124779797|NCT01317277|448823357|FG001|Overall Study|Unable to comply with intervention|0|||
124779798|NCT01317277|448823356|FG000|Overall Study|Withdrawal by Subject|1|||
124779799|NCT01317277|448823357|FG001|Overall Study|Withdrawal by Subject|0|||
124779800|NCT01317277|448823356|FG000|Overall Study|Adverse Event|1|||
124779801|NCT01317277|448823357|FG001|Overall Study|Adverse Event|0|||
124779802|NCT00774566|448823358|FG000|Overall Study|Protocol Violation|18|||
124779803|NCT00774566|448823359|FG001|Overall Study|Protocol Violation|15|||
124779804|NCT01075685|448823362|FG000|Overall Study|Protocol Violation|9|||
124779805|NCT01075685|448823363|FG001|Overall Study|Protocol Violation|1|||
124779806|NCT01075685|448823362|FG000|Overall Study|Withdrawal by Subject|20|||
124779807|NCT01075685|448823363|FG001|Overall Study|Withdrawal by Subject|5|||
124779808|NCT01075685|448823362|FG000|Overall Study|Lost to Follow-up|563|||
124779809|NCT01075685|448823363|FG001|Overall Study|Lost to Follow-up|220|||
124596589|NCT04117945|448141196|FG000|Overall Study|Death|1|||
124596590|NCT04117945|448141197|FG001|Overall Study|Death|0|||
124596591|NCT04117945|448141196|FG000|Overall Study|Withdrawal by Subject|3|||
124596592|NCT04117945|448141197|FG001|Overall Study|Withdrawal by Subject|1|||
124596593|NCT04117945|448141196|FG000|Overall Study|Disease Progression|0|||
124596594|NCT04117945|448141197|FG001|Overall Study|Disease Progression|2|||
124596595|NCT04117945|448141196|FG000|Overall Study|Ineligible|8|||
124596596|NCT04117945|448141197|FG001|Overall Study|Ineligible|7|||
124596597|NCT01917968|448141199|FG000|Overall Study|Death|3|||
124596598|NCT01917968|448141200|FG001|Overall Study|Death|2|||
124596599|NCT01917968|448141199|FG000|Overall Study|Lost to Follow-up|21|||
124596600|NCT01917968|448141200|FG001|Overall Study|Lost to Follow-up|39|||
124596601|NCT01917968|448141199|FG000|Overall Study|Physician Decision|1|||
124596602|NCT01917968|448141200|FG001|Overall Study|Physician Decision|2|||
124596603|NCT01917968|448141199|FG000|Overall Study|Withdrawal by Subject|20|||
124596604|NCT01917968|448141200|FG001|Overall Study|Withdrawal by Subject|35|||
124596605|NCT01917968|448141199|FG000|Overall Study|Subject Relocation|5|||
124596606|NCT01917968|448141200|FG001|Overall Study|Subject Relocation|1|||
124596607|NCT01917968|448141199|FG000|Overall Study|36M Missed Visit|3|||
124596608|NCT01917968|448141200|FG001|Overall Study|36M Missed Visit|2|||
124596609|NCT01917968|448141199|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
124596610|NCT01917968|448141200|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
124596611|NCT01917968|448141199|FG000|Overall Study|Change in Family Circumstances|0|||
124596612|NCT01917968|448141200|FG001|Overall Study|Change in Family Circumstances|1|||
124596613|NCT01917968|448141199|FG000|Overall Study|No Data Available|0|||
124596614|NCT01917968|448141200|FG001|Overall Study|No Data Available|2|||
124596615|NCT04232540|448141206|FG000|Overall Study|Lost to Follow-up|1|||
124596616|NCT04232540|448141207|FG001|Overall Study|Lost to Follow-up|0|||
124596617|NCT03438006|448141208|FG000|Overall Study|Adverse Event|1|||
124596618|NCT03438006|448141208|FG000|Overall Study|Lost to Follow-up|67|||
124596619|NCT03438006|448141208|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
124596620|NCT03438006|448141208|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
124596621|NCT03078478|448141227|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
124596622|NCT03078478|448141228|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
124596623|NCT03078478|448141227|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
124596624|NCT03078478|448141228|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
124596625|NCT03078478|448141227|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
124596626|NCT03078478|448141228|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
124596627|NCT03078478|448141227|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
124596628|NCT03078478|448141228|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
124596629|NCT03078478|448141227|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
124596630|NCT03078478|448141228|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
124596631|NCT03078478|448141227|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
124596632|NCT03078478|448141228|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
124596633|NCT03078478|448141227|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
124596634|NCT03078478|448141228|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
124596635|NCT03078478|448141227|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
124596636|NCT03078478|448141228|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
124596637|NCT02339090|448141230|FG000|Overall Study|Adverse Event|1|||
124596638|NCT02339090|448141231|FG001|Overall Study|Adverse Event|0|||
124596639|NCT02339090|448141230|FG000|Overall Study|Lost to Follow-up|0|||
124596640|NCT02339090|448141231|FG001|Overall Study|Lost to Follow-up|1|||
124596641|NCT02339090|448141230|FG000|Overall Study|Non-compliance With Study Drug|0|||
124596642|NCT02339090|448141231|FG001|Overall Study|Non-compliance With Study Drug|1|||
124596643|NCT02339090|448141230|FG000|Overall Study|Withdrawal by Subject|2|||
124596644|NCT02339090|448141231|FG001|Overall Study|Withdrawal by Subject|1|||
124596645|NCT02339090|448141230|FG000|Overall Study|Poor Growth|3|||
124596646|NCT02339090|448141231|FG001|Overall Study|Poor Growth|0|||
124596647|NCT02339090|448141230|FG000|Overall Study|Randomized but not treated|0|||
124596648|NCT02339090|448141231|FG001|Overall Study|Randomized but not treated|2|||
124596649|NCT02737592|448141235|FG000|Overall Study|Withdrawal by Subject|1|||
124596650|NCT00955721|448141237|FG000|Overall Study|Physician Decision|1|||
124596651|NCT00955721|448141238|FG001|Overall Study|Physician Decision|0|||
124596652|NCT00955721|448141237|FG000|Overall Study|Death|1|||
124596653|NCT00955721|448141238|FG001|Overall Study|Death|0|||
124596654|NCT00955721|448141237|FG000|Overall Study|Withdrawal by Subject|1|||
124596655|NCT00955721|448141238|FG001|Overall Study|Withdrawal by Subject|0|||
124596656|NCT03581188|448142744|FG000|Overall Study|Inclusion criteria not met|3|||
124596657|NCT03581188|448142745|FG001|Overall Study|Inclusion criteria not met|2|||
124596658|NCT03581188|448142744|FG000|Overall Study|Lost to Follow-up|5|||
124596659|NCT03581188|448142745|FG001|Overall Study|Lost to Follow-up|5|||
124596660|NCT03581188|448142744|FG000|Overall Study|Discontinued intervention|11|||
124596661|NCT03581188|448142745|FG001|Overall Study|Discontinued intervention|8|||
124596662|NCT03064438|448142746|FG000|Overall Study|Lost to Follow-up|1|||
124596663|NCT03064438|448142747|FG001|Overall Study|Lost to Follow-up|0|||
124596664|NCT03064438|448142746|FG000|Overall Study|Withdrawal by Subject|0|||
124596665|NCT03064438|448142747|FG001|Overall Study|Withdrawal by Subject|1|||
124596666|NCT01937351|448142748|FG000|Overall Study|Withdrawal by Subject|4|||
124596667|NCT01937351|448142749|FG001|Overall Study|Withdrawal by Subject|2|||
124596668|NCT01937351|448142748|FG000|Overall Study|Death|1|||
124596669|NCT01937351|448142749|FG001|Overall Study|Death|0|||
124596670|NCT01937351|448142748|FG000|Overall Study|Not treated w device, per protocol fail|4|||
124596671|NCT01937351|448142749|FG001|Overall Study|Not treated w device, per protocol fail|0|||
124596672|NCT01961687|448142750|FG000|Overall Study|Lost to Follow-up|19|||
124596673|NCT01961687|448142750|FG000|Overall Study|Re-operation|17|||
124596674|NCT01961687|448142750|FG000|Overall Study|Death|7|||
124596675|NCT01961687|448142750|FG000|Overall Study|Withdrawal by Subject|6|||
124596676|NCT01961687|448142750|FG000|Overall Study|Adverse Event|6|||
124596677|NCT01961687|448142750|FG000|Overall Study|Moved to area without study site|2|||
124596678|NCT01961687|448142750|FG000|Overall Study|Sponsor decision|2|||
124596679|NCT01961687|448142750|FG000|Overall Study|Physician Decision|1|||
124596680|NCT01961687|448142750|FG000|Overall Study|Unable to meet follow-up requirements|1|||
124596681|NCT02284347|448142751|FG000|Overall Study|Lost to Follow-up|2|||
124596682|NCT02284347|448142751|FG000|Overall Study|Withdrawn prior to treatment|1|||
124596683|NCT01301482|448142753|FG000|Overall Study|Withdrawal by Subject|1|||
124596684|NCT00480324|448142754|FG000|Overall Study|Adverse Event|1|||
124596685|NCT00480324|448142755|FG001|Overall Study|Adverse Event|1|||
124596686|NCT00480324|448142754|FG000|Overall Study|Protocol Violation|0|||
124596687|NCT00480324|448142755|FG001|Overall Study|Protocol Violation|1|||
124596688|NCT00480324|448142754|FG000|Overall Study|Withdrawal by Subject|14|||
124596689|NCT00480324|448142755|FG001|Overall Study|Withdrawal by Subject|5|||
124596690|NCT00480324|448142754|FG000|Overall Study|Lost to Follow-up|17|||
124596691|NCT00480324|448142755|FG001|Overall Study|Lost to Follow-up|8|||
124596692|NCT00480324|448142754|FG000|Overall Study|Subject's mother pregnant|0|||
124596693|NCT00480324|448142755|FG001|Overall Study|Subject's mother pregnant|1|||
124596694|NCT02999984|448142756|FG000|Overall Study|Treatment Failure|1|||
124596695|NCT01316419|448142757|FG000|Overall Study|Not treated|103|||
124596696|NCT01316419|448142757|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
124596697|NCT01316419|448142757|FG000|Overall Study|Lost to Follow-up|19|||
124596698|NCT04039919|448142758|FG000|Treatment Period 1|Withdrawal by Subject|1|||
124596699|NCT04039919|448142759|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124596700|NCT04039919|448142760|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124596701|NCT04039919|448142761|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124596702|NCT04039919|448142762|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124596703|NCT04039919|448142758|FG000|Treatment Period 1|Sponsor's decision|0|||
124596704|NCT04039919|448142759|FG001|Treatment Period 1|Sponsor's decision|0|||
124596705|NCT04039919|448142760|FG002|Treatment Period 1|Sponsor's decision|0|||
124596706|NCT04039919|448142761|FG003|Treatment Period 1|Sponsor's decision|0|||
124596707|NCT04039919|448142762|FG004|Treatment Period 1|Sponsor's decision|16|||
124596708|NCT04039919|448142758|FG000|Treatment Period 5|Withdrawal by Subject|1|||
124596709|NCT04039919|448142759|FG001|Treatment Period 5|Withdrawal by Subject|0|||
124596710|NCT04039919|448142760|FG002|Treatment Period 5|Withdrawal by Subject|0|||
124596711|NCT04039919|448142761|FG003|Treatment Period 5|Withdrawal by Subject|0|||
124596712|NCT04039919|448142762|FG004|Treatment Period 5|Withdrawal by Subject|0|||
124596713|NCT00754013|448142763|FG000|Overall Study|Lost to Follow-up|1|||
124596714|NCT00754013|448142764|FG001|Overall Study|Lost to Follow-up|1|||
124596715|NCT00754013|448142763|FG000|Overall Study|didn't return after study termed|3|||
124596716|NCT00754013|448142764|FG001|Overall Study|didn't return after study termed|4|||
124596717|NCT02310789|448142765|FG000|Overall Study|Adverse Event|1|||
124596718|NCT00983918|448142766|FG000|Overall Study|conversion to open cholecystectomy|0|||
124596719|NCT00983918|448142767|FG001|Overall Study|conversion to open cholecystectomy|2|||
124596720|NCT00983918|448142768|FG002|Overall Study|conversion to open cholecystectomy|2|||
124596721|NCT00983918|448142769|FG003|Overall Study|conversion to open cholecystectomy|2|||
124596722|NCT00977548|448142771|FG000|Overall Study|Ineligible|4|||
124596723|NCT00977548|448142771|FG000|Overall Study|Adverse Event|8|||
124596724|NCT00977548|448142771|FG000|Overall Study|Withdrawal by Subject|1|||
124596725|NCT02070757|448142772|FG000|Overall Study|Adverse Event|107|||
124596726|NCT02070757|448142773|FG001|Overall Study|Adverse Event|99|||
124596727|NCT02070757|448142772|FG000|Overall Study|Lost to Follow-up|7|||
124596728|NCT02070757|448142773|FG001|Overall Study|Lost to Follow-up|4|||
124596729|NCT02070757|448142772|FG000|Overall Study|Protocol Violation|0|||
124596730|NCT02070757|448142773|FG001|Overall Study|Protocol Violation|4|||
124596731|NCT02070757|448142772|FG000|Overall Study|Withdrawal by Subject|1|||
124596732|NCT02070757|448142773|FG001|Overall Study|Withdrawal by Subject|3|||
124596733|NCT02070757|448142772|FG000|Overall Study|Investigator Decision|0|||
124596734|NCT02070757|448142773|FG001|Overall Study|Investigator Decision|2|||
124596735|NCT02070757|448142772|FG000|Overall Study|Discharged from Study Hospital|2|||
124596736|NCT02070757|448142773|FG001|Overall Study|Discharged from Study Hospital|2|||
124596737|NCT01546922|448142774|FG000|First Period of 10 Weeks|Protocol Violation|3|||
124596738|NCT01546922|448142775|FG001|First Period of 10 Weeks|Protocol Violation|1|||
124596739|NCT01546922|448142774|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
124730798|NCT01666119|448635586|FG000|Overall Study|non compliance with study medication, pa|18|||
124779810|NCT02858362|448823364|FG000|Overall Study|Protocol Violation|0|||
124779811|NCT02858362|448823365|FG001|Overall Study|Protocol Violation|1|||
124779812|NCT02858362|448823366|FG002|Overall Study|Protocol Violation|0|||
124779813|NCT02858362|448823364|FG000|Overall Study|Withdrawal by Subject|1|||
124779814|NCT02858362|448823365|FG001|Overall Study|Withdrawal by Subject|0|||
124779815|NCT02858362|448823366|FG002|Overall Study|Withdrawal by Subject|0|||
124779816|NCT02858362|448823364|FG000|Overall Study|Early Study Termination|0|||
124779817|NCT02858362|448823365|FG001|Overall Study|Early Study Termination|0|||
124779818|NCT02858362|448823366|FG002|Overall Study|Early Study Termination|3|||
124779819|NCT02858362|448823364|FG000|Overall Study|Lost to Follow-up|1|||
124779820|NCT02858362|448823365|FG001|Overall Study|Lost to Follow-up|0|||
124779821|NCT02858362|448823366|FG002|Overall Study|Lost to Follow-up|0|||
124779822|NCT01262989|448823367|FG000|Period 1|Lost to Follow-up|1|||
124779823|NCT01262989|448823368|FG001|Period 1|Lost to Follow-up|1|||
124779824|NCT01262989|448823367|FG000|Period 1|Intercurrent disease|0|||
124779825|NCT01262989|448823368|FG001|Period 1|Intercurrent disease|1|||
124779826|NCT01262989|448823367|FG000|Period 1|Positive answer for exclusion criteria|0|||
124779827|NCT01262989|448823368|FG001|Period 1|Positive answer for exclusion criteria|1|||
124779828|NCT01262989|448823367|FG000|Period 2|Intercurrent disease|0|||
124779829|NCT01262989|448823368|FG001|Period 2|Intercurrent disease|1|||
124779830|NCT02813577|448823369|FG000|Overall Study|Study terminated|4|||
124779831|NCT00775593|448823375|FG000|Overall Study|Unmet eligibility criteria|6|||
124779832|NCT00775593|448823375|FG000|Overall Study|Death|1|||
124779833|NCT02067676|448823376|FG000|Overall Study|Withdrawal by Subject|1|||
124779834|NCT02067676|448823377|FG001|Overall Study|Withdrawal by Subject|0|||
124779835|NCT02067676|448823378|FG002|Overall Study|Withdrawal by Subject|0|||
124779836|NCT02067676|448823379|FG003|Overall Study|Withdrawal by Subject|0|||
124779837|NCT02067676|448823380|FG004|Overall Study|Withdrawal by Subject|0|||
124779838|NCT02067676|448823381|FG005|Overall Study|Withdrawal by Subject|0|||
124779839|NCT02164461|448823389|FG000|Overall Study|Adverse Event|0|||
124779840|NCT02164461|448823390|FG001|Overall Study|Adverse Event|0|||
124779841|NCT02164461|448823391|FG002|Overall Study|Adverse Event|1|||
124779842|NCT02164461|448823389|FG000|Overall Study|Disease Progression|1|||
124779843|NCT02164461|448823390|FG001|Overall Study|Disease Progression|3|||
124779844|NCT02164461|448823391|FG002|Overall Study|Disease Progression|4|||
124779845|NCT02164461|448823389|FG000|Overall Study|Withdrawal by Subject|0|||
124779846|NCT02164461|448823390|FG001|Overall Study|Withdrawal by Subject|3|||
124779847|NCT02164461|448823391|FG002|Overall Study|Withdrawal by Subject|0|||
124779848|NCT02100696|448823393|FG000|Induction Phase|Adverse Event|0|||
124779849|NCT02100696|448823394|FG001|Induction Phase|Adverse Event|0|||
124779850|NCT02100696|448823395|FG002|Induction Phase|Adverse Event|1|||
124779851|NCT02100696|448823396|FG003|Induction Phase|Adverse Event|0|||
124779852|NCT02100696|448823397|FG004|Induction Phase|Adverse Event|0|||
124779853|NCT02100696|448823398|FG005|Induction Phase|Adverse Event|0|||
124779854|NCT02100696|448823393|FG000|Induction Phase|Lost to Follow-up|1|||
124779855|NCT02100696|448823394|FG001|Induction Phase|Lost to Follow-up|0|||
124779856|NCT02100696|448823395|FG002|Induction Phase|Lost to Follow-up|1|||
124596740|NCT01546922|448142775|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
124596741|NCT01546922|448142774|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
124596742|NCT01546922|448142775|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
124596743|NCT01546922|448142774|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
124596744|NCT01546922|448142775|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
124596745|NCT01546922|448142774|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
124596746|NCT01546922|448142775|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
124596747|NCT04086641|448142778|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
124596748|NCT04086641|448142779|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
124596749|NCT01613378|448142782|FG000|Overall Study|Lack of Efficacy|13|||
124596750|NCT01613378|448142782|FG000|Overall Study|Adverse Event|11|||
124596751|NCT01613378|448142782|FG000|Overall Study|Withdrawal by Subject|8|||
124596752|NCT01613378|448142782|FG000|Overall Study|Death|2|||
124596753|NCT01613378|448142782|FG000|Overall Study|Lost to Follow-up|1|||
124596754|NCT01613378|448142782|FG000|Overall Study|Other Reason|4|||
124596755|NCT00794417|448142783|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
124596756|NCT00794417|448142784|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
124596757|NCT00794417|448142785|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
124596758|NCT00794417|448142786|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
124779857|NCT02100696|448823396|FG003|Induction Phase|Lost to Follow-up|0|||
124779858|NCT02100696|448823397|FG004|Induction Phase|Lost to Follow-up|0|||
124779859|NCT02100696|448823398|FG005|Induction Phase|Lost to Follow-up|0|||
124779860|NCT02100696|448823393|FG000|Induction Phase|Protocol Violation|0|||
124779861|NCT02100696|448823394|FG001|Induction Phase|Protocol Violation|1|||
124779862|NCT02100696|448823395|FG002|Induction Phase|Protocol Violation|1|||
124779863|NCT02100696|448823396|FG003|Induction Phase|Protocol Violation|0|||
124779864|NCT02100696|448823397|FG004|Induction Phase|Protocol Violation|0|||
124779865|NCT02100696|448823398|FG005|Induction Phase|Protocol Violation|0|||
124779866|NCT02100696|448823393|FG000|Induction Phase|Withdrawal by Subject|8|||
124779867|NCT02100696|448823394|FG001|Induction Phase|Withdrawal by Subject|2|||
124596759|NCT00794417|448142783|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
124596760|NCT00794417|448142784|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
124596761|NCT00794417|448142785|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
124596762|NCT00794417|448142786|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
124596763|NCT00794417|448142783|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
124596764|NCT00794417|448142784|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
124596765|NCT00794417|448142785|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
124596766|NCT00794417|448142786|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
124596767|NCT00794417|448142783|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
124596768|NCT00794417|448142784|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
124596769|NCT00794417|448142785|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
124596770|NCT00794417|448142786|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
124596771|NCT00794417|448142783|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
124596772|NCT00794417|448142784|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
124596773|NCT00794417|448142785|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
124596774|NCT00794417|448142786|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
124596775|NCT00794417|448142783|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
124596776|NCT00794417|448142784|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
124596777|NCT00794417|448142785|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
124596778|NCT00794417|448142786|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
124596779|NCT00792623|448142787|FG000|Overall Study|Adverse Event|2|||
124596780|NCT00792623|448142787|FG000|Overall Study|Withdrawal by Subject|5|||
124596781|NCT02065713|448142793|FG000|Overall Study|Adverse Event|0|||
124596782|NCT02065713|448142794|FG001|Overall Study|Adverse Event|1|||
124596783|NCT02065713|448142793|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124596784|NCT02065713|448142794|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124596785|NCT02694549|448142797|FG000|Overall Study|screen failures|2|||
124596786|NCT01534078|448142798|FG000|Overall Study|Death|1|||
124596787|NCT01534078|448142798|FG000|Overall Study|Withdrawal by Subject|1|||
124596788|NCT02459665|448142799|FG000|Overall Study|Withdrawal by Subject|0|||
124596789|NCT02459665|448142800|FG001|Overall Study|Withdrawal by Subject|1|||
124596790|NCT02459665|448142801|FG002|Overall Study|Withdrawal by Subject|1|||
124596791|NCT02459665|448142802|FG003|Overall Study|Withdrawal by Subject|2|||
124596792|NCT01220609|448142803|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
124596793|NCT01220609|448142803|FG000|Overall Study|Ineligible- Wrong cell type|1|||
124596794|NCT01220609|448142803|FG000|Overall Study|Ineligible-Never treated|1|||
124596795|NCT02225665|448142804|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
124596796|NCT02225665|448142805|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
124596797|NCT02225665|448142804|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
124596798|NCT02225665|448142805|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
124596799|NCT01470417|448142810|FG000|Overall Study|Disease progression|0|||
124596800|NCT01470417|448142811|FG001|Overall Study|Disease progression|2|||
124596801|NCT01790113|448142814|FG000|Overall Study|Adverse Event|2|||
124596802|NCT01790113|448142815|FG001|Overall Study|Adverse Event|7|||
124596803|NCT01790113|448142814|FG000|Overall Study|Study ended due to FDA clearance|1|||
124596804|NCT01790113|448142815|FG001|Overall Study|Study ended due to FDA clearance|68|||
124596805|NCT00194792|448142816|FG000|Overall Study|Withdrawal by Subject|1|||
124596806|NCT01714739|448142817|FG000|Overall Study|Disease progression|3|||
124596807|NCT01714739|448142818|FG001|Overall Study|Disease progression|5|||
124596808|NCT01714739|448142819|FG002|Overall Study|Disease progression|5|||
124596809|NCT01714739|448142820|FG003|Overall Study|Disease progression|204|||
124596810|NCT01714739|448142821|FG004|Overall Study|Disease progression|1|||
124596811|NCT01714739|448142822|FG005|Overall Study|Disease progression|3|||
124596812|NCT01714739|448142823|FG006|Overall Study|Disease progression|5|||
124596813|NCT01714739|448142817|FG000|Overall Study|Study drug toxicity|1|||
124596814|NCT01714739|448142818|FG001|Overall Study|Study drug toxicity|1|||
124596815|NCT01714739|448142819|FG002|Overall Study|Study drug toxicity|1|||
124596816|NCT01714739|448142820|FG003|Overall Study|Study drug toxicity|15|||
124596817|NCT01714739|448142821|FG004|Overall Study|Study drug toxicity|0|||
124596818|NCT01714739|448142822|FG005|Overall Study|Study drug toxicity|0|||
124596819|NCT01714739|448142823|FG006|Overall Study|Study drug toxicity|5|||
124596820|NCT01714739|448142817|FG000|Overall Study|Death|0|||
124596821|NCT01714739|448142818|FG001|Overall Study|Death|0|||
124730799|NCT01666119|448635586|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
124596822|NCT01714739|448142819|FG002|Overall Study|Death|0|||
124596823|NCT01714739|448142820|FG003|Overall Study|Death|1|||
124596824|NCT01714739|448142821|FG004|Overall Study|Death|0|||
124596825|NCT01714739|448142822|FG005|Overall Study|Death|0|||
124596826|NCT01714739|448142823|FG006|Overall Study|Death|0|||
124596827|NCT01714739|448142817|FG000|Overall Study|Adverse Event unrelated to drug|0|||
124596828|NCT01714739|448142818|FG001|Overall Study|Adverse Event unrelated to drug|0|||
124596829|NCT01714739|448142819|FG002|Overall Study|Adverse Event unrelated to drug|3|||
124730800|NCT05479097|448635592|FG000|Overall Study|Withdrawal by Subject|2|||
124779868|NCT02100696|448823395|FG002|Induction Phase|Withdrawal by Subject|13|||
124779869|NCT02100696|448823396|FG003|Induction Phase|Withdrawal by Subject|0|||
124779870|NCT02100696|448823397|FG004|Induction Phase|Withdrawal by Subject|0|||
124596830|NCT01714739|448142820|FG003|Overall Study|Adverse Event unrelated to drug|21|||
124596831|NCT01714739|448142821|FG004|Overall Study|Adverse Event unrelated to drug|0|||
124596832|NCT01714739|448142822|FG005|Overall Study|Adverse Event unrelated to drug|0|||
124596833|NCT01714739|448142823|FG006|Overall Study|Adverse Event unrelated to drug|0|||
124596834|NCT01714739|448142817|FG000|Overall Study|Participant request to stop therapy|0|||
124596835|NCT01714739|448142818|FG001|Overall Study|Participant request to stop therapy|1|||
124596836|NCT01714739|448142819|FG002|Overall Study|Participant request to stop therapy|0|||
124596837|NCT01714739|448142820|FG003|Overall Study|Participant request to stop therapy|6|||
124596838|NCT01714739|448142821|FG004|Overall Study|Participant request to stop therapy|0|||
124779871|NCT02100696|448823398|FG005|Induction Phase|Withdrawal by Subject|0|||
124779872|NCT02100696|448823393|FG000|Induction Phase|Physician Decision|1|||
124779873|NCT02100696|448823394|FG001|Induction Phase|Physician Decision|0|||
124596839|NCT01714739|448142822|FG005|Overall Study|Participant request to stop therapy|0|||
124596840|NCT01714739|448142823|FG006|Overall Study|Participant request to stop therapy|0|||
124596841|NCT01714739|448142817|FG000|Overall Study|Participant withdrew consent|0|||
124596842|NCT01714739|448142818|FG001|Overall Study|Participant withdrew consent|1|||
124596843|NCT01714739|448142819|FG002|Overall Study|Participant withdrew consent|0|||
124596844|NCT01714739|448142820|FG003|Overall Study|Participant withdrew consent|8|||
124596845|NCT01714739|448142821|FG004|Overall Study|Participant withdrew consent|0|||
124596846|NCT01714739|448142822|FG005|Overall Study|Participant withdrew consent|0|||
124596847|NCT01714739|448142823|FG006|Overall Study|Participant withdrew consent|0|||
124596848|NCT01714739|448142817|FG000|Overall Study|Lost to Follow-up|0|||
124779874|NCT02100696|448823395|FG002|Induction Phase|Physician Decision|2|||
124779875|NCT02100696|448823396|FG003|Induction Phase|Physician Decision|0|||
124779876|NCT02100696|448823397|FG004|Induction Phase|Physician Decision|0|||
124779877|NCT02100696|448823398|FG005|Induction Phase|Physician Decision|0|||
124779878|NCT02100696|448823393|FG000|Induction Phase|Multiple Reasons|5|||
124779879|NCT02100696|448823394|FG001|Induction Phase|Multiple Reasons|2|||
124779880|NCT02100696|448823395|FG002|Induction Phase|Multiple Reasons|8|||
124779881|NCT02100696|448823396|FG003|Induction Phase|Multiple Reasons|0|||
124779882|NCT02100696|448823397|FG004|Induction Phase|Multiple Reasons|0|||
124779883|NCT02100696|448823398|FG005|Induction Phase|Multiple Reasons|0|||
124779884|NCT02100696|448823393|FG000|Maintenance Phase|Adverse Event|0|||
124779885|NCT02100696|448823394|FG001|Maintenance Phase|Adverse Event|0|||
124779886|NCT02100696|448823395|FG002|Maintenance Phase|Adverse Event|0|||
124779887|NCT02100696|448823396|FG003|Maintenance Phase|Adverse Event|0|||
124779888|NCT02100696|448823397|FG004|Maintenance Phase|Adverse Event|0|||
124779889|NCT02100696|448823398|FG005|Maintenance Phase|Adverse Event|2|||
124779890|NCT02100696|448823393|FG000|Maintenance Phase|Lost to Follow-up|0|||
124779891|NCT02100696|448823394|FG001|Maintenance Phase|Lost to Follow-up|0|||
124779892|NCT02100696|448823395|FG002|Maintenance Phase|Lost to Follow-up|0|||
124779893|NCT02100696|448823396|FG003|Maintenance Phase|Lost to Follow-up|0|||
124779894|NCT02100696|448823397|FG004|Maintenance Phase|Lost to Follow-up|1|||
124779895|NCT02100696|448823398|FG005|Maintenance Phase|Lost to Follow-up|0|||
124779896|NCT02100696|448823393|FG000|Maintenance Phase|Protocol Violation|0|||
124779897|NCT02100696|448823394|FG001|Maintenance Phase|Protocol Violation|0|||
124779898|NCT02100696|448823395|FG002|Maintenance Phase|Protocol Violation|0|||
124779899|NCT02100696|448823396|FG003|Maintenance Phase|Protocol Violation|0|||
124779900|NCT02100696|448823397|FG004|Maintenance Phase|Protocol Violation|1|||
124779901|NCT02100696|448823398|FG005|Maintenance Phase|Protocol Violation|0|||
124779902|NCT02100696|448823393|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124779903|NCT02100696|448823394|FG001|Maintenance Phase|Withdrawal by Subject|0|||
124779904|NCT02100696|448823395|FG002|Maintenance Phase|Withdrawal by Subject|0|||
124596849|NCT01714739|448142818|FG001|Overall Study|Lost to Follow-up|0|||
124596850|NCT01714739|448142819|FG002|Overall Study|Lost to Follow-up|0|||
124596851|NCT01714739|448142820|FG003|Overall Study|Lost to Follow-up|1|||
124596852|NCT01714739|448142821|FG004|Overall Study|Lost to Follow-up|0|||
124596853|NCT01714739|448142822|FG005|Overall Study|Lost to Follow-up|0|||
124596854|NCT01714739|448142823|FG006|Overall Study|Lost to Follow-up|0|||
124596855|NCT01714739|448142817|FG000|Overall Study|Maximum clinical benefit|0|||
124596856|NCT01714739|448142818|FG001|Overall Study|Maximum clinical benefit|1|||
124596857|NCT01714739|448142819|FG002|Overall Study|Maximum clinical benefit|1|||
124596858|NCT01714739|448142820|FG003|Overall Study|Maximum clinical benefit|3|||
124779905|NCT02100696|448823396|FG003|Maintenance Phase|Withdrawal by Subject|1|||
124779906|NCT02100696|448823397|FG004|Maintenance Phase|Withdrawal by Subject|4|||
124779907|NCT02100696|448823398|FG005|Maintenance Phase|Withdrawal by Subject|2|||
124779908|NCT02100696|448823393|FG000|Maintenance Phase|Physician Decision|0|||
124779909|NCT02100696|448823394|FG001|Maintenance Phase|Physician Decision|0|||
124779910|NCT02100696|448823395|FG002|Maintenance Phase|Physician Decision|0|||
124779911|NCT02100696|448823396|FG003|Maintenance Phase|Physician Decision|0|||
124779912|NCT02100696|448823397|FG004|Maintenance Phase|Physician Decision|1|||
124779913|NCT02100696|448823398|FG005|Maintenance Phase|Physician Decision|0|||
124596859|NCT01714739|448142821|FG004|Overall Study|Maximum clinical benefit|0|||
124596860|NCT01714739|448142822|FG005|Overall Study|Maximum clinical benefit|0|||
124596861|NCT01714739|448142823|FG006|Overall Study|Maximum clinical benefit|0|||
124596862|NCT01714739|448142817|FG000|Overall Study|Poor/non-comliance|0|||
124596863|NCT01714739|448142818|FG001|Overall Study|Poor/non-comliance|1|||
124596864|NCT01714739|448142819|FG002|Overall Study|Poor/non-comliance|0|||
124596865|NCT01714739|448142820|FG003|Overall Study|Poor/non-comliance|1|||
124596866|NCT01714739|448142821|FG004|Overall Study|Poor/non-comliance|0|||
124596867|NCT01714739|448142822|FG005|Overall Study|Poor/non-comliance|0|||
124596868|NCT01714739|448142823|FG006|Overall Study|Poor/non-comliance|0|||
124596869|NCT01714739|448142817|FG000|Overall Study|No longer meets study criteria|0|||
124596870|NCT01714739|448142818|FG001|Overall Study|No longer meets study criteria|0|||
124596871|NCT01714739|448142819|FG002|Overall Study|No longer meets study criteria|0|||
124596872|NCT01714739|448142820|FG003|Overall Study|No longer meets study criteria|1|||
124596873|NCT01714739|448142821|FG004|Overall Study|No longer meets study criteria|0|||
124596874|NCT01714739|448142822|FG005|Overall Study|No longer meets study criteria|0|||
124596875|NCT01714739|448142823|FG006|Overall Study|No longer meets study criteria|0|||
124596876|NCT01714739|448142817|FG000|Overall Study|Other reason|0|||
124596877|NCT01714739|448142818|FG001|Overall Study|Other reason|0|||
124596878|NCT01714739|448142819|FG002|Overall Study|Other reason|0|||
124596879|NCT01714739|448142820|FG003|Overall Study|Other reason|3|||
124596880|NCT01714739|448142821|FG004|Overall Study|Other reason|1|||
124596881|NCT01714739|448142822|FG005|Overall Study|Other reason|0|||
124596882|NCT01714739|448142823|FG006|Overall Study|Other reason|0|||
124596883|NCT03585959|448142824|FG000|Overall Study|Physician Decision|1|||
124596884|NCT03585959|448142824|FG000|Overall Study|Unsuccessful Procedure|2|||
124596885|NCT00614822|448142826|FG000|Overall Study|Adverse Event|3|||
124596886|NCT02674386|448142829|FG000|Overall Study|Lost to Follow-up|0|||
124596887|NCT02674386|448142830|FG001|Overall Study|Lost to Follow-up|1|||
124596888|NCT02674386|448142831|FG002|Overall Study|Lost to Follow-up|1|||
124596889|NCT02674386|448142829|FG000|Overall Study|Withdrawal by Subject|0|||
124596890|NCT02674386|448142830|FG001|Overall Study|Withdrawal by Subject|4|||
124596891|NCT02674386|448142831|FG002|Overall Study|Withdrawal by Subject|0|||
124596892|NCT02674386|448142829|FG000|Overall Study|Other|0|||
124596893|NCT02674386|448142830|FG001|Overall Study|Other|1|||
124596894|NCT02674386|448142831|FG002|Overall Study|Other|0|||
124596895|NCT02674386|448142829|FG000|Overall Study|Enrolled but not evaluated|0|||
124596896|NCT02674386|448142830|FG001|Overall Study|Enrolled but not evaluated|4|||
124596897|NCT02674386|448142831|FG002|Overall Study|Enrolled but not evaluated|0|||
124596898|NCT01439724|448142836|FG000|Overall Study|missing consultation|9|||
124596899|NCT01439724|448142837|FG001|Overall Study|missing consultation|8|||
124596900|NCT01040793|448142842|FG000|Overall Study|Adverse Event|5|||
124596901|NCT01040793|448142843|FG001|Overall Study|Adverse Event|3|||
124596902|NCT01040793|448142844|FG002|Overall Study|Adverse Event|0|||
124596903|NCT01040793|448142845|FG003|Overall Study|Adverse Event|2|||
124596904|NCT01040793|448142846|FG004|Overall Study|Adverse Event|2|||
124596905|NCT01040793|448142847|FG005|Overall Study|Adverse Event|1|||
124596906|NCT01040793|448142842|FG000|Overall Study|Protocol Violation|1|||
124596907|NCT01040793|448142843|FG001|Overall Study|Protocol Violation|1|||
124596908|NCT01040793|448142844|FG002|Overall Study|Protocol Violation|1|||
124596909|NCT01040793|448142845|FG003|Overall Study|Protocol Violation|0|||
124596910|NCT01040793|448142846|FG004|Overall Study|Protocol Violation|1|||
124596911|NCT01040793|448142847|FG005|Overall Study|Protocol Violation|0|||
124596912|NCT01040793|448142842|FG000|Overall Study|Lost to Follow-up|0|||
124730801|NCT04003207|448635595|FG000|Overall Study|Protocol Violation|1|||
124730802|NCT03894969|448635599|FG000|Overall Study|Adverse Event|0|||
124730803|NCT03894969|448635600|FG001|Overall Study|Adverse Event|2|||
124730804|NCT03894969|448635601|FG002|Overall Study|Adverse Event|0|||
124730805|NCT03894969|448635602|FG003|Overall Study|Adverse Event|1|||
124730806|NCT03894969|448635603|FG004|Overall Study|Adverse Event|2|||
124596913|NCT01040793|448142843|FG001|Overall Study|Lost to Follow-up|1|||
124596914|NCT01040793|448142844|FG002|Overall Study|Lost to Follow-up|1|||
124596915|NCT01040793|448142845|FG003|Overall Study|Lost to Follow-up|0|||
124730807|NCT03894969|448635599|FG000|Overall Study|Lost to Follow-up|3|||
124596916|NCT01040793|448142846|FG004|Overall Study|Lost to Follow-up|0|||
124596917|NCT01040793|448142847|FG005|Overall Study|Lost to Follow-up|0|||
124596918|NCT01040793|448142842|FG000|Overall Study|Withdrawal by Subject|0|||
124596919|NCT01040793|448142843|FG001|Overall Study|Withdrawal by Subject|0|||
124596920|NCT01040793|448142844|FG002|Overall Study|Withdrawal by Subject|0|||
124596921|NCT01040793|448142845|FG003|Overall Study|Withdrawal by Subject|2|||
124596922|NCT01040793|448142846|FG004|Overall Study|Withdrawal by Subject|0|||
124596923|NCT01040793|448142847|FG005|Overall Study|Withdrawal by Subject|0|||
124596924|NCT01040793|448142842|FG000|Overall Study|Other reasons not listed above|0|||
124730808|NCT03894969|448635600|FG001|Overall Study|Lost to Follow-up|1|||
124596925|NCT01040793|448142843|FG001|Overall Study|Other reasons not listed above|0|||
124596926|NCT01040793|448142844|FG002|Overall Study|Other reasons not listed above|1|||
124596927|NCT01040793|448142845|FG003|Overall Study|Other reasons not listed above|0|||
124596928|NCT01040793|448142846|FG004|Overall Study|Other reasons not listed above|1|||
124779914|NCT02100696|448823393|FG000|Maintenance Phase|Multiple Reasons|0|||
124779915|NCT02100696|448823394|FG001|Maintenance Phase|Multiple Reasons|0|||
124779916|NCT02100696|448823395|FG002|Maintenance Phase|Multiple Reasons|0|||
124779917|NCT02100696|448823396|FG003|Maintenance Phase|Multiple Reasons|0|||
124779918|NCT02100696|448823397|FG004|Maintenance Phase|Multiple Reasons|2|||
124779919|NCT02100696|448823398|FG005|Maintenance Phase|Multiple Reasons|1|||
124779920|NCT03865381|448823401|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
124779921|NCT03865381|448823401|FG000|Overall Study|Withdrawal by Subject|2|||
124779922|NCT05626322|448823402|FG000|Overall Study|Death|2|||
124779923|NCT05626322|448823403|FG001|Overall Study|Death|0|||
124779924|NCT05626322|448823404|FG002|Overall Study|Death|0|||
124779925|NCT05626322|448823402|FG000|Overall Study|Physician Decision|1|||
124779926|NCT05626322|448823403|FG001|Overall Study|Physician Decision|0|||
124779927|NCT05626322|448823404|FG002|Overall Study|Physician Decision|0|||
124779928|NCT05626322|448823402|FG000|Overall Study|Progressive Disease|0|||
124779929|NCT05626322|448823403|FG001|Overall Study|Progressive Disease|1|||
124779930|NCT05626322|448823404|FG002|Overall Study|Progressive Disease|1|||
124779931|NCT05626322|448823402|FG000|Overall Study|Study terminated by sponsor|0|||
124779932|NCT05626322|448823403|FG001|Overall Study|Study terminated by sponsor|1|||
124779933|NCT05626322|448823404|FG002|Overall Study|Study terminated by sponsor|0|||
124779934|NCT00369265|448823405|FG000|Overall Study|Study terminated|4|||
124779935|NCT00369265|448823406|FG001|Overall Study|Study terminated|7|||
124779936|NCT00048074|448823409|FG000|Overall Study|Adverse Event|46|||
124779937|NCT00048074|448823410|FG001|Overall Study|Adverse Event|41|||
124779938|NCT00048074|448823411|FG002|Overall Study|Adverse Event|53|||
124779939|NCT00048074|448823409|FG000|Overall Study|Death|3|||
124779940|NCT00048074|448823410|FG001|Overall Study|Death|3|||
124779941|NCT00048074|448823411|FG002|Overall Study|Death|2|||
124779942|NCT00048074|448823409|FG000|Overall Study|Lost to Follow-up|2|||
124779943|NCT00048074|448823410|FG001|Overall Study|Lost to Follow-up|6|||
124779944|NCT00048074|448823411|FG002|Overall Study|Lost to Follow-up|6|||
124779945|NCT00048074|448823409|FG000|Overall Study|Withdrawal by Subject|28|||
124779946|NCT00048074|448823410|FG001|Overall Study|Withdrawal by Subject|30|||
124779947|NCT00048074|448823411|FG002|Overall Study|Withdrawal by Subject|35|||
124779948|NCT00048074|448823409|FG000|Overall Study|Protocol Violation|1|||
124779949|NCT00048074|448823410|FG001|Overall Study|Protocol Violation|3|||
124779950|NCT00048074|448823411|FG002|Overall Study|Protocol Violation|0|||
124779951|NCT00048074|448823409|FG000|Overall Study|Study participation was terminated|0|||
124779952|NCT00048074|448823410|FG001|Overall Study|Study participation was terminated|1|||
124779953|NCT00048074|448823411|FG002|Overall Study|Study participation was terminated|0|||
124779954|NCT00048074|448823409|FG000|Overall Study|Husband ill|0|||
124779955|NCT00048074|448823410|FG001|Overall Study|Husband ill|1|||
124779956|NCT00048074|448823411|FG002|Overall Study|Husband ill|0|||
124779957|NCT00048074|448823409|FG000|Overall Study|Poor compliance|0|||
124779958|NCT00048074|448823410|FG001|Overall Study|Poor compliance|1|||
124779959|NCT00048074|448823411|FG002|Overall Study|Poor compliance|0|||
124779960|NCT00048074|448823409|FG000|Overall Study|Out of station|0|||
124779961|NCT00048074|448823410|FG001|Overall Study|Out of station|1|||
124779962|NCT00048074|448823411|FG002|Overall Study|Out of station|1|||
124779963|NCT00048074|448823409|FG000|Overall Study|Social reasons|1|||
124779964|NCT00048074|448823410|FG001|Overall Study|Social reasons|0|||
124779965|NCT00048074|448823411|FG002|Overall Study|Social reasons|0|||
124779966|NCT02873377|448823412|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
124779967|NCT02873377|448823413|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
124779968|NCT02873377|448823412|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
124779969|NCT02873377|448823413|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
124779970|NCT00314795|448823419|FG000|Overall Study|Adverse Event|8|||
124779971|NCT00314795|448823419|FG000|Overall Study|Death|4|||
124779972|NCT00314795|448823419|FG000|Overall Study|Reason not Specified|3|||
124779973|NCT00314795|448823419|FG000|Overall Study|Renal Transplant|3|||
124779974|NCT00314795|448823419|FG000|Overall Study|Participants Withdrew Consent|2|||
124779975|NCT00740857|448823424|FG000|Overall Study|Withdrawal by Subject|1|||
124779976|NCT00740857|448823425|FG001|Overall Study|Withdrawal by Subject|0|||
124779977|NCT00740857|448823426|FG002|Overall Study|Withdrawal by Subject|0|||
124779978|NCT03532451|448823430|FG000|Overall Study|Withdrawal by Subject|0|||
124779979|NCT03532451|448823431|FG001|Overall Study|Withdrawal by Subject|1|||
124779980|NCT03532451|448823430|FG000|Overall Study|Did not undergo surgery|1|||
124779981|NCT03532451|448823431|FG001|Overall Study|Did not undergo surgery|1|||
124779982|NCT01519167|448823432|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
124779983|NCT01519167|448823433|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
124779984|NCT01519167|448823432|FG000|Overall Study|Adverse Event|0|||
124779985|NCT01519167|448823433|FG001|Overall Study|Adverse Event|1|||
124779986|NCT01519167|448823432|FG000|Overall Study|Lack of Efficacy|0|||
124779987|NCT01519167|448823433|FG001|Overall Study|Lack of Efficacy|1|||
124779988|NCT01519167|448823432|FG000|Overall Study|Medical condition changes&deep sedation|0|||
124779989|NCT01519167|448823433|FG001|Overall Study|Medical condition changes&deep sedation|2|||
124779990|NCT01519167|448823432|FG000|Overall Study|Physician Decision|0|||
124779991|NCT01519167|448823433|FG001|Overall Study|Physician Decision|1|||
124730809|NCT03894969|448635601|FG002|Overall Study|Lost to Follow-up|1|||
124730810|NCT03894969|448635602|FG003|Overall Study|Lost to Follow-up|0|||
124730811|NCT03894969|448635603|FG004|Overall Study|Lost to Follow-up|0|||
124730812|NCT03894969|448635599|FG000|Overall Study|Withdrawal by Subject|2|||
124730813|NCT03894969|448635600|FG001|Overall Study|Withdrawal by Subject|1|||
124730814|NCT03894969|448635601|FG002|Overall Study|Withdrawal by Subject|3|||
124730815|NCT03894969|448635602|FG003|Overall Study|Withdrawal by Subject|4|||
124730816|NCT03894969|448635603|FG004|Overall Study|Withdrawal by Subject|8|||
124730817|NCT03894969|448635599|FG000|Overall Study|Other|0|||
124730818|NCT03894969|448635600|FG001|Overall Study|Other|0|||
124730819|NCT03894969|448635601|FG002|Overall Study|Other|0|||
124730820|NCT03894969|448635602|FG003|Overall Study|Other|0|||
124730821|NCT03894969|448635603|FG004|Overall Study|Other|3|||
124730822|NCT03894969|448635599|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
124730823|NCT03894969|448635600|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
124730824|NCT03894969|448635601|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
124730825|NCT03894969|448635602|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
124730826|NCT03894969|448635603|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
124730827|NCT03894969|448635599|FG000|Overall Study|Solicited Adverse Event|0|||
124730828|NCT03894969|448635600|FG001|Overall Study|Solicited Adverse Event|1|||
124730829|NCT03894969|448635601|FG002|Overall Study|Solicited Adverse Event|0|||
124730830|NCT03894969|448635602|FG003|Overall Study|Solicited Adverse Event|0|||
124730831|NCT03894969|448635603|FG004|Overall Study|Solicited Adverse Event|0|||
124730832|NCT00468676|448635606|FG000|Overall Study|Lost to Follow-up|14|||
124730833|NCT00468676|448635607|FG001|Overall Study|Lost to Follow-up|11|||
124730834|NCT00468676|448635606|FG000|Overall Study|Death|2|||
124730835|NCT00468676|448635607|FG001|Overall Study|Death|1|||
124730836|NCT01327053|448635611|FG000|Overall Study|Adverse Event|23|||
124730837|NCT01327053|448635612|FG001|Overall Study|Adverse Event|57|||
124730838|NCT01327053|448635611|FG000|Overall Study|Patient/guardian decision|11|||
124730839|NCT01327053|448635612|FG001|Overall Study|Patient/guardian decision|35|||
124730840|NCT01327053|448635611|FG000|Overall Study|Physician Decision|10|||
124730841|NCT01327053|448635612|FG001|Overall Study|Physician Decision|14|||
124730842|NCT01327053|448635611|FG000|Overall Study|Death|1|||
124730843|NCT01327053|448635612|FG001|Overall Study|Death|5|||
124730844|NCT01327053|448635611|FG000|Overall Study|Lost to Follow-up|2|||
124730845|NCT01327053|448635612|FG001|Overall Study|Lost to Follow-up|4|||
124730846|NCT01327053|448635611|FG000|Overall Study|Non-compliance with study treatment|0|||
124730847|NCT01327053|448635612|FG001|Overall Study|Non-compliance with study treatment|5|||
124730848|NCT01327053|448635611|FG000|Overall Study|Study terminated by Sponsor|1|||
124730849|NCT01327053|448635612|FG001|Overall Study|Study terminated by Sponsor|3|||
124730850|NCT01327053|448635611|FG000|Overall Study|Progressive disease|31|||
124730851|NCT01327053|448635612|FG001|Overall Study|Progressive disease|26|||
124730852|NCT01327053|448635611|FG000|Overall Study|Protocol Violation|0|||
124730853|NCT01327053|448635612|FG001|Overall Study|Protocol Violation|1|||
124730854|NCT01327053|448635611|FG000|Overall Study|Untreated|0|||
124730855|NCT01327053|448635612|FG001|Overall Study|Untreated|1|||
124730856|NCT01574157|448635613|FG000|Overall Study|Withdrawal by Subject|4|||
124730857|NCT01574157|448635614|FG001|Overall Study|Withdrawal by Subject|5|||
124730858|NCT01574157|448635613|FG000|Overall Study|Lost to Follow-up|0|||
124730859|NCT01574157|448635614|FG001|Overall Study|Lost to Follow-up|3|||
124730860|NCT00721578|448635615|FG000|Overall Study|Death|1|||
124730861|NCT00721578|448635616|FG001|Overall Study|Death|1|||
124730862|NCT00721578|448635615|FG000|Overall Study|Withdrawal by Subject|1|||
124730863|NCT00721578|448635616|FG001|Overall Study|Withdrawal by Subject|1|||
124730864|NCT01330628|448635618|FG000|Overall Study|Death|2|||
124730865|NCT01330628|448635619|FG001|Overall Study|Death|3|||
124730866|NCT01330628|448635618|FG000|Overall Study|Lost to Follow-up|5|||
124730867|NCT01330628|448635619|FG001|Overall Study|Lost to Follow-up|6|||
124730868|NCT01330628|448635618|FG000|Overall Study|Adverse Event|44|||
124730869|NCT01330628|448635619|FG001|Overall Study|Adverse Event|25|||
124730870|NCT01330628|448635618|FG000|Overall Study|Withdrawn|18|||
124730871|NCT01330628|448635619|FG001|Overall Study|Withdrawn|6|||
124730872|NCT01330628|448635618|FG000|Overall Study|Didn't receive study treatment|1|||
124730873|NCT01330628|448635619|FG001|Overall Study|Didn't receive study treatment|0|||
124730874|NCT02910401|448635620|FG000|Overall Study|Study closure Study closure|0|||
124730875|NCT02910401|448635621|FG001|Overall Study|Study closure Study closure|0|||
124730876|NCT02910401|448635622|FG002|Overall Study|Study closure Study closure|2|||
124730877|NCT02910401|448635620|FG000|Overall Study|Physician Decision|1|||
124730878|NCT02910401|448635621|FG001|Overall Study|Physician Decision|0|||
124730879|NCT02910401|448635622|FG002|Overall Study|Physician Decision|0|||
124730880|NCT03222973|448635633|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
124730881|NCT03222973|448635634|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
124730882|NCT03222973|448635635|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
124730883|NCT03222973|448635636|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
124730884|NCT03222973|448635633|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
124779992|NCT04200352|448823444|FG000|Overall Study|Death|1|||
124779993|NCT04200352|448823444|FG000|Overall Study|Adverse Event|6|||
124779994|NCT04200352|448823444|FG000|Overall Study|Withdrawal by parent/guardian|6|||
124779995|NCT04200352|448823444|FG000|Overall Study|Lack of Efficacy|1|||
124779996|NCT04200352|448823444|FG000|Overall Study|Other than specified|6|||
124596929|NCT01040793|448142847|FG005|Overall Study|Other reasons not listed above|0|||
124596930|NCT00939627|448142852|FG000|Overall Study|Disease Progression|16|||
124596931|NCT00939627|448142853|FG001|Overall Study|Disease Progression|12|||
124596932|NCT00939627|448142854|FG002|Overall Study|Disease Progression|0|||
124596933|NCT00939627|448142852|FG000|Overall Study|Adverse Event|6|||
124596934|NCT00939627|448142853|FG001|Overall Study|Adverse Event|7|||
124596935|NCT00939627|448142854|FG002|Overall Study|Adverse Event|0|||
124596936|NCT00939627|448142852|FG000|Overall Study|Death|0|||
124596937|NCT00939627|448142853|FG001|Overall Study|Death|2|||
124596938|NCT00939627|448142854|FG002|Overall Study|Death|0|||
124596939|NCT00939627|448142852|FG000|Overall Study|Withdrawal by Subject|2|||
124596940|NCT00939627|448142853|FG001|Overall Study|Withdrawal by Subject|4|||
124596941|NCT00939627|448142854|FG002|Overall Study|Withdrawal by Subject|0|||
124596942|NCT00939627|448142852|FG000|Overall Study|Other complicating disease|1|||
124596943|NCT00939627|448142853|FG001|Overall Study|Other complicating disease|1|||
124596944|NCT00939627|448142854|FG002|Overall Study|Other complicating disease|0|||
124596945|NCT00939627|448142852|FG000|Overall Study|Not compliant|2|||
124596946|NCT00939627|448142853|FG001|Overall Study|Not compliant|0|||
124596947|NCT00939627|448142854|FG002|Overall Study|Not compliant|0|||
124596948|NCT00939627|448142852|FG000|Overall Study|No off-tx reason given|0|||
124596949|NCT00939627|448142853|FG001|Overall Study|No off-tx reason given|2|||
124596950|NCT00939627|448142854|FG002|Overall Study|No off-tx reason given|0|||
124596951|NCT03297294|448142855|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
124596952|NCT03297294|448142856|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
124596953|NCT03297294|448142857|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
124596954|NCT03297294|448142858|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
124596955|NCT03297294|448142859|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
124596956|NCT03297294|448142855|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
124596957|NCT03297294|448142856|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
124596958|NCT03297294|448142857|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
124596959|NCT03297294|448142858|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
124596960|NCT03297294|448142859|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
124596961|NCT03297294|448142855|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
124596962|NCT03297294|448142856|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
124596963|NCT03297294|448142857|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
124596964|NCT03297294|448142858|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
124596965|NCT03297294|448142859|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
124596966|NCT03297294|448142855|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
124596967|NCT03297294|448142856|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
124596968|NCT03297294|448142857|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
124596969|NCT03297294|448142858|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
124596970|NCT03297294|448142859|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
124596971|NCT03297294|448142855|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
124596972|NCT03297294|448142856|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
124596973|NCT03297294|448142857|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
124596974|NCT03297294|448142858|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
124779997|NCT00233064|448823445|FG000|Overall Study|Lost to Follow-up|7|||
124779998|NCT00233064|448823446|FG001|Overall Study|Lost to Follow-up|7|||
124779999|NCT00233064|448823445|FG000|Overall Study|Withdrawal by Subject|5|||
124780000|NCT00233064|448823446|FG001|Overall Study|Withdrawal by Subject|3|||
124780001|NCT00233064|448823445|FG000|Overall Study|Death|0|||
124596975|NCT03297294|448142859|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
124596976|NCT02776553|448142865|FG000|Overall Study|Lost to Follow-up|1|||
124596977|NCT02776553|448142866|FG001|Overall Study|Lost to Follow-up|0|||
124596978|NCT02776553|448142865|FG000|Overall Study|got liver transplant|1|||
124596979|NCT02776553|448142866|FG001|Overall Study|got liver transplant|2|||
124596980|NCT02776553|448142865|FG000|Overall Study|had other surgery|1|||
124596981|NCT02776553|448142866|FG001|Overall Study|had other surgery|0|||
124596982|NCT02776553|448142865|FG000|Overall Study|Protocol Violation|0|||
124596983|NCT02776553|448142866|FG001|Overall Study|Protocol Violation|1|||
124596984|NCT00104247|448142875|FG000|Overall Study|Withdrawal by Subject|1|||
124780002|NCT00233064|448823446|FG001|Overall Study|Death|1|||
124596985|NCT00104247|448142876|FG001|Overall Study|Withdrawal by Subject|0|||
124596986|NCT00104247|448142875|FG000|Overall Study|Noncompliant with dosing|0|||
124596987|NCT00104247|448142876|FG001|Overall Study|Noncompliant with dosing|1|||
124596988|NCT00063882|448142880|FG000|Overall Study|Protocol Violation|3|||
124780003|NCT00233064|448823445|FG000|Overall Study|Relocation|0|||
124780004|NCT00233064|448823446|FG001|Overall Study|Relocation|1|||
124780005|NCT00233064|448823445|FG000|Overall Study|Protocol Violation|1|||
124596989|NCT00063882|448142881|FG001|Overall Study|Protocol Violation|3|||
124596990|NCT00063882|448142880|FG000|Overall Study|Withdrawal by Subject|2|||
124596991|NCT00063882|448142881|FG001|Overall Study|Withdrawal by Subject|1|||
124596992|NCT01930175|448142882|FG000|Core Study|Lost to Follow-up|0|||
124596993|NCT01930175|448142883|FG001|Core Study|Lost to Follow-up|1|||
124596994|NCT01930175|448142884|FG002|Core Study|Lost to Follow-up|0|||
124730885|NCT03222973|448635634|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
124730886|NCT03222973|448635635|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
124730887|NCT03222973|448635636|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
124730888|NCT03222973|448635633|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
124730889|NCT03222973|448635634|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
124730890|NCT03222973|448635635|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
124730891|NCT03222973|448635636|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
124730892|NCT03222973|448635633|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
124730893|NCT03222973|448635634|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
124730894|NCT03222973|448635635|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
124730895|NCT03222973|448635636|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
124730896|NCT03222973|448635633|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
124730897|NCT03222973|448635634|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
124730898|NCT03222973|448635635|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
124730899|NCT03222973|448635636|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
124730900|NCT03222973|448635633|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
124730901|NCT03222973|448635634|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
124730902|NCT03222973|448635635|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
124730903|NCT03222973|448635636|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
124730904|NCT03222973|448635633|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
124730905|NCT03222973|448635634|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
124730906|NCT03222973|448635635|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
124730907|NCT03222973|448635636|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
124730908|NCT03222973|448635633|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
124730909|NCT03222973|448635634|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
124730910|NCT03222973|448635635|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
124730911|NCT03222973|448635636|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
124730912|NCT03222973|448635633|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
124730913|NCT03222973|448635634|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
124730914|NCT03222973|448635635|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
124730915|NCT03222973|448635636|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
124730916|NCT03222973|448635633|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
124730917|NCT03222973|448635634|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
124730918|NCT03222973|448635635|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
124730919|NCT03222973|448635636|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
124730920|NCT03222973|448635633|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
124730921|NCT03222973|448635634|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
124730922|NCT03222973|448635635|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
124730923|NCT03222973|448635636|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
124730924|NCT03222973|448635633|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
124730925|NCT03222973|448635634|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
124730926|NCT03222973|448635635|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
124730927|NCT03222973|448635636|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
124730928|NCT02080481|448635637|FG000|Overall Study|Never received a block.|1|||
124730929|NCT02080481|448635638|FG001|Overall Study|Never received a block.|0|||
124730930|NCT01440517|448637409|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
124730931|NCT02723006|448637414|FG000|Overall Study|Withdrawal by Subject|0|||
124730932|NCT02723006|448637415|FG001|Overall Study|Withdrawal by Subject|1|||
124730933|NCT02723006|448637416|FG002|Overall Study|Withdrawal by Subject|1|||
124730934|NCT02723006|448637414|FG000|Overall Study|Study Terminated by Sponsor|1|||
124730935|NCT02723006|448637415|FG001|Overall Study|Study Terminated by Sponsor|6|||
124730936|NCT02723006|448637416|FG002|Overall Study|Study Terminated by Sponsor|6|||
124730937|NCT00983515|448637417|FG000|Ritonavir Alone|liver panel out of range|6|||
124730938|NCT00983515|448637417|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
124730939|NCT01967823|448637420|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
124730940|NCT00539513|448637421|FG000|Overall Study|Withdrawal by Subject|2|||
124730941|NCT00539513|448637422|FG001|Overall Study|Withdrawal by Subject|1|||
124596995|NCT01930175|448142882|FG000|Core Study|Adverse Event|0|||
124730942|NCT00539513|448637421|FG000|Overall Study|Lost to Follow-up|0|||
124730943|NCT00539513|448637422|FG001|Overall Study|Lost to Follow-up|1|||
124730944|NCT00316693|448637423|FG000|Overall Study|Adverse Event|6|||
124730945|NCT00316693|448637424|FG001|Overall Study|Adverse Event|1|||
124730946|NCT00316693|448637423|FG000|Overall Study|Protocol Violation|1|||
124730947|NCT00316693|448637424|FG001|Overall Study|Protocol Violation|0|||
124730948|NCT00316693|448637423|FG000|Overall Study|Withdrawal by Subject|6|||
124730949|NCT00316693|448637424|FG001|Overall Study|Withdrawal by Subject|6|||
124730950|NCT00316693|448637423|FG000|Overall Study|Lost to Follow-up|26|||
124596996|NCT01930175|448142883|FG001|Core Study|Adverse Event|0|||
124596997|NCT01930175|448142884|FG002|Core Study|Adverse Event|1|||
124596998|NCT00834899|448142885|FG000|Overall Study|Withdrawal by Subject|1|||
124596999|NCT00834899|448142886|FG001|Overall Study|Withdrawal by Subject|1|||
124597000|NCT03314662|448142889|FG000|Overall Study|Withdrawal by Subject|1|||
124597001|NCT03314662|448142890|FG001|Overall Study|Withdrawal by Subject|1|||
124597002|NCT03314662|448142891|FG002|Overall Study|Withdrawal by Subject|1|||
124597003|NCT03314662|448142889|FG000|Overall Study|Lost to Follow-up|5|||
124597004|NCT03314662|448142890|FG001|Overall Study|Lost to Follow-up|4|||
124597005|NCT03314662|448142891|FG002|Overall Study|Lost to Follow-up|4|||
124597006|NCT03314662|448142889|FG000|Overall Study|Death|2|||
124597007|NCT03314662|448142890|FG001|Overall Study|Death|0|||
124597008|NCT03314662|448142891|FG002|Overall Study|Death|0|||
124597009|NCT01117766|448142896|FG000|First Intervention|Adverse Event|0|||
124597010|NCT01117766|448142897|FG001|First Intervention|Adverse Event|1|||
124597011|NCT01117766|448142896|FG000|First Intervention|Protocol Violation|1|||
124597012|NCT01117766|448142897|FG001|First Intervention|Protocol Violation|0|||
124597013|NCT01117766|448142896|FG000|Washout Period|Protocol Violation|0|||
124597014|NCT01117766|448142897|FG001|Washout Period|Protocol Violation|2|||
124597015|NCT01117766|448142896|FG000|Second Intervention|Lost to Follow-up|1|||
124597016|NCT01117766|448142897|FG001|Second Intervention|Lost to Follow-up|0|||
124597017|NCT01117766|448142896|FG000|Second Intervention|Other|1|||
124597018|NCT01117766|448142897|FG001|Second Intervention|Other|2|||
124597019|NCT01117766|448142896|FG000|Second Intervention|Adverse Event|0|||
124597020|NCT01117766|448142897|FG001|Second Intervention|Adverse Event|2|||
124597021|NCT01117766|448142896|FG000|Second Intervention|Withdrawal by Subject|0|||
124597022|NCT01117766|448142897|FG001|Second Intervention|Withdrawal by Subject|1|||
124597023|NCT00438659|448142898|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
124597024|NCT00438659|448142899|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
124597025|NCT00438659|448142898|FG000|Overall Study|Cancel|5|||
124597026|NCT00438659|448142899|FG001|Overall Study|Cancel|2|||
124597027|NCT02244424|448142900|FG000|Overall Study|Lost to Follow-up|20|||
124597028|NCT02244424|448142901|FG001|Overall Study|Lost to Follow-up|10|||
124597029|NCT03366194|448142905|FG000|Overall Study|Lost to Follow-up|2|||
124597030|NCT01684215|448144159|FG000|Phase 1, Part 1|Adverse Event|1|||
124597031|NCT01684215|448144160|FG001|Phase 1, Part 1|Adverse Event|0|||
124597032|NCT01684215|448144161|FG002|Phase 1, Part 1|Adverse Event|0|||
124597033|NCT01684215|448144162|FG003|Phase 1, Part 1|Adverse Event|0|||
124597034|NCT01684215|448144159|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
124597035|NCT01684215|448144160|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
124597036|NCT01684215|448144161|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
124597037|NCT01684215|448144162|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
124597038|NCT01684215|448144159|FG000|Phase 1, Part 2|Adverse Event|0|||
124597039|NCT01684215|448144160|FG001|Phase 1, Part 2|Adverse Event|0|||
124597040|NCT01684215|448144161|FG002|Phase 1, Part 2|Adverse Event|1|||
124597041|NCT01684215|448144162|FG003|Phase 1, Part 2|Adverse Event|0|||
124597042|NCT01684215|448144159|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
124597043|NCT01684215|448144160|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
124597044|NCT01684215|448144161|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
124597045|NCT01684215|448144162|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
124597046|NCT01684215|448144159|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
124597047|NCT01684215|448144160|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
124597048|NCT01684215|448144161|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
124597049|NCT01684215|448144162|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
124597050|NCT01684215|448144159|FG000|Phase 2|Death|0|||
124597051|NCT01684215|448144160|FG001|Phase 2|Death|0|||
124597052|NCT01684215|448144161|FG002|Phase 2|Death|0|||
124597053|NCT01684215|448144162|FG003|Phase 2|Death|8|||
124597054|NCT01684215|448144159|FG000|Phase 2|Study terminated by sponsor|0|||
124597055|NCT01684215|448144160|FG001|Phase 2|Study terminated by sponsor|0|||
124597056|NCT01684215|448144161|FG002|Phase 2|Study terminated by sponsor|0|||
124597057|NCT01684215|448144162|FG003|Phase 2|Study terminated by sponsor|30|||
124597058|NCT01684215|448144159|FG000|Phase 2|Enrolled but not treated|0|||
124597059|NCT01684215|448144160|FG001|Phase 2|Enrolled but not treated|0|||
124597060|NCT01684215|448144161|FG002|Phase 2|Enrolled but not treated|0|||
124597061|NCT01684215|448144162|FG003|Phase 2|Enrolled but not treated|1|||
124597062|NCT01684215|448144159|FG000|Phase 2|Lost to Follow-up|0|||
124597063|NCT01684215|448144160|FG001|Phase 2|Lost to Follow-up|0|||
124597064|NCT01684215|448144161|FG002|Phase 2|Lost to Follow-up|0|||
124597065|NCT01684215|448144162|FG003|Phase 2|Lost to Follow-up|4|||
124597066|NCT01552369|448144165|FG000|Overall Study|Did not consent to extended follow up|8|||
124597067|NCT01552369|448144166|FG001|Overall Study|Did not consent to extended follow up|9|||
124597068|NCT03919448|448144169|FG000|Overall Study|Withdrawal by Subject|1|||
124597069|NCT03919448|448144170|FG001|Overall Study|Withdrawal by Subject|0|||
124597070|NCT03919448|448144171|FG002|Overall Study|Withdrawal by Subject|0|||
124597071|NCT03438539|448144172|FG000|Overall Study|Lost to Follow-up|8|||
124597072|NCT03438539|448144173|FG001|Overall Study|Lost to Follow-up|4|||
124597073|NCT03438539|448144174|FG002|Overall Study|Lost to Follow-up|10|||
124597074|NCT03438539|448144175|FG003|Overall Study|Lost to Follow-up|9|||
124597075|NCT03438539|448144176|FG004|Overall Study|Lost to Follow-up|3|||
124597076|NCT03438539|448144177|FG005|Overall Study|Lost to Follow-up|8|||
124597077|NCT04213209|448144181|FG000|Overall Study|Protocol Violation|1|||
124597078|NCT04213209|448144182|FG001|Overall Study|Protocol Violation|0|||
124597079|NCT04213209|448144183|FG002|Overall Study|Protocol Violation|0|||
124597080|NCT04213209|448144184|FG003|Overall Study|Protocol Violation|0|||
124597081|NCT04213209|448144185|FG004|Overall Study|Protocol Violation|0|||
124597082|NCT04213209|448144186|FG005|Overall Study|Protocol Violation|0|||
124597083|NCT00880087|448144189|FG000|Overall Study|Lost to Follow-up|0|||
124597084|NCT00880087|448144190|FG001|Overall Study|Lost to Follow-up|2|||
124597085|NCT01005329|448144193|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
124597086|NCT00483548|448144194|FG000|Overall Study|Randomized; not treated with study drug|1|||
124597087|NCT00483548|448144195|FG001|Overall Study|Randomized; not treated with study drug|3|||
124597088|NCT00483548|448144194|FG000|Overall Study|Adverse Event|25|||
124597089|NCT00483548|448144195|FG001|Overall Study|Adverse Event|14|||
124597090|NCT00483548|448144194|FG000|Overall Study|Laboratory abnormality|1|||
124597091|NCT00483548|448144195|FG001|Overall Study|Laboratory abnormality|2|||
124597092|NCT00483548|448144194|FG000|Overall Study|Lack of Efficacy|4|||
124597093|NCT00483548|448144195|FG001|Overall Study|Lack of Efficacy|8|||
124597094|NCT00483548|448144194|FG000|Overall Study|Protocol Violation|11|||
124597095|NCT00483548|448144195|FG001|Overall Study|Protocol Violation|7|||
124597096|NCT00483548|448144194|FG000|Overall Study|Pregnancy|1|||
124597097|NCT00483548|448144195|FG001|Overall Study|Pregnancy|0|||
124597098|NCT00483548|448144194|FG000|Overall Study|Protocol required discontinuation|6|||
124597099|NCT00483548|448144195|FG001|Overall Study|Protocol required discontinuation|6|||
124597100|NCT00483548|448144194|FG000|Overall Study|Unable to comply with protocol schedule|1|||
124597101|NCT00483548|448144195|FG001|Overall Study|Unable to comply with protocol schedule|0|||
124597102|NCT00483548|448144194|FG000|Overall Study|Non-compliance with medication|2|||
124597103|NCT00483548|448144195|FG001|Overall Study|Non-compliance with medication|0|||
124597104|NCT00483548|448144194|FG000|Overall Study|Lost to Follow-up|3|||
124597105|NCT00483548|448144195|FG001|Overall Study|Lost to Follow-up|4|||
124597106|NCT00483548|448144194|FG000|Overall Study|Withdrawal by Subject|5|||
124597107|NCT00483548|448144195|FG001|Overall Study|Withdrawal by Subject|2|||
124597108|NCT01272921|448144200|FG000|Overall Study|Protocol Violation|2|||
124597109|NCT01272921|448144201|FG001|Overall Study|Protocol Violation|1|||
124597110|NCT01132664|448144202|FG000|Phase lb|Adverse Event|0|||
124597111|NCT01132664|448144203|FG001|Phase lb|Adverse Event|1|||
124597112|NCT01132664|448144204|FG002|Phase lb|Adverse Event|0|||
124597113|NCT01132664|448144205|FG003|Phase lb|Adverse Event|0|||
124597114|NCT01132664|448144206|FG004|Phase lb|Adverse Event|0|||
124597115|NCT01132664|448144202|FG000|Phase lb|Withdrawal by Subject|1|||
124597116|NCT01132664|448144203|FG001|Phase lb|Withdrawal by Subject|2|||
124597117|NCT01132664|448144204|FG002|Phase lb|Withdrawal by Subject|0|||
124597118|NCT01132664|448144205|FG003|Phase lb|Withdrawal by Subject|0|||
124597119|NCT01132664|448144206|FG004|Phase lb|Withdrawal by Subject|0|||
124597120|NCT01132664|448144202|FG000|Phase lb|Disease Progression|4|||
124597121|NCT01132664|448144203|FG001|Phase lb|Disease Progression|9|||
124597122|NCT01132664|448144204|FG002|Phase lb|Disease Progression|0|||
124597123|NCT01132664|448144205|FG003|Phase lb|Disease Progression|0|||
124597124|NCT01132664|448144206|FG004|Phase lb|Disease Progression|0|||
124597125|NCT01132664|448144202|FG000|Phase ll|Death|0|||
124597126|NCT01132664|448144203|FG001|Phase ll|Death|0|||
124597127|NCT01132664|448144204|FG002|Phase ll|Death|2|||
124597128|NCT01132664|448144205|FG003|Phase ll|Death|0|||
124597129|NCT01132664|448144206|FG004|Phase ll|Death|0|||
124597130|NCT01132664|448144202|FG000|Phase ll|Adverse Event|0|||
124597131|NCT01132664|448144203|FG001|Phase ll|Adverse Event|0|||
124597132|NCT01132664|448144204|FG002|Phase ll|Adverse Event|10|||
124597133|NCT01132664|448144205|FG003|Phase ll|Adverse Event|0|||
124597134|NCT01132664|448144206|FG004|Phase ll|Adverse Event|0|||
124597135|NCT01132664|448144202|FG000|Phase ll|Withdrawal by Subject|0|||
124597136|NCT01132664|448144203|FG001|Phase ll|Withdrawal by Subject|0|||
124597137|NCT01132664|448144204|FG002|Phase ll|Withdrawal by Subject|3|||
124597138|NCT01132664|448144205|FG003|Phase ll|Withdrawal by Subject|0|||
124597139|NCT01132664|448144206|FG004|Phase ll|Withdrawal by Subject|0|||
124597140|NCT01132664|448144202|FG000|Phase ll|Disease progression|0|||
124597141|NCT01132664|448144203|FG001|Phase ll|Disease progression|0|||
124597142|NCT01132664|448144204|FG002|Phase ll|Disease progression|35|||
124597143|NCT01132664|448144205|FG003|Phase ll|Disease progression|0|||
124597144|NCT01132664|448144206|FG004|Phase ll|Disease progression|0|||
124597145|NCT01132664|448144202|FG000|BM Cohort|Disease progression|0|||
124597146|NCT01132664|448144203|FG001|BM Cohort|Disease progression|0|||
124597147|NCT01132664|448144204|FG002|BM Cohort|Disease progression|0|||
124597148|NCT01132664|448144205|FG003|BM Cohort|Disease progression|3|||
124597149|NCT01132664|448144206|FG004|BM Cohort|Disease progression|4|||
124597150|NCT01132664|448144202|FG000|BM Cohort|Adverse Event|0|||
124597151|NCT01132664|448144203|FG001|BM Cohort|Adverse Event|0|||
124597152|NCT01132664|448144204|FG002|BM Cohort|Adverse Event|0|||
124597153|NCT01132664|448144205|FG003|BM Cohort|Adverse Event|0|||
124597154|NCT01132664|448144206|FG004|BM Cohort|Adverse Event|1|||
124597155|NCT01132664|448144202|FG000|BM Cohort|Withdrawal by Subject|0|||
124597156|NCT01132664|448144203|FG001|BM Cohort|Withdrawal by Subject|0|||
124780006|NCT00233064|448823446|FG001|Overall Study|Protocol Violation|0|||
124780007|NCT00233064|448823445|FG000|Overall Study|Moved to Dom. Republic|1|||
124780008|NCT00233064|448823446|FG001|Overall Study|Moved to Dom. Republic|0|||
124780009|NCT01120964|448823453|FG000|Overall Study|Did not receive full treatment|1|||
124780010|NCT01120964|448823454|FG001|Overall Study|Did not receive full treatment|0|||
124780011|NCT04237116|448823458|FG000|Overall Study|Adverse Event|0|||
124780012|NCT04237116|448823459|FG001|Overall Study|Adverse Event|1|||
124780013|NCT04237116|448823458|FG000|Overall Study|Study terminated by Sponsor|4|||
124780014|NCT04237116|448823459|FG001|Overall Study|Study terminated by Sponsor|1|||
124780015|NCT00829504|448823460|FG000|First Intervention|Adverse Event|1|||
124780016|NCT00829504|448823461|FG001|First Intervention|Adverse Event|0|||
124780017|NCT00829504|448823460|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
124780018|NCT00829504|448823461|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
124780019|NCT00829504|448823460|FG000|Second Intervention|Physician Decision|1|||
124780020|NCT00829504|448823461|FG001|Second Intervention|Physician Decision|0|||
124780021|NCT03212144|448823462|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
124780022|NCT03212144|448823463|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
124780023|NCT03212144|448823462|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
124780024|NCT03212144|448823463|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
124780025|NCT00599339|448823464|FG000|Overall Study|Adverse Event|79|||
124780026|NCT00599339|448823464|FG000|Overall Study|Withdrawal by Subject|137|||
124780027|NCT00599339|448823464|FG000|Overall Study|Other Reason|179|||
124780028|NCT00599339|448823464|FG000|Overall Study|Lost to Follow-up|221|||
124780029|NCT00599339|448823464|FG000|Overall Study|No valid data consent|36|||
124780030|NCT00599339|448823464|FG000|Overall Study|Study Termination Status Unknown|12|||
124780031|NCT05307692|448823466|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
124780032|NCT05307692|448823467|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
124780033|NCT05307692|448823468|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
124780034|NCT05307692|448823469|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
124780035|NCT05307692|448823466|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
124780036|NCT05307692|448823467|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
124780037|NCT05307692|448823468|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
124780038|NCT05307692|448823469|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
124780039|NCT05307692|448823466|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
124780040|NCT05307692|448823467|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
124780041|NCT05307692|448823468|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
124780042|NCT05307692|448823469|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
124780043|NCT05307692|448823466|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
124780044|NCT05307692|448823467|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
124780045|NCT05307692|448823468|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
124780046|NCT05307692|448823469|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
124780047|NCT05307692|448823466|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
124780048|NCT05307692|448823467|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
124780049|NCT05307692|448823468|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
124780050|NCT05307692|448823469|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
124780051|NCT05307692|448823466|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
124780052|NCT05307692|448823467|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
124780053|NCT05307692|448823468|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
124780054|NCT05307692|448823469|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
124780055|NCT05307692|448823466|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
124780056|NCT05307692|448823467|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
124780057|NCT05307692|448823468|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
124780058|NCT05307692|448823469|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
124780059|NCT05307692|448823466|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
124780060|NCT05307692|448823467|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
124780061|NCT05307692|448823468|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
124780062|NCT05307692|448823469|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
124780063|NCT02003924|448823477|FG000|Double-blind Phase|Lost to Follow-up|2|||
124780064|NCT02003924|448823478|FG001|Double-blind Phase|Lost to Follow-up|1|||
124597157|NCT01132664|448144204|FG002|BM Cohort|Withdrawal by Subject|0|||
124597158|NCT01132664|448144205|FG003|BM Cohort|Withdrawal by Subject|0|||
124597159|NCT01132664|448144206|FG004|BM Cohort|Withdrawal by Subject|1|||
124597160|NCT00126126|448144207|FG000|Overall Study|Lost to Follow-up|0|||
124597161|NCT00126126|448144208|FG001|Overall Study|Lost to Follow-up|2|||
124597162|NCT01223235|448144213|FG000|Overall Study|Withdrawal by Subject|1|||
124780065|NCT02003924|448823479|FG002|Double-blind Phase|Lost to Follow-up|0|||
124780066|NCT02003924|448823477|FG000|Double-blind Phase|Protocol Violation|1|||
124780067|NCT02003924|448823478|FG001|Double-blind Phase|Protocol Violation|2|||
124780068|NCT02003924|448823479|FG002|Double-blind Phase|Protocol Violation|0|||
124597163|NCT00868296|448144220|FG000|Overall Study|Adverse Event|0|||
124597164|NCT00868296|448144221|FG001|Overall Study|Adverse Event|2|||
124597165|NCT00868296|448144220|FG000|Overall Study|Withdrawal by Subject|0|||
124597166|NCT00868296|448144221|FG001|Overall Study|Withdrawal by Subject|1|||
124597167|NCT00804141|448144226|FG000|Overall Study|Adverse Event|157|||
124597168|NCT00804141|448144226|FG000|Overall Study|Death|4|||
124730951|NCT00316693|448637424|FG001|Overall Study|Lost to Follow-up|34|||
124597169|NCT00804141|448144226|FG000|Overall Study|Failed to return|96|||
124597170|NCT00804141|448144226|FG000|Overall Study|Investigator request|8|||
124597171|NCT00804141|448144226|FG000|Overall Study|Protocol Violation|85|||
124597172|NCT00804141|448144226|FG000|Overall Study|Withdrawal by Subject|131|||
124597173|NCT00804141|448144226|FG000|Overall Study|Lack of Efficacy|46|||
124597174|NCT00804141|448144226|FG000|Overall Study|Other than specified|30|||
124597175|NCT00804141|448144226|FG000|Overall Study|Enrolled but not treated|6|||
124597176|NCT00572039|448144227|FG000|Overall Study|Withdrawal by Subject|9|||
124597177|NCT00572039|448144228|FG001|Overall Study|Withdrawal by Subject|6|||
124597178|NCT00572039|448144227|FG000|Overall Study|Death|2|||
124597179|NCT00572039|448144228|FG001|Overall Study|Death|3|||
124597180|NCT00572039|448144227|FG000|Overall Study|Ill|5|||
124597181|NCT00572039|448144228|FG001|Overall Study|Ill|1|||
124597182|NCT02462486|448144229|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
124597183|NCT02462486|448144230|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
124597184|NCT02462486|448144231|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
124597185|NCT02462486|448144229|FG000|Overall Study|Adverse Event|53|||
124597186|NCT02462486|448144230|FG001|Overall Study|Adverse Event|48|||
124597187|NCT02462486|448144231|FG002|Overall Study|Adverse Event|21|||
124597188|NCT02462486|448144229|FG000|Overall Study|Lack of Efficacy|6|||
124597189|NCT02462486|448144230|FG001|Overall Study|Lack of Efficacy|12|||
124597190|NCT02462486|448144231|FG002|Overall Study|Lack of Efficacy|3|||
124597191|NCT02462486|448144229|FG000|Overall Study|Lost to Follow-up|3|||
124597192|NCT02462486|448144230|FG001|Overall Study|Lost to Follow-up|4|||
124597193|NCT02462486|448144231|FG002|Overall Study|Lost to Follow-up|2|||
124597194|NCT02462486|448144229|FG000|Overall Study|Withdrawal by Subject|25|||
124597195|NCT02462486|448144230|FG001|Overall Study|Withdrawal by Subject|22|||
124597196|NCT02462486|448144231|FG002|Overall Study|Withdrawal by Subject|19|||
124597197|NCT02462486|448144229|FG000|Overall Study|Protocol Violation|3|||
124597198|NCT02462486|448144230|FG001|Overall Study|Protocol Violation|1|||
124597199|NCT02462486|448144231|FG002|Overall Study|Protocol Violation|1|||
124597200|NCT02462486|448144229|FG000|Overall Study|Reason not Specified|3|||
124597201|NCT02462486|448144230|FG001|Overall Study|Reason not Specified|4|||
124597202|NCT02462486|448144231|FG002|Overall Study|Reason not Specified|3|||
124597203|NCT00941720|448144235|FG000|Overall Study|Withdrawal by Subject|1|||
124597204|NCT00941720|448144235|FG000|Overall Study|Insurance denied participation|11|||
124730952|NCT00316693|448637423|FG000|Overall Study|Other|38|||
124730953|NCT00316693|448637424|FG001|Overall Study|Other|44|||
124597205|NCT00941720|448144235|FG000|Overall Study|ineligible|2|||
124597206|NCT01682148|448144236|FG000|Overall Study|Withdrawal by Subject|2|||
124597207|NCT01682148|448144237|FG001|Overall Study|Withdrawal by Subject|0|||
124597208|NCT01682148|448144236|FG000|Overall Study|Lost to Follow-up|1|||
124597209|NCT01682148|448144237|FG001|Overall Study|Lost to Follow-up|2|||
124597210|NCT01682148|448144236|FG000|Overall Study|Protocol Violation|1|||
124597211|NCT01682148|448144237|FG001|Overall Study|Protocol Violation|1|||
124597212|NCT00775528|448144238|FG000|Overall Study|Protocol Violation|1|||
124597213|NCT02087176|448144239|FG000|Overall Study|Withdrawal by Subject|1|||
124597214|NCT02087176|448144239|FG000|Overall Study|Death|10|||
124597215|NCT02087176|448144239|FG000|Overall Study|Censored|19|||
124597216|NCT02087176|448144239|FG000|Overall Study|Study Terminated by Sponsor|2|||
124597217|NCT03648879|448144240|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
124597218|NCT03812991|448144243|FG000|Overall Study|Lost to Follow-up|3|||
124597219|NCT03812991|448144244|FG001|Overall Study|Lost to Follow-up|1|||
124597220|NCT04740931|448144245|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
124597221|NCT04740931|448144246|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
124597222|NCT04740931|448144245|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
124597223|NCT04740931|448144246|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
124597224|NCT04740931|448144245|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
124597225|NCT04740931|448144246|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
124597226|NCT04740931|448144245|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
124597227|NCT04740931|448144246|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
124597228|NCT04740931|448144245|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
124730954|NCT03002818|448637425|FG000|Overall Study|Decision of the investigator|1|||
124597229|NCT04740931|448144246|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
124597230|NCT04740931|448144245|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
124597231|NCT04740931|448144246|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
124597232|NCT04740931|448144245|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
124597233|NCT04740931|448144246|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
124730955|NCT00711113|448637429|FG000|Overall Study|Lost to Follow-up|9|||
124780069|NCT02003924|448823477|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
124780070|NCT02003924|448823478|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
124780071|NCT02003924|448823479|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
124780072|NCT02003924|448823477|FG000|Double-blind Phase|Disease Progression|229|||
124780073|NCT02003924|448823478|FG001|Double-blind Phase|Disease Progression|247|||
124780074|NCT02003924|448823479|FG002|Double-blind Phase|Disease Progression|0|||
124780075|NCT02003924|448823477|FG000|Double-blind Phase|Adverse Event|120|||
124780076|NCT02003924|448823478|FG001|Double-blind Phase|Adverse Event|31|||
124780077|NCT02003924|448823479|FG002|Double-blind Phase|Adverse Event|0|||
124780078|NCT02003924|448823477|FG000|Double-blind Phase|Randomized But not Treated|3|||
124780079|NCT02003924|448823478|FG001|Double-blind Phase|Randomized But not Treated|3|||
124780080|NCT02003924|448823479|FG002|Double-blind Phase|Randomized But not Treated|0|||
124780081|NCT02003924|448823477|FG000|Double-blind Phase|Other|29|||
124780082|NCT02003924|448823478|FG001|Double-blind Phase|Other|50|||
124780083|NCT02003924|448823479|FG002|Double-blind Phase|Other|0|||
124780084|NCT02003924|448823477|FG000|Open-label Phase|Lost to Follow-up|0|||
124780085|NCT02003924|448823478|FG001|Open-label Phase|Lost to Follow-up|0|||
124780086|NCT02003924|448823479|FG002|Open-label Phase|Lost to Follow-up|1|||
124780087|NCT02003924|448823477|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
124780088|NCT02003924|448823478|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
124780089|NCT02003924|448823479|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
124780090|NCT02003924|448823477|FG000|Open-label Phase|Disease Progression|59|||
124780091|NCT02003924|448823478|FG001|Open-label Phase|Disease Progression|0|||
124780092|NCT02003924|448823479|FG002|Open-label Phase|Disease Progression|5|||
124780093|NCT02003924|448823477|FG000|Open-label Phase|Adverse Event|25|||
124780094|NCT02003924|448823478|FG001|Open-label Phase|Adverse Event|0|||
124780095|NCT02003924|448823479|FG002|Open-label Phase|Adverse Event|10|||
124780096|NCT02003924|448823477|FG000|Open-label Phase|Other|7|||
124780097|NCT02003924|448823478|FG001|Open-label Phase|Other|0|||
124780098|NCT02003924|448823479|FG002|Open-label Phase|Other|0|||
124780099|NCT02003924|448823477|FG000|Long-term Follow-up Phase|Death|288|||
124780100|NCT02003924|448823478|FG001|Long-term Follow-up Phase|Death|174|||
124780101|NCT02003924|448823479|FG002|Long-term Follow-up Phase|Death|4|||
124780102|NCT02003924|448823477|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
124780103|NCT02003924|448823478|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
124780104|NCT02003924|448823479|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
124780105|NCT02003924|448823477|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
124780106|NCT02003924|448823478|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
124780107|NCT02003924|448823479|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
124780108|NCT02003924|448823477|FG000|Long-term Follow-up Phase|Other|5|||
124780109|NCT02003924|448823478|FG001|Long-term Follow-up Phase|Other|2|||
124780110|NCT02003924|448823479|FG002|Long-term Follow-up Phase|Other|1|||
124780111|NCT00114517|448823486|FG000|Overall Study|Adverse Event|6|||
124780112|NCT00114517|448823487|FG001|Overall Study|Adverse Event|1|||
124780113|NCT00114517|448823488|FG002|Overall Study|Adverse Event|6|||
124780114|NCT00114517|448823489|FG003|Overall Study|Adverse Event|3|||
124780115|NCT00114517|448823486|FG000|Overall Study|Lost to Follow-up|2|||
124780116|NCT00114517|448823487|FG001|Overall Study|Lost to Follow-up|2|||
124780117|NCT00114517|448823488|FG002|Overall Study|Lost to Follow-up|2|||
124780118|NCT00114517|448823489|FG003|Overall Study|Lost to Follow-up|1|||
124780119|NCT00114517|448823486|FG000|Overall Study|Too busy|3|||
124780120|NCT00114517|448823487|FG001|Overall Study|Too busy|1|||
124780121|NCT00114517|448823488|FG002|Overall Study|Too busy|1|||
124780122|NCT00114517|448823489|FG003|Overall Study|Too busy|2|||
124780123|NCT00114517|448823486|FG000|Overall Study|Moved from area|0|||
124780124|NCT00114517|448823487|FG001|Overall Study|Moved from area|3|||
124780125|NCT00114517|448823488|FG002|Overall Study|Moved from area|2|||
124780126|NCT00114517|448823489|FG003|Overall Study|Moved from area|1|||
124780127|NCT00114517|448823486|FG000|Overall Study|Did not want estradiol|1|||
124780128|NCT00114517|448823487|FG001|Overall Study|Did not want estradiol|1|||
124780129|NCT00114517|448823488|FG002|Overall Study|Did not want estradiol|0|||
124780130|NCT00114517|448823489|FG003|Overall Study|Did not want estradiol|0|||
124780131|NCT00114517|448823486|FG000|Overall Study|Armed-services duty|0|||
124780132|NCT00114517|448823487|FG001|Overall Study|Armed-services duty|1|||
124780133|NCT00114517|448823488|FG002|Overall Study|Armed-services duty|0|||
124780134|NCT00114517|448823489|FG003|Overall Study|Armed-services duty|1|||
124780135|NCT00114517|448823486|FG000|Overall Study|Competing family issue|0|||
124780136|NCT00114517|448823487|FG001|Overall Study|Competing family issue|1|||
124780137|NCT00114517|448823488|FG002|Overall Study|Competing family issue|0|||
124780138|NCT00114517|448823489|FG003|Overall Study|Competing family issue|1|||
124780139|NCT00114517|448823486|FG000|Overall Study|Physician Decision|0|||
124780140|NCT00114517|448823487|FG001|Overall Study|Physician Decision|1|||
124780141|NCT00114517|448823488|FG002|Overall Study|Physician Decision|0|||
124780142|NCT00114517|448823489|FG003|Overall Study|Physician Decision|0|||
124780143|NCT00114517|448823486|FG000|Overall Study|Lost interest|0|||
124780144|NCT00114517|448823487|FG001|Overall Study|Lost interest|0|||
124780145|NCT00114517|448823488|FG002|Overall Study|Lost interest|1|||
124597234|NCT04740931|448144245|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
124597235|NCT04740931|448144246|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
124597236|NCT04740931|448144245|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
124597237|NCT04740931|448144246|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
124597238|NCT04740931|448144245|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
124597239|NCT04740931|448144246|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
124597240|NCT04740931|448144245|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
124597241|NCT04740931|448144246|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
124597242|NCT04740931|448144245|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
124597243|NCT04740931|448144246|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
124597244|NCT04740931|448144245|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
124597245|NCT04740931|448144246|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
124597246|NCT04740931|448144245|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
124597247|NCT04740931|448144246|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
124597248|NCT04740931|448144245|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
124597249|NCT04740931|448144246|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
124597250|NCT00895037|448144247|FG000|Overall Study|Death|0|||
124597251|NCT00895037|448144248|FG001|Overall Study|Death|2|||
124597252|NCT00895037|448144249|FG002|Overall Study|Death|1|||
124597253|NCT01029392|448144255|FG000|Overall Study|Withdrawal by Subject|18|||
124597254|NCT01029392|448144256|FG001|Overall Study|Withdrawal by Subject|11|||
124597255|NCT01029392|448144255|FG000|Overall Study|Physician Decision|2|||
124597256|NCT01029392|448144256|FG001|Overall Study|Physician Decision|0|||
124597257|NCT01103479|448144257|FG000|Overall Study|Up to date with CRC screening|1|||
124597258|NCT01103479|448144258|FG001|Overall Study|Up to date with CRC screening|9|||
124597259|NCT01103479|448144259|FG002|Overall Study|Up to date with CRC screening|12|||
124597260|NCT01103479|448144257|FG000|Overall Study|Family history of CRC|1|||
124597261|NCT01103479|448144258|FG001|Overall Study|Family history of CRC|0|||
124597262|NCT01103479|448144259|FG002|Overall Study|Family history of CRC|2|||
124597263|NCT01103479|448144257|FG000|Overall Study|Active cancer|1|||
124597264|NCT01103479|448144258|FG001|Overall Study|Active cancer|0|||
124597265|NCT01103479|448144259|FG002|Overall Study|Active cancer|0|||
124597266|NCT01103479|448144257|FG000|Overall Study|Saw non-study physician|2|||
124597267|NCT01103479|448144258|FG001|Overall Study|Saw non-study physician|0|||
124597268|NCT01103479|448144259|FG002|Overall Study|Saw non-study physician|0|||
124597269|NCT01534637|448144260|FG000|Overall Study|Physician Decision|3|||
124597270|NCT01534637|448144260|FG000|Overall Study|Lack of Efficacy|3|||
124730956|NCT00711113|448637429|FG000|Overall Study|Implant lost|2|||
124597271|NCT01534637|448144260|FG000|Overall Study|Withdrawal by Subject|1|||
124597272|NCT01534637|448144260|FG000|Overall Study|Adverse Event|1|||
124597273|NCT01534637|448144260|FG000|Overall Study|Liver Mets before treatment|1|||
124597274|NCT00605917|448144261|FG000|Overall Study|Protocol Violation|79|||
124597275|NCT00890552|448144262|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
124597276|NCT00890552|448144262|FG000|On-treatment|Early prog disease/ death|10|||
124597277|NCT00724373|448144263|FG000|Overall Study|Adverse Event|41|||
124597278|NCT00724373|448144263|FG000|Overall Study|Lack of Efficacy|82|||
124597279|NCT00724373|448144263|FG000|Overall Study|Lost to Follow-up|7|||
124597280|NCT00724373|448144263|FG000|Overall Study|Non-compliance|2|||
124597281|NCT00724373|448144263|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
124597282|NCT00724373|448144263|FG000|Overall Study|Participant moved away|1|||
124597283|NCT00724373|448144263|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
124597284|NCT00724373|448144263|FG000|Overall Study|Only to have 24 week regimen|1|||
124597285|NCT00724373|448144263|FG000|Overall Study|Viral Relapse|1|||
124597286|NCT00724373|448144263|FG000|Overall Study|Acute HCV infection|1|||
124597287|NCT00724373|448144263|FG000|Overall Study|Drug Relapse|1|||
124597288|NCT00724373|448144263|FG000|Overall Study|Tolerability|23|||
124597289|NCT02549573|448144264|FG000|Overall Study|Withdrawal by Subject|0|||
124597290|NCT02549573|448144265|FG001|Overall Study|Withdrawal by Subject|2|||
124597291|NCT02549573|448144264|FG000|Overall Study|Protocol Violation|0|||
124597292|NCT02549573|448144265|FG001|Overall Study|Protocol Violation|1|||
124597293|NCT03043560|448144268|FG000|Overall Study|Discontinued Intervention|1|||
124597294|NCT03043560|448144269|FG001|Overall Study|Discontinued Intervention|2|||
124597295|NCT03043560|448144268|FG000|Overall Study|Lost to Follow-up|0|||
124597296|NCT03043560|448144269|FG001|Overall Study|Lost to Follow-up|1|||
124597297|NCT00440115|448144270|FG000|Overall Study|Death|7|||
124597298|NCT00440115|448144271|FG001|Overall Study|Death|9|||
124597299|NCT00440115|448144272|FG002|Overall Study|Death|5|||
124597300|NCT00440115|448144270|FG000|Overall Study|Incarceration|0|||
124597301|NCT00440115|448144271|FG001|Overall Study|Incarceration|2|||
124597302|NCT00440115|448144272|FG002|Overall Study|Incarceration|1|||
124730957|NCT01606787|448637436|FG000|Overall Study|Withdrawal by Subject|4|||
124597303|NCT00206102|448144274|FG000|Overall Study|Adverse Event|119|||
124597304|NCT00206102|448144275|FG001|Overall Study|Adverse Event|82|||
124597305|NCT00206102|448144274|FG000|Overall Study|Protocol Violation|0|||
124597306|NCT00206102|448144275|FG001|Overall Study|Protocol Violation|2|||
124597307|NCT00206102|448144274|FG000|Overall Study|Lack of therapeutic response|16|||
124597308|NCT00206102|448144275|FG001|Overall Study|Lack of therapeutic response|11|||
124780146|NCT00114517|448823489|FG003|Overall Study|Lost interest|0|||
124780147|NCT00114517|448823486|FG000|Overall Study|Weight increase|0|||
124780148|NCT00114517|448823487|FG001|Overall Study|Weight increase|0|||
124780149|NCT00114517|448823488|FG002|Overall Study|Weight increase|1|||
124780150|NCT00114517|448823489|FG003|Overall Study|Weight increase|0|||
124780151|NCT00114517|448823486|FG000|Overall Study|Concern about blood clots|0|||
124780152|NCT00114517|448823487|FG001|Overall Study|Concern about blood clots|0|||
124780153|NCT00114517|448823488|FG002|Overall Study|Concern about blood clots|1|||
124780154|NCT00114517|448823489|FG003|Overall Study|Concern about blood clots|0|||
124780155|NCT00114517|448823486|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
124780156|NCT00114517|448823487|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
124780157|NCT00114517|448823488|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
124780158|NCT00114517|448823489|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
124780159|NCT00684060|448825291|FG000|Overall Study|Lost to Follow-up|1|||
124780160|NCT00684060|448825292|FG001|Overall Study|Lost to Follow-up|0|||
124780161|NCT00684060|448825291|FG000|Overall Study|New stenosis identified|1|||
124780162|NCT00684060|448825292|FG001|Overall Study|New stenosis identified|0|||
124780163|NCT00684060|448825291|FG000|Overall Study|Unable to collect MRI|1|||
124780164|NCT00684060|448825292|FG001|Overall Study|Unable to collect MRI|2|||
124780165|NCT00684060|448825291|FG000|Overall Study|Death|0|||
124780166|NCT00684060|448825292|FG001|Overall Study|Death|1|||
124780167|NCT00702715|448825297|FG000|Overall Study|Lost to Follow-up|1|||
124780168|NCT00702715|448825298|FG001|Overall Study|Lost to Follow-up|0|||
124780169|NCT02840799|448825301|FG000|Phase 1|Physician Decision|1|||
124780170|NCT02840799|448825302|FG001|Phase 1|Physician Decision|3|||
124780171|NCT02840799|448825301|FG000|Phase 1|Withdrawal by Subject|4|||
124780172|NCT02840799|448825302|FG001|Phase 1|Withdrawal by Subject|0|||
124780173|NCT02840799|448825301|FG000|Phase 2 (Crossover)|Adverse Event|0|||
124780174|NCT02840799|448825302|FG001|Phase 2 (Crossover)|Adverse Event|1|||
124780175|NCT02840799|448825301|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
124780176|NCT02840799|448825302|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
124780177|NCT01193257|448825308|FG000|Overall Study|Death|202|||
124780178|NCT01193257|448825309|FG001|Overall Study|Death|391|||
124780179|NCT01193257|448825308|FG000|Overall Study|Study termination by sponsor|0|||
124780180|NCT01193257|448825309|FG001|Overall Study|Study termination by sponsor|3|||
124780181|NCT01193257|448825308|FG000|Overall Study|Withdrawal by Subject|26|||
124780182|NCT01193257|448825309|FG001|Overall Study|Withdrawal by Subject|86|||
124780183|NCT01193257|448825308|FG000|Overall Study|Lost to Follow-up|2|||
124780184|NCT01193257|448825309|FG001|Overall Study|Lost to Follow-up|3|||
124780185|NCT01193257|448825308|FG000|Overall Study|Unblinded due to futility|135|||
124780186|NCT01193257|448825309|FG001|Overall Study|Unblinded due to futility|251|||
124780187|NCT01621802|448825313|FG000|Overall Study|Protocol Violation|0|||
124780188|NCT01621802|448825314|FG001|Overall Study|Protocol Violation|0|||
124780189|NCT01621802|448825315|FG002|Overall Study|Protocol Violation|0|||
124780190|NCT01621802|448825316|FG003|Overall Study|Protocol Violation|0|||
124597309|NCT00206102|448144274|FG000|Overall Study|Lost to Follow-up|95|||
124597310|NCT00206102|448144275|FG001|Overall Study|Lost to Follow-up|66|||
124597311|NCT00206102|448144274|FG000|Overall Study|Withdrawal by Subject|118|||
124597312|NCT00206102|448144275|FG001|Overall Study|Withdrawal by Subject|101|||
124597313|NCT00206102|448144274|FG000|Overall Study|Study-specific discontinuation criteria|18|||
124597314|NCT00206102|448144275|FG001|Overall Study|Study-specific discontinuation criteria|17|||
124597315|NCT00206102|448144274|FG000|Overall Study|None of those categories|42|||
124597316|NCT00206102|448144275|FG001|Overall Study|None of those categories|36|||
124597317|NCT03123783|448144276|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
124597318|NCT03123783|448144277|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
124597319|NCT03123783|448144278|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
124597320|NCT03123783|448144279|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
124597321|NCT03123783|448144280|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
124597322|NCT03123783|448144281|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
124597323|NCT03123783|448144282|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
124597324|NCT03123783|448144276|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
124597325|NCT03123783|448144277|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
124597326|NCT03123783|448144278|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
124597327|NCT03123783|448144279|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
124597328|NCT03123783|448144280|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
124780191|NCT01621802|448825317|FG004|Overall Study|Protocol Violation|0|||
124780192|NCT01621802|448825318|FG005|Overall Study|Protocol Violation|1|||
124780193|NCT01621802|448825313|FG000|Overall Study|Withdrawal by Subject|8|||
124780194|NCT01621802|448825314|FG001|Overall Study|Withdrawal by Subject|4|||
124780195|NCT01621802|448825315|FG002|Overall Study|Withdrawal by Subject|4|||
124780196|NCT01621802|448825316|FG003|Overall Study|Withdrawal by Subject|2|||
124780197|NCT01621802|448825317|FG004|Overall Study|Withdrawal by Subject|2|||
124780198|NCT01621802|448825318|FG005|Overall Study|Withdrawal by Subject|0|||
124597329|NCT03123783|448144281|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
124597330|NCT03123783|448144282|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
124597331|NCT03123783|448144276|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
124597332|NCT03123783|448144277|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
124597333|NCT03123783|448144278|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
124597334|NCT03123783|448144279|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
124597335|NCT03123783|448144280|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
124597336|NCT03123783|448144281|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
124597337|NCT03123783|448144282|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
124597338|NCT03123783|448144276|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
124597339|NCT03123783|448144277|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
124597340|NCT03123783|448144278|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
124597341|NCT03123783|448144279|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
124597342|NCT03123783|448144280|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
124597343|NCT03123783|448144281|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
124597344|NCT03123783|448144282|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
124597345|NCT02953678|448144285|FG000|Overall Study|Adverse Event|20|||
124597346|NCT02953678|448144285|FG000|Overall Study|Death|7|||
124597347|NCT02953678|448144285|FG000|Overall Study|Physician Decision|23|||
124597348|NCT02953678|448144285|FG000|Overall Study|Progressive Disease of GVHD|7|||
124597349|NCT02953678|448144285|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
124597350|NCT02953678|448144285|FG000|Overall Study|Withdrawal by participant|3|||
124597351|NCT02953678|448144285|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
124597352|NCT02953678|448144285|FG000|Overall Study|Participants were transferred to commercial product.|3|||
124597353|NCT01730040|448145758|FG000|Overall Study|Randomized but not treated|0|||
124597354|NCT01730040|448145759|FG001|Overall Study|Randomized but not treated|0|||
124597355|NCT01730040|448145760|FG002|Overall Study|Randomized but not treated|0|||
124597356|NCT01730040|448145761|FG003|Overall Study|Randomized but not treated|0|||
124597357|NCT01730040|448145762|FG004|Overall Study|Randomized but not treated|0|||
124597358|NCT01730040|448145763|FG005|Overall Study|Randomized but not treated|1|||
124597359|NCT01730040|448145764|FG006|Overall Study|Randomized but not treated|0|||
124597360|NCT01730040|448145758|FG000|Overall Study|Subject moved|0|||
124597361|NCT01730040|448145759|FG001|Overall Study|Subject moved|0|||
124597362|NCT01730040|448145760|FG002|Overall Study|Subject moved|1|||
124597363|NCT01730040|448145761|FG003|Overall Study|Subject moved|0|||
124597364|NCT01730040|448145762|FG004|Overall Study|Subject moved|0|||
124597365|NCT01730040|448145763|FG005|Overall Study|Subject moved|0|||
124597366|NCT01730040|448145764|FG006|Overall Study|Subject moved|1|||
124597367|NCT01730040|448145758|FG000|Overall Study|Physician Decision|0|||
124597368|NCT01730040|448145759|FG001|Overall Study|Physician Decision|0|||
124597369|NCT01730040|448145760|FG002|Overall Study|Physician Decision|0|||
124597370|NCT01730040|448145761|FG003|Overall Study|Physician Decision|0|||
124597371|NCT01730040|448145762|FG004|Overall Study|Physician Decision|0|||
124597372|NCT01730040|448145763|FG005|Overall Study|Physician Decision|1|||
124597373|NCT01730040|448145764|FG006|Overall Study|Physician Decision|1|||
124597374|NCT01730040|448145758|FG000|Overall Study|Other than specified|7|||
124597375|NCT01730040|448145759|FG001|Overall Study|Other than specified|8|||
124597376|NCT01730040|448145760|FG002|Overall Study|Other than specified|5|||
124597377|NCT01730040|448145761|FG003|Overall Study|Other than specified|5|||
124597378|NCT01730040|448145762|FG004|Overall Study|Other than specified|5|||
124597379|NCT01730040|448145763|FG005|Overall Study|Other than specified|4|||
124597380|NCT01730040|448145764|FG006|Overall Study|Other than specified|4|||
124597381|NCT01730040|448145758|FG000|Overall Study|Adverse Event|4|||
124597382|NCT01730040|448145759|FG001|Overall Study|Adverse Event|3|||
124597383|NCT01730040|448145760|FG002|Overall Study|Adverse Event|5|||
124597384|NCT01730040|448145761|FG003|Overall Study|Adverse Event|3|||
124597385|NCT01730040|448145762|FG004|Overall Study|Adverse Event|1|||
124597386|NCT01730040|448145763|FG005|Overall Study|Adverse Event|1|||
124597387|NCT01730040|448145764|FG006|Overall Study|Adverse Event|2|||
124597388|NCT01730040|448145758|FG000|Overall Study|Poor compliance to protocol|2|||
124597389|NCT01730040|448145759|FG001|Overall Study|Poor compliance to protocol|4|||
124597390|NCT01730040|448145760|FG002|Overall Study|Poor compliance to protocol|0|||
124597391|NCT01730040|448145761|FG003|Overall Study|Poor compliance to protocol|0|||
124597392|NCT01730040|448145762|FG004|Overall Study|Poor compliance to protocol|0|||
124597393|NCT01730040|448145763|FG005|Overall Study|Poor compliance to protocol|0|||
124597394|NCT01730040|448145764|FG006|Overall Study|Poor compliance to protocol|1|||
124597395|NCT01042535|448145765|FG000|Overall Study|disease progression prior to treatment|3|||
124597396|NCT01042535|448145765|FG000|Overall Study|disease progression during treatment|3|||
124597397|NCT01042535|448145765|FG000|Overall Study|complications from other disease|2|||
124597398|NCT01546142|448145766|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
124597399|NCT01546142|448145767|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
124597400|NCT01546142|448145766|FG000|Overall Study|Subject Noncompliance|1|||
124597401|NCT01546142|448145767|FG001|Overall Study|Subject Noncompliance|1|||
124730958|NCT01606787|448637437|FG001|Overall Study|Withdrawal by Subject|5|||
124597402|NCT01546142|448145766|FG000|Overall Study|Adverse Event|6|||
124597403|NCT01546142|448145767|FG001|Overall Study|Adverse Event|3|||
124597404|NCT01546142|448145766|FG000|Overall Study|Lost to Follow-up|20|||
124597405|NCT01546142|448145767|FG001|Overall Study|Lost to Follow-up|15|||
124597406|NCT01546142|448145766|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
124597407|NCT01546142|448145767|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
124597408|NCT01546142|448145766|FG000|Overall Study|Subject Randomized but Not Treated|1|||
124597409|NCT01546142|448145767|FG001|Overall Study|Subject Randomized but Not Treated|0|||
124597410|NCT01213836|448145770|FG000|Period 1, First Intervention|Adverse Event|2|||
124597411|NCT01213836|448145771|FG001|Period 1, First Intervention|Adverse Event|1|||
124597412|NCT01213836|448145770|FG000|Period 1, First Intervention|Protocol Violation|0|||
124597413|NCT01213836|448145771|FG001|Period 1, First Intervention|Protocol Violation|1|||
124597414|NCT01213836|448145770|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
124597415|NCT01213836|448145771|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
124597416|NCT00255151|448145772|FG000|Overall Study|Adverse Event|10|||
124597417|NCT00255151|448145773|FG001|Overall Study|Adverse Event|6|||
124597418|NCT00255151|448145774|FG002|Overall Study|Adverse Event|9|||
124597419|NCT00255151|448145772|FG000|Overall Study|Lost to Follow-up|4|||
124597420|NCT00255151|448145773|FG001|Overall Study|Lost to Follow-up|3|||
124597421|NCT00255151|448145774|FG002|Overall Study|Lost to Follow-up|4|||
124597422|NCT00255151|448145772|FG000|Overall Study|Withdrawal by Subject|18|||
124597423|NCT00255151|448145773|FG001|Overall Study|Withdrawal by Subject|17|||
124597424|NCT00255151|448145774|FG002|Overall Study|Withdrawal by Subject|8|||
124597425|NCT00255151|448145772|FG000|Overall Study|Noncompliance|0|||
124597426|NCT00255151|448145773|FG001|Overall Study|Noncompliance|1|||
124597427|NCT00255151|448145774|FG002|Overall Study|Noncompliance|2|||
124597428|NCT00255151|448145772|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
124597429|NCT00255151|448145773|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
124597430|NCT00255151|448145774|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
124597431|NCT00255151|448145772|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
124597432|NCT00255151|448145773|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
124597433|NCT00255151|448145774|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
124597434|NCT00255151|448145772|FG000|Overall Study|Possible Barrett's Esophagus|1|||
124597435|NCT00255151|448145773|FG001|Overall Study|Possible Barrett's Esophagus|3|||
124597436|NCT00255151|448145774|FG002|Overall Study|Possible Barrett's Esophagus|8|||
124597437|NCT00255151|448145772|FG000|Overall Study|Esophageal Stricture|0|||
124597438|NCT00255151|448145773|FG001|Overall Study|Esophageal Stricture|0|||
124597439|NCT00255151|448145774|FG002|Overall Study|Esophageal Stricture|1|||
124597440|NCT00255151|448145772|FG000|Overall Study|Therapeutic Failure|11|||
124597441|NCT00255151|448145773|FG001|Overall Study|Therapeutic Failure|2|||
124597442|NCT00255151|448145774|FG002|Overall Study|Therapeutic Failure|3|||
124597443|NCT00107042|448145775|FG000|Overall Study|Lost to Follow-up|9|||
124597444|NCT00107042|448145776|FG001|Overall Study|Lost to Follow-up|7|||
124597445|NCT00107042|448145775|FG000|Overall Study|Withdrawal by Subject|6|||
124597446|NCT00107042|448145776|FG001|Overall Study|Withdrawal by Subject|1|||
124597447|NCT00107042|448145775|FG000|Overall Study|Moved out of area|5|||
124597448|NCT00107042|448145776|FG001|Overall Study|Moved out of area|3|||
124597449|NCT00107042|448145775|FG000|Overall Study|Pregnancy|1|||
124597450|NCT00107042|448145776|FG001|Overall Study|Pregnancy|1|||
124597451|NCT00107042|448145775|FG000|Overall Study|Inadvertent enrollment|0|||
124597452|NCT00107042|448145776|FG001|Overall Study|Inadvertent enrollment|1|||
124597453|NCT00107042|448145775|FG000|Overall Study|vaccinated outside window|1|||
124597454|NCT00107042|448145776|FG001|Overall Study|vaccinated outside window|1|||
124597455|NCT00107042|448145775|FG000|Overall Study|Disallowed medications|0|||
124597456|NCT00107042|448145776|FG001|Overall Study|Disallowed medications|2|||
124597457|NCT01286558|448145779|FG000|Overall Study|Adverse Event|1|||
124597458|NCT01286558|448145780|FG001|Overall Study|Adverse Event|1|||
124597459|NCT01286558|448145779|FG000|Overall Study|Withdrawal by Subject|0|||
124597460|NCT01286558|448145780|FG001|Overall Study|Withdrawal by Subject|1|||
124597461|NCT04109313|448145786|FG000|Overall Study|Pregnancy|1|||
124597462|NCT04109313|448145786|FG000|Overall Study|Adverse Event|11|||
124597463|NCT04109313|448145786|FG000|Overall Study|Lack of Efficacy|11|||
124597464|NCT04109313|448145786|FG000|Overall Study|Lost to Follow-up|1|||
124597465|NCT04109313|448145786|FG000|Overall Study|Physician Decision|2|||
124597466|NCT04109313|448145786|FG000|Overall Study|Subject Decision|13|||
124597467|NCT04109313|448145786|FG000|Overall Study|Covid-19 situation|2|||
124597468|NCT00655850|448145789|FG000|Overall Study|Death|2|||
124597469|NCT00655850|448145789|FG000|Overall Study|Withdrawal by Subject|1|||
124597470|NCT01567826|448145790|FG000|Overall Study|Lost to Follow-up|3|||
124597471|NCT01567826|448145791|FG001|Overall Study|Lost to Follow-up|2|||
124597472|NCT04364737|448145792|FG000|Overall Study|Withdrawal by Subject|4|||
124597473|NCT04364737|448145793|FG001|Overall Study|Withdrawal by Subject|9|||
124597474|NCT04364737|448145792|FG000|Overall Study|Lost to Follow-up|1|||
124597475|NCT04364737|448145793|FG001|Overall Study|Lost to Follow-up|1|||
124597476|NCT03702049|448145794|FG000|Overall Study|Lost to Follow-up|4|||
124597477|NCT03702049|448145794|FG000|Overall Study|Physician Decision|1|||
124597478|NCT00573170|448145795|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
124597479|NCT00573170|448145796|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
124597480|NCT00573170|448145797|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
124597481|NCT00573170|448145798|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
124597482|NCT00573170|448145799|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
124597483|NCT00573170|448145800|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
124597484|NCT00573170|448145795|FG000|First Washout Period|Adverse Event|1|||
124597485|NCT00573170|448145796|FG001|First Washout Period|Adverse Event|1|||
124597486|NCT00573170|448145797|FG002|First Washout Period|Adverse Event|0|||
124597487|NCT00573170|448145798|FG003|First Washout Period|Adverse Event|0|||
124597488|NCT00573170|448145799|FG004|First Washout Period|Adverse Event|0|||
124597489|NCT00573170|448145800|FG005|First Washout Period|Adverse Event|1|||
124597490|NCT00573170|448145795|FG000|First Washout Period|Lack of Efficacy|0|||
124597491|NCT00573170|448145796|FG001|First Washout Period|Lack of Efficacy|0|||
124597492|NCT00573170|448145797|FG002|First Washout Period|Lack of Efficacy|0|||
124597493|NCT00573170|448145798|FG003|First Washout Period|Lack of Efficacy|0|||
124597494|NCT00573170|448145799|FG004|First Washout Period|Lack of Efficacy|0|||
124597495|NCT00573170|448145800|FG005|First Washout Period|Lack of Efficacy|1|||
124597496|NCT00573170|448145795|FG000|First Washout Period|Lost to Follow-up|1|||
124597497|NCT00573170|448145796|FG001|First Washout Period|Lost to Follow-up|1|||
124597498|NCT00573170|448145797|FG002|First Washout Period|Lost to Follow-up|0|||
124597499|NCT00573170|448145798|FG003|First Washout Period|Lost to Follow-up|2|||
124597500|NCT00573170|448145799|FG004|First Washout Period|Lost to Follow-up|0|||
124597501|NCT00573170|448145800|FG005|First Washout Period|Lost to Follow-up|2|||
124597502|NCT00573170|448145795|FG000|First Washout Period|Withdrawal by Subject|2|||
124597503|NCT00573170|448145796|FG001|First Washout Period|Withdrawal by Subject|0|||
124597504|NCT00573170|448145797|FG002|First Washout Period|Withdrawal by Subject|0|||
124597505|NCT00573170|448145798|FG003|First Washout Period|Withdrawal by Subject|2|||
124597506|NCT00573170|448145799|FG004|First Washout Period|Withdrawal by Subject|3|||
124597507|NCT00573170|448145800|FG005|First Washout Period|Withdrawal by Subject|3|||
124597508|NCT00573170|448145795|FG000|First Washout Period|Other|4|||
124597509|NCT00573170|448145796|FG001|First Washout Period|Other|0|||
124597510|NCT00573170|448145797|FG002|First Washout Period|Other|1|||
124597511|NCT00573170|448145798|FG003|First Washout Period|Other|1|||
124597512|NCT00573170|448145799|FG004|First Washout Period|Other|0|||
124597513|NCT00573170|448145800|FG005|First Washout Period|Other|0|||
124597514|NCT00573170|448145795|FG000|Second Washout Period|Adverse Event|1|||
124597515|NCT00573170|448145796|FG001|Second Washout Period|Adverse Event|0|||
124597516|NCT00573170|448145797|FG002|Second Washout Period|Adverse Event|0|||
124597517|NCT00573170|448145798|FG003|Second Washout Period|Adverse Event|0|||
124597518|NCT00573170|448145799|FG004|Second Washout Period|Adverse Event|1|||
124597519|NCT00573170|448145800|FG005|Second Washout Period|Adverse Event|0|||
124597520|NCT00573170|448145795|FG000|Second Washout Period|Protocol Violation|2|||
124597521|NCT00573170|448145796|FG001|Second Washout Period|Protocol Violation|1|||
124597522|NCT00573170|448145797|FG002|Second Washout Period|Protocol Violation|1|||
124597523|NCT00573170|448145798|FG003|Second Washout Period|Protocol Violation|0|||
124597524|NCT00573170|448145799|FG004|Second Washout Period|Protocol Violation|0|||
124597525|NCT00573170|448145800|FG005|Second Washout Period|Protocol Violation|0|||
124597526|NCT00573170|448145795|FG000|Second Washout Period|Withdrawal by Subject|1|||
124597527|NCT00573170|448145796|FG001|Second Washout Period|Withdrawal by Subject|1|||
124597528|NCT00573170|448145797|FG002|Second Washout Period|Withdrawal by Subject|2|||
124597529|NCT00573170|448145798|FG003|Second Washout Period|Withdrawal by Subject|0|||
124597530|NCT00573170|448145799|FG004|Second Washout Period|Withdrawal by Subject|1|||
124597531|NCT00573170|448145800|FG005|Second Washout Period|Withdrawal by Subject|0|||
124597532|NCT00573170|448145795|FG000|Second Washout Period|Lost to Follow-up|0|||
124780199|NCT01621802|448825313|FG000|Overall Study|Migrated/moved from study area|0|||
124780200|NCT01621802|448825314|FG001|Overall Study|Migrated/moved from study area|0|||
124780201|NCT01621802|448825315|FG002|Overall Study|Migrated/moved from study area|2|||
124780202|NCT01621802|448825316|FG003|Overall Study|Migrated/moved from study area|0|||
124780203|NCT01621802|448825317|FG004|Overall Study|Migrated/moved from study area|1|||
124780204|NCT01621802|448825318|FG005|Overall Study|Migrated/moved from study area|0|||
124780205|NCT01621802|448825313|FG000|Overall Study|Others|3|||
124780206|NCT01621802|448825314|FG001|Overall Study|Others|3|||
124597533|NCT00573170|448145796|FG001|Second Washout Period|Lost to Follow-up|0|||
124597534|NCT00573170|448145797|FG002|Second Washout Period|Lost to Follow-up|0|||
124597535|NCT00573170|448145798|FG003|Second Washout Period|Lost to Follow-up|1|||
124597536|NCT00573170|448145799|FG004|Second Washout Period|Lost to Follow-up|0|||
124597537|NCT00573170|448145800|FG005|Second Washout Period|Lost to Follow-up|0|||
124597538|NCT00573170|448145795|FG000|Second Washout Period|Other|1|||
124597539|NCT00573170|448145796|FG001|Second Washout Period|Other|2|||
124597540|NCT00573170|448145797|FG002|Second Washout Period|Other|1|||
124780207|NCT01621802|448825315|FG002|Overall Study|Others|3|||
124597541|NCT00573170|448145798|FG003|Second Washout Period|Other|4|||
124780208|NCT01621802|448825316|FG003|Overall Study|Others|2|||
124780209|NCT01621802|448825317|FG004|Overall Study|Others|1|||
124780210|NCT01621802|448825318|FG005|Overall Study|Others|0|||
124780211|NCT01621802|448825313|FG000|Overall Study|Lost to Follow-up|36|||
124780212|NCT01621802|448825314|FG001|Overall Study|Lost to Follow-up|16|||
124780213|NCT01621802|448825315|FG002|Overall Study|Lost to Follow-up|24|||
124780214|NCT01621802|448825316|FG003|Overall Study|Lost to Follow-up|7|||
124780215|NCT01621802|448825317|FG004|Overall Study|Lost to Follow-up|31|||
124780216|NCT01621802|448825318|FG005|Overall Study|Lost to Follow-up|11|||
124780217|NCT02948634|448825319|FG000|Overall Study|Lack of efficacy and study suspended|10|||
124780218|NCT02948634|448825320|FG001|Overall Study|Lack of efficacy and study suspended|2|||
124780219|NCT03052400|448825323|FG000|Overall Study|Lost to Follow-up|1|||
124780220|NCT03052400|448825324|FG001|Overall Study|Lost to Follow-up|0|||
124780221|NCT03052400|448825323|FG000|Overall Study|Withdrawal by Subject|0|||
124780222|NCT03052400|448825324|FG001|Overall Study|Withdrawal by Subject|1|||
124780223|NCT00555061|448825325|FG000|Overall Study|Adverse Event|3|||
124780224|NCT00555061|448825325|FG000|Overall Study|Protocol Violation|1|||
124780225|NCT00555061|448825325|FG000|Overall Study|Lost to Follow-up|2|||
124780226|NCT00555061|448825325|FG000|Overall Study|Withdrawal by Subject|2|||
124780227|NCT00555061|448825325|FG000|Overall Study|Participant enrolled, but never treated|1|||
124780228|NCT00485134|448825327|FG000|Overall Study|Lost to Follow-up|1|||
124780229|NCT00485134|448825328|FG001|Overall Study|Lost to Follow-up|0|||
124780230|NCT00485134|448825329|FG002|Overall Study|Lost to Follow-up|0|||
124780231|NCT00485134|448825330|FG003|Overall Study|Lost to Follow-up|0|||
124780232|NCT00485134|448825331|FG004|Overall Study|Lost to Follow-up|0|||
124780233|NCT00485134|448825332|FG005|Overall Study|Lost to Follow-up|0|||
124780234|NCT00485134|448825333|FG006|Overall Study|Lost to Follow-up|0|||
124780235|NCT00485134|448825334|FG007|Overall Study|Lost to Follow-up|0|||
124780236|NCT00485134|448825327|FG000|Overall Study|Withdrawal by Subject|0|||
124780237|NCT00485134|448825328|FG001|Overall Study|Withdrawal by Subject|1|||
124780238|NCT00485134|448825329|FG002|Overall Study|Withdrawal by Subject|0|||
124780239|NCT00485134|448825330|FG003|Overall Study|Withdrawal by Subject|0|||
124780240|NCT00485134|448825331|FG004|Overall Study|Withdrawal by Subject|0|||
124780241|NCT00485134|448825332|FG005|Overall Study|Withdrawal by Subject|0|||
124780242|NCT00485134|448825333|FG006|Overall Study|Withdrawal by Subject|0|||
124780243|NCT00485134|448825334|FG007|Overall Study|Withdrawal by Subject|0|||
124780244|NCT00485134|448825327|FG000|Overall Study|Change in health status|0|||
124780245|NCT00485134|448825328|FG001|Overall Study|Change in health status|1|||
124780246|NCT00485134|448825329|FG002|Overall Study|Change in health status|2|||
124780247|NCT00485134|448825330|FG003|Overall Study|Change in health status|1|||
124780248|NCT00485134|448825331|FG004|Overall Study|Change in health status|0|||
124780249|NCT00485134|448825332|FG005|Overall Study|Change in health status|1|||
124780250|NCT00485134|448825333|FG006|Overall Study|Change in health status|0|||
124780251|NCT00485134|448825334|FG007|Overall Study|Change in health status|0|||
124780252|NCT00485134|448825327|FG000|Overall Study|Withdrew for adverse event|0|||
124780253|NCT00485134|448825328|FG001|Overall Study|Withdrew for adverse event|0|||
124780254|NCT00485134|448825329|FG002|Overall Study|Withdrew for adverse event|1|||
124780255|NCT00485134|448825330|FG003|Overall Study|Withdrew for adverse event|0|||
124780256|NCT00485134|448825331|FG004|Overall Study|Withdrew for adverse event|0|||
124780257|NCT00485134|448825332|FG005|Overall Study|Withdrew for adverse event|0|||
124780258|NCT00485134|448825333|FG006|Overall Study|Withdrew for adverse event|0|||
124780259|NCT00485134|448825334|FG007|Overall Study|Withdrew for adverse event|0|||
124780260|NCT00485134|448825327|FG000|Overall Study|Positive drug test|0|||
124780261|NCT00485134|448825328|FG001|Overall Study|Positive drug test|0|||
124780262|NCT00485134|448825329|FG002|Overall Study|Positive drug test|0|||
124780263|NCT00485134|448825330|FG003|Overall Study|Positive drug test|0|||
124597542|NCT00573170|448145799|FG004|Second Washout Period|Other|6|||
124597543|NCT00573170|448145800|FG005|Second Washout Period|Other|2|||
124597544|NCT00573170|448145795|FG000|Third Treatment Period|Withdrawal by Subject|1|||
124597545|NCT00573170|448145796|FG001|Third Treatment Period|Withdrawal by Subject|0|||
124597546|NCT00573170|448145797|FG002|Third Treatment Period|Withdrawal by Subject|0|||
124780264|NCT00485134|448825331|FG004|Overall Study|Positive drug test|2|||
124780265|NCT00485134|448825332|FG005|Overall Study|Positive drug test|1|||
124780266|NCT00485134|448825333|FG006|Overall Study|Positive drug test|0|||
124780267|NCT00485134|448825334|FG007|Overall Study|Positive drug test|0|||
124780268|NCT00485134|448825327|FG000|Overall Study|Non-compliance|0|||
124780269|NCT00485134|448825328|FG001|Overall Study|Non-compliance|0|||
124597547|NCT00573170|448145798|FG003|Third Treatment Period|Withdrawal by Subject|0|||
124780270|NCT00485134|448825329|FG002|Overall Study|Non-compliance|0|||
124780271|NCT00485134|448825330|FG003|Overall Study|Non-compliance|0|||
124597548|NCT00573170|448145799|FG004|Third Treatment Period|Withdrawal by Subject|0|||
124780272|NCT00485134|448825331|FG004|Overall Study|Non-compliance|1|||
124780273|NCT00485134|448825332|FG005|Overall Study|Non-compliance|2|||
124780274|NCT00485134|448825333|FG006|Overall Study|Non-compliance|2|||
124780275|NCT00485134|448825334|FG007|Overall Study|Non-compliance|0|||
124780276|NCT00485134|448825327|FG000|Overall Study|Unable to comply with study schedule|0|||
124597549|NCT00573170|448145800|FG005|Third Treatment Period|Withdrawal by Subject|0|||
124597550|NCT00573170|448145795|FG000|Third Treatment Period|Lost to Follow-up|0|||
124597551|NCT00573170|448145796|FG001|Third Treatment Period|Lost to Follow-up|0|||
124597552|NCT00573170|448145797|FG002|Third Treatment Period|Lost to Follow-up|0|||
124597553|NCT00573170|448145798|FG003|Third Treatment Period|Lost to Follow-up|0|||
124597554|NCT00573170|448145799|FG004|Third Treatment Period|Lost to Follow-up|0|||
124597555|NCT00573170|448145800|FG005|Third Treatment Period|Lost to Follow-up|2|||
124597556|NCT00986570|448145801|FG000|Overall Study|Lost to Follow-up|6|||
124597557|NCT00986570|448145801|FG000|Overall Study|Potential bias for objective assessment|1|||
124597558|NCT00608517|448145803|FG000|Overall Study|Death|1|||
124597559|NCT00608517|448145804|FG001|Overall Study|Death|0|||
124597560|NCT00608517|448145805|FG002|Overall Study|Death|0|||
124597561|NCT01833533|448145807|FG000|Overall Study|Adverse Event|0|||
124597562|NCT01833533|448145808|FG001|Overall Study|Adverse Event|1|||
124597563|NCT01833533|448145807|FG000|Overall Study|Lost to Follow-up|4|||
124597564|NCT01833533|448145808|FG001|Overall Study|Lost to Follow-up|9|||
124597565|NCT01833533|448145807|FG000|Overall Study|To Enter an Extension Study|0|||
124597566|NCT01833533|448145808|FG001|Overall Study|To Enter an Extension Study|4|||
124597567|NCT01833533|448145807|FG000|Overall Study|Other|2|||
124597568|NCT01833533|448145808|FG001|Overall Study|Other|7|||
124597569|NCT02457611|448145810|FG000|Overall Study|Lost to Follow-up|3|||
124597570|NCT00384293|448145811|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
124597571|NCT00384293|448145812|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
124597572|NCT00384293|448145813|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
124597573|NCT00384293|448145811|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
124597574|NCT00384293|448145812|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
124597575|NCT00384293|448145813|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
124597576|NCT00384293|448145811|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
124597577|NCT00384293|448145812|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
124597578|NCT00384293|448145813|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
124597579|NCT00384293|448145811|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
124597580|NCT00384293|448145812|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
124597581|NCT00384293|448145813|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
124597582|NCT00384293|448145811|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
124597583|NCT00384293|448145812|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
124597584|NCT00384293|448145813|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
124597585|NCT00384293|448145811|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
124597586|NCT00384293|448145812|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
124597587|NCT00384293|448145813|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
124597588|NCT00384293|448145811|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
124597589|NCT00384293|448145812|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
124597590|NCT00384293|448145813|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
124597591|NCT00384293|448145811|FG000|Post-randomization Period|Adverse Event|0|||
124597592|NCT00384293|448145812|FG001|Post-randomization Period|Adverse Event|23|||
124597593|NCT00384293|448145813|FG002|Post-randomization Period|Adverse Event|7|||
124597594|NCT00384293|448145811|FG000|Post-randomization Period|Lost to Follow-up|0|||
124597595|NCT00384293|448145812|FG001|Post-randomization Period|Lost to Follow-up|2|||
124597596|NCT00384293|448145813|FG002|Post-randomization Period|Lost to Follow-up|1|||
124597597|NCT00384293|448145811|FG000|Post-randomization Period|Protocol Violation|0|||
124597598|NCT00384293|448145812|FG001|Post-randomization Period|Protocol Violation|1|||
124597599|NCT00384293|448145813|FG002|Post-randomization Period|Protocol Violation|0|||
124597600|NCT00384293|448145811|FG000|Post-randomization Period|Withdrawal by Subject|0|||
124597601|NCT00384293|448145812|FG001|Post-randomization Period|Withdrawal by Subject|8|||
124597602|NCT00384293|448145813|FG002|Post-randomization Period|Withdrawal by Subject|6|||
124597603|NCT00384293|448145811|FG000|Post-randomization Period|Trial Termination|0|||
124597604|NCT00384293|448145812|FG001|Post-randomization Period|Trial Termination|180|||
124597605|NCT00384293|448145813|FG002|Post-randomization Period|Trial Termination|204|||
124597606|NCT00384293|448145811|FG000|Post-randomization Period|Patient Randomized in Error|0|||
124597607|NCT00384293|448145812|FG001|Post-randomization Period|Patient Randomized in Error|0|||
124730959|NCT01606787|448637436|FG000|Overall Study|Surgery canceled|0|||
124730960|NCT01606787|448637437|FG001|Overall Study|Surgery canceled|2|||
124730961|NCT00413894|448637438|FG000|Overall Study|Withdrawal by Subject|10|||
124730962|NCT00413894|448637438|FG000|Overall Study|Administrative Reasons|1|||
124597608|NCT00384293|448145813|FG002|Post-randomization Period|Patient Randomized in Error|1|||
124597609|NCT00493454|448145814|FG000|Overall Study|Withdrawal by Subject|1|||
124597610|NCT00103038|448145815|FG000|Overall Study|Withdrawal by Subject|8|||
124597611|NCT00103038|448145815|FG000|Overall Study|Screen failure|3|||
124597612|NCT00103038|448145815|FG000|Overall Study|Death|1|||
124597613|NCT00103038|448145815|FG000|Overall Study|Physician Decision|1|||
124597614|NCT02865395|448145822|FG000|Overall Study|Physician Decision|6|||
124780277|NCT00485134|448825328|FG001|Overall Study|Unable to comply with study schedule|0|||
124597615|NCT02865395|448145823|FG001|Overall Study|Physician Decision|10|||
124597616|NCT02865395|448145824|FG002|Overall Study|Physician Decision|7|||
124597617|NCT01501110|448145825|FG000|Overall Study|Death|0|||
124597618|NCT01501110|448145826|FG001|Overall Study|Death|1|||
124597619|NCT02075606|448145827|FG000|Overall Study|Adverse Event|5|||
124597620|NCT02075606|448145827|FG000|Overall Study|Withdrawal by Subject|1|||
124597621|NCT02075606|448145827|FG000|Overall Study|Death|1|||
124597622|NCT02075606|448145827|FG000|Overall Study|Investigator's decision|1|||
124597623|NCT02075606|448145827|FG000|Overall Study|Symptom management|1|||
124597624|NCT02075606|448145827|FG000|Overall Study|Increasing Symptoms|1|||
124597625|NCT01483625|448145828|FG000|Overall Study|Adverse Event|1|||
124597626|NCT01483625|448145829|FG001|Overall Study|Adverse Event|1|||
124597627|NCT01483625|448145828|FG000|Overall Study|Refused to continue medication|2|||
124597628|NCT01483625|448145829|FG001|Overall Study|Refused to continue medication|1|||
124597629|NCT01483625|448145828|FG000|Overall Study|Due to other reason|1|||
124597630|NCT01483625|448145829|FG001|Overall Study|Due to other reason|0|||
124597631|NCT02310763|448145833|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
124597632|NCT02310763|448145834|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
124597633|NCT02310763|448145835|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
124597634|NCT02310763|448145833|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
124597635|NCT02310763|448145834|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
124597636|NCT02310763|448145835|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
124597637|NCT02310763|448145833|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
124597638|NCT02310763|448145834|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
124597639|NCT02310763|448145835|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
124597640|NCT02310763|448145833|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
124597641|NCT02310763|448145834|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
124597642|NCT02310763|448145835|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
124597643|NCT02310763|448145833|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
124597644|NCT02310763|448145834|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
124597645|NCT02310763|448145835|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
124597646|NCT04019054|448145836|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
124597647|NCT04019054|448145837|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
124597648|NCT04019054|448145836|FG000|Overall Study|Withdrawal by Subject|3|||
124597649|NCT04019054|448145837|FG001|Overall Study|Withdrawal by Subject|1|||
124597650|NCT05444543|448145838|FG000|Overall Study|Withdrawal by Subject|1|||
124597651|NCT05444543|448145839|FG001|Overall Study|Withdrawal by Subject|0|||
124597652|NCT05444543|448145838|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
124597653|NCT05444543|448145839|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
124597654|NCT05444543|448145838|FG000|Overall Study|Adverse Event|0|||
124597655|NCT05444543|448145839|FG001|Overall Study|Adverse Event|1|||
124597656|NCT05444543|448145838|FG000|Overall Study|Family relocating at a distance from study site|0|||
124597657|NCT05444543|448145839|FG001|Overall Study|Family relocating at a distance from study site|1|||
124597658|NCT01261624|448145840|FG000|Week 0 to Week 12|Disease Progression|1|||
124597659|NCT01261624|448145841|FG001|Week 0 to Week 12|Disease Progression|1|||
124597660|NCT01261624|448145840|FG000|Week 0 to Week 12|Insufficient Response|0|||
124597661|NCT01261624|448145841|FG001|Week 0 to Week 12|Insufficient Response|2|||
124597662|NCT01261624|448145840|FG000|Week 13 to Week 24|Insufficient Response|0|||
124597663|NCT01261624|448145841|FG001|Week 13 to Week 24|Insufficient Response|1|||
124597664|NCT02094261|448145844|FG000|Overall Study|Death|24|||
124597665|NCT02094261|448145844|FG000|Overall Study|Lost to Follow-up|1|||
124597666|NCT02094261|448145844|FG000|Overall Study|Withdrawal by Subject|4|||
124597667|NCT02094261|448145844|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
124597668|NCT03877926|448145845|FG000|Overall Study|Adverse Event|1|||
124597669|NCT03877926|448145846|FG001|Overall Study|Adverse Event|0|||
124597670|NCT03877926|448145847|FG002|Overall Study|Adverse Event|0|||
124597671|NCT03877926|448145848|FG003|Overall Study|Adverse Event|0|||
124597672|NCT03877926|448145845|FG000|Overall Study|Death|2|||
124597673|NCT03877926|448145846|FG001|Overall Study|Death|2|||
124597674|NCT03877926|448145847|FG002|Overall Study|Death|2|||
124597675|NCT03877926|448145848|FG003|Overall Study|Death|0|||
124597676|NCT03877926|448145845|FG000|Overall Study|Lost to Follow-up|41|||
124597677|NCT03877926|448145846|FG001|Overall Study|Lost to Follow-up|52|||
124597678|NCT03877926|448145847|FG002|Overall Study|Lost to Follow-up|45|||
124597679|NCT03877926|448145848|FG003|Overall Study|Lost to Follow-up|17|||
124597680|NCT03877926|448145845|FG000|Overall Study|Physician Decision|2|||
124597681|NCT03877926|448145846|FG001|Overall Study|Physician Decision|0|||
124597682|NCT03877926|448145847|FG002|Overall Study|Physician Decision|2|||
124597683|NCT03877926|448145848|FG003|Overall Study|Physician Decision|0|||
124597684|NCT03877926|448145845|FG000|Overall Study|Withdrawal by Subject|18|||
124597685|NCT03877926|448145846|FG001|Overall Study|Withdrawal by Subject|21|||
124597686|NCT03877926|448145847|FG002|Overall Study|Withdrawal by Subject|12|||
124597687|NCT03877926|448145848|FG003|Overall Study|Withdrawal by Subject|4|||
124780278|NCT00485134|448825329|FG002|Overall Study|Unable to comply with study schedule|0|||
124780279|NCT00485134|448825330|FG003|Overall Study|Unable to comply with study schedule|0|||
124780280|NCT00485134|448825331|FG004|Overall Study|Unable to comply with study schedule|0|||
124780281|NCT00485134|448825332|FG005|Overall Study|Unable to comply with study schedule|0|||
124780282|NCT00485134|448825333|FG006|Overall Study|Unable to comply with study schedule|0|||
124780283|NCT00485134|448825334|FG007|Overall Study|Unable to comply with study schedule|1|||
124780284|NCT00485134|448825327|FG000|Overall Study|Pregnancy|0|||
124730963|NCT00413894|448637438|FG000|Overall Study|Hb <10 grams/deciliter|12|||
124730964|NCT00413894|448637438|FG000|Overall Study|Adverse Event|28|||
124730965|NCT00413894|448637438|FG000|Overall Study|Protocol Violation|11|||
124730966|NCT00413894|448637438|FG000|Overall Study|Other|18|||
124730967|NCT04225676|448637439|FG000|Overall Study|Physician Decision|1|||
124730968|NCT04225676|448637439|FG000|Overall Study|Lack of Efficacy|1|||
124730969|NCT04225676|448637439|FG000|Overall Study|Study terminated by sponsor|3|||
124730970|NCT03245736|448637440|FG000|Overall Study|Adverse Event|1|||
124730971|NCT03245736|448637440|FG000|Overall Study|Progressive Disease|4|||
124730972|NCT01942161|448637441|FG000|Overall Study|Adverse Event|1|||
124730973|NCT01942161|448637442|FG001|Overall Study|Adverse Event|2|||
124730974|NCT01942161|448637443|FG002|Overall Study|Adverse Event|5|||
124730975|NCT01942161|448637441|FG000|Overall Study|Physician Decision|3|||
124730976|NCT01942161|448637442|FG001|Overall Study|Physician Decision|1|||
124730977|NCT01942161|448637443|FG002|Overall Study|Physician Decision|0|||
124730978|NCT01942161|448637441|FG000|Overall Study|Protocol Violation|1|||
124730979|NCT01942161|448637442|FG001|Overall Study|Protocol Violation|0|||
124730980|NCT01942161|448637443|FG002|Overall Study|Protocol Violation|0|||
124730981|NCT01942161|448637441|FG000|Overall Study|Withdrawal by Subject|3|||
124730982|NCT01942161|448637442|FG001|Overall Study|Withdrawal by Subject|3|||
124730983|NCT01942161|448637443|FG002|Overall Study|Withdrawal by Subject|1|||
124730984|NCT05289271|448637446|FG000|Overall Study|Mistakenly allocated, untreated|1|||
124730985|NCT05289271|448637447|FG001|Overall Study|Mistakenly allocated, untreated|0|||
124730986|NCT01257568|448637449|FG000|Overall Study|Lost to Follow-up|2|||
124730987|NCT01257568|448637449|FG000|Overall Study|Withdrawal by Subject|6|||
124730988|NCT01257568|448637449|FG000|Overall Study|Terminated|1|||
124730989|NCT01257568|448637449|FG000|Overall Study|Component Revision|24|||
124730990|NCT03392883|448637451|FG000|Overall Study|Lost to Follow-up|122|||
124730991|NCT03392883|448637452|FG001|Overall Study|Lost to Follow-up|13|||
124730992|NCT03392883|448637453|FG002|Overall Study|Lost to Follow-up|9|||
124730993|NCT03392883|448637451|FG000|Overall Study|Death|4|||
124730994|NCT03392883|448637452|FG001|Overall Study|Death|0|||
124730995|NCT03392883|448637453|FG002|Overall Study|Death|0|||
124730996|NCT03392883|448637451|FG000|Overall Study|Lack of Efficacy|29|||
124730997|NCT03392883|448637452|FG001|Overall Study|Lack of Efficacy|0|||
124730998|NCT03392883|448637453|FG002|Overall Study|Lack of Efficacy|0|||
124730999|NCT03392883|448637451|FG000|Overall Study|Withdrawal by Subject|180|||
124731000|NCT03392883|448637452|FG001|Overall Study|Withdrawal by Subject|0|||
124731001|NCT03392883|448637453|FG002|Overall Study|Withdrawal by Subject|0|||
124731002|NCT03392883|448637451|FG000|Overall Study|Adverse Event|1|||
124731003|NCT03392883|448637452|FG001|Overall Study|Adverse Event|0|||
124731004|NCT03392883|448637453|FG002|Overall Study|Adverse Event|0|||
124731005|NCT00132691|448637454|FG000|Overall Study|Lost to Follow-up|5|||
124731006|NCT00132691|448637455|FG001|Overall Study|Lost to Follow-up|8|||
124731007|NCT00132691|448637454|FG000|Overall Study|Missed 2-year visit|4|||
124731008|NCT00132691|448637455|FG001|Overall Study|Missed 2-year visit|4|||
124731009|NCT00132691|448637454|FG000|Overall Study|Death|2|||
124731010|NCT00132691|448637455|FG001|Overall Study|Death|0|||
124731011|NCT01739933|448637465|FG000|Overall Study|Death|89|||
124731012|NCT01739933|448637466|FG001|Overall Study|Death|86|||
124731013|NCT01739933|448637465|FG000|Overall Study|Withdrawal by Subject|10|||
124731014|NCT01739933|448637466|FG001|Overall Study|Withdrawal by Subject|8|||
124731015|NCT01739933|448637465|FG000|Overall Study|Lost to Follow-up|3|||
124731016|NCT01739933|448637466|FG001|Overall Study|Lost to Follow-up|10|||
124731017|NCT01739933|448637465|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
124731018|NCT01739933|448637466|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
124731019|NCT04098367|448637467|FG000|Overall Study|Adverse Event|0|||
124731020|NCT04098367|448637468|FG001|Overall Study|Adverse Event|0|||
124731021|NCT04098367|448637469|FG002|Overall Study|Adverse Event|1|||
124731022|NCT04098367|448637467|FG000|Overall Study|Lost to Follow-up|1|||
124731023|NCT04098367|448637468|FG001|Overall Study|Lost to Follow-up|5|||
124731024|NCT04098367|448637469|FG002|Overall Study|Lost to Follow-up|2|||
124731025|NCT04098367|448637467|FG000|Overall Study|Withdrawal by Subject|0|||
124731026|NCT04098367|448637468|FG001|Overall Study|Withdrawal by Subject|0|||
124731027|NCT04098367|448637469|FG002|Overall Study|Withdrawal by Subject|1|||
124731028|NCT04098367|448637467|FG000|Overall Study|Sick . Could not attend visit|1|||
124731029|NCT04098367|448637468|FG001|Overall Study|Sick . Could not attend visit|0|||
124731030|NCT04098367|448637469|FG002|Overall Study|Sick . Could not attend visit|0|||
124731031|NCT01231321|448637475|FG000|Overall Study|Adverse Event|3|||
124731032|NCT01231321|448637475|FG000|Overall Study|Lack of Efficacy|2|||
124731033|NCT03575065|448637479|FG000|Overall Study|Death|31|||
124597688|NCT03877926|448145845|FG000|Overall Study|Other - Various|4|||
124597689|NCT03877926|448145846|FG001|Overall Study|Other - Various|1|||
124597690|NCT03877926|448145847|FG002|Overall Study|Other - Various|1|||
124597691|NCT03877926|448145848|FG003|Overall Study|Other - Various|0|||
124597692|NCT03877926|448145845|FG000|Overall Study|Not Treated|3|||
124597693|NCT03877926|448145846|FG001|Overall Study|Not Treated|1|||
124597694|NCT03877926|448145847|FG002|Overall Study|Not Treated|1|||
124597695|NCT03877926|448145848|FG003|Overall Study|Not Treated|0|||
124597696|NCT03554317|448145851|FG000|Overall Study|Withdrawal by Subject|1|||
124731034|NCT03575065|448637480|FG001|Overall Study|Death|12|||
124731035|NCT03575065|448637479|FG000|Overall Study|Sponsor's Decision|28|||
124731036|NCT03575065|448637480|FG001|Overall Study|Sponsor's Decision|13|||
124731037|NCT03575065|448637479|FG000|Overall Study|Withdrawal by Subject|2|||
124731038|NCT03575065|448637480|FG001|Overall Study|Withdrawal by Subject|1|||
124731039|NCT03575065|448637479|FG000|Overall Study|Lost to Follow-up|1|||
124731040|NCT03575065|448637480|FG001|Overall Study|Lost to Follow-up|0|||
124731041|NCT02359045|448637481|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
124731042|NCT02359045|448637482|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
124731043|NCT02359045|448637481|FG000|Overall Study|Lost to Follow-up|1|||
124731044|NCT02359045|448637482|FG001|Overall Study|Lost to Follow-up|1|||
124731045|NCT02359045|448637481|FG000|Overall Study|Adverse Event|0|||
124731046|NCT02359045|448637482|FG001|Overall Study|Adverse Event|1|||
124731047|NCT00541866|448637483|FG000|Overall Study|Adverse Event|3|||
124731048|NCT00541866|448637484|FG001|Overall Study|Adverse Event|0|||
124731049|NCT00541866|448637485|FG002|Overall Study|Adverse Event|0|||
124731050|NCT00541866|448637486|FG003|Overall Study|Adverse Event|0|||
124731051|NCT00541866|448637487|FG004|Overall Study|Adverse Event|0|||
124731052|NCT00541866|448637483|FG000|Overall Study|Death|1|||
124731053|NCT00541866|448637484|FG001|Overall Study|Death|0|||
124731054|NCT00541866|448637485|FG002|Overall Study|Death|0|||
124731055|NCT00541866|448637486|FG003|Overall Study|Death|0|||
124731056|NCT00541866|448637487|FG004|Overall Study|Death|0|||
124731057|NCT00541866|448637483|FG000|Overall Study|Lack of Efficacy|19|||
124731058|NCT00541866|448637484|FG001|Overall Study|Lack of Efficacy|15|||
124731059|NCT00541866|448637485|FG002|Overall Study|Lack of Efficacy|10|||
124731060|NCT00541866|448637486|FG003|Overall Study|Lack of Efficacy|12|||
124731061|NCT00541866|448637487|FG004|Overall Study|Lack of Efficacy|14|||
124731062|NCT00541866|448637483|FG000|Overall Study|Not Reported or Other|11|||
124731063|NCT00541866|448637484|FG001|Overall Study|Not Reported or Other|3|||
124731064|NCT00541866|448637485|FG002|Overall Study|Not Reported or Other|3|||
124731065|NCT00541866|448637486|FG003|Overall Study|Not Reported or Other|3|||
124731066|NCT00541866|448637487|FG004|Overall Study|Not Reported or Other|1|||
124731067|NCT00541866|448637483|FG000|Overall Study|Physician Decision|0|||
124731068|NCT00541866|448637484|FG001|Overall Study|Physician Decision|0|||
124731069|NCT00541866|448637485|FG002|Overall Study|Physician Decision|2|||
124731070|NCT00541866|448637486|FG003|Overall Study|Physician Decision|1|||
124731071|NCT00541866|448637487|FG004|Overall Study|Physician Decision|0|||
124731072|NCT00957944|448637488|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
124731073|NCT00957944|448637489|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
124731074|NCT01482169|448637494|FG000|Overall Study|Physician Decision|2|||
124731075|NCT00522418|448637495|FG000|Overall Study|Local IRB Consent Violation|5|||
124731076|NCT00522418|448637496|FG001|Overall Study|Local IRB Consent Violation|5|||
124731077|NCT00522418|448637495|FG000|Overall Study|Early Study Termination|46|||
124731078|NCT00522418|448637496|FG001|Overall Study|Early Study Termination|47|||
124731079|NCT00522418|448637495|FG000|Overall Study|Noncompliance|2|||
124731080|NCT00522418|448637496|FG001|Overall Study|Noncompliance|2|||
124731081|NCT00522418|448637495|FG000|Overall Study|Reason Not Specified|3|||
124731082|NCT00522418|448637496|FG001|Overall Study|Reason Not Specified|1|||
124731083|NCT00522418|448637495|FG000|Overall Study|Consent Withdraw|1|||
124731084|NCT00522418|448637496|FG001|Overall Study|Consent Withdraw|2|||
124731085|NCT00522418|448637495|FG000|Overall Study|Lack of Efficacy|0|||
124731086|NCT00522418|448637496|FG001|Overall Study|Lack of Efficacy|1|||
124731087|NCT01944098|448637497|FG000|Overall Study|Physician Decision|1|||
124731088|NCT01944098|448637498|FG001|Overall Study|Physician Decision|0|||
124731089|NCT00951080|448637499|FG000|Overall Study|Adverse Event|3|||
124731090|NCT00951080|448637500|FG001|Overall Study|Adverse Event|3|||
124731091|NCT00951080|448637499|FG000|Overall Study|Lost to Follow-up|0|||
124731092|NCT00951080|448637500|FG001|Overall Study|Lost to Follow-up|1|||
124731093|NCT00951080|448637499|FG000|Overall Study|Physician Decision|4|||
124731094|NCT00951080|448637500|FG001|Overall Study|Physician Decision|1|||
124731095|NCT00951080|448637499|FG000|Overall Study|Other|19|||
124731096|NCT00951080|448637500|FG001|Overall Study|Other|22|||
124731097|NCT00759356|448637501|FG000|Overall Study|Adverse Event|0|||
124731098|NCT00759356|448637502|FG001|Overall Study|Adverse Event|1|||
124731099|NCT00759356|448637501|FG000|Overall Study|Withdrawal by Subject|0|||
124597697|NCT03554317|448145851|FG000|Overall Study|PSA Progression|3|||
124731100|NCT00759356|448637502|FG001|Overall Study|Withdrawal by Subject|2|||
124731101|NCT00759356|448637501|FG000|Overall Study|Subject was unable to return|1|||
124731102|NCT00759356|448637502|FG001|Overall Study|Subject was unable to return|0|||
124731103|NCT01939002|448637511|FG000|Overall Study|Adverse Event|13|||
124597698|NCT03554317|448145851|FG000|Overall Study|Radiographic Progression|4|||
124597699|NCT00124462|448145854|FG000|Overall Study|Lost to Follow-up|3|||
124597700|NCT00124462|448145855|FG001|Overall Study|Lost to Follow-up|3|||
124597701|NCT00124462|448145854|FG000|Overall Study|Physician Decision|3|||
124597702|NCT00124462|448145855|FG001|Overall Study|Physician Decision|4|||
124597703|NCT00124462|448145854|FG000|Overall Study|Withdrawal by Subject|4|||
124597704|NCT00124462|448145855|FG001|Overall Study|Withdrawal by Subject|5|||
124597705|NCT00124462|448145854|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
124597706|NCT00124462|448145855|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
124597707|NCT00537199|448145856|FG000|Overall Study|Study Terminated|1|||
124597708|NCT00860743|448145857|FG000|Overall Study|Withdrawal by Subject|3|||
124597709|NCT00860743|448145858|FG001|Overall Study|Withdrawal by Subject|0|||
124597710|NCT03827018|448145860|FG000|Overall Study|Adverse Event|1|||
124597711|NCT03827018|448145861|FG001|Overall Study|Adverse Event|0|||
124597712|NCT03827018|448145860|FG000|Overall Study|Withdrawal by Subject|2|||
124597713|NCT03827018|448145861|FG001|Overall Study|Withdrawal by Subject|2|||
124597714|NCT03827018|448145860|FG000|Overall Study|Lack of Efficacy|0|||
124597715|NCT03827018|448145861|FG001|Overall Study|Lack of Efficacy|1|||
124597716|NCT00350402|448145866|FG000|Overall Study|Lost to Follow-up|1|||
124597717|NCT00350402|448145867|FG001|Overall Study|Lost to Follow-up|1|||
124597718|NCT01884688|448145870|FG000|Overall Study|Screen Failure|2|||
124597719|NCT04099641|448145874|FG000|Overall Study|Death|46|||
124597720|NCT04099641|448145875|FG001|Overall Study|Death|12|||
124597721|NCT04099641|448145874|FG000|Overall Study|Lost to Follow-up|1|||
124597722|NCT04099641|448145875|FG001|Overall Study|Lost to Follow-up|0|||
124597723|NCT04099641|448145874|FG000|Overall Study|Withdrawal by Subject|2|||
124597724|NCT04099641|448145875|FG001|Overall Study|Withdrawal by Subject|0|||
124597725|NCT04798482|448145883|FG000|Overall Study|Physician Decision|1|||
124597726|NCT04798482|448145883|FG000|Overall Study|Lost eligibility|1|||
124597727|NCT01192399|448145884|FG000|Overall Study|Lack of Efficacy|2|||
124597728|NCT01382251|448145886|FG000|Overall Study|Surgeries cancelled or delayed|16|||
124597729|NCT01382251|448145887|FG001|Overall Study|Surgeries cancelled or delayed|16|||
124597730|NCT01382251|448145886|FG000|Overall Study|Lost to Follow-up|4|||
124597731|NCT01382251|448145887|FG001|Overall Study|Lost to Follow-up|4|||
124597732|NCT01382251|448145886|FG000|Overall Study|Contacted after study closed|1|||
124597733|NCT01382251|448145887|FG001|Overall Study|Contacted after study closed|1|||
124597734|NCT00562120|448145888|FG000|First Intervention Period|Adverse Event|1|||
124597735|NCT00562120|448145889|FG001|First Intervention Period|Adverse Event|0|||
124597736|NCT00562120|448145890|FG002|First Intervention Period|Adverse Event|0|||
124597737|NCT00562120|448145891|FG003|First Intervention Period|Adverse Event|0|||
124597738|NCT00562120|448145888|FG000|First Intervention Period|Randomized but not Treated|1|||
124597739|NCT00562120|448145889|FG001|First Intervention Period|Randomized but not Treated|0|||
124597740|NCT00562120|448145890|FG002|First Intervention Period|Randomized but not Treated|0|||
124597741|NCT00562120|448145891|FG003|First Intervention Period|Randomized but not Treated|0|||
124597742|NCT00545688|448145892|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
124597743|NCT00545688|448145893|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
124597744|NCT00545688|448145894|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
124597745|NCT00545688|448145895|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
124597746|NCT00545688|448145892|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
124597747|NCT00545688|448145893|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
124597748|NCT00545688|448145894|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
124597749|NCT00545688|448145895|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
124597750|NCT00545688|448145892|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
124597751|NCT00545688|448145893|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
124597752|NCT00545688|448145894|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
124597753|NCT00545688|448145895|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
124597754|NCT00545688|448145892|FG000|Neo-Adjuvant Treatment Period|Death|0|||
124597755|NCT00545688|448145893|FG001|Neo-Adjuvant Treatment Period|Death|1|||
124597756|NCT00545688|448145894|FG002|Neo-Adjuvant Treatment Period|Death|0|||
124597757|NCT00545688|448145895|FG003|Neo-Adjuvant Treatment Period|Death|0|||
124597758|NCT00545688|448145892|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
124597759|NCT00545688|448145893|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
124597760|NCT00545688|448145894|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
124597761|NCT00545688|448145895|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
124597762|NCT00545688|448145892|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
124597763|NCT00545688|448145893|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
124597764|NCT00545688|448145894|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
124597765|NCT00545688|448145895|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
124597766|NCT00545688|448145892|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
124597767|NCT00545688|448145893|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
124597768|NCT00545688|448145894|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
124597769|NCT00545688|448145895|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
124597770|NCT00545688|448145892|FG000|Adjuvant Treatment Period|Disease Progression|3|||
124597771|NCT00545688|448145893|FG001|Adjuvant Treatment Period|Disease Progression|3|||
124597772|NCT00545688|448145894|FG002|Adjuvant Treatment Period|Disease Progression|0|||
124597773|NCT00545688|448145895|FG003|Adjuvant Treatment Period|Disease Progression|7|||
124597774|NCT00545688|448145892|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
124597775|NCT00545688|448145893|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
124597776|NCT00545688|448145894|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
124597777|NCT00545688|448145895|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
124597778|NCT00545688|448145892|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
124597779|NCT00545688|448145893|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
124597780|NCT00545688|448145894|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
124597781|NCT00545688|448145895|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
124597782|NCT00545688|448145892|FG000|Adjuvant Treatment Period|Adverse Event|0|||
124597783|NCT00545688|448145893|FG001|Adjuvant Treatment Period|Adverse Event|3|||
124597784|NCT00545688|448145894|FG002|Adjuvant Treatment Period|Adverse Event|2|||
124597785|NCT00545688|448145895|FG003|Adjuvant Treatment Period|Adverse Event|2|||
124597786|NCT00545688|448145892|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
124597787|NCT00545688|448145893|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
124597788|NCT00545688|448145894|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
124597789|NCT00545688|448145895|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
124597790|NCT00545688|448145892|FG000|Follow-Up Period|Death|4|||
124597791|NCT00545688|448145893|FG001|Follow-Up Period|Death|2|||
124597792|NCT00545688|448145894|FG002|Follow-Up Period|Death|2|||
124597793|NCT00545688|448145895|FG003|Follow-Up Period|Death|6|||
124597794|NCT00545688|448145892|FG000|Follow-Up Period|Disease Progression|6|||
124597795|NCT00545688|448145893|FG001|Follow-Up Period|Disease Progression|5|||
124597796|NCT00545688|448145894|FG002|Follow-Up Period|Disease Progression|9|||
124597797|NCT00545688|448145895|FG003|Follow-Up Period|Disease Progression|9|||
124597798|NCT00545688|448145892|FG000|Follow-Up Period|Refused Treatment|6|||
124597799|NCT00545688|448145893|FG001|Follow-Up Period|Refused Treatment|2|||
124597800|NCT00545688|448145894|FG002|Follow-Up Period|Refused Treatment|0|||
124597801|NCT00545688|448145895|FG003|Follow-Up Period|Refused Treatment|2|||
124597802|NCT00545688|448145892|FG000|Follow-Up Period|Lost to Follow-up|3|||
124597803|NCT00545688|448145893|FG001|Follow-Up Period|Lost to Follow-up|3|||
124597804|NCT00545688|448145894|FG002|Follow-Up Period|Lost to Follow-up|3|||
124597805|NCT00545688|448145895|FG003|Follow-Up Period|Lost to Follow-up|1|||
124597806|NCT00545688|448145892|FG000|Follow-Up Period|Unspecified Reason|2|||
124597807|NCT00545688|448145893|FG001|Follow-Up Period|Unspecified Reason|5|||
124597808|NCT00545688|448145894|FG002|Follow-Up Period|Unspecified Reason|6|||
124597809|NCT00545688|448145895|FG003|Follow-Up Period|Unspecified Reason|8|||
124597810|NCT00545688|448145892|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
124597811|NCT00545688|448145893|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
124597812|NCT00545688|448145894|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
124597813|NCT00545688|448145895|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
124597814|NCT04678817|448147824|FG000|Overall Study|Lost to Follow-up|28|||
124597815|NCT04678817|448147825|FG001|Overall Study|Lost to Follow-up|0|||
124597816|NCT04678817|448147826|FG002|Overall Study|Lost to Follow-up|0|||
124597817|NCT01010126|448147835|FG000|Overall Study|Withdrawal by Subject|1|||
124597818|NCT01010126|448147836|FG001|Overall Study|Withdrawal by Subject|0|||
124597819|NCT01010126|448147837|FG002|Overall Study|Withdrawal by Subject|1|||
124597820|NCT01010126|448147838|FG003|Overall Study|Withdrawal by Subject|0|||
124597821|NCT01010126|448147839|FG004|Overall Study|Withdrawal by Subject|3|||
124597822|NCT01010126|448147840|FG005|Overall Study|Withdrawal by Subject|0|||
124597823|NCT00784134|448147850|FG000|Overall Study|Lost to Follow-up|3|||
124597824|NCT00784134|448147851|FG001|Overall Study|Lost to Follow-up|6|||
124597825|NCT03785145|448147852|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
124597826|NCT03785145|448147853|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
124597827|NCT03785145|448147852|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
124597828|NCT03785145|448147853|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
124597829|NCT03785145|448147852|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
124597830|NCT03785145|448147853|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
124597831|NCT03785145|448147852|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
124597832|NCT03785145|448147853|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
124597833|NCT03785145|448147852|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
124597834|NCT03785145|448147853|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
124597835|NCT03785145|448147852|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
124597836|NCT03785145|448147853|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
124597837|NCT03785145|448147852|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
124597838|NCT03785145|448147853|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
124597839|NCT03785145|448147852|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
124597840|NCT03785145|448147853|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
124597841|NCT03785145|448147852|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
124597842|NCT03785145|448147853|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
124780285|NCT00485134|448825328|FG001|Overall Study|Pregnancy|0|||
124780286|NCT00485134|448825329|FG002|Overall Study|Pregnancy|0|||
124780287|NCT00485134|448825330|FG003|Overall Study|Pregnancy|0|||
124780288|NCT00485134|448825331|FG004|Overall Study|Pregnancy|0|||
124780289|NCT00485134|448825332|FG005|Overall Study|Pregnancy|0|||
124780290|NCT00485134|448825333|FG006|Overall Study|Pregnancy|1|||
124780291|NCT00485134|448825334|FG007|Overall Study|Pregnancy|0|||
124780292|NCT00970684|448825335|FG000|Overall Study|Lack of Efficacy|5|||
124780293|NCT00970684|448825335|FG000|Overall Study|Adverse Event|4|||
124780294|NCT00970684|448825335|FG000|Overall Study|Withdrawal by Subject|1|||
124780295|NCT00481091|448825336|FG000|Overall Study|Withdrawal by Subject|0|||
124780296|NCT00481091|448825337|FG001|Overall Study|Withdrawal by Subject|1|||
124780297|NCT00481091|448825338|FG002|Overall Study|Withdrawal by Subject|1|||
124780298|NCT00481091|448825339|FG003|Overall Study|Withdrawal by Subject|0|||
124780299|NCT00481091|448825340|FG004|Overall Study|Withdrawal by Subject|0|||
124780300|NCT00481091|448825341|FG005|Overall Study|Withdrawal by Subject|0|||
124780301|NCT00481091|448825342|FG006|Overall Study|Withdrawal by Subject|0|||
124780302|NCT00481091|448825343|FG007|Overall Study|Withdrawal by Subject|0|||
124780303|NCT00481091|448825344|FG008|Overall Study|Withdrawal by Subject|1|||
124780304|NCT00481091|448825345|FG009|Overall Study|Withdrawal by Subject|6|||
124780305|NCT00481091|448825336|FG000|Overall Study|Other, Not Specified|0|||
124780306|NCT00481091|448825337|FG001|Overall Study|Other, Not Specified|1|||
124780307|NCT00481091|448825338|FG002|Overall Study|Other, Not Specified|1|||
124780308|NCT00481091|448825339|FG003|Overall Study|Other, Not Specified|0|||
124780309|NCT00481091|448825340|FG004|Overall Study|Other, Not Specified|0|||
124780310|NCT00481091|448825341|FG005|Overall Study|Other, Not Specified|1|||
124780311|NCT00481091|448825342|FG006|Overall Study|Other, Not Specified|0|||
124780312|NCT00481091|448825343|FG007|Overall Study|Other, Not Specified|0|||
124780313|NCT00481091|448825344|FG008|Overall Study|Other, Not Specified|0|||
124780314|NCT00481091|448825345|FG009|Overall Study|Other, Not Specified|4|||
124780315|NCT00481091|448825336|FG000|Overall Study|Adverse Event|1|||
124780316|NCT00481091|448825337|FG001|Overall Study|Adverse Event|2|||
124780317|NCT00481091|448825338|FG002|Overall Study|Adverse Event|0|||
124780318|NCT00481091|448825339|FG003|Overall Study|Adverse Event|1|||
124780319|NCT00481091|448825340|FG004|Overall Study|Adverse Event|1|||
124780320|NCT00481091|448825341|FG005|Overall Study|Adverse Event|1|||
124780321|NCT00481091|448825342|FG006|Overall Study|Adverse Event|2|||
124780322|NCT00481091|448825343|FG007|Overall Study|Adverse Event|1|||
124780323|NCT00481091|448825344|FG008|Overall Study|Adverse Event|1|||
124780324|NCT00481091|448825345|FG009|Overall Study|Adverse Event|6|||
124780325|NCT00481091|448825336|FG000|Overall Study|Progressive disease clinical|0|||
124780326|NCT00481091|448825337|FG001|Overall Study|Progressive disease clinical|0|||
124780327|NCT00481091|448825338|FG002|Overall Study|Progressive disease clinical|0|||
124780328|NCT00481091|448825339|FG003|Overall Study|Progressive disease clinical|0|||
124780329|NCT00481091|448825340|FG004|Overall Study|Progressive disease clinical|0|||
124780330|NCT00481091|448825341|FG005|Overall Study|Progressive disease clinical|0|||
124780331|NCT00481091|448825342|FG006|Overall Study|Progressive disease clinical|0|||
124780332|NCT00481091|448825343|FG007|Overall Study|Progressive disease clinical|0|||
124780333|NCT00481091|448825344|FG008|Overall Study|Progressive disease clinical|1|||
124780334|NCT00481091|448825345|FG009|Overall Study|Progressive disease clinical|7|||
124780335|NCT00481091|448825336|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
124780336|NCT00481091|448825337|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
124780337|NCT00481091|448825338|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
124780338|NCT00481091|448825339|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
124780339|NCT00481091|448825340|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
124780340|NCT00481091|448825341|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
124780341|NCT00481091|448825342|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
124780342|NCT00481091|448825343|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
124780343|NCT00481091|448825344|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
124780344|NCT00481091|448825345|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
124780345|NCT00481091|448825336|FG000|Overall Study|Progressive disease other|1|||
124780346|NCT00481091|448825337|FG001|Overall Study|Progressive disease other|1|||
124780347|NCT00481091|448825338|FG002|Overall Study|Progressive disease other|0|||
124780348|NCT00481091|448825339|FG003|Overall Study|Progressive disease other|1|||
124780349|NCT00481091|448825340|FG004|Overall Study|Progressive disease other|1|||
124780350|NCT00481091|448825341|FG005|Overall Study|Progressive disease other|1|||
124780351|NCT00481091|448825342|FG006|Overall Study|Progressive disease other|0|||
124780352|NCT00481091|448825343|FG007|Overall Study|Progressive disease other|2|||
124780353|NCT00481091|448825344|FG008|Overall Study|Progressive disease other|0|||
124780354|NCT00481091|448825345|FG009|Overall Study|Progressive disease other|0|||
124780355|NCT00481091|448825336|FG000|Overall Study|No reason given|0|||
124780356|NCT00481091|448825337|FG001|Overall Study|No reason given|0|||
124780357|NCT00481091|448825338|FG002|Overall Study|No reason given|1|||
124780358|NCT00481091|448825339|FG003|Overall Study|No reason given|1|||
124597843|NCT03785145|448147852|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
124597844|NCT03785145|448147853|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
124597845|NCT03785145|448147852|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
124597846|NCT03785145|448147853|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
124597847|NCT03250299|448147858|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
124597848|NCT03250299|448147859|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
124597849|NCT03250299|448147860|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
124597850|NCT03250299|448147861|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
124597851|NCT03250299|448147862|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
124597852|NCT03250299|448147858|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
124597853|NCT03250299|448147859|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
124597854|NCT03250299|448147860|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
124597855|NCT03250299|448147861|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
124597856|NCT03250299|448147862|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
124597857|NCT03250299|448147858|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
124597858|NCT03250299|448147859|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
124597859|NCT03250299|448147860|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
124597860|NCT03250299|448147861|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
124597861|NCT03250299|448147862|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
124597862|NCT03250299|448147858|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
124597863|NCT03250299|448147859|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
124597864|NCT03250299|448147860|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
124597865|NCT03250299|448147861|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
124597866|NCT03250299|448147862|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
124597867|NCT03346070|448147867|FG000|Overall Study|Death|0|||
124597868|NCT03346070|448147868|FG001|Overall Study|Death|0|||
124597869|NCT03346070|448147869|FG002|Overall Study|Death|0|||
124597870|NCT03346070|448147870|FG003|Overall Study|Death|0|||
124597871|NCT03346070|448147871|FG004|Overall Study|Death|1|||
124597872|NCT03346070|448147867|FG000|Overall Study|Lost to Follow-up|0|||
124597873|NCT03346070|448147868|FG001|Overall Study|Lost to Follow-up|1|||
124597874|NCT03346070|448147869|FG002|Overall Study|Lost to Follow-up|2|||
124597875|NCT03346070|448147870|FG003|Overall Study|Lost to Follow-up|0|||
124597876|NCT03346070|448147871|FG004|Overall Study|Lost to Follow-up|0|||
124597877|NCT03346070|448147867|FG000|Overall Study|Physician Decision|0|||
124597878|NCT03346070|448147868|FG001|Overall Study|Physician Decision|0|||
124597879|NCT03346070|448147869|FG002|Overall Study|Physician Decision|0|||
124597880|NCT03346070|448147870|FG003|Overall Study|Physician Decision|1|||
124597881|NCT03346070|448147871|FG004|Overall Study|Physician Decision|1|||
124597882|NCT03346070|448147867|FG000|Overall Study|Withdrawal by Subject|1|||
124597883|NCT03346070|448147868|FG001|Overall Study|Withdrawal by Subject|0|||
124597884|NCT03346070|448147869|FG002|Overall Study|Withdrawal by Subject|0|||
124597885|NCT03346070|448147870|FG003|Overall Study|Withdrawal by Subject|1|||
124597886|NCT03346070|448147871|FG004|Overall Study|Withdrawal by Subject|0|||
124597887|NCT03346070|448147867|FG000|Overall Study|Study medication not received as planned|2|||
124597888|NCT03346070|448147868|FG001|Overall Study|Study medication not received as planned|3|||
124597889|NCT03346070|448147869|FG002|Overall Study|Study medication not received as planned|2|||
124597890|NCT03346070|448147870|FG003|Overall Study|Study medication not received as planned|3|||
124597891|NCT03346070|448147871|FG004|Overall Study|Study medication not received as planned|2|||
124597892|NCT03346070|448147867|FG000|Overall Study|Screen Failure|0|||
124597893|NCT03346070|448147868|FG001|Overall Study|Screen Failure|0|||
124597894|NCT03346070|448147869|FG002|Overall Study|Screen Failure|0|||
124597895|NCT03346070|448147870|FG003|Overall Study|Screen Failure|1|||
124597896|NCT03346070|448147871|FG004|Overall Study|Screen Failure|1|||
124597897|NCT01221090|448147878|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
124597898|NCT01221090|448147879|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
124597899|NCT01221090|448147880|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
124597900|NCT01221090|448147881|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
124597901|NCT01221090|448147878|FG000|Overall Study|Withdrawal by Subject|0|||
124597902|NCT01221090|448147879|FG001|Overall Study|Withdrawal by Subject|22|||
124597903|NCT01221090|448147880|FG002|Overall Study|Withdrawal by Subject|27|||
124597904|NCT01221090|448147881|FG003|Overall Study|Withdrawal by Subject|2|||
124597905|NCT00708708|448147882|FG000|Overall Study|Another therapy instead of Enbrel|141|||
124597906|NCT00708708|448147882|FG000|Overall Study|Lost to Follow-up|52|||
124597907|NCT00708708|448147882|FG000|Overall Study|Withdrawal by Subject|51|||
124597908|NCT00708708|448147882|FG000|Overall Study|Intolerance|42|||
124597909|NCT00708708|448147882|FG000|Overall Study|Another therapy along with Enbrel|15|||
124597910|NCT00708708|448147882|FG000|Overall Study|Other unspecified|11|||
124597911|NCT00708708|448147882|FG000|Overall Study|Good effectiveness|9|||
124597912|NCT00708708|448147882|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
124597913|NCT00708708|448147882|FG000|Overall Study|Administrative reasons|7|||
124597914|NCT00708708|448147882|FG000|Overall Study|Lack of effectiveness|4|||
124597915|NCT00708708|448147882|FG000|Overall Study|Lack of compliance|3|||
124597916|NCT00708708|448147882|FG000|Overall Study|Pregnancy|3|||
124597917|NCT00708708|448147882|FG000|Overall Study|Adverse Event|3|||
124597918|NCT00708708|448147882|FG000|Overall Study|Missing values|392|||
124597919|NCT04776746|448147885|FG000|Overall Study|Study terminated by sponsor|61|||
124597920|NCT04776746|448147885|FG000|Overall Study|Adverse Event|5|||
124597921|NCT04776746|448147885|FG000|Overall Study|Death|4|||
124597922|NCT04776746|448147885|FG000|Overall Study|Lack of Efficacy|3|||
124597923|NCT04776746|448147885|FG000|Overall Study|Noncompliance with study drug|2|||
124597924|NCT04776746|448147885|FG000|Overall Study|Not related to COVID-19|2|||
124597925|NCT00418522|448147886|FG000|Overall Study|Adverse Event|7|||
124597926|NCT00418522|448147887|FG001|Overall Study|Adverse Event|1|||
124597927|NCT00418522|448147886|FG000|Overall Study|Lack of Efficacy|1|||
124597928|NCT00418522|448147887|FG001|Overall Study|Lack of Efficacy|3|||
124597929|NCT00418522|448147886|FG000|Overall Study|Lost to Follow-up|10|||
124597930|NCT00418522|448147887|FG001|Overall Study|Lost to Follow-up|4|||
124597931|NCT00418522|448147886|FG000|Overall Study|Withdrawal by Subject|31|||
124597932|NCT00418522|448147887|FG001|Overall Study|Withdrawal by Subject|7|||
124597933|NCT00418522|448147886|FG000|Overall Study|Other|27|||
124597934|NCT00418522|448147887|FG001|Overall Study|Other|23|||
124597935|NCT00418522|448147886|FG000|Overall Study|Randomized but did not receive treatment|7|||
124597936|NCT00418522|448147887|FG001|Overall Study|Randomized but did not receive treatment|4|||
124597937|NCT00892281|448147891|FG000|Overall Study|Adverse Event|65|||
124597938|NCT00892281|448147892|FG001|Overall Study|Adverse Event|8|||
124597939|NCT00892281|448147891|FG000|Overall Study|Lost to Follow-up|81|||
124597940|NCT00892281|448147892|FG001|Overall Study|Lost to Follow-up|8|||
124597941|NCT00892281|448147891|FG000|Overall Study|Pregnancy|1|||
124597942|NCT00892281|448147892|FG001|Overall Study|Pregnancy|0|||
124597943|NCT00892281|448147891|FG000|Overall Study|Protocol Violation|7|||
124597944|NCT00892281|448147892|FG001|Overall Study|Protocol Violation|2|||
124597945|NCT00892281|448147891|FG000|Overall Study|Withdrawal by Subject|86|||
124597946|NCT00892281|448147892|FG001|Overall Study|Withdrawal by Subject|14|||
124597947|NCT00892281|448147891|FG000|Overall Study|Subject failed to return for final visit|2|||
124597948|NCT00892281|448147892|FG001|Overall Study|Subject failed to return for final visit|0|||
124597949|NCT00892281|448147891|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
124597950|NCT00892281|448147892|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
124597951|NCT00892281|448147891|FG000|Overall Study|Final visit completed 4 weeks late|0|||
124597952|NCT00892281|448147892|FG001|Overall Study|Final visit completed 4 weeks late|1|||
124597953|NCT00892281|448147891|FG000|Overall Study|Subject completed day after study closed|1|||
124597954|NCT00892281|448147892|FG001|Overall Study|Subject completed day after study closed|0|||
124597955|NCT00892281|448147891|FG000|Overall Study|Family emergency|1|||
124597956|NCT00892281|448147892|FG001|Overall Study|Family emergency|0|||
124597957|NCT00892281|448147891|FG000|Overall Study|Last visit not done - death in family|1|||
124597958|NCT00892281|448147892|FG001|Overall Study|Last visit not done - death in family|0|||
124597959|NCT00892281|448147891|FG000|Overall Study|Did not meet incl/excl criteria|1|||
124597960|NCT00892281|448147892|FG001|Overall Study|Did not meet incl/excl criteria|0|||
124597961|NCT00892281|448147891|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
124597962|NCT00892281|448147892|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
124597963|NCT00892281|448147891|FG000|Overall Study|Unable to redeem the drug voucher|1|||
124597964|NCT00892281|448147892|FG001|Overall Study|Unable to redeem the drug voucher|0|||
124597965|NCT00892281|448147891|FG000|Overall Study|Subject not good candidate for study|1|||
124597966|NCT00892281|448147892|FG001|Overall Study|Subject not good candidate for study|0|||
124597967|NCT00892281|448147891|FG000|Overall Study|Subject did not return for any visits|1|||
124597968|NCT00892281|448147892|FG001|Overall Study|Subject did not return for any visits|0|||
124597969|NCT00892281|448147891|FG000|Overall Study|Subject missed several visits/lost meds|1|||
124597970|NCT00892281|448147892|FG001|Overall Study|Subject missed several visits/lost meds|0|||
124597971|NCT00892281|448147891|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
124597972|NCT00892281|448147892|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
124597973|NCT00892281|448147891|FG000|Overall Study|Scheduled for knee replacement|0|||
124597974|NCT00892281|448147892|FG001|Overall Study|Scheduled for knee replacement|1|||
124597975|NCT00892281|448147891|FG000|Overall Study|PI complained of inadequate compensation|3|||
124597976|NCT00892281|448147892|FG001|Overall Study|PI complained of inadequate compensation|0|||
124597977|NCT00892281|448147891|FG000|Overall Study|Subject lost interest in program|0|||
124597978|NCT00892281|448147892|FG001|Overall Study|Subject lost interest in program|1|||
124597979|NCT00892281|448147891|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
124597980|NCT00892281|448147892|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
124597981|NCT00892281|448147891|FG000|Overall Study|Death in family|1|||
124597982|NCT00892281|448147892|FG001|Overall Study|Death in family|0|||
124597983|NCT00892281|448147891|FG000|Overall Study|Lack of efficacy of study product|2|||
124597984|NCT00892281|448147892|FG001|Overall Study|Lack of efficacy of study product|0|||
124597985|NCT00892281|448147891|FG000|Overall Study|Subject not seen by PI at final visit|1|||
124597986|NCT00892281|448147892|FG001|Overall Study|Subject not seen by PI at final visit|0|||
124597987|NCT00892281|448147891|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
124597988|NCT00892281|448147892|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
124597989|NCT00892281|448147891|FG000|Overall Study|Missed multiple visits|1|||
124597990|NCT00892281|448147892|FG001|Overall Study|Missed multiple visits|0|||
124597991|NCT00892281|448147891|FG000|Overall Study|Missed visits rescheduled out of window|1|||
124597992|NCT00892281|448147892|FG001|Overall Study|Missed visits rescheduled out of window|0|||
124597993|NCT00892281|448147891|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
124597994|NCT00892281|448147892|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
124597995|NCT00892281|448147891|FG000|Overall Study|Subject had history of drug abuse|1|||
124597996|NCT00892281|448147892|FG001|Overall Study|Subject had history of drug abuse|0|||
124597997|NCT00892281|448147891|FG000|Overall Study|Rash on hand|1|||
124597998|NCT00892281|448147892|FG001|Overall Study|Rash on hand|0|||
124597999|NCT00892281|448147891|FG000|Overall Study|Visit 4 date out of window|1|||
124598000|NCT00892281|448147892|FG001|Overall Study|Visit 4 date out of window|0|||
124598001|NCT00865098|448147895|FG000|Overall Study|Progressive disease|1|||
124598002|NCT01138826|448147902|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
124598003|NCT01138826|448147903|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
124598004|NCT01138826|448147904|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
124598005|NCT01138826|448147905|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
124598006|NCT01138826|448147906|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
124598007|NCT01138826|448147907|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
124598008|NCT05206448|448147908|FG000|Overall Study|Lost to Follow-up|2|||
124598009|NCT05206448|448147909|FG001|Overall Study|Lost to Follow-up|2|||
124598010|NCT05206448|448147908|FG000|Overall Study|Withdrawal by Subject|2|||
124598011|NCT05206448|448147909|FG001|Overall Study|Withdrawal by Subject|0|||
124598012|NCT05206448|448147908|FG000|Overall Study|found ineligible after randomization|1|||
124598013|NCT05206448|448147909|FG001|Overall Study|found ineligible after randomization|1|||
124598014|NCT05206448|448147908|FG000|Overall Study|unable to complete study due to personal constraints|1|||
124598015|NCT05206448|448147909|FG001|Overall Study|unable to complete study due to personal constraints|0|||
124598016|NCT05206448|448147908|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
124598017|NCT05206448|448147909|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
124598018|NCT01333072|448147913|FG000|Overall Study|Lost to Follow-up|3|||
124598019|NCT01333072|448147914|FG001|Overall Study|Lost to Follow-up|0|||
124598020|NCT01333072|448147913|FG000|Overall Study|Adverse Event|2|||
124598021|NCT01333072|448147914|FG001|Overall Study|Adverse Event|4|||
124598022|NCT01333072|448147913|FG000|Overall Study|Physician Decision|1|||
124598023|NCT01333072|448147914|FG001|Overall Study|Physician Decision|0|||
124598024|NCT02502734|448147915|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
124598025|NCT02502734|448147916|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
124598026|NCT02502734|448147915|FG000|Washout Period|Adverse Event|1|||
124598027|NCT02502734|448147916|FG001|Washout Period|Adverse Event|0|||
124598028|NCT03649412|448147919|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
124598029|NCT03649412|448147920|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
124598030|NCT03649412|448147919|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
124598031|NCT03649412|448147920|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
124598032|NCT03649412|448147919|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
124598033|NCT03649412|448147920|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
124598034|NCT03649412|448147919|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
124598035|NCT03649412|448147920|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
124598036|NCT03649412|448147919|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
124598037|NCT03649412|448147920|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
124598038|NCT03649412|448147919|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
124598039|NCT03649412|448147920|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
124598040|NCT02280187|448147921|FG000|Overall Study|Lost to Follow-up|218|||
124598041|NCT04668274|448147922|FG000|Part 1 Study Period 1|Adverse Event|3|||
124598042|NCT04668274|448147923|FG001|Part 1 Study Period 1|Adverse Event|0|||
124598043|NCT04668274|448147924|FG002|Part 1 Study Period 1|Adverse Event|0|||
124598044|NCT04668274|448147925|FG003|Part 1 Study Period 1|Adverse Event|0|||
124598045|NCT04668274|448147922|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
124598046|NCT04668274|448147923|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
124598047|NCT04668274|448147924|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
124598048|NCT04668274|448147925|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
124598049|NCT04668274|448147922|FG000|Part 1 Study Period 2|Other|0|||
124598050|NCT04668274|448147923|FG001|Part 1 Study Period 2|Other|1|||
124598051|NCT04668274|448147924|FG002|Part 1 Study Period 2|Other|0|||
124598052|NCT04668274|448147925|FG003|Part 1 Study Period 2|Other|0|||
124598053|NCT04668274|448147922|FG000|Part 1 Study Period 3|Adverse Event|0|||
124598054|NCT04668274|448147923|FG001|Part 1 Study Period 3|Adverse Event|0|||
124598055|NCT04668274|448147924|FG002|Part 1 Study Period 3|Adverse Event|1|||
124598056|NCT04668274|448147925|FG003|Part 1 Study Period 3|Adverse Event|0|||
124598057|NCT04668274|448147922|FG000|Part 1 Study Period 3|Other|0|||
124598058|NCT04668274|448147923|FG001|Part 1 Study Period 3|Other|0|||
124598059|NCT04668274|448147924|FG002|Part 1 Study Period 3|Other|2|||
124598060|NCT04668274|448147925|FG003|Part 1 Study Period 3|Other|0|||
124598061|NCT04668274|448147922|FG000|Part 2 Study Period 4|Other|0|||
124780359|NCT00481091|448825340|FG004|Overall Study|No reason given|1|||
124780360|NCT00481091|448825341|FG005|Overall Study|No reason given|0|||
124780361|NCT00481091|448825342|FG006|Overall Study|No reason given|1|||
124780362|NCT00481091|448825343|FG007|Overall Study|No reason given|1|||
124780363|NCT00481091|448825344|FG008|Overall Study|No reason given|1|||
124780364|NCT00481091|448825345|FG009|Overall Study|No reason given|4|||
124780365|NCT04294680|448825346|FG000|Overall Study|Withdrawal by Subject|2|||
124780366|NCT04294680|448825347|FG001|Overall Study|Withdrawal by Subject|1|||
124780367|NCT04294680|448825346|FG000|Overall Study|Follow-up visits completed outside of window|1|||
124780368|NCT04294680|448825347|FG001|Overall Study|Follow-up visits completed outside of window|0|||
124780369|NCT01296672|448825348|FG000|Overall Study|Lost to Follow-up|73|||
124780370|NCT01296672|448825349|FG001|Overall Study|Lost to Follow-up|18|||
124780371|NCT04027608|448825350|FG000|Overall Study|Withdrawal by Subject|13|||
124780372|NCT04027608|448825351|FG001|Overall Study|Withdrawal by Subject|2|||
124780373|NCT04027608|448825350|FG000|Overall Study|Protocol Violation|2|||
124780374|NCT04027608|448825351|FG001|Overall Study|Protocol Violation|1|||
124780375|NCT04027608|448825350|FG000|Overall Study|Physician Decision|1|||
124780376|NCT04027608|448825351|FG001|Overall Study|Physician Decision|0|||
124780377|NCT04027608|448825350|FG000|Overall Study|Lost to Follow-up|20|||
124780378|NCT04027608|448825351|FG001|Overall Study|Lost to Follow-up|4|||
124780379|NCT01386970|448825353|FG000|Overall Study|Withdrawal by Subject|0|||
124780380|NCT01386970|448825354|FG001|Overall Study|Withdrawal by Subject|1|||
124780381|NCT01386970|448825353|FG000|Overall Study|Adverse Event|4|||
124780382|NCT01386970|448825354|FG001|Overall Study|Adverse Event|1|||
124780383|NCT04881942|448825355|FG000|Overall Study|Adverse Event|0|||
124780384|NCT04881942|448825356|FG001|Overall Study|Adverse Event|0|||
124780385|NCT04881942|448825357|FG002|Overall Study|Adverse Event|0|||
124780386|NCT04881942|448825358|FG003|Overall Study|Adverse Event|0|||
124780387|NCT04881942|448825359|FG004|Overall Study|Adverse Event|1|||
124780388|NCT04881942|448825355|FG000|Overall Study|Alternates|0|||
124780389|NCT04881942|448825356|FG001|Overall Study|Alternates|0|||
124780390|NCT04881942|448825357|FG002|Overall Study|Alternates|0|||
124780391|NCT04881942|448825358|FG003|Overall Study|Alternates|0|||
124780392|NCT04881942|448825359|FG004|Overall Study|Alternates|2|||
124780393|NCT01349959|448825360|FG000|Overall Study|Adverse Event|7|||
124780394|NCT02675634|448825361|FG000|Test Period 1|Adverse Event|0|||
124780395|NCT02675634|448825362|FG001|Test Period 1|Adverse Event|1|||
124780396|NCT02675634|448825363|FG002|Test Period 1|Adverse Event|0|||
124780397|NCT02675634|448825364|FG003|Test Period 1|Adverse Event|1|||
124780398|NCT02675634|448825365|FG004|Test Period 1|Adverse Event|0|||
124780399|NCT02675634|448825366|FG005|Test Period 1|Adverse Event|0|||
124780400|NCT02675634|448825361|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
124780401|NCT02675634|448825362|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
124780402|NCT02675634|448825363|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
124780403|NCT02675634|448825364|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
124780404|NCT02675634|448825365|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
124780405|NCT02675634|448825366|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
124780406|NCT02675634|448825361|FG000|Test Period 2|Lack of Efficacy|1|||
124780407|NCT02675634|448825362|FG001|Test Period 2|Lack of Efficacy|0|||
124780408|NCT02675634|448825363|FG002|Test Period 2|Lack of Efficacy|0|||
124598062|NCT04668274|448147923|FG001|Part 2 Study Period 4|Other|0|||
124598063|NCT04668274|448147924|FG002|Part 2 Study Period 4|Other|0|||
124598064|NCT04668274|448147925|FG003|Part 2 Study Period 4|Other|1|||
124598065|NCT02363439|448147926|FG000|Overall Study|Lack of Efficacy|4|||
124598066|NCT01719562|448147935|FG000|Overall Study|Lost to Follow-up|1|||
124598067|NCT01719562|448147936|FG001|Overall Study|Lost to Follow-up|0|||
124598068|NCT01719562|448147935|FG000|Overall Study|Death|1|||
124598069|NCT01719562|448147936|FG001|Overall Study|Death|0|||
124598070|NCT01719562|448147935|FG000|Overall Study|New cancer diagnosis|1|||
124598071|NCT01719562|448147936|FG001|Overall Study|New cancer diagnosis|0|||
124598072|NCT00508027|448147937|FG000|Dose Level 1|Lost to Follow-up|4|||
124598073|NCT00508027|448147937|FG000|Dose Level 1|Withdrawal by Subject|2|||
124598074|NCT00508027|448147937|FG000|Dose Level 1|Physician Decision|2|||
124598075|NCT00508027|448147937|FG000|Dose Level 2|Lost to Follow-up|2|||
124598076|NCT00508027|448147937|FG000|Dose Level 2|Withdrawal by Subject|2|||
124598077|NCT03891329|448147942|FG000|Overall Study|Death|5|||
124780409|NCT02675634|448825364|FG003|Test Period 2|Lack of Efficacy|0|||
124780410|NCT02675634|448825365|FG004|Test Period 2|Lack of Efficacy|0|||
124780411|NCT02675634|448825366|FG005|Test Period 2|Lack of Efficacy|0|||
124780412|NCT02675634|448825361|FG000|Test Period 2|Adverse Event|0|||
124598078|NCT03891329|448147942|FG000|Overall Study|Lost to Follow-up|4|||
124780413|NCT02675634|448825362|FG001|Test Period 2|Adverse Event|0|||
124780414|NCT02675634|448825363|FG002|Test Period 2|Adverse Event|0|||
124780415|NCT02675634|448825364|FG003|Test Period 2|Adverse Event|0|||
124780416|NCT02675634|448825365|FG004|Test Period 2|Adverse Event|0|||
124780417|NCT02675634|448825366|FG005|Test Period 2|Adverse Event|1|||
124598079|NCT03891329|448147942|FG000|Overall Study|Physician Decision|4|||
124598080|NCT03891329|448147942|FG000|Overall Study|Device explanted|3|||
124598081|NCT03891329|448147942|FG000|Overall Study|No study device implanted|3|||
124598082|NCT01832402|448147947|FG000|Overall Study|Lost to Follow-up|2|||
124598083|NCT01832402|448147948|FG001|Overall Study|Lost to Follow-up|0|||
124598084|NCT01832402|448147947|FG000|Overall Study|Withdrawal by Subject|3|||
124598085|NCT01832402|448147948|FG001|Overall Study|Withdrawal by Subject|3|||
124598086|NCT01832402|448147947|FG000|Overall Study|Declining Performance status|2|||
124598087|NCT01832402|448147948|FG001|Overall Study|Declining Performance status|1|||
124598088|NCT01202877|448147951|FG000|Overall Study|Disease Progression|0|||
124598089|NCT01202877|448147952|FG001|Overall Study|Disease Progression|1|||
124598090|NCT01202877|448147953|FG002|Overall Study|Disease Progression|2|||
124598091|NCT01202877|448147951|FG000|Overall Study|Adverse Event|0|||
124598092|NCT01202877|448147952|FG001|Overall Study|Adverse Event|0|||
124598093|NCT01202877|448147953|FG002|Overall Study|Adverse Event|2|||
124598094|NCT01202877|448147951|FG000|Overall Study|Withdrawal by Subject|0|||
124598095|NCT01202877|448147952|FG001|Overall Study|Withdrawal by Subject|0|||
124598096|NCT01202877|448147953|FG002|Overall Study|Withdrawal by Subject|1|||
124598097|NCT01202877|448147951|FG000|Overall Study|Death|0|||
124598098|NCT01202877|448147952|FG001|Overall Study|Death|0|||
124598099|NCT01202877|448147953|FG002|Overall Study|Death|1|||
124598100|NCT00396331|448147954|FG000|Overall Study|Failed to mobilize - no transplant|8|||
124598101|NCT00396331|448147954|FG000|Overall Study|Did not go on to transplant|5|||
124598102|NCT00396331|448147954|FG000|Overall Study|Lost to Follow-up|3|||
124598103|NCT00396331|448147954|FG000|Overall Study|Death|16|||
124598104|NCT01351350|448147957|FG000|Overall Study|Disease Progression|5|||
124598105|NCT01351350|448147958|FG001|Overall Study|Disease Progression|13|||
124598106|NCT01351350|448147959|FG002|Overall Study|Disease Progression|6|||
124598107|NCT01351350|448147960|FG003|Overall Study|Disease Progression|8|||
124598108|NCT01351350|448147961|FG004|Overall Study|Disease Progression|5|||
124598109|NCT01351350|448147957|FG000|Overall Study|Adverse Event|1|||
124598110|NCT01351350|448147958|FG001|Overall Study|Adverse Event|10|||
124598111|NCT01351350|448147959|FG002|Overall Study|Adverse Event|1|||
124598112|NCT01351350|448147960|FG003|Overall Study|Adverse Event|2|||
124598113|NCT01351350|448147961|FG004|Overall Study|Adverse Event|0|||
124598114|NCT01351350|448147957|FG000|Overall Study|Participant Decision|2|||
124598115|NCT01351350|448147958|FG001|Overall Study|Participant Decision|6|||
124598116|NCT01351350|448147959|FG002|Overall Study|Participant Decision|3|||
124598117|NCT01351350|448147960|FG003|Overall Study|Participant Decision|3|||
124598118|NCT01351350|448147961|FG004|Overall Study|Participant Decision|2|||
124598119|NCT01351350|448147957|FG000|Overall Study|Enrolled but not Treated|0|||
124598120|NCT01351350|448147958|FG001|Overall Study|Enrolled but not Treated|0|||
124598121|NCT01351350|448147959|FG002|Overall Study|Enrolled but not Treated|1|||
124598122|NCT01351350|448147960|FG003|Overall Study|Enrolled but not Treated|0|||
124598123|NCT01351350|448147961|FG004|Overall Study|Enrolled but not Treated|0|||
124598124|NCT02339740|448147962|FG000|Overall Study|Death|1|||
124598125|NCT02339740|448147963|FG001|Overall Study|Death|0|||
124598126|NCT02339740|448147962|FG000|Overall Study|Physician Decision|0|||
124598127|NCT02339740|448147963|FG001|Overall Study|Physician Decision|2|||
124598128|NCT02339740|448147962|FG000|Overall Study|Withdrawal by Subject|5|||
124598129|NCT02339740|448147963|FG001|Overall Study|Withdrawal by Subject|1|||
124598130|NCT02339740|448147962|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
124598131|NCT02339740|448147963|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
124598132|NCT02096588|448147972|FG000|Overall Study|Lack of Efficacy|2|||
124598133|NCT02096588|448147973|FG001|Overall Study|Lack of Efficacy|0|||
124598134|NCT02096588|448147972|FG000|Overall Study|Withdrawal by Subject|0|||
124598135|NCT02096588|448147973|FG001|Overall Study|Withdrawal by Subject|1|||
124598136|NCT00303667|448147974|FG000|Overall Study|Death|0|||
124598137|NCT00303667|448147975|FG001|Overall Study|Death|4|||
124598138|NCT02377921|448147976|FG000|Overall Study|Subject non-compliance|1|||
124598139|NCT02377921|448147977|FG001|Overall Study|Subject non-compliance|1|||
124598140|NCT03903159|448147980|FG000|Overall Study|Discharged with Staff Approval|2|||
124598141|NCT03903159|448147980|FG000|Overall Study|Discharged at Staff Request|2|||
124598142|NCT03903159|448147980|FG000|Overall Study|Discharged Against Staff Advice|1|||
124598143|NCT02443545|448147985|FG000|Overall Study|Adverse Event|1|||
124598144|NCT02443545|448147986|FG001|Overall Study|Adverse Event|1|||
124731104|NCT01939002|448637512|FG001|Overall Study|Adverse Event|13|||
124598145|NCT02443545|448147985|FG000|Overall Study|Lost to Follow-up|0|||
124598146|NCT02443545|448147986|FG001|Overall Study|Lost to Follow-up|2|||
124598147|NCT02443545|448147985|FG000|Overall Study|Physician Decision|3|||
124598148|NCT02443545|448147986|FG001|Overall Study|Physician Decision|0|||
124598149|NCT02443545|448147985|FG000|Overall Study|Protocol Violation|8|||
124598150|NCT02443545|448147986|FG001|Overall Study|Protocol Violation|1|||
124598151|NCT02443545|448147985|FG000|Overall Study|Pregnancy|1|||
124598152|NCT02443545|448147986|FG001|Overall Study|Pregnancy|1|||
124598153|NCT02443545|448147985|FG000|Overall Study|Withdrawal by Subject|6|||
124598154|NCT02443545|448147986|FG001|Overall Study|Withdrawal by Subject|3|||
124598155|NCT02443545|448147985|FG000|Overall Study|Termination of study|20|||
124780418|NCT01652534|448825367|FG000|Overall Study|Lack of Efficacy|1|||
124598156|NCT02443545|448147986|FG001|Overall Study|Termination of study|11|||
124598157|NCT00536484|448147988|FG000|Overall Study|Adverse Event|21|||
124598158|NCT00536484|448147989|FG001|Overall Study|Adverse Event|34|||
124598159|NCT00536484|448147988|FG000|Overall Study|Withdrawal by Subject|11|||
124598160|NCT00536484|448147989|FG001|Overall Study|Withdrawal by Subject|11|||
124598161|NCT00536484|448147988|FG000|Overall Study|Lost to Follow-up|8|||
124598162|NCT00536484|448147989|FG001|Overall Study|Lost to Follow-up|6|||
124598163|NCT00536484|448147988|FG000|Overall Study|Lack of Efficacy|16|||
124598164|NCT00536484|448147989|FG001|Overall Study|Lack of Efficacy|5|||
124598165|NCT00536484|448147988|FG000|Overall Study|Other|4|||
124598166|NCT00536484|448147989|FG001|Overall Study|Other|0|||
124598167|NCT00706355|448147990|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
124598168|NCT00706355|448147991|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
124598169|NCT00706355|448147992|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
124598170|NCT00706355|448147993|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
124598171|NCT00706355|448147990|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
124598172|NCT00706355|448147991|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
124598173|NCT00706355|448147992|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
124598174|NCT00706355|448147993|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
124598175|NCT00706355|448147990|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
124598176|NCT00706355|448147991|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
124598177|NCT00706355|448147992|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
124598178|NCT00706355|448147993|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
124598179|NCT00706355|448147990|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
124598180|NCT00706355|448147991|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
124598181|NCT00706355|448147992|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
124598182|NCT00706355|448147993|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
124598183|NCT00706355|448147990|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
124598184|NCT00706355|448147991|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
124598185|NCT00706355|448147992|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
124598186|NCT00706355|448147993|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
124598187|NCT00706355|448147990|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
124598188|NCT00706355|448147991|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
124598189|NCT00706355|448147992|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
124598190|NCT00706355|448147993|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
124598191|NCT00706355|448147990|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
124598192|NCT00706355|448147991|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
124598193|NCT00706355|448147992|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
124598194|NCT00706355|448147993|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
124598195|NCT00706355|448147990|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
124598196|NCT00706355|448147991|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
124598197|NCT00706355|448147992|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
124598198|NCT00706355|448147993|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
124598199|NCT00706355|448147990|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
124598200|NCT00706355|448147991|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
124598201|NCT00706355|448147992|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
124598202|NCT00706355|448147993|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
124598203|NCT01506908|448147994|FG000|Overall Study|Adverse Event|1|||
124598204|NCT01506908|448147995|FG001|Overall Study|Adverse Event|0|||
124598205|NCT01020799|448147996|FG000|Overall Study|Adverse Event|4|||
124598206|NCT01020799|448147997|FG001|Overall Study|Adverse Event|3|||
124598207|NCT01020799|448147998|FG002|Overall Study|Adverse Event|2|||
124598208|NCT01020799|448147996|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
124598209|NCT01020799|448147997|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
124598210|NCT01020799|448147998|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
124598211|NCT01020799|448147996|FG000|Overall Study|Protocol Violation|3|||
124598212|NCT01020799|448147997|FG001|Overall Study|Protocol Violation|2|||
124598213|NCT01020799|448147998|FG002|Overall Study|Protocol Violation|0|||
124598214|NCT01020799|448147996|FG000|Overall Study|Withdrawal by Subject|2|||
124598215|NCT01020799|448147997|FG001|Overall Study|Withdrawal by Subject|2|||
124598216|NCT01020799|448147998|FG002|Overall Study|Withdrawal by Subject|3|||
124598217|NCT01020799|448147996|FG000|Overall Study|Lost to Follow-up|6|||
124598218|NCT01020799|448147997|FG001|Overall Study|Lost to Follow-up|4|||
124598219|NCT01020799|448147998|FG002|Overall Study|Lost to Follow-up|2|||
124598220|NCT01425528|448148000|FG000|Overall Study|Withdrawal by Subject|1|||
124598221|NCT01425528|448148001|FG001|Overall Study|Withdrawal by Subject|1|||
124598222|NCT02985879|448148004|FG000|Overall Study|Adverse Event|7|||
124598223|NCT02985879|448148005|FG001|Overall Study|Adverse Event|9|||
124598224|NCT02985879|448148006|FG002|Overall Study|Adverse Event|7|||
124598225|NCT02985879|448148004|FG000|Overall Study|Withdrew consent|6|||
124598226|NCT02985879|448148005|FG001|Overall Study|Withdrew consent|8|||
124598227|NCT02985879|448148006|FG002|Overall Study|Withdrew consent|10|||
124598228|NCT02985879|448148004|FG000|Overall Study|Lost to Follow-up|1|||
124598229|NCT02985879|448148005|FG001|Overall Study|Lost to Follow-up|0|||
124598230|NCT02985879|448148006|FG002|Overall Study|Lost to Follow-up|2|||
124598231|NCT02985879|448148004|FG000|Overall Study|Other, not specified|62|||
124598232|NCT02985879|448148005|FG001|Overall Study|Other, not specified|58|||
124598233|NCT02985879|448148006|FG002|Overall Study|Other, not specified|58|||
124598234|NCT00595335|448149581|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
124598235|NCT00595335|448149582|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
124598236|NCT00595335|448149581|FG000|Baseline to Six Months|Disease Progression|1|||
124598237|NCT00595335|448149582|FG001|Baseline to Six Months|Disease Progression|1|||
124598238|NCT00595335|448149581|FG000|Baseline to Six Months|Adverse Event|1|||
124598239|NCT00595335|448149582|FG001|Baseline to Six Months|Adverse Event|0|||
124598240|NCT00595335|448149581|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
124598241|NCT00595335|448149582|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
124598242|NCT00595335|448149581|FG000|Six Months to Twelve Months|Disease Progression|1|||
124598243|NCT00595335|448149582|FG001|Six Months to Twelve Months|Disease Progression|0|||
124598244|NCT01647958|448149587|FG000|Initial Study|Lost to Follow-up|2|||
124598245|NCT01647958|448149588|FG001|Initial Study|Lost to Follow-up|3|||
124598246|NCT01647958|448149587|FG000|Continuation Phase|treatment received during Overall Study|39|||
124598247|NCT01647958|448149588|FG001|Continuation Phase|treatment received during Overall Study|0|||
124598248|NCT01647958|448149587|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
124598249|NCT01647958|448149588|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
124598250|NCT00544817|448149589|FG000|Combined Modality|Lack of Efficacy|2|||
124598251|NCT00544817|448149589|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
124598252|NCT00544817|448149589|FG000|Combined Modality|Adverse Event|2|||
124598253|NCT00544817|448149589|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
124598254|NCT00544817|448149589|FG000|No Treatment Interval|Lack of Efficacy|8|||
124598255|NCT00544817|448149589|FG000|No Treatment Interval|Physician Decision|3|||
124598256|NCT00544817|448149589|FG000|No Treatment Interval|Adverse Event|1|||
124598257|NCT00544817|448149589|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
124598258|NCT00544817|448149589|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
124598259|NCT00544817|448149589|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
124598260|NCT01131299|448149590|FG000|Overall Study|Withdrawal by Subject|4|||
124598261|NCT01131299|448149591|FG001|Overall Study|Withdrawal by Subject|7|||
124598262|NCT01885182|448149598|FG000|Overall Study|Adverse Event|11|||
124598263|NCT01885182|448149599|FG001|Overall Study|Adverse Event|13|||
124598264|NCT01885182|448149598|FG000|Overall Study|Withdrawal by Subject|13|||
124598265|NCT01885182|448149599|FG001|Overall Study|Withdrawal by Subject|6|||
124598266|NCT01885182|448149598|FG000|Overall Study|Lost to Follow-up|2|||
124598267|NCT01885182|448149599|FG001|Overall Study|Lost to Follow-up|2|||
124598268|NCT01885182|448149598|FG000|Overall Study|Lack of Efficacy|8|||
124598269|NCT01885182|448149599|FG001|Overall Study|Lack of Efficacy|1|||
124598270|NCT03686150|448149600|FG000|Overall Study|Withdrawal by Subject|1|||
124598271|NCT03686150|448149601|FG001|Overall Study|Withdrawal by Subject|1|||
124598272|NCT03686150|448149602|FG002|Overall Study|Withdrawal by Subject|1|||
124598273|NCT03686150|448149603|FG003|Overall Study|Withdrawal by Subject|0|||
124598274|NCT03686150|448149604|FG004|Overall Study|Withdrawal by Subject|1|||
124598275|NCT03686150|448149605|FG005|Overall Study|Withdrawal by Subject|2|||
124598276|NCT03686150|448149600|FG000|Overall Study|Physician Decision|1|||
124598277|NCT03686150|448149601|FG001|Overall Study|Physician Decision|0|||
124598278|NCT03686150|448149602|FG002|Overall Study|Physician Decision|0|||
124598279|NCT03686150|448149603|FG003|Overall Study|Physician Decision|0|||
124598280|NCT03686150|448149604|FG004|Overall Study|Physician Decision|0|||
124598281|NCT03686150|448149605|FG005|Overall Study|Physician Decision|1|||
124598282|NCT03686150|448149600|FG000|Overall Study|Lost to Follow-up|0|||
124598283|NCT03686150|448149601|FG001|Overall Study|Lost to Follow-up|1|||
124598284|NCT03686150|448149602|FG002|Overall Study|Lost to Follow-up|0|||
124598285|NCT03686150|448149603|FG003|Overall Study|Lost to Follow-up|0|||
124598286|NCT03686150|448149604|FG004|Overall Study|Lost to Follow-up|0|||
124598287|NCT03686150|448149605|FG005|Overall Study|Lost to Follow-up|0|||
124598288|NCT01207440|448149606|FG000|Overall Study|Adverse Event|46|||
124598289|NCT01207440|448149607|FG001|Overall Study|Adverse Event|11|||
124598290|NCT01207440|448149608|FG002|Overall Study|Adverse Event|7|||
124598291|NCT01207440|448149609|FG003|Overall Study|Adverse Event|2|||
124598292|NCT01207440|448149610|FG004|Overall Study|Adverse Event|6|||
124598293|NCT01207440|448149611|FG005|Overall Study|Adverse Event|6|||
124598294|NCT01207440|448149612|FG006|Overall Study|Adverse Event|2|||
124598295|NCT01207440|448149606|FG000|Overall Study|Death|6|||
124598296|NCT01207440|448149607|FG001|Overall Study|Death|3|||
124598297|NCT01207440|448149608|FG002|Overall Study|Death|2|||
124598298|NCT01207440|448149609|FG003|Overall Study|Death|2|||
124598299|NCT01207440|448149610|FG004|Overall Study|Death|7|||
124780419|NCT01652534|448825368|FG001|Overall Study|Lack of Efficacy|0|||
124598300|NCT01207440|448149611|FG005|Overall Study|Death|5|||
124598301|NCT01207440|448149612|FG006|Overall Study|Death|1|||
124598302|NCT01207440|448149606|FG000|Overall Study|Lack of Efficacy|13|||
124598303|NCT01207440|448149607|FG001|Overall Study|Lack of Efficacy|2|||
124598304|NCT01207440|448149608|FG002|Overall Study|Lack of Efficacy|5|||
124598305|NCT01207440|448149609|FG003|Overall Study|Lack of Efficacy|1|||
124598306|NCT01207440|448149610|FG004|Overall Study|Lack of Efficacy|2|||
124598307|NCT01207440|448149611|FG005|Overall Study|Lack of Efficacy|3|||
124598308|NCT01207440|448149612|FG006|Overall Study|Lack of Efficacy|0|||
124598309|NCT01207440|448149606|FG000|Overall Study|Lost to Follow-up|0|||
124598310|NCT01207440|448149607|FG001|Overall Study|Lost to Follow-up|0|||
124598311|NCT01207440|448149608|FG002|Overall Study|Lost to Follow-up|2|||
124598312|NCT01207440|448149609|FG003|Overall Study|Lost to Follow-up|1|||
124598313|NCT01207440|448149610|FG004|Overall Study|Lost to Follow-up|0|||
124598314|NCT01207440|448149611|FG005|Overall Study|Lost to Follow-up|0|||
124598315|NCT01207440|448149612|FG006|Overall Study|Lost to Follow-up|0|||
124598316|NCT01207440|448149606|FG000|Overall Study|Non-compliance with Study Drug|3|||
124598317|NCT01207440|448149607|FG001|Overall Study|Non-compliance with Study Drug|0|||
124598318|NCT01207440|448149608|FG002|Overall Study|Non-compliance with Study Drug|1|||
124598319|NCT01207440|448149609|FG003|Overall Study|Non-compliance with Study Drug|0|||
124598320|NCT01207440|448149610|FG004|Overall Study|Non-compliance with Study Drug|0|||
124598321|NCT01207440|448149611|FG005|Overall Study|Non-compliance with Study Drug|0|||
124598322|NCT01207440|448149612|FG006|Overall Study|Non-compliance with Study Drug|0|||
124598323|NCT01207440|448149606|FG000|Overall Study|Physician Decision|6|||
124598324|NCT01207440|448149607|FG001|Overall Study|Physician Decision|5|||
124598325|NCT01207440|448149608|FG002|Overall Study|Physician Decision|5|||
124598326|NCT01207440|448149609|FG003|Overall Study|Physician Decision|0|||
124598327|NCT01207440|448149610|FG004|Overall Study|Physician Decision|1|||
124598328|NCT01207440|448149611|FG005|Overall Study|Physician Decision|0|||
124598329|NCT01207440|448149612|FG006|Overall Study|Physician Decision|0|||
124598330|NCT01207440|448149606|FG000|Overall Study|Progressive Disease|19|||
124598331|NCT01207440|448149607|FG001|Overall Study|Progressive Disease|10|||
124598332|NCT01207440|448149608|FG002|Overall Study|Progressive Disease|19|||
124598333|NCT01207440|448149609|FG003|Overall Study|Progressive Disease|7|||
124598334|NCT01207440|448149610|FG004|Overall Study|Progressive Disease|23|||
124598335|NCT01207440|448149611|FG005|Overall Study|Progressive Disease|27|||
124598336|NCT01207440|448149612|FG006|Overall Study|Progressive Disease|0|||
124598337|NCT01207440|448149606|FG000|Overall Study|Protocol Violation|2|||
124598338|NCT01207440|448149607|FG001|Overall Study|Protocol Violation|0|||
124598339|NCT01207440|448149608|FG002|Overall Study|Protocol Violation|0|||
124598340|NCT01207440|448149609|FG003|Overall Study|Protocol Violation|0|||
124598341|NCT01207440|448149610|FG004|Overall Study|Protocol Violation|0|||
124598342|NCT01207440|448149611|FG005|Overall Study|Protocol Violation|0|||
124598343|NCT01207440|448149612|FG006|Overall Study|Protocol Violation|0|||
124598344|NCT01207440|448149606|FG000|Overall Study|Site Terminated by Sponsor|69|||
124598345|NCT01207440|448149607|FG001|Overall Study|Site Terminated by Sponsor|19|||
124598346|NCT01207440|448149608|FG002|Overall Study|Site Terminated by Sponsor|12|||
124598347|NCT01207440|448149609|FG003|Overall Study|Site Terminated by Sponsor|2|||
124598348|NCT01207440|448149610|FG004|Overall Study|Site Terminated by Sponsor|3|||
124598349|NCT01207440|448149611|FG005|Overall Study|Site Terminated by Sponsor|0|||
124598350|NCT01207440|448149612|FG006|Overall Study|Site Terminated by Sponsor|2|||
124598351|NCT01207440|448149606|FG000|Overall Study|Withdrawal by Subject|29|||
124598352|NCT01207440|448149607|FG001|Overall Study|Withdrawal by Subject|4|||
124598353|NCT01207440|448149608|FG002|Overall Study|Withdrawal by Subject|5|||
124598354|NCT01207440|448149609|FG003|Overall Study|Withdrawal by Subject|3|||
124598355|NCT01207440|448149610|FG004|Overall Study|Withdrawal by Subject|2|||
124598356|NCT01207440|448149611|FG005|Overall Study|Withdrawal by Subject|2|||
124598357|NCT01207440|448149612|FG006|Overall Study|Withdrawal by Subject|0|||
124598358|NCT01207440|448149606|FG000|Overall Study|Reason Not Specified|10|||
124598359|NCT01207440|448149607|FG001|Overall Study|Reason Not Specified|10|||
124598360|NCT01207440|448149608|FG002|Overall Study|Reason Not Specified|7|||
124598361|NCT01207440|448149609|FG003|Overall Study|Reason Not Specified|0|||
124598362|NCT01207440|448149610|FG004|Overall Study|Reason Not Specified|4|||
124598363|NCT01207440|448149611|FG005|Overall Study|Reason Not Specified|3|||
124598364|NCT01207440|448149612|FG006|Overall Study|Reason Not Specified|0|||
124598365|NCT03341000|448149613|FG000|Overall Study|Adverse Event|1|||
124598366|NCT02813421|448149616|FG000|Overall Study|Withdrawal by Subject|1|||
124598367|NCT02813421|448149617|FG001|Overall Study|Withdrawal by Subject|2|||
124598368|NCT02813421|448149616|FG000|Overall Study|Lost to Follow-up|1|||
124598369|NCT02813421|448149617|FG001|Overall Study|Lost to Follow-up|1|||
124598370|NCT03135899|448149618|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
124598371|NCT03135899|448149619|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
124598372|NCT03135899|448149620|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
124598373|NCT03135899|448149621|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
124598374|NCT03135899|448149622|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
124598375|NCT03135899|448149623|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
124780420|NCT03860259|448825369|FG000|Overall Study|Lost to Follow-up|5|||
124598376|NCT03135899|448149624|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
124598377|NCT03135899|448149625|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
124598378|NCT03135899|448149618|FG000|Overall Study|Withdrawal by Subject|0|||
124780421|NCT03860259|448825370|FG001|Overall Study|Lost to Follow-up|5|||
124598379|NCT03135899|448149619|FG001|Overall Study|Withdrawal by Subject|0|||
124598380|NCT03135899|448149620|FG002|Overall Study|Withdrawal by Subject|0|||
124598381|NCT03135899|448149621|FG003|Overall Study|Withdrawal by Subject|0|||
124598382|NCT03135899|448149622|FG004|Overall Study|Withdrawal by Subject|0|||
124598383|NCT03135899|448149623|FG005|Overall Study|Withdrawal by Subject|2|||
124598384|NCT03135899|448149624|FG006|Overall Study|Withdrawal by Subject|0|||
124598385|NCT03135899|448149625|FG007|Overall Study|Withdrawal by Subject|0|||
124598386|NCT04146363|448149634|FG000|Induction Period|Adverse Event|1|||
124598387|NCT04146363|448149635|FG001|Induction Period|Adverse Event|2|||
124598388|NCT04146363|448149636|FG002|Induction Period|Adverse Event|0|||
124598389|NCT04146363|448149637|FG003|Induction Period|Adverse Event|0|||
124598390|NCT04146363|448149638|FG004|Induction Period|Adverse Event|0|||
124598391|NCT04146363|448149639|FG005|Induction Period|Adverse Event|0|||
124598392|NCT04146363|448149640|FG006|Induction Period|Adverse Event|0|||
124598393|NCT04146363|448149641|FG007|Induction Period|Adverse Event|0|||
124598394|NCT04146363|448149642|FG008|Induction Period|Adverse Event|0|||
124598395|NCT04146363|448149643|FG009|Induction Period|Adverse Event|0|||
124598396|NCT04146363|448149644|FG010|Induction Period|Adverse Event|0|||
124598397|NCT04146363|448149634|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
124598398|NCT04146363|448149635|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
124598399|NCT04146363|448149636|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
124598400|NCT04146363|448149637|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
124598401|NCT04146363|448149638|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
124598402|NCT04146363|448149639|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
124598403|NCT04146363|448149640|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
124598404|NCT04146363|448149641|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
124598405|NCT04146363|448149642|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
124598406|NCT04146363|448149643|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
124598407|NCT04146363|448149644|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
124598408|NCT04146363|448149634|FG000|Induction Period|Lack of Efficacy|7|||
124598409|NCT04146363|448149635|FG001|Induction Period|Lack of Efficacy|2|||
124598410|NCT04146363|448149636|FG002|Induction Period|Lack of Efficacy|0|||
124598411|NCT04146363|448149637|FG003|Induction Period|Lack of Efficacy|0|||
124598412|NCT04146363|448149638|FG004|Induction Period|Lack of Efficacy|0|||
124598413|NCT04146363|448149639|FG005|Induction Period|Lack of Efficacy|0|||
124598414|NCT04146363|448149640|FG006|Induction Period|Lack of Efficacy|0|||
124598415|NCT04146363|448149641|FG007|Induction Period|Lack of Efficacy|0|||
124598416|NCT04146363|448149642|FG008|Induction Period|Lack of Efficacy|0|||
124598417|NCT04146363|448149643|FG009|Induction Period|Lack of Efficacy|0|||
124598418|NCT04146363|448149644|FG010|Induction Period|Lack of Efficacy|0|||
124598419|NCT04146363|448149634|FG000|Induction Period|Lost to Follow-up|1|||
124598420|NCT04146363|448149635|FG001|Induction Period|Lost to Follow-up|4|||
124598421|NCT04146363|448149636|FG002|Induction Period|Lost to Follow-up|0|||
124598422|NCT04146363|448149637|FG003|Induction Period|Lost to Follow-up|0|||
124598423|NCT04146363|448149638|FG004|Induction Period|Lost to Follow-up|0|||
124598424|NCT04146363|448149639|FG005|Induction Period|Lost to Follow-up|0|||
124598425|NCT04146363|448149640|FG006|Induction Period|Lost to Follow-up|0|||
124598426|NCT04146363|448149641|FG007|Induction Period|Lost to Follow-up|0|||
124598427|NCT04146363|448149642|FG008|Induction Period|Lost to Follow-up|0|||
124598428|NCT04146363|448149643|FG009|Induction Period|Lost to Follow-up|0|||
124598429|NCT04146363|448149644|FG010|Induction Period|Lost to Follow-up|0|||
124598430|NCT04146363|448149634|FG000|Induction Period|Positive quantiferon test|0|||
124598431|NCT04146363|448149635|FG001|Induction Period|Positive quantiferon test|1|||
124598432|NCT04146363|448149636|FG002|Induction Period|Positive quantiferon test|0|||
124598433|NCT04146363|448149637|FG003|Induction Period|Positive quantiferon test|0|||
124598434|NCT04146363|448149638|FG004|Induction Period|Positive quantiferon test|0|||
124598435|NCT04146363|448149639|FG005|Induction Period|Positive quantiferon test|0|||
124598436|NCT04146363|448149640|FG006|Induction Period|Positive quantiferon test|0|||
124598437|NCT04146363|448149641|FG007|Induction Period|Positive quantiferon test|0|||
124598438|NCT04146363|448149642|FG008|Induction Period|Positive quantiferon test|0|||
124598439|NCT04146363|448149643|FG009|Induction Period|Positive quantiferon test|0|||
124731105|NCT01939002|448637511|FG000|Overall Study|Withdrawal by Subject|5|||
124731106|NCT01939002|448637512|FG001|Overall Study|Withdrawal by Subject|3|||
124731107|NCT01939002|448637511|FG000|Overall Study|Other|1|||
124598440|NCT04146363|448149644|FG010|Induction Period|Positive quantiferon test|0|||
124598441|NCT04146363|448149634|FG000|Induction Period|Protocol Deviation|5|||
124598442|NCT04146363|448149635|FG001|Induction Period|Protocol Deviation|6|||
124598443|NCT04146363|448149636|FG002|Induction Period|Protocol Deviation|0|||
124598444|NCT04146363|448149637|FG003|Induction Period|Protocol Deviation|0|||
124598445|NCT04146363|448149638|FG004|Induction Period|Protocol Deviation|0|||
124598446|NCT04146363|448149639|FG005|Induction Period|Protocol Deviation|0|||
124598447|NCT04146363|448149640|FG006|Induction Period|Protocol Deviation|0|||
124598448|NCT04146363|448149641|FG007|Induction Period|Protocol Deviation|0|||
124598449|NCT04146363|448149642|FG008|Induction Period|Protocol Deviation|0|||
124598450|NCT04146363|448149643|FG009|Induction Period|Protocol Deviation|0|||
124598451|NCT04146363|448149644|FG010|Induction Period|Protocol Deviation|0|||
124598452|NCT04146363|448149634|FG000|Induction Period|Withdrawal by Subject|6|||
124780422|NCT03860259|448825369|FG000|Overall Study|Protocol Violation|1|||
124780423|NCT03860259|448825370|FG001|Overall Study|Protocol Violation|0|||
124780424|NCT00811018|448825371|FG000|Overall Study|Additional Chronic Treatment|31|||
124780425|NCT00811018|448825371|FG000|Overall Study|Adverse Event|79|||
124780426|NCT00811018|448825371|FG000|Overall Study|Death|147|||
124780427|NCT00811018|448825371|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
124780428|NCT00811018|448825371|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
124780429|NCT00811018|448825371|FG000|Overall Study|Investigator Decision|57|||
124780430|NCT00811018|448825371|FG000|Overall Study|Lost to Follow-up|19|||
124780431|NCT00811018|448825371|FG000|Overall Study|Pregnancy|6|||
124780432|NCT00811018|448825371|FG000|Overall Study|Sponsor Decision|450|||
124780433|NCT00811018|448825371|FG000|Overall Study|Withdrawal by Subject|70|||
124780434|NCT00811018|448825371|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
124780435|NCT00811018|448825371|FG000|Overall Study|Other|26|||
124780436|NCT00934362|448825375|FG000|Overall Study|Adverse Event|1|||
124780437|NCT00934362|448825376|FG001|Overall Study|Adverse Event|0|||
124780438|NCT03527732|448825377|FG000|Overall Study|Lost to Follow-up|21|||
124780439|NCT03527732|448825378|FG001|Overall Study|Lost to Follow-up|23|||
124780440|NCT03527732|448825379|FG002|Overall Study|Lost to Follow-up|80|||
124780441|NCT03527732|448825380|FG003|Overall Study|Lost to Follow-up|62|||
124780442|NCT03527732|448825381|FG004|Overall Study|Lost to Follow-up|12|||
124780443|NCT03527732|448825382|FG005|Overall Study|Lost to Follow-up|20|||
124780444|NCT02280408|448825383|FG000|Overall Study|Lost to Follow-up|0|||
124780445|NCT02280408|448825384|FG001|Overall Study|Lost to Follow-up|2|||
124780446|NCT02280408|448825385|FG002|Overall Study|Lost to Follow-up|0|||
124780447|NCT02280408|448825386|FG003|Overall Study|Lost to Follow-up|0|||
124780448|NCT01092117|448825387|FG000|Index Procedure to 1 Month|Death|1|||
124780449|NCT01092117|448825387|FG000|1 Month|Death|1|||
124780450|NCT01092117|448825387|FG000|1 Month|Withdrawal by Subject|1|||
124780451|NCT01092117|448825387|FG000|1 Month|Lost to Follow-up|1|||
124780452|NCT01092117|448825387|FG000|6 Months|Death|2|||
124780453|NCT01092117|448825387|FG000|6 Months|Withdrawal by Subject|3|||
124780454|NCT01092117|448825387|FG000|12 Month|Death|11|||
124780455|NCT01092117|448825387|FG000|12 Month|Withdrawal by Subject|2|||
124780456|NCT01092117|448825387|FG000|12 Month|Lost to Follow-up|1|||
124780457|NCT01092117|448825387|FG000|Year 2|Death|5|||
124780458|NCT01092117|448825387|FG000|Year 2|Withdrawal by Subject|4|||
124780459|NCT01092117|448825387|FG000|Year 2|Lost to Follow-up|1|||
124780460|NCT01092117|448825387|FG000|Year 3|Death|7|||
124780461|NCT01092117|448825387|FG000|Year 3|Withdrawal by Subject|9|||
124780462|NCT01092117|448825387|FG000|Year 3|Lost to Follow-up|3|||
124780463|NCT01092117|448825387|FG000|Year 4|Death|8|||
124780464|NCT01092117|448825387|FG000|Year 4|Withdrawal by Subject|4|||
124780465|NCT01092117|448825387|FG000|Year 4|Lost to Follow-up|4|||
124780466|NCT00441064|448825392|FG000|Overall Study|Adverse Event|1|||
124780467|NCT00441064|448825393|FG001|Overall Study|Adverse Event|0|||
124780468|NCT00441064|448825392|FG000|Overall Study|Abnormal laboratory values|0|||
124780469|NCT00441064|448825393|FG001|Overall Study|Abnormal laboratory values|2|||
124780470|NCT00441064|448825392|FG000|Overall Study|Abnormal test procedure results|0|||
124780471|NCT00441064|448825393|FG001|Overall Study|Abnormal test procedure results|1|||
124598453|NCT04146363|448149635|FG001|Induction Period|Withdrawal by Subject|3|||
124598454|NCT04146363|448149636|FG002|Induction Period|Withdrawal by Subject|0|||
124598455|NCT04146363|448149637|FG003|Induction Period|Withdrawal by Subject|0|||
124598456|NCT04146363|448149638|FG004|Induction Period|Withdrawal by Subject|0|||
124598457|NCT04146363|448149639|FG005|Induction Period|Withdrawal by Subject|0|||
124598458|NCT04146363|448149640|FG006|Induction Period|Withdrawal by Subject|0|||
124780472|NCT00441064|448825392|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124780473|NCT00441064|448825393|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124780474|NCT00441064|448825392|FG000|Overall Study|Protocol Deviation|3|||
124780475|NCT00441064|448825393|FG001|Overall Study|Protocol Deviation|2|||
124780476|NCT00441064|448825392|FG000|Overall Study|Patient withdrew consent|5|||
124780477|NCT00441064|448825393|FG001|Overall Study|Patient withdrew consent|2|||
124780478|NCT00953056|448825394|FG000|Overall Study|Withdrew Consent|0|||
124598459|NCT04146363|448149641|FG007|Induction Period|Withdrawal by Subject|0|||
124598460|NCT04146363|448149642|FG008|Induction Period|Withdrawal by Subject|0|||
124780479|NCT00953056|448825395|FG001|Overall Study|Withdrew Consent|0|||
124780480|NCT00953056|448825396|FG002|Overall Study|Withdrew Consent|0|||
124780481|NCT00953056|448825397|FG003|Overall Study|Withdrew Consent|0|||
124780482|NCT00953056|448825398|FG004|Overall Study|Withdrew Consent|2|||
124780483|NCT00953056|448825399|FG005|Overall Study|Withdrew Consent|3|||
124780484|NCT00953056|448825394|FG000|Overall Study|Serious Adverse Event|0|||
124598461|NCT04146363|448149643|FG009|Induction Period|Withdrawal by Subject|0|||
124780485|NCT00953056|448825395|FG001|Overall Study|Serious Adverse Event|0|||
124780486|NCT00953056|448825396|FG002|Overall Study|Serious Adverse Event|0|||
124598462|NCT04146363|448149644|FG010|Induction Period|Withdrawal by Subject|0|||
124780487|NCT00953056|448825397|FG003|Overall Study|Serious Adverse Event|0|||
124780488|NCT00953056|448825398|FG004|Overall Study|Serious Adverse Event|0|||
124780489|NCT00953056|448825399|FG005|Overall Study|Serious Adverse Event|1|||
124780490|NCT03962504|448825400|FG000|Overall Study|Other|11|||
124780491|NCT03962504|448825401|FG001|Overall Study|Other|32|||
124598463|NCT04146363|448149634|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
124598464|NCT04146363|448149635|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
124598465|NCT04146363|448149636|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
124598466|NCT04146363|448149637|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
124598467|NCT04146363|448149638|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
124598468|NCT04146363|448149639|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
124598469|NCT04146363|448149640|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
124598470|NCT04146363|448149641|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
124598471|NCT04146363|448149642|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
124598472|NCT04146363|448149643|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
124598473|NCT04146363|448149644|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
124598474|NCT04146363|448149634|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124598475|NCT04146363|448149635|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124598476|NCT04146363|448149636|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124598477|NCT04146363|448149637|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124598478|NCT04146363|448149638|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124598479|NCT04146363|448149639|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124598480|NCT04146363|448149640|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124598481|NCT04146363|448149641|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
124598482|NCT04146363|448149642|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124598483|NCT04146363|448149643|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124598484|NCT04146363|448149644|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
124598485|NCT04146363|448149634|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124598486|NCT04146363|448149635|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124598487|NCT04146363|448149636|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124598488|NCT04146363|448149637|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124598489|NCT04146363|448149638|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124598490|NCT04146363|448149639|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124598491|NCT04146363|448149640|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
124598492|NCT04146363|448149641|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
124598493|NCT04146363|448149642|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124598494|NCT04146363|448149643|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124598495|NCT04146363|448149644|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
124598496|NCT04146363|448149634|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
124598497|NCT04146363|448149635|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
124598498|NCT04146363|448149636|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
124598499|NCT04146363|448149637|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
124598500|NCT04146363|448149638|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
124731108|NCT01939002|448637512|FG001|Overall Study|Other|2|||
124731109|NCT03300024|448637514|FG000|Overall Study|Physician Decision|4|||
124731110|NCT03300024|448637515|FG001|Overall Study|Physician Decision|6|||
124731111|NCT00433160|448637518|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
124731112|NCT00433160|448637519|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
124731113|NCT00433160|448637518|FG000|52-Week Double-Blind (DB) Period|Death|0|||
124731114|NCT00433160|448637519|FG001|52-Week Double-Blind (DB) Period|Death|0|||
124731115|NCT00433160|448637518|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
124731116|NCT00433160|448637519|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
124731117|NCT00433160|448637518|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
124731118|NCT00433160|448637519|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
124731119|NCT00433160|448637518|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
124731120|NCT00433160|448637519|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
124731121|NCT00433160|448637518|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
124731122|NCT00433160|448637519|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
124731123|NCT00433160|448637518|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
124731124|NCT00433160|448637519|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
124731125|NCT00433160|448637518|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
124731126|NCT00433160|448637519|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
124731127|NCT00433160|448637518|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
124731128|NCT00433160|448637519|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
124731129|NCT00433160|448637518|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
124731130|NCT00433160|448637519|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
124731131|NCT00433160|448637518|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
124731132|NCT00433160|448637519|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
124598501|NCT04146363|448149639|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
124598502|NCT04146363|448149640|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
124598503|NCT04146363|448149641|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
124598504|NCT04146363|448149642|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
124598505|NCT04146363|448149643|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
124598506|NCT04146363|448149644|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
124598507|NCT04146363|448149634|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
124598508|NCT04146363|448149635|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
124598509|NCT04146363|448149636|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
124598510|NCT04146363|448149637|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
124598511|NCT04146363|448149638|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
124598512|NCT04146363|448149639|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
124598513|NCT04146363|448149640|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
124598514|NCT04146363|448149641|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
124598515|NCT04146363|448149642|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
124598516|NCT04146363|448149643|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
124598517|NCT04146363|448149644|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
124598518|NCT04146363|448149634|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
124598519|NCT04146363|448149635|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
124598520|NCT04146363|448149636|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
124598521|NCT04146363|448149637|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
124598522|NCT04146363|448149638|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
124598523|NCT04146363|448149639|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
124598524|NCT04146363|448149640|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
124598525|NCT04146363|448149641|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
124598526|NCT04146363|448149642|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
124598527|NCT04146363|448149643|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
124598528|NCT04146363|448149644|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
124598529|NCT04146363|448149634|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
124598530|NCT04146363|448149635|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
124598531|NCT04146363|448149636|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
124598532|NCT04146363|448149637|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
124598533|NCT04146363|448149638|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
124598534|NCT04146363|448149639|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
124598535|NCT04146363|448149640|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
124598536|NCT04146363|448149641|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
124598537|NCT04146363|448149642|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
124598538|NCT04146363|448149643|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
124598539|NCT04146363|448149644|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
124598540|NCT04146363|448149634|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124598541|NCT04146363|448149635|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124598542|NCT04146363|448149636|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124598543|NCT04146363|448149637|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124598544|NCT04146363|448149638|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124598545|NCT04146363|448149639|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124598546|NCT04146363|448149640|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124598547|NCT04146363|448149641|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
124598548|NCT04146363|448149642|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
124598549|NCT04146363|448149643|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
124598550|NCT04146363|448149644|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
124598551|NCT04146363|448149634|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124598552|NCT04146363|448149635|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124598553|NCT04146363|448149636|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124598554|NCT04146363|448149637|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124598555|NCT04146363|448149638|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124598556|NCT04146363|448149639|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124598557|NCT04146363|448149640|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124598558|NCT04146363|448149641|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124598559|NCT04146363|448149642|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
124598560|NCT04146363|448149643|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
124598561|NCT04146363|448149644|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
124598562|NCT04146363|448149634|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
124598563|NCT04146363|448149635|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
124598564|NCT04146363|448149636|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
124598565|NCT04146363|448149637|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
124780492|NCT01077076|448825402|FG000|First Intervention|Withdrawal by Subject|1|||
124780493|NCT01077076|448825403|FG001|First Intervention|Withdrawal by Subject|0|||
124780494|NCT01077076|448825404|FG002|First Intervention|Withdrawal by Subject|0|||
124780495|NCT01077076|448825405|FG003|First Intervention|Withdrawal by Subject|0|||
124598566|NCT04146363|448149638|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
124598567|NCT04146363|448149639|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
124598568|NCT04146363|448149640|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
124598569|NCT04146363|448149641|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
124598570|NCT04146363|448149642|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
124598571|NCT04146363|448149643|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
124598572|NCT04146363|448149644|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
124598573|NCT04146363|448149634|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124598574|NCT04146363|448149635|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124598575|NCT04146363|448149636|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124598576|NCT04146363|448149637|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124598577|NCT04146363|448149638|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124598578|NCT04146363|448149639|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124598579|NCT04146363|448149640|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124598580|NCT04146363|448149641|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
124598581|NCT04146363|448149642|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
124598582|NCT04146363|448149643|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
124598583|NCT04146363|448149644|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
124598584|NCT04146363|448149634|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
124598585|NCT04146363|448149635|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
124598586|NCT04146363|448149636|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
124598587|NCT04146363|448149637|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
124598588|NCT04146363|448149638|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
124598589|NCT04146363|448149639|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
124598590|NCT04146363|448149640|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
124598591|NCT04146363|448149641|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
124598592|NCT04146363|448149642|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
124598593|NCT04146363|448149643|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
124598594|NCT04146363|448149644|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
124598595|NCT04146363|448149634|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
124598596|NCT04146363|448149635|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
124598597|NCT04146363|448149636|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
124598598|NCT04146363|448149637|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
124598599|NCT04146363|448149638|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
124598600|NCT04146363|448149639|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
124598601|NCT04146363|448149640|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
124598602|NCT04146363|448149641|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
124598603|NCT04146363|448149642|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
124598604|NCT04146363|448149643|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
124598605|NCT04146363|448149644|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
124598606|NCT02914236|448149645|FG000|Overall Study|Lost to Follow-up|1|||
124598607|NCT00706095|448149652|FG000|Overall Study|Progressive Disease|4|||
124598608|NCT00706095|448149653|FG001|Overall Study|Progressive Disease|5|||
124598609|NCT00706095|448149654|FG002|Overall Study|Progressive Disease|3|||
124598610|NCT00706095|448149652|FG000|Overall Study|Clinical Progression|1|||
124598611|NCT00706095|448149653|FG001|Overall Study|Clinical Progression|2|||
124598612|NCT00706095|448149654|FG002|Overall Study|Clinical Progression|2|||
124598613|NCT00706095|448149652|FG000|Overall Study|Withdrawal by Subject|1|||
124598614|NCT00706095|448149653|FG001|Overall Study|Withdrawal by Subject|0|||
124598615|NCT00706095|448149654|FG002|Overall Study|Withdrawal by Subject|0|||
124598616|NCT02676284|448149655|FG000|Overall Study|Withdrawal by Subject|1|||
124598617|NCT01685073|448149656|FG000|Overall Study|Lost to Follow-up|6|||
124598618|NCT01685073|448149657|FG001|Overall Study|Lost to Follow-up|8|||
124598619|NCT01685073|448149656|FG000|Overall Study|Withdrawal by Subject|24|||
124598620|NCT01685073|448149657|FG001|Overall Study|Withdrawal by Subject|24|||
124598621|NCT00440466|448149661|FG000|Overall Study|Death|3|||
124598622|NCT00440466|448149662|FG001|Overall Study|Death|2|||
124598623|NCT00440466|448149663|FG002|Overall Study|Death|9|||
124598624|NCT00440466|448149661|FG000|Overall Study|Adverse Event|3|||
124598625|NCT00440466|448149662|FG001|Overall Study|Adverse Event|4|||
124598626|NCT00440466|448149663|FG002|Overall Study|Adverse Event|11|||
124598627|NCT00440466|448149661|FG000|Overall Study|Lost to Follow-up|1|||
124598628|NCT00440466|448149662|FG001|Overall Study|Lost to Follow-up|0|||
124598629|NCT00440466|448149663|FG002|Overall Study|Lost to Follow-up|2|||
124598630|NCT00440466|448149661|FG000|Overall Study|Physician Decision|2|||
124598631|NCT00440466|448149662|FG001|Overall Study|Physician Decision|0|||
124598632|NCT00440466|448149663|FG002|Overall Study|Physician Decision|1|||
124598633|NCT00440466|448149661|FG000|Overall Study|Protocol Violation|2|||
124598634|NCT00440466|448149662|FG001|Overall Study|Protocol Violation|0|||
124598635|NCT00440466|448149663|FG002|Overall Study|Protocol Violation|4|||
124598636|NCT00440466|448149661|FG000|Overall Study|Withdrawal by Subject|2|||
124598637|NCT00440466|448149662|FG001|Overall Study|Withdrawal by Subject|5|||
124780496|NCT01077076|448825406|FG004|First Intervention|Withdrawal by Subject|0|||
124780497|NCT01077076|448825407|FG005|First Intervention|Withdrawal by Subject|0|||
124780498|NCT01077076|448825402|FG000|Third Intervention|Death in the participant's family|0|||
124780499|NCT01077076|448825403|FG001|Third Intervention|Death in the participant's family|0|||
124780500|NCT01077076|448825404|FG002|Third Intervention|Death in the participant's family|0|||
124780501|NCT01077076|448825405|FG003|Third Intervention|Death in the participant's family|0|||
124780502|NCT01077076|448825406|FG004|Third Intervention|Death in the participant's family|0|||
124780503|NCT01077076|448825407|FG005|Third Intervention|Death in the participant's family|1|||
124780504|NCT01976741|448825408|FG000|Overall Study|Withdrawal by Subject|1|||
124780505|NCT01976741|448825409|FG001|Overall Study|Withdrawal by Subject|0|||
124780506|NCT01976741|448825410|FG002|Overall Study|Withdrawal by Subject|1|||
124780507|NCT01976741|448825411|FG003|Overall Study|Withdrawal by Subject|1|||
124780508|NCT01976741|448825412|FG004|Overall Study|Withdrawal by Subject|0|||
124780509|NCT01976741|448825413|FG005|Overall Study|Withdrawal by Subject|0|||
124780510|NCT01976741|448825414|FG006|Overall Study|Withdrawal by Subject|1|||
124780511|NCT01976741|448825415|FG007|Overall Study|Withdrawal by Subject|4|||
124780512|NCT01976741|448825416|FG008|Overall Study|Withdrawal by Subject|0|||
124780513|NCT01976741|448825417|FG009|Overall Study|Withdrawal by Subject|0|||
124780514|NCT01976741|448825408|FG000|Overall Study|Adverse Event|0|||
124780515|NCT01976741|448825409|FG001|Overall Study|Adverse Event|0|||
124780516|NCT01976741|448825410|FG002|Overall Study|Adverse Event|2|||
124780517|NCT01976741|448825411|FG003|Overall Study|Adverse Event|0|||
124780518|NCT01976741|448825412|FG004|Overall Study|Adverse Event|0|||
124780519|NCT01976741|448825413|FG005|Overall Study|Adverse Event|0|||
124780520|NCT01976741|448825414|FG006|Overall Study|Adverse Event|3|||
124780521|NCT01976741|448825415|FG007|Overall Study|Adverse Event|8|||
124780522|NCT01976741|448825416|FG008|Overall Study|Adverse Event|1|||
124780523|NCT01976741|448825417|FG009|Overall Study|Adverse Event|4|||
124780524|NCT00889720|448825418|FG000|Overall Study|Withdrawal by Subject|4|||
124780525|NCT00889720|448825418|FG000|Overall Study|Other|4|||
124780526|NCT00670306|448825419|FG000|Overall Study|Adverse Event|8|||
124780527|NCT00670306|448825419|FG000|Overall Study|Lack of Efficacy|10|||
124780528|NCT00670306|448825419|FG000|Overall Study|Withdrawal by Subject|9|||
124780529|NCT00670306|448825419|FG000|Overall Study|Physician Decision|1|||
124780530|NCT00670306|448825419|FG000|Overall Study|Lost to Follow-up|8|||
124780531|NCT00670306|448825419|FG000|Overall Study|incl/excl criterias did not meet|19|||
124780532|NCT01327482|448825420|FG000|Overall Study|Adverse Event|1|||
124780533|NCT00476229|448825421|FG000|Overall Study|Progressive shortness of breath|1|||
124780534|NCT01032889|448825422|FG000|Overall Study|Adverse Event|2|||
124780535|NCT01032889|448825423|FG001|Overall Study|Adverse Event|2|||
124780536|NCT01032889|448825424|FG002|Overall Study|Adverse Event|0|||
124780537|NCT01032889|448825422|FG000|Overall Study|Withdrawal of Consent|1|||
124780538|NCT01032889|448825423|FG001|Overall Study|Withdrawal of Consent|2|||
124780539|NCT01032889|448825424|FG002|Overall Study|Withdrawal of Consent|1|||
124780540|NCT01032889|448825422|FG000|Overall Study|Patient Request|0|||
124780541|NCT01032889|448825423|FG001|Overall Study|Patient Request|1|||
124780542|NCT01032889|448825424|FG002|Overall Study|Patient Request|0|||
124780543|NCT01032889|448825422|FG000|Overall Study|Lost to Follow-up|1|||
124780544|NCT01032889|448825423|FG001|Overall Study|Lost to Follow-up|1|||
124598638|NCT00440466|448149663|FG002|Overall Study|Withdrawal by Subject|9|||
124598639|NCT00440466|448149661|FG000|Overall Study|Began Dialysis|0|||
124598640|NCT00440466|448149662|FG001|Overall Study|Began Dialysis|0|||
124598641|NCT00440466|448149663|FG002|Overall Study|Began Dialysis|1|||
124598642|NCT00440466|448149661|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
124598643|NCT00440466|448149662|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
124598644|NCT00440466|448149663|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
124598645|NCT00743509|448149664|FG000|Overall Study|Withdrawal by Subject|2|||
124598646|NCT03768726|448149669|FG000|Treatment Phase|Adverse Event|2|||
124598647|NCT03768726|448149670|FG001|Treatment Phase|Adverse Event|2|||
124598648|NCT03768726|448149669|FG000|Treatment Phase|Lost to Follow-up|1|||
124598649|NCT03768726|448149670|FG001|Treatment Phase|Lost to Follow-up|0|||
124598650|NCT03768726|448149669|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
124598651|NCT03768726|448149670|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
124598652|NCT03768726|448149669|FG000|Treatment Phase|Withdrawal by Subject|3|||
124598653|NCT03768726|448149670|FG001|Treatment Phase|Withdrawal by Subject|1|||
124780545|NCT01032889|448825424|FG002|Overall Study|Lost to Follow-up|0|||
124780546|NCT01032889|448825422|FG000|Overall Study|Lack of Submental Fat|2|||
124780547|NCT01032889|448825423|FG001|Overall Study|Lack of Submental Fat|8|||
124780548|NCT01032889|448825424|FG002|Overall Study|Lack of Submental Fat|1|||
124780549|NCT01032889|448825422|FG000|Overall Study|Miscellaneous Reasons|2|||
124780550|NCT01032889|448825423|FG001|Overall Study|Miscellaneous Reasons|1|||
124780551|NCT01032889|448825424|FG002|Overall Study|Miscellaneous Reasons|1|||
124780552|NCT00993148|448825426|FG000|Overall Study|Lost to Follow-up|2|||
124780553|NCT00993148|448825426|FG000|Overall Study|never initiated treatment|1|||
124780554|NCT00472030|448825427|FG000|Overall Study|Physician Decision|1|||
124780555|NCT00472030|448825428|FG001|Overall Study|Physician Decision|0|||
124598654|NCT03768726|448149669|FG000|Follow-Up|Adverse Event|2|||
124598655|NCT03768726|448149670|FG001|Follow-Up|Adverse Event|2|||
124598656|NCT03768726|448149669|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
124598657|NCT03768726|448149670|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
124598658|NCT03768726|448149669|FG000|Follow-Up|Withdrawal by Subject|2|||
124598659|NCT03768726|448149670|FG001|Follow-Up|Withdrawal by Subject|0|||
124598660|NCT03768726|448149669|FG000|Follow-Up|Other|1|||
124598661|NCT03768726|448149670|FG001|Follow-Up|Other|0|||
124598662|NCT01787279|448149671|FG000|Overall Study|Lost to Follow-up|2|||
124598663|NCT01787279|448149671|FG000|Overall Study|Lack of Efficacy|1|||
124598664|NCT02695719|448149672|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
124598665|NCT02695719|448149673|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
124598666|NCT02695719|448149672|FG000|Overall Study|Significant Protocol Deviation|0|||
124598667|NCT02695719|448149673|FG001|Overall Study|Significant Protocol Deviation|1|||
124598668|NCT02695719|448149672|FG000|Overall Study|Voluntary Withdrawal|1|||
124598669|NCT02695719|448149673|FG001|Overall Study|Voluntary Withdrawal|0|||
124598670|NCT00140413|448149674|FG000|Overall Study|Lost to Follow-up|1|||
124598671|NCT00140413|448149675|FG001|Overall Study|Lost to Follow-up|0|||
124598672|NCT00140413|448149674|FG000|Overall Study|Withdrawal by Subject|2|||
124598673|NCT00140413|448149675|FG001|Overall Study|Withdrawal by Subject|0|||
124598674|NCT01360866|448149680|FG000|Overall Study|Lost to Follow-up|11|||
124598675|NCT01360866|448149681|FG001|Overall Study|Lost to Follow-up|28|||
124598676|NCT01360866|448149682|FG002|Overall Study|Lost to Follow-up|41|||
124598677|NCT01360866|448149683|FG003|Overall Study|Lost to Follow-up|0|||
124598678|NCT01360866|448149680|FG000|Overall Study|Adverse Event|56|||
124598679|NCT01360866|448149681|FG001|Overall Study|Adverse Event|61|||
124598680|NCT01360866|448149682|FG002|Overall Study|Adverse Event|134|||
124598681|NCT01360866|448149683|FG003|Overall Study|Adverse Event|6|||
124598682|NCT01360866|448149680|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
124598683|NCT01360866|448149681|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
124598684|NCT01360866|448149682|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
124598685|NCT01360866|448149683|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
124598686|NCT01360866|448149680|FG000|Overall Study|Withdrawn by Investigator|9|||
124598687|NCT01360866|448149681|FG001|Overall Study|Withdrawn by Investigator|8|||
124598688|NCT01360866|448149682|FG002|Overall Study|Withdrawn by Investigator|31|||
124598689|NCT01360866|448149683|FG003|Overall Study|Withdrawn by Investigator|2|||
124598690|NCT01360866|448149680|FG000|Overall Study|Withdrawal by participant|79|||
124598691|NCT01360866|448149681|FG001|Overall Study|Withdrawal by participant|89|||
124598692|NCT01360866|448149682|FG002|Overall Study|Withdrawal by participant|168|||
124598693|NCT01360866|448149683|FG003|Overall Study|Withdrawal by participant|8|||
124598694|NCT01360866|448149680|FG000|Overall Study|Protocol Deviation|25|||
124598695|NCT01360866|448149681|FG001|Overall Study|Protocol Deviation|33|||
124598696|NCT01360866|448149682|FG002|Overall Study|Protocol Deviation|61|||
124598697|NCT01360866|448149683|FG003|Overall Study|Protocol Deviation|2|||
124598698|NCT01360866|448149680|FG000|Overall Study|Lack of Efficacy|30|||
124598699|NCT01360866|448149681|FG001|Overall Study|Lack of Efficacy|40|||
124598700|NCT01360866|448149682|FG002|Overall Study|Lack of Efficacy|30|||
124598701|NCT01360866|448149683|FG003|Overall Study|Lack of Efficacy|4|||
124598702|NCT01304693|448149684|FG000|Overall Study|Adverse Event|0|||
124598703|NCT01304693|448149685|FG001|Overall Study|Adverse Event|0|||
124598704|NCT01304693|448149686|FG002|Overall Study|Adverse Event|0|||
124598705|NCT01304693|448149687|FG003|Overall Study|Adverse Event|0|||
124598706|NCT01304693|448149688|FG004|Overall Study|Adverse Event|1|||
124598707|NCT01304693|448149684|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
124598708|NCT01304693|448149685|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
124598709|NCT01304693|448149686|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
124598710|NCT01304693|448149687|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
124598711|NCT01304693|448149688|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
124598712|NCT02129647|448149689|FG000|Overall Study|Adverse Event|2|||
124598713|NCT02129647|448149689|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
124598714|NCT00918463|448149691|FG000|Overall Study|Death|1|||
124598715|NCT00918463|448149691|FG000|Overall Study|Lack of Efficacy|1|||
124598716|NCT01014624|448149695|FG000|Overall Study|Adverse Event|0|||
124598717|NCT01014624|448149696|FG001|Overall Study|Adverse Event|1|||
124598718|NCT01014624|448149695|FG000|Overall Study|Protocol Violation|1|||
124598719|NCT01014624|448149696|FG001|Overall Study|Protocol Violation|0|||
124598720|NCT01014624|448149695|FG000|Overall Study|Withdrawal by Subject|1|||
124598721|NCT01014624|448149696|FG001|Overall Study|Withdrawal by Subject|0|||
124598722|NCT01715896|448149698|FG000|Overall Study|Lost to Follow-up|0|||
124598723|NCT01715896|448149699|FG001|Overall Study|Lost to Follow-up|2|||
124598724|NCT01715896|448149698|FG000|Overall Study|Withdrawal by Subject|1|||
124598725|NCT01715896|448149699|FG001|Overall Study|Withdrawal by Subject|4|||
124598726|NCT01715896|448149698|FG000|Overall Study|Other|2|||
124598727|NCT01715896|448149699|FG001|Overall Study|Other|5|||
124598728|NCT03028740|448149705|FG000|Overall Study|Did not Receive Study Drug|4|||
124598729|NCT03028740|448149706|FG001|Overall Study|Did not Receive Study Drug|5|||
124598730|NCT03028740|448149705|FG000|Overall Study|Adverse Event|8|||
124598731|NCT03028740|448149706|FG001|Overall Study|Adverse Event|26|||
124598732|NCT03028740|448149705|FG000|Overall Study|Lack of Efficacy|0|||
124598733|NCT03028740|448149706|FG001|Overall Study|Lack of Efficacy|1|||
124598734|NCT03028740|448149705|FG000|Overall Study|Withdrawal by Subject|48|||
124598735|NCT03028740|448149706|FG001|Overall Study|Withdrawal by Subject|101|||
124598736|NCT03028740|448149705|FG000|Overall Study|Lost to Follow-up|30|||
124598737|NCT03028740|448149706|FG001|Overall Study|Lost to Follow-up|54|||
124598738|NCT03028740|448149705|FG000|Overall Study|Physician Decision|4|||
124598739|NCT03028740|448149706|FG001|Overall Study|Physician Decision|11|||
124598740|NCT03028740|448149705|FG000|Overall Study|Protocol Violation|4|||
124598741|NCT03028740|448149706|FG001|Overall Study|Protocol Violation|8|||
124598742|NCT03028740|448149705|FG000|Overall Study|Non-compliance with Study Drug|0|||
124598743|NCT03028740|448149706|FG001|Overall Study|Non-compliance with Study Drug|2|||
124598744|NCT03028740|448149705|FG000|Overall Study|Study Terminated by Sponsor|467|||
124598745|NCT03028740|448149706|FG001|Overall Study|Study Terminated by Sponsor|917|||
124598746|NCT03028740|448149705|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
124598747|NCT03028740|448149706|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
124598748|NCT03028740|448149705|FG000|Overall Study|Reason not Specified|1|||
124598749|NCT03028740|448149706|FG001|Overall Study|Reason not Specified|5|||
124598750|NCT01048502|448149712|FG000|Overall Study|Lost to Follow-up|2|||
124598751|NCT01048502|448149713|FG001|Overall Study|Lost to Follow-up|0|||
124598752|NCT01048502|448149714|FG002|Overall Study|Lost to Follow-up|0|||
124598753|NCT01048502|448149715|FG003|Overall Study|Lost to Follow-up|0|||
124598754|NCT01048502|448149712|FG000|Overall Study|Adverse Event|1|||
124598755|NCT01048502|448149713|FG001|Overall Study|Adverse Event|0|||
124598756|NCT01048502|448149714|FG002|Overall Study|Adverse Event|0|||
124598757|NCT01048502|448149715|FG003|Overall Study|Adverse Event|0|||
124598758|NCT01048502|448149712|FG000|Overall Study|Withdrawal by Subject|1|||
124598759|NCT01048502|448149713|FG001|Overall Study|Withdrawal by Subject|4|||
124598760|NCT01048502|448149714|FG002|Overall Study|Withdrawal by Subject|5|||
124598761|NCT01048502|448149715|FG003|Overall Study|Withdrawal by Subject|3|||
124598762|NCT01048502|448149712|FG000|Overall Study|Physician Decision|0|||
124598763|NCT01048502|448149713|FG001|Overall Study|Physician Decision|3|||
124598764|NCT01048502|448149714|FG002|Overall Study|Physician Decision|0|||
124598765|NCT01048502|448149715|FG003|Overall Study|Physician Decision|1|||
124598766|NCT03336242|448149716|FG000|Overall Study|Adverse Event|0|||
124598767|NCT03336242|448149717|FG001|Overall Study|Adverse Event|1|||
124598768|NCT02224573|448149718|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
124598769|NCT02224573|448149719|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
124598770|NCT02224573|448149718|FG000|Treatment Phase|Started on Other IMP|1|||
124598771|NCT02224573|448149719|FG001|Treatment Phase|Started on Other IMP|0|||
124598772|NCT02224573|448149718|FG000|Treatment Phase|Participant Discontinued IMP|0|||
124598773|NCT02224573|448149719|FG001|Treatment Phase|Participant Discontinued IMP|1|||
124598774|NCT02224573|448149718|FG000|Treatment Phase|Lack of Efficacy|15|||
124598775|NCT02224573|448149719|FG001|Treatment Phase|Lack of Efficacy|8|||
124598776|NCT02224573|448149718|FG000|Treatment Phase|Began Commercial Product|1|||
124598777|NCT02224573|448149719|FG001|Treatment Phase|Began Commercial Product|0|||
124598778|NCT02224573|448149718|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
124598779|NCT02224573|448149719|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
124598780|NCT02224573|448149718|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
124598781|NCT02224573|448149719|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
124598782|NCT02224573|448149718|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
124598783|NCT02224573|448149719|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
124598784|NCT02224573|448149718|FG000|Treatment Phase|Continued Compassionate Use|1|||
124598785|NCT02224573|448149719|FG001|Treatment Phase|Continued Compassionate Use|0|||
124598786|NCT02224573|448149718|FG000|Treatment Phase|Lack of Efficiency|2|||
124598787|NCT02224573|448149719|FG001|Treatment Phase|Lack of Efficiency|1|||
124598788|NCT02224573|448149718|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
124598789|NCT02224573|448149719|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
124598790|NCT02224573|448149718|FG000|Treatment Phase|Participant Moved|2|||
124598791|NCT02224573|448149719|FG001|Treatment Phase|Participant Moved|0|||
124598792|NCT02224573|448149718|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
124598793|NCT02224573|448149719|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
124598794|NCT02224573|448149718|FG000|Treatment Phase|Refused Medication|1|||
124598795|NCT02224573|448149719|FG001|Treatment Phase|Refused Medication|1|||
124598796|NCT02224573|448149718|FG000|Treatment Phase|Adverse Event|26|||
124598797|NCT02224573|448149719|FG001|Treatment Phase|Adverse Event|38|||
124731133|NCT00433160|448637518|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
124598798|NCT02224573|448149718|FG000|Treatment Phase|Placed in Group Home|0|||
124598799|NCT02224573|448149719|FG001|Treatment Phase|Placed in Group Home|1|||
124598800|NCT02224573|448149718|FG000|Treatment Phase|Pursued Other Trials|1|||
124598801|NCT02224573|448149719|FG001|Treatment Phase|Pursued Other Trials|0|||
124598802|NCT02224573|448149718|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
124598803|NCT02224573|448149719|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
124598804|NCT02224573|448149718|FG000|Treatment Phase|Lost to Follow-up|2|||
124598805|NCT02224573|448149719|FG001|Treatment Phase|Lost to Follow-up|1|||
124598806|NCT02224573|448149718|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
124598807|NCT02224573|448149719|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
124598808|NCT02224573|448149718|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
124598809|NCT02224573|448149719|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
124598810|NCT02224573|448149718|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
124598811|NCT02224573|448149719|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
124598812|NCT02224573|448149718|FG000|Taper Phase|Adverse Event|1|||
124598813|NCT02224573|448149719|FG001|Taper Phase|Adverse Event|1|||
124598814|NCT01557842|448149720|FG000|Overall Study|Lost to Follow-up|0|||
124598815|NCT01557842|448149721|FG001|Overall Study|Lost to Follow-up|1|||
124598816|NCT01557842|448149720|FG000|Overall Study|Death|1|||
124598817|NCT01557842|448149721|FG001|Overall Study|Death|0|||
124598818|NCT01557842|448149720|FG000|Overall Study|Lack of Efficacy|0|||
124598819|NCT01557842|448149721|FG001|Overall Study|Lack of Efficacy|1|||
124598820|NCT01557842|448149720|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
124598821|NCT01557842|448149721|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
124598822|NCT01557842|448149720|FG000|Overall Study|Study Terminated by Sponsor|3|||
124598823|NCT01557842|448149721|FG001|Overall Study|Study Terminated by Sponsor|4|||
124598824|NCT01557842|448149720|FG000|Overall Study|Not Ablated|2|||
124598825|NCT01557842|448149721|FG001|Overall Study|Not Ablated|0|||
124598826|NCT03005067|448149725|FG000|Overall Study|Withdrawal by Subject|3|||
124598827|NCT03005067|448149726|FG001|Overall Study|Withdrawal by Subject|2|||
124598828|NCT03005067|448149725|FG000|Overall Study|Adverse Event|4|||
124598829|NCT03005067|448149726|FG001|Overall Study|Adverse Event|3|||
124598830|NCT03005067|448149725|FG000|Overall Study|Other (reason not specified)|3|||
124598831|NCT03005067|448149726|FG001|Overall Study|Other (reason not specified)|1|||
124598832|NCT03005067|448149725|FG000|Overall Study|Protocol Violation|0|||
124598833|NCT03005067|448149726|FG001|Overall Study|Protocol Violation|1|||
124598834|NCT00619359|448149731|FG000|Overall Study|Adverse Event|32|||
124598835|NCT00619359|448149732|FG001|Overall Study|Adverse Event|36|||
124598836|NCT00619359|448149731|FG000|Overall Study|Lost to Follow-up|12|||
124598837|NCT00619359|448149732|FG001|Overall Study|Lost to Follow-up|16|||
124598838|NCT00619359|448149731|FG000|Overall Study|Physician Decision|0|||
124598839|NCT00619359|448149732|FG001|Overall Study|Physician Decision|7|||
124598840|NCT00619359|448149731|FG000|Overall Study|Protocol Violation|1|||
124598841|NCT00619359|448149732|FG001|Overall Study|Protocol Violation|1|||
124598842|NCT00619359|448149731|FG000|Overall Study|Withdrawal by Subject|19|||
124598843|NCT00619359|448149732|FG001|Overall Study|Withdrawal by Subject|20|||
124598844|NCT00619359|448149731|FG000|Overall Study|Progressive Disease|3|||
124598845|NCT00619359|448149732|FG001|Overall Study|Progressive Disease|1|||
124598846|NCT01661881|448149734|FG000|Overall Study|Disease Progression|1|||
124598847|NCT01803269|448149739|FG000|Overall Study|Withdrawal by Subject|3|||
124598848|NCT01803269|448149740|FG001|Overall Study|Withdrawal by Subject|0|||
124598849|NCT01803269|448149741|FG002|Overall Study|Withdrawal by Subject|0|||
124598850|NCT04647383|448149742|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
124598851|NCT04647383|448149743|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
124598852|NCT04647383|448149744|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
124598853|NCT04647383|448149745|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
124598854|NCT00873119|448149746|FG000|Overall Study|Patient request|4|||
124598855|NCT00873119|448149747|FG001|Overall Study|Patient request|2|||
124598856|NCT00873119|448149746|FG000|Overall Study|Adverse Event|8|||
124731134|NCT00433160|448637519|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
124731135|NCT00433160|448637518|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
124731136|NCT00433160|448637519|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
124731137|NCT00433160|448637518|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
124731138|NCT00433160|448637519|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
124731139|NCT00433160|448637518|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
124731140|NCT00433160|448637519|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
124731141|NCT00433160|448637518|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
124598857|NCT00873119|448149747|FG001|Overall Study|Adverse Event|0|||
124598858|NCT00873119|448149746|FG000|Overall Study|Progressive disease|26|||
124598859|NCT00873119|448149747|FG001|Overall Study|Progressive disease|18|||
124731142|NCT00433160|448637519|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
124598860|NCT00873119|448149746|FG000|Overall Study|Death|2|||
124598861|NCT00873119|448149747|FG001|Overall Study|Death|1|||
124598862|NCT00873119|448149746|FG000|Overall Study|Other|2|||
124598863|NCT00873119|448149747|FG001|Overall Study|Other|5|||
124598864|NCT00873119|448149746|FG000|Overall Study|Not treated|2|||
124598865|NCT00873119|448149747|FG001|Overall Study|Not treated|0|||
124598866|NCT01258101|448149750|FG000|Overall Study|Adverse Event|5|||
124598867|NCT01258101|448149751|FG001|Overall Study|Adverse Event|6|||
124598868|NCT01258101|448149752|FG002|Overall Study|Adverse Event|0|||
124598869|NCT01258101|448149753|FG003|Overall Study|Adverse Event|0|||
124598870|NCT01258101|448149750|FG000|Overall Study|Extra exclusion criterion amended|2|||
124598871|NCT01258101|448149751|FG001|Overall Study|Extra exclusion criterion amended|1|||
124598872|NCT01258101|448149752|FG002|Overall Study|Extra exclusion criterion amended|1|||
124598873|NCT01258101|448149753|FG003|Overall Study|Extra exclusion criterion amended|1|||
124598874|NCT01258101|448149750|FG000|Overall Study|Informed consent has been withdrawn|2|||
124598875|NCT01258101|448149751|FG001|Overall Study|Informed consent has been withdrawn|2|||
124598876|NCT01258101|448149752|FG002|Overall Study|Informed consent has been withdrawn|1|||
124598877|NCT01258101|448149753|FG003|Overall Study|Informed consent has been withdrawn|1|||
124598878|NCT01258101|448149750|FG000|Overall Study|Patient is not able to attend visits|8|||
124598879|NCT01258101|448149751|FG001|Overall Study|Patient is not able to attend visits|9|||
124598880|NCT01258101|448149752|FG002|Overall Study|Patient is not able to attend visits|7|||
124598881|NCT01258101|448149753|FG003|Overall Study|Patient is not able to attend visits|6|||
124598882|NCT01258101|448149750|FG000|Overall Study|Patient´s compliance|4|||
124598883|NCT01258101|448149751|FG001|Overall Study|Patient´s compliance|3|||
124598884|NCT01258101|448149752|FG002|Overall Study|Patient´s compliance|1|||
124598885|NCT01258101|448149753|FG003|Overall Study|Patient´s compliance|2|||
124598886|NCT01258101|448149750|FG000|Overall Study|Lost to Follow-up|5|||
124598887|NCT01258101|448149751|FG001|Overall Study|Lost to Follow-up|5|||
124598888|NCT01258101|448149752|FG002|Overall Study|Lost to Follow-up|0|||
124598889|NCT01258101|448149753|FG003|Overall Study|Lost to Follow-up|6|||
124598890|NCT01258101|448149750|FG000|Overall Study|PCR positive at week 24|0|||
124598891|NCT01258101|448149751|FG001|Overall Study|PCR positive at week 24|0|||
124598892|NCT01258101|448149752|FG002|Overall Study|PCR positive at week 24|0|||
124598893|NCT01258101|448149753|FG003|Overall Study|PCR positive at week 24|1|||
124598894|NCT01258101|448149750|FG000|Overall Study|Other reason|7|||
124598895|NCT01258101|448149751|FG001|Overall Study|Other reason|8|||
124598896|NCT01258101|448149752|FG002|Overall Study|Other reason|1|||
124598897|NCT01258101|448149753|FG003|Overall Study|Other reason|8|||
124598898|NCT02243293|448149754|FG000|Overall Study|Adverse Event|1|||
124598899|NCT02243293|448149755|FG001|Overall Study|Adverse Event|0|||
124598900|NCT02243293|448149756|FG002|Overall Study|Adverse Event|0|||
124598901|NCT02243293|448149757|FG003|Overall Study|Adverse Event|0|||
124598902|NCT02243293|448149758|FG004|Overall Study|Adverse Event|0|||
124598903|NCT02243293|448149759|FG005|Overall Study|Adverse Event|0|||
124598904|NCT02243293|448149760|FG006|Overall Study|Adverse Event|0|||
124598905|NCT02243293|448149761|FG007|Overall Study|Adverse Event|0|||
124598906|NCT02243293|448149762|FG008|Overall Study|Adverse Event|0|||
124598907|NCT02243293|448149763|FG009|Overall Study|Adverse Event|0|||
124598908|NCT02243293|448149764|FG010|Overall Study|Adverse Event|0|||
124598909|NCT02243293|448149765|FG011|Overall Study|Adverse Event|0|||
124598910|NCT02243293|448149766|FG012|Overall Study|Adverse Event|0|||
124598911|NCT02243293|448149767|FG013|Overall Study|Adverse Event|0|||
124598912|NCT02243293|448149768|FG014|Overall Study|Adverse Event|0|||
124598913|NCT02243293|448149769|FG015|Overall Study|Adverse Event|1|||
124598914|NCT02243293|448149770|FG016|Overall Study|Adverse Event|0|||
124598915|NCT02243293|448149771|FG017|Overall Study|Adverse Event|0|||
124598916|NCT02243293|448149772|FG018|Overall Study|Adverse Event|0|||
124598917|NCT02243293|448149773|FG019|Overall Study|Adverse Event|0|||
124598918|NCT02243293|448149774|FG020|Overall Study|Adverse Event|1|||
124598919|NCT02243293|448149775|FG021|Overall Study|Adverse Event|0|||
124598920|NCT02243293|448149754|FG000|Overall Study|Withdrawal by Subject|1|||
124598921|NCT02243293|448149755|FG001|Overall Study|Withdrawal by Subject|0|||
124598922|NCT02243293|448149756|FG002|Overall Study|Withdrawal by Subject|0|||
124598923|NCT02243293|448149757|FG003|Overall Study|Withdrawal by Subject|0|||
124598924|NCT02243293|448149758|FG004|Overall Study|Withdrawal by Subject|0|||
124598925|NCT02243293|448149759|FG005|Overall Study|Withdrawal by Subject|0|||
124598926|NCT02243293|448149760|FG006|Overall Study|Withdrawal by Subject|0|||
124598927|NCT02243293|448149761|FG007|Overall Study|Withdrawal by Subject|0|||
124598928|NCT02243293|448149762|FG008|Overall Study|Withdrawal by Subject|0|||
124598929|NCT02243293|448149763|FG009|Overall Study|Withdrawal by Subject|1|||
124598930|NCT02243293|448149764|FG010|Overall Study|Withdrawal by Subject|0|||
124598931|NCT02243293|448149765|FG011|Overall Study|Withdrawal by Subject|1|||
124598932|NCT02243293|448149766|FG012|Overall Study|Withdrawal by Subject|0|||
124598933|NCT02243293|448149767|FG013|Overall Study|Withdrawal by Subject|0|||
124598934|NCT02243293|448149768|FG014|Overall Study|Withdrawal by Subject|0|||
124598935|NCT02243293|448149769|FG015|Overall Study|Withdrawal by Subject|0|||
124598936|NCT02243293|448149770|FG016|Overall Study|Withdrawal by Subject|0|||
124598937|NCT02243293|448149771|FG017|Overall Study|Withdrawal by Subject|0|||
124598938|NCT02243293|448149772|FG018|Overall Study|Withdrawal by Subject|0|||
124780556|NCT00912197|448825429|FG000|Overall Study|Withdrawal by Subject|3|||
124598939|NCT02243293|448149773|FG019|Overall Study|Withdrawal by Subject|0|||
124598940|NCT02243293|448149774|FG020|Overall Study|Withdrawal by Subject|0|||
124598941|NCT02243293|448149775|FG021|Overall Study|Withdrawal by Subject|1|||
124598942|NCT02243293|448149754|FG000|Overall Study|Lost to Follow-up|0|||
124598943|NCT02243293|448149755|FG001|Overall Study|Lost to Follow-up|1|||
124598944|NCT02243293|448149756|FG002|Overall Study|Lost to Follow-up|1|||
124598945|NCT02243293|448149757|FG003|Overall Study|Lost to Follow-up|1|||
124598946|NCT02243293|448149758|FG004|Overall Study|Lost to Follow-up|0|||
124598947|NCT02243293|448149759|FG005|Overall Study|Lost to Follow-up|0|||
124598948|NCT02243293|448149760|FG006|Overall Study|Lost to Follow-up|3|||
124598949|NCT02243293|448149761|FG007|Overall Study|Lost to Follow-up|0|||
124598950|NCT02243293|448149762|FG008|Overall Study|Lost to Follow-up|0|||
124598951|NCT02243293|448149763|FG009|Overall Study|Lost to Follow-up|0|||
124598952|NCT02243293|448149764|FG010|Overall Study|Lost to Follow-up|0|||
124598953|NCT02243293|448149765|FG011|Overall Study|Lost to Follow-up|2|||
124598954|NCT02243293|448149766|FG012|Overall Study|Lost to Follow-up|0|||
124598955|NCT02243293|448149767|FG013|Overall Study|Lost to Follow-up|0|||
124598956|NCT02243293|448149768|FG014|Overall Study|Lost to Follow-up|0|||
124598957|NCT02243293|448149769|FG015|Overall Study|Lost to Follow-up|0|||
124598958|NCT02243293|448149770|FG016|Overall Study|Lost to Follow-up|3|||
124598959|NCT02243293|448149771|FG017|Overall Study|Lost to Follow-up|1|||
124598960|NCT02243293|448149772|FG018|Overall Study|Lost to Follow-up|0|||
124598961|NCT02243293|448149773|FG019|Overall Study|Lost to Follow-up|0|||
124598962|NCT02243293|448149774|FG020|Overall Study|Lost to Follow-up|1|||
124598963|NCT02243293|448149775|FG021|Overall Study|Lost to Follow-up|2|||
124598964|NCT02243293|448149754|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
124598965|NCT02243293|448149755|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
124598966|NCT02243293|448149756|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
124598967|NCT02243293|448149757|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
124598968|NCT02243293|448149758|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
124598969|NCT02243293|448149759|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
124598970|NCT02243293|448149760|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
124598971|NCT02243293|448149761|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
124598972|NCT02243293|448149762|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
124598973|NCT02243293|448149763|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
124598974|NCT02243293|448149764|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
124598975|NCT02243293|448149765|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
124598976|NCT02243293|448149766|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
124598977|NCT02243293|448149767|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
124598978|NCT02243293|448149768|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
124598979|NCT02243293|448149769|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
124598980|NCT02243293|448149770|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
124598981|NCT02243293|448149771|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
124598982|NCT02243293|448149772|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
124598983|NCT02243293|448149773|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
124598984|NCT02243293|448149774|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
124598985|NCT02243293|448149775|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
124598986|NCT02243293|448149754|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
124598987|NCT02243293|448149755|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
124598988|NCT02243293|448149756|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
124598989|NCT02243293|448149757|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
124598990|NCT02243293|448149758|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
124598991|NCT02243293|448149759|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
124598992|NCT02243293|448149760|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
124731143|NCT00570037|448637520|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
124731144|NCT00570037|448637521|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
124731145|NCT03372460|448637522|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
124598993|NCT02243293|448149761|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
124598994|NCT02243293|448149762|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
124598995|NCT02243293|448149763|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
124598996|NCT02243293|448149764|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
124598997|NCT02243293|448149765|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
124598998|NCT02243293|448149766|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
124598999|NCT02243293|448149767|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
124599000|NCT02243293|448149768|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
124599001|NCT02243293|448149769|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
124599002|NCT02243293|448149770|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
124599003|NCT02243293|448149771|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
124599004|NCT02243293|448149772|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
124599005|NCT02243293|448149773|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
124599006|NCT02243293|448149774|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
124599007|NCT02243293|448149775|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
124599008|NCT02181296|448149776|FG000|Overall Study|Lost to Follow-up|7|||
124599009|NCT02181296|448149777|FG001|Overall Study|Lost to Follow-up|6|||
124599010|NCT00952276|448149780|FG000|Overall Study|Withdrawal by Subject|1|||
124599011|NCT00952276|448149781|FG001|Overall Study|Withdrawal by Subject|0|||
124599012|NCT00952276|448149782|FG002|Overall Study|Withdrawal by Subject|0|||
124599013|NCT00952276|448149783|FG003|Overall Study|Withdrawal by Subject|1|||
124599014|NCT00952276|448149784|FG004|Overall Study|Withdrawal by Subject|0|||
124599015|NCT02658487|448151342|FG000|Overall Study|Death|2|||
124599016|NCT02658487|448151342|FG000|Overall Study|Disease progression|10|||
124599017|NCT02658487|448151342|FG000|Overall Study|Alternative therapy|1|||
124599018|NCT02658487|448151342|FG000|Overall Study|Adverse Event|1|||
124599019|NCT02658487|448151342|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
124599020|NCT02658487|448151342|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
124599021|NCT00614926|448151350|FG000|Overall Study|Burden of travel|1|||
124599022|NCT00614926|448151351|FG001|Overall Study|Burden of travel|0|||
124599023|NCT00614926|448151350|FG000|Overall Study|Adverse Event|3|||
124599024|NCT00614926|448151351|FG001|Overall Study|Adverse Event|0|||
124599025|NCT00856830|448151354|FG000|Irinotecan & Bendamustine|Death|0|||
124599026|NCT00856830|448151355|FG001|Irinotecan & Bendamustine|Death|0|||
124599027|NCT00856830|448151356|FG002|Irinotecan & Bendamustine|Death|0|||
124599028|NCT00856830|448151357|FG003|Irinotecan & Bendamustine|Death|2|||
124599029|NCT00856830|448151354|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
124599030|NCT00856830|448151355|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
124599031|NCT00856830|448151356|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
124599032|NCT00856830|448151357|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
124599033|NCT02954159|448151358|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
124599034|NCT02954159|448151359|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
124599035|NCT02954159|448151358|FG000|Overall Study|Withdrawal by Subject|0|||
124599036|NCT02954159|448151359|FG001|Overall Study|Withdrawal by Subject|1|||
124599037|NCT01117337|448151366|FG000|Overall Study|Lost to Follow-up|4|||
124599038|NCT01117337|448151367|FG001|Overall Study|Lost to Follow-up|0|||
124599039|NCT03575871|448151368|FG000|Overall Study|Adverse Event|5|||
124599040|NCT03575871|448151369|FG001|Overall Study|Adverse Event|5|||
124599041|NCT03575871|448151370|FG002|Overall Study|Adverse Event|8|||
124599042|NCT03575871|448151368|FG000|Overall Study|Death|1|||
124599043|NCT03575871|448151369|FG001|Overall Study|Death|0|||
124599044|NCT03575871|448151370|FG002|Overall Study|Death|0|||
124599045|NCT03575871|448151368|FG000|Overall Study|Lack of Efficacy|5|||
124599046|NCT03575871|448151369|FG001|Overall Study|Lack of Efficacy|4|||
124599047|NCT03575871|448151370|FG002|Overall Study|Lack of Efficacy|7|||
124599048|NCT03575871|448151368|FG000|Overall Study|Lost to Follow-up|1|||
124599049|NCT03575871|448151369|FG001|Overall Study|Lost to Follow-up|1|||
124599050|NCT03575871|448151370|FG002|Overall Study|Lost to Follow-up|1|||
124599051|NCT03575871|448151368|FG000|Overall Study|Protocol Deviation|1|||
124599052|NCT03575871|448151369|FG001|Overall Study|Protocol Deviation|1|||
124599053|NCT03575871|448151370|FG002|Overall Study|Protocol Deviation|1|||
124599054|NCT03575871|448151368|FG000|Overall Study|Withdrawal by Subject|6|||
124599055|NCT03575871|448151369|FG001|Overall Study|Withdrawal by Subject|1|||
124599056|NCT03575871|448151370|FG002|Overall Study|Withdrawal by Subject|9|||
124599057|NCT03575871|448151368|FG000|Overall Study|Other than specified|2|||
124599058|NCT03575871|448151369|FG001|Overall Study|Other than specified|2|||
124599059|NCT03575871|448151370|FG002|Overall Study|Other than specified|0|||
124599060|NCT02791893|448151373|FG000|Blinded Phase|Lost to Follow-up|2|||
124599061|NCT02791893|448151374|FG001|Blinded Phase|Lost to Follow-up|2|||
124599062|NCT02791893|448151373|FG000|Blinded Phase|Withdrawal by Subject|1|||
124599063|NCT02791893|448151374|FG001|Blinded Phase|Withdrawal by Subject|2|||
124599064|NCT02791893|448151373|FG000|Open Label Phase|Lost to Follow-up|3|||
124599065|NCT02791893|448151374|FG001|Open Label Phase|Lost to Follow-up|0|||
124599066|NCT02791893|448151373|FG000|Open Label Phase|Withdrawal by Subject|0|||
124599067|NCT02791893|448151374|FG001|Open Label Phase|Withdrawal by Subject|2|||
124599068|NCT01744093|448151378|FG000|Overall Study|Withdrawal by Subject|6|||
124599069|NCT01744093|448151379|FG001|Overall Study|Withdrawal by Subject|1|||
124599070|NCT01570283|448151380|FG000|Cohort 1: Dose Level 1|Death|0|||
124599071|NCT01570283|448151381|FG001|Cohort 1: Dose Level 1|Death|1|||
124599072|NCT01570283|448151382|FG002|Cohort 1: Dose Level 1|Death|0|||
124599073|NCT01570283|448151383|FG003|Cohort 1: Dose Level 1|Death|0|||
124599074|NCT01570283|448151384|FG004|Cohort 1: Dose Level 1|Death|0|||
124599075|NCT01570283|448151385|FG005|Cohort 1: Dose Level 1|Death|0|||
124599076|NCT01570283|448151380|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
124599077|NCT01570283|448151381|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
124599078|NCT01570283|448151382|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
124599079|NCT01570283|448151383|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
124599080|NCT01570283|448151384|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
124599081|NCT01570283|448151385|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
124599082|NCT01570283|448151380|FG000|Cohort 2: Dose Level 2|Death|0|||
124599083|NCT01570283|448151381|FG001|Cohort 2: Dose Level 2|Death|0|||
124599084|NCT01570283|448151382|FG002|Cohort 2: Dose Level 2|Death|1|||
124599085|NCT01570283|448151383|FG003|Cohort 2: Dose Level 2|Death|0|||
124599086|NCT01570283|448151384|FG004|Cohort 2: Dose Level 2|Death|0|||
124599087|NCT01570283|448151385|FG005|Cohort 2: Dose Level 2|Death|0|||
124599088|NCT01570283|448151380|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
124599089|NCT01570283|448151381|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
124599090|NCT01570283|448151382|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
124599091|NCT01570283|448151383|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
124780557|NCT00912197|448825430|FG001|Overall Study|Withdrawal by Subject|3|||
124780558|NCT01615029|448825438|FG000|Overall Study|Adverse Event|0|||
124599092|NCT01570283|448151384|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
124599093|NCT01570283|448151385|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
124599094|NCT01570283|448151380|FG000|Cohort 3: Dose Level 3|Death|0|||
124599095|NCT01570283|448151381|FG001|Cohort 3: Dose Level 3|Death|0|||
124599096|NCT01570283|448151382|FG002|Cohort 3: Dose Level 3|Death|0|||
124599097|NCT01570283|448151383|FG003|Cohort 3: Dose Level 3|Death|0|||
124599098|NCT01570283|448151384|FG004|Cohort 3: Dose Level 3|Death|0|||
124599099|NCT01570283|448151385|FG005|Cohort 3: Dose Level 3|Death|1|||
124599100|NCT01570283|448151380|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
124599101|NCT01570283|448151381|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
124599102|NCT01570283|448151382|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
124599103|NCT01570283|448151383|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
124599104|NCT01570283|448151384|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
124599105|NCT01570283|448151385|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
124599106|NCT01173471|448151388|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124599107|NCT01173471|448151389|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124599108|NCT01173471|448151390|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
124599109|NCT01173471|448151391|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
124599110|NCT01173471|448151388|FG000|Overall Study|Condition under investigation worsened|2|||
124599111|NCT01173471|448151389|FG001|Overall Study|Condition under investigation worsened|0|||
124599112|NCT01173471|448151390|FG002|Overall Study|Condition under investigation worsened|0|||
124599113|NCT01173471|448151391|FG003|Overall Study|Condition under investigation worsened|0|||
124599114|NCT01173471|448151388|FG000|Overall Study|Lost to Follow-up|0|||
124599115|NCT01173471|448151389|FG001|Overall Study|Lost to Follow-up|0|||
124599116|NCT01173471|448151390|FG002|Overall Study|Lost to Follow-up|1|||
124599117|NCT01173471|448151391|FG003|Overall Study|Lost to Follow-up|0|||
124599118|NCT01173471|448151388|FG000|Overall Study|Reason given as Other|0|||
124599119|NCT01173471|448151389|FG001|Overall Study|Reason given as Other|0|||
124599120|NCT01173471|448151390|FG002|Overall Study|Reason given as Other|1|||
124599121|NCT01173471|448151391|FG003|Overall Study|Reason given as Other|0|||
124599122|NCT00685802|448151394|FG000|Washout Period of 7 Days|Protocol Violation|2|||
124599123|NCT00685802|448151395|FG001|Washout Period of 7 Days|Protocol Violation|0|||
124599124|NCT00685802|448151394|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
124599125|NCT00685802|448151395|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
124599126|NCT02546362|448151400|FG000|4-week Treatment Period|Lost to Follow-up|1|||
124599127|NCT02546362|448151400|FG000|4-week Treatment Period|Change in medication|2|||
124599128|NCT02546362|448151400|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
124599129|NCT02546362|448151400|FG000|12-week Treatment Period|Lost to Follow-up|2|||
124599130|NCT02546362|448151400|FG000|12-week Treatment Period|Change in medication|1|||
124599131|NCT00355472|448151409|FG000|Overall Study|Physician Decision|1|||
124599132|NCT03095118|448151410|FG000|Overall Study|Adverse Event|1|||
124599133|NCT03095118|448151410|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
124599134|NCT02408120|448151411|FG000|Overall Study|Withdrawal by Subject|0|||
124599135|NCT02408120|448151412|FG001|Overall Study|Withdrawal by Subject|1|||
124599136|NCT02408120|448151411|FG000|Overall Study|Treatment Refusal|1|||
124599137|NCT02408120|448151412|FG001|Overall Study|Treatment Refusal|0|||
124599138|NCT02408120|448151411|FG000|Overall Study|Received Steroids|1|||
124599139|NCT02408120|448151412|FG001|Overall Study|Received Steroids|1|||
124599140|NCT02408120|448151411|FG000|Overall Study|Discharged same day|1|||
124599141|NCT02408120|448151412|FG001|Overall Study|Discharged same day|1|||
124599142|NCT02408120|448151411|FG000|Overall Study|Did not receive insulin|1|||
124599143|NCT02408120|448151412|FG001|Overall Study|Did not receive insulin|2|||
124599144|NCT01144403|448151413|FG000|Overall Study|Lost to Follow-up|3|||
124599145|NCT01144403|448151413|FG000|Overall Study|Death|1|||
124599146|NCT01144403|448151413|FG000|Overall Study|Adverse Event|1|||
124599147|NCT01825837|448151414|FG000|PART I|Withdrawal by Subject|0|||
124599148|NCT01825837|448151415|FG001|PART I|Withdrawal by Subject|0|||
124599149|NCT01825837|448151416|FG002|PART I|Withdrawal by Subject|0|||
124599150|NCT01825837|448151417|FG003|PART I|Withdrawal by Subject|6|||
124599151|NCT01825837|448151414|FG000|PART I|Patient non-compliance|0|||
124599152|NCT01825837|448151415|FG001|PART I|Patient non-compliance|0|||
124599153|NCT01825837|448151416|FG002|PART I|Patient non-compliance|0|||
124599154|NCT01825837|448151417|FG003|PART I|Patient non-compliance|1|||
124599155|NCT01825837|448151414|FG000|PART I|Treatment failure|0|||
124599156|NCT01825837|448151415|FG001|PART I|Treatment failure|0|||
124599157|NCT01825837|448151416|FG002|PART I|Treatment failure|0|||
124599158|NCT01825837|448151417|FG003|PART I|Treatment failure|7|||
124599159|NCT01825837|448151414|FG000|PART I|reason unspecified|0|||
124599160|NCT01825837|448151415|FG001|PART I|reason unspecified|0|||
124599161|NCT01825837|448151416|FG002|PART I|reason unspecified|0|||
124599162|NCT01825837|448151417|FG003|PART I|reason unspecified|3|||
124599163|NCT01825837|448151414|FG000|PART II|Withdrawal by Subject|3|||
124599164|NCT01825837|448151415|FG001|PART II|Withdrawal by Subject|3|||
124599165|NCT01825837|448151416|FG002|PART II|Withdrawal by Subject|7|||
124599166|NCT01825837|448151417|FG003|PART II|Withdrawal by Subject|0|||
124599167|NCT01825837|448151414|FG000|PART II|Patient non-compliance|5|||
124599168|NCT01825837|448151415|FG001|PART II|Patient non-compliance|2|||
124599169|NCT01825837|448151416|FG002|PART II|Patient non-compliance|4|||
124599170|NCT01825837|448151417|FG003|PART II|Patient non-compliance|0|||
124599171|NCT01825837|448151414|FG000|PART II|Adverse Event|3|||
124599172|NCT01825837|448151415|FG001|PART II|Adverse Event|3|||
124599173|NCT01825837|448151416|FG002|PART II|Adverse Event|1|||
124599174|NCT01825837|448151417|FG003|PART II|Adverse Event|0|||
124599175|NCT01825837|448151414|FG000|PART II|Treatment failure|6|||
124599176|NCT01825837|448151415|FG001|PART II|Treatment failure|4|||
124599177|NCT01825837|448151416|FG002|PART II|Treatment failure|5|||
124780559|NCT01615029|448825439|FG001|Overall Study|Adverse Event|0|||
124599178|NCT01825837|448151417|FG003|PART II|Treatment failure|0|||
124599179|NCT01825837|448151414|FG000|PART II|reason unspecified|2|||
124599180|NCT01825837|448151415|FG001|PART II|reason unspecified|2|||
124599181|NCT01825837|448151416|FG002|PART II|reason unspecified|2|||
124599182|NCT01825837|448151417|FG003|PART II|reason unspecified|0|||
124599183|NCT00904748|448151420|FG000|Overall Study|Withdrawal by Subject|1|||
124599184|NCT00904748|448151421|FG001|Overall Study|Withdrawal by Subject|1|||
124599185|NCT00904748|448151422|FG002|Overall Study|Withdrawal by Subject|1|||
124599186|NCT00904748|448151423|FG003|Overall Study|Withdrawal by Subject|2|||
124599187|NCT00904748|448151424|FG004|Overall Study|Withdrawal by Subject|0|||
124599188|NCT00904748|448151425|FG005|Overall Study|Withdrawal by Subject|0|||
124599189|NCT00904748|448151420|FG000|Overall Study|Adverse Event|0|||
124599190|NCT00904748|448151421|FG001|Overall Study|Adverse Event|0|||
124599191|NCT00904748|448151422|FG002|Overall Study|Adverse Event|0|||
124599192|NCT00904748|448151423|FG003|Overall Study|Adverse Event|0|||
124599193|NCT00904748|448151424|FG004|Overall Study|Adverse Event|1|||
124599194|NCT00904748|448151425|FG005|Overall Study|Adverse Event|0|||
124599195|NCT00680186|448151429|FG000|Overall Study|Adverse Event|47|||
124599196|NCT00680186|448151430|FG001|Overall Study|Adverse Event|44|||
124599197|NCT00680186|448151429|FG000|Overall Study|Protocol Violation|31|||
124599198|NCT00680186|448151430|FG001|Overall Study|Protocol Violation|26|||
124599199|NCT00680186|448151429|FG000|Overall Study|Lost to Follow-up|11|||
124599200|NCT00680186|448151430|FG001|Overall Study|Lost to Follow-up|6|||
124599201|NCT00680186|448151429|FG000|Overall Study|Withdrawal by Subject|32|||
124599202|NCT00680186|448151430|FG001|Overall Study|Withdrawal by Subject|39|||
124599203|NCT00680186|448151429|FG000|Overall Study|Other|4|||
124599204|NCT00680186|448151430|FG001|Overall Study|Other|1|||
124599205|NCT00285584|448151438|FG000|Month 3|Lost to Follow-up|3|||
124599206|NCT00285584|448151439|FG001|Month 3|Lost to Follow-up|3|||
124599207|NCT00285584|448151438|FG000|Month 3|Withdrawal by Subject|1|||
124599208|NCT00285584|448151439|FG001|Month 3|Withdrawal by Subject|0|||
124599209|NCT00285584|448151438|FG000|Month 6|Lost to Follow-up|0|||
124599210|NCT00285584|448151439|FG001|Month 6|Lost to Follow-up|1|||
124599211|NCT00645944|448151440|FG000|Randomized|Withdrawal by Subject|1|||
124599212|NCT00645944|448151441|FG001|Randomized|Withdrawal by Subject|2|||
124599213|NCT00645944|448151440|FG000|Received Medication|Adverse Event|2|||
124599214|NCT00645944|448151441|FG001|Received Medication|Adverse Event|1|||
124599215|NCT00645944|448151440|FG000|Received Medication|Withdrawal by Subject|1|||
124599216|NCT00645944|448151441|FG001|Received Medication|Withdrawal by Subject|1|||
124599217|NCT00645944|448151440|FG000|Received Medication|Lost to Follow-up|1|||
124599218|NCT00645944|448151441|FG001|Received Medication|Lost to Follow-up|0|||
124599219|NCT00645944|448151440|FG000|Received Medication|Protocol Violation|2|||
124599220|NCT00645944|448151441|FG001|Received Medication|Protocol Violation|1|||
124599221|NCT01807117|448151443|FG000|Overall Study|Physician Decision|2|||
124599222|NCT01807117|448151443|FG000|Overall Study|Disease diagnosis not a study disease|1|||
124599223|NCT01523587|448151444|FG000|Overall Study|Other than listed|5|||
124599224|NCT01523587|448151445|FG001|Overall Study|Other than listed|5|||
124599225|NCT01523587|448151444|FG000|Overall Study|Worsening of underlying cancer disease|19|||
124599226|NCT01523587|448151445|FG001|Overall Study|Worsening of underlying cancer disease|34|||
124599227|NCT01523587|448151444|FG000|Overall Study|Adverse Event|68|||
124599228|NCT01523587|448151445|FG001|Overall Study|Adverse Event|52|||
124599229|NCT01523587|448151444|FG000|Overall Study|Protocol Violation|5|||
124599230|NCT01523587|448151445|FG001|Overall Study|Protocol Violation|3|||
124599231|NCT01523587|448151444|FG000|Overall Study|Lost to Follow-up|2|||
124599232|NCT01523587|448151445|FG001|Overall Study|Lost to Follow-up|2|||
124599233|NCT01523587|448151444|FG000|Overall Study|Withdrawal by Subject|28|||
124599234|NCT01523587|448151445|FG001|Overall Study|Withdrawal by Subject|20|||
124599235|NCT01523587|448151444|FG000|Overall Study|Withdrew due to Progressive disease|265|||
124599236|NCT01523587|448151445|FG001|Overall Study|Withdrew due to Progressive disease|279|||
124599237|NCT01523587|448151444|FG000|Overall Study|Randomised but bot treated|6|||
124599238|NCT01523587|448151445|FG001|Overall Study|Randomised but bot treated|2|||
124599239|NCT01298778|448151446|FG000|Overall Study|Lost to Follow-up|2|||
124599240|NCT01298778|448151447|FG001|Overall Study|Lost to Follow-up|3|||
124599241|NCT01298778|448151446|FG000|Overall Study|Incorrect use of VAS|1|||
124599242|NCT01298778|448151447|FG001|Overall Study|Incorrect use of VAS|0|||
124599243|NCT01298778|448151446|FG000|Overall Study|Withdrawal by Subject|0|||
124780560|NCT01615029|448825440|FG002|Overall Study|Adverse Event|0|||
124599244|NCT01298778|448151447|FG001|Overall Study|Withdrawal by Subject|1|||
124599245|NCT01298778|448151446|FG000|Overall Study|Protocol Violation|0|||
124599246|NCT01298778|448151447|FG001|Overall Study|Protocol Violation|1|||
124599247|NCT01298778|448151446|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
124599248|NCT01298778|448151447|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
124599249|NCT04965389|448151448|FG000|Overall Study|Other reasons|1|||
124599250|NCT04965389|448151449|FG001|Overall Study|Other reasons|0|||
124599251|NCT04965389|448151450|FG002|Overall Study|Other reasons|0|||
124599252|NCT04965389|448151451|FG003|Overall Study|Other reasons|0|||
124599253|NCT04965389|448151448|FG000|Overall Study|Participant withdrew consent|0|||
124599254|NCT04965389|448151449|FG001|Overall Study|Participant withdrew consent|1|||
124599255|NCT04965389|448151450|FG002|Overall Study|Participant withdrew consent|0|||
124599256|NCT04965389|448151451|FG003|Overall Study|Participant withdrew consent|0|||
124599257|NCT04965389|448151448|FG000|Overall Study|Poor/Non-compliance|0|||
124599258|NCT04965389|448151449|FG001|Overall Study|Poor/Non-compliance|1|||
124599259|NCT04965389|448151450|FG002|Overall Study|Poor/Non-compliance|0|||
124599260|NCT04965389|448151451|FG003|Overall Study|Poor/Non-compliance|0|||
124599261|NCT02709486|448151454|FG000|Overall Study|Adverse Event|2|||
124599262|NCT02709486|448151455|FG001|Overall Study|Adverse Event|5|||
124599263|NCT02709486|448151456|FG002|Overall Study|Adverse Event|3|||
124599264|NCT02709486|448151454|FG000|Overall Study|Death|0|||
124599265|NCT02709486|448151455|FG001|Overall Study|Death|0|||
124599266|NCT02709486|448151456|FG002|Overall Study|Death|2|||
124599267|NCT02709486|448151454|FG000|Overall Study|Insufficient clinical response|7|||
124599268|NCT02709486|448151455|FG001|Overall Study|Insufficient clinical response|3|||
124599269|NCT02709486|448151456|FG002|Overall Study|Insufficient clinical response|3|||
124599270|NCT02709486|448151454|FG000|Overall Study|Lost to Follow-up|3|||
124599271|NCT02709486|448151455|FG001|Overall Study|Lost to Follow-up|2|||
124599272|NCT02709486|448151456|FG002|Overall Study|Lost to Follow-up|2|||
124599273|NCT02709486|448151454|FG000|Overall Study|Other|0|||
124599274|NCT02709486|448151455|FG001|Overall Study|Other|2|||
124599275|NCT02709486|448151456|FG002|Overall Study|Other|3|||
124599276|NCT02709486|448151454|FG000|Overall Study|Withdrawal by Subject|32|||
124599277|NCT02709486|448151455|FG001|Overall Study|Withdrawal by Subject|22|||
124599278|NCT02709486|448151456|FG002|Overall Study|Withdrawal by Subject|32|||
124599279|NCT01855048|448151468|FG000|Overall Study|Withdrawal by Subject|0|||
124599280|NCT01855048|448151469|FG001|Overall Study|Withdrawal by Subject|1|||
124599281|NCT01855048|448151470|FG002|Overall Study|Withdrawal by Subject|0|||
124599282|NCT01855048|448151471|FG003|Overall Study|Withdrawal by Subject|0|||
124599283|NCT01855048|448151472|FG004|Overall Study|Withdrawal by Subject|1|||
124599284|NCT01855048|448151473|FG005|Overall Study|Withdrawal by Subject|0|||
124599285|NCT02139124|448151474|FG000|Overall Study|Adverse Event|2|||
124599286|NCT02139124|448151475|FG001|Overall Study|Adverse Event|0|||
124599287|NCT02139124|448151476|FG002|Overall Study|Adverse Event|1|||
124599288|NCT02139124|448151477|FG003|Overall Study|Adverse Event|2|||
124599289|NCT02139124|448151478|FG004|Overall Study|Adverse Event|5|||
124599290|NCT02139124|448151474|FG000|Overall Study|Withdrawal by Subject|2|||
124599291|NCT02139124|448151475|FG001|Overall Study|Withdrawal by Subject|2|||
124599292|NCT02139124|448151476|FG002|Overall Study|Withdrawal by Subject|2|||
124599293|NCT02139124|448151477|FG003|Overall Study|Withdrawal by Subject|2|||
124599294|NCT02139124|448151478|FG004|Overall Study|Withdrawal by Subject|3|||
124599295|NCT02139124|448151474|FG000|Overall Study|Protocol Violation|0|||
124599296|NCT02139124|448151475|FG001|Overall Study|Protocol Violation|0|||
124599297|NCT02139124|448151476|FG002|Overall Study|Protocol Violation|0|||
124599298|NCT02139124|448151477|FG003|Overall Study|Protocol Violation|1|||
124599299|NCT02139124|448151478|FG004|Overall Study|Protocol Violation|1|||
124599300|NCT02139124|448151474|FG000|Overall Study|non-compliant|1|||
124599301|NCT02139124|448151475|FG001|Overall Study|non-compliant|0|||
124599302|NCT02139124|448151476|FG002|Overall Study|non-compliant|0|||
124599303|NCT02139124|448151477|FG003|Overall Study|non-compliant|2|||
124599304|NCT02139124|448151478|FG004|Overall Study|non-compliant|0|||
124599305|NCT02139124|448151474|FG000|Overall Study|incarceration|0|||
124599306|NCT02139124|448151475|FG001|Overall Study|incarceration|0|||
124599307|NCT02139124|448151476|FG002|Overall Study|incarceration|1|||
124599308|NCT02139124|448151477|FG003|Overall Study|incarceration|0|||
124599309|NCT02139124|448151478|FG004|Overall Study|incarceration|0|||
124599310|NCT02139124|448151474|FG000|Overall Study|subject moved|1|||
124599311|NCT02139124|448151475|FG001|Overall Study|subject moved|0|||
124599312|NCT02139124|448151476|FG002|Overall Study|subject moved|0|||
124599313|NCT02139124|448151477|FG003|Overall Study|subject moved|0|||
124599314|NCT02139124|448151478|FG004|Overall Study|subject moved|0|||
124599315|NCT02139124|448151474|FG000|Overall Study|Lost to Follow-up|3|||
124599316|NCT02139124|448151475|FG001|Overall Study|Lost to Follow-up|2|||
124731146|NCT03372460|448637523|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
124599317|NCT02139124|448151476|FG002|Overall Study|Lost to Follow-up|0|||
124599318|NCT02139124|448151477|FG003|Overall Study|Lost to Follow-up|5|||
124599319|NCT02139124|448151478|FG004|Overall Study|Lost to Follow-up|4|||
124599320|NCT02691741|448151479|FG000|Overall Study|Adverse Event|0|||
124599321|NCT02691741|448151480|FG001|Overall Study|Adverse Event|2|||
124780561|NCT01615029|448825441|FG003|Overall Study|Adverse Event|0|||
124780562|NCT01615029|448825442|FG004|Overall Study|Adverse Event|1|||
124780563|NCT01615029|448825438|FG000|Overall Study|Death|0|||
124780564|NCT01615029|448825439|FG001|Overall Study|Death|0|||
124780565|NCT01615029|448825440|FG002|Overall Study|Death|0|||
124780566|NCT01615029|448825441|FG003|Overall Study|Death|0|||
124780567|NCT01615029|448825442|FG004|Overall Study|Death|1|||
124780568|NCT01615029|448825438|FG000|Overall Study|Lost to Follow-up|0|||
124780569|NCT01615029|448825439|FG001|Overall Study|Lost to Follow-up|0|||
124780570|NCT01615029|448825440|FG002|Overall Study|Lost to Follow-up|0|||
124780571|NCT01615029|448825441|FG003|Overall Study|Lost to Follow-up|0|||
124780572|NCT01615029|448825442|FG004|Overall Study|Lost to Follow-up|1|||
124780573|NCT01615029|448825438|FG000|Overall Study|Progressive disease|2|||
124780574|NCT01615029|448825439|FG001|Overall Study|Progressive disease|1|||
124780575|NCT01615029|448825440|FG002|Overall Study|Progressive disease|1|||
124780576|NCT01615029|448825441|FG003|Overall Study|Progressive disease|1|||
124780577|NCT01615029|448825442|FG004|Overall Study|Progressive disease|5|||
124780578|NCT01615029|448825438|FG000|Overall Study|Physician Decision|0|||
124780579|NCT01615029|448825439|FG001|Overall Study|Physician Decision|0|||
124780580|NCT01615029|448825440|FG002|Overall Study|Physician Decision|0|||
124780581|NCT01615029|448825441|FG003|Overall Study|Physician Decision|0|||
124780582|NCT01615029|448825442|FG004|Overall Study|Physician Decision|1|||
124780583|NCT01615029|448825438|FG000|Overall Study|Ongoing|1|||
124780584|NCT01615029|448825439|FG001|Overall Study|Ongoing|2|||
124780585|NCT01615029|448825440|FG002|Overall Study|Ongoing|3|||
124780586|NCT01615029|448825441|FG003|Overall Study|Ongoing|2|||
124780587|NCT01615029|448825442|FG004|Overall Study|Ongoing|23|||
124780588|NCT01326104|448825443|FG000|Overall Study|progressed prior to vaccine|0|||
124780589|NCT01326104|448825444|FG001|Overall Study|progressed prior to vaccine|2|||
124780590|NCT01326104|448825443|FG000|Overall Study|unable to make vaccine|0|||
124780591|NCT01326104|448825444|FG001|Overall Study|unable to make vaccine|2|||
124780592|NCT01287741|448825445|FG000|Overall Study|Withdrawal by Subject|35|||
124780593|NCT01287741|448825446|FG001|Overall Study|Withdrawal by Subject|38|||
124780594|NCT01287741|448825445|FG000|Overall Study|Protocol Violation|2|||
124780595|NCT01287741|448825446|FG001|Overall Study|Protocol Violation|0|||
124780596|NCT01287741|448825445|FG000|Overall Study|Physician Decision|15|||
124780597|NCT01287741|448825446|FG001|Overall Study|Physician Decision|23|||
124780598|NCT01287741|448825445|FG000|Overall Study|Non-compliance|8|||
124780599|NCT01287741|448825446|FG001|Overall Study|Non-compliance|6|||
124780600|NCT01287741|448825445|FG000|Overall Study|Lost to Follow-up|10|||
124780601|NCT01287741|448825446|FG001|Overall Study|Lost to Follow-up|8|||
124780602|NCT01287741|448825445|FG000|Overall Study|Death|32|||
124780603|NCT01287741|448825446|FG001|Overall Study|Death|44|||
124780604|NCT01287741|448825445|FG000|Overall Study|Adverse Event|4|||
124780605|NCT01287741|448825446|FG001|Overall Study|Adverse Event|6|||
124780606|NCT01287741|448825445|FG000|Overall Study|Study terminated by Sponsor|307|||
124780607|NCT01287741|448825446|FG001|Overall Study|Study terminated by Sponsor|315|||
124780608|NCT01287741|448825445|FG000|Overall Study|Progressive disease|190|||
124780609|NCT01287741|448825446|FG001|Overall Study|Progressive disease|166|||
124780610|NCT01287741|448825445|FG000|Overall Study|Reason not specified|23|||
124780611|NCT01287741|448825446|FG001|Overall Study|Reason not specified|9|||
124780612|NCT00802945|448825447|FG000|Overall Study|Death|27|||
124780613|NCT00802945|448825448|FG001|Overall Study|Death|23|||
124780614|NCT00802945|448825447|FG000|Overall Study|Terminated by sponsor|8|||
124780615|NCT00802945|448825448|FG001|Overall Study|Terminated by sponsor|12|||
124780616|NCT04421027|448825449|FG000|Treatment Period|Adverse Event|5|||
124780617|NCT04421027|448825450|FG001|Treatment Period|Adverse Event|3|||
124780618|NCT04421027|448825451|FG002|Treatment Period|Adverse Event|0|||
124780619|NCT04421027|448825452|FG003|Treatment Period|Adverse Event|0|||
124780620|NCT04421027|448825449|FG000|Treatment Period|Death|98|||
124780621|NCT04421027|448825450|FG001|Treatment Period|Death|61|||
124780622|NCT04421027|448825451|FG002|Treatment Period|Death|0|||
124780623|NCT04421027|448825452|FG003|Treatment Period|Death|0|||
124780624|NCT04421027|448825449|FG000|Treatment Period|Lost to Follow-up|22|||
124780625|NCT04421027|448825450|FG001|Treatment Period|Lost to Follow-up|20|||
124780626|NCT04421027|448825451|FG002|Treatment Period|Lost to Follow-up|0|||
124780627|NCT04421027|448825452|FG003|Treatment Period|Lost to Follow-up|0|||
124780628|NCT04421027|448825449|FG000|Treatment Period|Other-Unknown|15|||
124780629|NCT04421027|448825450|FG001|Treatment Period|Other-Unknown|9|||
124780630|NCT04421027|448825451|FG002|Treatment Period|Other-Unknown|0|||
124780631|NCT04421027|448825452|FG003|Treatment Period|Other-Unknown|0|||
124780632|NCT04421027|448825449|FG000|Treatment Period|Physician Decision|1|||
124780633|NCT04421027|448825450|FG001|Treatment Period|Physician Decision|1|||
124780634|NCT04421027|448825451|FG002|Treatment Period|Physician Decision|0|||
124780635|NCT04421027|448825452|FG003|Treatment Period|Physician Decision|0|||
124780636|NCT04421027|448825449|FG000|Treatment Period|Withdrawal by Subject|7|||
124780637|NCT04421027|448825450|FG001|Treatment Period|Withdrawal by Subject|12|||
124780638|NCT04421027|448825451|FG002|Treatment Period|Withdrawal by Subject|0|||
124780639|NCT04421027|448825452|FG003|Treatment Period|Withdrawal by Subject|0|||
124780640|NCT04421027|448825449|FG000|Treatment Period|Randomized Not Dosed|9|||
124780641|NCT04421027|448825450|FG001|Treatment Period|Randomized Not Dosed|14|||
124599322|NCT02691741|448151479|FG000|Overall Study|Lost to Follow-up|1|||
124599323|NCT02691741|448151480|FG001|Overall Study|Lost to Follow-up|0|||
124599324|NCT02691741|448151479|FG000|Overall Study|Physician Decision|0|||
124599325|NCT02691741|448151480|FG001|Overall Study|Physician Decision|1|||
124599326|NCT02691741|448151479|FG000|Overall Study|Withdrawal by Subject|0|||
124599327|NCT02691741|448151480|FG001|Overall Study|Withdrawal by Subject|4|||
124599328|NCT03465436|448151481|FG000|Period 1|Protocol Violation|0|||
124599329|NCT03465436|448151482|FG001|Period 1|Protocol Violation|0|||
124599330|NCT03465436|448151483|FG002|Period 1|Protocol Violation|1|||
124599331|NCT03465436|448151484|FG003|Period 1|Protocol Violation|0|||
124599332|NCT03465436|448151481|FG000|Period 2|Protocol Violation|0|||
124599333|NCT03465436|448151482|FG001|Period 2|Protocol Violation|1|||
124599334|NCT03465436|448151483|FG002|Period 2|Protocol Violation|0|||
124599335|NCT03465436|448151484|FG003|Period 2|Protocol Violation|0|||
124599336|NCT03465436|448151481|FG000|Period 3|Protocol Violation|1|||
124599337|NCT03465436|448151482|FG001|Period 3|Protocol Violation|1|||
124599338|NCT03465436|448151483|FG002|Period 3|Protocol Violation|0|||
124599339|NCT03465436|448151484|FG003|Period 3|Protocol Violation|0|||
124599340|NCT03465436|448151481|FG000|Period 4|Protocol Violation|0|||
124599341|NCT03465436|448151482|FG001|Period 4|Protocol Violation|0|||
124599342|NCT03465436|448151483|FG002|Period 4|Protocol Violation|1|||
124599343|NCT03465436|448151484|FG003|Period 4|Protocol Violation|0|||
124599344|NCT02697773|448151485|FG000|Overall Study|Adverse Event|2|||
124599345|NCT02697773|448151486|FG001|Overall Study|Adverse Event|1|||
124599346|NCT02697773|448151487|FG002|Overall Study|Adverse Event|2|||
124599347|NCT02697773|448151485|FG000|Overall Study|Death|0|||
124599348|NCT02697773|448151486|FG001|Overall Study|Death|0|||
124599349|NCT02697773|448151487|FG002|Overall Study|Death|2|||
124599350|NCT02697773|448151485|FG000|Overall Study|Lack of Efficacy|4|||
124599351|NCT02697773|448151486|FG001|Overall Study|Lack of Efficacy|6|||
124599352|NCT02697773|448151487|FG002|Overall Study|Lack of Efficacy|6|||
124599353|NCT02697773|448151485|FG000|Overall Study|Lost to Follow-up|5|||
124599354|NCT02697773|448151486|FG001|Overall Study|Lost to Follow-up|5|||
124599355|NCT02697773|448151487|FG002|Overall Study|Lost to Follow-up|7|||
124599356|NCT02697773|448151485|FG000|Overall Study|Other|15|||
124599357|NCT02697773|448151486|FG001|Overall Study|Other|11|||
124599358|NCT02697773|448151487|FG002|Overall Study|Other|10|||
124599359|NCT02697773|448151485|FG000|Overall Study|Protocol Violation|1|||
124599360|NCT02697773|448151486|FG001|Overall Study|Protocol Violation|1|||
124599361|NCT02697773|448151487|FG002|Overall Study|Protocol Violation|0|||
124599362|NCT02697773|448151485|FG000|Overall Study|Withdrawal by Subject|10|||
124599363|NCT02697773|448151486|FG001|Overall Study|Withdrawal by Subject|13|||
124599364|NCT02697773|448151487|FG002|Overall Study|Withdrawal by Subject|13|||
124599365|NCT02697773|448151485|FG000|Overall Study|Randomized but not treated|1|||
124599366|NCT02697773|448151486|FG001|Overall Study|Randomized but not treated|1|||
124599367|NCT02697773|448151487|FG002|Overall Study|Randomized but not treated|0|||
124599368|NCT01118117|448151488|FG000|Overall Study|Death|8|||
124599369|NCT01118117|448151489|FG001|Overall Study|Death|0|||
124599370|NCT01118117|448151488|FG000|Overall Study|Lost to Follow-up|6|||
124599371|NCT01118117|448151489|FG001|Overall Study|Lost to Follow-up|0|||
124599372|NCT01118117|448151488|FG000|Overall Study|Missed 12 Month Visit|7|||
124599373|NCT01118117|448151489|FG001|Overall Study|Missed 12 Month Visit|0|||
124599374|NCT02149121|448151491|FG000|Main Study Period|Lack of Efficacy|2|||
124599375|NCT02149121|448151492|FG001|Main Study Period|Lack of Efficacy|2|||
124599376|NCT02149121|448151493|FG002|Main Study Period|Lack of Efficacy|1|||
124599377|NCT02149121|448151494|FG003|Main Study Period|Lack of Efficacy|0|||
124599378|NCT02149121|448151495|FG004|Main Study Period|Lack of Efficacy|0|||
124599379|NCT02149121|448151496|FG005|Main Study Period|Lack of Efficacy|0|||
124780642|NCT04421027|448825451|FG002|Treatment Period|Randomized Not Dosed|0|||
124599380|NCT02149121|448151497|FG006|Main Study Period|Lack of Efficacy|0|||
124599381|NCT02149121|448151491|FG000|Main Study Period|Withdrawal by Subject|9|||
124599382|NCT02149121|448151492|FG001|Main Study Period|Withdrawal by Subject|5|||
124599383|NCT02149121|448151493|FG002|Main Study Period|Withdrawal by Subject|1|||
124599384|NCT02149121|448151494|FG003|Main Study Period|Withdrawal by Subject|0|||
124599385|NCT02149121|448151495|FG004|Main Study Period|Withdrawal by Subject|0|||
124599386|NCT02149121|448151496|FG005|Main Study Period|Withdrawal by Subject|0|||
124599387|NCT02149121|448151497|FG006|Main Study Period|Withdrawal by Subject|0|||
124599388|NCT02149121|448151491|FG000|Main Study Period|Adverse Event|2|||
124599389|NCT02149121|448151492|FG001|Main Study Period|Adverse Event|5|||
124599390|NCT02149121|448151493|FG002|Main Study Period|Adverse Event|1|||
124599391|NCT02149121|448151494|FG003|Main Study Period|Adverse Event|0|||
124599392|NCT02149121|448151495|FG004|Main Study Period|Adverse Event|0|||
124599393|NCT02149121|448151496|FG005|Main Study Period|Adverse Event|0|||
124599394|NCT02149121|448151497|FG006|Main Study Period|Adverse Event|0|||
124599395|NCT02149121|448151491|FG000|Main Study Period|Protocol Violation|2|||
124599396|NCT02149121|448151492|FG001|Main Study Period|Protocol Violation|0|||
124599397|NCT02149121|448151493|FG002|Main Study Period|Protocol Violation|0|||
124599398|NCT02149121|448151494|FG003|Main Study Period|Protocol Violation|0|||
124599399|NCT02149121|448151495|FG004|Main Study Period|Protocol Violation|0|||
124599400|NCT02149121|448151496|FG005|Main Study Period|Protocol Violation|0|||
124599401|NCT02149121|448151497|FG006|Main Study Period|Protocol Violation|0|||
124599402|NCT02149121|448151491|FG000|Main Study Period|Lost to Follow-up|2|||
124599403|NCT02149121|448151492|FG001|Main Study Period|Lost to Follow-up|1|||
124599404|NCT02149121|448151493|FG002|Main Study Period|Lost to Follow-up|0|||
124599405|NCT02149121|448151494|FG003|Main Study Period|Lost to Follow-up|0|||
124599406|NCT02149121|448151495|FG004|Main Study Period|Lost to Follow-up|0|||
124599407|NCT02149121|448151496|FG005|Main Study Period|Lost to Follow-up|0|||
124599408|NCT02149121|448151497|FG006|Main Study Period|Lost to Follow-up|0|||
124599409|NCT02149121|448151491|FG000|Main Study Period|Death|1|||
124599410|NCT02149121|448151492|FG001|Main Study Period|Death|0|||
124599411|NCT02149121|448151493|FG002|Main Study Period|Death|0|||
124599412|NCT02149121|448151494|FG003|Main Study Period|Death|0|||
124599413|NCT02149121|448151495|FG004|Main Study Period|Death|0|||
124599414|NCT02149121|448151496|FG005|Main Study Period|Death|0|||
124599415|NCT02149121|448151497|FG006|Main Study Period|Death|0|||
124599416|NCT02149121|448151491|FG000|Main Study Period|Physician Decision|1|||
124599417|NCT02149121|448151492|FG001|Main Study Period|Physician Decision|0|||
124599418|NCT02149121|448151493|FG002|Main Study Period|Physician Decision|0|||
124599419|NCT02149121|448151494|FG003|Main Study Period|Physician Decision|0|||
124599420|NCT02149121|448151495|FG004|Main Study Period|Physician Decision|0|||
124599421|NCT02149121|448151496|FG005|Main Study Period|Physician Decision|0|||
124599422|NCT02149121|448151497|FG006|Main Study Period|Physician Decision|0|||
124599423|NCT02149121|448151491|FG000|Main Study Period|Developed any malignancy|0|||
124599424|NCT02149121|448151492|FG001|Main Study Period|Developed any malignancy|1|||
124599425|NCT02149121|448151493|FG002|Main Study Period|Developed any malignancy|1|||
124599426|NCT02149121|448151494|FG003|Main Study Period|Developed any malignancy|0|||
124599427|NCT02149121|448151495|FG004|Main Study Period|Developed any malignancy|0|||
124599428|NCT02149121|448151496|FG005|Main Study Period|Developed any malignancy|0|||
124599429|NCT02149121|448151497|FG006|Main Study Period|Developed any malignancy|0|||
124599430|NCT02149121|448151491|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
124599431|NCT02149121|448151492|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
124599432|NCT02149121|448151493|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
124599433|NCT02149121|448151494|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
124599434|NCT02149121|448151495|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
124731147|NCT02499900|448637524|FG000|Core Study Period|Other|1|||
124731148|NCT02499900|448637525|FG001|Core Study Period|Other|4|||
124731149|NCT02499900|448637524|FG000|Core Study Period|Lost to Follow-up|1|||
124731150|NCT02499900|448637525|FG001|Core Study Period|Lost to Follow-up|2|||
124731151|NCT02499900|448637524|FG000|Core Study Period|Per sponsor request|0|||
124731152|NCT02499900|448637525|FG001|Core Study Period|Per sponsor request|1|||
124599435|NCT02149121|448151496|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
124599436|NCT02149121|448151497|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
124599437|NCT02149121|448151491|FG000|Main Study Period|Disease progression|0|||
124599438|NCT02149121|448151492|FG001|Main Study Period|Disease progression|1|||
124599439|NCT02149121|448151493|FG002|Main Study Period|Disease progression|0|||
124599440|NCT02149121|448151494|FG003|Main Study Period|Disease progression|0|||
124599441|NCT02149121|448151495|FG004|Main Study Period|Disease progression|0|||
124599442|NCT02149121|448151496|FG005|Main Study Period|Disease progression|0|||
124599443|NCT02149121|448151497|FG006|Main Study Period|Disease progression|0|||
124599444|NCT02149121|448151491|FG000|Extension Study Period|Withdrawal by Subject|0|||
124599445|NCT02149121|448151492|FG001|Extension Study Period|Withdrawal by Subject|0|||
124599446|NCT02149121|448151493|FG002|Extension Study Period|Withdrawal by Subject|0|||
124599447|NCT02149121|448151494|FG003|Extension Study Period|Withdrawal by Subject|1|||
124599448|NCT02149121|448151495|FG004|Extension Study Period|Withdrawal by Subject|0|||
124599449|NCT02149121|448151496|FG005|Extension Study Period|Withdrawal by Subject|2|||
124599450|NCT02149121|448151497|FG006|Extension Study Period|Withdrawal by Subject|0|||
124599451|NCT03166124|448151500|FG000|Treatment Period 1|Adverse Event|0|||
124599452|NCT03166124|448151501|FG001|Treatment Period 1|Adverse Event|0|||
124599453|NCT03166124|448151502|FG002|Treatment Period 1|Adverse Event|1|||
124599454|NCT03166124|448151503|FG003|Treatment Period 1|Adverse Event|0|||
124599455|NCT03166124|448151500|FG000|Wash-out Period|Withdrawal by Subject|0|||
124599456|NCT03166124|448151501|FG001|Wash-out Period|Withdrawal by Subject|1|||
124599457|NCT03166124|448151502|FG002|Wash-out Period|Withdrawal by Subject|0|||
124599458|NCT03166124|448151503|FG003|Wash-out Period|Withdrawal by Subject|1|||
124599459|NCT03166124|448151500|FG000|Wash-out Period|Adverse Event|0|||
124599460|NCT03166124|448151501|FG001|Wash-out Period|Adverse Event|1|||
124599461|NCT03166124|448151502|FG002|Wash-out Period|Adverse Event|1|||
124599462|NCT03166124|448151503|FG003|Wash-out Period|Adverse Event|0|||
124599463|NCT04974619|448153514|FG000|Overall Study|Lost to Follow-up|0|||
124731153|NCT02499900|448637524|FG000|Core Study Period|Pregnancy|1|||
124731154|NCT02499900|448637525|FG001|Core Study Period|Pregnancy|0|||
124599464|NCT04974619|448153515|FG001|Overall Study|Lost to Follow-up|0|||
124599465|NCT04974619|448153516|FG002|Overall Study|Lost to Follow-up|1|||
124599466|NCT04974619|448153514|FG000|Overall Study|Withdrawal by Subject|0|||
124780643|NCT04421027|448825452|FG003|Treatment Period|Randomized Not Dosed|0|||
124780644|NCT04421027|448825449|FG000|Follow-Up Period|Adverse Event|0|||
124780645|NCT04421027|448825450|FG001|Follow-Up Period|Adverse Event|0|||
124599467|NCT04974619|448153515|FG001|Overall Study|Withdrawal by Subject|0|||
124599468|NCT04974619|448153516|FG002|Overall Study|Withdrawal by Subject|1|||
124599469|NCT04974619|448153514|FG000|Overall Study|Protocol Violation|0|||
124599470|NCT04974619|448153515|FG001|Overall Study|Protocol Violation|1|||
124599471|NCT04974619|448153516|FG002|Overall Study|Protocol Violation|0|||
124599472|NCT00493779|448153517|FG000|Overall Study|Logistical issue at site|1|||
124599473|NCT01475253|448153518|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
124599474|NCT01475253|448153519|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
124599475|NCT01475253|448153520|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
124599476|NCT01475253|448153521|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
124599477|NCT01475253|448153518|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
124599478|NCT01475253|448153519|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
124599479|NCT01475253|448153520|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
124599480|NCT01475253|448153521|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
124599481|NCT02148913|448153523|FG000|Overall Study|Death|0|||
124599482|NCT02148913|448153524|FG001|Overall Study|Death|1|||
124599483|NCT02148913|448153525|FG002|Overall Study|Death|0|||
124599484|NCT02148913|448153526|FG003|Overall Study|Death|0|||
124599485|NCT01045993|448153530|FG000|Overall Study|Treated-later found eligibility not met|0|||
124599486|NCT01045993|448153531|FG001|Overall Study|Treated-later found eligibility not met|1|||
124599487|NCT01045993|448153532|FG002|Overall Study|Treated-later found eligibility not met|0|||
124599488|NCT01045993|448153533|FG003|Overall Study|Treated-later found eligibility not met|0|||
124599489|NCT05506358|448153534|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
124599490|NCT05506358|448153535|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
124599491|NCT05506358|448153536|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
124599492|NCT05506358|448153537|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
124599493|NCT05506358|448153538|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
124599494|NCT05506358|448153534|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
124599495|NCT05506358|448153535|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
124599496|NCT05506358|448153536|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
124599497|NCT05506358|448153537|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
124599498|NCT05506358|448153538|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
124599499|NCT05506358|448153534|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
124599500|NCT05506358|448153535|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
124599501|NCT05506358|448153536|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
124599502|NCT05506358|448153537|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
124599503|NCT05506358|448153538|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
124599504|NCT05506358|448153534|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
124599505|NCT05506358|448153535|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
124599506|NCT05506358|448153536|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
124599507|NCT05506358|448153537|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
124599508|NCT05506358|448153538|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
124599509|NCT05506358|448153534|FG000|Overall Study|HbE trait|0|||
124599510|NCT05506358|448153535|FG001|Overall Study|HbE trait|0|||
124599511|NCT05506358|448153536|FG002|Overall Study|HbE trait|0|||
124599512|NCT05506358|448153537|FG003|Overall Study|HbE trait|1|||
124599513|NCT05506358|448153538|FG004|Overall Study|HbE trait|0|||
124599514|NCT01659736|448153539|FG000|Treatment Period|Adverse Event|1|||
124599515|NCT01659736|448153540|FG001|Treatment Period|Adverse Event|1|||
124599516|NCT01659736|448153539|FG000|Treatment Period|Protocol Violation|3|||
124599517|NCT01659736|448153540|FG001|Treatment Period|Protocol Violation|1|||
124599518|NCT01659736|448153539|FG000|Treatment Period|Withdrawal by Subject|1|||
124599519|NCT01659736|448153540|FG001|Treatment Period|Withdrawal by Subject|0|||
124599520|NCT01659736|448153539|FG000|3-month Follow-up|Lost to Follow-up|0|||
124599521|NCT01659736|448153540|FG001|3-month Follow-up|Lost to Follow-up|1|||
124599522|NCT00262041|448153546|FG000|Overall Study|Withdrawal by Subject|0|||
124599523|NCT00262041|448153547|FG001|Overall Study|Withdrawal by Subject|3|||
124599524|NCT00262041|448153548|FG002|Overall Study|Withdrawal by Subject|1|||
124599525|NCT00262041|448153546|FG000|Overall Study|Lost to Follow-up|1|||
124599526|NCT00262041|448153547|FG001|Overall Study|Lost to Follow-up|1|||
124599527|NCT00262041|448153548|FG002|Overall Study|Lost to Follow-up|5|||
124599528|NCT00262041|448153546|FG000|Overall Study|Unable to classify|1|||
124599529|NCT00262041|448153547|FG001|Overall Study|Unable to classify|0|||
124599530|NCT00262041|448153548|FG002|Overall Study|Unable to classify|0|||
124599531|NCT02384941|448153551|FG000|Overall Study|Adverse Event|11|||
124599532|NCT02384941|448153552|FG001|Overall Study|Adverse Event|13|||
124599533|NCT02384941|448153553|FG002|Overall Study|Adverse Event|17|||
124780646|NCT04421027|448825451|FG002|Follow-Up Period|Adverse Event|0|||
124780647|NCT04421027|448825452|FG003|Follow-Up Period|Adverse Event|3|||
124780648|NCT04421027|448825449|FG000|Follow-Up Period|Death|0|||
124780649|NCT04421027|448825450|FG001|Follow-Up Period|Death|0|||
124780650|NCT04421027|448825451|FG002|Follow-Up Period|Death|16|||
124780651|NCT04421027|448825452|FG003|Follow-Up Period|Death|17|||
124780652|NCT04421027|448825449|FG000|Follow-Up Period|Lost to Follow-up|0|||
124780653|NCT04421027|448825450|FG001|Follow-Up Period|Lost to Follow-up|0|||
124780654|NCT04421027|448825451|FG002|Follow-Up Period|Lost to Follow-up|7|||
124780655|NCT04421027|448825452|FG003|Follow-Up Period|Lost to Follow-up|7|||
124780656|NCT04421027|448825449|FG000|Follow-Up Period|Protocol Deviation|0|||
124780657|NCT04421027|448825450|FG001|Follow-Up Period|Protocol Deviation|0|||
124780658|NCT04421027|448825451|FG002|Follow-Up Period|Protocol Deviation|1|||
124780659|NCT04421027|448825452|FG003|Follow-Up Period|Protocol Deviation|0|||
124780660|NCT04421027|448825449|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
124780661|NCT04421027|448825450|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
124780662|NCT04421027|448825451|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
124780663|NCT04421027|448825452|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
124780664|NCT04421027|448825449|FG000|Follow-Up Period|Left message, participant did not call back|0|||
124780665|NCT04421027|448825450|FG001|Follow-Up Period|Left message, participant did not call back|0|||
124780666|NCT04421027|448825451|FG002|Follow-Up Period|Left message, participant did not call back|0|||
124780667|NCT04421027|448825452|FG003|Follow-Up Period|Left message, participant did not call back|1|||
124780668|NCT04421027|448825449|FG000|Follow-Up Period|Participant died|0|||
124780669|NCT04421027|448825450|FG001|Follow-Up Period|Participant died|0|||
124780670|NCT04421027|448825451|FG002|Follow-Up Period|Participant died|0|||
124780671|NCT04421027|448825452|FG003|Follow-Up Period|Participant died|1|||
124780672|NCT04421027|448825449|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
124780673|NCT04421027|448825450|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
124780674|NCT04421027|448825451|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
124780675|NCT04421027|448825452|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
124780676|NCT02930018|448825454|FG000|Overall Study|Lost to Follow-up|1|||
124780677|NCT02930018|448825455|FG001|Overall Study|Lost to Follow-up|1|||
124599534|NCT02384941|448153551|FG000|Overall Study|Lost to Follow-up|3|||
124599535|NCT02384941|448153552|FG001|Overall Study|Lost to Follow-up|2|||
124599536|NCT02384941|448153553|FG002|Overall Study|Lost to Follow-up|1|||
124599537|NCT02384941|448153551|FG000|Overall Study|Non-Compliance With Study Drug|2|||
124599538|NCT02384941|448153552|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124599539|NCT02384941|448153553|FG002|Overall Study|Non-Compliance With Study Drug|1|||
124599540|NCT02384941|448153551|FG000|Overall Study|Physician Decision|1|||
124599541|NCT02384941|448153552|FG001|Overall Study|Physician Decision|1|||
124599542|NCT02384941|448153553|FG002|Overall Study|Physician Decision|0|||
124599543|NCT02384941|448153551|FG000|Overall Study|Protocol Violation|3|||
124599544|NCT02384941|448153552|FG001|Overall Study|Protocol Violation|0|||
124599545|NCT02384941|448153553|FG002|Overall Study|Protocol Violation|0|||
124599546|NCT02384941|448153551|FG000|Overall Study|Withdrawal by Subject|26|||
124599547|NCT02384941|448153552|FG001|Overall Study|Withdrawal by Subject|19|||
124599548|NCT02384941|448153553|FG002|Overall Study|Withdrawal by Subject|20|||
124599549|NCT02384941|448153551|FG000|Overall Study|Pregnancy|0|||
124599550|NCT02384941|448153552|FG001|Overall Study|Pregnancy|0|||
124599551|NCT02384941|448153553|FG002|Overall Study|Pregnancy|1|||
124599552|NCT02384941|448153551|FG000|Overall Study|Other than specified above|4|||
124599553|NCT02384941|448153552|FG001|Overall Study|Other than specified above|0|||
124599554|NCT02384941|448153553|FG002|Overall Study|Other than specified above|1|||
124731155|NCT02499900|448637524|FG000|Core Study Period|Protocol Violation|3|||
124731156|NCT02499900|448637525|FG001|Core Study Period|Protocol Violation|0|||
124731157|NCT02499900|448637524|FG000|Core Study Period|Withdrawal by Subject|11|||
124731158|NCT02499900|448637525|FG001|Core Study Period|Withdrawal by Subject|10|||
124731159|NCT02499900|448637524|FG000|Core Study Period|Adverse Event|18|||
124731160|NCT02499900|448637525|FG001|Core Study Period|Adverse Event|14|||
124731161|NCT02499900|448637524|FG000|Core Study Period|Death|0|||
124731162|NCT02499900|448637525|FG001|Core Study Period|Death|1|||
124731163|NCT02499900|448637524|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
124731164|NCT02499900|448637525|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
124731165|NCT02499900|448637524|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
124731166|NCT02499900|448637525|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
124731167|NCT02499900|448637524|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
124731168|NCT02499900|448637525|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
124731169|NCT02499900|448637524|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
124599555|NCT00252174|448153556|FG000|Overall Study|Withdrawal by Subject|0|||
124599556|NCT00252174|448153557|FG001|Overall Study|Withdrawal by Subject|1|||
124599557|NCT00252174|448153558|FG002|Overall Study|Withdrawal by Subject|0|||
124599558|NCT02025010|448153559|FG000|Overall Study|Symptomatic or radiographic progression|36|||
124599559|NCT02025010|448153559|FG000|Overall Study|Adverse Event|6|||
124599560|NCT02025010|448153559|FG000|Overall Study|Physician Decision|7|||
124599561|NCT02025010|448153559|FG000|Overall Study|Withdrawal by Subject|3|||
124599562|NCT02025010|448153559|FG000|Overall Study|Intercurrent illness|3|||
124599563|NCT02025010|448153559|FG000|Overall Study|Patients still on treatment|3|||
124599564|NCT02025010|448153559|FG000|Overall Study|Never initiate the treatment|2|||
124599565|NCT00949988|448153560|FG000|Overall Study|Withdrawal by Subject|3|||
124599566|NCT00484419|448153564|FG000|Overall Study|Adverse Event|3|||
124599567|NCT00484419|448153565|FG001|Overall Study|Adverse Event|0|||
124599568|NCT00484419|448153566|FG002|Overall Study|Adverse Event|0|||
124599569|NCT00484419|448153564|FG000|Overall Study|Lost to Follow-up|1|||
124599570|NCT00484419|448153565|FG001|Overall Study|Lost to Follow-up|0|||
124599571|NCT00484419|448153566|FG002|Overall Study|Lost to Follow-up|2|||
124599572|NCT00484419|448153564|FG000|Overall Study|Withdrawal by Subject|3|||
124599573|NCT00484419|448153565|FG001|Overall Study|Withdrawal by Subject|1|||
124599574|NCT00484419|448153566|FG002|Overall Study|Withdrawal by Subject|1|||
124599575|NCT00484419|448153564|FG000|Overall Study|subject met discontinuation criteria|2|||
124599576|NCT00484419|448153565|FG001|Overall Study|subject met discontinuation criteria|2|||
124599577|NCT00484419|448153566|FG002|Overall Study|subject met discontinuation criteria|4|||
124599578|NCT00484419|448153564|FG000|Overall Study|required restricted medication|1|||
124599579|NCT00484419|448153565|FG001|Overall Study|required restricted medication|0|||
124599580|NCT00484419|448153566|FG002|Overall Study|required restricted medication|1|||
124599581|NCT00484419|448153564|FG000|Overall Study|Physician Decision|1|||
124599582|NCT00484419|448153565|FG001|Overall Study|Physician Decision|1|||
124599583|NCT00484419|448153566|FG002|Overall Study|Physician Decision|1|||
124599584|NCT00484419|448153564|FG000|Overall Study|subject unable to receive medication|1|||
124599585|NCT00484419|448153565|FG001|Overall Study|subject unable to receive medication|0|||
124599586|NCT00484419|448153566|FG002|Overall Study|subject unable to receive medication|0|||
124599587|NCT00484419|448153564|FG000|Overall Study|subject relocated|0|||
124599588|NCT00484419|448153565|FG001|Overall Study|subject relocated|1|||
124599589|NCT00484419|448153566|FG002|Overall Study|subject relocated|0|||
124599590|NCT00484419|448153564|FG000|Overall Study|sponsor decision, randomized in error|0|||
124599591|NCT00484419|448153565|FG001|Overall Study|sponsor decision, randomized in error|0|||
124599592|NCT00484419|448153566|FG002|Overall Study|sponsor decision, randomized in error|2|||
124599593|NCT05212883|448153567|FG000|Overall Study|Invalid test result|125|||
124599594|NCT00102687|448153568|FG000|Initial Period|Withdrawal by Subject|6|||
124599595|NCT00102687|448153569|FG001|Initial Period|Withdrawal by Subject|3|||
124599596|NCT00102687|448153570|FG002|Initial Period|Withdrawal by Subject|5|||
124599597|NCT00102687|448153571|FG003|Initial Period|Withdrawal by Subject|0|||
124599598|NCT00102687|448153572|FG004|Initial Period|Withdrawal by Subject|0|||
124599599|NCT00102687|448153568|FG000|Initial Period|Adverse Event|4|||
124599600|NCT00102687|448153569|FG001|Initial Period|Adverse Event|7|||
124599601|NCT00102687|448153570|FG002|Initial Period|Adverse Event|9|||
124599602|NCT00102687|448153571|FG003|Initial Period|Adverse Event|0|||
124599603|NCT00102687|448153572|FG004|Initial Period|Adverse Event|0|||
124599604|NCT00102687|448153568|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
124599605|NCT00102687|448153569|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
124599606|NCT00102687|448153570|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
124599607|NCT00102687|448153571|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
124599608|NCT00102687|448153572|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
124599609|NCT00102687|448153568|FG000|Initial Period|Protocol Violation|0|||
124599610|NCT00102687|448153569|FG001|Initial Period|Protocol Violation|0|||
124599611|NCT00102687|448153570|FG002|Initial Period|Protocol Violation|2|||
124599612|NCT00102687|448153571|FG003|Initial Period|Protocol Violation|0|||
124599613|NCT00102687|448153572|FG004|Initial Period|Protocol Violation|0|||
124599614|NCT00102687|448153568|FG000|Initial Period|Physician Decision|2|||
124599615|NCT00102687|448153569|FG001|Initial Period|Physician Decision|9|||
124599616|NCT00102687|448153570|FG002|Initial Period|Physician Decision|6|||
124599617|NCT00102687|448153571|FG003|Initial Period|Physician Decision|0|||
124599618|NCT00102687|448153572|FG004|Initial Period|Physician Decision|0|||
124599619|NCT00102687|448153568|FG000|Initial Period|Sponsor's decision|0|||
124599620|NCT00102687|448153569|FG001|Initial Period|Sponsor's decision|1|||
124599621|NCT00102687|448153570|FG002|Initial Period|Sponsor's decision|1|||
124599622|NCT00102687|448153571|FG003|Initial Period|Sponsor's decision|0|||
124599623|NCT00102687|448153572|FG004|Initial Period|Sponsor's decision|0|||
124599624|NCT00102687|448153568|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
124599625|NCT00102687|448153569|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
124599626|NCT00102687|448153570|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
124599627|NCT00102687|448153571|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
124599628|NCT00102687|448153572|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
124599629|NCT00102687|448153568|FG000|Initial Period|Death|1|||
124599630|NCT00102687|448153569|FG001|Initial Period|Death|1|||
124599631|NCT00102687|448153570|FG002|Initial Period|Death|1|||
124599632|NCT00102687|448153571|FG003|Initial Period|Death|0|||
124599633|NCT00102687|448153572|FG004|Initial Period|Death|0|||
124599634|NCT00102687|448153568|FG000|Maintenance Period|Withdrawal by Subject|4|||
124599635|NCT00102687|448153569|FG001|Maintenance Period|Withdrawal by Subject|0|||
124599636|NCT00102687|448153570|FG002|Maintenance Period|Withdrawal by Subject|2|||
124599637|NCT00102687|448153571|FG003|Maintenance Period|Withdrawal by Subject|3|||
124599638|NCT00102687|448153572|FG004|Maintenance Period|Withdrawal by Subject|1|||
124599639|NCT00102687|448153568|FG000|Maintenance Period|Adverse Event|1|||
124599640|NCT00102687|448153569|FG001|Maintenance Period|Adverse Event|0|||
124599641|NCT00102687|448153570|FG002|Maintenance Period|Adverse Event|0|||
124599642|NCT00102687|448153571|FG003|Maintenance Period|Adverse Event|1|||
124599643|NCT00102687|448153572|FG004|Maintenance Period|Adverse Event|3|||
124599644|NCT00102687|448153568|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
124599645|NCT00102687|448153569|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
124599646|NCT00102687|448153570|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
124599647|NCT00102687|448153571|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
124599648|NCT00102687|448153572|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
124599649|NCT00102687|448153568|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
124599650|NCT00102687|448153569|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
124599651|NCT00102687|448153570|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
124599652|NCT00102687|448153571|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
124599653|NCT00102687|448153572|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
124599654|NCT00102687|448153568|FG000|Maintenance Period|Death|0|||
124599655|NCT00102687|448153569|FG001|Maintenance Period|Death|0|||
124599656|NCT00102687|448153570|FG002|Maintenance Period|Death|0|||
124599657|NCT00102687|448153571|FG003|Maintenance Period|Death|1|||
124599658|NCT00102687|448153572|FG004|Maintenance Period|Death|1|||
124599659|NCT00102687|448153568|FG000|Maintenance Period|Physician Decision|1|||
124599660|NCT00102687|448153569|FG001|Maintenance Period|Physician Decision|2|||
124599661|NCT00102687|448153570|FG002|Maintenance Period|Physician Decision|3|||
124599662|NCT00102687|448153571|FG003|Maintenance Period|Physician Decision|0|||
124599663|NCT00102687|448153572|FG004|Maintenance Period|Physician Decision|4|||
124599664|NCT03847194|448153573|FG000|Overall Study|Lost to Follow-up|2|||
124599665|NCT03847194|448153574|FG001|Overall Study|Lost to Follow-up|5|||
124599666|NCT03847194|448153573|FG000|Overall Study|Withdrawal by Subject|1|||
124599667|NCT03847194|448153574|FG001|Overall Study|Withdrawal by Subject|2|||
124599668|NCT03847194|448153573|FG000|Overall Study|Death|0|||
124599669|NCT03847194|448153574|FG001|Overall Study|Death|1|||
124599670|NCT03176784|448153575|FG000|Overall Study|Lost to Follow-up|77|||
124599671|NCT03176784|448153576|FG001|Overall Study|Lost to Follow-up|79|||
124599672|NCT03176784|448153577|FG002|Overall Study|Lost to Follow-up|79|||
124599673|NCT03176784|448153578|FG003|Overall Study|Lost to Follow-up|49|||
124599674|NCT03176784|448153575|FG000|Overall Study|Withdrawal by Subject|28|||
124599675|NCT03176784|448153576|FG001|Overall Study|Withdrawal by Subject|34|||
124599676|NCT03176784|448153577|FG002|Overall Study|Withdrawal by Subject|34|||
124599677|NCT03176784|448153578|FG003|Overall Study|Withdrawal by Subject|21|||
124599678|NCT03739138|448153580|FG000|Overall Study|Death|0|||
124599679|NCT03739138|448153581|FG001|Overall Study|Death|7|||
124599680|NCT03739138|448153582|FG002|Overall Study|Death|4|||
124599681|NCT03739138|448153583|FG003|Overall Study|Death|13|||
124599682|NCT03739138|448153584|FG004|Overall Study|Death|0|||
124599683|NCT03739138|448153580|FG000|Overall Study|Lost to Follow-up|0|||
124599684|NCT03739138|448153581|FG001|Overall Study|Lost to Follow-up|0|||
124599685|NCT03739138|448153582|FG002|Overall Study|Lost to Follow-up|1|||
124599686|NCT03739138|448153583|FG003|Overall Study|Lost to Follow-up|0|||
124599687|NCT03739138|448153584|FG004|Overall Study|Lost to Follow-up|0|||
124599688|NCT03739138|448153580|FG000|Overall Study|Study Terminated By Sponsor|0|||
124599689|NCT03739138|448153581|FG001|Overall Study|Study Terminated By Sponsor|0|||
124599690|NCT03739138|448153582|FG002|Overall Study|Study Terminated By Sponsor|0|||
124599691|NCT03739138|448153583|FG003|Overall Study|Study Terminated By Sponsor|4|||
124599692|NCT03739138|448153584|FG004|Overall Study|Study Terminated By Sponsor|0|||
124599693|NCT03739138|448153580|FG000|Overall Study|Withdrawal by Subject|0|||
124599694|NCT03739138|448153581|FG001|Overall Study|Withdrawal by Subject|0|||
124599695|NCT03739138|448153582|FG002|Overall Study|Withdrawal by Subject|0|||
124599696|NCT03739138|448153583|FG003|Overall Study|Withdrawal by Subject|1|||
124599697|NCT03739138|448153584|FG004|Overall Study|Withdrawal by Subject|0|||
124599698|NCT04403763|448153587|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
124599699|NCT04403763|448153588|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
124599700|NCT04403763|448153589|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
124599701|NCT04403763|448153590|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
124599702|NCT04403763|448153591|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
124599703|NCT04403763|448153592|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
124599704|NCT04403763|448153593|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
124599705|NCT04403763|448153587|FG000|Stage 1|Early termination due to PK tube failure|0|||
124599706|NCT04403763|448153588|FG001|Stage 1|Early termination due to PK tube failure|0|||
124599707|NCT04403763|448153589|FG002|Stage 1|Early termination due to PK tube failure|1|||
124599708|NCT04403763|448153590|FG003|Stage 1|Early termination due to PK tube failure|0|||
124599709|NCT04403763|448153591|FG004|Stage 1|Early termination due to PK tube failure|0|||
124599710|NCT04403763|448153592|FG005|Stage 1|Early termination due to PK tube failure|0|||
124599711|NCT04403763|448153593|FG006|Stage 1|Early termination due to PK tube failure|0|||
124599712|NCT04403763|448153587|FG000|Stage 2A|Adverse Event|0|||
124599713|NCT04403763|448153588|FG001|Stage 2A|Adverse Event|0|||
124599714|NCT04403763|448153589|FG002|Stage 2A|Adverse Event|0|||
124599715|NCT04403763|448153590|FG003|Stage 2A|Adverse Event|0|||
124599716|NCT04403763|448153591|FG004|Stage 2A|Adverse Event|0|||
124599717|NCT04403763|448153592|FG005|Stage 2A|Adverse Event|0|||
124599718|NCT04403763|448153593|FG006|Stage 2A|Adverse Event|1|||
124599719|NCT01376310|448153594|FG000|Overall Study|Study closed/terminated|1|||
124599720|NCT01376310|448153595|FG001|Overall Study|Study closed/terminated|2|||
124599721|NCT01376310|448153594|FG000|Overall Study|Withdrawal by Subject|8|||
124599722|NCT01376310|448153595|FG001|Overall Study|Withdrawal by Subject|2|||
124599723|NCT01376310|448153594|FG000|Overall Study|Physician Decision|26|||
124599724|NCT01376310|448153595|FG001|Overall Study|Physician Decision|7|||
124599725|NCT01376310|448153594|FG000|Overall Study|Lost to Follow-up|1|||
124599726|NCT01376310|448153595|FG001|Overall Study|Lost to Follow-up|0|||
124599727|NCT00767520|448153607|FG000|Overall Study|Participants still on treatment|11|||
124599728|NCT00767520|448153608|FG001|Overall Study|Participants still on treatment|15|||
124599729|NCT00767520|448153607|FG000|Overall Study|Randomized in error and Never treated|0|||
124599730|NCT00767520|448153608|FG001|Overall Study|Randomized in error and Never treated|2|||
124599731|NCT00958126|448153609|FG000|Overall Study|Serious Adverse Event|0|||
124599732|NCT00958126|448153610|FG001|Overall Study|Serious Adverse Event|2|||
124599733|NCT00958126|448153611|FG002|Overall Study|Serious Adverse Event|0|||
124599734|NCT00958126|448153612|FG003|Overall Study|Serious Adverse Event|0|||
124599735|NCT00958126|448153613|FG004|Overall Study|Serious Adverse Event|0|||
124599736|NCT00958126|448153614|FG005|Overall Study|Serious Adverse Event|0|||
124599737|NCT00958126|448153615|FG006|Overall Study|Serious Adverse Event|1|||
124599738|NCT00958126|448153616|FG007|Overall Study|Serious Adverse Event|0|||
124599739|NCT00958126|448153609|FG000|Overall Study|Withdrawal by Subject|0|||
124599740|NCT00958126|448153610|FG001|Overall Study|Withdrawal by Subject|2|||
124599741|NCT00958126|448153611|FG002|Overall Study|Withdrawal by Subject|0|||
124599742|NCT00958126|448153612|FG003|Overall Study|Withdrawal by Subject|0|||
124599743|NCT00958126|448153613|FG004|Overall Study|Withdrawal by Subject|0|||
124599744|NCT00958126|448153614|FG005|Overall Study|Withdrawal by Subject|0|||
124599745|NCT00958126|448153615|FG006|Overall Study|Withdrawal by Subject|0|||
124599746|NCT00958126|448153616|FG007|Overall Study|Withdrawal by Subject|0|||
124599747|NCT00958126|448153609|FG000|Overall Study|Moved away from study area|0|||
124599748|NCT00958126|448153610|FG001|Overall Study|Moved away from study area|0|||
124599749|NCT00958126|448153611|FG002|Overall Study|Moved away from study area|1|||
124599750|NCT00958126|448153612|FG003|Overall Study|Moved away from study area|1|||
124599751|NCT00958126|448153613|FG004|Overall Study|Moved away from study area|0|||
124599752|NCT00958126|448153614|FG005|Overall Study|Moved away from study area|0|||
124599753|NCT00958126|448153615|FG006|Overall Study|Moved away from study area|0|||
124599754|NCT00958126|448153616|FG007|Overall Study|Moved away from study area|0|||
124599755|NCT00958126|448153609|FG000|Overall Study|Lost to Follow-up|1|||
124599756|NCT00958126|448153610|FG001|Overall Study|Lost to Follow-up|5|||
124599757|NCT00958126|448153611|FG002|Overall Study|Lost to Follow-up|9|||
124599758|NCT00958126|448153612|FG003|Overall Study|Lost to Follow-up|8|||
124599759|NCT00958126|448153613|FG004|Overall Study|Lost to Follow-up|0|||
124599760|NCT00958126|448153614|FG005|Overall Study|Lost to Follow-up|0|||
124599761|NCT00958126|448153615|FG006|Overall Study|Lost to Follow-up|0|||
124599762|NCT00958126|448153616|FG007|Overall Study|Lost to Follow-up|0|||
124599763|NCT00958126|448153609|FG000|Overall Study|Sponsor/Investigator decision|0|||
124599764|NCT00958126|448153610|FG001|Overall Study|Sponsor/Investigator decision|0|||
124599765|NCT00958126|448153611|FG002|Overall Study|Sponsor/Investigator decision|0|||
124599766|NCT00958126|448153612|FG003|Overall Study|Sponsor/Investigator decision|1|||
124599767|NCT00958126|448153613|FG004|Overall Study|Sponsor/Investigator decision|0|||
124599768|NCT00958126|448153614|FG005|Overall Study|Sponsor/Investigator decision|0|||
124599769|NCT00958126|448153615|FG006|Overall Study|Sponsor/Investigator decision|0|||
124599770|NCT00958126|448153616|FG007|Overall Study|Sponsor/Investigator decision|0|||
124599771|NCT00958126|448153609|FG000|Overall Study|Other Reason|0|||
124780678|NCT02930018|448825454|FG000|Overall Study|Withdrawal by Subject|5|||
124780679|NCT02930018|448825455|FG001|Overall Study|Withdrawal by Subject|2|||
124599772|NCT00958126|448153610|FG001|Overall Study|Other Reason|0|||
124599773|NCT00958126|448153611|FG002|Overall Study|Other Reason|0|||
124599774|NCT00958126|448153612|FG003|Overall Study|Other Reason|1|||
124599775|NCT00958126|448153613|FG004|Overall Study|Other Reason|0|||
124599776|NCT00958126|448153614|FG005|Overall Study|Other Reason|1|||
124599777|NCT00958126|448153615|FG006|Overall Study|Other Reason|0|||
124599778|NCT00958126|448153616|FG007|Overall Study|Other Reason|0|||
124599779|NCT00720226|448153617|FG000|Overall Study|Withdrawal by Subject|7|||
124599780|NCT00720226|448153618|FG001|Overall Study|Withdrawal by Subject|4|||
124599781|NCT03401073|448153619|FG000|Overall Study|Lost to Follow-up|1|||
124599782|NCT03401073|448153620|FG001|Overall Study|Lost to Follow-up|2|||
124599783|NCT00733369|448153623|FG000|Overall Study|Lost to Follow-up|2|||
124780680|NCT04193189|448825457|FG000|Overall Study|Lost to Follow-up|9|||
124780681|NCT04193189|448825458|FG001|Overall Study|Lost to Follow-up|7|||
124780682|NCT04193189|448825459|FG002|Overall Study|Lost to Follow-up|9|||
124780683|NCT04193189|448825460|FG003|Overall Study|Lost to Follow-up|0|||
124780684|NCT04193189|448825457|FG000|Overall Study|Withdrawal by Subject|1|||
124780685|NCT04193189|448825458|FG001|Overall Study|Withdrawal by Subject|2|||
124780686|NCT04193189|448825459|FG002|Overall Study|Withdrawal by Subject|2|||
124780687|NCT04193189|448825460|FG003|Overall Study|Withdrawal by Subject|0|||
124780688|NCT04193189|448825457|FG000|Overall Study|Death|1|||
124780689|NCT04193189|448825458|FG001|Overall Study|Death|1|||
124780690|NCT04193189|448825459|FG002|Overall Study|Death|0|||
124780691|NCT04193189|448825460|FG003|Overall Study|Death|0|||
124780692|NCT04193189|448825457|FG000|Overall Study|Protocol Violation|0|||
124780693|NCT04193189|448825458|FG001|Overall Study|Protocol Violation|0|||
124780694|NCT04193189|448825459|FG002|Overall Study|Protocol Violation|0|||
124780695|NCT04193189|448825460|FG003|Overall Study|Protocol Violation|1|||
124780696|NCT00539864|448826989|FG000|Overall Study|Lost to Follow-up|0|||
124780697|NCT00539864|448826990|FG001|Overall Study|Lost to Follow-up|1|||
124780698|NCT00539864|448826989|FG000|Overall Study|Withdrawal by Subject|1|||
124780699|NCT00539864|448826990|FG001|Overall Study|Withdrawal by Subject|1|||
124780700|NCT02565784|448826991|FG000|First Treatment|Adverse Event|1|||
124780701|NCT02565784|448826991|FG000|First Treatment|Withdrawal by Subject|1|||
124599784|NCT00733369|448153624|FG001|Overall Study|Lost to Follow-up|1|||
124599785|NCT00733369|448153623|FG000|Overall Study|Adverse Event|4|||
124599786|NCT00733369|448153624|FG001|Overall Study|Adverse Event|4|||
124599787|NCT00733369|448153623|FG000|Overall Study|Protocol Violation|4|||
124599788|NCT00733369|448153624|FG001|Overall Study|Protocol Violation|4|||
124599789|NCT02510014|448153628|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
124599790|NCT02510014|448153629|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
124599791|NCT02510014|448153628|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
124599792|NCT02510014|448153629|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
124599793|NCT02510014|448153628|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
124599794|NCT02510014|448153629|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
124599795|NCT02510014|448153628|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
124599796|NCT02510014|448153629|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
124599797|NCT02510014|448153628|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
124599798|NCT02510014|448153629|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
124599799|NCT02510014|448153628|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
124599800|NCT02510014|448153629|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
124599801|NCT02510014|448153628|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
124599802|NCT02510014|448153629|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
124599803|NCT02510014|448153628|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
124599804|NCT02510014|448153629|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
124599805|NCT02510014|448153628|FG000|Treatment Period|Adverse Event|11|||
124599806|NCT02510014|448153629|FG001|Treatment Period|Adverse Event|4|||
124599807|NCT02510014|448153628|FG000|Treatment Period|Withdrawal symptoms|3|||
124599808|NCT02510014|448153629|FG001|Treatment Period|Withdrawal symptoms|0|||
124599809|NCT02510014|448153628|FG000|Treatment Period|Lost to Follow-up|80|||
124599810|NCT02510014|448153629|FG001|Treatment Period|Lost to Follow-up|19|||
124599811|NCT02510014|448153628|FG000|Treatment Period|Physician Decision|5|||
124599812|NCT02510014|448153629|FG001|Treatment Period|Physician Decision|0|||
124599813|NCT02510014|448153628|FG000|Treatment Period|Withdrawal by Subject|67|||
124599814|NCT02510014|448153629|FG001|Treatment Period|Withdrawal by Subject|24|||
124599815|NCT02510014|448153628|FG000|Treatment Period|Withdrawn by the investigator|7|||
124599816|NCT02510014|448153629|FG001|Treatment Period|Withdrawn by the investigator|1|||
124599817|NCT02510014|448153628|FG000|Treatment Period|Protocol Violation|4|||
124599818|NCT02510014|448153629|FG001|Treatment Period|Protocol Violation|4|||
124599819|NCT02510014|448153628|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
124599820|NCT02510014|448153629|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
124599821|NCT01875471|448153633|FG000|Overall Study|Adverse Event|0|||
124599822|NCT01875471|448153634|FG001|Overall Study|Adverse Event|1|||
124599823|NCT01875471|448153633|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
124599824|NCT01875471|448153634|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
124780702|NCT02565784|448826991|FG000|Second Treatment|Withdrawal by Subject|2|||
124780703|NCT00943072|448826997|FG000|Overall Study|Adverse Event|0|||
124780704|NCT00943072|448826998|FG001|Overall Study|Adverse Event|3|||
124599825|NCT04179019|448153636|FG000|Overall Study|Lost to Follow-up|2|||
124599826|NCT04179019|448153636|FG000|Overall Study|Physician Decision|2|||
124599827|NCT04179019|448153636|FG000|Overall Study|Withdrawal by Subject|5|||
124599828|NCT04179019|448153636|FG000|Overall Study|Adverse Event|4|||
124599829|NCT02083926|448153637|FG000|Overall Study|Withdrawal by Subject|1|||
124599830|NCT02083926|448153638|FG001|Overall Study|Withdrawal by Subject|0|||
124599831|NCT02610816|448153639|FG000|Phase 1|Withdrawal by Subject|2|||
124599832|NCT02610816|448153640|FG001|Phase 1|Withdrawal by Subject|6|||
124780705|NCT00943072|448826997|FG000|Overall Study|Death|0|||
124780706|NCT00943072|448826998|FG001|Overall Study|Death|2|||
124599833|NCT02610816|448153641|FG002|Phase 1|Withdrawal by Subject|0|||
124599834|NCT02610816|448153642|FG003|Phase 1|Withdrawal by Subject|0|||
124599835|NCT02610816|448153639|FG000|Phase 1|Lost to Follow-up|2|||
124599836|NCT02610816|448153640|FG001|Phase 1|Lost to Follow-up|1|||
124599837|NCT02610816|448153641|FG002|Phase 1|Lost to Follow-up|0|||
124599838|NCT02610816|448153642|FG003|Phase 1|Lost to Follow-up|0|||
124599839|NCT02610816|448153639|FG000|Phase 1|Physician Decision|0|||
124599840|NCT02610816|448153640|FG001|Phase 1|Physician Decision|1|||
124599841|NCT02610816|448153641|FG002|Phase 1|Physician Decision|0|||
124599842|NCT02610816|448153642|FG003|Phase 1|Physician Decision|0|||
124599843|NCT02610816|448153639|FG000|Phase 2|Withdrawal by Subject|0|||
124599844|NCT02610816|448153640|FG001|Phase 2|Withdrawal by Subject|0|||
124599845|NCT02610816|448153641|FG002|Phase 2|Withdrawal by Subject|9|||
124599846|NCT02610816|448153642|FG003|Phase 2|Withdrawal by Subject|3|||
124599847|NCT02610816|448153639|FG000|Phase 2|Lost to Follow-up|0|||
124599848|NCT02610816|448153640|FG001|Phase 2|Lost to Follow-up|0|||
124599849|NCT02610816|448153641|FG002|Phase 2|Lost to Follow-up|2|||
124599850|NCT02610816|448153642|FG003|Phase 2|Lost to Follow-up|0|||
124599851|NCT02610816|448153639|FG000|Phase 2|Physician Decision|0|||
124599852|NCT02610816|448153640|FG001|Phase 2|Physician Decision|0|||
124599853|NCT02610816|448153641|FG002|Phase 2|Physician Decision|0|||
124599854|NCT02610816|448153642|FG003|Phase 2|Physician Decision|2|||
124599855|NCT02610816|448153639|FG000|Phase 2|Pregnancy|0|||
124599856|NCT02610816|448153640|FG001|Phase 2|Pregnancy|0|||
124599857|NCT02610816|448153641|FG002|Phase 2|Pregnancy|0|||
124599858|NCT02610816|448153642|FG003|Phase 2|Pregnancy|1|||
124599859|NCT01949116|448153643|FG000|Overall Study|Death|2|||
124599860|NCT01949116|448153644|FG001|Overall Study|Death|0|||
124599861|NCT01949116|448153643|FG000|Overall Study|Lost to Follow-up|1|||
124599862|NCT01949116|448153644|FG001|Overall Study|Lost to Follow-up|3|||
124599863|NCT01949116|448153643|FG000|Overall Study|Withdrawal by Subject|5|||
124599864|NCT01949116|448153644|FG001|Overall Study|Withdrawal by Subject|3|||
124599865|NCT03438227|448153646|FG000|Overall Study|Withdrawal by Subject|10|||
124599866|NCT03438227|448153647|FG001|Overall Study|Withdrawal by Subject|5|||
124599867|NCT00049842|448153648|FG000|Treatment Phase|Adverse Event|47|||
124599868|NCT00049842|448153649|FG001|Treatment Phase|Adverse Event|12|||
124599869|NCT00049842|448153648|FG000|Treatment Phase|Withdrawal by Subject|35|||
124599870|NCT00049842|448153649|FG001|Treatment Phase|Withdrawal by Subject|46|||
124599871|NCT00049842|448153648|FG000|Treatment Phase|Non-compliance with protocol|7|||
124599872|NCT00049842|448153649|FG001|Treatment Phase|Non-compliance with protocol|8|||
124599873|NCT00049842|448153648|FG000|Treatment Phase|Lost to Follow-up|4|||
124599874|NCT00049842|448153649|FG001|Treatment Phase|Lost to Follow-up|8|||
124599875|NCT00049842|448153648|FG000|Treatment Phase|Administrative|0|||
124599876|NCT00049842|448153649|FG001|Treatment Phase|Administrative|3|||
124599877|NCT00049842|448153648|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
124599878|NCT00049842|448153649|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
124599879|NCT00049842|448153648|FG000|Follow-up Phase|Adverse Event|6|||
124599880|NCT00049842|448153649|FG001|Follow-up Phase|Adverse Event|1|||
124599881|NCT00049842|448153648|FG000|Follow-up Phase|Other|1|||
124599882|NCT00049842|448153649|FG001|Follow-up Phase|Other|4|||
124599883|NCT01813071|448153650|FG000|Overall Study|Protocol Violation|0|||
124599884|NCT01813071|448153651|FG001|Overall Study|Protocol Violation|0|||
124599885|NCT01813071|448153652|FG002|Overall Study|Protocol Violation|0|||
124599886|NCT01813071|448153653|FG003|Overall Study|Protocol Violation|0|||
124599887|NCT01813071|448153654|FG004|Overall Study|Protocol Violation|1|||
124599888|NCT01813071|448153655|FG005|Overall Study|Protocol Violation|4|||
124599889|NCT01813071|448153656|FG006|Overall Study|Protocol Violation|2|||
124599890|NCT01813071|448153657|FG007|Overall Study|Protocol Violation|4|||
124599891|NCT01813071|448153658|FG008|Overall Study|Protocol Violation|2|||
124599892|NCT01813071|448153650|FG000|Overall Study|Withdrawal by Subject|0|||
124599893|NCT01813071|448153651|FG001|Overall Study|Withdrawal by Subject|0|||
124599894|NCT01813071|448153652|FG002|Overall Study|Withdrawal by Subject|0|||
124599895|NCT01813071|448153653|FG003|Overall Study|Withdrawal by Subject|0|||
124599896|NCT01813071|448153654|FG004|Overall Study|Withdrawal by Subject|0|||
124599897|NCT01813071|448153655|FG005|Overall Study|Withdrawal by Subject|1|||
124599898|NCT01813071|448153656|FG006|Overall Study|Withdrawal by Subject|0|||
124599899|NCT01813071|448153657|FG007|Overall Study|Withdrawal by Subject|0|||
124599900|NCT01813071|448153658|FG008|Overall Study|Withdrawal by Subject|0|||
124599901|NCT01813071|448153650|FG000|Overall Study|Adverse Event|0|||
124599902|NCT01813071|448153651|FG001|Overall Study|Adverse Event|0|||
124599903|NCT01813071|448153652|FG002|Overall Study|Adverse Event|0|||
124599904|NCT01813071|448153653|FG003|Overall Study|Adverse Event|0|||
124599905|NCT01813071|448153654|FG004|Overall Study|Adverse Event|0|||
124599906|NCT01813071|448153655|FG005|Overall Study|Adverse Event|1|||
124599907|NCT01813071|448153656|FG006|Overall Study|Adverse Event|0|||
124731170|NCT02499900|448637525|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
124599908|NCT01813071|448153657|FG007|Overall Study|Adverse Event|0|||
124599909|NCT01813071|448153658|FG008|Overall Study|Adverse Event|0|||
124599910|NCT01813071|448153650|FG000|Overall Study|Physician Decision|0|||
124599911|NCT01813071|448153651|FG001|Overall Study|Physician Decision|0|||
124599912|NCT01813071|448153652|FG002|Overall Study|Physician Decision|0|||
124599913|NCT01813071|448153653|FG003|Overall Study|Physician Decision|0|||
124599914|NCT01813071|448153654|FG004|Overall Study|Physician Decision|0|||
124599915|NCT01813071|448153655|FG005|Overall Study|Physician Decision|0|||
124599916|NCT01813071|448153656|FG006|Overall Study|Physician Decision|1|||
124599917|NCT01813071|448153657|FG007|Overall Study|Physician Decision|0|||
124599918|NCT01813071|448153658|FG008|Overall Study|Physician Decision|0|||
124599919|NCT01813071|448153650|FG000|Overall Study|Met inc/exc criteria|0|||
124599920|NCT01813071|448153651|FG001|Overall Study|Met inc/exc criteria|0|||
124599921|NCT01813071|448153652|FG002|Overall Study|Met inc/exc criteria|0|||
124599922|NCT01813071|448153653|FG003|Overall Study|Met inc/exc criteria|0|||
124599923|NCT01813071|448153654|FG004|Overall Study|Met inc/exc criteria|0|||
124599924|NCT01813071|448153655|FG005|Overall Study|Met inc/exc criteria|1|||
124599925|NCT01813071|448153656|FG006|Overall Study|Met inc/exc criteria|0|||
124599926|NCT01813071|448153657|FG007|Overall Study|Met inc/exc criteria|1|||
124599927|NCT01813071|448153658|FG008|Overall Study|Met inc/exc criteria|1|||
124599928|NCT00613834|448153659|FG000|Overall Study|Withdrawal by Subject|0|||
124599929|NCT00613834|448153660|FG001|Overall Study|Withdrawal by Subject|3|||
124599930|NCT00842530|448153661|FG000|Overall Study|Serious adverse event|0|||
124599931|NCT00842530|448153662|FG001|Overall Study|Serious adverse event|6|||
124599932|NCT00842530|448153661|FG000|Overall Study|Other adverse event|6|||
124599933|NCT00842530|448153662|FG001|Overall Study|Other adverse event|1|||
124599934|NCT00842530|448153661|FG000|Overall Study|Protocol Violation|32|||
124599935|NCT00842530|448153662|FG001|Overall Study|Protocol Violation|14|||
124599936|NCT00842530|448153661|FG000|Overall Study|Lost to Follow-up|6|||
124599937|NCT00842530|448153662|FG001|Overall Study|Lost to Follow-up|8|||
124599938|NCT00842530|448153661|FG000|Overall Study|Withdrawal by Subject|73|||
124599939|NCT00842530|448153662|FG001|Overall Study|Withdrawal by Subject|28|||
124599940|NCT02939950|448153665|FG000|Overall Study|Lost to Follow-up|13|||
124599941|NCT02939950|448153666|FG001|Overall Study|Lost to Follow-up|16|||
124599942|NCT02939950|448153665|FG000|Overall Study|Positive slit lamp findings|0|||
124599943|NCT02939950|448153666|FG001|Overall Study|Positive slit lamp findings|1|||
124599944|NCT02939950|448153665|FG000|Overall Study|Chalazion upper lid|0|||
124599945|NCT02939950|448153666|FG001|Overall Study|Chalazion upper lid|1|||
124599946|NCT02939950|448153665|FG000|Overall Study|Lack of motivation|0|||
124731171|NCT02499900|448637524|FG000|Extension Study Period|Adverse Event|2|||
124731172|NCT02499900|448637525|FG001|Extension Study Period|Adverse Event|4|||
124731173|NCT02499900|448637524|FG000|Extension Study Period|Withdrawal by Subject|5|||
124731174|NCT02499900|448637525|FG001|Extension Study Period|Withdrawal by Subject|2|||
124731175|NCT02499900|448637524|FG000|Extension Study Period|Physician Decision|2|||
124731176|NCT02499900|448637525|FG001|Extension Study Period|Physician Decision|5|||
124731177|NCT02499900|448637524|FG000|Extension Study Period|Pregnancy|1|||
124731178|NCT02499900|448637525|FG001|Extension Study Period|Pregnancy|2|||
124731179|NCT02499900|448637524|FG000|Extension Study Period|Lost to Follow-up|2|||
124731180|NCT02499900|448637525|FG001|Extension Study Period|Lost to Follow-up|5|||
124731181|NCT02499900|448637524|FG000|Extension Study Period|Other|0|||
124731182|NCT02499900|448637525|FG001|Extension Study Period|Other|2|||
124731183|NCT02439450|448637528|FG000|Overall Study|Adverse Event|4|||
124731184|NCT02439450|448637529|FG001|Overall Study|Adverse Event|1|||
124731185|NCT02439450|448637530|FG002|Overall Study|Adverse Event|0|||
124731186|NCT02439450|448637531|FG003|Overall Study|Adverse Event|0|||
124731187|NCT02439450|448637528|FG000|Overall Study|Withdrawal by Subject|1|||
124731188|NCT02439450|448637529|FG001|Overall Study|Withdrawal by Subject|2|||
124731189|NCT02439450|448637530|FG002|Overall Study|Withdrawal by Subject|0|||
124731190|NCT02439450|448637531|FG003|Overall Study|Withdrawal by Subject|0|||
124731191|NCT02439450|448637528|FG000|Overall Study|Death|3|||
124731192|NCT02439450|448637529|FG001|Overall Study|Death|0|||
124731193|NCT02439450|448637530|FG002|Overall Study|Death|0|||
124731194|NCT02439450|448637531|FG003|Overall Study|Death|1|||
124731195|NCT02439450|448637528|FG000|Overall Study|Progressive Disease|18|||
124731196|NCT02439450|448637529|FG001|Overall Study|Progressive Disease|41|||
124731197|NCT02439450|448637530|FG002|Overall Study|Progressive Disease|2|||
124731198|NCT02439450|448637531|FG003|Overall Study|Progressive Disease|3|||
124731199|NCT01170065|448637534|FG000|Overall Study|Adverse Event|17|||
124731200|NCT01170065|448637535|FG001|Overall Study|Adverse Event|50|||
124599947|NCT02939950|448153666|FG001|Overall Study|Lack of motivation|2|||
124731201|NCT01170065|448637536|FG002|Overall Study|Adverse Event|10|||
124731202|NCT01170065|448637534|FG000|Overall Study|Lost to Follow-up|1|||
124731203|NCT01170065|448637535|FG001|Overall Study|Lost to Follow-up|4|||
124731204|NCT01170065|448637536|FG002|Overall Study|Lost to Follow-up|1|||
124731205|NCT01170065|448637534|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
124731206|NCT01170065|448637535|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
124731207|NCT01170065|448637536|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
124731208|NCT01170065|448637534|FG000|Overall Study|Reason other than specified|3|||
124599948|NCT02939950|448153665|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
124599949|NCT02939950|448153666|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
124731209|NCT01170065|448637535|FG001|Overall Study|Reason other than specified|8|||
124599950|NCT02939950|448153665|FG000|Overall Study|Military orders|1|||
124599951|NCT02939950|448153666|FG001|Overall Study|Military orders|0|||
124599952|NCT02939950|448153665|FG000|Overall Study|Participant Relocated|5|||
124599953|NCT02939950|448153666|FG001|Overall Study|Participant Relocated|3|||
124599954|NCT02939950|448153665|FG000|Overall Study|Study related symptoms|8|||
124599955|NCT02939950|448153666|FG001|Overall Study|Study related symptoms|8|||
124599956|NCT02939950|448153665|FG000|Overall Study|Unacceptable lens movement|2|||
124599957|NCT02939950|448153666|FG001|Overall Study|Unacceptable lens movement|0|||
124599958|NCT02939950|448153665|FG000|Overall Study|Protocol Violation|6|||
124599959|NCT02939950|448153666|FG001|Overall Study|Protocol Violation|3|||
124599960|NCT02939950|448153665|FG000|Overall Study|Physician Decision|2|||
124599961|NCT02939950|448153666|FG001|Overall Study|Physician Decision|0|||
124599962|NCT02939950|448153665|FG000|Overall Study|Pregnancy|6|||
124599963|NCT02939950|448153666|FG001|Overall Study|Pregnancy|7|||
124599964|NCT02939950|448153665|FG000|Overall Study|Withdrawal by Subject|12|||
124599965|NCT02939950|448153666|FG001|Overall Study|Withdrawal by Subject|28|||
124599966|NCT02939950|448153665|FG000|Overall Study|Adverse Event|7|||
124599967|NCT02939950|448153666|FG001|Overall Study|Adverse Event|3|||
124599968|NCT02939950|448153665|FG000|Overall Study|Randomized, not dispensed|1|||
124599969|NCT02939950|448153666|FG001|Overall Study|Randomized, not dispensed|0|||
124599970|NCT02939950|448153665|FG000|Overall Study|Ineligible at Baseline|2|||
124599971|NCT02939950|448153666|FG001|Overall Study|Ineligible at Baseline|8|||
124599972|NCT01660022|448153670|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
124599973|NCT01660022|448153671|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
124599974|NCT01660022|448153672|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
124599975|NCT01660022|448153673|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
124599976|NCT01660022|448153674|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
124599977|NCT01660022|448153675|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
124731210|NCT01170065|448637536|FG002|Overall Study|Reason other than specified|3|||
124731211|NCT01170065|448637534|FG000|Overall Study|Ongoing after planned observation time|5|||
124731212|NCT01170065|448637535|FG001|Overall Study|Ongoing after planned observation time|26|||
124731213|NCT01170065|448637536|FG002|Overall Study|Ongoing after planned observation time|10|||
124731214|NCT04258995|448640044|FG000|Overall Study|Lost to Follow-up|1|||
124731215|NCT04258995|448640045|FG001|Overall Study|Lost to Follow-up|1|||
124731216|NCT00642174|448640055|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
124731217|NCT00642174|448640056|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
124731218|NCT00896363|448640057|FG000|Overall Study|Adverse Event|3|||
124731219|NCT00896363|448640058|FG001|Overall Study|Adverse Event|4|||
124731220|NCT00896363|448640059|FG002|Overall Study|Adverse Event|2|||
124731221|NCT00896363|448640057|FG000|Overall Study|Lack of Efficacy|0|||
124731222|NCT00896363|448640058|FG001|Overall Study|Lack of Efficacy|2|||
124731223|NCT00896363|448640059|FG002|Overall Study|Lack of Efficacy|1|||
124731224|NCT00896363|448640057|FG000|Overall Study|Withdrawal by Subject|3|||
124731225|NCT00896363|448640058|FG001|Overall Study|Withdrawal by Subject|5|||
124731226|NCT00896363|448640059|FG002|Overall Study|Withdrawal by Subject|5|||
124731227|NCT02982018|448640060|FG000|Overall Study|Incorrect Lens Dispensed|1|||
124731228|NCT02982018|448640061|FG001|Overall Study|Incorrect Lens Dispensed|0|||
124731229|NCT02982018|448640060|FG000|Overall Study|Protocol Violation|1|||
124731230|NCT02982018|448640061|FG001|Overall Study|Protocol Violation|1|||
124731231|NCT02982018|448640060|FG000|Overall Study|Adverse Event|1|||
124731232|NCT02982018|448640061|FG001|Overall Study|Adverse Event|1|||
124731233|NCT02982018|448640060|FG000|Overall Study|Lens Discomfort|2|||
124731234|NCT02982018|448640061|FG001|Overall Study|Lens Discomfort|0|||
124731235|NCT02982018|448640060|FG000|Overall Study|Withdrawal by Subject|0|||
124731236|NCT02982018|448640061|FG001|Overall Study|Withdrawal by Subject|1|||
124731237|NCT03334851|448640064|FG000|Overall Study|Other|0|||
124731238|NCT03334851|448640065|FG001|Overall Study|Other|0|||
124731239|NCT03334851|448640066|FG002|Overall Study|Other|0|||
124731240|NCT03334851|448640067|FG003|Overall Study|Other|0|||
124731241|NCT03334851|448640068|FG004|Overall Study|Other|0|||
124731242|NCT03334851|448640069|FG005|Overall Study|Other|0|||
124731243|NCT03334851|448640070|FG006|Overall Study|Other|0|||
124731244|NCT03334851|448640071|FG007|Overall Study|Other|1|||
124731245|NCT03334851|448640072|FG008|Overall Study|Other|0|||
124731246|NCT03334851|448640073|FG009|Overall Study|Other|0|||
124731247|NCT03334851|448640074|FG010|Overall Study|Other|0|||
124731248|NCT03334851|448640075|FG011|Overall Study|Other|0|||
124731249|NCT03334851|448640076|FG012|Overall Study|Other|0|||
124731250|NCT03334851|448640064|FG000|Overall Study|Adverse Event|0|||
124731251|NCT03334851|448640065|FG001|Overall Study|Adverse Event|0|||
124731252|NCT03334851|448640066|FG002|Overall Study|Adverse Event|0|||
124599978|NCT01660022|448153670|FG000|First Sequence (7 Days)|Adverse Event|0|||
124599979|NCT01660022|448153671|FG001|First Sequence (7 Days)|Adverse Event|0|||
124731253|NCT03334851|448640067|FG003|Overall Study|Adverse Event|0|||
124731254|NCT03334851|448640068|FG004|Overall Study|Adverse Event|0|||
124731255|NCT03334851|448640069|FG005|Overall Study|Adverse Event|0|||
124731256|NCT03334851|448640070|FG006|Overall Study|Adverse Event|0|||
124599980|NCT01660022|448153672|FG002|First Sequence (7 Days)|Adverse Event|0|||
124731257|NCT03334851|448640071|FG007|Overall Study|Adverse Event|1|||
124731258|NCT03334851|448640072|FG008|Overall Study|Adverse Event|0|||
124731259|NCT03334851|448640073|FG009|Overall Study|Adverse Event|0|||
124599981|NCT01660022|448153673|FG003|First Sequence (7 Days)|Adverse Event|0|||
124599982|NCT01660022|448153674|FG004|First Sequence (7 Days)|Adverse Event|1|||
124599983|NCT01660022|448153675|FG005|First Sequence (7 Days)|Adverse Event|3|||
124599984|NCT01660022|448153670|FG000|First Sequence (7 Days)|Protocol Violation|0|||
124599985|NCT01660022|448153671|FG001|First Sequence (7 Days)|Protocol Violation|0|||
124599986|NCT01660022|448153672|FG002|First Sequence (7 Days)|Protocol Violation|0|||
124599987|NCT01660022|448153673|FG003|First Sequence (7 Days)|Protocol Violation|0|||
124599988|NCT01660022|448153674|FG004|First Sequence (7 Days)|Protocol Violation|0|||
124599989|NCT01660022|448153675|FG005|First Sequence (7 Days)|Protocol Violation|1|||
124599990|NCT00766831|448153680|FG000|Overall Study|Withdrawal by Subject|4|||
124599991|NCT00766831|448153680|FG000|Overall Study|Lost to Follow-up|3|||
124599992|NCT00766831|448153680|FG000|Overall Study|Adverse Event|20|||
124599993|NCT00766831|448153680|FG000|Overall Study|Protocol Violation|15|||
124599994|NCT00766831|448153680|FG000|Overall Study|Physician Decision|5|||
124599995|NCT00766831|448153680|FG000|Overall Study|Withdrawal of consent|26|||
124599996|NCT00766831|448153680|FG000|Overall Study|Non cooperation by participants|14|||
124599997|NCT00766831|448153680|FG000|Overall Study|Other|28|||
124599998|NCT00788593|448153681|FG000|Placebo Run-in Phase|Adverse Event|2|||
124599999|NCT00788593|448153682|FG001|Placebo Run-in Phase|Adverse Event|0|||
124600000|NCT00788593|448153683|FG002|Placebo Run-in Phase|Adverse Event|0|||
124600001|NCT00788593|448153681|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
124600002|NCT00788593|448153682|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
124600003|NCT00788593|448153683|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
124600004|NCT00788593|448153681|FG000|Placebo Run-in Phase|Protocol Violation|2|||
124600005|NCT00788593|448153682|FG001|Placebo Run-in Phase|Protocol Violation|0|||
124600006|NCT00788593|448153683|FG002|Placebo Run-in Phase|Protocol Violation|0|||
124600007|NCT00788593|448153681|FG000|First Intervention Period|Adverse Event|0|||
124600008|NCT00788593|448153682|FG001|First Intervention Period|Adverse Event|1|||
124600009|NCT00788593|448153683|FG002|First Intervention Period|Adverse Event|0|||
124600010|NCT00788593|448153681|FG000|Second Intervention Period|Lost to Follow-up|0|||
124600011|NCT00788593|448153682|FG001|Second Intervention Period|Lost to Follow-up|1|||
124600012|NCT00788593|448153683|FG002|Second Intervention Period|Lost to Follow-up|0|||
124600013|NCT00788593|448153681|FG000|Second Intervention Period|Other|0|||
124600014|NCT00788593|448153682|FG001|Second Intervention Period|Other|0|||
124600015|NCT00788593|448153683|FG002|Second Intervention Period|Other|1|||
124600016|NCT04553913|448153690|FG000|Overall Study|patient's block resolved prior to PACU|1|||
124600017|NCT04553913|448153690|FG000|Overall Study|did not use the device properly|5|||
124600018|NCT00094094|448153691|FG000|Overall Study|Death|2|||
124600019|NCT00094094|448153691|FG000|Overall Study|Lack of Efficacy|23|||
124600020|NCT00094094|448153691|FG000|Overall Study|Adverse Event|7|||
124600021|NCT00710749|448153692|FG000|First Intervention|Withdrawal by Subject|1|||
124600022|NCT00710749|448153693|FG001|First Intervention|Withdrawal by Subject|0|||
124600023|NCT01000610|448156090|FG000|Overall Study|Adverse Event|1|||
124600024|NCT01000610|448156090|FG000|Overall Study|Lost to Follow-up|4|||
124600025|NCT01000610|448156090|FG000|Overall Study|Treatment failure|1|||
124600026|NCT02631876|448156097|FG000|Overall Study|Death|96|||
124600027|NCT02631876|448156098|FG001|Overall Study|Death|50|||
124600028|NCT02631876|448156097|FG000|Overall Study|Investigator's discretion|1|||
124600029|NCT02631876|448156098|FG001|Overall Study|Investigator's discretion|0|||
124600030|NCT02631876|448156097|FG000|Overall Study|Lost to Follow-up|2|||
124600031|NCT02631876|448156098|FG001|Overall Study|Lost to Follow-up|0|||
124600032|NCT02631876|448156097|FG000|Overall Study|Withdrawal by Subject|16|||
124600033|NCT02631876|448156098|FG001|Overall Study|Withdrawal by Subject|9|||
124600034|NCT02631876|448156097|FG000|Overall Study|Other than specified|4|||
124600035|NCT02631876|448156098|FG001|Overall Study|Other than specified|4|||
124600036|NCT01592721|448156099|FG000|Long-term Follow-up|Death|1|||
124600037|NCT01408563|448156104|FG000|Overall Study|Ineligible after consent/ registration|2|||
124600038|NCT01432574|448156105|FG000|Overall Study|Moved|2|||
124600039|NCT01432574|448156105|FG000|Overall Study|Not interested|1|||
124600040|NCT02516410|448156106|FG000|Overall Study|Adverse Event|0|||
124600041|NCT02516410|448156107|FG001|Overall Study|Adverse Event|1|||
124600042|NCT02516410|448156106|FG000|Overall Study|Withdrawal by Subject|0|||
124600043|NCT02516410|448156107|FG001|Overall Study|Withdrawal by Subject|1|||
124731260|NCT03334851|448640074|FG010|Overall Study|Adverse Event|0|||
124731261|NCT03334851|448640075|FG011|Overall Study|Adverse Event|0|||
124600044|NCT02698865|448156116|FG000|Overall Study|Other|11|||
124600045|NCT02698865|448156117|FG001|Overall Study|Other|11|||
124600046|NCT02698865|448156116|FG000|Overall Study|Withdrawal by Subject|20|||
124600047|NCT02698865|448156117|FG001|Overall Study|Withdrawal by Subject|16|||
124600048|NCT02698865|448156116|FG000|Overall Study|Physician Decision|0|||
124600049|NCT02698865|448156117|FG001|Overall Study|Physician Decision|4|||
124600050|NCT02698865|448156116|FG000|Overall Study|Lost to Follow-up|4|||
124600051|NCT02698865|448156117|FG001|Overall Study|Lost to Follow-up|2|||
124600052|NCT03861481|448156118|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
124600053|NCT03861481|448156119|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
124600054|NCT03861481|448156118|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
124600055|NCT03861481|448156119|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
124600056|NCT03861481|448156118|FG000|Overall Study|Relapse|1|||
124600057|NCT03861481|448156119|FG001|Overall Study|Relapse|0|||
124600058|NCT03861481|448156118|FG000|Overall Study|Withdrawal by Subject|0|||
124600059|NCT03861481|448156119|FG001|Overall Study|Withdrawal by Subject|1|||
124600060|NCT03861481|448156118|FG000|Overall Study|Lack of Efficacy|4|||
124600061|NCT03861481|448156119|FG001|Overall Study|Lack of Efficacy|5|||
124600062|NCT00773734|448156120|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
124600063|NCT00773734|448156121|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
124600064|NCT00773734|448156122|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
124600065|NCT00773734|448156123|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
124600066|NCT00773734|448156124|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
124600067|NCT00773734|448156125|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
124600068|NCT00773734|448156120|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
124600069|NCT00773734|448156121|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
124600070|NCT00773734|448156122|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
124600071|NCT00773734|448156123|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
124600072|NCT00773734|448156124|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
124600073|NCT00773734|448156125|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
124600074|NCT00773734|448156120|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
124600075|NCT00773734|448156121|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
124600076|NCT00773734|448156122|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
124600077|NCT00773734|448156123|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
124600078|NCT00773734|448156124|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
124600079|NCT00773734|448156125|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
124600080|NCT00773734|448156120|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
124600081|NCT00773734|448156121|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
124600082|NCT00773734|448156122|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
124600083|NCT00773734|448156123|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
124600084|NCT00773734|448156124|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
124600085|NCT00773734|448156125|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
124600086|NCT00773734|448156120|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
124600087|NCT00773734|448156121|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
124600088|NCT00773734|448156122|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
124600089|NCT00773734|448156123|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
124600090|NCT00773734|448156124|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
124600091|NCT00773734|448156125|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
124600092|NCT00773734|448156120|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
124600093|NCT00773734|448156121|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
124600094|NCT00773734|448156122|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
124600095|NCT00773734|448156123|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
124600096|NCT00773734|448156124|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
124600097|NCT00773734|448156125|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
124600098|NCT00773734|448156120|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
124600099|NCT00773734|448156121|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
124600100|NCT00773734|448156122|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
124600101|NCT00773734|448156123|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
124600102|NCT00773734|448156124|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
124600103|NCT00773734|448156125|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
124600104|NCT00773734|448156120|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
124600105|NCT00773734|448156121|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
124600106|NCT00773734|448156122|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
124600107|NCT00773734|448156123|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
124600108|NCT00773734|448156124|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
124600109|NCT00773734|448156125|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
124600110|NCT00773734|448156120|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
124600111|NCT00773734|448156121|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
124600112|NCT00773734|448156122|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
124600113|NCT00773734|448156123|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
124600114|NCT00773734|448156124|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
124600115|NCT00773734|448156125|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
124600116|NCT00773734|448156120|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
124780707|NCT00943072|448826997|FG000|Overall Study|Withdrawal by Subject|3|||
124780708|NCT00943072|448826998|FG001|Overall Study|Withdrawal by Subject|1|||
124600117|NCT00773734|448156121|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
124780709|NCT00943072|448826997|FG000|Overall Study|Protocol Violation|0|||
124780710|NCT00943072|448826998|FG001|Overall Study|Protocol Violation|1|||
124600118|NCT00773734|448156122|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
124600119|NCT00773734|448156123|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
124600120|NCT00773734|448156124|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
124600121|NCT00773734|448156125|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
124600122|NCT00773734|448156120|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
124600123|NCT00773734|448156121|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
124600124|NCT00773734|448156122|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
124600125|NCT00773734|448156123|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
124600126|NCT00773734|448156124|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
124600127|NCT00773734|448156125|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
124600128|NCT00773734|448156120|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
124600129|NCT00773734|448156121|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
124600130|NCT00773734|448156122|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
124600131|NCT00773734|448156123|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
124600132|NCT00773734|448156124|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
124600133|NCT00773734|448156125|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
124600134|NCT00773734|448156120|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
124600135|NCT00773734|448156121|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
124600136|NCT00773734|448156122|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
124600137|NCT00773734|448156123|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
124600138|NCT00773734|448156124|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
124600139|NCT00773734|448156125|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
124600140|NCT00773734|448156120|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
124600141|NCT00773734|448156121|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
124600142|NCT00773734|448156122|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
124600143|NCT00773734|448156123|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
124600144|NCT00773734|448156124|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
124600145|NCT00773734|448156125|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
124600146|NCT00773734|448156120|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
124600147|NCT00773734|448156121|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
124600148|NCT00773734|448156122|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
124600149|NCT00773734|448156123|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
124600150|NCT00773734|448156124|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
124600151|NCT00773734|448156125|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
124600152|NCT00773734|448156120|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
124600153|NCT00773734|448156121|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
124600154|NCT00773734|448156122|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
124600155|NCT00773734|448156123|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
124600156|NCT00773734|448156124|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
124600157|NCT00773734|448156125|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
124600158|NCT00773734|448156120|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
124600159|NCT00773734|448156121|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
124600160|NCT00773734|448156122|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
124600161|NCT00773734|448156123|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
124600162|NCT00773734|448156124|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
124600163|NCT00773734|448156125|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
124600164|NCT00773734|448156120|FG000|Extension: Active Treatment Week 24-52|Other|0|||
124600165|NCT00773734|448156121|FG001|Extension: Active Treatment Week 24-52|Other|0|||
124600166|NCT00773734|448156122|FG002|Extension: Active Treatment Week 24-52|Other|1|||
124600167|NCT00773734|448156123|FG003|Extension: Active Treatment Week 24-52|Other|2|||
124600168|NCT00773734|448156124|FG004|Extension: Active Treatment Week 24-52|Other|0|||
124600169|NCT00773734|448156125|FG005|Extension: Active Treatment Week 24-52|Other|1|||
124600170|NCT00773734|448156120|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
124600171|NCT00773734|448156121|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
124600172|NCT00773734|448156122|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
124600173|NCT00773734|448156123|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
124600174|NCT00773734|448156124|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
124600175|NCT00773734|448156125|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
124600176|NCT00773734|448156120|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
124600177|NCT00773734|448156121|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
124600178|NCT00773734|448156122|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
124600179|NCT00773734|448156123|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
124600180|NCT00773734|448156124|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
124731262|NCT03334851|448640076|FG012|Overall Study|Adverse Event|0|||
124600181|NCT00773734|448156125|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
124731263|NCT03334851|448640064|FG000|Overall Study|Withdrawal by Subject|0|||
124600182|NCT00773734|448156120|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
124600183|NCT00773734|448156121|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
124600184|NCT00773734|448156122|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
124600185|NCT00773734|448156123|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
124600186|NCT00773734|448156124|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
124600187|NCT00773734|448156125|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
124600188|NCT00773734|448156120|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
124600189|NCT00773734|448156121|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
124600190|NCT00773734|448156122|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
124600191|NCT00773734|448156123|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
124600192|NCT00773734|448156124|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
124600193|NCT00773734|448156125|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
124600194|NCT01220297|448156128|FG000|Overall Study|Death|2|||
124600195|NCT01220297|448156128|FG000|Overall Study|Lost to Follow-up|1|||
124600196|NCT01287039|448156129|FG000|Overall Study|Noncompliance with study procedures|0|||
124600197|NCT01287039|448156130|FG001|Overall Study|Noncompliance with study procedures|1|||
124600198|NCT01287039|448156129|FG000|Overall Study|Change of location/residence|0|||
124600199|NCT01287039|448156130|FG001|Overall Study|Change of location/residence|3|||
124600200|NCT01287039|448156129|FG000|Overall Study|Elective surgery|0|||
124600201|NCT01287039|448156130|FG001|Overall Study|Elective surgery|1|||
124600202|NCT01287039|448156129|FG000|Overall Study|Protocol Violation|2|||
124600203|NCT01287039|448156130|FG001|Overall Study|Protocol Violation|3|||
124600204|NCT01287039|448156129|FG000|Overall Study|Excluded medication taken|1|||
124600205|NCT01287039|448156130|FG001|Overall Study|Excluded medication taken|0|||
124600206|NCT01287039|448156129|FG000|Overall Study|Noncompliance with study medication|0|||
124600207|NCT01287039|448156130|FG001|Overall Study|Noncompliance with study medication|1|||
124600208|NCT01287039|448156129|FG000|Overall Study|Problem with travel|0|||
124600209|NCT01287039|448156130|FG001|Overall Study|Problem with travel|1|||
124600210|NCT01287039|448156129|FG000|Overall Study|Death|1|||
124600211|NCT01287039|448156130|FG001|Overall Study|Death|0|||
124600212|NCT01287039|448156129|FG000|Overall Study|Change of residence|1|||
124600213|NCT01287039|448156130|FG001|Overall Study|Change of residence|0|||
124600214|NCT01287039|448156129|FG000|Overall Study|Adverse Event|7|||
124600215|NCT01287039|448156130|FG001|Overall Study|Adverse Event|4|||
124600216|NCT01287039|448156129|FG000|Overall Study|Withdrawal by Subject|14|||
124600217|NCT01287039|448156130|FG001|Overall Study|Withdrawal by Subject|11|||
124600218|NCT01287039|448156129|FG000|Overall Study|Lost to Follow-up|3|||
124600219|NCT01287039|448156130|FG001|Overall Study|Lost to Follow-up|2|||
124600220|NCT00099268|448156131|FG000|Overall Study|Withdrawal by Subject|46|||
124600221|NCT00099268|448156132|FG001|Overall Study|Withdrawal by Subject|28|||
124600222|NCT00099268|448156131|FG000|Overall Study|Adverse Event|19|||
124600223|NCT00099268|448156132|FG001|Overall Study|Adverse Event|19|||
124600224|NCT00099268|448156131|FG000|Overall Study|Protocol Violation|9|||
124600225|NCT00099268|448156132|FG001|Overall Study|Protocol Violation|8|||
124600226|NCT00099268|448156131|FG000|Overall Study|Lost to Follow-up|6|||
124600227|NCT00099268|448156132|FG001|Overall Study|Lost to Follow-up|4|||
124600228|NCT00099268|448156131|FG000|Overall Study|Lack of Efficacy|5|||
124600229|NCT00099268|448156132|FG001|Overall Study|Lack of Efficacy|18|||
124600230|NCT00099268|448156131|FG000|Overall Study|Administrative problems|4|||
124600231|NCT00099268|448156132|FG001|Overall Study|Administrative problems|4|||
124600232|NCT00099268|448156131|FG000|Overall Study|Death|3|||
124600233|NCT00099268|448156132|FG001|Overall Study|Death|1|||
124600234|NCT05016622|448156133|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
124600235|NCT05016622|448156133|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
124600236|NCT02581163|448156135|FG000|Overall Study|Failure to return|15|||
124600237|NCT02581163|448156135|FG000|Overall Study|Insufficient virological response|3|||
124600238|NCT02581163|448156135|FG000|Overall Study|Withdrew consent|1|||
124600239|NCT02581163|448156135|FG000|Overall Study|Death|1|||
124600240|NCT02581163|448156135|FG000|Overall Study|Other, not specified|9|||
124780711|NCT00943072|448826997|FG000|Overall Study|Lost to Follow-up|1|||
124600241|NCT03438396|448156136|FG000|Overall Study|Reason Not Specified|9|||
124600242|NCT03438396|448156136|FG000|Overall Study|Withdrawal by Subject|5|||
124600243|NCT03438396|448156136|FG000|Overall Study|Lost to Follow-up|2|||
124780712|NCT00943072|448826998|FG001|Overall Study|Lost to Follow-up|2|||
124600244|NCT03438396|448156136|FG000|Overall Study|Death|85|||
124600245|NCT03438396|448156136|FG000|Overall Study|Not treated|1|||
124600246|NCT02006628|448156137|FG000|Overall Study|Adverse Event|1|||
124600247|NCT02006628|448156138|FG001|Overall Study|Adverse Event|1|||
124600248|NCT02006628|448156137|FG000|Overall Study|Withdrawal by Subject|2|||
124600249|NCT02006628|448156138|FG001|Overall Study|Withdrawal by Subject|1|||
124600250|NCT01421342|448156139|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
124600251|NCT01421342|448156140|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
124600252|NCT01421342|448156141|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
124600253|NCT01421342|448156139|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
124600254|NCT01421342|448156140|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
124600255|NCT01421342|448156141|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
124600256|NCT01421342|448156139|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
124600257|NCT01421342|448156140|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
124600258|NCT01421342|448156141|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
124600259|NCT01421342|448156139|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
124600260|NCT01421342|448156140|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
124600261|NCT01421342|448156141|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
124600262|NCT01421342|448156139|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
124600263|NCT01421342|448156140|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
124600264|NCT01421342|448156141|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
124600265|NCT01421342|448156139|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
124600266|NCT01421342|448156140|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
124600267|NCT01421342|448156141|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
124600268|NCT01421342|448156139|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
124600269|NCT01421342|448156140|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
124600270|NCT01421342|448156141|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
124600271|NCT01421342|448156139|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
124600272|NCT01421342|448156140|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
124600273|NCT01421342|448156141|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
124600274|NCT01421342|448156139|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
124600275|NCT01421342|448156140|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
124600276|NCT01421342|448156141|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
124600277|NCT01421342|448156139|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
124600278|NCT01421342|448156140|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
124600279|NCT01421342|448156141|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
124600280|NCT01421342|448156139|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
124600281|NCT01421342|448156140|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
124600282|NCT01421342|448156141|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
124600283|NCT01421342|448156139|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
124600284|NCT01421342|448156140|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
124600285|NCT01421342|448156141|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
124600286|NCT01421342|448156139|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
124600287|NCT01421342|448156140|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
124600288|NCT01421342|448156141|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
124600289|NCT01421342|448156139|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
124600290|NCT01421342|448156140|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
124600291|NCT01421342|448156141|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
124600292|NCT01421342|448156139|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
124600293|NCT01421342|448156140|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
124600294|NCT01421342|448156141|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
124600295|NCT01421342|448156139|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
124600296|NCT01421342|448156140|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
124600297|NCT01421342|448156141|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
124600298|NCT01421342|448156139|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
124600299|NCT01421342|448156140|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
124600300|NCT01421342|448156141|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
124600301|NCT01421342|448156139|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
124600302|NCT01421342|448156140|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
124600303|NCT01421342|448156141|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
124600304|NCT01421342|448156139|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
124600305|NCT01421342|448156140|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
124600306|NCT01421342|448156141|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
124600307|NCT01421342|448156139|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
124600308|NCT01421342|448156140|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
124600309|NCT01421342|448156141|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
124600310|NCT01421342|448156139|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
124600311|NCT01421342|448156140|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
124600312|NCT01421342|448156141|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
124600313|NCT01421342|448156139|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
124600314|NCT01421342|448156140|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
124600315|NCT01421342|448156141|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
124600316|NCT01421342|448156139|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
124600317|NCT01421342|448156140|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
124600318|NCT01421342|448156141|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
124600319|NCT01421342|448156139|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
124780713|NCT00943072|448826997|FG000|Overall Study|Lack of Efficacy|0|||
124600320|NCT01421342|448156140|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
124600321|NCT01421342|448156141|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
124600322|NCT01421342|448156139|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
124600323|NCT01421342|448156140|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
124600324|NCT01421342|448156141|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
124600325|NCT01421342|448156139|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
124600326|NCT01421342|448156140|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
124600327|NCT01421342|448156141|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
124600328|NCT01421342|448156139|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
124600329|NCT01421342|448156140|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
124600330|NCT01421342|448156141|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
124600331|NCT01421342|448156139|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
124600332|NCT01421342|448156140|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
124600333|NCT01421342|448156141|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
124600334|NCT03578237|448156142|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
124600335|NCT03578237|448156143|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
124600336|NCT02488330|448156144|FG000|Overall Study|Adverse Event|1|||
124600337|NCT02488330|448156144|FG000|Overall Study|Physician Decision|2|||
124600338|NCT02488330|448156144|FG000|Overall Study|Death|2|||
124600339|NCT02488330|448156144|FG000|Overall Study|Disease Progression|3|||
124600340|NCT02488330|448156144|FG000|Overall Study|Study Termination by Sponsor|4|||
124600341|NCT01642914|448156146|FG000|Overall Study|Adverse Event|11|||
124600342|NCT01642914|448156147|FG001|Overall Study|Adverse Event|7|||
124600343|NCT01642914|448156148|FG002|Overall Study|Adverse Event|15|||
124600344|NCT01642914|448156146|FG000|Overall Study|Lack of Efficacy|9|||
124600345|NCT01642914|448156147|FG001|Overall Study|Lack of Efficacy|4|||
124600346|NCT01642914|448156148|FG002|Overall Study|Lack of Efficacy|2|||
124600347|NCT01642914|448156146|FG000|Overall Study|Protocol Violation|15|||
124600348|NCT01642914|448156147|FG001|Overall Study|Protocol Violation|13|||
124600349|NCT01642914|448156148|FG002|Overall Study|Protocol Violation|6|||
124600350|NCT01642914|448156146|FG000|Overall Study|Withdrawal by Subject|5|||
124600351|NCT01642914|448156147|FG001|Overall Study|Withdrawal by Subject|5|||
124600352|NCT01642914|448156148|FG002|Overall Study|Withdrawal by Subject|10|||
124600353|NCT01642914|448156146|FG000|Overall Study|Lost to Follow-up|5|||
124600354|NCT01642914|448156147|FG001|Overall Study|Lost to Follow-up|3|||
124600355|NCT01642914|448156148|FG002|Overall Study|Lost to Follow-up|7|||
124600356|NCT01642914|448156146|FG000|Overall Study|Other Reason|1|||
124600357|NCT01642914|448156147|FG001|Overall Study|Other Reason|0|||
124600358|NCT01642914|448156148|FG002|Overall Study|Other Reason|0|||
124600359|NCT01705236|448156149|FG000|Overall Study|Lost to Follow-up|1|||
124600360|NCT01705236|448156149|FG000|Overall Study|Administrative problems|2|||
124600361|NCT01705236|448156149|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
124600362|NCT01705236|448156149|FG000|Overall Study|Protocol Violation|3|||
124600363|NCT01705236|448156149|FG000|Overall Study|Abnormal test procedure result(s)|4|||
124600364|NCT01705236|448156149|FG000|Overall Study|Abnormal laboratory value(s)|4|||
124600365|NCT01705236|448156149|FG000|Overall Study|Withdrawal by Subject|5|||
124600366|NCT01705236|448156149|FG000|Overall Study|Adverse Event|5|||
124600367|NCT00171301|448156150|FG000|Overall Study|Death|1|||
124600368|NCT00171301|448156151|FG001|Overall Study|Death|2|||
124600369|NCT00171301|448156150|FG000|Overall Study|Adverse Event|1|||
124600370|NCT00171301|448156151|FG001|Overall Study|Adverse Event|2|||
124600371|NCT00171301|448156150|FG000|Overall Study|Lost to Follow-up|6|||
124600372|NCT00171301|448156151|FG001|Overall Study|Lost to Follow-up|2|||
124600373|NCT00171301|448156150|FG000|Overall Study|Protocol Violation|0|||
124600374|NCT00171301|448156151|FG001|Overall Study|Protocol Violation|2|||
124600375|NCT00171301|448156150|FG000|Overall Study|Withdrawal by Subject|0|||
124600376|NCT00171301|448156151|FG001|Overall Study|Withdrawal by Subject|1|||
124600377|NCT04319159|448156152|FG000|Overall Study|Screening failure|13|||
124600378|NCT04319159|448156152|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
124600379|NCT04319159|448156152|FG000|Overall Study|Withdrawal by Subject|1|||
124600380|NCT02100319|448156153|FG000|Overall Study|Case Report Forms Uncollected|11|||
124600381|NCT02100319|448156153|FG000|Overall Study|Protocol Deviation|5|||
124600382|NCT02370914|448156154|FG000|Overall Study|Protocol Violation|2|||
124600383|NCT00296491|448156155|FG000|Overall Study|Low Pollen Counts|18|||
124600384|NCT00296491|448156156|FG001|Overall Study|Low Pollen Counts|26|||
124731264|NCT03334851|448640065|FG001|Overall Study|Withdrawal by Subject|0|||
124731265|NCT03334851|448640066|FG002|Overall Study|Withdrawal by Subject|0|||
124731266|NCT03334851|448640067|FG003|Overall Study|Withdrawal by Subject|0|||
124600385|NCT00296491|448156157|FG002|Overall Study|Low Pollen Counts|25|||
124600386|NCT00296491|448156158|FG003|Overall Study|Low Pollen Counts|16|||
124600387|NCT00296491|448156155|FG000|Overall Study|Protocol Violation|4|||
124600388|NCT00296491|448156156|FG001|Overall Study|Protocol Violation|6|||
124600389|NCT00296491|448156157|FG002|Overall Study|Protocol Violation|2|||
124600390|NCT00296491|448156158|FG003|Overall Study|Protocol Violation|3|||
124600391|NCT00296491|448156155|FG000|Overall Study|Adverse Event|1|||
124600392|NCT00296491|448156156|FG001|Overall Study|Adverse Event|3|||
124600393|NCT00296491|448156157|FG002|Overall Study|Adverse Event|1|||
124600394|NCT00296491|448156158|FG003|Overall Study|Adverse Event|4|||
124600395|NCT00296491|448156155|FG000|Overall Study|Withdrawn due to Asthma|0|||
124600396|NCT00296491|448156156|FG001|Overall Study|Withdrawn due to Asthma|0|||
124600397|NCT00296491|448156157|FG002|Overall Study|Withdrawn due to Asthma|0|||
124600398|NCT00296491|448156158|FG003|Overall Study|Withdrawn due to Asthma|4|||
124600399|NCT00296491|448156155|FG000|Overall Study|Withdrawal by Subject|7|||
124600400|NCT00296491|448156156|FG001|Overall Study|Withdrawal by Subject|3|||
124600401|NCT00296491|448156157|FG002|Overall Study|Withdrawal by Subject|3|||
124600402|NCT00296491|448156158|FG003|Overall Study|Withdrawal by Subject|2|||
124600403|NCT00296491|448156155|FG000|Overall Study|Non-Compliance|12|||
124600404|NCT00296491|448156156|FG001|Overall Study|Non-Compliance|13|||
124600405|NCT00296491|448156157|FG002|Overall Study|Non-Compliance|10|||
124600406|NCT00296491|448156158|FG003|Overall Study|Non-Compliance|14|||
124600407|NCT00296491|448156155|FG000|Overall Study|Lost to Follow-up|0|||
124600408|NCT00296491|448156156|FG001|Overall Study|Lost to Follow-up|2|||
124600409|NCT00296491|448156157|FG002|Overall Study|Lost to Follow-up|2|||
124600410|NCT00296491|448156158|FG003|Overall Study|Lost to Follow-up|0|||
124600411|NCT01300052|448156159|FG000|Overall Study|Adverse Event|3|||
124600412|NCT01300052|448156160|FG001|Overall Study|Adverse Event|0|||
124600413|NCT01300052|448156159|FG000|Overall Study|Withdrawal by Subject|2|||
124600414|NCT01300052|448156160|FG001|Overall Study|Withdrawal by Subject|2|||
124600415|NCT01300052|448156159|FG000|Overall Study|Protocol Violation|1|||
124600416|NCT01300052|448156160|FG001|Overall Study|Protocol Violation|1|||
124600417|NCT03451006|448156161|FG000|Overall Study|Withdrawal by Subject|2|||
124600418|NCT03451006|448156162|FG001|Overall Study|Withdrawal by Subject|2|||
124600419|NCT01929395|448156163|FG000|Overall Study|Did not complete - non-related toxicity|1|||
124600420|NCT01929395|448156164|FG001|Overall Study|Did not complete - non-related toxicity|0|||
124600421|NCT01929395|448156165|FG002|Overall Study|Did not complete - non-related toxicity|0|||
124600422|NCT01929395|448156163|FG000|Overall Study|Withdrawal by Subject|0|||
124600423|NCT01929395|448156164|FG001|Overall Study|Withdrawal by Subject|1|||
124600424|NCT01929395|448156165|FG002|Overall Study|Withdrawal by Subject|0|||
124600425|NCT01929395|448156163|FG000|Overall Study|Screen Fail|0|||
124600426|NCT01929395|448156164|FG001|Overall Study|Screen Fail|0|||
124600427|NCT01929395|448156165|FG002|Overall Study|Screen Fail|1|||
124600428|NCT03604341|448156166|FG000|Overall Study|Withdrawal by Subject|1|||
124600429|NCT03604341|448156167|FG001|Overall Study|Withdrawal by Subject|1|||
124600430|NCT03604341|448156166|FG000|Overall Study|Adverse Event|1|||
124600431|NCT03604341|448156167|FG001|Overall Study|Adverse Event|0|||
124600432|NCT03604341|448156166|FG000|Overall Study|Protocol Violation|0|||
124600433|NCT03604341|448156167|FG001|Overall Study|Protocol Violation|1|||
124600434|NCT00897949|448156171|FG000|Overall Study|Adverse Event|1|||
124600435|NCT00897949|448156172|FG001|Overall Study|Adverse Event|1|||
124600436|NCT00897949|448156173|FG002|Overall Study|Adverse Event|0|||
124600437|NCT00897949|448156171|FG000|Overall Study|Lost to Follow-up|0|||
124600438|NCT00897949|448156172|FG001|Overall Study|Lost to Follow-up|2|||
124600439|NCT00897949|448156173|FG002|Overall Study|Lost to Follow-up|1|||
124600440|NCT00897949|448156171|FG000|Overall Study|Protocol Violation|6|||
124600441|NCT00897949|448156172|FG001|Overall Study|Protocol Violation|3|||
124600442|NCT00897949|448156173|FG002|Overall Study|Protocol Violation|1|||
124600443|NCT00897949|448156171|FG000|Overall Study|Withdrawal by Subject|1|||
124600444|NCT00897949|448156172|FG001|Overall Study|Withdrawal by Subject|2|||
124600445|NCT00897949|448156173|FG002|Overall Study|Withdrawal by Subject|0|||
124600446|NCT00897949|448156171|FG000|Overall Study|Patient Uncoorperative|0|||
124600447|NCT00897949|448156172|FG001|Overall Study|Patient Uncoorperative|2|||
124600448|NCT00897949|448156173|FG002|Overall Study|Patient Uncoorperative|1|||
124600449|NCT00897949|448156171|FG000|Overall Study|Lost to Follow-up|30|||
124780714|NCT00943072|448826998|FG001|Overall Study|Lack of Efficacy|4|||
124600450|NCT00897949|448156172|FG001|Overall Study|Lost to Follow-up|23|||
124600451|NCT00897949|448156173|FG002|Overall Study|Lost to Follow-up|17|||
124600452|NCT00897949|448156171|FG000|Overall Study|Withdrawal by Subject|24|||
124600453|NCT00897949|448156172|FG001|Overall Study|Withdrawal by Subject|31|||
124600454|NCT00897949|448156173|FG002|Overall Study|Withdrawal by Subject|17|||
124600455|NCT00897949|448156171|FG000|Overall Study|Abnormal Prestudy Labs|2|||
124600456|NCT00897949|448156172|FG001|Overall Study|Abnormal Prestudy Labs|3|||
124600457|NCT00897949|448156173|FG002|Overall Study|Abnormal Prestudy Labs|4|||
124600458|NCT00897949|448156171|FG000|Overall Study|Abnormal Baseline ECG|2|||
124600459|NCT00897949|448156172|FG001|Overall Study|Abnormal Baseline ECG|2|||
124600460|NCT00897949|448156173|FG002|Overall Study|Abnormal Baseline ECG|4|||
124600461|NCT00897949|448156171|FG000|Overall Study|Need for Concom. Med.|0|||
124600462|NCT00897949|448156172|FG001|Overall Study|Need for Concom. Med.|1|||
124600463|NCT00897949|448156173|FG002|Overall Study|Need for Concom. Med.|1|||
124600464|NCT00897949|448156171|FG000|Overall Study|Lack of Migraine Attack|29|||
124600465|NCT00897949|448156172|FG001|Overall Study|Lack of Migraine Attack|30|||
124600466|NCT00897949|448156173|FG002|Overall Study|Lack of Migraine Attack|19|||
124600467|NCT00897949|448156171|FG000|Overall Study|Did not take study drug|9|||
124600468|NCT00897949|448156172|FG001|Overall Study|Did not take study drug|3|||
124600469|NCT00897949|448156173|FG002|Overall Study|Did not take study drug|4|||
124600470|NCT01553747|448156174|FG000|Overall Study|Protocol Violation|0|||
124600471|NCT01553747|448156175|FG001|Overall Study|Protocol Violation|2|||
124600472|NCT01553747|448156176|FG002|Overall Study|Protocol Violation|0|||
124600473|NCT01553747|448156174|FG000|Overall Study|Voluntarily withdrew|70|||
124600474|NCT01553747|448156175|FG001|Overall Study|Voluntarily withdrew|66|||
124600475|NCT01553747|448156176|FG002|Overall Study|Voluntarily withdrew|74|||
124600476|NCT01553747|448156174|FG000|Overall Study|Adverse event or SAE|32|||
124600477|NCT01553747|448156175|FG001|Overall Study|Adverse event or SAE|28|||
124600478|NCT01553747|448156176|FG002|Overall Study|Adverse event or SAE|19|||
124600479|NCT01553747|448156174|FG000|Overall Study|Physician decision: other|10|||
124600480|NCT01553747|448156175|FG001|Overall Study|Physician decision: other|8|||
124600481|NCT01553747|448156176|FG002|Overall Study|Physician decision: other|7|||
124600482|NCT01553747|448156174|FG000|Overall Study|Lost to Follow-up|11|||
124600483|NCT01553747|448156175|FG001|Overall Study|Lost to Follow-up|5|||
124600484|NCT01553747|448156176|FG002|Overall Study|Lost to Follow-up|6|||
124600485|NCT01553747|448156174|FG000|Overall Study|Sponsor decision, specify|7|||
124600486|NCT01553747|448156175|FG001|Overall Study|Sponsor decision, specify|5|||
124600487|NCT01553747|448156176|FG002|Overall Study|Sponsor decision, specify|0|||
124600488|NCT01553747|448156174|FG000|Overall Study|Physician decision: lack of efficacy|1|||
124600489|NCT01553747|448156175|FG001|Overall Study|Physician decision: lack of efficacy|5|||
124600490|NCT01553747|448156176|FG002|Overall Study|Physician decision: lack of efficacy|3|||
124600491|NCT01341587|448156177|FG000|Overall Study|Lost to Follow-up|2|||
124600492|NCT01341587|448156178|FG001|Overall Study|Lost to Follow-up|0|||
124600493|NCT01341587|448156177|FG000|Overall Study|stopped using the meters|2|||
124600494|NCT01341587|448156178|FG001|Overall Study|stopped using the meters|10|||
124600495|NCT02990806|448156179|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
124600496|NCT02990806|448156180|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
124600497|NCT02990806|448156181|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
124600498|NCT02990806|448156182|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
124600499|NCT02990806|448156179|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
124600500|NCT02990806|448156180|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
124600501|NCT02990806|448156181|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
124600502|NCT02990806|448156182|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
124600503|NCT02990806|448156179|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
124600504|NCT02990806|448156180|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
124600505|NCT02990806|448156181|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
124600506|NCT02990806|448156182|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
124600507|NCT02990806|448156179|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
124600508|NCT02990806|448156180|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
124600509|NCT02990806|448156181|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
124600510|NCT02990806|448156182|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
124600511|NCT02990806|448156179|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
124600512|NCT02990806|448156180|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
124600513|NCT02990806|448156181|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
124600514|NCT02990806|448156182|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
124600515|NCT02990806|448156179|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
124600516|NCT02990806|448156180|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
124600517|NCT02990806|448156181|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
124600518|NCT02990806|448156182|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
124600519|NCT02990806|448156179|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
124600520|NCT02990806|448156180|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
124600521|NCT02990806|448156181|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
124600522|NCT02990806|448156182|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
124600523|NCT02990806|448156179|FG000|Stage 1 (22 Weeks)|Death|0|||
124600524|NCT02990806|448156180|FG001|Stage 1 (22 Weeks)|Death|1|||
124600525|NCT02990806|448156181|FG002|Stage 1 (22 Weeks)|Death|0|||
124600526|NCT02990806|448156182|FG003|Stage 1 (22 Weeks)|Death|0|||
124600527|NCT02990806|448156179|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
124600528|NCT02990806|448156180|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
124600529|NCT02990806|448156181|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
124600530|NCT02990806|448156182|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
124600531|NCT02990806|448156179|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
124600532|NCT02990806|448156180|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
124600533|NCT02990806|448156181|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
124600534|NCT02990806|448156182|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
124600535|NCT02990806|448156179|FG000|Stage 1 (22 Weeks)|Other|1|||
124731267|NCT03334851|448640068|FG004|Overall Study|Withdrawal by Subject|0|||
124731268|NCT03334851|448640069|FG005|Overall Study|Withdrawal by Subject|0|||
124600536|NCT02990806|448156180|FG001|Stage 1 (22 Weeks)|Other|3|||
124600537|NCT02990806|448156181|FG002|Stage 1 (22 Weeks)|Other|0|||
124600538|NCT02990806|448156182|FG003|Stage 1 (22 Weeks)|Other|0|||
124600539|NCT02990806|448156179|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
124600540|NCT02990806|448156180|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
124600541|NCT02990806|448156181|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
124600542|NCT02990806|448156182|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
124600543|NCT02990806|448156179|FG000|Stage 2 (32 Weeks)|Death|1|||
124600544|NCT02990806|448156180|FG001|Stage 2 (32 Weeks)|Death|0|||
124600545|NCT02990806|448156181|FG002|Stage 2 (32 Weeks)|Death|0|||
124600546|NCT02990806|448156182|FG003|Stage 2 (32 Weeks)|Death|0|||
124600547|NCT02990806|448156179|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
124600548|NCT02990806|448156180|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
124600549|NCT02990806|448156181|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
124600550|NCT02990806|448156182|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
124600551|NCT02990806|448156179|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
124600552|NCT02990806|448156180|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
124600553|NCT02990806|448156181|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
124600554|NCT02990806|448156182|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
124600555|NCT02990806|448156179|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
124600556|NCT02990806|448156180|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
124600557|NCT02990806|448156181|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
124600558|NCT02990806|448156182|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
124600559|NCT02990806|448156179|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
124600560|NCT02990806|448156180|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
124600561|NCT02990806|448156181|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
124600562|NCT02990806|448156182|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
124600563|NCT02990806|448156179|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
124600564|NCT02990806|448156180|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
124600565|NCT02990806|448156181|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
124600566|NCT02990806|448156182|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
124600567|NCT02990806|448156179|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
124600568|NCT02990806|448156180|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
124600569|NCT02990806|448156181|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
124600570|NCT02990806|448156182|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
124600571|NCT02990806|448156179|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
124600572|NCT02990806|448156180|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
124600573|NCT02990806|448156181|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
124600574|NCT02990806|448156182|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
124600575|NCT02990806|448156179|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
124600576|NCT02990806|448156180|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
124600577|NCT02990806|448156181|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
124600578|NCT02990806|448156182|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
124600579|NCT02990806|448156179|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
124600580|NCT02990806|448156180|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
124600581|NCT02990806|448156181|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
124600582|NCT02990806|448156182|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
124600583|NCT02990806|448156179|FG000|Stage 2 (32 Weeks)|Other|3|||
124600584|NCT02990806|448156180|FG001|Stage 2 (32 Weeks)|Other|0|||
124600585|NCT02990806|448156181|FG002|Stage 2 (32 Weeks)|Other|4|||
124600586|NCT02990806|448156182|FG003|Stage 2 (32 Weeks)|Other|1|||
124600587|NCT02990806|448156179|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
124600588|NCT02990806|448156180|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
124600589|NCT02990806|448156181|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
124600590|NCT02990806|448156182|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
124600591|NCT02990806|448156179|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
124600592|NCT02990806|448156180|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
124600593|NCT02990806|448156181|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
124600594|NCT02990806|448156182|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
124600595|NCT02990806|448156179|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
124600596|NCT02990806|448156180|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
124600597|NCT02990806|448156181|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
124600598|NCT02990806|448156182|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
124600599|NCT02990806|448156179|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
124600600|NCT02990806|448156180|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
124600601|NCT02990806|448156181|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
124600602|NCT02990806|448156182|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
124600603|NCT02990806|448156179|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
124600604|NCT02990806|448156180|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
124780715|NCT00943072|448826997|FG000|Overall Study|Other|1|||
124780716|NCT00943072|448826998|FG001|Overall Study|Other|1|||
124600605|NCT02990806|448156181|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
124600606|NCT02990806|448156182|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
124600607|NCT02990806|448156179|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
124600608|NCT02990806|448156180|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
124600609|NCT02990806|448156181|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
124600610|NCT02990806|448156182|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
124600611|NCT02990806|448156179|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
124600612|NCT02990806|448156180|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
124600613|NCT02990806|448156181|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
124600614|NCT02990806|448156182|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
124600615|NCT02990806|448156179|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
124600616|NCT02990806|448156180|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
124600617|NCT02990806|448156181|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
124600618|NCT02990806|448156182|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
124600619|NCT02990806|448156179|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
124600620|NCT02990806|448156180|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
124600621|NCT02990806|448156181|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
124600622|NCT02990806|448156182|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
124600623|NCT00466726|448156183|FG000|Overall Study|Not evaluable for response|14|||
124600624|NCT02470091|448156184|FG000|Overall Study|Withdrawal by Subject|1|||
124600625|NCT02470091|448156185|FG001|Overall Study|Withdrawal by Subject|0|||
124600626|NCT02470091|448156184|FG000|Overall Study|Ineligible|0|||
124600627|NCT02470091|448156185|FG001|Overall Study|Ineligible|2|||
124600628|NCT02903238|448156187|FG000|Overall Study|Lost to Follow-up|4|||
124600629|NCT00700817|448156188|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
124600630|NCT00700817|448156189|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
124600631|NCT00700817|448156190|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
124600632|NCT00700817|448156191|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
124600633|NCT00700817|448156192|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
124600634|NCT00700817|448156188|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
124600635|NCT00700817|448156189|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
124600636|NCT00700817|448156190|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
124600637|NCT00700817|448156191|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
124600638|NCT00700817|448156192|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
124600639|NCT00700817|448156188|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
124600640|NCT00700817|448156189|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
124600641|NCT00700817|448156190|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
124600642|NCT00700817|448156191|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
124600643|NCT00700817|448156192|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
124600644|NCT00700817|448156188|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
124600645|NCT00700817|448156189|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
124600646|NCT00700817|448156190|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
124600647|NCT00700817|448156191|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
124600648|NCT00700817|448156192|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
124600649|NCT00700817|448156188|FG000|Week 0-26 (Main Period)|Unclassified|14|||
124600650|NCT00700817|448156189|FG001|Week 0-26 (Main Period)|Unclassified|4|||
124600651|NCT00700817|448156190|FG002|Week 0-26 (Main Period)|Unclassified|8|||
124600652|NCT00700817|448156191|FG003|Week 0-26 (Main Period)|Unclassified|0|||
124600653|NCT00700817|448156192|FG004|Week 0-26 (Main Period)|Unclassified|0|||
124600654|NCT00700817|448156188|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
124600655|NCT00700817|448156189|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
124600656|NCT00700817|448156190|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
124600657|NCT00700817|448156191|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
124600658|NCT00700817|448156192|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
124600659|NCT00700817|448156188|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
124600660|NCT00700817|448156189|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
124600661|NCT00700817|448156190|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
124600662|NCT00700817|448156191|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
124600663|NCT00700817|448156192|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
124600664|NCT00700817|448156188|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
124600665|NCT00700817|448156189|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
124600666|NCT00700817|448156190|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
124600667|NCT00700817|448156191|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
124600668|NCT00700817|448156192|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
124780717|NCT00552188|448826999|FG000|Overall Study|Adverse Event|0|||
124600669|NCT00700817|448156188|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
124600670|NCT00700817|448156189|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
124600671|NCT00700817|448156190|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
124600672|NCT00700817|448156191|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
124600673|NCT00700817|448156192|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
124600674|NCT00700817|448156188|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
124600675|NCT00700817|448156189|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
124600676|NCT00700817|448156190|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
124600677|NCT00700817|448156191|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
124600678|NCT00700817|448156192|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
124600679|NCT00700817|448156188|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
124600680|NCT00700817|448156189|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
124600681|NCT00700817|448156190|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
124600682|NCT00700817|448156191|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
124600683|NCT00700817|448156192|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
124600684|NCT00700817|448156188|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
124600685|NCT00700817|448156189|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
124600686|NCT00700817|448156190|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
124600687|NCT00700817|448156191|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
124600688|NCT00700817|448156192|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
124600689|NCT00700817|448156188|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
124600690|NCT00700817|448156189|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
124600691|NCT00700817|448156190|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
124600692|NCT00700817|448156191|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
124600693|NCT00700817|448156192|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
124600694|NCT00700817|448156188|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
124600695|NCT00700817|448156189|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
124600696|NCT00700817|448156190|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
124600697|NCT00700817|448156191|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
124600698|NCT00700817|448156192|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
124600699|NCT00700817|448156188|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
124600700|NCT00700817|448156189|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
124600701|NCT00700817|448156190|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
124600702|NCT00700817|448156191|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
124600703|NCT00700817|448156192|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
124600704|NCT01338987|448156193|FG000|Overall Study|enrolled on new protocol|0|||
124600705|NCT01338987|448156194|FG001|Overall Study|enrolled on new protocol|0|||
124600706|NCT01338987|448156195|FG002|Overall Study|enrolled on new protocol|1|||
124600707|NCT01338987|448156196|FG003|Overall Study|enrolled on new protocol|0|||
124600708|NCT01338987|448156197|FG004|Overall Study|enrolled on new protocol|0|||
124600709|NCT01338987|448156193|FG000|Overall Study|Disease progression on study|2|||
124600710|NCT01338987|448156194|FG001|Overall Study|Disease progression on study|1|||
124600711|NCT01338987|448156195|FG002|Overall Study|Disease progression on study|1|||
124600712|NCT01338987|448156196|FG003|Overall Study|Disease progression on study|0|||
124600713|NCT01338987|448156197|FG004|Overall Study|Disease progression on study|0|||
124600714|NCT00606502|448156200|FG000|Randomization|Randomized but not treated|3|||
124600715|NCT00606502|448156201|FG001|Randomization|Randomized but not treated|0|||
124600716|NCT00606502|448156200|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
124600717|NCT00606502|448156201|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
124600718|NCT01470612|448156210|FG000|Overall Study|Adverse Event|20|||
124600719|NCT01470612|448156211|FG001|Overall Study|Adverse Event|80|||
124600720|NCT01470612|448156210|FG000|Overall Study|Death|0|||
124600721|NCT01470612|448156211|FG001|Overall Study|Death|1|||
124600722|NCT01470612|448156210|FG000|Overall Study|Lack of Efficacy|20|||
124600723|NCT01470612|448156211|FG001|Overall Study|Lack of Efficacy|326|||
124600724|NCT01470612|448156210|FG000|Overall Study|Lost to Follow-up|2|||
124600725|NCT01470612|448156211|FG001|Overall Study|Lost to Follow-up|5|||
124600726|NCT01470612|448156210|FG000|Overall Study|Did not meet entrance criteria|0|||
124600727|NCT01470612|448156211|FG001|Overall Study|Did not meet entrance criteria|1|||
124600728|NCT01470612|448156210|FG000|Overall Study|Pregnancy|2|||
124600729|NCT01470612|448156211|FG001|Overall Study|Pregnancy|10|||
124600730|NCT01470612|448156210|FG000|Overall Study|Protocol Violation|2|||
124600731|NCT01470612|448156211|FG001|Overall Study|Protocol Violation|7|||
124600732|NCT01470612|448156210|FG000|Overall Study|Withdrawal by Subject|24|||
124600733|NCT01470612|448156211|FG001|Overall Study|Withdrawal by Subject|79|||
124600734|NCT01470612|448156210|FG000|Overall Study|Other|14|||
124600735|NCT01470612|448156211|FG001|Overall Study|Other|156|||
124600736|NCT03407118|448156215|FG000|Period 2|Withdrawal by Subject|1|||
124600737|NCT03407118|448156216|FG001|Period 2|Withdrawal by Subject|0|||
124600738|NCT02556307|448156217|FG000|Overall Study|Premature treatment interruption|11|||
124600739|NCT02556307|448156217|FG000|Overall Study|Lost to Follow-up|36|||
124600740|NCT02556307|448156217|FG000|Overall Study|Change to triple therapy|4|||
124600741|NCT02556307|448156217|FG000|Overall Study|Enrolled but not treated|2|||
124600742|NCT00384176|448156220|FG000|Overall Study|Death|239|||
124600743|NCT00384176|448156221|FG001|Overall Study|Death|247|||
124600744|NCT00384176|448156222|FG002|Overall Study|Death|105|||
124780718|NCT00552188|448827000|FG001|Overall Study|Adverse Event|2|||
124600745|NCT00384176|448156220|FG000|Overall Study|Withdrawal by Subject|52|||
124600746|NCT00384176|448156221|FG001|Overall Study|Withdrawal by Subject|48|||
124600747|NCT00384176|448156222|FG002|Overall Study|Withdrawal by Subject|22|||
124600748|NCT00384176|448156220|FG000|Overall Study|Lost to Follow-up|16|||
124600749|NCT00384176|448156221|FG001|Overall Study|Lost to Follow-up|18|||
124600750|NCT00384176|448156222|FG002|Overall Study|Lost to Follow-up|4|||
124600751|NCT00384176|448156220|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
124600752|NCT00384176|448156221|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
124600753|NCT00384176|448156222|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
124600754|NCT00384176|448156220|FG000|Overall Study|Longer QTC as Visit 1|1|||
124600755|NCT00384176|448156221|FG001|Overall Study|Longer QTC as Visit 1|0|||
124600756|NCT00384176|448156222|FG002|Overall Study|Longer QTC as Visit 1|0|||
124600757|NCT00384176|448156220|FG000|Overall Study|Toxicity of treatment|1|||
124600758|NCT00384176|448156221|FG001|Overall Study|Toxicity of treatment|0|||
124600759|NCT00384176|448156222|FG002|Overall Study|Toxicity of treatment|0|||
124600760|NCT00384176|448156220|FG000|Overall Study|Did not receive study treatment|0|||
124600761|NCT00384176|448156221|FG001|Overall Study|Did not receive study treatment|1|||
124600762|NCT00384176|448156222|FG002|Overall Study|Did not receive study treatment|1|||
124600763|NCT00384176|448156220|FG000|Overall Study|Physician Decision|0|||
124600764|NCT00384176|448156221|FG001|Overall Study|Physician Decision|2|||
124600765|NCT00384176|448156222|FG002|Overall Study|Physician Decision|0|||
124600766|NCT00384176|448156220|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
124600767|NCT00384176|448156221|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
124600768|NCT00384176|448156222|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
124600769|NCT00854373|448156223|FG000|Overall Study|Withdrawal by Subject|1|||
124600770|NCT00854373|448156224|FG001|Overall Study|Withdrawal by Subject|3|||
124600771|NCT00854373|448156223|FG000|Overall Study|Forgot to take study drug|1|||
124600772|NCT00854373|448156224|FG001|Overall Study|Forgot to take study drug|1|||
124600773|NCT00307931|448156225|FG000|Overall Study|Adverse Event|1|||
124600774|NCT00515034|448156226|FG000|Overall Study|Adverse Event|2|||
124600775|NCT00515034|448156227|FG001|Overall Study|Adverse Event|0|||
124600776|NCT00515034|448156228|FG002|Overall Study|Adverse Event|1|||
124600777|NCT00515034|448156229|FG003|Overall Study|Adverse Event|0|||
124600778|NCT00515034|448156226|FG000|Overall Study|Death|4|||
124600779|NCT00515034|448156227|FG001|Overall Study|Death|2|||
124600780|NCT00515034|448156228|FG002|Overall Study|Death|1|||
124600781|NCT00515034|448156229|FG003|Overall Study|Death|3|||
124600782|NCT00515034|448156226|FG000|Overall Study|Withdrawal by Subject|1|||
124600783|NCT00515034|448156227|FG001|Overall Study|Withdrawal by Subject|0|||
124600784|NCT00515034|448156228|FG002|Overall Study|Withdrawal by Subject|3|||
124600785|NCT00515034|448156229|FG003|Overall Study|Withdrawal by Subject|0|||
124600786|NCT00515034|448156226|FG000|Overall Study|Physician Decision|0|||
124600787|NCT00515034|448156227|FG001|Overall Study|Physician Decision|0|||
124600788|NCT00515034|448156228|FG002|Overall Study|Physician Decision|1|||
124600789|NCT00515034|448156229|FG003|Overall Study|Physician Decision|1|||
124600790|NCT00515034|448156226|FG000|Overall Study|Other|1|||
124600791|NCT00515034|448156227|FG001|Overall Study|Other|0|||
124600792|NCT00515034|448156228|FG002|Overall Study|Other|2|||
124600793|NCT00515034|448156229|FG003|Overall Study|Other|1|||
124600794|NCT01392326|448156230|FG000|Overall Study|Death|2|||
124600795|NCT01392326|448156231|FG001|Overall Study|Death|0|||
124600796|NCT01392326|448156232|FG002|Overall Study|Death|0|||
124600797|NCT01392326|448156230|FG000|Overall Study|Withdrawal by Subject|12|||
124600798|NCT01392326|448156231|FG001|Overall Study|Withdrawal by Subject|11|||
124600799|NCT01392326|448156232|FG002|Overall Study|Withdrawal by Subject|15|||
124600800|NCT01392326|448156230|FG000|Overall Study|Protocol Violation|2|||
124600801|NCT01392326|448156231|FG001|Overall Study|Protocol Violation|0|||
124600802|NCT01392326|448156232|FG002|Overall Study|Protocol Violation|0|||
124600803|NCT01392326|448156230|FG000|Overall Study|Pregnancy|0|||
124600804|NCT01392326|448156231|FG001|Overall Study|Pregnancy|0|||
124600805|NCT01392326|448156232|FG002|Overall Study|Pregnancy|1|||
124600806|NCT01392326|448156230|FG000|Overall Study|Physician Decision|7|||
124600807|NCT01392326|448156231|FG001|Overall Study|Physician Decision|5|||
124600808|NCT01392326|448156232|FG002|Overall Study|Physician Decision|2|||
124600809|NCT01392326|448156230|FG000|Overall Study|Lost to Follow-up|1|||
124600810|NCT01392326|448156231|FG001|Overall Study|Lost to Follow-up|3|||
124600811|NCT01392326|448156232|FG002|Overall Study|Lost to Follow-up|4|||
124600812|NCT01392326|448156230|FG000|Overall Study|Lack of Efficacy|14|||
124600813|NCT01392326|448156231|FG001|Overall Study|Lack of Efficacy|10|||
124600814|NCT01392326|448156232|FG002|Overall Study|Lack of Efficacy|15|||
124600815|NCT01392326|448156230|FG000|Overall Study|Adverse Event|9|||
124600816|NCT01392326|448156231|FG001|Overall Study|Adverse Event|6|||
124600817|NCT01392326|448156232|FG002|Overall Study|Adverse Event|11|||
124600818|NCT05626803|448158434|FG000|Overall Study|Lost to Follow-up|0|||
124600819|NCT05626803|448158435|FG001|Overall Study|Lost to Follow-up|1|||
124600820|NCT05626803|448158436|FG002|Overall Study|Lost to Follow-up|0|||
124600821|NCT05626803|448158437|FG003|Overall Study|Lost to Follow-up|0|||
124600822|NCT00493246|448158438|FG000|Overall Study|Withdrawal by Subject|0|||
124600823|NCT00493246|448158439|FG001|Overall Study|Withdrawal by Subject|0|||
124600824|NCT00493246|448158440|FG002|Overall Study|Withdrawal by Subject|0|||
124600825|NCT00493246|448158441|FG003|Overall Study|Withdrawal by Subject|0|||
124600826|NCT00493246|448158442|FG004|Overall Study|Withdrawal by Subject|1|||
124600827|NCT00493246|448158443|FG005|Overall Study|Withdrawal by Subject|0|||
124600828|NCT00493246|448158444|FG006|Overall Study|Withdrawal by Subject|0|||
124600829|NCT00493246|448158445|FG007|Overall Study|Withdrawal by Subject|0|||
124600830|NCT00493246|448158438|FG000|Overall Study|No access to draw blood|0|||
124600831|NCT00493246|448158439|FG001|Overall Study|No access to draw blood|0|||
124600832|NCT00493246|448158440|FG002|Overall Study|No access to draw blood|0|||
124600833|NCT00493246|448158441|FG003|Overall Study|No access to draw blood|0|||
124600834|NCT00493246|448158442|FG004|Overall Study|No access to draw blood|0|||
124600835|NCT00493246|448158443|FG005|Overall Study|No access to draw blood|1|||
124600836|NCT00493246|448158444|FG006|Overall Study|No access to draw blood|0|||
124600837|NCT00493246|448158445|FG007|Overall Study|No access to draw blood|0|||
124600838|NCT00493246|448158438|FG000|Overall Study|Lost to Follow-up|0|||
124600839|NCT00493246|448158439|FG001|Overall Study|Lost to Follow-up|0|||
124600840|NCT00493246|448158440|FG002|Overall Study|Lost to Follow-up|0|||
124600841|NCT00493246|448158441|FG003|Overall Study|Lost to Follow-up|0|||
124600842|NCT00493246|448158442|FG004|Overall Study|Lost to Follow-up|0|||
124600843|NCT00493246|448158443|FG005|Overall Study|Lost to Follow-up|0|||
124600844|NCT00493246|448158444|FG006|Overall Study|Lost to Follow-up|1|||
124600845|NCT00493246|448158445|FG007|Overall Study|Lost to Follow-up|0|||
124600846|NCT02054130|448158450|FG000|Overall Study|Withdrawal by Subject|4|||
124600847|NCT02054130|448158451|FG001|Overall Study|Withdrawal by Subject|4|||
124600848|NCT02054130|448158452|FG002|Overall Study|Withdrawal by Subject|7|||
124600849|NCT02054130|448158453|FG003|Overall Study|Withdrawal by Subject|10|||
124600850|NCT02054130|448158450|FG000|Overall Study|Death|0|||
124600851|NCT02054130|448158451|FG001|Overall Study|Death|1|||
124600852|NCT02054130|448158452|FG002|Overall Study|Death|0|||
124600853|NCT02054130|448158453|FG003|Overall Study|Death|0|||
124600854|NCT02054130|448158450|FG000|Overall Study|Lost to Follow-up|0|||
124600855|NCT02054130|448158451|FG001|Overall Study|Lost to Follow-up|0|||
124600856|NCT02054130|448158452|FG002|Overall Study|Lost to Follow-up|1|||
124600857|NCT02054130|448158453|FG003|Overall Study|Lost to Follow-up|2|||
124600858|NCT02054130|448158450|FG000|Overall Study|Missed dose|4|||
124600859|NCT02054130|448158451|FG001|Overall Study|Missed dose|6|||
124600860|NCT02054130|448158452|FG002|Overall Study|Missed dose|7|||
124600861|NCT02054130|448158453|FG003|Overall Study|Missed dose|10|||
124600862|NCT00094458|448158454|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
124600863|NCT00094458|448158455|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
124600864|NCT00094458|448158456|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
124600865|NCT00094458|448158457|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
124600866|NCT00094458|448158458|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
124600867|NCT00094458|448158459|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
124600868|NCT00094458|448158454|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
124600869|NCT00094458|448158455|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
124600870|NCT00094458|448158456|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
124600871|NCT00094458|448158457|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
124600872|NCT00094458|448158458|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
124600873|NCT00094458|448158459|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
124600874|NCT00094458|448158454|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
124600875|NCT00094458|448158455|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
124600876|NCT00094458|448158456|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
124600877|NCT00094458|448158457|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
124600878|NCT00094458|448158458|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
124600879|NCT00094458|448158459|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
124600880|NCT00094458|448158454|FG000|Main Study: Through Week 30|Adverse Event|38|||
124600881|NCT00094458|448158455|FG001|Main Study: Through Week 30|Adverse Event|20|||
124780719|NCT00552188|448826999|FG000|Overall Study|Lost to Follow-up|2|||
124780720|NCT00552188|448827000|FG001|Overall Study|Lost to Follow-up|1|||
124780721|NCT00552188|448826999|FG000|Overall Study|Withdrawal of consent|0|||
124780722|NCT00552188|448827000|FG001|Overall Study|Withdrawal of consent|1|||
124600882|NCT00094458|448158456|FG002|Main Study: Through Week 30|Adverse Event|28|||
124600883|NCT00094458|448158457|FG003|Main Study: Through Week 30|Adverse Event|0|||
124600884|NCT00094458|448158458|FG004|Main Study: Through Week 30|Adverse Event|0|||
124600885|NCT00094458|448158459|FG005|Main Study: Through Week 30|Adverse Event|0|||
124600886|NCT00094458|448158454|FG000|Main Study: Through Week 30|Death|1|||
124600887|NCT00094458|448158455|FG001|Main Study: Through Week 30|Death|0|||
124600888|NCT00094458|448158456|FG002|Main Study: Through Week 30|Death|0|||
124600889|NCT00094458|448158457|FG003|Main Study: Through Week 30|Death|0|||
124780723|NCT00552188|448826999|FG000|Overall Study|Subject returned to home country|0|||
124600890|NCT00094458|448158458|FG004|Main Study: Through Week 30|Death|0|||
124600891|NCT00094458|448158459|FG005|Main Study: Through Week 30|Death|0|||
124600892|NCT00094458|448158454|FG000|Main Study: Through Week 30|Other|19|||
124600893|NCT00094458|448158455|FG001|Main Study: Through Week 30|Other|16|||
124600894|NCT00094458|448158456|FG002|Main Study: Through Week 30|Other|9|||
124600895|NCT00094458|448158457|FG003|Main Study: Through Week 30|Other|0|||
124600896|NCT00094458|448158458|FG004|Main Study: Through Week 30|Other|0|||
124600897|NCT00094458|448158459|FG005|Main Study: Through Week 30|Other|0|||
124600898|NCT00094458|448158454|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
124600899|NCT00094458|448158455|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
124600900|NCT00094458|448158456|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
124600901|NCT00094458|448158457|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
124600902|NCT00094458|448158458|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
124600903|NCT00094458|448158459|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
124600904|NCT00094458|448158454|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
124600905|NCT00094458|448158455|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
124600906|NCT00094458|448158456|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
124600907|NCT00094458|448158457|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
124600908|NCT00094458|448158458|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
124600909|NCT00094458|448158459|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
124600910|NCT00094458|448158454|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
124600911|NCT00094458|448158455|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
124600912|NCT00094458|448158456|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
124600913|NCT00094458|448158457|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
124600914|NCT00094458|448158458|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
124600915|NCT00094458|448158459|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
124600916|NCT00094458|448158454|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
124600917|NCT00094458|448158455|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
124600918|NCT00094458|448158456|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
124600919|NCT00094458|448158457|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
124600920|NCT00094458|448158458|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
124600921|NCT00094458|448158459|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
124600922|NCT00094458|448158454|FG000|OLE: Open-Label Extension|Adverse Event|0|||
124600923|NCT00094458|448158455|FG001|OLE: Open-Label Extension|Adverse Event|0|||
124600924|NCT00094458|448158456|FG002|OLE: Open-Label Extension|Adverse Event|0|||
124600925|NCT00094458|448158457|FG003|OLE: Open-Label Extension|Adverse Event|0|||
124600926|NCT00094458|448158458|FG004|OLE: Open-Label Extension|Adverse Event|3|||
124600927|NCT00094458|448158459|FG005|OLE: Open-Label Extension|Adverse Event|4|||
124600928|NCT00094458|448158454|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
124600929|NCT00094458|448158455|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
124600930|NCT00094458|448158456|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
124600931|NCT00094458|448158457|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
124600932|NCT00094458|448158458|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
124600933|NCT00094458|448158459|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
124600934|NCT00094458|448158454|FG000|OLE: Open-Label Extension|Patient decision|0|||
124600935|NCT00094458|448158455|FG001|OLE: Open-Label Extension|Patient decision|0|||
124600936|NCT00094458|448158456|FG002|OLE: Open-Label Extension|Patient decision|0|||
124600937|NCT00094458|448158457|FG003|OLE: Open-Label Extension|Patient decision|0|||
124600938|NCT00094458|448158458|FG004|OLE: Open-Label Extension|Patient decision|1|||
124600939|NCT00094458|448158459|FG005|OLE: Open-Label Extension|Patient decision|0|||
124600940|NCT02017860|448158464|FG000|Overall Study|Adverse Event|1|||
124600941|NCT02017860|448158464|FG000|Overall Study|Withdrawal by Subject|1|||
124600942|NCT01206816|448158467|FG000|Overall Study|Protocol Violation|0|||
124600943|NCT01206816|448158468|FG001|Overall Study|Protocol Violation|0|||
124600944|NCT01206816|448158469|FG002|Overall Study|Protocol Violation|1|||
124600945|NCT01206816|448158470|FG003|Overall Study|Protocol Violation|0|||
124600946|NCT01206816|448158471|FG004|Overall Study|Protocol Violation|0|||
124600947|NCT01206816|448158472|FG005|Overall Study|Protocol Violation|0|||
124600948|NCT01206816|448158473|FG006|Overall Study|Protocol Violation|0|||
124600949|NCT01206816|448158467|FG000|Overall Study|Withdrawal by Subject|0|||
124600950|NCT01206816|448158468|FG001|Overall Study|Withdrawal by Subject|0|||
124600951|NCT01206816|448158469|FG002|Overall Study|Withdrawal by Subject|1|||
124600952|NCT01206816|448158470|FG003|Overall Study|Withdrawal by Subject|0|||
124600953|NCT01206816|448158471|FG004|Overall Study|Withdrawal by Subject|0|||
124600954|NCT01206816|448158472|FG005|Overall Study|Withdrawal by Subject|0|||
124600955|NCT01206816|448158473|FG006|Overall Study|Withdrawal by Subject|0|||
124600956|NCT01206816|448158467|FG000|Overall Study|Progressive disease|3|||
124600957|NCT01206816|448158468|FG001|Overall Study|Progressive disease|3|||
124600958|NCT01206816|448158469|FG002|Overall Study|Progressive disease|13|||
124600959|NCT01206816|448158470|FG003|Overall Study|Progressive disease|3|||
124600960|NCT01206816|448158471|FG004|Overall Study|Progressive disease|3|||
124600961|NCT01206816|448158472|FG005|Overall Study|Progressive disease|16|||
124600962|NCT01206816|448158473|FG006|Overall Study|Progressive disease|3|||
124600963|NCT01206816|448158467|FG000|Overall Study|Other AE|0|||
124600964|NCT01206816|448158468|FG001|Overall Study|Other AE|0|||
124600965|NCT01206816|448158469|FG002|Overall Study|Other AE|4|||
124600966|NCT01206816|448158470|FG003|Overall Study|Other AE|0|||
124600967|NCT01206816|448158471|FG004|Overall Study|Other AE|0|||
124600968|NCT01206816|448158472|FG005|Overall Study|Other AE|3|||
124600969|NCT01206816|448158473|FG006|Overall Study|Other AE|2|||
124600970|NCT01206816|448158467|FG000|Overall Study|other than stated above|0|||
124600971|NCT01206816|448158468|FG001|Overall Study|other than stated above|0|||
124600972|NCT01206816|448158469|FG002|Overall Study|other than stated above|1|||
124600973|NCT01206816|448158470|FG003|Overall Study|other than stated above|0|||
124600974|NCT01206816|448158471|FG004|Overall Study|other than stated above|0|||
124600975|NCT01206816|448158472|FG005|Overall Study|other than stated above|0|||
124600976|NCT01206816|448158473|FG006|Overall Study|other than stated above|1|||
124600977|NCT02493777|448158476|FG000|Overall Study|Lost to Follow-up|0|||
124600978|NCT02493777|448158477|FG001|Overall Study|Lost to Follow-up|1|||
124600979|NCT00754442|448158478|FG000|Overall Study|Withdrawal by Subject|5|||
124600980|NCT00754442|448158479|FG001|Overall Study|Withdrawal by Subject|3|||
124600981|NCT01231373|448158480|FG000|Overall Study|Withdrew consent prior to randomization|2|||
124600982|NCT01231373|448158481|FG001|Overall Study|Withdrew consent prior to randomization|1|||
124600983|NCT01231373|448158482|FG002|Overall Study|Withdrew consent prior to randomization|0|||
124600984|NCT01231373|448158483|FG003|Overall Study|Withdrew consent prior to randomization|0|||
124600985|NCT01231373|448158480|FG000|Overall Study|Lost to Follow-up|0|||
124600986|NCT01231373|448158481|FG001|Overall Study|Lost to Follow-up|0|||
124600987|NCT01231373|448158482|FG002|Overall Study|Lost to Follow-up|0|||
124600988|NCT01231373|448158483|FG003|Overall Study|Lost to Follow-up|1|||
124600989|NCT01231373|448158480|FG000|Overall Study|Withdrew Consent|1|||
124600990|NCT01231373|448158481|FG001|Overall Study|Withdrew Consent|0|||
124600991|NCT01231373|448158482|FG002|Overall Study|Withdrew Consent|0|||
124600992|NCT01231373|448158483|FG003|Overall Study|Withdrew Consent|0|||
124600993|NCT02547766|448158484|FG000|Overall Study|Withdrawal by Subject|1|||
124600994|NCT00351351|448158485|FG000|Overall Study|surgical access pbs; device issues|9|||
124600995|NCT00351351|448158486|FG001|Overall Study|surgical access pbs; device issues|4|||
124600996|NCT01134627|448158487|FG000|Overall Study|Adverse Event|47|||
124600997|NCT01134627|448158488|FG001|Overall Study|Adverse Event|31|||
124600998|NCT01134627|448158487|FG000|Overall Study|Lost to Follow-up|1|||
124600999|NCT01134627|448158488|FG001|Overall Study|Lost to Follow-up|2|||
124601000|NCT01134627|448158487|FG000|Overall Study|Protocol Violation|3|||
124601001|NCT01134627|448158488|FG001|Overall Study|Protocol Violation|5|||
124601002|NCT01134627|448158487|FG000|Overall Study|Lack of Efficacy|2|||
124601003|NCT01134627|448158488|FG001|Overall Study|Lack of Efficacy|12|||
124601004|NCT01134627|448158487|FG000|Overall Study|Withdrawal by Subject|4|||
124601005|NCT01134627|448158488|FG001|Overall Study|Withdrawal by Subject|3|||
124601006|NCT01134627|448158487|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
124601007|NCT01134627|448158488|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
124601008|NCT01134627|448158487|FG000|Overall Study|Other|11|||
124601009|NCT01134627|448158488|FG001|Overall Study|Other|14|||
124601010|NCT00977431|448158494|FG000|Overall Study|Other than listed|1|||
124601011|NCT00977431|448158495|FG001|Overall Study|Other than listed|0|||
124601012|NCT00977431|448158496|FG002|Overall Study|Other than listed|0|||
124601013|NCT00977431|448158497|FG003|Overall Study|Other than listed|0|||
124601014|NCT00977431|448158498|FG004|Overall Study|Other than listed|2|||
124601015|NCT00977431|448158494|FG000|Overall Study|Protocol Violation|0|||
124601016|NCT00977431|448158495|FG001|Overall Study|Protocol Violation|0|||
124601017|NCT00977431|448158496|FG002|Overall Study|Protocol Violation|1|||
124601018|NCT00977431|448158497|FG003|Overall Study|Protocol Violation|0|||
124601019|NCT00977431|448158498|FG004|Overall Study|Protocol Violation|0|||
124601020|NCT00977431|448158494|FG000|Overall Study|Adverse Event|3|||
124601021|NCT00977431|448158495|FG001|Overall Study|Adverse Event|0|||
124601022|NCT00977431|448158496|FG002|Overall Study|Adverse Event|4|||
124601023|NCT00977431|448158497|FG003|Overall Study|Adverse Event|0|||
124601024|NCT00977431|448158498|FG004|Overall Study|Adverse Event|6|||
124601025|NCT00977431|448158494|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
124601026|NCT00977431|448158495|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
124601027|NCT00977431|448158496|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
124601028|NCT00977431|448158497|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
124601029|NCT00977431|448158498|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
124601030|NCT00977431|448158494|FG000|Overall Study|Progressive disease|2|||
124601031|NCT00977431|448158495|FG001|Overall Study|Progressive disease|6|||
124601032|NCT00977431|448158496|FG002|Overall Study|Progressive disease|1|||
124601033|NCT00977431|448158497|FG003|Overall Study|Progressive disease|3|||
124601034|NCT00977431|448158498|FG004|Overall Study|Progressive disease|5|||
124601035|NCT01010750|448158499|FG000|Second Intervention|Adverse Event|0|||
124601036|NCT01010750|448158500|FG001|Second Intervention|Adverse Event|1|||
124601037|NCT01010750|448158501|FG002|Second Intervention|Adverse Event|0|||
124601038|NCT01010750|448158502|FG003|Second Intervention|Adverse Event|0|||
124601039|NCT01010750|448158503|FG004|Second Intervention|Adverse Event|0|||
124601040|NCT01010750|448158504|FG005|Second Intervention|Adverse Event|0|||
124601041|NCT00518882|448158507|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
124601042|NCT00518882|448158508|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
124601043|NCT00518882|448158507|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
124601044|NCT00518882|448158508|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
124601045|NCT00518882|448158507|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
124601046|NCT00518882|448158508|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
124601047|NCT00518882|448158507|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
124601048|NCT00518882|448158508|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
124601049|NCT00518882|448158507|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
124601050|NCT00518882|448158508|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
124601051|NCT00518882|448158507|FG000|Double-Blind, Week 0-26|Subject decision|1|||
124601052|NCT00518882|448158508|FG001|Double-Blind, Week 0-26|Subject decision|1|||
124601053|NCT00518882|448158507|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
124601054|NCT00518882|448158508|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
124601055|NCT00518882|448158507|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
124601056|NCT00518882|448158508|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
124601057|NCT00518882|448158507|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
124601058|NCT00518882|448158508|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
124601059|NCT00518882|448158507|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
124601060|NCT00518882|448158508|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
124601061|NCT00518882|448158507|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
124601062|NCT00518882|448158508|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
124601063|NCT00518882|448158507|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
124601064|NCT00518882|448158508|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
124601065|NCT00518882|448158507|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
124601066|NCT00518882|448158508|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
124601067|NCT00518882|448158507|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
124601068|NCT00518882|448158508|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
124601069|NCT00518882|448158507|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
124601070|NCT00518882|448158508|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
124601071|NCT00518882|448158507|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
124601072|NCT00518882|448158508|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
124601073|NCT00518882|448158507|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
124601074|NCT00518882|448158508|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
124601075|NCT00518882|448158507|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
124601076|NCT00518882|448158508|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
124601077|NCT00518882|448158507|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
124601078|NCT00518882|448158508|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
124601079|NCT00518882|448158507|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
124601080|NCT00518882|448158508|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
124601081|NCT00518882|448158507|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
124601082|NCT00518882|448158508|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
124601083|NCT00518882|448158507|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
124601084|NCT00518882|448158508|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
124601085|NCT00518882|448158507|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
124601086|NCT00518882|448158508|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
124601087|NCT00518882|448158507|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
124601088|NCT00518882|448158508|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
124601089|NCT00567476|448158512|FG000|Overall Study|Adverse Event|2|||
124601090|NCT00567476|448158513|FG001|Overall Study|Adverse Event|0|||
124601091|NCT00567476|448158512|FG000|Overall Study|Pregnancy|1|||
124601092|NCT00567476|448158513|FG001|Overall Study|Pregnancy|0|||
124601093|NCT00567476|448158512|FG000|Overall Study|Protocol Violation|4|||
124601094|NCT00567476|448158513|FG001|Overall Study|Protocol Violation|1|||
124601095|NCT00567476|448158512|FG000|Overall Study|Lost to Follow-up|0|||
124601096|NCT00567476|448158513|FG001|Overall Study|Lost to Follow-up|1|||
124601097|NCT00567476|448158512|FG000|Overall Study|Administrative issues|1|||
124601098|NCT00567476|448158513|FG001|Overall Study|Administrative issues|0|||
124601099|NCT00567476|448158512|FG000|Overall Study|Medical Decision|0|||
124601100|NCT00567476|448158513|FG001|Overall Study|Medical Decision|1|||
124601101|NCT00567476|448158512|FG000|Overall Study|Non-adherence to protocol|0|||
124601102|NCT00567476|448158513|FG001|Overall Study|Non-adherence to protocol|1|||
124601103|NCT02696031|448158514|FG000|Up to Week 24|Adverse Event|2|||
124601104|NCT02696031|448158515|FG001|Up to Week 24|Adverse Event|4|||
124601105|NCT02696031|448158516|FG002|Up to Week 24|Adverse Event|2|||
124601106|NCT02696031|448158517|FG003|Up to Week 24|Adverse Event|0|||
124601107|NCT02696031|448158518|FG004|Up to Week 24|Adverse Event|0|||
124601108|NCT02696031|448158519|FG005|Up to Week 24|Adverse Event|0|||
124601109|NCT02696031|448158514|FG000|Up to Week 24|Lack of Efficacy|2|||
124601110|NCT02696031|448158515|FG001|Up to Week 24|Lack of Efficacy|1|||
124601111|NCT02696031|448158516|FG002|Up to Week 24|Lack of Efficacy|2|||
124601112|NCT02696031|448158517|FG003|Up to Week 24|Lack of Efficacy|0|||
124601113|NCT02696031|448158518|FG004|Up to Week 24|Lack of Efficacy|0|||
124601114|NCT02696031|448158519|FG005|Up to Week 24|Lack of Efficacy|0|||
124601115|NCT02696031|448158514|FG000|Up to Week 24|Lost to Follow-up|0|||
124601116|NCT02696031|448158515|FG001|Up to Week 24|Lost to Follow-up|1|||
124601117|NCT02696031|448158516|FG002|Up to Week 24|Lost to Follow-up|1|||
124601118|NCT02696031|448158517|FG003|Up to Week 24|Lost to Follow-up|0|||
124601119|NCT02696031|448158518|FG004|Up to Week 24|Lost to Follow-up|0|||
124601120|NCT02696031|448158519|FG005|Up to Week 24|Lost to Follow-up|0|||
124601121|NCT02696031|448158514|FG000|Up to Week 24|Physician Decision|1|||
124601122|NCT02696031|448158515|FG001|Up to Week 24|Physician Decision|0|||
124601123|NCT02696031|448158516|FG002|Up to Week 24|Physician Decision|1|||
124601124|NCT02696031|448158517|FG003|Up to Week 24|Physician Decision|0|||
124601125|NCT02696031|448158518|FG004|Up to Week 24|Physician Decision|0|||
124601126|NCT02696031|448158519|FG005|Up to Week 24|Physician Decision|0|||
124601127|NCT02696031|448158514|FG000|Up to Week 24|Protocol Violation|1|||
124601128|NCT02696031|448158515|FG001|Up to Week 24|Protocol Violation|0|||
124601129|NCT02696031|448158516|FG002|Up to Week 24|Protocol Violation|0|||
124601130|NCT02696031|448158517|FG003|Up to Week 24|Protocol Violation|0|||
124601131|NCT02696031|448158518|FG004|Up to Week 24|Protocol Violation|0|||
124601132|NCT02696031|448158519|FG005|Up to Week 24|Protocol Violation|0|||
124601133|NCT02696031|448158514|FG000|Up to Week 24|Withdrawal by Subject|4|||
124601134|NCT02696031|448158515|FG001|Up to Week 24|Withdrawal by Subject|1|||
124601135|NCT02696031|448158516|FG002|Up to Week 24|Withdrawal by Subject|5|||
124601136|NCT02696031|448158517|FG003|Up to Week 24|Withdrawal by Subject|0|||
124601137|NCT02696031|448158518|FG004|Up to Week 24|Withdrawal by Subject|0|||
124601138|NCT02696031|448158519|FG005|Up to Week 24|Withdrawal by Subject|0|||
124601139|NCT02696031|448158514|FG000|Up to Week 52|Adverse Event|4|||
124601140|NCT02696031|448158515|FG001|Up to Week 52|Adverse Event|5|||
124601141|NCT02696031|448158516|FG002|Up to Week 52|Adverse Event|3|||
124601142|NCT02696031|448158517|FG003|Up to Week 52|Adverse Event|0|||
124601143|NCT02696031|448158518|FG004|Up to Week 52|Adverse Event|0|||
124601144|NCT02696031|448158519|FG005|Up to Week 52|Adverse Event|0|||
124601145|NCT02696031|448158514|FG000|Up to Week 52|Lack of Efficacy|10|||
124601146|NCT02696031|448158515|FG001|Up to Week 52|Lack of Efficacy|7|||
124601147|NCT02696031|448158516|FG002|Up to Week 52|Lack of Efficacy|11|||
124601148|NCT02696031|448158517|FG003|Up to Week 52|Lack of Efficacy|0|||
124601149|NCT02696031|448158518|FG004|Up to Week 52|Lack of Efficacy|0|||
124601150|NCT02696031|448158519|FG005|Up to Week 52|Lack of Efficacy|0|||
124601151|NCT02696031|448158514|FG000|Up to Week 52|Lost to Follow-up|1|||
124601152|NCT02696031|448158515|FG001|Up to Week 52|Lost to Follow-up|1|||
124601153|NCT02696031|448158516|FG002|Up to Week 52|Lost to Follow-up|1|||
124601154|NCT02696031|448158517|FG003|Up to Week 52|Lost to Follow-up|0|||
124601155|NCT02696031|448158518|FG004|Up to Week 52|Lost to Follow-up|0|||
124601156|NCT02696031|448158519|FG005|Up to Week 52|Lost to Follow-up|0|||
124601157|NCT02696031|448158514|FG000|Up to Week 52|Physician Decision|1|||
124601158|NCT02696031|448158515|FG001|Up to Week 52|Physician Decision|1|||
124601159|NCT02696031|448158516|FG002|Up to Week 52|Physician Decision|2|||
124601160|NCT02696031|448158517|FG003|Up to Week 52|Physician Decision|0|||
124601161|NCT02696031|448158518|FG004|Up to Week 52|Physician Decision|0|||
124601162|NCT02696031|448158519|FG005|Up to Week 52|Physician Decision|0|||
124601163|NCT02696031|448158514|FG000|Up to Week 52|Pregnancy|0|||
124601164|NCT02696031|448158515|FG001|Up to Week 52|Pregnancy|2|||
124601165|NCT02696031|448158516|FG002|Up to Week 52|Pregnancy|0|||
124601166|NCT02696031|448158517|FG003|Up to Week 52|Pregnancy|0|||
124601167|NCT02696031|448158518|FG004|Up to Week 52|Pregnancy|0|||
124601168|NCT02696031|448158519|FG005|Up to Week 52|Pregnancy|0|||
124601169|NCT02696031|448158514|FG000|Up to Week 52|Protocol Violation|1|||
124601170|NCT02696031|448158515|FG001|Up to Week 52|Protocol Violation|0|||
124601171|NCT02696031|448158516|FG002|Up to Week 52|Protocol Violation|0|||
124601172|NCT02696031|448158517|FG003|Up to Week 52|Protocol Violation|0|||
124601173|NCT02696031|448158518|FG004|Up to Week 52|Protocol Violation|0|||
124601174|NCT02696031|448158519|FG005|Up to Week 52|Protocol Violation|0|||
124601175|NCT02696031|448158514|FG000|Up to Week 52|Withdrawal by Subject|12|||
124601176|NCT02696031|448158515|FG001|Up to Week 52|Withdrawal by Subject|3|||
124601177|NCT02696031|448158516|FG002|Up to Week 52|Withdrawal by Subject|9|||
124601178|NCT02696031|448158517|FG003|Up to Week 52|Withdrawal by Subject|0|||
124601179|NCT02696031|448158518|FG004|Up to Week 52|Withdrawal by Subject|0|||
124601180|NCT02696031|448158519|FG005|Up to Week 52|Withdrawal by Subject|0|||
124601181|NCT02696031|448158514|FG000|Up to Week 104|Pregnancy|0|||
124601182|NCT02696031|448158515|FG001|Up to Week 104|Pregnancy|2|||
124601183|NCT02696031|448158516|FG002|Up to Week 104|Pregnancy|1|||
124601184|NCT02696031|448158517|FG003|Up to Week 104|Pregnancy|0|||
124601185|NCT02696031|448158518|FG004|Up to Week 104|Pregnancy|0|||
124601186|NCT02696031|448158519|FG005|Up to Week 104|Pregnancy|0|||
124601187|NCT02696031|448158514|FG000|Up to Week 104|Withdrawal by Subject|15|||
124601188|NCT02696031|448158515|FG001|Up to Week 104|Withdrawal by Subject|10|||
124601189|NCT02696031|448158516|FG002|Up to Week 104|Withdrawal by Subject|16|||
124601190|NCT02696031|448158517|FG003|Up to Week 104|Withdrawal by Subject|0|||
124601191|NCT02696031|448158518|FG004|Up to Week 104|Withdrawal by Subject|0|||
124601192|NCT02696031|448158519|FG005|Up to Week 104|Withdrawal by Subject|0|||
124601193|NCT02696031|448158514|FG000|Up to Week 104|Protocol Violation|1|||
124601194|NCT02696031|448158515|FG001|Up to Week 104|Protocol Violation|0|||
124601195|NCT02696031|448158516|FG002|Up to Week 104|Protocol Violation|0|||
124601196|NCT02696031|448158517|FG003|Up to Week 104|Protocol Violation|0|||
124601197|NCT02696031|448158518|FG004|Up to Week 104|Protocol Violation|0|||
124601198|NCT02696031|448158519|FG005|Up to Week 104|Protocol Violation|0|||
124601199|NCT02696031|448158514|FG000|Up to Week 104|Physician Decision|1|||
124601200|NCT02696031|448158515|FG001|Up to Week 104|Physician Decision|2|||
124601201|NCT02696031|448158516|FG002|Up to Week 104|Physician Decision|3|||
124601202|NCT02696031|448158517|FG003|Up to Week 104|Physician Decision|0|||
124601203|NCT02696031|448158518|FG004|Up to Week 104|Physician Decision|0|||
124601204|NCT02696031|448158519|FG005|Up to Week 104|Physician Decision|0|||
124601205|NCT02696031|448158514|FG000|Up to Week 104|Lost to Follow-up|2|||
124601206|NCT02696031|448158515|FG001|Up to Week 104|Lost to Follow-up|3|||
124601207|NCT02696031|448158516|FG002|Up to Week 104|Lost to Follow-up|1|||
124601208|NCT02696031|448158517|FG003|Up to Week 104|Lost to Follow-up|0|||
124601209|NCT02696031|448158518|FG004|Up to Week 104|Lost to Follow-up|0|||
124601210|NCT02696031|448158519|FG005|Up to Week 104|Lost to Follow-up|0|||
124601211|NCT02696031|448158514|FG000|Up to Week 104|Lack of Efficacy|13|||
124601212|NCT02696031|448158515|FG001|Up to Week 104|Lack of Efficacy|12|||
124601213|NCT02696031|448158516|FG002|Up to Week 104|Lack of Efficacy|11|||
124601214|NCT02696031|448158517|FG003|Up to Week 104|Lack of Efficacy|0|||
124601215|NCT02696031|448158518|FG004|Up to Week 104|Lack of Efficacy|0|||
124601216|NCT02696031|448158519|FG005|Up to Week 104|Lack of Efficacy|0|||
124601217|NCT02696031|448158514|FG000|Up to Week 104|Adverse Event|7|||
124601218|NCT02696031|448158515|FG001|Up to Week 104|Adverse Event|11|||
124601219|NCT02696031|448158516|FG002|Up to Week 104|Adverse Event|5|||
124601220|NCT02696031|448158517|FG003|Up to Week 104|Adverse Event|0|||
124601221|NCT02696031|448158518|FG004|Up to Week 104|Adverse Event|0|||
124601222|NCT02696031|448158519|FG005|Up to Week 104|Adverse Event|0|||
124601223|NCT02696031|448158514|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
124601224|NCT02696031|448158515|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
124601225|NCT02696031|448158516|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
124601226|NCT02696031|448158517|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
124601227|NCT02696031|448158518|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
124601228|NCT02696031|448158519|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
124601229|NCT02696031|448158514|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
124601230|NCT02696031|448158515|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
124601231|NCT02696031|448158516|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
124601232|NCT02696031|448158517|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
124601233|NCT02696031|448158518|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
124601234|NCT02696031|448158519|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
124601235|NCT02696031|448158514|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
124601236|NCT02696031|448158515|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
124601237|NCT02696031|448158516|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
124601238|NCT02696031|448158517|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
124601239|NCT02696031|448158518|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
124601240|NCT02696031|448158519|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
124601241|NCT02696031|448158514|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
124601242|NCT02696031|448158515|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
124601243|NCT02696031|448158516|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
124601244|NCT02696031|448158517|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
124601245|NCT02696031|448158518|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
124601246|NCT02696031|448158519|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
124601247|NCT02696031|448158514|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
124601248|NCT02696031|448158515|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
124601249|NCT02696031|448158516|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
124601250|NCT02696031|448158517|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
124601251|NCT02696031|448158518|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
124601252|NCT02696031|448158519|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
124601253|NCT02696031|448158514|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
124601254|NCT02696031|448158515|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
124601255|NCT02696031|448158516|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
124601256|NCT02696031|448158517|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
124601257|NCT02696031|448158518|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
124731269|NCT03334851|448640070|FG006|Overall Study|Withdrawal by Subject|0|||
124731270|NCT03334851|448640071|FG007|Overall Study|Withdrawal by Subject|0|||
124731271|NCT03334851|448640072|FG008|Overall Study|Withdrawal by Subject|0|||
124731272|NCT03334851|448640073|FG009|Overall Study|Withdrawal by Subject|0|||
124601258|NCT02696031|448158519|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
124601259|NCT02696031|448158514|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
124601260|NCT02696031|448158515|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
124601261|NCT02696031|448158516|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
124731273|NCT03334851|448640074|FG010|Overall Study|Withdrawal by Subject|1|||
124780724|NCT00552188|448827000|FG001|Overall Study|Subject returned to home country|1|||
124780725|NCT03887702|448827001|FG000|Overall Study|Study terminated|0|||
124780726|NCT03887702|448827002|FG001|Overall Study|Study terminated|0|||
124780727|NCT03887702|448827003|FG002|Overall Study|Study terminated|2|||
124780728|NCT03887702|448827004|FG003|Overall Study|Study terminated|2|||
124780729|NCT01675544|448827007|FG000|Overall Study|Withdrawal by Subject|2|||
124780730|NCT00476008|448827012|FG000|Overall Study|Adverse Event|4|||
124780731|NCT00476008|448827013|FG001|Overall Study|Adverse Event|4|||
124780732|NCT00476008|448827012|FG000|Overall Study|Placebo concerns|2|||
124780733|NCT00476008|448827013|FG001|Overall Study|Placebo concerns|2|||
124780734|NCT00476008|448827012|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
124780735|NCT00476008|448827013|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
124780736|NCT00476008|448827012|FG000|Overall Study|Withdrawal by Subject|0|||
124780737|NCT00476008|448827013|FG001|Overall Study|Withdrawal by Subject|1|||
124601262|NCT02696031|448158517|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
124601263|NCT02696031|448158518|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
124601264|NCT02696031|448158519|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
124601265|NCT02777918|448158520|FG000|Overall Study|Medical reasons|1|||
124601266|NCT02777918|448158521|FG001|Overall Study|Medical reasons|2|||
124601267|NCT02777918|448158520|FG000|Overall Study|Too busy / stressed|1|||
124601268|NCT02777918|448158521|FG001|Overall Study|Too busy / stressed|1|||
124601269|NCT02777918|448158520|FG000|Overall Study|Withdrawal by Subject|1|||
124601270|NCT02777918|448158521|FG001|Overall Study|Withdrawal by Subject|1|||
124601271|NCT00058214|448158522|FG000|Overall Study|Adverse Event|1|||
124601272|NCT03856593|448158526|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
124601273|NCT03856593|448158527|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
124601274|NCT03978091|448158531|FG000|Overall Study|Lost to Follow-up|0|||
124601275|NCT03978091|448158532|FG001|Overall Study|Lost to Follow-up|0|||
124601276|NCT03978091|448158533|FG002|Overall Study|Lost to Follow-up|1|||
124731274|NCT03334851|448640075|FG011|Overall Study|Withdrawal by Subject|0|||
124731275|NCT03334851|448640076|FG012|Overall Study|Withdrawal by Subject|1|||
124731276|NCT03334851|448640064|FG000|Overall Study|Lost to Follow-up|0|||
124731277|NCT03334851|448640065|FG001|Overall Study|Lost to Follow-up|0|||
124731278|NCT03334851|448640066|FG002|Overall Study|Lost to Follow-up|0|||
124731279|NCT03334851|448640067|FG003|Overall Study|Lost to Follow-up|0|||
124731280|NCT03334851|448640068|FG004|Overall Study|Lost to Follow-up|0|||
124731281|NCT03334851|448640069|FG005|Overall Study|Lost to Follow-up|0|||
124731282|NCT03334851|448640070|FG006|Overall Study|Lost to Follow-up|0|||
124731283|NCT03334851|448640071|FG007|Overall Study|Lost to Follow-up|0|||
124731284|NCT03334851|448640072|FG008|Overall Study|Lost to Follow-up|0|||
124731285|NCT03334851|448640073|FG009|Overall Study|Lost to Follow-up|0|||
124731286|NCT03334851|448640074|FG010|Overall Study|Lost to Follow-up|2|||
124731287|NCT03334851|448640075|FG011|Overall Study|Lost to Follow-up|1|||
124731288|NCT03334851|448640076|FG012|Overall Study|Lost to Follow-up|0|||
124731289|NCT01691885|448640077|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
124731290|NCT01691885|448640078|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
124731291|NCT01691885|448640077|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
124731292|NCT01691885|448640078|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
124731293|NCT03555981|448640079|FG000|Overall Study|Lost to Follow-up|0|||
124731294|NCT03555981|448640080|FG001|Overall Study|Lost to Follow-up|2|||
124731295|NCT02754141|448640084|FG000|Overall Study|Disease progression|11|||
124731296|NCT02754141|448640085|FG001|Overall Study|Disease progression|7|||
124731297|NCT02754141|448640086|FG002|Overall Study|Disease progression|8|||
124731298|NCT02754141|448640087|FG003|Overall Study|Disease progression|5|||
124731299|NCT02754141|448640088|FG004|Overall Study|Disease progression|7|||
124731300|NCT02754141|448640089|FG005|Overall Study|Disease progression|7|||
124731301|NCT02754141|448640090|FG006|Overall Study|Disease progression|7|||
124731302|NCT02754141|448640091|FG007|Overall Study|Disease progression|6|||
124731303|NCT02754141|448640092|FG008|Overall Study|Disease progression|11|||
124731304|NCT02754141|448640093|FG009|Overall Study|Disease progression|16|||
124731305|NCT02754141|448640094|FG010|Overall Study|Disease progression|18|||
124731306|NCT02754141|448640095|FG011|Overall Study|Disease progression|13|||
124731307|NCT02754141|448640096|FG012|Overall Study|Disease progression|10|||
124731308|NCT02754141|448640097|FG013|Overall Study|Disease progression|12|||
124731309|NCT02754141|448640098|FG014|Overall Study|Disease progression|12|||
124731310|NCT02754141|448640099|FG015|Overall Study|Disease progression|14|||
124731311|NCT02754141|448640100|FG016|Overall Study|Disease progression|0|||
124731312|NCT02754141|448640101|FG017|Overall Study|Disease progression|1|||
124731313|NCT02754141|448640084|FG000|Overall Study|Study drug toxicity|1|||
124780738|NCT00476008|448827012|FG000|Overall Study|Death|1|||
124780739|NCT00476008|448827013|FG001|Overall Study|Death|0|||
124601277|NCT03978091|448158534|FG003|Overall Study|Lost to Follow-up|0|||
124731314|NCT02754141|448640085|FG001|Overall Study|Study drug toxicity|1|||
124731315|NCT02754141|448640086|FG002|Overall Study|Study drug toxicity|0|||
124731316|NCT02754141|448640087|FG003|Overall Study|Study drug toxicity|0|||
124731317|NCT02754141|448640088|FG004|Overall Study|Study drug toxicity|0|||
124731318|NCT02754141|448640089|FG005|Overall Study|Study drug toxicity|0|||
124601278|NCT03978091|448158535|FG004|Overall Study|Lost to Follow-up|0|||
124601279|NCT03978091|448158536|FG005|Overall Study|Lost to Follow-up|0|||
124601280|NCT03978091|448158531|FG000|Overall Study|Withdrawal by Subject|0|||
124601281|NCT03978091|448158532|FG001|Overall Study|Withdrawal by Subject|0|||
124601282|NCT03978091|448158533|FG002|Overall Study|Withdrawal by Subject|0|||
124601283|NCT03978091|448158534|FG003|Overall Study|Withdrawal by Subject|1|||
124601284|NCT03978091|448158535|FG004|Overall Study|Withdrawal by Subject|1|||
124601285|NCT03978091|448158536|FG005|Overall Study|Withdrawal by Subject|0|||
124601286|NCT02595008|448158541|FG000|Overall Study|Enrolled In Error|1|||
124601287|NCT02595008|448158542|FG001|Overall Study|Enrolled In Error|0|||
124601288|NCT03078582|448158545|FG000|Overall Study|Adverse Event|0|||
124601289|NCT03078582|448158546|FG001|Overall Study|Adverse Event|8|||
124601290|NCT02972502|448158557|FG000|Overall Study|Lost to Follow-up|3|||
124601291|NCT02972502|448158558|FG001|Overall Study|Lost to Follow-up|1|||
124601292|NCT02972502|448158557|FG000|Overall Study|Withdrawal by Subject|1|||
124601293|NCT02972502|448158558|FG001|Overall Study|Withdrawal by Subject|1|||
124601294|NCT01347866|448158561|FG000|Overall Study|Death|0|||
124601295|NCT01347866|448158562|FG001|Overall Study|Death|0|||
124601296|NCT01347866|448158563|FG002|Overall Study|Death|0|||
124601297|NCT01347866|448158564|FG003|Overall Study|Death|1|||
124601298|NCT01347866|448158565|FG004|Overall Study|Death|2|||
124601299|NCT01347866|448158566|FG005|Overall Study|Death|2|||
124601300|NCT01347866|448158567|FG006|Overall Study|Death|1|||
124601301|NCT01347866|448158568|FG007|Overall Study|Death|0|||
124601302|NCT01347866|448158569|FG008|Overall Study|Death|4|||
124601303|NCT01347866|448158570|FG009|Overall Study|Death|1|||
124601304|NCT01347866|448158571|FG010|Overall Study|Death|3|||
124601305|NCT01347866|448158572|FG011|Overall Study|Death|1|||
124601306|NCT01347866|448158573|FG012|Overall Study|Death|2|||
124601307|NCT01347866|448158574|FG013|Overall Study|Death|0|||
124601308|NCT01347866|448158575|FG014|Overall Study|Death|0|||
124601309|NCT01347866|448158576|FG015|Overall Study|Death|1|||
124601310|NCT01347866|448158577|FG016|Overall Study|Death|0|||
124601311|NCT01347866|448158561|FG000|Overall Study|Lost to Follow-up|0|||
124601312|NCT01347866|448158562|FG001|Overall Study|Lost to Follow-up|0|||
124601313|NCT01347866|448158563|FG002|Overall Study|Lost to Follow-up|0|||
124601314|NCT01347866|448158564|FG003|Overall Study|Lost to Follow-up|0|||
124601315|NCT01347866|448158565|FG004|Overall Study|Lost to Follow-up|0|||
124601316|NCT01347866|448158566|FG005|Overall Study|Lost to Follow-up|0|||
124601317|NCT01347866|448158567|FG006|Overall Study|Lost to Follow-up|0|||
124601318|NCT01347866|448158568|FG007|Overall Study|Lost to Follow-up|1|||
124601319|NCT01347866|448158569|FG008|Overall Study|Lost to Follow-up|1|||
124601320|NCT01347866|448158570|FG009|Overall Study|Lost to Follow-up|0|||
124601321|NCT01347866|448158571|FG010|Overall Study|Lost to Follow-up|0|||
124601322|NCT01347866|448158572|FG011|Overall Study|Lost to Follow-up|0|||
124601323|NCT01347866|448158573|FG012|Overall Study|Lost to Follow-up|0|||
124601324|NCT01347866|448158574|FG013|Overall Study|Lost to Follow-up|0|||
124601325|NCT01347866|448158575|FG014|Overall Study|Lost to Follow-up|0|||
124601326|NCT01347866|448158576|FG015|Overall Study|Lost to Follow-up|0|||
124601327|NCT01347866|448158577|FG016|Overall Study|Lost to Follow-up|0|||
124601328|NCT01347866|448158561|FG000|Overall Study|Other|3|||
124601329|NCT01347866|448158562|FG001|Overall Study|Other|1|||
124601330|NCT01347866|448158563|FG002|Overall Study|Other|1|||
124601331|NCT01347866|448158564|FG003|Overall Study|Other|4|||
124601332|NCT01347866|448158565|FG004|Overall Study|Other|5|||
124601333|NCT01347866|448158566|FG005|Overall Study|Other|0|||
124601334|NCT01347866|448158567|FG006|Overall Study|Other|5|||
124601335|NCT01347866|448158568|FG007|Overall Study|Other|3|||
124601336|NCT01347866|448158569|FG008|Overall Study|Other|22|||
124601337|NCT01347866|448158570|FG009|Overall Study|Other|5|||
124601338|NCT01347866|448158571|FG010|Overall Study|Other|0|||
124601339|NCT01347866|448158572|FG011|Overall Study|Other|3|||
124601340|NCT01347866|448158573|FG012|Overall Study|Other|4|||
124601341|NCT01347866|448158574|FG013|Overall Study|Other|4|||
124601342|NCT01347866|448158575|FG014|Overall Study|Other|2|||
124731319|NCT02754141|448640090|FG006|Overall Study|Study drug toxicity|0|||
124601343|NCT01347866|448158576|FG015|Overall Study|Other|3|||
124601344|NCT01347866|448158577|FG016|Overall Study|Other|0|||
124601345|NCT01347866|448158561|FG000|Overall Study|Subject refused further follow-up|2|||
124601346|NCT01347866|448158562|FG001|Overall Study|Subject refused further follow-up|0|||
124601347|NCT01347866|448158563|FG002|Overall Study|Subject refused further follow-up|0|||
124601348|NCT01347866|448158564|FG003|Overall Study|Subject refused further follow-up|2|||
124601349|NCT01347866|448158565|FG004|Overall Study|Subject refused further follow-up|0|||
124731320|NCT02754141|448640091|FG007|Overall Study|Study drug toxicity|0|||
124601350|NCT01347866|448158566|FG005|Overall Study|Subject refused further follow-up|1|||
124601351|NCT01347866|448158567|FG006|Overall Study|Subject refused further follow-up|0|||
124601352|NCT01347866|448158568|FG007|Overall Study|Subject refused further follow-up|0|||
124601353|NCT01347866|448158569|FG008|Overall Study|Subject refused further follow-up|4|||
124601354|NCT01347866|448158570|FG009|Overall Study|Subject refused further follow-up|1|||
124601355|NCT01347866|448158571|FG010|Overall Study|Subject refused further follow-up|0|||
124601356|NCT01347866|448158572|FG011|Overall Study|Subject refused further follow-up|0|||
124601357|NCT01347866|448158573|FG012|Overall Study|Subject refused further follow-up|1|||
124601358|NCT01347866|448158574|FG013|Overall Study|Subject refused further follow-up|3|||
124601359|NCT01347866|448158575|FG014|Overall Study|Subject refused further follow-up|1|||
124601360|NCT01347866|448158576|FG015|Overall Study|Subject refused further follow-up|0|||
124601361|NCT01347866|448158577|FG016|Overall Study|Subject refused further follow-up|2|||
124601362|NCT00869024|448158578|FG000|Overall Study|Death|2|||
124601363|NCT00869024|448158579|FG001|Overall Study|Death|3|||
124601364|NCT00869024|448158578|FG000|Overall Study|Lost to Follow-up|0|||
124601365|NCT00869024|448158579|FG001|Overall Study|Lost to Follow-up|1|||
124601366|NCT00869024|448158578|FG000|Overall Study|Protocol Violation|0|||
124601367|NCT00869024|448158579|FG001|Overall Study|Protocol Violation|1|||
124601368|NCT00293202|448158580|FG000|Overall Study|Withdrawal by Subject|1|||
124601369|NCT00293202|448158581|FG001|Overall Study|Withdrawal by Subject|2|||
124601370|NCT00293202|448158580|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
124601371|NCT00293202|448158581|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
124601372|NCT00293202|448158580|FG000|Overall Study|on-hold due to fistula maturation time|1|||
124601373|NCT00293202|448158581|FG001|Overall Study|on-hold due to fistula maturation time|0|||
124601374|NCT02442271|448158582|FG000|Overall Study|Adverse Event|1|||
124601375|NCT02442271|448158582|FG000|Overall Study|Withdrew Consent|1|||
124601376|NCT02442271|448158582|FG000|Overall Study|Lost to Follow-up|1|||
124601377|NCT02442271|448158582|FG000|Overall Study|Other|1|||
124601378|NCT01560507|448158584|FG000|Overall Study|Lost to Follow-up|3|||
124731321|NCT02754141|448640092|FG008|Overall Study|Study drug toxicity|0|||
124731322|NCT02754141|448640093|FG009|Overall Study|Study drug toxicity|0|||
124731323|NCT02754141|448640094|FG010|Overall Study|Study drug toxicity|2|||
124731324|NCT02754141|448640095|FG011|Overall Study|Study drug toxicity|1|||
124731325|NCT02754141|448640096|FG012|Overall Study|Study drug toxicity|1|||
124731326|NCT02754141|448640097|FG013|Overall Study|Study drug toxicity|0|||
124731327|NCT02754141|448640098|FG014|Overall Study|Study drug toxicity|0|||
124731328|NCT02754141|448640099|FG015|Overall Study|Study drug toxicity|0|||
124731329|NCT02754141|448640100|FG016|Overall Study|Study drug toxicity|0|||
124731330|NCT02754141|448640101|FG017|Overall Study|Study drug toxicity|0|||
124780740|NCT00792571|448827019|FG000|Overall Study|Death|1|||
124780741|NCT00792571|448827019|FG000|Overall Study|Adverse Event|4|||
124780742|NCT00792571|448827019|FG000|Overall Study|Withdrawal by Subject|1|||
124780743|NCT00792571|448827019|FG000|Overall Study|Other|4|||
124780744|NCT03790696|448827021|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
124780745|NCT03790696|448827022|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
124780746|NCT01149148|448827023|FG000|Overall Study|Lost to Follow-up|1|||
124780747|NCT01149148|448827024|FG001|Overall Study|Lost to Follow-up|2|||
124780748|NCT01149148|448827023|FG000|Overall Study|Death|1|||
124780749|NCT01149148|448827024|FG001|Overall Study|Death|0|||
124780750|NCT03436082|448827025|FG000|Overall Study|Did not undergo procedure|1|||
124780751|NCT03436082|448827026|FG001|Overall Study|Did not undergo procedure|0|||
124780752|NCT00950859|448827029|FG000|Overall Study|Adverse Event|3|||
124780753|NCT00950859|448827030|FG001|Overall Study|Adverse Event|3|||
124731331|NCT02754141|448640084|FG000|Overall Study|AE unrelated to study drug|1|||
124780754|NCT00950859|448827029|FG000|Overall Study|Insufficient Viral Load Response|12|||
124780755|NCT00950859|448827030|FG001|Overall Study|Insufficient Viral Load Response|3|||
124780756|NCT00950859|448827029|FG000|Overall Study|Protocol Violation|1|||
124601379|NCT01560507|448158585|FG001|Overall Study|Lost to Follow-up|1|||
124601380|NCT01560507|448158586|FG002|Overall Study|Lost to Follow-up|2|||
124601381|NCT01560507|448158584|FG000|Overall Study|Withdrawal by Subject|1|||
124601382|NCT01560507|448158585|FG001|Overall Study|Withdrawal by Subject|1|||
124601383|NCT01560507|448158586|FG002|Overall Study|Withdrawal by Subject|0|||
124601384|NCT02080832|448158587|FG000|Overall Study|Excluded from analysis by MRI|9|||
124601385|NCT02080832|448158588|FG001|Overall Study|Excluded from analysis by MRI|10|||
124601386|NCT02080832|448158589|FG002|Overall Study|Excluded from analysis by MRI|14|||
124601387|NCT02080832|448158587|FG000|Overall Study|Lost to Follow-up|0|||
124601388|NCT02080832|448158588|FG001|Overall Study|Lost to Follow-up|2|||
124601389|NCT02080832|448158589|FG002|Overall Study|Lost to Follow-up|2|||
124601390|NCT02427984|448158590|FG000|Overall Study|Lost to Follow-up|13|||
124601391|NCT02427984|448158591|FG001|Overall Study|Lost to Follow-up|5|||
124601392|NCT02427984|448158592|FG002|Overall Study|Lost to Follow-up|18|||
124601393|NCT01491035|448158597|FG000|Overall Study|Lost to Follow-up|0|||
124601394|NCT01491035|448158598|FG001|Overall Study|Lost to Follow-up|0|||
124601395|NCT01491035|448158599|FG002|Overall Study|Lost to Follow-up|0|||
124601396|NCT01491035|448158600|FG003|Overall Study|Lost to Follow-up|0|||
124601397|NCT01491035|448158601|FG004|Overall Study|Lost to Follow-up|1|||
124601398|NCT01491035|448158602|FG005|Overall Study|Lost to Follow-up|0|||
124601399|NCT01491035|448158603|FG006|Overall Study|Lost to Follow-up|0|||
124601400|NCT01491035|448158604|FG007|Overall Study|Lost to Follow-up|0|||
124601401|NCT01277718|448158606|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
124601402|NCT01277718|448158607|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
124601403|NCT01277718|448158606|FG000|Period 2 - Second Intervention|Physician Decision|0|||
124601404|NCT01277718|448158607|FG001|Period 2 - Second Intervention|Physician Decision|2|||
124731332|NCT02754141|448640085|FG001|Overall Study|AE unrelated to study drug|1|||
124780757|NCT00950859|448827030|FG001|Overall Study|Protocol Violation|1|||
124780758|NCT00950859|448827029|FG000|Overall Study|Lost to Follow-up|0|||
124780759|NCT00950859|448827030|FG001|Overall Study|Lost to Follow-up|3|||
124780760|NCT04896086|448827031|FG000|Overall Study|Lost to Follow-up|0|||
124780761|NCT04896086|448827032|FG001|Overall Study|Lost to Follow-up|2|||
124780762|NCT04896086|448827033|FG002|Overall Study|Lost to Follow-up|1|||
124780763|NCT04896086|448827034|FG003|Overall Study|Lost to Follow-up|0|||
124780764|NCT04896086|448827035|FG004|Overall Study|Lost to Follow-up|0|||
124780765|NCT04896086|448827031|FG000|Overall Study|Physician Decision|0|||
124780766|NCT04896086|448827032|FG001|Overall Study|Physician Decision|1|||
124780767|NCT04896086|448827033|FG002|Overall Study|Physician Decision|0|||
124780768|NCT04896086|448827034|FG003|Overall Study|Physician Decision|0|||
124780769|NCT04896086|448827035|FG004|Overall Study|Physician Decision|0|||
124780770|NCT04896086|448827031|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
124780771|NCT04896086|448827032|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
124780772|NCT04896086|448827033|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
124780773|NCT04896086|448827034|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
124780774|NCT04896086|448827035|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
124780775|NCT04896086|448827031|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
124780776|NCT04896086|448827032|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
124780777|NCT04896086|448827033|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
124780778|NCT04896086|448827034|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
124780779|NCT04896086|448827035|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
124780780|NCT02249832|448827038|FG000|Overall Study|Withdrawal by Subject|3|||
124780781|NCT02249832|448827038|FG000|Overall Study|Lost to Follow-up|10|||
124780782|NCT02563067|448827045|FG000|Overall Study|Subject/guardian decision|14|||
124780783|NCT02563067|448827046|FG001|Overall Study|Subject/guardian decision|20|||
124780784|NCT02563067|448827047|FG002|Overall Study|Subject/guardian decision|16|||
124780785|NCT02563067|448827045|FG000|Overall Study|Physician Decision|0|||
124780786|NCT02563067|448827046|FG001|Overall Study|Physician Decision|1|||
124780787|NCT02563067|448827047|FG002|Overall Study|Physician Decision|3|||
124780788|NCT02563067|448827045|FG000|Overall Study|Lost to Follow-up|1|||
124780789|NCT02563067|448827046|FG001|Overall Study|Lost to Follow-up|2|||
124780790|NCT02563067|448827047|FG002|Overall Study|Lost to Follow-up|0|||
124780791|NCT02563067|448827045|FG000|Overall Study|Technical problems|0|||
124780792|NCT02563067|448827046|FG001|Overall Study|Technical problems|1|||
124780793|NCT02563067|448827047|FG002|Overall Study|Technical problems|0|||
124780794|NCT02563067|448827045|FG000|Overall Study|Lack of Efficacy|1|||
124780795|NCT02563067|448827046|FG001|Overall Study|Lack of Efficacy|0|||
124780796|NCT02563067|448827047|FG002|Overall Study|Lack of Efficacy|0|||
124780797|NCT02563067|448827045|FG000|Overall Study|Death|0|||
124780798|NCT02563067|448827046|FG001|Overall Study|Death|1|||
124780799|NCT02563067|448827047|FG002|Overall Study|Death|1|||
124780800|NCT02563067|448827045|FG000|Overall Study|Adverse Event|2|||
124780801|NCT02563067|448827046|FG001|Overall Study|Adverse Event|1|||
124780802|NCT02563067|448827047|FG002|Overall Study|Adverse Event|0|||
124780803|NCT02563067|448827045|FG000|Overall Study|Death post Treatment/safety period|1|||
124780804|NCT02563067|448827046|FG001|Overall Study|Death post Treatment/safety period|0|||
124780805|NCT02563067|448827047|FG002|Overall Study|Death post Treatment/safety period|0|||
124780806|NCT03544333|448827057|FG000|Overall Study|Withdrawal by Subject|1|||
124780807|NCT03544333|448827058|FG001|Overall Study|Withdrawal by Subject|0|||
124780808|NCT01039519|448827059|FG000|Treatment|Progressive disease|20|||
124780809|NCT01039519|448827059|FG000|Treatment|Treatment failure|2|||
124780810|NCT01039519|448827059|FG000|Treatment|Adverse Event|3|||
124780811|NCT01039519|448827059|FG000|Treatment|Physician Decision|2|||
124780812|NCT01039519|448827059|FG000|Survival Follow-up|Death|23|||
124780813|NCT01039519|448827059|FG000|Survival Follow-up|Sponsor decision|4|||
124780814|NCT00808080|448827063|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
124601405|NCT01524913|448158611|FG000|Overall Study|Lost to Follow-up|4|||
124601406|NCT01524913|448158612|FG001|Overall Study|Lost to Follow-up|0|||
124601407|NCT01524913|448158613|FG002|Overall Study|Lost to Follow-up|0|||
124601408|NCT03351231|448158627|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
124601409|NCT03351231|448158627|FG000|Combination Therapy Period|Disease progression|2|||
124601410|NCT03351231|448158627|FG000|Combination Therapy Period|Study drug toxicity|1|||
124780815|NCT00423917|448827066|FG000|Overall Study|Cancel|2|||
124780816|NCT00423917|448827066|FG000|Overall Study|Ineligible|1|||
124601411|NCT03351231|448158627|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
124780817|NCT01396447|448827069|FG000|Overall Study|Did Not Receive Treatment|3|||
124780818|NCT01396447|448827070|FG001|Overall Study|Did Not Receive Treatment|2|||
124780819|NCT01396447|448827071|FG002|Overall Study|Did Not Receive Treatment|1|||
124601412|NCT03351231|448158627|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
124780820|NCT01396447|448827072|FG003|Overall Study|Did Not Receive Treatment|0|||
124780821|NCT01396447|448827069|FG000|Overall Study|Adverse Event|15|||
124780822|NCT01396447|448827070|FG001|Overall Study|Adverse Event|12|||
124780823|NCT01396447|448827071|FG002|Overall Study|Adverse Event|12|||
124780824|NCT01396447|448827072|FG003|Overall Study|Adverse Event|17|||
124780825|NCT01396447|448827069|FG000|Overall Study|Insufficient Therapeutic Response|5|||
124780826|NCT01396447|448827070|FG001|Overall Study|Insufficient Therapeutic Response|5|||
124780827|NCT01396447|448827071|FG002|Overall Study|Insufficient Therapeutic Response|2|||
124780828|NCT01396447|448827072|FG003|Overall Study|Insufficient Therapeutic Response|4|||
124780829|NCT01396447|448827069|FG000|Overall Study|Protocol Violation|5|||
124780830|NCT01396447|448827070|FG001|Overall Study|Protocol Violation|2|||
124780831|NCT01396447|448827071|FG002|Overall Study|Protocol Violation|3|||
124780832|NCT01396447|448827072|FG003|Overall Study|Protocol Violation|7|||
124780833|NCT01396447|448827069|FG000|Overall Study|Withdrawal of Consent|11|||
124780834|NCT01396447|448827070|FG001|Overall Study|Withdrawal of Consent|9|||
124780835|NCT01396447|448827071|FG002|Overall Study|Withdrawal of Consent|4|||
124780836|NCT01396447|448827072|FG003|Overall Study|Withdrawal of Consent|15|||
124780837|NCT01396447|448827069|FG000|Overall Study|Lost to Follow-up|4|||
124780838|NCT01396447|448827070|FG001|Overall Study|Lost to Follow-up|8|||
124780839|NCT01396447|448827071|FG002|Overall Study|Lost to Follow-up|7|||
124780840|NCT01396447|448827072|FG003|Overall Study|Lost to Follow-up|9|||
124780841|NCT01396447|448827069|FG000|Overall Study|Other Miscellaneous Reasons|0|||
124780842|NCT01396447|448827070|FG001|Overall Study|Other Miscellaneous Reasons|2|||
124780843|NCT01396447|448827071|FG002|Overall Study|Other Miscellaneous Reasons|1|||
124780844|NCT01396447|448827072|FG003|Overall Study|Other Miscellaneous Reasons|0|||
124780845|NCT00578292|448827073|FG000|Overall Study|Death|1|||
124780846|NCT00578292|448827073|FG000|Overall Study|Graft failure|2|||
124780847|NCT00856518|448827077|FG000|Overall Study|Lost to Follow-up|4|||
124780848|NCT00856518|448827078|FG001|Overall Study|Lost to Follow-up|2|||
124780849|NCT00947193|448827079|FG000|Overall Study|Lost to Follow-up|1|||
124780850|NCT00947193|448827080|FG001|Overall Study|Lost to Follow-up|0|||
124780851|NCT00947193|448827079|FG000|Overall Study|Withdrawal by Subject|1|||
124780852|NCT00947193|448827080|FG001|Overall Study|Withdrawal by Subject|0|||
124780853|NCT00947193|448827079|FG000|Overall Study|Factor VIII >1%|1|||
124780854|NCT00947193|448827080|FG001|Overall Study|Factor VIII >1%|0|||
124780855|NCT04849559|448827081|FG000|Overall Study|Withdrawal by Subject|2|||
124780856|NCT04849559|448827082|FG001|Overall Study|Withdrawal by Subject|1|||
124780857|NCT02105961|448827083|FG000|Overall Study|Adverse Event|18|||
124780858|NCT02105961|448827084|FG001|Overall Study|Adverse Event|7|||
124780859|NCT02105961|448827085|FG002|Overall Study|Adverse Event|13|||
124780860|NCT02105961|448827083|FG000|Overall Study|Lack of Efficacy|3|||
124780861|NCT02105961|448827084|FG001|Overall Study|Lack of Efficacy|0|||
124780862|NCT02105961|448827085|FG002|Overall Study|Lack of Efficacy|3|||
124780863|NCT02105961|448827083|FG000|Overall Study|Lost to Follow-up|2|||
124780864|NCT02105961|448827084|FG001|Overall Study|Lost to Follow-up|0|||
124780865|NCT02105961|448827085|FG002|Overall Study|Lost to Follow-up|1|||
124780866|NCT02105961|448827083|FG000|Overall Study|Physician Decision|3|||
124780867|NCT02105961|448827084|FG001|Overall Study|Physician Decision|3|||
124780868|NCT02105961|448827085|FG002|Overall Study|Physician Decision|2|||
124780869|NCT02105961|448827083|FG000|Overall Study|Withdrawal by Subject|15|||
124780870|NCT02105961|448827084|FG001|Overall Study|Withdrawal by Subject|7|||
124780871|NCT02105961|448827085|FG002|Overall Study|Withdrawal by Subject|11|||
124780872|NCT00459186|448827086|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
124780873|NCT00459186|448827086|FG000|PET Imaging and Assessment|Adverse Event|3|||
124780874|NCT03710083|448827087|FG000|Overall Study|Withdrawal by Subject|2|||
124780875|NCT03710083|448827087|FG000|Overall Study|Unsuccessful Procedure|1|||
124780876|NCT05300763|448827088|FG000|Overall Study|Adverse Event|0|||
124780877|NCT05300763|448827089|FG001|Overall Study|Adverse Event|1|||
124780878|NCT05300763|448827088|FG000|Overall Study|Major Protocol Deviation|1|||
124780879|NCT05300763|448827089|FG001|Overall Study|Major Protocol Deviation|0|||
124780880|NCT05300763|448827088|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
124780881|NCT05300763|448827089|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
124780882|NCT01485172|448827090|FG000|Overall Study|Adverse Event|2|||
124780883|NCT01485172|448827091|FG001|Overall Study|Adverse Event|1|||
124780884|NCT01485172|448827092|FG002|Overall Study|Adverse Event|2|||
124780885|NCT01485172|448827093|FG003|Overall Study|Adverse Event|2|||
124780886|NCT01485172|448827094|FG004|Overall Study|Adverse Event|1|||
124780887|NCT01485172|448827095|FG005|Overall Study|Adverse Event|2|||
124780888|NCT01485172|448827090|FG000|Overall Study|Lack of Efficacy|2|||
124780889|NCT01485172|448827091|FG001|Overall Study|Lack of Efficacy|0|||
124780890|NCT01485172|448827092|FG002|Overall Study|Lack of Efficacy|0|||
124780891|NCT01485172|448827093|FG003|Overall Study|Lack of Efficacy|0|||
124780892|NCT01485172|448827094|FG004|Overall Study|Lack of Efficacy|0|||
124780893|NCT01485172|448827095|FG005|Overall Study|Lack of Efficacy|0|||
124780894|NCT01485172|448827090|FG000|Overall Study|Protocol Violation|0|||
124780895|NCT01485172|448827091|FG001|Overall Study|Protocol Violation|0|||
124780896|NCT01485172|448827092|FG002|Overall Study|Protocol Violation|4|||
124780897|NCT01485172|448827093|FG003|Overall Study|Protocol Violation|5|||
124780898|NCT01485172|448827094|FG004|Overall Study|Protocol Violation|1|||
124780899|NCT01485172|448827095|FG005|Overall Study|Protocol Violation|0|||
124780900|NCT01485172|448827090|FG000|Overall Study|Protocol defined stopping criteria|1|||
124601413|NCT03351231|448158627|FG000|Safety Follow-Up Period|Other reason|2|||
124601414|NCT02858726|448158628|FG000|Overall Study|Adverse Event|4|||
124601415|NCT02858726|448158629|FG001|Overall Study|Adverse Event|4|||
124601416|NCT02858726|448158630|FG002|Overall Study|Adverse Event|9|||
124601417|NCT02858726|448158631|FG003|Overall Study|Adverse Event|1|||
124601418|NCT02858726|448158628|FG000|Overall Study|Physician Decision|0|||
124601419|NCT02858726|448158629|FG001|Overall Study|Physician Decision|0|||
124601420|NCT02858726|448158630|FG002|Overall Study|Physician Decision|1|||
124601421|NCT02858726|448158631|FG003|Overall Study|Physician Decision|0|||
124601422|NCT02858726|448158628|FG000|Overall Study|Protocol Violation|0|||
124601423|NCT02858726|448158629|FG001|Overall Study|Protocol Violation|0|||
124601424|NCT02858726|448158630|FG002|Overall Study|Protocol Violation|0|||
124601425|NCT02858726|448158631|FG003|Overall Study|Protocol Violation|1|||
124601426|NCT02858726|448158628|FG000|Overall Study|Study Terminated by Sponsor|0|||
124601427|NCT02858726|448158629|FG001|Overall Study|Study Terminated by Sponsor|0|||
124601428|NCT02858726|448158630|FG002|Overall Study|Study Terminated by Sponsor|0|||
124601429|NCT02858726|448158631|FG003|Overall Study|Study Terminated by Sponsor|1|||
124601430|NCT02858726|448158628|FG000|Overall Study|Withdrawal by Subject|1|||
124601431|NCT02858726|448158629|FG001|Overall Study|Withdrawal by Subject|2|||
124601432|NCT02858726|448158630|FG002|Overall Study|Withdrawal by Subject|1|||
124601433|NCT02858726|448158631|FG003|Overall Study|Withdrawal by Subject|0|||
124601434|NCT02858726|448158628|FG000|Overall Study|Noncompliance|0|||
124601435|NCT02858726|448158629|FG001|Overall Study|Noncompliance|1|||
124601436|NCT02858726|448158630|FG002|Overall Study|Noncompliance|0|||
124601437|NCT02858726|448158631|FG003|Overall Study|Noncompliance|0|||
124601438|NCT00233987|448158634|FG000|Overall Study|Withdrawal by Subject|1|||
124601439|NCT00233987|448158634|FG000|Overall Study|Lack of Efficacy|2|||
124601440|NCT00233987|448158634|FG000|Overall Study|Reason Under Review|1|||
124601441|NCT00233987|448158634|FG000|Overall Study|Other - Not Protocol Specified|5|||
124601442|NCT00233987|448158634|FG000|Overall Study|Eligible but No Treatment Received|2|||
124601443|NCT00233987|448158634|FG000|Overall Study|Ineligible|4|||
124601444|NCT00518622|448158637|FG000|Overall Study|Lost to Follow-up|0|||
124601445|NCT00518622|448158638|FG001|Overall Study|Lost to Follow-up|0|||
124601446|NCT00518622|448158639|FG002|Overall Study|Lost to Follow-up|1|||
124601447|NCT00518622|448158640|FG003|Overall Study|Lost to Follow-up|0|||
124601448|NCT00518622|448158641|FG004|Overall Study|Lost to Follow-up|0|||
124601449|NCT00518622|448158642|FG005|Overall Study|Lost to Follow-up|0|||
124601450|NCT00518622|448158643|FG006|Overall Study|Lost to Follow-up|0|||
124601451|NCT00518622|448158644|FG007|Overall Study|Lost to Follow-up|0|||
124601452|NCT00518622|448158637|FG000|Overall Study|Study medication taken incorrectly|0|||
124601453|NCT00518622|448158638|FG001|Overall Study|Study medication taken incorrectly|1|||
124601454|NCT00518622|448158639|FG002|Overall Study|Study medication taken incorrectly|0|||
124601455|NCT00518622|448158640|FG003|Overall Study|Study medication taken incorrectly|0|||
124601456|NCT00518622|448158641|FG004|Overall Study|Study medication taken incorrectly|0|||
124601457|NCT00518622|448158642|FG005|Overall Study|Study medication taken incorrectly|0|||
124601458|NCT00518622|448158643|FG006|Overall Study|Study medication taken incorrectly|0|||
124601459|NCT00518622|448158644|FG007|Overall Study|Study medication taken incorrectly|0|||
124601460|NCT01688726|448158645|FG000|Overall Study|Adverse Event|1|||
124601461|NCT01688726|448158646|FG001|Overall Study|Adverse Event|0|||
124601462|NCT01688726|448158645|FG000|Overall Study|Relocated abroad|0|||
124601463|NCT01688726|448158646|FG001|Overall Study|Relocated abroad|1|||
124601464|NCT02177136|448160383|FG000|DB Phase|Withdrawal by Subject|2|||
124601465|NCT02177136|448160384|FG001|DB Phase|Withdrawal by Subject|0|||
124601466|NCT02177136|448160385|FG002|DB Phase|Withdrawal by Subject|0|||
124601467|NCT02177136|448160386|FG003|DB Phase|Withdrawal by Subject|0|||
124601468|NCT02177136|448160383|FG000|DB Phase|Discontinued Due to Pruritus|1|||
124601469|NCT02177136|448160384|FG001|DB Phase|Discontinued Due to Pruritus|3|||
124601470|NCT02177136|448160385|FG002|DB Phase|Discontinued Due to Pruritus|0|||
124601471|NCT02177136|448160386|FG003|DB Phase|Discontinued Due to Pruritus|0|||
124601472|NCT02177136|448160383|FG000|DB Phase|Adverse Event|3|||
124601473|NCT02177136|448160384|FG001|DB Phase|Adverse Event|2|||
124601474|NCT02177136|448160385|FG002|DB Phase|Adverse Event|3|||
124601475|NCT02177136|448160386|FG003|DB Phase|Adverse Event|0|||
124601476|NCT02177136|448160383|FG000|DB Phase|Protocol Violation|0|||
124601477|NCT02177136|448160384|FG001|DB Phase|Protocol Violation|0|||
124601478|NCT02177136|448160385|FG002|DB Phase|Protocol Violation|1|||
124601479|NCT02177136|448160386|FG003|DB Phase|Protocol Violation|0|||
124601480|NCT02177136|448160383|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
124601481|NCT02177136|448160384|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
124601482|NCT02177136|448160385|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
124601483|NCT02177136|448160386|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
124601484|NCT02177136|448160383|FG000|LTSE Phase|Withdrawal by Subject|0|||
124601485|NCT02177136|448160384|FG001|LTSE Phase|Withdrawal by Subject|0|||
124601486|NCT02177136|448160385|FG002|LTSE Phase|Withdrawal by Subject|0|||
124601487|NCT02177136|448160386|FG003|LTSE Phase|Withdrawal by Subject|6|||
124601488|NCT02177136|448160383|FG000|LTSE Phase|Adverse Event|0|||
124601489|NCT02177136|448160384|FG001|LTSE Phase|Adverse Event|0|||
124601490|NCT02177136|448160385|FG002|LTSE Phase|Adverse Event|0|||
124601491|NCT02177136|448160386|FG003|LTSE Phase|Adverse Event|10|||
124601492|NCT02177136|448160383|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
124601493|NCT02177136|448160384|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
124601494|NCT02177136|448160385|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
124601495|NCT02177136|448160386|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
124601496|NCT02177136|448160383|FG000|LTSE Phase|Physician Decision|0|||
124601497|NCT02177136|448160384|FG001|LTSE Phase|Physician Decision|0|||
124601498|NCT02177136|448160385|FG002|LTSE Phase|Physician Decision|0|||
124601499|NCT02177136|448160386|FG003|LTSE Phase|Physician Decision|2|||
124601500|NCT02177136|448160383|FG000|LTSE Phase|Lost to Follow-up|0|||
124601501|NCT02177136|448160384|FG001|LTSE Phase|Lost to Follow-up|0|||
124601502|NCT02177136|448160385|FG002|LTSE Phase|Lost to Follow-up|0|||
124601503|NCT02177136|448160386|FG003|LTSE Phase|Lost to Follow-up|1|||
124601504|NCT02177136|448160383|FG000|LTSE Phase|Participant Moved|0|||
124601505|NCT02177136|448160384|FG001|LTSE Phase|Participant Moved|0|||
124601506|NCT02177136|448160385|FG002|LTSE Phase|Participant Moved|0|||
124601507|NCT02177136|448160386|FG003|LTSE Phase|Participant Moved|1|||
124601508|NCT01386684|448160387|FG000|Overall Study|Lost to Follow-up|51|||
124601509|NCT01386684|448160387|FG000|Overall Study|Other|51|||
124601510|NCT01386684|448160387|FG000|Overall Study|Death|47|||
124601511|NCT01386684|448160387|FG000|Overall Study|Withdrawal of Consent|44|||
124601512|NCT01386684|448160387|FG000|Overall Study|Alternative Therapy Required|37|||
124601513|NCT01386684|448160387|FG000|Overall Study|Disease Progression|28|||
124601514|NCT01386684|448160387|FG000|Overall Study|Adverse Event|20|||
124601515|NCT01386684|448160387|FG000|Overall Study|Noncompliance|8|||
124601516|NCT01386684|448160387|FG000|Overall Study|Protocol Violation|4|||
124601517|NCT01386684|448160387|FG000|Overall Study|Missing|3|||
124601518|NCT03197558|448160392|FG000|Overall Study|Tubes not placed|1|||
124601519|NCT02072148|448160403|FG000|Overall Study|withdrew prior to surgery|23|||
124601520|NCT02072148|448160404|FG001|Overall Study|withdrew prior to surgery|0|||
124601521|NCT02072148|448160405|FG002|Overall Study|withdrew prior to surgery|0|||
124601522|NCT02072148|448160403|FG000|Overall Study|Death|0|||
124601523|NCT02072148|448160404|FG001|Overall Study|Death|0|||
124601524|NCT02072148|448160405|FG002|Overall Study|Death|1|||
124601525|NCT02072148|448160403|FG000|Overall Study|Withdrawal by Subject|0|||
124601526|NCT02072148|448160404|FG001|Overall Study|Withdrawal by Subject|13|||
124601527|NCT02072148|448160405|FG002|Overall Study|Withdrawal by Subject|12|||
124601528|NCT02528123|448160411|FG000|Overall Study|Lost to Follow-up|1|||
124601529|NCT01892657|448160415|FG000|Overall Study|Withdrawal by Subject|6|||
124601530|NCT01892657|448160415|FG000|Overall Study|Protocol Violation|12|||
124601531|NCT03463993|448160421|FG000|Overall Study|Lost to Follow-up|7|||
124601532|NCT03463993|448160422|FG001|Overall Study|Lost to Follow-up|8|||
124601533|NCT03463993|448160421|FG000|Overall Study|Withdrawal by Subject|2|||
124601534|NCT03463993|448160422|FG001|Overall Study|Withdrawal by Subject|0|||
124601535|NCT03463993|448160421|FG000|Overall Study|Protocol Violation|4|||
124601536|NCT03463993|448160422|FG001|Overall Study|Protocol Violation|1|||
124601537|NCT03463993|448160421|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
124601538|NCT03463993|448160422|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
124601539|NCT03463993|448160421|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
124601540|NCT03463993|448160422|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
124601541|NCT01478828|448160423|FG000|Overall Study|Adverse Event|1|||
124601542|NCT00136318|448160426|FG000|Overall Study|Adverse Event|5|||
124601543|NCT00136318|448160427|FG001|Overall Study|Adverse Event|5|||
124601544|NCT00136318|448160426|FG000|Overall Study|Withdrawal by Subject|2|||
124601545|NCT00136318|448160427|FG001|Overall Study|Withdrawal by Subject|2|||
124601546|NCT01829113|448160430|FG000|Overall Study|Disease Progression|37|||
124601547|NCT01829113|448160431|FG001|Overall Study|Disease Progression|48|||
124601548|NCT01829113|448160430|FG000|Overall Study|Adverse Event|14|||
124601549|NCT01829113|448160431|FG001|Overall Study|Adverse Event|10|||
124601550|NCT01829113|448160430|FG000|Overall Study|Withdrawal by Subject|17|||
124601551|NCT01829113|448160431|FG001|Overall Study|Withdrawal by Subject|10|||
124601552|NCT01829113|448160430|FG000|Overall Study|Death|4|||
124601553|NCT01829113|448160431|FG001|Overall Study|Death|6|||
124601554|NCT01829113|448160430|FG000|Overall Study|Sponsor Decision|1|||
124601555|NCT01829113|448160431|FG001|Overall Study|Sponsor Decision|1|||
124601556|NCT01829113|448160430|FG000|Overall Study|No Study Treatment Received|3|||
124601557|NCT01829113|448160431|FG001|Overall Study|No Study Treatment Received|2|||
124601558|NCT01829113|448160430|FG000|Overall Study|Physician Decision|1|||
124601559|NCT01829113|448160431|FG001|Overall Study|Physician Decision|1|||
124601560|NCT02010255|448160438|FG000|Overall Study|Death|0|||
124601561|NCT02010255|448160439|FG001|Overall Study|Death|1|||
124601562|NCT02010255|448160440|FG002|Overall Study|Death|4|||
124601563|NCT02010255|448160441|FG003|Overall Study|Death|4|||
124601564|NCT02010255|448160442|FG004|Overall Study|Death|2|||
124601565|NCT02010255|448160443|FG005|Overall Study|Death|0|||
124601566|NCT02010255|448160444|FG006|Overall Study|Death|1|||
124601567|NCT02010255|448160445|FG007|Overall Study|Death|1|||
124601568|NCT02010255|448160446|FG008|Overall Study|Death|1|||
124601569|NCT02010255|448160447|FG009|Overall Study|Death|0|||
124601570|NCT02010255|448160448|FG010|Overall Study|Death|1|||
124601571|NCT02010255|448160449|FG011|Overall Study|Death|1|||
124601572|NCT02010255|448160450|FG012|Overall Study|Death|0|||
124601573|NCT02010255|448160451|FG013|Overall Study|Death|0|||
124601574|NCT02010255|448160438|FG000|Overall Study|Lack of Efficacy|4|||
124601575|NCT02010255|448160439|FG001|Overall Study|Lack of Efficacy|1|||
124601576|NCT02010255|448160440|FG002|Overall Study|Lack of Efficacy|2|||
124601577|NCT02010255|448160441|FG003|Overall Study|Lack of Efficacy|1|||
124601578|NCT02010255|448160442|FG004|Overall Study|Lack of Efficacy|1|||
124601579|NCT02010255|448160443|FG005|Overall Study|Lack of Efficacy|0|||
124601580|NCT02010255|448160444|FG006|Overall Study|Lack of Efficacy|0|||
124601581|NCT02010255|448160445|FG007|Overall Study|Lack of Efficacy|0|||
124601582|NCT02010255|448160446|FG008|Overall Study|Lack of Efficacy|0|||
124601583|NCT02010255|448160447|FG009|Overall Study|Lack of Efficacy|0|||
124601584|NCT02010255|448160448|FG010|Overall Study|Lack of Efficacy|1|||
124601585|NCT02010255|448160449|FG011|Overall Study|Lack of Efficacy|0|||
124601586|NCT02010255|448160450|FG012|Overall Study|Lack of Efficacy|0|||
124601587|NCT02010255|448160451|FG013|Overall Study|Lack of Efficacy|0|||
124601588|NCT02010255|448160438|FG000|Overall Study|Withdrew Consent|1|||
124601589|NCT02010255|448160439|FG001|Overall Study|Withdrew Consent|0|||
124601590|NCT02010255|448160440|FG002|Overall Study|Withdrew Consent|0|||
124601591|NCT02010255|448160441|FG003|Overall Study|Withdrew Consent|1|||
124601592|NCT02010255|448160442|FG004|Overall Study|Withdrew Consent|0|||
124601593|NCT02010255|448160443|FG005|Overall Study|Withdrew Consent|0|||
124601594|NCT02010255|448160444|FG006|Overall Study|Withdrew Consent|0|||
124601595|NCT02010255|448160445|FG007|Overall Study|Withdrew Consent|0|||
124601596|NCT02010255|448160446|FG008|Overall Study|Withdrew Consent|0|||
124601597|NCT02010255|448160447|FG009|Overall Study|Withdrew Consent|0|||
124601598|NCT02010255|448160448|FG010|Overall Study|Withdrew Consent|0|||
124601599|NCT02010255|448160449|FG011|Overall Study|Withdrew Consent|0|||
124601600|NCT02010255|448160450|FG012|Overall Study|Withdrew Consent|0|||
124601601|NCT02010255|448160451|FG013|Overall Study|Withdrew Consent|0|||
124601602|NCT02010255|448160438|FG000|Overall Study|Adverse Event|1|||
124601603|NCT02010255|448160439|FG001|Overall Study|Adverse Event|0|||
124601604|NCT02010255|448160440|FG002|Overall Study|Adverse Event|0|||
124601605|NCT02010255|448160441|FG003|Overall Study|Adverse Event|0|||
124601606|NCT02010255|448160442|FG004|Overall Study|Adverse Event|0|||
124601607|NCT02010255|448160443|FG005|Overall Study|Adverse Event|0|||
124601608|NCT02010255|448160444|FG006|Overall Study|Adverse Event|0|||
124601609|NCT02010255|448160445|FG007|Overall Study|Adverse Event|0|||
124601610|NCT02010255|448160446|FG008|Overall Study|Adverse Event|0|||
124601611|NCT02010255|448160447|FG009|Overall Study|Adverse Event|0|||
124601612|NCT02010255|448160448|FG010|Overall Study|Adverse Event|0|||
124601613|NCT02010255|448160449|FG011|Overall Study|Adverse Event|0|||
124601614|NCT02010255|448160450|FG012|Overall Study|Adverse Event|0|||
124601615|NCT02010255|448160451|FG013|Overall Study|Adverse Event|0|||
124601616|NCT02010255|448160438|FG000|Overall Study|Lost to Follow-up|0|||
124601617|NCT02010255|448160439|FG001|Overall Study|Lost to Follow-up|0|||
124601618|NCT02010255|448160440|FG002|Overall Study|Lost to Follow-up|1|||
124601619|NCT02010255|448160441|FG003|Overall Study|Lost to Follow-up|0|||
124601620|NCT02010255|448160442|FG004|Overall Study|Lost to Follow-up|1|||
124601621|NCT02010255|448160443|FG005|Overall Study|Lost to Follow-up|0|||
124601622|NCT02010255|448160444|FG006|Overall Study|Lost to Follow-up|0|||
124601623|NCT02010255|448160445|FG007|Overall Study|Lost to Follow-up|0|||
124601624|NCT02010255|448160446|FG008|Overall Study|Lost to Follow-up|0|||
124601625|NCT02010255|448160447|FG009|Overall Study|Lost to Follow-up|0|||
124601626|NCT02010255|448160448|FG010|Overall Study|Lost to Follow-up|0|||
124601627|NCT02010255|448160449|FG011|Overall Study|Lost to Follow-up|0|||
124601628|NCT02010255|448160450|FG012|Overall Study|Lost to Follow-up|0|||
124601629|NCT02010255|448160451|FG013|Overall Study|Lost to Follow-up|0|||
124601630|NCT02010255|448160438|FG000|Overall Study|Randomized but Not Treated|0|||
124601631|NCT02010255|448160439|FG001|Overall Study|Randomized but Not Treated|0|||
124601632|NCT02010255|448160440|FG002|Overall Study|Randomized but Not Treated|0|||
124601633|NCT02010255|448160441|FG003|Overall Study|Randomized but Not Treated|0|||
124601634|NCT02010255|448160442|FG004|Overall Study|Randomized but Not Treated|0|||
124601635|NCT02010255|448160443|FG005|Overall Study|Randomized but Not Treated|0|||
124601636|NCT02010255|448160444|FG006|Overall Study|Randomized but Not Treated|0|||
124601637|NCT02010255|448160445|FG007|Overall Study|Randomized but Not Treated|0|||
124601638|NCT02010255|448160446|FG008|Overall Study|Randomized but Not Treated|0|||
124601639|NCT02010255|448160447|FG009|Overall Study|Randomized but Not Treated|0|||
124601640|NCT02010255|448160448|FG010|Overall Study|Randomized but Not Treated|0|||
124601641|NCT02010255|448160449|FG011|Overall Study|Randomized but Not Treated|0|||
124601642|NCT02010255|448160450|FG012|Overall Study|Randomized but Not Treated|0|||
124601643|NCT02010255|448160451|FG013|Overall Study|Randomized but Not Treated|1|||
124601644|NCT02654587|448160457|FG000|Overall Study|patient alive at end of study|22|||
124601645|NCT02654587|448160458|FG001|Overall Study|patient alive at end of study|8|||
124601646|NCT02654587|448160457|FG000|Overall Study|Withdrawal by Subject|1|||
124601647|NCT02654587|448160458|FG001|Overall Study|Withdrawal by Subject|7|||
124601648|NCT01843348|448160461|FG000|Overall Study|Withdrawal by Subject|4|||
124601649|NCT01843348|448160462|FG001|Overall Study|Withdrawal by Subject|16|||
124601650|NCT01843348|448160463|FG002|Overall Study|Withdrawal by Subject|18|||
124601651|NCT01843348|448160461|FG000|Overall Study|Lost to Follow-up|5|||
124601652|NCT01843348|448160462|FG001|Overall Study|Lost to Follow-up|4|||
124601653|NCT01843348|448160463|FG002|Overall Study|Lost to Follow-up|2|||
124601654|NCT01843348|448160461|FG000|Overall Study|Death|5|||
124601655|NCT01843348|448160462|FG001|Overall Study|Death|3|||
124601656|NCT01843348|448160463|FG002|Overall Study|Death|4|||
124601657|NCT01843348|448160461|FG000|Overall Study|Graft loss/retransplantation|5|||
124601658|NCT01843348|448160462|FG001|Overall Study|Graft loss/retransplantation|8|||
124601659|NCT01843348|448160463|FG002|Overall Study|Graft loss/retransplantation|11|||
124601660|NCT01843348|448160461|FG000|Overall Study|Various reasons|4|||
124601661|NCT01843348|448160462|FG001|Overall Study|Various reasons|9|||
124601662|NCT01843348|448160463|FG002|Overall Study|Various reasons|6|||
124601663|NCT02039414|448160464|FG000|Overall Study|Delivered|1|||
124601664|NCT02039414|448160465|FG001|Overall Study|Delivered|1|||
124601665|NCT02039414|448160464|FG000|Overall Study|Lost to Follow-up|2|||
124601666|NCT02039414|448160465|FG001|Overall Study|Lost to Follow-up|0|||
124601667|NCT02039414|448160464|FG000|Overall Study|Protocol Violation|3|||
124731333|NCT02754141|448640086|FG002|Overall Study|AE unrelated to study drug|0|||
124731334|NCT02754141|448640087|FG003|Overall Study|AE unrelated to study drug|1|||
124731335|NCT02754141|448640088|FG004|Overall Study|AE unrelated to study drug|3|||
124601668|NCT02039414|448160465|FG001|Overall Study|Protocol Violation|1|||
124601669|NCT00430950|448160466|FG000|Overall Study|Adverse Event|7|||
124601670|NCT00430950|448160467|FG001|Overall Study|Adverse Event|6|||
124601671|NCT00430950|448160466|FG000|Overall Study|Withdrawal by Subject|1|||
124601672|NCT00430950|448160467|FG001|Overall Study|Withdrawal by Subject|0|||
124601673|NCT00430950|448160466|FG000|Overall Study|concomitant medication,etc.|5|||
124601674|NCT00430950|448160467|FG001|Overall Study|concomitant medication,etc.|7|||
124601675|NCT02429934|448160470|FG000|Overall Study|Withdrawal by Subject|0|||
124601676|NCT02429934|448160471|FG001|Overall Study|Withdrawal by Subject|2|||
124601677|NCT02429934|448160470|FG000|Overall Study|Adverse Event|2|||
124601678|NCT02429934|448160471|FG001|Overall Study|Adverse Event|0|||
124601679|NCT02429934|448160470|FG000|Overall Study|Lost to Follow-up|1|||
124601680|NCT02429934|448160471|FG001|Overall Study|Lost to Follow-up|1|||
124601681|NCT02429934|448160470|FG000|Overall Study|Physician Decision|1|||
124601682|NCT02429934|448160471|FG001|Overall Study|Physician Decision|0|||
124601683|NCT00831623|448160476|FG000|Overall Study|Withdrawal by Subject|9|||
124601684|NCT00831623|448160476|FG000|Overall Study|Lost to Follow-up|1|||
124601685|NCT00831623|448160476|FG000|Overall Study|Not 2 years post-treatment|12|||
124601686|NCT01564459|448160479|FG000|Run-In|Adverse Event|7|||
124601687|NCT01564459|448160480|FG001|Run-In|Adverse Event|0|||
124601688|NCT01564459|448160481|FG002|Run-In|Adverse Event|0|||
124601689|NCT01564459|448160479|FG000|Run-In|Lost to Follow-up|1|||
124601690|NCT01564459|448160480|FG001|Run-In|Lost to Follow-up|0|||
124601691|NCT01564459|448160481|FG002|Run-In|Lost to Follow-up|0|||
124601692|NCT01564459|448160479|FG000|Run-In|Non-compliance with study drug|2|||
124601693|NCT01564459|448160480|FG001|Run-In|Non-compliance with study drug|0|||
124601694|NCT01564459|448160481|FG002|Run-In|Non-compliance with study drug|0|||
124601695|NCT01564459|448160479|FG000|Run-In|Protocol Violation|1|||
124601696|NCT01564459|448160480|FG001|Run-In|Protocol Violation|0|||
124601697|NCT01564459|448160481|FG002|Run-In|Protocol Violation|0|||
124601698|NCT01564459|448160479|FG000|Run-In|Withdrawal by Subject|1|||
124601699|NCT01564459|448160480|FG001|Run-In|Withdrawal by Subject|0|||
124601700|NCT01564459|448160481|FG002|Run-In|Withdrawal by Subject|0|||
124601701|NCT01564459|448160479|FG000|Double-blind Treatment|Adverse Event|0|||
124601702|NCT01564459|448160480|FG001|Double-blind Treatment|Adverse Event|0|||
124601703|NCT01564459|448160481|FG002|Double-blind Treatment|Adverse Event|1|||
124601704|NCT03545191|448160487|FG000|Overall Study|Death|1|||
124601705|NCT03545191|448160488|FG001|Overall Study|Death|0|||
124601706|NCT03545191|448160489|FG002|Overall Study|Death|0|||
124601707|NCT03545191|448160487|FG000|Overall Study|Adverse Event|4|||
124601708|NCT03545191|448160488|FG001|Overall Study|Adverse Event|2|||
124601709|NCT03545191|448160489|FG002|Overall Study|Adverse Event|7|||
124601710|NCT03545191|448160487|FG000|Overall Study|Other reasons|3|||
124601711|NCT03545191|448160488|FG001|Overall Study|Other reasons|11|||
124601712|NCT03545191|448160489|FG002|Overall Study|Other reasons|8|||
124601713|NCT03545191|448160487|FG000|Overall Study|Withdrawal by Subject|13|||
124601714|NCT03545191|448160488|FG001|Overall Study|Withdrawal by Subject|10|||
124601715|NCT03545191|448160489|FG002|Overall Study|Withdrawal by Subject|12|||
124601716|NCT03545191|448160487|FG000|Overall Study|Lost to Follow-up|1|||
124601717|NCT03545191|448160488|FG001|Overall Study|Lost to Follow-up|2|||
124601718|NCT03545191|448160489|FG002|Overall Study|Lost to Follow-up|3|||
124601719|NCT02746627|448160493|FG000|Overall Study|Withdrawal by Subject|1|||
124601720|NCT02746627|448160494|FG001|Overall Study|Withdrawal by Subject|1|||
124601721|NCT02746627|448160495|FG002|Overall Study|Withdrawal by Subject|1|||
124601722|NCT02340221|448160498|FG000|Overall Study|Death|100|||
124601723|NCT02340221|448160499|FG001|Overall Study|Death|197|||
124601724|NCT02340221|448160498|FG000|Overall Study|Withdrawal by Participant|24|||
124601725|NCT02340221|448160499|FG001|Overall Study|Withdrawal by Participant|37|||
124601726|NCT02340221|448160498|FG000|Overall Study|Lost to Follow-up|4|||
124601727|NCT02340221|448160499|FG001|Overall Study|Lost to Follow-up|15|||
124780901|NCT01485172|448827091|FG001|Overall Study|Protocol defined stopping criteria|0|||
124780902|NCT01485172|448827092|FG002|Overall Study|Protocol defined stopping criteria|0|||
124780903|NCT01485172|448827093|FG003|Overall Study|Protocol defined stopping criteria|0|||
124780904|NCT01485172|448827094|FG004|Overall Study|Protocol defined stopping criteria|1|||
124780905|NCT01485172|448827095|FG005|Overall Study|Protocol defined stopping criteria|0|||
124780906|NCT01485172|448827090|FG000|Overall Study|Lost to Follow-up|0|||
124780907|NCT01485172|448827091|FG001|Overall Study|Lost to Follow-up|0|||
124780908|NCT01485172|448827092|FG002|Overall Study|Lost to Follow-up|1|||
124780909|NCT01485172|448827093|FG003|Overall Study|Lost to Follow-up|0|||
124780910|NCT01485172|448827094|FG004|Overall Study|Lost to Follow-up|0|||
124601728|NCT02340221|448160498|FG000|Overall Study|Reason Not Specified|85|||
124601729|NCT02340221|448160499|FG001|Overall Study|Reason Not Specified|165|||
124601730|NCT02340221|448160498|FG000|Overall Study|Study Terminated by Sponsor|1|||
124601731|NCT02340221|448160499|FG001|Overall Study|Study Terminated by Sponsor|3|||
124601732|NCT03499119|448160500|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
124601733|NCT03499119|448160501|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
124601734|NCT03499119|448160502|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
124601735|NCT03499119|448160503|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
124601736|NCT03499119|448160500|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
124601737|NCT03499119|448160501|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
124601738|NCT03499119|448160502|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
124601739|NCT03499119|448160503|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
124601740|NCT03499119|448160500|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
124601741|NCT03499119|448160501|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
124601742|NCT03499119|448160502|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
124601743|NCT03499119|448160503|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
124601744|NCT03499119|448160500|FG000|Optional Extension Phase|Lost to Follow-up|0|||
124601745|NCT03499119|448160501|FG001|Optional Extension Phase|Lost to Follow-up|0|||
124601746|NCT03499119|448160502|FG002|Optional Extension Phase|Lost to Follow-up|0|||
124601747|NCT03499119|448160503|FG003|Optional Extension Phase|Lost to Follow-up|1|||
124601748|NCT03499119|448160500|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
124601749|NCT03499119|448160501|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
124601750|NCT03499119|448160502|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
124601751|NCT03499119|448160503|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
124601752|NCT03499119|448160500|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
124601753|NCT03499119|448160501|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
124601754|NCT03499119|448160502|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
124601755|NCT03499119|448160503|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
124601756|NCT00588640|448160504|FG000|Overall Study|Physician Decision|1|||
124601757|NCT00588640|448160504|FG000|Overall Study|Ineligible Patient|1|||
124601758|NCT01393730|448160505|FG000|Overall Study|Withdrawal by Subject|3|||
124601759|NCT01393730|448160505|FG000|Overall Study|Other|2|||
124601760|NCT01393730|448160505|FG000|Overall Study|Adverse Event|1|||
124601761|NCT00103402|448160506|FG000|Overall Study|Adverse Event|3|||
124601762|NCT00103402|448160507|FG001|Overall Study|Adverse Event|4|||
124601763|NCT00103402|448160506|FG000|Overall Study|Lost to Follow-up|8|||
124601764|NCT00103402|448160507|FG001|Overall Study|Lost to Follow-up|7|||
124601765|NCT00103402|448160506|FG000|Overall Study|Dissatisfied/No longer interested|6|||
124601766|NCT00103402|448160507|FG001|Overall Study|Dissatisfied/No longer interested|6|||
124601767|NCT00103402|448160506|FG000|Overall Study|Personal constraints/Other|5|||
124601768|NCT00103402|448160507|FG001|Overall Study|Personal constraints/Other|0|||
124601769|NCT01481324|448160510|FG000|Overall Study|Missing Data|0|||
124601770|NCT01481324|448160511|FG001|Overall Study|Missing Data|2|||
124601771|NCT01481324|448160512|FG002|Overall Study|Missing Data|2|||
124601772|NCT01172821|448160514|FG000|Overall Study|Adverse Event|5|||
124601773|NCT01172821|448160515|FG001|Overall Study|Adverse Event|2|||
124601774|NCT01172821|448160516|FG002|Overall Study|Adverse Event|2|||
124601775|NCT01172821|448160517|FG003|Overall Study|Adverse Event|7|||
124601776|NCT01172821|448160514|FG000|Overall Study|Protocol Violation|0|||
124601777|NCT01172821|448160515|FG001|Overall Study|Protocol Violation|2|||
124601778|NCT01172821|448160516|FG002|Overall Study|Protocol Violation|1|||
124601779|NCT01172821|448160517|FG003|Overall Study|Protocol Violation|2|||
124601780|NCT01172821|448160514|FG000|Overall Study|Lost to Follow-up|4|||
124601781|NCT01172821|448160515|FG001|Overall Study|Lost to Follow-up|1|||
124601782|NCT01172821|448160516|FG002|Overall Study|Lost to Follow-up|2|||
124601783|NCT01172821|448160517|FG003|Overall Study|Lost to Follow-up|2|||
124601784|NCT01172821|448160514|FG000|Overall Study|Withdrawal by Subject|2|||
124601785|NCT01172821|448160515|FG001|Overall Study|Withdrawal by Subject|3|||
124601786|NCT01172821|448160516|FG002|Overall Study|Withdrawal by Subject|3|||
124601787|NCT01172821|448160517|FG003|Overall Study|Withdrawal by Subject|3|||
124601788|NCT01172821|448160514|FG000|Overall Study|Other|3|||
124601789|NCT01172821|448160515|FG001|Overall Study|Other|4|||
124601790|NCT01172821|448160516|FG002|Overall Study|Other|5|||
124601791|NCT01172821|448160517|FG003|Overall Study|Other|3|||
124780911|NCT01485172|448827095|FG005|Overall Study|Lost to Follow-up|1|||
124601792|NCT00123955|448160518|FG000|Overall Study|Adverse Event|1|||
124601793|NCT00123955|448160519|FG001|Overall Study|Adverse Event|0|||
124601794|NCT00123955|448160518|FG000|Overall Study|Withdrawal by Subject|4|||
124601795|NCT00123955|448160519|FG001|Overall Study|Withdrawal by Subject|3|||
124601796|NCT00123955|448160518|FG000|Overall Study|Death|0|||
124601797|NCT00123955|448160519|FG001|Overall Study|Death|1|||
124601798|NCT01663727|448160521|FG000|Overall Study|Death|161|||
124601799|NCT01663727|448160522|FG001|Overall Study|Death|155|||
124601800|NCT01663727|448160521|FG000|Overall Study|Lost to Follow-up|10|||
124601801|NCT01663727|448160522|FG001|Overall Study|Lost to Follow-up|8|||
124780912|NCT01485172|448827090|FG000|Overall Study|Physician Decision|0|||
124780913|NCT01485172|448827091|FG001|Overall Study|Physician Decision|0|||
124780914|NCT01485172|448827092|FG002|Overall Study|Physician Decision|0|||
124780915|NCT01485172|448827093|FG003|Overall Study|Physician Decision|0|||
124780916|NCT01485172|448827094|FG004|Overall Study|Physician Decision|1|||
124780917|NCT01485172|448827095|FG005|Overall Study|Physician Decision|0|||
124780918|NCT01485172|448827090|FG000|Overall Study|Withdrawal by Subject|2|||
124780919|NCT01485172|448827091|FG001|Overall Study|Withdrawal by Subject|0|||
124601802|NCT01663727|448160521|FG000|Overall Study|Withdrawal by Subject|18|||
124601803|NCT01663727|448160522|FG001|Overall Study|Withdrawal by Subject|25|||
124601804|NCT01663727|448160521|FG000|Overall Study|Study Terminated|51|||
124601805|NCT01663727|448160522|FG001|Overall Study|Study Terminated|50|||
124601806|NCT01663727|448160521|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
124601807|NCT01663727|448160522|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
124601808|NCT01663727|448160521|FG000|Overall Study|Withdrawal prior to dosing.|1|||
124601809|NCT01663727|448160522|FG001|Overall Study|Withdrawal prior to dosing.|0|||
124601810|NCT00003138|448162364|FG000|Step 1|Reasons off treatment not documented|60|||
124601811|NCT00003138|448162365|FG001|Step 1|Reasons off treatment not documented|57|||
124601812|NCT00003138|448162364|FG000|Step 1|Never started treatment|1|||
124601813|NCT00003138|448162365|FG001|Step 1|Never started treatment|0|||
124601814|NCT00003138|448162364|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
124601815|NCT00003138|448162365|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
124601816|NCT00003138|448162364|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
124601817|NCT00003138|448162365|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
124601818|NCT00003138|448162364|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
124601819|NCT00003138|448162365|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
124601820|NCT00003138|448162364|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
124601821|NCT00003138|448162365|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
124601822|NCT04495283|448162367|FG000|Overall Study|Physician Decision|0|||
124601823|NCT04495283|448162368|FG001|Overall Study|Physician Decision|0|||
124601824|NCT04495283|448162369|FG002|Overall Study|Physician Decision|1|||
124601825|NCT04495283|448162367|FG000|Overall Study|Withdrawal by Subject|0|||
124601826|NCT04495283|448162368|FG001|Overall Study|Withdrawal by Subject|1|||
124601827|NCT04495283|448162369|FG002|Overall Study|Withdrawal by Subject|1|||
124601828|NCT04495283|448162367|FG000|Overall Study|Other|1|||
124601829|NCT04495283|448162368|FG001|Overall Study|Other|0|||
124601830|NCT04495283|448162369|FG002|Overall Study|Other|1|||
124601831|NCT05142566|448162372|FG000|Overall Study|Protocol Violation|1|||
124601832|NCT02246439|448162373|FG000|Overall Study|Adverse Event|3|||
124601833|NCT02246439|448162374|FG001|Overall Study|Adverse Event|0|||
124601834|NCT02246439|448162373|FG000|Overall Study|Lost to Follow-up|7|||
124601835|NCT02246439|448162374|FG001|Overall Study|Lost to Follow-up|5|||
124601836|NCT02246439|448162373|FG000|Overall Study|Protocol Violation|0|||
124601837|NCT02246439|448162374|FG001|Overall Study|Protocol Violation|2|||
124601838|NCT02246439|448162373|FG000|Overall Study|Physician Decision|0|||
124601839|NCT02246439|448162374|FG001|Overall Study|Physician Decision|1|||
124601840|NCT02246439|448162373|FG000|Overall Study|Unkonwn|1|||
124601841|NCT02246439|448162374|FG001|Overall Study|Unkonwn|3|||
124601842|NCT02246439|448162373|FG000|Overall Study|Withdrawal by Subject|1|||
124601843|NCT02246439|448162374|FG001|Overall Study|Withdrawal by Subject|0|||
124601844|NCT01553279|448162375|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
124601845|NCT01553279|448162376|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
124601846|NCT01553279|448162375|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
124601847|NCT01553279|448162376|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
124601848|NCT01553279|448162375|FG000|Interim Period|Withdrawal by Subject|2|||
124601849|NCT01553279|448162376|FG001|Interim Period|Withdrawal by Subject|2|||
124601850|NCT01553279|448162375|FG000|Interim Period|Lost to Follow-up|1|||
124601851|NCT01553279|448162376|FG001|Interim Period|Lost to Follow-up|0|||
124601852|NCT01553279|448162375|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
124601853|NCT01553279|448162376|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
124601854|NCT01553279|448162375|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
124601855|NCT01553279|448162376|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
124601856|NCT00380692|448162377|FG000|Study Period II - Double Blind|Adverse Event|1|||
124601857|NCT00380692|448162378|FG001|Study Period II - Double Blind|Adverse Event|0|||
124780920|NCT01485172|448827092|FG002|Overall Study|Withdrawal by Subject|0|||
124601858|NCT00380692|448162377|FG000|Study Period II - Double Blind|Protocol Violation|2|||
124601859|NCT00380692|448162378|FG001|Study Period II - Double Blind|Protocol Violation|2|||
124601860|NCT00380692|448162377|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
124601861|NCT00380692|448162378|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
124601862|NCT00380692|448162377|FG000|Study Period II - Double Blind|Physician Decision|0|||
124601863|NCT00380692|448162378|FG001|Study Period II - Double Blind|Physician Decision|1|||
124601864|NCT00380692|448162377|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
124601865|NCT00380692|448162378|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
124601866|NCT00380692|448162377|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
124601867|NCT00380692|448162378|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
124601868|NCT00380692|448162377|FG000|Study Period III - Open Label|Adverse Event|5|||
124601869|NCT00380692|448162378|FG001|Study Period III - Open Label|Adverse Event|3|||
124601870|NCT00380692|448162377|FG000|Study Period III - Open Label|Protocol Violation|0|||
124601871|NCT00380692|448162378|FG001|Study Period III - Open Label|Protocol Violation|0|||
124601872|NCT00380692|448162377|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
124601873|NCT00380692|448162378|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
124601874|NCT00380692|448162377|FG000|Study Period III - Open Label|Physician Decision|0|||
124601875|NCT00380692|448162378|FG001|Study Period III - Open Label|Physician Decision|3|||
124601876|NCT00380692|448162377|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
124601877|NCT00380692|448162378|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
124601878|NCT00380692|448162377|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
124601879|NCT00380692|448162378|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
124601880|NCT01388166|448162379|FG000|Overall Study|Adverse Event|16|||
124601881|NCT01388166|448162379|FG000|Overall Study|Lost to Follow-up|30|||
124601882|NCT01388166|448162379|FG000|Overall Study|Others than specified above|13|||
124601883|NCT00158756|448162380|FG000|Overall Study|Withdrawal by Subject|5|||
124601884|NCT00158756|448162381|FG001|Overall Study|Withdrawal by Subject|0|||
124601885|NCT00158756|448162382|FG002|Overall Study|Withdrawal by Subject|6|||
124601886|NCT00158756|448162383|FG003|Overall Study|Withdrawal by Subject|1|||
124601887|NCT00158756|448162384|FG004|Overall Study|Withdrawal by Subject|3|||
124601888|NCT00158756|448162380|FG000|Overall Study|Adverse Event|0|||
124601889|NCT00158756|448162381|FG001|Overall Study|Adverse Event|0|||
124601890|NCT00158756|448162382|FG002|Overall Study|Adverse Event|1|||
124601891|NCT00158756|448162383|FG003|Overall Study|Adverse Event|0|||
124601892|NCT00158756|448162384|FG004|Overall Study|Adverse Event|0|||
124601893|NCT00158756|448162380|FG000|Overall Study|Serious adverse event|0|||
124601894|NCT00158756|448162381|FG001|Overall Study|Serious adverse event|0|||
124601895|NCT00158756|448162382|FG002|Overall Study|Serious adverse event|1|||
124601896|NCT00158756|448162383|FG003|Overall Study|Serious adverse event|0|||
124601897|NCT00158756|448162384|FG004|Overall Study|Serious adverse event|0|||
124601898|NCT01429051|448162385|FG000|Titration Phase|Death|1|||
124601899|NCT01429051|448162385|FG000|Titration Phase|Withdrawal by Subject|7|||
124601900|NCT01429051|448162385|FG000|Titration Phase|Physician Decision|1|||
124601901|NCT01429051|448162385|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
124601902|NCT01429051|448162385|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
124601903|NCT01429051|448162385|FG000|Efficacy Phase|Adverse Event|1|||
124601904|NCT01429051|448162385|FG000|Efficacy Phase|Death|1|||
124601905|NCT01429051|448162385|FG000|Tolerability Phase|Death|5|||
124601906|NCT01429051|448162385|FG000|Tolerability Phase|Adverse Event|2|||
124601907|NCT01429051|448162385|FG000|Tolerability Phase|Withdrawal by Subject|5|||
124601908|NCT01429051|448162385|FG000|Tolerability Phase|Physician Decision|1|||
124601909|NCT01429051|448162385|FG000|Tolerability Phase|Other|2|||
124601910|NCT04132336|448162386|FG000|Overall Study|Investigator Decision|0|||
124601911|NCT04132336|448162387|FG001|Overall Study|Investigator Decision|1|||
124601912|NCT04132336|448162388|FG002|Overall Study|Investigator Decision|0|||
124601913|NCT04132336|448162389|FG003|Overall Study|Investigator Decision|0|||
124601914|NCT04132336|448162390|FG004|Overall Study|Investigator Decision|0|||
124601915|NCT04132336|448162391|FG005|Overall Study|Investigator Decision|0|||
124601916|NCT04132336|448162392|FG006|Overall Study|Investigator Decision|0|||
124601917|NCT01939496|448162393|FG000|Overall Study|Adverse Event|2|||
124601918|NCT01939496|448162394|FG001|Overall Study|Adverse Event|0|||
124601919|NCT01939496|448162395|FG002|Overall Study|Adverse Event|0|||
124601920|NCT01939496|448162393|FG000|Overall Study|Lost to Follow-up|1|||
124601921|NCT01939496|448162394|FG001|Overall Study|Lost to Follow-up|1|||
124601922|NCT01939496|448162395|FG002|Overall Study|Lost to Follow-up|0|||
124601923|NCT01939496|448162393|FG000|Overall Study|Physician Decision|1|||
124601924|NCT01939496|448162394|FG001|Overall Study|Physician Decision|0|||
124601925|NCT01939496|448162395|FG002|Overall Study|Physician Decision|0|||
124601926|NCT01939496|448162393|FG000|Overall Study|Protocol Violation|3|||
124601927|NCT01939496|448162394|FG001|Overall Study|Protocol Violation|0|||
124601928|NCT01939496|448162395|FG002|Overall Study|Protocol Violation|0|||
124601929|NCT01939496|448162393|FG000|Overall Study|Withdrawal by Subject|0|||
124601930|NCT01939496|448162394|FG001|Overall Study|Withdrawal by Subject|1|||
124601931|NCT01939496|448162395|FG002|Overall Study|Withdrawal by Subject|1|||
124601932|NCT01939496|448162393|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
124601933|NCT01939496|448162394|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
124601934|NCT01939496|448162395|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
124601935|NCT01939496|448162393|FG000|Overall Study|Other|2|||
124601936|NCT01939496|448162394|FG001|Overall Study|Other|0|||
124601937|NCT01939496|448162395|FG002|Overall Study|Other|1|||
124601938|NCT03052322|448162396|FG000|Overall Study|Other un-specified|1|||
124601939|NCT03052322|448162397|FG001|Overall Study|Other un-specified|2|||
124601940|NCT03052322|448162396|FG000|Overall Study|Withdrawal by Subject|10|||
124601941|NCT03052322|448162397|FG001|Overall Study|Withdrawal by Subject|9|||
124601942|NCT03052322|448162396|FG000|Overall Study|Death|0|||
124601943|NCT03052322|448162397|FG001|Overall Study|Death|2|||
124601944|NCT03052322|448162396|FG000|Overall Study|Lack of Efficacy|1|||
124601945|NCT03052322|448162397|FG001|Overall Study|Lack of Efficacy|2|||
124601946|NCT03052322|448162396|FG000|Overall Study|Protocol Violation|1|||
124601947|NCT03052322|448162397|FG001|Overall Study|Protocol Violation|0|||
124601948|NCT03052322|448162396|FG000|Overall Study|Lost to Follow-up|2|||
124601949|NCT03052322|448162397|FG001|Overall Study|Lost to Follow-up|4|||
124601950|NCT03052322|448162396|FG000|Overall Study|Adverse Event|6|||
124601951|NCT03052322|448162397|FG001|Overall Study|Adverse Event|13|||
124601952|NCT00973765|448162398|FG000|Overall Study|Lost to Follow-up|8|||
124601953|NCT00973765|448162399|FG001|Overall Study|Lost to Follow-up|14|||
124601954|NCT04920916|448162400|FG000|Phase IIa 60 Day Study|Death|2|||
124601955|NCT04920916|448162401|FG001|Phase IIa 60 Day Study|Death|5|||
124601956|NCT04920916|448162400|FG000|1 Year Follow up (Phone Call)|Death|1|||
124601957|NCT04920916|448162401|FG001|1 Year Follow up (Phone Call)|Death|3|||
124601958|NCT04920916|448162400|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
124601959|NCT04920916|448162401|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
124601960|NCT02011113|448162402|FG000|Overall Study|Adverse Event|4|||
124601961|NCT02011113|448162402|FG000|Overall Study|Disease Progression (DP)|16|||
124601962|NCT02011113|448162402|FG000|Overall Study|Death|1|||
124601963|NCT02011113|448162402|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
124601964|NCT02011113|448162402|FG000|Overall Study|Investigator's judgement- DP|3|||
124601965|NCT02011113|448162402|FG000|Overall Study|Study terminated by sponsor|11|||
124601966|NCT00468728|448162409|FG000|Treatment|criteria for mITT population|4|||
124601967|NCT00468728|448162410|FG001|Treatment|criteria for mITT population|11|||
124601968|NCT00468728|448162409|FG000|Follow-up|mITT failure|34|||
124601969|NCT00468728|448162410|FG001|Follow-up|mITT failure|31|||
124601970|NCT03251963|448162411|FG000|Overall Study|inappropriate Xa level timing|6|||
124601971|NCT03251963|448162412|FG001|Overall Study|inappropriate Xa level timing|3|||
124601972|NCT03251963|448162411|FG000|Overall Study|no peak Xa level drawn|2|||
124601973|NCT03251963|448162412|FG001|Overall Study|no peak Xa level drawn|0|||
124601974|NCT03251963|448162411|FG000|Overall Study|bled prior to Xa level|1|||
124601975|NCT03251963|448162412|FG001|Overall Study|bled prior to Xa level|2|||
124601976|NCT04505293|448162413|FG000|Overall Study|Lost to Follow-up|2|||
124601977|NCT04505293|448162413|FG000|Overall Study|Withdrawal by Subject|6|||
124601978|NCT04505293|448162413|FG000|Overall Study|CT scan unreadable|277|||
124601979|NCT02712333|448162415|FG000|First Period|Withdrawal by Subject|3|||
124601980|NCT02712333|448162416|FG001|First Period|Withdrawal by Subject|2|||
124601981|NCT00775606|448162417|FG000|Overall Study|Study sponsor terminated funding|3|||
124601982|NCT00775606|448162418|FG001|Overall Study|Study sponsor terminated funding|0|||
124601983|NCT02278718|448162419|FG000|Overall Study|Adverse Event|1|||
124601984|NCT02278718|448162420|FG001|Overall Study|Adverse Event|0|||
124601985|NCT02278718|448162419|FG000|Overall Study|Lost to Follow-up|2|||
124601986|NCT02278718|448162420|FG001|Overall Study|Lost to Follow-up|4|||
124601987|NCT02278718|448162419|FG000|Overall Study|Withdrawal by Subject|1|||
124601988|NCT02278718|448162420|FG001|Overall Study|Withdrawal by Subject|4|||
124601989|NCT02278718|448162419|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
124601990|NCT02278718|448162420|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
124601991|NCT02278718|448162419|FG000|Overall Study|Missing|0|||
124601992|NCT02278718|448162420|FG001|Overall Study|Missing|1|||
124601993|NCT01546649|448162421|FG000|Overall Study|Adverse Event|4|||
124601994|NCT01546649|448162422|FG001|Overall Study|Adverse Event|5|||
124601995|NCT01546649|448162421|FG000|Overall Study|Protocol Violation|1|||
124601996|NCT01546649|448162422|FG001|Overall Study|Protocol Violation|0|||
124601997|NCT01546649|448162421|FG000|Overall Study|Lack of Efficacy|1|||
124601998|NCT01546649|448162422|FG001|Overall Study|Lack of Efficacy|0|||
124601999|NCT01546649|448162421|FG000|Overall Study|Recurrence|1|||
124602000|NCT01546649|448162422|FG001|Overall Study|Recurrence|1|||
124602001|NCT01546649|448162421|FG000|Overall Study|Discovery of secondary cancer|0|||
124780921|NCT01485172|448827093|FG003|Overall Study|Withdrawal by Subject|1|||
124602002|NCT01546649|448162422|FG001|Overall Study|Discovery of secondary cancer|1|||
124602003|NCT01546649|448162421|FG000|Overall Study|Withdrawal by Subject|1|||
124602004|NCT01546649|448162422|FG001|Overall Study|Withdrawal by Subject|2|||
124602005|NCT04440449|448162423|FG000|Overall Study|Lost to Follow-up|2|||
124602006|NCT04440449|448162424|FG001|Overall Study|Lost to Follow-up|0|||
124602007|NCT03212794|448162425|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
124637355|NCT05310071|448290491|FG001|Overall Study|Study Terminated by Sponsor|559|||
124602008|NCT03212794|448162426|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
124602009|NCT03212794|448162425|FG000|Overall Study|Lost to Follow-up|5|||
124602010|NCT03212794|448162426|FG001|Overall Study|Lost to Follow-up|6|||
124602011|NCT03212794|448162425|FG000|Overall Study|Incarcerated; unable to participate|2|||
124602012|NCT03212794|448162426|FG001|Overall Study|Incarcerated; unable to participate|0|||
124602013|NCT03212794|448162425|FG000|Overall Study|Withdrawal by Subject|1|||
124602014|NCT03212794|448162426|FG001|Overall Study|Withdrawal by Subject|0|||
124602015|NCT03212794|448162425|FG000|Overall Study|Death|0|||
124602016|NCT03212794|448162426|FG001|Overall Study|Death|1|||
124602017|NCT03212794|448162425|FG000|Overall Study|Found to be ineligible after allocation|0|||
124602018|NCT03212794|448162426|FG001|Overall Study|Found to be ineligible after allocation|1|||
124602019|NCT03212794|448162425|FG000|Overall Study|Relocated out of area|2|||
124602020|NCT03212794|448162426|FG001|Overall Study|Relocated out of area|0|||
124602021|NCT01763918|448162427|FG000|Overall Study|Withdrawal by Subject|2|||
124602022|NCT01763918|448162428|FG001|Overall Study|Withdrawal by Subject|1|||
124602023|NCT01763918|448162429|FG002|Overall Study|Withdrawal by Subject|1|||
124602024|NCT01763918|448162430|FG003|Overall Study|Withdrawal by Subject|2|||
124602025|NCT01763918|448162427|FG000|Overall Study|Sponsor Decision|4|||
124602026|NCT01763918|448162428|FG001|Overall Study|Sponsor Decision|0|||
124602027|NCT01763918|448162429|FG002|Overall Study|Sponsor Decision|9|||
124602028|NCT01763918|448162430|FG003|Overall Study|Sponsor Decision|0|||
124602029|NCT03395639|448162441|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
124602030|NCT03395639|448162442|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
124602031|NCT03395639|448162443|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
124602032|NCT03395639|448162441|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
124602033|NCT03395639|448162442|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
124602034|NCT03395639|448162443|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
124602035|NCT03395639|448162441|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
124602036|NCT03395639|448162442|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
124602037|NCT03395639|448162443|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
124602038|NCT03395639|448162441|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
124602039|NCT03395639|448162442|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
124602040|NCT03395639|448162443|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
124602041|NCT03395639|448162441|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
124602042|NCT03395639|448162442|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
124602043|NCT03395639|448162443|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
124602044|NCT00942331|448162444|FG000|Overall Study|Did not start treatment|15|||
124602045|NCT00942331|448162445|FG001|Overall Study|Did not start treatment|22|||
124602046|NCT00597116|448162448|FG000|Overall Study|Adverse Event|2|||
124602047|NCT00597116|448162449|FG001|Overall Study|Adverse Event|1|||
124602048|NCT00597116|448162448|FG000|Overall Study|Withdrawal by Subject|0|||
124602049|NCT00597116|448162449|FG001|Overall Study|Withdrawal by Subject|2|||
124602050|NCT00597116|448162448|FG000|Overall Study|Physician Decision|0|||
124602051|NCT00597116|448162449|FG001|Overall Study|Physician Decision|1|||
124602052|NCT00597116|448162448|FG000|Overall Study|Death|0|||
124602053|NCT00597116|448162449|FG001|Overall Study|Death|1|||
124602054|NCT00597116|448162448|FG000|Overall Study|Lost to Follow-up|1|||
124602055|NCT00597116|448162449|FG001|Overall Study|Lost to Follow-up|0|||
124602056|NCT00597116|448162448|FG000|Overall Study|Progressive disease|11|||
124602057|NCT00597116|448162449|FG001|Overall Study|Progressive disease|6|||
124602058|NCT00757848|448162453|FG000|Overall Study|Voluntary discontinuation|1|||
124602059|NCT00757848|448162454|FG001|Overall Study|Voluntary discontinuation|0|||
124602060|NCT00757848|448162453|FG000|Overall Study|Adverse Event|1|||
124602061|NCT00757848|448162454|FG001|Overall Study|Adverse Event|2|||
124602062|NCT00757848|448162453|FG000|Overall Study|Incorrect enrolment|1|||
124602063|NCT00757848|448162454|FG001|Overall Study|Incorrect enrolment|0|||
124602064|NCT01901874|448162457|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
124602065|NCT01901874|448162457|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
124602066|NCT01901874|448162457|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
124602067|NCT01901874|448162457|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
124602068|NCT01901874|448162457|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
124602069|NCT01901874|448162457|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
124602070|NCT03832738|448162463|FG000|Overall Study|Withdrawal by Subject|6|||
124602071|NCT03832738|448162464|FG001|Overall Study|Withdrawal by Subject|7|||
124602072|NCT03832738|448162465|FG002|Overall Study|Withdrawal by Subject|16|||
124602073|NCT03832738|448162463|FG000|Overall Study|Physician Decision|0|||
124602074|NCT03832738|448162464|FG001|Overall Study|Physician Decision|1|||
124602075|NCT03832738|448162465|FG002|Overall Study|Physician Decision|2|||
124602076|NCT03832738|448162463|FG000|Overall Study|Adverse Event|2|||
124602077|NCT03832738|448162464|FG001|Overall Study|Adverse Event|3|||
124602078|NCT03832738|448162465|FG002|Overall Study|Adverse Event|1|||
124602079|NCT03832738|448162463|FG000|Overall Study|Pregnancy|0|||
124602080|NCT03832738|448162464|FG001|Overall Study|Pregnancy|1|||
124602081|NCT03832738|448162465|FG002|Overall Study|Pregnancy|0|||
124602082|NCT03977701|448162466|FG000|Overall Study|COVID-19 pandemic|0|||
124602083|NCT03977701|448162467|FG001|Overall Study|COVID-19 pandemic|0|||
124602084|NCT03977701|448162468|FG002|Overall Study|COVID-19 pandemic|0|||
124602085|NCT03977701|448162469|FG003|Overall Study|COVID-19 pandemic|0|||
124602086|NCT03977701|448162470|FG004|Overall Study|COVID-19 pandemic|0|||
124602087|NCT03977701|448162471|FG005|Overall Study|COVID-19 pandemic|1|||
124602088|NCT03977701|448162472|FG006|Overall Study|COVID-19 pandemic|0|||
124602089|NCT03977701|448162473|FG007|Overall Study|COVID-19 pandemic|1|||
124602090|NCT03977701|448162474|FG008|Overall Study|COVID-19 pandemic|0|||
124602091|NCT03977701|448162475|FG009|Overall Study|COVID-19 pandemic|0|||
124602092|NCT00706992|448162476|FG000|Overall Study|Study termination|5|||
124602093|NCT00706992|448162477|FG001|Overall Study|Study termination|5|||
124602094|NCT00706992|448162478|FG002|Overall Study|Study termination|6|||
124602095|NCT00706992|448162479|FG003|Overall Study|Study termination|2|||
124602096|NCT00706992|448162480|FG004|Overall Study|Study termination|3|||
124602097|NCT00706992|448162481|FG005|Overall Study|Study termination|2|||
124602098|NCT00706992|448162482|FG006|Overall Study|Study termination|3|||
124602099|NCT00706992|448162476|FG000|Overall Study|Disease progression before treatment|0|||
124602100|NCT00706992|448162477|FG001|Overall Study|Disease progression before treatment|0|||
124602101|NCT00706992|448162478|FG002|Overall Study|Disease progression before treatment|0|||
124602102|NCT00706992|448162479|FG003|Overall Study|Disease progression before treatment|0|||
124602103|NCT00706992|448162480|FG004|Overall Study|Disease progression before treatment|1|||
124602104|NCT00706992|448162481|FG005|Overall Study|Disease progression before treatment|0|||
124602105|NCT00706992|448162482|FG006|Overall Study|Disease progression before treatment|0|||
124602106|NCT02377063|448162488|FG000|Overall Study|Non-compliance|5|||
124602107|NCT00702208|448162489|FG000|Overall Study|Lost to Follow-up|28|||
124602108|NCT00702208|448162489|FG000|Overall Study|Did not self-lavage|1|||
124602109|NCT00702208|448162489|FG000|Overall Study|Unsatisfactory colposcopy|2|||
124602110|NCT02025751|448162490|FG000|Overall Study|Lost to Follow-up|1|||
124602111|NCT02025751|448162491|FG001|Overall Study|Lost to Follow-up|0|||
124602112|NCT02025751|448162490|FG000|Overall Study|Adverse Event|0|||
124602113|NCT02025751|448162491|FG001|Overall Study|Adverse Event|1|||
124602114|NCT02025751|448162490|FG000|Overall Study|Physician Decision|0|||
124602115|NCT02025751|448162491|FG001|Overall Study|Physician Decision|1|||
124602116|NCT02025751|448162490|FG000|Overall Study|Withdrawal by Subject|0|||
124602117|NCT02025751|448162491|FG001|Overall Study|Withdrawal by Subject|1|||
124602118|NCT03864042|448162492|FG000|DDI Phase|Adverse Event|2|||
124602119|NCT03864042|448162493|FG001|DDI Phase|Adverse Event|0|||
124602120|NCT03864042|448162494|FG002|DDI Phase|Adverse Event|0|||
124602121|NCT03864042|448162492|FG000|DDI Phase|Physician Decision|1|||
124602122|NCT03864042|448162493|FG001|DDI Phase|Physician Decision|0|||
124602123|NCT03864042|448162494|FG002|DDI Phase|Physician Decision|0|||
124602124|NCT03864042|448162492|FG000|DDI Phase|Progressive Disease|1|||
124602125|NCT03864042|448162493|FG001|DDI Phase|Progressive Disease|0|||
124602126|NCT03864042|448162494|FG002|DDI Phase|Progressive Disease|0|||
124602127|NCT03864042|448162492|FG000|Post-DDI Phase|Adverse Event|5|||
124602128|NCT03864042|448162493|FG001|Post-DDI Phase|Adverse Event|3|||
124602129|NCT03864042|448162494|FG002|Post-DDI Phase|Adverse Event|2|||
124602130|NCT03864042|448162492|FG000|Post-DDI Phase|Progressive Disease|11|||
124602131|NCT03864042|448162493|FG001|Post-DDI Phase|Progressive Disease|6|||
124602132|NCT03864042|448162494|FG002|Post-DDI Phase|Progressive Disease|13|||
124602133|NCT03864042|448162492|FG000|Post-DDI Phase|Discretion of investigator|1|||
124602134|NCT03864042|448162493|FG001|Post-DDI Phase|Discretion of investigator|1|||
124602135|NCT03864042|448162494|FG002|Post-DDI Phase|Discretion of investigator|0|||
124602136|NCT03864042|448162492|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
124602137|NCT03864042|448162493|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
124602138|NCT03864042|448162494|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
124602139|NCT03864042|448162492|FG000|Post-DDI Phase|Withdrawal of consent|1|||
124602140|NCT03864042|448162493|FG001|Post-DDI Phase|Withdrawal of consent|2|||
124602141|NCT03864042|448162494|FG002|Post-DDI Phase|Withdrawal of consent|0|||
124731336|NCT02754141|448640089|FG005|Overall Study|AE unrelated to study drug|2|||
124731337|NCT02754141|448640090|FG006|Overall Study|AE unrelated to study drug|1|||
124731338|NCT02754141|448640091|FG007|Overall Study|AE unrelated to study drug|0|||
124731339|NCT02754141|448640092|FG008|Overall Study|AE unrelated to study drug|0|||
124731340|NCT02754141|448640093|FG009|Overall Study|AE unrelated to study drug|0|||
124602142|NCT02220725|448162495|FG000|Overall Study|Lost to Follow-up|0|||
124602143|NCT02220725|448162496|FG001|Overall Study|Lost to Follow-up|0|||
124602144|NCT02220725|448162497|FG002|Overall Study|Lost to Follow-up|0|||
124602145|NCT02220725|448162498|FG003|Overall Study|Lost to Follow-up|1|||
124731341|NCT02754141|448640094|FG010|Overall Study|AE unrelated to study drug|0|||
124602146|NCT02220725|448162495|FG000|Overall Study|Withdrawal by Subject|0|||
124602147|NCT02220725|448162496|FG001|Overall Study|Withdrawal by Subject|0|||
124602148|NCT02220725|448162497|FG002|Overall Study|Withdrawal by Subject|0|||
124602149|NCT02220725|448162498|FG003|Overall Study|Withdrawal by Subject|1|||
124602150|NCT03487848|448162499|FG000|Overall Study|Lost to Follow-up|1|||
124602151|NCT00731549|448162500|FG000|Overall Study|Lost to Follow-up|19|||
124602152|NCT00731549|448162500|FG000|Overall Study|Met withdrawal criteria|24|||
124602153|NCT00731549|448162500|FG000|Overall Study|Physician Decision|16|||
124602154|NCT00731549|448162500|FG000|Overall Study|Withdrawal by Subject|89|||
124602155|NCT00731549|448162500|FG000|Overall Study|Protocol deviation|1|||
124602156|NCT00731549|448162500|FG000|Overall Study|Adverse Event|31|||
124602157|NCT00731549|448162500|FG000|Overall Study|Lack of efficacy with AE|37|||
124602158|NCT00731549|448162500|FG000|Overall Study|Lack of efficacy without AE|6|||
124602159|NCT02333487|448162501|FG000|Overall Study|Adverse Event|0|||
124602160|NCT02333487|448162502|FG001|Overall Study|Adverse Event|2|||
124602161|NCT02333487|448162503|FG002|Overall Study|Adverse Event|0|||
124602162|NCT01111019|448162504|FG000|Overall Study|Withdrew Prematurely|2|||
124602163|NCT01111019|448162504|FG000|Overall Study|Other|1|||
124602164|NCT01583218|448162508|FG000|Overall Study|Withdrawal by Subject|43|||
124602165|NCT01583218|448162509|FG001|Overall Study|Withdrawal by Subject|29|||
124602166|NCT01583218|448162508|FG000|Overall Study|Death|206|||
124602167|NCT01583218|448162509|FG001|Overall Study|Death|211|||
124602168|NCT01583218|448162508|FG000|Overall Study|Lost to Follow-up|11|||
124602169|NCT01583218|448162509|FG001|Overall Study|Lost to Follow-up|17|||
124602170|NCT01583218|448162508|FG000|Overall Study|Adverse event or serious adverse event|3|||
124602171|NCT01583218|448162509|FG001|Overall Study|Adverse event or serious adverse event|3|||
124602172|NCT01583218|448162508|FG000|Overall Study|Patient /Family decision|3|||
124602173|NCT01583218|448162509|FG001|Overall Study|Patient /Family decision|0|||
124602174|NCT01583218|448162508|FG000|Overall Study|Cannot contact patient directly|1|||
124602175|NCT01583218|448162509|FG001|Overall Study|Cannot contact patient directly|2|||
124602176|NCT01583218|448162508|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
124602177|NCT01583218|448162509|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
124602178|NCT01583218|448162508|FG000|Overall Study|Patient did not wish to attend visits|0|||
124602179|NCT01583218|448162509|FG001|Overall Study|Patient did not wish to attend visits|1|||
124602180|NCT01583218|448162508|FG000|Overall Study|Patient randomized but not dosed|17|||
124602181|NCT01583218|448162509|FG001|Overall Study|Patient randomized but not dosed|16|||
124602182|NCT01583218|448162508|FG000|Overall Study|Patient was assessed via phone in person|1|||
124602183|NCT01583218|448162509|FG001|Overall Study|Patient was assessed via phone in person|0|||
124602184|NCT01583218|448162508|FG000|Overall Study|Patient deemed ineligible after random|2|||
124602185|NCT01583218|448162509|FG001|Overall Study|Patient deemed ineligible after random|0|||
124602186|NCT01583218|448162508|FG000|Overall Study|Patient was early terminated from study|0|||
124602187|NCT01583218|448162509|FG001|Overall Study|Patient was early terminated from study|1|||
124602188|NCT01583218|448162508|FG000|Overall Study|Patient was randomized due to mistake|1|||
124602189|NCT01583218|448162509|FG001|Overall Study|Patient was randomized due to mistake|0|||
124602190|NCT01583218|448162508|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
124602191|NCT01583218|448162509|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
124602192|NCT01583218|448162508|FG000|Overall Study|Withdraw of consent on day of random|1|||
124602193|NCT01583218|448162509|FG001|Overall Study|Withdraw of consent on day of random|0|||
124602194|NCT01299805|448162512|FG000|Overall Study|Adverse Event|2|||
124602195|NCT01299805|448162513|FG001|Overall Study|Adverse Event|0|||
124602196|NCT02522403|448163668|FG000|Overall Study|Lost to Follow-up|2|||
124602197|NCT02522403|448163669|FG001|Overall Study|Lost to Follow-up|2|||
124602198|NCT02522403|448163668|FG000|Overall Study|Withdrawal by Subject|2|||
124602199|NCT02522403|448163669|FG001|Overall Study|Withdrawal by Subject|4|||
124602200|NCT04718194|448163674|FG000|Overall Study|Withdrawal by Subject|3|||
124602201|NCT04718194|448163675|FG001|Overall Study|Withdrawal by Subject|0|||
124602202|NCT04718194|448163674|FG000|Overall Study|Lost to Follow-up|3|||
124602203|NCT04718194|448163675|FG001|Overall Study|Lost to Follow-up|0|||
124602204|NCT02091141|448163677|FG000|Overall Study|Death|280|||
124602205|NCT02091141|448163678|FG001|Overall Study|Death|118|||
124602206|NCT02091141|448163679|FG002|Overall Study|Death|46|||
124602207|NCT02091141|448163680|FG003|Overall Study|Death|13|||
124602208|NCT02091141|448163681|FG004|Overall Study|Death|31|||
124602209|NCT02091141|448163682|FG005|Overall Study|Death|16|||
124602210|NCT02091141|448163683|FG006|Overall Study|Death|12|||
124602211|NCT02091141|448163677|FG000|Overall Study|Withdrawal by Subject|21|||
124602212|NCT02091141|448163678|FG001|Overall Study|Withdrawal by Subject|13|||
124602213|NCT02091141|448163679|FG002|Overall Study|Withdrawal by Subject|3|||
124602214|NCT02091141|448163680|FG003|Overall Study|Withdrawal by Subject|2|||
124602215|NCT02091141|448163681|FG004|Overall Study|Withdrawal by Subject|2|||
124602216|NCT02091141|448163682|FG005|Overall Study|Withdrawal by Subject|3|||
124602217|NCT02091141|448163683|FG006|Overall Study|Withdrawal by Subject|0|||
124602218|NCT02091141|448163677|FG000|Overall Study|Lost to Follow-up|21|||
124602219|NCT02091141|448163678|FG001|Overall Study|Lost to Follow-up|5|||
124602220|NCT02091141|448163679|FG002|Overall Study|Lost to Follow-up|1|||
124602221|NCT02091141|448163680|FG003|Overall Study|Lost to Follow-up|0|||
124602222|NCT02091141|448163681|FG004|Overall Study|Lost to Follow-up|1|||
124602223|NCT02091141|448163682|FG005|Overall Study|Lost to Follow-up|2|||
124602224|NCT02091141|448163683|FG006|Overall Study|Lost to Follow-up|0|||
124602225|NCT02091141|448163677|FG000|Overall Study|Reason Not Specified|6|||
124602226|NCT02091141|448163678|FG001|Overall Study|Reason Not Specified|5|||
124602227|NCT02091141|448163679|FG002|Overall Study|Reason Not Specified|2|||
124602228|NCT02091141|448163680|FG003|Overall Study|Reason Not Specified|0|||
124602229|NCT02091141|448163681|FG004|Overall Study|Reason Not Specified|0|||
124602230|NCT02091141|448163682|FG005|Overall Study|Reason Not Specified|0|||
124602231|NCT02091141|448163683|FG006|Overall Study|Reason Not Specified|1|||
124602232|NCT02091141|448163677|FG000|Overall Study|Study Ended by Sponsor|1|||
124602233|NCT02091141|448163678|FG001|Overall Study|Study Ended by Sponsor|9|||
124602234|NCT02091141|448163679|FG002|Overall Study|Study Ended by Sponsor|0|||
124602235|NCT02091141|448163680|FG003|Overall Study|Study Ended by Sponsor|0|||
124602236|NCT02091141|448163681|FG004|Overall Study|Study Ended by Sponsor|0|||
124602237|NCT02091141|448163682|FG005|Overall Study|Study Ended by Sponsor|0|||
124602238|NCT02091141|448163683|FG006|Overall Study|Study Ended by Sponsor|0|||
124602239|NCT02091141|448163677|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
124602240|NCT02091141|448163678|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
124602241|NCT02091141|448163679|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
124602242|NCT02091141|448163680|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
124602243|NCT02091141|448163681|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
124602244|NCT02091141|448163682|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
124602245|NCT02091141|448163683|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
124602246|NCT00605865|448163684|FG000|Overall Study|Protocol Violation|115|||
124602247|NCT03955471|448163685|FG000|Overall Study|Death|22|||
124602248|NCT03955471|448163685|FG000|Overall Study|Lost to Follow-up|1|||
124602249|NCT03955471|448163685|FG000|Overall Study|Withdrawal by Subject|6|||
124602250|NCT03955471|448163685|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
124602251|NCT01032018|448163696|FG000|Overall Study|Lost to Follow-up|6|||
124602252|NCT01032018|448163697|FG001|Overall Study|Lost to Follow-up|5|||
124602253|NCT01032018|448163696|FG000|Overall Study|Death|0|||
124602254|NCT01032018|448163697|FG001|Overall Study|Death|1|||
124602255|NCT02119286|448163700|FG000|Overall Study|Adverse Event|9|||
124602256|NCT02119286|448163701|FG001|Overall Study|Adverse Event|7|||
124602257|NCT02119286|448163702|FG002|Overall Study|Adverse Event|2|||
124602258|NCT02119286|448163700|FG000|Overall Study|Lack of Efficacy|11|||
124602259|NCT02119286|448163701|FG001|Overall Study|Lack of Efficacy|3|||
124602260|NCT02119286|448163702|FG002|Overall Study|Lack of Efficacy|4|||
124602261|NCT02119286|448163700|FG000|Overall Study|Lost to Follow-up|2|||
124602262|NCT02119286|448163701|FG001|Overall Study|Lost to Follow-up|0|||
124602263|NCT02119286|448163702|FG002|Overall Study|Lost to Follow-up|1|||
124602264|NCT02119286|448163700|FG000|Overall Study|Withdrawal by Subject|4|||
124602265|NCT02119286|448163701|FG001|Overall Study|Withdrawal by Subject|1|||
124602266|NCT02119286|448163702|FG002|Overall Study|Withdrawal by Subject|0|||
124602267|NCT00619112|448163703|FG000|Overall Study|Adverse Event|1|||
124602268|NCT00619112|448163704|FG001|Overall Study|Adverse Event|2|||
124602269|NCT01996332|448163705|FG000|Overall Study|Adverse Event|117|||
124602270|NCT01996332|448163705|FG000|Overall Study|Lack of Efficacy|1245|||
124602271|NCT01996332|448163705|FG000|Overall Study|Death|264|||
124602272|NCT01996332|448163705|FG000|Overall Study|Protocol Violation|9|||
124602273|NCT01996332|448163705|FG000|Overall Study|Withdrawal by Subject|71|||
124602274|NCT01996332|448163705|FG000|Overall Study|Other|20|||
124602275|NCT01996332|448163705|FG000|Overall Study|Clinical Deterioration|28|||
124602276|NCT01996332|448163705|FG000|Overall Study|Physician Decision|17|||
124602277|NCT01996332|448163705|FG000|Overall Study|Lost to Follow-up|34|||
124602278|NCT02113189|448163706|FG000|Overall Study|Lost to follow up|2|||
124602279|NCT02113189|448163707|FG001|Overall Study|Lost to follow up|1|||
124602280|NCT02113189|448163708|FG002|Overall Study|Lost to follow up|3|||
124602281|NCT03265288|448163709|FG000|Overall Study|Adverse Event|0|||
124602282|NCT03265288|448163710|FG001|Overall Study|Adverse Event|1|||
124731342|NCT02754141|448640095|FG011|Overall Study|AE unrelated to study drug|0|||
124731343|NCT02754141|448640096|FG012|Overall Study|AE unrelated to study drug|0|||
124731344|NCT02754141|448640097|FG013|Overall Study|AE unrelated to study drug|0|||
124731345|NCT02754141|448640098|FG014|Overall Study|AE unrelated to study drug|0|||
124731346|NCT02754141|448640099|FG015|Overall Study|AE unrelated to study drug|0|||
124731347|NCT02754141|448640100|FG016|Overall Study|AE unrelated to study drug|0|||
124602283|NCT03265288|448163709|FG000|Overall Study|Withdrawal by Subject|13|||
124602284|NCT03265288|448163710|FG001|Overall Study|Withdrawal by Subject|5|||
124602285|NCT03265288|448163709|FG000|Overall Study|Drug Withdrawn|3|||
124731348|NCT02754141|448640101|FG017|Overall Study|AE unrelated to study drug|0|||
124731349|NCT02754141|448640084|FG000|Overall Study|Request to discontinue|0|||
124731350|NCT02754141|448640085|FG001|Overall Study|Request to discontinue|0|||
124602286|NCT03265288|448163710|FG001|Overall Study|Drug Withdrawn|3|||
124602287|NCT03265288|448163709|FG000|Overall Study|Any Other Reason|7|||
124602288|NCT03265288|448163710|FG001|Overall Study|Any Other Reason|3|||
124602289|NCT00652028|448163711|FG000|Overall Study|Adverse Event|1|||
124602290|NCT00652028|448163712|FG001|Overall Study|Adverse Event|0|||
124602291|NCT00652028|448163713|FG002|Overall Study|Adverse Event|0|||
124602292|NCT00652028|448163714|FG003|Overall Study|Adverse Event|0|||
124602293|NCT00652028|448163711|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
124780922|NCT01485172|448827094|FG004|Overall Study|Withdrawal by Subject|1|||
124780923|NCT01485172|448827095|FG005|Overall Study|Withdrawal by Subject|1|||
124780924|NCT02920242|448827099|FG000|Overall Study|Withdrawal by Subject|1|||
124780925|NCT02920242|448827100|FG001|Overall Study|Withdrawal by Subject|0|||
124602294|NCT00652028|448163712|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
124602295|NCT00652028|448163713|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
124602296|NCT00652028|448163714|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
124602297|NCT00652028|448163711|FG000|Overall Study|Physician Decision|0|||
124780926|NCT02920242|448827101|FG002|Overall Study|Withdrawal by Subject|1|||
124780927|NCT02920242|448827099|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
124780928|NCT02920242|448827100|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
124780929|NCT02920242|448827101|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
124780930|NCT01587014|448827102|FG000|Overall Study|Death|2|||
124780931|NCT02948088|448827103|FG000|Overall Study|Lost to Follow-up|8|||
124780932|NCT02948088|448827103|FG000|Overall Study|Death|1|||
124780933|NCT02948088|448827103|FG000|Overall Study|Withdrawal by Subject|4|||
124780934|NCT02948088|448827103|FG000|Overall Study|Other|2|||
124780935|NCT01409811|448827104|FG000|Overall Study|Insurance denial|1|||
124602298|NCT00652028|448163712|FG001|Overall Study|Physician Decision|0|||
124602299|NCT00652028|448163713|FG002|Overall Study|Physician Decision|1|||
124602300|NCT00652028|448163714|FG003|Overall Study|Physician Decision|0|||
124602301|NCT00931268|448163718|FG000|Overall Study|Lost to Follow-up|6|||
124602302|NCT00430495|448163719|FG000|Overall Study|Adverse Event|2|||
124602303|NCT00430495|448163720|FG001|Overall Study|Adverse Event|3|||
124602304|NCT00430495|448163721|FG002|Overall Study|Adverse Event|2|||
124602305|NCT00430495|448163722|FG003|Overall Study|Adverse Event|0|||
124602306|NCT00430495|448163719|FG000|Overall Study|Death|0|||
124602307|NCT00430495|448163720|FG001|Overall Study|Death|0|||
124602308|NCT00430495|448163721|FG002|Overall Study|Death|1|||
124602309|NCT00430495|448163722|FG003|Overall Study|Death|0|||
124602310|NCT00430495|448163719|FG000|Overall Study|Lost to Follow-up|0|||
124602311|NCT00430495|448163720|FG001|Overall Study|Lost to Follow-up|1|||
124602312|NCT00430495|448163721|FG002|Overall Study|Lost to Follow-up|4|||
124602313|NCT00430495|448163722|FG003|Overall Study|Lost to Follow-up|0|||
124602314|NCT00430495|448163719|FG000|Overall Study|Protocol Violation|1|||
124602315|NCT00430495|448163720|FG001|Overall Study|Protocol Violation|0|||
124602316|NCT00430495|448163721|FG002|Overall Study|Protocol Violation|1|||
124602317|NCT00430495|448163722|FG003|Overall Study|Protocol Violation|0|||
124602318|NCT00430495|448163719|FG000|Overall Study|Disease Progression|1|||
124602319|NCT00430495|448163720|FG001|Overall Study|Disease Progression|1|||
124602320|NCT00430495|448163721|FG002|Overall Study|Disease Progression|0|||
124602321|NCT00430495|448163722|FG003|Overall Study|Disease Progression|0|||
124602322|NCT00430495|448163719|FG000|Overall Study|Other|8|||
124602323|NCT00430495|448163720|FG001|Overall Study|Other|2|||
124602324|NCT00430495|448163721|FG002|Overall Study|Other|5|||
124602325|NCT00430495|448163722|FG003|Overall Study|Other|4|||
124602326|NCT00430495|448163719|FG000|Overall Study|Randomized but not Treated|2|||
124602327|NCT00430495|448163720|FG001|Overall Study|Randomized but not Treated|0|||
124602328|NCT00430495|448163721|FG002|Overall Study|Randomized but not Treated|0|||
124602329|NCT00430495|448163722|FG003|Overall Study|Randomized but not Treated|0|||
124602330|NCT02751359|448163723|FG000|Overall Study|Lost to Follow-up|1|||
124602331|NCT02400671|448163724|FG000|Overall Study|Death|5|||
124602332|NCT02400671|448163725|FG001|Overall Study|Death|3|||
124602333|NCT02400671|448163726|FG002|Overall Study|Death|4|||
124602334|NCT02400671|448163724|FG000|Overall Study|Lost to Follow-up|20|||
124602335|NCT02400671|448163725|FG001|Overall Study|Lost to Follow-up|27|||
124602336|NCT02400671|448163726|FG002|Overall Study|Lost to Follow-up|24|||
124602337|NCT02400671|448163724|FG000|Overall Study|Withdrawal by Subject|2|||
124602338|NCT02400671|448163725|FG001|Overall Study|Withdrawal by Subject|2|||
124602339|NCT02400671|448163726|FG002|Overall Study|Withdrawal by Subject|0|||
124602340|NCT02145026|448163727|FG000|Overall Study|Adverse Event|2|||
124602341|NCT02145026|448163727|FG000|Overall Study|Death|4|||
124602342|NCT02145026|448163727|FG000|Overall Study|Withdrawal by Subject|2|||
124602343|NCT02145026|448163727|FG000|Overall Study|Physician Decision|4|||
124780936|NCT01942733|448827105|FG000|Overall Study|Lost to Follow-up|1|||
124602344|NCT00857792|448163728|FG000|Overall Study|inadequate image quality for analysis|12|||
124602345|NCT01797835|448163729|FG000|Overall Study|Lost to Follow-up|31|||
124602346|NCT01797835|448163730|FG001|Overall Study|Lost to Follow-up|27|||
124602347|NCT04421586|448163738|FG000|Overall Study|Death|0|||
124780937|NCT01942733|448827105|FG000|Overall Study|Non-compliance with IMP|1|||
124780938|NCT01942733|448827105|FG000|Overall Study|Administrative|1|||
124780939|NCT00634101|448827106|FG000|Overall Study|Study Terminated|3|||
124602348|NCT04421586|448163739|FG001|Overall Study|Death|1|||
124602349|NCT04421586|448163738|FG000|Overall Study|Lost to Follow-up|2|||
124602350|NCT04421586|448163739|FG001|Overall Study|Lost to Follow-up|2|||
124602351|NCT04421586|448163738|FG000|Overall Study|Withdrawn by PI|1|||
124602352|NCT04421586|448163739|FG001|Overall Study|Withdrawn by PI|0|||
124602353|NCT04421586|448163738|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
124602354|NCT04421586|448163739|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
124602355|NCT00076804|448163741|FG000|Overall Study|Death|9|||
124602356|NCT00076804|448163742|FG001|Overall Study|Death|20|||
124602357|NCT00076804|448163741|FG000|Overall Study|Lost to Follow-up|9|||
124602358|NCT00076804|448163742|FG001|Overall Study|Lost to Follow-up|9|||
124602359|NCT00076804|448163741|FG000|Overall Study|Withdrawal by Subject|10|||
124602360|NCT00076804|448163742|FG001|Overall Study|Withdrawal by Subject|8|||
124602361|NCT00076804|448163741|FG000|Overall Study|Early study Closure|32|||
124602362|NCT00076804|448163742|FG001|Overall Study|Early study Closure|32|||
124602363|NCT04295135|448163744|FG000|Overall Study|Withdrawal by Subject|2|||
124602364|NCT04295135|448163745|FG001|Overall Study|Withdrawal by Subject|1|||
124602365|NCT04295135|448163744|FG000|Overall Study|Subject left organization|8|||
124602366|NCT04295135|448163745|FG001|Overall Study|Subject left organization|4|||
124602367|NCT03484117|448163746|FG000|Overall Study|Lost to Follow-up|1|||
124602368|NCT03484117|448163747|FG001|Overall Study|Lost to Follow-up|3|||
124602369|NCT03484117|448163746|FG000|Overall Study|Declined participation in exit assess|1|||
124602370|NCT03484117|448163747|FG001|Overall Study|Declined participation in exit assess|1|||
124602371|NCT00289874|448163748|FG000|Overall Study|Adverse Event|1|||
124602372|NCT00289874|448163749|FG001|Overall Study|Adverse Event|5|||
124602373|NCT00289874|448163748|FG000|Overall Study|Lost to Follow-up|1|||
124602374|NCT00289874|448163749|FG001|Overall Study|Lost to Follow-up|1|||
124602375|NCT00289874|448163748|FG000|Overall Study|Protocol Violation|3|||
124602376|NCT00289874|448163749|FG001|Overall Study|Protocol Violation|2|||
124602377|NCT00289874|448163748|FG000|Overall Study|Did not meet eligibility|1|||
124602378|NCT00289874|448163749|FG001|Overall Study|Did not meet eligibility|0|||
124602379|NCT03835325|448163750|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
124602380|NCT03835325|448163750|FG000|Overall Study|Selection failure|1|||
124602381|NCT03852459|448163751|FG000|Overall Study|Adverse Event|2|||
124602382|NCT03852459|448163752|FG001|Overall Study|Adverse Event|2|||
124602383|NCT03852459|448163751|FG000|Overall Study|Withdrawal by Subject|1|||
124602384|NCT03852459|448163752|FG001|Overall Study|Withdrawal by Subject|1|||
124602385|NCT00770692|448163754|FG000|Overall Study|Withdrawal by Subject|7|||
124602386|NCT00770692|448163755|FG001|Overall Study|Withdrawal by Subject|9|||
124602387|NCT00770692|448163756|FG002|Overall Study|Withdrawal by Subject|9|||
124602388|NCT00770692|448163757|FG003|Overall Study|Withdrawal by Subject|6|||
124602389|NCT00770692|448163754|FG000|Overall Study|Adverse Event|3|||
124602390|NCT00770692|448163755|FG001|Overall Study|Adverse Event|0|||
124602391|NCT00770692|448163756|FG002|Overall Study|Adverse Event|4|||
124602392|NCT00770692|448163757|FG003|Overall Study|Adverse Event|4|||
124602393|NCT00770692|448163754|FG000|Overall Study|Investigator judgment|2|||
124602394|NCT00770692|448163755|FG001|Overall Study|Investigator judgment|0|||
124602395|NCT00770692|448163756|FG002|Overall Study|Investigator judgment|1|||
124602396|NCT00770692|448163757|FG003|Overall Study|Investigator judgment|1|||
124602397|NCT00560937|448163759|FG000|Overall Study|Withdrawal by Subject|0|||
124602398|NCT00560937|448163760|FG001|Overall Study|Withdrawal by Subject|1|||
124602399|NCT00560937|448163759|FG000|Overall Study|Physician Decision|1|||
124602400|NCT00560937|448163760|FG001|Overall Study|Physician Decision|1|||
124602401|NCT01138111|448163763|FG000|Overall Study|Withdrawal by Subject|5|||
124602402|NCT01138111|448163763|FG000|Overall Study|Adverse Event|1|||
124602403|NCT01138111|448163763|FG000|Overall Study|Death|1|||
124602404|NCT01138111|448163763|FG000|Overall Study|Lost to Follow-up|2|||
124602405|NCT03629028|448163764|FG000|Overall Study|Lost to Follow-up|26|||
124602406|NCT03629028|448163765|FG001|Overall Study|Lost to Follow-up|23|||
124602407|NCT03629028|448163764|FG000|Overall Study|Pregnancy|4|||
124602408|NCT03629028|448163765|FG001|Overall Study|Pregnancy|2|||
124602409|NCT03629028|448163764|FG000|Overall Study|intolerance to examination|2|||
124602410|NCT03629028|448163765|FG001|Overall Study|intolerance to examination|0|||
124602411|NCT02687360|448163770|FG000|Overall Study|Withdrawal by Subject|3|||
124602412|NCT02687360|448163771|FG001|Overall Study|Withdrawal by Subject|0|||
124602413|NCT02989168|448163772|FG000|Overall Study|Withdrawal by Subject|2|||
124602414|NCT02989168|448163773|FG001|Overall Study|Withdrawal by Subject|0|||
124780940|NCT00634101|448827107|FG001|Overall Study|Study Terminated|3|||
124780941|NCT00634101|448827106|FG000|Overall Study|Lost to Follow-up|2|||
124602415|NCT02989168|448163772|FG000|Overall Study|Physician Decision|0|||
124602416|NCT02989168|448163773|FG001|Overall Study|Physician Decision|1|||
124780942|NCT00634101|448827107|FG001|Overall Study|Lost to Follow-up|0|||
124780943|NCT00838513|448827109|FG000|Screening Period|Screen Failure|3|||
124780944|NCT00838513|448827109|FG000|Extension Treatment Period|Death|1|||
124602417|NCT02989168|448163772|FG000|Overall Study|Adverse Event|1|||
124602418|NCT02989168|448163773|FG001|Overall Study|Adverse Event|2|||
124602419|NCT02989168|448163772|FG000|Overall Study|Sponsor stopped study.|1|||
124780945|NCT00838513|448827109|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
124602420|NCT02989168|448163773|FG001|Overall Study|Sponsor stopped study.|0|||
124602421|NCT01846273|448163774|FG000|Overall Study|Adverse Event|9|||
124602422|NCT01846273|448163775|FG001|Overall Study|Adverse Event|7|||
124602423|NCT01846273|448163776|FG002|Overall Study|Adverse Event|0|||
124602424|NCT01846273|448163774|FG000|Overall Study|Subject withdrew consent|5|||
124602425|NCT01846273|448163775|FG001|Overall Study|Subject withdrew consent|8|||
124602426|NCT01846273|448163776|FG002|Overall Study|Subject withdrew consent|0|||
124602427|NCT01846273|448163774|FG000|Overall Study|Lost to Follow-up|2|||
124602428|NCT01846273|448163775|FG001|Overall Study|Lost to Follow-up|1|||
124602429|NCT01846273|448163776|FG002|Overall Study|Lost to Follow-up|0|||
124602430|NCT01846273|448163774|FG000|Overall Study|Administrative problems|1|||
124602431|NCT01846273|448163775|FG001|Overall Study|Administrative problems|0|||
124602432|NCT01846273|448163776|FG002|Overall Study|Administrative problems|0|||
124602433|NCT01846273|448163774|FG000|Overall Study|Death|2|||
124602434|NCT01846273|448163775|FG001|Overall Study|Death|1|||
124602435|NCT01846273|448163776|FG002|Overall Study|Death|0|||
124602436|NCT01846273|448163774|FG000|Overall Study|Disease Progression|0|||
124602437|NCT01846273|448163775|FG001|Overall Study|Disease Progression|4|||
124602438|NCT01846273|448163776|FG002|Overall Study|Disease Progression|0|||
124602439|NCT01846273|448163774|FG000|Overall Study|Protocol Deviation|2|||
124602440|NCT01846273|448163775|FG001|Overall Study|Protocol Deviation|3|||
124602441|NCT01846273|448163776|FG002|Overall Study|Protocol Deviation|0|||
124602442|NCT01846273|448163774|FG000|Overall Study|Physician Decision|1|||
124602443|NCT01846273|448163775|FG001|Overall Study|Physician Decision|2|||
124602444|NCT01846273|448163776|FG002|Overall Study|Physician Decision|0|||
124602445|NCT02939014|448163779|FG000|Overall Study|Lost to Follow-up|1|||
124602446|NCT02939014|448163780|FG001|Overall Study|Lost to Follow-up|0|||
124602447|NCT02939014|448163779|FG000|Overall Study|Death|4|||
124602448|NCT02939014|448163780|FG001|Overall Study|Death|3|||
124602449|NCT00456495|448163781|FG000|Overall Study|Physician Decision|2|||
124602450|NCT05069155|448163782|FG000|Overall Study|Withdrawal by Subject|1|||
124602451|NCT05069155|448163783|FG001|Overall Study|Withdrawal by Subject|3|||
124602452|NCT01297322|448163784|FG000|Overall Study|Lost to Follow-up|1|||
124602453|NCT01297322|448163785|FG001|Overall Study|Lost to Follow-up|0|||
124602454|NCT01297322|448163784|FG000|Overall Study|Withdrawal by Subject|0|||
124602455|NCT01297322|448163785|FG001|Overall Study|Withdrawal by Subject|1|||
124602456|NCT01297322|448163784|FG000|Overall Study|Protocol Violation|0|||
124602457|NCT01297322|448163785|FG001|Overall Study|Protocol Violation|3|||
124602458|NCT00712985|448163786|FG000|Overall Study|1 withdrew prior to start of drug|1|||
124602459|NCT00712985|448163786|FG000|Overall Study|1 patient moved out of state|1|||
124602460|NCT00712985|448163786|FG000|Overall Study|Lack of Efficacy|3|||
124602461|NCT03334721|448163789|FG000|Overall Study|Withdrawal by Subject|1|||
124602462|NCT03334721|448163790|FG001|Overall Study|Withdrawal by Subject|0|||
124602463|NCT03334721|448163789|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
124602464|NCT03334721|448163790|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
124602465|NCT01902628|448163791|FG000|Overall Study|Withdrawal of participant's consent|7|||
124602466|NCT01902628|448163791|FG000|Overall Study|Adverse Event|41|||
124602467|NCT01902628|448163791|FG000|Overall Study|Lost to Follow-up|35|||
124602468|NCT04969861|448163792|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
124602469|NCT04969861|448163793|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
124602470|NCT03340064|448165393|FG000|First Period|Adverse Event, non-fatal|2|||
124602471|NCT03340064|448165394|FG001|First Period|Adverse Event, non-fatal|0|||
124602472|NCT03340064|448165393|FG000|First Period|Lack of Efficacy|3|||
124602473|NCT03340064|448165394|FG001|First Period|Lack of Efficacy|0|||
124602474|NCT03340064|448165393|FG000|Second Period|Adverse Event, non-fatal|1|||
124602475|NCT03340064|448165394|FG001|Second Period|Adverse Event, non-fatal|1|||
124602476|NCT03340064|448165393|FG000|Second Period|Lack of Efficacy|11|||
124602477|NCT03340064|448165394|FG001|Second Period|Lack of Efficacy|0|||
124602478|NCT03340064|448165393|FG000|Second Period|Physician Decision|3|||
124602479|NCT03340064|448165394|FG001|Second Period|Physician Decision|0|||
124602480|NCT03340064|448165393|FG000|Second Period|Withdrawal by Subject|2|||
124602481|NCT03340064|448165394|FG001|Second Period|Withdrawal by Subject|1|||
124602482|NCT03340064|448165393|FG000|Second Period|Approved Drug Available For Indication|1|||
124602483|NCT03340064|448165394|FG001|Second Period|Approved Drug Available For Indication|0|||
124602484|NCT03340064|448165393|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
124602485|NCT03340064|448165394|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
124602486|NCT00856973|448165397|FG000|Overall Study|Adverse Event|5|||
124602487|NCT00856973|448165398|FG001|Overall Study|Adverse Event|5|||
124602488|NCT00856973|448165399|FG002|Overall Study|Adverse Event|3|||
124602489|NCT00856973|448165397|FG000|Overall Study|Lost to Follow-up|6|||
124602490|NCT00856973|448165398|FG001|Overall Study|Lost to Follow-up|3|||
124602491|NCT00856973|448165399|FG002|Overall Study|Lost to Follow-up|5|||
124602492|NCT00856973|448165397|FG000|Overall Study|Physician Decision|0|||
124602493|NCT00856973|448165398|FG001|Overall Study|Physician Decision|3|||
124602494|NCT00856973|448165399|FG002|Overall Study|Physician Decision|1|||
124602495|NCT00856973|448165397|FG000|Overall Study|Protocol Violation|1|||
124602496|NCT00856973|448165398|FG001|Overall Study|Protocol Violation|2|||
124602497|NCT00856973|448165399|FG002|Overall Study|Protocol Violation|1|||
124602498|NCT00856973|448165397|FG000|Overall Study|Withdrawal by Subject|13|||
124602499|NCT00856973|448165398|FG001|Overall Study|Withdrawal by Subject|16|||
124602500|NCT00856973|448165399|FG002|Overall Study|Withdrawal by Subject|15|||
124602501|NCT00856973|448165397|FG000|Overall Study|Other|11|||
124602502|NCT00856973|448165398|FG001|Overall Study|Other|12|||
124602503|NCT00856973|448165399|FG002|Overall Study|Other|13|||
124602504|NCT04556552|448165403|FG000|Overall Study|Lost to Follow-up|1|||
124602505|NCT04556552|448165404|FG001|Overall Study|Lost to Follow-up|0|||
124602506|NCT04556552|448165403|FG000|Overall Study|Claustrophobia|0|||
124602507|NCT04556552|448165404|FG001|Overall Study|Claustrophobia|1|||
124602508|NCT04556552|448165403|FG000|Overall Study|Inability to continue|0|||
124602509|NCT04556552|448165404|FG001|Overall Study|Inability to continue|1|||
124602510|NCT03439852|448165405|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
124602511|NCT03439852|448165406|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
124602512|NCT03439852|448165405|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
124602513|NCT03439852|448165406|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
124602514|NCT03439852|448165405|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
124602515|NCT03439852|448165406|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
124602516|NCT01215513|448165407|FG000|Overall Study|Not completed CS42|9|||
124602517|NCT01215513|448165407|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
124602518|NCT01215513|448165407|FG000|Overall Study|Adverse event (CS42A)|2|||
124602519|NCT01215513|448165407|FG000|Overall Study|Physician decision (CS42A)|6|||
124602520|NCT01215513|448165407|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
124602521|NCT01215513|448165407|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
124602522|NCT00793780|448165410|FG000|Overall Study|Withdrawal by Subject|2|||
124602523|NCT00793780|448165411|FG001|Overall Study|Withdrawal by Subject|1|||
124602524|NCT02858492|448165412|FG000|Overall Study|Withdrawal by Subject|0|||
124602525|NCT02858492|448165413|FG001|Overall Study|Withdrawal by Subject|1|||
124602526|NCT02858492|448165414|FG002|Overall Study|Withdrawal by Subject|0|||
124602527|NCT02858492|448165415|FG003|Overall Study|Withdrawal by Subject|1|||
124602528|NCT02858492|448165412|FG000|Overall Study|Adverse Event|0|||
124602529|NCT02858492|448165413|FG001|Overall Study|Adverse Event|0|||
124602530|NCT02858492|448165414|FG002|Overall Study|Adverse Event|0|||
124602531|NCT02858492|448165415|FG003|Overall Study|Adverse Event|3|||
124602532|NCT02858492|448165412|FG000|Overall Study|Lack of Efficacy|0|||
124602533|NCT02858492|448165413|FG001|Overall Study|Lack of Efficacy|0|||
124602534|NCT02858492|448165414|FG002|Overall Study|Lack of Efficacy|0|||
124602535|NCT02858492|448165415|FG003|Overall Study|Lack of Efficacy|1|||
124602536|NCT02858492|448165412|FG000|Overall Study|Protocol defined stopping criteria|0|||
124602537|NCT02858492|448165413|FG001|Overall Study|Protocol defined stopping criteria|0|||
124602538|NCT02858492|448165414|FG002|Overall Study|Protocol defined stopping criteria|0|||
124602539|NCT02858492|448165415|FG003|Overall Study|Protocol defined stopping criteria|1|||
124602540|NCT03247517|448165420|FG000|Overall Study|Adverse Event|0|||
124602541|NCT03247517|448165421|FG001|Overall Study|Adverse Event|4|||
124602542|NCT03247517|448165422|FG002|Overall Study|Adverse Event|2|||
124602543|NCT03247517|448165420|FG000|Overall Study|Lost to Follow-up|2|||
124602544|NCT03247517|448165421|FG001|Overall Study|Lost to Follow-up|6|||
124602545|NCT03247517|448165422|FG002|Overall Study|Lost to Follow-up|4|||
124602546|NCT03247517|448165420|FG000|Overall Study|Consent withdrawn by caregiver|1|||
124602547|NCT03247517|448165421|FG001|Overall Study|Consent withdrawn by caregiver|4|||
124602548|NCT03247517|448165422|FG002|Overall Study|Consent withdrawn by caregiver|7|||
124602549|NCT03247517|448165420|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
124602550|NCT03247517|448165421|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
124602551|NCT03247517|448165422|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
124602552|NCT03247517|448165420|FG000|Overall Study|Protocol Violation|0|||
124602553|NCT03247517|448165421|FG001|Overall Study|Protocol Violation|2|||
124602554|NCT03247517|448165422|FG002|Overall Study|Protocol Violation|0|||
124602555|NCT03247517|448165420|FG000|Overall Study|Multiple reasons|3|||
124602556|NCT03247517|448165421|FG001|Overall Study|Multiple reasons|1|||
124602557|NCT03247517|448165422|FG002|Overall Study|Multiple reasons|0|||
124602558|NCT02040779|448165423|FG000|Overall Study|Adverse Event|1|||
124602559|NCT02040779|448165424|FG001|Overall Study|Adverse Event|0|||
124602560|NCT02040779|448165425|FG002|Overall Study|Adverse Event|0|||
124731351|NCT02754141|448640086|FG002|Overall Study|Request to discontinue|0|||
124731352|NCT02754141|448640087|FG003|Overall Study|Request to discontinue|0|||
124731353|NCT02754141|448640088|FG004|Overall Study|Request to discontinue|0|||
124731354|NCT02754141|448640089|FG005|Overall Study|Request to discontinue|0|||
124731355|NCT02754141|448640090|FG006|Overall Study|Request to discontinue|0|||
124731356|NCT02754141|448640091|FG007|Overall Study|Request to discontinue|0|||
124731357|NCT02754141|448640092|FG008|Overall Study|Request to discontinue|1|||
124731358|NCT02754141|448640093|FG009|Overall Study|Request to discontinue|0|||
124731359|NCT02754141|448640094|FG010|Overall Study|Request to discontinue|0|||
124731360|NCT02754141|448640095|FG011|Overall Study|Request to discontinue|0|||
124731361|NCT02754141|448640096|FG012|Overall Study|Request to discontinue|0|||
124731362|NCT02754141|448640097|FG013|Overall Study|Request to discontinue|1|||
124731363|NCT02754141|448640098|FG014|Overall Study|Request to discontinue|1|||
124731364|NCT02754141|448640099|FG015|Overall Study|Request to discontinue|0|||
124602561|NCT02040779|448165423|FG000|Overall Study|Withdrawal by Subject|4|||
124602562|NCT02040779|448165424|FG001|Overall Study|Withdrawal by Subject|1|||
124731365|NCT02754141|448640100|FG016|Overall Study|Request to discontinue|0|||
124731366|NCT02754141|448640101|FG017|Overall Study|Request to discontinue|0|||
124602563|NCT02040779|448165425|FG002|Overall Study|Withdrawal by Subject|3|||
124602564|NCT02040779|448165423|FG000|Overall Study|Non-compliance|0|||
124602565|NCT02040779|448165424|FG001|Overall Study|Non-compliance|1|||
124602566|NCT02040779|448165425|FG002|Overall Study|Non-compliance|0|||
124602567|NCT02040779|448165423|FG000|Overall Study|Protocol Violation|2|||
124602568|NCT02040779|448165424|FG001|Overall Study|Protocol Violation|1|||
124602569|NCT02040779|448165425|FG002|Overall Study|Protocol Violation|0|||
124602570|NCT02040779|448165423|FG000|Overall Study|Lost to Follow-up|1|||
124602571|NCT02040779|448165424|FG001|Overall Study|Lost to Follow-up|2|||
124602572|NCT02040779|448165425|FG002|Overall Study|Lost to Follow-up|1|||
124602573|NCT02040779|448165423|FG000|Overall Study|Lack of Efficacy|4|||
124602574|NCT02040779|448165424|FG001|Overall Study|Lack of Efficacy|2|||
124602575|NCT02040779|448165425|FG002|Overall Study|Lack of Efficacy|0|||
124602576|NCT02132637|448165426|FG000|Study Period 1|Withdrawal by Subject|0|||
124602577|NCT02132637|448165427|FG001|Study Period 1|Withdrawal by Subject|4|||
124602578|NCT02132637|448165426|FG000|Study Period 1|Physician Decision|1|||
124602579|NCT02132637|448165427|FG001|Study Period 1|Physician Decision|0|||
124602580|NCT02132637|448165426|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
124602581|NCT02132637|448165427|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
124602582|NCT02132637|448165426|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
124602583|NCT02132637|448165427|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
124602584|NCT00127036|448165435|FG000|Overall Study|Insufficient Data for Analysis|6|||
124602585|NCT00127036|448165436|FG001|Overall Study|Insufficient Data for Analysis|11|||
124602586|NCT00127036|448165435|FG000|Overall Study|Screen Failure|2|||
124602587|NCT00127036|448165436|FG001|Overall Study|Screen Failure|0|||
124602588|NCT03656874|448165439|FG000|Overall Study|Lost to Follow-up|3|||
124602589|NCT03656874|448165440|FG001|Overall Study|Lost to Follow-up|17|||
124602590|NCT00584844|448165441|FG000|Overall Study|Withdrawal by Subject|59|||
124602591|NCT00584844|448165441|FG000|Overall Study|Screen Failure|20|||
124602592|NCT01195103|448165442|FG000|Overall Study|Withdrawal by Subject|1|||
124602593|NCT01195103|448165443|FG001|Overall Study|Withdrawal by Subject|0|||
124602594|NCT01195103|448165444|FG002|Overall Study|Withdrawal by Subject|0|||
124602595|NCT03760250|448165445|FG000|Overall Study|Withdrawal by Subject|1|||
124602596|NCT03760250|448165445|FG000|Overall Study|Physician Decision|1|||
124602597|NCT01615263|448165446|FG000|Overall Study|Post-randomization exclusion|0|||
124602598|NCT01615263|448165447|FG001|Overall Study|Post-randomization exclusion|2|||
124602599|NCT00857259|448165448|FG000|Overall Study|Protocol Violation|1|||
124602600|NCT00857259|448165449|FG001|Overall Study|Protocol Violation|0|||
124602601|NCT00857259|448165450|FG002|Overall Study|Protocol Violation|1|||
124602602|NCT01370213|448165451|FG000|Overall Study|Early Death|1|||
124602603|NCT01370213|448165452|FG001|Overall Study|Early Death|0|||
124602604|NCT01370213|448165453|FG002|Overall Study|Early Death|0|||
124602605|NCT01370213|448165451|FG000|Overall Study|Not evaluable|0|||
124602606|NCT01370213|448165452|FG001|Overall Study|Not evaluable|2|||
124602607|NCT01370213|448165453|FG002|Overall Study|Not evaluable|0|||
124602608|NCT02701413|448165454|FG000|Overall Study|Withdrawal by Subject|7|||
124602609|NCT02701413|448165455|FG001|Overall Study|Withdrawal by Subject|11|||
124602610|NCT01621191|448165461|FG000|Overall Study|Adverse Event|9|||
124602611|NCT01621191|448165461|FG000|Overall Study|Withdrawal by Subject|8|||
124602612|NCT01621191|448165461|FG000|Overall Study|Lack of Efficacy|6|||
124602613|NCT01621191|448165461|FG000|Overall Study|Lost to Follow-up|1|||
124602614|NCT01621191|448165461|FG000|Overall Study|Site Removed From Study|1|||
124602615|NCT01321008|448165462|FG000|Overall Study|Early Study Termination|1|||
124602616|NCT02749292|448165467|FG000|Overall Study|Physician Decision|1|||
124602617|NCT02749292|448165468|FG001|Overall Study|Physician Decision|0|||
124602618|NCT02749292|448165467|FG000|Overall Study|Withdrawal by Subject|5|||
124602619|NCT02749292|448165468|FG001|Overall Study|Withdrawal by Subject|7|||
124602620|NCT02749292|448165467|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
124602621|NCT02749292|448165468|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
124602622|NCT02749292|448165467|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
124602623|NCT02749292|448165468|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
124602624|NCT02749292|448165467|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
124602625|NCT02749292|448165468|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
124602626|NCT02749292|448165467|FG000|Overall Study|Adverse Event|4|||
124602627|NCT02749292|448165468|FG001|Overall Study|Adverse Event|1|||
124602628|NCT02749292|448165467|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
124602629|NCT02749292|448165468|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
124602630|NCT02749292|448165467|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
124602631|NCT02749292|448165468|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
124602632|NCT02749292|448165467|FG000|Overall Study|Requiring glucocorticoids|0|||
124602633|NCT02749292|448165468|FG001|Overall Study|Requiring glucocorticoids|3|||
124602634|NCT02749292|448165467|FG000|Overall Study|Cancer|1|||
124602635|NCT02749292|448165468|FG001|Overall Study|Cancer|0|||
124602636|NCT02458092|448165469|FG000|Overall Study|Withdrawal by Subject|1|||
124602637|NCT02458092|448165470|FG001|Overall Study|Withdrawal by Subject|0|||
124602638|NCT00251641|448165473|FG000|Overall Study|Adverse Event|80|||
124602639|NCT00251641|448165474|FG001|Overall Study|Adverse Event|8|||
124602640|NCT00251641|448165473|FG000|Overall Study|Lack of Efficacy|2|||
124602641|NCT00251641|448165474|FG001|Overall Study|Lack of Efficacy|1|||
124602642|NCT00251641|448165473|FG000|Overall Study|Progression of Disease|0|||
124602643|NCT00251641|448165474|FG001|Overall Study|Progression of Disease|2|||
124602644|NCT00251641|448165473|FG000|Overall Study|Lost to Follow-up|3|||
124602645|NCT00251641|448165474|FG001|Overall Study|Lost to Follow-up|3|||
124602646|NCT00251641|448165473|FG000|Overall Study|Withdrawal by Subject|6|||
124602647|NCT00251641|448165474|FG001|Overall Study|Withdrawal by Subject|8|||
124602648|NCT00251641|448165473|FG000|Overall Study|Protocol Violation|10|||
124602649|NCT00251641|448165474|FG001|Overall Study|Protocol Violation|2|||
124602650|NCT00251641|448165473|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
124602651|NCT00251641|448165474|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
124602652|NCT00251641|448165473|FG000|Overall Study|Switched Treatment|9|||
124602653|NCT00251641|448165474|FG001|Overall Study|Switched Treatment|63|||
124602654|NCT02093221|448165477|FG000|Overall Study|Adverse Event|1|||
124780946|NCT00139477|448827113|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
124780947|NCT00139477|448827114|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
124780948|NCT00139477|448827113|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
124780949|NCT00139477|448827114|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
124780950|NCT00139477|448827113|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
124780951|NCT00139477|448827114|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
124602655|NCT02093221|448165478|FG001|Overall Study|Adverse Event|0|||
124602656|NCT02093221|448165479|FG002|Overall Study|Adverse Event|0|||
124602657|NCT02093221|448165480|FG003|Overall Study|Adverse Event|0|||
124602658|NCT02093221|448165481|FG004|Overall Study|Adverse Event|0|||
124602659|NCT02093221|448165477|FG000|Overall Study|Withdrawal by Subject|1|||
124602660|NCT02093221|448165478|FG001|Overall Study|Withdrawal by Subject|1|||
124602661|NCT02093221|448165479|FG002|Overall Study|Withdrawal by Subject|4|||
124602662|NCT02093221|448165480|FG003|Overall Study|Withdrawal by Subject|1|||
124602663|NCT02093221|448165481|FG004|Overall Study|Withdrawal by Subject|1|||
124602664|NCT02093221|448165477|FG000|Overall Study|Lost to Follow-up|2|||
124602665|NCT02093221|448165478|FG001|Overall Study|Lost to Follow-up|0|||
124602666|NCT02093221|448165479|FG002|Overall Study|Lost to Follow-up|1|||
124602667|NCT02093221|448165480|FG003|Overall Study|Lost to Follow-up|1|||
124602668|NCT02093221|448165481|FG004|Overall Study|Lost to Follow-up|0|||
124731367|NCT02754141|448640084|FG000|Overall Study|Withdrew consent|0|||
124731368|NCT02754141|448640085|FG001|Overall Study|Withdrew consent|0|||
124731369|NCT02754141|448640086|FG002|Overall Study|Withdrew consent|0|||
124731370|NCT02754141|448640087|FG003|Overall Study|Withdrew consent|0|||
124731371|NCT02754141|448640088|FG004|Overall Study|Withdrew consent|0|||
124731372|NCT02754141|448640089|FG005|Overall Study|Withdrew consent|0|||
124731373|NCT02754141|448640090|FG006|Overall Study|Withdrew consent|0|||
124731374|NCT02754141|448640091|FG007|Overall Study|Withdrew consent|0|||
124731375|NCT02754141|448640092|FG008|Overall Study|Withdrew consent|0|||
124731376|NCT02754141|448640093|FG009|Overall Study|Withdrew consent|1|||
124731377|NCT02754141|448640094|FG010|Overall Study|Withdrew consent|0|||
124731378|NCT02754141|448640095|FG011|Overall Study|Withdrew consent|0|||
124731379|NCT02754141|448640096|FG012|Overall Study|Withdrew consent|0|||
124731380|NCT02754141|448640097|FG013|Overall Study|Withdrew consent|0|||
124731381|NCT02754141|448640098|FG014|Overall Study|Withdrew consent|0|||
124731382|NCT02754141|448640099|FG015|Overall Study|Withdrew consent|0|||
124731383|NCT02754141|448640100|FG016|Overall Study|Withdrew consent|0|||
124731384|NCT02754141|448640101|FG017|Overall Study|Withdrew consent|0|||
124731385|NCT02754141|448640084|FG000|Overall Study|Maximum clinical benefit|0|||
124731386|NCT02754141|448640085|FG001|Overall Study|Maximum clinical benefit|0|||
124731387|NCT02754141|448640086|FG002|Overall Study|Maximum clinical benefit|0|||
124731388|NCT02754141|448640087|FG003|Overall Study|Maximum clinical benefit|1|||
124731389|NCT02754141|448640088|FG004|Overall Study|Maximum clinical benefit|0|||
124731390|NCT02754141|448640089|FG005|Overall Study|Maximum clinical benefit|0|||
124731391|NCT02754141|448640090|FG006|Overall Study|Maximum clinical benefit|0|||
124731392|NCT02754141|448640091|FG007|Overall Study|Maximum clinical benefit|0|||
124780952|NCT00139477|448827113|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
124780953|NCT00139477|448827114|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
124602669|NCT02093221|448165477|FG000|Overall Study|Death|0|||
124602670|NCT02093221|448165478|FG001|Overall Study|Death|1|||
124602671|NCT02093221|448165479|FG002|Overall Study|Death|0|||
124602672|NCT02093221|448165480|FG003|Overall Study|Death|0|||
124602673|NCT02093221|448165481|FG004|Overall Study|Death|0|||
124731393|NCT02754141|448640092|FG008|Overall Study|Maximum clinical benefit|0|||
124731394|NCT02754141|448640093|FG009|Overall Study|Maximum clinical benefit|0|||
124731395|NCT02754141|448640094|FG010|Overall Study|Maximum clinical benefit|0|||
124731396|NCT02754141|448640095|FG011|Overall Study|Maximum clinical benefit|0|||
124731397|NCT02754141|448640096|FG012|Overall Study|Maximum clinical benefit|0|||
124731398|NCT02754141|448640097|FG013|Overall Study|Maximum clinical benefit|0|||
124731399|NCT02754141|448640098|FG014|Overall Study|Maximum clinical benefit|0|||
124731400|NCT02754141|448640099|FG015|Overall Study|Maximum clinical benefit|0|||
124780954|NCT00139477|448827113|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
124602674|NCT02093221|448165477|FG000|Overall Study|Protocol Violation|0|||
124602675|NCT02093221|448165478|FG001|Overall Study|Protocol Violation|1|||
124780955|NCT00139477|448827114|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
124780956|NCT00139477|448827113|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
124602676|NCT02093221|448165479|FG002|Overall Study|Protocol Violation|0|||
124602677|NCT02093221|448165480|FG003|Overall Study|Protocol Violation|0|||
124602678|NCT02093221|448165481|FG004|Overall Study|Protocol Violation|0|||
124602679|NCT02093221|448165477|FG000|Overall Study|Study termination|6|||
124602680|NCT02093221|448165478|FG001|Overall Study|Study termination|5|||
124602681|NCT02093221|448165479|FG002|Overall Study|Study termination|4|||
124602682|NCT02093221|448165480|FG003|Overall Study|Study termination|6|||
124602683|NCT02093221|448165481|FG004|Overall Study|Study termination|7|||
124602684|NCT00257920|448165484|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
124602685|NCT00257920|448165485|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
124602686|NCT00257920|448165484|FG000|Period: Second Intervention|Other|2|||
124602687|NCT00257920|448165485|FG001|Period: Second Intervention|Other|1|||
124602688|NCT03097588|448165491|FG000|Overall Study|Adverse Event|1|||
124602689|NCT03456960|448165492|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
124602690|NCT03456960|448165493|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
124602691|NCT03456960|448165494|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
124602692|NCT03456960|448165495|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
124602693|NCT03456960|448165496|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
124602694|NCT03456960|448165497|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
124602695|NCT03456960|448165492|FG000|Period 2 (1 Day)|Adverse Event|1|||
124602696|NCT03456960|448165493|FG001|Period 2 (1 Day)|Adverse Event|0|||
124602697|NCT03456960|448165494|FG002|Period 2 (1 Day)|Adverse Event|0|||
124602698|NCT03456960|448165495|FG003|Period 2 (1 Day)|Adverse Event|1|||
124602699|NCT03456960|448165496|FG004|Period 2 (1 Day)|Adverse Event|0|||
124602700|NCT03456960|448165497|FG005|Period 2 (1 Day)|Adverse Event|0|||
124602701|NCT00653991|448165498|FG000|3 Month Follow-up|Participant would not respond|150|||
124602702|NCT00653991|448165499|FG001|3 Month Follow-up|Participant would not respond|157|||
124602703|NCT00653991|448165498|FG000|6 Month Follow-up|Participant would not respond|133|||
124602704|NCT00653991|448165499|FG001|6 Month Follow-up|Participant would not respond|141|||
124602705|NCT03828448|448165500|FG000|Overall Study|Sponsor's Discretion|34|||
124602706|NCT02037165|448165501|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
124602707|NCT02037165|448165502|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
124602708|NCT02037165|448165503|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
124602709|NCT02037165|448165504|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
124602710|NCT02037165|448165505|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
124602711|NCT00532935|448165506|FG000|Overall Study|Adverse Event|11|||
124602712|NCT00532935|448165507|FG001|Overall Study|Adverse Event|12|||
124602713|NCT00532935|448165506|FG000|Overall Study|Lack of Efficacy|0|||
124602714|NCT00532935|448165507|FG001|Overall Study|Lack of Efficacy|3|||
124602715|NCT00532935|448165506|FG000|Overall Study|Lost to Follow-up|10|||
124602716|NCT00532935|448165507|FG001|Overall Study|Lost to Follow-up|6|||
124602717|NCT00532935|448165506|FG000|Overall Study|Physician Decision|4|||
124602718|NCT00532935|448165507|FG001|Overall Study|Physician Decision|5|||
124602719|NCT00532935|448165506|FG000|Overall Study|Pregnancy|1|||
124602720|NCT00532935|448165507|FG001|Overall Study|Pregnancy|0|||
124602721|NCT00532935|448165506|FG000|Overall Study|Protocol Violation|4|||
124602722|NCT00532935|448165507|FG001|Overall Study|Protocol Violation|2|||
124602723|NCT00532935|448165506|FG000|Overall Study|Withdrawal by Subject|10|||
124602724|NCT00532935|448165507|FG001|Overall Study|Withdrawal by Subject|9|||
124602725|NCT00532935|448165506|FG000|Overall Study|Protocol Specific Criteria|11|||
124602726|NCT00532935|448165507|FG001|Overall Study|Protocol Specific Criteria|15|||
124602727|NCT01300923|448165508|FG000|Overall Study|Physician Decision|0|||
124602728|NCT01300923|448165509|FG001|Overall Study|Physician Decision|2|||
124602729|NCT01568866|448165510|FG000|Overall Study|Disease Progression|208|||
124780957|NCT00139477|448827114|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
124780958|NCT00139477|448827113|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
124602730|NCT01568866|448165511|FG001|Overall Study|Disease Progression|183|||
124602731|NCT01568866|448165510|FG000|Overall Study|Adverse Event|94|||
124602732|NCT01568866|448165511|FG001|Overall Study|Adverse Event|96|||
124602733|NCT01568866|448165510|FG000|Overall Study|Patient Request|55|||
124602734|NCT01568866|448165511|FG001|Overall Study|Patient Request|71|||
124602735|NCT01568866|448165510|FG000|Overall Study|Physician Decision|40|||
124602736|NCT01568866|448165511|FG001|Overall Study|Physician Decision|32|||
124602737|NCT01568866|448165510|FG000|Overall Study|Withdrawal by Subject|19|||
124602738|NCT01568866|448165511|FG001|Overall Study|Withdrawal by Subject|11|||
124602739|NCT01568866|448165510|FG000|Overall Study|Death|10|||
124602740|NCT01568866|448165511|FG001|Overall Study|Death|18|||
124602741|NCT01568866|448165510|FG000|Overall Study|Protocol Non-compliance|2|||
124602742|NCT01568866|448165511|FG001|Overall Study|Protocol Non-compliance|4|||
124602743|NCT01568866|448165510|FG000|Overall Study|Lost to Follow-up|1|||
124602744|NCT01568866|448165511|FG001|Overall Study|Lost to Follow-up|0|||
124731401|NCT02754141|448640100|FG016|Overall Study|Maximum clinical benefit|0|||
124731402|NCT02754141|448640101|FG017|Overall Study|Maximum clinical benefit|0|||
124731403|NCT02754141|448640084|FG000|Overall Study|No longer meets study criteria|0|||
124731404|NCT02754141|448640085|FG001|Overall Study|No longer meets study criteria|0|||
124731405|NCT02754141|448640086|FG002|Overall Study|No longer meets study criteria|0|||
124731406|NCT02754141|448640087|FG003|Overall Study|No longer meets study criteria|1|||
124731407|NCT02754141|448640088|FG004|Overall Study|No longer meets study criteria|0|||
124731408|NCT02754141|448640089|FG005|Overall Study|No longer meets study criteria|0|||
124731409|NCT02754141|448640090|FG006|Overall Study|No longer meets study criteria|0|||
124731410|NCT02754141|448640091|FG007|Overall Study|No longer meets study criteria|0|||
124731411|NCT02754141|448640092|FG008|Overall Study|No longer meets study criteria|0|||
124731412|NCT02754141|448640093|FG009|Overall Study|No longer meets study criteria|0|||
124731413|NCT02754141|448640094|FG010|Overall Study|No longer meets study criteria|0|||
124731414|NCT02754141|448640095|FG011|Overall Study|No longer meets study criteria|0|||
124731415|NCT02754141|448640096|FG012|Overall Study|No longer meets study criteria|0|||
124731416|NCT02754141|448640097|FG013|Overall Study|No longer meets study criteria|0|||
124731417|NCT02754141|448640098|FG014|Overall Study|No longer meets study criteria|0|||
124731418|NCT02754141|448640099|FG015|Overall Study|No longer meets study criteria|0|||
124731419|NCT02754141|448640100|FG016|Overall Study|No longer meets study criteria|0|||
124731420|NCT02754141|448640101|FG017|Overall Study|No longer meets study criteria|0|||
124731421|NCT02754141|448640084|FG000|Overall Study|Other reasons|0|||
124731422|NCT02754141|448640085|FG001|Overall Study|Other reasons|0|||
124731423|NCT02754141|448640086|FG002|Overall Study|Other reasons|0|||
124731424|NCT02754141|448640087|FG003|Overall Study|Other reasons|0|||
124731425|NCT02754141|448640088|FG004|Overall Study|Other reasons|0|||
124780959|NCT00139477|448827114|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
124780960|NCT00573144|448827117|FG000|Overall Study|Withdrawal by Subject|2|||
124602745|NCT01568866|448165510|FG000|Overall Study|Randomized but Not Dosed|9|||
124602746|NCT01568866|448165511|FG001|Overall Study|Randomized but Not Dosed|1|||
124602747|NCT01698775|448165512|FG000|Phase A|Adverse Event|2|||
124602748|NCT01698775|448165513|FG001|Phase A|Adverse Event|1|||
124602749|NCT01698775|448165512|FG000|Phase A|Death|1|||
124602750|NCT01698775|448165513|FG001|Phase A|Death|1|||
124602751|NCT01698775|448165512|FG000|Phase A|Lack of Efficacy|1|||
124602752|NCT01698775|448165513|FG001|Phase A|Lack of Efficacy|0|||
124602753|NCT01698775|448165512|FG000|Phase A|Lost to Follow-up|1|||
124602754|NCT01698775|448165513|FG001|Phase A|Lost to Follow-up|2|||
124602755|NCT01698775|448165512|FG000|Phase A|Protocol Violation|1|||
124602756|NCT01698775|448165513|FG001|Phase A|Protocol Violation|0|||
124602757|NCT01698775|448165512|FG000|Phase A|Withdrawal by Subject|3|||
124602758|NCT01698775|448165513|FG001|Phase A|Withdrawal by Subject|4|||
124602759|NCT01698775|448165512|FG000|Phase A|Kidney [transplant]|0|||
124602760|NCT01698775|448165513|FG001|Phase A|Kidney [transplant]|1|||
124602761|NCT01698775|448165512|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
124602762|NCT01698775|448165513|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
124602763|NCT01698775|448165512|FG000|Phase B|Adverse Event|6|||
124602764|NCT01698775|448165513|FG001|Phase B|Adverse Event|3|||
124602765|NCT01698775|448165512|FG000|Phase B|Death|0|||
124602766|NCT01698775|448165513|FG001|Phase B|Death|1|||
124602767|NCT01698775|448165512|FG000|Phase B|Lack of Efficacy|0|||
124602768|NCT01698775|448165513|FG001|Phase B|Lack of Efficacy|1|||
124602769|NCT01698775|448165512|FG000|Phase B|Lost to Follow-up|0|||
124602770|NCT01698775|448165513|FG001|Phase B|Lost to Follow-up|1|||
124602771|NCT01698775|448165512|FG000|Phase B|Physician Decision|1|||
124602772|NCT01698775|448165513|FG001|Phase B|Physician Decision|1|||
124602773|NCT01698775|448165512|FG000|Phase B|Protocol Violation|1|||
124602774|NCT01698775|448165513|FG001|Phase B|Protocol Violation|1|||
124602775|NCT01698775|448165512|FG000|Phase B|Withdrawal by Subject|6|||
124602776|NCT01698775|448165513|FG001|Phase B|Withdrawal by Subject|2|||
124602777|NCT01244061|448165516|FG000|Overall Study|Death|1|||
124602778|NCT01244061|448165517|FG001|Overall Study|Death|0|||
124602779|NCT01244061|448165516|FG000|Overall Study|Did not meet entrance criteria|1|||
124602780|NCT01244061|448165517|FG001|Overall Study|Did not meet entrance criteria|0|||
124602781|NCT01244061|448165516|FG000|Overall Study|Lack of Efficacy|1|||
124602782|NCT01244061|448165517|FG001|Overall Study|Lack of Efficacy|3|||
124602783|NCT01244061|448165516|FG000|Overall Study|Lost to Follow-up|34|||
124602784|NCT01244061|448165517|FG001|Overall Study|Lost to Follow-up|30|||
124602785|NCT01244061|448165516|FG000|Overall Study|Withdrawal by Subject|29|||
124602786|NCT01244061|448165517|FG001|Overall Study|Withdrawal by Subject|46|||
124602787|NCT01244061|448165516|FG000|Overall Study|Other|8|||
124602788|NCT01244061|448165517|FG001|Overall Study|Other|19|||
124602789|NCT01244061|448165516|FG000|Overall Study|Protocol Violation|1|||
124602790|NCT01244061|448165517|FG001|Overall Study|Protocol Violation|1|||
124602791|NCT01244061|448165516|FG000|Overall Study|Adverse Event|5|||
124731426|NCT02754141|448640089|FG005|Overall Study|Other reasons|0|||
124731427|NCT02754141|448640090|FG006|Overall Study|Other reasons|0|||
124731428|NCT02754141|448640091|FG007|Overall Study|Other reasons|1|||
124731429|NCT02754141|448640092|FG008|Overall Study|Other reasons|0|||
124731430|NCT02754141|448640093|FG009|Overall Study|Other reasons|0|||
124602792|NCT01244061|448165517|FG001|Overall Study|Adverse Event|2|||
124602793|NCT01244061|448165516|FG000|Overall Study|Randomized but not treated|2|||
124602794|NCT01244061|448165517|FG001|Overall Study|Randomized but not treated|2|||
124602795|NCT02384850|448165520|FG000|Overall Study|Withdrawal by Subject|2|||
124602796|NCT02384850|448165521|FG001|Overall Study|Withdrawal by Subject|2|||
124602797|NCT02013375|448165525|FG000|Overall Study|Did not engraft|1|||
124602798|NCT02013375|448165525|FG000|Overall Study|Did not engraft|1|||
124602799|NCT02674061|448165526|FG000|Overall Study|Death|229|||
124602800|NCT02674061|448165527|FG001|Overall Study|Death|77|||
124602801|NCT02674061|448165526|FG000|Overall Study|Lost to Follow-up|3|||
124602802|NCT02674061|448165527|FG001|Overall Study|Lost to Follow-up|3|||
124602803|NCT02674061|448165526|FG000|Overall Study|Withdrawal by Subject|9|||
124602804|NCT02674061|448165527|FG001|Overall Study|Withdrawal by Subject|1|||
124602805|NCT02674061|448165526|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
124602806|NCT02674061|448165527|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
124602807|NCT01334710|448165534|FG000|Overall Study|Trial was terminated|3|||
124602808|NCT01558297|448165535|FG000|Overall Study|Withdrawal by Subject|2|||
124602809|NCT01558297|448165536|FG001|Overall Study|Withdrawal by Subject|2|||
124602810|NCT01558297|448165537|FG002|Overall Study|Withdrawal by Subject|1|||
124602811|NCT00375492|448165538|FG000|Overall Study|Adverse Event|4|||
124602812|NCT00375492|448165539|FG001|Overall Study|Adverse Event|5|||
124602813|NCT00375492|448165538|FG000|Overall Study|Entry Criteria Not Met|0|||
124602814|NCT00375492|448165539|FG001|Overall Study|Entry Criteria Not Met|1|||
124602815|NCT00375492|448165538|FG000|Overall Study|Loss of Glucose Control|0|||
124602816|NCT00375492|448165539|FG001|Overall Study|Loss of Glucose Control|1|||
124602817|NCT00375492|448165538|FG000|Overall Study|Lost to Follow-up|10|||
124602818|NCT00375492|448165539|FG001|Overall Study|Lost to Follow-up|5|||
124602819|NCT00375492|448165538|FG000|Overall Study|Physician Decision|0|||
124602820|NCT00375492|448165539|FG001|Overall Study|Physician Decision|4|||
124602821|NCT00375492|448165538|FG000|Overall Study|Protocol Violation|6|||
124602822|NCT00375492|448165539|FG001|Overall Study|Protocol Violation|3|||
124602823|NCT00375492|448165538|FG000|Overall Study|Sponsor Decision|0|||
124602824|NCT00375492|448165539|FG001|Overall Study|Sponsor Decision|1|||
124602825|NCT00375492|448165538|FG000|Overall Study|Withdrawal by Subject|6|||
124602826|NCT00375492|448165539|FG001|Overall Study|Withdrawal by Subject|6|||
124602827|NCT01232491|448165540|FG000|Overall Study|Adverse Event|13|||
124602828|NCT01232491|448165541|FG001|Overall Study|Adverse Event|8|||
124602829|NCT01232491|448165540|FG000|Overall Study|Lack of Efficacy|1|||
124602830|NCT01232491|448165541|FG001|Overall Study|Lack of Efficacy|5|||
124602831|NCT01232491|448165540|FG000|Overall Study|Protocol Violation|13|||
124602832|NCT01232491|448165541|FG001|Overall Study|Protocol Violation|11|||
124602833|NCT01232491|448165540|FG000|Overall Study|Withdrawal Criteria|12|||
124602834|NCT01232491|448165541|FG001|Overall Study|Withdrawal Criteria|21|||
124602835|NCT01232491|448165540|FG000|Overall Study|Other|21|||
124602836|NCT01232491|448165541|FG001|Overall Study|Other|18|||
124602837|NCT02932228|448165544|FG000|Overall Study|Death|8|||
124602838|NCT02932228|448165545|FG001|Overall Study|Death|23|||
124602839|NCT02932228|448165544|FG000|Overall Study|not eligible upon chart review|2|||
124602840|NCT02932228|448165545|FG001|Overall Study|not eligible upon chart review|5|||
124602841|NCT00821873|448167274|FG000|Overall Study|Lost to Follow-up|4|||
124602842|NCT03310411|448167275|FG000|Period 1|Adverse Event|0|||
124602843|NCT03310411|448167276|FG001|Period 1|Adverse Event|0|||
124602844|NCT03310411|448167277|FG002|Period 1|Adverse Event|0|||
124602845|NCT03310411|448167278|FG003|Period 1|Adverse Event|1|||
124602846|NCT03623386|448167279|FG000|Overall Study|Protocol Violation|3|||
124602847|NCT03623386|448167280|FG001|Overall Study|Protocol Violation|2|||
124602848|NCT03623386|448167281|FG002|Overall Study|Protocol Violation|0|||
124602849|NCT03623386|448167279|FG000|Overall Study|Physician Decision|1|||
124602850|NCT03623386|448167280|FG001|Overall Study|Physician Decision|1|||
124602851|NCT03623386|448167281|FG002|Overall Study|Physician Decision|0|||
124602852|NCT03623386|448167279|FG000|Overall Study|Lost to Follow-up|0|||
124602853|NCT03623386|448167280|FG001|Overall Study|Lost to Follow-up|2|||
124602854|NCT03623386|448167281|FG002|Overall Study|Lost to Follow-up|0|||
124602855|NCT03623386|448167279|FG000|Overall Study|COVID-19|0|||
124602856|NCT03623386|448167280|FG001|Overall Study|COVID-19|1|||
124602857|NCT03623386|448167281|FG002|Overall Study|COVID-19|0|||
124602858|NCT04271735|448167284|FG000|Overall Study|Physician Decision|2|||
124602859|NCT04271735|448167285|FG001|Overall Study|Physician Decision|0|||
124602860|NCT00515541|448167286|FG000|Overall Study|Physician Decision|0|||
124602861|NCT00515541|448167287|FG001|Overall Study|Physician Decision|2|||
124602862|NCT00515541|448167288|FG002|Overall Study|Physician Decision|0|||
124602863|NCT00515541|448167289|FG003|Overall Study|Physician Decision|1|||
124780961|NCT00573144|448827118|FG001|Overall Study|Withdrawal by Subject|3|||
124602864|NCT00515541|448167286|FG000|Overall Study|No show for appointments|0|||
124602865|NCT00515541|448167287|FG001|Overall Study|No show for appointments|1|||
124602866|NCT00515541|448167288|FG002|Overall Study|No show for appointments|0|||
124602867|NCT00515541|448167289|FG003|Overall Study|No show for appointments|2|||
124602868|NCT00515541|448167286|FG000|Overall Study|Withdrawal by Subject|0|||
124602869|NCT00515541|448167287|FG001|Overall Study|Withdrawal by Subject|2|||
124780962|NCT02625909|448827119|FG000|Overall Study|Death|2|||
124602870|NCT00515541|448167288|FG002|Overall Study|Withdrawal by Subject|0|||
124602871|NCT00515541|448167289|FG003|Overall Study|Withdrawal by Subject|2|||
124602872|NCT00922272|448167290|FG000|Open-label Phase|Adverse Event|5|||
124602873|NCT00922272|448167291|FG001|Open-label Phase|Adverse Event|0|||
124602874|NCT00922272|448167290|FG000|Open-label Phase|Protocol Violation|1|||
124602875|NCT00922272|448167291|FG001|Open-label Phase|Protocol Violation|0|||
124602876|NCT00922272|448167290|FG000|Open-label Phase|Withdrawal by Subject|11|||
124602877|NCT00922272|448167291|FG001|Open-label Phase|Withdrawal by Subject|0|||
124602878|NCT00922272|448167290|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
124602879|NCT00922272|448167291|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
124602880|NCT00922272|448167290|FG000|Open-label Phase|Withdrawal criteria met|5|||
124602881|NCT00922272|448167291|FG001|Open-label Phase|Withdrawal criteria met|0|||
124602882|NCT00922272|448167290|FG000|Double-blind Phase|Adverse Event|1|||
124602883|NCT00922272|448167291|FG001|Double-blind Phase|Adverse Event|1|||
124602884|NCT00922272|448167290|FG000|Double-blind Phase|Withdrawal by Subject|1|||
124602885|NCT00922272|448167291|FG001|Double-blind Phase|Withdrawal by Subject|1|||
124602886|NCT00922272|448167290|FG000|Double-blind Phase|Lost to Follow-up|2|||
124602887|NCT00922272|448167291|FG001|Double-blind Phase|Lost to Follow-up|1|||
124602888|NCT00922272|448167290|FG000|Double-blind Phase|Withdrawal criteria met|1|||
124602889|NCT00922272|448167291|FG001|Double-blind Phase|Withdrawal criteria met|1|||
124602890|NCT00922272|448167290|FG000|Double-blind Phase|Noncompliance|1|||
124602891|NCT00922272|448167291|FG001|Double-blind Phase|Noncompliance|1|||
124602892|NCT00922272|448167290|FG000|Double-blind Phase|Positive urine drug screen|1|||
124602893|NCT00922272|448167291|FG001|Double-blind Phase|Positive urine drug screen|1|||
124731431|NCT02754141|448640094|FG010|Overall Study|Other reasons|0|||
124731432|NCT02754141|448640095|FG011|Overall Study|Other reasons|0|||
124602894|NCT02588950|448167292|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
124602895|NCT02588950|448167293|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
124602896|NCT02588950|448167294|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
124602897|NCT02588950|448167295|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
124602898|NCT02588950|448167292|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
124602899|NCT02588950|448167293|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
124602900|NCT02588950|448167294|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
124602901|NCT02588950|448167295|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
124602902|NCT03188718|448167296|FG000|Overall Study|Participant noncompliance|4|||
124602903|NCT03188718|448167296|FG000|Overall Study|Withdrawal by Subject|1|||
124602904|NCT03188718|448167296|FG000|Overall Study|Device failure|3|||
124602905|NCT02072824|448167297|FG000|Overall Study|Insufficient clinical response|1|||
124602906|NCT02072824|448167298|FG001|Overall Study|Insufficient clinical response|0|||
124602907|NCT02072824|448167299|FG002|Overall Study|Insufficient clinical response|1|||
124602908|NCT02072824|448167297|FG000|Overall Study|No longer willing to participate|1|||
124602909|NCT02072824|448167298|FG001|Overall Study|No longer willing to participate|0|||
124602910|NCT02072824|448167299|FG002|Overall Study|No longer willing to participate|1|||
124602911|NCT02072824|448167297|FG000|Overall Study|Medication error|0|||
124602912|NCT02072824|448167298|FG001|Overall Study|Medication error|1|||
124602913|NCT02072824|448167299|FG002|Overall Study|Medication error|0|||
124602914|NCT02072824|448167297|FG000|Overall Study|Adverse Event|0|||
124602915|NCT02072824|448167298|FG001|Overall Study|Adverse Event|0|||
124602916|NCT02072824|448167299|FG002|Overall Study|Adverse Event|1|||
124602917|NCT03084367|448167300|FG000|Overall Study|Lost to Follow-up|32|||
124602918|NCT03084367|448167300|FG000|Overall Study|Withdrawal by Subject|4|||
124731433|NCT02754141|448640096|FG012|Overall Study|Other reasons|2|||
124731434|NCT02754141|448640097|FG013|Overall Study|Other reasons|0|||
124602919|NCT03084367|448167300|FG000|Overall Study|Other|1|||
124602920|NCT00841906|448167301|FG000|Overall Study|Withdrawal by Subject|2|||
124602921|NCT00841906|448167302|FG001|Overall Study|Withdrawal by Subject|0|||
124602922|NCT02667288|448167305|FG000|Overall Study|Protocol Violation|5|||
124731435|NCT02754141|448640098|FG014|Overall Study|Other reasons|0|||
124731436|NCT02754141|448640099|FG015|Overall Study|Other reasons|0|||
124731437|NCT02754141|448640100|FG016|Overall Study|Other reasons|0|||
124731438|NCT02754141|448640101|FG017|Overall Study|Other reasons|0|||
124731439|NCT02754141|448640084|FG000|Overall Study|Completed treatment as per protocol|0|||
124602923|NCT02667288|448167305|FG000|Overall Study|Lost to Follow-up|3|||
124602924|NCT02667288|448167305|FG000|Overall Study|Withdrawal by Subject|5|||
124602925|NCT00912093|448167306|FG000|The Controlled Phase|Death|0|||
124602926|NCT00912093|448167307|FG001|The Controlled Phase|Death|1|||
124602927|NCT00912093|448167308|FG002|The Controlled Phase|Death|0|||
124602928|NCT00912093|448167309|FG003|The Controlled Phase|Death|0|||
124602929|NCT00912093|448167310|FG004|The Controlled Phase|Death|0|||
124602930|NCT00912093|448167306|FG000|The Controlled Phase|Medical Condition|0|||
124602931|NCT00912093|448167307|FG001|The Controlled Phase|Medical Condition|1|||
124602932|NCT00912093|448167308|FG002|The Controlled Phase|Medical Condition|0|||
124602933|NCT00912093|448167309|FG003|The Controlled Phase|Medical Condition|0|||
124602934|NCT00912093|448167310|FG004|The Controlled Phase|Medical Condition|0|||
124731440|NCT02754141|448640085|FG001|Overall Study|Completed treatment as per protocol|1|||
124731441|NCT02754141|448640086|FG002|Overall Study|Completed treatment as per protocol|0|||
124602935|NCT00912093|448167306|FG000|The Controlled Phase|Lost to Follow-up|0|||
124602936|NCT00912093|448167307|FG001|The Controlled Phase|Lost to Follow-up|0|||
124602937|NCT00912093|448167308|FG002|The Controlled Phase|Lost to Follow-up|0|||
124602938|NCT00912093|448167309|FG003|The Controlled Phase|Lost to Follow-up|0|||
124602939|NCT00912093|448167310|FG004|The Controlled Phase|Lost to Follow-up|1|||
124602940|NCT04397445|448167313|FG000|Overall Study|Withdrawal by Subject|1|||
124602941|NCT04397445|448167314|FG001|Overall Study|Withdrawal by Subject|0|||
124602942|NCT04397445|448167315|FG002|Overall Study|Withdrawal by Subject|0|||
124602943|NCT04397445|448167316|FG003|Overall Study|Withdrawal by Subject|0|||
124602944|NCT03921151|448167317|FG000|Overall Study|Withdrawal by Subject|11|||
124602945|NCT03921151|448167318|FG001|Overall Study|Withdrawal by Subject|16|||
124602946|NCT00270257|448167320|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
124602947|NCT00270257|448167321|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
124602948|NCT03001219|448167326|FG000|Proof of Concept|Study Termination by Sponsor|0|||
124602949|NCT03001219|448167327|FG001|Proof of Concept|Study Termination by Sponsor|1|||
124602950|NCT03001219|448167326|FG000|Proof of Concept|Withdrawal by Subject|0|||
124602951|NCT03001219|448167327|FG001|Proof of Concept|Withdrawal by Subject|4|||
124602952|NCT03001219|448167326|FG000|Proof of Concept|Protocol Deviation|0|||
124602953|NCT03001219|448167327|FG001|Proof of Concept|Protocol Deviation|1|||
124602954|NCT03001219|448167326|FG000|Proof of Concept|Adverse Event|1|||
124602955|NCT03001219|448167327|FG001|Proof of Concept|Adverse Event|1|||
124602956|NCT03001219|448167326|FG000|Proof of Concept|Physician Decision|1|||
124602957|NCT03001219|448167327|FG001|Proof of Concept|Physician Decision|0|||
124602958|NCT03001219|448167326|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
124602959|NCT03001219|448167327|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
124602960|NCT03001219|448167326|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
124602961|NCT03001219|448167327|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
124602962|NCT03001219|448167326|FG000|Extension Period Analysis|Physician Decision|0|||
124602963|NCT03001219|448167327|FG001|Extension Period Analysis|Physician Decision|1|||
124602964|NCT03001219|448167326|FG000|Extension Period Analysis|Adverse Event|1|||
124602965|NCT03001219|448167327|FG001|Extension Period Analysis|Adverse Event|1|||
124602966|NCT03001219|448167326|FG000|Extension Period Analysis|Protocol Deviation|0|||
124602967|NCT03001219|448167327|FG001|Extension Period Analysis|Protocol Deviation|1|||
124602968|NCT03001219|448167326|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
124602969|NCT03001219|448167327|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
124602970|NCT03733210|448167328|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
124602971|NCT03733210|448167329|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
124602972|NCT02621034|448167330|FG000|Overall Study|Lost to Follow-up|3|||
124602973|NCT02621034|448167331|FG001|Overall Study|Lost to Follow-up|2|||
124602974|NCT02621034|448167332|FG002|Overall Study|Lost to Follow-up|5|||
124602975|NCT02963441|448167333|FG000|Overall Study|Protocol violation or withdrawn|8|||
124602976|NCT02963441|448167333|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
124602977|NCT02963441|448167333|FG000|Overall Study|IDx-DR insufficient quality|33|||
124602978|NCT02669940|448167336|FG000|Overall Study|Failure to return|0|||
124602979|NCT02669940|448167337|FG001|Overall Study|Failure to return|3|||
124602980|NCT02669940|448167336|FG000|Overall Study|Insufficient follow-up data|1|||
124602981|NCT02669940|448167337|FG001|Overall Study|Insufficient follow-up data|0|||
124602982|NCT00361335|448167338|FG000|IV Period: Baseline to E0|Adverse Event|9|||
124602983|NCT00361335|448167339|FG001|IV Period: Baseline to E0|Adverse Event|4|||
124602984|NCT00361335|448167340|FG002|IV Period: Baseline to E0|Adverse Event|5|||
124602985|NCT00361335|448167341|FG003|IV Period: Baseline to E0|Adverse Event|9|||
124602986|NCT00361335|448167342|FG004|IV Period: Baseline to E0|Adverse Event|8|||
124602987|NCT00361335|448167343|FG005|IV Period: Baseline to E0|Adverse Event|0|||
124602988|NCT00361335|448167344|FG006|IV Period: Baseline to E0|Adverse Event|0|||
124602989|NCT00361335|448167338|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
124602990|NCT00361335|448167339|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
124602991|NCT00361335|448167340|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
124602992|NCT00361335|448167341|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
124602993|NCT00361335|448167342|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
124602994|NCT00361335|448167343|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
124602995|NCT00361335|448167344|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
124602996|NCT00361335|448167338|FG000|IV Period: Baseline to E0|Death|1|||
124602997|NCT00361335|448167339|FG001|IV Period: Baseline to E0|Death|1|||
124602998|NCT00361335|448167340|FG002|IV Period: Baseline to E0|Death|1|||
124602999|NCT00361335|448167341|FG003|IV Period: Baseline to E0|Death|1|||
124603000|NCT00361335|448167342|FG004|IV Period: Baseline to E0|Death|0|||
124603001|NCT00361335|448167343|FG005|IV Period: Baseline to E0|Death|0|||
124603002|NCT00361335|448167344|FG006|IV Period: Baseline to E0|Death|0|||
124603003|NCT00361335|448167338|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
124603004|NCT00361335|448167339|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
124603005|NCT00361335|448167340|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
124603006|NCT00361335|448167341|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
124603007|NCT00361335|448167342|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
124603008|NCT00361335|448167343|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
124603009|NCT00361335|448167344|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
124603010|NCT00361335|448167338|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
124603011|NCT00361335|448167339|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
124603012|NCT00361335|448167340|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
124603013|NCT00361335|448167341|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
124603014|NCT00361335|448167342|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
124603015|NCT00361335|448167343|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
124603016|NCT00361335|448167344|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
124603017|NCT00361335|448167338|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
124603018|NCT00361335|448167339|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
124603019|NCT00361335|448167340|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
124603020|NCT00361335|448167341|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
124603021|NCT00361335|448167342|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
124603022|NCT00361335|448167343|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
124603023|NCT00361335|448167344|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
124603024|NCT00361335|448167338|FG000|IV Period: Baseline to E0|Other|2|||
124603025|NCT00361335|448167339|FG001|IV Period: Baseline to E0|Other|9|||
124603026|NCT00361335|448167340|FG002|IV Period: Baseline to E0|Other|9|||
124603027|NCT00361335|448167341|FG003|IV Period: Baseline to E0|Other|3|||
124603028|NCT00361335|448167342|FG004|IV Period: Baseline to E0|Other|2|||
124603029|NCT00361335|448167343|FG005|IV Period: Baseline to E0|Other|0|||
124603030|NCT00361335|448167344|FG006|IV Period: Baseline to E0|Other|0|||
124603031|NCT00361335|448167338|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
124603032|NCT00361335|448167339|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
124603033|NCT00361335|448167340|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
124603034|NCT00361335|448167341|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
124603035|NCT00361335|448167342|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
124603036|NCT00361335|448167343|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
124603037|NCT00361335|448167344|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
124603038|NCT00361335|448167338|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
124603039|NCT00361335|448167339|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
124603040|NCT00361335|448167340|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
124603041|NCT00361335|448167341|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
124603042|NCT00361335|448167342|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
124603043|NCT00361335|448167343|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
124603044|NCT00361335|448167344|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
124603045|NCT00361335|448167338|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
124603046|NCT00361335|448167339|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
124603047|NCT00361335|448167340|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
124603048|NCT00361335|448167341|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
124603049|NCT00361335|448167342|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
124603050|NCT00361335|448167343|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
124603051|NCT00361335|448167344|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
124603052|NCT00361335|448167338|FG000|SC Period: Week E0 to Week E24|Death|0|||
124603053|NCT00361335|448167339|FG001|SC Period: Week E0 to Week E24|Death|0|||
124603054|NCT00361335|448167340|FG002|SC Period: Week E0 to Week E24|Death|0|||
124603055|NCT00361335|448167341|FG003|SC Period: Week E0 to Week E24|Death|0|||
124603056|NCT00361335|448167342|FG004|SC Period: Week E0 to Week E24|Death|0|||
124603057|NCT00361335|448167343|FG005|SC Period: Week E0 to Week E24|Death|0|||
124603058|NCT00361335|448167344|FG006|SC Period: Week E0 to Week E24|Death|1|||
124603059|NCT00361335|448167338|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
124603060|NCT00361335|448167339|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
124603061|NCT00361335|448167340|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
124603062|NCT00361335|448167341|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
124603063|NCT00361335|448167342|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
124603064|NCT00361335|448167343|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
124603065|NCT00361335|448167344|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
124603066|NCT00361335|448167338|FG000|SC Period: Week E0 to Week E24|Other|1|||
124603067|NCT00361335|448167339|FG001|SC Period: Week E0 to Week E24|Other|0|||
124603068|NCT00361335|448167340|FG002|SC Period: Week E0 to Week E24|Other|0|||
124780963|NCT02625909|448827120|FG001|Overall Study|Death|0|||
124603069|NCT00361335|448167341|FG003|SC Period: Week E0 to Week E24|Other|1|||
124603070|NCT00361335|448167342|FG004|SC Period: Week E0 to Week E24|Other|0|||
124603071|NCT00361335|448167343|FG005|SC Period: Week E0 to Week E24|Other|1|||
124603072|NCT00361335|448167344|FG006|SC Period: Week E0 to Week E24|Other|2|||
124603073|NCT00361335|448167338|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
124603074|NCT00361335|448167339|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
124780964|NCT02625909|448827119|FG000|Overall Study|Lost to Follow-up|3|||
124603075|NCT00361335|448167340|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
124603076|NCT00361335|448167341|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
124603077|NCT00361335|448167342|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
124603078|NCT00361335|448167343|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
124603079|NCT00361335|448167344|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
124603080|NCT05065983|448167345|FG000|Overall Study|Lost to Follow-up|2|||
124603081|NCT00986180|448167346|FG000|Overall Study|Adverse Event|21|||
124603082|NCT00986180|448167347|FG001|Overall Study|Adverse Event|23|||
124603083|NCT00986180|448167346|FG000|Overall Study|Lack of Efficacy|4|||
124603084|NCT00986180|448167347|FG001|Overall Study|Lack of Efficacy|3|||
124603085|NCT00986180|448167346|FG000|Overall Study|Lost to Follow-up|5|||
124603086|NCT00986180|448167347|FG001|Overall Study|Lost to Follow-up|7|||
124603087|NCT00986180|448167346|FG000|Overall Study|Physician Decision|1|||
124603088|NCT00986180|448167347|FG001|Overall Study|Physician Decision|3|||
124603089|NCT00986180|448167346|FG000|Overall Study|Protocol Violation|2|||
124603090|NCT00986180|448167347|FG001|Overall Study|Protocol Violation|0|||
124603091|NCT00986180|448167346|FG000|Overall Study|Withdrawal by Subject|1|||
124603092|NCT00986180|448167347|FG001|Overall Study|Withdrawal by Subject|9|||
124603093|NCT00986180|448167346|FG000|Overall Study|Miscellanies|10|||
124603094|NCT00986180|448167347|FG001|Overall Study|Miscellanies|11|||
124603095|NCT01765582|448167348|FG000|Overall Study|Other|3|||
124603096|NCT01765582|448167349|FG001|Overall Study|Other|6|||
124603097|NCT01765582|448167350|FG002|Overall Study|Other|9|||
124603098|NCT01765582|448167348|FG000|Overall Study|Lost to Follow-up|2|||
124603099|NCT01765582|448167349|FG001|Overall Study|Lost to Follow-up|2|||
124603100|NCT01765582|448167350|FG002|Overall Study|Lost to Follow-up|1|||
124603101|NCT01765582|448167348|FG000|Overall Study|Death|31|||
124603102|NCT01765582|448167349|FG001|Overall Study|Death|36|||
124603103|NCT01765582|448167350|FG002|Overall Study|Death|33|||
124603104|NCT01765582|448167348|FG000|Overall Study|Sponsor Decision|46|||
124603105|NCT01765582|448167349|FG001|Overall Study|Sponsor Decision|42|||
124603106|NCT01765582|448167350|FG002|Overall Study|Sponsor Decision|42|||
124603107|NCT01765582|448167348|FG000|Overall Study|Withdrawal of Consent|11|||
124603108|NCT01765582|448167349|FG001|Overall Study|Withdrawal of Consent|6|||
124603109|NCT01765582|448167350|FG002|Overall Study|Withdrawal of Consent|10|||
124603110|NCT01691820|448167351|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
124603111|NCT01691820|448167352|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
124603112|NCT01691820|448167351|FG000|Overall Study|Migrated/moved from study area|7|||
124603113|NCT01691820|448167352|FG001|Overall Study|Migrated/moved from study area|4|||
124603114|NCT01691820|448167351|FG000|Overall Study|Lost to Follow-up|6|||
124603115|NCT01691820|448167352|FG001|Overall Study|Lost to Follow-up|17|||
124603116|NCT01691820|448167351|FG000|Overall Study|Other (unspecified)|4|||
124603117|NCT01691820|448167352|FG001|Overall Study|Other (unspecified)|1|||
124603118|NCT00616941|448167357|FG000|Overall Study|Progressive Disease|1|||
124603119|NCT00616941|448167358|FG001|Overall Study|Progressive Disease|2|||
124603120|NCT00616941|448167359|FG002|Overall Study|Progressive Disease|1|||
124603121|NCT00616941|448167357|FG000|Overall Study|Adverse Event|0|||
124603122|NCT00616941|448167358|FG001|Overall Study|Adverse Event|1|||
124603123|NCT00616941|448167359|FG002|Overall Study|Adverse Event|1|||
124603124|NCT00616941|448167357|FG000|Overall Study|Subject Non-compliance|0|||
124603125|NCT00616941|448167358|FG001|Overall Study|Subject Non-compliance|0|||
124603126|NCT00616941|448167359|FG002|Overall Study|Subject Non-compliance|1|||
124603127|NCT00616941|448167357|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
124603128|NCT00616941|448167358|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
124603129|NCT00616941|448167359|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
124603130|NCT00616941|448167357|FG000|Overall Study|Vaccination Suspended|0|||
124603131|NCT00616941|448167358|FG001|Overall Study|Vaccination Suspended|0|||
124603132|NCT00616941|448167359|FG002|Overall Study|Vaccination Suspended|3|||
124603133|NCT02372071|448167360|FG000|Overall Study|Protocol Violation|18|||
124603134|NCT00714493|448167361|FG000|Overall Study|Adverse Event|11|||
124603135|NCT00714493|448167361|FG000|Overall Study|Death|3|||
124603136|NCT00714493|448167361|FG000|Overall Study|Lack of Efficacy|10|||
124603137|NCT00714493|448167361|FG000|Overall Study|Lost to Follow-up|3|||
124603138|NCT00714493|448167361|FG000|Overall Study|Protocol Violation|12|||
124603139|NCT00714493|448167361|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
124603140|NCT00714493|448167361|FG000|Overall Study|OTHER|2|||
124603141|NCT00506129|448167362|FG000|Overall Study|Disease Progression/Relapse|15|||
124603142|NCT00506129|448167362|FG000|Overall Study|Death|7|||
124603143|NCT00557076|448167367|FG000|Overall Study|Unblinding|0|||
124603144|NCT00557076|448167368|FG001|Overall Study|Unblinding|1|||
124603145|NCT02408068|448167370|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
124603146|NCT02408068|448167371|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
124603147|NCT02408068|448167372|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
124603148|NCT02408068|448167373|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
124603149|NCT02408068|448167374|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
124731442|NCT02754141|448640087|FG003|Overall Study|Completed treatment as per protocol|0|||
124603150|NCT02408068|448167375|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
124603151|NCT02138136|448167382|FG000|Overall Study|Protocol Violation|4|||
124603152|NCT02138136|448167382|FG000|Overall Study|Physician Decision|7|||
124603153|NCT02138136|448167382|FG000|Overall Study|Lack of Efficacy|35|||
124603154|NCT02138136|448167382|FG000|Overall Study|Pregnancy|2|||
124603155|NCT02138136|448167382|FG000|Overall Study|Adverse Event|18|||
124603156|NCT02138136|448167382|FG000|Overall Study|Withdrawal by Subject|36|||
124603157|NCT02138136|448167382|FG000|Overall Study|Lost to Follow-up|32|||
124603158|NCT02138136|448167382|FG000|Overall Study|Withdrawn by Sponsor|5|||
124603159|NCT00706381|448167385|FG000|Overall Study|Lost to Follow-up|0|||
124603160|NCT00706381|448167386|FG001|Overall Study|Lost to Follow-up|1|||
124603161|NCT00706381|448167387|FG002|Overall Study|Lost to Follow-up|1|||
124603162|NCT00706381|448167388|FG003|Overall Study|Lost to Follow-up|0|||
124603163|NCT01782482|448167394|FG000|Overall Study|Adverse Event|2|||
124603164|NCT01782482|448167395|FG001|Overall Study|Adverse Event|1|||
124603165|NCT01782482|448167394|FG000|Overall Study|Lost to Follow-up|2|||
124603166|NCT01782482|448167395|FG001|Overall Study|Lost to Follow-up|3|||
124603167|NCT01782482|448167394|FG000|Overall Study|Physician Decision|1|||
124603168|NCT01782482|448167395|FG001|Overall Study|Physician Decision|0|||
124603169|NCT01782482|448167394|FG000|Overall Study|Protocol Violation|1|||
124603170|NCT01782482|448167395|FG001|Overall Study|Protocol Violation|0|||
124603171|NCT01782482|448167394|FG000|Overall Study|Withdrawal by Subject|2|||
124603172|NCT01782482|448167395|FG001|Overall Study|Withdrawal by Subject|3|||
124603173|NCT01782482|448167394|FG000|Overall Study|Randomized in Error|2|||
124603174|NCT01782482|448167395|FG001|Overall Study|Randomized in Error|2|||
124603175|NCT01782482|448167394|FG000|Overall Study|Habitually wearing toric lens OS|0|||
124603176|NCT01782482|448167395|FG001|Overall Study|Habitually wearing toric lens OS|1|||
124603177|NCT00038649|448167399|FG000|Overall Study|Adverse Event|9|||
124603178|NCT00995085|448167400|FG000|Overall Study|Withdrawal by Subject|5|||
124603179|NCT03096847|448167406|FG000|Overall Study|Other|2|||
124603180|NCT03096847|448167407|FG001|Overall Study|Other|1|||
124603181|NCT03096847|448167408|FG002|Overall Study|Other|2|||
124603182|NCT03096847|448167406|FG000|Overall Study|Lost to Follow-up|1|||
124603183|NCT03096847|448167407|FG001|Overall Study|Lost to Follow-up|0|||
124603184|NCT03096847|448167408|FG002|Overall Study|Lost to Follow-up|1|||
124603185|NCT03096847|448167406|FG000|Overall Study|Death|6|||
124603186|NCT03096847|448167407|FG001|Overall Study|Death|0|||
124603187|NCT03096847|448167408|FG002|Overall Study|Death|2|||
124603188|NCT03096847|448167406|FG000|Overall Study|Protocol Violation|3|||
124603189|NCT03096847|448167407|FG001|Overall Study|Protocol Violation|0|||
124603190|NCT03096847|448167408|FG002|Overall Study|Protocol Violation|6|||
124603191|NCT03096847|448167406|FG000|Overall Study|Physician Decision|12|||
124603192|NCT03096847|448167407|FG001|Overall Study|Physician Decision|2|||
124603193|NCT03096847|448167408|FG002|Overall Study|Physician Decision|8|||
124603194|NCT03096847|448167406|FG000|Overall Study|Withdrawal by Subject|24|||
124603195|NCT03096847|448167407|FG001|Overall Study|Withdrawal by Subject|1|||
124603196|NCT03096847|448167408|FG002|Overall Study|Withdrawal by Subject|12|||
124603197|NCT03096847|448167406|FG000|Overall Study|Adverse Event|72|||
124603198|NCT03096847|448167407|FG001|Overall Study|Adverse Event|6|||
124603199|NCT03096847|448167408|FG002|Overall Study|Adverse Event|28|||
124603200|NCT03096847|448167406|FG000|Overall Study|Progressive disease|97|||
124603201|NCT03096847|448167407|FG001|Overall Study|Progressive disease|10|||
124603202|NCT03096847|448167408|FG002|Overall Study|Progressive disease|78|||
124603203|NCT03096847|448167406|FG000|Overall Study|Non-compliance with study medication|1|||
124603204|NCT03096847|448167407|FG001|Overall Study|Non-compliance with study medication|0|||
124603205|NCT03096847|448167408|FG002|Overall Study|Non-compliance with study medication|0|||
124603206|NCT03096847|448167406|FG000|Overall Study|New therapy for study indication|1|||
124603207|NCT03096847|448167407|FG001|Overall Study|New therapy for study indication|0|||
124603208|NCT03096847|448167408|FG002|Overall Study|New therapy for study indication|1|||
124603209|NCT01640873|448167409|FG000|Overall Study|Protocol Violation|2|||
124603210|NCT01640873|448167410|FG001|Overall Study|Protocol Violation|1|||
124603211|NCT00891839|448167413|FG000|Overall Study|Adverse Event|2|||
124603212|NCT00891839|448167413|FG000|Overall Study|Withdrawal by Subject|2|||
124603213|NCT00891839|448167413|FG000|Overall Study|Disease progression|3|||
124603214|NCT02192164|448167414|FG000|Overall Study|Other|8|||
124603215|NCT02192164|448167414|FG000|Overall Study|Withdrawal by Subject|1|||
124603216|NCT02192164|448167414|FG000|Overall Study|Physician Decision|4|||
124603217|NCT02192164|448167414|FG000|Overall Study|Did not meet the exclusion criteria|1|||
124603218|NCT00359788|448167417|FG000|Overall Study|Adverse Event|11|||
124603219|NCT00359788|448167418|FG001|Overall Study|Adverse Event|10|||
124603220|NCT00359788|448167417|FG000|Overall Study|Lack of Efficacy|1|||
124603221|NCT00359788|448167418|FG001|Overall Study|Lack of Efficacy|2|||
124603222|NCT00359788|448167417|FG000|Overall Study|Lost to Follow-up|3|||
124603223|NCT00359788|448167418|FG001|Overall Study|Lost to Follow-up|2|||
124603224|NCT00359788|448167417|FG000|Overall Study|Withdrawal by Subject|4|||
124603225|NCT00359788|448167418|FG001|Overall Study|Withdrawal by Subject|1|||
124603226|NCT00359788|448167417|FG000|Overall Study|Protocol Violation|4|||
124603227|NCT00359788|448167418|FG001|Overall Study|Protocol Violation|2|||
124603228|NCT02143583|448167419|FG000|Overall Study|Withdrawal by Subject|1|||
124603229|NCT02143583|448167420|FG001|Overall Study|Withdrawal by Subject|0|||
124603230|NCT02143583|448167421|FG002|Overall Study|Withdrawal by Subject|1|||
124603231|NCT02143583|448167419|FG000|Overall Study|husband illness|0|||
124603232|NCT02143583|448167420|FG001|Overall Study|husband illness|0|||
124603233|NCT02143583|448167421|FG002|Overall Study|husband illness|1|||
124603234|NCT00673933|448167422|FG000|Overall Study|Withdrawal by Subject|2|||
124603235|NCT00673933|448167422|FG000|Overall Study|Lost to Follow-up|1|||
124603236|NCT04932941|448167423|FG000|Overall Study|Lost to Follow-up|3|||
124603237|NCT04932941|448167424|FG001|Overall Study|Lost to Follow-up|1|||
124603238|NCT04932941|448167423|FG000|Overall Study|Withdrawal by Subject|7|||
124603239|NCT04932941|448167424|FG001|Overall Study|Withdrawal by Subject|4|||
124603240|NCT04932941|448167423|FG000|Overall Study|Other|4|||
124603241|NCT04932941|448167424|FG001|Overall Study|Other|2|||
124603242|NCT01195272|448167433|FG000|Overall Study|Adverse Event|1|||
124603243|NCT01195272|448167433|FG000|Overall Study|Lack of Efficacy|3|||
124603244|NCT04905290|448169139|FG000|Overall Study|Adverse Event|4|||
124603245|NCT04905290|448169139|FG000|Overall Study|Death|2|||
124603246|NCT04905290|448169139|FG000|Overall Study|Withdrawal by Subject|4|||
124603247|NCT04905290|448169139|FG000|Overall Study|Physician Decision|2|||
124603248|NCT04905290|448169139|FG000|Overall Study|Lost to Follow-up|2|||
124603249|NCT04905290|448169139|FG000|Overall Study|Screen Failure|2|||
124603250|NCT04905290|448169139|FG000|Overall Study|Unsuccessful Procedure|2|||
124603251|NCT03295318|448169140|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
124603252|NCT03295318|448169141|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
124603253|NCT03295318|448169142|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
124603254|NCT03295318|448169140|FG000|Overall Study|Death|1|||
124603255|NCT03295318|448169141|FG001|Overall Study|Death|1|||
124603256|NCT03295318|448169142|FG002|Overall Study|Death|1|||
124603257|NCT03295318|448169140|FG000|Overall Study|Protocol Violation|4|||
124603258|NCT03295318|448169141|FG001|Overall Study|Protocol Violation|3|||
124603259|NCT03295318|448169142|FG002|Overall Study|Protocol Violation|3|||
124603260|NCT03295318|448169140|FG000|Overall Study|Withdrawal by Subject|0|||
124603261|NCT03295318|448169141|FG001|Overall Study|Withdrawal by Subject|0|||
124603262|NCT03295318|448169142|FG002|Overall Study|Withdrawal by Subject|1|||
124603263|NCT03295318|448169140|FG000|Overall Study|Subject discontinued due to travel|0|||
124603264|NCT03295318|448169141|FG001|Overall Study|Subject discontinued due to travel|1|||
124603265|NCT03295318|448169142|FG002|Overall Study|Subject discontinued due to travel|0|||
124603266|NCT04319718|448169143|FG000|Overall Study|Adverse Event|0|||
124603267|NCT04319718|448169144|FG001|Overall Study|Adverse Event|2|||
124603268|NCT04319718|448169143|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
124603269|NCT04319718|448169144|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
124603270|NCT01288053|448169145|FG000|Overall Study|Death|1|||
124603271|NCT00144781|448169146|FG000|Overall Study|Adverse Event|0|||
124603272|NCT00144781|448169147|FG001|Overall Study|Adverse Event|1|||
124603273|NCT00144781|448169148|FG002|Overall Study|Adverse Event|0|||
124603274|NCT00144781|448169149|FG003|Overall Study|Adverse Event|0|||
124603275|NCT00144781|448169146|FG000|Overall Study|Non-compliant|0|||
124603276|NCT00144781|448169147|FG001|Overall Study|Non-compliant|1|||
124603277|NCT00144781|448169148|FG002|Overall Study|Non-compliant|0|||
124603278|NCT00144781|448169149|FG003|Overall Study|Non-compliant|0|||
124603279|NCT02068092|448169150|FG000|Overall Study|Physician Decision|2|||
124603280|NCT02068092|448169150|FG000|Overall Study|Adverse Event|2|||
124603281|NCT02068092|448169150|FG000|Overall Study|Lost to Follow-up|4|||
124603282|NCT02068092|448169150|FG000|Overall Study|Withdrawal by Subject|2|||
124603283|NCT01045421|448169151|FG000|Phase 1|Progressive Disease|0|||
124603284|NCT01045421|448169152|FG001|Phase 1|Progressive Disease|0|||
124603285|NCT01045421|448169153|FG002|Phase 1|Progressive Disease|0|||
124603286|NCT01045421|448169154|FG003|Phase 1|Progressive Disease|0|||
124603287|NCT01045421|448169155|FG004|Phase 1|Progressive Disease|1|||
124603288|NCT01045421|448169156|FG005|Phase 1|Progressive Disease|0|||
124603289|NCT01045421|448169157|FG006|Phase 1|Progressive Disease|0|||
124603290|NCT01045421|448169158|FG007|Phase 1|Progressive Disease|0|||
124603291|NCT01045421|448169159|FG008|Phase 1|Progressive Disease|0|||
124603292|NCT01045421|448169160|FG009|Phase 1|Progressive Disease|0|||
124603293|NCT01045421|448169161|FG010|Phase 1|Progressive Disease|0|||
124603294|NCT01045421|448169151|FG000|Phase 1|Withdrawal by Subject|0|||
124603295|NCT01045421|448169152|FG001|Phase 1|Withdrawal by Subject|0|||
124603296|NCT01045421|448169153|FG002|Phase 1|Withdrawal by Subject|0|||
124603297|NCT01045421|448169154|FG003|Phase 1|Withdrawal by Subject|1|||
124603298|NCT01045421|448169155|FG004|Phase 1|Withdrawal by Subject|0|||
124603299|NCT01045421|448169156|FG005|Phase 1|Withdrawal by Subject|0|||
124603300|NCT01045421|448169157|FG006|Phase 1|Withdrawal by Subject|0|||
124603301|NCT01045421|448169158|FG007|Phase 1|Withdrawal by Subject|0|||
124603302|NCT01045421|448169159|FG008|Phase 1|Withdrawal by Subject|0|||
124603303|NCT01045421|448169160|FG009|Phase 1|Withdrawal by Subject|0|||
124603304|NCT01045421|448169161|FG010|Phase 1|Withdrawal by Subject|0|||
124603305|NCT01045421|448169151|FG000|Phase 2|Progressive Disease|0|||
124603306|NCT01045421|448169152|FG001|Phase 2|Progressive Disease|0|||
124603307|NCT01045421|448169153|FG002|Phase 2|Progressive Disease|0|||
124603308|NCT01045421|448169154|FG003|Phase 2|Progressive Disease|0|||
124603309|NCT01045421|448169155|FG004|Phase 2|Progressive Disease|0|||
124603310|NCT01045421|448169156|FG005|Phase 2|Progressive Disease|0|||
124603311|NCT01045421|448169157|FG006|Phase 2|Progressive Disease|0|||
124603312|NCT01045421|448169158|FG007|Phase 2|Progressive Disease|1|||
124603313|NCT01045421|448169159|FG008|Phase 2|Progressive Disease|1|||
124603314|NCT01045421|448169160|FG009|Phase 2|Progressive Disease|1|||
124603315|NCT01045421|448169161|FG010|Phase 2|Progressive Disease|1|||
124603316|NCT01045421|448169151|FG000|Phase 2|Death|0|||
124603317|NCT01045421|448169152|FG001|Phase 2|Death|0|||
124603318|NCT01045421|448169153|FG002|Phase 2|Death|0|||
124603319|NCT01045421|448169154|FG003|Phase 2|Death|0|||
124603320|NCT01045421|448169155|FG004|Phase 2|Death|0|||
124603321|NCT01045421|448169156|FG005|Phase 2|Death|0|||
124603322|NCT01045421|448169157|FG006|Phase 2|Death|0|||
124603323|NCT01045421|448169158|FG007|Phase 2|Death|1|||
124603324|NCT01045421|448169159|FG008|Phase 2|Death|1|||
124603325|NCT01045421|448169160|FG009|Phase 2|Death|2|||
124603326|NCT01045421|448169161|FG010|Phase 2|Death|0|||
124603327|NCT01045421|448169151|FG000|Phase 2|Other|0|||
124603328|NCT01045421|448169152|FG001|Phase 2|Other|0|||
124603329|NCT01045421|448169153|FG002|Phase 2|Other|0|||
124603330|NCT01045421|448169154|FG003|Phase 2|Other|0|||
124603331|NCT01045421|448169155|FG004|Phase 2|Other|0|||
124603332|NCT01045421|448169156|FG005|Phase 2|Other|0|||
124603333|NCT01045421|448169157|FG006|Phase 2|Other|0|||
124603334|NCT01045421|448169158|FG007|Phase 2|Other|3|||
124603335|NCT01045421|448169159|FG008|Phase 2|Other|0|||
124603336|NCT01045421|448169160|FG009|Phase 2|Other|0|||
124603337|NCT01045421|448169161|FG010|Phase 2|Other|1|||
124603338|NCT02221037|448169162|FG000|Overall Study|Physician Decision|0|||
124603339|NCT02221037|448169163|FG001|Overall Study|Physician Decision|0|||
124603340|NCT02221037|448169164|FG002|Overall Study|Physician Decision|1|||
124603341|NCT02221037|448169165|FG003|Overall Study|Physician Decision|0|||
124603342|NCT02307266|448169166|FG000|Overall Study|Adverse Event|3|||
124603343|NCT02307266|448169167|FG001|Overall Study|Adverse Event|1|||
124603344|NCT02307266|448169168|FG002|Overall Study|Adverse Event|5|||
124603345|NCT02307266|448169166|FG000|Overall Study|Withdrawal by Subject|2|||
124603346|NCT02307266|448169167|FG001|Overall Study|Withdrawal by Subject|0|||
124603347|NCT02307266|448169168|FG002|Overall Study|Withdrawal by Subject|1|||
124603348|NCT02307266|448169166|FG000|Overall Study|Lost to Follow-up|3|||
124603349|NCT02307266|448169167|FG001|Overall Study|Lost to Follow-up|0|||
124603350|NCT02307266|448169168|FG002|Overall Study|Lost to Follow-up|0|||
124603351|NCT01995266|448169177|FG000|Overall Study|Death|1|||
124603352|NCT01995266|448169177|FG000|Overall Study|Lack of Efficacy|6|||
124603353|NCT01995266|448169177|FG000|Overall Study|Adverse Event|2|||
124603354|NCT03596151|448169181|FG000|Overall Study|Withdrawal by Subject|1|||
124603355|NCT00729248|448169189|FG000|Overall Study|Physician Decision|2|||
124603356|NCT04280705|448169192|FG000|Overall Study|Enrolled but not treated|4|||
124603357|NCT04280705|448169193|FG001|Overall Study|Enrolled but not treated|10|||
124603358|NCT04280705|448169192|FG000|Overall Study|Physician Decision|1|||
124603359|NCT04280705|448169193|FG001|Overall Study|Physician Decision|0|||
124603360|NCT04280705|448169192|FG000|Overall Study|Withdrawal by Subject|7|||
124603361|NCT04280705|448169193|FG001|Overall Study|Withdrawal by Subject|9|||
124603362|NCT04280705|448169192|FG000|Overall Study|Adverse Event|0|||
124603363|NCT04280705|448169193|FG001|Overall Study|Adverse Event|4|||
124603364|NCT04280705|448169192|FG000|Overall Study|Transferred to another hospital|1|||
124603365|NCT04280705|448169193|FG001|Overall Study|Transferred to another hospital|1|||
124603366|NCT03573505|448169194|FG000|Overall Study|Adverse Event|1|||
124603367|NCT03573505|448169195|FG001|Overall Study|Adverse Event|1|||
124603368|NCT03573505|448169194|FG000|Overall Study|Consent withdrawn|0|||
124603369|NCT03573505|448169195|FG001|Overall Study|Consent withdrawn|1|||
124603370|NCT03573505|448169194|FG000|Overall Study|Disease progression|0|||
124603371|NCT03573505|448169195|FG001|Overall Study|Disease progression|1|||
124603372|NCT03573505|448169194|FG000|Overall Study|Site Terminated by Sponsor|1|||
124603373|NCT03573505|448169195|FG001|Overall Study|Site Terminated by Sponsor|1|||
124603374|NCT03573505|448169194|FG000|Overall Study|Study terminated by sponsor|50|||
124603375|NCT03573505|448169195|FG001|Overall Study|Study terminated by sponsor|45|||
124603376|NCT03573505|448169194|FG000|Overall Study|Reason not specified|0|||
124603377|NCT03573505|448169195|FG001|Overall Study|Reason not specified|1|||
124603378|NCT03573505|448169194|FG000|Overall Study|Death|0|||
124603379|NCT03573505|448169195|FG001|Overall Study|Death|4|||
124603380|NCT03222583|448169196|FG000|Overall Study|Withdrawal by Subject|3|||
124603381|NCT03222583|448169197|FG001|Overall Study|Withdrawal by Subject|3|||
124603382|NCT03222583|448169196|FG000|Overall Study|Lost to Follow-up|1|||
124603383|NCT03222583|448169197|FG001|Overall Study|Lost to Follow-up|0|||
124603384|NCT03222583|448169196|FG000|Overall Study|Other|1|||
124603385|NCT03222583|448169197|FG001|Overall Study|Other|3|||
124603386|NCT04268316|448169200|FG000|Overall Study|Withdrawal by Subject|2|||
124603387|NCT04268316|448169201|FG001|Overall Study|Withdrawal by Subject|1|||
124603388|NCT04268316|448169202|FG002|Overall Study|Withdrawal by Subject|0|||
124603389|NCT05855616|448169212|FG000|Overall Study|Lost to Follow-up|1|||
124603390|NCT05855616|448169213|FG001|Overall Study|Lost to Follow-up|2|||
124603391|NCT04032158|448169214|FG000|Overall Study|Study Termination|2|||
124603392|NCT04032158|448169215|FG001|Overall Study|Study Termination|1|||
124603393|NCT00059787|448169216|FG000|Overall Study|Adverse Event|13|||
124603394|NCT00059787|448169216|FG000|Overall Study|disease progression|2|||
124603395|NCT00059787|448169216|FG000|Overall Study|ineligible|1|||
124603396|NCT00059787|448169216|FG000|Overall Study|Other|4|||
124603397|NCT01196078|448169223|FG000|Overall Study|Withdrawal by Subject|3|||
124603398|NCT01196078|448169224|FG001|Overall Study|Withdrawal by Subject|5|||
124603399|NCT01196078|448169223|FG000|Overall Study|Adverse Event|4|||
124603400|NCT01196078|448169224|FG001|Overall Study|Adverse Event|4|||
124603401|NCT01196078|448169223|FG000|Overall Study|Protocol Violation|2|||
124603402|NCT01196078|448169224|FG001|Overall Study|Protocol Violation|1|||
124603403|NCT01196078|448169223|FG000|Overall Study|Lack of Efficacy|17|||
124603404|NCT01196078|448169224|FG001|Overall Study|Lack of Efficacy|23|||
124603405|NCT01196078|448169223|FG000|Overall Study|Lost to Follow-up|1|||
124603406|NCT01196078|448169224|FG001|Overall Study|Lost to Follow-up|0|||
124603407|NCT01196078|448169223|FG000|Overall Study|Death|6|||
124603408|NCT01196078|448169224|FG001|Overall Study|Death|4|||
124603409|NCT00103311|448169225|FG000|Overall Study|Lost to Follow-up|1|||
124603410|NCT00103311|448169226|FG001|Overall Study|Lost to Follow-up|0|||
124603411|NCT00103311|448169225|FG000|Overall Study|Withdrawal by Subject|2|||
124603412|NCT00103311|448169226|FG001|Overall Study|Withdrawal by Subject|1|||
124603413|NCT00103311|448169225|FG000|Overall Study|Adverse Event|1|||
124603414|NCT00103311|448169226|FG001|Overall Study|Adverse Event|0|||
124603415|NCT01403064|448169227|FG000|Overall Study|Death|0|||
124603416|NCT01403064|448169228|FG001|Overall Study|Death|0|||
124603417|NCT01403064|448169229|FG002|Overall Study|Death|1|||
124603418|NCT01403064|448169230|FG003|Overall Study|Death|1|||
124603419|NCT01403064|448169227|FG000|Overall Study|Withdrawal by Subject|0|||
124603420|NCT01403064|448169228|FG001|Overall Study|Withdrawal by Subject|0|||
124603421|NCT01403064|448169229|FG002|Overall Study|Withdrawal by Subject|1|||
124603422|NCT01403064|448169230|FG003|Overall Study|Withdrawal by Subject|1|||
124603423|NCT01403064|448169227|FG000|Overall Study|Other|1|||
124603424|NCT01403064|448169228|FG001|Overall Study|Other|0|||
124603425|NCT01403064|448169229|FG002|Overall Study|Other|2|||
124603426|NCT01403064|448169230|FG003|Overall Study|Other|1|||
124603427|NCT04688931|448169240|FG000|Overall Study|Adverse Event|4|||
124603428|NCT04688931|448169241|FG001|Overall Study|Adverse Event|1|||
124603429|NCT04688931|448169240|FG000|Overall Study|Withdrawal by Subject|5|||
124603430|NCT04688931|448169241|FG001|Overall Study|Withdrawal by Subject|16|||
124603431|NCT04688931|448169240|FG000|Overall Study|Physician Decision|3|||
124603432|NCT04688931|448169241|FG001|Overall Study|Physician Decision|5|||
124603433|NCT04688931|448169240|FG000|Overall Study|Noncompliance|0|||
124603434|NCT04688931|448169241|FG001|Overall Study|Noncompliance|1|||
124603435|NCT04688931|448169240|FG000|Overall Study|Lost to Follow-up|1|||
124603436|NCT04688931|448169241|FG001|Overall Study|Lost to Follow-up|3|||
124603437|NCT04688931|448169240|FG000|Overall Study|Randomization Error|3|||
124603438|NCT04688931|448169241|FG001|Overall Study|Randomization Error|0|||
124603439|NCT04688931|448169240|FG000|Overall Study|Not Eligible|1|||
124603440|NCT04688931|448169241|FG001|Overall Study|Not Eligible|3|||
124603441|NCT04688931|448169240|FG000|Overall Study|Disease Progression|0|||
124603442|NCT04688931|448169241|FG001|Overall Study|Disease Progression|2|||
124603443|NCT04688931|448169240|FG000|Overall Study|Sponsor Requirement|1|||
124603444|NCT04688931|448169241|FG001|Overall Study|Sponsor Requirement|1|||
124603445|NCT04688931|448169240|FG000|Overall Study|Other Reason|1|||
124603446|NCT04688931|448169241|FG001|Overall Study|Other Reason|2|||
124731443|NCT02754141|448640088|FG004|Overall Study|Completed treatment as per protocol|0|||
124731444|NCT02754141|448640089|FG005|Overall Study|Completed treatment as per protocol|0|||
124603449|NCT00450619|448169244|FG000|Overall Study|refused treatment after randomization|2|||
124603450|NCT00450619|448169245|FG001|Overall Study|refused treatment after randomization|0|||
124603451|NCT00450619|448169244|FG000|Overall Study|did not progress; refused further trmt|1|||
124603452|NCT00450619|448169245|FG001|Overall Study|did not progress; refused further trmt|1|||
124603453|NCT00450619|448169244|FG000|Overall Study|Adverse Event|1|||
124603454|NCT00450619|448169245|FG001|Overall Study|Adverse Event|0|||
124603455|NCT02034058|448169246|FG000|Overall Study|Death|3|||
124603456|NCT02963311|448169251|FG000|Overall Study|Withdrawal by Subject|1|||
124603457|NCT02963311|448169251|FG000|Overall Study|Screen Failure|4|||
124603458|NCT01968694|448169271|FG000|Washout (1 Month)|Lost to Follow-up|0|||
124731445|NCT02754141|448640090|FG006|Overall Study|Completed treatment as per protocol|0|||
124603459|NCT01968694|448169272|FG001|Washout (1 Month)|Lost to Follow-up|1|||
124603460|NCT00354341|448169275|FG000|Overall Study|Adverse Event|1|||
124731446|NCT02754141|448640091|FG007|Overall Study|Completed treatment as per protocol|0|||
124603461|NCT00354341|448169276|FG001|Overall Study|Adverse Event|0|||
124603462|NCT00354341|448169275|FG000|Overall Study|Death|0|||
124603463|NCT00354341|448169276|FG001|Overall Study|Death|2|||
124731447|NCT02754141|448640092|FG008|Overall Study|Completed treatment as per protocol|0|||
124603464|NCT00354341|448169275|FG000|Overall Study|Refused treatment|1|||
124603465|NCT00354341|448169276|FG001|Overall Study|Refused treatment|2|||
124603466|NCT00354341|448169275|FG000|Overall Study|Failure to return|0|||
124603467|NCT00354341|448169276|FG001|Overall Study|Failure to return|1|||
124603468|NCT00354341|448169275|FG000|Overall Study|Other|1|||
124603469|NCT00354341|448169276|FG001|Overall Study|Other|2|||
124731448|NCT02754141|448640093|FG009|Overall Study|Completed treatment as per protocol|0|||
124780965|NCT02625909|448827120|FG001|Overall Study|Lost to Follow-up|5|||
124603470|NCT02836496|448169277|FG000|Overall Study|Adverse Event|2|||
124603471|NCT02836496|448169278|FG001|Overall Study|Adverse Event|1|||
124603472|NCT02836496|448169277|FG000|Overall Study|Withdrawal by Subject|0|||
124603473|NCT02836496|448169278|FG001|Overall Study|Withdrawal by Subject|1|||
124603474|NCT01400919|448169279|FG000|Overall Study|Withdrawal by Subject|4|||
124603475|NCT01400919|448169279|FG000|Overall Study|Lost to Follow-up|2|||
124603476|NCT01400919|448169279|FG000|Overall Study|Missed visit|2|||
124603477|NCT00251719|448169280|FG000|Overall Study|Adverse Event|14|||
124603478|NCT00251719|448169281|FG001|Overall Study|Adverse Event|8|||
124603479|NCT00251719|448169282|FG002|Overall Study|Adverse Event|7|||
124603480|NCT00251719|448169280|FG000|Overall Study|Protocol Violation|1|||
124603481|NCT00251719|448169281|FG001|Overall Study|Protocol Violation|1|||
124603482|NCT00251719|448169282|FG002|Overall Study|Protocol Violation|1|||
124603483|NCT00251719|448169280|FG000|Overall Study|Lost to Follow-up|5|||
124603484|NCT00251719|448169281|FG001|Overall Study|Lost to Follow-up|11|||
124603485|NCT00251719|448169282|FG002|Overall Study|Lost to Follow-up|8|||
124603486|NCT00251719|448169280|FG000|Overall Study|Withdrawal by Subject|14|||
124603487|NCT00251719|448169281|FG001|Overall Study|Withdrawal by Subject|12|||
124603488|NCT00251719|448169282|FG002|Overall Study|Withdrawal by Subject|11|||
124603489|NCT00251719|448169280|FG000|Overall Study|Lack of Efficacy|2|||
124603490|NCT00251719|448169281|FG001|Overall Study|Lack of Efficacy|1|||
124603491|NCT00251719|448169282|FG002|Overall Study|Lack of Efficacy|0|||
124603492|NCT00251719|448169280|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
124603493|NCT00251719|448169281|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
124603494|NCT00251719|448169282|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
124603495|NCT00251719|448169280|FG000|Overall Study|Investigator decision|1|||
124603496|NCT00251719|448169281|FG001|Overall Study|Investigator decision|1|||
124603497|NCT00251719|448169282|FG002|Overall Study|Investigator decision|0|||
124603498|NCT00251719|448169280|FG000|Overall Study|Noncompliance|2|||
124603499|NCT00251719|448169281|FG001|Overall Study|Noncompliance|3|||
124603500|NCT00251719|448169282|FG002|Overall Study|Noncompliance|1|||
124603501|NCT00251719|448169280|FG000|Overall Study|Barrett's esophagus|2|||
124603502|NCT00251719|448169281|FG001|Overall Study|Barrett's esophagus|2|||
124603503|NCT00251719|448169282|FG002|Overall Study|Barrett's esophagus|0|||
124603504|NCT03822832|448169283|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
124603505|NCT03822832|448169284|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
124603506|NCT03822832|448169283|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
124603507|NCT03822832|448169284|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
124603508|NCT03822832|448169283|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
124603509|NCT03822832|448169284|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
124603510|NCT03822832|448169283|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
124603511|NCT03822832|448169284|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
124603512|NCT03822832|448169283|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
124603513|NCT03822832|448169284|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
124603514|NCT03822832|448169283|FG000|Re-allocation|Not re-allocated to open label period|2|||
124603515|NCT03822832|448169284|FG001|Re-allocation|Not re-allocated to open label period|6|||
124603516|NCT03822832|448169283|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
124603517|NCT03822832|448169284|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
124603518|NCT03822832|448169283|FG000|Period 2 - Open Label Period|Adverse Event|0|||
124603519|NCT03822832|448169284|FG001|Period 2 - Open Label Period|Adverse Event|3|||
124603520|NCT01732874|448169285|FG000|Overall Study|Withdrawal by Subject|5|||
124603521|NCT01732874|448169286|FG001|Overall Study|Withdrawal by Subject|1|||
124603522|NCT01732874|448169285|FG000|Overall Study|Death of Infant|3|||
124603523|NCT01732874|448169286|FG001|Overall Study|Death of Infant|2|||
124603524|NCT00846521|448169289|FG000|Overall Study|Withdrawal by Subject|5|||
124603525|NCT00846521|448169289|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
124603526|NCT00846521|448169289|FG000|Overall Study|Protocol Violation|1|||
124603527|NCT01246011|448169290|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
124603528|NCT01246011|448169291|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
124603529|NCT01246011|448169292|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
124603530|NCT01246011|448169290|FG000|Overall Study|Withdrawal by Subject|0|||
124603531|NCT01246011|448169291|FG001|Overall Study|Withdrawal by Subject|0|||
124603532|NCT01246011|448169292|FG002|Overall Study|Withdrawal by Subject|1|||
124780966|NCT02625909|448827119|FG000|Overall Study|Lack of Efficacy|9|||
124603533|NCT04392583|448169293|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
124603534|NCT02303041|448169294|FG000|Overall Study|Adverse Event|1|||
124603535|NCT02303041|448169295|FG001|Overall Study|Adverse Event|2|||
124603536|NCT03979820|448169298|FG000|Overall Study|Protocol Violation|1|||
124603537|NCT03979820|448169299|FG001|Overall Study|Protocol Violation|0|||
124603538|NCT03979820|448169300|FG002|Overall Study|Protocol Violation|0|||
124603539|NCT03979820|448169301|FG003|Overall Study|Protocol Violation|0|||
124603540|NCT03979820|448169298|FG000|Overall Study|Withdrawal by Subject|0|||
124603541|NCT03979820|448169299|FG001|Overall Study|Withdrawal by Subject|0|||
124603542|NCT03979820|448169300|FG002|Overall Study|Withdrawal by Subject|1|||
124603543|NCT03979820|448169301|FG003|Overall Study|Withdrawal by Subject|0|||
124603544|NCT03979820|448169298|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
124603545|NCT03979820|448169299|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
124603546|NCT03979820|448169300|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
124603547|NCT03979820|448169301|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
124603548|NCT00160641|448169302|FG000|Overall Study|Adverse Event|102|||
124603549|NCT00160641|448169302|FG000|Overall Study|Withdrawal by Subject|87|||
124603550|NCT00160641|448169302|FG000|Overall Study|Lost to Follow-up|8|||
124603551|NCT00160641|448169302|FG000|Overall Study|Lack of Efficacy|12|||
124603552|NCT00160641|448169302|FG000|Overall Study|Protocol Violation|3|||
124603553|NCT00160641|448169302|FG000|Overall Study|Other|9|||
124603554|NCT01929031|448169316|FG000|Overall Study|Adverse Event|3|||
124603555|NCT01929031|448169317|FG001|Overall Study|Adverse Event|1|||
124603556|NCT01929031|448169318|FG002|Overall Study|Adverse Event|1|||
124603557|NCT01929031|448169319|FG003|Overall Study|Adverse Event|0|||
124603558|NCT01929031|448169320|FG004|Overall Study|Adverse Event|0|||
124603559|NCT01929031|448169321|FG005|Overall Study|Adverse Event|0|||
124603560|NCT01929031|448169316|FG000|Overall Study|Protocol Violation|1|||
124603561|NCT01929031|448169317|FG001|Overall Study|Protocol Violation|0|||
124603562|NCT01929031|448169318|FG002|Overall Study|Protocol Violation|0|||
124603563|NCT01929031|448169319|FG003|Overall Study|Protocol Violation|0|||
124603564|NCT01929031|448169320|FG004|Overall Study|Protocol Violation|0|||
124603565|NCT01929031|448169321|FG005|Overall Study|Protocol Violation|1|||
124603566|NCT01929031|448169316|FG000|Overall Study|Reason other than specified above|0|||
124603567|NCT01929031|448169317|FG001|Overall Study|Reason other than specified above|1|||
124603568|NCT01929031|448169318|FG002|Overall Study|Reason other than specified above|0|||
124603569|NCT01929031|448169319|FG003|Overall Study|Reason other than specified above|0|||
124603570|NCT01929031|448169320|FG004|Overall Study|Reason other than specified above|1|||
124603571|NCT01929031|448169321|FG005|Overall Study|Reason other than specified above|0|||
124603572|NCT02394730|448169324|FG000|Overall Study|Lost to Follow-up|1|||
124603573|NCT02394730|448169325|FG001|Overall Study|Lost to Follow-up|0|||
124603574|NCT02394730|448169324|FG000|Overall Study|Withdrawal by Subject|0|||
124603575|NCT02394730|448169325|FG001|Overall Study|Withdrawal by Subject|1|||
124603576|NCT03512262|448169326|FG000|Overall Study|Adverse Event|8|||
124603577|NCT03512262|448169327|FG001|Overall Study|Adverse Event|3|||
124603578|NCT03512262|448169326|FG000|Overall Study|Death (non-treatment emergent)|1|||
124603579|NCT03512262|448169327|FG001|Overall Study|Death (non-treatment emergent)|0|||
124603580|NCT03512262|448169326|FG000|Overall Study|Withdrawal by Subject|17|||
124603581|NCT03512262|448169327|FG001|Overall Study|Withdrawal by Subject|9|||
124603582|NCT03512262|448169326|FG000|Overall Study|Lost to Follow-up|7|||
124603583|NCT03512262|448169327|FG001|Overall Study|Lost to Follow-up|1|||
124603584|NCT03512262|448169326|FG000|Overall Study|Other than Specified|2|||
124603585|NCT03512262|448169327|FG001|Overall Study|Other than Specified|2|||
124603586|NCT03510182|448169328|FG000|Overall Study|Withdrawal by Subject|2|||
124603587|NCT03502707|448170858|FG000|Overall Study|Adverse Event|0|||
124603588|NCT03502707|448170859|FG001|Overall Study|Adverse Event|0|||
124603589|NCT03502707|448170860|FG002|Overall Study|Adverse Event|0|||
124603590|NCT03502707|448170861|FG003|Overall Study|Adverse Event|0|||
124603591|NCT03502707|448170862|FG004|Overall Study|Adverse Event|0|||
124603592|NCT03502707|448170863|FG005|Overall Study|Adverse Event|0|||
124603593|NCT03502707|448170864|FG006|Overall Study|Adverse Event|0|||
124603594|NCT03502707|448170865|FG007|Overall Study|Adverse Event|0|||
124603595|NCT03502707|448170866|FG008|Overall Study|Adverse Event|0|||
124603596|NCT03502707|448170867|FG009|Overall Study|Adverse Event|0|||
124603597|NCT03502707|448170868|FG010|Overall Study|Adverse Event|0|||
124603598|NCT03502707|448170869|FG011|Overall Study|Adverse Event|0|||
124603599|NCT03502707|448170870|FG012|Overall Study|Adverse Event|0|||
124603600|NCT03502707|448170871|FG013|Overall Study|Adverse Event|0|||
124603601|NCT03502707|448170872|FG014|Overall Study|Adverse Event|0|||
124603602|NCT03502707|448170873|FG015|Overall Study|Adverse Event|1|||
124603603|NCT03502707|448170874|FG016|Overall Study|Adverse Event|5|||
124603604|NCT03502707|448170875|FG017|Overall Study|Adverse Event|0|||
124603605|NCT03502707|448170858|FG000|Overall Study|Death|0|||
124603606|NCT03502707|448170859|FG001|Overall Study|Death|0|||
124603607|NCT03502707|448170860|FG002|Overall Study|Death|0|||
124603608|NCT03502707|448170861|FG003|Overall Study|Death|1|||
124603609|NCT03502707|448170862|FG004|Overall Study|Death|0|||
124603610|NCT03502707|448170863|FG005|Overall Study|Death|0|||
124603611|NCT03502707|448170864|FG006|Overall Study|Death|0|||
124603612|NCT03502707|448170865|FG007|Overall Study|Death|0|||
124603613|NCT03502707|448170866|FG008|Overall Study|Death|1|||
124731449|NCT02754141|448640094|FG010|Overall Study|Completed treatment as per protocol|0|||
124731450|NCT02754141|448640095|FG011|Overall Study|Completed treatment as per protocol|0|||
124603614|NCT03502707|448170867|FG009|Overall Study|Death|1|||
124603615|NCT03502707|448170868|FG010|Overall Study|Death|0|||
124603616|NCT03502707|448170869|FG011|Overall Study|Death|0|||
124603617|NCT03502707|448170870|FG012|Overall Study|Death|1|||
124603618|NCT03502707|448170871|FG013|Overall Study|Death|0|||
124603619|NCT03502707|448170872|FG014|Overall Study|Death|0|||
124603620|NCT03502707|448170873|FG015|Overall Study|Death|1|||
124603621|NCT03502707|448170874|FG016|Overall Study|Death|0|||
124603622|NCT03502707|448170875|FG017|Overall Study|Death|0|||
124603623|NCT03502707|448170858|FG000|Overall Study|Lost to Follow-up|0|||
124603624|NCT03502707|448170859|FG001|Overall Study|Lost to Follow-up|0|||
124603625|NCT03502707|448170860|FG002|Overall Study|Lost to Follow-up|0|||
124603626|NCT03502707|448170861|FG003|Overall Study|Lost to Follow-up|0|||
124603627|NCT03502707|448170862|FG004|Overall Study|Lost to Follow-up|0|||
124603628|NCT03502707|448170863|FG005|Overall Study|Lost to Follow-up|0|||
124603629|NCT03502707|448170864|FG006|Overall Study|Lost to Follow-up|0|||
124603630|NCT03502707|448170865|FG007|Overall Study|Lost to Follow-up|5|||
124603631|NCT03502707|448170866|FG008|Overall Study|Lost to Follow-up|0|||
124603632|NCT03502707|448170867|FG009|Overall Study|Lost to Follow-up|2|||
124603633|NCT03502707|448170868|FG010|Overall Study|Lost to Follow-up|1|||
124603634|NCT03502707|448170869|FG011|Overall Study|Lost to Follow-up|2|||
124603635|NCT03502707|448170870|FG012|Overall Study|Lost to Follow-up|1|||
124603636|NCT03502707|448170871|FG013|Overall Study|Lost to Follow-up|1|||
124603637|NCT03502707|448170872|FG014|Overall Study|Lost to Follow-up|0|||
124603638|NCT03502707|448170873|FG015|Overall Study|Lost to Follow-up|4|||
124603639|NCT03502707|448170874|FG016|Overall Study|Lost to Follow-up|9|||
124603640|NCT03502707|448170875|FG017|Overall Study|Lost to Follow-up|2|||
124603641|NCT03502707|448170858|FG000|Overall Study|Physician Decision|0|||
124603642|NCT03502707|448170859|FG001|Overall Study|Physician Decision|0|||
124603643|NCT03502707|448170860|FG002|Overall Study|Physician Decision|0|||
124603644|NCT03502707|448170861|FG003|Overall Study|Physician Decision|0|||
124603645|NCT03502707|448170862|FG004|Overall Study|Physician Decision|0|||
124603646|NCT03502707|448170863|FG005|Overall Study|Physician Decision|0|||
124603647|NCT03502707|448170864|FG006|Overall Study|Physician Decision|0|||
124603648|NCT03502707|448170865|FG007|Overall Study|Physician Decision|0|||
124603649|NCT03502707|448170866|FG008|Overall Study|Physician Decision|2|||
124603650|NCT03502707|448170867|FG009|Overall Study|Physician Decision|1|||
124603651|NCT03502707|448170868|FG010|Overall Study|Physician Decision|0|||
124603652|NCT03502707|448170869|FG011|Overall Study|Physician Decision|0|||
124603653|NCT03502707|448170870|FG012|Overall Study|Physician Decision|0|||
124603654|NCT03502707|448170871|FG013|Overall Study|Physician Decision|0|||
124603655|NCT03502707|448170872|FG014|Overall Study|Physician Decision|1|||
124603656|NCT03502707|448170873|FG015|Overall Study|Physician Decision|3|||
124603657|NCT03502707|448170874|FG016|Overall Study|Physician Decision|0|||
124603658|NCT03502707|448170875|FG017|Overall Study|Physician Decision|0|||
124603659|NCT03502707|448170858|FG000|Overall Study|Protocol Violation|0|||
124603660|NCT03502707|448170859|FG001|Overall Study|Protocol Violation|0|||
124603661|NCT03502707|448170860|FG002|Overall Study|Protocol Violation|0|||
124603662|NCT03502707|448170861|FG003|Overall Study|Protocol Violation|0|||
124603663|NCT03502707|448170862|FG004|Overall Study|Protocol Violation|0|||
124603664|NCT03502707|448170863|FG005|Overall Study|Protocol Violation|0|||
124603665|NCT03502707|448170864|FG006|Overall Study|Protocol Violation|0|||
124603666|NCT03502707|448170865|FG007|Overall Study|Protocol Violation|0|||
124603667|NCT03502707|448170866|FG008|Overall Study|Protocol Violation|0|||
124603668|NCT03502707|448170867|FG009|Overall Study|Protocol Violation|0|||
124603669|NCT03502707|448170868|FG010|Overall Study|Protocol Violation|0|||
124603670|NCT03502707|448170869|FG011|Overall Study|Protocol Violation|0|||
124603671|NCT03502707|448170870|FG012|Overall Study|Protocol Violation|0|||
124603672|NCT03502707|448170871|FG013|Overall Study|Protocol Violation|0|||
124603673|NCT03502707|448170872|FG014|Overall Study|Protocol Violation|0|||
124603674|NCT03502707|448170873|FG015|Overall Study|Protocol Violation|1|||
124603675|NCT03502707|448170874|FG016|Overall Study|Protocol Violation|0|||
124603676|NCT03502707|448170875|FG017|Overall Study|Protocol Violation|0|||
124603677|NCT03502707|448170858|FG000|Overall Study|Withdrawal by Subject|1|||
124603678|NCT03502707|448170859|FG001|Overall Study|Withdrawal by Subject|1|||
124603679|NCT03502707|448170860|FG002|Overall Study|Withdrawal by Subject|0|||
124603680|NCT03502707|448170861|FG003|Overall Study|Withdrawal by Subject|0|||
124603681|NCT03502707|448170862|FG004|Overall Study|Withdrawal by Subject|0|||
124603682|NCT03502707|448170863|FG005|Overall Study|Withdrawal by Subject|2|||
124603683|NCT03502707|448170864|FG006|Overall Study|Withdrawal by Subject|0|||
124603684|NCT03502707|448170865|FG007|Overall Study|Withdrawal by Subject|3|||
124603685|NCT03502707|448170866|FG008|Overall Study|Withdrawal by Subject|1|||
124603686|NCT03502707|448170867|FG009|Overall Study|Withdrawal by Subject|2|||
124603687|NCT03502707|448170868|FG010|Overall Study|Withdrawal by Subject|12|||
124603688|NCT03502707|448170869|FG011|Overall Study|Withdrawal by Subject|23|||
124603689|NCT03502707|448170870|FG012|Overall Study|Withdrawal by Subject|5|||
124603690|NCT03502707|448170871|FG013|Overall Study|Withdrawal by Subject|3|||
124731451|NCT02754141|448640096|FG012|Overall Study|Completed treatment as per protocol|1|||
124731452|NCT02754141|448640097|FG013|Overall Study|Completed treatment as per protocol|0|||
124603691|NCT03502707|448170872|FG014|Overall Study|Withdrawal by Subject|3|||
124603692|NCT03502707|448170873|FG015|Overall Study|Withdrawal by Subject|43|||
124603693|NCT03502707|448170874|FG016|Overall Study|Withdrawal by Subject|44|||
124603694|NCT03502707|448170875|FG017|Overall Study|Withdrawal by Subject|18|||
124603695|NCT03502707|448170858|FG000|Overall Study|Sponsor's Decision|1|||
124603696|NCT03502707|448170859|FG001|Overall Study|Sponsor's Decision|0|||
124603697|NCT03502707|448170860|FG002|Overall Study|Sponsor's Decision|0|||
124603698|NCT03502707|448170861|FG003|Overall Study|Sponsor's Decision|0|||
124603699|NCT03502707|448170862|FG004|Overall Study|Sponsor's Decision|0|||
124603700|NCT03502707|448170863|FG005|Overall Study|Sponsor's Decision|0|||
124603701|NCT03502707|448170864|FG006|Overall Study|Sponsor's Decision|0|||
124603702|NCT03502707|448170865|FG007|Overall Study|Sponsor's Decision|0|||
124603703|NCT03502707|448170866|FG008|Overall Study|Sponsor's Decision|0|||
124603704|NCT03502707|448170867|FG009|Overall Study|Sponsor's Decision|1|||
124603705|NCT03502707|448170868|FG010|Overall Study|Sponsor's Decision|0|||
124603706|NCT03502707|448170869|FG011|Overall Study|Sponsor's Decision|0|||
124603707|NCT03502707|448170870|FG012|Overall Study|Sponsor's Decision|0|||
124603708|NCT03502707|448170871|FG013|Overall Study|Sponsor's Decision|0|||
124603709|NCT03502707|448170872|FG014|Overall Study|Sponsor's Decision|0|||
124603710|NCT03502707|448170873|FG015|Overall Study|Sponsor's Decision|2|||
124603711|NCT03502707|448170874|FG016|Overall Study|Sponsor's Decision|1|||
124603712|NCT03502707|448170875|FG017|Overall Study|Sponsor's Decision|0|||
124603713|NCT03502707|448170858|FG000|Overall Study|Initiated Prohibited Medication|0|||
124603714|NCT03502707|448170859|FG001|Overall Study|Initiated Prohibited Medication|0|||
124603715|NCT03502707|448170860|FG002|Overall Study|Initiated Prohibited Medication|0|||
124603716|NCT03502707|448170861|FG003|Overall Study|Initiated Prohibited Medication|0|||
124603717|NCT03502707|448170862|FG004|Overall Study|Initiated Prohibited Medication|0|||
124603718|NCT03502707|448170863|FG005|Overall Study|Initiated Prohibited Medication|0|||
124603719|NCT03502707|448170864|FG006|Overall Study|Initiated Prohibited Medication|0|||
124603720|NCT03502707|448170865|FG007|Overall Study|Initiated Prohibited Medication|0|||
124603721|NCT03502707|448170866|FG008|Overall Study|Initiated Prohibited Medication|0|||
124603722|NCT03502707|448170867|FG009|Overall Study|Initiated Prohibited Medication|0|||
124603723|NCT03502707|448170868|FG010|Overall Study|Initiated Prohibited Medication|0|||
124603724|NCT03502707|448170869|FG011|Overall Study|Initiated Prohibited Medication|0|||
124603725|NCT03502707|448170870|FG012|Overall Study|Initiated Prohibited Medication|0|||
124603726|NCT03502707|448170871|FG013|Overall Study|Initiated Prohibited Medication|0|||
124603727|NCT03502707|448170872|FG014|Overall Study|Initiated Prohibited Medication|0|||
124603728|NCT03502707|448170873|FG015|Overall Study|Initiated Prohibited Medication|0|||
124603729|NCT03502707|448170874|FG016|Overall Study|Initiated Prohibited Medication|1|||
124603730|NCT03502707|448170875|FG017|Overall Study|Initiated Prohibited Medication|0|||
124603731|NCT03502707|448170858|FG000|Overall Study|Other|0|||
124603732|NCT03502707|448170859|FG001|Overall Study|Other|0|||
124603733|NCT03502707|448170860|FG002|Overall Study|Other|0|||
124603734|NCT03502707|448170861|FG003|Overall Study|Other|0|||
124603735|NCT03502707|448170862|FG004|Overall Study|Other|0|||
124603736|NCT03502707|448170863|FG005|Overall Study|Other|0|||
124603737|NCT03502707|448170864|FG006|Overall Study|Other|0|||
124603738|NCT03502707|448170865|FG007|Overall Study|Other|0|||
124603739|NCT03502707|448170866|FG008|Overall Study|Other|1|||
124603740|NCT03502707|448170867|FG009|Overall Study|Other|1|||
124603741|NCT03502707|448170868|FG010|Overall Study|Other|2|||
124603742|NCT03502707|448170869|FG011|Overall Study|Other|0|||
124603743|NCT03502707|448170870|FG012|Overall Study|Other|0|||
124603744|NCT03502707|448170871|FG013|Overall Study|Other|0|||
124603745|NCT03502707|448170872|FG014|Overall Study|Other|0|||
124603746|NCT03502707|448170873|FG015|Overall Study|Other|4|||
124731453|NCT02754141|448640098|FG014|Overall Study|Completed treatment as per protocol|0|||
124731454|NCT02754141|448640099|FG015|Overall Study|Completed treatment as per protocol|0|||
124603747|NCT03502707|448170874|FG016|Overall Study|Other|1|||
124603748|NCT03502707|448170875|FG017|Overall Study|Other|0|||
124603749|NCT03502707|448170858|FG000|Overall Study|Randomized but not vaccinated|0|||
124603750|NCT03502707|448170859|FG001|Overall Study|Randomized but not vaccinated|0|||
124603751|NCT03502707|448170860|FG002|Overall Study|Randomized but not vaccinated|0|||
124603752|NCT03502707|448170861|FG003|Overall Study|Randomized but not vaccinated|0|||
124603753|NCT03502707|448170862|FG004|Overall Study|Randomized but not vaccinated|0|||
124603754|NCT03502707|448170863|FG005|Overall Study|Randomized but not vaccinated|0|||
124603755|NCT03502707|448170864|FG006|Overall Study|Randomized but not vaccinated|0|||
124603756|NCT03502707|448170865|FG007|Overall Study|Randomized but not vaccinated|0|||
124603757|NCT03502707|448170866|FG008|Overall Study|Randomized but not vaccinated|0|||
124603758|NCT03502707|448170867|FG009|Overall Study|Randomized but not vaccinated|0|||
124603759|NCT03502707|448170868|FG010|Overall Study|Randomized but not vaccinated|0|||
124603760|NCT03502707|448170869|FG011|Overall Study|Randomized but not vaccinated|1|||
124603761|NCT03502707|448170870|FG012|Overall Study|Randomized but not vaccinated|0|||
124603762|NCT03502707|448170871|FG013|Overall Study|Randomized but not vaccinated|0|||
124603763|NCT03502707|448170872|FG014|Overall Study|Randomized but not vaccinated|0|||
124603764|NCT03502707|448170873|FG015|Overall Study|Randomized but not vaccinated|0|||
124603765|NCT03502707|448170874|FG016|Overall Study|Randomized but not vaccinated|0|||
124603766|NCT03502707|448170875|FG017|Overall Study|Randomized but not vaccinated|1|||
124731455|NCT02754141|448640100|FG016|Overall Study|Completed treatment as per protocol|0|||
124603767|NCT04551911|448170876|FG000|Overall Study|Lost to Follow-up|2|||
124603768|NCT04551911|448170877|FG001|Overall Study|Lost to Follow-up|1|||
124603769|NCT04551911|448170876|FG000|Overall Study|Withdrawal by Subject|10|||
124603770|NCT04551911|448170877|FG001|Overall Study|Withdrawal by Subject|10|||
124603771|NCT04551911|448170876|FG000|Overall Study|Did not receive the study drug|3|||
124603772|NCT04551911|448170877|FG001|Overall Study|Did not receive the study drug|4|||
124603773|NCT01030341|448170878|FG000|Overall Study|Withdrawal by Subject|1|||
124603774|NCT01030341|448170878|FG000|Overall Study|Lost to Follow-up|2|||
124603775|NCT01884311|448170879|FG000|Overall Study|Withdrawal by Subject|3|||
124603776|NCT01884311|448170879|FG000|Overall Study|withdrew consent due to AEs|1|||
124603777|NCT01884311|448170879|FG000|Overall Study|Precautionary measure|1|||
124603778|NCT02031458|448170882|FG000|May 8, 2015 to January 11, 2019|Death|89|||
124603779|NCT02031458|448170883|FG001|May 8, 2015 to January 11, 2019|Death|193|||
124603780|NCT02031458|448170884|FG002|May 8, 2015 to January 11, 2019|Death|198|||
124603781|NCT02031458|448170882|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
124603782|NCT02031458|448170883|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
124603783|NCT02031458|448170884|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
124603784|NCT02031458|448170882|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
124603785|NCT02031458|448170883|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
124603786|NCT02031458|448170884|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
124603787|NCT02031458|448170882|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
124603788|NCT02031458|448170883|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
124603789|NCT02031458|448170884|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
124603790|NCT02031458|448170882|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
124603791|NCT02031458|448170883|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
124603792|NCT02031458|448170884|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
124603793|NCT02031458|448170882|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
124603794|NCT02031458|448170883|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
124603795|NCT02031458|448170884|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
124603796|NCT02031458|448170882|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
124603797|NCT02031458|448170883|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
124603798|NCT02031458|448170884|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
124603799|NCT02031458|448170882|FG000|Baseline to May 8, 2015|Death|36|||
124603800|NCT02031458|448170883|FG001|Baseline to May 8, 2015|Death|87|||
124603801|NCT02031458|448170884|FG002|Baseline to May 8, 2015|Death|100|||
124603802|NCT02031458|448170882|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
124603803|NCT02031458|448170883|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
124603804|NCT02031458|448170884|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
124603805|NCT02031458|448170882|FG000|Baseline to May 8, 2015|Physician Decision|0|||
124603806|NCT02031458|448170883|FG001|Baseline to May 8, 2015|Physician Decision|1|||
124603807|NCT02031458|448170884|FG002|Baseline to May 8, 2015|Physician Decision|0|||
124603808|NCT02031458|448170882|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
124603809|NCT02031458|448170883|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
124603810|NCT02031458|448170884|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
124603811|NCT02031458|448170882|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
124603812|NCT02031458|448170883|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
124603813|NCT02031458|448170884|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
124603814|NCT02031458|448170882|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
124603815|NCT02031458|448170883|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
124603816|NCT02031458|448170884|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
124603817|NCT02031458|448170882|FG000|Baseline to May 8, 2015|On Treatment|43|||
124603818|NCT02031458|448170883|FG001|Baseline to May 8, 2015|On Treatment|81|||
124603819|NCT02031458|448170884|FG002|Baseline to May 8, 2015|On Treatment|73|||
124603820|NCT02031458|448170882|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
124603821|NCT02031458|448170883|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
124603822|NCT02031458|448170884|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
124603823|NCT00609518|448170886|FG000|Overall Study|Death from Study Disease|32|||
124603824|NCT00609518|448170887|FG001|Overall Study|Death from Study Disease|32|||
124603825|NCT00609518|448170886|FG000|Overall Study|Withdrawal by Subject|5|||
124603826|NCT00609518|448170887|FG001|Overall Study|Withdrawal by Subject|3|||
124603827|NCT00609518|448170886|FG000|Overall Study|Lost to Follow-up|3|||
124603828|NCT00609518|448170887|FG001|Overall Study|Lost to Follow-up|0|||
124603829|NCT00609518|448170886|FG000|Overall Study|Physician Decision|1|||
124603830|NCT00609518|448170887|FG001|Overall Study|Physician Decision|3|||
124603831|NCT00609518|448170886|FG000|Overall Study|Death from Adverse Event|2|||
124603832|NCT00609518|448170887|FG001|Overall Study|Death from Adverse Event|2|||
124603833|NCT00292188|448170891|FG000|Single-Blind|Adverse Event|14|||
124603834|NCT00292188|448170892|FG001|Single-Blind|Adverse Event|0|||
124603835|NCT00292188|448170893|FG002|Single-Blind|Adverse Event|0|||
124603836|NCT00292188|448170891|FG000|Single-Blind|Lack of Efficacy|2|||
124603837|NCT00292188|448170892|FG001|Single-Blind|Lack of Efficacy|0|||
124603838|NCT00292188|448170893|FG002|Single-Blind|Lack of Efficacy|0|||
124603839|NCT00292188|448170891|FG000|Single-Blind|Laboratory Abnormality|5|||
124603840|NCT00292188|448170892|FG001|Single-Blind|Laboratory Abnormality|0|||
124603841|NCT00292188|448170893|FG002|Single-Blind|Laboratory Abnormality|0|||
124603842|NCT00292188|448170891|FG000|Single-Blind|Lost to Follow-up|3|||
124603843|NCT00292188|448170892|FG001|Single-Blind|Lost to Follow-up|0|||
124603844|NCT00292188|448170893|FG002|Single-Blind|Lost to Follow-up|0|||
124603845|NCT00292188|448170891|FG000|Single-Blind|Other|77|||
124603846|NCT00292188|448170892|FG001|Single-Blind|Other|0|||
124603847|NCT00292188|448170893|FG002|Single-Blind|Other|0|||
124603848|NCT00292188|448170891|FG000|Single-Blind|Withdrawal by Subject|12|||
124603849|NCT00292188|448170892|FG001|Single-Blind|Withdrawal by Subject|0|||
124603850|NCT00292188|448170893|FG002|Single-Blind|Withdrawal by Subject|0|||
124603851|NCT00292188|448170891|FG000|Single-Blind|Did not receive treatment|1|||
124603852|NCT00292188|448170892|FG001|Single-Blind|Did not receive treatment|0|||
124603853|NCT00292188|448170893|FG002|Single-Blind|Did not receive treatment|0|||
124603854|NCT00292188|448170891|FG000|Double-Blind|Adverse Event|0|||
124603855|NCT00292188|448170892|FG001|Double-Blind|Adverse Event|25|||
124603856|NCT00292188|448170893|FG002|Double-Blind|Adverse Event|9|||
124603857|NCT00292188|448170891|FG000|Double-Blind|Lack of Efficacy|0|||
124603858|NCT00292188|448170892|FG001|Double-Blind|Lack of Efficacy|2|||
124603859|NCT00292188|448170893|FG002|Double-Blind|Lack of Efficacy|12|||
124603860|NCT00292188|448170891|FG000|Double-Blind|Lost to Follow-up|0|||
124603861|NCT00292188|448170892|FG001|Double-Blind|Lost to Follow-up|1|||
124603862|NCT00292188|448170893|FG002|Double-Blind|Lost to Follow-up|0|||
124603863|NCT00292188|448170891|FG000|Double-Blind|Other|0|||
124603864|NCT00292188|448170892|FG001|Double-Blind|Other|3|||
124603865|NCT00292188|448170893|FG002|Double-Blind|Other|4|||
124603866|NCT00292188|448170891|FG000|Double-Blind|Withdrawal by Subject|0|||
124603867|NCT00292188|448170892|FG001|Double-Blind|Withdrawal by Subject|0|||
124603868|NCT00292188|448170893|FG002|Double-Blind|Withdrawal by Subject|3|||
124603869|NCT00292188|448170891|FG000|Double-Blind|Laboratory Abnormality|0|||
124603870|NCT00292188|448170892|FG001|Double-Blind|Laboratory Abnormality|0|||
124603871|NCT00292188|448170893|FG002|Double-Blind|Laboratory Abnormality|1|||
124603872|NCT00824616|448170894|FG000|Overall Study|Adverse Event|2|||
124603873|NCT00824616|448170895|FG001|Overall Study|Adverse Event|1|||
124603874|NCT00824616|448170894|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
124603875|NCT00824616|448170895|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
124603876|NCT00824616|448170894|FG000|Overall Study|Hyperglycemia|1|||
124603877|NCT00824616|448170895|FG001|Overall Study|Hyperglycemia|1|||
124603878|NCT00824616|448170894|FG000|Overall Study|Lack of Efficacy|2|||
124603879|NCT00824616|448170895|FG001|Overall Study|Lack of Efficacy|1|||
124603880|NCT00824616|448170894|FG000|Overall Study|Lost to Follow-up|0|||
124603881|NCT00824616|448170895|FG001|Overall Study|Lost to Follow-up|1|||
124603882|NCT00824616|448170894|FG000|Overall Study|Withdrawal by Subject|1|||
124603883|NCT00824616|448170895|FG001|Overall Study|Withdrawal by Subject|1|||
124603884|NCT00974974|448170905|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
124603885|NCT00974974|448170906|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
124603886|NCT00974974|448170905|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
124603887|NCT00974974|448170906|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
124603888|NCT00974974|448170905|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
124731456|NCT02754141|448640101|FG017|Overall Study|Completed treatment as per protocol|0|||
124731457|NCT02754141|448640084|FG000|Overall Study|Not completing monotherapy|0|||
124731458|NCT02754141|448640085|FG001|Overall Study|Not completing monotherapy|0|||
124731459|NCT02754141|448640086|FG002|Overall Study|Not completing monotherapy|0|||
124731460|NCT02754141|448640087|FG003|Overall Study|Not completing monotherapy|0|||
124731461|NCT02754141|448640088|FG004|Overall Study|Not completing monotherapy|0|||
124731462|NCT02754141|448640089|FG005|Overall Study|Not completing monotherapy|0|||
124731463|NCT02754141|448640090|FG006|Overall Study|Not completing monotherapy|0|||
124731464|NCT02754141|448640091|FG007|Overall Study|Not completing monotherapy|0|||
124780967|NCT02625909|448827120|FG001|Overall Study|Lack of Efficacy|2|||
124780968|NCT02625909|448827119|FG000|Overall Study|Reinfection|3|||
124780969|NCT02625909|448827120|FG001|Overall Study|Reinfection|2|||
124780970|NCT02367833|448827121|FG000|Overall Study|Withdrawal by Subject|1|||
124603889|NCT00974974|448170906|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
124731465|NCT02754141|448640092|FG008|Overall Study|Not completing monotherapy|0|||
124731466|NCT02754141|448640093|FG009|Overall Study|Not completing monotherapy|0|||
124603890|NCT00974974|448170905|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
124731467|NCT02754141|448640094|FG010|Overall Study|Not completing monotherapy|0|||
124731468|NCT02754141|448640095|FG011|Overall Study|Not completing monotherapy|0|||
124780971|NCT02367833|448827122|FG001|Overall Study|Withdrawal by Subject|1|||
124603891|NCT00974974|448170906|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
124603892|NCT00974974|448170905|FG000|IR CD-LD Dose Adjustment|Various|0|||
124603893|NCT00974974|448170906|FG001|IR CD-LD Dose Adjustment|Various|9|||
124603894|NCT00974974|448170905|FG000|IPX066 Dose Conversion|Adverse Event|23|||
124603895|NCT00974974|448170906|FG001|IPX066 Dose Conversion|Adverse Event|0|||
124603896|NCT00974974|448170905|FG000|IPX066 Dose Conversion|Death|2|||
124603897|NCT00974974|448170906|FG001|IPX066 Dose Conversion|Death|0|||
124731469|NCT02754141|448640096|FG012|Overall Study|Not completing monotherapy|0|||
124603898|NCT00974974|448170905|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
124731470|NCT02754141|448640097|FG013|Overall Study|Not completing monotherapy|1|||
124731471|NCT02754141|448640098|FG014|Overall Study|Not completing monotherapy|0|||
124603899|NCT00974974|448170906|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
124603900|NCT00974974|448170905|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
124603901|NCT00974974|448170906|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
124603902|NCT00974974|448170905|FG000|IPX066 Dose Conversion|Various|3|||
124603903|NCT00974974|448170906|FG001|IPX066 Dose Conversion|Various|0|||
124603904|NCT00974974|448170905|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
124603905|NCT00974974|448170906|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
124603906|NCT00974974|448170905|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
124603907|NCT00974974|448170906|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
124603908|NCT00974974|448170905|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
124603909|NCT00974974|448170906|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
124603910|NCT00974974|448170905|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
124603911|NCT00974974|448170906|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
124603912|NCT00974974|448170905|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
124603913|NCT00974974|448170906|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
124603914|NCT00974974|448170905|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
124603915|NCT00974974|448170906|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
124603916|NCT00974974|448170905|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
124603917|NCT00974974|448170906|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
124603918|NCT00974974|448170905|FG000|Maintenance - Double Blind Treatment|Various|4|||
124603919|NCT00974974|448170906|FG001|Maintenance - Double Blind Treatment|Various|0|||
124603920|NCT01959035|448170907|FG000|Overall Study|Adverse Event|5|||
124603921|NCT01959035|448170907|FG000|Overall Study|Withdrawal by Subject|4|||
124603922|NCT01959035|448170907|FG000|Overall Study|Lost to Follow-up|1|||
124603923|NCT01959035|448170907|FG000|Overall Study|Other (no primary reason given)|1|||
124603924|NCT03254602|448170908|FG000|Overall Study|Lost to Follow-up|4|||
124603925|NCT00688376|448170912|FG000|Double-Blind Phase|Adverse Event|4|||
124603926|NCT00688376|448170913|FG001|Double-Blind Phase|Adverse Event|4|||
124603927|NCT00688376|448170912|FG000|Double-Blind Phase|Protocol Violation|1|||
124603928|NCT00688376|448170913|FG001|Double-Blind Phase|Protocol Violation|2|||
124603929|NCT00688376|448170912|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
124603930|NCT00688376|448170913|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
124603931|NCT00688376|448170912|FG000|Double-Blind Phase|Not treated|0|||
124603932|NCT00688376|448170913|FG001|Double-Blind Phase|Not treated|1|||
124603933|NCT00688376|448170912|FG000|Blinded Extension Phase|Adverse Event|3|||
124603934|NCT00688376|448170913|FG001|Blinded Extension Phase|Adverse Event|4|||
124603935|NCT00688376|448170912|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
124603936|NCT00688376|448170913|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
124603937|NCT00688376|448170912|FG000|Blinded Extension Phase|Physician Decision|1|||
124603938|NCT00688376|448170913|FG001|Blinded Extension Phase|Physician Decision|0|||
124603939|NCT00688376|448170912|FG000|Blinded Extension Phase|Other|1|||
124603940|NCT00688376|448170913|FG001|Blinded Extension Phase|Other|0|||
124603941|NCT04492020|448170919|FG000|Overall Study|Adverse Event|1|||
124603942|NCT04492020|448170920|FG001|Overall Study|Adverse Event|3|||
124603943|NCT04492020|448170919|FG000|Overall Study|Withdrawal by Subject|4|||
124603944|NCT04492020|448170920|FG001|Overall Study|Withdrawal by Subject|3|||
124603945|NCT04492020|448170919|FG000|Overall Study|Lost to Follow-up|4|||
124603946|NCT04492020|448170920|FG001|Overall Study|Lost to Follow-up|3|||
124603947|NCT04492020|448170919|FG000|Overall Study|Protocol Violation|5|||
124603948|NCT04492020|448170920|FG001|Overall Study|Protocol Violation|2|||
124603949|NCT04492020|448170919|FG000|Overall Study|Lack of Qualifying Event|25|||
124603950|NCT04492020|448170920|FG001|Overall Study|Lack of Qualifying Event|27|||
124603951|NCT04492020|448170919|FG000|Overall Study|Non-compliance with Study Drug|2|||
124603952|NCT04492020|448170920|FG001|Overall Study|Non-compliance with Study Drug|1|||
124603953|NCT02792959|448170925|FG000|Overall Study|Protocol Violation|1|||
124603954|NCT03914950|448170929|FG000|Overall Study|Physician Decision|54|||
124603955|NCT00003875|448170938|FG000|Overall Study|Screen Failed|1|||
124603956|NCT01780987|448170939|FG000|Overall Study|Adverse Event|0|||
124603957|NCT01780987|448170940|FG001|Overall Study|Adverse Event|4|||
124603958|NCT01780987|448170939|FG000|Overall Study|Withdrawal by Subject|2|||
124603959|NCT01780987|448170940|FG001|Overall Study|Withdrawal by Subject|0|||
124603960|NCT01780987|448170939|FG000|Overall Study|Request of Changing Hospital|0|||
124603961|NCT01780987|448170940|FG001|Overall Study|Request of Changing Hospital|1|||
124603962|NCT01780987|448170939|FG000|Overall Study|Changing Residence|1|||
124603963|NCT01780987|448170940|FG001|Overall Study|Changing Residence|0|||
124603964|NCT01780987|448170939|FG000|Overall Study|Not Receiving any Study Medication|0|||
124603965|NCT01780987|448170940|FG001|Overall Study|Not Receiving any Study Medication|1|||
124603966|NCT04168190|448170941|FG000|Overall Study|Lost to Follow-up|0|||
124603967|NCT04168190|448170942|FG001|Overall Study|Lost to Follow-up|1|||
124603968|NCT04168190|448170943|FG002|Overall Study|Lost to Follow-up|0|||
124603969|NCT04168190|448170944|FG003|Overall Study|Lost to Follow-up|7|||
124603970|NCT04168190|448170945|FG004|Overall Study|Lost to Follow-up|5|||
124603971|NCT04168190|448170941|FG000|Overall Study|Withdrawal by Subject|1|||
124603972|NCT04168190|448170942|FG001|Overall Study|Withdrawal by Subject|0|||
124780972|NCT02367833|448827123|FG002|Overall Study|Withdrawal by Subject|0|||
124780973|NCT00035932|448827126|FG000|Overall Study|Adverse Event|10|||
124780974|NCT00035932|448827127|FG001|Overall Study|Adverse Event|9|||
124780975|NCT00035932|448827128|FG002|Overall Study|Adverse Event|9|||
124780976|NCT00035932|448827126|FG000|Overall Study|Death|0|||
124780977|NCT00035932|448827127|FG001|Overall Study|Death|0|||
124780978|NCT00035932|448827128|FG002|Overall Study|Death|1|||
124780979|NCT00035932|448827126|FG000|Overall Study|Disease Progression / Relapse|1|||
124780980|NCT00035932|448827127|FG001|Overall Study|Disease Progression / Relapse|1|||
124780981|NCT00035932|448827128|FG002|Overall Study|Disease Progression / Relapse|0|||
124780982|NCT00035932|448827126|FG000|Overall Study|Lost to Follow-up|4|||
124780983|NCT00035932|448827127|FG001|Overall Study|Lost to Follow-up|4|||
124780984|NCT00035932|448827128|FG002|Overall Study|Lost to Follow-up|3|||
124780985|NCT00035932|448827126|FG000|Overall Study|Noncompliance|6|||
124780986|NCT00035932|448827127|FG001|Overall Study|Noncompliance|7|||
124780987|NCT00035932|448827128|FG002|Overall Study|Noncompliance|6|||
124780988|NCT00035932|448827126|FG000|Overall Study|Protocol Violation While on Study|0|||
124780989|NCT00035932|448827127|FG001|Overall Study|Protocol Violation While on Study|1|||
124780990|NCT00035932|448827128|FG002|Overall Study|Protocol Violation While on Study|2|||
124780991|NCT00035932|448827126|FG000|Overall Study|Withdrawal by Subject|1|||
124780992|NCT00035932|448827127|FG001|Overall Study|Withdrawal by Subject|5|||
124780993|NCT00035932|448827128|FG002|Overall Study|Withdrawal by Subject|0|||
124780994|NCT00035932|448827126|FG000|Overall Study|Study Termination by Sponsor|1|||
124780995|NCT00035932|448827127|FG001|Overall Study|Study Termination by Sponsor|0|||
124780996|NCT00035932|448827128|FG002|Overall Study|Study Termination by Sponsor|0|||
124780997|NCT00035932|448827126|FG000|Overall Study|Lack of Efficacy|33|||
124780998|NCT00035932|448827127|FG001|Overall Study|Lack of Efficacy|33|||
124780999|NCT00035932|448827128|FG002|Overall Study|Lack of Efficacy|28|||
124781000|NCT01459497|448827129|FG000|Overall Study|Inability to meet trial constraints.|1|||
124781001|NCT01459497|448827130|FG001|Overall Study|Inability to meet trial constraints.|0|||
124781002|NCT01459497|448827129|FG000|Overall Study|Physician Decision|1|||
124781003|NCT01459497|448827130|FG001|Overall Study|Physician Decision|1|||
124781004|NCT01459497|448827129|FG000|Overall Study|Hospitalization.|0|||
124781005|NCT01459497|448827130|FG001|Overall Study|Hospitalization.|3|||
124781006|NCT01459497|448827129|FG000|Overall Study|Disease progression.|0|||
124781007|NCT01459497|448827130|FG001|Overall Study|Disease progression.|1|||
124781008|NCT01192191|448827131|FG000|Overall Study|Adverse Event|7|||
124781009|NCT01192191|448827132|FG001|Overall Study|Adverse Event|12|||
124781010|NCT01192191|448827131|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
124781011|NCT01192191|448827132|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
124781012|NCT01192191|448827131|FG000|Overall Study|Lost to Follow-up|0|||
124781013|NCT01192191|448827132|FG001|Overall Study|Lost to Follow-up|1|||
124781014|NCT01192191|448827131|FG000|Overall Study|Withdrawal by Subject|1|||
124781015|NCT01192191|448827132|FG001|Overall Study|Withdrawal by Subject|6|||
124781016|NCT03179319|448827133|FG000|Overall Study|Lost to Follow-up|6|||
124781017|NCT03179319|448827134|FG001|Overall Study|Lost to Follow-up|0|||
124781018|NCT04393454|448827137|FG000|Overall Study|Death|1|||
124781019|NCT04393454|448827137|FG000|Overall Study|Lost to Follow-up|1|||
124781020|NCT03860818|448829064|FG000|Overall Study|Death|144|||
124781021|NCT03860818|448829065|FG001|Overall Study|Death|195|||
124781022|NCT03860818|448829064|FG000|Overall Study|Graft Loss|32|||
124781023|NCT03860818|448829065|FG001|Overall Study|Graft Loss|45|||
124781024|NCT03126344|448829066|FG000|Overall Study|Lost to Follow-up|0|||
124603973|NCT04168190|448170943|FG002|Overall Study|Withdrawal by Subject|0|||
124603974|NCT04168190|448170944|FG003|Overall Study|Withdrawal by Subject|2|||
124603975|NCT04168190|448170945|FG004|Overall Study|Withdrawal by Subject|4|||
124603976|NCT04168190|448170941|FG000|Overall Study|Death|0|||
124603977|NCT04168190|448170942|FG001|Overall Study|Death|0|||
124603978|NCT04168190|448170943|FG002|Overall Study|Death|0|||
124603979|NCT04168190|448170944|FG003|Overall Study|Death|1|||
124603980|NCT04168190|448170945|FG004|Overall Study|Death|0|||
124603981|NCT00629265|448170946|FG000|Overall Study|Lost to Follow-up|4|||
124603982|NCT00629265|448170947|FG001|Overall Study|Lost to Follow-up|5|||
124603983|NCT00629265|448170946|FG000|Overall Study|Withdrawal by Subject|11|||
124781025|NCT03126344|448829067|FG001|Overall Study|Lost to Follow-up|0|||
124781026|NCT03126344|448829068|FG002|Overall Study|Lost to Follow-up|5|||
124781027|NCT05367492|448829069|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
124781028|NCT05367492|448829070|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
124603984|NCT00629265|448170947|FG001|Overall Study|Withdrawal by Subject|8|||
124603985|NCT00629265|448170946|FG000|Overall Study|Death|1|||
124781029|NCT05367492|448829071|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
124781030|NCT05367492|448829069|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
124781031|NCT05367492|448829070|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
124781032|NCT05367492|448829071|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
124603986|NCT00629265|448170947|FG001|Overall Study|Death|0|||
124603987|NCT00629265|448170946|FG000|Overall Study|Adverse Event|2|||
124603988|NCT00629265|448170947|FG001|Overall Study|Adverse Event|0|||
124781033|NCT05367492|448829069|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
124781034|NCT05367492|448829070|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
124781035|NCT05367492|448829071|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
124781036|NCT05367492|448829069|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
124781037|NCT05367492|448829070|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
124781038|NCT05367492|448829071|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
124603989|NCT00629265|448170946|FG000|Overall Study|HNC Recurrence|4|||
124603990|NCT00629265|448170947|FG001|Overall Study|HNC Recurrence|0|||
124603991|NCT00629265|448170946|FG000|Overall Study|Other CA Requiring Treatment|1|||
124603992|NCT00629265|448170947|FG001|Overall Study|Other CA Requiring Treatment|3|||
124603993|NCT00629265|448170946|FG000|Overall Study|Needed Esophageal Dilation|4|||
124603994|NCT00629265|448170947|FG001|Overall Study|Needed Esophageal Dilation|1|||
124603995|NCT00629265|448170946|FG000|Overall Study|Unrelated Medical Complications|3|||
124603996|NCT00629265|448170947|FG001|Overall Study|Unrelated Medical Complications|1|||
124603997|NCT00629265|448170946|FG000|Overall Study|Unknown Reason|2|||
124603998|NCT00629265|448170947|FG001|Overall Study|Unknown Reason|2|||
124603999|NCT04465630|448170948|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
124604000|NCT04465630|448170948|FG000|Overall Study|Screen failure|8|||
124604001|NCT04465630|448170948|FG000|Overall Study|Baseline failure|16|||
124604002|NCT01169532|448170952|FG000|Overall Study|Withdrawal by Subject|1|||
124604003|NCT04355663|448170954|FG000|Overall Study|Physician Decision|2|||
124604004|NCT04355663|448170955|FG001|Overall Study|Physician Decision|7|||
124604005|NCT04355663|448170956|FG002|Overall Study|Physician Decision|0|||
124604006|NCT04355663|448170954|FG000|Overall Study|Adverse Event|0|||
124604007|NCT04355663|448170955|FG001|Overall Study|Adverse Event|0|||
124604008|NCT04355663|448170956|FG002|Overall Study|Adverse Event|1|||
124604009|NCT04355663|448170954|FG000|Overall Study|Withdrawal by Subject|0|||
124604010|NCT04355663|448170955|FG001|Overall Study|Withdrawal by Subject|8|||
124604011|NCT04355663|448170956|FG002|Overall Study|Withdrawal by Subject|3|||
124604012|NCT00876018|448170959|FG000|Overall Study|Lost to Follow-up|0|||
124604013|NCT00876018|448170960|FG001|Overall Study|Lost to Follow-up|1|||
124604014|NCT00876018|448170961|FG002|Overall Study|Lost to Follow-up|1|||
124604015|NCT00876018|448170959|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
124604016|NCT00876018|448170960|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
124604017|NCT00876018|448170961|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
124604018|NCT01230892|448170962|FG000|Overall Study|Withdrawal by Subject|1|||
124604019|NCT01230892|448170963|FG001|Overall Study|Withdrawal by Subject|1|||
124604020|NCT01230892|448170962|FG000|Overall Study|Lost to Follow-up|2|||
124604021|NCT01230892|448170963|FG001|Overall Study|Lost to Follow-up|0|||
124604022|NCT00679913|448170964|FG000|Overall Study|Protocol Violation|18|||
124604023|NCT00679913|448170965|FG001|Overall Study|Protocol Violation|13|||
124604024|NCT00725621|448170966|FG000|Overall Study|Adverse Event|25|||
124604025|NCT00725621|448170966|FG000|Overall Study|Lack of Efficacy|46|||
124604026|NCT00725621|448170966|FG000|Overall Study|Withdrawal by Subject|57|||
124604027|NCT00725621|448170966|FG000|Overall Study|Physician Decision|19|||
124604028|NCT00725621|448170966|FG000|Overall Study|Lost to Follow-up|52|||
124604029|NCT00725621|448170966|FG000|Overall Study|Non-compliance|8|||
124604030|NCT00725621|448170966|FG000|Overall Study|Continued treatment by other physician|6|||
124604031|NCT00725621|448170966|FG000|Overall Study|Switched to other study|1|||
124604032|NCT00725621|448170966|FG000|Overall Study|Switched to other drug|1|||
124604033|NCT00725621|448170966|FG000|Overall Study|Prepared for elective surgery|1|||
124604034|NCT00725621|448170966|FG000|Overall Study|Reason not specified|55|||
124604035|NCT01189500|448170967|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
124604036|NCT01189500|448170967|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
124604037|NCT00062751|448170968|FG000|Overall Study|Disease progression|24|||
124604038|NCT00062751|448170969|FG001|Overall Study|Disease progression|17|||
124604039|NCT00062751|448170970|FG002|Overall Study|Disease progression|24|||
124731472|NCT02754141|448640099|FG015|Overall Study|Not completing monotherapy|0|||
124731473|NCT02754141|448640100|FG016|Overall Study|Not completing monotherapy|0|||
124731474|NCT02754141|448640101|FG017|Overall Study|Not completing monotherapy|0|||
124731475|NCT03361189|448640102|FG000|Overall Study|Received heart transplant|1|||
124731476|NCT03361189|448640103|FG001|Overall Study|Received heart transplant|0|||
124731477|NCT03361189|448640102|FG000|Overall Study|Pacemake replacement|0|||
124731478|NCT03361189|448640103|FG001|Overall Study|Pacemake replacement|1|||
124731479|NCT03344549|448640108|FG000|Overall Study|Withdrawal by Subject|3|||
124731480|NCT03344549|448640109|FG001|Overall Study|Withdrawal by Subject|2|||
124781039|NCT01088048|448829072|FG000|Overall Study|Adverse Event|7|||
124781040|NCT01088048|448829073|FG001|Overall Study|Adverse Event|9|||
124604040|NCT00062751|448170971|FG003|Overall Study|Disease progression|2|||
124604041|NCT00062751|448170972|FG004|Overall Study|Disease progression|2|||
124604042|NCT00062751|448170968|FG000|Overall Study|Adverse Event|4|||
124604043|NCT00062751|448170969|FG001|Overall Study|Adverse Event|7|||
124604044|NCT00062751|448170970|FG002|Overall Study|Adverse Event|2|||
124604045|NCT00062751|448170971|FG003|Overall Study|Adverse Event|2|||
124604046|NCT00062751|448170972|FG004|Overall Study|Adverse Event|2|||
124731481|NCT03344549|448640108|FG000|Overall Study|Dialysis|2|||
124604047|NCT00062751|448170968|FG000|Overall Study|Other|2|||
124604048|NCT00062751|448170969|FG001|Overall Study|Other|3|||
124604049|NCT00062751|448170970|FG002|Overall Study|Other|1|||
124604050|NCT00062751|448170971|FG003|Overall Study|Other|0|||
124604051|NCT00062751|448170972|FG004|Overall Study|Other|1|||
124604052|NCT00062751|448170968|FG000|Overall Study|Withdrawal by Subject|1|||
124604053|NCT00062751|448170969|FG001|Overall Study|Withdrawal by Subject|2|||
124604054|NCT00062751|448170970|FG002|Overall Study|Withdrawal by Subject|2|||
124604055|NCT00062751|448170971|FG003|Overall Study|Withdrawal by Subject|1|||
124604056|NCT00062751|448170972|FG004|Overall Study|Withdrawal by Subject|0|||
124604057|NCT00062751|448170968|FG000|Overall Study|Symptomatic deterioration|1|||
124604058|NCT00062751|448170969|FG001|Overall Study|Symptomatic deterioration|1|||
124604059|NCT00062751|448170970|FG002|Overall Study|Symptomatic deterioration|0|||
124604060|NCT00062751|448170971|FG003|Overall Study|Symptomatic deterioration|0|||
124604061|NCT00062751|448170972|FG004|Overall Study|Symptomatic deterioration|1|||
124604062|NCT00062751|448170968|FG000|Overall Study|Death|1|||
124604063|NCT00062751|448170969|FG001|Overall Study|Death|0|||
124604064|NCT00062751|448170970|FG002|Overall Study|Death|1|||
124604065|NCT00062751|448170971|FG003|Overall Study|Death|0|||
124604066|NCT00062751|448170972|FG004|Overall Study|Death|0|||
124604067|NCT00851643|448170977|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
124604068|NCT00851643|448170978|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
124604069|NCT00851643|448170979|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
124604070|NCT00851643|448170980|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
124604071|NCT00851643|448170981|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
124604072|NCT00851643|448170982|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
124604073|NCT00851643|448170977|FG000|Base Study (Up to 12 Months)|Other|0|||
124604074|NCT00851643|448170978|FG001|Base Study (Up to 12 Months)|Other|0|||
124604075|NCT00851643|448170979|FG002|Base Study (Up to 12 Months)|Other|0|||
124604076|NCT00851643|448170980|FG003|Base Study (Up to 12 Months)|Other|0|||
124604077|NCT00851643|448170981|FG004|Base Study (Up to 12 Months)|Other|0|||
124604078|NCT00851643|448170982|FG005|Base Study (Up to 12 Months)|Other|1|||
124604079|NCT00851643|448170977|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
124604080|NCT00851643|448170978|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
124604081|NCT00851643|448170979|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
124604082|NCT00851643|448170980|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
124604083|NCT00851643|448170981|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
124604084|NCT00851643|448170982|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
124604085|NCT00851643|448170977|FG000|Extension Study (Up to 36 Months)|Moved|0|||
124604086|NCT00851643|448170978|FG001|Extension Study (Up to 36 Months)|Moved|2|||
124604087|NCT00851643|448170979|FG002|Extension Study (Up to 36 Months)|Moved|1|||
124604088|NCT00851643|448170980|FG003|Extension Study (Up to 36 Months)|Moved|1|||
124604089|NCT00851643|448170981|FG004|Extension Study (Up to 36 Months)|Moved|0|||
124604090|NCT00851643|448170982|FG005|Extension Study (Up to 36 Months)|Moved|1|||
124604091|NCT01940497|448170985|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
124604092|NCT01940497|448170986|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
124604093|NCT01940497|448170985|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
124604094|NCT01940497|448170986|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
124604095|NCT01940497|448170985|FG000|Overall Study|Violation of Entry Criteria|1|||
124604096|NCT01940497|448170986|FG001|Overall Study|Violation of Entry Criteria|1|||
124604097|NCT01940497|448170985|FG000|Overall Study|Refused Treatment|1|||
124604098|NCT01940497|448170986|FG001|Overall Study|Refused Treatment|3|||
124604099|NCT01940497|448170985|FG000|Overall Study|Withdrew Consent|6|||
124604100|NCT01940497|448170986|FG001|Overall Study|Withdrew Consent|2|||
124604101|NCT01940497|448170985|FG000|Overall Study|Administrative/Other|1|||
124604102|NCT01940497|448170986|FG001|Overall Study|Administrative/Other|1|||
124604103|NCT02707861|448170987|FG000|Overall Study|Went onto commercial drug|30|||
124604104|NCT02707861|448170988|FG001|Overall Study|Went onto commercial drug|23|||
124604105|NCT02707861|448170987|FG000|Overall Study|Adverse Event|2|||
124604106|NCT02707861|448170988|FG001|Overall Study|Adverse Event|3|||
124604107|NCT02707861|448170987|FG000|Overall Study|Death|5|||
124604108|NCT02707861|448170988|FG001|Overall Study|Death|2|||
124604109|NCT02707861|448170987|FG000|Overall Study|Lack of Efficacy|0|||
124604110|NCT02707861|448170988|FG001|Overall Study|Lack of Efficacy|2|||
124604111|NCT02707861|448170987|FG000|Overall Study|Physician Decision|1|||
124604112|NCT02707861|448170988|FG001|Overall Study|Physician Decision|4|||
124604113|NCT02707861|448170987|FG000|Overall Study|Withdrawal by Subject|2|||
124604114|NCT02707861|448170988|FG001|Overall Study|Withdrawal by Subject|1|||
124604115|NCT02707861|448170987|FG000|Overall Study|Lost to Follow-up|1|||
124604116|NCT02707861|448170988|FG001|Overall Study|Lost to Follow-up|3|||
124604117|NCT01641133|448170989|FG000|Overall Study|Protocol Violation|0|||
124604118|NCT01641133|448170990|FG001|Overall Study|Protocol Violation|1|||
124604119|NCT01641133|448170991|FG002|Overall Study|Protocol Violation|1|||
124731482|NCT03344549|448640109|FG001|Overall Study|Dialysis|0|||
124604120|NCT01641133|448170989|FG000|Overall Study|Migrated/moved from study area|5|||
124604121|NCT01641133|448170990|FG001|Overall Study|Migrated/moved from study area|3|||
124604122|NCT01641133|448170991|FG002|Overall Study|Migrated/moved from study area|1|||
124604123|NCT01641133|448170989|FG000|Overall Study|Adverse Event|0|||
124604124|NCT01641133|448170990|FG001|Overall Study|Adverse Event|0|||
124604125|NCT01641133|448170991|FG002|Overall Study|Adverse Event|1|||
124604126|NCT01641133|448170989|FG000|Overall Study|Withdrawal by Subject|5|||
124604127|NCT01641133|448170990|FG001|Overall Study|Withdrawal by Subject|3|||
124604128|NCT01641133|448170991|FG002|Overall Study|Withdrawal by Subject|3|||
124604129|NCT01641133|448170989|FG000|Overall Study|Lost to Follow-up|0|||
124604130|NCT01641133|448170990|FG001|Overall Study|Lost to Follow-up|2|||
124604131|NCT01641133|448170991|FG002|Overall Study|Lost to Follow-up|2|||
124604132|NCT05816200|448170992|FG000|Overall Study|Lost to Follow-up|2|||
124604133|NCT05816200|448170993|FG001|Overall Study|Lost to Follow-up|1|||
124604134|NCT01366443|448170994|FG000|Overall Study|Lost to Follow-up|2|||
124604135|NCT01366443|448170994|FG000|Overall Study|Under 18 yo|1|||
124604136|NCT00369382|448170995|FG000|Overall Study|Death|0|||
124604137|NCT00369382|448170996|FG001|Overall Study|Death|2|||
124604138|NCT00369382|448170995|FG000|Overall Study|Physician Decision|2|||
124604139|NCT00369382|448170996|FG001|Overall Study|Physician Decision|1|||
124604140|NCT00369382|448170995|FG000|Overall Study|Withdrawal by Subject|5|||
124604141|NCT00369382|448170996|FG001|Overall Study|Withdrawal by Subject|0|||
124604142|NCT00369382|448170995|FG000|Overall Study|Randomized, not treated|2|||
124604143|NCT00369382|448170996|FG001|Overall Study|Randomized, not treated|0|||
124604144|NCT00369382|448170995|FG000|Overall Study|Other|1|||
124604145|NCT00369382|448170996|FG001|Overall Study|Other|0|||
124604146|NCT00507546|448170999|FG000|Overall Study|Withdrawal by Subject|1|||
124604147|NCT00507546|448171000|FG001|Overall Study|Withdrawal by Subject|0|||
124604148|NCT00507546|448170999|FG000|Overall Study|Protocol Violation|1|||
124604149|NCT00507546|448171000|FG001|Overall Study|Protocol Violation|0|||
124604150|NCT00507546|448170999|FG000|Overall Study|Physician Decision|0|||
124604151|NCT00507546|448171000|FG001|Overall Study|Physician Decision|1|||
124604152|NCT01673698|448171001|FG000|Overall Study|Lost to Follow-up|51|||
124604153|NCT01673698|448171002|FG001|Overall Study|Lost to Follow-up|13|||
124604154|NCT00448136|448171004|FG000|Overall Study|Death|3|||
124604155|NCT00448136|448171005|FG001|Overall Study|Death|8|||
124604156|NCT00448136|448171004|FG000|Overall Study|Investigator's decision (progression)|1|||
124604157|NCT00448136|448171005|FG001|Overall Study|Investigator's decision (progression)|0|||
124604158|NCT00609466|448171006|FG000|Overall Study|Withdrawal by Subject|0|||
124604159|NCT00609466|448171007|FG001|Overall Study|Withdrawal by Subject|1|||
124604160|NCT00609466|448171008|FG002|Overall Study|Withdrawal by Subject|1|||
124604161|NCT00609466|448171006|FG000|Overall Study|Adverse Event|2|||
124604162|NCT00609466|448171007|FG001|Overall Study|Adverse Event|3|||
124604163|NCT00609466|448171008|FG002|Overall Study|Adverse Event|1|||
124604164|NCT00609466|448171006|FG000|Overall Study|Lack of Efficacy|0|||
124604165|NCT00609466|448171007|FG001|Overall Study|Lack of Efficacy|2|||
124604166|NCT00609466|448171008|FG002|Overall Study|Lack of Efficacy|2|||
124604167|NCT03407430|448171009|FG000|Washout|Protocol Violation|1|||
124604168|NCT03407430|448171010|FG001|Washout|Protocol Violation|0|||
124604169|NCT02518919|448171963|FG000|Overall Study|Protocol Violation|1|||
124604170|NCT02518919|448171964|FG001|Overall Study|Protocol Violation|1|||
124604171|NCT02518919|448171965|FG002|Overall Study|Protocol Violation|2|||
124604172|NCT02227147|448171967|FG000|Controlled Treatment Period|Adverse Event|4|||
124604173|NCT02227147|448171968|FG001|Controlled Treatment Period|Adverse Event|3|||
124604174|NCT02227147|448171967|FG000|Controlled Treatment Period|Other|2|||
124604175|NCT02227147|448171968|FG001|Controlled Treatment Period|Other|0|||
124604176|NCT02227147|448171967|FG000|Follow-up Period|Other|3|||
124604177|NCT02227147|448171968|FG001|Follow-up Period|Other|5|||
124604178|NCT02923674|448171969|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
124604179|NCT02923674|448171970|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
124604180|NCT02923674|448171971|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
124604181|NCT02923674|448171969|FG000|Overall Study|Lost to Follow-up|7|||
124604182|NCT02923674|448171970|FG001|Overall Study|Lost to Follow-up|12|||
124604183|NCT02923674|448171971|FG002|Overall Study|Lost to Follow-up|7|||
124604184|NCT02923674|448171969|FG000|Overall Study|Problem with intervention|2|||
124604185|NCT02923674|448171970|FG001|Overall Study|Problem with intervention|2|||
124604186|NCT02923674|448171971|FG002|Overall Study|Problem with intervention|1|||
124731483|NCT03344549|448640108|FG000|Overall Study|Cancer|1|||
124731484|NCT03344549|448640109|FG001|Overall Study|Cancer|0|||
124731485|NCT03344549|448640108|FG000|Overall Study|Lack of electronic device|1|||
124731486|NCT03344549|448640109|FG001|Overall Study|Lack of electronic device|0|||
124604187|NCT02923674|448171969|FG000|Overall Study|Adverse Event|3|||
124604188|NCT02923674|448171970|FG001|Overall Study|Adverse Event|1|||
124604189|NCT02923674|448171971|FG002|Overall Study|Adverse Event|1|||
124604190|NCT02923674|448171969|FG000|Overall Study|Withdrawal by Subject|2|||
124731487|NCT03344549|448640108|FG000|Overall Study|Transportation difficulty|0|||
124604191|NCT02923674|448171970|FG001|Overall Study|Withdrawal by Subject|2|||
124604192|NCT02923674|448171971|FG002|Overall Study|Withdrawal by Subject|2|||
124604193|NCT03709823|448171972|FG000|Overall Study|Adverse Event|0|||
124604194|NCT03709823|448171973|FG001|Overall Study|Adverse Event|0|||
124604195|NCT03709823|448171974|FG002|Overall Study|Adverse Event|1|||
124731488|NCT03344549|448640109|FG001|Overall Study|Transportation difficulty|13|||
124731489|NCT02323126|448640110|FG000|Overall Study|Patient / guardian decision|0|||
124731490|NCT02323126|448640111|FG001|Overall Study|Patient / guardian decision|1|||
124731491|NCT02323126|448640112|FG002|Overall Study|Patient / guardian decision|2|||
124731492|NCT02323126|448640110|FG000|Overall Study|Progressive disease|14|||
124731493|NCT02323126|448640111|FG001|Overall Study|Progressive disease|8|||
124731494|NCT02323126|448640112|FG002|Overall Study|Progressive disease|14|||
124731495|NCT02323126|448640110|FG000|Overall Study|Physician Decision|0|||
124731496|NCT02323126|448640111|FG001|Overall Study|Physician Decision|1|||
124731497|NCT02323126|448640112|FG002|Overall Study|Physician Decision|3|||
124731498|NCT02323126|448640110|FG000|Overall Study|Death|1|||
124731499|NCT02323126|448640111|FG001|Overall Study|Death|1|||
124731500|NCT02323126|448640112|FG002|Overall Study|Death|4|||
124731501|NCT02323126|448640110|FG000|Overall Study|Adverse Event|3|||
124731502|NCT02323126|448640111|FG001|Overall Study|Adverse Event|5|||
124731503|NCT02323126|448640112|FG002|Overall Study|Adverse Event|7|||
124731504|NCT03333252|448640113|FG000|Overall Study|Adverse Event|10|||
124781041|NCT01088048|448829074|FG002|Overall Study|Adverse Event|7|||
124781042|NCT01088048|448829075|FG003|Overall Study|Adverse Event|5|||
124604196|NCT03709823|448171975|FG003|Overall Study|Adverse Event|0|||
124604197|NCT03709823|448171976|FG004|Overall Study|Adverse Event|0|||
124604198|NCT03709823|448171977|FG005|Overall Study|Adverse Event|0|||
124604199|NCT03709823|448171972|FG000|Overall Study|Lost to Follow-up|2|||
124781043|NCT01088048|448829076|FG004|Overall Study|Adverse Event|6|||
124781044|NCT01088048|448829077|FG005|Overall Study|Adverse Event|3|||
124781045|NCT01088048|448829078|FG006|Overall Study|Adverse Event|3|||
124781046|NCT01088048|448829079|FG007|Overall Study|Adverse Event|0|||
124781047|NCT01088048|448829080|FG008|Overall Study|Adverse Event|2|||
124781048|NCT01088048|448829081|FG009|Overall Study|Adverse Event|2|||
124781049|NCT01088048|448829072|FG000|Overall Study|Withdrew Consent|1|||
124781050|NCT01088048|448829073|FG001|Overall Study|Withdrew Consent|1|||
124781051|NCT01088048|448829074|FG002|Overall Study|Withdrew Consent|1|||
124781052|NCT01088048|448829075|FG003|Overall Study|Withdrew Consent|1|||
124781053|NCT01088048|448829076|FG004|Overall Study|Withdrew Consent|2|||
124781054|NCT01088048|448829077|FG005|Overall Study|Withdrew Consent|1|||
124781055|NCT01088048|448829078|FG006|Overall Study|Withdrew Consent|0|||
124781056|NCT01088048|448829079|FG007|Overall Study|Withdrew Consent|2|||
124781057|NCT01088048|448829080|FG008|Overall Study|Withdrew Consent|2|||
124604200|NCT03709823|448171973|FG001|Overall Study|Lost to Follow-up|2|||
124604201|NCT03709823|448171974|FG002|Overall Study|Lost to Follow-up|2|||
124604202|NCT03709823|448171975|FG003|Overall Study|Lost to Follow-up|1|||
124604203|NCT03709823|448171976|FG004|Overall Study|Lost to Follow-up|1|||
124604204|NCT03709823|448171977|FG005|Overall Study|Lost to Follow-up|0|||
124604205|NCT03709823|448171972|FG000|Overall Study|Withdrawal by Subject|1|||
124604206|NCT03709823|448171973|FG001|Overall Study|Withdrawal by Subject|3|||
124604207|NCT03709823|448171974|FG002|Overall Study|Withdrawal by Subject|0|||
124604208|NCT03709823|448171975|FG003|Overall Study|Withdrawal by Subject|0|||
124604209|NCT03709823|448171976|FG004|Overall Study|Withdrawal by Subject|0|||
124604210|NCT03709823|448171977|FG005|Overall Study|Withdrawal by Subject|0|||
124604211|NCT03709823|448171972|FG000|Overall Study|Other, Not Specified|0|||
124604212|NCT03709823|448171973|FG001|Overall Study|Other, Not Specified|0|||
124604213|NCT03709823|448171974|FG002|Overall Study|Other, Not Specified|0|||
124604214|NCT03709823|448171975|FG003|Overall Study|Other, Not Specified|1|||
124604215|NCT03709823|448171976|FG004|Overall Study|Other, Not Specified|0|||
124604216|NCT03709823|448171977|FG005|Overall Study|Other, Not Specified|0|||
124604217|NCT01055132|448171978|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
124604218|NCT01055132|448171979|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
124604219|NCT01055132|448171978|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
124604220|NCT01055132|448171979|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
124604221|NCT00158600|448171980|FG000|Overall Study|unable to commit time to study|0|||
124604222|NCT00158600|448171981|FG001|Overall Study|unable to commit time to study|1|||
124604223|NCT00158600|448171980|FG000|Overall Study|Adverse Event|2|||
124604224|NCT00158600|448171981|FG001|Overall Study|Adverse Event|1|||
124604225|NCT00158600|448171980|FG000|Overall Study|Death|1|||
124604226|NCT00158600|448171981|FG001|Overall Study|Death|0|||
124604227|NCT00158600|448171980|FG000|Overall Study|Withdrawal by Subject|2|||
124604228|NCT00158600|448171981|FG001|Overall Study|Withdrawal by Subject|2|||
124604229|NCT02618408|448171983|FG000|Overall Study|Withdrawal by Subject|1|||
124604230|NCT02618408|448171984|FG001|Overall Study|Withdrawal by Subject|0|||
124731505|NCT03333252|448640114|FG001|Overall Study|Adverse Event|6|||
124731506|NCT03333252|448640115|FG002|Overall Study|Adverse Event|5|||
124731507|NCT03333252|448640116|FG003|Overall Study|Adverse Event|2|||
124781058|NCT01088048|448829081|FG009|Overall Study|Withdrew Consent|1|||
124604231|NCT02618408|448171985|FG002|Overall Study|Withdrawal by Subject|4|||
124781059|NCT01088048|448829072|FG000|Overall Study|Concomitant Medication Prohibited|1|||
124604232|NCT02618408|448171983|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
124731508|NCT03333252|448640113|FG000|Overall Study|Death|1|||
124781060|NCT01088048|448829073|FG001|Overall Study|Concomitant Medication Prohibited|0|||
124604233|NCT02618408|448171984|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
124604234|NCT02618408|448171985|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
124604235|NCT02618408|448171983|FG000|Overall Study|Lost to Follow-up|4|||
124604236|NCT02618408|448171984|FG001|Overall Study|Lost to Follow-up|2|||
124604237|NCT02618408|448171985|FG002|Overall Study|Lost to Follow-up|6|||
124604238|NCT02618408|448171983|FG000|Overall Study|Adverse Event|4|||
124604239|NCT02618408|448171984|FG001|Overall Study|Adverse Event|0|||
124604240|NCT02618408|448171985|FG002|Overall Study|Adverse Event|10|||
124604241|NCT02618408|448171983|FG000|Overall Study|Physician Decision|1|||
124604242|NCT02618408|448171984|FG001|Overall Study|Physician Decision|1|||
124604243|NCT02618408|448171985|FG002|Overall Study|Physician Decision|2|||
124604244|NCT02618408|448171983|FG000|Overall Study|Protocol Violation|1|||
124604245|NCT02618408|448171984|FG001|Overall Study|Protocol Violation|1|||
124604246|NCT02618408|448171985|FG002|Overall Study|Protocol Violation|2|||
124604247|NCT02618408|448171983|FG000|Overall Study|Other, Multiple Categories|0|||
124604248|NCT02618408|448171984|FG001|Overall Study|Other, Multiple Categories|0|||
124604249|NCT02618408|448171985|FG002|Overall Study|Other, Multiple Categories|4|||
124604250|NCT02575911|448171989|FG000|Overall Study|Lost to Follow-up|1|||
124604251|NCT01249365|448171990|FG000|Overall Study|Lost to Follow-up|1|||
124604252|NCT01070771|448171991|FG000|Overall Study|Adverse Event|2|||
124604253|NCT01070771|448171991|FG000|Overall Study|Protocol Violation|1|||
124604254|NCT01460901|448171992|FG000|Overall Study|Withdrawal by Subject|2|||
124604255|NCT02566993|448171993|FG000|Overall Study|Randomized but not treated|5|||
124604256|NCT02566993|448171994|FG001|Overall Study|Randomized but not treated|16|||
124604257|NCT02566993|448171993|FG000|Overall Study|Progressive disease|213|||
124604258|NCT02566993|448171994|FG001|Overall Study|Progressive disease|152|||
124604259|NCT02566993|448171993|FG000|Overall Study|Withdrawal by Subject|12|||
124604260|NCT02566993|448171994|FG001|Overall Study|Withdrawal by Subject|28|||
124604261|NCT02566993|448171993|FG000|Overall Study|Death|17|||
124604262|NCT02566993|448171994|FG001|Overall Study|Death|23|||
124604263|NCT02566993|448171993|FG000|Overall Study|Physician Decision|10|||
124604264|NCT02566993|448171994|FG001|Overall Study|Physician Decision|17|||
124604265|NCT02566993|448171993|FG000|Overall Study|Study drug-related adverse event|20|||
124604266|NCT02566993|448171994|FG001|Overall Study|Study drug-related adverse event|41|||
124604267|NCT02566993|448171993|FG000|Overall Study|Non study drug-related adverse event|9|||
124604268|NCT02566993|448171994|FG001|Overall Study|Non study drug-related adverse event|9|||
124604269|NCT02566993|448171993|FG000|Overall Study|Symptomatic deterioration|9|||
124604270|NCT02566993|448171994|FG001|Overall Study|Symptomatic deterioration|16|||
124604271|NCT02566993|448171993|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
124604272|NCT02566993|448171994|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
124604273|NCT02566993|448171993|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
124604274|NCT02566993|448171994|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
124604275|NCT02566993|448171993|FG000|Overall Study|Screening failure|2|||
124604276|NCT02566993|448171994|FG001|Overall Study|Screening failure|0|||
124604277|NCT02566993|448171993|FG000|Overall Study|Lost to Follow-up|0|||
124604278|NCT02566993|448171994|FG001|Overall Study|Lost to Follow-up|1|||
124604279|NCT02566993|448171993|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
124604280|NCT02566993|448171994|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
124604281|NCT03127644|448172004|FG000|Overall Study|Study-specific withdrawal criteria|0|||
124604282|NCT03127644|448172005|FG001|Overall Study|Study-specific withdrawal criteria|0|||
124604283|NCT03127644|448172006|FG002|Overall Study|Study-specific withdrawal criteria|2|||
124604284|NCT02032706|448172007|FG000|Overall Study|Did not qualify|5|||
124604285|NCT02032706|448172007|FG000|Overall Study|Protocol Violation|1|||
124604286|NCT00893737|448172010|FG000|Overall Study|Adverse Event|4|||
124604287|NCT00893737|448172010|FG000|Overall Study|Withdrawal by Subject|2|||
124604288|NCT00893737|448172010|FG000|Overall Study|Lost to Follow-up|6|||
124604289|NCT01156142|448172011|FG000|Overall Study|Withdrawal by Subject|8|||
124604290|NCT01156142|448172012|FG001|Overall Study|Withdrawal by Subject|6|||
124604291|NCT01156142|448172011|FG000|Overall Study|Ineligible|0|||
124604292|NCT01156142|448172012|FG001|Overall Study|Ineligible|1|||
124604293|NCT02140411|448172013|FG000|Overall Study|Adverse Event|1|||
124604294|NCT03981419|448172016|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
124604295|NCT03981419|448172017|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
124604296|NCT01330459|448172018|FG000|Overall Study|Physician Decision|0|||
124604297|NCT01330459|448172019|FG001|Overall Study|Physician Decision|2|||
124604298|NCT00895947|448172025|FG000|Overall Study|Adverse Event|3|||
124604299|NCT00895947|448172026|FG001|Overall Study|Adverse Event|4|||
124604300|NCT00895947|448172025|FG000|Overall Study|Lost to Follow-up|3|||
124604301|NCT00895947|448172026|FG001|Overall Study|Lost to Follow-up|4|||
124604302|NCT00895947|448172025|FG000|Overall Study|Protocol Violation|4|||
124604303|NCT00895947|448172026|FG001|Overall Study|Protocol Violation|2|||
124604304|NCT00895947|448172025|FG000|Overall Study|Withdrawal by Subject|2|||
124604305|NCT00895947|448172026|FG001|Overall Study|Withdrawal by Subject|0|||
124604306|NCT02005887|448172027|FG000|Overall Study|Protocol Violation|0|||
124604307|NCT02005887|448172028|FG001|Overall Study|Protocol Violation|2|||
124604308|NCT01550744|448172029|FG000|Open-Label|Lost to Follow-up|7|||
124604309|NCT01550744|448172030|FG001|Open-Label|Lost to Follow-up|0|||
124604310|NCT01550744|448172031|FG002|Open-Label|Lost to Follow-up|0|||
124604311|NCT01550744|448172029|FG000|Open-Label|Withdrawal by Subject|13|||
124604312|NCT01550744|448172030|FG001|Open-Label|Withdrawal by Subject|0|||
124604313|NCT01550744|448172031|FG002|Open-Label|Withdrawal by Subject|0|||
124604314|NCT01550744|448172029|FG000|Open-Label|Adverse Event|11|||
124604315|NCT01550744|448172030|FG001|Open-Label|Adverse Event|0|||
124604316|NCT01550744|448172031|FG002|Open-Label|Adverse Event|0|||
124604317|NCT01550744|448172029|FG000|Open-Label|Lack of Efficacy|4|||
124604318|NCT01550744|448172030|FG001|Open-Label|Lack of Efficacy|0|||
124604319|NCT01550744|448172031|FG002|Open-Label|Lack of Efficacy|0|||
124731509|NCT03333252|448640114|FG001|Overall Study|Death|3|||
124731510|NCT03333252|448640115|FG002|Overall Study|Death|0|||
124731511|NCT03333252|448640116|FG003|Overall Study|Death|0|||
124731512|NCT03333252|448640113|FG000|Overall Study|Lack of Efficacy|8|||
124731513|NCT03333252|448640114|FG001|Overall Study|Lack of Efficacy|4|||
124731514|NCT03333252|448640115|FG002|Overall Study|Lack of Efficacy|0|||
124731515|NCT03333252|448640116|FG003|Overall Study|Lack of Efficacy|7|||
124731516|NCT03333252|448640113|FG000|Overall Study|Lost to Follow-up|0|||
124731517|NCT03333252|448640114|FG001|Overall Study|Lost to Follow-up|5|||
124731518|NCT03333252|448640115|FG002|Overall Study|Lost to Follow-up|9|||
124731519|NCT03333252|448640116|FG003|Overall Study|Lost to Follow-up|3|||
124604320|NCT01550744|448172029|FG000|Open-Label|Protocol Violation|4|||
124604321|NCT01550744|448172030|FG001|Open-Label|Protocol Violation|0|||
124604322|NCT01550744|448172031|FG002|Open-Label|Protocol Violation|0|||
124604323|NCT01550744|448172029|FG000|Open-Label|Not all 3 study drug injections received|2|||
124604324|NCT01550744|448172030|FG001|Open-Label|Not all 3 study drug injections received|0|||
124604325|NCT01550744|448172031|FG002|Open-Label|Not all 3 study drug injections received|0|||
124604326|NCT01550744|448172029|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
124604327|NCT01550744|448172030|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
124604328|NCT01550744|448172031|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
124604329|NCT01550744|448172029|FG000|Open-Label|Other|1|||
124604330|NCT01550744|448172030|FG001|Open-Label|Other|0|||
124604331|NCT01550744|448172031|FG002|Open-Label|Other|0|||
124604332|NCT01550744|448172029|FG000|Double-Blind|Lost to Follow-up|0|||
124604333|NCT01550744|448172030|FG001|Double-Blind|Lost to Follow-up|6|||
124604334|NCT01550744|448172031|FG002|Double-Blind|Lost to Follow-up|12|||
124604335|NCT01550744|448172029|FG000|Double-Blind|Withdrawal by Subject|0|||
124604336|NCT01550744|448172030|FG001|Double-Blind|Withdrawal by Subject|2|||
124604337|NCT01550744|448172031|FG002|Double-Blind|Withdrawal by Subject|15|||
124604338|NCT01550744|448172029|FG000|Double-Blind|Adverse Event|0|||
124604339|NCT01550744|448172030|FG001|Double-Blind|Adverse Event|4|||
124604340|NCT01550744|448172031|FG002|Double-Blind|Adverse Event|15|||
124604341|NCT01550744|448172029|FG000|Double-Blind|Death|0|||
124604342|NCT01550744|448172030|FG001|Double-Blind|Death|1|||
124604343|NCT01550744|448172031|FG002|Double-Blind|Death|0|||
124604344|NCT01550744|448172029|FG000|Double-Blind|Lack of Efficacy|0|||
124604345|NCT01550744|448172030|FG001|Double-Blind|Lack of Efficacy|2|||
124604346|NCT01550744|448172031|FG002|Double-Blind|Lack of Efficacy|8|||
124604347|NCT01550744|448172029|FG000|Double-Blind|Protocol Violation|0|||
124604348|NCT01550744|448172030|FG001|Double-Blind|Protocol Violation|0|||
124604349|NCT01550744|448172031|FG002|Double-Blind|Protocol Violation|4|||
124604350|NCT01550744|448172029|FG000|Double-Blind|Pregnancy|0|||
124604351|NCT01550744|448172030|FG001|Double-Blind|Pregnancy|0|||
124604352|NCT01550744|448172031|FG002|Double-Blind|Pregnancy|3|||
124604353|NCT01550744|448172029|FG000|Double-Blind|Other|0|||
124604354|NCT01550744|448172030|FG001|Double-Blind|Other|2|||
124604355|NCT01550744|448172031|FG002|Double-Blind|Other|10|||
124604356|NCT01660334|448172032|FG000|Overall Study|Lost to Follow-up|1|||
124604357|NCT00311311|448172034|FG000|Overall Study|Adverse Event|3|||
124604358|NCT00311311|448172035|FG001|Overall Study|Adverse Event|2|||
124731520|NCT03333252|448640113|FG000|Overall Study|Withdrawal by Subject|14|||
124604359|NCT00311311|448172034|FG000|Overall Study|Withdrawal by Subject|1|||
124604360|NCT00311311|448172035|FG001|Overall Study|Withdrawal by Subject|1|||
124604361|NCT00311311|448172034|FG000|Overall Study|Noncompliance|0|||
124604362|NCT00311311|448172035|FG001|Overall Study|Noncompliance|1|||
124604363|NCT00311311|448172034|FG000|Overall Study|Study Termination by Sponsor|3|||
124604364|NCT00311311|448172035|FG001|Overall Study|Study Termination by Sponsor|4|||
124604365|NCT00311311|448172034|FG000|Overall Study|Death|1|||
124604366|NCT00311311|448172035|FG001|Overall Study|Death|0|||
124604367|NCT00311311|448172034|FG000|Overall Study|Lack of ancillary assistance|0|||
124604368|NCT00311311|448172035|FG001|Overall Study|Lack of ancillary assistance|1|||
124604369|NCT01229735|448172036|FG000|Overall Study|Lack of Efficacy|8|||
124604370|NCT01229735|448172037|FG001|Overall Study|Lack of Efficacy|8|||
124604371|NCT01229735|448172036|FG000|Overall Study|Protocol Violation|13|||
124604372|NCT01229735|448172037|FG001|Overall Study|Protocol Violation|8|||
124604373|NCT01229735|448172036|FG000|Overall Study|Lost to Follow-up|0|||
124731521|NCT03333252|448640114|FG001|Overall Study|Withdrawal by Subject|24|||
124731522|NCT03333252|448640115|FG002|Overall Study|Withdrawal by Subject|11|||
124731523|NCT03333252|448640116|FG003|Overall Study|Withdrawal by Subject|17|||
124731524|NCT00666588|448640120|FG000|Overall Study|ineligible|2|||
124731525|NCT00666588|448640121|FG001|Overall Study|ineligible|0|||
124731526|NCT00666588|448640122|FG002|Overall Study|ineligible|0|||
124731527|NCT00666588|448640123|FG003|Overall Study|ineligible|2|||
124731528|NCT00666588|448640120|FG000|Overall Study|inevaluable|2|||
124731529|NCT00666588|448640121|FG001|Overall Study|inevaluable|0|||
124731530|NCT00666588|448640122|FG002|Overall Study|inevaluable|0|||
124731531|NCT00666588|448640123|FG003|Overall Study|inevaluable|0|||
124731532|NCT02075047|448640124|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
124731533|NCT02075047|448640125|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
124731534|NCT02075047|448640124|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
124731535|NCT02075047|448640125|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
124731536|NCT02075047|448640124|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
124781061|NCT01088048|448829074|FG002|Overall Study|Concomitant Medication Prohibited|0|||
124781062|NCT01088048|448829075|FG003|Overall Study|Concomitant Medication Prohibited|0|||
124781063|NCT01088048|448829076|FG004|Overall Study|Concomitant Medication Prohibited|0|||
124604374|NCT01229735|448172037|FG001|Overall Study|Lost to Follow-up|2|||
124604375|NCT01229735|448172036|FG000|Overall Study|Withdrawal by Subject|18|||
124604376|NCT01229735|448172037|FG001|Overall Study|Withdrawal by Subject|17|||
124604377|NCT01229735|448172036|FG000|Overall Study|Other Reason|13|||
124604378|NCT01229735|448172037|FG001|Overall Study|Other Reason|10|||
124604379|NCT01229735|448172036|FG000|Overall Study|SAE, non-fatal|0|||
124604380|NCT01229735|448172037|FG001|Overall Study|SAE, non-fatal|4|||
124604381|NCT01229735|448172036|FG000|Overall Study|AE, non-serious non-fatal|13|||
124604382|NCT01229735|448172037|FG001|Overall Study|AE, non-serious non-fatal|17|||
124604383|NCT01229735|448172036|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
124604384|NCT01229735|448172037|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
124604385|NCT02787408|448172044|FG000|Overall Study|Death|16|||
124604386|NCT02787408|448172044|FG000|Overall Study|Withdrawal by Subject|1|||
124604387|NCT02787408|448172044|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
124604388|NCT00985712|448172047|FG000|Overall Study|Adverse Event|0|||
124604389|NCT00985712|448172048|FG001|Overall Study|Adverse Event|1|||
124604390|NCT00985712|448172047|FG000|Overall Study|Lost to Follow-up|2|||
124604391|NCT00985712|448172048|FG001|Overall Study|Lost to Follow-up|2|||
124604392|NCT00985712|448172047|FG000|Overall Study|Protocol Violation|0|||
124604393|NCT00985712|448172048|FG001|Overall Study|Protocol Violation|1|||
124604394|NCT00985712|448172047|FG000|Overall Study|Withdrawal by Subject|4|||
124604395|NCT00985712|448172048|FG001|Overall Study|Withdrawal by Subject|1|||
124604396|NCT00985712|448172047|FG000|Overall Study|Sponsor decision|0|||
124604397|NCT00985712|448172048|FG001|Overall Study|Sponsor decision|2|||
124604398|NCT01144364|448172051|FG000|Induction Phase|Disease progression|14|||
124604399|NCT01144364|448172052|FG001|Induction Phase|Disease progression|0|||
124604400|NCT01144364|448172053|FG002|Induction Phase|Disease progression|0|||
124604401|NCT01144364|448172051|FG000|Induction Phase|Adverse Event|9|||
124604402|NCT01144364|448172052|FG001|Induction Phase|Adverse Event|0|||
124604403|NCT01144364|448172053|FG002|Induction Phase|Adverse Event|0|||
124604404|NCT01144364|448172051|FG000|Induction Phase|Death|1|||
124604405|NCT01144364|448172052|FG001|Induction Phase|Death|0|||
124604406|NCT01144364|448172053|FG002|Induction Phase|Death|0|||
124604407|NCT01144364|448172051|FG000|Induction Phase|Withdrawal by Subject|1|||
124604408|NCT01144364|448172052|FG001|Induction Phase|Withdrawal by Subject|0|||
124604409|NCT01144364|448172053|FG002|Induction Phase|Withdrawal by Subject|0|||
124604410|NCT01144364|448172051|FG000|Induction Phase|Lost to Follow-up|2|||
124604411|NCT01144364|448172052|FG001|Induction Phase|Lost to Follow-up|0|||
124604412|NCT01144364|448172053|FG002|Induction Phase|Lost to Follow-up|0|||
124604413|NCT01144364|448172051|FG000|Induction Phase|Physician Decision|1|||
124604414|NCT01144364|448172052|FG001|Induction Phase|Physician Decision|0|||
124604415|NCT01144364|448172053|FG002|Induction Phase|Physician Decision|0|||
124604416|NCT01144364|448172051|FG000|Induction Phase|Stable disease|2|||
124604417|NCT01144364|448172052|FG001|Induction Phase|Stable disease|0|||
124604418|NCT01144364|448172053|FG002|Induction Phase|Stable disease|0|||
124604419|NCT01144364|448172051|FG000|Induction Phase|Secondary neoplasia|1|||
124731537|NCT02075047|448640125|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
124731538|NCT02075047|448640124|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
124604420|NCT01144364|448172052|FG001|Induction Phase|Secondary neoplasia|0|||
124604421|NCT01144364|448172053|FG002|Induction Phase|Secondary neoplasia|0|||
124604422|NCT01144364|448172051|FG000|Induction Phase|Protocol Violation|1|||
124604423|NCT01144364|448172052|FG001|Induction Phase|Protocol Violation|0|||
124604424|NCT01144364|448172053|FG002|Induction Phase|Protocol Violation|0|||
124604425|NCT01144364|448172051|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
124604426|NCT01144364|448172052|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
124604427|NCT01144364|448172053|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
124604428|NCT01144364|448172051|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
124604429|NCT01144364|448172052|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
124731539|NCT02075047|448640125|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
124604430|NCT01144364|448172053|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
124604431|NCT01144364|448172051|FG000|Follow-Up/Maintenance Phase|Death|0|||
124604432|NCT01144364|448172052|FG001|Follow-Up/Maintenance Phase|Death|2|||
124604433|NCT01144364|448172053|FG002|Follow-Up/Maintenance Phase|Death|0|||
124604434|NCT01144364|448172051|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
124604435|NCT01144364|448172052|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
124604436|NCT01144364|448172053|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
124604437|NCT01144364|448172051|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
124604438|NCT01144364|448172052|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
124604439|NCT01144364|448172053|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
124604440|NCT01144364|448172051|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
124604441|NCT01144364|448172052|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
124604442|NCT01144364|448172053|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
124604443|NCT01144364|448172051|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
124604444|NCT01144364|448172052|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
124604445|NCT01144364|448172053|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
124604446|NCT01301508|448172054|FG000|Overall Study|Withdrawal by Subject|1|||
124604447|NCT01301508|448172055|FG001|Overall Study|Withdrawal by Subject|2|||
124604448|NCT01301508|448172054|FG000|Overall Study|Lost to Follow-up|0|||
124604449|NCT01301508|448172055|FG001|Overall Study|Lost to Follow-up|1|||
124604450|NCT03123861|448172056|FG000|Overall Study|Protocol Violation|1|||
124604451|NCT03123861|448172057|FG001|Overall Study|Protocol Violation|1|||
124604452|NCT03123861|448172056|FG000|Overall Study|Withdrawal by Subject|2|||
124604453|NCT03123861|448172057|FG001|Overall Study|Withdrawal by Subject|2|||
124604454|NCT02206620|448172058|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
124604455|NCT02206620|448172059|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
124604456|NCT02206620|448172058|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
124604457|NCT02206620|448172059|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
124604458|NCT01346774|448172060|FG000|Overall Study|Did not take a single dose|6|||
124604459|NCT01346774|448172061|FG001|Overall Study|Did not take a single dose|4|||
124604460|NCT01346774|448172060|FG000|Overall Study|Lost to Follow-up|3|||
124604461|NCT01346774|448172061|FG001|Overall Study|Lost to Follow-up|4|||
124604462|NCT01346774|448172060|FG000|Overall Study|Withdrawal by Subject|1|||
124604463|NCT01346774|448172061|FG001|Overall Study|Withdrawal by Subject|4|||
124604464|NCT01346774|448172060|FG000|Overall Study|Protocol Violation|2|||
124604465|NCT01346774|448172061|FG001|Overall Study|Protocol Violation|3|||
124604466|NCT01346774|448172060|FG000|Overall Study|Adverse Event|1|||
124604467|NCT01346774|448172061|FG001|Overall Study|Adverse Event|2|||
124604468|NCT00502801|448172062|FG000|Treatment Period|Withdrawal by Subject|3|||
124604469|NCT00502801|448172062|FG000|Treatment Period|Adverse Event|7|||
124604470|NCT00502801|448172062|FG000|Treatment Period|Death|14|||
124604471|NCT00502801|448172062|FG000|Treatment Period|OTHER|30|||
124604472|NCT00502801|448172062|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
124604473|NCT00502801|448172062|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
124604474|NCT00502801|448172062|FG000|End of Therapy to Test of Cure|Death|3|||
124604475|NCT00502801|448172062|FG000|End of Therapy to Test of Cure|OTHER|2|||
124604476|NCT03212521|448172066|FG000|Overall Study|Adverse Event|1|||
124604477|NCT03212521|448172066|FG000|Overall Study|Lost to Follow-up|4|||
124604478|NCT03212521|448172066|FG000|Overall Study|Withdrawal by Subject|1|||
124604479|NCT03212521|448172066|FG000|Overall Study|Other|1|||
124604480|NCT00444457|448172069|FG000|Infant Series|Other|0|||
124604481|NCT00444457|448172070|FG001|Infant Series|Other|1|||
124604482|NCT00444457|448172071|FG002|Infant Series|Other|0|||
124604483|NCT00444457|448172072|FG003|Infant Series|Other|0|||
124604484|NCT00444457|448172069|FG000|Infant Series|Parent or legal guardian request|18|||
124604485|NCT00444457|448172070|FG001|Infant Series|Parent or legal guardian request|29|||
124604486|NCT00444457|448172071|FG002|Infant Series|Parent or legal guardian request|34|||
124604487|NCT00444457|448172072|FG003|Infant Series|Parent or legal guardian request|14|||
124604488|NCT00444457|448172069|FG000|Infant Series|Lost to Follow-up|10|||
124604489|NCT00444457|448172070|FG001|Infant Series|Lost to Follow-up|11|||
124604490|NCT00444457|448172071|FG002|Infant Series|Lost to Follow-up|7|||
124604491|NCT00444457|448172072|FG003|Infant Series|Lost to Follow-up|6|||
124604492|NCT00444457|448172069|FG000|Infant Series|Protocol Violation|16|||
124604493|NCT00444457|448172070|FG001|Infant Series|Protocol Violation|8|||
124604494|NCT00444457|448172071|FG002|Infant Series|Protocol Violation|6|||
124731540|NCT02075047|448640124|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
124604495|NCT00444457|448172072|FG003|Infant Series|Protocol Violation|3|||
124731541|NCT02075047|448640125|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
124604496|NCT00444457|448172069|FG000|Infant Series|Failed to return|5|||
124604497|NCT00444457|448172070|FG001|Infant Series|Failed to return|4|||
124731542|NCT02075047|448640124|FG000|Treatment Phase (4 Weeks)|Other|1|||
124604498|NCT00444457|448172071|FG002|Infant Series|Failed to return|4|||
124604499|NCT00444457|448172072|FG003|Infant Series|Failed to return|2|||
124604500|NCT00444457|448172069|FG000|Infant Series|Investigator request|4|||
124604501|NCT00444457|448172070|FG001|Infant Series|Investigator request|3|||
124604502|NCT00444457|448172071|FG002|Infant Series|Investigator request|3|||
124604503|NCT00444457|448172072|FG003|Infant Series|Investigator request|2|||
124604504|NCT00444457|448172069|FG000|Infant Series|Other|0|||
124604505|NCT00444457|448172070|FG001|Infant Series|Other|2|||
124604506|NCT00444457|448172071|FG002|Infant Series|Other|4|||
124604507|NCT00444457|448172072|FG003|Infant Series|Other|0|||
124604508|NCT00444457|448172069|FG000|Infant Series|Adverse Event|1|||
124604509|NCT00444457|448172070|FG001|Infant Series|Adverse Event|2|||
124604510|NCT00444457|448172071|FG002|Infant Series|Adverse Event|2|||
124604511|NCT00444457|448172072|FG003|Infant Series|Adverse Event|0|||
124604512|NCT00444457|448172069|FG000|Infant Series|Death|0|||
124604513|NCT00444457|448172070|FG001|Infant Series|Death|1|||
124604514|NCT00444457|448172071|FG002|Infant Series|Death|1|||
124604515|NCT00444457|448172072|FG003|Infant Series|Death|1|||
124604516|NCT00444457|448172069|FG000|After Infant Series|Other|0|||
124604517|NCT00444457|448172070|FG001|After Infant Series|Other|1|||
124604518|NCT00444457|448172071|FG002|After Infant Series|Other|1|||
124604519|NCT00444457|448172072|FG003|After Infant Series|Other|1|||
124604520|NCT00444457|448172069|FG000|After Infant Series|Parent or legal guardian request|4|||
124604521|NCT00444457|448172070|FG001|After Infant Series|Parent or legal guardian request|11|||
124604522|NCT00444457|448172071|FG002|After Infant Series|Parent or legal guardian request|6|||
124604523|NCT00444457|448172072|FG003|After Infant Series|Parent or legal guardian request|3|||
124604524|NCT00444457|448172069|FG000|After Infant Series|Failed to return|7|||
124604525|NCT00444457|448172070|FG001|After Infant Series|Failed to return|6|||
124604526|NCT00444457|448172071|FG002|After Infant Series|Failed to return|5|||
124604527|NCT00444457|448172072|FG003|After Infant Series|Failed to return|1|||
124604528|NCT00444457|448172069|FG000|After Infant Series|Lost to Follow-up|5|||
124604529|NCT00444457|448172070|FG001|After Infant Series|Lost to Follow-up|5|||
124604530|NCT00444457|448172071|FG002|After Infant Series|Lost to Follow-up|5|||
124604531|NCT00444457|448172072|FG003|After Infant Series|Lost to Follow-up|2|||
124604532|NCT00444457|448172069|FG000|After Infant Series|Protocol Violation|2|||
124604533|NCT00444457|448172070|FG001|After Infant Series|Protocol Violation|4|||
124604534|NCT00444457|448172071|FG002|After Infant Series|Protocol Violation|2|||
124604535|NCT00444457|448172072|FG003|After Infant Series|Protocol Violation|2|||
124604536|NCT00444457|448172069|FG000|After Infant Series|Adverse Event|2|||
124604537|NCT00444457|448172070|FG001|After Infant Series|Adverse Event|2|||
124604538|NCT00444457|448172071|FG002|After Infant Series|Adverse Event|0|||
124604539|NCT00444457|448172072|FG003|After Infant Series|Adverse Event|0|||
124604540|NCT00444457|448172069|FG000|After Infant Series|Investigator request|0|||
124604541|NCT00444457|448172070|FG001|After Infant Series|Investigator request|0|||
124604542|NCT00444457|448172071|FG002|After Infant Series|Investigator request|0|||
124604543|NCT00444457|448172072|FG003|After Infant Series|Investigator request|1|||
124604544|NCT00444457|448172069|FG000|After Infant Series|Other|0|||
124604545|NCT00444457|448172070|FG001|After Infant Series|Other|1|||
124604546|NCT00444457|448172071|FG002|After Infant Series|Other|0|||
124604547|NCT00444457|448172072|FG003|After Infant Series|Other|0|||
124604548|NCT00444457|448172069|FG000|Toddler Dose|Lost to Follow-up|4|||
124604549|NCT00444457|448172070|FG001|Toddler Dose|Lost to Follow-up|1|||
124604550|NCT00444457|448172071|FG002|Toddler Dose|Lost to Follow-up|1|||
124604551|NCT00444457|448172072|FG003|Toddler Dose|Lost to Follow-up|3|||
124604552|NCT00444457|448172069|FG000|Toddler Dose|Failed to return|2|||
124604553|NCT00444457|448172070|FG001|Toddler Dose|Failed to return|2|||
124604554|NCT00444457|448172071|FG002|Toddler Dose|Failed to return|1|||
124604555|NCT00444457|448172072|FG003|Toddler Dose|Failed to return|3|||
124604556|NCT00444457|448172069|FG000|Toddler Dose|Parent or legal guardian request|0|||
124604557|NCT00444457|448172070|FG001|Toddler Dose|Parent or legal guardian request|3|||
124604558|NCT00444457|448172071|FG002|Toddler Dose|Parent or legal guardian request|2|||
124604559|NCT00444457|448172072|FG003|Toddler Dose|Parent or legal guardian request|1|||
124604560|NCT00444457|448172069|FG000|Toddler Dose|Protocol Violation|1|||
124604561|NCT00444457|448172070|FG001|Toddler Dose|Protocol Violation|0|||
124604562|NCT00444457|448172071|FG002|Toddler Dose|Protocol Violation|0|||
124604563|NCT00444457|448172072|FG003|Toddler Dose|Protocol Violation|1|||
124731543|NCT02075047|448640125|FG001|Treatment Phase (4 Weeks)|Other|1|||
124731544|NCT02075047|448640124|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
124731545|NCT02075047|448640125|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
124604564|NCT01602965|448172077|FG000|Overall Study|Lost to Follow-up|4|||
124604565|NCT01602965|448172078|FG001|Overall Study|Lost to Follow-up|2|||
124604566|NCT02283294|448172079|FG000|Overall Study|Lost to Follow-up|1|||
124604567|NCT02283294|448172080|FG001|Overall Study|Lost to Follow-up|1|||
124604568|NCT02283294|448172079|FG000|Overall Study|Withdrawal by Subject|1|||
124604569|NCT02283294|448172080|FG001|Overall Study|Withdrawal by Subject|6|||
124731546|NCT02075047|448640124|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
124604570|NCT02283294|448172079|FG000|Overall Study|Protocol Violation|1|||
124604571|NCT02283294|448172080|FG001|Overall Study|Protocol Violation|0|||
124604572|NCT02283294|448172079|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
124604573|NCT02283294|448172080|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
124604574|NCT01769339|448172081|FG000|Overall Study|Lost to Follow-up|42|||
124604575|NCT01769339|448172081|FG000|Overall Study|Adverse Event|1|||
124604576|NCT04062448|448174591|FG000|Overall Study|Lost to Follow-up|1|||
124604577|NCT04062448|448174591|FG000|Overall Study|Withdrawal by Subject|2|||
124604578|NCT05101486|448174592|FG000|Overall Study|Death|1|||
124604579|NCT05101486|448174593|FG001|Overall Study|Death|0|||
124604580|NCT05101486|448174594|FG002|Overall Study|Death|1|||
124604581|NCT05101486|448174592|FG000|Overall Study|Lost to Follow-up|12|||
124604582|NCT05101486|448174593|FG001|Overall Study|Lost to Follow-up|8|||
124604583|NCT05101486|448174594|FG002|Overall Study|Lost to Follow-up|17|||
124604584|NCT05101486|448174592|FG000|Overall Study|Physician Decision|1|||
124604585|NCT05101486|448174593|FG001|Overall Study|Physician Decision|0|||
124604586|NCT05101486|448174594|FG002|Overall Study|Physician Decision|0|||
124604587|NCT05101486|448174592|FG000|Overall Study|Protocol Violation|0|||
124604588|NCT05101486|448174593|FG001|Overall Study|Protocol Violation|0|||
124604589|NCT05101486|448174594|FG002|Overall Study|Protocol Violation|1|||
124604590|NCT05101486|448174592|FG000|Overall Study|Withdrawal by Subject|5|||
124604591|NCT05101486|448174593|FG001|Overall Study|Withdrawal by Subject|2|||
124604592|NCT05101486|448174594|FG002|Overall Study|Withdrawal by Subject|4|||
124604593|NCT05101486|448174592|FG000|Overall Study|Randomized but not vaccinated|1|||
124604594|NCT05101486|448174593|FG001|Overall Study|Randomized but not vaccinated|1|||
124604595|NCT05101486|448174594|FG002|Overall Study|Randomized but not vaccinated|1|||
124604596|NCT02788045|448174595|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
124604597|NCT02788045|448174596|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
124604598|NCT02788045|448174597|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
124604599|NCT02788045|448174595|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
124604600|NCT02788045|448174596|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
124604601|NCT02788045|448174597|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
124604602|NCT02788045|448174595|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
124604603|NCT02788045|448174596|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
124604604|NCT02788045|448174597|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
124604605|NCT02788045|448174595|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
124604606|NCT02788045|448174596|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
124604607|NCT02788045|448174597|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
124604608|NCT02788045|448174595|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
124604609|NCT02788045|448174596|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
124604610|NCT02788045|448174597|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
124604611|NCT02788045|448174595|FG000|Main Study (Up to Week 72)|Other|3|||
124604612|NCT02788045|448174596|FG001|Main Study (Up to Week 72)|Other|0|||
124604613|NCT02788045|448174597|FG002|Main Study (Up to Week 72)|Other|0|||
124604614|NCT02788045|448174595|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
124604615|NCT02788045|448174596|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
124604616|NCT02788045|448174597|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
124604617|NCT02788045|448174595|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
124604618|NCT02788045|448174596|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
124604619|NCT02788045|448174597|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
124604620|NCT02788045|448174595|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
124604621|NCT02788045|448174596|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
124604622|NCT02788045|448174597|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
124604623|NCT03188666|448174598|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
124604624|NCT03188666|448174599|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
124604625|NCT03188666|448174600|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
124604626|NCT03188666|448174601|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
124604627|NCT03188666|448174598|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
124604628|NCT03188666|448174599|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
124604629|NCT03188666|448174600|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
124604630|NCT03188666|448174601|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
124604631|NCT03188666|448174598|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
124604632|NCT03188666|448174599|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
124604633|NCT03188666|448174600|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
124604634|NCT03188666|448174601|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
124604635|NCT03188666|448174598|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
124604636|NCT03188666|448174599|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
124604637|NCT03188666|448174600|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
124604638|NCT03188666|448174601|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
124604639|NCT03696953|448174602|FG000|Overall Study|Withdrawal by Subject|6|||
124604640|NCT03696953|448174603|FG001|Overall Study|Withdrawal by Subject|1|||
124604641|NCT03696953|448174602|FG000|Overall Study|missed GBS swabs|2|||
124604642|NCT03696953|448174603|FG001|Overall Study|missed GBS swabs|2|||
124604643|NCT03696953|448174602|FG000|Overall Study|lost study bottle containing capsules|2|||
124604644|NCT03696953|448174603|FG001|Overall Study|lost study bottle containing capsules|0|||
124604645|NCT03696953|448174602|FG000|Overall Study|Premature birth|1|||
124604646|NCT03696953|448174603|FG001|Overall Study|Premature birth|4|||
124604647|NCT03696953|448174602|FG000|Overall Study|Gestational hypertension|1|||
124604648|NCT03696953|448174603|FG001|Overall Study|Gestational hypertension|1|||
124604649|NCT03696953|448174602|FG000|Overall Study|Gestational diabetes|2|||
124604650|NCT03696953|448174603|FG001|Overall Study|Gestational diabetes|1|||
124604651|NCT03696953|448174602|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
124604652|NCT03696953|448174603|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
124604653|NCT03696953|448174602|FG000|Overall Study|Changed prenatal provider|1|||
124604654|NCT03696953|448174603|FG001|Overall Study|Changed prenatal provider|1|||
124604655|NCT05104476|448174604|FG000|Overall Study|Randomized But Not Treated|1|||
124604656|NCT05104476|448174605|FG001|Overall Study|Randomized But Not Treated|2|||
124604657|NCT05104476|448174604|FG000|Overall Study|Adverse Event|2|||
124604658|NCT05104476|448174605|FG001|Overall Study|Adverse Event|2|||
124604659|NCT05104476|448174604|FG000|Overall Study|Withdrawal by Subject|3|||
124604660|NCT05104476|448174605|FG001|Overall Study|Withdrawal by Subject|3|||
124604661|NCT05104476|448174604|FG000|Overall Study|Other Than Specified|0|||
124604662|NCT05104476|448174605|FG001|Overall Study|Other Than Specified|3|||
124604663|NCT04908683|448174606|FG000|Overall Study|Failure to meet continuation criteria|34|||
124604664|NCT04908683|448174607|FG001|Overall Study|Failure to meet continuation criteria|22|||
124604665|NCT04908683|448174606|FG000|Overall Study|Initiated prohibited medication|3|||
124604666|NCT04908683|448174607|FG001|Overall Study|Initiated prohibited medication|0|||
124604667|NCT04908683|448174606|FG000|Overall Study|Randomized by mistake|1|||
124604668|NCT04908683|448174607|FG001|Overall Study|Randomized by mistake|0|||
124604669|NCT04908683|448174606|FG000|Overall Study|Lost to Follow-up|679|||
124604670|NCT04908683|448174607|FG001|Overall Study|Lost to Follow-up|341|||
124604671|NCT04908683|448174606|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
124604672|NCT04908683|448174607|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
124604673|NCT04908683|448174606|FG000|Overall Study|Physician Decision|44|||
124604674|NCT04908683|448174607|FG001|Overall Study|Physician Decision|35|||
124604675|NCT04908683|448174606|FG000|Overall Study|Technical problems|12|||
124604676|NCT04908683|448174607|FG001|Overall Study|Technical problems|9|||
124604677|NCT04908683|448174606|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
124604678|NCT04908683|448174607|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
124604679|NCT04908683|448174606|FG000|Overall Study|Protocol Violation|2|||
124604680|NCT04908683|448174607|FG001|Overall Study|Protocol Violation|0|||
124604681|NCT04908683|448174606|FG000|Overall Study|Withdrawal by Subject|1188|||
124604682|NCT04908683|448174607|FG001|Overall Study|Withdrawal by Subject|570|||
124604683|NCT04908683|448174606|FG000|Overall Study|Site Closure by Sponsor|6|||
124604684|NCT04908683|448174607|FG001|Overall Study|Site Closure by Sponsor|3|||
124604685|NCT04908683|448174606|FG000|Overall Study|Adverse Event|21|||
124604686|NCT04908683|448174607|FG001|Overall Study|Adverse Event|11|||
124604687|NCT04908683|448174606|FG000|Overall Study|Death|101|||
124604688|NCT04908683|448174607|FG001|Overall Study|Death|61|||
124604689|NCT04908683|448174606|FG000|Overall Study|Sponsor's decision|14398|||
124604690|NCT04908683|448174607|FG001|Overall Study|Sponsor's decision|7205|||
124604691|NCT04908683|448174606|FG000|Overall Study|Other|92|||
124604692|NCT04908683|448174607|FG001|Overall Study|Other|50|||
124604693|NCT04908683|448174606|FG000|Overall Study|Randomized not vaccinated|108|||
124604694|NCT04908683|448174607|FG001|Overall Study|Randomized not vaccinated|52|||
124604695|NCT03047473|448174609|FG000|Overall Study|Lost to Follow-up|2|||
124604696|NCT06204887|448174610|FG000|Overall Study|Lost to Follow-up|3|||
124604697|NCT06204887|448174611|FG001|Overall Study|Lost to Follow-up|4|||
124604698|NCT06204887|448174612|FG002|Overall Study|Lost to Follow-up|1|||
124604699|NCT06204887|448174613|FG003|Overall Study|Lost to Follow-up|6|||
124604700|NCT02935686|448174614|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
124604701|NCT02935686|448174615|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
124604702|NCT02935686|448174616|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
124604703|NCT02935686|448174617|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
124604704|NCT02935686|448174618|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
124604705|NCT02935686|448174614|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
124604706|NCT02935686|448174615|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
124604707|NCT02935686|448174616|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
124604708|NCT02935686|448174617|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
124604709|NCT02935686|448174618|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
124604710|NCT02935686|448174614|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
124604711|NCT02935686|448174615|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
124604712|NCT02935686|448174616|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
124604713|NCT02935686|448174617|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
124604714|NCT02935686|448174618|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
124604715|NCT02935686|448174614|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
124604716|NCT02935686|448174615|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
124604717|NCT02935686|448174616|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
124604718|NCT02935686|448174617|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
124604719|NCT02935686|448174618|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
124604720|NCT02935686|448174614|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
124604721|NCT02935686|448174615|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
124604722|NCT02935686|448174616|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
124604723|NCT02935686|448174617|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
124604724|NCT02935686|448174618|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
124604725|NCT02935686|448174614|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
124604726|NCT02935686|448174615|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
124604727|NCT02935686|448174616|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
124604728|NCT02935686|448174617|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
124604729|NCT02935686|448174618|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
124604730|NCT02935686|448174614|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
124731547|NCT02075047|448640125|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
124731548|NCT02075047|448640124|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
124604731|NCT02935686|448174615|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
124604732|NCT02935686|448174616|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
124604733|NCT02935686|448174617|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
124604734|NCT02935686|448174618|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
124604735|NCT02935686|448174614|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
124604736|NCT02935686|448174615|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
124604737|NCT02935686|448174616|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
124604738|NCT02935686|448174617|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
124604739|NCT02935686|448174618|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
124604740|NCT02935686|448174614|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
124604741|NCT02935686|448174615|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
124604742|NCT02935686|448174616|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
124604743|NCT02935686|448174617|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
124604744|NCT02935686|448174618|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
124604745|NCT02935686|448174614|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
124604746|NCT02935686|448174615|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
124604747|NCT02935686|448174616|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
124604748|NCT02935686|448174617|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
124604749|NCT02935686|448174618|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
124604750|NCT02935686|448174614|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
124604751|NCT02935686|448174615|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
124604752|NCT02935686|448174616|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
124604753|NCT02935686|448174617|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
124604754|NCT02935686|448174618|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
124604755|NCT00062010|448174620|FG000|Overall Study|Ineligible|3|||
124604756|NCT02856880|448174621|FG000|Overall Study|Withdrawal of consent|1|||
124604757|NCT00573157|448174622|FG000|Overall Study|Adverse Event|3|||
124604758|NCT00573157|448174623|FG001|Overall Study|Adverse Event|1|||
124604759|NCT00573157|448174622|FG000|Overall Study|Other|1|||
124604760|NCT00573157|448174623|FG001|Overall Study|Other|1|||
124604761|NCT02944383|448174624|FG000|Overall Study|Lost to Follow-up|0|||
124604762|NCT02944383|448174625|FG001|Overall Study|Lost to Follow-up|0|||
124604763|NCT02944383|448174626|FG002|Overall Study|Lost to Follow-up|1|||
124604764|NCT02944383|448174624|FG000|Overall Study|Withdrawal by Subject|1|||
124604765|NCT02944383|448174625|FG001|Overall Study|Withdrawal by Subject|0|||
124604766|NCT02944383|448174626|FG002|Overall Study|Withdrawal by Subject|0|||
124604767|NCT01183221|448174629|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
124604768|NCT01183221|448174630|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
124604769|NCT00807248|448174634|FG000|Overall Study|Adverse Event|1|||
124604770|NCT00807248|448174635|FG001|Overall Study|Adverse Event|2|||
124604771|NCT00807248|448174636|FG002|Overall Study|Adverse Event|2|||
124604772|NCT00807248|448174637|FG003|Overall Study|Adverse Event|6|||
124604773|NCT00807248|448174634|FG000|Overall Study|Lack of Efficacy|14|||
124604774|NCT00807248|448174635|FG001|Overall Study|Lack of Efficacy|4|||
124731549|NCT02075047|448640125|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
124604775|NCT00807248|448174636|FG002|Overall Study|Lack of Efficacy|8|||
124604776|NCT00807248|448174637|FG003|Overall Study|Lack of Efficacy|3|||
124604777|NCT00807248|448174634|FG000|Overall Study|Protocol Violation|0|||
124604778|NCT00807248|448174635|FG001|Overall Study|Protocol Violation|1|||
124604779|NCT00807248|448174636|FG002|Overall Study|Protocol Violation|1|||
124604780|NCT00807248|448174637|FG003|Overall Study|Protocol Violation|0|||
124604781|NCT00807248|448174634|FG000|Overall Study|Withdrawal of Consent|5|||
124604782|NCT00807248|448174635|FG001|Overall Study|Withdrawal of Consent|5|||
124604783|NCT00807248|448174636|FG002|Overall Study|Withdrawal of Consent|5|||
124604784|NCT00807248|448174637|FG003|Overall Study|Withdrawal of Consent|5|||
124604785|NCT00807248|448174634|FG000|Overall Study|Lost to Follow-up|1|||
124731550|NCT02075047|448640124|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
124604786|NCT00807248|448174635|FG001|Overall Study|Lost to Follow-up|0|||
124604787|NCT00807248|448174636|FG002|Overall Study|Lost to Follow-up|0|||
124731551|NCT02075047|448640125|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
124604788|NCT00807248|448174637|FG003|Overall Study|Lost to Follow-up|0|||
124604789|NCT00807248|448174634|FG000|Overall Study|Other Reason|0|||
124604790|NCT00807248|448174635|FG001|Overall Study|Other Reason|0|||
124604791|NCT00807248|448174636|FG002|Overall Study|Other Reason|2|||
124604792|NCT00807248|448174637|FG003|Overall Study|Other Reason|0|||
124604793|NCT02504671|448174639|FG000|Overall Study|Withdrawal by Subject|1|||
124604794|NCT02504671|448174640|FG001|Overall Study|Withdrawal by Subject|5|||
124604795|NCT02504671|448174641|FG002|Overall Study|Withdrawal by Subject|4|||
124604796|NCT02504671|448174642|FG003|Overall Study|Withdrawal by Subject|4|||
124604797|NCT02504671|448174643|FG004|Overall Study|Withdrawal by Subject|5|||
124604798|NCT02504671|448174644|FG005|Overall Study|Withdrawal by Subject|3|||
124604799|NCT02504671|448174639|FG000|Overall Study|Lack of Efficacy|1|||
124604800|NCT02504671|448174640|FG001|Overall Study|Lack of Efficacy|3|||
124604801|NCT02504671|448174641|FG002|Overall Study|Lack of Efficacy|1|||
124604802|NCT02504671|448174642|FG003|Overall Study|Lack of Efficacy|0|||
124604803|NCT02504671|448174643|FG004|Overall Study|Lack of Efficacy|4|||
124604804|NCT02504671|448174644|FG005|Overall Study|Lack of Efficacy|4|||
124604805|NCT02504671|448174639|FG000|Overall Study|Adverse Event|1|||
124604806|NCT02504671|448174640|FG001|Overall Study|Adverse Event|1|||
124604807|NCT02504671|448174641|FG002|Overall Study|Adverse Event|0|||
124604808|NCT02504671|448174642|FG003|Overall Study|Adverse Event|1|||
124604809|NCT02504671|448174643|FG004|Overall Study|Adverse Event|0|||
124604810|NCT02504671|448174644|FG005|Overall Study|Adverse Event|2|||
124604811|NCT02504671|448174639|FG000|Overall Study|Protocol Violation|2|||
124604812|NCT02504671|448174640|FG001|Overall Study|Protocol Violation|1|||
124604813|NCT02504671|448174641|FG002|Overall Study|Protocol Violation|0|||
124604814|NCT02504671|448174642|FG003|Overall Study|Protocol Violation|0|||
124604815|NCT02504671|448174643|FG004|Overall Study|Protocol Violation|0|||
124604816|NCT02504671|448174644|FG005|Overall Study|Protocol Violation|1|||
124604817|NCT02504671|448174639|FG000|Overall Study|Lost to Follow-up|0|||
124604818|NCT02504671|448174640|FG001|Overall Study|Lost to Follow-up|0|||
124604819|NCT02504671|448174641|FG002|Overall Study|Lost to Follow-up|2|||
124604820|NCT02504671|448174642|FG003|Overall Study|Lost to Follow-up|0|||
124604821|NCT02504671|448174643|FG004|Overall Study|Lost to Follow-up|0|||
124604822|NCT02504671|448174644|FG005|Overall Study|Lost to Follow-up|1|||
124604823|NCT02504671|448174639|FG000|Overall Study|Protocol defined stopping criteria|7|||
124604824|NCT02504671|448174640|FG001|Overall Study|Protocol defined stopping criteria|4|||
124604825|NCT02504671|448174641|FG002|Overall Study|Protocol defined stopping criteria|3|||
124604826|NCT02504671|448174642|FG003|Overall Study|Protocol defined stopping criteria|5|||
124604827|NCT02504671|448174643|FG004|Overall Study|Protocol defined stopping criteria|3|||
124604828|NCT02504671|448174644|FG005|Overall Study|Protocol defined stopping criteria|3|||
124604829|NCT00210249|448174645|FG000|Overall Study|Lost to Follow-up|5|||
124604830|NCT00210249|448174645|FG000|Overall Study|Protocol Violation|11|||
124604831|NCT00599521|448174646|FG000|Overall Study|Lack of Efficacy|4|||
124604832|NCT00599521|448174647|FG001|Overall Study|Lack of Efficacy|8|||
124604833|NCT00599521|448174646|FG000|Overall Study|Adverse Event|4|||
124604834|NCT00599521|448174647|FG001|Overall Study|Adverse Event|1|||
124604835|NCT00599521|448174646|FG000|Overall Study|Withdrawal by Subject|28|||
124604836|NCT00599521|448174647|FG001|Overall Study|Withdrawal by Subject|34|||
124604837|NCT00599521|448174646|FG000|Overall Study|Protocol Violation|1|||
124604838|NCT00599521|448174647|FG001|Overall Study|Protocol Violation|1|||
124604839|NCT00599521|448174646|FG000|Overall Study|Lost to Follow-up|23|||
124604840|NCT00599521|448174647|FG001|Overall Study|Lost to Follow-up|23|||
124604841|NCT00599521|448174646|FG000|Overall Study|Pregnancy|0|||
124604842|NCT00599521|448174647|FG001|Overall Study|Pregnancy|2|||
124604843|NCT01293539|448174648|FG000|Overall Study|Physician Decision|1|||
124781064|NCT01088048|448829077|FG005|Overall Study|Concomitant Medication Prohibited|0|||
124781065|NCT01088048|448829078|FG006|Overall Study|Concomitant Medication Prohibited|0|||
124781066|NCT01088048|448829079|FG007|Overall Study|Concomitant Medication Prohibited|0|||
124781067|NCT01088048|448829080|FG008|Overall Study|Concomitant Medication Prohibited|0|||
124781068|NCT01088048|448829081|FG009|Overall Study|Concomitant Medication Prohibited|0|||
124604844|NCT01687478|448174651|FG000|Overall Study|Adverse Event|3|||
124604845|NCT01687478|448174652|FG001|Overall Study|Adverse Event|10|||
124604846|NCT01687478|448174651|FG000|Overall Study|Lost to Follow-up|1|||
124604847|NCT01687478|448174652|FG001|Overall Study|Lost to Follow-up|3|||
124604848|NCT01687478|448174651|FG000|Overall Study|Protocol Violation|0|||
124604849|NCT01687478|448174652|FG001|Overall Study|Protocol Violation|2|||
124604850|NCT01687478|448174651|FG000|Overall Study|Withdrawal by Subject|21|||
124604851|NCT01687478|448174652|FG001|Overall Study|Withdrawal by Subject|19|||
124604852|NCT01687478|448174651|FG000|Overall Study|Physician Decision|1|||
124604853|NCT01687478|448174652|FG001|Overall Study|Physician Decision|3|||
124604854|NCT01687478|448174651|FG000|Overall Study|Entry Criteria Not Met|6|||
124604855|NCT01687478|448174652|FG001|Overall Study|Entry Criteria Not Met|2|||
124604856|NCT04322149|448174653|FG000|Overall Study|Adverse Event|1|||
124604857|NCT04322149|448174654|FG001|Overall Study|Adverse Event|1|||
124604858|NCT04322149|448174655|FG002|Overall Study|Adverse Event|0|||
124604859|NCT04322149|448174656|FG003|Overall Study|Adverse Event|0|||
124604860|NCT04322149|448174653|FG000|Overall Study|Withdrawal by Subject|0|||
124604861|NCT04322149|448174654|FG001|Overall Study|Withdrawal by Subject|0|||
124604862|NCT04322149|448174655|FG002|Overall Study|Withdrawal by Subject|0|||
124604863|NCT04322149|448174656|FG003|Overall Study|Withdrawal by Subject|2|||
124604864|NCT04322149|448174653|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
124604865|NCT04322149|448174654|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
124604866|NCT04322149|448174655|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
124604867|NCT04322149|448174656|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
124604868|NCT01700049|448174657|FG000|Overall Study|Withdrawal by Subject|1|||
124604869|NCT01206101|448174658|FG000|Overall Study|Adverse Event|1|||
124604870|NCT01206101|448174659|FG001|Overall Study|Adverse Event|0|||
124604871|NCT01206101|448174658|FG000|Overall Study|Physician Decision|0|||
124604872|NCT01206101|448174659|FG001|Overall Study|Physician Decision|1|||
124604873|NCT01206101|448174658|FG000|Overall Study|Unclassified|1|||
124604874|NCT01206101|448174659|FG001|Overall Study|Unclassified|0|||
124604875|NCT01248013|448174660|FG000|Overall Study|Withdrawal by Subject|14|||
124604876|NCT00667810|448174664|FG000|Overall Study|Adverse Event|13|||
124604877|NCT00667810|448174665|FG001|Overall Study|Adverse Event|14|||
124604878|NCT00667810|448174666|FG002|Overall Study|Adverse Event|19|||
124604879|NCT00667810|448174667|FG003|Overall Study|Adverse Event|1|||
124604880|NCT00667810|448174664|FG000|Overall Study|Death|1|||
124604881|NCT00667810|448174665|FG001|Overall Study|Death|1|||
124604882|NCT00667810|448174666|FG002|Overall Study|Death|3|||
124604883|NCT00667810|448174667|FG003|Overall Study|Death|0|||
124604884|NCT00667810|448174664|FG000|Overall Study|Lack of Efficacy|1|||
124604885|NCT00667810|448174665|FG001|Overall Study|Lack of Efficacy|0|||
124604886|NCT00667810|448174666|FG002|Overall Study|Lack of Efficacy|2|||
124604887|NCT00667810|448174667|FG003|Overall Study|Lack of Efficacy|0|||
124604888|NCT00667810|448174664|FG000|Overall Study|Lost to Follow-up|1|||
124604889|NCT00667810|448174665|FG001|Overall Study|Lost to Follow-up|4|||
124604890|NCT00667810|448174666|FG002|Overall Study|Lost to Follow-up|2|||
124604891|NCT00667810|448174667|FG003|Overall Study|Lost to Follow-up|0|||
124604892|NCT00667810|448174664|FG000|Overall Study|Physician Decision|1|||
124604893|NCT00667810|448174665|FG001|Overall Study|Physician Decision|1|||
124604894|NCT00667810|448174666|FG002|Overall Study|Physician Decision|2|||
124604895|NCT00667810|448174667|FG003|Overall Study|Physician Decision|0|||
124604896|NCT00667810|448174664|FG000|Overall Study|Protocol Violation|0|||
124604897|NCT00667810|448174665|FG001|Overall Study|Protocol Violation|2|||
124604898|NCT00667810|448174666|FG002|Overall Study|Protocol Violation|0|||
124604899|NCT00667810|448174667|FG003|Overall Study|Protocol Violation|0|||
124604900|NCT00667810|448174664|FG000|Overall Study|Withdrawal by Subject|14|||
124604901|NCT00667810|448174665|FG001|Overall Study|Withdrawal by Subject|20|||
124604902|NCT00667810|448174666|FG002|Overall Study|Withdrawal by Subject|29|||
124604903|NCT00667810|448174667|FG003|Overall Study|Withdrawal by Subject|1|||
124604904|NCT00667810|448174664|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
124604905|NCT00667810|448174665|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
124604906|NCT00667810|448174666|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
124604907|NCT00667810|448174667|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
124604908|NCT00667810|448174664|FG000|Overall Study|Failed to Return|0|||
124604909|NCT00667810|448174665|FG001|Overall Study|Failed to Return|0|||
124604910|NCT00667810|448174666|FG002|Overall Study|Failed to Return|2|||
124604911|NCT00667810|448174667|FG003|Overall Study|Failed to Return|0|||
124604912|NCT00667810|448174664|FG000|Overall Study|Loss of Caregiver|0|||
124604913|NCT00667810|448174665|FG001|Overall Study|Loss of Caregiver|1|||
124604914|NCT00667810|448174666|FG002|Overall Study|Loss of Caregiver|3|||
124604915|NCT00667810|448174667|FG003|Overall Study|Loss of Caregiver|0|||
124604916|NCT00667810|448174664|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
124604917|NCT00667810|448174665|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
124604918|NCT00667810|448174666|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
124604919|NCT00667810|448174667|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
124604920|NCT00667810|448174664|FG000|Overall Study|Other|6|||
124604921|NCT00667810|448174665|FG001|Overall Study|Other|6|||
124604922|NCT00667810|448174666|FG002|Overall Study|Other|5|||
124604923|NCT00667810|448174667|FG003|Overall Study|Other|0|||
124604924|NCT03514641|448174668|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
124604925|NCT03514641|448174669|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
124604926|NCT03514641|448174670|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
124604927|NCT03514641|448174671|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
124604928|NCT03514641|448174668|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
124604929|NCT03514641|448174669|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
124604930|NCT03514641|448174670|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
124604931|NCT03514641|448174671|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
124604932|NCT03514641|448174668|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
124604933|NCT03514641|448174669|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
124604934|NCT03514641|448174670|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
124604935|NCT03514641|448174671|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
124604936|NCT03514641|448174668|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
124604937|NCT03514641|448174669|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
124604938|NCT03514641|448174670|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
124604939|NCT03514641|448174671|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
124604940|NCT03514641|448174668|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
124604941|NCT03514641|448174669|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
124604942|NCT03514641|448174670|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
124604943|NCT03514641|448174671|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
124604944|NCT03514641|448174668|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
124604945|NCT03514641|448174669|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
124604946|NCT03514641|448174670|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
124604947|NCT03514641|448174671|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
124604948|NCT03514641|448174668|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
124604949|NCT03514641|448174669|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
124604950|NCT03514641|448174670|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
124604951|NCT03514641|448174671|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
124604952|NCT03514641|448174668|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
124604953|NCT03514641|448174669|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
124604954|NCT03514641|448174670|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
124604955|NCT03514641|448174671|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
124604956|NCT03514641|448174668|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
124604957|NCT03514641|448174669|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
124731552|NCT02075047|448640124|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
124731553|NCT02075047|448640125|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
124731554|NCT02075047|448640124|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
124731555|NCT02075047|448640125|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
124731556|NCT02075047|448640124|FG000|Follow up Phase (5 Weeks)|Other|1|||
124731557|NCT02075047|448640125|FG001|Follow up Phase (5 Weeks)|Other|2|||
124731558|NCT02075047|448640124|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
124731559|NCT02075047|448640125|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
124731560|NCT04195438|448640135|FG000|Overall Study|Withdrawal by Subject|1|||
124731561|NCT03447314|448640141|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
124731562|NCT03447314|448640142|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
124731563|NCT03447314|448640143|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
124731564|NCT03447314|448640144|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
124731565|NCT03447314|448640145|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
124731566|NCT03447314|448640146|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
124731567|NCT03447314|448640147|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
124731568|NCT03447314|448640148|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
124731569|NCT03447314|448640149|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
124731570|NCT03447314|448640150|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
124731571|NCT03447314|448640151|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
124731572|NCT03447314|448640152|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
124731573|NCT03447314|448640153|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
124731574|NCT03447314|448640154|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
124731575|NCT03447314|448640155|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
124731576|NCT03447314|448640156|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
124731577|NCT03447314|448640157|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
124731578|NCT03447314|448640158|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
124731579|NCT03447314|448640141|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
124731580|NCT03447314|448640142|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
124731581|NCT03447314|448640143|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
124731582|NCT03447314|448640144|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
124731583|NCT03447314|448640145|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
124731584|NCT03447314|448640146|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
124731585|NCT03447314|448640147|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
124731586|NCT03447314|448640148|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
124731587|NCT03447314|448640149|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
124731588|NCT03447314|448640150|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
124731589|NCT03447314|448640151|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
124731590|NCT03447314|448640152|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
124731591|NCT03447314|448640153|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
124731592|NCT03447314|448640154|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
124731593|NCT03447314|448640155|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
124731594|NCT03447314|448640156|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
124604958|NCT03514641|448174670|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
124604959|NCT03514641|448174671|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
124604960|NCT03514641|448174668|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
124604961|NCT03514641|448174669|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
124604962|NCT03514641|448174670|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
124604963|NCT03514641|448174671|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
124604964|NCT03514641|448174668|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
124604965|NCT03514641|448174669|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
124604966|NCT03514641|448174670|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
124604967|NCT03514641|448174671|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
124604968|NCT03514641|448174668|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
124604969|NCT03514641|448174669|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
124604970|NCT03514641|448174670|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
124604971|NCT03514641|448174671|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
124604972|NCT04234984|448174672|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
124604973|NCT04234984|448174672|FG000|Follow-up at the Second Time Point|Death|1|||
124604974|NCT04234984|448174672|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
124604975|NCT02038907|448174673|FG000|Overall Study|Protocol Violation|0|||
124604976|NCT02038907|448174674|FG001|Overall Study|Protocol Violation|0|||
124604977|NCT02038907|448174675|FG002|Overall Study|Protocol Violation|0|||
124604978|NCT02038907|448174676|FG003|Overall Study|Protocol Violation|0|||
124604979|NCT02038907|448174677|FG004|Overall Study|Protocol Violation|0|||
124604980|NCT02038907|448174678|FG005|Overall Study|Protocol Violation|0|||
124604981|NCT02038907|448174679|FG006|Overall Study|Protocol Violation|0|||
124604982|NCT02038907|448174680|FG007|Overall Study|Protocol Violation|0|||
124604983|NCT02038907|448174681|FG008|Overall Study|Protocol Violation|0|||
124604984|NCT02038907|448174682|FG009|Overall Study|Protocol Violation|0|||
124604985|NCT02038907|448174683|FG010|Overall Study|Protocol Violation|1|||
124604986|NCT02038907|448174684|FG011|Overall Study|Protocol Violation|0|||
124604987|NCT02038907|448174685|FG012|Overall Study|Protocol Violation|0|||
124604988|NCT02038907|448174686|FG013|Overall Study|Protocol Violation|0|||
124604989|NCT02038907|448174673|FG000|Overall Study|Withdrawal by Subject|0|||
124604990|NCT02038907|448174674|FG001|Overall Study|Withdrawal by Subject|0|||
124604991|NCT02038907|448174675|FG002|Overall Study|Withdrawal by Subject|0|||
124604992|NCT02038907|448174676|FG003|Overall Study|Withdrawal by Subject|0|||
124604993|NCT02038907|448174677|FG004|Overall Study|Withdrawal by Subject|0|||
124604994|NCT02038907|448174678|FG005|Overall Study|Withdrawal by Subject|0|||
124604995|NCT02038907|448174679|FG006|Overall Study|Withdrawal by Subject|0|||
124604996|NCT02038907|448174680|FG007|Overall Study|Withdrawal by Subject|0|||
124604997|NCT02038907|448174681|FG008|Overall Study|Withdrawal by Subject|0|||
124604998|NCT02038907|448174682|FG009|Overall Study|Withdrawal by Subject|0|||
124604999|NCT02038907|448174683|FG010|Overall Study|Withdrawal by Subject|1|||
124605000|NCT02038907|448174684|FG011|Overall Study|Withdrawal by Subject|0|||
124605001|NCT02038907|448174685|FG012|Overall Study|Withdrawal by Subject|0|||
124605002|NCT02038907|448174686|FG013|Overall Study|Withdrawal by Subject|0|||
124605003|NCT01732484|448174693|FG000|Overall Study|Death|7|||
124605004|NCT01732484|448174693|FG000|Overall Study|Lost to Follow-up|14|||
124605005|NCT01732484|448174693|FG000|Overall Study|chronical illness|5|||
124605006|NCT04620135|448174696|FG000|Study Completion|Adverse Event|2|||
124605007|NCT04620135|448174697|FG001|Study Completion|Adverse Event|3|||
124605008|NCT04620135|448174696|FG000|Study Completion|Withdrawal by Subject|2|||
124605009|NCT04620135|448174697|FG001|Study Completion|Withdrawal by Subject|0|||
124605010|NCT00988065|448174706|FG000|Overall Study|Adverse Event|4|||
124605011|NCT00988065|448174707|FG001|Overall Study|Adverse Event|10|||
124605012|NCT00988065|448174708|FG002|Overall Study|Adverse Event|2|||
124605013|NCT00988065|448174706|FG000|Overall Study|Lost to Follow-up|1|||
124605014|NCT00988065|448174707|FG001|Overall Study|Lost to Follow-up|2|||
124605015|NCT00988065|448174708|FG002|Overall Study|Lost to Follow-up|2|||
124605016|NCT00988065|448174706|FG000|Overall Study|Subject withdrew consent|3|||
124605017|NCT00988065|448174707|FG001|Overall Study|Subject withdrew consent|5|||
124605018|NCT00988065|448174708|FG002|Overall Study|Subject withdrew consent|2|||
124605019|NCT00988065|448174706|FG000|Overall Study|Noncompliance with protocol|5|||
124605020|NCT00988065|448174707|FG001|Overall Study|Noncompliance with protocol|6|||
124605021|NCT00988065|448174708|FG002|Overall Study|Noncompliance with protocol|9|||
124605022|NCT02685202|448174709|FG000|Overall Study|Lost to Follow-up|9|||
124605023|NCT02130882|448174710|FG000|Overall Study|Withdrawal by Subject|0|||
124605024|NCT02130882|448174711|FG001|Overall Study|Withdrawal by Subject|1|||
124605025|NCT00669071|448174714|FG000|Overall Study|Lost to Follow-up|3|||
124605026|NCT00669071|448174714|FG000|Overall Study|Final visit 40 days out of window|1|||
124605027|NCT01194973|448174715|FG000|Screening Period|Screen Failure|3|||
124605028|NCT01194973|448174715|FG000|26 Week Treatment Period|Adverse Event|1|||
124605029|NCT01194973|448174715|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
124605030|NCT01194973|448174715|FG000|26 Week Treatment Period|Pregnancy|1|||
124605031|NCT00359632|448174718|FG000|Overall Study|Death|2|||
124605032|NCT00359632|448174719|FG001|Overall Study|Death|0|||
124605033|NCT00359632|448174718|FG000|Overall Study|Adverse Event|1|||
124605034|NCT00359632|448174719|FG001|Overall Study|Adverse Event|0|||
124605035|NCT00359632|448174718|FG000|Overall Study|Non-compliance with visit schedule|1|||
124605036|NCT00359632|448174719|FG001|Overall Study|Non-compliance with visit schedule|0|||
124605037|NCT02615171|448174720|FG000|Overall Study|Lost to Follow-up|2|||
124605038|NCT02615171|448174721|FG001|Overall Study|Lost to Follow-up|1|||
124605039|NCT01000493|448174729|FG000|Overall Study|Adverse Event|3|||
124605040|NCT01000493|448174730|FG001|Overall Study|Adverse Event|6|||
124605041|NCT01000493|448174729|FG000|Overall Study|Lack of Efficacy|1|||
124605042|NCT01000493|448174730|FG001|Overall Study|Lack of Efficacy|1|||
124605043|NCT01000493|448174729|FG000|Overall Study|Protocol Violation|1|||
124605044|NCT01000493|448174730|FG001|Overall Study|Protocol Violation|8|||
124605045|NCT01000493|448174729|FG000|Overall Study|Study closed/terminated|25|||
124605046|NCT01000493|448174730|FG001|Overall Study|Study closed/terminated|23|||
124605047|NCT01000493|448174729|FG000|Overall Study|Lost to Follow-up|5|||
124605048|NCT01000493|448174730|FG001|Overall Study|Lost to Follow-up|9|||
124605049|NCT01000493|448174729|FG000|Overall Study|Physician Decision|1|||
124605050|NCT01000493|448174730|FG001|Overall Study|Physician Decision|1|||
124605051|NCT01000493|448174729|FG000|Overall Study|Withdrawal by Subject|3|||
124605052|NCT01000493|448174730|FG001|Overall Study|Withdrawal by Subject|7|||
124605053|NCT01408628|448174731|FG000|Consented|Withdrawal by Subject|12|||
124605054|NCT01408628|448174731|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
124605055|NCT01408628|448174731|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
124605056|NCT01408628|448174731|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
124605057|NCT01941940|448174732|FG000|Overall Study|Adverse Event|11|||
124605058|NCT01941940|448174732|FG000|Overall Study|Lost to Follow-up|2|||
124605059|NCT01941940|448174732|FG000|Overall Study|Physician Decision|2|||
124605060|NCT01941940|448174732|FG000|Overall Study|Withdrawal by Subject|15|||
124605061|NCT01941940|448174732|FG000|Overall Study|Death|1|||
124605062|NCT01941940|448174732|FG000|Overall Study|Other|1|||
124605063|NCT01941940|448174732|FG000|Overall Study|Other|1|||
124605064|NCT00750308|448174733|FG000|First Treatment|Adverse Event|0|||
124605065|NCT00750308|448174734|FG001|First Treatment|Adverse Event|1|||
124605066|NCT00750308|448174735|FG002|First Treatment|Adverse Event|0|||
124605067|NCT00750308|448174736|FG003|First Treatment|Adverse Event|0|||
124605068|NCT00750308|448174737|FG004|First Treatment|Adverse Event|0|||
124605069|NCT00750308|448174738|FG005|First Treatment|Adverse Event|0|||
124605070|NCT00750308|448174739|FG006|First Treatment|Adverse Event|0|||
124605071|NCT00750308|448174740|FG007|First Treatment|Adverse Event|0|||
124605072|NCT00750308|448174741|FG008|First Treatment|Adverse Event|0|||
124605073|NCT00750308|448174742|FG009|First Treatment|Adverse Event|0|||
124605074|NCT00750308|448174743|FG010|First Treatment|Adverse Event|1|||
124605075|NCT00750308|448174744|FG011|First Treatment|Adverse Event|1|||
124605076|NCT00750308|448174733|FG000|First Treatment|Withdrawal by Subject|0|||
124605077|NCT00750308|448174734|FG001|First Treatment|Withdrawal by Subject|0|||
124605078|NCT00750308|448174735|FG002|First Treatment|Withdrawal by Subject|0|||
124605079|NCT00750308|448174736|FG003|First Treatment|Withdrawal by Subject|1|||
124605080|NCT00750308|448174737|FG004|First Treatment|Withdrawal by Subject|0|||
124605081|NCT00750308|448174738|FG005|First Treatment|Withdrawal by Subject|0|||
124605082|NCT00750308|448174739|FG006|First Treatment|Withdrawal by Subject|0|||
124605083|NCT00750308|448174740|FG007|First Treatment|Withdrawal by Subject|1|||
124605084|NCT00750308|448174741|FG008|First Treatment|Withdrawal by Subject|0|||
124605085|NCT00750308|448174742|FG009|First Treatment|Withdrawal by Subject|0|||
124605086|NCT00750308|448174743|FG010|First Treatment|Withdrawal by Subject|0|||
124605087|NCT00750308|448174744|FG011|First Treatment|Withdrawal by Subject|0|||
124605088|NCT00750308|448174733|FG000|Second Treatment|Adverse Event|0|||
124605089|NCT00750308|448174734|FG001|Second Treatment|Adverse Event|0|||
124605090|NCT00750308|448174735|FG002|Second Treatment|Adverse Event|0|||
124605091|NCT00750308|448174736|FG003|Second Treatment|Adverse Event|0|||
124605092|NCT00750308|448174737|FG004|Second Treatment|Adverse Event|0|||
124605093|NCT00750308|448174738|FG005|Second Treatment|Adverse Event|1|||
124605094|NCT00750308|448174739|FG006|Second Treatment|Adverse Event|0|||
124605095|NCT00750308|448174740|FG007|Second Treatment|Adverse Event|0|||
124605096|NCT00750308|448174741|FG008|Second Treatment|Adverse Event|1|||
124605097|NCT00750308|448174742|FG009|Second Treatment|Adverse Event|0|||
124605098|NCT00750308|448174743|FG010|Second Treatment|Adverse Event|0|||
124605099|NCT00750308|448174744|FG011|Second Treatment|Adverse Event|0|||
124605100|NCT00750308|448174733|FG000|Second Treatment|Withdrawal by Subject|0|||
124605101|NCT00750308|448174734|FG001|Second Treatment|Withdrawal by Subject|0|||
124605102|NCT00750308|448174735|FG002|Second Treatment|Withdrawal by Subject|0|||
124605103|NCT00750308|448174736|FG003|Second Treatment|Withdrawal by Subject|0|||
124731595|NCT03447314|448640157|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
124605104|NCT00750308|448174737|FG004|Second Treatment|Withdrawal by Subject|1|||
124605105|NCT00750308|448174738|FG005|Second Treatment|Withdrawal by Subject|0|||
124605106|NCT00750308|448174739|FG006|Second Treatment|Withdrawal by Subject|0|||
124605107|NCT00750308|448174740|FG007|Second Treatment|Withdrawal by Subject|0|||
124605108|NCT00750308|448174741|FG008|Second Treatment|Withdrawal by Subject|0|||
124605109|NCT00750308|448174742|FG009|Second Treatment|Withdrawal by Subject|0|||
124605110|NCT00750308|448174743|FG010|Second Treatment|Withdrawal by Subject|0|||
124605111|NCT00750308|448174744|FG011|Second Treatment|Withdrawal by Subject|0|||
124605112|NCT00750308|448174733|FG000|Third Treatment|Withdrawal by Subject|0|||
124605113|NCT00750308|448174734|FG001|Third Treatment|Withdrawal by Subject|1|||
124605114|NCT00750308|448174735|FG002|Third Treatment|Withdrawal by Subject|0|||
124605115|NCT00750308|448174736|FG003|Third Treatment|Withdrawal by Subject|0|||
124605116|NCT00750308|448174737|FG004|Third Treatment|Withdrawal by Subject|0|||
124605117|NCT00750308|448174738|FG005|Third Treatment|Withdrawal by Subject|0|||
124605118|NCT00750308|448174739|FG006|Third Treatment|Withdrawal by Subject|0|||
124605119|NCT00750308|448174740|FG007|Third Treatment|Withdrawal by Subject|0|||
124605120|NCT00750308|448174741|FG008|Third Treatment|Withdrawal by Subject|0|||
124605121|NCT00750308|448174742|FG009|Third Treatment|Withdrawal by Subject|0|||
124605122|NCT00750308|448174743|FG010|Third Treatment|Withdrawal by Subject|0|||
124605123|NCT00750308|448174744|FG011|Third Treatment|Withdrawal by Subject|0|||
124605124|NCT00513682|448174745|FG000|Washout Phase|Adverse Event|2|||
124605125|NCT01121666|448174747|FG000|Overall Study|Protocol Violation|29|||
124605126|NCT01121666|448174748|FG001|Overall Study|Protocol Violation|10|||
124605127|NCT03176459|448174749|FG000|Overall Study|Lost to Follow-up|5|||
124605128|NCT03176459|448174750|FG001|Overall Study|Lost to Follow-up|7|||
124605129|NCT00321737|448174751|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
124605130|NCT00321737|448174752|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
124605131|NCT00321737|448174753|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
124605132|NCT00321737|448174751|FG000|Overall Study|Adverse Event|11|||
124605133|NCT00321737|448174752|FG001|Overall Study|Adverse Event|3|||
124605134|NCT00321737|448174753|FG002|Overall Study|Adverse Event|6|||
124605135|NCT00321737|448174751|FG000|Overall Study|Lost to Follow-up|5|||
124605136|NCT00321737|448174752|FG001|Overall Study|Lost to Follow-up|5|||
124605137|NCT00321737|448174753|FG002|Overall Study|Lost to Follow-up|6|||
124605138|NCT00321737|448174751|FG000|Overall Study|Withdrawal by Subject|19|||
124605139|NCT00321737|448174752|FG001|Overall Study|Withdrawal by Subject|12|||
124605140|NCT00321737|448174753|FG002|Overall Study|Withdrawal by Subject|17|||
124605141|NCT00321737|448174751|FG000|Overall Study|Protocol Violation|0|||
124605142|NCT00321737|448174752|FG001|Overall Study|Protocol Violation|0|||
124605143|NCT00321737|448174753|FG002|Overall Study|Protocol Violation|1|||
124605144|NCT00321737|448174751|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
124605145|NCT00321737|448174752|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
124605146|NCT00321737|448174753|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
124605147|NCT00321737|448174751|FG000|Overall Study|Possible Barrett's Esophagus|2|||
124605148|NCT00321737|448174752|FG001|Overall Study|Possible Barrett's Esophagus|1|||
124605149|NCT00321737|448174753|FG002|Overall Study|Possible Barrett's Esophagus|1|||
124605150|NCT00321737|448174751|FG000|Overall Study|Therapeutic Failure|6|||
124605151|NCT00321737|448174752|FG001|Overall Study|Therapeutic Failure|0|||
124605152|NCT00321737|448174753|FG002|Overall Study|Therapeutic Failure|2|||
124605153|NCT00321737|448174751|FG000|Overall Study|Pregnancy|0|||
124605154|NCT00321737|448174752|FG001|Overall Study|Pregnancy|2|||
124605155|NCT00321737|448174753|FG002|Overall Study|Pregnancy|0|||
124605156|NCT00321737|448174751|FG000|Overall Study|Noncompliance|2|||
124605157|NCT00321737|448174752|FG001|Overall Study|Noncompliance|0|||
124605158|NCT00321737|448174753|FG002|Overall Study|Noncompliance|0|||
124605159|NCT00321737|448174751|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
124605160|NCT00321737|448174752|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
124605161|NCT00321737|448174753|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
124605162|NCT00290251|448174754|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
124605163|NCT00290251|448174755|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
124605164|NCT00290251|448174756|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
124605165|NCT00290251|448174757|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
124605166|NCT00290251|448174758|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
124605167|NCT00290251|448174759|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
124605168|NCT00290251|448174754|FG000|Treatment 1 (Months 2-4)|headache|0|||
124605169|NCT00290251|448174755|FG001|Treatment 1 (Months 2-4)|headache|0|||
124605170|NCT00290251|448174756|FG002|Treatment 1 (Months 2-4)|headache|0|||
124605171|NCT00290251|448174757|FG003|Treatment 1 (Months 2-4)|headache|0|||
124605172|NCT00290251|448174758|FG004|Treatment 1 (Months 2-4)|headache|1|||
124605173|NCT00290251|448174759|FG005|Treatment 1 (Months 2-4)|headache|0|||
124605174|NCT00290251|448174754|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
124605175|NCT00290251|448174755|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
124605176|NCT00290251|448174756|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
124605177|NCT00290251|448174757|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
124605178|NCT00290251|448174758|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
124605179|NCT00290251|448174759|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
124605180|NCT06077487|448177529|FG000|Overall Study|Withdrawal by Subject|0|||
124605181|NCT06077487|448177530|FG001|Overall Study|Withdrawal by Subject|1|||
124605182|NCT00759902|448177531|FG000|Overall Study|Adverse Event|0|||
124605183|NCT00759902|448177532|FG001|Overall Study|Adverse Event|1|||
124605184|NCT02128217|448177539|FG000|Overall Study|Lost to Follow-up|0|||
124781069|NCT01088048|448829072|FG000|Overall Study|Investigator Request|2|||
124605185|NCT02128217|448177540|FG001|Overall Study|Lost to Follow-up|1|||
124605186|NCT05071313|448177541|FG000|Overall Study|Lost to Follow-up|17|||
124605187|NCT05071313|448177542|FG001|Overall Study|Lost to Follow-up|10|||
124605188|NCT05071313|448177541|FG000|Overall Study|Physician Decision|1|||
124605189|NCT05071313|448177542|FG001|Overall Study|Physician Decision|6|||
124605190|NCT05071313|448177541|FG000|Overall Study|Death|1|||
124605191|NCT05071313|448177542|FG001|Overall Study|Death|0|||
124605192|NCT05071313|448177541|FG000|Overall Study|Withdrawal by Subject|10|||
124605193|NCT05071313|448177542|FG001|Overall Study|Withdrawal by Subject|15|||
124605194|NCT05071313|448177541|FG000|Overall Study|Other|1|||
124605195|NCT05071313|448177542|FG001|Overall Study|Other|0|||
124605196|NCT05071313|448177541|FG000|Overall Study|Randomized but not vaccinated|4|||
124605197|NCT05071313|448177542|FG001|Overall Study|Randomized but not vaccinated|2|||
124605198|NCT00541970|448177543|FG000|Month 7|Protocol Violation|9|||
124605199|NCT00541970|448177544|FG001|Month 7|Protocol Violation|13|||
124605200|NCT00541970|448177545|FG002|Month 7|Protocol Violation|11|||
124605201|NCT00541970|448177546|FG003|Month 7|Protocol Violation|5|||
124605202|NCT00541970|448177543|FG000|Month 12|Adverse Event|0|||
124605203|NCT00541970|448177544|FG001|Month 12|Adverse Event|1|||
124605204|NCT00541970|448177545|FG002|Month 12|Adverse Event|1|||
124605205|NCT00541970|448177546|FG003|Month 12|Adverse Event|1|||
124605206|NCT00541970|448177543|FG000|Month 12|Protocol Violation|12|||
124605207|NCT00541970|448177544|FG001|Month 12|Protocol Violation|21|||
124605208|NCT00541970|448177545|FG002|Month 12|Protocol Violation|20|||
124605209|NCT00541970|448177546|FG003|Month 12|Protocol Violation|15|||
124605210|NCT00541970|448177543|FG000|Month 18|Adverse Event|0|||
124605211|NCT00541970|448177544|FG001|Month 18|Adverse Event|1|||
124605212|NCT00541970|448177545|FG002|Month 18|Adverse Event|1|||
124605213|NCT00541970|448177546|FG003|Month 18|Adverse Event|1|||
124605214|NCT00541970|448177543|FG000|Month 18|Protocol Violation|14|||
124605215|NCT00541970|448177544|FG001|Month 18|Protocol Violation|23|||
124605216|NCT00541970|448177545|FG002|Month 18|Protocol Violation|24|||
124605217|NCT00541970|448177546|FG003|Month 18|Protocol Violation|16|||
124605218|NCT00541970|448177543|FG000|Month 24|Adverse Event|0|||
124605219|NCT00541970|448177544|FG001|Month 24|Adverse Event|1|||
124605220|NCT00541970|448177545|FG002|Month 24|Adverse Event|1|||
124605221|NCT00541970|448177546|FG003|Month 24|Adverse Event|1|||
124605222|NCT00541970|448177543|FG000|Month 24|Protocol Violation|29|||
124605223|NCT00541970|448177544|FG001|Month 24|Protocol Violation|31|||
124605224|NCT00541970|448177545|FG002|Month 24|Protocol Violation|31|||
124605225|NCT00541970|448177546|FG003|Month 24|Protocol Violation|21|||
124605226|NCT00541970|448177543|FG000|Month 36|Protocol Violation|61|||
124605227|NCT00541970|448177544|FG001|Month 36|Protocol Violation|66|||
124605228|NCT00541970|448177545|FG002|Month 36|Protocol Violation|66|||
124605229|NCT00541970|448177546|FG003|Month 36|Protocol Violation|60|||
124605230|NCT00541970|448177543|FG000|Month 48|Withdrawal by Subject|2|||
124605231|NCT00541970|448177544|FG001|Month 48|Withdrawal by Subject|4|||
124605232|NCT00541970|448177545|FG002|Month 48|Withdrawal by Subject|4|||
124605233|NCT00541970|448177546|FG003|Month 48|Withdrawal by Subject|2|||
124605234|NCT00541970|448177543|FG000|Month 48|Other|3|||
124605235|NCT00541970|448177544|FG001|Month 48|Other|1|||
124605236|NCT00541970|448177545|FG002|Month 48|Other|1|||
124605237|NCT00541970|448177546|FG003|Month 48|Other|0|||
124605238|NCT00541970|448177543|FG000|Month 48|Lost to Follow-up|66|||
124605239|NCT00541970|448177544|FG001|Month 48|Lost to Follow-up|68|||
124605240|NCT00541970|448177545|FG002|Month 48|Lost to Follow-up|68|||
124605241|NCT00541970|448177546|FG003|Month 48|Lost to Follow-up|73|||
124605242|NCT00541970|448177543|FG000|Month 60|Protocol Violation|78|||
124605243|NCT00541970|448177544|FG001|Month 60|Protocol Violation|77|||
124605244|NCT00541970|448177545|FG002|Month 60|Protocol Violation|82|||
124605245|NCT00541970|448177546|FG003|Month 60|Protocol Violation|72|||
124605246|NCT00321828|448177547|FG000|Overall Study|Ineligible|3|||
124605247|NCT00321828|448177547|FG000|Overall Study|No follow up data|1|||
124605248|NCT00858143|448177552|FG000|Overall Study|Adverse Event|16|||
124605249|NCT00858143|448177552|FG000|Overall Study|Lack of Efficacy|4|||
124605250|NCT00858143|448177552|FG000|Overall Study|Death|7|||
124605251|NCT00858143|448177552|FG000|Overall Study|Other|23|||
124605252|NCT03853148|448177553|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
124605253|NCT03853148|448177554|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
124605254|NCT03853148|448177555|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
124605255|NCT03853148|448177556|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
124605256|NCT00852969|448177557|FG000|Overall Study|Adverse Event|0|||
124605257|NCT00852969|448177558|FG001|Overall Study|Adverse Event|1|||
124605258|NCT00852969|448177557|FG000|Overall Study|Lost to Follow-up|0|||
124605259|NCT00852969|448177558|FG001|Overall Study|Lost to Follow-up|1|||
124605260|NCT00658658|448177561|FG000|Overall Study|Withdrawal by Subject|0|||
124605261|NCT00658658|448177562|FG001|Overall Study|Withdrawal by Subject|1|||
124605262|NCT00658658|448177563|FG002|Overall Study|Withdrawal by Subject|0|||
124605263|NCT00658658|448177564|FG003|Overall Study|Withdrawal by Subject|0|||
124605264|NCT00658658|448177565|FG004|Overall Study|Withdrawal by Subject|0|||
124605265|NCT00658658|448177561|FG000|Overall Study|Death|4|||
124605266|NCT00658658|448177562|FG001|Overall Study|Death|0|||
124605267|NCT00658658|448177563|FG002|Overall Study|Death|0|||
124605268|NCT00658658|448177564|FG003|Overall Study|Death|1|||
124605269|NCT00658658|448177565|FG004|Overall Study|Death|1|||
124605270|NCT00658658|448177561|FG000|Overall Study|Disease Progression|0|||
124605271|NCT00658658|448177562|FG001|Overall Study|Disease Progression|1|||
124605272|NCT00658658|448177563|FG002|Overall Study|Disease Progression|0|||
124605273|NCT00658658|448177564|FG003|Overall Study|Disease Progression|1|||
124605274|NCT00658658|448177565|FG004|Overall Study|Disease Progression|3|||
124605275|NCT00658658|448177561|FG000|Overall Study|Protocol-specified Criteria|1|||
124605276|NCT00658658|448177562|FG001|Overall Study|Protocol-specified Criteria|0|||
124605277|NCT00658658|448177563|FG002|Overall Study|Protocol-specified Criteria|0|||
124605278|NCT00658658|448177564|FG003|Overall Study|Protocol-specified Criteria|0|||
124605279|NCT00658658|448177565|FG004|Overall Study|Protocol-specified Criteria|0|||
124605280|NCT00658658|448177561|FG000|Overall Study|Other|0|||
124605281|NCT00658658|448177562|FG001|Overall Study|Other|0|||
124605282|NCT00658658|448177563|FG002|Overall Study|Other|0|||
124605283|NCT00658658|448177564|FG003|Overall Study|Other|0|||
124605284|NCT00658658|448177565|FG004|Overall Study|Other|1|||
124605285|NCT00678041|448177566|FG000|Overall Study|Physician Decision|5|||
124605286|NCT00678041|448177567|FG001|Overall Study|Physician Decision|5|||
124605287|NCT02358343|448177568|FG000|Screening Intervention|Death|0|||
124605288|NCT02358343|448177569|FG001|Screening Intervention|Death|2|||
124605289|NCT02358343|448177570|FG002|Screening Intervention|Death|0|||
124605290|NCT02358343|448177571|FG003|Screening Intervention|Death|0|||
124605291|NCT02358343|448177572|FG004|Screening Intervention|Death|0|||
124605292|NCT02358343|448177568|FG000|Screening Intervention|Withdrawal by Subject|1|||
124605293|NCT02358343|448177569|FG001|Screening Intervention|Withdrawal by Subject|0|||
124605294|NCT02358343|448177570|FG002|Screening Intervention|Withdrawal by Subject|0|||
124605295|NCT02358343|448177571|FG003|Screening Intervention|Withdrawal by Subject|0|||
124605296|NCT02358343|448177572|FG004|Screening Intervention|Withdrawal by Subject|0|||
124605297|NCT02358343|448177568|FG000|Screening Intervention|Determined Ineligible|5|||
124605298|NCT02358343|448177569|FG001|Screening Intervention|Determined Ineligible|6|||
124605299|NCT02358343|448177570|FG002|Screening Intervention|Determined Ineligible|0|||
124605300|NCT02358343|448177571|FG003|Screening Intervention|Determined Ineligible|0|||
124605301|NCT02358343|448177572|FG004|Screening Intervention|Determined Ineligible|0|||
124605302|NCT02358343|448177568|FG000|Comparative Efficacy Trial / Observation|Death|0|||
124605303|NCT02358343|448177569|FG001|Comparative Efficacy Trial / Observation|Death|0|||
124605304|NCT02358343|448177570|FG002|Comparative Efficacy Trial / Observation|Death|2|||
124605305|NCT02358343|448177571|FG003|Comparative Efficacy Trial / Observation|Death|0|||
124605306|NCT02358343|448177572|FG004|Comparative Efficacy Trial / Observation|Death|0|||
124605307|NCT02358343|448177568|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
124605308|NCT02358343|448177569|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
124605309|NCT02358343|448177570|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
124605310|NCT02358343|448177571|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
124605311|NCT02358343|448177572|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
124605312|NCT02358343|448177568|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
124605313|NCT02358343|448177569|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
124605314|NCT02358343|448177570|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
124605315|NCT02358343|448177571|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
124605316|NCT02358343|448177572|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
124605317|NCT00090610|448177575|FG000|Overall Study|Withdrawal by Subject|1|||
124605318|NCT00090610|448177576|FG001|Overall Study|Withdrawal by Subject|1|||
124605319|NCT02444793|448177577|FG000|Overall Study|Lost to Follow-up|2|||
124605320|NCT02444793|448177578|FG001|Overall Study|Lost to Follow-up|2|||
124605321|NCT02444793|448177579|FG002|Overall Study|Lost to Follow-up|0|||
124605322|NCT02444793|448177580|FG003|Overall Study|Lost to Follow-up|0|||
124605323|NCT02444793|448177577|FG000|Overall Study|Death|0|||
124605324|NCT02444793|448177578|FG001|Overall Study|Death|3|||
124605325|NCT02444793|448177579|FG002|Overall Study|Death|0|||
124605326|NCT02444793|448177580|FG003|Overall Study|Death|0|||
124605327|NCT02444793|448177577|FG000|Overall Study|Other|0|||
124605328|NCT02444793|448177578|FG001|Overall Study|Other|0|||
124605329|NCT02444793|448177579|FG002|Overall Study|Other|2|||
124605330|NCT02444793|448177580|FG003|Overall Study|Other|0|||
124605331|NCT02444793|448177577|FG000|Overall Study|Objective progression or relapse|9|||
124605332|NCT02444793|448177578|FG001|Overall Study|Objective progression or relapse|1|||
124605333|NCT02444793|448177579|FG002|Overall Study|Objective progression or relapse|2|||
124605334|NCT02444793|448177580|FG003|Overall Study|Objective progression or relapse|3|||
124605335|NCT04498403|448177583|FG000|Overall Study|Adverse Event|1|||
124605336|NCT04498403|448177584|FG001|Overall Study|Adverse Event|0|||
124605337|NCT04498403|448177583|FG000|Overall Study|Study Terminated By Sponsor|29|||
124605338|NCT04498403|448177584|FG001|Overall Study|Study Terminated By Sponsor|10|||
124605339|NCT01951885|448177585|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
124605340|NCT01951885|448177586|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
124605341|NCT01951885|448177585|FG000|Overall Study|Adverse Event|1|||
124605342|NCT01951885|448177586|FG001|Overall Study|Adverse Event|0|||
124605343|NCT01951885|448177585|FG000|Overall Study|Withdrawal by Subject|0|||
124605344|NCT01951885|448177586|FG001|Overall Study|Withdrawal by Subject|1|||
124605345|NCT01951885|448177585|FG000|Overall Study|ineligible due to a change in donor|0|||
124605346|NCT01951885|448177586|FG001|Overall Study|ineligible due to a change in donor|1|||
124605347|NCT01951885|448177585|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
124605348|NCT01951885|448177586|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
124605349|NCT00866658|448177587|FG000|Overall Study|Adverse Event|5|||
124605350|NCT00866658|448177588|FG001|Overall Study|Adverse Event|14|||
124605351|NCT00866658|448177587|FG000|Overall Study|Lack of Efficacy|2|||
124605352|NCT00866658|448177588|FG001|Overall Study|Lack of Efficacy|1|||
124605353|NCT00866658|448177587|FG000|Overall Study|Withdrawal by Subject|1|||
124605354|NCT00866658|448177588|FG001|Overall Study|Withdrawal by Subject|0|||
124605355|NCT00866658|448177587|FG000|Overall Study|Protocol Violation|1|||
124605356|NCT00866658|448177588|FG001|Overall Study|Protocol Violation|1|||
124605357|NCT00866658|448177587|FG000|Overall Study|Familial and Personal Reasons|4|||
124605358|NCT00866658|448177588|FG001|Overall Study|Familial and Personal Reasons|5|||
124605359|NCT01859130|448177591|FG000|Overall Study|Death|4|||
124605360|NCT01859130|448177591|FG000|Overall Study|Lost to Follow-up|16|||
124605361|NCT01859130|448177591|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
124605362|NCT01859130|448177591|FG000|Overall Study|Physician Decision|6|||
124605363|NCT01859130|448177591|FG000|Overall Study|Withdrawal by Subject|17|||
124605364|NCT01859130|448177591|FG000|Overall Study|Adverse Event|11|||
124605365|NCT01462318|448177594|FG000|Main Study / TP-DI Study|Other|2|||
124605366|NCT01462318|448177595|FG001|Main Study / TP-DI Study|Other|0|||
124605367|NCT01462318|448177596|FG002|Main Study / TP-DI Study|Other|0|||
124605368|NCT01462318|448177594|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
124605369|NCT01462318|448177595|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
124605370|NCT01462318|448177596|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
124605371|NCT01462318|448177594|FG000|Main Study / TP-DI Study|Adverse Event|4|||
124605372|NCT01462318|448177595|FG001|Main Study / TP-DI Study|Adverse Event|0|||
124605373|NCT01462318|448177596|FG002|Main Study / TP-DI Study|Adverse Event|0|||
124605374|NCT01462318|448177594|FG000|Extension Phase|Lost to Follow-up|0|||
124605375|NCT01462318|448177595|FG001|Extension Phase|Lost to Follow-up|0|||
124605376|NCT01462318|448177596|FG002|Extension Phase|Lost to Follow-up|1|||
124605377|NCT01462318|448177594|FG000|Extension Phase|Other|0|||
124605378|NCT01462318|448177595|FG001|Extension Phase|Other|0|||
124605379|NCT01462318|448177596|FG002|Extension Phase|Other|1|||
124605380|NCT01462318|448177594|FG000|Extension Phase|Disease Progression|0|||
124605381|NCT01462318|448177595|FG001|Extension Phase|Disease Progression|0|||
124605382|NCT01462318|448177596|FG002|Extension Phase|Disease Progression|1|||
124605383|NCT01462318|448177594|FG000|Extension Phase|Withdrawal by Subject|0|||
124605384|NCT01462318|448177595|FG001|Extension Phase|Withdrawal by Subject|0|||
124605385|NCT01462318|448177596|FG002|Extension Phase|Withdrawal by Subject|15|||
124605386|NCT01462318|448177594|FG000|Extension Phase|Investigator Decision|0|||
124605387|NCT01462318|448177595|FG001|Extension Phase|Investigator Decision|0|||
124605388|NCT01462318|448177596|FG002|Extension Phase|Investigator Decision|5|||
124605389|NCT01462318|448177594|FG000|Extension Phase|Adverse Event|0|||
124605390|NCT01462318|448177595|FG001|Extension Phase|Adverse Event|0|||
124605391|NCT01462318|448177596|FG002|Extension Phase|Adverse Event|22|||
124605392|NCT03827564|448177597|FG000|Overall Study|Discontinued due to Study Termination|1|||
124605393|NCT03827564|448177598|FG001|Overall Study|Discontinued due to Study Termination|0|||
124605394|NCT00891371|448177599|FG000|Pre-assignment|Inclusion/exclusion|5|||
124605395|NCT00891371|448177599|FG000|Pre-assignment|Consent withdrawal|1|||
124605396|NCT00891371|448177599|FG000|Treatment|Lack of Efficacy|5|||
124605397|NCT00891371|448177599|FG000|Treatment|Adverse Event|2|||
124605398|NCT00891371|448177599|FG000|Treatment|Death|1|||
124605399|NCT00891371|448177599|FG000|Treatment|Lost to Follow-up|1|||
124605400|NCT02238626|448177600|FG000|Overall Study|Adverse Event|3|||
124605401|NCT02238626|448177601|FG001|Overall Study|Adverse Event|5|||
124605402|NCT02238626|448177602|FG002|Overall Study|Adverse Event|0|||
124605403|NCT02238626|448177603|FG003|Overall Study|Adverse Event|3|||
124605404|NCT02238626|448177600|FG000|Overall Study|Lost to Follow-up|2|||
124605405|NCT02238626|448177601|FG001|Overall Study|Lost to Follow-up|4|||
124605406|NCT02238626|448177602|FG002|Overall Study|Lost to Follow-up|2|||
124605407|NCT02238626|448177603|FG003|Overall Study|Lost to Follow-up|2|||
124605408|NCT02238626|448177600|FG000|Overall Study|Withdrawal by Subject|0|||
124605409|NCT02238626|448177601|FG001|Overall Study|Withdrawal by Subject|3|||
124605410|NCT02238626|448177602|FG002|Overall Study|Withdrawal by Subject|0|||
124605411|NCT02238626|448177603|FG003|Overall Study|Withdrawal by Subject|1|||
124605412|NCT02238626|448177600|FG000|Overall Study|Death|0|||
124605413|NCT02238626|448177601|FG001|Overall Study|Death|0|||
124605414|NCT02238626|448177602|FG002|Overall Study|Death|1|||
124605415|NCT02238626|448177603|FG003|Overall Study|Death|1|||
124605416|NCT02238626|448177600|FG000|Overall Study|Other|0|||
124605417|NCT02238626|448177601|FG001|Overall Study|Other|2|||
124605418|NCT02238626|448177602|FG002|Overall Study|Other|0|||
124605419|NCT02238626|448177603|FG003|Overall Study|Other|0|||
124731596|NCT03447314|448640158|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
124731597|NCT03447314|448640141|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
124731598|NCT03447314|448640142|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
124731599|NCT03447314|448640143|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
124731600|NCT03447314|448640144|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
124731601|NCT03447314|448640145|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
124731602|NCT03447314|448640146|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
124731603|NCT03447314|448640147|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
124731604|NCT03447314|448640148|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
124731605|NCT03447314|448640149|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
124731606|NCT03447314|448640150|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
124731607|NCT03447314|448640151|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
124731608|NCT03447314|448640152|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
124731609|NCT03447314|448640153|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
124731610|NCT03447314|448640154|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
124731611|NCT03447314|448640155|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
124731612|NCT03447314|448640156|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
124731613|NCT03447314|448640157|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
124731614|NCT03447314|448640158|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
124731615|NCT03447314|448640141|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
124731616|NCT03447314|448640142|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
124731617|NCT03447314|448640143|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
124731618|NCT03447314|448640144|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
124731619|NCT03447314|448640145|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
124731620|NCT03447314|448640146|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
124731621|NCT03447314|448640147|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
124731622|NCT03447314|448640148|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
124731623|NCT03447314|448640149|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
124731624|NCT03447314|448640150|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
124605420|NCT02622113|448177606|FG000|Overall Study|Adverse Event|4|||
124605421|NCT02622113|448177607|FG001|Overall Study|Adverse Event|4|||
124605422|NCT02622113|448177606|FG000|Overall Study|Physician Decision|0|||
124605423|NCT02622113|448177607|FG001|Overall Study|Physician Decision|1|||
124605424|NCT02622113|448177606|FG000|Overall Study|Withdrawal by Subject|0|||
124605425|NCT02622113|448177607|FG001|Overall Study|Withdrawal by Subject|2|||
124605426|NCT02622113|448177606|FG000|Overall Study|Stopping Criteria|1|||
124605427|NCT02622113|448177607|FG001|Overall Study|Stopping Criteria|3|||
124605428|NCT00307034|448177608|FG000|Overall Study|Adverse Event|1|||
124605429|NCT00307034|448177609|FG001|Overall Study|Adverse Event|2|||
124605430|NCT00307034|448177608|FG000|Overall Study|Withdrawal by Subject|1|||
124605431|NCT00307034|448177609|FG001|Overall Study|Withdrawal by Subject|2|||
124605432|NCT00307034|448177608|FG000|Overall Study|Lost to Follow-up|0|||
124605433|NCT00307034|448177609|FG001|Overall Study|Lost to Follow-up|3|||
124605434|NCT04442490|448177616|FG000|Overall Study|Withdrawal by Subject|18|||
124605435|NCT04442490|448177617|FG001|Overall Study|Withdrawal by Subject|10|||
124605436|NCT04442490|448177616|FG000|Overall Study|Lost to Follow-up|7|||
124605437|NCT04442490|448177617|FG001|Overall Study|Lost to Follow-up|7|||
124605438|NCT04442490|448177616|FG000|Overall Study|Adverse Event|2|||
124605439|NCT04442490|448177617|FG001|Overall Study|Adverse Event|6|||
124605440|NCT04442490|448177616|FG000|Overall Study|Noncompliance|3|||
124605441|NCT04442490|448177617|FG001|Overall Study|Noncompliance|1|||
124605442|NCT04442490|448177616|FG000|Overall Study|Physician Decision|2|||
124605443|NCT04442490|448177617|FG001|Overall Study|Physician Decision|1|||
124605444|NCT04442490|448177616|FG000|Overall Study|Reason not Specified|2|||
124605445|NCT04442490|448177617|FG001|Overall Study|Reason not Specified|1|||
124605446|NCT04442490|448177616|FG000|Overall Study|Randomized but not Treated|3|||
124605447|NCT04442490|448177617|FG001|Overall Study|Randomized but not Treated|3|||
124605448|NCT01449279|448177618|FG000|Overall Study|Lack of Efficacy|5|||
124605449|NCT01449279|448177618|FG000|Overall Study|Toxicity|2|||
124605450|NCT00505375|448177619|FG000|Overall Study|Death|1|||
124605451|NCT00505375|448177620|FG001|Overall Study|Death|0|||
124605452|NCT00505375|448177619|FG000|Overall Study|Withdrawal by Subject|2|||
124605453|NCT00505375|448177620|FG001|Overall Study|Withdrawal by Subject|2|||
124605454|NCT00505375|448177619|FG000|Overall Study|Lost to Follow-up|0|||
124605455|NCT00505375|448177620|FG001|Overall Study|Lost to Follow-up|2|||
124605456|NCT00505375|448177619|FG000|Overall Study|Pregnancy|1|||
124605457|NCT00505375|448177620|FG001|Overall Study|Pregnancy|0|||
124605458|NCT00505375|448177619|FG000|Overall Study|Travel issues|0|||
124605459|NCT00505375|448177620|FG001|Overall Study|Travel issues|1|||
124605460|NCT03347422|448177621|FG000|Part A (26 Weeks)|Adverse Event|3|||
124605461|NCT03347422|448177622|FG001|Part A (26 Weeks)|Adverse Event|0|||
124605462|NCT03347422|448177621|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
124731625|NCT03447314|448640151|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
124731626|NCT03447314|448640152|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
124731627|NCT03447314|448640153|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
124731628|NCT03447314|448640154|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
124731629|NCT03447314|448640155|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
124605463|NCT03347422|448177622|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
124605464|NCT03347422|448177621|FG000|Part B (149 Weeks)|Adverse Event|0|||
124605465|NCT03347422|448177622|FG001|Part B (149 Weeks)|Adverse Event|1|||
124605466|NCT03347422|448177621|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
124605467|NCT03347422|448177622|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
124605468|NCT03347422|448177621|FG000|Part B (149 Weeks)|Other|1|||
124605469|NCT03347422|448177622|FG001|Part B (149 Weeks)|Other|0|||
124605470|NCT02746471|448177623|FG000|Overall Study|Death|43|||
124605471|NCT02746471|448177623|FG000|Overall Study|Exited before 36 months|1119|||
124605472|NCT00910091|448177624|FG000|Pre-assignment|Withdrawal by Subject|0|||
124605473|NCT00910091|448177625|FG001|Pre-assignment|Withdrawal by Subject|2|||
124605474|NCT00910091|448177624|FG000|Treatment and Survival|Withdrawal by Subject|3|||
124605475|NCT00910091|448177625|FG001|Treatment and Survival|Withdrawal by Subject|4|||
124605476|NCT00910091|448177624|FG000|Treatment and Survival|Adverse Event|1|||
124731630|NCT03447314|448640156|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
124605477|NCT00910091|448177625|FG001|Treatment and Survival|Adverse Event|0|||
124605478|NCT04594707|448177629|FG000|Overall Study|Adverse Event|0|||
124605479|NCT04594707|448177630|FG001|Overall Study|Adverse Event|0|||
124605480|NCT04594707|448177631|FG002|Overall Study|Adverse Event|1|||
124605481|NCT04594707|448177629|FG000|Overall Study|Death|0|||
124605482|NCT04594707|448177630|FG001|Overall Study|Death|2|||
124605483|NCT04594707|448177631|FG002|Overall Study|Death|2|||
124605484|NCT04594707|448177629|FG000|Overall Study|Lung Transplant|0|||
124605485|NCT04594707|448177630|FG001|Overall Study|Lung Transplant|0|||
124605486|NCT04594707|448177631|FG002|Overall Study|Lung Transplant|1|||
124605487|NCT04594707|448177629|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
124605488|NCT04594707|448177630|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
124605489|NCT04594707|448177631|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
124605490|NCT04594707|448177629|FG000|Overall Study|Study Terminated By Sponsor|19|||
124605491|NCT04594707|448177630|FG001|Overall Study|Study Terminated By Sponsor|47|||
124605492|NCT04594707|448177631|FG002|Overall Study|Study Terminated By Sponsor|41|||
124605493|NCT04594707|448177629|FG000|Overall Study|Withdrawal by Subject|1|||
124605494|NCT04594707|448177630|FG001|Overall Study|Withdrawal by Subject|0|||
124605495|NCT04594707|448177631|FG002|Overall Study|Withdrawal by Subject|2|||
124605496|NCT01155024|448177632|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
124605497|NCT01155024|448177633|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
124605498|NCT01155024|448177632|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
124605499|NCT01155024|448177633|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
124605500|NCT01155024|448177632|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
124605501|NCT01155024|448177633|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
124605502|NCT01593696|448177634|FG000|Dose Escalation|Progressive Disease|2|||
124605503|NCT01593696|448177635|FG001|Dose Escalation|Progressive Disease|0|||
124605504|NCT01593696|448177636|FG002|Dose Escalation|Progressive Disease|0|||
124605505|NCT01593696|448177637|FG003|Dose Escalation|Progressive Disease|0|||
124605506|NCT01593696|448177634|FG000|Dose Expansion|Fungal infection|0|||
124605507|NCT01593696|448177635|FG001|Dose Expansion|Fungal infection|0|||
124605508|NCT01593696|448177636|FG002|Dose Expansion|Fungal infection|1|||
124605509|NCT01593696|448177637|FG003|Dose Expansion|Fungal infection|0|||
124605510|NCT01936623|448177640|FG000|Overall Study|Lost to Follow-up|0|||
124605511|NCT01936623|448177641|FG001|Overall Study|Lost to Follow-up|5|||
124605512|NCT03167723|448177642|FG000|Overall Study|Protocol Violation|4|||
124605513|NCT03167723|448177643|FG001|Overall Study|Protocol Violation|6|||
124605514|NCT01175811|448177645|FG000|Overall Study|Adverse Event|1|||
124605515|NCT01175811|448177646|FG001|Overall Study|Adverse Event|1|||
124605516|NCT01175811|448177645|FG000|Overall Study|Entry criteria not met|3|||
124605517|NCT01175811|448177646|FG001|Overall Study|Entry criteria not met|1|||
124605518|NCT01175811|448177645|FG000|Overall Study|Lack of Efficacy|1|||
124605519|NCT01175811|448177646|FG001|Overall Study|Lack of Efficacy|0|||
124605520|NCT01175811|448177645|FG000|Overall Study|Lost to Follow-up|3|||
124605521|NCT01175811|448177646|FG001|Overall Study|Lost to Follow-up|2|||
124605522|NCT01175811|448177645|FG000|Overall Study|Physician Decision|1|||
124731631|NCT03447314|448640157|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
124605523|NCT01175811|448177646|FG001|Overall Study|Physician Decision|1|||
124605524|NCT01175811|448177645|FG000|Overall Study|Protocol Violation|1|||
124605525|NCT01175811|448177646|FG001|Overall Study|Protocol Violation|2|||
124605526|NCT01175811|448177645|FG000|Overall Study|Withdrawal by Subject|6|||
124605527|NCT01175811|448177646|FG001|Overall Study|Withdrawal by Subject|7|||
124605528|NCT03579966|448177647|FG000|Overall Study|Adverse Event|6|||
124605529|NCT03579966|448177647|FG000|Overall Study|Lost to Follow-up|4|||
124605530|NCT03579966|448177647|FG000|Overall Study|Physician Decision|10|||
124605531|NCT03579966|448177647|FG000|Overall Study|Pregnancy|1|||
124605532|NCT03579966|448177647|FG000|Overall Study|Withdrawal by Subject|16|||
124605533|NCT03579966|448177647|FG000|Overall Study|Study terminated by Sponsor|22|||
124605534|NCT03579966|448177647|FG000|Overall Study|Protocol Violation|1|||
124605535|NCT01340768|448177650|FG000|Overall Study|Lost to Follow-up|10|||
124605536|NCT01340768|448177651|FG001|Overall Study|Lost to Follow-up|4|||
124605537|NCT01340768|448177650|FG000|Overall Study|Withdrawal by Subject|5|||
124605538|NCT01340768|448177651|FG001|Overall Study|Withdrawal by Subject|1|||
124605539|NCT01340768|448177650|FG000|Overall Study|Other|2|||
124605540|NCT01340768|448177651|FG001|Overall Study|Other|0|||
124605541|NCT03052959|448177652|FG000|Overall Study|Lost to Follow-up|4|||
124605542|NCT03052959|448177653|FG001|Overall Study|Lost to Follow-up|5|||
124605543|NCT00950963|448177654|FG000|Overall Study|Lost to Follow-up|29|||
124731632|NCT03447314|448640158|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
124731633|NCT03447314|448640141|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124731634|NCT03447314|448640142|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124731635|NCT03447314|448640143|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124731636|NCT03447314|448640144|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124731637|NCT03447314|448640145|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124731638|NCT03447314|448640146|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124731639|NCT03447314|448640147|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124781070|NCT01088048|448829073|FG001|Overall Study|Investigator Request|2|||
124781071|NCT01088048|448829074|FG002|Overall Study|Investigator Request|0|||
124781072|NCT01088048|448829075|FG003|Overall Study|Investigator Request|0|||
124781073|NCT01088048|448829076|FG004|Overall Study|Investigator Request|3|||
124605544|NCT00950963|448177655|FG001|Overall Study|Lost to Follow-up|24|||
124605545|NCT00848107|448177656|FG000|Overall Study|Lost to Follow-up|2|||
124605546|NCT00848107|448177656|FG000|Overall Study|Withdrawal by Subject|8|||
124605547|NCT00848107|448177656|FG000|Overall Study|Adverse Event|9|||
124605548|NCT00848107|448177656|FG000|Overall Study|Death|1|||
124605549|NCT00848107|448177656|FG000|Overall Study|Pregnancy|1|||
124605550|NCT00326963|448177657|FG000|Overall Study|Adverse Event|2|||
124605551|NCT00326963|448177657|FG000|Overall Study|Injection site reaction|1|||
124605552|NCT00326963|448177657|FG000|Overall Study|Death|1|||
124605553|NCT00326963|448177657|FG000|Overall Study|Failure to return|10|||
124605554|NCT00326963|448177657|FG000|Overall Study|Withdrawal by Subject|10|||
124605555|NCT00326963|448177657|FG000|Overall Study|Refused treatment / did not cooperate|5|||
124605556|NCT00326963|448177657|FG000|Overall Study|Violation of selection criteria at entry|2|||
124605557|NCT00326963|448177657|FG000|Overall Study|Other protocol violation|1|||
124605558|NCT00326963|448177657|FG000|Overall Study|Administrative / other|1|||
124605559|NCT00859586|448177658|FG000|Overall Study|Donors|4|||
124605560|NCT02992418|448177659|FG000|Overall Study|Withdrawal by Subject|11|||
124605561|NCT02992418|448177660|FG001|Overall Study|Withdrawal by Subject|12|||
124605562|NCT02992418|448177659|FG000|Overall Study|Non-compliance with the protocol|308|||
124605563|NCT02992418|448177660|FG001|Overall Study|Non-compliance with the protocol|308|||
124605564|NCT02992418|448177659|FG000|Overall Study|Lost to Follow-up|27|||
124605565|NCT02992418|448177660|FG001|Overall Study|Lost to Follow-up|22|||
124605566|NCT03246126|448177665|FG000|Overall Study|Withdrawal by Subject|0|||
124605567|NCT03246126|448177666|FG001|Overall Study|Withdrawal by Subject|1|||
124605568|NCT01006135|448177669|FG000|Overall Study|Adverse Event|22|||
124605569|NCT01006135|448177669|FG000|Overall Study|Protocol Violation|14|||
124605570|NCT01006135|448177669|FG000|Overall Study|Lost to Follow-up|32|||
124605571|NCT01006135|448177669|FG000|Overall Study|Other|72|||
124605572|NCT00928707|448177671|FG000|Overall Study|Protocol Violation|1|||
124605573|NCT00928707|448177672|FG001|Overall Study|Protocol Violation|0|||
124605574|NCT00132028|448177673|FG000|Overall Study|Adverse Event|7|||
124605575|NCT00132028|448177673|FG000|Overall Study|Death|2|||
124605576|NCT00132028|448177673|FG000|Overall Study|Lack of Efficacy|11|||
124605577|NCT00132028|448177673|FG000|Overall Study|Withdrawal by Subject|2|||
124605578|NCT00132028|448177673|FG000|Overall Study|not eligible|2|||
124605579|NCT00132028|448177673|FG000|Overall Study|Physician Decision|3|||
124605580|NCT02731326|448177679|FG000|Overall Study|Withdrawal by Subject|4|||
124605581|NCT02731326|448177680|FG001|Overall Study|Withdrawal by Subject|1|||
124605582|NCT02731326|448177679|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
124605583|NCT02731326|448177680|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
124605584|NCT02731326|448177679|FG000|Overall Study|Discharged without AliveCor|10|||
124605585|NCT02731326|448177680|FG001|Overall Study|Discharged without AliveCor|0|||
124605586|NCT02731326|448177679|FG000|Overall Study|Duplicate Participant|1|||
124605587|NCT02731326|448177680|FG001|Overall Study|Duplicate Participant|1|||
124605588|NCT02272634|448177682|FG000|Overall Study|Adverse Event|1|||
124605589|NCT02272634|448177683|FG001|Overall Study|Adverse Event|0|||
124605590|NCT02272634|448177684|FG002|Overall Study|Adverse Event|0|||
124605591|NCT02272634|448177682|FG000|Overall Study|Protocol Violation|0|||
124605592|NCT02272634|448177683|FG001|Overall Study|Protocol Violation|0|||
124605593|NCT02272634|448177684|FG002|Overall Study|Protocol Violation|1|||
124605594|NCT02272634|448177682|FG000|Overall Study|Withdrawal by Subject|0|||
124605595|NCT02272634|448177683|FG001|Overall Study|Withdrawal by Subject|1|||
124605596|NCT02272634|448177684|FG002|Overall Study|Withdrawal by Subject|0|||
124605597|NCT05070546|448177685|FG000|Overall Study|Death|0|||
124605598|NCT05070546|448177686|FG001|Overall Study|Death|0|||
124605599|NCT05070546|448177687|FG002|Overall Study|Death|0|||
124605600|NCT05070546|448177688|FG003|Overall Study|Death|0|||
124605601|NCT05070546|448177689|FG004|Overall Study|Death|0|||
124605602|NCT05070546|448177690|FG005|Overall Study|Death|1|||
124605603|NCT05070546|448177685|FG000|Overall Study|Lost to Follow-up|8|||
124605604|NCT05070546|448177686|FG001|Overall Study|Lost to Follow-up|2|||
124605605|NCT05070546|448177687|FG002|Overall Study|Lost to Follow-up|7|||
124605606|NCT05070546|448177688|FG003|Overall Study|Lost to Follow-up|1|||
124605607|NCT05070546|448177689|FG004|Overall Study|Lost to Follow-up|2|||
124605608|NCT05070546|448177690|FG005|Overall Study|Lost to Follow-up|0|||
124605609|NCT05070546|448177685|FG000|Overall Study|Withdrawal by Subject|1|||
124605610|NCT05070546|448177686|FG001|Overall Study|Withdrawal by Subject|1|||
124605611|NCT05070546|448177687|FG002|Overall Study|Withdrawal by Subject|3|||
124605612|NCT05070546|448177688|FG003|Overall Study|Withdrawal by Subject|0|||
124605613|NCT05070546|448177689|FG004|Overall Study|Withdrawal by Subject|0|||
124605614|NCT05070546|448177690|FG005|Overall Study|Withdrawal by Subject|0|||
124605615|NCT05070546|448177685|FG000|Overall Study|Other|0|||
124605616|NCT05070546|448177686|FG001|Overall Study|Other|0|||
124605617|NCT05070546|448177687|FG002|Overall Study|Other|0|||
124605618|NCT05070546|448177688|FG003|Overall Study|Other|0|||
124605619|NCT05070546|448177689|FG004|Overall Study|Other|3|||
124605620|NCT05070546|448177690|FG005|Overall Study|Other|0|||
124605621|NCT05070546|448177685|FG000|Overall Study|Randomized but not vaccinated|1|||
124605622|NCT05070546|448177686|FG001|Overall Study|Randomized but not vaccinated|0|||
124605623|NCT05070546|448177687|FG002|Overall Study|Randomized but not vaccinated|1|||
124605624|NCT05070546|448177688|FG003|Overall Study|Randomized but not vaccinated|1|||
124605625|NCT05070546|448177689|FG004|Overall Study|Randomized but not vaccinated|3|||
124605626|NCT05070546|448177690|FG005|Overall Study|Randomized but not vaccinated|0|||
124605627|NCT00302081|448177691|FG000|Overall Study|Adverse Event|6|||
124605628|NCT00302081|448177692|FG001|Overall Study|Adverse Event|5|||
124605629|NCT00302081|448177693|FG002|Overall Study|Adverse Event|4|||
124605630|NCT00302081|448177691|FG000|Overall Study|Lost to Follow-up|21|||
124605631|NCT00302081|448177692|FG001|Overall Study|Lost to Follow-up|18|||
124605632|NCT00302081|448177693|FG002|Overall Study|Lost to Follow-up|28|||
124605633|NCT00302081|448177691|FG000|Overall Study|Withdrawal by Subject|8|||
124605634|NCT00302081|448177692|FG001|Overall Study|Withdrawal by Subject|12|||
124605635|NCT00302081|448177693|FG002|Overall Study|Withdrawal by Subject|8|||
124605636|NCT00302081|448177691|FG000|Overall Study|Protocol Violation|5|||
124605637|NCT00302081|448177692|FG001|Overall Study|Protocol Violation|1|||
124605638|NCT00302081|448177693|FG002|Overall Study|Protocol Violation|2|||
124605639|NCT00302081|448177691|FG000|Overall Study|Lack of Efficacy|1|||
124605640|NCT00302081|448177692|FG001|Overall Study|Lack of Efficacy|0|||
124605641|NCT00302081|448177693|FG002|Overall Study|Lack of Efficacy|5|||
124605642|NCT00302081|448177691|FG000|Overall Study|Death|2|||
124605643|NCT00302081|448177692|FG001|Overall Study|Death|1|||
124605644|NCT00302081|448177693|FG002|Overall Study|Death|0|||
124605645|NCT00302081|448177691|FG000|Overall Study|Other|13|||
124605646|NCT00302081|448177692|FG001|Overall Study|Other|6|||
124605647|NCT00302081|448177693|FG002|Overall Study|Other|5|||
124605648|NCT01616953|448177694|FG000|Overall Study|Lost to Follow-up|1|||
124605649|NCT01616953|448177695|FG001|Overall Study|Lost to Follow-up|0|||
124605650|NCT01616953|448177694|FG000|Overall Study|lack of bone and soft tissue|1|||
124731640|NCT03447314|448640148|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124605651|NCT01616953|448177695|FG001|Overall Study|lack of bone and soft tissue|0|||
124605652|NCT01359644|448177696|FG000|Treatment Period|Lack of Efficacy|0|||
124605653|NCT01359644|448177697|FG001|Treatment Period|Lack of Efficacy|1|||
124605654|NCT01359644|448177698|FG002|Treatment Period|Lack of Efficacy|0|||
124605655|NCT01359644|448177699|FG003|Treatment Period|Lack of Efficacy|0|||
124605656|NCT01359644|448177700|FG004|Treatment Period|Lack of Efficacy|0|||
124605657|NCT01359644|448177701|FG005|Treatment Period|Lack of Efficacy|0|||
124605658|NCT01359644|448177702|FG006|Treatment Period|Lack of Efficacy|0|||
124605659|NCT01359644|448177703|FG007|Treatment Period|Lack of Efficacy|0|||
124605660|NCT01359644|448177704|FG008|Treatment Period|Lack of Efficacy|0|||
124605661|NCT01359644|448177705|FG009|Treatment Period|Lack of Efficacy|0|||
124605662|NCT01359644|448177696|FG000|Treatment Period|Adverse Event|0|||
124605663|NCT01359644|448177697|FG001|Treatment Period|Adverse Event|0|||
124605664|NCT01359644|448177698|FG002|Treatment Period|Adverse Event|1|||
124605665|NCT01359644|448177699|FG003|Treatment Period|Adverse Event|0|||
124605666|NCT01359644|448177700|FG004|Treatment Period|Adverse Event|0|||
124605667|NCT01359644|448177701|FG005|Treatment Period|Adverse Event|1|||
124605668|NCT01359644|448177702|FG006|Treatment Period|Adverse Event|0|||
124605669|NCT01359644|448177703|FG007|Treatment Period|Adverse Event|0|||
124605670|NCT01359644|448177704|FG008|Treatment Period|Adverse Event|0|||
124605671|NCT01359644|448177705|FG009|Treatment Period|Adverse Event|0|||
124605672|NCT01359644|448177696|FG000|Treatment Period|Lost to Follow-up|0|||
124605673|NCT01359644|448177697|FG001|Treatment Period|Lost to Follow-up|0|||
124605674|NCT01359644|448177698|FG002|Treatment Period|Lost to Follow-up|0|||
124605675|NCT01359644|448177699|FG003|Treatment Period|Lost to Follow-up|0|||
124605676|NCT01359644|448177700|FG004|Treatment Period|Lost to Follow-up|0|||
124605677|NCT01359644|448177701|FG005|Treatment Period|Lost to Follow-up|1|||
124605678|NCT01359644|448177702|FG006|Treatment Period|Lost to Follow-up|0|||
124605679|NCT01359644|448177703|FG007|Treatment Period|Lost to Follow-up|0|||
124605680|NCT01359644|448177704|FG008|Treatment Period|Lost to Follow-up|0|||
124605681|NCT01359644|448177705|FG009|Treatment Period|Lost to Follow-up|0|||
124605682|NCT01359644|448177696|FG000|Follow-up Period|Withdrawal by Subject|0|||
124605683|NCT01359644|448177697|FG001|Follow-up Period|Withdrawal by Subject|0|||
124605684|NCT01359644|448177698|FG002|Follow-up Period|Withdrawal by Subject|0|||
124605685|NCT01359644|448177699|FG003|Follow-up Period|Withdrawal by Subject|0|||
124605686|NCT01359644|448177700|FG004|Follow-up Period|Withdrawal by Subject|0|||
124605687|NCT01359644|448177701|FG005|Follow-up Period|Withdrawal by Subject|1|||
124605688|NCT01359644|448177702|FG006|Follow-up Period|Withdrawal by Subject|0|||
124605689|NCT01359644|448177703|FG007|Follow-up Period|Withdrawal by Subject|0|||
124605690|NCT01359644|448177704|FG008|Follow-up Period|Withdrawal by Subject|0|||
124605691|NCT01359644|448177705|FG009|Follow-up Period|Withdrawal by Subject|0|||
124605692|NCT01359644|448177696|FG000|Follow-up Period|Lost to Follow-up|0|||
124605693|NCT01359644|448177697|FG001|Follow-up Period|Lost to Follow-up|0|||
124605694|NCT01359644|448177698|FG002|Follow-up Period|Lost to Follow-up|0|||
124605695|NCT01359644|448177699|FG003|Follow-up Period|Lost to Follow-up|0|||
124605696|NCT01359644|448177700|FG004|Follow-up Period|Lost to Follow-up|0|||
124605697|NCT01359644|448177701|FG005|Follow-up Period|Lost to Follow-up|0|||
124605698|NCT01359644|448177702|FG006|Follow-up Period|Lost to Follow-up|1|||
124605699|NCT01359644|448177703|FG007|Follow-up Period|Lost to Follow-up|2|||
124605700|NCT01359644|448177704|FG008|Follow-up Period|Lost to Follow-up|0|||
124605701|NCT01359644|448177705|FG009|Follow-up Period|Lost to Follow-up|0|||
124605702|NCT02500641|448177708|FG000|Overall Study|Adverse Event|0|||
124605703|NCT02500641|448177709|FG001|Overall Study|Adverse Event|2|||
124605704|NCT02500641|448177708|FG000|Overall Study|Withdrawal by Subject|4|||
124605705|NCT02500641|448177709|FG001|Overall Study|Withdrawal by Subject|5|||
124605706|NCT02500641|448177708|FG000|Overall Study|Unable to follow study procedures|3|||
124605707|NCT02500641|448177709|FG001|Overall Study|Unable to follow study procedures|2|||
124605708|NCT02500641|448177708|FG000|Overall Study|Protocol Violation|1|||
124605709|NCT02500641|448177709|FG001|Overall Study|Protocol Violation|2|||
124605710|NCT02500641|448177708|FG000|Overall Study|Lost to Follow-up|1|||
124605711|NCT02500641|448177709|FG001|Overall Study|Lost to Follow-up|0|||
124605712|NCT02500641|448177708|FG000|Overall Study|Sponsor decision|1|||
124605713|NCT02500641|448177709|FG001|Overall Study|Sponsor decision|0|||
124605714|NCT02500641|448177708|FG000|Overall Study|Non compliance to study drug|0|||
124605715|NCT02500641|448177709|FG001|Overall Study|Non compliance to study drug|1|||
124605716|NCT00643565|448177711|FG000|Overall Study|Death|12|||
124605717|NCT00643565|448177712|FG001|Overall Study|Death|11|||
124605718|NCT00643565|448177711|FG000|Overall Study|Withdrawal by Subject|4|||
124605719|NCT00643565|448177712|FG001|Overall Study|Withdrawal by Subject|1|||
124605720|NCT00643565|448177711|FG000|Overall Study|Lost to Follow-up|0|||
124605721|NCT00643565|448177712|FG001|Overall Study|Lost to Follow-up|6|||
124605722|NCT00643565|448177711|FG000|Overall Study|Other|7|||
124605723|NCT00643565|448177712|FG001|Overall Study|Other|8|||
124605724|NCT00643565|448177711|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
124605725|NCT00643565|448177712|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
124605726|NCT00643565|448177711|FG000|Overall Study|Recurrence of Disease|2|||
124605727|NCT00643565|448177712|FG001|Overall Study|Recurrence of Disease|1|||
124605728|NCT00643565|448177711|FG000|Overall Study|Progression of Disease|18|||
124605729|NCT00643565|448177712|FG001|Overall Study|Progression of Disease|14|||
124605730|NCT00643565|448177711|FG000|Overall Study|Protocol Violation|3|||
124605731|NCT00643565|448177712|FG001|Overall Study|Protocol Violation|0|||
124605732|NCT00643565|448177711|FG000|Overall Study|Did Not Cooperate|0|||
124605733|NCT00643565|448177712|FG001|Overall Study|Did Not Cooperate|1|||
124605734|NCT00643565|448177711|FG000|Overall Study|Administrative|22|||
124605735|NCT00643565|448177712|FG001|Overall Study|Administrative|16|||
124605736|NCT00643565|448177711|FG000|Overall Study|Adverse Event|5|||
124605737|NCT00643565|448177712|FG001|Overall Study|Adverse Event|8|||
124605738|NCT02317614|448177713|FG000|Overall Study|Lost to Follow-up|1|||
124605739|NCT02317614|448177714|FG001|Overall Study|Lost to Follow-up|1|||
124605740|NCT02317614|448177713|FG000|Overall Study|Withdrawal by Subject|1|||
124605741|NCT02317614|448177714|FG001|Overall Study|Withdrawal by Subject|0|||
124605742|NCT02317614|448177713|FG000|Overall Study|Death|1|||
124605743|NCT02317614|448177714|FG001|Overall Study|Death|1|||
124605744|NCT01355159|448177715|FG000|Overall Study|Withdrew consent|39|||
124605745|NCT01355159|448177716|FG001|Overall Study|Withdrew consent|47|||
124605746|NCT01355159|448177715|FG000|Overall Study|No primary outcome data|17|||
124605747|NCT01355159|448177716|FG001|Overall Study|No primary outcome data|11|||
124605748|NCT01355159|448177715|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
124605749|NCT01355159|448177716|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
124605750|NCT01355159|448177715|FG000|Overall Study|Early intrauterine fetal death|6|||
124605751|NCT01355159|448177716|FG001|Overall Study|Early intrauterine fetal death|6|||
124605752|NCT00741936|448177717|FG000|Overall Study|Lost to Follow-up|1|||
124605753|NCT00741936|448177718|FG001|Overall Study|Lost to Follow-up|1|||
124605754|NCT00741936|448177717|FG000|Overall Study|Adverse Event|3|||
124605755|NCT00741936|448177718|FG001|Overall Study|Adverse Event|4|||
124605756|NCT00741936|448177717|FG000|Overall Study|Pregnancy|0|||
124605757|NCT00741936|448177718|FG001|Overall Study|Pregnancy|1|||
124605758|NCT00741936|448177717|FG000|Overall Study|Protocol Violation|2|||
124605759|NCT00741936|448177718|FG001|Overall Study|Protocol Violation|0|||
124605760|NCT00741936|448177717|FG000|Overall Study|Lack of Efficacy|0|||
124605761|NCT00741936|448177718|FG001|Overall Study|Lack of Efficacy|2|||
124605762|NCT00741936|448177717|FG000|Overall Study|Low compliance|3|||
124605763|NCT00741936|448177718|FG001|Overall Study|Low compliance|0|||
124605764|NCT02450526|448177719|FG000|DB Period (Cycle 1)|Adverse Event|0|||
124605765|NCT02450526|448177720|FG001|DB Period (Cycle 1)|Adverse Event|0|||
124605766|NCT02450526|448177721|FG002|DB Period (Cycle 1)|Adverse Event|2|||
124605767|NCT02450526|448177722|FG003|DB Period (Cycle 1)|Adverse Event|0|||
124605768|NCT02450526|448177723|FG004|DB Period (Cycle 1)|Adverse Event|0|||
124605769|NCT02450526|448177719|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
124605770|NCT02450526|448177720|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
124605771|NCT02450526|448177721|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
124605772|NCT02450526|448177722|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
124605773|NCT02450526|448177723|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
124781074|NCT01088048|448829077|FG005|Overall Study|Investigator Request|1|||
124781075|NCT01088048|448829078|FG006|Overall Study|Investigator Request|1|||
124781076|NCT01088048|448829079|FG007|Overall Study|Investigator Request|0|||
124781077|NCT01088048|448829080|FG008|Overall Study|Investigator Request|0|||
124781078|NCT01088048|448829081|FG009|Overall Study|Investigator Request|0|||
124781079|NCT01088048|448829072|FG000|Overall Study|Patient Non-compliance|0|||
124781080|NCT01088048|448829073|FG001|Overall Study|Patient Non-compliance|1|||
124781081|NCT01088048|448829074|FG002|Overall Study|Patient Non-compliance|0|||
124781082|NCT01088048|448829075|FG003|Overall Study|Patient Non-compliance|0|||
124781083|NCT01088048|448829076|FG004|Overall Study|Patient Non-compliance|0|||
124781084|NCT01088048|448829077|FG005|Overall Study|Patient Non-compliance|0|||
124781085|NCT01088048|448829078|FG006|Overall Study|Patient Non-compliance|0|||
124781086|NCT01088048|448829079|FG007|Overall Study|Patient Non-compliance|0|||
124781087|NCT01088048|448829080|FG008|Overall Study|Patient Non-compliance|0|||
124781088|NCT01088048|448829081|FG009|Overall Study|Patient Non-compliance|0|||
124781089|NCT01088048|448829072|FG000|Overall Study|Disease Progression|7|||
124605774|NCT02450526|448177719|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
124605775|NCT02450526|448177720|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
124605776|NCT02450526|448177721|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
124605777|NCT02450526|448177722|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
124605778|NCT02450526|448177723|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
124605779|NCT02450526|448177719|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
124605780|NCT02450526|448177720|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
124605781|NCT02450526|448177721|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
124605782|NCT02450526|448177722|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
124605783|NCT02450526|448177723|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
124605784|NCT02450526|448177719|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
124605785|NCT02450526|448177720|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
124605786|NCT02450526|448177721|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
124605787|NCT02450526|448177722|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
124605788|NCT02450526|448177723|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
124605789|NCT02450526|448177719|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
124605790|NCT02450526|448177720|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
124781090|NCT01088048|448829073|FG001|Overall Study|Disease Progression|4|||
124781091|NCT01088048|448829074|FG002|Overall Study|Disease Progression|3|||
124605791|NCT02450526|448177721|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
124605792|NCT02450526|448177722|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
124605793|NCT02450526|448177723|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
124605794|NCT02450526|448177719|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
124605795|NCT02450526|448177720|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
124605796|NCT02450526|448177721|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
124605797|NCT02450526|448177722|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
124605798|NCT02450526|448177723|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
124605799|NCT02450526|448177719|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
124605800|NCT02450526|448177720|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
124605801|NCT02450526|448177721|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
124781092|NCT01088048|448829075|FG003|Overall Study|Disease Progression|5|||
124781093|NCT01088048|448829076|FG004|Overall Study|Disease Progression|3|||
124781094|NCT01088048|448829077|FG005|Overall Study|Disease Progression|3|||
124605802|NCT02450526|448177722|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
124605803|NCT02450526|448177723|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
124605804|NCT01970865|448177724|FG000|Overall Study|Death|3|||
124605805|NCT01970865|448177725|FG001|Overall Study|Death|2|||
124605806|NCT01970865|448177726|FG002|Overall Study|Death|3|||
124605807|NCT01970865|448177727|FG003|Overall Study|Death|6|||
124605808|NCT01970865|448177728|FG004|Overall Study|Death|9|||
124605809|NCT01970865|448177729|FG005|Overall Study|Death|3|||
124605810|NCT01970865|448177730|FG006|Overall Study|Death|2|||
124605811|NCT01970865|448177731|FG007|Overall Study|Death|3|||
124605812|NCT01970865|448177732|FG008|Overall Study|Death|2|||
124605813|NCT01970865|448177733|FG009|Overall Study|Death|2|||
124605814|NCT01970865|448177734|FG010|Overall Study|Death|8|||
124605815|NCT01970865|448177735|FG011|Overall Study|Death|13|||
124605816|NCT01970865|448177736|FG012|Overall Study|Death|25|||
124605817|NCT01970865|448177737|FG013|Overall Study|Death|46|||
124605818|NCT01970865|448177738|FG014|Overall Study|Death|37|||
124605819|NCT01970865|448177739|FG015|Overall Study|Death|22|||
124605820|NCT01970865|448177740|FG016|Overall Study|Death|1|||
124605821|NCT01970865|448177741|FG017|Overall Study|Death|17|||
124605822|NCT01970865|448177724|FG000|Overall Study|Lost to Follow-up|0|||
124605823|NCT01970865|448177725|FG001|Overall Study|Lost to Follow-up|0|||
124605824|NCT01970865|448177726|FG002|Overall Study|Lost to Follow-up|0|||
124605825|NCT01970865|448177727|FG003|Overall Study|Lost to Follow-up|1|||
124605826|NCT01970865|448177728|FG004|Overall Study|Lost to Follow-up|1|||
124605827|NCT01970865|448177729|FG005|Overall Study|Lost to Follow-up|0|||
124605828|NCT01970865|448177730|FG006|Overall Study|Lost to Follow-up|0|||
124605829|NCT01970865|448177731|FG007|Overall Study|Lost to Follow-up|0|||
124605830|NCT01970865|448177732|FG008|Overall Study|Lost to Follow-up|0|||
124605831|NCT01970865|448177733|FG009|Overall Study|Lost to Follow-up|0|||
124605832|NCT01970865|448177734|FG010|Overall Study|Lost to Follow-up|1|||
124605833|NCT01970865|448177735|FG011|Overall Study|Lost to Follow-up|0|||
124605834|NCT01970865|448177736|FG012|Overall Study|Lost to Follow-up|2|||
124605835|NCT01970865|448177737|FG013|Overall Study|Lost to Follow-up|0|||
124605836|NCT01970865|448177738|FG014|Overall Study|Lost to Follow-up|1|||
124605837|NCT01970865|448177739|FG015|Overall Study|Lost to Follow-up|4|||
124605838|NCT01970865|448177740|FG016|Overall Study|Lost to Follow-up|0|||
124605839|NCT01970865|448177741|FG017|Overall Study|Lost to Follow-up|1|||
124605840|NCT01970865|448177724|FG000|Overall Study|Other|0|||
124605841|NCT01970865|448177725|FG001|Overall Study|Other|1|||
124605842|NCT01970865|448177726|FG002|Overall Study|Other|0|||
124605843|NCT01970865|448177727|FG003|Overall Study|Other|1|||
124731641|NCT03447314|448640149|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124731642|NCT03447314|448640150|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124731643|NCT03447314|448640151|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
124731644|NCT03447314|448640152|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124731645|NCT03447314|448640153|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124731646|NCT03447314|448640154|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124731647|NCT03447314|448640155|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124731648|NCT03447314|448640156|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124731649|NCT03447314|448640157|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124731650|NCT03447314|448640158|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
124731651|NCT03447314|448640141|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
124731652|NCT03447314|448640142|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
124731653|NCT03447314|448640143|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
124731654|NCT03447314|448640144|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
124731655|NCT03447314|448640145|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
124731656|NCT03447314|448640146|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
124605844|NCT01970865|448177728|FG004|Overall Study|Other|1|||
124605845|NCT01970865|448177729|FG005|Overall Study|Other|0|||
124605846|NCT01970865|448177730|FG006|Overall Study|Other|1|||
124605847|NCT01970865|448177731|FG007|Overall Study|Other|0|||
124605848|NCT01970865|448177732|FG008|Overall Study|Other|0|||
124605849|NCT01970865|448177733|FG009|Overall Study|Other|0|||
124605850|NCT01970865|448177734|FG010|Overall Study|Other|2|||
124605851|NCT01970865|448177735|FG011|Overall Study|Other|3|||
124605852|NCT01970865|448177736|FG012|Overall Study|Other|8|||
124605853|NCT01970865|448177737|FG013|Overall Study|Other|3|||
124605854|NCT01970865|448177738|FG014|Overall Study|Other|2|||
124605855|NCT01970865|448177739|FG015|Overall Study|Other|3|||
124605856|NCT01970865|448177740|FG016|Overall Study|Other|0|||
124605857|NCT01970865|448177741|FG017|Overall Study|Other|2|||
124605858|NCT01970865|448177724|FG000|Overall Study|Participant refused further follow-up|0|||
124605859|NCT01970865|448177725|FG001|Overall Study|Participant refused further follow-up|0|||
124605860|NCT01970865|448177726|FG002|Overall Study|Participant refused further follow-up|0|||
124605861|NCT01970865|448177727|FG003|Overall Study|Participant refused further follow-up|2|||
124605862|NCT01970865|448177728|FG004|Overall Study|Participant refused further follow-up|3|||
124605863|NCT01970865|448177729|FG005|Overall Study|Participant refused further follow-up|0|||
124605864|NCT01970865|448177730|FG006|Overall Study|Participant refused further follow-up|0|||
124605865|NCT01970865|448177731|FG007|Overall Study|Participant refused further follow-up|0|||
124605866|NCT01970865|448177732|FG008|Overall Study|Participant refused further follow-up|0|||
124605867|NCT01970865|448177733|FG009|Overall Study|Participant refused further follow-up|0|||
124605868|NCT01970865|448177734|FG010|Overall Study|Participant refused further follow-up|1|||
124605869|NCT01970865|448177735|FG011|Overall Study|Participant refused further follow-up|4|||
124605870|NCT01970865|448177736|FG012|Overall Study|Participant refused further follow-up|7|||
124605871|NCT01970865|448177737|FG013|Overall Study|Participant refused further follow-up|8|||
124605872|NCT01970865|448177738|FG014|Overall Study|Participant refused further follow-up|3|||
124605873|NCT01970865|448177739|FG015|Overall Study|Participant refused further follow-up|11|||
124605874|NCT01970865|448177740|FG016|Overall Study|Participant refused further follow-up|0|||
124605875|NCT01970865|448177741|FG017|Overall Study|Participant refused further follow-up|6|||
124605876|NCT03071094|448177744|FG000|Overall Study|Death|1|||
124605877|NCT03071094|448177745|FG001|Overall Study|Death|1|||
124605878|NCT03071094|448177744|FG000|Overall Study|Adverse Event|1|||
124605879|NCT03071094|448177745|FG001|Overall Study|Adverse Event|0|||
124605880|NCT01079832|448177746|FG000|Overall Study|Withdrawal by Subject|1|||
124605881|NCT03982199|448177747|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
124605882|NCT03982199|448177748|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
124605883|NCT03982199|448177749|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
124605884|NCT03982199|448177750|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
124605885|NCT03982199|448177751|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
124605886|NCT03982199|448177752|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
124605887|NCT03982199|448177753|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
124605888|NCT03982199|448177754|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
124605889|NCT03982199|448177755|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
124605890|NCT03982199|448177756|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
124605891|NCT03982199|448177757|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
124605892|NCT03982199|448177758|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
124605893|NCT03982199|448177759|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
124605894|NCT03982199|448177760|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
124605895|NCT03982199|448177747|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
124605896|NCT03982199|448177748|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
124605897|NCT03982199|448177749|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
124605898|NCT03982199|448177750|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
124605899|NCT03982199|448177751|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
124605900|NCT03982199|448177752|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
124605901|NCT03982199|448177753|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
124605902|NCT03982199|448177754|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
124605903|NCT03982199|448177755|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
124605904|NCT03982199|448177756|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
124605905|NCT03982199|448177757|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
124605906|NCT03982199|448177758|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
124605907|NCT03982199|448177759|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
124605908|NCT03982199|448177760|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
124605909|NCT03982199|448177747|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
124605910|NCT03982199|448177748|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
124605911|NCT03982199|448177749|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
124605912|NCT03982199|448177750|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
124605913|NCT03982199|448177751|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
124605914|NCT03982199|448177752|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
124605915|NCT03982199|448177753|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
124605916|NCT03982199|448177754|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
124605917|NCT03982199|448177755|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
124605918|NCT03982199|448177756|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
124605919|NCT03982199|448177757|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
124605920|NCT03982199|448177758|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
124605921|NCT03982199|448177759|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
124605922|NCT03982199|448177760|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
124605923|NCT03982199|448177747|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
124605924|NCT03982199|448177748|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
124605925|NCT03982199|448177749|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
124605926|NCT03982199|448177750|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
124605927|NCT03982199|448177751|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
124605928|NCT03982199|448177752|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
124605929|NCT03982199|448177753|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
124605930|NCT03982199|448177754|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
124605931|NCT03982199|448177755|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
124605932|NCT03982199|448177756|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
124605933|NCT03982199|448177757|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
124605934|NCT03982199|448177758|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
124605935|NCT03982199|448177759|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
124605936|NCT03982199|448177760|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
124605937|NCT03982199|448177747|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
124605938|NCT03982199|448177748|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
124605939|NCT03982199|448177749|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
124605940|NCT03982199|448177750|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
124605941|NCT03982199|448177751|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
124605942|NCT03982199|448177752|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
124605943|NCT03982199|448177753|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
124605944|NCT03982199|448177754|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
124605945|NCT03982199|448177755|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
124605946|NCT03982199|448177756|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
124605947|NCT03982199|448177757|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
124605948|NCT03982199|448177758|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
124605949|NCT03982199|448177759|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
124605950|NCT03982199|448177760|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
124605951|NCT03982199|448177747|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
124605952|NCT03982199|448177748|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
124605953|NCT03982199|448177749|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
124605954|NCT03982199|448177750|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
124605955|NCT03982199|448177751|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
124605956|NCT03982199|448177752|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
124605957|NCT03982199|448177753|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
124605958|NCT03982199|448177754|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
124605959|NCT03982199|448177755|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
124605960|NCT03982199|448177756|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
124605961|NCT03982199|448177757|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
124605962|NCT03982199|448177758|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
124605963|NCT03982199|448177759|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
124605964|NCT03982199|448177760|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
124605965|NCT03982199|448177747|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
124605966|NCT03982199|448177748|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
124605967|NCT03982199|448177749|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
124605968|NCT03982199|448177750|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
124605969|NCT03982199|448177751|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
124605970|NCT03982199|448177752|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
124605971|NCT03982199|448177753|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
124605972|NCT03982199|448177754|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
124605973|NCT03982199|448177755|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
124605974|NCT03982199|448177756|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
124605975|NCT03982199|448177757|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
124605976|NCT03982199|448177758|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
124605977|NCT03982199|448177759|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
124605978|NCT03982199|448177760|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
124605979|NCT03982199|448177747|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
124605980|NCT03982199|448177748|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
124605981|NCT03982199|448177749|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
124605982|NCT03982199|448177750|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
124605983|NCT03982199|448177751|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
124605984|NCT03982199|448177752|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
124605985|NCT03982199|448177753|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
124605986|NCT03982199|448177754|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
124605987|NCT03982199|448177755|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
124605988|NCT03982199|448177756|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
124605989|NCT03982199|448177757|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
124605990|NCT03982199|448177758|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
124605991|NCT03982199|448177759|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
124605992|NCT03982199|448177760|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
124605993|NCT03982199|448177747|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
124605994|NCT03982199|448177748|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
124605995|NCT03982199|448177749|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
124605996|NCT03982199|448177750|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
124605997|NCT03982199|448177751|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
124605998|NCT03982199|448177752|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
124605999|NCT03982199|448177753|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
124606000|NCT03982199|448177754|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
124606001|NCT03982199|448177755|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
124606002|NCT03982199|448177756|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
124606003|NCT03982199|448177757|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
124606004|NCT03982199|448177758|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
124606005|NCT03982199|448177759|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
124606006|NCT03982199|448177760|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
124606007|NCT03982199|448177747|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
124606008|NCT03982199|448177748|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
124606009|NCT03982199|448177749|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
124606010|NCT03982199|448177750|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
124606011|NCT03982199|448177751|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
124606012|NCT03982199|448177752|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
124606013|NCT03982199|448177753|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
124606014|NCT03982199|448177754|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
124606015|NCT03982199|448177755|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
124606016|NCT03982199|448177756|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
124606017|NCT03982199|448177757|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
124606018|NCT03982199|448177758|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
124606019|NCT03982199|448177759|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
124606020|NCT03982199|448177760|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
124606021|NCT03982199|448177747|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
124606022|NCT03982199|448177748|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
124606023|NCT03982199|448177749|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
124606024|NCT03982199|448177750|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
124606025|NCT03982199|448177751|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
124606026|NCT03982199|448177752|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
124606027|NCT03982199|448177753|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
124606028|NCT03982199|448177754|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
124606029|NCT03982199|448177755|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
124606030|NCT03982199|448177756|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
124606031|NCT03982199|448177757|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
124606032|NCT03982199|448177758|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
124606033|NCT03982199|448177759|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
124606034|NCT03982199|448177760|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
124606035|NCT03982199|448177747|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
124606036|NCT03982199|448177748|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
124606037|NCT03982199|448177749|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
124606038|NCT03982199|448177750|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
124606039|NCT03982199|448177751|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
124606040|NCT03982199|448177752|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
124606041|NCT03982199|448177753|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
124606042|NCT03982199|448177754|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
124606043|NCT03982199|448177755|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
124606044|NCT03982199|448177756|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
124606045|NCT03982199|448177757|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
124606046|NCT03982199|448177758|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
124606047|NCT03982199|448177759|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
124606048|NCT03982199|448177760|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
124606049|NCT03982199|448177747|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
124606050|NCT03982199|448177748|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
124606051|NCT03982199|448177749|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
124606052|NCT03982199|448177750|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
124606053|NCT03982199|448177751|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
124606054|NCT03982199|448177752|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
124606055|NCT03982199|448177753|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
124606056|NCT03982199|448177754|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
124781095|NCT01088048|448829078|FG006|Overall Study|Disease Progression|2|||
124606057|NCT03982199|448177755|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
124606058|NCT03982199|448177756|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
124606059|NCT03982199|448177757|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
124606060|NCT03982199|448177758|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
124606061|NCT03982199|448177759|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
124606062|NCT03982199|448177760|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
124606063|NCT03982199|448177747|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
124606064|NCT03982199|448177748|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
124606065|NCT03982199|448177749|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
124606066|NCT03982199|448177750|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
124606067|NCT03982199|448177751|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
124606068|NCT03982199|448177752|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
124606069|NCT03982199|448177753|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
124606070|NCT03982199|448177754|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
124606071|NCT03982199|448177755|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
124606072|NCT03982199|448177756|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
124606073|NCT03982199|448177757|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
124606074|NCT03982199|448177758|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
124606075|NCT03982199|448177759|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
124606076|NCT03982199|448177760|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
124606077|NCT03982199|448177747|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
124606078|NCT03982199|448177748|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
124606079|NCT03982199|448177749|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
124606080|NCT03982199|448177750|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
124606081|NCT03982199|448177751|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
124606082|NCT03982199|448177752|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
124606083|NCT03982199|448177753|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
124606084|NCT03982199|448177754|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
124606085|NCT03982199|448177755|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
124606086|NCT03982199|448177756|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
124606087|NCT03982199|448177757|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
124606088|NCT03982199|448177758|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
124606089|NCT03982199|448177759|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
124606090|NCT03982199|448177760|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
124606091|NCT03982199|448177747|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
124606092|NCT03982199|448177748|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
124606093|NCT03982199|448177749|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
124606094|NCT03982199|448177750|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
124606095|NCT03982199|448177751|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
124606096|NCT03982199|448177752|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
124606097|NCT03982199|448177753|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
124606098|NCT03982199|448177754|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
124606099|NCT03982199|448177755|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
124606100|NCT03982199|448177756|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
124606101|NCT03982199|448177757|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
124606102|NCT03982199|448177758|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
124606103|NCT03982199|448177759|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
124606104|NCT03982199|448177760|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
124606105|NCT03982199|448177747|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
124606106|NCT03982199|448177748|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
124606107|NCT03982199|448177749|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
124606108|NCT03982199|448177750|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
124606109|NCT03982199|448177751|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
124606110|NCT03982199|448177752|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
124606111|NCT03982199|448177753|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
124606112|NCT03982199|448177754|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
124606113|NCT03982199|448177755|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
124606114|NCT03982199|448177756|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
124606115|NCT03982199|448177757|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
124606116|NCT03982199|448177758|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
124606117|NCT03982199|448177759|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
124606118|NCT03982199|448177760|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
124606119|NCT03982199|448177747|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
124606120|NCT03982199|448177748|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
124606121|NCT03982199|448177749|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
124606122|NCT03982199|448177750|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
124606123|NCT03982199|448177751|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
124606124|NCT03982199|448177752|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
124606125|NCT03982199|448177753|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
124606126|NCT03982199|448177754|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
124606127|NCT03982199|448177755|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
124606128|NCT03982199|448177756|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
124606129|NCT03982199|448177757|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
124606130|NCT03982199|448177758|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
124606131|NCT03982199|448177759|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
124606132|NCT03982199|448177760|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
124606133|NCT03982199|448177747|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
124606134|NCT03982199|448177748|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
124606135|NCT03982199|448177749|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
124606136|NCT03982199|448177750|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
124606137|NCT03982199|448177751|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
124606138|NCT03982199|448177752|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
124606139|NCT03982199|448177753|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
124606140|NCT03982199|448177754|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
124606141|NCT03982199|448177755|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
124606142|NCT03982199|448177756|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
124606143|NCT03982199|448177757|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
124606144|NCT03982199|448177758|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
124606145|NCT03982199|448177759|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
124606146|NCT03982199|448177760|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
124606147|NCT03982199|448177747|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
124606148|NCT03982199|448177748|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
124606149|NCT03982199|448177749|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
124606150|NCT03982199|448177750|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
124606151|NCT03982199|448177751|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
124606152|NCT03982199|448177752|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
124606153|NCT03982199|448177753|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
124606154|NCT03982199|448177754|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
124606155|NCT03982199|448177755|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
124606156|NCT03982199|448177756|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
124606157|NCT03982199|448177757|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
124606158|NCT03982199|448177758|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
124606159|NCT03982199|448177759|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
124606160|NCT03982199|448177760|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
124606161|NCT03982199|448177747|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
124606162|NCT03982199|448177748|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
124606163|NCT03982199|448177749|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
124606164|NCT03982199|448177750|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
124606165|NCT03982199|448177751|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
124606166|NCT03982199|448177752|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
124606167|NCT03982199|448177753|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
124606168|NCT03982199|448177754|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
124606169|NCT03982199|448177755|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
124606170|NCT03982199|448177756|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
124606171|NCT03982199|448177757|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
124606172|NCT03982199|448177758|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
124606173|NCT03982199|448177759|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
124606174|NCT03982199|448177760|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
124606175|NCT03982199|448177747|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
124606176|NCT03982199|448177748|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
124606177|NCT03982199|448177749|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
124606178|NCT03982199|448177750|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
124606179|NCT03982199|448177751|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
124606180|NCT03982199|448177752|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
124606181|NCT03982199|448177753|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
124781096|NCT01088048|448829079|FG007|Overall Study|Disease Progression|1|||
124781097|NCT01088048|448829080|FG008|Overall Study|Disease Progression|0|||
124606182|NCT03982199|448177754|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
124606183|NCT03982199|448177755|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
124606184|NCT03982199|448177756|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
124606185|NCT03982199|448177757|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
124606186|NCT03982199|448177758|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
124606187|NCT03982199|448177759|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
124606188|NCT03982199|448177760|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
124606189|NCT03982199|448177747|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
124606190|NCT03982199|448177748|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
124606191|NCT03982199|448177749|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
124606192|NCT03982199|448177750|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
124606193|NCT03982199|448177751|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
124606194|NCT03982199|448177752|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
124606195|NCT03982199|448177753|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
124606196|NCT03982199|448177754|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
124606197|NCT03982199|448177755|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
124606198|NCT03982199|448177756|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
124606199|NCT03982199|448177757|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
124606200|NCT03982199|448177758|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
124606201|NCT03982199|448177759|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
124606202|NCT03982199|448177760|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
124606203|NCT03982199|448177747|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
124606204|NCT03982199|448177748|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
124606205|NCT03982199|448177749|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
124606206|NCT03982199|448177750|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
124606207|NCT03982199|448177751|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
124606208|NCT03982199|448177752|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
124606209|NCT03982199|448177753|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
124606210|NCT03982199|448177754|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
124606211|NCT03982199|448177755|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
124606212|NCT03982199|448177756|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
124606213|NCT03982199|448177757|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
124606214|NCT03982199|448177758|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
124606215|NCT03982199|448177759|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
124606216|NCT03982199|448177760|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
124606217|NCT03982199|448177747|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
124606218|NCT03982199|448177748|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
124606219|NCT03982199|448177749|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
124606220|NCT03982199|448177750|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
124606221|NCT03982199|448177751|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
124606222|NCT03982199|448177752|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
124606223|NCT03982199|448177753|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
124606224|NCT03982199|448177754|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
124606225|NCT03982199|448177755|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
124606226|NCT03982199|448177756|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
124606227|NCT03982199|448177757|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
124606228|NCT03982199|448177758|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
124606229|NCT03982199|448177759|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
124606230|NCT03982199|448177760|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
124606231|NCT03982199|448177747|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
124606232|NCT03982199|448177748|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
124606233|NCT03982199|448177749|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
124606234|NCT03982199|448177750|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
124606235|NCT03982199|448177751|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
124606236|NCT03982199|448177752|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
124606237|NCT03982199|448177753|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
124606238|NCT03982199|448177754|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
124606239|NCT03982199|448177755|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
124606240|NCT03982199|448177756|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
124606241|NCT03982199|448177757|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
124606242|NCT03982199|448177758|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
124606243|NCT03982199|448177759|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
124731657|NCT03447314|448640147|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
124606244|NCT03982199|448177760|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
124606245|NCT03982199|448177747|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
124606246|NCT03982199|448177748|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
124606247|NCT03982199|448177749|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
124606248|NCT03982199|448177750|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
124606249|NCT03982199|448177751|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
124606250|NCT03982199|448177752|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
124606251|NCT03982199|448177753|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
124606252|NCT03982199|448177754|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
124606253|NCT03982199|448177755|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
124606254|NCT03982199|448177756|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
124606255|NCT03982199|448177757|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
124606256|NCT03982199|448177758|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
124606257|NCT03982199|448177759|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
124606258|NCT03982199|448177760|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
124606259|NCT03982199|448177747|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
124606260|NCT03982199|448177748|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
124606261|NCT03982199|448177749|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
124606262|NCT03982199|448177750|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
124606263|NCT03982199|448177751|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
124606264|NCT03982199|448177752|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
124606265|NCT03982199|448177753|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
124606266|NCT03982199|448177754|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
124606267|NCT03982199|448177755|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
124606268|NCT03982199|448177756|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
124606269|NCT03982199|448177757|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
124606270|NCT03982199|448177758|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
124606271|NCT03982199|448177759|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
124606272|NCT03982199|448177760|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
124606273|NCT03982199|448177747|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
124606274|NCT03982199|448177748|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
124606275|NCT03982199|448177749|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
124606276|NCT03982199|448177750|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
124606277|NCT03982199|448177751|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
124606278|NCT03982199|448177752|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
124606279|NCT03982199|448177753|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
124606280|NCT03982199|448177754|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
124606281|NCT03982199|448177755|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
124606282|NCT03982199|448177756|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
124606283|NCT03982199|448177757|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
124606284|NCT03982199|448177758|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
124606285|NCT03982199|448177759|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
124606286|NCT03982199|448177760|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
124606287|NCT03982199|448177747|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
124606288|NCT03982199|448177748|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
124606289|NCT03982199|448177749|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
124606290|NCT03982199|448177750|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
124606291|NCT03982199|448177751|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
124606292|NCT03982199|448177752|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
124606293|NCT03982199|448177753|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
124606294|NCT03982199|448177754|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
124606295|NCT03982199|448177755|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
124606296|NCT03982199|448177756|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
124606297|NCT03982199|448177757|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
124606298|NCT03982199|448177758|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
124606299|NCT03982199|448177759|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
124606300|NCT03982199|448177760|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
124606301|NCT03982199|448177747|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
124606302|NCT03982199|448177748|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
124606303|NCT03982199|448177749|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
124781098|NCT01088048|448829081|FG009|Overall Study|Disease Progression|0|||
124781099|NCT01088048|448829072|FG000|Overall Study|Death|1|||
124606304|NCT03982199|448177750|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
124606305|NCT03982199|448177751|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
124606306|NCT03982199|448177752|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
124606307|NCT03982199|448177753|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
124606308|NCT03982199|448177754|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
124606309|NCT03982199|448177755|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
124606310|NCT03982199|448177756|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
124606311|NCT03982199|448177757|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
124606312|NCT03982199|448177758|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
124606313|NCT03982199|448177759|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
124606314|NCT03982199|448177760|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
124606315|NCT03982199|448177747|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
124606316|NCT03982199|448177748|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
124606317|NCT03982199|448177749|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
124606318|NCT03982199|448177750|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
124606319|NCT03982199|448177751|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
124606320|NCT03982199|448177752|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
124606321|NCT03982199|448177753|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
124606322|NCT03982199|448177754|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
124606323|NCT03982199|448177755|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
124606324|NCT03982199|448177756|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
124606325|NCT03982199|448177757|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
124606326|NCT03982199|448177758|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
124606327|NCT03982199|448177759|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
124606328|NCT03982199|448177760|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
124606329|NCT03982199|448177747|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
124606330|NCT03982199|448177748|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
124606331|NCT03982199|448177749|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
124606332|NCT03982199|448177750|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
124606333|NCT03982199|448177751|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
124606334|NCT03982199|448177752|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
124606335|NCT03982199|448177753|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
124606336|NCT03982199|448177754|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
124606337|NCT03982199|448177755|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
124606338|NCT03982199|448177756|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
124606339|NCT03982199|448177757|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
124606340|NCT03982199|448177758|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
124606341|NCT03982199|448177759|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
124606342|NCT03982199|448177760|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
124606343|NCT00594646|448177761|FG000|Overall Study|Withdrawal by Subject|1|||
124606344|NCT00594646|448177761|FG000|Overall Study|Lost to Follow-up|15|||
124606345|NCT03907462|448177764|FG000|Overall Study|Physician Decision|1|||
124606346|NCT03907462|448177765|FG001|Overall Study|Physician Decision|3|||
124606347|NCT03907462|448177766|FG002|Overall Study|Physician Decision|1|||
124606348|NCT03907462|448177764|FG000|Overall Study|Withdrawal by Subject|6|||
124606349|NCT03907462|448177765|FG001|Overall Study|Withdrawal by Subject|3|||
124606350|NCT03907462|448177766|FG002|Overall Study|Withdrawal by Subject|3|||
124606351|NCT03907462|448177764|FG000|Overall Study|Pregnancy|4|||
124606352|NCT03907462|448177765|FG001|Overall Study|Pregnancy|2|||
124606353|NCT03907462|448177766|FG002|Overall Study|Pregnancy|6|||
124606354|NCT03907462|448177764|FG000|Overall Study|Lost to Follow-up|16|||
124606355|NCT03907462|448177765|FG001|Overall Study|Lost to Follow-up|18|||
124606356|NCT03907462|448177766|FG002|Overall Study|Lost to Follow-up|22|||
124606357|NCT03107026|448179524|FG000|Overall Study|Adverse Event|2|||
124606358|NCT03107026|448179525|FG001|Overall Study|Adverse Event|14|||
124606359|NCT03107026|448179526|FG002|Overall Study|Adverse Event|23|||
124606360|NCT03107026|448179524|FG000|Overall Study|Lost to Follow-up|12|||
124606361|NCT03107026|448179525|FG001|Overall Study|Lost to Follow-up|12|||
124606362|NCT03107026|448179526|FG002|Overall Study|Lost to Follow-up|13|||
124606363|NCT03107026|448179524|FG000|Overall Study|Protocol Violation|1|||
124606364|NCT03107026|448179525|FG001|Overall Study|Protocol Violation|2|||
124606365|NCT03107026|448179526|FG002|Overall Study|Protocol Violation|0|||
124606366|NCT03107026|448179524|FG000|Overall Study|Pregnancy|1|||
124606367|NCT03107026|448179525|FG001|Overall Study|Pregnancy|0|||
124606368|NCT03107026|448179526|FG002|Overall Study|Pregnancy|0|||
124606369|NCT03107026|448179524|FG000|Overall Study|Withdrawal by Subject|13|||
124606370|NCT03107026|448179525|FG001|Overall Study|Withdrawal by Subject|5|||
124606371|NCT03107026|448179526|FG002|Overall Study|Withdrawal by Subject|17|||
124606372|NCT03107026|448179524|FG000|Overall Study|non compliance with study visits|1|||
124781100|NCT01088048|448829073|FG001|Overall Study|Death|5|||
124606373|NCT03107026|448179525|FG001|Overall Study|non compliance with study visits|2|||
124606374|NCT03107026|448179526|FG002|Overall Study|non compliance with study visits|0|||
124606375|NCT03107026|448179524|FG000|Overall Study|non-compliance with study drug|2|||
124606376|NCT03107026|448179525|FG001|Overall Study|non-compliance with study drug|2|||
124606377|NCT03107026|448179526|FG002|Overall Study|non-compliance with study drug|3|||
124606378|NCT03107026|448179524|FG000|Overall Study|Physician Decision|0|||
124606379|NCT03107026|448179525|FG001|Overall Study|Physician Decision|1|||
124606380|NCT03107026|448179526|FG002|Overall Study|Physician Decision|0|||
124606381|NCT02049450|448179527|FG000|Overall Study|Adverse Event|2|||
124606382|NCT02049450|448179527|FG000|Overall Study|Withdrawal by Subject|1|||
124606383|NCT02049450|448179527|FG000|Overall Study|Patients/guardian decision|1|||
124606384|NCT00577395|448179528|FG000|Overall Study|Study was terminated early by Sponsor|7|||
124606385|NCT00577395|448179529|FG001|Overall Study|Study was terminated early by Sponsor|6|||
124606386|NCT00554190|448179532|FG000|Overall Study|Termination forms not completed|10|||
124606387|NCT04709835|448179536|FG000|Overall Study|Withdrawal by Subject|0|||
124606388|NCT04709835|448179537|FG001|Overall Study|Withdrawal by Subject|1|||
124606389|NCT04709835|448179538|FG002|Overall Study|Withdrawal by Subject|0|||
124606390|NCT04325204|448179539|FG000|Overall Study|Death|0|||
124606391|NCT04325204|448179540|FG001|Overall Study|Death|1|||
124606392|NCT04325204|448179539|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
124606393|NCT04325204|448179540|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
124606394|NCT04325204|448179539|FG000|Overall Study|Lost to Follow-up|8|||
124606395|NCT04325204|448179540|FG001|Overall Study|Lost to Follow-up|8|||
124606396|NCT04325204|448179539|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
124606397|NCT04325204|448179540|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
124606398|NCT04711902|448179542|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
124606399|NCT04711902|448179543|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
124606400|NCT04711902|448179544|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
124606401|NCT04711902|448179545|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
124606402|NCT04711902|448179546|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
124606403|NCT04711902|448179547|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
124606404|NCT04710979|448179548|FG000|Overall Study|Lost to Follow-up|2|||
124606405|NCT04710979|448179549|FG001|Overall Study|Lost to Follow-up|4|||
124606406|NCT04710979|448179548|FG000|Overall Study|Withdrawal by Subject|1|||
124606407|NCT04710979|448179549|FG001|Overall Study|Withdrawal by Subject|0|||
124606408|NCT01561430|448179555|FG000|Overall Study|Adverse Event|0|||
124606409|NCT01561430|448179556|FG001|Overall Study|Adverse Event|0|||
124606410|NCT01561430|448179557|FG002|Overall Study|Adverse Event|3|||
124606411|NCT01561430|448179558|FG003|Overall Study|Adverse Event|1|||
124606412|NCT01561430|448179555|FG000|Overall Study|Withdrawal by Subject|0|||
124606413|NCT01561430|448179556|FG001|Overall Study|Withdrawal by Subject|0|||
124606414|NCT01561430|448179557|FG002|Overall Study|Withdrawal by Subject|1|||
124606415|NCT01561430|448179558|FG003|Overall Study|Withdrawal by Subject|0|||
124606416|NCT01561430|448179555|FG000|Overall Study|Physician Decision|0|||
124606417|NCT01561430|448179556|FG001|Overall Study|Physician Decision|1|||
124606418|NCT01561430|448179557|FG002|Overall Study|Physician Decision|0|||
124606419|NCT01561430|448179558|FG003|Overall Study|Physician Decision|0|||
124606420|NCT01561430|448179555|FG000|Overall Study|Sponsor Decision|1|||
124606421|NCT01561430|448179556|FG001|Overall Study|Sponsor Decision|14|||
124606422|NCT01561430|448179557|FG002|Overall Study|Sponsor Decision|13|||
124606423|NCT01561430|448179558|FG003|Overall Study|Sponsor Decision|12|||
124606424|NCT02570113|448179559|FG000|Overall Study|Withdrawal by Subject|3|||
124606425|NCT02564211|448179560|FG000|Overall Study|Adverse Event|4|||
124606426|NCT01908816|448179561|FG000|Overall Study|Subject's no longer requires study drug|0|||
124606427|NCT01908816|448179562|FG001|Overall Study|Subject's no longer requires study drug|0|||
124606428|NCT01908816|448179563|FG002|Overall Study|Subject's no longer requires study drug|0|||
124606429|NCT01908816|448179564|FG003|Overall Study|Subject's no longer requires study drug|1|||
124606430|NCT01908816|448179561|FG000|Overall Study|Protocol deviation|1|||
124606431|NCT01908816|448179562|FG001|Overall Study|Protocol deviation|2|||
124606432|NCT01908816|448179563|FG002|Overall Study|Protocol deviation|1|||
124606433|NCT01908816|448179564|FG003|Overall Study|Protocol deviation|1|||
124606434|NCT01908816|448179561|FG000|Overall Study|Withdrawal by Subject|0|||
124606435|NCT01908816|448179562|FG001|Overall Study|Withdrawal by Subject|4|||
124606436|NCT01908816|448179563|FG002|Overall Study|Withdrawal by Subject|2|||
124606437|NCT01908816|448179564|FG003|Overall Study|Withdrawal by Subject|2|||
124606438|NCT01908816|448179561|FG000|Overall Study|Lost to Follow-up|3|||
124606439|NCT01908816|448179562|FG001|Overall Study|Lost to Follow-up|5|||
124606440|NCT01908816|448179563|FG002|Overall Study|Lost to Follow-up|4|||
124606441|NCT01908816|448179564|FG003|Overall Study|Lost to Follow-up|2|||
124606442|NCT01908816|448179561|FG000|Overall Study|Death|1|||
124606443|NCT01908816|448179562|FG001|Overall Study|Death|0|||
124606444|NCT01908816|448179563|FG002|Overall Study|Death|7|||
124606445|NCT01908816|448179564|FG003|Overall Study|Death|1|||
124781101|NCT01088048|448829074|FG002|Overall Study|Death|3|||
124781102|NCT01088048|448829075|FG003|Overall Study|Death|3|||
124606446|NCT01908816|448179561|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124606447|NCT01908816|448179562|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
124606448|NCT01908816|448179563|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
124606449|NCT01908816|448179564|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
124606450|NCT01908816|448179561|FG000|Overall Study|Early termination|87|||
124606451|NCT01908816|448179562|FG001|Overall Study|Early termination|60|||
124606452|NCT01908816|448179563|FG002|Overall Study|Early termination|43|||
124606453|NCT01908816|448179564|FG003|Overall Study|Early termination|28|||
124606454|NCT05183217|448179565|FG000|Overall Study|Withdrawal by Subject|1|||
124606455|NCT05183217|448179566|FG001|Overall Study|Withdrawal by Subject|1|||
124606456|NCT03201250|448179567|FG000|Overall Study|screen failures|3|||
124606457|NCT03201250|448179568|FG001|Overall Study|screen failures|0|||
124606458|NCT03201250|448179569|FG002|Overall Study|screen failures|0|||
124606459|NCT01297465|448179570|FG000|Overall Study|Lack of Ovarian Response|1|||
124606460|NCT01297465|448179571|FG001|Overall Study|Lack of Ovarian Response|1|||
124606461|NCT01297465|448179570|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
124606462|NCT01297465|448179571|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
124606463|NCT01297465|448179570|FG000|Overall Study|No Oocytes Retrieved|1|||
124606464|NCT01297465|448179571|FG001|Overall Study|No Oocytes Retrieved|1|||
124606465|NCT01297465|448179570|FG000|Overall Study|Poor oocyte quality|0|||
124606466|NCT01297465|448179571|FG001|Overall Study|Poor oocyte quality|1|||
124606467|NCT01297465|448179570|FG000|Overall Study|No Fertilization|6|||
124606468|NCT01297465|448179571|FG001|Overall Study|No Fertilization|4|||
124606469|NCT01297465|448179570|FG000|Overall Study|All Embryos Discarded|0|||
124606470|NCT01297465|448179571|FG001|Overall Study|All Embryos Discarded|1|||
124606471|NCT01297465|448179570|FG000|Overall Study|Intention to Freeze all Embryos|0|||
124606472|NCT01297465|448179571|FG001|Overall Study|Intention to Freeze all Embryos|1|||
124606473|NCT00969540|448179572|FG000|Overall Study|Lost to Follow-up|1|||
124606474|NCT00969540|448179573|FG001|Overall Study|Lost to Follow-up|1|||
124606475|NCT01646138|448179574|FG000|Overall Study|Lost to Follow-up|0|||
124606476|NCT01646138|448179575|FG001|Overall Study|Lost to Follow-up|0|||
124606477|NCT01646138|448179576|FG002|Overall Study|Lost to Follow-up|0|||
124606478|NCT01646138|448179577|FG003|Overall Study|Lost to Follow-up|0|||
124606479|NCT01646138|448179578|FG004|Overall Study|Lost to Follow-up|2|||
124606480|NCT01683838|448179579|FG000|Overall Study|Adverse Event|12|||
124606481|NCT01683838|448179580|FG001|Overall Study|Adverse Event|2|||
124606482|NCT01683838|448179579|FG000|Overall Study|Protocol Violation|3|||
124606483|NCT01683838|448179580|FG001|Overall Study|Protocol Violation|1|||
124606484|NCT01683838|448179579|FG000|Overall Study|Withdrawal by Subject|6|||
124606485|NCT01683838|448179580|FG001|Overall Study|Withdrawal by Subject|5|||
124606486|NCT01683838|448179579|FG000|Overall Study|Lost to Follow-up|1|||
124606487|NCT01683838|448179580|FG001|Overall Study|Lost to Follow-up|1|||
124606488|NCT01683838|448179579|FG000|Overall Study|Other|4|||
124606489|NCT01683838|448179580|FG001|Overall Study|Other|3|||
124606490|NCT04049617|448179581|FG000|Overall Study|Adverse Event|0|||
124606491|NCT04049617|448179582|FG001|Overall Study|Adverse Event|0|||
124606492|NCT04049617|448179583|FG002|Overall Study|Adverse Event|0|||
124606493|NCT04049617|448179584|FG003|Overall Study|Adverse Event|1|||
124606494|NCT04049617|448179585|FG004|Overall Study|Adverse Event|0|||
124606495|NCT04049617|448179586|FG005|Overall Study|Adverse Event|0|||
124606496|NCT04049617|448179581|FG000|Overall Study|Death|0|||
124606497|NCT04049617|448179582|FG001|Overall Study|Death|0|||
124606498|NCT04049617|448179583|FG002|Overall Study|Death|0|||
124606499|NCT04049617|448179584|FG003|Overall Study|Death|0|||
124606500|NCT04049617|448179585|FG004|Overall Study|Death|0|||
124606501|NCT04049617|448179586|FG005|Overall Study|Death|1|||
124606502|NCT04049617|448179581|FG000|Overall Study|Lost to Follow-up|0|||
124781103|NCT01088048|448829076|FG004|Overall Study|Death|1|||
124606503|NCT04049617|448179582|FG001|Overall Study|Lost to Follow-up|0|||
124606504|NCT04049617|448179583|FG002|Overall Study|Lost to Follow-up|0|||
124606505|NCT04049617|448179584|FG003|Overall Study|Lost to Follow-up|1|||
124606506|NCT04049617|448179585|FG004|Overall Study|Lost to Follow-up|0|||
124606507|NCT04049617|448179586|FG005|Overall Study|Lost to Follow-up|0|||
124606508|NCT04049617|448179581|FG000|Overall Study|Withdrew consent|0|||
124781104|NCT01088048|448829077|FG005|Overall Study|Death|3|||
124781105|NCT01088048|448829078|FG006|Overall Study|Death|0|||
124781106|NCT01088048|448829079|FG007|Overall Study|Death|0|||
124606509|NCT04049617|448179582|FG001|Overall Study|Withdrew consent|0|||
124606510|NCT04049617|448179583|FG002|Overall Study|Withdrew consent|1|||
124606511|NCT04049617|448179584|FG003|Overall Study|Withdrew consent|0|||
124606512|NCT04049617|448179585|FG004|Overall Study|Withdrew consent|0|||
124606513|NCT04049617|448179586|FG005|Overall Study|Withdrew consent|0|||
124606514|NCT03551496|448179587|FG000|Overall Study|Death|11|||
124606515|NCT03551496|448179588|FG001|Overall Study|Death|7|||
124606516|NCT03551496|448179587|FG000|Overall Study|Withdrawal by Subject|4|||
124606517|NCT03551496|448179588|FG001|Overall Study|Withdrawal by Subject|3|||
124606518|NCT03551496|448179587|FG000|Overall Study|Other Reasons|1|||
124606519|NCT03551496|448179588|FG001|Overall Study|Other Reasons|0|||
124606520|NCT01524679|448179589|FG000|Overall Study|Lost to Follow-up|1|||
124606521|NCT01524679|448179590|FG001|Overall Study|Lost to Follow-up|4|||
124606522|NCT01524679|448179589|FG000|Overall Study|Withdrawal by Subject|4|||
124606523|NCT01524679|448179590|FG001|Overall Study|Withdrawal by Subject|4|||
124606524|NCT01524679|448179589|FG000|Overall Study|Adverse Event|9|||
124606525|NCT01524679|448179590|FG001|Overall Study|Adverse Event|0|||
124606526|NCT01524679|448179589|FG000|Overall Study|Protocol Violation|1|||
124606527|NCT01524679|448179590|FG001|Overall Study|Protocol Violation|0|||
124606528|NCT01524679|448179589|FG000|Overall Study|Lack of Efficacy|2|||
124606529|NCT01524679|448179590|FG001|Overall Study|Lack of Efficacy|0|||
124781107|NCT01088048|448829080|FG008|Overall Study|Death|3|||
124781108|NCT01088048|448829081|FG009|Overall Study|Death|1|||
124781109|NCT01088048|448829072|FG000|Overall Study|Other|3|||
124781110|NCT01088048|448829073|FG001|Overall Study|Other|5|||
124781111|NCT01088048|448829074|FG002|Overall Study|Other|0|||
124781112|NCT01088048|448829075|FG003|Overall Study|Other|0|||
124781113|NCT01088048|448829076|FG004|Overall Study|Other|2|||
124781114|NCT01088048|448829077|FG005|Overall Study|Other|0|||
124781115|NCT01088048|448829078|FG006|Overall Study|Other|0|||
124781116|NCT01088048|448829079|FG007|Overall Study|Other|2|||
124781117|NCT01088048|448829080|FG008|Overall Study|Other|0|||
124781118|NCT01088048|448829081|FG009|Overall Study|Other|0|||
124781119|NCT01330108|448829085|FG000|Overall Study|Withdrawal by Subject|4|||
124781120|NCT00243269|448829086|FG000|Overall Study|Protocol Violation|2|||
124781121|NCT00243269|448829087|FG001|Overall Study|Protocol Violation|1|||
124781122|NCT00243269|448829088|FG002|Overall Study|Protocol Violation|0|||
124781123|NCT00243269|448829089|FG003|Overall Study|Protocol Violation|1|||
124781124|NCT00243269|448829086|FG000|Overall Study|Lost to Follow-up|1|||
124606530|NCT01524679|448179589|FG000|Overall Study|e.g.wish for children, relocation|6|||
124606531|NCT01524679|448179590|FG001|Overall Study|e.g.wish for children, relocation|1|||
124606532|NCT00801099|448179591|FG000|Overall Study|Lost to Follow-up|101|||
124606533|NCT00140426|448179594|FG000|Overall Study|Withdrawal by Subject|0|||
124606534|NCT00140426|448179595|FG001|Overall Study|Withdrawal by Subject|3|||
124606535|NCT02149108|448179596|FG000|Overall Study|Not treated|1|||
124781125|NCT00243269|448829087|FG001|Overall Study|Lost to Follow-up|0|||
124781126|NCT00243269|448829088|FG002|Overall Study|Lost to Follow-up|1|||
124781127|NCT00243269|448829089|FG003|Overall Study|Lost to Follow-up|3|||
124781128|NCT03085797|448829091|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
124781129|NCT03085797|448829092|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
124606536|NCT02149108|448179597|FG001|Overall Study|Not treated|2|||
124606537|NCT02149108|448179596|FG000|Overall Study|Progressive Disease (PD)|324|||
124731658|NCT03447314|448640148|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
124731659|NCT03447314|448640149|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
124731660|NCT03447314|448640150|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
124606538|NCT02149108|448179597|FG001|Overall Study|Progressive Disease (PD)|318|||
124606539|NCT02149108|448179596|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
124606540|NCT02149108|448179597|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
124606541|NCT02149108|448179596|FG000|Overall Study|Other Adverse Event (AE)|8|||
124606542|NCT02149108|448179597|FG001|Overall Study|Other Adverse Event (AE)|18|||
124606543|NCT02149108|448179596|FG000|Overall Study|Other not defined above|0|||
124606544|NCT02149108|448179597|FG001|Overall Study|Other not defined above|2|||
124606545|NCT02149108|448179596|FG000|Overall Study|Refusal to continue trial medication|15|||
124606546|NCT02149108|448179597|FG001|Overall Study|Refusal to continue trial medication|11|||
124731661|NCT03447314|448640151|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
124731662|NCT03447314|448640152|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
124731663|NCT03447314|448640153|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
124731664|NCT03447314|448640154|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
124606547|NCT02149108|448179596|FG000|Overall Study|Lost to Follow-up|1|||
124606548|NCT02149108|448179597|FG001|Overall Study|Lost to Follow-up|0|||
124606549|NCT02981303|448179598|FG000|Overall Study|Progressive Disease|17|||
124606550|NCT02981303|448179599|FG001|Overall Study|Progressive Disease|37|||
124731665|NCT03447314|448640155|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
124781130|NCT03085797|448829091|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
124606551|NCT02981303|448179598|FG000|Overall Study|Adverse Event|1|||
124606552|NCT02981303|448179599|FG001|Overall Study|Adverse Event|4|||
124606553|NCT02981303|448179598|FG000|Overall Study|Withdrawal by Subject|0|||
124606554|NCT02981303|448179599|FG001|Overall Study|Withdrawal by Subject|1|||
124606555|NCT02393248|448179600|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124781131|NCT03085797|448829092|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
124781132|NCT03085797|448829091|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
124781133|NCT03085797|448829092|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
124781134|NCT00545272|448829093|FG000|Overall Study|Protocol deviation|0|||
124781135|NCT00545272|448829094|FG001|Overall Study|Protocol deviation|1|||
124606556|NCT02393248|448179601|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
124606557|NCT02393248|448179602|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606558|NCT02393248|448179603|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124781136|NCT00545272|448829095|FG002|Overall Study|Protocol deviation|0|||
124606559|NCT02393248|448179604|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606560|NCT02393248|448179605|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
124606561|NCT02393248|448179606|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
124606562|NCT02393248|448179607|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606563|NCT02393248|448179608|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606564|NCT02393248|448179609|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606565|NCT02393248|448179610|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606566|NCT02393248|448179611|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606567|NCT02393248|448179612|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606568|NCT02393248|448179613|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606569|NCT02393248|448179614|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606570|NCT02393248|448179615|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606571|NCT02393248|448179616|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606572|NCT02393248|448179617|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606573|NCT02393248|448179618|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606574|NCT02393248|448179619|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606575|NCT02393248|448179620|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606576|NCT02393248|448179621|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606577|NCT02393248|448179622|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606578|NCT02393248|448179623|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606579|NCT02393248|448179624|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
124606580|NCT02393248|448179600|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606581|NCT02393248|448179601|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
124606582|NCT02393248|448179602|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606583|NCT02393248|448179603|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606584|NCT02393248|448179604|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606585|NCT02393248|448179605|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606586|NCT02393248|448179606|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606587|NCT02393248|448179607|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606588|NCT02393248|448179608|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606589|NCT02393248|448179609|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606590|NCT02393248|448179610|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606591|NCT02393248|448179611|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606592|NCT02393248|448179612|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606593|NCT02393248|448179613|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606594|NCT02393248|448179614|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606595|NCT02393248|448179615|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606596|NCT02393248|448179616|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606597|NCT02393248|448179617|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606598|NCT02393248|448179618|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606599|NCT02393248|448179619|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606600|NCT02393248|448179620|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606601|NCT02393248|448179621|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606602|NCT02393248|448179622|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606603|NCT02393248|448179623|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606604|NCT02393248|448179624|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
124606605|NCT02393248|448179600|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
124606606|NCT02393248|448179601|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
124606607|NCT02393248|448179602|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
124606608|NCT02393248|448179603|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
124606609|NCT02393248|448179604|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
124606610|NCT02393248|448179605|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
124606611|NCT02393248|448179606|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
124606612|NCT02393248|448179607|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
124606613|NCT02393248|448179608|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
124606614|NCT02393248|448179609|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
124606615|NCT02393248|448179610|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
124606616|NCT02393248|448179611|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
124606617|NCT02393248|448179612|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
124606618|NCT02393248|448179613|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
124781137|NCT00545272|448829096|FG003|Overall Study|Protocol deviation|1|||
124606619|NCT02393248|448179614|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
124606620|NCT02393248|448179615|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
124606621|NCT02393248|448179616|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
124606622|NCT02393248|448179617|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
124606623|NCT02393248|448179618|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
124606624|NCT02393248|448179619|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
124606625|NCT02393248|448179620|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
124606626|NCT02393248|448179621|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
124606627|NCT02393248|448179622|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
124606628|NCT02393248|448179623|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
124606629|NCT02393248|448179624|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
124606630|NCT02393248|448179600|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
124606631|NCT02393248|448179601|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606632|NCT02393248|448179602|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606633|NCT02393248|448179603|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606634|NCT02393248|448179604|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606635|NCT02393248|448179605|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606636|NCT02393248|448179606|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606637|NCT02393248|448179607|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606638|NCT02393248|448179608|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606639|NCT02393248|448179609|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606640|NCT02393248|448179610|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606641|NCT02393248|448179611|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606642|NCT02393248|448179612|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606643|NCT02393248|448179613|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606644|NCT02393248|448179614|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606645|NCT02393248|448179615|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606646|NCT02393248|448179616|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606647|NCT02393248|448179617|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606648|NCT02393248|448179618|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606649|NCT02393248|448179619|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606650|NCT02393248|448179620|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606651|NCT02393248|448179621|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606652|NCT02393248|448179622|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606653|NCT02393248|448179623|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606654|NCT02393248|448179624|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
124606655|NCT02393248|448179600|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606656|NCT02393248|448179601|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606657|NCT02393248|448179602|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606658|NCT02393248|448179603|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606659|NCT02393248|448179604|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606660|NCT02393248|448179605|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
124606661|NCT02393248|448179606|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
124731666|NCT03447314|448640156|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
124606662|NCT02393248|448179607|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606663|NCT02393248|448179608|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606664|NCT02393248|448179609|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
124606665|NCT02393248|448179610|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606666|NCT02393248|448179611|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124731667|NCT03447314|448640157|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
124731668|NCT03447314|448640158|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
124731669|NCT04600076|448640163|FG000|Overall Study|Lost to Follow-up|3|||
124731670|NCT03006458|448640164|FG000|First Intervention|Unsatisfied Vision|0|||
124731671|NCT03006458|448640165|FG001|First Intervention|Unsatisfied Vision|3|||
124731672|NCT01468233|448640166|FG000|Treatment Period 1|Adverse Event|5|||
124731673|NCT01468233|448640167|FG001|Treatment Period 1|Adverse Event|3|||
124731674|NCT01468233|448640168|FG002|Treatment Period 1|Adverse Event|0|||
124731675|NCT01468233|448640169|FG003|Treatment Period 1|Adverse Event|0|||
124731676|NCT01468233|448640170|FG004|Treatment Period 1|Adverse Event|0|||
124731677|NCT01468233|448640171|FG005|Treatment Period 1|Adverse Event|0|||
124731678|NCT01468233|448640166|FG000|Treatment Period 1|Withdrawal by Subject|3|||
124731679|NCT01468233|448640167|FG001|Treatment Period 1|Withdrawal by Subject|4|||
124731680|NCT01468233|448640168|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124731681|NCT01468233|448640169|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124731682|NCT01468233|448640170|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124731683|NCT01468233|448640171|FG005|Treatment Period 1|Withdrawal by Subject|0|||
124731684|NCT01468233|448640166|FG000|Treatment Period 1|Lost to Follow-up|3|||
124731685|NCT01468233|448640167|FG001|Treatment Period 1|Lost to Follow-up|0|||
124731686|NCT01468233|448640168|FG002|Treatment Period 1|Lost to Follow-up|0|||
124731687|NCT01468233|448640169|FG003|Treatment Period 1|Lost to Follow-up|0|||
124731688|NCT01468233|448640170|FG004|Treatment Period 1|Lost to Follow-up|0|||
124731689|NCT01468233|448640171|FG005|Treatment Period 1|Lost to Follow-up|0|||
124731690|NCT01468233|448640166|FG000|Treatment Period 1|Other|1|||
124731691|NCT01468233|448640167|FG001|Treatment Period 1|Other|1|||
124731692|NCT01468233|448640168|FG002|Treatment Period 1|Other|0|||
124731693|NCT01468233|448640169|FG003|Treatment Period 1|Other|0|||
124606667|NCT02393248|448179612|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606668|NCT02393248|448179613|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606669|NCT02393248|448179614|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606670|NCT02393248|448179615|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606671|NCT02393248|448179616|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606672|NCT02393248|448179617|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606673|NCT02393248|448179618|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606674|NCT02393248|448179619|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606675|NCT02393248|448179620|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606676|NCT02393248|448179621|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606677|NCT02393248|448179622|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606678|NCT02393248|448179623|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606679|NCT02393248|448179624|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
124606680|NCT02393248|448179600|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606681|NCT02393248|448179601|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606682|NCT02393248|448179602|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606683|NCT02393248|448179603|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606684|NCT02393248|448179604|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606685|NCT02393248|448179605|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606686|NCT02393248|448179606|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
124606687|NCT02393248|448179607|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606688|NCT02393248|448179608|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606689|NCT02393248|448179609|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606690|NCT02393248|448179610|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606691|NCT02393248|448179611|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606692|NCT02393248|448179612|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606693|NCT02393248|448179613|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606694|NCT02393248|448179614|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606695|NCT02393248|448179615|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606696|NCT02393248|448179616|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606697|NCT02393248|448179617|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606698|NCT02393248|448179618|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606699|NCT02393248|448179619|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606700|NCT02393248|448179620|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606701|NCT02393248|448179621|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606702|NCT02393248|448179622|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606703|NCT02393248|448179623|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606704|NCT02393248|448179624|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
124606705|NCT02393248|448179600|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606706|NCT02393248|448179601|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606707|NCT02393248|448179602|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606708|NCT02393248|448179603|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606709|NCT02393248|448179604|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606710|NCT02393248|448179605|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606711|NCT02393248|448179606|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606712|NCT02393248|448179607|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606713|NCT02393248|448179608|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606714|NCT02393248|448179609|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606715|NCT02393248|448179610|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606716|NCT02393248|448179611|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
124606717|NCT02393248|448179612|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
124606718|NCT02393248|448179613|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
124606719|NCT02393248|448179614|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
124606720|NCT02393248|448179615|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606721|NCT02393248|448179616|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606722|NCT02393248|448179617|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606723|NCT02393248|448179618|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606724|NCT02393248|448179619|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606725|NCT02393248|448179620|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606726|NCT02393248|448179621|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606727|NCT02393248|448179622|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606728|NCT02393248|448179623|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606729|NCT02393248|448179624|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
124606730|NCT02393248|448179600|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606731|NCT02393248|448179601|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606732|NCT02393248|448179602|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606733|NCT02393248|448179603|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606734|NCT02393248|448179604|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606735|NCT02393248|448179605|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606736|NCT02393248|448179606|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606737|NCT02393248|448179607|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606738|NCT02393248|448179608|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606739|NCT02393248|448179609|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606740|NCT02393248|448179610|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
124606741|NCT02393248|448179611|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
124606742|NCT02393248|448179612|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606743|NCT02393248|448179613|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606744|NCT02393248|448179614|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606745|NCT02393248|448179615|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606746|NCT02393248|448179616|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606747|NCT02393248|448179617|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606748|NCT02393248|448179618|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606749|NCT02393248|448179619|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606750|NCT02393248|448179620|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606751|NCT02393248|448179621|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606752|NCT02393248|448179622|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606753|NCT02393248|448179623|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606754|NCT02393248|448179624|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
124606755|NCT02393248|448179600|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
124606756|NCT02393248|448179601|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
124606757|NCT02393248|448179602|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
124606758|NCT02393248|448179603|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
124606759|NCT02393248|448179604|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
124606760|NCT02393248|448179605|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
124606761|NCT02393248|448179606|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
124606762|NCT02393248|448179607|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
124606763|NCT02393248|448179608|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
124606764|NCT02393248|448179609|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
124606765|NCT02393248|448179610|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
124606766|NCT02393248|448179611|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
124606767|NCT02393248|448179612|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
124606768|NCT02393248|448179613|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
124606769|NCT02393248|448179614|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
124606770|NCT02393248|448179615|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
124606771|NCT02393248|448179616|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
124606772|NCT02393248|448179617|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
124606773|NCT02393248|448179618|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
124606774|NCT02393248|448179619|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
124606775|NCT02393248|448179620|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
124606776|NCT02393248|448179621|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
124606777|NCT02393248|448179622|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
124606778|NCT02393248|448179623|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
124606779|NCT02393248|448179624|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
124606780|NCT02393248|448179600|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606781|NCT02393248|448179601|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606782|NCT02393248|448179602|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606783|NCT02393248|448179603|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606784|NCT02393248|448179604|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606785|NCT02393248|448179605|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606786|NCT02393248|448179606|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606787|NCT02393248|448179607|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606788|NCT02393248|448179608|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606789|NCT02393248|448179609|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606790|NCT02393248|448179610|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606791|NCT02393248|448179611|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
124606792|NCT02393248|448179612|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606793|NCT02393248|448179613|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
124781138|NCT00545272|448829097|FG004|Overall Study|Protocol deviation|0|||
124606794|NCT02393248|448179614|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606795|NCT02393248|448179615|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606796|NCT02393248|448179616|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606797|NCT02393248|448179617|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606798|NCT02393248|448179618|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606799|NCT02393248|448179619|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606800|NCT02393248|448179620|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606801|NCT02393248|448179621|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606802|NCT02393248|448179622|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606803|NCT02393248|448179623|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606804|NCT02393248|448179624|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
124606805|NCT02393248|448179600|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606806|NCT02393248|448179601|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606807|NCT02393248|448179602|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606808|NCT02393248|448179603|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606809|NCT02393248|448179604|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606810|NCT02393248|448179605|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606811|NCT02393248|448179606|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606812|NCT02393248|448179607|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606813|NCT02393248|448179608|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606814|NCT02393248|448179609|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606815|NCT02393248|448179610|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606816|NCT02393248|448179611|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606817|NCT02393248|448179612|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606818|NCT02393248|448179613|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606819|NCT02393248|448179614|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606820|NCT02393248|448179615|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606821|NCT02393248|448179616|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606822|NCT02393248|448179617|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606823|NCT02393248|448179618|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
124606824|NCT02393248|448179619|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606825|NCT02393248|448179620|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
124606826|NCT02393248|448179621|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
124606827|NCT02393248|448179622|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606828|NCT02393248|448179623|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
124606829|NCT02393248|448179624|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
124606830|NCT02393248|448179600|FG000|Part 3: Combination Therapy|Death|0|||
124606831|NCT02393248|448179601|FG001|Part 3: Combination Therapy|Death|0|||
124606832|NCT02393248|448179602|FG002|Part 3: Combination Therapy|Death|0|||
124606833|NCT02393248|448179603|FG003|Part 3: Combination Therapy|Death|0|||
124606834|NCT02393248|448179604|FG004|Part 3: Combination Therapy|Death|0|||
124606835|NCT02393248|448179605|FG005|Part 3: Combination Therapy|Death|0|||
124606836|NCT02393248|448179606|FG006|Part 3: Combination Therapy|Death|0|||
124606837|NCT02393248|448179607|FG007|Part 3: Combination Therapy|Death|0|||
124606838|NCT02393248|448179608|FG008|Part 3: Combination Therapy|Death|0|||
124606839|NCT02393248|448179609|FG009|Part 3: Combination Therapy|Death|0|||
124606840|NCT02393248|448179610|FG010|Part 3: Combination Therapy|Death|0|||
124606841|NCT02393248|448179611|FG011|Part 3: Combination Therapy|Death|0|||
124606842|NCT02393248|448179612|FG012|Part 3: Combination Therapy|Death|0|||
124606843|NCT02393248|448179613|FG013|Part 3: Combination Therapy|Death|0|||
124606844|NCT02393248|448179614|FG014|Part 3: Combination Therapy|Death|0|||
124606845|NCT02393248|448179615|FG015|Part 3: Combination Therapy|Death|1|||
124606846|NCT02393248|448179616|FG016|Part 3: Combination Therapy|Death|7|||
124606847|NCT02393248|448179617|FG017|Part 3: Combination Therapy|Death|5|||
124606848|NCT02393248|448179618|FG018|Part 3: Combination Therapy|Death|5|||
124606849|NCT02393248|448179619|FG019|Part 3: Combination Therapy|Death|3|||
124606850|NCT02393248|448179620|FG020|Part 3: Combination Therapy|Death|7|||
124606851|NCT02393248|448179621|FG021|Part 3: Combination Therapy|Death|5|||
124606852|NCT02393248|448179622|FG022|Part 3: Combination Therapy|Death|6|||
124606853|NCT02393248|448179623|FG023|Part 3: Combination Therapy|Death|3|||
124606854|NCT02393248|448179624|FG024|Part 3: Combination Therapy|Death|0|||
124606855|NCT02393248|448179600|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606856|NCT02393248|448179601|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606857|NCT02393248|448179602|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606858|NCT02393248|448179603|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606859|NCT02393248|448179604|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606860|NCT02393248|448179605|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606861|NCT02393248|448179606|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606862|NCT02393248|448179607|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606863|NCT02393248|448179608|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606864|NCT02393248|448179609|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606865|NCT02393248|448179610|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606866|NCT02393248|448179611|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606867|NCT02393248|448179612|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606868|NCT02393248|448179613|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606869|NCT02393248|448179614|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606870|NCT02393248|448179615|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606871|NCT02393248|448179616|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606872|NCT02393248|448179617|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
124606873|NCT02393248|448179618|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
124606874|NCT02393248|448179619|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
124606875|NCT02393248|448179620|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
124606876|NCT02393248|448179621|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
124606877|NCT02393248|448179622|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
124606878|NCT02393248|448179623|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
124606879|NCT02393248|448179624|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
124606880|NCT02393248|448179600|FG000|Part 3: Combination Therapy|Disease Progression|0|||
124606881|NCT02393248|448179601|FG001|Part 3: Combination Therapy|Disease Progression|0|||
124606882|NCT02393248|448179602|FG002|Part 3: Combination Therapy|Disease Progression|0|||
124606883|NCT02393248|448179603|FG003|Part 3: Combination Therapy|Disease Progression|0|||
124606884|NCT02393248|448179604|FG004|Part 3: Combination Therapy|Disease Progression|0|||
124606885|NCT02393248|448179605|FG005|Part 3: Combination Therapy|Disease Progression|0|||
124606886|NCT02393248|448179606|FG006|Part 3: Combination Therapy|Disease Progression|0|||
124606887|NCT02393248|448179607|FG007|Part 3: Combination Therapy|Disease Progression|0|||
124606888|NCT02393248|448179608|FG008|Part 3: Combination Therapy|Disease Progression|0|||
124606889|NCT02393248|448179609|FG009|Part 3: Combination Therapy|Disease Progression|0|||
124606890|NCT02393248|448179610|FG010|Part 3: Combination Therapy|Disease Progression|0|||
124606891|NCT02393248|448179611|FG011|Part 3: Combination Therapy|Disease Progression|0|||
124606892|NCT02393248|448179612|FG012|Part 3: Combination Therapy|Disease Progression|0|||
124606893|NCT02393248|448179613|FG013|Part 3: Combination Therapy|Disease Progression|0|||
124606894|NCT02393248|448179614|FG014|Part 3: Combination Therapy|Disease Progression|0|||
124606895|NCT02393248|448179615|FG015|Part 3: Combination Therapy|Disease Progression|0|||
124606896|NCT02393248|448179616|FG016|Part 3: Combination Therapy|Disease Progression|0|||
124606897|NCT02393248|448179617|FG017|Part 3: Combination Therapy|Disease Progression|0|||
124606898|NCT02393248|448179618|FG018|Part 3: Combination Therapy|Disease Progression|0|||
124606899|NCT02393248|448179619|FG019|Part 3: Combination Therapy|Disease Progression|0|||
124606900|NCT02393248|448179620|FG020|Part 3: Combination Therapy|Disease Progression|2|||
124606901|NCT02393248|448179621|FG021|Part 3: Combination Therapy|Disease Progression|1|||
124606902|NCT02393248|448179622|FG022|Part 3: Combination Therapy|Disease Progression|0|||
124606903|NCT02393248|448179623|FG023|Part 3: Combination Therapy|Disease Progression|0|||
124606904|NCT02393248|448179624|FG024|Part 3: Combination Therapy|Disease Progression|0|||
124606905|NCT02393248|448179600|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606906|NCT02393248|448179601|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606907|NCT02393248|448179602|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606908|NCT02393248|448179603|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606909|NCT02393248|448179604|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606910|NCT02393248|448179605|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606911|NCT02393248|448179606|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606912|NCT02393248|448179607|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606913|NCT02393248|448179608|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606914|NCT02393248|448179609|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606915|NCT02393248|448179610|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606916|NCT02393248|448179611|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606917|NCT02393248|448179612|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606918|NCT02393248|448179613|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606919|NCT02393248|448179614|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606920|NCT02393248|448179615|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606921|NCT02393248|448179616|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606922|NCT02393248|448179617|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606923|NCT02393248|448179618|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606924|NCT02393248|448179619|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606925|NCT02393248|448179620|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
124606926|NCT02393248|448179621|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
124606927|NCT02393248|448179622|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606928|NCT02393248|448179623|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606929|NCT02393248|448179624|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
124606930|NCT02393248|448179600|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606931|NCT02393248|448179601|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606932|NCT02393248|448179602|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606933|NCT02393248|448179603|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606934|NCT02393248|448179604|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606935|NCT02393248|448179605|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606936|NCT02393248|448179606|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606937|NCT02393248|448179607|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606938|NCT02393248|448179608|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606939|NCT02393248|448179609|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606940|NCT02393248|448179610|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606941|NCT02393248|448179611|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606942|NCT02393248|448179612|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606943|NCT02393248|448179613|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606944|NCT02393248|448179614|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606945|NCT02393248|448179615|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606946|NCT02393248|448179616|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606947|NCT02393248|448179617|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606948|NCT02393248|448179618|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606949|NCT02393248|448179619|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606950|NCT02393248|448179620|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
124606951|NCT02393248|448179621|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606952|NCT02393248|448179622|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606953|NCT02393248|448179623|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606954|NCT02393248|448179624|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
124606955|NCT02393248|448179600|FG000|Part 3: Combination Therapy|Adverse Event|0|||
124606956|NCT02393248|448179601|FG001|Part 3: Combination Therapy|Adverse Event|0|||
124606957|NCT02393248|448179602|FG002|Part 3: Combination Therapy|Adverse Event|0|||
124606958|NCT02393248|448179603|FG003|Part 3: Combination Therapy|Adverse Event|0|||
124606959|NCT02393248|448179604|FG004|Part 3: Combination Therapy|Adverse Event|0|||
124606960|NCT02393248|448179605|FG005|Part 3: Combination Therapy|Adverse Event|0|||
124606961|NCT02393248|448179606|FG006|Part 3: Combination Therapy|Adverse Event|0|||
124606962|NCT02393248|448179607|FG007|Part 3: Combination Therapy|Adverse Event|0|||
124606963|NCT02393248|448179608|FG008|Part 3: Combination Therapy|Adverse Event|0|||
124606964|NCT02393248|448179609|FG009|Part 3: Combination Therapy|Adverse Event|0|||
124606965|NCT02393248|448179610|FG010|Part 3: Combination Therapy|Adverse Event|0|||
124606966|NCT02393248|448179611|FG011|Part 3: Combination Therapy|Adverse Event|0|||
124606967|NCT02393248|448179612|FG012|Part 3: Combination Therapy|Adverse Event|0|||
124606968|NCT02393248|448179613|FG013|Part 3: Combination Therapy|Adverse Event|0|||
124606969|NCT02393248|448179614|FG014|Part 3: Combination Therapy|Adverse Event|0|||
124606970|NCT02393248|448179615|FG015|Part 3: Combination Therapy|Adverse Event|0|||
124606971|NCT02393248|448179616|FG016|Part 3: Combination Therapy|Adverse Event|0|||
124606972|NCT02393248|448179617|FG017|Part 3: Combination Therapy|Adverse Event|0|||
124606973|NCT02393248|448179618|FG018|Part 3: Combination Therapy|Adverse Event|0|||
124606974|NCT02393248|448179619|FG019|Part 3: Combination Therapy|Adverse Event|0|||
124606975|NCT02393248|448179620|FG020|Part 3: Combination Therapy|Adverse Event|0|||
124606976|NCT02393248|448179621|FG021|Part 3: Combination Therapy|Adverse Event|0|||
124606977|NCT02393248|448179622|FG022|Part 3: Combination Therapy|Adverse Event|0|||
124606978|NCT02393248|448179623|FG023|Part 3: Combination Therapy|Adverse Event|1|||
124606979|NCT02393248|448179624|FG024|Part 3: Combination Therapy|Adverse Event|0|||
124606980|NCT02393248|448179600|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606981|NCT02393248|448179601|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606982|NCT02393248|448179602|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606983|NCT02393248|448179603|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606984|NCT02393248|448179604|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606985|NCT02393248|448179605|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606986|NCT02393248|448179606|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606987|NCT02393248|448179607|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124731694|NCT01468233|448640170|FG004|Treatment Period 1|Other|0|||
124731695|NCT01468233|448640171|FG005|Treatment Period 1|Other|0|||
124731696|NCT01468233|448640166|FG000|Treatment Period 2|Adverse Event|0|||
124731697|NCT01468233|448640167|FG001|Treatment Period 2|Adverse Event|0|||
124731698|NCT01468233|448640168|FG002|Treatment Period 2|Adverse Event|3|||
124731699|NCT01468233|448640169|FG003|Treatment Period 2|Adverse Event|0|||
124731700|NCT01468233|448640170|FG004|Treatment Period 2|Adverse Event|2|||
124606988|NCT02393248|448179608|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606989|NCT02393248|448179609|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606990|NCT02393248|448179610|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606991|NCT02393248|448179611|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606992|NCT02393248|448179612|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606993|NCT02393248|448179613|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606994|NCT02393248|448179614|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606995|NCT02393248|448179615|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606996|NCT02393248|448179616|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606997|NCT02393248|448179617|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606998|NCT02393248|448179618|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124606999|NCT02393248|448179619|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124607000|NCT02393248|448179620|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124607001|NCT02393248|448179621|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124607002|NCT02393248|448179622|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124607003|NCT02393248|448179623|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
124607004|NCT02393248|448179624|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
124607005|NCT00987389|448179625|FG000|Overall Study|Ineligible|0|||
124607006|NCT00987389|448179626|FG001|Overall Study|Ineligible|3|||
124607007|NCT00987389|448179627|FG002|Overall Study|Ineligible|0|||
124607008|NCT00987389|448179628|FG003|Overall Study|Ineligible|0|||
124607009|NCT00987389|448179625|FG000|Overall Study|Lost to Follow-up|4|||
124607010|NCT00987389|448179626|FG001|Overall Study|Lost to Follow-up|1|||
124607011|NCT00987389|448179627|FG002|Overall Study|Lost to Follow-up|3|||
124607012|NCT00987389|448179628|FG003|Overall Study|Lost to Follow-up|1|||
124607013|NCT00987389|448179625|FG000|Overall Study|Withdrawal by Subject|4|||
124607014|NCT00987389|448179626|FG001|Overall Study|Withdrawal by Subject|3|||
124607015|NCT00987389|448179627|FG002|Overall Study|Withdrawal by Subject|2|||
124607016|NCT00987389|448179628|FG003|Overall Study|Withdrawal by Subject|1|||
124607017|NCT00987389|448179625|FG000|Overall Study|Withdrawn from Treatment|0|||
124607018|NCT00987389|448179626|FG001|Overall Study|Withdrawn from Treatment|1|||
124607019|NCT00987389|448179627|FG002|Overall Study|Withdrawn from Treatment|0|||
124607020|NCT00987389|448179628|FG003|Overall Study|Withdrawn from Treatment|0|||
124607021|NCT00987389|448179625|FG000|Overall Study|Multiple different reasons|1|||
124607022|NCT00987389|448179626|FG001|Overall Study|Multiple different reasons|0|||
124607023|NCT00987389|448179627|FG002|Overall Study|Multiple different reasons|3|||
124607024|NCT00987389|448179628|FG003|Overall Study|Multiple different reasons|1|||
124607025|NCT00507130|448179629|FG000|Overall Study|Lost to Follow-up|0|||
124607026|NCT00507130|448179630|FG001|Overall Study|Lost to Follow-up|0|||
124607027|NCT00507130|448179631|FG002|Overall Study|Lost to Follow-up|1|||
124607028|NCT00507130|448179632|FG003|Overall Study|Lost to Follow-up|1|||
124607029|NCT00507130|448179629|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
124607030|NCT00507130|448179630|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
124607031|NCT00507130|448179631|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
124607032|NCT00507130|448179632|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
124607033|NCT00080938|448179637|FG000|Overall Study|Adverse Event|3|||
124607034|NCT00080938|448179637|FG000|Overall Study|Withdrawal by Subject|6|||
124607035|NCT00080938|448179637|FG000|Overall Study|Death|2|||
124607036|NCT00080938|448179637|FG000|Overall Study|Lack of Efficacy|7|||
124607037|NCT00080938|448179637|FG000|Overall Study|other disease|1|||
124607038|NCT00080938|448179637|FG000|Overall Study|Not started protocol therapy|1|||
124607039|NCT00080938|448179637|FG000|Overall Study|Ineligible|4|||
124607040|NCT00338455|448179643|FG000|Overall Study|Death|2|||
124607041|NCT00338455|448179644|FG001|Overall Study|Death|1|||
124607042|NCT00338455|448179643|FG000|Overall Study|Physician Decision|1|||
124607043|NCT00338455|448179644|FG001|Overall Study|Physician Decision|0|||
124607044|NCT02266134|448179645|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
124607045|NCT02266134|448179646|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
124607046|NCT02266134|448179647|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
124607047|NCT02266134|448179648|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
124607048|NCT02266134|448179645|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
124607049|NCT02266134|448179646|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
124607050|NCT02266134|448179647|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
124607051|NCT02266134|448179648|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
124607052|NCT02266134|448179645|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
124607053|NCT02266134|448179646|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
124731701|NCT01468233|448640171|FG005|Treatment Period 2|Adverse Event|1|||
124731702|NCT01468233|448640166|FG000|Treatment Period 2|Lack of Efficacy|0|||
124607054|NCT02266134|448179647|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
124731703|NCT01468233|448640167|FG001|Treatment Period 2|Lack of Efficacy|0|||
124607055|NCT02266134|448179648|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
124731704|NCT01468233|448640168|FG002|Treatment Period 2|Lack of Efficacy|9|||
124731705|NCT01468233|448640169|FG003|Treatment Period 2|Lack of Efficacy|2|||
124731706|NCT01468233|448640170|FG004|Treatment Period 2|Lack of Efficacy|0|||
124731707|NCT01468233|448640171|FG005|Treatment Period 2|Lack of Efficacy|1|||
124731708|NCT01468233|448640166|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124731709|NCT01468233|448640167|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124731710|NCT01468233|448640168|FG002|Treatment Period 2|Withdrawal by Subject|9|||
124731711|NCT01468233|448640169|FG003|Treatment Period 2|Withdrawal by Subject|1|||
124731712|NCT01468233|448640170|FG004|Treatment Period 2|Withdrawal by Subject|1|||
124731713|NCT01468233|448640171|FG005|Treatment Period 2|Withdrawal by Subject|1|||
124731714|NCT01468233|448640166|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
124731715|NCT01468233|448640167|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
124607056|NCT02266134|448179645|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
124607057|NCT02266134|448179646|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
124607058|NCT02266134|448179647|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
124607059|NCT02266134|448179648|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
124607060|NCT02266134|448179645|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
124607061|NCT02266134|448179646|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
124607062|NCT02266134|448179647|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
124607063|NCT02266134|448179648|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
124607064|NCT02266134|448179645|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
124607065|NCT02266134|448179646|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
124607066|NCT02266134|448179647|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
124607067|NCT02266134|448179648|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
124607068|NCT01437943|448179650|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
124607069|NCT01437943|448179651|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
124607070|NCT01437943|448179650|FG000|Overall Study|Subject expressed pregnancy plans|1|||
124607071|NCT01437943|448179651|FG001|Overall Study|Subject expressed pregnancy plans|0|||
124607072|NCT01437943|448179650|FG000|Overall Study|Adverse Event|2|||
124607073|NCT01437943|448179651|FG001|Overall Study|Adverse Event|0|||
124607074|NCT04647721|448179653|FG000|Overall Study|Withdrawal by Subject|0|||
124607075|NCT04647721|448179654|FG001|Overall Study|Withdrawal by Subject|2|||
124607076|NCT04647721|448179653|FG000|Overall Study|Lost to Follow-up|2|||
124607077|NCT04647721|448179654|FG001|Overall Study|Lost to Follow-up|0|||
124607078|NCT04771403|448179655|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
124607079|NCT04771403|448179656|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
124607080|NCT04771403|448179655|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
124607081|NCT04771403|448179656|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
124607082|NCT04771403|448179655|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
124607083|NCT04771403|448179656|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
124607084|NCT04771403|448179655|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
124607085|NCT04771403|448179656|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
124607086|NCT04771403|448179655|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
124607087|NCT04771403|448179656|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
124607088|NCT04771403|448179655|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
124607089|NCT04771403|448179656|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
124607090|NCT04771403|448179655|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
124607091|NCT04771403|448179656|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
124607092|NCT04771403|448179655|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
124607093|NCT04771403|448179656|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
124607094|NCT05442866|448179657|FG000|Overall Study|Death|1|||
124607095|NCT05442866|448179657|FG000|Overall Study|Lost to Follow-up|9|||
124607096|NCT05442866|448179657|FG000|Overall Study|Protocol Violation|1|||
124607097|NCT01568320|448179658|FG000|Overall Study|Death|20|||
124607098|NCT01568320|448179658|FG000|Overall Study|Lost to Follow-up|9|||
124607099|NCT01568320|448179658|FG000|Overall Study|Withdrawal by Subject|10|||
124607100|NCT01568320|448179658|FG000|Overall Study|Conversion to open repair|1|||
124607101|NCT01568320|448179658|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
124607102|NCT00546572|448179659|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
124607103|NCT00546572|448179660|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
124607104|NCT00546572|448179659|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
124607105|NCT00546572|448179660|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
124607106|NCT00546572|448179659|FG000|Vax 1 / Year 0|Protocol Violation|3|||
124607107|NCT00546572|448179660|FG001|Vax 1 / Year 0|Protocol Violation|4|||
124607108|NCT00546572|448179659|FG000|Vax 1 / Year 0|Death|2|||
124607109|NCT00546572|448179660|FG001|Vax 1 / Year 0|Death|2|||
124607110|NCT00546572|448179659|FG000|Vax 1 / Year 0|Adverse Event|0|||
124607111|NCT00546572|448179660|FG001|Vax 1 / Year 0|Adverse Event|1|||
124607112|NCT00546572|448179659|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
124607113|NCT00546572|448179660|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
124607114|NCT00546572|448179659|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
124607115|NCT00546572|448179660|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
124607116|NCT00546572|448179659|FG000|Vax 2 / Year 1|Other|1|||
124607117|NCT00546572|448179660|FG001|Vax 2 / Year 1|Other|1|||
124607118|NCT00546572|448179659|FG000|Vax 2 / Year 1|Adverse Event|1|||
124607119|NCT00546572|448179660|FG001|Vax 2 / Year 1|Adverse Event|0|||
124607120|NCT00546572|448179659|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
124607121|NCT00546572|448179660|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
124607122|NCT01394952|448179661|FG000|Overall Study|Lost to Follow-up|0|||
124607123|NCT01394952|448179662|FG001|Overall Study|Lost to Follow-up|5|||
124607124|NCT01394952|448179661|FG000|Overall Study|Withdrawal by Subject|10|||
124607125|NCT01394952|448179662|FG001|Overall Study|Withdrawal by Subject|5|||
124607126|NCT01394952|448179661|FG000|Overall Study|Physician Decision|2|||
124607127|NCT01394952|448179662|FG001|Overall Study|Physician Decision|0|||
124607128|NCT01394952|448179661|FG000|Overall Study|Sponsor Decision|5|||
124607129|NCT01394952|448179662|FG001|Overall Study|Sponsor Decision|7|||
124607130|NCT01335997|448179663|FG000|Period I and II|Adverse Event|63|||
124607131|NCT01335997|448179664|FG001|Period I and II|Adverse Event|43|||
124607132|NCT01335997|448179663|FG000|Period I and II|Noncompliance with Study Drug|1|||
124607133|NCT01335997|448179664|FG001|Period I and II|Noncompliance with Study Drug|1|||
124607134|NCT01335997|448179663|FG000|Period I and II|Lost to Follow-up|3|||
124607135|NCT01335997|448179664|FG001|Period I and II|Lost to Follow-up|5|||
124607136|NCT01335997|448179663|FG000|Period I and II|Withdrawal by Subject|9|||
124607137|NCT01335997|448179664|FG001|Period I and II|Withdrawal by Subject|4|||
124607138|NCT01335997|448179663|FG000|Period I and II|Study Terminated by Sponsor|406|||
124607139|NCT01335997|448179664|FG001|Period I and II|Study Terminated by Sponsor|415|||
124607140|NCT01335997|448179663|FG000|Period I and II|Protocol Violation|9|||
124607141|NCT01335997|448179664|FG001|Period I and II|Protocol Violation|10|||
124607142|NCT01335997|448179663|FG000|Period I and II|Physician Decision|2|||
124607143|NCT01335997|448179664|FG001|Period I and II|Physician Decision|1|||
124607144|NCT01335997|448179663|FG000|Period III|Adverse Event|0|||
124607145|NCT01335997|448179664|FG001|Period III|Adverse Event|2|||
124607146|NCT01335997|448179663|FG000|Period III|Study Terminated by Sponsor|77|||
124607147|NCT01335997|448179664|FG001|Period III|Study Terminated by Sponsor|76|||
124607148|NCT01335997|448179663|FG000|Period III|Protocol Violation|0|||
124607149|NCT01335997|448179664|FG001|Period III|Protocol Violation|1|||
124607150|NCT01335997|448179663|FG000|Period III|Lost to Follow-up|1|||
124607151|NCT01335997|448179664|FG001|Period III|Lost to Follow-up|0|||
124607152|NCT01763684|448179665|FG000|Overall Study|Study terminated early due to low enrollment|126|||
124607153|NCT01763684|448179666|FG001|Overall Study|Study terminated early due to low enrollment|127|||
124607154|NCT01763684|448179665|FG000|Overall Study|Study surgery not performed|7|||
124607155|NCT01763684|448179666|FG001|Overall Study|Study surgery not performed|6|||
124607156|NCT04453202|448179671|FG000|Overall Study|Adverse Event|0|||
124607157|NCT04453202|448179672|FG001|Overall Study|Adverse Event|0|||
124607158|NCT04453202|448179673|FG002|Overall Study|Adverse Event|0|||
124607159|NCT04453202|448179674|FG003|Overall Study|Adverse Event|0|||
124607160|NCT04453202|448179675|FG004|Overall Study|Adverse Event|0|||
124607161|NCT04453202|448179676|FG005|Overall Study|Adverse Event|0|||
124607162|NCT04453202|448179677|FG006|Overall Study|Adverse Event|1|||
124607163|NCT04453202|448179678|FG007|Overall Study|Adverse Event|0|||
124607164|NCT04453202|448179679|FG008|Overall Study|Adverse Event|0|||
124607165|NCT04453202|448179680|FG009|Overall Study|Adverse Event|0|||
124607166|NCT04453202|448179681|FG010|Overall Study|Adverse Event|0|||
124607167|NCT04453202|448179671|FG000|Overall Study|Death|0|||
124607168|NCT04453202|448179672|FG001|Overall Study|Death|0|||
124607169|NCT04453202|448179673|FG002|Overall Study|Death|0|||
124607170|NCT04453202|448179674|FG003|Overall Study|Death|0|||
124607171|NCT04453202|448179675|FG004|Overall Study|Death|0|||
124607172|NCT04453202|448179676|FG005|Overall Study|Death|0|||
124607173|NCT04453202|448179677|FG006|Overall Study|Death|0|||
124607174|NCT04453202|448179678|FG007|Overall Study|Death|0|||
124607175|NCT04453202|448179679|FG008|Overall Study|Death|0|||
124607176|NCT04453202|448179680|FG009|Overall Study|Death|1|||
124607177|NCT04453202|448179681|FG010|Overall Study|Death|0|||
124607178|NCT04453202|448179671|FG000|Overall Study|Lost to Follow-up|0|||
124607179|NCT04453202|448179672|FG001|Overall Study|Lost to Follow-up|1|||
124607180|NCT04453202|448179673|FG002|Overall Study|Lost to Follow-up|0|||
124607181|NCT04453202|448179674|FG003|Overall Study|Lost to Follow-up|1|||
124607182|NCT04453202|448179675|FG004|Overall Study|Lost to Follow-up|0|||
124607183|NCT04453202|448179676|FG005|Overall Study|Lost to Follow-up|0|||
124607184|NCT04453202|448179677|FG006|Overall Study|Lost to Follow-up|0|||
124607185|NCT04453202|448179678|FG007|Overall Study|Lost to Follow-up|0|||
124607186|NCT04453202|448179679|FG008|Overall Study|Lost to Follow-up|0|||
124607187|NCT04453202|448179680|FG009|Overall Study|Lost to Follow-up|1|||
124607188|NCT04453202|448179681|FG010|Overall Study|Lost to Follow-up|1|||
124607189|NCT04453202|448179671|FG000|Overall Study|Withdrawal by Subject|1|||
124607190|NCT04453202|448179672|FG001|Overall Study|Withdrawal by Subject|2|||
124607191|NCT04453202|448179673|FG002|Overall Study|Withdrawal by Subject|1|||
124607192|NCT04453202|448179674|FG003|Overall Study|Withdrawal by Subject|2|||
124607193|NCT04453202|448179675|FG004|Overall Study|Withdrawal by Subject|1|||
124607194|NCT04453202|448179676|FG005|Overall Study|Withdrawal by Subject|1|||
124607195|NCT04453202|448179677|FG006|Overall Study|Withdrawal by Subject|0|||
124607196|NCT04453202|448179678|FG007|Overall Study|Withdrawal by Subject|0|||
124607197|NCT04453202|448179679|FG008|Overall Study|Withdrawal by Subject|0|||
124607198|NCT04453202|448179680|FG009|Overall Study|Withdrawal by Subject|1|||
124607199|NCT04453202|448179681|FG010|Overall Study|Withdrawal by Subject|0|||
124607200|NCT04453202|448179671|FG000|Overall Study|Adverse Event|0|||
124607201|NCT04453202|448179672|FG001|Overall Study|Adverse Event|0|||
124607202|NCT04453202|448179673|FG002|Overall Study|Adverse Event|0|||
124607203|NCT04453202|448179674|FG003|Overall Study|Adverse Event|0|||
124607204|NCT04453202|448179675|FG004|Overall Study|Adverse Event|0|||
124607205|NCT04453202|448179676|FG005|Overall Study|Adverse Event|1|||
124607206|NCT04453202|448179677|FG006|Overall Study|Adverse Event|0|||
124607207|NCT04453202|448179678|FG007|Overall Study|Adverse Event|0|||
124607208|NCT04453202|448179679|FG008|Overall Study|Adverse Event|0|||
124607209|NCT04453202|448179680|FG009|Overall Study|Adverse Event|0|||
124607210|NCT04453202|448179681|FG010|Overall Study|Adverse Event|0|||
124607211|NCT01157897|448179682|FG000|Overall Study|Lost to Follow-up|2|||
124607212|NCT01157897|448179683|FG001|Overall Study|Lost to Follow-up|0|||
124607213|NCT01157897|448179684|FG002|Overall Study|Lost to Follow-up|0|||
124607214|NCT01157897|448179685|FG003|Overall Study|Lost to Follow-up|1|||
124607215|NCT01157897|448179682|FG000|Overall Study|Relocated|0|||
124607216|NCT01157897|448179683|FG001|Overall Study|Relocated|2|||
124607217|NCT01157897|448179684|FG002|Overall Study|Relocated|0|||
124607218|NCT01157897|448179685|FG003|Overall Study|Relocated|0|||
124607219|NCT03276221|448179686|FG000|Overall Study|Lost to Follow-up|6|||
124607220|NCT03276221|448179687|FG001|Overall Study|Lost to Follow-up|2|||
124607221|NCT03276221|448179688|FG002|Overall Study|Lost to Follow-up|0|||
124607222|NCT03276221|448179686|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
124607223|NCT03276221|448179687|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
124607224|NCT03276221|448179688|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
124607225|NCT02912650|448179689|FG000|Overall Study|Withdrawal by Subject|1|||
124607226|NCT02912650|448179690|FG001|Overall Study|Withdrawal by Subject|0|||
124607227|NCT02912650|448179691|FG002|Overall Study|Withdrawal by Subject|1|||
124607228|NCT02912650|448179692|FG003|Overall Study|Withdrawal by Subject|5|||
124607229|NCT02912650|448179689|FG000|Overall Study|Adverse Event|0|||
124607230|NCT02912650|448179690|FG001|Overall Study|Adverse Event|0|||
124607231|NCT02912650|448179691|FG002|Overall Study|Adverse Event|1|||
124607232|NCT02912650|448179692|FG003|Overall Study|Adverse Event|0|||
124607233|NCT04700280|448179694|FG000|Overall Study|Adverse Event|4|||
124607234|NCT04700280|448179695|FG001|Overall Study|Adverse Event|0|||
124607235|NCT04700280|448179694|FG000|Overall Study|Lack of Efficacy|1|||
124607236|NCT04700280|448179695|FG001|Overall Study|Lack of Efficacy|0|||
124607237|NCT04700280|448179694|FG000|Overall Study|Study terminated by sponsor|5|||
124607238|NCT04700280|448179695|FG001|Overall Study|Study terminated by sponsor|3|||
124607239|NCT04700280|448179694|FG000|Overall Study|Other than specified|1|||
124607240|NCT04700280|448179695|FG001|Overall Study|Other than specified|0|||
124607241|NCT02562482|448179696|FG000|Overall Study|Enrolled, but did not receive product|4|||
124607242|NCT02562482|448179697|FG001|Overall Study|Enrolled, but did not receive product|0|||
124607243|NCT02562482|448179696|FG000|Overall Study|Lost to Follow-up|9|||
124607244|NCT02562482|448179697|FG001|Overall Study|Lost to Follow-up|6|||
124607245|NCT02562482|448179696|FG000|Overall Study|Moved from area|2|||
124607246|NCT02562482|448179697|FG001|Overall Study|Moved from area|3|||
124607247|NCT02562482|448179696|FG000|Overall Study|Withdrawal by Subject|5|||
124607248|NCT02562482|448179697|FG001|Overall Study|Withdrawal by Subject|3|||
124607249|NCT02562482|448179696|FG000|Overall Study|Physician Decision|1|||
124607250|NCT02562482|448179697|FG001|Overall Study|Physician Decision|3|||
124607251|NCT02562482|448179696|FG000|Overall Study|Illness/Injury unrelated to product|0|||
124607252|NCT02562482|448179697|FG001|Overall Study|Illness/Injury unrelated to product|1|||
124607253|NCT02435836|448179705|FG000|Overall Study|Lost to Follow-up|21|||
124607254|NCT02435836|448179705|FG000|Overall Study|Lack of Efficacy|1|||
124607255|NCT02435836|448179705|FG000|Overall Study|Withdrawal by Subject|236|||
124607256|NCT02435836|448179705|FG000|Overall Study|Insufficient Clinical Response|26|||
124607257|NCT02435836|448179705|FG000|Overall Study|Adverse Event|44|||
124607258|NCT02435836|448179705|FG000|Overall Study|Sponsor discontinued trial|167|||
124607259|NCT02435836|448179705|FG000|Overall Study|Noncompliance|27|||
124607260|NCT02435836|448179705|FG000|Overall Study|Protocol Violation|6|||
124607261|NCT02435836|448179705|FG000|Overall Study|Met Withdrawal Criteria|7|||
124607262|NCT02435836|448179705|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
124607263|NCT02041091|448179706|FG000|Treatment|Adverse Event|3|||
124607264|NCT02041091|448179707|FG001|Treatment|Adverse Event|3|||
124607265|NCT02041091|448179706|FG000|Treatment|Withdrawal by Subject|2|||
124607266|NCT02041091|448179707|FG001|Treatment|Withdrawal by Subject|4|||
124607267|NCT02041091|448179706|FG000|Treatment|Physician Decision|1|||
124607268|NCT02041091|448179707|FG001|Treatment|Physician Decision|0|||
124607269|NCT02041091|448179706|FG000|Treatment|Sponsor Decision|15|||
124607270|NCT02041091|448179707|FG001|Treatment|Sponsor Decision|16|||
124607271|NCT02041091|448179706|FG000|Treatment|Lost to Follow-up|1|||
124607272|NCT02041091|448179707|FG001|Treatment|Lost to Follow-up|0|||
124607273|NCT02041091|448179706|FG000|Optional Safety Extension Period|Adverse Event|4|||
124607274|NCT02041091|448179707|FG001|Optional Safety Extension Period|Adverse Event|2|||
124607275|NCT02041091|448179706|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
124607276|NCT02041091|448179707|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
124607277|NCT02041091|448179706|FG000|Optional Safety Extension Period|Protocol Violation|2|||
124607278|NCT02041091|448179707|FG001|Optional Safety Extension Period|Protocol Violation|0|||
124607279|NCT02041091|448179706|FG000|Optional Safety Extension Period|Physician Decision|2|||
124607280|NCT02041091|448179707|FG001|Optional Safety Extension Period|Physician Decision|1|||
124607281|NCT02041091|448179706|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
124607282|NCT02041091|448179707|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
124607283|NCT02041091|448179706|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
124607284|NCT02041091|448179707|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
124607285|NCT01855074|448179708|FG000|Overall Study|Adverse Event|1|||
124607286|NCT01855074|448179708|FG000|Overall Study|Lost to Follow-up|4|||
124607287|NCT01855074|448179708|FG000|Overall Study|Withdrawal by Subject|8|||
124607288|NCT01855074|448179708|FG000|Overall Study|Started but not treated|1|||
124607289|NCT01150890|448179709|FG000|Overall Study|Other|0|||
124607290|NCT01150890|448179710|FG001|Overall Study|Other|1|||
124607291|NCT01150890|448179711|FG002|Overall Study|Other|0|||
124607292|NCT01150890|448179712|FG003|Overall Study|Other|2|||
124607293|NCT01150890|448179709|FG000|Overall Study|Pregnancy|0|||
124607294|NCT01150890|448179710|FG001|Overall Study|Pregnancy|0|||
124607295|NCT01150890|448179711|FG002|Overall Study|Pregnancy|0|||
124607296|NCT01150890|448179712|FG003|Overall Study|Pregnancy|1|||
124607297|NCT01150890|448179709|FG000|Overall Study|Administrative Decision|4|||
124607298|NCT01150890|448179710|FG001|Overall Study|Administrative Decision|4|||
124607299|NCT01150890|448179711|FG002|Overall Study|Administrative Decision|5|||
124607300|NCT01150890|448179712|FG003|Overall Study|Administrative Decision|6|||
124607301|NCT01150890|448179709|FG000|Overall Study|Ineligibility determined|0|||
124607302|NCT01150890|448179710|FG001|Overall Study|Ineligibility determined|1|||
124607303|NCT01150890|448179711|FG002|Overall Study|Ineligibility determined|0|||
124607304|NCT01150890|448179712|FG003|Overall Study|Ineligibility determined|0|||
124607305|NCT01150890|448179709|FG000|Overall Study|Adverse Event|0|||
124607306|NCT01150890|448179710|FG001|Overall Study|Adverse Event|0|||
124607307|NCT01150890|448179711|FG002|Overall Study|Adverse Event|2|||
124607308|NCT01150890|448179712|FG003|Overall Study|Adverse Event|0|||
124607309|NCT01150890|448179709|FG000|Overall Study|Withdrawal by Subject|0|||
124607310|NCT01150890|448179710|FG001|Overall Study|Withdrawal by Subject|0|||
124607311|NCT01150890|448179711|FG002|Overall Study|Withdrawal by Subject|2|||
124607312|NCT01150890|448179712|FG003|Overall Study|Withdrawal by Subject|1|||
124607313|NCT01150890|448179709|FG000|Overall Study|Disease progression|0|||
124607314|NCT01150890|448179710|FG001|Overall Study|Disease progression|7|||
124607315|NCT01150890|448179711|FG002|Overall Study|Disease progression|3|||
124607316|NCT01150890|448179712|FG003|Overall Study|Disease progression|7|||
124607317|NCT00922987|448179713|FG000|Overall Study|Insufficient clinical response|1|||
124607318|NCT00922987|448179713|FG000|Overall Study|Protocol Violation|2|||
124607319|NCT00922987|448179713|FG000|Overall Study|Adverse Event|1|||
124607320|NCT02312063|448179717|FG000|Overall Study|Withdrawal by Subject|0|||
124607321|NCT02312063|448179718|FG001|Overall Study|Withdrawal by Subject|1|||
124607322|NCT05091307|448182404|FG000|Overall Study|Death|0|||
124607323|NCT05091307|448182405|FG001|Overall Study|Death|0|||
124607324|NCT05091307|448182406|FG002|Overall Study|Death|1|||
124607325|NCT05091307|448182407|FG003|Overall Study|Death|0|||
124607326|NCT05091307|448182404|FG000|Overall Study|Lost to Follow-up|33|||
124607327|NCT05091307|448182405|FG001|Overall Study|Lost to Follow-up|33|||
124607328|NCT05091307|448182406|FG002|Overall Study|Lost to Follow-up|2|||
124607329|NCT05091307|448182407|FG003|Overall Study|Lost to Follow-up|0|||
124607330|NCT05091307|448182404|FG000|Overall Study|Physician Decision|1|||
124607331|NCT05091307|448182405|FG001|Overall Study|Physician Decision|0|||
124607332|NCT05091307|448182406|FG002|Overall Study|Physician Decision|0|||
124607333|NCT05091307|448182407|FG003|Overall Study|Physician Decision|0|||
124607334|NCT05091307|448182404|FG000|Overall Study|Protocol Violation|1|||
124607335|NCT05091307|448182405|FG001|Overall Study|Protocol Violation|0|||
124607336|NCT05091307|448182406|FG002|Overall Study|Protocol Violation|0|||
124607337|NCT05091307|448182407|FG003|Overall Study|Protocol Violation|0|||
124607338|NCT05091307|448182404|FG000|Overall Study|Withdrawal by Subject|16|||
124781139|NCT00545272|448829098|FG005|Overall Study|Protocol deviation|1|||
124607339|NCT05091307|448182405|FG001|Overall Study|Withdrawal by Subject|16|||
124607340|NCT05091307|448182406|FG002|Overall Study|Withdrawal by Subject|0|||
124607341|NCT05091307|448182407|FG003|Overall Study|Withdrawal by Subject|1|||
124607342|NCT05091307|448182404|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
124607343|NCT05091307|448182405|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
124607344|NCT05091307|448182406|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
124607345|NCT05091307|448182407|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
124607346|NCT05091307|448182404|FG000|Overall Study|Initiated Prohibited Medication|1|||
124607347|NCT05091307|448182405|FG001|Overall Study|Initiated Prohibited Medication|0|||
124607348|NCT05091307|448182406|FG002|Overall Study|Initiated Prohibited Medication|0|||
124607349|NCT05091307|448182407|FG003|Overall Study|Initiated Prohibited Medication|0|||
124607350|NCT05091307|448182404|FG000|Overall Study|Other|4|||
124607351|NCT05091307|448182405|FG001|Overall Study|Other|4|||
124607352|NCT05091307|448182406|FG002|Overall Study|Other|0|||
124607353|NCT05091307|448182407|FG003|Overall Study|Other|0|||
124607354|NCT05091307|448182404|FG000|Overall Study|Randomized but not vaccinated|0|||
124607355|NCT05091307|448182405|FG001|Overall Study|Randomized but not vaccinated|2|||
124607356|NCT05091307|448182406|FG002|Overall Study|Randomized but not vaccinated|0|||
124607357|NCT05091307|448182407|FG003|Overall Study|Randomized but not vaccinated|0|||
124607358|NCT03303625|448182408|FG000|Overall Study|Withdrawal by Subject|2|||
124607359|NCT03303625|448182409|FG001|Overall Study|Withdrawal by Subject|0|||
124607360|NCT03303625|448182410|FG002|Overall Study|Withdrawal by Subject|0|||
124607361|NCT03303625|448182411|FG003|Overall Study|Withdrawal by Subject|0|||
124607362|NCT01167257|448182412|FG000|Overall Study|Lost to Follow-up|2|||
124607363|NCT01167257|448182413|FG001|Overall Study|Lost to Follow-up|2|||
124607364|NCT01167257|448182412|FG000|Overall Study|Withdrew consent|1|||
124607365|NCT01167257|448182413|FG001|Overall Study|Withdrew consent|1|||
124607366|NCT02492880|448182414|FG000|Overall Study|Lost to Follow-up|1|||
124607367|NCT02492880|448182414|FG000|Overall Study|Protocol Violation|1|||
124607368|NCT02771795|448182415|FG000|Overall Study|Withdrawal by Subject|47|||
124607369|NCT02771795|448182416|FG001|Overall Study|Withdrawal by Subject|37|||
124607370|NCT02771795|448182415|FG000|Overall Study|Termination by premature discontinuation of study|168|||
124607371|NCT02771795|448182416|FG001|Overall Study|Termination by premature discontinuation of study|185|||
124607372|NCT02906930|448182417|FG000|Overall Study|Withdrawal by Subject|0|||
124607373|NCT02906930|448182418|FG001|Overall Study|Withdrawal by Subject|5|||
124607374|NCT02906930|448182419|FG002|Overall Study|Withdrawal by Subject|5|||
124607375|NCT02906930|448182420|FG003|Overall Study|Withdrawal by Subject|4|||
124607376|NCT02906930|448182417|FG000|Overall Study|Lost to Follow-up|5|||
124607377|NCT02906930|448182418|FG001|Overall Study|Lost to Follow-up|7|||
124607378|NCT02906930|448182419|FG002|Overall Study|Lost to Follow-up|5|||
124607379|NCT02906930|448182420|FG003|Overall Study|Lost to Follow-up|2|||
124607380|NCT02906930|448182417|FG000|Overall Study|Death|0|||
124607381|NCT02906930|448182418|FG001|Overall Study|Death|0|||
124607382|NCT02906930|448182419|FG002|Overall Study|Death|1|||
124607383|NCT02906930|448182420|FG003|Overall Study|Death|0|||
124607384|NCT02906930|448182417|FG000|Overall Study|Other|1|||
124607385|NCT02906930|448182418|FG001|Overall Study|Other|2|||
124607386|NCT02906930|448182419|FG002|Overall Study|Other|1|||
124607387|NCT02906930|448182420|FG003|Overall Study|Other|2|||
124607388|NCT00622466|448182432|FG000|Overall Study|Death|1|||
124607389|NCT00622466|448182432|FG000|Overall Study|Adverse Event|1|||
124607390|NCT00622466|448182432|FG000|Overall Study|Withdrawal by Subject|2|||
124607391|NCT04585789|448182434|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
124607392|NCT04585789|448182435|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
124607393|NCT04585789|448182436|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
124607394|NCT04585789|448182434|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
124607395|NCT04585789|448182435|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
124607396|NCT04585789|448182436|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
124607397|NCT01383135|448182439|FG000|Overall Study|Not Scanned / Imaged|1|||
124607398|NCT01383135|448182440|FG001|Overall Study|Not Scanned / Imaged|0|||
124607399|NCT01383135|448182441|FG002|Overall Study|Not Scanned / Imaged|1|||
124607400|NCT01383135|448182442|FG003|Overall Study|Not Scanned / Imaged|0|||
124607401|NCT00415194|448182443|FG000|Overall Study|Adverse Event|37|||
124607402|NCT00415194|448182444|FG001|Overall Study|Adverse Event|32|||
124607403|NCT00415194|448182443|FG000|Overall Study|Entry Criteria Not Met|4|||
124607404|NCT00415194|448182444|FG001|Overall Study|Entry Criteria Not Met|8|||
124607405|NCT00415194|448182443|FG000|Overall Study|Lost to Follow-up|1|||
124607406|NCT00415194|448182444|FG001|Overall Study|Lost to Follow-up|0|||
124607407|NCT00415194|448182443|FG000|Overall Study|Physician Decision|10|||
124607408|NCT00415194|448182444|FG001|Overall Study|Physician Decision|16|||
124607409|NCT00415194|448182443|FG000|Overall Study|Progressive Disease|180|||
124607410|NCT00415194|448182444|FG001|Overall Study|Progressive Disease|217|||
124607411|NCT00415194|448182443|FG000|Overall Study|Protocol Violation|4|||
124781140|NCT00545272|448829093|FG000|Overall Study|Adverse Event|0|||
124607412|NCT00415194|448182444|FG001|Overall Study|Protocol Violation|2|||
124607413|NCT00415194|448182443|FG000|Overall Study|Withdrawal by Subject|28|||
124607414|NCT00415194|448182444|FG001|Overall Study|Withdrawal by Subject|21|||
124607415|NCT00415194|448182443|FG000|Overall Study|Death Due to Study Disease|26|||
124607416|NCT00415194|448182444|FG001|Overall Study|Death Due to Study Disease|29|||
124607417|NCT00415194|448182443|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
124607418|NCT00415194|448182444|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
124607419|NCT00415194|448182443|FG000|Overall Study|Death Due to Procedural Related AE|0|||
124607420|NCT00415194|448182444|FG001|Overall Study|Death Due to Procedural Related AE|1|||
124607421|NCT00415194|448182443|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
124607422|NCT00415194|448182444|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
124607423|NCT00369655|448182445|FG000|Overall Study|Refusal of further treatment|2|||
124607424|NCT02397408|448182446|FG000|Overall Study|Physician Decision|4|||
124607425|NCT02397408|448182446|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
124607426|NCT01154816|448182447|FG000|Overall Study|Withdrawal by Subject|1|||
124607427|NCT01154816|448182448|FG001|Overall Study|Withdrawal by Subject|0|||
124607428|NCT01154816|448182449|FG002|Overall Study|Withdrawal by Subject|0|||
124607429|NCT01154816|448182450|FG003|Overall Study|Withdrawal by Subject|1|||
124607430|NCT01154816|448182451|FG004|Overall Study|Withdrawal by Subject|0|||
124607431|NCT01154816|448182452|FG005|Overall Study|Withdrawal by Subject|0|||
124607432|NCT01154816|448182453|FG006|Overall Study|Withdrawal by Subject|0|||
124607433|NCT01154816|448182454|FG007|Overall Study|Withdrawal by Subject|0|||
124607434|NCT01154816|448182455|FG008|Overall Study|Withdrawal by Subject|1|||
124607435|NCT01154816|448182456|FG009|Overall Study|Withdrawal by Subject|3|||
124607436|NCT01154816|448182457|FG010|Overall Study|Withdrawal by Subject|0|||
124607437|NCT01154816|448182458|FG011|Overall Study|Withdrawal by Subject|0|||
124607438|NCT01154816|448182447|FG000|Overall Study|Progressive Disease|13|||
124607439|NCT01154816|448182448|FG001|Overall Study|Progressive Disease|8|||
124607440|NCT01154816|448182449|FG002|Overall Study|Progressive Disease|9|||
124607441|NCT01154816|448182450|FG003|Overall Study|Progressive Disease|9|||
124607442|NCT01154816|448182451|FG004|Overall Study|Progressive Disease|8|||
124607443|NCT01154816|448182452|FG005|Overall Study|Progressive Disease|8|||
124607444|NCT01154816|448182453|FG006|Overall Study|Progressive Disease|5|||
124607445|NCT01154816|448182454|FG007|Overall Study|Progressive Disease|6|||
124607446|NCT01154816|448182455|FG008|Overall Study|Progressive Disease|8|||
124607447|NCT01154816|448182456|FG009|Overall Study|Progressive Disease|6|||
124607448|NCT01154816|448182457|FG010|Overall Study|Progressive Disease|10|||
124607449|NCT01154816|448182458|FG011|Overall Study|Progressive Disease|3|||
124607450|NCT01154816|448182447|FG000|Overall Study|Physician Decision|1|||
124607451|NCT01154816|448182448|FG001|Overall Study|Physician Decision|0|||
124607452|NCT01154816|448182449|FG002|Overall Study|Physician Decision|1|||
124607453|NCT01154816|448182450|FG003|Overall Study|Physician Decision|0|||
124607454|NCT01154816|448182451|FG004|Overall Study|Physician Decision|2|||
124607455|NCT01154816|448182452|FG005|Overall Study|Physician Decision|0|||
124607456|NCT01154816|448182453|FG006|Overall Study|Physician Decision|0|||
124607457|NCT01154816|448182454|FG007|Overall Study|Physician Decision|0|||
124607458|NCT01154816|448182455|FG008|Overall Study|Physician Decision|0|||
124607459|NCT01154816|448182456|FG009|Overall Study|Physician Decision|1|||
124607460|NCT01154816|448182457|FG010|Overall Study|Physician Decision|1|||
124607461|NCT01154816|448182458|FG011|Overall Study|Physician Decision|1|||
124607462|NCT01154816|448182447|FG000|Overall Study|Adverse Event|5|||
124607463|NCT01154816|448182448|FG001|Overall Study|Adverse Event|2|||
124607464|NCT01154816|448182449|FG002|Overall Study|Adverse Event|0|||
124607465|NCT01154816|448182450|FG003|Overall Study|Adverse Event|0|||
124607466|NCT01154816|448182451|FG004|Overall Study|Adverse Event|0|||
124607467|NCT01154816|448182452|FG005|Overall Study|Adverse Event|0|||
124607468|NCT01154816|448182453|FG006|Overall Study|Adverse Event|1|||
124607469|NCT01154816|448182454|FG007|Overall Study|Adverse Event|1|||
124607470|NCT01154816|448182455|FG008|Overall Study|Adverse Event|0|||
124607471|NCT01154816|448182456|FG009|Overall Study|Adverse Event|0|||
124607472|NCT01154816|448182457|FG010|Overall Study|Adverse Event|0|||
124607473|NCT01154816|448182458|FG011|Overall Study|Adverse Event|0|||
124607474|NCT03397771|448182459|FG000|Overall Study|2 erroneously randomized, never treated|3|||
124607475|NCT03397771|448182460|FG001|Overall Study|2 erroneously randomized, never treated|1|||
124607476|NCT03397771|448182459|FG000|Overall Study|Withdrawal by Subject|1|||
124607477|NCT03397771|448182460|FG001|Overall Study|Withdrawal by Subject|3|||
124607478|NCT03397771|448182459|FG000|Overall Study|Protocol Violation|2|||
124607479|NCT03397771|448182460|FG001|Overall Study|Protocol Violation|2|||
124607480|NCT03397771|448182459|FG000|Overall Study|Adverse Event|2|||
124607481|NCT03397771|448182460|FG001|Overall Study|Adverse Event|1|||
124607482|NCT04078126|448182463|FG000|Washout|Study put on hold due to COVID-19|0|||
124607483|NCT04078126|448182464|FG001|Washout|Study put on hold due to COVID-19|2|||
124607484|NCT04078126|448182463|FG000|Period 2|Study put on hold due to COVID-19|1|||
124607485|NCT04078126|448182464|FG001|Period 2|Study put on hold due to COVID-19|1|||
124607486|NCT03321630|448182465|FG000|Overall Study|Adverse Event|1|||
124607487|NCT03321630|448182465|FG000|Overall Study|Investigator Discretion|2|||
124607488|NCT03321630|448182465|FG000|Overall Study|Withdrawal by Subject|1|||
124607489|NCT02669758|448182466|FG000|Overall Study|Withdrawal by Subject|43|||
124607490|NCT02669758|448182466|FG000|Overall Study|Lost to Follow-up|19|||
124607491|NCT02669758|448182466|FG000|Overall Study|Adverse Event|16|||
124607492|NCT02669758|448182466|FG000|Overall Study|Non-Compliance with Study Drug|8|||
124607493|NCT02669758|448182466|FG000|Overall Study|Lack of Efficacy|5|||
124607494|NCT02669758|448182466|FG000|Overall Study|Pregnancy|1|||
124607495|NCT02669758|448182466|FG000|Overall Study|Study noncompliance|1|||
124607496|NCT02669758|448182466|FG000|Overall Study|Protocol Violation|1|||
124607497|NCT02455050|448182467|FG000|Treatment Period 1|Lost to Follow-up|1|||
124607498|NCT02455050|448182468|FG001|Treatment Period 1|Lost to Follow-up|1|||
124607499|NCT02455050|448182469|FG002|Treatment Period 1|Lost to Follow-up|1|||
124607500|NCT02455050|448182470|FG003|Treatment Period 1|Lost to Follow-up|2|||
124607501|NCT02455050|448182467|FG000|Treatment Period 2|Lost to Follow-up|1|||
124607502|NCT02455050|448182468|FG001|Treatment Period 2|Lost to Follow-up|0|||
124607503|NCT02455050|448182469|FG002|Treatment Period 2|Lost to Follow-up|2|||
124607504|NCT02455050|448182470|FG003|Treatment Period 2|Lost to Follow-up|1|||
124607505|NCT02325518|448182471|FG000|Overall Study|Adverse Event|4|||
124607506|NCT02325518|448182472|FG001|Overall Study|Adverse Event|1|||
124607507|NCT02325518|448182471|FG000|Overall Study|Physician Decision|0|||
124607508|NCT02325518|448182472|FG001|Overall Study|Physician Decision|1|||
124607509|NCT02325518|448182471|FG000|Overall Study|Withdrawal by Subject|0|||
124607510|NCT02325518|448182472|FG001|Overall Study|Withdrawal by Subject|1|||
124607511|NCT03393806|448182475|FG000|Overall Study|Physician Decision|1|||
124607512|NCT03393806|448182476|FG001|Overall Study|Physician Decision|0|||
124607513|NCT00886288|448182477|FG000|Overall Study|no respect of the 12 weeks period|657|||
124607514|NCT00886288|448182478|FG001|Overall Study|no respect of the 12 weeks period|227|||
124607515|NCT00886288|448182477|FG000|Overall Study|Lost to Follow-up|86|||
124607516|NCT00886288|448182478|FG001|Overall Study|Lost to Follow-up|0|||
124607517|NCT01675661|448182479|FG000|Overall Study|Lost to Follow-up|22|||
124607518|NCT01675661|448182480|FG001|Overall Study|Lost to Follow-up|23|||
124607519|NCT01675661|448182479|FG000|Overall Study|Practical problems|9|||
124607520|NCT01675661|448182480|FG001|Overall Study|Practical problems|5|||
124607521|NCT01675661|448182479|FG000|Overall Study|Moved away|5|||
124607522|NCT01675661|448182480|FG001|Overall Study|Moved away|6|||
124607523|NCT01675661|448182479|FG000|Overall Study|Withdrawal by Subject|3|||
124607524|NCT01675661|448182480|FG001|Overall Study|Withdrawal by Subject|7|||
124607525|NCT01675661|448182479|FG000|Overall Study|Physician Decision|0|||
124607526|NCT01675661|448182480|FG001|Overall Study|Physician Decision|2|||
124607527|NCT01675661|448182479|FG000|Overall Study|Death|0|||
124607528|NCT01675661|448182480|FG001|Overall Study|Death|1|||
124607529|NCT01675661|448182479|FG000|Overall Study|Other reason|1|||
124607530|NCT01675661|448182480|FG001|Overall Study|Other reason|2|||
124607531|NCT04765384|448182481|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
124607532|NCT04765384|448182482|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
124607533|NCT04765384|448182483|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
124607534|NCT04765384|448182484|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
124607535|NCT04765384|448182485|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
124607536|NCT04765384|448182486|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
124607537|NCT04765384|448182481|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
124607538|NCT04765384|448182482|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
124607539|NCT04765384|448182483|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
124607540|NCT04765384|448182484|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
124607541|NCT04765384|448182485|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
124607542|NCT04765384|448182486|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
124607543|NCT04765384|448182481|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
124607544|NCT04765384|448182482|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
124607545|NCT04765384|448182483|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
124607546|NCT04765384|448182484|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
124607547|NCT04765384|448182485|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
124731716|NCT01468233|448640168|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
124731717|NCT01468233|448640169|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
124607548|NCT04765384|448182486|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
124607549|NCT04765384|448182481|FG000|Post-natal: Neonates and Infants|Death|0|||
124607550|NCT04765384|448182482|FG001|Post-natal: Neonates and Infants|Death|0|||
124607551|NCT04765384|448182483|FG002|Post-natal: Neonates and Infants|Death|0|||
124607552|NCT04765384|448182484|FG003|Post-natal: Neonates and Infants|Death|1|||
124607553|NCT04765384|448182485|FG004|Post-natal: Neonates and Infants|Death|0|||
124607554|NCT04765384|448182486|FG005|Post-natal: Neonates and Infants|Death|0|||
124607555|NCT04765384|448182481|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
124607556|NCT04765384|448182482|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
124607557|NCT04765384|448182483|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
124607558|NCT04765384|448182484|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
124607559|NCT04765384|448182485|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
124607560|NCT04765384|448182486|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
124731718|NCT01468233|448640170|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
124607561|NCT01971970|448182487|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
124607562|NCT01971970|448182488|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
124607563|NCT01971970|448182487|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
124607564|NCT01971970|448182488|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
124607565|NCT01971970|448182487|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
124607566|NCT01971970|448182488|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
124607567|NCT01971970|448182487|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
124607568|NCT01971970|448182488|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
124607569|NCT01971970|448182487|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
124607570|NCT01971970|448182488|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
124607571|NCT01971970|448182487|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
124607572|NCT01971970|448182488|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
124607573|NCT01971970|448182487|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
124607574|NCT01971970|448182488|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
124607575|NCT02335983|448182489|FG000|Overall Study|Sponsor Decision|0|||
124607576|NCT02335983|448182490|FG001|Overall Study|Sponsor Decision|0|||
124607577|NCT02335983|448182491|FG002|Overall Study|Sponsor Decision|1|||
124607578|NCT02335983|448182492|FG003|Overall Study|Sponsor Decision|1|||
124607579|NCT02335983|448182493|FG004|Overall Study|Sponsor Decision|0|||
124607580|NCT02335983|448182494|FG005|Overall Study|Sponsor Decision|1|||
124607581|NCT02335983|448182489|FG000|Overall Study|Withdrawal by Subject|3|||
124607582|NCT02335983|448182490|FG001|Overall Study|Withdrawal by Subject|2|||
124607583|NCT02335983|448182491|FG002|Overall Study|Withdrawal by Subject|2|||
124607584|NCT02335983|448182492|FG003|Overall Study|Withdrawal by Subject|1|||
124607585|NCT02335983|448182493|FG004|Overall Study|Withdrawal by Subject|3|||
124607586|NCT02335983|448182494|FG005|Overall Study|Withdrawal by Subject|9|||
124607587|NCT02335983|448182489|FG000|Overall Study|Death|0|||
124607588|NCT02335983|448182490|FG001|Overall Study|Death|0|||
124607589|NCT02335983|448182491|FG002|Overall Study|Death|2|||
124607590|NCT02335983|448182492|FG003|Overall Study|Death|0|||
124607591|NCT02335983|448182493|FG004|Overall Study|Death|0|||
124607592|NCT02335983|448182494|FG005|Overall Study|Death|0|||
124607593|NCT02335983|448182489|FG000|Overall Study|Lost to Follow-up|0|||
124607594|NCT02335983|448182490|FG001|Overall Study|Lost to Follow-up|0|||
124607595|NCT02335983|448182491|FG002|Overall Study|Lost to Follow-up|0|||
124607596|NCT02335983|448182492|FG003|Overall Study|Lost to Follow-up|0|||
124607597|NCT02335983|448182493|FG004|Overall Study|Lost to Follow-up|0|||
124607598|NCT02335983|448182494|FG005|Overall Study|Lost to Follow-up|1|||
124607599|NCT02335983|448182489|FG000|Overall Study|Protocol Specified Criteria|5|||
124607600|NCT02335983|448182490|FG001|Overall Study|Protocol Specified Criteria|7|||
124607601|NCT02335983|448182491|FG002|Overall Study|Protocol Specified Criteria|27|||
124607602|NCT02335983|448182492|FG003|Overall Study|Protocol Specified Criteria|7|||
124607603|NCT02335983|448182493|FG004|Overall Study|Protocol Specified Criteria|5|||
124607604|NCT02335983|448182494|FG005|Overall Study|Protocol Specified Criteria|21|||
124607605|NCT00655876|448182495|FG000|Overall Study|Protocol Violation|9|||
124607606|NCT00655876|448182496|FG001|Overall Study|Protocol Violation|7|||
124607607|NCT01831765|448182497|FG000|Overall Study|Lack of Efficacy|1|||
124607608|NCT01831765|448182498|FG001|Overall Study|Lack of Efficacy|0|||
124607609|NCT01831765|448182499|FG002|Overall Study|Lack of Efficacy|0|||
124607610|NCT01831765|448182497|FG000|Overall Study|Other, sponsor withdrew subject|0|||
124607611|NCT01831765|448182498|FG001|Overall Study|Other, sponsor withdrew subject|1|||
124607612|NCT01831765|448182499|FG002|Overall Study|Other, sponsor withdrew subject|0|||
124607613|NCT01831765|448182497|FG000|Overall Study|Pregnancy|1|||
124607614|NCT01831765|448182498|FG001|Overall Study|Pregnancy|1|||
124607615|NCT01831765|448182499|FG002|Overall Study|Pregnancy|2|||
124607616|NCT01831765|448182497|FG000|Overall Study|Death|0|||
124607617|NCT01831765|448182498|FG001|Overall Study|Death|1|||
124607618|NCT01831765|448182499|FG002|Overall Study|Death|1|||
124607619|NCT01831765|448182497|FG000|Overall Study|Other, site closed|1|||
124607620|NCT01831765|448182498|FG001|Overall Study|Other, site closed|1|||
124607621|NCT01831765|448182499|FG002|Overall Study|Other, site closed|0|||
124607622|NCT01831765|448182497|FG000|Overall Study|Adverse Event|5|||
124607623|NCT01831765|448182498|FG001|Overall Study|Adverse Event|3|||
124607624|NCT01831765|448182499|FG002|Overall Study|Adverse Event|3|||
124607625|NCT01831765|448182497|FG000|Overall Study|Withdrawal by Subject|22|||
124607626|NCT01831765|448182498|FG001|Overall Study|Withdrawal by Subject|7|||
124607627|NCT01831765|448182499|FG002|Overall Study|Withdrawal by Subject|17|||
124607628|NCT01831765|448182497|FG000|Overall Study|Withdrawal criteria|12|||
124607629|NCT01831765|448182498|FG001|Overall Study|Withdrawal criteria|10|||
124607630|NCT01831765|448182499|FG002|Overall Study|Withdrawal criteria|16|||
124607631|NCT01831765|448182497|FG000|Overall Study|Lost to Follow-up|2|||
124607632|NCT01831765|448182498|FG001|Overall Study|Lost to Follow-up|3|||
124607633|NCT01831765|448182499|FG002|Overall Study|Lost to Follow-up|3|||
124607634|NCT00977379|448182500|FG000|Overall Study|Withdrawal by Subject|1|||
124607635|NCT00977379|448182501|FG001|Overall Study|Withdrawal by Subject|1|||
124607636|NCT00977379|448182500|FG000|Overall Study|Death|7|||
124607637|NCT00977379|448182501|FG001|Overall Study|Death|9|||
124607638|NCT00977379|448182500|FG000|Overall Study|Premature Study Termination|4|||
124607639|NCT00977379|448182501|FG001|Overall Study|Premature Study Termination|0|||
124607640|NCT00977379|448182500|FG000|Overall Study|Participant Moving House|0|||
124607641|NCT00977379|448182501|FG001|Overall Study|Participant Moving House|1|||
124607642|NCT00977379|448182500|FG000|Overall Study|Randomization Error|0|||
124607643|NCT00977379|448182501|FG001|Overall Study|Randomization Error|1|||
124607644|NCT00706511|448182506|FG000|Overall Study|Withdrawal by Subject|1|||
124607645|NCT00706511|448182507|FG001|Overall Study|Withdrawal by Subject|0|||
124607646|NCT00706511|448182508|FG002|Overall Study|Withdrawal by Subject|0|||
124607647|NCT00706511|448182509|FG003|Overall Study|Withdrawal by Subject|0|||
124607648|NCT02605993|448182510|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
124607649|NCT02605993|448182511|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
124607650|NCT02605993|448182512|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
124607651|NCT02605993|448182513|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
124607652|NCT02603393|448182514|FG000|Overall Study|Patient/guardian decision|32|||
124607653|NCT02603393|448182515|FG001|Overall Study|Patient/guardian decision|18|||
124607654|NCT02603393|448182514|FG000|Overall Study|Adverse Event|17|||
124607655|NCT02603393|448182515|FG001|Overall Study|Adverse Event|15|||
124607656|NCT02603393|448182514|FG000|Overall Study|Technical problems|4|||
124607657|NCT02603393|448182515|FG001|Overall Study|Technical problems|7|||
124607658|NCT02603393|448182514|FG000|Overall Study|Lack of Efficacy|7|||
124607659|NCT02603393|448182515|FG001|Overall Study|Lack of Efficacy|2|||
124607660|NCT02603393|448182514|FG000|Overall Study|Death|3|||
124607661|NCT02603393|448182515|FG001|Overall Study|Death|4|||
124607662|NCT02603393|448182514|FG000|Overall Study|Physician Decision|3|||
124607663|NCT02603393|448182515|FG001|Overall Study|Physician Decision|3|||
124607664|NCT02603393|448182514|FG000|Overall Study|Protocol deviation|2|||
124607665|NCT02603393|448182515|FG001|Overall Study|Protocol deviation|3|||
124607666|NCT02603393|448182514|FG000|Overall Study|Lost to Follow-up|1|||
124607667|NCT02603393|448182515|FG001|Overall Study|Lost to Follow-up|2|||
124607668|NCT02603393|448182514|FG000|Overall Study|Non-compliance with study treatment|1|||
124607669|NCT02603393|448182515|FG001|Overall Study|Non-compliance with study treatment|0|||
124607670|NCT02603393|448182514|FG000|Overall Study|Sponsor decision|1|||
124607671|NCT02603393|448182515|FG001|Overall Study|Sponsor decision|0|||
124607672|NCT01974440|448182518|FG000|Overall Study|Lost to Follow-up|7|||
124607673|NCT01974440|448182519|FG001|Overall Study|Lost to Follow-up|7|||
124607674|NCT01974440|448182518|FG000|Overall Study|Withdrawal by Subject|24|||
124607675|NCT01974440|448182519|FG001|Overall Study|Withdrawal by Subject|20|||
124607676|NCT01974440|448182518|FG000|Overall Study|Sponsor decision|109|||
124607677|NCT01974440|448182519|FG001|Overall Study|Sponsor decision|110|||
124607678|NCT00762437|448182520|FG000|Overall Study|Lost to Follow-up|7|||
124607679|NCT00762437|448182520|FG000|Overall Study|Missed final study visit|11|||
124607680|NCT00762437|448182520|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
124607681|NCT02387983|448182521|FG000|Overall Study|Adverse Event|4|||
124607682|NCT02387983|448182521|FG000|Overall Study|Protocol Violation|1|||
124607683|NCT02387983|448182521|FG000|Overall Study|Withdrawal by Subject|2|||
124607684|NCT05084963|448182522|FG000|Overall Study|Withdrawal by Subject|0|||
124607685|NCT05084963|448182523|FG001|Overall Study|Withdrawal by Subject|0|||
124607686|NCT05084963|448182524|FG002|Overall Study|Withdrawal by Subject|1|||
124607687|NCT03569228|448182525|FG000|Overall Study|Withdrawal by PI|0|||
124607688|NCT03569228|448182526|FG001|Overall Study|Withdrawal by PI|0|||
124607689|NCT03569228|448182527|FG002|Overall Study|Withdrawal by PI|2|||
124607690|NCT03569228|448182528|FG003|Overall Study|Withdrawal by PI|2|||
124607691|NCT03569228|448182529|FG004|Overall Study|Withdrawal by PI|1|||
124607692|NCT03569228|448182530|FG005|Overall Study|Withdrawal by PI|0|||
124607693|NCT03569228|448182531|FG006|Overall Study|Withdrawal by PI|0|||
124607694|NCT03569228|448182532|FG007|Overall Study|Withdrawal by PI|0|||
124607695|NCT03569228|448182533|FG008|Overall Study|Withdrawal by PI|0|||
124607696|NCT03569228|448182525|FG000|Overall Study|Lost to Follow-up|0|||
124607697|NCT03569228|448182526|FG001|Overall Study|Lost to Follow-up|0|||
124607698|NCT03569228|448182527|FG002|Overall Study|Lost to Follow-up|0|||
124607699|NCT03569228|448182528|FG003|Overall Study|Lost to Follow-up|0|||
124607700|NCT03569228|448182529|FG004|Overall Study|Lost to Follow-up|0|||
124607701|NCT03569228|448182530|FG005|Overall Study|Lost to Follow-up|0|||
124607702|NCT03569228|448182531|FG006|Overall Study|Lost to Follow-up|0|||
124607703|NCT03569228|448182532|FG007|Overall Study|Lost to Follow-up|0|||
124607704|NCT03569228|448182533|FG008|Overall Study|Lost to Follow-up|1|||
124607705|NCT03569228|448182525|FG000|Overall Study|Screen Fail|2|||
124607706|NCT03569228|448182526|FG001|Overall Study|Screen Fail|2|||
124607707|NCT03569228|448182527|FG002|Overall Study|Screen Fail|1|||
124607708|NCT03569228|448182528|FG003|Overall Study|Screen Fail|1|||
124607709|NCT03569228|448182529|FG004|Overall Study|Screen Fail|1|||
124607710|NCT03569228|448182530|FG005|Overall Study|Screen Fail|3|||
124607711|NCT03569228|448182531|FG006|Overall Study|Screen Fail|1|||
124607712|NCT03569228|448182532|FG007|Overall Study|Screen Fail|5|||
124607713|NCT03569228|448182533|FG008|Overall Study|Screen Fail|2|||
124607714|NCT06354998|448182534|FG000|Overall Study|Withdrawal by Subject|3|||
124607715|NCT06354998|448182535|FG001|Overall Study|Withdrawal by Subject|0|||
124781141|NCT00545272|448829094|FG001|Overall Study|Adverse Event|0|||
124781142|NCT00545272|448829095|FG002|Overall Study|Adverse Event|1|||
124607716|NCT03819049|448182536|FG000|Overall Study|Lost to Follow-up|1|||
124607717|NCT03819049|448182537|FG001|Overall Study|Lost to Follow-up|2|||
124607718|NCT03819049|448182538|FG002|Overall Study|Lost to Follow-up|9|||
124607719|NCT03819049|448182539|FG003|Overall Study|Lost to Follow-up|0|||
124607720|NCT03819049|448182540|FG004|Overall Study|Lost to Follow-up|3|||
124731719|NCT01468233|448640171|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
124731720|NCT01468233|448640166|FG000|Treatment Period 2|Lost to Follow-up|0|||
124731721|NCT01468233|448640167|FG001|Treatment Period 2|Lost to Follow-up|0|||
124731722|NCT01468233|448640168|FG002|Treatment Period 2|Lost to Follow-up|3|||
124731723|NCT01468233|448640169|FG003|Treatment Period 2|Lost to Follow-up|0|||
124731724|NCT01468233|448640170|FG004|Treatment Period 2|Lost to Follow-up|2|||
124731725|NCT01468233|448640171|FG005|Treatment Period 2|Lost to Follow-up|0|||
124731726|NCT01468233|448640166|FG000|Treatment Period 2|Other|0|||
124731727|NCT01468233|448640167|FG001|Treatment Period 2|Other|0|||
124731728|NCT01468233|448640168|FG002|Treatment Period 2|Other|3|||
124731729|NCT01468233|448640169|FG003|Treatment Period 2|Other|0|||
124731730|NCT01468233|448640170|FG004|Treatment Period 2|Other|1|||
124731731|NCT01468233|448640171|FG005|Treatment Period 2|Other|0|||
124607721|NCT03819049|448182541|FG005|Overall Study|Lost to Follow-up|1|||
124607722|NCT03819049|448182542|FG006|Overall Study|Lost to Follow-up|0|||
124607723|NCT03819049|448182536|FG000|Overall Study|Withdrawal by Subject|0|||
124607724|NCT03819049|448182537|FG001|Overall Study|Withdrawal by Subject|0|||
124607725|NCT03819049|448182538|FG002|Overall Study|Withdrawal by Subject|18|||
124607726|NCT03819049|448182539|FG003|Overall Study|Withdrawal by Subject|0|||
124607727|NCT03819049|448182540|FG004|Overall Study|Withdrawal by Subject|10|||
124607728|NCT03819049|448182541|FG005|Overall Study|Withdrawal by Subject|9|||
124607729|NCT03819049|448182542|FG006|Overall Study|Withdrawal by Subject|1|||
124607730|NCT03819049|448182536|FG000|Overall Study|Ongoing|0|||
124607731|NCT03819049|448182537|FG001|Overall Study|Ongoing|0|||
124607732|NCT03819049|448182538|FG002|Overall Study|Ongoing|75|||
124607733|NCT03819049|448182539|FG003|Overall Study|Ongoing|0|||
124607734|NCT03819049|448182540|FG004|Overall Study|Ongoing|41|||
124607735|NCT03819049|448182541|FG005|Overall Study|Ongoing|0|||
124607736|NCT03819049|448182542|FG006|Overall Study|Ongoing|0|||
124607737|NCT03819049|448182536|FG000|Overall Study|Other|0|||
124607738|NCT03819049|448182537|FG001|Overall Study|Other|0|||
124607739|NCT03819049|448182538|FG002|Overall Study|Other|2|||
124607740|NCT03819049|448182539|FG003|Overall Study|Other|0|||
124607741|NCT03819049|448182540|FG004|Overall Study|Other|0|||
124607742|NCT03819049|448182541|FG005|Overall Study|Other|0|||
124607743|NCT03819049|448182542|FG006|Overall Study|Other|0|||
124607744|NCT03819049|448182536|FG000|Overall Study|Randomized but not vaccinated|0|||
124607745|NCT03819049|448182537|FG001|Overall Study|Randomized but not vaccinated|0|||
124607746|NCT03819049|448182538|FG002|Overall Study|Randomized but not vaccinated|0|||
124607747|NCT03819049|448182539|FG003|Overall Study|Randomized but not vaccinated|1|||
124607748|NCT03819049|448182540|FG004|Overall Study|Randomized but not vaccinated|0|||
124607749|NCT03819049|448182541|FG005|Overall Study|Randomized but not vaccinated|2|||
124607750|NCT03819049|448182542|FG006|Overall Study|Randomized but not vaccinated|1|||
124607751|NCT03819049|448182536|FG000|Overall Study|Physician Decision|0|||
124607752|NCT03819049|448182537|FG001|Overall Study|Physician Decision|0|||
124607753|NCT03819049|448182538|FG002|Overall Study|Physician Decision|0|||
124607754|NCT03819049|448182539|FG003|Overall Study|Physician Decision|0|||
124607755|NCT03819049|448182540|FG004|Overall Study|Physician Decision|0|||
124607756|NCT03819049|448182541|FG005|Overall Study|Physician Decision|0|||
124607757|NCT03819049|448182542|FG006|Overall Study|Physician Decision|1|||
124607758|NCT00816361|448182547|FG000|Overall Study|Withdrawal by Subject|0|||
124607759|NCT00816361|448182548|FG001|Overall Study|Withdrawal by Subject|0|||
124607760|NCT00816361|448182549|FG002|Overall Study|Withdrawal by Subject|0|||
124607761|NCT00816361|448182550|FG003|Overall Study|Withdrawal by Subject|0|||
124607762|NCT00816361|448182551|FG004|Overall Study|Withdrawal by Subject|1|||
124731732|NCT00457821|448640172|FG000|Part 2|Withdrawal by Subject|0|||
124731733|NCT00457821|448640173|FG001|Part 2|Withdrawal by Subject|0|||
124731734|NCT00457821|448640174|FG002|Part 2|Withdrawal by Subject|0|||
124731735|NCT00457821|448640175|FG003|Part 2|Withdrawal by Subject|0|||
124781143|NCT00545272|448829096|FG003|Overall Study|Adverse Event|0|||
124607763|NCT00816361|448182552|FG005|Overall Study|Withdrawal by Subject|2|||
124607764|NCT00816361|448182553|FG006|Overall Study|Withdrawal by Subject|0|||
124607765|NCT00816361|448182554|FG007|Overall Study|Withdrawal by Subject|2|||
124607766|NCT00816361|448182555|FG008|Overall Study|Withdrawal by Subject|1|||
124607767|NCT00816361|448182547|FG000|Overall Study|Death|4|||
124607768|NCT00816361|448182548|FG001|Overall Study|Death|3|||
124607769|NCT00816361|448182549|FG002|Overall Study|Death|3|||
124607770|NCT00816361|448182550|FG003|Overall Study|Death|3|||
124607771|NCT00816361|448182551|FG004|Overall Study|Death|1|||
124607772|NCT00816361|448182552|FG005|Overall Study|Death|1|||
124607773|NCT00816361|448182553|FG006|Overall Study|Death|3|||
124607774|NCT00816361|448182554|FG007|Overall Study|Death|7|||
124607775|NCT00816361|448182555|FG008|Overall Study|Death|8|||
124607776|NCT00816361|448182547|FG000|Overall Study|Other|0|||
124607777|NCT00816361|448182548|FG001|Overall Study|Other|0|||
124607778|NCT00816361|448182549|FG002|Overall Study|Other|0|||
124607779|NCT00816361|448182550|FG003|Overall Study|Other|0|||
124607780|NCT00816361|448182551|FG004|Overall Study|Other|0|||
124607781|NCT00816361|448182552|FG005|Overall Study|Other|0|||
124607782|NCT00816361|448182553|FG006|Overall Study|Other|0|||
124607783|NCT00816361|448182554|FG007|Overall Study|Other|0|||
124607784|NCT00816361|448182555|FG008|Overall Study|Other|1|||
124607785|NCT01986010|448182557|FG000|Overall Study|Adverse Event|0|||
124607786|NCT01986010|448182558|FG001|Overall Study|Adverse Event|1|||
124607787|NCT01986010|448182559|FG002|Overall Study|Adverse Event|0|||
124607788|NCT01986010|448182560|FG003|Overall Study|Adverse Event|0|||
124607789|NCT01986010|448182561|FG004|Overall Study|Adverse Event|0|||
124607790|NCT01986010|448182562|FG005|Overall Study|Adverse Event|0|||
124607791|NCT01986010|448182563|FG006|Overall Study|Adverse Event|0|||
124607792|NCT01986010|448182564|FG007|Overall Study|Adverse Event|0|||
124607793|NCT01986010|448182565|FG008|Overall Study|Adverse Event|0|||
124607794|NCT01986010|448182566|FG009|Overall Study|Adverse Event|0|||
124607795|NCT01986010|448182567|FG010|Overall Study|Adverse Event|0|||
124607796|NCT01986010|448182568|FG011|Overall Study|Adverse Event|0|||
124607797|NCT01986010|448182569|FG012|Overall Study|Adverse Event|0|||
124607798|NCT01986010|448182570|FG013|Overall Study|Adverse Event|0|||
124607799|NCT01986010|448182571|FG014|Overall Study|Adverse Event|0|||
124607800|NCT01986010|448182572|FG015|Overall Study|Adverse Event|1|||
124607801|NCT01986010|448182573|FG016|Overall Study|Adverse Event|0|||
124607802|NCT01986010|448182557|FG000|Overall Study|Lost to Follow-up|2|||
124607803|NCT01986010|448182558|FG001|Overall Study|Lost to Follow-up|1|||
124607804|NCT01986010|448182559|FG002|Overall Study|Lost to Follow-up|2|||
124607805|NCT01986010|448182560|FG003|Overall Study|Lost to Follow-up|2|||
124607806|NCT01986010|448182561|FG004|Overall Study|Lost to Follow-up|2|||
124607807|NCT01986010|448182562|FG005|Overall Study|Lost to Follow-up|2|||
124607808|NCT01986010|448182563|FG006|Overall Study|Lost to Follow-up|0|||
124607809|NCT01986010|448182564|FG007|Overall Study|Lost to Follow-up|0|||
124607810|NCT01986010|448182565|FG008|Overall Study|Lost to Follow-up|4|||
124607811|NCT01986010|448182566|FG009|Overall Study|Lost to Follow-up|2|||
124607812|NCT01986010|448182567|FG010|Overall Study|Lost to Follow-up|0|||
124607813|NCT01986010|448182568|FG011|Overall Study|Lost to Follow-up|1|||
124607814|NCT01986010|448182569|FG012|Overall Study|Lost to Follow-up|1|||
124607815|NCT01986010|448182570|FG013|Overall Study|Lost to Follow-up|1|||
124607816|NCT01986010|448182571|FG014|Overall Study|Lost to Follow-up|2|||
124607817|NCT01986010|448182572|FG015|Overall Study|Lost to Follow-up|0|||
124607818|NCT01986010|448182573|FG016|Overall Study|Lost to Follow-up|0|||
124607819|NCT01986010|448182557|FG000|Overall Study|Physician Decision|0|||
124607820|NCT01986010|448182558|FG001|Overall Study|Physician Decision|0|||
124607821|NCT01986010|448182559|FG002|Overall Study|Physician Decision|0|||
124607822|NCT01986010|448182560|FG003|Overall Study|Physician Decision|0|||
124607823|NCT01986010|448182561|FG004|Overall Study|Physician Decision|0|||
124607824|NCT01986010|448182562|FG005|Overall Study|Physician Decision|0|||
124607825|NCT01986010|448182563|FG006|Overall Study|Physician Decision|0|||
124607826|NCT01986010|448182564|FG007|Overall Study|Physician Decision|0|||
124607827|NCT01986010|448182565|FG008|Overall Study|Physician Decision|0|||
124607828|NCT01986010|448182566|FG009|Overall Study|Physician Decision|0|||
124607829|NCT01986010|448182567|FG010|Overall Study|Physician Decision|0|||
124607830|NCT01986010|448182568|FG011|Overall Study|Physician Decision|0|||
124607831|NCT01986010|448182569|FG012|Overall Study|Physician Decision|0|||
124607832|NCT01986010|448182570|FG013|Overall Study|Physician Decision|0|||
124607833|NCT01986010|448182571|FG014|Overall Study|Physician Decision|1|||
124607834|NCT01986010|448182572|FG015|Overall Study|Physician Decision|0|||
124607835|NCT01986010|448182573|FG016|Overall Study|Physician Decision|0|||
124607836|NCT01986010|448182557|FG000|Overall Study|Withdrawal by Subject|2|||
124731736|NCT00457821|448640176|FG004|Part 2|Withdrawal by Subject|0|||
124607837|NCT01986010|448182558|FG001|Overall Study|Withdrawal by Subject|2|||
124731737|NCT00457821|448640177|FG005|Part 2|Withdrawal by Subject|0|||
124731738|NCT00457821|448640178|FG006|Part 2|Withdrawal by Subject|0|||
124731739|NCT00457821|448640179|FG007|Part 2|Withdrawal by Subject|1|||
124607838|NCT01986010|448182559|FG002|Overall Study|Withdrawal by Subject|3|||
124607839|NCT01986010|448182560|FG003|Overall Study|Withdrawal by Subject|0|||
124607840|NCT01986010|448182561|FG004|Overall Study|Withdrawal by Subject|2|||
124607841|NCT01986010|448182562|FG005|Overall Study|Withdrawal by Subject|4|||
124607842|NCT01986010|448182563|FG006|Overall Study|Withdrawal by Subject|0|||
124731740|NCT00578877|448640182|FG000|Overall Study|Lost to Follow-up|8|||
124607843|NCT01986010|448182564|FG007|Overall Study|Withdrawal by Subject|0|||
124607844|NCT01986010|448182565|FG008|Overall Study|Withdrawal by Subject|0|||
124607845|NCT01986010|448182566|FG009|Overall Study|Withdrawal by Subject|0|||
124607846|NCT01986010|448182567|FG010|Overall Study|Withdrawal by Subject|0|||
124607847|NCT01986010|448182568|FG011|Overall Study|Withdrawal by Subject|2|||
124607848|NCT01986010|448182569|FG012|Overall Study|Withdrawal by Subject|0|||
124607849|NCT01986010|448182570|FG013|Overall Study|Withdrawal by Subject|1|||
124607850|NCT01986010|448182571|FG014|Overall Study|Withdrawal by Subject|2|||
124731741|NCT00578877|448640183|FG001|Overall Study|Lost to Follow-up|10|||
124607851|NCT01986010|448182572|FG015|Overall Study|Withdrawal by Subject|0|||
124607852|NCT01986010|448182573|FG016|Overall Study|Withdrawal by Subject|0|||
124607853|NCT01986010|448182557|FG000|Overall Study|Status Not Recorded|2|||
124607854|NCT01986010|448182558|FG001|Overall Study|Status Not Recorded|4|||
124607855|NCT01986010|448182559|FG002|Overall Study|Status Not Recorded|2|||
124607856|NCT01986010|448182560|FG003|Overall Study|Status Not Recorded|0|||
124607857|NCT01986010|448182561|FG004|Overall Study|Status Not Recorded|1|||
124607858|NCT01986010|448182562|FG005|Overall Study|Status Not Recorded|2|||
124607859|NCT01986010|448182563|FG006|Overall Study|Status Not Recorded|0|||
124607860|NCT01986010|448182564|FG007|Overall Study|Status Not Recorded|0|||
124607861|NCT01986010|448182565|FG008|Overall Study|Status Not Recorded|2|||
124607862|NCT01986010|448182566|FG009|Overall Study|Status Not Recorded|1|||
124607863|NCT01986010|448182567|FG010|Overall Study|Status Not Recorded|7|||
124607864|NCT01986010|448182568|FG011|Overall Study|Status Not Recorded|7|||
124607865|NCT01986010|448182569|FG012|Overall Study|Status Not Recorded|9|||
124607866|NCT01986010|448182570|FG013|Overall Study|Status Not Recorded|9|||
124607867|NCT01986010|448182571|FG014|Overall Study|Status Not Recorded|5|||
124607868|NCT01986010|448182572|FG015|Overall Study|Status Not Recorded|10|||
124607869|NCT01986010|448182573|FG016|Overall Study|Status Not Recorded|4|||
124607870|NCT04740814|448182574|FG000|Overall Study|Adverse Event|3|||
124607871|NCT04740814|448182574|FG000|Overall Study|Protocol Violation|2|||
124607872|NCT04740814|448182574|FG000|Overall Study|Lost to Follow-up|2|||
124607873|NCT04740814|448182574|FG000|Overall Study|Withdrawal by Subject|3|||
124607874|NCT02440568|448182575|FG000|Overall Study|Death|1|||
124607875|NCT02440568|448182576|FG001|Overall Study|Death|3|||
124607876|NCT02440568|448182577|FG002|Overall Study|Death|4|||
124607877|NCT02440568|448182578|FG003|Overall Study|Death|2|||
124607878|NCT02440568|448182575|FG000|Overall Study|Lack of Efficacy|2|||
124607879|NCT02440568|448182576|FG001|Overall Study|Lack of Efficacy|0|||
124607880|NCT02440568|448182577|FG002|Overall Study|Lack of Efficacy|1|||
124607881|NCT02440568|448182578|FG003|Overall Study|Lack of Efficacy|0|||
124607882|NCT02440568|448182575|FG000|Overall Study|Lost to Follow-up|1|||
124607883|NCT02440568|448182576|FG001|Overall Study|Lost to Follow-up|0|||
124607884|NCT02440568|448182577|FG002|Overall Study|Lost to Follow-up|0|||
124607885|NCT02440568|448182578|FG003|Overall Study|Lost to Follow-up|0|||
124607886|NCT01103466|448182588|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
124607887|NCT01103466|448182589|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
124607888|NCT01103466|448182590|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
124607889|NCT01103466|448182588|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
124607890|NCT01103466|448182589|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
124607891|NCT01103466|448182590|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
124607892|NCT01103466|448182588|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
124607893|NCT01103466|448182589|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
124607894|NCT01103466|448182590|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
124607895|NCT01103466|448182588|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
124607896|NCT01103466|448182589|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
124607897|NCT01103466|448182590|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
124607898|NCT01103466|448182588|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
124607899|NCT01103466|448182589|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
124607900|NCT01103466|448182590|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
124607901|NCT01103466|448182588|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
124607902|NCT01103466|448182589|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
124607903|NCT01103466|448182590|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
124607904|NCT02331368|448182595|FG000|Overall Study|Withdrawal by Subject|3|||
124607905|NCT02302859|448182599|FG000|Overall Study|Lost Phone|1|||
124607906|NCT02302859|448182600|FG001|Overall Study|Lost Phone|1|||
124607907|NCT02302859|448182599|FG000|Overall Study|Withdrawal by Subject|0|||
124607908|NCT02302859|448182600|FG001|Overall Study|Withdrawal by Subject|1|||
124607909|NCT03285308|448182603|FG000|Overall Study|Adverse Event|3|||
124607910|NCT03285308|448182604|FG001|Overall Study|Adverse Event|7|||
124607911|NCT03285308|448182603|FG000|Overall Study|Withdrawal by Subject|8|||
124607912|NCT03285308|448182604|FG001|Overall Study|Withdrawal by Subject|9|||
124607913|NCT03285308|448182603|FG000|Overall Study|Lost to Follow-up|3|||
124607914|NCT03285308|448182604|FG001|Overall Study|Lost to Follow-up|1|||
124607915|NCT03285308|448182603|FG000|Overall Study|Protocol Deviation|6|||
124607916|NCT03285308|448182604|FG001|Overall Study|Protocol Deviation|5|||
124607917|NCT03285308|448182603|FG000|Overall Study|Reason not Specified|0|||
124607918|NCT03285308|448182604|FG001|Overall Study|Reason not Specified|1|||
124607919|NCT02283983|448182605|FG000|Overall Study|Inclusion criteria not met|0|||
124607920|NCT02283983|448182606|FG001|Overall Study|Inclusion criteria not met|1|||
124607921|NCT02283983|448182605|FG000|Overall Study|Withdrawal by Subject|4|||
124607922|NCT02283983|448182606|FG001|Overall Study|Withdrawal by Subject|2|||
124607923|NCT02283983|448182605|FG000|Overall Study|Protocol Violation|0|||
124607924|NCT02283983|448182606|FG001|Overall Study|Protocol Violation|4|||
124607925|NCT02283983|448182605|FG000|Overall Study|Physician Decision|2|||
124607926|NCT02283983|448182606|FG001|Overall Study|Physician Decision|4|||
124607927|NCT02283983|448182605|FG000|Overall Study|Death|1|||
124607928|NCT02283983|448182606|FG001|Overall Study|Death|0|||
124607929|NCT02283983|448182605|FG000|Overall Study|Adverse Event|1|||
124607930|NCT02283983|448182606|FG001|Overall Study|Adverse Event|0|||
124607931|NCT02283983|448182605|FG000|Overall Study|Lost to Follow-up|9|||
124607932|NCT02283983|448182606|FG001|Overall Study|Lost to Follow-up|8|||
124607933|NCT02283983|448182605|FG000|Overall Study|Relapse|1|||
124607934|NCT02283983|448182606|FG001|Overall Study|Relapse|0|||
124607935|NCT00424775|448182613|FG000|Overall Study|Adverse Event|2|||
124607936|NCT00424775|448182614|FG001|Overall Study|Adverse Event|0|||
124607937|NCT00424775|448182613|FG000|Overall Study|Lack of Efficacy|1|||
124607938|NCT00424775|448182614|FG001|Overall Study|Lack of Efficacy|0|||
124607939|NCT00681590|448182615|FG000|Overall Study|Withdrawal by Subject|2|||
124607940|NCT00681590|448182616|FG001|Overall Study|Withdrawal by Subject|12|||
124607941|NCT01898650|448182617|FG000|Overall Study|the subject would not lie still for imaging|1|||
124607942|NCT01791153|448182618|FG000|Part 1: Blinded Period|Adverse Event|7|||
124607943|NCT01791153|448182619|FG001|Part 1: Blinded Period|Adverse Event|3|||
124607944|NCT01791153|448182620|FG002|Part 1: Blinded Period|Adverse Event|2|||
124607945|NCT01791153|448182621|FG003|Part 1: Blinded Period|Adverse Event|0|||
124607946|NCT01791153|448182622|FG004|Part 1: Blinded Period|Adverse Event|0|||
124607947|NCT01791153|448182623|FG005|Part 1: Blinded Period|Adverse Event|0|||
124607948|NCT01791153|448182624|FG006|Part 1: Blinded Period|Adverse Event|0|||
124607949|NCT01791153|448182625|FG007|Part 1: Blinded Period|Adverse Event|0|||
124607950|NCT01791153|448182618|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
124607951|NCT01791153|448182619|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
124607952|NCT01791153|448182620|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
124607953|NCT01791153|448182621|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
124607954|NCT01791153|448182622|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
124607955|NCT01791153|448182623|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
124607956|NCT01791153|448182624|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
124607957|NCT01791153|448182625|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
124607958|NCT01791153|448182618|FG000|Part 1: Blinded Period|Non-Compliance|1|||
124607959|NCT01791153|448182619|FG001|Part 1: Blinded Period|Non-Compliance|0|||
124607960|NCT01791153|448182620|FG002|Part 1: Blinded Period|Non-Compliance|0|||
124607961|NCT01791153|448182621|FG003|Part 1: Blinded Period|Non-Compliance|0|||
124607962|NCT01791153|448182622|FG004|Part 1: Blinded Period|Non-Compliance|0|||
124607963|NCT01791153|448182623|FG005|Part 1: Blinded Period|Non-Compliance|0|||
124607964|NCT01791153|448182624|FG006|Part 1: Blinded Period|Non-Compliance|0|||
124607965|NCT01791153|448182625|FG007|Part 1: Blinded Period|Non-Compliance|0|||
124607966|NCT01791153|448182618|FG000|Part 1: Blinded Period|Physician Decision|0|||
124607967|NCT01791153|448182619|FG001|Part 1: Blinded Period|Physician Decision|0|||
124607968|NCT01791153|448182620|FG002|Part 1: Blinded Period|Physician Decision|0|||
124607969|NCT01791153|448182621|FG003|Part 1: Blinded Period|Physician Decision|1|||
124607970|NCT01791153|448182622|FG004|Part 1: Blinded Period|Physician Decision|0|||
124607971|NCT01791153|448182623|FG005|Part 1: Blinded Period|Physician Decision|0|||
124607972|NCT01791153|448182624|FG006|Part 1: Blinded Period|Physician Decision|0|||
124607973|NCT01791153|448182625|FG007|Part 1: Blinded Period|Physician Decision|0|||
124607974|NCT01791153|448182618|FG000|Part 1: Blinded Period|Protocol Violation|0|||
124607975|NCT01791153|448182619|FG001|Part 1: Blinded Period|Protocol Violation|0|||
124607976|NCT01791153|448182620|FG002|Part 1: Blinded Period|Protocol Violation|0|||
124607977|NCT01791153|448182621|FG003|Part 1: Blinded Period|Protocol Violation|1|||
124607978|NCT01791153|448182622|FG004|Part 1: Blinded Period|Protocol Violation|0|||
124607979|NCT01791153|448182623|FG005|Part 1: Blinded Period|Protocol Violation|0|||
124607980|NCT01791153|448182624|FG006|Part 1: Blinded Period|Protocol Violation|0|||
124607981|NCT01791153|448182625|FG007|Part 1: Blinded Period|Protocol Violation|0|||
124607982|NCT01791153|448182618|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
124607983|NCT01791153|448182619|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
124607984|NCT01791153|448182620|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
124607985|NCT01791153|448182621|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
124607986|NCT01791153|448182622|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
124607987|NCT01791153|448182623|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
124607988|NCT01791153|448182624|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
124607989|NCT01791153|448182625|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
124781144|NCT00545272|448829097|FG004|Overall Study|Adverse Event|0|||
124607990|NCT01791153|448182618|FG000|Part 2: Open-label Period|Adverse Event|0|||
124607991|NCT01791153|448182619|FG001|Part 2: Open-label Period|Adverse Event|0|||
124607992|NCT01791153|448182620|FG002|Part 2: Open-label Period|Adverse Event|0|||
124607993|NCT01791153|448182621|FG003|Part 2: Open-label Period|Adverse Event|0|||
124607994|NCT01791153|448182622|FG004|Part 2: Open-label Period|Adverse Event|0|||
124607995|NCT01791153|448182623|FG005|Part 2: Open-label Period|Adverse Event|1|||
124607996|NCT01791153|448182624|FG006|Part 2: Open-label Period|Adverse Event|1|||
124607997|NCT01791153|448182625|FG007|Part 2: Open-label Period|Adverse Event|2|||
124607998|NCT01791153|448182618|FG000|Part 2: Open-label Period|Death|0|||
124607999|NCT01791153|448182619|FG001|Part 2: Open-label Period|Death|0|||
124608000|NCT01791153|448182620|FG002|Part 2: Open-label Period|Death|0|||
124608001|NCT01791153|448182621|FG003|Part 2: Open-label Period|Death|0|||
124608002|NCT01791153|448182622|FG004|Part 2: Open-label Period|Death|0|||
124608003|NCT01791153|448182623|FG005|Part 2: Open-label Period|Death|1|||
124608004|NCT01791153|448182624|FG006|Part 2: Open-label Period|Death|1|||
124608005|NCT01791153|448182625|FG007|Part 2: Open-label Period|Death|1|||
124608006|NCT01791153|448182618|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
124608007|NCT01791153|448182619|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
124608008|NCT01791153|448182620|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
124608009|NCT01791153|448182621|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
124608010|NCT01791153|448182622|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
124608011|NCT01791153|448182623|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
124608012|NCT01791153|448182624|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
124608013|NCT01791153|448182625|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
124608014|NCT01791153|448182618|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
124608015|NCT01791153|448182619|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
124608016|NCT01791153|448182620|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
124608017|NCT01791153|448182621|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
124608018|NCT01791153|448182622|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
124608019|NCT01791153|448182623|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
124608020|NCT01791153|448182624|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
124608021|NCT01791153|448182625|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
124608022|NCT01791153|448182618|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
124608023|NCT01791153|448182619|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
124608024|NCT01791153|448182620|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
124608025|NCT01791153|448182621|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
124608026|NCT01791153|448182622|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
124608027|NCT01791153|448182623|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
124608028|NCT01791153|448182624|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
124608029|NCT01791153|448182625|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
124608030|NCT01791153|448182618|FG000|Part 2: Open-label Period|Physician Decision|0|||
124608031|NCT01791153|448182619|FG001|Part 2: Open-label Period|Physician Decision|0|||
124608032|NCT01791153|448182620|FG002|Part 2: Open-label Period|Physician Decision|0|||
124608033|NCT01791153|448182621|FG003|Part 2: Open-label Period|Physician Decision|0|||
124608034|NCT01791153|448182622|FG004|Part 2: Open-label Period|Physician Decision|1|||
124608035|NCT01791153|448182623|FG005|Part 2: Open-label Period|Physician Decision|1|||
124608036|NCT01791153|448182624|FG006|Part 2: Open-label Period|Physician Decision|0|||
124608037|NCT01791153|448182625|FG007|Part 2: Open-label Period|Physician Decision|0|||
124608038|NCT00975286|448182629|FG000|Overall Study|Adverse Event|9|||
124608039|NCT00975286|448182630|FG001|Overall Study|Adverse Event|19|||
124608040|NCT00975286|448182629|FG000|Overall Study|Protocol Violation|1|||
124608041|NCT00975286|448182630|FG001|Overall Study|Protocol Violation|2|||
124608042|NCT00975286|448182629|FG000|Overall Study|Withdrawal by Subject|0|||
124608043|NCT00975286|448182630|FG001|Overall Study|Withdrawal by Subject|2|||
124608044|NCT00975286|448182629|FG000|Overall Study|Familial and Personal Reasons|2|||
124608045|NCT00975286|448182630|FG001|Overall Study|Familial and Personal Reasons|2|||
124608046|NCT00975286|448182629|FG000|Overall Study|Poor Compliance to Protocol|0|||
124608047|NCT00975286|448182630|FG001|Overall Study|Poor Compliance to Protocol|2|||
124608048|NCT00975286|448182629|FG000|Overall Study|Sponsor Decision|0|||
124608049|NCT00975286|448182630|FG001|Overall Study|Sponsor Decision|2|||
124608050|NCT02357342|448182631|FG000|First 6 Months|Death|2|||
124608051|NCT02357342|448182632|FG001|First 6 Months|Death|0|||
124608052|NCT01674647|448182633|FG000|Treatment Period|Death|4|||
124608053|NCT01674647|448182634|FG001|Treatment Period|Death|1|||
124608054|NCT01674647|448182633|FG000|Treatment Period|Efficacy outcome reached|0|||
124608055|NCT01674647|448182634|FG001|Treatment Period|Efficacy outcome reached|1|||
124608056|NCT01674647|448182633|FG000|Treatment Period|Physician Decision|3|||
124608057|NCT01674647|448182634|FG001|Treatment Period|Physician Decision|1|||
124608058|NCT01674647|448182633|FG000|Treatment Period|Adverse Event|60|||
124608059|NCT01674647|448182634|FG001|Treatment Period|Adverse Event|22|||
124608060|NCT01674647|448182633|FG000|Treatment Period|Non-compliance with study drug|3|||
124608061|NCT01674647|448182634|FG001|Treatment Period|Non-compliance with study drug|0|||
124608062|NCT01674647|448182633|FG000|Treatment Period|Lost to Follow-up|1|||
124608063|NCT01674647|448182634|FG001|Treatment Period|Lost to Follow-up|1|||
124731742|NCT00578877|448640182|FG000|Overall Study|early discontinue|61|||
124731743|NCT00578877|448640183|FG001|Overall Study|early discontinue|101|||
124608064|NCT01674647|448182633|FG000|Treatment Period|Withdrawal by Subject|19|||
124608065|NCT01674647|448182634|FG001|Treatment Period|Withdrawal by Subject|16|||
124608066|NCT01674647|448182633|FG000|Treatment Period|Switching to other therapy|5|||
124608067|NCT01674647|448182634|FG001|Treatment Period|Switching to other therapy|2|||
124731744|NCT00578877|448640182|FG000|Overall Study|did not provide follow-up data|12|||
124608068|NCT01674647|448182633|FG000|Treatment Period|Logistical difficulties|5|||
124608069|NCT01674647|448182634|FG001|Treatment Period|Logistical difficulties|8|||
124608070|NCT01674647|448182633|FG000|Treatment Period|Treatment failure|0|||
124608071|NCT01674647|448182634|FG001|Treatment Period|Treatment failure|14|||
124608072|NCT01674647|448182633|FG000|Treatment Period|Protocol Violation|56|||
124608073|NCT01674647|448182634|FG001|Treatment Period|Protocol Violation|36|||
124608074|NCT01674647|448182633|FG000|30-day Safety Follow-up Period|Death|3|||
124608075|NCT01674647|448182634|FG001|30-day Safety Follow-up Period|Death|2|||
124608076|NCT01674647|448182633|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
124608077|NCT01674647|448182634|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
124608078|NCT01674647|448182633|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
124608079|NCT01674647|448182634|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
124608080|NCT01674647|448182633|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
124608081|NCT01674647|448182634|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
124608082|NCT01674647|448182633|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
124608083|NCT01674647|448182634|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
124608084|NCT01674647|448182633|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
124608085|NCT01674647|448182634|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
124608086|NCT01490866|448182635|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
124608087|NCT01490866|448182635|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
124608088|NCT01490866|448182635|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
124608089|NCT01490866|448182635|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
124608090|NCT01490866|448182635|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
124608091|NCT01490866|448182635|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
124608092|NCT01490866|448182635|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
124608093|NCT01490866|448182635|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
124608094|NCT01490866|448182635|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
124608095|NCT01490866|448182635|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
124608096|NCT01490866|448182635|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
124608097|NCT01181271|448182636|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
124608098|NCT01181271|448182636|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
124608099|NCT01181271|448182636|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
124608100|NCT01181271|448182636|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
124608101|NCT04156620|448182637|FG000|Overall Study|Adverse event - TP 1|5|||
124608102|NCT04156620|448182638|FG001|Overall Study|Adverse event - TP 1|2|||
124608103|NCT04156620|448182637|FG000|Overall Study|Lost to follow-up TP 1|1|||
124608104|NCT04156620|448182638|FG001|Overall Study|Lost to follow-up TP 1|1|||
124608105|NCT04156620|448182637|FG000|Overall Study|Progressive disease - TP 1|0|||
124608106|NCT04156620|448182638|FG001|Overall Study|Progressive disease - TP 1|1|||
124608107|NCT04156620|448182637|FG000|Overall Study|Subject decision - TP 1|3|||
124608108|NCT04156620|448182638|FG001|Overall Study|Subject decision - TP 1|5|||
124608109|NCT04156620|448182637|FG000|Overall Study|Adverse event - TP 2|5|||
124608110|NCT04156620|448182638|FG001|Overall Study|Adverse event - TP 2|6|||
124608111|NCT04156620|448182637|FG000|Overall Study|Death - TP 2|1|||
124608112|NCT04156620|448182638|FG001|Overall Study|Death - TP 2|0|||
124608113|NCT04156620|448182637|FG000|Overall Study|Lost to follow-up - TP 2|5|||
124608114|NCT04156620|448182638|FG001|Overall Study|Lost to follow-up - TP 2|2|||
124608115|NCT04156620|448182637|FG000|Overall Study|Physician decision - TP 2|4|||
124608116|NCT04156620|448182638|FG001|Overall Study|Physician decision - TP 2|2|||
124608117|NCT04156620|448182637|FG000|Overall Study|Pregnancy - TP 2|1|||
124608118|NCT04156620|448182638|FG001|Overall Study|Pregnancy - TP 2|1|||
124608119|NCT04156620|448182637|FG000|Overall Study|Subject decision - TP 2|11|||
124608120|NCT04156620|448182638|FG001|Overall Study|Subject decision - TP 2|9|||
124608121|NCT04156620|448182637|FG000|Overall Study|New therapy for study indication - TP 2|1|||
124608122|NCT04156620|448182638|FG001|Overall Study|New therapy for study indication - TP 2|0|||
124608123|NCT02980874|448182639|FG000|Overall Study|Adverse Event|2|||
124608124|NCT02980874|448182640|FG001|Overall Study|Adverse Event|7|||
124608125|NCT02980874|448182639|FG000|Overall Study|Withdrawal by Subject|7|||
124608126|NCT02980874|448182640|FG001|Overall Study|Withdrawal by Subject|2|||
124608127|NCT02980874|448182639|FG000|Overall Study|Lost to Follow-up|5|||
124608128|NCT02980874|448182640|FG001|Overall Study|Lost to Follow-up|5|||
124608129|NCT02980874|448182639|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
124608130|NCT02980874|448182640|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
124608131|NCT02980874|448182639|FG000|Overall Study|Unknown study completion status|1|||
124608132|NCT02980874|448182640|FG001|Overall Study|Unknown study completion status|0|||
124608133|NCT02722148|448182641|FG000|Overall Study|Lost to Follow-up|2|||
124608134|NCT02722148|448182641|FG000|Overall Study|Non compliant with treatment regimen|3|||
124608135|NCT01753336|448182642|FG000|Overall Study|Patient decision|12|||
124608136|NCT01753336|448182642|FG000|Overall Study|Lost to Follow-up|3|||
124608137|NCT01753336|448182642|FG000|Overall Study|Physician Decision|2|||
124608138|NCT01753336|448182642|FG000|Overall Study|Sponsor's decision|2|||
124608139|NCT01753336|448182642|FG000|Overall Study|Withdrawal by Subject|1|||
124608140|NCT00446199|448182646|FG000|Overall Study|Adverse Event|7|||
124608141|NCT00446199|448182647|FG001|Overall Study|Adverse Event|4|||
124608142|NCT00446199|448182648|FG002|Overall Study|Adverse Event|6|||
124608143|NCT00446199|448182649|FG003|Overall Study|Adverse Event|4|||
124608144|NCT00446199|448182646|FG000|Overall Study|Lost to Follow-up|4|||
124731745|NCT00578877|448640183|FG001|Overall Study|did not provide follow-up data|17|||
124608145|NCT00446199|448182647|FG001|Overall Study|Lost to Follow-up|5|||
124608146|NCT00446199|448182648|FG002|Overall Study|Lost to Follow-up|2|||
124608147|NCT00446199|448182649|FG003|Overall Study|Lost to Follow-up|6|||
124608148|NCT00446199|448182646|FG000|Overall Study|Protocol Violation|1|||
124608149|NCT00446199|448182647|FG001|Overall Study|Protocol Violation|2|||
124608150|NCT00446199|448182648|FG002|Overall Study|Protocol Violation|1|||
124608151|NCT00446199|448182649|FG003|Overall Study|Protocol Violation|3|||
124608152|NCT00446199|448182646|FG000|Overall Study|Withdrawal by Subject|2|||
124608153|NCT00446199|448182647|FG001|Overall Study|Withdrawal by Subject|5|||
124608154|NCT00446199|448182648|FG002|Overall Study|Withdrawal by Subject|9|||
124608155|NCT00446199|448182649|FG003|Overall Study|Withdrawal by Subject|10|||
124608156|NCT00446199|448182646|FG000|Overall Study|Site termination|2|||
124608157|NCT00446199|448182647|FG001|Overall Study|Site termination|0|||
124608158|NCT00446199|448182648|FG002|Overall Study|Site termination|0|||
124608159|NCT00446199|448182649|FG003|Overall Study|Site termination|1|||
124608160|NCT00446199|448182646|FG000|Overall Study|Randomization in Error|2|||
124608161|NCT00446199|448182647|FG001|Overall Study|Randomization in Error|0|||
124608162|NCT00446199|448182648|FG002|Overall Study|Randomization in Error|1|||
124608163|NCT00446199|448182649|FG003|Overall Study|Randomization in Error|1|||
124608164|NCT00446199|448182646|FG000|Overall Study|Lack of Efficacy|1|||
124608165|NCT00446199|448182647|FG001|Overall Study|Lack of Efficacy|0|||
124608166|NCT00446199|448182648|FG002|Overall Study|Lack of Efficacy|0|||
124608167|NCT00446199|448182649|FG003|Overall Study|Lack of Efficacy|1|||
124608168|NCT00446199|448182646|FG000|Overall Study|Non-compliant with study drug|1|||
124608169|NCT00446199|448182647|FG001|Overall Study|Non-compliant with study drug|0|||
124608170|NCT00446199|448182648|FG002|Overall Study|Non-compliant with study drug|5|||
124608171|NCT00446199|448182649|FG003|Overall Study|Non-compliant with study drug|0|||
124608172|NCT00446199|448182646|FG000|Overall Study|Non-compliant with visit schedule|1|||
124608173|NCT00446199|448182647|FG001|Overall Study|Non-compliant with visit schedule|1|||
124608174|NCT00446199|448182648|FG002|Overall Study|Non-compliant with visit schedule|1|||
124608175|NCT00446199|448182649|FG003|Overall Study|Non-compliant with visit schedule|2|||
124608176|NCT00446199|448182646|FG000|Overall Study|Hormone fear|0|||
124608177|NCT00446199|448182647|FG001|Overall Study|Hormone fear|0|||
124608178|NCT00446199|448182648|FG002|Overall Study|Hormone fear|0|||
124608179|NCT00446199|448182649|FG003|Overall Study|Hormone fear|1|||
124608180|NCT00446199|448182646|FG000|Overall Study|Lost interest in study participation|0|||
124608181|NCT00446199|448182647|FG001|Overall Study|Lost interest in study participation|1|||
124608182|NCT00446199|448182648|FG002|Overall Study|Lost interest in study participation|0|||
124608183|NCT00446199|448182649|FG003|Overall Study|Lost interest in study participation|0|||
124608184|NCT00446199|448182646|FG000|Overall Study|In-/Exclusion criterion violated|2|||
124608185|NCT00446199|448182647|FG001|Overall Study|In-/Exclusion criterion violated|1|||
124608186|NCT00446199|448182648|FG002|Overall Study|In-/Exclusion criterion violated|2|||
124608187|NCT00446199|448182649|FG003|Overall Study|In-/Exclusion criterion violated|1|||
124608188|NCT00446199|448182646|FG000|Overall Study|Move|0|||
124608189|NCT00446199|448182647|FG001|Overall Study|Move|1|||
124608190|NCT00446199|448182648|FG002|Overall Study|Move|0|||
124608191|NCT00446199|448182649|FG003|Overall Study|Move|0|||
124608192|NCT04188301|448182655|FG000|Month 3|Lost to Follow-up|0|||
124608193|NCT04188301|448182656|FG001|Month 3|Lost to Follow-up|0|||
124608194|NCT04188301|448182657|FG002|Month 3|Lost to Follow-up|1|||
124608195|NCT04188301|448182655|FG000|Month 12|Lost to Follow-up|0|||
124608196|NCT04188301|448182656|FG001|Month 12|Lost to Follow-up|0|||
124608197|NCT04188301|448182657|FG002|Month 12|Lost to Follow-up|2|||
124608198|NCT04188301|448182655|FG000|Month 12|Death|1|||
124608199|NCT04188301|448182656|FG001|Month 12|Death|1|||
124608200|NCT04188301|448182657|FG002|Month 12|Death|0|||
124608201|NCT04188301|448182655|FG000|Month 18|Lost to Follow-up|6|||
124608202|NCT04188301|448182656|FG001|Month 18|Lost to Follow-up|0|||
124608203|NCT04188301|448182657|FG002|Month 18|Lost to Follow-up|0|||
124608204|NCT03548064|448184985|FG000|Overall Study|Withdrawal by Subject|0|||
124608205|NCT03548064|448184986|FG001|Overall Study|Withdrawal by Subject|0|||
124608206|NCT03548064|448184987|FG002|Overall Study|Withdrawal by Subject|0|||
124731746|NCT02437409|448640188|FG000|Overall Study|Withdrawal by Subject|3|||
124608207|NCT03548064|448184988|FG003|Overall Study|Withdrawal by Subject|1|||
124731747|NCT02437409|448640188|FG000|Overall Study|Screening failure|12|||
124731748|NCT01632241|448640189|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
124608208|NCT03548064|448184989|FG004|Overall Study|Withdrawal by Subject|0|||
124608209|NCT03548064|448184990|FG005|Overall Study|Withdrawal by Subject|0|||
124608210|NCT03548064|448184991|FG006|Overall Study|Withdrawal by Subject|0|||
124608211|NCT03548064|448184992|FG007|Overall Study|Withdrawal by Subject|0|||
124608212|NCT03548064|448184985|FG000|Overall Study|Lost to Follow-up|0|||
124608213|NCT03548064|448184986|FG001|Overall Study|Lost to Follow-up|0|||
124608214|NCT03548064|448184987|FG002|Overall Study|Lost to Follow-up|0|||
124608215|NCT03548064|448184988|FG003|Overall Study|Lost to Follow-up|0|||
124608216|NCT03548064|448184989|FG004|Overall Study|Lost to Follow-up|2|||
124608217|NCT03548064|448184990|FG005|Overall Study|Lost to Follow-up|0|||
124608218|NCT03548064|448184991|FG006|Overall Study|Lost to Follow-up|0|||
124608219|NCT03548064|448184992|FG007|Overall Study|Lost to Follow-up|0|||
124608220|NCT03548064|448184985|FG000|Overall Study|Covid-19 Pandemic|0|||
124608221|NCT03548064|448184986|FG001|Overall Study|Covid-19 Pandemic|0|||
124608222|NCT03548064|448184987|FG002|Overall Study|Covid-19 Pandemic|0|||
124608223|NCT03548064|448184988|FG003|Overall Study|Covid-19 Pandemic|0|||
124608224|NCT03548064|448184989|FG004|Overall Study|Covid-19 Pandemic|10|||
124608225|NCT03548064|448184990|FG005|Overall Study|Covid-19 Pandemic|3|||
124608226|NCT03548064|448184991|FG006|Overall Study|Covid-19 Pandemic|0|||
124608227|NCT03548064|448184992|FG007|Overall Study|Covid-19 Pandemic|0|||
124608228|NCT05011123|448184993|FG000|Overall Study|Withdrawal by Subject|4|||
124608229|NCT05011123|448184994|FG001|Overall Study|Withdrawal by Subject|2|||
124608230|NCT05011123|448184993|FG000|Overall Study|Lost to Follow-up|7|||
124608231|NCT05011123|448184994|FG001|Overall Study|Lost to Follow-up|6|||
124608232|NCT05011123|448184993|FG000|Overall Study|Ongoing at the time of DBL date|36|||
124608233|NCT05011123|448184994|FG001|Overall Study|Ongoing at the time of DBL date|10|||
124608234|NCT05011123|448184993|FG000|Overall Study|Randomized but did not receive vaccination|1|||
124608235|NCT05011123|448184994|FG001|Overall Study|Randomized but did not receive vaccination|0|||
124608236|NCT04221789|448184995|FG000|Overall Study|deviation from protoco|22|||
124608237|NCT04221789|448184996|FG001|Overall Study|deviation from protoco|8|||
124608238|NCT04732221|448184997|FG000|Base Period|Death|2|||
124608239|NCT04732221|448184998|FG001|Base Period|Death|0|||
124608240|NCT04732221|448184999|FG002|Base Period|Death|0|||
124608241|NCT04732221|448185000|FG003|Base Period|Death|0|||
124608242|NCT04732221|448185001|FG004|Base Period|Death|0|||
124608243|NCT04732221|448185002|FG005|Base Period|Death|0|||
124608244|NCT04732221|448185003|FG006|Base Period|Death|0|||
124608245|NCT04732221|448184997|FG000|Base Period|Withdrawal by Subject|0|||
124608246|NCT04732221|448184998|FG001|Base Period|Withdrawal by Subject|1|||
124608247|NCT04732221|448184999|FG002|Base Period|Withdrawal by Subject|1|||
124608248|NCT04732221|448185000|FG003|Base Period|Withdrawal by Subject|0|||
124608249|NCT04732221|448185001|FG004|Base Period|Withdrawal by Subject|0|||
124608250|NCT04732221|448185002|FG005|Base Period|Withdrawal by Subject|0|||
124608251|NCT04732221|448185003|FG006|Base Period|Withdrawal by Subject|0|||
124608252|NCT04732221|448184997|FG000|Extension Period|Adverse Event|0|||
124608253|NCT04732221|448184998|FG001|Extension Period|Adverse Event|0|||
124608254|NCT04732221|448184999|FG002|Extension Period|Adverse Event|0|||
124608255|NCT04732221|448185000|FG003|Extension Period|Adverse Event|0|||
124608256|NCT04732221|448185001|FG004|Extension Period|Adverse Event|0|||
124608257|NCT04732221|448185002|FG005|Extension Period|Adverse Event|1|||
124608258|NCT04732221|448185003|FG006|Extension Period|Adverse Event|0|||
124608259|NCT04732221|448184997|FG000|Extension Period|Death|0|||
124608260|NCT04732221|448184998|FG001|Extension Period|Death|0|||
124608261|NCT04732221|448184999|FG002|Extension Period|Death|0|||
124608262|NCT04732221|448185000|FG003|Extension Period|Death|0|||
124608263|NCT04732221|448185001|FG004|Extension Period|Death|1|||
124608264|NCT04732221|448185002|FG005|Extension Period|Death|0|||
124608265|NCT04732221|448185003|FG006|Extension Period|Death|2|||
124608266|NCT04732221|448184997|FG000|Extension Period|Pregnancy|0|||
124608267|NCT04732221|448184998|FG001|Extension Period|Pregnancy|0|||
124608268|NCT04732221|448184999|FG002|Extension Period|Pregnancy|0|||
124608269|NCT04732221|448185000|FG003|Extension Period|Pregnancy|0|||
124608270|NCT04732221|448185001|FG004|Extension Period|Pregnancy|1|||
124608271|NCT04732221|448185002|FG005|Extension Period|Pregnancy|0|||
124608272|NCT04732221|448185003|FG006|Extension Period|Pregnancy|0|||
124608273|NCT04732221|448184997|FG000|Extension Period|Sponsors Decision|0|||
124608274|NCT04732221|448184998|FG001|Extension Period|Sponsors Decision|0|||
124608275|NCT04732221|448184999|FG002|Extension Period|Sponsors Decision|0|||
124608276|NCT04732221|448185000|FG003|Extension Period|Sponsors Decision|0|||
124608277|NCT04732221|448185001|FG004|Extension Period|Sponsors Decision|41|||
124608278|NCT04732221|448185002|FG005|Extension Period|Sponsors Decision|40|||
124608279|NCT04732221|448185003|FG006|Extension Period|Sponsors Decision|40|||
124608280|NCT04732221|448184997|FG000|Extension Period|Withdrawal by Subject|0|||
124608281|NCT04732221|448184998|FG001|Extension Period|Withdrawal by Subject|0|||
124608282|NCT04732221|448184999|FG002|Extension Period|Withdrawal by Subject|0|||
124608283|NCT04732221|448185000|FG003|Extension Period|Withdrawal by Subject|0|||
124608284|NCT04732221|448185001|FG004|Extension Period|Withdrawal by Subject|1|||
124608285|NCT04732221|448185002|FG005|Extension Period|Withdrawal by Subject|5|||
124608286|NCT04732221|448185003|FG006|Extension Period|Withdrawal by Subject|2|||
124608287|NCT03747601|448185004|FG000|Overall Study|COVID halt to visits|4|||
124608288|NCT05327816|448185005|FG000|Overall Study|Lost to Follow-up|1|||
124608289|NCT05327816|448185006|FG001|Overall Study|Lost to Follow-up|0|||
124608290|NCT05327816|448185007|FG002|Overall Study|Lost to Follow-up|0|||
124608291|NCT05327816|448185008|FG003|Overall Study|Lost to Follow-up|0|||
124608292|NCT05327816|448185009|FG004|Overall Study|Lost to Follow-up|0|||
124608293|NCT05327816|448185010|FG005|Overall Study|Lost to Follow-up|0|||
124608294|NCT05327816|448185011|FG006|Overall Study|Lost to Follow-up|0|||
124608295|NCT05327816|448185012|FG007|Overall Study|Lost to Follow-up|0|||
124608296|NCT05327816|448185013|FG008|Overall Study|Lost to Follow-up|0|||
124608297|NCT05327816|448185014|FG009|Overall Study|Lost to Follow-up|1|||
124608298|NCT05327816|448185015|FG010|Overall Study|Lost to Follow-up|0|||
124608299|NCT05327816|448185005|FG000|Overall Study|Withdrawal by Subject|0|||
124731749|NCT01632241|448640190|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
124731750|NCT01632241|448640189|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
124731751|NCT01632241|448640190|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
124731752|NCT01632241|448640189|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
124731753|NCT01632241|448640190|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
124731754|NCT01632241|448640189|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
124731755|NCT01632241|448640190|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
124731756|NCT01632241|448640189|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
124731757|NCT01632241|448640190|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
124731758|NCT01632241|448640189|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
124731759|NCT01632241|448640190|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
124731760|NCT01632241|448640189|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
124731761|NCT01632241|448640190|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
124731762|NCT01632241|448640189|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
124731763|NCT01632241|448640190|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
124731764|NCT01632241|448640189|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
124731765|NCT01632241|448640190|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
124731766|NCT01632241|448640189|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
124731767|NCT01632241|448640190|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
124731768|NCT01632241|448640189|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
124731769|NCT01632241|448640190|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
124731770|NCT01632241|448640189|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
124781145|NCT00545272|448829098|FG005|Overall Study|Adverse Event|1|||
124608300|NCT05327816|448185006|FG001|Overall Study|Withdrawal by Subject|0|||
124608301|NCT05327816|448185007|FG002|Overall Study|Withdrawal by Subject|0|||
124608302|NCT05327816|448185008|FG003|Overall Study|Withdrawal by Subject|0|||
124608303|NCT05327816|448185009|FG004|Overall Study|Withdrawal by Subject|1|||
124608304|NCT05327816|448185010|FG005|Overall Study|Withdrawal by Subject|1|||
124608305|NCT05327816|448185011|FG006|Overall Study|Withdrawal by Subject|0|||
124608306|NCT05327816|448185012|FG007|Overall Study|Withdrawal by Subject|0|||
124608307|NCT05327816|448185013|FG008|Overall Study|Withdrawal by Subject|0|||
124608308|NCT05327816|448185014|FG009|Overall Study|Withdrawal by Subject|0|||
124608309|NCT05327816|448185015|FG010|Overall Study|Withdrawal by Subject|0|||
124608310|NCT05327816|448185005|FG000|Overall Study|Study Terminated by Sponsor|11|||
124608311|NCT05327816|448185006|FG001|Overall Study|Study Terminated by Sponsor|12|||
124608312|NCT05327816|448185007|FG002|Overall Study|Study Terminated by Sponsor|12|||
124608313|NCT05327816|448185008|FG003|Overall Study|Study Terminated by Sponsor|12|||
124608314|NCT05327816|448185009|FG004|Overall Study|Study Terminated by Sponsor|11|||
124608315|NCT05327816|448185010|FG005|Overall Study|Study Terminated by Sponsor|11|||
124608316|NCT05327816|448185011|FG006|Overall Study|Study Terminated by Sponsor|11|||
124608317|NCT05327816|448185012|FG007|Overall Study|Study Terminated by Sponsor|11|||
124608318|NCT05327816|448185013|FG008|Overall Study|Study Terminated by Sponsor|11|||
124608319|NCT05327816|448185014|FG009|Overall Study|Study Terminated by Sponsor|11|||
124608320|NCT05327816|448185015|FG010|Overall Study|Study Terminated by Sponsor|12|||
124608321|NCT05327816|448185005|FG000|Overall Study|Randomized but not treated|0|||
124608322|NCT05327816|448185006|FG001|Overall Study|Randomized but not treated|0|||
124608323|NCT05327816|448185007|FG002|Overall Study|Randomized but not treated|0|||
124608324|NCT05327816|448185008|FG003|Overall Study|Randomized but not treated|0|||
124608325|NCT05327816|448185009|FG004|Overall Study|Randomized but not treated|0|||
124608326|NCT05327816|448185010|FG005|Overall Study|Randomized but not treated|0|||
124608327|NCT05327816|448185011|FG006|Overall Study|Randomized but not treated|1|||
124608328|NCT05327816|448185012|FG007|Overall Study|Randomized but not treated|1|||
124608329|NCT05327816|448185013|FG008|Overall Study|Randomized but not treated|1|||
124608330|NCT05327816|448185014|FG009|Overall Study|Randomized but not treated|0|||
124608331|NCT05327816|448185015|FG010|Overall Study|Randomized but not treated|0|||
124608332|NCT00112866|448185016|FG000|Overall Study|Protocol Violation|1|||
124608333|NCT00112866|448185017|FG001|Overall Study|Protocol Violation|0|||
124608334|NCT00112866|448185016|FG000|Overall Study|did not start treatment post-op|1|||
124608335|NCT00112866|448185017|FG001|Overall Study|did not start treatment post-op|2|||
124608336|NCT04305587|448185018|FG000|Overall Study|Withdrawal by Subject|0|||
124608337|NCT04305587|448185019|FG001|Overall Study|Withdrawal by Subject|0|||
124608338|NCT04305587|448185020|FG002|Overall Study|Withdrawal by Subject|0|||
124608339|NCT04305587|448185021|FG003|Overall Study|Withdrawal by Subject|1|||
124608340|NCT04305587|448185022|FG004|Overall Study|Withdrawal by Subject|0|||
124608341|NCT04305587|448185023|FG005|Overall Study|Withdrawal by Subject|0|||
124608342|NCT04305587|448185024|FG006|Overall Study|Withdrawal by Subject|0|||
124608343|NCT04305587|448185025|FG007|Overall Study|Withdrawal by Subject|0|||
124608344|NCT04305587|448185026|FG008|Overall Study|Withdrawal by Subject|0|||
124608345|NCT01367665|448185027|FG000|Overall Study|Death|102|||
124608346|NCT01367665|448185028|FG001|Overall Study|Death|19|||
124608347|NCT01367665|448185027|FG000|Overall Study|Lost to Follow-up|222|||
124608348|NCT01367665|448185028|FG001|Overall Study|Lost to Follow-up|22|||
124608349|NCT01367665|448185027|FG000|Overall Study|Not Done|118|||
124781146|NCT00545272|448829093|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124608350|NCT01367665|448185028|FG001|Overall Study|Not Done|14|||
124608351|NCT02752906|448185029|FG000|Overall Study|Protocol Violation|2|||
124608352|NCT02752906|448185030|FG001|Overall Study|Protocol Violation|1|||
124608353|NCT02752906|448185029|FG000|Overall Study|Withdrawal by Subject|2|||
124608354|NCT02752906|448185030|FG001|Overall Study|Withdrawal by Subject|2|||
124608355|NCT02752906|448185029|FG000|Overall Study|Lost to Follow-up|3|||
124608356|NCT02752906|448185030|FG001|Overall Study|Lost to Follow-up|2|||
124608357|NCT01345175|448185035|FG000|Overall Study|Physician Decision|0|||
124608358|NCT01345175|448185036|FG001|Overall Study|Physician Decision|1|||
124608359|NCT01345175|448185035|FG000|Overall Study|Withdrawal by Subject|1|||
124608360|NCT01345175|448185036|FG001|Overall Study|Withdrawal by Subject|1|||
124608361|NCT01345175|448185035|FG000|Overall Study|Failed to complete BFI|3|||
124608362|NCT01345175|448185036|FG001|Overall Study|Failed to complete BFI|2|||
124608363|NCT01345175|448185035|FG000|Overall Study|Stopped taking medication|2|||
124608364|NCT01345175|448185036|FG001|Overall Study|Stopped taking medication|2|||
124608365|NCT04112173|448185040|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
124608366|NCT01259115|448185042|FG000|Period 1|Adverse Event|1|||
124608367|NCT01259115|448185043|FG001|Period 1|Adverse Event|0|||
124608368|NCT01259115|448185042|FG000|Period 1|Protocol Violation|2|||
124608369|NCT01259115|448185043|FG001|Period 1|Protocol Violation|0|||
124608370|NCT01259115|448185042|FG000|Period 1|Lost to Follow-up|0|||
124608371|NCT01259115|448185043|FG001|Period 1|Lost to Follow-up|1|||
124608372|NCT01259115|448185042|FG000|Period 2|Adverse Event|1|||
124608373|NCT01259115|448185043|FG001|Period 2|Adverse Event|0|||
124608374|NCT03560986|448185044|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
124608375|NCT03560986|448185045|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
124608376|NCT03560986|448185044|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
124608377|NCT03560986|448185045|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
124608378|NCT03560986|448185044|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
124608379|NCT03560986|448185045|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
124608380|NCT03560986|448185044|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
124608381|NCT03560986|448185045|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
124608382|NCT03560986|448185044|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
124608383|NCT03560986|448185045|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
124608384|NCT03560986|448185044|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
124608385|NCT03560986|448185045|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
124608386|NCT03560986|448185044|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
124608387|NCT03560986|448185045|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
124608388|NCT02524730|448185046|FG000|Overall Study|Lost to Follow-up|5|||
124608389|NCT02524730|448185046|FG000|Overall Study|Withdrawal by Subject|18|||
124608390|NCT02524730|448185046|FG000|Overall Study|Death|10|||
124608391|NCT02524730|448185046|FG000|Overall Study|Adverse Event|8|||
124608392|NCT02524730|448185046|FG000|Overall Study|Protocol Violation|1|||
124608393|NCT02524730|448185046|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
124608394|NCT01868893|448185049|FG000|Overall Study|Adverse Event|2|||
124608395|NCT01868893|448185049|FG000|Overall Study|Commercial availability of study drug|17|||
124608396|NCT01868893|448185049|FG000|Overall Study|Neutropenia|1|||
124608397|NCT01857271|448185050|FG000|Overall Study|Lost to Follow-up|1|||
124608398|NCT01783548|448185051|FG000|Overall Study|Adverse Event|8|||
124608399|NCT01783548|448185052|FG001|Overall Study|Adverse Event|4|||
124608400|NCT01783548|448185051|FG000|Overall Study|Withdrawal by Subject|11|||
124608401|NCT01783548|448185052|FG001|Overall Study|Withdrawal by Subject|8|||
124608402|NCT01783548|448185051|FG000|Overall Study|Non-compliance|4|||
124608403|NCT01783548|448185052|FG001|Overall Study|Non-compliance|0|||
124608404|NCT01783548|448185051|FG000|Overall Study|Protocol Violation|2|||
124608405|NCT01783548|448185052|FG001|Overall Study|Protocol Violation|2|||
124608406|NCT01783548|448185051|FG000|Overall Study|Lost to Follow-up|8|||
124608407|NCT01783548|448185052|FG001|Overall Study|Lost to Follow-up|3|||
124608408|NCT01783548|448185051|FG000|Overall Study|Lack of Efficacy|1|||
124608409|NCT01783548|448185052|FG001|Overall Study|Lack of Efficacy|1|||
124608410|NCT03493386|448185053|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
124608411|NCT03493386|448185054|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
124608412|NCT03493386|448185055|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
124608413|NCT03493386|448185056|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
124781147|NCT00545272|448829094|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124608414|NCT00988442|448185057|FG000|Overall Study|Death|1|||
124608415|NCT00988442|448185058|FG001|Overall Study|Death|2|||
124608416|NCT00988442|448185057|FG000|Overall Study|Lost to Follow-up|0|||
124608417|NCT00988442|448185058|FG001|Overall Study|Lost to Follow-up|1|||
124608418|NCT00988442|448185057|FG000|Overall Study|Early Study Closure|29|||
124608419|NCT00988442|448185058|FG001|Overall Study|Early Study Closure|25|||
124608420|NCT05297578|448185064|FG000|Overall Study|Lost to Follow-up|1|||
124608421|NCT05297578|448185065|FG001|Overall Study|Lost to Follow-up|1|||
124608422|NCT05297578|448185066|FG002|Overall Study|Lost to Follow-up|2|||
124608423|NCT05297578|448185067|FG003|Overall Study|Lost to Follow-up|1|||
124608424|NCT05297578|448185064|FG000|Overall Study|Death|0|||
124608425|NCT05297578|448185065|FG001|Overall Study|Death|1|||
124608426|NCT05297578|448185066|FG002|Overall Study|Death|0|||
124608427|NCT05297578|448185067|FG003|Overall Study|Death|0|||
124608428|NCT05297578|448185064|FG000|Overall Study|Withdrawal by Subject|0|||
124608429|NCT05297578|448185065|FG001|Overall Study|Withdrawal by Subject|0|||
124608430|NCT05297578|448185066|FG002|Overall Study|Withdrawal by Subject|1|||
124608431|NCT05297578|448185067|FG003|Overall Study|Withdrawal by Subject|0|||
124608432|NCT01468818|448185074|FG000|Overall Study|Death during treatment|2|||
124608433|NCT01212588|448185076|FG000|Overall Study|Physician Decision|0|||
124608434|NCT01212588|448185077|FG001|Overall Study|Physician Decision|1|||
124608435|NCT01212588|448185076|FG000|Overall Study|Protocol Violation|1|||
124608436|NCT01212588|448185077|FG001|Overall Study|Protocol Violation|1|||
124608437|NCT01735955|448185078|FG000|Overall Study|Administrative problems|1|||
124608438|NCT01735955|448185078|FG000|Overall Study|Patient/guardian decision|1|||
124608439|NCT01735955|448185078|FG000|Overall Study|Patient withdrew consent|2|||
124608440|NCT01735955|448185078|FG000|Overall Study|Physician Decision|4|||
124608441|NCT01735955|448185078|FG000|Overall Study|Disease progression|24|||
124608442|NCT01735955|448185078|FG000|Overall Study|Adverse Event|5|||
124608443|NCT03893565|448185088|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
124608444|NCT03893565|448185089|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
124608445|NCT03893565|448185090|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
124608446|NCT03893565|448185091|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
124608447|NCT03893565|448185092|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
124608448|NCT03893565|448185093|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
124608449|NCT03893565|448185094|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
124608450|NCT03893565|448185095|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
124608451|NCT03893565|448185096|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
124608452|NCT03893565|448185088|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
124608453|NCT03893565|448185089|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
124608454|NCT03893565|448185090|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
124608455|NCT03893565|448185091|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
124608456|NCT03893565|448185092|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
124608457|NCT03893565|448185093|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
124608458|NCT03893565|448185094|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
124608459|NCT03893565|448185095|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
124608460|NCT03893565|448185096|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
124608461|NCT03893565|448185088|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
124608462|NCT03893565|448185089|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
124608463|NCT03893565|448185090|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
124608464|NCT03893565|448185091|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
124608465|NCT03893565|448185092|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
124608466|NCT03893565|448185093|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
124608467|NCT03893565|448185094|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
124608468|NCT03893565|448185095|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
124608469|NCT03893565|448185096|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
124608470|NCT03893565|448185088|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
124608471|NCT03893565|448185089|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
124608472|NCT03893565|448185090|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
124608473|NCT03893565|448185091|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
124608474|NCT03893565|448185092|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
124608475|NCT03893565|448185093|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
124608476|NCT03893565|448185094|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
124608477|NCT03893565|448185095|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
124608478|NCT03893565|448185096|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
124608479|NCT03893565|448185088|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
124608480|NCT03893565|448185089|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
124608481|NCT03893565|448185090|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
124608482|NCT03893565|448185091|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
124608483|NCT03893565|448185092|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
124608484|NCT03893565|448185093|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
124608485|NCT03893565|448185094|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
124608486|NCT03893565|448185095|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
124608487|NCT03893565|448185096|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
124608488|NCT03893565|448185088|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
124608489|NCT03893565|448185089|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
124608490|NCT03893565|448185090|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
124608491|NCT03893565|448185091|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
124608492|NCT03893565|448185092|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
124608493|NCT03893565|448185093|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
124608494|NCT03893565|448185094|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
124731771|NCT01632241|448640190|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
124731772|NCT01632241|448640189|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
124731773|NCT01632241|448640190|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
124731774|NCT01632241|448640189|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
124731775|NCT01632241|448640190|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
124731776|NCT05032690|448640200|FG000|Period 1|Adverse Event|0|||
124731777|NCT05032690|448640201|FG001|Period 1|Adverse Event|1|||
124731778|NCT05032690|448640202|FG002|Period 1|Adverse Event|0|||
124731779|NCT05032690|448640203|FG003|Period 1|Adverse Event|0|||
124731780|NCT05032690|448640200|FG000|Period 1|Withdrawal by Subject|1|||
124731781|NCT05032690|448640201|FG001|Period 1|Withdrawal by Subject|0|||
124731782|NCT05032690|448640202|FG002|Period 1|Withdrawal by Subject|0|||
124731783|NCT05032690|448640203|FG003|Period 1|Withdrawal by Subject|0|||
124731784|NCT05032690|448640200|FG000|Period 1|No longer meets eligibility criteria|0|||
124731785|NCT05032690|448640201|FG001|Period 1|No longer meets eligibility criteria|1|||
124731786|NCT05032690|448640202|FG002|Period 1|No longer meets eligibility criteria|0|||
124731787|NCT05032690|448640203|FG003|Period 1|No longer meets eligibility criteria|0|||
124731788|NCT05032690|448640200|FG000|Period 2|Adverse Event|1|||
124731789|NCT05032690|448640201|FG001|Period 2|Adverse Event|0|||
124731790|NCT05032690|448640202|FG002|Period 2|Adverse Event|0|||
124731791|NCT05032690|448640203|FG003|Period 2|Adverse Event|0|||
124731792|NCT05032690|448640200|FG000|Period 2|Withdrawal by Subject|0|||
124731793|NCT05032690|448640201|FG001|Period 2|Withdrawal by Subject|1|||
124731794|NCT05032690|448640202|FG002|Period 2|Withdrawal by Subject|0|||
124731795|NCT05032690|448640203|FG003|Period 2|Withdrawal by Subject|0|||
124731796|NCT05032690|448640200|FG000|Period 2|No longer meets eligibility criteria|0|||
124731797|NCT05032690|448640201|FG001|Period 2|No longer meets eligibility criteria|1|||
124731798|NCT05032690|448640202|FG002|Period 2|No longer meets eligibility criteria|0|||
124731799|NCT05032690|448640203|FG003|Period 2|No longer meets eligibility criteria|0|||
124731800|NCT05032690|448640200|FG000|Period 3|Adverse Event|0|||
124731801|NCT05032690|448640201|FG001|Period 3|Adverse Event|1|||
124731802|NCT05032690|448640202|FG002|Period 3|Adverse Event|0|||
124731803|NCT05032690|448640203|FG003|Period 3|Adverse Event|0|||
124731804|NCT04926831|448640204|FG000|Overall Study|Withdrawal by Subject|2|||
124731805|NCT04926831|448640204|FG000|Overall Study|Adverse Event|2|||
124731806|NCT00737568|448640207|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
124731807|NCT00737568|448640208|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
124731808|NCT00737568|448640207|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
124731809|NCT00737568|448640208|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
124781148|NCT00545272|448829095|FG002|Overall Study|Abnormal laboratory value(s)|0|||
124781149|NCT00545272|448829096|FG003|Overall Study|Abnormal laboratory value(s)|0|||
124781150|NCT00545272|448829097|FG004|Overall Study|Abnormal laboratory value(s)|0|||
124608495|NCT03893565|448185095|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
124608496|NCT03893565|448185096|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
124608497|NCT03893565|448185088|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
124608498|NCT03893565|448185089|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
124608499|NCT03893565|448185090|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
124608500|NCT03893565|448185091|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
124608501|NCT03893565|448185092|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
124608502|NCT03893565|448185093|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
124608503|NCT03893565|448185094|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
124608504|NCT03893565|448185095|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
124608505|NCT03893565|448185096|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
124608506|NCT03893565|448185088|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
124608507|NCT03893565|448185089|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
124608508|NCT03893565|448185090|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
124608509|NCT03893565|448185091|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
124608510|NCT03893565|448185092|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
124608511|NCT03893565|448185093|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
124731810|NCT00737568|448640207|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
124731811|NCT00737568|448640208|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
124731812|NCT00737568|448640207|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
124781151|NCT00545272|448829098|FG005|Overall Study|Abnormal laboratory value(s)|1|||
124608512|NCT03893565|448185094|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
124608513|NCT03893565|448185095|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
124608514|NCT03893565|448185096|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
124608515|NCT03893565|448185088|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
124608516|NCT03893565|448185089|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
124608517|NCT03893565|448185090|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
124608518|NCT03893565|448185091|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
124608519|NCT03893565|448185092|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
124608520|NCT03893565|448185093|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
124608521|NCT03893565|448185094|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
124608522|NCT03893565|448185095|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
124608523|NCT03893565|448185096|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
124608524|NCT03893565|448185088|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
124608525|NCT03893565|448185089|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
124608526|NCT03893565|448185090|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
124608527|NCT03893565|448185091|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
124608528|NCT03893565|448185092|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
124608529|NCT03893565|448185093|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
124608530|NCT03893565|448185094|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
124608531|NCT03893565|448185095|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
124608532|NCT03893565|448185096|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
124608533|NCT03893565|448185088|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
124608534|NCT03893565|448185089|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
124608535|NCT03893565|448185090|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
124608536|NCT03893565|448185091|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
124608537|NCT03893565|448185092|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
124608538|NCT03893565|448185093|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
124608539|NCT03893565|448185094|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
124608540|NCT03893565|448185095|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
124608541|NCT03893565|448185096|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
124608542|NCT03893565|448185088|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
124608543|NCT03893565|448185089|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
124608544|NCT03893565|448185090|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
124608545|NCT03893565|448185091|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
124608546|NCT03893565|448185092|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
124608547|NCT03893565|448185093|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
124608548|NCT03893565|448185094|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
124608549|NCT03893565|448185095|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
124608550|NCT03893565|448185096|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
124608551|NCT03893565|448185088|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
124608552|NCT03893565|448185089|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
124608553|NCT03893565|448185090|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
124608554|NCT03893565|448185091|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
124608555|NCT03893565|448185092|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
124608556|NCT03893565|448185093|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
124608557|NCT03893565|448185094|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
124608558|NCT03893565|448185095|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
124608559|NCT03893565|448185096|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
124608560|NCT03893565|448185088|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
124608561|NCT03893565|448185089|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
124608562|NCT03893565|448185090|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
124608563|NCT03893565|448185091|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
124608564|NCT03893565|448185092|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
124608565|NCT03893565|448185093|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
124608566|NCT03893565|448185094|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
124608567|NCT03893565|448185095|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
124608568|NCT03893565|448185096|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
124608569|NCT03893565|448185088|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
124608570|NCT03893565|448185089|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
124608571|NCT03893565|448185090|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
124608572|NCT03893565|448185091|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
124731813|NCT00737568|448640208|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
124731814|NCT00737568|448640207|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
124731815|NCT00737568|448640208|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
124608573|NCT03893565|448185092|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
124608574|NCT03893565|448185093|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
124608575|NCT03893565|448185094|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
124608576|NCT03893565|448185095|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
124608577|NCT03893565|448185096|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
124608578|NCT03893565|448185088|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
124608579|NCT03893565|448185089|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
124608580|NCT03893565|448185090|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
124608581|NCT03893565|448185091|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
124608582|NCT03893565|448185092|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
124608583|NCT03893565|448185093|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
124608584|NCT03893565|448185094|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
124608585|NCT03893565|448185095|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
124608586|NCT03893565|448185096|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
124608587|NCT03734666|448185100|FG000|Overall Study|Other|7|||
124608588|NCT03734666|448185101|FG001|Overall Study|Other|4|||
124608589|NCT03734666|448185100|FG000|Overall Study|Lost to Follow-up|12|||
124608590|NCT03734666|448185101|FG001|Overall Study|Lost to Follow-up|12|||
124608591|NCT00914459|448185104|FG000|Overall Study|Protocol Violation|0|||
124608592|NCT00914459|448185105|FG001|Overall Study|Protocol Violation|1|||
124608593|NCT00914459|448185104|FG000|Overall Study|Parent/Legal guardian request|1|||
124608594|NCT00914459|448185105|FG001|Overall Study|Parent/Legal guardian request|0|||
124608595|NCT01661179|448185106|FG000|Overall Study|Death|1|||
124608596|NCT01661179|448185106|FG000|Overall Study|Withdrawal by Subject|1|||
124608597|NCT01661179|448185106|FG000|Overall Study|Other Eligibility criteria|4|||
124608598|NCT01946191|448185107|FG000|Allocation|Did not complete orientation|1|||
124608599|NCT01946191|448185108|FG001|Allocation|Did not complete orientation|1|||
124608600|NCT01946191|448185107|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
124608601|NCT01946191|448185108|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
124608602|NCT01946191|448185107|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
124608603|NCT01946191|448185108|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
124608604|NCT01946191|448185107|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
124608605|NCT01946191|448185108|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
124608606|NCT03118570|448185109|FG000|Overall Study|Adverse Event|2|||
124608607|NCT03118570|448185110|FG001|Overall Study|Adverse Event|0|||
124608608|NCT03118570|448185111|FG002|Overall Study|Adverse Event|0|||
124608609|NCT03118570|448185112|FG003|Overall Study|Adverse Event|0|||
124608610|NCT03118570|448185113|FG004|Overall Study|Adverse Event|3|||
124608611|NCT03118570|448185109|FG000|Overall Study|Withdrawal by Subject|0|||
124608612|NCT03118570|448185110|FG001|Overall Study|Withdrawal by Subject|1|||
124608613|NCT03118570|448185111|FG002|Overall Study|Withdrawal by Subject|4|||
124608614|NCT03118570|448185112|FG003|Overall Study|Withdrawal by Subject|0|||
124608615|NCT03118570|448185113|FG004|Overall Study|Withdrawal by Subject|1|||
124608616|NCT03118570|448185109|FG000|Overall Study|Lost to Follow-up|2|||
124608617|NCT03118570|448185110|FG001|Overall Study|Lost to Follow-up|3|||
124608618|NCT03118570|448185111|FG002|Overall Study|Lost to Follow-up|1|||
124608619|NCT03118570|448185112|FG003|Overall Study|Lost to Follow-up|0|||
124608620|NCT03118570|448185113|FG004|Overall Study|Lost to Follow-up|1|||
124608621|NCT03118570|448185109|FG000|Overall Study|Other, Not Specified|1|||
124608622|NCT03118570|448185110|FG001|Overall Study|Other, Not Specified|3|||
124608623|NCT03118570|448185111|FG002|Overall Study|Other, Not Specified|0|||
124608624|NCT03118570|448185112|FG003|Overall Study|Other, Not Specified|0|||
124608625|NCT03118570|448185113|FG004|Overall Study|Other, Not Specified|0|||
124608626|NCT03970837|448185114|FG000|Overall Study|Adverse Event|23|||
124608627|NCT03970837|448185115|FG001|Overall Study|Adverse Event|20|||
124608628|NCT03970837|448185116|FG002|Overall Study|Adverse Event|16|||
124608629|NCT03970837|448185117|FG003|Overall Study|Adverse Event|6|||
124608630|NCT03970837|448185118|FG004|Overall Study|Adverse Event|4|||
124608631|NCT03970837|448185119|FG005|Overall Study|Adverse Event|5|||
124608632|NCT03970837|448185120|FG006|Overall Study|Adverse Event|1|||
124608633|NCT03970837|448185121|FG007|Overall Study|Adverse Event|5|||
124608634|NCT03970837|448185122|FG008|Overall Study|Adverse Event|0|||
124608635|NCT03970837|448185123|FG009|Overall Study|Adverse Event|0|||
124608636|NCT03970837|448185124|FG010|Overall Study|Adverse Event|1|||
124608637|NCT03970837|448185125|FG011|Overall Study|Adverse Event|1|||
124608638|NCT03970837|448185114|FG000|Overall Study|Lack of Efficacy|14|||
124608639|NCT03970837|448185115|FG001|Overall Study|Lack of Efficacy|12|||
124608640|NCT03970837|448185116|FG002|Overall Study|Lack of Efficacy|1|||
124608641|NCT03970837|448185117|FG003|Overall Study|Lack of Efficacy|2|||
124608642|NCT03970837|448185118|FG004|Overall Study|Lack of Efficacy|3|||
124608643|NCT03970837|448185119|FG005|Overall Study|Lack of Efficacy|4|||
124608644|NCT03970837|448185120|FG006|Overall Study|Lack of Efficacy|6|||
124608645|NCT03970837|448185121|FG007|Overall Study|Lack of Efficacy|1|||
124608646|NCT03970837|448185122|FG008|Overall Study|Lack of Efficacy|1|||
124608647|NCT03970837|448185123|FG009|Overall Study|Lack of Efficacy|0|||
124608648|NCT03970837|448185124|FG010|Overall Study|Lack of Efficacy|0|||
124608649|NCT03970837|448185125|FG011|Overall Study|Lack of Efficacy|0|||
124608650|NCT03970837|448185114|FG000|Overall Study|Lost to Follow-up|6|||
124608651|NCT03970837|448185115|FG001|Overall Study|Lost to Follow-up|5|||
124608652|NCT03970837|448185116|FG002|Overall Study|Lost to Follow-up|5|||
124608653|NCT03970837|448185117|FG003|Overall Study|Lost to Follow-up|1|||
124608654|NCT03970837|448185118|FG004|Overall Study|Lost to Follow-up|0|||
124608655|NCT03970837|448185119|FG005|Overall Study|Lost to Follow-up|2|||
124608656|NCT03970837|448185120|FG006|Overall Study|Lost to Follow-up|0|||
124608657|NCT03970837|448185121|FG007|Overall Study|Lost to Follow-up|0|||
124608658|NCT03970837|448185122|FG008|Overall Study|Lost to Follow-up|0|||
124608659|NCT03970837|448185123|FG009|Overall Study|Lost to Follow-up|0|||
124608660|NCT03970837|448185124|FG010|Overall Study|Lost to Follow-up|0|||
124608661|NCT03970837|448185125|FG011|Overall Study|Lost to Follow-up|0|||
124608662|NCT03970837|448185114|FG000|Overall Study|Protocol Violation|1|||
124608663|NCT03970837|448185115|FG001|Overall Study|Protocol Violation|0|||
124608664|NCT03970837|448185116|FG002|Overall Study|Protocol Violation|0|||
124608665|NCT03970837|448185117|FG003|Overall Study|Protocol Violation|0|||
124608666|NCT03970837|448185118|FG004|Overall Study|Protocol Violation|0|||
124608667|NCT03970837|448185119|FG005|Overall Study|Protocol Violation|0|||
124608668|NCT03970837|448185120|FG006|Overall Study|Protocol Violation|0|||
124608669|NCT03970837|448185121|FG007|Overall Study|Protocol Violation|0|||
124608670|NCT03970837|448185122|FG008|Overall Study|Protocol Violation|0|||
124608671|NCT03970837|448185123|FG009|Overall Study|Protocol Violation|0|||
124608672|NCT03970837|448185124|FG010|Overall Study|Protocol Violation|0|||
124608673|NCT03970837|448185125|FG011|Overall Study|Protocol Violation|0|||
124608674|NCT03970837|448185114|FG000|Overall Study|Physician Decision|5|||
124608675|NCT03970837|448185115|FG001|Overall Study|Physician Decision|8|||
124608676|NCT03970837|448185116|FG002|Overall Study|Physician Decision|4|||
124608677|NCT03970837|448185117|FG003|Overall Study|Physician Decision|1|||
124608678|NCT03970837|448185118|FG004|Overall Study|Physician Decision|5|||
124608679|NCT03970837|448185119|FG005|Overall Study|Physician Decision|2|||
124608680|NCT03970837|448185120|FG006|Overall Study|Physician Decision|4|||
124608681|NCT03970837|448185121|FG007|Overall Study|Physician Decision|5|||
124608682|NCT03970837|448185122|FG008|Overall Study|Physician Decision|0|||
124608683|NCT03970837|448185123|FG009|Overall Study|Physician Decision|1|||
124608684|NCT03970837|448185124|FG010|Overall Study|Physician Decision|0|||
124608685|NCT03970837|448185125|FG011|Overall Study|Physician Decision|0|||
124608686|NCT03970837|448185114|FG000|Overall Study|Withdrawal by Subject|32|||
124608687|NCT03970837|448185115|FG001|Overall Study|Withdrawal by Subject|35|||
124608688|NCT03970837|448185116|FG002|Overall Study|Withdrawal by Subject|12|||
124608689|NCT03970837|448185117|FG003|Overall Study|Withdrawal by Subject|8|||
124608690|NCT03970837|448185118|FG004|Overall Study|Withdrawal by Subject|6|||
124608691|NCT03970837|448185119|FG005|Overall Study|Withdrawal by Subject|8|||
124608692|NCT03970837|448185120|FG006|Overall Study|Withdrawal by Subject|2|||
124608693|NCT03970837|448185121|FG007|Overall Study|Withdrawal by Subject|3|||
124608694|NCT03970837|448185122|FG008|Overall Study|Withdrawal by Subject|0|||
124608695|NCT03970837|448185123|FG009|Overall Study|Withdrawal by Subject|0|||
124608696|NCT03970837|448185124|FG010|Overall Study|Withdrawal by Subject|0|||
124608697|NCT03970837|448185125|FG011|Overall Study|Withdrawal by Subject|1|||
124608698|NCT03970837|448185114|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
124608699|NCT03970837|448185115|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
124608700|NCT03970837|448185116|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
124608701|NCT03970837|448185117|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
124608702|NCT03970837|448185118|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
124608703|NCT03970837|448185119|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
124608704|NCT03970837|448185120|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
124608705|NCT03970837|448185121|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
124608706|NCT03970837|448185122|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
124608707|NCT03970837|448185123|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
124608708|NCT03970837|448185124|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
124608709|NCT03970837|448185125|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
124608710|NCT03970837|448185114|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
124608711|NCT03970837|448185115|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
124608712|NCT03970837|448185116|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
124608713|NCT03970837|448185117|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
124608714|NCT03970837|448185118|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
124608715|NCT03970837|448185119|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
124608716|NCT03970837|448185120|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
124608717|NCT03970837|448185121|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
124608718|NCT03970837|448185122|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
124608719|NCT03970837|448185123|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
124608720|NCT03970837|448185124|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
124608721|NCT03970837|448185125|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
124731816|NCT00737568|448640207|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
124731817|NCT00737568|448640208|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
124608722|NCT01425723|448185128|FG000|Overall Study|Lack of Efficacy|0|||
124608723|NCT01425723|448185129|FG001|Overall Study|Lack of Efficacy|1|||
124608724|NCT01425723|448185128|FG000|Overall Study|Withdrawal by Subject|1|||
124608725|NCT01425723|448185129|FG001|Overall Study|Withdrawal by Subject|4|||
124608726|NCT01425723|448185128|FG000|Overall Study|Lost to Follow-up|0|||
124608727|NCT01425723|448185129|FG001|Overall Study|Lost to Follow-up|3|||
124608728|NCT01425723|448185128|FG000|Overall Study|Physician Decision|2|||
124608729|NCT01425723|448185129|FG001|Overall Study|Physician Decision|0|||
124608730|NCT01425723|448185128|FG000|Overall Study|Other|1|||
124608731|NCT01425723|448185129|FG001|Overall Study|Other|10|||
124608732|NCT00186043|448185130|FG000|Overall Study|Lack of Efficacy|1|||
124608733|NCT00186043|448185131|FG001|Overall Study|Lack of Efficacy|3|||
124608734|NCT00186043|448185130|FG000|Overall Study|Lost to Follow-up|4|||
124608735|NCT00186043|448185131|FG001|Overall Study|Lost to Follow-up|6|||
124608736|NCT00186043|448185130|FG000|Overall Study|Withdrawal by Subject|1|||
124608737|NCT00186043|448185131|FG001|Overall Study|Withdrawal by Subject|0|||
124608738|NCT00186043|448185130|FG000|Overall Study|Adverse Event|7|||
124608739|NCT00186043|448185131|FG001|Overall Study|Adverse Event|3|||
124608740|NCT00186043|448185130|FG000|Overall Study|Protocol Violation|2|||
124608741|NCT00186043|448185131|FG001|Overall Study|Protocol Violation|1|||
124608742|NCT04874636|448185132|FG000|Overall Study|Adverse Event|17|||
124608743|NCT04874636|448185133|FG001|Overall Study|Adverse Event|7|||
124608744|NCT04874636|448185132|FG000|Overall Study|Lost to Follow-up|1|||
124608745|NCT04874636|448185133|FG001|Overall Study|Lost to Follow-up|0|||
124608746|NCT04874636|448185132|FG000|Overall Study|Non-Compliance with Study Drug|2|||
124608747|NCT04874636|448185133|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124608748|NCT04874636|448185132|FG000|Overall Study|Physician Decision|1|||
124608749|NCT04874636|448185133|FG001|Overall Study|Physician Decision|0|||
124608750|NCT04874636|448185132|FG000|Overall Study|Withdrawal by Subject|6|||
124608751|NCT04874636|448185133|FG001|Overall Study|Withdrawal by Subject|5|||
124608752|NCT00228423|448185136|FG000|Overall Study|Adverse Event|2|||
124608753|NCT00228423|448185137|FG001|Overall Study|Adverse Event|5|||
124608754|NCT00228423|448185136|FG000|Overall Study|Withdrawal by Subject|7|||
124608755|NCT00228423|448185137|FG001|Overall Study|Withdrawal by Subject|3|||
124608756|NCT00228423|448185136|FG000|Overall Study|Protocol Violation|1|||
124608757|NCT00228423|448185137|FG001|Overall Study|Protocol Violation|3|||
124608758|NCT00228423|448185136|FG000|Overall Study|Physician Decision|0|||
124608759|NCT00228423|448185137|FG001|Overall Study|Physician Decision|1|||
124608760|NCT01104779|448185144|FG000|Overall Study|Protocol Violation|1|||
124608761|NCT01104779|448185145|FG001|Overall Study|Protocol Violation|2|||
124608762|NCT01104779|448185146|FG002|Overall Study|Protocol Violation|2|||
124608763|NCT01104779|448185144|FG000|Overall Study|Lack of Efficacy|26|||
124608764|NCT01104779|448185145|FG001|Overall Study|Lack of Efficacy|12|||
124608765|NCT01104779|448185146|FG002|Overall Study|Lack of Efficacy|13|||
124608766|NCT01104779|448185144|FG000|Overall Study|Adverse Event|13|||
124608767|NCT01104779|448185145|FG001|Overall Study|Adverse Event|14|||
124608768|NCT01104779|448185146|FG002|Overall Study|Adverse Event|13|||
124608769|NCT01104779|448185144|FG000|Overall Study|Did not meet inc/exc criteria|1|||
124608770|NCT01104779|448185145|FG001|Overall Study|Did not meet inc/exc criteria|1|||
124608771|NCT01104779|448185146|FG002|Overall Study|Did not meet inc/exc criteria|1|||
124608772|NCT01104779|448185144|FG000|Overall Study|Other reasons|0|||
124608773|NCT01104779|448185145|FG001|Overall Study|Other reasons|1|||
124608774|NCT01104779|448185146|FG002|Overall Study|Other reasons|0|||
124608775|NCT01104779|448185144|FG000|Overall Study|Lost to Follow-up|2|||
124608776|NCT01104779|448185145|FG001|Overall Study|Lost to Follow-up|0|||
124608777|NCT01104779|448185146|FG002|Overall Study|Lost to Follow-up|1|||
124731818|NCT00737568|448640207|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
124731819|NCT00737568|448640208|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
124731820|NCT00737568|448640207|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
124608778|NCT01104779|448185144|FG000|Overall Study|Withdrawal by Subject|16|||
124608779|NCT01104779|448185145|FG001|Overall Study|Withdrawal by Subject|25|||
124608780|NCT01104779|448185146|FG002|Overall Study|Withdrawal by Subject|32|||
124608781|NCT03845296|448187152|FG000|Overall Study|On Treatment|2|||
124731821|NCT00737568|448640208|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
124731822|NCT00737568|448640207|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
124731823|NCT00737568|448640208|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
124608782|NCT03845296|448187153|FG001|Overall Study|On Treatment|1|||
124608783|NCT03845296|448187152|FG000|Overall Study|Adverse Event|4|||
124608784|NCT03845296|448187153|FG001|Overall Study|Adverse Event|11|||
124608785|NCT03845296|448187152|FG000|Overall Study|Refusal unrelated to adverse event|0|||
124731824|NCT00855933|448640209|FG000|Overall Study|Withdrawal by Subject|0|||
124731825|NCT00855933|448640210|FG001|Overall Study|Withdrawal by Subject|1|||
124608786|NCT03845296|448187153|FG001|Overall Study|Refusal unrelated to adverse event|1|||
124608787|NCT03845296|448187152|FG000|Overall Study|Progression/relapse|14|||
124608788|NCT03845296|448187153|FG001|Overall Study|Progression/relapse|18|||
124608789|NCT03845296|448187152|FG000|Overall Study|Death|4|||
124608790|NCT03845296|448187153|FG001|Overall Study|Death|0|||
124731826|NCT01960998|448640211|FG000|Overall Study|Lost to Follow-up|3|||
124731827|NCT01960998|448640212|FG001|Overall Study|Lost to Follow-up|7|||
124731828|NCT01960998|448640211|FG000|Overall Study|Death|0|||
124731829|NCT01960998|448640212|FG001|Overall Study|Death|1|||
124731830|NCT01960998|448640211|FG000|Overall Study|Withdrawal by Subject|8|||
124731831|NCT01960998|448640212|FG001|Overall Study|Withdrawal by Subject|2|||
124731832|NCT01960998|448640211|FG000|Overall Study|lost computer access|0|||
124731833|NCT01960998|448640212|FG001|Overall Study|lost computer access|1|||
124731834|NCT01713283|448640213|FG000|Overall Study|Lack of Efficacy|10|||
124731835|NCT01713283|448640214|FG001|Overall Study|Lack of Efficacy|2|||
124731836|NCT01713283|448640213|FG000|Overall Study|Lost to Follow-up|1|||
124731837|NCT01713283|448640214|FG001|Overall Study|Lost to Follow-up|1|||
124731838|NCT02403635|448640215|FG000|Overall Study|Not eligible|9|||
124731839|NCT01904149|448640218|FG000|Overall Study|Adverse Event|3|||
124731840|NCT01904149|448640219|FG001|Overall Study|Adverse Event|4|||
124731841|NCT01904149|448640220|FG002|Overall Study|Adverse Event|0|||
124731842|NCT01904149|448640221|FG003|Overall Study|Adverse Event|1|||
124731843|NCT01904149|448640222|FG004|Overall Study|Adverse Event|1|||
124731844|NCT01904149|448640223|FG005|Overall Study|Adverse Event|2|||
124731845|NCT01904149|448640218|FG000|Overall Study|Lack of Efficacy|0|||
124731846|NCT01904149|448640219|FG001|Overall Study|Lack of Efficacy|3|||
124731847|NCT01904149|448640220|FG002|Overall Study|Lack of Efficacy|1|||
124731848|NCT01904149|448640221|FG003|Overall Study|Lack of Efficacy|3|||
124731849|NCT01904149|448640222|FG004|Overall Study|Lack of Efficacy|3|||
124731850|NCT01904149|448640223|FG005|Overall Study|Lack of Efficacy|1|||
124731851|NCT01904149|448640218|FG000|Overall Study|Withdrawal by Subject|1|||
124731852|NCT01904149|448640219|FG001|Overall Study|Withdrawal by Subject|3|||
124731853|NCT01904149|448640220|FG002|Overall Study|Withdrawal by Subject|1|||
124731854|NCT01904149|448640221|FG003|Overall Study|Withdrawal by Subject|0|||
124731855|NCT01904149|448640222|FG004|Overall Study|Withdrawal by Subject|1|||
124731856|NCT01904149|448640223|FG005|Overall Study|Withdrawal by Subject|0|||
124731857|NCT01904149|448640218|FG000|Overall Study|Protocol Violation|0|||
124731858|NCT01904149|448640219|FG001|Overall Study|Protocol Violation|1|||
124731859|NCT01904149|448640220|FG002|Overall Study|Protocol Violation|0|||
124731860|NCT01904149|448640221|FG003|Overall Study|Protocol Violation|0|||
124731861|NCT01904149|448640222|FG004|Overall Study|Protocol Violation|0|||
124731862|NCT01904149|448640223|FG005|Overall Study|Protocol Violation|0|||
124731863|NCT01904149|448640218|FG000|Overall Study|non compliance with study drug|1|||
124731864|NCT01904149|448640219|FG001|Overall Study|non compliance with study drug|0|||
124731865|NCT01904149|448640220|FG002|Overall Study|non compliance with study drug|0|||
124731866|NCT01904149|448640221|FG003|Overall Study|non compliance with study drug|0|||
124731867|NCT01904149|448640222|FG004|Overall Study|non compliance with study drug|0|||
124731868|NCT01904149|448640223|FG005|Overall Study|non compliance with study drug|0|||
124731869|NCT00835640|448640224|FG000|Second Intervention|Protocol Violation|1|||
124731870|NCT00835640|448640225|FG001|Second Intervention|Protocol Violation|0|||
124731871|NCT00812006|448640226|FG000|Overall Study|Lost to Follow-up|0|||
124731872|NCT00812006|448640227|FG001|Overall Study|Lost to Follow-up|0|||
124731873|NCT00812006|448640228|FG002|Overall Study|Lost to Follow-up|2|||
124731874|NCT00812006|448640226|FG000|Overall Study|Physician Decision|0|||
124781152|NCT00545272|448829093|FG000|Overall Study|Abnormal test procedure result(s)|0|||
124608791|NCT03845296|448187152|FG000|Overall Study|Other - not protocol specified|1|||
124608792|NCT03845296|448187153|FG001|Overall Study|Other - not protocol specified|3|||
124608793|NCT01200992|448187157|FG000|Overall Study|Study terminated early|35|||
124608794|NCT01200992|448187158|FG001|Overall Study|Study terminated early|41|||
124608795|NCT01200992|448187157|FG000|Overall Study|Randomized but not treated|2|||
124608796|NCT01200992|448187158|FG001|Overall Study|Randomized but not treated|0|||
124608797|NCT02213510|448187167|FG000|Overall Study|Death|0|||
124608798|NCT02213510|448187168|FG001|Overall Study|Death|1|||
124608799|NCT02213510|448187167|FG000|Overall Study|Lost to Follow-up|1|||
124608800|NCT02213510|448187168|FG001|Overall Study|Lost to Follow-up|0|||
124608801|NCT04241315|448187177|FG000|Overall Study|Withdrawal by Subject|0|||
124608802|NCT04241315|448187178|FG001|Overall Study|Withdrawal by Subject|1|||
124608803|NCT00394524|448187179|FG000|Overall Study|Protocol Violation|2|||
124608804|NCT00394524|448187180|FG001|Overall Study|Protocol Violation|3|||
124731875|NCT00812006|448640227|FG001|Overall Study|Physician Decision|0|||
124731876|NCT00812006|448640228|FG002|Overall Study|Physician Decision|1|||
124731877|NCT00812006|448640226|FG000|Overall Study|Withdrawal by Subject|2|||
124731878|NCT00812006|448640227|FG001|Overall Study|Withdrawal by Subject|1|||
124731879|NCT00812006|448640228|FG002|Overall Study|Withdrawal by Subject|1|||
124731880|NCT00812006|448640226|FG000|Overall Study|Lack of Qualifying Event|4|||
124731881|NCT00812006|448640227|FG001|Overall Study|Lack of Qualifying Event|2|||
124731882|NCT00812006|448640228|FG002|Overall Study|Lack of Qualifying Event|2|||
124731883|NCT00068250|448640229|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
124731884|NCT00068250|448640230|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
124731885|NCT00068250|448640231|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
124781153|NCT00545272|448829094|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124608805|NCT00394524|448187179|FG000|Overall Study|Death|1|||
124731886|NCT00068250|448640232|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
124608806|NCT00394524|448187180|FG001|Overall Study|Death|0|||
124608807|NCT00394524|448187179|FG000|Overall Study|Withdrawal by Subject|0|||
124608808|NCT00394524|448187180|FG001|Overall Study|Withdrawal by Subject|1|||
124608809|NCT01398514|448187181|FG000|Overall Study|Adverse Event|1|||
124608810|NCT01398514|448187182|FG001|Overall Study|Adverse Event|0|||
124608811|NCT01398514|448187181|FG000|Overall Study|Non-compliance with study procedures|2|||
124608812|NCT01398514|448187182|FG001|Overall Study|Non-compliance with study procedures|0|||
124608813|NCT01398514|448187181|FG000|Overall Study|Physiologic non-responsiveness|1|||
124608814|NCT01398514|448187182|FG001|Overall Study|Physiologic non-responsiveness|3|||
124608815|NCT01398514|448187181|FG000|Overall Study|Failure to show a conditioned response|4|||
124608816|NCT01398514|448187182|FG001|Overall Study|Failure to show a conditioned response|3|||
124608817|NCT01007942|448187183|FG000|Overall Study|Adverse Event|29|||
124608818|NCT01007942|448187184|FG001|Overall Study|Adverse Event|14|||
124608819|NCT01007942|448187183|FG000|Overall Study|Abnormal test procedure|0|||
124608820|NCT01007942|448187184|FG001|Overall Study|Abnormal test procedure|1|||
124608821|NCT01007942|448187183|FG000|Overall Study|Disease progression|217|||
124608822|NCT01007942|448187184|FG001|Overall Study|Disease progression|242|||
124608823|NCT01007942|448187183|FG000|Overall Study|New cancer therapy|5|||
124608824|NCT01007942|448187184|FG001|Overall Study|New cancer therapy|1|||
124608825|NCT01007942|448187183|FG000|Overall Study|Protocol Violation|1|||
124608826|NCT01007942|448187184|FG001|Overall Study|Protocol Violation|1|||
124608827|NCT01007942|448187183|FG000|Overall Study|Withdrawal by Subject|19|||
124608828|NCT01007942|448187184|FG001|Overall Study|Withdrawal by Subject|14|||
124608829|NCT01007942|448187183|FG000|Overall Study|Lost to Follow-up|1|||
124608830|NCT01007942|448187184|FG001|Overall Study|Lost to Follow-up|0|||
124608831|NCT01007942|448187183|FG000|Overall Study|Administrative problems|2|||
124608832|NCT01007942|448187184|FG001|Overall Study|Administrative problems|0|||
124608833|NCT01007942|448187183|FG000|Overall Study|Death|3|||
124608834|NCT01007942|448187184|FG001|Overall Study|Death|2|||
124608835|NCT01007942|448187183|FG000|Overall Study|Patients untreated|4|||
124608836|NCT01007942|448187184|FG001|Overall Study|Patients untreated|3|||
124608837|NCT05083585|448187189|FG000|Overall Study|Death|1|||
124608838|NCT05083585|448187190|FG001|Overall Study|Death|1|||
124608839|NCT05083585|448187189|FG000|Overall Study|Lost to Follow-up|1|||
124608840|NCT05083585|448187190|FG001|Overall Study|Lost to Follow-up|1|||
124608841|NCT05083585|448187189|FG000|Overall Study|Withdrawal by Subject|2|||
124608842|NCT05083585|448187190|FG001|Overall Study|Withdrawal by Subject|0|||
124608843|NCT05083585|448187189|FG000|Overall Study|Randomized but not vaccinated|2|||
124608844|NCT05083585|448187190|FG001|Overall Study|Randomized but not vaccinated|0|||
124608845|NCT00114166|448187192|FG000|Overall Study|Wrong primary|0|||
124608846|NCT00114166|448187193|FG001|Overall Study|Wrong primary|1|||
124608847|NCT00806286|448187199|FG000|Overall Study|Adverse Event|5|||
124608848|NCT00806286|448187200|FG001|Overall Study|Adverse Event|2|||
124608849|NCT00806286|448187201|FG002|Overall Study|Adverse Event|0|||
124608850|NCT00806286|448187199|FG000|Overall Study|Disease progression|31|||
124608851|NCT00806286|448187200|FG001|Overall Study|Disease progression|38|||
124608852|NCT00806286|448187201|FG002|Overall Study|Disease progression|1|||
124608853|NCT00806286|448187199|FG000|Overall Study|Death|1|||
124608854|NCT00806286|448187200|FG001|Overall Study|Death|6|||
124608855|NCT00806286|448187201|FG002|Overall Study|Death|0|||
124608856|NCT00806286|448187199|FG000|Overall Study|Lost to Follow-up|0|||
124608857|NCT00806286|448187200|FG001|Overall Study|Lost to Follow-up|1|||
124608858|NCT00806286|448187201|FG002|Overall Study|Lost to Follow-up|0|||
124608859|NCT00806286|448187199|FG000|Overall Study|Withdrawal by Subject|8|||
124608860|NCT00806286|448187200|FG001|Overall Study|Withdrawal by Subject|3|||
124608861|NCT00806286|448187201|FG002|Overall Study|Withdrawal by Subject|1|||
124608862|NCT00806286|448187199|FG000|Overall Study|Physician Decision|2|||
124608863|NCT00806286|448187200|FG001|Overall Study|Physician Decision|2|||
124608864|NCT00806286|448187201|FG002|Overall Study|Physician Decision|0|||
124608865|NCT00806286|448187199|FG000|Overall Study|Due to a variety of reasons|7|||
124608866|NCT00806286|448187200|FG001|Overall Study|Due to a variety of reasons|2|||
124608867|NCT00806286|448187201|FG002|Overall Study|Due to a variety of reasons|1|||
124608868|NCT03402750|448187202|FG000|Overall Study|Lost to Follow-up|2|||
124608869|NCT03402750|448187203|FG001|Overall Study|Lost to Follow-up|1|||
124608870|NCT03469336|448187204|FG000|Overall Study|Adverse Event|1|||
124608871|NCT02628743|448187205|FG000|Overall Study|Other|3|||
124608872|NCT02628743|448187205|FG000|Overall Study|Withdrawal by Subject|50|||
124608873|NCT02628743|448187205|FG000|Overall Study|Study Terminated by Sponsor|76|||
124608874|NCT02628743|448187205|FG000|Overall Study|Physician Decision|2|||
124608875|NCT02534844|448187206|FG000|Part B|Withdrawal by Subject|0|||
124608876|NCT02534844|448187207|FG001|Part B|Withdrawal by Subject|0|||
124608877|NCT02534844|448187208|FG002|Part B|Withdrawal by Subject|0|||
124608878|NCT02534844|448187209|FG003|Part B|Withdrawal by Subject|0|||
124608879|NCT02534844|448187210|FG004|Part B|Withdrawal by Subject|2|||
124608880|NCT02534844|448187211|FG005|Part B|Withdrawal by Subject|1|||
124608881|NCT00593736|448187223|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
124608882|NCT00593736|448187224|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
124608883|NCT00593736|448187225|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
124731887|NCT00235391|448640233|FG000|Overall Study|Adverse Event|4|||
124731888|NCT00235391|448640234|FG001|Overall Study|Adverse Event|5|||
124731889|NCT00235391|448640235|FG002|Overall Study|Adverse Event|10|||
124731890|NCT00235391|448640236|FG003|Overall Study|Adverse Event|72|||
124731891|NCT00235391|448640237|FG004|Overall Study|Adverse Event|5|||
124731892|NCT00235391|448640238|FG005|Overall Study|Adverse Event|2|||
124731893|NCT00235391|448640233|FG000|Overall Study|Abnormal laboratory value(s)|3|||
124781154|NCT00545272|448829095|FG002|Overall Study|Abnormal test procedure result(s)|0|||
124781155|NCT00545272|448829096|FG003|Overall Study|Abnormal test procedure result(s)|0|||
124781156|NCT00545272|448829097|FG004|Overall Study|Abnormal test procedure result(s)|1|||
124781157|NCT00545272|448829098|FG005|Overall Study|Abnormal test procedure result(s)|0|||
124781158|NCT00545272|448829093|FG000|Overall Study|Lost to Follow-up|0|||
124781159|NCT00545272|448829094|FG001|Overall Study|Lost to Follow-up|0|||
124781160|NCT00545272|448829095|FG002|Overall Study|Lost to Follow-up|0|||
124781161|NCT00545272|448829096|FG003|Overall Study|Lost to Follow-up|0|||
124781162|NCT00545272|448829097|FG004|Overall Study|Lost to Follow-up|1|||
124781163|NCT00545272|448829098|FG005|Overall Study|Lost to Follow-up|0|||
124781164|NCT01837823|448829099|FG000|Overall Study|Lost to Follow-up|6|||
124781165|NCT00436345|448829104|FG000|Overall Study|ICU resident beyond follow-up period|3|||
124781166|NCT00436345|448829105|FG001|Overall Study|ICU resident beyond follow-up period|0|||
124608884|NCT00593736|448187226|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
124608885|NCT00593736|448187223|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
124608886|NCT00593736|448187224|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
124608887|NCT00593736|448187225|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
124608888|NCT00593736|448187226|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
124608889|NCT00593736|448187223|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
124608890|NCT00593736|448187224|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
124608891|NCT00593736|448187225|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
124608892|NCT00593736|448187226|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
124608893|NCT00593736|448187223|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
124608894|NCT00593736|448187224|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
124608895|NCT00593736|448187225|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
124608896|NCT00593736|448187226|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
124608897|NCT00593736|448187223|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
124608898|NCT00593736|448187224|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
124608899|NCT00593736|448187225|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
124608900|NCT00593736|448187226|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
124608901|NCT00593736|448187223|FG000|Screening Period and Placebo Run-in|Various|0|||
124608902|NCT00593736|448187224|FG001|Screening Period and Placebo Run-in|Various|0|||
124608903|NCT00593736|448187225|FG002|Screening Period and Placebo Run-in|Various|0|||
124608904|NCT00593736|448187226|FG003|Screening Period and Placebo Run-in|Various|25|||
124608905|NCT00593736|448187223|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
124608906|NCT00593736|448187224|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
124608907|NCT00593736|448187225|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
124608908|NCT00593736|448187226|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
124608909|NCT00593736|448187223|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
124608910|NCT00593736|448187224|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
124608911|NCT00593736|448187225|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
124608912|NCT00593736|448187226|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
124608913|NCT00593736|448187223|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
124608914|NCT00593736|448187224|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
124608915|NCT00593736|448187225|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
124608916|NCT00593736|448187226|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
124608917|NCT00593736|448187223|FG000|Treatment Period and Placebo Run-out|Various|1|||
124608918|NCT00593736|448187224|FG001|Treatment Period and Placebo Run-out|Various|1|||
124608919|NCT00593736|448187225|FG002|Treatment Period and Placebo Run-out|Various|1|||
124608920|NCT00593736|448187226|FG003|Treatment Period and Placebo Run-out|Various|0|||
124608921|NCT04645966|448187227|FG000|Vaccination Phase|Adverse Event|1|||
124608922|NCT04645966|448187228|FG001|Vaccination Phase|Adverse Event|0|||
124781167|NCT01175083|448829106|FG000|Primary Epoch|Withdrawal by Subject|0|||
124781168|NCT01175083|448829107|FG001|Primary Epoch|Withdrawal by Subject|0|||
124608923|NCT04645966|448187229|FG002|Vaccination Phase|Adverse Event|0|||
124781169|NCT01175083|448829108|FG002|Primary Epoch|Withdrawal by Subject|0|||
124731894|NCT00235391|448640234|FG001|Overall Study|Abnormal laboratory value(s)|5|||
124731895|NCT00235391|448640235|FG002|Overall Study|Abnormal laboratory value(s)|4|||
124731896|NCT00235391|448640236|FG003|Overall Study|Abnormal laboratory value(s)|27|||
124731897|NCT00235391|448640237|FG004|Overall Study|Abnormal laboratory value(s)|1|||
124781170|NCT01175083|448829109|FG003|Primary Epoch|Withdrawal by Subject|0|||
124781171|NCT01175083|448829110|FG004|Primary Epoch|Withdrawal by Subject|0|||
124781172|NCT01175083|448829111|FG005|Primary Epoch|Withdrawal by Subject|2|||
124608924|NCT04645966|448187230|FG003|Vaccination Phase|Adverse Event|0|||
124608925|NCT04645966|448187231|FG004|Vaccination Phase|Adverse Event|0|||
124608926|NCT04645966|448187232|FG005|Vaccination Phase|Adverse Event|0|||
124608927|NCT04645966|448187233|FG006|Vaccination Phase|Adverse Event|1|||
124608928|NCT04645966|448187234|FG007|Vaccination Phase|Adverse Event|0|||
124608929|NCT04645966|448187235|FG008|Vaccination Phase|Adverse Event|0|||
124608930|NCT04645966|448187227|FG000|Vaccination Phase|Death|0|||
124608931|NCT04645966|448187228|FG001|Vaccination Phase|Death|0|||
124608932|NCT04645966|448187229|FG002|Vaccination Phase|Death|0|||
124608933|NCT04645966|448187230|FG003|Vaccination Phase|Death|0|||
124608934|NCT04645966|448187231|FG004|Vaccination Phase|Death|0|||
124608935|NCT04645966|448187232|FG005|Vaccination Phase|Death|1|||
124608936|NCT04645966|448187233|FG006|Vaccination Phase|Death|0|||
124608937|NCT04645966|448187234|FG007|Vaccination Phase|Death|0|||
124608938|NCT04645966|448187235|FG008|Vaccination Phase|Death|0|||
124608939|NCT04645966|448187227|FG000|Vaccination Phase|Protocol Violation|0|||
124608940|NCT04645966|448187228|FG001|Vaccination Phase|Protocol Violation|0|||
124608941|NCT04645966|448187229|FG002|Vaccination Phase|Protocol Violation|0|||
124608942|NCT04645966|448187230|FG003|Vaccination Phase|Protocol Violation|0|||
124608943|NCT04645966|448187231|FG004|Vaccination Phase|Protocol Violation|1|||
124608944|NCT04645966|448187232|FG005|Vaccination Phase|Protocol Violation|0|||
124608945|NCT04645966|448187233|FG006|Vaccination Phase|Protocol Violation|0|||
124608946|NCT04645966|448187234|FG007|Vaccination Phase|Protocol Violation|0|||
124608947|NCT04645966|448187235|FG008|Vaccination Phase|Protocol Violation|0|||
124608948|NCT04645966|448187227|FG000|Vaccination Phase|Study terminated by sponsor|0|||
124608949|NCT04645966|448187228|FG001|Vaccination Phase|Study terminated by sponsor|0|||
124608950|NCT04645966|448187229|FG002|Vaccination Phase|Study terminated by sponsor|14|||
124608951|NCT04645966|448187230|FG003|Vaccination Phase|Study terminated by sponsor|15|||
124608952|NCT04645966|448187231|FG004|Vaccination Phase|Study terminated by sponsor|47|||
124608953|NCT04645966|448187232|FG005|Vaccination Phase|Study terminated by sponsor|43|||
124608954|NCT04645966|448187233|FG006|Vaccination Phase|Study terminated by sponsor|29|||
124608955|NCT04645966|448187234|FG007|Vaccination Phase|Study terminated by sponsor|29|||
124608956|NCT04645966|448187235|FG008|Vaccination Phase|Study terminated by sponsor|12|||
124608957|NCT04645966|448187227|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
124608958|NCT04645966|448187228|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
124608959|NCT04645966|448187229|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
124608960|NCT04645966|448187230|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
124608961|NCT04645966|448187231|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
124608962|NCT04645966|448187232|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
124608963|NCT04645966|448187233|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
124608964|NCT04645966|448187234|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
124608965|NCT04645966|448187235|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
124608966|NCT04645966|448187227|FG000|Vaccination Phase|Other|0|||
124608967|NCT04645966|448187228|FG001|Vaccination Phase|Other|0|||
124608968|NCT04645966|448187229|FG002|Vaccination Phase|Other|0|||
124608969|NCT04645966|448187230|FG003|Vaccination Phase|Other|0|||
124608970|NCT04645966|448187231|FG004|Vaccination Phase|Other|0|||
124608971|NCT04645966|448187232|FG005|Vaccination Phase|Other|2|||
124608972|NCT04645966|448187233|FG006|Vaccination Phase|Other|0|||
124608973|NCT04645966|448187234|FG007|Vaccination Phase|Other|0|||
124608974|NCT04645966|448187235|FG008|Vaccination Phase|Other|0|||
124608975|NCT04645966|448187227|FG000|Vaccination Phase|Lost to Follow-up|0|||
124608976|NCT04645966|448187228|FG001|Vaccination Phase|Lost to Follow-up|0|||
124608977|NCT04645966|448187229|FG002|Vaccination Phase|Lost to Follow-up|0|||
124608978|NCT04645966|448187230|FG003|Vaccination Phase|Lost to Follow-up|0|||
124608979|NCT04645966|448187231|FG004|Vaccination Phase|Lost to Follow-up|0|||
124608980|NCT04645966|448187232|FG005|Vaccination Phase|Lost to Follow-up|0|||
124608981|NCT04645966|448187233|FG006|Vaccination Phase|Lost to Follow-up|0|||
124608982|NCT04645966|448187234|FG007|Vaccination Phase|Lost to Follow-up|1|||
124608983|NCT04645966|448187235|FG008|Vaccination Phase|Lost to Follow-up|0|||
124608984|NCT04645966|448187227|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
124608985|NCT04645966|448187228|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
124608986|NCT04645966|448187229|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
124731898|NCT00235391|448640238|FG005|Overall Study|Abnormal laboratory value(s)|2|||
124731899|NCT00235391|448640233|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124731900|NCT00235391|448640234|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124781173|NCT01175083|448829106|FG000|Primary Epoch|Lost to Follow-up|0|||
124608987|NCT04645966|448187230|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
124608988|NCT04645966|448187231|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
124608989|NCT04645966|448187232|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
124608990|NCT04645966|448187233|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
124608991|NCT04645966|448187234|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
124608992|NCT04645966|448187235|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
124608993|NCT04645966|448187227|FG000|Follow-up Phase|Lost to Follow-up|0|||
124608994|NCT04645966|448187228|FG001|Follow-up Phase|Lost to Follow-up|0|||
124608995|NCT04645966|448187229|FG002|Follow-up Phase|Lost to Follow-up|0|||
124608996|NCT04645966|448187230|FG003|Follow-up Phase|Lost to Follow-up|0|||
124608997|NCT04645966|448187231|FG004|Follow-up Phase|Lost to Follow-up|0|||
124608998|NCT04645966|448187232|FG005|Follow-up Phase|Lost to Follow-up|0|||
124608999|NCT04645966|448187233|FG006|Follow-up Phase|Lost to Follow-up|0|||
124609000|NCT04645966|448187234|FG007|Follow-up Phase|Lost to Follow-up|1|||
124609001|NCT04645966|448187235|FG008|Follow-up Phase|Lost to Follow-up|0|||
124609002|NCT03825341|448187236|FG000|Overall Study|Withdrawal by Subject|0|||
124609003|NCT03825341|448187237|FG001|Overall Study|Withdrawal by Subject|1|||
124609004|NCT00289536|448187239|FG000|Period 3|Lost to Follow-up|0|||
124609005|NCT00289536|448187240|FG001|Period 3|Lost to Follow-up|0|||
124609006|NCT00289536|448187241|FG002|Period 3|Lost to Follow-up|1|||
124609007|NCT02116608|448187246|FG000|Overall Study|Lost to Follow-up|0|||
124609008|NCT02116608|448187247|FG001|Overall Study|Lost to Follow-up|0|||
124609009|NCT02116608|448187248|FG002|Overall Study|Lost to Follow-up|1|||
124609010|NCT02116608|448187246|FG000|Overall Study|Physician Decision|0|||
124609011|NCT02116608|448187247|FG001|Overall Study|Physician Decision|1|||
124609012|NCT02116608|448187248|FG002|Overall Study|Physician Decision|0|||
124609013|NCT02116608|448187246|FG000|Overall Study|Death|0|||
124609014|NCT02116608|448187247|FG001|Overall Study|Death|1|||
124609015|NCT02116608|448187248|FG002|Overall Study|Death|0|||
124609016|NCT04283500|448187249|FG000|Overall Study|Lost to Follow-up|8|||
124609017|NCT04283500|448187249|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
124609018|NCT02006693|448187253|FG000|Overall Study|No Reason Specified|6|||
124609019|NCT02006693|448187254|FG001|Overall Study|No Reason Specified|8|||
124609020|NCT02006693|448187253|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
124609021|NCT02006693|448187254|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
124609022|NCT02006693|448187253|FG000|Overall Study|XEN Implant Explantation|0|||
124609023|NCT02006693|448187254|FG001|Overall Study|XEN Implant Explantation|1|||
124609024|NCT02006693|448187253|FG000|Overall Study|Death|2|||
124609025|NCT02006693|448187254|FG001|Overall Study|Death|2|||
124609026|NCT02006693|448187253|FG000|Overall Study|Lost to Follow-up|4|||
124609027|NCT02006693|448187254|FG001|Overall Study|Lost to Follow-up|1|||
124609028|NCT02006693|448187253|FG000|Overall Study|Patient Decision|4|||
124609029|NCT02006693|448187254|FG001|Overall Study|Patient Decision|0|||
124609030|NCT01119508|448187257|FG000|Overall Study|Adverse Event|56|||
124609031|NCT01119508|448187257|FG000|Overall Study|Withdrawal by Subject|2|||
124609032|NCT01119508|448187257|FG000|Overall Study|Died before tumor response evaluation|1|||
124609033|NCT00265395|448187258|FG000|Overall Study|Adverse Event|3|||
124609034|NCT00265395|448187259|FG001|Overall Study|Adverse Event|6|||
124609035|NCT00265395|448187258|FG000|Overall Study|Lost to Follow-up|2|||
124609036|NCT00265395|448187259|FG001|Overall Study|Lost to Follow-up|1|||
124609037|NCT00265395|448187258|FG000|Overall Study|Withdrawal by Subject|1|||
124609038|NCT00265395|448187259|FG001|Overall Study|Withdrawal by Subject|6|||
124609039|NCT00265395|448187258|FG000|Overall Study|Protocol Violation|2|||
124609040|NCT00265395|448187259|FG001|Overall Study|Protocol Violation|2|||
124609041|NCT00265395|448187258|FG000|Overall Study|Lack of Efficacy|0|||
124609042|NCT00265395|448187259|FG001|Overall Study|Lack of Efficacy|1|||
124609043|NCT00265395|448187258|FG000|Overall Study|Administrative|0|||
124609044|NCT00265395|448187259|FG001|Overall Study|Administrative|1|||
124609045|NCT04053465|448187262|FG000|Overall Study|Withdrawal by Subject|4|||
124609046|NCT04053465|448187263|FG001|Overall Study|Withdrawal by Subject|4|||
124609047|NCT01087489|448187264|FG000|Overall Study|enrolled in another VA study|0|||
124609048|NCT01087489|448187265|FG001|Overall Study|enrolled in another VA study|1|||
124609049|NCT01087489|448187264|FG000|Overall Study|Death|0|||
124609050|NCT01087489|448187265|FG001|Overall Study|Death|1|||
124609051|NCT01087489|448187264|FG000|Overall Study|unable to survey by telephone|0|||
124609052|NCT01087489|448187265|FG001|Overall Study|unable to survey by telephone|1|||
124609053|NCT00117325|448187266|FG000|Overall Study|Adverse Event|3|||
124609054|NCT00117325|448187267|FG001|Overall Study|Adverse Event|3|||
124609055|NCT00117325|448187266|FG000|Overall Study|Lost to Follow-up|1|||
124609056|NCT00117325|448187267|FG001|Overall Study|Lost to Follow-up|1|||
124609057|NCT00117325|448187266|FG000|Overall Study|Protocol Violation|2|||
124609058|NCT00117325|448187267|FG001|Overall Study|Protocol Violation|3|||
124731901|NCT00235391|448640235|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
124731902|NCT00235391|448640236|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
124609059|NCT00117325|448187266|FG000|Overall Study|Withdrawal by Subject|3|||
124609060|NCT00117325|448187267|FG001|Overall Study|Withdrawal by Subject|2|||
124609061|NCT00117325|448187266|FG000|Overall Study|Lack of Efficacy|1|||
124609062|NCT00117325|448187267|FG001|Overall Study|Lack of Efficacy|0|||
124609063|NCT00117325|448187266|FG000|Overall Study|Use of prohibited medicine|1|||
124609064|NCT00117325|448187267|FG001|Overall Study|Use of prohibited medicine|2|||
124609065|NCT00117325|448187266|FG000|Overall Study|Early termination|1|||
124609066|NCT00117325|448187267|FG001|Overall Study|Early termination|1|||
124609067|NCT00117325|448187266|FG000|Overall Study|Admisnitrative|1|||
124609068|NCT00117325|448187267|FG001|Overall Study|Admisnitrative|0|||
124609069|NCT02338193|448187268|FG000|Overall Study|Withdrawal by Subject|0|||
124609070|NCT02338193|448187269|FG001|Overall Study|Withdrawal by Subject|0|||
124609071|NCT02338193|448187270|FG002|Overall Study|Withdrawal by Subject|2|||
124609072|NCT02338193|448187268|FG000|Overall Study|Pregnancy|0|||
124609073|NCT02338193|448187269|FG001|Overall Study|Pregnancy|1|||
124609074|NCT02338193|448187270|FG002|Overall Study|Pregnancy|1|||
124609075|NCT02338193|448187268|FG000|Overall Study|Noncompliant with visits|2|||
124609076|NCT02338193|448187269|FG001|Overall Study|Noncompliant with visits|2|||
124609077|NCT02338193|448187270|FG002|Overall Study|Noncompliant with visits|7|||
124609078|NCT02338193|448187268|FG000|Overall Study|moved out of state|0|||
124609079|NCT02338193|448187269|FG001|Overall Study|moved out of state|1|||
124609080|NCT02338193|448187270|FG002|Overall Study|moved out of state|0|||
124609081|NCT02338193|448187268|FG000|Overall Study|intolerant of side effects|1|||
124609082|NCT02338193|448187269|FG001|Overall Study|intolerant of side effects|0|||
124609083|NCT02338193|448187270|FG002|Overall Study|intolerant of side effects|0|||
124609084|NCT05788289|448187277|FG000|Overall Study|Death|3|||
124609085|NCT00085423|448187281|FG000|Overall Study|Withdrawal by Subject|1|||
124609086|NCT00085423|448187281|FG000|Overall Study|screen failure|1|||
124609087|NCT00536263|448187284|FG000|Overall Study|Adverse Event|5|||
124609088|NCT00536263|448187285|FG001|Overall Study|Adverse Event|5|||
124609089|NCT00536263|448187286|FG002|Overall Study|Adverse Event|7|||
124609090|NCT00536263|448187284|FG000|Overall Study|Lost to Follow-up|3|||
124609091|NCT00536263|448187285|FG001|Overall Study|Lost to Follow-up|4|||
124609092|NCT00536263|448187286|FG002|Overall Study|Lost to Follow-up|4|||
124609093|NCT00536263|448187284|FG000|Overall Study|Subject withdrew - not treatment related|2|||
124609094|NCT00536263|448187285|FG001|Overall Study|Subject withdrew - not treatment related|0|||
124609095|NCT00536263|448187286|FG002|Overall Study|Subject withdrew - not treatment related|5|||
124609096|NCT00536263|448187284|FG000|Overall Study|Subject withdrew - treatment related|0|||
124609097|NCT00536263|448187285|FG001|Overall Study|Subject withdrew - treatment related|3|||
124609098|NCT00536263|448187286|FG002|Overall Study|Subject withdrew - treatment related|2|||
124609099|NCT00536263|448187284|FG000|Overall Study|Noncompliance with protocol|0|||
124609100|NCT00536263|448187285|FG001|Overall Study|Noncompliance with protocol|0|||
124609101|NCT00536263|448187286|FG002|Overall Study|Noncompliance with protocol|1|||
124609102|NCT00536263|448187284|FG000|Overall Study|Did not meet protocol eligibility|1|||
124609103|NCT00536263|448187285|FG001|Overall Study|Did not meet protocol eligibility|2|||
124609104|NCT00536263|448187286|FG002|Overall Study|Did not meet protocol eligibility|2|||
124609105|NCT01140503|448187295|FG000|Overall Study|Withdrawal by Subject|1|||
124609106|NCT00809159|448187299|FG000|Part 1|Adverse Event|1|||
124609107|NCT00809159|448187300|FG001|Part 1|Adverse Event|1|||
124609108|NCT00809159|448187301|FG002|Part 1|Adverse Event|0|||
124609109|NCT00809159|448187302|FG003|Part 1|Adverse Event|0|||
124609110|NCT00809159|448187303|FG004|Part 1|Adverse Event|0|||
124609111|NCT00809159|448187304|FG005|Part 1|Adverse Event|0|||
124609112|NCT00809159|448187299|FG000|Part 1|Lost to Follow-up|1|||
124609113|NCT00809159|448187300|FG001|Part 1|Lost to Follow-up|0|||
124609114|NCT00809159|448187301|FG002|Part 1|Lost to Follow-up|0|||
124609115|NCT00809159|448187302|FG003|Part 1|Lost to Follow-up|0|||
124609116|NCT00809159|448187303|FG004|Part 1|Lost to Follow-up|0|||
124609117|NCT00809159|448187304|FG005|Part 1|Lost to Follow-up|0|||
124609118|NCT00809159|448187299|FG000|Part 1|Withdrawal by Subject|3|||
124609119|NCT00809159|448187300|FG001|Part 1|Withdrawal by Subject|1|||
124609120|NCT00809159|448187301|FG002|Part 1|Withdrawal by Subject|0|||
124609121|NCT00809159|448187302|FG003|Part 1|Withdrawal by Subject|0|||
124609122|NCT00809159|448187303|FG004|Part 1|Withdrawal by Subject|0|||
124609123|NCT00809159|448187304|FG005|Part 1|Withdrawal by Subject|0|||
124609124|NCT00809159|448187299|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
124609125|NCT00809159|448187300|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
124609126|NCT00809159|448187301|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
124609127|NCT00809159|448187302|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
124609128|NCT00809159|448187303|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
124609129|NCT00809159|448187304|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
124609130|NCT00809159|448187299|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
124609131|NCT00809159|448187300|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
124609132|NCT00809159|448187301|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
124609133|NCT00809159|448187302|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
124609134|NCT00809159|448187303|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
124609135|NCT00809159|448187304|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
124609136|NCT00809159|448187299|FG000|Part 1 and 2|Administrative problems|0|||
124609137|NCT00809159|448187300|FG001|Part 1 and 2|Administrative problems|0|||
124609138|NCT00809159|448187301|FG002|Part 1 and 2|Administrative problems|0|||
124609139|NCT00809159|448187302|FG003|Part 1 and 2|Administrative problems|1|||
124609140|NCT00809159|448187303|FG004|Part 1 and 2|Administrative problems|0|||
124609141|NCT00809159|448187304|FG005|Part 1 and 2|Administrative problems|0|||
124609142|NCT00809159|448187299|FG000|Part 1 and 2|Adverse Event|0|||
124609143|NCT00809159|448187300|FG001|Part 1 and 2|Adverse Event|0|||
124609144|NCT00809159|448187301|FG002|Part 1 and 2|Adverse Event|1|||
124609145|NCT00809159|448187302|FG003|Part 1 and 2|Adverse Event|0|||
124609146|NCT00809159|448187303|FG004|Part 1 and 2|Adverse Event|1|||
124609147|NCT00809159|448187304|FG005|Part 1 and 2|Adverse Event|1|||
124609148|NCT00809159|448187299|FG000|Part 1 and 2|Lost to Follow-up|0|||
124609149|NCT00809159|448187300|FG001|Part 1 and 2|Lost to Follow-up|0|||
124609150|NCT00809159|448187301|FG002|Part 1 and 2|Lost to Follow-up|1|||
124609151|NCT00809159|448187302|FG003|Part 1 and 2|Lost to Follow-up|1|||
124609152|NCT00809159|448187303|FG004|Part 1 and 2|Lost to Follow-up|0|||
124609153|NCT00809159|448187304|FG005|Part 1 and 2|Lost to Follow-up|0|||
124609154|NCT00809159|448187299|FG000|Part 1 and 2|Withdrawal by Subject|0|||
124609155|NCT00809159|448187300|FG001|Part 1 and 2|Withdrawal by Subject|0|||
124609156|NCT00809159|448187301|FG002|Part 1 and 2|Withdrawal by Subject|4|||
124609157|NCT00809159|448187302|FG003|Part 1 and 2|Withdrawal by Subject|0|||
124609158|NCT00809159|448187303|FG004|Part 1 and 2|Withdrawal by Subject|0|||
124609159|NCT00809159|448187304|FG005|Part 1 and 2|Withdrawal by Subject|1|||
124609160|NCT03201211|448187307|FG000|Overall Study|Adverse Event|1|||
124609161|NCT03201211|448187308|FG001|Overall Study|Adverse Event|0|||
124609162|NCT03201211|448187309|FG002|Overall Study|Adverse Event|0|||
124609163|NCT03201211|448187307|FG000|Overall Study|Protocol Violation|1|||
124609164|NCT03201211|448187308|FG001|Overall Study|Protocol Violation|0|||
124609165|NCT03201211|448187309|FG002|Overall Study|Protocol Violation|0|||
124609166|NCT03201211|448187307|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
124609167|NCT03201211|448187308|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
124609168|NCT03201211|448187309|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
124609169|NCT03201211|448187307|FG000|Overall Study|OTHER unknown reasons|0|||
124609170|NCT03201211|448187308|FG001|Overall Study|OTHER unknown reasons|1|||
124609171|NCT03201211|448187309|FG002|Overall Study|OTHER unknown reasons|0|||
124609172|NCT01083810|448187310|FG000|Overall Study|Lost to Follow-up|23|||
124609173|NCT01083810|448187311|FG001|Overall Study|Lost to Follow-up|11|||
124609174|NCT01083810|448187312|FG002|Overall Study|Lost to Follow-up|4|||
124609175|NCT01083810|448187310|FG000|Overall Study|Adverse Event|15|||
124609176|NCT01083810|448187311|FG001|Overall Study|Adverse Event|11|||
124609177|NCT01083810|448187312|FG002|Overall Study|Adverse Event|4|||
124609178|NCT01083810|448187310|FG000|Overall Study|Withdrawal by Subject|7|||
124609179|NCT01083810|448187311|FG001|Overall Study|Withdrawal by Subject|2|||
124609180|NCT01083810|448187312|FG002|Overall Study|Withdrawal by Subject|4|||
124609181|NCT01083810|448187310|FG000|Overall Study|Reason not reported|6|||
124609182|NCT01083810|448187311|FG001|Overall Study|Reason not reported|1|||
124609183|NCT01083810|448187312|FG002|Overall Study|Reason not reported|1|||
124609184|NCT01083810|448187310|FG000|Overall Study|Non-compliance|4|||
124731903|NCT00235391|448640237|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
124731904|NCT00235391|448640238|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
124731905|NCT00235391|448640233|FG000|Overall Study|Condition no longer requires treatment|3|||
124731906|NCT00235391|448640234|FG001|Overall Study|Condition no longer requires treatment|0|||
124731907|NCT00235391|448640235|FG002|Overall Study|Condition no longer requires treatment|0|||
124731908|NCT00235391|448640236|FG003|Overall Study|Condition no longer requires treatment|11|||
124731909|NCT00235391|448640237|FG004|Overall Study|Condition no longer requires treatment|1|||
124731910|NCT00235391|448640238|FG005|Overall Study|Condition no longer requires treatment|0|||
124731911|NCT00235391|448640233|FG000|Overall Study|Protocol deviation|0|||
124731912|NCT00235391|448640234|FG001|Overall Study|Protocol deviation|0|||
124731913|NCT00235391|448640235|FG002|Overall Study|Protocol deviation|1|||
124731914|NCT00235391|448640236|FG003|Overall Study|Protocol deviation|11|||
124731915|NCT00235391|448640237|FG004|Overall Study|Protocol deviation|0|||
124731916|NCT00235391|448640238|FG005|Overall Study|Protocol deviation|0|||
124731917|NCT00235391|448640233|FG000|Overall Study|Withdrawal by Subject|2|||
124731918|NCT00235391|448640234|FG001|Overall Study|Withdrawal by Subject|3|||
124731919|NCT00235391|448640235|FG002|Overall Study|Withdrawal by Subject|3|||
124731920|NCT00235391|448640236|FG003|Overall Study|Withdrawal by Subject|61|||
124731921|NCT00235391|448640237|FG004|Overall Study|Withdrawal by Subject|5|||
124731922|NCT00235391|448640238|FG005|Overall Study|Withdrawal by Subject|0|||
124731923|NCT00235391|448640233|FG000|Overall Study|Lost to Follow-up|0|||
124731924|NCT00235391|448640234|FG001|Overall Study|Lost to Follow-up|3|||
124731925|NCT00235391|448640235|FG002|Overall Study|Lost to Follow-up|3|||
124731926|NCT00235391|448640236|FG003|Overall Study|Lost to Follow-up|16|||
124731927|NCT00235391|448640237|FG004|Overall Study|Lost to Follow-up|0|||
124731928|NCT00235391|448640238|FG005|Overall Study|Lost to Follow-up|0|||
124731929|NCT00235391|448640233|FG000|Overall Study|Administrative problems|0|||
124731930|NCT00235391|448640234|FG001|Overall Study|Administrative problems|0|||
124731931|NCT00235391|448640235|FG002|Overall Study|Administrative problems|0|||
124781174|NCT01175083|448829107|FG001|Primary Epoch|Lost to Follow-up|0|||
124609185|NCT01083810|448187311|FG001|Overall Study|Non-compliance|7|||
124609186|NCT01083810|448187312|FG002|Overall Study|Non-compliance|2|||
124609187|NCT01083810|448187310|FG000|Overall Study|Simplification|4|||
124609188|NCT01083810|448187311|FG001|Overall Study|Simplification|1|||
124609189|NCT01083810|448187312|FG002|Overall Study|Simplification|0|||
124609190|NCT01083810|448187310|FG000|Overall Study|Death|2|||
124609191|NCT01083810|448187311|FG001|Overall Study|Death|2|||
124609192|NCT01083810|448187312|FG002|Overall Study|Death|3|||
124609193|NCT01083810|448187310|FG000|Overall Study|Co-morbidities|1|||
124609194|NCT01083810|448187311|FG001|Overall Study|Co-morbidities|0|||
124609195|NCT01083810|448187312|FG002|Overall Study|Co-morbidities|0|||
124609196|NCT01083810|448187310|FG000|Overall Study|Participation in study|1|||
124609197|NCT01083810|448187311|FG001|Overall Study|Participation in study|0|||
124609198|NCT01083810|448187312|FG002|Overall Study|Participation in study|0|||
124609199|NCT01083810|448187310|FG000|Overall Study|Therapy break|1|||
124609200|NCT01083810|448187311|FG001|Overall Study|Therapy break|2|||
124609201|NCT01083810|448187312|FG002|Overall Study|Therapy break|2|||
124609202|NCT01083810|448187310|FG000|Overall Study|Virologic failure|1|||
124609203|NCT01083810|448187311|FG001|Overall Study|Virologic failure|8|||
124609204|NCT01083810|448187312|FG002|Overall Study|Virologic failure|0|||
124609205|NCT01629966|448187313|FG000|Overall Study|Pregnancy|0|||
124609206|NCT01629966|448187314|FG001|Overall Study|Pregnancy|1|||
124609207|NCT01629966|448187315|FG002|Overall Study|Pregnancy|0|||
124609208|NCT01629966|448187313|FG000|Overall Study|Lost to Follow-up|10|||
124609209|NCT01629966|448187314|FG001|Overall Study|Lost to Follow-up|13|||
124609210|NCT01629966|448187315|FG002|Overall Study|Lost to Follow-up|9|||
124609211|NCT01629966|448187313|FG000|Overall Study|Withdrawal by Subject|8|||
124609212|NCT01629966|448187314|FG001|Overall Study|Withdrawal by Subject|9|||
124609213|NCT01629966|448187315|FG002|Overall Study|Withdrawal by Subject|16|||
124609214|NCT01629966|448187313|FG000|Overall Study|Protocol Violation|7|||
124609215|NCT01629966|448187314|FG001|Overall Study|Protocol Violation|9|||
124609216|NCT01629966|448187315|FG002|Overall Study|Protocol Violation|7|||
124609217|NCT01629966|448187313|FG000|Overall Study|Lack of Efficacy|5|||
124609218|NCT01629966|448187314|FG001|Overall Study|Lack of Efficacy|2|||
124609219|NCT01629966|448187315|FG002|Overall Study|Lack of Efficacy|4|||
124609220|NCT01629966|448187313|FG000|Overall Study|Adverse Event|11|||
124609221|NCT01629966|448187314|FG001|Overall Study|Adverse Event|18|||
124609222|NCT01629966|448187315|FG002|Overall Study|Adverse Event|30|||
124609223|NCT00477295|448187318|FG000|Overall Study|Adverse Event|31|||
124609224|NCT00477295|448187319|FG001|Overall Study|Adverse Event|35|||
124609225|NCT00477295|448187318|FG000|Overall Study|Withdrawal by Subject|35|||
124609226|NCT00477295|448187319|FG001|Overall Study|Withdrawal by Subject|24|||
124609227|NCT00477295|448187318|FG000|Overall Study|Lack of Efficacy|23|||
124609228|NCT00477295|448187319|FG001|Overall Study|Lack of Efficacy|23|||
124609229|NCT00477295|448187318|FG000|Overall Study|Protocol Violation|3|||
124609230|NCT00477295|448187319|FG001|Overall Study|Protocol Violation|8|||
124609231|NCT00477295|448187318|FG000|Overall Study|Physician Decision|4|||
124609232|NCT00477295|448187319|FG001|Overall Study|Physician Decision|5|||
124609233|NCT00477295|448187318|FG000|Overall Study|Lost to Follow-up|21|||
124609234|NCT00477295|448187319|FG001|Overall Study|Lost to Follow-up|11|||
124609235|NCT00477295|448187318|FG000|Overall Study|Other|4|||
124609236|NCT00477295|448187319|FG001|Overall Study|Other|3|||
124609237|NCT04568031|448187320|FG000|Overall Study|Lost to Follow-up|1|||
124609238|NCT04568031|448187321|FG001|Overall Study|Lost to Follow-up|0|||
124609239|NCT04568031|448187322|FG002|Overall Study|Lost to Follow-up|0|||
124609240|NCT04568031|448187323|FG003|Overall Study|Lost to Follow-up|0|||
124609241|NCT04568031|448187320|FG000|Overall Study|Physician Decision|1|||
124609242|NCT04568031|448187321|FG001|Overall Study|Physician Decision|0|||
124609243|NCT04568031|448187322|FG002|Overall Study|Physician Decision|1|||
124609244|NCT04568031|448187323|FG003|Overall Study|Physician Decision|0|||
124609245|NCT04568031|448187320|FG000|Overall Study|Withdrawal by Subject|1|||
124609246|NCT04568031|448187321|FG001|Overall Study|Withdrawal by Subject|0|||
124609247|NCT04568031|448187322|FG002|Overall Study|Withdrawal by Subject|4|||
124609248|NCT04568031|448187323|FG003|Overall Study|Withdrawal by Subject|1|||
124609249|NCT04430855|448187324|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
124609250|NCT04430855|448187325|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
124609251|NCT04430855|448187324|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
124609252|NCT04430855|448187325|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
124609253|NCT04430855|448187324|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
124609254|NCT04430855|448187325|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
124609255|NCT04430855|448187324|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
124609256|NCT04430855|448187325|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
124609257|NCT04430855|448187324|FG000|Period 1 (Weeks 1-12)|Other|0|||
124609258|NCT04430855|448187325|FG001|Period 1 (Weeks 1-12)|Other|1|||
124609259|NCT04430855|448187324|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
124609260|NCT04430855|448187325|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
124609261|NCT04430855|448187324|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
124609262|NCT04430855|448187325|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
124609263|NCT04430855|448187324|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
124609264|NCT04430855|448187325|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
124609265|NCT00390221|448187326|FG000|Overall Study|Lost to Follow-up|0|||
124609266|NCT00390221|448187327|FG001|Overall Study|Lost to Follow-up|3|||
124609267|NCT00390221|448187328|FG002|Overall Study|Lost to Follow-up|0|||
124609268|NCT00390221|448187326|FG000|Overall Study|Adverse Event|1|||
124609269|NCT00390221|448187327|FG001|Overall Study|Adverse Event|4|||
124609270|NCT00390221|448187328|FG002|Overall Study|Adverse Event|3|||
124609271|NCT00390221|448187326|FG000|Overall Study|Investigator Decision|0|||
124609272|NCT00390221|448187327|FG001|Overall Study|Investigator Decision|0|||
124609273|NCT00390221|448187328|FG002|Overall Study|Investigator Decision|1|||
124609274|NCT00390221|448187326|FG000|Overall Study|Withdrawal by Subject|13|||
124609275|NCT00390221|448187327|FG001|Overall Study|Withdrawal by Subject|9|||
124609276|NCT00390221|448187328|FG002|Overall Study|Withdrawal by Subject|7|||
124609277|NCT00390221|448187326|FG000|Overall Study|Subject Non-compliance|1|||
124609278|NCT00390221|448187327|FG001|Overall Study|Subject Non-compliance|0|||
124609279|NCT00390221|448187328|FG002|Overall Study|Subject Non-compliance|2|||
124609280|NCT00390221|448187326|FG000|Overall Study|Other|3|||
124609281|NCT00390221|448187327|FG001|Overall Study|Other|4|||
124609282|NCT00390221|448187328|FG002|Overall Study|Other|2|||
124609283|NCT03258853|448187344|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
124609284|NCT03258853|448187345|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
124609285|NCT03870477|448187346|FG000|Overall Study|Early Study Termination|1|||
124609286|NCT03753763|448187356|FG000|Overall Study|Adverse Event|2|||
124609287|NCT03753763|448187357|FG001|Overall Study|Adverse Event|0|||
124609288|NCT03753763|448187356|FG000|Overall Study|Withdrawal by Subject|3|||
124609289|NCT03753763|448187357|FG001|Overall Study|Withdrawal by Subject|1|||
124609290|NCT03753763|448187356|FG000|Overall Study|clinical deterioration|1|||
124609291|NCT03753763|448187357|FG001|Overall Study|clinical deterioration|0|||
124609292|NCT00389831|448187358|FG000|Overall Study|Lack of Efficacy|0|||
124609293|NCT00389831|448187359|FG001|Overall Study|Lack of Efficacy|2|||
124609294|NCT00389831|448187358|FG000|Overall Study|Did not receive treatment.|0|||
124609295|NCT00389831|448187359|FG001|Overall Study|Did not receive treatment.|2|||
124609296|NCT00389831|448187358|FG000|Overall Study|Other reasons|0|||
124609297|NCT00389831|448187359|FG001|Overall Study|Other reasons|2|||
124609298|NCT00389831|448187358|FG000|Overall Study|Lost to Follow-up|0|||
124609299|NCT00389831|448187359|FG001|Overall Study|Lost to Follow-up|1|||
124609300|NCT03433755|448187360|FG000|Overall Study|Lost to Follow-up|1|||
124609301|NCT03433755|448187361|FG001|Overall Study|Lost to Follow-up|0|||
124609302|NCT03433755|448187362|FG002|Overall Study|Lost to Follow-up|0|||
124609303|NCT03433755|448187363|FG003|Overall Study|Lost to Follow-up|0|||
124609304|NCT03433755|448187360|FG000|Overall Study|Decision by Sponsor|1|||
124609305|NCT03433755|448187361|FG001|Overall Study|Decision by Sponsor|0|||
124609306|NCT03433755|448187362|FG002|Overall Study|Decision by Sponsor|0|||
124609307|NCT03433755|448187363|FG003|Overall Study|Decision by Sponsor|0|||
124609308|NCT04941729|448189602|FG000|Overall Study|Death|0|||
124609309|NCT04941729|448189603|FG001|Overall Study|Death|1|||
124609310|NCT04941729|448189602|FG000|Overall Study|Study terminated by sponsor|11|||
124609311|NCT04941729|448189603|FG001|Overall Study|Study terminated by sponsor|10|||
124609312|NCT03190330|448189604|FG000|Overall Study|Adverse Event|2|||
124609313|NCT03190330|448189604|FG000|Overall Study|Death|10|||
124609314|NCT03190330|448189604|FG000|Overall Study|Lost to Follow-up|1|||
124609315|NCT03190330|448189604|FG000|Overall Study|Withdrawal by Subject|6|||
124609316|NCT03190330|448189604|FG000|Overall Study|Progressive Disease|1|||
124609317|NCT02081209|448189605|FG000|Overall Study|Withdrawal by Subject|1|||
124609318|NCT00191113|448189616|FG000|Core Study|Withdrawal by Subject|25|||
124609319|NCT00191113|448189617|FG001|Core Study|Withdrawal by Subject|9|||
124609320|NCT00191113|448189616|FG000|Core Study|Protocol Violation|6|||
124609321|NCT00191113|448189617|FG001|Core Study|Protocol Violation|2|||
124609322|NCT00191113|448189616|FG000|Core Study|Lost to Follow-up|3|||
124609323|NCT00191113|448189617|FG001|Core Study|Lost to Follow-up|0|||
124609324|NCT00191113|448189616|FG000|Core Study|Adverse Event|0|||
124609325|NCT00191113|448189617|FG001|Core Study|Adverse Event|2|||
124609326|NCT00191113|448189616|FG000|Core Study|Lack of Efficacy|0|||
124609327|NCT00191113|448189617|FG001|Core Study|Lack of Efficacy|2|||
124609328|NCT00191113|448189616|FG000|Core Study|Death|1|||
124609329|NCT00191113|448189617|FG001|Core Study|Death|0|||
124609330|NCT03786718|448189620|FG000|Overall Study|Lost to Follow-up|3|||
124609331|NCT03786718|448189620|FG000|Overall Study|Withdrawal by Subject|1|||
124609332|NCT03786718|448189620|FG000|Overall Study|Did not use the intervention|2|||
124609333|NCT03786718|448189620|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
124609334|NCT00368979|448189621|FG000|Overall Study|Adverse Event|9|||
124609335|NCT00368979|448189622|FG001|Overall Study|Adverse Event|16|||
124609336|NCT00368979|448189621|FG000|Overall Study|Lack of Efficacy|5|||
124609337|NCT00368979|448189622|FG001|Overall Study|Lack of Efficacy|3|||
124609338|NCT00368979|448189621|FG000|Overall Study|Other|3|||
124609339|NCT00368979|448189622|FG001|Overall Study|Other|1|||
124609340|NCT00368979|448189621|FG000|Overall Study|Lost to Follow-up|1|||
124609341|NCT00368979|448189622|FG001|Overall Study|Lost to Follow-up|0|||
124731932|NCT00235391|448640236|FG003|Overall Study|Administrative problems|1|||
124731933|NCT00235391|448640237|FG004|Overall Study|Administrative problems|0|||
124731934|NCT00235391|448640238|FG005|Overall Study|Administrative problems|0|||
124609342|NCT00368979|448189621|FG000|Overall Study|Protocol Violation|2|||
124609343|NCT00368979|448189622|FG001|Overall Study|Protocol Violation|1|||
124609344|NCT00368979|448189621|FG000|Overall Study|Withdrawal by Subject|5|||
124609345|NCT00368979|448189622|FG001|Overall Study|Withdrawal by Subject|9|||
124609346|NCT00699283|448189630|FG000|Overall Study|Lack of Efficacy|15|||
124609347|NCT00699283|448189631|FG001|Overall Study|Lack of Efficacy|5|||
124609348|NCT00699283|448189630|FG000|Overall Study|Lost to Follow-up|2|||
124609349|NCT00699283|448189631|FG001|Overall Study|Lost to Follow-up|0|||
124609350|NCT00699283|448189630|FG000|Overall Study|Withdrawal by Subject|1|||
124609351|NCT00699283|448189631|FG001|Overall Study|Withdrawal by Subject|0|||
124609352|NCT00699283|448189630|FG000|Overall Study|Other Reason|5|||
124609353|NCT00699283|448189631|FG001|Overall Study|Other Reason|1|||
124609354|NCT00699283|448189630|FG000|Overall Study|SAE, non-fatal|1|||
124609355|NCT00699283|448189631|FG001|Overall Study|SAE, non-fatal|1|||
124609356|NCT00699283|448189630|FG000|Overall Study|AE, non-serious non-fatal|8|||
124609357|NCT00699283|448189631|FG001|Overall Study|AE, non-serious non-fatal|1|||
124609358|NCT00699283|448189630|FG000|Overall Study|AE of unknown type|1|||
124609359|NCT00699283|448189631|FG001|Overall Study|AE of unknown type|0|||
124609360|NCT03537599|448189642|FG000|Overall Study|Disease Progression|2|||
124609361|NCT03537599|448189643|FG001|Overall Study|Disease Progression|1|||
124609362|NCT03537599|448189642|FG000|Overall Study|Death|0|||
124609363|NCT03537599|448189643|FG001|Overall Study|Death|1|||
124609364|NCT03929757|448189644|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
124609365|NCT03929757|448189645|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
124609366|NCT03929757|448189646|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
124609367|NCT03929757|448189644|FG000|Main Study: Up to Day 365|Other|1|||
124609368|NCT03929757|448189645|FG001|Main Study: Up to Day 365|Other|0|||
124609369|NCT03929757|448189646|FG002|Main Study: Up to Day 365|Other|0|||
124609370|NCT03929757|448189644|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
124609371|NCT03929757|448189645|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
124609372|NCT03929757|448189646|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
124609373|NCT01136967|448189648|FG000|Overall Study|Adverse Event|9|||
124609374|NCT01136967|448189649|FG001|Overall Study|Adverse Event|12|||
124609375|NCT01136967|448189648|FG000|Overall Study|Participant Choice|8|||
124609376|NCT01136967|448189649|FG001|Overall Study|Participant Choice|3|||
124609377|NCT01136967|448189648|FG000|Overall Study|Lost to Follow-up|0|||
124609378|NCT01136967|448189649|FG001|Overall Study|Lost to Follow-up|1|||
124609379|NCT01136967|448189648|FG000|Overall Study|Withdrawal by Subject|1|||
124609380|NCT01136967|448189649|FG001|Overall Study|Withdrawal by Subject|2|||
124609381|NCT01136967|448189648|FG000|Overall Study|Clinical Progression|3|||
124609382|NCT01136967|448189649|FG001|Overall Study|Clinical Progression|5|||
124609383|NCT01136967|448189648|FG000|Overall Study|Radiation|1|||
124609384|NCT01136967|448189649|FG001|Overall Study|Radiation|0|||
124609385|NCT01136967|448189648|FG000|Overall Study|Non-compliance|1|||
124609386|NCT01136967|448189649|FG001|Overall Study|Non-compliance|0|||
124609387|NCT01136967|448189648|FG000|Overall Study|Investigator's Choice|1|||
124609388|NCT01136967|448189649|FG001|Overall Study|Investigator's Choice|1|||
124609389|NCT01136967|448189648|FG000|Overall Study|Increase in Lesion Size|0|||
124609390|NCT01136967|448189649|FG001|Overall Study|Increase in Lesion Size|2|||
124609391|NCT01136967|448189648|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
124609392|NCT01136967|448189649|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
124609393|NCT02885181|448189650|FG000|Overall Study|Investigator's Discretion|0|||
124609394|NCT02885181|448189651|FG001|Overall Study|Investigator's Discretion|1|||
124609395|NCT02885181|448189652|FG002|Overall Study|Investigator's Discretion|0|||
124609396|NCT02885181|448189653|FG003|Overall Study|Investigator's Discretion|1|||
124609397|NCT02885181|448189650|FG000|Overall Study|Adverse Event|0|||
124609398|NCT02885181|448189651|FG001|Overall Study|Adverse Event|0|||
124609399|NCT02885181|448189652|FG002|Overall Study|Adverse Event|0|||
124609400|NCT02885181|448189653|FG003|Overall Study|Adverse Event|1|||
124609401|NCT02885181|448189650|FG000|Overall Study|Withdrawal by Subject|0|||
124609402|NCT02885181|448189651|FG001|Overall Study|Withdrawal by Subject|0|||
124609403|NCT02885181|448189652|FG002|Overall Study|Withdrawal by Subject|0|||
124609404|NCT02885181|448189653|FG003|Overall Study|Withdrawal by Subject|1|||
124609405|NCT03317834|448189654|FG000|Overall Study|Death|2|||
124609406|NCT03317834|448189654|FG000|Overall Study|Device Revision|5|||
124609407|NCT03317834|448189654|FG000|Overall Study|Withdrawal by Subject|13|||
124609408|NCT03317834|448189654|FG000|Overall Study|Lost to Follow-up|13|||
124609409|NCT03327792|448189655|FG000|Overall Study|Adverse Event|4|||
124609410|NCT03327792|448189656|FG001|Overall Study|Adverse Event|0|||
124609411|NCT03327792|448189655|FG000|Overall Study|Family/Personal issues|3|||
124609412|NCT03327792|448189656|FG001|Overall Study|Family/Personal issues|2|||
124609413|NCT03327792|448189655|FG000|Overall Study|Lost to Follow-up|0|||
124609414|NCT03327792|448189656|FG001|Overall Study|Lost to Follow-up|1|||
124609415|NCT00123474|448189666|FG000|Randomized to Treatment|Randomized, never treated|1|||
124609416|NCT00123474|448189667|FG001|Randomized to Treatment|Randomized, never treated|4|||
124609417|NCT00123474|448189668|FG002|Randomized to Treatment|Randomized, never treated|2|||
124609418|NCT00123474|448189669|FG003|Randomized to Treatment|Randomized, never treated|1|||
124609419|NCT00123474|448189666|FG000|As Treated at Study Closure|not reported when site closed|1|||
124609420|NCT00123474|448189667|FG001|As Treated at Study Closure|not reported when site closed|0|||
124609421|NCT00123474|448189668|FG002|As Treated at Study Closure|not reported when site closed|1|||
124609422|NCT00123474|448189669|FG003|As Treated at Study Closure|not reported when site closed|0|||
124609423|NCT00123474|448189666|FG000|As Treated at Study Closure|Adverse Event|10|||
124609424|NCT00123474|448189667|FG001|As Treated at Study Closure|Adverse Event|4|||
124609425|NCT00123474|448189668|FG002|As Treated at Study Closure|Adverse Event|10|||
124609426|NCT00123474|448189669|FG003|As Treated at Study Closure|Adverse Event|8|||
124609427|NCT00123474|448189666|FG000|As Treated at Study Closure|Disease Progression|35|||
124609428|NCT00123474|448189667|FG001|As Treated at Study Closure|Disease Progression|42|||
124609429|NCT00123474|448189668|FG002|As Treated at Study Closure|Disease Progression|29|||
124609430|NCT00123474|448189669|FG003|As Treated at Study Closure|Disease Progression|27|||
124609431|NCT00123474|448189666|FG000|As Treated at Study Closure|Investigator Request|12|||
124609432|NCT00123474|448189667|FG001|As Treated at Study Closure|Investigator Request|6|||
124609433|NCT00123474|448189668|FG002|As Treated at Study Closure|Investigator Request|7|||
124609434|NCT00123474|448189669|FG003|As Treated at Study Closure|Investigator Request|5|||
124609435|NCT00123474|448189666|FG000|As Treated at Study Closure|non-specified|54|||
124609436|NCT00123474|448189667|FG001|As Treated at Study Closure|non-specified|47|||
124609437|NCT00123474|448189668|FG002|As Treated at Study Closure|non-specified|57|||
124609438|NCT00123474|448189669|FG003|As Treated at Study Closure|non-specified|60|||
124609439|NCT00123474|448189666|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
124609440|NCT00123474|448189667|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
124609441|NCT00123474|448189668|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
124609442|NCT00123474|448189669|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
124609443|NCT00123474|448189666|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
124609444|NCT00123474|448189667|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
124609445|NCT00123474|448189668|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
124609446|NCT00123474|448189669|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
124609447|NCT01059344|448189670|FG000|Overall Study|Adverse Event|12|||
124609448|NCT01059344|448189671|FG001|Overall Study|Adverse Event|30|||
124609449|NCT01059344|448189670|FG000|Overall Study|Withdrawal by Subject|6|||
124609450|NCT01059344|448189671|FG001|Overall Study|Withdrawal by Subject|9|||
124609451|NCT01059344|448189670|FG000|Overall Study|Lost to Follow-up|1|||
124609452|NCT01059344|448189671|FG001|Overall Study|Lost to Follow-up|1|||
124609453|NCT01059344|448189670|FG000|Overall Study|Other|3|||
124609454|NCT01059344|448189671|FG001|Overall Study|Other|6|||
124609455|NCT00742924|448189672|FG000|Overall Study|Adverse Event|0|||
124609456|NCT00742924|448189673|FG001|Overall Study|Adverse Event|0|||
124609457|NCT00742924|448189674|FG002|Overall Study|Adverse Event|1|||
124609458|NCT00742924|448189675|FG003|Overall Study|Adverse Event|1|||
124609459|NCT00742924|448189672|FG000|Overall Study|Lack of Efficacy|5|||
124609460|NCT00742924|448189673|FG001|Overall Study|Lack of Efficacy|1|||
124609461|NCT00742924|448189674|FG002|Overall Study|Lack of Efficacy|2|||
124609462|NCT00742924|448189675|FG003|Overall Study|Lack of Efficacy|4|||
124609463|NCT00742924|448189672|FG000|Overall Study|Physician Decision|0|||
124609464|NCT00742924|448189673|FG001|Overall Study|Physician Decision|0|||
124609465|NCT00742924|448189674|FG002|Overall Study|Physician Decision|0|||
124609466|NCT00742924|448189675|FG003|Overall Study|Physician Decision|1|||
124609467|NCT00742924|448189672|FG000|Overall Study|Withdrawal by Subject|0|||
124609468|NCT00742924|448189673|FG001|Overall Study|Withdrawal by Subject|1|||
124609469|NCT00742924|448189674|FG002|Overall Study|Withdrawal by Subject|1|||
124609470|NCT00742924|448189675|FG003|Overall Study|Withdrawal by Subject|0|||
124609471|NCT00660400|448189676|FG000|Overall Study|Lack of insurance approval|1|||
124609472|NCT00660400|448189676|FG000|Overall Study|Suboptimal organ function|1|||
124609473|NCT00660400|448189676|FG000|Overall Study|Intracranial hemorrhage|1|||
124609474|NCT00660400|448189676|FG000|Overall Study|Withdrawal by Subject|1|||
124609475|NCT00528411|448189678|FG000|Overall Study|Adverse Event|4|||
124609476|NCT00528411|448189679|FG001|Overall Study|Adverse Event|0|||
124609477|NCT00528411|448189680|FG002|Overall Study|Adverse Event|1|||
124609478|NCT00528411|448189678|FG000|Overall Study|Incorrect Enrolment|1|||
124609479|NCT00528411|448189679|FG001|Overall Study|Incorrect Enrolment|1|||
124609480|NCT00528411|448189680|FG002|Overall Study|Incorrect Enrolment|0|||
124609481|NCT00528411|448189678|FG000|Overall Study|Severe non-compliance to protocol|0|||
124609482|NCT00528411|448189679|FG001|Overall Study|Severe non-compliance to protocol|1|||
124609483|NCT00528411|448189680|FG002|Overall Study|Severe non-compliance to protocol|0|||
124609484|NCT00528411|448189678|FG000|Overall Study|Prior commitment medication|0|||
124609485|NCT00528411|448189679|FG001|Overall Study|Prior commitment medication|1|||
124609486|NCT00528411|448189680|FG002|Overall Study|Prior commitment medication|0|||
124609487|NCT02643355|448189681|FG000|Overall Study|Withdrawal by Subject|1|||
124609488|NCT02643355|448189682|FG001|Overall Study|Withdrawal by Subject|3|||
124609489|NCT02643355|448189681|FG000|Overall Study|Protocol Violation|0|||
124609490|NCT02643355|448189682|FG001|Overall Study|Protocol Violation|2|||
124609491|NCT01715571|448189683|FG000|Overall Study|Lost to Follow-up|8|||
124609492|NCT04524364|448189688|FG000|Overall Study|Physician Decision|3|||
124609493|NCT04524364|448189689|FG001|Overall Study|Physician Decision|6|||
124609494|NCT04524364|448189688|FG000|Overall Study|Adverse Event|0|||
124609495|NCT04524364|448189689|FG001|Overall Study|Adverse Event|1|||
124609496|NCT04524364|448189688|FG000|Overall Study|Investigational device deficiency|0|||
124609497|NCT04524364|448189689|FG001|Overall Study|Investigational device deficiency|1|||
124609498|NCT04524364|448189688|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
124609499|NCT04524364|448189689|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
124609500|NCT04524364|448189688|FG000|Overall Study|Device unavailability|0|||
124609501|NCT04524364|448189689|FG001|Overall Study|Device unavailability|2|||
124609502|NCT04524364|448189688|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
124609503|NCT04524364|448189689|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
124609504|NCT04524364|448189688|FG000|Overall Study|Low International normalized ratio (INR)|1|||
124609505|NCT04524364|448189689|FG001|Overall Study|Low International normalized ratio (INR)|0|||
124609506|NCT00826449|448189690|FG000|Overall Study|Disease Progression|4|||
124609507|NCT00826449|448189690|FG000|Overall Study|Withdrawal by Subject|1|||
124731935|NCT00235391|448640233|FG000|Overall Study|Death|0|||
124731936|NCT00235391|448640234|FG001|Overall Study|Death|0|||
124731937|NCT00235391|448640235|FG002|Overall Study|Death|1|||
124731938|NCT00235391|448640236|FG003|Overall Study|Death|4|||
124731939|NCT00235391|448640237|FG004|Overall Study|Death|0|||
124731940|NCT00235391|448640238|FG005|Overall Study|Death|0|||
124731941|NCT03349645|448640239|FG000|Overall Study|Sponsor Terminated Study|75|||
124731942|NCT03349645|448640239|FG000|Overall Study|Withdrawal by Subject|4|||
124731943|NCT03349645|448640239|FG000|Overall Study|Protocol Violation|1|||
124731944|NCT03349645|448640239|FG000|Overall Study|Other|2|||
124731945|NCT00580034|448640243|FG000|Overall Study|Toxicity|10|||
124731946|NCT00580034|448640244|FG001|Overall Study|Toxicity|0|||
124731947|NCT00098748|448640247|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
124731948|NCT00098748|448640248|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
124731949|NCT00098748|448640249|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
124731950|NCT00098748|448640247|FG000|Received Study Treatment|Death|2|||
124731951|NCT00098748|448640248|FG001|Received Study Treatment|Death|1|||
124731952|NCT00098748|448640249|FG002|Received Study Treatment|Death|2|||
124731953|NCT00098748|448640247|FG000|Received Study Treatment|Adverse Event|1|||
124731954|NCT00098748|448640248|FG001|Received Study Treatment|Adverse Event|2|||
124731955|NCT00098748|448640249|FG002|Received Study Treatment|Adverse Event|5|||
124731956|NCT00098748|448640247|FG000|Received Study Treatment|Lack of Efficacy|40|||
124731957|NCT00098748|448640248|FG001|Received Study Treatment|Lack of Efficacy|27|||
124731958|NCT00098748|448640249|FG002|Received Study Treatment|Lack of Efficacy|27|||
124731959|NCT00098748|448640247|FG000|Received Study Treatment|Other|2|||
124731960|NCT00098748|448640248|FG001|Received Study Treatment|Other|2|||
124731961|NCT00098748|448640249|FG002|Received Study Treatment|Other|6|||
124731962|NCT00098748|448640247|FG000|Received Study Treatment|Subject defaulted|3|||
124731963|NCT00098748|448640248|FG001|Received Study Treatment|Subject defaulted|4|||
124731964|NCT00098748|448640249|FG002|Received Study Treatment|Subject defaulted|4|||
124731965|NCT00098748|448640247|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
124731966|NCT00098748|448640248|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
124731967|NCT00098748|448640249|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
124731968|NCT00098748|448640247|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
124609508|NCT03233230|448189691|FG000|Overall Study|Adverse Event|6|||
124609509|NCT03233230|448189692|FG001|Overall Study|Adverse Event|3|||
124609510|NCT03233230|448189693|FG002|Overall Study|Adverse Event|6|||
124609511|NCT03233230|448189694|FG003|Overall Study|Adverse Event|3|||
124609512|NCT03233230|448189691|FG000|Overall Study|Protocol Violation|1|||
124609513|NCT03233230|448189692|FG001|Overall Study|Protocol Violation|2|||
124609514|NCT03233230|448189693|FG002|Overall Study|Protocol Violation|1|||
124609515|NCT03233230|448189694|FG003|Overall Study|Protocol Violation|1|||
124609516|NCT03233230|448189691|FG000|Overall Study|Lack of Efficacy|1|||
124609517|NCT03233230|448189692|FG001|Overall Study|Lack of Efficacy|0|||
124609518|NCT03233230|448189693|FG002|Overall Study|Lack of Efficacy|0|||
124609519|NCT03233230|448189694|FG003|Overall Study|Lack of Efficacy|0|||
124609520|NCT03233230|448189691|FG000|Overall Study|Other|5|||
124609521|NCT03233230|448189692|FG001|Overall Study|Other|5|||
124609522|NCT03233230|448189693|FG002|Overall Study|Other|5|||
124609523|NCT03233230|448189694|FG003|Overall Study|Other|3|||
124609524|NCT03233230|448189691|FG000|Overall Study|Withdrawal by Subject|2|||
124609525|NCT03233230|448189692|FG001|Overall Study|Withdrawal by Subject|2|||
124609526|NCT03233230|448189693|FG002|Overall Study|Withdrawal by Subject|0|||
124609527|NCT03233230|448189694|FG003|Overall Study|Withdrawal by Subject|1|||
124609528|NCT03233230|448189691|FG000|Overall Study|Lost to Follow-up|0|||
124609529|NCT03233230|448189692|FG001|Overall Study|Lost to Follow-up|3|||
124731969|NCT00098748|448640248|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
124609530|NCT03233230|448189693|FG002|Overall Study|Lost to Follow-up|0|||
124609531|NCT03233230|448189694|FG003|Overall Study|Lost to Follow-up|0|||
124609532|NCT02994940|448189695|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
124609533|NCT02994940|448189696|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
124609534|NCT02994940|448189695|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
124609535|NCT02994940|448189696|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
124609536|NCT02994940|448189695|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
124731970|NCT00098748|448640249|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
124731971|NCT00098748|448640247|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
124609537|NCT02994940|448189696|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
124609538|NCT02987959|448189701|FG000|Overall Study|Grantor stopped supply of drugs|6|||
124731972|NCT00098748|448640248|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
124731973|NCT00098748|448640249|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
124609539|NCT04126213|448189702|FG000|Overall Study|Lost to Follow-up|9|||
124609540|NCT04126213|448189703|FG001|Overall Study|Lost to Follow-up|1|||
124609541|NCT04126213|448189704|FG002|Overall Study|Lost to Follow-up|5|||
124609542|NCT04126213|448189705|FG003|Overall Study|Lost to Follow-up|10|||
124609543|NCT04126213|448189706|FG004|Overall Study|Lost to Follow-up|4|||
124609544|NCT04126213|448189707|FG005|Overall Study|Lost to Follow-up|7|||
124609545|NCT04126213|448189702|FG000|Overall Study|Withdrawal by Subject|3|||
124609546|NCT04126213|448189703|FG001|Overall Study|Withdrawal by Subject|2|||
124609547|NCT04126213|448189704|FG002|Overall Study|Withdrawal by Subject|1|||
124609548|NCT04126213|448189705|FG003|Overall Study|Withdrawal by Subject|1|||
124609549|NCT04126213|448189706|FG004|Overall Study|Withdrawal by Subject|1|||
124609550|NCT04126213|448189707|FG005|Overall Study|Withdrawal by Subject|1|||
124609551|NCT04126213|448189702|FG000|Overall Study|Other|0|||
124609552|NCT04126213|448189703|FG001|Overall Study|Other|0|||
124609553|NCT04126213|448189704|FG002|Overall Study|Other|2|||
124609554|NCT04126213|448189705|FG003|Overall Study|Other|2|||
124609555|NCT04126213|448189706|FG004|Overall Study|Other|0|||
124609556|NCT04126213|448189707|FG005|Overall Study|Other|1|||
124609557|NCT04126213|448189702|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124609558|NCT04126213|448189703|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
124609559|NCT04126213|448189704|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124609560|NCT04126213|448189705|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124609561|NCT04126213|448189706|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124609562|NCT04126213|448189707|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
124609563|NCT02853370|448189710|FG000|Overall Study|Physician Decision|1|||
124609564|NCT02853370|448189710|FG000|Overall Study|Lack of Efficacy|2|||
124609565|NCT02853370|448189710|FG000|Overall Study|Death|1|||
124609566|NCT02853370|448189710|FG000|Overall Study|Adverse Event|4|||
124609567|NCT02853370|448189710|FG000|Overall Study|Withdrawal by Subject|3|||
124609568|NCT02196701|448189711|FG000|Overall Study|Adverse Event|1|||
124609569|NCT02196701|448189711|FG000|Overall Study|Lost to Follow-up|1|||
124609570|NCT02196701|448189711|FG000|Overall Study|Non-adherence to Protocol|1|||
124609571|NCT03275064|448189716|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
124609572|NCT03275064|448189717|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
124609573|NCT03275064|448189718|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
124609574|NCT03275064|448189719|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
124609575|NCT03275064|448189720|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
124731974|NCT00098748|448640247|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
124731975|NCT00098748|448640248|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
124731976|NCT00098748|448640249|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
124731977|NCT00098748|448640247|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
124731978|NCT00098748|448640248|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
124731979|NCT00098748|448640249|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
124731980|NCT01081301|448640253|FG000|Overall Study|Bereaved|3|||
124731981|NCT01081301|448640253|FG000|Overall Study|Too busy|5|||
124731982|NCT01081301|448640253|FG000|Overall Study|Patient too ill|2|||
124731983|NCT01081301|448640253|FG000|Overall Study|Lost to Follow-up|4|||
124731984|NCT03551665|448640256|FG000|Overall Study|Lost to Follow-up|11|||
124731985|NCT03551665|448640257|FG001|Overall Study|Lost to Follow-up|2|||
124731986|NCT00428220|448641871|FG000|Overall Study|Participant died|8|||
124731987|NCT00428220|448641871|FG000|Overall Study|Global deterioration of health status|7|||
124731988|NCT00428220|448641871|FG000|Overall Study|Lost to Follow-up|4|||
124731989|NCT00428220|448641871|FG000|Overall Study|Objective progression or relapse|123|||
124731990|NCT00428220|448641871|FG000|Overall Study|Participant refused continued treatment|7|||
124731991|NCT00428220|448641871|FG000|Overall Study|Adverse Event|51|||
124731992|NCT00428220|448641871|FG000|Overall Study|Other|23|||
124731993|NCT03283098|448641876|FG000|Overall Study|Withdrawal by Subject|0|||
124731994|NCT03283098|448641877|FG001|Overall Study|Withdrawal by Subject|1|||
124731995|NCT03356977|448641880|FG000|Overall Study|Lost to Follow-up|3|||
124731996|NCT03356977|448641880|FG000|Overall Study|Withdrawal by parent/guardian|2|||
124731997|NCT00445939|448641885|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
124731998|NCT00445939|448641886|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
124609576|NCT03275064|448189716|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
124637719|NCT00915018|448292404|FG001|Overall Study|Withdrawal by Subject|27|||
124637720|NCT00915018|448292403|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
124637721|NCT00915018|448292404|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
124637722|NCT00326716|448292405|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
124637723|NCT00326716|448292406|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
124637724|NCT00326716|448292407|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
124637725|NCT00326716|448292408|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
124637726|NCT00684411|448292409|FG000|Overall Study|New Primary Cancer|1|||
124637727|NCT00684411|448292409|FG000|Overall Study|Disease Progression|10|||
124609577|NCT03275064|448189717|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
124609578|NCT03275064|448189718|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
124609579|NCT03275064|448189719|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
124609580|NCT03275064|448189720|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
124609581|NCT03275064|448189716|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
124609582|NCT03275064|448189717|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
124609583|NCT03275064|448189718|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
124609584|NCT03275064|448189719|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
124609585|NCT03275064|448189720|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
124609586|NCT03275064|448189716|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
124609587|NCT03275064|448189717|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
124609588|NCT03275064|448189718|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
124609589|NCT03275064|448189719|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
124609590|NCT03275064|448189720|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
124609591|NCT03275064|448189716|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
124609592|NCT03275064|448189717|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
124609593|NCT03275064|448189718|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
124609594|NCT03275064|448189719|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
124609595|NCT03275064|448189720|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
124609596|NCT04159935|448189721|FG000|Overall Study|Study terminated due to COVID-19|1|||
124609597|NCT04159935|448189722|FG001|Overall Study|Study terminated due to COVID-19|3|||
124609598|NCT01341782|448189723|FG000|Overall Study|Adverse Event|1|||
124609599|NCT01341782|448189724|FG001|Overall Study|Adverse Event|1|||
124609600|NCT01341782|448189723|FG000|Overall Study|Withdrawal by Subject|6|||
124609601|NCT01341782|448189724|FG001|Overall Study|Withdrawal by Subject|5|||
124609602|NCT01341782|448189723|FG000|Overall Study|Missed 3 consecutive doses|0|||
124609603|NCT01341782|448189724|FG001|Overall Study|Missed 3 consecutive doses|4|||
124609604|NCT01341782|448189723|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
124609605|NCT01341782|448189724|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
124609606|NCT01341782|448189723|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
124609607|NCT01341782|448189724|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
124609608|NCT01341782|448189723|FG000|Overall Study|Other|5|||
124609609|NCT01341782|448189724|FG001|Overall Study|Other|0|||
124609610|NCT00620555|448189725|FG000|Overall Study|Adverse Event|4|||
124609611|NCT00620555|448189725|FG000|Overall Study|Protocol Violation|2|||
124609612|NCT00620555|448189725|FG000|Overall Study|Lack of Efficacy|12|||
124609613|NCT00620555|448189725|FG000|Overall Study|Withdrawal by Subject|1|||
124609614|NCT00620555|448189725|FG000|Overall Study|Choice of other treatment|1|||
124609615|NCT00620555|448189725|FG000|Overall Study|Visit failure against planned|1|||
124609616|NCT00724048|448189726|FG000|Overall Study|Adverse Event|1|||
124609617|NCT00724048|448189727|FG001|Overall Study|Adverse Event|1|||
124609618|NCT00724048|448189728|FG002|Overall Study|Adverse Event|1|||
124609619|NCT00724048|448189729|FG003|Overall Study|Adverse Event|0|||
124609620|NCT00724048|448189726|FG000|Overall Study|Lost to Follow-up|0|||
124609621|NCT00724048|448189727|FG001|Overall Study|Lost to Follow-up|1|||
124609622|NCT00724048|448189728|FG002|Overall Study|Lost to Follow-up|0|||
124609623|NCT00724048|448189729|FG003|Overall Study|Lost to Follow-up|0|||
124609624|NCT00724048|448189726|FG000|Overall Study|Withdrawal by Subject|1|||
124609625|NCT00724048|448189727|FG001|Overall Study|Withdrawal by Subject|2|||
124609626|NCT00724048|448189728|FG002|Overall Study|Withdrawal by Subject|1|||
124609627|NCT00724048|448189729|FG003|Overall Study|Withdrawal by Subject|2|||
124609628|NCT00724048|448189726|FG000|Overall Study|Investigator decision|0|||
124731999|NCT00445939|448641887|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
124732000|NCT00445939|448641888|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
124609629|NCT00724048|448189727|FG001|Overall Study|Investigator decision|0|||
124609630|NCT00724048|448189728|FG002|Overall Study|Investigator decision|1|||
124609631|NCT00724048|448189729|FG003|Overall Study|Investigator decision|0|||
124609632|NCT00724048|448189726|FG000|Overall Study|Did not tolerate study drug|0|||
124609633|NCT00724048|448189727|FG001|Overall Study|Did not tolerate study drug|0|||
124609634|NCT00724048|448189728|FG002|Overall Study|Did not tolerate study drug|0|||
124609635|NCT00724048|448189729|FG003|Overall Study|Did not tolerate study drug|1|||
124609636|NCT00724048|448189726|FG000|Overall Study|Other than specified|1|||
124609637|NCT00724048|448189727|FG001|Overall Study|Other than specified|1|||
124609638|NCT00724048|448189728|FG002|Overall Study|Other than specified|0|||
124609639|NCT00724048|448189729|FG003|Overall Study|Other than specified|0|||
124609640|NCT03923530|448189730|FG000|Overall Study|Withdrawal by Subject|1|||
124609641|NCT03923530|448189730|FG000|Overall Study|screen failure|3|||
124609642|NCT04135196|448189731|FG000|Overall Study|Lost to Follow-up|8|||
124609643|NCT04135196|448189732|FG001|Overall Study|Lost to Follow-up|7|||
124609644|NCT04135196|448189733|FG002|Overall Study|Lost to Follow-up|8|||
124609645|NCT04135196|448189734|FG003|Overall Study|Lost to Follow-up|9|||
124609646|NCT04135196|448189735|FG004|Overall Study|Lost to Follow-up|1|||
124609647|NCT04135196|448189731|FG000|Overall Study|Pregnancy|0|||
124609648|NCT04135196|448189732|FG001|Overall Study|Pregnancy|0|||
124609649|NCT04135196|448189733|FG002|Overall Study|Pregnancy|1|||
124609650|NCT04135196|448189734|FG003|Overall Study|Pregnancy|0|||
124609651|NCT04135196|448189735|FG004|Overall Study|Pregnancy|0|||
124609652|NCT04135196|448189731|FG000|Overall Study|Withdrawal by Subject|0|||
124609653|NCT04135196|448189732|FG001|Overall Study|Withdrawal by Subject|0|||
124609654|NCT04135196|448189733|FG002|Overall Study|Withdrawal by Subject|0|||
124609655|NCT04135196|448189734|FG003|Overall Study|Withdrawal by Subject|0|||
124609656|NCT04135196|448189735|FG004|Overall Study|Withdrawal by Subject|1|||
124609657|NCT00911807|448189736|FG000|Overall Study|Adverse Event|2|||
124609658|NCT00911807|448189737|FG001|Overall Study|Adverse Event|1|||
124609659|NCT00911807|448189738|FG002|Overall Study|Adverse Event|5|||
124609660|NCT00911807|448189736|FG000|Overall Study|Death|0|||
124609661|NCT00911807|448189737|FG001|Overall Study|Death|0|||
124609662|NCT00911807|448189738|FG002|Overall Study|Death|1|||
124609663|NCT00911807|448189736|FG000|Overall Study|Protocol Violation|6|||
124609664|NCT00911807|448189737|FG001|Overall Study|Protocol Violation|4|||
124609665|NCT00911807|448189738|FG002|Overall Study|Protocol Violation|9|||
124609666|NCT00911807|448189736|FG000|Overall Study|Withdrawal by Subject|8|||
124609667|NCT00911807|448189737|FG001|Overall Study|Withdrawal by Subject|10|||
124609668|NCT00911807|448189738|FG002|Overall Study|Withdrawal by Subject|7|||
124609669|NCT00911807|448189736|FG000|Overall Study|Organizational reasons|1|||
124609670|NCT00911807|448189737|FG001|Overall Study|Organizational reasons|3|||
124609671|NCT00911807|448189738|FG002|Overall Study|Organizational reasons|1|||
124609672|NCT02991430|448189741|FG000|Treatment Period 1|Adverse Event|1|||
124609673|NCT02991430|448189742|FG001|Treatment Period 1|Adverse Event|0|||
124609674|NCT02991430|448189743|FG002|Treatment Period 1|Adverse Event|2|||
124609675|NCT02991430|448189741|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124609676|NCT02991430|448189742|FG001|Treatment Period 1|Withdrawal by Subject|4|||
124609677|NCT02991430|448189743|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124609678|NCT02991430|448189741|FG000|Treatment Period 2|Study Termination|6|||
124609679|NCT02991430|448189742|FG001|Treatment Period 2|Study Termination|3|||
124609680|NCT02991430|448189743|FG002|Treatment Period 2|Study Termination|3|||
124609681|NCT02991430|448189741|FG000|Treatment Period 2|Lost to Follow-up|0|||
124609682|NCT02991430|448189742|FG001|Treatment Period 2|Lost to Follow-up|0|||
124609683|NCT02991430|448189743|FG002|Treatment Period 2|Lost to Follow-up|1|||
124609684|NCT02991430|448189741|FG000|Post-treatment Observation Period|Study Termination|3|||
124609685|NCT02991430|448189742|FG001|Post-treatment Observation Period|Study Termination|6|||
124609686|NCT02991430|448189743|FG002|Post-treatment Observation Period|Study Termination|5|||
124609687|NCT01672970|448189744|FG000|Overall Study|Lack of Efficacy|12|||
124609688|NCT01672970|448189744|FG000|Overall Study|Adverse Event|18|||
124609689|NCT01672970|448189744|FG000|Overall Study|Withdrawal by Subject|2|||
124609690|NCT01672970|448189744|FG000|Overall Study|Lost to Follow-up|5|||
124609691|NCT01672970|448189744|FG000|Overall Study|Other|9|||
124609692|NCT01672970|448189744|FG000|Overall Study|Enrolled but not treated|1|||
124609693|NCT01770392|448189749|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
124609694|NCT02533375|448189752|FG000|Overall Study|Lack of Efficacy|3|||
124609695|NCT02533375|448189752|FG000|Overall Study|Adverse Event|2|||
124609696|NCT01709838|448189755|FG000|Overall Study|Withdrawal by Subject|21|||
124609697|NCT01709838|448189755|FG000|Overall Study|Lost to Follow-up|16|||
124609698|NCT01709838|448189755|FG000|Overall Study|Pregnancy|10|||
124609699|NCT01709838|448189755|FG000|Overall Study|Subject/guardian decision|8|||
124609700|NCT01709838|448189755|FG000|Overall Study|Adverse Event|4|||
124609701|NCT01709838|448189755|FG000|Overall Study|Physician Decision|4|||
124609702|NCT01709838|448189755|FG000|Overall Study|Death|3|||
124609703|NCT01709838|448189755|FG000|Overall Study|Protocol Violation|1|||
124609704|NCT01193127|448189756|FG000|Randomized|Surgery Cancelled|0|||
124609705|NCT01193127|448189757|FG001|Randomized|Surgery Cancelled|0|||
124609706|NCT01193127|448189758|FG002|Randomized|Surgery Cancelled|0|||
124609707|NCT01193127|448189759|FG003|Randomized|Surgery Cancelled|1|||
124609708|NCT01193127|448189756|FG000|Treated|Withdrawal by Subject|0|||
124609709|NCT01193127|448189757|FG001|Treated|Withdrawal by Subject|0|||
124609710|NCT01193127|448189758|FG002|Treated|Withdrawal by Subject|0|||
124609711|NCT01193127|448189759|FG003|Treated|Withdrawal by Subject|1|||
124609712|NCT03246646|448189760|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
124609713|NCT03246646|448189761|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
124609714|NCT03246646|448189760|FG000|Overall Study|Withdrawal by Subject|3|||
124609715|NCT03246646|448189761|FG001|Overall Study|Withdrawal by Subject|0|||
124609716|NCT03246646|448189760|FG000|Overall Study|Lost to Follow-up|7|||
124609717|NCT03246646|448189761|FG001|Overall Study|Lost to Follow-up|0|||
124609718|NCT02352779|448189764|FG000|Overall Study|Personal Issues|1|||
124609719|NCT02352779|448189765|FG001|Overall Study|Personal Issues|1|||
124609720|NCT02352779|448189766|FG002|Overall Study|Personal Issues|0|||
124609721|NCT02352779|448189764|FG000|Overall Study|Too Many Forms|2|||
124609722|NCT02352779|448189765|FG001|Overall Study|Too Many Forms|0|||
124609723|NCT02352779|448189766|FG002|Overall Study|Too Many Forms|0|||
124609724|NCT02352779|448189764|FG000|Overall Study|Feeling Overwhelmed|1|||
124609725|NCT02352779|448189765|FG001|Overall Study|Feeling Overwhelmed|0|||
124609726|NCT02352779|448189766|FG002|Overall Study|Feeling Overwhelmed|0|||
124609727|NCT02352779|448189764|FG000|Overall Study|Disliked Intervention|1|||
124609728|NCT02352779|448189765|FG001|Overall Study|Disliked Intervention|0|||
124609729|NCT02352779|448189766|FG002|Overall Study|Disliked Intervention|0|||
124609730|NCT02352779|448189764|FG000|Overall Study|Changed Mind|1|||
124609731|NCT02352779|448189765|FG001|Overall Study|Changed Mind|0|||
124609732|NCT02352779|448189766|FG002|Overall Study|Changed Mind|0|||
124609733|NCT02352779|448189764|FG000|Overall Study|Study Related Symptoms|1|||
124609734|NCT02352779|448189765|FG001|Overall Study|Study Related Symptoms|0|||
124609735|NCT02352779|448189766|FG002|Overall Study|Study Related Symptoms|0|||
124609736|NCT02352779|448189764|FG000|Overall Study|Absence of Symptoms|1|||
124609737|NCT02352779|448189765|FG001|Overall Study|Absence of Symptoms|0|||
124609738|NCT02352779|448189766|FG002|Overall Study|Absence of Symptoms|0|||
124609739|NCT02352779|448189764|FG000|Overall Study|Other Medical Reason|0|||
124609740|NCT02352779|448189765|FG001|Overall Study|Other Medical Reason|0|||
124609741|NCT02352779|448189766|FG002|Overall Study|Other Medical Reason|1|||
124609742|NCT02352779|448189764|FG000|Overall Study|No Reason|0|||
124609743|NCT02352779|448189765|FG001|Overall Study|No Reason|0|||
124609744|NCT02352779|448189766|FG002|Overall Study|No Reason|1|||
124609745|NCT01565850|448189773|FG000|Overall Study|Adverse Event|0|||
124609746|NCT01565850|448189774|FG001|Overall Study|Adverse Event|1|||
124609747|NCT01565850|448189773|FG000|Overall Study|Lost to Follow-up|12|||
124609748|NCT01565850|448189774|FG001|Overall Study|Lost to Follow-up|4|||
124609749|NCT01565850|448189773|FG000|Overall Study|Investigator's Discretion|2|||
124609750|NCT01565850|448189774|FG001|Overall Study|Investigator's Discretion|1|||
124609751|NCT01565850|448189773|FG000|Overall Study|Participant noncompliance|2|||
124609752|NCT01565850|448189774|FG001|Overall Study|Participant noncompliance|0|||
124609753|NCT01565850|448189773|FG000|Overall Study|Withdrew Consent|4|||
124609754|NCT01565850|448189774|FG001|Overall Study|Withdrew Consent|2|||
124609755|NCT00006721|448191843|FG000|Overall Study|Adverse Event|0|||
124609756|NCT00006721|448191844|FG001|Overall Study|Adverse Event|4|||
124609757|NCT00006721|448191845|FG002|Overall Study|Adverse Event|4|||
124609758|NCT00006721|448191843|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
124609759|NCT00006721|448191844|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
124609760|NCT00006721|448191845|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
124609761|NCT00006721|448191843|FG000|Overall Study|Progression/Relapse|0|||
124609762|NCT00006721|448191844|FG001|Overall Study|Progression/Relapse|1|||
124609763|NCT00006721|448191845|FG002|Overall Study|Progression/Relapse|2|||
124609764|NCT00006721|448191843|FG000|Overall Study|Death|0|||
124609765|NCT00006721|448191844|FG001|Overall Study|Death|1|||
124609766|NCT00006721|448191845|FG002|Overall Study|Death|2|||
124609767|NCT00006721|448191843|FG000|Overall Study|Other - Not Protocol Specified|0|||
124609768|NCT00006721|448191844|FG001|Overall Study|Other - Not Protocol Specified|7|||
124609769|NCT00006721|448191845|FG002|Overall Study|Other - Not Protocol Specified|7|||
124609770|NCT00006721|448191843|FG000|Overall Study|Ineligible|2|||
124609771|NCT00006721|448191844|FG001|Overall Study|Ineligible|12|||
124609772|NCT00006721|448191845|FG002|Overall Study|Ineligible|10|||
124609773|NCT00006721|448191843|FG000|Overall Study|Eligible but no Treatment Received|1|||
124609774|NCT00006721|448191844|FG001|Overall Study|Eligible but no Treatment Received|0|||
124609775|NCT00006721|448191845|FG002|Overall Study|Eligible but no Treatment Received|0|||
124609776|NCT03611543|448191846|FG000|Overall Study|Withdrawal by Subject|4|||
124609777|NCT03611543|448191847|FG001|Overall Study|Withdrawal by Subject|4|||
124609778|NCT03611543|448191846|FG000|Overall Study|Physician Decision|1|||
124609779|NCT03611543|448191847|FG001|Overall Study|Physician Decision|1|||
124609780|NCT03611543|448191846|FG000|Overall Study|Protocol Violation|2|||
124609781|NCT03611543|448191847|FG001|Overall Study|Protocol Violation|2|||
124609782|NCT03611543|448191846|FG000|Overall Study|Device failure|2|||
124609783|NCT03611543|448191847|FG001|Overall Study|Device failure|2|||
124609784|NCT03611543|448191846|FG000|Overall Study|Missing information|5|||
124609785|NCT03611543|448191847|FG001|Overall Study|Missing information|5|||
124609786|NCT04395001|448191848|FG000|Overall Study|Lost to Follow-up|8|||
124609787|NCT04395001|448191849|FG001|Overall Study|Lost to Follow-up|9|||
124609788|NCT04395001|448191850|FG002|Overall Study|Lost to Follow-up|5|||
124609789|NCT04395001|448191848|FG000|Overall Study|Withdrawal by Subject|3|||
124609790|NCT04395001|448191849|FG001|Overall Study|Withdrawal by Subject|1|||
124609791|NCT04395001|448191850|FG002|Overall Study|Withdrawal by Subject|3|||
124609792|NCT04395001|448191848|FG000|Overall Study|missed appointment|7|||
124609793|NCT04395001|448191849|FG001|Overall Study|missed appointment|4|||
124609794|NCT04395001|448191850|FG002|Overall Study|missed appointment|1|||
124609795|NCT04347122|448191851|FG000|Overall Study|Physician Decision|0|||
124609796|NCT04347122|448191852|FG001|Overall Study|Physician Decision|3|||
124609797|NCT04347122|448191853|FG002|Overall Study|Physician Decision|3|||
124609798|NCT04347122|448191854|FG003|Overall Study|Physician Decision|6|||
124609799|NCT03186781|448191855|FG000|Overall Study|Lost to Follow-up|0|||
124609800|NCT03186781|448191856|FG001|Overall Study|Lost to Follow-up|0|||
124609801|NCT03186781|448191857|FG002|Overall Study|Lost to Follow-up|1|||
124609802|NCT03186781|448191858|FG003|Overall Study|Lost to Follow-up|0|||
124609803|NCT03186781|448191859|FG004|Overall Study|Lost to Follow-up|1|||
124609804|NCT03186781|448191860|FG005|Overall Study|Lost to Follow-up|0|||
124609805|NCT03186781|448191855|FG000|Overall Study|Moved from Area|0|||
124609806|NCT03186781|448191856|FG001|Overall Study|Moved from Area|0|||
124609807|NCT03186781|448191857|FG002|Overall Study|Moved from Area|0|||
124609808|NCT03186781|448191858|FG003|Overall Study|Moved from Area|0|||
124609809|NCT03186781|448191859|FG004|Overall Study|Moved from Area|1|||
124609810|NCT03186781|448191860|FG005|Overall Study|Moved from Area|0|||
124609811|NCT03186781|448191855|FG000|Overall Study|Withdrawal by Subject|0|||
124609812|NCT03186781|448191856|FG001|Overall Study|Withdrawal by Subject|0|||
124609813|NCT03186781|448191857|FG002|Overall Study|Withdrawal by Subject|0|||
124609814|NCT03186781|448191858|FG003|Overall Study|Withdrawal by Subject|0|||
124609815|NCT03186781|448191859|FG004|Overall Study|Withdrawal by Subject|1|||
124609816|NCT03186781|448191860|FG005|Overall Study|Withdrawal by Subject|0|||
124609817|NCT00792935|448191861|FG000|Overall Study|Adverse Event|2|||
124609818|NCT00792935|448191862|FG001|Overall Study|Adverse Event|1|||
124609819|NCT00792935|448191861|FG000|Overall Study|Lost to Follow-up|0|||
124609820|NCT00792935|448191862|FG001|Overall Study|Lost to Follow-up|1|||
124609821|NCT00792935|448191861|FG000|Overall Study|Protocol Violation|2|||
124609822|NCT00792935|448191862|FG001|Overall Study|Protocol Violation|0|||
124609823|NCT00792935|448191861|FG000|Overall Study|Withdrawal by Subject|0|||
124609824|NCT00792935|448191862|FG001|Overall Study|Withdrawal by Subject|1|||
124609825|NCT04663295|448191863|FG000|Run-in Period|Withdrawal by Subject|3|||
124609826|NCT04663295|448191863|FG000|Overall Study Period|Pregnancy|1|||
124609827|NCT04663295|448191863|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
124609828|NCT03954834|448191864|FG000|Overall Study|Adverse Event|1|||
124609829|NCT03954834|448191865|FG001|Overall Study|Adverse Event|3|||
124609830|NCT03954834|448191866|FG002|Overall Study|Adverse Event|1|||
124609831|NCT03954834|448191867|FG003|Overall Study|Adverse Event|1|||
124609832|NCT03954834|448191864|FG000|Overall Study|Death|0|||
124609833|NCT03954834|448191865|FG001|Overall Study|Death|0|||
124609834|NCT03954834|448191866|FG002|Overall Study|Death|0|||
124609835|NCT03954834|448191867|FG003|Overall Study|Death|1|||
124609836|NCT03954834|448191864|FG000|Overall Study|Physician Decision|0|||
124609837|NCT03954834|448191865|FG001|Overall Study|Physician Decision|1|||
124609838|NCT03954834|448191866|FG002|Overall Study|Physician Decision|0|||
124609839|NCT03954834|448191867|FG003|Overall Study|Physician Decision|2|||
124609840|NCT03954834|448191864|FG000|Overall Study|Protocol Violation|1|||
124609841|NCT03954834|448191865|FG001|Overall Study|Protocol Violation|0|||
124609842|NCT03954834|448191866|FG002|Overall Study|Protocol Violation|0|||
124609843|NCT03954834|448191867|FG003|Overall Study|Protocol Violation|1|||
124609844|NCT03954834|448191864|FG000|Overall Study|Withdrawal by Subject|2|||
124609845|NCT03954834|448191865|FG001|Overall Study|Withdrawal by Subject|3|||
124609846|NCT03954834|448191866|FG002|Overall Study|Withdrawal by Subject|13|||
124609847|NCT03954834|448191867|FG003|Overall Study|Withdrawal by Subject|6|||
124609848|NCT03954834|448191864|FG000|Overall Study|Participant left the country|0|||
124609849|NCT03954834|448191865|FG001|Overall Study|Participant left the country|0|||
124609850|NCT03954834|448191866|FG002|Overall Study|Participant left the country|1|||
124609851|NCT03954834|448191867|FG003|Overall Study|Participant left the country|0|||
124609852|NCT03954834|448191864|FG000|Overall Study|Lost to Follow-up|3|||
124609853|NCT03954834|448191865|FG001|Overall Study|Lost to Follow-up|2|||
124609854|NCT03954834|448191866|FG002|Overall Study|Lost to Follow-up|3|||
124732001|NCT00445939|448641885|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
124732002|NCT00445939|448641886|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
124732003|NCT00445939|448641887|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
124732004|NCT00445939|448641888|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
124732005|NCT00798317|448641892|FG000|Overall Study|Physician Decision|0|||
124732006|NCT00798317|448641893|FG001|Overall Study|Physician Decision|1|||
124732007|NCT00798317|448641892|FG000|Overall Study|Withdrawal by Subject|5|||
124732008|NCT00798317|448641893|FG001|Overall Study|Withdrawal by Subject|4|||
124732009|NCT00798317|448641892|FG000|Overall Study|Lost to Follow-up|2|||
124781175|NCT01175083|448829108|FG002|Primary Epoch|Lost to Follow-up|0|||
124609855|NCT03954834|448191867|FG003|Overall Study|Lost to Follow-up|5|||
124609856|NCT02903030|448191870|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
124609857|NCT02903030|448191871|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
124609858|NCT01502410|448191872|FG000|Overall Study|Adverse Event|1|||
124609859|NCT01502410|448191873|FG001|Overall Study|Adverse Event|2|||
124609860|NCT01502410|448191874|FG002|Overall Study|Adverse Event|0|||
124609861|NCT01502410|448191875|FG003|Overall Study|Adverse Event|0|||
124609862|NCT01502410|448191872|FG000|Overall Study|Lack of Efficacy|7|||
124732010|NCT00798317|448641893|FG001|Overall Study|Lost to Follow-up|2|||
124609863|NCT01502410|448191873|FG001|Overall Study|Lack of Efficacy|7|||
124609864|NCT01502410|448191874|FG002|Overall Study|Lack of Efficacy|0|||
124609865|NCT01502410|448191875|FG003|Overall Study|Lack of Efficacy|0|||
124609866|NCT01502410|448191872|FG000|Overall Study|Physician Decision|0|||
124609867|NCT01502410|448191873|FG001|Overall Study|Physician Decision|1|||
124609868|NCT01502410|448191874|FG002|Overall Study|Physician Decision|0|||
124609869|NCT01502410|448191875|FG003|Overall Study|Physician Decision|0|||
124781176|NCT01175083|448829109|FG003|Primary Epoch|Lost to Follow-up|0|||
124609870|NCT01502410|448191872|FG000|Overall Study|Withdrawal by Subject|2|||
124609871|NCT01502410|448191873|FG001|Overall Study|Withdrawal by Subject|0|||
124609872|NCT01502410|448191874|FG002|Overall Study|Withdrawal by Subject|0|||
124609873|NCT01502410|448191875|FG003|Overall Study|Withdrawal by Subject|0|||
124609874|NCT01284361|448191880|FG000|Overall Study|Withdrawal by Subject|1|||
124609875|NCT01284361|448191880|FG000|Overall Study|Protocol Violation|5|||
124609876|NCT01284361|448191880|FG000|Overall Study|Adverse Event|1|||
124609877|NCT01284361|448191880|FG000|Overall Study|Lost to Follow-up|2|||
124609878|NCT00663026|448191881|FG000|Overall Study|Lost to Follow-up|1|||
124609879|NCT00663026|448191882|FG001|Overall Study|Lost to Follow-up|0|||
124609880|NCT00663026|448191883|FG002|Overall Study|Lost to Follow-up|0|||
124609881|NCT00663026|448191881|FG000|Overall Study|Other|1|||
124609882|NCT00663026|448191882|FG001|Overall Study|Other|2|||
124609883|NCT00663026|448191883|FG002|Overall Study|Other|0|||
124609884|NCT00663026|448191881|FG000|Overall Study|Adverse Event|0|||
124609885|NCT00663026|448191882|FG001|Overall Study|Adverse Event|2|||
124609886|NCT00663026|448191883|FG002|Overall Study|Adverse Event|3|||
124609887|NCT00663026|448191881|FG000|Overall Study|Caregiver Request|0|||
124609888|NCT00663026|448191882|FG001|Overall Study|Caregiver Request|2|||
124609889|NCT00663026|448191883|FG002|Overall Study|Caregiver Request|0|||
124609890|NCT00663026|448191881|FG000|Overall Study|Withdrawal by Subject|0|||
124609891|NCT00663026|448191882|FG001|Overall Study|Withdrawal by Subject|0|||
124609892|NCT00663026|448191883|FG002|Overall Study|Withdrawal by Subject|1|||
124609893|NCT01570686|448191884|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124609894|NCT01570686|448191885|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124609895|NCT01570686|448191884|FG000|Overall Study|Administrative problems|0|||
124609896|NCT01570686|448191885|FG001|Overall Study|Administrative problems|1|||
124609897|NCT01570686|448191884|FG000|Overall Study|Adverse Event|8|||
124609898|NCT01570686|448191885|FG001|Overall Study|Adverse Event|6|||
124609899|NCT01570686|448191884|FG000|Overall Study|Lost to Follow-up|4|||
124609900|NCT01570686|448191885|FG001|Overall Study|Lost to Follow-up|3|||
124609901|NCT01570686|448191884|FG000|Overall Study|Protocol Deviation|3|||
124609902|NCT01570686|448191885|FG001|Overall Study|Protocol Deviation|0|||
124609903|NCT01570686|448191884|FG000|Overall Study|Withdrawal by Subject|4|||
124609904|NCT01570686|448191885|FG001|Overall Study|Withdrawal by Subject|4|||
124609905|NCT01570686|448191884|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124609906|NCT01570686|448191885|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124609907|NCT00754650|448191886|FG000|Overall Study|Disease Progression|2|||
124609908|NCT00805675|448191887|FG000|Overall Study|Adverse Event|0|||
124609909|NCT00805675|448191888|FG001|Overall Study|Adverse Event|0|||
124609910|NCT00805675|448191889|FG002|Overall Study|Adverse Event|1|||
124609911|NCT00325195|448191891|FG000|Randomized|Not dosed|5|||
124609912|NCT00325195|448191892|FG001|Randomized|Not dosed|5|||
124609913|NCT00325195|448191893|FG002|Randomized|Not dosed|3|||
124609914|NCT00325195|448191891|FG000|Received Intervention: ITT Population|Adverse Event|15|||
124609915|NCT00325195|448191892|FG001|Received Intervention: ITT Population|Adverse Event|17|||
124609916|NCT00325195|448191893|FG002|Received Intervention: ITT Population|Adverse Event|1|||
124609917|NCT00325195|448191891|FG000|Received Intervention: ITT Population|Death|3|||
124609918|NCT00325195|448191892|FG001|Received Intervention: ITT Population|Death|1|||
124609919|NCT00325195|448191893|FG002|Received Intervention: ITT Population|Death|0|||
124609920|NCT00325195|448191891|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
124609921|NCT00325195|448191892|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
124609922|NCT00325195|448191893|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
124609923|NCT00325195|448191891|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
124609924|NCT00325195|448191892|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
124609925|NCT00325195|448191893|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
124609926|NCT00325195|448191891|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
124609927|NCT00325195|448191892|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
124609928|NCT00325195|448191893|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
124609929|NCT00686075|448191895|FG000|Overall Study|Withdrawal by Subject|4|||
124609930|NCT00686075|448191896|FG001|Overall Study|Withdrawal by Subject|3|||
124609931|NCT00686075|448191897|FG002|Overall Study|Withdrawal by Subject|3|||
124609932|NCT00686075|448191898|FG003|Overall Study|Withdrawal by Subject|7|||
124609933|NCT00686075|448191899|FG004|Overall Study|Withdrawal by Subject|1|||
124609934|NCT00686075|448191900|FG005|Overall Study|Withdrawal by Subject|0|||
124609935|NCT00686075|448191901|FG006|Overall Study|Withdrawal by Subject|0|||
124732011|NCT00798317|448641892|FG000|Overall Study|Adverse Event|2|||
124732012|NCT00798317|448641893|FG001|Overall Study|Adverse Event|0|||
124732013|NCT00798317|448641892|FG000|Overall Study|Death|1|||
124609936|NCT00686075|448191902|FG007|Overall Study|Withdrawal by Subject|2|||
124609937|NCT00686075|448191903|FG008|Overall Study|Withdrawal by Subject|4|||
124609938|NCT00686075|448191904|FG009|Overall Study|Withdrawal by Subject|6|||
124609939|NCT00686075|448191895|FG000|Overall Study|Lost to Follow-up|3|||
124609940|NCT00686075|448191896|FG001|Overall Study|Lost to Follow-up|6|||
124732014|NCT00798317|448641893|FG001|Overall Study|Death|0|||
124609941|NCT00686075|448191897|FG002|Overall Study|Lost to Follow-up|3|||
124609942|NCT00686075|448191898|FG003|Overall Study|Lost to Follow-up|2|||
124609943|NCT00686075|448191899|FG004|Overall Study|Lost to Follow-up|3|||
124609944|NCT00686075|448191900|FG005|Overall Study|Lost to Follow-up|3|||
124609945|NCT00686075|448191901|FG006|Overall Study|Lost to Follow-up|0|||
124609946|NCT00686075|448191902|FG007|Overall Study|Lost to Follow-up|0|||
124609947|NCT00686075|448191903|FG008|Overall Study|Lost to Follow-up|2|||
124609948|NCT00686075|448191904|FG009|Overall Study|Lost to Follow-up|3|||
124609949|NCT00686075|448191895|FG000|Overall Study|Other|1|||
124609950|NCT00686075|448191896|FG001|Overall Study|Other|1|||
124609951|NCT00686075|448191897|FG002|Overall Study|Other|0|||
124609952|NCT00686075|448191898|FG003|Overall Study|Other|0|||
124609953|NCT00686075|448191899|FG004|Overall Study|Other|0|||
124609954|NCT00686075|448191900|FG005|Overall Study|Other|0|||
124609955|NCT00686075|448191901|FG006|Overall Study|Other|0|||
124609956|NCT00686075|448191902|FG007|Overall Study|Other|0|||
124609957|NCT00686075|448191903|FG008|Overall Study|Other|0|||
124609958|NCT00686075|448191904|FG009|Overall Study|Other|1|||
124609959|NCT04715932|448191905|FG000|Overall Study|Lost to Follow-up|1|||
124609960|NCT04715932|448191906|FG001|Overall Study|Lost to Follow-up|0|||
124609961|NCT02740699|448191917|FG000|Overall Study|Lost to Follow-up|5|||
124609962|NCT02740699|448191917|FG000|Overall Study|Withdrawal by Subject|14|||
124609963|NCT02740699|448191917|FG000|Overall Study|Physician Decision|5|||
124609964|NCT03783039|448191919|FG000|Overall Study|Death|2|||
124609965|NCT03783039|448191920|FG001|Overall Study|Death|1|||
124609966|NCT01682863|448191921|FG000|Overall Study|Subject/guardian decision|19|||
124609967|NCT01682863|448191922|FG001|Overall Study|Subject/guardian decision|12|||
124609968|NCT01682863|448191923|FG002|Overall Study|Subject/guardian decision|10|||
124609969|NCT01682863|448191921|FG000|Overall Study|Lost to Follow-up|5|||
124609970|NCT01682863|448191922|FG001|Overall Study|Lost to Follow-up|1|||
124609971|NCT01682863|448191923|FG002|Overall Study|Lost to Follow-up|6|||
124609972|NCT01682863|448191921|FG000|Overall Study|Death|1|||
124609973|NCT01682863|448191922|FG001|Overall Study|Death|3|||
124609974|NCT01682863|448191923|FG002|Overall Study|Death|4|||
124609975|NCT01682863|448191921|FG000|Overall Study|Protocol deviation|1|||
124609976|NCT01682863|448191922|FG001|Overall Study|Protocol deviation|0|||
124609977|NCT01682863|448191923|FG002|Overall Study|Protocol deviation|1|||
124609978|NCT01682863|448191921|FG000|Overall Study|Technical problems|1|||
124609979|NCT01682863|448191922|FG001|Overall Study|Technical problems|0|||
124609980|NCT01682863|448191923|FG002|Overall Study|Technical problems|0|||
124609981|NCT01682863|448191921|FG000|Overall Study|Adverse Event|0|||
124609982|NCT01682863|448191922|FG001|Overall Study|Adverse Event|1|||
124609983|NCT01682863|448191923|FG002|Overall Study|Adverse Event|2|||
124609984|NCT01682863|448191921|FG000|Overall Study|Physician Decision|0|||
124609985|NCT01682863|448191922|FG001|Overall Study|Physician Decision|0|||
124609986|NCT01682863|448191923|FG002|Overall Study|Physician Decision|1|||
124609987|NCT00918138|448191924|FG000|Overall Study|Subject withdrew consent|1|||
124609988|NCT00918138|448191925|FG001|Overall Study|Subject withdrew consent|1|||
124609989|NCT00918138|448191924|FG000|Overall Study|Death|1|||
124609990|NCT00918138|448191925|FG001|Overall Study|Death|0|||
124609991|NCT00552578|448191929|FG000|Overall Study|Lost to Follow-up|1|||
124609992|NCT00552578|448191930|FG001|Overall Study|Lost to Follow-up|1|||
124609993|NCT01716715|448191931|FG000|Overall Study|Never Treated|2|||
124609994|NCT01716715|448191932|FG001|Overall Study|Never Treated|4|||
124609995|NCT04228783|448191933|FG000|Overall Study|Adverse Event|1|||
124609996|NCT04228783|448191934|FG001|Overall Study|Adverse Event|0|||
124609997|NCT04228783|448191935|FG002|Overall Study|Adverse Event|2|||
124609998|NCT04228783|448191936|FG003|Overall Study|Adverse Event|0|||
124609999|NCT04228783|448191937|FG004|Overall Study|Adverse Event|0|||
124610000|NCT04228783|448191938|FG005|Overall Study|Adverse Event|1|||
124732015|NCT00378599|448641894|FG000|Overall Study|Adverse Event|38|||
124610001|NCT04228783|448191933|FG000|Overall Study|Death|0|||
124610002|NCT04228783|448191934|FG001|Overall Study|Death|0|||
124610003|NCT04228783|448191935|FG002|Overall Study|Death|0|||
124610004|NCT04228783|448191936|FG003|Overall Study|Death|0|||
124610005|NCT04228783|448191937|FG004|Overall Study|Death|1|||
124610006|NCT04228783|448191938|FG005|Overall Study|Death|0|||
124610007|NCT04228783|448191933|FG000|Overall Study|Lost to Follow-up|36|||
124610008|NCT04228783|448191934|FG001|Overall Study|Lost to Follow-up|36|||
124610009|NCT04228783|448191935|FG002|Overall Study|Lost to Follow-up|28|||
124610010|NCT04228783|448191936|FG003|Overall Study|Lost to Follow-up|6|||
124610011|NCT04228783|448191937|FG004|Overall Study|Lost to Follow-up|14|||
124732016|NCT00378599|448641894|FG000|Overall Study|Protocol Violation|2|||
124610012|NCT04228783|448191938|FG005|Overall Study|Lost to Follow-up|3|||
124610013|NCT04228783|448191933|FG000|Overall Study|Physician Decision|1|||
124610014|NCT04228783|448191934|FG001|Overall Study|Physician Decision|2|||
124610015|NCT04228783|448191935|FG002|Overall Study|Physician Decision|0|||
124610016|NCT04228783|448191936|FG003|Overall Study|Physician Decision|0|||
124610017|NCT04228783|448191937|FG004|Overall Study|Physician Decision|0|||
124610018|NCT04228783|448191938|FG005|Overall Study|Physician Decision|0|||
124610019|NCT04228783|448191933|FG000|Overall Study|Protocol Violation|0|||
124610020|NCT04228783|448191934|FG001|Overall Study|Protocol Violation|0|||
124732017|NCT00378599|448641894|FG000|Overall Study|Treatment failure|7|||
124732018|NCT00378599|448641894|FG000|Overall Study|Withdrawal by Subject|5|||
124732019|NCT00416715|448641895|FG000|Overall Study|Not evaluable for joint aches|7|||
124732020|NCT00416715|448641895|FG000|Overall Study|Vitamin D levels not evaluable|8|||
124732021|NCT00489736|448641899|FG000|Overall Study|Lack of Efficacy|53|||
124732022|NCT00489736|448641900|FG001|Overall Study|Lack of Efficacy|14|||
124732023|NCT00489736|448641899|FG000|Overall Study|Adverse Event|32|||
124732024|NCT00489736|448641900|FG001|Overall Study|Adverse Event|45|||
124732025|NCT00489736|448641899|FG000|Overall Study|Poor compliance|6|||
124732026|NCT00489736|448641900|FG001|Overall Study|Poor compliance|2|||
124732027|NCT00489736|448641899|FG000|Overall Study|Not coded/ Not pre-specified|5|||
124732028|NCT00489736|448641900|FG001|Overall Study|Not coded/ Not pre-specified|8|||
124732029|NCT03812185|448641901|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
124732030|NCT02576535|448641916|FG000|Overall Study|Withdrawal by Subject|2|||
124732031|NCT02545517|448641917|FG000|Overall Study|Death|2|||
124732032|NCT02545517|448641918|FG001|Overall Study|Death|2|||
124732033|NCT02545517|448641919|FG002|Overall Study|Death|1|||
124732034|NCT02545517|448641917|FG000|Overall Study|Lost to Follow-up|14|||
124732035|NCT02545517|448641918|FG001|Overall Study|Lost to Follow-up|13|||
124732036|NCT02545517|448641919|FG002|Overall Study|Lost to Follow-up|17|||
124732037|NCT02545517|448641917|FG000|Overall Study|Protocol Violation|0|||
124732038|NCT02545517|448641918|FG001|Overall Study|Protocol Violation|1|||
124732039|NCT02545517|448641919|FG002|Overall Study|Protocol Violation|1|||
124732040|NCT02545517|448641917|FG000|Overall Study|Withdrawal by Subject|5|||
124732041|NCT02545517|448641918|FG001|Overall Study|Withdrawal by Subject|8|||
124732042|NCT02545517|448641919|FG002|Overall Study|Withdrawal by Subject|9|||
124732043|NCT02545517|448641917|FG000|Overall Study|Administrative reason|5|||
124732044|NCT02545517|448641918|FG001|Overall Study|Administrative reason|6|||
124732045|NCT02545517|448641919|FG002|Overall Study|Administrative reason|10|||
124732046|NCT02545517|448641917|FG000|Overall Study|Other|2|||
124732047|NCT02545517|448641918|FG001|Overall Study|Other|4|||
124732048|NCT02545517|448641919|FG002|Overall Study|Other|3|||
124732049|NCT01529515|448641922|FG000|TRANSITION PHASE|Adverse Event|16|||
124732050|NCT01529515|448641923|FG001|TRANSITION PHASE|Adverse Event|0|||
124732051|NCT01529515|448641924|FG002|TRANSITION PHASE|Adverse Event|0|||
124732052|NCT01529515|448641925|FG003|TRANSITION PHASE|Adverse Event|0|||
124732053|NCT01529515|448641922|FG000|TRANSITION PHASE|Death|1|||
124732054|NCT01529515|448641923|FG001|TRANSITION PHASE|Death|0|||
124732055|NCT01529515|448641924|FG002|TRANSITION PHASE|Death|0|||
124732056|NCT01529515|448641925|FG003|TRANSITION PHASE|Death|0|||
124732057|NCT01529515|448641922|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
124732058|NCT01529515|448641923|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
124732059|NCT01529515|448641924|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
124732060|NCT01529515|448641925|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
124732061|NCT01529515|448641922|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
124732062|NCT01529515|448641923|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
124732063|NCT01529515|448641924|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
124732064|NCT01529515|448641925|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
124732065|NCT01529515|448641922|FG000|TRANSITION PHASE|Protocol Violation|4|||
124732066|NCT01529515|448641923|FG001|TRANSITION PHASE|Protocol Violation|0|||
124732067|NCT01529515|448641924|FG002|TRANSITION PHASE|Protocol Violation|0|||
124732068|NCT01529515|448641925|FG003|TRANSITION PHASE|Protocol Violation|0|||
124732069|NCT01529515|448641922|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
124732070|NCT01529515|448641923|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
124732071|NCT01529515|448641924|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
124732072|NCT01529515|448641925|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
124732073|NCT01529515|448641922|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
124732074|NCT01529515|448641923|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
124732075|NCT01529515|448641924|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
124732076|NCT01529515|448641925|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
124732077|NCT01529515|448641922|FG000|TRANSITION PHASE|Other|9|||
124732078|NCT01529515|448641923|FG001|TRANSITION PHASE|Other|0|||
124732079|NCT01529515|448641924|FG002|TRANSITION PHASE|Other|0|||
124732080|NCT01529515|448641925|FG003|TRANSITION PHASE|Other|0|||
124732081|NCT01529515|448641922|FG000|MAINTENANCE PHASE|Adverse Event|0|||
124781177|NCT01175083|448829110|FG004|Primary Epoch|Lost to Follow-up|0|||
124781178|NCT01175083|448829111|FG005|Primary Epoch|Lost to Follow-up|1|||
124732082|NCT01529515|448641923|FG001|MAINTENANCE PHASE|Adverse Event|10|||
124732083|NCT01529515|448641924|FG002|MAINTENANCE PHASE|Adverse Event|0|||
124732084|NCT01529515|448641925|FG003|MAINTENANCE PHASE|Adverse Event|0|||
124732085|NCT01529515|448641922|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
124732086|NCT01529515|448641923|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
124732087|NCT01529515|448641924|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
124732088|NCT01529515|448641925|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
124732089|NCT01529515|448641922|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
124732090|NCT01529515|448641923|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
124732091|NCT01529515|448641924|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
124732092|NCT01529515|448641925|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
124732093|NCT01529515|448641922|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
124732094|NCT01529515|448641923|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
124732095|NCT01529515|448641924|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
124732096|NCT01529515|448641925|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
124732097|NCT01529515|448641922|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
124732098|NCT01529515|448641923|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
124732099|NCT01529515|448641924|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
124732100|NCT01529515|448641925|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
124732101|NCT01529515|448641922|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
124732102|NCT01529515|448641923|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
124732103|NCT01529515|448641924|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
124732104|NCT01529515|448641925|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
124732105|NCT01529515|448641922|FG000|MAINTENANCE PHASE|Other|0|||
124732106|NCT01529515|448641923|FG001|MAINTENANCE PHASE|Other|10|||
124732107|NCT01529515|448641924|FG002|MAINTENANCE PHASE|Other|0|||
124732108|NCT01529515|448641925|FG003|MAINTENANCE PHASE|Other|0|||
124732109|NCT01529515|448641922|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
124732110|NCT01529515|448641923|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
124732111|NCT01529515|448641924|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
124732112|NCT01529515|448641925|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
124732113|NCT01529515|448641922|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
124732114|NCT01529515|448641923|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
124732115|NCT01529515|448641924|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
124732116|NCT01529515|448641925|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
124732117|NCT01529515|448641922|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
124732118|NCT01529515|448641923|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
124732119|NCT01529515|448641924|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
124732120|NCT01529515|448641925|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
124732121|NCT01529515|448641922|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
124732122|NCT01529515|448641923|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
124732123|NCT01529515|448641924|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
124732124|NCT01529515|448641925|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
124732125|NCT01529515|448641922|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
124732126|NCT01529515|448641923|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
124732127|NCT01529515|448641924|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
124732128|NCT01529515|448641925|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
124732129|NCT01529515|448641922|FG000|DOUBLE BLIND PHASE|Other|0|||
124732130|NCT01529515|448641923|FG001|DOUBLE BLIND PHASE|Other|0|||
124732131|NCT01529515|448641924|FG002|DOUBLE BLIND PHASE|Other|9|||
124732132|NCT01529515|448641925|FG003|DOUBLE BLIND PHASE|Other|2|||
124732133|NCT03920293|448641927|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
124732134|NCT03920293|448641928|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
124732135|NCT03920293|448641927|FG000|Randomized-Controlled Period|Physician Decision|1|||
124732136|NCT03920293|448641928|FG001|Randomized-Controlled Period|Physician Decision|2|||
124732137|NCT03920293|448641927|FG000|Randomized-Controlled Period|Adverse Event|0|||
124732138|NCT03920293|448641928|FG001|Randomized-Controlled Period|Adverse Event|2|||
124732139|NCT03920293|448641927|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
124732140|NCT03920293|448641928|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
124732141|NCT03920293|448641927|FG000|Randomized-Controlled Period|Death|2|||
124732142|NCT03920293|448641928|FG001|Randomized-Controlled Period|Death|0|||
124732143|NCT03920293|448641927|FG000|Randomized-Controlled Period|Protocol Violation|1|||
124732144|NCT03920293|448641928|FG001|Randomized-Controlled Period|Protocol Violation|0|||
124732145|NCT03920293|448641927|FG000|Randomized-Controlled Period|Noncompliance|1|||
124732146|NCT03920293|448641928|FG001|Randomized-Controlled Period|Noncompliance|0|||
124732147|NCT03920293|448641927|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
124732148|NCT03920293|448641928|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
124732149|NCT03920293|448641927|FG000|Open- Label Extension Period|Death|3|||
124732150|NCT03920293|448641928|FG001|Open- Label Extension Period|Death|3|||
124732151|NCT03920293|448641927|FG000|Open- Label Extension Period|Physician Decision|5|||
124732152|NCT03920293|448641928|FG001|Open- Label Extension Period|Physician Decision|3|||
124732153|NCT03920293|448641927|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
124732154|NCT03920293|448641928|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
124781179|NCT01175083|448829106|FG000|Booster Epoch|Death|0|||
124781180|NCT01175083|448829107|FG001|Booster Epoch|Death|0|||
124781181|NCT01175083|448829108|FG002|Booster Epoch|Death|1|||
124732155|NCT01069861|448641929|FG000|Overall Study|Death|1|||
124781182|NCT01175083|448829109|FG003|Booster Epoch|Death|0|||
124781183|NCT01175083|448829110|FG004|Booster Epoch|Death|0|||
124732156|NCT01069861|448641929|FG000|Overall Study|Adverse Event|1|||
124732157|NCT01069861|448641929|FG000|Overall Study|Did not meet entrance criteria|1|||
124732158|NCT03272828|448641931|FG000|Overall Study|Lost to Follow-up|7|||
124732159|NCT03272828|448641932|FG001|Overall Study|Lost to Follow-up|7|||
124732160|NCT03272828|448641931|FG000|Overall Study|Withdrawal by Subject|2|||
124781184|NCT01175083|448829111|FG005|Booster Epoch|Death|0|||
124732161|NCT03272828|448641932|FG001|Overall Study|Withdrawal by Subject|0|||
124781185|NCT01175083|448829106|FG000|Booster Epoch|Withdrawal by Subject|0|||
124732162|NCT03272828|448641931|FG000|Overall Study|Deceased|1|||
124732163|NCT03272828|448641932|FG001|Overall Study|Deceased|1|||
124732164|NCT03272828|448641931|FG000|Overall Study|Failed implant|1|||
124732165|NCT03272828|448641932|FG001|Overall Study|Failed implant|2|||
124732166|NCT00996281|448641934|FG000|Overall Study|Adverse Event|75|||
124732167|NCT00996281|448641935|FG001|Overall Study|Adverse Event|37|||
124732168|NCT00996281|448641934|FG000|Overall Study|Major Protocol Deviation|6|||
124732169|NCT00996281|448641935|FG001|Overall Study|Major Protocol Deviation|7|||
124732170|NCT00996281|448641934|FG000|Overall Study|Lost to Follow-up|14|||
124732171|NCT00996281|448641935|FG001|Overall Study|Lost to Follow-up|16|||
124732172|NCT00996281|448641934|FG000|Overall Study|Withdrawal by Subject|31|||
124732173|NCT00996281|448641935|FG001|Overall Study|Withdrawal by Subject|20|||
124732174|NCT00996281|448641934|FG000|Overall Study|Lack of Efficacy|0|||
124732175|NCT00996281|448641935|FG001|Overall Study|Lack of Efficacy|2|||
124732176|NCT00996281|448641934|FG000|Overall Study|Other|5|||
124732177|NCT00996281|448641935|FG001|Overall Study|Other|7|||
124732178|NCT03505788|448641936|FG000|Overall Study|Lost to Follow-up|2|||
124732179|NCT03505788|448641937|FG001|Overall Study|Lost to Follow-up|1|||
124732180|NCT03505788|448641936|FG000|Overall Study|Withdrawal by Subject|1|||
124732181|NCT03505788|448641937|FG001|Overall Study|Withdrawal by Subject|3|||
124732182|NCT03505788|448641936|FG000|Overall Study|Physician Decision|0|||
124732183|NCT03505788|448641937|FG001|Overall Study|Physician Decision|1|||
124732184|NCT01920568|448641938|FG000|Overall Study|Adverse Event|27|||
124732185|NCT01920568|448641939|FG001|Overall Study|Adverse Event|8|||
124732186|NCT01920568|448641938|FG000|Overall Study|Protocol Violation|5|||
124732187|NCT01920568|448641939|FG001|Overall Study|Protocol Violation|3|||
124732188|NCT01920568|448641938|FG000|Overall Study|Lost to Follow-up|2|||
124732189|NCT01920568|448641939|FG001|Overall Study|Lost to Follow-up|2|||
124732190|NCT01920568|448641938|FG000|Overall Study|Physician Decision|13|||
124732191|NCT01920568|448641939|FG001|Overall Study|Physician Decision|4|||
124732192|NCT01920568|448641938|FG000|Overall Study|Withdrawal by Subject|79|||
124732193|NCT01920568|448641939|FG001|Overall Study|Withdrawal by Subject|55|||
124732194|NCT01920568|448641938|FG000|Overall Study|Death due to disease progression|25|||
124732195|NCT01920568|448641939|FG001|Overall Study|Death due to disease progression|12|||
124732196|NCT02891681|448641942|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
124732197|NCT02891681|448641943|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
124732198|NCT02891681|448641944|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
124732199|NCT02891681|448641942|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
124732200|NCT02891681|448641943|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
124732201|NCT02891681|448641944|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
124732202|NCT02891681|448641942|FG000|Overall Study|Taken off study after first imaging appointment|1|||
124732203|NCT02891681|448641943|FG001|Overall Study|Taken off study after first imaging appointment|0|||
124732204|NCT02891681|448641944|FG002|Overall Study|Taken off study after first imaging appointment|0|||
124732205|NCT00856206|448641946|FG000|Overall Study|Protocol Violation|6|||
124732206|NCT00856206|448641947|FG001|Overall Study|Protocol Violation|18|||
124732207|NCT00856206|448641946|FG000|Overall Study|Adverse Event|10|||
124732208|NCT00856206|448641947|FG001|Overall Study|Adverse Event|46|||
124732209|NCT00856206|448641946|FG000|Overall Study|Lack of Efficacy|1|||
124732210|NCT00856206|448641947|FG001|Overall Study|Lack of Efficacy|2|||
124732211|NCT00856206|448641946|FG000|Overall Study|Withdrawal by Subject|15|||
124732212|NCT00856206|448641947|FG001|Overall Study|Withdrawal by Subject|36|||
124732213|NCT00856206|448641946|FG000|Overall Study|Lost to Follow-up|13|||
124732214|NCT00856206|448641947|FG001|Overall Study|Lost to Follow-up|39|||
124732215|NCT00856206|448641946|FG000|Overall Study|Death|2|||
124732216|NCT00856206|448641947|FG001|Overall Study|Death|2|||
124732217|NCT00856206|448641946|FG000|Overall Study|Decision by the Sponsor|4|||
124732218|NCT00856206|448641947|FG001|Overall Study|Decision by the Sponsor|8|||
124732219|NCT00856206|448641946|FG000|Overall Study|Other than specified above|3|||
124732220|NCT00856206|448641947|FG001|Overall Study|Other than specified above|10|||
124732221|NCT04584346|448641948|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
124732222|NCT04584346|448641949|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
124732223|NCT02780856|448641956|FG000|Overall Study|Lost to Follow-up|1|||
124732224|NCT03640052|448641957|FG000|Overall Study|Lost to Follow-up|0|||
124732225|NCT03640052|448641958|FG001|Overall Study|Lost to Follow-up|1|||
124732226|NCT03640052|448641959|FG002|Overall Study|Lost to Follow-up|0|||
124781186|NCT01175083|448829107|FG001|Booster Epoch|Withdrawal by Subject|0|||
124610021|NCT04228783|448191935|FG002|Overall Study|Protocol Violation|0|||
124732227|NCT03640052|448641960|FG003|Overall Study|Lost to Follow-up|0|||
124732228|NCT03640052|448641961|FG004|Overall Study|Lost to Follow-up|0|||
124732229|NCT04422561|448641962|FG000|Overall Study|Lost to Follow-up|25|||
124732230|NCT04422561|448641963|FG001|Overall Study|Lost to Follow-up|11|||
124732231|NCT04239222|448641966|FG000|Baseline|Withdrawal by Subject|0|||
124732232|NCT04239222|448641967|FG001|Baseline|Withdrawal by Subject|0|||
124732233|NCT04239222|448641968|FG002|Baseline|Withdrawal by Subject|1|||
124732234|NCT04239222|448641969|FG003|Baseline|Withdrawal by Subject|1|||
124732235|NCT04239222|448641966|FG000|First Foot Assignment|Withdrawal by Subject|0|||
124732236|NCT04239222|448641967|FG001|First Foot Assignment|Withdrawal by Subject|0|||
124732237|NCT04239222|448641968|FG002|First Foot Assignment|Withdrawal by Subject|1|||
124732238|NCT04239222|448641969|FG003|First Foot Assignment|Withdrawal by Subject|0|||
124732239|NCT04239222|448641966|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
124732240|NCT04239222|448641967|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
124732241|NCT04239222|448641968|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
124732242|NCT04239222|448641969|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
124732243|NCT00090233|448641975|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
124732244|NCT00090233|448641976|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
124732245|NCT00090233|448641975|FG000|Overall Study|Adverse Event|214|||
124732246|NCT00090233|448641976|FG001|Overall Study|Adverse Event|198|||
124732247|NCT00090233|448641975|FG000|Overall Study|Lost to Follow-up|68|||
124732248|NCT00090233|448641976|FG001|Overall Study|Lost to Follow-up|95|||
124732249|NCT00090233|448641975|FG000|Overall Study|Protocol Violation|960|||
124732250|NCT00090233|448641976|FG001|Overall Study|Protocol Violation|1022|||
124732251|NCT00090233|448641975|FG000|Overall Study|Withdrawal by Subject|182|||
124732252|NCT00090233|448641976|FG001|Overall Study|Withdrawal by Subject|211|||
124732253|NCT00090233|448641975|FG000|Overall Study|Moved|203|||
124732254|NCT00090233|448641976|FG001|Overall Study|Moved|189|||
124732255|NCT00090233|448641975|FG000|Overall Study|Other|1211|||
124732256|NCT00090233|448641976|FG001|Overall Study|Other|1160|||
124732257|NCT00090233|448641975|FG000|Overall Study|Data not available at data cut-off point|1552|||
124732258|NCT00090233|448641976|FG001|Overall Study|Data not available at data cut-off point|1563|||
124732259|NCT04863248|448641977|FG000|Overall Study|Sponsor Terminated|4|||
124732260|NCT04863248|448641978|FG001|Overall Study|Sponsor Terminated|1|||
124732261|NCT04863248|448641977|FG000|Overall Study|Death|0|||
124732262|NCT04863248|448641978|FG001|Overall Study|Death|1|||
124732263|NCT04863248|448641977|FG000|Overall Study|Withdrawal by Subject|0|||
124732264|NCT04863248|448641978|FG001|Overall Study|Withdrawal by Subject|1|||
124732265|NCT01691105|448641979|FG000|1 Month Follow-up|Lost to Follow-up|41|||
124732266|NCT01691105|448641980|FG001|1 Month Follow-up|Lost to Follow-up|38|||
124732267|NCT01691105|448641979|FG000|1 Month Follow-up|Death|2|||
124732268|NCT01691105|448641980|FG001|1 Month Follow-up|Death|3|||
124732269|NCT01691105|448641979|FG000|6 Month Follow-up|Lost to Follow-up|39|||
124732270|NCT01691105|448641980|FG001|6 Month Follow-up|Lost to Follow-up|58|||
124732271|NCT01691105|448641979|FG000|6 Month Follow-up|Death|13|||
124732272|NCT01691105|448641980|FG001|6 Month Follow-up|Death|13|||
124732273|NCT01691105|448641979|FG000|12 Month Follow-up|Lost to Follow-up|50|||
124732274|NCT01691105|448641980|FG001|12 Month Follow-up|Lost to Follow-up|71|||
124732275|NCT01691105|448641979|FG000|12 Month Follow-up|Death|22|||
124732276|NCT01691105|448641980|FG001|12 Month Follow-up|Death|30|||
124732277|NCT01691105|448641979|FG000|12 Month Biochemical Verification|Death|22|||
124732278|NCT01691105|448641980|FG001|12 Month Biochemical Verification|Death|30|||
124732279|NCT01691105|448641979|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
124732280|NCT01691105|448641980|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
124732281|NCT01691105|448641979|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
124732282|NCT01691105|448641980|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
124732283|NCT00790647|448641989|FG000|Overall Study|Adverse Event|1|||
124732284|NCT02701777|448641990|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
124732285|NCT02701777|448641991|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
124732286|NCT02701777|448641992|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
124732287|NCT02701777|448641993|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
124732288|NCT02701777|448641990|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
124732289|NCT02701777|448641991|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
124732290|NCT02701777|448641992|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
124732291|NCT02701777|448641993|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
124732292|NCT03549871|448641996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
124732293|NCT03549871|448641997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
124732294|NCT03549871|448641996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
124732295|NCT03549871|448641997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
124732296|NCT03549871|448641996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
124732297|NCT03549871|448641997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
124732298|NCT03549871|448641996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
124732299|NCT03549871|448641997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
124732300|NCT03549871|448641996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
124732301|NCT03549871|448641997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
124732302|NCT03549871|448641996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
124732303|NCT03549871|448641997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
124732304|NCT03549871|448641996|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
124610022|NCT04228783|448191936|FG003|Overall Study|Protocol Violation|1|||
124732305|NCT03549871|448641997|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
124732306|NCT03549871|448641996|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
124732307|NCT03549871|448641997|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
124732308|NCT03549871|448641996|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
124732309|NCT03549871|448641997|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
124732310|NCT03549871|448641996|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
124732311|NCT03549871|448641997|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
124732312|NCT03549871|448641996|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
124732313|NCT03549871|448641997|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
124732314|NCT01133626|448641999|FG000|Overall Study|Adverse Event|0|||
124732315|NCT01133626|448642000|FG001|Overall Study|Adverse Event|1|||
124732316|NCT01133626|448642001|FG002|Overall Study|Adverse Event|0|||
124732317|NCT01133626|448641999|FG000|Overall Study|Withdrawal by Subject|1|||
124732318|NCT01133626|448642000|FG001|Overall Study|Withdrawal by Subject|2|||
124732319|NCT01133626|448642001|FG002|Overall Study|Withdrawal by Subject|2|||
124732320|NCT01133626|448641999|FG000|Overall Study|Other|0|||
124732321|NCT01133626|448642000|FG001|Overall Study|Other|2|||
124732322|NCT01133626|448642001|FG002|Overall Study|Other|0|||
124732323|NCT03298984|448642004|FG000|Overall Study|Physician Decision|1|||
124732324|NCT03298984|448642005|FG001|Overall Study|Physician Decision|0|||
124732325|NCT03298984|448642006|FG002|Overall Study|Physician Decision|0|||
124732326|NCT03298984|448642007|FG003|Overall Study|Physician Decision|6|||
124732327|NCT03298984|448642004|FG000|Overall Study|Lack of Efficacy|0|||
124732328|NCT03298984|448642005|FG001|Overall Study|Lack of Efficacy|1|||
124732329|NCT03298984|448642006|FG002|Overall Study|Lack of Efficacy|1|||
124732330|NCT03298984|448642007|FG003|Overall Study|Lack of Efficacy|4|||
124732331|NCT03298984|448642004|FG000|Overall Study|Relapsed disease (following remission)|0|||
124732332|NCT03298984|448642005|FG001|Overall Study|Relapsed disease (following remission)|0|||
124732333|NCT03298984|448642006|FG002|Overall Study|Relapsed disease (following remission)|1|||
124732334|NCT03298984|448642007|FG003|Overall Study|Relapsed disease (following remission)|1|||
124732335|NCT03298984|448642004|FG000|Overall Study|Adverse Event|0|||
124732336|NCT03298984|448642005|FG001|Overall Study|Adverse Event|0|||
124732337|NCT03298984|448642006|FG002|Overall Study|Adverse Event|0|||
124732338|NCT03298984|448642007|FG003|Overall Study|Adverse Event|1|||
124732339|NCT03298984|448642004|FG000|Overall Study|Death|0|||
124732340|NCT03298984|448642005|FG001|Overall Study|Death|0|||
124732341|NCT03298984|448642006|FG002|Overall Study|Death|0|||
124732342|NCT03298984|448642007|FG003|Overall Study|Death|2|||
124732343|NCT03298984|448642004|FG000|Overall Study|Insurance Company Decision|0|||
124732344|NCT03298984|448642005|FG001|Overall Study|Insurance Company Decision|0|||
124732345|NCT03298984|448642006|FG002|Overall Study|Insurance Company Decision|0|||
124732346|NCT03298984|448642007|FG003|Overall Study|Insurance Company Decision|1|||
124732347|NCT02851407|448642008|FG000|Overall Study|Withdrawal by parent/guardian|2|||
124732348|NCT02851407|448642009|FG001|Overall Study|Withdrawal by parent/guardian|7|||
124732349|NCT02851407|448642008|FG000|Overall Study|Protocol deviation|0|||
124732350|NCT02851407|448642009|FG001|Overall Study|Protocol deviation|1|||
124732351|NCT02851407|448642008|FG000|Overall Study|Transferred to another hospital to continue|1|||
124732352|NCT02851407|448642009|FG001|Overall Study|Transferred to another hospital to continue|0|||
124732353|NCT02851407|448642008|FG000|Overall Study|Other Death|30|||
124732354|NCT02851407|448642009|FG001|Overall Study|Other Death|20|||
124732355|NCT02851407|448642008|FG000|Overall Study|Adverse event, serious fatal|6|||
124732356|NCT02851407|448642009|FG001|Overall Study|Adverse event, serious fatal|8|||
124732357|NCT02851407|448642008|FG000|Overall Study|Consent withdrawn by participant|5|||
124732358|NCT02851407|448642009|FG001|Overall Study|Consent withdrawn by participant|3|||
124732359|NCT02851407|448642008|FG000|Overall Study|Screen failure|2|||
124732360|NCT02851407|448642009|FG001|Overall Study|Screen failure|1|||
124732361|NCT02851407|448642008|FG000|Overall Study|Disease relapse|9|||
124732362|NCT02851407|448642009|FG001|Overall Study|Disease relapse|6|||
124732363|NCT02851407|448642008|FG000|Overall Study|Physician Decision|7|||
124732364|NCT02851407|448642009|FG001|Overall Study|Physician Decision|6|||
124781187|NCT01175083|448829108|FG002|Booster Epoch|Withdrawal by Subject|0|||
124781188|NCT01175083|448829109|FG003|Booster Epoch|Withdrawal by Subject|1|||
124781189|NCT01175083|448829110|FG004|Booster Epoch|Withdrawal by Subject|0|||
124781190|NCT01175083|448829111|FG005|Booster Epoch|Withdrawal by Subject|0|||
124781191|NCT00475306|448829112|FG000|Overall Study|Protocol Violation|1|||
124781192|NCT00475306|448829113|FG001|Overall Study|Protocol Violation|1|||
124610023|NCT04228783|448191937|FG004|Overall Study|Protocol Violation|0|||
124610024|NCT04228783|448191938|FG005|Overall Study|Protocol Violation|0|||
124610025|NCT04228783|448191933|FG000|Overall Study|Withdrawal by Subject|6|||
124732365|NCT02851407|448642008|FG000|Overall Study|Transferred to hospital closer to home|0|||
124732366|NCT02851407|448642009|FG001|Overall Study|Transferred to hospital closer to home|1|||
124732367|NCT02851407|448642008|FG000|Overall Study|Enrolled in an investigational study|0|||
124781193|NCT00475306|448829114|FG002|Overall Study|Protocol Violation|0|||
124781194|NCT00475306|448829115|FG003|Overall Study|Protocol Violation|1|||
124781195|NCT01716052|448829116|FG000|Overall Study|Withdrawal of funding|1|||
124732368|NCT02851407|448642009|FG001|Overall Study|Enrolled in an investigational study|1|||
124732369|NCT02851407|448642008|FG000|Overall Study|Early recovery|1|||
124732370|NCT02851407|448642009|FG001|Overall Study|Early recovery|0|||
124732371|NCT02851407|448642008|FG000|Overall Study|Adverse event, non-fatal|7|||
124732372|NCT02851407|448642009|FG001|Overall Study|Adverse event, non-fatal|5|||
124732373|NCT02851407|448642008|FG000|Overall Study|Lost to Follow-up|0|||
124732374|NCT02851407|448642009|FG001|Overall Study|Lost to Follow-up|2|||
124732375|NCT00294645|448642010|FG000|Overall Study|Death|10|||
124732376|NCT00294645|448642011|FG001|Overall Study|Death|18|||
124732377|NCT00294645|448642010|FG000|Overall Study|Lost to Follow-up|1|||
124732378|NCT00294645|448642011|FG001|Overall Study|Lost to Follow-up|10|||
124732379|NCT00294645|448642010|FG000|Overall Study|Withdrawal by Subject|18|||
124732380|NCT00294645|448642011|FG001|Overall Study|Withdrawal by Subject|34|||
124732381|NCT00294645|448642010|FG000|Overall Study|Physician Decision|15|||
124732382|NCT00294645|448642011|FG001|Overall Study|Physician Decision|20|||
124732383|NCT00294645|448642010|FG000|Overall Study|Other|4|||
124732384|NCT00294645|448642011|FG001|Overall Study|Other|10|||
124732385|NCT00075725|448642012|FG000|Overall Study|Adverse Event|6|||
124732386|NCT00075725|448642013|FG001|Overall Study|Adverse Event|6|||
124732387|NCT00075725|448642014|FG002|Overall Study|Adverse Event|20|||
124732388|NCT00075725|448642015|FG003|Overall Study|Adverse Event|8|||
124732389|NCT00075725|448642016|FG004|Overall Study|Adverse Event|4|||
124732390|NCT00075725|448642017|FG005|Overall Study|Adverse Event|38|||
124732391|NCT00075725|448642018|FG006|Overall Study|Adverse Event|3|||
124732392|NCT00075725|448642019|FG007|Overall Study|Adverse Event|51|||
124732393|NCT00075725|448642020|FG008|Overall Study|Adverse Event|15|||
124732394|NCT00075725|448642021|FG009|Overall Study|Adverse Event|4|||
124732395|NCT00075725|448642022|FG010|Overall Study|Adverse Event|2|||
124732396|NCT00075725|448642023|FG011|Overall Study|Adverse Event|2|||
124732397|NCT00075725|448642012|FG000|Overall Study|Death|3|||
124732398|NCT00075725|448642013|FG001|Overall Study|Death|5|||
124732399|NCT00075725|448642014|FG002|Overall Study|Death|10|||
124732400|NCT00075725|448642015|FG003|Overall Study|Death|2|||
124732401|NCT00075725|448642016|FG004|Overall Study|Death|3|||
124732402|NCT00075725|448642017|FG005|Overall Study|Death|25|||
124732403|NCT00075725|448642018|FG006|Overall Study|Death|4|||
124732404|NCT00075725|448642019|FG007|Overall Study|Death|22|||
124732405|NCT00075725|448642020|FG008|Overall Study|Death|14|||
124732406|NCT00075725|448642021|FG009|Overall Study|Death|4|||
124732407|NCT00075725|448642022|FG010|Overall Study|Death|3|||
124732408|NCT00075725|448642023|FG011|Overall Study|Death|0|||
124732409|NCT00075725|448642012|FG000|Overall Study|Lost to Follow-up|1|||
124732410|NCT00075725|448642013|FG001|Overall Study|Lost to Follow-up|1|||
124732411|NCT00075725|448642014|FG002|Overall Study|Lost to Follow-up|4|||
124732412|NCT00075725|448642015|FG003|Overall Study|Lost to Follow-up|1|||
124732413|NCT00075725|448642016|FG004|Overall Study|Lost to Follow-up|0|||
124732414|NCT00075725|448642017|FG005|Overall Study|Lost to Follow-up|13|||
124732415|NCT00075725|448642018|FG006|Overall Study|Lost to Follow-up|2|||
124732416|NCT00075725|448642019|FG007|Overall Study|Lost to Follow-up|4|||
124732417|NCT00075725|448642020|FG008|Overall Study|Lost to Follow-up|1|||
124732418|NCT00075725|448642021|FG009|Overall Study|Lost to Follow-up|0|||
124732419|NCT00075725|448642022|FG010|Overall Study|Lost to Follow-up|0|||
124732420|NCT00075725|448642023|FG011|Overall Study|Lost to Follow-up|0|||
124732421|NCT00075725|448642012|FG000|Overall Study|Physician Decision|2|||
124732422|NCT00075725|448642013|FG001|Overall Study|Physician Decision|6|||
124732423|NCT00075725|448642014|FG002|Overall Study|Physician Decision|5|||
124732424|NCT00075725|448642015|FG003|Overall Study|Physician Decision|8|||
124781196|NCT01716052|448829117|FG001|Overall Study|Withdrawal of funding|1|||
124610026|NCT04228783|448191934|FG001|Overall Study|Withdrawal by Subject|10|||
124610027|NCT04228783|448191935|FG002|Overall Study|Withdrawal by Subject|19|||
124610028|NCT04228783|448191936|FG003|Overall Study|Withdrawal by Subject|1|||
124610029|NCT04228783|448191937|FG004|Overall Study|Withdrawal by Subject|2|||
124610030|NCT04228783|448191938|FG005|Overall Study|Withdrawal by Subject|0|||
124610031|NCT04228783|448191933|FG000|Overall Study|Other|4|||
124610032|NCT04228783|448191934|FG001|Overall Study|Other|3|||
124610033|NCT04228783|448191935|FG002|Overall Study|Other|2|||
124610034|NCT04228783|448191936|FG003|Overall Study|Other|1|||
124732425|NCT00075725|448642016|FG004|Overall Study|Physician Decision|4|||
124732426|NCT00075725|448642017|FG005|Overall Study|Physician Decision|19|||
124732427|NCT00075725|448642018|FG006|Overall Study|Physician Decision|3|||
124732428|NCT00075725|448642019|FG007|Overall Study|Physician Decision|17|||
124732429|NCT00075725|448642020|FG008|Overall Study|Physician Decision|5|||
124732430|NCT00075725|448642021|FG009|Overall Study|Physician Decision|0|||
124732431|NCT00075725|448642022|FG010|Overall Study|Physician Decision|1|||
124732432|NCT00075725|448642023|FG011|Overall Study|Physician Decision|0|||
124732433|NCT00075725|448642012|FG000|Overall Study|Pregnancy|0|||
124732434|NCT00075725|448642013|FG001|Overall Study|Pregnancy|0|||
124610035|NCT04228783|448191937|FG004|Overall Study|Other|0|||
124732435|NCT00075725|448642014|FG002|Overall Study|Pregnancy|0|||
124732436|NCT00075725|448642015|FG003|Overall Study|Pregnancy|0|||
124732437|NCT00075725|448642016|FG004|Overall Study|Pregnancy|0|||
124732438|NCT00075725|448642017|FG005|Overall Study|Pregnancy|1|||
124610036|NCT04228783|448191938|FG005|Overall Study|Other|0|||
124610037|NCT00626392|448191939|FG000|Run-in Period|Adverse Event|0|||
124610038|NCT00626392|448191940|FG001|Run-in Period|Adverse Event|0|||
124610039|NCT00626392|448191941|FG002|Run-in Period|Adverse Event|1|||
124610040|NCT00626392|448191942|FG003|Run-in Period|Adverse Event|0|||
124610041|NCT00626392|448191943|FG004|Run-in Period|Adverse Event|1|||
124610042|NCT00626392|448191944|FG005|Run-in Period|Adverse Event|0|||
124610043|NCT00626392|448191939|FG000|Run-in Period|Withdrawal by Subject|0|||
124610044|NCT00626392|448191940|FG001|Run-in Period|Withdrawal by Subject|1|||
124610045|NCT00626392|448191941|FG002|Run-in Period|Withdrawal by Subject|1|||
124610046|NCT00626392|448191942|FG003|Run-in Period|Withdrawal by Subject|1|||
124610047|NCT00626392|448191943|FG004|Run-in Period|Withdrawal by Subject|3|||
124610048|NCT00626392|448191944|FG005|Run-in Period|Withdrawal by Subject|1|||
124610049|NCT00626392|448191939|FG000|Run-in Period|Noncompliance|1|||
124610050|NCT00626392|448191940|FG001|Run-in Period|Noncompliance|0|||
124610051|NCT00626392|448191941|FG002|Run-in Period|Noncompliance|1|||
124610052|NCT00626392|448191942|FG003|Run-in Period|Noncompliance|0|||
124610053|NCT00626392|448191943|FG004|Run-in Period|Noncompliance|0|||
124610054|NCT00626392|448191944|FG005|Run-in Period|Noncompliance|0|||
124610055|NCT00626392|448191939|FG000|Coadministration Period|Adverse Event|3|||
124610056|NCT00626392|448191940|FG001|Coadministration Period|Adverse Event|1|||
124610057|NCT00626392|448191941|FG002|Coadministration Period|Adverse Event|7|||
124610058|NCT00626392|448191942|FG003|Coadministration Period|Adverse Event|4|||
124610059|NCT00626392|448191943|FG004|Coadministration Period|Adverse Event|3|||
124610060|NCT00626392|448191944|FG005|Coadministration Period|Adverse Event|4|||
124610061|NCT00626392|448191939|FG000|Coadministration Period|Withdrawal by Subject|1|||
124610062|NCT00626392|448191940|FG001|Coadministration Period|Withdrawal by Subject|1|||
124610063|NCT00626392|448191941|FG002|Coadministration Period|Withdrawal by Subject|0|||
124610064|NCT00626392|448191942|FG003|Coadministration Period|Withdrawal by Subject|1|||
124610065|NCT00626392|448191943|FG004|Coadministration Period|Withdrawal by Subject|0|||
124610066|NCT00626392|448191944|FG005|Coadministration Period|Withdrawal by Subject|1|||
124610067|NCT00626392|448191939|FG000|Coadministration Period|Protocol Violation|0|||
124610068|NCT00626392|448191940|FG001|Coadministration Period|Protocol Violation|1|||
124610069|NCT00626392|448191941|FG002|Coadministration Period|Protocol Violation|0|||
124610070|NCT00626392|448191942|FG003|Coadministration Period|Protocol Violation|1|||
124610071|NCT00626392|448191943|FG004|Coadministration Period|Protocol Violation|1|||
124610072|NCT00626392|448191944|FG005|Coadministration Period|Protocol Violation|0|||
124610073|NCT00626392|448191939|FG000|Coadministration Period|Other|0|||
124610074|NCT00626392|448191940|FG001|Coadministration Period|Other|2|||
124610075|NCT00626392|448191941|FG002|Coadministration Period|Other|3|||
124610076|NCT00626392|448191942|FG003|Coadministration Period|Other|1|||
124610077|NCT00626392|448191943|FG004|Coadministration Period|Other|1|||
124610078|NCT00626392|448191944|FG005|Coadministration Period|Other|1|||
124610079|NCT03151811|448191947|FG000|Overall Study|Randomized But Not Treated|18|||
124610080|NCT03151811|448191948|FG001|Overall Study|Randomized But Not Treated|3|||
124610081|NCT03151811|448191947|FG000|Overall Study|Progressive Disease|130|||
124610082|NCT03151811|448191948|FG001|Overall Study|Progressive Disease|170|||
124610083|NCT03151811|448191947|FG000|Overall Study|Adverse Event|49|||
124610084|NCT03151811|448191948|FG001|Overall Study|Adverse Event|40|||
124610085|NCT03151811|448191947|FG000|Overall Study|Lack of Efficacy|6|||
124610086|NCT03151811|448191948|FG001|Overall Study|Lack of Efficacy|8|||
124610087|NCT03151811|448191947|FG000|Overall Study|Physician Decision|21|||
124610088|NCT03151811|448191948|FG001|Overall Study|Physician Decision|9|||
124610089|NCT03151811|448191947|FG000|Overall Study|Withdrawal by Subject|17|||
124610090|NCT03151811|448191948|FG001|Overall Study|Withdrawal by Subject|7|||
124610091|NCT03151811|448191947|FG000|Overall Study|Lost to Follow-up|0|||
124610092|NCT03151811|448191948|FG001|Overall Study|Lost to Follow-up|1|||
124610093|NCT03151811|448191947|FG000|Overall Study|Study Terminated by Sponsor|5|||
124610094|NCT03151811|448191948|FG001|Overall Study|Study Terminated by Sponsor|11|||
124610095|NCT01268501|448191949|FG000|Overall Study|Lost to Follow-up|1|||
124610096|NCT01268501|448191949|FG000|Overall Study|Withdrawal by Subject|3|||
124610097|NCT01268501|448191949|FG000|Overall Study|Unacceptable Subjective Vision|3|||
124610098|NCT01268501|448191949|FG000|Overall Study|Handling Difficulties|2|||
124610099|NCT05293639|448191950|FG000|Overall Study|Withdrawal by Subject|1|||
124610100|NCT05293639|448191951|FG001|Overall Study|Withdrawal by Subject|1|||
124610101|NCT05293639|448191952|FG002|Overall Study|Withdrawal by Subject|2|||
124610102|NCT05293639|448191950|FG000|Overall Study|Death|0|||
124610103|NCT05293639|448191951|FG001|Overall Study|Death|1|||
124610104|NCT05293639|448191952|FG002|Overall Study|Death|0|||
124610105|NCT05293639|448191950|FG000|Overall Study|Lost to Follow-up|0|||
124610106|NCT05293639|448191951|FG001|Overall Study|Lost to Follow-up|0|||
124610107|NCT05293639|448191952|FG002|Overall Study|Lost to Follow-up|5|||
124610108|NCT05293639|448191950|FG000|Overall Study|Other|0|||
124610109|NCT05293639|448191951|FG001|Overall Study|Other|0|||
124610110|NCT05293639|448191952|FG002|Overall Study|Other|1|||
124610111|NCT00827632|448191954|FG000|Overall Study|Lost to Follow-up|8|||
124610112|NCT00827632|448191955|FG001|Overall Study|Lost to Follow-up|12|||
124732439|NCT00075725|448642018|FG006|Overall Study|Pregnancy|0|||
124732440|NCT00075725|448642019|FG007|Overall Study|Pregnancy|1|||
124732441|NCT00075725|448642020|FG008|Overall Study|Pregnancy|0|||
124732442|NCT00075725|448642021|FG009|Overall Study|Pregnancy|0|||
124732443|NCT00075725|448642022|FG010|Overall Study|Pregnancy|0|||
124732444|NCT00075725|448642023|FG011|Overall Study|Pregnancy|0|||
124732445|NCT00075725|448642012|FG000|Overall Study|Protocol Violation|1|||
124732446|NCT00075725|448642013|FG001|Overall Study|Protocol Violation|1|||
124732447|NCT00075725|448642014|FG002|Overall Study|Protocol Violation|0|||
124732448|NCT00075725|448642015|FG003|Overall Study|Protocol Violation|3|||
124732449|NCT00075725|448642016|FG004|Overall Study|Protocol Violation|3|||
124732450|NCT00075725|448642017|FG005|Overall Study|Protocol Violation|2|||
124732451|NCT00075725|448642018|FG006|Overall Study|Protocol Violation|1|||
124732452|NCT00075725|448642019|FG007|Overall Study|Protocol Violation|2|||
124732453|NCT00075725|448642020|FG008|Overall Study|Protocol Violation|3|||
124732454|NCT00075725|448642021|FG009|Overall Study|Protocol Violation|0|||
124732455|NCT00075725|448642022|FG010|Overall Study|Protocol Violation|0|||
124732456|NCT00075725|448642023|FG011|Overall Study|Protocol Violation|1|||
124732457|NCT00075725|448642012|FG000|Overall Study|Withdrawal by Subject|12|||
124732458|NCT00075725|448642013|FG001|Overall Study|Withdrawal by Subject|3|||
124732459|NCT00075725|448642014|FG002|Overall Study|Withdrawal by Subject|6|||
124732460|NCT00075725|448642015|FG003|Overall Study|Withdrawal by Subject|10|||
124732461|NCT00075725|448642016|FG004|Overall Study|Withdrawal by Subject|6|||
124732462|NCT00075725|448642017|FG005|Overall Study|Withdrawal by Subject|27|||
124732463|NCT00075725|448642018|FG006|Overall Study|Withdrawal by Subject|7|||
124732464|NCT00075725|448642019|FG007|Overall Study|Withdrawal by Subject|31|||
124732465|NCT00075725|448642020|FG008|Overall Study|Withdrawal by Subject|10|||
124732466|NCT00075725|448642021|FG009|Overall Study|Withdrawal by Subject|2|||
124732467|NCT00075725|448642022|FG010|Overall Study|Withdrawal by Subject|0|||
124732468|NCT00075725|448642023|FG011|Overall Study|Withdrawal by Subject|0|||
124732469|NCT00075725|448642012|FG000|Overall Study|Disease Progression, all other reasons|17|||
124732470|NCT00075725|448642013|FG001|Overall Study|Disease Progression, all other reasons|5|||
124732471|NCT00075725|448642014|FG002|Overall Study|Disease Progression, all other reasons|33|||
124732472|NCT00075725|448642015|FG003|Overall Study|Disease Progression, all other reasons|6|||
124732473|NCT00075725|448642016|FG004|Overall Study|Disease Progression, all other reasons|21|||
124732474|NCT00075725|448642017|FG005|Overall Study|Disease Progression, all other reasons|59|||
124732475|NCT00075725|448642018|FG006|Overall Study|Disease Progression, all other reasons|20|||
124732476|NCT00075725|448642019|FG007|Overall Study|Disease Progression, all other reasons|46|||
124732477|NCT00075725|448642020|FG008|Overall Study|Disease Progression, all other reasons|21|||
124732478|NCT00075725|448642021|FG009|Overall Study|Disease Progression, all other reasons|4|||
124732479|NCT00075725|448642022|FG010|Overall Study|Disease Progression, all other reasons|0|||
124732480|NCT00075725|448642023|FG011|Overall Study|Disease Progression, all other reasons|5|||
124732481|NCT00075725|448642012|FG000|Overall Study|Patient off treatment|0|||
124732482|NCT00075725|448642013|FG001|Overall Study|Patient off treatment|0|||
124732483|NCT00075725|448642014|FG002|Overall Study|Patient off treatment|1|||
124732484|NCT00075725|448642015|FG003|Overall Study|Patient off treatment|2|||
124732485|NCT00075725|448642016|FG004|Overall Study|Patient off treatment|1|||
124732486|NCT00075725|448642017|FG005|Overall Study|Patient off treatment|0|||
124732487|NCT00075725|448642018|FG006|Overall Study|Patient off treatment|0|||
124732488|NCT00075725|448642019|FG007|Overall Study|Patient off treatment|2|||
124732489|NCT00075725|448642020|FG008|Overall Study|Patient off treatment|1|||
124732490|NCT00075725|448642021|FG009|Overall Study|Patient off treatment|0|||
124732491|NCT00075725|448642022|FG010|Overall Study|Patient off treatment|0|||
124732492|NCT00075725|448642023|FG011|Overall Study|Patient off treatment|0|||
124732493|NCT00075725|448642012|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
124732494|NCT00075725|448642013|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
124732495|NCT00075725|448642014|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
124781197|NCT02405442|448829118|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
124781198|NCT02405442|448829119|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
124781199|NCT02405442|448829120|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
124781200|NCT02405442|448829121|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
124781201|NCT02405442|448829118|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
124781202|NCT02405442|448829119|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
124781203|NCT02405442|448829120|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
124610113|NCT00827632|448191954|FG000|Overall Study|Early withdrawal|14|||
124610114|NCT00827632|448191955|FG001|Overall Study|Early withdrawal|11|||
124610115|NCT01910389|448191956|FG000|Overall Study|Withdrawal by Subject|2|||
124732496|NCT00075725|448642015|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
124732497|NCT00075725|448642016|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
124732498|NCT00075725|448642017|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
124732499|NCT00075725|448642018|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
124732500|NCT00075725|448642019|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
124732501|NCT00075725|448642020|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
124732502|NCT00075725|448642021|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
124732503|NCT00075725|448642022|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
124732504|NCT00075725|448642023|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
124732505|NCT00075725|448642012|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
124732506|NCT00075725|448642013|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
124732507|NCT00075725|448642014|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
124732508|NCT00075725|448642015|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
124732509|NCT00075725|448642016|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
124732510|NCT00075725|448642017|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
124732511|NCT00075725|448642018|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
124732512|NCT00075725|448642019|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
124732513|NCT00075725|448642020|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
124732514|NCT00075725|448642021|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
124732515|NCT00075725|448642022|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
124732516|NCT00075725|448642023|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
124732517|NCT00075725|448642012|FG000|Overall Study|Pt non compliant with therapy|2|||
124732518|NCT00075725|448642013|FG001|Overall Study|Pt non compliant with therapy|1|||
124732519|NCT00075725|448642014|FG002|Overall Study|Pt non compliant with therapy|1|||
124732520|NCT00075725|448642015|FG003|Overall Study|Pt non compliant with therapy|0|||
124732521|NCT00075725|448642016|FG004|Overall Study|Pt non compliant with therapy|2|||
124732522|NCT00075725|448642017|FG005|Overall Study|Pt non compliant with therapy|14|||
124732523|NCT00075725|448642018|FG006|Overall Study|Pt non compliant with therapy|2|||
124732524|NCT00075725|448642019|FG007|Overall Study|Pt non compliant with therapy|5|||
124732525|NCT00075725|448642020|FG008|Overall Study|Pt non compliant with therapy|3|||
124732526|NCT00075725|448642021|FG009|Overall Study|Pt non compliant with therapy|0|||
124732527|NCT00075725|448642022|FG010|Overall Study|Pt non compliant with therapy|0|||
124732528|NCT00075725|448642023|FG011|Overall Study|Pt non compliant with therapy|0|||
124732529|NCT00075725|448642012|FG000|Overall Study|Pt age out of range for treatment|0|||
124732530|NCT00075725|448642013|FG001|Overall Study|Pt age out of range for treatment|1|||
124732531|NCT00075725|448642014|FG002|Overall Study|Pt age out of range for treatment|0|||
124732532|NCT00075725|448642015|FG003|Overall Study|Pt age out of range for treatment|0|||
124732533|NCT00075725|448642016|FG004|Overall Study|Pt age out of range for treatment|0|||
124732534|NCT00075725|448642017|FG005|Overall Study|Pt age out of range for treatment|1|||
124732535|NCT00075725|448642018|FG006|Overall Study|Pt age out of range for treatment|0|||
124732536|NCT00075725|448642019|FG007|Overall Study|Pt age out of range for treatment|1|||
124732537|NCT00075725|448642020|FG008|Overall Study|Pt age out of range for treatment|0|||
124732538|NCT00075725|448642021|FG009|Overall Study|Pt age out of range for treatment|0|||
124732539|NCT00075725|448642022|FG010|Overall Study|Pt age out of range for treatment|0|||
124732540|NCT00075725|448642023|FG011|Overall Study|Pt age out of range for treatment|0|||
124732541|NCT00075725|448642012|FG000|Overall Study|Insurance issues|0|||
124732542|NCT00075725|448642013|FG001|Overall Study|Insurance issues|1|||
124732543|NCT00075725|448642014|FG002|Overall Study|Insurance issues|0|||
124732544|NCT00075725|448642015|FG003|Overall Study|Insurance issues|1|||
124732545|NCT00075725|448642016|FG004|Overall Study|Insurance issues|1|||
124732546|NCT00075725|448642017|FG005|Overall Study|Insurance issues|1|||
124732547|NCT00075725|448642018|FG006|Overall Study|Insurance issues|0|||
124732548|NCT00075725|448642019|FG007|Overall Study|Insurance issues|1|||
124732549|NCT00075725|448642020|FG008|Overall Study|Insurance issues|0|||
124732550|NCT00075725|448642021|FG009|Overall Study|Insurance issues|0|||
124732551|NCT00075725|448642022|FG010|Overall Study|Insurance issues|0|||
124732552|NCT00075725|448642023|FG011|Overall Study|Insurance issues|0|||
124732553|NCT00075725|448642012|FG000|Overall Study|MRD positive after extended ind|0|||
124732554|NCT00075725|448642013|FG001|Overall Study|MRD positive after extended ind|1|||
124732555|NCT00075725|448642014|FG002|Overall Study|MRD positive after extended ind|1|||
124732556|NCT00075725|448642015|FG003|Overall Study|MRD positive after extended ind|0|||
124732557|NCT00075725|448642016|FG004|Overall Study|MRD positive after extended ind|1|||
124732558|NCT00075725|448642017|FG005|Overall Study|MRD positive after extended ind|2|||
124732559|NCT00075725|448642018|FG006|Overall Study|MRD positive after extended ind|0|||
124732560|NCT00075725|448642019|FG007|Overall Study|MRD positive after extended ind|1|||
124732561|NCT00075725|448642020|FG008|Overall Study|MRD positive after extended ind|0|||
124732562|NCT00075725|448642021|FG009|Overall Study|MRD positive after extended ind|0|||
124732563|NCT00075725|448642022|FG010|Overall Study|MRD positive after extended ind|0|||
124732564|NCT00075725|448642023|FG011|Overall Study|MRD positive after extended ind|0|||
124781204|NCT02405442|448829121|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
124610116|NCT01910389|448191957|FG001|Overall Study|Withdrawal by Subject|0|||
124732565|NCT00075725|448642012|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
124732566|NCT00075725|448642013|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
124732567|NCT00075725|448642014|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
124732568|NCT00075725|448642015|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
124732569|NCT00075725|448642016|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
124732570|NCT00075725|448642017|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
124732571|NCT00075725|448642018|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
124732572|NCT00075725|448642019|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
124732573|NCT00075725|448642020|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
124732574|NCT00075725|448642021|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
124732575|NCT00075725|448642022|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
124732576|NCT00075725|448642023|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
124732577|NCT00075725|448642012|FG000|Overall Study|Inevaluable|1|||
124732578|NCT00075725|448642013|FG001|Overall Study|Inevaluable|1|||
124732579|NCT00075725|448642014|FG002|Overall Study|Inevaluable|4|||
124732580|NCT00075725|448642015|FG003|Overall Study|Inevaluable|2|||
124732581|NCT00075725|448642016|FG004|Overall Study|Inevaluable|2|||
124732582|NCT00075725|448642017|FG005|Overall Study|Inevaluable|9|||
124732583|NCT00075725|448642018|FG006|Overall Study|Inevaluable|1|||
124732584|NCT00075725|448642019|FG007|Overall Study|Inevaluable|11|||
124732585|NCT00075725|448642020|FG008|Overall Study|Inevaluable|2|||
124732586|NCT00075725|448642021|FG009|Overall Study|Inevaluable|0|||
124732587|NCT00075725|448642022|FG010|Overall Study|Inevaluable|1|||
124732588|NCT00075725|448642023|FG011|Overall Study|Inevaluable|0|||
124732589|NCT00075725|448642012|FG000|Overall Study|Other|4|||
124732590|NCT00075725|448642013|FG001|Overall Study|Other|2|||
124732591|NCT00075725|448642014|FG002|Overall Study|Other|1|||
124732592|NCT00075725|448642015|FG003|Overall Study|Other|1|||
124732593|NCT00075725|448642016|FG004|Overall Study|Other|1|||
124732594|NCT00075725|448642017|FG005|Overall Study|Other|4|||
124732595|NCT00075725|448642018|FG006|Overall Study|Other|2|||
124732596|NCT00075725|448642019|FG007|Overall Study|Other|9|||
124732597|NCT00075725|448642020|FG008|Overall Study|Other|2|||
124732598|NCT00075725|448642021|FG009|Overall Study|Other|1|||
124732599|NCT00075725|448642022|FG010|Overall Study|Other|0|||
124732600|NCT00075725|448642023|FG011|Overall Study|Other|3|||
124732601|NCT00075725|448642012|FG000|Overall Study|Pt trying to find a BM donor|0|||
124732602|NCT00075725|448642013|FG001|Overall Study|Pt trying to find a BM donor|1|||
124732603|NCT00075725|448642014|FG002|Overall Study|Pt trying to find a BM donor|0|||
124732604|NCT00075725|448642015|FG003|Overall Study|Pt trying to find a BM donor|0|||
124732605|NCT00075725|448642016|FG004|Overall Study|Pt trying to find a BM donor|0|||
124732606|NCT00075725|448642017|FG005|Overall Study|Pt trying to find a BM donor|0|||
124732607|NCT00075725|448642018|FG006|Overall Study|Pt trying to find a BM donor|0|||
124732608|NCT00075725|448642019|FG007|Overall Study|Pt trying to find a BM donor|0|||
124732609|NCT00075725|448642020|FG008|Overall Study|Pt trying to find a BM donor|0|||
124732610|NCT00075725|448642021|FG009|Overall Study|Pt trying to find a BM donor|0|||
124732611|NCT00075725|448642022|FG010|Overall Study|Pt trying to find a BM donor|0|||
124732612|NCT00075725|448642023|FG011|Overall Study|Pt trying to find a BM donor|0|||
124732613|NCT00075725|448642012|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
124732614|NCT00075725|448642013|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
124732615|NCT00075725|448642014|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
124732616|NCT00075725|448642015|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
124732617|NCT00075725|448642016|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
124732618|NCT00075725|448642017|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
124732619|NCT00075725|448642018|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
124732620|NCT00075725|448642019|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
124732621|NCT00075725|448642020|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
124732622|NCT00075725|448642021|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
124732623|NCT00075725|448642022|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
124732624|NCT00075725|448642023|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
124732625|NCT00075725|448642012|FG000|Overall Study|Unsuccessful institutional transfer|0|||
124732626|NCT00075725|448642013|FG001|Overall Study|Unsuccessful institutional transfer|0|||
124732627|NCT00075725|448642014|FG002|Overall Study|Unsuccessful institutional transfer|2|||
124732628|NCT00075725|448642015|FG003|Overall Study|Unsuccessful institutional transfer|0|||
124732629|NCT00075725|448642016|FG004|Overall Study|Unsuccessful institutional transfer|0|||
124732630|NCT00075725|448642017|FG005|Overall Study|Unsuccessful institutional transfer|0|||
124732631|NCT00075725|448642018|FG006|Overall Study|Unsuccessful institutional transfer|0|||
124732632|NCT00075725|448642019|FG007|Overall Study|Unsuccessful institutional transfer|0|||
124732633|NCT00075725|448642020|FG008|Overall Study|Unsuccessful institutional transfer|0|||
124732634|NCT00075725|448642021|FG009|Overall Study|Unsuccessful institutional transfer|1|||
124610117|NCT01910389|448191956|FG000|Overall Study|Study Closed|13|||
124610118|NCT01910389|448191957|FG001|Overall Study|Study Closed|8|||
124610119|NCT00407758|448191959|FG000|Overall Study|ineligible -improper prior treatment|1|||
124732635|NCT00075725|448642022|FG010|Overall Study|Unsuccessful institutional transfer|0|||
124732636|NCT00075725|448642023|FG011|Overall Study|Unsuccessful institutional transfer|0|||
124732637|NCT00075725|448642012|FG000|Overall Study|specimen(s) not submitted|0|||
124732638|NCT00075725|448642013|FG001|Overall Study|specimen(s) not submitted|0|||
124732639|NCT00075725|448642014|FG002|Overall Study|specimen(s) not submitted|2|||
124732640|NCT00075725|448642015|FG003|Overall Study|specimen(s) not submitted|0|||
124732641|NCT00075725|448642016|FG004|Overall Study|specimen(s) not submitted|0|||
124732642|NCT00075725|448642017|FG005|Overall Study|specimen(s) not submitted|0|||
124732643|NCT00075725|448642018|FG006|Overall Study|specimen(s) not submitted|0|||
124732644|NCT00075725|448642019|FG007|Overall Study|specimen(s) not submitted|0|||
124732645|NCT00075725|448642020|FG008|Overall Study|specimen(s) not submitted|0|||
124732646|NCT00075725|448642021|FG009|Overall Study|specimen(s) not submitted|0|||
124732647|NCT00075725|448642022|FG010|Overall Study|specimen(s) not submitted|0|||
124732648|NCT00075725|448642023|FG011|Overall Study|specimen(s) not submitted|0|||
124732649|NCT00075725|448642012|FG000|Overall Study|Pt went to transplant|0|||
124732650|NCT00075725|448642013|FG001|Overall Study|Pt went to transplant|0|||
124732651|NCT00075725|448642014|FG002|Overall Study|Pt went to transplant|0|||
124732652|NCT00075725|448642015|FG003|Overall Study|Pt went to transplant|1|||
124732653|NCT00075725|448642016|FG004|Overall Study|Pt went to transplant|0|||
124732654|NCT00075725|448642017|FG005|Overall Study|Pt went to transplant|1|||
124732655|NCT00075725|448642018|FG006|Overall Study|Pt went to transplant|0|||
124732656|NCT00075725|448642019|FG007|Overall Study|Pt went to transplant|0|||
124732657|NCT00075725|448642020|FG008|Overall Study|Pt went to transplant|0|||
124732658|NCT00075725|448642021|FG009|Overall Study|Pt went to transplant|0|||
124732659|NCT00075725|448642022|FG010|Overall Study|Pt went to transplant|0|||
124732660|NCT00075725|448642023|FG011|Overall Study|Pt went to transplant|0|||
124732661|NCT00075725|448642012|FG000|Overall Study|Pt received additional steroids|0|||
124732662|NCT00075725|448642013|FG001|Overall Study|Pt received additional steroids|0|||
124732663|NCT00075725|448642014|FG002|Overall Study|Pt received additional steroids|0|||
124732664|NCT00075725|448642015|FG003|Overall Study|Pt received additional steroids|1|||
124732665|NCT00075725|448642016|FG004|Overall Study|Pt received additional steroids|0|||
124732666|NCT00075725|448642017|FG005|Overall Study|Pt received additional steroids|0|||
124732667|NCT00075725|448642018|FG006|Overall Study|Pt received additional steroids|0|||
124732668|NCT00075725|448642019|FG007|Overall Study|Pt received additional steroids|0|||
124732669|NCT00075725|448642020|FG008|Overall Study|Pt received additional steroids|0|||
124732670|NCT00075725|448642021|FG009|Overall Study|Pt received additional steroids|0|||
124732671|NCT00075725|448642022|FG010|Overall Study|Pt received additional steroids|0|||
124732672|NCT00075725|448642023|FG011|Overall Study|Pt received additional steroids|0|||
124732673|NCT00075725|448642012|FG000|Overall Study|Pt relocated|0|||
124732674|NCT00075725|448642013|FG001|Overall Study|Pt relocated|0|||
124732675|NCT00075725|448642014|FG002|Overall Study|Pt relocated|0|||
124732676|NCT00075725|448642015|FG003|Overall Study|Pt relocated|2|||
124732677|NCT00075725|448642016|FG004|Overall Study|Pt relocated|0|||
124732678|NCT00075725|448642017|FG005|Overall Study|Pt relocated|1|||
124732679|NCT00075725|448642018|FG006|Overall Study|Pt relocated|1|||
124732680|NCT00075725|448642019|FG007|Overall Study|Pt relocated|2|||
124732681|NCT00075725|448642020|FG008|Overall Study|Pt relocated|1|||
124732682|NCT00075725|448642021|FG009|Overall Study|Pt relocated|0|||
124732683|NCT00075725|448642022|FG010|Overall Study|Pt relocated|0|||
124732684|NCT00075725|448642023|FG011|Overall Study|Pt relocated|0|||
124732685|NCT00075725|448642012|FG000|Overall Study|Institution Terminated|0|||
124732686|NCT00075725|448642013|FG001|Overall Study|Institution Terminated|0|||
124732687|NCT00075725|448642014|FG002|Overall Study|Institution Terminated|0|||
124732688|NCT00075725|448642015|FG003|Overall Study|Institution Terminated|0|||
124732689|NCT00075725|448642016|FG004|Overall Study|Institution Terminated|1|||
124732690|NCT00075725|448642017|FG005|Overall Study|Institution Terminated|0|||
124732691|NCT00075725|448642018|FG006|Overall Study|Institution Terminated|0|||
124732692|NCT00075725|448642019|FG007|Overall Study|Institution Terminated|3|||
124732693|NCT00075725|448642020|FG008|Overall Study|Institution Terminated|0|||
124732694|NCT00075725|448642021|FG009|Overall Study|Institution Terminated|0|||
124732695|NCT00075725|448642022|FG010|Overall Study|Institution Terminated|0|||
124732696|NCT00075725|448642023|FG011|Overall Study|Institution Terminated|0|||
124732697|NCT00075725|448642012|FG000|Overall Study|Study Closure|1|||
124732698|NCT00075725|448642013|FG001|Overall Study|Study Closure|0|||
124732699|NCT00075725|448642014|FG002|Overall Study|Study Closure|0|||
124732700|NCT00075725|448642015|FG003|Overall Study|Study Closure|0|||
124732701|NCT00075725|448642016|FG004|Overall Study|Study Closure|1|||
124732702|NCT00075725|448642017|FG005|Overall Study|Study Closure|3|||
124732703|NCT00075725|448642018|FG006|Overall Study|Study Closure|0|||
124732704|NCT00075725|448642019|FG007|Overall Study|Study Closure|1|||
124732705|NCT00075725|448642020|FG008|Overall Study|Study Closure|0|||
124732706|NCT00075725|448642021|FG009|Overall Study|Study Closure|0|||
124732707|NCT00075725|448642022|FG010|Overall Study|Study Closure|0|||
124732708|NCT00075725|448642023|FG011|Overall Study|Study Closure|0|||
124732709|NCT00075725|448642012|FG000|Overall Study|Other complications|0|||
124732710|NCT00075725|448642013|FG001|Overall Study|Other complications|0|||
124732711|NCT00075725|448642014|FG002|Overall Study|Other complications|0|||
124732712|NCT00075725|448642015|FG003|Overall Study|Other complications|0|||
124732713|NCT00075725|448642016|FG004|Overall Study|Other complications|0|||
124732714|NCT00075725|448642017|FG005|Overall Study|Other complications|1|||
124732715|NCT00075725|448642018|FG006|Overall Study|Other complications|0|||
124732716|NCT00075725|448642019|FG007|Overall Study|Other complications|0|||
124732717|NCT00075725|448642020|FG008|Overall Study|Other complications|0|||
124732718|NCT00075725|448642021|FG009|Overall Study|Other complications|0|||
124732719|NCT00075725|448642022|FG010|Overall Study|Other complications|0|||
124732720|NCT00075725|448642023|FG011|Overall Study|Other complications|0|||
124732721|NCT00075725|448642012|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
124732722|NCT00075725|448642013|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
124732723|NCT00075725|448642014|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
124732724|NCT00075725|448642015|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
124732725|NCT00075725|448642016|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
124732726|NCT00075725|448642017|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
124732727|NCT00075725|448642018|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
124732728|NCT00075725|448642019|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
124732729|NCT00075725|448642020|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
124732730|NCT00075725|448642021|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
124732731|NCT00075725|448642022|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
124732732|NCT00075725|448642023|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
124732733|NCT00075725|448642012|FG000|Overall Study|Pt incarcerated|0|||
124732734|NCT00075725|448642013|FG001|Overall Study|Pt incarcerated|0|||
124732735|NCT00075725|448642014|FG002|Overall Study|Pt incarcerated|0|||
124732736|NCT00075725|448642015|FG003|Overall Study|Pt incarcerated|0|||
124732737|NCT00075725|448642016|FG004|Overall Study|Pt incarcerated|0|||
124732738|NCT00075725|448642017|FG005|Overall Study|Pt incarcerated|0|||
124732739|NCT00075725|448642018|FG006|Overall Study|Pt incarcerated|0|||
124732740|NCT00075725|448642019|FG007|Overall Study|Pt incarcerated|1|||
124732741|NCT00075725|448642020|FG008|Overall Study|Pt incarcerated|0|||
124732742|NCT00075725|448642021|FG009|Overall Study|Pt incarcerated|0|||
124732743|NCT00075725|448642022|FG010|Overall Study|Pt incarcerated|0|||
124732744|NCT00075725|448642023|FG011|Overall Study|Pt incarcerated|0|||
124732745|NCT01444027|448642026|FG000|Overall Study|Withdrawal by Subject|4|||
124732746|NCT01444027|448642027|FG001|Overall Study|Withdrawal by Subject|10|||
124732747|NCT01444027|448642028|FG002|Overall Study|Withdrawal by Subject|24|||
124732748|NCT01444027|448642026|FG000|Overall Study|Lost to Follow-up|26|||
124732749|NCT01444027|448642027|FG001|Overall Study|Lost to Follow-up|20|||
124732750|NCT01444027|448642028|FG002|Overall Study|Lost to Follow-up|14|||
124732751|NCT00737711|448642030|FG000|Overall Study|Adverse Event|2|||
124732752|NCT00737711|448642030|FG000|Overall Study|Death|8|||
124732753|NCT00737711|448642030|FG000|Overall Study|Failure to return|4|||
124732754|NCT00737711|448642030|FG000|Overall Study|Protocol Violation|1|||
124732755|NCT00737711|448642030|FG000|Overall Study|Withdrawal by Subject|5|||
124732756|NCT00737711|448642030|FG000|Overall Study|Blood transfusion|6|||
124732757|NCT00737711|448642030|FG000|Overall Study|Other|5|||
124732758|NCT00840060|448643838|FG000|Overall Study|Withdrawal by Subject|1|||
124732759|NCT00840060|448643839|FG001|Overall Study|Withdrawal by Subject|0|||
124732760|NCT00840060|448643838|FG000|Overall Study|Change in emotional/behavioral status|0|||
124732761|NCT00840060|448643839|FG001|Overall Study|Change in emotional/behavioral status|1|||
124732762|NCT01263015|448643840|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
124732763|NCT01263015|448643841|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
124732764|NCT01263015|448643840|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
124732765|NCT01263015|448643841|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
124732766|NCT01263015|448643840|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
124732767|NCT01263015|448643841|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
124732768|NCT01263015|448643840|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
124732769|NCT01263015|448643841|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
124732770|NCT01263015|448643840|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
124732771|NCT01263015|448643841|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
124732772|NCT01263015|448643840|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
124732773|NCT01263015|448643841|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
124732774|NCT01263015|448643840|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
124732775|NCT01263015|448643841|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
124732776|NCT01263015|448643840|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
124732777|NCT01263015|448643841|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
124732778|NCT01263015|448643840|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
124732779|NCT01263015|448643841|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
124732780|NCT01263015|448643840|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
124732781|NCT01263015|448643841|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
124732782|NCT01263015|448643840|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
124732783|NCT01263015|448643841|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
124732784|NCT01263015|448643840|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
124732785|NCT01263015|448643841|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
124732786|NCT00303446|448643843|FG000|Overall Study|Withdrawal by Subject|2|||
124732787|NCT00303446|448643844|FG001|Overall Study|Withdrawal by Subject|2|||
124732788|NCT00303446|448643843|FG000|Overall Study|Death|0|||
124732789|NCT00303446|448643844|FG001|Overall Study|Death|1|||
124732790|NCT00303446|448643843|FG000|Overall Study|Physician Decision|0|||
124732791|NCT00303446|448643844|FG001|Overall Study|Physician Decision|1|||
124732792|NCT02251717|448643845|FG000|Overall Study|Adverse Event|0|||
124732793|NCT02251717|448643846|FG001|Overall Study|Adverse Event|1|||
124732794|NCT02251717|448643845|FG000|Overall Study|Withdrew Consent|1|||
124732795|NCT02251717|448643846|FG001|Overall Study|Withdrew Consent|0|||
124732796|NCT04035564|448643847|FG000|Overall Study|Protocol Violation|1|||
124732797|NCT04035564|448643848|FG001|Overall Study|Protocol Violation|2|||
124732798|NCT04035564|448643847|FG000|Overall Study|No laboratory available|2|||
124732799|NCT04035564|448643848|FG001|Overall Study|No laboratory available|2|||
124732800|NCT04035564|448643847|FG000|Overall Study|Guardian declined consent|1|||
124732801|NCT04035564|448643848|FG001|Overall Study|Guardian declined consent|2|||
124732802|NCT02324205|448643851|FG000|Overall Study|Withdrawal by Subject|37|||
124732803|NCT01774097|448643852|FG000|Overall Study|Withdrawal by Subject|1|||
124732804|NCT01774097|448643853|FG001|Overall Study|Withdrawal by Subject|1|||
124732805|NCT01774097|448643852|FG000|Overall Study|Adverse Event|1|||
124732806|NCT01774097|448643853|FG001|Overall Study|Adverse Event|1|||
124732807|NCT03664674|448643854|FG000|Overall Study|Adverse Event|1|||
124732808|NCT03664674|448643855|FG001|Overall Study|Adverse Event|1|||
124732809|NCT03664674|448643854|FG000|Overall Study|Physician Decision|0|||
124732810|NCT03664674|448643855|FG001|Overall Study|Physician Decision|1|||
124732811|NCT03664674|448643854|FG000|Overall Study|Withdrawal by Subject|2|||
124732812|NCT03664674|448643855|FG001|Overall Study|Withdrawal by Subject|0|||
124732813|NCT02174523|448643857|FG000|Overall Study|Withdrawal by Subject|1|||
124732814|NCT02174523|448643858|FG001|Overall Study|Withdrawal by Subject|0|||
124732815|NCT00794365|448643859|FG000|Overall Study|Lost to Follow-up|38|||
124732816|NCT00794365|448643859|FG000|Overall Study|Other|17|||
124732817|NCT00794365|448643859|FG000|Overall Study|Poor Compliance|11|||
124732818|NCT00794365|448643859|FG000|Overall Study|Adverse Event|10|||
124732819|NCT00794365|448643859|FG000|Overall Study|Lack of Efficacy|3|||
124732820|NCT00937404|448643860|FG000|Overall Study|Protocol Violation|1|||
124732821|NCT00937404|448643860|FG000|Overall Study|Withdrawal by Subject|1|||
124732822|NCT00230282|448643862|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
124732823|NCT00230282|448643862|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
124732824|NCT00230282|448643862|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
124732825|NCT00230282|448643862|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
124732826|NCT03263923|448643863|FG000|Overall Study|Withdrawal by Subject|10|||
124732827|NCT03263923|448643864|FG001|Overall Study|Withdrawal by Subject|8|||
124732828|NCT03263923|448643863|FG000|Overall Study|Lost to Follow-up|15|||
124732829|NCT03263923|448643864|FG001|Overall Study|Lost to Follow-up|13|||
124732830|NCT03362931|448643865|FG000|Overall Study|Adverse Event|1|||
124732831|NCT03362931|448643865|FG000|Overall Study|Death|2|||
124732832|NCT02229214|448643874|FG000|Overall Study|Adverse Event|2|||
124732833|NCT02229214|448643875|FG001|Overall Study|Adverse Event|0|||
124732834|NCT02229214|448643874|FG000|Overall Study|Withdrawal by Subject|4|||
124732835|NCT02229214|448643875|FG001|Overall Study|Withdrawal by Subject|0|||
124732836|NCT00969761|448643882|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
124732837|NCT00969761|448643883|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
124732838|NCT00969761|448643884|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
124732839|NCT00969761|448643885|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
124732840|NCT00969761|448643886|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
124732841|NCT00969761|448643887|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
124732842|NCT00969761|448643888|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
124732843|NCT00969761|448643889|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
124732844|NCT00969761|448643890|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
124732845|NCT00969761|448643891|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
124732846|NCT00969761|448643892|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
124732847|NCT00969761|448643893|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
124732848|NCT00969761|448643882|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
124732849|NCT00969761|448643883|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
124732850|NCT00969761|448643884|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
124732851|NCT00969761|448643885|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
124732852|NCT00969761|448643886|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
124732853|NCT00969761|448643887|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
124732854|NCT00969761|448643888|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
124732855|NCT00969761|448643889|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
124732856|NCT00969761|448643890|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
124732857|NCT00969761|448643891|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
124732858|NCT00969761|448643892|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
124732859|NCT00969761|448643893|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
124732860|NCT00969761|448643882|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
124732861|NCT00969761|448643883|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
124732862|NCT00969761|448643884|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
124732863|NCT00969761|448643885|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
124732864|NCT00969761|448643886|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
124732865|NCT00969761|448643887|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
124732866|NCT00969761|448643888|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
124732867|NCT00969761|448643889|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
124732868|NCT00969761|448643890|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
124732869|NCT00969761|448643891|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
124732870|NCT00969761|448643892|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
124732871|NCT00969761|448643893|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
124732872|NCT00969761|448643882|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
124732873|NCT00969761|448643883|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
124732874|NCT00969761|448643884|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
124732875|NCT00969761|448643885|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
124732876|NCT00969761|448643886|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
124732877|NCT00969761|448643887|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
124732878|NCT00969761|448643888|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
124732879|NCT00969761|448643889|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
124732880|NCT00969761|448643890|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
124732881|NCT00969761|448643891|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
124732882|NCT00969761|448643892|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
124732883|NCT00969761|448643893|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
124732884|NCT00969761|448643882|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
124732885|NCT00969761|448643883|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
124732886|NCT00969761|448643884|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
124732887|NCT00969761|448643885|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
124732888|NCT00969761|448643886|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
124732889|NCT00969761|448643887|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
124732890|NCT00969761|448643888|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
124732891|NCT00969761|448643889|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
124732892|NCT00969761|448643890|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
124732893|NCT00969761|448643891|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
124732894|NCT00969761|448643892|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
124732895|NCT00969761|448643893|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
124732896|NCT00969761|448643882|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
124732897|NCT00969761|448643883|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
124732898|NCT00969761|448643884|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
124732899|NCT00969761|448643885|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
124732900|NCT00969761|448643886|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
124732901|NCT00969761|448643887|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
124732902|NCT00969761|448643888|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
124732903|NCT00969761|448643889|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
124732904|NCT00969761|448643890|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
124732905|NCT00969761|448643891|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
124732906|NCT00969761|448643892|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
124732907|NCT00969761|448643893|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
124732908|NCT02927925|448643894|FG000|Overall Study|Death|16|||
124732909|NCT02927925|448643894|FG000|Overall Study|Physician Decision|1|||
124732910|NCT02927925|448643894|FG000|Overall Study|Withdrawal by Subject|11|||
124732911|NCT02927925|448643894|FG000|Overall Study|Other|3|||
124732912|NCT02927925|448643894|FG000|Overall Study|Disease progression at clinical cutoff|1|||
124732913|NCT03305081|448643897|FG000|Overall Study|Lost to Follow-up|10|||
124732914|NCT03305081|448643898|FG001|Overall Study|Lost to Follow-up|15|||
124732915|NCT01571284|448643905|FG000|Overall Study|Participant's decision|84|||
124732916|NCT01571284|448643905|FG000|Overall Study|Lost to Follow-up|3|||
124732917|NCT01571284|448643905|FG000|Overall Study|Enrolled but not treated|2|||
124732918|NCT01571284|448643905|FG000|Overall Study|Other than specified above|80|||
124732919|NCT04065074|448643906|FG000|Overall Study|Adverse Event|1|||
124610120|NCT00073021|448191965|FG000|Overall Study|Protocol Violation|2|||
124610121|NCT00073021|448191966|FG001|Overall Study|Protocol Violation|1|||
124610122|NCT00073021|448191965|FG000|Overall Study|Adverse Event|4|||
124610123|NCT00073021|448191966|FG001|Overall Study|Adverse Event|4|||
124732920|NCT04065074|448643906|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
124732921|NCT00871117|448643907|FG000|Overall Study|Lost to Follow-up|5|||
124732922|NCT00871117|448643908|FG001|Overall Study|Lost to Follow-up|6|||
124732923|NCT00871117|448643907|FG000|Overall Study|Other|0|||
124732924|NCT00871117|448643908|FG001|Overall Study|Other|4|||
124732925|NCT03385265|448643909|FG000|Overall Study|Withdrawal by Subject|5|||
124732926|NCT03385265|448643910|FG001|Overall Study|Withdrawal by Subject|2|||
124732927|NCT03385265|448643911|FG002|Overall Study|Withdrawal by Subject|5|||
124732928|NCT03385265|448643912|FG003|Overall Study|Withdrawal by Subject|2|||
124732929|NCT01560637|448643916|FG000|Overall Study|Adverse Event|63|||
124732930|NCT01560637|448643916|FG000|Overall Study|Death|69|||
124732931|NCT01560637|448643916|FG000|Overall Study|Lost to Follow-up|8|||
124732932|NCT01560637|448643916|FG000|Overall Study|Protocol Violation|8|||
124732933|NCT01560637|448643916|FG000|Overall Study|Withdrawal by Subject|24|||
124732934|NCT01560637|448643916|FG000|Overall Study|Progressive Disease|20|||
124732935|NCT01560637|448643916|FG000|Overall Study|Other Reason Not Specified|6|||
124732936|NCT02323204|448643917|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
124732937|NCT02323204|448643918|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
124732938|NCT02323204|448643919|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
124732939|NCT02323204|448643920|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
124732940|NCT02323204|448643917|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
124732941|NCT02323204|448643918|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
124732942|NCT02323204|448643919|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
124732943|NCT02323204|448643920|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
124732944|NCT02323204|448643917|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
124732945|NCT02323204|448643918|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
124732946|NCT02323204|448643919|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
124732947|NCT02323204|448643920|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
124732948|NCT02323204|448643917|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
124732949|NCT02323204|448643918|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
124732950|NCT02323204|448643919|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
124732951|NCT02323204|448643920|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
124732952|NCT02323204|448643917|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
124732953|NCT02323204|448643918|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
124732954|NCT02323204|448643919|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
124732955|NCT02323204|448643920|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
124732956|NCT02323204|448643917|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
124732957|NCT02323204|448643918|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
124732958|NCT02323204|448643919|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
124732959|NCT02323204|448643920|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
124732960|NCT02323204|448643917|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
124732961|NCT02323204|448643918|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
124732962|NCT02323204|448643919|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
124732963|NCT02323204|448643920|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
124732964|NCT02323204|448643917|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
124732965|NCT02323204|448643918|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
124732966|NCT02323204|448643919|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
124732967|NCT02323204|448643920|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
124732968|NCT02323204|448643917|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
124732969|NCT02323204|448643918|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
124732970|NCT02323204|448643919|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
124732971|NCT02323204|448643920|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
124732972|NCT03831880|448643926|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
124732973|NCT03831880|448643927|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
124732974|NCT03831880|448643926|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
124732975|NCT03831880|448643927|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
124732976|NCT01852825|448643928|FG000|Overall Study|Withdrawal by Subject|2|||
124732977|NCT01852825|448643929|FG001|Overall Study|Withdrawal by Subject|0|||
124732978|NCT01852825|448643930|FG002|Overall Study|Withdrawal by Subject|0|||
124732979|NCT00724854|448643932|FG000|Overall Study|Lack of Efficacy|187|||
124732980|NCT00724854|448643933|FG001|Overall Study|Lack of Efficacy|13|||
124732981|NCT00724854|448643932|FG000|Overall Study|Lost to Follow-up|87|||
124732982|NCT00724854|448643933|FG001|Overall Study|Lost to Follow-up|10|||
124732983|NCT00724854|448643932|FG000|Overall Study|Adverse Event|62|||
124732984|NCT00724854|448643933|FG001|Overall Study|Adverse Event|4|||
124732985|NCT00724854|448643932|FG000|Overall Study|Other|42|||
124732986|NCT00724854|448643933|FG001|Overall Study|Other|3|||
124732987|NCT00724854|448643932|FG000|Overall Study|Death|11|||
124732988|NCT00724854|448643933|FG001|Overall Study|Death|0|||
124732989|NCT00724854|448643932|FG000|Overall Study|Change of treatment|7|||
124732990|NCT00724854|448643933|FG001|Overall Study|Change of treatment|0|||
124732991|NCT00724854|448643932|FG000|Overall Study|Withdrawal by Subject|5|||
124732992|NCT00724854|448643933|FG001|Overall Study|Withdrawal by Subject|0|||
124732993|NCT00724854|448643932|FG000|Overall Study|Adverse event + lack of efficacy|2|||
124732994|NCT00724854|448643933|FG001|Overall Study|Adverse event + lack of efficacy|1|||
124732995|NCT01095653|448643934|FG000|Overall Study|Lack of Efficacy|3|||
124732996|NCT01095653|448643935|FG001|Overall Study|Lack of Efficacy|0|||
124732997|NCT01095653|448643936|FG002|Overall Study|Lack of Efficacy|0|||
124732998|NCT01095653|448643934|FG000|Overall Study|Adverse Event|1|||
124732999|NCT01095653|448643935|FG001|Overall Study|Adverse Event|4|||
124733000|NCT01095653|448643936|FG002|Overall Study|Adverse Event|4|||
124733001|NCT01095653|448643934|FG000|Overall Study|Lost to Follow-up|1|||
124733002|NCT01095653|448643935|FG001|Overall Study|Lost to Follow-up|0|||
124733003|NCT01095653|448643936|FG002|Overall Study|Lost to Follow-up|4|||
124733004|NCT01095653|448643934|FG000|Overall Study|Withdrawal by Subject|4|||
124733005|NCT01095653|448643935|FG001|Overall Study|Withdrawal by Subject|5|||
124733006|NCT01095653|448643936|FG002|Overall Study|Withdrawal by Subject|3|||
124733007|NCT01095653|448643934|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
124733008|NCT01095653|448643935|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
124733009|NCT01095653|448643936|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
124733010|NCT00171925|448643937|FG000|Overall Study|Adverse Event|10|||
124733011|NCT00171925|448643938|FG001|Overall Study|Adverse Event|6|||
124733012|NCT00171925|448643937|FG000|Overall Study|Protocol Violation|1|||
124733013|NCT00171925|448643938|FG001|Overall Study|Protocol Violation|1|||
124733014|NCT00171925|448643937|FG000|Overall Study|Withdrawal by Subject|6|||
124733015|NCT00171925|448643938|FG001|Overall Study|Withdrawal by Subject|9|||
124733016|NCT00171925|448643937|FG000|Overall Study|Lost to Follow-up|2|||
124733017|NCT00171925|448643938|FG001|Overall Study|Lost to Follow-up|2|||
124733018|NCT00171925|448643937|FG000|Overall Study|Administrative problems|10|||
124733019|NCT00171925|448643938|FG001|Overall Study|Administrative problems|11|||
124733020|NCT00171925|448643937|FG000|Overall Study|Death|1|||
124733021|NCT00171925|448643938|FG001|Overall Study|Death|2|||
124733022|NCT02692040|448643939|FG000|Overall Study|Protocol Violation|0|||
124733023|NCT02692040|448643940|FG001|Overall Study|Protocol Violation|0|||
124733024|NCT02692040|448643941|FG002|Overall Study|Protocol Violation|0|||
124733025|NCT02692040|448643942|FG003|Overall Study|Protocol Violation|0|||
124733026|NCT02692040|448643943|FG004|Overall Study|Protocol Violation|0|||
124733027|NCT02692040|448643944|FG005|Overall Study|Protocol Violation|0|||
124733028|NCT02692040|448643945|FG006|Overall Study|Protocol Violation|0|||
124733029|NCT02692040|448643946|FG007|Overall Study|Protocol Violation|0|||
124733030|NCT02692040|448643947|FG008|Overall Study|Protocol Violation|0|||
124733031|NCT02692040|448643948|FG009|Overall Study|Protocol Violation|0|||
124733032|NCT02692040|448643949|FG010|Overall Study|Protocol Violation|0|||
124733033|NCT02692040|448643950|FG011|Overall Study|Protocol Violation|0|||
124733034|NCT02692040|448643951|FG012|Overall Study|Protocol Violation|1|||
124733035|NCT02692040|448643952|FG013|Overall Study|Protocol Violation|0|||
124733036|NCT02692040|448643953|FG014|Overall Study|Protocol Violation|0|||
124733037|NCT02692040|448643954|FG015|Overall Study|Protocol Violation|0|||
124733038|NCT02692040|448643955|FG016|Overall Study|Protocol Violation|0|||
124733039|NCT02692040|448643939|FG000|Overall Study|Adverse Event|0|||
124733040|NCT02692040|448643940|FG001|Overall Study|Adverse Event|0|||
124733041|NCT02692040|448643941|FG002|Overall Study|Adverse Event|0|||
124733042|NCT02692040|448643942|FG003|Overall Study|Adverse Event|0|||
124733043|NCT02692040|448643943|FG004|Overall Study|Adverse Event|0|||
124733044|NCT02692040|448643944|FG005|Overall Study|Adverse Event|0|||
124733045|NCT02692040|448643945|FG006|Overall Study|Adverse Event|0|||
124733046|NCT02692040|448643946|FG007|Overall Study|Adverse Event|0|||
124733047|NCT02692040|448643947|FG008|Overall Study|Adverse Event|0|||
124733048|NCT02692040|448643948|FG009|Overall Study|Adverse Event|0|||
124733049|NCT02692040|448643949|FG010|Overall Study|Adverse Event|0|||
124733050|NCT02692040|448643950|FG011|Overall Study|Adverse Event|0|||
124733051|NCT02692040|448643951|FG012|Overall Study|Adverse Event|0|||
124733052|NCT02692040|448643952|FG013|Overall Study|Adverse Event|3|||
124733053|NCT02692040|448643953|FG014|Overall Study|Adverse Event|1|||
124733054|NCT02692040|448643954|FG015|Overall Study|Adverse Event|1|||
124733055|NCT02692040|448643955|FG016|Overall Study|Adverse Event|0|||
124733056|NCT02752958|448643956|FG000|Overall Study|Adverse Event|3|||
124733057|NCT02752958|448643956|FG000|Overall Study|Lost to Follow-up|1|||
124733058|NCT02752958|448643956|FG000|Overall Study|Protocol Violation|1|||
124733059|NCT02752958|448643956|FG000|Overall Study|Withdrawal by Subject|2|||
124733060|NCT02752958|448643956|FG000|Overall Study|Other (Reason not specified)|2|||
124733061|NCT00853125|448643957|FG000|Overall Study|Study participant's donor was CMV +|1|||
124733062|NCT03746600|448643963|FG000|Overall Study|Withdrawal by Subject|3|||
124733063|NCT03746600|448643964|FG001|Overall Study|Withdrawal by Subject|3|||
124733064|NCT03746600|448643963|FG000|Overall Study|dismissed from study|1|||
124733065|NCT03746600|448643964|FG001|Overall Study|dismissed from study|0|||
124733066|NCT03746600|448643963|FG000|Overall Study|Lost to Follow-up|1|||
124733067|NCT03746600|448643964|FG001|Overall Study|Lost to Follow-up|0|||
124733068|NCT03023826|448643965|FG000|Period 1|Withdrawal by Subject|0|||
124733069|NCT03023826|448643966|FG001|Period 1|Withdrawal by Subject|0|||
124733070|NCT03023826|448643967|FG002|Period 1|Withdrawal by Subject|0|||
124733071|NCT03023826|448643968|FG003|Period 1|Withdrawal by Subject|0|||
124733072|NCT03023826|448643969|FG004|Period 1|Withdrawal by Subject|1|||
124733073|NCT03023826|448643970|FG005|Period 1|Withdrawal by Subject|0|||
124733074|NCT00977938|448643971|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
124733075|NCT00977938|448643972|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
124610124|NCT00073021|448191965|FG000|Overall Study|Withdrawal by Subject|6|||
124610125|NCT00073021|448191966|FG001|Overall Study|Withdrawal by Subject|5|||
124610126|NCT00073021|448191965|FG000|Overall Study|Physician Decision|3|||
124610127|NCT00073021|448191966|FG001|Overall Study|Physician Decision|1|||
124610128|NCT00073021|448191965|FG000|Overall Study|Lack of Efficacy|11|||
124610129|NCT00073021|448191966|FG001|Overall Study|Lack of Efficacy|5|||
124610130|NCT01458106|448191967|FG000|Overall Study|Withdrawal by Subject|2|||
124610131|NCT01458106|448191968|FG001|Overall Study|Withdrawal by Subject|0|||
124610132|NCT01458106|448191967|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
124610133|NCT01458106|448191968|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
124610134|NCT01458106|448191967|FG000|Overall Study|Withdrawn Per Protocol|0|||
124610135|NCT01458106|448191968|FG001|Overall Study|Withdrawn Per Protocol|1|||
124610136|NCT00855803|448191969|FG000|Overall Study|Death|2|||
124610137|NCT00855803|448191969|FG000|Overall Study|Lost to Follow-up|2|||
124610138|NCT00855803|448191969|FG000|Overall Study|Technical inability to undergo procedure|2|||
124610139|NCT00855803|448191969|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
124610140|NCT00855803|448191969|FG000|Overall Study|Withdrawal by Subject|3|||
124610141|NCT00855803|448191969|FG000|Overall Study|Physician Decision|3|||
124610142|NCT03050060|448191971|FG000|Overall Study|Adverse Event|7|||
124610143|NCT03050060|448191971|FG000|Overall Study|Withdrawal by Subject|1|||
124610144|NCT03050060|448191971|FG000|Overall Study|Progression|7|||
124610145|NCT03276780|448191972|FG000|Overall Study|Withdrawal by Subject|5|||
124610146|NCT03276780|448191973|FG001|Overall Study|Withdrawal by Subject|3|||
124610147|NCT03276780|448191972|FG000|Overall Study|Lost to Follow-up|3|||
124610148|NCT03276780|448191973|FG001|Overall Study|Lost to Follow-up|5|||
124610149|NCT03276780|448191972|FG000|Overall Study|Moved out of state|1|||
124610150|NCT03276780|448191973|FG001|Overall Study|Moved out of state|1|||
124610151|NCT03276780|448191972|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
124610152|NCT03276780|448191973|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
124610153|NCT03276780|448191972|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
124610154|NCT03276780|448191973|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
124610155|NCT02304458|448191974|FG000|Overall Study|Adverse Event|0|||
124610156|NCT02304458|448191975|FG001|Overall Study|Adverse Event|0|||
124610157|NCT02304458|448191976|FG002|Overall Study|Adverse Event|7|||
124610158|NCT02304458|448191977|FG003|Overall Study|Adverse Event|0|||
124610159|NCT02304458|448191978|FG004|Overall Study|Adverse Event|0|||
124610160|NCT02304458|448191979|FG005|Overall Study|Adverse Event|0|||
124610161|NCT02304458|448191980|FG006|Overall Study|Adverse Event|3|||
124610162|NCT02304458|448191981|FG007|Overall Study|Adverse Event|4|||
124610163|NCT02304458|448191974|FG000|Overall Study|Death|0|||
124610164|NCT02304458|448191975|FG001|Overall Study|Death|0|||
124610165|NCT02304458|448191976|FG002|Overall Study|Death|2|||
124610166|NCT02304458|448191977|FG003|Overall Study|Death|0|||
124610167|NCT02304458|448191978|FG004|Overall Study|Death|0|||
124610168|NCT02304458|448191979|FG005|Overall Study|Death|0|||
124610169|NCT02304458|448191980|FG006|Overall Study|Death|1|||
124610170|NCT02304458|448191981|FG007|Overall Study|Death|0|||
124610171|NCT02304458|448191974|FG000|Overall Study|Lack of Efficacy|4|||
124610172|NCT02304458|448191975|FG001|Overall Study|Lack of Efficacy|6|||
124610173|NCT02304458|448191976|FG002|Overall Study|Lack of Efficacy|38|||
124610174|NCT02304458|448191977|FG003|Overall Study|Lack of Efficacy|5|||
124610175|NCT02304458|448191978|FG004|Overall Study|Lack of Efficacy|6|||
124610176|NCT02304458|448191979|FG005|Overall Study|Lack of Efficacy|6|||
124610177|NCT02304458|448191980|FG006|Overall Study|Lack of Efficacy|21|||
124610178|NCT02304458|448191981|FG007|Overall Study|Lack of Efficacy|4|||
124610179|NCT02304458|448191974|FG000|Overall Study|Physician Decision|2|||
124610180|NCT02304458|448191975|FG001|Overall Study|Physician Decision|0|||
124610181|NCT02304458|448191976|FG002|Overall Study|Physician Decision|16|||
124610182|NCT02304458|448191977|FG003|Overall Study|Physician Decision|1|||
124610183|NCT02304458|448191978|FG004|Overall Study|Physician Decision|0|||
124610184|NCT02304458|448191979|FG005|Overall Study|Physician Decision|0|||
124610185|NCT02304458|448191980|FG006|Overall Study|Physician Decision|3|||
124610186|NCT02304458|448191981|FG007|Overall Study|Physician Decision|0|||
124610187|NCT02304458|448191974|FG000|Overall Study|Protocol Violation|0|||
124610188|NCT02304458|448191975|FG001|Overall Study|Protocol Violation|0|||
124610189|NCT02304458|448191976|FG002|Overall Study|Protocol Violation|1|||
124610190|NCT02304458|448191977|FG003|Overall Study|Protocol Violation|0|||
124733076|NCT00977938|448643973|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
124733077|NCT00977938|448643974|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
124733078|NCT00977938|448643971|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
124610191|NCT02304458|448191978|FG004|Overall Study|Protocol Violation|0|||
124610192|NCT02304458|448191979|FG005|Overall Study|Protocol Violation|0|||
124610193|NCT02304458|448191980|FG006|Overall Study|Protocol Violation|0|||
124610194|NCT02304458|448191981|FG007|Overall Study|Protocol Violation|0|||
124610195|NCT02304458|448191974|FG000|Overall Study|Withdrawal by Subject|1|||
124610196|NCT02304458|448191975|FG001|Overall Study|Withdrawal by Subject|0|||
124610197|NCT02304458|448191976|FG002|Overall Study|Withdrawal by Subject|7|||
124733079|NCT00977938|448643972|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
124733080|NCT00977938|448643973|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
124733081|NCT00977938|448643974|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
124733082|NCT00977938|448643971|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
124733083|NCT00977938|448643972|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
124733084|NCT00977938|448643973|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
124733085|NCT00977938|448643974|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
124733086|NCT00977938|448643971|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
124733087|NCT00977938|448643972|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
124733088|NCT00977938|448643973|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
124733089|NCT00977938|448643974|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
124733090|NCT00977938|448643971|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
124733091|NCT00977938|448643972|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
124733092|NCT00977938|448643973|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
124733093|NCT00977938|448643974|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
124733094|NCT00977938|448643971|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
124733095|NCT00977938|448643972|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
124733096|NCT00977938|448643973|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
124733097|NCT00977938|448643974|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
124733098|NCT02142283|448643975|FG000|Overall Study|Death|20|||
124733099|NCT02142283|448643976|FG001|Overall Study|Death|18|||
124733100|NCT02142283|448643975|FG000|Overall Study|Withdrawal by Subject|1|||
124733101|NCT02142283|448643976|FG001|Overall Study|Withdrawal by Subject|3|||
124733102|NCT00717522|448643979|FG000|Overall Study|Disease Progression|5|||
124733103|NCT00717522|448643979|FG000|Overall Study|Adverse Event|1|||
124733104|NCT00717522|448643979|FG000|Overall Study|Death|1|||
124733105|NCT02981407|448643984|FG000|Overall Study|Withdrawal by Subject|2|||
124733106|NCT02981407|448643985|FG001|Overall Study|Withdrawal by Subject|0|||
124733107|NCT00355342|448643988|FG000|Overall Study|Adverse Event|13|||
124733108|NCT00355342|448643989|FG001|Overall Study|Adverse Event|15|||
124733109|NCT00355342|448643988|FG000|Overall Study|Lost to Follow-up|4|||
124733110|NCT00355342|448643989|FG001|Overall Study|Lost to Follow-up|2|||
124733111|NCT00355342|448643988|FG000|Overall Study|Withdrawal by Subject|14|||
124733112|NCT00355342|448643989|FG001|Overall Study|Withdrawal by Subject|11|||
124733113|NCT00355342|448643988|FG000|Overall Study|Sponsor terminated study|2|||
124733114|NCT00355342|448643989|FG001|Overall Study|Sponsor terminated study|2|||
124733115|NCT00355342|448643988|FG000|Overall Study|Overcompliant-PI discretion|1|||
124733116|NCT00355342|448643989|FG001|Overall Study|Overcompliant-PI discretion|0|||
124733117|NCT00355342|448643988|FG000|Overall Study|Use of prohibited medication|1|||
124733118|NCT00355342|448643989|FG001|Overall Study|Use of prohibited medication|0|||
124733119|NCT00355342|448643988|FG000|Overall Study|COPD exacerbation|1|||
124733120|NCT00355342|448643989|FG001|Overall Study|COPD exacerbation|1|||
124733121|NCT00355342|448643988|FG000|Overall Study|Dispensed wrong study drug kit|1|||
124733122|NCT00355342|448643989|FG001|Overall Study|Dispensed wrong study drug kit|0|||
124733123|NCT00355342|448643988|FG000|Overall Study|Non-compliance with Dexa scans|1|||
124733124|NCT00355342|448643989|FG001|Overall Study|Non-compliance with Dexa scans|0|||
124733125|NCT00355342|448643988|FG000|Overall Study|Withdrawal by participant and physician|1|||
124733126|NCT00355342|448643989|FG001|Overall Study|Withdrawal by participant and physician|0|||
124733127|NCT00355342|448643988|FG000|Overall Study|Participant relocated|0|||
124733128|NCT00355342|448643989|FG001|Overall Study|Participant relocated|1|||
124733129|NCT00355342|448643988|FG000|Overall Study|Participant discontinued study drug|0|||
124733130|NCT00355342|448643989|FG001|Overall Study|Participant discontinued study drug|1|||
124733131|NCT00355342|448643988|FG000|Overall Study|Study management|0|||
124733132|NCT00355342|448643989|FG001|Overall Study|Study management|1|||
124733133|NCT00355342|448643988|FG000|Overall Study|Protocol Violation|0|||
124733134|NCT00355342|448643989|FG001|Overall Study|Protocol Violation|1|||
124733135|NCT00355342|448643988|FG000|Overall Study|Use of protocol excluded medication|0|||
124733136|NCT00355342|448643989|FG001|Overall Study|Use of protocol excluded medication|1|||
124733137|NCT01416441|448643990|FG000|Overall Study|Lost to Follow-up|5|||
124733138|NCT01416441|448643990|FG000|Overall Study|Adverse Event|6|||
124733139|NCT01416441|448643990|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
124733140|NCT01416441|448643990|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
124733141|NCT01416441|448643990|FG000|Overall Study|Investigator Withdrew Subject|2|||
124733142|NCT01416441|448643990|FG000|Overall Study|Subject Withdrew Consent|12|||
124781205|NCT02405442|448829118|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
124781206|NCT02405442|448829119|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
124733143|NCT01416441|448643990|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
124733144|NCT02653495|448643995|FG000|Overall Study|Lost to Follow-up|2|||
124733145|NCT02653495|448643996|FG001|Overall Study|Lost to Follow-up|0|||
124733146|NCT02653495|448643995|FG000|Overall Study|Screening Failure|10|||
124733147|NCT02653495|448643996|FG001|Overall Study|Screening Failure|0|||
124733148|NCT00953680|448643997|FG000|Period 1|Withdrawal by Subject|0|||
124733149|NCT00953680|448643998|FG001|Period 1|Withdrawal by Subject|1|||
124733150|NCT01360398|448643999|FG000|Overall Study|Withdrawal by Subject|14|||
124733151|NCT01360398|448643999|FG000|Overall Study|Other|7|||
124733152|NCT01360398|448643999|FG000|Overall Study|Migrated/moved from study area|1|||
124733153|NCT00624780|448644003|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
124733154|NCT00624780|448644004|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
124733155|NCT00624780|448644005|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
124733156|NCT00624780|448644006|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
124733157|NCT00624780|448644007|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
124733158|NCT00624780|448644008|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
124733159|NCT00624780|448644003|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
124733160|NCT00624780|448644004|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
124733161|NCT00624780|448644005|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
124733162|NCT00624780|448644006|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
124733163|NCT00624780|448644007|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
124733164|NCT00624780|448644008|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
124733165|NCT00624780|448644003|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
124733166|NCT00624780|448644004|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
124733167|NCT00624780|448644005|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
124733168|NCT00624780|448644006|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
124733169|NCT00624780|448644007|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
124733170|NCT00624780|448644008|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
124733171|NCT00624780|448644003|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
124733172|NCT00624780|448644004|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
124733173|NCT00624780|448644005|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
124733174|NCT00624780|448644006|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
124733175|NCT00624780|448644007|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
124733176|NCT00624780|448644008|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
124733177|NCT00624780|448644003|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
124733178|NCT00624780|448644004|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
124733179|NCT00624780|448644005|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
124733180|NCT00624780|448644006|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
124733181|NCT00624780|448644007|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
124733182|NCT00624780|448644008|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
124733183|NCT00624780|448644003|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
124733184|NCT00624780|448644004|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
124733185|NCT00624780|448644005|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
124733186|NCT00624780|448644006|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
124733187|NCT00624780|448644007|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
124733188|NCT00624780|448644008|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
124733189|NCT00624780|448644003|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
124733190|NCT00624780|448644004|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
124733191|NCT00624780|448644005|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
124733192|NCT00624780|448644006|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
124733193|NCT00624780|448644007|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
124733194|NCT00624780|448644008|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
124733195|NCT00624780|448644003|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
124733196|NCT00624780|448644004|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
124733197|NCT00624780|448644005|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
124733198|NCT00624780|448644006|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
124733199|NCT00624780|448644007|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
124733200|NCT00624780|448644008|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
124733201|NCT00624780|448644003|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
124733202|NCT00624780|448644004|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
124733203|NCT00624780|448644005|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
124733204|NCT00624780|448644006|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
124733205|NCT00624780|448644007|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
124733206|NCT00624780|448644008|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
124733207|NCT00624780|448644003|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
124733208|NCT00624780|448644004|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
124733209|NCT00624780|448644005|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
124733210|NCT00624780|448644006|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
124733211|NCT00624780|448644007|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
124733212|NCT00624780|448644008|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
124733213|NCT00624780|448644003|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
124781207|NCT02405442|448829120|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
124781208|NCT02405442|448829121|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
124733214|NCT00624780|448644004|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
124733215|NCT00624780|448644005|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
124733216|NCT00624780|448644006|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
124733217|NCT00624780|448644007|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
124733218|NCT00624780|448644008|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
124733219|NCT00624780|448644003|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
124733220|NCT00624780|448644004|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
124733221|NCT00624780|448644005|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
124733222|NCT00624780|448644006|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
124733223|NCT00624780|448644007|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
124733224|NCT00624780|448644008|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
124733225|NCT00624780|448644003|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
124733226|NCT00624780|448644004|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
124733227|NCT00624780|448644005|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
124733228|NCT00624780|448644006|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
124733229|NCT00624780|448644007|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
124733230|NCT00624780|448644008|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
124733231|NCT00624780|448644003|FG000|Follow-up (Week 26)|Death|0|||
124733232|NCT00624780|448644004|FG001|Follow-up (Week 26)|Death|0|||
124733233|NCT00624780|448644005|FG002|Follow-up (Week 26)|Death|1|||
124733234|NCT00624780|448644006|FG003|Follow-up (Week 26)|Death|0|||
124733235|NCT00624780|448644007|FG004|Follow-up (Week 26)|Death|0|||
124733236|NCT00624780|448644008|FG005|Follow-up (Week 26)|Death|0|||
124733237|NCT00624780|448644003|FG000|Follow-up (Week 26)|Adverse Event|0|||
124733238|NCT00624780|448644004|FG001|Follow-up (Week 26)|Adverse Event|0|||
124733239|NCT00624780|448644005|FG002|Follow-up (Week 26)|Adverse Event|0|||
124733240|NCT00624780|448644006|FG003|Follow-up (Week 26)|Adverse Event|0|||
124733241|NCT00624780|448644007|FG004|Follow-up (Week 26)|Adverse Event|1|||
124733242|NCT00624780|448644008|FG005|Follow-up (Week 26)|Adverse Event|0|||
124733243|NCT00624780|448644003|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
124733244|NCT00624780|448644004|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
124733245|NCT00624780|448644005|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
124733246|NCT00624780|448644006|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
124733247|NCT00624780|448644007|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
124733248|NCT00624780|448644008|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
124733249|NCT00624780|448644003|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
124733250|NCT00624780|448644004|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
124733251|NCT00624780|448644005|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
124733252|NCT00624780|448644006|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
124733253|NCT00624780|448644007|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
124733254|NCT00624780|448644008|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
124733255|NCT00624780|448644003|FG000|Follow-up (Week 26)|Other|1|||
124733256|NCT00624780|448644004|FG001|Follow-up (Week 26)|Other|1|||
124733257|NCT00624780|448644005|FG002|Follow-up (Week 26)|Other|0|||
124733258|NCT00624780|448644006|FG003|Follow-up (Week 26)|Other|0|||
124733259|NCT00624780|448644007|FG004|Follow-up (Week 26)|Other|0|||
124733260|NCT00624780|448644008|FG005|Follow-up (Week 26)|Other|0|||
124733261|NCT01514240|448646223|FG000|Overall Study|Adverse Event|4|||
124733262|NCT01514240|448646224|FG001|Overall Study|Adverse Event|4|||
124733263|NCT01514240|448646223|FG000|Overall Study|Subject Decision|2|||
124733264|NCT01514240|448646224|FG001|Overall Study|Subject Decision|7|||
124733265|NCT00549900|448646226|FG000|Overall Study|Adverse Event|1|||
124733266|NCT01007123|448646231|FG000|Overall Study|Adverse Event|3|||
124733267|NCT01007123|448646232|FG001|Overall Study|Adverse Event|4|||
124733268|NCT01007123|448646233|FG002|Overall Study|Adverse Event|7|||
124733269|NCT01007123|448646234|FG003|Overall Study|Adverse Event|1|||
124733270|NCT01007123|448646231|FG000|Overall Study|Lack of Efficacy|1|||
124733271|NCT01007123|448646232|FG001|Overall Study|Lack of Efficacy|0|||
124733272|NCT01007123|448646233|FG002|Overall Study|Lack of Efficacy|1|||
124733273|NCT01007123|448646234|FG003|Overall Study|Lack of Efficacy|4|||
124733274|NCT01007123|448646231|FG000|Overall Study|Protocol Violation|1|||
124733275|NCT01007123|448646232|FG001|Overall Study|Protocol Violation|1|||
124733276|NCT01007123|448646233|FG002|Overall Study|Protocol Violation|2|||
124733277|NCT01007123|448646234|FG003|Overall Study|Protocol Violation|1|||
124733278|NCT01007123|448646231|FG000|Overall Study|Withdrawal by Subject|1|||
124733279|NCT01007123|448646232|FG001|Overall Study|Withdrawal by Subject|0|||
124733280|NCT01007123|448646233|FG002|Overall Study|Withdrawal by Subject|1|||
124733281|NCT01007123|448646234|FG003|Overall Study|Withdrawal by Subject|0|||
124733282|NCT01007123|448646231|FG000|Overall Study|Lost to Follow-up|0|||
124733283|NCT01007123|448646232|FG001|Overall Study|Lost to Follow-up|1|||
124733284|NCT01007123|448646233|FG002|Overall Study|Lost to Follow-up|0|||
124733285|NCT01007123|448646234|FG003|Overall Study|Lost to Follow-up|0|||
124733286|NCT00149994|448646235|FG000|Overall Study|Administrative problems:|1|||
124733287|NCT00149994|448646236|FG001|Overall Study|Administrative problems:|0|||
124733288|NCT00149994|448646235|FG000|Overall Study|Protocol Violation|0|||
124733289|NCT00149994|448646236|FG001|Overall Study|Protocol Violation|1|||
124733290|NCT00613925|448646237|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
124733291|NCT00613925|448646238|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
124733292|NCT00252694|448646241|FG000|Overall Study|Withdrawal by Subject|83|||
124733293|NCT00252694|448646242|FG001|Overall Study|Withdrawal by Subject|91|||
124733294|NCT00252694|448646241|FG000|Overall Study|Death|36|||
124733295|NCT00252694|448646242|FG001|Overall Study|Death|34|||
124733296|NCT00252694|448646241|FG000|Overall Study|Mostly Lost to Follow Up|8|||
124733297|NCT00252694|448646242|FG001|Overall Study|Mostly Lost to Follow Up|13|||
124733298|NCT00252694|448646241|FG000|Overall Study|Patient Moving|17|||
124733299|NCT00252694|448646242|FG001|Overall Study|Patient Moving|16|||
124733300|NCT01342965|448646243|FG000|Overall Study|Death|58|||
124733301|NCT01342965|448646244|FG001|Overall Study|Death|57|||
124733302|NCT01342965|448646243|FG000|Overall Study|Lost to Follow-up|5|||
124733303|NCT01342965|448646244|FG001|Overall Study|Lost to Follow-up|3|||
124733304|NCT01342965|448646243|FG000|Overall Study|Other Reasons- Unspecified|44|||
124733305|NCT01342965|448646244|FG001|Overall Study|Other Reasons- Unspecified|38|||
124733306|NCT01342965|448646243|FG000|Overall Study|Withdrawal by Subject|2|||
124733307|NCT01342965|448646244|FG001|Overall Study|Withdrawal by Subject|9|||
124733308|NCT01170598|448646255|FG000|Overall Study|Withdrawal by Subject|1|||
124733309|NCT01170598|448646255|FG000|Overall Study|Death|3|||
124733310|NCT01170598|448646255|FG000|Overall Study|Lost to Follow-up|1|||
124733311|NCT01170598|448646255|FG000|Overall Study|Refused|1|||
124733312|NCT03538444|448646256|FG000|Overall Study|opioid withdrawal|1|||
124733313|NCT03538444|448646257|FG001|Overall Study|opioid withdrawal|0|||
124733314|NCT02119156|448646260|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
124733315|NCT02119156|448646261|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
124733316|NCT02119156|448646262|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
124733317|NCT02119156|448646260|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
124733318|NCT02119156|448646261|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
124733319|NCT02119156|448646262|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
124733320|NCT02119156|448646260|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
124733321|NCT02119156|448646261|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
124733322|NCT02119156|448646262|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
124733323|NCT02119156|448646260|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
124733324|NCT02119156|448646261|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
124733325|NCT02119156|448646262|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
124733326|NCT02119156|448646260|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
124733327|NCT02119156|448646261|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
124733328|NCT02119156|448646262|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
124733329|NCT04644237|448646274|FG000|Overall Study|Death|3|||
124733330|NCT04644237|448646275|FG001|Overall Study|Death|2|||
124733331|NCT04644237|448646274|FG000|Overall Study|Adverse Event|15|||
124733332|NCT04644237|448646275|FG001|Overall Study|Adverse Event|12|||
124733333|NCT04644237|448646274|FG000|Overall Study|Progressive Disease|47|||
124733334|NCT04644237|448646275|FG001|Overall Study|Progressive Disease|19|||
124733335|NCT04644237|448646274|FG000|Overall Study|Clinical Progression|4|||
124733336|NCT04644237|448646275|FG001|Overall Study|Clinical Progression|1|||
124733337|NCT04644237|448646274|FG000|Overall Study|Withdrawal by Subject|1|||
124733338|NCT04644237|448646275|FG001|Overall Study|Withdrawal by Subject|2|||
124733339|NCT04644237|448646274|FG000|Overall Study|Physician Decision|3|||
124733340|NCT04644237|448646275|FG001|Overall Study|Physician Decision|0|||
124733341|NCT04644237|448646274|FG000|Overall Study|Other|1|||
124733342|NCT04644237|448646275|FG001|Overall Study|Other|0|||
124733343|NCT04644237|448646274|FG000|Overall Study|Randomized but not Treated|1|||
124733344|NCT04644237|448646275|FG001|Overall Study|Randomized but not Treated|0|||
124733345|NCT01779869|448646276|FG000|Overall Study|Physician Decision|2|||
124733346|NCT02233738|448646278|FG000|Overall Study|Lost to Follow-up|5|||
124733347|NCT02233738|448646279|FG001|Overall Study|Lost to Follow-up|12|||
124733348|NCT02233738|448646278|FG000|Overall Study|Death|0|||
124733349|NCT02233738|448646279|FG001|Overall Study|Death|1|||
124733350|NCT02233738|448646278|FG000|Overall Study|Withdrawal by Subject|0|||
124733351|NCT02233738|448646279|FG001|Overall Study|Withdrawal by Subject|1|||
124733352|NCT02233738|448646278|FG000|Overall Study|Did not return after Baseline|3|||
124733353|NCT02233738|448646279|FG001|Overall Study|Did not return after Baseline|2|||
124733354|NCT00096174|448646280|FG000|Overall Study|Lack of Efficacy|9|||
124733355|NCT00096174|448646280|FG000|Overall Study|Adverse Event|15|||
124733356|NCT00096174|448646280|FG000|Overall Study|Death|6|||
124733357|NCT00096174|448646280|FG000|Overall Study|Withdrawal by Subject|15|||
124733358|NCT00096174|448646280|FG000|Overall Study|Not started protocol therapy|3|||
124733359|NCT00096174|448646280|FG000|Overall Study|Ineligible|6|||
124733360|NCT00096174|448646280|FG000|Overall Study|other reason|8|||
124733361|NCT00027378|448646284|FG000|Overall Study|Physician Decision|0|||
124733362|NCT00027378|448646285|FG001|Overall Study|Physician Decision|3|||
124733363|NCT05605691|448646286|FG000|Overall Study|Lost to Follow-up|1|||
124733364|NCT04706273|448646287|FG000|Overall Study|Withdrawal by Subject|27|||
124733365|NCT04706273|448646287|FG000|Overall Study|Physician Decision|1|||
124733366|NCT04706273|448646287|FG000|Overall Study|Lost to Follow-up|42|||
124733367|NCT04706273|448646287|FG000|Overall Study|Death|85|||
124733368|NCT04706273|448646287|FG000|Overall Study|Amputation that removes study device|2|||
124733369|NCT04706273|448646287|FG000|Overall Study|Surgical bypass|3|||
124733370|NCT04706273|448646287|FG000|Overall Study|Changing hospital|23|||
124733371|NCT04706273|448646287|FG000|Overall Study|Unable to attend hospital|2|||
124733372|NCT03199053|448646290|FG000|ST Period|Withdrawal by Subject|2|||
124733373|NCT03199053|448646291|FG001|ST Period|Withdrawal by Subject|4|||
124733374|NCT03199053|448646292|FG002|ST Period|Withdrawal by Subject|6|||
124733375|NCT03199053|448646290|FG000|ST Period|Withdrawal by parent/guardian|1|||
124733376|NCT03199053|448646291|FG001|ST Period|Withdrawal by parent/guardian|1|||
124733377|NCT03199053|448646292|FG002|ST Period|Withdrawal by parent/guardian|1|||
124733378|NCT03199053|448646290|FG000|ST Period|Lost to Follow-up|2|||
124733379|NCT03199053|448646291|FG001|ST Period|Lost to Follow-up|0|||
124733380|NCT03199053|448646292|FG002|ST Period|Lost to Follow-up|1|||
124733381|NCT03199053|448646290|FG000|LT Period|Withdrawal by Subject|1|||
124733382|NCT03199053|448646291|FG001|LT Period|Withdrawal by Subject|3|||
124733383|NCT03199053|448646292|FG002|LT Period|Withdrawal by Subject|3|||
124733384|NCT03199053|448646290|FG000|LT Period|Withdrawal by parent/guardian|0|||
124733385|NCT03199053|448646291|FG001|LT Period|Withdrawal by parent/guardian|0|||
124733386|NCT03199053|448646292|FG002|LT Period|Withdrawal by parent/guardian|1|||
124733387|NCT03199053|448646290|FG000|LT Period|Lost to Follow-up|0|||
124733388|NCT03199053|448646291|FG001|LT Period|Lost to Follow-up|1|||
124733389|NCT03199053|448646292|FG002|LT Period|Lost to Follow-up|1|||
124733390|NCT03199053|448646290|FG000|LT Period|Miscellaneous|0|||
124733391|NCT03199053|448646291|FG001|LT Period|Miscellaneous|0|||
124733392|NCT03199053|448646292|FG002|LT Period|Miscellaneous|2|||
124733393|NCT03199053|448646290|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
124733394|NCT03199053|448646291|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
124733395|NCT03199053|448646292|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
124733396|NCT03199053|448646290|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
124733397|NCT03199053|448646291|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
124733398|NCT03199053|448646292|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
124733399|NCT03199053|448646290|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
124733400|NCT03199053|448646291|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
124733401|NCT03199053|448646292|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
124733402|NCT03199053|448646290|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
124733403|NCT03199053|448646291|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
124733404|NCT03199053|448646292|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
124733405|NCT01824823|448646295|FG000|Overall Study|Lack of Efficacy|1|||
124733406|NCT01824823|448646296|FG001|Overall Study|Lack of Efficacy|1|||
124733407|NCT01824823|448646295|FG000|Overall Study|Off-treatment reason not submitted|1|||
124733408|NCT01824823|448646296|FG001|Overall Study|Off-treatment reason not submitted|0|||
124733409|NCT02098369|448646297|FG000|Overall Study|Withdrawal by Subject|1|||
124733410|NCT02098369|448646298|FG001|Overall Study|Withdrawal by Subject|5|||
124733411|NCT02098369|448646299|FG002|Overall Study|Withdrawal by Subject|0|||
124733412|NCT02098369|448646297|FG000|Overall Study|Lost to Follow-up|5|||
124733413|NCT02098369|448646298|FG001|Overall Study|Lost to Follow-up|1|||
124733414|NCT02098369|448646299|FG002|Overall Study|Lost to Follow-up|3|||
124733415|NCT02098369|448646297|FG000|Overall Study|Death|1|||
124733416|NCT02098369|448646298|FG001|Overall Study|Death|1|||
124733417|NCT02098369|448646299|FG002|Overall Study|Death|1|||
124733418|NCT02098369|448646297|FG000|Overall Study|Other|0|||
124733419|NCT02098369|448646298|FG001|Overall Study|Other|2|||
124733420|NCT02098369|448646299|FG002|Overall Study|Other|1|||
124733421|NCT00246025|448646300|FG000|Overall Study|Adverse Event|7|||
124733422|NCT00246025|448646301|FG001|Overall Study|Adverse Event|9|||
124733423|NCT00246025|448646302|FG002|Overall Study|Adverse Event|9|||
124733424|NCT00246025|448646303|FG003|Overall Study|Adverse Event|10|||
124733425|NCT00246025|448646300|FG000|Overall Study|Withdrawal by Subject|3|||
124733426|NCT00246025|448646301|FG001|Overall Study|Withdrawal by Subject|0|||
124733427|NCT00246025|448646302|FG002|Overall Study|Withdrawal by Subject|1|||
124733428|NCT00246025|448646303|FG003|Overall Study|Withdrawal by Subject|2|||
124733429|NCT00246025|448646300|FG000|Overall Study|unsuitable medical history was found|0|||
124733430|NCT00246025|448646301|FG001|Overall Study|unsuitable medical history was found|0|||
124733431|NCT00246025|448646302|FG002|Overall Study|unsuitable medical history was found|0|||
124733432|NCT00246025|448646303|FG003|Overall Study|unsuitable medical history was found|1|||
124733433|NCT03958656|448646310|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
124733434|NCT03958656|448646311|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
124781209|NCT02405442|448829118|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
124733435|NCT03958656|448646312|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
124733436|NCT03958656|448646313|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
124781210|NCT02405442|448829119|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
124733437|NCT03958656|448646310|FG000|Overall Study|No longer meets eligibility criteria|0|||
124733438|NCT03958656|448646311|FG001|Overall Study|No longer meets eligibility criteria|0|||
124610198|NCT02304458|448191977|FG003|Overall Study|Withdrawal by Subject|0|||
124610199|NCT02304458|448191978|FG004|Overall Study|Withdrawal by Subject|0|||
124610200|NCT02304458|448191979|FG005|Overall Study|Withdrawal by Subject|0|||
124610201|NCT02304458|448191980|FG006|Overall Study|Withdrawal by Subject|1|||
124610202|NCT02304458|448191981|FG007|Overall Study|Withdrawal by Subject|0|||
124610203|NCT03835221|448191982|FG000|Methafilcon A|Withdrawal by Subject|1|||
124610204|NCT04639713|448191986|FG000|Overall Study|Protocol Noncompliance|2|||
124610205|NCT04639713|448191986|FG000|Overall Study|Withdrawal by Subject|1|||
124610206|NCT03401450|448191987|FG000|Overall Study|Lost to Follow-up|4|||
124610207|NCT03401450|448191988|FG001|Overall Study|Lost to Follow-up|6|||
124610208|NCT03401450|448191987|FG000|Overall Study|Anesthesia plan changed|2|||
124610209|NCT03401450|448191988|FG001|Overall Study|Anesthesia plan changed|2|||
124610210|NCT03401450|448191987|FG000|Overall Study|Did not complete medication diary|4|||
124610211|NCT03401450|448191988|FG001|Overall Study|Did not complete medication diary|2|||
124610212|NCT03401450|448191987|FG000|Overall Study|post surgery medication change|2|||
124610213|NCT03401450|448191988|FG001|Overall Study|post surgery medication change|1|||
124610214|NCT03401450|448191987|FG000|Overall Study|Cancelled surgery|0|||
124610215|NCT03401450|448191988|FG001|Overall Study|Cancelled surgery|2|||
124610216|NCT02823652|448191991|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
124610217|NCT02823652|448191992|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
124610218|NCT02823652|448191993|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
124610219|NCT02823652|448191991|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
124610220|NCT02823652|448191992|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
124610221|NCT02823652|448191993|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
124610222|NCT02823652|448191991|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
124610223|NCT02823652|448191992|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
124610224|NCT02823652|448191993|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
124610225|NCT02823652|448191991|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
124610226|NCT02823652|448191992|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
124610227|NCT02823652|448191993|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
124610228|NCT02582866|448191998|FG000|Overall Study|Death|1|||
124610229|NCT02582866|448191998|FG000|Overall Study|Lack of Efficacy|2|||
124610230|NCT02582866|448191998|FG000|Overall Study|Lost to Follow-up|2|||
124610231|NCT02582866|448191998|FG000|Overall Study|Withdrawal by Subject|7|||
124610232|NCT02582866|448191998|FG000|Overall Study|Investigator decision|5|||
124610233|NCT02582866|448191998|FG000|Overall Study|Participant wants to get pregnant|1|||
124610234|NCT02582866|448191998|FG000|Overall Study|Pregnancy|2|||
124610235|NCT02582866|448191998|FG000|Overall Study|Sponsor decision|1|||
124610236|NCT02582866|448191998|FG000|Overall Study|Withdrawal due to personal reasons|1|||
124610237|NCT00871741|448192003|FG000|Overall Study|Premature study termination|9|||
124610238|NCT00871741|448192004|FG001|Overall Study|Premature study termination|7|||
124610239|NCT00633243|448194190|FG000|Overall Study|Withdrawal by Subject|0|||
124610240|NCT00633243|448194191|FG001|Overall Study|Withdrawal by Subject|1|||
124610241|NCT00633243|448194190|FG000|Overall Study|incarceration|0|||
124610242|NCT00633243|448194191|FG001|Overall Study|incarceration|2|||
124610243|NCT00633243|448194190|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
124610244|NCT00633243|448194191|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
124610245|NCT00633243|448194190|FG000|Overall Study|Not comfortable with self-injecting|0|||
124610246|NCT00633243|448194191|FG001|Overall Study|Not comfortable with self-injecting|1|||
124610247|NCT00633243|448194190|FG000|Overall Study|Mental Health--Depression|0|||
124610248|NCT00633243|448194191|FG001|Overall Study|Mental Health--Depression|1|||
124610249|NCT00633243|448194190|FG000|Overall Study|Couldn't tolerate side-effects|1|||
124610250|NCT00633243|448194191|FG001|Overall Study|Couldn't tolerate side-effects|1|||
124610251|NCT02022748|448194192|FG000|Overall Study|Adverse Event|1|||
124610252|NCT02022748|448194193|FG001|Overall Study|Adverse Event|1|||
124610253|NCT02022748|448194194|FG002|Overall Study|Adverse Event|0|||
124610254|NCT02022748|448194192|FG000|Overall Study|Withdrawal by Subject|0|||
124610255|NCT02022748|448194193|FG001|Overall Study|Withdrawal by Subject|1|||
124610256|NCT02022748|448194194|FG002|Overall Study|Withdrawal by Subject|0|||
124610257|NCT02799095|448194195|FG000|Part A|Adverse Event|1|||
124610258|NCT02799095|448194196|FG001|Part A|Adverse Event|0|||
124610259|NCT02799095|448194197|FG002|Part A|Adverse Event|1|||
124610260|NCT02799095|448194198|FG003|Part A|Adverse Event|4|||
124610261|NCT02799095|448194199|FG004|Part A|Adverse Event|1|||
124733439|NCT03958656|448646312|FG002|Overall Study|No longer meets eligibility criteria|1|||
124733440|NCT03958656|448646313|FG003|Overall Study|No longer meets eligibility criteria|0|||
124733441|NCT03958656|448646310|FG000|Overall Study|Started anti-cancer treatment|0|||
124733442|NCT03958656|448646311|FG001|Overall Study|Started anti-cancer treatment|0|||
124733443|NCT03958656|448646312|FG002|Overall Study|Started anti-cancer treatment|1|||
124733444|NCT03958656|448646313|FG003|Overall Study|Started anti-cancer treatment|0|||
124610262|NCT02799095|448194200|FG005|Part A|Adverse Event|0|||
124733445|NCT03444766|448646316|FG000|Overall Study|Other Reasons|2|||
124610263|NCT02799095|448194201|FG006|Part A|Adverse Event|0|||
124610264|NCT02799095|448194202|FG007|Part A|Adverse Event|0|||
124610265|NCT02799095|448194203|FG008|Part A|Adverse Event|0|||
124733446|NCT03444766|448646316|FG000|Overall Study|Participant Withdrew Consent|5|||
124733447|NCT03444766|448646316|FG000|Overall Study|Lost to Follow-up|2|||
124733448|NCT03444766|448646316|FG000|Overall Study|Death|2|||
124733449|NCT03444766|448646316|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
124733450|NCT03444766|448646316|FG000|Overall Study|Disease Progression|49|||
124733451|NCT02836873|448646317|FG000|Overall Study|Protocol Violation|0|||
124733452|NCT02836873|448646318|FG001|Overall Study|Protocol Violation|1|||
124733453|NCT02836873|448646317|FG000|Overall Study|Adverse Event|1|||
124733454|NCT02836873|448646318|FG001|Overall Study|Adverse Event|4|||
124733455|NCT02836873|448646317|FG000|Overall Study|Withdrawal by Subject|2|||
124733456|NCT02836873|448646318|FG001|Overall Study|Withdrawal by Subject|2|||
124733457|NCT02836873|448646317|FG000|Overall Study|Lost to Follow-up|1|||
124733458|NCT02836873|448646318|FG001|Overall Study|Lost to Follow-up|3|||
124733459|NCT02836873|448646317|FG000|Overall Study|Physician Decision|0|||
124733460|NCT02836873|448646318|FG001|Overall Study|Physician Decision|1|||
124733461|NCT02836873|448646317|FG000|Overall Study|Other|1|||
124733462|NCT02836873|448646318|FG001|Overall Study|Other|0|||
124733463|NCT02460783|448646326|FG000|Overall Study|Withdrawal by Subject|1|||
124733464|NCT02460783|448646327|FG001|Overall Study|Withdrawal by Subject|3|||
124733465|NCT02460783|448646326|FG000|Overall Study|Lost to Follow-up|1|||
124733466|NCT02460783|448646327|FG001|Overall Study|Lost to Follow-up|1|||
124733467|NCT01646645|448646328|FG000|Overall Study|No Treated|1|||
124733468|NCT01646645|448646328|FG000|Overall Study|Inevaluable Donor|29|||
124733469|NCT02374814|448646334|FG000|Overall Study|Lost to Follow-up|1|||
124733470|NCT02374814|448646335|FG001|Overall Study|Lost to Follow-up|1|||
124733471|NCT02374814|448646336|FG002|Overall Study|Lost to Follow-up|0|||
124733472|NCT02374814|448646337|FG003|Overall Study|Lost to Follow-up|1|||
124733473|NCT02374814|448646338|FG004|Overall Study|Lost to Follow-up|0|||
124733474|NCT02374814|448646339|FG005|Overall Study|Lost to Follow-up|0|||
124733475|NCT02374814|448646334|FG000|Overall Study|Withdrawal by Subject|0|||
124733476|NCT02374814|448646335|FG001|Overall Study|Withdrawal by Subject|0|||
124733477|NCT02374814|448646336|FG002|Overall Study|Withdrawal by Subject|1|||
124733478|NCT02374814|448646337|FG003|Overall Study|Withdrawal by Subject|1|||
124733479|NCT02374814|448646338|FG004|Overall Study|Withdrawal by Subject|0|||
124733480|NCT02374814|448646339|FG005|Overall Study|Withdrawal by Subject|0|||
124733481|NCT00884039|448646343|FG000|Overall Study|Withdrawal by Subject|0|||
124733482|NCT00884039|448646344|FG001|Overall Study|Withdrawal by Subject|1|||
124781211|NCT02405442|448829120|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
124733483|NCT00884039|448646343|FG000|Overall Study|Lack of Efficacy|2|||
124733484|NCT00884039|448646344|FG001|Overall Study|Lack of Efficacy|0|||
124733485|NCT02214225|448646345|FG000|Overall Study|Lost to Follow-up|46|||
124733486|NCT02214225|448646346|FG001|Overall Study|Lost to Follow-up|18|||
124733487|NCT02214225|448646347|FG002|Overall Study|Lost to Follow-up|18|||
124733488|NCT02214225|448646345|FG000|Overall Study|Withdrawal by Subject|2|||
124733489|NCT02214225|448646346|FG001|Overall Study|Withdrawal by Subject|0|||
124733490|NCT02214225|448646347|FG002|Overall Study|Withdrawal by Subject|2|||
124733491|NCT02214225|448646345|FG000|Overall Study|Death|5|||
124733492|NCT02214225|448646346|FG001|Overall Study|Death|0|||
124733493|NCT02214225|448646347|FG002|Overall Study|Death|1|||
124733494|NCT02214225|448646345|FG000|Overall Study|randomized in error, not vaccinated|2|||
124733495|NCT02214225|448646346|FG001|Overall Study|randomized in error, not vaccinated|1|||
124733496|NCT02214225|448646347|FG002|Overall Study|randomized in error, not vaccinated|1|||
124733497|NCT00072293|448646350|FG000|Overall Study|Lost to Follow-up|1|||
124733498|NCT00072293|448646351|FG001|Overall Study|Lost to Follow-up|1|||
124733499|NCT00072293|448646350|FG000|Overall Study|Withdrawal by Subject|0|||
124733500|NCT00072293|448646351|FG001|Overall Study|Withdrawal by Subject|1|||
124733501|NCT01166958|448646352|FG000|Overall Study|Withdrawal by Subject|1|||
124733502|NCT01166958|448646353|FG001|Overall Study|Withdrawal by Subject|0|||
124733503|NCT04209114|448646354|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
124733504|NCT04209114|448646355|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
124733505|NCT04209114|448646356|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
124733506|NCT04209114|448646354|FG000|Pre-Treatment Phase|Other reasons|0|||
124733507|NCT04209114|448646355|FG001|Pre-Treatment Phase|Other reasons|0|||
124733508|NCT04209114|448646356|FG002|Pre-Treatment Phase|Other reasons|1|||
124733509|NCT04209114|448646354|FG000|Pre-Treatment Phase|Death|0|||
124733510|NCT04209114|448646355|FG001|Pre-Treatment Phase|Death|0|||
124733511|NCT04209114|448646356|FG002|Pre-Treatment Phase|Death|1|||
124610266|NCT02799095|448194204|FG009|Part A|Adverse Event|0|||
124610267|NCT02799095|448194205|FG010|Part A|Adverse Event|0|||
124733512|NCT04209114|448646354|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
124733513|NCT04209114|448646355|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
124733514|NCT04209114|448646356|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
124733515|NCT04209114|448646354|FG000|Treatment Phase|Other reasons|5|||
124733516|NCT04209114|448646355|FG001|Treatment Phase|Other reasons|3|||
124733517|NCT04209114|448646356|FG002|Treatment Phase|Other reasons|0|||
124733518|NCT04209114|448646354|FG000|Treatment Phase|Lost to Follow-up|1|||
124733519|NCT04209114|448646355|FG001|Treatment Phase|Lost to Follow-up|0|||
124733520|NCT04209114|448646356|FG002|Treatment Phase|Lost to Follow-up|0|||
124733521|NCT04209114|448646354|FG000|Treatment Phase|Participant withdrew consent|1|||
124733522|NCT04209114|448646355|FG001|Treatment Phase|Participant withdrew consent|0|||
124733523|NCT04209114|448646356|FG002|Treatment Phase|Participant withdrew consent|0|||
124733524|NCT04209114|448646354|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
124733525|NCT04209114|448646355|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
124733526|NCT04209114|448646356|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
124733527|NCT04209114|448646354|FG000|Treatment Phase|Death|4|||
124733528|NCT04209114|448646355|FG001|Treatment Phase|Death|1|||
124733529|NCT04209114|448646356|FG002|Treatment Phase|Death|0|||
124733530|NCT04209114|448646354|FG000|Treatment Phase|Study drug toxicity|4|||
124733531|NCT04209114|448646355|FG001|Treatment Phase|Study drug toxicity|6|||
124733532|NCT04209114|448646356|FG002|Treatment Phase|Study drug toxicity|0|||
124733533|NCT04209114|448646354|FG000|Treatment Phase|Disease progression|6|||
124733534|NCT04209114|448646355|FG001|Treatment Phase|Disease progression|9|||
124733535|NCT04209114|448646356|FG002|Treatment Phase|Disease progression|0|||
124733536|NCT00624819|448646359|FG000|Follow-up Period: Year 4|Parents decision|0|||
124733537|NCT00624819|448646360|FG001|Follow-up Period: Year 4|Parents decision|0|||
124733538|NCT00624819|448646361|FG002|Follow-up Period: Year 4|Parents decision|1|||
124733539|NCT00624819|448646362|FG003|Follow-up Period: Year 4|Parents decision|0|||
124733540|NCT00624819|448646359|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
124733541|NCT00624819|448646360|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
124733542|NCT00624819|448646361|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
124733543|NCT00624819|448646362|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
124733544|NCT02826421|448646367|FG000|Overall Study|Adverse Event|1|||
124733545|NCT02826421|448646368|FG001|Overall Study|Adverse Event|0|||
124733546|NCT02826421|448646369|FG002|Overall Study|Adverse Event|0|||
124733547|NCT02826421|448646370|FG003|Overall Study|Adverse Event|1|||
124733548|NCT02826421|448646367|FG000|Overall Study|Withdrawal by Subject|1|||
124733549|NCT02826421|448646368|FG001|Overall Study|Withdrawal by Subject|3|||
124733550|NCT02826421|448646369|FG002|Overall Study|Withdrawal by Subject|1|||
124733551|NCT02826421|448646370|FG003|Overall Study|Withdrawal by Subject|1|||
124733552|NCT02826421|448646367|FG000|Overall Study|Reason not given|1|||
124733553|NCT02826421|448646368|FG001|Overall Study|Reason not given|0|||
124733554|NCT02826421|448646369|FG002|Overall Study|Reason not given|1|||
124733555|NCT02826421|448646370|FG003|Overall Study|Reason not given|0|||
124733556|NCT02210221|448646373|FG000|Overall Study|Lack of Efficacy|7|||
124733557|NCT02210221|448646373|FG000|Overall Study|Withdrawal by Subject|43|||
124733558|NCT02141490|448646374|FG000|Overall Study|Screening failures|4|||
124733559|NCT02141490|448646375|FG001|Overall Study|Screening failures|0|||
124733560|NCT02141490|448646376|FG002|Overall Study|Screening failures|0|||
124733561|NCT00434759|448646377|FG000|Overall Study|Lack of Efficacy|5|||
124733562|NCT00434759|448646378|FG001|Overall Study|Lack of Efficacy|4|||
124733563|NCT00434759|448646377|FG000|Overall Study|Withdrawal by Subject|17|||
124733564|NCT00434759|448646378|FG001|Overall Study|Withdrawal by Subject|1|||
124733565|NCT00434759|448646377|FG000|Overall Study|family affairs|2|||
124733566|NCT00434759|448646378|FG001|Overall Study|family affairs|0|||
124733567|NCT02436408|448646380|FG000|Overall Study|Death|1|||
124733568|NCT02649855|448646381|FG000|Overall Study|Refused further treatment|2|||
124733569|NCT02649855|448646382|FG001|Overall Study|Refused further treatment|1|||
124733570|NCT02649855|448646383|FG002|Overall Study|Refused further treatment|1|||
124733571|NCT02649855|448646381|FG000|Overall Study|Withdrew consent|0|||
124733572|NCT02649855|448646382|FG001|Overall Study|Withdrew consent|1|||
124733573|NCT02649855|448646383|FG002|Overall Study|Withdrew consent|0|||
124733574|NCT02649855|448646381|FG000|Overall Study|Switched to alternative treatment|0|||
124733575|NCT02649855|448646382|FG001|Overall Study|Switched to alternative treatment|1|||
124733576|NCT02649855|448646383|FG002|Overall Study|Switched to alternative treatment|1|||
124733577|NCT02649855|448646381|FG000|Overall Study|Principal investigator discretion|0|||
124733578|NCT02649855|448646382|FG001|Overall Study|Principal investigator discretion|1|||
124733579|NCT02649855|448646383|FG002|Overall Study|Principal investigator discretion|1|||
124733580|NCT02649855|448646381|FG000|Overall Study|No treatment, per protocol|1|||
124733581|NCT02649855|448646382|FG001|Overall Study|No treatment, per protocol|0|||
124733582|NCT02649855|448646383|FG002|Overall Study|No treatment, per protocol|0|||
124733583|NCT02649855|448646381|FG000|Overall Study|Initiate new treatment|1|||
124733584|NCT02649855|448646382|FG001|Overall Study|Initiate new treatment|0|||
124733585|NCT02649855|448646383|FG002|Overall Study|Initiate new treatment|0|||
124733586|NCT01300819|448646384|FG000|Overall Study|Adverse Event|9|||
124733587|NCT01300819|448646385|FG001|Overall Study|Adverse Event|27|||
124733588|NCT01300819|448646384|FG000|Overall Study|Lack of Efficacy|2|||
124733589|NCT01300819|448646385|FG001|Overall Study|Lack of Efficacy|1|||
124733590|NCT01300819|448646384|FG000|Overall Study|Withdrawal by Subject|10|||
124733591|NCT01300819|448646385|FG001|Overall Study|Withdrawal by Subject|12|||
124610268|NCT02799095|448194206|FG011|Part A|Adverse Event|0|||
124733592|NCT01300819|448646384|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
124733593|NCT01300819|448646385|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
124733594|NCT01300819|448646384|FG000|Overall Study|Refusal to down titrate study drug|0|||
124733595|NCT01300819|448646385|FG001|Overall Study|Refusal to down titrate study drug|1|||
124610269|NCT02799095|448194207|FG012|Part A|Adverse Event|0|||
124610270|NCT02799095|448194208|FG013|Part A|Adverse Event|0|||
124610271|NCT02799095|448194209|FG014|Part A|Adverse Event|0|||
124610272|NCT02799095|448194210|FG015|Part A|Adverse Event|0|||
124610273|NCT02799095|448194211|FG016|Part A|Adverse Event|0|||
124610274|NCT02799095|448194195|FG000|Part A|Death|0|||
124610275|NCT02799095|448194196|FG001|Part A|Death|0|||
124610276|NCT02799095|448194197|FG002|Part A|Death|0|||
124610277|NCT02799095|448194198|FG003|Part A|Death|0|||
124610278|NCT02799095|448194199|FG004|Part A|Death|0|||
124610279|NCT02799095|448194200|FG005|Part A|Death|0|||
124610280|NCT02799095|448194201|FG006|Part A|Death|3|||
124610281|NCT02799095|448194202|FG007|Part A|Death|0|||
124610282|NCT02799095|448194203|FG008|Part A|Death|0|||
124610283|NCT02799095|448194204|FG009|Part A|Death|0|||
124610284|NCT02799095|448194205|FG010|Part A|Death|0|||
124610285|NCT02799095|448194206|FG011|Part A|Death|0|||
124610286|NCT02799095|448194207|FG012|Part A|Death|0|||
124610287|NCT02799095|448194208|FG013|Part A|Death|0|||
124610288|NCT02799095|448194209|FG014|Part A|Death|0|||
124610289|NCT02799095|448194210|FG015|Part A|Death|0|||
124610290|NCT02799095|448194211|FG016|Part A|Death|0|||
124610291|NCT02799095|448194195|FG000|Part A|Lost to Follow-up|0|||
124610292|NCT02799095|448194196|FG001|Part A|Lost to Follow-up|1|||
124610293|NCT02799095|448194197|FG002|Part A|Lost to Follow-up|0|||
124610294|NCT02799095|448194198|FG003|Part A|Lost to Follow-up|0|||
124610295|NCT02799095|448194199|FG004|Part A|Lost to Follow-up|0|||
124610296|NCT02799095|448194200|FG005|Part A|Lost to Follow-up|0|||
124610297|NCT02799095|448194201|FG006|Part A|Lost to Follow-up|1|||
124610298|NCT02799095|448194202|FG007|Part A|Lost to Follow-up|0|||
124610299|NCT02799095|448194203|FG008|Part A|Lost to Follow-up|0|||
124610300|NCT02799095|448194204|FG009|Part A|Lost to Follow-up|0|||
124610301|NCT02799095|448194205|FG010|Part A|Lost to Follow-up|0|||
124610302|NCT02799095|448194206|FG011|Part A|Lost to Follow-up|0|||
124610303|NCT02799095|448194207|FG012|Part A|Lost to Follow-up|0|||
124610304|NCT02799095|448194208|FG013|Part A|Lost to Follow-up|0|||
124610305|NCT02799095|448194209|FG014|Part A|Lost to Follow-up|0|||
124610306|NCT02799095|448194210|FG015|Part A|Lost to Follow-up|0|||
124610307|NCT02799095|448194211|FG016|Part A|Lost to Follow-up|0|||
124610308|NCT02799095|448194195|FG000|Part A|Progressive Disease|3|||
124610309|NCT02799095|448194196|FG001|Part A|Progressive Disease|3|||
124610310|NCT02799095|448194197|FG002|Part A|Progressive Disease|3|||
124610311|NCT02799095|448194198|FG003|Part A|Progressive Disease|2|||
124610312|NCT02799095|448194199|FG004|Part A|Progressive Disease|2|||
124610313|NCT02799095|448194200|FG005|Part A|Progressive Disease|0|||
124610314|NCT02799095|448194201|FG006|Part A|Progressive Disease|0|||
124610315|NCT02799095|448194202|FG007|Part A|Progressive Disease|0|||
124610316|NCT02799095|448194203|FG008|Part A|Progressive Disease|0|||
124610317|NCT02799095|448194204|FG009|Part A|Progressive Disease|0|||
124610318|NCT02799095|448194205|FG010|Part A|Progressive Disease|0|||
124610319|NCT02799095|448194206|FG011|Part A|Progressive Disease|0|||
124610320|NCT02799095|448194207|FG012|Part A|Progressive Disease|0|||
124610321|NCT02799095|448194208|FG013|Part A|Progressive Disease|0|||
124610322|NCT02799095|448194209|FG014|Part A|Progressive Disease|0|||
124610323|NCT02799095|448194210|FG015|Part A|Progressive Disease|0|||
124610324|NCT02799095|448194211|FG016|Part A|Progressive Disease|0|||
124610325|NCT02799095|448194195|FG000|Part A|Clinical Progression|1|||
124610326|NCT02799095|448194196|FG001|Part A|Clinical Progression|0|||
124610327|NCT02799095|448194197|FG002|Part A|Clinical Progression|2|||
124610328|NCT02799095|448194198|FG003|Part A|Clinical Progression|1|||
124610329|NCT02799095|448194199|FG004|Part A|Clinical Progression|5|||
124610330|NCT02799095|448194200|FG005|Part A|Clinical Progression|0|||
124610331|NCT02799095|448194201|FG006|Part A|Clinical Progression|0|||
124610332|NCT02799095|448194202|FG007|Part A|Clinical Progression|0|||
124610333|NCT02799095|448194203|FG008|Part A|Clinical Progression|0|||
124610334|NCT02799095|448194204|FG009|Part A|Clinical Progression|0|||
124610335|NCT02799095|448194205|FG010|Part A|Clinical Progression|0|||
124610336|NCT02799095|448194206|FG011|Part A|Clinical Progression|0|||
124610337|NCT02799095|448194207|FG012|Part A|Clinical Progression|0|||
124610338|NCT02799095|448194208|FG013|Part A|Clinical Progression|0|||
124610339|NCT02799095|448194209|FG014|Part A|Clinical Progression|0|||
124733596|NCT01300819|448646384|FG000|Overall Study|Administrative reason|0|||
124610340|NCT02799095|448194210|FG015|Part A|Clinical Progression|0|||
124733597|NCT01300819|448646385|FG001|Overall Study|Administrative reason|1|||
124610341|NCT02799095|448194211|FG016|Part A|Clinical Progression|0|||
124610342|NCT02799095|448194195|FG000|Part A|Protocol Deviation|0|||
124610343|NCT02799095|448194196|FG001|Part A|Protocol Deviation|0|||
124610344|NCT02799095|448194197|FG002|Part A|Protocol Deviation|1|||
124610345|NCT02799095|448194198|FG003|Part A|Protocol Deviation|0|||
124610346|NCT02799095|448194199|FG004|Part A|Protocol Deviation|0|||
124610347|NCT02799095|448194200|FG005|Part A|Protocol Deviation|0|||
124610348|NCT02799095|448194201|FG006|Part A|Protocol Deviation|0|||
124610349|NCT02799095|448194202|FG007|Part A|Protocol Deviation|0|||
124610350|NCT02799095|448194203|FG008|Part A|Protocol Deviation|0|||
124610351|NCT02799095|448194204|FG009|Part A|Protocol Deviation|0|||
124610352|NCT02799095|448194205|FG010|Part A|Protocol Deviation|0|||
124610353|NCT02799095|448194206|FG011|Part A|Protocol Deviation|0|||
124610354|NCT02799095|448194207|FG012|Part A|Protocol Deviation|0|||
124610355|NCT02799095|448194208|FG013|Part A|Protocol Deviation|0|||
124610356|NCT02799095|448194209|FG014|Part A|Protocol Deviation|0|||
124610357|NCT02799095|448194210|FG015|Part A|Protocol Deviation|0|||
124610358|NCT02799095|448194211|FG016|Part A|Protocol Deviation|0|||
124610359|NCT02799095|448194195|FG000|Part A|Withdrawal by Subject|0|||
124610360|NCT02799095|448194196|FG001|Part A|Withdrawal by Subject|0|||
124610361|NCT02799095|448194197|FG002|Part A|Withdrawal by Subject|0|||
124610362|NCT02799095|448194198|FG003|Part A|Withdrawal by Subject|1|||
124610363|NCT02799095|448194199|FG004|Part A|Withdrawal by Subject|3|||
124610364|NCT02799095|448194200|FG005|Part A|Withdrawal by Subject|1|||
124610365|NCT02799095|448194201|FG006|Part A|Withdrawal by Subject|1|||
124610366|NCT02799095|448194202|FG007|Part A|Withdrawal by Subject|0|||
124610367|NCT02799095|448194203|FG008|Part A|Withdrawal by Subject|0|||
124610368|NCT02799095|448194204|FG009|Part A|Withdrawal by Subject|0|||
124610369|NCT02799095|448194205|FG010|Part A|Withdrawal by Subject|0|||
124610370|NCT02799095|448194206|FG011|Part A|Withdrawal by Subject|0|||
124610371|NCT02799095|448194207|FG012|Part A|Withdrawal by Subject|0|||
124610372|NCT02799095|448194208|FG013|Part A|Withdrawal by Subject|0|||
124610373|NCT02799095|448194209|FG014|Part A|Withdrawal by Subject|0|||
124610374|NCT02799095|448194210|FG015|Part A|Withdrawal by Subject|0|||
124610375|NCT02799095|448194211|FG016|Part A|Withdrawal by Subject|0|||
124610376|NCT02799095|448194195|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
124610377|NCT02799095|448194196|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
124610378|NCT02799095|448194197|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
124610379|NCT02799095|448194198|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
124610380|NCT02799095|448194199|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
124610381|NCT02799095|448194200|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
124610382|NCT02799095|448194201|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
124610383|NCT02799095|448194202|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
124610384|NCT02799095|448194203|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
124610385|NCT02799095|448194204|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
124610386|NCT02799095|448194205|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
124610387|NCT02799095|448194206|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
124610388|NCT02799095|448194207|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
124610389|NCT02799095|448194208|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
124610390|NCT02799095|448194209|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
124610391|NCT02799095|448194210|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
124610392|NCT02799095|448194211|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
124610393|NCT02799095|448194195|FG000|Part B|Death|0|||
124610394|NCT02799095|448194196|FG001|Part B|Death|0|||
124610395|NCT02799095|448194197|FG002|Part B|Death|0|||
124610396|NCT02799095|448194198|FG003|Part B|Death|0|||
124610397|NCT02799095|448194199|FG004|Part B|Death|0|||
124610398|NCT02799095|448194200|FG005|Part B|Death|0|||
124610399|NCT02799095|448194201|FG006|Part B|Death|0|||
124610400|NCT02799095|448194202|FG007|Part B|Death|7|||
124610401|NCT02799095|448194203|FG008|Part B|Death|7|||
124610402|NCT02799095|448194204|FG009|Part B|Death|0|||
124610403|NCT02799095|448194205|FG010|Part B|Death|0|||
124610404|NCT02799095|448194206|FG011|Part B|Death|0|||
124610405|NCT02799095|448194207|FG012|Part B|Death|0|||
124610406|NCT02799095|448194208|FG013|Part B|Death|0|||
124610407|NCT02799095|448194209|FG014|Part B|Death|0|||
124610408|NCT02799095|448194210|FG015|Part B|Death|0|||
124610409|NCT02799095|448194211|FG016|Part B|Death|0|||
124610410|NCT02799095|448194195|FG000|Part B|Progressive Disease|0|||
124610411|NCT02799095|448194196|FG001|Part B|Progressive Disease|0|||
124610412|NCT02799095|448194197|FG002|Part B|Progressive Disease|0|||
124610413|NCT02799095|448194198|FG003|Part B|Progressive Disease|0|||
124610414|NCT02799095|448194199|FG004|Part B|Progressive Disease|0|||
124610415|NCT02799095|448194200|FG005|Part B|Progressive Disease|0|||
124610416|NCT02799095|448194201|FG006|Part B|Progressive Disease|0|||
124610417|NCT02799095|448194202|FG007|Part B|Progressive Disease|1|||
124610418|NCT02799095|448194203|FG008|Part B|Progressive Disease|0|||
124610419|NCT02799095|448194204|FG009|Part B|Progressive Disease|0|||
124610420|NCT02799095|448194205|FG010|Part B|Progressive Disease|0|||
124610421|NCT02799095|448194206|FG011|Part B|Progressive Disease|0|||
124610422|NCT02799095|448194207|FG012|Part B|Progressive Disease|0|||
124610423|NCT02799095|448194208|FG013|Part B|Progressive Disease|0|||
124610424|NCT02799095|448194209|FG014|Part B|Progressive Disease|0|||
124610425|NCT02799095|448194210|FG015|Part B|Progressive Disease|0|||
124610426|NCT02799095|448194211|FG016|Part B|Progressive Disease|0|||
124610427|NCT02799095|448194195|FG000|Part B|Withdrawal by Subject|0|||
124610428|NCT02799095|448194196|FG001|Part B|Withdrawal by Subject|0|||
124610429|NCT02799095|448194197|FG002|Part B|Withdrawal by Subject|0|||
124610430|NCT02799095|448194198|FG003|Part B|Withdrawal by Subject|0|||
124610431|NCT02799095|448194199|FG004|Part B|Withdrawal by Subject|0|||
124610432|NCT02799095|448194200|FG005|Part B|Withdrawal by Subject|0|||
124610433|NCT02799095|448194201|FG006|Part B|Withdrawal by Subject|0|||
124610434|NCT02799095|448194202|FG007|Part B|Withdrawal by Subject|10|||
124610435|NCT02799095|448194203|FG008|Part B|Withdrawal by Subject|7|||
124733598|NCT01300819|448646384|FG000|Overall Study|Safety follow up not done by mistake|0|||
124733599|NCT01300819|448646385|FG001|Overall Study|Safety follow up not done by mistake|1|||
124733600|NCT01300819|448646384|FG000|Overall Study|Follow up call was not done|1|||
124733601|NCT01300819|448646385|FG001|Overall Study|Follow up call was not done|0|||
124733602|NCT01319721|448646389|FG000|Overall Study|Lost to Follow-up|1|||
124733603|NCT01319721|448646390|FG001|Overall Study|Lost to Follow-up|6|||
124733604|NCT00461305|448646391|FG000|Treatment|Adverse Event|26|||
124733605|NCT00461305|448646392|FG001|Treatment|Adverse Event|3|||
124733606|NCT00461305|448646391|FG000|Treatment|Lost to Follow-up|4|||
124733607|NCT00461305|448646392|FG001|Treatment|Lost to Follow-up|2|||
124733608|NCT00461305|448646391|FG000|Treatment|Protocol Violation|13|||
124733609|NCT00461305|448646392|FG001|Treatment|Protocol Violation|2|||
124733610|NCT00461305|448646391|FG000|Treatment|Withdrawal by Subject|48|||
124733611|NCT00461305|448646392|FG001|Treatment|Withdrawal by Subject|2|||
124733612|NCT00461305|448646391|FG000|Treatment|Never dispensed|5|||
124733613|NCT00461305|448646392|FG001|Treatment|Never dispensed|0|||
124733614|NCT00461305|448646391|FG000|Treatment|Study drug not taken|1|||
124733615|NCT00461305|448646392|FG001|Treatment|Study drug not taken|0|||
124733616|NCT00461305|448646391|FG000|Treatment|Partially missing diary|2|||
124733617|NCT00461305|448646392|FG001|Treatment|Partially missing diary|0|||
124733618|NCT00461305|448646391|FG000|Treatment|Other (missing drug etc)|2|||
124733619|NCT00461305|448646392|FG001|Treatment|Other (missing drug etc)|0|||
124733620|NCT00461305|448646391|FG000|Continued Treatment|Adverse Event|26|||
124733621|NCT00461305|448646392|FG001|Continued Treatment|Adverse Event|0|||
124733622|NCT00461305|448646391|FG000|Continued Treatment|Lost to Follow-up|4|||
124733623|NCT00461305|448646392|FG001|Continued Treatment|Lost to Follow-up|0|||
124733624|NCT00461305|448646391|FG000|Continued Treatment|Protocol Violation|13|||
124733625|NCT00461305|448646392|FG001|Continued Treatment|Protocol Violation|0|||
124733626|NCT00461305|448646391|FG000|Continued Treatment|Withdrawal by Subject|48|||
124733627|NCT00461305|448646392|FG001|Continued Treatment|Withdrawal by Subject|0|||
124733628|NCT00461305|448646391|FG000|Continued Treatment|Partially missing diary|2|||
124733629|NCT00461305|448646392|FG001|Continued Treatment|Partially missing diary|0|||
124733630|NCT00461305|448646391|FG000|Continued Treatment|Other (missing drug etc)|2|||
124733631|NCT00461305|448646392|FG001|Continued Treatment|Other (missing drug etc)|0|||
124733632|NCT01103063|448648853|FG000|Overall Study|Adverse Event|3|||
124733633|NCT01103063|448648854|FG001|Overall Study|Adverse Event|1|||
124733634|NCT01103063|448648853|FG000|Overall Study|Lost to Follow-up|68|||
124733635|NCT01103063|448648854|FG001|Overall Study|Lost to Follow-up|51|||
124733636|NCT01103063|448648853|FG000|Overall Study|Withdrawal by Subject|60|||
124733637|NCT01103063|448648854|FG001|Overall Study|Withdrawal by Subject|15|||
124733638|NCT01103063|448648853|FG000|Overall Study|Other|16|||
124733639|NCT01103063|448648854|FG001|Overall Study|Other|11|||
124733640|NCT01103063|448648853|FG000|Overall Study|Protocol Violation|1|||
124733641|NCT01103063|448648854|FG001|Overall Study|Protocol Violation|0|||
124733642|NCT01103063|448648853|FG000|Overall Study|Study terminated by Sponsor|326|||
124733643|NCT01103063|448648854|FG001|Overall Study|Study terminated by Sponsor|342|||
124733644|NCT01103063|448648853|FG000|Overall Study|Death|3|||
124733645|NCT01103063|448648854|FG001|Overall Study|Death|1|||
124733646|NCT01187446|448648857|FG000|Overall Study|Patient started non-protocol therapy|0|||
124733647|NCT01187446|448648858|FG001|Overall Study|Patient started non-protocol therapy|1|||
124733648|NCT00496197|448648859|FG000|Overall Study|Discontinued study due to death|43|||
124733649|NCT00496197|448648859|FG000|Overall Study|Adverse Event|13|||
124733650|NCT00496197|448648859|FG000|Overall Study|Does not meet entrance criteria|5|||
124733651|NCT00496197|448648859|FG000|Overall Study|Insufficient clinical response|3|||
124733652|NCT00496197|448648859|FG000|Overall Study|Insufficient bacteriological response|10|||
124733653|NCT00496197|448648859|FG000|Overall Study|Lost to Follow-up|11|||
124733654|NCT00496197|448648859|FG000|Overall Study|Withdrawal by Subject|11|||
124733655|NCT00496197|448648859|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
124733656|NCT00496197|448648859|FG000|Overall Study|Other|14|||
124733657|NCT00496197|448648859|FG000|Overall Study|Protocol Violation|8|||
124733658|NCT01344538|448648860|FG000|Overall Study|Adverse Event|1|||
124733659|NCT01344538|448648861|FG001|Overall Study|Adverse Event|1|||
124733660|NCT01344538|448648860|FG000|Overall Study|Lost to Follow-up|1|||
124733661|NCT01344538|448648861|FG001|Overall Study|Lost to Follow-up|0|||
124733662|NCT01655381|448648862|FG000|Overall Study|Investigator Decision|1|||
124733663|NCT01655381|448648862|FG000|Overall Study|Moved to Another City|1|||
124733664|NCT01655381|448648862|FG000|Overall Study|Insufficient Treatment Response|1|||
124733665|NCT00320255|448648863|FG000|Overall Study|Lack of Efficacy|1|||
124733666|NCT00320255|448648864|FG001|Overall Study|Lack of Efficacy|0|||
124733667|NCT00320255|448648865|FG002|Overall Study|Lack of Efficacy|0|||
124733668|NCT00320255|448648866|FG003|Overall Study|Lack of Efficacy|0|||
124733669|NCT00320255|448648867|FG004|Overall Study|Lack of Efficacy|0|||
124733670|NCT00320255|448648868|FG005|Overall Study|Lack of Efficacy|0|||
124733671|NCT00320255|448648863|FG000|Overall Study|Adverse Event|5|||
124733672|NCT00320255|448648864|FG001|Overall Study|Adverse Event|2|||
124733673|NCT00320255|448648865|FG002|Overall Study|Adverse Event|3|||
124733674|NCT00320255|448648866|FG003|Overall Study|Adverse Event|2|||
124733675|NCT00320255|448648867|FG004|Overall Study|Adverse Event|0|||
124610436|NCT02799095|448194204|FG009|Part B|Withdrawal by Subject|0|||
124610437|NCT02799095|448194205|FG010|Part B|Withdrawal by Subject|0|||
124610438|NCT02799095|448194206|FG011|Part B|Withdrawal by Subject|0|||
124610439|NCT02799095|448194207|FG012|Part B|Withdrawal by Subject|0|||
124610440|NCT02799095|448194208|FG013|Part B|Withdrawal by Subject|0|||
124610441|NCT02799095|448194209|FG014|Part B|Withdrawal by Subject|0|||
124610442|NCT02799095|448194210|FG015|Part B|Withdrawal by Subject|0|||
124610443|NCT02799095|448194211|FG016|Part B|Withdrawal by Subject|0|||
124610444|NCT02799095|448194195|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
124610445|NCT02799095|448194196|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
124610446|NCT02799095|448194197|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
124610447|NCT02799095|448194198|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
124610448|NCT02799095|448194199|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
124610449|NCT02799095|448194200|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
124610450|NCT02799095|448194201|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
124610451|NCT02799095|448194202|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
124610452|NCT02799095|448194203|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
124610453|NCT02799095|448194204|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
124610454|NCT02799095|448194205|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
124610455|NCT02799095|448194206|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
124610456|NCT02799095|448194207|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
124610457|NCT02799095|448194208|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
124610458|NCT02799095|448194209|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
124610459|NCT02799095|448194210|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
124610460|NCT02799095|448194211|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
124610461|NCT02799095|448194195|FG000|Part C|Adverse Event|0|||
124610462|NCT02799095|448194196|FG001|Part C|Adverse Event|0|||
124610463|NCT02799095|448194197|FG002|Part C|Adverse Event|0|||
124610464|NCT02799095|448194198|FG003|Part C|Adverse Event|0|||
124610465|NCT02799095|448194199|FG004|Part C|Adverse Event|0|||
124610466|NCT02799095|448194200|FG005|Part C|Adverse Event|0|||
124610467|NCT02799095|448194201|FG006|Part C|Adverse Event|0|||
124610468|NCT02799095|448194202|FG007|Part C|Adverse Event|0|||
124610469|NCT02799095|448194203|FG008|Part C|Adverse Event|0|||
124610470|NCT02799095|448194204|FG009|Part C|Adverse Event|0|||
124610471|NCT02799095|448194205|FG010|Part C|Adverse Event|3|||
124610472|NCT02799095|448194206|FG011|Part C|Adverse Event|1|||
124610473|NCT02799095|448194207|FG012|Part C|Adverse Event|0|||
124610474|NCT02799095|448194208|FG013|Part C|Adverse Event|1|||
124610475|NCT02799095|448194209|FG014|Part C|Adverse Event|0|||
124610476|NCT02799095|448194210|FG015|Part C|Adverse Event|0|||
124610477|NCT02799095|448194211|FG016|Part C|Adverse Event|0|||
124610478|NCT02799095|448194195|FG000|Part C|Death|0|||
124610479|NCT02799095|448194196|FG001|Part C|Death|0|||
124610480|NCT02799095|448194197|FG002|Part C|Death|0|||
124610481|NCT02799095|448194198|FG003|Part C|Death|0|||
124610482|NCT02799095|448194199|FG004|Part C|Death|0|||
124610483|NCT02799095|448194200|FG005|Part C|Death|0|||
124610484|NCT02799095|448194201|FG006|Part C|Death|0|||
124610485|NCT02799095|448194202|FG007|Part C|Death|0|||
124610486|NCT02799095|448194203|FG008|Part C|Death|0|||
124610487|NCT02799095|448194204|FG009|Part C|Death|0|||
124610488|NCT02799095|448194205|FG010|Part C|Death|7|||
124610489|NCT02799095|448194206|FG011|Part C|Death|5|||
124610490|NCT02799095|448194207|FG012|Part C|Death|6|||
124610491|NCT02799095|448194208|FG013|Part C|Death|8|||
124610492|NCT02799095|448194209|FG014|Part C|Death|1|||
124610493|NCT02799095|448194210|FG015|Part C|Death|8|||
124610494|NCT02799095|448194211|FG016|Part C|Death|1|||
124610495|NCT02799095|448194195|FG000|Part C|Lost to Follow-up|0|||
124610496|NCT02799095|448194196|FG001|Part C|Lost to Follow-up|0|||
124610497|NCT02799095|448194197|FG002|Part C|Lost to Follow-up|0|||
124610498|NCT02799095|448194198|FG003|Part C|Lost to Follow-up|0|||
124781212|NCT02405442|448829121|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
124781213|NCT02405442|448829118|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
124781214|NCT02405442|448829119|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
124610499|NCT02799095|448194199|FG004|Part C|Lost to Follow-up|0|||
124610500|NCT02799095|448194200|FG005|Part C|Lost to Follow-up|0|||
124610501|NCT02799095|448194201|FG006|Part C|Lost to Follow-up|0|||
124781215|NCT02405442|448829120|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
124781216|NCT02405442|448829121|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
124781217|NCT02405442|448829118|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
124781218|NCT02405442|448829119|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
124610502|NCT02799095|448194202|FG007|Part C|Lost to Follow-up|0|||
124610503|NCT02799095|448194203|FG008|Part C|Lost to Follow-up|0|||
124610504|NCT02799095|448194204|FG009|Part C|Lost to Follow-up|0|||
124610505|NCT02799095|448194205|FG010|Part C|Lost to Follow-up|1|||
124610506|NCT02799095|448194206|FG011|Part C|Lost to Follow-up|1|||
124610507|NCT02799095|448194207|FG012|Part C|Lost to Follow-up|1|||
124610508|NCT02799095|448194208|FG013|Part C|Lost to Follow-up|3|||
124610509|NCT02799095|448194209|FG014|Part C|Lost to Follow-up|0|||
124610510|NCT02799095|448194210|FG015|Part C|Lost to Follow-up|0|||
124610511|NCT02799095|448194211|FG016|Part C|Lost to Follow-up|0|||
124733676|NCT00320255|448648868|FG005|Overall Study|Adverse Event|0|||
124733677|NCT00320255|448648863|FG000|Overall Study|Withdrawal by Subject|1|||
124733678|NCT00320255|448648864|FG001|Overall Study|Withdrawal by Subject|2|||
124733679|NCT00320255|448648865|FG002|Overall Study|Withdrawal by Subject|2|||
124733680|NCT00320255|448648866|FG003|Overall Study|Withdrawal by Subject|4|||
124733681|NCT00320255|448648867|FG004|Overall Study|Withdrawal by Subject|0|||
124733682|NCT00320255|448648868|FG005|Overall Study|Withdrawal by Subject|0|||
124733683|NCT00320255|448648863|FG000|Overall Study|Poor compliance/noncompliance|1|||
124733684|NCT00320255|448648864|FG001|Overall Study|Poor compliance/noncompliance|1|||
124733685|NCT00320255|448648865|FG002|Overall Study|Poor compliance/noncompliance|0|||
124733686|NCT00320255|448648866|FG003|Overall Study|Poor compliance/noncompliance|1|||
124733687|NCT00320255|448648867|FG004|Overall Study|Poor compliance/noncompliance|0|||
124733688|NCT00320255|448648868|FG005|Overall Study|Poor compliance/noncompliance|0|||
124733689|NCT00320255|448648863|FG000|Overall Study|No longer meets study criteria|0|||
124733690|NCT00320255|448648864|FG001|Overall Study|No longer meets study criteria|0|||
124733691|NCT00320255|448648865|FG002|Overall Study|No longer meets study criteria|0|||
124733692|NCT00320255|448648866|FG003|Overall Study|No longer meets study criteria|1|||
124733693|NCT00320255|448648867|FG004|Overall Study|No longer meets study criteria|0|||
124733694|NCT00320255|448648868|FG005|Overall Study|No longer meets study criteria|0|||
124733695|NCT00320255|448648863|FG000|Overall Study|Other|3|||
124733696|NCT00320255|448648864|FG001|Overall Study|Other|2|||
124733697|NCT00320255|448648865|FG002|Overall Study|Other|1|||
124733698|NCT00320255|448648866|FG003|Overall Study|Other|0|||
124733699|NCT00320255|448648867|FG004|Overall Study|Other|0|||
124733700|NCT00320255|448648868|FG005|Overall Study|Other|0|||
124733701|NCT03405935|448648870|FG000|Overall Study|Adverse Event|3|||
124733702|NCT03405935|448648870|FG000|Overall Study|Death|2|||
124733703|NCT03405935|448648870|FG000|Overall Study|Withdrawal by Subject|1|||
124733704|NCT03405935|448648870|FG000|Overall Study|Lost to Follow-up|2|||
124733705|NCT04979897|448648871|FG000|Overall Study|Death|1|||
124733706|NCT04979897|448648872|FG001|Overall Study|Death|8|||
124733707|NCT04979897|448648871|FG000|Overall Study|Lost to Follow-up|111|||
124733708|NCT04979897|448648872|FG001|Overall Study|Lost to Follow-up|56|||
124733709|NCT04979897|448648871|FG000|Overall Study|Withdrawal by Subject|7|||
124733710|NCT04979897|448648872|FG001|Overall Study|Withdrawal by Subject|2|||
124733711|NCT02781792|448648879|FG000|Overall Study|Adverse Event|1|||
124733712|NCT02781792|448648880|FG001|Overall Study|Adverse Event|2|||
124733713|NCT02781792|448648879|FG000|Overall Study|Withdrawal by Subject|3|||
124733714|NCT02781792|448648880|FG001|Overall Study|Withdrawal by Subject|1|||
124733715|NCT02781792|448648879|FG000|Overall Study|Lack of Efficacy|1|||
124733716|NCT02781792|448648880|FG001|Overall Study|Lack of Efficacy|1|||
124733717|NCT02781792|448648879|FG000|Overall Study|Hospice|0|||
124733718|NCT02781792|448648880|FG001|Overall Study|Hospice|1|||
124733719|NCT01703117|448648881|FG000|Overall Study|Adverse Event|4|||
124733720|NCT01703117|448648882|FG001|Overall Study|Adverse Event|3|||
124733721|NCT01703117|448648881|FG000|Overall Study|Withdrawal by Subject|0|||
124733722|NCT01703117|448648882|FG001|Overall Study|Withdrawal by Subject|1|||
124733723|NCT00683917|448648884|FG000|Overall Study|Study prematurely terminated|10|||
124733724|NCT02685748|448648888|FG000|Overall Study|Withdrawal by Subject|3|||
124733725|NCT02685748|448648889|FG001|Overall Study|Withdrawal by Subject|2|||
124733726|NCT02536300|448648893|FG000|Overall Study|Investigator's Discretion|17|||
124733727|NCT02536300|448648894|FG001|Overall Study|Investigator's Discretion|11|||
124733728|NCT02536300|448648895|FG002|Overall Study|Investigator's Discretion|2|||
124733729|NCT02536300|448648893|FG000|Overall Study|Progressive Disease|11|||
124733730|NCT02536300|448648894|FG001|Overall Study|Progressive Disease|7|||
124733731|NCT02536300|448648895|FG002|Overall Study|Progressive Disease|6|||
124733732|NCT02536300|448648893|FG000|Overall Study|Study Terminated by Sponsor|6|||
124733733|NCT02536300|448648894|FG001|Overall Study|Study Terminated by Sponsor|4|||
124733734|NCT02536300|448648895|FG002|Overall Study|Study Terminated by Sponsor|7|||
124733735|NCT02536300|448648893|FG000|Overall Study|Death|7|||
124733736|NCT02536300|448648894|FG001|Overall Study|Death|0|||
124733737|NCT02536300|448648895|FG002|Overall Study|Death|5|||
124733738|NCT02536300|448648893|FG000|Overall Study|Withdrew Consent|4|||
124733739|NCT02536300|448648894|FG001|Overall Study|Withdrew Consent|2|||
124733740|NCT02536300|448648895|FG002|Overall Study|Withdrew Consent|0|||
124733741|NCT02536300|448648893|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
124733742|NCT02536300|448648894|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
124733743|NCT02536300|448648895|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
124733744|NCT02536300|448648893|FG000|Overall Study|Enrolled but Never Treated|0|||
124733745|NCT02536300|448648894|FG001|Overall Study|Enrolled but Never Treated|0|||
124733746|NCT02536300|448648895|FG002|Overall Study|Enrolled but Never Treated|1|||
124733747|NCT02536300|448648893|FG000|Overall Study|Non-compliance With Study Drug|1|||
124733748|NCT02536300|448648894|FG001|Overall Study|Non-compliance With Study Drug|0|||
124733749|NCT02536300|448648895|FG002|Overall Study|Non-compliance With Study Drug|0|||
124781219|NCT02405442|448829120|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
124733750|NCT02536300|448648893|FG000|Overall Study|Protocol Violation|0|||
124610512|NCT02799095|448194195|FG000|Part C|Progressive Disease|0|||
124610513|NCT02799095|448194196|FG001|Part C|Progressive Disease|0|||
124610514|NCT02799095|448194197|FG002|Part C|Progressive Disease|0|||
124610515|NCT02799095|448194198|FG003|Part C|Progressive Disease|0|||
124610516|NCT02799095|448194199|FG004|Part C|Progressive Disease|0|||
124610517|NCT02799095|448194200|FG005|Part C|Progressive Disease|0|||
124610518|NCT02799095|448194201|FG006|Part C|Progressive Disease|0|||
124610519|NCT02799095|448194202|FG007|Part C|Progressive Disease|0|||
124610520|NCT02799095|448194203|FG008|Part C|Progressive Disease|0|||
124610521|NCT02799095|448194204|FG009|Part C|Progressive Disease|2|||
124610522|NCT02799095|448194205|FG010|Part C|Progressive Disease|13|||
124610523|NCT02799095|448194206|FG011|Part C|Progressive Disease|2|||
124610524|NCT02799095|448194207|FG012|Part C|Progressive Disease|0|||
124610525|NCT02799095|448194208|FG013|Part C|Progressive Disease|1|||
124610526|NCT02799095|448194209|FG014|Part C|Progressive Disease|0|||
124610527|NCT02799095|448194210|FG015|Part C|Progressive Disease|0|||
124610528|NCT02799095|448194211|FG016|Part C|Progressive Disease|0|||
124610529|NCT02799095|448194195|FG000|Part C|Clinical Progression|0|||
124610530|NCT02799095|448194196|FG001|Part C|Clinical Progression|0|||
124610531|NCT02799095|448194197|FG002|Part C|Clinical Progression|0|||
124610532|NCT02799095|448194198|FG003|Part C|Clinical Progression|0|||
124610533|NCT02799095|448194199|FG004|Part C|Clinical Progression|0|||
124610534|NCT02799095|448194200|FG005|Part C|Clinical Progression|0|||
124610535|NCT02799095|448194201|FG006|Part C|Clinical Progression|0|||
124610536|NCT02799095|448194202|FG007|Part C|Clinical Progression|0|||
124610537|NCT02799095|448194203|FG008|Part C|Clinical Progression|0|||
124610538|NCT02799095|448194204|FG009|Part C|Clinical Progression|1|||
124610539|NCT02799095|448194205|FG010|Part C|Clinical Progression|3|||
124610540|NCT02799095|448194206|FG011|Part C|Clinical Progression|0|||
124610541|NCT02799095|448194207|FG012|Part C|Clinical Progression|0|||
124610542|NCT02799095|448194208|FG013|Part C|Clinical Progression|1|||
124610543|NCT02799095|448194209|FG014|Part C|Clinical Progression|0|||
124610544|NCT02799095|448194210|FG015|Part C|Clinical Progression|0|||
124610545|NCT02799095|448194211|FG016|Part C|Clinical Progression|0|||
124610546|NCT02799095|448194195|FG000|Part C|Withdrawal by Subject|0|||
124610547|NCT02799095|448194196|FG001|Part C|Withdrawal by Subject|0|||
124610548|NCT02799095|448194197|FG002|Part C|Withdrawal by Subject|0|||
124610549|NCT02799095|448194198|FG003|Part C|Withdrawal by Subject|0|||
124610550|NCT02799095|448194199|FG004|Part C|Withdrawal by Subject|0|||
124610551|NCT02799095|448194200|FG005|Part C|Withdrawal by Subject|0|||
124610552|NCT02799095|448194201|FG006|Part C|Withdrawal by Subject|0|||
124610553|NCT02799095|448194202|FG007|Part C|Withdrawal by Subject|0|||
124610554|NCT02799095|448194203|FG008|Part C|Withdrawal by Subject|0|||
124610555|NCT02799095|448194204|FG009|Part C|Withdrawal by Subject|0|||
124610556|NCT02799095|448194205|FG010|Part C|Withdrawal by Subject|13|||
124610557|NCT02799095|448194206|FG011|Part C|Withdrawal by Subject|15|||
124610558|NCT02799095|448194207|FG012|Part C|Withdrawal by Subject|13|||
124610559|NCT02799095|448194208|FG013|Part C|Withdrawal by Subject|21|||
124610560|NCT02799095|448194209|FG014|Part C|Withdrawal by Subject|0|||
124610561|NCT02799095|448194210|FG015|Part C|Withdrawal by Subject|12|||
124610562|NCT02799095|448194211|FG016|Part C|Withdrawal by Subject|1|||
124610563|NCT02799095|448194195|FG000|Part C|Physician Decision|0|||
124610564|NCT02799095|448194196|FG001|Part C|Physician Decision|0|||
124610565|NCT02799095|448194197|FG002|Part C|Physician Decision|0|||
124610566|NCT02799095|448194198|FG003|Part C|Physician Decision|0|||
124610567|NCT02799095|448194199|FG004|Part C|Physician Decision|0|||
124610568|NCT02799095|448194200|FG005|Part C|Physician Decision|0|||
124610569|NCT02799095|448194201|FG006|Part C|Physician Decision|0|||
124610570|NCT02799095|448194202|FG007|Part C|Physician Decision|0|||
124610571|NCT02799095|448194203|FG008|Part C|Physician Decision|0|||
124610572|NCT02799095|448194204|FG009|Part C|Physician Decision|0|||
124610573|NCT02799095|448194205|FG010|Part C|Physician Decision|1|||
124610574|NCT02799095|448194206|FG011|Part C|Physician Decision|0|||
124610575|NCT02799095|448194207|FG012|Part C|Physician Decision|0|||
124610576|NCT02799095|448194208|FG013|Part C|Physician Decision|0|||
124610577|NCT02799095|448194209|FG014|Part C|Physician Decision|0|||
124610578|NCT02799095|448194210|FG015|Part C|Physician Decision|0|||
124610579|NCT02799095|448194211|FG016|Part C|Physician Decision|0|||
124610580|NCT02799095|448194195|FG000|Part C|Other|0|||
124610581|NCT02799095|448194196|FG001|Part C|Other|0|||
124610582|NCT02799095|448194197|FG002|Part C|Other|0|||
124610583|NCT02799095|448194198|FG003|Part C|Other|0|||
124733751|NCT02536300|448648894|FG001|Overall Study|Protocol Violation|1|||
124733752|NCT02536300|448648895|FG002|Overall Study|Protocol Violation|0|||
124733753|NCT01080768|448648898|FG000|Overall Study|Protocol Deviation|2|||
124610584|NCT02799095|448194199|FG004|Part C|Other|0|||
124610585|NCT02799095|448194200|FG005|Part C|Other|0|||
124610586|NCT02799095|448194201|FG006|Part C|Other|0|||
124610587|NCT02799095|448194202|FG007|Part C|Other|0|||
124610588|NCT02799095|448194203|FG008|Part C|Other|0|||
124610589|NCT02799095|448194204|FG009|Part C|Other|0|||
124610590|NCT02799095|448194205|FG010|Part C|Other|0|||
124610591|NCT02799095|448194206|FG011|Part C|Other|2|||
124610592|NCT02799095|448194207|FG012|Part C|Other|2|||
124610593|NCT02799095|448194208|FG013|Part C|Other|0|||
124610594|NCT02799095|448194209|FG014|Part C|Other|0|||
124610595|NCT02799095|448194210|FG015|Part C|Other|0|||
124610596|NCT02799095|448194211|FG016|Part C|Other|0|||
124610597|NCT04994483|448194212|FG000|Overall Study|Adverse Event|26|||
124610598|NCT04994483|448194213|FG001|Overall Study|Adverse Event|17|||
124610599|NCT04994483|448194212|FG000|Overall Study|Lost to Follow-up|6|||
124610600|NCT04994483|448194213|FG001|Overall Study|Lost to Follow-up|10|||
124610601|NCT04994483|448194212|FG000|Overall Study|Noncompliance with study drug|8|||
124610602|NCT04994483|448194213|FG001|Overall Study|Noncompliance with study drug|5|||
124610603|NCT04994483|448194212|FG000|Overall Study|Physician Decision|5|||
124610604|NCT04994483|448194213|FG001|Overall Study|Physician Decision|0|||
124610605|NCT04994483|448194212|FG000|Overall Study|Withdrawal by Subject|41|||
124610606|NCT04994483|448194213|FG001|Overall Study|Withdrawal by Subject|38|||
124610607|NCT04994483|448194212|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
124610608|NCT04994483|448194213|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
124610609|NCT04994483|448194212|FG000|Overall Study|Met stopping criteria|1|||
124610610|NCT04994483|448194213|FG001|Overall Study|Met stopping criteria|0|||
124610611|NCT04994483|448194212|FG000|Overall Study|Randomized in error, not treated|4|||
124610612|NCT04994483|448194213|FG001|Overall Study|Randomized in error, not treated|3|||
124610613|NCT04994483|448194212|FG000|Overall Study|Lack of a reliable study partner|0|||
124610614|NCT04994483|448194213|FG001|Overall Study|Lack of a reliable study partner|1|||
124610615|NCT04994483|448194212|FG000|Overall Study|Met MRI exclusion criteria|0|||
124610616|NCT04994483|448194213|FG001|Overall Study|Met MRI exclusion criteria|1|||
124610617|NCT03589768|448194218|FG000|Overall Study|Death|1|||
124610618|NCT03589768|448194219|FG001|Overall Study|Death|0|||
124610619|NCT03589768|448194220|FG002|Overall Study|Death|8|||
124610620|NCT03589768|448194221|FG003|Overall Study|Death|3|||
124610621|NCT03589768|448194218|FG000|Overall Study|Withdrawal by Subject|2|||
124610622|NCT03589768|448194219|FG001|Overall Study|Withdrawal by Subject|0|||
124610623|NCT03589768|448194220|FG002|Overall Study|Withdrawal by Subject|0|||
124610624|NCT03589768|448194221|FG003|Overall Study|Withdrawal by Subject|0|||
124610625|NCT03589768|448194218|FG000|Overall Study|Protocol Violation|1|||
124610626|NCT03589768|448194219|FG001|Overall Study|Protocol Violation|0|||
124610627|NCT03589768|448194220|FG002|Overall Study|Protocol Violation|0|||
124610628|NCT03589768|448194221|FG003|Overall Study|Protocol Violation|0|||
124610629|NCT03283319|448194222|FG000|Overall Study|Lost to Follow-up|5|||
124610630|NCT03283319|448194223|FG001|Overall Study|Lost to Follow-up|4|||
124610631|NCT03283319|448194224|FG002|Overall Study|Lost to Follow-up|5|||
124610632|NCT03283319|448194225|FG003|Overall Study|Lost to Follow-up|5|||
124610633|NCT03283319|448194226|FG004|Overall Study|Lost to Follow-up|4|||
124610634|NCT03283319|448194227|FG005|Overall Study|Lost to Follow-up|3|||
124610635|NCT03283319|448194222|FG000|Overall Study|Withdrawal by Subject|2|||
124610636|NCT03283319|448194223|FG001|Overall Study|Withdrawal by Subject|2|||
124610637|NCT03283319|448194224|FG002|Overall Study|Withdrawal by Subject|2|||
124610638|NCT03283319|448194225|FG003|Overall Study|Withdrawal by Subject|1|||
124610639|NCT03283319|448194226|FG004|Overall Study|Withdrawal by Subject|0|||
124610640|NCT03283319|448194227|FG005|Overall Study|Withdrawal by Subject|1|||
124610641|NCT03283319|448194222|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
124610642|NCT03283319|448194223|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
124610643|NCT03283319|448194224|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
124610644|NCT03283319|448194225|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
124610645|NCT03283319|448194226|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
124610646|NCT03283319|448194227|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
124610647|NCT00721630|448194228|FG000|Overall Study|Participant found to be ineligible|1|||
124610648|NCT03665441|448194229|FG000|Overall Study|survival follow up ongoing|23|||
124610649|NCT03665441|448194230|FG001|Overall Study|survival follow up ongoing|0|||
124610650|NCT03665441|448194229|FG000|Overall Study|Patients ongoing on treatment|9|||
124610651|NCT03665441|448194230|FG001|Overall Study|Patients ongoing on treatment|6|||
124610652|NCT03665441|448194229|FG000|Overall Study|Randomized but not treated|7|||
124610653|NCT03665441|448194230|FG001|Overall Study|Randomized but not treated|11|||
124610654|NCT04345601|448194231|FG000|Overall Study|Death|0|||
124610655|NCT04345601|448194232|FG001|Overall Study|Death|3|||
124610656|NCT04345601|448194233|FG002|Overall Study|Death|2|||
124610657|NCT04345601|448194231|FG000|Overall Study|Lost to Follow-up|0|||
124610658|NCT04345601|448194232|FG001|Overall Study|Lost to Follow-up|0|||
124610659|NCT04345601|448194233|FG002|Overall Study|Lost to Follow-up|2|||
124610660|NCT03700385|448194234|FG000|Overall Study|Lost to Follow-up|1|||
124610661|NCT00372411|448194237|FG000|Overall Study|Withdrawal by Subject|3|||
124610662|NCT00372411|448194238|FG001|Overall Study|Withdrawal by Subject|4|||
124610663|NCT00372411|448194239|FG002|Overall Study|Withdrawal by Subject|1|||
124610664|NCT00372411|448194237|FG000|Overall Study|Death|0|||
124610665|NCT00372411|448194238|FG001|Overall Study|Death|2|||
124610666|NCT00372411|448194239|FG002|Overall Study|Death|1|||
124610667|NCT00372411|448194237|FG000|Overall Study|Lost to Follow-up|1|||
124610668|NCT00372411|448194238|FG001|Overall Study|Lost to Follow-up|1|||
124610669|NCT00372411|448194239|FG002|Overall Study|Lost to Follow-up|1|||
124610670|NCT00372411|448194237|FG000|Overall Study|Adverse Event|1|||
124733754|NCT01080768|448648899|FG001|Overall Study|Protocol Deviation|1|||
124733755|NCT00931723|448648906|FG000|Overall Study|Withdrawal by Subject|11|||
124733756|NCT00931723|448648907|FG001|Overall Study|Withdrawal by Subject|13|||
124733757|NCT00931723|448648906|FG000|Overall Study|Adverse Event|6|||
124733758|NCT00931723|448648907|FG001|Overall Study|Adverse Event|13|||
124733759|NCT00931723|448648906|FG000|Overall Study|Lithium found in blood|0|||
124733760|NCT00931723|448648907|FG001|Overall Study|Lithium found in blood|1|||
124733761|NCT00931723|448648906|FG000|Overall Study|Condition under investigation worsened|1|||
124733762|NCT00931723|448648907|FG001|Overall Study|Condition under investigation worsened|2|||
124733763|NCT00931723|448648906|FG000|Overall Study|Lost to Follow-up|1|||
124733764|NCT00931723|448648907|FG001|Overall Study|Lost to Follow-up|2|||
124733765|NCT00931723|448648906|FG000|Overall Study|Study-specific discontinuation criteria|1|||
124733766|NCT00931723|448648907|FG001|Overall Study|Study-specific discontinuation criteria|1|||
124733767|NCT00931723|448648906|FG000|Overall Study|Severe non-compliance to protocol|2|||
124733768|NCT00931723|448648907|FG001|Overall Study|Severe non-compliance to protocol|0|||
124733769|NCT00931723|448648906|FG000|Overall Study|Safety reasons|0|||
124733770|NCT00931723|448648907|FG001|Overall Study|Safety reasons|1|||
124733771|NCT00931723|448648906|FG000|Overall Study|Took prohibited concomitant medication|0|||
124733772|NCT00931723|448648907|FG001|Overall Study|Took prohibited concomitant medication|1|||
124733773|NCT00931723|448648906|FG000|Overall Study|Lack or insufficient theraputic response|2|||
124733774|NCT00931723|448648907|FG001|Overall Study|Lack or insufficient theraputic response|5|||
124733775|NCT00931723|448648906|FG000|Overall Study|Sponsor decision|1|||
124733776|NCT00931723|448648907|FG001|Overall Study|Sponsor decision|0|||
124733777|NCT00931723|448648906|FG000|Overall Study|Late hospital discharge|1|||
124733778|NCT00931723|448648907|FG001|Overall Study|Late hospital discharge|0|||
124733779|NCT03054350|448648908|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
124733780|NCT03054350|448648909|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
124733781|NCT03054350|448648910|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
124733782|NCT03054350|448648911|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
124733783|NCT03054350|448648912|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
124733784|NCT03054350|448648913|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
124733785|NCT03054350|448648908|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
124733786|NCT03054350|448648909|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
124733787|NCT03054350|448648910|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
124733788|NCT03054350|448648911|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
124733789|NCT03054350|448648912|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
124733790|NCT03054350|448648913|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
124733791|NCT03054350|448648908|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
124733792|NCT03054350|448648909|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
124733793|NCT03054350|448648910|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
124733794|NCT03054350|448648911|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
124733795|NCT03054350|448648912|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
124733796|NCT03054350|448648913|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
124733797|NCT03054350|448648908|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
124733798|NCT03054350|448648909|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
124733799|NCT03054350|448648910|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
124733800|NCT03054350|448648911|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
124733801|NCT03054350|448648912|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
124733802|NCT03054350|448648913|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
124733803|NCT01133405|448648914|FG000|Period 1|Withdrawal by Subject|0|||
124733804|NCT01133405|448648915|FG001|Period 1|Withdrawal by Subject|1|||
124733805|NCT01133405|448648916|FG002|Period 1|Withdrawal by Subject|0|||
124733806|NCT01133405|448648917|FG003|Period 1|Withdrawal by Subject|1|||
124733807|NCT01133405|448648918|FG004|Period 1|Withdrawal by Subject|0|||
124733808|NCT01133405|448648919|FG005|Period 1|Withdrawal by Subject|1|||
124733809|NCT01133405|448648920|FG006|Period 1|Withdrawal by Subject|0|||
124733810|NCT01133405|448648921|FG007|Period 1|Withdrawal by Subject|0|||
124733811|NCT01133405|448648922|FG008|Period 1|Withdrawal by Subject|0|||
124733812|NCT01133405|448648923|FG009|Period 1|Withdrawal by Subject|0|||
124733813|NCT01133405|448648914|FG000|Period 1|Physician Decision|0|||
124733814|NCT01133405|448648915|FG001|Period 1|Physician Decision|0|||
124733815|NCT01133405|448648916|FG002|Period 1|Physician Decision|0|||
124733816|NCT01133405|448648917|FG003|Period 1|Physician Decision|1|||
124733817|NCT01133405|448648918|FG004|Period 1|Physician Decision|0|||
124733818|NCT01133405|448648919|FG005|Period 1|Physician Decision|0|||
124733819|NCT01133405|448648920|FG006|Period 1|Physician Decision|0|||
124733820|NCT01133405|448648921|FG007|Period 1|Physician Decision|0|||
124733821|NCT01133405|448648922|FG008|Period 1|Physician Decision|0|||
124733822|NCT01133405|448648923|FG009|Period 1|Physician Decision|0|||
124733823|NCT01133405|448648914|FG000|Period 1|Discontinued after randomization|1|||
124733824|NCT01133405|448648915|FG001|Period 1|Discontinued after randomization|0|||
124733825|NCT01133405|448648916|FG002|Period 1|Discontinued after randomization|0|||
124733826|NCT01133405|448648917|FG003|Period 1|Discontinued after randomization|0|||
124733827|NCT01133405|448648918|FG004|Period 1|Discontinued after randomization|0|||
124733828|NCT01133405|448648919|FG005|Period 1|Discontinued after randomization|0|||
124733829|NCT01133405|448648920|FG006|Period 1|Discontinued after randomization|1|||
124733830|NCT01133405|448648921|FG007|Period 1|Discontinued after randomization|0|||
124733831|NCT01133405|448648922|FG008|Period 1|Discontinued after randomization|0|||
124733832|NCT01133405|448648923|FG009|Period 1|Discontinued after randomization|0|||
124733833|NCT01133405|448648914|FG000|Period 1|Received drug only in period 2|0|||
124733834|NCT01133405|448648915|FG001|Period 1|Received drug only in period 2|1|||
124733835|NCT01133405|448648916|FG002|Period 1|Received drug only in period 2|0|||
124733836|NCT01133405|448648917|FG003|Period 1|Received drug only in period 2|2|||
124733837|NCT01133405|448648918|FG004|Period 1|Received drug only in period 2|0|||
124733838|NCT01133405|448648919|FG005|Period 1|Received drug only in period 2|1|||
124733839|NCT01133405|448648920|FG006|Period 1|Received drug only in period 2|0|||
124733840|NCT01133405|448648921|FG007|Period 1|Received drug only in period 2|0|||
124733841|NCT01133405|448648922|FG008|Period 1|Received drug only in period 2|0|||
124733842|NCT01133405|448648923|FG009|Period 1|Received drug only in period 2|0|||
124733843|NCT01133405|448648914|FG000|Period 1|Received drug only in period 3|0|||
124733844|NCT01133405|448648915|FG001|Period 1|Received drug only in period 3|1|||
124733845|NCT01133405|448648916|FG002|Period 1|Received drug only in period 3|1|||
124733846|NCT01133405|448648917|FG003|Period 1|Received drug only in period 3|0|||
124733847|NCT01133405|448648918|FG004|Period 1|Received drug only in period 3|0|||
124733848|NCT01133405|448648919|FG005|Period 1|Received drug only in period 3|0|||
124733849|NCT01133405|448648920|FG006|Period 1|Received drug only in period 3|0|||
124733850|NCT01133405|448648921|FG007|Period 1|Received drug only in period 3|0|||
124733851|NCT01133405|448648922|FG008|Period 1|Received drug only in period 3|0|||
124733852|NCT01133405|448648923|FG009|Period 1|Received drug only in period 3|0|||
124733853|NCT01133405|448648914|FG000|Period 2|Adverse Event|0|||
124733854|NCT01133405|448648915|FG001|Period 2|Adverse Event|0|||
124733855|NCT01133405|448648916|FG002|Period 2|Adverse Event|1|||
124733856|NCT01133405|448648917|FG003|Period 2|Adverse Event|0|||
124733857|NCT01133405|448648918|FG004|Period 2|Adverse Event|0|||
124733858|NCT01133405|448648919|FG005|Period 2|Adverse Event|0|||
124733859|NCT01133405|448648920|FG006|Period 2|Adverse Event|0|||
124733860|NCT01133405|448648921|FG007|Period 2|Adverse Event|0|||
124733861|NCT01133405|448648922|FG008|Period 2|Adverse Event|0|||
124733862|NCT01133405|448648923|FG009|Period 2|Adverse Event|0|||
124733863|NCT01133405|448648914|FG000|Period 2|Withdrawal by Subject|0|||
124733864|NCT01133405|448648915|FG001|Period 2|Withdrawal by Subject|0|||
124733865|NCT01133405|448648916|FG002|Period 2|Withdrawal by Subject|0|||
124733866|NCT01133405|448648917|FG003|Period 2|Withdrawal by Subject|1|||
124733867|NCT01133405|448648918|FG004|Period 2|Withdrawal by Subject|0|||
124733868|NCT01133405|448648919|FG005|Period 2|Withdrawal by Subject|1|||
124733869|NCT01133405|448648920|FG006|Period 2|Withdrawal by Subject|0|||
124733870|NCT01133405|448648921|FG007|Period 2|Withdrawal by Subject|0|||
124733871|NCT01133405|448648922|FG008|Period 2|Withdrawal by Subject|0|||
124733872|NCT01133405|448648923|FG009|Period 2|Withdrawal by Subject|0|||
124733873|NCT01133405|448648914|FG000|Period 2|Entry Criteria Not Met|0|||
124733874|NCT01133405|448648915|FG001|Period 2|Entry Criteria Not Met|1|||
124733875|NCT01133405|448648916|FG002|Period 2|Entry Criteria Not Met|0|||
124733876|NCT01133405|448648917|FG003|Period 2|Entry Criteria Not Met|0|||
124733877|NCT01133405|448648918|FG004|Period 2|Entry Criteria Not Met|0|||
124733878|NCT01133405|448648919|FG005|Period 2|Entry Criteria Not Met|0|||
124733879|NCT01133405|448648920|FG006|Period 2|Entry Criteria Not Met|0|||
124733880|NCT01133405|448648921|FG007|Period 2|Entry Criteria Not Met|0|||
124733881|NCT01133405|448648922|FG008|Period 2|Entry Criteria Not Met|0|||
124733882|NCT01133405|448648923|FG009|Period 2|Entry Criteria Not Met|0|||
124733883|NCT01133405|448648914|FG000|Period 2|Physician Decision|0|||
124733884|NCT01133405|448648915|FG001|Period 2|Physician Decision|0|||
124733885|NCT01133405|448648916|FG002|Period 2|Physician Decision|0|||
124733886|NCT01133405|448648917|FG003|Period 2|Physician Decision|0|||
124733887|NCT01133405|448648918|FG004|Period 2|Physician Decision|0|||
124733888|NCT01133405|448648919|FG005|Period 2|Physician Decision|1|||
124733889|NCT01133405|448648920|FG006|Period 2|Physician Decision|0|||
124733890|NCT01133405|448648921|FG007|Period 2|Physician Decision|0|||
124733891|NCT01133405|448648922|FG008|Period 2|Physician Decision|0|||
124733892|NCT01133405|448648923|FG009|Period 2|Physician Decision|0|||
124733893|NCT01238835|448648926|FG000|Overall Study|Death|124|||
124733894|NCT01238835|448648926|FG000|Overall Study|Withdrawal by Subject|9|||
124733895|NCT01238835|448648926|FG000|Overall Study|Lost to Follow-up|1|||
124733896|NCT01238835|448648926|FG000|Overall Study|Site early discontinuation|2|||
124733897|NCT00772369|448648927|FG000|Overall Study|Did not return record release form|1|||
124733898|NCT01774253|448648928|FG000|Overall Study|Lack of Efficacy|4|||
124733899|NCT01774253|448648928|FG000|Overall Study|Physician Decision|2|||
124733900|NCT01774253|448648928|FG000|Overall Study|Withdrawal by Subject|2|||
124733901|NCT01774253|448648928|FG000|Overall Study|Death|1|||
124733902|NCT00554619|448648929|FG000|Overall Study|Adverse Event|1|||
124733903|NCT00554619|448648929|FG000|Overall Study|Physician Decision|1|||
124733904|NCT00554619|448648929|FG000|Overall Study|Liver Function Test Abnormality|1|||
124733905|NCT02240368|448648933|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
124733906|NCT02240368|448648934|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
124733907|NCT02240368|448648935|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
124733908|NCT02240368|448648933|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
124733909|NCT02240368|448648934|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
124733910|NCT02240368|448648935|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
124733911|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|Death|1|||
124733912|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|Death|1|||
124733913|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|Death|0|||
124733914|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|Death|0|||
124733915|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|Death|1|||
124733916|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|Death|0|||
124733917|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|Death|0|||
124733918|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|Death|0|||
124733919|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|Death|0|||
124781220|NCT02405442|448829121|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
124781221|NCT02405442|448829118|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
124781222|NCT02405442|448829119|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
124781223|NCT02405442|448829120|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
124781224|NCT02405442|448829121|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
124781225|NCT02405442|448829118|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
124781226|NCT02405442|448829119|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
124781227|NCT02405442|448829120|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
124781228|NCT02405442|448829121|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
124781229|NCT02405442|448829118|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
124781230|NCT02405442|448829119|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
124781231|NCT02405442|448829120|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
124781232|NCT02405442|448829121|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
124781233|NCT02405442|448829118|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
124781234|NCT02405442|448829119|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
124781235|NCT02405442|448829120|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
124781236|NCT02405442|448829121|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
124781237|NCT02405442|448829118|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
124781238|NCT02405442|448829119|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
124781239|NCT02405442|448829120|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
124781240|NCT02405442|448829121|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
124781241|NCT02405442|448829118|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
124781242|NCT02405442|448829119|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
124610671|NCT00372411|448194238|FG001|Overall Study|Adverse Event|1|||
124610672|NCT00372411|448194239|FG002|Overall Study|Adverse Event|0|||
124610673|NCT00631657|448194240|FG000|6-Month Treatment Period|Adverse Event|47|||
124610674|NCT00631657|448194241|FG001|6-Month Treatment Period|Adverse Event|0|||
124610675|NCT00631657|448194242|FG002|6-Month Treatment Period|Adverse Event|7|||
124610676|NCT00631657|448194240|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
124610677|NCT00631657|448194241|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
124610678|NCT00631657|448194242|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
124610679|NCT00631657|448194240|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
124610680|NCT00631657|448194241|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
124610681|NCT00631657|448194242|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
124610682|NCT00631657|448194240|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
124781243|NCT02405442|448829120|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
124781244|NCT02405442|448829121|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
124781245|NCT02405442|448829118|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
124781246|NCT02405442|448829119|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
124781247|NCT02405442|448829120|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
124781248|NCT02405442|448829121|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
124781249|NCT02405442|448829118|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
124781250|NCT02405442|448829119|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
124781251|NCT02405442|448829120|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
124781252|NCT02405442|448829121|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
124781253|NCT03275350|448829123|FG000|Overall Study|Lost to Follow-up|4|||
124781254|NCT03275350|448829124|FG001|Overall Study|Lost to Follow-up|6|||
124781255|NCT03275350|448829123|FG000|Overall Study|Death|2|||
124781256|NCT03275350|448829124|FG001|Overall Study|Death|1|||
124781257|NCT03275350|448829123|FG000|Overall Study|Physician Decision|1|||
124610683|NCT00631657|448194241|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
124733920|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|Death|0|||
124610684|NCT00631657|448194242|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
124610685|NCT00631657|448194240|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
124610686|NCT00631657|448194241|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
124610687|NCT00631657|448194242|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
124610688|NCT00631657|448194240|FG000|6-Month Treatment Period|Other|16|||
124610689|NCT00631657|448194241|FG001|6-Month Treatment Period|Other|0|||
124610690|NCT00631657|448194242|FG002|6-Month Treatment Period|Other|4|||
124610691|NCT00631657|448194240|FG000|6-Month Treatment Period|Not Treated|2|||
124610692|NCT00631657|448194241|FG001|6-Month Treatment Period|Not Treated|0|||
124610693|NCT00631657|448194242|FG002|6-Month Treatment Period|Not Treated|1|||
124610694|NCT00631657|448194240|FG000|7-Day Discontinuation Period|Not Treated|1|||
124610695|NCT00631657|448194241|FG001|7-Day Discontinuation Period|Not Treated|1|||
124610696|NCT00631657|448194242|FG002|7-Day Discontinuation Period|Not Treated|1|||
124610697|NCT00631657|448194240|FG000|7-Day Discontinuation Period|Other|1|||
124610698|NCT00631657|448194241|FG001|7-Day Discontinuation Period|Other|0|||
124610699|NCT00631657|448194242|FG002|7-Day Discontinuation Period|Other|0|||
124610700|NCT00699374|448194244|FG000|Overall Study|Death|93|||
124610701|NCT00699374|448194245|FG001|Overall Study|Death|83|||
124610702|NCT00699374|448194244|FG000|Overall Study|Adverse Event|70|||
124610703|NCT00699374|448194245|FG001|Overall Study|Adverse Event|67|||
124610704|NCT00699374|448194244|FG000|Overall Study|Global deterioration of health status|7|||
124610705|NCT00699374|448194245|FG001|Overall Study|Global deterioration of health status|8|||
124610706|NCT00699374|448194244|FG000|Overall Study|Lost to Follow-up|3|||
124610707|NCT00699374|448194245|FG001|Overall Study|Lost to Follow-up|5|||
124610708|NCT00699374|448194244|FG000|Overall Study|Withdrawal by Subject|34|||
124610709|NCT00699374|448194245|FG001|Overall Study|Withdrawal by Subject|44|||
124610710|NCT00699374|448194244|FG000|Overall Study|Objective progression or relapse|281|||
124610711|NCT00699374|448194245|FG001|Overall Study|Objective progression or relapse|277|||
124610712|NCT00699374|448194244|FG000|Overall Study|Other|18|||
124610713|NCT00699374|448194245|FG001|Overall Study|Other|15|||
124610714|NCT00699374|448194244|FG000|Overall Study|Protocol Violation|2|||
124610715|NCT00699374|448194245|FG001|Overall Study|Protocol Violation|6|||
124610716|NCT00699374|448194244|FG000|Overall Study|Study terminated by sponsor|13|||
124610717|NCT00699374|448194245|FG001|Overall Study|Study terminated by sponsor|28|||
124610718|NCT00699374|448194244|FG000|Overall Study|Randomized but not treated|4|||
124610719|NCT00699374|448194245|FG001|Overall Study|Randomized but not treated|2|||
124610720|NCT00699374|448194244|FG000|Overall Study|Died 28 days after last dose|5|||
124610721|NCT00699374|448194245|FG001|Overall Study|Died 28 days after last dose|9|||
124610722|NCT04091659|448194252|FG000|Overall Study|Protocol Violation|3|||
124610723|NCT04091659|448194253|FG001|Overall Study|Protocol Violation|0|||
124610724|NCT04091659|448194252|FG000|Overall Study|Lost to Follow-up|0|||
124610725|NCT04091659|448194253|FG001|Overall Study|Lost to Follow-up|1|||
124610726|NCT01081834|448194257|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
124610727|NCT01081834|448194258|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
124610728|NCT01081834|448194259|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
124610729|NCT01081834|448194260|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
124610730|NCT01081834|448194261|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
124610731|NCT01081834|448194257|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
124610732|NCT01081834|448194258|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
124610733|NCT01081834|448194259|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
124610734|NCT01081834|448194260|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
124610735|NCT01081834|448194261|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
124610736|NCT01081834|448194257|FG000|Core Period: Baseline to Week 26|Death|1|||
124610737|NCT01081834|448194258|FG001|Core Period: Baseline to Week 26|Death|0|||
124610738|NCT01081834|448194259|FG002|Core Period: Baseline to Week 26|Death|0|||
124610739|NCT01081834|448194260|FG003|Core Period: Baseline to Week 26|Death|0|||
124610740|NCT01081834|448194261|FG004|Core Period: Baseline to Week 26|Death|0|||
124610741|NCT01081834|448194257|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
124610742|NCT01081834|448194258|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
124610743|NCT01081834|448194259|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
124610744|NCT01081834|448194260|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
124610745|NCT01081834|448194261|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
124610746|NCT01081834|448194257|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
124610747|NCT01081834|448194258|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
124610748|NCT01081834|448194259|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
124610749|NCT01081834|448194260|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
124610750|NCT01081834|448194261|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
124610751|NCT01081834|448194257|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
124610752|NCT01081834|448194258|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
124610753|NCT01081834|448194259|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
124610754|NCT01081834|448194260|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
124610755|NCT01081834|448194261|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
124733921|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
124733922|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
124733923|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
124733924|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
124733925|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
124733926|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
124733927|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
124733928|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
124733929|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
124733930|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
124733931|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
124733932|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
124733933|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
124733934|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
124733935|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
124733936|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
124733937|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
124733938|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
124733939|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
124733940|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
124733941|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
124733942|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
124733943|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
124733944|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
124733945|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
124733946|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
124733947|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
124733948|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
124733949|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
124733950|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
124733951|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
124733952|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
124733953|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
124733954|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
124733955|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
124733956|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
124733957|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
124733958|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
124733959|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
124733960|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
124610756|NCT01081834|448194257|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
124610757|NCT01081834|448194258|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
124610758|NCT01081834|448194259|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
124610759|NCT01081834|448194260|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
124610760|NCT01081834|448194261|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
124610761|NCT01081834|448194257|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
124610762|NCT01081834|448194258|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
124610763|NCT01081834|448194259|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
124610764|NCT01081834|448194260|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
124610765|NCT01081834|448194261|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
124610766|NCT01081834|448194257|FG000|Core Period: Baseline to Week 26|Other|4|||
124610767|NCT01081834|448194258|FG001|Core Period: Baseline to Week 26|Other|4|||
124610768|NCT01081834|448194259|FG002|Core Period: Baseline to Week 26|Other|3|||
124610769|NCT01081834|448194260|FG003|Core Period: Baseline to Week 26|Other|1|||
124610770|NCT01081834|448194261|FG004|Core Period: Baseline to Week 26|Other|0|||
124610771|NCT01081834|448194257|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
124610772|NCT01081834|448194258|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
124610773|NCT01081834|448194259|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
124610774|NCT01081834|448194260|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
124610775|NCT01081834|448194261|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
124610776|NCT01081834|448194257|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
124610777|NCT01081834|448194258|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
124610778|NCT01081834|448194259|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
124610779|NCT01081834|448194260|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
124610780|NCT01081834|448194261|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
124733961|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
124610781|NCT01081834|448194257|FG000|Extension Period: Week 26 to Week 52|Death|1|||
124733962|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
124781258|NCT03275350|448829124|FG001|Overall Study|Physician Decision|0|||
124781259|NCT03275350|448829123|FG000|Overall Study|Incarcerated|1|||
124781260|NCT03275350|448829124|FG001|Overall Study|Incarcerated|1|||
124781261|NCT00926029|448829125|FG000|Overall Study|Lost to Follow-up|2|||
124781262|NCT00926029|448829126|FG001|Overall Study|Lost to Follow-up|1|||
124781263|NCT00926029|448829127|FG002|Overall Study|Lost to Follow-up|1|||
124781264|NCT04154189|448829130|FG000|Overall Study|Withdrawal by Subject|4|||
124781265|NCT04154189|448829131|FG001|Overall Study|Withdrawal by Subject|6|||
124733963|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
124733964|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
124733965|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
124733966|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
124733967|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
124733968|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
124733969|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
124733970|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
124733971|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
124733972|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
124733973|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
124733974|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
124733975|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
124733976|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
124733977|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
124733978|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
124733979|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
124733980|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
124733981|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
124733982|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
124733983|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
124733984|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
124733985|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
124733986|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
124733987|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
124733988|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
124733989|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
124733990|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
124733991|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
124733992|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
124733993|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
124733994|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
124733995|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
124733996|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
124733997|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
124733998|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
124733999|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
124734000|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
124734001|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
124734002|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
124734003|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
124734004|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
124734005|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
124734006|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
124734007|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
124734008|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
124734009|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
124781266|NCT04154189|448829130|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
124781267|NCT04154189|448829131|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
124781268|NCT04154189|448829130|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
124734010|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
124734011|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
124734012|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
124734013|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
124734014|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
124734015|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
124734016|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
124734017|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
124734018|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
124734019|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
124734020|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
124734021|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
124734022|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
124734023|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
124734024|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
124734025|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
124734026|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
124734027|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
124734028|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
124734029|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
124734030|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
124734031|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
124734032|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
124734033|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
124734034|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
124734035|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
124734036|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
124734037|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
124734038|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
124734039|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
124734040|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
124734041|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
124734042|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
124734043|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
124734044|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
124734045|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
124734046|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
124734047|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
124734048|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
124734049|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
124734050|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
124734051|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
124734052|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
124734053|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
124734054|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
124734055|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
124734056|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
124734057|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
124734058|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
124734059|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
124734060|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
124734061|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
124610782|NCT01081834|448194258|FG001|Extension Period: Week 26 to Week 52|Death|0|||
124610783|NCT01081834|448194259|FG002|Extension Period: Week 26 to Week 52|Death|0|||
124610784|NCT01081834|448194260|FG003|Extension Period: Week 26 to Week 52|Death|0|||
124610785|NCT01081834|448194261|FG004|Extension Period: Week 26 to Week 52|Death|0|||
124610786|NCT01081834|448194257|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
124610787|NCT01081834|448194258|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
124610788|NCT01081834|448194259|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
124610789|NCT01081834|448194260|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
124610790|NCT01081834|448194261|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
124610791|NCT01081834|448194257|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
124610792|NCT01081834|448194258|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
124610793|NCT01081834|448194259|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
124610794|NCT01081834|448194260|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
124610795|NCT01081834|448194261|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
124610796|NCT01081834|448194257|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
124610797|NCT01081834|448194258|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
124610798|NCT01081834|448194259|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
124610799|NCT01081834|448194260|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
124610800|NCT01081834|448194261|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
124610801|NCT01081834|448194257|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
124610802|NCT01081834|448194258|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
124610803|NCT01081834|448194259|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
124610804|NCT01081834|448194260|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
124610805|NCT01081834|448194261|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
124610806|NCT01081834|448194257|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
124610807|NCT01081834|448194258|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
124610808|NCT01081834|448194259|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
124610809|NCT01081834|448194260|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
124610810|NCT01081834|448194261|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
124610811|NCT01081834|448194257|FG000|Extension Period: Week 26 to Week 52|Other|4|||
124610812|NCT01081834|448194258|FG001|Extension Period: Week 26 to Week 52|Other|5|||
124610813|NCT01081834|448194259|FG002|Extension Period: Week 26 to Week 52|Other|4|||
124610814|NCT01081834|448194260|FG003|Extension Period: Week 26 to Week 52|Other|0|||
124610815|NCT01081834|448194261|FG004|Extension Period: Week 26 to Week 52|Other|0|||
124610816|NCT01081834|448194257|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
124610817|NCT01081834|448194258|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
124610818|NCT01081834|448194259|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
124610819|NCT01081834|448194260|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
124610820|NCT01081834|448194261|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
124610821|NCT01081834|448194257|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
124610822|NCT01081834|448194258|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
124610823|NCT01081834|448194259|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
124610824|NCT01081834|448194260|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
124610825|NCT01081834|448194261|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
124610826|NCT01085734|448194262|FG000|Overall Study|Adverse Event|0|||
124610827|NCT01085734|448194263|FG001|Overall Study|Adverse Event|2|||
124610828|NCT01085734|448194262|FG000|Overall Study|Death|1|||
124610829|NCT01085734|448194263|FG001|Overall Study|Death|0|||
124610830|NCT01085734|448194262|FG000|Overall Study|Lost to Follow-up|0|||
124610831|NCT01085734|448194263|FG001|Overall Study|Lost to Follow-up|1|||
124610832|NCT01085734|448194262|FG000|Overall Study|Withdrawal by Subject|0|||
124610833|NCT01085734|448194263|FG001|Overall Study|Withdrawal by Subject|1|||
124610834|NCT01739348|448194264|FG000|Part I (Base Study)|Adverse Event|41|||
124610835|NCT01739348|448194265|FG001|Part I (Base Study)|Adverse Event|52|||
124610836|NCT01739348|448194266|FG002|Part I (Base Study)|Adverse Event|8|||
124610837|NCT01739348|448194267|FG003|Part I (Base Study)|Adverse Event|33|||
124610838|NCT01739348|448194264|FG000|Part I (Base Study)|Death|10|||
124610839|NCT01739348|448194265|FG001|Part I (Base Study)|Death|7|||
124610840|NCT01739348|448194266|FG002|Part I (Base Study)|Death|2|||
124610841|NCT01739348|448194267|FG003|Part I (Base Study)|Death|8|||
124610842|NCT01739348|448194264|FG000|Part I (Base Study)|Lack of Efficacy|3|||
124734062|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
124734063|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
124734064|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
124734065|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
124734066|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
124734067|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
124734068|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
124734069|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
124734070|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
124734071|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
124734072|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
124734073|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
124734074|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
124734075|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
124734076|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
124734077|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
124734078|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
124734079|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
124734080|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
124734081|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
124734082|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
124734083|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
124734084|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
124734085|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
124734086|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
124734087|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
124734088|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
124734089|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
124734090|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
124734091|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
124734092|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
124734093|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
124734094|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
124734095|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
124734096|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
124734097|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
124734098|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
124734099|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
124734100|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
124734101|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|Other|5|||
124734102|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|Other|1|||
124734103|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|Other|0|||
124734104|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|Other|3|||
124734105|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|Other|0|||
124734106|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|Other|0|||
124734107|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|Other|0|||
124734108|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|Other|0|||
124734109|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|Other|0|||
124734110|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|Other|0|||
124734111|NCT03352557|448648936|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
124734112|NCT03352557|448648937|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
124734113|NCT03352557|448648938|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
124734114|NCT03352557|448648939|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
124734115|NCT03352557|448648940|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
124734116|NCT03352557|448648941|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
124734117|NCT03352557|448648942|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
124734118|NCT03352557|448648943|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
124734119|NCT03352557|448648944|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
124734120|NCT03352557|448648945|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
124734121|NCT03352557|448648936|FG000|LTE Period: Week 80 to Week 173|Death|0|||
124734122|NCT03352557|448648937|FG001|LTE Period: Week 80 to Week 173|Death|0|||
124734123|NCT03352557|448648938|FG002|LTE Period: Week 80 to Week 173|Death|0|||
124734124|NCT03352557|448648939|FG003|LTE Period: Week 80 to Week 173|Death|0|||
124734125|NCT03352557|448648940|FG004|LTE Period: Week 80 to Week 173|Death|0|||
124734126|NCT03352557|448648941|FG005|LTE Period: Week 80 to Week 173|Death|1|||
124734127|NCT03352557|448648942|FG006|LTE Period: Week 80 to Week 173|Death|0|||
124734128|NCT03352557|448648943|FG007|LTE Period: Week 80 to Week 173|Death|1|||
124734129|NCT03352557|448648944|FG008|LTE Period: Week 80 to Week 173|Death|1|||
124734130|NCT03352557|448648945|FG009|LTE Period: Week 80 to Week 173|Death|1|||
124734131|NCT03352557|448648936|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
124734132|NCT03352557|448648937|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
124734133|NCT03352557|448648938|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
124734134|NCT03352557|448648939|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
124781269|NCT04154189|448829131|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
124781270|NCT04154189|448829130|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
124610843|NCT01739348|448194265|FG001|Part I (Base Study)|Lack of Efficacy|8|||
124610844|NCT01739348|448194266|FG002|Part I (Base Study)|Lack of Efficacy|0|||
124610845|NCT01739348|448194267|FG003|Part I (Base Study)|Lack of Efficacy|7|||
124610846|NCT01739348|448194264|FG000|Part I (Base Study)|Lost to Follow-up|4|||
124610847|NCT01739348|448194265|FG001|Part I (Base Study)|Lost to Follow-up|2|||
124610848|NCT01739348|448194266|FG002|Part I (Base Study)|Lost to Follow-up|4|||
124610849|NCT01739348|448194267|FG003|Part I (Base Study)|Lost to Follow-up|4|||
124610850|NCT01739348|448194264|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
124610851|NCT01739348|448194265|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
124610852|NCT01739348|448194266|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
124610853|NCT01739348|448194267|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
124610854|NCT01739348|448194264|FG000|Part I (Base Study)|Physician Decision|10|||
124610855|NCT01739348|448194265|FG001|Part I (Base Study)|Physician Decision|7|||
124610856|NCT01739348|448194266|FG002|Part I (Base Study)|Physician Decision|1|||
124610857|NCT01739348|448194267|FG003|Part I (Base Study)|Physician Decision|4|||
124610858|NCT01739348|448194264|FG000|Part I (Base Study)|Protocol Violation|2|||
124610859|NCT01739348|448194265|FG001|Part I (Base Study)|Protocol Violation|0|||
124610860|NCT01739348|448194266|FG002|Part I (Base Study)|Protocol Violation|1|||
124610861|NCT01739348|448194267|FG003|Part I (Base Study)|Protocol Violation|2|||
124610862|NCT01739348|448194264|FG000|Part I (Base Study)|Screen Failure|2|||
124610863|NCT01739348|448194265|FG001|Part I (Base Study)|Screen Failure|0|||
124610864|NCT01739348|448194266|FG002|Part I (Base Study)|Screen Failure|0|||
124610865|NCT01739348|448194267|FG003|Part I (Base Study)|Screen Failure|0|||
124610866|NCT01739348|448194264|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
124610867|NCT01739348|448194265|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
124610868|NCT01739348|448194266|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
124610869|NCT01739348|448194267|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
124610870|NCT01739348|448194264|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
124610871|NCT01739348|448194265|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
124610872|NCT01739348|448194266|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
124610873|NCT01739348|448194267|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
124610874|NCT01739348|448194264|FG000|Part I (Base Study)|Participant Moved|4|||
124610875|NCT01739348|448194265|FG001|Part I (Base Study)|Participant Moved|3|||
124610876|NCT01739348|448194266|FG002|Part I (Base Study)|Participant Moved|1|||
124610877|NCT01739348|448194267|FG003|Part I (Base Study)|Participant Moved|7|||
124610878|NCT01739348|448194264|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
124610879|NCT01739348|448194265|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
124610880|NCT01739348|448194266|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
124610881|NCT01739348|448194267|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
124610882|NCT01739348|448194264|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
124610883|NCT01739348|448194265|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
124610884|NCT01739348|448194266|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
124610885|NCT01739348|448194267|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
124610886|NCT01739348|448194264|FG000|Part II (Extension Study)|Adverse Event|10|||
124610887|NCT01739348|448194265|FG001|Part II (Extension Study)|Adverse Event|11|||
124610888|NCT01739348|448194266|FG002|Part II (Extension Study)|Adverse Event|7|||
124610889|NCT01739348|448194267|FG003|Part II (Extension Study)|Adverse Event|26|||
124610890|NCT01739348|448194264|FG000|Part II (Extension Study)|Death|3|||
124610891|NCT01739348|448194265|FG001|Part II (Extension Study)|Death|3|||
124610892|NCT01739348|448194266|FG002|Part II (Extension Study)|Death|2|||
124610893|NCT01739348|448194267|FG003|Part II (Extension Study)|Death|6|||
124610894|NCT01739348|448194264|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
124610895|NCT01739348|448194265|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
124610896|NCT01739348|448194266|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
124610897|NCT01739348|448194267|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
124610898|NCT01739348|448194264|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
124610899|NCT01739348|448194265|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
124610900|NCT01739348|448194266|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
124610901|NCT01739348|448194267|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
124610902|NCT01739348|448194264|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
124610903|NCT01739348|448194265|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
124610904|NCT01739348|448194266|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
124610905|NCT01739348|448194267|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
124610906|NCT01739348|448194264|FG000|Part II (Extension Study)|Physician Decision|7|||
124610907|NCT01739348|448194265|FG001|Part II (Extension Study)|Physician Decision|11|||
124610908|NCT01739348|448194266|FG002|Part II (Extension Study)|Physician Decision|6|||
124610909|NCT01739348|448194267|FG003|Part II (Extension Study)|Physician Decision|12|||
124610910|NCT01739348|448194264|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
124610911|NCT01739348|448194265|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
124610912|NCT01739348|448194266|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
124734135|NCT03352557|448648940|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
124734136|NCT03352557|448648941|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
124734137|NCT03352557|448648942|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
124734138|NCT03352557|448648943|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
124734139|NCT03352557|448648944|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
124734140|NCT03352557|448648945|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
124734141|NCT03352557|448648936|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
124734142|NCT03352557|448648937|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
124734143|NCT03352557|448648938|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
124734144|NCT03352557|448648939|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
124734145|NCT03352557|448648940|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
124734146|NCT03352557|448648941|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
124734147|NCT03352557|448648942|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
124734148|NCT03352557|448648943|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
124734149|NCT03352557|448648944|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
124734150|NCT03352557|448648945|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
124734151|NCT03352557|448648936|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
124734152|NCT03352557|448648937|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
124734153|NCT03352557|448648938|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
124734154|NCT03352557|448648939|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
124734155|NCT03352557|448648940|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
124734156|NCT03352557|448648941|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
124734157|NCT03352557|448648942|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
124734158|NCT03352557|448648943|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
124734159|NCT03352557|448648944|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
124734160|NCT03352557|448648945|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
124734161|NCT03352557|448648936|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
124734162|NCT03352557|448648937|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
124734163|NCT03352557|448648938|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
124734164|NCT03352557|448648939|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
124734165|NCT03352557|448648940|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
124734166|NCT03352557|448648941|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
124734167|NCT03352557|448648942|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
124734168|NCT03352557|448648943|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
124734169|NCT03352557|448648944|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
124734170|NCT03352557|448648945|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
124734171|NCT03352557|448648936|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
124734172|NCT03352557|448648937|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
124734173|NCT03352557|448648938|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
124734174|NCT03352557|448648939|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
124734175|NCT03352557|448648940|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
124734176|NCT03352557|448648941|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
124734177|NCT03352557|448648942|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
124734178|NCT03352557|448648943|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
124734179|NCT03352557|448648944|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
124734180|NCT03352557|448648945|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
124734181|NCT03352557|448648936|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
124734182|NCT03352557|448648937|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
124734183|NCT03352557|448648938|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
124734184|NCT03352557|448648939|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
124734185|NCT03352557|448648940|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
124781271|NCT04154189|448829131|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
124781272|NCT04154189|448829130|FG000|Overall Study|Death|25|||
124781273|NCT04154189|448829131|FG001|Overall Study|Death|25|||
124781274|NCT02147561|448829134|FG000|Overall Study|Lost to Follow-up|3|||
124781275|NCT02147561|448829134|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
124781276|NCT01191762|448829135|FG000|Overall Study|Adverse Event|1|||
124781277|NCT01191762|448829136|FG001|Overall Study|Adverse Event|0|||
124781278|NCT02283762|448829139|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
124734186|NCT03352557|448648941|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
124734187|NCT03352557|448648942|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
124734188|NCT03352557|448648943|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
124734189|NCT03352557|448648944|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
124734190|NCT03352557|448648945|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
124734191|NCT03352557|448648936|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
124734192|NCT03352557|448648937|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
124734193|NCT03352557|448648938|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
124734194|NCT03352557|448648939|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
124734195|NCT03352557|448648940|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
124734196|NCT03352557|448648941|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
124734197|NCT03352557|448648942|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
124734198|NCT03352557|448648943|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
124734199|NCT03352557|448648944|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
124734200|NCT03352557|448648945|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
124734201|NCT03352557|448648936|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
124734202|NCT03352557|448648937|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
124734203|NCT03352557|448648938|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
124734204|NCT03352557|448648939|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
124734205|NCT03352557|448648940|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
124734206|NCT03352557|448648941|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
124734207|NCT03352557|448648942|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
124734208|NCT03352557|448648943|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
124734209|NCT03352557|448648944|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
124734210|NCT03352557|448648945|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
124734211|NCT03352557|448648936|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
124734212|NCT03352557|448648937|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
124734213|NCT03352557|448648938|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
124734214|NCT03352557|448648939|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
124734215|NCT03352557|448648940|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
124734216|NCT03352557|448648941|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
124734217|NCT03352557|448648942|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
124734218|NCT03352557|448648943|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
124734219|NCT03352557|448648944|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
124734220|NCT03352557|448648945|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
124734221|NCT03352557|448648936|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
124734222|NCT03352557|448648937|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
124734223|NCT03352557|448648938|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
124734224|NCT03352557|448648939|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
124734225|NCT03352557|448648940|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
124734226|NCT03352557|448648941|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
124734227|NCT03352557|448648942|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
124734228|NCT03352557|448648943|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
124734229|NCT03352557|448648944|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
124734230|NCT03352557|448648945|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
124734231|NCT03352557|448648936|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
124734232|NCT03352557|448648937|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
124734233|NCT03352557|448648938|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
124734234|NCT03352557|448648939|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
124734235|NCT03352557|448648940|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
124734236|NCT03352557|448648941|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
124734237|NCT03352557|448648942|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
124781279|NCT02283762|448829140|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
124781280|NCT02283762|448829139|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
124781281|NCT02283762|448829140|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
124610913|NCT01739348|448194267|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
124610914|NCT01739348|448194264|FG000|Part II (Extension Study)|Participant Moved|3|||
124610915|NCT01739348|448194265|FG001|Part II (Extension Study)|Participant Moved|3|||
124610916|NCT01739348|448194266|FG002|Part II (Extension Study)|Participant Moved|0|||
124610917|NCT01739348|448194267|FG003|Part II (Extension Study)|Participant Moved|3|||
124610918|NCT01739348|448194264|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
124610919|NCT01739348|448194265|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
124610920|NCT01739348|448194266|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
124610921|NCT01739348|448194267|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
124610922|NCT01739348|448194264|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
124610923|NCT01739348|448194265|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
124610924|NCT01739348|448194266|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
124610925|NCT01739348|448194267|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
124610926|NCT01447420|448194271|FG000|Overall Study|Adverse Event|2|||
124610927|NCT01447420|448194272|FG001|Overall Study|Adverse Event|4|||
124610928|NCT01447420|448194273|FG002|Overall Study|Adverse Event|2|||
124610929|NCT01447420|448194271|FG000|Overall Study|Protocol Violation|3|||
124610930|NCT01447420|448194272|FG001|Overall Study|Protocol Violation|3|||
124610931|NCT01447420|448194273|FG002|Overall Study|Protocol Violation|0|||
124610932|NCT01447420|448194271|FG000|Overall Study|Withdrawal by Subject|4|||
124610933|NCT01447420|448194272|FG001|Overall Study|Withdrawal by Subject|1|||
124610934|NCT01447420|448194273|FG002|Overall Study|Withdrawal by Subject|0|||
124610935|NCT01447420|448194271|FG000|Overall Study|Lack of Efficacy|1|||
124610936|NCT01447420|448194272|FG001|Overall Study|Lack of Efficacy|19|||
124610937|NCT01447420|448194273|FG002|Overall Study|Lack of Efficacy|8|||
124610938|NCT04562155|448194274|FG000|Overall Study|COVID-19 pandemic|0|||
124610939|NCT04562155|448194275|FG001|Overall Study|COVID-19 pandemic|0|||
124610940|NCT04562155|448194276|FG002|Overall Study|COVID-19 pandemic|0|||
124610941|NCT04562155|448194277|FG003|Overall Study|COVID-19 pandemic|1|||
124610942|NCT04562155|448194274|FG000|Overall Study|Adverse Event|7|||
124610943|NCT04562155|448194275|FG001|Overall Study|Adverse Event|3|||
124610944|NCT04562155|448194276|FG002|Overall Study|Adverse Event|8|||
124610945|NCT04562155|448194277|FG003|Overall Study|Adverse Event|1|||
124610946|NCT04562155|448194274|FG000|Overall Study|Withdrawal by Subject|3|||
124610947|NCT04562155|448194275|FG001|Overall Study|Withdrawal by Subject|6|||
124610948|NCT04562155|448194276|FG002|Overall Study|Withdrawal by Subject|3|||
124610949|NCT04562155|448194277|FG003|Overall Study|Withdrawal by Subject|3|||
124610950|NCT04562155|448194274|FG000|Overall Study|Participant personal reason|1|||
124610951|NCT04562155|448194275|FG001|Overall Study|Participant personal reason|0|||
124610952|NCT04562155|448194276|FG002|Overall Study|Participant personal reason|2|||
124610953|NCT04562155|448194277|FG003|Overall Study|Participant personal reason|1|||
124610954|NCT01475097|448194282|FG000|Overall Study|Protocol Violation|1|||
124610955|NCT01475097|448194283|FG001|Overall Study|Protocol Violation|1|||
124610956|NCT01085201|448194294|FG000|Overall Study|Scheduling conflict|1|||
124610957|NCT01085201|448194295|FG001|Overall Study|Scheduling conflict|0|||
124610958|NCT01085201|448194296|FG002|Overall Study|Scheduling conflict|1|||
124610959|NCT01085201|448194297|FG003|Overall Study|Scheduling conflict|0|||
124610960|NCT01085201|448194298|FG004|Overall Study|Scheduling conflict|0|||
124610961|NCT01085201|448194294|FG000|Overall Study|Unknown- no study drug|2|||
124610962|NCT01085201|448194295|FG001|Overall Study|Unknown- no study drug|0|||
124610963|NCT01085201|448194296|FG002|Overall Study|Unknown- no study drug|0|||
124610964|NCT01085201|448194297|FG003|Overall Study|Unknown- no study drug|0|||
124610965|NCT01085201|448194298|FG004|Overall Study|Unknown- no study drug|0|||
124610966|NCT01085201|448194294|FG000|Overall Study|Fond ineligible after consent|0|||
124610967|NCT01085201|448194295|FG001|Overall Study|Fond ineligible after consent|1|||
124610968|NCT01085201|448194296|FG002|Overall Study|Fond ineligible after consent|1|||
124610969|NCT01085201|448194297|FG003|Overall Study|Fond ineligible after consent|0|||
124610970|NCT01085201|448194298|FG004|Overall Study|Fond ineligible after consent|0|||
124734238|NCT03352557|448648943|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
124610971|NCT00867503|448194303|FG000|Overall Study|Withdrawal by Subject|1|||
124610972|NCT01001988|448194304|FG000|Overall Study|Protocol Violation|84|||
124610973|NCT01001988|448194304|FG000|Overall Study|Withdrawal by Subject|18|||
124610974|NCT01001988|448194304|FG000|Overall Study|Lost to Follow-up|15|||
124610975|NCT01442688|448194307|FG000|First Intervention|Withdrawal by Subject|1|||
124610976|NCT01442688|448194308|FG001|First Intervention|Withdrawal by Subject|0|||
124610977|NCT01442688|448194307|FG000|First Intervention|subject incarcerated|1|||
124610978|NCT01442688|448194308|FG001|First Intervention|subject incarcerated|0|||
124610979|NCT01442688|448194307|FG000|Second Intervention|Adverse Event|1|||
124610980|NCT01442688|448194308|FG001|Second Intervention|Adverse Event|0|||
124734239|NCT03352557|448648944|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
124610981|NCT00927394|448194309|FG000|Overall Study|Adverse Event|14|||
124610982|NCT00927394|448194310|FG001|Overall Study|Adverse Event|9|||
124610983|NCT00927394|448194309|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
124610984|NCT00927394|448194310|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
124610985|NCT00927394|448194309|FG000|Overall Study|Withdrawal by Subject|20|||
124610986|NCT00927394|448194310|FG001|Overall Study|Withdrawal by Subject|24|||
124610987|NCT00927394|448194309|FG000|Overall Study|Lost to Follow-up|8|||
124610988|NCT00927394|448194310|FG001|Overall Study|Lost to Follow-up|14|||
124610989|NCT00927394|448194309|FG000|Overall Study|Administrative Problem|1|||
124610990|NCT00927394|448194310|FG001|Overall Study|Administrative Problem|0|||
124610991|NCT00927394|448194309|FG000|Overall Study|Death|1|||
124610992|NCT00927394|448194310|FG001|Overall Study|Death|1|||
124610993|NCT00927394|448194309|FG000|Overall Study|Protocol deviation|16|||
124610994|NCT00927394|448194310|FG001|Overall Study|Protocol deviation|13|||
124610995|NCT00927394|448194309|FG000|Overall Study|Randomized in error|0|||
124610996|NCT00927394|448194310|FG001|Overall Study|Randomized in error|1|||
124610997|NCT01221363|448194311|FG000|Overall Study|Pregnancy|1|||
124610998|NCT01221363|448194312|FG001|Overall Study|Pregnancy|0|||
124610999|NCT01221363|448194311|FG000|Overall Study|Withdrawal by Subject|11|||
124611000|NCT01221363|448194312|FG001|Overall Study|Withdrawal by Subject|5|||
124611001|NCT02865460|448194313|FG000|Overall Study|Adverse Event|1|||
124611002|NCT02865460|448194314|FG001|Overall Study|Adverse Event|0|||
124611003|NCT02865460|448194313|FG000|Overall Study|Withdrawal by Subject|1|||
124611004|NCT02865460|448194314|FG001|Overall Study|Withdrawal by Subject|1|||
124611005|NCT02865460|448194313|FG000|Overall Study|Lost to Follow-up|7|||
124611006|NCT02865460|448194314|FG001|Overall Study|Lost to Follow-up|4|||
124611007|NCT02865460|448194313|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
124611008|NCT02865460|448194314|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
124611009|NCT02238795|448194315|FG000|Overall Study|Patient without purpura fulminans|1|||
124611010|NCT04480710|448194318|FG000|Overall Study|Adverse Event|0|||
124611011|NCT04480710|448194319|FG001|Overall Study|Adverse Event|2|||
124611012|NCT04480710|448194320|FG002|Overall Study|Adverse Event|0|||
124611013|NCT04480710|448194321|FG003|Overall Study|Adverse Event|0|||
124611014|NCT04480710|448194318|FG000|Overall Study|Withdrawal by Subject|0|||
124611015|NCT04480710|448194319|FG001|Overall Study|Withdrawal by Subject|1|||
124611016|NCT04480710|448194320|FG002|Overall Study|Withdrawal by Subject|0|||
124611017|NCT04480710|448194321|FG003|Overall Study|Withdrawal by Subject|0|||
124611018|NCT04480710|448194318|FG000|Overall Study|Physician Decision|0|||
124611019|NCT04480710|448194319|FG001|Overall Study|Physician Decision|0|||
124611020|NCT04480710|448194320|FG002|Overall Study|Physician Decision|1|||
124611021|NCT04480710|448194321|FG003|Overall Study|Physician Decision|0|||
124611022|NCT04480021|448194322|FG000|Overall Study|Lost to Follow-up|3|||
124611023|NCT04480021|448194323|FG001|Overall Study|Lost to Follow-up|4|||
124611024|NCT03384654|448194327|FG000|Overall Study|Withdrawal by Subject|0|||
124611025|NCT03384654|448194328|FG001|Overall Study|Withdrawal by Subject|0|||
124611026|NCT03384654|448194329|FG002|Overall Study|Withdrawal by Subject|1|||
124611027|NCT03384654|448194330|FG003|Overall Study|Withdrawal by Subject|0|||
124611028|NCT00423319|448194331|FG000|Overall Study|Death|2|||
124611029|NCT00423319|448194332|FG001|Overall Study|Death|0|||
124611030|NCT00423319|448194331|FG000|Overall Study|Adverse Event|93|||
124611031|NCT00423319|448194332|FG001|Overall Study|Adverse Event|112|||
124611032|NCT00423319|448194331|FG000|Overall Study|Withdrawal by Subject|86|||
124611033|NCT00423319|448194332|FG001|Overall Study|Withdrawal by Subject|99|||
124611034|NCT00423319|448194331|FG000|Overall Study|Lost to Follow-up|4|||
124611035|NCT00423319|448194332|FG001|Overall Study|Lost to Follow-up|3|||
124611036|NCT00423319|448194331|FG000|Overall Study|Poor compliance or noncompliance|1|||
124611037|NCT00423319|448194332|FG001|Overall Study|Poor compliance or noncompliance|1|||
124611038|NCT00423319|448194331|FG000|Overall Study|No longer meets study criteria|15|||
124611039|NCT00423319|448194332|FG001|Overall Study|No longer meets study criteria|15|||
124611040|NCT00423319|448194331|FG000|Overall Study|Other|23|||
124611041|NCT00423319|448194332|FG001|Overall Study|Other|22|||
124611042|NCT01584843|448194333|FG000|First Treatment Period|Adverse Event|0|||
124611043|NCT01584843|448194334|FG001|First Treatment Period|Adverse Event|0|||
124611044|NCT01584843|448194335|FG002|First Treatment Period|Adverse Event|1|||
124611045|NCT01584843|448194336|FG003|First Treatment Period|Adverse Event|0|||
124611046|NCT01584843|448194337|FG004|First Treatment Period|Adverse Event|0|||
124611047|NCT01584843|448194338|FG005|First Treatment Period|Adverse Event|0|||
124611048|NCT01584843|448194333|FG000|First Treatment Period|Protocol Violation|0|||
124611049|NCT01584843|448194334|FG001|First Treatment Period|Protocol Violation|0|||
124611050|NCT01584843|448194335|FG002|First Treatment Period|Protocol Violation|0|||
124611051|NCT01584843|448194336|FG003|First Treatment Period|Protocol Violation|0|||
124611052|NCT01584843|448194337|FG004|First Treatment Period|Protocol Violation|0|||
124611053|NCT01584843|448194338|FG005|First Treatment Period|Protocol Violation|1|||
124611054|NCT01584843|448194333|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
124611055|NCT01584843|448194334|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
124611056|NCT01584843|448194335|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
124611057|NCT01584843|448194336|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
124611058|NCT01584843|448194337|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
124611059|NCT01584843|448194338|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
124611060|NCT01584843|448194333|FG000|Second Treatment Period|Withdrawal by Subject|0|||
124637728|NCT00684411|448292409|FG000|Overall Study|Adverse Event|1|||
124611061|NCT01584843|448194334|FG001|Second Treatment Period|Withdrawal by Subject|0|||
124611062|NCT01584843|448194335|FG002|Second Treatment Period|Withdrawal by Subject|0|||
124611063|NCT01584843|448194336|FG003|Second Treatment Period|Withdrawal by Subject|0|||
124611064|NCT01584843|448194337|FG004|Second Treatment Period|Withdrawal by Subject|0|||
124611065|NCT01584843|448194338|FG005|Second Treatment Period|Withdrawal by Subject|1|||
124611066|NCT00311402|448194339|FG000|Overall Study|Adverse Event|118|||
124611067|NCT00311402|448194340|FG001|Overall Study|Adverse Event|105|||
124611068|NCT00311402|448194339|FG000|Overall Study|Lost to Follow-up|0|||
124611069|NCT00311402|448194340|FG001|Overall Study|Lost to Follow-up|3|||
124611070|NCT00311402|448194339|FG000|Overall Study|Withdrawal by Subject|17|||
124611071|NCT00311402|448194340|FG001|Overall Study|Withdrawal by Subject|18|||
124611072|NCT00311402|448194339|FG000|Overall Study|Lack of Efficacy|58|||
124611073|NCT00311402|448194340|FG001|Overall Study|Lack of Efficacy|42|||
124611074|NCT00311402|448194339|FG000|Overall Study|Protocol Violation|7|||
124611075|NCT00311402|448194340|FG001|Overall Study|Protocol Violation|6|||
124611076|NCT00311402|448194339|FG000|Overall Study|IRB's rejection etc.|10|||
124611077|NCT00311402|448194340|FG001|Overall Study|IRB's rejection etc.|3|||
124611078|NCT02640053|448194341|FG000|Overall Study|Withdrawal by Subject|2|||
124611079|NCT02640053|448194342|FG001|Overall Study|Withdrawal by Subject|1|||
124611080|NCT02640053|448194341|FG000|Overall Study|Adverse Event|1|||
124611081|NCT02640053|448194342|FG001|Overall Study|Adverse Event|1|||
124611082|NCT02640053|448194341|FG000|Overall Study|Alternative Therapy|1|||
124611083|NCT02640053|448194342|FG001|Overall Study|Alternative Therapy|1|||
124611084|NCT02640053|448194341|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
124611085|NCT02640053|448194342|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
124611086|NCT03283761|448194343|FG000|Study Treatment|Patient Non-Compliance|1|||
124611087|NCT03283761|448194343|FG000|Study Treatment|Alternative Cancer Therapy|7|||
124611088|NCT03283761|448194343|FG000|Study Treatment|Disease progression|21|||
124611089|NCT03283761|448194343|FG000|Study Treatment|Adverse Event|3|||
124611090|NCT03283761|448194343|FG000|Study Treatment|Withdrawal by Subject|4|||
124611091|NCT03283761|448194343|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
124611092|NCT03283761|448194343|FG000|Study Treatment|Symptomatic Deterioration|1|||
124611093|NCT03283761|448194343|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
124611094|NCT03283761|448194343|FG000|Follow up|Lost to Follow-up|1|||
124611095|NCT03283761|448194343|FG000|Follow up|Symptomatic Deterioration|1|||
124611096|NCT03283761|448194343|FG000|Follow up|Death|29|||
124611097|NCT03283761|448194343|FG000|Follow up|study terminated|4|||
124611098|NCT03283761|448194343|FG000|Follow up|Primary Investigator Withdrawal|1|||
124611099|NCT03283761|448194343|FG000|Follow up|Switched to alternative therapy|1|||
124611100|NCT03283761|448194343|FG000|Follow up|Subject is now in Hospice|1|||
124611101|NCT02036775|448194344|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
124611102|NCT02036775|448194345|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
124611103|NCT02036775|448194346|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
124611104|NCT02036775|448194347|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
124611105|NCT02036775|448194348|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
124611106|NCT02036775|448194349|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
124611107|NCT00678886|448194350|FG000|Overall Study|Withdrawal by Subject|0|||
124611108|NCT00678886|448194351|FG001|Overall Study|Withdrawal by Subject|0|||
124611109|NCT00678886|448194352|FG002|Overall Study|Withdrawal by Subject|4|||
124611110|NCT00678886|448194353|FG003|Overall Study|Withdrawal by Subject|6|||
124611111|NCT00678886|448194350|FG000|Overall Study|Physician Decision|0|||
124611112|NCT00678886|448194351|FG001|Overall Study|Physician Decision|0|||
124611113|NCT00678886|448194352|FG002|Overall Study|Physician Decision|1|||
124611114|NCT00678886|448194353|FG003|Overall Study|Physician Decision|1|||
124611115|NCT00678886|448194350|FG000|Overall Study|Lost to Follow-up|0|||
124611116|NCT00678886|448194351|FG001|Overall Study|Lost to Follow-up|0|||
124611117|NCT00678886|448194352|FG002|Overall Study|Lost to Follow-up|3|||
124611118|NCT00678886|448194353|FG003|Overall Study|Lost to Follow-up|2|||
124611119|NCT00678886|448194350|FG000|Overall Study|Other|0|||
124611120|NCT00678886|448194351|FG001|Overall Study|Other|0|||
124611121|NCT00678886|448194352|FG002|Overall Study|Other|1|||
124611122|NCT00678886|448194353|FG003|Overall Study|Other|0|||
124611123|NCT00206323|448194354|FG000|Overall Study|Lack of Efficacy|4|||
124611124|NCT00206323|448194355|FG001|Overall Study|Lack of Efficacy|1|||
124611125|NCT00206323|448194354|FG000|Overall Study|Adverse Event|1|||
124611126|NCT00206323|448194355|FG001|Overall Study|Adverse Event|1|||
124611127|NCT00206323|448194354|FG000|Overall Study|Lost to Follow-up|1|||
124611128|NCT00206323|448194355|FG001|Overall Study|Lost to Follow-up|1|||
124611129|NCT02329847|448194356|FG000|Overall Study|Death|4|||
124611130|NCT02329847|448194357|FG001|Overall Study|Death|4|||
124611131|NCT02329847|448194358|FG002|Overall Study|Death|22|||
124611132|NCT02329847|448194359|FG003|Overall Study|Death|12|||
124611133|NCT02329847|448194360|FG004|Overall Study|Death|20|||
124611134|NCT02329847|448194361|FG005|Overall Study|Death|13|||
124611135|NCT02329847|448194356|FG000|Overall Study|Lost to Follow-up|0|||
124611136|NCT02329847|448194357|FG001|Overall Study|Lost to Follow-up|0|||
124611137|NCT02329847|448194358|FG002|Overall Study|Lost to Follow-up|2|||
124734240|NCT03352557|448648945|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
124734241|NCT03352557|448648936|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
124734242|NCT03352557|448648937|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
124734243|NCT03352557|448648938|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
124734244|NCT03352557|448648939|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
124734245|NCT03352557|448648940|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
124734246|NCT03352557|448648941|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
124734247|NCT03352557|448648942|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
124734248|NCT03352557|448648943|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
124734249|NCT03352557|448648944|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
124734250|NCT03352557|448648945|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
124734251|NCT03352557|448648936|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
124734252|NCT03352557|448648937|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
124734253|NCT03352557|448648938|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
124734254|NCT03352557|448648939|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
124734255|NCT03352557|448648940|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
124734256|NCT03352557|448648941|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
124734257|NCT03352557|448648942|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
124734258|NCT03352557|448648943|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
124734259|NCT03352557|448648944|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
124734260|NCT03352557|448648945|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
124734261|NCT03352557|448648936|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
124734262|NCT03352557|448648937|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
124734263|NCT03352557|448648938|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
124734264|NCT03352557|448648939|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
124734265|NCT03352557|448648940|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
124734266|NCT03352557|448648941|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
124734267|NCT03352557|448648942|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
124734268|NCT03352557|448648943|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
124734269|NCT03352557|448648944|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
124734270|NCT03352557|448648945|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
124734271|NCT03352557|448648936|FG000|LTE Period: Week 80 to Week 173|Other|0|||
124734272|NCT03352557|448648937|FG001|LTE Period: Week 80 to Week 173|Other|0|||
124734273|NCT03352557|448648938|FG002|LTE Period: Week 80 to Week 173|Other|0|||
124734274|NCT03352557|448648939|FG003|LTE Period: Week 80 to Week 173|Other|0|||
124734275|NCT03352557|448648940|FG004|LTE Period: Week 80 to Week 173|Other|0|||
124734276|NCT03352557|448648941|FG005|LTE Period: Week 80 to Week 173|Other|0|||
124734277|NCT03352557|448648942|FG006|LTE Period: Week 80 to Week 173|Other|0|||
124734278|NCT03352557|448648943|FG007|LTE Period: Week 80 to Week 173|Other|1|||
124734279|NCT03352557|448648944|FG008|LTE Period: Week 80 to Week 173|Other|0|||
124734280|NCT03352557|448648945|FG009|LTE Period: Week 80 to Week 173|Other|0|||
124734281|NCT00907803|448648946|FG000|Overall Study|Withdrawal of consent - long commute|1|||
124734282|NCT00907803|448648947|FG001|Overall Study|Withdrawal of consent - long commute|0|||
124734283|NCT00907803|448648948|FG002|Overall Study|Withdrawal of consent - long commute|0|||
124734284|NCT00907803|448648946|FG000|Overall Study|Adverse Event|2|||
124734285|NCT00907803|448648947|FG001|Overall Study|Adverse Event|0|||
124734286|NCT00907803|448648948|FG002|Overall Study|Adverse Event|0|||
124734287|NCT00907803|448648946|FG000|Overall Study|Withdrawal by Subject|0|||
124734288|NCT00907803|448648947|FG001|Overall Study|Withdrawal by Subject|1|||
124734289|NCT00907803|448648948|FG002|Overall Study|Withdrawal by Subject|0|||
124734290|NCT00907803|448648946|FG000|Overall Study|Lost to Follow-up|0|||
124734291|NCT00907803|448648947|FG001|Overall Study|Lost to Follow-up|1|||
124734292|NCT00907803|448648948|FG002|Overall Study|Lost to Follow-up|0|||
124734293|NCT00907803|448648946|FG000|Overall Study|Protocol Violation|0|||
124734294|NCT00907803|448648947|FG001|Overall Study|Protocol Violation|1|||
124734295|NCT00907803|448648948|FG002|Overall Study|Protocol Violation|0|||
124734296|NCT03510468|448648949|FG000|Overall Study|Lost to Follow-up|1|||
124734297|NCT03510468|448648949|FG000|Overall Study|Adverse Event|5|||
124734298|NCT03510468|448648949|FG000|Overall Study|Physician Decision|1|||
124734299|NCT03510468|448648949|FG000|Overall Study|non-compliant with treatment|2|||
124734300|NCT03510468|448648949|FG000|Overall Study|Missed visit|1|||
124734301|NCT04612842|448648950|FG000|Overall Study|Lost to Follow-up|20|||
124734302|NCT04612842|448648951|FG001|Overall Study|Lost to Follow-up|11|||
124734303|NCT04612842|448648950|FG000|Overall Study|Withdrawal by Subject|26|||
124734304|NCT04612842|448648951|FG001|Overall Study|Withdrawal by Subject|15|||
124734305|NCT04612842|448648950|FG000|Overall Study|Death|2|||
124734306|NCT04612842|448648951|FG001|Overall Study|Death|2|||
124734307|NCT02419131|448648952|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
124734308|NCT02419131|448648953|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
124734309|NCT02419131|448648954|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
124734310|NCT02419131|448648952|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
124611138|NCT02329847|448194359|FG003|Overall Study|Lost to Follow-up|3|||
124611139|NCT02329847|448194360|FG004|Overall Study|Lost to Follow-up|0|||
124611140|NCT02329847|448194361|FG005|Overall Study|Lost to Follow-up|1|||
124611141|NCT02329847|448194356|FG000|Overall Study|Physician Decision|0|||
124611142|NCT02329847|448194357|FG001|Overall Study|Physician Decision|0|||
124611143|NCT02329847|448194358|FG002|Overall Study|Physician Decision|0|||
124611144|NCT02329847|448194359|FG003|Overall Study|Physician Decision|0|||
124611145|NCT02329847|448194360|FG004|Overall Study|Physician Decision|1|||
124611146|NCT02329847|448194361|FG005|Overall Study|Physician Decision|0|||
124611147|NCT02329847|448194356|FG000|Overall Study|Withdrawal by Subject|2|||
124611148|NCT02329847|448194357|FG001|Overall Study|Withdrawal by Subject|1|||
124611149|NCT02329847|448194358|FG002|Overall Study|Withdrawal by Subject|5|||
124611150|NCT02329847|448194359|FG003|Overall Study|Withdrawal by Subject|7|||
124611151|NCT02329847|448194360|FG004|Overall Study|Withdrawal by Subject|8|||
124611152|NCT02329847|448194361|FG005|Overall Study|Withdrawal by Subject|3|||
124611153|NCT02329847|448194356|FG000|Overall Study|Other|1|||
124611154|NCT02329847|448194357|FG001|Overall Study|Other|2|||
124611155|NCT02329847|448194358|FG002|Overall Study|Other|6|||
124611156|NCT02329847|448194359|FG003|Overall Study|Other|13|||
124611157|NCT02329847|448194360|FG004|Overall Study|Other|10|||
124611158|NCT02329847|448194361|FG005|Overall Study|Other|3|||
124611159|NCT04669691|448194368|FG000|Overall Study|Death|0|||
124611160|NCT04669691|448194369|FG001|Overall Study|Death|1|||
124611161|NCT04669691|448194370|FG002|Overall Study|Death|0|||
124611162|NCT04669691|448194371|FG003|Overall Study|Death|0|||
124611163|NCT04669691|448194372|FG004|Overall Study|Death|0|||
124611164|NCT04669691|448194373|FG005|Overall Study|Death|0|||
124611165|NCT02288182|448194376|FG000|Overall Study|Adverse Event|0|||
124611166|NCT02288182|448194377|FG001|Overall Study|Adverse Event|1|||
124611167|NCT02288182|448194376|FG000|Overall Study|Lost to Follow-up|0|||
124611168|NCT02288182|448194377|FG001|Overall Study|Lost to Follow-up|1|||
124611169|NCT00620659|448194379|FG000|Treatment Period 1|Adverse Event|1|||
124611170|NCT00620659|448194380|FG001|Treatment Period 1|Adverse Event|0|||
124611171|NCT00620659|448194381|FG002|Treatment Period 1|Adverse Event|0|||
124611172|NCT00620659|448194382|FG003|Treatment Period 1|Adverse Event|3|||
124611173|NCT00620659|448194383|FG004|Treatment Period 1|Adverse Event|0|||
124611174|NCT00620659|448194384|FG005|Treatment Period 1|Adverse Event|0|||
124611175|NCT00620659|448194379|FG000|Treatment Period 1|Protocol Violation|1|||
124611176|NCT00620659|448194380|FG001|Treatment Period 1|Protocol Violation|0|||
124611177|NCT00620659|448194381|FG002|Treatment Period 1|Protocol Violation|0|||
124611178|NCT00620659|448194382|FG003|Treatment Period 1|Protocol Violation|0|||
124611179|NCT00620659|448194383|FG004|Treatment Period 1|Protocol Violation|0|||
124611180|NCT00620659|448194384|FG005|Treatment Period 1|Protocol Violation|0|||
124611181|NCT00620659|448194379|FG000|Treatment Period 1|Withdrawal by Subject|1|||
124611182|NCT00620659|448194380|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124611183|NCT00620659|448194381|FG002|Treatment Period 1|Withdrawal by Subject|1|||
124611184|NCT00620659|448194382|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124611185|NCT00620659|448194383|FG004|Treatment Period 1|Withdrawal by Subject|1|||
124611186|NCT00620659|448194384|FG005|Treatment Period 1|Withdrawal by Subject|0|||
124611187|NCT00620659|448194379|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
124611188|NCT00620659|448194380|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
124611189|NCT00620659|448194381|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
124611190|NCT00620659|448194382|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
124611191|NCT00620659|448194383|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
124611192|NCT00620659|448194384|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
124611193|NCT00620659|448194379|FG000|Treatment Period 2|Adverse Event|0|||
124611194|NCT00620659|448194380|FG001|Treatment Period 2|Adverse Event|3|||
124611195|NCT00620659|448194381|FG002|Treatment Period 2|Adverse Event|0|||
124611196|NCT00620659|448194382|FG003|Treatment Period 2|Adverse Event|0|||
124611197|NCT00620659|448194383|FG004|Treatment Period 2|Adverse Event|2|||
124611198|NCT00620659|448194384|FG005|Treatment Period 2|Adverse Event|0|||
124611199|NCT00620659|448194379|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124611200|NCT00620659|448194380|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124611201|NCT00620659|448194381|FG002|Treatment Period 2|Withdrawal by Subject|1|||
124611202|NCT00620659|448194382|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124611203|NCT00620659|448194383|FG004|Treatment Period 2|Withdrawal by Subject|3|||
124611204|NCT00620659|448194384|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124611205|NCT00620659|448194379|FG000|Placebo Washout Period 2|Adverse Event|2|||
124611206|NCT00620659|448194380|FG001|Placebo Washout Period 2|Adverse Event|0|||
124611207|NCT00620659|448194381|FG002|Placebo Washout Period 2|Adverse Event|0|||
124611208|NCT00620659|448194382|FG003|Placebo Washout Period 2|Adverse Event|0|||
124611209|NCT00620659|448194383|FG004|Placebo Washout Period 2|Adverse Event|0|||
124611210|NCT00620659|448194384|FG005|Placebo Washout Period 2|Adverse Event|0|||
124611211|NCT00620659|448194379|FG000|Treatment Period 3|Adverse Event|0|||
124611212|NCT00620659|448194380|FG001|Treatment Period 3|Adverse Event|2|||
124611213|NCT00620659|448194381|FG002|Treatment Period 3|Adverse Event|0|||
124611214|NCT00620659|448194382|FG003|Treatment Period 3|Adverse Event|0|||
124611215|NCT00620659|448194383|FG004|Treatment Period 3|Adverse Event|0|||
124611216|NCT00620659|448194384|FG005|Treatment Period 3|Adverse Event|0|||
124734311|NCT02419131|448648953|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
124734312|NCT02419131|448648954|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
124734313|NCT05426031|448648955|FG000|Overall Study|Circulatory Arrest|3|||
124734314|NCT05426031|448648956|FG001|Overall Study|Circulatory Arrest|2|||
124734315|NCT04677660|448648957|FG000|Overall Study|Lost to Follow-up|0|||
124734316|NCT04677660|448648958|FG001|Overall Study|Lost to Follow-up|2|||
124734317|NCT04677660|448648957|FG000|Overall Study|Withdrawal by Subject|0|||
124734318|NCT04677660|448648958|FG001|Overall Study|Withdrawal by Subject|1|||
124734319|NCT04677660|448648957|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
124734320|NCT04677660|448648958|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
124734321|NCT00089986|448648959|FG000|Overall Study|Adverse Event|6|||
124734322|NCT00089986|448648960|FG001|Overall Study|Adverse Event|9|||
124734323|NCT00089986|448648961|FG002|Overall Study|Adverse Event|6|||
124734324|NCT00089986|448648959|FG000|Overall Study|Lost to Follow-up|3|||
124734325|NCT00089986|448648960|FG001|Overall Study|Lost to Follow-up|1|||
124734326|NCT00089986|448648961|FG002|Overall Study|Lost to Follow-up|1|||
124734327|NCT00089986|448648959|FG000|Overall Study|Protocol Violation|0|||
124734328|NCT00089986|448648960|FG001|Overall Study|Protocol Violation|1|||
124734329|NCT00089986|448648961|FG002|Overall Study|Protocol Violation|0|||
124734330|NCT00089986|448648959|FG000|Overall Study|Patient transferred to another hospital|2|||
124734331|NCT00089986|448648960|FG001|Overall Study|Patient transferred to another hospital|1|||
124734332|NCT00089986|448648961|FG002|Overall Study|Patient transferred to another hospital|0|||
124734333|NCT00089986|448648959|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
124734334|NCT00089986|448648960|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
124734335|NCT00089986|448648961|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
124734336|NCT00089986|448648959|FG000|Overall Study|Hemohlobin stopping rule|0|||
124734337|NCT00089986|448648960|FG001|Overall Study|Hemohlobin stopping rule|1|||
124734338|NCT00089986|448648961|FG002|Overall Study|Hemohlobin stopping rule|0|||
124734339|NCT00089986|448648959|FG000|Overall Study|Investigator decision to withdrew|0|||
124734340|NCT00089986|448648960|FG001|Overall Study|Investigator decision to withdrew|1|||
124734341|NCT00089986|448648961|FG002|Overall Study|Investigator decision to withdrew|0|||
124734342|NCT00089986|448648959|FG000|Overall Study|Enrollment in another study|0|||
124734343|NCT00089986|448648960|FG001|Overall Study|Enrollment in another study|1|||
124734344|NCT00089986|448648961|FG002|Overall Study|Enrollment in another study|0|||
124734345|NCT00089986|448648959|FG000|Overall Study|Family decision|0|||
124734346|NCT00089986|448648960|FG001|Overall Study|Family decision|1|||
124734347|NCT00089986|448648961|FG002|Overall Study|Family decision|0|||
124611217|NCT00620659|448194379|FG000|Treatment Period 3|Withdrawal by Subject|0|||
124611218|NCT00620659|448194380|FG001|Treatment Period 3|Withdrawal by Subject|0|||
124611219|NCT00620659|448194381|FG002|Treatment Period 3|Withdrawal by Subject|0|||
124611220|NCT00620659|448194382|FG003|Treatment Period 3|Withdrawal by Subject|1|||
124611221|NCT00620659|448194383|FG004|Treatment Period 3|Withdrawal by Subject|0|||
124611222|NCT00620659|448194384|FG005|Treatment Period 3|Withdrawal by Subject|0|||
124611223|NCT01214915|448194386|FG000|Overall Study|Adverse Event|8|||
124611224|NCT01214915|448194386|FG000|Overall Study|Lack of Efficacy|3|||
124611225|NCT02056392|448194387|FG000|Overall Study|Lost to Follow-up|0|||
124611226|NCT02056392|448194388|FG001|Overall Study|Lost to Follow-up|1|||
124611227|NCT02056392|448194389|FG002|Overall Study|Lost to Follow-up|2|||
124611228|NCT02056392|448194390|FG003|Overall Study|Lost to Follow-up|0|||
124611229|NCT02056392|448194391|FG004|Overall Study|Lost to Follow-up|0|||
124611230|NCT02056392|448194392|FG005|Overall Study|Lost to Follow-up|0|||
124611231|NCT02056392|448194387|FG000|Overall Study|Protocol Violation|1|||
124611232|NCT02056392|448194388|FG001|Overall Study|Protocol Violation|0|||
124611233|NCT02056392|448194389|FG002|Overall Study|Protocol Violation|1|||
124611234|NCT02056392|448194390|FG003|Overall Study|Protocol Violation|0|||
124611235|NCT02056392|448194391|FG004|Overall Study|Protocol Violation|0|||
124611236|NCT02056392|448194392|FG005|Overall Study|Protocol Violation|0|||
124611237|NCT02056392|448194387|FG000|Overall Study|Withdrawal by Subject|1|||
124611238|NCT02056392|448194388|FG001|Overall Study|Withdrawal by Subject|0|||
124611239|NCT02056392|448194389|FG002|Overall Study|Withdrawal by Subject|0|||
124611240|NCT02056392|448194390|FG003|Overall Study|Withdrawal by Subject|0|||
124611241|NCT02056392|448194391|FG004|Overall Study|Withdrawal by Subject|1|||
124611242|NCT02056392|448194392|FG005|Overall Study|Withdrawal by Subject|0|||
124611243|NCT04555720|448194395|FG000|Overall Study|Lost to Follow-up|2|||
124611244|NCT04555720|448194396|FG001|Overall Study|Lost to Follow-up|0|||
124611245|NCT04555720|448194397|FG002|Overall Study|Lost to Follow-up|0|||
124611246|NCT04555720|448194398|FG003|Overall Study|Lost to Follow-up|0|||
124611247|NCT04555720|448194395|FG000|Overall Study|Withdrawal by Subject|4|||
124611248|NCT04555720|448194396|FG001|Overall Study|Withdrawal by Subject|6|||
124734348|NCT00089986|448648959|FG000|Overall Study|Do not resuscitate (DNR)|0|||
124734349|NCT00089986|448648960|FG001|Overall Study|Do not resuscitate (DNR)|0|||
124734350|NCT00089986|448648961|FG002|Overall Study|Do not resuscitate (DNR)|1|||
124734351|NCT00089986|448648959|FG000|Overall Study|Withdrawal by Subject|3|||
124734352|NCT00089986|448648960|FG001|Overall Study|Withdrawal by Subject|6|||
124734353|NCT00089986|448648961|FG002|Overall Study|Withdrawal by Subject|2|||
124734354|NCT02334683|448648962|FG000|First 12 Week Period|Lost to Follow-up|1|||
124734355|NCT02334683|448648963|FG001|First 12 Week Period|Lost to Follow-up|0|||
124734356|NCT02334683|448648962|FG000|Second 12 Week Period|Adverse Event|0|||
124734357|NCT02334683|448648963|FG001|Second 12 Week Period|Adverse Event|1|||
124734358|NCT00916058|448648964|FG000|Phase 1|Screen Failure|0|||
124734359|NCT00916058|448648965|FG001|Phase 1|Screen Failure|0|||
124734360|NCT00916058|448648966|FG002|Phase 1|Screen Failure|0|||
124734361|NCT00916058|448648967|FG003|Phase 1|Screen Failure|0|||
124734362|NCT00916058|448648968|FG004|Phase 1|Screen Failure|0|||
124734363|NCT00916058|448648969|FG005|Phase 1|Screen Failure|1|||
124734364|NCT00916058|448648970|FG006|Phase 1|Screen Failure|0|||
124734365|NCT00916058|448648964|FG000|Phase 2|Screen Failure|0|||
124734366|NCT00916058|448648965|FG001|Phase 2|Screen Failure|0|||
124734367|NCT00916058|448648966|FG002|Phase 2|Screen Failure|0|||
124734368|NCT00916058|448648967|FG003|Phase 2|Screen Failure|0|||
124734369|NCT00916058|448648968|FG004|Phase 2|Screen Failure|0|||
124734370|NCT00916058|448648969|FG005|Phase 2|Screen Failure|0|||
124734371|NCT00916058|448648970|FG006|Phase 2|Screen Failure|3|||
124734372|NCT02437305|448648971|FG000|Overall Study|Lost to Follow-up|18|||
124734373|NCT02437305|448648972|FG001|Overall Study|Lost to Follow-up|12|||
124734374|NCT01071200|448648991|FG000|Overall Study|Lack of ovarian response|1|||
124734375|NCT01071200|448648992|FG001|Overall Study|Lack of ovarian response|1|||
124734376|NCT01071200|448648991|FG000|Overall Study|No fertilization|4|||
124734377|NCT01071200|448648992|FG001|Overall Study|No fertilization|0|||
124734378|NCT01071200|448648991|FG000|Overall Study|No oocytes retrieved|1|||
124734379|NCT01071200|448648992|FG001|Overall Study|No oocytes retrieved|1|||
124734380|NCT01071200|448648991|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
124734381|NCT01071200|448648992|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
124734382|NCT01071200|448648991|FG000|Overall Study|No viable embryos|0|||
124734383|NCT01071200|448648992|FG001|Overall Study|No viable embryos|1|||
124734384|NCT04465877|448648997|FG000|Overall Study|Noncompliant with study requirements|0|||
124734385|NCT04465877|448648998|FG001|Overall Study|Noncompliant with study requirements|0|||
124734386|NCT04465877|448648999|FG002|Overall Study|Noncompliant with study requirements|1|||
124734387|NCT04465877|448649000|FG003|Overall Study|Noncompliant with study requirements|0|||
124734388|NCT03762616|448649001|FG000|Overall Study|Protocol Violation|2|||
124734389|NCT03576755|448649005|FG000|Overall Study|Withdrawal by Subject|1|||
124734390|NCT03576755|448649006|FG001|Overall Study|Withdrawal by Subject|0|||
124734391|NCT03576755|448649007|FG002|Overall Study|Withdrawal by Subject|0|||
124734392|NCT03576755|448649008|FG003|Overall Study|Withdrawal by Subject|0|||
124734393|NCT04962230|448649009|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
124734394|NCT04962230|448649009|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
124734395|NCT01767493|448649010|FG000|Overall Study|screen failures|3|||
124734396|NCT04346108|448649011|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
124734397|NCT04346108|448649012|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
124734398|NCT04346108|448649013|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
124734399|NCT04346108|448649011|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
124734400|NCT04346108|448649012|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
124734401|NCT04346108|448649013|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
124734402|NCT01598753|448649014|FG000|Overall Study|Adverse Event|1|||
124734403|NCT01598753|448649015|FG001|Overall Study|Adverse Event|9|||
124734404|NCT01598753|448649016|FG002|Overall Study|Adverse Event|1|||
124734405|NCT01598753|448649017|FG003|Overall Study|Adverse Event|7|||
124734406|NCT01598753|448649014|FG000|Overall Study|Lost to Follow-up|4|||
124734407|NCT01598753|448649015|FG001|Overall Study|Lost to Follow-up|3|||
124734408|NCT01598753|448649016|FG002|Overall Study|Lost to Follow-up|7|||
124734409|NCT01598753|448649017|FG003|Overall Study|Lost to Follow-up|5|||
124734410|NCT01598753|448649014|FG000|Overall Study|Physician Decision|0|||
124734411|NCT01598753|448649015|FG001|Overall Study|Physician Decision|1|||
124734412|NCT01598753|448649016|FG002|Overall Study|Physician Decision|0|||
124734413|NCT01598753|448649017|FG003|Overall Study|Physician Decision|2|||
124734414|NCT01598753|448649014|FG000|Overall Study|Withdrawal by Subject|7|||
124734415|NCT01598753|448649015|FG001|Overall Study|Withdrawal by Subject|2|||
124734416|NCT01598753|448649016|FG002|Overall Study|Withdrawal by Subject|0|||
124734417|NCT01598753|448649017|FG003|Overall Study|Withdrawal by Subject|1|||
124734418|NCT03158012|448649018|FG000|Overall Study|Withdrawal by Subject|0|||
124734419|NCT03158012|448649019|FG001|Overall Study|Withdrawal by Subject|1|||
124734420|NCT02788201|448649020|FG000|Overall Study|Death|1|||
124734421|NCT02788201|448649021|FG001|Overall Study|Death|1|||
124734422|NCT02788201|448649022|FG002|Overall Study|Death|1|||
124734423|NCT02788201|448649023|FG003|Overall Study|Death|1|||
124734424|NCT02788201|448649024|FG004|Overall Study|Death|0|||
124734425|NCT02788201|448649025|FG005|Overall Study|Death|1|||
124734426|NCT02788201|448649020|FG000|Overall Study|Ineligible|0|||
124734427|NCT02788201|448649021|FG001|Overall Study|Ineligible|0|||
124734428|NCT02788201|448649022|FG002|Overall Study|Ineligible|0|||
124734429|NCT02788201|448649023|FG003|Overall Study|Ineligible|0|||
124734430|NCT02788201|448649024|FG004|Overall Study|Ineligible|0|||
124734431|NCT02788201|448649025|FG005|Overall Study|Ineligible|1|||
124734432|NCT02788201|448649020|FG000|Overall Study|Withdrawal by Subject|0|||
124734433|NCT02788201|448649021|FG001|Overall Study|Withdrawal by Subject|0|||
124734434|NCT02788201|448649022|FG002|Overall Study|Withdrawal by Subject|0|||
124734435|NCT02788201|448649023|FG003|Overall Study|Withdrawal by Subject|0|||
124734436|NCT02788201|448649024|FG004|Overall Study|Withdrawal by Subject|0|||
124734437|NCT02788201|448649025|FG005|Overall Study|Withdrawal by Subject|1|||
124734438|NCT02446418|448649030|FG000|Overall Study|Adverse Event|4|||
124734439|NCT02446418|448649031|FG001|Overall Study|Adverse Event|8|||
124734440|NCT02446418|448649030|FG000|Overall Study|Physician Decision|5|||
124734441|NCT02446418|448649031|FG001|Overall Study|Physician Decision|1|||
124734442|NCT02446418|448649030|FG000|Overall Study|Withdrawal by Subject|3|||
124734443|NCT02446418|448649031|FG001|Overall Study|Withdrawal by Subject|3|||
124734444|NCT02446418|448649030|FG000|Overall Study|Lost to Follow-up|2|||
124734445|NCT02446418|448649031|FG001|Overall Study|Lost to Follow-up|2|||
124734446|NCT02446418|448649030|FG000|Overall Study|Protocol Violation|1|||
124734447|NCT02446418|448649031|FG001|Overall Study|Protocol Violation|2|||
124734448|NCT02446418|448649030|FG000|Overall Study|Lack of Efficacy|2|||
124734449|NCT02446418|448649031|FG001|Overall Study|Lack of Efficacy|0|||
124734450|NCT02446418|448649030|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
124734451|NCT02446418|448649031|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
124734452|NCT04508751|448649032|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
124734453|NCT04508751|448649033|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
124734454|NCT04508751|448649034|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
124734455|NCT02014480|448649037|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
124734456|NCT02014480|448649038|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
124734457|NCT02014480|448649039|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
124734458|NCT02014480|448649040|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
124734459|NCT02014480|448649041|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
124734460|NCT02014480|448649042|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
124734461|NCT02014480|448649037|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124734462|NCT02014480|448649038|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
124734463|NCT02014480|448649039|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124734464|NCT02014480|448649040|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
124734465|NCT02014480|448649041|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
124734466|NCT02014480|448649042|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124734467|NCT02014480|448649037|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
124734468|NCT02014480|448649038|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
124734469|NCT02014480|448649039|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
124734470|NCT02014480|448649040|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
124734471|NCT02014480|448649041|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
124734472|NCT02014480|448649042|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
124734473|NCT02014480|448649037|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
124734474|NCT02014480|448649038|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
124734475|NCT02014480|448649039|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
124734476|NCT02014480|448649040|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
124734477|NCT02014480|448649041|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
124734478|NCT02014480|448649042|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
124734479|NCT02014480|448649037|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
124734480|NCT02014480|448649038|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
124734481|NCT02014480|448649039|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
124734482|NCT02014480|448649040|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
124734483|NCT02014480|448649041|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
124734484|NCT02014480|448649042|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
124734485|NCT02014480|448649037|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
124734486|NCT02014480|448649038|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
124734487|NCT02014480|448649039|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
124734488|NCT02014480|448649040|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
124734489|NCT02014480|448649041|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
124734490|NCT02014480|448649042|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
124734491|NCT02014480|448649037|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
124734492|NCT02014480|448649038|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
124734493|NCT02014480|448649039|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
124734494|NCT02014480|448649040|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
124734495|NCT02014480|448649041|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
124734496|NCT02014480|448649042|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
124734497|NCT01338610|448649043|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
124734498|NCT01338610|448649044|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
124734499|NCT01338610|448649045|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
124734500|NCT01338610|448649043|FG000|Overall Study|Protocol Violation|1|||
124734501|NCT01338610|448649044|FG001|Overall Study|Protocol Violation|0|||
124734502|NCT01338610|448649045|FG002|Overall Study|Protocol Violation|1|||
124734503|NCT01338610|448649043|FG000|Overall Study|Adverse Event|3|||
124734504|NCT01338610|448649044|FG001|Overall Study|Adverse Event|0|||
124734505|NCT01338610|448649045|FG002|Overall Study|Adverse Event|0|||
124734506|NCT01865812|448649046|FG000|Primary Treatment Phase|Adverse Event|2|||
124734507|NCT01865812|448649047|FG001|Primary Treatment Phase|Adverse Event|0|||
124734508|NCT01865812|448649046|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
124734509|NCT01865812|448649047|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
124734510|NCT01865812|448649046|FG000|Long-term Safety Extension Phase|Pruritus|0|||
124734511|NCT01865812|448649047|FG001|Long-term Safety Extension Phase|Pruritus|3|||
124734512|NCT01865812|448649046|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
124734513|NCT01865812|448649047|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
124611249|NCT04555720|448194397|FG002|Overall Study|Withdrawal by Subject|0|||
124611250|NCT04555720|448194398|FG003|Overall Study|Withdrawal by Subject|0|||
124611251|NCT00968799|448194399|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
124611252|NCT00719849|448194400|FG000|Overall Study|Death|0|||
124611253|NCT00719849|448194401|FG001|Overall Study|Death|1|||
124611254|NCT01372774|448194404|FG000|Overall Study|Withdrawal prior to treatment|4|||
124611255|NCT01372774|448194405|FG001|Overall Study|Withdrawal prior to treatment|5|||
124611256|NCT02201290|448194406|FG000|Overall Study|Withdrawal by Subject|2|||
124611257|NCT02201290|448194406|FG000|Overall Study|Lack of Efficacy|2|||
124611258|NCT02201290|448194406|FG000|Overall Study|Adverse Event|1|||
124611259|NCT01177059|448194407|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
124611260|NCT01177059|448194407|FG000|Overall Study|Withdrew consent|2|||
124611261|NCT01177059|448194407|FG000|Overall Study|Lost to Follow-up|18|||
124611262|NCT02315196|448196873|FG000|Overall Study|Withdrew consent|9|||
124611263|NCT00470067|448196874|FG000|Overall Study|Death|1|||
124611264|NCT00470067|448196874|FG000|Overall Study|Disease Progression|6|||
124611265|NCT03839823|448196875|FG000|Overall Study|Adverse Event|8|||
124611266|NCT03839823|448196876|FG001|Overall Study|Adverse Event|4|||
124611267|NCT03839823|448196875|FG000|Overall Study|Death|1|||
124611268|NCT03839823|448196876|FG001|Overall Study|Death|0|||
124611269|NCT03839823|448196875|FG000|Overall Study|Physician Decision|1|||
124611270|NCT03839823|448196876|FG001|Overall Study|Physician Decision|5|||
124611271|NCT03839823|448196875|FG000|Overall Study|Progressive Disease (PD)|65|||
124611272|NCT03839823|448196876|FG001|Overall Study|Progressive Disease (PD)|65|||
124611273|NCT03839823|448196875|FG000|Overall Study|Subject Decision|2|||
124611274|NCT03839823|448196876|FG001|Overall Study|Subject Decision|9|||
124611275|NCT03839823|448196875|FG000|Overall Study|Not Treated|0|||
124611276|NCT03839823|448196876|FG001|Overall Study|Not Treated|10|||
124611277|NCT01517373|448196878|FG000|Run-in Period|Death|1|||
124611278|NCT01517373|448196879|FG001|Run-in Period|Death|0|||
124611279|NCT01517373|448196880|FG002|Run-in Period|Death|0|||
124611280|NCT01517373|448196881|FG003|Run-in Period|Death|0|||
124611281|NCT01517373|448196882|FG004|Run-in Period|Death|0|||
124611282|NCT01517373|448196883|FG005|Run-in Period|Death|0|||
124611283|NCT01517373|448196878|FG000|Run-in Period|Adverse Event|5|||
124611284|NCT01517373|448196879|FG001|Run-in Period|Adverse Event|0|||
124611285|NCT01517373|448196880|FG002|Run-in Period|Adverse Event|0|||
124611286|NCT01517373|448196881|FG003|Run-in Period|Adverse Event|0|||
124611287|NCT01517373|448196882|FG004|Run-in Period|Adverse Event|0|||
124611288|NCT01517373|448196883|FG005|Run-in Period|Adverse Event|0|||
124611289|NCT01517373|448196878|FG000|Run-in Period|Did not meet eligibility criteria|34|||
124611290|NCT01517373|448196879|FG001|Run-in Period|Did not meet eligibility criteria|0|||
124611291|NCT01517373|448196880|FG002|Run-in Period|Did not meet eligibility criteria|0|||
124611292|NCT01517373|448196881|FG003|Run-in Period|Did not meet eligibility criteria|0|||
124611293|NCT01517373|448196882|FG004|Run-in Period|Did not meet eligibility criteria|0|||
124611294|NCT01517373|448196883|FG005|Run-in Period|Did not meet eligibility criteria|0|||
124611295|NCT01517373|448196878|FG000|Run-in Period|Lost to Follow-up|1|||
124611296|NCT01517373|448196879|FG001|Run-in Period|Lost to Follow-up|0|||
124611297|NCT01517373|448196880|FG002|Run-in Period|Lost to Follow-up|0|||
124611298|NCT01517373|448196881|FG003|Run-in Period|Lost to Follow-up|0|||
124611299|NCT01517373|448196882|FG004|Run-in Period|Lost to Follow-up|0|||
124611300|NCT01517373|448196883|FG005|Run-in Period|Lost to Follow-up|0|||
124611301|NCT01517373|448196878|FG000|Run-in Period|Withdrawal by Subject|12|||
124734514|NCT01865812|448649046|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
124734515|NCT01865812|448649047|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
124781282|NCT02283762|448829139|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
124611302|NCT01517373|448196879|FG001|Run-in Period|Withdrawal by Subject|0|||
124611303|NCT01517373|448196880|FG002|Run-in Period|Withdrawal by Subject|0|||
124611304|NCT01517373|448196881|FG003|Run-in Period|Withdrawal by Subject|0|||
124611305|NCT01517373|448196882|FG004|Run-in Period|Withdrawal by Subject|0|||
124611306|NCT01517373|448196883|FG005|Run-in Period|Withdrawal by Subject|0|||
124611307|NCT01517373|448196878|FG000|Run-in Period|Sponsor Decision|3|||
124611308|NCT01517373|448196879|FG001|Run-in Period|Sponsor Decision|0|||
124611309|NCT01517373|448196880|FG002|Run-in Period|Sponsor Decision|0|||
124611310|NCT01517373|448196881|FG003|Run-in Period|Sponsor Decision|0|||
124611311|NCT01517373|448196882|FG004|Run-in Period|Sponsor Decision|0|||
124611312|NCT01517373|448196883|FG005|Run-in Period|Sponsor Decision|0|||
124734516|NCT01414205|448649050|FG000|Overall Study|Death|5|||
124734517|NCT01414205|448649051|FG001|Overall Study|Death|1|||
124734518|NCT01414205|448649050|FG000|Overall Study|Lost to Follow-up|1|||
124734519|NCT01414205|448649051|FG001|Overall Study|Lost to Follow-up|4|||
124734520|NCT01414205|448649050|FG000|Overall Study|Physician Decision|0|||
124734521|NCT01414205|448649051|FG001|Overall Study|Physician Decision|1|||
124734522|NCT01414205|448649050|FG000|Overall Study|Randomized but not Treated|1|||
124734523|NCT01414205|448649051|FG001|Overall Study|Randomized but not Treated|1|||
124734524|NCT02046226|448649052|FG000|Overall Study|Lost to Follow-up|7|||
124734525|NCT01166373|448649055|FG000|Overall Study|Lost to Follow-up|3|||
124734526|NCT01166373|448649056|FG001|Overall Study|Lost to Follow-up|2|||
124734527|NCT01166373|448649057|FG002|Overall Study|Lost to Follow-up|2|||
124734528|NCT01166373|448649058|FG003|Overall Study|Lost to Follow-up|2|||
124734529|NCT01166373|448649055|FG000|Overall Study|Withdrawal by Subject|1|||
124734530|NCT01166373|448649056|FG001|Overall Study|Withdrawal by Subject|2|||
124734531|NCT01166373|448649057|FG002|Overall Study|Withdrawal by Subject|2|||
124734532|NCT01166373|448649058|FG003|Overall Study|Withdrawal by Subject|3|||
124734533|NCT01166373|448649055|FG000|Overall Study|Physician Decision|1|||
124734534|NCT01166373|448649056|FG001|Overall Study|Physician Decision|0|||
124734535|NCT01166373|448649057|FG002|Overall Study|Physician Decision|0|||
124734536|NCT01166373|448649058|FG003|Overall Study|Physician Decision|0|||
124734537|NCT01819129|448649059|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
124734538|NCT01819129|448649060|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
124734539|NCT01819129|448649059|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
124734540|NCT01819129|448649060|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
124734541|NCT01819129|448649059|FG000|Overall Study|Other, Subject moved out of the country|0|||
124734542|NCT01819129|448649060|FG001|Overall Study|Other, Subject moved out of the country|1|||
124734543|NCT01819129|448649059|FG000|Overall Study|Withdrawal by Subject|15|||
124734544|NCT01819129|448649060|FG001|Overall Study|Withdrawal by Subject|15|||
124734545|NCT01819129|448649059|FG000|Overall Study|Lost to Follow-up|5|||
124734546|NCT01819129|448649060|FG001|Overall Study|Lost to Follow-up|2|||
124734547|NCT01819129|448649059|FG000|Overall Study|Lack of Efficacy|0|||
124734548|NCT01819129|448649060|FG001|Overall Study|Lack of Efficacy|1|||
124734549|NCT01819129|448649059|FG000|Overall Study|Adverse Event|1|||
124734550|NCT01819129|448649060|FG001|Overall Study|Adverse Event|4|||
124734551|NCT01819129|448649059|FG000|Overall Study|Death|1|||
124734552|NCT01819129|448649060|FG001|Overall Study|Death|1|||
124734553|NCT01819129|448649059|FG000|Overall Study|Withdrawal Criteria|20|||
124734554|NCT01819129|448649060|FG001|Overall Study|Withdrawal Criteria|15|||
124734555|NCT02914548|448649061|FG000|Overall Study|Adverse Event|15|||
124734556|NCT02914548|448649062|FG001|Overall Study|Adverse Event|7|||
124734557|NCT02914548|448649063|FG002|Overall Study|Adverse Event|15|||
124734558|NCT02914548|448649061|FG000|Overall Study|Physician Decision|2|||
124734559|NCT02914548|448649062|FG001|Overall Study|Physician Decision|2|||
124734560|NCT02914548|448649063|FG002|Overall Study|Physician Decision|0|||
124734561|NCT02914548|448649061|FG000|Overall Study|Protocol Violation|1|||
124734562|NCT02914548|448649062|FG001|Overall Study|Protocol Violation|0|||
124734563|NCT02914548|448649063|FG002|Overall Study|Protocol Violation|0|||
124734564|NCT02914548|448649061|FG000|Overall Study|Withdrawal by Subject|3|||
124734565|NCT02914548|448649062|FG001|Overall Study|Withdrawal by Subject|4|||
124734566|NCT02914548|448649063|FG002|Overall Study|Withdrawal by Subject|4|||
124734567|NCT02914548|448649061|FG000|Overall Study|>40% of body surface area|0|||
124734568|NCT02914548|448649062|FG001|Overall Study|>40% of body surface area|1|||
124734569|NCT02914548|448649063|FG002|Overall Study|>40% of body surface area|1|||
124734570|NCT02182440|448649064|FG000|Overall Study|Adverse Event|0|||
124734571|NCT02182440|448649065|FG001|Overall Study|Adverse Event|1|||
124734572|NCT02182440|448649066|FG002|Overall Study|Adverse Event|0|||
124734573|NCT02182440|448649067|FG003|Overall Study|Adverse Event|0|||
124734574|NCT02182440|448649064|FG000|Overall Study|Death|31|||
124734575|NCT02182440|448649065|FG001|Overall Study|Death|8|||
124734576|NCT02182440|448649066|FG002|Overall Study|Death|5|||
124734577|NCT02182440|448649067|FG003|Overall Study|Death|16|||
124734578|NCT02182440|448649064|FG000|Overall Study|Protocol Violation|0|||
124734579|NCT02182440|448649065|FG001|Overall Study|Protocol Violation|1|||
124734580|NCT02182440|448649066|FG002|Overall Study|Protocol Violation|0|||
124734581|NCT02182440|448649067|FG003|Overall Study|Protocol Violation|0|||
124734582|NCT02182440|448649064|FG000|Overall Study|Physician Decision|1|||
124734583|NCT02182440|448649065|FG001|Overall Study|Physician Decision|0|||
124734584|NCT02182440|448649066|FG002|Overall Study|Physician Decision|0|||
124734585|NCT02182440|448649067|FG003|Overall Study|Physician Decision|0|||
124734586|NCT02182440|448649064|FG000|Overall Study|Withdrawal by Subject|1|||
124734587|NCT02182440|448649065|FG001|Overall Study|Withdrawal by Subject|1|||
124734588|NCT02182440|448649066|FG002|Overall Study|Withdrawal by Subject|3|||
124734589|NCT02182440|448649067|FG003|Overall Study|Withdrawal by Subject|4|||
124734590|NCT02182440|448649064|FG000|Overall Study|different, e.g adm other hospital|12|||
124734591|NCT02182440|448649065|FG001|Overall Study|different, e.g adm other hospital|3|||
124734592|NCT02182440|448649066|FG002|Overall Study|different, e.g adm other hospital|3|||
124734593|NCT02182440|448649067|FG003|Overall Study|different, e.g adm other hospital|10|||
124734594|NCT00405964|448649070|FG000|Overall Study|Treatment Failure|17|||
124734595|NCT00405964|448649071|FG001|Overall Study|Treatment Failure|45|||
124734596|NCT00405964|448649070|FG000|Overall Study|Adverse Event|7|||
124734597|NCT00405964|448649071|FG001|Overall Study|Adverse Event|16|||
124734598|NCT00405964|448649070|FG000|Overall Study|Lost to Follow-up|5|||
124734599|NCT00405964|448649071|FG001|Overall Study|Lost to Follow-up|5|||
124734600|NCT00405964|448649070|FG000|Overall Study|Withdrawal by Subject|19|||
124734601|NCT00405964|448649071|FG001|Overall Study|Withdrawal by Subject|23|||
124734602|NCT00405964|448649070|FG000|Overall Study|Protocol Violation|11|||
124734603|NCT00405964|448649071|FG001|Overall Study|Protocol Violation|6|||
124734604|NCT01253265|448649076|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
124734605|NCT01253265|448649077|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
124734606|NCT01253265|448649078|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
124734607|NCT01253265|448649079|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
124734608|NCT01253265|448649080|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
124734609|NCT01253265|448649076|FG000|Overall Study|Withdrawal by Subject|0|||
124734610|NCT01253265|448649077|FG001|Overall Study|Withdrawal by Subject|0|||
124734611|NCT01253265|448649078|FG002|Overall Study|Withdrawal by Subject|0|||
124734612|NCT01253265|448649079|FG003|Overall Study|Withdrawal by Subject|0|||
124611313|NCT01517373|448196878|FG000|Run-in Period|Other|1|||
124611314|NCT01517373|448196879|FG001|Run-in Period|Other|0|||
124611315|NCT01517373|448196880|FG002|Run-in Period|Other|0|||
124611316|NCT01517373|448196881|FG003|Run-in Period|Other|0|||
124611317|NCT01517373|448196882|FG004|Run-in Period|Other|0|||
124611318|NCT01517373|448196883|FG005|Run-in Period|Other|0|||
124611319|NCT01517373|448196878|FG000|Treatment Period|Adverse Event|0|||
124611320|NCT01517373|448196879|FG001|Treatment Period|Adverse Event|0|||
124611321|NCT01517373|448196880|FG002|Treatment Period|Adverse Event|0|||
124611322|NCT01517373|448196881|FG003|Treatment Period|Adverse Event|0|||
124611323|NCT01517373|448196882|FG004|Treatment Period|Adverse Event|0|||
124611324|NCT01517373|448196883|FG005|Treatment Period|Adverse Event|2|||
124611325|NCT01517373|448196878|FG000|Treatment Period|Lost to Follow-up|0|||
124611326|NCT01517373|448196879|FG001|Treatment Period|Lost to Follow-up|0|||
124611327|NCT01517373|448196880|FG002|Treatment Period|Lost to Follow-up|1|||
124611328|NCT01517373|448196881|FG003|Treatment Period|Lost to Follow-up|1|||
124611329|NCT01517373|448196882|FG004|Treatment Period|Lost to Follow-up|0|||
124611330|NCT01517373|448196883|FG005|Treatment Period|Lost to Follow-up|0|||
124611331|NCT01517373|448196878|FG000|Treatment Period|Withdrawal by Subject|0|||
124611332|NCT01517373|448196879|FG001|Treatment Period|Withdrawal by Subject|3|||
124611333|NCT01517373|448196880|FG002|Treatment Period|Withdrawal by Subject|2|||
124611334|NCT01517373|448196881|FG003|Treatment Period|Withdrawal by Subject|2|||
124611335|NCT01517373|448196882|FG004|Treatment Period|Withdrawal by Subject|2|||
124611336|NCT01517373|448196883|FG005|Treatment Period|Withdrawal by Subject|3|||
124611337|NCT01517373|448196878|FG000|Treatment Period|Other|0|||
124611338|NCT01517373|448196879|FG001|Treatment Period|Other|0|||
124611339|NCT01517373|448196880|FG002|Treatment Period|Other|0|||
124611340|NCT01517373|448196881|FG003|Treatment Period|Other|0|||
124611341|NCT01517373|448196882|FG004|Treatment Period|Other|1|||
124611342|NCT01517373|448196883|FG005|Treatment Period|Other|0|||
124611343|NCT01517373|448196878|FG000|Treatment Period|Protocol Violation|0|||
124611344|NCT01517373|448196879|FG001|Treatment Period|Protocol Violation|0|||
124611345|NCT01517373|448196880|FG002|Treatment Period|Protocol Violation|0|||
124611346|NCT01517373|448196881|FG003|Treatment Period|Protocol Violation|0|||
124611347|NCT01517373|448196882|FG004|Treatment Period|Protocol Violation|1|||
124611348|NCT01517373|448196883|FG005|Treatment Period|Protocol Violation|0|||
124611349|NCT01517373|448196878|FG000|Treatment Period|Lack of Efficacy|0|||
124611350|NCT01517373|448196879|FG001|Treatment Period|Lack of Efficacy|1|||
124611351|NCT01517373|448196880|FG002|Treatment Period|Lack of Efficacy|1|||
124734613|NCT01253265|448649080|FG004|Overall Study|Withdrawal by Subject|1|||
124734614|NCT00066469|448649084|FG000|Overall Study|Death|3|||
124734615|NCT00066469|448649084|FG000|Overall Study|Lack of Efficacy|9|||
124734616|NCT00066469|448649084|FG000|Overall Study|Lost to Follow-up|1|||
124611352|NCT01517373|448196881|FG003|Treatment Period|Lack of Efficacy|3|||
124611353|NCT01517373|448196882|FG004|Treatment Period|Lack of Efficacy|2|||
124611354|NCT01517373|448196883|FG005|Treatment Period|Lack of Efficacy|0|||
124611355|NCT01517373|448196878|FG000|Treatment Period|Medication error without AEs|0|||
124611356|NCT01517373|448196879|FG001|Treatment Period|Medication error without AEs|0|||
124611357|NCT01517373|448196880|FG002|Treatment Period|Medication error without AEs|2|||
124611358|NCT01517373|448196881|FG003|Treatment Period|Medication error without AEs|1|||
124611359|NCT01517373|448196882|FG004|Treatment Period|Medication error without AEs|0|||
124611360|NCT01517373|448196883|FG005|Treatment Period|Medication error without AEs|2|||
124611361|NCT03678285|448196888|FG000|Overall Study|Adverse Event|2|||
124611362|NCT03678285|448196888|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
124734617|NCT00066469|448649084|FG000|Overall Study|Physician Decision|1|||
124734618|NCT00066469|448649084|FG000|Overall Study|Withdrawal by Subject|1|||
124734619|NCT00066469|448649084|FG000|Overall Study|ineligible|1|||
124734620|NCT03271047|448649085|FG000|Phase 1b: Dose Finding Period|Death|8|||
124734621|NCT03271047|448649086|FG001|Phase 1b: Dose Finding Period|Death|8|||
124734622|NCT03271047|448649087|FG002|Phase 1b: Dose Finding Period|Death|0|||
124734623|NCT03271047|448649088|FG003|Phase 1b: Dose Finding Period|Death|0|||
124734624|NCT03271047|448649085|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
124734625|NCT03271047|448649086|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
124734626|NCT03271047|448649087|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
124734627|NCT03271047|448649088|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
124734628|NCT03271047|448649085|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
124734629|NCT03271047|448649086|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
124734630|NCT03271047|448649087|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
124734631|NCT03271047|448649088|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
124734632|NCT03271047|448649085|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
124734633|NCT03271047|448649086|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
124734634|NCT03271047|448649087|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
124734635|NCT03271047|448649088|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
124734636|NCT03271047|448649085|FG000|Randomized Phase 2 Period|Other|0|||
124734637|NCT03271047|448649086|FG001|Randomized Phase 2 Period|Other|0|||
124734638|NCT03271047|448649087|FG002|Randomized Phase 2 Period|Other|0|||
124734639|NCT03271047|448649088|FG003|Randomized Phase 2 Period|Other|1|||
124734640|NCT03271047|448649085|FG000|Randomized Phase 2 Period|Death|0|||
124734641|NCT03271047|448649086|FG001|Randomized Phase 2 Period|Death|0|||
124734642|NCT03271047|448649087|FG002|Randomized Phase 2 Period|Death|20|||
124734643|NCT03271047|448649088|FG003|Randomized Phase 2 Period|Death|21|||
124734644|NCT03271047|448649085|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
124734645|NCT03271047|448649086|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
124734646|NCT03271047|448649087|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
124734647|NCT03271047|448649088|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
124734648|NCT03271047|448649085|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
124734649|NCT03271047|448649086|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
124734650|NCT03271047|448649087|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
124734651|NCT03271047|448649088|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
124734652|NCT03271047|448649085|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
124734653|NCT03271047|448649086|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
124734654|NCT03271047|448649087|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
124734655|NCT03271047|448649088|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
124734656|NCT00495521|448649094|FG000|Overall Study|Physician Decision|0|||
124734657|NCT00495521|448649095|FG001|Overall Study|Physician Decision|1|||
124734658|NCT00392808|448649096|FG000|Overall Study|Lost to Follow-up|3|||
124734659|NCT00392808|448649097|FG001|Overall Study|Lost to Follow-up|2|||
124734660|NCT00392808|448649098|FG002|Overall Study|Lost to Follow-up|1|||
124734661|NCT00392808|448649099|FG003|Overall Study|Lost to Follow-up|2|||
124734662|NCT00392808|448649096|FG000|Overall Study|Unable to withdraw blood|3|||
124734663|NCT00392808|448649097|FG001|Overall Study|Unable to withdraw blood|1|||
124734664|NCT00392808|448649098|FG002|Overall Study|Unable to withdraw blood|1|||
124734665|NCT00392808|448649099|FG003|Overall Study|Unable to withdraw blood|2|||
124734666|NCT00823212|448650906|FG000|Overall Study|Death|8|||
124734667|NCT00823212|448650907|FG001|Overall Study|Death|10|||
124734668|NCT00823212|448650906|FG000|Overall Study|Withdrawal by Subject|6|||
124734669|NCT00823212|448650907|FG001|Overall Study|Withdrawal by Subject|1|||
124734670|NCT00823212|448650906|FG000|Overall Study|Incarcerated|0|||
124734671|NCT00823212|448650907|FG001|Overall Study|Incarcerated|1|||
124734672|NCT00823212|448650906|FG000|Overall Study|Missed 12-month visit|21|||
124734673|NCT00823212|448650907|FG001|Overall Study|Missed 12-month visit|21|||
124734674|NCT02585830|448650910|FG000|Overall Study|Withdrawal by Subject|3|||
124734675|NCT02509052|448650911|FG000|Overall Study|Non compliance|0|||
124734676|NCT02509052|448650912|FG001|Overall Study|Non compliance|0|||
124734677|NCT02509052|448650913|FG002|Overall Study|Non compliance|1|||
124734678|NCT01323270|448650919|FG000|Overall Study|Withdrawal by Subject|19|||
124734679|NCT01323270|448650920|FG001|Overall Study|Withdrawal by Subject|10|||
124734680|NCT01323270|448650919|FG000|Overall Study|Protocol Violation|9|||
124734681|NCT01323270|448650920|FG001|Overall Study|Protocol Violation|7|||
124734682|NCT01323270|448650919|FG000|Overall Study|Lost to Follow-up|4|||
124734683|NCT01323270|448650920|FG001|Overall Study|Lost to Follow-up|6|||
124734684|NCT01323270|448650919|FG000|Overall Study|Adverse Event|8|||
124734685|NCT01323270|448650920|FG001|Overall Study|Adverse Event|0|||
124781283|NCT02283762|448829140|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
124734686|NCT01323270|448650919|FG000|Overall Study|Other|0|||
124734687|NCT01323270|448650920|FG001|Overall Study|Other|3|||
124734688|NCT01323270|448650919|FG000|Overall Study|Physician Decision|0|||
124781284|NCT02283762|448829139|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
124734689|NCT01323270|448650920|FG001|Overall Study|Physician Decision|2|||
124734690|NCT01323270|448650919|FG000|Overall Study|Not eligible|1|||
124611363|NCT03678285|448196888|FG000|Overall Study|Dehydrated prior to start of workout|1|||
124734691|NCT01323270|448650920|FG001|Overall Study|Not eligible|1|||
124734692|NCT01323270|448650919|FG000|Overall Study|Death|1|||
124734693|NCT01323270|448650920|FG001|Overall Study|Death|0|||
124734694|NCT01323270|448650919|FG000|Overall Study|Randomized, but not vaccinated|1|||
124734695|NCT01323270|448650920|FG001|Overall Study|Randomized, but not vaccinated|0|||
124734696|NCT03761394|448650924|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
124734697|NCT03761394|448650925|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
124734698|NCT03761394|448650926|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
124734699|NCT03761394|448650927|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
124734700|NCT03761394|448650924|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
124734701|NCT03761394|448650925|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
124734702|NCT03761394|448650926|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
124734703|NCT03761394|448650927|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
124734704|NCT03761394|448650924|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
124734705|NCT03761394|448650925|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
124734706|NCT03761394|448650926|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
124734707|NCT03761394|448650927|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
124734708|NCT03761394|448650924|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
124734709|NCT03761394|448650925|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
124734710|NCT03761394|448650926|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
124734711|NCT03761394|448650927|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
124734712|NCT01643850|448650937|FG000|Overall Study|Withdrawal by Subject|0|||
124734713|NCT01643850|448650938|FG001|Overall Study|Withdrawal by Subject|0|||
124734714|NCT01643850|448650939|FG002|Overall Study|Withdrawal by Subject|0|||
124734715|NCT01643850|448650940|FG003|Overall Study|Withdrawal by Subject|0|||
124734716|NCT01643850|448650941|FG004|Overall Study|Withdrawal by Subject|1|||
124734717|NCT01643850|448650942|FG005|Overall Study|Withdrawal by Subject|0|||
124734718|NCT01643850|448650943|FG006|Overall Study|Withdrawal by Subject|0|||
124734719|NCT01643850|448650944|FG007|Overall Study|Withdrawal by Subject|0|||
124734720|NCT01643850|448650945|FG008|Overall Study|Withdrawal by Subject|0|||
124734721|NCT01643850|448650937|FG000|Overall Study|Lost to Follow-up|0|||
124734722|NCT01643850|448650938|FG001|Overall Study|Lost to Follow-up|0|||
124734723|NCT01643850|448650939|FG002|Overall Study|Lost to Follow-up|0|||
124611364|NCT00616629|448196889|FG000|Overall Study|Protocol Violation|1|||
124611365|NCT00616629|448196890|FG001|Overall Study|Protocol Violation|2|||
124611366|NCT00616629|448196891|FG002|Overall Study|Protocol Violation|1|||
124611367|NCT00616629|448196892|FG003|Overall Study|Protocol Violation|0|||
124611368|NCT00616629|448196893|FG004|Overall Study|Protocol Violation|0|||
124611369|NCT00616629|448196889|FG000|Overall Study|AV-block|1|||
124611370|NCT00616629|448196890|FG001|Overall Study|AV-block|0|||
124611371|NCT00616629|448196891|FG002|Overall Study|AV-block|0|||
124611372|NCT00616629|448196892|FG003|Overall Study|AV-block|0|||
124611373|NCT00616629|448196893|FG004|Overall Study|AV-block|0|||
124611374|NCT01777620|448196894|FG000|Overall Study|Subject Withdrawal|1|||
124611375|NCT01777620|448196895|FG001|Overall Study|Subject Withdrawal|0|||
124611376|NCT04516759|448196901|FG000|Overall Study|Withdrawal by Subject|1|||
124611377|NCT04516759|448196902|FG001|Overall Study|Withdrawal by Subject|1|||
124611378|NCT04516759|448196901|FG000|Overall Study|Other|0|||
124611379|NCT04516759|448196902|FG001|Overall Study|Other|1|||
124611380|NCT04005352|448196903|FG000|Overall Study|Adverse Event|4|||
124611381|NCT04005352|448196904|FG001|Overall Study|Adverse Event|5|||
124611382|NCT04005352|448196903|FG000|Overall Study|Death|4|||
124611383|NCT04005352|448196904|FG001|Overall Study|Death|2|||
124611384|NCT04005352|448196903|FG000|Overall Study|Lost to Follow-up|6|||
124611385|NCT04005352|448196904|FG001|Overall Study|Lost to Follow-up|2|||
124611386|NCT04005352|448196903|FG000|Overall Study|Physician Decision|7|||
124611387|NCT04005352|448196904|FG001|Overall Study|Physician Decision|13|||
124611388|NCT04005352|448196903|FG000|Overall Study|Protocol Violation|0|||
124611389|NCT04005352|448196904|FG001|Overall Study|Protocol Violation|1|||
124611390|NCT04005352|448196903|FG000|Overall Study|Withdrawal by Subject|28|||
124611391|NCT04005352|448196904|FG001|Overall Study|Withdrawal by Subject|38|||
124611392|NCT04058067|448196907|FG000|Overall Study|Adverse Event|2|||
124611393|NCT04058067|448196908|FG001|Overall Study|Adverse Event|0|||
124611394|NCT04058067|448196907|FG000|Overall Study|Death|0|||
124611395|NCT04058067|448196908|FG001|Overall Study|Death|1|||
124611396|NCT04058067|448196907|FG000|Overall Study|Physician Decision|3|||
124611397|NCT04058067|448196908|FG001|Overall Study|Physician Decision|1|||
124611398|NCT04058067|448196907|FG000|Overall Study|Protocol Violation|0|||
124611399|NCT04058067|448196908|FG001|Overall Study|Protocol Violation|1|||
124611400|NCT04058067|448196907|FG000|Overall Study|Withdrawal by Subject|7|||
124611401|NCT04058067|448196908|FG001|Overall Study|Withdrawal by Subject|8|||
124611402|NCT00417170|448196910|FG000|Overall Study|Adverse Event|1|||
124611403|NCT00417170|448196911|FG001|Overall Study|Adverse Event|1|||
124611404|NCT00417170|448196910|FG000|Overall Study|Withdrawal by Subject|1|||
124611405|NCT00417170|448196911|FG001|Overall Study|Withdrawal by Subject|1|||
124611406|NCT00417170|448196910|FG000|Overall Study|Lost to Follow-up|0|||
124734724|NCT01643850|448650940|FG003|Overall Study|Lost to Follow-up|0|||
124611407|NCT00417170|448196911|FG001|Overall Study|Lost to Follow-up|1|||
124611408|NCT05005312|448196912|FG000|Overall Study|Enrolled, but not treated|0|||
124734725|NCT01643850|448650941|FG004|Overall Study|Lost to Follow-up|0|||
124734726|NCT01643850|448650942|FG005|Overall Study|Lost to Follow-up|0|||
124734727|NCT01643850|448650943|FG006|Overall Study|Lost to Follow-up|1|||
124734728|NCT01643850|448650944|FG007|Overall Study|Lost to Follow-up|0|||
124734729|NCT01643850|448650945|FG008|Overall Study|Lost to Follow-up|1|||
124734730|NCT01643850|448650937|FG000|Overall Study|Adverse Event|0|||
124734731|NCT01643850|448650938|FG001|Overall Study|Adverse Event|0|||
124734732|NCT01643850|448650939|FG002|Overall Study|Adverse Event|0|||
124734733|NCT01643850|448650940|FG003|Overall Study|Adverse Event|0|||
124734734|NCT01643850|448650941|FG004|Overall Study|Adverse Event|1|||
124734735|NCT01643850|448650942|FG005|Overall Study|Adverse Event|0|||
124734736|NCT01643850|448650943|FG006|Overall Study|Adverse Event|0|||
124611409|NCT05005312|448196913|FG001|Overall Study|Enrolled, but not treated|1|||
124611410|NCT01283035|448196914|FG000|Overall Study|Subject later found ineligible|1|||
124611411|NCT02704403|448196915|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
124611412|NCT02704403|448196916|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
124611413|NCT02704403|448196915|FG000|Overall Study|Administrative reasons by sponsor|1251|||
124611414|NCT02704403|448196916|FG001|Overall Study|Administrative reasons by sponsor|616|||
124611415|NCT02704403|448196915|FG000|Overall Study|Death|4|||
124611416|NCT02704403|448196916|FG001|Overall Study|Death|3|||
124611417|NCT02704403|448196915|FG000|Overall Study|Endpoint event|52|||
124611418|NCT02704403|448196916|FG001|Overall Study|Endpoint event|24|||
124611419|NCT02704403|448196915|FG000|Overall Study|Lost to Follow-up|22|||
124611420|NCT02704403|448196916|FG001|Overall Study|Lost to Follow-up|11|||
124611421|NCT02704403|448196915|FG000|Overall Study|Protocol Violation|15|||
124611422|NCT02704403|448196916|FG001|Overall Study|Protocol Violation|15|||
124611423|NCT02704403|448196915|FG000|Overall Study|Adverse Event|2|||
124611424|NCT02704403|448196916|FG001|Overall Study|Adverse Event|0|||
124611425|NCT02704403|448196915|FG000|Overall Study|Withdrawal by Subject|85|||
124611426|NCT02704403|448196916|FG001|Overall Study|Withdrawal by Subject|45|||
124611427|NCT02704403|448196915|FG000|Overall Study|Investigator decision|1|||
124611428|NCT02704403|448196916|FG001|Overall Study|Investigator decision|1|||
124611429|NCT02704403|448196915|FG000|Overall Study|Follow-up not possible|1|||
124611430|NCT02704403|448196916|FG001|Overall Study|Follow-up not possible|2|||
124611431|NCT00851318|448196917|FG000|Overall Study|Withdrawal by Subject|7|||
124611432|NCT00851318|448196918|FG001|Overall Study|Withdrawal by Subject|1|||
124611433|NCT00851318|448196919|FG002|Overall Study|Withdrawal by Subject|5|||
124611434|NCT00851318|448196920|FG003|Overall Study|Withdrawal by Subject|3|||
124611435|NCT00851318|448196917|FG000|Overall Study|Adverse Event|13|||
124611436|NCT00851318|448196918|FG001|Overall Study|Adverse Event|2|||
124611437|NCT00851318|448196919|FG002|Overall Study|Adverse Event|9|||
124611438|NCT00851318|448196920|FG003|Overall Study|Adverse Event|12|||
124611439|NCT00851318|448196917|FG000|Overall Study|Pregnancy|0|||
124611440|NCT00851318|448196918|FG001|Overall Study|Pregnancy|0|||
124611441|NCT00851318|448196919|FG002|Overall Study|Pregnancy|1|||
124611442|NCT00851318|448196920|FG003|Overall Study|Pregnancy|1|||
124611443|NCT00851318|448196917|FG000|Overall Study|Lack of Efficacy|8|||
124611444|NCT00851318|448196918|FG001|Overall Study|Lack of Efficacy|2|||
124611445|NCT00851318|448196919|FG002|Overall Study|Lack of Efficacy|4|||
124611446|NCT00851318|448196920|FG003|Overall Study|Lack of Efficacy|2|||
124611447|NCT00851318|448196917|FG000|Overall Study|Non-compliance with Study Procedures|2|||
124611448|NCT00851318|448196918|FG001|Overall Study|Non-compliance with Study Procedures|0|||
124611449|NCT00851318|448196919|FG002|Overall Study|Non-compliance with Study Procedures|1|||
124611450|NCT00851318|448196920|FG003|Overall Study|Non-compliance with Study Procedures|0|||
124611451|NCT00851318|448196917|FG000|Overall Study|Physician Decision|0|||
124611452|NCT00851318|448196918|FG001|Overall Study|Physician Decision|0|||
124611453|NCT00851318|448196919|FG002|Overall Study|Physician Decision|1|||
124611454|NCT00851318|448196920|FG003|Overall Study|Physician Decision|1|||
124611455|NCT01844856|448196927|FG000|Overall Study|Lost to Follow-up|15|||
124611456|NCT01844856|448196928|FG001|Overall Study|Lost to Follow-up|3|||
124611457|NCT01844856|448196927|FG000|Overall Study|Adverse Event|3|||
124611458|NCT01844856|448196928|FG001|Overall Study|Adverse Event|6|||
124611459|NCT01844856|448196927|FG000|Overall Study|Withdrawal by Subject|3|||
124611460|NCT01844856|448196928|FG001|Overall Study|Withdrawal by Subject|2|||
124611461|NCT01844856|448196927|FG000|Overall Study|Noncompliance|2|||
124611462|NCT01844856|448196928|FG001|Overall Study|Noncompliance|3|||
124611463|NCT01844856|448196927|FG000|Overall Study|Enterococcus Resistant|0|||
124611464|NCT01844856|448196928|FG001|Overall Study|Enterococcus Resistant|1|||
124611465|NCT01844856|448196927|FG000|Overall Study|Inadvertently Not Scheduled|1|||
124611466|NCT01844856|448196928|FG001|Overall Study|Inadvertently Not Scheduled|0|||
124611467|NCT01844856|448196927|FG000|Overall Study|Randomized but was a Screen Failure|0|||
124611468|NCT01844856|448196928|FG001|Overall Study|Randomized but was a Screen Failure|1|||
124611469|NCT01329549|448196935|FG000|Overall Study|Withdrawal by Subject|1|||
124611470|NCT01329549|448196935|FG000|Overall Study|Adverse Event|1|||
124734737|NCT01643850|448650944|FG007|Overall Study|Adverse Event|0|||
124734738|NCT01643850|448650945|FG008|Overall Study|Adverse Event|0|||
124734739|NCT01643850|448650937|FG000|Overall Study|Administrative Problems|0|||
124734740|NCT01643850|448650938|FG001|Overall Study|Administrative Problems|0|||
124734741|NCT01643850|448650939|FG002|Overall Study|Administrative Problems|1|||
124734742|NCT01643850|448650940|FG003|Overall Study|Administrative Problems|0|||
124734743|NCT01643850|448650941|FG004|Overall Study|Administrative Problems|1|||
124734744|NCT01643850|448650942|FG005|Overall Study|Administrative Problems|0|||
124734745|NCT01643850|448650943|FG006|Overall Study|Administrative Problems|0|||
124734746|NCT01643850|448650944|FG007|Overall Study|Administrative Problems|0|||
124734747|NCT01643850|448650945|FG008|Overall Study|Administrative Problems|0|||
124734748|NCT03242772|448650946|FG000|Overall Study|Lost to Follow-up|2|||
124734749|NCT03242772|448650947|FG001|Overall Study|Lost to Follow-up|0|||
124734750|NCT03242772|448650946|FG000|Overall Study|Physician Decision|0|||
124734751|NCT03242772|448650947|FG001|Overall Study|Physician Decision|1|||
124734752|NCT03242772|448650946|FG000|Overall Study|Withdrawal by Subject|1|||
124734753|NCT03242772|448650947|FG001|Overall Study|Withdrawal by Subject|0|||
124734754|NCT01118520|448650952|FG000|Overall Study|AAA repair|9|||
124734755|NCT01118520|448650953|FG001|Overall Study|AAA repair|7|||
124734756|NCT01118520|448650954|FG002|Overall Study|AAA repair|9|||
124734757|NCT01118520|448650952|FG000|Overall Study|Adverse Event|3|||
124734758|NCT01118520|448650953|FG001|Overall Study|Adverse Event|3|||
124734759|NCT01118520|448650954|FG002|Overall Study|Adverse Event|3|||
124734760|NCT01118520|448650952|FG000|Overall Study|Withdrawal by Subject|8|||
124734761|NCT01118520|448650953|FG001|Overall Study|Withdrawal by Subject|13|||
124734762|NCT01118520|448650954|FG002|Overall Study|Withdrawal by Subject|8|||
124734763|NCT01089023|448650960|FG000|Overall Study|Lost to Follow-up|3|||
124734764|NCT01089023|448650960|FG000|Overall Study|Adverse Event|1|||
124734765|NCT01089023|448650960|FG000|Overall Study|Withdrawal by Subject|1|||
124734766|NCT01089023|448650960|FG000|Overall Study|Protocol Violation|1|||
124734767|NCT01089023|448650960|FG000|Overall Study|Lack of Efficacy|1|||
124734768|NCT03220581|448650964|FG000|Overall Study|Withdrawal by Subject|0|||
124734769|NCT03220581|448650965|FG001|Overall Study|Withdrawal by Subject|1|||
124734770|NCT03220581|448650964|FG000|Overall Study|Lost to Follow-up|3|||
124734771|NCT03220581|448650965|FG001|Overall Study|Lost to Follow-up|6|||
124734772|NCT00413920|448650966|FG000|Overall Study|Adverse Event|9|||
124734773|NCT00413920|448650967|FG001|Overall Study|Adverse Event|11|||
124734774|NCT00413920|448650966|FG000|Overall Study|Lack of Efficacy|11|||
124734775|NCT00413920|448650967|FG001|Overall Study|Lack of Efficacy|9|||
124734776|NCT00413920|448650966|FG000|Overall Study|Death|3|||
124734777|NCT00413920|448650967|FG001|Overall Study|Death|5|||
124734778|NCT00413920|448650966|FG000|Overall Study|Graft Loss|5|||
124734779|NCT00413920|448650967|FG001|Overall Study|Graft Loss|3|||
124734780|NCT02434354|448650968|FG000|Overall Study|screen fail|3|||
124734781|NCT03730961|448650969|FG000|Overall Study|Adverse Event|0|||
124734782|NCT03730961|448650970|FG001|Overall Study|Adverse Event|1|||
124734783|NCT01185964|448650973|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
124734784|NCT01185964|448650974|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
124734785|NCT01185964|448650975|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
124734786|NCT01185964|448650976|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
124734787|NCT01185964|448650973|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
124734788|NCT01185964|448650974|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
124734789|NCT01185964|448650975|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
124734790|NCT01185964|448650976|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
124734791|NCT01185964|448650973|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
124734792|NCT01185964|448650974|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
124734793|NCT01185964|448650975|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
124734794|NCT01185964|448650976|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
124734795|NCT01185964|448650973|FG000|Phase 1b and Phase 2|Adverse Event|1|||
124734796|NCT01185964|448650974|FG001|Phase 1b and Phase 2|Adverse Event|0|||
124734797|NCT01185964|448650975|FG002|Phase 1b and Phase 2|Adverse Event|2|||
124734798|NCT01185964|448650976|FG003|Phase 1b and Phase 2|Adverse Event|0|||
124734799|NCT01185964|448650973|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
124734800|NCT01185964|448650974|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
124734801|NCT01185964|448650975|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
124734802|NCT01185964|448650976|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
124781285|NCT02283762|448829140|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
124781286|NCT02283762|448829139|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
124734803|NCT01185964|448650973|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
124734804|NCT01185964|448650974|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
124734805|NCT01185964|448650975|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
124734806|NCT01185964|448650976|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
124781287|NCT02283762|448829140|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
124734807|NCT01185964|448650973|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
124734808|NCT01185964|448650974|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
124781288|NCT02283762|448829139|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
124734809|NCT01185964|448650975|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
124734810|NCT01185964|448650976|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
124734811|NCT01185964|448650973|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
124734812|NCT01185964|448650974|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
124734813|NCT01185964|448650975|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
124734814|NCT01185964|448650976|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
124734815|NCT01920893|448650977|FG000|Overall Study|Adverse Event|5|||
124734816|NCT01920893|448650978|FG001|Overall Study|Adverse Event|2|||
124734817|NCT01920893|448650977|FG000|Overall Study|Lack of Efficacy|2|||
124734818|NCT01920893|448650978|FG001|Overall Study|Lack of Efficacy|0|||
124734819|NCT03440918|448650990|FG000|Overall Study|Protocol Violation|0|||
124734820|NCT03440918|448650991|FG001|Overall Study|Protocol Violation|16|||
124611471|NCT02695537|448196945|FG000|Overall Study|Adverse Event|3|||
124611472|NCT02695537|448196945|FG000|Overall Study|Lack of Efficacy|28|||
124611473|NCT02695537|448196945|FG000|Overall Study|Withdrawal by Subject|4|||
124611474|NCT02695537|448196945|FG000|Overall Study|Protocol Violation|3|||
124611475|NCT03597529|448196946|FG000|Overall Study|Lost to Follow-up|10|||
124611476|NCT03597529|448196947|FG001|Overall Study|Lost to Follow-up|12|||
124611477|NCT03597529|448196946|FG000|Overall Study|Physician Decision|3|||
124611478|NCT03597529|448196947|FG001|Overall Study|Physician Decision|1|||
124611479|NCT03597529|448196946|FG000|Overall Study|Withdrawal by Subject|6|||
124611480|NCT03597529|448196947|FG001|Overall Study|Withdrawal by Subject|3|||
124611481|NCT03597529|448196946|FG000|Overall Study|Non-compliant with study activities|1|||
124611482|NCT03597529|448196947|FG001|Overall Study|Non-compliant with study activities|2|||
124611483|NCT01755767|448196950|FG000|Overall Study|Progressive Disease|8|||
124611484|NCT01755767|448196951|FG001|Overall Study|Progressive Disease|7|||
124611485|NCT01755767|448196952|FG002|Overall Study|Progressive Disease|91|||
124611486|NCT01755767|448196953|FG003|Overall Study|Progressive Disease|43|||
124611487|NCT01755767|448196950|FG000|Overall Study|Clinical Disease Progression|4|||
124611488|NCT01755767|448196951|FG001|Overall Study|Clinical Disease Progression|2|||
124611489|NCT01755767|448196952|FG002|Overall Study|Clinical Disease Progression|29|||
124611490|NCT01755767|448196953|FG003|Overall Study|Clinical Disease Progression|20|||
124611491|NCT01755767|448196950|FG000|Overall Study|Radiographic Disease Progression|9|||
124611492|NCT01755767|448196951|FG001|Overall Study|Radiographic Disease Progression|4|||
124611493|NCT01755767|448196952|FG002|Overall Study|Radiographic Disease Progression|44|||
124611494|NCT01755767|448196953|FG003|Overall Study|Radiographic Disease Progression|27|||
124611495|NCT01755767|448196950|FG000|Overall Study|Adverse Event|6|||
124611496|NCT01755767|448196951|FG001|Overall Study|Adverse Event|0|||
124611497|NCT01755767|448196952|FG002|Overall Study|Adverse Event|28|||
124611498|NCT01755767|448196953|FG003|Overall Study|Adverse Event|11|||
124611499|NCT01755767|448196950|FG000|Overall Study|Death|1|||
124611500|NCT01755767|448196951|FG001|Overall Study|Death|2|||
124611501|NCT01755767|448196952|FG002|Overall Study|Death|15|||
124611502|NCT01755767|448196953|FG003|Overall Study|Death|4|||
124611503|NCT01755767|448196950|FG000|Overall Study|Subject Decision|0|||
124611504|NCT01755767|448196951|FG001|Overall Study|Subject Decision|0|||
124611505|NCT01755767|448196952|FG002|Overall Study|Subject Decision|10|||
124611506|NCT01755767|448196953|FG003|Overall Study|Subject Decision|3|||
124611507|NCT01755767|448196950|FG000|Overall Study|Withdrawal by Subject|0|||
124611508|NCT01755767|448196951|FG001|Overall Study|Withdrawal by Subject|0|||
124611509|NCT01755767|448196952|FG002|Overall Study|Withdrawal by Subject|2|||
124611510|NCT01755767|448196953|FG003|Overall Study|Withdrawal by Subject|1|||
124611511|NCT01755767|448196950|FG000|Overall Study|Other|0|||
124611512|NCT01755767|448196951|FG001|Overall Study|Other|0|||
124611513|NCT01755767|448196952|FG002|Overall Study|Other|2|||
124611514|NCT01755767|448196953|FG003|Overall Study|Other|3|||
124611515|NCT01755767|448196950|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
124611516|NCT01755767|448196951|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
124611517|NCT01755767|448196952|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
124611518|NCT01755767|448196953|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
124611519|NCT03464630|448196954|FG000|Overall Study|Lost to Follow-up|62|||
124611520|NCT03464630|448196955|FG001|Overall Study|Lost to Follow-up|52|||
124611521|NCT03464630|448196954|FG000|Overall Study|Withdrawal by Subject|16|||
124734821|NCT03754582|448650996|FG000|Treatment Phase|Adverse Event|0|||
124781289|NCT02283762|448829140|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
124611522|NCT03464630|448196955|FG001|Overall Study|Withdrawal by Subject|10|||
124611523|NCT03464630|448196954|FG000|Overall Study|Passive Disengagement|8|||
124611524|NCT03464630|448196955|FG001|Overall Study|Passive Disengagement|4|||
124611525|NCT00191165|448196956|FG000|Overall Study|Adverse Event|2|||
124611526|NCT00191165|448196957|FG001|Overall Study|Adverse Event|0|||
124611527|NCT00191165|448196956|FG000|Overall Study|Protocol Violation|0|||
124611528|NCT00191165|448196957|FG001|Overall Study|Protocol Violation|1|||
124611529|NCT00191165|448196956|FG000|Overall Study|Participant Moved Away|0|||
124611530|NCT00191165|448196957|FG001|Overall Study|Participant Moved Away|1|||
124611531|NCT03196635|448196959|FG000|Overall Study|Withdrawal by Subject|1|||
124611532|NCT00998309|448196963|FG000|Overall Study|Protocol Violation|4|||
124734822|NCT03754582|448650997|FG001|Treatment Phase|Adverse Event|1|||
124734823|NCT03754582|448650998|FG002|Treatment Phase|Adverse Event|0|||
124611533|NCT00380744|448196967|FG000|Overall Study|Death|0|||
124611534|NCT00380744|448196968|FG001|Overall Study|Death|0|||
124611535|NCT00380744|448196969|FG002|Overall Study|Death|0|||
124611536|NCT00380744|448196970|FG003|Overall Study|Death|0|||
124611537|NCT00380744|448196971|FG004|Overall Study|Death|0|||
124611538|NCT00380744|448196972|FG005|Overall Study|Death|0|||
124611539|NCT00380744|448196973|FG006|Overall Study|Death|1|||
124611540|NCT00380744|448196967|FG000|Overall Study|Withdrawal by Subject|1|||
124611541|NCT00380744|448196968|FG001|Overall Study|Withdrawal by Subject|0|||
124611542|NCT00380744|448196969|FG002|Overall Study|Withdrawal by Subject|0|||
124611543|NCT00380744|448196970|FG003|Overall Study|Withdrawal by Subject|0|||
124611544|NCT00380744|448196971|FG004|Overall Study|Withdrawal by Subject|0|||
124611545|NCT00380744|448196972|FG005|Overall Study|Withdrawal by Subject|0|||
124611546|NCT00380744|448196973|FG006|Overall Study|Withdrawal by Subject|0|||
124611547|NCT02348723|448196987|FG000|Overall Study|No ablation|21|||
124611548|NCT02348723|448196988|FG001|Overall Study|No ablation|20|||
124611549|NCT02348723|448196987|FG000|Overall Study|Non-compliant with Protocol|1|||
124611550|NCT02348723|448196988|FG001|Overall Study|Non-compliant with Protocol|0|||
124611551|NCT02348723|448196987|FG000|Overall Study|Lost to Follow-up|1|||
124611552|NCT02348723|448196988|FG001|Overall Study|Lost to Follow-up|1|||
124611553|NCT02348723|448196987|FG000|Overall Study|Consent withdrawn|1|||
124611554|NCT02348723|448196988|FG001|Overall Study|Consent withdrawn|3|||
124611555|NCT02348723|448196987|FG000|Overall Study|Reason other than specified|1|||
124611556|NCT02348723|448196988|FG001|Overall Study|Reason other than specified|1|||
124611557|NCT02348723|448196987|FG000|Overall Study|Adverse Event|3|||
124611558|NCT02348723|448196988|FG001|Overall Study|Adverse Event|1|||
124611559|NCT02365558|448196989|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
124611560|NCT02365558|448196990|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
124611561|NCT02365558|448196989|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
124611562|NCT02365558|448196990|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
124611563|NCT02828241|448196994|FG000|Overall Study|Adverse Event|7|||
124611564|NCT02828241|448196995|FG001|Overall Study|Adverse Event|2|||
124611565|NCT02828241|448196994|FG000|Overall Study|Protocol Violation|1|||
124611566|NCT02828241|448196995|FG001|Overall Study|Protocol Violation|0|||
124611567|NCT01822275|448197005|FG000|Overall Study|Withdrawal by Subject|3|||
124611568|NCT01822275|448197005|FG000|Overall Study|Adverse Event|3|||
124611569|NCT01822275|448197005|FG000|Overall Study|Progression|14|||
124611570|NCT01822275|448197005|FG000|Overall Study|Physician Decision|2|||
124611571|NCT02132754|448197006|FG000|Overall Study|Adverse Event|0|||
124611572|NCT02132754|448197007|FG001|Overall Study|Adverse Event|0|||
124611573|NCT02132754|448197008|FG002|Overall Study|Adverse Event|0|||
124611574|NCT02132754|448197009|FG003|Overall Study|Adverse Event|0|||
124611575|NCT02132754|448197010|FG004|Overall Study|Adverse Event|0|||
124611576|NCT02132754|448197011|FG005|Overall Study|Adverse Event|0|||
124611577|NCT02132754|448197012|FG006|Overall Study|Adverse Event|0|||
124611578|NCT02132754|448197013|FG007|Overall Study|Adverse Event|0|||
124611579|NCT02132754|448197014|FG008|Overall Study|Adverse Event|0|||
124611580|NCT02132754|448197015|FG009|Overall Study|Adverse Event|0|||
124611581|NCT02132754|448197016|FG010|Overall Study|Adverse Event|0|||
124611582|NCT02132754|448197017|FG011|Overall Study|Adverse Event|0|||
124611583|NCT02132754|448197018|FG012|Overall Study|Adverse Event|0|||
124611584|NCT02132754|448197019|FG013|Overall Study|Adverse Event|0|||
124611585|NCT02132754|448197020|FG014|Overall Study|Adverse Event|0|||
124611586|NCT02132754|448197021|FG015|Overall Study|Adverse Event|0|||
124611587|NCT02132754|448197022|FG016|Overall Study|Adverse Event|0|||
124611588|NCT02132754|448197023|FG017|Overall Study|Adverse Event|1|||
124611589|NCT02132754|448197024|FG018|Overall Study|Adverse Event|0|||
124611590|NCT02132754|448197025|FG019|Overall Study|Adverse Event|0|||
124611591|NCT02132754|448197026|FG020|Overall Study|Adverse Event|0|||
124611592|NCT02132754|448197027|FG021|Overall Study|Adverse Event|0|||
124611593|NCT02132754|448197028|FG022|Overall Study|Adverse Event|0|||
124611594|NCT02132754|448197029|FG023|Overall Study|Adverse Event|0|||
124611595|NCT02132754|448197030|FG024|Overall Study|Adverse Event|0|||
124611596|NCT02132754|448197031|FG025|Overall Study|Adverse Event|1|||
124611597|NCT02132754|448197032|FG026|Overall Study|Adverse Event|1|||
124611598|NCT02132754|448197033|FG027|Overall Study|Adverse Event|0|||
124611599|NCT02132754|448197034|FG028|Overall Study|Adverse Event|0|||
124611600|NCT02132754|448197035|FG029|Overall Study|Adverse Event|0|||
124611601|NCT02132754|448197036|FG030|Overall Study|Adverse Event|1|||
124611602|NCT02132754|448197037|FG031|Overall Study|Adverse Event|0|||
124611603|NCT02132754|448197038|FG032|Overall Study|Adverse Event|1|||
124611604|NCT02132754|448197039|FG033|Overall Study|Adverse Event|1|||
124611605|NCT02132754|448197006|FG000|Overall Study|Clinical Progression|0|||
124611606|NCT02132754|448197007|FG001|Overall Study|Clinical Progression|0|||
124611607|NCT02132754|448197008|FG002|Overall Study|Clinical Progression|0|||
124611608|NCT02132754|448197009|FG003|Overall Study|Clinical Progression|0|||
124611609|NCT02132754|448197010|FG004|Overall Study|Clinical Progression|0|||
124611610|NCT02132754|448197011|FG005|Overall Study|Clinical Progression|0|||
124611611|NCT02132754|448197012|FG006|Overall Study|Clinical Progression|0|||
124611612|NCT02132754|448197013|FG007|Overall Study|Clinical Progression|0|||
124611613|NCT02132754|448197014|FG008|Overall Study|Clinical Progression|0|||
124611614|NCT02132754|448197015|FG009|Overall Study|Clinical Progression|1|||
124611615|NCT02132754|448197016|FG010|Overall Study|Clinical Progression|0|||
124611616|NCT02132754|448197017|FG011|Overall Study|Clinical Progression|0|||
124611617|NCT02132754|448197018|FG012|Overall Study|Clinical Progression|0|||
124611618|NCT02132754|448197019|FG013|Overall Study|Clinical Progression|0|||
124611619|NCT02132754|448197020|FG014|Overall Study|Clinical Progression|0|||
124611620|NCT02132754|448197021|FG015|Overall Study|Clinical Progression|0|||
124611621|NCT02132754|448197022|FG016|Overall Study|Clinical Progression|1|||
124611622|NCT02132754|448197023|FG017|Overall Study|Clinical Progression|1|||
124611623|NCT02132754|448197024|FG018|Overall Study|Clinical Progression|0|||
124611624|NCT02132754|448197025|FG019|Overall Study|Clinical Progression|1|||
124611625|NCT02132754|448197026|FG020|Overall Study|Clinical Progression|0|||
124611626|NCT02132754|448197027|FG021|Overall Study|Clinical Progression|0|||
124611627|NCT02132754|448197028|FG022|Overall Study|Clinical Progression|1|||
124611628|NCT02132754|448197029|FG023|Overall Study|Clinical Progression|0|||
124611629|NCT02132754|448197030|FG024|Overall Study|Clinical Progression|1|||
124611630|NCT02132754|448197031|FG025|Overall Study|Clinical Progression|1|||
124611631|NCT02132754|448197032|FG026|Overall Study|Clinical Progression|0|||
124611632|NCT02132754|448197033|FG027|Overall Study|Clinical Progression|1|||
124734824|NCT03754582|448650996|FG000|Follow-up Phase|Other|0|||
124734825|NCT03754582|448650997|FG001|Follow-up Phase|Other|0|||
124734826|NCT03754582|448650998|FG002|Follow-up Phase|Other|1|||
124734827|NCT02680574|448650999|FG000|Overall Study|Death|137|||
124734828|NCT02680574|448651000|FG001|Overall Study|Death|137|||
124734829|NCT02680574|448650999|FG000|Overall Study|Withdrawal by Subject|17|||
124734830|NCT02680574|448651000|FG001|Overall Study|Withdrawal by Subject|9|||
124734831|NCT02680574|448650999|FG000|Overall Study|Lost to Follow-up|4|||
124734832|NCT02680574|448651000|FG001|Overall Study|Lost to Follow-up|6|||
124734833|NCT02847858|448651001|FG000|Overall Study|Lost to Follow-up|401|||
124734834|NCT02847858|448651002|FG001|Overall Study|Lost to Follow-up|269|||
124734835|NCT00711802|448651004|FG000|Overall Study|Not treated (no further detail)|2|||
124734836|NCT00711802|448651005|FG001|Overall Study|Not treated (no further detail)|1|||
124734837|NCT00711802|448651006|FG002|Overall Study|Not treated (no further detail)|2|||
124734838|NCT00711802|448651007|FG003|Overall Study|Not treated (no further detail)|0|||
124734839|NCT00711802|448651008|FG004|Overall Study|Not treated (no further detail)|2|||
124734840|NCT00711802|448651009|FG005|Overall Study|Not treated (no further detail)|0|||
124734841|NCT00711802|448651010|FG006|Overall Study|Not treated (no further detail)|0|||
124734842|NCT00711802|448651011|FG007|Overall Study|Not treated (no further detail)|0|||
124734843|NCT00711802|448651004|FG000|Overall Study|Adverse Event|0|||
124734844|NCT00711802|448651005|FG001|Overall Study|Adverse Event|0|||
124734845|NCT00711802|448651006|FG002|Overall Study|Adverse Event|0|||
124734846|NCT00711802|448651007|FG003|Overall Study|Adverse Event|0|||
124734847|NCT00711802|448651008|FG004|Overall Study|Adverse Event|1|||
124734848|NCT00711802|448651009|FG005|Overall Study|Adverse Event|1|||
124734849|NCT00711802|448651010|FG006|Overall Study|Adverse Event|0|||
124734850|NCT00711802|448651011|FG007|Overall Study|Adverse Event|0|||
124734851|NCT00711802|448651004|FG000|Overall Study|Microbiological failure|0|||
124734852|NCT00711802|448651005|FG001|Overall Study|Microbiological failure|1|||
124734853|NCT00711802|448651006|FG002|Overall Study|Microbiological failure|0|||
124734854|NCT00711802|448651007|FG003|Overall Study|Microbiological failure|0|||
124734855|NCT00711802|448651008|FG004|Overall Study|Microbiological failure|0|||
124734856|NCT00711802|448651009|FG005|Overall Study|Microbiological failure|1|||
124734857|NCT00711802|448651010|FG006|Overall Study|Microbiological failure|0|||
124734858|NCT00711802|448651011|FG007|Overall Study|Microbiological failure|0|||
124734859|NCT00711802|448651004|FG000|Overall Study|Protocol Violation|0|||
124734860|NCT00711802|448651005|FG001|Overall Study|Protocol Violation|0|||
124734861|NCT00711802|448651006|FG002|Overall Study|Protocol Violation|0|||
124734862|NCT00711802|448651007|FG003|Overall Study|Protocol Violation|1|||
124734863|NCT00711802|448651008|FG004|Overall Study|Protocol Violation|0|||
124734864|NCT00711802|448651009|FG005|Overall Study|Protocol Violation|0|||
124734865|NCT00711802|448651010|FG006|Overall Study|Protocol Violation|0|||
124734866|NCT00711802|448651011|FG007|Overall Study|Protocol Violation|0|||
124611633|NCT02132754|448197034|FG028|Overall Study|Clinical Progression|1|||
124611634|NCT02132754|448197035|FG029|Overall Study|Clinical Progression|0|||
124611635|NCT02132754|448197036|FG030|Overall Study|Clinical Progression|1|||
124734867|NCT00711802|448651004|FG000|Overall Study|Physician Decision|0|||
124734868|NCT00711802|448651005|FG001|Overall Study|Physician Decision|2|||
124734869|NCT00711802|448651006|FG002|Overall Study|Physician Decision|0|||
124734870|NCT00711802|448651007|FG003|Overall Study|Physician Decision|0|||
124734871|NCT00711802|448651008|FG004|Overall Study|Physician Decision|0|||
124611636|NCT02132754|448197037|FG031|Overall Study|Clinical Progression|0|||
124611637|NCT02132754|448197038|FG032|Overall Study|Clinical Progression|0|||
124734872|NCT00711802|448651009|FG005|Overall Study|Physician Decision|0|||
124734873|NCT00711802|448651010|FG006|Overall Study|Physician Decision|0|||
124734874|NCT00711802|448651011|FG007|Overall Study|Physician Decision|0|||
124734875|NCT00711802|448651004|FG000|Overall Study|Withdrawal by Subject|0|||
124734876|NCT00711802|448651005|FG001|Overall Study|Withdrawal by Subject|1|||
124734877|NCT00711802|448651006|FG002|Overall Study|Withdrawal by Subject|0|||
124734878|NCT00711802|448651007|FG003|Overall Study|Withdrawal by Subject|1|||
124734879|NCT00711802|448651008|FG004|Overall Study|Withdrawal by Subject|0|||
124734880|NCT00711802|448651009|FG005|Overall Study|Withdrawal by Subject|0|||
124734881|NCT00711802|448651010|FG006|Overall Study|Withdrawal by Subject|0|||
124734882|NCT00711802|448651011|FG007|Overall Study|Withdrawal by Subject|0|||
124734883|NCT00711802|448651004|FG000|Overall Study|Lost to Follow-up|0|||
124734884|NCT00711802|448651005|FG001|Overall Study|Lost to Follow-up|0|||
124734885|NCT00711802|448651006|FG002|Overall Study|Lost to Follow-up|3|||
124734886|NCT00711802|448651007|FG003|Overall Study|Lost to Follow-up|1|||
124734887|NCT00711802|448651008|FG004|Overall Study|Lost to Follow-up|10|||
124734888|NCT00711802|448651009|FG005|Overall Study|Lost to Follow-up|6|||
124734889|NCT00711802|448651010|FG006|Overall Study|Lost to Follow-up|4|||
124734890|NCT00711802|448651011|FG007|Overall Study|Lost to Follow-up|2|||
124734891|NCT00711802|448651004|FG000|Overall Study|Reason not reported|0|||
124734892|NCT00711802|448651005|FG001|Overall Study|Reason not reported|1|||
124734893|NCT00711802|448651006|FG002|Overall Study|Reason not reported|1|||
124734894|NCT00711802|448651007|FG003|Overall Study|Reason not reported|0|||
124734895|NCT00711802|448651008|FG004|Overall Study|Reason not reported|1|||
124734896|NCT00711802|448651009|FG005|Overall Study|Reason not reported|0|||
124734897|NCT00711802|448651010|FG006|Overall Study|Reason not reported|1|||
124734898|NCT00711802|448651011|FG007|Overall Study|Reason not reported|0|||
124734899|NCT02305849|448651012|FG000|Overall Study|Adverse Event|10|||
124734900|NCT02305849|448651013|FG001|Overall Study|Adverse Event|12|||
124734901|NCT02305849|448651014|FG002|Overall Study|Adverse Event|7|||
124734902|NCT02305849|448651015|FG003|Overall Study|Adverse Event|3|||
124734903|NCT02305849|448651012|FG000|Overall Study|Lack of Efficacy|10|||
124734904|NCT02305849|448651013|FG001|Overall Study|Lack of Efficacy|6|||
124734905|NCT02305849|448651014|FG002|Overall Study|Lack of Efficacy|3|||
124734906|NCT02305849|448651015|FG003|Overall Study|Lack of Efficacy|9|||
124734907|NCT02305849|448651012|FG000|Overall Study|Withdrawal by Subject|2|||
124734908|NCT02305849|448651013|FG001|Overall Study|Withdrawal by Subject|2|||
124734909|NCT02305849|448651014|FG002|Overall Study|Withdrawal by Subject|1|||
124734910|NCT02305849|448651015|FG003|Overall Study|Withdrawal by Subject|4|||
124734911|NCT02305849|448651012|FG000|Overall Study|Lost to Follow-up|0|||
124734912|NCT02305849|448651013|FG001|Overall Study|Lost to Follow-up|2|||
124734913|NCT02305849|448651014|FG002|Overall Study|Lost to Follow-up|0|||
124734914|NCT02305849|448651015|FG003|Overall Study|Lost to Follow-up|0|||
124734915|NCT02305849|448651012|FG000|Overall Study|Protocol Violation|3|||
124734916|NCT02305849|448651013|FG001|Overall Study|Protocol Violation|2|||
124734917|NCT02305849|448651014|FG002|Overall Study|Protocol Violation|1|||
124734918|NCT02305849|448651015|FG003|Overall Study|Protocol Violation|1|||
124734919|NCT02305849|448651012|FG000|Overall Study|Lab data met discontinuation criteria|0|||
124734920|NCT02305849|448651013|FG001|Overall Study|Lab data met discontinuation criteria|1|||
124734921|NCT02305849|448651014|FG002|Overall Study|Lab data met discontinuation criteria|2|||
124734922|NCT02305849|448651015|FG003|Overall Study|Lab data met discontinuation criteria|1|||
124734923|NCT02305849|448651012|FG000|Overall Study|Miscellaneous|1|||
124734924|NCT02305849|448651013|FG001|Overall Study|Miscellaneous|2|||
124734925|NCT02305849|448651014|FG002|Overall Study|Miscellaneous|4|||
124734926|NCT02305849|448651015|FG003|Overall Study|Miscellaneous|1|||
124734927|NCT02305849|448651012|FG000|Overall Study|Not fulfill eligibility criteria|1|||
124734928|NCT02305849|448651013|FG001|Overall Study|Not fulfill eligibility criteria|1|||
124734929|NCT02305849|448651014|FG002|Overall Study|Not fulfill eligibility criteria|0|||
124734930|NCT02305849|448651015|FG003|Overall Study|Not fulfill eligibility criteria|0|||
124734931|NCT02410824|448651016|FG000|First Intervention (One Week)|Headache|0|||
124734932|NCT02410824|448651017|FG001|First Intervention (One Week)|Headache|1|||
124734933|NCT02782325|448651018|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
124734934|NCT02782325|448651019|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
124734935|NCT02782325|448651020|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
124734936|NCT02782325|448651018|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
124611638|NCT02132754|448197039|FG033|Overall Study|Clinical Progression|2|||
124781290|NCT02283762|448829139|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
124781291|NCT02283762|448829140|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
124734937|NCT02782325|448651019|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
124734938|NCT02782325|448651020|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
124734939|NCT02818036|448651021|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
124734940|NCT02818036|448651022|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
124734941|NCT02818036|448651021|FG000|Overall Study|Withdrawal by Subject|1|||
124734942|NCT02818036|448651022|FG001|Overall Study|Withdrawal by Subject|0|||
124734943|NCT01038713|448651023|FG000|Overall Study|Patient to hospice|1|||
124734944|NCT01038713|448651024|FG001|Overall Study|Patient to hospice|1|||
124734945|NCT01038713|448651025|FG002|Overall Study|Patient to hospice|1|||
124734946|NCT01038713|448651023|FG000|Overall Study|Lost to Follow-up|3|||
124734947|NCT01038713|448651024|FG001|Overall Study|Lost to Follow-up|0|||
124734948|NCT01038713|448651025|FG002|Overall Study|Lost to Follow-up|0|||
124734949|NCT01038713|448651023|FG000|Overall Study|Neuroendocrine Tumor|0|||
124734950|NCT01038713|448651024|FG001|Overall Study|Neuroendocrine Tumor|1|||
124734951|NCT01038713|448651025|FG002|Overall Study|Neuroendocrine Tumor|0|||
124734952|NCT01038713|448651023|FG000|Overall Study|died from PEP|0|||
124734953|NCT01038713|448651024|FG001|Overall Study|died from PEP|1|||
124734954|NCT01038713|448651025|FG002|Overall Study|died from PEP|0|||
124734955|NCT01038713|448651023|FG000|Overall Study|Autoimmune Pancreatitis|1|||
124734956|NCT01038713|448651024|FG001|Overall Study|Autoimmune Pancreatitis|0|||
124734957|NCT01038713|448651025|FG002|Overall Study|Autoimmune Pancreatitis|0|||
124734958|NCT01154283|448651028|FG000|0-6 Weeks|Withdrawal by Subject|7|||
124734959|NCT01154283|448651029|FG001|0-6 Weeks|Withdrawal by Subject|2|||
124734960|NCT01154283|448651028|FG000|0-6 Weeks|Death|0|||
124734961|NCT01154283|448651029|FG001|0-6 Weeks|Death|1|||
124734962|NCT01154283|448651028|FG000|7-12 Weeks|Death|1|||
124734963|NCT01154283|448651029|FG001|7-12 Weeks|Death|0|||
124734964|NCT01154283|448651028|FG000|7-12 Weeks|Withdrawal by Subject|0|||
124734965|NCT01154283|448651029|FG001|7-12 Weeks|Withdrawal by Subject|1|||
124734966|NCT03777917|448651030|FG000|Overall Study|Withdrawal by Subject|1|||
124734967|NCT03777917|448651031|FG001|Overall Study|Withdrawal by Subject|0|||
124734968|NCT03777917|448651030|FG000|Overall Study|Physician Decision|1|||
124734969|NCT03777917|448651031|FG001|Overall Study|Physician Decision|0|||
124734970|NCT03777917|448651030|FG000|Overall Study|Lost to Follow-up|6|||
124734971|NCT03777917|448651031|FG001|Overall Study|Lost to Follow-up|2|||
124734972|NCT03777917|448651030|FG000|Overall Study|Other|1|||
124734973|NCT03777917|448651031|FG001|Overall Study|Other|0|||
124734974|NCT00042432|448651032|FG000|Overall Study|Adverse Event|4|||
124734975|NCT00042432|448651033|FG001|Overall Study|Adverse Event|1|||
124734976|NCT00042432|448651032|FG000|Overall Study|Withdrawal by Subject|1|||
124734977|NCT00042432|448651033|FG001|Overall Study|Withdrawal by Subject|3|||
124734978|NCT00042432|448651032|FG000|Overall Study|Death|0|||
124734979|NCT00042432|448651033|FG001|Overall Study|Death|2|||
124734980|NCT00042432|448651032|FG000|Overall Study|Ineligibility determined|1|||
124734981|NCT00042432|448651033|FG001|Overall Study|Ineligibility determined|0|||
124734982|NCT00042432|448651032|FG000|Overall Study|Initiation of maintenance dialysis|1|||
124734983|NCT00042432|448651033|FG001|Overall Study|Initiation of maintenance dialysis|1|||
124734984|NCT00042432|448651032|FG000|Overall Study|Other|2|||
124734985|NCT00042432|448651033|FG001|Overall Study|Other|0|||
124734986|NCT01853072|448651034|FG000|Overall Study|Adverse event prior to treatment|0|||
124734987|NCT01853072|448651035|FG001|Overall Study|Adverse event prior to treatment|1|||
124734988|NCT01853072|448651034|FG000|Overall Study|Adverse Event|0|||
124734989|NCT01853072|448651035|FG001|Overall Study|Adverse Event|3|||
124734990|NCT01853072|448651034|FG000|Overall Study|Death|1|||
124734991|NCT01853072|448651035|FG001|Overall Study|Death|4|||
124734992|NCT01853072|448651034|FG000|Overall Study|Lost to Follow-up|0|||
124734993|NCT01853072|448651035|FG001|Overall Study|Lost to Follow-up|3|||
124734994|NCT01853072|448651034|FG000|Overall Study|Non-compliance with study drug|0|||
124734995|NCT01853072|448651035|FG001|Overall Study|Non-compliance with study drug|1|||
124734996|NCT01853072|448651034|FG000|Overall Study|Physician Decision|1|||
124734997|NCT01853072|448651035|FG001|Overall Study|Physician Decision|1|||
124734998|NCT01853072|448651034|FG000|Overall Study|Withdrawal by Subject|1|||
124734999|NCT01853072|448651035|FG001|Overall Study|Withdrawal by Subject|2|||
124735000|NCT01853072|448651034|FG000|Overall Study|Reason not specified|9|||
124735001|NCT01853072|448651035|FG001|Overall Study|Reason not specified|6|||
124735002|NCT01816906|448651036|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
124735003|NCT01816906|448651037|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
124735004|NCT01816906|448651036|FG000|Six Months|Lost to Follow-up|14|||
124735005|NCT01816906|448651037|FG001|Six Months|Lost to Follow-up|16|||
124735006|NCT01816906|448651036|FG000|12 Months|Adverse Event|2|||
124735007|NCT01816906|448651037|FG001|12 Months|Adverse Event|2|||
124735008|NCT01816906|448651036|FG000|12 Months|Death|0|||
124735009|NCT01816906|448651037|FG001|12 Months|Death|2|||
124735010|NCT01816906|448651036|FG000|12 Months|Lost to Follow-up|2|||
124735011|NCT01816906|448651037|FG001|12 Months|Lost to Follow-up|1|||
124735012|NCT01527383|448651038|FG000|Overall Study|Adverse Event|5|||
124735013|NCT01527383|448651039|FG001|Overall Study|Adverse Event|0|||
124735014|NCT01527383|448651038|FG000|Overall Study|Lost to Follow-up|3|||
124735015|NCT01527383|448651039|FG001|Overall Study|Lost to Follow-up|0|||
124735016|NCT01527383|448651038|FG000|Overall Study|Physician Decision|2|||
124735017|NCT01527383|448651039|FG001|Overall Study|Physician Decision|0|||
124735018|NCT01527383|448651038|FG000|Overall Study|Pregnancy|1|||
124735019|NCT01527383|448651039|FG001|Overall Study|Pregnancy|0|||
124735020|NCT01527383|448651038|FG000|Overall Study|Protocol Violation|1|||
124735021|NCT01527383|448651039|FG001|Overall Study|Protocol Violation|0|||
124735022|NCT01527383|448651038|FG000|Overall Study|Screen failure|1|||
124735023|NCT01527383|448651039|FG001|Overall Study|Screen failure|0|||
124735024|NCT01527383|448651038|FG000|Overall Study|Participant moved|0|||
124735025|NCT01527383|448651039|FG001|Overall Study|Participant moved|1|||
124735026|NCT01527383|448651038|FG000|Overall Study|Withdrawal by Subject|2|||
124735027|NCT01527383|448651039|FG001|Overall Study|Withdrawal by Subject|3|||
124735028|NCT00746733|448651040|FG000|Second Intervention|Adverse Event|1|||
124735029|NCT00746733|448651041|FG001|Second Intervention|Adverse Event|0|||
124735030|NCT00746733|448651040|FG000|Third Intervention|Withdrawal by Subject|1|||
124735031|NCT00746733|448651041|FG001|Third Intervention|Withdrawal by Subject|1|||
124735032|NCT03412604|448651042|FG000|Overall Study|Withdrawal by Subject|1|||
124735033|NCT01287221|448651044|FG000|Overall Study|Lack of Perceived Benefit|1|||
124735034|NCT01287221|448651045|FG001|Overall Study|Lack of Perceived Benefit|1|||
124735035|NCT01287221|448651044|FG000|Overall Study|Adverse Event|3|||
124735036|NCT01287221|448651045|FG001|Overall Study|Adverse Event|3|||
124735037|NCT01287221|448651044|FG000|Overall Study|Withdrawal by Subject|0|||
124735038|NCT01287221|448651045|FG001|Overall Study|Withdrawal by Subject|1|||
124735039|NCT00930969|448651046|FG000|Overall Study|Death|5|||
124735040|NCT00930969|448651046|FG000|Overall Study|Lost to Follow-up|1|||
124735041|NCT00930969|448651046|FG000|Overall Study|Physician Decision|13|||
124735042|NCT00930969|448651046|FG000|Overall Study|Withdrawal by Subject|19|||
124735043|NCT00657150|448651047|FG000|Overall Study|Adverse Event|19|||
124735044|NCT00657150|448651048|FG001|Overall Study|Adverse Event|10|||
124735045|NCT00657150|448651047|FG000|Overall Study|Non-compliant with protocol|5|||
124735046|NCT00657150|448651048|FG001|Overall Study|Non-compliant with protocol|9|||
124735047|NCT00657150|448651047|FG000|Overall Study|Lost to Follow-up|2|||
124735048|NCT00657150|448651048|FG001|Overall Study|Lost to Follow-up|0|||
124735049|NCT00657150|448651047|FG000|Overall Study|Withdrawal by Subject|51|||
124735050|NCT00657150|448651048|FG001|Overall Study|Withdrawal by Subject|36|||
124735051|NCT00657150|448651047|FG000|Overall Study|Other|38|||
124735052|NCT00657150|448651048|FG001|Overall Study|Other|38|||
124735053|NCT00657150|448651047|FG000|Treatment|Adverse Event|60|||
124735054|NCT00657150|448651048|FG001|Treatment|Adverse Event|53|||
124735055|NCT00657150|448651047|FG000|Treatment|Non-compliant with protocol|10|||
124735056|NCT00657150|448651048|FG001|Treatment|Non-compliant with protocol|9|||
124735057|NCT00657150|448651047|FG000|Treatment|Lost to Follow-up|1|||
124735058|NCT00657150|448651048|FG001|Treatment|Lost to Follow-up|0|||
124735059|NCT00657150|448651047|FG000|Treatment|Withdrawal by Subject|23|||
124735060|NCT00657150|448651048|FG001|Treatment|Withdrawal by Subject|20|||
124735061|NCT00657150|448651047|FG000|Treatment|Other|13|||
124735062|NCT00657150|448651048|FG001|Treatment|Other|15|||
124735063|NCT02966795|448651049|FG000|Overall Study|Patient Left the Country|0|||
124735064|NCT02966795|448651050|FG001|Overall Study|Patient Left the Country|1|||
124735065|NCT00787137|448651066|FG000|Overall Study|Study Termination|0|||
124735066|NCT00787137|448651067|FG001|Overall Study|Study Termination|0|||
124735067|NCT00787137|448651068|FG002|Overall Study|Study Termination|1|||
124735068|NCT02395055|448651074|FG000|Overall Study|Withdrawal by Subject|7|||
124735069|NCT02395055|448651075|FG001|Overall Study|Withdrawal by Subject|3|||
124735070|NCT00787930|448651076|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
124735071|NCT01896271|448651077|FG000|Overall Study|Physician Decision|10|||
124735072|NCT01367704|448651083|FG000|Overall Study|Lost to Follow-up|47|||
124735073|NCT01367704|448651084|FG001|Overall Study|Lost to Follow-up|161|||
124735074|NCT00526110|448651085|FG000|Overall Study|Adverse Event|2|||
124735075|NCT00526110|448651086|FG001|Overall Study|Adverse Event|9|||
124735076|NCT00526110|448651085|FG000|Overall Study|Disease Progression|0|||
124735077|NCT00526110|448651086|FG001|Overall Study|Disease Progression|19|||
124735078|NCT00526110|448651085|FG000|Overall Study|Maximal Response|0|||
124735079|NCT00526110|448651086|FG001|Overall Study|Maximal Response|6|||
124735080|NCT00526110|448651085|FG000|Overall Study|Withdrawal by Subject|0|||
124735081|NCT00526110|448651086|FG001|Overall Study|Withdrawal by Subject|2|||
124735082|NCT00526110|448651085|FG000|Overall Study|Poor Tolerance|0|||
124735083|NCT00526110|448651086|FG001|Overall Study|Poor Tolerance|5|||
124735084|NCT02193087|448651087|FG000|Overall Study|Adverse Event|2|||
124735085|NCT02193087|448651088|FG001|Overall Study|Adverse Event|0|||
124735086|NCT02193087|448651089|FG002|Overall Study|Adverse Event|0|||
124735087|NCT02193087|448651090|FG003|Overall Study|Adverse Event|11|||
124735088|NCT02193087|448651087|FG000|Overall Study|Lost to Follow-up|14|||
124735089|NCT02193087|448651088|FG001|Overall Study|Lost to Follow-up|6|||
124735090|NCT02193087|448651089|FG002|Overall Study|Lost to Follow-up|4|||
124735091|NCT02193087|448651090|FG003|Overall Study|Lost to Follow-up|37|||
124735092|NCT02193087|448651087|FG000|Overall Study|Protocol Violation|2|||
124735093|NCT02193087|448651088|FG001|Overall Study|Protocol Violation|0|||
124735094|NCT02193087|448651089|FG002|Overall Study|Protocol Violation|1|||
124735095|NCT02193087|448651090|FG003|Overall Study|Protocol Violation|2|||
124735096|NCT02193087|448651087|FG000|Overall Study|Withdrawal by Subject|10|||
124735097|NCT02193087|448651088|FG001|Overall Study|Withdrawal by Subject|3|||
124735098|NCT02193087|448651089|FG002|Overall Study|Withdrawal by Subject|1|||
124735099|NCT02193087|448651090|FG003|Overall Study|Withdrawal by Subject|19|||
124735100|NCT02193087|448651087|FG000|Overall Study|Other Reason Not Specified|7|||
124735101|NCT02193087|448651088|FG001|Overall Study|Other Reason Not Specified|2|||
124735102|NCT02193087|448651089|FG002|Overall Study|Other Reason Not Specified|1|||
124735103|NCT02193087|448651090|FG003|Overall Study|Other Reason Not Specified|9|||
124735104|NCT02193087|448651087|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
124735105|NCT02193087|448651088|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
124735106|NCT02193087|448651089|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
124735107|NCT02193087|448651090|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
124735108|NCT04096820|448651091|FG000|Overall Study|Did not return for intervention|2|||
124735109|NCT04096820|448651091|FG000|Overall Study|Death|1|||
124735110|NCT04030247|448652985|FG000|Overall Study|Withdrawal by Subject|4|||
124735111|NCT04030247|448652985|FG000|Overall Study|Lost to Follow-up|13|||
124735112|NCT00509093|448652986|FG000|Overall Study|Adverse Event|10|||
124735113|NCT00509093|448652986|FG000|Overall Study|Disease Progression|9|||
124735114|NCT00509093|448652986|FG000|Overall Study|Transformed into MDS|1|||
124735115|NCT00509093|448652986|FG000|Overall Study|Withdrawal by Subject|3|||
124735116|NCT00509093|448652986|FG000|Overall Study|Physician Decision|1|||
124735117|NCT04431713|448652987|FG000|Overall Study|Withdrawal by Subject|2|||
124735118|NCT04431713|448652988|FG001|Overall Study|Withdrawal by Subject|0|||
124735119|NCT04431713|448652987|FG000|Overall Study|Death|2|||
124735120|NCT04431713|448652988|FG001|Overall Study|Death|2|||
124735121|NCT03383783|448652991|FG000|Overall Study|Withdrawal by Subject|2|||
124735122|NCT02838420|448652992|FG000|Overall Study|Ongoing in Study|113|||
124735123|NCT02838420|448652993|FG001|Overall Study|Ongoing in Study|45|||
124735124|NCT02838420|448652992|FG000|Overall Study|Lost to Follow-up|1|||
124735125|NCT02838420|448652993|FG001|Overall Study|Lost to Follow-up|0|||
124735126|NCT02838420|448652992|FG000|Overall Study|Withdrawal by Subject|3|||
124735127|NCT02838420|448652993|FG001|Overall Study|Withdrawal by Subject|4|||
124735128|NCT02838420|448652992|FG000|Overall Study|Death|8|||
124735129|NCT02838420|448652993|FG001|Overall Study|Death|13|||
124735130|NCT01224821|448652997|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
124735131|NCT01224821|448652997|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
124735132|NCT01224821|448652997|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
124735133|NCT01224821|448652997|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
124735134|NCT01224821|448652997|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
124735135|NCT01224821|448652997|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
124735136|NCT01224821|448652997|FG000|Long-Term Follow-Up|Death|2|||
124735137|NCT01224821|448652997|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
124735138|NCT01340937|448652998|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
124735139|NCT01340937|448652999|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
124735140|NCT01340937|448653000|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
124735141|NCT01340937|448653001|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
124735142|NCT01340937|448652998|FG000|Period 1: Infant Series|Adverse Event|0|||
124735143|NCT01340937|448652999|FG001|Period 1: Infant Series|Adverse Event|1|||
124735144|NCT01340937|448653000|FG002|Period 1: Infant Series|Adverse Event|4|||
124735145|NCT01340937|448653001|FG003|Period 1: Infant Series|Adverse Event|0|||
124735146|NCT01340937|448652998|FG000|Period 1: Infant Series|Death|2|||
124735147|NCT01340937|448652999|FG001|Period 1: Infant Series|Death|0|||
124735148|NCT01340937|448653000|FG002|Period 1: Infant Series|Death|2|||
124735149|NCT01340937|448653001|FG003|Period 1: Infant Series|Death|0|||
124735150|NCT01340937|448652998|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
124735151|NCT01340937|448652999|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
124735152|NCT01340937|448653000|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
124735153|NCT01340937|448653001|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
124735154|NCT01340937|448652998|FG000|Period 1: Infant Series|Physician Decision|2|||
124735155|NCT01340937|448652999|FG001|Period 1: Infant Series|Physician Decision|3|||
124735156|NCT01340937|448653000|FG002|Period 1: Infant Series|Physician Decision|1|||
124735157|NCT01340937|448653001|FG003|Period 1: Infant Series|Physician Decision|0|||
124735158|NCT01340937|448652998|FG000|Period 1: Infant Series|Protocol Violation|1|||
124735159|NCT01340937|448652999|FG001|Period 1: Infant Series|Protocol Violation|4|||
124735160|NCT01340937|448653000|FG002|Period 1: Infant Series|Protocol Violation|4|||
124735161|NCT01340937|448653001|FG003|Period 1: Infant Series|Protocol Violation|3|||
124781292|NCT02283762|448829139|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
124781293|NCT02283762|448829140|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
124781294|NCT02283762|448829139|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
124781295|NCT02283762|448829140|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
124781296|NCT02283762|448829139|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
124781297|NCT02283762|448829140|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
124735162|NCT01340937|448652998|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
124735163|NCT01340937|448652999|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
124735164|NCT01340937|448653000|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
124735165|NCT01340937|448653001|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
124735166|NCT01340937|448652998|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
124735167|NCT01340937|448652999|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
124735168|NCT01340937|448653000|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
124735169|NCT01340937|448653001|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
124735170|NCT01340937|448652998|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
124735171|NCT01340937|448652999|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
124781298|NCT02283762|448829139|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
124735172|NCT01340937|448653000|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
124735173|NCT01340937|448653001|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
124735174|NCT01340937|448652998|FG000|Period 2: Interim Period|Adverse Event|1|||
124735175|NCT01340937|448652999|FG001|Period 2: Interim Period|Adverse Event|0|||
124735176|NCT01340937|448653000|FG002|Period 2: Interim Period|Adverse Event|1|||
124735177|NCT01340937|448653001|FG003|Period 2: Interim Period|Adverse Event|0|||
124735178|NCT01340937|448652998|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
124735179|NCT01340937|448652999|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
124735180|NCT01340937|448653000|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
124735181|NCT01340937|448653001|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
124735182|NCT01340937|448652998|FG000|Period 2: Interim Period|Physician Decision|0|||
124735183|NCT01340937|448652999|FG001|Period 2: Interim Period|Physician Decision|1|||
124735184|NCT01340937|448653000|FG002|Period 2: Interim Period|Physician Decision|1|||
124735185|NCT01340937|448653001|FG003|Period 2: Interim Period|Physician Decision|0|||
124735186|NCT01340937|448652998|FG000|Period 2: Interim Period|Protocol Violation|5|||
124735187|NCT01340937|448652999|FG001|Period 2: Interim Period|Protocol Violation|3|||
124735188|NCT01340937|448653000|FG002|Period 2: Interim Period|Protocol Violation|6|||
124735189|NCT01340937|448653001|FG003|Period 2: Interim Period|Protocol Violation|3|||
124735190|NCT01340937|448652998|FG000|Period 2: Interim Period|Technical problems|4|||
124735191|NCT01340937|448652999|FG001|Period 2: Interim Period|Technical problems|4|||
124735192|NCT01340937|448653000|FG002|Period 2: Interim Period|Technical problems|6|||
124735193|NCT01340937|448653001|FG003|Period 2: Interim Period|Technical problems|3|||
124735194|NCT01340937|448652998|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
124735195|NCT01340937|448652999|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
124735196|NCT01340937|448653000|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
124735197|NCT01340937|448653001|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
124735198|NCT01340937|448652998|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
124735199|NCT01340937|448652999|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
124735200|NCT01340937|448653000|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
124735201|NCT01340937|448653001|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
124735202|NCT01340937|448652998|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
124735203|NCT01340937|448652999|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
124735204|NCT01340937|448653000|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
124735205|NCT01340937|448653001|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
124735206|NCT01340937|448652998|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
124735207|NCT01340937|448652999|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
124735208|NCT01340937|448653000|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
124735209|NCT01340937|448653001|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
124735210|NCT02469415|448653005|FG000|Overall Study|Withdrawal by Subject|1|||
124735211|NCT02469415|448653005|FG000|Overall Study|Investigational agent placed on hold|2|||
124735212|NCT00350623|448653008|FG000|Overall Study|Lost to Follow-up|8|||
124735213|NCT00350623|448653009|FG001|Overall Study|Lost to Follow-up|3|||
124735214|NCT00350623|448653010|FG002|Overall Study|Lost to Follow-up|4|||
124735215|NCT00350623|448653008|FG000|Overall Study|Withdrawal by Subject|0|||
124735216|NCT00350623|448653009|FG001|Overall Study|Withdrawal by Subject|1|||
124735217|NCT00350623|448653010|FG002|Overall Study|Withdrawal by Subject|1|||
124735218|NCT00350623|448653008|FG000|Overall Study|patient traveling outside the country|0|||
124735219|NCT00350623|448653009|FG001|Overall Study|patient traveling outside the country|0|||
124735220|NCT00350623|448653010|FG002|Overall Study|patient traveling outside the country|1|||
124735221|NCT00623545|448653011|FG000|Overall Study|Adverse Event|6|||
124735222|NCT00623545|448653011|FG000|Overall Study|Withdrawal by Subject|4|||
124735223|NCT04126564|448653012|FG000|Overall Study|Withdrawal by Subject|0|||
124735224|NCT04126564|448653013|FG001|Overall Study|Withdrawal by Subject|2|||
124735225|NCT04126564|448653012|FG000|Overall Study|Lost to Follow-up|0|||
124735226|NCT04126564|448653013|FG001|Overall Study|Lost to Follow-up|1|||
124735227|NCT03500172|448653014|FG000|Period 1: Baseline Randomization|Death|0|||
124735228|NCT03500172|448653015|FG001|Period 1: Baseline Randomization|Death|0|||
124735229|NCT03500172|448653016|FG002|Period 1: Baseline Randomization|Death|0|||
124735230|NCT03500172|448653017|FG003|Period 1: Baseline Randomization|Death|0|||
124735231|NCT03500172|448653018|FG004|Period 1: Baseline Randomization|Death|0|||
124735232|NCT03500172|448653019|FG005|Period 1: Baseline Randomization|Death|0|||
124735233|NCT03500172|448653020|FG006|Period 1: Baseline Randomization|Death|0|||
124735234|NCT03500172|448653021|FG007|Period 1: Baseline Randomization|Death|0|||
124735235|NCT03500172|448653022|FG008|Period 1: Baseline Randomization|Death|0|||
124735236|NCT03500172|448653023|FG009|Period 1: Baseline Randomization|Death|2|||
124735237|NCT03500172|448653024|FG010|Period 1: Baseline Randomization|Death|0|||
124735238|NCT03500172|448653014|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
124735239|NCT03500172|448653015|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
124735240|NCT03500172|448653016|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
124781299|NCT02283762|448829140|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
124781300|NCT02283762|448829139|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
124735241|NCT03500172|448653017|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
124735242|NCT03500172|448653018|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
124735243|NCT03500172|448653019|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
124735244|NCT03500172|448653020|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
124735245|NCT03500172|448653021|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
124735246|NCT03500172|448653022|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
124735247|NCT03500172|448653023|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
124735248|NCT03500172|448653024|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
124735249|NCT03500172|448653014|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
124735250|NCT03500172|448653015|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
124735251|NCT03500172|448653016|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
124735252|NCT03500172|448653017|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
124735253|NCT03500172|448653018|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
124735254|NCT03500172|448653019|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
124735255|NCT03500172|448653020|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
124735256|NCT03500172|448653021|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
124735257|NCT03500172|448653022|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
124735258|NCT03500172|448653023|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
124735259|NCT03500172|448653024|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
124735260|NCT03500172|448653014|FG000|Period 2: Re-Randomization|Death|0|||
124735261|NCT03500172|448653015|FG001|Period 2: Re-Randomization|Death|0|||
124735262|NCT03500172|448653016|FG002|Period 2: Re-Randomization|Death|0|||
124735263|NCT03500172|448653017|FG003|Period 2: Re-Randomization|Death|4|||
124735264|NCT03500172|448653018|FG004|Period 2: Re-Randomization|Death|2|||
124735265|NCT03500172|448653019|FG005|Period 2: Re-Randomization|Death|0|||
124735266|NCT03500172|448653020|FG006|Period 2: Re-Randomization|Death|5|||
124735267|NCT03500172|448653021|FG007|Period 2: Re-Randomization|Death|2|||
124735268|NCT03500172|448653022|FG008|Period 2: Re-Randomization|Death|0|||
124735269|NCT03500172|448653023|FG009|Period 2: Re-Randomization|Death|0|||
124735270|NCT03500172|448653024|FG010|Period 2: Re-Randomization|Death|0|||
124735271|NCT01974752|448653031|FG000|Overall Study|Death|33|||
124735272|NCT01974752|448653032|FG001|Overall Study|Death|11|||
124735273|NCT01974752|448653031|FG000|Overall Study|Lost to Follow-up|2|||
124735274|NCT01974752|448653032|FG001|Overall Study|Lost to Follow-up|0|||
124735275|NCT01974752|448653031|FG000|Overall Study|Withdrawal by Subject|2|||
124735276|NCT01974752|448653032|FG001|Overall Study|Withdrawal by Subject|3|||
124735277|NCT01974752|448653031|FG000|Overall Study|Other Eligibility Criteria|0|||
124735278|NCT01974752|448653032|FG001|Overall Study|Other Eligibility Criteria|1|||
124735279|NCT02435680|448653039|FG000|Overall Study|Physician Decision|3|||
124735280|NCT02435680|448653040|FG001|Overall Study|Physician Decision|0|||
124735281|NCT02435680|448653041|FG002|Overall Study|Physician Decision|0|||
124735282|NCT02435680|448653039|FG000|Overall Study|subject / guardian decision|0|||
124735283|NCT02435680|448653040|FG001|Overall Study|subject / guardian decision|3|||
124735284|NCT02435680|448653041|FG002|Overall Study|subject / guardian decision|2|||
124735285|NCT02435680|448653039|FG000|Overall Study|Adverse Event|8|||
124735286|NCT02435680|448653040|FG001|Overall Study|Adverse Event|3|||
124735287|NCT02435680|448653041|FG002|Overall Study|Adverse Event|2|||
124735288|NCT02435680|448653039|FG000|Overall Study|progressive disease|10|||
124735289|NCT02435680|448653040|FG001|Overall Study|progressive disease|7|||
124735290|NCT02435680|448653041|FG002|Overall Study|progressive disease|11|||
124735291|NCT02435680|448653039|FG000|Overall Study|not treated|0|||
124735292|NCT02435680|448653040|FG001|Overall Study|not treated|0|||
124735293|NCT02435680|448653041|FG002|Overall Study|not treated|1|||
124735294|NCT00330928|448653042|FG000|Overall Study|Lost to Follow-up|6|||
124735295|NCT00330928|448653042|FG000|Overall Study|Physician Decision|9|||
124735296|NCT00330928|448653042|FG000|Overall Study|Death|1|||
124735297|NCT00330928|448653042|FG000|Overall Study|IVUS could not be performed.|1|||
124735298|NCT00445848|448653043|FG000|Overall Study|Adverse Event|14|||
124735299|NCT00445848|448653043|FG000|Overall Study|Withdrawal by Subject|4|||
124735300|NCT00445848|448653043|FG000|Overall Study|Progression|62|||
124735301|NCT00445848|448653043|FG000|Overall Study|Other-Not protocol specified|5|||
124735302|NCT03028480|448653046|FG000|Overall Study|No revisit after the first prescription date|2|||
124735303|NCT03028480|448653046|FG000|Overall Study|Did not use the drug|1|||
124735304|NCT03028480|448653046|FG000|Overall Study|Violation of the enrollment deadline|10|||
124735305|NCT03028480|448653046|FG000|Overall Study|Case report forms were not collected|21|||
124781301|NCT02283762|448829140|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
124735306|NCT02279719|448653051|FG000|Overall Study|Patients randomized but never treated|0|||
124735307|NCT02279719|448653052|FG001|Overall Study|Patients randomized but never treated|0|||
124735308|NCT02279719|448653053|FG002|Overall Study|Patients randomized but never treated|0|||
124735309|NCT02279719|448653054|FG003|Overall Study|Patients randomized but never treated|0|||
124735310|NCT02279719|448653055|FG004|Overall Study|Patients randomized but never treated|3|||
124735311|NCT02279719|448653056|FG005|Overall Study|Patients randomized but never treated|0|||
124735312|NCT02279719|448653057|FG006|Overall Study|Patients randomized but never treated|3|||
124735313|NCT03541187|448653058|FG000|Overall Study|Lost to Follow-up|2|||
124735314|NCT03541187|448653059|FG001|Overall Study|Lost to Follow-up|6|||
124735315|NCT03541187|448653058|FG000|Overall Study|Pregnancy|0|||
124735316|NCT03541187|448653059|FG001|Overall Study|Pregnancy|1|||
124735317|NCT03541187|448653058|FG000|Overall Study|Withdrawal by Subject|6|||
124735318|NCT03541187|448653059|FG001|Overall Study|Withdrawal by Subject|2|||
124735319|NCT03541187|448653058|FG000|Overall Study|Moved out of town|1|||
124735320|NCT03541187|448653059|FG001|Overall Study|Moved out of town|0|||
124735321|NCT03541187|448653058|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
124735322|NCT03541187|448653059|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
124735323|NCT03541187|448653058|FG000|Overall Study|Did not meet randomization criteria|1|||
124735324|NCT03541187|448653059|FG001|Overall Study|Did not meet randomization criteria|1|||
124735325|NCT03541187|448653058|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
124735326|NCT03541187|448653059|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
124735327|NCT03541187|448653058|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
124735328|NCT03541187|448653059|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
124735329|NCT00869050|448653062|FG000|Overall Study|Screen Failure|3|||
124735330|NCT01369680|448653063|FG000|Overall Study|Lost to Follow-up|0|||
124735331|NCT01369680|448653064|FG001|Overall Study|Lost to Follow-up|0|||
124735332|NCT01369680|448653065|FG002|Overall Study|Lost to Follow-up|1|||
124735333|NCT01369680|448653066|FG003|Overall Study|Lost to Follow-up|2|||
124735334|NCT01062841|448653073|FG000|Overall Study|Indwelling Device Removed|41|||
124735335|NCT01062841|448653074|FG001|Overall Study|Indwelling Device Removed|48|||
124735336|NCT01062841|448653073|FG000|Overall Study|Death|3|||
124735337|NCT01062841|448653074|FG001|Overall Study|Death|5|||
124735338|NCT01062841|448653073|FG000|Overall Study|Withdrawal by Subject|2|||
124735339|NCT01062841|448653074|FG001|Overall Study|Withdrawal by Subject|0|||
124735340|NCT01062841|448653073|FG000|Overall Study|Withdrawal by Study|3|||
124735341|NCT01062841|448653074|FG001|Overall Study|Withdrawal by Study|0|||
124735342|NCT01218100|448653075|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
124735343|NCT01218100|448653076|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
124735344|NCT01218100|448653077|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
124735345|NCT01218100|448653078|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
124735346|NCT01218100|448653075|FG000|Overall Study|Adverse Event|4|||
124735347|NCT01218100|448653076|FG001|Overall Study|Adverse Event|6|||
124735348|NCT01218100|448653077|FG002|Overall Study|Adverse Event|6|||
124735349|NCT01218100|448653078|FG003|Overall Study|Adverse Event|7|||
124735350|NCT01218100|448653075|FG000|Overall Study|Lack of Efficacy|9|||
124735351|NCT01218100|448653076|FG001|Overall Study|Lack of Efficacy|6|||
124735352|NCT01218100|448653077|FG002|Overall Study|Lack of Efficacy|5|||
124735353|NCT01218100|448653078|FG003|Overall Study|Lack of Efficacy|12|||
124735354|NCT01218100|448653075|FG000|Overall Study|Protocol Violation|0|||
124735355|NCT01218100|448653076|FG001|Overall Study|Protocol Violation|0|||
124735356|NCT01218100|448653077|FG002|Overall Study|Protocol Violation|1|||
124735357|NCT01218100|448653078|FG003|Overall Study|Protocol Violation|1|||
124735358|NCT01218100|448653075|FG000|Overall Study|Withdrawal by Subject|5|||
124735359|NCT01218100|448653076|FG001|Overall Study|Withdrawal by Subject|2|||
124735360|NCT01218100|448653077|FG002|Overall Study|Withdrawal by Subject|6|||
124735361|NCT01218100|448653078|FG003|Overall Study|Withdrawal by Subject|7|||
124735362|NCT01218100|448653075|FG000|Overall Study|Lost to Follow-up|3|||
124735363|NCT01218100|448653076|FG001|Overall Study|Lost to Follow-up|8|||
124735364|NCT01218100|448653077|FG002|Overall Study|Lost to Follow-up|2|||
124735365|NCT01218100|448653078|FG003|Overall Study|Lost to Follow-up|1|||
124735366|NCT01218100|448653075|FG000|Overall Study|Other Reason|2|||
124735367|NCT01218100|448653076|FG001|Overall Study|Other Reason|2|||
124735368|NCT01218100|448653077|FG002|Overall Study|Other Reason|6|||
124735369|NCT01218100|448653078|FG003|Overall Study|Other Reason|4|||
124735370|NCT01396265|448653080|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
124735371|NCT02275117|448653081|FG000|Overall Study|Adverse Event|0|||
124735372|NCT02275117|448653082|FG001|Overall Study|Adverse Event|0|||
124735373|NCT02275117|448653083|FG002|Overall Study|Adverse Event|0|||
124735374|NCT02275117|448653084|FG003|Overall Study|Adverse Event|0|||
124735375|NCT02275117|448653085|FG004|Overall Study|Adverse Event|1|||
124735376|NCT02275117|448653081|FG000|Overall Study|Lack of Efficacy|6|||
124735377|NCT02275117|448653082|FG001|Overall Study|Lack of Efficacy|7|||
124735378|NCT02275117|448653083|FG002|Overall Study|Lack of Efficacy|5|||
124735379|NCT02275117|448653084|FG003|Overall Study|Lack of Efficacy|2|||
124735380|NCT02275117|448653085|FG004|Overall Study|Lack of Efficacy|10|||
124735381|NCT02275117|448653081|FG000|Overall Study|Lost to Follow-up|11|||
124735382|NCT02275117|448653082|FG001|Overall Study|Lost to Follow-up|16|||
124735383|NCT02275117|448653083|FG002|Overall Study|Lost to Follow-up|15|||
124735384|NCT02275117|448653084|FG003|Overall Study|Lost to Follow-up|16|||
124735385|NCT02275117|448653085|FG004|Overall Study|Lost to Follow-up|8|||
124735386|NCT02275117|448653081|FG000|Overall Study|Physician Decision|0|||
124781302|NCT00202878|448829141|FG000|Overall Study|Death|964|||
124781303|NCT00202878|448829142|FG001|Overall Study|Death|968|||
124735387|NCT02275117|448653082|FG001|Overall Study|Physician Decision|1|||
124781304|NCT00202878|448829141|FG000|Overall Study|Only Vital Status Known|357|||
124781305|NCT00202878|448829142|FG001|Overall Study|Only Vital Status Known|356|||
124611639|NCT02132754|448197006|FG000|Overall Study|Death|0|||
124611640|NCT02132754|448197007|FG001|Overall Study|Death|0|||
124611641|NCT02132754|448197008|FG002|Overall Study|Death|0|||
124611642|NCT02132754|448197009|FG003|Overall Study|Death|0|||
124611643|NCT02132754|448197010|FG004|Overall Study|Death|0|||
124611644|NCT02132754|448197011|FG005|Overall Study|Death|0|||
124611645|NCT02132754|448197012|FG006|Overall Study|Death|0|||
124611646|NCT02132754|448197013|FG007|Overall Study|Death|0|||
124611647|NCT02132754|448197014|FG008|Overall Study|Death|0|||
124611648|NCT02132754|448197015|FG009|Overall Study|Death|0|||
124611649|NCT02132754|448197016|FG010|Overall Study|Death|0|||
124611650|NCT02132754|448197017|FG011|Overall Study|Death|0|||
124611651|NCT02132754|448197018|FG012|Overall Study|Death|0|||
124611652|NCT02132754|448197019|FG013|Overall Study|Death|0|||
124611653|NCT02132754|448197020|FG014|Overall Study|Death|0|||
124611654|NCT02132754|448197021|FG015|Overall Study|Death|1|||
124611655|NCT02132754|448197022|FG016|Overall Study|Death|0|||
124611656|NCT02132754|448197023|FG017|Overall Study|Death|0|||
124611657|NCT02132754|448197024|FG018|Overall Study|Death|0|||
124611658|NCT02132754|448197025|FG019|Overall Study|Death|1|||
124611659|NCT02132754|448197026|FG020|Overall Study|Death|0|||
124611660|NCT02132754|448197027|FG021|Overall Study|Death|1|||
124611661|NCT02132754|448197028|FG022|Overall Study|Death|0|||
124611662|NCT02132754|448197029|FG023|Overall Study|Death|0|||
124611663|NCT02132754|448197030|FG024|Overall Study|Death|0|||
124611664|NCT02132754|448197031|FG025|Overall Study|Death|0|||
124611665|NCT02132754|448197032|FG026|Overall Study|Death|1|||
124611666|NCT02132754|448197033|FG027|Overall Study|Death|0|||
124611667|NCT02132754|448197034|FG028|Overall Study|Death|0|||
124611668|NCT02132754|448197035|FG029|Overall Study|Death|0|||
124611669|NCT02132754|448197036|FG030|Overall Study|Death|0|||
124611670|NCT02132754|448197037|FG031|Overall Study|Death|0|||
124611671|NCT02132754|448197038|FG032|Overall Study|Death|0|||
124611672|NCT02132754|448197039|FG033|Overall Study|Death|2|||
124611673|NCT02132754|448197006|FG000|Overall Study|Excluded Medication|0|||
124611674|NCT02132754|448197007|FG001|Overall Study|Excluded Medication|0|||
124611675|NCT02132754|448197008|FG002|Overall Study|Excluded Medication|0|||
124611676|NCT02132754|448197009|FG003|Overall Study|Excluded Medication|0|||
124611677|NCT02132754|448197010|FG004|Overall Study|Excluded Medication|0|||
124611678|NCT02132754|448197011|FG005|Overall Study|Excluded Medication|0|||
124611679|NCT02132754|448197012|FG006|Overall Study|Excluded Medication|0|||
124611680|NCT02132754|448197013|FG007|Overall Study|Excluded Medication|0|||
124611681|NCT02132754|448197014|FG008|Overall Study|Excluded Medication|0|||
124611682|NCT02132754|448197015|FG009|Overall Study|Excluded Medication|0|||
124611683|NCT02132754|448197016|FG010|Overall Study|Excluded Medication|0|||
124611684|NCT02132754|448197017|FG011|Overall Study|Excluded Medication|0|||
124611685|NCT02132754|448197018|FG012|Overall Study|Excluded Medication|0|||
124611686|NCT02132754|448197019|FG013|Overall Study|Excluded Medication|0|||
124611687|NCT02132754|448197020|FG014|Overall Study|Excluded Medication|0|||
124611688|NCT02132754|448197021|FG015|Overall Study|Excluded Medication|0|||
124611689|NCT02132754|448197022|FG016|Overall Study|Excluded Medication|0|||
124611690|NCT02132754|448197023|FG017|Overall Study|Excluded Medication|0|||
124611691|NCT02132754|448197024|FG018|Overall Study|Excluded Medication|0|||
124611692|NCT02132754|448197025|FG019|Overall Study|Excluded Medication|0|||
124611693|NCT02132754|448197026|FG020|Overall Study|Excluded Medication|1|||
124611694|NCT02132754|448197027|FG021|Overall Study|Excluded Medication|0|||
124611695|NCT02132754|448197028|FG022|Overall Study|Excluded Medication|0|||
124611696|NCT02132754|448197029|FG023|Overall Study|Excluded Medication|0|||
124611697|NCT02132754|448197030|FG024|Overall Study|Excluded Medication|0|||
124611698|NCT02132754|448197031|FG025|Overall Study|Excluded Medication|0|||
124611699|NCT02132754|448197032|FG026|Overall Study|Excluded Medication|0|||
124611700|NCT02132754|448197033|FG027|Overall Study|Excluded Medication|0|||
124611701|NCT02132754|448197034|FG028|Overall Study|Excluded Medication|0|||
124611702|NCT02132754|448197035|FG029|Overall Study|Excluded Medication|0|||
124611703|NCT02132754|448197036|FG030|Overall Study|Excluded Medication|0|||
124611704|NCT02132754|448197037|FG031|Overall Study|Excluded Medication|0|||
124611705|NCT02132754|448197038|FG032|Overall Study|Excluded Medication|0|||
124611706|NCT02132754|448197039|FG033|Overall Study|Excluded Medication|1|||
124611707|NCT02132754|448197006|FG000|Overall Study|Physician Decision|0|||
124611708|NCT02132754|448197007|FG001|Overall Study|Physician Decision|0|||
124611709|NCT02132754|448197008|FG002|Overall Study|Physician Decision|0|||
124611710|NCT02132754|448197009|FG003|Overall Study|Physician Decision|0|||
124611711|NCT02132754|448197010|FG004|Overall Study|Physician Decision|0|||
124611712|NCT02132754|448197011|FG005|Overall Study|Physician Decision|0|||
124611713|NCT02132754|448197012|FG006|Overall Study|Physician Decision|0|||
124611714|NCT02132754|448197013|FG007|Overall Study|Physician Decision|0|||
124611715|NCT02132754|448197014|FG008|Overall Study|Physician Decision|0|||
124611716|NCT02132754|448197015|FG009|Overall Study|Physician Decision|1|||
124611717|NCT02132754|448197016|FG010|Overall Study|Physician Decision|0|||
124611718|NCT02132754|448197017|FG011|Overall Study|Physician Decision|1|||
124611719|NCT02132754|448197018|FG012|Overall Study|Physician Decision|1|||
124611720|NCT02132754|448197019|FG013|Overall Study|Physician Decision|0|||
124611721|NCT02132754|448197020|FG014|Overall Study|Physician Decision|0|||
124735388|NCT02275117|448653083|FG002|Overall Study|Physician Decision|1|||
124735389|NCT02275117|448653084|FG003|Overall Study|Physician Decision|0|||
124735390|NCT02275117|448653085|FG004|Overall Study|Physician Decision|1|||
124735391|NCT02275117|448653081|FG000|Overall Study|Protocol Violation|1|||
124735392|NCT02275117|448653082|FG001|Overall Study|Protocol Violation|0|||
124735393|NCT02275117|448653083|FG002|Overall Study|Protocol Violation|1|||
124735394|NCT02275117|448653084|FG003|Overall Study|Protocol Violation|1|||
124735395|NCT02275117|448653085|FG004|Overall Study|Protocol Violation|0|||
124735396|NCT02275117|448653081|FG000|Overall Study|Withdrawal by Subject|6|||
124735397|NCT02275117|448653082|FG001|Overall Study|Withdrawal by Subject|4|||
124735398|NCT02275117|448653083|FG002|Overall Study|Withdrawal by Subject|7|||
124735399|NCT02275117|448653084|FG003|Overall Study|Withdrawal by Subject|3|||
124735400|NCT02275117|448653085|FG004|Overall Study|Withdrawal by Subject|3|||
124735401|NCT02275117|448653081|FG000|Overall Study|Terminated by Sponsor|4|||
124735402|NCT02275117|448653082|FG001|Overall Study|Terminated by Sponsor|4|||
124735403|NCT02275117|448653083|FG002|Overall Study|Terminated by Sponsor|4|||
124735404|NCT02275117|448653084|FG003|Overall Study|Terminated by Sponsor|6|||
124735405|NCT02275117|448653085|FG004|Overall Study|Terminated by Sponsor|4|||
124735406|NCT02275117|448653081|FG000|Overall Study|Worsening of Study Indication|0|||
124735407|NCT02275117|448653082|FG001|Overall Study|Worsening of Study Indication|1|||
124735408|NCT02275117|448653083|FG002|Overall Study|Worsening of Study Indication|2|||
124735409|NCT02275117|448653084|FG003|Overall Study|Worsening of Study Indication|0|||
124735410|NCT02275117|448653085|FG004|Overall Study|Worsening of Study Indication|0|||
124735411|NCT02275117|448653081|FG000|Overall Study|Study Burden|5|||
124735412|NCT02275117|448653082|FG001|Overall Study|Study Burden|4|||
124735413|NCT02275117|448653083|FG002|Overall Study|Study Burden|7|||
124735414|NCT02275117|448653084|FG003|Overall Study|Study Burden|5|||
124735415|NCT02275117|448653085|FG004|Overall Study|Study Burden|7|||
124735416|NCT02275117|448653081|FG000|Overall Study|Other|1|||
124735417|NCT02275117|448653082|FG001|Overall Study|Other|0|||
124735418|NCT02275117|448653083|FG002|Overall Study|Other|0|||
124735419|NCT02275117|448653084|FG003|Overall Study|Other|0|||
124735420|NCT02275117|448653085|FG004|Overall Study|Other|2|||
124735421|NCT03421743|448653089|FG000|Overall Study|Lack of Efficacy|1|||
124735422|NCT03421743|448653090|FG001|Overall Study|Lack of Efficacy|0|||
124735423|NCT03421743|448653089|FG000|Overall Study|Adverse Event|2|||
124735424|NCT03421743|448653090|FG001|Overall Study|Adverse Event|1|||
124735425|NCT03421743|448653089|FG000|Overall Study|Withdrawal by Subject|0|||
124735426|NCT03421743|448653090|FG001|Overall Study|Withdrawal by Subject|1|||
124735427|NCT00681564|448653092|FG000|Overall Study|Lost to Follow-up|6|||
124735428|NCT00681564|448653093|FG001|Overall Study|Lost to Follow-up|6|||
124735429|NCT00681564|448653092|FG000|Overall Study|Withdrawal by Subject|0|||
124735430|NCT00681564|448653093|FG001|Overall Study|Withdrawal by Subject|1|||
124735431|NCT00681564|448653092|FG000|Overall Study|Death|0|||
124735432|NCT00681564|448653093|FG001|Overall Study|Death|1|||
124735433|NCT01009346|448653098|FG000|Overall Study|Adverse Event|4|||
124735434|NCT00541099|448653102|FG000|Overall Study|Ineligible|3|||
124735435|NCT00432744|448653103|FG000|Months 0-6|Withdrawal by Subject|4|||
124735436|NCT00432744|448653104|FG001|Months 0-6|Withdrawal by Subject|4|||
124735437|NCT00432744|448653103|FG000|Months 0-6|Too disabled to score|1|||
124735438|NCT00432744|448653104|FG001|Months 0-6|Too disabled to score|0|||
124735439|NCT00432744|448653103|FG000|Months 7 - 12|Withdrawal by Subject|1|||
124735440|NCT00432744|448653104|FG001|Months 7 - 12|Withdrawal by Subject|0|||
124735441|NCT00432744|448653103|FG000|Months 7 - 12|Too disabled to score|0|||
124735442|NCT00432744|448653104|FG001|Months 7 - 12|Too disabled to score|1|||
124735443|NCT02759315|448653108|FG000|Overall Study|Adverse Event|0|||
124735444|NCT02759315|448653109|FG001|Overall Study|Adverse Event|0|||
124735445|NCT02759315|448653110|FG002|Overall Study|Adverse Event|0|||
124735446|NCT02759315|448653111|FG003|Overall Study|Adverse Event|1|||
124735447|NCT02759315|448653112|FG004|Overall Study|Adverse Event|0|||
124735448|NCT02759315|448653108|FG000|Overall Study|Death|0|||
124735449|NCT02759315|448653109|FG001|Overall Study|Death|0|||
124735450|NCT02759315|448653110|FG002|Overall Study|Death|1|||
124735451|NCT02759315|448653111|FG003|Overall Study|Death|0|||
124781306|NCT00202878|448829141|FG000|Overall Study|Lost to Follow-up|44|||
124781307|NCT00202878|448829142|FG001|Overall Study|Lost to Follow-up|49|||
124735452|NCT02759315|448653112|FG004|Overall Study|Death|0|||
124735453|NCT02759315|448653108|FG000|Overall Study|Lost to Follow-up|2|||
124735454|NCT02759315|448653109|FG001|Overall Study|Lost to Follow-up|0|||
124735455|NCT02759315|448653110|FG002|Overall Study|Lost to Follow-up|4|||
124735456|NCT02759315|448653111|FG003|Overall Study|Lost to Follow-up|0|||
124735457|NCT02759315|448653112|FG004|Overall Study|Lost to Follow-up|0|||
124735458|NCT02759315|448653108|FG000|Overall Study|Protocol Violation|0|||
124735459|NCT02759315|448653109|FG001|Overall Study|Protocol Violation|1|||
124735460|NCT02759315|448653110|FG002|Overall Study|Protocol Violation|0|||
124735461|NCT02759315|448653111|FG003|Overall Study|Protocol Violation|0|||
124735462|NCT02759315|448653112|FG004|Overall Study|Protocol Violation|0|||
124735463|NCT02759315|448653108|FG000|Overall Study|Study terminated prior to completion|2|||
124735464|NCT02759315|448653109|FG001|Overall Study|Study terminated prior to completion|0|||
124781308|NCT00202878|448829141|FG000|Overall Study|Site Closure|39|||
124735465|NCT02759315|448653110|FG002|Overall Study|Study terminated prior to completion|5|||
124735466|NCT02759315|448653111|FG003|Overall Study|Study terminated prior to completion|0|||
124735467|NCT02759315|448653112|FG004|Overall Study|Study terminated prior to completion|1|||
124735468|NCT02761694|448653116|FG000|Overall Study|Lack of Efficacy|0|||
124735469|NCT02761694|448653117|FG001|Overall Study|Lack of Efficacy|0|||
124735470|NCT02761694|448653118|FG002|Overall Study|Lack of Efficacy|0|||
124735471|NCT02761694|448653119|FG003|Overall Study|Lack of Efficacy|0|||
124735472|NCT02761694|448653120|FG004|Overall Study|Lack of Efficacy|0|||
124735473|NCT02761694|448653121|FG005|Overall Study|Lack of Efficacy|0|||
124735474|NCT02761694|448653122|FG006|Overall Study|Lack of Efficacy|6|||
124735475|NCT02761694|448653123|FG007|Overall Study|Lack of Efficacy|0|||
124735476|NCT02761694|448653124|FG008|Overall Study|Lack of Efficacy|0|||
124735477|NCT02761694|448653125|FG009|Overall Study|Lack of Efficacy|1|||
124735478|NCT02761694|448653126|FG010|Overall Study|Lack of Efficacy|1|||
124735479|NCT02761694|448653127|FG011|Overall Study|Lack of Efficacy|4|||
124735480|NCT02761694|448653116|FG000|Overall Study|Death|0|||
124735481|NCT02761694|448653117|FG001|Overall Study|Death|0|||
124735482|NCT02761694|448653118|FG002|Overall Study|Death|0|||
124735483|NCT02761694|448653119|FG003|Overall Study|Death|0|||
124735484|NCT02761694|448653120|FG004|Overall Study|Death|0|||
124735485|NCT02761694|448653121|FG005|Overall Study|Death|0|||
124735486|NCT02761694|448653122|FG006|Overall Study|Death|2|||
124735487|NCT02761694|448653123|FG007|Overall Study|Death|0|||
124735488|NCT02761694|448653124|FG008|Overall Study|Death|2|||
124735489|NCT02761694|448653125|FG009|Overall Study|Death|2|||
124735490|NCT02761694|448653126|FG010|Overall Study|Death|1|||
124735491|NCT02761694|448653127|FG011|Overall Study|Death|0|||
124735492|NCT02761694|448653116|FG000|Overall Study|Physician Decision|0|||
124735493|NCT02761694|448653117|FG001|Overall Study|Physician Decision|0|||
124735494|NCT02761694|448653118|FG002|Overall Study|Physician Decision|0|||
124735495|NCT02761694|448653119|FG003|Overall Study|Physician Decision|0|||
124735496|NCT02761694|448653120|FG004|Overall Study|Physician Decision|0|||
124735497|NCT02761694|448653121|FG005|Overall Study|Physician Decision|0|||
124735498|NCT02761694|448653122|FG006|Overall Study|Physician Decision|1|||
124735499|NCT02761694|448653123|FG007|Overall Study|Physician Decision|0|||
124735500|NCT02761694|448653124|FG008|Overall Study|Physician Decision|0|||
124735501|NCT02761694|448653125|FG009|Overall Study|Physician Decision|0|||
124735502|NCT02761694|448653126|FG010|Overall Study|Physician Decision|0|||
124735503|NCT02761694|448653127|FG011|Overall Study|Physician Decision|0|||
124735504|NCT02761694|448653116|FG000|Overall Study|Withdrawal by Subject|0|||
124735505|NCT02761694|448653117|FG001|Overall Study|Withdrawal by Subject|0|||
124735506|NCT02761694|448653118|FG002|Overall Study|Withdrawal by Subject|0|||
124735507|NCT02761694|448653119|FG003|Overall Study|Withdrawal by Subject|1|||
124735508|NCT02761694|448653120|FG004|Overall Study|Withdrawal by Subject|0|||
124735509|NCT02761694|448653121|FG005|Overall Study|Withdrawal by Subject|0|||
124735510|NCT02761694|448653122|FG006|Overall Study|Withdrawal by Subject|4|||
124735511|NCT02761694|448653123|FG007|Overall Study|Withdrawal by Subject|0|||
124735512|NCT02761694|448653124|FG008|Overall Study|Withdrawal by Subject|2|||
124735513|NCT02761694|448653125|FG009|Overall Study|Withdrawal by Subject|1|||
124735514|NCT02761694|448653126|FG010|Overall Study|Withdrawal by Subject|0|||
124735515|NCT02761694|448653127|FG011|Overall Study|Withdrawal by Subject|0|||
124735516|NCT02761694|448653116|FG000|Overall Study|Lost to Follow-up|0|||
124735517|NCT02761694|448653117|FG001|Overall Study|Lost to Follow-up|0|||
124735518|NCT02761694|448653118|FG002|Overall Study|Lost to Follow-up|0|||
124735519|NCT02761694|448653119|FG003|Overall Study|Lost to Follow-up|0|||
124735520|NCT02761694|448653120|FG004|Overall Study|Lost to Follow-up|0|||
124735521|NCT02761694|448653121|FG005|Overall Study|Lost to Follow-up|0|||
124735522|NCT02761694|448653122|FG006|Overall Study|Lost to Follow-up|1|||
124735523|NCT02761694|448653123|FG007|Overall Study|Lost to Follow-up|0|||
124735524|NCT02761694|448653124|FG008|Overall Study|Lost to Follow-up|0|||
124735525|NCT02761694|448653125|FG009|Overall Study|Lost to Follow-up|0|||
124735526|NCT02761694|448653126|FG010|Overall Study|Lost to Follow-up|0|||
124735527|NCT02761694|448653127|FG011|Overall Study|Lost to Follow-up|1|||
124735528|NCT02761694|448653116|FG000|Overall Study|Adverse Event|0|||
124735529|NCT02761694|448653117|FG001|Overall Study|Adverse Event|0|||
124735530|NCT02761694|448653118|FG002|Overall Study|Adverse Event|0|||
124735531|NCT02761694|448653119|FG003|Overall Study|Adverse Event|0|||
124735532|NCT02761694|448653120|FG004|Overall Study|Adverse Event|0|||
124735533|NCT02761694|448653121|FG005|Overall Study|Adverse Event|0|||
124735534|NCT02761694|448653122|FG006|Overall Study|Adverse Event|1|||
124735535|NCT02761694|448653123|FG007|Overall Study|Adverse Event|0|||
124735536|NCT02761694|448653124|FG008|Overall Study|Adverse Event|1|||
124781309|NCT00202878|448829142|FG001|Overall Study|Site Closure|36|||
124735537|NCT02761694|448653125|FG009|Overall Study|Adverse Event|0|||
124735538|NCT02761694|448653126|FG010|Overall Study|Adverse Event|0|||
124735539|NCT02761694|448653127|FG011|Overall Study|Adverse Event|1|||
124735540|NCT02761694|448653116|FG000|Overall Study|Other|4|||
124735541|NCT02761694|448653117|FG001|Overall Study|Other|4|||
124735542|NCT02761694|448653118|FG002|Overall Study|Other|1|||
124735543|NCT02761694|448653119|FG003|Overall Study|Other|2|||
124735544|NCT02761694|448653120|FG004|Overall Study|Other|3|||
124735545|NCT02761694|448653121|FG005|Overall Study|Other|3|||
124735546|NCT02761694|448653122|FG006|Overall Study|Other|18|||
124735547|NCT02761694|448653123|FG007|Overall Study|Other|8|||
124735548|NCT02761694|448653124|FG008|Overall Study|Other|0|||
124735549|NCT02761694|448653125|FG009|Overall Study|Other|1|||
124735550|NCT02761694|448653126|FG010|Overall Study|Other|1|||
124735551|NCT02761694|448653127|FG011|Overall Study|Other|0|||
124735552|NCT03464422|448653131|FG000|Overall Study|Lost to Follow-up|2|||
124735553|NCT03464422|448653131|FG000|Overall Study|Withdrawal by Subject|2|||
124735554|NCT01628367|448653134|FG000|Overall Study|Adverse Event|1|||
124735555|NCT01628367|448653135|FG001|Overall Study|Adverse Event|0|||
124735556|NCT02513823|448653138|FG000|Overall Study|Lost to Follow-up|4|||
124735557|NCT02513823|448653138|FG000|Overall Study|Physician Decision|1|||
124735558|NCT03353922|448653139|FG000|Overall Study|Withdrawal by Subject|1|||
124735559|NCT03353922|448653140|FG001|Overall Study|Withdrawal by Subject|0|||
124735560|NCT03353922|448653141|FG002|Overall Study|Withdrawal by Subject|1|||
124735561|NCT03353922|448653142|FG003|Overall Study|Withdrawal by Subject|1|||
124735562|NCT03353922|448653143|FG004|Overall Study|Withdrawal by Subject|0|||
124735563|NCT03353922|448653144|FG005|Overall Study|Withdrawal by Subject|0|||
124735564|NCT03353922|448653139|FG000|Overall Study|Adverse Event|0|||
124735565|NCT03353922|448653140|FG001|Overall Study|Adverse Event|1|||
124735566|NCT03353922|448653141|FG002|Overall Study|Adverse Event|0|||
124735567|NCT03353922|448653142|FG003|Overall Study|Adverse Event|0|||
124735568|NCT03353922|448653143|FG004|Overall Study|Adverse Event|0|||
124735569|NCT03353922|448653144|FG005|Overall Study|Adverse Event|0|||
124735570|NCT00740714|448653145|FG000|Overall Study|Withdrawal by Subject|17|||
124735571|NCT00740714|448653146|FG001|Overall Study|Withdrawal by Subject|19|||
124735572|NCT00740714|448653147|FG002|Overall Study|Withdrawal by Subject|29|||
124735573|NCT03688555|448653148|FG000|Treatment Period|Adverse Event|0|||
124735574|NCT03688555|448653149|FG001|Treatment Period|Adverse Event|0|||
124735575|NCT03688555|448653150|FG002|Treatment Period|Adverse Event|1|||
124735576|NCT00886119|448653156|FG000|Period 1|Did not meet inclusion criteria|1|||
124735577|NCT00886119|448653157|FG001|Period 1|Did not meet inclusion criteria|0|||
124735578|NCT01294462|448653158|FG000|Overall Study|Lost to Follow-up|1|||
124735579|NCT01294462|448653159|FG001|Overall Study|Lost to Follow-up|0|||
124735580|NCT01294462|448653158|FG000|Overall Study|Withdrawal by Subject|65|||
124735581|NCT01294462|448653159|FG001|Overall Study|Withdrawal by Subject|63|||
124735582|NCT02743780|448653160|FG000|Part 3 (7 Days)|Adverse Event|0|||
124735583|NCT02743780|448653161|FG001|Part 3 (7 Days)|Adverse Event|0|||
124735584|NCT02743780|448653162|FG002|Part 3 (7 Days)|Adverse Event|1|||
124735585|NCT02743780|448653163|FG003|Part 3 (7 Days)|Adverse Event|0|||
124735586|NCT02743780|448653164|FG004|Part 3 (7 Days)|Adverse Event|0|||
124735587|NCT01140568|448653165|FG000|Overall Study|disease progression|31|||
124735588|NCT01140568|448653165|FG000|Overall Study|Withdrawal by Subject|1|||
124735589|NCT01140568|448653165|FG000|Overall Study|Screen Fail|4|||
124735590|NCT01400243|448653166|FG000|Overall Study|Protocol Violation|8|||
124735591|NCT01400243|448653167|FG001|Overall Study|Protocol Violation|11|||
124735592|NCT02279498|448653169|FG000|Overall Study|Adverse Event|3|||
124735593|NCT02279498|448653170|FG001|Overall Study|Adverse Event|0|||
124735594|NCT02279498|448653169|FG000|Overall Study|Lack of Efficacy|4|||
124735595|NCT02279498|448653170|FG001|Overall Study|Lack of Efficacy|0|||
124735596|NCT02279498|448653169|FG000|Overall Study|Lost to Follow-up|0|||
124735597|NCT02279498|448653170|FG001|Overall Study|Lost to Follow-up|1|||
124735598|NCT02279498|448653169|FG000|Overall Study|Withdrawal by Subject|9|||
124735599|NCT02279498|448653170|FG001|Overall Study|Withdrawal by Subject|2|||
124735600|NCT02279498|448653169|FG000|Overall Study|Undefined|2|||
124735601|NCT02279498|448653170|FG001|Overall Study|Undefined|1|||
124735602|NCT01048866|448653171|FG000|Overall Study|Adverse Event|1|||
124735603|NCT01048866|448653172|FG001|Overall Study|Adverse Event|0|||
124735604|NCT01048866|448653171|FG000|Overall Study|Protocol Violation|1|||
124735605|NCT01048866|448653172|FG001|Overall Study|Protocol Violation|0|||
124735606|NCT01048866|448653171|FG000|Overall Study|Physician Decision|1|||
124735607|NCT01048866|448653172|FG001|Overall Study|Physician Decision|0|||
124735608|NCT01048866|448653171|FG000|Overall Study|Withdrawal by Subject|0|||
124735609|NCT01048866|448653172|FG001|Overall Study|Withdrawal by Subject|2|||
124735610|NCT01048866|448653171|FG000|Overall Study|Lost to Follow-up|0|||
124735611|NCT01048866|448653172|FG001|Overall Study|Lost to Follow-up|2|||
124735612|NCT01048866|448653171|FG000|Overall Study|Other|1|||
124735613|NCT01048866|448653172|FG001|Overall Study|Other|1|||
124735614|NCT00758589|448655129|FG000|Overall Study|Adverse Event|3|||
124735615|NCT00758589|448655130|FG001|Overall Study|Adverse Event|2|||
124735616|NCT00758589|448655131|FG002|Overall Study|Adverse Event|5|||
124735617|NCT00758589|448655132|FG003|Overall Study|Adverse Event|4|||
124735618|NCT00758589|448655129|FG000|Overall Study|Withdrawal by Subject|0|||
124735619|NCT00758589|448655130|FG001|Overall Study|Withdrawal by Subject|1|||
124735620|NCT00758589|448655131|FG002|Overall Study|Withdrawal by Subject|1|||
124735621|NCT00758589|448655132|FG003|Overall Study|Withdrawal by Subject|1|||
124735622|NCT00758589|448655129|FG000|Overall Study|Palm stopped to work|0|||
124735623|NCT00758589|448655130|FG001|Overall Study|Palm stopped to work|0|||
124735624|NCT00758589|448655131|FG002|Overall Study|Palm stopped to work|0|||
124735625|NCT00758589|448655132|FG003|Overall Study|Palm stopped to work|1|||
124735626|NCT05320393|448655133|FG000|Overall Study|Withdrawal by Subject|1|||
124735627|NCT05320393|448655134|FG001|Overall Study|Withdrawal by Subject|0|||
124735628|NCT05320393|448655135|FG002|Overall Study|Withdrawal by Subject|2|||
124735629|NCT05320393|448655133|FG000|Overall Study|Lost to Follow-up|1|||
124735630|NCT05320393|448655134|FG001|Overall Study|Lost to Follow-up|2|||
124735631|NCT05320393|448655135|FG002|Overall Study|Lost to Follow-up|1|||
124735632|NCT05320393|448655133|FG000|Overall Study|Moved; too much driving|0|||
124735633|NCT05320393|448655134|FG001|Overall Study|Moved; too much driving|0|||
124735634|NCT05320393|448655135|FG002|Overall Study|Moved; too much driving|2|||
124735635|NCT05320393|448655133|FG000|Overall Study|Did not receive treatment|0|||
124735636|NCT05320393|448655134|FG001|Overall Study|Did not receive treatment|0|||
124735637|NCT05320393|448655135|FG002|Overall Study|Did not receive treatment|1|||
124735638|NCT03187834|448655139|FG000|Overall Study|Lost to Follow-up|0|||
124735639|NCT03187834|448655140|FG001|Overall Study|Lost to Follow-up|1|||
124735640|NCT03187834|448655141|FG002|Overall Study|Lost to Follow-up|2|||
124735641|NCT03187834|448655142|FG003|Overall Study|Lost to Follow-up|2|||
124735642|NCT03187834|448655139|FG000|Overall Study|Had invalid anthropometric measurements|5|||
124735643|NCT03187834|448655140|FG001|Overall Study|Had invalid anthropometric measurements|3|||
124735644|NCT03187834|448655141|FG002|Overall Study|Had invalid anthropometric measurements|4|||
124735645|NCT03187834|448655142|FG003|Overall Study|Had invalid anthropometric measurements|2|||
124735646|NCT03559699|448655143|FG000|Overall Study|Withdrawal by Subject|6|||
124735647|NCT03559699|448655143|FG000|Overall Study|Lost to Follow-up|1|||
124735648|NCT05438602|448655150|FG000|Treatment (15 Days)|Adverse Event|2|||
124735649|NCT05438602|448655151|FG001|Treatment (15 Days)|Adverse Event|1|||
124735650|NCT05438602|448655152|FG002|Treatment (15 Days)|Adverse Event|3|||
124735651|NCT05438602|448655150|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
124735652|NCT05438602|448655151|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
124735653|NCT05438602|448655152|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
124735654|NCT05438602|448655150|FG000|Treatment (15 Days)|Other|0|||
124735655|NCT05438602|448655151|FG001|Treatment (15 Days)|Other|0|||
124735656|NCT05438602|448655152|FG002|Treatment (15 Days)|Other|1|||
124735657|NCT05438602|448655150|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
124735658|NCT05438602|448655151|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
124735659|NCT05438602|448655152|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
124735660|NCT05438602|448655150|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
124735661|NCT05438602|448655151|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
124735662|NCT05438602|448655152|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
124735663|NCT05438602|448655150|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
124735664|NCT05438602|448655151|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
124735665|NCT05438602|448655152|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
124735666|NCT05438602|448655150|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
124735667|NCT05438602|448655151|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
124735668|NCT05438602|448655152|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
124735669|NCT05438602|448655150|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
124735670|NCT05438602|448655151|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
124735671|NCT05438602|448655152|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
124735672|NCT05438602|448655150|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
124735673|NCT05438602|448655151|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
124735674|NCT05438602|448655152|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
124735675|NCT05438602|448655150|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
124735676|NCT05438602|448655151|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
124735677|NCT05438602|448655152|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
124735678|NCT01930890|448655153|FG000|Overall Study|Study Termination|14|||
124735679|NCT01930890|448655154|FG001|Overall Study|Study Termination|28|||
124735680|NCT01930890|448655155|FG002|Overall Study|Study Termination|13|||
124735681|NCT01930890|448655156|FG003|Overall Study|Study Termination|25|||
124735682|NCT01930890|448655153|FG000|Overall Study|Death|0|||
124735683|NCT01930890|448655154|FG001|Overall Study|Death|0|||
124735684|NCT01930890|448655155|FG002|Overall Study|Death|0|||
124735685|NCT01930890|448655156|FG003|Overall Study|Death|1|||
124735686|NCT01930890|448655153|FG000|Overall Study|Investigator Decision|0|||
124735687|NCT01930890|448655154|FG001|Overall Study|Investigator Decision|1|||
124735688|NCT01930890|448655155|FG002|Overall Study|Investigator Decision|0|||
124735689|NCT01930890|448655156|FG003|Overall Study|Investigator Decision|0|||
124735690|NCT01930890|448655153|FG000|Overall Study|Consent Withdrawn|0|||
124735691|NCT01930890|448655154|FG001|Overall Study|Consent Withdrawn|3|||
124735692|NCT01930890|448655155|FG002|Overall Study|Consent Withdrawn|0|||
124735693|NCT01930890|448655156|FG003|Overall Study|Consent Withdrawn|1|||
124735694|NCT01930890|448655153|FG000|Overall Study|Adverse Event|0|||
124735695|NCT01930890|448655154|FG001|Overall Study|Adverse Event|1|||
124735696|NCT01930890|448655155|FG002|Overall Study|Adverse Event|0|||
124735697|NCT01930890|448655156|FG003|Overall Study|Adverse Event|0|||
124735698|NCT02091284|448655157|FG000|Overall Study|Withdrawal by Subject|2|||
124735699|NCT02091284|448655158|FG001|Overall Study|Withdrawal by Subject|1|||
124611722|NCT02132754|448197021|FG015|Overall Study|Physician Decision|1|||
124611723|NCT02132754|448197022|FG016|Overall Study|Physician Decision|0|||
124611724|NCT02132754|448197023|FG017|Overall Study|Physician Decision|0|||
124611725|NCT02132754|448197024|FG018|Overall Study|Physician Decision|0|||
124611726|NCT02132754|448197025|FG019|Overall Study|Physician Decision|0|||
124611727|NCT02132754|448197026|FG020|Overall Study|Physician Decision|0|||
124611728|NCT02132754|448197027|FG021|Overall Study|Physician Decision|0|||
124611729|NCT02132754|448197028|FG022|Overall Study|Physician Decision|0|||
124611730|NCT02132754|448197029|FG023|Overall Study|Physician Decision|0|||
124611731|NCT02132754|448197030|FG024|Overall Study|Physician Decision|1|||
124611732|NCT02132754|448197031|FG025|Overall Study|Physician Decision|0|||
124611733|NCT02132754|448197032|FG026|Overall Study|Physician Decision|0|||
124611734|NCT02132754|448197033|FG027|Overall Study|Physician Decision|0|||
124611735|NCT02132754|448197034|FG028|Overall Study|Physician Decision|0|||
124611736|NCT02132754|448197035|FG029|Overall Study|Physician Decision|0|||
124611737|NCT02132754|448197036|FG030|Overall Study|Physician Decision|0|||
124611738|NCT02132754|448197037|FG031|Overall Study|Physician Decision|1|||
124611739|NCT02132754|448197038|FG032|Overall Study|Physician Decision|0|||
124611740|NCT02132754|448197039|FG033|Overall Study|Physician Decision|3|||
124611741|NCT02132754|448197006|FG000|Overall Study|Progressive Disease|1|||
124611742|NCT02132754|448197007|FG001|Overall Study|Progressive Disease|1|||
124611743|NCT02132754|448197008|FG002|Overall Study|Progressive Disease|1|||
124611744|NCT02132754|448197009|FG003|Overall Study|Progressive Disease|1|||
124611745|NCT02132754|448197010|FG004|Overall Study|Progressive Disease|1|||
124611746|NCT02132754|448197011|FG005|Overall Study|Progressive Disease|1|||
124611747|NCT02132754|448197012|FG006|Overall Study|Progressive Disease|1|||
124611748|NCT02132754|448197013|FG007|Overall Study|Progressive Disease|1|||
124611749|NCT02132754|448197014|FG008|Overall Study|Progressive Disease|1|||
124611750|NCT02132754|448197015|FG009|Overall Study|Progressive Disease|3|||
124611751|NCT02132754|448197016|FG010|Overall Study|Progressive Disease|3|||
124611752|NCT02132754|448197017|FG011|Overall Study|Progressive Disease|2|||
124611753|NCT02132754|448197018|FG012|Overall Study|Progressive Disease|2|||
124611754|NCT02132754|448197019|FG013|Overall Study|Progressive Disease|3|||
124611755|NCT02132754|448197020|FG014|Overall Study|Progressive Disease|2|||
124611756|NCT02132754|448197021|FG015|Overall Study|Progressive Disease|1|||
124611757|NCT02132754|448197022|FG016|Overall Study|Progressive Disease|2|||
124611758|NCT02132754|448197023|FG017|Overall Study|Progressive Disease|1|||
124611759|NCT02132754|448197024|FG018|Overall Study|Progressive Disease|3|||
124611760|NCT02132754|448197025|FG019|Overall Study|Progressive Disease|1|||
124611761|NCT02132754|448197026|FG020|Overall Study|Progressive Disease|1|||
124611762|NCT02132754|448197027|FG021|Overall Study|Progressive Disease|3|||
124611763|NCT02132754|448197028|FG022|Overall Study|Progressive Disease|2|||
124611764|NCT02132754|448197029|FG023|Overall Study|Progressive Disease|3|||
124611765|NCT02132754|448197030|FG024|Overall Study|Progressive Disease|0|||
124611766|NCT02132754|448197031|FG025|Overall Study|Progressive Disease|1|||
124611767|NCT02132754|448197032|FG026|Overall Study|Progressive Disease|2|||
124611768|NCT02132754|448197033|FG027|Overall Study|Progressive Disease|1|||
124611769|NCT02132754|448197034|FG028|Overall Study|Progressive Disease|2|||
124611770|NCT02132754|448197035|FG029|Overall Study|Progressive Disease|3|||
124611771|NCT02132754|448197036|FG030|Overall Study|Progressive Disease|1|||
124611772|NCT02132754|448197037|FG031|Overall Study|Progressive Disease|1|||
124611773|NCT02132754|448197038|FG032|Overall Study|Progressive Disease|3|||
124611774|NCT02132754|448197039|FG033|Overall Study|Progressive Disease|6|||
124611775|NCT02132754|448197006|FG000|Overall Study|Screen Failure|0|||
124611776|NCT02132754|448197007|FG001|Overall Study|Screen Failure|0|||
124611777|NCT02132754|448197008|FG002|Overall Study|Screen Failure|0|||
124611778|NCT02132754|448197009|FG003|Overall Study|Screen Failure|0|||
124611779|NCT02132754|448197010|FG004|Overall Study|Screen Failure|0|||
124611780|NCT02132754|448197011|FG005|Overall Study|Screen Failure|0|||
124611781|NCT02132754|448197012|FG006|Overall Study|Screen Failure|0|||
124611782|NCT02132754|448197013|FG007|Overall Study|Screen Failure|0|||
124611783|NCT02132754|448197014|FG008|Overall Study|Screen Failure|0|||
124611784|NCT02132754|448197015|FG009|Overall Study|Screen Failure|0|||
124611785|NCT02132754|448197016|FG010|Overall Study|Screen Failure|0|||
124611786|NCT02132754|448197017|FG011|Overall Study|Screen Failure|0|||
124611787|NCT02132754|448197018|FG012|Overall Study|Screen Failure|0|||
124611788|NCT02132754|448197019|FG013|Overall Study|Screen Failure|0|||
124611789|NCT02132754|448197020|FG014|Overall Study|Screen Failure|0|||
124611790|NCT02132754|448197021|FG015|Overall Study|Screen Failure|0|||
124611791|NCT02132754|448197022|FG016|Overall Study|Screen Failure|0|||
124611792|NCT02132754|448197023|FG017|Overall Study|Screen Failure|0|||
124611793|NCT02132754|448197024|FG018|Overall Study|Screen Failure|0|||
124611794|NCT02132754|448197025|FG019|Overall Study|Screen Failure|1|||
124611795|NCT02132754|448197026|FG020|Overall Study|Screen Failure|0|||
124611796|NCT02132754|448197027|FG021|Overall Study|Screen Failure|1|||
124611797|NCT02132754|448197028|FG022|Overall Study|Screen Failure|0|||
124611798|NCT02132754|448197029|FG023|Overall Study|Screen Failure|0|||
124611799|NCT02132754|448197030|FG024|Overall Study|Screen Failure|0|||
124611800|NCT02132754|448197031|FG025|Overall Study|Screen Failure|0|||
124611801|NCT02132754|448197032|FG026|Overall Study|Screen Failure|0|||
124611802|NCT02132754|448197033|FG027|Overall Study|Screen Failure|0|||
124735700|NCT02091284|448655157|FG000|Overall Study|unreliable data|1|||
124735701|NCT02091284|448655158|FG001|Overall Study|unreliable data|0|||
124735702|NCT01278407|448655159|FG000|Confirmatory Phase|Adverse Event|5|||
124735703|NCT01278407|448655160|FG001|Confirmatory Phase|Adverse Event|10|||
124735704|NCT01278407|448655161|FG002|Confirmatory Phase|Adverse Event|1|||
124735705|NCT01278407|448655162|FG003|Confirmatory Phase|Adverse Event|0|||
124735706|NCT01278407|448655163|FG004|Confirmatory Phase|Adverse Event|0|||
124735707|NCT01278407|448655159|FG000|Confirmatory Phase|Participant's Choice|3|||
124735708|NCT01278407|448655160|FG001|Confirmatory Phase|Participant's Choice|5|||
124735709|NCT01278407|448655161|FG002|Confirmatory Phase|Participant's Choice|3|||
124735710|NCT01278407|448655162|FG003|Confirmatory Phase|Participant's Choice|0|||
124735711|NCT01278407|448655163|FG004|Confirmatory Phase|Participant's Choice|0|||
124735712|NCT01278407|448655159|FG000|Confirmatory Phase|Other|1|||
124735713|NCT01278407|448655160|FG001|Confirmatory Phase|Other|1|||
124735714|NCT01278407|448655161|FG002|Confirmatory Phase|Other|2|||
124735715|NCT01278407|448655162|FG003|Confirmatory Phase|Other|0|||
124735716|NCT01278407|448655163|FG004|Confirmatory Phase|Other|0|||
124735717|NCT01278407|448655159|FG000|Extension Phase|Adverse Event|0|||
124735718|NCT01278407|448655160|FG001|Extension Phase|Adverse Event|0|||
124735719|NCT01278407|448655161|FG002|Extension Phase|Adverse Event|0|||
124735720|NCT01278407|448655162|FG003|Extension Phase|Adverse Event|7|||
124735721|NCT01278407|448655163|FG004|Extension Phase|Adverse Event|16|||
124735722|NCT01278407|448655159|FG000|Extension Phase|Participant's Choice|0|||
124735723|NCT01278407|448655160|FG001|Extension Phase|Participant's Choice|0|||
124735724|NCT01278407|448655161|FG002|Extension Phase|Participant's Choice|0|||
124735725|NCT01278407|448655162|FG003|Extension Phase|Participant's Choice|4|||
124735726|NCT01278407|448655163|FG004|Extension Phase|Participant's Choice|11|||
124735727|NCT01278407|448655159|FG000|Extension Phase|Other|0|||
124735728|NCT01278407|448655160|FG001|Extension Phase|Other|0|||
124735729|NCT01278407|448655161|FG002|Extension Phase|Other|0|||
124735730|NCT01278407|448655162|FG003|Extension Phase|Other|1|||
124735731|NCT01278407|448655163|FG004|Extension Phase|Other|3|||
124735732|NCT02534935|448655164|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
124735733|NCT02534935|448655165|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
124735734|NCT02534935|448655166|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
124735735|NCT02534935|448655164|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
124735736|NCT02534935|448655165|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
124735737|NCT02534935|448655166|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
124735738|NCT02534935|448655164|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
124735739|NCT02534935|448655165|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
124735740|NCT02534935|448655166|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
124735741|NCT02534935|448655164|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
124735742|NCT02534935|448655165|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
124735743|NCT02534935|448655166|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
124735744|NCT02534935|448655164|FG000|Stage 1: 24 Months|Adverse Event|0|||
124735745|NCT02534935|448655165|FG001|Stage 1: 24 Months|Adverse Event|2|||
124735746|NCT02534935|448655166|FG002|Stage 1: 24 Months|Adverse Event|0|||
124735747|NCT02534935|448655164|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
124735748|NCT02534935|448655165|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
124735749|NCT02534935|448655166|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
124735750|NCT02534935|448655164|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
124735751|NCT02534935|448655165|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
124735752|NCT02534935|448655166|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
124735753|NCT01460719|448655167|FG000|Overall Study|Adverse Event|1|||
124735754|NCT01460719|448655167|FG000|Overall Study|Withdrawal by Subject|1|||
124735755|NCT00076336|448655170|FG000|Overall Study|Death|13|||
124735756|NCT00076336|448655171|FG001|Overall Study|Death|17|||
124735757|NCT00076336|448655170|FG000|Overall Study|Adverse Event|4|||
124735758|NCT00076336|448655171|FG001|Overall Study|Adverse Event|4|||
124735759|NCT00076336|448655170|FG000|Overall Study|Lost to Follow-up|4|||
124735760|NCT00076336|448655171|FG001|Overall Study|Lost to Follow-up|4|||
124735761|NCT00076336|448655170|FG000|Overall Study|Non-Compliance|2|||
124735762|NCT00076336|448655171|FG001|Overall Study|Non-Compliance|0|||
124735763|NCT00076336|448655170|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
124781310|NCT00202878|448829141|FG000|Overall Study|Withdrawal by Subject|795|||
124781311|NCT00202878|448829142|FG001|Overall Study|Withdrawal by Subject|808|||
124781312|NCT03801031|448829147|FG000|Overall Study|Lost to Follow-up|1|||
124781313|NCT03801031|448829148|FG001|Overall Study|Lost to Follow-up|0|||
124781314|NCT03801031|448829147|FG000|Overall Study|Unable to comply|1|||
124781315|NCT03801031|448829148|FG001|Overall Study|Unable to comply|0|||
124735764|NCT00076336|448655171|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
124735765|NCT00076336|448655170|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
124735766|NCT00076336|448655171|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
124781316|NCT03801031|448829147|FG000|Overall Study|Withdrawal by Subject|0|||
124735767|NCT00076336|448655170|FG000|Overall Study|Liver Transplantation|3|||
124735768|NCT00076336|448655171|FG001|Overall Study|Liver Transplantation|3|||
124735769|NCT00076336|448655170|FG000|Overall Study|Virologic Breakthrough|14|||
124735770|NCT00076336|448655171|FG001|Overall Study|Virologic Breakthrough|16|||
124735771|NCT00076336|448655170|FG000|Overall Study|Treatment failure|4|||
124735772|NCT00076336|448655171|FG001|Overall Study|Treatment failure|5|||
124735773|NCT02838901|448655172|FG000|Overall Study|Withdrawal by Subject|1|||
124735774|NCT02838901|448655173|FG001|Overall Study|Withdrawal by Subject|1|||
124735775|NCT02838901|448655172|FG000|Overall Study|Lost to Follow-up|1|||
124735776|NCT02838901|448655173|FG001|Overall Study|Lost to Follow-up|1|||
124735777|NCT02285114|448655174|FG000|Main Phase|Investigator's Discretion|0|||
124735778|NCT02285114|448655175|FG001|Main Phase|Investigator's Discretion|2|||
124735779|NCT02285114|448655176|FG002|Main Phase|Investigator's Discretion|0|||
124735780|NCT02285114|448655177|FG003|Main Phase|Investigator's Discretion|0|||
124735781|NCT02285114|448655178|FG004|Main Phase|Investigator's Discretion|0|||
124735782|NCT02285114|448655179|FG005|Main Phase|Investigator's Discretion|0|||
124735783|NCT02285114|448655174|FG000|Main Phase|Enrolled but Never Treated|1|||
124735784|NCT02285114|448655175|FG001|Main Phase|Enrolled but Never Treated|0|||
124735785|NCT02285114|448655176|FG002|Main Phase|Enrolled but Never Treated|0|||
124735786|NCT02285114|448655177|FG003|Main Phase|Enrolled but Never Treated|0|||
124735787|NCT02285114|448655178|FG004|Main Phase|Enrolled but Never Treated|0|||
124735788|NCT02285114|448655179|FG005|Main Phase|Enrolled but Never Treated|0|||
124735789|NCT02285114|448655174|FG000|Main Phase|Withdrew Consent|0|||
124735790|NCT02285114|448655175|FG001|Main Phase|Withdrew Consent|0|||
124735791|NCT02285114|448655176|FG002|Main Phase|Withdrew Consent|1|||
124735792|NCT02285114|448655177|FG003|Main Phase|Withdrew Consent|0|||
124735793|NCT02285114|448655178|FG004|Main Phase|Withdrew Consent|0|||
124735794|NCT02285114|448655179|FG005|Main Phase|Withdrew Consent|0|||
124735795|NCT02285114|448655174|FG000|Extension Phase|Investigator's Discretion|0|||
124735796|NCT02285114|448655175|FG001|Extension Phase|Investigator's Discretion|0|||
124735797|NCT02285114|448655176|FG002|Extension Phase|Investigator's Discretion|0|||
124735798|NCT02285114|448655177|FG003|Extension Phase|Investigator's Discretion|14|||
124735799|NCT02285114|448655178|FG004|Extension Phase|Investigator's Discretion|1|||
124735800|NCT02285114|448655179|FG005|Extension Phase|Investigator's Discretion|0|||
124735801|NCT02285114|448655174|FG000|Extension Phase|Lost to Follow-up|0|||
124735802|NCT02285114|448655175|FG001|Extension Phase|Lost to Follow-up|0|||
124735803|NCT02285114|448655176|FG002|Extension Phase|Lost to Follow-up|0|||
124735804|NCT02285114|448655177|FG003|Extension Phase|Lost to Follow-up|1|||
124735805|NCT02285114|448655178|FG004|Extension Phase|Lost to Follow-up|1|||
124735806|NCT02285114|448655179|FG005|Extension Phase|Lost to Follow-up|0|||
124735807|NCT02285114|448655174|FG000|Extension Phase|Non-compliance with Study Drug|0|||
124735808|NCT02285114|448655175|FG001|Extension Phase|Non-compliance with Study Drug|0|||
124735809|NCT02285114|448655176|FG002|Extension Phase|Non-compliance with Study Drug|0|||
124611803|NCT02132754|448197034|FG028|Overall Study|Screen Failure|0|||
124611804|NCT02132754|448197035|FG029|Overall Study|Screen Failure|0|||
124611805|NCT02132754|448197036|FG030|Overall Study|Screen Failure|0|||
124611806|NCT02132754|448197037|FG031|Overall Study|Screen Failure|0|||
124611807|NCT02132754|448197038|FG032|Overall Study|Screen Failure|0|||
124611808|NCT02132754|448197039|FG033|Overall Study|Screen Failure|0|||
124611809|NCT02132754|448197006|FG000|Overall Study|Transferred to Extension Study|0|||
124611810|NCT02132754|448197007|FG001|Overall Study|Transferred to Extension Study|0|||
124611811|NCT02132754|448197008|FG002|Overall Study|Transferred to Extension Study|0|||
124611812|NCT02132754|448197009|FG003|Overall Study|Transferred to Extension Study|0|||
124611813|NCT02132754|448197010|FG004|Overall Study|Transferred to Extension Study|0|||
124611814|NCT02132754|448197011|FG005|Overall Study|Transferred to Extension Study|0|||
124611815|NCT02132754|448197012|FG006|Overall Study|Transferred to Extension Study|0|||
124611816|NCT02132754|448197013|FG007|Overall Study|Transferred to Extension Study|0|||
124611817|NCT02132754|448197014|FG008|Overall Study|Transferred to Extension Study|0|||
124611818|NCT02132754|448197015|FG009|Overall Study|Transferred to Extension Study|0|||
124611819|NCT02132754|448197016|FG010|Overall Study|Transferred to Extension Study|0|||
124611820|NCT02132754|448197017|FG011|Overall Study|Transferred to Extension Study|0|||
124611821|NCT02132754|448197018|FG012|Overall Study|Transferred to Extension Study|0|||
124611822|NCT02132754|448197019|FG013|Overall Study|Transferred to Extension Study|0|||
124735810|NCT02285114|448655177|FG003|Extension Phase|Non-compliance with Study Drug|2|||
124735811|NCT02285114|448655178|FG004|Extension Phase|Non-compliance with Study Drug|0|||
124735812|NCT02285114|448655179|FG005|Extension Phase|Non-compliance with Study Drug|0|||
124735813|NCT02285114|448655174|FG000|Extension Phase|Pregnancy|0|||
124611823|NCT02132754|448197020|FG014|Overall Study|Transferred to Extension Study|0|||
124611824|NCT02132754|448197021|FG015|Overall Study|Transferred to Extension Study|0|||
124611825|NCT02132754|448197022|FG016|Overall Study|Transferred to Extension Study|0|||
124611826|NCT02132754|448197023|FG017|Overall Study|Transferred to Extension Study|0|||
124611827|NCT02132754|448197024|FG018|Overall Study|Transferred to Extension Study|0|||
124611828|NCT02132754|448197025|FG019|Overall Study|Transferred to Extension Study|0|||
124735814|NCT02285114|448655175|FG001|Extension Phase|Pregnancy|0|||
124735815|NCT02285114|448655176|FG002|Extension Phase|Pregnancy|0|||
124735816|NCT02285114|448655177|FG003|Extension Phase|Pregnancy|1|||
124735817|NCT02285114|448655178|FG004|Extension Phase|Pregnancy|0|||
124735818|NCT02285114|448655179|FG005|Extension Phase|Pregnancy|0|||
124735819|NCT01156389|448655185|FG000|Overall Study|Elevated liver enzymes|4|||
124735820|NCT01156389|448655186|FG001|Overall Study|Elevated liver enzymes|0|||
124735821|NCT01156389|448655185|FG000|Overall Study|Vomiting|0|||
124735822|NCT01156389|448655186|FG001|Overall Study|Vomiting|1|||
124735823|NCT00585221|448655189|FG000|Overall Study|Protocol Violation|8|||
124735824|NCT03276052|448655191|FG000|Overall Study|Withdrawal by Subject|5|||
124735825|NCT03276052|448655191|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
124735826|NCT01994863|448655192|FG000|Period 1|Adverse Event|4|||
124735827|NCT01994863|448655193|FG001|Period 1|Adverse Event|0|||
124735828|NCT01994863|448655192|FG000|Period 1|Withdrawal by Subject|1|||
124735829|NCT01994863|448655193|FG001|Period 1|Withdrawal by Subject|0|||
124735830|NCT01994863|448655192|FG000|Period 1|Trial stopped by sponsor|1|||
124735831|NCT01994863|448655193|FG001|Period 1|Trial stopped by sponsor|3|||
124735832|NCT01994863|448655192|FG000|Period 1|Lack of Efficacy|1|||
124735833|NCT01994863|448655193|FG001|Period 1|Lack of Efficacy|0|||
124735834|NCT01994863|448655192|FG000|Period 2|Adverse Event|0|||
124735835|NCT01994863|448655193|FG001|Period 2|Adverse Event|1|||
124735836|NCT01994863|448655192|FG000|Period 2|Lack of Efficacy|0|||
124735837|NCT01994863|448655193|FG001|Period 2|Lack of Efficacy|2|||
124735838|NCT01994863|448655192|FG000|Period 2|Withdrawal by Subject|1|||
124735839|NCT01994863|448655193|FG001|Period 2|Withdrawal by Subject|1|||
124735840|NCT01145053|448655194|FG000|Overall Study|Adverse Event|22|||
124735841|NCT01145053|448655194|FG000|Overall Study|Lost to Follow-up|28|||
124735842|NCT01145053|448655194|FG000|Overall Study|Withdrawal by Subject|25|||
124735843|NCT01145053|448655194|FG000|Overall Study|Other|18|||
124735844|NCT03060512|448655195|FG000|Overall Study|Adverse Event|4|||
124735845|NCT03060512|448655196|FG001|Overall Study|Adverse Event|6|||
124735846|NCT03060512|448655195|FG000|Overall Study|Lost to Follow-up|1|||
124735847|NCT03060512|448655196|FG001|Overall Study|Lost to Follow-up|1|||
124735848|NCT03060512|448655195|FG000|Overall Study|Withdrawal by Subject|1|||
124735849|NCT03060512|448655196|FG001|Overall Study|Withdrawal by Subject|0|||
124735850|NCT03060512|448655195|FG000|Overall Study|Non-compliance with study medication|1|||
124735851|NCT03060512|448655196|FG001|Overall Study|Non-compliance with study medication|2|||
124735852|NCT03946124|448655197|FG000|Overall Study|Withdrawal by Subject|19|||
124735853|NCT00919867|448655199|FG000|First Intervention|Withdrawal by Subject|0|||
124735854|NCT00919867|448655200|FG001|First Intervention|Withdrawal by Subject|0|||
124735855|NCT00919867|448655201|FG002|First Intervention|Withdrawal by Subject|1|||
124735856|NCT00919867|448655202|FG003|First Intervention|Withdrawal by Subject|0|||
124735857|NCT00919867|448655203|FG004|First Intervention|Withdrawal by Subject|0|||
124735858|NCT00919867|448655204|FG005|First Intervention|Withdrawal by Subject|0|||
124735859|NCT00919867|448655199|FG000|First Intervention|Physician Decision|0|||
124735860|NCT00919867|448655200|FG001|First Intervention|Physician Decision|0|||
124735861|NCT00919867|448655201|FG002|First Intervention|Physician Decision|0|||
124735862|NCT00919867|448655202|FG003|First Intervention|Physician Decision|0|||
124735863|NCT00919867|448655203|FG004|First Intervention|Physician Decision|0|||
124735864|NCT00919867|448655204|FG005|First Intervention|Physician Decision|1|||
124735865|NCT02498067|448655210|FG000|Overall Study|Lost to Follow-up|22|||
124735866|NCT02498067|448655210|FG000|Overall Study|Did not meet inclusion criteria|11|||
124735867|NCT01484834|448655211|FG000|Overall Study|Lost to Follow-up|5|||
124735868|NCT01484834|448655212|FG001|Overall Study|Lost to Follow-up|8|||
124735869|NCT01484834|448655213|FG002|Overall Study|Lost to Follow-up|1|||
124735870|NCT01484834|448655214|FG003|Overall Study|Lost to Follow-up|4|||
124735871|NCT00747344|448655215|FG000|Controlled Period|Adverse Event|3|||
124735872|NCT00747344|448655216|FG001|Controlled Period|Adverse Event|0|||
124735873|NCT00747344|448655217|FG002|Controlled Period|Adverse Event|0|||
124735874|NCT00747344|448655218|FG003|Controlled Period|Adverse Event|0|||
124735875|NCT00747344|448655215|FG000|Controlled Period|Lack of Efficacy|2|||
124735876|NCT00747344|448655216|FG001|Controlled Period|Lack of Efficacy|1|||
124735877|NCT00747344|448655217|FG002|Controlled Period|Lack of Efficacy|0|||
124735878|NCT00747344|448655218|FG003|Controlled Period|Lack of Efficacy|0|||
124735879|NCT00747344|448655215|FG000|Controlled Period|Other|0|||
124735880|NCT00747344|448655216|FG001|Controlled Period|Other|3|||
124735881|NCT00747344|448655217|FG002|Controlled Period|Other|0|||
124735882|NCT00747344|448655218|FG003|Controlled Period|Other|0|||
124735883|NCT00747344|448655215|FG000|After Controlled Period|Adverse Event|0|||
124735884|NCT00747344|448655216|FG001|After Controlled Period|Adverse Event|0|||
124735885|NCT00747344|448655217|FG002|After Controlled Period|Adverse Event|0|||
124735886|NCT00747344|448655218|FG003|After Controlled Period|Adverse Event|1|||
124781317|NCT03801031|448829148|FG001|Overall Study|Withdrawal by Subject|1|||
124781318|NCT00486291|448829153|FG000|Overall Study|Adverse Event|3|||
124735887|NCT00765882|448655219|FG000|Overall Study|Adverse Event|10|||
124735888|NCT00765882|448655220|FG001|Overall Study|Adverse Event|21|||
124735889|NCT00765882|448655221|FG002|Overall Study|Adverse Event|20|||
124735890|NCT00765882|448655219|FG000|Overall Study|Lack of Efficacy|4|||
124735891|NCT00765882|448655220|FG001|Overall Study|Lack of Efficacy|0|||
124735892|NCT00765882|448655221|FG002|Overall Study|Lack of Efficacy|1|||
124735893|NCT00765882|448655219|FG000|Overall Study|Protocol Violation|4|||
124735894|NCT00765882|448655220|FG001|Overall Study|Protocol Violation|3|||
124735895|NCT00765882|448655221|FG002|Overall Study|Protocol Violation|1|||
124735896|NCT00765882|448655219|FG000|Overall Study|Withdrawal by Subject|2|||
124735897|NCT00765882|448655220|FG001|Overall Study|Withdrawal by Subject|6|||
124735898|NCT00765882|448655221|FG002|Overall Study|Withdrawal by Subject|6|||
124735899|NCT00765882|448655219|FG000|Overall Study|Lost to Follow-up|1|||
124735900|NCT00765882|448655220|FG001|Overall Study|Lost to Follow-up|9|||
124735901|NCT00765882|448655221|FG002|Overall Study|Lost to Follow-up|6|||
124735902|NCT00765882|448655219|FG000|Overall Study|Other Reason|3|||
124735903|NCT00765882|448655220|FG001|Overall Study|Other Reason|1|||
124735904|NCT00765882|448655221|FG002|Overall Study|Other Reason|2|||
124735905|NCT02231762|448655225|FG000|Combination Phase|Adverse Event|10|||
124735906|NCT02231762|448655226|FG001|Combination Phase|Adverse Event|0|||
124735907|NCT02231762|448655227|FG002|Combination Phase|Adverse Event|0|||
124735908|NCT02231762|448655228|FG003|Combination Phase|Adverse Event|0|||
124735909|NCT02231762|448655225|FG000|Combination Phase|Withdrawal by Subject|2|||
124735910|NCT02231762|448655226|FG001|Combination Phase|Withdrawal by Subject|0|||
124735911|NCT02231762|448655227|FG002|Combination Phase|Withdrawal by Subject|0|||
124735912|NCT02231762|448655228|FG003|Combination Phase|Withdrawal by Subject|0|||
124735913|NCT02231762|448655225|FG000|Combination Phase|Disease Progression|6|||
124735914|NCT02231762|448655226|FG001|Combination Phase|Disease Progression|0|||
124735915|NCT02231762|448655227|FG002|Combination Phase|Disease Progression|0|||
124735916|NCT02231762|448655228|FG003|Combination Phase|Disease Progression|0|||
124735917|NCT02231762|448655225|FG000|Combination Phase|Did not meet inclusion criteria|1|||
124735918|NCT02231762|448655226|FG001|Combination Phase|Did not meet inclusion criteria|0|||
124735919|NCT02231762|448655227|FG002|Combination Phase|Did not meet inclusion criteria|0|||
124735920|NCT02231762|448655228|FG003|Combination Phase|Did not meet inclusion criteria|0|||
124735921|NCT02231762|448655225|FG000|Combination Phase|Protocol Violation|1|||
124735922|NCT02231762|448655226|FG001|Combination Phase|Protocol Violation|0|||
124735923|NCT02231762|448655227|FG002|Combination Phase|Protocol Violation|0|||
124735924|NCT02231762|448655228|FG003|Combination Phase|Protocol Violation|0|||
124735925|NCT02231762|448655225|FG000|Maintenance Phase|Disease progression|0|||
124735926|NCT02231762|448655226|FG001|Maintenance Phase|Disease progression|3|||
124735927|NCT02231762|448655227|FG002|Maintenance Phase|Disease progression|4|||
124735928|NCT02231762|448655228|FG003|Maintenance Phase|Disease progression|3|||
124735929|NCT02231762|448655225|FG000|Maintenance Phase|Adverse Event|0|||
124735930|NCT02231762|448655226|FG001|Maintenance Phase|Adverse Event|0|||
124735931|NCT02231762|448655227|FG002|Maintenance Phase|Adverse Event|1|||
124735932|NCT02231762|448655228|FG003|Maintenance Phase|Adverse Event|2|||
124735933|NCT01799239|448655233|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
124735934|NCT01799239|448655234|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
124735935|NCT01799239|448655233|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
124735936|NCT01799239|448655234|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
124735937|NCT01799239|448655233|FG000|Period 1 (7 Days)|Protocol Violation|0|||
124735938|NCT01799239|448655234|FG001|Period 1 (7 Days)|Protocol Violation|1|||
124735939|NCT01799239|448655233|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
124735940|NCT01799239|448655234|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
124735941|NCT01799239|448655233|FG000|Period 2 (7 Days)|Protocol Violation|1|||
124735942|NCT01799239|448655234|FG001|Period 2 (7 Days)|Protocol Violation|0|||
124735943|NCT02594098|448655235|FG000|Overall Study|Lack of Efficacy|17|||
124735944|NCT02594098|448655236|FG001|Overall Study|Lack of Efficacy|6|||
124735945|NCT02594098|448655235|FG000|Overall Study|Withdrawal by Subject|1|||
124735946|NCT02594098|448655236|FG001|Overall Study|Withdrawal by Subject|3|||
124735947|NCT02594098|448655235|FG000|Overall Study|Terminated participation|6|||
124735948|NCT02594098|448655236|FG001|Overall Study|Terminated participation|2|||
124735949|NCT02594098|448655235|FG000|Overall Study|Seek alternative treatment|2|||
124735950|NCT02594098|448655236|FG001|Overall Study|Seek alternative treatment|1|||
124735951|NCT02594098|448655235|FG000|Overall Study|Other|0|||
124735952|NCT02594098|448655236|FG001|Overall Study|Other|1|||
124735953|NCT00033540|448655237|FG000|Overall Study|Adverse Event|14|||
124735954|NCT00033540|448655237|FG000|Overall Study|Death|1|||
124735955|NCT00033540|448655237|FG000|Overall Study|Progression|26|||
124735956|NCT00033540|448655237|FG000|Overall Study|Withdrawal by Subject|6|||
124735957|NCT00033540|448655237|FG000|Overall Study|Other|5|||
124735958|NCT00033540|448655237|FG000|Overall Study|Ineligible|3|||
124735959|NCT00033540|448655237|FG000|Overall Study|Never received treatment|2|||
124735960|NCT03366103|448655238|FG000|Overall Study|Disease Progression|3|||
124735961|NCT03366103|448655239|FG001|Overall Study|Disease Progression|1|||
124735962|NCT03366103|448655240|FG002|Overall Study|Disease Progression|0|||
124735963|NCT03366103|448655238|FG000|Overall Study|Adverse Event|0|||
124735964|NCT03366103|448655239|FG001|Overall Study|Adverse Event|1|||
124735965|NCT03366103|448655240|FG002|Overall Study|Adverse Event|0|||
124735966|NCT01036529|448655241|FG000|Overall Study|Adverse Event|0|||
124735967|NCT01036529|448655242|FG001|Overall Study|Adverse Event|1|||
124735968|NCT01036529|448655241|FG000|Overall Study|Lost to Follow-up|0|||
124735969|NCT01036529|448655242|FG001|Overall Study|Lost to Follow-up|1|||
124735970|NCT01036529|448655241|FG000|Overall Study|Physician Decision|1|||
124735971|NCT01036529|448655242|FG001|Overall Study|Physician Decision|0|||
124735972|NCT01036529|448655241|FG000|Overall Study|Withdrawal by Subject|1|||
124735973|NCT01036529|448655242|FG001|Overall Study|Withdrawal by Subject|1|||
124735974|NCT01036529|448655241|FG000|Overall Study|Sponsor study termination|11|||
124735975|NCT01036529|448655242|FG001|Overall Study|Sponsor study termination|12|||
124735976|NCT01945775|448655243|FG000|Overall Study|Death|214|||
124735977|NCT01945775|448655244|FG001|Overall Study|Death|98|||
124735978|NCT01945775|448655243|FG000|Overall Study|Lost to Follow-up|12|||
124735979|NCT01945775|448655244|FG001|Overall Study|Lost to Follow-up|7|||
124735980|NCT01945775|448655243|FG000|Overall Study|Withdrawal by Subject|11|||
124735981|NCT01945775|448655244|FG001|Overall Study|Withdrawal by Subject|21|||
124735982|NCT01945775|448655243|FG000|Overall Study|Other|50|||
124735983|NCT01945775|448655244|FG001|Overall Study|Other|18|||
124735984|NCT02876328|448655245|FG000|Overall Study|Death|2|||
124735985|NCT02876328|448655246|FG001|Overall Study|Death|1|||
124735986|NCT02876328|448655247|FG002|Overall Study|Death|3|||
124735987|NCT02876328|448655248|FG003|Overall Study|Death|0|||
124735988|NCT02876328|448655249|FG004|Overall Study|Death|0|||
124735989|NCT02876328|448655250|FG005|Overall Study|Death|0|||
124735990|NCT02876328|448655251|FG006|Overall Study|Death|1|||
124735991|NCT02876328|448655252|FG007|Overall Study|Death|3|||
124735992|NCT02876328|448655253|FG008|Overall Study|Death|0|||
124735993|NCT02876328|448655254|FG009|Overall Study|Death|1|||
124735994|NCT02876328|448655255|FG010|Overall Study|Death|1|||
124735995|NCT02876328|448655256|FG011|Overall Study|Death|0|||
124735996|NCT02876328|448655257|FG012|Overall Study|Death|0|||
124735997|NCT02876328|448655258|FG013|Overall Study|Death|0|||
124735998|NCT02876328|448655259|FG014|Overall Study|Death|0|||
124735999|NCT02876328|448655260|FG015|Overall Study|Death|0|||
124736000|NCT02876328|448655261|FG016|Overall Study|Death|1|||
124736001|NCT02876328|448655262|FG017|Overall Study|Death|1|||
124736002|NCT02876328|448655263|FG018|Overall Study|Death|0|||
124736003|NCT02876328|448655264|FG019|Overall Study|Death|0|||
124736004|NCT02876328|448655265|FG020|Overall Study|Death|0|||
124736005|NCT02876328|448655266|FG021|Overall Study|Death|1|||
124736006|NCT02876328|448655267|FG022|Overall Study|Death|0|||
124736007|NCT02876328|448655268|FG023|Overall Study|Death|0|||
124736008|NCT02876328|448655245|FG000|Overall Study|Withdrawal by Subject|0|||
124736009|NCT02876328|448655246|FG001|Overall Study|Withdrawal by Subject|2|||
124736010|NCT02876328|448655247|FG002|Overall Study|Withdrawal by Subject|3|||
124736011|NCT02876328|448655248|FG003|Overall Study|Withdrawal by Subject|3|||
124736012|NCT02876328|448655249|FG004|Overall Study|Withdrawal by Subject|0|||
124736013|NCT02876328|448655250|FG005|Overall Study|Withdrawal by Subject|1|||
124736014|NCT02876328|448655251|FG006|Overall Study|Withdrawal by Subject|0|||
124736015|NCT02876328|448655252|FG007|Overall Study|Withdrawal by Subject|1|||
124736016|NCT02876328|448655253|FG008|Overall Study|Withdrawal by Subject|1|||
124736017|NCT02876328|448655254|FG009|Overall Study|Withdrawal by Subject|2|||
124736018|NCT02876328|448655255|FG010|Overall Study|Withdrawal by Subject|0|||
124736019|NCT02876328|448655256|FG011|Overall Study|Withdrawal by Subject|0|||
124736020|NCT02876328|448655257|FG012|Overall Study|Withdrawal by Subject|0|||
124736021|NCT02876328|448655258|FG013|Overall Study|Withdrawal by Subject|0|||
124736022|NCT02876328|448655259|FG014|Overall Study|Withdrawal by Subject|0|||
124736023|NCT02876328|448655260|FG015|Overall Study|Withdrawal by Subject|0|||
124736024|NCT02876328|448655261|FG016|Overall Study|Withdrawal by Subject|1|||
124736025|NCT02876328|448655262|FG017|Overall Study|Withdrawal by Subject|3|||
124736026|NCT02876328|448655263|FG018|Overall Study|Withdrawal by Subject|0|||
124736027|NCT02876328|448655264|FG019|Overall Study|Withdrawal by Subject|0|||
124736028|NCT02876328|448655265|FG020|Overall Study|Withdrawal by Subject|1|||
124736029|NCT02876328|448655266|FG021|Overall Study|Withdrawal by Subject|0|||
124736030|NCT02876328|448655267|FG022|Overall Study|Withdrawal by Subject|0|||
124736031|NCT02876328|448655268|FG023|Overall Study|Withdrawal by Subject|0|||
124736032|NCT02876328|448655245|FG000|Overall Study|Missed 12 Month Visit|15|||
124736033|NCT02876328|448655246|FG001|Overall Study|Missed 12 Month Visit|10|||
124736034|NCT02876328|448655247|FG002|Overall Study|Missed 12 Month Visit|11|||
124736035|NCT02876328|448655248|FG003|Overall Study|Missed 12 Month Visit|6|||
124611829|NCT02132754|448197026|FG020|Overall Study|Transferred to Extension Study|0|||
124611830|NCT02132754|448197027|FG021|Overall Study|Transferred to Extension Study|0|||
124736036|NCT02876328|448655249|FG004|Overall Study|Missed 12 Month Visit|10|||
124736037|NCT02876328|448655250|FG005|Overall Study|Missed 12 Month Visit|14|||
124736038|NCT02876328|448655251|FG006|Overall Study|Missed 12 Month Visit|3|||
124736039|NCT02876328|448655252|FG007|Overall Study|Missed 12 Month Visit|8|||
124736040|NCT02876328|448655253|FG008|Overall Study|Missed 12 Month Visit|9|||
124736041|NCT02876328|448655254|FG009|Overall Study|Missed 12 Month Visit|5|||
124736042|NCT02876328|448655255|FG010|Overall Study|Missed 12 Month Visit|4|||
124781319|NCT00486291|448829154|FG001|Overall Study|Adverse Event|4|||
124781320|NCT00486291|448829153|FG000|Overall Study|Lost to Follow-up|3|||
124736043|NCT02876328|448655256|FG011|Overall Study|Missed 12 Month Visit|1|||
124736044|NCT02876328|448655257|FG012|Overall Study|Missed 12 Month Visit|5|||
124736045|NCT02876328|448655258|FG013|Overall Study|Missed 12 Month Visit|4|||
124736046|NCT02876328|448655259|FG014|Overall Study|Missed 12 Month Visit|4|||
124736047|NCT02876328|448655260|FG015|Overall Study|Missed 12 Month Visit|4|||
124736048|NCT02876328|448655261|FG016|Overall Study|Missed 12 Month Visit|3|||
124781321|NCT00486291|448829154|FG001|Overall Study|Lost to Follow-up|7|||
124736049|NCT02876328|448655262|FG017|Overall Study|Missed 12 Month Visit|6|||
124736050|NCT02876328|448655263|FG018|Overall Study|Missed 12 Month Visit|2|||
124736051|NCT02876328|448655264|FG019|Overall Study|Missed 12 Month Visit|2|||
124736052|NCT02876328|448655265|FG020|Overall Study|Missed 12 Month Visit|11|||
124736053|NCT02876328|448655266|FG021|Overall Study|Missed 12 Month Visit|7|||
124736054|NCT02876328|448655267|FG022|Overall Study|Missed 12 Month Visit|1|||
124736055|NCT02876328|448655268|FG023|Overall Study|Missed 12 Month Visit|0|||
124736056|NCT03515941|448655270|FG000|Overall Study|Adverse Event|1|||
124736057|NCT03515941|448655271|FG001|Overall Study|Adverse Event|0|||
124736058|NCT00468845|448655274|FG000|Overall Study|Adverse Event|9|||
124736059|NCT00468845|448655275|FG001|Overall Study|Adverse Event|14|||
124736060|NCT00468845|448655276|FG002|Overall Study|Adverse Event|11|||
124736061|NCT00468845|448655274|FG000|Overall Study|Lost to Follow-up|2|||
124736062|NCT00468845|448655275|FG001|Overall Study|Lost to Follow-up|1|||
124736063|NCT00468845|448655276|FG002|Overall Study|Lost to Follow-up|2|||
124736064|NCT00468845|448655274|FG000|Overall Study|Other|4|||
124736065|NCT00468845|448655275|FG001|Overall Study|Other|9|||
124736066|NCT00468845|448655276|FG002|Overall Study|Other|5|||
124736067|NCT00468845|448655274|FG000|Overall Study|No longer willing to participate|5|||
124736068|NCT00468845|448655275|FG001|Overall Study|No longer willing to participate|6|||
124736069|NCT00468845|448655276|FG002|Overall Study|No longer willing to participate|10|||
124736070|NCT00468845|448655274|FG000|Overall Study|Randomized, not treated|1|||
124736071|NCT00468845|448655275|FG001|Overall Study|Randomized, not treated|4|||
124736072|NCT00468845|448655276|FG002|Overall Study|Randomized, not treated|2|||
124736073|NCT00334282|448655277|FG000|Overall Study|Lost to Follow-up|11|||
124736074|NCT00334282|448655278|FG001|Overall Study|Lost to Follow-up|5|||
124736075|NCT00334282|448655277|FG000|Overall Study|Withdrawal by Subject|17|||
124736076|NCT00334282|448655278|FG001|Overall Study|Withdrawal by Subject|3|||
124736077|NCT00334282|448655277|FG000|Overall Study|Death|194|||
124736078|NCT00334282|448655278|FG001|Overall Study|Death|100|||
124736079|NCT04342689|448655291|FG000|Overall Study|Withdrawal by Subject|32|||
124736080|NCT04342689|448655292|FG001|Overall Study|Withdrawal by Subject|33|||
124736081|NCT04342689|448655291|FG000|Overall Study|Lost to Follow-up|10|||
124736082|NCT04342689|448655292|FG001|Overall Study|Lost to Follow-up|12|||
124736083|NCT01460407|448655293|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
124736084|NCT01460407|448655294|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
124736085|NCT00844805|448655299|FG000|Treatment Phase|Adverse Event|5|||
124736086|NCT00844805|448655300|FG001|Treatment Phase|Adverse Event|1|||
124736087|NCT00844805|448655301|FG002|Treatment Phase|Adverse Event|0|||
124736088|NCT00844805|448655302|FG003|Treatment Phase|Adverse Event|0|||
124736089|NCT00844805|448655299|FG000|Treatment Phase|Withdrawal by Subject|3|||
124736090|NCT00844805|448655300|FG001|Treatment Phase|Withdrawal by Subject|4|||
124736091|NCT00844805|448655301|FG002|Treatment Phase|Withdrawal by Subject|0|||
124736092|NCT00844805|448655302|FG003|Treatment Phase|Withdrawal by Subject|0|||
124736093|NCT00844805|448655299|FG000|Treatment Phase|Noncompliance With Protocol|1|||
124736094|NCT00844805|448655300|FG001|Treatment Phase|Noncompliance With Protocol|0|||
124736095|NCT00844805|448655301|FG002|Treatment Phase|Noncompliance With Protocol|0|||
124736096|NCT00844805|448655302|FG003|Treatment Phase|Noncompliance With Protocol|0|||
124736097|NCT00844805|448655299|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
124736098|NCT00844805|448655300|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
124736099|NCT00844805|448655301|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
124736100|NCT00844805|448655302|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
124736101|NCT00844805|448655299|FG000|Follow-Up Phase|Adverse Event|0|||
124736102|NCT00844805|448655300|FG001|Follow-Up Phase|Adverse Event|0|||
124736103|NCT00844805|448655301|FG002|Follow-Up Phase|Adverse Event|1|||
124736104|NCT00844805|448655302|FG003|Follow-Up Phase|Adverse Event|0|||
124736105|NCT00844805|448655299|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
124736106|NCT00844805|448655300|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
124736107|NCT00844805|448655301|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
124736108|NCT00844805|448655302|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
124736109|NCT00844805|448655299|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
124736110|NCT00844805|448655300|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
124736111|NCT00844805|448655301|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
124736112|NCT00844805|448655302|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
124736113|NCT00844805|448655299|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
124736114|NCT00844805|448655300|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
124736115|NCT00844805|448655301|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
124736116|NCT00844805|448655302|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
124736117|NCT00844805|448655299|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
124736118|NCT00844805|448655300|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
124736119|NCT00844805|448655301|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
124736120|NCT00844805|448655302|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
124736121|NCT03618628|448655306|FG000|Overall Study|Death|1|||
124736122|NCT03618628|448655306|FG000|Overall Study|Lost to Follow-up|1|||
124736123|NCT01741532|448655308|FG000|Overall Study|Adverse Event|4|||
124736124|NCT01741532|448655309|FG001|Overall Study|Adverse Event|0|||
124736125|NCT01741532|448655308|FG000|Overall Study|Withdrawal by Subject|1|||
124736126|NCT01741532|448655309|FG001|Overall Study|Withdrawal by Subject|1|||
124736127|NCT01741532|448655308|FG000|Overall Study|Protocol Violation|0|||
124736128|NCT01741532|448655309|FG001|Overall Study|Protocol Violation|1|||
124736129|NCT01741532|448655308|FG000|Overall Study|Worsening of the disease|3|||
124736130|NCT01741532|448655309|FG001|Overall Study|Worsening of the disease|1|||
124736131|NCT01741532|448655308|FG000|Overall Study|Sponsor decision|1|||
124736132|NCT01741532|448655309|FG001|Overall Study|Sponsor decision|0|||
124736133|NCT01741532|448655308|FG000|Overall Study|Medical event|1|||
124736134|NCT01741532|448655309|FG001|Overall Study|Medical event|0|||
124736135|NCT00475865|448655310|FG000|Overall Study|Adverse Event|0|||
124736136|NCT00475865|448655311|FG001|Overall Study|Adverse Event|3|||
124736137|NCT00475865|448655312|FG002|Overall Study|Adverse Event|4|||
124736138|NCT00475865|448655310|FG000|Overall Study|Lack of Efficacy|1|||
124736139|NCT00475865|448655311|FG001|Overall Study|Lack of Efficacy|0|||
124736140|NCT00475865|448655312|FG002|Overall Study|Lack of Efficacy|0|||
124736141|NCT00475865|448655310|FG000|Overall Study|Progressive disease|0|||
124736142|NCT00475865|448655311|FG001|Overall Study|Progressive disease|1|||
124736143|NCT00475865|448655312|FG002|Overall Study|Progressive disease|2|||
124736144|NCT00475865|448655310|FG000|Overall Study|Participant did not wish to continue|1|||
124736145|NCT00475865|448655311|FG001|Overall Study|Participant did not wish to continue|0|||
124736146|NCT00475865|448655312|FG002|Overall Study|Participant did not wish to continue|0|||
124736147|NCT00475865|448655310|FG000|Overall Study|Other than above|0|||
124736148|NCT00475865|448655311|FG001|Overall Study|Other than above|1|||
124736149|NCT00475865|448655312|FG002|Overall Study|Other than above|0|||
124736150|NCT01453946|448655315|FG000|Overall Study|Did not receive drug for the taper phase|1|||
124736151|NCT01453946|448655315|FG000|Overall Study|Protocol Violation|2|||
124736152|NCT01453946|448655315|FG000|Overall Study|Lack of Efficacy|3|||
124736153|NCT01453946|448655315|FG000|Overall Study|Adverse Event|3|||
124736154|NCT00846040|448655316|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
124736155|NCT00846040|448655317|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
124736156|NCT00846040|448655318|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
124736157|NCT00846040|448655316|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
124736158|NCT00846040|448655317|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
124736159|NCT00846040|448655318|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
124736160|NCT03158272|448655321|FG000|Overall Study|Disease progression|3|||
124736161|NCT03158272|448655322|FG001|Overall Study|Disease progression|3|||
124736162|NCT03158272|448655323|FG002|Overall Study|Disease progression|4|||
124736163|NCT03158272|448655324|FG003|Overall Study|Disease progression|6|||
124736164|NCT03158272|448655321|FG000|Overall Study|Death|0|||
124736165|NCT03158272|448655322|FG001|Overall Study|Death|0|||
124736166|NCT03158272|448655323|FG002|Overall Study|Death|1|||
124736167|NCT03158272|448655324|FG003|Overall Study|Death|0|||
124736168|NCT03158272|448655321|FG000|Overall Study|Other reasons|0|||
124736169|NCT03158272|448655322|FG001|Overall Study|Other reasons|0|||
124736170|NCT03158272|448655323|FG002|Overall Study|Other reasons|1|||
124736171|NCT03158272|448655324|FG003|Overall Study|Other reasons|0|||
124736172|NCT03158272|448655321|FG000|Overall Study|Adverse event unrelated to the drug|0|||
124736173|NCT03158272|448655322|FG001|Overall Study|Adverse event unrelated to the drug|1|||
124736174|NCT03158272|448655323|FG002|Overall Study|Adverse event unrelated to the drug|0|||
124736175|NCT03158272|448655324|FG003|Overall Study|Adverse event unrelated to the drug|0|||
124736176|NCT02725593|448655325|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
124736177|NCT02725593|448655326|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
124736178|NCT02725593|448655325|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
124736179|NCT02725593|448655326|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
124736180|NCT02725593|448655325|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
124736181|NCT02725593|448655326|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
124736182|NCT02725593|448655325|FG000|Long Term Extension|Withdrawal by Subject|1|||
124736183|NCT02725593|448655326|FG001|Long Term Extension|Withdrawal by Subject|3|||
124736184|NCT01822535|448655327|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
124736185|NCT01822535|448655328|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
124736186|NCT01822535|448655327|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
124736187|NCT01822535|448655328|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
124736188|NCT01822535|448655327|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
124736189|NCT01822535|448655328|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
124736190|NCT02278614|448655331|FG000|Overall Study|Withdrawal by Subject|3|||
124736191|NCT02278614|448655332|FG001|Overall Study|Withdrawal by Subject|5|||
124736192|NCT02278614|448655331|FG000|Overall Study|Adverse Event|1|||
124736193|NCT02278614|448655332|FG001|Overall Study|Adverse Event|0|||
124736194|NCT02278614|448655331|FG000|Overall Study|left eye was not eligible|1|||
124736195|NCT02278614|448655332|FG001|Overall Study|left eye was not eligible|0|||
124736196|NCT03582813|448655335|FG000|Overall Study|Lost to Follow-up|18|||
124736197|NCT03582813|448655336|FG001|Overall Study|Lost to Follow-up|21|||
124736198|NCT03582813|448655335|FG000|Overall Study|Withdrawal by Subject|1|||
124736199|NCT03582813|448655336|FG001|Overall Study|Withdrawal by Subject|0|||
124736200|NCT02366767|448655339|FG000|Overall Study|left for home after 1 day at camp|1|||
124736201|NCT02366767|448655340|FG001|Overall Study|left for home after 1 day at camp|0|||
124736202|NCT02558400|448655343|FG000|Overall Study|Adverse Event|47|||
124736203|NCT02558400|448655344|FG001|Overall Study|Adverse Event|53|||
124736204|NCT02558400|448655345|FG002|Overall Study|Adverse Event|4|||
124736205|NCT02558400|448655343|FG000|Overall Study|Withdrawal by Subject|13|||
124736206|NCT02558400|448655344|FG001|Overall Study|Withdrawal by Subject|9|||
124736207|NCT02558400|448655345|FG002|Overall Study|Withdrawal by Subject|8|||
124736208|NCT02558400|448655343|FG000|Overall Study|Non-Compliant|0|||
124736209|NCT02558400|448655344|FG001|Overall Study|Non-Compliant|1|||
124736210|NCT02558400|448655345|FG002|Overall Study|Non-Compliant|3|||
124736211|NCT02558400|448655343|FG000|Overall Study|Lost to Follow-up|5|||
124736212|NCT02558400|448655344|FG001|Overall Study|Lost to Follow-up|5|||
124736213|NCT02558400|448655345|FG002|Overall Study|Lost to Follow-up|4|||
124736214|NCT02558400|448655343|FG000|Overall Study|Lack of Efficacy|0|||
124736215|NCT02558400|448655344|FG001|Overall Study|Lack of Efficacy|13|||
124736216|NCT02558400|448655345|FG002|Overall Study|Lack of Efficacy|1|||
124736217|NCT02558400|448655343|FG000|Overall Study|Disallowed Concurrent Medication|6|||
124736218|NCT02558400|448655344|FG001|Overall Study|Disallowed Concurrent Medication|7|||
124736219|NCT02558400|448655345|FG002|Overall Study|Disallowed Concurrent Medication|5|||
124736220|NCT02558400|448655343|FG000|Overall Study|Physician Decision|2|||
124736221|NCT02558400|448655344|FG001|Overall Study|Physician Decision|2|||
124736222|NCT02558400|448655345|FG002|Overall Study|Physician Decision|0|||
124736223|NCT02558400|448655343|FG000|Overall Study|Protocol Violation|6|||
124736224|NCT02558400|448655344|FG001|Overall Study|Protocol Violation|3|||
124736225|NCT02558400|448655345|FG002|Overall Study|Protocol Violation|8|||
124736226|NCT02558400|448655343|FG000|Overall Study|Death|0|||
124736227|NCT02558400|448655344|FG001|Overall Study|Death|1|||
124736228|NCT02558400|448655345|FG002|Overall Study|Death|0|||
124736229|NCT02558400|448655343|FG000|Overall Study|Ineligible for the study|0|||
124736230|NCT02558400|448655344|FG001|Overall Study|Ineligible for the study|2|||
124736231|NCT02558400|448655345|FG002|Overall Study|Ineligible for the study|0|||
124736232|NCT02230683|448655346|FG000|Overall Study|Adverse Event|1|||
124736233|NCT00260065|448655347|FG000|Overall Study|Progressive Disease|22|||
124736234|NCT00260065|448655347|FG000|Overall Study|Adverse Event|17|||
124736235|NCT00260065|448655347|FG000|Overall Study|Death|13|||
124736236|NCT00260065|448655347|FG000|Overall Study|Withdrawal by Subject|13|||
124736237|NCT00260065|448655347|FG000|Overall Study|Physician Decision|19|||
124736238|NCT00260065|448655347|FG000|Overall Study|Not otherwise specified|8|||
124736239|NCT00260065|448655347|FG000|Overall Study|Medication Noncompliance|1|||
124736240|NCT04068519|448655348|FG000|Dose Verification|Death|15|||
124736241|NCT04068519|448655348|FG000|Dose Verification|Withdrawal by Subject|1|||
124736242|NCT04068519|448655348|FG000|Pharmacokinetic Sub-study|Death|35|||
124736243|NCT04068519|448655348|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
124736244|NCT04068519|448655348|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
124736245|NCT04068519|448655348|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
124736246|NCT04068519|448655348|FG000|Indication Expansion|Death|152|||
124736247|NCT04068519|448655348|FG000|Indication Expansion|Withdrawal by Subject|10|||
124736248|NCT04068519|448655348|FG000|Indication Expansion|Lost to Follow-up|7|||
124736249|NCT05275582|448657251|FG000|Overall Study|Lost to Follow-up|1|||
124736250|NCT05275582|448657252|FG001|Overall Study|Lost to Follow-up|0|||
124736251|NCT05275582|448657251|FG000|Overall Study|Withdrawal by Subject|0|||
124736252|NCT05275582|448657252|FG001|Overall Study|Withdrawal by Subject|2|||
124736253|NCT05275582|448657251|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
124736254|NCT05275582|448657252|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
124736255|NCT05275582|448657251|FG000|Overall Study|Death|1|||
124736256|NCT05275582|448657252|FG001|Overall Study|Death|0|||
124736257|NCT05275582|448657251|FG000|Overall Study|Protocol Violation|1|||
124736258|NCT05275582|448657252|FG001|Overall Study|Protocol Violation|0|||
124736259|NCT04599166|448657257|FG000|Overall Study|Technological failure connecting to study app|80|||
124781322|NCT00486291|448829153|FG000|Overall Study|protocol non-compliance|10|||
124736260|NCT01777542|448657258|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
124736261|NCT01777542|448657259|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
124736262|NCT00953524|448657260|FG000|Overall Study|Adverse Event|2|||
124736263|NCT00953524|448657261|FG001|Overall Study|Adverse Event|0|||
124736264|NCT00953524|448657262|FG002|Overall Study|Adverse Event|1|||
124736265|NCT00953524|448657263|FG003|Overall Study|Adverse Event|2|||
124736266|NCT00953524|448657260|FG000|Overall Study|Protocol Violation|18|||
124736267|NCT00953524|448657261|FG001|Overall Study|Protocol Violation|10|||
124736268|NCT00953524|448657262|FG002|Overall Study|Protocol Violation|11|||
124736269|NCT00953524|448657263|FG003|Overall Study|Protocol Violation|6|||
124736270|NCT00953524|448657260|FG000|Overall Study|Lost to Follow-up|0|||
124736271|NCT00953524|448657261|FG001|Overall Study|Lost to Follow-up|1|||
124736272|NCT00953524|448657262|FG002|Overall Study|Lost to Follow-up|1|||
124736273|NCT00953524|448657263|FG003|Overall Study|Lost to Follow-up|0|||
124736274|NCT00953524|448657260|FG000|Overall Study|Withdrawal by Subject|2|||
124736275|NCT00953524|448657261|FG001|Overall Study|Withdrawal by Subject|4|||
124611831|NCT02132754|448197028|FG022|Overall Study|Transferred to Extension Study|0|||
124611832|NCT02132754|448197029|FG023|Overall Study|Transferred to Extension Study|0|||
124611833|NCT02132754|448197030|FG024|Overall Study|Transferred to Extension Study|0|||
124611834|NCT02132754|448197031|FG025|Overall Study|Transferred to Extension Study|0|||
124611835|NCT02132754|448197032|FG026|Overall Study|Transferred to Extension Study|0|||
124611836|NCT02132754|448197033|FG027|Overall Study|Transferred to Extension Study|0|||
124611837|NCT02132754|448197034|FG028|Overall Study|Transferred to Extension Study|0|||
124611838|NCT02132754|448197035|FG029|Overall Study|Transferred to Extension Study|0|||
124611839|NCT02132754|448197036|FG030|Overall Study|Transferred to Extension Study|0|||
124611840|NCT02132754|448197037|FG031|Overall Study|Transferred to Extension Study|0|||
124611841|NCT02132754|448197038|FG032|Overall Study|Transferred to Extension Study|0|||
124611842|NCT02132754|448197039|FG033|Overall Study|Transferred to Extension Study|6|||
124611843|NCT02132754|448197006|FG000|Overall Study|Withdrawal by Subject|0|||
124611844|NCT02132754|448197007|FG001|Overall Study|Withdrawal by Subject|0|||
124611845|NCT02132754|448197008|FG002|Overall Study|Withdrawal by Subject|0|||
124611846|NCT02132754|448197009|FG003|Overall Study|Withdrawal by Subject|0|||
124611847|NCT02132754|448197010|FG004|Overall Study|Withdrawal by Subject|0|||
124611848|NCT02132754|448197011|FG005|Overall Study|Withdrawal by Subject|0|||
124611849|NCT02132754|448197012|FG006|Overall Study|Withdrawal by Subject|0|||
124611850|NCT02132754|448197013|FG007|Overall Study|Withdrawal by Subject|0|||
124611851|NCT02132754|448197014|FG008|Overall Study|Withdrawal by Subject|0|||
124611852|NCT02132754|448197015|FG009|Overall Study|Withdrawal by Subject|1|||
124611853|NCT02132754|448197016|FG010|Overall Study|Withdrawal by Subject|0|||
124611854|NCT02132754|448197017|FG011|Overall Study|Withdrawal by Subject|0|||
124611855|NCT02132754|448197018|FG012|Overall Study|Withdrawal by Subject|1|||
124611856|NCT02132754|448197019|FG013|Overall Study|Withdrawal by Subject|0|||
124611857|NCT02132754|448197020|FG014|Overall Study|Withdrawal by Subject|1|||
124611858|NCT02132754|448197021|FG015|Overall Study|Withdrawal by Subject|2|||
124611859|NCT02132754|448197022|FG016|Overall Study|Withdrawal by Subject|1|||
124611860|NCT02132754|448197023|FG017|Overall Study|Withdrawal by Subject|0|||
124611861|NCT02132754|448197024|FG018|Overall Study|Withdrawal by Subject|0|||
124611862|NCT02132754|448197025|FG019|Overall Study|Withdrawal by Subject|0|||
124611863|NCT02132754|448197026|FG020|Overall Study|Withdrawal by Subject|1|||
124611864|NCT02132754|448197027|FG021|Overall Study|Withdrawal by Subject|0|||
124611865|NCT02132754|448197028|FG022|Overall Study|Withdrawal by Subject|0|||
124611866|NCT02132754|448197029|FG023|Overall Study|Withdrawal by Subject|0|||
124611867|NCT02132754|448197030|FG024|Overall Study|Withdrawal by Subject|1|||
124611868|NCT02132754|448197031|FG025|Overall Study|Withdrawal by Subject|0|||
124611869|NCT02132754|448197032|FG026|Overall Study|Withdrawal by Subject|0|||
124611870|NCT02132754|448197033|FG027|Overall Study|Withdrawal by Subject|1|||
124611871|NCT02132754|448197034|FG028|Overall Study|Withdrawal by Subject|0|||
124611872|NCT02132754|448197035|FG029|Overall Study|Withdrawal by Subject|0|||
124611873|NCT02132754|448197036|FG030|Overall Study|Withdrawal by Subject|0|||
124611874|NCT02132754|448197037|FG031|Overall Study|Withdrawal by Subject|1|||
124611875|NCT02132754|448197038|FG032|Overall Study|Withdrawal by Subject|0|||
124611876|NCT02132754|448197039|FG033|Overall Study|Withdrawal by Subject|2|||
124611877|NCT03567382|448197040|FG000|Overall Study|Lost to Follow-up|1|||
124611878|NCT03567382|448197041|FG001|Overall Study|Lost to Follow-up|21|||
124611879|NCT03567382|448197042|FG002|Overall Study|Lost to Follow-up|1|||
124611880|NCT03567382|448197043|FG003|Overall Study|Lost to Follow-up|21|||
124611881|NCT03567382|448197040|FG000|Overall Study|Withdrawal by Subject|2|||
124611882|NCT03567382|448197041|FG001|Overall Study|Withdrawal by Subject|14|||
124611883|NCT03567382|448197042|FG002|Overall Study|Withdrawal by Subject|1|||
124611884|NCT03567382|448197043|FG003|Overall Study|Withdrawal by Subject|12|||
124611885|NCT00499174|448197046|FG000|Overall Study|Physician Decision|78|||
124611886|NCT00499174|448197047|FG001|Overall Study|Physician Decision|9|||
124611887|NCT02269163|448197048|FG000|Overall Study|Lost to Follow-up|1|||
124611888|NCT02269163|448197049|FG001|Overall Study|Lost to Follow-up|0|||
124611889|NCT02269163|448197048|FG000|Overall Study|Major protocol violation|0|||
124611890|NCT02269163|448197049|FG001|Overall Study|Major protocol violation|1|||
124611891|NCT02269163|448197048|FG000|Overall Study|Other|2|||
124611892|NCT02269163|448197049|FG001|Overall Study|Other|2|||
124611893|NCT02269163|448197048|FG000|Overall Study|Withdrawal by Subject|0|||
124611894|NCT02269163|448197049|FG001|Overall Study|Withdrawal by Subject|3|||
124611895|NCT02269163|448197048|FG000|Overall Study|Physician Decision|0|||
124611896|NCT02269163|448197049|FG001|Overall Study|Physician Decision|1|||
124611897|NCT00638027|448197053|FG000|Overall Study|Adverse Event|0|||
124611898|NCT00638027|448197054|FG001|Overall Study|Adverse Event|2|||
124611899|NCT00371397|448197055|FG000|Session 1|Withdrawal by Subject|1|||
124611900|NCT00371397|448197056|FG001|Session 1|Withdrawal by Subject|0|||
124611901|NCT00371397|448197057|FG002|Session 1|Withdrawal by Subject|0|||
124611902|NCT00371397|448197058|FG003|Session 1|Withdrawal by Subject|0|||
124611903|NCT00371397|448197059|FG004|Session 1|Withdrawal by Subject|0|||
124611904|NCT00371397|448197060|FG005|Session 1|Withdrawal by Subject|0|||
124611905|NCT00371397|448197061|FG006|Session 1|Withdrawal by Subject|0|||
124611906|NCT00371397|448197062|FG007|Session 1|Withdrawal by Subject|1|||
124736276|NCT00953524|448657262|FG002|Overall Study|Withdrawal by Subject|1|||
124736277|NCT00953524|448657263|FG003|Overall Study|Withdrawal by Subject|0|||
124736278|NCT03554772|448657270|FG000|Overall Study|Lost to Follow-up|0|||
124736279|NCT03554772|448657271|FG001|Overall Study|Lost to Follow-up|0|||
124736280|NCT03554772|448657272|FG002|Overall Study|Lost to Follow-up|0|||
124736281|NCT03554772|448657273|FG003|Overall Study|Lost to Follow-up|2|||
124736282|NCT05136898|448657274|FG000|Overall Study|Adverse Event|2|||
124736283|NCT03784846|448657275|FG000|Pre-COVID Study|Lost to Follow-up|3|||
124736284|NCT03784846|448657276|FG001|Pre-COVID Study|Lost to Follow-up|3|||
124736285|NCT03784846|448657277|FG002|Pre-COVID Study|Lost to Follow-up|2|||
124736286|NCT03784846|448657275|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
124736287|NCT03784846|448657276|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
124736288|NCT03784846|448657277|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
124736289|NCT03784846|448657275|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
124736290|NCT03784846|448657276|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
124736291|NCT03784846|448657277|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
124736292|NCT03784846|448657275|FG000|Post-COVID Study|Lost to Follow-up|3|||
124736293|NCT03784846|448657276|FG001|Post-COVID Study|Lost to Follow-up|5|||
124736294|NCT03784846|448657277|FG002|Post-COVID Study|Lost to Follow-up|1|||
124736295|NCT03784846|448657275|FG000|Post-COVID Study|Withdrawal by Subject|1|||
124736296|NCT03784846|448657276|FG001|Post-COVID Study|Withdrawal by Subject|2|||
124736297|NCT03784846|448657277|FG002|Post-COVID Study|Withdrawal by Subject|0|||
124736298|NCT00867087|448657278|FG000|Overall Study|Other|1|||
124736299|NCT00867087|448657278|FG000|Overall Study|Withdrawal by Subject|4|||
124736300|NCT00867087|448657278|FG000|Overall Study|Death|37|||
124736301|NCT02088073|448657280|FG000|Acute Phase|Withdrawal by Subject|5|||
124736302|NCT02088073|448657281|FG001|Acute Phase|Withdrawal by Subject|0|||
124736303|NCT02088073|448657282|FG002|Acute Phase|Withdrawal by Subject|0|||
124736304|NCT02088073|448657283|FG003|Acute Phase|Withdrawal by Subject|0|||
124736305|NCT02088073|448657284|FG004|Acute Phase|Withdrawal by Subject|0|||
124736306|NCT02088073|448657280|FG000|Acute Phase|Hyperkalemia|2|||
124736307|NCT02088073|448657281|FG001|Acute Phase|Hyperkalemia|0|||
124736308|NCT02088073|448657282|FG002|Acute Phase|Hyperkalemia|0|||
124736309|NCT02088073|448657283|FG003|Acute Phase|Hyperkalemia|0|||
124736310|NCT02088073|448657284|FG004|Acute Phase|Hyperkalemia|0|||
124736311|NCT02088073|448657280|FG000|Maintanance Phase|Withdrawal by Subject|0|||
124736312|NCT02088073|448657281|FG001|Maintanance Phase|Withdrawal by Subject|2|||
124736313|NCT02088073|448657282|FG002|Maintanance Phase|Withdrawal by Subject|0|||
124736314|NCT02088073|448657283|FG003|Maintanance Phase|Withdrawal by Subject|0|||
124736315|NCT02088073|448657284|FG004|Maintanance Phase|Withdrawal by Subject|0|||
124736316|NCT02088073|448657280|FG000|Maintanance Phase|Adverse Event|0|||
124736317|NCT02088073|448657281|FG001|Maintanance Phase|Adverse Event|0|||
124736318|NCT02088073|448657282|FG002|Maintanance Phase|Adverse Event|3|||
124736319|NCT02088073|448657283|FG003|Maintanance Phase|Adverse Event|0|||
124736320|NCT02088073|448657284|FG004|Maintanance Phase|Adverse Event|1|||
124736321|NCT02088073|448657280|FG000|Maintanance Phase|Physician Decision|0|||
124736322|NCT02088073|448657281|FG001|Maintanance Phase|Physician Decision|0|||
124736323|NCT02088073|448657282|FG002|Maintanance Phase|Physician Decision|0|||
124736324|NCT02088073|448657283|FG003|Maintanance Phase|Physician Decision|0|||
124736325|NCT02088073|448657284|FG004|Maintanance Phase|Physician Decision|1|||
124736326|NCT02088073|448657280|FG000|Maintanance Phase|Sponsor's decision|0|||
124736327|NCT02088073|448657281|FG001|Maintanance Phase|Sponsor's decision|2|||
124736328|NCT02088073|448657282|FG002|Maintanance Phase|Sponsor's decision|0|||
124736329|NCT02088073|448657283|FG003|Maintanance Phase|Sponsor's decision|2|||
124736330|NCT02088073|448657284|FG004|Maintanance Phase|Sponsor's decision|1|||
124736331|NCT02088073|448657280|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
124736332|NCT02088073|448657281|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
124736333|NCT02088073|448657282|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
124736334|NCT02088073|448657283|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
124736335|NCT02088073|448657284|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
124736336|NCT02088073|448657280|FG000|Maintanance Phase|Miscellaneous|0|||
124736337|NCT02088073|448657281|FG001|Maintanance Phase|Miscellaneous|2|||
124736338|NCT02088073|448657282|FG002|Maintanance Phase|Miscellaneous|1|||
124736339|NCT02088073|448657283|FG003|Maintanance Phase|Miscellaneous|2|||
124736340|NCT02088073|448657284|FG004|Maintanance Phase|Miscellaneous|1|||
124736341|NCT02088073|448657280|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
124736342|NCT02088073|448657281|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
124736343|NCT02088073|448657282|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
124736344|NCT02088073|448657283|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
124736345|NCT02088073|448657284|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
124736346|NCT02088073|448657280|FG000|Maintanance Phase|Subject compliance|0|||
124736347|NCT02088073|448657281|FG001|Maintanance Phase|Subject compliance|1|||
124736348|NCT02088073|448657282|FG002|Maintanance Phase|Subject compliance|0|||
124736349|NCT02088073|448657283|FG003|Maintanance Phase|Subject compliance|0|||
124736350|NCT02088073|448657284|FG004|Maintanance Phase|Subject compliance|0|||
124736351|NCT00241631|448657285|FG000|Run in (2 Weeks)|Physician Decision|3|||
124736352|NCT00241631|448657286|FG001|Run in (2 Weeks)|Physician Decision|3|||
124736353|NCT00241631|448657285|FG000|Phase 1 (4 Weeks)|sore throat|1|||
124736354|NCT00241631|448657286|FG001|Phase 1 (4 Weeks)|sore throat|0|||
124736355|NCT00241631|448657285|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
124736356|NCT00241631|448657286|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
124736357|NCT00241631|448657285|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
124736358|NCT00241631|448657286|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
124736359|NCT00241631|448657285|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
124736360|NCT00241631|448657286|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
124736361|NCT03883113|448657287|FG000|Overall Study|Physician Decision|4|||
124736362|NCT03883113|448657288|FG001|Overall Study|Physician Decision|2|||
124736363|NCT03883113|448657287|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
124736364|NCT03883113|448657288|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
124736365|NCT03883113|448657287|FG000|Overall Study|Pregnancy|1|||
124736366|NCT03883113|448657288|FG001|Overall Study|Pregnancy|0|||
124736367|NCT03883113|448657287|FG000|Overall Study|Adverse Event|0|||
124736368|NCT03883113|448657288|FG001|Overall Study|Adverse Event|1|||
124736369|NCT03883113|448657287|FG000|Overall Study|Withdrawal by Subject|1|||
124736370|NCT03883113|448657288|FG001|Overall Study|Withdrawal by Subject|2|||
124736371|NCT03883113|448657287|FG000|Overall Study|Lost to Follow-up|1|||
124736372|NCT03883113|448657288|FG001|Overall Study|Lost to Follow-up|0|||
124736373|NCT01457950|448657296|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
124736374|NCT01457950|448657297|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
124736375|NCT01457950|448657298|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
124736376|NCT01457950|448657299|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
124736377|NCT01457950|448657296|FG000|Double-Blind Phase|Protocol Violation|2|||
124736378|NCT01457950|448657297|FG001|Double-Blind Phase|Protocol Violation|1|||
124736379|NCT01457950|448657298|FG002|Double-Blind Phase|Protocol Violation|0|||
124736380|NCT01457950|448657299|FG003|Double-Blind Phase|Protocol Violation|0|||
124736381|NCT01457950|448657296|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
124736382|NCT01457950|448657297|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
124736383|NCT01457950|448657298|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
124736384|NCT01457950|448657299|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
124736385|NCT01457950|448657296|FG000|Open-Label Phase|Adverse Event|0|||
124736386|NCT01457950|448657297|FG001|Open-Label Phase|Adverse Event|0|||
124736387|NCT01457950|448657298|FG002|Open-Label Phase|Adverse Event|0|||
124736388|NCT01457950|448657299|FG003|Open-Label Phase|Adverse Event|1|||
124736389|NCT01457950|448657296|FG000|Open-Label Phase|Protocol Violation|0|||
124736390|NCT01457950|448657297|FG001|Open-Label Phase|Protocol Violation|0|||
124736391|NCT01457950|448657298|FG002|Open-Label Phase|Protocol Violation|0|||
124736392|NCT01457950|448657299|FG003|Open-Label Phase|Protocol Violation|1|||
124736393|NCT01457950|448657296|FG000|Open-Label Phase|Withdrawal by Subject|0|||
124736394|NCT01457950|448657297|FG001|Open-Label Phase|Withdrawal by Subject|0|||
124736395|NCT01457950|448657298|FG002|Open-Label Phase|Withdrawal by Subject|2|||
124736396|NCT01457950|448657299|FG003|Open-Label Phase|Withdrawal by Subject|0|||
124736397|NCT00435162|448657300|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
124736398|NCT00435162|448657301|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
124736399|NCT00435162|448657302|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
124736400|NCT00435162|448657303|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
124736401|NCT00435162|448657304|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
124736402|NCT00435162|448657305|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
124736403|NCT01765426|448657308|FG000|Overall Study|Lost to Follow-up|0|||
124736404|NCT01765426|448657309|FG001|Overall Study|Lost to Follow-up|1|||
124736405|NCT01765426|448657310|FG002|Overall Study|Lost to Follow-up|0|||
124736406|NCT01765426|448657311|FG003|Overall Study|Lost to Follow-up|0|||
124736407|NCT01510184|448657312|FG000|Overall Study|Sponsor discretion|28|||
124736408|NCT01510184|448657313|FG001|Overall Study|Sponsor discretion|28|||
124736409|NCT01510184|448657312|FG000|Overall Study|Death|1|||
124736410|NCT01510184|448657313|FG001|Overall Study|Death|2|||
124736411|NCT01510184|448657312|FG000|Overall Study|Withdrawal by Subject|1|||
124736412|NCT01510184|448657313|FG001|Overall Study|Withdrawal by Subject|4|||
124736413|NCT01510184|448657312|FG000|Overall Study|Other|0|||
124736414|NCT01510184|448657313|FG001|Overall Study|Other|1|||
124736415|NCT00694096|448657322|FG000|Overall Study|Withdrawal by Subject|5|||
124736416|NCT03351114|448657326|FG000|Overall Study|Withdrawal by Subject|1|||
124736417|NCT01665430|448657327|FG000|Overall Study|Adverse Event|1|||
124736418|NCT01665430|448657327|FG000|Overall Study|Withdrawal by Subject|6|||
124736419|NCT01665430|448657327|FG000|Overall Study|Other Unspecified|2|||
124736420|NCT02310230|448657328|FG000|Overall Study|Physician Decision|1|||
124736421|NCT02310230|448657329|FG001|Overall Study|Physician Decision|3|||
124736422|NCT02310230|448657328|FG000|Overall Study|monitor baseline taken after induction|2|||
124736423|NCT02310230|448657329|FG001|Overall Study|monitor baseline taken after induction|7|||
124736424|NCT02310230|448657328|FG000|Overall Study|Poor signal quality|5|||
124736425|NCT02310230|448657329|FG001|Overall Study|Poor signal quality|8|||
124736426|NCT02310230|448657328|FG000|Overall Study|Case cancelled|1|||
124736427|NCT02310230|448657329|FG001|Overall Study|Case cancelled|0|||
124736428|NCT01371643|448657330|FG000|Overall Study|Withdrawal by Subject|3|||
124736429|NCT01371643|448657331|FG001|Overall Study|Withdrawal by Subject|0|||
124781323|NCT00486291|448829154|FG001|Overall Study|protocol non-compliance|15|||
124611907|NCT00371397|448197063|FG008|Session 1|Withdrawal by Subject|0|||
124611908|NCT00371397|448197064|FG009|Session 1|Withdrawal by Subject|0|||
124611909|NCT00371397|448197065|FG010|Session 1|Withdrawal by Subject|0|||
124611910|NCT00371397|448197066|FG011|Session 1|Withdrawal by Subject|0|||
124736430|NCT03249935|448657332|FG000|Overall Study|Discharged from facility early|36|||
124736431|NCT03249935|448657332|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
124736432|NCT03249935|448657332|FG000|Overall Study|Protocol Violation|5|||
124736433|NCT01669421|448657337|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
124736434|NCT01669421|448657337|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
124736435|NCT01561755|448657342|FG000|Overall Study|Lost to Follow-up|0|||
124736436|NCT01561755|448657343|FG001|Overall Study|Lost to Follow-up|1|||
124736437|NCT01286987|448657346|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
124736438|NCT01286987|448657347|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
124736439|NCT01286987|448657348|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
124736440|NCT01286987|448657349|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
124736441|NCT01286987|448657350|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
124736442|NCT01286987|448657351|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
124736443|NCT01286987|448657352|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
124736444|NCT01286987|448657353|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
124736445|NCT01286987|448657354|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
124736446|NCT01286987|448657355|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
124736447|NCT01286987|448657356|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
124736448|NCT01286987|448657357|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
124736449|NCT01286987|448657358|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
124736450|NCT01286987|448657359|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
124736451|NCT01286987|448657360|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
124736452|NCT01286987|448657346|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
124736453|NCT01286987|448657347|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
124736454|NCT01286987|448657348|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
124736455|NCT01286987|448657349|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
124736456|NCT01286987|448657350|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
124736457|NCT01286987|448657351|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
124736458|NCT01286987|448657352|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
124736459|NCT01286987|448657353|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
124736460|NCT01286987|448657354|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
124736461|NCT01286987|448657355|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
124736462|NCT01286987|448657356|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
124736463|NCT01286987|448657357|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
124736464|NCT01286987|448657358|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
124736465|NCT01286987|448657359|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
124736466|NCT01286987|448657360|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
124736467|NCT01286987|448657346|FG000|Part 1: Dose Escalation|Physician Decision|0|||
124736468|NCT01286987|448657347|FG001|Part 1: Dose Escalation|Physician Decision|0|||
124736469|NCT01286987|448657348|FG002|Part 1: Dose Escalation|Physician Decision|0|||
124736470|NCT01286987|448657349|FG003|Part 1: Dose Escalation|Physician Decision|0|||
124736471|NCT01286987|448657350|FG004|Part 1: Dose Escalation|Physician Decision|1|||
124736472|NCT01286987|448657351|FG005|Part 1: Dose Escalation|Physician Decision|0|||
124736473|NCT01286987|448657352|FG006|Part 1: Dose Escalation|Physician Decision|0|||
124736474|NCT01286987|448657353|FG007|Part 1: Dose Escalation|Physician Decision|0|||
124736475|NCT01286987|448657354|FG008|Part 1: Dose Escalation|Physician Decision|0|||
124736476|NCT01286987|448657355|FG009|Part 1: Dose Escalation|Physician Decision|0|||
124736477|NCT01286987|448657356|FG010|Part 1: Dose Escalation|Physician Decision|0|||
124736478|NCT01286987|448657357|FG011|Part 1: Dose Escalation|Physician Decision|0|||
124736479|NCT01286987|448657358|FG012|Part 1: Dose Escalation|Physician Decision|0|||
124736480|NCT01286987|448657359|FG013|Part 1: Dose Escalation|Physician Decision|0|||
124736481|NCT01286987|448657360|FG014|Part 1: Dose Escalation|Physician Decision|0|||
124736482|NCT01286987|448657346|FG000|Part 2: Dose Expansion|Death|0|||
124736483|NCT01286987|448657347|FG001|Part 2: Dose Expansion|Death|0|||
124736484|NCT01286987|448657348|FG002|Part 2: Dose Expansion|Death|0|||
124736485|NCT01286987|448657349|FG003|Part 2: Dose Expansion|Death|0|||
124736486|NCT01286987|448657350|FG004|Part 2: Dose Expansion|Death|0|||
124736487|NCT01286987|448657351|FG005|Part 2: Dose Expansion|Death|0|||
124736488|NCT01286987|448657352|FG006|Part 2: Dose Expansion|Death|0|||
124736489|NCT01286987|448657353|FG007|Part 2: Dose Expansion|Death|0|||
124736490|NCT01286987|448657354|FG008|Part 2: Dose Expansion|Death|0|||
124736491|NCT01286987|448657355|FG009|Part 2: Dose Expansion|Death|0|||
124736492|NCT01286987|448657356|FG010|Part 2: Dose Expansion|Death|0|||
124736493|NCT01286987|448657357|FG011|Part 2: Dose Expansion|Death|0|||
124736494|NCT01286987|448657358|FG012|Part 2: Dose Expansion|Death|1|||
124736495|NCT01286987|448657359|FG013|Part 2: Dose Expansion|Death|1|||
124736496|NCT01286987|448657360|FG014|Part 2: Dose Expansion|Death|0|||
124611911|NCT01284621|448197067|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
124781324|NCT00486291|448829153|FG000|Overall Study|requirement for restricted medication|0|||
124781325|NCT00486291|448829154|FG001|Overall Study|requirement for restricted medication|3|||
124781326|NCT00126490|448829156|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
124781327|NCT00975780|448829157|FG000|Follow Up|Death|88|||
124781328|NCT00975780|448829158|FG001|Follow Up|Death|122|||
124781329|NCT00975780|448829157|FG000|Follow Up|Facility Withdrawal|7|||
124781330|NCT00975780|448829158|FG001|Follow Up|Facility Withdrawal|23|||
124781331|NCT00975780|448829157|FG000|Follow Up|Discharged from Facility|7|||
124781332|NCT00975780|448829158|FG001|Follow Up|Discharged from Facility|12|||
124781333|NCT03051178|448829161|FG000|Overall Study|Withdrawal by Subject|5|||
124781334|NCT01598506|448829162|FG000|Overall Study|Withdrawal by Subject|2|||
124781335|NCT04080167|448829167|FG000|Overall Study|Lost to Follow-up-Patients|7|||
124781336|NCT04080167|448829168|FG001|Overall Study|Lost to Follow-up-Patients|14|||
124781337|NCT04080167|448829169|FG002|Overall Study|Lost to Follow-up-Patients|0|||
124781338|NCT04080167|448829167|FG000|Overall Study|Lost to Follow-up-Providers|2|||
124781339|NCT04080167|448829168|FG001|Overall Study|Lost to Follow-up-Providers|2|||
124736497|NCT01286987|448657346|FG000|Part 2: Dose Expansion|Physician Decision|0|||
124736498|NCT01286987|448657347|FG001|Part 2: Dose Expansion|Physician Decision|0|||
124736499|NCT01286987|448657348|FG002|Part 2: Dose Expansion|Physician Decision|0|||
124736500|NCT01286987|448657349|FG003|Part 2: Dose Expansion|Physician Decision|0|||
124736501|NCT01286987|448657350|FG004|Part 2: Dose Expansion|Physician Decision|0|||
124736502|NCT01286987|448657351|FG005|Part 2: Dose Expansion|Physician Decision|0|||
124736503|NCT01286987|448657352|FG006|Part 2: Dose Expansion|Physician Decision|0|||
124736504|NCT01286987|448657353|FG007|Part 2: Dose Expansion|Physician Decision|0|||
124736505|NCT01286987|448657354|FG008|Part 2: Dose Expansion|Physician Decision|0|||
124736506|NCT01286987|448657355|FG009|Part 2: Dose Expansion|Physician Decision|0|||
124736507|NCT01286987|448657356|FG010|Part 2: Dose Expansion|Physician Decision|1|||
124736508|NCT01286987|448657357|FG011|Part 2: Dose Expansion|Physician Decision|1|||
124736509|NCT01286987|448657358|FG012|Part 2: Dose Expansion|Physician Decision|0|||
124736510|NCT01286987|448657359|FG013|Part 2: Dose Expansion|Physician Decision|1|||
124736511|NCT01286987|448657360|FG014|Part 2: Dose Expansion|Physician Decision|0|||
124736512|NCT01286987|448657346|FG000|Part 2: Dose Expansion|Other|0|||
124736513|NCT01286987|448657347|FG001|Part 2: Dose Expansion|Other|0|||
124736514|NCT01286987|448657348|FG002|Part 2: Dose Expansion|Other|0|||
124736515|NCT01286987|448657349|FG003|Part 2: Dose Expansion|Other|0|||
124736516|NCT01286987|448657350|FG004|Part 2: Dose Expansion|Other|0|||
124736517|NCT01286987|448657351|FG005|Part 2: Dose Expansion|Other|0|||
124736518|NCT01286987|448657352|FG006|Part 2: Dose Expansion|Other|0|||
124736519|NCT01286987|448657353|FG007|Part 2: Dose Expansion|Other|0|||
124736520|NCT01286987|448657354|FG008|Part 2: Dose Expansion|Other|0|||
124736521|NCT01286987|448657355|FG009|Part 2: Dose Expansion|Other|0|||
124736522|NCT01286987|448657356|FG010|Part 2: Dose Expansion|Other|0|||
124736523|NCT01286987|448657357|FG011|Part 2: Dose Expansion|Other|0|||
124736524|NCT01286987|448657358|FG012|Part 2: Dose Expansion|Other|0|||
124736525|NCT01286987|448657359|FG013|Part 2: Dose Expansion|Other|1|||
124736526|NCT01286987|448657360|FG014|Part 2: Dose Expansion|Other|0|||
124736527|NCT01286987|448657346|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
124736528|NCT01286987|448657347|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
124736529|NCT01286987|448657348|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
124736530|NCT01286987|448657349|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
124736531|NCT01286987|448657350|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
124736532|NCT01286987|448657351|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
124736533|NCT01286987|448657352|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
124736534|NCT01286987|448657353|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
124736535|NCT01286987|448657354|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
124736536|NCT01286987|448657355|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
124736537|NCT01286987|448657356|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
124781340|NCT04080167|448829169|FG002|Overall Study|Lost to Follow-up-Providers|0|||
124781341|NCT04080167|448829167|FG000|Overall Study|Withdrawal by Subject|1|||
124781342|NCT04080167|448829168|FG001|Overall Study|Withdrawal by Subject|2|||
124781343|NCT04080167|448829169|FG002|Overall Study|Withdrawal by Subject|0|||
124781344|NCT04080167|448829167|FG000|Overall Study|Withdrawal by Provider|0|||
124781345|NCT04080167|448829168|FG001|Overall Study|Withdrawal by Provider|0|||
124736538|NCT01286987|448657357|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
124736539|NCT01286987|448657358|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
124736540|NCT01286987|448657359|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
124736541|NCT01286987|448657360|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
124736542|NCT01286987|448657346|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
124736543|NCT01286987|448657347|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
124736544|NCT01286987|448657348|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
124781346|NCT04080167|448829169|FG002|Overall Study|Withdrawal by Provider|4|||
124781347|NCT04080167|448829167|FG000|Overall Study|Death-Patient|2|||
124781348|NCT04080167|448829168|FG001|Overall Study|Death-Patient|1|||
124736545|NCT01286987|448657349|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
124736546|NCT01286987|448657350|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
124736547|NCT01286987|448657351|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
124736548|NCT01286987|448657352|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
124736549|NCT01286987|448657353|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
124736550|NCT01286987|448657354|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
124736551|NCT01286987|448657355|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
124736552|NCT01286987|448657356|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
124736553|NCT01286987|448657357|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
124736554|NCT01286987|448657358|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
124736555|NCT01286987|448657359|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
124736556|NCT01286987|448657360|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
124736557|NCT01286987|448657346|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124736558|NCT01286987|448657347|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124736559|NCT01286987|448657348|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124736560|NCT01286987|448657349|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124736561|NCT01286987|448657350|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124736562|NCT01286987|448657351|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124736563|NCT01286987|448657352|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124736564|NCT01286987|448657353|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124736565|NCT01286987|448657354|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124736566|NCT01286987|448657355|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124736567|NCT01286987|448657356|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
124736568|NCT01286987|448657357|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124736569|NCT01286987|448657358|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124736570|NCT01286987|448657359|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124736571|NCT01286987|448657360|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
124736572|NCT04662073|448657361|FG000|Overall Study|Withdrawal by Subject|1|||
124736573|NCT04662073|448657362|FG001|Overall Study|Withdrawal by Subject|0|||
124736574|NCT01479595|448657375|FG000|Overall Study|Protocol deviation|0|||
124736575|NCT01479595|448657376|FG001|Overall Study|Protocol deviation|1|||
124736576|NCT01479595|448657375|FG000|Overall Study|Adverse Event|2|||
124736577|NCT01479595|448657376|FG001|Overall Study|Adverse Event|1|||
124736578|NCT02255565|448657378|FG000|Overall Study|Withdrawal by Subject|0|||
124736579|NCT02255565|448657379|FG001|Overall Study|Withdrawal by Subject|1|||
124736580|NCT02255565|448657380|FG002|Overall Study|Withdrawal by Subject|0|||
124736581|NCT02133664|448657384|FG000|Overall Study|Lost to Follow-up|2|||
124736582|NCT02133664|448657385|FG001|Overall Study|Lost to Follow-up|1|||
124736583|NCT02133664|448657384|FG000|Overall Study|Adverse Event|3|||
124736584|NCT02133664|448657385|FG001|Overall Study|Adverse Event|6|||
124736585|NCT03906656|448657386|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
124736586|NCT03906656|448657387|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
124736587|NCT03906656|448657386|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
124736588|NCT03906656|448657387|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
124736589|NCT03906656|448657386|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
124736590|NCT03906656|448657387|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
124736591|NCT03906656|448657386|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
124736592|NCT03906656|448657387|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
124736593|NCT03906656|448657386|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
124736594|NCT03906656|448657387|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
124736595|NCT03906656|448657386|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
124736596|NCT03906656|448657387|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
124736597|NCT03906656|448657386|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
124736598|NCT03906656|448657387|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
124736599|NCT03906656|448657386|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
124736600|NCT03906656|448657387|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
124736601|NCT03906656|448657386|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
124736602|NCT03906656|448657387|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
124736603|NCT03906656|448657386|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
124736604|NCT03906656|448657387|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
124736605|NCT03906656|448657386|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
124736606|NCT03906656|448657387|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
124736607|NCT03906656|448657386|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
124736608|NCT03906656|448657387|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
124736609|NCT03906656|448657386|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
124736610|NCT03906656|448657387|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
124736611|NCT03906656|448657386|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
124736612|NCT03906656|448657387|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
124736613|NCT03906656|448657386|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
124736614|NCT03906656|448657387|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
124736615|NCT03906656|448657386|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
124781349|NCT04080167|448829169|FG002|Overall Study|Death-Patient|0|||
124781350|NCT04080167|448829167|FG000|Overall Study|Hydroxyurea New Starts|0|||
124781351|NCT04080167|448829168|FG001|Overall Study|Hydroxyurea New Starts|0|||
124781352|NCT04080167|448829169|FG002|Overall Study|Hydroxyurea New Starts|1|||
124781353|NCT04080167|448829167|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
124781354|NCT04080167|448829168|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
124781355|NCT04080167|448829169|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
124781356|NCT03530124|448829172|FG000|Overall Study|Withdrawal by Subject|0|||
124781357|NCT03530124|448829173|FG001|Overall Study|Withdrawal by Subject|1|||
124781358|NCT03530124|448829172|FG000|Overall Study|Protocol Violation|1|||
124781359|NCT03530124|448829173|FG001|Overall Study|Protocol Violation|0|||
124781360|NCT03530124|448829172|FG000|Overall Study|Discharged prior to study completion|1|||
124781361|NCT03530124|448829173|FG001|Overall Study|Discharged prior to study completion|0|||
124781362|NCT01583296|448829174|FG000|Overall Study|Withdrawal by Subject|11|||
124781363|NCT01583296|448829175|FG001|Overall Study|Withdrawal by Subject|10|||
124781364|NCT01047553|448829176|FG000|Overall Study|Adverse Event|10|||
124781365|NCT01047553|448829177|FG001|Overall Study|Adverse Event|5|||
124781366|NCT01047553|448829176|FG000|Overall Study|Withdrawal by Subject|4|||
124781367|NCT01047553|448829177|FG001|Overall Study|Withdrawal by Subject|2|||
124781368|NCT01047553|448829176|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
124781369|NCT01047553|448829177|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
124781370|NCT01047553|448829176|FG000|Overall Study|Lost to Follow-up|1|||
124781371|NCT01047553|448829177|FG001|Overall Study|Lost to Follow-up|0|||
124781372|NCT01047553|448829176|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
124781373|NCT01047553|448829177|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
124781374|NCT01047553|448829176|FG000|Overall Study|PI's decision|0|||
124781375|NCT01047553|448829177|FG001|Overall Study|PI's decision|1|||
124781376|NCT01063283|448829178|FG000|Cycle 1|Adverse Event|2|||
124781377|NCT01063283|448829179|FG001|Cycle 1|Adverse Event|0|||
124781378|NCT01063283|448829180|FG002|Cycle 1|Adverse Event|0|||
124781379|NCT01063283|448829178|FG000|Cycle 1|Technical failure in data collection|1|||
124781380|NCT01063283|448829179|FG001|Cycle 1|Technical failure in data collection|0|||
124781381|NCT01063283|448829180|FG002|Cycle 1|Technical failure in data collection|0|||
124781382|NCT01120717|448829181|FG000|Overall Study|Withdrawal by Subject|11|||
124781383|NCT01120717|448829182|FG001|Overall Study|Withdrawal by Subject|6|||
124781384|NCT01120717|448829181|FG000|Overall Study|Adverse Event|10|||
124781385|NCT01120717|448829182|FG001|Overall Study|Adverse Event|6|||
124781386|NCT01120717|448829181|FG000|Overall Study|Protocol Deviation|2|||
124781387|NCT01120717|448829182|FG001|Overall Study|Protocol Deviation|5|||
124781388|NCT01120717|448829181|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
124781389|NCT01120717|448829182|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
124781390|NCT01120717|448829181|FG000|Overall Study|Lost to Follow-up|2|||
124781391|NCT01120717|448829182|FG001|Overall Study|Lost to Follow-up|3|||
124781392|NCT01120717|448829181|FG000|Overall Study|Death|3|||
124611912|NCT01284621|448197068|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
124611913|NCT01284621|448197069|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
124611914|NCT01284621|448197070|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
124611915|NCT01284621|448197071|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
124611916|NCT01284621|448197072|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
124611917|NCT02802631|448197073|FG000|Overall Study|Withdrawal by Subject|1|||
124611918|NCT02802631|448197074|FG001|Overall Study|Withdrawal by Subject|0|||
124611919|NCT02802631|448197075|FG002|Overall Study|Withdrawal by Subject|0|||
124611920|NCT02802631|448197076|FG003|Overall Study|Withdrawal by Subject|0|||
124611921|NCT02802631|448197077|FG004|Overall Study|Withdrawal by Subject|0|||
124611922|NCT02802631|448197078|FG005|Overall Study|Withdrawal by Subject|0|||
124611923|NCT02802631|448197079|FG006|Overall Study|Withdrawal by Subject|0|||
124611924|NCT02802631|448197080|FG007|Overall Study|Withdrawal by Subject|0|||
124611925|NCT02802631|448197073|FG000|Overall Study|Physician Decision|1|||
124611926|NCT02802631|448197074|FG001|Overall Study|Physician Decision|0|||
124611927|NCT02802631|448197075|FG002|Overall Study|Physician Decision|0|||
124611928|NCT02802631|448197076|FG003|Overall Study|Physician Decision|0|||
124611929|NCT02802631|448197077|FG004|Overall Study|Physician Decision|0|||
124781393|NCT01120717|448829182|FG001|Overall Study|Death|1|||
124781394|NCT01120717|448829181|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
124781395|NCT01120717|448829182|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
124611930|NCT02802631|448197078|FG005|Overall Study|Physician Decision|0|||
124781396|NCT05343624|448829183|FG000|Overall Study|Chart review not completed|1|||
124781397|NCT02504216|448829188|FG000|Overall Study|Lost to Follow-up|3|||
124781398|NCT02504216|448829189|FG001|Overall Study|Lost to Follow-up|3|||
124781399|NCT02504216|448829188|FG000|Overall Study|Withdrawal by Subject|8|||
124781400|NCT02504216|448829189|FG001|Overall Study|Withdrawal by Subject|12|||
124611931|NCT02802631|448197079|FG006|Overall Study|Physician Decision|1|||
124611932|NCT02802631|448197080|FG007|Overall Study|Physician Decision|0|||
124611933|NCT02802631|448197073|FG000|Overall Study|Adverse Event|0|||
124611934|NCT02802631|448197074|FG001|Overall Study|Adverse Event|2|||
124611935|NCT02802631|448197075|FG002|Overall Study|Adverse Event|0|||
124611936|NCT02802631|448197076|FG003|Overall Study|Adverse Event|1|||
124611937|NCT02802631|448197077|FG004|Overall Study|Adverse Event|6|||
124611938|NCT02802631|448197078|FG005|Overall Study|Adverse Event|1|||
124611939|NCT02802631|448197079|FG006|Overall Study|Adverse Event|4|||
124611940|NCT02802631|448197080|FG007|Overall Study|Adverse Event|0|||
124611941|NCT02802631|448197073|FG000|Overall Study|Sponsor Decision|0|||
124611942|NCT02802631|448197074|FG001|Overall Study|Sponsor Decision|0|||
124611943|NCT02802631|448197075|FG002|Overall Study|Sponsor Decision|6|||
124611944|NCT02802631|448197076|FG003|Overall Study|Sponsor Decision|0|||
124611945|NCT02802631|448197077|FG004|Overall Study|Sponsor Decision|2|||
124611946|NCT02802631|448197078|FG005|Overall Study|Sponsor Decision|0|||
124611947|NCT02802631|448197079|FG006|Overall Study|Sponsor Decision|0|||
124611948|NCT02802631|448197080|FG007|Overall Study|Sponsor Decision|4|||
124611949|NCT02968849|448197081|FG000|Overall Study|Death|8|||
124736616|NCT03906656|448657387|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
124736617|NCT03906656|448657386|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
124736618|NCT03906656|448657387|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
124736619|NCT03906656|448657386|FG000|Home Use 2 (3 Months)|Death|2|||
124736620|NCT03906656|448657387|FG001|Home Use 2 (3 Months)|Death|0|||
124736621|NCT03906656|448657386|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
124736622|NCT03906656|448657387|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
124736623|NCT03906656|448657386|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
124736624|NCT03906656|448657387|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
124736625|NCT00343915|448657394|FG000|Primary Study|Withdrawal by Subject|1|||
124736626|NCT00343915|448657395|FG001|Primary Study|Withdrawal by Subject|0|||
124736627|NCT00343915|448657394|FG000|Primary Study|Lost to Follow-up|2|||
124736628|NCT00343915|448657395|FG001|Primary Study|Lost to Follow-up|3|||
124736629|NCT00343915|448657394|FG000|Primary Study|Other|1|||
124736630|NCT00343915|448657395|FG001|Primary Study|Other|0|||
124736631|NCT00882908|448657396|FG000|Overall Study|Adverse Event|0|||
124736632|NCT00882908|448657397|FG001|Overall Study|Adverse Event|0|||
124736633|NCT00882908|448657398|FG002|Overall Study|Adverse Event|1|||
124736634|NCT00882908|448657399|FG003|Overall Study|Adverse Event|0|||
124736635|NCT00882908|448657400|FG004|Overall Study|Adverse Event|1|||
124736636|NCT00882908|448657396|FG000|Overall Study|Lost to Follow-up|3|||
124736637|NCT00882908|448657397|FG001|Overall Study|Lost to Follow-up|5|||
124736638|NCT00882908|448657398|FG002|Overall Study|Lost to Follow-up|3|||
124736639|NCT00882908|448657399|FG003|Overall Study|Lost to Follow-up|1|||
124736640|NCT00882908|448657400|FG004|Overall Study|Lost to Follow-up|2|||
124736641|NCT00882908|448657396|FG000|Overall Study|Protocol Violation|0|||
124736642|NCT00882908|448657397|FG001|Overall Study|Protocol Violation|1|||
124736643|NCT00882908|448657398|FG002|Overall Study|Protocol Violation|0|||
124736644|NCT00882908|448657399|FG003|Overall Study|Protocol Violation|0|||
124736645|NCT00882908|448657400|FG004|Overall Study|Protocol Violation|0|||
124736646|NCT00882908|448657396|FG000|Overall Study|Withdrawal by Subject|0|||
124736647|NCT00882908|448657397|FG001|Overall Study|Withdrawal by Subject|0|||
124736648|NCT00882908|448657398|FG002|Overall Study|Withdrawal by Subject|3|||
124736649|NCT00882908|448657399|FG003|Overall Study|Withdrawal by Subject|5|||
124736650|NCT00882908|448657400|FG004|Overall Study|Withdrawal by Subject|2|||
124736651|NCT00882908|448657396|FG000|Overall Study|Subject reached a virologic endpoint|0|||
124736652|NCT00882908|448657397|FG001|Overall Study|Subject reached a virologic endpoint|0|||
124736653|NCT00882908|448657398|FG002|Overall Study|Subject reached a virologic endpoint|0|||
124736654|NCT00882908|448657399|FG003|Overall Study|Subject reached a virologic endpoint|0|||
124736655|NCT00882908|448657400|FG004|Overall Study|Subject reached a virologic endpoint|1|||
124736656|NCT00882908|448657396|FG000|Overall Study|Study terminated in error|0|||
124736657|NCT00882908|448657397|FG001|Overall Study|Study terminated in error|0|||
124736658|NCT00882908|448657398|FG002|Overall Study|Study terminated in error|0|||
124736659|NCT00882908|448657399|FG003|Overall Study|Study terminated in error|1|||
124736660|NCT00882908|448657400|FG004|Overall Study|Study terminated in error|0|||
124736661|NCT05291936|448657401|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
124736662|NCT05291936|448657402|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
124736663|NCT05291936|448657401|FG000|Period 1|Withdrew Consent during study|1|||
124736664|NCT05291936|448657402|FG001|Period 1|Withdrew Consent during study|0|||
124736665|NCT05291936|448657401|FG000|Period 2|Adverse Event|0|||
124736666|NCT05291936|448657402|FG001|Period 2|Adverse Event|1|||
124736667|NCT05291936|448657401|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
124736668|NCT05291936|448657402|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
124736669|NCT02370095|448657403|FG000|Overall Study|Withdrawal by Subject|0|||
124736670|NCT02370095|448657404|FG001|Overall Study|Withdrawal by Subject|1|||
124736671|NCT01667562|448657408|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
124611950|NCT02968849|448197082|FG001|Overall Study|Death|10|||
124611951|NCT02968849|448197081|FG000|Overall Study|Lost to Follow-up|31|||
124611952|NCT02968849|448197082|FG001|Overall Study|Lost to Follow-up|29|||
124611953|NCT02968849|448197081|FG000|Overall Study|Withdrawal by Subject|73|||
124611954|NCT02968849|448197082|FG001|Overall Study|Withdrawal by Subject|64|||
124781401|NCT00862082|448829190|FG000|Overall Study|Sponsor decision to terminate the study|5|||
124611955|NCT02968849|448197081|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
124611956|NCT02968849|448197082|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
124611957|NCT02968849|448197081|FG000|Overall Study|Physician Decision|6|||
124611958|NCT02968849|448197082|FG001|Overall Study|Physician Decision|9|||
124611959|NCT02968849|448197081|FG000|Overall Study|Other|16|||
124611960|NCT02968849|448197082|FG001|Overall Study|Other|10|||
124611961|NCT02551666|448197083|FG000|Overall Study|Withdrawal by Subject|1|||
124611962|NCT02551666|448197084|FG001|Overall Study|Withdrawal by Subject|3|||
124611963|NCT03395405|448198621|FG000|Overall Study|Death|0|||
124611964|NCT03395405|448198622|FG001|Overall Study|Death|2|||
124611965|NCT03395405|448198621|FG000|Overall Study|Lost to Follow-up|0|||
124611966|NCT03395405|448198622|FG001|Overall Study|Lost to Follow-up|1|||
124611967|NCT03395405|448198621|FG000|Overall Study|Protocol Violation|0|||
124611968|NCT03395405|448198622|FG001|Overall Study|Protocol Violation|1|||
124611969|NCT03395405|448198621|FG000|Overall Study|Withdrawal by Subject|3|||
124611970|NCT03395405|448198622|FG001|Overall Study|Withdrawal by Subject|1|||
124611971|NCT03395405|448198621|FG000|Overall Study|COVID-19 Pandemic|1|||
124611972|NCT03395405|448198622|FG001|Overall Study|COVID-19 Pandemic|0|||
124611973|NCT00461253|448198623|FG000|Overall Study|Death|985|||
124611974|NCT00461253|448198624|FG001|Overall Study|Death|0|||
124611975|NCT00461253|448198623|FG000|Overall Study|Protocol Violation|613|||
124611976|NCT00461253|448198624|FG001|Overall Study|Protocol Violation|236|||
124611977|NCT00461253|448198623|FG000|Overall Study|no response|2609|||
124611978|NCT00461253|448198624|FG001|Overall Study|no response|11789|||
124611979|NCT00461253|448198623|FG000|Overall Study|administrative|773|||
124611980|NCT00461253|448198624|FG001|Overall Study|administrative|7773|||
124611981|NCT03510598|448198625|FG000|Overall Study|Withdrawal by Subject|1|||
124611982|NCT04240392|448198627|FG000|Overall Study|Withdrawal by Subject|13|||
124611983|NCT04240392|448198628|FG001|Overall Study|Withdrawal by Subject|4|||
124611984|NCT04240392|448198627|FG000|Overall Study|Lost to Follow-up|11|||
124611985|NCT04240392|448198628|FG001|Overall Study|Lost to Follow-up|12|||
124611986|NCT05307510|448198629|FG000|Overall Study|Lost to Follow-up|3|||
124611987|NCT05307510|448198630|FG001|Overall Study|Lost to Follow-up|6|||
124611988|NCT05307510|448198629|FG000|Overall Study|Withdrawal by Subject|0|||
124611989|NCT05307510|448198630|FG001|Overall Study|Withdrawal by Subject|1|||
124611990|NCT01555671|448198633|FG000|Overall Study|Physician Decision|20|||
124611991|NCT01555671|448198634|FG001|Overall Study|Physician Decision|25|||
124611992|NCT03047330|448198635|FG000|Sleep Block 1|Withdrawal by Subject|3|||
124611993|NCT04590040|448198639|FG000|Treatment Period|Lost to Follow-up|2|||
124611994|NCT04590040|448198640|FG001|Treatment Period|Lost to Follow-up|5|||
124611995|NCT04590040|448198641|FG002|Treatment Period|Lost to Follow-up|0|||
124611996|NCT04590040|448198639|FG000|Treatment Period|Physician Decision|0|||
124611997|NCT04590040|448198640|FG001|Treatment Period|Physician Decision|0|||
124611998|NCT04590040|448198641|FG002|Treatment Period|Physician Decision|2|||
124611999|NCT00000378|448198642|FG000|Overall Study|Lack of Efficacy|16|||
124612000|NCT00000378|448198643|FG001|Overall Study|Lack of Efficacy|14|||
124612001|NCT04003896|448198646|FG000|Overall Study|Withdrawal by Subject|3|||
124612002|NCT04003896|448198646|FG000|Overall Study|Physician Decision|1|||
124612003|NCT01957397|448198649|FG000|Test Period 1|sudden leakage/small bag|1|||
124612004|NCT01957397|448198650|FG001|Test Period 1|sudden leakage/small bag|1|||
124612005|NCT01957397|448198649|FG000|Test Period 1|Withdrawal by Subject|1|||
124612006|NCT01957397|448198650|FG001|Test Period 1|Withdrawal by Subject|0|||
124612007|NCT01957397|448198649|FG000|Test Period 2|Adverse Event|0|||
124612008|NCT01957397|448198650|FG001|Test Period 2|Adverse Event|1|||
124612009|NCT01957397|448198649|FG000|Test Period 3|Adverse Event|1|||
124612010|NCT01957397|448198650|FG001|Test Period 3|Adverse Event|2|||
124612011|NCT01957397|448198649|FG000|Test Period 3|the adhesive did not work|1|||
124612012|NCT01957397|448198650|FG001|Test Period 3|the adhesive did not work|0|||
124612013|NCT00324649|448198651|FG000|Overall Study|Adverse Event|1|||
124612014|NCT00324649|448198652|FG001|Overall Study|Adverse Event|4|||
124612015|NCT00324649|448198651|FG000|Overall Study|Withdrawal by Subject|0|||
124612016|NCT00324649|448198652|FG001|Overall Study|Withdrawal by Subject|1|||
124612017|NCT00324649|448198651|FG000|Overall Study|Noncompliance|1|||
124612018|NCT00324649|448198652|FG001|Overall Study|Noncompliance|0|||
124612019|NCT00540293|448198653|FG000|Overall Study|Adverse event related to study drug|10|||
124612020|NCT00540293|448198653|FG000|Overall Study|Adverse event not related to study drug|7|||
124612021|NCT00540293|448198653|FG000|Overall Study|Withdrawal by Subject|6|||
124612022|NCT00540293|448198653|FG000|Overall Study|Protocol violation, & subject schedule|12|||
124612023|NCT02585934|448198658|FG000|Overall Study|Lost to Follow-up|2|||
124612024|NCT02585934|448198659|FG001|Overall Study|Lost to Follow-up|2|||
124612025|NCT02585934|448198658|FG000|Overall Study|Protocol Violation|14|||
124612026|NCT02585934|448198659|FG001|Overall Study|Protocol Violation|11|||
124612027|NCT02585934|448198658|FG000|Overall Study|Adverse Event|21|||
124612028|NCT02585934|448198659|FG001|Overall Study|Adverse Event|22|||
124612029|NCT02585934|448198658|FG000|Overall Study|Physician Decision|3|||
124612030|NCT02585934|448198659|FG001|Overall Study|Physician Decision|2|||
124612031|NCT02585934|448198658|FG000|Overall Study|Withdrawal by Subject|7|||
124612032|NCT02585934|448198659|FG001|Overall Study|Withdrawal by Subject|21|||
124612033|NCT02585934|448198658|FG000|Overall Study|Lack of Efficacy|2|||
124612034|NCT02585934|448198659|FG001|Overall Study|Lack of Efficacy|1|||
124612035|NCT02585934|448198658|FG000|Overall Study|Death|2|||
124612036|NCT02585934|448198659|FG001|Overall Study|Death|0|||
124612037|NCT02585934|448198658|FG000|Overall Study|Caregiver Withdrew Consent|7|||
124612038|NCT02585934|448198659|FG001|Overall Study|Caregiver Withdrew Consent|7|||
124612039|NCT02585934|448198658|FG000|Overall Study|Sponsor Termination|1|||
124612040|NCT02585934|448198659|FG001|Overall Study|Sponsor Termination|2|||
124612041|NCT02585934|448198658|FG000|Overall Study|Another Reason|10|||
124612042|NCT02585934|448198659|FG001|Overall Study|Another Reason|5|||
124612043|NCT04713553|448198660|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
124612044|NCT04713553|448198661|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
124612045|NCT04713553|448198662|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
124612046|NCT04713553|448198663|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
124612047|NCT04713553|448198664|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
124612048|NCT04713553|448198665|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
124612049|NCT04713553|448198666|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
124612050|NCT04713553|448198660|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
124612051|NCT04713553|448198661|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
124612052|NCT04713553|448198662|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
124612053|NCT04713553|448198663|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
124612054|NCT04713553|448198664|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
124612055|NCT04713553|448198665|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
124612056|NCT04713553|448198666|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
124612057|NCT04713553|448198660|FG000|Primary Study (2 Months)|Other|1|||
124612058|NCT04713553|448198661|FG001|Primary Study (2 Months)|Other|2|||
124612059|NCT04713553|448198662|FG002|Primary Study (2 Months)|Other|0|||
124612060|NCT04713553|448198663|FG003|Primary Study (2 Months)|Other|0|||
124612061|NCT04713553|448198664|FG004|Primary Study (2 Months)|Other|1|||
124612062|NCT04713553|448198665|FG005|Primary Study (2 Months)|Other|0|||
124612063|NCT04713553|448198666|FG006|Primary Study (2 Months)|Other|0|||
124612064|NCT04713553|448198660|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
124612065|NCT04713553|448198661|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
124612066|NCT04713553|448198662|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
124612067|NCT04713553|448198663|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
124612068|NCT04713553|448198664|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
124612069|NCT04713553|448198665|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
124612070|NCT04713553|448198666|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
124612071|NCT04713553|448198660|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
124637729|NCT05253573|448292410|FG000|Overall Study|Death|1|||
124637730|NCT05253573|448292411|FG001|Overall Study|Death|0|||
124637731|NCT06098339|448292412|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
124637732|NCT06098339|448292413|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
124637733|NCT06098339|448292412|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
124637734|NCT06098339|448292413|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
124637735|NCT02276560|448292414|FG000|Overall Study|Adverse Event|1|||
124637736|NCT02276560|448292415|FG001|Overall Study|Adverse Event|0|||
124637737|NCT02276560|448292416|FG002|Overall Study|Adverse Event|0|||
124637738|NCT04134767|448292417|FG000|Overall Study|Death|0|||
124637739|NCT04134767|448292418|FG001|Overall Study|Death|1|||
124637740|NCT04134767|448292417|FG000|Overall Study|Removed for harassing staff|0|||
124637741|NCT04134767|448292418|FG001|Overall Study|Removed for harassing staff|1|||
124637742|NCT04134767|448292417|FG000|Overall Study|Lost to Follow-up|44|||
124637743|NCT04134767|448292418|FG001|Overall Study|Lost to Follow-up|40|||
124637744|NCT02582242|448292419|FG000|Overall Study|Adverse Event|4|||
124637745|NCT02582242|448292420|FG001|Overall Study|Adverse Event|3|||
124637746|NCT02582242|448292419|FG000|Overall Study|Protocol Violation|3|||
124637747|NCT02582242|448292420|FG001|Overall Study|Protocol Violation|1|||
124637748|NCT02582242|448292419|FG000|Overall Study|Lost to Follow-up|0|||
124637749|NCT02582242|448292420|FG001|Overall Study|Lost to Follow-up|1|||
124637750|NCT02582242|448292419|FG000|Overall Study|Withdrawal by Subject|11|||
124637751|NCT02582242|448292420|FG001|Overall Study|Withdrawal by Subject|11|||
124637752|NCT02582242|448292419|FG000|Overall Study|Unclassified|2|||
124637753|NCT02582242|448292420|FG001|Overall Study|Unclassified|1|||
124637754|NCT00300885|448292421|FG000|Treatment|Adverse Event|134|||
124637755|NCT00300885|448292422|FG001|Treatment|Adverse Event|82|||
124637756|NCT00300885|448292421|FG000|Treatment|Death|20|||
124637757|NCT00300885|448292422|FG001|Treatment|Death|7|||
124637758|NCT00300885|448292421|FG000|Treatment|Lack of Efficacy|1|||
124637759|NCT00300885|448292422|FG001|Treatment|Lack of Efficacy|1|||
124637760|NCT00300885|448292421|FG000|Treatment|Lost to Follow-up|3|||
124637761|NCT00300885|448292422|FG001|Treatment|Lost to Follow-up|2|||
124637762|NCT00300885|448292421|FG000|Treatment|Physician Decision|4|||
124612072|NCT04713553|448198661|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
124612073|NCT04713553|448198662|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
124612074|NCT04713553|448198663|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
124612075|NCT04713553|448198664|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
124612076|NCT04713553|448198665|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
124612077|NCT04713553|448198666|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
124612078|NCT02448706|448198667|FG000|Overall Study|Withdrawal by Subject|4|||
124612079|NCT02448706|448198668|FG001|Overall Study|Withdrawal by Subject|3|||
124612080|NCT02448706|448198667|FG000|Overall Study|Protocol Violation|1|||
124612081|NCT02448706|448198668|FG001|Overall Study|Protocol Violation|1|||
124612082|NCT01359969|448198669|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
124612083|NCT03972163|448198676|FG000|Overall Study|Death|0|||
124612084|NCT03972163|448198677|FG001|Overall Study|Death|1|||
124612085|NCT01059539|448198679|FG000|Overall Study|Adverse Event|66|||
124612086|NCT01059539|448198679|FG000|Overall Study|Insufficient Therapeutic Response|26|||
124612087|NCT01059539|448198679|FG000|Overall Study|Protocol Violation|55|||
124612088|NCT01059539|448198679|FG000|Overall Study|Withdrawal of Consent|80|||
124612089|NCT01059539|448198679|FG000|Overall Study|Lost to Follow-up|42|||
124612090|NCT01059539|448198679|FG000|Overall Study|Reason Not Specified|2|||
124612091|NCT00537303|448198680|FG000|Overall Study|Adverse Event|1|||
124612092|NCT00537303|448198681|FG001|Overall Study|Adverse Event|4|||
124612093|NCT00537303|448198680|FG000|Overall Study|Lack of Efficacy|6|||
124612094|NCT00537303|448198681|FG001|Overall Study|Lack of Efficacy|7|||
124612095|NCT00537303|448198680|FG000|Overall Study|Protocol Violation|8|||
124612096|NCT00537303|448198681|FG001|Overall Study|Protocol Violation|4|||
124612097|NCT00537303|448198680|FG000|Overall Study|Withdrawal criteria|3|||
124612098|NCT00537303|448198681|FG001|Overall Study|Withdrawal criteria|3|||
124612099|NCT00537303|448198680|FG000|Overall Study|Unclassified|8|||
124612100|NCT00537303|448198681|FG001|Overall Study|Unclassified|7|||
124612101|NCT02085135|448198682|FG000|Overall Study|Adverse Event|4|||
124612102|NCT02085135|448198683|FG001|Overall Study|Adverse Event|7|||
124612103|NCT02085135|448198682|FG000|Overall Study|Lost to Follow-up|2|||
124612104|NCT02085135|448198683|FG001|Overall Study|Lost to Follow-up|2|||
124612105|NCT02085135|448198682|FG000|Overall Study|Withdrawal by Subject|3|||
124612106|NCT02085135|448198683|FG001|Overall Study|Withdrawal by Subject|0|||
124612107|NCT02085135|448198682|FG000|Overall Study|Lack of Efficacy|2|||
124612108|NCT02085135|448198683|FG001|Overall Study|Lack of Efficacy|0|||
124612109|NCT00554606|448198686|FG000|Overall Study|Adverse Event|3|||
124612110|NCT00554606|448198686|FG000|Overall Study|Abnormal laboratory values|1|||
124612111|NCT00554606|448198686|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
124612112|NCT00554606|448198686|FG000|Overall Study|Subject withdrew consent|2|||
124612113|NCT00554606|448198686|FG000|Overall Study|Lost to Follow-up|2|||
124612114|NCT00554606|448198686|FG000|Overall Study|Administrative problems|60|||
124612115|NCT00554606|448198686|FG000|Overall Study|Death|1|||
124612116|NCT00554606|448198686|FG000|Overall Study|Protocol deviation|2|||
124612117|NCT00849186|448198695|FG000|Overall Study|Adverse Event|2|||
124612118|NCT00849186|448198695|FG000|Overall Study|Withdrawal by Subject|1|||
124612119|NCT00849186|448198695|FG000|Overall Study|not treated|6|||
124612120|NCT00849186|448198695|FG000|Overall Study|Other|1|||
124612121|NCT00492024|448198696|FG000|Treatment|Adverse Event|3|||
124612122|NCT00492024|448198697|FG001|Treatment|Adverse Event|1|||
124612123|NCT00492024|448198696|FG000|Treatment|Lack of Efficacy|21|||
124612124|NCT00492024|448198697|FG001|Treatment|Lack of Efficacy|20|||
124612125|NCT00492024|448198696|FG000|Treatment|Lost to Follow-up|3|||
124612126|NCT00492024|448198697|FG001|Treatment|Lost to Follow-up|1|||
124612127|NCT00492024|448198696|FG000|Treatment|Withdrawal by Subject|2|||
124612128|NCT00492024|448198697|FG001|Treatment|Withdrawal by Subject|0|||
124612129|NCT00492024|448198696|FG000|Follow up|Lack of Efficacy|0|||
124612130|NCT00492024|448198697|FG001|Follow up|Lack of Efficacy|1|||
124612131|NCT00492024|448198696|FG000|Follow up|Lost to Follow-up|1|||
124612132|NCT00492024|448198697|FG001|Follow up|Lost to Follow-up|1|||
124612133|NCT03247816|448198698|FG000|Overall Study|Adverse Event|12|||
124612134|NCT03247816|448198698|FG000|Overall Study|Physician Decision|3|||
124612135|NCT03247816|448198698|FG000|Overall Study|Lack of Efficacy|1|||
124612136|NCT03247816|448198698|FG000|Overall Study|Lost to Follow-up|10|||
124612137|NCT03247816|448198698|FG000|Overall Study|Missing Feraccru stop date|3|||
124612138|NCT00936897|448198703|FG000|Overall Study|Withdrawal by Subject|9|||
124612139|NCT00936897|448198704|FG001|Overall Study|Withdrawal by Subject|19|||
124781402|NCT00862082|448829191|FG001|Overall Study|Sponsor decision to terminate the study|0|||
124612140|NCT00936897|448198703|FG000|Overall Study|Adverse Event|4|||
124612141|NCT00936897|448198704|FG001|Overall Study|Adverse Event|13|||
124612142|NCT00936897|448198703|FG000|Overall Study|Other|3|||
124612143|NCT00936897|448198704|FG001|Overall Study|Other|9|||
124612144|NCT00936897|448198703|FG000|Overall Study|Lost to Follow-up|1|||
124612145|NCT00936897|448198704|FG001|Overall Study|Lost to Follow-up|10|||
124612146|NCT00936897|448198703|FG000|Overall Study|Administrative Decision|1|||
124612147|NCT00936897|448198704|FG001|Overall Study|Administrative Decision|2|||
124612148|NCT00936897|448198703|FG000|Overall Study|Protocol Violation|1|||
124612149|NCT00936897|448198704|FG001|Overall Study|Protocol Violation|1|||
124612150|NCT00936897|448198703|FG000|Overall Study|Ineligibility Determined|0|||
124612151|NCT00936897|448198704|FG001|Overall Study|Ineligibility Determined|3|||
124612152|NCT00936897|448198703|FG000|Overall Study|Noncompliance|0|||
124612153|NCT00936897|448198704|FG001|Overall Study|Noncompliance|2|||
124612154|NCT00936897|448198703|FG000|Overall Study|Death|0|||
124612155|NCT00936897|448198704|FG001|Overall Study|Death|1|||
124612156|NCT03257865|448198707|FG000|Overall Study|Adverse Event|4|||
124612157|NCT03257865|448198708|FG001|Overall Study|Adverse Event|8|||
124612158|NCT03257865|448198707|FG000|Overall Study|Lack of Efficacy|1|||
124612159|NCT03257865|448198708|FG001|Overall Study|Lack of Efficacy|2|||
124612160|NCT03257865|448198707|FG000|Overall Study|Non-compliance with Study Drug|0|||
124612161|NCT03257865|448198708|FG001|Overall Study|Non-compliance with Study Drug|2|||
124612162|NCT03257865|448198707|FG000|Overall Study|Withdrawal by Subject|23|||
124612163|NCT03257865|448198708|FG001|Overall Study|Withdrawal by Subject|17|||
124612164|NCT03257865|448198707|FG000|Overall Study|Physician Decision|3|||
124612165|NCT03257865|448198708|FG001|Overall Study|Physician Decision|1|||
124612166|NCT03257865|448198707|FG000|Overall Study|Other|0|||
124612167|NCT03257865|448198708|FG001|Overall Study|Other|1|||
124612168|NCT03257865|448198707|FG000|Overall Study|Lost to Follow-up|4|||
124612169|NCT03257865|448198708|FG001|Overall Study|Lost to Follow-up|4|||
124612170|NCT02677714|448198709|FG000|Overall Study|Withdrawal by Subject|2|||
124781403|NCT00862082|448829190|FG000|Overall Study|Withdrawal by Subject|0|||
124781404|NCT00862082|448829191|FG001|Overall Study|Withdrawal by Subject|1|||
124781405|NCT02598583|448829192|FG000|Extension Period|Withdrawal by Subject|1|||
124781406|NCT02598583|448829193|FG001|Extension Period|Withdrawal by Subject|0|||
124781407|NCT05334212|448829202|FG000|Overall Study|Study terminated prematurely|7|||
124781408|NCT02152956|448829203|FG000|Overall Study|Adverse Event|0|||
124781409|NCT02152956|448829204|FG001|Overall Study|Adverse Event|0|||
124781410|NCT02152956|448829205|FG002|Overall Study|Adverse Event|0|||
124781411|NCT02152956|448829206|FG003|Overall Study|Adverse Event|0|||
124781412|NCT02152956|448829207|FG004|Overall Study|Adverse Event|0|||
124781413|NCT02152956|448829208|FG005|Overall Study|Adverse Event|0|||
124781414|NCT02152956|448829209|FG006|Overall Study|Adverse Event|0|||
124781415|NCT02152956|448829210|FG007|Overall Study|Adverse Event|0|||
124781416|NCT02152956|448829211|FG008|Overall Study|Adverse Event|0|||
124781417|NCT02152956|448829212|FG009|Overall Study|Adverse Event|0|||
124781418|NCT02152956|448829213|FG010|Overall Study|Adverse Event|0|||
124612171|NCT02677714|448198710|FG001|Overall Study|Withdrawal by Subject|0|||
124612172|NCT02538965|448198711|FG000|Treatment Period|Other = Death due to disease progression|1|||
124612173|NCT02538965|448198711|FG000|Treatment Period|Adverse Event|2|||
124612174|NCT02538965|448198711|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
124612175|NCT02538965|448198711|FG000|Treatment Period|Treatment Failure|9|||
124612176|NCT02538965|448198711|FG000|Treatment Period|Disease Progression|1|||
124612177|NCT02538965|448198711|FG000|Treatment Period|Physician Decision|2|||
124612178|NCT02538965|448198711|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
124612179|NCT02538965|448198711|FG000|Follow-Up Period|Withdrawal by Parent|4|||
124736672|NCT01667562|448657409|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
124736673|NCT01667562|448657408|FG000|Erlotinib Phase|Lost to Follow-up|0|||
124736674|NCT01667562|448657409|FG001|Erlotinib Phase|Lost to Follow-up|1|||
124736675|NCT01667562|448657408|FG000|Erlotinib Phase|Adverse Event|0|||
124736676|NCT01667562|448657409|FG001|Erlotinib Phase|Adverse Event|1|||
124736677|NCT01667562|448657408|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
124736678|NCT01667562|448657409|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
124736679|NCT01129882|448657410|FG000|Overall Study|Adverse Event|39|||
124736680|NCT01129882|448657410|FG000|Overall Study|Death|6|||
124736681|NCT01129882|448657410|FG000|Overall Study|Lack of Efficacy|5|||
124736682|NCT01129882|448657410|FG000|Overall Study|Lost to Follow-up|13|||
124736683|NCT01129882|448657410|FG000|Overall Study|Physician Decision|27|||
124736684|NCT01129882|448657410|FG000|Overall Study|Protocol Deviation|3|||
124736685|NCT01129882|448657410|FG000|Overall Study|Withdrawal Criteria Met|19|||
124736686|NCT01129882|448657410|FG000|Overall Study|Trial Termination by Sponsor|6|||
124736687|NCT01129882|448657410|FG000|Overall Study|Withdrawal by Subject|160|||
124736688|NCT02130986|448657411|FG000|Overall Study|Withdrawal by Subject|4|||
124736689|NCT02130986|448657412|FG001|Overall Study|Withdrawal by Subject|4|||
124781419|NCT02152956|448829214|FG011|Overall Study|Adverse Event|4|||
124781420|NCT02152956|448829215|FG012|Overall Study|Adverse Event|0|||
124781421|NCT02152956|448829203|FG000|Overall Study|Death|0|||
124781422|NCT02152956|448829204|FG001|Overall Study|Death|3|||
124781423|NCT02152956|448829205|FG002|Overall Study|Death|3|||
124781424|NCT02152956|448829206|FG003|Overall Study|Death|4|||
124781425|NCT02152956|448829207|FG004|Overall Study|Death|1|||
124781426|NCT02152956|448829208|FG005|Overall Study|Death|2|||
124612180|NCT00875797|448198712|FG000|Overall Study|Protocol Violation|6|||
124612181|NCT00875797|448198713|FG001|Overall Study|Protocol Violation|3|||
124612182|NCT02871492|448198718|FG000|Overall Study|Lost to Follow-up|6|||
124612183|NCT02871492|448198719|FG001|Overall Study|Lost to Follow-up|3|||
124612184|NCT02871492|448198720|FG002|Overall Study|Lost to Follow-up|5|||
124736690|NCT02130986|448657411|FG000|Overall Study|Lost to Follow-up|151|||
124736691|NCT02130986|448657412|FG001|Overall Study|Lost to Follow-up|160|||
124736692|NCT00993499|448657416|FG000|Run-in Period (8 Days)|Adverse Event|0|||
124736693|NCT00993499|448657417|FG001|Run-in Period (8 Days)|Adverse Event|1|||
124736694|NCT00993499|448657418|FG002|Run-in Period (8 Days)|Adverse Event|0|||
124736695|NCT00993499|448657419|FG003|Run-in Period (8 Days)|Adverse Event|0|||
124736696|NCT00993499|448657420|FG004|Run-in Period (8 Days)|Adverse Event|0|||
124736697|NCT00993499|448657421|FG005|Run-in Period (8 Days)|Adverse Event|0|||
124736698|NCT00993499|448657416|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
124736699|NCT00993499|448657417|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
124736700|NCT00993499|448657418|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
124736701|NCT00993499|448657419|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
124736702|NCT00993499|448657420|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
124736703|NCT00993499|448657421|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
124736704|NCT00993499|448657416|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
124736705|NCT00993499|448657417|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
124736706|NCT00993499|448657418|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
124736707|NCT00993499|448657419|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
124736708|NCT00993499|448657420|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
124736709|NCT00993499|448657421|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
124736710|NCT00993499|448657416|FG000|Run-in Period (8 Days)|Progressive disease|0|||
124736711|NCT00993499|448657417|FG001|Run-in Period (8 Days)|Progressive disease|1|||
124736712|NCT00993499|448657418|FG002|Run-in Period (8 Days)|Progressive disease|1|||
124736713|NCT00993499|448657419|FG003|Run-in Period (8 Days)|Progressive disease|0|||
124736714|NCT00993499|448657420|FG004|Run-in Period (8 Days)|Progressive disease|0|||
124736715|NCT00993499|448657421|FG005|Run-in Period (8 Days)|Progressive disease|0|||
124736716|NCT00993499|448657416|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
124736717|NCT00993499|448657417|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
124781427|NCT02152956|448829209|FG006|Overall Study|Death|6|||
124781428|NCT02152956|448829210|FG007|Overall Study|Death|6|||
124781429|NCT02152956|448829211|FG008|Overall Study|Death|4|||
124781430|NCT02152956|448829212|FG009|Overall Study|Death|5|||
124781431|NCT02152956|448829213|FG010|Overall Study|Death|3|||
124781432|NCT02152956|448829214|FG011|Overall Study|Death|143|||
124781433|NCT02152956|448829215|FG012|Overall Study|Death|12|||
124781434|NCT02152956|448829203|FG000|Overall Study|Lost to Follow-up|0|||
124781435|NCT02152956|448829204|FG001|Overall Study|Lost to Follow-up|1|||
124781436|NCT02152956|448829205|FG002|Overall Study|Lost to Follow-up|0|||
124781437|NCT02152956|448829206|FG003|Overall Study|Lost to Follow-up|0|||
124781438|NCT02152956|448829207|FG004|Overall Study|Lost to Follow-up|0|||
124781439|NCT02152956|448829208|FG005|Overall Study|Lost to Follow-up|0|||
124781440|NCT02152956|448829209|FG006|Overall Study|Lost to Follow-up|0|||
124781441|NCT02152956|448829210|FG007|Overall Study|Lost to Follow-up|0|||
124781442|NCT02152956|448829211|FG008|Overall Study|Lost to Follow-up|0|||
124781443|NCT02152956|448829212|FG009|Overall Study|Lost to Follow-up|0|||
124781444|NCT02152956|448829213|FG010|Overall Study|Lost to Follow-up|0|||
124781445|NCT02152956|448829214|FG011|Overall Study|Lost to Follow-up|3|||
124781446|NCT02152956|448829215|FG012|Overall Study|Lost to Follow-up|0|||
124781447|NCT02152956|448829203|FG000|Overall Study|Withdrawal by Subject|1|||
124781448|NCT02152956|448829204|FG001|Overall Study|Withdrawal by Subject|0|||
124781449|NCT02152956|448829205|FG002|Overall Study|Withdrawal by Subject|1|||
124781450|NCT02152956|448829206|FG003|Overall Study|Withdrawal by Subject|0|||
124781451|NCT02152956|448829207|FG004|Overall Study|Withdrawal by Subject|2|||
124781452|NCT02152956|448829208|FG005|Overall Study|Withdrawal by Subject|2|||
124781453|NCT02152956|448829209|FG006|Overall Study|Withdrawal by Subject|0|||
124781454|NCT02152956|448829210|FG007|Overall Study|Withdrawal by Subject|0|||
124781455|NCT02152956|448829211|FG008|Overall Study|Withdrawal by Subject|1|||
124781456|NCT02152956|448829212|FG009|Overall Study|Withdrawal by Subject|0|||
124781457|NCT02152956|448829213|FG010|Overall Study|Withdrawal by Subject|0|||
124781458|NCT02152956|448829214|FG011|Overall Study|Withdrawal by Subject|4|||
124781459|NCT02152956|448829215|FG012|Overall Study|Withdrawal by Subject|0|||
124781460|NCT02152956|448829203|FG000|Overall Study|Physician Decision|0|||
124781461|NCT02152956|448829204|FG001|Overall Study|Physician Decision|0|||
124781462|NCT02152956|448829205|FG002|Overall Study|Physician Decision|0|||
124736718|NCT00993499|448657418|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
124781463|NCT02152956|448829206|FG003|Overall Study|Physician Decision|0|||
124781464|NCT02152956|448829207|FG004|Overall Study|Physician Decision|0|||
124736719|NCT00993499|448657419|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
124736720|NCT00993499|448657420|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
124736721|NCT00993499|448657421|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
124781465|NCT02152956|448829208|FG005|Overall Study|Physician Decision|0|||
124781466|NCT02152956|448829209|FG006|Overall Study|Physician Decision|0|||
124781467|NCT02152956|448829210|FG007|Overall Study|Physician Decision|0|||
124781468|NCT02152956|448829211|FG008|Overall Study|Physician Decision|0|||
124781469|NCT02152956|448829212|FG009|Overall Study|Physician Decision|0|||
124781470|NCT02152956|448829213|FG010|Overall Study|Physician Decision|0|||
124736722|NCT00993499|448657416|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
124736723|NCT00993499|448657417|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
124736724|NCT00993499|448657418|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
124736725|NCT00993499|448657419|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
124736726|NCT00993499|448657420|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
124736727|NCT00993499|448657421|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
124736728|NCT00993499|448657416|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
124736729|NCT00993499|448657417|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
124736730|NCT00993499|448657418|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
124736731|NCT00993499|448657419|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
124736732|NCT00993499|448657420|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
124736733|NCT00993499|448657421|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
124736734|NCT00993499|448657416|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
124736735|NCT00993499|448657417|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
124736736|NCT00993499|448657418|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
124736737|NCT00993499|448657419|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
124736738|NCT00993499|448657420|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
124736739|NCT00993499|448657421|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
124736740|NCT00993499|448657416|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
124736741|NCT00993499|448657417|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
124736742|NCT00993499|448657418|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
124736743|NCT00993499|448657419|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
124736744|NCT00993499|448657420|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
124736745|NCT00993499|448657421|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
124736746|NCT00993499|448657416|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
124736747|NCT00993499|448657417|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
124736748|NCT00993499|448657418|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
124736749|NCT00993499|448657419|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
124736750|NCT00993499|448657420|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
124736751|NCT00993499|448657421|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
124736752|NCT00993499|448657416|FG000|Discontinued After Starting Course 3|DLT|1|||
124736753|NCT00993499|448657417|FG001|Discontinued After Starting Course 3|DLT|0|||
124736754|NCT00993499|448657418|FG002|Discontinued After Starting Course 3|DLT|2|||
124736755|NCT00993499|448657419|FG003|Discontinued After Starting Course 3|DLT|1|||
124736756|NCT00993499|448657420|FG004|Discontinued After Starting Course 3|DLT|0|||
124736757|NCT00993499|448657421|FG005|Discontinued After Starting Course 3|DLT|0|||
124736758|NCT00993499|448657416|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
124736759|NCT00993499|448657417|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
124736760|NCT00993499|448657418|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
124736761|NCT00993499|448657419|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
124736762|NCT00993499|448657420|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
124736763|NCT00993499|448657421|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
124736764|NCT01352741|448657422|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
124736765|NCT01352741|448657423|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
124736766|NCT01352741|448657422|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
124736767|NCT01352741|448657423|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
124736768|NCT01352741|448657422|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
124736769|NCT01352741|448657423|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
124736770|NCT01352741|448657422|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
124736771|NCT01352741|448657423|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
124736772|NCT01352741|448657422|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
124736773|NCT01352741|448657423|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
124736774|NCT01352741|448657422|FG000|Open-label Tapentadol Titration Period|Other|4|||
124736775|NCT01352741|448657423|FG001|Open-label Tapentadol Titration Period|Other|0|||
124736776|NCT01352741|448657422|FG000|Double-blind Comparative Period|Protocol Violation|2|||
124736777|NCT01352741|448657423|FG001|Double-blind Comparative Period|Protocol Violation|0|||
124736778|NCT01352741|448657422|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
124736779|NCT01352741|448657423|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
124736780|NCT01352741|448657422|FG000|Double-blind Comparative Period|Adverse Event|16|||
124736781|NCT01352741|448657423|FG001|Double-blind Comparative Period|Adverse Event|17|||
124736782|NCT01352741|448657422|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
124736783|NCT01352741|448657423|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
124736784|NCT01352741|448657422|FG000|Double-blind Comparative Period|Death|0|||
124781471|NCT02152956|448829214|FG011|Overall Study|Physician Decision|1|||
124736785|NCT01352741|448657423|FG001|Double-blind Comparative Period|Death|1|||
124736786|NCT01352741|448657422|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
124736787|NCT01352741|448657423|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
124736788|NCT01352741|448657422|FG000|Double-blind Comparative Period|Other|1|||
124736789|NCT01352741|448657423|FG001|Double-blind Comparative Period|Other|2|||
124736790|NCT01352741|448657422|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
124736791|NCT01352741|448657423|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
124736792|NCT01352741|448657422|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
124736793|NCT01352741|448657423|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
124736794|NCT01352741|448657422|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
124736795|NCT01352741|448657423|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
124736796|NCT01352741|448657422|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
124736797|NCT01352741|448657423|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
124736798|NCT04070326|448657424|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
124736799|NCT04070326|448657425|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
124736800|NCT00645528|448657426|FG000|Overall Study|Did not show up for Visit 2|7|||
124736801|NCT01498185|448657429|FG000|Overall Study|Adverse Event|0|||
124736802|NCT01498185|448657430|FG001|Overall Study|Adverse Event|0|||
124736803|NCT01498185|448657431|FG002|Overall Study|Adverse Event|0|||
124736804|NCT01498185|448657432|FG003|Overall Study|Adverse Event|1|||
124736805|NCT01498185|448657433|FG004|Overall Study|Adverse Event|0|||
124736806|NCT01498185|448657429|FG000|Overall Study|Withdrawal by Subject|1|||
124736807|NCT01498185|448657430|FG001|Overall Study|Withdrawal by Subject|1|||
124736808|NCT01498185|448657431|FG002|Overall Study|Withdrawal by Subject|0|||
124736809|NCT01498185|448657432|FG003|Overall Study|Withdrawal by Subject|2|||
124736810|NCT01498185|448657433|FG004|Overall Study|Withdrawal by Subject|1|||
124736811|NCT01498185|448657429|FG000|Overall Study|No longer met criteria, etc|0|||
124736812|NCT01498185|448657430|FG001|Overall Study|No longer met criteria, etc|0|||
124736813|NCT01498185|448657431|FG002|Overall Study|No longer met criteria, etc|0|||
124736814|NCT01498185|448657432|FG003|Overall Study|No longer met criteria, etc|0|||
124736815|NCT01498185|448657433|FG004|Overall Study|No longer met criteria, etc|2|||
124736816|NCT00946322|448657434|FG000|Pre-treatment|participant failure to follow up|1|||
124736817|NCT00946322|448657434|FG000|Post-treatment|participant failure to follow up|2|||
124736818|NCT02153346|448657435|FG000|Overall Study|Lost to Follow-up|11|||
124736819|NCT03959982|448658833|FG000|Overall Study|Withdrawal by Subject|1|||
124736820|NCT03959982|448658834|FG001|Overall Study|Withdrawal by Subject|0|||
124736821|NCT03959982|448658833|FG000|Overall Study|Physician Decision|2|||
124736822|NCT03959982|448658834|FG001|Overall Study|Physician Decision|0|||
124736823|NCT03959982|448658833|FG000|Overall Study|Lost to Follow-up|1|||
124736824|NCT03959982|448658834|FG001|Overall Study|Lost to Follow-up|0|||
124736825|NCT04411420|448658837|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
124736826|NCT04411420|448658838|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
124736827|NCT04411420|448658837|FG000|Survey Subset|Lost to Follow-up|134|||
124736828|NCT04411420|448658838|FG001|Survey Subset|Lost to Follow-up|120|||
124736829|NCT00524589|448658842|FG000|Overall Study|Withdrawal by Subject|2|||
124736830|NCT00524589|448658842|FG000|Overall Study|Disease Progression|16|||
124736831|NCT01030874|448658845|FG000|Overall Study|Withdrawal by Subject|1|||
124736832|NCT01030874|448658846|FG001|Overall Study|Withdrawal by Subject|0|||
124736833|NCT01030874|448658845|FG000|Overall Study|Discharged in first 2 weeks|17|||
124736834|NCT01030874|448658846|FG001|Overall Study|Discharged in first 2 weeks|16|||
124736835|NCT04639219|448658849|FG000|Overall Study|Withdrawal by Subject|8|||
124736836|NCT04639219|448658849|FG000|Overall Study|Lost to Follow-up|6|||
124736837|NCT04639219|448658849|FG000|Overall Study|Death|55|||
124736838|NCT01998893|448658852|FG000|Overall Study|Adverse Event|2|||
124736839|NCT01998893|448658852|FG000|Overall Study|Death|1|||
124736840|NCT01998893|448658852|FG000|Overall Study|Lost to Follow-up|8|||
124736841|NCT01998893|448658852|FG000|Overall Study|Physician Decision|2|||
124736842|NCT01998893|448658852|FG000|Overall Study|Protocol Violation|2|||
124736843|NCT01998893|448658852|FG000|Overall Study|Withdrawal by Subject|1|||
124736844|NCT01998893|448658852|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
124736845|NCT02046174|448658853|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
124736846|NCT02046174|448658854|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
124736847|NCT02118597|448658855|FG000|Overall Study|Sponsor terminated the study|14|||
124736848|NCT02118597|448658855|FG000|Overall Study|Serious Adverse Event|1|||
124736849|NCT02118597|448658855|FG000|Overall Study|Investigator's decision|1|||
124736850|NCT01891344|448658856|FG000|Overall Study|Ongoing|6|||
124736851|NCT01891344|448658857|FG001|Overall Study|Ongoing|2|||
124736852|NCT01891344|448658858|FG002|Overall Study|Ongoing|0|||
124736853|NCT01891344|448658859|FG003|Overall Study|Ongoing|1|||
124736854|NCT01891344|448658860|FG004|Overall Study|Ongoing|4|||
124736855|NCT01891344|448658861|FG005|Overall Study|Ongoing|1|||
124736856|NCT01891344|448658862|FG006|Overall Study|Ongoing|0|||
124736857|NCT01891344|448658863|FG007|Overall Study|Ongoing|0|||
124736858|NCT02969590|448658864|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
124781472|NCT02152956|448829215|FG012|Overall Study|Physician Decision|0|||
124612185|NCT02871492|448198718|FG000|Overall Study|Withdrawal by Subject|0|||
124612186|NCT02871492|448198719|FG001|Overall Study|Withdrawal by Subject|0|||
124612187|NCT02871492|448198720|FG002|Overall Study|Withdrawal by Subject|1|||
124612188|NCT04546724|448198721|FG000|Overall Study|Withdrawal by Subject|145|||
124612189|NCT04546724|448198722|FG001|Overall Study|Withdrawal by Subject|41|||
124612190|NCT04546724|448198721|FG000|Overall Study|Adverse Event|1|||
124612191|NCT04546724|448198722|FG001|Overall Study|Adverse Event|1|||
124612192|NCT04546724|448198721|FG000|Overall Study|Lost to Follow-up|186|||
124612193|NCT04546724|448198722|FG001|Overall Study|Lost to Follow-up|63|||
124612194|NCT04546724|448198721|FG000|Overall Study|Physician Decision|8|||
124612195|NCT04546724|448198722|FG001|Overall Study|Physician Decision|2|||
124612196|NCT04546724|448198721|FG000|Overall Study|Death|2|||
124612197|NCT04546724|448198722|FG001|Overall Study|Death|1|||
124612198|NCT04546724|448198721|FG000|Overall Study|subject has been out of town|1|||
124612199|NCT04546724|448198722|FG001|Overall Study|subject has been out of town|0|||
124612200|NCT04546724|448198721|FG000|Overall Study|subject is incarcerated|2|||
124612201|NCT04546724|448198722|FG001|Overall Study|subject is incarcerated|0|||
124612202|NCT04546724|448198721|FG000|Overall Study|subject is relocating|12|||
124612203|NCT04546724|448198722|FG001|Overall Study|subject is relocating|4|||
124612204|NCT04546724|448198721|FG000|Overall Study|Subject in another study|1|||
124612205|NCT04546724|448198722|FG001|Overall Study|Subject in another study|1|||
124612206|NCT02256436|448198723|FG000|Overall Study|Adverse Event|9|||
124612207|NCT02256436|448198724|FG001|Overall Study|Adverse Event|14|||
124612208|NCT02256436|448198723|FG000|Overall Study|Death|216|||
124612209|NCT02256436|448198724|FG001|Overall Study|Death|208|||
124612210|NCT02256436|448198723|FG000|Overall Study|Lost to Follow-up|1|||
124612211|NCT02256436|448198724|FG001|Overall Study|Lost to Follow-up|2|||
124612212|NCT02256436|448198723|FG000|Overall Study|Physician Decision|1|||
124612213|NCT02256436|448198724|FG001|Overall Study|Physician Decision|0|||
124612214|NCT02256436|448198723|FG000|Overall Study|Protocol Violation|0|||
124612215|NCT02256436|448198724|FG001|Overall Study|Protocol Violation|1|||
124612216|NCT02256436|448198723|FG000|Overall Study|Withdrawal by Subject|26|||
124612217|NCT02256436|448198724|FG001|Overall Study|Withdrawal by Subject|10|||
124612218|NCT02256436|448198723|FG000|Overall Study|Transferred to Extension Study|11|||
124612219|NCT02256436|448198724|FG001|Overall Study|Transferred to Extension Study|23|||
124612220|NCT02256436|448198723|FG000|Overall Study|Did Not Continue on Extension Study|8|||
124612221|NCT02256436|448198724|FG001|Overall Study|Did Not Continue on Extension Study|12|||
124612222|NCT01441947|448198726|FG000|Overall Study|Withdrawal by Subject|3|||
124612223|NCT01441947|448198727|FG001|Overall Study|Withdrawal by Subject|0|||
124612224|NCT00077857|448198729|FG000|Overall Study|Adverse Event|30|||
124612225|NCT00077857|448198730|FG001|Overall Study|Adverse Event|32|||
124612226|NCT00077857|448198729|FG000|Overall Study|Death|7|||
124612227|NCT00077857|448198730|FG001|Overall Study|Death|3|||
124612228|NCT00077857|448198729|FG000|Overall Study|Insufficient therapeutic response|112|||
124612229|NCT00077857|448198730|FG001|Overall Study|Insufficient therapeutic response|128|||
124612230|NCT00077857|448198729|FG000|Overall Study|Violation of selection criteria at entry|3|||
124612231|NCT00077857|448198730|FG001|Overall Study|Violation of selection criteria at entry|1|||
124612232|NCT00077857|448198729|FG000|Overall Study|Other protocol violation|0|||
124612233|NCT00077857|448198730|FG001|Overall Study|Other protocol violation|1|||
124612234|NCT00077857|448198729|FG000|Overall Study|Refused treatment|29|||
124612235|NCT00077857|448198730|FG001|Overall Study|Refused treatment|21|||
124612236|NCT00077857|448198729|FG000|Overall Study|Failure to return|5|||
124612237|NCT00077857|448198730|FG001|Overall Study|Failure to return|5|||
124612238|NCT00077857|448198729|FG000|Overall Study|Other|15|||
124612239|NCT00077857|448198730|FG001|Overall Study|Other|13|||
124612240|NCT01292226|448198731|FG000|Overall Study|Adverse Event|5|||
124612241|NCT01292226|448198731|FG000|Overall Study|Death|1|||
124612242|NCT01292226|448198731|FG000|Overall Study|Graft loss|1|||
124612243|NCT01292226|448198731|FG000|Overall Study|Protocol Violation|3|||
124612244|NCT01292226|448198731|FG000|Overall Study|Withdrawal by Subject|1|||
124612245|NCT01292226|448198731|FG000|Overall Study|Other|2|||
124612246|NCT01844505|448198732|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
124612247|NCT01844505|448198733|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
124612248|NCT01844505|448198734|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
124612249|NCT01844505|448198732|FG000|Treatment Period|Other Reasons|120|||
124612250|NCT01844505|448198733|FG001|Treatment Period|Other Reasons|136|||
124612251|NCT01844505|448198734|FG002|Treatment Period|Other Reasons|58|||
124612252|NCT01844505|448198732|FG000|Treatment Period|Lost to Follow-up|9|||
124612253|NCT01844505|448198733|FG001|Treatment Period|Lost to Follow-up|11|||
124612254|NCT01844505|448198734|FG002|Treatment Period|Lost to Follow-up|6|||
124612255|NCT01844505|448198732|FG000|Treatment Period|Death|175|||
124612256|NCT01844505|448198733|FG001|Treatment Period|Death|154|||
124612257|NCT01844505|448198734|FG002|Treatment Period|Death|228|||
124612258|NCT00468650|448198735|FG000|Overall Study|Lost to Follow-up|4|||
124612259|NCT00468650|448198735|FG000|Overall Study|Withdrawal by Subject|2|||
124612260|NCT00468650|448198735|FG000|Overall Study|Protocol Violation|1|||
124612261|NCT04874155|448198736|FG000|Overall Study|Lost to Follow-up|1|||
124612262|NCT04874155|448198737|FG001|Overall Study|Lost to Follow-up|1|||
124637763|NCT00300885|448292422|FG001|Treatment|Physician Decision|5|||
124736859|NCT02969590|448658865|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
124736860|NCT02969590|448658866|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
124736861|NCT00186537|448658867|FG000|Overall Study|Withdrawal by Subject|4|||
124736862|NCT00186537|448658868|FG001|Overall Study|Withdrawal by Subject|0|||
124736863|NCT00186537|448658869|FG002|Overall Study|Withdrawal by Subject|3|||
124736864|NCT00186537|448658867|FG000|Overall Study|ALT > 1.5 x ULN|3|||
124736865|NCT00186537|448658868|FG001|Overall Study|ALT > 1.5 x ULN|0|||
124736866|NCT00186537|448658869|FG002|Overall Study|ALT > 1.5 x ULN|0|||
124736867|NCT03294135|448658870|FG000|Overall Study|Serious Adverse Event|1|||
124736868|NCT03294135|448658871|FG001|Overall Study|Serious Adverse Event|0|||
124736869|NCT03294135|448658872|FG002|Overall Study|Serious Adverse Event|0|||
124736870|NCT03294135|448658870|FG000|Overall Study|Lost to Follow-up|1|||
124736871|NCT03294135|448658871|FG001|Overall Study|Lost to Follow-up|0|||
124736872|NCT03294135|448658872|FG002|Overall Study|Lost to Follow-up|1|||
124736873|NCT03294135|448658870|FG000|Overall Study|Withdrawal by Subject|0|||
124736874|NCT03294135|448658871|FG001|Overall Study|Withdrawal by Subject|0|||
124736875|NCT03294135|448658872|FG002|Overall Study|Withdrawal by Subject|1|||
124736876|NCT03294135|448658870|FG000|Overall Study|Other|2|||
124736877|NCT03294135|448658871|FG001|Overall Study|Other|0|||
124736878|NCT03294135|448658872|FG002|Overall Study|Other|0|||
124736879|NCT02590562|448658873|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
124736880|NCT02763254|448658874|FG000|Overall Study|Adverse Event|1|||
124736881|NCT03684304|448658875|FG000|Overall Study|Lost to Follow-up|19|||
124736882|NCT03684304|448658876|FG001|Overall Study|Lost to Follow-up|17|||
124736883|NCT00054691|448658877|FG000|Overall Study|Unmeasurable Disease|2|||
124736884|NCT00054691|448658877|FG000|Overall Study|Noncompliant|1|||
124736885|NCT03593681|448658878|FG000|Overall Study|Inadequate sample collected|12|||
124736886|NCT03593681|448658878|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
124736887|NCT03593681|448658878|FG000|Overall Study|Protocol Violation|3|||
124736888|NCT03593681|448658878|FG000|Overall Study|Withdrawal by Subject|3|||
124736889|NCT03593681|448658878|FG000|Overall Study|Procedure not attempted|3|||
124736890|NCT03593681|448658878|FG000|Overall Study|Adverse Event|2|||
124736891|NCT03593681|448658878|FG000|Overall Study|Physician Decision|1|||
124736892|NCT03987932|448658881|FG000|Overall Study|Lost to Follow-up|2|||
124736893|NCT03987932|448658882|FG001|Overall Study|Lost to Follow-up|1|||
124736894|NCT03987932|448658883|FG002|Overall Study|Lost to Follow-up|1|||
124736895|NCT03987932|448658881|FG000|Overall Study|Non-study related elective surgery|0|||
124736896|NCT03987932|448658882|FG001|Overall Study|Non-study related elective surgery|0|||
124736897|NCT03987932|448658883|FG002|Overall Study|Non-study related elective surgery|1|||
124736898|NCT02813668|448658889|FG000|Overall Study|Death|4|||
124736899|NCT02813668|448658889|FG000|Overall Study|Lost to Follow-up|509|||
124736900|NCT02813668|448658889|FG000|Overall Study|Withdrawal by Subject|148|||
124736901|NCT02813668|448658889|FG000|Overall Study|No longer at worksite|85|||
124736902|NCT02813668|448658889|FG000|Overall Study|Medical reasons not related to the study|4|||
124736903|NCT02961790|448658890|FG000|Overall Study|Canceled|4|||
124736904|NCT02961790|448658891|FG001|Overall Study|Canceled|5|||
124736905|NCT02961790|448658892|FG002|Overall Study|Canceled|1|||
124736906|NCT02961790|448658893|FG003|Overall Study|Canceled|4|||
124736907|NCT02961790|448658890|FG000|Overall Study|without baseline data|4|||
124736908|NCT02961790|448658891|FG001|Overall Study|without baseline data|0|||
124736909|NCT02961790|448658892|FG002|Overall Study|without baseline data|1|||
124736910|NCT02961790|448658893|FG003|Overall Study|without baseline data|0|||
124736911|NCT02961790|448658890|FG000|Overall Study|without post baseline data|7|||
124736912|NCT02961790|448658891|FG001|Overall Study|without post baseline data|6|||
124736913|NCT02961790|448658892|FG002|Overall Study|without post baseline data|4|||
124736914|NCT02961790|448658893|FG003|Overall Study|without post baseline data|1|||
124781473|NCT02152956|448829203|FG000|Overall Study|Study terminated by sponsor|0|||
124736915|NCT02078102|448658894|FG000|Overall Study|Adverse Event|1|||
124736916|NCT02078102|448658895|FG001|Overall Study|Adverse Event|0|||
124736917|NCT02078102|448658894|FG000|Overall Study|Withdrawal by Subject|1|||
124736918|NCT02078102|448658895|FG001|Overall Study|Withdrawal by Subject|0|||
124736919|NCT02078102|448658894|FG000|Overall Study|Physician Decision|0|||
124736920|NCT02078102|448658895|FG001|Overall Study|Physician Decision|1|||
124736921|NCT00598078|448658898|FG000|Period 2 (Day 2)|Adverse Event|1|||
124736922|NCT00598078|448658899|FG001|Period 2 (Day 2)|Adverse Event|0|||
124736923|NCT02185014|448658900|FG000|Overall Study|Adverse Event|18|||
124736924|NCT02185014|448658900|FG000|Overall Study|Withdrew Consent|8|||
124736925|NCT02185014|448658900|FG000|Overall Study|Lost to Follow-up|4|||
124736926|NCT02185014|448658900|FG000|Overall Study|Lack of Efficacy|14|||
124736927|NCT02185014|448658900|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
124736928|NCT02185014|448658900|FG000|Overall Study|Subject Noncompliance|1|||
124736929|NCT02185014|448658900|FG000|Overall Study|Other|4|||
124736930|NCT03093974|448658901|FG000|Overall Study|Withdrawal by Subject|32|||
124781474|NCT02152956|448829204|FG001|Overall Study|Study terminated by sponsor|0|||
124736931|NCT03093974|448658902|FG001|Overall Study|Withdrawal by Subject|27|||
124736932|NCT03093974|448658901|FG000|Overall Study|Adverse Event|17|||
124736933|NCT03093974|448658902|FG001|Overall Study|Adverse Event|24|||
124736934|NCT03093974|448658901|FG000|Overall Study|Death|0|||
124612263|NCT04874155|448198736|FG000|Overall Study|Withdrawal by Subject|2|||
124612264|NCT04874155|448198737|FG001|Overall Study|Withdrawal by Subject|2|||
124612265|NCT03477903|448198742|FG000|Overall Study|Study Terminated by Sponsor|1|||
124612266|NCT03201965|448198743|FG000|Overall Study|Death|5|||
124612267|NCT03201965|448198744|FG001|Overall Study|Death|27|||
124612268|NCT03201965|448198745|FG002|Overall Study|Death|27|||
124612269|NCT03201965|448198743|FG000|Overall Study|Lost to Follow-up|0|||
124612270|NCT03201965|448198744|FG001|Overall Study|Lost to Follow-up|1|||
124612271|NCT03201965|448198745|FG002|Overall Study|Lost to Follow-up|0|||
124612272|NCT03201965|448198743|FG000|Overall Study|Withdrawal by Subject|3|||
124612273|NCT03201965|448198744|FG001|Overall Study|Withdrawal by Subject|13|||
124612274|NCT03201965|448198745|FG002|Overall Study|Withdrawal by Subject|4|||
124612275|NCT03201965|448198743|FG000|Overall Study|Ongoing|20|||
124612276|NCT03201965|448198744|FG001|Overall Study|Ongoing|152|||
124612277|NCT03201965|448198745|FG002|Overall Study|Ongoing|164|||
124612278|NCT03918109|448198750|FG000|Overall Study|Withdrawal by Subject|0|||
124612279|NCT03918109|448198751|FG001|Overall Study|Withdrawal by Subject|0|||
124612280|NCT03918109|448198752|FG002|Overall Study|Withdrawal by Subject|2|||
124612281|NCT03918109|448198753|FG003|Overall Study|Withdrawal by Subject|1|||
124612282|NCT03918109|448198750|FG000|Overall Study|Lost to Follow-up|0|||
124612283|NCT03918109|448198751|FG001|Overall Study|Lost to Follow-up|0|||
124612284|NCT03918109|448198752|FG002|Overall Study|Lost to Follow-up|0|||
124612285|NCT03918109|448198753|FG003|Overall Study|Lost to Follow-up|1|||
124612286|NCT00861198|448198754|FG000|Overall Study|SpyGlass Failed|5|||
124612287|NCT01197755|448198755|FG000|Overall Study|Adverse Event|8|||
124612288|NCT01197755|448198756|FG001|Overall Study|Adverse Event|10|||
124612289|NCT01197755|448198757|FG002|Overall Study|Adverse Event|10|||
124612290|NCT01197755|448198755|FG000|Overall Study|Study-specific discontinuation criteria|2|||
124612291|NCT01197755|448198756|FG001|Overall Study|Study-specific discontinuation criteria|1|||
124612292|NCT01197755|448198757|FG002|Overall Study|Study-specific discontinuation criteria|0|||
124612293|NCT01197755|448198755|FG000|Overall Study|Entered the long-term extension study|18|||
124612294|NCT01197755|448198756|FG001|Overall Study|Entered the long-term extension study|21|||
124612295|NCT01197755|448198757|FG002|Overall Study|Entered the long-term extension study|35|||
124612296|NCT01197755|448198755|FG000|Overall Study|Lack of therapeutic response|0|||
124612297|NCT01197755|448198756|FG001|Overall Study|Lack of therapeutic response|7|||
124612298|NCT01197755|448198757|FG002|Overall Study|Lack of therapeutic response|4|||
124612299|NCT01197755|448198755|FG000|Overall Study|Severe non-compliance to the protocol|2|||
124612300|NCT01197755|448198756|FG001|Overall Study|Severe non-compliance to the protocol|1|||
124612301|NCT01197755|448198757|FG002|Overall Study|Severe non-compliance to the protocol|2|||
124612302|NCT01197755|448198755|FG000|Overall Study|Withdrawal by Subject|1|||
124612303|NCT01197755|448198756|FG001|Overall Study|Withdrawal by Subject|0|||
124612304|NCT01197755|448198757|FG002|Overall Study|Withdrawal by Subject|0|||
124612305|NCT01197755|448198755|FG000|Overall Study|Lost to Follow-up|0|||
124612306|NCT01197755|448198756|FG001|Overall Study|Lost to Follow-up|0|||
124612307|NCT01197755|448198757|FG002|Overall Study|Lost to Follow-up|1|||
124612308|NCT01197755|448198755|FG000|Overall Study|eg, change in circumstances|7|||
124612309|NCT01197755|448198756|FG001|Overall Study|eg, change in circumstances|3|||
124612310|NCT01197755|448198757|FG002|Overall Study|eg, change in circumstances|2|||
124612311|NCT00761865|448198760|FG000|Overall Study|Lost to Follow-up|8|||
124612312|NCT00761865|448198761|FG001|Overall Study|Lost to Follow-up|7|||
124612313|NCT00758680|448198764|FG000|Overall Study|Adverse Event|0|||
124612314|NCT00758680|448198765|FG001|Overall Study|Adverse Event|0|||
124612315|NCT00758680|448198766|FG002|Overall Study|Adverse Event|0|||
124612316|NCT00758680|448198767|FG003|Overall Study|Adverse Event|0|||
124612317|NCT00758680|448198768|FG004|Overall Study|Adverse Event|0|||
124612318|NCT00758680|448198769|FG005|Overall Study|Adverse Event|0|||
124612319|NCT00758680|448198770|FG006|Overall Study|Adverse Event|0|||
124612320|NCT00758680|448198771|FG007|Overall Study|Adverse Event|1|||
124612321|NCT00758680|448198772|FG008|Overall Study|Adverse Event|0|||
124612322|NCT00758680|448198773|FG009|Overall Study|Adverse Event|1|||
124612323|NCT00758680|448198764|FG000|Overall Study|Laboratory Adverse Event|0|||
124612324|NCT00758680|448198765|FG001|Overall Study|Laboratory Adverse Event|0|||
124612325|NCT00758680|448198766|FG002|Overall Study|Laboratory Adverse Event|0|||
124612326|NCT00758680|448198767|FG003|Overall Study|Laboratory Adverse Event|0|||
124612327|NCT00758680|448198768|FG004|Overall Study|Laboratory Adverse Event|0|||
124612328|NCT00758680|448198769|FG005|Overall Study|Laboratory Adverse Event|0|||
124612329|NCT00758680|448198770|FG006|Overall Study|Laboratory Adverse Event|0|||
124612330|NCT00758680|448198771|FG007|Overall Study|Laboratory Adverse Event|0|||
124612331|NCT00758680|448198772|FG008|Overall Study|Laboratory Adverse Event|1|||
124612332|NCT00758680|448198773|FG009|Overall Study|Laboratory Adverse Event|0|||
124612333|NCT00758680|448198764|FG000|Overall Study|Withdrawal by Subject|0|||
124612334|NCT00758680|448198765|FG001|Overall Study|Withdrawal by Subject|0|||
124612335|NCT00758680|448198766|FG002|Overall Study|Withdrawal by Subject|0|||
124612336|NCT00758680|448198767|FG003|Overall Study|Withdrawal by Subject|0|||
124612337|NCT00758680|448198768|FG004|Overall Study|Withdrawal by Subject|0|||
124612338|NCT00758680|448198769|FG005|Overall Study|Withdrawal by Subject|0|||
124781475|NCT02152956|448829205|FG002|Overall Study|Study terminated by sponsor|0|||
124781476|NCT02152956|448829206|FG003|Overall Study|Study terminated by sponsor|0|||
124781477|NCT02152956|448829207|FG004|Overall Study|Study terminated by sponsor|0|||
124781478|NCT02152956|448829208|FG005|Overall Study|Study terminated by sponsor|0|||
124781479|NCT02152956|448829209|FG006|Overall Study|Study terminated by sponsor|0|||
124781480|NCT02152956|448829210|FG007|Overall Study|Study terminated by sponsor|0|||
124781481|NCT02152956|448829211|FG008|Overall Study|Study terminated by sponsor|0|||
124781482|NCT02152956|448829212|FG009|Overall Study|Study terminated by sponsor|0|||
124781483|NCT02152956|448829213|FG010|Overall Study|Study terminated by sponsor|0|||
124781484|NCT02152956|448829214|FG011|Overall Study|Study terminated by sponsor|29|||
124781485|NCT02152956|448829215|FG012|Overall Study|Study terminated by sponsor|0|||
124781486|NCT02152956|448829203|FG000|Overall Study|progressive disease|0|||
124781487|NCT02152956|448829204|FG001|Overall Study|progressive disease|0|||
124781488|NCT02152956|448829205|FG002|Overall Study|progressive disease|0|||
124781489|NCT02152956|448829206|FG003|Overall Study|progressive disease|0|||
124781490|NCT02152956|448829207|FG004|Overall Study|progressive disease|0|||
124781491|NCT02152956|448829208|FG005|Overall Study|progressive disease|0|||
124781492|NCT02152956|448829209|FG006|Overall Study|progressive disease|0|||
124781493|NCT02152956|448829210|FG007|Overall Study|progressive disease|0|||
124781494|NCT02152956|448829211|FG008|Overall Study|progressive disease|1|||
124781495|NCT02152956|448829212|FG009|Overall Study|progressive disease|0|||
124781496|NCT02152956|448829213|FG010|Overall Study|progressive disease|0|||
124781497|NCT02152956|448829214|FG011|Overall Study|progressive disease|1|||
124781498|NCT02152956|448829215|FG012|Overall Study|progressive disease|0|||
124612339|NCT00758680|448198770|FG006|Overall Study|Withdrawal by Subject|1|||
124612340|NCT00758680|448198771|FG007|Overall Study|Withdrawal by Subject|0|||
124736935|NCT03093974|448658902|FG001|Overall Study|Death|1|||
124736936|NCT03093974|448658901|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124736937|NCT03093974|448658902|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124736938|NCT03093974|448658901|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
124736939|NCT03093974|448658902|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
124736940|NCT03093974|448658901|FG000|Overall Study|Lost to Follow-up|0|||
124736941|NCT03093974|448658902|FG001|Overall Study|Lost to Follow-up|1|||
124736942|NCT03093974|448658901|FG000|Overall Study|Other|1|||
124736943|NCT03093974|448658902|FG001|Overall Study|Other|2|||
124736944|NCT02387164|448658903|FG000|Overall Study|Lost to Follow-up|2|||
124736945|NCT02387164|448658904|FG001|Overall Study|Lost to Follow-up|0|||
124736946|NCT02387164|448658903|FG000|Overall Study|Diagnosed|1|||
124736947|NCT02387164|448658904|FG001|Overall Study|Diagnosed|2|||
124736948|NCT02370641|448658905|FG000|Overall Study|dropped study|4|||
124736949|NCT02370641|448658906|FG001|Overall Study|dropped study|2|||
124781499|NCT02445794|448829216|FG000|Overall Study|Adverse Event|0|||
124612341|NCT00758680|448198772|FG008|Overall Study|Withdrawal by Subject|1|||
124612342|NCT00758680|448198773|FG009|Overall Study|Withdrawal by Subject|0|||
124612343|NCT03014180|448198774|FG000|Overall Study|Protocol Violation|2|||
124612344|NCT02377427|448198775|FG000|Part A (Up to Week 20)|Physician Decision|1|||
124612345|NCT02377427|448198776|FG001|Part A (Up to Week 20)|Physician Decision|0|||
124612346|NCT02377427|448198777|FG002|Part A (Up to Week 20)|Physician Decision|0|||
124612347|NCT02377427|448198778|FG003|Part A (Up to Week 20)|Physician Decision|0|||
124612348|NCT02377427|448198779|FG004|Part A (Up to Week 20)|Physician Decision|0|||
124612349|NCT02377427|448198775|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
124612350|NCT02377427|448198776|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
124612351|NCT02377427|448198777|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
124612352|NCT02377427|448198778|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
124612353|NCT02377427|448198779|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
124612354|NCT02377427|448198775|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
124612355|NCT02377427|448198776|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
124612356|NCT02377427|448198777|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
124612357|NCT02377427|448198778|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
124612358|NCT02377427|448198779|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
124612359|NCT02377427|448198775|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
124612360|NCT02377427|448198776|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
124612361|NCT02377427|448198777|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
124612362|NCT02377427|448198778|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
124612363|NCT02377427|448198779|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
124736950|NCT02120365|448658907|FG000|Overall Study|Withdrawal by Subject|0|||
124736951|NCT02120365|448658908|FG001|Overall Study|Withdrawal by Subject|0|||
124736952|NCT02120365|448658909|FG002|Overall Study|Withdrawal by Subject|2|||
124736953|NCT02120365|448658910|FG003|Overall Study|Withdrawal by Subject|4|||
124781500|NCT02445794|448829217|FG001|Overall Study|Adverse Event|0|||
124736954|NCT02120365|448658911|FG004|Overall Study|Withdrawal by Subject|0|||
124736955|NCT02120365|448658912|FG005|Overall Study|Withdrawal by Subject|2|||
124781501|NCT02445794|448829218|FG002|Overall Study|Adverse Event|2|||
124781502|NCT02445794|448829219|FG003|Overall Study|Adverse Event|0|||
124781503|NCT01668589|448829220|FG000|Overall Study|Lost to Follow-up|29|||
124781504|NCT01668589|448829221|FG001|Overall Study|Lost to Follow-up|37|||
124781505|NCT01668589|448829222|FG002|Overall Study|Lost to Follow-up|15|||
124781506|NCT01668589|448829223|FG003|Overall Study|Lost to Follow-up|5|||
124781507|NCT01668589|448829220|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
124781508|NCT01668589|448829221|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
124781509|NCT01668589|448829222|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
124781510|NCT01668589|448829223|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
124781511|NCT01668589|448829220|FG000|Overall Study|Death|12|||
124781512|NCT01668589|448829221|FG001|Overall Study|Death|3|||
124781513|NCT01668589|448829222|FG002|Overall Study|Death|2|||
124781514|NCT01668589|448829223|FG003|Overall Study|Death|11|||
124781515|NCT01668589|448829220|FG000|Overall Study|Other|44|||
124781516|NCT01668589|448829221|FG001|Overall Study|Other|10|||
124781517|NCT01668589|448829222|FG002|Overall Study|Other|7|||
124781518|NCT01668589|448829223|FG003|Overall Study|Other|15|||
124781519|NCT00661427|448829226|FG000|Overall Study|Adverse Event|5|||
124781520|NCT00661427|448829227|FG001|Overall Study|Adverse Event|5|||
124781521|NCT00661427|448829226|FG000|Overall Study|Patient not treated|0|||
124781522|NCT00661427|448829227|FG001|Overall Study|Patient not treated|2|||
124781523|NCT00488683|448829228|FG000|Overall Study|Withdrawal by Subject|1|||
124781524|NCT00488683|448829229|FG001|Overall Study|Withdrawal by Subject|2|||
124781525|NCT00488683|448829230|FG002|Overall Study|Withdrawal by Subject|2|||
124781526|NCT00488683|448829228|FG000|Overall Study|Lost to Follow-up|5|||
124781527|NCT00488683|448829229|FG001|Overall Study|Lost to Follow-up|3|||
124781528|NCT00488683|448829230|FG002|Overall Study|Lost to Follow-up|0|||
124781529|NCT00488683|448829228|FG000|Overall Study|Protocol Violation|5|||
124781530|NCT00488683|448829229|FG001|Overall Study|Protocol Violation|1|||
124736956|NCT01719003|448658915|FG000|Overall Study|Non compliant with protocol|1|||
124736957|NCT01719003|448658916|FG001|Overall Study|Non compliant with protocol|1|||
124736958|NCT01719003|448658917|FG002|Overall Study|Non compliant with protocol|0|||
124736959|NCT01719003|448658918|FG003|Overall Study|Non compliant with protocol|1|||
124736960|NCT01719003|448658919|FG004|Overall Study|Non compliant with protocol|2|||
124736961|NCT01719003|448658920|FG005|Overall Study|Non compliant with protocol|1|||
124736962|NCT01719003|448658921|FG006|Overall Study|Non compliant with protocol|2|||
124736963|NCT01719003|448658922|FG007|Overall Study|Non compliant with protocol|3|||
124736964|NCT01719003|448658923|FG008|Overall Study|Non compliant with protocol|0|||
124736965|NCT01719003|448658915|FG000|Overall Study|Adverse Event|6|||
124736966|NCT01719003|448658916|FG001|Overall Study|Adverse Event|5|||
124736967|NCT01719003|448658917|FG002|Overall Study|Adverse Event|4|||
124736968|NCT01719003|448658918|FG003|Overall Study|Adverse Event|3|||
124736969|NCT01719003|448658919|FG004|Overall Study|Adverse Event|4|||
124736970|NCT01719003|448658920|FG005|Overall Study|Adverse Event|3|||
124736971|NCT01719003|448658921|FG006|Overall Study|Adverse Event|6|||
124736972|NCT01719003|448658922|FG007|Overall Study|Adverse Event|5|||
124736973|NCT01719003|448658923|FG008|Overall Study|Adverse Event|0|||
124736974|NCT01719003|448658915|FG000|Overall Study|Lost to Follow-up|0|||
124736975|NCT01719003|448658916|FG001|Overall Study|Lost to Follow-up|6|||
124736976|NCT01719003|448658917|FG002|Overall Study|Lost to Follow-up|7|||
124736977|NCT01719003|448658918|FG003|Overall Study|Lost to Follow-up|2|||
124736978|NCT01719003|448658919|FG004|Overall Study|Lost to Follow-up|3|||
124736979|NCT01719003|448658920|FG005|Overall Study|Lost to Follow-up|4|||
124736980|NCT01719003|448658921|FG006|Overall Study|Lost to Follow-up|3|||
124736981|NCT01719003|448658922|FG007|Overall Study|Lost to Follow-up|2|||
124736982|NCT01719003|448658923|FG008|Overall Study|Lost to Follow-up|2|||
124736983|NCT01719003|448658915|FG000|Overall Study|Refusal to continue, not due to AE|2|||
124736984|NCT01719003|448658916|FG001|Overall Study|Refusal to continue, not due to AE|5|||
124736985|NCT01719003|448658917|FG002|Overall Study|Refusal to continue, not due to AE|4|||
124736986|NCT01719003|448658918|FG003|Overall Study|Refusal to continue, not due to AE|4|||
124781531|NCT00488683|448829230|FG002|Overall Study|Protocol Violation|0|||
124781532|NCT00488683|448829228|FG000|Overall Study|Unable to Classify|1|||
124781533|NCT00488683|448829229|FG001|Overall Study|Unable to Classify|0|||
124781534|NCT00488683|448829230|FG002|Overall Study|Unable to Classify|0|||
124781535|NCT02260180|448831084|FG000|Overall Study|Adverse Event|2|||
124781536|NCT02260180|448831085|FG001|Overall Study|Adverse Event|0|||
124781537|NCT02260180|448831086|FG002|Overall Study|Adverse Event|1|||
124736987|NCT01719003|448658919|FG004|Overall Study|Refusal to continue, not due to AE|4|||
124736988|NCT01719003|448658920|FG005|Overall Study|Refusal to continue, not due to AE|3|||
124736989|NCT01719003|448658921|FG006|Overall Study|Refusal to continue, not due to AE|8|||
124736990|NCT01719003|448658922|FG007|Overall Study|Refusal to continue, not due to AE|7|||
124736991|NCT01719003|448658923|FG008|Overall Study|Refusal to continue, not due to AE|1|||
124736992|NCT01719003|448658915|FG000|Overall Study|Reason other than those specified|0|||
124736993|NCT01719003|448658916|FG001|Overall Study|Reason other than those specified|0|||
124781538|NCT02741518|448831089|FG000|Overall Study|Withdrawal by Subject|1|||
124781539|NCT02741518|448831090|FG001|Overall Study|Withdrawal by Subject|1|||
124736994|NCT01719003|448658917|FG002|Overall Study|Reason other than those specified|2|||
124736995|NCT01719003|448658918|FG003|Overall Study|Reason other than those specified|3|||
124736996|NCT01719003|448658919|FG004|Overall Study|Reason other than those specified|4|||
124781540|NCT01139008|448831091|FG000|Overall Study|Withdrawal by Subject|5|||
124736997|NCT01719003|448658920|FG005|Overall Study|Reason other than those specified|1|||
124736998|NCT01719003|448658921|FG006|Overall Study|Reason other than those specified|0|||
124736999|NCT01719003|448658922|FG007|Overall Study|Reason other than those specified|3|||
124737000|NCT01719003|448658923|FG008|Overall Study|Reason other than those specified|1|||
124737001|NCT01719003|448658915|FG000|Overall Study|Lack of Efficacy|0|||
124737002|NCT01719003|448658916|FG001|Overall Study|Lack of Efficacy|0|||
124737003|NCT01719003|448658917|FG002|Overall Study|Lack of Efficacy|0|||
124737004|NCT01719003|448658918|FG003|Overall Study|Lack of Efficacy|0|||
124737005|NCT01719003|448658919|FG004|Overall Study|Lack of Efficacy|0|||
124737006|NCT01719003|448658920|FG005|Overall Study|Lack of Efficacy|0|||
124737007|NCT01719003|448658921|FG006|Overall Study|Lack of Efficacy|1|||
124737008|NCT01719003|448658922|FG007|Overall Study|Lack of Efficacy|0|||
124737009|NCT01719003|448658923|FG008|Overall Study|Lack of Efficacy|0|||
124737010|NCT00581828|448658924|FG000|Overall Study|Protocol Violation|1|||
124737011|NCT01996592|448658934|FG000|Overall Study|no response to text/no diary entry|32|||
124737012|NCT01996592|448658934|FG000|Overall Study|change in surgical date|4|||
124737013|NCT01996592|448658934|FG000|Overall Study|Withdrawal by Subject|5|||
124737014|NCT01996592|448658934|FG000|Overall Study|change in mode of delivery|4|||
124737015|NCT01406015|448658935|FG000|Overall Study|Withdrawal by Subject|3|||
124737016|NCT01406015|448658936|FG001|Overall Study|Withdrawal by Subject|3|||
124737017|NCT00394901|448658937|FG000|Baseline Phase|Protocol Violation|0|||
124737018|NCT00394901|448658938|FG001|Baseline Phase|Protocol Violation|0|||
124737019|NCT00394901|448658939|FG002|Baseline Phase|Protocol Violation|1|||
124737020|NCT00394901|448658940|FG003|Baseline Phase|Protocol Violation|0|||
124737021|NCT00394901|448658937|FG000|Double-blind Phase|Adverse Event|5|||
124737022|NCT00394901|448658938|FG001|Double-blind Phase|Adverse Event|7|||
124737023|NCT00394901|448658939|FG002|Double-blind Phase|Adverse Event|16|||
124737024|NCT00394901|448658940|FG003|Double-blind Phase|Adverse Event|20|||
124737025|NCT00394901|448658937|FG000|Double-blind Phase|Lack of Efficacy|6|||
124737026|NCT00394901|448658938|FG001|Double-blind Phase|Lack of Efficacy|4|||
124737027|NCT00394901|448658939|FG002|Double-blind Phase|Lack of Efficacy|1|||
124737028|NCT00394901|448658940|FG003|Double-blind Phase|Lack of Efficacy|3|||
124737029|NCT00394901|448658937|FG000|Double-blind Phase|Withdrawal by Subject|2|||
124737030|NCT00394901|448658938|FG001|Double-blind Phase|Withdrawal by Subject|0|||
124737031|NCT00394901|448658939|FG002|Double-blind Phase|Withdrawal by Subject|0|||
124737032|NCT00394901|448658940|FG003|Double-blind Phase|Withdrawal by Subject|0|||
124737033|NCT00394901|448658937|FG000|Double-blind Phase|Lost to Follow-up|0|||
124737034|NCT00394901|448658938|FG001|Double-blind Phase|Lost to Follow-up|0|||
124737035|NCT00394901|448658939|FG002|Double-blind Phase|Lost to Follow-up|0|||
124737036|NCT00394901|448658940|FG003|Double-blind Phase|Lost to Follow-up|1|||
124737037|NCT00394901|448658937|FG000|Double-blind Phase|Protocol Violation|0|||
124737038|NCT00394901|448658938|FG001|Double-blind Phase|Protocol Violation|0|||
124737039|NCT00394901|448658939|FG002|Double-blind Phase|Protocol Violation|0|||
124737040|NCT00394901|448658940|FG003|Double-blind Phase|Protocol Violation|1|||
124737041|NCT00394901|448658937|FG000|Double-blind Phase|Death|1|||
124737042|NCT00394901|448658938|FG001|Double-blind Phase|Death|0|||
124737043|NCT00394901|448658939|FG002|Double-blind Phase|Death|0|||
124737044|NCT00394901|448658940|FG003|Double-blind Phase|Death|0|||
124737045|NCT00394901|448658937|FG000|Double-blind Phase|Subject's Personal Reason|1|||
124737046|NCT00394901|448658938|FG001|Double-blind Phase|Subject's Personal Reason|0|||
124737047|NCT00394901|448658939|FG002|Double-blind Phase|Subject's Personal Reason|0|||
124737048|NCT00394901|448658940|FG003|Double-blind Phase|Subject's Personal Reason|1|||
124737049|NCT00394901|448658937|FG000|Double-blind Phase|Lack of Compliance|0|||
124737050|NCT00394901|448658938|FG001|Double-blind Phase|Lack of Compliance|3|||
124737051|NCT00394901|448658939|FG002|Double-blind Phase|Lack of Compliance|0|||
124737052|NCT00394901|448658940|FG003|Double-blind Phase|Lack of Compliance|0|||
124737053|NCT00394901|448658937|FG000|Double-blind Phase|Entry into another study was found|0|||
124737054|NCT00394901|448658938|FG001|Double-blind Phase|Entry into another study was found|0|||
124737055|NCT00394901|448658939|FG002|Double-blind Phase|Entry into another study was found|1|||
124737056|NCT00394901|448658940|FG003|Double-blind Phase|Entry into another study was found|0|||
124737057|NCT00394901|448658937|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
124737058|NCT00394901|448658938|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
124737059|NCT00394901|448658939|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
124737060|NCT00394901|448658940|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
124737061|NCT01886690|448658942|FG000|Overall Study|Protocol Violation|0|||
124737062|NCT01886690|448658943|FG001|Overall Study|Protocol Violation|1|||
124737063|NCT01886690|448658942|FG000|Overall Study|Personal Reasons|0|||
124737064|NCT01886690|448658943|FG001|Overall Study|Personal Reasons|1|||
124737065|NCT03757130|448658944|FG000|Overall Study|Lost to Follow-up|0|||
124737066|NCT03757130|448658945|FG001|Overall Study|Lost to Follow-up|0|||
124737067|NCT03757130|448658946|FG002|Overall Study|Lost to Follow-up|0|||
124737068|NCT03757130|448658947|FG003|Overall Study|Lost to Follow-up|1|||
124737069|NCT03757130|448658948|FG004|Overall Study|Lost to Follow-up|0|||
124737070|NCT03757130|448658949|FG005|Overall Study|Lost to Follow-up|0|||
124737071|NCT03757130|448658950|FG006|Overall Study|Lost to Follow-up|0|||
124781541|NCT01139008|448831091|FG000|Overall Study|Non-compliant, lost product|1|||
124737072|NCT03757130|448658951|FG007|Overall Study|Lost to Follow-up|1|||
124737073|NCT03757130|448658944|FG000|Overall Study|Withdrawal by Subject|0|||
124737074|NCT03757130|448658945|FG001|Overall Study|Withdrawal by Subject|0|||
124737075|NCT03757130|448658946|FG002|Overall Study|Withdrawal by Subject|0|||
124737076|NCT03757130|448658947|FG003|Overall Study|Withdrawal by Subject|0|||
124737077|NCT03757130|448658948|FG004|Overall Study|Withdrawal by Subject|0|||
124737078|NCT03757130|448658949|FG005|Overall Study|Withdrawal by Subject|0|||
124737079|NCT03757130|448658950|FG006|Overall Study|Withdrawal by Subject|1|||
124737080|NCT03757130|448658951|FG007|Overall Study|Withdrawal by Subject|0|||
124737081|NCT02360293|448658952|FG000|Overall Study|Lost to Follow-up|73|||
124737082|NCT02360293|448658953|FG001|Overall Study|Lost to Follow-up|95|||
124737083|NCT02360293|448658952|FG000|Overall Study|Withdrawal by Subject|2|||
124737084|NCT02360293|448658953|FG001|Overall Study|Withdrawal by Subject|1|||
124737085|NCT02360293|448658952|FG000|Overall Study|Excluded|1|||
124737086|NCT02360293|448658953|FG001|Overall Study|Excluded|0|||
124737087|NCT02226549|448658954|FG000|Overall Study|Randomized but Never Treated|1|||
124737088|NCT02226549|448658955|FG001|Overall Study|Randomized but Never Treated|0|||
124737089|NCT02226549|448658954|FG000|Overall Study|Lost to Follow-up|0|||
124737090|NCT02226549|448658955|FG001|Overall Study|Lost to Follow-up|1|||
124737091|NCT02726880|448658956|FG000|Overall Study|Withdrawal by Subject|2|||
124737092|NCT02726880|448658957|FG001|Overall Study|Withdrawal by Subject|0|||
124737093|NCT02726880|448658956|FG000|Overall Study|Lost to Follow-up|1|||
124737094|NCT02726880|448658957|FG001|Overall Study|Lost to Follow-up|3|||
124737095|NCT04316741|448658958|FG000|Baseline Enrollment|Lost to Follow-up|1|||
124737096|NCT04316741|448658959|FG001|Baseline Enrollment|Lost to Follow-up|1|||
124737097|NCT04316741|448658958|FG000|Immediate Post-Test|Lost to Follow-up|5|||
124737098|NCT04316741|448658959|FG001|Immediate Post-Test|Lost to Follow-up|1|||
124737099|NCT04316741|448658958|FG000|1-month Post-test|Lost to Follow-up|7|||
124737100|NCT04316741|448658959|FG001|1-month Post-test|Lost to Follow-up|2|||
124737101|NCT04316741|448658958|FG000|3-month Follow-up|Lost to Follow-up|10|||
124737102|NCT04316741|448658959|FG001|3-month Follow-up|Lost to Follow-up|2|||
124737103|NCT01510145|448658960|FG000|Overall Study|Adverse Event|6|||
124737104|NCT01510145|448658960|FG000|Overall Study|Lost to Follow-up|5|||
124737105|NCT01510145|448658960|FG000|Overall Study|Withdrawal by Subject|6|||
124737106|NCT01510145|448658960|FG000|Overall Study|Relative reported subject withdrew|1|||
124737107|NCT02312219|448658961|FG000|Overall Study|Withdrawal by Subject|1|||
124737108|NCT02312219|448658962|FG001|Overall Study|Withdrawal by Subject|2|||
124781542|NCT01715857|448831092|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
124612364|NCT00704730|448198780|FG000|Overall Study|Adverse Event|35|||
124612365|NCT00704730|448198781|FG001|Overall Study|Adverse Event|9|||
124612366|NCT00704730|448198780|FG000|Overall Study|Death|11|||
124612367|NCT00704730|448198781|FG001|Overall Study|Death|5|||
124612368|NCT00704730|448198780|FG000|Overall Study|Physician Decision|2|||
124612369|NCT00704730|448198781|FG001|Overall Study|Physician Decision|0|||
124612370|NCT00704730|448198780|FG000|Overall Study|Did not receive drug|5|||
124612371|NCT00704730|448198781|FG001|Overall Study|Did not receive drug|2|||
124612372|NCT00704730|448198780|FG000|Overall Study|Disease progression per PI|58|||
124612373|NCT00704730|448198781|FG001|Overall Study|Disease progression per PI|67|||
124612374|NCT00704730|448198780|FG000|Overall Study|data unavailable|1|||
124612375|NCT00704730|448198781|FG001|Overall Study|data unavailable|0|||
124612376|NCT00704730|448198780|FG000|Overall Study|Withdrawal by Subject|9|||
124612377|NCT00704730|448198781|FG001|Overall Study|Withdrawal by Subject|13|||
124612378|NCT01523457|448200390|FG000|Overall Study|Withdrawal by Subject|7|||
124612379|NCT01523457|448200391|FG001|Overall Study|Withdrawal by Subject|2|||
124612380|NCT02886624|448200395|FG000|12-week Post Treatment Follow-up|Death|1|||
124612381|NCT02886624|448200395|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
124612382|NCT03400943|448200399|FG000|Treatment Period 1|Adverse Event|0|||
124612383|NCT03400943|448200400|FG001|Treatment Period 1|Adverse Event|0|||
124612384|NCT03400943|448200401|FG002|Treatment Period 1|Adverse Event|0|||
124612385|NCT03400943|448200402|FG003|Treatment Period 1|Adverse Event|1|||
124612386|NCT03400943|448200399|FG000|Treatment Period 1|Lost to Follow-up|1|||
124612387|NCT03400943|448200400|FG001|Treatment Period 1|Lost to Follow-up|0|||
124612388|NCT03400943|448200401|FG002|Treatment Period 1|Lost to Follow-up|0|||
124612389|NCT03400943|448200402|FG003|Treatment Period 1|Lost to Follow-up|0|||
124737109|NCT02312219|448658961|FG000|Overall Study|could not schedule imaging in time|0|||
124737110|NCT02312219|448658962|FG001|Overall Study|could not schedule imaging in time|2|||
124737111|NCT02312219|448658961|FG000|Overall Study|Other|0|||
124781543|NCT02785770|448831093|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
124737112|NCT02312219|448658962|FG001|Overall Study|Other|1|||
124737113|NCT02312219|448658961|FG000|Overall Study|Not randomized. Ineligible|0|||
124737114|NCT02312219|448658962|FG001|Overall Study|Not randomized. Ineligible|1|||
124781544|NCT02785770|448831094|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
124781545|NCT02785770|448831095|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
124612390|NCT03400943|448200399|FG000|Treatment Period 1|Protocol Violation|0|||
124612391|NCT03400943|448200400|FG001|Treatment Period 1|Protocol Violation|1|||
124612392|NCT03400943|448200401|FG002|Treatment Period 1|Protocol Violation|1|||
124612393|NCT03400943|448200402|FG003|Treatment Period 1|Protocol Violation|0|||
124612394|NCT03400943|448200399|FG000|Treatment Period 1|Study terminated by sponsor|2|||
124612395|NCT03400943|448200400|FG001|Treatment Period 1|Study terminated by sponsor|0|||
124612396|NCT03400943|448200401|FG002|Treatment Period 1|Study terminated by sponsor|0|||
124612397|NCT03400943|448200402|FG003|Treatment Period 1|Study terminated by sponsor|1|||
124612398|NCT03400943|448200399|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124612399|NCT03400943|448200400|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124612400|NCT03400943|448200401|FG002|Treatment Period 1|Withdrawal by Subject|3|||
124612401|NCT03400943|448200402|FG003|Treatment Period 1|Withdrawal by Subject|1|||
124612402|NCT03400943|448200399|FG000|Treatment Period 1|Other|2|||
124612403|NCT03400943|448200400|FG001|Treatment Period 1|Other|1|||
124612404|NCT03400943|448200401|FG002|Treatment Period 1|Other|2|||
124612405|NCT03400943|448200402|FG003|Treatment Period 1|Other|2|||
124612406|NCT03400943|448200399|FG000|Post-treatment Period 1|Adverse Event|2|||
124612407|NCT03400943|448200400|FG001|Post-treatment Period 1|Adverse Event|0|||
124612408|NCT03400943|448200401|FG002|Post-treatment Period 1|Adverse Event|0|||
124612409|NCT03400943|448200402|FG003|Post-treatment Period 1|Adverse Event|0|||
124612410|NCT03400943|448200399|FG000|Post-treatment Period 1|Protocol Violation|1|||
124612411|NCT03400943|448200400|FG001|Post-treatment Period 1|Protocol Violation|0|||
124612412|NCT03400943|448200401|FG002|Post-treatment Period 1|Protocol Violation|0|||
124612413|NCT03400943|448200402|FG003|Post-treatment Period 1|Protocol Violation|0|||
124612414|NCT03400943|448200399|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
124612415|NCT03400943|448200400|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
124612416|NCT03400943|448200401|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
124612417|NCT03400943|448200402|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
124612418|NCT03400943|448200399|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
124612419|NCT03400943|448200400|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
124612420|NCT03400943|448200401|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
124612421|NCT03400943|448200402|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
124612422|NCT03400943|448200399|FG000|Post-treatment Period 1|Other|2|||
124612423|NCT03400943|448200400|FG001|Post-treatment Period 1|Other|0|||
124612424|NCT03400943|448200401|FG002|Post-treatment Period 1|Other|4|||
124612425|NCT03400943|448200402|FG003|Post-treatment Period 1|Other|5|||
124612426|NCT03400943|448200399|FG000|Treatment Period 2|Study terminated by sponsor|0|||
124612427|NCT03400943|448200400|FG001|Treatment Period 2|Study terminated by sponsor|1|||
124612428|NCT03400943|448200401|FG002|Treatment Period 2|Study terminated by sponsor|0|||
124612429|NCT03400943|448200402|FG003|Treatment Period 2|Study terminated by sponsor|0|||
124612430|NCT03400943|448200399|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124612431|NCT03400943|448200400|FG001|Treatment Period 2|Withdrawal by Subject|1|||
124612432|NCT03400943|448200401|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124612433|NCT03400943|448200402|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124612434|NCT03400943|448200399|FG000|Treatment Period 2|Other|1|||
124612435|NCT03400943|448200400|FG001|Treatment Period 2|Other|6|||
124737115|NCT01269385|448658963|FG000|Overall Study|Adverse Event|1|||
124737116|NCT01269385|448658964|FG001|Overall Study|Adverse Event|1|||
124737117|NCT01269385|448658965|FG002|Overall Study|Adverse Event|0|||
124737118|NCT01269385|448658966|FG003|Overall Study|Adverse Event|0|||
124737119|NCT04941807|448658968|FG000|Overall Study|Lost to Follow-up|1|||
124737120|NCT04941807|448658969|FG001|Overall Study|Lost to Follow-up|1|||
124737121|NCT01827332|448658970|FG000|Overall Study|Lost to Follow-up|2|||
124612436|NCT03400943|448200401|FG002|Treatment Period 2|Other|0|||
124612437|NCT03400943|448200402|FG003|Treatment Period 2|Other|0|||
124612438|NCT03400943|448200399|FG000|Follow-up Period|Withdrawal by Subject|1|||
124612439|NCT03400943|448200400|FG001|Follow-up Period|Withdrawal by Subject|0|||
124612440|NCT03400943|448200401|FG002|Follow-up Period|Withdrawal by Subject|0|||
124612441|NCT03400943|448200402|FG003|Follow-up Period|Withdrawal by Subject|0|||
124612442|NCT02563106|448200403|FG000|Overall Study|Withdrawal by Subject|7|||
124612443|NCT02563106|448200404|FG001|Overall Study|Withdrawal by Subject|8|||
124612444|NCT02563106|448200403|FG000|Overall Study|Adverse Event|17|||
124612445|NCT02563106|448200404|FG001|Overall Study|Adverse Event|15|||
124612446|NCT02563106|448200403|FG000|Overall Study|Protocol Violation|1|||
124737122|NCT01827332|448658971|FG001|Overall Study|Lost to Follow-up|1|||
124612447|NCT02563106|448200404|FG001|Overall Study|Protocol Violation|0|||
124612448|NCT02563106|448200403|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
124612449|NCT02563106|448200404|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
124612450|NCT02563106|448200403|FG000|Overall Study|Lost to Follow-up|3|||
124612451|NCT02563106|448200404|FG001|Overall Study|Lost to Follow-up|2|||
124612452|NCT02563106|448200403|FG000|Overall Study|Physician Decision|3|||
124612453|NCT02563106|448200404|FG001|Overall Study|Physician Decision|1|||
124612454|NCT02563106|448200403|FG000|Overall Study|Other reason - not specified|2|||
124612455|NCT02563106|448200404|FG001|Overall Study|Other reason - not specified|1|||
124612456|NCT04729309|448200405|FG000|Period 1|Subject unable to return for Period 2|3|||
124612457|NCT04729309|448200406|FG001|Period 1|Subject unable to return for Period 2|0|||
124612458|NCT04729309|448200405|FG000|Period 1|Lost to Follow-up|1|||
124737123|NCT00546260|448658972|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
124737124|NCT00546260|448658973|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
124781546|NCT02785770|448831096|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
124781547|NCT02785770|448831093|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
124781548|NCT02785770|448831094|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
124781549|NCT02785770|448831095|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
124781550|NCT02785770|448831096|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
124781551|NCT02785770|448831093|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
124612459|NCT04729309|448200406|FG001|Period 1|Lost to Follow-up|0|||
124612460|NCT01664130|448200413|FG000|Overall Study|competing secondary disease|2|||
124612461|NCT01161407|448200415|FG000|Overall Study|Protocol Violation|3|||
124612462|NCT01161407|448200416|FG001|Overall Study|Protocol Violation|1|||
124612463|NCT04746794|448200418|FG000|Overall Study|Did not complete any study assessment|50303|||
124612464|NCT04746794|448200419|FG001|Overall Study|Did not complete any study assessment|44997|||
124612465|NCT04040192|448200420|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
124612466|NCT04040192|448200421|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
124612467|NCT04040192|448200422|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
124612468|NCT04040192|448200420|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
124612469|NCT04040192|448200421|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
124612470|NCT04040192|448200422|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
124612471|NCT04040192|448200420|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
124612472|NCT04040192|448200421|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
124612473|NCT04040192|448200422|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
124612474|NCT04040192|448200420|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
124612475|NCT04040192|448200421|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
124612476|NCT04040192|448200422|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
124612477|NCT04040192|448200420|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
124612478|NCT04040192|448200421|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
124612479|NCT04040192|448200422|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
124612480|NCT04040192|448200420|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
124612481|NCT04040192|448200421|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
124612482|NCT04040192|448200422|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
124612483|NCT04040192|448200420|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
124612484|NCT04040192|448200421|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
124612485|NCT04040192|448200422|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
124612486|NCT04040192|448200420|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
124612487|NCT04040192|448200421|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
124612488|NCT04040192|448200422|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
124612489|NCT04040192|448200420|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
124612490|NCT04040192|448200421|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
124612491|NCT04040192|448200422|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
124612492|NCT04040192|448200420|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
124612493|NCT04040192|448200421|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
124612494|NCT04040192|448200422|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
124612495|NCT04040192|448200420|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
124612496|NCT04040192|448200421|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
124612497|NCT04040192|448200422|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
124612498|NCT04040192|448200420|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
124612499|NCT04040192|448200421|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
124612500|NCT04040192|448200422|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
124612501|NCT04040192|448200420|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
124612502|NCT04040192|448200421|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
124612503|NCT04040192|448200422|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
124612504|NCT04040192|448200420|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
124612505|NCT04040192|448200421|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
124612506|NCT04040192|448200422|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
124612507|NCT04040192|448200420|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
124612508|NCT04040192|448200421|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
124612509|NCT04040192|448200422|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
124612510|NCT04040192|448200420|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
124612511|NCT04040192|448200421|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
124612512|NCT04040192|448200422|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
124612513|NCT04040192|448200420|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
124612514|NCT04040192|448200421|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
124612515|NCT04040192|448200422|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
124612516|NCT02792699|448200423|FG000|Overall Study|Adverse Event|1|||
124612517|NCT02792699|448200424|FG001|Overall Study|Adverse Event|2|||
124612518|NCT02792699|448200425|FG002|Overall Study|Adverse Event|4|||
124612519|NCT02792699|448200423|FG000|Overall Study|Withdrawal by Subject|4|||
124612520|NCT02792699|448200424|FG001|Overall Study|Withdrawal by Subject|4|||
124612521|NCT02792699|448200425|FG002|Overall Study|Withdrawal by Subject|3|||
124612522|NCT02792699|448200423|FG000|Overall Study|Lost to Follow-up|0|||
124612523|NCT02792699|448200424|FG001|Overall Study|Lost to Follow-up|1|||
124612524|NCT02792699|448200425|FG002|Overall Study|Lost to Follow-up|2|||
124612525|NCT02792699|448200423|FG000|Overall Study|Physician Decision|2|||
124612526|NCT02792699|448200424|FG001|Overall Study|Physician Decision|0|||
124612527|NCT02792699|448200425|FG002|Overall Study|Physician Decision|0|||
124612528|NCT02792699|448200423|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
124612529|NCT02792699|448200424|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
124612530|NCT02792699|448200425|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
124612531|NCT02792699|448200423|FG000|Overall Study|Other|1|||
124612532|NCT02792699|448200424|FG001|Overall Study|Other|0|||
124612533|NCT02792699|448200425|FG002|Overall Study|Other|0|||
124612534|NCT03200912|448200426|FG000|Overall Study|Adverse Event|3|||
124612535|NCT03200912|448200427|FG001|Overall Study|Adverse Event|0|||
124612536|NCT03200912|448200428|FG002|Overall Study|Adverse Event|0|||
124612537|NCT03200912|448200426|FG000|Overall Study|Withdrawal by Subject|1|||
124612538|NCT03200912|448200427|FG001|Overall Study|Withdrawal by Subject|2|||
124612539|NCT03200912|448200428|FG002|Overall Study|Withdrawal by Subject|4|||
124612540|NCT03200912|448200426|FG000|Overall Study|Non-compliance with study drug|0|||
124612541|NCT03200912|448200427|FG001|Overall Study|Non-compliance with study drug|1|||
124612542|NCT03200912|448200428|FG002|Overall Study|Non-compliance with study drug|0|||
124612543|NCT01338870|448200432|FG000|Overall Study|Lost to Follow-up|0|||
124612544|NCT01338870|448200433|FG001|Overall Study|Lost to Follow-up|0|||
124612545|NCT01338870|448200434|FG002|Overall Study|Lost to Follow-up|1|||
124612546|NCT01338870|448200435|FG003|Overall Study|Lost to Follow-up|0|||
124612547|NCT01338870|448200436|FG004|Overall Study|Lost to Follow-up|1|||
124612548|NCT01338870|448200437|FG005|Overall Study|Lost to Follow-up|0|||
124612549|NCT01338870|448200432|FG000|Overall Study|Withdrawal by Subject|2|||
124612550|NCT01338870|448200433|FG001|Overall Study|Withdrawal by Subject|3|||
124612551|NCT01338870|448200434|FG002|Overall Study|Withdrawal by Subject|4|||
124612552|NCT01338870|448200435|FG003|Overall Study|Withdrawal by Subject|0|||
124612553|NCT01338870|448200436|FG004|Overall Study|Withdrawal by Subject|0|||
124612554|NCT01338870|448200437|FG005|Overall Study|Withdrawal by Subject|2|||
124612555|NCT01338870|448200432|FG000|Overall Study|Other|3|||
124612556|NCT01338870|448200433|FG001|Overall Study|Other|3|||
124612557|NCT01338870|448200434|FG002|Overall Study|Other|3|||
124612558|NCT01338870|448200435|FG003|Overall Study|Other|2|||
124612559|NCT01338870|448200436|FG004|Overall Study|Other|0|||
124612560|NCT01338870|448200437|FG005|Overall Study|Other|2|||
124612561|NCT01338870|448200432|FG000|Overall Study|Protocol Violation|0|||
124612562|NCT01338870|448200433|FG001|Overall Study|Protocol Violation|2|||
124612563|NCT01338870|448200434|FG002|Overall Study|Protocol Violation|2|||
124612564|NCT01338870|448200435|FG003|Overall Study|Protocol Violation|2|||
124612565|NCT01338870|448200436|FG004|Overall Study|Protocol Violation|1|||
124612566|NCT01338870|448200437|FG005|Overall Study|Protocol Violation|1|||
124612567|NCT01338870|448200432|FG000|Overall Study|Adverse Event|4|||
124612568|NCT01338870|448200433|FG001|Overall Study|Adverse Event|4|||
124612569|NCT01338870|448200434|FG002|Overall Study|Adverse Event|1|||
124612570|NCT01338870|448200435|FG003|Overall Study|Adverse Event|5|||
124612571|NCT01338870|448200436|FG004|Overall Study|Adverse Event|4|||
124612572|NCT01338870|448200437|FG005|Overall Study|Adverse Event|1|||
124612573|NCT01955083|448200438|FG000|Overall Study|Lost to Follow-up|1|||
124612574|NCT01955083|448200439|FG001|Overall Study|Lost to Follow-up|1|||
124612575|NCT03583086|448200442|FG000|Overall Study|Death|2|||
124612576|NCT03583086|448200443|FG001|Overall Study|Death|6|||
124612577|NCT03583086|448200444|FG002|Overall Study|Death|12|||
124612578|NCT03583086|448200445|FG003|Overall Study|Death|10|||
124612579|NCT03583086|448200446|FG004|Overall Study|Death|14|||
124612580|NCT03583086|448200447|FG005|Overall Study|Death|14|||
124612581|NCT03583086|448200448|FG006|Overall Study|Death|4|||
124612582|NCT03583086|448200442|FG000|Overall Study|Withdrawal by Subject|0|||
124612583|NCT03583086|448200443|FG001|Overall Study|Withdrawal by Subject|0|||
124612584|NCT03583086|448200444|FG002|Overall Study|Withdrawal by Subject|1|||
124612585|NCT03583086|448200445|FG003|Overall Study|Withdrawal by Subject|0|||
124612586|NCT03583086|448200446|FG004|Overall Study|Withdrawal by Subject|0|||
124612587|NCT03583086|448200447|FG005|Overall Study|Withdrawal by Subject|0|||
124612588|NCT03583086|448200448|FG006|Overall Study|Withdrawal by Subject|1|||
124612589|NCT03583086|448200442|FG000|Overall Study|Refused follow-up|0|||
124612590|NCT03583086|448200443|FG001|Overall Study|Refused follow-up|0|||
124612591|NCT03583086|448200444|FG002|Overall Study|Refused follow-up|1|||
124612592|NCT03583086|448200445|FG003|Overall Study|Refused follow-up|0|||
124612593|NCT03583086|448200446|FG004|Overall Study|Refused follow-up|1|||
124612594|NCT03583086|448200447|FG005|Overall Study|Refused follow-up|0|||
124612595|NCT03583086|448200448|FG006|Overall Study|Refused follow-up|0|||
124612596|NCT03583086|448200442|FG000|Overall Study|Declining Performance Status|0|||
124637764|NCT00300885|448292421|FG000|Treatment|Protocol Violation|11|||
124612597|NCT03583086|448200443|FG001|Overall Study|Declining Performance Status|0|||
124612598|NCT03583086|448200444|FG002|Overall Study|Declining Performance Status|1|||
124612599|NCT03583086|448200445|FG003|Overall Study|Declining Performance Status|0|||
124612600|NCT03583086|448200446|FG004|Overall Study|Declining Performance Status|0|||
124612601|NCT03583086|448200447|FG005|Overall Study|Declining Performance Status|0|||
124612602|NCT03583086|448200448|FG006|Overall Study|Declining Performance Status|0|||
124612603|NCT03583086|448200442|FG000|Overall Study|Still on study|0|||
124737125|NCT03654885|448660743|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
124737126|NCT03654885|448660744|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
124737127|NCT03654885|448660743|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
124737128|NCT03654885|448660744|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
124737129|NCT03654885|448660743|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
124737130|NCT03654885|448660744|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
124737131|NCT03654885|448660743|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
124737132|NCT03654885|448660744|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
124737133|NCT03654885|448660743|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
124737134|NCT03654885|448660744|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
124737135|NCT03654885|448660743|FG000|Overall Study|Adverse Event in Study Eye|3|||
124737136|NCT03654885|448660744|FG001|Overall Study|Adverse Event in Study Eye|0|||
124737137|NCT03654885|448660743|FG000|Overall Study|Consent Withdrawn|1|||
124737138|NCT03654885|448660744|FG001|Overall Study|Consent Withdrawn|0|||
124737139|NCT03654885|448660743|FG000|Overall Study|Death|3|||
124737140|NCT03654885|448660744|FG001|Overall Study|Death|1|||
124737141|NCT03654885|448660743|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
124737142|NCT03654885|448660744|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
124737143|NCT03654885|448660743|FG000|Overall Study|Lost to Follow-up|3|||
124737144|NCT03654885|448660744|FG001|Overall Study|Lost to Follow-up|3|||
124737145|NCT00289198|448660763|FG000|Overall Study|Adverse Event|0|||
124737146|NCT00289198|448660764|FG001|Overall Study|Adverse Event|2|||
124737147|NCT00289198|448660763|FG000|Overall Study|Protocol Violation|2|||
124737148|NCT00289198|448660764|FG001|Overall Study|Protocol Violation|1|||
124737149|NCT00289198|448660763|FG000|Overall Study|Withdrawal by Subject|4|||
124737150|NCT00289198|448660764|FG001|Overall Study|Withdrawal by Subject|1|||
124737151|NCT00289198|448660763|FG000|Overall Study|Lack of Efficacy|2|||
124737152|NCT00289198|448660764|FG001|Overall Study|Lack of Efficacy|0|||
124737153|NCT00289198|448660763|FG000|Overall Study|Other: Low compliance|0|||
124737154|NCT00289198|448660764|FG001|Overall Study|Other: Low compliance|1|||
124737155|NCT00289198|448660763|FG000|Overall Study|Other: Physician's decision|0|||
124737156|NCT00289198|448660764|FG001|Overall Study|Other: Physician's decision|1|||
124737157|NCT00289198|448660763|FG000|Overall Study|Other: Unable to attend on schedule|2|||
124737158|NCT00289198|448660764|FG001|Overall Study|Other: Unable to attend on schedule|1|||
124737159|NCT00289198|448660763|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
124737160|NCT00289198|448660764|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
124737161|NCT00289198|448660763|FG000|Overall Study|Other: Impossible to come on visit|0|||
124737162|NCT00289198|448660764|FG001|Overall Study|Other: Impossible to come on visit|1|||
124737163|NCT01176565|448660765|FG000|Overall Study|Lost to Follow-up|12|||
124737164|NCT01176565|448660766|FG001|Overall Study|Lost to Follow-up|16|||
124737165|NCT01176565|448660765|FG000|Overall Study|Withdrawal by Subject|7|||
124737166|NCT01176565|448660766|FG001|Overall Study|Withdrawal by Subject|1|||
124737167|NCT01176565|448660765|FG000|Overall Study|Not Analyzed (any other reason)|1|||
124737168|NCT01176565|448660766|FG001|Overall Study|Not Analyzed (any other reason)|2|||
124737169|NCT01062061|448660769|FG000|Overall Study|Enrolled more than once|2|||
124737170|NCT01062061|448660769|FG000|Overall Study|Investigated before study start|13|||
124737171|NCT01062061|448660769|FG000|Overall Study|Outside chief indications|10|||
124737172|NCT01062061|448660769|FG000|Overall Study|Failed to meet inclusion criteria|2|||
124737173|NCT01143051|448660775|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
124737174|NCT01143051|448660776|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
124737175|NCT01143051|448660777|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
124737176|NCT01143051|448660778|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
124737177|NCT01143051|448660779|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
124737178|NCT01143051|448660780|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
124737179|NCT01143051|448660775|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
124737180|NCT01143051|448660776|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
124737181|NCT01143051|448660777|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
124737182|NCT01143051|448660778|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
124737183|NCT01143051|448660779|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
124737184|NCT01143051|448660780|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
124737185|NCT01605227|448660782|FG000|Overall Study|Did not receive study treatment|2|||
124737186|NCT01605227|448660783|FG001|Overall Study|Did not receive study treatment|3|||
124612604|NCT03583086|448200443|FG001|Overall Study|Still on study|0|||
124737187|NCT01605227|448660782|FG000|Overall Study|Adverse Event|228|||
124737188|NCT01605227|448660783|FG001|Overall Study|Adverse Event|42|||
124737189|NCT01605227|448660782|FG000|Overall Study|Progressive Disease|132|||
124737190|NCT01605227|448660783|FG001|Overall Study|Progressive Disease|128|||
124737191|NCT01605227|448660782|FG000|Overall Study|Clinical Deterioration|227|||
124737192|NCT01605227|448660783|FG001|Overall Study|Clinical Deterioration|133|||
124737193|NCT01605227|448660782|FG000|Overall Study|Lost to Follow-up|1|||
124737194|NCT01605227|448660783|FG001|Overall Study|Lost to Follow-up|0|||
124737195|NCT01605227|448660782|FG000|Overall Study|Protocol Violation|1|||
124737196|NCT01605227|448660783|FG001|Overall Study|Protocol Violation|0|||
124737197|NCT01605227|448660782|FG000|Overall Study|Physician Decision|9|||
124737198|NCT01605227|448660783|FG001|Overall Study|Physician Decision|7|||
124737199|NCT01605227|448660782|FG000|Overall Study|Withdrawal by Subject|18|||
124737200|NCT01605227|448660783|FG001|Overall Study|Withdrawal by Subject|14|||
124737201|NCT01605227|448660782|FG000|Overall Study|Sponsor Decision|2|||
124737202|NCT01605227|448660783|FG001|Overall Study|Sponsor Decision|0|||
124737203|NCT01605227|448660782|FG000|Overall Study|Started New Therapy|1|||
124737204|NCT01605227|448660783|FG001|Overall Study|Started New Therapy|0|||
124737205|NCT01605227|448660782|FG000|Overall Study|Subject Decision|0|||
124737206|NCT01605227|448660783|FG001|Overall Study|Subject Decision|1|||
124737207|NCT01605227|448660782|FG000|Overall Study|Dose Held >6 weeks|0|||
124737208|NCT01605227|448660783|FG001|Overall Study|Dose Held >6 weeks|1|||
124737209|NCT01813721|448660787|FG000|Overall Study|Ineligibility determined|63|||
124737210|NCT01813721|448660787|FG000|Overall Study|Withdrawal by Subject|1|||
124737211|NCT01866423|448660788|FG000|Overall Study|Lack of Efficacy|3|||
124737212|NCT01866423|448660788|FG000|Overall Study|Sponsor Decision|1|||
124737213|NCT00810901|448660789|FG000|Overall Study|Lost to Follow-up|88|||
124737214|NCT00810901|448660790|FG001|Overall Study|Lost to Follow-up|58|||
124737215|NCT01133275|448660791|FG000|Overall Study|Withdrawal by Subject|1|||
124737216|NCT01133275|448660791|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
124737217|NCT00900146|448660792|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
124737218|NCT00900146|448660793|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
124737219|NCT00900146|448660794|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
124737220|NCT00900146|448660795|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
124737221|NCT00900146|448660796|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
124737222|NCT00900146|448660792|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
124737223|NCT00900146|448660793|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
124737224|NCT00900146|448660794|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
124737225|NCT00900146|448660795|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
124737226|NCT00900146|448660796|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
124737227|NCT00900146|448660792|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
124737228|NCT00900146|448660793|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
124737229|NCT00900146|448660794|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
124737230|NCT00900146|448660795|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
124737231|NCT00900146|448660796|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
124737232|NCT00900146|448660792|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
124737233|NCT00900146|448660793|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
124737234|NCT00900146|448660794|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
124737235|NCT00900146|448660795|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
124737236|NCT00900146|448660796|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
124737237|NCT00900146|448660792|FG000|Intermediate: Period III|Lost to Follow-up|2|||
124737238|NCT00900146|448660793|FG001|Intermediate: Period III|Lost to Follow-up|0|||
124737239|NCT00900146|448660794|FG002|Intermediate: Period III|Lost to Follow-up|0|||
124737240|NCT00900146|448660795|FG003|Intermediate: Period III|Lost to Follow-up|0|||
124737241|NCT00900146|448660796|FG004|Intermediate: Period III|Lost to Follow-up|1|||
124737242|NCT00900146|448660792|FG000|Intermediate: Period III|Administrative problems|85|||
124737243|NCT00900146|448660793|FG001|Intermediate: Period III|Administrative problems|92|||
124737244|NCT00900146|448660794|FG002|Intermediate: Period III|Administrative problems|84|||
124737245|NCT00900146|448660795|FG003|Intermediate: Period III|Administrative problems|90|||
124737246|NCT00900146|448660796|FG004|Intermediate: Period III|Administrative problems|163|||
124737247|NCT00700102|448660797|FG000|Overall Study|Died|394|||
124737248|NCT00700102|448660798|FG001|Overall Study|Died|385|||
124612605|NCT03583086|448200444|FG002|Overall Study|Still on study|0|||
124737249|NCT00700102|448660797|FG000|Overall Study|Lost to Follow-up|8|||
124737250|NCT00700102|448660798|FG001|Overall Study|Lost to Follow-up|10|||
124737251|NCT02525939|448660803|FG000|Overall Study|Lost to Follow-up|27|||
124737252|NCT02525939|448660804|FG001|Overall Study|Lost to Follow-up|24|||
124737253|NCT02525939|448660803|FG000|Overall Study|Physician Decision|0|||
124737254|NCT02525939|448660804|FG001|Overall Study|Physician Decision|1|||
124737255|NCT02525939|448660803|FG000|Overall Study|Withdrawal by Subject|24|||
124737256|NCT02525939|448660804|FG001|Overall Study|Withdrawal by Subject|39|||
124737257|NCT02525939|448660803|FG000|Overall Study|Death|180|||
124737258|NCT02525939|448660804|FG001|Overall Study|Death|179|||
124737259|NCT01028716|448660805|FG000|Overall Study|Physician Decision|1|||
124737260|NCT05590000|448660806|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
124737261|NCT00536874|448660807|FG000|Overall Study|Adverse Event|1|||
124737262|NCT00536874|448660807|FG000|Overall Study|Death|2|||
124737263|NCT00536874|448660807|FG000|Overall Study|Withdrawal by Subject|1|||
124737264|NCT00762996|448660808|FG000|Period One|Protocol Violation|0|||
124737265|NCT00762996|448660809|FG001|Period One|Protocol Violation|0|||
124737266|NCT00762996|448660810|FG002|Period One|Protocol Violation|1|||
124737267|NCT00762996|448660811|FG003|Period One|Protocol Violation|0|||
124737268|NCT00762996|448660808|FG000|Period One|ineligible|0|||
124737269|NCT00762996|448660809|FG001|Period One|ineligible|0|||
124737270|NCT00762996|448660810|FG002|Period One|ineligible|1|||
124737271|NCT00762996|448660811|FG003|Period One|ineligible|1|||
124737272|NCT00762996|448660808|FG000|Period One|Adverse Event|0|||
124737273|NCT00762996|448660809|FG001|Period One|Adverse Event|0|||
124737274|NCT00762996|448660810|FG002|Period One|Adverse Event|1|||
124737275|NCT00762996|448660811|FG003|Period One|Adverse Event|0|||
124737276|NCT00762996|448660808|FG000|Period One|Withdrawal by Subject|0|||
124737277|NCT00762996|448660809|FG001|Period One|Withdrawal by Subject|0|||
124737278|NCT00762996|448660810|FG002|Period One|Withdrawal by Subject|1|||
124737279|NCT00762996|448660811|FG003|Period One|Withdrawal by Subject|0|||
124737280|NCT02689076|448660813|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
124737281|NCT02689076|448660814|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
124737282|NCT02689076|448660815|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
124737283|NCT02689076|448660813|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
124737284|NCT02689076|448660814|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
124737285|NCT02689076|448660815|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
124737286|NCT02689076|448660813|FG000|Overall Study|Did not have an HIE match|2|||
124737287|NCT02689076|448660814|FG001|Overall Study|Did not have an HIE match|0|||
124737288|NCT02689076|448660815|FG002|Overall Study|Did not have an HIE match|0|||
124737289|NCT02689076|448660813|FG000|Overall Study|Death during non-VA encounter|2|||
124737290|NCT02689076|448660814|FG001|Overall Study|Death during non-VA encounter|5|||
124737291|NCT02689076|448660815|FG002|Overall Study|Death during non-VA encounter|0|||
124737292|NCT02689076|448660813|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
124781552|NCT02785770|448831094|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
124781553|NCT02785770|448831095|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
124781554|NCT02785770|448831096|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
124781555|NCT00505778|448831100|FG000|Overall Study|Adverse Event|2|||
124781556|NCT00505778|448831101|FG001|Overall Study|Adverse Event|7|||
124781557|NCT00505778|448831100|FG000|Overall Study|Physician Decision|8|||
124781558|NCT00505778|448831101|FG001|Overall Study|Physician Decision|14|||
124781559|NCT00505778|448831100|FG000|Overall Study|Lost to Follow-up|17|||
124781560|NCT00505778|448831101|FG001|Overall Study|Lost to Follow-up|23|||
124781561|NCT00505778|448831100|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
124781562|NCT00505778|448831101|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
124781563|NCT00505778|448831100|FG000|Overall Study|Protocol Violation|7|||
124781564|NCT00505778|448831101|FG001|Overall Study|Protocol Violation|9|||
124781565|NCT00505778|448831100|FG000|Overall Study|Withdrawal by Subject|29|||
124781566|NCT00505778|448831101|FG001|Overall Study|Withdrawal by Subject|14|||
124781567|NCT00505778|448831100|FG000|Overall Study|Relapse|65|||
124781568|NCT00505778|448831101|FG001|Overall Study|Relapse|65|||
124781569|NCT00505778|448831100|FG000|Overall Study|Took No Study Drug|2|||
124781570|NCT00505778|448831101|FG001|Overall Study|Took No Study Drug|2|||
124781571|NCT02136069|448831103|FG000|Overall Study|UC flare-up|1|||
124781572|NCT02136069|448831104|FG001|Overall Study|UC flare-up|0|||
124781573|NCT02136069|448831103|FG000|Overall Study|Adverse Event|6|||
124781574|NCT02136069|448831104|FG001|Overall Study|Adverse Event|8|||
124781575|NCT02136069|448831103|FG000|Overall Study|Death|0|||
124781576|NCT02136069|448831104|FG001|Overall Study|Death|1|||
124781577|NCT02136069|448831103|FG000|Overall Study|Lack of Efficacy|10|||
124781578|NCT02136069|448831104|FG001|Overall Study|Lack of Efficacy|4|||
124781579|NCT02136069|448831103|FG000|Overall Study|Lost to Follow-up|1|||
124781580|NCT02136069|448831104|FG001|Overall Study|Lost to Follow-up|0|||
124781581|NCT02136069|448831103|FG000|Overall Study|Non-Compliance|1|||
124781582|NCT02136069|448831104|FG001|Overall Study|Non-Compliance|0|||
124737293|NCT02689076|448660814|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
124737294|NCT02689076|448660815|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
124737295|NCT02689076|448660813|FG000|Overall Study|Participant no longer active in VA system|1|||
124737296|NCT02689076|448660814|FG001|Overall Study|Participant no longer active in VA system|0|||
124781583|NCT02136069|448831103|FG000|Overall Study|Physician Decision|5|||
124781584|NCT02136069|448831104|FG001|Overall Study|Physician Decision|4|||
124781585|NCT02136069|448831103|FG000|Overall Study|Withdrawal by Subject|10|||
124781586|NCT02136069|448831104|FG001|Overall Study|Withdrawal by Subject|11|||
124781587|NCT01092546|448831105|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
124781588|NCT01667419|448831106|FG000|Overall Study|Reason Not Specified|1|||
124737297|NCT02689076|448660815|FG002|Overall Study|Participant no longer active in VA system|0|||
124737298|NCT02689076|448660813|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
124737299|NCT02689076|448660814|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
124737300|NCT02689076|448660815|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
124737301|NCT01143896|448660817|FG000|Overall Study|Did not complete Baseline Interview|5|||
124737302|NCT01143896|448660818|FG001|Overall Study|Did not complete Baseline Interview|4|||
124737303|NCT01143896|448660817|FG000|Overall Study|Lost to Follow-up|18|||
124737304|NCT01143896|448660818|FG001|Overall Study|Lost to Follow-up|13|||
124737305|NCT01143896|448660817|FG000|Overall Study|Withdrawal by Subject|13|||
124737306|NCT01143896|448660818|FG001|Overall Study|Withdrawal by Subject|5|||
124737307|NCT01143896|448660817|FG000|Overall Study|Death|6|||
124737308|NCT01143896|448660818|FG001|Overall Study|Death|3|||
124737309|NCT02084238|448660819|FG000|Overall Study|Lost to Follow-up|2|||
124737310|NCT00320372|448660820|FG000|Overall Study|Physician Decision|4|||
124737311|NCT00320372|448660821|FG001|Overall Study|Physician Decision|7|||
124737312|NCT00320372|448660820|FG000|Overall Study|Death|7|||
124737313|NCT00320372|448660821|FG001|Overall Study|Death|8|||
124737314|NCT00320372|448660820|FG000|Overall Study|Withdrawal by Subject|55|||
124737315|NCT00320372|448660821|FG001|Overall Study|Withdrawal by Subject|37|||
124737316|NCT00320372|448660820|FG000|Overall Study|Non-Compliance|40|||
124737317|NCT00320372|448660821|FG001|Overall Study|Non-Compliance|39|||
124737318|NCT00320372|448660820|FG000|Overall Study|Did not Meet (I/E)|3|||
124737319|NCT00320372|448660821|FG001|Overall Study|Did not Meet (I/E)|1|||
124737320|NCT00320372|448660820|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
124737321|NCT00320372|448660821|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
124737322|NCT00849875|448660822|FG000|Overall Study|Death|28|||
124737323|NCT00849875|448660822|FG000|Overall Study|Ongoing (unknown completion status)|11|||
124737324|NCT00849875|448660822|FG000|Overall Study|Others|6|||
124737325|NCT00849875|448660822|FG000|Overall Study|Lost to Follow-up|2|||
124737326|NCT00086502|448660823|FG000|Overall Study|Adverse Event|11|||
124737327|NCT00086502|448660824|FG001|Overall Study|Adverse Event|2|||
124737328|NCT00086502|448660823|FG000|Overall Study|Lack of Efficacy|0|||
124737329|NCT00086502|448660824|FG001|Overall Study|Lack of Efficacy|2|||
124737330|NCT00086502|448660823|FG000|Overall Study|Lost to Follow-up|3|||
124737331|NCT00086502|448660824|FG001|Overall Study|Lost to Follow-up|1|||
124737332|NCT00086502|448660823|FG000|Overall Study|Physician Decision|1|||
124737333|NCT00086502|448660824|FG001|Overall Study|Physician Decision|1|||
124737334|NCT00086502|448660823|FG000|Overall Study|Pregnancy|0|||
124737335|NCT00086502|448660824|FG001|Overall Study|Pregnancy|1|||
124737336|NCT00086502|448660823|FG000|Overall Study|Protocol Violation|3|||
124737337|NCT00086502|448660824|FG001|Overall Study|Protocol Violation|3|||
124737338|NCT00086502|448660823|FG000|Overall Study|Withdrawal by Subject|5|||
124737339|NCT00086502|448660824|FG001|Overall Study|Withdrawal by Subject|6|||
124737340|NCT00086502|448660823|FG000|Overall Study|Patient Moved|1|||
124737341|NCT00086502|448660824|FG001|Overall Study|Patient Moved|1|||
124737342|NCT00086502|448660823|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
124737343|NCT00086502|448660824|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
124612606|NCT03583086|448200445|FG003|Overall Study|Still on study|1|||
124612607|NCT03583086|448200446|FG004|Overall Study|Still on study|0|||
124612608|NCT03583086|448200447|FG005|Overall Study|Still on study|0|||
124612609|NCT03583086|448200448|FG006|Overall Study|Still on study|1|||
124612610|NCT03583086|448200442|FG000|Overall Study|Disease progression|0|||
124612611|NCT03583086|448200443|FG001|Overall Study|Disease progression|0|||
124612612|NCT03583086|448200444|FG002|Overall Study|Disease progression|0|||
124612613|NCT03583086|448200445|FG003|Overall Study|Disease progression|0|||
124612614|NCT03583086|448200446|FG004|Overall Study|Disease progression|0|||
124612615|NCT03583086|448200447|FG005|Overall Study|Disease progression|0|||
124612616|NCT03583086|448200448|FG006|Overall Study|Disease progression|1|||
124612617|NCT03583086|448200442|FG000|Overall Study|Undergoing radiation therapy|0|||
124612618|NCT03583086|448200443|FG001|Overall Study|Undergoing radiation therapy|0|||
124612619|NCT03583086|448200444|FG002|Overall Study|Undergoing radiation therapy|0|||
124612620|NCT03583086|448200445|FG003|Overall Study|Undergoing radiation therapy|0|||
124612621|NCT03583086|448200446|FG004|Overall Study|Undergoing radiation therapy|0|||
124612622|NCT03583086|448200447|FG005|Overall Study|Undergoing radiation therapy|0|||
124612623|NCT03583086|448200448|FG006|Overall Study|Undergoing radiation therapy|1|||
124612624|NCT03583086|448200442|FG000|Overall Study|Lost to Follow-up|0|||
124737344|NCT00086502|448660823|FG000|Overall Study|Patient Accidentally Unblinded|1|||
124737345|NCT00086502|448660824|FG001|Overall Study|Patient Accidentally Unblinded|0|||
124737346|NCT01304329|448660825|FG000|Third Intervention (3 Days)|Adverse Event|0|||
124737347|NCT01304329|448660826|FG001|Third Intervention (3 Days)|Adverse Event|1|||
124612625|NCT03583086|448200443|FG001|Overall Study|Lost to Follow-up|0|||
124612626|NCT03583086|448200444|FG002|Overall Study|Lost to Follow-up|0|||
124612627|NCT03583086|448200445|FG003|Overall Study|Lost to Follow-up|0|||
124612628|NCT03583086|448200446|FG004|Overall Study|Lost to Follow-up|0|||
124737348|NCT01304329|448660827|FG002|Third Intervention (3 Days)|Adverse Event|0|||
124737349|NCT01304329|448660828|FG003|Third Intervention (3 Days)|Adverse Event|0|||
124737350|NCT01304329|448660829|FG004|Third Intervention (3 Days)|Adverse Event|0|||
124737351|NCT01304329|448660830|FG005|Third Intervention (3 Days)|Adverse Event|0|||
124737352|NCT02068118|448660838|FG000|18-month Comparative Study Period|Death|90|||
124737353|NCT02068118|448660839|FG001|18-month Comparative Study Period|Death|97|||
124737354|NCT02068118|448660838|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
124737355|NCT02068118|448660839|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
124737356|NCT02068118|448660838|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
124737357|NCT02068118|448660839|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
124737358|NCT02068118|448660838|FG000|18-month Comparative Study Period|Heart transplant|9|||
124737359|NCT02068118|448660839|FG001|18-month Comparative Study Period|Heart transplant|15|||
124737360|NCT02068118|448660838|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
124737361|NCT02068118|448660839|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
124737362|NCT02068118|448660838|FG000|18-month Comparative Study Period|Hemiplegia|0|||
124737363|NCT02068118|448660839|FG001|18-month Comparative Study Period|Hemiplegia|1|||
124737364|NCT02068118|448660838|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
124737365|NCT02068118|448660839|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
124737366|NCT02068118|448660838|FG000|18-month Comparative Study Period|Move|0|||
124737367|NCT02068118|448660839|FG001|18-month Comparative Study Period|Move|1|||
124737368|NCT02068118|448660838|FG000|18-month Comparative Study Period|Hearing loss|0|||
124737369|NCT02068118|448660839|FG001|18-month Comparative Study Period|Hearing loss|1|||
124737370|NCT02068118|448660838|FG000|Extension Period|Death|0|||
124737371|NCT02068118|448660839|FG001|Extension Period|Death|2|||
124737372|NCT02068118|448660838|FG000|Extension Period|Withdrawal by Subject|1|||
124737373|NCT02068118|448660839|FG001|Extension Period|Withdrawal by Subject|0|||
124737374|NCT02068118|448660838|FG000|Extension Period|Heart transplant|1|||
124737375|NCT02068118|448660839|FG001|Extension Period|Heart transplant|0|||
124737376|NCT02068118|448660838|FG000|Extension Period|Wrong device use|0|||
124737377|NCT02068118|448660839|FG001|Extension Period|Wrong device use|1|||
124737378|NCT00283868|448660840|FG000|Overall Study|Lost to Follow-up|7|||
124737379|NCT00283868|448660841|FG001|Overall Study|Lost to Follow-up|8|||
124737380|NCT01515475|448660842|FG000|Overall Study|Lost to Follow-up|20|||
124737381|NCT01515475|448660843|FG001|Overall Study|Lost to Follow-up|15|||
124737382|NCT01515475|448660844|FG002|Overall Study|Lost to Follow-up|12|||
124737383|NCT01515475|448660845|FG003|Overall Study|Lost to Follow-up|12|||
124737384|NCT01420627|448660846|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
124737385|NCT00837876|448660847|FG000|Overall Study|Death|2|||
124737386|NCT00837876|448660847|FG000|Overall Study|Adverse Event|7|||
124737387|NCT00837876|448660847|FG000|Overall Study|Physician Decision|1|||
124737388|NCT00837876|448660847|FG000|Overall Study|Withdrawal by Subject|3|||
124737389|NCT00837876|448660847|FG000|Overall Study|disease progression|24|||
124737390|NCT00453973|448660848|FG000|Overall Study|Adverse Event|4|||
124737391|NCT00453973|448660849|FG001|Overall Study|Adverse Event|9|||
124737392|NCT00453973|448660848|FG000|Overall Study|Withdrawal by Subject|7|||
124737393|NCT00453973|448660849|FG001|Overall Study|Withdrawal by Subject|6|||
124737394|NCT00453973|448660848|FG000|Overall Study|PI Decision|0|||
124737395|NCT00453973|448660849|FG001|Overall Study|PI Decision|2|||
124737396|NCT00453973|448660848|FG000|Overall Study|Relocation|1|||
124737397|NCT00453973|448660849|FG001|Overall Study|Relocation|0|||
124737398|NCT00453973|448660848|FG000|Overall Study|Renal transplant|1|||
124737399|NCT00453973|448660849|FG001|Overall Study|Renal transplant|1|||
124737400|NCT00453973|448660848|FG000|Overall Study|Site closed by sponsor|3|||
124737401|NCT00453973|448660849|FG001|Overall Study|Site closed by sponsor|0|||
124737402|NCT00453973|448660848|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
124737403|NCT00453973|448660849|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
124737404|NCT00276094|448660850|FG000|Overall Study|Adverse Event|15|||
124737405|NCT00276094|448660851|FG001|Overall Study|Adverse Event|13|||
124737406|NCT00276094|448660852|FG002|Overall Study|Adverse Event|11|||
124737407|NCT00276094|448660850|FG000|Overall Study|Withdrawal by Subject|14|||
124737408|NCT00276094|448660851|FG001|Overall Study|Withdrawal by Subject|14|||
124737409|NCT00276094|448660852|FG002|Overall Study|Withdrawal by Subject|12|||
124737410|NCT00276094|448660850|FG000|Overall Study|Protocol Violation|16|||
124737411|NCT00276094|448660851|FG001|Overall Study|Protocol Violation|7|||
124737412|NCT00276094|448660852|FG002|Overall Study|Protocol Violation|10|||
124737413|NCT00276094|448660850|FG000|Overall Study|Lost to Follow-up|8|||
124737414|NCT00276094|448660851|FG001|Overall Study|Lost to Follow-up|6|||
124737415|NCT00276094|448660852|FG002|Overall Study|Lost to Follow-up|4|||
124737416|NCT00276094|448660850|FG000|Overall Study|Other-Subject moved out of country|1|||
124737417|NCT00276094|448660851|FG001|Overall Study|Other-Subject moved out of country|0|||
124737418|NCT00276094|448660852|FG002|Overall Study|Other-Subject moved out of country|0|||
124737419|NCT00276094|448660850|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
124737420|NCT00276094|448660851|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
124737421|NCT00276094|448660852|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
124737422|NCT00276094|448660850|FG000|Overall Study|Other-Lack of efficacy|1|||
124737423|NCT00276094|448660851|FG001|Overall Study|Other-Lack of efficacy|0|||
124737424|NCT00276094|448660852|FG002|Overall Study|Other-Lack of efficacy|0|||
124737425|NCT00276094|448660850|FG000|Overall Study|Other-Refused follow-up visit|1|||
124737426|NCT00276094|448660851|FG001|Overall Study|Other-Refused follow-up visit|0|||
124737427|NCT00276094|448660852|FG002|Overall Study|Other-Refused follow-up visit|0|||
124737428|NCT00276094|448660850|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
124737429|NCT00276094|448660851|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
124737430|NCT00276094|448660852|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
124737431|NCT00276094|448660850|FG000|Overall Study|Other-Relocation|0|||
124737432|NCT00276094|448660851|FG001|Overall Study|Other-Relocation|1|||
124737433|NCT00276094|448660852|FG002|Overall Study|Other-Relocation|0|||
124737434|NCT00276094|448660850|FG000|Overall Study|Other-Study medication lost|0|||
124737435|NCT00276094|448660851|FG001|Overall Study|Other-Study medication lost|0|||
124737436|NCT00276094|448660852|FG002|Overall Study|Other-Study medication lost|1|||
124737437|NCT02075632|448660857|FG000|Overall Study|Adverse Event|1|||
124737438|NCT02075632|448660858|FG001|Overall Study|Adverse Event|1|||
124737439|NCT02075632|448660857|FG000|Overall Study|Lost to Follow-up|0|||
124737440|NCT02075632|448660858|FG001|Overall Study|Lost to Follow-up|3|||
124737441|NCT02075632|448660857|FG000|Overall Study|Withdrawal by Subject|0|||
124737442|NCT02075632|448660858|FG001|Overall Study|Withdrawal by Subject|1|||
124737443|NCT05028517|448660859|FG000|Overall Study|Lost to Follow-up|13|||
124737444|NCT05028517|448660860|FG001|Overall Study|Lost to Follow-up|20|||
124737445|NCT05028517|448660861|FG002|Overall Study|Lost to Follow-up|12|||
124737446|NCT05028517|448660859|FG000|Overall Study|Withdrawal by Subject|0|||
124737447|NCT05028517|448660860|FG001|Overall Study|Withdrawal by Subject|0|||
124737448|NCT05028517|448660861|FG002|Overall Study|Withdrawal by Subject|1|||
124737449|NCT02256267|448660862|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
124737450|NCT02256267|448660862|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
124737451|NCT00259298|448660869|FG000|Overall Study|Withdrawal by Subject|1|||
124737452|NCT00259298|448660869|FG000|Overall Study|Physician Decision|2|||
124737453|NCT01969500|448660875|FG000|Overall Study|Death|0|||
124737454|NCT01969500|448660876|FG001|Overall Study|Death|1|||
124737455|NCT01969500|448660875|FG000|Overall Study|extended hospitalization|1|||
124737456|NCT01969500|448660876|FG001|Overall Study|extended hospitalization|1|||
124737457|NCT00613080|448660877|FG000|Overall Study|Ineligible / no protocol treatment|11|||
124737458|NCT03553498|448660878|FG000|Overall Study|Missing primary outcome|1|||
124737459|NCT03553498|448660879|FG001|Overall Study|Missing primary outcome|2|||
124737460|NCT01100567|448660880|FG000|Overall Study|Withdrawal by Subject|5|||
124737461|NCT01100567|448660881|FG001|Overall Study|Withdrawal by Subject|8|||
124737462|NCT01100567|448660880|FG000|Overall Study|Early Hospital Discharge|6|||
124737463|NCT01100567|448660881|FG001|Overall Study|Early Hospital Discharge|4|||
124737464|NCT01100567|448660880|FG000|Overall Study|Lost to Follow-up|1|||
124737465|NCT01100567|448660881|FG001|Overall Study|Lost to Follow-up|2|||
124737466|NCT01100567|448660880|FG000|Overall Study|Physician Decision|0|||
124737467|NCT01100567|448660881|FG001|Overall Study|Physician Decision|1|||
124737468|NCT01100567|448660880|FG000|Overall Study|Deemed ineligible after consent|0|||
124737469|NCT01100567|448660881|FG001|Overall Study|Deemed ineligible after consent|1|||
124737470|NCT02741570|448660882|FG000|Pre-Treatment Period|Other reasons|0|||
124737471|NCT02741570|448660883|FG001|Pre-Treatment Period|Other reasons|3|||
124737472|NCT02741570|448660882|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
124737473|NCT02741570|448660883|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
124737474|NCT02741570|448660882|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
124737475|NCT02741570|448660883|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
124737476|NCT02741570|448660882|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
124737477|NCT02741570|448660883|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
124737478|NCT02741570|448660882|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
124737479|NCT02741570|448660883|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
124737480|NCT02741570|448660882|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
124737481|NCT02741570|448660883|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
124737482|NCT02741570|448660882|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
124737483|NCT02741570|448660883|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
124737484|NCT02741570|448660882|FG000|Pre-Treatment Period|Death|0|||
124737485|NCT02741570|448660883|FG001|Pre-Treatment Period|Death|1|||
124737486|NCT02741570|448660882|FG000|Pre-Treatment Period|Disease progression|0|||
124781589|NCT01667419|448831107|FG001|Overall Study|Reason Not Specified|0|||
124737487|NCT02741570|448660883|FG001|Pre-Treatment Period|Disease progression|1|||
124737488|NCT02741570|448660882|FG000|Treatment Period|Other reasons|47|||
124737489|NCT02741570|448660883|FG001|Treatment Period|Other reasons|12|||
124737490|NCT02741570|448660882|FG000|Treatment Period|Poor/non-compliance|0|||
124737491|NCT02741570|448660883|FG001|Treatment Period|Poor/non-compliance|2|||
124737492|NCT02741570|448660882|FG000|Treatment Period|Maximum clinical benefit|4|||
124737493|NCT02741570|448660883|FG001|Treatment Period|Maximum clinical benefit|6|||
124737494|NCT02741570|448660882|FG000|Treatment Period|Lost to Follow-up|1|||
124737495|NCT02741570|448660883|FG001|Treatment Period|Lost to Follow-up|3|||
124737496|NCT02741570|448660882|FG000|Treatment Period|Participant withdrew consent|9|||
124781590|NCT01667419|448831108|FG002|Overall Study|Reason Not Specified|0|||
124781591|NCT01667419|448831109|FG003|Overall Study|Reason Not Specified|0|||
124737497|NCT02741570|448660883|FG001|Treatment Period|Participant withdrew consent|13|||
124737498|NCT02741570|448660882|FG000|Treatment Period|Participant request to discontinue treatment|8|||
124737499|NCT02741570|448660883|FG001|Treatment Period|Participant request to discontinue treatment|23|||
124737500|NCT02741570|448660882|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
124737501|NCT02741570|448660883|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
124737502|NCT02741570|448660882|FG000|Treatment Period|Death|9|||
124737503|NCT02741570|448660883|FG001|Treatment Period|Death|7|||
124737504|NCT02741570|448660882|FG000|Treatment Period|Study drug toxicity|55|||
124737505|NCT02741570|448660883|FG001|Treatment Period|Study drug toxicity|47|||
124737506|NCT02741570|448660882|FG000|Treatment Period|Disease progression|294|||
124737507|NCT02741570|448660883|FG001|Treatment Period|Disease progression|301|||
124737508|NCT02741570|448660882|FG000|Treatment Period|Administrative reason by sponsor|0|||
124737509|NCT02741570|448660883|FG001|Treatment Period|Administrative reason by sponsor|1|||
124737510|NCT00160199|448660885|FG000|Overall Study|Adverse Event|5|||
124737511|NCT00160199|448660886|FG001|Overall Study|Adverse Event|14|||
124737512|NCT00160199|448660885|FG000|Overall Study|Lack of Efficacy|0|||
124737513|NCT00160199|448660886|FG001|Overall Study|Lack of Efficacy|1|||
124737514|NCT00160199|448660885|FG000|Overall Study|Lost to Follow-up|7|||
124737515|NCT00160199|448660886|FG001|Overall Study|Lost to Follow-up|7|||
124737516|NCT00160199|448660885|FG000|Overall Study|Withdrawal by Subject|4|||
124737517|NCT00160199|448660886|FG001|Overall Study|Withdrawal by Subject|6|||
124737518|NCT00160199|448660885|FG000|Overall Study|Administrative|0|||
124737519|NCT00160199|448660886|FG001|Overall Study|Administrative|1|||
124737520|NCT00160199|448660885|FG000|Overall Study|Protocol Violation|8|||
124737521|NCT00160199|448660886|FG001|Overall Study|Protocol Violation|8|||
124737522|NCT03352453|448660887|FG000|Overall Study|Miscellaneous Reasons|1|||
124737523|NCT03352453|448660888|FG001|Overall Study|Miscellaneous Reasons|2|||
124737524|NCT03352453|448660887|FG000|Overall Study|Lack of Efficacy|1|||
124737525|NCT03352453|448660888|FG001|Overall Study|Lack of Efficacy|0|||
124737526|NCT03352453|448660887|FG000|Overall Study|Withdrawal by Subject|8|||
124737527|NCT03352453|448660888|FG001|Overall Study|Withdrawal by Subject|14|||
124737528|NCT03352453|448660887|FG000|Overall Study|Study Terminated by Sponsor|2|||
124737529|NCT03352453|448660888|FG001|Overall Study|Study Terminated by Sponsor|1|||
124737530|NCT03352453|448660887|FG000|Overall Study|Protocol Deviation|1|||
124737531|NCT03352453|448660888|FG001|Overall Study|Protocol Deviation|0|||
124737532|NCT03352453|448660887|FG000|Overall Study|Lost to Follow-up|7|||
124737533|NCT03352453|448660888|FG001|Overall Study|Lost to Follow-up|6|||
124737534|NCT03352453|448660887|FG000|Overall Study|Adverse Event|2|||
124737535|NCT03352453|448660888|FG001|Overall Study|Adverse Event|9|||
124737536|NCT01241760|448660889|FG000|Overall Study|Adverse Event|1|||
124737537|NCT01241760|448660890|FG001|Overall Study|Adverse Event|0|||
124737538|NCT01241760|448660889|FG000|Overall Study|Lost to Follow-up|18|||
124737539|NCT01241760|448660890|FG001|Overall Study|Lost to Follow-up|22|||
124737540|NCT01241760|448660889|FG000|Overall Study|Withdrawal by Subject|13|||
124737541|NCT01241760|448660890|FG001|Overall Study|Withdrawal by Subject|13|||
124737542|NCT01241760|448660889|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
124737543|NCT01241760|448660890|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
124737544|NCT01241760|448660889|FG000|Overall Study|Other|1|||
124737545|NCT01241760|448660890|FG001|Overall Study|Other|1|||
124737546|NCT03689244|448660893|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
124737547|NCT03689244|448660894|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
124737548|NCT03689244|448660895|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
124737549|NCT03689244|448660896|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
124737550|NCT03689244|448660893|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
124737551|NCT03689244|448660894|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
124737552|NCT03689244|448660895|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
124737553|NCT03689244|448660896|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
124737554|NCT03689244|448660893|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
124737555|NCT03689244|448660894|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
124737556|NCT03689244|448660895|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
124737557|NCT03689244|448660896|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
124737558|NCT03689244|448660893|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
124737559|NCT03689244|448660894|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
124612629|NCT03583086|448200447|FG005|Overall Study|Lost to Follow-up|1|||
124737560|NCT03689244|448660895|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
124737561|NCT03689244|448660896|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
124737562|NCT03689244|448660893|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
124737563|NCT03689244|448660894|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
124737564|NCT03689244|448660895|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
124737565|NCT03689244|448660896|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
124737566|NCT03689244|448660893|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
124737567|NCT03689244|448660894|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
124737568|NCT03689244|448660895|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
124737569|NCT03689244|448660896|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
124737570|NCT03689244|448660893|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
124737571|NCT03689244|448660894|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
124737572|NCT03689244|448660895|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
124737573|NCT03689244|448660896|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
124737574|NCT03689244|448660893|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
124737575|NCT03689244|448660894|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
124737576|NCT03689244|448660895|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
124737577|NCT03689244|448660896|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
124737578|NCT03697993|448660905|FG000|Overall Study|Became Ineligible after Enrollment|1|||
124737579|NCT03697993|448660906|FG001|Overall Study|Became Ineligible after Enrollment|3|||
124737580|NCT03697993|448660905|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
124737581|NCT03697993|448660906|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
124737582|NCT03697993|448660905|FG000|Overall Study|Lost to Follow-up|3|||
124737583|NCT03697993|448660906|FG001|Overall Study|Lost to Follow-up|0|||
124737584|NCT03697993|448660905|FG000|Overall Study|Physician Decision|4|||
124737585|NCT03697993|448660906|FG001|Overall Study|Physician Decision|0|||
124737586|NCT03697993|448660905|FG000|Overall Study|Initial Urine Culture Negative|0|||
124737587|NCT03697993|448660906|FG001|Overall Study|Initial Urine Culture Negative|1|||
124737588|NCT03759041|448660907|FG000|Overall Study|Withdrawal by Subject|4|||
124737589|NCT03759041|448660908|FG001|Overall Study|Withdrawal by Subject|10|||
124737590|NCT03759041|448660909|FG002|Overall Study|Withdrawal by Subject|10|||
124737591|NCT03759041|448660907|FG000|Overall Study|Adverse Event|1|||
124737592|NCT03759041|448660908|FG001|Overall Study|Adverse Event|3|||
124737593|NCT03759041|448660909|FG002|Overall Study|Adverse Event|4|||
124737594|NCT03759041|448660907|FG000|Overall Study|Lack of Efficacy|0|||
124737595|NCT03759041|448660908|FG001|Overall Study|Lack of Efficacy|0|||
124737596|NCT03759041|448660909|FG002|Overall Study|Lack of Efficacy|1|||
124737597|NCT03759041|448660907|FG000|Overall Study|Study Terminated by Sponsor|15|||
124737598|NCT03759041|448660908|FG001|Overall Study|Study Terminated by Sponsor|16|||
124737599|NCT03759041|448660909|FG002|Overall Study|Study Terminated by Sponsor|10|||
124737600|NCT03759041|448660907|FG000|Overall Study|Other reason for discontinuation|0|||
124737601|NCT03759041|448660908|FG001|Overall Study|Other reason for discontinuation|2|||
124737602|NCT03759041|448660909|FG002|Overall Study|Other reason for discontinuation|1|||
124737603|NCT03759041|448660907|FG000|Overall Study|Lost to Follow-up|7|||
124737604|NCT03759041|448660908|FG001|Overall Study|Lost to Follow-up|2|||
124737605|NCT03759041|448660909|FG002|Overall Study|Lost to Follow-up|2|||
124737606|NCT03759041|448660907|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
124737607|NCT03759041|448660908|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
124737608|NCT03759041|448660909|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
124737609|NCT04384107|448660910|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
124737610|NCT04384107|448660911|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
124737611|NCT04384107|448660910|FG000|Overall Study|Lost to Follow-up|1|||
124737612|NCT04384107|448660911|FG001|Overall Study|Lost to Follow-up|0|||
124737613|NCT00276614|448660912|FG000|Overall Study|Progression of disease under study|3|||
124737614|NCT01522404|448660915|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
124737615|NCT01522404|448660916|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
124737616|NCT01522404|448660915|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
124737617|NCT01522404|448660916|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
124737618|NCT01522404|448660915|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
124737619|NCT01522404|448660916|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
124737620|NCT02698371|448660917|FG000|All Participants Flow|Lost to Follow-up|3|||
124737621|NCT02698371|448660917|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
124737622|NCT02698371|448660917|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
124737623|NCT02698371|448660917|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
124737624|NCT02698371|448660917|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
124737625|NCT02698371|448660917|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
124737626|NCT02698371|448660917|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
124737627|NCT03734029|448660918|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
124737628|NCT03734029|448660919|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
124737629|NCT03734029|448660918|FG000|Overall Study|Adverse Event|60|||
124737630|NCT03734029|448660919|FG001|Overall Study|Adverse Event|14|||
124737631|NCT03734029|448660918|FG000|Overall Study|Withdrawal by Subject|12|||
124737632|NCT03734029|448660919|FG001|Overall Study|Withdrawal by Subject|11|||
124737633|NCT03734029|448660918|FG000|Overall Study|Clinical progression by investigator|10|||
124737634|NCT03734029|448660919|FG001|Overall Study|Clinical progression by investigator|8|||
124737635|NCT03734029|448660918|FG000|Overall Study|Death|5|||
124737636|NCT03734029|448660919|FG001|Overall Study|Death|2|||
124737637|NCT03734029|448660918|FG000|Overall Study|Physician Decision|4|||
124737638|NCT03734029|448660919|FG001|Overall Study|Physician Decision|3|||
124737639|NCT03734029|448660918|FG000|Overall Study|Other|2|||
124737640|NCT03734029|448660919|FG001|Overall Study|Other|0|||
124737641|NCT03734029|448660918|FG000|Overall Study|Lost to Follow-up|0|||
124737642|NCT03734029|448660919|FG001|Overall Study|Lost to Follow-up|1|||
124737643|NCT03734029|448660918|FG000|Overall Study|Randomized, but not treated|2|||
124737644|NCT03734029|448660919|FG001|Overall Study|Randomized, but not treated|12|||
124737645|NCT03081858|448662426|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
124737646|NCT03081858|448662427|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
124737647|NCT03081858|448662428|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
124737648|NCT03081858|448662429|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
124737649|NCT00664326|448662436|FG000|Overall Study|Adverse Event|14|||
124737650|NCT00664326|448662436|FG000|Overall Study|Noncompliance with study medication|3|||
124737651|NCT00664326|448662436|FG000|Overall Study|Withdrawal by Subject|1|||
124737652|NCT00664326|448662436|FG000|Overall Study|Physician Decision|1|||
124737653|NCT00664326|448662436|FG000|Overall Study|Other Reasons|3|||
124737654|NCT00664326|448662436|FG000|Overall Study|Death|2|||
124737655|NCT00664326|448662436|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
124737656|NCT00262847|448662437|FG000|Overall Study|Disease Progression|309|||
124737657|NCT00262847|448662438|FG001|Overall Study|Disease Progression|274|||
124737658|NCT00262847|448662439|FG002|Overall Study|Disease Progression|195|||
124737659|NCT00262847|448662437|FG000|Overall Study|Patient Refusal|41|||
124737660|NCT00262847|448662438|FG001|Overall Study|Patient Refusal|52|||
124737661|NCT00262847|448662439|FG002|Overall Study|Patient Refusal|47|||
124737662|NCT00262847|448662437|FG000|Overall Study|Adverse Event|74|||
124737663|NCT00262847|448662438|FG001|Overall Study|Adverse Event|88|||
124737664|NCT00262847|448662439|FG002|Overall Study|Adverse Event|108|||
124737665|NCT00262847|448662437|FG000|Overall Study|Death|8|||
124737666|NCT00262847|448662438|FG001|Overall Study|Death|8|||
124737667|NCT00262847|448662439|FG002|Overall Study|Death|11|||
124737668|NCT00262847|448662437|FG000|Overall Study|Concomitant disease|3|||
124737669|NCT00262847|448662438|FG001|Overall Study|Concomitant disease|2|||
124737670|NCT00262847|448662439|FG002|Overall Study|Concomitant disease|4|||
124737671|NCT00262847|448662437|FG000|Overall Study|Other Reasons|79|||
124737672|NCT00262847|448662438|FG001|Overall Study|Other Reasons|88|||
124737673|NCT00262847|448662439|FG002|Overall Study|Other Reasons|27|||
124737674|NCT00262847|448662437|FG000|Overall Study|Did not receive study treatment|4|||
124737675|NCT00262847|448662438|FG001|Overall Study|Did not receive study treatment|1|||
124737676|NCT00262847|448662439|FG002|Overall Study|Did not receive study treatment|4|||
124737677|NCT03966885|448662440|FG000|Overall Study|Death|1|||
124737678|NCT03966885|448662441|FG001|Overall Study|Death|0|||
124737679|NCT03966885|448662440|FG000|Overall Study|Lost to Follow-up|1|||
124737680|NCT03966885|448662441|FG001|Overall Study|Lost to Follow-up|2|||
124737681|NCT03966885|448662440|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
124737682|NCT03966885|448662441|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
124737683|NCT03966885|448662440|FG000|Overall Study|Moved from study area.|0|||
124737684|NCT03966885|448662441|FG001|Overall Study|Moved from study area.|2|||
124737685|NCT03899064|448662456|FG000|Overall Study|Lost to Follow-up|1|||
124737686|NCT03899064|448662456|FG000|Overall Study|Protocol Violation|2|||
124737687|NCT03899064|448662456|FG000|Overall Study|Withdrawal by Subject|2|||
124737688|NCT03899064|448662456|FG000|Overall Study|Other|2|||
124737689|NCT00031460|448662459|FG000|Overall Study|Lost to Follow-up|0|||
124737690|NCT00031460|448662460|FG001|Overall Study|Lost to Follow-up|1|||
124737691|NCT00031460|448662459|FG000|Overall Study|Withdrawal by Subject|1|||
124737692|NCT00031460|448662460|FG001|Overall Study|Withdrawal by Subject|1|||
124737693|NCT00031460|448662459|FG000|Overall Study|Non-Compliant|1|||
124737694|NCT00031460|448662460|FG001|Overall Study|Non-Compliant|1|||
124737695|NCT00031460|448662459|FG000|Overall Study|Death|0|||
124737696|NCT00031460|448662460|FG001|Overall Study|Death|1|||
124737697|NCT00031460|448662459|FG000|Overall Study|Reactivation of Disease|5|||
124737698|NCT00031460|448662460|FG001|Overall Study|Reactivation of Disease|9|||
124737699|NCT00031460|448662459|FG000|Overall Study|Disruption of blinded drug supply|2|||
124737700|NCT00031460|448662460|FG001|Overall Study|Disruption of blinded drug supply|0|||
124737701|NCT00031460|448662459|FG000|Overall Study|Confirmed unevaluable|0|||
124737702|NCT00031460|448662460|FG001|Overall Study|Confirmed unevaluable|1|||
124737703|NCT02210832|448662461|FG000|Overall Study|Pregnancy termination .|3|||
124737704|NCT02210832|448662462|FG001|Overall Study|Pregnancy termination .|4|||
124737705|NCT02210832|448662463|FG002|Overall Study|Pregnancy termination .|1|||
124612630|NCT03583086|448200448|FG006|Overall Study|Lost to Follow-up|0|||
124737706|NCT02210832|448662461|FG000|Overall Study|Lost to Follow-up|26|||
124737707|NCT02210832|448662462|FG001|Overall Study|Lost to Follow-up|32|||
124737708|NCT02210832|448662463|FG002|Overall Study|Lost to Follow-up|17|||
124737709|NCT02080260|448662470|FG000|Overall Study|Death|18|||
124737710|NCT02080260|448662470|FG000|Overall Study|Withdrawal by Subject|1|||
124737711|NCT00471887|448662471|FG000|Overall Study|Adverse Event|9|||
124737712|NCT03602885|448662472|FG000|Overall Study|Lost to Follow-up|3|||
124737713|NCT03602885|448662473|FG001|Overall Study|Lost to Follow-up|0|||
124737714|NCT00098722|448662474|FG000|Double Blind Phase|Adverse Event|7|||
124737715|NCT00098722|448662475|FG001|Double Blind Phase|Adverse Event|7|||
124737716|NCT00098722|448662476|FG002|Double Blind Phase|Adverse Event|3|||
124737717|NCT00098722|448662477|FG003|Double Blind Phase|Adverse Event|0|||
124737718|NCT00098722|448662478|FG004|Double Blind Phase|Adverse Event|0|||
124737719|NCT00098722|448662479|FG005|Double Blind Phase|Adverse Event|0|||
124737720|NCT00098722|448662480|FG006|Double Blind Phase|Adverse Event|0|||
124737721|NCT00098722|448662474|FG000|Double Blind Phase|Death|2|||
124737722|NCT00098722|448662475|FG001|Double Blind Phase|Death|5|||
124737723|NCT00098722|448662476|FG002|Double Blind Phase|Death|0|||
124737724|NCT00098722|448662477|FG003|Double Blind Phase|Death|0|||
124737725|NCT00098722|448662478|FG004|Double Blind Phase|Death|0|||
124737726|NCT00098722|448662479|FG005|Double Blind Phase|Death|0|||
124737727|NCT00098722|448662480|FG006|Double Blind Phase|Death|0|||
124737728|NCT00098722|448662474|FG000|Double Blind Phase|Lack of Efficacy|21|||
124737729|NCT00098722|448662475|FG001|Double Blind Phase|Lack of Efficacy|23|||
124737730|NCT00098722|448662476|FG002|Double Blind Phase|Lack of Efficacy|15|||
124737731|NCT00098722|448662477|FG003|Double Blind Phase|Lack of Efficacy|0|||
124737732|NCT00098722|448662478|FG004|Double Blind Phase|Lack of Efficacy|0|||
124737733|NCT00098722|448662479|FG005|Double Blind Phase|Lack of Efficacy|0|||
124737734|NCT00098722|448662480|FG006|Double Blind Phase|Lack of Efficacy|0|||
124737735|NCT00098722|448662474|FG000|Double Blind Phase|Participant defaulted|16|||
124737736|NCT00098722|448662475|FG001|Double Blind Phase|Participant defaulted|11|||
124737737|NCT00098722|448662476|FG002|Double Blind Phase|Participant defaulted|9|||
124737738|NCT00098722|448662477|FG003|Double Blind Phase|Participant defaulted|0|||
124737739|NCT00098722|448662478|FG004|Double Blind Phase|Participant defaulted|0|||
124737740|NCT00098722|448662479|FG005|Double Blind Phase|Participant defaulted|0|||
124737741|NCT00098722|448662480|FG006|Double Blind Phase|Participant defaulted|0|||
124737742|NCT00098722|448662474|FG000|Double Blind Phase|Pregnancy|1|||
124737743|NCT00098722|448662475|FG001|Double Blind Phase|Pregnancy|0|||
124737744|NCT00098722|448662476|FG002|Double Blind Phase|Pregnancy|0|||
124737745|NCT00098722|448662477|FG003|Double Blind Phase|Pregnancy|0|||
124737746|NCT00098722|448662478|FG004|Double Blind Phase|Pregnancy|0|||
124737747|NCT00098722|448662479|FG005|Double Blind Phase|Pregnancy|0|||
124737748|NCT00098722|448662480|FG006|Double Blind Phase|Pregnancy|0|||
124737749|NCT00098722|448662474|FG000|Double Blind Phase|Randomized, not treated|4|||
124737750|NCT00098722|448662475|FG001|Double Blind Phase|Randomized, not treated|3|||
124737751|NCT00098722|448662476|FG002|Double Blind Phase|Randomized, not treated|3|||
124737752|NCT00098722|448662477|FG003|Double Blind Phase|Randomized, not treated|0|||
124737753|NCT00098722|448662478|FG004|Double Blind Phase|Randomized, not treated|0|||
124737754|NCT00098722|448662479|FG005|Double Blind Phase|Randomized, not treated|0|||
124737755|NCT00098722|448662480|FG006|Double Blind Phase|Randomized, not treated|0|||
124737756|NCT00098722|448662474|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
124737757|NCT00098722|448662475|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
124737758|NCT00098722|448662476|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
124737759|NCT00098722|448662477|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
124737760|NCT00098722|448662478|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
124737761|NCT00098722|448662479|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
124781592|NCT01667419|448831106|FG000|Overall Study|Withdrawal by Subject|16|||
124781593|NCT01667419|448831107|FG001|Overall Study|Withdrawal by Subject|8|||
124612631|NCT03583086|448200442|FG000|Overall Study|Adverse Event|0|||
124612632|NCT03583086|448200443|FG001|Overall Study|Adverse Event|0|||
124612633|NCT03583086|448200444|FG002|Overall Study|Adverse Event|0|||
124612634|NCT03583086|448200445|FG003|Overall Study|Adverse Event|0|||
124737762|NCT00098722|448662480|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
124737763|NCT00098722|448662474|FG000|Double Blind Phase|Other|7|||
124737764|NCT00098722|448662475|FG001|Double Blind Phase|Other|8|||
124737765|NCT00098722|448662476|FG002|Double Blind Phase|Other|7|||
124737766|NCT00098722|448662477|FG003|Double Blind Phase|Other|0|||
124737767|NCT00098722|448662478|FG004|Double Blind Phase|Other|0|||
124737768|NCT00098722|448662479|FG005|Double Blind Phase|Other|0|||
124737769|NCT00098722|448662480|FG006|Double Blind Phase|Other|0|||
124737770|NCT00098722|448662474|FG000|Open Label Phase|Adverse Event|0|||
124737771|NCT00098722|448662475|FG001|Open Label Phase|Adverse Event|0|||
124737772|NCT00098722|448662476|FG002|Open Label Phase|Adverse Event|0|||
124737773|NCT00098722|448662477|FG003|Open Label Phase|Adverse Event|5|||
124737774|NCT00098722|448662478|FG004|Open Label Phase|Adverse Event|0|||
124737775|NCT00098722|448662479|FG005|Open Label Phase|Adverse Event|0|||
124737776|NCT00098722|448662480|FG006|Open Label Phase|Adverse Event|0|||
124737777|NCT00098722|448662474|FG000|Open Label Phase|Death|0|||
124781594|NCT01667419|448831108|FG002|Overall Study|Withdrawal by Subject|9|||
124781595|NCT01667419|448831109|FG003|Overall Study|Withdrawal by Subject|8|||
124612635|NCT03583086|448200446|FG004|Overall Study|Adverse Event|0|||
124737778|NCT00098722|448662475|FG001|Open Label Phase|Death|0|||
124737779|NCT00098722|448662476|FG002|Open Label Phase|Death|0|||
124737780|NCT00098722|448662477|FG003|Open Label Phase|Death|2|||
124737781|NCT00098722|448662478|FG004|Open Label Phase|Death|0|||
124737782|NCT00098722|448662479|FG005|Open Label Phase|Death|0|||
124737783|NCT00098722|448662480|FG006|Open Label Phase|Death|0|||
124737784|NCT00098722|448662474|FG000|Open Label Phase|Lack of Efficacy|0|||
124737785|NCT00098722|448662475|FG001|Open Label Phase|Lack of Efficacy|0|||
124612636|NCT03583086|448200447|FG005|Overall Study|Adverse Event|1|||
124612637|NCT03583086|448200448|FG006|Overall Study|Adverse Event|0|||
124612638|NCT00128830|448200450|FG000|Overall Study|Adverse Event|10|||
124612639|NCT00128830|448200450|FG000|Overall Study|Withdrawal by Subject|14|||
124612640|NCT00128830|448200450|FG000|Overall Study|Lost to Follow-up|4|||
124781596|NCT01667419|448831106|FG000|Overall Study|Non-compliance|0|||
124781597|NCT01667419|448831107|FG001|Overall Study|Non-compliance|0|||
124781598|NCT01667419|448831108|FG002|Overall Study|Non-compliance|0|||
124612641|NCT00128830|448200450|FG000|Overall Study|Reached a virologic endpoint|29|||
124612642|NCT00128830|448200450|FG000|Overall Study|Non-compliant|4|||
124612643|NCT00128830|448200450|FG000|Overall Study|Discontinued or ineligible for study|2|||
124612644|NCT00128830|448200450|FG000|Overall Study|Other|9|||
124612645|NCT02927366|448200452|FG000|Overall Study|Adverse Event|1|||
124612646|NCT02927366|448200453|FG001|Overall Study|Adverse Event|0|||
124612647|NCT02927366|448200452|FG000|Overall Study|Patient schedule|1|||
124612648|NCT02927366|448200453|FG001|Overall Study|Patient schedule|0|||
124612649|NCT00369317|448200457|FG000|Overall Study|Adverse Event|3|||
124612650|NCT00369317|448200457|FG000|Overall Study|Death|1|||
124612651|NCT00369317|448200457|FG000|Overall Study|Lack of Efficacy|5|||
124612652|NCT00369317|448200457|FG000|Overall Study|Physician Decision|2|||
124612653|NCT00369317|448200457|FG000|Overall Study|Withdrawal by Subject|8|||
124612654|NCT00369317|448200457|FG000|Overall Study|Ineligible|1|||
124612655|NCT00426361|448200462|FG000|Overall Study|Lost to Follow-up|3|||
124612656|NCT00426361|448200463|FG001|Overall Study|Lost to Follow-up|2|||
124612657|NCT00426361|448200464|FG002|Overall Study|Lost to Follow-up|5|||
124612658|NCT00426361|448200462|FG000|Overall Study|Withdrawal by Subject|1|||
124612659|NCT00426361|448200463|FG001|Overall Study|Withdrawal by Subject|3|||
124612660|NCT00426361|448200464|FG002|Overall Study|Withdrawal by Subject|0|||
124612661|NCT02478320|448200467|FG000|Overall Study|Adverse Event|2|||
124612662|NCT02478320|448200468|FG001|Overall Study|Adverse Event|0|||
124612663|NCT02478320|448200467|FG000|Overall Study|Death|1|||
124612664|NCT02478320|448200468|FG001|Overall Study|Death|0|||
124612665|NCT02478320|448200467|FG000|Overall Study|Lack of Efficacy|4|||
124612666|NCT02478320|448200468|FG001|Overall Study|Lack of Efficacy|0|||
124612667|NCT02478320|448200467|FG000|Overall Study|Withdrawal by Subject|2|||
124612668|NCT02478320|448200468|FG001|Overall Study|Withdrawal by Subject|0|||
124612669|NCT02478320|448200467|FG000|Overall Study|Screen Failure|3|||
124612670|NCT02478320|448200468|FG001|Overall Study|Screen Failure|0|||
124612671|NCT03185013|448200469|FG000|Overall Study|Withdrawal by Subject|5|||
124612672|NCT03185013|448200470|FG001|Overall Study|Withdrawal by Subject|3|||
124612673|NCT03185013|448200469|FG000|Overall Study|Adverse Event|1|||
124612674|NCT03185013|448200470|FG001|Overall Study|Adverse Event|0|||
124612675|NCT03185013|448200469|FG000|Overall Study|Progressive Disease|1|||
124612676|NCT03185013|448200470|FG001|Overall Study|Progressive Disease|0|||
124612677|NCT03185013|448200469|FG000|Overall Study|Lost to Follow-up|8|||
124612678|NCT03185013|448200470|FG001|Overall Study|Lost to Follow-up|2|||
124612679|NCT03185013|448200469|FG000|Overall Study|Physician Decision|1|||
124612680|NCT03185013|448200470|FG001|Overall Study|Physician Decision|0|||
124612681|NCT03185013|448200469|FG000|Overall Study|Protocol Deviation|2|||
124612682|NCT03185013|448200470|FG001|Overall Study|Protocol Deviation|0|||
124612683|NCT03185013|448200469|FG000|Overall Study|Reason not Specified|3|||
124612684|NCT03185013|448200470|FG001|Overall Study|Reason not Specified|2|||
124612685|NCT03185013|448200469|FG000|Overall Study|Death|1|||
124612686|NCT03185013|448200470|FG001|Overall Study|Death|0|||
124612687|NCT00673387|448200476|FG000|Overall Study|Withdrawal by Subject|15|||
124612688|NCT00673387|448200477|FG001|Overall Study|Withdrawal by Subject|16|||
124612689|NCT00673387|448200478|FG002|Overall Study|Withdrawal by Subject|20|||
124612690|NCT00673387|448200479|FG003|Overall Study|Withdrawal by Subject|16|||
124612691|NCT00673387|448200480|FG004|Overall Study|Withdrawal by Subject|18|||
124612692|NCT00673387|448200481|FG005|Overall Study|Withdrawal by Subject|21|||
124612693|NCT00673387|448200482|FG006|Overall Study|Withdrawal by Subject|15|||
124612694|NCT00673387|448200483|FG007|Overall Study|Withdrawal by Subject|21|||
124612695|NCT00673387|448200476|FG000|Overall Study|Adverse Event|3|||
124612696|NCT00673387|448200477|FG001|Overall Study|Adverse Event|1|||
124612697|NCT00673387|448200478|FG002|Overall Study|Adverse Event|5|||
124612698|NCT00673387|448200479|FG003|Overall Study|Adverse Event|2|||
124612699|NCT00673387|448200480|FG004|Overall Study|Adverse Event|6|||
124612700|NCT00673387|448200481|FG005|Overall Study|Adverse Event|2|||
124612701|NCT00673387|448200482|FG006|Overall Study|Adverse Event|5|||
124612702|NCT00673387|448200483|FG007|Overall Study|Adverse Event|5|||
124612703|NCT00673387|448200476|FG000|Overall Study|Physician Decision|0|||
124781599|NCT01667419|448831109|FG003|Overall Study|Non-compliance|1|||
124612704|NCT00673387|448200477|FG001|Overall Study|Physician Decision|0|||
124612705|NCT00673387|448200478|FG002|Overall Study|Physician Decision|0|||
124612706|NCT00673387|448200479|FG003|Overall Study|Physician Decision|0|||
124612707|NCT00673387|448200480|FG004|Overall Study|Physician Decision|0|||
124612708|NCT00673387|448200481|FG005|Overall Study|Physician Decision|5|||
124612709|NCT00673387|448200482|FG006|Overall Study|Physician Decision|1|||
124612710|NCT00673387|448200483|FG007|Overall Study|Physician Decision|1|||
124612711|NCT00673387|448200476|FG000|Overall Study|Protocol Violation|3|||
124612712|NCT00673387|448200477|FG001|Overall Study|Protocol Violation|0|||
124612713|NCT00673387|448200478|FG002|Overall Study|Protocol Violation|1|||
124612714|NCT00673387|448200479|FG003|Overall Study|Protocol Violation|2|||
124612715|NCT00673387|448200480|FG004|Overall Study|Protocol Violation|0|||
124612716|NCT00673387|448200481|FG005|Overall Study|Protocol Violation|1|||
124612717|NCT00673387|448200482|FG006|Overall Study|Protocol Violation|1|||
124612718|NCT00673387|448200483|FG007|Overall Study|Protocol Violation|3|||
124612719|NCT00673387|448200476|FG000|Overall Study|Lost to Follow-up|8|||
124612720|NCT00673387|448200477|FG001|Overall Study|Lost to Follow-up|6|||
124612721|NCT00673387|448200478|FG002|Overall Study|Lost to Follow-up|5|||
124612722|NCT00673387|448200479|FG003|Overall Study|Lost to Follow-up|6|||
124612723|NCT00673387|448200480|FG004|Overall Study|Lost to Follow-up|6|||
124612724|NCT00673387|448200481|FG005|Overall Study|Lost to Follow-up|5|||
124612725|NCT00673387|448200482|FG006|Overall Study|Lost to Follow-up|8|||
124612726|NCT00673387|448200483|FG007|Overall Study|Lost to Follow-up|5|||
124612727|NCT00960115|448200486|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
124612728|NCT00960115|448200487|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
124612729|NCT02351960|448200488|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
124612730|NCT02351960|448200489|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
124612731|NCT02351960|448200488|FG000|Overall Study|Voluntary Withdrawal|5|||
124612732|NCT02351960|448200489|FG001|Overall Study|Voluntary Withdrawal|4|||
124612733|NCT02351960|448200488|FG000|Overall Study|Significant Protocol Deviation|0|||
124612734|NCT02351960|448200489|FG001|Overall Study|Significant Protocol Deviation|5|||
124612735|NCT00319982|448200490|FG000|Overall Study|Withdrawal by Subject|1|||
124612736|NCT00319982|448200491|FG001|Overall Study|Withdrawal by Subject|0|||
124612737|NCT03480386|448200492|FG000|Overall Study|Did not complete measures at 3-months|17|||
124612738|NCT03480386|448200493|FG001|Overall Study|Did not complete measures at 3-months|14|||
124612739|NCT03480386|448200492|FG000|Overall Study|No baseline measures|11|||
124612740|NCT03480386|448200493|FG001|Overall Study|No baseline measures|14|||
124612741|NCT03480386|448200492|FG000|Overall Study|Death|0|||
124612742|NCT03480386|448200493|FG001|Overall Study|Death|5|||
124612743|NCT03480386|448200492|FG000|Overall Study|Withdrawal by Subject|12|||
124612744|NCT03480386|448200493|FG001|Overall Study|Withdrawal by Subject|8|||
124612745|NCT03480386|448200492|FG000|Overall Study|Lost to Follow-up|2|||
124612746|NCT03480386|448200493|FG001|Overall Study|Lost to Follow-up|1|||
124612747|NCT03480386|448200492|FG000|Overall Study|Complicating disease|0|||
124612748|NCT03480386|448200493|FG001|Overall Study|Complicating disease|1|||
124612749|NCT03480386|448200492|FG000|Overall Study|Disease progression|3|||
124612750|NCT03480386|448200493|FG001|Overall Study|Disease progression|0|||
124612751|NCT03480386|448200492|FG000|Overall Study|Became ineligible|0|||
124612752|NCT03480386|448200493|FG001|Overall Study|Became ineligible|2|||
124612753|NCT01094886|448200494|FG000|Overall Study|Adverse Event|2|||
124612754|NCT01094886|448200494|FG000|Overall Study|Withdrawal by Subject|5|||
124612755|NCT00574912|448200495|FG000|Overall Study|Could not place IV lines.|3|||
124612756|NCT00574912|448200495|FG000|Overall Study|scheduling conflicts|3|||
124612757|NCT00574912|448200495|FG000|Overall Study|Physician Decision|2|||
124612758|NCT03866902|448200497|FG000|Overall Study|Lost to Follow-up|98|||
124612759|NCT03866902|448200498|FG001|Overall Study|Lost to Follow-up|82|||
124612760|NCT03866902|448200497|FG000|Overall Study|Pregnancy|18|||
124612761|NCT03866902|448200498|FG001|Overall Study|Pregnancy|24|||
124612762|NCT02013674|448200504|FG000|Overall Study|Death|0|||
124612763|NCT02013674|448200505|FG001|Overall Study|Death|1|||
124612764|NCT02013674|448200504|FG000|Overall Study|Lost to Follow-up|1|||
124612765|NCT02013674|448200505|FG001|Overall Study|Lost to Follow-up|0|||
124612766|NCT00416884|448200507|FG000|Overall Study|Study terminated due to low accrual|1|||
124612767|NCT04051619|448200509|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
124612768|NCT04051619|448200510|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
124612769|NCT04051619|448200509|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
124612770|NCT04051619|448200510|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
124612771|NCT03610516|448202119|FG000|Treatment Epoch|Adverse Event|3|||
124612772|NCT03610516|448202120|FG001|Treatment Epoch|Adverse Event|1|||
124612773|NCT03610516|448202119|FG000|Treatment Epoch|Death|1|||
124612774|NCT03610516|448202120|FG001|Treatment Epoch|Death|0|||
124612775|NCT03610516|448202119|FG000|Treatment Epoch|Lack of Efficacy|0|||
124612776|NCT03610516|448202120|FG001|Treatment Epoch|Lack of Efficacy|1|||
124612777|NCT03610516|448202119|FG000|Treatment Epoch|No longer requires treatment|1|||
124612778|NCT03610516|448202120|FG001|Treatment Epoch|No longer requires treatment|0|||
124612779|NCT03610516|448202119|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
124612780|NCT03610516|448202120|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
124612781|NCT03610516|448202119|FG000|Treatment Epoch|Physician Decision|8|||
124612782|NCT03610516|448202120|FG001|Treatment Epoch|Physician Decision|5|||
124612783|NCT03610516|448202119|FG000|Treatment Epoch|Protocol Deviation|1|||
124612784|NCT03610516|448202120|FG001|Treatment Epoch|Protocol Deviation|0|||
124612785|NCT03610516|448202119|FG000|Treatment Epoch|Withdrawal by Subject|3|||
124612786|NCT03610516|448202120|FG001|Treatment Epoch|Withdrawal by Subject|1|||
124612787|NCT03610516|448202119|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
124737786|NCT00098722|448662476|FG002|Open Label Phase|Lack of Efficacy|0|||
124737787|NCT00098722|448662477|FG003|Open Label Phase|Lack of Efficacy|8|||
124737788|NCT00098722|448662478|FG004|Open Label Phase|Lack of Efficacy|0|||
124737789|NCT00098722|448662479|FG005|Open Label Phase|Lack of Efficacy|0|||
124737790|NCT00098722|448662480|FG006|Open Label Phase|Lack of Efficacy|0|||
124737791|NCT00098722|448662474|FG000|Open Label Phase|Pregnancy|0|||
124737792|NCT00098722|448662475|FG001|Open Label Phase|Pregnancy|0|||
124737793|NCT00098722|448662476|FG002|Open Label Phase|Pregnancy|0|||
124737794|NCT00098722|448662477|FG003|Open Label Phase|Pregnancy|1|||
124737795|NCT00098722|448662478|FG004|Open Label Phase|Pregnancy|0|||
124737796|NCT00098722|448662479|FG005|Open Label Phase|Pregnancy|0|||
124737797|NCT00098722|448662480|FG006|Open Label Phase|Pregnancy|0|||
124737798|NCT00098722|448662474|FG000|Open Label Phase|Participant defaulted|0|||
124737799|NCT00098722|448662475|FG001|Open Label Phase|Participant defaulted|0|||
124737800|NCT00098722|448662476|FG002|Open Label Phase|Participant defaulted|0|||
124737801|NCT00098722|448662477|FG003|Open Label Phase|Participant defaulted|18|||
124737802|NCT00098722|448662478|FG004|Open Label Phase|Participant defaulted|0|||
124737803|NCT00098722|448662479|FG005|Open Label Phase|Participant defaulted|0|||
124737804|NCT00098722|448662480|FG006|Open Label Phase|Participant defaulted|0|||
124737805|NCT00098722|448662474|FG000|Open Label Phase|Ongoing at cut-off date|0|||
124737806|NCT00098722|448662475|FG001|Open Label Phase|Ongoing at cut-off date|0|||
124737807|NCT00098722|448662476|FG002|Open Label Phase|Ongoing at cut-off date|0|||
124737808|NCT00098722|448662477|FG003|Open Label Phase|Ongoing at cut-off date|220|||
124737809|NCT00098722|448662478|FG004|Open Label Phase|Ongoing at cut-off date|50|||
124737810|NCT00098722|448662479|FG005|Open Label Phase|Ongoing at cut-off date|0|||
124737811|NCT00098722|448662480|FG006|Open Label Phase|Ongoing at cut-off date|0|||
124737812|NCT00098722|448662474|FG000|Open Label Phase|Other|0|||
124737813|NCT00098722|448662475|FG001|Open Label Phase|Other|0|||
124737814|NCT00098722|448662476|FG002|Open Label Phase|Other|0|||
124737815|NCT00098722|448662477|FG003|Open Label Phase|Other|18|||
124737816|NCT00098722|448662478|FG004|Open Label Phase|Other|0|||
124737817|NCT00098722|448662479|FG005|Open Label Phase|Other|0|||
124737818|NCT00098722|448662480|FG006|Open Label Phase|Other|0|||
124737819|NCT00098722|448662474|FG000|Observation Phase|Death|0|||
124737820|NCT00098722|448662475|FG001|Observation Phase|Death|0|||
124737821|NCT00098722|448662476|FG002|Observation Phase|Death|0|||
124737822|NCT00098722|448662477|FG003|Observation Phase|Death|0|||
124737823|NCT00098722|448662478|FG004|Observation Phase|Death|0|||
124737824|NCT00098722|448662479|FG005|Observation Phase|Death|5|||
124737825|NCT00098722|448662480|FG006|Observation Phase|Death|3|||
124737826|NCT00098722|448662474|FG000|Observation Phase|Lack of Efficacy|0|||
124737827|NCT00098722|448662475|FG001|Observation Phase|Lack of Efficacy|0|||
124737828|NCT00098722|448662476|FG002|Observation Phase|Lack of Efficacy|0|||
124737829|NCT00098722|448662477|FG003|Observation Phase|Lack of Efficacy|0|||
124737830|NCT00098722|448662478|FG004|Observation Phase|Lack of Efficacy|0|||
124612788|NCT03610516|448202120|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
124612789|NCT03610516|448202119|FG000|Post-Treatment Follow-up|Death|1|||
124612790|NCT03610516|448202120|FG001|Post-Treatment Follow-up|Death|0|||
124612791|NCT00660907|448202124|FG000|Overall Study|Incorrect Enrollment|1|||
124612792|NCT00660907|448202125|FG001|Overall Study|Incorrect Enrollment|1|||
124612793|NCT00660907|448202124|FG000|Overall Study|Adverse Event|33|||
124612794|NCT00660907|448202125|FG001|Overall Study|Adverse Event|19|||
124612795|NCT00660907|448202124|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
124612796|NCT00660907|448202125|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
124612797|NCT00660907|448202124|FG000|Overall Study|Withdrawal by Subject|23|||
124612798|NCT00660907|448202125|FG001|Overall Study|Withdrawal by Subject|32|||
124612799|NCT00660907|448202124|FG000|Overall Study|Lost to Follow-up|3|||
124737831|NCT00098722|448662479|FG005|Observation Phase|Lack of Efficacy|2|||
124737832|NCT00098722|448662480|FG006|Observation Phase|Lack of Efficacy|0|||
124737833|NCT00098722|448662474|FG000|Observation Phase|Participant defaulted|0|||
124737834|NCT00098722|448662475|FG001|Observation Phase|Participant defaulted|0|||
124737835|NCT00098722|448662476|FG002|Observation Phase|Participant defaulted|0|||
124737836|NCT00098722|448662477|FG003|Observation Phase|Participant defaulted|0|||
124737837|NCT00098722|448662478|FG004|Observation Phase|Participant defaulted|0|||
124737838|NCT00098722|448662479|FG005|Observation Phase|Participant defaulted|17|||
124737839|NCT00098722|448662480|FG006|Observation Phase|Participant defaulted|4|||
124737840|NCT00098722|448662474|FG000|Observation Phase|Other|0|||
124737841|NCT00098722|448662475|FG001|Observation Phase|Other|0|||
124737842|NCT00098722|448662476|FG002|Observation Phase|Other|0|||
124737843|NCT00098722|448662477|FG003|Observation Phase|Other|0|||
124737844|NCT00098722|448662478|FG004|Observation Phase|Other|0|||
124737845|NCT00098722|448662479|FG005|Observation Phase|Other|21|||
124737846|NCT00098722|448662480|FG006|Observation Phase|Other|10|||
124737847|NCT02351349|448662481|FG000|Overall Study|Withdrawal by Subject|2|||
124612800|NCT00660907|448202125|FG001|Overall Study|Lost to Follow-up|3|||
124612801|NCT00660907|448202124|FG000|Overall Study|Poor/Non-Compliance|5|||
124737848|NCT02351349|448662482|FG001|Overall Study|Withdrawal by Subject|3|||
124737849|NCT00440310|448662483|FG000|Overall Study|Lost to Follow-up|4|||
124737850|NCT00440310|448662484|FG001|Overall Study|Lost to Follow-up|5|||
124612802|NCT00660907|448202125|FG001|Overall Study|Poor/Non-Compliance|1|||
124612803|NCT00660907|448202124|FG000|Overall Study|Safety|1|||
124612804|NCT00660907|448202125|FG001|Overall Study|Safety|0|||
124612805|NCT00660907|448202124|FG000|Overall Study|Death|1|||
124612806|NCT00660907|448202125|FG001|Overall Study|Death|3|||
124612807|NCT00660907|448202124|FG000|Overall Study|Various|11|||
124612808|NCT00660907|448202125|FG001|Overall Study|Various|8|||
124612809|NCT02932306|448202146|FG000|Overall Study|Withdrawal by Subject|16|||
124612810|NCT02932306|448202147|FG001|Overall Study|Withdrawal by Subject|25|||
124612811|NCT02932306|448202146|FG000|Overall Study|Adverse Event|3|||
124612812|NCT02932306|448202147|FG001|Overall Study|Adverse Event|0|||
124612813|NCT02932306|448202146|FG000|Overall Study|Pregnancy|2|||
124612814|NCT02932306|448202147|FG001|Overall Study|Pregnancy|0|||
124612815|NCT02932306|448202146|FG000|Overall Study|Protocol Violation|1|||
124612816|NCT02932306|448202147|FG001|Overall Study|Protocol Violation|1|||
124612817|NCT02932306|448202146|FG000|Overall Study|Noncompliance with Study Drug|1|||
124612818|NCT02932306|448202147|FG001|Overall Study|Noncompliance with Study Drug|1|||
124612819|NCT02932306|448202146|FG000|Overall Study|Lost to Follow-up|36|||
124612820|NCT02932306|448202147|FG001|Overall Study|Lost to Follow-up|40|||
124612821|NCT02932306|448202146|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
124737851|NCT00440310|448662483|FG000|Overall Study|Protocol Violation|0|||
124737852|NCT00440310|448662484|FG001|Overall Study|Protocol Violation|1|||
124737853|NCT00440310|448662483|FG000|Overall Study|Withdrawal by Subject|15|||
124737854|NCT00440310|448662484|FG001|Overall Study|Withdrawal by Subject|14|||
124737855|NCT00440310|448662483|FG000|Overall Study|No Reply at EOS|7|||
124737856|NCT00440310|448662484|FG001|Overall Study|No Reply at EOS|7|||
124737857|NCT00440310|448662483|FG000|Overall Study|Other|1|||
124737858|NCT00440310|448662484|FG001|Overall Study|Other|0|||
124737859|NCT00440310|448662483|FG000|Overall Study|Status Unknown|1|||
124737860|NCT00440310|448662484|FG001|Overall Study|Status Unknown|3|||
124737861|NCT01610596|448662491|FG000|Overall Study|Lost to Follow-up|0|||
124737862|NCT01610596|448662492|FG001|Overall Study|Lost to Follow-up|1|||
124737863|NCT01519674|448662493|FG000|Overall Study|Adverse Event|3|||
124737864|NCT01519674|448662494|FG001|Overall Study|Adverse Event|3|||
124737865|NCT01519674|448662495|FG002|Overall Study|Adverse Event|0|||
124737866|NCT01519674|448662493|FG000|Overall Study|Lack of Efficacy|1|||
124737867|NCT01519674|448662494|FG001|Overall Study|Lack of Efficacy|1|||
124737868|NCT01519674|448662495|FG002|Overall Study|Lack of Efficacy|1|||
124737869|NCT01519674|448662493|FG000|Overall Study|Protocol Violation|0|||
124737870|NCT01519674|448662494|FG001|Overall Study|Protocol Violation|3|||
124737871|NCT01519674|448662495|FG002|Overall Study|Protocol Violation|1|||
124737872|NCT01519674|448662493|FG000|Overall Study|Withdrawal Criteria|7|||
124737873|NCT01519674|448662494|FG001|Overall Study|Withdrawal Criteria|2|||
124737874|NCT01519674|448662495|FG002|Overall Study|Withdrawal Criteria|7|||
124737875|NCT01519674|448662493|FG000|Overall Study|Unsclassified|10|||
124737876|NCT01519674|448662494|FG001|Overall Study|Unsclassified|4|||
124737877|NCT01519674|448662495|FG002|Overall Study|Unsclassified|3|||
124737878|NCT00799591|448662496|FG000|Overall Study|De-escalation of doses|20|||
124737879|NCT00799591|448662496|FG000|Overall Study|Death|14|||
124737880|NCT00799591|448662496|FG000|Overall Study|Technical failure|12|||
124737881|NCT00799591|448662496|FG000|Overall Study|Resistant germ|11|||
124737882|NCT00799591|448662496|FG000|Overall Study|New infection|4|||
124737883|NCT00799591|448662496|FG000|Overall Study|Resistance germ and technical failure|2|||
124737884|NCT00799591|448662496|FG000|Overall Study|Persistance of fever undetermined origin|1|||
124737885|NCT00799591|448662496|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
124737886|NCT00799591|448662496|FG000|Overall Study|Infectious origin not probable|1|||
124737887|NCT02317809|448662497|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
124737888|NCT02317809|448662498|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
124737889|NCT02317809|448662497|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
124737890|NCT02317809|448662498|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
124737891|NCT03106415|448662501|FG000|Phase 1|Withdrawal by Subject|1|||
124737892|NCT03106415|448662502|FG001|Phase 1|Withdrawal by Subject|0|||
124781600|NCT01667419|448831106|FG000|Overall Study|Protocol Violation|1|||
124781601|NCT01667419|448831107|FG001|Overall Study|Protocol Violation|0|||
124612822|NCT02932306|448202147|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
124612823|NCT02932306|448202146|FG000|Overall Study|Lack of Efficacy|0|||
124612824|NCT02932306|448202147|FG001|Overall Study|Lack of Efficacy|2|||
124737893|NCT03106415|448662503|FG002|Phase 1|Withdrawal by Subject|0|||
124737894|NCT03106415|448662501|FG000|Phase 1|Adverse Event|1|||
124737895|NCT03106415|448662502|FG001|Phase 1|Adverse Event|1|||
124737896|NCT03106415|448662503|FG002|Phase 1|Adverse Event|0|||
124737897|NCT03106415|448662501|FG000|Phase 1|Protocol Violation|0|||
124737898|NCT03106415|448662502|FG001|Phase 1|Protocol Violation|1|||
124612825|NCT02932306|448202146|FG000|Overall Study|Worsening condition|2|||
124612826|NCT02932306|448202147|FG001|Overall Study|Worsening condition|0|||
124612827|NCT02932306|448202146|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
124612828|NCT02932306|448202147|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
124612829|NCT05776862|448202148|FG000|Overall Study|Adverse Event|0|||
124737899|NCT03106415|448662503|FG002|Phase 1|Protocol Violation|0|||
124737900|NCT00293709|448662504|FG000|Overall Study|Other|47|||
124737901|NCT02785458|448662505|FG000|1 Month|Withdrawal by Subject|2|||
124737902|NCT02785458|448662506|FG001|1 Month|Withdrawal by Subject|1|||
124737903|NCT02785458|448662505|FG000|1 Month|Lost to Follow-up|38|||
124737904|NCT02785458|448662506|FG001|1 Month|Lost to Follow-up|31|||
124737905|NCT02785458|448662505|FG000|1 Month|Deemed Ineligible|1|||
124737906|NCT02785458|448662506|FG001|1 Month|Deemed Ineligible|0|||
124737907|NCT02785458|448662505|FG000|1 Month|Completed Evaluation by Baseline|42|||
124737908|NCT02785458|448662506|FG001|1 Month|Completed Evaluation by Baseline|39|||
124737909|NCT02785458|448662505|FG000|1 Month|Partial Interview|0|||
124737910|NCT02785458|448662506|FG001|1 Month|Partial Interview|4|||
124737911|NCT02785458|448662505|FG000|3 Months|Withdrawal by Subject|3|||
124737912|NCT02785458|448662506|FG001|3 Months|Withdrawal by Subject|1|||
124737913|NCT02785458|448662505|FG000|3 Months|Lost to Follow-up|25|||
124737914|NCT02785458|448662506|FG001|3 Months|Lost to Follow-up|21|||
124737915|NCT02785458|448662505|FG000|3 Months|Completed Evaluation at 1 Month|100|||
124737916|NCT02785458|448662506|FG001|3 Months|Completed Evaluation at 1 Month|89|||
124737917|NCT01804582|448662507|FG000|Overall Study|Lost to Follow-up|47|||
124737918|NCT01804582|448662508|FG001|Overall Study|Lost to Follow-up|56|||
124737919|NCT01804582|448662507|FG000|Overall Study|Physician Decision|2|||
124737920|NCT01804582|448662508|FG001|Overall Study|Physician Decision|0|||
124612830|NCT05776862|448202149|FG001|Overall Study|Adverse Event|1|||
124612831|NCT05776862|448202148|FG000|Overall Study|non-compliance|1|||
124612832|NCT05776862|448202149|FG001|Overall Study|non-compliance|0|||
124612833|NCT01199471|448202150|FG000|Overall Study|Protocol Violation|4|||
124612834|NCT01199471|448202150|FG000|Overall Study|Withdrawal by Subject|1|||
124612835|NCT01199471|448202150|FG000|Overall Study|Physician Decision|1|||
124612836|NCT02065700|448202151|FG000|Overall Study|Adverse Event|165|||
124612837|NCT02065700|448202152|FG001|Overall Study|Adverse Event|101|||
124612838|NCT02065700|448202151|FG000|Overall Study|Withdrawal by Subject|90|||
124612839|NCT02065700|448202152|FG001|Overall Study|Withdrawal by Subject|29|||
124612840|NCT02065700|448202151|FG000|Overall Study|Lost to Follow-up|12|||
124612841|NCT02065700|448202152|FG001|Overall Study|Lost to Follow-up|9|||
124612842|NCT02065700|448202151|FG000|Overall Study|Physician Decision|2|||
124612843|NCT02065700|448202152|FG001|Overall Study|Physician Decision|0|||
124612844|NCT02065700|448202151|FG000|Overall Study|Sponsor Request|38|||
124612845|NCT02065700|448202152|FG001|Overall Study|Sponsor Request|15|||
124612846|NCT02065700|448202151|FG000|Overall Study|Treatment Failure|3|||
124612847|NCT02065700|448202152|FG001|Overall Study|Treatment Failure|2|||
124637765|NCT00300885|448292422|FG001|Treatment|Protocol Violation|11|||
124637766|NCT00300885|448292421|FG000|Treatment|Withdrawal by Subject|26|||
124637767|NCT00300885|448292422|FG001|Treatment|Withdrawal by Subject|23|||
124637768|NCT00300885|448292421|FG000|Treatment|Disease progression|171|||
124637769|NCT00300885|448292422|FG001|Treatment|Disease progression|238|||
124637770|NCT00300885|448292421|FG000|Treatment|Random code broken (subject died)|0|||
124637771|NCT00300885|448292422|FG001|Treatment|Random code broken (subject died)|1|||
124637772|NCT00300885|448292421|FG000|Treatment|Non-compliant with study medication|3|||
124637773|NCT00300885|448292422|FG001|Treatment|Non-compliant with study medication|4|||
124637774|NCT00300885|448292421|FG000|Follow-up|Death|141|||
124637775|NCT00300885|448292422|FG001|Follow-up|Death|163|||
124637776|NCT00300885|448292421|FG000|Follow-up|Lost to Follow-up|11|||
124637777|NCT00300885|448292422|FG001|Follow-up|Lost to Follow-up|7|||
124637778|NCT00300885|448292421|FG000|Follow-up|Withdrawal by Subject|26|||
124637779|NCT00300885|448292422|FG001|Follow-up|Withdrawal by Subject|25|||
124637780|NCT00459290|448292426|FG000|Overall Study|Adverse Event|3|||
124637781|NCT00459290|448292426|FG000|Overall Study|Ineligible|2|||
124637782|NCT02366637|448292427|FG000|First Intervention Period|Adverse Event|0|||
124637783|NCT02366637|448292428|FG001|First Intervention Period|Adverse Event|1|||
124637784|NCT02366637|448292427|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
124637785|NCT02366637|448292428|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
124637786|NCT02366637|448292427|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
124637787|NCT02366637|448292428|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
124637788|NCT02309411|448292429|FG000|Overall Study|Physician Decision|1|||
124637789|NCT02309411|448292430|FG001|Overall Study|Physician Decision|0|||
124637790|NCT02309411|448292431|FG002|Overall Study|Physician Decision|0|||
124637791|NCT02309411|448292429|FG000|Overall Study|Withdrawal by Subject|1|||
124637792|NCT02309411|448292430|FG001|Overall Study|Withdrawal by Subject|1|||
124637793|NCT02309411|448292431|FG002|Overall Study|Withdrawal by Subject|0|||
124637794|NCT02027545|448292432|FG000|Overall Study|Failed to sign HIPAA|0|||
124637795|NCT02027545|448292433|FG001|Overall Study|Failed to sign HIPAA|2|||
124637796|NCT02027545|448292432|FG000|Overall Study|Failed to attend study visit|2|||
124637797|NCT02027545|448292433|FG001|Overall Study|Failed to attend study visit|0|||
124637798|NCT02027545|448292432|FG000|Overall Study|Protocol Violation|1|||
124637799|NCT02027545|448292433|FG001|Overall Study|Protocol Violation|0|||
124637800|NCT02693106|448292436|FG000|Overall Study|No time|3|||
124637801|NCT02509507|448292437|FG000|Overall Study|Death|21|||
124637802|NCT02509507|448292438|FG001|Overall Study|Death|3|||
124737921|NCT00520013|448662509|FG000|Overall Study|Withdrawal by Subject|0|||
124737922|NCT00520013|448662510|FG001|Overall Study|Withdrawal by Subject|0|||
124737923|NCT00520013|448662511|FG002|Overall Study|Withdrawal by Subject|1|||
124737924|NCT00520013|448662509|FG000|Overall Study|Adverse Event|2|||
124737925|NCT00520013|448662510|FG001|Overall Study|Adverse Event|10|||
124737926|NCT00520013|448662511|FG002|Overall Study|Adverse Event|7|||
124737927|NCT00520013|448662509|FG000|Overall Study|Progressive Disease|7|||
124737928|NCT00520013|448662510|FG001|Overall Study|Progressive Disease|3|||
124737929|NCT00520013|448662511|FG002|Overall Study|Progressive Disease|0|||
124737930|NCT00520013|448662509|FG000|Overall Study|Clinical Progression|3|||
124737931|NCT00520013|448662510|FG001|Overall Study|Clinical Progression|1|||
124737932|NCT00520013|448662511|FG002|Overall Study|Clinical Progression|0|||
124737933|NCT00520013|448662509|FG000|Overall Study|Death|0|||
124737934|NCT00520013|448662510|FG001|Overall Study|Death|1|||
124737935|NCT00520013|448662511|FG002|Overall Study|Death|0|||
124737936|NCT00520013|448662509|FG000|Overall Study|Physician Decision|0|||
124737937|NCT00520013|448662510|FG001|Overall Study|Physician Decision|0|||
124737938|NCT00520013|448662511|FG002|Overall Study|Physician Decision|3|||
124737939|NCT02677844|448662512|FG000|Period 3|Withdrawal by Subject|0|||
124737940|NCT02677844|448662513|FG001|Period 3|Withdrawal by Subject|0|||
124737941|NCT02677844|448662514|FG002|Period 3|Withdrawal by Subject|0|||
124737942|NCT02677844|448662515|FG003|Period 3|Withdrawal by Subject|1|||
124737943|NCT02677844|448662516|FG004|Period 3|Withdrawal by Subject|0|||
124737944|NCT02677844|448662517|FG005|Period 3|Withdrawal by Subject|0|||
124737945|NCT02677844|448662518|FG006|Period 3|Withdrawal by Subject|0|||
124737946|NCT01697462|448662519|FG000|Overall Study|Disease Progression|1|||
124737947|NCT01697462|448662519|FG000|Overall Study|Adverse Event|6|||
124737948|NCT01697462|448662519|FG000|Overall Study|Lost to Follow-up|21|||
124737949|NCT01697462|448662519|FG000|Overall Study|Withdrawal by Subject|12|||
124737950|NCT01697462|448662519|FG000|Overall Study|Investigator Decision|21|||
124737951|NCT01697462|448662519|FG000|Overall Study|Death|1|||
124737952|NCT01697462|448662519|FG000|Overall Study|Other|10|||
124737953|NCT01697462|448662519|FG000|Overall Study|Missing|5|||
124737954|NCT03630302|448662520|FG000|Surgery|hardware issue prevented LFP recordings|1|||
124737955|NCT03630302|448662520|FG000|3 Month Visit|Adverse Event|2|||
124737956|NCT03630302|448662520|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
124737957|NCT01135914|448662521|FG000|Overall Study|Withdrawal by Subject|1|||
124737958|NCT01135914|448662522|FG001|Overall Study|Withdrawal by Subject|3|||
124737959|NCT01135914|448662523|FG002|Overall Study|Withdrawal by Subject|6|||
124737960|NCT01135914|448662521|FG000|Overall Study|Lost to Follow-up|1|||
124737961|NCT01135914|448662522|FG001|Overall Study|Lost to Follow-up|0|||
124737962|NCT01135914|448662523|FG002|Overall Study|Lost to Follow-up|1|||
124737963|NCT01135914|448662521|FG000|Overall Study|Protocol Violation|0|||
124737964|NCT01135914|448662522|FG001|Overall Study|Protocol Violation|0|||
124737965|NCT01135914|448662523|FG002|Overall Study|Protocol Violation|3|||
124737966|NCT01135914|448662521|FG000|Overall Study|Lack of Efficacy|2|||
124737967|NCT01135914|448662522|FG001|Overall Study|Lack of Efficacy|1|||
124737968|NCT01135914|448662523|FG002|Overall Study|Lack of Efficacy|10|||
124737969|NCT01135914|448662521|FG000|Overall Study|Adverse Event|0|||
124737970|NCT01135914|448662522|FG001|Overall Study|Adverse Event|1|||
124737971|NCT01135914|448662523|FG002|Overall Study|Adverse Event|2|||
124737972|NCT03532932|448662526|FG000|Overall Study|Protocol Deviation|33|||
124737973|NCT03532932|448662527|FG001|Overall Study|Protocol Deviation|31|||
124612848|NCT02065700|448202151|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
124737974|NCT03532932|448662526|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
124737975|NCT03532932|448662527|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
124737976|NCT03532932|448662526|FG000|Overall Study|Withdrawal by Subject|2|||
124737977|NCT03532932|448662527|FG001|Overall Study|Withdrawal by Subject|0|||
124737978|NCT03532932|448662526|FG000|Overall Study|Lost to Follow-up|15|||
124737979|NCT03532932|448662527|FG001|Overall Study|Lost to Follow-up|9|||
124737980|NCT03532932|448662526|FG000|Overall Study|Adverse Event|4|||
124737981|NCT03532932|448662527|FG001|Overall Study|Adverse Event|3|||
124737982|NCT03532932|448662526|FG000|Overall Study|Death|0|||
124737983|NCT03532932|448662527|FG001|Overall Study|Death|2|||
124737984|NCT03532932|448662526|FG000|Overall Study|Other|11|||
124737985|NCT03532932|448662527|FG001|Overall Study|Other|16|||
124737986|NCT02699450|448662528|FG000|Overall Study|Death|2|||
124737987|NCT02699450|448662529|FG001|Overall Study|Death|1|||
124737988|NCT02699450|448662530|FG002|Overall Study|Death|2|||
124737989|NCT02699450|448662528|FG000|Overall Study|Met Criteria for Study Exit|0|||
124737990|NCT02699450|448662529|FG001|Overall Study|Met Criteria for Study Exit|0|||
124737991|NCT02699450|448662530|FG002|Overall Study|Met Criteria for Study Exit|1|||
124737992|NCT02699450|448662528|FG000|Overall Study|Protocol Violation|4|||
124737993|NCT02699450|448662529|FG001|Overall Study|Protocol Violation|3|||
124737994|NCT02699450|448662530|FG002|Overall Study|Protocol Violation|5|||
124737995|NCT02699450|448662528|FG000|Overall Study|Lost to Follow-up|3|||
124737996|NCT02699450|448662529|FG001|Overall Study|Lost to Follow-up|0|||
124737997|NCT02699450|448662530|FG002|Overall Study|Lost to Follow-up|5|||
124737998|NCT02699450|448662528|FG000|Overall Study|Physician Decision|2|||
124737999|NCT02699450|448662529|FG001|Overall Study|Physician Decision|0|||
124738000|NCT02699450|448662530|FG002|Overall Study|Physician Decision|0|||
124738001|NCT02699450|448662528|FG000|Overall Study|Withdrawal by Subject|3|||
124738002|NCT02699450|448662529|FG001|Overall Study|Withdrawal by Subject|1|||
124738003|NCT02699450|448662530|FG002|Overall Study|Withdrawal by Subject|2|||
124738004|NCT02699450|448662528|FG000|Overall Study|Adverse Event|1|||
124738005|NCT02699450|448662529|FG001|Overall Study|Adverse Event|0|||
124738006|NCT02699450|448662530|FG002|Overall Study|Adverse Event|0|||
124738007|NCT01344629|448662531|FG000|Crossover Period 2|Withdrawal by Subject|0|||
124738008|NCT01344629|448662532|FG001|Crossover Period 2|Withdrawal by Subject|1|||
124738009|NCT00693472|448662538|FG000|Part 1|Adverse Event|1|||
124738010|NCT00693472|448662539|FG001|Part 1|Adverse Event|1|||
124738011|NCT00693472|448662540|FG002|Part 1|Adverse Event|0|||
124738012|NCT00693472|448662541|FG003|Part 1|Adverse Event|0|||
124738013|NCT00693472|448662538|FG000|Part 1|Lost to Follow-up|0|||
124738014|NCT00693472|448662539|FG001|Part 1|Lost to Follow-up|1|||
124738015|NCT00693472|448662540|FG002|Part 1|Lost to Follow-up|0|||
124738016|NCT00693472|448662541|FG003|Part 1|Lost to Follow-up|0|||
124738017|NCT00693472|448662538|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
124738018|NCT00693472|448662539|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
124738019|NCT00693472|448662540|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
124738020|NCT00693472|448662541|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
124738021|NCT00693472|448662538|FG000|Part 2|Adverse Event|0|||
124738022|NCT00693472|448662539|FG001|Part 2|Adverse Event|0|||
124738023|NCT00693472|448662540|FG002|Part 2|Adverse Event|1|||
124738024|NCT00693472|448662541|FG003|Part 2|Adverse Event|0|||
124738025|NCT00693472|448662538|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
124738026|NCT00693472|448662539|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
124738027|NCT00693472|448662540|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
124738028|NCT00693472|448662541|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
124738029|NCT04063787|448662544|FG000|Overall Study|Inadequate Doppler data|4|||
124738030|NCT04063787|448662544|FG000|Overall Study|Lost to Follow-up|2|||
124738031|NCT04063787|448662544|FG000|Overall Study|Death|3|||
124738032|NCT04375397|448662545|FG000|Overall Study|Death|1|||
124738033|NCT04375397|448662546|FG001|Overall Study|Death|1|||
124738034|NCT04375397|448662545|FG000|Overall Study|Withdrew consent|2|||
124738035|NCT04375397|448662546|FG001|Overall Study|Withdrew consent|0|||
124738036|NCT04375397|448662545|FG000|Overall Study|Lost to Follow-up|6|||
124738037|NCT04375397|448662546|FG001|Overall Study|Lost to Follow-up|4|||
124738038|NCT04375397|448662545|FG000|Overall Study|Other, not specified|0|||
124738039|NCT04375397|448662546|FG001|Overall Study|Other, not specified|1|||
124738040|NCT05545644|448662548|FG000|Overall Study|Lost to Follow-up|4|||
124738041|NCT05545644|448662549|FG001|Overall Study|Lost to Follow-up|3|||
124738042|NCT01873729|448662552|FG000|Overall Study|Withdrawal by Subject|1|||
124738043|NCT02463032|448662553|FG000|Overall Study|Lack of Efficacy|61|||
124738044|NCT02463032|448662554|FG001|Overall Study|Lack of Efficacy|50|||
124738045|NCT02463032|448662553|FG000|Overall Study|Death|8|||
124738046|NCT02463032|448662554|FG001|Overall Study|Death|8|||
124738047|NCT02463032|448662553|FG000|Overall Study|Adverse Event|2|||
124738048|NCT02463032|448662554|FG001|Overall Study|Adverse Event|6|||
124738049|NCT01565564|448662560|FG000|Overall Study|Lost to Follow-up|5|||
124738050|NCT01565564|448662561|FG001|Overall Study|Lost to Follow-up|1|||
124738051|NCT01591863|448662563|FG000|Overall Study|Adverse Event|3|||
124738052|NCT01591863|448662563|FG000|Overall Study|Withdrawal by Subject|1|||
124738053|NCT01591863|448662563|FG000|Overall Study|recurrence|9|||
124738054|NCT01591863|448662563|FG000|Overall Study|Lack of Efficacy|1|||
124738055|NCT00969436|448662564|FG000|Overall Study|Protocol Violation|1|||
124738056|NCT00969436|448662565|FG001|Overall Study|Protocol Violation|3|||
124738057|NCT00969436|448662566|FG002|Overall Study|Protocol Violation|0|||
124738058|NCT00969436|448662564|FG000|Overall Study|Migrated/moved from study area|12|||
124738059|NCT00969436|448662565|FG001|Overall Study|Migrated/moved from study area|10|||
124738060|NCT00969436|448662566|FG002|Overall Study|Migrated/moved from study area|2|||
124738061|NCT00969436|448662564|FG000|Overall Study|Father - serious health problem|0|||
124738062|NCT00969436|448662565|FG001|Overall Study|Father - serious health problem|0|||
124738063|NCT00969436|448662566|FG002|Overall Study|Father - serious health problem|1|||
124738064|NCT00969436|448662564|FG000|Overall Study|Parents personal problem|0|||
124738065|NCT00969436|448662565|FG001|Overall Study|Parents personal problem|0|||
124738066|NCT00969436|448662566|FG002|Overall Study|Parents personal problem|1|||
124738067|NCT00969436|448662564|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
124738068|NCT00969436|448662565|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
124738069|NCT00969436|448662566|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
124738070|NCT00969436|448662564|FG000|Overall Study|Withdrawal by Subject|3|||
124738071|NCT00969436|448662565|FG001|Overall Study|Withdrawal by Subject|0|||
124738072|NCT00969436|448662566|FG002|Overall Study|Withdrawal by Subject|2|||
124738073|NCT00969436|448662564|FG000|Overall Study|Lost to Follow-up|8|||
124738074|NCT00969436|448662565|FG001|Overall Study|Lost to Follow-up|8|||
124738075|NCT00969436|448662566|FG002|Overall Study|Lost to Follow-up|5|||
124738076|NCT00459537|448662577|FG000|Overall Study|Adverse Event|1|||
124738077|NCT00459537|448662578|FG001|Overall Study|Adverse Event|6|||
124738078|NCT00459537|448662577|FG000|Overall Study|Lack of Efficacy|10|||
124738079|NCT00459537|448662578|FG001|Overall Study|Lack of Efficacy|11|||
124738080|NCT00459537|448662577|FG000|Overall Study|Withdrawal by Subject|20|||
124738081|NCT00459537|448662578|FG001|Overall Study|Withdrawal by Subject|26|||
124738082|NCT00459537|448662577|FG000|Overall Study|Lost to Follow-up|27|||
124738083|NCT00459537|448662578|FG001|Overall Study|Lost to Follow-up|30|||
124738084|NCT00459537|448662577|FG000|Overall Study|Administrative problems|3|||
124637803|NCT02509507|448292439|FG002|Overall Study|Death|22|||
124637804|NCT02509507|448292440|FG003|Overall Study|Death|14|||
124637805|NCT02509507|448292441|FG004|Overall Study|Death|8|||
124637806|NCT02509507|448292442|FG005|Overall Study|Death|12|||
124637807|NCT02509507|448292443|FG006|Overall Study|Death|5|||
124637808|NCT02509507|448292444|FG007|Overall Study|Death|4|||
124637809|NCT02509507|448292445|FG008|Overall Study|Death|8|||
124637810|NCT02509507|448292437|FG000|Overall Study|Lost to Follow-up|0|||
124637811|NCT02509507|448292438|FG001|Overall Study|Lost to Follow-up|1|||
124637812|NCT02509507|448292439|FG002|Overall Study|Lost to Follow-up|0|||
124637813|NCT02509507|448292440|FG003|Overall Study|Lost to Follow-up|0|||
124637814|NCT02509507|448292441|FG004|Overall Study|Lost to Follow-up|0|||
124637815|NCT02509507|448292442|FG005|Overall Study|Lost to Follow-up|2|||
124637816|NCT02509507|448292443|FG006|Overall Study|Lost to Follow-up|0|||
124637817|NCT02509507|448292444|FG007|Overall Study|Lost to Follow-up|0|||
124637818|NCT02509507|448292445|FG008|Overall Study|Lost to Follow-up|0|||
124637819|NCT02509507|448292437|FG000|Overall Study|Withdrawal by Subject|2|||
124637820|NCT02509507|448292438|FG001|Overall Study|Withdrawal by Subject|0|||
124637821|NCT02509507|448292439|FG002|Overall Study|Withdrawal by Subject|1|||
124637822|NCT02509507|448292440|FG003|Overall Study|Withdrawal by Subject|4|||
124637823|NCT02509507|448292441|FG004|Overall Study|Withdrawal by Subject|1|||
124637824|NCT02509507|448292442|FG005|Overall Study|Withdrawal by Subject|3|||
124637825|NCT02509507|448292443|FG006|Overall Study|Withdrawal by Subject|4|||
124637826|NCT02509507|448292444|FG007|Overall Study|Withdrawal by Subject|0|||
124637827|NCT02509507|448292445|FG008|Overall Study|Withdrawal by Subject|1|||
124637828|NCT00839800|448292451|FG000|Overall Study|Adverse Event|8|||
124637829|NCT00839800|448292452|FG001|Overall Study|Adverse Event|12|||
124637830|NCT00839800|448292451|FG000|Overall Study|Lost to Follow-up|31|||
124637831|NCT00839800|448292452|FG001|Overall Study|Lost to Follow-up|26|||
124637832|NCT00839800|448292451|FG000|Overall Study|Withdrawal by Subject|28|||
124637833|NCT00839800|448292452|FG001|Overall Study|Withdrawal by Subject|34|||
124637834|NCT00839800|448292451|FG000|Overall Study|Incorrect Enrolment|3|||
124637835|NCT00839800|448292452|FG001|Overall Study|Incorrect Enrolment|3|||
124637836|NCT00839800|448292451|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
124637837|NCT00839800|448292452|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
124637838|NCT00839800|448292451|FG000|Overall Study|Safety Reasons|2|||
124637839|NCT00839800|448292452|FG001|Overall Study|Safety Reasons|1|||
124637840|NCT00839800|448292451|FG000|Overall Study|Other|8|||
124637841|NCT00839800|448292452|FG001|Overall Study|Other|14|||
124637842|NCT00839800|448292451|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
124637843|NCT00839800|448292452|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
124637844|NCT02510664|448292455|FG000|Overall Study|Transferred Care|9|||
124637845|NCT02510664|448292456|FG001|Overall Study|Transferred Care|9|||
124637846|NCT02510664|448292457|FG002|Overall Study|Transferred Care|0|||
124637847|NCT02510664|448292455|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
124637848|NCT02510664|448292456|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
124637849|NCT02510664|448292457|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
124637850|NCT02510664|448292455|FG000|Overall Study|Time Constraints|1|||
124637851|NCT02510664|448292456|FG001|Overall Study|Time Constraints|1|||
124637852|NCT02510664|448292457|FG002|Overall Study|Time Constraints|0|||
124637853|NCT03337113|448292458|FG000|Overall Study|Adverse Event|1|||
124637854|NCT03337113|448292459|FG001|Overall Study|Adverse Event|1|||
124637855|NCT03337113|448292460|FG002|Overall Study|Adverse Event|0|||
124637856|NCT03337113|448292461|FG003|Overall Study|Adverse Event|1|||
124637857|NCT03337113|448292458|FG000|Overall Study|Physician Decision|0|||
124637858|NCT03337113|448292459|FG001|Overall Study|Physician Decision|2|||
124637859|NCT03337113|448292460|FG002|Overall Study|Physician Decision|0|||
124637860|NCT03337113|448292461|FG003|Overall Study|Physician Decision|1|||
124637861|NCT03337113|448292458|FG000|Overall Study|Withdrawal by Subject|0|||
124637862|NCT03337113|448292459|FG001|Overall Study|Withdrawal by Subject|0|||
124637863|NCT03337113|448292460|FG002|Overall Study|Withdrawal by Subject|1|||
124637864|NCT03337113|448292461|FG003|Overall Study|Withdrawal by Subject|0|||
124637865|NCT02176655|448292465|FG000|Overall Study|Subjects did not treat|6|||
124637866|NCT04938180|448292472|FG000|Overall Study|Adverse Event|1|||
124637867|NCT04747886|448292473|FG000|Overall Study|Withdrawal by Subject|1|||
124637868|NCT04747886|448292474|FG001|Overall Study|Withdrawal by Subject|4|||
124637869|NCT03777436|448292478|FG000|Placebo-controlled Phase|Adverse Event|8|||
124637870|NCT03777436|448292479|FG001|Placebo-controlled Phase|Adverse Event|10|||
124637871|NCT03777436|448292480|FG002|Placebo-controlled Phase|Adverse Event|0|||
124637872|NCT03777436|448292478|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
124738085|NCT00459537|448662578|FG001|Overall Study|Administrative problems|0|||
124738086|NCT00459537|448662577|FG000|Overall Study|Protocol Violation|4|||
124738087|NCT00459537|448662578|FG001|Overall Study|Protocol Violation|3|||
124738088|NCT00459537|448662577|FG000|Overall Study|Missing|1|||
124738089|NCT00459537|448662578|FG001|Overall Study|Missing|0|||
124738090|NCT03159104|448662579|FG000|Overall Study|Violation of inclusion criteria|1|||
124738091|NCT03159104|448662580|FG001|Overall Study|Violation of inclusion criteria|2|||
124738092|NCT00456599|448662581|FG000|Overall Study|Non-compliance|1|||
124738093|NCT00456599|448662581|FG000|Overall Study|Withdrawal by Subject|2|||
124738094|NCT01999218|448662582|FG000|Overall Study|Hyperglycemia|18|||
124738095|NCT01999218|448662583|FG001|Overall Study|Hyperglycemia|17|||
124738096|NCT01999218|448662584|FG002|Overall Study|Hyperglycemia|17|||
124738097|NCT01999218|448662582|FG000|Overall Study|Lack of Efficacy|1|||
124738098|NCT01999218|448662583|FG001|Overall Study|Lack of Efficacy|0|||
124738099|NCT01999218|448662584|FG002|Overall Study|Lack of Efficacy|1|||
124738100|NCT01999218|448662582|FG000|Overall Study|Lost to Follow-up|22|||
124738101|NCT01999218|448662583|FG001|Overall Study|Lost to Follow-up|17|||
124738102|NCT01999218|448662584|FG002|Overall Study|Lost to Follow-up|18|||
124738103|NCT01999218|448662582|FG000|Overall Study|Non-Compliance With Study Drug|6|||
124738104|NCT01999218|448662583|FG001|Overall Study|Non-Compliance With Study Drug|4|||
124738105|NCT01999218|448662584|FG002|Overall Study|Non-Compliance With Study Drug|1|||
124738106|NCT01999218|448662582|FG000|Overall Study|Physician Decision|1|||
124738107|NCT01999218|448662583|FG001|Overall Study|Physician Decision|4|||
124738108|NCT01999218|448662584|FG002|Overall Study|Physician Decision|6|||
124738109|NCT01999218|448662582|FG000|Overall Study|Protocol Violation|4|||
124738110|NCT01999218|448662583|FG001|Overall Study|Protocol Violation|5|||
124738111|NCT01999218|448662584|FG002|Overall Study|Protocol Violation|4|||
124738112|NCT01999218|448662582|FG000|Overall Study|Screen failure|0|||
124738113|NCT01999218|448662583|FG001|Overall Study|Screen failure|1|||
124738114|NCT01999218|448662584|FG002|Overall Study|Screen failure|0|||
124738115|NCT01999218|448662582|FG000|Overall Study|Study Terminated By Sponsor|7|||
124738116|NCT01999218|448662583|FG001|Overall Study|Study Terminated By Sponsor|5|||
124738117|NCT01999218|448662584|FG002|Overall Study|Study Terminated By Sponsor|12|||
124738118|NCT01999218|448662582|FG000|Overall Study|Participant moves|2|||
124738119|NCT01999218|448662583|FG001|Overall Study|Participant moves|5|||
124738120|NCT01999218|448662584|FG002|Overall Study|Participant moves|3|||
124738121|NCT01999218|448662582|FG000|Overall Study|Withdrawal by Subject|28|||
124738122|NCT01999218|448662583|FG001|Overall Study|Withdrawal by Subject|29|||
124738123|NCT01999218|448662584|FG002|Overall Study|Withdrawal by Subject|34|||
124738124|NCT01999218|448662582|FG000|Overall Study|Creatinine/eGFR|0|||
124738125|NCT01999218|448662583|FG001|Overall Study|Creatinine/eGFR|0|||
124738126|NCT01999218|448662584|FG002|Overall Study|Creatinine/eGFR|1|||
124738127|NCT01999218|448662582|FG000|Overall Study|Death|7|||
124738128|NCT01999218|448662583|FG001|Overall Study|Death|1|||
124738129|NCT01999218|448662584|FG002|Overall Study|Death|2|||
124738130|NCT01999218|448662582|FG000|Overall Study|Excluded Medication|1|||
124738131|NCT01999218|448662583|FG001|Overall Study|Excluded Medication|1|||
124738132|NCT01999218|448662584|FG002|Overall Study|Excluded Medication|2|||
124738133|NCT01999218|448662582|FG000|Overall Study|Adverse Event|9|||
124738134|NCT01999218|448662583|FG001|Overall Study|Adverse Event|7|||
124738135|NCT01999218|448662584|FG002|Overall Study|Adverse Event|7|||
124738136|NCT01999218|448662582|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
124738137|NCT01999218|448662583|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
124738138|NCT01999218|448662584|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
124738139|NCT00387647|448664019|FG000|Overall Study|Death|18|||
124738140|NCT02032407|448664020|FG000|Overall Study|Lost to Follow-up|2|||
124738141|NCT02032407|448664020|FG000|Overall Study|Pregnancy|1|||
124738142|NCT02032407|448664020|FG000|Overall Study|Other Miscellaneous Reasons|2|||
124738143|NCT02191605|448664021|FG000|Overall Study|Lost to Follow-up|9|||
124738144|NCT02191605|448664022|FG001|Overall Study|Lost to Follow-up|4|||
124738145|NCT02191605|448664023|FG002|Overall Study|Lost to Follow-up|7|||
124738146|NCT02191605|448664024|FG003|Overall Study|Lost to Follow-up|3|||
124738147|NCT02191605|448664025|FG004|Overall Study|Lost to Follow-up|4|||
124738148|NCT01309269|448664028|FG000|Overall Study|Adverse Event|56|||
124738149|NCT01309269|448664028|FG000|Overall Study|Withdrawal by Subject|25|||
124781602|NCT01667419|448831108|FG002|Overall Study|Protocol Violation|0|||
124738150|NCT01309269|448664028|FG000|Overall Study|Lack of Acceptance|15|||
124738151|NCT01309269|448664028|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
124738152|NCT01309269|448664028|FG000|Overall Study|Kidney Transplant|25|||
124738153|NCT01309269|448664028|FG000|Overall Study|Administrative Problems|141|||
124738154|NCT01309269|448664028|FG000|Overall Study|Other|256|||
124738155|NCT01309269|448664028|FG000|Overall Study|Other|1|||
124738156|NCT01309269|448664028|FG000|Overall Study|Study Completion Data Not Recorded|95|||
124738157|NCT01309269|448664028|FG000|Overall Study|Enrolled but not Treated|107|||
124738158|NCT03647267|448664032|FG000|Overall Study|Lost to Follow-up|1|||
124738159|NCT03647267|448664033|FG001|Overall Study|Lost to Follow-up|0|||
124738160|NCT01350115|448664034|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
124738161|NCT01350115|448664035|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
124781603|NCT01667419|448831109|FG003|Overall Study|Protocol Violation|0|||
124738162|NCT01350115|448664034|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
124738163|NCT01350115|448664035|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
124738164|NCT01350115|448664034|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
124738165|NCT01350115|448664035|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
124738166|NCT05079477|448664036|FG000|Overall Study|Lost to Follow-up|2|||
124738167|NCT05079477|448664037|FG001|Overall Study|Lost to Follow-up|0|||
124738168|NCT05079477|448664036|FG000|Overall Study|Withdrawal by Subject|1|||
124738169|NCT05079477|448664037|FG001|Overall Study|Withdrawal by Subject|0|||
124738170|NCT05079477|448664036|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
124738171|NCT05079477|448664037|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
124738172|NCT05079477|448664036|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
124738173|NCT05079477|448664037|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
124738174|NCT05013424|448664040|FG000|Overall Study|Lost to Follow-up|1|||
124738175|NCT05013424|448664041|FG001|Overall Study|Lost to Follow-up|1|||
124738176|NCT05013424|448664042|FG002|Overall Study|Lost to Follow-up|1|||
124738177|NCT05013424|448664040|FG000|Overall Study|Withdrawal by Subject|0|||
124738178|NCT05013424|448664041|FG001|Overall Study|Withdrawal by Subject|1|||
124738179|NCT05013424|448664042|FG002|Overall Study|Withdrawal by Subject|0|||
124738180|NCT00240110|448664043|FG000|Overall Study|Lost to Follow-up|6|||
124738181|NCT00240110|448664044|FG001|Overall Study|Lost to Follow-up|7|||
124738182|NCT02654236|448664048|FG000|Overall Study|Withdrawal by Subject|0|||
124738183|NCT02654236|448664049|FG001|Overall Study|Withdrawal by Subject|0|||
124738184|NCT02654236|448664050|FG002|Overall Study|Withdrawal by Subject|2|||
124738185|NCT03204890|448664051|FG000|Overall Study|Withdrawal by Subject|1|||
124738186|NCT01549873|448664052|FG000|Overall Study|Physician Decision|0|||
124738187|NCT01549873|448664053|FG001|Overall Study|Physician Decision|1|||
124738188|NCT03769311|448664054|FG000|Overall Study|Withdrawal by Subject|1|||
124738189|NCT01596335|448664055|FG000|Overall Study|exacerbation of primary disease|5|||
124738190|NCT01596335|448664056|FG001|Overall Study|exacerbation of primary disease|9|||
124738191|NCT03627065|448664057|FG000|Overall Study|Study Terminated by sponsor|1|||
124738192|NCT03627065|448664057|FG000|Overall Study|Withdrawal by Subject|2|||
124738193|NCT04524455|448664059|FG000|Overall Study|Death|3|||
124738194|NCT04524455|448664060|FG001|Overall Study|Death|3|||
124738195|NCT04524455|448664059|FG000|Overall Study|Decision by Sponsor|0|||
124738196|NCT04524455|448664060|FG001|Overall Study|Decision by Sponsor|2|||
124738197|NCT04524455|448664059|FG000|Overall Study|Withdrawal of Consent From Study|1|||
124738198|NCT04524455|448664060|FG001|Overall Study|Withdrawal of Consent From Study|0|||
124738199|NCT04524455|448664059|FG000|Overall Study|Lost to Follow-up|0|||
124738200|NCT04524455|448664060|FG001|Overall Study|Lost to Follow-up|1|||
124738201|NCT00996801|448664063|FG000|Overall Study|Adverse Event|6|||
124738202|NCT00996801|448664064|FG001|Overall Study|Adverse Event|4|||
124738203|NCT00996801|448664065|FG002|Overall Study|Adverse Event|12|||
124738204|NCT00996801|448664066|FG003|Overall Study|Adverse Event|17|||
124738205|NCT00996801|448664067|FG004|Overall Study|Adverse Event|31|||
124738206|NCT00996801|448664068|FG005|Overall Study|Adverse Event|3|||
124738207|NCT00996801|448664063|FG000|Overall Study|Lack of Efficacy|3|||
124738208|NCT00996801|448664064|FG001|Overall Study|Lack of Efficacy|0|||
124738209|NCT00996801|448664065|FG002|Overall Study|Lack of Efficacy|1|||
124738210|NCT00996801|448664066|FG003|Overall Study|Lack of Efficacy|3|||
124738211|NCT00996801|448664067|FG004|Overall Study|Lack of Efficacy|0|||
124738212|NCT00996801|448664068|FG005|Overall Study|Lack of Efficacy|1|||
124738213|NCT00996801|448664063|FG000|Overall Study|Lost to Follow-up|0|||
124738214|NCT00996801|448664064|FG001|Overall Study|Lost to Follow-up|0|||
124738215|NCT00996801|448664065|FG002|Overall Study|Lost to Follow-up|0|||
124738216|NCT00996801|448664066|FG003|Overall Study|Lost to Follow-up|3|||
124738217|NCT00996801|448664067|FG004|Overall Study|Lost to Follow-up|3|||
124738218|NCT00996801|448664068|FG005|Overall Study|Lost to Follow-up|2|||
124738219|NCT00996801|448664063|FG000|Overall Study|Physician Decision|0|||
124738220|NCT00996801|448664064|FG001|Overall Study|Physician Decision|0|||
124738221|NCT00996801|448664065|FG002|Overall Study|Physician Decision|0|||
124738222|NCT00996801|448664066|FG003|Overall Study|Physician Decision|1|||
124738223|NCT00996801|448664067|FG004|Overall Study|Physician Decision|0|||
124738224|NCT00996801|448664068|FG005|Overall Study|Physician Decision|0|||
124738225|NCT00996801|448664063|FG000|Overall Study|Progressive Disease|0|||
124738226|NCT00996801|448664064|FG001|Overall Study|Progressive Disease|1|||
124738227|NCT00996801|448664065|FG002|Overall Study|Progressive Disease|0|||
124738228|NCT00996801|448664066|FG003|Overall Study|Progressive Disease|0|||
124738229|NCT00996801|448664067|FG004|Overall Study|Progressive Disease|0|||
124738230|NCT00996801|448664068|FG005|Overall Study|Progressive Disease|0|||
124738231|NCT00996801|448664063|FG000|Overall Study|Protocol Violation|3|||
124738232|NCT00996801|448664064|FG001|Overall Study|Protocol Violation|4|||
124738233|NCT00996801|448664065|FG002|Overall Study|Protocol Violation|1|||
124738234|NCT00996801|448664066|FG003|Overall Study|Protocol Violation|2|||
124738235|NCT00996801|448664067|FG004|Overall Study|Protocol Violation|3|||
124738236|NCT00996801|448664068|FG005|Overall Study|Protocol Violation|4|||
124738237|NCT00996801|448664063|FG000|Overall Study|Study Terminated by Sponsor|0|||
124738238|NCT00996801|448664064|FG001|Overall Study|Study Terminated by Sponsor|1|||
124738239|NCT00996801|448664065|FG002|Overall Study|Study Terminated by Sponsor|0|||
124738240|NCT00996801|448664066|FG003|Overall Study|Study Terminated by Sponsor|0|||
124738241|NCT00996801|448664067|FG004|Overall Study|Study Terminated by Sponsor|46|||
124738242|NCT00996801|448664068|FG005|Overall Study|Study Terminated by Sponsor|0|||
124738243|NCT00996801|448664063|FG000|Overall Study|Withdrawal by Subject|8|||
124738244|NCT00996801|448664064|FG001|Overall Study|Withdrawal by Subject|6|||
124738245|NCT00996801|448664065|FG002|Overall Study|Withdrawal by Subject|9|||
124738246|NCT00996801|448664066|FG003|Overall Study|Withdrawal by Subject|5|||
124738247|NCT00996801|448664067|FG004|Overall Study|Withdrawal by Subject|5|||
124738248|NCT00996801|448664068|FG005|Overall Study|Withdrawal by Subject|9|||
124738249|NCT01688739|448664069|FG000|Overall Study|Administrative Decision|1|||
124738250|NCT01688739|448664070|FG001|Overall Study|Administrative Decision|0|||
124738251|NCT01688739|448664071|FG002|Overall Study|Administrative Decision|0|||
124738252|NCT01688739|448664072|FG003|Overall Study|Administrative Decision|0|||
124738253|NCT01688739|448664073|FG004|Overall Study|Administrative Decision|0|||
124738254|NCT01688739|448664074|FG005|Overall Study|Administrative Decision|0|||
124738255|NCT01688739|448664075|FG006|Overall Study|Administrative Decision|0|||
124738256|NCT01688739|448664076|FG007|Overall Study|Administrative Decision|0|||
124738257|NCT01688739|448664077|FG008|Overall Study|Administrative Decision|0|||
124738258|NCT01688739|448664078|FG009|Overall Study|Administrative Decision|0|||
124738259|NCT02804750|448664079|FG000|Period 1|Adverse Event|0|||
124738260|NCT02804750|448664080|FG001|Period 1|Adverse Event|2|||
124738261|NCT02804750|448664079|FG000|Period 1|Withdrawal by Subject|0|||
124738262|NCT02804750|448664080|FG001|Period 1|Withdrawal by Subject|1|||
124738263|NCT02804750|448664079|FG000|Period 2|Adverse Event|1|||
124738264|NCT02804750|448664080|FG001|Period 2|Adverse Event|0|||
124738265|NCT02804750|448664079|FG000|Period 3|Adverse Event|0|||
124738266|NCT02804750|448664080|FG001|Period 3|Adverse Event|2|||
124738267|NCT02804750|448664079|FG000|Period 4|Adverse Event|0|||
124738268|NCT02804750|448664080|FG001|Period 4|Adverse Event|5|||
124738269|NCT02559414|448664081|FG000|Overall Study|Lost to Follow-up|0|||
124738270|NCT02559414|448664082|FG001|Overall Study|Lost to Follow-up|1|||
124738271|NCT02559414|448664083|FG002|Overall Study|Lost to Follow-up|0|||
124738272|NCT02559414|448664081|FG000|Overall Study|Withdrawal by Subject|1|||
124738273|NCT02559414|448664082|FG001|Overall Study|Withdrawal by Subject|0|||
124738274|NCT02559414|448664083|FG002|Overall Study|Withdrawal by Subject|1|||
124738275|NCT02559414|448664081|FG000|Overall Study|Other|0|||
124738276|NCT02559414|448664082|FG001|Overall Study|Other|1|||
124738277|NCT02559414|448664083|FG002|Overall Study|Other|1|||
124738278|NCT03369431|448664084|FG000|Overall Study|Lost to Follow-up|1|||
124738279|NCT03369431|448664085|FG001|Overall Study|Lost to Follow-up|3|||
124738280|NCT03369431|448664084|FG000|Overall Study|Withdrawal by Subject|2|||
124738281|NCT03369431|448664085|FG001|Overall Study|Withdrawal by Subject|3|||
124738282|NCT03369431|448664084|FG000|Overall Study|Protocol Violation|1|||
124738283|NCT03369431|448664085|FG001|Overall Study|Protocol Violation|1|||
124738284|NCT00046930|448664090|FG000|Overall Study|Ineligible|12|||
124738285|NCT00046930|448664091|FG001|Overall Study|Ineligible|4|||
124738286|NCT01113580|448664092|FG000|Overall Study|Protocol Violation|1|||
124738287|NCT01113580|448664093|FG001|Overall Study|Protocol Violation|0|||
124738288|NCT04912895|448664101|FG000|Overall Study|Unable to provide specimen|2|||
124738289|NCT04912895|448664102|FG001|Overall Study|Unable to provide specimen|0|||
124738290|NCT04912895|448664103|FG002|Overall Study|Unable to provide specimen|0|||
124738291|NCT03458702|448664104|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
124738292|NCT03458702|448664105|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
124738293|NCT03458702|448664104|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
124738294|NCT03458702|448664105|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
124738295|NCT01390779|448664106|FG000|Overall Study|Physician Decision|1|||
124738296|NCT00545532|448664107|FG000|Overall Study|Withdrawal by Subject|1|||
124738297|NCT00545532|448664108|FG001|Overall Study|Withdrawal by Subject|3|||
124738298|NCT00545532|448664107|FG000|Overall Study|Lost to Follow-up|5|||
124738299|NCT00545532|448664108|FG001|Overall Study|Lost to Follow-up|6|||
124738300|NCT00545532|448664107|FG000|Overall Study|Death|0|||
124738301|NCT00545532|448664108|FG001|Overall Study|Death|1|||
124738302|NCT01149486|448664111|FG000|First Intervention|Adverse Event|0|||
124612849|NCT02065700|448202152|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
124738303|NCT01149486|448664112|FG001|First Intervention|Adverse Event|1|||
124738304|NCT00931801|448664121|FG000|Overall Study|Adverse Event|0|||
124738305|NCT00931801|448664122|FG001|Overall Study|Adverse Event|0|||
124738306|NCT00931801|448664123|FG002|Overall Study|Adverse Event|1|||
124738307|NCT00931801|448664121|FG000|Overall Study|Lost to Follow-up|0|||
124738308|NCT00931801|448664122|FG001|Overall Study|Lost to Follow-up|1|||
124738309|NCT00931801|448664123|FG002|Overall Study|Lost to Follow-up|0|||
124738310|NCT00931801|448664121|FG000|Overall Study|Withdrawal by Subject|1|||
124738311|NCT00931801|448664122|FG001|Overall Study|Withdrawal by Subject|0|||
124738312|NCT00931801|448664123|FG002|Overall Study|Withdrawal by Subject|0|||
124738313|NCT00931801|448664121|FG000|Overall Study|Confirmed Virologic Failure|0|||
124738314|NCT00931801|448664122|FG001|Overall Study|Confirmed Virologic Failure|0|||
124612850|NCT02065700|448202151|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
124612851|NCT02065700|448202152|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
124738315|NCT00931801|448664123|FG002|Overall Study|Confirmed Virologic Failure|3|||
124738316|NCT01635764|448664125|FG000|Overall Study|Adverse Event|46|||
124738317|NCT01635764|448664125|FG000|Overall Study|Lack of Efficacy|76|||
124738318|NCT01635764|448664125|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
124738319|NCT01635764|448664125|FG000|Overall Study|Protocol Deviation|1|||
124738320|NCT01635764|448664125|FG000|Overall Study|Withdrew Consent|67|||
124738321|NCT01635764|448664125|FG000|Overall Study|Lost to Follow-up|53|||
124738322|NCT01635764|448664125|FG000|Overall Study|Other|28|||
124738323|NCT01174004|448664127|FG000|Overall Study|Adverse Event|2|||
124738324|NCT01174004|448664128|FG001|Overall Study|Adverse Event|10|||
124738325|NCT01174004|448664127|FG000|Overall Study|Withdrawal by Subject|2|||
124738326|NCT01174004|448664128|FG001|Overall Study|Withdrawal by Subject|3|||
124738327|NCT01174004|448664127|FG000|Overall Study|At Discretion of Sponsor|2|||
124738328|NCT01174004|448664128|FG001|Overall Study|At Discretion of Sponsor|2|||
124738329|NCT01174004|448664127|FG000|Overall Study|Protocol Violation|0|||
124738330|NCT01174004|448664128|FG001|Overall Study|Protocol Violation|1|||
124738331|NCT01174004|448664127|FG000|Overall Study|Physician Decision|1|||
124738332|NCT01174004|448664128|FG001|Overall Study|Physician Decision|0|||
124738333|NCT00933244|448664129|FG000|Overall Study|Withdrawal by Subject|5|||
124738334|NCT00933244|448664130|FG001|Overall Study|Withdrawal by Subject|1|||
124738335|NCT00933244|448664131|FG002|Overall Study|Withdrawal by Subject|3|||
124738336|NCT00610441|448664133|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
124738337|NCT00610441|448664134|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
124738338|NCT00610441|448664135|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
124738339|NCT00610441|448664136|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
124738340|NCT00610441|448664133|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
124738341|NCT00610441|448664134|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
124738342|NCT00610441|448664135|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
124738343|NCT00610441|448664136|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
124738344|NCT00610441|448664133|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
124738345|NCT00610441|448664134|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
124738346|NCT00610441|448664135|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
124612852|NCT02065700|448202151|FG000|Overall Study|Non-compliance with Study Procedures|2|||
124612853|NCT02065700|448202152|FG001|Overall Study|Non-compliance with Study Procedures|0|||
124738347|NCT00610441|448664136|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
124738348|NCT00610441|448664133|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
124738349|NCT00610441|448664134|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
124738350|NCT00610441|448664135|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
124738351|NCT00610441|448664136|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
124738352|NCT00610441|448664133|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
124738353|NCT00610441|448664134|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
124738354|NCT00610441|448664135|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
124738355|NCT00610441|448664136|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
124738356|NCT00610441|448664133|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
124738357|NCT00610441|448664134|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
124738358|NCT00610441|448664135|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
124738359|NCT00610441|448664136|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
124738360|NCT00610441|448664133|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
124738361|NCT00610441|448664134|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
124738362|NCT00610441|448664135|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
124738363|NCT00610441|448664136|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
124738364|NCT00610441|448664133|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
124738365|NCT00610441|448664134|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
124738366|NCT00610441|448664135|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
124738367|NCT00610441|448664136|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
124738368|NCT00610441|448664133|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
124738369|NCT00610441|448664134|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
124738370|NCT00610441|448664135|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
124738371|NCT00610441|448664136|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
124738372|NCT03002623|448664141|FG000|Overall Study|Lost to Follow-up|1|||
124612854|NCT02065700|448202151|FG000|Overall Study|Not Defined|21|||
124738373|NCT03002623|448664142|FG001|Overall Study|Lost to Follow-up|0|||
124738374|NCT03002623|448664141|FG000|Overall Study|Physician Decision|1|||
124738375|NCT03002623|448664142|FG001|Overall Study|Physician Decision|1|||
124738376|NCT02639338|448664143|FG000|Overall Study|Lost to Follow-up|2|||
124781604|NCT01667419|448831106|FG000|Overall Study|Lost to Follow-up|7|||
124612855|NCT02065700|448202152|FG001|Overall Study|Not Defined|3|||
124612856|NCT01305044|448202157|FG000|Overall Study|Withdrawal by Subject|3|||
124738377|NCT02639338|448664144|FG001|Overall Study|Lost to Follow-up|2|||
124738378|NCT02639338|448664143|FG000|Overall Study|Withdrew Consent|1|||
124612857|NCT01305044|448202158|FG001|Overall Study|Withdrawal by Subject|6|||
124738379|NCT02639338|448664144|FG001|Overall Study|Withdrew Consent|2|||
124738380|NCT02639338|448664143|FG000|Overall Study|Death|1|||
124738381|NCT02639338|448664144|FG001|Overall Study|Death|0|||
124738382|NCT02639338|448664143|FG000|Overall Study|Randomized but Not Treated|0|||
124738383|NCT02639338|448664144|FG001|Overall Study|Randomized but Not Treated|1|||
124738384|NCT00493636|448664145|FG000|Overall Study|Withdrawal by Subject|1|||
124738385|NCT00493636|448664146|FG001|Overall Study|Withdrawal by Subject|0|||
124738386|NCT00493636|448664145|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
124738387|NCT00493636|448664146|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
124738388|NCT00493636|448664145|FG000|Overall Study|Mis-randomization|1|||
124738389|NCT00493636|448664146|FG001|Overall Study|Mis-randomization|1|||
124738390|NCT01066780|448664153|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
124738391|NCT01066780|448664154|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
124738392|NCT00787202|448664156|FG000|Overall Study|Adverse Event|3|||
124738393|NCT00787202|448664157|FG001|Overall Study|Adverse Event|2|||
124738394|NCT00787202|448664158|FG002|Overall Study|Adverse Event|0|||
124738395|NCT00787202|448664159|FG003|Overall Study|Adverse Event|0|||
124738396|NCT00787202|448664160|FG004|Overall Study|Adverse Event|2|||
124738397|NCT00787202|448664156|FG000|Overall Study|Lack of Efficacy|5|||
124738398|NCT00787202|448664157|FG001|Overall Study|Lack of Efficacy|6|||
124738399|NCT00787202|448664158|FG002|Overall Study|Lack of Efficacy|5|||
124738400|NCT00787202|448664159|FG003|Overall Study|Lack of Efficacy|2|||
124738401|NCT00787202|448664160|FG004|Overall Study|Lack of Efficacy|1|||
124738402|NCT00787202|448664156|FG000|Overall Study|Lost to Follow-up|1|||
124738403|NCT00787202|448664157|FG001|Overall Study|Lost to Follow-up|0|||
124738404|NCT00787202|448664158|FG002|Overall Study|Lost to Follow-up|0|||
124738405|NCT00787202|448664159|FG003|Overall Study|Lost to Follow-up|0|||
124738406|NCT00787202|448664160|FG004|Overall Study|Lost to Follow-up|0|||
124738407|NCT00787202|448664156|FG000|Overall Study|Withdrawal by Subject|2|||
124738408|NCT00787202|448664157|FG001|Overall Study|Withdrawal by Subject|2|||
124738409|NCT00787202|448664158|FG002|Overall Study|Withdrawal by Subject|2|||
124738410|NCT00787202|448664159|FG003|Overall Study|Withdrawal by Subject|0|||
124738411|NCT00787202|448664160|FG004|Overall Study|Withdrawal by Subject|0|||
124738412|NCT00787202|448664156|FG000|Overall Study|Protocol Violation|2|||
124738413|NCT00787202|448664157|FG001|Overall Study|Protocol Violation|1|||
124738414|NCT00787202|448664158|FG002|Overall Study|Protocol Violation|0|||
124738415|NCT00787202|448664159|FG003|Overall Study|Protocol Violation|0|||
124738416|NCT00787202|448664160|FG004|Overall Study|Protocol Violation|1|||
124738417|NCT00787202|448664156|FG000|Overall Study|Randomized, not treated|1|||
124738418|NCT00787202|448664157|FG001|Overall Study|Randomized, not treated|0|||
124738419|NCT00787202|448664158|FG002|Overall Study|Randomized, not treated|0|||
124738420|NCT00787202|448664159|FG003|Overall Study|Randomized, not treated|0|||
124738421|NCT00787202|448664160|FG004|Overall Study|Randomized, not treated|0|||
124738422|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
124738423|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
124738424|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
124738425|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
124738426|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
124738427|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
124738428|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
124738429|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
124738430|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
124738431|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
124738432|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
124738433|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
124738434|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
124738435|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
124738436|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
124738437|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
124738438|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
124738439|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
124738440|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
124738441|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
124738442|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
124738443|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
124738444|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
124738445|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
124738446|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
124752826|NCT00858637|448716863|FG000|Active Comparison Phase|Adverse Event|14|||
124752827|NCT00858637|448716864|FG001|Active Comparison Phase|Adverse Event|0|||
124752828|NCT00858637|448716865|FG002|Active Comparison Phase|Adverse Event|0|||
124738447|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
124738448|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
124738449|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
124738450|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
124738451|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
124738452|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
124738453|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
124738454|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
124738455|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
124738456|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
124738457|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
124738458|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
124738459|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
124738460|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
124738461|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
124738462|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
124738463|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
124738464|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
124738465|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
124738466|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
124738467|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
124738468|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
124738469|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
124738470|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
124738471|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
124738472|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
124738473|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
124738474|NCT02008357|448664161|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
124738475|NCT02008357|448664162|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
124738476|NCT02008357|448664161|FG000|Open-label Extension Period|Adverse Event|8|||
124738477|NCT02008357|448664162|FG001|Open-label Extension Period|Adverse Event|7|||
124738478|NCT02008357|448664161|FG000|Open-label Extension Period|Death|7|||
124738479|NCT02008357|448664162|FG001|Open-label Extension Period|Death|4|||
124738480|NCT02008357|448664161|FG000|Open-label Extension Period|Lack of Efficacy|9|||
124738481|NCT02008357|448664162|FG001|Open-label Extension Period|Lack of Efficacy|5|||
124738482|NCT02008357|448664161|FG000|Open-label Extension Period|Lost to Follow-up|2|||
124738483|NCT02008357|448664162|FG001|Open-label Extension Period|Lost to Follow-up|2|||
124738484|NCT02008357|448664161|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
124738485|NCT02008357|448664162|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
124738486|NCT02008357|448664161|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
124738487|NCT02008357|448664162|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
124738488|NCT02008357|448664161|FG000|Open-label Extension Period|Safety Risk|2|||
124738489|NCT02008357|448664162|FG001|Open-label Extension Period|Safety Risk|1|||
124738490|NCT02008357|448664161|FG000|Open-label Extension Period|Non-Compliance|0|||
124738491|NCT02008357|448664162|FG001|Open-label Extension Period|Non-Compliance|1|||
124738492|NCT02008357|448664161|FG000|Open-label Extension Period|Investigator Recommendation|0|||
124738493|NCT02008357|448664162|FG001|Open-label Extension Period|Investigator Recommendation|1|||
124738494|NCT02008357|448664161|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
124738495|NCT02008357|448664162|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
124738496|NCT02008357|448664161|FG000|Open-label Extension Period|Coordinating Center Request|2|||
124738497|NCT02008357|448664162|FG001|Open-label Extension Period|Coordinating Center Request|4|||
124738498|NCT02008357|448664161|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
124738499|NCT02008357|448664162|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
124738500|NCT02008357|448664161|FG000|Open-label Extension Period|Study Ended|20|||
124738501|NCT02008357|448664162|FG001|Open-label Extension Period|Study Ended|25|||
124738502|NCT02008357|448664161|FG000|Open-label Extension Period|Personal Reasons|0|||
124738503|NCT02008357|448664162|FG001|Open-label Extension Period|Personal Reasons|1|||
124738504|NCT02008357|448664161|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
124738505|NCT02008357|448664162|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
124738506|NCT02008357|448664161|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
124738507|NCT02008357|448664162|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
124612858|NCT02278055|448202162|FG000|Overall Study|Adverse Event|1|||
124738508|NCT02008357|448664161|FG000|Open-label Extension Period|Other|2|||
124738509|NCT02008357|448664162|FG001|Open-label Extension Period|Other|0|||
124738510|NCT00966719|448664163|FG000|Overall Study|Lost to Follow-up|6|||
124738511|NCT00966719|448664164|FG001|Overall Study|Lost to Follow-up|11|||
124738512|NCT03089944|448664165|FG000|Overall Study|Lost to Follow-up|8|||
124738513|NCT03089944|448664165|FG000|Overall Study|Withdrew Consent|2|||
124738514|NCT03089944|448664165|FG000|Overall Study|Adverse Event|1|||
124738515|NCT03089944|448664165|FG000|Overall Study|Other|1|||
124738516|NCT00831701|448664167|FG000|Overall Study|Withdrawal by Subject|2|||
124738517|NCT00831701|448664168|FG001|Overall Study|Withdrawal by Subject|0|||
124738518|NCT00831701|448664167|FG000|Overall Study|Stone expulsion before first medication|2|||
124738519|NCT00831701|448664168|FG001|Overall Study|Stone expulsion before first medication|2|||
124738520|NCT00831701|448664167|FG000|Overall Study|Lost to Follow-up|1|||
124738521|NCT00831701|448664168|FG001|Overall Study|Lost to Follow-up|3|||
124738522|NCT03131596|448666149|FG000|Overall Study|Protocol Violation|3|||
124738523|NCT03131596|448666150|FG001|Overall Study|Protocol Violation|3|||
124738524|NCT03131596|448666149|FG000|Overall Study|Lost to Follow-up|3|||
124738525|NCT03131596|448666150|FG001|Overall Study|Lost to Follow-up|0|||
124738526|NCT00734071|448666153|FG000|Overall Study|Adverse Event|4|||
124738527|NCT00734071|448666154|FG001|Overall Study|Adverse Event|3|||
124738528|NCT00734071|448666153|FG000|Overall Study|Lack of Efficacy|3|||
124738529|NCT00734071|448666154|FG001|Overall Study|Lack of Efficacy|1|||
124738530|NCT00734071|448666153|FG000|Overall Study|Noncompliance|2|||
124738531|NCT00734071|448666154|FG001|Overall Study|Noncompliance|2|||
124738532|NCT00734071|448666153|FG000|Overall Study|Protocol Deviations|3|||
124738533|NCT00734071|448666154|FG001|Overall Study|Protocol Deviations|4|||
124738534|NCT00734071|448666153|FG000|Overall Study|Voluntary Withdrawal|9|||
124738535|NCT00734071|448666154|FG001|Overall Study|Voluntary Withdrawal|7|||
124738536|NCT00734071|448666153|FG000|Overall Study|Lost to Follow-up|16|||
124738537|NCT00734071|448666154|FG001|Overall Study|Lost to Follow-up|8|||
124738538|NCT00734071|448666153|FG000|Overall Study|Other|1|||
124738539|NCT00734071|448666154|FG001|Overall Study|Other|2|||
124738540|NCT00151372|448666155|FG000|Overall Study|Death|12|||
124738541|NCT00151372|448666156|FG001|Overall Study|Death|11|||
124738542|NCT00151372|448666155|FG000|Overall Study|Lost to Follow-up|5|||
124738543|NCT00151372|448666156|FG001|Overall Study|Lost to Follow-up|5|||
124738544|NCT00151372|448666155|FG000|Overall Study|Too sick medically to continue|5|||
124738545|NCT00151372|448666156|FG001|Overall Study|Too sick medically to continue|6|||
124738546|NCT00151372|448666155|FG000|Overall Study|Withdrawal by Subject|7|||
124738547|NCT00151372|448666156|FG001|Overall Study|Withdrawal by Subject|7|||
124738548|NCT00541346|448666158|FG000|Follow-up|Adverse Event|1|||
124738549|NCT04732949|448666159|FG000|Overall Study|Withdrawal by Subject|23|||
124738550|NCT04732949|448666160|FG001|Overall Study|Withdrawal by Subject|27|||
124738551|NCT04732949|448666159|FG000|Overall Study|Protocol Violation|0|||
124738552|NCT04732949|448666160|FG001|Overall Study|Protocol Violation|1|||
124738553|NCT04732949|448666159|FG000|Overall Study|Non-compliance|0|||
124738554|NCT04732949|448666160|FG001|Overall Study|Non-compliance|2|||
124738555|NCT04732949|448666159|FG000|Overall Study|Physician Decision|2|||
124738556|NCT04732949|448666160|FG001|Overall Study|Physician Decision|1|||
124738557|NCT04732949|448666159|FG000|Overall Study|Serious adverse event (Fatal)|16|||
124738558|NCT04732949|448666160|FG001|Overall Study|Serious adverse event (Fatal)|18|||
124738559|NCT04732949|448666159|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
124738560|NCT04732949|448666160|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
124738561|NCT04732949|448666159|FG000|Overall Study|Non-serious adverse event|1|||
124738562|NCT04732949|448666160|FG001|Overall Study|Non-serious adverse event|3|||
124738563|NCT04732949|448666159|FG000|Overall Study|Lost to Follow-up|26|||
124738564|NCT04732949|448666160|FG001|Overall Study|Lost to Follow-up|27|||
124738565|NCT04732949|448666159|FG000|Overall Study|Other|6|||
124738566|NCT04732949|448666160|FG001|Overall Study|Other|3|||
124738567|NCT00583791|448666163|FG000|Overall Study|Other|67|||
124738568|NCT00583791|448666163|FG000|Overall Study|Death|6|||
124738569|NCT03323736|448666164|FG000|Overall Study|Screen Failure|14|||
124738570|NCT03323736|448666165|FG001|Overall Study|Screen Failure|9|||
124738571|NCT03323736|448666166|FG002|Overall Study|Screen Failure|1|||
124738572|NCT03323736|448666164|FG000|Overall Study|Withdrawal Before Treatment|3|||
124738573|NCT03323736|448666165|FG001|Overall Study|Withdrawal Before Treatment|1|||
124738574|NCT03323736|448666166|FG002|Overall Study|Withdrawal Before Treatment|1|||
124738575|NCT03323736|448666164|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
124738576|NCT03323736|448666165|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
124738577|NCT03323736|448666166|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
124738578|NCT03710876|448666167|FG000|Overall Study|Death|0|||
124781605|NCT01667419|448831107|FG001|Overall Study|Lost to Follow-up|6|||
124781606|NCT01667419|448831108|FG002|Overall Study|Lost to Follow-up|2|||
124738579|NCT03710876|448666168|FG001|Overall Study|Death|2|||
124738580|NCT03710876|448666167|FG000|Overall Study|Withdrawal by Subject|0|||
124738581|NCT03710876|448666168|FG001|Overall Study|Withdrawal by Subject|2|||
124738582|NCT02853435|448666169|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
124738583|NCT02853435|448666170|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
124781607|NCT01667419|448831109|FG003|Overall Study|Lost to Follow-up|4|||
124738584|NCT02853435|448666171|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
124738585|NCT02853435|448666172|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
124738586|NCT02853435|448666173|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
124738587|NCT02853435|448666174|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
124738588|NCT03747120|448666177|FG000|Overall Study|treatment related toxicity|3|||
124738589|NCT03747120|448666178|FG001|Overall Study|treatment related toxicity|0|||
124738590|NCT03747120|448666179|FG002|Overall Study|treatment related toxicity|0|||
124738591|NCT03747120|448666177|FG000|Overall Study|Withdrawal by Subject|0|||
124738592|NCT03747120|448666178|FG001|Overall Study|Withdrawal by Subject|1|||
124738593|NCT03747120|448666179|FG002|Overall Study|Withdrawal by Subject|2|||
124738594|NCT04191499|448666188|FG000|Overall Study|Adverse Event|1|||
124738595|NCT04191499|448666189|FG001|Overall Study|Adverse Event|0|||
124738596|NCT04191499|448666188|FG000|Overall Study|Death|42|||
124738597|NCT04191499|448666189|FG001|Overall Study|Death|55|||
124738598|NCT04191499|448666188|FG000|Overall Study|Lost to Follow-up|4|||
124738599|NCT04191499|448666189|FG001|Overall Study|Lost to Follow-up|1|||
124738600|NCT04191499|448666188|FG000|Overall Study|Physician Decision|1|||
124738601|NCT04191499|448666189|FG001|Overall Study|Physician Decision|0|||
124738602|NCT04191499|448666188|FG000|Overall Study|Progressive Disease|1|||
124738603|NCT04191499|448666189|FG001|Overall Study|Progressive Disease|0|||
124738604|NCT04191499|448666188|FG000|Overall Study|Symptomatic Deterioration|1|||
124738605|NCT04191499|448666189|FG001|Overall Study|Symptomatic Deterioration|0|||
124738606|NCT04191499|448666188|FG000|Overall Study|Withdrawal by Subject|7|||
124738607|NCT04191499|448666189|FG001|Overall Study|Withdrawal by Subject|11|||
124738608|NCT04191499|448666188|FG000|Overall Study|Ongoing in the study|104|||
124738609|NCT04191499|448666189|FG001|Overall Study|Ongoing in the study|97|||
124738610|NCT01266317|448666190|FG000|Overall Study|Withdrawal by Subject|2|||
124738611|NCT00490776|448666191|FG000|Overall Study|Withdrawal by Subject|1|||
124738612|NCT00490776|448666191|FG000|Overall Study|Administrative Problems|1|||
124738613|NCT00490776|448666191|FG000|Overall Study|Death|1|||
124738614|NCT00490776|448666191|FG000|Overall Study|New Cancer Therapy|1|||
124738615|NCT00490776|448666191|FG000|Overall Study|Disease Progression|5|||
124738616|NCT04271475|448666203|FG000|DB Period: Day 1 up to EODBT|Death|1|||
124738617|NCT04271475|448666204|FG001|DB Period: Day 1 up to EODBT|Death|0|||
124738618|NCT04271475|448666205|FG002|DB Period: Day 1 up to EODBT|Death|0|||
124738619|NCT04271475|448666206|FG003|DB Period: Day 1 up to EODBT|Death|0|||
124738620|NCT04271475|448666203|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
124738621|NCT04271475|448666204|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
124738622|NCT04271475|448666205|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
124738623|NCT04271475|448666206|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
124738624|NCT04271475|448666203|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
124738625|NCT04271475|448666204|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
124738626|NCT04271475|448666205|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
124738627|NCT04271475|448666206|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
124738628|NCT04271475|448666203|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
124738629|NCT04271475|448666204|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
124738630|NCT04271475|448666205|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
124738631|NCT04271475|448666206|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
124738632|NCT04271475|448666203|FG000|DB Period: Day 1 up to EODBT|Other|8|||
124738633|NCT04271475|448666204|FG001|DB Period: Day 1 up to EODBT|Other|5|||
124738634|NCT04271475|448666205|FG002|DB Period: Day 1 up to EODBT|Other|0|||
124738635|NCT04271475|448666206|FG003|DB Period: Day 1 up to EODBT|Other|0|||
124738636|NCT04271475|448666203|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
124738637|NCT04271475|448666204|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
124738638|NCT04271475|448666205|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
124738639|NCT04271475|448666206|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
124738640|NCT04271475|448666203|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
124738641|NCT04271475|448666204|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
124738642|NCT04271475|448666205|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
124738643|NCT04271475|448666206|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
124738644|NCT00159913|448666208|FG000|Overall Study|Adverse Event|1|||
124738645|NCT00159913|448666209|FG001|Overall Study|Adverse Event|0|||
124738646|NCT00159913|448666210|FG002|Overall Study|Adverse Event|1|||
124738647|NCT00159913|448666211|FG003|Overall Study|Adverse Event|0|||
124738648|NCT00159913|448666208|FG000|Overall Study|Withdrawal by Subject|0|||
124781608|NCT01667419|448831106|FG000|Overall Study|Death|18|||
124612859|NCT02278055|448202162|FG000|Overall Study|Lost to Follow-up|1|||
124738649|NCT00159913|448666209|FG001|Overall Study|Withdrawal by Subject|0|||
124738650|NCT00159913|448666210|FG002|Overall Study|Withdrawal by Subject|0|||
124738651|NCT00159913|448666211|FG003|Overall Study|Withdrawal by Subject|1|||
124738652|NCT00159913|448666208|FG000|Overall Study|Lost to Follow-up|0|||
124738653|NCT00159913|448666209|FG001|Overall Study|Lost to Follow-up|0|||
124738654|NCT00159913|448666210|FG002|Overall Study|Lost to Follow-up|0|||
124781609|NCT01667419|448831107|FG001|Overall Study|Death|33|||
124781610|NCT01667419|448831108|FG002|Overall Study|Death|25|||
124781611|NCT01667419|448831109|FG003|Overall Study|Death|26|||
124781612|NCT04364984|448831111|FG000|Overall Study|Death|2|||
124781613|NCT04364984|448831112|FG001|Overall Study|Death|2|||
124781614|NCT04364984|448831113|FG002|Overall Study|Death|0|||
124781615|NCT01941186|448831114|FG000|Follow-up|Lost to Follow-up|1|||
124781616|NCT01941186|448831115|FG001|Follow-up|Lost to Follow-up|0|||
124781617|NCT04380519|448831116|FG000|Overall Study|Withdrawal by Subject|4|||
124781618|NCT04380519|448831117|FG001|Overall Study|Withdrawal by Subject|0|||
124781619|NCT04380519|448831118|FG002|Overall Study|Withdrawal by Subject|1|||
124781620|NCT04380519|448831116|FG000|Overall Study|Death|14|||
124781621|NCT04380519|448831117|FG001|Overall Study|Death|9|||
124781622|NCT04380519|448831118|FG002|Overall Study|Death|6|||
124781623|NCT04380519|448831116|FG000|Overall Study|Adverse Event|0|||
124781624|NCT04380519|448831117|FG001|Overall Study|Adverse Event|1|||
124781625|NCT04380519|448831118|FG002|Overall Study|Adverse Event|0|||
124781626|NCT04380519|448831116|FG000|Overall Study|relatives' decision|0|||
124781627|NCT04380519|448831117|FG001|Overall Study|relatives' decision|1|||
124781628|NCT04380519|448831118|FG002|Overall Study|relatives' decision|0|||
124612860|NCT02278055|448202162|FG000|Overall Study|Withdrawal by Subject|2|||
124612861|NCT02278055|448202162|FG000|Overall Study|Progressive Disease|4|||
124612862|NCT03207243|448202163|FG000|Overall Study|Adverse Event|2|||
124612863|NCT03207243|448202164|FG001|Overall Study|Adverse Event|2|||
124612864|NCT03207243|448202163|FG000|Overall Study|Loss of Asthma Control|47|||
124612865|NCT03207243|448202164|FG001|Overall Study|Loss of Asthma Control|31|||
124612866|NCT03207243|448202163|FG000|Overall Study|Withdrawal by Subject|2|||
124612867|NCT03207243|448202164|FG001|Overall Study|Withdrawal by Subject|4|||
124612868|NCT03207243|448202163|FG000|Overall Study|Physician Decision|1|||
124612869|NCT03207243|448202164|FG001|Overall Study|Physician Decision|1|||
124612870|NCT03207243|448202163|FG000|Overall Study|Lost to Follow-up|0|||
124612871|NCT03207243|448202164|FG001|Overall Study|Lost to Follow-up|1|||
124612872|NCT03207243|448202163|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
124612873|NCT03207243|448202164|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
124612874|NCT03207243|448202163|FG000|Overall Study|Protocol Violation|0|||
124612875|NCT03207243|448202164|FG001|Overall Study|Protocol Violation|3|||
124612876|NCT04015908|448202165|FG000|Overall Study|Lost to Follow-up|0|||
124612877|NCT04015908|448202166|FG001|Overall Study|Lost to Follow-up|1|||
124612878|NCT00715624|448202167|FG000|Overall Study|Adverse Event|12|||
124612879|NCT00715624|448202168|FG001|Overall Study|Adverse Event|37|||
124612880|NCT00715624|448202167|FG000|Overall Study|Lack of Efficacy|11|||
124612881|NCT00715624|448202168|FG001|Overall Study|Lack of Efficacy|11|||
124612882|NCT00715624|448202167|FG000|Overall Study|Lost to Follow-up|1|||
124612883|NCT00715624|448202168|FG001|Overall Study|Lost to Follow-up|2|||
124612884|NCT00715624|448202167|FG000|Overall Study|Protocol Violation|1|||
124612885|NCT00715624|448202168|FG001|Overall Study|Protocol Violation|0|||
124612886|NCT00715624|448202167|FG000|Overall Study|Withdrawal by Subject|11|||
124612887|NCT00715624|448202168|FG001|Overall Study|Withdrawal by Subject|25|||
124612888|NCT00715624|448202167|FG000|Overall Study|Familial and personal reasons|10|||
124612889|NCT00715624|448202168|FG001|Overall Study|Familial and personal reasons|22|||
124612890|NCT00715624|448202167|FG000|Overall Study|Poor compliance|6|||
124612891|NCT00715624|448202168|FG001|Overall Study|Poor compliance|13|||
124612892|NCT00715624|448202167|FG000|Overall Study|Sponsor decision|0|||
124612893|NCT00715624|448202168|FG001|Overall Study|Sponsor decision|4|||
124612894|NCT00715624|448202167|FG000|Overall Study|Incorrect randomization (not treated)|0|||
124612895|NCT00715624|448202168|FG001|Overall Study|Incorrect randomization (not treated)|1|||
124612896|NCT00715624|448202167|FG000|Overall Study|Other|0|||
124612897|NCT00715624|448202168|FG001|Overall Study|Other|1|||
124612898|NCT00229723|448202169|FG000|Concomitant Phase|Adverse Event|4|||
124612899|NCT00229723|448202170|FG001|Concomitant Phase|Adverse Event|2|||
124612900|NCT00229723|448202171|FG002|Concomitant Phase|Adverse Event|5|||
124612901|NCT00229723|448202172|FG003|Concomitant Phase|Adverse Event|2|||
124612902|NCT00229723|448202173|FG004|Concomitant Phase|Adverse Event|0|||
124612903|NCT00229723|448202174|FG005|Concomitant Phase|Adverse Event|1|||
124612904|NCT00229723|448202175|FG006|Concomitant Phase|Adverse Event|2|||
124781629|NCT04173494|448831119|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
124612905|NCT00229723|448202169|FG000|Concomitant Phase|Objective disease progression|0|||
124612906|NCT00229723|448202170|FG001|Concomitant Phase|Objective disease progression|0|||
124612907|NCT00229723|448202171|FG002|Concomitant Phase|Objective disease progression|0|||
124612908|NCT00229723|448202172|FG003|Concomitant Phase|Objective disease progression|0|||
124612909|NCT00229723|448202173|FG004|Concomitant Phase|Objective disease progression|0|||
124612910|NCT00229723|448202174|FG005|Concomitant Phase|Objective disease progression|0|||
124612911|NCT00229723|448202175|FG006|Concomitant Phase|Objective disease progression|0|||
124612912|NCT00229723|448202169|FG000|Concomitant Phase|Clinical progression|0|||
124612913|NCT00229723|448202170|FG001|Concomitant Phase|Clinical progression|0|||
124612914|NCT00229723|448202171|FG002|Concomitant Phase|Clinical progression|0|||
124781630|NCT04173494|448831120|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
124781631|NCT04173494|448831119|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
124781632|NCT04173494|448831120|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
124738655|NCT00159913|448666211|FG003|Overall Study|Lost to Follow-up|1|||
124738656|NCT00159913|448666208|FG000|Overall Study|Protocol Violation|1|||
124738657|NCT00159913|448666209|FG001|Overall Study|Protocol Violation|0|||
124738658|NCT00159913|448666210|FG002|Overall Study|Protocol Violation|1|||
124738659|NCT00159913|448666211|FG003|Overall Study|Protocol Violation|0|||
124738660|NCT00824005|448666212|FG000|Overall Study|Death|0|||
124738661|NCT00824005|448666213|FG001|Overall Study|Death|1|||
124738662|NCT00824005|448666212|FG000|Overall Study|Lost to Follow-up|0|||
124738663|NCT00824005|448666213|FG001|Overall Study|Lost to Follow-up|1|||
124738664|NCT01874275|448666214|FG000|Overall Study|Lost to Follow-up|1|||
124738665|NCT01874275|448666215|FG001|Overall Study|Lost to Follow-up|0|||
124738666|NCT00168103|448666218|FG000|Overall Study|Withdrawal by Subject|1|||
124738667|NCT00168103|448666219|FG001|Overall Study|Withdrawal by Subject|2|||
124738668|NCT00168103|448666220|FG002|Overall Study|Withdrawal by Subject|1|||
124738669|NCT00168103|448666221|FG003|Overall Study|Withdrawal by Subject|0|||
124738670|NCT00168103|448666218|FG000|Overall Study|Lost to Follow-up|1|||
124738671|NCT00168103|448666219|FG001|Overall Study|Lost to Follow-up|3|||
124738672|NCT00168103|448666220|FG002|Overall Study|Lost to Follow-up|0|||
124738673|NCT00168103|448666221|FG003|Overall Study|Lost to Follow-up|0|||
124738674|NCT00989235|448666222|FG000|Overall Study|Death|0|||
124738675|NCT00989235|448666223|FG001|Overall Study|Death|1|||
124738676|NCT00989235|448666222|FG000|Overall Study|Adverse Event|0|||
124738677|NCT00989235|448666223|FG001|Overall Study|Adverse Event|1|||
124738678|NCT00989235|448666222|FG000|Overall Study|Lack of Efficacy|1|||
124738679|NCT00989235|448666223|FG001|Overall Study|Lack of Efficacy|0|||
124738680|NCT00989235|448666222|FG000|Overall Study|Withdrawal of Consent|1|||
124738681|NCT00989235|448666223|FG001|Overall Study|Withdrawal of Consent|1|||
124738682|NCT00989235|448666222|FG000|Overall Study|Desire to Become Pregnant|1|||
124738683|NCT00989235|448666223|FG001|Overall Study|Desire to Become Pregnant|0|||
124738684|NCT00989235|448666222|FG000|Overall Study|Randomized by Mistake|0|||
124738685|NCT00989235|448666223|FG001|Overall Study|Randomized by Mistake|2|||
124738686|NCT00989235|448666222|FG000|Overall Study|Lost to Follow-up|0|||
124738687|NCT00989235|448666223|FG001|Overall Study|Lost to Follow-up|1|||
124738688|NCT02266875|448666224|FG000|Overall Study|Withdrawal by Subject|9|||
124738689|NCT02266875|448666225|FG001|Overall Study|Withdrawal by Subject|0|||
124738690|NCT02266875|448666224|FG000|Overall Study|Lost to Follow-up|2|||
124738691|NCT02266875|448666225|FG001|Overall Study|Lost to Follow-up|0|||
124738692|NCT00875056|448666228|FG000|Overall Study|Adverse Event|6|||
124738693|NCT00875056|448666229|FG001|Overall Study|Adverse Event|1|||
124738694|NCT00875056|448666230|FG002|Overall Study|Adverse Event|2|||
124738695|NCT00875056|448666228|FG000|Overall Study|Progressive Disease|14|||
124738696|NCT00875056|448666229|FG001|Overall Study|Progressive Disease|8|||
124738697|NCT00875056|448666230|FG002|Overall Study|Progressive Disease|3|||
124738698|NCT00875056|448666228|FG000|Overall Study|Withdrawal by Subject|3|||
124738699|NCT00875056|448666229|FG001|Overall Study|Withdrawal by Subject|0|||
124738700|NCT00875056|448666230|FG002|Overall Study|Withdrawal by Subject|1|||
124738701|NCT01318070|448666231|FG000|Overall Study|Adverse Event|1|||
124738702|NCT01318070|448666232|FG001|Overall Study|Adverse Event|1|||
124738703|NCT01318070|448666233|FG002|Overall Study|Adverse Event|5|||
124738704|NCT01318070|448666231|FG000|Overall Study|Withdrawal by Subject|0|||
124738705|NCT01318070|448666232|FG001|Overall Study|Withdrawal by Subject|1|||
124738706|NCT01318070|448666233|FG002|Overall Study|Withdrawal by Subject|1|||
124738707|NCT01318070|448666231|FG000|Overall Study|Lack of Efficacy|0|||
124738708|NCT01318070|448666232|FG001|Overall Study|Lack of Efficacy|0|||
124738709|NCT01318070|448666233|FG002|Overall Study|Lack of Efficacy|1|||
124738710|NCT01318070|448666231|FG000|Overall Study|Principal Investigator Discretion|1|||
124738711|NCT01318070|448666232|FG001|Overall Study|Principal Investigator Discretion|0|||
124738712|NCT01318070|448666233|FG002|Overall Study|Principal Investigator Discretion|0|||
124738713|NCT02956850|448666234|FG000|Overall Study|Withdrawal by Subject|0|||
124738714|NCT02956850|448666235|FG001|Overall Study|Withdrawal by Subject|0|||
124781633|NCT04173494|448831119|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
124612915|NCT00229723|448202172|FG003|Concomitant Phase|Clinical progression|0|||
124612916|NCT00229723|448202173|FG004|Concomitant Phase|Clinical progression|0|||
124738715|NCT02956850|448666236|FG002|Overall Study|Withdrawal by Subject|0|||
124738716|NCT02956850|448666237|FG003|Overall Study|Withdrawal by Subject|0|||
124738717|NCT02956850|448666238|FG004|Overall Study|Withdrawal by Subject|0|||
124738718|NCT02956850|448666239|FG005|Overall Study|Withdrawal by Subject|0|||
124738719|NCT02956850|448666240|FG006|Overall Study|Withdrawal by Subject|0|||
124738720|NCT02956850|448666241|FG007|Overall Study|Withdrawal by Subject|0|||
124738721|NCT02956850|448666242|FG008|Overall Study|Withdrawal by Subject|0|||
124738722|NCT02956850|448666243|FG009|Overall Study|Withdrawal by Subject|0|||
124738723|NCT02956850|448666244|FG010|Overall Study|Withdrawal by Subject|0|||
124738724|NCT02956850|448666245|FG011|Overall Study|Withdrawal by Subject|0|||
124738725|NCT02956850|448666246|FG012|Overall Study|Withdrawal by Subject|0|||
124738726|NCT02956850|448666247|FG013|Overall Study|Withdrawal by Subject|0|||
124738727|NCT02956850|448666248|FG014|Overall Study|Withdrawal by Subject|0|||
124738728|NCT02956850|448666249|FG015|Overall Study|Withdrawal by Subject|0|||
124738729|NCT02956850|448666250|FG016|Overall Study|Withdrawal by Subject|0|||
124612917|NCT00229723|448202174|FG005|Concomitant Phase|Clinical progression|0|||
124612918|NCT00229723|448202175|FG006|Concomitant Phase|Clinical progression|1|||
124612919|NCT00229723|448202169|FG000|Concomitant Phase|Lost to Follow-up|0|||
124612920|NCT00229723|448202170|FG001|Concomitant Phase|Lost to Follow-up|0|||
124612921|NCT00229723|448202171|FG002|Concomitant Phase|Lost to Follow-up|0|||
124612922|NCT00229723|448202172|FG003|Concomitant Phase|Lost to Follow-up|0|||
124612923|NCT00229723|448202173|FG004|Concomitant Phase|Lost to Follow-up|1|||
124612924|NCT00229723|448202174|FG005|Concomitant Phase|Lost to Follow-up|0|||
124612925|NCT00229723|448202175|FG006|Concomitant Phase|Lost to Follow-up|0|||
124612926|NCT00229723|448202169|FG000|Concomitant Phase|Informed consent withdrawn|3|||
124612927|NCT00229723|448202170|FG001|Concomitant Phase|Informed consent withdrawn|2|||
124612928|NCT00229723|448202171|FG002|Concomitant Phase|Informed consent withdrawn|0|||
124612929|NCT00229723|448202172|FG003|Concomitant Phase|Informed consent withdrawn|2|||
124612930|NCT00229723|448202173|FG004|Concomitant Phase|Informed consent withdrawn|0|||
124612931|NCT00229723|448202174|FG005|Concomitant Phase|Informed consent withdrawn|0|||
124612932|NCT00229723|448202175|FG006|Concomitant Phase|Informed consent withdrawn|0|||
124612933|NCT00229723|448202169|FG000|Concomitant Phase|Severe non-compliance|0|||
124612934|NCT00229723|448202170|FG001|Concomitant Phase|Severe non-compliance|1|||
124612935|NCT00229723|448202171|FG002|Concomitant Phase|Severe non-compliance|0|||
124612936|NCT00229723|448202172|FG003|Concomitant Phase|Severe non-compliance|0|||
124612937|NCT00229723|448202173|FG004|Concomitant Phase|Severe non-compliance|1|||
124612938|NCT00229723|448202174|FG005|Concomitant Phase|Severe non-compliance|0|||
124612939|NCT00229723|448202175|FG006|Concomitant Phase|Severe non-compliance|0|||
124612940|NCT00229723|448202169|FG000|Concomitant Phase|Other|3|||
124612941|NCT00229723|448202170|FG001|Concomitant Phase|Other|0|||
124612942|NCT00229723|448202171|FG002|Concomitant Phase|Other|1|||
124612943|NCT00229723|448202172|FG003|Concomitant Phase|Other|1|||
124612944|NCT00229723|448202173|FG004|Concomitant Phase|Other|0|||
124612945|NCT00229723|448202174|FG005|Concomitant Phase|Other|2|||
124612946|NCT00229723|448202175|FG006|Concomitant Phase|Other|0|||
124612947|NCT00229723|448202169|FG000|Maintenance Phase|Adverse Event|7|||
124612948|NCT00229723|448202170|FG001|Maintenance Phase|Adverse Event|2|||
124612949|NCT00229723|448202171|FG002|Maintenance Phase|Adverse Event|1|||
124612950|NCT00229723|448202172|FG003|Maintenance Phase|Adverse Event|4|||
124612951|NCT00229723|448202173|FG004|Maintenance Phase|Adverse Event|7|||
124612952|NCT00229723|448202174|FG005|Maintenance Phase|Adverse Event|5|||
124612953|NCT00229723|448202175|FG006|Maintenance Phase|Adverse Event|2|||
124612954|NCT00229723|448202169|FG000|Maintenance Phase|Objective disease progression|5|||
124612955|NCT00229723|448202170|FG001|Maintenance Phase|Objective disease progression|5|||
124612956|NCT00229723|448202171|FG002|Maintenance Phase|Objective disease progression|3|||
124612957|NCT00229723|448202172|FG003|Maintenance Phase|Objective disease progression|6|||
124612958|NCT00229723|448202173|FG004|Maintenance Phase|Objective disease progression|2|||
124612959|NCT00229723|448202174|FG005|Maintenance Phase|Objective disease progression|9|||
124612960|NCT00229723|448202175|FG006|Maintenance Phase|Objective disease progression|5|||
124612961|NCT00229723|448202169|FG000|Maintenance Phase|Clinical progression|4|||
124612962|NCT00229723|448202170|FG001|Maintenance Phase|Clinical progression|1|||
124612963|NCT00229723|448202171|FG002|Maintenance Phase|Clinical progression|2|||
124612964|NCT00229723|448202172|FG003|Maintenance Phase|Clinical progression|2|||
124612965|NCT00229723|448202173|FG004|Maintenance Phase|Clinical progression|1|||
124612966|NCT00229723|448202174|FG005|Maintenance Phase|Clinical progression|1|||
124612967|NCT00229723|448202175|FG006|Maintenance Phase|Clinical progression|1|||
124612968|NCT00229723|448202169|FG000|Maintenance Phase|Lost to Follow-up|0|||
124612969|NCT00229723|448202170|FG001|Maintenance Phase|Lost to Follow-up|1|||
124612970|NCT00229723|448202171|FG002|Maintenance Phase|Lost to Follow-up|2|||
124612971|NCT00229723|448202172|FG003|Maintenance Phase|Lost to Follow-up|2|||
124612972|NCT00229723|448202173|FG004|Maintenance Phase|Lost to Follow-up|0|||
124612973|NCT00229723|448202174|FG005|Maintenance Phase|Lost to Follow-up|0|||
124612974|NCT00229723|448202175|FG006|Maintenance Phase|Lost to Follow-up|1|||
124612975|NCT00229723|448202169|FG000|Maintenance Phase|Informed consent withdrawn|1|||
124612976|NCT00229723|448202170|FG001|Maintenance Phase|Informed consent withdrawn|0|||
124612977|NCT00229723|448202171|FG002|Maintenance Phase|Informed consent withdrawn|0|||
124612978|NCT00229723|448202172|FG003|Maintenance Phase|Informed consent withdrawn|1|||
124612979|NCT00229723|448202173|FG004|Maintenance Phase|Informed consent withdrawn|1|||
124612980|NCT00229723|448202174|FG005|Maintenance Phase|Informed consent withdrawn|1|||
124612981|NCT00229723|448202175|FG006|Maintenance Phase|Informed consent withdrawn|0|||
124612982|NCT00229723|448202169|FG000|Maintenance Phase|Severe non-compliance|3|||
124612983|NCT00229723|448202170|FG001|Maintenance Phase|Severe non-compliance|1|||
124612984|NCT00229723|448202171|FG002|Maintenance Phase|Severe non-compliance|0|||
124612985|NCT00229723|448202172|FG003|Maintenance Phase|Severe non-compliance|0|||
124612986|NCT00229723|448202173|FG004|Maintenance Phase|Severe non-compliance|1|||
124612987|NCT00229723|448202174|FG005|Maintenance Phase|Severe non-compliance|0|||
124612988|NCT00229723|448202175|FG006|Maintenance Phase|Severe non-compliance|0|||
124612989|NCT00229723|448202169|FG000|Maintenance Phase|Other|5|||
124612990|NCT00229723|448202170|FG001|Maintenance Phase|Other|4|||
124612991|NCT00229723|448202171|FG002|Maintenance Phase|Other|1|||
124612992|NCT00229723|448202172|FG003|Maintenance Phase|Other|2|||
124738730|NCT02956850|448666251|FG017|Overall Study|Withdrawal by Subject|1|||
124738731|NCT00391391|448666252|FG000|Overall Study|Adverse Event|0|||
124738732|NCT00391391|448666253|FG001|Overall Study|Adverse Event|0|||
124738733|NCT00391391|448666254|FG002|Overall Study|Adverse Event|0|||
124738734|NCT00391391|448666255|FG003|Overall Study|Adverse Event|1|||
124738735|NCT00391391|448666252|FG000|Overall Study|Lost to Follow-up|1|||
124738736|NCT00391391|448666253|FG001|Overall Study|Lost to Follow-up|3|||
124738737|NCT00391391|448666254|FG002|Overall Study|Lost to Follow-up|7|||
124738738|NCT00391391|448666255|FG003|Overall Study|Lost to Follow-up|4|||
124738739|NCT00391391|448666252|FG000|Overall Study|Protocol Violation|2|||
124738740|NCT00391391|448666253|FG001|Overall Study|Protocol Violation|3|||
124738741|NCT00391391|448666254|FG002|Overall Study|Protocol Violation|6|||
124738742|NCT00391391|448666255|FG003|Overall Study|Protocol Violation|7|||
124738743|NCT00391391|448666252|FG000|Overall Study|Withdrawal by Subject|6|||
124738744|NCT00391391|448666253|FG001|Overall Study|Withdrawal by Subject|4|||
124738745|NCT00391391|448666254|FG002|Overall Study|Withdrawal by Subject|10|||
124738746|NCT00391391|448666255|FG003|Overall Study|Withdrawal by Subject|7|||
124738747|NCT01920152|448666258|FG000|Overall Study|Withdrawal by Subject|1|||
124738748|NCT01920152|448666259|FG001|Overall Study|Withdrawal by Subject|2|||
124738749|NCT01995552|448666262|FG000|Overall Study|Protocol Violation|1|||
124738750|NCT01995552|448666262|FG000|Overall Study|Lack of Efficacy|15|||
124738751|NCT01995552|448666262|FG000|Overall Study|Death|1|||
124781634|NCT04173494|448831120|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
124781635|NCT04173494|448831119|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
124781636|NCT04173494|448831120|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
124781637|NCT04173494|448831119|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
124781638|NCT04173494|448831120|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
124781639|NCT04173494|448831119|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
124781640|NCT04173494|448831120|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
124781641|NCT04173494|448831119|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
124781642|NCT04173494|448831120|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
124612993|NCT00229723|448202173|FG004|Maintenance Phase|Other|3|||
124612994|NCT00229723|448202174|FG005|Maintenance Phase|Other|3|||
124781643|NCT04173494|448831119|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
124781644|NCT04173494|448831120|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
124781645|NCT04173494|448831119|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
124781646|NCT04173494|448831120|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
124781647|NCT04173494|448831119|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
124781648|NCT04173494|448831120|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
124781649|NCT04173494|448831119|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
124781650|NCT04173494|448831120|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
124781651|NCT04173494|448831119|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
124781652|NCT04173494|448831120|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
124781653|NCT04173494|448831119|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
124781654|NCT04173494|448831120|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
124781655|NCT04173494|448831119|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
124612995|NCT00229723|448202175|FG006|Maintenance Phase|Other|1|||
124612996|NCT03421730|448202178|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
124612997|NCT03421730|448202179|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
124612998|NCT03421730|448202180|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
124612999|NCT03421730|448202181|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
124613000|NCT03421730|448202182|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
124613001|NCT03421730|448202183|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
124613002|NCT03421730|448202184|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
124613003|NCT03421730|448202185|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
124613004|NCT03421730|448202186|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
124613005|NCT03421730|448202187|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
124613006|NCT03421730|448202188|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
124613007|NCT03421730|448202189|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
124613008|NCT03421730|448202178|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
124613009|NCT03421730|448202179|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
124738752|NCT00353873|448666263|FG000|Overall Study|Protocol Violation|1|||
124738753|NCT00353873|448666264|FG001|Overall Study|Protocol Violation|2|||
124738754|NCT00353873|448666263|FG000|Overall Study|Exacerbation|1|||
124738755|NCT00353873|448666264|FG001|Overall Study|Exacerbation|0|||
124738756|NCT00353873|448666263|FG000|Overall Study|Adverse Event|1|||
124738757|NCT00353873|448666264|FG001|Overall Study|Adverse Event|0|||
124738758|NCT00353873|448666263|FG000|Overall Study|Physician Decision|2|||
124738759|NCT00353873|448666264|FG001|Overall Study|Physician Decision|0|||
124613010|NCT03421730|448202180|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
124613011|NCT03421730|448202181|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
124613012|NCT03421730|448202182|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
124613013|NCT03421730|448202183|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
124613014|NCT03421730|448202184|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
124613015|NCT03421730|448202185|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
124613016|NCT03421730|448202186|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
124613017|NCT03421730|448202187|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
124781656|NCT04173494|448831120|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
124781657|NCT04173494|448831119|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
124781658|NCT04173494|448831120|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
124781659|NCT04173494|448831119|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
124781660|NCT04173494|448831120|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
124781661|NCT02474069|448831121|FG000|Selection Phase (SP)|Adverse Event|8|||
124781662|NCT02474069|448831122|FG001|Selection Phase (SP)|Adverse Event|0|||
124781663|NCT02474069|448831123|FG002|Selection Phase (SP)|Adverse Event|0|||
124781664|NCT02474069|448831121|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
124613018|NCT03421730|448202188|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
124613019|NCT03421730|448202189|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
124613020|NCT03016975|448202196|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
124613021|NCT03016975|448202197|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
124613022|NCT03016975|448202198|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
124613023|NCT03016975|448202196|FG000|At 6 Months Follow-up|Death|2|||
124613024|NCT03016975|448202197|FG001|At 6 Months Follow-up|Death|0|||
124613025|NCT03016975|448202198|FG002|At 6 Months Follow-up|Death|0|||
124613026|NCT03016975|448202196|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
124613027|NCT03016975|448202197|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
124613028|NCT03016975|448202198|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
124613029|NCT03016975|448202196|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
124613030|NCT03016975|448202197|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
124613031|NCT03016975|448202198|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
124613032|NCT03016975|448202196|FG000|At 6 Months Follow-up|Aborted implant|1|||
124613033|NCT03016975|448202197|FG001|At 6 Months Follow-up|Aborted implant|0|||
124613034|NCT03016975|448202198|FG002|At 6 Months Follow-up|Aborted implant|0|||
124613035|NCT03016975|448202196|FG000|At 2 Year Follow-up|Death|1|||
124613036|NCT03016975|448202197|FG001|At 2 Year Follow-up|Death|0|||
124613037|NCT03016975|448202198|FG002|At 2 Year Follow-up|Death|0|||
124613038|NCT03016975|448202196|FG000|At 3 Year Follow-up|Death|1|||
124613039|NCT03016975|448202197|FG001|At 3 Year Follow-up|Death|0|||
124613040|NCT03016975|448202198|FG002|At 3 Year Follow-up|Death|0|||
124613041|NCT03016975|448202196|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
124613042|NCT03016975|448202197|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
124613043|NCT03016975|448202198|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
124613044|NCT03016975|448202196|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
124738760|NCT00353873|448666263|FG000|Overall Study|Withdrawal by Subject|1|||
124738761|NCT00353873|448666264|FG001|Overall Study|Withdrawal by Subject|1|||
124738762|NCT00870194|448666267|FG000|Overall Study|Adverse Event|10|||
124738763|NCT00870194|448666268|FG001|Overall Study|Adverse Event|5|||
124738764|NCT00870194|448666267|FG000|Overall Study|Lack of Efficacy|0|||
124738765|NCT00870194|448666268|FG001|Overall Study|Lack of Efficacy|1|||
124738766|NCT00870194|448666267|FG000|Overall Study|Lost to Follow-up|2|||
124613045|NCT03016975|448202197|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
124613046|NCT03016975|448202198|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
124613047|NCT01590797|448202199|FG000|Overall Study|Adverse Event|4|||
124613048|NCT01590797|448202200|FG001|Overall Study|Adverse Event|3|||
124613049|NCT01590797|448202199|FG000|Overall Study|Lack of Efficacy|0|||
124613050|NCT01590797|448202200|FG001|Overall Study|Lack of Efficacy|2|||
124738767|NCT00870194|448666268|FG001|Overall Study|Lost to Follow-up|0|||
124781665|NCT02474069|448831122|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
124613051|NCT01590797|448202199|FG000|Overall Study|Lost to Follow-up|0|||
124613052|NCT01590797|448202200|FG001|Overall Study|Lost to Follow-up|1|||
124613053|NCT01590797|448202199|FG000|Overall Study|Protocol Violation|4|||
124613054|NCT01590797|448202200|FG001|Overall Study|Protocol Violation|1|||
124613055|NCT01590797|448202199|FG000|Overall Study|Withdrawal by Subject|7|||
124613056|NCT01590797|448202200|FG001|Overall Study|Withdrawal by Subject|5|||
124613057|NCT01590797|448202199|FG000|Overall Study|Other Protocol Specified Criteria|2|||
124613058|NCT01590797|448202200|FG001|Overall Study|Other Protocol Specified Criteria|4|||
124613059|NCT02901548|448202203|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
124738768|NCT00870194|448666267|FG000|Overall Study|Physician Decision|3|||
124738769|NCT00870194|448666268|FG001|Overall Study|Physician Decision|1|||
124781666|NCT02474069|448831123|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
124781667|NCT02474069|448831121|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
124738770|NCT00870194|448666267|FG000|Overall Study|Protocol Violation|3|||
124738771|NCT00870194|448666268|FG001|Overall Study|Protocol Violation|3|||
124738772|NCT00870194|448666267|FG000|Overall Study|Entry Criteria Not Met|1|||
124738773|NCT00870194|448666268|FG001|Overall Study|Entry Criteria Not Met|2|||
124738774|NCT00870194|448666267|FG000|Overall Study|Subject Decision|7|||
124738775|NCT00870194|448666268|FG001|Overall Study|Subject Decision|2|||
124738776|NCT02717130|448666269|FG000|Overall Study|Withdrawal by Subject|1|||
124738777|NCT02717130|448666269|FG000|Overall Study|Adverse Event|1|||
124738778|NCT02717130|448666269|FG000|Overall Study|Physician Decision|1|||
124738779|NCT02717130|448666269|FG000|Overall Study|Study Closure|4|||
124738780|NCT00554099|448666270|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
124738781|NCT00554099|448666271|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
124738782|NCT00554099|448666272|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
124738783|NCT00554099|448666270|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
124738784|NCT00554099|448666271|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
124738785|NCT00554099|448666272|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
124738786|NCT00554099|448666270|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
124738787|NCT00554099|448666271|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
124738788|NCT00554099|448666272|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
124738789|NCT00554099|448666270|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
124738790|NCT00554099|448666271|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
124738791|NCT00554099|448666272|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
124738792|NCT00554099|448666270|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
124738793|NCT00554099|448666271|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
124738794|NCT00554099|448666272|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
124738795|NCT00554099|448666270|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
124738796|NCT00554099|448666271|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
124738797|NCT00554099|448666272|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
124738798|NCT00554099|448666270|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
124738799|NCT00554099|448666271|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
124738800|NCT00554099|448666272|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
124738801|NCT00554099|448666270|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
124738802|NCT00554099|448666271|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
124738803|NCT00554099|448666272|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
124738804|NCT00554099|448666270|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
124738805|NCT00554099|448666271|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
124738806|NCT00554099|448666272|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
124738807|NCT01443130|448666273|FG000|Overall Study|Lost to Follow-up|44|||
124738808|NCT01443130|448666274|FG001|Overall Study|Lost to Follow-up|42|||
124738809|NCT01443130|448666275|FG002|Overall Study|Lost to Follow-up|50|||
124738810|NCT01443130|448666276|FG003|Overall Study|Lost to Follow-up|23|||
124738811|NCT01443130|448666277|FG004|Overall Study|Lost to Follow-up|25|||
124738812|NCT01443130|448666278|FG005|Overall Study|Lost to Follow-up|21|||
124738813|NCT01443130|448666273|FG000|Overall Study|Death|0|||
124738814|NCT01443130|448666274|FG001|Overall Study|Death|1|||
124738815|NCT01443130|448666275|FG002|Overall Study|Death|0|||
124738816|NCT01443130|448666276|FG003|Overall Study|Death|7|||
124738817|NCT01443130|448666277|FG004|Overall Study|Death|10|||
124738818|NCT01443130|448666278|FG005|Overall Study|Death|8|||
124738819|NCT01443130|448666273|FG000|Overall Study|Adverse Event|2|||
124738820|NCT01443130|448666274|FG001|Overall Study|Adverse Event|1|||
124738821|NCT01443130|448666275|FG002|Overall Study|Adverse Event|1|||
124738822|NCT01443130|448666276|FG003|Overall Study|Adverse Event|0|||
124738823|NCT01443130|448666277|FG004|Overall Study|Adverse Event|0|||
124738824|NCT01443130|448666278|FG005|Overall Study|Adverse Event|0|||
124738825|NCT01443130|448666273|FG000|Overall Study|Protocol Violation|2|||
124738826|NCT01443130|448666274|FG001|Overall Study|Protocol Violation|1|||
124738827|NCT01443130|448666275|FG002|Overall Study|Protocol Violation|3|||
124738828|NCT01443130|448666276|FG003|Overall Study|Protocol Violation|2|||
124738829|NCT01443130|448666277|FG004|Overall Study|Protocol Violation|2|||
124738830|NCT01443130|448666278|FG005|Overall Study|Protocol Violation|3|||
124738831|NCT01443130|448666273|FG000|Overall Study|Withdrawal by Subject|15|||
124738832|NCT01443130|448666274|FG001|Overall Study|Withdrawal by Subject|14|||
124738833|NCT01443130|448666275|FG002|Overall Study|Withdrawal by Subject|12|||
124738834|NCT01443130|448666276|FG003|Overall Study|Withdrawal by Subject|7|||
124738835|NCT01443130|448666277|FG004|Overall Study|Withdrawal by Subject|7|||
124738836|NCT01443130|448666278|FG005|Overall Study|Withdrawal by Subject|2|||
124738837|NCT01443130|448666273|FG000|Overall Study|Death of Subject's Infant|5|||
124738838|NCT01443130|448666274|FG001|Overall Study|Death of Subject's Infant|10|||
124738839|NCT01443130|448666275|FG002|Overall Study|Death of Subject's Infant|11|||
124738840|NCT01443130|448666276|FG003|Overall Study|Death of Subject's Infant|0|||
124738841|NCT01443130|448666277|FG004|Overall Study|Death of Subject's Infant|0|||
124738842|NCT01443130|448666278|FG005|Overall Study|Death of Subject's Infant|0|||
124738843|NCT03461406|448666281|FG000|Overall Study|Death|1|||
124738844|NCT03461406|448666282|FG001|Overall Study|Death|2|||
124738845|NCT03461406|448666281|FG000|Overall Study|Consent Withdrawn by Participant|0|||
124613060|NCT01696279|448202207|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
124613061|NCT01696279|448202208|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
124613062|NCT01696279|448202209|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
124613063|NCT01696279|448202210|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
124613064|NCT01696279|448202207|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
124613065|NCT01696279|448202208|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
124613066|NCT01696279|448202209|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
124613067|NCT01696279|448202210|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
124613068|NCT01696279|448202207|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
124613069|NCT01696279|448202208|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
124613070|NCT01696279|448202209|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
124613071|NCT01696279|448202210|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
124613072|NCT01696279|448202207|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
124613073|NCT01696279|448202208|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
124613074|NCT01696279|448202209|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
124613075|NCT01696279|448202210|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
124613076|NCT01696279|448202207|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
124613077|NCT01696279|448202208|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
124613078|NCT01696279|448202209|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
124613079|NCT01696279|448202210|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
124613080|NCT01696279|448202207|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
124613081|NCT01696279|448202208|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
124613082|NCT01696279|448202209|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
124613083|NCT01696279|448202210|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
124613084|NCT01696279|448202207|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
124613085|NCT01696279|448202208|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
124613086|NCT01696279|448202209|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
124613087|NCT01696279|448202210|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
124613088|NCT01696279|448202207|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
124613089|NCT01696279|448202208|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
124613090|NCT01696279|448202209|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
124613091|NCT01696279|448202210|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
124613092|NCT01696279|448202207|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
124613093|NCT01696279|448202208|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
124613094|NCT01696279|448202209|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
124613095|NCT01696279|448202210|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
124613096|NCT01696279|448202207|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
124613097|NCT01696279|448202208|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
124613098|NCT01696279|448202209|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
124613099|NCT01696279|448202210|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
124613100|NCT01696279|448202207|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
124613101|NCT01696279|448202208|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
124613102|NCT01696279|448202209|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
124613103|NCT01696279|448202210|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
124613104|NCT04106661|448202215|FG000|Overall Study|Protocol Violation|3|||
124613105|NCT04106661|448202216|FG001|Overall Study|Protocol Violation|0|||
124613106|NCT04106661|448202215|FG000|Overall Study|Scheduling difficulties|1|||
124613107|NCT04106661|448202216|FG001|Overall Study|Scheduling difficulties|1|||
124613108|NCT03503864|448202217|FG000|Overall Study|Protocol Violation|6|||
124613109|NCT03503864|448202217|FG000|Overall Study|Withdrawal by Subject|7|||
124613110|NCT02639052|448202219|FG000|Overall Study|Lost to Follow-up|1|||
124613111|NCT02730351|448202220|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
124613112|NCT02730351|448202221|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
124613113|NCT02730351|448202220|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
124613114|NCT02730351|448202221|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
124613115|NCT02730351|448202220|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
124613116|NCT02730351|448202221|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
124738846|NCT03461406|448666282|FG001|Overall Study|Consent Withdrawn by Participant|1|||
124738847|NCT03461406|448666281|FG000|Overall Study|Screen Failure|3|||
124738848|NCT03461406|448666282|FG001|Overall Study|Screen Failure|1|||
124738849|NCT03461406|448666281|FG000|Overall Study|Reason not Specified|1|||
124738850|NCT03461406|448666282|FG001|Overall Study|Reason not Specified|3|||
124738851|NCT03461406|448666281|FG000|Overall Study|Lost to Follow-up|3|||
124738852|NCT03461406|448666282|FG001|Overall Study|Lost to Follow-up|0|||
124738853|NCT01011933|448666285|FG000|Overall Study|Wrong cell type|1|||
124738854|NCT01011933|448666285|FG000|Overall Study|Improper pre-protocol Rx|1|||
124738855|NCT01011933|448666285|FG000|Overall Study|Inadequate pathology|1|||
124738856|NCT01011933|448666285|FG000|Overall Study|Never treated|1|||
124738857|NCT01439074|448666286|FG000|Overall Study|Lost to Follow-up|3|||
124738858|NCT01439074|448666287|FG001|Overall Study|Lost to Follow-up|4|||
124738859|NCT01439074|448666286|FG000|Overall Study|Subject shedding|1|||
124738860|NCT01439074|448666287|FG001|Overall Study|Subject shedding|0|||
124738861|NCT01439074|448666286|FG000|Overall Study|Withdrawal by Subject|1|||
124738862|NCT01439074|448666287|FG001|Overall Study|Withdrawal by Subject|5|||
124738863|NCT01439074|448666286|FG000|Overall Study|Other|4|||
124738864|NCT01439074|448666287|FG001|Overall Study|Other|4|||
124738865|NCT00612508|448666288|FG000|Overall Study|Withdrawal by Subject|3|||
124738866|NCT00612508|448666289|FG001|Overall Study|Withdrawal by Subject|4|||
124738867|NCT02012686|448666290|FG000|Overall Study|muscle contraction|0|||
124738868|NCT02012686|448666291|FG001|Overall Study|muscle contraction|1|||
124738869|NCT02012686|448666290|FG000|Overall Study|electrocardiography monitoring noise|0|||
124738870|NCT02012686|448666291|FG001|Overall Study|electrocardiography monitoring noise|1|||
124738871|NCT01442064|448666292|FG000|Overall Study|Adverse Event|2|||
124738872|NCT01442064|448666293|FG001|Overall Study|Adverse Event|2|||
124738873|NCT01442064|448666294|FG002|Overall Study|Adverse Event|2|||
124738874|NCT01442064|448666295|FG003|Overall Study|Adverse Event|1|||
124738875|NCT01442064|448666296|FG004|Overall Study|Adverse Event|2|||
124613117|NCT02730351|448202220|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
124738876|NCT01442064|448666297|FG005|Overall Study|Adverse Event|0|||
124738877|NCT01442064|448666292|FG000|Overall Study|Death|0|||
124738878|NCT01442064|448666293|FG001|Overall Study|Death|1|||
124738879|NCT01442064|448666294|FG002|Overall Study|Death|3|||
124738880|NCT01442064|448666295|FG003|Overall Study|Death|3|||
124738881|NCT01442064|448666296|FG004|Overall Study|Death|1|||
124738882|NCT01442064|448666297|FG005|Overall Study|Death|3|||
124738883|NCT01442064|448666292|FG000|Overall Study|Lost to Follow-up|5|||
124738884|NCT01442064|448666293|FG001|Overall Study|Lost to Follow-up|5|||
124738885|NCT01442064|448666294|FG002|Overall Study|Lost to Follow-up|1|||
124738886|NCT01442064|448666295|FG003|Overall Study|Lost to Follow-up|1|||
124738887|NCT01442064|448666296|FG004|Overall Study|Lost to Follow-up|3|||
124738888|NCT01442064|448666297|FG005|Overall Study|Lost to Follow-up|3|||
124738889|NCT01442064|448666292|FG000|Overall Study|Physician Decision|1|||
124738890|NCT01442064|448666293|FG001|Overall Study|Physician Decision|1|||
124738891|NCT01442064|448666294|FG002|Overall Study|Physician Decision|2|||
124738892|NCT01442064|448666295|FG003|Overall Study|Physician Decision|3|||
124738893|NCT01442064|448666296|FG004|Overall Study|Physician Decision|3|||
124738894|NCT01442064|448666297|FG005|Overall Study|Physician Decision|1|||
124738895|NCT01442064|448666292|FG000|Overall Study|Withdrawal by Subject|6|||
124738896|NCT01442064|448666293|FG001|Overall Study|Withdrawal by Subject|3|||
124738897|NCT01442064|448666294|FG002|Overall Study|Withdrawal by Subject|2|||
124738898|NCT01442064|448666295|FG003|Overall Study|Withdrawal by Subject|2|||
124738899|NCT01442064|448666296|FG004|Overall Study|Withdrawal by Subject|2|||
124738900|NCT01442064|448666297|FG005|Overall Study|Withdrawal by Subject|1|||
124738901|NCT01442064|448666292|FG000|Overall Study|Sponsor decision|82|||
124738902|NCT01442064|448666293|FG001|Overall Study|Sponsor decision|88|||
124738903|NCT01442064|448666294|FG002|Overall Study|Sponsor decision|92|||
124738904|NCT01442064|448666295|FG003|Overall Study|Sponsor decision|88|||
124738905|NCT01442064|448666296|FG004|Overall Study|Sponsor decision|95|||
124738906|NCT01442064|448666297|FG005|Overall Study|Sponsor decision|87|||
124738907|NCT01442064|448666292|FG000|Overall Study|Subject non-compliance|0|||
124738908|NCT01442064|448666293|FG001|Overall Study|Subject non-compliance|0|||
124738909|NCT01442064|448666294|FG002|Overall Study|Subject non-compliance|0|||
124738910|NCT01442064|448666295|FG003|Overall Study|Subject non-compliance|0|||
124738911|NCT01442064|448666296|FG004|Overall Study|Subject non-compliance|0|||
124738912|NCT01442064|448666297|FG005|Overall Study|Subject non-compliance|2|||
124738913|NCT01442064|448666292|FG000|Overall Study|Condition mandated other intervention|1|||
124738914|NCT01442064|448666293|FG001|Overall Study|Condition mandated other intervention|1|||
124738915|NCT01442064|448666294|FG002|Overall Study|Condition mandated other intervention|2|||
124738916|NCT01442064|448666295|FG003|Overall Study|Condition mandated other intervention|0|||
124738917|NCT01442064|448666296|FG004|Overall Study|Condition mandated other intervention|0|||
124738918|NCT01442064|448666297|FG005|Overall Study|Condition mandated other intervention|2|||
124738919|NCT01703065|448666298|FG000|Overall Study|Lack of Efficacy|1|||
124738920|NCT01703065|448666299|FG001|Overall Study|Lack of Efficacy|0|||
124738921|NCT02635347|448666300|FG000|Overall Study|Failed screening|20|||
124738922|NCT02635347|448666301|FG001|Overall Study|Failed screening|7|||
124738923|NCT00514020|448666303|FG000|Overall Study|Adverse Event|6|||
124738924|NCT00514020|448666303|FG000|Overall Study|Withdrawal by Subject|3|||
124738925|NCT00514020|448666303|FG000|Overall Study|Physician Decision|1|||
124738926|NCT00514020|448666303|FG000|Overall Study|disease progression|9|||
124781668|NCT02474069|448831122|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
124781669|NCT02474069|448831123|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
124781670|NCT02474069|448831121|FG000|Selection Phase (SP)|Physician Decision|1|||
124738927|NCT00514020|448666303|FG000|Overall Study|other complicating disease|2|||
124738928|NCT00514020|448666303|FG000|Overall Study|patient went to radiation treatment|1|||
124738929|NCT00514020|448666303|FG000|Overall Study|"patients moved to the no tx group"|6|||
124738930|NCT01688921|448666304|FG000|Overall Study|Lost to Follow-up|7|||
124613118|NCT02730351|448202221|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
124613119|NCT02730351|448202220|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
124613120|NCT02730351|448202221|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
124613121|NCT00838435|448202222|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
124613122|NCT00838435|448202222|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
124613123|NCT00838435|448202222|FG000|Part 2 (7 Years)|Adverse Event|2|||
124613124|NCT00838435|448202222|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
124613125|NCT00838435|448202222|FG000|Part 2 (7 Years)|Physician Decision|1|||
124613126|NCT00838435|448202222|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
124613127|NCT00838435|448202222|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
124613128|NCT03796039|448202224|FG000|Overall Study|Death|2|||
124613129|NCT03796039|448202225|FG001|Overall Study|Death|1|||
124613130|NCT03796039|448202224|FG000|Overall Study|Withdrawal by Subject|7|||
124613131|NCT03796039|448202225|FG001|Overall Study|Withdrawal by Subject|4|||
124613132|NCT00530218|448202226|FG000|Overall Study|CMV Not Detected|13|||
124613133|NCT00530218|448202226|FG000|Overall Study|Death|12|||
124613134|NCT04642365|448202232|FG000|Overall Study|Death|3|||
124613135|NCT04642365|448202233|FG001|Overall Study|Death|2|||
124613136|NCT04642365|448202234|FG002|Overall Study|Death|4|||
124613137|NCT04642365|448202235|FG003|Overall Study|Death|5|||
124613138|NCT04642365|448202236|FG004|Overall Study|Death|5|||
124613139|NCT04642365|448202237|FG005|Overall Study|Death|3|||
124613140|NCT04642365|448202238|FG006|Overall Study|Death|2|||
124613141|NCT04642365|448202239|FG007|Overall Study|Death|1|||
124613142|NCT04642365|448202232|FG000|Overall Study|Physician Decision|1|||
124613143|NCT04642365|448202233|FG001|Overall Study|Physician Decision|0|||
124613144|NCT04642365|448202234|FG002|Overall Study|Physician Decision|0|||
124613145|NCT04642365|448202235|FG003|Overall Study|Physician Decision|0|||
124613146|NCT04642365|448202236|FG004|Overall Study|Physician Decision|0|||
124613147|NCT04642365|448202237|FG005|Overall Study|Physician Decision|0|||
124613148|NCT04642365|448202238|FG006|Overall Study|Physician Decision|0|||
124613149|NCT04642365|448202239|FG007|Overall Study|Physician Decision|0|||
124613150|NCT04642365|448202232|FG000|Overall Study|Progressive Disease|1|||
124613151|NCT04642365|448202233|FG001|Overall Study|Progressive Disease|1|||
124613152|NCT04642365|448202234|FG002|Overall Study|Progressive Disease|1|||
124613153|NCT04642365|448202235|FG003|Overall Study|Progressive Disease|0|||
124613154|NCT04642365|448202236|FG004|Overall Study|Progressive Disease|0|||
124613155|NCT04642365|448202237|FG005|Overall Study|Progressive Disease|0|||
124613156|NCT04642365|448202238|FG006|Overall Study|Progressive Disease|1|||
124613157|NCT04642365|448202239|FG007|Overall Study|Progressive Disease|0|||
124613158|NCT04642365|448202232|FG000|Overall Study|Study Terminated By Sponsor|0|||
124613159|NCT04642365|448202233|FG001|Overall Study|Study Terminated By Sponsor|2|||
124613160|NCT04642365|448202234|FG002|Overall Study|Study Terminated By Sponsor|1|||
124613161|NCT04642365|448202235|FG003|Overall Study|Study Terminated By Sponsor|1|||
124613162|NCT04642365|448202236|FG004|Overall Study|Study Terminated By Sponsor|1|||
124613163|NCT04642365|448202237|FG005|Overall Study|Study Terminated By Sponsor|2|||
124613164|NCT04642365|448202238|FG006|Overall Study|Study Terminated By Sponsor|2|||
124613165|NCT04642365|448202239|FG007|Overall Study|Study Terminated By Sponsor|1|||
124613166|NCT04642365|448202232|FG000|Overall Study|Symptomatic Deterioration|1|||
124613167|NCT04642365|448202233|FG001|Overall Study|Symptomatic Deterioration|1|||
124613168|NCT04642365|448202234|FG002|Overall Study|Symptomatic Deterioration|0|||
124613169|NCT04642365|448202235|FG003|Overall Study|Symptomatic Deterioration|0|||
124613170|NCT04642365|448202236|FG004|Overall Study|Symptomatic Deterioration|0|||
124613171|NCT04642365|448202237|FG005|Overall Study|Symptomatic Deterioration|1|||
124613172|NCT04642365|448202238|FG006|Overall Study|Symptomatic Deterioration|0|||
124613173|NCT04642365|448202239|FG007|Overall Study|Symptomatic Deterioration|0|||
124613174|NCT04642365|448202232|FG000|Overall Study|Withdrawal by Subject|0|||
124613175|NCT04642365|448202233|FG001|Overall Study|Withdrawal by Subject|0|||
124613176|NCT04642365|448202234|FG002|Overall Study|Withdrawal by Subject|1|||
124613177|NCT04642365|448202235|FG003|Overall Study|Withdrawal by Subject|1|||
124613178|NCT04642365|448202236|FG004|Overall Study|Withdrawal by Subject|0|||
124613179|NCT04642365|448202237|FG005|Overall Study|Withdrawal by Subject|0|||
124613180|NCT04642365|448202238|FG006|Overall Study|Withdrawal by Subject|2|||
124613181|NCT04642365|448202239|FG007|Overall Study|Withdrawal by Subject|0|||
124613182|NCT04642365|448202232|FG000|Overall Study|Adverse Event|0|||
124613183|NCT04642365|448202233|FG001|Overall Study|Adverse Event|0|||
124613184|NCT04642365|448202234|FG002|Overall Study|Adverse Event|0|||
124781671|NCT02474069|448831122|FG001|Selection Phase (SP)|Physician Decision|0|||
124613185|NCT04642365|448202235|FG003|Overall Study|Adverse Event|0|||
124613186|NCT04642365|448202236|FG004|Overall Study|Adverse Event|0|||
124613187|NCT04642365|448202237|FG005|Overall Study|Adverse Event|0|||
124613188|NCT04642365|448202238|FG006|Overall Study|Adverse Event|0|||
124613189|NCT04642365|448202239|FG007|Overall Study|Adverse Event|1|||
124613190|NCT01144715|448202240|FG000|Overall Study|Lost to Follow-up|2|||
124781672|NCT02474069|448831123|FG002|Selection Phase (SP)|Physician Decision|0|||
124613191|NCT01144715|448202241|FG001|Overall Study|Lost to Follow-up|1|||
124613192|NCT01144715|448202240|FG000|Overall Study|Withdrawal by Subject|2|||
124613193|NCT01144715|448202241|FG001|Overall Study|Withdrawal by Subject|1|||
124738931|NCT01688921|448666305|FG001|Overall Study|Lost to Follow-up|13|||
124738932|NCT01688921|448666304|FG000|Overall Study|Physician Decision|6|||
124738933|NCT01688921|448666305|FG001|Overall Study|Physician Decision|1|||
124738934|NCT01688921|448666304|FG000|Overall Study|Protocol Violation|0|||
124738935|NCT01688921|448666305|FG001|Overall Study|Protocol Violation|1|||
124738936|NCT01688921|448666304|FG000|Overall Study|informed consent|3|||
124738937|NCT01688921|448666305|FG001|Overall Study|informed consent|0|||
124738938|NCT03780959|448666306|FG000|Part 1|Adverse Event|1|||
124738939|NCT03780959|448666307|FG001|Part 1|Adverse Event|0|||
124738940|NCT03780959|448666308|FG002|Part 1|Adverse Event|0|||
124738941|NCT03780959|448666306|FG000|Part 1|Withdrawal by Subject|1|||
124738942|NCT03780959|448666307|FG001|Part 1|Withdrawal by Subject|0|||
124738943|NCT03780959|448666308|FG002|Part 1|Withdrawal by Subject|0|||
124738944|NCT03780959|448666306|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
124738945|NCT03780959|448666307|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
124738946|NCT03780959|448666308|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
124738947|NCT03780959|448666306|FG000|Part 1|Response Status|2|||
124738948|NCT03780959|448666307|FG001|Part 1|Response Status|0|||
124738949|NCT03780959|448666308|FG002|Part 1|Response Status|0|||
124738950|NCT03780959|448666306|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
124738951|NCT03780959|448666307|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
124738952|NCT03780959|448666308|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
124738953|NCT03780959|448666306|FG000|Part 2|Response Status|0|||
124738954|NCT03780959|448666307|FG001|Part 2|Response Status|18|||
124738955|NCT03780959|448666308|FG002|Part 2|Response Status|6|||
124738956|NCT01636713|448666312|FG000|Overall Study|Adverse Event|16|||
124738957|NCT01636713|448666313|FG001|Overall Study|Adverse Event|16|||
124738958|NCT01636713|448666314|FG002|Overall Study|Adverse Event|7|||
124738959|NCT01636713|448666312|FG000|Overall Study|Lack of Efficacy|6|||
124738960|NCT01636713|448666313|FG001|Overall Study|Lack of Efficacy|6|||
124738961|NCT01636713|448666314|FG002|Overall Study|Lack of Efficacy|2|||
124738962|NCT01636713|448666312|FG000|Overall Study|Protocol Violation|3|||
124738963|NCT01636713|448666313|FG001|Overall Study|Protocol Violation|0|||
124738964|NCT01636713|448666314|FG002|Overall Study|Protocol Violation|1|||
124738965|NCT01636713|448666312|FG000|Overall Study|Lost to Follow-up|0|||
124738966|NCT01636713|448666313|FG001|Overall Study|Lost to Follow-up|0|||
124738967|NCT01636713|448666314|FG002|Overall Study|Lost to Follow-up|1|||
124738968|NCT01636713|448666312|FG000|Overall Study|Withdrawal by Subject|5|||
124738969|NCT01636713|448666313|FG001|Overall Study|Withdrawal by Subject|4|||
124738970|NCT01636713|448666314|FG002|Overall Study|Withdrawal by Subject|8|||
124738971|NCT01636713|448666312|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
124738972|NCT01636713|448666313|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
124738973|NCT01636713|448666314|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
124738974|NCT02525094|448666315|FG000|Overall Study|Lost to Follow-up|2|||
124738975|NCT02525094|448666316|FG001|Overall Study|Lost to Follow-up|1|||
124738976|NCT02525094|448666315|FG000|Overall Study|Withdrawal by Subject|5|||
124738977|NCT02525094|448666316|FG001|Overall Study|Withdrawal by Subject|6|||
124738978|NCT02525094|448666315|FG000|Overall Study|Not Treated|1|||
124738979|NCT02525094|448666316|FG001|Overall Study|Not Treated|1|||
124738980|NCT02242981|448666318|FG000|Overall Study|Withdrawal by Subject|1|||
124738981|NCT01831817|448666319|FG000|Overall Study|Lost to Follow-up|1|||
124738982|NCT01831817|448666320|FG001|Overall Study|Lost to Follow-up|0|||
124738983|NCT01831817|448666321|FG002|Overall Study|Lost to Follow-up|0|||
124738984|NCT01831817|448666322|FG003|Overall Study|Lost to Follow-up|0|||
124738985|NCT01831817|448666319|FG000|Overall Study|Withdrawl of Consent|3|||
124738986|NCT01831817|448666320|FG001|Overall Study|Withdrawl of Consent|0|||
124738987|NCT01831817|448666321|FG002|Overall Study|Withdrawl of Consent|0|||
124738988|NCT01831817|448666322|FG003|Overall Study|Withdrawl of Consent|0|||
124738989|NCT00940485|448667659|FG000|Overall Study|HBeAb positive at Baseline|3|||
124738990|NCT00940485|448667660|FG001|Overall Study|HBeAb positive at Baseline|2|||
124738991|NCT00940485|448667659|FG000|Overall Study|Lost to Follow-up|2|||
124738992|NCT00940485|448667660|FG001|Overall Study|Lost to Follow-up|3|||
124738993|NCT00940485|448667659|FG000|Overall Study|Adverse Event|8|||
124738994|NCT00940485|448667660|FG001|Overall Study|Adverse Event|0|||
124738995|NCT00940485|448667659|FG000|Overall Study|Withdrawal by Subject|1|||
124738996|NCT00940485|448667660|FG001|Overall Study|Withdrawal by Subject|1|||
124738997|NCT00940485|448667659|FG000|Overall Study|Others|1|||
124738998|NCT00940485|448667660|FG001|Overall Study|Others|1|||
124738999|NCT03921554|448667664|FG000|Overall Study|Adverse Event|2|||
124739000|NCT03921554|448667664|FG000|Overall Study|Withdrawal by Subject|1|||
124739001|NCT03921554|448667664|FG000|Overall Study|Death|3|||
124739002|NCT03283150|448667671|FG000|Overall Study|Withdrawal by Subject|6|||
124781673|NCT02474069|448831121|FG000|Selection Phase (SP)|Protocol Violation|1|||
124739003|NCT03283150|448667672|FG001|Overall Study|Withdrawal by Subject|0|||
124739004|NCT03283150|448667673|FG002|Overall Study|Withdrawal by Subject|0|||
124739005|NCT01299571|448667676|FG000|Overall Study|Protocol Violation|107|||
124739006|NCT00864851|448667677|FG000|Overall Study|Withdrawal by Subject|0|||
124739007|NCT00864851|448667678|FG001|Overall Study|Withdrawal by Subject|1|||
124739008|NCT00864851|448667679|FG002|Overall Study|Withdrawal by Subject|0|||
124739009|NCT00864851|448667677|FG000|Overall Study|Physician Decision|1|||
124739010|NCT00864851|448667678|FG001|Overall Study|Physician Decision|0|||
124739011|NCT00864851|448667679|FG002|Overall Study|Physician Decision|0|||
124739012|NCT00864851|448667677|FG000|Overall Study|Death|1|||
124739013|NCT00864851|448667678|FG001|Overall Study|Death|0|||
124739014|NCT00864851|448667679|FG002|Overall Study|Death|0|||
124739015|NCT00864851|448667677|FG000|Overall Study|Patient uncooperative|1|||
124739016|NCT00864851|448667678|FG001|Overall Study|Patient uncooperative|0|||
124739017|NCT00864851|448667679|FG002|Overall Study|Patient uncooperative|0|||
124739018|NCT01842581|448667685|FG000|Overall Study|Adverse Event|6|||
124739019|NCT01842581|448667686|FG001|Overall Study|Adverse Event|4|||
124739020|NCT01842581|448667685|FG000|Overall Study|HE breakthrough|26|||
124739021|NCT01842581|448667686|FG001|Overall Study|HE breakthrough|13|||
124739022|NCT01842581|448667685|FG000|Overall Study|Liver transplant|2|||
124739023|NCT01842581|448667686|FG001|Overall Study|Liver transplant|0|||
124739024|NCT01842581|448667685|FG000|Overall Study|Lost to Follow-up|2|||
124739025|NCT01842581|448667686|FG001|Overall Study|Lost to Follow-up|5|||
124739026|NCT01842581|448667685|FG000|Overall Study|Withdrawal by Subject|5|||
124739027|NCT01842581|448667686|FG001|Overall Study|Withdrawal by Subject|7|||
124739028|NCT01842581|448667685|FG000|Overall Study|Other than specified|3|||
124739029|NCT01842581|448667686|FG001|Overall Study|Other than specified|1|||
124739030|NCT01287195|448667687|FG000|Overall Study|Withdrawal by Subject|2|||
124739031|NCT02006069|448667690|FG000|Overall Study|MPP other programming|239|||
124739032|NCT02006069|448667691|FG001|Overall Study|MPP other programming|0|||
124739033|NCT02006069|448667690|FG000|Overall Study|RV only pacing|0|||
124739034|NCT02006069|448667691|FG001|Overall Study|RV only pacing|3|||
124739035|NCT00106691|448667692|FG000|Overall Study|Adverse Event|60|||
124739036|NCT00106691|448667693|FG001|Overall Study|Adverse Event|64|||
124739037|NCT00106691|448667692|FG000|Overall Study|Lost to Follow-up|23|||
124739038|NCT00106691|448667693|FG001|Overall Study|Lost to Follow-up|18|||
124739039|NCT00106691|448667692|FG000|Overall Study|Physician Decision|18|||
124739040|NCT00106691|448667693|FG001|Overall Study|Physician Decision|21|||
124739041|NCT00106691|448667692|FG000|Overall Study|Protocol Violation|13|||
124739042|NCT00106691|448667693|FG001|Overall Study|Protocol Violation|18|||
124739043|NCT00106691|448667692|FG000|Overall Study|Withdrawal by Subject|75|||
124739044|NCT00106691|448667693|FG001|Overall Study|Withdrawal by Subject|70|||
124739045|NCT00106691|448667692|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
124739046|NCT00106691|448667693|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
124739047|NCT00106691|448667692|FG000|Overall Study|QTc>480|3|||
124739048|NCT00106691|448667693|FG001|Overall Study|QTc>480|1|||
124739049|NCT00106691|448667692|FG000|Overall Study|mililtary deployment|2|||
124739050|NCT00106691|448667693|FG001|Overall Study|mililtary deployment|0|||
124739051|NCT00106691|448667692|FG000|Overall Study|Study Site Closing/PI Moved|1|||
124739052|NCT00106691|448667693|FG001|Overall Study|Study Site Closing/PI Moved|2|||
124739053|NCT00106691|448667692|FG000|Overall Study|Cardiologist recommendation|1|||
124739054|NCT00106691|448667693|FG001|Overall Study|Cardiologist recommendation|0|||
124739055|NCT00106691|448667692|FG000|Overall Study|Pt. moved to another state|1|||
124739056|NCT00106691|448667693|FG001|Overall Study|Pt. moved to another state|0|||
124739057|NCT00106691|448667692|FG000|Overall Study|Taking exclusionary avodart|1|||
124739058|NCT00106691|448667693|FG001|Overall Study|Taking exclusionary avodart|0|||
124739059|NCT00106691|448667692|FG000|Overall Study|Not able to discontinue plavix|0|||
124739060|NCT00106691|448667693|FG001|Overall Study|Not able to discontinue plavix|1|||
124739061|NCT00530920|448667694|FG000|Overall Study|Randomized but not treated|0|||
124739062|NCT00530920|448667695|FG001|Overall Study|Randomized but not treated|2|||
124739063|NCT00530920|448667696|FG002|Overall Study|Randomized but not treated|0|||
124739064|NCT00530920|448667694|FG000|Overall Study|Adverse Event|0|||
124739065|NCT00530920|448667695|FG001|Overall Study|Adverse Event|0|||
124739066|NCT00530920|448667696|FG002|Overall Study|Adverse Event|3|||
124739067|NCT00530920|448667694|FG000|Overall Study|Withdrawal by Subject|0|||
124613194|NCT01144715|448202240|FG000|Overall Study|Adverse Event|0|||
124613195|NCT01144715|448202241|FG001|Overall Study|Adverse Event|1|||
124613196|NCT00510289|448202242|FG000|Overall Study|Withdrawal by Subject|7|||
124613197|NCT00510289|448202242|FG000|Overall Study|Refused bone marrow biopsy|2|||
124613198|NCT00510289|448202242|FG000|Overall Study|Lost to Follow-up|1|||
124613199|NCT00510289|448202242|FG000|Overall Study|Progressed prior to starting drug|2|||
124739068|NCT00530920|448667695|FG001|Overall Study|Withdrawal by Subject|0|||
124739069|NCT00530920|448667696|FG002|Overall Study|Withdrawal by Subject|1|||
124739070|NCT04957758|448667698|FG000|Overall Study|Adverse Event|1|||
124739071|NCT04957758|448667699|FG001|Overall Study|Adverse Event|0|||
124739072|NCT04957758|448667698|FG000|Overall Study|Lost to Follow-up|0|||
124781674|NCT02474069|448831122|FG001|Selection Phase (SP)|Protocol Violation|0|||
124739073|NCT04957758|448667699|FG001|Overall Study|Lost to Follow-up|2|||
124781675|NCT02474069|448831123|FG002|Selection Phase (SP)|Protocol Violation|0|||
124613200|NCT04428333|448202243|FG000|Overall Study|Physician Decision|5|||
124613201|NCT04428333|448202244|FG001|Overall Study|Physician Decision|6|||
124613202|NCT04428333|448202243|FG000|Overall Study|Withdrawal by Subject|1|||
124739074|NCT04957758|448667698|FG000|Overall Study|Withdrawal by Subject|4|||
124781676|NCT02474069|448831121|FG000|Selection Phase (SP)|No longer requires treatment|1|||
124739075|NCT04957758|448667699|FG001|Overall Study|Withdrawal by Subject|2|||
124739076|NCT04957758|448667698|FG000|Overall Study|Protocol Violation|0|||
124739077|NCT04957758|448667699|FG001|Overall Study|Protocol Violation|1|||
124739078|NCT00707746|448667700|FG000|Treatment Period|Adverse Event|2|||
124739079|NCT00707746|448667701|FG001|Treatment Period|Adverse Event|4|||
124739080|NCT00707746|448667700|FG000|Treatment Period|Ineligibility|0|||
124739081|NCT00707746|448667701|FG001|Treatment Period|Ineligibility|1|||
124739082|NCT02322190|448667702|FG000|Overall Study|Death on study|1|||
124739083|NCT02322190|448667703|FG001|Overall Study|Death on study|0|||
124739084|NCT01685983|448667708|FG000|Overall Study|Adverse Event|7|||
124739085|NCT01685983|448667708|FG000|Overall Study|Death|1|||
124739086|NCT01685983|448667708|FG000|Overall Study|Withdrawal by Subject|19|||
124739087|NCT01685983|448667708|FG000|Overall Study|Protocol Violation|2|||
124739088|NCT01685983|448667708|FG000|Overall Study|Physician Decision|13|||
124739089|NCT01685983|448667708|FG000|Overall Study|Other|7|||
124739090|NCT01685983|448667708|FG000|Overall Study|Progressive Disease|32|||
124739091|NCT01685983|448667708|FG000|Overall Study|Noncompliance with Study Drug|1|||
124739092|NCT00685373|448667709|FG000|Overall Study|Adverse Event|3|||
124739093|NCT00685373|448667709|FG000|Overall Study|Withdrawal by Subject|5|||
124739094|NCT00685373|448667709|FG000|Overall Study|Lack of Efficacy|3|||
124739095|NCT00685373|448667709|FG000|Overall Study|Condition no longer requires study drug|1|||
124739096|NCT00685373|448667709|FG000|Overall Study|Lost to Follow-up|2|||
124739097|NCT00685373|448667709|FG000|Overall Study|Protocol Violation|1|||
124739098|NCT02642965|448667710|FG000|Overall Study|Lack of Efficacy|4|||
124739099|NCT02642965|448667710|FG000|Overall Study|Physician Decision|9|||
124739100|NCT01167907|448667711|FG000|Overall Study|Protocol Violation|1|||
124739101|NCT01167907|448667712|FG001|Overall Study|Protocol Violation|0|||
124739102|NCT01167907|448667711|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
124739103|NCT01167907|448667712|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
124739104|NCT00857948|448667713|FG000|Overall Study|Withdrawal by Subject|2|||
124739105|NCT00857948|448667714|FG001|Overall Study|Withdrawal by Subject|0|||
124739106|NCT00857948|448667715|FG002|Overall Study|Withdrawal by Subject|0|||
124739107|NCT00857948|448667716|FG003|Overall Study|Withdrawal by Subject|0|||
124739108|NCT00857948|448667713|FG000|Overall Study|Protocol Violation|1|||
124739109|NCT00857948|448667714|FG001|Overall Study|Protocol Violation|0|||
124739110|NCT00857948|448667715|FG002|Overall Study|Protocol Violation|1|||
124739111|NCT00857948|448667716|FG003|Overall Study|Protocol Violation|0|||
124739112|NCT03077698|448667719|FG000|Progestin Monotherapy|Stable Disease|8|||
124739113|NCT03077698|448667720|FG001|Progestin Monotherapy|Stable Disease|0|||
124739114|NCT03077698|448667719|FG000|Progestin Monotherapy|Adverse Event|1|||
124739115|NCT03077698|448667720|FG001|Progestin Monotherapy|Adverse Event|0|||
124739116|NCT03077698|448667719|FG000|Progestin Monotherapy|Death|1|||
124739117|NCT03077698|448667720|FG001|Progestin Monotherapy|Death|0|||
124739118|NCT03077698|448667719|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
124739119|NCT03077698|448667720|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
124739120|NCT03077698|448667719|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
124739121|NCT03077698|448667720|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
124739122|NCT03077698|448667719|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
124739123|NCT03077698|448667720|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
124739124|NCT03077698|448667719|FG000|Safety Follow Up|Withdrawal by Subject|2|||
124739125|NCT03077698|448667720|FG001|Safety Follow Up|Withdrawal by Subject|1|||
124739126|NCT03077698|448667719|FG000|Safety Follow Up|Transfer of care to hospice|1|||
124739127|NCT03077698|448667720|FG001|Safety Follow Up|Transfer of care to hospice|0|||
124739128|NCT00973102|448667723|FG000|Overall Study|Protocol Violation|1|||
124739129|NCT00973102|448667724|FG001|Overall Study|Protocol Violation|0|||
124739130|NCT00973102|448667723|FG000|Overall Study|Prisoner|0|||
124739131|NCT00973102|448667724|FG001|Overall Study|Prisoner|1|||
124739132|NCT03099148|448667727|FG000|Wash-out|scheduling conflict|0|||
124739133|NCT03099148|448667728|FG001|Wash-out|scheduling conflict|1|||
124739134|NCT03099148|448667729|FG002|Wash-out|scheduling conflict|0|||
124739135|NCT03099148|448667730|FG003|Wash-out|scheduling conflict|0|||
124613203|NCT04428333|448202244|FG001|Overall Study|Withdrawal by Subject|3|||
124613204|NCT04428333|448202243|FG000|Overall Study|Study Terminated By Sponsor|14|||
124739136|NCT03099148|448667727|FG000|Wash-out|Adverse Event|0|||
124739137|NCT03099148|448667728|FG001|Wash-out|Adverse Event|1|||
124739138|NCT03099148|448667729|FG002|Wash-out|Adverse Event|0|||
124739139|NCT03099148|448667730|FG003|Wash-out|Adverse Event|0|||
124739140|NCT01439126|448667731|FG000|Overall Study|Adverse Event|2|||
124739141|NCT01439126|448667732|FG001|Overall Study|Adverse Event|0|||
124739142|NCT01439126|448667731|FG000|Overall Study|Withdrawal by Subject|5|||
124739143|NCT01439126|448667732|FG001|Overall Study|Withdrawal by Subject|21|||
124739144|NCT01439126|448667731|FG000|Overall Study|Protocol Violation|6|||
124739145|NCT01439126|448667732|FG001|Overall Study|Protocol Violation|4|||
124739146|NCT01439126|448667731|FG000|Overall Study|Lost to Follow-up|6|||
124739147|NCT01439126|448667732|FG001|Overall Study|Lost to Follow-up|3|||
124739148|NCT01439126|448667731|FG000|Overall Study|Other-Use of prohibited treatment|0|||
124739149|NCT01439126|448667732|FG001|Overall Study|Other-Use of prohibited treatment|2|||
124613205|NCT04428333|448202244|FG001|Overall Study|Study Terminated By Sponsor|16|||
124613206|NCT03365011|448202245|FG000|Overall Study|Withdrawal by Subject|1|||
124613207|NCT03365011|448202246|FG001|Overall Study|Withdrawal by Subject|2|||
124739150|NCT01439126|448667731|FG000|Overall Study|Other-Miscellaneous|12|||
124739151|NCT01439126|448667732|FG001|Overall Study|Other-Miscellaneous|12|||
124739152|NCT01710527|448667733|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
124739153|NCT01710527|448667734|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
124739154|NCT02124772|448667737|FG000|Overall Study|Lack of Efficacy|2|||
124739155|NCT02124772|448667738|FG001|Overall Study|Lack of Efficacy|0|||
124739156|NCT02124772|448667739|FG002|Overall Study|Lack of Efficacy|0|||
124739157|NCT02124772|448667740|FG003|Overall Study|Lack of Efficacy|1|||
124739158|NCT02124772|448667741|FG004|Overall Study|Lack of Efficacy|2|||
124739159|NCT02124772|448667742|FG005|Overall Study|Lack of Efficacy|3|||
124739160|NCT02124772|448667743|FG006|Overall Study|Lack of Efficacy|0|||
124739161|NCT02124772|448667744|FG007|Overall Study|Lack of Efficacy|2|||
124739162|NCT02124772|448667745|FG008|Overall Study|Lack of Efficacy|0|||
124739163|NCT02124772|448667746|FG009|Overall Study|Lack of Efficacy|1|||
124739164|NCT02124772|448667747|FG010|Overall Study|Lack of Efficacy|0|||
124739165|NCT02124772|448667748|FG011|Overall Study|Lack of Efficacy|0|||
124739166|NCT02124772|448667749|FG012|Overall Study|Lack of Efficacy|1|||
124739167|NCT02124772|448667737|FG000|Overall Study|Adverse Event|1|||
124739168|NCT02124772|448667738|FG001|Overall Study|Adverse Event|4|||
124739169|NCT02124772|448667739|FG002|Overall Study|Adverse Event|1|||
124739170|NCT02124772|448667740|FG003|Overall Study|Adverse Event|5|||
124739171|NCT02124772|448667741|FG004|Overall Study|Adverse Event|2|||
124739172|NCT02124772|448667742|FG005|Overall Study|Adverse Event|1|||
124739173|NCT02124772|448667743|FG006|Overall Study|Adverse Event|1|||
124739174|NCT02124772|448667744|FG007|Overall Study|Adverse Event|5|||
124739175|NCT02124772|448667745|FG008|Overall Study|Adverse Event|0|||
124739176|NCT02124772|448667746|FG009|Overall Study|Adverse Event|3|||
124739177|NCT02124772|448667747|FG010|Overall Study|Adverse Event|1|||
124739178|NCT02124772|448667748|FG011|Overall Study|Adverse Event|3|||
124739179|NCT02124772|448667749|FG012|Overall Study|Adverse Event|1|||
124739180|NCT02124772|448667737|FG000|Overall Study|Withdrawal consent|0|||
124739181|NCT02124772|448667738|FG001|Overall Study|Withdrawal consent|1|||
124739182|NCT02124772|448667739|FG002|Overall Study|Withdrawal consent|1|||
124739183|NCT02124772|448667740|FG003|Overall Study|Withdrawal consent|1|||
124739184|NCT02124772|448667741|FG004|Overall Study|Withdrawal consent|0|||
124739185|NCT02124772|448667742|FG005|Overall Study|Withdrawal consent|1|||
124739186|NCT02124772|448667743|FG006|Overall Study|Withdrawal consent|1|||
124739187|NCT02124772|448667744|FG007|Overall Study|Withdrawal consent|0|||
124739188|NCT02124772|448667745|FG008|Overall Study|Withdrawal consent|0|||
124739189|NCT02124772|448667746|FG009|Overall Study|Withdrawal consent|1|||
124739190|NCT02124772|448667747|FG010|Overall Study|Withdrawal consent|0|||
124739191|NCT02124772|448667748|FG011|Overall Study|Withdrawal consent|1|||
124739192|NCT02124772|448667749|FG012|Overall Study|Withdrawal consent|0|||
124739193|NCT02124772|448667737|FG000|Overall Study|Investigator discretion|0|||
124739194|NCT02124772|448667738|FG001|Overall Study|Investigator discretion|2|||
124739195|NCT02124772|448667739|FG002|Overall Study|Investigator discretion|2|||
124739196|NCT02124772|448667740|FG003|Overall Study|Investigator discretion|1|||
124739197|NCT02124772|448667741|FG004|Overall Study|Investigator discretion|1|||
124739198|NCT02124772|448667742|FG005|Overall Study|Investigator discretion|0|||
124739199|NCT02124772|448667743|FG006|Overall Study|Investigator discretion|1|||
124739200|NCT02124772|448667744|FG007|Overall Study|Investigator discretion|0|||
124739201|NCT02124772|448667745|FG008|Overall Study|Investigator discretion|0|||
124739202|NCT02124772|448667746|FG009|Overall Study|Investigator discretion|1|||
124781677|NCT02474069|448831122|FG001|Selection Phase (SP)|No longer requires treatment|0|||
124613208|NCT03582826|448202247|FG000|Overall Study|Lost to Follow-up|39|||
124613209|NCT03582826|448202248|FG001|Overall Study|Lost to Follow-up|0|||
124739203|NCT02124772|448667747|FG010|Overall Study|Investigator discretion|0|||
124739204|NCT02124772|448667748|FG011|Overall Study|Investigator discretion|1|||
124739205|NCT02124772|448667749|FG012|Overall Study|Investigator discretion|0|||
124739206|NCT02124772|448667737|FG000|Overall Study|Progressive disease|0|||
124739207|NCT02124772|448667738|FG001|Overall Study|Progressive disease|0|||
124739208|NCT02124772|448667739|FG002|Overall Study|Progressive disease|0|||
124739209|NCT02124772|448667740|FG003|Overall Study|Progressive disease|0|||
124739210|NCT02124772|448667741|FG004|Overall Study|Progressive disease|0|||
124739211|NCT02124772|448667742|FG005|Overall Study|Progressive disease|0|||
124739212|NCT02124772|448667743|FG006|Overall Study|Progressive disease|1|||
124739213|NCT02124772|448667744|FG007|Overall Study|Progressive disease|1|||
124613210|NCT03582826|448202247|FG000|Overall Study|Withdrawal by Subject|2|||
124739214|NCT02124772|448667745|FG008|Overall Study|Progressive disease|0|||
124739215|NCT02124772|448667746|FG009|Overall Study|Progressive disease|0|||
124739216|NCT02124772|448667747|FG010|Overall Study|Progressive disease|0|||
124613211|NCT03582826|448202248|FG001|Overall Study|Withdrawal by Subject|0|||
124739217|NCT02124772|448667748|FG011|Overall Study|Progressive disease|0|||
124739218|NCT02124772|448667749|FG012|Overall Study|Progressive disease|0|||
124739219|NCT02124772|448667737|FG000|Overall Study|Other|0|||
124739220|NCT02124772|448667738|FG001|Overall Study|Other|7|||
124781678|NCT02474069|448831123|FG002|Selection Phase (SP)|No longer requires treatment|0|||
124781679|NCT02474069|448831121|FG000|Selection Phase (SP)|Technical Problem|1|||
124781680|NCT02474069|448831122|FG001|Selection Phase (SP)|Technical Problem|0|||
124781681|NCT02474069|448831123|FG002|Selection Phase (SP)|Technical Problem|0|||
124781682|NCT02474069|448831121|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
124781683|NCT02474069|448831122|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
124781684|NCT02474069|448831123|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
124781685|NCT02474069|448831121|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
124613212|NCT04730349|448202253|FG000|Overall Study|Participant withdrew consent|1|||
124613213|NCT04730349|448202254|FG001|Overall Study|Participant withdrew consent|0|||
124613214|NCT04730349|448202253|FG000|Overall Study|Disease progression|6|||
124613215|NCT04730349|448202254|FG001|Overall Study|Disease progression|4|||
124613216|NCT04730349|448202253|FG000|Overall Study|Study drug toxicity|0|||
124613217|NCT04730349|448202254|FG001|Overall Study|Study drug toxicity|1|||
124613218|NCT02099682|448202258|FG000|Overall Study|Data Not Available|51|||
124613219|NCT02099682|448202258|FG000|Overall Study|Lost to Follow-up|31|||
124613220|NCT02099682|448202258|FG000|Overall Study|Other|29|||
124613221|NCT02342639|448202259|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
124613222|NCT02342639|448202260|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
124613223|NCT02342639|448202259|FG000|Overall Study|Protocol Violation|0|||
124613224|NCT02342639|448202260|FG001|Overall Study|Protocol Violation|2|||
124613225|NCT02212379|448202261|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
124613226|NCT02212379|448202261|FG000|From Baseline to Week 48|Adverse Event|7|||
124613227|NCT02212379|448202261|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
124613228|NCT02212379|448202261|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
124613229|NCT02212379|448202261|FG000|From Week 48 to Week 96|Adverse Event|1|||
124613230|NCT02212379|448202261|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
124613231|NCT02105974|448202262|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
124613232|NCT02105974|448202263|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
124613233|NCT02105974|448202264|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
124613234|NCT02105974|448202262|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
124613235|NCT02105974|448202263|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
124613236|NCT02105974|448202264|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
124613237|NCT02105974|448202262|FG000|2 Week Run-in Period|Adverse Event|6|||
124613238|NCT02105974|448202263|FG001|2 Week Run-in Period|Adverse Event|0|||
124613239|NCT02105974|448202264|FG002|2 Week Run-in Period|Adverse Event|0|||
124613240|NCT02105974|448202262|FG000|2 Week Run-in Period|Study closed/terminated|1|||
124613241|NCT02105974|448202263|FG001|2 Week Run-in Period|Study closed/terminated|0|||
124613242|NCT02105974|448202264|FG002|2 Week Run-in Period|Study closed/terminated|0|||
124613243|NCT02105974|448202262|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
124613244|NCT02105974|448202263|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
124613245|NCT02105974|448202264|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
124613246|NCT02105974|448202262|FG000|2 Week Run-in Period|Withdrew consent|23|||
124613247|NCT02105974|448202263|FG001|2 Week Run-in Period|Withdrew consent|0|||
124613248|NCT02105974|448202264|FG002|2 Week Run-in Period|Withdrew consent|0|||
124613249|NCT02105974|448202262|FG000|2 Week Run-in Period|Investigator discretion|8|||
124613250|NCT02105974|448202263|FG001|2 Week Run-in Period|Investigator discretion|0|||
124613251|NCT02105974|448202264|FG002|2 Week Run-in Period|Investigator discretion|0|||
124613252|NCT02105974|448202262|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
124613253|NCT02105974|448202263|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
124613254|NCT02105974|448202264|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
124613255|NCT02105974|448202262|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
124613256|NCT02105974|448202263|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
124613257|NCT02105974|448202264|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
124613258|NCT02105974|448202262|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
124613259|NCT02105974|448202263|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
124613260|NCT02105974|448202264|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
124613261|NCT02105974|448202262|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
124613262|NCT02105974|448202263|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
124613263|NCT02105974|448202264|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
124613264|NCT02105974|448202262|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
124613265|NCT02105974|448202263|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
124613266|NCT02105974|448202264|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
124613267|NCT02105974|448202262|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
124613268|NCT02105974|448202263|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
124613269|NCT02105974|448202264|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
124613270|NCT02105974|448202262|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
124613271|NCT02105974|448202263|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
124781686|NCT02474069|448831122|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
124781687|NCT02474069|448831123|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
124739221|NCT02124772|448667739|FG002|Overall Study|Other|2|||
124739222|NCT02124772|448667740|FG003|Overall Study|Other|5|||
124739223|NCT02124772|448667741|FG004|Overall Study|Other|4|||
124739224|NCT02124772|448667742|FG005|Overall Study|Other|3|||
124739225|NCT02124772|448667743|FG006|Overall Study|Other|4|||
124739226|NCT02124772|448667744|FG007|Overall Study|Other|1|||
124739227|NCT02124772|448667745|FG008|Overall Study|Other|1|||
124739228|NCT02124772|448667746|FG009|Overall Study|Other|1|||
124739229|NCT02124772|448667747|FG010|Overall Study|Other|1|||
124739230|NCT02124772|448667748|FG011|Overall Study|Other|1|||
124739231|NCT02124772|448667749|FG012|Overall Study|Other|0|||
124739232|NCT01617447|448667750|FG000|Overall Study|Adverse Event|0|||
124739233|NCT01617447|448667751|FG001|Overall Study|Adverse Event|1|||
124739234|NCT01617447|448667750|FG000|Overall Study|Physician Decision|0|||
124739235|NCT01617447|448667751|FG001|Overall Study|Physician Decision|2|||
124739236|NCT02713529|448667753|FG000|Overall Study|Withdrawal by Subject|3|||
124739237|NCT02713529|448667754|FG001|Overall Study|Withdrawal by Subject|1|||
124739238|NCT02713529|448667755|FG002|Overall Study|Withdrawal by Subject|4|||
124739239|NCT02713529|448667756|FG003|Overall Study|Withdrawal by Subject|2|||
124739240|NCT02713529|448667757|FG004|Overall Study|Withdrawal by Subject|0|||
124739241|NCT02713529|448667758|FG005|Overall Study|Withdrawal by Subject|1|||
124739242|NCT02713529|448667759|FG006|Overall Study|Withdrawal by Subject|1|||
124739243|NCT02713529|448667753|FG000|Overall Study|Lost to Follow-up|1|||
124739244|NCT02713529|448667754|FG001|Overall Study|Lost to Follow-up|0|||
124739245|NCT02713529|448667755|FG002|Overall Study|Lost to Follow-up|1|||
124739246|NCT02713529|448667756|FG003|Overall Study|Lost to Follow-up|0|||
124739247|NCT02713529|448667757|FG004|Overall Study|Lost to Follow-up|0|||
124739248|NCT02713529|448667758|FG005|Overall Study|Lost to Follow-up|0|||
124739249|NCT02713529|448667759|FG006|Overall Study|Lost to Follow-up|0|||
124739250|NCT02713529|448667753|FG000|Overall Study|Death|3|||
124739251|NCT02713529|448667754|FG001|Overall Study|Death|3|||
124739252|NCT02713529|448667755|FG002|Overall Study|Death|26|||
124739253|NCT02713529|448667756|FG003|Overall Study|Death|27|||
124739254|NCT02713529|448667757|FG004|Overall Study|Death|3|||
124739255|NCT02713529|448667758|FG005|Overall Study|Death|13|||
124739256|NCT02713529|448667759|FG006|Overall Study|Death|3|||
124739257|NCT00780273|448667762|FG000|Overall Study|Death|1|||
124739258|NCT00780273|448667762|FG000|Overall Study|Lost to Follow-up|1|||
124739259|NCT02827500|448667763|FG000|Overall Study|Death|7|||
124739260|NCT02827500|448667764|FG001|Overall Study|Death|3|||
124739261|NCT02827500|448667763|FG000|Overall Study|Lost to Follow-up|1|||
124739262|NCT02827500|448667764|FG001|Overall Study|Lost to Follow-up|1|||
124739263|NCT02827500|448667763|FG000|Overall Study|Withdrawal by Subject|3|||
124739264|NCT02827500|448667764|FG001|Overall Study|Withdrawal by Subject|1|||
124739265|NCT02827500|448667763|FG000|Overall Study|Missing primary endpoint data|3|||
124739266|NCT02827500|448667764|FG001|Overall Study|Missing primary endpoint data|1|||
124739267|NCT02827500|448667763|FG000|Overall Study|Other|5|||
124739268|NCT02827500|448667764|FG001|Overall Study|Other|1|||
124739269|NCT02358044|448667765|FG000|Overall Study|Adverse Event|0|||
124739270|NCT02358044|448667766|FG001|Overall Study|Adverse Event|1|||
124739271|NCT02358044|448667765|FG000|Overall Study|Lost to Follow-up|2|||
124613272|NCT02105974|448202264|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
124739272|NCT02358044|448667766|FG001|Overall Study|Lost to Follow-up|1|||
124739273|NCT02358044|448667765|FG000|Overall Study|Physician Decision|0|||
124739274|NCT02358044|448667766|FG001|Overall Study|Physician Decision|1|||
124739275|NCT02358044|448667765|FG000|Overall Study|Withdrawal by Subject|0|||
124739276|NCT02358044|448667766|FG001|Overall Study|Withdrawal by Subject|4|||
124739277|NCT02308488|448667769|FG000|Overall Study|Withdrawal by Subject|2|||
124739278|NCT01739803|448667770|FG000|Overall Study|Lost to Follow-up|9|||
124739279|NCT01739803|448667771|FG001|Overall Study|Lost to Follow-up|6|||
124739280|NCT02210091|448667779|FG000|Overall Study|Physician Decision|0|||
124739281|NCT02210091|448667780|FG001|Overall Study|Physician Decision|1|||
124739282|NCT02210091|448667779|FG000|Overall Study|Withdrawal by Sponsor|0|||
124739283|NCT02210091|448667780|FG001|Overall Study|Withdrawal by Sponsor|1|||
124739284|NCT02739321|448667781|FG000|Overall Study|Lack of Efficacy|1|||
124739285|NCT02739321|448667782|FG001|Overall Study|Lack of Efficacy|1|||
124739286|NCT02739321|448667781|FG000|Overall Study|Lost to Follow-up|1|||
124739287|NCT02739321|448667782|FG001|Overall Study|Lost to Follow-up|1|||
124739288|NCT02739321|448667781|FG000|Overall Study|Withdrawal by Subject|1|||
124739289|NCT02739321|448667782|FG001|Overall Study|Withdrawal by Subject|2|||
124739290|NCT02290938|448667783|FG000|Overall Study|Lost to Follow-up|14|||
124739291|NCT02290938|448667784|FG001|Overall Study|Lost to Follow-up|43|||
124739292|NCT05065190|448669538|FG000|Overall Study|Other than listed|2|||
124739293|NCT05065190|448669539|FG001|Overall Study|Other than listed|12|||
124739294|NCT05065190|448669538|FG000|Overall Study|Lack of Efficacy|4|||
124739295|NCT05065190|448669539|FG001|Overall Study|Lack of Efficacy|0|||
124739296|NCT05065190|448669538|FG000|Overall Study|Adverse Event|1|||
124739297|NCT05065190|448669539|FG001|Overall Study|Adverse Event|10|||
124739298|NCT04938037|448669540|FG000|Overall Study|Lost to Follow-up|4|||
124739299|NCT04938037|448669541|FG001|Overall Study|Lost to Follow-up|3|||
124739300|NCT03320330|448669544|FG000|Overall Study|Lack of Efficacy|5|||
124739301|NCT03320330|448669545|FG001|Overall Study|Lack of Efficacy|5|||
124739302|NCT03320330|448669546|FG002|Overall Study|Lack of Efficacy|14|||
124739303|NCT03320330|448669544|FG000|Overall Study|Physician Decision|1|||
124739304|NCT03320330|448669545|FG001|Overall Study|Physician Decision|0|||
124739305|NCT03320330|448669546|FG002|Overall Study|Physician Decision|0|||
124739306|NCT00203021|448669547|FG000|Overall Study|Death|4|||
124739307|NCT00203021|448669548|FG001|Overall Study|Death|1|||
124739308|NCT00203021|448669547|FG000|Overall Study|Adverse Event|10|||
124739309|NCT00203021|448669548|FG001|Overall Study|Adverse Event|5|||
124739310|NCT00203021|448669547|FG000|Overall Study|Withdrawal by Subject|45|||
124739311|NCT00203021|448669548|FG001|Overall Study|Withdrawal by Subject|48|||
124739312|NCT00203021|448669547|FG000|Overall Study|Lost to Follow-up|9|||
124739313|NCT00203021|448669548|FG001|Overall Study|Lost to Follow-up|7|||
124739314|NCT00203021|448669547|FG000|Overall Study|Other than specified|11|||
124739315|NCT00203021|448669548|FG001|Overall Study|Other than specified|16|||
124739316|NCT02936284|448669552|FG000|Overall Study|Withdrawal by Subject|3|||
124739317|NCT02936284|448669553|FG001|Overall Study|Withdrawal by Subject|1|||
124739318|NCT02936284|448669552|FG000|Overall Study|Lost to Follow-up|7|||
124739319|NCT02936284|448669553|FG001|Overall Study|Lost to Follow-up|8|||
124739320|NCT04284813|448669554|FG000|Overall Study|Withdrawal by Subject|1|||
124739321|NCT01146652|448669559|FG000|Overall Study|Adverse Event|506|||
124739322|NCT01146652|448669560|FG001|Overall Study|Adverse Event|15|||
124739323|NCT01146652|448669559|FG000|Overall Study|Lack of Efficacy|91|||
124739324|NCT01146652|448669560|FG001|Overall Study|Lack of Efficacy|7|||
124739325|NCT01146652|448669559|FG000|Overall Study|Poor compliance to protocol|38|||
124739326|NCT01146652|448669560|FG001|Overall Study|Poor compliance to protocol|1|||
124739327|NCT01146652|448669559|FG000|Overall Study|Other unspecified reasons|314|||
124739328|NCT01146652|448669560|FG001|Overall Study|Other unspecified reasons|22|||
124739329|NCT01146652|448669559|FG000|Overall Study|Enrolled but not treated|2|||
124739330|NCT01146652|448669560|FG001|Overall Study|Enrolled but not treated|0|||
124739331|NCT01300351|448669564|FG000|Overall Study|Did not receive treatment|2|||
124739332|NCT01300351|448669565|FG001|Overall Study|Did not receive treatment|0|||
124739333|NCT01300351|448669564|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
124739334|NCT01300351|448669565|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
124739335|NCT01300351|448669564|FG000|Overall Study|Lost to Follow-up|0|||
124739336|NCT01300351|448669565|FG001|Overall Study|Lost to Follow-up|1|||
124739337|NCT01300351|448669564|FG000|Overall Study|Adverse Event|0|||
124739338|NCT01300351|448669565|FG001|Overall Study|Adverse Event|4|||
124739339|NCT01300351|448669564|FG000|Overall Study|Withdrawal by Subject|7|||
124739340|NCT01300351|448669565|FG001|Overall Study|Withdrawal by Subject|10|||
124739341|NCT00431951|448669566|FG000|Overall Study|Inability to follow study procedures|1|||
124739342|NCT00431951|448669567|FG001|Overall Study|Inability to follow study procedures|0|||
124739343|NCT00431951|448669568|FG002|Overall Study|Inability to follow study procedures|1|||
124739344|NCT00431951|448669569|FG003|Overall Study|Inability to follow study procedures|2|||
124739345|NCT00431951|448669566|FG000|Overall Study|Lost to Follow-up|0|||
124739346|NCT00431951|448669567|FG001|Overall Study|Lost to Follow-up|1|||
124739347|NCT00431951|448669568|FG002|Overall Study|Lost to Follow-up|0|||
124739348|NCT00431951|448669569|FG003|Overall Study|Lost to Follow-up|0|||
124739349|NCT00431951|448669566|FG000|Overall Study|Withdrawal by Subject|0|||
124739350|NCT00431951|448669567|FG001|Overall Study|Withdrawal by Subject|1|||
124739351|NCT00431951|448669568|FG002|Overall Study|Withdrawal by Subject|0|||
124739352|NCT00431951|448669569|FG003|Overall Study|Withdrawal by Subject|0|||
124739353|NCT00431951|448669566|FG000|Overall Study|Adverse Event|0|||
124739354|NCT00431951|448669567|FG001|Overall Study|Adverse Event|0|||
124739355|NCT00431951|448669568|FG002|Overall Study|Adverse Event|1|||
124739356|NCT00431951|448669569|FG003|Overall Study|Adverse Event|0|||
124739357|NCT00673881|448669572|FG000|Overall Study|Withdrawal by Subject|1|||
124739358|NCT00096018|448669573|FG000|Overall Study|Became Ineligible (not treated)|0|||
124739359|NCT00096018|448669574|FG001|Overall Study|Became Ineligible (not treated)|3|||
124739360|NCT00096018|448669573|FG000|Overall Study|Miscellaneous (not treated)|0|||
124739361|NCT00096018|448669574|FG001|Overall Study|Miscellaneous (not treated)|2|||
124739362|NCT00096018|448669573|FG000|Overall Study|Adverse Event|0|||
124739363|NCT00096018|448669574|FG001|Overall Study|Adverse Event|5|||
124739364|NCT00096018|448669573|FG000|Overall Study|Death|0|||
124739365|NCT00096018|448669574|FG001|Overall Study|Death|1|||
124739366|NCT00096018|448669573|FG000|Overall Study|Withdrawal by Subject|0|||
124739367|NCT00096018|448669574|FG001|Overall Study|Withdrawal by Subject|2|||
124739368|NCT00096018|448669573|FG000|Overall Study|Miscellaneous|2|||
124739369|NCT00096018|448669574|FG001|Overall Study|Miscellaneous|1|||
124739370|NCT00689793|448669575|FG000|Overall Study|Lost to Follow-up|4|||
124739371|NCT00689793|448669576|FG001|Overall Study|Lost to Follow-up|5|||
124739372|NCT01100528|448669577|FG000|Overall Study|Death|1|||
124739373|NCT01100528|448669577|FG000|Overall Study|Withdrawal by Subject|2|||
124739374|NCT03968159|448669578|FG000|Overall Study|Adverse Event|4|||
124739375|NCT03968159|448669579|FG001|Overall Study|Adverse Event|4|||
124739376|NCT03968159|448669578|FG000|Overall Study|Lost to Follow-up|1|||
124739377|NCT03968159|448669579|FG001|Overall Study|Lost to Follow-up|1|||
124613273|NCT03155945|448202265|FG000|Overall Study|Lost to Follow-up|0|||
124613274|NCT03155945|448202266|FG001|Overall Study|Lost to Follow-up|1|||
124613275|NCT03155945|448202265|FG000|Overall Study|Withdrawal by Subject|0|||
124613276|NCT03155945|448202266|FG001|Overall Study|Withdrawal by Subject|1|||
124613277|NCT03155945|448202265|FG000|Overall Study|Other Reason|0|||
124613278|NCT03155945|448202266|FG001|Overall Study|Other Reason|1|||
124613279|NCT02203331|448202267|FG000|Overall Study|Pregnancy|1|||
124613280|NCT02203331|448202268|FG001|Overall Study|Pregnancy|0|||
124613281|NCT02203331|448202269|FG002|Overall Study|Pregnancy|0|||
124613282|NCT02203331|448202270|FG003|Overall Study|Pregnancy|0|||
124613283|NCT02203331|448202271|FG004|Overall Study|Pregnancy|2|||
124613284|NCT02203331|448202272|FG005|Overall Study|Pregnancy|0|||
124613285|NCT02203331|448202267|FG000|Overall Study|Withdrawal by Subject|1|||
124781688|NCT02474069|448831121|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
124781689|NCT02474069|448831122|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
124613286|NCT02203331|448202268|FG001|Overall Study|Withdrawal by Subject|0|||
124613287|NCT02203331|448202269|FG002|Overall Study|Withdrawal by Subject|1|||
124613288|NCT02203331|448202270|FG003|Overall Study|Withdrawal by Subject|0|||
124613289|NCT02203331|448202271|FG004|Overall Study|Withdrawal by Subject|0|||
124613290|NCT02203331|448202272|FG005|Overall Study|Withdrawal by Subject|3|||
124613291|NCT02203331|448202267|FG000|Overall Study|Adverse Event|4|||
124613292|NCT02203331|448202268|FG001|Overall Study|Adverse Event|8|||
124613293|NCT02203331|448202269|FG002|Overall Study|Adverse Event|3|||
124613294|NCT02203331|448202270|FG003|Overall Study|Adverse Event|4|||
124613295|NCT02203331|448202271|FG004|Overall Study|Adverse Event|3|||
124613296|NCT02203331|448202272|FG005|Overall Study|Adverse Event|3|||
124613297|NCT02203331|448202267|FG000|Overall Study|Other Reasons|1|||
124613298|NCT02203331|448202268|FG001|Overall Study|Other Reasons|2|||
124613299|NCT02203331|448202269|FG002|Overall Study|Other Reasons|0|||
124613300|NCT02203331|448202270|FG003|Overall Study|Other Reasons|2|||
124613301|NCT02203331|448202271|FG004|Overall Study|Other Reasons|0|||
124613302|NCT02203331|448202272|FG005|Overall Study|Other Reasons|0|||
124613303|NCT02203331|448202267|FG000|Overall Study|Lack of Efficacy|0|||
124613304|NCT02203331|448202268|FG001|Overall Study|Lack of Efficacy|2|||
124613305|NCT02203331|448202269|FG002|Overall Study|Lack of Efficacy|1|||
124739378|NCT03968159|448669578|FG000|Overall Study|Use of prohibited medication|0|||
124739379|NCT03968159|448669579|FG001|Overall Study|Use of prohibited medication|1|||
124739380|NCT03968159|448669578|FG000|Overall Study|Protocol Violation|2|||
124739381|NCT03968159|448669579|FG001|Overall Study|Protocol Violation|2|||
124739382|NCT03968159|448669578|FG000|Overall Study|Withdrawal by Subject|4|||
124739383|NCT03968159|448669579|FG001|Overall Study|Withdrawal by Subject|6|||
124781690|NCT02474069|448831123|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
124781691|NCT02474069|448831121|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
124781692|NCT02474069|448831122|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
124781693|NCT02474069|448831123|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
124781694|NCT02474069|448831121|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
124781695|NCT02474069|448831122|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
124739384|NCT03968159|448669578|FG000|Overall Study|Lack of Efficacy|0|||
124739385|NCT03968159|448669579|FG001|Overall Study|Lack of Efficacy|1|||
124739386|NCT03968159|448669578|FG000|Overall Study|Not further specified|2|||
124739387|NCT03968159|448669579|FG001|Overall Study|Not further specified|0|||
124739388|NCT01541917|448669585|FG000|Overall Study|Lost to Follow-up|2|||
124739389|NCT01541917|448669586|FG001|Overall Study|Lost to Follow-up|2|||
124739390|NCT01541917|448669585|FG000|Overall Study|Withdrawal by Subject|13|||
124739391|NCT01541917|448669586|FG001|Overall Study|Withdrawal by Subject|7|||
124739392|NCT00094107|448669591|FG000|Overall Study|Lack of Efficacy|23|||
124739393|NCT00094107|448669591|FG000|Overall Study|Death|5|||
124739394|NCT00094107|448669591|FG000|Overall Study|Adverse Event|3|||
124739395|NCT00094107|448669591|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
124739396|NCT00525824|448669592|FG000|Overall Study|Adverse Event|7|||
124781696|NCT02474069|448831123|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
124781697|NCT02474069|448831121|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
124781698|NCT02474069|448831122|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
124781699|NCT02474069|448831123|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
124781700|NCT01623050|448831126|FG000|Overall Study|Lost to Follow-up|9|||
124781701|NCT00393861|448831127|FG000|Overall Study|Adverse Event|2|||
124739397|NCT00525824|448669593|FG001|Overall Study|Adverse Event|11|||
124739398|NCT00525824|448669594|FG002|Overall Study|Adverse Event|6|||
124739399|NCT00525824|448669595|FG003|Overall Study|Adverse Event|7|||
124613306|NCT02203331|448202270|FG003|Overall Study|Lack of Efficacy|0|||
124613307|NCT02203331|448202271|FG004|Overall Study|Lack of Efficacy|0|||
124613308|NCT02203331|448202272|FG005|Overall Study|Lack of Efficacy|1|||
124613309|NCT02203331|448202267|FG000|Overall Study|Protocol Violation|0|||
124613310|NCT02203331|448202268|FG001|Overall Study|Protocol Violation|2|||
124739400|NCT00525824|448669592|FG000|Overall Study|Withdrawal by Subject|5|||
124739401|NCT00525824|448669593|FG001|Overall Study|Withdrawal by Subject|9|||
124613311|NCT02203331|448202269|FG002|Overall Study|Protocol Violation|0|||
124739402|NCT00525824|448669594|FG002|Overall Study|Withdrawal by Subject|3|||
124739403|NCT00525824|448669595|FG003|Overall Study|Withdrawal by Subject|4|||
124739404|NCT00525824|448669592|FG000|Overall Study|Lost to Follow-up|4|||
124739405|NCT00525824|448669593|FG001|Overall Study|Lost to Follow-up|2|||
124739406|NCT00525824|448669594|FG002|Overall Study|Lost to Follow-up|4|||
124739407|NCT00525824|448669595|FG003|Overall Study|Lost to Follow-up|0|||
124739408|NCT00525824|448669592|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
124739409|NCT00525824|448669593|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
124739410|NCT00525824|448669594|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
124739411|NCT00525824|448669595|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
124739412|NCT00525824|448669592|FG000|Overall Study|Severe non-compliance|0|||
124739413|NCT00525824|448669593|FG001|Overall Study|Severe non-compliance|1|||
124739414|NCT00525824|448669594|FG002|Overall Study|Severe non-compliance|1|||
124739415|NCT00525824|448669595|FG003|Overall Study|Severe non-compliance|1|||
124739416|NCT00525824|448669592|FG000|Overall Study|Safety reasons|1|||
124739417|NCT00525824|448669593|FG001|Overall Study|Safety reasons|0|||
124739418|NCT00525824|448669594|FG002|Overall Study|Safety reasons|1|||
124739419|NCT00525824|448669595|FG003|Overall Study|Safety reasons|0|||
124739420|NCT00525824|448669592|FG000|Overall Study|Other|1|||
124739421|NCT00525824|448669593|FG001|Overall Study|Other|3|||
124739422|NCT00525824|448669594|FG002|Overall Study|Other|3|||
124739423|NCT00525824|448669595|FG003|Overall Study|Other|1|||
124739424|NCT01378429|448669604|FG000|Overall Study|Noncompliance with study drug|1|||
124739425|NCT01378429|448669605|FG001|Overall Study|Noncompliance with study drug|0|||
124739426|NCT02356887|448669608|FG000|Overall Study|poor compliance|2|||
124739427|NCT01490294|448669609|FG000|Overall Study|Prematurely discontinuation|4|||
124739428|NCT01490294|448669610|FG001|Overall Study|Prematurely discontinuation|0|||
124739429|NCT01490294|448669611|FG002|Overall Study|Prematurely discontinuation|1|||
124739430|NCT01490294|448669612|FG003|Overall Study|Prematurely discontinuation|1|||
124739431|NCT01490294|448669609|FG000|Overall Study|Adverse Event|1|||
124739432|NCT01490294|448669610|FG001|Overall Study|Adverse Event|0|||
124739433|NCT01490294|448669611|FG002|Overall Study|Adverse Event|0|||
124739434|NCT01490294|448669612|FG003|Overall Study|Adverse Event|0|||
124781702|NCT00393861|448831127|FG000|Overall Study|Disease Progression|24|||
124781703|NCT01388335|448831130|FG000|Period 1|Progressive Disease|1|||
124613312|NCT02203331|448202270|FG003|Overall Study|Protocol Violation|1|||
124613313|NCT02203331|448202271|FG004|Overall Study|Protocol Violation|1|||
124613314|NCT02203331|448202272|FG005|Overall Study|Protocol Violation|0|||
124613315|NCT02203331|448202267|FG000|Overall Study|Lost to Follow-up|0|||
124613316|NCT02203331|448202268|FG001|Overall Study|Lost to Follow-up|0|||
124613317|NCT02203331|448202269|FG002|Overall Study|Lost to Follow-up|0|||
124613318|NCT02203331|448202270|FG003|Overall Study|Lost to Follow-up|0|||
124613319|NCT02203331|448202271|FG004|Overall Study|Lost to Follow-up|1|||
124613320|NCT02203331|448202272|FG005|Overall Study|Lost to Follow-up|0|||
124613321|NCT05065567|448202276|FG000|Overall Study|Lost to Follow-up|10|||
124613322|NCT05065567|448202277|FG001|Overall Study|Lost to Follow-up|9|||
124613323|NCT05065567|448202278|FG002|Overall Study|Lost to Follow-up|6|||
124613324|NCT04975191|448203619|FG000|Overall Study|Protocol Violation|1|||
124613325|NCT04975191|448203620|FG001|Overall Study|Protocol Violation|2|||
124613326|NCT04975191|448203621|FG002|Overall Study|Protocol Violation|2|||
124613327|NCT04975191|448203622|FG003|Overall Study|Protocol Violation|2|||
124613328|NCT04975191|448203619|FG000|Overall Study|Lost to Follow-up|13|||
124613329|NCT04975191|448203620|FG001|Overall Study|Lost to Follow-up|3|||
124613330|NCT04975191|448203621|FG002|Overall Study|Lost to Follow-up|8|||
124613331|NCT04975191|448203622|FG003|Overall Study|Lost to Follow-up|8|||
124613332|NCT02618759|448203624|FG000|Overall Study|Lost to Follow-up|0|||
124613333|NCT02618759|448203625|FG001|Overall Study|Lost to Follow-up|1|||
124613334|NCT02618759|448203624|FG000|Overall Study|Withdrawal by Subject|1|||
124613335|NCT02618759|448203625|FG001|Overall Study|Withdrawal by Subject|0|||
124613336|NCT02618759|448203624|FG000|Overall Study|Other Reasons|1|||
124613337|NCT02618759|448203625|FG001|Overall Study|Other Reasons|4|||
124613338|NCT02856555|448203628|FG000|Overall Study|Adverse Event|1|||
124613339|NCT02856555|448203629|FG001|Overall Study|Adverse Event|0|||
124613340|NCT02856555|448203630|FG002|Overall Study|Adverse Event|0|||
124739435|NCT00199888|448669613|FG000|Overall Study|Lost to Follow-up|1|||
124739436|NCT01751776|448669616|FG000|Overall Study|Adverse Event|0|||
124739437|NCT01751776|448669617|FG001|Overall Study|Adverse Event|0|||
124739438|NCT01751776|448669618|FG002|Overall Study|Adverse Event|0|||
124739439|NCT01751776|448669619|FG003|Overall Study|Adverse Event|0|||
124739440|NCT01751776|448669620|FG004|Overall Study|Adverse Event|0|||
124739441|NCT01751776|448669621|FG005|Overall Study|Adverse Event|0|||
124613341|NCT02856555|448203628|FG000|Overall Study|Lost to Follow-up|1|||
124613342|NCT02856555|448203629|FG001|Overall Study|Lost to Follow-up|3|||
124613343|NCT02856555|448203630|FG002|Overall Study|Lost to Follow-up|0|||
124613344|NCT02856555|448203628|FG000|Overall Study|Withdrawal by Subject|3|||
124613345|NCT02856555|448203629|FG001|Overall Study|Withdrawal by Subject|0|||
124739442|NCT01751776|448669622|FG006|Overall Study|Adverse Event|4|||
124739443|NCT01751776|448669623|FG007|Overall Study|Adverse Event|2|||
124739444|NCT01751776|448669616|FG000|Overall Study|Consent withdrawn|0|||
124613346|NCT02856555|448203630|FG002|Overall Study|Withdrawal by Subject|0|||
124613347|NCT02856555|448203628|FG000|Overall Study|Randomized but Never Treated|0|||
124613348|NCT02856555|448203629|FG001|Overall Study|Randomized but Never Treated|1|||
124613349|NCT02856555|448203630|FG002|Overall Study|Randomized but Never Treated|0|||
124613350|NCT03333941|448203631|FG000|Overall Study|Lost to Follow-up|10|||
124613351|NCT03333941|448203631|FG000|Overall Study|Death|2|||
124613352|NCT03333941|448203631|FG000|Overall Study|Adverse Event|1|||
124613353|NCT03323437|448203636|FG000|Overall Study|Withdrawal by Subject|0|||
124613354|NCT03323437|448203637|FG001|Overall Study|Withdrawal by Subject|4|||
124613355|NCT00605540|448203638|FG000|Overall Study|Death|15|||
124613356|NCT00605540|448203638|FG000|Overall Study|Lost to Follow-up|23|||
124613357|NCT00049530|448203640|FG000|Overall Study|Lack of Efficacy|25|||
124613358|NCT00049530|448203640|FG000|Overall Study|Adverse Event|2|||
124613359|NCT00049530|448203640|FG000|Overall Study|Death|1|||
124613360|NCT00049530|448203640|FG000|Overall Study|symptomatic deterioration|1|||
124613361|NCT00049530|448203640|FG000|Overall Study|ineligible|3|||
124739445|NCT01751776|448669617|FG001|Overall Study|Consent withdrawn|0|||
124739446|NCT01751776|448669618|FG002|Overall Study|Consent withdrawn|0|||
124739447|NCT01751776|448669619|FG003|Overall Study|Consent withdrawn|0|||
124739448|NCT01751776|448669620|FG004|Overall Study|Consent withdrawn|0|||
124739449|NCT01751776|448669621|FG005|Overall Study|Consent withdrawn|0|||
124739450|NCT01751776|448669622|FG006|Overall Study|Consent withdrawn|0|||
124739451|NCT01751776|448669623|FG007|Overall Study|Consent withdrawn|1|||
124739452|NCT01751776|448669616|FG000|Overall Study|Other reason not specified above|0|||
124739453|NCT01751776|448669617|FG001|Overall Study|Other reason not specified above|0|||
124739454|NCT01751776|448669618|FG002|Overall Study|Other reason not specified above|0|||
124739455|NCT01751776|448669619|FG003|Overall Study|Other reason not specified above|0|||
124739456|NCT01751776|448669620|FG004|Overall Study|Other reason not specified above|0|||
124739457|NCT01751776|448669621|FG005|Overall Study|Other reason not specified above|0|||
124739458|NCT01751776|448669622|FG006|Overall Study|Other reason not specified above|0|||
124739459|NCT01751776|448669623|FG007|Overall Study|Other reason not specified above|1|||
124739460|NCT05219669|448669626|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
124739461|NCT05219669|448669627|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
124739462|NCT05219669|448669628|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
124739463|NCT05219669|448669629|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
124739464|NCT05219669|448669630|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
124739465|NCT05219669|448669631|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
124739466|NCT02404649|448669636|FG000|Overall Study|Adverse Event|1|||
124739467|NCT02404649|448669637|FG001|Overall Study|Adverse Event|2|||
124739468|NCT00330668|448669643|FG000|BID Dosing Period|Adverse Event|1|||
124739469|NCT00330668|448669643|FG000|BID Dosing Period|Lost to Follow-up|7|||
124739470|NCT00330668|448669643|FG000|BID Dosing Period|Non-Compliance|5|||
124739471|NCT00330668|448669643|FG000|BID Dosing Period|Withdrawal by Subject|19|||
124739472|NCT00330668|448669643|FG000|BID Dosing Period|Sponsor's decision|1|||
124739473|NCT00330668|448669643|FG000|BID Dosing Period|Other|3|||
124739474|NCT00330668|448669643|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
124739475|NCT00330668|448669643|FG000|QD Dosing Period|Other|1|||
124739476|NCT00330668|448669643|FG000|QD Dosing Period|Withdrawal by Subject|1|||
124739477|NCT00330668|448669643|FG000|QD Dosing Period|Lost to Follow-up|2|||
124739478|NCT01839656|448669644|FG000|Overall Study|Withdrawal by Subject|1|||
124739479|NCT01839656|448669645|FG001|Overall Study|Withdrawal by Subject|1|||
124739480|NCT01839656|448669644|FG000|Overall Study|Adverse event, serious fatal|1|||
124739481|NCT01839656|448669645|FG001|Overall Study|Adverse event, serious fatal|4|||
124739482|NCT01839656|448669644|FG000|Overall Study|Early study closure|0|||
124739483|NCT01839656|448669645|FG001|Overall Study|Early study closure|11|||
124739484|NCT01839656|448669644|FG000|Overall Study|Adverse Event|1|||
124739485|NCT01839656|448669645|FG001|Overall Study|Adverse Event|0|||
124739486|NCT01595581|448669646|FG000|Overall Study|Withdrawal by Subject|1|||
124739487|NCT01595581|448669647|FG001|Overall Study|Withdrawal by Subject|0|||
124739488|NCT02621073|448669657|FG000|Overall Study|Lost to Follow-up|0|||
124739489|NCT02621073|448669658|FG001|Overall Study|Lost to Follow-up|1|||
124739490|NCT02621073|448669657|FG000|Overall Study|Physician Decision|3|||
124739491|NCT02621073|448669658|FG001|Overall Study|Physician Decision|2|||
124739492|NCT01440881|448669659|FG000|Overall Study|Death|0|||
124739493|NCT01440881|448669660|FG001|Overall Study|Death|1|||
124739494|NCT03474081|448669661|FG000|Overall Study|Adverse Event|6|||
124739495|NCT03474081|448669662|FG001|Overall Study|Adverse Event|3|||
124739496|NCT03474081|448669661|FG000|Overall Study|Lost to Follow-up|2|||
124739497|NCT03474081|448669662|FG001|Overall Study|Lost to Follow-up|1|||
124739498|NCT03474081|448669661|FG000|Overall Study|Physician Decision|3|||
124739499|NCT03474081|448669662|FG001|Overall Study|Physician Decision|2|||
124781704|NCT01388335|448831130|FG000|Period 2|Progressive Disease|2|||
124781705|NCT01388335|448831130|FG000|Period 2|Sponsor Decision|1|||
124613362|NCT02383810|448203641|FG000|Overall Study|Physician Decision|1|||
124613363|NCT02383810|448203642|FG001|Overall Study|Physician Decision|1|||
124613364|NCT02383810|448203643|FG002|Overall Study|Physician Decision|0|||
124739500|NCT03474081|448669661|FG000|Overall Study|Withdrawal by Subject|5|||
124739501|NCT03474081|448669662|FG001|Overall Study|Withdrawal by Subject|7|||
124739502|NCT03474081|448669661|FG000|Overall Study|Investigator site closed|1|||
124739503|NCT03474081|448669662|FG001|Overall Study|Investigator site closed|0|||
124739504|NCT02920957|448669669|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
124739505|NCT02920957|448669670|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
124739506|NCT02920957|448669669|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
124739507|NCT02920957|448669670|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
124739508|NCT02920957|448669669|FG000|First Intervention : 1 Month|Adverse Event|1|||
124739509|NCT02920957|448669670|FG001|First Intervention : 1 Month|Adverse Event|0|||
124739510|NCT02920957|448669669|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
124739511|NCT02920957|448669670|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
124739512|NCT02644356|448669672|FG000|Overall Study|Withdrawal by Subject|2|||
124739513|NCT01711866|448669679|FG000|Overall Study|Noncompliant|3|||
124739514|NCT01711866|448669679|FG000|Overall Study|Withdrawal by Subject|3|||
124739515|NCT01711866|448669679|FG000|Overall Study|Adverse Event|2|||
124739516|NCT01345682|448669680|FG000|Overall Study|Progressive disease per RECIST|226|||
124739517|NCT01345682|448669681|FG001|Overall Study|Progressive disease per RECIST|93|||
124739518|NCT01345682|448669680|FG000|Overall Study|Worsening of underlying cancer disease|23|||
124739519|NCT01345682|448669681|FG001|Overall Study|Worsening of underlying cancer disease|12|||
124739520|NCT01345682|448669680|FG000|Overall Study|Adverse Event|51|||
124739521|NCT01345682|448669681|FG001|Overall Study|Adverse Event|41|||
124739522|NCT01345682|448669680|FG000|Overall Study|Non-compliance with protocol|0|||
124739523|NCT01345682|448669681|FG001|Overall Study|Non-compliance with protocol|1|||
124739524|NCT01345682|448669680|FG000|Overall Study|Lost to Follow-up|0|||
124739525|NCT01345682|448669681|FG001|Overall Study|Lost to Follow-up|1|||
124739526|NCT01345682|448669680|FG000|Overall Study|Refused to continue trial medication|16|||
124739527|NCT01345682|448669681|FG001|Overall Study|Refused to continue trial medication|9|||
124739528|NCT01345682|448669680|FG000|Overall Study|Not treated|2|||
124739529|NCT01345682|448669681|FG001|Overall Study|Not treated|1|||
124739530|NCT01345682|448669680|FG000|Overall Study|Reason other than those specified above|4|||
124739531|NCT01345682|448669681|FG001|Overall Study|Reason other than those specified above|3|||
124739532|NCT00897390|448669684|FG000|Overall Study|Adverse Event|2|||
124739533|NCT00897390|448669684|FG000|Overall Study|No Longer Met Study Criteria|1|||
124739534|NCT00897390|448669684|FG000|Overall Study|Personal Reasons|1|||
124739535|NCT00897390|448669684|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
124739536|NCT00958217|448669685|FG000|Overall Study|Death|2|||
124739537|NCT00958217|448669686|FG001|Overall Study|Death|1|||
124739538|NCT00958217|448669685|FG000|Overall Study|Withdrawal by Subject|4|||
124739539|NCT00958217|448669686|FG001|Overall Study|Withdrawal by Subject|3|||
124739540|NCT00958217|448669685|FG000|Overall Study|Lost to Follow-up|17|||
124739541|NCT00958217|448669686|FG001|Overall Study|Lost to Follow-up|19|||
124739542|NCT00958217|448669685|FG000|Overall Study|Moved out of area|1|||
124739543|NCT00958217|448669686|FG001|Overall Study|Moved out of area|1|||
124739544|NCT00958217|448669685|FG000|Overall Study|Inpatient hospitalization|0|||
124739545|NCT00958217|448669686|FG001|Overall Study|Inpatient hospitalization|1|||
124739546|NCT01075984|448669689|FG000|Treatment Phase|Adverse Event|0|||
124739547|NCT01075984|448669690|FG001|Treatment Phase|Adverse Event|1|||
124739548|NCT01075984|448669691|FG002|Treatment Phase|Adverse Event|3|||
124739549|NCT01075984|448669692|FG003|Treatment Phase|Adverse Event|7|||
124739550|NCT01075984|448669693|FG004|Treatment Phase|Adverse Event|35|||
124739551|NCT01075984|448669689|FG000|Treatment Phase|Protocol Violation|0|||
124739552|NCT01075984|448669690|FG001|Treatment Phase|Protocol Violation|0|||
124739553|NCT01075984|448669691|FG002|Treatment Phase|Protocol Violation|1|||
124739554|NCT01075984|448669692|FG003|Treatment Phase|Protocol Violation|0|||
124739555|NCT01075984|448669693|FG004|Treatment Phase|Protocol Violation|3|||
124739556|NCT01075984|448669689|FG000|Treatment Phase|Withdrawal by Subject|0|||
124739557|NCT01075984|448669690|FG001|Treatment Phase|Withdrawal by Subject|0|||
124739558|NCT01075984|448669691|FG002|Treatment Phase|Withdrawal by Subject|2|||
124739559|NCT01075984|448669692|FG003|Treatment Phase|Withdrawal by Subject|0|||
124739560|NCT01075984|448669693|FG004|Treatment Phase|Withdrawal by Subject|15|||
124739561|NCT01075984|448669689|FG000|Treatment Phase|Treatment Failure|0|||
124739562|NCT01075984|448669690|FG001|Treatment Phase|Treatment Failure|0|||
124739563|NCT01075984|448669691|FG002|Treatment Phase|Treatment Failure|1|||
124739564|NCT01075984|448669692|FG003|Treatment Phase|Treatment Failure|0|||
124739565|NCT01075984|448669693|FG004|Treatment Phase|Treatment Failure|5|||
124739566|NCT01075984|448669689|FG000|Treatment Phase|Progression of disease|0|||
124739567|NCT01075984|448669690|FG001|Treatment Phase|Progression of disease|0|||
124739568|NCT01075984|448669691|FG002|Treatment Phase|Progression of disease|0|||
124739569|NCT01075984|448669692|FG003|Treatment Phase|Progression of disease|0|||
124739570|NCT01075984|448669693|FG004|Treatment Phase|Progression of disease|2|||
124739571|NCT01075984|448669689|FG000|Follow-up Phase|Protocol Violation|0|||
124739572|NCT01075984|448669690|FG001|Follow-up Phase|Protocol Violation|0|||
124739573|NCT01075984|448669691|FG002|Follow-up Phase|Protocol Violation|1|||
124739574|NCT01075984|448669692|FG003|Follow-up Phase|Protocol Violation|0|||
124739575|NCT01075984|448669693|FG004|Follow-up Phase|Protocol Violation|3|||
124739576|NCT01075984|448669689|FG000|Follow-up Phase|Adverse Event|0|||
124739577|NCT01075984|448669690|FG001|Follow-up Phase|Adverse Event|0|||
124739578|NCT01075984|448669691|FG002|Follow-up Phase|Adverse Event|0|||
124739579|NCT01075984|448669692|FG003|Follow-up Phase|Adverse Event|2|||
124739580|NCT01075984|448669693|FG004|Follow-up Phase|Adverse Event|27|||
124739581|NCT01075984|448669689|FG000|Follow-up Phase|Administrative|0|||
124739582|NCT01075984|448669690|FG001|Follow-up Phase|Administrative|0|||
124739583|NCT01075984|448669691|FG002|Follow-up Phase|Administrative|0|||
124739584|NCT01075984|448669692|FG003|Follow-up Phase|Administrative|0|||
124739585|NCT01075984|448669693|FG004|Follow-up Phase|Administrative|1|||
124739586|NCT01075984|448669689|FG000|Follow-up Phase|Withdrawal by Subject|0|||
124739587|NCT01075984|448669690|FG001|Follow-up Phase|Withdrawal by Subject|0|||
124739588|NCT01075984|448669691|FG002|Follow-up Phase|Withdrawal by Subject|0|||
124739589|NCT01075984|448669692|FG003|Follow-up Phase|Withdrawal by Subject|0|||
124739590|NCT01075984|448669693|FG004|Follow-up Phase|Withdrawal by Subject|10|||
124739591|NCT01075984|448669689|FG000|Follow-up Phase|Progression of disease|0|||
124739592|NCT01075984|448669690|FG001|Follow-up Phase|Progression of disease|0|||
124739593|NCT01075984|448669691|FG002|Follow-up Phase|Progression of disease|0|||
124739594|NCT01075984|448669692|FG003|Follow-up Phase|Progression of disease|0|||
124739595|NCT01075984|448669693|FG004|Follow-up Phase|Progression of disease|2|||
124739596|NCT01075984|448669689|FG000|Follow-up Phase|Treatment failure|0|||
124739597|NCT01075984|448669690|FG001|Follow-up Phase|Treatment failure|0|||
124739598|NCT01075984|448669691|FG002|Follow-up Phase|Treatment failure|0|||
124739599|NCT01075984|448669692|FG003|Follow-up Phase|Treatment failure|0|||
124739600|NCT01075984|448669693|FG004|Follow-up Phase|Treatment failure|4|||
124739601|NCT02198235|448669695|FG000|Overall Study|Lost to Follow-up|3|||
124739602|NCT02198235|448669696|FG001|Overall Study|Lost to Follow-up|2|||
124739603|NCT02198235|448669697|FG002|Overall Study|Lost to Follow-up|2|||
124739604|NCT02440789|448669701|FG000|Overall Study|Withdrawal by Subject|3|||
124739605|NCT02440789|448669701|FG000|Overall Study|Not willing to adhere to reqs|1|||
124739606|NCT04573881|448669703|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
124739607|NCT02564978|448669704|FG000|Overall Study|Adverse Event|8|||
124739608|NCT02564978|448669704|FG000|Overall Study|Death|1|||
124739609|NCT02564978|448669704|FG000|Overall Study|Lost to Follow-up|1|||
124739610|NCT02564978|448669704|FG000|Overall Study|Withdrawal by Subject|15|||
124739611|NCT02564978|448669704|FG000|Overall Study|Early Study Closure|2|||
124739612|NCT02564978|448669704|FG000|Overall Study|Other Reason|5|||
124739613|NCT03684694|448669705|FG000|Phase 1|Withdrawal by Subject|1|||
124739614|NCT03684694|448669706|FG001|Phase 1|Withdrawal by Subject|0|||
124739615|NCT03684694|448669707|FG002|Phase 1|Withdrawal by Subject|0|||
124739616|NCT03684694|448669708|FG003|Phase 1|Withdrawal by Subject|0|||
124739617|NCT03684694|448669709|FG004|Phase 1|Withdrawal by Subject|0|||
124739618|NCT03684694|448669710|FG005|Phase 1|Withdrawal by Subject|0|||
124739619|NCT03684694|448669705|FG000|Phase 1|Investigator/Sponsor Decision|12|||
124739620|NCT03684694|448669706|FG001|Phase 1|Investigator/Sponsor Decision|2|||
124739621|NCT03684694|448669707|FG002|Phase 1|Investigator/Sponsor Decision|1|||
124739622|NCT03684694|448669708|FG003|Phase 1|Investigator/Sponsor Decision|0|||
124739623|NCT03684694|448669709|FG004|Phase 1|Investigator/Sponsor Decision|0|||
124739624|NCT03684694|448669710|FG005|Phase 1|Investigator/Sponsor Decision|0|||
124739625|NCT03684694|448669705|FG000|Phase 1|Death|24|||
124739626|NCT03684694|448669706|FG001|Phase 1|Death|0|||
124739627|NCT03684694|448669707|FG002|Phase 1|Death|3|||
124739628|NCT03684694|448669708|FG003|Phase 1|Death|0|||
124739629|NCT03684694|448669709|FG004|Phase 1|Death|0|||
124739630|NCT03684694|448669710|FG005|Phase 1|Death|0|||
124739631|NCT03684694|448669705|FG000|Phase 1|Lost to Follow-up|0|||
124739632|NCT03684694|448669706|FG001|Phase 1|Lost to Follow-up|0|||
124739633|NCT03684694|448669707|FG002|Phase 1|Lost to Follow-up|1|||
124739634|NCT03684694|448669708|FG003|Phase 1|Lost to Follow-up|0|||
124739635|NCT03684694|448669709|FG004|Phase 1|Lost to Follow-up|0|||
124739636|NCT03684694|448669710|FG005|Phase 1|Lost to Follow-up|0|||
124739637|NCT03684694|448669705|FG000|Phase 1|Miscellaneous|0|||
124739638|NCT03684694|448669706|FG001|Phase 1|Miscellaneous|1|||
124739639|NCT03684694|448669707|FG002|Phase 1|Miscellaneous|0|||
124739640|NCT03684694|448669708|FG003|Phase 1|Miscellaneous|0|||
124739641|NCT03684694|448669709|FG004|Phase 1|Miscellaneous|0|||
124739642|NCT03684694|448669710|FG005|Phase 1|Miscellaneous|0|||
124739643|NCT03684694|448669705|FG000|Phase 2|Withdrawal by Subject|0|||
124739644|NCT03684694|448669706|FG001|Phase 2|Withdrawal by Subject|0|||
124739645|NCT03684694|448669707|FG002|Phase 2|Withdrawal by Subject|0|||
124739646|NCT03684694|448669708|FG003|Phase 2|Withdrawal by Subject|0|||
124739647|NCT03684694|448669709|FG004|Phase 2|Withdrawal by Subject|0|||
124739648|NCT03684694|448669710|FG005|Phase 2|Withdrawal by Subject|1|||
124739649|NCT03684694|448669705|FG000|Phase 2|Investigator/Sponsor Decision|0|||
124739650|NCT03684694|448669706|FG001|Phase 2|Investigator/Sponsor Decision|0|||
124739651|NCT03684694|448669707|FG002|Phase 2|Investigator/Sponsor Decision|0|||
124739652|NCT03684694|448669708|FG003|Phase 2|Investigator/Sponsor Decision|17|||
124739653|NCT03684694|448669709|FG004|Phase 2|Investigator/Sponsor Decision|16|||
124739654|NCT03684694|448669710|FG005|Phase 2|Investigator/Sponsor Decision|6|||
124739655|NCT03684694|448669705|FG000|Phase 2|Death|0|||
124739656|NCT03684694|448669706|FG001|Phase 2|Death|0|||
124739657|NCT03684694|448669707|FG002|Phase 2|Death|0|||
124739658|NCT03684694|448669708|FG003|Phase 2|Death|28|||
124739659|NCT03684694|448669709|FG004|Phase 2|Death|14|||
124739660|NCT03684694|448669710|FG005|Phase 2|Death|3|||
124739661|NCT03684694|448669705|FG000|Phase 2|Lost to Follow-up|0|||
124739662|NCT03684694|448669706|FG001|Phase 2|Lost to Follow-up|0|||
124739663|NCT03684694|448669707|FG002|Phase 2|Lost to Follow-up|0|||
124739664|NCT03684694|448669708|FG003|Phase 2|Lost to Follow-up|1|||
124739665|NCT03684694|448669709|FG004|Phase 2|Lost to Follow-up|0|||
124739666|NCT03684694|448669710|FG005|Phase 2|Lost to Follow-up|0|||
124739667|NCT03684694|448669705|FG000|Phase 2|Miscellaneous|0|||
124739668|NCT03684694|448669706|FG001|Phase 2|Miscellaneous|0|||
124739669|NCT03684694|448669707|FG002|Phase 2|Miscellaneous|0|||
124739670|NCT03684694|448669708|FG003|Phase 2|Miscellaneous|3|||
124739671|NCT03684694|448669709|FG004|Phase 2|Miscellaneous|0|||
124739672|NCT03684694|448669710|FG005|Phase 2|Miscellaneous|0|||
124739673|NCT01825941|448671182|FG000|Overall Study|Lost to Follow-up|4|||
124739674|NCT01825941|448671183|FG001|Overall Study|Lost to Follow-up|1|||
124739675|NCT00528996|448671184|FG000|Overall Study|Other reasons than listing|6|||
124739676|NCT00528996|448671185|FG001|Overall Study|Other reasons than listing|7|||
124739677|NCT00528996|448671186|FG002|Overall Study|Other reasons than listing|14|||
124739678|NCT00528996|448671187|FG003|Overall Study|Other reasons than listing|11|||
124739679|NCT00528996|448671188|FG004|Overall Study|Other reasons than listing|5|||
124739680|NCT00528996|448671184|FG000|Overall Study|Refused continue medication|16|||
124739681|NCT00528996|448671185|FG001|Overall Study|Refused continue medication|0|||
124739682|NCT00528996|448671186|FG002|Overall Study|Refused continue medication|3|||
124739683|NCT00528996|448671187|FG003|Overall Study|Refused continue medication|3|||
124739684|NCT00528996|448671188|FG004|Overall Study|Refused continue medication|6|||
124739685|NCT00528996|448671184|FG000|Overall Study|Lost to Follow-up|2|||
124739686|NCT00528996|448671185|FG001|Overall Study|Lost to Follow-up|0|||
124739687|NCT00528996|448671186|FG002|Overall Study|Lost to Follow-up|4|||
124739688|NCT00528996|448671187|FG003|Overall Study|Lost to Follow-up|1|||
124739689|NCT00528996|448671188|FG004|Overall Study|Lost to Follow-up|3|||
124739690|NCT00528996|448671184|FG000|Overall Study|Protocol Violation|1|||
124739691|NCT00528996|448671185|FG001|Overall Study|Protocol Violation|2|||
124739692|NCT00528996|448671186|FG002|Overall Study|Protocol Violation|3|||
124739693|NCT00528996|448671187|FG003|Overall Study|Protocol Violation|3|||
124739694|NCT00528996|448671188|FG004|Overall Study|Protocol Violation|2|||
124613365|NCT02383810|448203644|FG003|Overall Study|Physician Decision|0|||
124613366|NCT02383810|448203645|FG004|Overall Study|Physician Decision|0|||
124613367|NCT02383810|448203646|FG005|Overall Study|Physician Decision|0|||
124613368|NCT02383810|448203647|FG006|Overall Study|Physician Decision|0|||
124613369|NCT02383810|448203648|FG007|Overall Study|Physician Decision|0|||
124613370|NCT02383810|448203641|FG000|Overall Study|Withdrawal by Subject|2|||
124613371|NCT02383810|448203642|FG001|Overall Study|Withdrawal by Subject|3|||
124613372|NCT02383810|448203643|FG002|Overall Study|Withdrawal by Subject|3|||
124613373|NCT02383810|448203644|FG003|Overall Study|Withdrawal by Subject|3|||
124613374|NCT02383810|448203645|FG004|Overall Study|Withdrawal by Subject|0|||
124613375|NCT02383810|448203646|FG005|Overall Study|Withdrawal by Subject|0|||
124613376|NCT02383810|448203647|FG006|Overall Study|Withdrawal by Subject|0|||
124613377|NCT02383810|448203648|FG007|Overall Study|Withdrawal by Subject|0|||
124613378|NCT02383810|448203641|FG000|Overall Study|Adverse Event|0|||
124613379|NCT02383810|448203642|FG001|Overall Study|Adverse Event|2|||
124613380|NCT02383810|448203643|FG002|Overall Study|Adverse Event|4|||
124613381|NCT02383810|448203644|FG003|Overall Study|Adverse Event|5|||
124613382|NCT02383810|448203645|FG004|Overall Study|Adverse Event|0|||
124613383|NCT02383810|448203646|FG005|Overall Study|Adverse Event|1|||
124739695|NCT00528996|448671184|FG000|Overall Study|Lack of Efficacy|7|||
124739696|NCT00528996|448671185|FG001|Overall Study|Lack of Efficacy|2|||
124739697|NCT00528996|448671186|FG002|Overall Study|Lack of Efficacy|1|||
124739698|NCT00528996|448671187|FG003|Overall Study|Lack of Efficacy|3|||
124739699|NCT00528996|448671188|FG004|Overall Study|Lack of Efficacy|3|||
124613384|NCT02383810|448203647|FG006|Overall Study|Adverse Event|1|||
124613385|NCT02383810|448203648|FG007|Overall Study|Adverse Event|0|||
124613386|NCT02383810|448203641|FG000|Overall Study|Lost to Follow-up|0|||
124613387|NCT02383810|448203642|FG001|Overall Study|Lost to Follow-up|1|||
124613388|NCT02383810|448203643|FG002|Overall Study|Lost to Follow-up|0|||
124613389|NCT02383810|448203644|FG003|Overall Study|Lost to Follow-up|1|||
124613390|NCT02383810|448203645|FG004|Overall Study|Lost to Follow-up|0|||
124613391|NCT02383810|448203646|FG005|Overall Study|Lost to Follow-up|0|||
124613392|NCT02383810|448203647|FG006|Overall Study|Lost to Follow-up|0|||
124613393|NCT02383810|448203648|FG007|Overall Study|Lost to Follow-up|0|||
124613394|NCT02383810|448203641|FG000|Overall Study|other|0|||
124613395|NCT02383810|448203642|FG001|Overall Study|other|0|||
124739700|NCT00528996|448671184|FG000|Overall Study|Adverse Event|32|||
124739701|NCT00528996|448671185|FG001|Overall Study|Adverse Event|13|||
124739702|NCT00528996|448671186|FG002|Overall Study|Adverse Event|18|||
124739703|NCT00528996|448671187|FG003|Overall Study|Adverse Event|29|||
124739704|NCT00528996|448671188|FG004|Overall Study|Adverse Event|18|||
124739705|NCT05565937|448671195|FG000|Overall Study|Adverse Event|0|||
124739706|NCT05565937|448671196|FG001|Overall Study|Adverse Event|1|||
124739707|NCT05565937|448671195|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
124739708|NCT05565937|448671196|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
124613396|NCT02383810|448203643|FG002|Overall Study|other|0|||
124739709|NCT05565937|448671195|FG000|Overall Study|Lost to Follow-up|2|||
124739710|NCT05565937|448671196|FG001|Overall Study|Lost to Follow-up|0|||
124739711|NCT05565937|448671195|FG000|Overall Study|Pregnancy|0|||
124739712|NCT05565937|448671196|FG001|Overall Study|Pregnancy|2|||
124739713|NCT05565937|448671195|FG000|Overall Study|Anisometropia|0|||
124739714|NCT05565937|448671196|FG001|Overall Study|Anisometropia|1|||
124739715|NCT01022424|448671197|FG000|Overall Study|Adverse Event|1|||
124739716|NCT01022424|448671197|FG000|Overall Study|Physician Decision|1|||
124739717|NCT01022424|448671197|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
124739718|NCT01806064|448671202|FG000|Overall Study|Randomized Not Enrolled|0|||
124739719|NCT01806064|448671203|FG001|Overall Study|Randomized Not Enrolled|0|||
124739720|NCT01806064|448671204|FG002|Overall Study|Randomized Not Enrolled|0|||
124739721|NCT01806064|448671205|FG003|Overall Study|Randomized Not Enrolled|1|||
124739722|NCT01806064|448671206|FG004|Overall Study|Randomized Not Enrolled|2|||
124739723|NCT05160766|448671211|FG000|Overall Study|Adverse Event|0|||
124739724|NCT05160766|448671212|FG001|Overall Study|Adverse Event|1|||
124739725|NCT05160766|448671213|FG002|Overall Study|Adverse Event|0|||
124739726|NCT05160766|448671214|FG003|Overall Study|Adverse Event|0|||
124739727|NCT05160766|448671211|FG000|Overall Study|COVID-19 infection|0|||
124739728|NCT05160766|448671212|FG001|Overall Study|COVID-19 infection|1|||
124739729|NCT05160766|448671213|FG002|Overall Study|COVID-19 infection|0|||
124739730|NCT05160766|448671214|FG003|Overall Study|COVID-19 infection|0|||
124739731|NCT05160766|448671211|FG000|Overall Study|travel time|1|||
124739732|NCT05160766|448671212|FG001|Overall Study|travel time|0|||
124739733|NCT05160766|448671213|FG002|Overall Study|travel time|0|||
124739734|NCT05160766|448671214|FG003|Overall Study|travel time|1|||
124739735|NCT05160766|448671211|FG000|Overall Study|Withdrawal by Subject|3|||
124739736|NCT05160766|448671212|FG001|Overall Study|Withdrawal by Subject|5|||
124739737|NCT05160766|448671213|FG002|Overall Study|Withdrawal by Subject|4|||
124739738|NCT05160766|448671214|FG003|Overall Study|Withdrawal by Subject|2|||
124739739|NCT05160766|448671211|FG000|Overall Study|Death|0|||
124739740|NCT05160766|448671212|FG001|Overall Study|Death|0|||
124739741|NCT05160766|448671213|FG002|Overall Study|Death|2|||
124739742|NCT05160766|448671214|FG003|Overall Study|Death|5|||
124739743|NCT05160766|448671211|FG000|Overall Study|Lost to Follow-up|0|||
124739744|NCT05160766|448671212|FG001|Overall Study|Lost to Follow-up|0|||
124739745|NCT05160766|448671213|FG002|Overall Study|Lost to Follow-up|1|||
124739746|NCT05160766|448671214|FG003|Overall Study|Lost to Follow-up|2|||
124739747|NCT05160766|448671211|FG000|Overall Study|No show|0|||
124739748|NCT05160766|448671212|FG001|Overall Study|No show|0|||
124739749|NCT05160766|448671213|FG002|Overall Study|No show|1|||
124739750|NCT05160766|448671214|FG003|Overall Study|No show|1|||
124739751|NCT05160766|448671211|FG000|Overall Study|Physician Decision|0|||
124739752|NCT05160766|448671212|FG001|Overall Study|Physician Decision|0|||
124739753|NCT05160766|448671213|FG002|Overall Study|Physician Decision|0|||
124739754|NCT05160766|448671214|FG003|Overall Study|Physician Decision|1|||
124739755|NCT05160766|448671211|FG000|Overall Study|Protocol Violation|0|||
124739756|NCT05160766|448671212|FG001|Overall Study|Protocol Violation|0|||
124739757|NCT05160766|448671213|FG002|Overall Study|Protocol Violation|1|||
124739758|NCT05160766|448671214|FG003|Overall Study|Protocol Violation|0|||
124739759|NCT01282294|448671215|FG000|Overall Study|Lost to Follow-up|14|||
124739760|NCT01282294|448671215|FG000|Overall Study|Screening failure|1|||
124739761|NCT01282294|448671215|FG000|Overall Study|Adverse Event|1|||
124739762|NCT01282294|448671215|FG000|Overall Study|Patient non-compliance|2|||
124739763|NCT01282294|448671215|FG000|Overall Study|Physician Decision|1|||
124739764|NCT00004445|448671217|FG000|Overall Study|Physician Decision|2|||
124739765|NCT00004445|448671217|FG000|Overall Study|Withdrawal by Subject|1|||
124739766|NCT04692077|448671218|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
124739767|NCT02753127|448671225|FG000|Overall Study|Lost to Follow-up|13|||
124739768|NCT02753127|448671226|FG001|Overall Study|Lost to Follow-up|11|||
124739769|NCT02753127|448671225|FG000|Overall Study|Withdrawal by Subject|37|||
124739770|NCT02753127|448671226|FG001|Overall Study|Withdrawal by Subject|47|||
124739771|NCT02753127|448671225|FG000|Overall Study|Other|3|||
124739772|NCT02753127|448671226|FG001|Overall Study|Other|8|||
124739773|NCT02753127|448671225|FG000|Overall Study|Hospice|0|||
124739774|NCT02753127|448671226|FG001|Overall Study|Hospice|2|||
124739775|NCT03826342|448671227|FG000|Overall Study|Withdrawal by Subject|8|||
124613397|NCT02383810|448203644|FG003|Overall Study|other|2|||
124739776|NCT03826342|448671228|FG001|Overall Study|Withdrawal by Subject|1|||
124739777|NCT03826342|448671227|FG000|Overall Study|Lost to Follow-up|7|||
124739778|NCT03826342|448671228|FG001|Overall Study|Lost to Follow-up|7|||
124613398|NCT02383810|448203645|FG004|Overall Study|other|0|||
124613399|NCT02383810|448203646|FG005|Overall Study|other|0|||
124739779|NCT03826342|448671227|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
124739780|NCT03826342|448671228|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
124613400|NCT02383810|448203647|FG006|Overall Study|other|0|||
124739781|NCT01657760|448671231|FG000|Overall Study|Withdrawal by Subject|0|||
124739782|NCT01657760|448671232|FG001|Overall Study|Withdrawal by Subject|0|||
124739783|NCT01657760|448671233|FG002|Overall Study|Withdrawal by Subject|0|||
124781706|NCT01388335|448831130|FG000|Safety Extension|Progressive Disease|7|||
124781707|NCT04413617|448831136|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
124781708|NCT04413617|448831137|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
124781709|NCT04413617|448831138|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
124781710|NCT04413617|448831139|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
124781711|NCT04413617|448831140|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
124781712|NCT04413617|448831136|FG000|Overall Study|Protocol Violation|0|||
124781713|NCT04413617|448831137|FG001|Overall Study|Protocol Violation|1|||
124781714|NCT04413617|448831138|FG002|Overall Study|Protocol Violation|0|||
124781715|NCT04413617|448831139|FG003|Overall Study|Protocol Violation|0|||
124781716|NCT04413617|448831140|FG004|Overall Study|Protocol Violation|1|||
124781717|NCT04413617|448831136|FG000|Overall Study|Lack of Efficacy|2|||
124781718|NCT04413617|448831137|FG001|Overall Study|Lack of Efficacy|0|||
124781719|NCT04413617|448831138|FG002|Overall Study|Lack of Efficacy|2|||
124781720|NCT04413617|448831139|FG003|Overall Study|Lack of Efficacy|1|||
124781721|NCT04413617|448831140|FG004|Overall Study|Lack of Efficacy|0|||
124781722|NCT04413617|448831136|FG000|Overall Study|Withdrawal by Subject|3|||
124781723|NCT04413617|448831137|FG001|Overall Study|Withdrawal by Subject|4|||
124781724|NCT04413617|448831138|FG002|Overall Study|Withdrawal by Subject|2|||
124781725|NCT04413617|448831139|FG003|Overall Study|Withdrawal by Subject|5|||
124781726|NCT04413617|448831140|FG004|Overall Study|Withdrawal by Subject|3|||
124781727|NCT04413617|448831136|FG000|Overall Study|Death|1|||
124781728|NCT04413617|448831137|FG001|Overall Study|Death|0|||
124781729|NCT04413617|448831138|FG002|Overall Study|Death|0|||
124781730|NCT04413617|448831139|FG003|Overall Study|Death|0|||
124781731|NCT04413617|448831140|FG004|Overall Study|Death|0|||
124613401|NCT02383810|448203648|FG007|Overall Study|other|0|||
124613402|NCT02383810|448203641|FG000|Overall Study|subject did not receive study treatment|0|||
124613403|NCT02383810|448203642|FG001|Overall Study|subject did not receive study treatment|1|||
124613404|NCT02383810|448203643|FG002|Overall Study|subject did not receive study treatment|0|||
124739784|NCT01657760|448671234|FG003|Overall Study|Withdrawal by Subject|1|||
124739785|NCT01657760|448671231|FG000|Overall Study|Physician Decision|1|||
124739786|NCT01657760|448671232|FG001|Overall Study|Physician Decision|1|||
124739787|NCT01657760|448671233|FG002|Overall Study|Physician Decision|1|||
124739788|NCT01657760|448671234|FG003|Overall Study|Physician Decision|2|||
124739789|NCT06250738|448671242|FG000|Overall Study|Lost to Follow-up|1|||
124739790|NCT01818284|448671246|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
124739791|NCT01818284|448671247|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
124739792|NCT01818284|448671246|FG000|Overall Study|Death|0|||
124739793|NCT01818284|448671247|FG001|Overall Study|Death|2|||
124739794|NCT03681678|448671248|FG000|Overall Study|Lost to Follow-up|20|||
124739795|NCT01068249|448671249|FG000|Overall Study|Death|1|||
124739796|NCT01068249|448671249|FG000|Overall Study|Withdrawal by Subject|3|||
124739797|NCT04030962|448671251|FG000|Stage 2|Adverse Event|0|||
124739798|NCT04030962|448671252|FG001|Stage 2|Adverse Event|0|||
124739799|NCT04030962|448671253|FG002|Stage 2|Adverse Event|0|||
124739800|NCT04030962|448671254|FG003|Stage 2|Adverse Event|0|||
124739801|NCT04030962|448671255|FG004|Stage 2|Adverse Event|0|||
124739802|NCT04030962|448671256|FG005|Stage 2|Adverse Event|0|||
124739803|NCT04030962|448671257|FG006|Stage 2|Adverse Event|0|||
124739804|NCT04030962|448671258|FG007|Stage 2|Adverse Event|0|||
124739805|NCT04030962|448671259|FG008|Stage 2|Adverse Event|1|||
124739806|NCT04030962|448671260|FG009|Stage 2|Adverse Event|0|||
124739807|NCT04030962|448671261|FG010|Stage 2|Adverse Event|1|||
124739808|NCT04030962|448671262|FG011|Stage 2|Adverse Event|1|||
124739809|NCT04030962|448671263|FG012|Stage 2|Adverse Event|1|||
124739810|NCT04030962|448671251|FG000|Stage 2|Withdrawal by Subject|0|||
124739811|NCT04030962|448671252|FG001|Stage 2|Withdrawal by Subject|0|||
124739812|NCT04030962|448671253|FG002|Stage 2|Withdrawal by Subject|0|||
124739813|NCT04030962|448671254|FG003|Stage 2|Withdrawal by Subject|0|||
124613405|NCT02383810|448203644|FG003|Overall Study|subject did not receive study treatment|0|||
124739814|NCT04030962|448671255|FG004|Stage 2|Withdrawal by Subject|0|||
124739815|NCT04030962|448671256|FG005|Stage 2|Withdrawal by Subject|0|||
124781732|NCT04413617|448831136|FG000|Overall Study|Adverse Event|1|||
124781733|NCT04413617|448831137|FG001|Overall Study|Adverse Event|0|||
124613406|NCT02383810|448203645|FG004|Overall Study|subject did not receive study treatment|0|||
124739816|NCT04030962|448671257|FG006|Stage 2|Withdrawal by Subject|0|||
124613407|NCT02383810|448203646|FG005|Overall Study|subject did not receive study treatment|0|||
124781734|NCT04413617|448831138|FG002|Overall Study|Adverse Event|0|||
124781735|NCT04413617|448831139|FG003|Overall Study|Adverse Event|1|||
124739817|NCT04030962|448671258|FG007|Stage 2|Withdrawal by Subject|0|||
124739818|NCT04030962|448671259|FG008|Stage 2|Withdrawal by Subject|1|||
124739819|NCT04030962|448671260|FG009|Stage 2|Withdrawal by Subject|0|||
124739820|NCT04030962|448671261|FG010|Stage 2|Withdrawal by Subject|0|||
124739821|NCT04030962|448671262|FG011|Stage 2|Withdrawal by Subject|2|||
124781736|NCT04413617|448831140|FG004|Overall Study|Adverse Event|1|||
124739822|NCT04030962|448671263|FG012|Stage 2|Withdrawal by Subject|1|||
124739823|NCT04030962|448671251|FG000|Stage 2|Lost to Follow-up|0|||
124781737|NCT04413617|448831136|FG000|Overall Study|COVID-19|0|||
124739824|NCT04030962|448671252|FG001|Stage 2|Lost to Follow-up|0|||
124739825|NCT04030962|448671253|FG002|Stage 2|Lost to Follow-up|0|||
124739826|NCT04030962|448671254|FG003|Stage 2|Lost to Follow-up|0|||
124739827|NCT04030962|448671255|FG004|Stage 2|Lost to Follow-up|0|||
124739828|NCT04030962|448671256|FG005|Stage 2|Lost to Follow-up|0|||
124739829|NCT04030962|448671257|FG006|Stage 2|Lost to Follow-up|0|||
124739830|NCT04030962|448671258|FG007|Stage 2|Lost to Follow-up|0|||
124739831|NCT04030962|448671259|FG008|Stage 2|Lost to Follow-up|1|||
124739832|NCT04030962|448671260|FG009|Stage 2|Lost to Follow-up|0|||
124739833|NCT04030962|448671261|FG010|Stage 2|Lost to Follow-up|0|||
124739834|NCT04030962|448671262|FG011|Stage 2|Lost to Follow-up|0|||
124739835|NCT04030962|448671263|FG012|Stage 2|Lost to Follow-up|0|||
124739836|NCT04030962|448671251|FG000|Stage 2|Technical Problems|0|||
124739837|NCT04030962|448671252|FG001|Stage 2|Technical Problems|0|||
124739838|NCT04030962|448671253|FG002|Stage 2|Technical Problems|0|||
124739839|NCT04030962|448671254|FG003|Stage 2|Technical Problems|0|||
124739840|NCT04030962|448671255|FG004|Stage 2|Technical Problems|0|||
124739841|NCT04030962|448671256|FG005|Stage 2|Technical Problems|0|||
124739842|NCT04030962|448671257|FG006|Stage 2|Technical Problems|0|||
124739843|NCT04030962|448671258|FG007|Stage 2|Technical Problems|0|||
124739844|NCT04030962|448671259|FG008|Stage 2|Technical Problems|0|||
124739845|NCT04030962|448671260|FG009|Stage 2|Technical Problems|0|||
124739846|NCT04030962|448671261|FG010|Stage 2|Technical Problems|0|||
124739847|NCT04030962|448671262|FG011|Stage 2|Technical Problems|1|||
124739848|NCT04030962|448671263|FG012|Stage 2|Technical Problems|0|||
124739849|NCT05288166|448671264|FG000|Overall Study|Adverse Event|1|||
124739850|NCT05288166|448671265|FG001|Overall Study|Adverse Event|0|||
124739851|NCT05288166|448671264|FG000|Overall Study|Lost to Follow-up|2|||
124739852|NCT05288166|448671265|FG001|Overall Study|Lost to Follow-up|0|||
124739853|NCT05288166|448671264|FG000|Overall Study|Physician Decision|0|||
124739854|NCT05288166|448671265|FG001|Overall Study|Physician Decision|2|||
124739855|NCT05288166|448671264|FG000|Overall Study|Screen Failure|1|||
124739856|NCT05288166|448671265|FG001|Overall Study|Screen Failure|1|||
124739857|NCT05288166|448671264|FG000|Overall Study|Withdrawal by Subject|4|||
124739858|NCT05288166|448671265|FG001|Overall Study|Withdrawal by Subject|2|||
124739859|NCT05288166|448671264|FG000|Overall Study|On Study Treatment|408|||
124739860|NCT05288166|448671265|FG001|Overall Study|On Study Treatment|418|||
124739861|NCT01114360|448671266|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
124739862|NCT01114360|448671267|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
124739863|NCT03007745|448671268|FG000|Overall Study|Sleep test negative for OSA|53|||
124739864|NCT03007745|448671269|FG001|Overall Study|Sleep test negative for OSA|49|||
124739865|NCT03007745|448671268|FG000|Overall Study|Physician Decision|6|||
124739866|NCT03007745|448671269|FG001|Overall Study|Physician Decision|9|||
124739867|NCT03007745|448671268|FG000|Overall Study|Withdrawal by Subject|38|||
124739868|NCT03007745|448671269|FG001|Overall Study|Withdrawal by Subject|16|||
124739869|NCT03007745|448671268|FG000|Overall Study|Lost to Follow-up|19|||
124739870|NCT03007745|448671269|FG001|Overall Study|Lost to Follow-up|25|||
124739871|NCT03007745|448671268|FG000|Overall Study|Unable to login to website|17|||
124739872|NCT03007745|448671269|FG001|Overall Study|Unable to login to website|4|||
124739873|NCT01146288|448671271|FG000|First Intervention(1 Day)|Adverse Event|0|||
124739874|NCT01146288|448671272|FG001|First Intervention(1 Day)|Adverse Event|1|||
124739875|NCT00385723|448671273|FG000|Overall Study|Lost to Follow-up|1|||
124739876|NCT00385723|448671274|FG001|Overall Study|Lost to Follow-up|1|||
124739877|NCT00385723|448671275|FG002|Overall Study|Lost to Follow-up|0|||
124739878|NCT00385723|448671273|FG000|Overall Study|Withdrawal by Subject|1|||
124739879|NCT00385723|448671274|FG001|Overall Study|Withdrawal by Subject|0|||
124739880|NCT00385723|448671275|FG002|Overall Study|Withdrawal by Subject|2|||
124739881|NCT03455829|448671276|FG000|Overall Study|Death|2|||
124739882|NCT03455829|448671277|FG001|Overall Study|Death|3|||
124739883|NCT03455829|448671278|FG002|Overall Study|Death|2|||
124739884|NCT03455829|448671279|FG003|Overall Study|Death|4|||
124739885|NCT03455829|448671280|FG004|Overall Study|Death|2|||
124739886|NCT03455829|448671276|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
124739887|NCT03455829|448671277|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
124739888|NCT03455829|448671278|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
124739889|NCT03455829|448671279|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
124739890|NCT03455829|448671280|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
124739891|NCT03455829|448671276|FG000|Overall Study|Disease progression|0|||
124613408|NCT02383810|448203647|FG006|Overall Study|subject did not receive study treatment|0|||
124613409|NCT02383810|448203648|FG007|Overall Study|subject did not receive study treatment|0|||
124739892|NCT03455829|448671277|FG001|Overall Study|Disease progression|0|||
124739893|NCT03455829|448671278|FG002|Overall Study|Disease progression|0|||
124739894|NCT03455829|448671279|FG003|Overall Study|Disease progression|1|||
124739895|NCT03455829|448671280|FG004|Overall Study|Disease progression|1|||
124739896|NCT05824936|448671282|FG000|Overall Study|Lost to Follow-up|1|||
124739897|NCT03689712|448671283|FG000|Overall Study|Adverse Event|1|||
124739898|NCT03689712|448671284|FG001|Overall Study|Adverse Event|0|||
124739899|NCT03689712|448671283|FG000|Overall Study|Death|20|||
124739900|NCT03689712|448671284|FG001|Overall Study|Death|10|||
124739901|NCT03689712|448671283|FG000|Overall Study|Lost to Follow-up|6|||
124739902|NCT03689712|448671284|FG001|Overall Study|Lost to Follow-up|6|||
124739903|NCT03689712|448671283|FG000|Overall Study|Other|1|||
124739904|NCT03689712|448671284|FG001|Overall Study|Other|0|||
124739905|NCT03689712|448671283|FG000|Overall Study|Patient Non-Compliance|0|||
124739906|NCT03689712|448671284|FG001|Overall Study|Patient Non-Compliance|1|||
124739907|NCT03689712|448671283|FG000|Overall Study|Withdrawal by Subject|20|||
124739908|NCT03689712|448671284|FG001|Overall Study|Withdrawal by Subject|4|||
124739909|NCT03689712|448671283|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
124739910|NCT03689712|448671284|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
124739911|NCT03689712|448671283|FG000|Overall Study|Randomized but not Treated|13|||
124739912|NCT03689712|448671284|FG001|Overall Study|Randomized but not Treated|7|||
124739913|NCT03689712|448671283|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
124739914|NCT03689712|448671284|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
124739915|NCT01533922|448671288|FG000|Overall Study|Adverse Event|5|||
124739916|NCT01533922|448671289|FG001|Overall Study|Adverse Event|8|||
124739917|NCT01533922|448671290|FG002|Overall Study|Adverse Event|6|||
124739918|NCT01533922|448671291|FG003|Overall Study|Adverse Event|3|||
124739919|NCT01533922|448671292|FG004|Overall Study|Adverse Event|4|||
124739920|NCT01533922|448671288|FG000|Overall Study|Lack of Efficacy|0|||
124739921|NCT01533922|448671289|FG001|Overall Study|Lack of Efficacy|0|||
124739922|NCT01533922|448671290|FG002|Overall Study|Lack of Efficacy|1|||
124739923|NCT01533922|448671291|FG003|Overall Study|Lack of Efficacy|0|||
124739924|NCT01533922|448671292|FG004|Overall Study|Lack of Efficacy|0|||
124739925|NCT01533922|448671288|FG000|Overall Study|Protocol Violation|0|||
124739926|NCT01533922|448671289|FG001|Overall Study|Protocol Violation|3|||
124739927|NCT01533922|448671290|FG002|Overall Study|Protocol Violation|0|||
124739928|NCT01533922|448671291|FG003|Overall Study|Protocol Violation|0|||
124739929|NCT01533922|448671292|FG004|Overall Study|Protocol Violation|1|||
124739930|NCT01533922|448671288|FG000|Overall Study|Withdrawal by Subject|3|||
124739931|NCT01533922|448671289|FG001|Overall Study|Withdrawal by Subject|1|||
124739932|NCT01533922|448671290|FG002|Overall Study|Withdrawal by Subject|2|||
124739933|NCT01533922|448671291|FG003|Overall Study|Withdrawal by Subject|2|||
124739934|NCT01533922|448671292|FG004|Overall Study|Withdrawal by Subject|1|||
124739935|NCT01533922|448671288|FG000|Overall Study|Other reason not defined above|2|||
124739936|NCT01533922|448671289|FG001|Overall Study|Other reason not defined above|0|||
124739937|NCT01533922|448671290|FG002|Overall Study|Other reason not defined above|1|||
124739938|NCT01533922|448671291|FG003|Overall Study|Other reason not defined above|0|||
124739939|NCT01533922|448671292|FG004|Overall Study|Other reason not defined above|0|||
124739940|NCT02634606|448671293|FG000|Overall Study|unable to obtain the drug at start|13|||
124739941|NCT00286221|448671294|FG000|Overall Study|Protocol Violation|2|||
124739942|NCT00286221|448671295|FG001|Overall Study|Protocol Violation|1|||
124739943|NCT00286221|448671296|FG002|Overall Study|Protocol Violation|6|||
124739944|NCT00286221|448671297|FG003|Overall Study|Protocol Violation|4|||
124739945|NCT00286221|448671294|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
124739946|NCT00286221|448671295|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
124739947|NCT00286221|448671296|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
124739948|NCT00286221|448671297|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
124739949|NCT00286221|448671294|FG000|Overall Study|Inability to trigger PCA|2|||
124739950|NCT00286221|448671295|FG001|Overall Study|Inability to trigger PCA|0|||
124739951|NCT00286221|448671296|FG002|Overall Study|Inability to trigger PCA|0|||
124739952|NCT00286221|448671297|FG003|Overall Study|Inability to trigger PCA|0|||
124739953|NCT00286221|448671294|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
124739954|NCT00286221|448671295|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
124739955|NCT00286221|448671296|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
124739956|NCT00286221|448671297|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
124739957|NCT02276547|448671299|FG000|Overall Study|Death|2|||
124739958|NCT02276547|448671299|FG000|Overall Study|Explant|2|||
124739959|NCT01754194|448671300|FG000|Overall Study|Lost to Follow-up|39|||
124739960|NCT01754194|448671301|FG001|Overall Study|Lost to Follow-up|14|||
124739961|NCT01754194|448671300|FG000|Overall Study|Withdrawal by Subject|4|||
124739962|NCT01754194|448671301|FG001|Overall Study|Withdrawal by Subject|5|||
124781738|NCT04413617|448831137|FG001|Overall Study|COVID-19|1|||
124781739|NCT04413617|448831138|FG002|Overall Study|COVID-19|0|||
124613410|NCT01635283|448203651|FG000|Overall Study|Tumor Progression|3|||
124739963|NCT01754194|448671300|FG000|Overall Study|Other|9|||
124739964|NCT01754194|448671301|FG001|Overall Study|Other|8|||
124739965|NCT00907296|448671302|FG000|Overall Study|Ineligibility Determined|1|||
124739966|NCT00907296|448671303|FG001|Overall Study|Ineligibility Determined|0|||
124739967|NCT00907296|448671304|FG002|Overall Study|Ineligibility Determined|0|||
124739968|NCT00907296|448671305|FG003|Overall Study|Ineligibility Determined|1|||
124739969|NCT00907296|448671306|FG004|Overall Study|Ineligibility Determined|0|||
124739970|NCT00907296|448671307|FG005|Overall Study|Ineligibility Determined|0|||
124739971|NCT00907296|448671308|FG006|Overall Study|Ineligibility Determined|0|||
124739972|NCT00907296|448671309|FG007|Overall Study|Ineligibility Determined|1|||
124739973|NCT00907296|448671310|FG008|Overall Study|Ineligibility Determined|0|||
124739974|NCT00907296|448671311|FG009|Overall Study|Ineligibility Determined|0|||
124739975|NCT00907296|448671302|FG000|Overall Study|Protocol Deviation|0|||
124739976|NCT00907296|448671303|FG001|Overall Study|Protocol Deviation|1|||
124739977|NCT00907296|448671304|FG002|Overall Study|Protocol Deviation|0|||
124739978|NCT00907296|448671305|FG003|Overall Study|Protocol Deviation|0|||
124739979|NCT00907296|448671306|FG004|Overall Study|Protocol Deviation|0|||
124739980|NCT00907296|448671307|FG005|Overall Study|Protocol Deviation|0|||
124739981|NCT00907296|448671308|FG006|Overall Study|Protocol Deviation|0|||
124739982|NCT00907296|448671309|FG007|Overall Study|Protocol Deviation|0|||
124739983|NCT00907296|448671310|FG008|Overall Study|Protocol Deviation|0|||
124739984|NCT00907296|448671311|FG009|Overall Study|Protocol Deviation|0|||
124739985|NCT00907296|448671302|FG000|Overall Study|Noncompliance|1|||
124739986|NCT00907296|448671303|FG001|Overall Study|Noncompliance|1|||
124739987|NCT00907296|448671304|FG002|Overall Study|Noncompliance|1|||
124739988|NCT00907296|448671305|FG003|Overall Study|Noncompliance|0|||
124739989|NCT00907296|448671306|FG004|Overall Study|Noncompliance|0|||
124739990|NCT00907296|448671307|FG005|Overall Study|Noncompliance|1|||
124739991|NCT00907296|448671308|FG006|Overall Study|Noncompliance|0|||
124739992|NCT00907296|448671309|FG007|Overall Study|Noncompliance|2|||
124739993|NCT00907296|448671310|FG008|Overall Study|Noncompliance|0|||
124739994|NCT00907296|448671311|FG009|Overall Study|Noncompliance|0|||
124739995|NCT00907296|448671302|FG000|Overall Study|Adverse Event|2|||
124739996|NCT00907296|448671303|FG001|Overall Study|Adverse Event|0|||
124739997|NCT00907296|448671304|FG002|Overall Study|Adverse Event|0|||
124739998|NCT00907296|448671305|FG003|Overall Study|Adverse Event|0|||
124739999|NCT00907296|448671306|FG004|Overall Study|Adverse Event|0|||
124740000|NCT00907296|448671307|FG005|Overall Study|Adverse Event|0|||
124740001|NCT00907296|448671308|FG006|Overall Study|Adverse Event|1|||
124740002|NCT00907296|448671309|FG007|Overall Study|Adverse Event|0|||
124740003|NCT00907296|448671310|FG008|Overall Study|Adverse Event|0|||
124740004|NCT00907296|448671311|FG009|Overall Study|Adverse Event|1|||
124740005|NCT00907296|448671302|FG000|Overall Study|Withdrawal by Subject|7|||
124740006|NCT00907296|448671303|FG001|Overall Study|Withdrawal by Subject|2|||
124740007|NCT00907296|448671304|FG002|Overall Study|Withdrawal by Subject|1|||
124740008|NCT00907296|448671305|FG003|Overall Study|Withdrawal by Subject|1|||
124740009|NCT00907296|448671306|FG004|Overall Study|Withdrawal by Subject|1|||
124740010|NCT00907296|448671307|FG005|Overall Study|Withdrawal by Subject|5|||
124740011|NCT00907296|448671308|FG006|Overall Study|Withdrawal by Subject|3|||
124740012|NCT00907296|448671309|FG007|Overall Study|Withdrawal by Subject|2|||
124740013|NCT00907296|448671310|FG008|Overall Study|Withdrawal by Subject|4|||
124740014|NCT00907296|448671311|FG009|Overall Study|Withdrawal by Subject|2|||
124740015|NCT00907296|448671302|FG000|Overall Study|Lost to Follow-up|9|||
124740016|NCT00907296|448671303|FG001|Overall Study|Lost to Follow-up|1|||
124740017|NCT00907296|448671304|FG002|Overall Study|Lost to Follow-up|0|||
124740018|NCT00907296|448671305|FG003|Overall Study|Lost to Follow-up|2|||
124740019|NCT00907296|448671306|FG004|Overall Study|Lost to Follow-up|0|||
124740020|NCT00907296|448671307|FG005|Overall Study|Lost to Follow-up|3|||
124740021|NCT00907296|448671308|FG006|Overall Study|Lost to Follow-up|2|||
124740022|NCT00907296|448671309|FG007|Overall Study|Lost to Follow-up|2|||
124740023|NCT00907296|448671310|FG008|Overall Study|Lost to Follow-up|0|||
124740024|NCT00907296|448671311|FG009|Overall Study|Lost to Follow-up|4|||
124740025|NCT03344640|448671313|FG000|Overall Study|Adverse Event|1|||
124740026|NCT03344640|448671314|FG001|Overall Study|Adverse Event|0|||
124740027|NCT03344640|448671313|FG000|Overall Study|Physician Decision|1|||
124740028|NCT03344640|448671314|FG001|Overall Study|Physician Decision|1|||
124740029|NCT03344640|448671313|FG000|Overall Study|Withdrawal by Subject|1|||
124740030|NCT03344640|448671314|FG001|Overall Study|Withdrawal by Subject|2|||
124740031|NCT03344640|448671313|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
124740032|NCT03344640|448671314|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
124740033|NCT00815191|448671318|FG000|Overall Study|Protocol Violation|1|||
124740034|NCT00815191|448671319|FG001|Overall Study|Protocol Violation|1|||
124740035|NCT02576860|448671320|FG000|Overall Study|Adverse Event|6|||
124740036|NCT02576860|448671321|FG001|Overall Study|Adverse Event|6|||
124613411|NCT01635283|448203651|FG000|Overall Study|Lost to Follow-up|1|||
124740037|NCT02576860|448671320|FG000|Overall Study|Lost to Follow-up|5|||
124740038|NCT02576860|448671321|FG001|Overall Study|Lost to Follow-up|7|||
124613412|NCT01433549|448203652|FG000|Phase 2: Second Study Product|Adverse Event|0|||
124613413|NCT01433549|448203653|FG001|Phase 2: Second Study Product|Adverse Event|1|||
124740039|NCT02576860|448671320|FG000|Overall Study|Physician Decision|0|||
124740040|NCT02576860|448671321|FG001|Overall Study|Physician Decision|1|||
124740041|NCT02576860|448671320|FG000|Overall Study|Protocol Violation|0|||
124740042|NCT02576860|448671321|FG001|Overall Study|Protocol Violation|2|||
124740043|NCT02576860|448671320|FG000|Overall Study|Withdrawal by Subject|13|||
124740044|NCT02576860|448671321|FG001|Overall Study|Withdrawal by Subject|8|||
124740045|NCT02576860|448671320|FG000|Overall Study|Disallowed medication|1|||
124740046|NCT02576860|448671321|FG001|Overall Study|Disallowed medication|0|||
124740047|NCT00160654|448671355|FG000|Overall Study|Adverse Event|14|||
124740048|NCT00160654|448671355|FG000|Overall Study|Lack of Efficacy|4|||
124740049|NCT00160654|448671355|FG000|Overall Study|Lost to Follow-up|2|||
124740050|NCT00160654|448671355|FG000|Overall Study|Intake of expired drug|7|||
124740051|NCT00160654|448671355|FG000|Overall Study|Psychological trauma|1|||
124740052|NCT00160654|448671355|FG000|Overall Study|Sponsor decision|1|||
124740053|NCT00160654|448671355|FG000|Overall Study|Patient met exclusion criteria|1|||
124740054|NCT00160654|448671355|FG000|Overall Study|Patient decision|1|||
124740055|NCT00160654|448671355|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
124740056|NCT00160654|448671355|FG000|Overall Study|Met exclusion criteria|1|||
124740057|NCT02544373|448671357|FG000|Overall Study|Lost to Follow-up|5|||
124740058|NCT02544373|448671358|FG001|Overall Study|Lost to Follow-up|3|||
124740059|NCT02544373|448671357|FG000|Overall Study|Withdrawal by Subject|8|||
124740060|NCT02544373|448671358|FG001|Overall Study|Withdrawal by Subject|2|||
124740061|NCT03172130|448672610|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
124740062|NCT03172130|448672611|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
124740063|NCT02783170|448672616|FG000|Overall Study|Randomized but not Vaccinated|1|||
124740064|NCT02783170|448672617|FG001|Overall Study|Randomized but not Vaccinated|0|||
124740065|NCT02943915|448672618|FG000|Overall Study|Withdrawal by Subject|2|||
124740066|NCT02943915|448672619|FG001|Overall Study|Withdrawal by Subject|1|||
124740067|NCT02943915|448672620|FG002|Overall Study|Withdrawal by Subject|0|||
124740068|NCT02943915|448672621|FG003|Overall Study|Withdrawal by Subject|0|||
124740069|NCT02943915|448672618|FG000|Overall Study|Lost to Follow-up|3|||
124740070|NCT02943915|448672619|FG001|Overall Study|Lost to Follow-up|1|||
124740071|NCT02943915|448672620|FG002|Overall Study|Lost to Follow-up|0|||
124740072|NCT02943915|448672621|FG003|Overall Study|Lost to Follow-up|0|||
124740073|NCT02943915|448672618|FG000|Overall Study|excluded|0|||
124740074|NCT02943915|448672619|FG001|Overall Study|excluded|1|||
124740075|NCT02943915|448672620|FG002|Overall Study|excluded|0|||
124740076|NCT02943915|448672621|FG003|Overall Study|excluded|0|||
124740077|NCT05601102|448672622|FG000|Overall Study|Death|1|||
124740078|NCT05601102|448672623|FG001|Overall Study|Death|2|||
124740079|NCT05601102|448672622|FG000|Overall Study|Withdrawal by Subject|1|||
124740080|NCT05601102|448672623|FG001|Overall Study|Withdrawal by Subject|1|||
124740081|NCT05601102|448672622|FG000|Overall Study|Lost to Follow-up|0|||
124740082|NCT05601102|448672623|FG001|Overall Study|Lost to Follow-up|2|||
124740083|NCT02981524|448672625|FG000|Overall Study|Progressive Disease|14|||
124740084|NCT02981524|448672625|FG000|Overall Study|Death (unrelated)|1|||
124740085|NCT02981524|448672625|FG000|Overall Study|Treatment Related Toxicity|1|||
124740086|NCT02981524|448672625|FG000|Overall Study|Withdrawal by Subject|1|||
124740087|NCT00483041|448672626|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
124740088|NCT00483041|448672627|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
124740089|NCT00413010|448672630|FG000|Overall Study|Adverse Event|8|||
124740090|NCT00413010|448672631|FG001|Overall Study|Adverse Event|4|||
124740091|NCT00413010|448672630|FG000|Overall Study|Laboratory abnormality|0|||
124740092|NCT00413010|448672631|FG001|Overall Study|Laboratory abnormality|2|||
124740093|NCT00413010|448672630|FG000|Overall Study|Lack of Efficacy|0|||
124740094|NCT00413010|448672631|FG001|Overall Study|Lack of Efficacy|3|||
124740095|NCT00413010|448672630|FG000|Overall Study|Lost to Follow-up|3|||
124740096|NCT00413010|448672631|FG001|Overall Study|Lost to Follow-up|0|||
124740097|NCT00413010|448672630|FG000|Overall Study|Withdrawal by Subject|7|||
124740098|NCT00413010|448672631|FG001|Overall Study|Withdrawal by Subject|2|||
124740099|NCT00413010|448672630|FG000|Overall Study|Due to termination of the study|54|||
124740100|NCT00413010|448672631|FG001|Overall Study|Due to termination of the study|52|||
124740101|NCT00708734|448672634|FG000|Overall Study|scheduling conflict|2|||
124740102|NCT00708734|448672634|FG000|Overall Study|moved|1|||
124740103|NCT00708734|448672634|FG000|Overall Study|leg injury|1|||
124740104|NCT00708734|448672634|FG000|Overall Study|knee replacement|1|||
124740105|NCT00708734|448672634|FG000|Overall Study|vertigo|1|||
124740106|NCT00708734|448672634|FG000|Overall Study|leg fracture|1|||
124740107|NCT00895661|448672636|FG000|Overall Study|Death|1|||
124740108|NCT00895661|448672636|FG000|Overall Study|reason unknown|2|||
124740109|NCT02066129|448672637|FG000|Overall Study|Lost to Follow-up|13|||
124740110|NCT02066129|448672638|FG001|Overall Study|Lost to Follow-up|12|||
124740111|NCT02066129|448672637|FG000|Overall Study|Withdrawal by Subject|7|||
124740112|NCT02066129|448672638|FG001|Overall Study|Withdrawal by Subject|10|||
124740113|NCT02066129|448672637|FG000|Overall Study|Lack of Efficacy|8|||
124740114|NCT02066129|448672638|FG001|Overall Study|Lack of Efficacy|10|||
124740115|NCT02066129|448672637|FG000|Overall Study|Physician Decision|1|||
124613414|NCT03511326|448203656|FG000|Overall Study|Withdrawal by Subject|1|||
124613415|NCT04628793|448203657|FG000|Overall Study|Study terminated by sponsor|0|||
124613416|NCT04628793|448203658|FG001|Overall Study|Study terminated by sponsor|0|||
124613417|NCT04628793|448203659|FG002|Overall Study|Study terminated by sponsor|8|||
124740116|NCT02066129|448672638|FG001|Overall Study|Physician Decision|1|||
124740117|NCT00357656|448672639|FG000|Overall Study|Other, No surgery performed|0|||
124740118|NCT00357656|448672640|FG001|Overall Study|Other, No surgery performed|3|||
124740119|NCT02573246|448672641|FG000|Overall Study|Lost to Follow-up|2|||
124740120|NCT02573246|448672642|FG001|Overall Study|Lost to Follow-up|0|||
124740121|NCT02573246|448672643|FG002|Overall Study|Lost to Follow-up|0|||
124740122|NCT02573246|448672644|FG003|Overall Study|Lost to Follow-up|0|||
124740123|NCT02573246|448672645|FG004|Overall Study|Lost to Follow-up|1|||
124740124|NCT02573246|448672641|FG000|Overall Study|Withdrawal by Subject|0|||
124740125|NCT02573246|448672642|FG001|Overall Study|Withdrawal by Subject|0|||
124740126|NCT02573246|448672643|FG002|Overall Study|Withdrawal by Subject|0|||
124740127|NCT02573246|448672644|FG003|Overall Study|Withdrawal by Subject|0|||
124740128|NCT02573246|448672645|FG004|Overall Study|Withdrawal by Subject|1|||
124740129|NCT02573246|448672641|FG000|Overall Study|Physician Decision|1|||
124740130|NCT02573246|448672642|FG001|Overall Study|Physician Decision|1|||
124740131|NCT02573246|448672643|FG002|Overall Study|Physician Decision|3|||
124740132|NCT02573246|448672644|FG003|Overall Study|Physician Decision|2|||
124740133|NCT02573246|448672645|FG004|Overall Study|Physician Decision|2|||
124740134|NCT01219933|448672646|FG000|Overall Study|Adverse Event|8|||
124740135|NCT01219933|448672646|FG000|Overall Study|No LDA reached|5|||
124740136|NCT01219933|448672646|FG000|Overall Study|No LDA maintained|7|||
124740137|NCT01219933|448672646|FG000|Overall Study|Lost to Follow-up|3|||
124740138|NCT01219933|448672646|FG000|Overall Study|GC free|1|||
124740139|NCT01219933|448672646|FG000|Overall Study|Withdrawal by Subject|5|||
124740140|NCT01219933|448672646|FG000|Overall Study|Protocol Violation|8|||
124740141|NCT01219933|448672646|FG000|Overall Study|Lack of Efficacy|1|||
124740142|NCT01902888|448672647|FG000|Overall Study|Study Terminated|3|||
124740143|NCT00316888|448672648|FG000|Overall Study|Adverse Event|4|||
124740144|NCT00316888|448672649|FG001|Overall Study|Adverse Event|5|||
124740145|NCT00316888|448672648|FG000|Overall Study|Withdrawal by Subject|2|||
124740146|NCT00316888|448672649|FG001|Overall Study|Withdrawal by Subject|2|||
124740147|NCT00316888|448672648|FG000|Overall Study|Not start protocol therapy|0|||
124740148|NCT00316888|448672649|FG001|Overall Study|Not start protocol therapy|1|||
124740149|NCT03149003|448672650|FG000|Overall Study|Randomized but not treated|0|||
124740150|NCT03149003|448672651|FG001|Overall Study|Randomized but not treated|1|||
124740151|NCT03149003|448672652|FG002|Overall Study|Randomized but not treated|18|||
124740152|NCT04135859|448672653|FG000|Overall Study|Withdrawal by Subject|1|||
124740153|NCT04135859|448672654|FG001|Overall Study|Withdrawal by Subject|0|||
124740154|NCT04135859|448672653|FG000|Overall Study|Withdrawal due to screening failure|1|||
124740155|NCT04135859|448672654|FG001|Overall Study|Withdrawal due to screening failure|2|||
124740156|NCT04135859|448672653|FG000|Overall Study|Did not complete stress test|3|||
124740157|NCT04135859|448672654|FG001|Overall Study|Did not complete stress test|3|||
124740158|NCT04135859|448672653|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
124740159|NCT04135859|448672654|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
124740160|NCT01814670|448672657|FG000|Overall Study|Protocol Violation|12|||
124740161|NCT01565941|448672658|FG000|Overall Study|Withdrawn by parent/guardian|3|||
124740162|NCT01565941|448672659|FG001|Overall Study|Withdrawn by parent/guardian|2|||
124740163|NCT01565941|448672658|FG000|Overall Study|Randomized; did not receive intevention|8|||
124740164|NCT01565941|448672659|FG001|Overall Study|Randomized; did not receive intevention|2|||
124740165|NCT04047420|448672660|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
124740166|NCT04047420|448672660|FG000|Washout Period|Refused Participation|2|||
124740167|NCT03242018|448672661|FG000|Overall Study|Adverse Event|7|||
124740168|NCT03242018|448672662|FG001|Overall Study|Adverse Event|7|||
124740169|NCT03242018|448672663|FG002|Overall Study|Adverse Event|6|||
124740170|NCT03242018|448672661|FG000|Overall Study|Lost to Follow-up|2|||
124740171|NCT03242018|448672662|FG001|Overall Study|Lost to Follow-up|2|||
124740172|NCT03242018|448672663|FG002|Overall Study|Lost to Follow-up|2|||
124740173|NCT03242018|448672661|FG000|Overall Study|At the Participant's Own Request|5|||
124740174|NCT03242018|448672662|FG001|Overall Study|At the Participant's Own Request|1|||
124740175|NCT03242018|448672663|FG002|Overall Study|At the Participant's Own Request|4|||
124740176|NCT03242018|448672661|FG000|Overall Study|Reason Not Specified|3|||
124740177|NCT03242018|448672662|FG001|Overall Study|Reason Not Specified|4|||
124740178|NCT03242018|448672663|FG002|Overall Study|Reason Not Specified|1|||
124740179|NCT03242018|448672661|FG000|Overall Study|Study Terminated by Sponsor|1|||
124613418|NCT04628793|448203657|FG000|Overall Study|Withdrawal by Subject|2|||
124613419|NCT04628793|448203658|FG001|Overall Study|Withdrawal by Subject|3|||
124740180|NCT03242018|448672662|FG001|Overall Study|Study Terminated by Sponsor|0|||
124740181|NCT03242018|448672663|FG002|Overall Study|Study Terminated by Sponsor|1|||
124740182|NCT02365285|448672664|FG000|Overall Study|Physician Decision|0|||
124740183|NCT02365285|448672665|FG001|Overall Study|Physician Decision|1|||
124740184|NCT02365285|448672666|FG002|Overall Study|Physician Decision|1|||
124740185|NCT02365285|448672667|FG003|Overall Study|Physician Decision|0|||
124740186|NCT02365285|448672664|FG000|Overall Study|Adverse Event|0|||
124740187|NCT02365285|448672665|FG001|Overall Study|Adverse Event|0|||
124613420|NCT04628793|448203659|FG002|Overall Study|Withdrawal by Subject|0|||
124740188|NCT02365285|448672666|FG002|Overall Study|Adverse Event|0|||
124740189|NCT02365285|448672667|FG003|Overall Study|Adverse Event|2|||
124740190|NCT03262116|448672668|FG000|Overall Study|Physician Decision|0|||
124740191|NCT03262116|448672669|FG001|Overall Study|Physician Decision|2|||
124740192|NCT03262116|448672670|FG002|Overall Study|Physician Decision|1|||
124740193|NCT03262116|448672671|FG003|Overall Study|Physician Decision|1|||
124740194|NCT03262116|448672672|FG004|Overall Study|Physician Decision|1|||
124740195|NCT03262116|448672673|FG005|Overall Study|Physician Decision|2|||
124740196|NCT02636946|448672676|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
124740197|NCT02636946|448672677|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
124740198|NCT02636946|448672676|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
124740199|NCT02636946|448672677|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
124740200|NCT02636946|448672676|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
124740201|NCT02636946|448672677|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
124740202|NCT02636946|448672676|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
124740203|NCT02636946|448672677|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
124740204|NCT02636946|448672676|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
124740205|NCT02636946|448672677|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
124740206|NCT02636946|448672676|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
124740207|NCT02636946|448672677|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
124740208|NCT00121641|448672678|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
124740209|NCT00121641|448672679|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
124740210|NCT00121641|448672680|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
124740211|NCT00121641|448672681|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
124740212|NCT00121641|448672682|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
124740213|NCT00121641|448672678|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
124740214|NCT00121641|448672679|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
124740215|NCT00121641|448672680|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
124740216|NCT00121641|448672681|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
124740217|NCT00121641|448672682|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
124740218|NCT00121641|448672678|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
124740219|NCT00121641|448672679|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
124740220|NCT00121641|448672680|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
124740221|NCT00121641|448672681|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
124613421|NCT04628793|448203657|FG000|Overall Study|Lost to Follow-up|0|||
124613422|NCT04628793|448203658|FG001|Overall Study|Lost to Follow-up|1|||
124613423|NCT04628793|448203659|FG002|Overall Study|Lost to Follow-up|0|||
124613424|NCT01696058|448203660|FG000|Overall Study|Adverse Event|21|||
124613425|NCT01696058|448203661|FG001|Overall Study|Adverse Event|11|||
124613426|NCT01696058|448203660|FG000|Overall Study|Lack of Efficacy|2|||
124613427|NCT01696058|448203661|FG001|Overall Study|Lack of Efficacy|3|||
124613428|NCT01696058|448203660|FG000|Overall Study|Protocol Violation|9|||
124613429|NCT01696058|448203661|FG001|Overall Study|Protocol Violation|3|||
124613430|NCT01696058|448203660|FG000|Overall Study|Lost to Follow-up|2|||
124613431|NCT01696058|448203661|FG001|Overall Study|Lost to Follow-up|5|||
124613432|NCT01696058|448203660|FG000|Overall Study|Withdrawal by Subject|4|||
124613433|NCT01696058|448203661|FG001|Overall Study|Withdrawal by Subject|6|||
124613434|NCT01696058|448203660|FG000|Overall Study|Other reason prematurely discontinued|5|||
124613435|NCT01696058|448203661|FG001|Overall Study|Other reason prematurely discontinued|3|||
124613436|NCT01934335|448203662|FG000|Overall Study|Withdrawal by Subject|1|||
124613437|NCT01934335|448203663|FG001|Overall Study|Withdrawal by Subject|1|||
124613438|NCT05384171|448203664|FG000|Overall Study|Lost to Follow-up|9|||
124613439|NCT05384171|448203665|FG001|Overall Study|Lost to Follow-up|9|||
124613440|NCT05384171|448203664|FG000|Overall Study|Withdrawal by Subject|3|||
124613441|NCT05384171|448203665|FG001|Overall Study|Withdrawal by Subject|0|||
124613442|NCT00106964|448203666|FG000|Overall Study|Lost to Follow-up|8|||
124613443|NCT00106964|448203667|FG001|Overall Study|Lost to Follow-up|6|||
124613444|NCT00106964|448203668|FG002|Overall Study|Lost to Follow-up|2|||
124613445|NCT00106964|448203666|FG000|Overall Study|Pregnancy|2|||
124613446|NCT00106964|448203667|FG001|Overall Study|Pregnancy|3|||
124613447|NCT00106964|448203668|FG002|Overall Study|Pregnancy|2|||
124613448|NCT00106964|448203666|FG000|Overall Study|Death|1|||
124613449|NCT00106964|448203667|FG001|Overall Study|Death|1|||
124613450|NCT00106964|448203668|FG002|Overall Study|Death|0|||
124613451|NCT00106964|448203666|FG000|Overall Study|Incarceration|0|||
124613452|NCT00106964|448203667|FG001|Overall Study|Incarceration|1|||
124613453|NCT00106964|448203668|FG002|Overall Study|Incarceration|0|||
124613454|NCT00106964|448203666|FG000|Overall Study|Site Funding Terminated|0|||
124613455|NCT00106964|448203667|FG001|Overall Study|Site Funding Terminated|1|||
124613456|NCT00106964|448203668|FG002|Overall Study|Site Funding Terminated|1|||
124613457|NCT00106964|448203666|FG000|Overall Study|Failure to adhere|2|||
124613458|NCT00106964|448203667|FG001|Overall Study|Failure to adhere|0|||
124613459|NCT00106964|448203668|FG002|Overall Study|Failure to adhere|0|||
124613460|NCT00106964|448203666|FG000|Overall Study|Did not meet eligibility criteria|0|||
124613461|NCT00106964|448203667|FG001|Overall Study|Did not meet eligibility criteria|2|||
124613462|NCT00106964|448203668|FG002|Overall Study|Did not meet eligibility criteria|2|||
124613463|NCT00106964|448203666|FG000|Overall Study|Required disallowed medication|0|||
124613464|NCT00106964|448203667|FG001|Overall Study|Required disallowed medication|1|||
124613465|NCT00106964|448203668|FG002|Overall Study|Required disallowed medication|0|||
124613466|NCT01422187|448203673|FG000|Overall Study|Personal reason|1|||
124613467|NCT01422187|448203674|FG001|Overall Study|Personal reason|0|||
124613468|NCT01422187|448203675|FG002|Overall Study|Personal reason|0|||
124740222|NCT00121641|448672682|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
124740223|NCT00121641|448672678|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
124740224|NCT00121641|448672679|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
124740225|NCT00121641|448672680|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
124740226|NCT00121641|448672681|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
124740227|NCT00121641|448672682|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
124740228|NCT00121641|448672678|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
124740229|NCT00121641|448672679|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
124740230|NCT00121641|448672680|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
124740231|NCT00121641|448672681|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
124740232|NCT00121641|448672682|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
124740233|NCT00121641|448672678|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
124740234|NCT00121641|448672679|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
124740235|NCT00121641|448672680|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
124740236|NCT00121641|448672681|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
124740237|NCT00121641|448672682|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
124740238|NCT00121641|448672678|FG000|24-week Short-term Treatment Period|Other Reason|1|||
124740239|NCT00121641|448672679|FG001|24-week Short-term Treatment Period|Other Reason|0|||
124740240|NCT00121641|448672680|FG002|24-week Short-term Treatment Period|Other Reason|0|||
124740241|NCT00121641|448672681|FG003|24-week Short-term Treatment Period|Other Reason|0|||
124740242|NCT00121641|448672682|FG004|24-week Short-term Treatment Period|Other Reason|0|||
124740243|NCT00121641|448672678|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
124740244|NCT00121641|448672679|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
124740245|NCT00121641|448672680|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
124740246|NCT00121641|448672681|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
124740247|NCT00121641|448672682|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
124740248|NCT00121641|448672678|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
124740249|NCT00121641|448672679|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
124740250|NCT00121641|448672680|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
124740251|NCT00121641|448672681|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
124740252|NCT00121641|448672682|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
124740253|NCT00121641|448672678|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
124740254|NCT00121641|448672679|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
124740255|NCT00121641|448672680|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
124740256|NCT00121641|448672681|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
124740257|NCT00121641|448672682|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
124740258|NCT00121641|448672678|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
124740259|NCT00121641|448672679|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
124740260|NCT00121641|448672680|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
124740261|NCT00121641|448672681|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
124740262|NCT00121641|448672682|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
124740263|NCT00121641|448672678|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
124740264|NCT00121641|448672679|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
124740265|NCT00121641|448672680|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
124740266|NCT00121641|448672681|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
124740267|NCT00121641|448672682|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
124740268|NCT00121641|448672678|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
124740269|NCT00121641|448672679|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
124740270|NCT00121641|448672680|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
124740271|NCT00121641|448672681|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
124740272|NCT00121641|448672682|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
124740273|NCT00121641|448672678|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
124740274|NCT00121641|448672679|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
124740275|NCT00121641|448672680|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
124740276|NCT00121641|448672681|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
124740277|NCT00121641|448672682|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
124740278|NCT00121641|448672678|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
124740279|NCT00121641|448672679|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
124740280|NCT00121641|448672680|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
124740281|NCT00121641|448672681|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
124740282|NCT00121641|448672682|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
124740283|NCT00121641|448672678|FG000|48-month Short Term + Long Term Period|Death|0|||
124740284|NCT00121641|448672679|FG001|48-month Short Term + Long Term Period|Death|0|||
124740285|NCT00121641|448672680|FG002|48-month Short Term + Long Term Period|Death|0|||
124740286|NCT00121641|448672681|FG003|48-month Short Term + Long Term Period|Death|1|||
124740287|NCT00121641|448672682|FG004|48-month Short Term + Long Term Period|Death|0|||
124740288|NCT00121641|448672678|FG000|48-month Short Term + Long Term Period|Missing|0|||
124740289|NCT00121641|448672679|FG001|48-month Short Term + Long Term Period|Missing|0|||
124740290|NCT00121641|448672680|FG002|48-month Short Term + Long Term Period|Missing|1|||
124740291|NCT00121641|448672681|FG003|48-month Short Term + Long Term Period|Missing|0|||
124740292|NCT00121641|448672682|FG004|48-month Short Term + Long Term Period|Missing|0|||
124740293|NCT00121641|448672678|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
124740294|NCT00121641|448672679|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
124740295|NCT00121641|448672680|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
124740296|NCT00121641|448672681|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
124740297|NCT00121641|448672682|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
124740298|NCT01792518|448672685|FG000|Overall Study|Adverse Event|3|||
124740299|NCT01792518|448672686|FG001|Overall Study|Adverse Event|4|||
124740300|NCT01792518|448672685|FG000|Overall Study|Protocol Violation|0|||
124740301|NCT01792518|448672686|FG001|Overall Study|Protocol Violation|1|||
124740302|NCT01792518|448672685|FG000|Overall Study|Lost to Follow-up|3|||
124740303|NCT01792518|448672686|FG001|Overall Study|Lost to Follow-up|1|||
124740304|NCT01792518|448672685|FG000|Overall Study|Withdrawal by Subject|2|||
124740305|NCT01792518|448672686|FG001|Overall Study|Withdrawal by Subject|0|||
124740306|NCT01792518|448672685|FG000|Overall Study|Other Reason|0|||
124740307|NCT01792518|448672686|FG001|Overall Study|Other Reason|1|||
124740308|NCT00249613|448672690|FG000|12 Month Follow-up|Death|1|||
124740309|NCT00249613|448672691|FG001|12 Month Follow-up|Death|1|||
124740310|NCT00249613|448672690|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
124740311|NCT00249613|448672691|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
124740312|NCT00249613|448672690|FG000|12 Month Follow-up|Lost to Follow-up|10|||
124740313|NCT00249613|448672691|FG001|12 Month Follow-up|Lost to Follow-up|8|||
124740314|NCT00806442|448672700|FG000|Overall Study|Lost to Follow-up|3|||
124740315|NCT00806442|448672701|FG001|Overall Study|Lost to Follow-up|2|||
124740316|NCT00806442|448672700|FG000|Overall Study|Withdrawal by Subject|1|||
124740317|NCT00806442|448672701|FG001|Overall Study|Withdrawal by Subject|5|||
124740318|NCT00654004|448672702|FG000|Overall Study|Lost to Follow-up|1|||
124740319|NCT00654004|448672703|FG001|Overall Study|Lost to Follow-up|0|||
124740320|NCT01264770|448672704|FG000|Overall Study|Not reported|0|||
124740321|NCT01264770|448672705|FG001|Overall Study|Not reported|0|||
124740322|NCT01264770|448672706|FG002|Overall Study|Not reported|1|||
124740323|NCT01264770|448672707|FG003|Overall Study|Not reported|0|||
124740324|NCT01264770|448672708|FG004|Overall Study|Not reported|0|||
124740325|NCT01264770|448672709|FG005|Overall Study|Not reported|0|||
124740326|NCT01264770|448672704|FG000|Overall Study|e.g., change in circumstances|8|||
124740327|NCT01264770|448672705|FG001|Overall Study|e.g., change in circumstances|3|||
124740328|NCT01264770|448672706|FG002|Overall Study|e.g., change in circumstances|3|||
124740329|NCT01264770|448672707|FG003|Overall Study|e.g., change in circumstances|3|||
124740330|NCT01264770|448672708|FG004|Overall Study|e.g., change in circumstances|4|||
124740331|NCT01264770|448672709|FG005|Overall Study|e.g., change in circumstances|4|||
124740332|NCT01264770|448672704|FG000|Overall Study|Severe non-compliance to protocol|0|||
124740333|NCT01264770|448672705|FG001|Overall Study|Severe non-compliance to protocol|0|||
124740334|NCT01264770|448672706|FG002|Overall Study|Severe non-compliance to protocol|1|||
124740335|NCT01264770|448672707|FG003|Overall Study|Severe non-compliance to protocol|1|||
124740336|NCT01264770|448672708|FG004|Overall Study|Severe non-compliance to protocol|0|||
124740337|NCT01264770|448672709|FG005|Overall Study|Severe non-compliance to protocol|0|||
124740338|NCT01264770|448672704|FG000|Overall Study|Lack of therapeutic response|1|||
124740339|NCT01264770|448672705|FG001|Overall Study|Lack of therapeutic response|0|||
124740340|NCT01264770|448672706|FG002|Overall Study|Lack of therapeutic response|2|||
124740341|NCT01264770|448672707|FG003|Overall Study|Lack of therapeutic response|1|||
124740342|NCT01264770|448672708|FG004|Overall Study|Lack of therapeutic response|1|||
124740343|NCT01264770|448672709|FG005|Overall Study|Lack of therapeutic response|0|||
124740344|NCT01264770|448672704|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
124740345|NCT01264770|448672705|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
124740346|NCT01264770|448672706|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
124740347|NCT01264770|448672707|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
124740348|NCT01264770|448672708|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
124740349|NCT01264770|448672709|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
124740350|NCT01264770|448672704|FG000|Overall Study|Lost to Follow-up|0|||
124740351|NCT01264770|448672705|FG001|Overall Study|Lost to Follow-up|0|||
124740352|NCT01264770|448672706|FG002|Overall Study|Lost to Follow-up|1|||
124781740|NCT04413617|448831139|FG003|Overall Study|COVID-19|0|||
124740353|NCT01264770|448672707|FG003|Overall Study|Lost to Follow-up|1|||
124740354|NCT01264770|448672708|FG004|Overall Study|Lost to Follow-up|0|||
124740355|NCT01264770|448672709|FG005|Overall Study|Lost to Follow-up|0|||
124740356|NCT01264770|448672704|FG000|Overall Study|Adverse Event|7|||
124740357|NCT01264770|448672705|FG001|Overall Study|Adverse Event|7|||
124613469|NCT01422187|448203673|FG000|Overall Study|Lost to Follow-up|0|||
124613470|NCT01422187|448203674|FG001|Overall Study|Lost to Follow-up|1|||
124613471|NCT01422187|448203675|FG002|Overall Study|Lost to Follow-up|0|||
124613472|NCT00168818|448203676|FG000|Overall Study|Adverse Event|23|||
124613473|NCT00168818|448203677|FG001|Overall Study|Adverse Event|29|||
124613474|NCT00168818|448203678|FG002|Overall Study|Adverse Event|31|||
124613475|NCT00168818|448203676|FG000|Overall Study|Protocol Violation|16|||
124613476|NCT00168818|448203677|FG001|Overall Study|Protocol Violation|11|||
124613477|NCT00168818|448203678|FG002|Overall Study|Protocol Violation|11|||
124613478|NCT00168818|448203676|FG000|Overall Study|Lost to Follow-up|13|||
124613479|NCT00168818|448203677|FG001|Overall Study|Lost to Follow-up|4|||
124740358|NCT01264770|448672706|FG002|Overall Study|Adverse Event|8|||
124740359|NCT01264770|448672707|FG003|Overall Study|Adverse Event|0|||
124740360|NCT01264770|448672708|FG004|Overall Study|Adverse Event|2|||
124613480|NCT00168818|448203678|FG002|Overall Study|Lost to Follow-up|15|||
124613481|NCT00168818|448203676|FG000|Overall Study|Withdrawal by Subject|43|||
124613482|NCT00168818|448203677|FG001|Overall Study|Withdrawal by Subject|41|||
124613483|NCT00168818|448203678|FG002|Overall Study|Withdrawal by Subject|37|||
124613484|NCT00168818|448203676|FG000|Overall Study|Other|22|||
124613485|NCT00168818|448203677|FG001|Overall Study|Other|24|||
124613486|NCT00168818|448203678|FG002|Overall Study|Other|30|||
124613487|NCT00168818|448203676|FG000|Treatment|Adverse Event|77|||
124613488|NCT00168818|448203677|FG001|Treatment|Adverse Event|89|||
124613489|NCT00168818|448203678|FG002|Treatment|Adverse Event|68|||
124613490|NCT00168818|448203676|FG000|Treatment|Protocol Violation|8|||
124613491|NCT00168818|448203677|FG001|Treatment|Protocol Violation|11|||
124613492|NCT00168818|448203678|FG002|Treatment|Protocol Violation|11|||
124613493|NCT00168818|448203676|FG000|Treatment|Lost to Follow-up|0|||
124613494|NCT00168818|448203677|FG001|Treatment|Lost to Follow-up|2|||
124613495|NCT00168818|448203678|FG002|Treatment|Lost to Follow-up|1|||
124740361|NCT01264770|448672709|FG005|Overall Study|Adverse Event|1|||
124740362|NCT00424190|448672711|FG000|Overall Study|Withdrew consent|3|||
124740363|NCT00424190|448672712|FG001|Overall Study|Withdrew consent|4|||
124740364|NCT00424190|448672711|FG000|Overall Study|Death|3|||
124740365|NCT00424190|448672712|FG001|Overall Study|Death|0|||
124740366|NCT00424190|448672711|FG000|Overall Study|Noncompliance|1|||
124740367|NCT00424190|448672712|FG001|Overall Study|Noncompliance|2|||
124740368|NCT00424190|448672711|FG000|Overall Study|Request of sponsor or investigator|0|||
124740369|NCT00424190|448672712|FG001|Overall Study|Request of sponsor or investigator|2|||
124740370|NCT00424190|448672711|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
124740371|NCT00424190|448672712|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
124740372|NCT00424190|448672711|FG000|Overall Study|Other|15|||
124740373|NCT00424190|448672712|FG001|Overall Study|Other|21|||
124740374|NCT00351273|448672713|FG000|Overall Study|Lost to Follow-up|1|||
124740375|NCT00351273|448672714|FG001|Overall Study|Lost to Follow-up|2|||
124740376|NCT00351273|448672715|FG002|Overall Study|Lost to Follow-up|5|||
124740377|NCT01672866|448672716|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
124740378|NCT01672866|448672717|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
124740379|NCT01672866|448672718|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
124740380|NCT01672866|448672716|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
124740381|NCT01672866|448672717|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
124740382|NCT01672866|448672718|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
124740383|NCT01672866|448672716|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
124740384|NCT01672866|448672717|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
124740385|NCT01672866|448672718|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
124740386|NCT01672866|448672716|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
124740387|NCT01672866|448672717|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
124740388|NCT01672866|448672718|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
124740389|NCT01672866|448672716|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
124740390|NCT01672866|448672717|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
124740391|NCT01672866|448672718|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
124740392|NCT01672866|448672716|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
124740393|NCT01672866|448672717|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
124613496|NCT00168818|448203676|FG000|Treatment|Withdrawal by Subject|25|||
124613497|NCT00168818|448203677|FG001|Treatment|Withdrawal by Subject|20|||
124613498|NCT00168818|448203678|FG002|Treatment|Withdrawal by Subject|22|||
124613499|NCT00168818|448203676|FG000|Treatment|Other|23|||
124613500|NCT00168818|448203677|FG001|Treatment|Other|29|||
124613501|NCT00168818|448203678|FG002|Treatment|Other|31|||
124740394|NCT01672866|448672718|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
124740395|NCT01672866|448672716|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
124740396|NCT01672866|448672717|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
124613502|NCT02227446|448203679|FG000|Overall Study|not eligible post randomization|18|||
124613503|NCT02227446|448203680|FG001|Overall Study|not eligible post randomization|29|||
124613504|NCT02227446|448203679|FG000|Overall Study|Withdrawal by Subject|4|||
124613505|NCT02227446|448203680|FG001|Overall Study|Withdrawal by Subject|5|||
124613506|NCT04623086|448203681|FG000|Overall Study|Withdrawal by Subject|0|||
124740397|NCT01672866|448672718|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
124740398|NCT01672866|448672716|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
124740399|NCT01672866|448672717|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
124740400|NCT01672866|448672718|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
124740401|NCT01672866|448672716|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
124740402|NCT01672866|448672717|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
124740403|NCT01672866|448672718|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
124740404|NCT01672866|448672716|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
124740405|NCT01672866|448672717|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
124740406|NCT01672866|448672718|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
124740407|NCT01672866|448672716|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
124740408|NCT01672866|448672717|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
124740409|NCT01672866|448672718|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
124740410|NCT01672866|448672716|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
124740411|NCT01672866|448672717|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
124740412|NCT01672866|448672718|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
124740413|NCT01672866|448672716|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
124740414|NCT01672866|448672717|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
124740415|NCT01672866|448672718|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
124740416|NCT02241187|448672719|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
124740417|NCT02383433|448672724|FG000|Overall Study|Disease progression|2|||
124740418|NCT02535416|448672725|FG000|Overall Study|Family bereavement overseas|1|||
124740419|NCT02535416|448672726|FG001|Overall Study|Family bereavement overseas|0|||
124740420|NCT02535416|448672727|FG002|Overall Study|Family bereavement overseas|0|||
124740421|NCT02535416|448672728|FG003|Overall Study|Family bereavement overseas|0|||
124740422|NCT02535416|448672729|FG004|Overall Study|Family bereavement overseas|0|||
124740423|NCT02535416|448672730|FG005|Overall Study|Family bereavement overseas|0|||
124740424|NCT02535416|448672731|FG006|Overall Study|Family bereavement overseas|0|||
124740425|NCT02535416|448672732|FG007|Overall Study|Family bereavement overseas|0|||
124740426|NCT02535416|448672733|FG008|Overall Study|Family bereavement overseas|0|||
124740427|NCT02831933|448673973|FG000|Overall Study|Physician Decision|11|||
124740428|NCT04544683|448673974|FG000|Overall Study|Lost to Follow-up|2|||
124740429|NCT04544683|448673974|FG000|Overall Study|Underwent cervical spine surgery|6|||
124740430|NCT01073930|448673975|FG000|Overall Study|Withdrawal by Subject|3|||
124740431|NCT01073930|448673976|FG001|Overall Study|Withdrawal by Subject|2|||
124740432|NCT01073930|448673975|FG000|Overall Study|Lost to Follow-up|0|||
124740433|NCT01073930|448673976|FG001|Overall Study|Lost to Follow-up|1|||
124740434|NCT01073930|448673975|FG000|Overall Study|Adverse Event|0|||
124740435|NCT01073930|448673976|FG001|Overall Study|Adverse Event|1|||
124740436|NCT01073930|448673975|FG000|Overall Study|Noncompliance with study drug|0|||
124740437|NCT01073930|448673976|FG001|Overall Study|Noncompliance with study drug|1|||
124740438|NCT01073930|448673975|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
124740439|NCT01073930|448673976|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
124740440|NCT02081599|448673977|FG000|Period 1：Double-blind Period|Adverse Event|3|||
124740441|NCT02081599|448673978|FG001|Period 1：Double-blind Period|Adverse Event|0|||
124740442|NCT02081599|448673977|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
124740443|NCT02081599|448673978|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
124740444|NCT02081599|448673977|FG000|Period 1：Double-blind Period|Physician Decision|1|||
124740445|NCT02081599|448673978|FG001|Period 1：Double-blind Period|Physician Decision|0|||
124740446|NCT02081599|448673977|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
124740447|NCT02081599|448673978|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
124740448|NCT02081599|448673977|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
124740449|NCT02081599|448673978|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
124740450|NCT02081599|448673977|FG000|Period 1：Double-blind Period|stopping criteria|1|||
124740451|NCT02081599|448673978|FG001|Period 1：Double-blind Period|stopping criteria|0|||
124740452|NCT02081599|448673977|FG000|Period 2：Open-label Period|Adverse Event|1|||
124740453|NCT02081599|448673978|FG001|Period 2：Open-label Period|Adverse Event|0|||
124740454|NCT02081599|448673977|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
124740455|NCT02081599|448673978|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
124740456|NCT02081599|448673977|FG000|Period 2：Open-label Period|Physician Decision|1|||
124740457|NCT02081599|448673978|FG001|Period 2：Open-label Period|Physician Decision|0|||
124740458|NCT02081599|448673977|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
124740459|NCT02081599|448673978|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
124740460|NCT01266590|448673979|FG000|Overall Study|Adverse Event|3|||
124740461|NCT01266590|448673979|FG000|Overall Study|Lost to Follow-up|1|||
124740462|NCT01266590|448673979|FG000|Overall Study|Withdrawal by Subject|1|||
124740463|NCT01266590|448673979|FG000|Overall Study|Physician Decision|1|||
124740464|NCT00720343|448673982|FG000|Overall Study|Lost to Follow-up|1|||
124740465|NCT00720343|448673983|FG001|Overall Study|Lost to Follow-up|0|||
124740466|NCT00720343|448673982|FG000|Overall Study|Protocol Violation|0|||
124740467|NCT00720343|448673983|FG001|Overall Study|Protocol Violation|2|||
124613507|NCT04623086|448203682|FG001|Overall Study|Withdrawal by Subject|0|||
124613508|NCT04623086|448203683|FG002|Overall Study|Withdrawal by Subject|10|||
124613509|NCT02309138|448203684|FG000|Overall Study|Withdrawal by Subject|44|||
124613510|NCT02309138|448203685|FG001|Overall Study|Withdrawal by Subject|15|||
124613511|NCT02309138|448203684|FG000|Overall Study|Protocol Violation|4|||
124613512|NCT02309138|448203685|FG001|Overall Study|Protocol Violation|2|||
124613513|NCT02309138|448203684|FG000|Overall Study|delivered before visit 2|0|||
124613514|NCT02309138|448203685|FG001|Overall Study|delivered before visit 2|1|||
124613515|NCT00735397|448203694|FG000|Overall Study|Adverse Event|194|||
124613516|NCT00735397|448203694|FG000|Overall Study|Lost to Follow-up|33|||
124613517|NCT00735397|448203694|FG000|Overall Study|Participant choice|252|||
124613518|NCT00735397|448203694|FG000|Overall Study|Inadequate therapeutic effect|202|||
124613519|NCT00735397|448203694|FG000|Overall Study|Administrative/Other|502|||
124613520|NCT00901576|448203703|FG000|Second Intervention|Withdrawal by Subject|0|||
124613521|NCT00901576|448203704|FG001|Second Intervention|Withdrawal by Subject|0|||
124613522|NCT00901576|448203705|FG002|Second Intervention|Withdrawal by Subject|0|||
124613523|NCT00901576|448203706|FG003|Second Intervention|Withdrawal by Subject|1|||
124613524|NCT00901576|448203707|FG004|Second Intervention|Withdrawal by Subject|0|||
124613525|NCT00901576|448203708|FG005|Second Intervention|Withdrawal by Subject|1|||
124613526|NCT00901576|448203703|FG000|Second Intervention|Physician Decision|1|||
124613527|NCT00901576|448203704|FG001|Second Intervention|Physician Decision|0|||
124613528|NCT00901576|448203705|FG002|Second Intervention|Physician Decision|0|||
124613529|NCT00901576|448203706|FG003|Second Intervention|Physician Decision|0|||
124613530|NCT00901576|448203707|FG004|Second Intervention|Physician Decision|0|||
124613531|NCT00901576|448203708|FG005|Second Intervention|Physician Decision|0|||
124613532|NCT01559389|448203709|FG000|Overall Study|Withdrawal by Subject|20|||
124613533|NCT01559389|448203710|FG001|Overall Study|Withdrawal by Subject|20|||
124613534|NCT01346293|448203711|FG000|Overall Study|Protocol Violation|30|||
124613535|NCT01346293|448203712|FG001|Overall Study|Protocol Violation|9|||
124613536|NCT01346293|448203711|FG000|Overall Study|Lost to Follow-up|21|||
124613537|NCT01346293|448203712|FG001|Overall Study|Lost to Follow-up|8|||
124613538|NCT01346293|448203711|FG000|Overall Study|Withdrawal by Subject|15|||
124613539|NCT01346293|448203712|FG001|Overall Study|Withdrawal by Subject|4|||
124613540|NCT01346293|448203711|FG000|Overall Study|Other|1|||
124613541|NCT01346293|448203712|FG001|Overall Study|Other|0|||
124613542|NCT01147107|448203716|FG000|Overall Study|Lack of Efficacy|5|||
124613543|NCT01147107|448203717|FG001|Overall Study|Lack of Efficacy|0|||
124613544|NCT01147107|448203716|FG000|Overall Study|Withdrawal by Subject|1|||
124613545|NCT01147107|448203717|FG001|Overall Study|Withdrawal by Subject|1|||
124613546|NCT04693416|448203718|FG000|Overall Study|Lost to Follow-up|13|||
124613547|NCT04693416|448203719|FG001|Overall Study|Lost to Follow-up|0|||
124613548|NCT00474266|448203720|FG000|Overall Study|Withdrawal by Subject|7|||
124613549|NCT00474266|448203721|FG001|Overall Study|Withdrawal by Subject|20|||
124613550|NCT00474266|448203722|FG002|Overall Study|Withdrawal by Subject|4|||
124613551|NCT00474266|448203723|FG003|Overall Study|Withdrawal by Subject|7|||
124613552|NCT02774642|448203724|FG000|Overall Study|Lost to Follow-up|9|||
124613553|NCT02774642|448203725|FG001|Overall Study|Lost to Follow-up|7|||
124613554|NCT00813800|448203728|FG000|Overall Study|Screen Failure after Consent|2|||
124613555|NCT00813800|448203728|FG000|Overall Study|Adverse Event|1|||
124613556|NCT00813800|448203728|FG000|Overall Study|Worsening of depression|2|||
124613557|NCT00813800|448203728|FG000|Overall Study|Physician Decision|1|||
124613558|NCT03456453|448203729|FG000|Overall Study|Withdrawal by Subject|2|||
124613559|NCT03456453|448203730|FG001|Overall Study|Withdrawal by Subject|0|||
124613560|NCT03456453|448203729|FG000|Overall Study|Not released to community|1|||
124613561|NCT03456453|448203730|FG001|Overall Study|Not released to community|5|||
124613562|NCT03456453|448203729|FG000|Overall Study|Lost to Follow-up|0|||
124613563|NCT03456453|448203730|FG001|Overall Study|Lost to Follow-up|2|||
124613564|NCT02369458|448203746|FG000|Overall Study|Determined to be not eligible|1|||
124613565|NCT02369458|448203747|FG001|Overall Study|Determined to be not eligible|0|||
124613566|NCT00121134|448203748|FG000|Overall Study|Progression of Disease|5|||
124613567|NCT00121134|448203749|FG001|Overall Study|Progression of Disease|3|||
124613568|NCT00121134|448203750|FG002|Overall Study|Progression of Disease|4|||
124613569|NCT00121134|448203751|FG003|Overall Study|Progression of Disease|2|||
124613570|NCT00121134|448203748|FG000|Overall Study|Toxicity|4|||
124613571|NCT00121134|448203749|FG001|Overall Study|Toxicity|7|||
124613572|NCT00121134|448203750|FG002|Overall Study|Toxicity|13|||
124613573|NCT00121134|448203751|FG003|Overall Study|Toxicity|5|||
124613574|NCT00121134|448203748|FG000|Overall Study|Physician Decision|6|||
124613575|NCT00121134|448203749|FG001|Overall Study|Physician Decision|4|||
124613576|NCT00121134|448203750|FG002|Overall Study|Physician Decision|4|||
124613577|NCT00121134|448203751|FG003|Overall Study|Physician Decision|1|||
124613578|NCT00121134|448203748|FG000|Overall Study|Treatment Delay|1|||
124613579|NCT00121134|448203749|FG001|Overall Study|Treatment Delay|0|||
124613580|NCT00121134|448203750|FG002|Overall Study|Treatment Delay|0|||
124613581|NCT00121134|448203751|FG003|Overall Study|Treatment Delay|0|||
124613582|NCT00121134|448203748|FG000|Overall Study|Intercurrent Illness|0|||
124613583|NCT00121134|448203749|FG001|Overall Study|Intercurrent Illness|0|||
124613584|NCT00121134|448203750|FG002|Overall Study|Intercurrent Illness|0|||
124740468|NCT02008773|448673986|FG000|Overall Study|Adverse Event|3|||
124740469|NCT02008773|448673987|FG001|Overall Study|Adverse Event|3|||
124740470|NCT02008773|448673988|FG002|Overall Study|Adverse Event|1|||
124740471|NCT02008773|448673989|FG003|Overall Study|Adverse Event|2|||
124740472|NCT02008773|448673986|FG000|Overall Study|Medication Non-compliance|2|||
124740473|NCT02008773|448673987|FG001|Overall Study|Medication Non-compliance|1|||
124740474|NCT02008773|448673988|FG002|Overall Study|Medication Non-compliance|3|||
124740475|NCT02008773|448673989|FG003|Overall Study|Medication Non-compliance|2|||
124740476|NCT02008773|448673986|FG000|Overall Study|Withdrawal by Subject|8|||
124740477|NCT02008773|448673987|FG001|Overall Study|Withdrawal by Subject|4|||
124740478|NCT02008773|448673988|FG002|Overall Study|Withdrawal by Subject|7|||
124740479|NCT02008773|448673989|FG003|Overall Study|Withdrawal by Subject|6|||
124740480|NCT02008773|448673986|FG000|Overall Study|Lost to Follow-up|0|||
124740481|NCT02008773|448673987|FG001|Overall Study|Lost to Follow-up|1|||
124740482|NCT02008773|448673988|FG002|Overall Study|Lost to Follow-up|3|||
124740483|NCT02008773|448673989|FG003|Overall Study|Lost to Follow-up|2|||
124740484|NCT02198794|448673990|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
124740485|NCT02198794|448673991|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
124740486|NCT02198794|448673992|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
124740487|NCT02198794|448673993|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
124740488|NCT02198794|448673990|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
124740489|NCT02198794|448673991|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
124740490|NCT02198794|448673992|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
124740491|NCT02198794|448673993|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
124740492|NCT02198794|448673990|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
124740493|NCT02198794|448673991|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
124740494|NCT02198794|448673992|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
124740495|NCT02198794|448673993|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
124740496|NCT02198794|448673990|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
124740497|NCT02198794|448673991|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
124740498|NCT02198794|448673992|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
124740499|NCT02198794|448673993|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
124740500|NCT02198794|448673990|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
124740501|NCT02198794|448673991|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
124740502|NCT02198794|448673992|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
124740503|NCT02198794|448673993|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
124740504|NCT02198794|448673990|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
124740505|NCT02198794|448673991|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
124740506|NCT02198794|448673992|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
124740507|NCT02198794|448673993|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
124740508|NCT02198794|448673990|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
124740509|NCT02198794|448673991|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
124740510|NCT02198794|448673992|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
124740511|NCT02198794|448673993|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
124740512|NCT02198794|448673990|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
124740513|NCT02198794|448673991|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
124740514|NCT02198794|448673992|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
124740515|NCT02198794|448673993|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
124740516|NCT02198794|448673990|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
124740517|NCT02198794|448673991|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
124740518|NCT02198794|448673992|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
124740519|NCT02198794|448673993|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
124740520|NCT02198794|448673990|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
124740521|NCT02198794|448673991|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
124740522|NCT02198794|448673992|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
124740523|NCT02198794|448673993|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
124740524|NCT02198794|448673990|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
124740525|NCT02198794|448673991|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
124740526|NCT02198794|448673992|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
124740527|NCT02198794|448673993|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
124740528|NCT02198794|448673990|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
124740529|NCT02198794|448673991|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
124740530|NCT02198794|448673992|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
124740531|NCT02198794|448673993|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
124740532|NCT02198794|448673990|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
124740533|NCT02198794|448673991|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
124613585|NCT00121134|448203751|FG003|Overall Study|Intercurrent Illness|1|||
124613586|NCT00121134|448203748|FG000|Overall Study|Patient Personal Reasons|0|||
124740534|NCT02198794|448673992|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
124740535|NCT02198794|448673993|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
124740536|NCT02198794|448673990|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
124740537|NCT02198794|448673991|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
124740538|NCT02198794|448673992|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
124740539|NCT02198794|448673993|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
124740540|NCT02198794|448673990|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
124740541|NCT02198794|448673991|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
124740542|NCT02198794|448673992|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
124740543|NCT02198794|448673993|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
124740544|NCT00701805|448673994|FG000|Overall Study|Withdrawal by Subject|3|||
124740545|NCT00701805|448673995|FG001|Overall Study|Withdrawal by Subject|1|||
124740546|NCT00701805|448673996|FG002|Overall Study|Withdrawal by Subject|4|||
124740547|NCT00701805|448673997|FG003|Overall Study|Withdrawal by Subject|3|||
124740548|NCT00701805|448673994|FG000|Overall Study|Adverse Event|0|||
124740549|NCT00701805|448673995|FG001|Overall Study|Adverse Event|1|||
124740550|NCT00701805|448673996|FG002|Overall Study|Adverse Event|1|||
124613587|NCT00121134|448203749|FG001|Overall Study|Patient Personal Reasons|1|||
124613588|NCT00121134|448203750|FG002|Overall Study|Patient Personal Reasons|0|||
124613589|NCT00121134|448203751|FG003|Overall Study|Patient Personal Reasons|0|||
124613590|NCT00857584|448203763|FG000|Overall Study|Lack of Efficacy|1|||
124613591|NCT00857584|448203764|FG001|Overall Study|Lack of Efficacy|2|||
124613592|NCT00857584|448203763|FG000|Overall Study|Adverse Event|2|||
124613593|NCT00857584|448203764|FG001|Overall Study|Adverse Event|2|||
124613594|NCT00857584|448203763|FG000|Overall Study|Physician Decision|1|||
124613595|NCT00857584|448203764|FG001|Overall Study|Physician Decision|1|||
124613596|NCT02011386|448203765|FG000|Overall Study|Non-compliance|2|||
124613597|NCT02011386|448203765|FG000|Overall Study|Lack of Efficacy|3|||
124613598|NCT03255655|448203766|FG000|Overall Study|Lost to Follow-up|7|||
124613599|NCT03255655|448203767|FG001|Overall Study|Lost to Follow-up|4|||
124613600|NCT04853992|448203768|FG000|Treatment Period A|Adverse Event|0|||
124613601|NCT04853992|448203769|FG001|Treatment Period A|Adverse Event|1|||
124613602|NCT04853992|448203768|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
124613603|NCT04853992|448203769|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
124613604|NCT00259272|448203770|FG000|Overall Study|Adverse Event|2|||
124613605|NCT00259272|448203771|FG001|Overall Study|Adverse Event|1|||
124613606|NCT00259272|448203772|FG002|Overall Study|Adverse Event|0|||
124613607|NCT00259272|448203773|FG003|Overall Study|Adverse Event|3|||
124613608|NCT00259272|448203770|FG000|Overall Study|Lack of Efficacy|5|||
124613609|NCT00259272|448203771|FG001|Overall Study|Lack of Efficacy|1|||
124613610|NCT00259272|448203772|FG002|Overall Study|Lack of Efficacy|2|||
124613611|NCT00259272|448203773|FG003|Overall Study|Lack of Efficacy|6|||
124613612|NCT00259272|448203770|FG000|Overall Study|Physician Decision|1|||
124613613|NCT00259272|448203771|FG001|Overall Study|Physician Decision|2|||
124613614|NCT00259272|448203772|FG002|Overall Study|Physician Decision|1|||
124613615|NCT00259272|448203773|FG003|Overall Study|Physician Decision|3|||
124613616|NCT00259272|448203770|FG000|Overall Study|Protocol Violation|2|||
124613617|NCT00259272|448203771|FG001|Overall Study|Protocol Violation|0|||
124613618|NCT00259272|448203772|FG002|Overall Study|Protocol Violation|0|||
124613619|NCT00259272|448203773|FG003|Overall Study|Protocol Violation|1|||
124613620|NCT00259272|448203770|FG000|Overall Study|Sponsor Decision|0|||
124613621|NCT00259272|448203771|FG001|Overall Study|Sponsor Decision|1|||
124613622|NCT00259272|448203772|FG002|Overall Study|Sponsor Decision|0|||
124613623|NCT00259272|448203773|FG003|Overall Study|Sponsor Decision|0|||
124613624|NCT00259272|448203770|FG000|Overall Study|Withdrawal by Subject|4|||
124613625|NCT00259272|448203771|FG001|Overall Study|Withdrawal by Subject|2|||
124613626|NCT00259272|448203772|FG002|Overall Study|Withdrawal by Subject|2|||
124613627|NCT00259272|448203773|FG003|Overall Study|Withdrawal by Subject|7|||
124613628|NCT00259272|448203770|FG000|Overall Study|Lost to Follow-up|1|||
124613629|NCT00259272|448203771|FG001|Overall Study|Lost to Follow-up|0|||
124613630|NCT00259272|448203772|FG002|Overall Study|Lost to Follow-up|0|||
124613631|NCT00259272|448203773|FG003|Overall Study|Lost to Follow-up|1|||
124613632|NCT01908907|448205495|FG000|Overall Study|Physician Decision|1|||
124613633|NCT01908907|448205496|FG001|Overall Study|Physician Decision|0|||
124613634|NCT01908907|448205495|FG000|Overall Study|Protocol Violation|1|||
124613635|NCT01908907|448205496|FG001|Overall Study|Protocol Violation|0|||
124613636|NCT00761657|448205497|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
124613637|NCT00761657|448205498|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
124613638|NCT00761657|448205499|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
124613639|NCT00761657|448205500|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
124740551|NCT00701805|448673997|FG003|Overall Study|Adverse Event|0|||
124740552|NCT00701805|448673994|FG000|Overall Study|Missed 7 consecutive doses|0|||
124740553|NCT00701805|448673995|FG001|Overall Study|Missed 7 consecutive doses|1|||
124613640|NCT00761657|448205501|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
124613641|NCT00761657|448205502|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
124613642|NCT00761657|448205503|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
124613643|NCT00761657|448205504|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
124613644|NCT00761657|448205505|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
124613645|NCT00761657|448205497|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
124740554|NCT00701805|448673996|FG002|Overall Study|Missed 7 consecutive doses|0|||
124740555|NCT00701805|448673997|FG003|Overall Study|Missed 7 consecutive doses|0|||
124740556|NCT00701805|448673994|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
124740557|NCT00701805|448673995|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
124740558|NCT00701805|448673996|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
124740559|NCT00701805|448673997|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
124740560|NCT00701805|448673994|FG000|Overall Study|Physician decision, change of therapy|0|||
124740561|NCT00701805|448673995|FG001|Overall Study|Physician decision, change of therapy|0|||
124740562|NCT00701805|448673996|FG002|Overall Study|Physician decision, change of therapy|0|||
124740563|NCT00701805|448673997|FG003|Overall Study|Physician decision, change of therapy|1|||
124740564|NCT00701805|448673994|FG000|Overall Study|Difficult to travel to dialysis site|0|||
124740565|NCT00701805|448673995|FG001|Overall Study|Difficult to travel to dialysis site|0|||
124740566|NCT00701805|448673996|FG002|Overall Study|Difficult to travel to dialysis site|1|||
124740567|NCT00701805|448673997|FG003|Overall Study|Difficult to travel to dialysis site|0|||
124740568|NCT00701805|448673994|FG000|Overall Study|Resumption criteria were not met|0|||
124740569|NCT00701805|448673995|FG001|Overall Study|Resumption criteria were not met|1|||
124740570|NCT00701805|448673996|FG002|Overall Study|Resumption criteria were not met|0|||
124740571|NCT00701805|448673997|FG003|Overall Study|Resumption criteria were not met|0|||
124740572|NCT02252965|448674001|FG000|Overall Study|Adverse Event|9|||
124740573|NCT02252965|448674002|FG001|Overall Study|Adverse Event|14|||
124740574|NCT02252965|448674001|FG000|Overall Study|Lost to Follow-up|16|||
124740575|NCT02252965|448674002|FG001|Overall Study|Lost to Follow-up|8|||
124740576|NCT02252965|448674001|FG000|Overall Study|Protocol Violation|4|||
124740577|NCT02252965|448674002|FG001|Overall Study|Protocol Violation|5|||
124740578|NCT02252965|448674001|FG000|Overall Study|Lack of Efficacy|0|||
124740579|NCT02252965|448674002|FG001|Overall Study|Lack of Efficacy|2|||
124740580|NCT02252965|448674001|FG000|Overall Study|Withdrawal by Subject|7|||
124740581|NCT02252965|448674002|FG001|Overall Study|Withdrawal by Subject|9|||
124740582|NCT02252965|448674001|FG000|Overall Study|Other|4|||
124740583|NCT02252965|448674002|FG001|Overall Study|Other|5|||
124740584|NCT04435600|448674010|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
124740585|NCT04435600|448674011|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
124740586|NCT04435600|448674012|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
124740587|NCT04435600|448674013|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
124740588|NCT04435600|448674014|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
124740589|NCT04435600|448674015|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
124740590|NCT04435600|448674016|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
124740591|NCT04435600|448674017|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
124740592|NCT04435600|448674018|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
124740593|NCT04435600|448674019|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
124740594|NCT04435600|448674010|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
124740595|NCT04435600|448674011|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
124740596|NCT04435600|448674012|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
124740597|NCT04435600|448674013|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
124740598|NCT04435600|448674014|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
124740599|NCT04435600|448674015|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
124740600|NCT04435600|448674016|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
124740601|NCT04435600|448674017|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
124740602|NCT04435600|448674018|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
124740603|NCT04435600|448674019|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
124740604|NCT04435600|448674010|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
124740605|NCT04435600|448674011|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
124740606|NCT04435600|448674012|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
124740607|NCT04435600|448674013|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
124740608|NCT04435600|448674014|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
124740609|NCT04435600|448674015|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
124740610|NCT04435600|448674016|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
124740611|NCT04435600|448674017|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
124740612|NCT04435600|448674018|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
124740613|NCT04435600|448674019|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
124740614|NCT04435600|448674010|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
124740615|NCT04435600|448674011|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
124740616|NCT04435600|448674012|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
124740617|NCT04435600|448674013|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
124740618|NCT04435600|448674014|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
124740619|NCT04435600|448674015|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
124740620|NCT04435600|448674016|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
124740621|NCT04435600|448674017|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
124740622|NCT04435600|448674018|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
124613646|NCT00761657|448205498|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
124740623|NCT04435600|448674019|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
124740624|NCT02797184|448674022|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
124740625|NCT02797184|448674023|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
124740626|NCT05149313|448674024|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
124740627|NCT05149313|448674025|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
124740628|NCT05149313|448674026|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
124740629|NCT05149313|448674027|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
124740630|NCT05149313|448674024|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
124740631|NCT05149313|448674025|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
124740632|NCT05149313|448674026|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
124740633|NCT05149313|448674027|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
124740634|NCT05149313|448674024|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
124740635|NCT05149313|448674025|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
124740636|NCT05149313|448674026|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
124740637|NCT05149313|448674027|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
124740638|NCT05149313|448674024|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
124740639|NCT05149313|448674025|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
124740640|NCT05149313|448674026|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
124740641|NCT05149313|448674027|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
124740642|NCT05149313|448674024|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
124740643|NCT05149313|448674025|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
124740644|NCT05149313|448674026|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
124740645|NCT05149313|448674027|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
124740646|NCT05149313|448674024|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
124740647|NCT05149313|448674025|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
124740648|NCT05149313|448674026|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
124740649|NCT05149313|448674027|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
124740650|NCT05149313|448674024|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
124740651|NCT05149313|448674025|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
124740652|NCT05149313|448674026|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
124740653|NCT05149313|448674027|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
124740654|NCT05149313|448674024|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124740655|NCT05149313|448674025|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
124740656|NCT05149313|448674026|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
124740657|NCT05149313|448674027|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
124740658|NCT05149313|448674024|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
124740659|NCT05149313|448674025|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
124740660|NCT05149313|448674026|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
124740661|NCT05149313|448674027|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
124740662|NCT05149313|448674024|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124740663|NCT05149313|448674025|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124740664|NCT05149313|448674026|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
124740665|NCT05149313|448674027|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
124740666|NCT05149313|448674024|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
124740667|NCT05149313|448674025|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
124740668|NCT05149313|448674026|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
124740669|NCT05149313|448674027|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
124740670|NCT03199391|448674032|FG000|Overall Study|Death|1|||
124740671|NCT03199391|448674032|FG000|Overall Study|Lost to Follow-up|3|||
124740672|NCT03199391|448674032|FG000|Overall Study|Adverse Event|2|||
124740673|NCT03199391|448674032|FG000|Overall Study|Withdrawal by Subject|10|||
124740674|NCT04736628|448674033|FG000|Overall Study|Not treated|0|||
124740675|NCT04736628|448674034|FG001|Overall Study|Not treated|0|||
124740676|NCT04736628|448674035|FG002|Overall Study|Not treated|0|||
124740677|NCT04736628|448674036|FG003|Overall Study|Not treated|2|||
124740678|NCT04736628|448674033|FG000|Overall Study|Other reason than listed|1|||
124740679|NCT04736628|448674034|FG001|Overall Study|Other reason than listed|2|||
124740680|NCT04736628|448674035|FG002|Overall Study|Other reason than listed|2|||
124740681|NCT04736628|448674036|FG003|Overall Study|Other reason than listed|3|||
124740682|NCT04736628|448674033|FG000|Overall Study|Protocol deviation|0|||
124740683|NCT04736628|448674034|FG001|Overall Study|Protocol deviation|0|||
124740684|NCT04736628|448674035|FG002|Overall Study|Protocol deviation|0|||
124740685|NCT04736628|448674036|FG003|Overall Study|Protocol deviation|1|||
124740686|NCT04736628|448674033|FG000|Overall Study|Burden of study procedures|1|||
124740687|NCT04736628|448674034|FG001|Overall Study|Burden of study procedures|0|||
124740688|NCT04736628|448674035|FG002|Overall Study|Burden of study procedures|0|||
124740689|NCT04736628|448674036|FG003|Overall Study|Burden of study procedures|1|||
124740690|NCT04736628|448674033|FG000|Overall Study|Change of residence|0|||
124740691|NCT04736628|448674034|FG001|Overall Study|Change of residence|1|||
124740692|NCT04736628|448674035|FG002|Overall Study|Change of residence|0|||
124740693|NCT04736628|448674036|FG003|Overall Study|Change of residence|0|||
124740694|NCT04736628|448674033|FG000|Overall Study|Perceived lack of efficacy|1|||
124740695|NCT04736628|448674034|FG001|Overall Study|Perceived lack of efficacy|0|||
124740696|NCT04736628|448674035|FG002|Overall Study|Perceived lack of efficacy|0|||
124740697|NCT04736628|448674036|FG003|Overall Study|Perceived lack of efficacy|1|||
124740698|NCT04736628|448674033|FG000|Overall Study|Adverse Event|3|||
124740699|NCT04736628|448674034|FG001|Overall Study|Adverse Event|2|||
124740700|NCT04736628|448674035|FG002|Overall Study|Adverse Event|4|||
124740701|NCT04736628|448674036|FG003|Overall Study|Adverse Event|3|||
124740702|NCT02046070|448674046|FG000|Overall Study|Progressive Disease|18|||
124740703|NCT02046070|448674047|FG001|Overall Study|Progressive Disease|11|||
124740704|NCT02046070|448674048|FG002|Overall Study|Progressive Disease|40|||
124740705|NCT02046070|448674046|FG000|Overall Study|Adverse Event|8|||
124740706|NCT02046070|448674047|FG001|Overall Study|Adverse Event|10|||
124740707|NCT02046070|448674048|FG002|Overall Study|Adverse Event|17|||
124740708|NCT02046070|448674046|FG000|Overall Study|Withdrawal by Subject|1|||
124740709|NCT02046070|448674047|FG001|Overall Study|Withdrawal by Subject|2|||
124740710|NCT02046070|448674048|FG002|Overall Study|Withdrawal by Subject|6|||
124740711|NCT02046070|448674046|FG000|Overall Study|Study Terminated by Sponsor|1|||
124740712|NCT02046070|448674047|FG001|Overall Study|Study Terminated by Sponsor|1|||
124740713|NCT02046070|448674048|FG002|Overall Study|Study Terminated by Sponsor|1|||
124740714|NCT02046070|448674046|FG000|Overall Study|Reason not Specified|4|||
124740715|NCT02046070|448674047|FG001|Overall Study|Reason not Specified|4|||
124740716|NCT02046070|448674048|FG002|Overall Study|Reason not Specified|6|||
124740717|NCT04619004|448674049|FG000|Overall Study|Death|114|||
124740718|NCT04619004|448674050|FG001|Overall Study|Death|28|||
124740719|NCT04619004|448674049|FG000|Overall Study|Lost to Follow-up|1|||
124740720|NCT04619004|448674050|FG001|Overall Study|Lost to Follow-up|1|||
124740721|NCT04619004|448674049|FG000|Overall Study|Withdrawal by Subject|24|||
124740722|NCT04619004|448674050|FG001|Overall Study|Withdrawal by Subject|7|||
124740723|NCT04619004|448674049|FG000|Overall Study|Other - Not specified|0|||
124740724|NCT04619004|448674050|FG001|Overall Study|Other - Not specified|1|||
124740725|NCT02258529|448674054|FG000|Overall Study|Study Terminated by Sponsor|9|||
124740726|NCT02258529|448674054|FG000|Overall Study|Adverse Event|1|||
124740727|NCT05432167|448674060|FG000|Overall Study|Adverse Event|0|||
124740728|NCT05432167|448674061|FG001|Overall Study|Adverse Event|2|||
124740729|NCT05432167|448674062|FG002|Overall Study|Adverse Event|1|||
124740730|NCT05432167|448674060|FG000|Overall Study|Lost to Follow-up|3|||
124740731|NCT05432167|448674061|FG001|Overall Study|Lost to Follow-up|3|||
124740732|NCT05432167|448674062|FG002|Overall Study|Lost to Follow-up|2|||
124740733|NCT05432167|448674060|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
124740734|NCT05432167|448674061|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
124740735|NCT05432167|448674062|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
124740736|NCT05432167|448674060|FG000|Overall Study|Physician Decision|1|||
124613647|NCT00761657|448205499|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
124613648|NCT00761657|448205500|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
124740737|NCT05432167|448674061|FG001|Overall Study|Physician Decision|0|||
124740738|NCT05432167|448674062|FG002|Overall Study|Physician Decision|0|||
124740739|NCT05432167|448674060|FG000|Overall Study|Withdrawal by Subject|7|||
124740740|NCT05432167|448674061|FG001|Overall Study|Withdrawal by Subject|4|||
124740741|NCT05432167|448674062|FG002|Overall Study|Withdrawal by Subject|11|||
124740742|NCT05432167|448674060|FG000|Overall Study|Other|0|||
124740743|NCT05432167|448674061|FG001|Overall Study|Other|0|||
124740744|NCT05432167|448674062|FG002|Overall Study|Other|1|||
124740745|NCT01267175|448674063|FG000|Overall Study|Withdrawal by Subject|1|||
124740746|NCT01267175|448674063|FG000|Overall Study|Lost to Follow-up|1|||
124740747|NCT02553538|448674068|FG000|Overall Study|Could Not Reach by Telephone|133|||
124740748|NCT02553538|448674069|FG001|Overall Study|Could Not Reach by Telephone|0|||
124740749|NCT02553538|448674068|FG000|Overall Study|Died or Left Network|54|||
124740750|NCT02553538|448674069|FG001|Overall Study|Died or Left Network|56|||
124740751|NCT04094584|448674070|FG000|Overall Study|No interest in study|88|||
124740752|NCT04094584|448674070|FG000|Overall Study|Unwilling to undergo screening tests|36|||
124740753|NCT04094584|448674070|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
124740754|NCT04094584|448674070|FG000|Overall Study|Opioid use|7|||
124740755|NCT04094584|448674070|FG000|Overall Study|Need for major surgery in study period|4|||
124740756|NCT04094584|448674070|FG000|Overall Study|eligible but declined enrollment|4|||
124740757|NCT04094584|448674070|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
124740758|NCT04094584|448674070|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
124740759|NCT04094584|448674070|FG000|Overall Study|Lost to Follow-up|3|||
124740760|NCT04094584|448674070|FG000|Overall Study|Withdrawal by Subject|2|||
124740761|NCT02690649|448674071|FG000|Overall Study|Withdrawal by Subject|1|||
124740762|NCT02690649|448674072|FG001|Overall Study|Withdrawal by Subject|1|||
124740763|NCT02690649|448674071|FG000|Overall Study|Protocol Violation|0|||
124613649|NCT00761657|448205501|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
124613650|NCT00761657|448205502|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
124613651|NCT00761657|448205503|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
124613652|NCT00761657|448205504|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
124613653|NCT00761657|448205505|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
124613654|NCT00761657|448205497|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
124613655|NCT00761657|448205498|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
124613656|NCT00761657|448205499|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
124613657|NCT00761657|448205500|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
124613658|NCT00761657|448205501|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
124613659|NCT00761657|448205502|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
124613660|NCT00761657|448205503|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
124613661|NCT00761657|448205504|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
124613662|NCT00761657|448205505|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
124613663|NCT00761657|448205497|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
124613664|NCT00761657|448205498|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
124613665|NCT00761657|448205499|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
124613666|NCT00761657|448205500|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
124613667|NCT00761657|448205501|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
124613668|NCT00761657|448205502|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
124613669|NCT00761657|448205503|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
124613670|NCT00761657|448205504|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
124613671|NCT00761657|448205505|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
124613672|NCT01056289|448205513|FG000|Open-label Phase|Adverse Event|29|||
124613673|NCT01056289|448205514|FG001|Open-label Phase|Adverse Event|0|||
124613674|NCT01056289|448205515|FG002|Open-label Phase|Adverse Event|0|||
124613675|NCT01056289|448205516|FG003|Open-label Phase|Adverse Event|0|||
124613676|NCT01056289|448205513|FG000|Open-label Phase|Lost to Follow-up|30|||
124613677|NCT01056289|448205514|FG001|Open-label Phase|Lost to Follow-up|0|||
124613678|NCT01056289|448205515|FG002|Open-label Phase|Lost to Follow-up|0|||
124613679|NCT01056289|448205516|FG003|Open-label Phase|Lost to Follow-up|0|||
124613680|NCT01056289|448205513|FG000|Open-label Phase|Other|9|||
124613681|NCT01056289|448205514|FG001|Open-label Phase|Other|0|||
124613682|NCT01056289|448205515|FG002|Open-label Phase|Other|0|||
124613683|NCT01056289|448205516|FG003|Open-label Phase|Other|0|||
124613684|NCT01056289|448205513|FG000|Open-label Phase|Protocol Violation|6|||
124613685|NCT01056289|448205514|FG001|Open-label Phase|Protocol Violation|0|||
124613686|NCT01056289|448205515|FG002|Open-label Phase|Protocol Violation|0|||
124613687|NCT01056289|448205516|FG003|Open-label Phase|Protocol Violation|0|||
124613688|NCT01056289|448205513|FG000|Open-label Phase|Withdrawal by Subject|26|||
124613689|NCT01056289|448205514|FG001|Open-label Phase|Withdrawal by Subject|0|||
124613690|NCT01056289|448205515|FG002|Open-label Phase|Withdrawal by Subject|0|||
124613691|NCT01056289|448205516|FG003|Open-label Phase|Withdrawal by Subject|0|||
124613692|NCT01056289|448205513|FG000|Open-label Phase|Lack of Efficacy|18|||
124613693|NCT01056289|448205514|FG001|Open-label Phase|Lack of Efficacy|0|||
124613694|NCT01056289|448205515|FG002|Open-label Phase|Lack of Efficacy|0|||
124613695|NCT01056289|448205516|FG003|Open-label Phase|Lack of Efficacy|0|||
124613696|NCT01056289|448205513|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
124613697|NCT01056289|448205514|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
124613698|NCT01056289|448205515|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
124613699|NCT01056289|448205516|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
124613700|NCT01056289|448205513|FG000|Double-blind Phase|Adverse Event|0|||
124613701|NCT01056289|448205514|FG001|Double-blind Phase|Adverse Event|1|||
124613702|NCT01056289|448205515|FG002|Double-blind Phase|Adverse Event|2|||
124613703|NCT01056289|448205516|FG003|Double-blind Phase|Adverse Event|1|||
124613704|NCT01056289|448205513|FG000|Double-blind Phase|Lost to Follow-up|0|||
124613705|NCT01056289|448205514|FG001|Double-blind Phase|Lost to Follow-up|2|||
124613706|NCT01056289|448205515|FG002|Double-blind Phase|Lost to Follow-up|2|||
124613707|NCT01056289|448205516|FG003|Double-blind Phase|Lost to Follow-up|2|||
124613708|NCT01056289|448205513|FG000|Double-blind Phase|Other|0|||
124613709|NCT01056289|448205514|FG001|Double-blind Phase|Other|0|||
124613710|NCT01056289|448205515|FG002|Double-blind Phase|Other|1|||
124613711|NCT01056289|448205516|FG003|Double-blind Phase|Other|2|||
124613712|NCT01056289|448205513|FG000|Double-blind Phase|Protocol Violation|0|||
124613713|NCT01056289|448205514|FG001|Double-blind Phase|Protocol Violation|0|||
124613714|NCT01056289|448205515|FG002|Double-blind Phase|Protocol Violation|1|||
124613715|NCT01056289|448205516|FG003|Double-blind Phase|Protocol Violation|1|||
124613716|NCT01056289|448205513|FG000|Double-blind Phase|Withdrawal by Subject|0|||
124613717|NCT01056289|448205514|FG001|Double-blind Phase|Withdrawal by Subject|0|||
124613718|NCT01056289|448205515|FG002|Double-blind Phase|Withdrawal by Subject|4|||
124613719|NCT01056289|448205516|FG003|Double-blind Phase|Withdrawal by Subject|2|||
124613720|NCT01056289|448205513|FG000|Double-blind Phase|Discontinuation symptom|0|||
124613721|NCT01056289|448205514|FG001|Double-blind Phase|Discontinuation symptom|1|||
124613722|NCT01056289|448205515|FG002|Double-blind Phase|Discontinuation symptom|2|||
124613723|NCT01056289|448205516|FG003|Double-blind Phase|Discontinuation symptom|2|||
124613724|NCT01056289|448205513|FG000|Double-blind Phase|Physician Decision|0|||
124740764|NCT02690649|448674072|FG001|Overall Study|Protocol Violation|3|||
124740765|NCT00791557|448674073|FG000|Overall Study|Adverse Event|1|||
124740766|NCT02616393|448674079|FG000|Overall Study|Death|5|||
124740767|NCT02616393|448674080|FG001|Overall Study|Death|12|||
124740768|NCT02616393|448674081|FG002|Overall Study|Death|1|||
124740769|NCT02616393|448674079|FG000|Overall Study|Termination by Sponsor|4|||
124740770|NCT02616393|448674080|FG001|Overall Study|Termination by Sponsor|5|||
124740771|NCT02616393|448674081|FG002|Overall Study|Termination by Sponsor|2|||
124740772|NCT02616393|448674079|FG000|Overall Study|Other|3|||
124740773|NCT02616393|448674080|FG001|Overall Study|Other|0|||
124740774|NCT02616393|448674081|FG002|Overall Study|Other|0|||
124740775|NCT02616393|448674079|FG000|Overall Study|Withdrawal by Subject|1|||
124740776|NCT02616393|448674080|FG001|Overall Study|Withdrawal by Subject|1|||
124740777|NCT02616393|448674081|FG002|Overall Study|Withdrawal by Subject|0|||
124740778|NCT02616393|448674079|FG000|Overall Study|Lost to Follow-up|0|||
124740779|NCT02616393|448674080|FG001|Overall Study|Lost to Follow-up|2|||
124740780|NCT02616393|448674081|FG002|Overall Study|Lost to Follow-up|0|||
124740781|NCT02900170|448674085|FG000|Overall Study|Lost to Follow-up|8|||
124740782|NCT01600053|448674086|FG000|Overall Study|Adverse Event|2|||
124740783|NCT01600053|448674086|FG000|Overall Study|trial will not meet the interim endpoint|9|||
124740784|NCT02855944|448674087|FG000|Period 1: Treatment|Ongoing|14|||
124740785|NCT02855944|448674088|FG001|Period 1: Treatment|Ongoing|0|||
124740786|NCT02855944|448674087|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
124740787|NCT02855944|448674088|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
124740788|NCT02855944|448674087|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
124740789|NCT02855944|448674088|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
124740790|NCT01475162|448674095|FG000|Overall Study|Physician Decision|1|||
124740791|NCT01475162|448674095|FG000|Overall Study|Death|10|||
124740792|NCT01475162|448674095|FG000|Overall Study|Study closed for safety|3|||
124740793|NCT00490022|448674096|FG000|Overall Study|Adverse Event|0|||
124740794|NCT00490022|448674097|FG001|Overall Study|Adverse Event|2|||
124740795|NCT00490022|448674096|FG000|Overall Study|Withdrawal by Subject|1|||
124740796|NCT00490022|448674097|FG001|Overall Study|Withdrawal by Subject|0|||
124740797|NCT00490022|448674096|FG000|Overall Study|Subject failed to disclose concommitant|0|||
124740798|NCT00490022|448674097|FG001|Overall Study|Subject failed to disclose concommitant|1|||
124740799|NCT02608450|448674098|FG000|Overall Study|Lost to Follow-up|39|||
124740800|NCT02608450|448674099|FG001|Overall Study|Lost to Follow-up|32|||
124740801|NCT02608450|448674098|FG000|Overall Study|Withdrawal by Subject|21|||
124740802|NCT02608450|448674099|FG001|Overall Study|Withdrawal by Subject|15|||
124740803|NCT02608450|448674098|FG000|Overall Study|Adverse Event|3|||
124740804|NCT02608450|448674099|FG001|Overall Study|Adverse Event|6|||
124740805|NCT02608450|448674098|FG000|Overall Study|Withdrawal by parent|2|||
124740806|NCT02608450|448674099|FG001|Overall Study|Withdrawal by parent|3|||
124740807|NCT02608450|448674098|FG000|Overall Study|Lack of Efficacy|0|||
124740808|NCT02608450|448674099|FG001|Overall Study|Lack of Efficacy|3|||
124740809|NCT02608450|448674098|FG000|Overall Study|Noncompliance with study drug|0|||
124740810|NCT02608450|448674099|FG001|Overall Study|Noncompliance with study drug|2|||
124740811|NCT02608450|448674098|FG000|Overall Study|Physician Decision|0|||
124740812|NCT02608450|448674099|FG001|Overall Study|Physician Decision|1|||
124740813|NCT02608450|448674098|FG000|Overall Study|Pregnancy|0|||
124740814|NCT02608450|448674099|FG001|Overall Study|Pregnancy|1|||
124740815|NCT02608450|448674098|FG000|Overall Study|Progressive disease|1|||
124740816|NCT02608450|448674099|FG001|Overall Study|Progressive disease|0|||
124740817|NCT02608450|448674098|FG000|Overall Study|Multiple reasons|0|||
124740818|NCT02608450|448674099|FG001|Overall Study|Multiple reasons|2|||
124740819|NCT01283542|448674100|FG000|Main Phase|Acute or progressive vision loss|1|||
124740820|NCT01283542|448674100|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
124740821|NCT01283542|448674100|FG000|Main Phase|abnormal laboratory values|5|||
124740822|NCT01283542|448674100|FG000|Extension Phase|Physician Decision|1|||
124740823|NCT01283542|448674100|FG000|Extension Phase|Adverse Event|1|||
124740824|NCT01283542|448674100|FG000|Extension Phase|Administrative problems|1|||
124740825|NCT03443427|448674101|FG000|Overall Study|Adverse Event|2|||
124740826|NCT03443427|448674102|FG001|Overall Study|Adverse Event|3|||
124740827|NCT03443427|448674101|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
124740828|NCT03443427|448674102|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
124740829|NCT03443427|448674101|FG000|Overall Study|Other|4|||
124740830|NCT03443427|448674102|FG001|Overall Study|Other|6|||
124740831|NCT00477269|448674104|FG000|Core Study|Adverse Event|6|||
124740832|NCT00477269|448674105|FG001|Core Study|Adverse Event|4|||
124740833|NCT00477269|448674106|FG002|Core Study|Adverse Event|0|||
124740834|NCT00477269|448674104|FG000|Core Study|Death|3|||
124740835|NCT00477269|448674105|FG001|Core Study|Death|3|||
124740836|NCT00477269|448674106|FG002|Core Study|Death|0|||
124740837|NCT00477269|448674104|FG000|Core Study|Withdrawn Consent|0|||
124740838|NCT00477269|448674105|FG001|Core Study|Withdrawn Consent|1|||
124740839|NCT00477269|448674106|FG002|Core Study|Withdrawn Consent|0|||
124740840|NCT00477269|448674104|FG000|Open Label Extension|Adverse Event|0|||
124740841|NCT00477269|448674105|FG001|Open Label Extension|Adverse Event|0|||
124740842|NCT00477269|448674106|FG002|Open Label Extension|Adverse Event|4|||
124740843|NCT00477269|448674104|FG000|Open Label Extension|Abnormal laboratory values|0|||
124740844|NCT00477269|448674105|FG001|Open Label Extension|Abnormal laboratory values|0|||
124740845|NCT00477269|448674106|FG002|Open Label Extension|Abnormal laboratory values|1|||
124740846|NCT00477269|448674104|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
124740847|NCT00477269|448674105|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
124740848|NCT00477269|448674106|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
124740849|NCT00477269|448674104|FG000|Open Label Extension|Adminiatrative problems|0|||
124740850|NCT00477269|448674105|FG001|Open Label Extension|Adminiatrative problems|0|||
124740851|NCT00477269|448674106|FG002|Open Label Extension|Adminiatrative problems|2|||
124740852|NCT00477269|448674104|FG000|Open Label Extension|Death|0|||
124740853|NCT00477269|448674105|FG001|Open Label Extension|Death|0|||
124740854|NCT00477269|448674106|FG002|Open Label Extension|Death|4|||
124740855|NCT03263780|448674107|FG000|Overall Study|Withdrawal by Subject|3|||
124740856|NCT03263780|448674107|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
124740857|NCT02449018|448674110|FG000|Overall Study|Abnormal laboratory value|0|||
124740858|NCT02449018|448674111|FG001|Overall Study|Abnormal laboratory value|1|||
124740859|NCT02449018|448674110|FG000|Overall Study|Administrative problems|1|||
124740860|NCT02449018|448674111|FG001|Overall Study|Administrative problems|0|||
124740861|NCT02449018|448674110|FG000|Overall Study|Adverse Event|5|||
124740862|NCT02449018|448674111|FG001|Overall Study|Adverse Event|1|||
124740863|NCT02449018|448674110|FG000|Overall Study|Protocol deviation|4|||
124740864|NCT02449018|448674111|FG001|Overall Study|Protocol deviation|0|||
124740865|NCT02449018|448674110|FG000|Overall Study|Patient decision|2|||
124740866|NCT02449018|448674111|FG001|Overall Study|Patient decision|0|||
124740867|NCT03831945|448674112|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
124740868|NCT03831945|448674113|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
124740869|NCT03831945|448674112|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
124740870|NCT03831945|448674113|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
124740871|NCT03831945|448674112|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
124740872|NCT03831945|448674113|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
124740873|NCT03426631|448674114|FG000|Overall Study|Lost to Follow-up|0|||
124740874|NCT03426631|448674115|FG001|Overall Study|Lost to Follow-up|1|||
124740875|NCT00447122|448674116|FG000|Overall Study|worsening medical condition -came off|0|||
124740876|NCT00447122|448674117|FG001|Overall Study|worsening medical condition -came off|1|||
124740877|NCT00447122|448674118|FG002|Overall Study|worsening medical condition -came off|0|||
124740878|NCT00447122|448674119|FG003|Overall Study|worsening medical condition -came off|0|||
124740879|NCT02540291|448674120|FG000|Overall Study|Death|7|||
124740880|NCT02540291|448674121|FG001|Overall Study|Death|7|||
124740881|NCT02540291|448674122|FG002|Overall Study|Death|5|||
124740882|NCT02540291|448674123|FG003|Overall Study|Death|7|||
124740883|NCT02540291|448674120|FG000|Overall Study|Lost to Follow-up|0|||
124740884|NCT02540291|448674121|FG001|Overall Study|Lost to Follow-up|0|||
124740885|NCT02540291|448674122|FG002|Overall Study|Lost to Follow-up|1|||
124740886|NCT02540291|448674123|FG003|Overall Study|Lost to Follow-up|0|||
124740887|NCT02540291|448674120|FG000|Overall Study|Withdrawal Of Consent|0|||
124740888|NCT02540291|448674121|FG001|Overall Study|Withdrawal Of Consent|1|||
124740889|NCT02540291|448674122|FG002|Overall Study|Withdrawal Of Consent|0|||
124740890|NCT02540291|448674123|FG003|Overall Study|Withdrawal Of Consent|0|||
124740891|NCT02540291|448674120|FG000|Overall Study|Study Terminated By Sponsor|1|||
124740892|NCT02540291|448674121|FG001|Overall Study|Study Terminated By Sponsor|0|||
124740893|NCT02540291|448674122|FG002|Overall Study|Study Terminated By Sponsor|0|||
124740894|NCT02540291|448674123|FG003|Overall Study|Study Terminated By Sponsor|0|||
124740895|NCT02540291|448674120|FG000|Overall Study|Other|0|||
124740896|NCT02540291|448674121|FG001|Overall Study|Other|0|||
124740897|NCT02540291|448674122|FG002|Overall Study|Other|1|||
124740898|NCT02540291|448674123|FG003|Overall Study|Other|0|||
124740899|NCT01174173|448674128|FG000|Overall Study|drug-drug interaction|1|||
124740900|NCT03938324|448675251|FG000|Overall Study|Lost to Follow-up|42|||
124740901|NCT03938324|448675252|FG001|Overall Study|Lost to Follow-up|21|||
124740902|NCT03938324|448675251|FG000|Overall Study|Withdrawal by Subject|6|||
124740903|NCT03938324|448675252|FG001|Overall Study|Withdrawal by Subject|1|||
124740904|NCT02769962|448675253|FG000|Overall Study|Physician Decision|0|||
124740905|NCT02769962|448675254|FG001|Overall Study|Physician Decision|0|||
124740906|NCT02769962|448675255|FG002|Overall Study|Physician Decision|0|||
124740907|NCT02769962|448675256|FG003|Overall Study|Physician Decision|0|||
124740908|NCT02769962|448675257|FG004|Overall Study|Physician Decision|0|||
124740909|NCT02769962|448675258|FG005|Overall Study|Physician Decision|1|||
124740910|NCT02769962|448675259|FG006|Overall Study|Physician Decision|0|||
124740911|NCT02769962|448675260|FG007|Overall Study|Physician Decision|1|||
124740912|NCT02769962|448675253|FG000|Overall Study|Refused further treatment|0|||
124740913|NCT02769962|448675254|FG001|Overall Study|Refused further treatment|0|||
124740914|NCT02769962|448675255|FG002|Overall Study|Refused further treatment|0|||
124740915|NCT02769962|448675256|FG003|Overall Study|Refused further treatment|0|||
124613725|NCT01056289|448205514|FG001|Double-blind Phase|Physician Decision|0|||
124613726|NCT01056289|448205515|FG002|Double-blind Phase|Physician Decision|1|||
124613727|NCT01056289|448205516|FG003|Double-blind Phase|Physician Decision|0|||
124613728|NCT00270855|448205525|FG000|Overall Study|Withdrawal by Subject|8|||
124613729|NCT00270855|448205526|FG001|Overall Study|Withdrawal by Subject|8|||
124613730|NCT02152605|448205529|FG000|Overall Study|Adverse Event|6|||
124613731|NCT02152605|448205530|FG001|Overall Study|Adverse Event|8|||
124613732|NCT02152605|448205529|FG000|Overall Study|Lack of Efficacy|7|||
124613733|NCT02152605|448205530|FG001|Overall Study|Lack of Efficacy|4|||
124613734|NCT02152605|448205529|FG000|Overall Study|Protocol deviation|1|||
124613735|NCT02152605|448205530|FG001|Overall Study|Protocol deviation|4|||
124613736|NCT02152605|448205529|FG000|Overall Study|Lost to Follow-up|1|||
124613737|NCT02152605|448205530|FG001|Overall Study|Lost to Follow-up|0|||
124613738|NCT02152605|448205529|FG000|Overall Study|Withdrew consent|4|||
124613739|NCT02152605|448205530|FG001|Overall Study|Withdrew consent|2|||
124613740|NCT03151408|448205531|FG000|Overall Study|Adverse Event|24|||
124613741|NCT03151408|448205532|FG001|Overall Study|Adverse Event|23|||
124613742|NCT03151408|448205531|FG000|Overall Study|Death|46|||
124613743|NCT03151408|448205532|FG001|Overall Study|Death|26|||
124613744|NCT03151408|448205531|FG000|Overall Study|Physician Decision|13|||
124613745|NCT03151408|448205532|FG001|Overall Study|Physician Decision|19|||
124613746|NCT03151408|448205531|FG000|Overall Study|Withdrawal by Subject|16|||
124613747|NCT03151408|448205532|FG001|Overall Study|Withdrawal by Subject|20|||
124781741|NCT04413617|448831140|FG004|Overall Study|COVID-19|0|||
124781742|NCT02657408|448831141|FG000|Overall Study|Adverse Event|3|||
124781743|NCT02657408|448831142|FG001|Overall Study|Adverse Event|7|||
124781744|NCT00324961|448831144|FG000|Overall Study|Adverse Event|5|||
124781745|NCT00324961|448831144|FG000|Overall Study|Consent Withdrawn|11|||
124740916|NCT02769962|448675257|FG004|Overall Study|Refused further treatment|0|||
124740917|NCT02769962|448675258|FG005|Overall Study|Refused further treatment|1|||
124740918|NCT02769962|448675259|FG006|Overall Study|Refused further treatment|1|||
124740919|NCT02769962|448675260|FG007|Overall Study|Refused further treatment|0|||
124740920|NCT00837759|448675261|FG000|Overall Study|Protocol Violation|3|||
124740921|NCT00837759|448675261|FG000|Overall Study|Lost to Follow-up|1|||
124740922|NCT05063539|448675262|FG000|Overall Study|Adverse Event|1|||
124740923|NCT05063539|448675263|FG001|Overall Study|Adverse Event|2|||
124740924|NCT05063539|448675264|FG002|Overall Study|Adverse Event|1|||
124740925|NCT05063539|448675262|FG000|Overall Study|Death|0|||
124740926|NCT05063539|448675263|FG001|Overall Study|Death|1|||
124740927|NCT05063539|448675264|FG002|Overall Study|Death|1|||
124740928|NCT05063539|448675262|FG000|Overall Study|Lost to Follow-up|0|||
124740929|NCT05063539|448675263|FG001|Overall Study|Lost to Follow-up|1|||
124740930|NCT05063539|448675264|FG002|Overall Study|Lost to Follow-up|0|||
124740931|NCT05063539|448675262|FG000|Overall Study|Physician Decision|4|||
124740932|NCT05063539|448675263|FG001|Overall Study|Physician Decision|3|||
124740933|NCT05063539|448675264|FG002|Overall Study|Physician Decision|1|||
124740934|NCT05063539|448675262|FG000|Overall Study|Progressive Disease|0|||
124740935|NCT05063539|448675263|FG001|Overall Study|Progressive Disease|2|||
124740936|NCT05063539|448675264|FG002|Overall Study|Progressive Disease|0|||
124740937|NCT05063539|448675262|FG000|Overall Study|Withdrawal by Subject|17|||
124740938|NCT05063539|448675263|FG001|Overall Study|Withdrawal by Subject|26|||
124740939|NCT05063539|448675264|FG002|Overall Study|Withdrawal by Subject|14|||
124781746|NCT00324961|448831144|FG000|Overall Study|Lost to Follow-up|22|||
124781747|NCT00324961|448831144|FG000|Overall Study|Protocol Violation|3|||
124613748|NCT03151408|448205531|FG000|Overall Study|Progressive disease|45|||
124613749|NCT03151408|448205532|FG001|Overall Study|Progressive disease|61|||
124613750|NCT03151408|448205531|FG000|Overall Study|non-compliance by patient|1|||
124613751|NCT03151408|448205532|FG001|Overall Study|non-compliance by patient|0|||
124613752|NCT03151408|448205531|FG000|Overall Study|other reasons|56|||
124613753|NCT03151408|448205532|FG001|Overall Study|other reasons|52|||
124613754|NCT03151408|448205531|FG000|Overall Study|randomized and not treated|2|||
124740940|NCT05063539|448675262|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
124740941|NCT05063539|448675263|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
124740942|NCT05063539|448675264|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
124740943|NCT05063539|448675262|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
124740944|NCT05063539|448675263|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
124740945|NCT05063539|448675264|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
124613755|NCT03151408|448205532|FG001|Overall Study|randomized and not treated|2|||
124613756|NCT00837473|448205533|FG000|Overall Study|Lost to Follow-up|1|||
124613757|NCT00837473|448205533|FG000|Overall Study|Withdrawal by Subject|2|||
124740946|NCT05063539|448675262|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
124740947|NCT05063539|448675263|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
124740948|NCT05063539|448675264|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
124781748|NCT00324961|448831144|FG000|Overall Study|Other|2|||
124781749|NCT03350672|448831148|FG000|Overall Study|Withdrawal by Subject|7|||
124781750|NCT03350672|448831149|FG001|Overall Study|Withdrawal by Subject|0|||
124740949|NCT05063539|448675262|FG000|Overall Study|Discontinued due to Common Close Design|0|||
124740950|NCT05063539|448675263|FG001|Overall Study|Discontinued due to Common Close Design|1|||
124740951|NCT05063539|448675264|FG002|Overall Study|Discontinued due to Common Close Design|0|||
124740952|NCT05063539|448675262|FG000|Overall Study|Participant not co-operative|0|||
124740953|NCT05063539|448675263|FG001|Overall Study|Participant not co-operative|1|||
124740954|NCT05063539|448675264|FG002|Overall Study|Participant not co-operative|0|||
124740955|NCT05063539|448675262|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
124740956|NCT05063539|448675263|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
124740957|NCT05063539|448675264|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
124613758|NCT01724489|448205534|FG000|Overall Study|Adverse Event|8|||
124613759|NCT01724489|448205535|FG001|Overall Study|Adverse Event|3|||
124740958|NCT05063539|448675262|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
124740959|NCT05063539|448675263|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
124740960|NCT05063539|448675264|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
124740961|NCT04256512|448675265|FG000|Overall Study|Withdrawal by Subject|1|||
124740962|NCT01646203|448675268|FG000|Overall Study|Adverse Event|2|||
124740963|NCT01646203|448675269|FG001|Overall Study|Adverse Event|0|||
124740964|NCT01646203|448675270|FG002|Overall Study|Adverse Event|1|||
124740965|NCT01646203|448675268|FG000|Overall Study|Withdrawal by Subject|0|||
124740966|NCT01646203|448675269|FG001|Overall Study|Withdrawal by Subject|1|||
124740967|NCT01646203|448675270|FG002|Overall Study|Withdrawal by Subject|0|||
124613760|NCT01724489|448205534|FG000|Overall Study|Surgery, medication|1|||
124613761|NCT01724489|448205535|FG001|Overall Study|Surgery, medication|1|||
124613762|NCT01724489|448205534|FG000|Overall Study|Lost to Follow-up|1|||
124613763|NCT01724489|448205535|FG001|Overall Study|Lost to Follow-up|2|||
124613764|NCT01724489|448205534|FG000|Overall Study|Withdrawal by Subject|6|||
124613765|NCT01724489|448205535|FG001|Overall Study|Withdrawal by Subject|6|||
124613766|NCT04576923|448205536|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
124613767|NCT00923273|448205539|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
124613768|NCT00923273|448205540|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
124613769|NCT00923273|448205541|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
124613770|NCT00923273|448205542|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
124613771|NCT00923273|448205543|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
124613772|NCT00923273|448205539|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
124613773|NCT00923273|448205540|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
124613774|NCT00923273|448205541|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
124613775|NCT00923273|448205542|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
124613776|NCT00923273|448205543|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
124613777|NCT01473524|448205546|FG000|DB Phase|Adverse Event|4|||
124613778|NCT01473524|448205547|FG001|DB Phase|Adverse Event|8|||
124613779|NCT01473524|448205548|FG002|DB Phase|Adverse Event|2|||
124613780|NCT01473524|448205549|FG003|DB Phase|Adverse Event|0|||
124613781|NCT01473524|448205550|FG004|DB Phase|Adverse Event|0|||
124613782|NCT01473524|448205551|FG005|DB Phase|Adverse Event|0|||
124613783|NCT01473524|448205546|FG000|DB Phase|Death|1|||
124613784|NCT01473524|448205547|FG001|DB Phase|Death|0|||
124613785|NCT01473524|448205548|FG002|DB Phase|Death|0|||
124613786|NCT01473524|448205549|FG003|DB Phase|Death|0|||
124613787|NCT01473524|448205550|FG004|DB Phase|Death|0|||
124613788|NCT01473524|448205551|FG005|DB Phase|Death|0|||
124613789|NCT01473524|448205546|FG000|DB Phase|Withdrawal by Subject|2|||
124613790|NCT01473524|448205547|FG001|DB Phase|Withdrawal by Subject|1|||
124613791|NCT01473524|448205548|FG002|DB Phase|Withdrawal by Subject|1|||
124613792|NCT01473524|448205549|FG003|DB Phase|Withdrawal by Subject|0|||
124613793|NCT01473524|448205550|FG004|DB Phase|Withdrawal by Subject|0|||
124613794|NCT01473524|448205551|FG005|DB Phase|Withdrawal by Subject|0|||
124613795|NCT01473524|448205546|FG000|LTSE Phase|Withdrawal by Subject|0|||
124613796|NCT01473524|448205547|FG001|LTSE Phase|Withdrawal by Subject|0|||
124613797|NCT01473524|448205548|FG002|LTSE Phase|Withdrawal by Subject|0|||
124613798|NCT01473524|448205549|FG003|LTSE Phase|Withdrawal by Subject|3|||
124613799|NCT01473524|448205550|FG004|LTSE Phase|Withdrawal by Subject|3|||
124613800|NCT01473524|448205551|FG005|LTSE Phase|Withdrawal by Subject|6|||
124613801|NCT01473524|448205546|FG000|LTSE Phase|Death|0|||
124613802|NCT01473524|448205547|FG001|LTSE Phase|Death|0|||
124613803|NCT01473524|448205548|FG002|LTSE Phase|Death|0|||
124613804|NCT01473524|448205549|FG003|LTSE Phase|Death|0|||
124740968|NCT01646203|448675268|FG000|Overall Study|Physician's Decision|0|||
124740969|NCT01646203|448675269|FG001|Overall Study|Physician's Decision|1|||
124740970|NCT01646203|448675270|FG002|Overall Study|Physician's Decision|0|||
124740971|NCT00680368|448675274|FG000|Overall Study|not supervised, not eligible|15|||
124740972|NCT00443781|448675279|FG000|Overall Study|Lost to Follow-up|10|||
124613805|NCT01473524|448205550|FG004|LTSE Phase|Death|1|||
124613806|NCT01473524|448205551|FG005|LTSE Phase|Death|0|||
124740973|NCT00443781|448675279|FG000|Overall Study|Physician Decision|2|||
124740974|NCT00443781|448675279|FG000|Overall Study|Protocol Violation|1|||
124740975|NCT00443781|448675279|FG000|Overall Study|Withdrawal by Subject|6|||
124740976|NCT00443781|448675279|FG000|Overall Study|Unable to comply with study follow up|2|||
124740977|NCT00443781|448675279|FG000|Overall Study|Investigator terminated participation|1|||
124740978|NCT00443781|448675279|FG000|Overall Study|Insurance not covered|2|||
124740979|NCT00443781|448675279|FG000|Overall Study|PD/FAD not done|1|||
124740980|NCT00582738|448675285|FG000|Overall Study|Administrative Problems|7|||
124740981|NCT00582738|448675286|FG001|Overall Study|Administrative Problems|8|||
124740982|NCT00582738|448675285|FG000|Overall Study|Adverse Event|0|||
124740983|NCT00582738|448675286|FG001|Overall Study|Adverse Event|5|||
124740984|NCT00582738|448675285|FG000|Overall Study|Graft Lost|0|||
124740985|NCT00582738|448675286|FG001|Overall Study|Graft Lost|1|||
124740986|NCT00582738|448675285|FG000|Overall Study|Other|1|||
124740987|NCT00582738|448675286|FG001|Overall Study|Other|0|||
124740988|NCT00582738|448675285|FG000|Overall Study|Protocol Violation|1|||
124740989|NCT00582738|448675286|FG001|Overall Study|Protocol Violation|1|||
124740990|NCT00582738|448675285|FG000|Overall Study|Withdrawal by Subject|0|||
124740991|NCT00582738|448675286|FG001|Overall Study|Withdrawal by Subject|3|||
124740992|NCT02758301|448675287|FG000|Overall Study|Death|12|||
124740993|NCT02758301|448675288|FG001|Overall Study|Death|0|||
124740994|NCT02758301|448675287|FG000|Overall Study|Physician Decision|10|||
124740995|NCT02758301|448675288|FG001|Overall Study|Physician Decision|1|||
124740996|NCT02758301|448675287|FG000|Overall Study|Withdrawal by Subject|5|||
124740997|NCT02758301|448675288|FG001|Overall Study|Withdrawal by Subject|6|||
124740998|NCT02758301|448675287|FG000|Overall Study|Lost to Follow-up|7|||
124740999|NCT02758301|448675288|FG001|Overall Study|Lost to Follow-up|0|||
124741000|NCT02758301|448675287|FG000|Overall Study|Protocol Violation|0|||
124741001|NCT02758301|448675288|FG001|Overall Study|Protocol Violation|1|||
124741002|NCT00364533|448675289|FG000|Overall Study|Adverse Event|8|||
124741003|NCT00364533|448675290|FG001|Overall Study|Adverse Event|7|||
124741004|NCT00364533|448675291|FG002|Overall Study|Adverse Event|15|||
124741005|NCT00364533|448675292|FG003|Overall Study|Adverse Event|5|||
124741006|NCT00364533|448675293|FG004|Overall Study|Adverse Event|2|||
124741007|NCT00364533|448675289|FG000|Overall Study|Withdrawal by Subject|4|||
124741008|NCT00364533|448675290|FG001|Overall Study|Withdrawal by Subject|8|||
124741009|NCT00364533|448675291|FG002|Overall Study|Withdrawal by Subject|6|||
124741010|NCT00364533|448675292|FG003|Overall Study|Withdrawal by Subject|6|||
124741011|NCT00364533|448675293|FG004|Overall Study|Withdrawal by Subject|6|||
124741012|NCT00364533|448675289|FG000|Overall Study|Lack of Efficacy|22|||
124741013|NCT00364533|448675290|FG001|Overall Study|Lack of Efficacy|22|||
124741014|NCT00364533|448675291|FG002|Overall Study|Lack of Efficacy|21|||
124741015|NCT00364533|448675292|FG003|Overall Study|Lack of Efficacy|17|||
124741016|NCT00364533|448675293|FG004|Overall Study|Lack of Efficacy|42|||
124741017|NCT00364533|448675289|FG000|Overall Study|Subject discharged from hospital|4|||
124741018|NCT00364533|448675290|FG001|Overall Study|Subject discharged from hospital|1|||
124741019|NCT00364533|448675291|FG002|Overall Study|Subject discharged from hospital|2|||
124741020|NCT00364533|448675292|FG003|Overall Study|Subject discharged from hospital|3|||
124741021|NCT00364533|448675293|FG004|Overall Study|Subject discharged from hospital|1|||
124741022|NCT00364533|448675289|FG000|Overall Study|Variations in drug compliance|2|||
124741023|NCT00364533|448675290|FG001|Overall Study|Variations in drug compliance|1|||
124741024|NCT00364533|448675291|FG002|Overall Study|Variations in drug compliance|1|||
124741025|NCT00364533|448675292|FG003|Overall Study|Variations in drug compliance|0|||
124741026|NCT00364533|448675293|FG004|Overall Study|Variations in drug compliance|0|||
124741027|NCT00364533|448675289|FG000|Overall Study|Non-compliance|1|||
124741028|NCT00364533|448675290|FG001|Overall Study|Non-compliance|0|||
124741029|NCT00364533|448675291|FG002|Overall Study|Non-compliance|0|||
124741030|NCT00364533|448675292|FG003|Overall Study|Non-compliance|0|||
124741031|NCT00364533|448675293|FG004|Overall Study|Non-compliance|0|||
124741032|NCT00364533|448675289|FG000|Overall Study|Protocol Violation|1|||
124741033|NCT00364533|448675290|FG001|Overall Study|Protocol Violation|1|||
124741034|NCT00364533|448675291|FG002|Overall Study|Protocol Violation|0|||
124741035|NCT00364533|448675292|FG003|Overall Study|Protocol Violation|0|||
124741036|NCT00364533|448675293|FG004|Overall Study|Protocol Violation|0|||
124741037|NCT00652899|448675294|FG000|Overall Study|Death|1|||
124741038|NCT00652899|448675294|FG000|Overall Study|Treating physician decision|1|||
124613807|NCT01473524|448205546|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
124613808|NCT01473524|448205547|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
124741039|NCT00551291|448675295|FG000|Overall Study|Physician Decision|1|||
124741040|NCT01943552|448675296|FG000|Overall Study|Adverse Event|3|||
124741041|NCT01943552|448675297|FG001|Overall Study|Adverse Event|2|||
124741042|NCT01943552|448675296|FG000|Overall Study|Withdrawal by Subject|6|||
124741043|NCT01943552|448675297|FG001|Overall Study|Withdrawal by Subject|6|||
124741044|NCT01943552|448675296|FG000|Overall Study|Other Reasons|16|||
124741045|NCT01943552|448675297|FG001|Overall Study|Other Reasons|17|||
124741046|NCT05059977|448675300|FG000|Overall Study|Withdrawal by Subject|0|||
124741047|NCT05059977|448675301|FG001|Overall Study|Withdrawal by Subject|0|||
124741048|NCT05059977|448675302|FG002|Overall Study|Withdrawal by Subject|1|||
124741049|NCT00576472|448675303|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
124741050|NCT00576472|448675304|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
124741051|NCT00576472|448675305|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
124741052|NCT00576472|448675306|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
124741053|NCT00576472|448675307|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
124741054|NCT00576472|448675308|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
124741055|NCT00576472|448675309|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
124741056|NCT00576472|448675310|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
124741057|NCT00576472|448675311|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
124741058|NCT00576472|448675312|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
124741059|NCT00576472|448675313|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
124741060|NCT00576472|448675314|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
124741061|NCT00576472|448675315|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
124741062|NCT00576472|448675316|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
124741063|NCT00576472|448675317|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
124741064|NCT00576472|448675303|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
124741065|NCT00576472|448675304|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
124741066|NCT00576472|448675305|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
124741067|NCT00576472|448675306|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
124741068|NCT00576472|448675307|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
124741069|NCT00576472|448675308|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
124741070|NCT00576472|448675309|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
124741071|NCT00576472|448675310|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
124741072|NCT00576472|448675311|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
124741073|NCT00576472|448675312|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
124741074|NCT00576472|448675313|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
124741075|NCT00576472|448675314|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
124741076|NCT00576472|448675315|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
124741077|NCT00576472|448675316|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
124741078|NCT00576472|448675317|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
124741079|NCT00576472|448675303|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
124741080|NCT00576472|448675304|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
124741081|NCT00576472|448675305|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
124741082|NCT00576472|448675306|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
124741083|NCT00576472|448675307|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
124741084|NCT00576472|448675308|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
124741085|NCT00576472|448675309|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
124741086|NCT00576472|448675310|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
124741087|NCT00576472|448675311|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
124741088|NCT00576472|448675312|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
124741089|NCT00576472|448675313|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
124741090|NCT00576472|448675314|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
124741091|NCT00576472|448675315|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
124741092|NCT00576472|448675316|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
124741093|NCT00576472|448675317|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
124741094|NCT00576472|448675303|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
124741095|NCT00576472|448675304|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
124741096|NCT00576472|448675305|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
124741097|NCT00576472|448675306|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
124741098|NCT00576472|448675307|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
124741099|NCT00576472|448675308|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
124741100|NCT00576472|448675309|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
124741101|NCT00576472|448675310|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
124741102|NCT00576472|448675311|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
124741103|NCT00576472|448675312|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
124741104|NCT00576472|448675313|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
124741105|NCT00576472|448675314|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
124741106|NCT00576472|448675315|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
124741107|NCT00576472|448675316|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
124741108|NCT00576472|448675317|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
124741109|NCT00576472|448675303|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
124741110|NCT00576472|448675304|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
124741111|NCT00576472|448675305|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
124741112|NCT00576472|448675306|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
124741113|NCT00576472|448675307|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
124741114|NCT00576472|448675308|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
124741115|NCT00576472|448675309|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
124741116|NCT00576472|448675310|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
124741117|NCT00576472|448675311|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
124741118|NCT00576472|448675312|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
124741119|NCT00576472|448675313|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
124741120|NCT00576472|448675314|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
124741121|NCT00576472|448675315|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
124741122|NCT00576472|448675316|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
124741123|NCT00576472|448675317|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
124741124|NCT00576472|448675303|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
124741125|NCT00576472|448675304|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
124741126|NCT00576472|448675305|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
124741127|NCT00576472|448675306|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
124741128|NCT00576472|448675307|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
124741129|NCT00576472|448675308|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
124741130|NCT00576472|448675309|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
124741131|NCT00576472|448675310|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
124741132|NCT00576472|448675311|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
124741133|NCT00576472|448675312|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
124741134|NCT00576472|448675313|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
124741135|NCT00576472|448675314|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
124741136|NCT00576472|448675315|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
124741137|NCT00576472|448675316|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
124741138|NCT00576472|448675317|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
124741139|NCT00576472|448675303|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
124741140|NCT00576472|448675304|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
124741141|NCT00576472|448675305|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
124741142|NCT00576472|448675306|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
124741143|NCT00576472|448675307|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
124741144|NCT00576472|448675308|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
124741145|NCT00576472|448675309|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
124741146|NCT00576472|448675310|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
124741147|NCT00576472|448675311|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
124741148|NCT00576472|448675312|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
124741149|NCT00576472|448675313|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
124741150|NCT00576472|448675314|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
124741151|NCT00576472|448675315|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
124741152|NCT00576472|448675316|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
124741153|NCT00576472|448675317|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
124741154|NCT00576472|448675303|FG000|MPH Cross Over Phase|Physician Decision|0|||
124741155|NCT00576472|448675304|FG001|MPH Cross Over Phase|Physician Decision|0|||
124741156|NCT00576472|448675305|FG002|MPH Cross Over Phase|Physician Decision|0|||
124741157|NCT00576472|448675306|FG003|MPH Cross Over Phase|Physician Decision|0|||
124741158|NCT00576472|448675307|FG004|MPH Cross Over Phase|Physician Decision|0|||
124741159|NCT00576472|448675308|FG005|MPH Cross Over Phase|Physician Decision|0|||
124741160|NCT00576472|448675309|FG006|MPH Cross Over Phase|Physician Decision|4|||
124741161|NCT00576472|448675310|FG007|MPH Cross Over Phase|Physician Decision|0|||
124741162|NCT00576472|448675311|FG008|MPH Cross Over Phase|Physician Decision|0|||
124741163|NCT00576472|448675312|FG009|MPH Cross Over Phase|Physician Decision|0|||
124741164|NCT00576472|448675313|FG010|MPH Cross Over Phase|Physician Decision|0|||
124741165|NCT00576472|448675314|FG011|MPH Cross Over Phase|Physician Decision|0|||
124741166|NCT00576472|448675315|FG012|MPH Cross Over Phase|Physician Decision|0|||
124741167|NCT00576472|448675316|FG013|MPH Cross Over Phase|Physician Decision|0|||
124741168|NCT00576472|448675317|FG014|MPH Cross Over Phase|Physician Decision|0|||
124741169|NCT00576472|448675303|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
124741170|NCT00576472|448675304|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
124741171|NCT00576472|448675305|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
124781751|NCT03350672|448831150|FG002|Overall Study|Withdrawal by Subject|0|||
124741172|NCT00576472|448675306|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
124741173|NCT00576472|448675307|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
124741174|NCT00576472|448675308|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
124741175|NCT00576472|448675309|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
124741176|NCT00576472|448675310|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
124741177|NCT00576472|448675311|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
124741178|NCT00576472|448675312|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
124781752|NCT00223080|448831153|FG000|Overall Study|Withdrawal by Subject|253|||
124781753|NCT00223080|448831154|FG001|Overall Study|Withdrawal by Subject|232|||
124741179|NCT00576472|448675313|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
124741180|NCT00576472|448675314|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
124741181|NCT00576472|448675315|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
124741182|NCT00576472|448675316|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
124741183|NCT00576472|448675317|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
124741184|NCT00576472|448675303|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
124741185|NCT00576472|448675304|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
124741186|NCT00576472|448675305|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
124741187|NCT00576472|448675306|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
124741188|NCT00576472|448675307|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
124741189|NCT00576472|448675308|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
124741190|NCT00576472|448675309|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
124741191|NCT00576472|448675310|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
124741192|NCT00576472|448675311|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
124741193|NCT00576472|448675312|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
124741194|NCT00576472|448675313|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
124741195|NCT00576472|448675314|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
124741196|NCT00576472|448675315|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
124741197|NCT00576472|448675316|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
124741198|NCT00576472|448675317|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
124741199|NCT00576472|448675303|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
124741200|NCT00576472|448675304|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
124741201|NCT00576472|448675305|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
124741202|NCT00576472|448675306|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
124741203|NCT00576472|448675307|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
124741204|NCT00576472|448675308|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
124741205|NCT00576472|448675309|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
124741206|NCT00576472|448675310|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
124741207|NCT00576472|448675311|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
124741208|NCT00576472|448675312|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
124741209|NCT00576472|448675313|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
124741210|NCT00576472|448675314|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
124741211|NCT00576472|448675315|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
124741212|NCT00576472|448675316|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
124741213|NCT00576472|448675317|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
124741214|NCT00576472|448675303|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
124741215|NCT00576472|448675304|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
124741216|NCT00576472|448675305|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
124741217|NCT00576472|448675306|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
124741218|NCT00576472|448675307|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
124741219|NCT00576472|448675308|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
124741220|NCT00576472|448675309|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
124741221|NCT00576472|448675310|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
124741222|NCT00576472|448675311|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
124741223|NCT00576472|448675312|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
124741224|NCT00576472|448675313|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
124741225|NCT00576472|448675314|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
124741226|NCT00576472|448675315|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
124741227|NCT00576472|448675316|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
124741228|NCT00576472|448675317|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
124741229|NCT00576472|448675303|FG000|MPH Home Maintenance Phase|Side effects|0|||
124741230|NCT00576472|448675304|FG001|MPH Home Maintenance Phase|Side effects|0|||
124741231|NCT00576472|448675305|FG002|MPH Home Maintenance Phase|Side effects|0|||
124741232|NCT00576472|448675306|FG003|MPH Home Maintenance Phase|Side effects|0|||
124741233|NCT00576472|448675307|FG004|MPH Home Maintenance Phase|Side effects|0|||
124741234|NCT00576472|448675308|FG005|MPH Home Maintenance Phase|Side effects|0|||
124741235|NCT00576472|448675309|FG006|MPH Home Maintenance Phase|Side effects|0|||
124741236|NCT00576472|448675310|FG007|MPH Home Maintenance Phase|Side effects|0|||
124741237|NCT00576472|448675311|FG008|MPH Home Maintenance Phase|Side effects|0|||
124741238|NCT00576472|448675312|FG009|MPH Home Maintenance Phase|Side effects|0|||
124741239|NCT00576472|448675313|FG010|MPH Home Maintenance Phase|Side effects|0|||
124741240|NCT00576472|448675314|FG011|MPH Home Maintenance Phase|Side effects|0|||
124741241|NCT00576472|448675315|FG012|MPH Home Maintenance Phase|Side effects|0|||
124741242|NCT00576472|448675316|FG013|MPH Home Maintenance Phase|Side effects|0|||
124741243|NCT00576472|448675317|FG014|MPH Home Maintenance Phase|Side effects|8|||
124741244|NCT00576472|448675303|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124741245|NCT00576472|448675304|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124781754|NCT00223080|448831153|FG000|Overall Study|Required contraindicated med|0|||
124613809|NCT01473524|448205548|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
124781755|NCT00223080|448831154|FG001|Overall Study|Required contraindicated med|1|||
124741246|NCT00576472|448675305|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124741247|NCT00576472|448675306|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124741248|NCT00576472|448675307|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124741249|NCT00576472|448675308|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124741250|NCT00576472|448675309|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124741251|NCT00576472|448675310|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124741252|NCT00576472|448675311|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124741253|NCT00576472|448675312|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124741254|NCT00576472|448675313|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124741255|NCT00576472|448675314|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124741256|NCT00576472|448675315|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124741257|NCT00576472|448675316|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
124741258|NCT00576472|448675317|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
124741259|NCT00576472|448675303|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
124741260|NCT00576472|448675304|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
124741261|NCT00576472|448675305|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
124741262|NCT00576472|448675306|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
124741263|NCT00576472|448675307|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
124741264|NCT00576472|448675308|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
124741265|NCT00576472|448675309|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
124741266|NCT00576472|448675310|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
124741267|NCT00576472|448675311|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
124741268|NCT00576472|448675312|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
124741269|NCT00576472|448675313|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
124741270|NCT00576472|448675314|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
124741271|NCT00576472|448675315|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
124741272|NCT00576472|448675316|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
124741273|NCT00576472|448675317|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
124741274|NCT00576472|448675303|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
124741275|NCT00576472|448675304|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
124741276|NCT00576472|448675305|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
124741277|NCT00576472|448675306|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
124741278|NCT00576472|448675307|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
124613810|NCT01473524|448205549|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
124613811|NCT01473524|448205550|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
124613812|NCT01473524|448205551|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
124613813|NCT01473524|448205546|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
124613814|NCT01473524|448205547|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
124613815|NCT01473524|448205548|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
124613816|NCT01473524|448205549|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
124613817|NCT01473524|448205550|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
124613818|NCT01473524|448205551|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
124613819|NCT01473524|448205546|FG000|LTSE Phase|Lost to Follow-up|0|||
124613820|NCT01473524|448205547|FG001|LTSE Phase|Lost to Follow-up|0|||
124613821|NCT01473524|448205548|FG002|LTSE Phase|Lost to Follow-up|0|||
124613822|NCT01473524|448205549|FG003|LTSE Phase|Lost to Follow-up|1|||
124613823|NCT01473524|448205550|FG004|LTSE Phase|Lost to Follow-up|3|||
124613824|NCT01473524|448205551|FG005|LTSE Phase|Lost to Follow-up|2|||
124613825|NCT01473524|448205546|FG000|LTSE Phase|Principal Investigator Decision|0|||
124613826|NCT01473524|448205547|FG001|LTSE Phase|Principal Investigator Decision|0|||
124613827|NCT01473524|448205548|FG002|LTSE Phase|Principal Investigator Decision|0|||
124613828|NCT01473524|448205549|FG003|LTSE Phase|Principal Investigator Decision|1|||
124613829|NCT01473524|448205550|FG004|LTSE Phase|Principal Investigator Decision|1|||
124613830|NCT01473524|448205551|FG005|LTSE Phase|Principal Investigator Decision|3|||
124613831|NCT01473524|448205546|FG000|LTSE Phase|Liver Transplantation|0|||
124613832|NCT01473524|448205547|FG001|LTSE Phase|Liver Transplantation|0|||
124613833|NCT01473524|448205548|FG002|LTSE Phase|Liver Transplantation|0|||
124613834|NCT01473524|448205549|FG003|LTSE Phase|Liver Transplantation|0|||
124613835|NCT01473524|448205550|FG004|LTSE Phase|Liver Transplantation|0|||
124613836|NCT01473524|448205551|FG005|LTSE Phase|Liver Transplantation|1|||
124613837|NCT01473524|448205546|FG000|LTSE Phase|Pregnancy|0|||
124613838|NCT01473524|448205547|FG001|LTSE Phase|Pregnancy|0|||
124613839|NCT01473524|448205548|FG002|LTSE Phase|Pregnancy|0|||
124613840|NCT01473524|448205549|FG003|LTSE Phase|Pregnancy|1|||
124613841|NCT01473524|448205550|FG004|LTSE Phase|Pregnancy|0|||
124613842|NCT01473524|448205551|FG005|LTSE Phase|Pregnancy|0|||
124613843|NCT01473524|448205546|FG000|LTSE Phase|Protocol Violation|0|||
124613844|NCT01473524|448205547|FG001|LTSE Phase|Protocol Violation|0|||
124613845|NCT01473524|448205548|FG002|LTSE Phase|Protocol Violation|0|||
124613846|NCT01473524|448205549|FG003|LTSE Phase|Protocol Violation|0|||
124613847|NCT01473524|448205550|FG004|LTSE Phase|Protocol Violation|0|||
124613848|NCT01473524|448205551|FG005|LTSE Phase|Protocol Violation|1|||
124613849|NCT01544179|448205552|FG000|Overall Study|Death|50|||
124613850|NCT01544179|448205553|FG001|Overall Study|Death|37|||
124613851|NCT01544179|448205552|FG000|Overall Study|Lost to Follow-up|0|||
124613852|NCT01544179|448205553|FG001|Overall Study|Lost to Follow-up|1|||
124613853|NCT01544179|448205552|FG000|Overall Study|Adverse Event|0|||
124613854|NCT01544179|448205553|FG001|Overall Study|Adverse Event|1|||
124613855|NCT01544179|448205552|FG000|Overall Study|Withdrawal by Subject|12|||
124613856|NCT01544179|448205553|FG001|Overall Study|Withdrawal by Subject|7|||
124613857|NCT01544179|448205552|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
124741279|NCT00576472|448675308|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
124741280|NCT00576472|448675309|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
124741281|NCT00576472|448675310|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
124741282|NCT00576472|448675311|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
124741283|NCT00576472|448675312|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
124741284|NCT00576472|448675313|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
124741285|NCT00576472|448675314|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
124741286|NCT00576472|448675315|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
124741287|NCT00576472|448675316|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
124741288|NCT00576472|448675317|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
124741289|NCT01504204|448675330|FG000|Overall Study|Lost to Follow-up|1|||
124741290|NCT01504204|448675331|FG001|Overall Study|Lost to Follow-up|1|||
124741291|NCT00903331|448675332|FG000|Overall Study|Death|4|||
124741292|NCT00903331|448675333|FG001|Overall Study|Death|8|||
124741293|NCT00903331|448675332|FG000|Overall Study|Withdrawal of consent|1|||
124741294|NCT00903331|448675333|FG001|Overall Study|Withdrawal of consent|8|||
124741295|NCT00903331|448675332|FG000|Overall Study|Lung transplant|0|||
124741296|NCT00903331|448675333|FG001|Overall Study|Lung transplant|2|||
124741297|NCT02723175|448675334|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
124741298|NCT02723175|448675335|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
124741299|NCT02723175|448675334|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
124741300|NCT02723175|448675335|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
124741301|NCT00257660|448675338|FG000|Overall Study|Lack of Efficacy|5|||
124741302|NCT00257660|448675339|FG001|Overall Study|Lack of Efficacy|23|||
124741303|NCT00257660|448675338|FG000|Overall Study|Withdrawal by Subject|2|||
124741304|NCT00257660|448675339|FG001|Overall Study|Withdrawal by Subject|0|||
124741305|NCT00257660|448675338|FG000|Overall Study|Lost to Follow-up|1|||
124741306|NCT00257660|448675339|FG001|Overall Study|Lost to Follow-up|0|||
124741307|NCT00257660|448675338|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
124741308|NCT00257660|448675339|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
124741309|NCT00257660|448675338|FG000|Overall Study|No longer wanted to do blood draws|1|||
124741310|NCT00257660|448675339|FG001|Overall Study|No longer wanted to do blood draws|0|||
124741311|NCT04109976|448675340|FG000|Overall Study|Withdrawal by Subject|1|||
124741312|NCT04109976|448675341|FG001|Overall Study|Withdrawal by Subject|0|||
124741313|NCT03691779|448675347|FG000|Part B (24 Weeks)|Adverse Event|0|||
124741314|NCT03691779|448675348|FG001|Part B (24 Weeks)|Adverse Event|1|||
124741315|NCT03691779|448675347|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
124741316|NCT03691779|448675348|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
124741317|NCT00267150|448675349|FG000|Overall Study|Adverse Event|1|||
124741318|NCT00521222|448675351|FG000|Overall Study|Lost to Follow-up|0|||
124741319|NCT00521222|448675352|FG001|Overall Study|Lost to Follow-up|0|||
124741320|NCT00521222|448675353|FG002|Overall Study|Lost to Follow-up|1|||
124741321|NCT00521222|448675354|FG003|Overall Study|Lost to Follow-up|1|||
124741322|NCT00521222|448675351|FG000|Overall Study|Withdrawal by Subject|0|||
124741323|NCT00521222|448675352|FG001|Overall Study|Withdrawal by Subject|0|||
124741324|NCT00521222|448675353|FG002|Overall Study|Withdrawal by Subject|2|||
124741325|NCT00521222|448675354|FG003|Overall Study|Withdrawal by Subject|0|||
124741326|NCT00521222|448675351|FG000|Overall Study|Physician Decision|0|||
124741327|NCT00521222|448675352|FG001|Overall Study|Physician Decision|1|||
124741328|NCT00521222|448675353|FG002|Overall Study|Physician Decision|0|||
124741329|NCT00521222|448675354|FG003|Overall Study|Physician Decision|1|||
124741330|NCT03332160|448675357|FG000|Overall Study|Withdrawal by Subject|1|||
124741331|NCT03332160|448675358|FG001|Overall Study|Withdrawal by Subject|1|||
124741332|NCT03332160|448675357|FG000|Overall Study|Adverse Event|0|||
124741333|NCT03332160|448675358|FG001|Overall Study|Adverse Event|1|||
124741334|NCT03332160|448675357|FG000|Overall Study|Developed Exclusion Criteria|0|||
124741335|NCT03332160|448675358|FG001|Overall Study|Developed Exclusion Criteria|1|||
124741336|NCT03332160|448675357|FG000|Overall Study|Non-adherence to treatment|0|||
124741337|NCT03332160|448675358|FG001|Overall Study|Non-adherence to treatment|2|||
124741338|NCT01561963|448675359|FG000|Overall Study|Adverse Event|1|||
124741339|NCT04208087|448675362|FG000|Overall Study|Adverse Event|1|||
124741340|NCT04208087|448675363|FG001|Overall Study|Adverse Event|0|||
124741341|NCT04208087|448675364|FG002|Overall Study|Adverse Event|0|||
124741342|NCT04208087|448675365|FG003|Overall Study|Adverse Event|0|||
124741343|NCT04208087|448675366|FG004|Overall Study|Adverse Event|0|||
124741344|NCT04208087|448675362|FG000|Overall Study|Withdrawal by Subject|0|||
124741345|NCT04208087|448675363|FG001|Overall Study|Withdrawal by Subject|0|||
124741346|NCT04208087|448675364|FG002|Overall Study|Withdrawal by Subject|1|||
124741347|NCT04208087|448675365|FG003|Overall Study|Withdrawal by Subject|0|||
124741348|NCT04208087|448675366|FG004|Overall Study|Withdrawal by Subject|0|||
124781756|NCT00223080|448831153|FG000|Overall Study|Non-compliant|7|||
124741349|NCT04208087|448675362|FG000|Overall Study|Other|0|||
124741350|NCT04208087|448675363|FG001|Overall Study|Other|0|||
124741351|NCT04208087|448675364|FG002|Overall Study|Other|0|||
124741352|NCT04208087|448675365|FG003|Overall Study|Other|0|||
124741353|NCT04208087|448675366|FG004|Overall Study|Other|1|||
124741354|NCT01977690|448675367|FG000|Overall Study|Withdrawal by Subject|0|||
124741355|NCT01977690|448675368|FG001|Overall Study|Withdrawal by Subject|4|||
124741356|NCT00952614|448675369|FG000|Overall Study|Death|3|||
124741357|NCT00952614|448675369|FG000|Overall Study|Lost to Follow-up|3|||
124741358|NCT00952614|448675369|FG000|Overall Study|other reason|1|||
124741359|NCT04023682|448675370|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
124741360|NCT00637572|448675372|FG000|Overall Study|Adverse Event|1|||
124741361|NCT00637572|448675373|FG001|Overall Study|Adverse Event|2|||
124741362|NCT00637572|448675372|FG000|Overall Study|Death|0|||
124741363|NCT00637572|448675373|FG001|Overall Study|Death|1|||
124741364|NCT00637572|448675372|FG000|Overall Study|Lost to Follow-up|0|||
124741365|NCT00637572|448675373|FG001|Overall Study|Lost to Follow-up|1|||
124741366|NCT00637572|448675372|FG000|Overall Study|Physician Decision|1|||
124741367|NCT00637572|448675373|FG001|Overall Study|Physician Decision|1|||
124741368|NCT00637572|448675372|FG000|Overall Study|Withdrawal by Subject|0|||
124741369|NCT00637572|448675373|FG001|Overall Study|Withdrawal by Subject|2|||
124741370|NCT00637572|448675372|FG000|Overall Study|Illicit Drug Use|1|||
124741371|NCT00637572|448675373|FG001|Overall Study|Illicit Drug Use|0|||
124741372|NCT04268745|448675381|FG000|Overall Study|Lost to Follow-up|2|||
124741373|NCT04268745|448675382|FG001|Overall Study|Lost to Follow-up|3|||
124741374|NCT04268745|448675381|FG000|Overall Study|Withdrawal by Subject|4|||
124741375|NCT04268745|448675382|FG001|Overall Study|Withdrawal by Subject|2|||
124741376|NCT04268745|448675381|FG000|Overall Study|Death in the family|1|||
124741377|NCT04268745|448675382|FG001|Overall Study|Death in the family|0|||
124741378|NCT01286077|448676985|FG000|Overall Study|Adverse Event|2|||
124741379|NCT01286077|448676986|FG001|Overall Study|Adverse Event|0|||
124741380|NCT01286077|448676985|FG000|Overall Study|Death|1|||
124741381|NCT01286077|448676986|FG001|Overall Study|Death|0|||
124741382|NCT01286077|448676985|FG000|Overall Study|Protocol Violation|1|||
124741383|NCT01286077|448676986|FG001|Overall Study|Protocol Violation|1|||
124741384|NCT01286077|448676985|FG000|Overall Study|Withdrawal by Subject|0|||
124741385|NCT01286077|448676986|FG001|Overall Study|Withdrawal by Subject|2|||
124741386|NCT01286077|448676985|FG000|Overall Study|Intercurrent illness|1|||
124741387|NCT01286077|448676986|FG001|Overall Study|Intercurrent illness|0|||
124741388|NCT01286077|448676985|FG000|Overall Study|Non-compliance|1|||
124741389|NCT01286077|448676986|FG001|Overall Study|Non-compliance|0|||
124741390|NCT01286077|448676985|FG000|Overall Study|The subject starts with alternative MMY|0|||
124741391|NCT01286077|448676986|FG001|Overall Study|The subject starts with alternative MMY|3|||
124741392|NCT01286077|448676985|FG000|Overall Study|Patient's decision to stop treatment|3|||
124741393|NCT01286077|448676986|FG001|Overall Study|Patient's decision to stop treatment|0|||
124741394|NCT01286077|448676985|FG000|Overall Study|Progression of disease|0|||
124741395|NCT01286077|448676986|FG001|Overall Study|Progression of disease|1|||
124741396|NCT01286077|448676985|FG000|Overall Study|refill medication not received in time|1|||
124741397|NCT01286077|448676986|FG001|Overall Study|refill medication not received in time|0|||
124741398|NCT01918332|448676987|FG000|Overall Study|Adverse Event|0|||
124741399|NCT01918332|448676988|FG001|Overall Study|Adverse Event|0|||
124741400|NCT01918332|448676989|FG002|Overall Study|Adverse Event|0|||
124741401|NCT01918332|448676990|FG003|Overall Study|Adverse Event|1|||
124741402|NCT01918332|448676987|FG000|Overall Study|Withdrawal by Subject|2|||
124741403|NCT01918332|448676988|FG001|Overall Study|Withdrawal by Subject|3|||
124741404|NCT01918332|448676989|FG002|Overall Study|Withdrawal by Subject|2|||
124741405|NCT01918332|448676990|FG003|Overall Study|Withdrawal by Subject|3|||
124741406|NCT01918332|448676987|FG000|Overall Study|Protocol Violation|6|||
124741407|NCT01918332|448676988|FG001|Overall Study|Protocol Violation|2|||
124741408|NCT01918332|448676989|FG002|Overall Study|Protocol Violation|6|||
124741409|NCT01918332|448676990|FG003|Overall Study|Protocol Violation|3|||
124741410|NCT01918332|448676987|FG000|Overall Study|lipid result by central lab did not meet|0|||
124741411|NCT01918332|448676988|FG001|Overall Study|lipid result by central lab did not meet|0|||
124741412|NCT01918332|448676989|FG002|Overall Study|lipid result by central lab did not meet|1|||
124741413|NCT01918332|448676990|FG003|Overall Study|lipid result by central lab did not meet|0|||
124741414|NCT02408523|448676991|FG000|Overall Study|Adverse Event|4|||
124741415|NCT02408523|448676992|FG001|Overall Study|Adverse Event|10|||
124741416|NCT02408523|448676991|FG000|Overall Study|Lack of Efficacy|0|||
124741417|NCT02408523|448676992|FG001|Overall Study|Lack of Efficacy|1|||
124741418|NCT02408523|448676991|FG000|Overall Study|Protocol Violation|1|||
124781757|NCT00223080|448831154|FG001|Overall Study|Non-compliant|7|||
124781758|NCT00223080|448831153|FG000|Overall Study|Moved from study area|37|||
124613858|NCT01544179|448205553|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124613859|NCT00282919|448205556|FG000|Overall Study|Lack of Efficacy|4|||
124741419|NCT02408523|448676992|FG001|Overall Study|Protocol Violation|2|||
124741420|NCT02408523|448676991|FG000|Overall Study|Lost to Follow-up|2|||
124741421|NCT02408523|448676992|FG001|Overall Study|Lost to Follow-up|3|||
124741422|NCT02408523|448676991|FG000|Overall Study|Withdrawal by Subject|3|||
124741423|NCT02408523|448676992|FG001|Overall Study|Withdrawal by Subject|1|||
124741424|NCT02408523|448676991|FG000|Overall Study|Sponsor request|1|||
124741425|NCT02408523|448676992|FG001|Overall Study|Sponsor request|0|||
124741426|NCT02408523|448676991|FG000|Overall Study|Did not satisfy extension conditions|0|||
124741427|NCT02408523|448676992|FG001|Overall Study|Did not satisfy extension conditions|1|||
124613860|NCT00282919|448205556|FG000|Overall Study|Withdrawal by Subject|1|||
124613861|NCT00282919|448205556|FG000|Overall Study|Asymptomatic Parasitemia|2|||
124613862|NCT01438996|448205557|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
124613863|NCT01438996|448205558|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
124613864|NCT01438996|448205559|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
124613865|NCT02540850|448205560|FG000|Overall Study|Lost to Follow-up|69|||
124613866|NCT02540850|448205561|FG001|Overall Study|Lost to Follow-up|66|||
124613867|NCT02540850|448205562|FG002|Overall Study|Lost to Follow-up|34|||
124613868|NCT02861014|448205563|FG000|Primary Analysis|Adverse Event|7|||
124613869|NCT02861014|448205563|FG000|Primary Analysis|Death|1|||
124613870|NCT02861014|448205563|FG000|Primary Analysis|Lack of Efficacy|3|||
124613871|NCT02861014|448205563|FG000|Primary Analysis|Physician Decision|2|||
124613872|NCT02861014|448205563|FG000|Primary Analysis|Pregnancy|4|||
124613873|NCT02861014|448205563|FG000|Primary Analysis|Protocol Violation|2|||
124613874|NCT02861014|448205563|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
124613875|NCT02861014|448205563|FG000|Primary Analysis|Withdrawal by Subject|14|||
124613876|NCT02861014|448205563|FG000|Primary Analysis|Commercial ocrelizumab|3|||
124613877|NCT02861014|448205563|FG000|Safety Follow-up|Adverse Event|1|||
124613878|NCT02861014|448205563|FG000|Safety Follow-up|Pregnancy|1|||
124613879|NCT02861014|448205563|FG000|Safety Follow-up|Withdrawal by Subject|9|||
124613880|NCT02861014|448205563|FG000|Safety Follow-up|Study terminated by sponsor|1|||
124613881|NCT02861014|448205563|FG000|Safety Follow-up|Physician Decision|1|||
124613882|NCT02861014|448205563|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
124613883|NCT02861014|448205563|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
124613884|NCT01756079|448205569|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
124613885|NCT01756079|448205569|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
124613886|NCT01756079|448205569|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
124613887|NCT01756079|448205569|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
124613888|NCT01756079|448205569|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
124613889|NCT02794246|448205570|FG000|Overall Study|Withdrawal by Subject|2|||
124613890|NCT02794246|448205570|FG000|Overall Study|Physician Decision|4|||
124613891|NCT01994291|448205571|FG000|Overall Study|Adverse Event|4|||
124613892|NCT01994291|448205572|FG001|Overall Study|Adverse Event|1|||
124613893|NCT01994291|448205573|FG002|Overall Study|Adverse Event|3|||
124613894|NCT01994291|448205571|FG000|Overall Study|Lost to Follow-up|1|||
124613895|NCT01994291|448205572|FG001|Overall Study|Lost to Follow-up|1|||
124613896|NCT01994291|448205573|FG002|Overall Study|Lost to Follow-up|0|||
124613897|NCT01994291|448205571|FG000|Overall Study|Does not meet entrance criteria|1|||
124613898|NCT01994291|448205572|FG001|Overall Study|Does not meet entrance criteria|0|||
124613899|NCT01994291|448205573|FG002|Overall Study|Does not meet entrance criteria|0|||
124613900|NCT01994291|448205571|FG000|Overall Study|Medication error without associated AE|1|||
124613901|NCT01994291|448205572|FG001|Overall Study|Medication error without associated AE|0|||
124613902|NCT01994291|448205573|FG002|Overall Study|Medication error without associated AE|1|||
124613903|NCT01994291|448205571|FG000|Overall Study|Protocol Violation|1|||
124613904|NCT01994291|448205572|FG001|Overall Study|Protocol Violation|0|||
124613905|NCT01994291|448205573|FG002|Overall Study|Protocol Violation|0|||
124613906|NCT01994291|448205571|FG000|Overall Study|Withdrawal by Subject|6|||
124613907|NCT01994291|448205572|FG001|Overall Study|Withdrawal by Subject|3|||
124613908|NCT01994291|448205573|FG002|Overall Study|Withdrawal by Subject|5|||
124613909|NCT01994291|448205571|FG000|Overall Study|Other|1|||
124613910|NCT01994291|448205572|FG001|Overall Study|Other|2|||
124613911|NCT01994291|448205573|FG002|Overall Study|Other|0|||
124613912|NCT00856375|448205576|FG000|Overall Study|Other|0|||
124613913|NCT00856375|448205577|FG001|Overall Study|Other|1|||
124613914|NCT00856375|448205576|FG000|Overall Study|Death|32|||
124613915|NCT00856375|448205577|FG001|Overall Study|Death|30|||
124613916|NCT00856375|448205576|FG000|Overall Study|Sponsor Terminated Study|7|||
124613917|NCT00856375|448205577|FG001|Overall Study|Sponsor Terminated Study|7|||
124613918|NCT00856375|448205576|FG000|Overall Study|Withdrawal by Subject|2|||
124613919|NCT00856375|448205577|FG001|Overall Study|Withdrawal by Subject|1|||
124613920|NCT00856375|448205576|FG000|Overall Study|Lost to Follow-up|1|||
124613921|NCT00856375|448205577|FG001|Overall Study|Lost to Follow-up|2|||
124613922|NCT03201445|448205584|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
124613923|NCT03201445|448205585|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
124613924|NCT03201445|448205584|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
124613925|NCT03201445|448205585|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
124613926|NCT03201445|448205584|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
124613927|NCT03201445|448205585|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
124613928|NCT03201445|448205584|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
124613929|NCT03201445|448205585|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
124613930|NCT03201445|448205584|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
124613931|NCT03201445|448205585|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
124613932|NCT03201445|448205584|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
124613933|NCT03201445|448205585|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
124741428|NCT01751139|448676993|FG000|Overall Study|Other|135|||
124741429|NCT01751139|448676993|FG000|Overall Study|Sponsor study termination|1609|||
124741430|NCT01751139|448676993|FG000|Overall Study|Lost to Follow-up|240|||
124741431|NCT01751139|448676993|FG000|Overall Study|Withdrawal by Subject|251|||
124741432|NCT01751139|448676993|FG000|Overall Study|Adverse Event|1|||
124741433|NCT01751139|448676993|FG000|Overall Study|Death|31|||
124741434|NCT01867086|448676994|FG000|Overall Study|Disease Progression|1|||
124741435|NCT04279613|448676995|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
124741436|NCT04279613|448676996|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
124741437|NCT04279613|448676997|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
124741438|NCT04279613|448676998|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
124741439|NCT04279613|448676999|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
124741440|NCT04279613|448676995|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
124741441|NCT04279613|448676996|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
124741442|NCT04279613|448676997|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
124741443|NCT04279613|448676998|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
124741444|NCT04279613|448676999|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
124741445|NCT04279613|448676995|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
124741446|NCT04279613|448676996|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
124741447|NCT04279613|448676997|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
124741448|NCT04279613|448676998|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
124741449|NCT04279613|448676999|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
124741450|NCT04279613|448676995|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
124741451|NCT04279613|448676996|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
124741452|NCT04279613|448676997|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
124741453|NCT04279613|448676998|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
124741454|NCT04279613|448676999|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
124741455|NCT04279613|448676995|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
124741456|NCT04279613|448676996|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
124741457|NCT04279613|448676997|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
124741458|NCT04279613|448676998|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
124741459|NCT04279613|448676999|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
124741460|NCT04428151|448677000|FG000|Overall Study|Death|100|||
124741461|NCT04428151|448677001|FG001|Overall Study|Death|86|||
124741462|NCT04428151|448677002|FG002|Overall Study|Death|57|||
124741463|NCT04428151|448677000|FG000|Overall Study|Lost to Follow-up|1|||
124741464|NCT04428151|448677001|FG001|Overall Study|Lost to Follow-up|1|||
124741465|NCT04428151|448677002|FG002|Overall Study|Lost to Follow-up|0|||
124741466|NCT04428151|448677000|FG000|Overall Study|Withdrawal by Subject|2|||
124741467|NCT04428151|448677001|FG001|Overall Study|Withdrawal by Subject|2|||
124741468|NCT04428151|448677002|FG002|Overall Study|Withdrawal by Subject|3|||
124741469|NCT04428151|448677000|FG000|Overall Study|Participant Ongoing in Study|41|||
124741470|NCT04428151|448677001|FG001|Overall Study|Participant Ongoing in Study|53|||
124741471|NCT04428151|448677002|FG002|Overall Study|Participant Ongoing in Study|28|||
124741472|NCT02704689|448677003|FG000|Overall Study|Physician Decision|1|||
124741473|NCT02704689|448677003|FG000|Overall Study|Study device not implanted|2|||
124741474|NCT02212678|448677006|FG000|Overall Study|Adverse Event|1|||
124741475|NCT02337634|448677007|FG000|Overall Study|Protocol Violation|3|||
124741476|NCT02337634|448677008|FG001|Overall Study|Protocol Violation|1|||
124741477|NCT02337634|448677007|FG000|Overall Study|Lost to Follow-up|1|||
124741478|NCT02337634|448677008|FG001|Overall Study|Lost to Follow-up|0|||
124741479|NCT04068610|448677009|FG000|Overall Study|Death|4|||
124741480|NCT04068610|448677010|FG001|Overall Study|Death|8|||
124741481|NCT04068610|448677011|FG002|Overall Study|Death|13|||
124741482|NCT04068610|448677009|FG000|Overall Study|Lost to Follow-up|0|||
124741483|NCT04068610|448677010|FG001|Overall Study|Lost to Follow-up|2|||
124741484|NCT04068610|448677011|FG002|Overall Study|Lost to Follow-up|0|||
124741485|NCT04068610|448677009|FG000|Overall Study|Withdrawal by Subject|0|||
124741486|NCT04068610|448677010|FG001|Overall Study|Withdrawal by Subject|4|||
124741487|NCT04068610|448677011|FG002|Overall Study|Withdrawal by Subject|2|||
124741488|NCT04068610|448677009|FG000|Overall Study|Other|3|||
124741489|NCT04068610|448677010|FG001|Overall Study|Other|12|||
124741490|NCT04068610|448677011|FG002|Overall Study|Other|11|||
124613934|NCT03201445|448205584|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
124741491|NCT02428205|448677012|FG000|Overall Study|Lack of Efficacy|1|||
124741492|NCT02428205|448677013|FG001|Overall Study|Lack of Efficacy|0|||
124741493|NCT02428205|448677012|FG000|Overall Study|Lost to Follow-up|1|||
124741494|NCT02428205|448677013|FG001|Overall Study|Lost to Follow-up|1|||
124741495|NCT02428205|448677012|FG000|Overall Study|Worse behavior|0|||
124741496|NCT02428205|448677013|FG001|Overall Study|Worse behavior|1|||
124741497|NCT00527319|448677014|FG000|Overall Study|Withdrawal by Subject|5|||
124741498|NCT00527319|448677015|FG001|Overall Study|Withdrawal by Subject|0|||
124741499|NCT00527319|448677016|FG002|Overall Study|Withdrawal by Subject|1|||
124741500|NCT00527319|448677014|FG000|Overall Study|Lost to Follow-up|1|||
124613935|NCT03201445|448205585|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
124741501|NCT00527319|448677015|FG001|Overall Study|Lost to Follow-up|0|||
124741502|NCT00527319|448677016|FG002|Overall Study|Lost to Follow-up|0|||
124741503|NCT00527319|448677014|FG000|Overall Study|Death|0|||
124741504|NCT00527319|448677015|FG001|Overall Study|Death|3|||
124741505|NCT00527319|448677016|FG002|Overall Study|Death|1|||
124741506|NCT00527319|448677014|FG000|Overall Study|Intercurrent Medical Illness|0|||
124741507|NCT00527319|448677015|FG001|Overall Study|Intercurrent Medical Illness|1|||
124741508|NCT00527319|448677016|FG002|Overall Study|Intercurrent Medical Illness|3|||
124741509|NCT00527319|448677014|FG000|Overall Study|Adverse Event|0|||
124741510|NCT00527319|448677015|FG001|Overall Study|Adverse Event|0|||
124741511|NCT00527319|448677016|FG002|Overall Study|Adverse Event|1|||
124741512|NCT02066415|448677017|FG000|Overall Study|Decision by Sponsor|5|||
124741513|NCT02066415|448677018|FG001|Overall Study|Decision by Sponsor|4|||
124741514|NCT02066415|448677019|FG002|Overall Study|Decision by Sponsor|2|||
124741515|NCT02066415|448677017|FG000|Overall Study|Withdrawal by Subject|9|||
124741516|NCT02066415|448677018|FG001|Overall Study|Withdrawal by Subject|1|||
124741517|NCT02066415|448677019|FG002|Overall Study|Withdrawal by Subject|4|||
124741518|NCT02066415|448677017|FG000|Overall Study|Lost to Follow-up|7|||
124741519|NCT02066415|448677018|FG001|Overall Study|Lost to Follow-up|2|||
124741520|NCT02066415|448677019|FG002|Overall Study|Lost to Follow-up|2|||
124741521|NCT00430937|448677020|FG000|Overall Study|Adverse Event|3|||
124741522|NCT00430937|448677021|FG001|Overall Study|Adverse Event|8|||
124741523|NCT00430937|448677020|FG000|Overall Study|Death|0|||
124741524|NCT00430937|448677021|FG001|Overall Study|Death|1|||
124741525|NCT00430937|448677020|FG000|Overall Study|Lost to Follow-up|6|||
124741526|NCT00430937|448677021|FG001|Overall Study|Lost to Follow-up|6|||
124741527|NCT00430937|448677020|FG000|Overall Study|Withdrawal by Subject|5|||
124741528|NCT00430937|448677021|FG001|Overall Study|Withdrawal by Subject|2|||
124741529|NCT00430937|448677020|FG000|Overall Study|Protocol Violation|3|||
124741530|NCT00430937|448677021|FG001|Overall Study|Protocol Violation|2|||
124741531|NCT00430937|448677020|FG000|Overall Study|Lack of Efficacy|6|||
124741532|NCT00430937|448677021|FG001|Overall Study|Lack of Efficacy|5|||
124741533|NCT00430937|448677020|FG000|Overall Study|Inappropriate enrollment|2|||
124741534|NCT00430937|448677021|FG001|Overall Study|Inappropriate enrollment|1|||
124741535|NCT00430937|448677020|FG000|Overall Study|Administrative reasons|1|||
124741536|NCT00430937|448677021|FG001|Overall Study|Administrative reasons|0|||
124741537|NCT00430937|448677020|FG000|Overall Study|Protocol discontinuation criteria met|1|||
124741538|NCT00430937|448677021|FG001|Overall Study|Protocol discontinuation criteria met|2|||
124741539|NCT00430937|448677020|FG000|Overall Study|Unable to classify|0|||
124741540|NCT00430937|448677021|FG001|Overall Study|Unable to classify|1|||
124741541|NCT03242252|448677023|FG000|Overall Study|At the Participant's own Request|18|||
124741542|NCT03242252|448677024|FG001|Overall Study|At the Participant's own Request|10|||
124741543|NCT03242252|448677025|FG002|Overall Study|At the Participant's own Request|15|||
124741544|NCT03242252|448677023|FG000|Overall Study|Adverse Event|8|||
124741545|NCT03242252|448677024|FG001|Overall Study|Adverse Event|6|||
124741546|NCT03242252|448677025|FG002|Overall Study|Adverse Event|9|||
124741547|NCT03242252|448677023|FG000|Overall Study|Poor Compliance to Protocol|0|||
124741548|NCT03242252|448677024|FG001|Overall Study|Poor Compliance to Protocol|2|||
124741549|NCT03242252|448677025|FG002|Overall Study|Poor Compliance to Protocol|3|||
124741550|NCT03242252|448677023|FG000|Overall Study|Study Terminated by Sponsor|1|||
124741551|NCT03242252|448677024|FG001|Overall Study|Study Terminated by Sponsor|0|||
124741552|NCT03242252|448677025|FG002|Overall Study|Study Terminated by Sponsor|0|||
124741553|NCT03242252|448677023|FG000|Overall Study|Reason not Specified|4|||
124741554|NCT03242252|448677024|FG001|Overall Study|Reason not Specified|4|||
124741555|NCT03242252|448677025|FG002|Overall Study|Reason not Specified|1|||
124741556|NCT03242252|448677023|FG000|Overall Study|Lost to Follow-up|5|||
124741557|NCT03242252|448677024|FG001|Overall Study|Lost to Follow-up|1|||
124741558|NCT03242252|448677025|FG002|Overall Study|Lost to Follow-up|4|||
124741559|NCT01659255|448677026|FG000|Overall Study|Adverse Event|0|||
124741560|NCT01659255|448677027|FG001|Overall Study|Adverse Event|0|||
124741561|NCT01659255|448677028|FG002|Overall Study|Adverse Event|0|||
124741562|NCT01659255|448677029|FG003|Overall Study|Adverse Event|0|||
124741563|NCT01659255|448677030|FG004|Overall Study|Adverse Event|0|||
124741564|NCT01659255|448677031|FG005|Overall Study|Adverse Event|1|||
124741565|NCT01659255|448677032|FG006|Overall Study|Adverse Event|1|||
124741566|NCT01659255|448677033|FG007|Overall Study|Adverse Event|0|||
124741567|NCT01659255|448677034|FG008|Overall Study|Adverse Event|0|||
124741568|NCT01659255|448677035|FG009|Overall Study|Adverse Event|1|||
124741569|NCT01659255|448677036|FG010|Overall Study|Adverse Event|0|||
124741570|NCT01659255|448677037|FG011|Overall Study|Adverse Event|1|||
124741571|NCT01659255|448677038|FG012|Overall Study|Adverse Event|0|||
124741572|NCT01659255|448677039|FG013|Overall Study|Adverse Event|2|||
124741573|NCT01659255|448677040|FG014|Overall Study|Adverse Event|0|||
124741574|NCT01659255|448677041|FG015|Overall Study|Adverse Event|1|||
124741575|NCT01659255|448677042|FG016|Overall Study|Adverse Event|0|||
124741576|NCT01659255|448677026|FG000|Overall Study|Death|0|||
124741577|NCT01659255|448677027|FG001|Overall Study|Death|1|||
124741578|NCT01659255|448677028|FG002|Overall Study|Death|0|||
124741579|NCT01659255|448677029|FG003|Overall Study|Death|0|||
124741580|NCT01659255|448677030|FG004|Overall Study|Death|0|||
124741581|NCT01659255|448677031|FG005|Overall Study|Death|0|||
124741582|NCT01659255|448677032|FG006|Overall Study|Death|0|||
124741583|NCT01659255|448677033|FG007|Overall Study|Death|1|||
124741584|NCT01659255|448677034|FG008|Overall Study|Death|1|||
124741585|NCT01659255|448677035|FG009|Overall Study|Death|0|||
124741586|NCT01659255|448677036|FG010|Overall Study|Death|0|||
124741587|NCT01659255|448677037|FG011|Overall Study|Death|0|||
124741588|NCT01659255|448677038|FG012|Overall Study|Death|1|||
124741589|NCT01659255|448677039|FG013|Overall Study|Death|1|||
124741590|NCT01659255|448677040|FG014|Overall Study|Death|2|||
124741591|NCT01659255|448677041|FG015|Overall Study|Death|1|||
124741592|NCT01659255|448677042|FG016|Overall Study|Death|0|||
124741593|NCT01659255|448677026|FG000|Overall Study|Progressive Disease|2|||
124741594|NCT01659255|448677027|FG001|Overall Study|Progressive Disease|0|||
124741595|NCT01659255|448677028|FG002|Overall Study|Progressive Disease|0|||
124741596|NCT01659255|448677029|FG003|Overall Study|Progressive Disease|0|||
124741597|NCT01659255|448677030|FG004|Overall Study|Progressive Disease|0|||
124741598|NCT01659255|448677031|FG005|Overall Study|Progressive Disease|0|||
124741599|NCT01659255|448677032|FG006|Overall Study|Progressive Disease|0|||
124741600|NCT01659255|448677033|FG007|Overall Study|Progressive Disease|1|||
124741601|NCT01659255|448677034|FG008|Overall Study|Progressive Disease|0|||
124741602|NCT01659255|448677035|FG009|Overall Study|Progressive Disease|2|||
124741603|NCT01659255|448677036|FG010|Overall Study|Progressive Disease|2|||
124741604|NCT01659255|448677037|FG011|Overall Study|Progressive Disease|3|||
124741605|NCT01659255|448677038|FG012|Overall Study|Progressive Disease|5|||
124741606|NCT01659255|448677039|FG013|Overall Study|Progressive Disease|13|||
124741607|NCT01659255|448677040|FG014|Overall Study|Progressive Disease|6|||
124741608|NCT01659255|448677041|FG015|Overall Study|Progressive Disease|2|||
124741609|NCT01659255|448677042|FG016|Overall Study|Progressive Disease|3|||
124741610|NCT01659255|448677026|FG000|Overall Study|Withdrew Consent|0|||
124741611|NCT01659255|448677027|FG001|Overall Study|Withdrew Consent|0|||
124741612|NCT01659255|448677028|FG002|Overall Study|Withdrew Consent|0|||
124741613|NCT01659255|448677029|FG003|Overall Study|Withdrew Consent|0|||
124741614|NCT01659255|448677030|FG004|Overall Study|Withdrew Consent|0|||
124741615|NCT01659255|448677031|FG005|Overall Study|Withdrew Consent|0|||
124741616|NCT01659255|448677032|FG006|Overall Study|Withdrew Consent|0|||
124741617|NCT01659255|448677033|FG007|Overall Study|Withdrew Consent|0|||
124741618|NCT01659255|448677034|FG008|Overall Study|Withdrew Consent|0|||
124741619|NCT01659255|448677035|FG009|Overall Study|Withdrew Consent|0|||
124741620|NCT01659255|448677036|FG010|Overall Study|Withdrew Consent|1|||
124741621|NCT01659255|448677037|FG011|Overall Study|Withdrew Consent|0|||
124741622|NCT01659255|448677038|FG012|Overall Study|Withdrew Consent|0|||
124741623|NCT01659255|448677039|FG013|Overall Study|Withdrew Consent|1|||
124741624|NCT01659255|448677040|FG014|Overall Study|Withdrew Consent|0|||
124741625|NCT01659255|448677041|FG015|Overall Study|Withdrew Consent|0|||
124741626|NCT01659255|448677042|FG016|Overall Study|Withdrew Consent|0|||
124741627|NCT01659255|448677026|FG000|Overall Study|Investigator Decision|0|||
124741628|NCT01659255|448677027|FG001|Overall Study|Investigator Decision|0|||
124741629|NCT01659255|448677028|FG002|Overall Study|Investigator Decision|0|||
124741630|NCT01659255|448677029|FG003|Overall Study|Investigator Decision|0|||
124741631|NCT01659255|448677030|FG004|Overall Study|Investigator Decision|0|||
124741632|NCT01659255|448677031|FG005|Overall Study|Investigator Decision|0|||
124741633|NCT01659255|448677032|FG006|Overall Study|Investigator Decision|0|||
124741634|NCT01659255|448677033|FG007|Overall Study|Investigator Decision|0|||
124741635|NCT01659255|448677034|FG008|Overall Study|Investigator Decision|0|||
124741636|NCT01659255|448677035|FG009|Overall Study|Investigator Decision|0|||
124741637|NCT01659255|448677036|FG010|Overall Study|Investigator Decision|0|||
124741638|NCT01659255|448677037|FG011|Overall Study|Investigator Decision|0|||
124741639|NCT01659255|448677038|FG012|Overall Study|Investigator Decision|1|||
124741640|NCT01659255|448677039|FG013|Overall Study|Investigator Decision|1|||
124741641|NCT01659255|448677040|FG014|Overall Study|Investigator Decision|0|||
124741642|NCT01659255|448677041|FG015|Overall Study|Investigator Decision|0|||
124741643|NCT01659255|448677042|FG016|Overall Study|Investigator Decision|0|||
124741644|NCT01659255|448677026|FG000|Overall Study|Sponsor's Decision|0|||
124741645|NCT01659255|448677027|FG001|Overall Study|Sponsor's Decision|0|||
124741646|NCT01659255|448677028|FG002|Overall Study|Sponsor's Decision|0|||
124741647|NCT01659255|448677029|FG003|Overall Study|Sponsor's Decision|0|||
124741648|NCT01659255|448677030|FG004|Overall Study|Sponsor's Decision|0|||
124741649|NCT01659255|448677031|FG005|Overall Study|Sponsor's Decision|0|||
124741650|NCT01659255|448677032|FG006|Overall Study|Sponsor's Decision|1|||
124741651|NCT01659255|448677033|FG007|Overall Study|Sponsor's Decision|0|||
124741652|NCT01659255|448677034|FG008|Overall Study|Sponsor's Decision|0|||
124741653|NCT01659255|448677035|FG009|Overall Study|Sponsor's Decision|0|||
124741654|NCT01659255|448677036|FG010|Overall Study|Sponsor's Decision|0|||
124741655|NCT01659255|448677037|FG011|Overall Study|Sponsor's Decision|0|||
124741656|NCT01659255|448677038|FG012|Overall Study|Sponsor's Decision|0|||
124741657|NCT01659255|448677039|FG013|Overall Study|Sponsor's Decision|0|||
124741658|NCT01659255|448677040|FG014|Overall Study|Sponsor's Decision|0|||
124741659|NCT01659255|448677041|FG015|Overall Study|Sponsor's Decision|0|||
124741660|NCT01659255|448677042|FG016|Overall Study|Sponsor's Decision|0|||
124741661|NCT01659255|448677026|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
124741662|NCT01659255|448677027|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
124741663|NCT01659255|448677028|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
124741664|NCT01659255|448677029|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
124741665|NCT01659255|448677030|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
124741666|NCT01659255|448677031|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
124741667|NCT01659255|448677032|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
124741668|NCT01659255|448677033|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
124741669|NCT01659255|448677034|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
124741670|NCT01659255|448677035|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
124741671|NCT01659255|448677036|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
124741672|NCT01659255|448677037|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
124741673|NCT01659255|448677038|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
124741674|NCT01659255|448677039|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
124741675|NCT01659255|448677040|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
124741676|NCT01659255|448677041|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
124741677|NCT01659255|448677042|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
124741678|NCT01659255|448677026|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
124741679|NCT01659255|448677027|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
124741680|NCT01659255|448677028|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
124741681|NCT01659255|448677029|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
124741682|NCT01659255|448677030|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
124741683|NCT01659255|448677031|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
124741684|NCT01659255|448677032|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
124741685|NCT01659255|448677033|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
124741686|NCT01659255|448677034|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
124741687|NCT01659255|448677035|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
124741688|NCT01659255|448677036|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
124741689|NCT01659255|448677037|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
124741690|NCT01659255|448677038|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
124741691|NCT01659255|448677039|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
124741692|NCT01659255|448677040|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
124741693|NCT01659255|448677041|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
124741694|NCT01659255|448677042|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
124741695|NCT01116427|448677045|FG000|Core Phase|Adverse Event|0|||
124741696|NCT01116427|448677046|FG001|Core Phase|Adverse Event|1|||
124741697|NCT01116427|448677045|FG000|Core Phase|Lost to Follow-up|1|||
124741698|NCT01116427|448677046|FG001|Core Phase|Lost to Follow-up|0|||
124741699|NCT01116427|448677045|FG000|Core Phase|Withdrawal by Subject|3|||
124741700|NCT01116427|448677046|FG001|Core Phase|Withdrawal by Subject|0|||
124741701|NCT01116427|448677045|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
124741702|NCT01116427|448677046|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
124741703|NCT01116427|448677045|FG000|Extension Phase|Adverse Event|1|||
124741704|NCT01116427|448677046|FG001|Extension Phase|Adverse Event|1|||
124741705|NCT01116427|448677045|FG000|Extension Phase|Lost to Follow-up|2|||
124741706|NCT01116427|448677046|FG001|Extension Phase|Lost to Follow-up|0|||
124741707|NCT01116427|448677045|FG000|Extension Phase|Withdrawal by Subject|5|||
124741708|NCT01116427|448677046|FG001|Extension Phase|Withdrawal by Subject|1|||
124741709|NCT01116427|448677045|FG000|Extension Phase|Not using appropriate birth control|1|||
124741710|NCT01116427|448677046|FG001|Extension Phase|Not using appropriate birth control|0|||
124741711|NCT02989805|448677047|FG000|Overall Study|invalid consent|6|||
124741712|NCT02989805|448677048|FG001|Overall Study|invalid consent|4|||
124741713|NCT02211313|448677049|FG000|Overall Study|Treatment Failure|5|||
124741714|NCT02211313|448677050|FG001|Overall Study|Treatment Failure|2|||
124741715|NCT02211313|448677049|FG000|Overall Study|No Follow up Questionnaires|1|||
124741716|NCT02211313|448677050|FG001|Overall Study|No Follow up Questionnaires|1|||
124741717|NCT02648217|448677053|FG000|Overall Study|Adverse Event|0|||
124741718|NCT02648217|448677054|FG001|Overall Study|Adverse Event|1|||
124741719|NCT02648217|448677053|FG000|Overall Study|Lost to Follow-up|1|||
124741720|NCT02648217|448677054|FG001|Overall Study|Lost to Follow-up|1|||
124741721|NCT02648217|448677053|FG000|Overall Study|Withdrawal by Subject|4|||
124741722|NCT02648217|448677054|FG001|Overall Study|Withdrawal by Subject|3|||
124741723|NCT02648217|448677053|FG000|Overall Study|Unclassified|5|||
124741724|NCT02648217|448677054|FG001|Overall Study|Unclassified|0|||
124741725|NCT03316950|448677055|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
124741726|NCT03316950|448677056|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
124741727|NCT03316950|448677057|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
124741728|NCT03316950|448677058|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
124741729|NCT03316950|448677055|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
124741730|NCT03316950|448677056|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
124613936|NCT03201445|448205584|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
124613937|NCT03201445|448205585|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
124741731|NCT03316950|448677057|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
124741732|NCT03316950|448677058|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
124741733|NCT03316950|448677055|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
124741734|NCT03316950|448677056|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
124741735|NCT03316950|448677057|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
124741736|NCT03316950|448677058|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
124741737|NCT02392403|448677059|FG000|Overall Study|Adverse Event|1|||
124741738|NCT02392403|448677059|FG000|Overall Study|Death|1|||
124741739|NCT02392403|448677059|FG000|Overall Study|Withdrawal by Subject|1|||
124741740|NCT02335424|448677063|FG000|Overall Study|Withdrawal by Subject|19|||
124741741|NCT02335424|448677063|FG000|Overall Study|Adverse Event|25|||
124741742|NCT02335424|448677063|FG000|Overall Study|Death|273|||
124741743|NCT02335424|448677063|FG000|Overall Study|Lost to Follow-up|3|||
124741744|NCT02335424|448677063|FG000|Overall Study|Physician Decision|13|||
124741745|NCT02335424|448677063|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
124741746|NCT02335424|448677063|FG000|Overall Study|Protocol Violation|1|||
124741747|NCT02335424|448677063|FG000|Overall Study|Screen failure|1|||
124741748|NCT02776033|448677066|FG000|Overall Study|Withdrawal by Subject|0|||
124741749|NCT02776033|448677067|FG001|Overall Study|Withdrawal by Subject|0|||
124741750|NCT02776033|448677068|FG002|Overall Study|Withdrawal by Subject|2|||
124741751|NCT02776033|448677066|FG000|Overall Study|Physician Decision|2|||
124741752|NCT02776033|448677067|FG001|Overall Study|Physician Decision|0|||
124741753|NCT02776033|448677068|FG002|Overall Study|Physician Decision|0|||
124741754|NCT02776033|448677066|FG000|Overall Study|Lost to Follow-up|1|||
124741755|NCT02776033|448677067|FG001|Overall Study|Lost to Follow-up|0|||
124741756|NCT02776033|448677068|FG002|Overall Study|Lost to Follow-up|0|||
124741757|NCT02776033|448677066|FG000|Overall Study|Adverse Event|1|||
124741758|NCT02776033|448677067|FG001|Overall Study|Adverse Event|2|||
124741759|NCT02776033|448677068|FG002|Overall Study|Adverse Event|0|||
124741760|NCT02712424|448677069|FG000|Overall Study|Lost to Follow-up|34|||
124741761|NCT02712424|448677070|FG001|Overall Study|Lost to Follow-up|32|||
124741762|NCT00657371|448677071|FG000|Overall Study|Poor bowel preparation|15|||
124741763|NCT00657371|448677071|FG000|Overall Study|Unable to intubate the cecum|5|||
124741764|NCT00657371|448677071|FG000|Overall Study|Protocol Violation|2|||
124741765|NCT00657371|448677071|FG000|Overall Study|Device- related reasons|13|||
124741766|NCT00657371|448677071|FG000|Overall Study|Pre-existing medical condition|4|||
124741767|NCT02713867|448677072|FG000|Randomization|Other Reason|2|||
124741768|NCT02713867|448677073|FG001|Randomization|Other Reason|1|||
124741769|NCT02713867|448677072|FG000|Randomization|Participant Withdrew consent|0|||
124741770|NCT02713867|448677073|FG001|Randomization|Participant Withdrew consent|2|||
124613938|NCT03201445|448205584|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
124613939|NCT03201445|448205585|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
124613940|NCT03201445|448205584|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
124613941|NCT03201445|448205585|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
124613942|NCT03201445|448205584|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
124613943|NCT03201445|448205585|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
124613944|NCT03201445|448205584|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
124613945|NCT03201445|448205585|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
124613946|NCT03201445|448205584|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
124613947|NCT03201445|448205585|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
124741771|NCT02713867|448677072|FG000|Treatment Period|Other Reasons|22|||
124741772|NCT02713867|448677073|FG001|Treatment Period|Other Reasons|28|||
124741773|NCT02713867|448677072|FG000|Treatment Period|Administrative reason by sponsor|21|||
124741774|NCT02713867|448677073|FG001|Treatment Period|Administrative reason by sponsor|16|||
124741775|NCT02713867|448677072|FG000|Treatment Period|No longer meets study criteria|2|||
124613948|NCT03201445|448205584|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
124613949|NCT03201445|448205585|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
124613950|NCT03201445|448205584|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
124741776|NCT02713867|448677073|FG001|Treatment Period|No longer meets study criteria|1|||
124741777|NCT02713867|448677072|FG000|Treatment Period|Poor/Non Compliance|1|||
124741778|NCT02713867|448677073|FG001|Treatment Period|Poor/Non Compliance|0|||
124613951|NCT03201445|448205585|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
124613952|NCT03201445|448205584|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
124741779|NCT02713867|448677072|FG000|Treatment Period|Maximum Clinical Benefit|5|||
124741780|NCT02713867|448677073|FG001|Treatment Period|Maximum Clinical Benefit|6|||
124741781|NCT02713867|448677072|FG000|Treatment Period|Withdrew consent|3|||
124781759|NCT00223080|448831154|FG001|Overall Study|Moved from study area|47|||
124741782|NCT02713867|448677073|FG001|Treatment Period|Withdrew consent|6|||
124741783|NCT02713867|448677072|FG000|Treatment Period|Requested to Discontinue|8|||
124741784|NCT02713867|448677073|FG001|Treatment Period|Requested to Discontinue|8|||
124741785|NCT02713867|448677072|FG000|Treatment Period|AE unrelated to Study Drug|11|||
124741786|NCT02713867|448677073|FG001|Treatment Period|AE unrelated to Study Drug|10|||
124741787|NCT02713867|448677072|FG000|Treatment Period|Death|7|||
124741788|NCT02713867|448677073|FG001|Treatment Period|Death|3|||
124741789|NCT02713867|448677072|FG000|Treatment Period|Study Drug Toxicity|16|||
124741790|NCT02713867|448677073|FG001|Treatment Period|Study Drug Toxicity|19|||
124741791|NCT02713867|448677072|FG000|Treatment Period|Disease Progression|82|||
124741792|NCT02713867|448677073|FG001|Treatment Period|Disease Progression|83|||
124741793|NCT02715726|448677077|FG000|Overall Study|Adverse Event|2|||
124741794|NCT02715726|448677078|FG001|Overall Study|Adverse Event|6|||
124741795|NCT02715726|448677077|FG000|Overall Study|Protocol Violation|1|||
124741796|NCT02715726|448677078|FG001|Overall Study|Protocol Violation|0|||
124741797|NCT02715726|448677077|FG000|Overall Study|Death|2|||
124741798|NCT02715726|448677078|FG001|Overall Study|Death|1|||
124741799|NCT02715726|448677077|FG000|Overall Study|Participant moved|1|||
124741800|NCT02715726|448677078|FG001|Overall Study|Participant moved|3|||
124741801|NCT02715726|448677077|FG000|Overall Study|Other than specified above|11|||
124741802|NCT02715726|448677078|FG001|Overall Study|Other than specified above|15|||
124741803|NCT02715726|448677077|FG000|Overall Study|Randomized but not treated|1|||
124741804|NCT02715726|448677078|FG001|Overall Study|Randomized but not treated|2|||
124741805|NCT01177969|448677079|FG000|Overall Study|Protocol Violation|2|||
124741806|NCT01177969|448677080|FG001|Overall Study|Protocol Violation|1|||
124741807|NCT01177969|448677079|FG000|Overall Study|Withdrawal by Subject|1|||
124741808|NCT01177969|448677080|FG001|Overall Study|Withdrawal by Subject|2|||
124741809|NCT02445573|448677081|FG000|Overall Study|Withdrawal by Subject|1|||
124741810|NCT02445573|448677082|FG001|Overall Study|Withdrawal by Subject|1|||
124741811|NCT02445573|448677081|FG000|Overall Study|Lost to Follow-up|0|||
124741812|NCT02445573|448677082|FG001|Overall Study|Lost to Follow-up|1|||
124741813|NCT03230292|448677083|FG000|Overall Study|Adverse Event|1|||
124741814|NCT03230292|448677083|FG000|Overall Study|Protocol Violation|1|||
124741815|NCT03230292|448677083|FG000|Overall Study|Lost to Follow-up|1|||
124741816|NCT03230292|448677083|FG000|Overall Study|Withdrawal by Subject|3|||
124741817|NCT01639755|448677084|FG000|Overall Study|Study Ongoing|15|||
124741818|NCT01639755|448677084|FG000|Overall Study|Patient had device explantation|4|||
124741819|NCT03995355|448677090|FG000|Overall Study|Adverse Event|1|||
124741820|NCT03995355|448677091|FG001|Overall Study|Adverse Event|0|||
124741821|NCT03995355|448677090|FG000|Overall Study|Withdrawal by Subject|1|||
124741822|NCT03995355|448677091|FG001|Overall Study|Withdrawal by Subject|0|||
124741823|NCT03995355|448677090|FG000|Overall Study|Scheduling Issues|0|||
124741824|NCT03995355|448677091|FG001|Overall Study|Scheduling Issues|1|||
124741825|NCT00710385|448677099|FG000|Overall Study|Did not qualify|1|||
124741826|NCT00710385|448677099|FG000|Overall Study|Withdrawal by Subject|1|||
124741827|NCT00710385|448677099|FG000|Overall Study|Undisclosed back pain|1|||
124741828|NCT00710385|448677099|FG000|Overall Study|Physician Decision|1|||
124741829|NCT00710385|448677099|FG000|Overall Study|Undisclosed excessive methadone use|1|||
124741830|NCT02914561|448677102|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
124741831|NCT02914561|448677103|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
124741832|NCT02914561|448677104|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
124741833|NCT02914561|448677105|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
124741834|NCT02914561|448677106|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
124741835|NCT02914561|448677107|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
124741836|NCT02914561|448677108|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
124741837|NCT02914561|448677109|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
124741838|NCT02914561|448677110|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
124741839|NCT02914561|448677111|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
124741840|NCT02914561|448677112|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
124741841|NCT02914561|448677102|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
124741842|NCT02914561|448677103|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
124741843|NCT02914561|448677104|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
124741844|NCT02914561|448677105|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
124741845|NCT02914561|448677106|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
124741846|NCT02914561|448677107|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
124741847|NCT02914561|448677108|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
124741848|NCT02914561|448677109|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
124741849|NCT02914561|448677110|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
124741850|NCT02914561|448677111|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
124741851|NCT02914561|448677112|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
124741852|NCT02914561|448677102|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
124741853|NCT02914561|448677103|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
124741854|NCT02914561|448677104|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
124741855|NCT02914561|448677105|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
124741856|NCT02914561|448677106|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
124741857|NCT02914561|448677107|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
124781760|NCT00223080|448831153|FG000|Overall Study|Lost to Follow-up|259|||
124741858|NCT02914561|448677108|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
124741859|NCT02914561|448677109|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
124741860|NCT02914561|448677110|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
124741861|NCT02914561|448677111|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
124741862|NCT02914561|448677112|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
124741863|NCT02914561|448677102|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
124741864|NCT02914561|448677103|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
124741865|NCT02914561|448677104|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
124741866|NCT02914561|448677105|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
124741867|NCT02914561|448677106|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
124741868|NCT02914561|448677107|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
124741869|NCT02914561|448677108|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
124741870|NCT02914561|448677109|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
124741871|NCT02914561|448677110|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
124741872|NCT02914561|448677111|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
124741873|NCT02914561|448677112|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
124741874|NCT02914561|448677102|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
124741875|NCT02914561|448677103|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
124741876|NCT02914561|448677104|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
124741877|NCT02914561|448677105|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
124741878|NCT02914561|448677106|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
124741879|NCT02914561|448677107|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
124741880|NCT02914561|448677108|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
124741881|NCT02914561|448677109|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
124741882|NCT02914561|448677110|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
124741883|NCT02914561|448677111|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
124741884|NCT02914561|448677112|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
124741885|NCT02914561|448677102|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
124741886|NCT02914561|448677103|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
124741887|NCT02914561|448677104|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
124741888|NCT02914561|448677105|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
124741889|NCT02914561|448677106|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
124741890|NCT02914561|448677107|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
124741891|NCT02914561|448677108|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
124741892|NCT02914561|448677109|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
124741893|NCT02914561|448677110|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
124741894|NCT02914561|448677111|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
124741895|NCT02914561|448677112|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
124741896|NCT02914561|448677102|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
124741897|NCT02914561|448677103|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
124741898|NCT02914561|448677104|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
124741899|NCT02914561|448677105|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
124613953|NCT03201445|448205585|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
124613954|NCT03201445|448205584|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
124613955|NCT03201445|448205585|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
124613956|NCT03201445|448205584|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
124741900|NCT02914561|448677106|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
124741901|NCT02914561|448677107|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
124741902|NCT02914561|448677108|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
124741903|NCT02914561|448677109|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
124741904|NCT02914561|448677110|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
124741905|NCT02914561|448677111|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
124741906|NCT02914561|448677112|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
124741907|NCT02914561|448677102|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
124741908|NCT02914561|448677103|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
124741909|NCT02914561|448677104|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
124741910|NCT02914561|448677105|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
124741911|NCT02914561|448677106|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
124741912|NCT02914561|448677107|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
124741913|NCT02914561|448677108|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
124741914|NCT02914561|448677109|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
124741915|NCT02914561|448677110|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
124741916|NCT02914561|448677111|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
124781761|NCT00223080|448831154|FG001|Overall Study|Lost to Follow-up|284|||
124781762|NCT00223080|448831153|FG000|Overall Study|Death|85|||
124741917|NCT02914561|448677112|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
124741918|NCT02914561|448677102|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
124741919|NCT02914561|448677103|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
124741920|NCT02914561|448677104|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
124741921|NCT02914561|448677105|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
124741922|NCT02914561|448677106|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
124741923|NCT02914561|448677107|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
124741924|NCT02914561|448677108|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
124741925|NCT02914561|448677109|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
124741926|NCT02914561|448677110|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
124741927|NCT02914561|448677111|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
124741928|NCT02914561|448677112|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
124741929|NCT02914561|448677102|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
124741930|NCT02914561|448677103|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
124741931|NCT02914561|448677104|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
124741932|NCT02914561|448677105|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
124741933|NCT02914561|448677106|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
124741934|NCT02914561|448677107|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
124741935|NCT02914561|448677108|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
124741936|NCT02914561|448677109|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
124741937|NCT02914561|448677110|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
124741938|NCT02914561|448677111|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
124741939|NCT02914561|448677112|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
124741940|NCT02914561|448677102|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
124741941|NCT02914561|448677103|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
124741942|NCT02914561|448677104|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
124741943|NCT02914561|448677105|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
124741944|NCT02914561|448677106|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
124741945|NCT02914561|448677107|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
124741946|NCT02914561|448677108|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
124741947|NCT02914561|448677109|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
124741948|NCT02914561|448677110|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
124741949|NCT02914561|448677111|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
124741950|NCT02914561|448677112|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
124613957|NCT03201445|448205585|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
124613958|NCT03201445|448205584|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
124781763|NCT00223080|448831154|FG001|Overall Study|Death|74|||
124781764|NCT00223080|448831153|FG000|Overall Study|Other|14|||
124781765|NCT00223080|448831154|FG001|Overall Study|Other|11|||
124781766|NCT00223080|448831153|FG000|Overall Study|Reason not provided|141|||
124781767|NCT00223080|448831154|FG001|Overall Study|Reason not provided|140|||
124781768|NCT00223080|448831153|FG000|Overall Study|Adverse Event|0|||
124781769|NCT00223080|448831154|FG001|Overall Study|Adverse Event|1|||
124781770|NCT03237286|448831155|FG000|Overall Study|Withdrawal by Subject|1|||
124781771|NCT03237286|448831156|FG001|Overall Study|Withdrawal by Subject|0|||
124781772|NCT03237286|448831157|FG002|Overall Study|Withdrawal by Subject|2|||
124781773|NCT03237286|448831155|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
124781774|NCT03237286|448831156|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
124613959|NCT03201445|448205585|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
124613960|NCT03201445|448205584|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
124613961|NCT03201445|448205585|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
124613962|NCT03201445|448205584|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
124613963|NCT03201445|448205585|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
124613964|NCT01228019|448205586|FG000|Overall Study|Dose Violation|70|||
124613965|NCT01228019|448205586|FG000|Overall Study|Duplicate enrollment|1|||
124613966|NCT01228019|448205586|FG000|Overall Study|Missing pre-treatment data|72|||
124613967|NCT01228019|448205586|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
124613968|NCT01228019|448205586|FG000|Overall Study|Violation of Entry Criterion|9|||
124613969|NCT02087189|448205588|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
124613970|NCT01189487|448205595|FG000|Overall Study|Lack of Efficacy|2|||
124613971|NCT01189487|448205595|FG000|Overall Study|Adverse Event|1|||
124613972|NCT00587990|448205596|FG000|Overall Study|Death|0|||
124613973|NCT00587990|448205597|FG001|Overall Study|Death|0|||
124613974|NCT00587990|448205598|FG002|Overall Study|Death|1|||
124741951|NCT02914561|448677102|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
124781775|NCT03237286|448831157|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
124781776|NCT00948441|448831165|FG000|Overall Study|no longer meet inclusion criteria|1|||
124613975|NCT02754856|448205599|FG000|Overall Study|Withdrawal by Subject|1|||
124741952|NCT02914561|448677103|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
124741953|NCT02914561|448677104|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
124741954|NCT02914561|448677105|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
124741955|NCT02914561|448677106|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
124741956|NCT02914561|448677107|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
124741957|NCT02914561|448677108|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
124741958|NCT02914561|448677109|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
124741959|NCT02914561|448677110|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
124741960|NCT02914561|448677111|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
124741961|NCT02914561|448677112|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
124741962|NCT02914561|448677102|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
124741963|NCT02914561|448677103|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
124741964|NCT02914561|448677104|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
124741965|NCT02914561|448677105|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
124741966|NCT02914561|448677106|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
124741967|NCT02914561|448677107|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
124741968|NCT02914561|448677108|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
124741969|NCT02914561|448677109|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
124741970|NCT02914561|448677110|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
124741971|NCT02914561|448677111|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
124741972|NCT02914561|448677112|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
124741973|NCT02914561|448677102|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
124741974|NCT02914561|448677103|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
124741975|NCT02914561|448677104|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
124741976|NCT02914561|448677105|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
124741977|NCT02914561|448677106|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
124741978|NCT02914561|448677107|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
124741979|NCT02914561|448677108|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
124741980|NCT02914561|448677109|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
124741981|NCT02914561|448677110|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
124741982|NCT02914561|448677111|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
124741983|NCT02914561|448677112|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
124741984|NCT02914561|448677102|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
124741985|NCT02914561|448677103|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
124741986|NCT02914561|448677104|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
124613976|NCT04630158|448205600|FG000|Overall Study|Adverse Event|1|||
124613977|NCT04630158|448205601|FG001|Overall Study|Adverse Event|1|||
124613978|NCT04630158|448205602|FG002|Overall Study|Adverse Event|1|||
124613979|NCT04630158|448205600|FG000|Overall Study|Physician Decision|0|||
124613980|NCT04630158|448205601|FG001|Overall Study|Physician Decision|2|||
124613981|NCT04630158|448205602|FG002|Overall Study|Physician Decision|0|||
124613982|NCT04630158|448205600|FG000|Overall Study|Protocol Violation|1|||
124613983|NCT04630158|448205601|FG001|Overall Study|Protocol Violation|0|||
124741987|NCT02914561|448677105|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
124741988|NCT02914561|448677106|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
124741989|NCT02914561|448677107|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
124741990|NCT02914561|448677108|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
124741991|NCT02914561|448677109|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
124741992|NCT02914561|448677110|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
124741993|NCT02914561|448677111|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
124741994|NCT02914561|448677112|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
124741995|NCT02914561|448677102|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
124741996|NCT02914561|448677103|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
124741997|NCT02914561|448677104|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
124741998|NCT02914561|448677105|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
124741999|NCT02914561|448677106|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
124742000|NCT02914561|448677107|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
124742001|NCT02914561|448677108|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
124742002|NCT02914561|448677109|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
124742003|NCT02914561|448677110|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
124742004|NCT02914561|448677111|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
124742005|NCT02914561|448677112|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
124613984|NCT04630158|448205602|FG002|Overall Study|Protocol Violation|1|||
124742006|NCT02914561|448677102|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
124742007|NCT02914561|448677103|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
124613985|NCT04630158|448205600|FG000|Overall Study|Withdrawal by Subject|2|||
124613986|NCT04630158|448205601|FG001|Overall Study|Withdrawal by Subject|1|||
124742008|NCT02914561|448677104|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
124742009|NCT02914561|448677105|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
124742010|NCT02914561|448677106|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
124742011|NCT02914561|448677107|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
124742012|NCT02914561|448677108|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
124742013|NCT02914561|448677109|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
124742014|NCT02914561|448677110|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
124742015|NCT02914561|448677111|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
124742016|NCT02914561|448677112|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
124742017|NCT01459913|448677119|FG000|Overall Study|Adverse Event|0|||
124742018|NCT01459913|448677120|FG001|Overall Study|Adverse Event|0|||
124742019|NCT01459913|448677121|FG002|Overall Study|Adverse Event|0|||
124742020|NCT01459913|448677122|FG003|Overall Study|Adverse Event|3|||
124742021|NCT01459913|448677119|FG000|Overall Study|Withdrawal by Subject|4|||
124742022|NCT01459913|448677120|FG001|Overall Study|Withdrawal by Subject|0|||
124742023|NCT01459913|448677121|FG002|Overall Study|Withdrawal by Subject|0|||
124742024|NCT01459913|448677122|FG003|Overall Study|Withdrawal by Subject|5|||
124742025|NCT01459913|448677119|FG000|Overall Study|Lost to Follow-up|7|||
124742026|NCT01459913|448677120|FG001|Overall Study|Lost to Follow-up|4|||
124742027|NCT01459913|448677121|FG002|Overall Study|Lost to Follow-up|1|||
124742028|NCT01459913|448677122|FG003|Overall Study|Lost to Follow-up|8|||
124742029|NCT01459913|448677119|FG000|Overall Study|Death|0|||
124742030|NCT01459913|448677120|FG001|Overall Study|Death|0|||
124742031|NCT01459913|448677121|FG002|Overall Study|Death|0|||
124742032|NCT01459913|448677122|FG003|Overall Study|Death|1|||
124742033|NCT01459913|448677119|FG000|Overall Study|Non- Compliance|0|||
124742034|NCT01459913|448677120|FG001|Overall Study|Non- Compliance|0|||
124742035|NCT01459913|448677121|FG002|Overall Study|Non- Compliance|0|||
124742036|NCT01459913|448677122|FG003|Overall Study|Non- Compliance|3|||
124742037|NCT01459913|448677119|FG000|Overall Study|Physician Decision|0|||
124742038|NCT01459913|448677120|FG001|Overall Study|Physician Decision|1|||
124742039|NCT01459913|448677121|FG002|Overall Study|Physician Decision|0|||
124742040|NCT01459913|448677122|FG003|Overall Study|Physician Decision|0|||
124742041|NCT01459913|448677119|FG000|Overall Study|Study Terminated by Sponsor|30|||
124742042|NCT01459913|448677120|FG001|Overall Study|Study Terminated by Sponsor|15|||
124742043|NCT01459913|448677121|FG002|Overall Study|Study Terminated by Sponsor|9|||
124742044|NCT01459913|448677122|FG003|Overall Study|Study Terminated by Sponsor|11|||
124742045|NCT01459913|448677119|FG000|Overall Study|Other|0|||
124742046|NCT01459913|448677120|FG001|Overall Study|Other|0|||
124742047|NCT01459913|448677121|FG002|Overall Study|Other|3|||
124742048|NCT01459913|448677122|FG003|Overall Study|Other|1|||
124742049|NCT01459913|448677119|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
124742050|NCT01459913|448677120|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
124742051|NCT01459913|448677121|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
124742052|NCT01459913|448677122|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
124742053|NCT01064687|448677125|FG000|Overall Study|Adverse Event|9|||
124742054|NCT01064687|448677126|FG001|Overall Study|Adverse Event|4|||
124742055|NCT01064687|448677127|FG002|Overall Study|Adverse Event|10|||
124742056|NCT01064687|448677128|FG003|Overall Study|Adverse Event|3|||
124742057|NCT01064687|448677125|FG000|Overall Study|Death|1|||
124742058|NCT01064687|448677126|FG001|Overall Study|Death|1|||
124742059|NCT01064687|448677127|FG002|Overall Study|Death|0|||
124742060|NCT01064687|448677128|FG003|Overall Study|Death|0|||
124742061|NCT01064687|448677125|FG000|Overall Study|Entry Criteria Not Met|3|||
124742062|NCT01064687|448677126|FG001|Overall Study|Entry Criteria Not Met|0|||
124742063|NCT01064687|448677127|FG002|Overall Study|Entry Criteria Not Met|0|||
124742064|NCT01064687|448677128|FG003|Overall Study|Entry Criteria Not Met|0|||
124613987|NCT04630158|448205602|FG002|Overall Study|Withdrawal by Subject|2|||
124742065|NCT01064687|448677125|FG000|Overall Study|Lack of Efficacy|1|||
124742066|NCT01064687|448677126|FG001|Overall Study|Lack of Efficacy|0|||
124742067|NCT01064687|448677127|FG002|Overall Study|Lack of Efficacy|2|||
124742068|NCT01064687|448677128|FG003|Overall Study|Lack of Efficacy|3|||
124742069|NCT01064687|448677125|FG000|Overall Study|Lost to Follow-up|7|||
124742070|NCT01064687|448677126|FG001|Overall Study|Lost to Follow-up|10|||
124742071|NCT01064687|448677127|FG002|Overall Study|Lost to Follow-up|13|||
124742072|NCT01064687|448677128|FG003|Overall Study|Lost to Follow-up|5|||
124742073|NCT01064687|448677125|FG000|Overall Study|Physician Decision|2|||
124742074|NCT01064687|448677126|FG001|Overall Study|Physician Decision|2|||
124742075|NCT01064687|448677127|FG002|Overall Study|Physician Decision|0|||
124742076|NCT01064687|448677128|FG003|Overall Study|Physician Decision|0|||
124742077|NCT01064687|448677125|FG000|Overall Study|Protocol Violation|1|||
124742078|NCT01064687|448677126|FG001|Overall Study|Protocol Violation|1|||
124742079|NCT01064687|448677127|FG002|Overall Study|Protocol Violation|0|||
124742080|NCT01064687|448677128|FG003|Overall Study|Protocol Violation|1|||
124742081|NCT01064687|448677125|FG000|Overall Study|Sponsor Decision|0|||
124742082|NCT01064687|448677126|FG001|Overall Study|Sponsor Decision|0|||
124742083|NCT01064687|448677127|FG002|Overall Study|Sponsor Decision|3|||
124742084|NCT01064687|448677128|FG003|Overall Study|Sponsor Decision|0|||
124613988|NCT01860677|448205605|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
124742085|NCT01064687|448677125|FG000|Overall Study|Withdrawal by Subject|9|||
124742086|NCT01064687|448677126|FG001|Overall Study|Withdrawal by Subject|7|||
124742087|NCT01064687|448677127|FG002|Overall Study|Withdrawal by Subject|12|||
124742088|NCT01064687|448677128|FG003|Overall Study|Withdrawal by Subject|5|||
124742089|NCT01064687|448677125|FG000|Overall Study|Treatment Noncompliance|1|||
124742090|NCT01064687|448677126|FG001|Overall Study|Treatment Noncompliance|1|||
124742091|NCT01064687|448677127|FG002|Overall Study|Treatment Noncompliance|1|||
124742092|NCT01064687|448677128|FG003|Overall Study|Treatment Noncompliance|0|||
124742093|NCT02299076|448677129|FG000|Overall Study|Fraudulent Entries|20|||
124742094|NCT02299076|448677130|FG001|Overall Study|Fraudulent Entries|14|||
124742095|NCT01969721|448677131|FG000|Overall Study|Adverse Event|3|||
124742096|NCT01969721|448677132|FG001|Overall Study|Adverse Event|8|||
124742097|NCT01969721|448677133|FG002|Overall Study|Adverse Event|3|||
124742098|NCT01969721|448677134|FG003|Overall Study|Adverse Event|2|||
124742099|NCT01969721|448677131|FG000|Overall Study|Lack of Efficacy|0|||
124742100|NCT01969721|448677132|FG001|Overall Study|Lack of Efficacy|0|||
124742101|NCT01969721|448677133|FG002|Overall Study|Lack of Efficacy|1|||
124742102|NCT01969721|448677134|FG003|Overall Study|Lack of Efficacy|0|||
124742103|NCT01969721|448677131|FG000|Overall Study|Non compliant with protocol|1|||
124742104|NCT01969721|448677132|FG001|Overall Study|Non compliant with protocol|1|||
124742105|NCT01969721|448677133|FG002|Overall Study|Non compliant with protocol|0|||
124742106|NCT01969721|448677134|FG003|Overall Study|Non compliant with protocol|2|||
124742107|NCT01969721|448677131|FG000|Overall Study|Other not defined above|0|||
124742108|NCT01969721|448677132|FG001|Overall Study|Other not defined above|2|||
124742109|NCT01969721|448677133|FG002|Overall Study|Other not defined above|0|||
124742110|NCT01969721|448677134|FG003|Overall Study|Other not defined above|0|||
124742111|NCT01969721|448677131|FG000|Overall Study|Discontinued during washout periods.|0|||
124742112|NCT01969721|448677132|FG001|Overall Study|Discontinued during washout periods.|1|||
124742113|NCT01969721|448677133|FG002|Overall Study|Discontinued during washout periods.|1|||
124742114|NCT01969721|448677134|FG003|Overall Study|Discontinued during washout periods.|2|||
124742115|NCT00495755|448677135|FG000|Overall Study|Adverse Event|3|||
124742116|NCT02117349|448677136|FG000|Overall Study|Withdrawal by Subject|1|||
124742117|NCT02117349|448677137|FG001|Overall Study|Withdrawal by Subject|0|||
124742118|NCT02117349|448677136|FG000|Overall Study|Lost to Follow-up|1|||
124742119|NCT02117349|448677137|FG001|Overall Study|Lost to Follow-up|1|||
124742120|NCT02117349|448677136|FG000|Overall Study|Death|1|||
124742121|NCT02117349|448677137|FG001|Overall Study|Death|0|||
124742122|NCT01012323|448677138|FG000|Overall Study|Investigator Judgment|1|||
124742123|NCT02265796|448677139|FG000|Overall Study|Death|1|||
124742124|NCT02265796|448677140|FG001|Overall Study|Death|0|||
124742125|NCT02265796|448677139|FG000|Overall Study|started on excluded medication|1|||
124742126|NCT02265796|448677140|FG001|Overall Study|started on excluded medication|0|||
124742127|NCT02265796|448677139|FG000|Overall Study|Withdrawal by Subject|1|||
124742128|NCT02265796|448677140|FG001|Overall Study|Withdrawal by Subject|1|||
124742129|NCT02477553|448677141|FG000|Overall Study|Screening up-to-date|12|||
124742130|NCT02477553|448677142|FG001|Overall Study|Screening up-to-date|13|||
124742131|NCT02477553|448677141|FG000|Overall Study|No MD visit|1|||
124742132|NCT02477553|448677142|FG001|Overall Study|No MD visit|1|||
124742133|NCT02477553|448677141|FG000|Overall Study|Workup consistent w/CRC|1|||
124742134|NCT02477553|448677142|FG001|Overall Study|Workup consistent w/CRC|1|||
124742135|NCT02477553|448677141|FG000|Overall Study|Technical issues with intervention|2|||
124742136|NCT02477553|448677142|FG001|Overall Study|Technical issues with intervention|0|||
124742137|NCT02477553|448677141|FG000|Overall Study|Elevated risk for CRC|2|||
124742138|NCT02477553|448677142|FG001|Overall Study|Elevated risk for CRC|2|||
124742139|NCT02477553|448677141|FG000|Overall Study|MD advised against screening|1|||
124742140|NCT02477553|448677142|FG001|Overall Study|MD advised against screening|3|||
124742141|NCT02477553|448677141|FG000|Overall Study|patient deceased|1|||
124742142|NCT02477553|448677142|FG001|Overall Study|patient deceased|0|||
124742143|NCT02963701|448677143|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
124742144|NCT02963701|448677144|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
124742145|NCT00896649|448677147|FG000|Overall Study|Physician Decision|1|||
124742146|NCT00896649|448677147|FG000|Overall Study|Pregnancy|1|||
124742147|NCT00896649|448677147|FG000|Overall Study|missing documentation|1|||
124613989|NCT01860677|448205606|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
124613990|NCT04762277|448205607|FG000|Overall Study|Withdrawal by Subject|0|||
124613991|NCT04762277|448205608|FG001|Overall Study|Withdrawal by Subject|2|||
124742148|NCT00896649|448677147|FG000|Overall Study|technical difficulties|2|||
124742149|NCT03652675|448677148|FG000|Overall Study|Lost to Follow-up|4|||
124742150|NCT03652675|448677149|FG001|Overall Study|Lost to Follow-up|4|||
124742151|NCT03442296|448677150|FG000|3 Month Follow-up|Death|3|||
124613992|NCT04762277|448205607|FG000|Overall Study|Protocol Violation|0|||
124742152|NCT03442296|448677151|FG001|3 Month Follow-up|Death|1|||
124742153|NCT03442296|448677150|FG000|3 Month Follow-up|Lost to Follow-up|1|||
124742154|NCT03442296|448677151|FG001|3 Month Follow-up|Lost to Follow-up|1|||
124742155|NCT03442296|448677150|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
124742156|NCT03442296|448677151|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
124742157|NCT03442296|448677150|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
124742158|NCT03442296|448677151|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
124742159|NCT03442296|448677150|FG000|12 Month Follow-up|Incomplete measurement|1|||
124742160|NCT03442296|448677151|FG001|12 Month Follow-up|Incomplete measurement|1|||
124742161|NCT00707954|448678875|FG000|Overall Study|Physician Decision|0|||
124742162|NCT00707954|448678876|FG001|Overall Study|Physician Decision|0|||
124742163|NCT00707954|448678877|FG002|Overall Study|Physician Decision|0|||
124742164|NCT00707954|448678878|FG003|Overall Study|Physician Decision|0|||
124742165|NCT00707954|448678879|FG004|Overall Study|Physician Decision|1|||
124742166|NCT01306656|448678880|FG000|Overall Study|Lost to Follow-up|1|||
124742167|NCT01306656|448678881|FG001|Overall Study|Lost to Follow-up|0|||
124742168|NCT01571232|448678882|FG000|Overall Study|Lost to Follow-up|0|||
124742169|NCT01571232|448678883|FG001|Overall Study|Lost to Follow-up|1|||
124742170|NCT01571232|448678882|FG000|Overall Study|Withdrawal by Subject|1|||
124742171|NCT01571232|448678883|FG001|Overall Study|Withdrawal by Subject|0|||
124742172|NCT03517969|448678885|FG000|Overall Study|Never started protocol treatment|3|||
124742173|NCT03517969|448678886|FG001|Overall Study|Never started protocol treatment|5|||
124742174|NCT03517969|448678885|FG000|Overall Study|Disease progression|11|||
124742175|NCT03517969|448678886|FG001|Overall Study|Disease progression|16|||
124742176|NCT03517969|448678885|FG000|Overall Study|PSA progression|8|||
124742177|NCT03517969|448678886|FG001|Overall Study|PSA progression|1|||
124742178|NCT03517969|448678885|FG000|Overall Study|Clinical progression|4|||
124742179|NCT03517969|448678886|FG001|Overall Study|Clinical progression|2|||
124742180|NCT03517969|448678885|FG000|Overall Study|Adverse Event|5|||
124742181|NCT03517969|448678886|FG001|Overall Study|Adverse Event|4|||
124742182|NCT03517969|448678885|FG000|Overall Study|Intercurrent illness|1|||
124742183|NCT03517969|448678886|FG001|Overall Study|Intercurrent illness|2|||
124742184|NCT03517969|448678885|FG000|Overall Study|Death|1|||
124742185|NCT03517969|448678886|FG001|Overall Study|Death|1|||
124742186|NCT03517969|448678885|FG000|Overall Study|Withdrawal by Subject|1|||
124742187|NCT03517969|448678886|FG001|Overall Study|Withdrawal by Subject|2|||
124742188|NCT03517969|448678885|FG000|Overall Study|Physician Decision|1|||
124742189|NCT03517969|448678886|FG001|Overall Study|Physician Decision|1|||
124742190|NCT03517969|448678885|FG000|Overall Study|No clinical benefit|1|||
124742191|NCT03517969|448678886|FG001|Overall Study|No clinical benefit|0|||
124742192|NCT03517969|448678885|FG000|Overall Study|Delayed treatment for dental treatment|1|||
124742193|NCT03517969|448678886|FG001|Overall Study|Delayed treatment for dental treatment|0|||
124742194|NCT03517969|448678885|FG000|Overall Study|Difficult to maintain appointment|0|||
124742195|NCT03517969|448678886|FG001|Overall Study|Difficult to maintain appointment|1|||
124742196|NCT03517969|448678885|FG000|Overall Study|Protocol Violation|0|||
124742197|NCT03517969|448678886|FG001|Overall Study|Protocol Violation|1|||
124742198|NCT03344172|448678893|FG000|Overall Study|Received <1 dose of treatment|1|||
124742199|NCT03344172|448678894|FG001|Overall Study|Received <1 dose of treatment|0|||
124742200|NCT03779503|448678895|FG000|First Intervention|Adverse Event|0|||
124742201|NCT03779503|448678896|FG001|First Intervention|Adverse Event|1|||
124742202|NCT03779503|448678895|FG000|First Intervention|Withdrawal by Subject|1|||
124742203|NCT03779503|448678896|FG001|First Intervention|Withdrawal by Subject|0|||
124742204|NCT03629912|448678897|FG000|Overall Study|Lost to Follow-up|19|||
124742205|NCT03629912|448678898|FG001|Overall Study|Lost to Follow-up|7|||
124742206|NCT03629912|448678899|FG002|Overall Study|Lost to Follow-up|5|||
124742207|NCT03629912|448678900|FG003|Overall Study|Lost to Follow-up|1|||
124742208|NCT03629912|448678897|FG000|Overall Study|Withdrawal by Subject|6|||
124742209|NCT03629912|448678898|FG001|Overall Study|Withdrawal by Subject|0|||
124742210|NCT03629912|448678899|FG002|Overall Study|Withdrawal by Subject|1|||
124742211|NCT03629912|448678900|FG003|Overall Study|Withdrawal by Subject|2|||
124742212|NCT03629912|448678897|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
124742213|NCT03629912|448678898|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
124742214|NCT03629912|448678899|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
124742215|NCT03629912|448678900|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
124742216|NCT03629912|448678897|FG000|Overall Study|Death|1|||
124742217|NCT03629912|448678898|FG001|Overall Study|Death|0|||
124781777|NCT00948441|448831166|FG001|Overall Study|no longer meet inclusion criteria|4|||
124742218|NCT03629912|448678899|FG002|Overall Study|Death|0|||
124742219|NCT03629912|448678900|FG003|Overall Study|Death|0|||
124742220|NCT00687609|448678901|FG000|Overall Study|Physician Decision|1|||
124742221|NCT00687609|448678901|FG000|Overall Study|Withdrawal by Subject|2|||
124742222|NCT00908037|448678902|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
124742223|NCT00908037|448678903|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
124742224|NCT00908037|448678904|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
124742225|NCT00908037|448678905|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
124742226|NCT00908037|448678906|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
124742227|NCT00908037|448678907|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
124742228|NCT00908037|448678908|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
124742229|NCT00908037|448678909|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
124742230|NCT00908037|448678910|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
124742231|NCT00908037|448678911|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
124742232|NCT00908037|448678912|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
124742233|NCT00908037|448678913|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
124742234|NCT00908037|448678902|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
124742235|NCT00908037|448678903|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
124742236|NCT00908037|448678904|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
124742237|NCT00908037|448678905|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
124742238|NCT00908037|448678906|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
124742239|NCT00908037|448678907|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
124742240|NCT00908037|448678908|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
124742241|NCT00908037|448678909|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
124613993|NCT04762277|448205608|FG001|Overall Study|Protocol Violation|1|||
124613994|NCT04762277|448205607|FG000|Overall Study|Adverse Event|1|||
124613995|NCT04762277|448205608|FG001|Overall Study|Adverse Event|0|||
124613996|NCT00642278|448205609|FG000|Overall Study|Adverse Event|2|||
124613997|NCT00642278|448205610|FG001|Overall Study|Adverse Event|1|||
124613998|NCT00642278|448205611|FG002|Overall Study|Adverse Event|3|||
124613999|NCT00642278|448205612|FG003|Overall Study|Adverse Event|1|||
124614000|NCT00642278|448205613|FG004|Overall Study|Adverse Event|2|||
124614001|NCT00642278|448205614|FG005|Overall Study|Adverse Event|2|||
124614002|NCT00642278|448205615|FG006|Overall Study|Adverse Event|0|||
124614003|NCT00642278|448205609|FG000|Overall Study|Lack of Efficacy|0|||
124614004|NCT00642278|448205610|FG001|Overall Study|Lack of Efficacy|1|||
124614005|NCT00642278|448205611|FG002|Overall Study|Lack of Efficacy|0|||
124614006|NCT00642278|448205612|FG003|Overall Study|Lack of Efficacy|0|||
124614007|NCT00642278|448205613|FG004|Overall Study|Lack of Efficacy|0|||
124614008|NCT00642278|448205614|FG005|Overall Study|Lack of Efficacy|0|||
124614009|NCT00642278|448205615|FG006|Overall Study|Lack of Efficacy|0|||
124614010|NCT00642278|448205609|FG000|Overall Study|Lost to Follow-up|5|||
124614011|NCT00642278|448205610|FG001|Overall Study|Lost to Follow-up|1|||
124614012|NCT00642278|448205611|FG002|Overall Study|Lost to Follow-up|0|||
124614013|NCT00642278|448205612|FG003|Overall Study|Lost to Follow-up|1|||
124614014|NCT00642278|448205613|FG004|Overall Study|Lost to Follow-up|0|||
124614015|NCT00642278|448205614|FG005|Overall Study|Lost to Follow-up|1|||
124614016|NCT00642278|448205615|FG006|Overall Study|Lost to Follow-up|1|||
124614017|NCT00642278|448205609|FG000|Overall Study|Physician Decision|0|||
124614018|NCT00642278|448205610|FG001|Overall Study|Physician Decision|0|||
124614019|NCT00642278|448205611|FG002|Overall Study|Physician Decision|0|||
124614020|NCT00642278|448205612|FG003|Overall Study|Physician Decision|1|||
124614021|NCT00642278|448205613|FG004|Overall Study|Physician Decision|0|||
124742242|NCT00908037|448678910|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
124742243|NCT00908037|448678911|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
124742244|NCT00908037|448678912|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
124742245|NCT00908037|448678913|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
124742246|NCT00908037|448678902|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
124742247|NCT00908037|448678903|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
124742248|NCT00908037|448678904|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
124742249|NCT00908037|448678905|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
124742250|NCT00908037|448678906|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
124742251|NCT00908037|448678907|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
124742252|NCT00908037|448678908|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
124742253|NCT00908037|448678909|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
124742254|NCT00908037|448678910|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
124742255|NCT00908037|448678911|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
124742256|NCT00908037|448678912|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
124742257|NCT00908037|448678913|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
124742258|NCT00908037|448678902|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
124742259|NCT00908037|448678903|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
124742260|NCT00908037|448678904|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
124742261|NCT00908037|448678905|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
124742262|NCT00908037|448678906|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
124742263|NCT00908037|448678907|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
124742264|NCT00908037|448678908|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
124742265|NCT00908037|448678909|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
124742266|NCT00908037|448678910|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
124614022|NCT00642278|448205614|FG005|Overall Study|Physician Decision|0|||
124614023|NCT00642278|448205615|FG006|Overall Study|Physician Decision|0|||
124614024|NCT00642278|448205609|FG000|Overall Study|Protocol Violation|0|||
124614025|NCT00642278|448205610|FG001|Overall Study|Protocol Violation|0|||
124614026|NCT00642278|448205611|FG002|Overall Study|Protocol Violation|1|||
124742267|NCT00908037|448678911|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
124742268|NCT00908037|448678912|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
124742269|NCT00908037|448678913|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
124742270|NCT00908037|448678902|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
124742271|NCT00908037|448678903|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
124742272|NCT00908037|448678904|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
124742273|NCT00908037|448678905|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
124742274|NCT00908037|448678906|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
124742275|NCT00908037|448678907|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
124742276|NCT00908037|448678908|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
124742277|NCT00908037|448678909|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
124742278|NCT00908037|448678910|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
124742279|NCT00908037|448678911|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
124742280|NCT00908037|448678912|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
124742281|NCT00908037|448678913|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
124742282|NCT00908037|448678902|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
124742283|NCT00908037|448678903|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
124742284|NCT00908037|448678904|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
124742285|NCT00908037|448678905|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
124742286|NCT00908037|448678906|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
124742287|NCT00908037|448678907|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
124742288|NCT00908037|448678908|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
124742289|NCT00908037|448678909|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
124742290|NCT00908037|448678910|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
124742291|NCT00908037|448678911|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
124742292|NCT00908037|448678912|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
124742293|NCT00908037|448678913|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
124742294|NCT00908037|448678902|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
124742295|NCT00908037|448678903|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
124742296|NCT00908037|448678904|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
124742297|NCT00908037|448678905|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
124742298|NCT00908037|448678906|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
124742299|NCT00908037|448678907|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
124742300|NCT00908037|448678908|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
124742301|NCT00908037|448678909|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
124742302|NCT00908037|448678910|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
124742303|NCT00908037|448678911|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
124742304|NCT00908037|448678912|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
124742305|NCT00908037|448678913|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
124742306|NCT00908037|448678902|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
124742307|NCT00908037|448678903|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
124742308|NCT00908037|448678904|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
124742309|NCT00908037|448678905|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
124742310|NCT00908037|448678906|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
124742311|NCT00908037|448678907|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
124742312|NCT00908037|448678908|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
124742313|NCT00908037|448678909|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
124742314|NCT00908037|448678910|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
124742315|NCT00908037|448678911|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
124742316|NCT00908037|448678912|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
124742317|NCT00908037|448678913|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
124742318|NCT00908037|448678902|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
124742319|NCT00908037|448678903|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
124742320|NCT00908037|448678904|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
124742321|NCT00908037|448678905|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
124742322|NCT00908037|448678906|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
124742323|NCT00908037|448678907|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
124742324|NCT00908037|448678908|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
124742325|NCT00908037|448678909|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
124752829|NCT00858637|448716866|FG003|Active Comparison Phase|Adverse Event|9|||
124752830|NCT00858637|448716867|FG004|Active Comparison Phase|Adverse Event|0|||
124752831|NCT00858637|448716868|FG005|Active Comparison Phase|Adverse Event|0|||
124742326|NCT00908037|448678910|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
124742327|NCT00908037|448678911|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
124742328|NCT00908037|448678912|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
124742329|NCT00908037|448678913|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
124742330|NCT00869401|448678915|FG000|Overall Study|Withdrawal by Subject|0|||
124742331|NCT00869401|448678916|FG001|Overall Study|Withdrawal by Subject|0|||
124742332|NCT00869401|448678917|FG002|Overall Study|Withdrawal by Subject|0|||
124742333|NCT00869401|448678918|FG003|Overall Study|Withdrawal by Subject|5|||
124742334|NCT00869401|448678919|FG004|Overall Study|Withdrawal by Subject|3|||
124742335|NCT01147900|448678920|FG000|At Year 10|Lost to Follow-up|0|||
124742336|NCT01147900|448678921|FG001|At Year 10|Lost to Follow-up|1|||
124742337|NCT01147900|448678922|FG002|At Year 10|Lost to Follow-up|0|||
124742338|NCT00581360|448678925|FG000|Overall Study|Withdrawal by Subject|1|||
124742339|NCT04405245|448678926|FG000|Overall Study|Adverse Event|0|||
124742340|NCT04405245|448678927|FG001|Overall Study|Adverse Event|1|||
124742341|NCT04405245|448678928|FG002|Overall Study|Adverse Event|0|||
124742342|NCT02391961|448678929|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
124742343|NCT02391961|448678930|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
124742344|NCT02391961|448678929|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
124742345|NCT02391961|448678930|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
124742346|NCT02391961|448678929|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
124742347|NCT02391961|448678930|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
124742348|NCT00491608|448678934|FG000|Overall Study|Death|2|||
124742349|NCT00491608|448678934|FG000|Overall Study|Withdrawal by Subject|1|||
124742350|NCT00025155|448678935|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
124742351|NCT00025155|448678935|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
124742352|NCT00413374|448678936|FG000|Overall Study|Ineligible due to screening criteria.|3|||
124742353|NCT00413374|448678937|FG001|Overall Study|Ineligible due to screening criteria.|0|||
124742354|NCT00413374|448678936|FG000|Overall Study|Adverse Event|1|||
124742355|NCT00413374|448678937|FG001|Overall Study|Adverse Event|0|||
124742356|NCT00413374|448678936|FG000|Overall Study|Lost to Follow-up|1|||
124742357|NCT00413374|448678937|FG001|Overall Study|Lost to Follow-up|0|||
124742358|NCT00413374|448678936|FG000|Overall Study|Surgery|1|||
124742359|NCT00413374|448678937|FG001|Overall Study|Surgery|0|||
124742360|NCT00552760|448678938|FG000|Overall Study|Adverse Event|3|||
124742361|NCT00552760|448678939|FG001|Overall Study|Adverse Event|5|||
124742362|NCT00552760|448678938|FG000|Overall Study|Relapsed- Depressed Event|10|||
124742363|NCT00552760|448678939|FG001|Overall Study|Relapsed- Depressed Event|16|||
124742364|NCT00552760|448678938|FG000|Overall Study|Relapse- Manic Event|3|||
124742365|NCT00552760|448678939|FG001|Overall Study|Relapse- Manic Event|3|||
124742366|NCT00552760|448678938|FG000|Overall Study|Relapsed- Mixed Event|3|||
124742367|NCT00552760|448678939|FG001|Overall Study|Relapsed- Mixed Event|5|||
124742368|NCT00552760|448678938|FG000|Overall Study|Protocol Violation|0|||
124742369|NCT00552760|448678939|FG001|Overall Study|Protocol Violation|1|||
124742370|NCT00552760|448678938|FG000|Overall Study|Lost to Follow-up|1|||
124742371|NCT00552760|448678939|FG001|Overall Study|Lost to Follow-up|1|||
124742372|NCT00552760|448678938|FG000|Overall Study|Non-compliance|1|||
124742373|NCT00552760|448678939|FG001|Overall Study|Non-compliance|1|||
124742374|NCT00552760|448678938|FG000|Overall Study|Medical Condition|1|||
124742375|NCT00552760|448678939|FG001|Overall Study|Medical Condition|1|||
124742376|NCT00552760|448678938|FG000|Overall Study|Withdrawal by Subject|3|||
124742377|NCT00552760|448678939|FG001|Overall Study|Withdrawal by Subject|0|||
124742378|NCT00552760|448678938|FG000|Overall Study|Medication Change|1|||
124742379|NCT00552760|448678939|FG001|Overall Study|Medication Change|0|||
124742380|NCT00924404|448678943|FG000|Overall Study|Lost to Follow-up|6|||
124742381|NCT00924404|448678944|FG001|Overall Study|Lost to Follow-up|4|||
124742382|NCT02613169|448678945|FG000|Overall Study|Withdrawal by Subject|4|||
124742383|NCT02613169|448678946|FG001|Overall Study|Withdrawal by Subject|1|||
124742384|NCT02613169|448678945|FG000|Overall Study|Lost to Follow-up|0|||
124742385|NCT02613169|448678946|FG001|Overall Study|Lost to Follow-up|5|||
124742386|NCT02613169|448678945|FG000|Overall Study|HIV|0|||
124742387|NCT02613169|448678946|FG001|Overall Study|HIV|2|||
124742388|NCT02613169|448678945|FG000|Overall Study|No TB infection endpoint|14|||
124742389|NCT02613169|448678946|FG001|Overall Study|No TB infection endpoint|9|||
124742390|NCT00343382|448678947|FG000|Overall Study|Adverse Event|2|||
124614027|NCT00642278|448205612|FG003|Overall Study|Protocol Violation|1|||
124742391|NCT00343382|448678948|FG001|Overall Study|Adverse Event|10|||
124742392|NCT00343382|448678949|FG002|Overall Study|Adverse Event|7|||
124742393|NCT00343382|448678947|FG000|Overall Study|Withdrawal by Subject|1|||
124742394|NCT00343382|448678948|FG001|Overall Study|Withdrawal by Subject|2|||
124742395|NCT00343382|448678949|FG002|Overall Study|Withdrawal by Subject|6|||
124742396|NCT00343382|448678947|FG000|Overall Study|Other Reason Not Specified|1|||
124742397|NCT00343382|448678948|FG001|Overall Study|Other Reason Not Specified|2|||
124742398|NCT00343382|448678949|FG002|Overall Study|Other Reason Not Specified|4|||
124742399|NCT01985360|448678950|FG000|Overall Study|Withdrawal by Subject|4|||
124742400|NCT01985360|448678951|FG001|Overall Study|Withdrawal by Subject|0|||
124742401|NCT01985360|448678950|FG000|Overall Study|Lost to Follow-up|5|||
124742402|NCT01985360|448678951|FG001|Overall Study|Lost to Follow-up|3|||
124742403|NCT02976103|448678952|FG000|Overall Study|Withdrawal by Subject|1|||
124742404|NCT02976103|448678953|FG001|Overall Study|Withdrawal by Subject|0|||
124742405|NCT02976103|448678952|FG000|Overall Study|Lost to Follow-up|12|||
124742406|NCT02976103|448678953|FG001|Overall Study|Lost to Follow-up|8|||
124742407|NCT01455220|448678954|FG000|Overall Study|screen fail|30|||
124742408|NCT04881747|448678955|FG000|Period 2 Washout|Adverse Event|1|||
124742409|NCT04881747|448678956|FG001|Period 2 Washout|Adverse Event|0|||
124742410|NCT04881747|448678957|FG002|Period 2 Washout|Adverse Event|0|||
124742411|NCT04881747|448678958|FG003|Period 2 Washout|Adverse Event|0|||
124742412|NCT04881747|448678959|FG004|Period 2 Washout|Adverse Event|1|||
124742413|NCT04881747|448678960|FG005|Period 2 Washout|Adverse Event|0|||
124742414|NCT04881747|448678955|FG000|Period 2 Washout|Withdrawal by Subject|1|||
124742415|NCT04881747|448678956|FG001|Period 2 Washout|Withdrawal by Subject|0|||
124742416|NCT04881747|448678957|FG002|Period 2 Washout|Withdrawal by Subject|0|||
124742417|NCT04881747|448678958|FG003|Period 2 Washout|Withdrawal by Subject|1|||
124742418|NCT04881747|448678959|FG004|Period 2 Washout|Withdrawal by Subject|0|||
124742419|NCT04881747|448678960|FG005|Period 2 Washout|Withdrawal by Subject|0|||
124742420|NCT04598269|448678961|FG000|Overall Study|Adverse Event|0|||
124742421|NCT04598269|448678962|FG001|Overall Study|Adverse Event|3|||
124742422|NCT04598269|448678961|FG000|Overall Study|Withdrawal by Subject|1|||
124742423|NCT04598269|448678962|FG001|Overall Study|Withdrawal by Subject|4|||
124742424|NCT04598269|448678961|FG000|Overall Study|Lost to Follow-up|1|||
124742425|NCT04598269|448678962|FG001|Overall Study|Lost to Follow-up|0|||
124742426|NCT04598269|448678961|FG000|Overall Study|Not Treated|2|||
124742427|NCT04598269|448678962|FG001|Overall Study|Not Treated|0|||
124742428|NCT03869333|448678967|FG000|Overall Study|Lost to Follow-up|1|||
124742429|NCT03869333|448678968|FG001|Overall Study|Lost to Follow-up|0|||
124742430|NCT03869333|448678969|FG002|Overall Study|Lost to Follow-up|0|||
124742431|NCT03869333|448678970|FG003|Overall Study|Lost to Follow-up|0|||
124742432|NCT03869333|448678967|FG000|Overall Study|Pregnancy|1|||
124742433|NCT03869333|448678968|FG001|Overall Study|Pregnancy|0|||
124742434|NCT03869333|448678969|FG002|Overall Study|Pregnancy|0|||
124742435|NCT03869333|448678970|FG003|Overall Study|Pregnancy|0|||
124742436|NCT03869333|448678967|FG000|Overall Study|Physician Decision|0|||
124742437|NCT03869333|448678968|FG001|Overall Study|Physician Decision|1|||
124742438|NCT03869333|448678969|FG002|Overall Study|Physician Decision|0|||
124742439|NCT03869333|448678970|FG003|Overall Study|Physician Decision|0|||
124742440|NCT02598128|448678971|FG000|Period A: Days -7 to -1|Adverse Event|1|||
124742441|NCT02598128|448678972|FG001|Period A: Days -7 to -1|Adverse Event|0|||
124742442|NCT02598128|448678973|FG002|Period A: Days -7 to -1|Adverse Event|0|||
124742443|NCT02598128|448678974|FG003|Period A: Days -7 to -1|Adverse Event|0|||
124742444|NCT03134183|448678975|FG000|Overall Study|Withdrawal by Subject|1|||
124742445|NCT03134183|448678976|FG001|Overall Study|Withdrawal by Subject|1|||
124742446|NCT00845065|448678979|FG000|Overall Study|Adverse Event|3|||
124742447|NCT00845065|448678980|FG001|Overall Study|Adverse Event|23|||
124742448|NCT00845065|448678979|FG000|Overall Study|Lack of Efficacy|43|||
124742449|NCT00845065|448678980|FG001|Overall Study|Lack of Efficacy|21|||
124742450|NCT00845065|448678979|FG000|Overall Study|Non-Medical Reasons|1|||
124742451|NCT00845065|448678980|FG001|Overall Study|Non-Medical Reasons|11|||
124742452|NCT00162266|448678981|FG000|Double-Blind Period|Adverse Event|5|||
124742453|NCT00162266|448678982|FG001|Double-Blind Period|Adverse Event|9|||
124742454|NCT00162266|448678983|FG002|Double-Blind Period|Adverse Event|11|||
124742455|NCT00162266|448678984|FG003|Double-Blind Period|Adverse Event|0|||
124742456|NCT00162266|448678981|FG000|Double-Blind Period|Death|0|||
124742457|NCT00162266|448678982|FG001|Double-Blind Period|Death|1|||
124742458|NCT00162266|448678983|FG002|Double-Blind Period|Death|0|||
124742459|NCT00162266|448678984|FG003|Double-Blind Period|Death|0|||
124742460|NCT00162266|448678981|FG000|Double-Blind Period|Lost to Follow-up|1|||
124742461|NCT00162266|448678982|FG001|Double-Blind Period|Lost to Follow-up|2|||
124742462|NCT00162266|448678983|FG002|Double-Blind Period|Lost to Follow-up|0|||
124742463|NCT00162266|448678984|FG003|Double-Blind Period|Lost to Follow-up|0|||
124742464|NCT00162266|448678981|FG000|Double-Blind Period|Other Reason|1|||
124742465|NCT00162266|448678982|FG001|Double-Blind Period|Other Reason|0|||
124742466|NCT00162266|448678983|FG002|Double-Blind Period|Other Reason|1|||
124742467|NCT00162266|448678984|FG003|Double-Blind Period|Other Reason|0|||
124742468|NCT00162266|448678981|FG000|Double-Blind Period|Lack of Efficacy|13|||
124742469|NCT00162266|448678982|FG001|Double-Blind Period|Lack of Efficacy|17|||
124742470|NCT00162266|448678983|FG002|Double-Blind Period|Lack of Efficacy|30|||
124742471|NCT00162266|448678984|FG003|Double-Blind Period|Lack of Efficacy|0|||
124742472|NCT00162266|448678981|FG000|Double-Blind Period|Withdrawal by Subject|5|||
124742473|NCT00162266|448678982|FG001|Double-Blind Period|Withdrawal by Subject|2|||
124742474|NCT00162266|448678983|FG002|Double-Blind Period|Withdrawal by Subject|6|||
124742475|NCT00162266|448678984|FG003|Double-Blind Period|Withdrawal by Subject|0|||
124742476|NCT00162266|448678981|FG000|Open-Label Period|Death|0|||
124742477|NCT00162266|448678982|FG001|Open-Label Period|Death|0|||
124742478|NCT00162266|448678983|FG002|Open-Label Period|Death|0|||
124742479|NCT00162266|448678984|FG003|Open-Label Period|Death|7|||
124742480|NCT00162266|448678981|FG000|Open-Label Period|Adverse Event|0|||
124614028|NCT00642278|448205613|FG004|Overall Study|Protocol Violation|0|||
124614029|NCT00642278|448205614|FG005|Overall Study|Protocol Violation|1|||
124614030|NCT00642278|448205615|FG006|Overall Study|Protocol Violation|2|||
124742481|NCT00162266|448678982|FG001|Open-Label Period|Adverse Event|0|||
124742482|NCT00162266|448678983|FG002|Open-Label Period|Adverse Event|0|||
124742483|NCT00162266|448678984|FG003|Open-Label Period|Adverse Event|46|||
124742484|NCT00162266|448678981|FG000|Open-Label Period|Lack of Efficacy|0|||
124742485|NCT00162266|448678982|FG001|Open-Label Period|Lack of Efficacy|0|||
124742486|NCT00162266|448678983|FG002|Open-Label Period|Lack of Efficacy|0|||
124742487|NCT00162266|448678984|FG003|Open-Label Period|Lack of Efficacy|26|||
124742488|NCT00162266|448678981|FG000|Open-Label Period|Lost to Follow-up|0|||
124742489|NCT00162266|448678982|FG001|Open-Label Period|Lost to Follow-up|0|||
124742490|NCT00162266|448678983|FG002|Open-Label Period|Lost to Follow-up|0|||
124742491|NCT00162266|448678984|FG003|Open-Label Period|Lost to Follow-up|3|||
124742492|NCT00162266|448678981|FG000|Open-Label Period|Withdrawal by Subject|0|||
124742493|NCT00162266|448678982|FG001|Open-Label Period|Withdrawal by Subject|0|||
124742494|NCT00162266|448678983|FG002|Open-Label Period|Withdrawal by Subject|0|||
124742495|NCT00162266|448678984|FG003|Open-Label Period|Withdrawal by Subject|31|||
124742496|NCT00162266|448678981|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
124742497|NCT00162266|448678982|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
124742498|NCT00162266|448678983|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
124742499|NCT00162266|448678984|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
124742500|NCT00162266|448678981|FG000|Open-Label Period|Other Reasons|0|||
124742501|NCT00162266|448678982|FG001|Open-Label Period|Other Reasons|0|||
124742502|NCT00162266|448678983|FG002|Open-Label Period|Other Reasons|0|||
124742503|NCT00162266|448678984|FG003|Open-Label Period|Other Reasons|15|||
124742504|NCT01198509|448678985|FG000|Overall Study|Withdrawal by Subject|1|||
124742505|NCT01198509|448678986|FG001|Overall Study|Withdrawal by Subject|0|||
124742506|NCT01198509|448678987|FG002|Overall Study|Withdrawal by Subject|0|||
124742507|NCT01198509|448678988|FG003|Overall Study|Withdrawal by Subject|0|||
124742508|NCT01198509|448678989|FG004|Overall Study|Withdrawal by Subject|0|||
124742509|NCT01198509|448678990|FG005|Overall Study|Withdrawal by Subject|0|||
124742510|NCT00499746|448678991|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
124742511|NCT00499746|448678991|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
124742512|NCT00499746|448678991|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
124742513|NCT00499746|448678991|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
124742514|NCT01291277|448678994|FG000|Overall Study|Death|2|||
124742515|NCT01291277|448678995|FG001|Overall Study|Death|2|||
124742516|NCT01291277|448678994|FG000|Overall Study|Lost to Follow-up|3|||
124742517|NCT01291277|448678995|FG001|Overall Study|Lost to Follow-up|1|||
124742518|NCT03480009|448678996|FG000|Overall Study|Lost to Follow-up|4|||
124742519|NCT03480009|448678997|FG001|Overall Study|Lost to Follow-up|5|||
124742520|NCT03480009|448678998|FG002|Overall Study|Lost to Follow-up|4|||
124742521|NCT03480009|448678999|FG003|Overall Study|Lost to Follow-up|0|||
124742522|NCT01563172|448679000|FG000|Overall Study|Adverse Event|5|||
124742523|NCT01563172|448679000|FG000|Overall Study|Lost to Follow-up|2|||
124742524|NCT01563172|448679000|FG000|Overall Study|Other (Protocol deviation)|5|||
124742525|NCT01563172|448679000|FG000|Overall Study|Other (Not specified)|1|||
124742526|NCT01638559|448679003|FG000|Overall Study|Lost to Follow-up|1|||
124742527|NCT01638559|448679003|FG000|Overall Study|Withdrawal by Subject|1|||
124742528|NCT01638559|448679003|FG000|Overall Study|Subject declined to travel for biopsy|1|||
124742529|NCT00483002|448679006|FG000|Overall Study|Adverse Event|68|||
124742530|NCT00483002|448679006|FG000|Overall Study|Lack of Efficacy|555|||
124742531|NCT00483002|448679006|FG000|Overall Study|Lost to Follow-up|962|||
124742532|NCT00483002|448679006|FG000|Overall Study|Other|2|||
124742533|NCT00483002|448679006|FG000|Overall Study|Other|967|||
124742534|NCT00772109|448679007|FG000|Overall Study|Serious adverse event|1|||
124742535|NCT00772109|448679008|FG001|Overall Study|Serious adverse event|0|||
124742536|NCT00772109|448679009|FG002|Overall Study|Serious adverse event|1|||
124614031|NCT00642278|448205609|FG000|Overall Study|Withdrawal by Subject|1|||
124781778|NCT00947882|448831169|FG000|Overall Study|Adverse Event|0|||
124781779|NCT00947882|448831170|FG001|Overall Study|Adverse Event|1|||
124781780|NCT00947882|448831171|FG002|Overall Study|Adverse Event|4|||
124781781|NCT00947882|448831172|FG003|Overall Study|Adverse Event|4|||
124742537|NCT00772109|448679010|FG003|Overall Study|Serious adverse event|0|||
124742538|NCT00772109|448679007|FG000|Overall Study|Protocol Violation|5|||
124742539|NCT00772109|448679008|FG001|Overall Study|Protocol Violation|8|||
124742540|NCT00772109|448679009|FG002|Overall Study|Protocol Violation|7|||
124742541|NCT00772109|448679010|FG003|Overall Study|Protocol Violation|6|||
124742542|NCT00772109|448679007|FG000|Overall Study|Lost to Follow-up|7|||
124742543|NCT00772109|448679008|FG001|Overall Study|Lost to Follow-up|3|||
124742544|NCT00772109|448679009|FG002|Overall Study|Lost to Follow-up|5|||
124742545|NCT00772109|448679010|FG003|Overall Study|Lost to Follow-up|9|||
124742546|NCT00772109|448679007|FG000|Overall Study|Withdrawal by Subject|8|||
124742547|NCT00772109|448679008|FG001|Overall Study|Withdrawal by Subject|8|||
124742548|NCT00772109|448679009|FG002|Overall Study|Withdrawal by Subject|6|||
124742549|NCT00772109|448679010|FG003|Overall Study|Withdrawal by Subject|16|||
124742550|NCT01624090|448679011|FG000|Overall Study|DLT, taken off therapy|0|||
124742551|NCT01624090|448679012|FG001|Overall Study|DLT, taken off therapy|1|||
124742552|NCT01624090|448679013|FG002|Overall Study|DLT, taken off therapy|0|||
124742553|NCT01624090|448679014|FG003|Overall Study|DLT, taken off therapy|0|||
124742554|NCT01624090|448679011|FG000|Overall Study|Withdrew prior to treatment|0|||
124742555|NCT01624090|448679012|FG001|Overall Study|Withdrew prior to treatment|1|||
124742556|NCT01624090|448679013|FG002|Overall Study|Withdrew prior to treatment|0|||
124742557|NCT01624090|448679014|FG003|Overall Study|Withdrew prior to treatment|0|||
124742558|NCT01624090|448679011|FG000|Overall Study|Died on study|0|||
124742559|NCT01624090|448679012|FG001|Overall Study|Died on study|0|||
124742560|NCT01624090|448679013|FG002|Overall Study|Died on study|2|||
124742561|NCT01624090|448679014|FG003|Overall Study|Died on study|0|||
124742562|NCT01624090|448679011|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
124742563|NCT01624090|448679012|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
124742564|NCT01624090|448679013|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
124742565|NCT01624090|448679014|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
124742566|NCT01624090|448679011|FG000|Overall Study|Dose escalated|0|||
124742567|NCT01624090|448679012|FG001|Overall Study|Dose escalated|0|||
124742568|NCT01624090|448679013|FG002|Overall Study|Dose escalated|3|||
124742569|NCT01624090|448679014|FG003|Overall Study|Dose escalated|0|||
124742570|NCT00752726|448679015|FG000|Overall Study|Lost to Follow-up|2|||
124742571|NCT00752726|448679016|FG001|Overall Study|Lost to Follow-up|1|||
124742572|NCT00752726|448679015|FG000|Overall Study|Adverse Event|3|||
124742573|NCT00752726|448679016|FG001|Overall Study|Adverse Event|0|||
124742574|NCT00752726|448679015|FG000|Overall Study|Withdrawal by Subject|5|||
124742575|NCT00752726|448679016|FG001|Overall Study|Withdrawal by Subject|10|||
124742576|NCT00752726|448679015|FG000|Overall Study|Other Reason|1|||
124742577|NCT00752726|448679016|FG001|Overall Study|Other Reason|2|||
124742578|NCT01403116|448679017|FG000|Overall Study|Adverse Event|7|||
124742579|NCT01403116|448679018|FG001|Overall Study|Adverse Event|4|||
124742580|NCT01403116|448679017|FG000|Overall Study|Lost to Follow-up|7|||
124742581|NCT01403116|448679018|FG001|Overall Study|Lost to Follow-up|5|||
124742582|NCT01403116|448679017|FG000|Overall Study|Withdrawal by Subject|12|||
124742583|NCT01403116|448679018|FG001|Overall Study|Withdrawal by Subject|15|||
124742584|NCT01403116|448679017|FG000|Overall Study|Non-compliance of study drug|3|||
124742585|NCT01403116|448679018|FG001|Overall Study|Non-compliance of study drug|0|||
124742586|NCT01403116|448679017|FG000|Overall Study|Protocol Violation|0|||
124742587|NCT01403116|448679018|FG001|Overall Study|Protocol Violation|1|||
124742588|NCT01403116|448679017|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
124742589|NCT01403116|448679018|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
124742590|NCT01403116|448679017|FG000|Overall Study|Hct >54%|2|||
124742591|NCT01403116|448679018|FG001|Overall Study|Hct >54%|0|||
124742592|NCT01403116|448679017|FG000|Overall Study|unable to keep appointments|0|||
124742593|NCT01403116|448679018|FG001|Overall Study|unable to keep appointments|2|||
124742594|NCT01895309|448679019|FG000|Overall Study|Adverse Event|13|||
124742595|NCT01895309|448679020|FG001|Overall Study|Adverse Event|17|||
124742596|NCT01895309|448679019|FG000|Overall Study|Protocol Violation|1|||
124742597|NCT01895309|448679020|FG001|Overall Study|Protocol Violation|0|||
124742598|NCT01895309|448679019|FG000|Overall Study|Lack of Efficacy|1|||
124742599|NCT01895309|448679020|FG001|Overall Study|Lack of Efficacy|3|||
124742600|NCT01895309|448679019|FG000|Overall Study|Lost to Follow-up|1|||
124742601|NCT01895309|448679020|FG001|Overall Study|Lost to Follow-up|3|||
124742602|NCT01895309|448679019|FG000|Overall Study|Physician Decision|15|||
124742603|NCT01895309|448679020|FG001|Overall Study|Physician Decision|10|||
124742604|NCT01895309|448679019|FG000|Overall Study|Withdrawal by Subject|9|||
124742605|NCT01895309|448679020|FG001|Overall Study|Withdrawal by Subject|18|||
124742606|NCT00042666|448679021|FG000|Overall Study|Adverse Event|2|||
124742607|NCT00042666|448679021|FG000|Overall Study|Death|4|||
124614032|NCT00642278|448205610|FG001|Overall Study|Withdrawal by Subject|1|||
124742608|NCT00042666|448679021|FG000|Overall Study|Protocol Violation|1|||
124742609|NCT00042666|448679021|FG000|Overall Study|Participant/Physician Perception|1|||
124742610|NCT00042666|448679021|FG000|Overall Study|Progressive Disease|41|||
124742611|NCT00042666|448679021|FG000|Overall Study|Other|1|||
124742612|NCT00042666|448679021|FG000|Overall Study|Other|4|||
124614033|NCT00642278|448205611|FG002|Overall Study|Withdrawal by Subject|1|||
124742613|NCT04232215|448679022|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
124742614|NCT04232215|448679023|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
124742615|NCT01879072|448679035|FG000|Overall Study|Withdrawal by Subject|121|||
124742616|NCT01879072|448679035|FG000|Overall Study|Not Transplanted|30|||
124614034|NCT00642278|448205612|FG003|Overall Study|Withdrawal by Subject|3|||
124742617|NCT00626405|448679038|FG000|Overall Study|Deemed Ineligible|1|||
124742618|NCT00626405|448679039|FG001|Overall Study|Deemed Ineligible|0|||
124742619|NCT00626405|448679038|FG000|Overall Study|Withdrawal by Subject|0|||
124742620|NCT00626405|448679039|FG001|Overall Study|Withdrawal by Subject|1|||
124742621|NCT04046250|448679042|FG000|Overall Study|Death|0|||
124742622|NCT04046250|448679043|FG001|Overall Study|Death|1|||
124742623|NCT04046250|448679042|FG000|Overall Study|Withdrawal by Subject|3|||
124742624|NCT04046250|448679043|FG001|Overall Study|Withdrawal by Subject|3|||
124614035|NCT00642278|448205613|FG004|Overall Study|Withdrawal by Subject|6|||
124614036|NCT00642278|448205614|FG005|Overall Study|Withdrawal by Subject|2|||
124614037|NCT00642278|448205615|FG006|Overall Study|Withdrawal by Subject|2|||
124614038|NCT00642278|448205609|FG000|Overall Study|Noncompliance with study drug regimen|0|||
124614039|NCT00642278|448205610|FG001|Overall Study|Noncompliance with study drug regimen|0|||
124614040|NCT00642278|448205611|FG002|Overall Study|Noncompliance with study drug regimen|0|||
124614041|NCT00642278|448205612|FG003|Overall Study|Noncompliance with study drug regimen|1|||
124614042|NCT00642278|448205613|FG004|Overall Study|Noncompliance with study drug regimen|0|||
124614043|NCT00642278|448205614|FG005|Overall Study|Noncompliance with study drug regimen|0|||
124614044|NCT00642278|448205615|FG006|Overall Study|Noncompliance with study drug regimen|0|||
124614045|NCT00642278|448205609|FG000|Overall Study|Other|2|||
124614046|NCT00642278|448205610|FG001|Overall Study|Other|1|||
124614047|NCT00642278|448205611|FG002|Overall Study|Other|0|||
124614048|NCT00642278|448205612|FG003|Overall Study|Other|1|||
124614049|NCT00642278|448205613|FG004|Overall Study|Other|0|||
124614050|NCT00642278|448205614|FG005|Overall Study|Other|1|||
124614051|NCT00642278|448205615|FG006|Overall Study|Other|0|||
124614052|NCT00090363|448205616|FG000|Overall Study|Lost to Follow-up|1|||
124614053|NCT00090363|448205617|FG001|Overall Study|Lost to Follow-up|2|||
124614054|NCT00090363|448205618|FG002|Overall Study|Lost to Follow-up|1|||
124614055|NCT00090363|448205616|FG000|Overall Study|Withdrawal by Subject|7|||
124614056|NCT00090363|448205617|FG001|Overall Study|Withdrawal by Subject|7|||
124614057|NCT00090363|448205618|FG002|Overall Study|Withdrawal by Subject|6|||
124614058|NCT00090363|448205616|FG000|Overall Study|Study-specific discontinuation criteria|75|||
124614059|NCT00090363|448205617|FG001|Overall Study|Study-specific discontinuation criteria|74|||
124614060|NCT00090363|448205618|FG002|Overall Study|Study-specific discontinuation criteria|62|||
124614061|NCT00090363|448205616|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124614062|NCT00090363|448205617|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124614063|NCT00090363|448205618|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
124614064|NCT00090363|448205616|FG000|Overall Study|Consent expired|7|||
124614065|NCT00090363|448205617|FG001|Overall Study|Consent expired|10|||
124614066|NCT00090363|448205618|FG002|Overall Study|Consent expired|9|||
124614067|NCT00090363|448205616|FG000|Overall Study|Reasons not specified|2|||
124614068|NCT00090363|448205617|FG001|Overall Study|Reasons not specified|1|||
124614069|NCT00090363|448205618|FG002|Overall Study|Reasons not specified|1|||
124614070|NCT00090363|448205616|FG000|Overall Study|Continuing on study off treatment|14|||
124614071|NCT00090363|448205617|FG001|Overall Study|Continuing on study off treatment|13|||
124614072|NCT00090363|448205618|FG002|Overall Study|Continuing on study off treatment|16|||
124614073|NCT03713619|448205619|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
124614074|NCT03713619|448205620|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
124614075|NCT03713619|448205621|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
124614076|NCT03713619|448205622|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
124614077|NCT03713619|448205623|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
124614078|NCT03713619|448205619|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
124614079|NCT03713619|448205620|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
124614080|NCT03713619|448205621|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
124614081|NCT03713619|448205622|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
124614082|NCT03713619|448205623|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
124614083|NCT03713619|448205619|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
124614084|NCT03713619|448205620|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
124614085|NCT03713619|448205621|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
124614086|NCT03713619|448205622|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
124614087|NCT03713619|448205623|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
124614088|NCT03713619|448205619|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
124614089|NCT03713619|448205620|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
124614090|NCT03713619|448205621|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
124614091|NCT03713619|448205622|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
124614092|NCT03713619|448205623|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
124614093|NCT03713619|448205619|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
124614094|NCT03713619|448205620|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
124614095|NCT03713619|448205621|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
124614096|NCT03713619|448205622|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
124614097|NCT03713619|448205623|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
124614098|NCT03713619|448205619|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
124614099|NCT03713619|448205620|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
124614100|NCT03713619|448205621|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
124614101|NCT03713619|448205622|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
124614102|NCT03713619|448205623|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
124614103|NCT03713619|448205619|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
124614104|NCT03713619|448205620|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
124614105|NCT03713619|448205621|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
124742625|NCT04576897|448679048|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
124742626|NCT00527332|448679049|FG000|Overall Study|Protocol Violation|4|||
124742627|NCT00527332|448679050|FG001|Overall Study|Protocol Violation|8|||
124742628|NCT00527332|448679049|FG000|Overall Study|Withdrew consent|5|||
124742629|NCT00527332|448679050|FG001|Overall Study|Withdrew consent|1|||
124742630|NCT02666105|448679051|FG000|Overall Study|Death|1|||
124742631|NCT01078168|448679052|FG000|Overall Study|Physician Decision|0|||
124742632|NCT01078168|448679053|FG001|Overall Study|Physician Decision|1|||
124742633|NCT01264419|448679055|FG000|Overall Study|Lost to Follow-up|3|||
124742634|NCT00358436|448681305|FG000|Overall Study|Adverse Event|29|||
124742635|NCT00358436|448681306|FG001|Overall Study|Adverse Event|13|||
124742636|NCT00358436|448681305|FG000|Overall Study|Lack of Efficacy|34|||
124742637|NCT00358436|448681306|FG001|Overall Study|Lack of Efficacy|36|||
124742638|NCT00358436|448681305|FG000|Overall Study|Lost to Follow-up|11|||
124742639|NCT00358436|448681306|FG001|Overall Study|Lost to Follow-up|6|||
124742640|NCT00358436|448681305|FG000|Overall Study|Protocol Violation|8|||
124742641|NCT00358436|448681306|FG001|Overall Study|Protocol Violation|3|||
124742642|NCT00358436|448681305|FG000|Overall Study|Withdrawal by Subject|40|||
124742643|NCT00358436|448681306|FG001|Overall Study|Withdrawal by Subject|17|||
124742644|NCT00358436|448681305|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
124742645|NCT00358436|448681306|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
124742646|NCT00358436|448681305|FG000|Overall Study|COPD exacerbation|22|||
124742647|NCT00358436|448681306|FG001|Overall Study|COPD exacerbation|10|||
124742648|NCT00358436|448681305|FG000|Overall Study|Other|6|||
124742649|NCT00358436|448681306|FG001|Overall Study|Other|1|||
124742650|NCT02905006|448681308|FG000|Overall Study|Adverse Event|1|||
124742651|NCT02905006|448681309|FG001|Overall Study|Adverse Event|1|||
124742652|NCT02905006|448681310|FG002|Overall Study|Adverse Event|1|||
124742653|NCT02905006|448681311|FG003|Overall Study|Adverse Event|1|||
124742654|NCT02905006|448681312|FG004|Overall Study|Adverse Event|0|||
124742655|NCT02905006|448681313|FG005|Overall Study|Adverse Event|1|||
124742656|NCT02905006|448681308|FG000|Overall Study|Lack of Efficacy|1|||
124742657|NCT02905006|448681309|FG001|Overall Study|Lack of Efficacy|0|||
124742658|NCT02905006|448681310|FG002|Overall Study|Lack of Efficacy|0|||
124742659|NCT02905006|448681311|FG003|Overall Study|Lack of Efficacy|0|||
124742660|NCT02905006|448681312|FG004|Overall Study|Lack of Efficacy|0|||
124742661|NCT02905006|448681313|FG005|Overall Study|Lack of Efficacy|0|||
124742662|NCT02905006|448681308|FG000|Overall Study|Protocol Violation|2|||
124742663|NCT02905006|448681309|FG001|Overall Study|Protocol Violation|0|||
124742664|NCT02905006|448681310|FG002|Overall Study|Protocol Violation|0|||
124742665|NCT02905006|448681311|FG003|Overall Study|Protocol Violation|0|||
124742666|NCT02905006|448681312|FG004|Overall Study|Protocol Violation|0|||
124742667|NCT02905006|448681313|FG005|Overall Study|Protocol Violation|0|||
124742668|NCT02905006|448681308|FG000|Overall Study|Lost to Follow-up|0|||
124742669|NCT02905006|448681309|FG001|Overall Study|Lost to Follow-up|0|||
124742670|NCT02905006|448681310|FG002|Overall Study|Lost to Follow-up|0|||
124742671|NCT02905006|448681311|FG003|Overall Study|Lost to Follow-up|1|||
124742672|NCT02905006|448681312|FG004|Overall Study|Lost to Follow-up|1|||
124742673|NCT02905006|448681313|FG005|Overall Study|Lost to Follow-up|0|||
124742674|NCT02905006|448681308|FG000|Overall Study|Withdrawal by Subject|0|||
124742675|NCT02905006|448681309|FG001|Overall Study|Withdrawal by Subject|0|||
124742676|NCT02905006|448681310|FG002|Overall Study|Withdrawal by Subject|1|||
124742677|NCT02905006|448681311|FG003|Overall Study|Withdrawal by Subject|1|||
124742678|NCT02905006|448681312|FG004|Overall Study|Withdrawal by Subject|0|||
124742679|NCT02905006|448681313|FG005|Overall Study|Withdrawal by Subject|1|||
124742680|NCT02905006|448681308|FG000|Overall Study|Screening exclusion criteria met|1|||
124742681|NCT02905006|448681309|FG001|Overall Study|Screening exclusion criteria met|0|||
124742682|NCT02905006|448681310|FG002|Overall Study|Screening exclusion criteria met|0|||
124742683|NCT02905006|448681311|FG003|Overall Study|Screening exclusion criteria met|0|||
124742684|NCT02905006|448681312|FG004|Overall Study|Screening exclusion criteria met|0|||
124742685|NCT02905006|448681313|FG005|Overall Study|Screening exclusion criteria met|0|||
124742686|NCT02905006|448681308|FG000|Overall Study|Lab withdrawal criterion met|0|||
124742687|NCT02905006|448681309|FG001|Overall Study|Lab withdrawal criterion met|1|||
124742688|NCT02905006|448681310|FG002|Overall Study|Lab withdrawal criterion met|2|||
124742689|NCT02905006|448681311|FG003|Overall Study|Lab withdrawal criterion met|2|||
124742690|NCT02905006|448681312|FG004|Overall Study|Lab withdrawal criterion met|2|||
124742691|NCT02905006|448681313|FG005|Overall Study|Lab withdrawal criterion met|1|||
124742692|NCT02905006|448681308|FG000|Overall Study|Positive for Tuberculosis|0|||
124742693|NCT02905006|448681309|FG001|Overall Study|Positive for Tuberculosis|1|||
124742694|NCT02905006|448681310|FG002|Overall Study|Positive for Tuberculosis|0|||
124742695|NCT02905006|448681311|FG003|Overall Study|Positive for Tuberculosis|0|||
124742696|NCT02905006|448681312|FG004|Overall Study|Positive for Tuberculosis|0|||
124742697|NCT02905006|448681313|FG005|Overall Study|Positive for Tuberculosis|0|||
124742698|NCT02905006|448681308|FG000|Overall Study|Subject positive for Hep B|0|||
124742699|NCT02905006|448681309|FG001|Overall Study|Subject positive for Hep B|0|||
124742700|NCT02905006|448681310|FG002|Overall Study|Subject positive for Hep B|1|||
124742701|NCT02905006|448681311|FG003|Overall Study|Subject positive for Hep B|0|||
124742702|NCT02905006|448681312|FG004|Overall Study|Subject positive for Hep B|0|||
124742703|NCT02905006|448681313|FG005|Overall Study|Subject positive for Hep B|0|||
124742704|NCT02905006|448681308|FG000|Overall Study|Patient moved abroad|0|||
124742705|NCT02905006|448681309|FG001|Overall Study|Patient moved abroad|0|||
124742706|NCT02905006|448681310|FG002|Overall Study|Patient moved abroad|0|||
124742707|NCT02905006|448681311|FG003|Overall Study|Patient moved abroad|1|||
124742708|NCT02905006|448681312|FG004|Overall Study|Patient moved abroad|0|||
124742709|NCT02905006|448681313|FG005|Overall Study|Patient moved abroad|0|||
124742710|NCT02905006|448681308|FG000|Overall Study|Patient randomized by mistake|0|||
124742711|NCT02905006|448681309|FG001|Overall Study|Patient randomized by mistake|0|||
124742712|NCT02905006|448681310|FG002|Overall Study|Patient randomized by mistake|0|||
124742713|NCT02905006|448681311|FG003|Overall Study|Patient randomized by mistake|0|||
124742714|NCT02905006|448681312|FG004|Overall Study|Patient randomized by mistake|0|||
124742715|NCT02905006|448681313|FG005|Overall Study|Patient randomized by mistake|1|||
124742716|NCT04201093|448681318|FG000|Overall Study|Adverse Event|6|||
124742717|NCT04201093|448681319|FG001|Overall Study|Adverse Event|29|||
124742718|NCT04201093|448681320|FG002|Overall Study|Adverse Event|35|||
124742719|NCT04201093|448681318|FG000|Overall Study|Death|2|||
124742720|NCT04201093|448681319|FG001|Overall Study|Death|1|||
124742721|NCT04201093|448681320|FG002|Overall Study|Death|0|||
124742722|NCT04201093|448681318|FG000|Overall Study|Lack of Efficacy|5|||
124742723|NCT04201093|448681319|FG001|Overall Study|Lack of Efficacy|1|||
124742724|NCT04201093|448681320|FG002|Overall Study|Lack of Efficacy|2|||
124742725|NCT04201093|448681318|FG000|Overall Study|Lost to Follow-up|0|||
124742726|NCT04201093|448681319|FG001|Overall Study|Lost to Follow-up|0|||
124742727|NCT04201093|448681320|FG002|Overall Study|Lost to Follow-up|1|||
124742728|NCT04201093|448681318|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
124742729|NCT04201093|448681319|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
124742730|NCT04201093|448681320|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
124742731|NCT04201093|448681318|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
124742732|NCT04201093|448681319|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
124742733|NCT04201093|448681320|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
124742734|NCT04201093|448681318|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
124742735|NCT04201093|448681319|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
124742736|NCT04201093|448681320|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
124742737|NCT04201093|448681318|FG000|Overall Study|Physician Decision|1|||
124742738|NCT04201093|448681319|FG001|Overall Study|Physician Decision|0|||
124742739|NCT04201093|448681320|FG002|Overall Study|Physician Decision|0|||
124742740|NCT04201093|448681318|FG000|Overall Study|Protocol Deviation|1|||
124742741|NCT04201093|448681319|FG001|Overall Study|Protocol Deviation|0|||
124742742|NCT04201093|448681320|FG002|Overall Study|Protocol Deviation|0|||
124742743|NCT04201093|448681318|FG000|Overall Study|Site Terminated by Sponsor|5|||
124742744|NCT04201093|448681319|FG001|Overall Study|Site Terminated by Sponsor|3|||
124742745|NCT04201093|448681320|FG002|Overall Study|Site Terminated by Sponsor|1|||
124742746|NCT04201093|448681318|FG000|Overall Study|Withdrawal by Subject|7|||
124742747|NCT04201093|448681319|FG001|Overall Study|Withdrawal by Subject|8|||
124742748|NCT04201093|448681320|FG002|Overall Study|Withdrawal by Subject|15|||
124742749|NCT04201093|448681318|FG000|Overall Study|Other|0|||
124742750|NCT04201093|448681319|FG001|Overall Study|Other|1|||
124742751|NCT04201093|448681320|FG002|Overall Study|Other|2|||
124742752|NCT00881504|448681321|FG000|Overall Study|Withdrawal by Subject|1|||
124742753|NCT00007020|448681322|FG000|Overall Study|Death|16|||
124742754|NCT00007020|448681322|FG000|Overall Study|Lost to Follow-up|13|||
124742755|NCT00007020|448681322|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
124742756|NCT00007020|448681322|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
124742757|NCT00007020|448681322|FG000|Overall Study|Pt cared for by outside physician|4|||
124742758|NCT00007020|448681322|FG000|Overall Study|No evidence of treatment|6|||
124742759|NCT01276223|448681323|FG000|Overall Study|Adverse Event|7|||
124742760|NCT01276223|448681324|FG001|Overall Study|Adverse Event|4|||
124742761|NCT01276223|448681325|FG002|Overall Study|Adverse Event|1|||
124742762|NCT01276223|448681323|FG000|Overall Study|Lost to Follow-up|0|||
124742763|NCT01276223|448681324|FG001|Overall Study|Lost to Follow-up|0|||
124742764|NCT01276223|448681325|FG002|Overall Study|Lost to Follow-up|1|||
124742765|NCT01276223|448681323|FG000|Overall Study|Other|0|||
124742766|NCT01276223|448681324|FG001|Overall Study|Other|0|||
124742767|NCT01276223|448681325|FG002|Overall Study|Other|1|||
124742768|NCT01276223|448681323|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
124742769|NCT01276223|448681324|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
124742770|NCT01276223|448681325|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
124742771|NCT01276223|448681323|FG000|Overall Study|Protocol Violation|1|||
124742772|NCT01276223|448681324|FG001|Overall Study|Protocol Violation|0|||
124742773|NCT01276223|448681325|FG002|Overall Study|Protocol Violation|0|||
124742774|NCT02455076|448681327|FG000|Inpatient|Withdrawal by Subject|1|||
124742775|NCT02455076|448681328|FG001|Inpatient|Withdrawal by Subject|0|||
124742776|NCT02455076|448681329|FG002|Inpatient|Withdrawal by Subject|0|||
124742777|NCT02455076|448681330|FG003|Inpatient|Withdrawal by Subject|0|||
124742778|NCT02455076|448681331|FG004|Inpatient|Withdrawal by Subject|0|||
124742779|NCT02455076|448681327|FG000|Inpatient|Discharged <24 h after admission|0|||
124742780|NCT02455076|448681328|FG001|Inpatient|Discharged <24 h after admission|1|||
124742781|NCT02455076|448681329|FG002|Inpatient|Discharged <24 h after admission|0|||
124742782|NCT02455076|448681330|FG003|Inpatient|Discharged <24 h after admission|0|||
124742783|NCT02455076|448681331|FG004|Inpatient|Discharged <24 h after admission|0|||
124742784|NCT02455076|448681327|FG000|Inpatient|Adverse Event|3|||
124742785|NCT02455076|448681328|FG001|Inpatient|Adverse Event|0|||
124742786|NCT02455076|448681329|FG002|Inpatient|Adverse Event|0|||
124742787|NCT02455076|448681330|FG003|Inpatient|Adverse Event|0|||
124742788|NCT02455076|448681331|FG004|Inpatient|Adverse Event|0|||
124742789|NCT02455076|448681327|FG000|Outpatient|Adverse Event|0|||
124742790|NCT02455076|448681328|FG001|Outpatient|Adverse Event|0|||
124742791|NCT02455076|448681329|FG002|Outpatient|Adverse Event|0|||
124742792|NCT02455076|448681330|FG003|Outpatient|Adverse Event|5|||
124742793|NCT02455076|448681331|FG004|Outpatient|Adverse Event|0|||
124742794|NCT02455076|448681327|FG000|Outpatient|Lost to Follow-up|0|||
124742795|NCT02455076|448681328|FG001|Outpatient|Lost to Follow-up|0|||
124742796|NCT02455076|448681329|FG002|Outpatient|Lost to Follow-up|0|||
124742797|NCT02455076|448681330|FG003|Outpatient|Lost to Follow-up|1|||
124742798|NCT02455076|448681331|FG004|Outpatient|Lost to Follow-up|12|||
124742799|NCT04051827|448681332|FG000|Overall Study|Death|1|||
124742800|NCT04051827|448681332|FG000|Overall Study|Withdrawal by Subject|4|||
124742801|NCT04051827|448681332|FG000|Overall Study|Progressive disease|16|||
124742802|NCT04051827|448681332|FG000|Overall Study|Physician Decision|1|||
124742803|NCT04051827|448681332|FG000|Overall Study|Other|4|||
124742804|NCT03743064|448681337|FG000|Overall Study|Adverse Event|7|||
124742805|NCT03743064|448681338|FG001|Overall Study|Adverse Event|9|||
124742806|NCT03743064|448681337|FG000|Overall Study|Death|25|||
124742807|NCT03743064|448681338|FG001|Overall Study|Death|28|||
124742808|NCT03743064|448681337|FG000|Overall Study|Lost to Follow-up|3|||
124742809|NCT03743064|448681338|FG001|Overall Study|Lost to Follow-up|6|||
124742810|NCT03743064|448681337|FG000|Overall Study|Withdrawal by Subject|28|||
124742811|NCT03743064|448681338|FG001|Overall Study|Withdrawal by Subject|25|||
124742812|NCT03743064|448681337|FG000|Overall Study|Physician Decision|2|||
124742813|NCT03743064|448681338|FG001|Overall Study|Physician Decision|4|||
124742814|NCT03743064|448681337|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
124742815|NCT03743064|448681338|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
124742816|NCT02771626|448681341|FG000|Overall Study|Adverse Event|1|||
124742817|NCT02771626|448681342|FG001|Overall Study|Adverse Event|5|||
124742818|NCT02771626|448681343|FG002|Overall Study|Adverse Event|3|||
124742819|NCT02771626|448681344|FG003|Overall Study|Adverse Event|0|||
124742820|NCT02771626|448681345|FG004|Overall Study|Adverse Event|1|||
124742821|NCT02771626|448681346|FG005|Overall Study|Adverse Event|1|||
124742822|NCT02771626|448681341|FG000|Overall Study|Radiologic Disease Progression|6|||
124742823|NCT02771626|448681342|FG001|Overall Study|Radiologic Disease Progression|13|||
124742824|NCT02771626|448681343|FG002|Overall Study|Radiologic Disease Progression|10|||
124742825|NCT02771626|448681344|FG003|Overall Study|Radiologic Disease Progression|7|||
124742826|NCT02771626|448681345|FG004|Overall Study|Radiologic Disease Progression|28|||
124742827|NCT02771626|448681346|FG005|Overall Study|Radiologic Disease Progression|15|||
124742828|NCT02771626|448681341|FG000|Overall Study|Symptomatic Deterioration|0|||
124742829|NCT02771626|448681342|FG001|Overall Study|Symptomatic Deterioration|4|||
124742830|NCT02771626|448681343|FG002|Overall Study|Symptomatic Deterioration|2|||
124742831|NCT02771626|448681344|FG003|Overall Study|Symptomatic Deterioration|0|||
124742832|NCT02771626|448681345|FG004|Overall Study|Symptomatic Deterioration|5|||
124614106|NCT03713619|448205622|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
124614107|NCT03713619|448205623|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
124614108|NCT03713619|448205619|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
124614109|NCT03713619|448205620|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
124614110|NCT03713619|448205621|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
124614111|NCT03713619|448205622|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
124614112|NCT03713619|448205623|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
124614113|NCT03713619|448205619|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
124614114|NCT03713619|448205620|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
124614115|NCT03713619|448205621|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
124742833|NCT02771626|448681346|FG005|Overall Study|Symptomatic Deterioration|2|||
124742834|NCT02771626|448681341|FG000|Overall Study|Participant Request|0|||
124742835|NCT02771626|448681342|FG001|Overall Study|Participant Request|1|||
124742836|NCT02771626|448681343|FG002|Overall Study|Participant Request|0|||
124742837|NCT02771626|448681344|FG003|Overall Study|Participant Request|2|||
124742838|NCT02771626|448681345|FG004|Overall Study|Participant Request|0|||
124742839|NCT02771626|448681346|FG005|Overall Study|Participant Request|1|||
124742840|NCT02771626|448681341|FG000|Overall Study|Investigator Decision|0|||
124742841|NCT02771626|448681342|FG001|Overall Study|Investigator Decision|1|||
124742842|NCT02771626|448681343|FG002|Overall Study|Investigator Decision|0|||
124742843|NCT02771626|448681344|FG003|Overall Study|Investigator Decision|0|||
124742844|NCT02771626|448681345|FG004|Overall Study|Investigator Decision|1|||
124742845|NCT02771626|448681346|FG005|Overall Study|Investigator Decision|0|||
124742846|NCT02771626|448681341|FG000|Overall Study|Study Termination by Sponsor|0|||
124742847|NCT02771626|448681342|FG001|Overall Study|Study Termination by Sponsor|2|||
124742848|NCT02771626|448681343|FG002|Overall Study|Study Termination by Sponsor|1|||
124742849|NCT02771626|448681344|FG003|Overall Study|Study Termination by Sponsor|0|||
124742850|NCT02771626|448681345|FG004|Overall Study|Study Termination by Sponsor|1|||
124742851|NCT02771626|448681346|FG005|Overall Study|Study Termination by Sponsor|0|||
124742852|NCT02771626|448681341|FG000|Overall Study|Informed Consent Withdrawn|0|||
124742853|NCT02771626|448681342|FG001|Overall Study|Informed Consent Withdrawn|0|||
124742854|NCT02771626|448681343|FG002|Overall Study|Informed Consent Withdrawn|1|||
124742855|NCT02771626|448681344|FG003|Overall Study|Informed Consent Withdrawn|0|||
124742856|NCT02771626|448681345|FG004|Overall Study|Informed Consent Withdrawn|1|||
124742857|NCT02771626|448681346|FG005|Overall Study|Informed Consent Withdrawn|1|||
124742858|NCT02771626|448681341|FG000|Overall Study|Other, Not Specified|1|||
124742859|NCT02771626|448681342|FG001|Overall Study|Other, Not Specified|0|||
124742860|NCT02771626|448681343|FG002|Overall Study|Other, Not Specified|0|||
124742861|NCT02771626|448681344|FG003|Overall Study|Other, Not Specified|0|||
124742862|NCT02771626|448681345|FG004|Overall Study|Other, Not Specified|0|||
124742863|NCT02771626|448681346|FG005|Overall Study|Other, Not Specified|1|||
124742864|NCT00635089|448681348|FG000|Overall Study|Adverse Event|7|||
124742865|NCT00635089|448681348|FG000|Overall Study|Lack of Efficacy|28|||
124742866|NCT00635089|448681348|FG000|Overall Study|Protocol Deviation|4|||
124742867|NCT00635089|448681348|FG000|Overall Study|Lost to Follow-up|8|||
124742868|NCT00635089|448681348|FG000|Overall Study|Other|31|||
124742869|NCT00444067|448681349|FG000|Overall Study|Lost to Follow-up|0|||
124742870|NCT00444067|448681350|FG001|Overall Study|Lost to Follow-up|1|||
124742871|NCT01300455|448681351|FG000|Washout|Withdrawal by Subject|1|||
124742872|NCT01300455|448681352|FG001|Washout|Withdrawal by Subject|0|||
124742873|NCT02528357|448681353|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742874|NCT02528357|448681354|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
124742875|NCT02528357|448681355|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742876|NCT02528357|448681356|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742877|NCT02528357|448681357|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742878|NCT02528357|448681358|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742879|NCT02528357|448681359|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742880|NCT02528357|448681360|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742881|NCT02528357|448681361|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742882|NCT02528357|448681362|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742883|NCT02528357|448681363|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742884|NCT02528357|448681364|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742885|NCT02528357|448681365|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742886|NCT02528357|448681366|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742887|NCT02528357|448681367|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742888|NCT02528357|448681368|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742889|NCT02528357|448681369|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742890|NCT02528357|448681370|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742891|NCT02528357|448681371|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
124742892|NCT02528357|448681353|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
124742893|NCT02528357|448681354|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
124742894|NCT02528357|448681355|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
124742895|NCT02528357|448681356|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
124742896|NCT02528357|448681357|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
124742897|NCT02528357|448681358|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
124742898|NCT02528357|448681359|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
124742899|NCT02528357|448681360|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
124742900|NCT02528357|448681361|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
124742901|NCT02528357|448681362|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
124742902|NCT02528357|448681363|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
124614116|NCT03713619|448205622|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
124614117|NCT03713619|448205623|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
124614118|NCT03713619|448205619|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
124614119|NCT03713619|448205620|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
124614120|NCT03713619|448205621|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
124742903|NCT02528357|448681364|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
124742904|NCT02528357|448681365|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
124742905|NCT02528357|448681366|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
124742906|NCT02528357|448681367|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
124742907|NCT02528357|448681368|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
124742908|NCT02528357|448681369|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
124742909|NCT02528357|448681370|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
124742910|NCT02528357|448681371|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
124742911|NCT02528357|448681353|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
124742912|NCT02528357|448681354|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
124742913|NCT02528357|448681355|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
124742914|NCT02528357|448681356|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
124742915|NCT02528357|448681357|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
124742916|NCT02528357|448681358|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
124742917|NCT02528357|448681359|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
124742918|NCT02528357|448681360|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
124742919|NCT02528357|448681361|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
124742920|NCT02528357|448681362|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
124742921|NCT02528357|448681363|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
124742922|NCT02528357|448681364|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
124742923|NCT02528357|448681365|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
124742924|NCT02528357|448681366|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
124742925|NCT02528357|448681367|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
124742926|NCT02528357|448681368|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
124742927|NCT02528357|448681369|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
124742928|NCT02528357|448681370|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
124742929|NCT02528357|448681371|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
124742930|NCT02528357|448681353|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742931|NCT02528357|448681354|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742932|NCT02528357|448681355|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742933|NCT02528357|448681356|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742934|NCT02528357|448681357|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
124742935|NCT02528357|448681358|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742936|NCT02528357|448681359|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742937|NCT02528357|448681360|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742938|NCT02528357|448681361|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742939|NCT02528357|448681362|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742940|NCT02528357|448681363|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742941|NCT02528357|448681364|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742942|NCT02528357|448681365|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742943|NCT02528357|448681366|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742944|NCT02528357|448681367|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742945|NCT02528357|448681368|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742946|NCT02528357|448681369|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742947|NCT02528357|448681370|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742948|NCT02528357|448681371|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124742949|NCT02528357|448681353|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
124742950|NCT02528357|448681354|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
124742951|NCT02528357|448681355|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
124742952|NCT02528357|448681356|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
124742953|NCT02528357|448681357|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
124742954|NCT02528357|448681358|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
124742955|NCT02528357|448681359|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
124742956|NCT02528357|448681360|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
124742957|NCT02528357|448681361|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
124742958|NCT02528357|448681362|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
124742959|NCT02528357|448681363|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
124742960|NCT02528357|448681364|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
124742961|NCT02528357|448681365|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
124742962|NCT02528357|448681366|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
124742963|NCT02528357|448681367|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
124742964|NCT02528357|448681368|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
124742965|NCT02528357|448681369|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
124742966|NCT02528357|448681370|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
124742967|NCT02528357|448681371|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
124742968|NCT02528357|448681353|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742969|NCT02528357|448681354|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742970|NCT02528357|448681355|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742971|NCT02528357|448681356|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742972|NCT02528357|448681357|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742973|NCT02528357|448681358|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742974|NCT02528357|448681359|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742975|NCT02528357|448681360|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742976|NCT02528357|448681361|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742977|NCT02528357|448681362|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742978|NCT02528357|448681363|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742979|NCT02528357|448681364|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742980|NCT02528357|448681365|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742981|NCT02528357|448681366|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
124742982|NCT02528357|448681367|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742983|NCT02528357|448681368|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742984|NCT02528357|448681369|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742985|NCT02528357|448681370|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742986|NCT02528357|448681371|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
124742987|NCT02528357|448681353|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
124742988|NCT02528357|448681354|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
124742989|NCT02528357|448681355|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
124742990|NCT02528357|448681356|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
124742991|NCT02528357|448681357|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
124742992|NCT02528357|448681358|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
124742993|NCT02528357|448681359|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
124742994|NCT02528357|448681360|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
124742995|NCT02528357|448681361|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
124742996|NCT02528357|448681362|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
124742997|NCT02528357|448681363|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
124742998|NCT02528357|448681364|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
124742999|NCT02528357|448681365|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
124743000|NCT02528357|448681366|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
124743001|NCT02528357|448681367|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
124743002|NCT02528357|448681368|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
124743003|NCT02528357|448681369|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
124743004|NCT02528357|448681370|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
124743005|NCT02528357|448681371|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
124743006|NCT02528357|448681353|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743007|NCT02528357|448681354|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743008|NCT02528357|448681355|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743009|NCT02528357|448681356|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743010|NCT02528357|448681357|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743011|NCT02528357|448681358|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743012|NCT02528357|448681359|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743013|NCT02528357|448681360|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743014|NCT02528357|448681361|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
124743015|NCT02528357|448681362|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
124743016|NCT02528357|448681363|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124752832|NCT00858637|448716863|FG000|Active Comparison Phase|Death|1|||
124614121|NCT03713619|448205622|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
124614122|NCT03713619|448205623|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
124614123|NCT03713619|448205619|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
124614124|NCT03713619|448205620|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
124614125|NCT03713619|448205621|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
124614126|NCT03713619|448205622|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
124614127|NCT03713619|448205623|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
124614128|NCT03713619|448205619|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
124614129|NCT03713619|448205620|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
124614130|NCT03713619|448205621|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
124614131|NCT03713619|448205622|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
124614132|NCT03713619|448205623|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
124614133|NCT03713619|448205619|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
124614134|NCT03713619|448205620|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
124614135|NCT03713619|448205621|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
124614136|NCT03713619|448205622|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
124614137|NCT03713619|448205623|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
124614138|NCT06281171|448205624|FG000|Timepoint 2|Lost to Follow-up|6|||
124614139|NCT06281171|448205625|FG001|Timepoint 2|Lost to Follow-up|4|||
124743017|NCT02528357|448681364|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
124743018|NCT02528357|448681365|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
124743019|NCT02528357|448681366|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
124743020|NCT02528357|448681367|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
124743021|NCT02528357|448681368|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743022|NCT02528357|448681369|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743023|NCT02528357|448681370|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743024|NCT02528357|448681371|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743025|NCT02528357|448681353|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743026|NCT02528357|448681354|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743027|NCT02528357|448681355|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743028|NCT02528357|448681356|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743029|NCT02528357|448681357|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743030|NCT02528357|448681358|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743031|NCT02528357|448681359|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743032|NCT02528357|448681360|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743033|NCT02528357|448681361|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743034|NCT02528357|448681362|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743035|NCT02528357|448681363|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743036|NCT02528357|448681364|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743037|NCT02528357|448681365|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743038|NCT02528357|448681366|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743039|NCT02528357|448681367|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743040|NCT02528357|448681368|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743041|NCT02528357|448681369|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
124743042|NCT02528357|448681370|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743043|NCT02528357|448681371|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
124743044|NCT02528357|448681353|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743045|NCT02528357|448681354|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743046|NCT02528357|448681355|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743047|NCT02528357|448681356|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743048|NCT02528357|448681357|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743049|NCT02528357|448681358|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743050|NCT02528357|448681359|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743051|NCT02528357|448681360|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743052|NCT02528357|448681361|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743053|NCT02528357|448681362|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743054|NCT02528357|448681363|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124614140|NCT06281171|448205624|FG000|Timepoint 3|Lost to Follow-up|0|||
124614141|NCT06281171|448205625|FG001|Timepoint 3|Lost to Follow-up|5|||
124614142|NCT02552212|448205626|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
124614143|NCT02552212|448205627|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
124614144|NCT02552212|448205628|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
124614145|NCT02552212|448205626|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
124614146|NCT02552212|448205627|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
124614147|NCT02552212|448205628|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
124614148|NCT02552212|448205626|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
124614149|NCT02552212|448205627|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
124614150|NCT02552212|448205628|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
124614151|NCT02552212|448205626|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
124614152|NCT02552212|448205627|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
124614153|NCT02552212|448205628|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
124614154|NCT02552212|448205626|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
124614155|NCT02552212|448205627|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
124614156|NCT02552212|448205628|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
124614157|NCT02552212|448205626|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
124614158|NCT02552212|448205627|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
124614159|NCT02552212|448205628|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
124614160|NCT02552212|448205626|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
124614161|NCT02552212|448205627|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
124781782|NCT00947882|448831169|FG000|Overall Study|Withdrawal by Subject|2|||
124781783|NCT00947882|448831170|FG001|Overall Study|Withdrawal by Subject|0|||
124781784|NCT00947882|448831171|FG002|Overall Study|Withdrawal by Subject|8|||
124781785|NCT00947882|448831172|FG003|Overall Study|Withdrawal by Subject|2|||
124781786|NCT00947882|448831169|FG000|Overall Study|Protocol Violation|0|||
124614162|NCT02552212|448205628|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
124614163|NCT02552212|448205626|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
124614164|NCT02552212|448205627|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
124614165|NCT02552212|448205628|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
124614166|NCT02552212|448205626|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
124614167|NCT02552212|448205627|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
124614168|NCT02552212|448205628|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
124614169|NCT02552212|448205626|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
124614170|NCT02552212|448205627|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
124614171|NCT02552212|448205628|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
124614172|NCT02552212|448205626|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
124614173|NCT02552212|448205627|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
124614174|NCT02552212|448205628|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
124614175|NCT02552212|448205626|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
124614176|NCT02552212|448205627|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
124614177|NCT02552212|448205628|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
124614178|NCT02552212|448205626|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
124614179|NCT02552212|448205627|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
124614180|NCT02552212|448205628|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
124614181|NCT02552212|448205626|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
124614182|NCT02552212|448205627|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
124614183|NCT02552212|448205628|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
124614184|NCT02552212|448205626|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
124614185|NCT02552212|448205627|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
124614186|NCT02552212|448205628|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
124614187|NCT02552212|448205626|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
124614188|NCT02552212|448205627|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
124614189|NCT02552212|448205628|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
124614190|NCT02552212|448205626|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
124614191|NCT02552212|448205627|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
124614192|NCT02552212|448205628|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
124614193|NCT02552212|448205626|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
124614194|NCT02552212|448205627|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
124614195|NCT02552212|448205628|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
124614196|NCT02552212|448205626|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
124614197|NCT02552212|448205627|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
124614198|NCT02552212|448205628|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
124614199|NCT02552212|448205626|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
124614200|NCT02552212|448205627|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
124614201|NCT02552212|448205628|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
124614202|NCT02552212|448205626|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
124614203|NCT02552212|448205627|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
124614204|NCT02552212|448205628|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
124614205|NCT04572893|448205631|FG000|Part A|Adverse Event|1|||
124614206|NCT04572893|448205632|FG001|Part A|Adverse Event|0|||
124614207|NCT04572893|448205633|FG002|Part A|Adverse Event|0|||
124781787|NCT00947882|448831170|FG001|Overall Study|Protocol Violation|0|||
124781788|NCT00947882|448831171|FG002|Overall Study|Protocol Violation|1|||
124743055|NCT02528357|448681364|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743056|NCT02528357|448681365|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743057|NCT02528357|448681366|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743058|NCT02528357|448681367|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743059|NCT02528357|448681368|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
124743060|NCT02528357|448681369|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
124743061|NCT02528357|448681370|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
124743062|NCT02528357|448681371|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
124743063|NCT02438813|448681377|FG000|Overall Study|Patient Decision|59|||
124743064|NCT02438813|448681377|FG000|Overall Study|Patient Lost to Follow-Up|137|||
124743065|NCT02438813|448681377|FG000|Overall Study|Study Ended by Sponsor|80|||
124743066|NCT02438813|448681377|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
124743067|NCT01927055|448681378|FG000|Open-label|Adverse Event|6|||
124743068|NCT01927055|448681379|FG001|Open-label|Adverse Event|0|||
124743069|NCT01927055|448681380|FG002|Open-label|Adverse Event|0|||
124743070|NCT01927055|448681378|FG000|Open-label|Withdrawal by Subject|1|||
124743071|NCT01927055|448681379|FG001|Open-label|Withdrawal by Subject|0|||
124743072|NCT01927055|448681380|FG002|Open-label|Withdrawal by Subject|0|||
124743073|NCT01927055|448681378|FG000|Open-label|Study Stopped|4|||
124743074|NCT01927055|448681379|FG001|Open-label|Study Stopped|0|||
124743075|NCT01927055|448681380|FG002|Open-label|Study Stopped|0|||
124743076|NCT01927055|448681378|FG000|Open-label|Supine Hypertension|4|||
124743077|NCT01927055|448681379|FG001|Open-label|Supine Hypertension|0|||
124743078|NCT01927055|448681380|FG002|Open-label|Supine Hypertension|0|||
124743079|NCT01927055|448681378|FG000|Open-label|Difficulty attending study visits|1|||
124743080|NCT01927055|448681379|FG001|Open-label|Difficulty attending study visits|0|||
124743081|NCT01927055|448681380|FG002|Open-label|Difficulty attending study visits|0|||
124743082|NCT01927055|448681378|FG000|Double-Blind|Adverse Event|0|||
124743083|NCT01927055|448681379|FG001|Double-Blind|Adverse Event|1|||
124743084|NCT01927055|448681380|FG002|Double-Blind|Adverse Event|1|||
124743085|NCT01927055|448681378|FG000|Double-Blind|Protocol Violation|0|||
124743086|NCT01927055|448681379|FG001|Double-Blind|Protocol Violation|0|||
124743087|NCT01927055|448681380|FG002|Double-Blind|Protocol Violation|1|||
124743088|NCT01927055|448681378|FG000|Double-Blind|Withdrawal by Subject|0|||
124614208|NCT04572893|448205634|FG003|Part A|Adverse Event|0|||
124614209|NCT04572893|448205635|FG004|Part A|Adverse Event|0|||
124614210|NCT04572893|448205636|FG005|Part A|Adverse Event|0|||
124614211|NCT04572893|448205637|FG006|Part A|Adverse Event|0|||
124614212|NCT04572893|448205631|FG000|Part B|Withdrawal by Subject|0|||
124614213|NCT04572893|448205632|FG001|Part B|Withdrawal by Subject|0|||
124614214|NCT04572893|448205633|FG002|Part B|Withdrawal by Subject|0|||
124614215|NCT04572893|448205634|FG003|Part B|Withdrawal by Subject|0|||
124614216|NCT04572893|448205635|FG004|Part B|Withdrawal by Subject|0|||
124614217|NCT04572893|448205636|FG005|Part B|Withdrawal by Subject|1|||
124614218|NCT04572893|448205637|FG006|Part B|Withdrawal by Subject|0|||
124614219|NCT04572893|448205631|FG000|Part B|Study terminated by sponsor|0|||
124614220|NCT04572893|448205632|FG001|Part B|Study terminated by sponsor|0|||
124614221|NCT04572893|448205633|FG002|Part B|Study terminated by sponsor|0|||
124614222|NCT04572893|448205634|FG003|Part B|Study terminated by sponsor|0|||
124614223|NCT04572893|448205635|FG004|Part B|Study terminated by sponsor|7|||
124614224|NCT04572893|448205636|FG005|Part B|Study terminated by sponsor|5|||
124614225|NCT04572893|448205637|FG006|Part B|Study terminated by sponsor|3|||
124614226|NCT04572893|448205631|FG000|Part B|Lost to Follow-up|0|||
124614227|NCT04572893|448205632|FG001|Part B|Lost to Follow-up|0|||
124614228|NCT04572893|448205633|FG002|Part B|Lost to Follow-up|0|||
124614229|NCT04572893|448205634|FG003|Part B|Lost to Follow-up|0|||
124614230|NCT04572893|448205635|FG004|Part B|Lost to Follow-up|0|||
124614231|NCT04572893|448205636|FG005|Part B|Lost to Follow-up|0|||
124614232|NCT04572893|448205637|FG006|Part B|Lost to Follow-up|1|||
124614233|NCT04572893|448205631|FG000|Part B|Adverse Event|0|||
124614234|NCT04572893|448205632|FG001|Part B|Adverse Event|0|||
124614235|NCT04572893|448205633|FG002|Part B|Adverse Event|0|||
124614236|NCT04572893|448205634|FG003|Part B|Adverse Event|0|||
124614237|NCT04572893|448205635|FG004|Part B|Adverse Event|1|||
124614238|NCT04572893|448205636|FG005|Part B|Adverse Event|1|||
124743089|NCT01927055|448681379|FG001|Double-Blind|Withdrawal by Subject|2|||
124743090|NCT01927055|448681380|FG002|Double-Blind|Withdrawal by Subject|3|||
124743091|NCT01927055|448681378|FG000|Double-Blind|Study Stopped|0|||
124614239|NCT04572893|448205637|FG006|Part B|Adverse Event|0|||
124614240|NCT00197496|448205638|FG000|Baseline to Discharge|not interested|1|||
124614241|NCT00197496|448205639|FG001|Baseline to Discharge|not interested|0|||
124614242|NCT00197496|448205638|FG000|Baseline to Discharge|MRSA|1|||
124614243|NCT00197496|448205639|FG001|Baseline to Discharge|MRSA|0|||
124614244|NCT00197496|448205638|FG000|Baseline to Discharge|Physician Decision|0|||
124614245|NCT00197496|448205639|FG001|Baseline to Discharge|Physician Decision|1|||
124614246|NCT00197496|448205638|FG000|Baseline to Discharge|Protocol Violation|0|||
124743092|NCT01927055|448681379|FG001|Double-Blind|Study Stopped|7|||
124743093|NCT01927055|448681380|FG002|Double-Blind|Study Stopped|7|||
124614247|NCT00197496|448205639|FG001|Baseline to Discharge|Protocol Violation|1|||
124614248|NCT00197496|448205638|FG000|Follow-up|Lost to Follow-up|2|||
124614249|NCT00197496|448205639|FG001|Follow-up|Lost to Follow-up|1|||
124614250|NCT00418821|448205640|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
124614251|NCT00103610|448205641|FG000|Overall Study|Entered Rescue Procedure|10|||
124614252|NCT00103610|448205642|FG001|Overall Study|Entered Rescue Procedure|52|||
124743094|NCT01927055|448681378|FG000|Double-Blind|Supine Hypertension|0|||
124743095|NCT01927055|448681379|FG001|Double-Blind|Supine Hypertension|0|||
124743096|NCT01927055|448681380|FG002|Double-Blind|Supine Hypertension|1|||
124743097|NCT01927055|448681378|FG000|Double-Blind|Extended Vacation|0|||
124743098|NCT01927055|448681379|FG001|Double-Blind|Extended Vacation|1|||
124743099|NCT01927055|448681380|FG002|Double-Blind|Extended Vacation|0|||
124743100|NCT00619489|448681383|FG000|Overall Study|Adverse Event|0|||
124743101|NCT00619489|448681384|FG001|Overall Study|Adverse Event|7|||
124743102|NCT00619489|448681383|FG000|Overall Study|Withdrawal by Subject|1|||
124743103|NCT00619489|448681384|FG001|Overall Study|Withdrawal by Subject|1|||
124743104|NCT00619489|448681383|FG000|Overall Study|Lack of Efficacy|0|||
124743105|NCT00619489|448681384|FG001|Overall Study|Lack of Efficacy|11|||
124743106|NCT00619489|448681383|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
124743107|NCT00619489|448681384|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
124743108|NCT02966015|448681385|FG000|Inclusion Visit|did not answer questionnaire|8|||
124743109|NCT02966015|448681386|FG001|Inclusion Visit|did not answer questionnaire|3|||
124743110|NCT01183468|448681395|FG000|Overall Study|Lost to Follow-up|2|||
124743111|NCT01183468|448681396|FG001|Overall Study|Lost to Follow-up|1|||
124743112|NCT01183468|448681397|FG002|Overall Study|Lost to Follow-up|0|||
124743113|NCT01183468|448681398|FG003|Overall Study|Lost to Follow-up|0|||
124743114|NCT01183468|448681395|FG000|Overall Study|Physician Decision|1|||
124743115|NCT01183468|448681396|FG001|Overall Study|Physician Decision|0|||
124743116|NCT01183468|448681397|FG002|Overall Study|Physician Decision|0|||
124743117|NCT01183468|448681398|FG003|Overall Study|Physician Decision|0|||
124743118|NCT01183468|448681395|FG000|Overall Study|Withdrawal by Subject|0|||
124743119|NCT01183468|448681396|FG001|Overall Study|Withdrawal by Subject|1|||
124743120|NCT01183468|448681397|FG002|Overall Study|Withdrawal by Subject|0|||
124743121|NCT01183468|448681398|FG003|Overall Study|Withdrawal by Subject|0|||
124743122|NCT02228096|448681407|FG000|Overall Study|Study terminated by Sponsor|24|||
124743123|NCT02228096|448681407|FG000|Overall Study|Lack of Efficacy|18|||
124743124|NCT02228096|448681407|FG000|Overall Study|Death|12|||
124743125|NCT02228096|448681407|FG000|Overall Study|Physician Decision|3|||
124743126|NCT02228096|448681407|FG000|Overall Study|Subject/guardian decision|2|||
124743127|NCT02228096|448681407|FG000|Overall Study|New therapy for study indication|1|||
124743128|NCT02228096|448681407|FG000|Overall Study|Enrolled, not infused|11|||
124743129|NCT00558272|448681408|FG000|Overall Study|Adverse Event|10|||
124743130|NCT00558272|448681409|FG001|Overall Study|Adverse Event|0|||
124743131|NCT00558272|448681408|FG000|Overall Study|Death|1|||
124743132|NCT00558272|448681409|FG001|Overall Study|Death|0|||
124743133|NCT00558272|448681408|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
124743134|NCT00558272|448681409|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
124743135|NCT00558272|448681408|FG000|Overall Study|AZ study team decision|0|||
124743136|NCT00558272|448681409|FG001|Overall Study|AZ study team decision|1|||
124743137|NCT00558272|448681408|FG000|Overall Study|Incorrectly enrolled|1|||
124743138|NCT00558272|448681409|FG001|Overall Study|Incorrectly enrolled|0|||
124743139|NCT00558272|448681408|FG000|Overall Study|Withdrawal by Subject|0|||
124743140|NCT00558272|448681409|FG001|Overall Study|Withdrawal by Subject|1|||
124743141|NCT00454649|448681410|FG000|Overall Study|Lack of Efficacy|2|||
124743142|NCT00454649|448681411|FG001|Overall Study|Lack of Efficacy|2|||
124743143|NCT00454649|448681412|FG002|Overall Study|Lack of Efficacy|10|||
124743144|NCT00454649|448681413|FG003|Overall Study|Lack of Efficacy|3|||
124743145|NCT00454649|448681414|FG004|Overall Study|Lack of Efficacy|0|||
124743146|NCT00454649|448681415|FG005|Overall Study|Lack of Efficacy|4|||
124743147|NCT00454649|448681416|FG006|Overall Study|Lack of Efficacy|5|||
124743148|NCT00454649|448681417|FG007|Overall Study|Lack of Efficacy|13|||
124743149|NCT00454649|448681418|FG008|Overall Study|Lack of Efficacy|10|||
124614253|NCT00103610|448205641|FG000|Overall Study|Death|16|||
124614254|NCT00103610|448205642|FG001|Overall Study|Death|12|||
124614255|NCT00103610|448205641|FG000|Overall Study|Elective Withdrawal|4|||
124743150|NCT00454649|448681419|FG009|Overall Study|Lack of Efficacy|2|||
124743151|NCT00454649|448681410|FG000|Overall Study|Adverse Event|0|||
124743152|NCT00454649|448681411|FG001|Overall Study|Adverse Event|1|||
124743153|NCT00454649|448681412|FG002|Overall Study|Adverse Event|3|||
124743154|NCT00454649|448681413|FG003|Overall Study|Adverse Event|0|||
124614256|NCT00103610|448205642|FG001|Overall Study|Elective Withdrawal|0|||
124743155|NCT00454649|448681414|FG004|Overall Study|Adverse Event|1|||
124743156|NCT00454649|448681415|FG005|Overall Study|Adverse Event|2|||
124743157|NCT00454649|448681416|FG006|Overall Study|Adverse Event|3|||
124743158|NCT00454649|448681417|FG007|Overall Study|Adverse Event|4|||
124743159|NCT00454649|448681418|FG008|Overall Study|Adverse Event|6|||
124781789|NCT00947882|448831172|FG003|Overall Study|Protocol Violation|0|||
124781790|NCT00947882|448831169|FG000|Overall Study|Lost to Follow-up|0|||
124781791|NCT00947882|448831170|FG001|Overall Study|Lost to Follow-up|2|||
124781792|NCT00947882|448831171|FG002|Overall Study|Lost to Follow-up|1|||
124614257|NCT00103610|448205641|FG000|Overall Study|Lost to Follow-up|3|||
124614258|NCT00103610|448205642|FG001|Overall Study|Lost to Follow-up|1|||
124614259|NCT00103610|448205641|FG000|Overall Study|Adverse Event|2|||
124614260|NCT00103610|448205642|FG001|Overall Study|Adverse Event|2|||
124614261|NCT00103610|448205641|FG000|Overall Study|Other|2|||
124614262|NCT00103610|448205642|FG001|Overall Study|Other|7|||
124614263|NCT00103610|448205641|FG000|Overall Study|Failed mobilization|1|||
124614264|NCT00103610|448205642|FG001|Overall Study|Failed mobilization|5|||
124614265|NCT00103610|448205641|FG000|Overall Study|Noncompliance|0|||
124614266|NCT00103610|448205642|FG001|Overall Study|Noncompliance|1|||
124614267|NCT04042376|448205657|FG000|Overall Study|Withdrawal by Subject|1|||
124614268|NCT04042376|448205657|FG000|Overall Study|Death|3|||
124614269|NCT00805467|448207539|FG000|Overall Study|Lack of Efficacy|0|||
124614270|NCT00805467|448207540|FG001|Overall Study|Lack of Efficacy|8|||
124614271|NCT00805467|448207541|FG002|Overall Study|Lack of Efficacy|13|||
124614272|NCT00805467|448207542|FG003|Overall Study|Lack of Efficacy|86|||
124614273|NCT00805467|448207539|FG000|Overall Study|Lost to Follow-up|0|||
124614274|NCT00805467|448207540|FG001|Overall Study|Lost to Follow-up|1|||
124614275|NCT00805467|448207541|FG002|Overall Study|Lost to Follow-up|7|||
124614276|NCT00805467|448207542|FG003|Overall Study|Lost to Follow-up|21|||
124614277|NCT00805467|448207539|FG000|Overall Study|Withdrawal by Subject|0|||
124614278|NCT00805467|448207540|FG001|Overall Study|Withdrawal by Subject|6|||
124614279|NCT00805467|448207541|FG002|Overall Study|Withdrawal by Subject|45|||
124614280|NCT00805467|448207542|FG003|Overall Study|Withdrawal by Subject|50|||
124614281|NCT00805467|448207539|FG000|Overall Study|Protocol Violation|0|||
124614282|NCT00805467|448207540|FG001|Overall Study|Protocol Violation|3|||
124614283|NCT00805467|448207541|FG002|Overall Study|Protocol Violation|0|||
124614284|NCT00805467|448207542|FG003|Overall Study|Protocol Violation|5|||
124614285|NCT00805467|448207539|FG000|Overall Study|Adverse Event|0|||
124614286|NCT00805467|448207540|FG001|Overall Study|Adverse Event|13|||
124614287|NCT00805467|448207541|FG002|Overall Study|Adverse Event|26|||
124614288|NCT00805467|448207542|FG003|Overall Study|Adverse Event|57|||
124614289|NCT00805467|448207539|FG000|Overall Study|Death|0|||
124614290|NCT00805467|448207540|FG001|Overall Study|Death|2|||
124614291|NCT00805467|448207541|FG002|Overall Study|Death|7|||
124614292|NCT00805467|448207542|FG003|Overall Study|Death|5|||
124614293|NCT00805467|448207539|FG000|Overall Study|Physician Decision|0|||
124614294|NCT00805467|448207540|FG001|Overall Study|Physician Decision|1|||
124614295|NCT00805467|448207541|FG002|Overall Study|Physician Decision|2|||
124614296|NCT00805467|448207542|FG003|Overall Study|Physician Decision|6|||
124614297|NCT00805467|448207539|FG000|Overall Study|Not reported|0|||
124614298|NCT00805467|448207540|FG001|Overall Study|Not reported|0|||
124614299|NCT00805467|448207541|FG002|Overall Study|Not reported|3|||
124614300|NCT00805467|448207542|FG003|Overall Study|Not reported|7|||
124614301|NCT00213135|448207543|FG000|Overall Study|Adverse Event|9|||
124614302|NCT00213135|448207544|FG001|Overall Study|Adverse Event|5|||
124614303|NCT00213135|448207545|FG002|Overall Study|Adverse Event|5|||
124614304|NCT00213135|448207543|FG000|Overall Study|Lost to Follow-up|11|||
124614305|NCT00213135|448207544|FG001|Overall Study|Lost to Follow-up|8|||
124614306|NCT00213135|448207545|FG002|Overall Study|Lost to Follow-up|4|||
124614307|NCT00213135|448207543|FG000|Overall Study|Protocol Violation|4|||
124614308|NCT00213135|448207544|FG001|Overall Study|Protocol Violation|4|||
124614309|NCT00213135|448207545|FG002|Overall Study|Protocol Violation|10|||
124614310|NCT00213135|448207543|FG000|Overall Study|Death|1|||
124614311|NCT00213135|448207544|FG001|Overall Study|Death|1|||
124614312|NCT00213135|448207545|FG002|Overall Study|Death|2|||
124614313|NCT00213135|448207543|FG000|Overall Study|Disease progression|4|||
124614314|NCT00213135|448207544|FG001|Overall Study|Disease progression|5|||
124614315|NCT00213135|448207545|FG002|Overall Study|Disease progression|21|||
124614316|NCT00213135|448207543|FG000|Overall Study|Other|21|||
124781793|NCT00947882|448831172|FG003|Overall Study|Lost to Follow-up|0|||
124781794|NCT00947882|448831169|FG000|Overall Study|Other/Unknown|10|||
124781795|NCT00947882|448831170|FG001|Overall Study|Other/Unknown|13|||
124614317|NCT00213135|448207544|FG001|Overall Study|Other|12|||
124614318|NCT00213135|448207545|FG002|Overall Study|Other|15|||
124614319|NCT00359801|448207546|FG000|Overall Study|Lost to Follow-up|72|||
124614320|NCT00359801|448207547|FG001|Overall Study|Lost to Follow-up|58|||
124614321|NCT00359801|448207546|FG000|Overall Study|Withdrawal by Subject|143|||
124614322|NCT00359801|448207547|FG001|Overall Study|Withdrawal by Subject|96|||
124614323|NCT00359801|448207546|FG000|Overall Study|Other|66|||
124614324|NCT00359801|448207547|FG001|Overall Study|Other|46|||
124614325|NCT00359801|448207546|FG000|Overall Study|Final Status Unknown: missing data|7|||
124614326|NCT00359801|448207547|FG001|Overall Study|Final Status Unknown: missing data|4|||
124614327|NCT00359801|448207546|FG000|Overall Study|Sponsor Decision|17|||
124614328|NCT00359801|448207547|FG001|Overall Study|Sponsor Decision|16|||
124614329|NCT01396512|448207549|FG000|Overall Study|Withdrawal by Subject|0|||
124781796|NCT00947882|448831171|FG002|Overall Study|Other/Unknown|3|||
124743160|NCT00454649|448681419|FG009|Overall Study|Adverse Event|2|||
124743161|NCT00454649|448681410|FG000|Overall Study|Lost to Follow-up|0|||
124743162|NCT00454649|448681411|FG001|Overall Study|Lost to Follow-up|0|||
124743163|NCT00454649|448681412|FG002|Overall Study|Lost to Follow-up|1|||
124743164|NCT00454649|448681413|FG003|Overall Study|Lost to Follow-up|0|||
124743165|NCT00454649|448681414|FG004|Overall Study|Lost to Follow-up|0|||
124743166|NCT00454649|448681415|FG005|Overall Study|Lost to Follow-up|0|||
124743167|NCT00454649|448681416|FG006|Overall Study|Lost to Follow-up|1|||
124743168|NCT00454649|448681417|FG007|Overall Study|Lost to Follow-up|0|||
124743169|NCT00454649|448681418|FG008|Overall Study|Lost to Follow-up|0|||
124743170|NCT00454649|448681419|FG009|Overall Study|Lost to Follow-up|0|||
124743171|NCT00454649|448681410|FG000|Overall Study|Other|1|||
124743172|NCT00454649|448681411|FG001|Overall Study|Other|1|||
124743173|NCT00454649|448681412|FG002|Overall Study|Other|5|||
124743174|NCT00454649|448681413|FG003|Overall Study|Other|3|||
124743175|NCT00454649|448681414|FG004|Overall Study|Other|0|||
124743176|NCT00454649|448681415|FG005|Overall Study|Other|0|||
124743177|NCT00454649|448681416|FG006|Overall Study|Other|0|||
124743178|NCT00454649|448681417|FG007|Overall Study|Other|0|||
124743179|NCT00454649|448681418|FG008|Overall Study|Other|3|||
124743180|NCT00454649|448681419|FG009|Overall Study|Other|1|||
124743181|NCT00454649|448681410|FG000|Overall Study|Withdrawal by Subject|0|||
124743182|NCT00454649|448681411|FG001|Overall Study|Withdrawal by Subject|0|||
124743183|NCT00454649|448681412|FG002|Overall Study|Withdrawal by Subject|0|||
124743184|NCT00454649|448681413|FG003|Overall Study|Withdrawal by Subject|0|||
124743185|NCT00454649|448681414|FG004|Overall Study|Withdrawal by Subject|0|||
124743186|NCT00454649|448681415|FG005|Overall Study|Withdrawal by Subject|1|||
124743187|NCT00454649|448681416|FG006|Overall Study|Withdrawal by Subject|0|||
124743188|NCT00454649|448681417|FG007|Overall Study|Withdrawal by Subject|2|||
124743189|NCT00454649|448681418|FG008|Overall Study|Withdrawal by Subject|1|||
124743190|NCT00454649|448681419|FG009|Overall Study|Withdrawal by Subject|0|||
124743191|NCT02745535|448681420|FG000|Overall Study|Death|1|||
124743192|NCT02745535|448681420|FG000|Overall Study|Adverse Event|3|||
124743193|NCT02745535|448681420|FG000|Overall Study|Lost to Follow-up|2|||
124743194|NCT01789606|448681421|FG000|Overall Study|Participant not Purchased the Product|0|||
124743195|NCT01789606|448681422|FG001|Overall Study|Participant not Purchased the Product|20|||
124743196|NCT01789606|448681421|FG000|Overall Study|Withdrawal by Subject|0|||
124743197|NCT01789606|448681422|FG001|Overall Study|Withdrawal by Subject|1|||
124743198|NCT01789606|448681421|FG000|Overall Study|Ineligible|6|||
124743199|NCT01789606|448681422|FG001|Overall Study|Ineligible|2|||
124743200|NCT01789606|448681421|FG000|Overall Study|Administrative Reasons|17|||
124743201|NCT01789606|448681422|FG001|Overall Study|Administrative Reasons|6|||
124743202|NCT01789606|448681421|FG000|Overall Study|No Study Medication Taken|0|||
124743203|NCT01789606|448681422|FG001|Overall Study|No Study Medication Taken|1|||
124743204|NCT01789606|448681421|FG000|Overall Study|Protocol Violation|0|||
124743205|NCT01789606|448681422|FG001|Overall Study|Protocol Violation|55|||
124743206|NCT01789606|448681421|FG000|Overall Study|Adverse Event|0|||
124743207|NCT01789606|448681422|FG001|Overall Study|Adverse Event|3|||
124743208|NCT01789606|448681421|FG000|Overall Study|Lost to Follow-up|0|||
124743209|NCT01789606|448681422|FG001|Overall Study|Lost to Follow-up|14|||
124743210|NCT01789606|448681421|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
124743211|NCT01789606|448681422|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
124743212|NCT00849108|448681423|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
124743213|NCT00849108|448681424|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
124743214|NCT00849108|448681423|FG000|Cohort 2 Efficacy|Adverse Event|0|||
124743215|NCT00849108|448681424|FG001|Cohort 2 Efficacy|Adverse Event|1|||
124743216|NCT00849108|448681423|FG000|Cohort 2 Efficacy|Other|0|||
124743217|NCT00849108|448681424|FG001|Cohort 2 Efficacy|Other|9|||
124743218|NCT01105377|448681428|FG000|Overall Study|Withdrawal by Subject|0|||
124743219|NCT01105377|448681429|FG001|Overall Study|Withdrawal by Subject|1|||
124743220|NCT02014584|448681435|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
124743221|NCT02014584|448681436|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
124743222|NCT02014584|448681437|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
124743223|NCT02014584|448681438|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
124614330|NCT01396512|448207550|FG001|Overall Study|Withdrawal by Subject|1|||
124743224|NCT02014584|448681439|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
124743225|NCT02014584|448681440|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
124743226|NCT02014584|448681435|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
124743227|NCT02014584|448681436|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
124743228|NCT02014584|448681437|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
124743229|NCT02014584|448681438|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
124743230|NCT02014584|448681439|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
124743231|NCT02014584|448681440|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
124743232|NCT02014584|448681435|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
124743233|NCT02014584|448681436|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
124743234|NCT02014584|448681437|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
124743235|NCT02014584|448681438|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
124743236|NCT02014584|448681439|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
124743237|NCT02014584|448681440|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
124743238|NCT02014584|448681435|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
124743239|NCT02014584|448681436|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
124743240|NCT02014584|448681437|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
124743241|NCT02014584|448681438|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
124743242|NCT02014584|448681439|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
124743243|NCT02014584|448681440|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
124743244|NCT02014584|448681435|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
124743245|NCT02014584|448681436|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
124743246|NCT02014584|448681437|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
124743247|NCT02014584|448681438|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
124743248|NCT02014584|448681439|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
124743249|NCT02014584|448681440|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
124743250|NCT01555125|448681441|FG000|Induction Period|Lost to Follow-up|0|||
124743251|NCT01555125|448681442|FG001|Induction Period|Lost to Follow-up|2|||
124743252|NCT01555125|448681443|FG002|Induction Period|Lost to Follow-up|0|||
124743253|NCT01555125|448681444|FG003|Induction Period|Lost to Follow-up|0|||
124743254|NCT01555125|448681445|FG004|Induction Period|Lost to Follow-up|0|||
124743255|NCT01555125|448681441|FG000|Induction Period|Adverse Event|0|||
124743256|NCT01555125|448681442|FG001|Induction Period|Adverse Event|1|||
124743257|NCT01555125|448681443|FG002|Induction Period|Adverse Event|0|||
124743258|NCT01555125|448681444|FG003|Induction Period|Adverse Event|0|||
124743259|NCT01555125|448681445|FG004|Induction Period|Adverse Event|1|||
124743260|NCT01555125|448681441|FG000|Induction Period|Subject / guardian decision|0|||
124743261|NCT01555125|448681442|FG001|Induction Period|Subject / guardian decision|0|||
124743262|NCT01555125|448681443|FG002|Induction Period|Subject / guardian decision|0|||
124743263|NCT01555125|448681444|FG003|Induction Period|Subject / guardian decision|0|||
124743264|NCT01555125|448681445|FG004|Induction Period|Subject / guardian decision|2|||
124743265|NCT01555125|448681441|FG000|Induction Period|Death|1|||
124743266|NCT01555125|448681442|FG001|Induction Period|Death|0|||
124743267|NCT01555125|448681443|FG002|Induction Period|Death|0|||
124743268|NCT01555125|448681444|FG003|Induction Period|Death|0|||
124743269|NCT01555125|448681445|FG004|Induction Period|Death|0|||
124743270|NCT01555125|448681441|FG000|Maintenance Period|Adverse Event|1|||
124743271|NCT01555125|448681442|FG001|Maintenance Period|Adverse Event|1|||
124743272|NCT01555125|448681443|FG002|Maintenance Period|Adverse Event|0|||
124743273|NCT01555125|448681444|FG003|Maintenance Period|Adverse Event|0|||
124743274|NCT01555125|448681445|FG004|Maintenance Period|Adverse Event|0|||
124743275|NCT01555125|448681441|FG000|Maintenance Period|Subject / guardian decision|1|||
124743276|NCT01555125|448681442|FG001|Maintenance Period|Subject / guardian decision|2|||
124743277|NCT01555125|448681443|FG002|Maintenance Period|Subject / guardian decision|0|||
124743278|NCT01555125|448681444|FG003|Maintenance Period|Subject / guardian decision|0|||
124743279|NCT01555125|448681445|FG004|Maintenance Period|Subject / guardian decision|0|||
124743280|NCT01555125|448681441|FG000|Maintenance Period|Lost to Follow-up|2|||
124743281|NCT01555125|448681442|FG001|Maintenance Period|Lost to Follow-up|0|||
124743282|NCT01555125|448681443|FG002|Maintenance Period|Lost to Follow-up|0|||
124743283|NCT01555125|448681444|FG003|Maintenance Period|Lost to Follow-up|1|||
124743284|NCT01555125|448681445|FG004|Maintenance Period|Lost to Follow-up|0|||
124743285|NCT01555125|448681441|FG000|Maintenance Period|Lack of Efficacy|6|||
124743286|NCT01555125|448681442|FG001|Maintenance Period|Lack of Efficacy|1|||
124743287|NCT01555125|448681443|FG002|Maintenance Period|Lack of Efficacy|3|||
124743288|NCT01555125|448681444|FG003|Maintenance Period|Lack of Efficacy|0|||
124743289|NCT01555125|448681445|FG004|Maintenance Period|Lack of Efficacy|0|||
124743290|NCT01555125|448681441|FG000|Maintenance Period|Physician Decision|0|||
124743291|NCT01555125|448681442|FG001|Maintenance Period|Physician Decision|0|||
124743292|NCT01555125|448681443|FG002|Maintenance Period|Physician Decision|1|||
124743293|NCT01555125|448681444|FG003|Maintenance Period|Physician Decision|0|||
124743294|NCT01555125|448681445|FG004|Maintenance Period|Physician Decision|0|||
124743295|NCT01555125|448681441|FG000|Maintenance Period|Death|0|||
124743296|NCT01555125|448681442|FG001|Maintenance Period|Death|0|||
124743297|NCT01555125|448681443|FG002|Maintenance Period|Death|0|||
124743298|NCT01555125|448681444|FG003|Maintenance Period|Death|1|||
124743299|NCT01555125|448681445|FG004|Maintenance Period|Death|0|||
124743300|NCT01555125|448681441|FG000|Extension|Adverse Event|1|||
124743301|NCT01555125|448681442|FG001|Extension|Adverse Event|2|||
124743302|NCT01555125|448681443|FG002|Extension|Adverse Event|1|||
124743303|NCT01555125|448681444|FG003|Extension|Adverse Event|1|||
124743304|NCT01555125|448681445|FG004|Extension|Adverse Event|0|||
124743305|NCT01555125|448681441|FG000|Extension|Protocol deviation|1|||
124743306|NCT01555125|448681442|FG001|Extension|Protocol deviation|0|||
124743307|NCT01555125|448681443|FG002|Extension|Protocol deviation|0|||
124743308|NCT01555125|448681444|FG003|Extension|Protocol deviation|0|||
124743309|NCT01555125|448681445|FG004|Extension|Protocol deviation|0|||
124743310|NCT01555125|448681441|FG000|Extension|Lack of Efficacy|7|||
124743311|NCT01555125|448681442|FG001|Extension|Lack of Efficacy|6|||
124743312|NCT01555125|448681443|FG002|Extension|Lack of Efficacy|3|||
124743313|NCT01555125|448681444|FG003|Extension|Lack of Efficacy|0|||
124743314|NCT01555125|448681445|FG004|Extension|Lack of Efficacy|0|||
124743315|NCT01555125|448681441|FG000|Extension|Lost to Follow-up|2|||
124743316|NCT01555125|448681442|FG001|Extension|Lost to Follow-up|1|||
124743317|NCT01555125|448681443|FG002|Extension|Lost to Follow-up|2|||
124743318|NCT01555125|448681444|FG003|Extension|Lost to Follow-up|0|||
124743319|NCT01555125|448681445|FG004|Extension|Lost to Follow-up|0|||
124743320|NCT01555125|448681441|FG000|Extension|Study terminated by sponsor|32|||
124743321|NCT01555125|448681442|FG001|Extension|Study terminated by sponsor|33|||
124743322|NCT01555125|448681443|FG002|Extension|Study terminated by sponsor|16|||
124743323|NCT01555125|448681444|FG003|Extension|Study terminated by sponsor|20|||
124743324|NCT01555125|448681445|FG004|Extension|Study terminated by sponsor|0|||
124743325|NCT01555125|448681441|FG000|Extension|Subject/guardian decision|1|||
124743326|NCT01555125|448681442|FG001|Extension|Subject/guardian decision|9|||
124743327|NCT01555125|448681443|FG002|Extension|Subject/guardian decision|1|||
124743328|NCT01555125|448681444|FG003|Extension|Subject/guardian decision|0|||
124743329|NCT01555125|448681445|FG004|Extension|Subject/guardian decision|0|||
124743330|NCT01555125|448681441|FG000|Extension|Technical Problems|1|||
124743331|NCT01555125|448681442|FG001|Extension|Technical Problems|0|||
124743332|NCT01555125|448681443|FG002|Extension|Technical Problems|0|||
124743333|NCT01555125|448681444|FG003|Extension|Technical Problems|1|||
124743334|NCT01555125|448681445|FG004|Extension|Technical Problems|0|||
124743335|NCT01555125|448681441|FG000|Follow-Up Period|Lost to Follow-up|1|||
124743336|NCT01555125|448681442|FG001|Follow-Up Period|Lost to Follow-up|0|||
124743337|NCT01555125|448681443|FG002|Follow-Up Period|Lost to Follow-up|0|||
124743338|NCT01555125|448681444|FG003|Follow-Up Period|Lost to Follow-up|0|||
124743339|NCT01555125|448681445|FG004|Follow-Up Period|Lost to Follow-up|0|||
124743340|NCT01555125|448681441|FG000|Follow-Up Period|Subject / guardian decision|3|||
124743341|NCT01555125|448681442|FG001|Follow-Up Period|Subject / guardian decision|1|||
124743342|NCT01555125|448681443|FG002|Follow-Up Period|Subject / guardian decision|1|||
124743343|NCT01555125|448681444|FG003|Follow-Up Period|Subject / guardian decision|1|||
124743344|NCT01555125|448681445|FG004|Follow-Up Period|Subject / guardian decision|0|||
124743345|NCT02651220|448681446|FG000|Overall Study|Adverse Event|1|||
124743346|NCT02651220|448681447|FG001|Overall Study|Adverse Event|5|||
124743347|NCT02651220|448681448|FG002|Overall Study|Adverse Event|1|||
124743348|NCT02651220|448681446|FG000|Overall Study|Lost to Follow-up|8|||
124743349|NCT02651220|448681447|FG001|Overall Study|Lost to Follow-up|14|||
124743350|NCT02651220|448681448|FG002|Overall Study|Lost to Follow-up|14|||
124743351|NCT02651220|448681446|FG000|Overall Study|Non-Compliance with Study Drug|4|||
124743352|NCT02651220|448681447|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124743353|NCT02651220|448681448|FG002|Overall Study|Non-Compliance with Study Drug|1|||
124743354|NCT02651220|448681446|FG000|Overall Study|Pregnancy|1|||
124743355|NCT02651220|448681447|FG001|Overall Study|Pregnancy|0|||
124743356|NCT02651220|448681448|FG002|Overall Study|Pregnancy|1|||
124743357|NCT02651220|448681446|FG000|Overall Study|Protocol Violation|0|||
124743358|NCT02651220|448681447|FG001|Overall Study|Protocol Violation|0|||
124743359|NCT02651220|448681448|FG002|Overall Study|Protocol Violation|1|||
124743360|NCT02651220|448681446|FG000|Overall Study|Withdrawal by Subject|5|||
124743361|NCT02651220|448681447|FG001|Overall Study|Withdrawal by Subject|6|||
124743362|NCT02651220|448681448|FG002|Overall Study|Withdrawal by Subject|8|||
124743363|NCT02651220|448681446|FG000|Overall Study|Miscellaneous|4|||
124743364|NCT02651220|448681447|FG001|Overall Study|Miscellaneous|1|||
124743365|NCT02651220|448681448|FG002|Overall Study|Miscellaneous|2|||
124743366|NCT02651220|448681446|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124743367|NCT02651220|448681447|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
124743368|NCT02651220|448681448|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
124743369|NCT02039856|448681449|FG000|Overall Study|Death|5|||
124743370|NCT02039856|448681450|FG001|Overall Study|Death|3|||
124743371|NCT02039856|448681449|FG000|Overall Study|Partial survey completion|61|||
124743372|NCT02039856|448681450|FG001|Overall Study|Partial survey completion|26|||
124743373|NCT02039856|448681449|FG000|Overall Study|Lost to Follow-up|388|||
124743374|NCT02039856|448681450|FG001|Overall Study|Lost to Follow-up|206|||
124743375|NCT02039856|448681449|FG000|Overall Study|Withdrawal by Subject|1573|||
124743376|NCT02039856|448681450|FG001|Overall Study|Withdrawal by Subject|618|||
124743377|NCT02409342|448681455|FG000|Overall Study|Death|211|||
124743378|NCT02409342|448681456|FG001|Overall Study|Death|201|||
124743379|NCT02409342|448681455|FG000|Overall Study|Withdrawal by Subject|24|||
124743380|NCT02409342|448681456|FG001|Overall Study|Withdrawal by Subject|17|||
124743381|NCT02409342|448681455|FG000|Overall Study|Study Terminated By Sponsor|48|||
124743382|NCT02409342|448681456|FG001|Overall Study|Study Terminated By Sponsor|59|||
124743383|NCT02409342|448681455|FG000|Overall Study|Lost to Follow-up|3|||
124743384|NCT02409342|448681456|FG001|Overall Study|Lost to Follow-up|5|||
124752833|NCT00858637|448716864|FG001|Active Comparison Phase|Death|0|||
124752834|NCT00858637|448716865|FG002|Active Comparison Phase|Death|0|||
124752835|NCT00858637|448716866|FG003|Active Comparison Phase|Death|1|||
124743385|NCT02409342|448681455|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
124743386|NCT02409342|448681456|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
124743387|NCT02409342|448681455|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
124743388|NCT02409342|448681456|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
124743389|NCT02409342|448681455|FG000|Overall Study|Sponsor Decision|1|||
124743390|NCT02409342|448681456|FG001|Overall Study|Sponsor Decision|0|||
124743391|NCT03908970|448681457|FG000|Overall Study|Adverse Event|7|||
124743392|NCT03908970|448681458|FG001|Overall Study|Adverse Event|21|||
124743393|NCT03908970|448681457|FG000|Overall Study|Physician Decision|1|||
124743394|NCT03908970|448681458|FG001|Overall Study|Physician Decision|4|||
124743395|NCT03908970|448681457|FG000|Overall Study|Withdrawal by Subject|9|||
124743396|NCT03908970|448681458|FG001|Overall Study|Withdrawal by Subject|22|||
124743397|NCT00279812|448681459|FG000|Overall Study|Protocol Violation|1|||
124743398|NCT00279812|448681460|FG001|Overall Study|Protocol Violation|1|||
124743399|NCT00279812|448681461|FG002|Overall Study|Protocol Violation|0|||
124743400|NCT00279812|448681462|FG003|Overall Study|Protocol Violation|0|||
124743401|NCT00279812|448681463|FG004|Overall Study|Protocol Violation|1|||
124743402|NCT00279812|448681464|FG005|Overall Study|Protocol Violation|0|||
124743403|NCT00279812|448681459|FG000|Overall Study|Withdrawal by Subject|0|||
124743404|NCT00279812|448681460|FG001|Overall Study|Withdrawal by Subject|4|||
124743405|NCT00279812|448681461|FG002|Overall Study|Withdrawal by Subject|2|||
124743406|NCT00279812|448681462|FG003|Overall Study|Withdrawal by Subject|0|||
124743407|NCT00279812|448681463|FG004|Overall Study|Withdrawal by Subject|0|||
124743408|NCT00279812|448681464|FG005|Overall Study|Withdrawal by Subject|0|||
124743409|NCT00279812|448681459|FG000|Overall Study|Adverse Event|0|||
124743410|NCT00279812|448681460|FG001|Overall Study|Adverse Event|1|||
124743411|NCT00279812|448681461|FG002|Overall Study|Adverse Event|1|||
124743412|NCT00279812|448681462|FG003|Overall Study|Adverse Event|0|||
124743413|NCT00279812|448681463|FG004|Overall Study|Adverse Event|2|||
124743414|NCT00279812|448681464|FG005|Overall Study|Adverse Event|1|||
124743415|NCT01274429|448681465|FG000|Overall Study|Study closed do to lack of funding|5|||
124743416|NCT05327361|448681473|FG000|Overall Study|Lost to Follow-up|4|||
124743417|NCT01439373|448681483|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
124743418|NCT01439373|448681484|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
124743419|NCT01439373|448681483|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
124743420|NCT01439373|448681484|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
124743421|NCT03281304|448681485|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
124743422|NCT03281304|448681486|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
124743423|NCT03281304|448681485|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
124743424|NCT03281304|448681486|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
124743425|NCT03281304|448681485|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
124743426|NCT03281304|448681486|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
124743427|NCT03281304|448681485|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
124743428|NCT03281304|448681486|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
124743429|NCT03281304|448681485|FG000|Treatment Phase (up to 42 Months)|Death|0|||
124743430|NCT03281304|448681486|FG001|Treatment Phase (up to 42 Months)|Death|1|||
124743431|NCT03281304|448681485|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
124743432|NCT03281304|448681486|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
124743433|NCT03281304|448681485|FG000|Treatment Phase (up to 42 Months)|Other|0|||
124743434|NCT03281304|448681486|FG001|Treatment Phase (up to 42 Months)|Other|2|||
124743435|NCT03281304|448681485|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
124743436|NCT03281304|448681486|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
124743437|NCT03834220|448681487|FG000|Overall Study|Adverse Event|1|||
124743438|NCT03834220|448681488|FG001|Overall Study|Adverse Event|0|||
124743439|NCT03834220|448681489|FG002|Overall Study|Adverse Event|0|||
124743440|NCT03834220|448681487|FG000|Overall Study|Death|8|||
124743441|NCT03834220|448681488|FG001|Overall Study|Death|1|||
124743442|NCT03834220|448681489|FG002|Overall Study|Death|17|||
124743443|NCT03834220|448681487|FG000|Overall Study|Reason not Specified|9|||
124743444|NCT03834220|448681488|FG001|Overall Study|Reason not Specified|0|||
124743445|NCT03834220|448681489|FG002|Overall Study|Reason not Specified|6|||
124743446|NCT03834220|448681487|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
124743447|NCT03834220|448681488|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
124743448|NCT03834220|448681489|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
124743449|NCT03834220|448681487|FG000|Overall Study|Withdrawal of Consent|2|||
124743450|NCT03834220|448681488|FG001|Overall Study|Withdrawal of Consent|2|||
124743451|NCT03834220|448681489|FG002|Overall Study|Withdrawal of Consent|2|||
124743452|NCT02593318|448681490|FG000|Overall Study|Withdrawal by Subject|1|||
124743453|NCT02593318|448681491|FG001|Overall Study|Withdrawal by Subject|1|||
124743454|NCT02720692|448683034|FG000|Overall Study|Withdrawal by Subject|3|||
124743455|NCT02720692|448683035|FG001|Overall Study|Withdrawal by Subject|0|||
124743456|NCT02720692|448683034|FG000|Overall Study|Physician Decision|1|||
124743457|NCT02720692|448683035|FG001|Overall Study|Physician Decision|0|||
124743458|NCT02720692|448683034|FG000|Overall Study|Lost to Follow-up|8|||
124743459|NCT02720692|448683035|FG001|Overall Study|Lost to Follow-up|3|||
124743460|NCT02720692|448683034|FG000|Overall Study|Subject unable to return for visit|1|||
124743461|NCT02720692|448683035|FG001|Overall Study|Subject unable to return for visit|0|||
124743462|NCT05011513|448683036|FG000|Overall Study|Death|0|||
124743463|NCT05011513|448683037|FG001|Overall Study|Death|1|||
124743464|NCT05011513|448683036|FG000|Overall Study|Lost to Follow-up|4|||
124743465|NCT05011513|448683037|FG001|Overall Study|Lost to Follow-up|0|||
124743466|NCT05011513|448683036|FG000|Overall Study|Withdrawal by Subject|18|||
124743467|NCT05011513|448683037|FG001|Overall Study|Withdrawal by Subject|17|||
124743468|NCT05011513|448683036|FG000|Overall Study|Other|4|||
124743469|NCT05011513|448683037|FG001|Overall Study|Other|2|||
124743470|NCT03878758|448683038|FG000|Overall Study|Withdrawal by Subject|1|||
124743471|NCT03878758|448683038|FG000|Overall Study|Protocol defined|2|||
124743472|NCT03878758|448683038|FG000|Overall Study|Improper consent documentation|1|||
124743473|NCT02315560|448683039|FG000|Overall Study|noncompliance by subjects|3|||
124743474|NCT02100969|448683041|FG000|Overall Study|Did not pass screening phase|1|||
124743475|NCT01629953|448683042|FG000|Overall Study|Death|3|||
124743476|NCT01629953|448683043|FG001|Overall Study|Death|1|||
124743477|NCT01629953|448683042|FG000|Overall Study|Lost to Follow-up|10|||
124743478|NCT01629953|448683043|FG001|Overall Study|Lost to Follow-up|14|||
124743479|NCT06359080|448683044|FG000|Overall Study|Withdrawal by Subject|3|||
124743480|NCT00306527|448683047|FG000|Overall Study|Lost to Follow-up|3|||
124743481|NCT00306527|448683048|FG001|Overall Study|Lost to Follow-up|4|||
124743482|NCT00306527|448683049|FG002|Overall Study|Lost to Follow-up|3|||
124743483|NCT00306527|448683050|FG003|Overall Study|Lost to Follow-up|0|||
124743484|NCT00306527|448683047|FG000|Overall Study|Withdrawal by Subject|2|||
124743485|NCT00306527|448683048|FG001|Overall Study|Withdrawal by Subject|3|||
124743486|NCT00306527|448683049|FG002|Overall Study|Withdrawal by Subject|0|||
124743487|NCT00306527|448683050|FG003|Overall Study|Withdrawal by Subject|3|||
124743488|NCT00306527|448683047|FG000|Overall Study|Adverse Event|0|||
124743489|NCT00306527|448683048|FG001|Overall Study|Adverse Event|0|||
124743490|NCT00306527|448683049|FG002|Overall Study|Adverse Event|1|||
124743491|NCT00306527|448683050|FG003|Overall Study|Adverse Event|1|||
124743492|NCT00306527|448683047|FG000|Overall Study|Death|1|||
124743493|NCT00306527|448683048|FG001|Overall Study|Death|0|||
124743494|NCT00306527|448683049|FG002|Overall Study|Death|1|||
124743495|NCT00306527|448683050|FG003|Overall Study|Death|2|||
124743496|NCT04037254|448683051|FG000|Overall Study|Protocol Violation|1|||
124743497|NCT04037254|448683052|FG001|Overall Study|Protocol Violation|0|||
124743498|NCT04037254|448683053|FG002|Overall Study|Protocol Violation|0|||
124743499|NCT04037254|448683054|FG003|Overall Study|Protocol Violation|0|||
124743500|NCT04037254|448683055|FG004|Overall Study|Protocol Violation|0|||
124743501|NCT04037254|448683051|FG000|Overall Study|Withdrawal by Subject|0|||
124743502|NCT04037254|448683052|FG001|Overall Study|Withdrawal by Subject|0|||
124743503|NCT04037254|448683053|FG002|Overall Study|Withdrawal by Subject|1|||
124743504|NCT04037254|448683054|FG003|Overall Study|Withdrawal by Subject|0|||
124743505|NCT04037254|448683055|FG004|Overall Study|Withdrawal by Subject|0|||
124743506|NCT04037254|448683051|FG000|Overall Study|Delayed or incomplete treatment|0|||
124743507|NCT04037254|448683052|FG001|Overall Study|Delayed or incomplete treatment|2|||
124743508|NCT04037254|448683053|FG002|Overall Study|Delayed or incomplete treatment|1|||
124743509|NCT04037254|448683054|FG003|Overall Study|Delayed or incomplete treatment|0|||
124743510|NCT04037254|448683055|FG004|Overall Study|Delayed or incomplete treatment|0|||
124743511|NCT01023672|448683056|FG000|Overall Study|Worsening disease|2|||
124743512|NCT01023672|448683056|FG000|Overall Study|Death|1|||
124743513|NCT02504580|448683057|FG000|Overall Study|Other|1|||
124743514|NCT02504580|448683058|FG001|Overall Study|Other|0|||
124743515|NCT02504580|448683059|FG002|Overall Study|Other|0|||
124743516|NCT02504580|448683060|FG003|Overall Study|Other|2|||
124743517|NCT02504580|448683061|FG004|Overall Study|Other|1|||
124743518|NCT02504580|448683062|FG005|Overall Study|Other|1|||
124743519|NCT02504580|448683063|FG006|Overall Study|Other|1|||
124743520|NCT02504580|448683064|FG007|Overall Study|Other|2|||
124743521|NCT02504580|448683065|FG008|Overall Study|Other|0|||
124743522|NCT02504580|448683066|FG009|Overall Study|Other|0|||
124781797|NCT00947882|448831172|FG003|Overall Study|Other/Unknown|6|||
124743523|NCT02504580|448683067|FG010|Overall Study|Other|0|||
124743524|NCT02504580|448683068|FG011|Overall Study|Other|2|||
124743525|NCT02504580|448683057|FG000|Overall Study|Subject refusal to continue|0|||
124743526|NCT02504580|448683058|FG001|Overall Study|Subject refusal to continue|1|||
124743527|NCT02504580|448683059|FG002|Overall Study|Subject refusal to continue|0|||
124743528|NCT02504580|448683060|FG003|Overall Study|Subject refusal to continue|0|||
124743529|NCT02504580|448683061|FG004|Overall Study|Subject refusal to continue|0|||
124743530|NCT02504580|448683062|FG005|Overall Study|Subject refusal to continue|0|||
124743531|NCT02504580|448683063|FG006|Overall Study|Subject refusal to continue|0|||
124781798|NCT00947882|448831169|FG000|Overall Study|Trial Terminated by Sponsor|62|||
124743532|NCT02504580|448683064|FG007|Overall Study|Subject refusal to continue|0|||
124743533|NCT02504580|448683065|FG008|Overall Study|Subject refusal to continue|0|||
124743534|NCT02504580|448683066|FG009|Overall Study|Subject refusal to continue|0|||
124743535|NCT02504580|448683067|FG010|Overall Study|Subject refusal to continue|0|||
124743536|NCT02504580|448683068|FG011|Overall Study|Subject refusal to continue|0|||
124743537|NCT00448747|448683069|FG000|Overall Study|collapsed veins|1|||
124743538|NCT00448747|448683070|FG001|Overall Study|collapsed veins|0|||
124743539|NCT00387725|448683071|FG000|Overall Study|Adverse Event|0|||
124743540|NCT00387725|448683072|FG001|Overall Study|Adverse Event|0|||
124743541|NCT00387725|448683073|FG002|Overall Study|Adverse Event|0|||
124743542|NCT00387725|448683074|FG003|Overall Study|Adverse Event|1|||
124743543|NCT00387725|448683071|FG000|Overall Study|Protocol Violation|0|||
124743544|NCT00387725|448683072|FG001|Overall Study|Protocol Violation|1|||
124743545|NCT00387725|448683073|FG002|Overall Study|Protocol Violation|0|||
124743546|NCT00387725|448683074|FG003|Overall Study|Protocol Violation|0|||
124743547|NCT00387725|448683071|FG000|Overall Study|Withdrawal by Subject|1|||
124743548|NCT00387725|448683072|FG001|Overall Study|Withdrawal by Subject|0|||
124743549|NCT00387725|448683073|FG002|Overall Study|Withdrawal by Subject|1|||
124743550|NCT00387725|448683074|FG003|Overall Study|Withdrawal by Subject|0|||
124743551|NCT00387725|448683071|FG000|Overall Study|Parent/legal guardian request|0|||
124743552|NCT00387725|448683072|FG001|Overall Study|Parent/legal guardian request|0|||
124743553|NCT00387725|448683073|FG002|Overall Study|Parent/legal guardian request|1|||
124743554|NCT00387725|448683074|FG003|Overall Study|Parent/legal guardian request|1|||
124743555|NCT02429791|448683077|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
124743556|NCT02429791|448683078|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
124743557|NCT02429791|448683077|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
124743558|NCT02429791|448683078|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
124743559|NCT02429791|448683077|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
124743560|NCT02429791|448683078|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
124743561|NCT02429791|448683077|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
124743562|NCT02429791|448683078|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
124743563|NCT02429791|448683077|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
124743564|NCT02429791|448683078|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
124743565|NCT02429791|448683077|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
124743566|NCT02429791|448683078|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
124743567|NCT02429791|448683077|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
124743568|NCT02429791|448683078|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
124743569|NCT02429791|448683077|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
124743570|NCT02429791|448683078|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
124743571|NCT02429791|448683077|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
124743572|NCT02429791|448683078|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
124743573|NCT02429791|448683077|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
124743574|NCT02429791|448683078|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
124743575|NCT02429791|448683077|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
124743576|NCT02429791|448683078|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
124743577|NCT02429791|448683077|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
124743578|NCT02429791|448683078|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
124743579|NCT02429791|448683077|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
124743580|NCT02429791|448683078|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
124743581|NCT02429791|448683077|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
124743582|NCT02429791|448683078|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
124743583|NCT02429791|448683077|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
124743584|NCT02429791|448683078|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
124743585|NCT02429791|448683077|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
124743586|NCT02429791|448683078|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
124743587|NCT02429791|448683077|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
124743588|NCT02429791|448683078|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
124743589|NCT02429791|448683077|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
124743590|NCT02429791|448683078|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
124743591|NCT02166463|448683079|FG000|Overall Study|Lost to Follow-up|0|||
124743592|NCT02166463|448683080|FG001|Overall Study|Lost to Follow-up|1|||
124743593|NCT02166463|448683079|FG000|Overall Study|Physician Decision|10|||
124743594|NCT02166463|448683080|FG001|Overall Study|Physician Decision|10|||
124743595|NCT02166463|448683079|FG000|Overall Study|Ineligible|11|||
124743596|NCT02166463|448683080|FG001|Overall Study|Ineligible|2|||
124743597|NCT02166463|448683079|FG000|Overall Study|Progressive Disease|9|||
124743598|NCT02166463|448683080|FG001|Overall Study|Progressive Disease|6|||
124743599|NCT02166463|448683079|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
124614331|NCT02500043|448207553|FG000|Overall Study|Randomized, but not Treated|2|||
124614332|NCT02500043|448207554|FG001|Overall Study|Randomized, but not Treated|2|||
124614333|NCT02500043|448207553|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
124781799|NCT00947882|448831170|FG001|Overall Study|Trial Terminated by Sponsor|61|||
124781800|NCT00947882|448831171|FG002|Overall Study|Trial Terminated by Sponsor|62|||
124743600|NCT02166463|448683080|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
124743601|NCT02166463|448683079|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
124743602|NCT02166463|448683080|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
124743603|NCT02166463|448683079|FG000|Overall Study|Refusal of further protocol therapy|5|||
124743604|NCT02166463|448683080|FG001|Overall Study|Refusal of further protocol therapy|6|||
124743605|NCT05856227|448683081|FG000|Overall Study|Adverse Event|0|||
124743606|NCT05856227|448683082|FG001|Overall Study|Adverse Event|1|||
124743607|NCT05856227|448683081|FG000|Overall Study|Due to Investigator absence|1|||
124743608|NCT05856227|448683082|FG001|Overall Study|Due to Investigator absence|0|||
124743609|NCT05856227|448683081|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
124743610|NCT05856227|448683082|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
124743611|NCT01272869|448683083|FG000|Period 2 (14 Days)|Adverse Event|1|||
124743612|NCT01272869|448683084|FG001|Period 2 (14 Days)|Adverse Event|0|||
124743613|NCT00771615|448683085|FG000|Overall Study|Withdrawal by Subject|0|||
124743614|NCT00771615|448683086|FG001|Overall Study|Withdrawal by Subject|1|||
124743615|NCT00771615|448683087|FG002|Overall Study|Withdrawal by Subject|0|||
124743616|NCT00771615|448683088|FG003|Overall Study|Withdrawal by Subject|0|||
124743617|NCT00771615|448683089|FG004|Overall Study|Withdrawal by Subject|0|||
124743618|NCT00771615|448683090|FG005|Overall Study|Withdrawal by Subject|0|||
124743619|NCT00771615|448683091|FG006|Overall Study|Withdrawal by Subject|0|||
124743620|NCT00771615|448683092|FG007|Overall Study|Withdrawal by Subject|1|||
124743621|NCT00771615|448683093|FG008|Overall Study|Withdrawal by Subject|0|||
124743622|NCT00771615|448683085|FG000|Overall Study|Lost to Follow-up|1|||
124743623|NCT00771615|448683086|FG001|Overall Study|Lost to Follow-up|1|||
124743624|NCT00771615|448683087|FG002|Overall Study|Lost to Follow-up|1|||
124743625|NCT00771615|448683088|FG003|Overall Study|Lost to Follow-up|1|||
124743626|NCT00771615|448683089|FG004|Overall Study|Lost to Follow-up|0|||
124743627|NCT00771615|448683090|FG005|Overall Study|Lost to Follow-up|1|||
124743628|NCT00771615|448683091|FG006|Overall Study|Lost to Follow-up|1|||
124743629|NCT00771615|448683092|FG007|Overall Study|Lost to Follow-up|0|||
124743630|NCT00771615|448683093|FG008|Overall Study|Lost to Follow-up|0|||
124743631|NCT00859937|448683094|FG000|Overall Study|Protocol Violation|1|||
124743632|NCT00859937|448683095|FG001|Overall Study|Protocol Violation|0|||
124743633|NCT02478164|448683096|FG000|Overall Study|Lack of Efficacy|13|||
124743634|NCT02478164|448683096|FG000|Overall Study|Adverse Event|1|||
124743635|NCT02478164|448683096|FG000|Overall Study|Withdrawal by Subject|1|||
124743636|NCT04588389|448683097|FG000|Overall Study|Issues with anesthesia during surgery|2|||
124743637|NCT04588389|448683098|FG001|Overall Study|Issues with anesthesia during surgery|0|||
124743638|NCT04588389|448683099|FG002|Overall Study|Issues with anesthesia during surgery|0|||
124743639|NCT05147662|448683112|FG000|Overall Study|Withdrawal by parent/guardian|3|||
124743640|NCT05147662|448683112|FG000|Overall Study|Assigned to treatment but never treated|1|||
124743641|NCT04676867|448683113|FG000|Overall Study|Screen failure|0|||
124743642|NCT04676867|448683114|FG001|Overall Study|Screen failure|0|||
124743643|NCT04676867|448683115|FG002|Overall Study|Screen failure|6|||
124743644|NCT04676867|448683116|FG003|Overall Study|Screen failure|2|||
124743645|NCT04676867|448683113|FG000|Overall Study|Death|0|||
124743646|NCT04676867|448683114|FG001|Overall Study|Death|0|||
124743647|NCT04676867|448683115|FG002|Overall Study|Death|1|||
124743648|NCT04676867|448683116|FG003|Overall Study|Death|0|||
124743649|NCT04676867|448683113|FG000|Overall Study|Withdrawal by Subject|2|||
124743650|NCT04676867|448683114|FG001|Overall Study|Withdrawal by Subject|2|||
124743651|NCT04676867|448683115|FG002|Overall Study|Withdrawal by Subject|4|||
124743652|NCT04676867|448683116|FG003|Overall Study|Withdrawal by Subject|4|||
124743653|NCT04676867|448683113|FG000|Overall Study|Lost to Follow-up|1|||
124743654|NCT04676867|448683114|FG001|Overall Study|Lost to Follow-up|0|||
124743655|NCT04676867|448683115|FG002|Overall Study|Lost to Follow-up|0|||
124743656|NCT04676867|448683116|FG003|Overall Study|Lost to Follow-up|0|||
124743657|NCT00549770|448683117|FG000|Overall Study|Protocol deviation|1|||
124743658|NCT00549770|448683118|FG001|Overall Study|Protocol deviation|1|||
124743659|NCT00549770|448683119|FG002|Overall Study|Protocol deviation|1|||
124743660|NCT00549770|448683120|FG003|Overall Study|Protocol deviation|2|||
124743661|NCT00549770|448683121|FG004|Overall Study|Protocol deviation|2|||
124743662|NCT00549770|448683122|FG005|Overall Study|Protocol deviation|2|||
124743663|NCT00549770|448683123|FG006|Overall Study|Protocol deviation|1|||
124743664|NCT00549770|448683124|FG007|Overall Study|Protocol deviation|2|||
124743665|NCT00549770|448683117|FG000|Overall Study|Administrative problems|0|||
124743666|NCT00549770|448683118|FG001|Overall Study|Administrative problems|1|||
124743667|NCT00549770|448683119|FG002|Overall Study|Administrative problems|0|||
124743668|NCT00549770|448683120|FG003|Overall Study|Administrative problems|0|||
124743669|NCT00549770|448683121|FG004|Overall Study|Administrative problems|0|||
124743670|NCT00549770|448683122|FG005|Overall Study|Administrative problems|0|||
124743671|NCT00549770|448683123|FG006|Overall Study|Administrative problems|0|||
124743672|NCT00549770|448683124|FG007|Overall Study|Administrative problems|1|||
124743673|NCT00549770|448683117|FG000|Overall Study|Lost to Follow-up|0|||
124743674|NCT00549770|448683118|FG001|Overall Study|Lost to Follow-up|0|||
124743675|NCT00549770|448683119|FG002|Overall Study|Lost to Follow-up|2|||
124614334|NCT02500043|448207554|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
124614335|NCT02500043|448207553|FG000|Overall Study|Adverse Event|33|||
124614336|NCT02500043|448207554|FG001|Overall Study|Adverse Event|11|||
124614337|NCT02500043|448207553|FG000|Overall Study|Clinical Progression|54|||
124614338|NCT02500043|448207554|FG001|Overall Study|Clinical Progression|35|||
124614339|NCT02500043|448207553|FG000|Overall Study|Radiological Progression|192|||
124614340|NCT02500043|448207554|FG001|Overall Study|Radiological Progression|110|||
124743676|NCT00549770|448683120|FG003|Overall Study|Lost to Follow-up|2|||
124743677|NCT00549770|448683121|FG004|Overall Study|Lost to Follow-up|3|||
124743678|NCT00549770|448683122|FG005|Overall Study|Lost to Follow-up|2|||
124743679|NCT00549770|448683123|FG006|Overall Study|Lost to Follow-up|0|||
124743680|NCT00549770|448683124|FG007|Overall Study|Lost to Follow-up|0|||
124743681|NCT00549770|448683117|FG000|Overall Study|Withdrawal by Subject|4|||
124743682|NCT00549770|448683118|FG001|Overall Study|Withdrawal by Subject|6|||
124743683|NCT00549770|448683119|FG002|Overall Study|Withdrawal by Subject|4|||
124743684|NCT00549770|448683120|FG003|Overall Study|Withdrawal by Subject|5|||
124743685|NCT00549770|448683121|FG004|Overall Study|Withdrawal by Subject|6|||
124743686|NCT00549770|448683122|FG005|Overall Study|Withdrawal by Subject|6|||
124743687|NCT00549770|448683123|FG006|Overall Study|Withdrawal by Subject|4|||
124743688|NCT00549770|448683124|FG007|Overall Study|Withdrawal by Subject|9|||
124743689|NCT00549770|448683117|FG000|Overall Study|Lack of Efficacy|1|||
124743690|NCT00549770|448683118|FG001|Overall Study|Lack of Efficacy|0|||
124743691|NCT00549770|448683119|FG002|Overall Study|Lack of Efficacy|2|||
124743692|NCT00549770|448683120|FG003|Overall Study|Lack of Efficacy|3|||
124743693|NCT00549770|448683121|FG004|Overall Study|Lack of Efficacy|5|||
124743694|NCT00549770|448683122|FG005|Overall Study|Lack of Efficacy|1|||
124743695|NCT00549770|448683123|FG006|Overall Study|Lack of Efficacy|3|||
124743696|NCT00549770|448683124|FG007|Overall Study|Lack of Efficacy|8|||
124743697|NCT00549770|448683117|FG000|Overall Study|Abnormal test procedure results|0|||
124743698|NCT00549770|448683118|FG001|Overall Study|Abnormal test procedure results|0|||
124743699|NCT00549770|448683119|FG002|Overall Study|Abnormal test procedure results|0|||
124743700|NCT00549770|448683120|FG003|Overall Study|Abnormal test procedure results|2|||
124743701|NCT00549770|448683121|FG004|Overall Study|Abnormal test procedure results|0|||
124743702|NCT00549770|448683122|FG005|Overall Study|Abnormal test procedure results|1|||
124743703|NCT00549770|448683123|FG006|Overall Study|Abnormal test procedure results|1|||
124743704|NCT00549770|448683124|FG007|Overall Study|Abnormal test procedure results|1|||
124743705|NCT00549770|448683117|FG000|Overall Study|Abnormal laboratory values|0|||
124743706|NCT00549770|448683118|FG001|Overall Study|Abnormal laboratory values|0|||
124743707|NCT00549770|448683119|FG002|Overall Study|Abnormal laboratory values|0|||
124743708|NCT00549770|448683120|FG003|Overall Study|Abnormal laboratory values|0|||
124743709|NCT00549770|448683121|FG004|Overall Study|Abnormal laboratory values|0|||
124614341|NCT02500043|448207553|FG000|Overall Study|Physician's Decision|11|||
124614342|NCT02500043|448207554|FG001|Overall Study|Physician's Decision|3|||
124614343|NCT02500043|448207553|FG000|Overall Study|Withdrawal by Subject|14|||
124614344|NCT02500043|448207554|FG001|Overall Study|Withdrawal by Subject|4|||
124614345|NCT02500043|448207553|FG000|Overall Study|Death|11|||
124614346|NCT02500043|448207554|FG001|Overall Study|Death|2|||
124614347|NCT02500043|448207553|FG000|Overall Study|Protocol Deviation|1|||
124614348|NCT02500043|448207554|FG001|Overall Study|Protocol Deviation|0|||
124614349|NCT02094417|448207555|FG000|Overall Study|Adverse Event|0|||
124614350|NCT02094417|448207556|FG001|Overall Study|Adverse Event|0|||
124614351|NCT02094417|448207557|FG002|Overall Study|Adverse Event|0|||
124614352|NCT02094417|448207558|FG003|Overall Study|Adverse Event|1|||
124614353|NCT02094417|448207555|FG000|Overall Study|Eligibility criteria|0|||
124614354|NCT02094417|448207556|FG001|Overall Study|Eligibility criteria|1|||
124614355|NCT02094417|448207557|FG002|Overall Study|Eligibility criteria|0|||
124614356|NCT02094417|448207558|FG003|Overall Study|Eligibility criteria|0|||
124614357|NCT02094417|448207555|FG000|Overall Study|No responder|4|||
124614358|NCT02094417|448207556|FG001|Overall Study|No responder|4|||
124614359|NCT02094417|448207557|FG002|Overall Study|No responder|4|||
124614360|NCT02094417|448207558|FG003|Overall Study|No responder|3|||
124614361|NCT02094417|448207555|FG000|Overall Study|Unable to conduct observations or assess|0|||
124614362|NCT02094417|448207556|FG001|Overall Study|Unable to conduct observations or assess|1|||
124614363|NCT02094417|448207557|FG002|Overall Study|Unable to conduct observations or assess|0|||
124614364|NCT02094417|448207558|FG003|Overall Study|Unable to conduct observations or assess|0|||
124614365|NCT02094417|448207555|FG000|Overall Study|Withdrawal by Subject|1|||
124614366|NCT02094417|448207556|FG001|Overall Study|Withdrawal by Subject|2|||
124614367|NCT02094417|448207557|FG002|Overall Study|Withdrawal by Subject|1|||
124614368|NCT02094417|448207558|FG003|Overall Study|Withdrawal by Subject|3|||
124743710|NCT00549770|448683122|FG005|Overall Study|Abnormal laboratory values|1|||
124743711|NCT00549770|448683123|FG006|Overall Study|Abnormal laboratory values|0|||
124743712|NCT00549770|448683124|FG007|Overall Study|Abnormal laboratory values|0|||
124743713|NCT00549770|448683117|FG000|Overall Study|Adverse Event|1|||
124743714|NCT00549770|448683118|FG001|Overall Study|Adverse Event|3|||
124743715|NCT00549770|448683119|FG002|Overall Study|Adverse Event|1|||
124743716|NCT00549770|448683120|FG003|Overall Study|Adverse Event|2|||
124743717|NCT00549770|448683121|FG004|Overall Study|Adverse Event|1|||
124743718|NCT00549770|448683122|FG005|Overall Study|Adverse Event|0|||
124743719|NCT00549770|448683123|FG006|Overall Study|Adverse Event|5|||
124743720|NCT00549770|448683124|FG007|Overall Study|Adverse Event|4|||
124743721|NCT01079936|448683125|FG000|Phase I: MTD|First Remission Status|2|||
124743722|NCT01079936|448683126|FG001|Phase I: MTD|First Remission Status|0|||
124743723|NCT01079936|448683127|FG002|Phase I: MTD|First Remission Status|0|||
124743724|NCT01079936|448683128|FG003|Phase I: MTD|First Remission Status|0|||
124743725|NCT01079936|448683129|FG004|Phase I: MTD|First Remission Status|0|||
124743726|NCT01079936|448683125|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
124743727|NCT01079936|448683126|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
124743728|NCT01079936|448683127|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
124743729|NCT01079936|448683128|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
124743730|NCT01079936|448683129|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
124743731|NCT01079936|448683125|FG000|Phase II|Adverse Event|0|||
124743732|NCT01079936|448683126|FG001|Phase II|Adverse Event|0|||
124743733|NCT01079936|448683127|FG002|Phase II|Adverse Event|1|||
124743734|NCT01079936|448683128|FG003|Phase II|Adverse Event|0|||
124743735|NCT01079936|448683129|FG004|Phase II|Adverse Event|0|||
124743736|NCT01079936|448683125|FG000|Phase II|Insurance Issue|0|||
124743737|NCT01079936|448683126|FG001|Phase II|Insurance Issue|0|||
124743738|NCT01079936|448683127|FG002|Phase II|Insurance Issue|0|||
124743739|NCT01079936|448683128|FG003|Phase II|Insurance Issue|0|||
124743740|NCT01079936|448683129|FG004|Phase II|Insurance Issue|1|||
124743741|NCT00548717|448683130|FG000|Overall Study|Death|5|||
124743742|NCT00548717|448683131|FG001|Overall Study|Death|2|||
124743743|NCT00548717|448683130|FG000|Overall Study|Relapse|3|||
124743744|NCT00548717|448683131|FG001|Overall Study|Relapse|0|||
124743745|NCT00548717|448683130|FG000|Overall Study|Alternative treatment for GVHD|1|||
124743746|NCT00548717|448683131|FG001|Overall Study|Alternative treatment for GVHD|0|||
124743747|NCT01302054|448683132|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
124743748|NCT01302054|448683133|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
124743749|NCT01302054|448683134|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
124743750|NCT01302054|448683132|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
124743751|NCT01302054|448683133|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
124743752|NCT01302054|448683134|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
124743753|NCT01302054|448683132|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
124743754|NCT01302054|448683133|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
124743755|NCT01302054|448683134|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
124743756|NCT01302054|448683132|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
124743757|NCT01302054|448683133|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
124743758|NCT01302054|448683134|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
124743759|NCT01302054|448683132|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
124743760|NCT01302054|448683133|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
124743761|NCT01302054|448683134|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
124743762|NCT01302054|448683132|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
124743763|NCT01302054|448683133|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
124743764|NCT01302054|448683134|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
124743765|NCT01302054|448683132|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
124743766|NCT01302054|448683133|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
124743767|NCT01302054|448683134|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
124743768|NCT01302054|448683132|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
124743769|NCT01302054|448683133|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
124743770|NCT01302054|448683134|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
124743771|NCT01302054|448683132|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
124743772|NCT01302054|448683133|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
124743773|NCT01302054|448683134|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
124743774|NCT01302054|448683132|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
124743775|NCT01302054|448683133|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
124743776|NCT01302054|448683134|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
124743777|NCT01302054|448683132|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
124743778|NCT01302054|448683133|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
124743779|NCT01302054|448683134|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
124743780|NCT01302054|448683132|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
124743781|NCT01302054|448683133|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
124743782|NCT01302054|448683134|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
124743783|NCT01302054|448683132|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
124743784|NCT01302054|448683133|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
124743785|NCT01302054|448683134|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
124743786|NCT01302054|448683132|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
124743787|NCT01302054|448683133|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
124743788|NCT01302054|448683134|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
124743789|NCT01302054|448683132|FG000|Double-Blind Treatment Phase|Other|0|||
124743790|NCT01302054|448683133|FG001|Double-Blind Treatment Phase|Other|4|||
124743791|NCT01302054|448683134|FG002|Double-Blind Treatment Phase|Other|9|||
124743792|NCT00847015|448683135|FG000|Overall Study|Withdrawal by Subject|1|||
124743793|NCT00847015|448683135|FG000|Overall Study|declined any surgery|1|||
124743794|NCT00847015|448683135|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
124743795|NCT02809053|448683136|FG000|Overall Study|Death|0|||
124743796|NCT02809053|448683137|FG001|Overall Study|Death|1|||
124743797|NCT02809053|448683136|FG000|Overall Study|Lost to Follow-up|3|||
124743798|NCT02809053|448683137|FG001|Overall Study|Lost to Follow-up|1|||
124743799|NCT02809053|448683136|FG000|Overall Study|Withdrawal by Subject|2|||
124743800|NCT02809053|448683137|FG001|Overall Study|Withdrawal by Subject|3|||
124743801|NCT02809053|448683136|FG000|Overall Study|Disease Progression|2|||
124743802|NCT02809053|448683137|FG001|Overall Study|Disease Progression|1|||
124743803|NCT02565810|448683140|FG000|Overall Study|Withdrawal by Subject|1|||
124743804|NCT01732913|448683147|FG000|Overall Study|Study Terminated by Sponsor|105|||
124743805|NCT01732913|448683148|FG001|Overall Study|Study Terminated by Sponsor|55|||
124743806|NCT01732913|448683147|FG000|Overall Study|Withdrawal by Subject|27|||
124743807|NCT01732913|448683148|FG001|Overall Study|Withdrawal by Subject|4|||
124743808|NCT01732913|448683147|FG000|Overall Study|Physician Decision|14|||
124743809|NCT01732913|448683148|FG001|Overall Study|Physician Decision|7|||
124743810|NCT01732913|448683147|FG000|Overall Study|Other|7|||
124743811|NCT01732913|448683148|FG001|Overall Study|Other|1|||
124743812|NCT01732913|448683147|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
124743813|NCT01732913|448683148|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
124743814|NCT02925741|448683149|FG000|Overall Study|Withdrawal by Subject|11|||
124743815|NCT02925741|448683150|FG001|Overall Study|Withdrawal by Subject|0|||
124743816|NCT05086510|448683151|FG000|Overall Study|Lost to Follow-up|0|||
124743817|NCT05086510|448683152|FG001|Overall Study|Lost to Follow-up|2|||
124743818|NCT05086510|448683151|FG000|Overall Study|Death|0|||
124743819|NCT05086510|448683152|FG001|Overall Study|Death|2|||
124743820|NCT03022981|448683153|FG000|Overall Study|Adverse Event|0|||
124743821|NCT03022981|448683154|FG001|Overall Study|Adverse Event|1|||
124743822|NCT03022981|448683155|FG002|Overall Study|Adverse Event|0|||
124743823|NCT03022981|448683153|FG000|Overall Study|Investigator's Discretion|0|||
124743824|NCT03022981|448683154|FG001|Overall Study|Investigator's Discretion|1|||
124743825|NCT03022981|448683155|FG002|Overall Study|Investigator's Discretion|2|||
124743826|NCT03022981|448683153|FG000|Overall Study|Lost to Follow-up|6|||
124743827|NCT03022981|448683154|FG001|Overall Study|Lost to Follow-up|2|||
124743828|NCT03022981|448683155|FG002|Overall Study|Lost to Follow-up|1|||
124743829|NCT03022981|448683153|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124743830|NCT03022981|448683154|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124743831|NCT03022981|448683155|FG002|Overall Study|Non-Compliance With Study Drug|2|||
124743832|NCT03022981|448683153|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
124743833|NCT03022981|448683154|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
124743834|NCT03022981|448683155|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
124743835|NCT00295932|448683156|FG000|Overall Study|Not Treated|0|||
124743836|NCT00295932|448683157|FG001|Overall Study|Not Treated|0|||
124743837|NCT00295932|448683158|FG002|Overall Study|Not Treated|0|||
124743838|NCT00295932|448683159|FG003|Overall Study|Not Treated|0|||
124743839|NCT00295932|448683160|FG004|Overall Study|Not Treated|0|||
124743840|NCT00295932|448683161|FG005|Overall Study|Not Treated|0|||
124743841|NCT00295932|448683162|FG006|Overall Study|Not Treated|0|||
124743842|NCT00295932|448683163|FG007|Overall Study|Not Treated|0|||
124743843|NCT00295932|448683164|FG008|Overall Study|Not Treated|0|||
124743844|NCT00295932|448683165|FG009|Overall Study|Not Treated|0|||
124743845|NCT00295932|448683166|FG010|Overall Study|Not Treated|1|||
124743846|NCT04891107|448683167|FG000|Overall Study|Physician Decision|1|||
124743847|NCT04891107|448683167|FG000|Overall Study|Withdrawal by Subject|1|||
124743848|NCT04891107|448683167|FG000|Overall Study|Screen failure after consent|1|||
124743849|NCT01571453|448683168|FG000|Overall Study|Adverse Event|14|||
124743850|NCT01571453|448683169|FG001|Overall Study|Adverse Event|32|||
124743851|NCT01571453|448683168|FG000|Overall Study|Lack of Efficacy|8|||
124743852|NCT01571453|448683169|FG001|Overall Study|Lack of Efficacy|3|||
124743853|NCT01571453|448683168|FG000|Overall Study|Non-compliance|2|||
124743854|NCT01571453|448683169|FG001|Overall Study|Non-compliance|4|||
124743855|NCT01571453|448683168|FG000|Overall Study|Protocol Violation|1|||
124743856|NCT01571453|448683169|FG001|Overall Study|Protocol Violation|5|||
124743857|NCT01571453|448683168|FG000|Overall Study|Withdrawal of consent|5|||
124743858|NCT01571453|448683169|FG001|Overall Study|Withdrawal of consent|13|||
124743859|NCT01571453|448683168|FG000|Overall Study|Lost to Follow-up|4|||
124743860|NCT01571453|448683169|FG001|Overall Study|Lost to Follow-up|2|||
124743861|NCT01571453|448683168|FG000|Overall Study|Administrative or other reason(s)|4|||
124743862|NCT01571453|448683169|FG001|Overall Study|Administrative or other reason(s)|3|||
124743863|NCT00084487|448683176|FG000|Overall Study|Death|1|||
124743864|NCT03040986|448683178|FG000|Overall Study|Hospice|1|||
124743865|NCT03040986|448683179|FG001|Overall Study|Hospice|0|||
124743866|NCT03040986|448683178|FG000|Overall Study|Adverse Event|2|||
124743867|NCT03040986|448683179|FG001|Overall Study|Adverse Event|1|||
124743868|NCT03040986|448683178|FG000|Overall Study|Disease progression on study|3|||
124743869|NCT03040986|448683179|FG001|Overall Study|Disease progression on study|1|||
124743870|NCT02273960|448683180|FG000|Short Term Period|Lost to Follow-up|1|||
124743871|NCT02273960|448683181|FG001|Short Term Period|Lost to Follow-up|0|||
124743872|NCT02273960|448683182|FG002|Short Term Period|Lost to Follow-up|0|||
124743873|NCT02273960|448683183|FG003|Short Term Period|Lost to Follow-up|0|||
124743874|NCT02273960|448683180|FG000|Short Term Period|Lack of Efficacy|0|||
124743875|NCT02273960|448683181|FG001|Short Term Period|Lack of Efficacy|0|||
124743876|NCT02273960|448683182|FG002|Short Term Period|Lack of Efficacy|0|||
124743877|NCT02273960|448683183|FG003|Short Term Period|Lack of Efficacy|1|||
124743878|NCT02273960|448683180|FG000|Short Term Period|ST complete, not entering LTE|4|||
124743879|NCT02273960|448683181|FG001|Short Term Period|ST complete, not entering LTE|6|||
124743880|NCT02273960|448683182|FG002|Short Term Period|ST complete, not entering LTE|4|||
124743881|NCT02273960|448683183|FG003|Short Term Period|ST complete, not entering LTE|5|||
124743882|NCT02273960|448683180|FG000|Long Term Extension|Death|0|||
124743883|NCT02273960|448683181|FG001|Long Term Extension|Death|0|||
124743884|NCT02273960|448683182|FG002|Long Term Extension|Death|0|||
124743885|NCT02273960|448683183|FG003|Long Term Extension|Death|1|||
124743886|NCT04033068|448683184|FG000|Overall Study|Withdrawal by Subject|0|||
124743887|NCT04033068|448683185|FG001|Overall Study|Withdrawal by Subject|0|||
124743888|NCT04033068|448683186|FG002|Overall Study|Withdrawal by Subject|1|||
124743889|NCT04033068|448683187|FG003|Overall Study|Withdrawal by Subject|0|||
124743890|NCT04033068|448683184|FG000|Overall Study|Lost to Follow-up|0|||
124743891|NCT04033068|448683185|FG001|Overall Study|Lost to Follow-up|1|||
124743892|NCT04033068|448683186|FG002|Overall Study|Lost to Follow-up|0|||
124743893|NCT04033068|448683187|FG003|Overall Study|Lost to Follow-up|0|||
124743894|NCT04033068|448683184|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
124743895|NCT04033068|448683185|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
124743896|NCT04033068|448683186|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
124743897|NCT04033068|448683187|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
124743898|NCT00417963|448684796|FG000|Overall Study|Lost to Follow-up|3|||
124743899|NCT00417963|448684796|FG000|Overall Study|Withdrawal by Subject|18|||
124743900|NCT00417963|448684796|FG000|Overall Study|Death|17|||
124743901|NCT00417963|448684796|FG000|Overall Study|Study device could not be deployed|3|||
124743902|NCT00477152|448684798|FG000|Overall Study|Parent withdrew consent|2|||
124743903|NCT00477152|448684798|FG000|Overall Study|Adverse Event|1|||
124743904|NCT00568126|448684800|FG000|Overall Study|Adverse Event|3|||
124743905|NCT00568126|448684801|FG001|Overall Study|Adverse Event|0|||
124743906|NCT00568126|448684800|FG000|Overall Study|Withdrawal by Subject|2|||
124743907|NCT00568126|448684801|FG001|Overall Study|Withdrawal by Subject|3|||
124743908|NCT00568126|448684800|FG000|Overall Study|Lost to Follow-up|4|||
124743909|NCT00568126|448684801|FG001|Overall Study|Lost to Follow-up|3|||
124743910|NCT00568126|448684800|FG000|Overall Study|Lack of Efficacy|0|||
124743911|NCT00568126|448684801|FG001|Overall Study|Lack of Efficacy|1|||
124743912|NCT00568126|448684800|FG000|Overall Study|Physician Decision|2|||
124743913|NCT00568126|448684801|FG001|Overall Study|Physician Decision|2|||
124743914|NCT02911142|448684802|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
124743915|NCT02911142|448684802|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
124743916|NCT02911142|448684802|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
124743917|NCT02911142|448684802|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
124743918|NCT02883062|448684803|FG000|Overall Study|Withdrawal by Subject|6|||
124743919|NCT02883062|448684804|FG001|Overall Study|Withdrawal by Subject|0|||
124743920|NCT02888743|448684805|FG000|Overall Study|Withdrawal by Subject|1|||
124743921|NCT02888743|448684806|FG001|Overall Study|Withdrawal by Subject|2|||
124743922|NCT02888743|448684807|FG002|Overall Study|Withdrawal by Subject|2|||
124614369|NCT03301649|448207561|FG000|Overall Study|Need alternate therapy due to live lice|17|||
124614370|NCT03301649|448207562|FG001|Overall Study|Need alternate therapy due to live lice|25|||
124781801|NCT00947882|448831172|FG003|Overall Study|Trial Terminated by Sponsor|70|||
124781802|NCT01396057|448831173|FG000|Overall Study|Adverse Event|2|||
124743923|NCT02888743|448684808|FG003|Overall Study|Withdrawal by Subject|0|||
124743924|NCT02888743|448684809|FG004|Overall Study|Withdrawal by Subject|1|||
124743925|NCT02888743|448684805|FG000|Overall Study|Disease progression before treatment|2|||
124614371|NCT03301649|448207563|FG002|Overall Study|Need alternate therapy due to live lice|81|||
124743926|NCT02888743|448684806|FG001|Overall Study|Disease progression before treatment|0|||
124743927|NCT02888743|448684807|FG002|Overall Study|Disease progression before treatment|2|||
124781803|NCT01396057|448831174|FG001|Overall Study|Adverse Event|6|||
124614372|NCT03301649|448207561|FG000|Overall Study|Lost to Follow-up|11|||
124743928|NCT02888743|448684808|FG003|Overall Study|Disease progression before treatment|0|||
124743929|NCT02888743|448684809|FG004|Overall Study|Disease progression before treatment|0|||
124743930|NCT02888743|448684805|FG000|Overall Study|Patient ineligible|1|||
124743931|NCT02888743|448684806|FG001|Overall Study|Patient ineligible|2|||
124743932|NCT02888743|448684807|FG002|Overall Study|Patient ineligible|0|||
124743933|NCT02888743|448684808|FG003|Overall Study|Patient ineligible|0|||
124743934|NCT02888743|448684809|FG004|Overall Study|Patient ineligible|0|||
124743935|NCT05779007|448684810|FG000|Overall Study|not meeting eligibility criteria|3517|||
124743936|NCT05779007|448684811|FG001|Overall Study|not meeting eligibility criteria|2009|||
124743937|NCT01424566|448684812|FG000|Single-blind Treatment|Adverse Event|71|||
124743938|NCT01424566|448684813|FG001|Single-blind Treatment|Adverse Event|0|||
124743939|NCT01424566|448684814|FG002|Single-blind Treatment|Adverse Event|0|||
124743940|NCT01424566|448684812|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
124743941|NCT01424566|448684813|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
124743942|NCT01424566|448684814|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
124743943|NCT01424566|448684812|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
124743944|NCT01424566|448684813|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
124743945|NCT01424566|448684814|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
124743946|NCT01424566|448684812|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
124743947|NCT01424566|448684813|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
124743948|NCT01424566|448684814|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
124743949|NCT01424566|448684812|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
124743950|NCT01424566|448684813|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
124743951|NCT01424566|448684814|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
124743952|NCT01424566|448684812|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
124743953|NCT01424566|448684813|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
124743954|NCT01424566|448684814|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
124743955|NCT01424566|448684812|FG000|Double-blind Treatment|Adverse Event|0|||
124743956|NCT01424566|448684813|FG001|Double-blind Treatment|Adverse Event|21|||
124743957|NCT01424566|448684814|FG002|Double-blind Treatment|Adverse Event|13|||
124743958|NCT01424566|448684812|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
124743959|NCT01424566|448684813|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
124743960|NCT01424566|448684814|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
124743961|NCT01424566|448684812|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
124743962|NCT01424566|448684813|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
124743963|NCT01424566|448684814|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
124743964|NCT01424566|448684812|FG000|Double-blind Treatment|Lack of Efficacy|0|||
124743965|NCT01424566|448684813|FG001|Double-blind Treatment|Lack of Efficacy|1|||
124743966|NCT01424566|448684814|FG002|Double-blind Treatment|Lack of Efficacy|1|||
124743967|NCT04816721|448684815|FG000|Overall Study|Withdrawal by Subject|0|||
124743968|NCT04816721|448684816|FG001|Overall Study|Withdrawal by Subject|2|||
124743969|NCT04816721|448684817|FG002|Overall Study|Withdrawal by Subject|0|||
124743970|NCT04816721|448684818|FG003|Overall Study|Withdrawal by Subject|1|||
124743971|NCT04816721|448684819|FG004|Overall Study|Withdrawal by Subject|1|||
124743972|NCT04816721|448684820|FG005|Overall Study|Withdrawal by Subject|0|||
124743973|NCT04816721|448684821|FG006|Overall Study|Withdrawal by Subject|0|||
124743974|NCT04816721|448684822|FG007|Overall Study|Withdrawal by Subject|0|||
124743975|NCT04816721|448684815|FG000|Overall Study|Miscellaneous|0|||
124743976|NCT04816721|448684816|FG001|Overall Study|Miscellaneous|0|||
124743977|NCT04816721|448684817|FG002|Overall Study|Miscellaneous|0|||
124743978|NCT04816721|448684818|FG003|Overall Study|Miscellaneous|0|||
124743979|NCT04816721|448684819|FG004|Overall Study|Miscellaneous|0|||
124743980|NCT04816721|448684820|FG005|Overall Study|Miscellaneous|1|||
124743981|NCT04816721|448684821|FG006|Overall Study|Miscellaneous|0|||
124743982|NCT04816721|448684822|FG007|Overall Study|Miscellaneous|0|||
124743983|NCT04816721|448684815|FG000|Overall Study|Lost to Follow-up|0|||
124743984|NCT04816721|448684816|FG001|Overall Study|Lost to Follow-up|0|||
124743985|NCT04816721|448684817|FG002|Overall Study|Lost to Follow-up|0|||
124743986|NCT04816721|448684818|FG003|Overall Study|Lost to Follow-up|1|||
124743987|NCT04816721|448684819|FG004|Overall Study|Lost to Follow-up|0|||
124743988|NCT04816721|448684820|FG005|Overall Study|Lost to Follow-up|0|||
124743989|NCT04816721|448684821|FG006|Overall Study|Lost to Follow-up|0|||
124743990|NCT04816721|448684822|FG007|Overall Study|Lost to Follow-up|0|||
124743991|NCT00026312|448684823|FG000|Overall Study|Adverse Event|0|||
124743992|NCT00026312|448684824|FG001|Overall Study|Adverse Event|32|||
124743993|NCT00026312|448684823|FG000|Overall Study|Death|1|||
124743994|NCT00026312|448684824|FG001|Overall Study|Death|7|||
124743995|NCT00026312|448684823|FG000|Overall Study|Lack of Efficacy|19|||
124743996|NCT00026312|448684824|FG001|Overall Study|Lack of Efficacy|114|||
124743997|NCT00026312|448684823|FG000|Overall Study|Lost to Follow-up|0|||
124743998|NCT00026312|448684824|FG001|Overall Study|Lost to Follow-up|5|||
124743999|NCT00026312|448684823|FG000|Overall Study|Physician Decision|1|||
124744000|NCT00026312|448684824|FG001|Overall Study|Physician Decision|37|||
124744001|NCT00026312|448684823|FG000|Overall Study|Protocol Violation|0|||
124744002|NCT00026312|448684824|FG001|Overall Study|Protocol Violation|3|||
124744003|NCT00026312|448684823|FG000|Overall Study|Withdrawal by Subject|1|||
124744004|NCT00026312|448684824|FG001|Overall Study|Withdrawal by Subject|6|||
124744005|NCT00026312|448684823|FG000|Overall Study|Ineligible|4|||
124744006|NCT00026312|448684824|FG001|Overall Study|Ineligible|5|||
124744007|NCT00026312|448684823|FG000|Overall Study|Entry onto another COG study|0|||
124744008|NCT00026312|448684824|FG001|Overall Study|Entry onto another COG study|1|||
124744009|NCT00026312|448684823|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
124744010|NCT00026312|448684824|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
124744011|NCT01638546|448684825|FG000|Overall Study|Adverse Event|1|||
124744012|NCT01638546|448684826|FG001|Overall Study|Adverse Event|3|||
124744013|NCT03194438|448684829|FG000|Overall Study|Withdrawal by Subject|2|||
124744014|NCT02294734|448684830|FG000|Overall Study|Adverse Event|5|||
124744015|NCT02294734|448684831|FG001|Overall Study|Adverse Event|5|||
124744016|NCT02294734|448684830|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
124744017|NCT02294734|448684831|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
124744018|NCT02294734|448684830|FG000|Overall Study|Lost to Follow-up|2|||
124744019|NCT02294734|448684831|FG001|Overall Study|Lost to Follow-up|0|||
124744020|NCT02294734|448684830|FG000|Overall Study|Physician Decision|2|||
124614373|NCT03301649|448207562|FG001|Overall Study|Lost to Follow-up|11|||
124614374|NCT03301649|448207563|FG002|Overall Study|Lost to Follow-up|3|||
124614375|NCT03301649|448207561|FG000|Overall Study|Protocol Violation|0|||
124614376|NCT03301649|448207562|FG001|Overall Study|Protocol Violation|1|||
124614377|NCT03301649|448207563|FG002|Overall Study|Protocol Violation|1|||
124614378|NCT03301649|448207561|FG000|Overall Study|Withdrawal by Subject|10|||
124614379|NCT03301649|448207562|FG001|Overall Study|Withdrawal by Subject|4|||
124614380|NCT03301649|448207563|FG002|Overall Study|Withdrawal by Subject|0|||
124614381|NCT03301649|448207561|FG000|Overall Study|Other than specified|5|||
124614382|NCT03301649|448207562|FG001|Overall Study|Other than specified|3|||
124614383|NCT03301649|448207563|FG002|Overall Study|Other than specified|0|||
124614384|NCT01564537|448207564|FG000|Overall Study|Site Terminated by Sponsor|1|||
124614385|NCT01564537|448207565|FG001|Overall Study|Site Terminated by Sponsor|0|||
124614386|NCT01564537|448207564|FG000|Overall Study|Withdrawal by Subject|12|||
124614387|NCT01564537|448207565|FG001|Overall Study|Withdrawal by Subject|14|||
124614388|NCT01564537|448207564|FG000|Overall Study|Lost to Follow-up|7|||
124614389|NCT01564537|448207565|FG001|Overall Study|Lost to Follow-up|3|||
124614390|NCT01564537|448207564|FG000|Overall Study|Reason not specified|81|||
124614391|NCT01564537|448207565|FG001|Overall Study|Reason not specified|82|||
124614392|NCT01635218|448207566|FG000|Overall Study|Lost to Follow-up|3|||
124614393|NCT01635218|448207567|FG001|Overall Study|Lost to Follow-up|7|||
124614394|NCT01635218|448207568|FG002|Overall Study|Lost to Follow-up|6|||
124614395|NCT03559400|448207569|FG000|Overall Study|Lost to Follow-up|9|||
124614396|NCT03559400|448207570|FG001|Overall Study|Lost to Follow-up|7|||
124614397|NCT03559400|448207569|FG000|Overall Study|Death|0|||
124614398|NCT03559400|448207570|FG001|Overall Study|Death|2|||
124614399|NCT03262038|448207571|FG000|Overall Study|Withdrawal by Subject|0|||
124614400|NCT03262038|448207572|FG001|Overall Study|Withdrawal by Subject|1|||
124614401|NCT02679235|448207573|FG000|Overall Study|Withdrawal by Subject|3|||
124614402|NCT02679235|448207573|FG000|Overall Study|Adverse Event|1|||
124614403|NCT00094861|448207574|FG000|Overall Study|Adverse Event|5|||
124614404|NCT00094861|448207575|FG001|Overall Study|Adverse Event|2|||
124614405|NCT00094861|448207574|FG000|Overall Study|Withdrawal by Subject|5|||
124614406|NCT00094861|448207575|FG001|Overall Study|Withdrawal by Subject|3|||
124614407|NCT00094861|448207574|FG000|Overall Study|Physician Decision|1|||
124614408|NCT00094861|448207575|FG001|Overall Study|Physician Decision|1|||
124614409|NCT00094861|448207574|FG000|Overall Study|Lost to Follow-up|0|||
124614410|NCT00094861|448207575|FG001|Overall Study|Lost to Follow-up|1|||
124614411|NCT00094861|448207574|FG000|Overall Study|Death|4|||
124614412|NCT00094861|448207575|FG001|Overall Study|Death|2|||
124614413|NCT00094861|448207574|FG000|Overall Study|Other|3|||
124614414|NCT00094861|448207575|FG001|Overall Study|Other|0|||
124614415|NCT02549027|448207577|FG000|Washout After Period 4|Withdrawal by Subject|0|||
124614416|NCT02549027|448207578|FG001|Washout After Period 4|Withdrawal by Subject|1|||
124614417|NCT02549027|448207579|FG002|Washout After Period 4|Withdrawal by Subject|1|||
124614418|NCT02549027|448207580|FG003|Washout After Period 4|Withdrawal by Subject|1|||
124614419|NCT02549027|448207581|FG004|Washout After Period 4|Withdrawal by Subject|0|||
124614420|NCT02549027|448207582|FG005|Washout After Period 4|Withdrawal by Subject|0|||
124614421|NCT02549027|448207577|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
124614422|NCT02549027|448207578|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
124614423|NCT02549027|448207579|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
124614424|NCT02549027|448207580|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
124614425|NCT02549027|448207581|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
124614426|NCT02549027|448207582|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
124614427|NCT01421511|448207588|FG000|Overall Study|Lost to Follow-up|11|||
124614428|NCT01421511|448207589|FG001|Overall Study|Lost to Follow-up|14|||
124614429|NCT01421511|448207588|FG000|Overall Study|Randomized but didn't receive study drug|1|||
124614430|NCT01421511|448207589|FG001|Overall Study|Randomized but didn't receive study drug|7|||
124744021|NCT02294734|448684831|FG001|Overall Study|Physician Decision|1|||
124614431|NCT01421511|448207588|FG000|Overall Study|Physician Decision|0|||
124614432|NCT01421511|448207589|FG001|Overall Study|Physician Decision|1|||
124614433|NCT01421511|448207588|FG000|Overall Study|Withdrawal by Subject|6|||
124614434|NCT01421511|448207589|FG001|Overall Study|Withdrawal by Subject|5|||
124744022|NCT02294734|448684830|FG000|Overall Study|Withdrawal by Subject|4|||
124744023|NCT02294734|448684831|FG001|Overall Study|Withdrawal by Subject|2|||
124744024|NCT03157583|448684832|FG000|Overall Study|Other (did not meet study criteria)|1|||
124744025|NCT01141478|448684836|FG000|Overall Study|Withdrawal by Subject|1|||
124744026|NCT01141478|448684837|FG001|Overall Study|Withdrawal by Subject|1|||
124744027|NCT02250664|448684847|FG000|Overall Study|Lost to Follow-up|18|||
124744028|NCT02250664|448684848|FG001|Overall Study|Lost to Follow-up|28|||
124744029|NCT02250664|448684849|FG002|Overall Study|Lost to Follow-up|33|||
124744030|NCT02250664|448684847|FG000|Overall Study|Personal Reasons|7|||
124744031|NCT02250664|448684848|FG001|Overall Study|Personal Reasons|8|||
124744032|NCT02250664|448684849|FG002|Overall Study|Personal Reasons|14|||
124744033|NCT02250664|448684847|FG000|Overall Study|Adverse Event|6|||
124744034|NCT02250664|448684848|FG001|Overall Study|Adverse Event|3|||
124744035|NCT02250664|448684849|FG002|Overall Study|Adverse Event|8|||
124744036|NCT02250664|448684847|FG000|Overall Study|Incarcerated|2|||
124744037|NCT02250664|448684848|FG001|Overall Study|Incarcerated|1|||
124744038|NCT02250664|448684849|FG002|Overall Study|Incarcerated|2|||
124744039|NCT02250664|448684847|FG000|Overall Study|Withdrawal by Subject|0|||
124744040|NCT02250664|448684848|FG001|Overall Study|Withdrawal by Subject|1|||
124744041|NCT02250664|448684849|FG002|Overall Study|Withdrawal by Subject|2|||
124744042|NCT02250664|448684847|FG000|Overall Study|Death|0|||
124614435|NCT01421511|448207588|FG000|Overall Study|Death|1|||
124614436|NCT01421511|448207589|FG001|Overall Study|Death|1|||
124614437|NCT04581369|448207590|FG000|Overall Study|Death|7|||
124614438|NCT04581369|448207591|FG001|Overall Study|Death|6|||
124614439|NCT04581369|448207592|FG002|Overall Study|Death|0|||
124614440|NCT04581369|448207590|FG000|Overall Study|Lost to Follow-up|7|||
124614441|NCT04581369|448207591|FG001|Overall Study|Lost to Follow-up|3|||
124614442|NCT04581369|448207592|FG002|Overall Study|Lost to Follow-up|0|||
124614443|NCT04581369|448207590|FG000|Overall Study|liver transplant|2|||
124614444|NCT04581369|448207591|FG001|Overall Study|liver transplant|2|||
124614445|NCT04581369|448207592|FG002|Overall Study|liver transplant|0|||
124614446|NCT04581369|448207590|FG000|Overall Study|transitioned to hospice care|0|||
124614447|NCT04581369|448207591|FG001|Overall Study|transitioned to hospice care|5|||
124614448|NCT04581369|448207592|FG002|Overall Study|transitioned to hospice care|0|||
124614449|NCT00780910|448207593|FG000|Overall Study|Adverse Event|2|||
124614450|NCT01111825|448207595|FG000|Overall Study|Withdrawal by Subject|0|||
124614451|NCT01111825|448207596|FG001|Overall Study|Withdrawal by Subject|0|||
124614452|NCT01111825|448207597|FG002|Overall Study|Withdrawal by Subject|1|||
124614453|NCT01111825|448207598|FG003|Overall Study|Withdrawal by Subject|0|||
124614454|NCT01111825|448207595|FG000|Overall Study|Lost to Follow-up|0|||
124614455|NCT01111825|448207596|FG001|Overall Study|Lost to Follow-up|0|||
124614456|NCT01111825|448207597|FG002|Overall Study|Lost to Follow-up|3|||
124614457|NCT01111825|448207598|FG003|Overall Study|Lost to Follow-up|1|||
124614458|NCT01111825|448207595|FG000|Overall Study|Adverse Event|2|||
124614459|NCT01111825|448207596|FG001|Overall Study|Adverse Event|1|||
124614460|NCT01111825|448207597|FG002|Overall Study|Adverse Event|4|||
124614461|NCT01111825|448207598|FG003|Overall Study|Adverse Event|0|||
124614462|NCT01111825|448207595|FG000|Overall Study|Disease Progression|1|||
124614463|NCT01111825|448207596|FG001|Overall Study|Disease Progression|0|||
124614464|NCT01111825|448207597|FG002|Overall Study|Disease Progression|0|||
124614465|NCT01111825|448207598|FG003|Overall Study|Disease Progression|0|||
124614466|NCT01111825|448207595|FG000|Overall Study|Discontinuation by Sponsor|0|||
124614467|NCT01111825|448207596|FG001|Overall Study|Discontinuation by Sponsor|0|||
124614468|NCT01111825|448207597|FG002|Overall Study|Discontinuation by Sponsor|0|||
124614469|NCT01111825|448207598|FG003|Overall Study|Discontinuation by Sponsor|20|||
124614470|NCT01377987|448207605|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
124614471|NCT01377987|448207606|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
124614472|NCT02552303|448207607|FG000|Allocation|Withdrawal by Subject|2|||
124614473|NCT02552303|448207608|FG001|Allocation|Withdrawal by Subject|1|||
124614474|NCT02552303|448207609|FG002|Allocation|Withdrawal by Subject|1|||
124614475|NCT02552303|448207610|FG003|Allocation|Withdrawal by Subject|1|||
124614476|NCT02552303|448207607|FG000|Allocation|ineligible|1|||
124614477|NCT02552303|448207608|FG001|Allocation|ineligible|1|||
124614478|NCT02552303|448207609|FG002|Allocation|ineligible|0|||
124614479|NCT02552303|448207610|FG003|Allocation|ineligible|0|||
124614480|NCT02552303|448207607|FG000|Follow-Up|Lost to Follow-up|0|||
124744043|NCT02250664|448684848|FG001|Overall Study|Death|1|||
124744044|NCT02250664|448684849|FG002|Overall Study|Death|1|||
124744045|NCT02250664|448684847|FG000|Overall Study|Physician Decision|1|||
124744046|NCT02250664|448684848|FG001|Overall Study|Physician Decision|3|||
124614481|NCT02552303|448207608|FG001|Follow-Up|Lost to Follow-up|0|||
124614482|NCT02552303|448207609|FG002|Follow-Up|Lost to Follow-up|1|||
124614483|NCT02552303|448207610|FG003|Follow-Up|Lost to Follow-up|0|||
124614484|NCT02552303|448207607|FG000|Follow-Up|ineligible|0|||
124614485|NCT02552303|448207608|FG001|Follow-Up|ineligible|2|||
124614486|NCT02552303|448207609|FG002|Follow-Up|ineligible|0|||
124614487|NCT02552303|448207610|FG003|Follow-Up|ineligible|0|||
124614488|NCT01775189|448207611|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
124614489|NCT01775189|448207612|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
124614490|NCT01775189|448207613|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
124744047|NCT02250664|448684849|FG002|Overall Study|Physician Decision|1|||
124744048|NCT02250664|448684847|FG000|Overall Study|Protocol Violation|1|||
124744049|NCT02250664|448684848|FG001|Overall Study|Protocol Violation|0|||
124744050|NCT02250664|448684849|FG002|Overall Study|Protocol Violation|1|||
124744051|NCT02250664|448684847|FG000|Overall Study|Reason unknown|1|||
124744052|NCT02250664|448684848|FG001|Overall Study|Reason unknown|0|||
124744053|NCT02250664|448684849|FG002|Overall Study|Reason unknown|0|||
124744054|NCT03847909|448684850|FG000|Overall Study|Withdrawal by Subject|1|||
124744055|NCT03847909|448684851|FG001|Overall Study|Withdrawal by Subject|1|||
124744056|NCT00117793|448684852|FG000|Overall Study|Withdrawal by Subject|12|||
124744057|NCT04268173|448684853|FG000|Overall Study|Lost to Follow-up|75|||
124744058|NCT04268173|448684854|FG001|Overall Study|Lost to Follow-up|108|||
124744059|NCT00975143|448684855|FG000|Overall Study|Adverse Event|19|||
124744060|NCT00975143|448684856|FG001|Overall Study|Adverse Event|15|||
124744061|NCT00975143|448684855|FG000|Overall Study|Withdrawal by Subject|15|||
124744062|NCT00975143|448684856|FG001|Overall Study|Withdrawal by Subject|15|||
124744063|NCT00975143|448684855|FG000|Overall Study|Lost to Follow-up|20|||
124744064|NCT00975143|448684856|FG001|Overall Study|Lost to Follow-up|16|||
124744065|NCT00975143|448684855|FG000|Overall Study|Non-compliance|5|||
124744066|NCT00975143|448684856|FG001|Overall Study|Non-compliance|8|||
124744067|NCT00975143|448684855|FG000|Overall Study|Physician Decision|1|||
124744068|NCT00975143|448684856|FG001|Overall Study|Physician Decision|2|||
124744069|NCT00975143|448684855|FG000|Overall Study|Details not available|10|||
124744070|NCT00975143|448684856|FG001|Overall Study|Details not available|4|||
124744071|NCT01375608|448684857|FG000|Overall Study|Withdrawal by Subject|2|||
124744072|NCT00545103|448684858|FG000|Overall Study|Lack of Efficacy|48|||
124744073|NCT00545103|448684859|FG001|Overall Study|Lack of Efficacy|45|||
124744074|NCT00545103|448684860|FG002|Overall Study|Lack of Efficacy|31|||
124744075|NCT00545103|448684861|FG003|Overall Study|Lack of Efficacy|27|||
124744076|NCT00545103|448684858|FG000|Overall Study|Withdrawal by Subject|6|||
124744077|NCT00545103|448684859|FG001|Overall Study|Withdrawal by Subject|10|||
124744078|NCT00545103|448684860|FG002|Overall Study|Withdrawal by Subject|18|||
124744079|NCT00545103|448684861|FG003|Overall Study|Withdrawal by Subject|22|||
124744080|NCT00545103|448684858|FG000|Overall Study|Adverse Event|11|||
124744081|NCT00545103|448684859|FG001|Overall Study|Adverse Event|12|||
124744082|NCT00545103|448684860|FG002|Overall Study|Adverse Event|17|||
124744083|NCT00545103|448684861|FG003|Overall Study|Adverse Event|10|||
124744084|NCT00545103|448684858|FG000|Overall Study|Lost to Follow-up|4|||
124744085|NCT00545103|448684859|FG001|Overall Study|Lost to Follow-up|6|||
124744086|NCT00545103|448684860|FG002|Overall Study|Lost to Follow-up|3|||
124744087|NCT00545103|448684861|FG003|Overall Study|Lost to Follow-up|4|||
124744088|NCT00545103|448684858|FG000|Overall Study|Protocol Violation|1|||
124744089|NCT00545103|448684859|FG001|Overall Study|Protocol Violation|2|||
124744090|NCT00545103|448684860|FG002|Overall Study|Protocol Violation|3|||
124744091|NCT00545103|448684861|FG003|Overall Study|Protocol Violation|0|||
124744092|NCT00545103|448684858|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
124744093|NCT00545103|448684859|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
124744094|NCT00545103|448684860|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
124744095|NCT00545103|448684861|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
124744096|NCT00545103|448684858|FG000|Overall Study|Difficult to open package|0|||
124744097|NCT00545103|448684859|FG001|Overall Study|Difficult to open package|0|||
124744098|NCT00545103|448684860|FG002|Overall Study|Difficult to open package|0|||
124744099|NCT00545103|448684861|FG003|Overall Study|Difficult to open package|1|||
124744100|NCT00545103|448684858|FG000|Overall Study|Investigational product not taken|1|||
124744101|NCT00545103|448684859|FG001|Overall Study|Investigational product not taken|0|||
124744102|NCT00545103|448684860|FG002|Overall Study|Investigational product not taken|0|||
124744103|NCT00545103|448684861|FG003|Overall Study|Investigational product not taken|1|||
124744104|NCT00545103|448684858|FG000|Overall Study|Wish to start a family|0|||
124744105|NCT00545103|448684859|FG001|Overall Study|Wish to start a family|0|||
124744106|NCT00545103|448684860|FG002|Overall Study|Wish to start a family|0|||
124744107|NCT00545103|448684861|FG003|Overall Study|Wish to start a family|1|||
124744108|NCT00545103|448684858|FG000|Overall Study|Diverticulitis crisis|0|||
124744109|NCT00545103|448684859|FG001|Overall Study|Diverticulitis crisis|0|||
124744110|NCT00545103|448684860|FG002|Overall Study|Diverticulitis crisis|0|||
124744111|NCT00545103|448684861|FG003|Overall Study|Diverticulitis crisis|1|||
124744112|NCT00545103|448684858|FG000|Overall Study|Personal reasons|1|||
124744113|NCT00545103|448684859|FG001|Overall Study|Personal reasons|0|||
124744114|NCT00545103|448684860|FG002|Overall Study|Personal reasons|0|||
124744115|NCT00545103|448684861|FG003|Overall Study|Personal reasons|0|||
124744116|NCT00545103|448684858|FG000|Overall Study|Subject's decision|1|||
124744117|NCT00545103|448684859|FG001|Overall Study|Subject's decision|0|||
124744118|NCT00545103|448684860|FG002|Overall Study|Subject's decision|0|||
124744119|NCT00545103|448684861|FG003|Overall Study|Subject's decision|0|||
124744120|NCT00545103|448684858|FG000|Overall Study|Noncompliance|0|||
124744121|NCT00545103|448684859|FG001|Overall Study|Noncompliance|1|||
124744122|NCT00545103|448684860|FG002|Overall Study|Noncompliance|0|||
124744123|NCT00545103|448684861|FG003|Overall Study|Noncompliance|0|||
124744124|NCT00545103|448684858|FG000|Overall Study|Investigator decision|0|||
124744125|NCT00545103|448684859|FG001|Overall Study|Investigator decision|0|||
124752836|NCT00858637|448716867|FG004|Active Comparison Phase|Death|0|||
124744126|NCT00545103|448684860|FG002|Overall Study|Investigator decision|1|||
124744127|NCT00545103|448684861|FG003|Overall Study|Investigator decision|0|||
124744128|NCT00545103|448684858|FG000|Overall Study|Subject moved|0|||
124744129|NCT00545103|448684859|FG001|Overall Study|Subject moved|1|||
124744130|NCT00545103|448684860|FG002|Overall Study|Subject moved|0|||
124744131|NCT00545103|448684861|FG003|Overall Study|Subject moved|0|||
124744132|NCT00545103|448684858|FG000|Overall Study|Use of prohibited medication|0|||
124744133|NCT00545103|448684859|FG001|Overall Study|Use of prohibited medication|0|||
124744134|NCT00545103|448684860|FG002|Overall Study|Use of prohibited medication|1|||
124614491|NCT01775189|448207614|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
124614492|NCT01775189|448207615|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
124614493|NCT01775189|448207616|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
124614494|NCT01775189|448207617|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
124614495|NCT01775189|448207611|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
124614496|NCT01775189|448207612|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
124614497|NCT01775189|448207613|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
124614498|NCT01775189|448207614|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
124614499|NCT01775189|448207615|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
124614500|NCT01775189|448207616|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
124614501|NCT01775189|448207617|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
124614502|NCT01775189|448207611|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
124614503|NCT01775189|448207612|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
124614504|NCT01775189|448207613|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
124614505|NCT01775189|448207614|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
124614506|NCT01775189|448207615|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
124614507|NCT01775189|448207616|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
124614508|NCT01775189|448207617|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
124614509|NCT01775189|448207611|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
124614510|NCT01775189|448207612|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
124614511|NCT01775189|448207613|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
124614512|NCT01775189|448207614|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
124614513|NCT01775189|448207615|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
124614514|NCT01775189|448207616|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
124614515|NCT01775189|448207617|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
124614516|NCT01775189|448207611|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
124614517|NCT01775189|448207612|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
124614518|NCT01775189|448207613|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
124614519|NCT01775189|448207614|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
124614520|NCT01775189|448207615|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
124614521|NCT01775189|448207616|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
124614522|NCT01775189|448207617|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
124614523|NCT01775189|448207611|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
124614524|NCT01775189|448207612|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
124614525|NCT01775189|448207613|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
124614526|NCT01775189|448207614|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
124614527|NCT01775189|448207615|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
124614528|NCT01775189|448207616|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
124614529|NCT01775189|448207617|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
124614530|NCT02121392|448207620|FG000|Prior to Intervention|Protocol Violation|40|||
124614531|NCT02121392|448207621|FG001|Prior to Intervention|Protocol Violation|35|||
124614532|NCT02121392|448207620|FG000|Prior to Intervention|Withdrawal by Subject|8|||
124614533|NCT02121392|448207621|FG001|Prior to Intervention|Withdrawal by Subject|6|||
124614534|NCT02121392|448207620|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
124614535|NCT02121392|448207621|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
124614536|NCT02121392|448207620|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
124614537|NCT02121392|448207621|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
124614538|NCT00741286|448207622|FG000|Overall Study|Lost to Follow-up|15|||
124614539|NCT00741286|448207623|FG001|Overall Study|Lost to Follow-up|10|||
124614540|NCT00741286|448207622|FG000|Overall Study|Adverse Event|1|||
124744135|NCT00545103|448684861|FG003|Overall Study|Use of prohibited medication|0|||
124781804|NCT01396057|448831173|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124781805|NCT01396057|448831174|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
124614541|NCT00741286|448207623|FG001|Overall Study|Adverse Event|6|||
124781806|NCT01396057|448831173|FG000|Overall Study|Protocol deviation|4|||
124614542|NCT00741286|448207622|FG000|Overall Study|Protocol Violation|3|||
124614543|NCT00741286|448207623|FG001|Overall Study|Protocol Violation|2|||
124614544|NCT00741286|448207622|FG000|Overall Study|Primary Outcome|1|||
124744136|NCT00545103|448684858|FG000|Overall Study|Does not want to take study drug anymore|1|||
124744137|NCT00545103|448684859|FG001|Overall Study|Does not want to take study drug anymore|0|||
124614545|NCT00741286|448207623|FG001|Overall Study|Primary Outcome|1|||
124614546|NCT01352416|448207624|FG000|Overall Study|Physician Decision|1|||
124614547|NCT01352416|448207625|FG001|Overall Study|Physician Decision|2|||
124614548|NCT01352416|448207626|FG002|Overall Study|Physician Decision|2|||
124614549|NCT01352416|448207627|FG003|Overall Study|Physician Decision|1|||
124614550|NCT01831258|448207628|FG000|Overall Study|Withdrawal by Subject|2|||
124614551|NCT01831258|448207629|FG001|Overall Study|Withdrawal by Subject|1|||
124614552|NCT01831258|448207628|FG000|Overall Study|Lost to Follow-up|3|||
124614553|NCT01831258|448207629|FG001|Overall Study|Lost to Follow-up|2|||
124614554|NCT00811928|448207638|FG000|Overall Study|AEs and SAEs Including Death|7|||
124614555|NCT00811928|448207639|FG001|Overall Study|AEs and SAEs Including Death|11|||
124614556|NCT00811928|448207638|FG000|Overall Study|Withdrawal by Subject|18|||
124614557|NCT00811928|448207639|FG001|Overall Study|Withdrawal by Subject|12|||
124614558|NCT00811928|448207638|FG000|Overall Study|Did Not Take Study Drug|3|||
124614559|NCT00811928|448207639|FG001|Overall Study|Did Not Take Study Drug|0|||
124614560|NCT00811928|448207638|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
124614561|NCT00811928|448207639|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
124614562|NCT00811928|448207638|FG000|Overall Study|Investigator Decision|2|||
124614563|NCT00811928|448207639|FG001|Overall Study|Investigator Decision|1|||
124614564|NCT00811928|448207638|FG000|Overall Study|Poor Compliance|2|||
124614565|NCT00811928|448207639|FG001|Overall Study|Poor Compliance|5|||
124614566|NCT00171951|448207640|FG000|Overall Study|Adverse Event|1|||
124614567|NCT00171951|448207640|FG000|Overall Study|Abnormal Laboratory Values|2|||
124614568|NCT00171951|448207640|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
124614569|NCT00171951|448207640|FG000|Overall Study|Participants Withdrew Consent|3|||
124614570|NCT00171951|448207640|FG000|Overall Study|New Cancer Therapy|5|||
124744138|NCT00545103|448684860|FG002|Overall Study|Does not want to take study drug anymore|1|||
124744139|NCT00545103|448684861|FG003|Overall Study|Does not want to take study drug anymore|0|||
124744140|NCT00545103|448684858|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
124744141|NCT00545103|448684859|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
124744142|NCT00545103|448684860|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
124744143|NCT00545103|448684861|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
124744144|NCT00545103|448684858|FG000|Overall Study|Death|0|||
124744145|NCT00545103|448684859|FG001|Overall Study|Death|1|||
124744146|NCT00545103|448684860|FG002|Overall Study|Death|0|||
124744147|NCT00545103|448684861|FG003|Overall Study|Death|0|||
124744148|NCT01953913|448684862|FG000|Overall Study|Disease Progression|349|||
124744149|NCT01953913|448684862|FG000|Overall Study|Worsening of underlying cancer|22|||
124744150|NCT01953913|448684862|FG000|Overall Study|Adverse Event|20|||
124744151|NCT01953913|448684862|FG000|Overall Study|Protocol Violation|6|||
124744152|NCT01953913|448684862|FG000|Overall Study|Lost to Follow-up|4|||
124744153|NCT01953913|448684862|FG000|Overall Study|Withdrawal by Subject|32|||
124744154|NCT01953913|448684862|FG000|Overall Study|Other than listed|108|||
124744155|NCT01953913|448684862|FG000|Overall Study|Not Treated|1|||
124744156|NCT00082381|448684863|FG000|Overall Study|Adverse Event|27|||
124744157|NCT00082381|448684864|FG001|Overall Study|Adverse Event|2|||
124744158|NCT00082381|448684863|FG000|Overall Study|Lost to Follow-up|5|||
124744159|NCT00082381|448684864|FG001|Overall Study|Lost to Follow-up|7|||
124744160|NCT00082381|448684863|FG000|Overall Study|Patient Decision|8|||
124744161|NCT00082381|448684864|FG001|Overall Study|Patient Decision|4|||
124744162|NCT00082381|448684863|FG000|Overall Study|Physician Decision|1|||
124744163|NCT00082381|448684864|FG001|Overall Study|Physician Decision|2|||
124744164|NCT00082381|448684863|FG000|Overall Study|Protocol Violation|10|||
124744165|NCT00082381|448684864|FG001|Overall Study|Protocol Violation|11|||
124744166|NCT00082381|448684863|FG000|Overall Study|Loss of Glucose Control|4|||
124744167|NCT00082381|448684864|FG001|Overall Study|Loss of Glucose Control|0|||
124744168|NCT02049138|448684865|FG000|Overall Study|Adverse Event|46|||
124744169|NCT02049138|448684866|FG001|Overall Study|Adverse Event|25|||
124744170|NCT02049138|448684867|FG002|Overall Study|Adverse Event|1|||
124744171|NCT02049138|448684865|FG000|Overall Study|Withdrawal by Subject|57|||
124744172|NCT02049138|448684866|FG001|Overall Study|Withdrawal by Subject|21|||
124614571|NCT00171951|448207640|FG000|Overall Study|Reason not Specified|2|||
124614572|NCT00396812|448207641|FG000|Overall Study|Physician Decision|1|||
124614573|NCT03485365|448207646|FG000|Overall Study|Protocol Violation|0|||
124614574|NCT03485365|448207647|FG001|Overall Study|Protocol Violation|0|||
124614575|NCT03485365|448207648|FG002|Overall Study|Protocol Violation|0|||
124614576|NCT03485365|448207649|FG003|Overall Study|Protocol Violation|1|||
124744173|NCT02049138|448684867|FG002|Overall Study|Withdrawal by Subject|5|||
124744174|NCT02049138|448684865|FG000|Overall Study|Lost to Follow-up|18|||
124744175|NCT02049138|448684866|FG001|Overall Study|Lost to Follow-up|5|||
124744176|NCT02049138|448684867|FG002|Overall Study|Lost to Follow-up|1|||
124744177|NCT02049138|448684865|FG000|Overall Study|Lack of Efficacy|10|||
124744178|NCT02049138|448684866|FG001|Overall Study|Lack of Efficacy|26|||
124744179|NCT02049138|448684867|FG002|Overall Study|Lack of Efficacy|1|||
124744180|NCT02049138|448684865|FG000|Overall Study|Non-Compliance|15|||
124744181|NCT02049138|448684866|FG001|Overall Study|Non-Compliance|6|||
124744182|NCT02049138|448684867|FG002|Overall Study|Non-Compliance|0|||
124752837|NCT00858637|448716868|FG005|Active Comparison Phase|Death|0|||
124614577|NCT03485365|448207650|FG004|Overall Study|Protocol Violation|0|||
124614578|NCT03485365|448207651|FG005|Overall Study|Protocol Violation|0|||
124614579|NCT03485365|448207652|FG006|Overall Study|Protocol Violation|1|||
124614580|NCT03485365|448207653|FG007|Overall Study|Protocol Violation|0|||
124614581|NCT03485365|448207654|FG008|Overall Study|Protocol Violation|0|||
124614582|NCT03136965|448207655|FG000|Overall Study|Lost to Follow-up|0|||
124614583|NCT03136965|448207656|FG001|Overall Study|Lost to Follow-up|1|||
124614584|NCT03136965|448207657|FG002|Overall Study|Lost to Follow-up|0|||
124614585|NCT04868968|448207658|FG000|Overall Study|Lost to Follow-up|1|||
124614586|NCT02910063|448207665|FG000|Phase 2|Withdrawal by Subject|3|||
124614587|NCT02910063|448207666|FG001|Phase 2|Withdrawal by Subject|0|||
124614588|NCT02910063|448207667|FG002|Phase 2|Withdrawal by Subject|0|||
124614589|NCT02910063|448207665|FG000|Phase 2|Lost to Follow-up|1|||
124614590|NCT02910063|448207666|FG001|Phase 2|Lost to Follow-up|0|||
124614591|NCT02910063|448207667|FG002|Phase 2|Lost to Follow-up|0|||
124614592|NCT02910063|448207665|FG000|Phase 2|Death|24|||
124614593|NCT02910063|448207666|FG001|Phase 2|Death|0|||
124614594|NCT02910063|448207667|FG002|Phase 2|Death|0|||
124614595|NCT02752087|448207668|FG000|Washout|Physician Decision|1|||
124614596|NCT02752087|448207669|FG001|Washout|Physician Decision|0|||
124614597|NCT01547130|448207670|FG000|Overall Study|Lost to Follow-up|9|||
124614598|NCT01547130|448207671|FG001|Overall Study|Lost to Follow-up|5|||
124614599|NCT00843635|448207672|FG000|Overall Study|Adverse Event|2|||
124614600|NCT00843635|448207673|FG001|Overall Study|Adverse Event|2|||
124614601|NCT00843635|448207674|FG002|Overall Study|Adverse Event|0|||
124614602|NCT03496610|448207675|FG000|Overall Study|Lost to Follow-up|3|||
124614603|NCT03496610|448207676|FG001|Overall Study|Lost to Follow-up|2|||
124614604|NCT03496610|448207675|FG000|Overall Study|Physician Decision|1|||
124614605|NCT03496610|448207676|FG001|Overall Study|Physician Decision|0|||
124614606|NCT03496610|448207675|FG000|Overall Study|Withdrawal by Subject|1|||
124614607|NCT03496610|448207676|FG001|Overall Study|Withdrawal by Subject|0|||
124614608|NCT04435184|448207680|FG000|Overall Study|follow-up blood draws missing|3|||
124614609|NCT04435184|448207681|FG001|Overall Study|follow-up blood draws missing|5|||
124614610|NCT02714426|448207682|FG000|Overall Study|Withdrawal by Subject|2|||
124614611|NCT02714426|448207683|FG001|Overall Study|Withdrawal by Subject|2|||
124614612|NCT00896480|448207685|FG000|Overall Study|Disease progression/recurrence|21|||
124614613|NCT00205803|448207689|FG000|Infant Series|Lost to Follow-up|10|||
124614614|NCT00205803|448207690|FG001|Infant Series|Lost to Follow-up|4|||
124614615|NCT00205803|448207689|FG000|Infant Series|Withdrawal by Subject|2|||
124614616|NCT00205803|448207690|FG001|Infant Series|Withdrawal by Subject|5|||
124614617|NCT00205803|448207689|FG000|Infant Series|Physician Decision|3|||
124614618|NCT00205803|448207690|FG001|Infant Series|Physician Decision|1|||
124614619|NCT00205803|448207689|FG000|Infant Series|Protocol Violation|1|||
124614620|NCT00205803|448207690|FG001|Infant Series|Protocol Violation|0|||
124614621|NCT00205803|448207689|FG000|Infant Series|Lost Kaiser coverage|0|||
124614622|NCT00205803|448207690|FG001|Infant Series|Lost Kaiser coverage|1|||
124614623|NCT00205803|448207689|FG000|Infant Series|Non-compliant|1|||
124614624|NCT00205803|448207690|FG001|Infant Series|Non-compliant|0|||
124614625|NCT00205803|448207689|FG000|Infant Series|Sponsor request|1|||
124614626|NCT00205803|448207690|FG001|Infant Series|Sponsor request|0|||
124614627|NCT00205803|448207689|FG000|After Infant Series|Adverse Event|1|||
124614628|NCT00205803|448207690|FG001|After Infant Series|Adverse Event|1|||
124614629|NCT00205803|448207689|FG000|After Infant Series|Protocol Violation|1|||
124614630|NCT00205803|448207690|FG001|After Infant Series|Protocol Violation|1|||
124614631|NCT00205803|448207689|FG000|After Infant Series|Lost to Follow-up|2|||
124614632|NCT00205803|448207690|FG001|After Infant Series|Lost to Follow-up|1|||
124614633|NCT00205803|448207689|FG000|After Infant Series|Physician Decision|3|||
124614634|NCT00205803|448207690|FG001|After Infant Series|Physician Decision|2|||
124614635|NCT00205803|448207689|FG000|After Infant Series|Withdrawal by Subject|1|||
124614636|NCT00205803|448207690|FG001|After Infant Series|Withdrawal by Subject|4|||
124614637|NCT00205803|448207689|FG000|After Infant Series|Other|10|||
124614638|NCT00205803|448207690|FG001|After Infant Series|Other|4|||
124614639|NCT00205803|448207689|FG000|Toddler Dose|Lost to Follow-up|2|||
124614640|NCT00205803|448207690|FG001|Toddler Dose|Lost to Follow-up|3|||
124614641|NCT05038800|448207692|FG000|Overall Study|Death|1|||
124614642|NCT05038800|448207693|FG001|Overall Study|Death|1|||
124614643|NCT05038800|448207694|FG002|Overall Study|Death|5|||
124614644|NCT05038800|448207695|FG003|Overall Study|Death|3|||
124614645|NCT05038800|448207696|FG004|Overall Study|Death|1|||
124744183|NCT02049138|448684865|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
124744184|NCT02049138|448684866|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
124614646|NCT05038800|448207692|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124614647|NCT05038800|448207693|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124614648|NCT05038800|448207694|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124614649|NCT05038800|448207695|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124614650|NCT05038800|448207696|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
124614651|NCT05038800|448207692|FG000|Overall Study|Lack of Efficacy|0|||
124614652|NCT05038800|448207693|FG001|Overall Study|Lack of Efficacy|0|||
124781807|NCT01396057|448831174|FG001|Overall Study|Protocol deviation|4|||
124614653|NCT05038800|448207694|FG002|Overall Study|Lack of Efficacy|0|||
124614654|NCT05038800|448207695|FG003|Overall Study|Lack of Efficacy|0|||
124614655|NCT05038800|448207696|FG004|Overall Study|Lack of Efficacy|1|||
124614656|NCT01104792|448207699|FG000|Overall Study|Adverse Event|77|||
124614657|NCT01104792|448207699|FG000|Overall Study|Insufficient Therapeutic Response|22|||
124614658|NCT01104792|448207699|FG000|Overall Study|Protocol Violation|45|||
124614659|NCT01104792|448207699|FG000|Overall Study|Withdrawal of Consent|179|||
124614660|NCT01104792|448207699|FG000|Overall Study|Lost to Follow-up|43|||
124614661|NCT01104792|448207699|FG000|Overall Study|Reasons Not Specified|27|||
124614662|NCT01104792|448207699|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
124614663|NCT01102374|448207700|FG000|Overall Study|Death|9|||
124614664|NCT01102374|448207701|FG001|Overall Study|Death|13|||
124614665|NCT01102374|448207700|FG000|Overall Study|Lost to Follow-up|7|||
124614666|NCT01102374|448207701|FG001|Overall Study|Lost to Follow-up|6|||
124614667|NCT02071849|448207702|FG000|6-month Primary Endpoint|Did not receive device|4|||
124614668|NCT02071849|448207702|FG000|6-month Primary Endpoint|Adverse Event|1|||
124614669|NCT02071849|448207702|FG000|2-year Extended Follow-up|Adverse Event|1|||
124614670|NCT04619992|448207703|FG000|Overall Study|Withdrawal by Subject|1|||
124614671|NCT04619992|448207704|FG001|Overall Study|Withdrawal by Subject|0|||
124614672|NCT03301623|448207708|FG000|Overall Study|Death|3|||
124614673|NCT03301623|448207709|FG001|Overall Study|Death|1|||
124614674|NCT03301623|448207708|FG000|Overall Study|Withdrawal by Subject|11|||
124614675|NCT03301623|448207709|FG001|Overall Study|Withdrawal by Subject|13|||
124614676|NCT03301623|448207708|FG000|Overall Study|Lost to Follow-up|3|||
124614677|NCT03301623|448207709|FG001|Overall Study|Lost to Follow-up|1|||
124614678|NCT00658021|448207710|FG000|28-Week Treatment Period|Adverse Event|3|||
124614679|NCT00658021|448207711|FG001|28-Week Treatment Period|Adverse Event|1|||
124614680|NCT00658021|448207712|FG002|28-Week Treatment Period|Adverse Event|0|||
124614681|NCT00658021|448207710|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
124614682|NCT00658021|448207711|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
124614683|NCT00658021|448207712|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
124614684|NCT00658021|448207710|FG000|28-Week Treatment Period|Protocol Violation|0|||
124614685|NCT00658021|448207711|FG001|28-Week Treatment Period|Protocol Violation|2|||
124614686|NCT00658021|448207712|FG002|28-Week Treatment Period|Protocol Violation|1|||
124614687|NCT00658021|448207710|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
124614688|NCT00658021|448207711|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
124614689|NCT00658021|448207712|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
124614690|NCT00658021|448207710|FG000|28-Week Treatment Period|Physician Decision|1|||
124614691|NCT00658021|448207711|FG001|28-Week Treatment Period|Physician Decision|2|||
124614692|NCT00658021|448207712|FG002|28-Week Treatment Period|Physician Decision|1|||
124614693|NCT00658021|448207710|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
124614694|NCT00658021|448207711|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
124614695|NCT00658021|448207712|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
124614696|NCT00658021|448207710|FG000|28-Week Treatment Period|Loss of glucose control|1|||
124614697|NCT00658021|448207711|FG001|28-Week Treatment Period|Loss of glucose control|1|||
124614698|NCT00658021|448207712|FG002|28-Week Treatment Period|Loss of glucose control|10|||
124614699|NCT00658021|448207710|FG000|28-Week Treatment Period|Other|2|||
124614700|NCT00658021|448207711|FG001|28-Week Treatment Period|Other|3|||
124614701|NCT00658021|448207712|FG002|28-Week Treatment Period|Other|1|||
124614702|NCT00658021|448207710|FG000|28-Week Treatment Period|Did not receive treatment|2|||
124614703|NCT00658021|448207711|FG001|28-Week Treatment Period|Did not receive treatment|0|||
124614704|NCT00658021|448207712|FG002|28-Week Treatment Period|Did not receive treatment|0|||
124614705|NCT00658021|448207710|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
124614706|NCT00658021|448207711|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
124614707|NCT00658021|448207712|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
124614708|NCT00658021|448207710|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
124614709|NCT00658021|448207711|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
124614710|NCT00658021|448207712|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
124614711|NCT02092467|448207715|FG000|Overall Study|Death|49|||
124614712|NCT02092467|448207716|FG001|Overall Study|Death|66|||
124614713|NCT02092467|448207717|FG002|Overall Study|Death|38|||
124614714|NCT02092467|448207715|FG000|Overall Study|Lost to Follow-up|38|||
124614715|NCT02092467|448207716|FG001|Overall Study|Lost to Follow-up|35|||
124614716|NCT02092467|448207717|FG002|Overall Study|Lost to Follow-up|40|||
124614717|NCT02092467|448207715|FG000|Overall Study|Global Deterioration of Health Status|1|||
124614718|NCT02092467|448207716|FG001|Overall Study|Global Deterioration of Health Status|0|||
124744185|NCT02049138|448684867|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
124744186|NCT02049138|448684865|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
124744187|NCT02049138|448684866|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
124744188|NCT02049138|448684867|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
124614719|NCT02092467|448207717|FG002|Overall Study|Global Deterioration of Health Status|0|||
124614720|NCT02092467|448207715|FG000|Overall Study|Other|32|||
124614721|NCT02092467|448207716|FG001|Overall Study|Other|30|||
124614722|NCT02092467|448207717|FG002|Overall Study|Other|24|||
124614723|NCT02092467|448207715|FG000|Overall Study|Withdrawal by Subject|282|||
124614724|NCT02092467|448207716|FG001|Overall Study|Withdrawal by Subject|327|||
124614725|NCT02092467|448207717|FG002|Overall Study|Withdrawal by Subject|289|||
124614726|NCT02092467|448207715|FG000|Overall Study|Randomized but not treated|2|||
124614727|NCT02092467|448207716|FG001|Overall Study|Randomized but not treated|1|||
124614728|NCT02092467|448207717|FG002|Overall Study|Randomized but not treated|7|||
124614729|NCT02952898|448207725|FG000|Overall Study|Withdrawal by Subject|10|||
124614730|NCT02952898|448207726|FG001|Overall Study|Withdrawal by Subject|8|||
124614731|NCT02952898|448207727|FG002|Overall Study|Withdrawal by Subject|8|||
124614732|NCT02952898|448207725|FG000|Overall Study|Adverse Event|8|||
124614733|NCT02952898|448207726|FG001|Overall Study|Adverse Event|8|||
124614734|NCT02952898|448207727|FG002|Overall Study|Adverse Event|3|||
124614735|NCT02952898|448207725|FG000|Overall Study|Lost to Follow-up|3|||
124614736|NCT02952898|448207726|FG001|Overall Study|Lost to Follow-up|2|||
124614737|NCT02952898|448207727|FG002|Overall Study|Lost to Follow-up|2|||
124614738|NCT02952898|448207725|FG000|Overall Study|Non-compliance with study drug|1|||
124614739|NCT02952898|448207726|FG001|Overall Study|Non-compliance with study drug|1|||
124614740|NCT02952898|448207727|FG002|Overall Study|Non-compliance with study drug|2|||
124614741|NCT04400682|448207730|FG000|Period 1|Withdrawal by Subject|1|||
124614742|NCT04400682|448207731|FG001|Period 1|Withdrawal by Subject|4|||
124614743|NCT02293863|448207732|FG000|Overall Study|Death|4|||
124614744|NCT02293863|448207733|FG001|Overall Study|Death|6|||
124614745|NCT02293863|448207734|FG002|Overall Study|Death|4|||
124614746|NCT02293863|448207732|FG000|Overall Study|Lost to Follow-up|2|||
124614747|NCT02293863|448207733|FG001|Overall Study|Lost to Follow-up|2|||
124614748|NCT02293863|448207734|FG002|Overall Study|Lost to Follow-up|2|||
124614749|NCT02293863|448207732|FG000|Overall Study|Withdrawal by Subject|3|||
124614750|NCT02293863|448207733|FG001|Overall Study|Withdrawal by Subject|3|||
124614751|NCT02293863|448207734|FG002|Overall Study|Withdrawal by Subject|1|||
124614752|NCT02293863|448207732|FG000|Overall Study|Reason Not Specified|0|||
124614753|NCT02293863|448207733|FG001|Overall Study|Reason Not Specified|2|||
124614754|NCT02293863|448207734|FG002|Overall Study|Reason Not Specified|2|||
124614755|NCT00261443|448209330|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
124614756|NCT00261443|448209331|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
124614757|NCT00261443|448209332|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
124614758|NCT00261443|448209330|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
124614759|NCT00261443|448209331|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
124614760|NCT00261443|448209332|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
124614761|NCT00261443|448209330|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
124614762|NCT00261443|448209331|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
124614763|NCT00261443|448209332|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
124614764|NCT00261443|448209330|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
124614765|NCT00261443|448209331|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
124614766|NCT00261443|448209332|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
124614767|NCT00261443|448209330|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
124614768|NCT00261443|448209331|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
124614769|NCT00261443|448209332|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
124614770|NCT00261443|448209330|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
124614771|NCT00261443|448209331|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
124614772|NCT00261443|448209332|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
124614773|NCT00261443|448209330|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
124614774|NCT00261443|448209331|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
124614775|NCT00261443|448209332|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
124614776|NCT00261443|448209330|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
124614777|NCT00261443|448209331|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
124614778|NCT00261443|448209332|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
124614779|NCT00261443|448209330|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
124614780|NCT00261443|448209331|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
124614781|NCT00261443|448209332|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
124614782|NCT00261443|448209330|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
124614783|NCT00261443|448209331|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
124614784|NCT00261443|448209332|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
124614785|NCT00261443|448209330|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
124614786|NCT00261443|448209331|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
124614787|NCT00261443|448209332|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
124614788|NCT00261443|448209330|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
124614789|NCT00261443|448209331|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
124614790|NCT00261443|448209332|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
124614791|NCT00261443|448209330|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
124781808|NCT01396057|448831173|FG000|Overall Study|Consent withdrawn|3|||
124614792|NCT00261443|448209331|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
124614793|NCT00261443|448209332|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
124614794|NCT00261443|448209330|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
124614795|NCT00261443|448209331|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
124614796|NCT00261443|448209332|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
124614797|NCT00261443|448209330|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
124614798|NCT00261443|448209331|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
124614799|NCT00261443|448209332|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
124614800|NCT00261443|448209330|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
124614801|NCT00261443|448209331|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
124614802|NCT00261443|448209332|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
124614803|NCT00261443|448209330|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
124614804|NCT00261443|448209331|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
124614805|NCT00261443|448209332|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
124614806|NCT00261443|448209330|FG000|3: Assessment of Relapse|Adverse Event|0|||
124614807|NCT00261443|448209331|FG001|3: Assessment of Relapse|Adverse Event|15|||
124614808|NCT00261443|448209332|FG002|3: Assessment of Relapse|Adverse Event|19|||
124614809|NCT00261443|448209330|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
124614810|NCT00261443|448209331|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
124614811|NCT00261443|448209332|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
124614812|NCT00261443|448209330|FG000|3: Assessment of Relapse|Death|0|||
124614813|NCT00261443|448209331|FG001|3: Assessment of Relapse|Death|0|||
124614814|NCT00261443|448209332|FG002|3: Assessment of Relapse|Death|1|||
124614815|NCT00261443|448209330|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
124614816|NCT00261443|448209331|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
124614817|NCT00261443|448209332|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
124614818|NCT00261443|448209330|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
124614819|NCT00261443|448209331|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
124614820|NCT00261443|448209332|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
124614821|NCT00261443|448209330|FG000|3: Assessment of Relapse|Pregnancy|0|||
124614822|NCT00261443|448209331|FG001|3: Assessment of Relapse|Pregnancy|2|||
124614823|NCT00261443|448209332|FG002|3: Assessment of Relapse|Pregnancy|1|||
124614824|NCT00261443|448209330|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
124614825|NCT00261443|448209331|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
124614826|NCT00261443|448209332|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
124614827|NCT00261443|448209330|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
124614828|NCT00261443|448209331|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
124614829|NCT00261443|448209332|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
124614830|NCT00261443|448209330|FG000|3: Assessment of Relapse|Other Reasons|0|||
124614831|NCT00261443|448209331|FG001|3: Assessment of Relapse|Other Reasons|4|||
124614832|NCT00261443|448209332|FG002|3: Assessment of Relapse|Other Reasons|3|||
124614833|NCT00261443|448209330|FG000|4: Extension Phase|Adverse Event|0|||
124614834|NCT00261443|448209331|FG001|4: Extension Phase|Adverse Event|1|||
124614835|NCT00261443|448209332|FG002|4: Extension Phase|Adverse Event|0|||
124614836|NCT00261443|448209330|FG000|4: Extension Phase|Withdrawal by Subject|0|||
124614837|NCT00261443|448209331|FG001|4: Extension Phase|Withdrawal by Subject|1|||
124614838|NCT00261443|448209332|FG002|4: Extension Phase|Withdrawal by Subject|2|||
124614839|NCT00261443|448209330|FG000|4: Extension Phase|Lost to Follow-up|0|||
124614840|NCT00261443|448209331|FG001|4: Extension Phase|Lost to Follow-up|1|||
124614841|NCT00261443|448209332|FG002|4: Extension Phase|Lost to Follow-up|0|||
124614842|NCT02755649|448209333|FG000|Overall Study|Transitioned into OLE study|99|||
124614843|NCT02755649|448209334|FG001|Overall Study|Transitioned into OLE study|98|||
124614844|NCT02755649|448209335|FG002|Overall Study|Transitioned into OLE study|100|||
124614845|NCT02755649|448209333|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
124614846|NCT02755649|448209334|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
124614847|NCT02755649|448209335|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
124614848|NCT02755649|448209333|FG000|Overall Study|Physician Decision|0|||
124614849|NCT02755649|448209334|FG001|Overall Study|Physician Decision|0|||
124614850|NCT02755649|448209335|FG002|Overall Study|Physician Decision|2|||
124614851|NCT02755649|448209333|FG000|Overall Study|Withdrawal by Subject|0|||
124614852|NCT02755649|448209334|FG001|Overall Study|Withdrawal by Subject|1|||
124781809|NCT01396057|448831174|FG001|Overall Study|Consent withdrawn|2|||
124781810|NCT03037580|448831177|FG000|Overall Study|Withdrawal by Subject|3|||
124614853|NCT02755649|448209335|FG002|Overall Study|Withdrawal by Subject|0|||
124614854|NCT02755649|448209333|FG000|Overall Study|Undecided|1|||
124781811|NCT03037580|448831178|FG001|Overall Study|Withdrawal by Subject|0|||
124781812|NCT03037580|448831177|FG000|Overall Study|Adverse Event|1|||
124781813|NCT03037580|448831178|FG001|Overall Study|Adverse Event|0|||
124614855|NCT02755649|448209334|FG001|Overall Study|Undecided|0|||
124614856|NCT02755649|448209335|FG002|Overall Study|Undecided|0|||
124614857|NCT01286753|448209336|FG000|Overall Study|Adverse Event|7|||
124614858|NCT01286753|448209337|FG001|Overall Study|Adverse Event|6|||
124614859|NCT01286753|448209336|FG000|Overall Study|Progression|11|||
124614860|NCT01286753|448209337|FG001|Overall Study|Progression|13|||
124614861|NCT01286753|448209336|FG000|Overall Study|Refused Treatment|1|||
124614862|NCT01286753|448209337|FG001|Overall Study|Refused Treatment|0|||
124614863|NCT01286753|448209336|FG000|Overall Study|Withdrawal of Consent|0|||
124614864|NCT01286753|448209337|FG001|Overall Study|Withdrawal of Consent|2|||
124614865|NCT01286753|448209336|FG000|Overall Study|Discontinued to Join Extension Study|6|||
124614866|NCT01286753|448209337|FG001|Overall Study|Discontinued to Join Extension Study|4|||
124614867|NCT01286753|448209336|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
124614868|NCT01286753|448209337|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
124614869|NCT04933968|448209340|FG000|Overall Study|Adverse Event|0|||
124614870|NCT04933968|448209341|FG001|Overall Study|Adverse Event|0|||
124614871|NCT04933968|448209342|FG002|Overall Study|Adverse Event|1|||
124614872|NCT04933968|448209343|FG003|Overall Study|Adverse Event|1|||
124614873|NCT04933968|448209344|FG004|Overall Study|Adverse Event|0|||
124614874|NCT04933968|448209345|FG005|Overall Study|Adverse Event|0|||
124614875|NCT04933968|448209340|FG000|Overall Study|Lost to Follow-up|1|||
124614876|NCT04933968|448209341|FG001|Overall Study|Lost to Follow-up|0|||
124614877|NCT04933968|448209342|FG002|Overall Study|Lost to Follow-up|1|||
124614878|NCT04933968|448209343|FG003|Overall Study|Lost to Follow-up|0|||
124614879|NCT04933968|448209344|FG004|Overall Study|Lost to Follow-up|0|||
124614880|NCT04933968|448209345|FG005|Overall Study|Lost to Follow-up|0|||
124614881|NCT04933968|448209340|FG000|Overall Study|Randomized not treated|1|||
124614882|NCT04933968|448209341|FG001|Overall Study|Randomized not treated|0|||
124614883|NCT04933968|448209342|FG002|Overall Study|Randomized not treated|0|||
124614884|NCT04933968|448209343|FG003|Overall Study|Randomized not treated|0|||
124614885|NCT04933968|448209344|FG004|Overall Study|Randomized not treated|0|||
124614886|NCT04933968|448209345|FG005|Overall Study|Randomized not treated|0|||
124614887|NCT04933968|448209340|FG000|Overall Study|Sponsor terminated study|0|||
124614888|NCT04933968|448209341|FG001|Overall Study|Sponsor terminated study|0|||
124614889|NCT04933968|448209342|FG002|Overall Study|Sponsor terminated study|0|||
124614890|NCT04933968|448209343|FG003|Overall Study|Sponsor terminated study|1|||
124614891|NCT04933968|448209344|FG004|Overall Study|Sponsor terminated study|2|||
124614892|NCT04933968|448209345|FG005|Overall Study|Sponsor terminated study|0|||
124614893|NCT04933968|448209340|FG000|Overall Study|Other|0|||
124614894|NCT04933968|448209341|FG001|Overall Study|Other|0|||
124614895|NCT04933968|448209342|FG002|Overall Study|Other|0|||
124614896|NCT04933968|448209343|FG003|Overall Study|Other|1|||
124614897|NCT04933968|448209344|FG004|Overall Study|Other|0|||
124744189|NCT02049138|448684865|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
124744190|NCT02049138|448684866|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
124744191|NCT02049138|448684867|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
124744192|NCT02049138|448684865|FG000|Overall Study|Other|15|||
124744193|NCT02049138|448684866|FG001|Overall Study|Other|13|||
124744194|NCT02049138|448684867|FG002|Overall Study|Other|0|||
124744195|NCT02049138|448684865|FG000|Overall Study|Missing|0|||
124744196|NCT02049138|448684866|FG001|Overall Study|Missing|1|||
124744197|NCT02049138|448684867|FG002|Overall Study|Missing|0|||
124744198|NCT00884832|448684868|FG000|Overall Study|Withdrawal by Subject|0|||
124744199|NCT00884832|448684869|FG001|Overall Study|Withdrawal by Subject|1|||
124744200|NCT03322423|448684870|FG000|Period 1|Subject no longer eligible|0|||
124744201|NCT03322423|448684871|FG001|Period 1|Subject no longer eligible|1|||
124744202|NCT03322423|448684870|FG000|Period 1|Withdrawal by Subject|0|||
124744203|NCT03322423|448684871|FG001|Period 1|Withdrawal by Subject|1|||
124744204|NCT03322423|448684870|FG000|Period 1|Incorrect Lens Dispensed|1|||
124744205|NCT03322423|448684871|FG001|Period 1|Incorrect Lens Dispensed|0|||
124744206|NCT03322423|448684870|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
124744207|NCT03322423|448684871|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
124744208|NCT03322423|448684870|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
124744209|NCT03322423|448684871|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
124744210|NCT03322423|448684870|FG000|Period 2|Protocol Violation|1|||
124744211|NCT03322423|448684871|FG001|Period 2|Protocol Violation|0|||
124744212|NCT03322423|448684870|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
124614898|NCT04933968|448209345|FG005|Overall Study|Other|0|||
124614899|NCT04933968|448209340|FG000|Overall Study|Missing|1|||
124614900|NCT04933968|448209341|FG001|Overall Study|Missing|3|||
124614901|NCT04933968|448209342|FG002|Overall Study|Missing|2|||
124614902|NCT04933968|448209343|FG003|Overall Study|Missing|1|||
124744213|NCT03322423|448684871|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
124744214|NCT02096263|448684872|FG000|Overall Study|Adverse Event|1|||
124744215|NCT02096263|448684873|FG001|Overall Study|Adverse Event|0|||
124744216|NCT02096263|448684874|FG002|Overall Study|Adverse Event|1|||
124744217|NCT02096263|448684872|FG000|Overall Study|Lost to Follow-up|14|||
124744218|NCT02096263|448684873|FG001|Overall Study|Lost to Follow-up|18|||
124744219|NCT02096263|448684874|FG002|Overall Study|Lost to Follow-up|15|||
124744220|NCT02096263|448684872|FG000|Overall Study|Other|7|||
124744221|NCT02096263|448684873|FG001|Overall Study|Other|9|||
124744222|NCT02096263|448684874|FG002|Overall Study|Other|6|||
124614903|NCT04933968|448209344|FG004|Overall Study|Missing|1|||
124614904|NCT04933968|448209345|FG005|Overall Study|Missing|0|||
124614905|NCT02119819|448209346|FG000|Overall Study|Adverse Event|3|||
124614906|NCT02119819|448209347|FG001|Overall Study|Adverse Event|1|||
124614907|NCT02119819|448209348|FG002|Overall Study|Adverse Event|2|||
124614908|NCT02119819|448209349|FG003|Overall Study|Adverse Event|3|||
124614909|NCT02119819|448209350|FG004|Overall Study|Adverse Event|0|||
124781814|NCT03037580|448831177|FG000|Overall Study|Study Terminated by Sponsor|12|||
124614910|NCT02119819|448209351|FG005|Overall Study|Adverse Event|1|||
124614911|NCT02119819|448209346|FG000|Overall Study|Lack of Efficacy|0|||
124614912|NCT02119819|448209347|FG001|Overall Study|Lack of Efficacy|0|||
124614913|NCT02119819|448209348|FG002|Overall Study|Lack of Efficacy|0|||
124614914|NCT02119819|448209349|FG003|Overall Study|Lack of Efficacy|0|||
124614915|NCT02119819|448209350|FG004|Overall Study|Lack of Efficacy|0|||
124614916|NCT02119819|448209351|FG005|Overall Study|Lack of Efficacy|1|||
124614917|NCT02119819|448209346|FG000|Overall Study|Lost to Follow-up|0|||
124614918|NCT02119819|448209347|FG001|Overall Study|Lost to Follow-up|0|||
124614919|NCT02119819|448209348|FG002|Overall Study|Lost to Follow-up|1|||
124614920|NCT02119819|448209349|FG003|Overall Study|Lost to Follow-up|2|||
124614921|NCT02119819|448209350|FG004|Overall Study|Lost to Follow-up|1|||
124614922|NCT02119819|448209351|FG005|Overall Study|Lost to Follow-up|2|||
124614923|NCT02119819|448209346|FG000|Overall Study|Physician Decision|1|||
124614924|NCT02119819|448209347|FG001|Overall Study|Physician Decision|1|||
124614925|NCT02119819|448209348|FG002|Overall Study|Physician Decision|0|||
124614926|NCT02119819|448209349|FG003|Overall Study|Physician Decision|0|||
124614927|NCT02119819|448209350|FG004|Overall Study|Physician Decision|0|||
124614928|NCT02119819|448209351|FG005|Overall Study|Physician Decision|1|||
124614929|NCT02119819|448209346|FG000|Overall Study|Withdrawal by Subject|5|||
124614930|NCT02119819|448209347|FG001|Overall Study|Withdrawal by Subject|3|||
124614931|NCT02119819|448209348|FG002|Overall Study|Withdrawal by Subject|0|||
124614932|NCT02119819|448209349|FG003|Overall Study|Withdrawal by Subject|0|||
124614933|NCT02119819|448209350|FG004|Overall Study|Withdrawal by Subject|6|||
124614934|NCT02119819|448209351|FG005|Overall Study|Withdrawal by Subject|10|||
124614935|NCT02119819|448209346|FG000|Overall Study|Jury Duty|0|||
124614936|NCT02119819|448209347|FG001|Overall Study|Jury Duty|0|||
124781815|NCT03037580|448831178|FG001|Overall Study|Study Terminated by Sponsor|15|||
124781816|NCT03037580|448831177|FG000|Overall Study|Death|0|||
124781817|NCT03037580|448831178|FG001|Overall Study|Death|1|||
124781818|NCT02087423|448831179|FG000|Overall Study|Withdrawal by Subject|20|||
124781819|NCT02087423|448831180|FG001|Overall Study|Withdrawal by Subject|20|||
124781820|NCT02087423|448831181|FG002|Overall Study|Withdrawal by Subject|3|||
124781821|NCT02087423|448831179|FG000|Overall Study|Death|68|||
124781822|NCT02087423|448831180|FG001|Overall Study|Death|207|||
124781823|NCT02087423|448831181|FG002|Overall Study|Death|40|||
124614937|NCT02119819|448209348|FG002|Overall Study|Jury Duty|1|||
124614938|NCT02119819|448209349|FG003|Overall Study|Jury Duty|0|||
124614939|NCT02119819|448209350|FG004|Overall Study|Jury Duty|0|||
124614940|NCT02119819|448209351|FG005|Overall Study|Jury Duty|0|||
124614941|NCT02119819|448209346|FG000|Overall Study|Protocol Violation|0|||
124614942|NCT02119819|448209347|FG001|Overall Study|Protocol Violation|0|||
124614943|NCT02119819|448209348|FG002|Overall Study|Protocol Violation|0|||
124614944|NCT02119819|448209349|FG003|Overall Study|Protocol Violation|1|||
124614945|NCT02119819|448209350|FG004|Overall Study|Protocol Violation|0|||
124614946|NCT02119819|448209351|FG005|Overall Study|Protocol Violation|0|||
124614947|NCT02119819|448209346|FG000|Overall Study|Left the city to get a job|0|||
124614948|NCT02119819|448209347|FG001|Overall Study|Left the city to get a job|0|||
124744223|NCT02096263|448684872|FG000|Overall Study|Sponsor study termination|0|||
124744224|NCT02096263|448684873|FG001|Overall Study|Sponsor study termination|0|||
124744225|NCT02096263|448684874|FG002|Overall Study|Sponsor study termination|1|||
124744226|NCT02096263|448684872|FG000|Overall Study|Protocol Violation|7|||
124744227|NCT02096263|448684873|FG001|Overall Study|Protocol Violation|2|||
124744228|NCT02096263|448684874|FG002|Overall Study|Protocol Violation|8|||
124744229|NCT02096263|448684872|FG000|Overall Study|Withdrawal by Subject|5|||
124781824|NCT02087423|448831179|FG000|Overall Study|Lost to Follow-up|0|||
124614949|NCT02119819|448209348|FG002|Overall Study|Left the city to get a job|0|||
124781825|NCT02087423|448831180|FG001|Overall Study|Lost to Follow-up|2|||
124614950|NCT02119819|448209349|FG003|Overall Study|Left the city to get a job|1|||
124614951|NCT02119819|448209350|FG004|Overall Study|Left the city to get a job|0|||
124614952|NCT02119819|448209351|FG005|Overall Study|Left the city to get a job|0|||
124614953|NCT02699684|448209352|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
124614954|NCT02699684|448209353|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
124614955|NCT04839692|448209354|FG000|Overall Study|Withdrawal by Subject|0|||
124614956|NCT04839692|448209355|FG001|Overall Study|Withdrawal by Subject|3|||
124614957|NCT04839692|448209354|FG000|Overall Study|Physician Decision|1|||
124614958|NCT04839692|448209355|FG001|Overall Study|Physician Decision|0|||
124744230|NCT02096263|448684873|FG001|Overall Study|Withdrawal by Subject|7|||
124744231|NCT02096263|448684874|FG002|Overall Study|Withdrawal by Subject|8|||
124744232|NCT02337725|448684875|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
124781826|NCT02087423|448831181|FG002|Overall Study|Lost to Follow-up|0|||
124781827|NCT02087423|448831179|FG000|Overall Study|Terminated from study at final DCO|23|||
124614959|NCT03146962|448209356|FG000|Overall Study|Lost to Follow-up|1|||
124614960|NCT03146962|448209357|FG001|Overall Study|Lost to Follow-up|1|||
124614961|NCT03146962|448209358|FG002|Overall Study|Lost to Follow-up|0|||
124614962|NCT03146962|448209359|FG003|Overall Study|Lost to Follow-up|0|||
124614963|NCT03146962|448209360|FG004|Overall Study|Lost to Follow-up|0|||
124614964|NCT03146962|448209361|FG005|Overall Study|Lost to Follow-up|0|||
124614965|NCT03146962|448209362|FG006|Overall Study|Lost to Follow-up|0|||
124614966|NCT03146962|448209363|FG007|Overall Study|Lost to Follow-up|0|||
124614967|NCT03146962|448209364|FG008|Overall Study|Lost to Follow-up|0|||
124614968|NCT03146962|448209365|FG009|Overall Study|Lost to Follow-up|0|||
124614969|NCT03146962|448209356|FG000|Overall Study|Adverse Event|0|||
124614970|NCT03146962|448209357|FG001|Overall Study|Adverse Event|3|||
124614971|NCT03146962|448209358|FG002|Overall Study|Adverse Event|0|||
124614972|NCT03146962|448209359|FG003|Overall Study|Adverse Event|0|||
124614973|NCT03146962|448209360|FG004|Overall Study|Adverse Event|0|||
124614974|NCT03146962|448209361|FG005|Overall Study|Adverse Event|0|||
124614975|NCT03146962|448209362|FG006|Overall Study|Adverse Event|0|||
124614976|NCT03146962|448209363|FG007|Overall Study|Adverse Event|1|||
124614977|NCT03146962|448209364|FG008|Overall Study|Adverse Event|0|||
124614978|NCT03146962|448209365|FG009|Overall Study|Adverse Event|0|||
124614979|NCT03146962|448209356|FG000|Overall Study|Withdrawal by Subject|0|||
124614980|NCT03146962|448209357|FG001|Overall Study|Withdrawal by Subject|0|||
124614981|NCT03146962|448209358|FG002|Overall Study|Withdrawal by Subject|0|||
124614982|NCT03146962|448209359|FG003|Overall Study|Withdrawal by Subject|0|||
124614983|NCT03146962|448209360|FG004|Overall Study|Withdrawal by Subject|1|||
124614984|NCT03146962|448209361|FG005|Overall Study|Withdrawal by Subject|0|||
124614985|NCT03146962|448209362|FG006|Overall Study|Withdrawal by Subject|0|||
124614986|NCT03146962|448209363|FG007|Overall Study|Withdrawal by Subject|0|||
124614987|NCT03146962|448209364|FG008|Overall Study|Withdrawal by Subject|0|||
124614988|NCT03146962|448209365|FG009|Overall Study|Withdrawal by Subject|0|||
124614989|NCT03146962|448209356|FG000|Overall Study|Death|0|||
124614990|NCT03146962|448209357|FG001|Overall Study|Death|1|||
124614991|NCT03146962|448209358|FG002|Overall Study|Death|0|||
124614992|NCT03146962|448209359|FG003|Overall Study|Death|0|||
124614993|NCT03146962|448209360|FG004|Overall Study|Death|0|||
124614994|NCT03146962|448209361|FG005|Overall Study|Death|0|||
124614995|NCT03146962|448209362|FG006|Overall Study|Death|0|||
124614996|NCT03146962|448209363|FG007|Overall Study|Death|0|||
124614997|NCT03146962|448209364|FG008|Overall Study|Death|0|||
124614998|NCT03146962|448209365|FG009|Overall Study|Death|0|||
124614999|NCT03146962|448209356|FG000|Overall Study|COVID Precautions|1|||
124615000|NCT03146962|448209357|FG001|Overall Study|COVID Precautions|0|||
124615001|NCT03146962|448209358|FG002|Overall Study|COVID Precautions|0|||
124615002|NCT03146962|448209359|FG003|Overall Study|COVID Precautions|0|||
124615003|NCT03146962|448209360|FG004|Overall Study|COVID Precautions|0|||
124615004|NCT03146962|448209361|FG005|Overall Study|COVID Precautions|0|||
124615005|NCT03146962|448209362|FG006|Overall Study|COVID Precautions|0|||
124615006|NCT03146962|448209363|FG007|Overall Study|COVID Precautions|0|||
124615007|NCT03146962|448209364|FG008|Overall Study|COVID Precautions|0|||
124615008|NCT03146962|448209365|FG009|Overall Study|COVID Precautions|0|||
124615009|NCT03146962|448209356|FG000|Overall Study|Physician Decision|0|||
124615010|NCT03146962|448209357|FG001|Overall Study|Physician Decision|0|||
124615011|NCT03146962|448209358|FG002|Overall Study|Physician Decision|0|||
124615012|NCT03146962|448209359|FG003|Overall Study|Physician Decision|0|||
124615013|NCT03146962|448209360|FG004|Overall Study|Physician Decision|0|||
124615014|NCT03146962|448209361|FG005|Overall Study|Physician Decision|0|||
124615015|NCT03146962|448209362|FG006|Overall Study|Physician Decision|0|||
124615016|NCT03146962|448209363|FG007|Overall Study|Physician Decision|0|||
124615017|NCT03146962|448209364|FG008|Overall Study|Physician Decision|0|||
124615018|NCT03146962|448209365|FG009|Overall Study|Physician Decision|1|||
124615019|NCT03146962|448209356|FG000|Overall Study|Started New Treatment|0|||
124615020|NCT03146962|448209357|FG001|Overall Study|Started New Treatment|1|||
124615021|NCT03146962|448209358|FG002|Overall Study|Started New Treatment|0|||
124615022|NCT03146962|448209359|FG003|Overall Study|Started New Treatment|0|||
124615023|NCT03146962|448209360|FG004|Overall Study|Started New Treatment|0|||
124615024|NCT03146962|448209361|FG005|Overall Study|Started New Treatment|0|||
124615025|NCT03146962|448209362|FG006|Overall Study|Started New Treatment|0|||
124615026|NCT03146962|448209363|FG007|Overall Study|Started New Treatment|0|||
124615027|NCT03146962|448209364|FG008|Overall Study|Started New Treatment|0|||
124615028|NCT03146962|448209365|FG009|Overall Study|Started New Treatment|0|||
124615029|NCT00926783|448209367|FG000|Overall Study|Incomplete CFAE Procedures|3|||
124615030|NCT00926783|448209368|FG001|Overall Study|Incomplete CFAE Procedures|3|||
124615031|NCT02186834|448209371|FG000|Dose Escalation|Death|0|||
124615032|NCT02186834|448209372|FG001|Dose Escalation|Death|0|||
124615033|NCT02186834|448209373|FG002|Dose Escalation|Death|0|||
124615034|NCT02186834|448209374|FG003|Dose Escalation|Death|1|||
124615035|NCT02186834|448209375|FG004|Dose Escalation|Death|0|||
124615036|NCT02186834|448209376|FG005|Dose Escalation|Death|0|||
124615037|NCT02186834|448209371|FG000|Treatment at RP2D|Died prior to treatment|0|||
124615038|NCT02186834|448209372|FG001|Treatment at RP2D|Died prior to treatment|0|||
124615039|NCT02186834|448209373|FG002|Treatment at RP2D|Died prior to treatment|0|||
124615040|NCT02186834|448209374|FG003|Treatment at RP2D|Died prior to treatment|0|||
124615041|NCT02186834|448209375|FG004|Treatment at RP2D|Died prior to treatment|0|||
124615042|NCT02186834|448209376|FG005|Treatment at RP2D|Died prior to treatment|1|||
124615043|NCT00749892|448209377|FG000|Overall Study|Withdrawal by Subject|3|||
124615044|NCT01191944|448209380|FG000|Overall Study|Adverse Event|11|||
124615045|NCT01191944|448209381|FG001|Overall Study|Adverse Event|12|||
124615046|NCT01191944|448209380|FG000|Overall Study|Protocol Violation|1|||
124615047|NCT01191944|448209381|FG001|Overall Study|Protocol Violation|2|||
124615048|NCT01191944|448209380|FG000|Overall Study|Withdrawal by Subject|4|||
124615049|NCT01191944|448209381|FG001|Overall Study|Withdrawal by Subject|2|||
124615050|NCT01191944|448209380|FG000|Overall Study|Other|1|||
124615051|NCT01191944|448209381|FG001|Overall Study|Other|3|||
124615052|NCT00469144|448209386|FG000|Overall Study|Death|0|||
124615053|NCT00469144|448209387|FG001|Overall Study|Death|1|||
124615054|NCT00469144|448209386|FG000|Overall Study|No Response|5|||
124615055|NCT00469144|448209387|FG001|Overall Study|No Response|5|||
124615056|NCT00469144|448209386|FG000|Overall Study|Progressive Disease|1|||
124615057|NCT00469144|448209387|FG001|Overall Study|Progressive Disease|0|||
124615058|NCT04602546|448209388|FG000|Overall Study|Training|2|||
124615059|NCT04602546|448209389|FG001|Overall Study|Training|2|||
124615060|NCT04602546|448209390|FG002|Overall Study|Training|1|||
124615061|NCT04602546|448209391|FG003|Overall Study|Training|2|||
124615062|NCT04602546|448209392|FG004|Overall Study|Training|0|||
124615063|NCT04602546|448209388|FG000|Overall Study|Randomized with disqualified data|2|||
124615064|NCT04602546|448209389|FG001|Overall Study|Randomized with disqualified data|0|||
124615065|NCT04602546|448209390|FG002|Overall Study|Randomized with disqualified data|2|||
124615066|NCT04602546|448209391|FG003|Overall Study|Randomized with disqualified data|5|||
124615067|NCT04602546|448209392|FG004|Overall Study|Randomized with disqualified data|3|||
124615068|NCT00253448|448209396|FG000|Overall Study|Withdrawal by Subject|1|||
124615069|NCT02564887|448209397|FG000|Overall Study|Lost to Follow-up|6|||
124615070|NCT02564887|448209398|FG001|Overall Study|Lost to Follow-up|0|||
124615071|NCT00000620|448209399|FG000|Overall Study|Death|86|||
124615072|NCT00000620|448209400|FG001|Overall Study|Death|67|||
124615073|NCT00000620|448209401|FG002|Overall Study|Death|112|||
124615074|NCT00000620|448209402|FG003|Overall Study|Death|126|||
124615075|NCT00000620|448209403|FG004|Overall Study|Death|64|||
124615076|NCT00000620|448209404|FG005|Overall Study|Death|77|||
124615077|NCT00000620|448209405|FG006|Overall Study|Death|91|||
124615078|NCT00000620|448209406|FG007|Overall Study|Death|95|||
124615079|NCT00000620|448209399|FG000|Overall Study|Lost to Follow-up|14|||
124615080|NCT00000620|448209400|FG001|Overall Study|Lost to Follow-up|14|||
124615081|NCT00000620|448209401|FG002|Overall Study|Lost to Follow-up|14|||
124615082|NCT00000620|448209402|FG003|Overall Study|Lost to Follow-up|14|||
124615083|NCT00000620|448209403|FG004|Overall Study|Lost to Follow-up|15|||
124615084|NCT00000620|448209404|FG005|Overall Study|Lost to Follow-up|15|||
124615085|NCT00000620|448209405|FG006|Overall Study|Lost to Follow-up|13|||
124615086|NCT00000620|448209406|FG007|Overall Study|Lost to Follow-up|14|||
124615087|NCT00000620|448209399|FG000|Overall Study|Withdrawal by Subject|40|||
124615088|NCT00000620|448209400|FG001|Overall Study|Withdrawal by Subject|27|||
124615089|NCT00000620|448209401|FG002|Overall Study|Withdrawal by Subject|28|||
124615090|NCT00000620|448209402|FG003|Overall Study|Withdrawal by Subject|27|||
124615091|NCT00000620|448209403|FG004|Overall Study|Withdrawal by Subject|30|||
124615092|NCT00000620|448209404|FG005|Overall Study|Withdrawal by Subject|32|||
124615093|NCT00000620|448209405|FG006|Overall Study|Withdrawal by Subject|32|||
124615094|NCT00000620|448209406|FG007|Overall Study|Withdrawal by Subject|21|||
124615095|NCT00000620|448209399|FG000|Overall Study|missed closeout visit|22|||
124615096|NCT00000620|448209400|FG001|Overall Study|missed closeout visit|28|||
124615097|NCT00000620|448209401|FG002|Overall Study|missed closeout visit|16|||
124615098|NCT00000620|448209402|FG003|Overall Study|missed closeout visit|11|||
124615099|NCT00000620|448209403|FG004|Overall Study|missed closeout visit|26|||
124615100|NCT00000620|448209404|FG005|Overall Study|missed closeout visit|28|||
124615101|NCT00000620|448209405|FG006|Overall Study|missed closeout visit|13|||
124615102|NCT00000620|448209406|FG007|Overall Study|missed closeout visit|16|||
124615103|NCT01199016|448209407|FG000|Overall Study|No longer meets eligibility criteria|4|||
124615104|NCT01199016|448209407|FG000|Overall Study|Entrance criteria|5|||
124615105|NCT01199016|448209407|FG000|Overall Study|Protocol Violation|9|||
124615106|NCT01199016|448209407|FG000|Overall Study|Other|13|||
124615107|NCT01199016|448209407|FG000|Overall Study|Withdrawal by Subject|21|||
124615108|NCT01199016|448209407|FG000|Overall Study|Lost to Follow-up|25|||
124615109|NCT00314951|448209416|FG000|Treatment|Didn't meet criteria for mITT population|16|||
124615110|NCT00314951|448209417|FG001|Treatment|Didn't meet criteria for mITT population|11|||
124615111|NCT00314951|448209416|FG000|Follow-up|mITT failure|44|||
124615112|NCT00314951|448209417|FG001|Follow-up|mITT failure|34|||
124615113|NCT05320887|448209420|FG000|Overall Study|Lost to Follow-up|0|||
124615114|NCT05320887|448209421|FG001|Overall Study|Lost to Follow-up|3|||
124615115|NCT05320887|448209422|FG002|Overall Study|Lost to Follow-up|0|||
124615116|NCT05320887|448209423|FG003|Overall Study|Lost to Follow-up|0|||
124615117|NCT02015065|448209428|FG000|Overall Study|Death on study|1|||
124615118|NCT02015065|448209429|FG001|Overall Study|Death on study|2|||
124615119|NCT02015065|448209430|FG002|Overall Study|Death on study|1|||
124615120|NCT00233402|448209463|FG000|Overall Study|No pathology data|12|||
124615121|NCT00233402|448209464|FG001|Overall Study|No pathology data|9|||
124615122|NCT00233402|448209463|FG000|Overall Study|No Ta/T1|89|||
124615123|NCT00233402|448209464|FG001|Overall Study|No Ta/T1|94|||
124615124|NCT00233402|448209463|FG000|Overall Study|Lost to follow up etc|3|||
124615125|NCT00233402|448209464|FG001|Overall Study|Lost to follow up etc|21|||
124615126|NCT03553576|448209469|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
124615127|NCT03553576|448209470|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
124615128|NCT03553576|448209469|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
124615129|NCT03553576|448209470|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
124615130|NCT03553576|448209469|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
124615131|NCT03553576|448209470|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
124615132|NCT03553576|448209469|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
124615133|NCT03553576|448209470|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
124615134|NCT03553576|448209469|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
124615135|NCT03553576|448209470|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
124615136|NCT03553576|448209469|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
124615137|NCT03553576|448209470|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
124615138|NCT03553576|448209469|FG000|Overall Study|Physician Decision|2|||
124615139|NCT03553576|448209470|FG001|Overall Study|Physician Decision|5|||
124615140|NCT01671332|448209471|FG000|Overall Study|Withdrawal by Subject|1|||
124615141|NCT01671332|448209472|FG001|Overall Study|Withdrawal by Subject|1|||
124615142|NCT02728843|448209473|FG000|Overall Study|Adverse Event|0|||
124615143|NCT02728843|448209474|FG001|Overall Study|Adverse Event|2|||
124615144|NCT02728843|448209475|FG002|Overall Study|Adverse Event|3|||
124615145|NCT02728843|448209476|FG003|Overall Study|Adverse Event|1|||
124615146|NCT02728843|448209477|FG004|Overall Study|Adverse Event|2|||
124615147|NCT02728843|448209473|FG000|Overall Study|Lack of Efficacy|0|||
124615148|NCT02728843|448209474|FG001|Overall Study|Lack of Efficacy|1|||
124615149|NCT02728843|448209475|FG002|Overall Study|Lack of Efficacy|1|||
124615150|NCT02728843|448209476|FG003|Overall Study|Lack of Efficacy|0|||
124615151|NCT02728843|448209477|FG004|Overall Study|Lack of Efficacy|0|||
124615152|NCT02728843|448209473|FG000|Overall Study|Protocol Violation|2|||
124615153|NCT02728843|448209474|FG001|Overall Study|Protocol Violation|0|||
124615154|NCT02728843|448209475|FG002|Overall Study|Protocol Violation|4|||
124615155|NCT02728843|448209476|FG003|Overall Study|Protocol Violation|2|||
124615156|NCT02728843|448209477|FG004|Overall Study|Protocol Violation|2|||
124615157|NCT02728843|448209473|FG000|Overall Study|Withdrawal by Subject|1|||
124615158|NCT02728843|448209474|FG001|Overall Study|Withdrawal by Subject|0|||
124615159|NCT02728843|448209475|FG002|Overall Study|Withdrawal by Subject|0|||
124615160|NCT02728843|448209476|FG003|Overall Study|Withdrawal by Subject|1|||
124615161|NCT02728843|448209477|FG004|Overall Study|Withdrawal by Subject|0|||
124615162|NCT02728843|448209473|FG000|Overall Study|Use of rescue medication|0|||
124615163|NCT02728843|448209474|FG001|Overall Study|Use of rescue medication|2|||
124615164|NCT02728843|448209475|FG002|Overall Study|Use of rescue medication|0|||
124615165|NCT02728843|448209476|FG003|Overall Study|Use of rescue medication|2|||
124615166|NCT02728843|448209477|FG004|Overall Study|Use of rescue medication|1|||
124615167|NCT01806506|448209479|FG000|Overall Study|Lost to Follow-up|2|||
124615168|NCT01806506|448209480|FG001|Overall Study|Lost to Follow-up|1|||
124615169|NCT04844762|448209485|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
124615170|NCT04844762|448209486|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
124615171|NCT04844762|448209487|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
124615172|NCT04844762|448209488|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
124615173|NCT04844762|448209489|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
124615174|NCT04844762|448209490|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
124615175|NCT04844762|448209485|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
124615176|NCT04844762|448209486|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
124615177|NCT04844762|448209487|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
124615178|NCT04844762|448209488|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
124615179|NCT04844762|448209489|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
124615180|NCT04844762|448209490|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
124615181|NCT04844762|448209485|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
124615182|NCT04844762|448209486|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
124615183|NCT04844762|448209487|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
124615184|NCT04844762|448209488|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
124615185|NCT04844762|448209489|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
124615186|NCT04844762|448209490|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
124615187|NCT04844762|448209485|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
124615188|NCT04844762|448209486|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
124615189|NCT04844762|448209487|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
124615190|NCT04844762|448209488|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
124615191|NCT04844762|448209489|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
124615192|NCT04844762|448209490|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
124615193|NCT04844762|448209485|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
124615194|NCT04844762|448209486|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
124744233|NCT02337725|448684876|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
124744234|NCT02337725|448684875|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
124744235|NCT02337725|448684876|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
124744236|NCT02337725|448684875|FG000|Overall Study|Major Protocol Deviation|0|||
124744237|NCT02337725|448684876|FG001|Overall Study|Major Protocol Deviation|1|||
124744238|NCT02337725|448684875|FG000|Overall Study|Voluntary Withdrawal|14|||
124744239|NCT02337725|448684876|FG001|Overall Study|Voluntary Withdrawal|3|||
124744240|NCT02337725|448684875|FG000|Overall Study|Lack of Efficacy|4|||
124744241|NCT02337725|448684876|FG001|Overall Study|Lack of Efficacy|0|||
124744242|NCT02453555|448684877|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
124744243|NCT02453555|448684878|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
124744244|NCT02453555|448684879|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
124744245|NCT02453555|448684880|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
124744246|NCT02453555|448684881|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
124744247|NCT02453555|448684882|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
124744248|NCT02453555|448684877|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
124744249|NCT02453555|448684878|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
124744250|NCT02453555|448684879|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
124744251|NCT02453555|448684880|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
124781828|NCT02087423|448831180|FG001|Overall Study|Terminated from study at final DCO|36|||
124781829|NCT02087423|448831181|FG002|Overall Study|Terminated from study at final DCO|25|||
124615195|NCT04844762|448209487|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
124615196|NCT04844762|448209488|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
124615197|NCT04844762|448209489|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
124615198|NCT04844762|448209490|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
124615199|NCT04844762|448209485|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
124615200|NCT04844762|448209486|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
124615201|NCT04844762|448209487|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
124615202|NCT04844762|448209488|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
124615203|NCT04844762|448209489|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
124615204|NCT04844762|448209490|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
124615205|NCT04844762|448209485|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
124615206|NCT04844762|448209486|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
124615207|NCT04844762|448209487|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
124615208|NCT04844762|448209488|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
124615209|NCT04844762|448209489|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
124615210|NCT04844762|448209490|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
124615211|NCT04844762|448209485|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
124615212|NCT04844762|448209486|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
124615213|NCT04844762|448209487|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
124615214|NCT04844762|448209488|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
124615215|NCT04844762|448209489|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
124615216|NCT04844762|448209490|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
124615217|NCT04844762|448209485|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
124615218|NCT04844762|448209486|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
124615219|NCT04844762|448209487|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
124615220|NCT04844762|448209488|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
124615221|NCT04844762|448209489|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
124615222|NCT04844762|448209490|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
124615223|NCT04844762|448209485|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
124615224|NCT04844762|448209486|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
124615225|NCT04844762|448209487|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
124615226|NCT04844762|448209488|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
124744252|NCT02453555|448684881|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
124744253|NCT02453555|448684882|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
124744254|NCT02453555|448684877|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
124744255|NCT02453555|448684878|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
124615227|NCT04844762|448209489|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
124615228|NCT04844762|448209490|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
124615229|NCT04844762|448209485|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
124615230|NCT04844762|448209486|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
124615231|NCT04844762|448209487|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
124615232|NCT04844762|448209488|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
124615233|NCT04844762|448209489|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
124615234|NCT04844762|448209490|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
124615235|NCT00477633|448209491|FG000|Overall Study|Did not receive treatment|23|||
124615236|NCT00477633|448209491|FG000|Overall Study|Adverse Event|143|||
124615237|NCT00477633|448209491|FG000|Overall Study|Pregnancy|23|||
124615238|NCT00477633|448209491|FG000|Overall Study|Lost to Follow-up|271|||
124615239|NCT00477633|448209491|FG000|Overall Study|Withdrawal by Subject|149|||
124615240|NCT00477633|448209491|FG000|Overall Study|Protocol Violation|25|||
124615241|NCT00477633|448209491|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
124615242|NCT04123561|448209497|FG000|Overall Study|Lost to Follow-up|20|||
124615243|NCT04123561|448209498|FG001|Overall Study|Lost to Follow-up|12|||
124615244|NCT04123561|448209499|FG002|Overall Study|Lost to Follow-up|5|||
124615245|NCT04123561|448209497|FG000|Overall Study|Withdrawal by Subject|9|||
124615246|NCT04123561|448209498|FG001|Overall Study|Withdrawal by Subject|7|||
124615247|NCT04123561|448209499|FG002|Overall Study|Withdrawal by Subject|9|||
124615248|NCT04123561|448209497|FG000|Overall Study|Lack of Efficacy|7|||
124615249|NCT04123561|448209498|FG001|Overall Study|Lack of Efficacy|8|||
124615250|NCT04123561|448209499|FG002|Overall Study|Lack of Efficacy|6|||
124615251|NCT04123561|448209497|FG000|Overall Study|Adverse Event|5|||
124615252|NCT04123561|448209498|FG001|Overall Study|Adverse Event|2|||
124615253|NCT04123561|448209499|FG002|Overall Study|Adverse Event|3|||
124615254|NCT04123561|448209497|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
124615255|NCT04123561|448209498|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
124615256|NCT04123561|448209499|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
124615257|NCT04123561|448209497|FG000|Overall Study|Death|0|||
124615258|NCT04123561|448209498|FG001|Overall Study|Death|0|||
124615259|NCT04123561|448209499|FG002|Overall Study|Death|1|||
124615260|NCT04123561|448209497|FG000|Overall Study|Protocol Violation|0|||
124615261|NCT04123561|448209498|FG001|Overall Study|Protocol Violation|1|||
124615262|NCT04123561|448209499|FG002|Overall Study|Protocol Violation|0|||
124615263|NCT01374269|448209507|FG000|Overall Study|Withdrawal by Subject|4|||
124615264|NCT01374269|448209508|FG001|Overall Study|Withdrawal by Subject|0|||
124615265|NCT01374269|448209507|FG000|Overall Study|Lost to Follow-up|1|||
124615266|NCT01374269|448209508|FG001|Overall Study|Lost to Follow-up|3|||
124615267|NCT01374269|448209507|FG000|Overall Study|closed research|1|||
124615268|NCT01374269|448209508|FG001|Overall Study|closed research|2|||
124615269|NCT00278889|448209509|FG000|Overall Study|Withdrawal by Subject|0|||
124615270|NCT00278889|448209510|FG001|Overall Study|Withdrawal by Subject|5|||
124615271|NCT00278889|448209511|FG002|Overall Study|Withdrawal by Subject|3|||
124615272|NCT00278889|448209509|FG000|Overall Study|Lost to Follow-up|1|||
124615273|NCT00278889|448209510|FG001|Overall Study|Lost to Follow-up|1|||
124615274|NCT00278889|448209511|FG002|Overall Study|Lost to Follow-up|0|||
124615275|NCT00278889|448209509|FG000|Overall Study|Death|24|||
124615276|NCT00278889|448209510|FG001|Overall Study|Death|21|||
124615277|NCT00278889|448209511|FG002|Overall Study|Death|17|||
124615278|NCT01987479|448209512|FG000|Overall Study|Protocol Violation|1|||
124615279|NCT01987479|448209512|FG000|Overall Study|Physician Decision|2|||
124615280|NCT01987479|448209512|FG000|Overall Study|Participant/legal guardian decision|1|||
124615281|NCT01987479|448209512|FG000|Overall Study|Other|5|||
124615282|NCT01987479|448209512|FG000|Overall Study|Lost to Follow-up|1|||
124615283|NCT01987479|448209512|FG000|Overall Study|Adverse Event|7|||
124615284|NCT03462459|448209513|FG000|Overall Study|Death|1|||
124615285|NCT03462459|448209514|FG001|Overall Study|Death|0|||
124615286|NCT03462459|448209513|FG000|Overall Study|Lack of Efficacy|2|||
124615287|NCT03462459|448209514|FG001|Overall Study|Lack of Efficacy|4|||
124615288|NCT03462459|448209513|FG000|Overall Study|Lost to Follow-up|1|||
124615289|NCT03462459|448209514|FG001|Overall Study|Lost to Follow-up|3|||
124615290|NCT03462459|448209513|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
124615291|NCT03462459|448209514|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
124615292|NCT03462459|448209513|FG000|Overall Study|Withdrawal by Subject|3|||
124615293|NCT03462459|448209514|FG001|Overall Study|Withdrawal by Subject|2|||
124615294|NCT03462459|448209513|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
124615295|NCT03462459|448209514|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
124615296|NCT04998851|448211551|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
124615297|NCT04998851|448211552|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
124615298|NCT04998851|448211551|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
124615299|NCT04998851|448211552|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
124615300|NCT00478244|448211555|FG000|Overall Study|Did not receive transplant|1|||
124615301|NCT02929056|448211556|FG000|Overall Study|Lost to Follow-up|0|||
124615302|NCT02929056|448211557|FG001|Overall Study|Lost to Follow-up|1|||
124615303|NCT03132155|448211558|FG000|Overall Study|Lack of Efficacy|6|||
124615304|NCT03132155|448211558|FG000|Overall Study|Lost to Follow-up|1|||
124615305|NCT03132155|448211558|FG000|Overall Study|Withdrawal by Subject|1|||
124615306|NCT02925403|448211562|FG000|Overall Study|Lost to Follow-up|0|||
124615307|NCT02925403|448211563|FG001|Overall Study|Lost to Follow-up|1|||
124615308|NCT00459043|448211564|FG000|Overall Study|Withdrawal by Subject|1|||
124615309|NCT00459043|448211565|FG001|Overall Study|Withdrawal by Subject|0|||
124615310|NCT02899195|448211568|FG000|Concurrent Durvalumab|Adverse Event|4|||
124615311|NCT02899195|448211568|FG000|Concurrent Durvalumab|Physician Decision|1|||
124615312|NCT02899195|448211568|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
124615313|NCT02899195|448211568|FG000|Concurrent Durvalumab|Progressive Disease|5|||
124615314|NCT02899195|448211568|FG000|Maintenance Durvalumab|Adverse Event|1|||
124615315|NCT02899195|448211568|FG000|Maintenance Durvalumab|Physician Decision|1|||
124615316|NCT02899195|448211568|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
124615317|NCT02899195|448211568|FG000|Maintenance Durvalumab|Progressive Disease|31|||
124615318|NCT03156504|448211569|FG000|Overall Study|Withdrawal by Subject|1|||
124615319|NCT00450801|448211570|FG000|Overall Study|Death|1|||
124615320|NCT03452137|448211571|FG000|Overall Study|Death|67|||
124615321|NCT03452137|448211572|FG001|Overall Study|Death|70|||
124615322|NCT03452137|448211571|FG000|Overall Study|Lost to Follow-up|4|||
124615323|NCT03452137|448211572|FG001|Overall Study|Lost to Follow-up|2|||
124615324|NCT03452137|448211571|FG000|Overall Study|Physician Decision|0|||
124615325|NCT03452137|448211572|FG001|Overall Study|Physician Decision|1|||
124615326|NCT03452137|448211571|FG000|Overall Study|Study Terminated by Sponsor|120|||
124615327|NCT03452137|448211572|FG001|Overall Study|Study Terminated by Sponsor|121|||
124615328|NCT03452137|448211571|FG000|Overall Study|Withdrawal by Subject|12|||
124615329|NCT03452137|448211572|FG001|Overall Study|Withdrawal by Subject|9|||
124615330|NCT00509366|448211579|FG000|Overall Study|Not Treated (Screen Failure)|1|||
124615331|NCT00509366|448211580|FG001|Overall Study|Not Treated (Screen Failure)|1|||
124615332|NCT00509366|448211581|FG002|Overall Study|Not Treated (Screen Failure)|1|||
124615333|NCT00509366|448211582|FG003|Overall Study|Not Treated (Screen Failure)|0|||
124615334|NCT00509366|448211583|FG004|Overall Study|Not Treated (Screen Failure)|0|||
124615335|NCT02906358|448211584|FG000|Overall Study|Withdrawal by Subject|10|||
124615336|NCT02906358|448211585|FG001|Overall Study|Withdrawal by Subject|7|||
124615337|NCT02906358|448211584|FG000|Overall Study|Lost to Follow-up|12|||
124615338|NCT02906358|448211585|FG001|Overall Study|Lost to Follow-up|15|||
124615339|NCT01145508|448211587|FG000|Overall Study|Adverse Event|1|||
124615340|NCT01145508|448211588|FG001|Overall Study|Adverse Event|0|||
124615341|NCT01145508|448211587|FG000|Overall Study|Death|1|||
124615342|NCT01145508|448211588|FG001|Overall Study|Death|0|||
124615343|NCT01145508|448211587|FG000|Overall Study|Physician Decision|2|||
124615344|NCT01145508|448211588|FG001|Overall Study|Physician Decision|1|||
124615345|NCT01145508|448211587|FG000|Overall Study|Never started treatment|1|||
124615346|NCT01145508|448211588|FG001|Overall Study|Never started treatment|1|||
124615347|NCT02045147|448211589|FG000|Overall Study|Withdrawal by Subject|2|||
124615348|NCT02045147|448211590|FG001|Overall Study|Withdrawal by Subject|0|||
124615349|NCT02045147|448211591|FG002|Overall Study|Withdrawal by Subject|0|||
124615350|NCT02045147|448211592|FG003|Overall Study|Withdrawal by Subject|0|||
124615351|NCT02045147|448211593|FG004|Overall Study|Withdrawal by Subject|0|||
124615352|NCT02045147|448211594|FG005|Overall Study|Withdrawal by Subject|0|||
124615353|NCT02045147|448211595|FG006|Overall Study|Withdrawal by Subject|0|||
124615354|NCT02045147|448211596|FG007|Overall Study|Withdrawal by Subject|1|||
124615355|NCT02045147|448211589|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
124615356|NCT02045147|448211590|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
124615357|NCT02045147|448211591|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
124615358|NCT02045147|448211592|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
124615359|NCT02045147|448211593|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
124615360|NCT02045147|448211594|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
124615361|NCT02045147|448211595|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
124615362|NCT02045147|448211596|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
124615363|NCT00264550|448211597|FG000|Overall Study|Death|0|||
124615364|NCT00264550|448211598|FG001|Overall Study|Death|3|||
124615365|NCT00264550|448211599|FG002|Overall Study|Death|0|||
124615366|NCT00264550|448211600|FG003|Overall Study|Death|0|||
124615367|NCT00264550|448211597|FG000|Overall Study|Lost to Follow-up|3|||
124615368|NCT00264550|448211598|FG001|Overall Study|Lost to Follow-up|1|||
124615369|NCT00264550|448211599|FG002|Overall Study|Lost to Follow-up|1|||
124615370|NCT00264550|448211600|FG003|Overall Study|Lost to Follow-up|1|||
124615371|NCT00264550|448211597|FG000|Overall Study|Adverse Event|23|||
124615372|NCT00264550|448211598|FG001|Overall Study|Adverse Event|18|||
124615373|NCT00264550|448211599|FG002|Overall Study|Adverse Event|9|||
124615374|NCT00264550|448211600|FG003|Overall Study|Adverse Event|14|||
124615375|NCT00264550|448211597|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
124615376|NCT00264550|448211598|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
124615377|NCT00264550|448211599|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
124615378|NCT00264550|448211600|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
124615379|NCT00264550|448211597|FG000|Overall Study|Discontinued oral study agent|0|||
124615380|NCT00264550|448211598|FG001|Overall Study|Discontinued oral study agent|1|||
124615381|NCT00264550|448211599|FG002|Overall Study|Discontinued oral study agent|0|||
124615382|NCT00264550|448211600|FG003|Overall Study|Discontinued oral study agent|0|||
124615383|NCT00264550|448211597|FG000|Overall Study|Other|13|||
124615384|NCT00264550|448211598|FG001|Overall Study|Other|7|||
124615385|NCT00264550|448211599|FG002|Overall Study|Other|3|||
124615386|NCT00264550|448211600|FG003|Overall Study|Other|9|||
124615387|NCT02246114|448211601|FG000|Overall Study|miscarriage|1|||
124615388|NCT02246114|448211602|FG001|Overall Study|miscarriage|0|||
124615389|NCT01439009|448211608|FG000|Overall Study|Physician Decision|5|||
124615390|NCT01439009|448211609|FG001|Overall Study|Physician Decision|3|||
124615391|NCT01439009|448211608|FG000|Overall Study|Protocol Violation|2|||
124615392|NCT01439009|448211609|FG001|Overall Study|Protocol Violation|0|||
124615393|NCT01439009|448211608|FG000|Overall Study|Deviation of exclusion criteria|1|||
124615394|NCT01439009|448211609|FG001|Overall Study|Deviation of exclusion criteria|0|||
124615395|NCT00696787|448211611|FG000|Overall Study|Adverse Event|1|||
124615396|NCT00696787|448211612|FG001|Overall Study|Adverse Event|0|||
124615397|NCT00696787|448211613|FG002|Overall Study|Adverse Event|6|||
124615398|NCT00696787|448211611|FG000|Overall Study|Discontinuation by Sponsor|9|||
124615399|NCT00696787|448211612|FG001|Overall Study|Discontinuation by Sponsor|13|||
124615400|NCT00696787|448211613|FG002|Overall Study|Discontinuation by Sponsor|14|||
124615401|NCT00696787|448211611|FG000|Overall Study|Lack of Efficacy|0|||
124615402|NCT00696787|448211612|FG001|Overall Study|Lack of Efficacy|1|||
124615403|NCT00696787|448211613|FG002|Overall Study|Lack of Efficacy|0|||
124615404|NCT00696787|448211611|FG000|Overall Study|Lost to Follow-up|4|||
124615405|NCT00696787|448211612|FG001|Overall Study|Lost to Follow-up|0|||
124615406|NCT00696787|448211613|FG002|Overall Study|Lost to Follow-up|3|||
124615407|NCT00696787|448211611|FG000|Overall Study|Withdrawal by Subject|0|||
124615408|NCT00696787|448211612|FG001|Overall Study|Withdrawal by Subject|3|||
124615409|NCT00696787|448211613|FG002|Overall Study|Withdrawal by Subject|2|||
124615410|NCT00696787|448211611|FG000|Overall Study|Failed to return|1|||
124615411|NCT00696787|448211612|FG001|Overall Study|Failed to return|3|||
124615412|NCT00696787|448211613|FG002|Overall Study|Failed to return|1|||
124615413|NCT00129389|448211616|FG000|Overall Study|Adverse Event|19|||
124615414|NCT00129389|448211617|FG001|Overall Study|Adverse Event|87|||
124615415|NCT00129389|448211616|FG000|Overall Study|Death|0|||
124615416|NCT00129389|448211617|FG001|Overall Study|Death|1|||
124615417|NCT00129389|448211616|FG000|Overall Study|Lost to Follow-up|2|||
124615418|NCT00129389|448211617|FG001|Overall Study|Lost to Follow-up|1|||
124615419|NCT00129389|448211616|FG000|Overall Study|Physician Decision|0|||
124615420|NCT00129389|448211617|FG001|Overall Study|Physician Decision|4|||
124615421|NCT00129389|448211616|FG000|Overall Study|Protocol Violation|0|||
124615422|NCT00129389|448211617|FG001|Overall Study|Protocol Violation|6|||
124615423|NCT00129389|448211616|FG000|Overall Study|Withdrawal by Subject|9|||
124615424|NCT00129389|448211617|FG001|Overall Study|Withdrawal by Subject|23|||
124615425|NCT00129389|448211616|FG000|Overall Study|Relapse|1|||
124615426|NCT00129389|448211617|FG001|Overall Study|Relapse|0|||
124615427|NCT00129389|448211616|FG000|Overall Study|Not eligible|1|||
124615428|NCT00129389|448211617|FG001|Overall Study|Not eligible|2|||
124615429|NCT00129389|448211616|FG000|Overall Study|Crossed to the other arm|1|||
124615430|NCT00129389|448211617|FG001|Overall Study|Crossed to the other arm|16|||
124615431|NCT00603837|448211622|FG000|Overall Study|Physician Decision|3|||
124615432|NCT00603837|448211623|FG001|Overall Study|Physician Decision|0|||
124615433|NCT04611529|448211624|FG000|2-day Follow up|Lost to Follow-up|5|||
124615434|NCT04611529|448211625|FG001|2-day Follow up|Lost to Follow-up|6|||
124615435|NCT04611529|448211626|FG002|2-day Follow up|Lost to Follow-up|3|||
124615436|NCT00425373|448211691|FG000|Overall Study|Adverse Event|2|||
124615437|NCT00425373|448211692|FG001|Overall Study|Adverse Event|2|||
124744256|NCT02453555|448684879|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
124744257|NCT02453555|448684880|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
124615438|NCT00425373|448211693|FG002|Overall Study|Adverse Event|0|||
124615439|NCT00425373|448211694|FG003|Overall Study|Adverse Event|1|||
124615440|NCT00425373|448211695|FG004|Overall Study|Adverse Event|4|||
124615441|NCT00425373|448211696|FG005|Overall Study|Adverse Event|6|||
124615442|NCT00425373|448211697|FG006|Overall Study|Adverse Event|2|||
124615443|NCT00425373|448211698|FG007|Overall Study|Adverse Event|3|||
124615444|NCT00425373|448211699|FG008|Overall Study|Adverse Event|8|||
124615445|NCT00425373|448211691|FG000|Overall Study|Lost to Follow-up|0|||
124615446|NCT00425373|448211692|FG001|Overall Study|Lost to Follow-up|1|||
124615447|NCT00425373|448211693|FG002|Overall Study|Lost to Follow-up|0|||
124615448|NCT00425373|448211694|FG003|Overall Study|Lost to Follow-up|0|||
124615449|NCT00425373|448211695|FG004|Overall Study|Lost to Follow-up|1|||
124615450|NCT00425373|448211696|FG005|Overall Study|Lost to Follow-up|0|||
124615451|NCT00425373|448211697|FG006|Overall Study|Lost to Follow-up|0|||
124615452|NCT00425373|448211698|FG007|Overall Study|Lost to Follow-up|0|||
124615453|NCT00425373|448211699|FG008|Overall Study|Lost to Follow-up|0|||
124615454|NCT00425373|448211691|FG000|Overall Study|Protocol Violation|1|||
124615455|NCT00425373|448211692|FG001|Overall Study|Protocol Violation|0|||
124615456|NCT00425373|448211693|FG002|Overall Study|Protocol Violation|1|||
124615457|NCT00425373|448211694|FG003|Overall Study|Protocol Violation|0|||
124615458|NCT00425373|448211695|FG004|Overall Study|Protocol Violation|0|||
124615459|NCT00425373|448211696|FG005|Overall Study|Protocol Violation|0|||
124615460|NCT00425373|448211697|FG006|Overall Study|Protocol Violation|0|||
124615461|NCT00425373|448211698|FG007|Overall Study|Protocol Violation|5|||
124615462|NCT00425373|448211699|FG008|Overall Study|Protocol Violation|3|||
124615463|NCT00425373|448211691|FG000|Overall Study|Withdrawal by Subject|2|||
124615464|NCT00425373|448211692|FG001|Overall Study|Withdrawal by Subject|0|||
124615465|NCT00425373|448211693|FG002|Overall Study|Withdrawal by Subject|2|||
124615466|NCT00425373|448211694|FG003|Overall Study|Withdrawal by Subject|1|||
124615467|NCT00425373|448211695|FG004|Overall Study|Withdrawal by Subject|4|||
124615468|NCT00425373|448211696|FG005|Overall Study|Withdrawal by Subject|0|||
124615469|NCT00425373|448211697|FG006|Overall Study|Withdrawal by Subject|2|||
124615470|NCT00425373|448211698|FG007|Overall Study|Withdrawal by Subject|2|||
124615471|NCT00425373|448211699|FG008|Overall Study|Withdrawal by Subject|2|||
124615472|NCT00425373|448211691|FG000|Overall Study|Lack of Efficacy|0|||
124615473|NCT00425373|448211692|FG001|Overall Study|Lack of Efficacy|0|||
124615474|NCT00425373|448211693|FG002|Overall Study|Lack of Efficacy|0|||
124615475|NCT00425373|448211694|FG003|Overall Study|Lack of Efficacy|0|||
124615476|NCT00425373|448211695|FG004|Overall Study|Lack of Efficacy|1|||
124615477|NCT00425373|448211696|FG005|Overall Study|Lack of Efficacy|3|||
124615478|NCT00425373|448211697|FG006|Overall Study|Lack of Efficacy|3|||
124615479|NCT00425373|448211698|FG007|Overall Study|Lack of Efficacy|0|||
124615480|NCT00425373|448211699|FG008|Overall Study|Lack of Efficacy|5|||
124615481|NCT02052011|448211700|FG000|Overall Study|Lost to Follow-up|3|||
124615482|NCT02052011|448211701|FG001|Overall Study|Lost to Follow-up|0|||
124615483|NCT02052011|448211700|FG000|Overall Study|Withdrawal by Subject|1|||
124615484|NCT02052011|448211701|FG001|Overall Study|Withdrawal by Subject|2|||
124615485|NCT01851330|448211702|FG000|Overall Study|Lack of Efficacy|10|||
124615486|NCT01851330|448211703|FG001|Overall Study|Lack of Efficacy|9|||
124615487|NCT01851330|448211704|FG002|Overall Study|Lack of Efficacy|2|||
124615488|NCT01851330|448211702|FG000|Overall Study|Lost to Follow-up|1|||
124615489|NCT01851330|448211703|FG001|Overall Study|Lost to Follow-up|6|||
124615490|NCT01851330|448211704|FG002|Overall Study|Lost to Follow-up|9|||
124615491|NCT01851330|448211702|FG000|Overall Study|Withdrew Consent|2|||
124615492|NCT01851330|448211703|FG001|Overall Study|Withdrew Consent|1|||
124615493|NCT01851330|448211704|FG002|Overall Study|Withdrew Consent|0|||
124615494|NCT01851330|448211702|FG000|Overall Study|Investigator's Discretion|0|||
124615495|NCT01851330|448211703|FG001|Overall Study|Investigator's Discretion|0|||
124615496|NCT01851330|448211704|FG002|Overall Study|Investigator's Discretion|1|||
124615497|NCT02960490|448211706|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
124615498|NCT02960490|448211707|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
124615499|NCT02960490|448211708|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
124615500|NCT02960490|448211709|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
124615501|NCT02960490|448211710|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
124615502|NCT02960490|448211711|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
124615503|NCT02960490|448211712|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
124615504|NCT02960490|448211713|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
124615505|NCT02960490|448211714|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
124615506|NCT02960490|448211715|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
124615507|NCT02960490|448211706|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
124615508|NCT02960490|448211707|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
124615509|NCT02960490|448211708|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
124615510|NCT02960490|448211709|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
124615511|NCT02960490|448211710|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
124615512|NCT02960490|448211711|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
124615513|NCT02960490|448211712|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
124615514|NCT02960490|448211713|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
124615515|NCT02960490|448211714|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
124615516|NCT02960490|448211715|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
124615517|NCT02960490|448211706|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
124615518|NCT02960490|448211707|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
124615519|NCT02960490|448211708|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
124615520|NCT02960490|448211709|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
124615521|NCT02960490|448211710|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
124615522|NCT02960490|448211711|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
124615523|NCT02960490|448211712|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
124615524|NCT02960490|448211713|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
124615525|NCT02960490|448211714|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
124781830|NCT03500224|448831182|FG000|Overall Study|Withdrawal by Subject|2|||
124781831|NCT01324401|448831185|FG000|Overall Study|Withdrawn before any treatment|0|||
124781832|NCT01324401|448831186|FG001|Overall Study|Withdrawn before any treatment|3|||
124781833|NCT01324401|448831185|FG000|Overall Study|Adverse Event|1|||
124781834|NCT01324401|448831186|FG001|Overall Study|Adverse Event|3|||
124781835|NCT01708902|448831188|FG000|Overall Study|Adverse Event|3|||
124781836|NCT01708902|448831189|FG001|Overall Study|Adverse Event|4|||
124781837|NCT01708902|448831190|FG002|Overall Study|Adverse Event|9|||
124781838|NCT01708902|448831191|FG003|Overall Study|Adverse Event|2|||
124781839|NCT01708902|448831192|FG004|Overall Study|Adverse Event|7|||
124781840|NCT01708902|448831193|FG005|Overall Study|Adverse Event|3|||
124781841|NCT01708902|448831194|FG006|Overall Study|Adverse Event|5|||
124781842|NCT01708902|448831188|FG000|Overall Study|Lack of Efficacy|3|||
124781843|NCT01708902|448831189|FG001|Overall Study|Lack of Efficacy|1|||
124781844|NCT01708902|448831190|FG002|Overall Study|Lack of Efficacy|0|||
124781845|NCT01708902|448831191|FG003|Overall Study|Lack of Efficacy|0|||
124781846|NCT01708902|448831192|FG004|Overall Study|Lack of Efficacy|0|||
124781847|NCT01708902|448831193|FG005|Overall Study|Lack of Efficacy|1|||
124781848|NCT01708902|448831194|FG006|Overall Study|Lack of Efficacy|0|||
124781849|NCT01708902|448831188|FG000|Overall Study|Non compliance with protocol|0|||
124781850|NCT01708902|448831189|FG001|Overall Study|Non compliance with protocol|2|||
124781851|NCT01708902|448831190|FG002|Overall Study|Non compliance with protocol|1|||
124781852|NCT01708902|448831191|FG003|Overall Study|Non compliance with protocol|3|||
124781853|NCT01708902|448831192|FG004|Overall Study|Non compliance with protocol|0|||
124615526|NCT02960490|448211715|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
124615527|NCT02960490|448211706|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
124615528|NCT02960490|448211707|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
124615529|NCT02960490|448211708|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
124615530|NCT02960490|448211709|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
124615531|NCT02960490|448211710|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
124615532|NCT02960490|448211711|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
124615533|NCT02960490|448211712|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
124615534|NCT02960490|448211713|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
124615535|NCT02960490|448211714|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
124615536|NCT02960490|448211715|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
124615537|NCT02960490|448211706|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
124615538|NCT02960490|448211707|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
124615539|NCT02960490|448211708|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
124615540|NCT02960490|448211709|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
124615541|NCT02960490|448211710|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
124615542|NCT02960490|448211711|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
124615543|NCT02960490|448211712|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
124615544|NCT02960490|448211713|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
124615545|NCT02960490|448211714|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
124615546|NCT02960490|448211715|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
124615547|NCT02960490|448211706|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
124615548|NCT02960490|448211707|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
124615549|NCT02960490|448211708|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
124615550|NCT02960490|448211709|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
124615551|NCT02960490|448211710|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
124615552|NCT02960490|448211711|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
124615553|NCT02960490|448211712|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
124615554|NCT02960490|448211713|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
124615555|NCT02960490|448211714|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
124615556|NCT02960490|448211715|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
124615557|NCT02960490|448211706|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
124615558|NCT02960490|448211707|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
124781854|NCT01708902|448831193|FG005|Overall Study|Non compliance with protocol|0|||
124781855|NCT01708902|448831194|FG006|Overall Study|Non compliance with protocol|0|||
124781856|NCT01708902|448831188|FG000|Overall Study|Lost to Follow-up|2|||
124781857|NCT01708902|448831189|FG001|Overall Study|Lost to Follow-up|1|||
124781858|NCT01708902|448831190|FG002|Overall Study|Lost to Follow-up|2|||
124781859|NCT01708902|448831191|FG003|Overall Study|Lost to Follow-up|2|||
124781860|NCT01708902|448831192|FG004|Overall Study|Lost to Follow-up|0|||
124781861|NCT01708902|448831193|FG005|Overall Study|Lost to Follow-up|0|||
124781862|NCT01708902|448831194|FG006|Overall Study|Lost to Follow-up|1|||
124781863|NCT01708902|448831188|FG000|Overall Study|Refused to continue trial medication|8|||
124615559|NCT02960490|448211708|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
124781864|NCT01708902|448831189|FG001|Overall Study|Refused to continue trial medication|0|||
124781865|NCT01708902|448831190|FG002|Overall Study|Refused to continue trial medication|4|||
124781866|NCT01708902|448831191|FG003|Overall Study|Refused to continue trial medication|2|||
124781867|NCT01708902|448831192|FG004|Overall Study|Refused to continue trial medication|8|||
124781868|NCT01708902|448831193|FG005|Overall Study|Refused to continue trial medication|1|||
124781869|NCT01708902|448831194|FG006|Overall Study|Refused to continue trial medication|1|||
124781870|NCT01708902|448831188|FG000|Overall Study|Other Reason|1|||
124781871|NCT01708902|448831189|FG001|Overall Study|Other Reason|0|||
124781872|NCT01708902|448831190|FG002|Overall Study|Other Reason|1|||
124781873|NCT01708902|448831191|FG003|Overall Study|Other Reason|1|||
124781874|NCT01708902|448831192|FG004|Overall Study|Other Reason|1|||
124615560|NCT02960490|448211709|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
124615561|NCT02960490|448211710|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
124615562|NCT02960490|448211711|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
124615563|NCT02960490|448211712|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
124615564|NCT02960490|448211713|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
124615565|NCT02960490|448211714|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
124615566|NCT02960490|448211715|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
124615567|NCT02960490|448211706|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
124615568|NCT02960490|448211707|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
124615569|NCT02960490|448211708|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
124615570|NCT02960490|448211709|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
124615571|NCT02960490|448211710|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
124615572|NCT02960490|448211711|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
124615573|NCT02960490|448211712|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
124615574|NCT02960490|448211713|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
124615575|NCT02960490|448211714|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
124615576|NCT02960490|448211715|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
124615577|NCT02960490|448211706|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
124615578|NCT02960490|448211707|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
124615579|NCT02960490|448211708|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
124615580|NCT02960490|448211709|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
124615581|NCT02960490|448211710|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
124615582|NCT02960490|448211711|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
124615583|NCT02960490|448211712|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
124615584|NCT02960490|448211713|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
124615585|NCT02960490|448211714|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
124615586|NCT02960490|448211715|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
124615587|NCT02960490|448211706|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
124615588|NCT02960490|448211707|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
124615589|NCT02960490|448211708|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
124615590|NCT02960490|448211709|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
124615591|NCT02960490|448211710|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
124615592|NCT02960490|448211711|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
124615593|NCT02960490|448211712|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
124615594|NCT02960490|448211713|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
124615595|NCT02960490|448211714|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
124615596|NCT02960490|448211715|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
124615597|NCT02960490|448211706|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
124615598|NCT02960490|448211707|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
124615599|NCT02960490|448211708|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
124615600|NCT02960490|448211709|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
124615601|NCT02960490|448211710|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
124615602|NCT02960490|448211711|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
124615603|NCT02960490|448211712|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
124615604|NCT02960490|448211713|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
124615605|NCT02960490|448211714|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
124615606|NCT02960490|448211715|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
124615607|NCT02960490|448211706|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
124615608|NCT02960490|448211707|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
124615609|NCT02960490|448211708|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
124615610|NCT02960490|448211709|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
124615611|NCT02960490|448211710|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
124615612|NCT02960490|448211711|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
124615613|NCT02960490|448211712|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
124781875|NCT01708902|448831193|FG005|Overall Study|Other Reason|2|||
124781876|NCT01708902|448831194|FG006|Overall Study|Other Reason|0|||
124781877|NCT00530816|448831196|FG000|Overall Study|Progressive Disease|16|||
124781878|NCT00530816|448831197|FG001|Overall Study|Progressive Disease|24|||
124781879|NCT00530816|448831198|FG002|Overall Study|Progressive Disease|24|||
124781880|NCT00530816|448831196|FG000|Overall Study|Adverse Event|6|||
124615614|NCT02960490|448211713|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
124615615|NCT02960490|448211714|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
124615616|NCT02960490|448211715|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
124615617|NCT02368314|448211718|FG000|Overall Study|Withdrawal by Subject|2|||
124615618|NCT02368314|448211719|FG001|Overall Study|Withdrawal by Subject|1|||
124615619|NCT02368314|448211718|FG000|Overall Study|Adverse Event|1|||
124615620|NCT02368314|448211719|FG001|Overall Study|Adverse Event|2|||
124615621|NCT02289456|448211720|FG000|Induction Period|Death|2|||
124615622|NCT02289456|448211720|FG000|Induction Period|Adverse Event|11|||
124615623|NCT02289456|448211720|FG000|Induction Period|Progressive Disease (PD)|4|||
124615624|NCT02289456|448211720|FG000|Induction Period|Symptomatic Deterioration|4|||
124615625|NCT02289456|448211720|FG000|Induction Period|Withdrawal by Subject|2|||
124615626|NCT02289456|448211720|FG000|Induction Period|Miscellaneous|1|||
124615627|NCT02289456|448211720|FG000|Monotherapy Period|Death|1|||
124615628|NCT02289456|448211720|FG000|Monotherapy Period|Adverse Event|1|||
124615629|NCT02289456|448211720|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
124615630|NCT02289456|448211720|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
124615631|NCT02289456|448211720|FG000|Monotherapy Period|Withdrawal by Subject|2|||
124615632|NCT02289456|448211720|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
124615633|NCT02289456|448211720|FG000|Monotherapy Period|Miscellaneous|1|||
124615634|NCT00920790|448211721|FG000|Overall Study|aggravation of general condition|14|||
124615635|NCT01661062|448211724|FG000|Overall Study|Completed Treatment Off Study|3|||
124615636|NCT01661062|448211724|FG000|Overall Study|Withdrawal by Subject|2|||
124615637|NCT04411914|448211725|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
124615638|NCT04411914|448211726|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
124615639|NCT00895414|448211732|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
124615640|NCT00895414|448211733|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
124615641|NCT00895414|448211732|FG000|First Intervention (14 Days)|Physician Decision|0|||
124615642|NCT00895414|448211733|FG001|First Intervention (14 Days)|Physician Decision|1|||
124615643|NCT00252239|448211734|FG000|Overall Study|Withdrawal by Subject|1|||
124615644|NCT00252239|448211735|FG001|Overall Study|Withdrawal by Subject|0|||
124615645|NCT00252239|448211736|FG002|Overall Study|Withdrawal by Subject|0|||
124615646|NCT00252239|448211737|FG003|Overall Study|Withdrawal by Subject|1|||
124615647|NCT00252239|448211734|FG000|Overall Study|Lost to Follow-up|0|||
124615648|NCT00252239|448211735|FG001|Overall Study|Lost to Follow-up|0|||
124615649|NCT00252239|448211736|FG002|Overall Study|Lost to Follow-up|2|||
124615650|NCT00252239|448211737|FG003|Overall Study|Lost to Follow-up|0|||
124615651|NCT00478426|448211738|FG000|Overall Study|Withdrawal by Subject|1|||
124615652|NCT03489109|448211745|FG000|Overall Study|Lost to Follow-up|1|||
124615653|NCT03489109|448211746|FG001|Overall Study|Lost to Follow-up|2|||
124615654|NCT02181790|448211747|FG000|Overall Study|study terminated|2|||
124615655|NCT02181790|448211748|FG001|Overall Study|study terminated|0|||
124615656|NCT00025259|448211750|FG000|Overall Study|Death|1|||
124615657|NCT00025259|448211751|FG001|Overall Study|Death|3|||
124615658|NCT00025259|448211752|FG002|Overall Study|Death|0|||
124615659|NCT00025259|448211753|FG003|Overall Study|Death|3|||
124615660|NCT00025259|448211754|FG004|Overall Study|Death|0|||
124615661|NCT00025259|448211755|FG005|Overall Study|Death|1|||
124615662|NCT00025259|448211756|FG006|Overall Study|Death|2|||
124615663|NCT00025259|448211750|FG000|Overall Study|Lack of Efficacy|2|||
124615664|NCT00025259|448211751|FG001|Overall Study|Lack of Efficacy|46|||
124615665|NCT00025259|448211752|FG002|Overall Study|Lack of Efficacy|60|||
124615666|NCT00025259|448211753|FG003|Overall Study|Lack of Efficacy|78|||
124615667|NCT00025259|448211754|FG004|Overall Study|Lack of Efficacy|11|||
124615668|NCT00025259|448211755|FG005|Overall Study|Lack of Efficacy|30|||
124615669|NCT00025259|448211756|FG006|Overall Study|Lack of Efficacy|38|||
124615670|NCT00025259|448211750|FG000|Overall Study|Lost to Follow-up|2|||
124615671|NCT00025259|448211751|FG001|Overall Study|Lost to Follow-up|9|||
124615672|NCT00025259|448211752|FG002|Overall Study|Lost to Follow-up|13|||
124615673|NCT00025259|448211753|FG003|Overall Study|Lost to Follow-up|13|||
124615674|NCT00025259|448211754|FG004|Overall Study|Lost to Follow-up|1|||
124615675|NCT00025259|448211755|FG005|Overall Study|Lost to Follow-up|3|||
124615676|NCT00025259|448211756|FG006|Overall Study|Lost to Follow-up|1|||
124615677|NCT00025259|448211750|FG000|Overall Study|Physician Decision|12|||
124615678|NCT00025259|448211751|FG001|Overall Study|Physician Decision|1|||
124615679|NCT00025259|448211752|FG002|Overall Study|Physician Decision|0|||
124615680|NCT00025259|448211753|FG003|Overall Study|Physician Decision|5|||
124615681|NCT00025259|448211754|FG004|Overall Study|Physician Decision|4|||
124615682|NCT00025259|448211755|FG005|Overall Study|Physician Decision|2|||
124615683|NCT00025259|448211756|FG006|Overall Study|Physician Decision|1|||
124615684|NCT00025259|448211750|FG000|Overall Study|Protocol Violation|3|||
124615685|NCT00025259|448211751|FG001|Overall Study|Protocol Violation|2|||
124615686|NCT00025259|448211752|FG002|Overall Study|Protocol Violation|2|||
124615687|NCT00025259|448211753|FG003|Overall Study|Protocol Violation|1|||
124615688|NCT00025259|448211754|FG004|Overall Study|Protocol Violation|2|||
124615689|NCT00025259|448211755|FG005|Overall Study|Protocol Violation|1|||
124615690|NCT00025259|448211756|FG006|Overall Study|Protocol Violation|3|||
124615691|NCT00025259|448211750|FG000|Overall Study|Withdrawal by Subject|9|||
124781881|NCT00530816|448831197|FG001|Overall Study|Adverse Event|13|||
124615692|NCT00025259|448211751|FG001|Overall Study|Withdrawal by Subject|27|||
124615693|NCT00025259|448211752|FG002|Overall Study|Withdrawal by Subject|6|||
124615694|NCT00025259|448211753|FG003|Overall Study|Withdrawal by Subject|14|||
124615695|NCT00025259|448211754|FG004|Overall Study|Withdrawal by Subject|11|||
124615696|NCT00025259|448211755|FG005|Overall Study|Withdrawal by Subject|8|||
124615697|NCT00025259|448211756|FG006|Overall Study|Withdrawal by Subject|3|||
124615698|NCT00025259|448211750|FG000|Overall Study|Ineligible|14|||
124615699|NCT00025259|448211751|FG001|Overall Study|Ineligible|1|||
124615700|NCT00025259|448211752|FG002|Overall Study|Ineligible|0|||
124615701|NCT00025259|448211753|FG003|Overall Study|Ineligible|0|||
124615702|NCT00025259|448211754|FG004|Overall Study|Ineligible|6|||
124615703|NCT00025259|448211755|FG005|Overall Study|Ineligible|0|||
124615704|NCT00025259|448211756|FG006|Overall Study|Ineligible|1|||
124615705|NCT00025259|448211750|FG000|Overall Study|Randomization error|1|||
124615706|NCT00025259|448211751|FG001|Overall Study|Randomization error|0|||
124615707|NCT00025259|448211752|FG002|Overall Study|Randomization error|0|||
124615708|NCT00025259|448211753|FG003|Overall Study|Randomization error|0|||
124615709|NCT00025259|448211754|FG004|Overall Study|Randomization error|1|||
124615710|NCT00025259|448211755|FG005|Overall Study|Randomization error|7|||
124615711|NCT00025259|448211756|FG006|Overall Study|Randomization error|2|||
124615712|NCT00025259|448211750|FG000|Overall Study|Adverse Event|1|||
124615713|NCT00025259|448211751|FG001|Overall Study|Adverse Event|0|||
124615714|NCT00025259|448211752|FG002|Overall Study|Adverse Event|0|||
124615715|NCT00025259|448211753|FG003|Overall Study|Adverse Event|0|||
124615716|NCT00025259|448211754|FG004|Overall Study|Adverse Event|0|||
124615717|NCT00025259|448211755|FG005|Overall Study|Adverse Event|0|||
124615718|NCT00025259|448211756|FG006|Overall Study|Adverse Event|0|||
124615719|NCT00863772|448211757|FG000|Overall Study|Adverse Event|1|||
124615720|NCT00863772|448211758|FG001|Overall Study|Adverse Event|4|||
124615721|NCT00863772|448211759|FG002|Overall Study|Adverse Event|0|||
124615722|NCT00863772|448211757|FG000|Overall Study|Lack of Efficacy|4|||
124615723|NCT00863772|448211758|FG001|Overall Study|Lack of Efficacy|2|||
124615724|NCT00863772|448211759|FG002|Overall Study|Lack of Efficacy|4|||
124615725|NCT00863772|448211757|FG000|Overall Study|Lost to Follow-up|5|||
124615726|NCT00863772|448211758|FG001|Overall Study|Lost to Follow-up|1|||
124615727|NCT00863772|448211759|FG002|Overall Study|Lost to Follow-up|1|||
124615728|NCT00863772|448211757|FG000|Overall Study|Protocol Violation|2|||
124615729|NCT00863772|448211758|FG001|Overall Study|Protocol Violation|0|||
124615730|NCT00863772|448211759|FG002|Overall Study|Protocol Violation|2|||
124615731|NCT00863772|448211757|FG000|Overall Study|Withdrawal by Subject|4|||
124615732|NCT00863772|448211758|FG001|Overall Study|Withdrawal by Subject|7|||
124615733|NCT00863772|448211759|FG002|Overall Study|Withdrawal by Subject|5|||
124615734|NCT00863772|448211757|FG000|Overall Study|Study terminated by sponsor|44|||
124615735|NCT00863772|448211758|FG001|Overall Study|Study terminated by sponsor|45|||
124615736|NCT00863772|448211759|FG002|Overall Study|Study terminated by sponsor|36|||
124615737|NCT00863772|448211757|FG000|Overall Study|Entered extension study|6|||
124615738|NCT00863772|448211758|FG001|Overall Study|Entered extension study|4|||
124615739|NCT00863772|448211759|FG002|Overall Study|Entered extension study|9|||
124615740|NCT00863772|448211757|FG000|Overall Study|Other|1|||
124615741|NCT00863772|448211758|FG001|Overall Study|Other|2|||
124615742|NCT00863772|448211759|FG002|Overall Study|Other|4|||
124615743|NCT00863772|448211757|FG000|Overall Study|Randomized but not Treated|1|||
124615744|NCT00863772|448211758|FG001|Overall Study|Randomized but not Treated|0|||
124615745|NCT00863772|448211759|FG002|Overall Study|Randomized but not Treated|0|||
124615746|NCT01449370|448211760|FG000|Overall Study|Disease Progression|5|||
124615747|NCT01449370|448211761|FG001|Overall Study|Disease Progression|4|||
124615748|NCT01449370|448211762|FG002|Overall Study|Disease Progression|8|||
124615749|NCT01449370|448211763|FG003|Overall Study|Disease Progression|3|||
124615750|NCT01449370|448211764|FG004|Overall Study|Disease Progression|3|||
124615751|NCT01449370|448211765|FG005|Overall Study|Disease Progression|3|||
124615752|NCT01449370|448211766|FG006|Overall Study|Disease Progression|3|||
124615753|NCT01449370|448211767|FG007|Overall Study|Disease Progression|2|||
124615754|NCT01449370|448211768|FG008|Overall Study|Disease Progression|9|||
124615755|NCT01449370|448211769|FG009|Overall Study|Disease Progression|1|||
124615756|NCT01449370|448211770|FG010|Overall Study|Disease Progression|3|||
124615757|NCT01449370|448211771|FG011|Overall Study|Disease Progression|3|||
124615758|NCT01449370|448211772|FG012|Overall Study|Disease Progression|2|||
124615759|NCT01449370|448211773|FG013|Overall Study|Disease Progression|8|||
124615760|NCT01449370|448211774|FG014|Overall Study|Disease Progression|3|||
124615761|NCT01449370|448211775|FG015|Overall Study|Disease Progression|1|||
124615762|NCT01449370|448211776|FG016|Overall Study|Disease Progression|4|||
124615763|NCT01449370|448211777|FG017|Overall Study|Disease Progression|3|||
124615764|NCT01449370|448211778|FG018|Overall Study|Disease Progression|1|||
124615765|NCT01449370|448211779|FG019|Overall Study|Disease Progression|2|||
124615766|NCT01449370|448211780|FG020|Overall Study|Disease Progression|5|||
124615767|NCT01449370|448211781|FG021|Overall Study|Disease Progression|2|||
124615768|NCT01449370|448211782|FG022|Overall Study|Disease Progression|3|||
124615769|NCT01449370|448211783|FG023|Overall Study|Disease Progression|7|||
124615770|NCT01449370|448211784|FG024|Overall Study|Disease Progression|3|||
124615771|NCT01449370|448211760|FG000|Overall Study|Adverse Event|1|||
124615772|NCT01449370|448211761|FG001|Overall Study|Adverse Event|2|||
124615773|NCT01449370|448211762|FG002|Overall Study|Adverse Event|0|||
124615774|NCT01449370|448211763|FG003|Overall Study|Adverse Event|1|||
124615775|NCT01449370|448211764|FG004|Overall Study|Adverse Event|0|||
124615776|NCT01449370|448211765|FG005|Overall Study|Adverse Event|0|||
124615777|NCT01449370|448211766|FG006|Overall Study|Adverse Event|0|||
124615778|NCT01449370|448211767|FG007|Overall Study|Adverse Event|0|||
124615779|NCT01449370|448211768|FG008|Overall Study|Adverse Event|1|||
124615780|NCT01449370|448211769|FG009|Overall Study|Adverse Event|1|||
124615781|NCT01449370|448211770|FG010|Overall Study|Adverse Event|0|||
124615782|NCT01449370|448211771|FG011|Overall Study|Adverse Event|0|||
124615783|NCT01449370|448211772|FG012|Overall Study|Adverse Event|0|||
124615784|NCT01449370|448211773|FG013|Overall Study|Adverse Event|2|||
124615785|NCT01449370|448211774|FG014|Overall Study|Adverse Event|0|||
124615786|NCT01449370|448211775|FG015|Overall Study|Adverse Event|1|||
124615787|NCT01449370|448211776|FG016|Overall Study|Adverse Event|0|||
124615788|NCT01449370|448211777|FG017|Overall Study|Adverse Event|0|||
124615789|NCT01449370|448211778|FG018|Overall Study|Adverse Event|1|||
124615790|NCT01449370|448211779|FG019|Overall Study|Adverse Event|1|||
124615791|NCT01449370|448211780|FG020|Overall Study|Adverse Event|0|||
124615792|NCT01449370|448211781|FG021|Overall Study|Adverse Event|1|||
124615793|NCT01449370|448211782|FG022|Overall Study|Adverse Event|0|||
124615794|NCT01449370|448211783|FG023|Overall Study|Adverse Event|1|||
124615795|NCT01449370|448211784|FG024|Overall Study|Adverse Event|3|||
124615796|NCT01449370|448211760|FG000|Overall Study|Participant Decision|0|||
124615797|NCT01449370|448211761|FG001|Overall Study|Participant Decision|0|||
124615798|NCT01449370|448211762|FG002|Overall Study|Participant Decision|0|||
124615799|NCT01449370|448211763|FG003|Overall Study|Participant Decision|0|||
124615800|NCT01449370|448211764|FG004|Overall Study|Participant Decision|0|||
124615801|NCT01449370|448211765|FG005|Overall Study|Participant Decision|0|||
124615802|NCT01449370|448211766|FG006|Overall Study|Participant Decision|0|||
124615803|NCT01449370|448211767|FG007|Overall Study|Participant Decision|1|||
124615804|NCT01449370|448211768|FG008|Overall Study|Participant Decision|1|||
124615805|NCT01449370|448211769|FG009|Overall Study|Participant Decision|0|||
124615806|NCT01449370|448211770|FG010|Overall Study|Participant Decision|0|||
124615807|NCT01449370|448211771|FG011|Overall Study|Participant Decision|0|||
124615808|NCT01449370|448211772|FG012|Overall Study|Participant Decision|1|||
124615809|NCT01449370|448211773|FG013|Overall Study|Participant Decision|1|||
124615810|NCT01449370|448211774|FG014|Overall Study|Participant Decision|0|||
124615811|NCT01449370|448211775|FG015|Overall Study|Participant Decision|1|||
124615812|NCT01449370|448211776|FG016|Overall Study|Participant Decision|3|||
124615813|NCT01449370|448211777|FG017|Overall Study|Participant Decision|0|||
124615814|NCT01449370|448211778|FG018|Overall Study|Participant Decision|1|||
124615815|NCT01449370|448211779|FG019|Overall Study|Participant Decision|0|||
124615816|NCT01449370|448211780|FG020|Overall Study|Participant Decision|0|||
124615817|NCT01449370|448211781|FG021|Overall Study|Participant Decision|1|||
124615818|NCT01449370|448211782|FG022|Overall Study|Participant Decision|0|||
124615819|NCT01449370|448211783|FG023|Overall Study|Participant Decision|0|||
124615820|NCT01449370|448211784|FG024|Overall Study|Participant Decision|1|||
124615821|NCT01449370|448211760|FG000|Overall Study|Lost to Follow-up|0|||
124615822|NCT01449370|448211761|FG001|Overall Study|Lost to Follow-up|0|||
124615823|NCT01449370|448211762|FG002|Overall Study|Lost to Follow-up|0|||
124615824|NCT01449370|448211763|FG003|Overall Study|Lost to Follow-up|0|||
124615825|NCT01449370|448211764|FG004|Overall Study|Lost to Follow-up|0|||
124615826|NCT01449370|448211765|FG005|Overall Study|Lost to Follow-up|0|||
124615827|NCT01449370|448211766|FG006|Overall Study|Lost to Follow-up|0|||
124615828|NCT01449370|448211767|FG007|Overall Study|Lost to Follow-up|0|||
124615829|NCT01449370|448211768|FG008|Overall Study|Lost to Follow-up|0|||
124615830|NCT01449370|448211769|FG009|Overall Study|Lost to Follow-up|0|||
124615831|NCT01449370|448211770|FG010|Overall Study|Lost to Follow-up|0|||
124615832|NCT01449370|448211771|FG011|Overall Study|Lost to Follow-up|0|||
124615833|NCT01449370|448211772|FG012|Overall Study|Lost to Follow-up|0|||
124615834|NCT01449370|448211773|FG013|Overall Study|Lost to Follow-up|0|||
124615835|NCT01449370|448211774|FG014|Overall Study|Lost to Follow-up|0|||
124615836|NCT01449370|448211775|FG015|Overall Study|Lost to Follow-up|0|||
124615837|NCT01449370|448211776|FG016|Overall Study|Lost to Follow-up|0|||
124615838|NCT01449370|448211777|FG017|Overall Study|Lost to Follow-up|0|||
124615839|NCT01449370|448211778|FG018|Overall Study|Lost to Follow-up|0|||
124615840|NCT01449370|448211779|FG019|Overall Study|Lost to Follow-up|0|||
124615841|NCT01449370|448211780|FG020|Overall Study|Lost to Follow-up|1|||
124615842|NCT01449370|448211781|FG021|Overall Study|Lost to Follow-up|0|||
124615843|NCT01449370|448211782|FG022|Overall Study|Lost to Follow-up|0|||
124615844|NCT01449370|448211783|FG023|Overall Study|Lost to Follow-up|0|||
124615845|NCT01449370|448211784|FG024|Overall Study|Lost to Follow-up|0|||
124615846|NCT01449370|448211760|FG000|Overall Study|Other|0|||
124615847|NCT01449370|448211761|FG001|Overall Study|Other|0|||
124615848|NCT01449370|448211762|FG002|Overall Study|Other|0|||
124615849|NCT01449370|448211763|FG003|Overall Study|Other|0|||
124615850|NCT01449370|448211764|FG004|Overall Study|Other|0|||
124615851|NCT01449370|448211765|FG005|Overall Study|Other|0|||
124615852|NCT01449370|448211766|FG006|Overall Study|Other|0|||
124615853|NCT01449370|448211767|FG007|Overall Study|Other|0|||
124615854|NCT01449370|448211768|FG008|Overall Study|Other|1|||
124615855|NCT01449370|448211769|FG009|Overall Study|Other|1|||
124615856|NCT01449370|448211770|FG010|Overall Study|Other|0|||
124615857|NCT01449370|448211771|FG011|Overall Study|Other|0|||
124615858|NCT01449370|448211772|FG012|Overall Study|Other|0|||
124615859|NCT01449370|448211773|FG013|Overall Study|Other|0|||
124615860|NCT01449370|448211774|FG014|Overall Study|Other|0|||
124615861|NCT01449370|448211775|FG015|Overall Study|Other|0|||
124615862|NCT01449370|448211776|FG016|Overall Study|Other|0|||
124615863|NCT01449370|448211777|FG017|Overall Study|Other|0|||
124615864|NCT01449370|448211778|FG018|Overall Study|Other|0|||
124615865|NCT01449370|448211779|FG019|Overall Study|Other|0|||
124615866|NCT01449370|448211780|FG020|Overall Study|Other|0|||
124615867|NCT01449370|448211781|FG021|Overall Study|Other|0|||
124615868|NCT01449370|448211782|FG022|Overall Study|Other|1|||
124615869|NCT01449370|448211783|FG023|Overall Study|Other|1|||
124615870|NCT01449370|448211784|FG024|Overall Study|Other|0|||
124615871|NCT01449370|448211760|FG000|Overall Study|Medication Prohibited by Protocol|0|||
124615872|NCT01449370|448211761|FG001|Overall Study|Medication Prohibited by Protocol|0|||
124615873|NCT01449370|448211762|FG002|Overall Study|Medication Prohibited by Protocol|0|||
124615874|NCT01449370|448211763|FG003|Overall Study|Medication Prohibited by Protocol|0|||
124615875|NCT01449370|448211764|FG004|Overall Study|Medication Prohibited by Protocol|0|||
124615876|NCT01449370|448211765|FG005|Overall Study|Medication Prohibited by Protocol|0|||
124615877|NCT01449370|448211766|FG006|Overall Study|Medication Prohibited by Protocol|0|||
124615878|NCT01449370|448211767|FG007|Overall Study|Medication Prohibited by Protocol|0|||
124615879|NCT01449370|448211768|FG008|Overall Study|Medication Prohibited by Protocol|0|||
124615880|NCT01449370|448211769|FG009|Overall Study|Medication Prohibited by Protocol|0|||
124615881|NCT01449370|448211770|FG010|Overall Study|Medication Prohibited by Protocol|0|||
124615882|NCT01449370|448211771|FG011|Overall Study|Medication Prohibited by Protocol|0|||
124615883|NCT01449370|448211772|FG012|Overall Study|Medication Prohibited by Protocol|0|||
124615884|NCT01449370|448211773|FG013|Overall Study|Medication Prohibited by Protocol|0|||
124615885|NCT01449370|448211774|FG014|Overall Study|Medication Prohibited by Protocol|0|||
124615886|NCT01449370|448211775|FG015|Overall Study|Medication Prohibited by Protocol|0|||
124615887|NCT01449370|448211776|FG016|Overall Study|Medication Prohibited by Protocol|0|||
124615888|NCT01449370|448211777|FG017|Overall Study|Medication Prohibited by Protocol|0|||
124615889|NCT01449370|448211778|FG018|Overall Study|Medication Prohibited by Protocol|0|||
124615890|NCT01449370|448211779|FG019|Overall Study|Medication Prohibited by Protocol|0|||
124615891|NCT01449370|448211780|FG020|Overall Study|Medication Prohibited by Protocol|0|||
124615892|NCT01449370|448211781|FG021|Overall Study|Medication Prohibited by Protocol|0|||
124615893|NCT01449370|448211782|FG022|Overall Study|Medication Prohibited by Protocol|0|||
124615894|NCT01449370|448211783|FG023|Overall Study|Medication Prohibited by Protocol|1|||
124615895|NCT01449370|448211784|FG024|Overall Study|Medication Prohibited by Protocol|0|||
124615896|NCT01449370|448211760|FG000|Overall Study|Death|0|||
124615897|NCT01449370|448211761|FG001|Overall Study|Death|0|||
124615898|NCT01449370|448211762|FG002|Overall Study|Death|0|||
124615899|NCT01449370|448211763|FG003|Overall Study|Death|0|||
124615900|NCT01449370|448211764|FG004|Overall Study|Death|0|||
124615901|NCT01449370|448211765|FG005|Overall Study|Death|0|||
124615902|NCT01449370|448211766|FG006|Overall Study|Death|0|||
124615903|NCT01449370|448211767|FG007|Overall Study|Death|0|||
124615904|NCT01449370|448211768|FG008|Overall Study|Death|0|||
124615905|NCT01449370|448211769|FG009|Overall Study|Death|0|||
124615906|NCT01449370|448211770|FG010|Overall Study|Death|0|||
124615907|NCT01449370|448211771|FG011|Overall Study|Death|0|||
124615908|NCT01449370|448211772|FG012|Overall Study|Death|0|||
124615909|NCT01449370|448211773|FG013|Overall Study|Death|0|||
124615910|NCT01449370|448211774|FG014|Overall Study|Death|0|||
124615911|NCT01449370|448211775|FG015|Overall Study|Death|0|||
124615912|NCT01449370|448211776|FG016|Overall Study|Death|0|||
124615913|NCT01449370|448211777|FG017|Overall Study|Death|0|||
124615914|NCT01449370|448211778|FG018|Overall Study|Death|0|||
124615915|NCT01449370|448211779|FG019|Overall Study|Death|0|||
124615916|NCT01449370|448211780|FG020|Overall Study|Death|0|||
124615917|NCT01449370|448211781|FG021|Overall Study|Death|0|||
124615918|NCT01449370|448211782|FG022|Overall Study|Death|0|||
124615919|NCT01449370|448211783|FG023|Overall Study|Death|0|||
124615920|NCT01449370|448211784|FG024|Overall Study|Death|1|||
124615921|NCT00908310|448211785|FG000|Overall Study|Death|37|||
124615922|NCT00908310|448211785|FG000|Overall Study|Withdrawal by Subject|7|||
124615923|NCT00908310|448211785|FG000|Overall Study|Lost to Follow-up|7|||
124615924|NCT00908310|448211785|FG000|Overall Study|Screening failure|5|||
124615925|NCT00908310|448211785|FG000|Overall Study|Other reasons|4|||
124615926|NCT00534404|448211788|FG000|Overall Study|Death|0|||
124615927|NCT00534404|448211789|FG001|Overall Study|Death|0|||
124615928|NCT00534404|448211790|FG002|Overall Study|Death|2|||
124615929|NCT00534404|448211788|FG000|Overall Study|Withdrawal by Subject|8|||
124615930|NCT00534404|448211789|FG001|Overall Study|Withdrawal by Subject|2|||
124615931|NCT00534404|448211790|FG002|Overall Study|Withdrawal by Subject|38|||
124615932|NCT00534404|448211788|FG000|Overall Study|Removed by study staff|2|||
124781882|NCT00530816|448831198|FG002|Overall Study|Adverse Event|7|||
124615933|NCT00534404|448211789|FG001|Overall Study|Removed by study staff|3|||
124615934|NCT00534404|448211790|FG002|Overall Study|Removed by study staff|1|||
124615935|NCT00534404|448211788|FG000|Overall Study|Lost to Follow-up|170|||
124615936|NCT00534404|448211789|FG001|Overall Study|Lost to Follow-up|138|||
124615937|NCT00534404|448211790|FG002|Overall Study|Lost to Follow-up|201|||
124615938|NCT02785952|448211794|FG000|Overall Study|Adverse Event|31|||
124615939|NCT02785952|448211795|FG001|Overall Study|Adverse Event|19|||
124615940|NCT02785952|448211794|FG000|Overall Study|Refusal unrelated to adverse events|10|||
124615941|NCT02785952|448211795|FG001|Overall Study|Refusal unrelated to adverse events|5|||
124615942|NCT02785952|448211794|FG000|Overall Study|Disease progression/relapse|61|||
124615943|NCT02785952|448211795|FG001|Overall Study|Disease progression/relapse|89|||
124615944|NCT02785952|448211794|FG000|Overall Study|Death|11|||
124615945|NCT02785952|448211795|FG001|Overall Study|Death|7|||
124615946|NCT02785952|448211794|FG000|Overall Study|Other- not protocol specified|6|||
124615947|NCT02785952|448211795|FG001|Overall Study|Other- not protocol specified|4|||
124615948|NCT02785952|448211794|FG000|Overall Study|On protocol treatment|6|||
124615949|NCT02785952|448211795|FG001|Overall Study|On protocol treatment|3|||
124615950|NCT00315731|448211796|FG000|Overall Study|Lost to Follow-up|1|||
124615951|NCT00315731|448211796|FG000|Overall Study|Death|5|||
124615952|NCT04614246|448211797|FG000|Overall Study|Adverse Event|0|||
124615953|NCT04614246|448211798|FG001|Overall Study|Adverse Event|1|||
124615954|NCT04614246|448211799|FG002|Overall Study|Adverse Event|1|||
124615955|NCT04614246|448211800|FG003|Overall Study|Adverse Event|2|||
124615956|NCT04614246|448211801|FG004|Overall Study|Adverse Event|1|||
124615957|NCT04614246|448211797|FG000|Overall Study|Lost to Follow-up|0|||
124615958|NCT04614246|448211798|FG001|Overall Study|Lost to Follow-up|1|||
124615959|NCT04614246|448211799|FG002|Overall Study|Lost to Follow-up|0|||
124615960|NCT04614246|448211800|FG003|Overall Study|Lost to Follow-up|1|||
124615961|NCT04614246|448211801|FG004|Overall Study|Lost to Follow-up|3|||
124615962|NCT04614246|448211797|FG000|Overall Study|Other reason|0|||
124615963|NCT04614246|448211798|FG001|Overall Study|Other reason|1|||
124615964|NCT04614246|448211799|FG002|Overall Study|Other reason|2|||
124615965|NCT04614246|448211800|FG003|Overall Study|Other reason|0|||
124615966|NCT04614246|448211801|FG004|Overall Study|Other reason|0|||
124615967|NCT04614246|448211797|FG000|Overall Study|Withdrawal by Subject|4|||
124615968|NCT04614246|448211798|FG001|Overall Study|Withdrawal by Subject|2|||
124615969|NCT04614246|448211799|FG002|Overall Study|Withdrawal by Subject|4|||
124615970|NCT04614246|448211800|FG003|Overall Study|Withdrawal by Subject|3|||
124615971|NCT04614246|448211801|FG004|Overall Study|Withdrawal by Subject|4|||
124615972|NCT04614246|448211797|FG000|Overall Study|Physician Decision|0|||
124615973|NCT04614246|448211798|FG001|Overall Study|Physician Decision|2|||
124615974|NCT04614246|448211799|FG002|Overall Study|Physician Decision|1|||
124615975|NCT04614246|448211800|FG003|Overall Study|Physician Decision|0|||
124615976|NCT04614246|448211801|FG004|Overall Study|Physician Decision|0|||
124615977|NCT04614246|448211797|FG000|Overall Study|Study terminated by sponsor|10|||
124615978|NCT04614246|448211798|FG001|Overall Study|Study terminated by sponsor|15|||
124615979|NCT04614246|448211799|FG002|Overall Study|Study terminated by sponsor|12|||
124615980|NCT04614246|448211800|FG003|Overall Study|Study terminated by sponsor|13|||
124615981|NCT04614246|448211801|FG004|Overall Study|Study terminated by sponsor|9|||
124615982|NCT04614246|448211797|FG000|Overall Study|Pregnancy|2|||
124615983|NCT04614246|448211798|FG001|Overall Study|Pregnancy|0|||
124615984|NCT04614246|448211799|FG002|Overall Study|Pregnancy|1|||
124615985|NCT04614246|448211800|FG003|Overall Study|Pregnancy|0|||
124615986|NCT04614246|448211801|FG004|Overall Study|Pregnancy|0|||
124615987|NCT01680497|448211802|FG000|Overall Study|Lost to Follow-up|2|||
124615988|NCT00725205|448211803|FG000|Overall Study|Adverse Event|22|||
124615989|NCT00725205|448211803|FG000|Overall Study|Investigator Discontinued|1|||
124615990|NCT00725205|448211803|FG000|Overall Study|Non-compliance With Protocol|14|||
124615991|NCT00725205|448211803|FG000|Overall Study|Other|8|||
124615992|NCT00725205|448211803|FG000|Overall Study|Protocol Defined Clinical Event|1|||
124615993|NCT00725205|448211803|FG000|Overall Study|Treatment Failure|41|||
124615994|NCT00602641|448213939|FG000|Overall Study|Never started protocol therapy|6|||
124615995|NCT00602641|448213940|FG001|Overall Study|Never started protocol therapy|2|||
124615996|NCT00602641|448213939|FG000|Overall Study|Still on treatment at time of analysis|8|||
124615997|NCT00602641|448213940|FG001|Overall Study|Still on treatment at time of analysis|15|||
124615998|NCT00602641|448213939|FG000|Overall Study|Adverse Event|62|||
124615999|NCT00602641|448213940|FG001|Overall Study|Adverse Event|53|||
124616000|NCT00602641|448213939|FG000|Overall Study|Disease progression|38|||
124616001|NCT00602641|448213940|FG001|Overall Study|Disease progression|55|||
124616002|NCT00602641|448213939|FG000|Overall Study|Death|6|||
124616003|NCT00602641|448213940|FG001|Overall Study|Death|5|||
124616004|NCT00602641|448213939|FG000|Overall Study|Withdrawal by Subject|15|||
124616005|NCT00602641|448213940|FG001|Overall Study|Withdrawal by Subject|12|||
124616006|NCT00602641|448213939|FG000|Overall Study|Alternative therapy|5|||
124616007|NCT00602641|448213940|FG001|Overall Study|Alternative therapy|2|||
124616008|NCT00602641|448213939|FG000|Overall Study|Other Complicating Disease|5|||
124616009|NCT00602641|448213940|FG001|Overall Study|Other Complicating Disease|2|||
124616010|NCT00602641|448213939|FG000|Overall Study|Physician Decision|5|||
124616011|NCT00602641|448213940|FG001|Overall Study|Physician Decision|4|||
124616012|NCT00602641|448213939|FG000|Overall Study|Administrative Closure|1|||
124616013|NCT00602641|448213940|FG001|Overall Study|Administrative Closure|1|||
124616014|NCT00602641|448213939|FG000|Overall Study|Other|3|||
124616015|NCT00602641|448213940|FG001|Overall Study|Other|1|||
124616016|NCT03408639|448213946|FG000|Overall Study|Death|5|||
124616017|NCT03408639|448213947|FG001|Overall Study|Death|5|||
124616018|NCT03408639|448213946|FG000|Overall Study|Lost to Follow-up|1|||
124616019|NCT03408639|448213947|FG001|Overall Study|Lost to Follow-up|4|||
124616020|NCT03408639|448213946|FG000|Overall Study|Withdrawal by Subject|2|||
124616021|NCT03408639|448213947|FG001|Overall Study|Withdrawal by Subject|7|||
124616022|NCT03408639|448213946|FG000|Overall Study|Physician Decision|3|||
124616023|NCT03408639|448213947|FG001|Overall Study|Physician Decision|6|||
124616024|NCT00070499|448213948|FG000|Overall Study|Adverse Event|6|||
124616025|NCT00070499|448213949|FG001|Overall Study|Adverse Event|6|||
124616026|NCT00070499|448213950|FG002|Overall Study|Adverse Event|19|||
124616027|NCT00070499|448213951|FG003|Overall Study|Adverse Event|15|||
124616028|NCT00070499|448213948|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
124616029|NCT00070499|448213949|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
124616030|NCT00070499|448213950|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
124616031|NCT00070499|448213951|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
124616032|NCT00070499|448213948|FG000|Overall Study|Progression/relapse|4|||
124616033|NCT00070499|448213949|FG001|Overall Study|Progression/relapse|2|||
124616034|NCT00070499|448213950|FG002|Overall Study|Progression/relapse|1|||
124616035|NCT00070499|448213951|FG003|Overall Study|Progression/relapse|4|||
124616036|NCT00070499|448213948|FG000|Overall Study|Death|1|||
124616037|NCT00070499|448213949|FG001|Overall Study|Death|1|||
124616038|NCT00070499|448213950|FG002|Overall Study|Death|1|||
124616039|NCT00070499|448213951|FG003|Overall Study|Death|2|||
124616040|NCT00070499|448213948|FG000|Overall Study|Other - not protocol specified|7|||
124616041|NCT00070499|448213949|FG001|Overall Study|Other - not protocol specified|3|||
124616042|NCT00070499|448213950|FG002|Overall Study|Other - not protocol specified|12|||
124616043|NCT00070499|448213951|FG003|Overall Study|Other - not protocol specified|20|||
124616044|NCT00070499|448213948|FG000|Overall Study|Still on protocol treatment|10|||
124616045|NCT00070499|448213949|FG001|Overall Study|Still on protocol treatment|4|||
124616046|NCT00070499|448213950|FG002|Overall Study|Still on protocol treatment|79|||
124616047|NCT00070499|448213951|FG003|Overall Study|Still on protocol treatment|57|||
124616048|NCT00070499|448213948|FG000|Overall Study|Did not start treatment|1|||
124616049|NCT00070499|448213949|FG001|Overall Study|Did not start treatment|0|||
124616050|NCT00070499|448213950|FG002|Overall Study|Did not start treatment|0|||
124616051|NCT00070499|448213951|FG003|Overall Study|Did not start treatment|2|||
124616052|NCT00070499|448213948|FG000|Overall Study|Not eligible|2|||
124616053|NCT00070499|448213949|FG001|Overall Study|Not eligible|5|||
124616054|NCT00070499|448213950|FG002|Overall Study|Not eligible|3|||
124616055|NCT00070499|448213951|FG003|Overall Study|Not eligible|2|||
124616056|NCT00587860|448213959|FG000|Overall Study|Lost to Follow-up|2|||
124616057|NCT00587860|448213960|FG001|Overall Study|Lost to Follow-up|2|||
124616058|NCT00587860|448213959|FG000|Overall Study|Withdrawal by Subject|3|||
124616059|NCT00587860|448213960|FG001|Overall Study|Withdrawal by Subject|3|||
124616060|NCT01371747|448213961|FG000|Overall Study|Adverse Event|4|||
124616061|NCT01371747|448213962|FG001|Overall Study|Adverse Event|2|||
124616062|NCT01371747|448213963|FG002|Overall Study|Adverse Event|7|||
124616063|NCT01371747|448213964|FG003|Overall Study|Adverse Event|2|||
124616064|NCT01371747|448213965|FG004|Overall Study|Adverse Event|2|||
124616065|NCT01371747|448213966|FG005|Overall Study|Adverse Event|2|||
124616066|NCT01371747|448213961|FG000|Overall Study|Death|1|||
124616067|NCT01371747|448213962|FG001|Overall Study|Death|0|||
124616068|NCT01371747|448213963|FG002|Overall Study|Death|4|||
124616069|NCT01371747|448213964|FG003|Overall Study|Death|1|||
124616070|NCT01371747|448213965|FG004|Overall Study|Death|2|||
124616071|NCT01371747|448213966|FG005|Overall Study|Death|0|||
124616072|NCT01371747|448213961|FG000|Overall Study|Abnormal Renal Function|0|||
124616073|NCT01371747|448213962|FG001|Overall Study|Abnormal Renal Function|2|||
124616074|NCT01371747|448213963|FG002|Overall Study|Abnormal Renal Function|0|||
124616075|NCT01371747|448213964|FG003|Overall Study|Abnormal Renal Function|1|||
124616076|NCT01371747|448213965|FG004|Overall Study|Abnormal Renal Function|0|||
124616077|NCT01371747|448213966|FG005|Overall Study|Abnormal Renal Function|1|||
124616078|NCT01371747|448213961|FG000|Overall Study|High Serum Potassium Results|1|||
124616079|NCT01371747|448213962|FG001|Overall Study|High Serum Potassium Results|1|||
124616080|NCT01371747|448213963|FG002|Overall Study|High Serum Potassium Results|1|||
124616081|NCT01371747|448213964|FG003|Overall Study|High Serum Potassium Results|2|||
124616082|NCT01371747|448213965|FG004|Overall Study|High Serum Potassium Results|0|||
124616083|NCT01371747|448213966|FG005|Overall Study|High Serum Potassium Results|2|||
124616084|NCT01371747|448213961|FG000|Overall Study|Low Serum Potassium Results|1|||
124616085|NCT01371747|448213962|FG001|Overall Study|Low Serum Potassium Results|1|||
124616086|NCT01371747|448213963|FG002|Overall Study|Low Serum Potassium Results|1|||
124616087|NCT01371747|448213964|FG003|Overall Study|Low Serum Potassium Results|1|||
124616088|NCT01371747|448213965|FG004|Overall Study|Low Serum Potassium Results|0|||
124616089|NCT01371747|448213966|FG005|Overall Study|Low Serum Potassium Results|3|||
124616090|NCT01371747|448213961|FG000|Overall Study|Protocol Violation|0|||
124616091|NCT01371747|448213962|FG001|Overall Study|Protocol Violation|0|||
124616092|NCT01371747|448213963|FG002|Overall Study|Protocol Violation|1|||
124616093|NCT01371747|448213964|FG003|Overall Study|Protocol Violation|0|||
124616094|NCT01371747|448213965|FG004|Overall Study|Protocol Violation|0|||
124616095|NCT01371747|448213966|FG005|Overall Study|Protocol Violation|0|||
124616096|NCT01371747|448213961|FG000|Overall Study|Non-Compliance|3|||
124616097|NCT01371747|448213962|FG001|Overall Study|Non-Compliance|4|||
124616098|NCT01371747|448213963|FG002|Overall Study|Non-Compliance|3|||
124616099|NCT01371747|448213964|FG003|Overall Study|Non-Compliance|0|||
124616100|NCT01371747|448213965|FG004|Overall Study|Non-Compliance|0|||
124616101|NCT01371747|448213966|FG005|Overall Study|Non-Compliance|1|||
124616102|NCT01371747|448213961|FG000|Overall Study|Physician Decision|0|||
124616103|NCT01371747|448213962|FG001|Overall Study|Physician Decision|0|||
124616104|NCT01371747|448213963|FG002|Overall Study|Physician Decision|0|||
124616105|NCT01371747|448213964|FG003|Overall Study|Physician Decision|0|||
124616106|NCT01371747|448213965|FG004|Overall Study|Physician Decision|1|||
124616107|NCT01371747|448213966|FG005|Overall Study|Physician Decision|0|||
124616108|NCT01371747|448213961|FG000|Overall Study|Withdrawal by Subject|6|||
124616109|NCT01371747|448213962|FG001|Overall Study|Withdrawal by Subject|12|||
124616110|NCT01371747|448213963|FG002|Overall Study|Withdrawal by Subject|5|||
124616111|NCT01371747|448213964|FG003|Overall Study|Withdrawal by Subject|2|||
124616112|NCT01371747|448213965|FG004|Overall Study|Withdrawal by Subject|2|||
124616113|NCT01371747|448213966|FG005|Overall Study|Withdrawal by Subject|4|||
124616114|NCT01371747|448213961|FG000|Overall Study|Other Reasons|2|||
124616115|NCT01371747|448213962|FG001|Overall Study|Other Reasons|1|||
124616116|NCT01371747|448213963|FG002|Overall Study|Other Reasons|2|||
124616117|NCT01371747|448213964|FG003|Overall Study|Other Reasons|0|||
124616118|NCT01371747|448213965|FG004|Overall Study|Other Reasons|0|||
124616119|NCT01371747|448213966|FG005|Overall Study|Other Reasons|1|||
124616120|NCT01403051|448213967|FG000|Overall Study|Protocol Violation|2|||
124616121|NCT01403051|448213968|FG001|Overall Study|Protocol Violation|0|||
124616122|NCT01403051|448213967|FG000|Overall Study|Death|1|||
124616123|NCT01403051|448213968|FG001|Overall Study|Death|0|||
124616124|NCT01403051|448213967|FG000|Overall Study|Withdrawal by Subject|2|||
124616125|NCT01403051|448213968|FG001|Overall Study|Withdrawal by Subject|1|||
124616126|NCT01403051|448213967|FG000|Overall Study|Lost to Follow-up|5|||
124616127|NCT01403051|448213968|FG001|Overall Study|Lost to Follow-up|5|||
124616128|NCT03760185|448213971|FG000|Overall Study|Lost to Follow-up|1|||
124616129|NCT03760185|448213972|FG001|Overall Study|Lost to Follow-up|1|||
124616130|NCT02473523|448213973|FG000|Overall Study|Death|1|||
124616131|NCT02473523|448213973|FG000|Overall Study|Lost to Follow-up|1|||
124616132|NCT00976911|448213976|FG000|Overall Study|Withdrawal by Subject|4|||
124616133|NCT00976911|448213977|FG001|Overall Study|Withdrawal by Subject|6|||
124616134|NCT00976911|448213976|FG000|Overall Study|Death|138|||
124616135|NCT00976911|448213977|FG001|Overall Study|Death|126|||
124616136|NCT00976911|448213976|FG000|Overall Study|Adverse Event|0|||
124616137|NCT00976911|448213977|FG001|Overall Study|Adverse Event|1|||
124616138|NCT00976911|448213976|FG000|Overall Study|Protocol Violation|2|||
124616139|NCT00976911|448213977|FG001|Overall Study|Protocol Violation|0|||
124616140|NCT00976911|448213976|FG000|Overall Study|Other|8|||
124616141|NCT00976911|448213977|FG001|Overall Study|Other|9|||
124616142|NCT00976911|448213976|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
124616143|NCT00976911|448213977|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
124616144|NCT02954991|448213978|FG000|Overall Study|Death|92|||
124616145|NCT02954991|448213979|FG001|Overall Study|Death|11|||
124616146|NCT02954991|448213980|FG002|Overall Study|Death|2|||
124616147|NCT02954991|448213978|FG000|Overall Study|Lost to Follow-up|3|||
124616148|NCT02954991|448213979|FG001|Overall Study|Lost to Follow-up|2|||
124616149|NCT02954991|448213980|FG002|Overall Study|Lost to Follow-up|0|||
124616150|NCT02954991|448213978|FG000|Overall Study|Withdrawal by Subject|9|||
124616151|NCT02954991|448213979|FG001|Overall Study|Withdrawal by Subject|8|||
124616152|NCT02954991|448213980|FG002|Overall Study|Withdrawal by Subject|1|||
124616153|NCT02954991|448213978|FG000|Overall Study|Study Terminated by Sponsor|18|||
124616154|NCT02954991|448213979|FG001|Overall Study|Study Terminated by Sponsor|10|||
124616155|NCT02954991|448213980|FG002|Overall Study|Study Terminated by Sponsor|1|||
124616156|NCT02954991|448213978|FG000|Overall Study|Miscellaneous|2|||
124616157|NCT02954991|448213979|FG001|Overall Study|Miscellaneous|1|||
124616158|NCT02954991|448213980|FG002|Overall Study|Miscellaneous|1|||
124616159|NCT00576316|448213981|FG000|Overall Study|Adverse Event|9|||
124616160|NCT00576316|448213981|FG000|Overall Study|Withdrawal by Subject|2|||
124616161|NCT00576316|448213981|FG000|Overall Study|Protocol Violation|9|||
124616162|NCT01434810|448213985|FG000|Overall Study|Did not receive treatment|11|||
124616163|NCT01434810|448213986|FG001|Overall Study|Did not receive treatment|3|||
124616164|NCT01434810|448213985|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
124616165|NCT01434810|448213986|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
124616166|NCT04893018|448213987|FG000|Overall Study|Lost to Follow-up|1|||
124616167|NCT04893018|448213988|FG001|Overall Study|Lost to Follow-up|0|||
124616168|NCT04893018|448213987|FG000|Overall Study|Withdrawal by Subject|2|||
124616169|NCT04893018|448213988|FG001|Overall Study|Withdrawal by Subject|0|||
124781883|NCT00530816|448831196|FG000|Overall Study|Other|3|||
124781884|NCT00530816|448831197|FG001|Overall Study|Other|3|||
124781885|NCT00530816|448831198|FG002|Overall Study|Other|4|||
124781886|NCT00530816|448831196|FG000|Overall Study|Withdrawal by Subject|1|||
124781887|NCT00530816|448831197|FG001|Overall Study|Withdrawal by Subject|2|||
124781888|NCT00530816|448831198|FG002|Overall Study|Withdrawal by Subject|6|||
124781889|NCT01388985|448831201|FG000|Overall Study|Death|0|||
124781890|NCT01388985|448831202|FG001|Overall Study|Death|1|||
124781891|NCT01388985|448831201|FG000|Overall Study|Lost to Follow-up|30|||
124781892|NCT01388985|448831202|FG001|Overall Study|Lost to Follow-up|30|||
124781893|NCT01388985|448831201|FG000|Overall Study|Withdrawal by Subject|13|||
124781894|NCT01388985|448831202|FG001|Overall Study|Withdrawal by Subject|4|||
124616170|NCT04893018|448213987|FG000|Overall Study|Study Terminated|1|||
124616171|NCT04893018|448213988|FG001|Overall Study|Study Terminated|2|||
124616172|NCT01307111|448213991|FG000|IUD Insertion|Lost to Follow-up|2|||
124616173|NCT01307111|448213992|FG001|IUD Insertion|Lost to Follow-up|0|||
124616174|NCT01307111|448213991|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
124616175|NCT01307111|448213992|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
124781895|NCT01388985|448831201|FG000|Overall Study|Subject unavailable|1|||
124781896|NCT01388985|448831202|FG001|Overall Study|Subject unavailable|1|||
124781897|NCT01388985|448831201|FG000|Overall Study|Other (no reason)|0|||
124781898|NCT01388985|448831202|FG001|Overall Study|Other (no reason)|1|||
124781899|NCT01388985|448831201|FG000|Overall Study|Error of nurse|5|||
124781900|NCT01388985|448831202|FG001|Overall Study|Error of nurse|1|||
124616176|NCT02252406|448213999|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
124616177|NCT02252406|448214000|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
124616178|NCT02252406|448213999|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
124616179|NCT02252406|448214000|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
124616180|NCT02252406|448213999|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
124616181|NCT02252406|448214000|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
124616182|NCT02252406|448213999|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
124616183|NCT02252406|448214000|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
124616184|NCT02252406|448213999|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
124616185|NCT02252406|448214000|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
124616186|NCT02533180|448214001|FG000|Overall Study|Death|0|||
124616187|NCT02533180|448214002|FG001|Overall Study|Death|2|||
124616188|NCT02533180|448214001|FG000|Overall Study|Lost to Follow-up|0|||
124616189|NCT02533180|448214002|FG001|Overall Study|Lost to Follow-up|1|||
124616190|NCT02533180|448214001|FG000|Overall Study|Physician Decision|0|||
124616191|NCT02533180|448214002|FG001|Overall Study|Physician Decision|1|||
124616192|NCT02533180|448214001|FG000|Overall Study|Withdrawal by Subject|2|||
124744258|NCT02453555|448684881|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
124744259|NCT02453555|448684882|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
124744260|NCT02453555|448684877|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
124744261|NCT02453555|448684878|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
124744262|NCT02453555|448684879|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
124744263|NCT02453555|448684880|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
124744264|NCT02453555|448684881|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
124744265|NCT02453555|448684882|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
124744266|NCT02453555|448684877|FG000|Extension Period|Adverse Event|0|||
124744267|NCT02453555|448684878|FG001|Extension Period|Adverse Event|0|||
124744268|NCT02453555|448684879|FG002|Extension Period|Adverse Event|1|||
124744269|NCT02453555|448684880|FG003|Extension Period|Adverse Event|2|||
124744270|NCT02453555|448684881|FG004|Extension Period|Adverse Event|1|||
124744271|NCT02453555|448684882|FG005|Extension Period|Adverse Event|1|||
124744272|NCT02453555|448684877|FG000|Extension Period|Protocol Violation|0|||
124744273|NCT02453555|448684878|FG001|Extension Period|Protocol Violation|0|||
124744274|NCT02453555|448684879|FG002|Extension Period|Protocol Violation|1|||
124744275|NCT02453555|448684880|FG003|Extension Period|Protocol Violation|0|||
124744276|NCT02453555|448684881|FG004|Extension Period|Protocol Violation|0|||
124744277|NCT02453555|448684882|FG005|Extension Period|Protocol Violation|0|||
124744278|NCT02453555|448684877|FG000|Extension Period|Withdrawal by Subject|0|||
124744279|NCT02453555|448684878|FG001|Extension Period|Withdrawal by Subject|0|||
124744280|NCT02453555|448684879|FG002|Extension Period|Withdrawal by Subject|1|||
124616193|NCT02533180|448214002|FG001|Overall Study|Withdrawal by Subject|5|||
124616194|NCT02533180|448214001|FG000|Overall Study|Screen Failure|37|||
124616195|NCT02533180|448214002|FG001|Overall Study|Screen Failure|0|||
124744281|NCT02453555|448684880|FG003|Extension Period|Withdrawal by Subject|0|||
124744282|NCT02453555|448684881|FG004|Extension Period|Withdrawal by Subject|0|||
124744283|NCT02453555|448684882|FG005|Extension Period|Withdrawal by Subject|0|||
124744284|NCT00500760|448684883|FG000|Overall Study|Death|32|||
124744285|NCT00500760|448684884|FG001|Overall Study|Death|15|||
124744286|NCT00500760|448684883|FG000|Overall Study|Withdrawal by Subject|5|||
124744287|NCT00500760|448684884|FG001|Overall Study|Withdrawal by Subject|7|||
124781901|NCT01057589|448831203|FG000|Overall Study|Disease Progression|35|||
124616196|NCT02533180|448214001|FG000|Overall Study|Protocol Deviation|0|||
124616197|NCT02533180|448214002|FG001|Overall Study|Protocol Deviation|1|||
124616198|NCT02533180|448214001|FG000|Overall Study|Non-compliance|0|||
124616199|NCT02533180|448214002|FG001|Overall Study|Non-compliance|1|||
124616200|NCT00447876|448214003|FG000|Overall Study|Withdrawal by Subject|1|||
124616201|NCT00447876|448214004|FG001|Overall Study|Withdrawal by Subject|4|||
124616202|NCT00447876|448214003|FG000|Overall Study|Lost to Follow-up|1|||
124616203|NCT00447876|448214004|FG001|Overall Study|Lost to Follow-up|0|||
124616204|NCT00447876|448214003|FG000|Overall Study|Deterioration of symptomology|1|||
124616205|NCT00447876|448214004|FG001|Overall Study|Deterioration of symptomology|0|||
124616206|NCT01609023|448214007|FG000|Overall Study|Lack of Efficacy|3|||
124616207|NCT01609023|448214007|FG000|Overall Study|Withdrawal by Subject|4|||
124616208|NCT01609023|448214007|FG000|Overall Study|Lost to Follow-up|8|||
124616209|NCT01609023|448214007|FG000|Overall Study|Toxicity|3|||
124616210|NCT01609023|448214007|FG000|Overall Study|Disease progression|10|||
124616211|NCT01609023|448214007|FG000|Overall Study|Physician Decision|2|||
124616212|NCT01609023|448214007|FG000|Overall Study|Death|2|||
124616213|NCT01609023|448214007|FG000|Overall Study|Personal reasons|1|||
124616214|NCT02047734|448214008|FG000|Overall Study|Adverse Event|18|||
124616215|NCT02047734|448214009|FG001|Overall Study|Adverse Event|13|||
124616216|NCT02047734|448214010|FG002|Overall Study|Adverse Event|13|||
124616217|NCT02047734|448214008|FG000|Overall Study|Lack of Efficacy|4|||
124616218|NCT02047734|448214009|FG001|Overall Study|Lack of Efficacy|5|||
124616219|NCT02047734|448214010|FG002|Overall Study|Lack of Efficacy|1|||
124616220|NCT02047734|448214008|FG000|Overall Study|Protocol Violation|3|||
124616221|NCT02047734|448214009|FG001|Overall Study|Protocol Violation|1|||
124616222|NCT02047734|448214010|FG002|Overall Study|Protocol Violation|1|||
124616223|NCT02047734|448214008|FG000|Overall Study|Lost to Follow-up|1|||
124616224|NCT02047734|448214009|FG001|Overall Study|Lost to Follow-up|4|||
124616225|NCT02047734|448214010|FG002|Overall Study|Lost to Follow-up|0|||
124616226|NCT02047734|448214008|FG000|Overall Study|Death|0|||
124616227|NCT02047734|448214009|FG001|Overall Study|Death|1|||
124616228|NCT02047734|448214010|FG002|Overall Study|Death|0|||
124616229|NCT02047734|448214008|FG000|Overall Study|Withdrawal by Subject|30|||
124616230|NCT02047734|448214009|FG001|Overall Study|Withdrawal by Subject|31|||
124616231|NCT02047734|448214010|FG002|Overall Study|Withdrawal by Subject|19|||
124616232|NCT02047734|448214008|FG000|Overall Study|Physician Decision|7|||
124616233|NCT02047734|448214009|FG001|Overall Study|Physician Decision|6|||
124616234|NCT02047734|448214010|FG002|Overall Study|Physician Decision|5|||
124616235|NCT02047734|448214008|FG000|Overall Study|Miscellaneous|2|||
124616236|NCT02047734|448214009|FG001|Overall Study|Miscellaneous|4|||
124616237|NCT02047734|448214010|FG002|Overall Study|Miscellaneous|6|||
124616238|NCT02047734|448214008|FG000|Overall Study|Did Not Receive Study Drug|2|||
124616239|NCT02047734|448214009|FG001|Overall Study|Did Not Receive Study Drug|4|||
124616240|NCT02047734|448214010|FG002|Overall Study|Did Not Receive Study Drug|1|||
124616241|NCT01333397|448214014|FG000|Overall Study|Lost to Follow-up|1|||
124616242|NCT01333397|448214015|FG001|Overall Study|Lost to Follow-up|0|||
124616243|NCT01333397|448214016|FG002|Overall Study|Lost to Follow-up|0|||
124616244|NCT01333397|448214017|FG003|Overall Study|Lost to Follow-up|1|||
124616245|NCT01333397|448214018|FG004|Overall Study|Lost to Follow-up|0|||
124616246|NCT01085357|448214019|FG000|Overall Study|Adverse Event|1|||
124616247|NCT01085357|448214020|FG001|Overall Study|Adverse Event|1|||
124616248|NCT01085357|448214019|FG000|Overall Study|Subject Decision|4|||
124616249|NCT01085357|448214020|FG001|Overall Study|Subject Decision|3|||
124616250|NCT01085357|448214019|FG000|Overall Study|Investigator Decision|1|||
124616251|NCT01085357|448214020|FG001|Overall Study|Investigator Decision|1|||
124616252|NCT01085357|448214019|FG000|Overall Study|Death|11|||
124616253|NCT01085357|448214020|FG001|Overall Study|Death|1|||
124616254|NCT01085357|448214019|FG000|Overall Study|Lost to Follow-up|2|||
124616255|NCT01085357|448214020|FG001|Overall Study|Lost to Follow-up|0|||
124616256|NCT02952586|448214033|FG000|Lead-In Phase (7 Days)|Death|0|||
124616257|NCT02952586|448214034|FG001|Lead-In Phase (7 Days)|Death|1|||
124616258|NCT02952586|448214033|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
124616259|NCT02952586|448214034|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
124616260|NCT02952586|448214033|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
124616261|NCT02952586|448214034|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
124616262|NCT02952586|448214033|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
124616263|NCT02952586|448214034|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
124616264|NCT02952586|448214033|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
124616265|NCT02952586|448214034|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
124616266|NCT02952586|448214033|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
124616267|NCT02952586|448214034|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
124616268|NCT02952586|448214033|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
124616269|NCT02952586|448214034|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
124616270|NCT02952586|448214033|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
124616271|NCT02952586|448214034|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
124616272|NCT02952586|448214033|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
124616273|NCT02952586|448214034|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
124616274|NCT02952586|448214033|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
124616275|NCT02952586|448214034|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
124616276|NCT02952586|448214033|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
124616277|NCT02952586|448214034|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
124616278|NCT02952586|448214033|FG000|CRT for Cisplatin (63 Days)|Death|3|||
124616279|NCT02952586|448214034|FG001|CRT for Cisplatin (63 Days)|Death|8|||
124616280|NCT02952586|448214033|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
124616281|NCT02952586|448214034|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
124616282|NCT02952586|448214033|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
124616283|NCT02952586|448214034|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
124616284|NCT02952586|448214033|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
124616285|NCT02952586|448214034|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
124616286|NCT02952586|448214033|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
124616287|NCT02952586|448214034|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
124616288|NCT02952586|448214033|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
124616289|NCT02952586|448214034|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
124616290|NCT02952586|448214033|FG000|CRT for Cisplatin (63 Days)|Other|1|||
124616291|NCT02952586|448214034|FG001|CRT for Cisplatin (63 Days)|Other|1|||
124616292|NCT02952586|448214033|FG000|CRT for IMRT (63 Days)|Death|5|||
124616293|NCT02952586|448214034|FG001|CRT for IMRT (63 Days)|Death|8|||
124616294|NCT02952586|448214033|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
124616295|NCT02952586|448214034|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
124616296|NCT02952586|448214033|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
124616297|NCT02952586|448214034|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
124616298|NCT02952586|448214033|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
124616299|NCT02952586|448214034|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
124616300|NCT02952586|448214033|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
124616301|NCT02952586|448214034|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
124616302|NCT02952586|448214033|FG000|CRT for IMRT (63 Days)|Other|1|||
124616303|NCT02952586|448214034|FG001|CRT for IMRT (63 Days)|Other|0|||
124616304|NCT02952586|448214033|FG000|Maintenance Phase (12 Months)|Death|17|||
124616305|NCT02952586|448214034|FG001|Maintenance Phase (12 Months)|Death|11|||
124616306|NCT02952586|448214033|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
124616307|NCT02952586|448214034|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
124616308|NCT02952586|448214033|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
124616309|NCT02952586|448214034|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
124616310|NCT02952586|448214033|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
124616311|NCT02952586|448214034|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
124616312|NCT02952586|448214033|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
124616313|NCT02952586|448214034|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
124616314|NCT02952586|448214033|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
124616315|NCT02952586|448214034|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
124616316|NCT02952586|448214033|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
124616317|NCT02952586|448214034|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
124616318|NCT02952586|448214033|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
124616319|NCT02952586|448214034|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
124616320|NCT02952586|448214033|FG000|Maintenance Phase (12 Months)|Other|2|||
124616321|NCT02952586|448214034|FG001|Maintenance Phase (12 Months)|Other|1|||
124616322|NCT02952586|448214033|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
124616323|NCT02952586|448214034|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
124616324|NCT02952586|448214033|FG000|Follow-Up Phase (90 Days)|Death|12|||
124616325|NCT02952586|448214034|FG001|Follow-Up Phase (90 Days)|Death|10|||
124616326|NCT02952586|448214033|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
124616327|NCT02952586|448214034|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
124616328|NCT02952586|448214033|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
124616329|NCT02952586|448214034|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
124616330|NCT02952586|448214033|FG000|Follow-Up Phase (90 Days)|Other|7|||
124616331|NCT02952586|448214034|FG001|Follow-Up Phase (90 Days)|Other|5|||
124616332|NCT02952586|448214033|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
124616333|NCT02952586|448214034|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
124781902|NCT01057589|448831203|FG000|Overall Study|Adverse Event|10|||
124616334|NCT02952586|448214033|FG000|LT Follow-up (up to 45 Months)|Death|51|||
124616335|NCT02952586|448214034|FG001|LT Follow-up (up to 45 Months)|Death|31|||
124616336|NCT02952586|448214033|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
124616337|NCT02952586|448214034|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
124616338|NCT02952586|448214033|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
124616339|NCT02952586|448214034|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
124616340|NCT02952586|448214033|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
124781903|NCT01057589|448831203|FG000|Overall Study|Physician Decision|8|||
124781904|NCT01057589|448831203|FG000|Overall Study|Withdrawal by Subject|3|||
124781905|NCT01057589|448831203|FG000|Overall Study|Sponsor Decision|1|||
124781906|NCT01057589|448831203|FG000|Overall Study|Death|8|||
124781907|NCT01057589|448831203|FG000|Overall Study|Lost to Follow-up|1|||
124616341|NCT02952586|448214034|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
124616342|NCT00492778|448214035|FG000|Overall Study|Ineligible by Pathology Review|8|||
124616343|NCT00492778|448214036|FG001|Overall Study|Ineligible by Pathology Review|1|||
124616344|NCT00789035|448214037|FG000|Overall Study|Adverse Event|0|||
124616345|NCT00789035|448214038|FG001|Overall Study|Adverse Event|2|||
124616346|NCT00789035|448214039|FG002|Overall Study|Adverse Event|0|||
124616347|NCT00789035|448214040|FG003|Overall Study|Adverse Event|1|||
124616348|NCT00789035|448214041|FG004|Overall Study|Adverse Event|3|||
124781908|NCT00899431|448831206|FG000|Overall Study|Physician Decision|1|||
124781909|NCT00899431|448831207|FG001|Overall Study|Physician Decision|0|||
124781910|NCT00899431|448831208|FG002|Overall Study|Physician Decision|0|||
124781911|NCT03304249|448831212|FG000|Overall Study|Lost to Follow-up|8|||
124781912|NCT03304249|448831213|FG001|Overall Study|Lost to Follow-up|10|||
124781913|NCT03304249|448831212|FG000|Overall Study|Withdrawal by Subject|12|||
124781914|NCT03304249|448831213|FG001|Overall Study|Withdrawal by Subject|2|||
124781915|NCT03304249|448831212|FG000|Overall Study|Moved Out of District|4|||
124781916|NCT03304249|448831213|FG001|Overall Study|Moved Out of District|2|||
124781917|NCT01253577|448831214|FG000|Overall Study|Lost to Follow-up|3|||
124616349|NCT00789035|448214037|FG000|Overall Study|Lack of Efficacy|3|||
124616350|NCT00789035|448214038|FG001|Overall Study|Lack of Efficacy|0|||
124616351|NCT00789035|448214039|FG002|Overall Study|Lack of Efficacy|0|||
124616352|NCT00789035|448214040|FG003|Overall Study|Lack of Efficacy|0|||
124616353|NCT00789035|448214041|FG004|Overall Study|Lack of Efficacy|2|||
124616354|NCT00789035|448214037|FG000|Overall Study|Protocol Violation|1|||
124616355|NCT00789035|448214038|FG001|Overall Study|Protocol Violation|0|||
124616356|NCT00789035|448214039|FG002|Overall Study|Protocol Violation|0|||
124616357|NCT00789035|448214040|FG003|Overall Study|Protocol Violation|0|||
124616358|NCT00789035|448214041|FG004|Overall Study|Protocol Violation|0|||
124616359|NCT00789035|448214037|FG000|Overall Study|Withdrawal by Subject|0|||
124616360|NCT00789035|448214038|FG001|Overall Study|Withdrawal by Subject|2|||
124616361|NCT00789035|448214039|FG002|Overall Study|Withdrawal by Subject|0|||
124781918|NCT00334113|448831215|FG000|Overall Study|Lost to Follow-up|2|||
124781919|NCT00334113|448831216|FG001|Overall Study|Lost to Follow-up|2|||
124781920|NCT00334113|448831215|FG000|Overall Study|Withdrawal by Subject|0|||
124781921|NCT00334113|448831216|FG001|Overall Study|Withdrawal by Subject|1|||
124781922|NCT04189224|448831217|FG000|Period 2|Adverse Event|0|||
124781923|NCT04189224|448831218|FG001|Period 2|Adverse Event|1|||
124781924|NCT02509026|448831219|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
124781925|NCT02509026|448831219|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
124781926|NCT02509026|448831219|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
124616362|NCT00789035|448214040|FG003|Overall Study|Withdrawal by Subject|0|||
124616363|NCT00789035|448214041|FG004|Overall Study|Withdrawal by Subject|0|||
124616364|NCT00789035|448214037|FG000|Overall Study|Other reason not defined above|2|||
124781927|NCT02509026|448831219|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
124781928|NCT02509026|448831219|FG000|Induction Period (24 Weeks)|Other|2|||
124781929|NCT02509026|448831219|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
124781930|NCT02509026|448831219|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
124781931|NCT02509026|448831219|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
124781932|NCT02509026|448831219|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
124781933|NCT02509026|448831219|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
124781934|NCT02509026|448831219|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
124781935|NCT02509026|448831219|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
124781936|NCT02509026|448831219|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
124781937|NCT00721968|448831220|FG000|Overall Study|Lost to Follow-up|2|||
124781938|NCT00721968|448831221|FG001|Overall Study|Lost to Follow-up|0|||
124781939|NCT04198714|448831222|FG000|Overall Study|Physician Decision|0|||
124781940|NCT04198714|448831223|FG001|Overall Study|Physician Decision|1|||
124781941|NCT01064947|448831224|FG000|Overall Study|negative culture|41|||
124781942|NCT02970942|448831225|FG000|Overall Study|Death|0|||
124781943|NCT02970942|448831226|FG001|Overall Study|Death|1|||
124616365|NCT00789035|448214038|FG001|Overall Study|Other reason not defined above|3|||
124616366|NCT00789035|448214039|FG002|Overall Study|Other reason not defined above|1|||
124616367|NCT00789035|448214040|FG003|Overall Study|Other reason not defined above|0|||
124616368|NCT00789035|448214041|FG004|Overall Study|Other reason not defined above|1|||
124616369|NCT01118975|448214042|FG000|Overall Study|Adverse Event|0|||
124781944|NCT02970942|448831227|FG002|Overall Study|Death|0|||
124781945|NCT02970942|448831228|FG003|Overall Study|Death|0|||
124781946|NCT02970942|448831225|FG000|Overall Study|Lost to Follow-up|1|||
124781947|NCT02970942|448831226|FG001|Overall Study|Lost to Follow-up|0|||
124781948|NCT02970942|448831227|FG002|Overall Study|Lost to Follow-up|2|||
124781949|NCT02970942|448831228|FG003|Overall Study|Lost to Follow-up|1|||
124781950|NCT02970942|448831225|FG000|Overall Study|Withdrawal by Subject|3|||
124781951|NCT02970942|448831226|FG001|Overall Study|Withdrawal by Subject|5|||
124781952|NCT02970942|448831227|FG002|Overall Study|Withdrawal by Subject|3|||
124781953|NCT02970942|448831228|FG003|Overall Study|Withdrawal by Subject|2|||
124781954|NCT02529553|448831231|FG000|Overall Study|Progressive Disease|1|||
124781955|NCT02529553|448831232|FG001|Overall Study|Progressive Disease|0|||
124781956|NCT02529553|448831233|FG002|Overall Study|Progressive Disease|1|||
124616370|NCT01118975|448214043|FG001|Overall Study|Adverse Event|1|||
124616371|NCT00789737|448214054|FG000|Overall Study|Withdrawal by Subject|13|||
124616372|NCT00789737|448214055|FG001|Overall Study|Withdrawal by Subject|22|||
124616373|NCT00789737|448214054|FG000|Overall Study|Lost to Follow-up|10|||
124616374|NCT00789737|448214055|FG001|Overall Study|Lost to Follow-up|14|||
124616375|NCT00789737|448214054|FG000|Overall Study|Adverse Event|8|||
124616376|NCT00789737|448214055|FG001|Overall Study|Adverse Event|8|||
124616377|NCT00789737|448214054|FG000|Overall Study|Protocol Violation|3|||
124616378|NCT00789737|448214055|FG001|Overall Study|Protocol Violation|0|||
124616379|NCT00789737|448214054|FG000|Overall Study|Lack of Efficacy|3|||
124616380|NCT00789737|448214055|FG001|Overall Study|Lack of Efficacy|0|||
124616381|NCT00789737|448214054|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
124616382|NCT00789737|448214055|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
124616383|NCT00789737|448214054|FG000|Overall Study|Other|11|||
124616384|NCT00789737|448214055|FG001|Overall Study|Other|7|||
124616385|NCT00384930|448214056|FG000|Overall Study|Adverse Event|5|||
124616386|NCT00384930|448214057|FG001|Overall Study|Adverse Event|4|||
124616387|NCT00384930|448214058|FG002|Overall Study|Adverse Event|12|||
124616388|NCT00384930|448214059|FG003|Overall Study|Adverse Event|11|||
124616389|NCT00384930|448214060|FG004|Overall Study|Adverse Event|14|||
124616390|NCT00384930|448214056|FG000|Overall Study|Entry Criteria Not Met|2|||
124616391|NCT00384930|448214057|FG001|Overall Study|Entry Criteria Not Met|6|||
124616392|NCT00384930|448214058|FG002|Overall Study|Entry Criteria Not Met|7|||
124616393|NCT00384930|448214059|FG003|Overall Study|Entry Criteria Not Met|8|||
124616394|NCT00384930|448214060|FG004|Overall Study|Entry Criteria Not Met|4|||
124616395|NCT00384930|448214056|FG000|Overall Study|Lack of Efficacy|1|||
124616396|NCT00384930|448214057|FG001|Overall Study|Lack of Efficacy|1|||
124616397|NCT00384930|448214058|FG002|Overall Study|Lack of Efficacy|2|||
124616398|NCT00384930|448214059|FG003|Overall Study|Lack of Efficacy|1|||
124616399|NCT00384930|448214060|FG004|Overall Study|Lack of Efficacy|2|||
124616400|NCT00384930|448214056|FG000|Overall Study|Lost to Follow-up|5|||
124616401|NCT00384930|448214057|FG001|Overall Study|Lost to Follow-up|3|||
124616402|NCT00384930|448214058|FG002|Overall Study|Lost to Follow-up|0|||
124616403|NCT00384930|448214059|FG003|Overall Study|Lost to Follow-up|4|||
124616404|NCT00384930|448214060|FG004|Overall Study|Lost to Follow-up|6|||
124616405|NCT00384930|448214056|FG000|Overall Study|Physician Decision|0|||
124616406|NCT00384930|448214057|FG001|Overall Study|Physician Decision|1|||
124616407|NCT00384930|448214058|FG002|Overall Study|Physician Decision|1|||
124616408|NCT00384930|448214059|FG003|Overall Study|Physician Decision|0|||
124616409|NCT00384930|448214060|FG004|Overall Study|Physician Decision|1|||
124616410|NCT00384930|448214056|FG000|Overall Study|Protocol Violation|1|||
124616411|NCT00384930|448214057|FG001|Overall Study|Protocol Violation|0|||
124616412|NCT00384930|448214058|FG002|Overall Study|Protocol Violation|1|||
124616413|NCT00384930|448214059|FG003|Overall Study|Protocol Violation|6|||
124616414|NCT00384930|448214060|FG004|Overall Study|Protocol Violation|4|||
124616415|NCT00384930|448214056|FG000|Overall Study|Sponsor Decision|3|||
124616416|NCT00384930|448214057|FG001|Overall Study|Sponsor Decision|4|||
124616417|NCT00384930|448214058|FG002|Overall Study|Sponsor Decision|0|||
124616418|NCT00384930|448214059|FG003|Overall Study|Sponsor Decision|5|||
124616419|NCT00384930|448214060|FG004|Overall Study|Sponsor Decision|0|||
124616420|NCT00384930|448214056|FG000|Overall Study|Withdrawal by Subject|9|||
124616421|NCT00384930|448214057|FG001|Overall Study|Withdrawal by Subject|7|||
124616422|NCT00384930|448214058|FG002|Overall Study|Withdrawal by Subject|7|||
124616423|NCT00384930|448214059|FG003|Overall Study|Withdrawal by Subject|6|||
124616424|NCT00384930|448214060|FG004|Overall Study|Withdrawal by Subject|16|||
124616425|NCT00384930|448214056|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
124616426|NCT00384930|448214057|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
124781957|NCT02529553|448831234|FG003|Overall Study|Progressive Disease|3|||
124781958|NCT02529553|448831235|FG004|Overall Study|Progressive Disease|2|||
124616427|NCT00384930|448214058|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
124616428|NCT00384930|448214059|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
124616429|NCT00384930|448214060|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
124616430|NCT04988087|448214063|FG000|Overall Study|Adverse Event|4|||
124616431|NCT04988087|448214064|FG001|Overall Study|Adverse Event|0|||
124616432|NCT04988087|448214065|FG002|Overall Study|Adverse Event|0|||
124616433|NCT04988087|448214066|FG003|Overall Study|Adverse Event|0|||
124616434|NCT04988087|448214063|FG000|Overall Study|Withdrawal by Subject|1|||
124616435|NCT04988087|448214064|FG001|Overall Study|Withdrawal by Subject|1|||
124616436|NCT04988087|448214065|FG002|Overall Study|Withdrawal by Subject|0|||
124616437|NCT04988087|448214066|FG003|Overall Study|Withdrawal by Subject|0|||
124616438|NCT04988087|448214063|FG000|Overall Study|Technical problems|7|||
124616439|NCT04988087|448214064|FG001|Overall Study|Technical problems|9|||
124616440|NCT04988087|448214065|FG002|Overall Study|Technical problems|1|||
124616441|NCT04988087|448214066|FG003|Overall Study|Technical problems|2|||
124616442|NCT02613182|448214067|FG000|Overall Study|Death|6|||
124616443|NCT02613182|448214067|FG000|Overall Study|Physician Decision|1|||
124616444|NCT02613182|448214067|FG000|Overall Study|Study Terminated by Sponsor|21|||
124616445|NCT02613182|448214067|FG000|Overall Study|Withdrawal by Subject|6|||
124616446|NCT03968978|448214068|FG000|Overall Study|Adverse Event|1|||
124616447|NCT03968978|448214069|FG001|Overall Study|Adverse Event|0|||
124616448|NCT00351533|448214075|FG000|Overall Study|Extubated before first BAL|1|||
124616449|NCT00351533|448214076|FG001|Overall Study|Extubated before first BAL|0|||
124616450|NCT00351533|448214075|FG000|Overall Study|Lost to Follow-up|1|||
124616451|NCT00351533|448214076|FG001|Overall Study|Lost to Follow-up|3|||
124616452|NCT00351533|448214075|FG000|Overall Study|Physician Decision|0|||
124616453|NCT00351533|448214076|FG001|Overall Study|Physician Decision|1|||
124616454|NCT00351533|448214075|FG000|Overall Study|Withdrawal by Subject|0|||
124616455|NCT00351533|448214076|FG001|Overall Study|Withdrawal by Subject|1|||
124616456|NCT00996892|448214078|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
124616457|NCT00996892|448214079|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
124616458|NCT00996892|448214080|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
124616459|NCT00996892|448214081|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
124616460|NCT00996892|448214082|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
124616461|NCT00996892|448214083|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
124616462|NCT00996892|448214084|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
124616463|NCT00996892|448214085|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
124616464|NCT00996892|448214086|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
124616465|NCT00996892|448214087|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
124616466|NCT00996892|448214088|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
124616467|NCT00996892|448214089|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
124616468|NCT00996892|448214090|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
124616469|NCT00996892|448214091|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
124616470|NCT00996892|448214092|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
124616471|NCT00996892|448214093|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
124616472|NCT00996892|448214094|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
124616473|NCT00996892|448214095|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
124616474|NCT00996892|448214096|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
124616475|NCT00996892|448214097|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
124616476|NCT00996892|448214078|FG000|Dose-Escalation Stage 1|Death|1|||
124616477|NCT00996892|448214079|FG001|Dose-Escalation Stage 1|Death|0|||
124616478|NCT00996892|448214080|FG002|Dose-Escalation Stage 1|Death|0|||
124616479|NCT00996892|448214081|FG003|Dose-Escalation Stage 1|Death|0|||
124616480|NCT00996892|448214082|FG004|Dose-Escalation Stage 1|Death|0|||
124616481|NCT00996892|448214083|FG005|Dose-Escalation Stage 1|Death|1|||
124616482|NCT00996892|448214084|FG006|Dose-Escalation Stage 1|Death|0|||
124616483|NCT00996892|448214085|FG007|Dose-Escalation Stage 1|Death|0|||
124616484|NCT00996892|448214086|FG008|Dose-Escalation Stage 1|Death|0|||
124616485|NCT00996892|448214087|FG009|Dose-Escalation Stage 1|Death|0|||
124616486|NCT00996892|448214088|FG010|Dose-Escalation Stage 1|Death|0|||
124616487|NCT00996892|448214089|FG011|Dose-Escalation Stage 1|Death|0|||
124616488|NCT00996892|448214090|FG012|Dose-Escalation Stage 1|Death|0|||
124616489|NCT00996892|448214091|FG013|Dose-Escalation Stage 1|Death|0|||
124616490|NCT00996892|448214092|FG014|Dose-Escalation Stage 1|Death|0|||
124616491|NCT00996892|448214093|FG015|Dose-Escalation Stage 1|Death|0|||
124616492|NCT00996892|448214094|FG016|Dose-Escalation Stage 1|Death|0|||
124616493|NCT00996892|448214095|FG017|Dose-Escalation Stage 1|Death|0|||
124616494|NCT00996892|448214096|FG018|Dose-Escalation Stage 1|Death|0|||
124616495|NCT00996892|448214097|FG019|Dose-Escalation Stage 1|Death|0|||
124616496|NCT00996892|448214078|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
124744288|NCT00500760|448684883|FG000|Overall Study|Administrative decision|2|||
124744289|NCT00500760|448684884|FG001|Overall Study|Administrative decision|0|||
124744290|NCT00500760|448684883|FG000|Overall Study|Lost to Follow-up|3|||
124744291|NCT00500760|448684884|FG001|Overall Study|Lost to Follow-up|0|||
124744292|NCT00500760|448684883|FG000|Overall Study|Other|1|||
124744293|NCT00500760|448684884|FG001|Overall Study|Other|2|||
124744294|NCT00129961|448684886|FG000|Overall Study|Adverse Event|1|||
124616497|NCT00996892|448214079|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
124616498|NCT00996892|448214080|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
124616499|NCT00996892|448214081|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
124616500|NCT00996892|448214082|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
124616501|NCT00996892|448214083|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
124616502|NCT00996892|448214084|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
124616503|NCT00996892|448214085|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
124616504|NCT00996892|448214086|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
124616505|NCT00996892|448214087|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
124616506|NCT00996892|448214088|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
124616507|NCT00996892|448214089|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
124616508|NCT00996892|448214090|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
124744295|NCT00129961|448684887|FG001|Overall Study|Adverse Event|0|||
124744296|NCT00129961|448684886|FG000|Overall Study|Death|1|||
124744297|NCT00129961|448684887|FG001|Overall Study|Death|1|||
124616509|NCT00996892|448214091|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
124616510|NCT00996892|448214092|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
124616511|NCT00996892|448214093|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
124616512|NCT00996892|448214094|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
124781959|NCT02529553|448831236|FG005|Overall Study|Progressive Disease|3|||
124781960|NCT02529553|448831237|FG006|Overall Study|Progressive Disease|3|||
124781961|NCT02529553|448831238|FG007|Overall Study|Progressive Disease|5|||
124781962|NCT02529553|448831239|FG008|Overall Study|Progressive Disease|3|||
124781963|NCT02529553|448831231|FG000|Overall Study|Physician Decision|0|||
124781964|NCT02529553|448831232|FG001|Overall Study|Physician Decision|1|||
124781965|NCT02529553|448831233|FG002|Overall Study|Physician Decision|0|||
124781966|NCT02529553|448831234|FG003|Overall Study|Physician Decision|0|||
124781967|NCT02529553|448831235|FG004|Overall Study|Physician Decision|1|||
124781968|NCT02529553|448831236|FG005|Overall Study|Physician Decision|0|||
124781969|NCT02529553|448831237|FG006|Overall Study|Physician Decision|0|||
124781970|NCT02529553|448831238|FG007|Overall Study|Physician Decision|0|||
124781971|NCT02529553|448831239|FG008|Overall Study|Physician Decision|0|||
124781972|NCT02529553|448831231|FG000|Overall Study|Withdrawal by Subject|0|||
124781973|NCT02529553|448831232|FG001|Overall Study|Withdrawal by Subject|0|||
124781974|NCT02529553|448831233|FG002|Overall Study|Withdrawal by Subject|0|||
124781975|NCT02529553|448831234|FG003|Overall Study|Withdrawal by Subject|0|||
124781976|NCT02529553|448831235|FG004|Overall Study|Withdrawal by Subject|0|||
124781977|NCT02529553|448831236|FG005|Overall Study|Withdrawal by Subject|1|||
124781978|NCT02529553|448831237|FG006|Overall Study|Withdrawal by Subject|0|||
124781979|NCT02529553|448831238|FG007|Overall Study|Withdrawal by Subject|1|||
124781980|NCT02529553|448831239|FG008|Overall Study|Withdrawal by Subject|0|||
124616513|NCT00996892|448214095|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
124616514|NCT00996892|448214096|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
124616515|NCT00996892|448214097|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
124616516|NCT00996892|448214078|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
124616517|NCT00996892|448214079|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
124616518|NCT00996892|448214080|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
124616519|NCT00996892|448214081|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
124616520|NCT00996892|448214082|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
124616521|NCT00996892|448214083|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
124616522|NCT00996892|448214084|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
124616523|NCT00996892|448214085|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
124616524|NCT00996892|448214086|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
124616525|NCT00996892|448214087|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
124616526|NCT00996892|448214088|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
124616527|NCT00996892|448214089|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
124616528|NCT00996892|448214090|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
124616529|NCT00996892|448214091|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
124616530|NCT00996892|448214092|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
124616531|NCT00996892|448214093|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
124616532|NCT00996892|448214094|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
124616533|NCT00996892|448214095|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
124616534|NCT00996892|448214096|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
124616535|NCT00996892|448214097|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
124616536|NCT00996892|448214078|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
124616537|NCT00996892|448214079|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
124616538|NCT00996892|448214080|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
124616539|NCT00996892|448214081|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
124616540|NCT00996892|448214082|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
124616541|NCT00996892|448214083|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
124616542|NCT00996892|448214084|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
124616543|NCT00996892|448214085|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
124616544|NCT00996892|448214086|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
124616545|NCT00996892|448214087|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
124616546|NCT00996892|448214088|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
124781981|NCT04549545|448832722|FG000|Initial Period|Withdrawal by Subject|4|||
124781982|NCT04549545|448832723|FG001|Initial Period|Withdrawal by Subject|0|||
124781983|NCT04549545|448832722|FG000|Initial Period|Additional ENT Procedure|3|||
124781984|NCT04549545|448832723|FG001|Initial Period|Additional ENT Procedure|0|||
124781985|NCT04549545|448832722|FG000|Initial Period|Lost to Follow-up|3|||
124616547|NCT00996892|448214089|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
124616548|NCT00996892|448214090|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
124616549|NCT00996892|448214091|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
124616550|NCT00996892|448214092|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
124781986|NCT04549545|448832723|FG001|Initial Period|Lost to Follow-up|1|||
124781987|NCT04549545|448832722|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
124781988|NCT04549545|448832723|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
124781989|NCT04549545|448832722|FG000|Crossover Period|Additional ENT Procedure|0|||
124616551|NCT00996892|448214093|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
124616552|NCT00996892|448214094|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
124616553|NCT00996892|448214095|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
124616554|NCT00996892|448214096|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
124616555|NCT00996892|448214097|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
124616556|NCT00996892|448214078|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
124616557|NCT00996892|448214079|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
124616558|NCT00996892|448214080|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
124616559|NCT00996892|448214081|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
124616560|NCT00996892|448214082|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
124616561|NCT00996892|448214083|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
124616562|NCT00996892|448214084|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
124616563|NCT00996892|448214085|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
124616564|NCT00996892|448214086|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
124616565|NCT00996892|448214087|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
124616566|NCT00996892|448214088|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
124616567|NCT00996892|448214089|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
124616568|NCT00996892|448214090|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
124616569|NCT00996892|448214091|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
124616570|NCT00996892|448214092|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
124616571|NCT00996892|448214093|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
124616572|NCT00996892|448214094|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
124616573|NCT00996892|448214095|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
124616574|NCT00996892|448214096|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
124616575|NCT00996892|448214097|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
124616576|NCT00996892|448214078|FG000|Dose-Escalation Stage 1A|Death|0|||
124616577|NCT00996892|448214079|FG001|Dose-Escalation Stage 1A|Death|0|||
124616578|NCT00996892|448214080|FG002|Dose-Escalation Stage 1A|Death|0|||
124616579|NCT00996892|448214081|FG003|Dose-Escalation Stage 1A|Death|0|||
124616580|NCT00996892|448214082|FG004|Dose-Escalation Stage 1A|Death|0|||
124616581|NCT00996892|448214083|FG005|Dose-Escalation Stage 1A|Death|0|||
124616582|NCT00996892|448214084|FG006|Dose-Escalation Stage 1A|Death|0|||
124616583|NCT00996892|448214085|FG007|Dose-Escalation Stage 1A|Death|0|||
124616584|NCT00996892|448214086|FG008|Dose-Escalation Stage 1A|Death|0|||
124616585|NCT00996892|448214087|FG009|Dose-Escalation Stage 1A|Death|2|||
124616586|NCT00996892|448214088|FG010|Dose-Escalation Stage 1A|Death|0|||
124616587|NCT00996892|448214089|FG011|Dose-Escalation Stage 1A|Death|1|||
124616588|NCT00996892|448214090|FG012|Dose-Escalation Stage 1A|Death|1|||
124616589|NCT00996892|448214091|FG013|Dose-Escalation Stage 1A|Death|0|||
124616590|NCT00996892|448214092|FG014|Dose-Escalation Stage 1A|Death|0|||
124616591|NCT00996892|448214093|FG015|Dose-Escalation Stage 1A|Death|0|||
124616592|NCT00996892|448214094|FG016|Dose-Escalation Stage 1A|Death|0|||
124616593|NCT00996892|448214095|FG017|Dose-Escalation Stage 1A|Death|0|||
124616594|NCT00996892|448214096|FG018|Dose-Escalation Stage 1A|Death|0|||
124616595|NCT00996892|448214097|FG019|Dose-Escalation Stage 1A|Death|0|||
124616596|NCT00996892|448214078|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
124616597|NCT00996892|448214079|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
124616598|NCT00996892|448214080|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
124616599|NCT00996892|448214081|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
124616600|NCT00996892|448214082|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
124616601|NCT00996892|448214083|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
124616602|NCT00996892|448214084|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
124616603|NCT00996892|448214085|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
124616604|NCT00996892|448214086|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
124616605|NCT00996892|448214087|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
124616606|NCT00996892|448214088|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
124616607|NCT00996892|448214089|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
124616608|NCT00996892|448214090|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
124616609|NCT00996892|448214091|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
124616610|NCT00996892|448214092|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
124616611|NCT00996892|448214093|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
124616612|NCT00996892|448214094|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
124616613|NCT00996892|448214095|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
124616614|NCT00996892|448214096|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
124616615|NCT00996892|448214097|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
124616616|NCT00996892|448214078|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
124616617|NCT00996892|448214079|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
124616618|NCT00996892|448214080|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
124616619|NCT00996892|448214081|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
124616620|NCT00996892|448214082|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
124616621|NCT00996892|448214083|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
124616622|NCT00996892|448214084|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
124616623|NCT00996892|448214085|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
124616624|NCT00996892|448214086|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
124616625|NCT00996892|448214087|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
124616626|NCT00996892|448214088|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
124616627|NCT00996892|448214089|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
124616628|NCT00996892|448214090|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
124616629|NCT00996892|448214091|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
124616630|NCT00996892|448214092|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
124616631|NCT00996892|448214093|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
124616632|NCT00996892|448214094|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
124616633|NCT00996892|448214095|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
124616634|NCT00996892|448214096|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
124616635|NCT00996892|448214097|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
124616636|NCT00996892|448214078|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
124616637|NCT00996892|448214079|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
124616638|NCT00996892|448214080|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
124616639|NCT00996892|448214081|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
124616640|NCT00996892|448214082|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
124616641|NCT00996892|448214083|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
124616642|NCT00996892|448214084|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
124616643|NCT00996892|448214085|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
124616644|NCT00996892|448214086|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
124616645|NCT00996892|448214087|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
124616646|NCT00996892|448214088|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
124616647|NCT00996892|448214089|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
124616648|NCT00996892|448214090|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
124616649|NCT00996892|448214091|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
124616650|NCT00996892|448214092|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
124616651|NCT00996892|448214093|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
124616652|NCT00996892|448214094|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
124616653|NCT00996892|448214095|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
124616654|NCT00996892|448214096|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
124616655|NCT00996892|448214097|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
124616656|NCT00996892|448214078|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
124616657|NCT00996892|448214079|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
124616658|NCT00996892|448214080|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
124616659|NCT00996892|448214081|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
124616660|NCT00996892|448214082|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
124616661|NCT00996892|448214083|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
124616662|NCT00996892|448214084|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
124616663|NCT00996892|448214085|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
124616664|NCT00996892|448214086|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
124616665|NCT00996892|448214087|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
124616666|NCT00996892|448214088|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
124616667|NCT00996892|448214089|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
124616668|NCT00996892|448214090|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
124616669|NCT00996892|448214091|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
124616670|NCT00996892|448214092|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
124616671|NCT00996892|448214093|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
124616672|NCT00996892|448214094|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
124616673|NCT00996892|448214095|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
124616674|NCT00996892|448214096|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
124616675|NCT00996892|448214097|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
124616676|NCT00996892|448214078|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
124616677|NCT00996892|448214079|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
124616678|NCT00996892|448214080|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
124616679|NCT00996892|448214081|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
124616680|NCT00996892|448214082|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
124616681|NCT00996892|448214083|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
124616682|NCT00996892|448214084|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
124616683|NCT00996892|448214085|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
124616684|NCT00996892|448214086|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
124616685|NCT00996892|448214087|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
124616686|NCT00996892|448214088|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
124616687|NCT00996892|448214089|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
124616688|NCT00996892|448214090|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
124616689|NCT00996892|448214091|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
124616690|NCT00996892|448214092|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
124744298|NCT00129961|448684886|FG000|Overall Study|Withdrawal by Sponsor|14|||
124616691|NCT00996892|448214093|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
124616692|NCT00996892|448214094|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
124744299|NCT00129961|448684887|FG001|Overall Study|Withdrawal by Sponsor|20|||
124616693|NCT00996892|448214095|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
124616694|NCT00996892|448214096|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
124616695|NCT00996892|448214097|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
124616696|NCT00996892|448214078|FG000|Expansion Stage 2|Adverse Event|0|||
124616697|NCT00996892|448214079|FG001|Expansion Stage 2|Adverse Event|0|||
124616698|NCT00996892|448214080|FG002|Expansion Stage 2|Adverse Event|0|||
124616699|NCT00996892|448214081|FG003|Expansion Stage 2|Adverse Event|0|||
124616700|NCT00996892|448214082|FG004|Expansion Stage 2|Adverse Event|0|||
124616701|NCT00996892|448214083|FG005|Expansion Stage 2|Adverse Event|0|||
124616702|NCT00996892|448214084|FG006|Expansion Stage 2|Adverse Event|0|||
124616703|NCT00996892|448214085|FG007|Expansion Stage 2|Adverse Event|0|||
124616704|NCT00996892|448214086|FG008|Expansion Stage 2|Adverse Event|0|||
124616705|NCT00996892|448214087|FG009|Expansion Stage 2|Adverse Event|0|||
124616706|NCT00996892|448214088|FG010|Expansion Stage 2|Adverse Event|0|||
124616707|NCT00996892|448214089|FG011|Expansion Stage 2|Adverse Event|0|||
124616708|NCT00996892|448214090|FG012|Expansion Stage 2|Adverse Event|0|||
124616709|NCT00996892|448214091|FG013|Expansion Stage 2|Adverse Event|0|||
124616710|NCT00996892|448214092|FG014|Expansion Stage 2|Adverse Event|0|||
124616711|NCT00996892|448214093|FG015|Expansion Stage 2|Adverse Event|0|||
124616712|NCT00996892|448214094|FG016|Expansion Stage 2|Adverse Event|0|||
124616713|NCT00996892|448214095|FG017|Expansion Stage 2|Adverse Event|0|||
124616714|NCT00996892|448214096|FG018|Expansion Stage 2|Adverse Event|3|||
124616715|NCT00996892|448214097|FG019|Expansion Stage 2|Adverse Event|0|||
124616716|NCT00996892|448214078|FG000|Expansion Stage 2|Death|0|||
124616717|NCT00996892|448214079|FG001|Expansion Stage 2|Death|0|||
124616718|NCT00996892|448214080|FG002|Expansion Stage 2|Death|0|||
124616719|NCT00996892|448214081|FG003|Expansion Stage 2|Death|0|||
124616720|NCT00996892|448214082|FG004|Expansion Stage 2|Death|0|||
124616721|NCT00996892|448214083|FG005|Expansion Stage 2|Death|0|||
124616722|NCT00996892|448214084|FG006|Expansion Stage 2|Death|0|||
124616723|NCT00996892|448214085|FG007|Expansion Stage 2|Death|0|||
124616724|NCT00996892|448214086|FG008|Expansion Stage 2|Death|0|||
124616725|NCT00996892|448214087|FG009|Expansion Stage 2|Death|0|||
124616726|NCT00996892|448214088|FG010|Expansion Stage 2|Death|0|||
124616727|NCT00996892|448214089|FG011|Expansion Stage 2|Death|0|||
124616728|NCT00996892|448214090|FG012|Expansion Stage 2|Death|0|||
124616729|NCT00996892|448214091|FG013|Expansion Stage 2|Death|0|||
124616730|NCT00996892|448214092|FG014|Expansion Stage 2|Death|0|||
124616731|NCT00996892|448214093|FG015|Expansion Stage 2|Death|0|||
124616732|NCT00996892|448214094|FG016|Expansion Stage 2|Death|0|||
124616733|NCT00996892|448214095|FG017|Expansion Stage 2|Death|0|||
124616734|NCT00996892|448214096|FG018|Expansion Stage 2|Death|2|||
124616735|NCT00996892|448214097|FG019|Expansion Stage 2|Death|0|||
124616736|NCT00996892|448214078|FG000|Expansion Stage 2|Physician Decision|0|||
124616737|NCT00996892|448214079|FG001|Expansion Stage 2|Physician Decision|0|||
124616738|NCT00996892|448214080|FG002|Expansion Stage 2|Physician Decision|0|||
124616739|NCT00996892|448214081|FG003|Expansion Stage 2|Physician Decision|0|||
124616740|NCT00996892|448214082|FG004|Expansion Stage 2|Physician Decision|0|||
124616741|NCT00996892|448214083|FG005|Expansion Stage 2|Physician Decision|0|||
124616742|NCT00996892|448214084|FG006|Expansion Stage 2|Physician Decision|0|||
124616743|NCT00996892|448214085|FG007|Expansion Stage 2|Physician Decision|0|||
124616744|NCT00996892|448214086|FG008|Expansion Stage 2|Physician Decision|0|||
124616745|NCT00996892|448214087|FG009|Expansion Stage 2|Physician Decision|0|||
124616746|NCT00996892|448214088|FG010|Expansion Stage 2|Physician Decision|0|||
124616747|NCT00996892|448214089|FG011|Expansion Stage 2|Physician Decision|0|||
124616748|NCT00996892|448214090|FG012|Expansion Stage 2|Physician Decision|0|||
124616749|NCT00996892|448214091|FG013|Expansion Stage 2|Physician Decision|0|||
124616750|NCT00996892|448214092|FG014|Expansion Stage 2|Physician Decision|0|||
124616751|NCT00996892|448214093|FG015|Expansion Stage 2|Physician Decision|0|||
124616752|NCT00996892|448214094|FG016|Expansion Stage 2|Physician Decision|0|||
124616753|NCT00996892|448214095|FG017|Expansion Stage 2|Physician Decision|0|||
124616754|NCT00996892|448214096|FG018|Expansion Stage 2|Physician Decision|1|||
124616755|NCT00996892|448214097|FG019|Expansion Stage 2|Physician Decision|0|||
124616756|NCT00996892|448214078|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
124616757|NCT00996892|448214079|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
124616758|NCT00996892|448214080|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
124616759|NCT00996892|448214081|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
124616760|NCT00996892|448214082|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
124616761|NCT00996892|448214083|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
124616762|NCT00996892|448214084|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
124616763|NCT00996892|448214085|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
124616764|NCT00996892|448214086|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
124616765|NCT00996892|448214087|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
124616766|NCT00996892|448214088|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
124616767|NCT00996892|448214089|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
124616768|NCT00996892|448214090|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
124616769|NCT00996892|448214091|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
124616770|NCT00996892|448214092|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
124616771|NCT00996892|448214093|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
124616772|NCT00996892|448214094|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
124616773|NCT00996892|448214095|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
124616774|NCT00996892|448214096|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
124616775|NCT00996892|448214097|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
124616776|NCT00996892|448214078|FG000|Expansion Stage 2|Disease Progression|0|||
124616777|NCT00996892|448214079|FG001|Expansion Stage 2|Disease Progression|0|||
124616778|NCT00996892|448214080|FG002|Expansion Stage 2|Disease Progression|0|||
124616779|NCT00996892|448214081|FG003|Expansion Stage 2|Disease Progression|0|||
124616780|NCT00996892|448214082|FG004|Expansion Stage 2|Disease Progression|0|||
124616781|NCT00996892|448214083|FG005|Expansion Stage 2|Disease Progression|0|||
124616782|NCT00996892|448214084|FG006|Expansion Stage 2|Disease Progression|0|||
124616783|NCT00996892|448214085|FG007|Expansion Stage 2|Disease Progression|0|||
124781990|NCT04549545|448832723|FG001|Crossover Period|Additional ENT Procedure|6|||
124781991|NCT04549545|448832722|FG000|Crossover Period|Lost to Follow-up|0|||
124781992|NCT04549545|448832723|FG001|Crossover Period|Lost to Follow-up|1|||
124781993|NCT04549545|448832722|FG000|Crossover Period|Withdrawal by Subject|0|||
124781994|NCT04549545|448832723|FG001|Crossover Period|Withdrawal by Subject|4|||
124616784|NCT00996892|448214086|FG008|Expansion Stage 2|Disease Progression|0|||
124616785|NCT00996892|448214087|FG009|Expansion Stage 2|Disease Progression|0|||
124616786|NCT00996892|448214088|FG010|Expansion Stage 2|Disease Progression|0|||
124616787|NCT00996892|448214089|FG011|Expansion Stage 2|Disease Progression|0|||
124616788|NCT00996892|448214090|FG012|Expansion Stage 2|Disease Progression|0|||
124616789|NCT00996892|448214091|FG013|Expansion Stage 2|Disease Progression|0|||
124616790|NCT00996892|448214092|FG014|Expansion Stage 2|Disease Progression|0|||
124616791|NCT00996892|448214093|FG015|Expansion Stage 2|Disease Progression|0|||
124616792|NCT00996892|448214094|FG016|Expansion Stage 2|Disease Progression|0|||
124616793|NCT00996892|448214095|FG017|Expansion Stage 2|Disease Progression|0|||
124616794|NCT00996892|448214096|FG018|Expansion Stage 2|Disease Progression|28|||
124616795|NCT00996892|448214097|FG019|Expansion Stage 2|Disease Progression|0|||
124616796|NCT00996892|448214078|FG000|Expansion Stage 2A|Adverse Event|0|||
124616797|NCT00996892|448214079|FG001|Expansion Stage 2A|Adverse Event|0|||
124616798|NCT00996892|448214080|FG002|Expansion Stage 2A|Adverse Event|0|||
124616799|NCT00996892|448214081|FG003|Expansion Stage 2A|Adverse Event|0|||
124616800|NCT00996892|448214082|FG004|Expansion Stage 2A|Adverse Event|0|||
124616801|NCT00996892|448214083|FG005|Expansion Stage 2A|Adverse Event|0|||
124616802|NCT00996892|448214084|FG006|Expansion Stage 2A|Adverse Event|0|||
124616803|NCT00996892|448214085|FG007|Expansion Stage 2A|Adverse Event|0|||
124616804|NCT00996892|448214086|FG008|Expansion Stage 2A|Adverse Event|0|||
124616805|NCT00996892|448214087|FG009|Expansion Stage 2A|Adverse Event|0|||
124616806|NCT00996892|448214088|FG010|Expansion Stage 2A|Adverse Event|0|||
124616807|NCT00996892|448214089|FG011|Expansion Stage 2A|Adverse Event|0|||
124616808|NCT00996892|448214090|FG012|Expansion Stage 2A|Adverse Event|0|||
124616809|NCT00996892|448214091|FG013|Expansion Stage 2A|Adverse Event|0|||
124616810|NCT00996892|448214092|FG014|Expansion Stage 2A|Adverse Event|0|||
124616811|NCT00996892|448214093|FG015|Expansion Stage 2A|Adverse Event|0|||
124616812|NCT00996892|448214094|FG016|Expansion Stage 2A|Adverse Event|0|||
124616813|NCT00996892|448214095|FG017|Expansion Stage 2A|Adverse Event|0|||
124616814|NCT00996892|448214096|FG018|Expansion Stage 2A|Adverse Event|0|||
124616815|NCT00996892|448214097|FG019|Expansion Stage 2A|Adverse Event|8|||
124616816|NCT00996892|448214078|FG000|Expansion Stage 2A|Physician Decision|0|||
124616817|NCT00996892|448214079|FG001|Expansion Stage 2A|Physician Decision|0|||
124616818|NCT00996892|448214080|FG002|Expansion Stage 2A|Physician Decision|0|||
124616819|NCT00996892|448214081|FG003|Expansion Stage 2A|Physician Decision|0|||
124616820|NCT00996892|448214082|FG004|Expansion Stage 2A|Physician Decision|0|||
124616821|NCT00996892|448214083|FG005|Expansion Stage 2A|Physician Decision|0|||
124616822|NCT00996892|448214084|FG006|Expansion Stage 2A|Physician Decision|0|||
124616823|NCT00996892|448214085|FG007|Expansion Stage 2A|Physician Decision|0|||
124616824|NCT00996892|448214086|FG008|Expansion Stage 2A|Physician Decision|0|||
124616825|NCT00996892|448214087|FG009|Expansion Stage 2A|Physician Decision|0|||
124616826|NCT00996892|448214088|FG010|Expansion Stage 2A|Physician Decision|0|||
124616827|NCT00996892|448214089|FG011|Expansion Stage 2A|Physician Decision|0|||
124616828|NCT00996892|448214090|FG012|Expansion Stage 2A|Physician Decision|0|||
124616829|NCT00996892|448214091|FG013|Expansion Stage 2A|Physician Decision|0|||
124616830|NCT00996892|448214092|FG014|Expansion Stage 2A|Physician Decision|0|||
124616831|NCT00996892|448214093|FG015|Expansion Stage 2A|Physician Decision|0|||
124781995|NCT01006291|448832727|FG000|Overall Study|Adverse Event|2|||
124616832|NCT00996892|448214094|FG016|Expansion Stage 2A|Physician Decision|0|||
124616833|NCT00996892|448214095|FG017|Expansion Stage 2A|Physician Decision|0|||
124616834|NCT00996892|448214096|FG018|Expansion Stage 2A|Physician Decision|0|||
124616835|NCT00996892|448214097|FG019|Expansion Stage 2A|Physician Decision|2|||
124781996|NCT01006291|448832728|FG001|Overall Study|Adverse Event|1|||
124616836|NCT00996892|448214078|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
124616837|NCT00996892|448214079|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
124616838|NCT00996892|448214080|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
124616839|NCT00996892|448214081|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
124781997|NCT01006291|448832729|FG002|Overall Study|Adverse Event|2|||
124616840|NCT00996892|448214082|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
124616841|NCT00996892|448214083|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
124616842|NCT00996892|448214084|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
124616843|NCT00996892|448214085|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
124616844|NCT00996892|448214086|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
124616845|NCT00996892|448214087|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
124616846|NCT00996892|448214088|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
124616847|NCT00996892|448214089|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
124616848|NCT00996892|448214090|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
124616849|NCT00996892|448214091|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
124616850|NCT00996892|448214092|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
124616851|NCT00996892|448214093|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
124616852|NCT00996892|448214094|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
124616853|NCT00996892|448214095|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
124616854|NCT00996892|448214096|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
124616855|NCT00996892|448214097|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
124616856|NCT00996892|448214078|FG000|Expansion Stage 2A|Disease Progression|0|||
124616857|NCT00996892|448214079|FG001|Expansion Stage 2A|Disease Progression|0|||
124616858|NCT00996892|448214080|FG002|Expansion Stage 2A|Disease Progression|0|||
124616859|NCT00996892|448214081|FG003|Expansion Stage 2A|Disease Progression|0|||
124616860|NCT00996892|448214082|FG004|Expansion Stage 2A|Disease Progression|0|||
124616861|NCT00996892|448214083|FG005|Expansion Stage 2A|Disease Progression|0|||
124616862|NCT00996892|448214084|FG006|Expansion Stage 2A|Disease Progression|0|||
124616863|NCT00996892|448214085|FG007|Expansion Stage 2A|Disease Progression|0|||
124616864|NCT00996892|448214086|FG008|Expansion Stage 2A|Disease Progression|0|||
124616865|NCT00996892|448214087|FG009|Expansion Stage 2A|Disease Progression|0|||
124616866|NCT00996892|448214088|FG010|Expansion Stage 2A|Disease Progression|0|||
124616867|NCT00996892|448214089|FG011|Expansion Stage 2A|Disease Progression|0|||
124616868|NCT00996892|448214090|FG012|Expansion Stage 2A|Disease Progression|0|||
124616869|NCT00996892|448214091|FG013|Expansion Stage 2A|Disease Progression|0|||
124616870|NCT00996892|448214092|FG014|Expansion Stage 2A|Disease Progression|0|||
124616871|NCT00996892|448214093|FG015|Expansion Stage 2A|Disease Progression|0|||
124616872|NCT00996892|448214094|FG016|Expansion Stage 2A|Disease Progression|0|||
124616873|NCT00996892|448214095|FG017|Expansion Stage 2A|Disease Progression|0|||
124616874|NCT00996892|448214096|FG018|Expansion Stage 2A|Disease Progression|0|||
124616875|NCT00996892|448214097|FG019|Expansion Stage 2A|Disease Progression|31|||
124616876|NCT01653912|448214098|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
124616877|NCT01653912|448214099|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
124616878|NCT01653912|448214100|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
124616879|NCT01653912|448214101|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
124616880|NCT01653912|448214102|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
124616881|NCT01653912|448214103|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
124616882|NCT01653912|448214098|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
124616883|NCT01653912|448214099|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
124616884|NCT01653912|448214100|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
124616885|NCT01653912|448214101|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
124616886|NCT01653912|448214102|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
124616887|NCT01653912|448214103|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
124616888|NCT01653912|448214098|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
124616889|NCT01653912|448214099|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
124616890|NCT01653912|448214100|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
124616891|NCT01653912|448214101|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
124616892|NCT01653912|448214102|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
124616893|NCT01653912|448214103|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
124616894|NCT01653912|448214098|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
124616895|NCT01653912|448214099|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
124616896|NCT01653912|448214100|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
124616897|NCT01653912|448214101|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
124616898|NCT01653912|448214102|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
124616899|NCT01653912|448214103|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
124616900|NCT01653912|448214098|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
124616901|NCT01653912|448214099|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
124616902|NCT01653912|448214100|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
124616903|NCT01653912|448214101|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
124616904|NCT01653912|448214102|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
124616905|NCT01653912|448214103|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
124616906|NCT01653912|448214098|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
124616907|NCT01653912|448214099|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
124616908|NCT01653912|448214100|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
124616909|NCT01653912|448214101|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
124616910|NCT01653912|448214102|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
124616911|NCT01653912|448214103|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
124616912|NCT01653912|448214098|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
124616913|NCT01653912|448214099|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
124616914|NCT01653912|448214100|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
124616915|NCT01653912|448214101|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
124616916|NCT01653912|448214102|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
124616917|NCT01653912|448214103|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
124637356|NCT05310071|448290490|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
124637357|NCT05310071|448290491|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
124637358|NCT05310071|448290490|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
124637359|NCT05310071|448290491|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
124637360|NCT05310071|448290490|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
124637361|NCT05310071|448290491|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
124637362|NCT05310071|448290490|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
124637363|NCT05310071|448290491|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
124781998|NCT01006291|448832727|FG000|Overall Study|Lack of Efficacy|2|||
124781999|NCT01006291|448832728|FG001|Overall Study|Lack of Efficacy|2|||
124782000|NCT01006291|448832729|FG002|Overall Study|Lack of Efficacy|1|||
124782001|NCT01006291|448832727|FG000|Overall Study|Protocol Violation|3|||
124637364|NCT05310071|448290490|FG000|Overall Study|Withdrawal by Participant - Other|25|||
124637365|NCT05310071|448290491|FG001|Overall Study|Withdrawal by Participant - Other|30|||
124637366|NCT05310071|448290490|FG000|Overall Study|Lost to Follow-up|2|||
124637367|NCT05310071|448290491|FG001|Overall Study|Lost to Follow-up|4|||
124637368|NCT05310071|448290490|FG000|Overall Study|Reason Not Specified|1|||
124637369|NCT05310071|448290491|FG001|Overall Study|Reason Not Specified|3|||
124637370|NCT01303172|448290503|FG000|Overall Study|Physician Decision|9|||
124637371|NCT01303172|448290504|FG001|Overall Study|Physician Decision|6|||
124637372|NCT01303172|448290503|FG000|Overall Study|Adverse Event|5|||
124637373|NCT01303172|448290504|FG001|Overall Study|Adverse Event|2|||
124637374|NCT01303172|448290503|FG000|Overall Study|Withdrawal by Subject|4|||
124637375|NCT01303172|448290504|FG001|Overall Study|Withdrawal by Subject|2|||
124637376|NCT01303172|448290503|FG000|Overall Study|Death|20|||
124637377|NCT01303172|448290504|FG001|Overall Study|Death|7|||
124637378|NCT01303172|448290503|FG000|Overall Study|Lack of Efficacy|25|||
124637379|NCT01303172|448290504|FG001|Overall Study|Lack of Efficacy|17|||
124637380|NCT00554515|448290511|FG000|Overall Study|Withdrawal by Subject|3|||
124637381|NCT00554515|448290511|FG000|Overall Study|Disease progression|52|||
124637382|NCT00554515|448290511|FG000|Overall Study|Physician Decision|18|||
124637383|NCT00554515|448290511|FG000|Overall Study|Withdrawal by Subject|11|||
124637384|NCT00554515|448290511|FG000|Overall Study|Adverse Event|9|||
124637385|NCT00554515|448290511|FG000|Overall Study|Death|2|||
124637386|NCT00554515|448290511|FG000|Overall Study|Achieved Stable Disease|7|||
124637387|NCT00554515|448290511|FG000|Overall Study|Other|1|||
124637388|NCT00554515|448290511|FG000|Overall Study|Misc|15|||
124637389|NCT00488644|448290512|FG000|Overall Study|Not Eligible|1|||
124637390|NCT00488644|448290512|FG000|Overall Study|Not Evaluable|1|||
124637391|NCT02977572|448290513|FG000|Overall Study|Exclusion criterion|2|||
124637392|NCT02977572|448290514|FG001|Overall Study|Exclusion criterion|2|||
124637393|NCT05107492|448290515|FG000|Overall Study|Lost to Follow-up|1|||
124637394|NCT05107492|448290516|FG001|Overall Study|Lost to Follow-up|0|||
124637395|NCT01197534|448290517|FG000|Overall Study|Not reported|16|||
124637396|NCT01197534|448290518|FG001|Overall Study|Not reported|10|||
124637397|NCT01197534|448290519|FG002|Overall Study|Not reported|16|||
124637398|NCT01197534|448290517|FG000|Overall Study|Enrolment in long term extension|57|||
124637399|NCT01197534|448290518|FG001|Overall Study|Enrolment in long term extension|66|||
124637400|NCT01197534|448290519|FG002|Overall Study|Enrolment in long term extension|119|||
124637401|NCT01197534|448290517|FG000|Overall Study|Severe non-compliance to protocol|3|||
124637402|NCT01197534|448290518|FG001|Overall Study|Severe non-compliance to protocol|4|||
124637403|NCT01197534|448290519|FG002|Overall Study|Severe non-compliance to protocol|1|||
124637404|NCT01197534|448290517|FG000|Overall Study|Lack of therapeutic response|9|||
124637405|NCT01197534|448290518|FG001|Overall Study|Lack of therapeutic response|4|||
124637406|NCT01197534|448290519|FG002|Overall Study|Lack of therapeutic response|9|||
124637407|NCT01197534|448290517|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
124637408|NCT01197534|448290518|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
124637409|NCT01197534|448290519|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
124637410|NCT01197534|448290517|FG000|Overall Study|Lost to Follow-up|1|||
124637411|NCT01197534|448290518|FG001|Overall Study|Lost to Follow-up|4|||
124637412|NCT01197534|448290519|FG002|Overall Study|Lost to Follow-up|2|||
124637413|NCT01197534|448290517|FG000|Overall Study|Adverse Event|35|||
124637414|NCT01197534|448290518|FG001|Overall Study|Adverse Event|36|||
124637415|NCT01197534|448290519|FG002|Overall Study|Adverse Event|24|||
124637416|NCT02589639|448290532|FG000|Overall Study|Lost to Follow-up|1|||
124637417|NCT02589639|448290533|FG001|Overall Study|Lost to Follow-up|0|||
124637418|NCT02589639|448290534|FG002|Overall Study|Lost to Follow-up|0|||
124782002|NCT01006291|448832728|FG001|Overall Study|Protocol Violation|3|||
124616918|NCT01200069|448215931|FG000|Overall Study|Withdrawal by Subject|0|||
124616919|NCT01200069|448215932|FG001|Overall Study|Withdrawal by Subject|1|||
124616920|NCT02883049|448215933|FG000|Induction|Adverse Event|52|||
124616921|NCT02883049|448215934|FG001|Induction|Adverse Event|2|||
124616922|NCT02883049|448215935|FG002|Induction|Adverse Event|0|||
124616923|NCT02883049|448215936|FG003|Induction|Adverse Event|0|||
124616924|NCT02883049|448215937|FG004|Induction|Adverse Event|0|||
124616925|NCT02883049|448215938|FG005|Induction|Adverse Event|0|||
124616926|NCT02883049|448215939|FG006|Induction|Adverse Event|0|||
124616927|NCT02883049|448215940|FG007|Induction|Adverse Event|0|||
124616928|NCT02883049|448215941|FG008|Induction|Adverse Event|0|||
124616929|NCT02883049|448215942|FG009|Induction|Adverse Event|0|||
124616930|NCT02883049|448215943|FG010|Induction|Adverse Event|0|||
124616931|NCT02883049|448215944|FG011|Induction|Adverse Event|0|||
124616932|NCT02883049|448215945|FG012|Induction|Adverse Event|0|||
124616933|NCT02883049|448215946|FG013|Induction|Adverse Event|0|||
124616934|NCT02883049|448215947|FG014|Induction|Adverse Event|0|||
124616935|NCT02883049|448215948|FG015|Induction|Adverse Event|0|||
124616936|NCT02883049|448215933|FG000|Induction|Death|76|||
124616937|NCT02883049|448215934|FG001|Induction|Death|8|||
124616938|NCT02883049|448215935|FG002|Induction|Death|0|||
124616939|NCT02883049|448215936|FG003|Induction|Death|0|||
124616940|NCT02883049|448215937|FG004|Induction|Death|0|||
124616941|NCT02883049|448215938|FG005|Induction|Death|0|||
124616942|NCT02883049|448215939|FG006|Induction|Death|0|||
124616943|NCT02883049|448215940|FG007|Induction|Death|0|||
124616944|NCT02883049|448215941|FG008|Induction|Death|0|||
124616945|NCT02883049|448215942|FG009|Induction|Death|0|||
124616946|NCT02883049|448215943|FG010|Induction|Death|0|||
124616947|NCT02883049|448215944|FG011|Induction|Death|0|||
124616948|NCT02883049|448215945|FG012|Induction|Death|0|||
124616949|NCT02883049|448215946|FG013|Induction|Death|0|||
124616950|NCT02883049|448215947|FG014|Induction|Death|0|||
124616951|NCT02883049|448215948|FG015|Induction|Death|0|||
124616952|NCT02883049|448215933|FG000|Induction|Lost to Follow-up|2|||
124616953|NCT02883049|448215934|FG001|Induction|Lost to Follow-up|0|||
124616954|NCT02883049|448215935|FG002|Induction|Lost to Follow-up|0|||
124616955|NCT02883049|448215936|FG003|Induction|Lost to Follow-up|0|||
124616956|NCT02883049|448215937|FG004|Induction|Lost to Follow-up|0|||
124616957|NCT02883049|448215938|FG005|Induction|Lost to Follow-up|0|||
124616958|NCT02883049|448215939|FG006|Induction|Lost to Follow-up|0|||
124616959|NCT02883049|448215940|FG007|Induction|Lost to Follow-up|0|||
124616960|NCT02883049|448215941|FG008|Induction|Lost to Follow-up|0|||
124616961|NCT02883049|448215942|FG009|Induction|Lost to Follow-up|0|||
124616962|NCT02883049|448215943|FG010|Induction|Lost to Follow-up|0|||
124616963|NCT02883049|448215944|FG011|Induction|Lost to Follow-up|0|||
124616964|NCT02883049|448215945|FG012|Induction|Lost to Follow-up|0|||
124616965|NCT02883049|448215946|FG013|Induction|Lost to Follow-up|0|||
124616966|NCT02883049|448215947|FG014|Induction|Lost to Follow-up|0|||
124616967|NCT02883049|448215948|FG015|Induction|Lost to Follow-up|0|||
124616968|NCT02883049|448215933|FG000|Induction|Physician Decision|1407|||
124616969|NCT02883049|448215934|FG001|Induction|Physician Decision|8|||
124616970|NCT02883049|448215935|FG002|Induction|Physician Decision|0|||
124616971|NCT02883049|448215936|FG003|Induction|Physician Decision|0|||
124616972|NCT02883049|448215937|FG004|Induction|Physician Decision|0|||
124616973|NCT02883049|448215938|FG005|Induction|Physician Decision|0|||
124616974|NCT02883049|448215939|FG006|Induction|Physician Decision|0|||
124616975|NCT02883049|448215940|FG007|Induction|Physician Decision|0|||
124616976|NCT02883049|448215941|FG008|Induction|Physician Decision|0|||
124616977|NCT02883049|448215942|FG009|Induction|Physician Decision|0|||
124616978|NCT02883049|448215943|FG010|Induction|Physician Decision|0|||
124616979|NCT02883049|448215944|FG011|Induction|Physician Decision|0|||
124616980|NCT02883049|448215945|FG012|Induction|Physician Decision|0|||
124782003|NCT01006291|448832729|FG002|Overall Study|Protocol Violation|3|||
124782004|NCT01006291|448832727|FG000|Overall Study|Withdrawal criteria|5|||
124782005|NCT01006291|448832728|FG001|Overall Study|Withdrawal criteria|4|||
124616981|NCT02883049|448215946|FG013|Induction|Physician Decision|0|||
124616982|NCT02883049|448215947|FG014|Induction|Physician Decision|0|||
124616983|NCT02883049|448215948|FG015|Induction|Physician Decision|0|||
124616984|NCT02883049|448215933|FG000|Induction|Protocol Violation|6|||
124616985|NCT02883049|448215934|FG001|Induction|Protocol Violation|0|||
124616986|NCT02883049|448215935|FG002|Induction|Protocol Violation|0|||
124616987|NCT02883049|448215936|FG003|Induction|Protocol Violation|0|||
124616988|NCT02883049|448215937|FG004|Induction|Protocol Violation|0|||
124616989|NCT02883049|448215938|FG005|Induction|Protocol Violation|0|||
124616990|NCT02883049|448215939|FG006|Induction|Protocol Violation|0|||
124616991|NCT02883049|448215940|FG007|Induction|Protocol Violation|0|||
124782006|NCT01006291|448832729|FG002|Overall Study|Withdrawal criteria|4|||
124616992|NCT02883049|448215941|FG008|Induction|Protocol Violation|0|||
124616993|NCT02883049|448215942|FG009|Induction|Protocol Violation|0|||
124616994|NCT02883049|448215943|FG010|Induction|Protocol Violation|0|||
124616995|NCT02883049|448215944|FG011|Induction|Protocol Violation|0|||
124616996|NCT02883049|448215945|FG012|Induction|Protocol Violation|0|||
124616997|NCT02883049|448215946|FG013|Induction|Protocol Violation|0|||
124782007|NCT01006291|448832727|FG000|Overall Study|Other|14|||
124782008|NCT01006291|448832728|FG001|Overall Study|Other|14|||
124782009|NCT01006291|448832729|FG002|Overall Study|Other|17|||
124616998|NCT02883049|448215947|FG014|Induction|Protocol Violation|0|||
124616999|NCT02883049|448215948|FG015|Induction|Protocol Violation|0|||
124617000|NCT02883049|448215933|FG000|Induction|Withdrawal by Subject|6|||
124782010|NCT02102204|448832730|FG000|Overall Study|Withdrawal by Subject|137|||
124782011|NCT02102204|448832730|FG000|Overall Study|Death|92|||
124782012|NCT02102204|448832730|FG000|Overall Study|Lost to Follow-up|65|||
124782013|NCT02102204|448832730|FG000|Overall Study|Sponsor Decision|5|||
124782014|NCT02102204|448832730|FG000|Overall Study|Ongoing|5|||
124782015|NCT01865552|448832731|FG000|Period 1|Adverse Event|1|||
124782016|NCT01865552|448832732|FG001|Period 1|Adverse Event|0|||
124782017|NCT01865552|448832733|FG002|Period 1|Adverse Event|0|||
124782018|NCT01865552|448832734|FG003|Period 1|Adverse Event|1|||
124782019|NCT01865552|448832735|FG004|Period 1|Adverse Event|1|||
124782020|NCT01865552|448832736|FG005|Period 1|Adverse Event|1|||
124782021|NCT01865552|448832731|FG000|Period 1|Pathological lab|0|||
124782022|NCT01865552|448832732|FG001|Period 1|Pathological lab|0|||
124782023|NCT01865552|448832733|FG002|Period 1|Pathological lab|0|||
124617001|NCT02883049|448215934|FG001|Induction|Withdrawal by Subject|0|||
124617002|NCT02883049|448215935|FG002|Induction|Withdrawal by Subject|0|||
124617003|NCT02883049|448215936|FG003|Induction|Withdrawal by Subject|0|||
124617004|NCT02883049|448215937|FG004|Induction|Withdrawal by Subject|0|||
124617005|NCT02883049|448215938|FG005|Induction|Withdrawal by Subject|0|||
124617006|NCT02883049|448215939|FG006|Induction|Withdrawal by Subject|0|||
124617007|NCT02883049|448215940|FG007|Induction|Withdrawal by Subject|0|||
124617008|NCT02883049|448215941|FG008|Induction|Withdrawal by Subject|0|||
124617009|NCT02883049|448215942|FG009|Induction|Withdrawal by Subject|0|||
124617010|NCT02883049|448215943|FG010|Induction|Withdrawal by Subject|0|||
124617011|NCT02883049|448215944|FG011|Induction|Withdrawal by Subject|0|||
124617012|NCT02883049|448215945|FG012|Induction|Withdrawal by Subject|0|||
124617013|NCT02883049|448215946|FG013|Induction|Withdrawal by Subject|0|||
124617014|NCT02883049|448215947|FG014|Induction|Withdrawal by Subject|0|||
124617015|NCT02883049|448215948|FG015|Induction|Withdrawal by Subject|0|||
124617016|NCT02883049|448215933|FG000|Induction|Ineligible|35|||
124617017|NCT02883049|448215934|FG001|Induction|Ineligible|1|||
124617018|NCT02883049|448215935|FG002|Induction|Ineligible|0|||
124617019|NCT02883049|448215936|FG003|Induction|Ineligible|0|||
124617020|NCT02883049|448215937|FG004|Induction|Ineligible|0|||
124617021|NCT02883049|448215938|FG005|Induction|Ineligible|0|||
124617022|NCT02883049|448215939|FG006|Induction|Ineligible|0|||
124617023|NCT02883049|448215940|FG007|Induction|Ineligible|0|||
124617024|NCT02883049|448215941|FG008|Induction|Ineligible|0|||
124617025|NCT02883049|448215942|FG009|Induction|Ineligible|0|||
124617026|NCT02883049|448215943|FG010|Induction|Ineligible|0|||
124617027|NCT02883049|448215944|FG011|Induction|Ineligible|0|||
124617028|NCT02883049|448215945|FG012|Induction|Ineligible|0|||
124617029|NCT02883049|448215946|FG013|Induction|Ineligible|0|||
124617030|NCT02883049|448215947|FG014|Induction|Ineligible|0|||
124617031|NCT02883049|448215948|FG015|Induction|Ineligible|0|||
124617032|NCT02883049|448215933|FG000|Induction|Refusal of further protocol therapy|466|||
124617033|NCT02883049|448215934|FG001|Induction|Refusal of further protocol therapy|2|||
124617034|NCT02883049|448215935|FG002|Induction|Refusal of further protocol therapy|0|||
124617035|NCT02883049|448215936|FG003|Induction|Refusal of further protocol therapy|0|||
124617036|NCT02883049|448215937|FG004|Induction|Refusal of further protocol therapy|0|||
124617037|NCT02883049|448215938|FG005|Induction|Refusal of further protocol therapy|0|||
124617038|NCT02883049|448215939|FG006|Induction|Refusal of further protocol therapy|0|||
124782024|NCT01865552|448832734|FG003|Period 1|Pathological lab|0|||
124782025|NCT01865552|448832735|FG004|Period 1|Pathological lab|1|||
124782026|NCT01865552|448832736|FG005|Period 1|Pathological lab|0|||
124782027|NCT01865552|448832731|FG000|Period 1|Other|0|||
124782028|NCT01865552|448832732|FG001|Period 1|Other|0|||
124617039|NCT02883049|448215940|FG007|Induction|Refusal of further protocol therapy|0|||
124617040|NCT02883049|448215941|FG008|Induction|Refusal of further protocol therapy|0|||
124617041|NCT02883049|448215942|FG009|Induction|Refusal of further protocol therapy|0|||
124617042|NCT02883049|448215943|FG010|Induction|Refusal of further protocol therapy|0|||
124617043|NCT02883049|448215944|FG011|Induction|Refusal of further protocol therapy|0|||
124617044|NCT02883049|448215945|FG012|Induction|Refusal of further protocol therapy|0|||
124617045|NCT02883049|448215946|FG013|Induction|Refusal of further protocol therapy|0|||
124617046|NCT02883049|448215947|FG014|Induction|Refusal of further protocol therapy|0|||
124617047|NCT02883049|448215948|FG015|Induction|Refusal of further protocol therapy|0|||
124617048|NCT02883049|448215933|FG000|Induction|Identified as Ph+ patients|279|||
124782029|NCT01865552|448832733|FG002|Period 1|Other|0|||
124782030|NCT01865552|448832734|FG003|Period 1|Other|0|||
124782031|NCT01865552|448832735|FG004|Period 1|Other|1|||
124617049|NCT02883049|448215934|FG001|Induction|Identified as Ph+ patients|1|||
124617050|NCT02883049|448215935|FG002|Induction|Identified as Ph+ patients|0|||
124782032|NCT01865552|448832736|FG005|Period 1|Other|0|||
124782033|NCT03079102|448832737|FG000|Overall Study|Physician Decision|0|||
124782034|NCT03079102|448832738|FG001|Overall Study|Physician Decision|1|||
124782035|NCT02923921|448832739|FG000|Overall Study|Sponsor Decision|39|||
124782036|NCT02923921|448832740|FG001|Overall Study|Sponsor Decision|38|||
124617051|NCT02883049|448215936|FG003|Induction|Identified as Ph+ patients|0|||
124617052|NCT02883049|448215937|FG004|Induction|Identified as Ph+ patients|0|||
124617053|NCT02883049|448215938|FG005|Induction|Identified as Ph+ patients|0|||
124617054|NCT02883049|448215939|FG006|Induction|Identified as Ph+ patients|0|||
124617055|NCT02883049|448215940|FG007|Induction|Identified as Ph+ patients|0|||
124617056|NCT02883049|448215941|FG008|Induction|Identified as Ph+ patients|0|||
124617057|NCT02883049|448215942|FG009|Induction|Identified as Ph+ patients|0|||
124617058|NCT02883049|448215943|FG010|Induction|Identified as Ph+ patients|0|||
124617059|NCT02883049|448215944|FG011|Induction|Identified as Ph+ patients|0|||
124617060|NCT02883049|448215945|FG012|Induction|Identified as Ph+ patients|0|||
124617061|NCT02883049|448215946|FG013|Induction|Identified as Ph+ patients|0|||
124617062|NCT02883049|448215947|FG014|Induction|Identified as Ph+ patients|0|||
124617063|NCT02883049|448215948|FG015|Induction|Identified as Ph+ patients|0|||
124617064|NCT02883049|448215933|FG000|Induction|M3 Marrow at Day29|8|||
124617065|NCT02883049|448215934|FG001|Induction|M3 Marrow at Day29|1|||
124617066|NCT02883049|448215935|FG002|Induction|M3 Marrow at Day29|0|||
124617067|NCT02883049|448215936|FG003|Induction|M3 Marrow at Day29|0|||
124617068|NCT02883049|448215937|FG004|Induction|M3 Marrow at Day29|0|||
124617069|NCT02883049|448215938|FG005|Induction|M3 Marrow at Day29|0|||
124617070|NCT02883049|448215939|FG006|Induction|M3 Marrow at Day29|0|||
124617071|NCT02883049|448215940|FG007|Induction|M3 Marrow at Day29|0|||
124617072|NCT02883049|448215941|FG008|Induction|M3 Marrow at Day29|0|||
124617073|NCT02883049|448215942|FG009|Induction|M3 Marrow at Day29|0|||
124617074|NCT02883049|448215943|FG010|Induction|M3 Marrow at Day29|0|||
124617075|NCT02883049|448215944|FG011|Induction|M3 Marrow at Day29|0|||
124617076|NCT02883049|448215945|FG012|Induction|M3 Marrow at Day29|0|||
124617077|NCT02883049|448215946|FG013|Induction|M3 Marrow at Day29|0|||
124617078|NCT02883049|448215947|FG014|Induction|M3 Marrow at Day29|0|||
124617079|NCT02883049|448215948|FG015|Induction|M3 Marrow at Day29|0|||
124617080|NCT02883049|448215933|FG000|Induction|Inevaluable|33|||
124617081|NCT02883049|448215934|FG001|Induction|Inevaluable|1|||
124617082|NCT02883049|448215935|FG002|Induction|Inevaluable|0|||
124617083|NCT02883049|448215936|FG003|Induction|Inevaluable|0|||
124617084|NCT02883049|448215937|FG004|Induction|Inevaluable|0|||
124617085|NCT02883049|448215938|FG005|Induction|Inevaluable|0|||
124617086|NCT02883049|448215939|FG006|Induction|Inevaluable|0|||
124617087|NCT02883049|448215940|FG007|Induction|Inevaluable|0|||
124617088|NCT02883049|448215941|FG008|Induction|Inevaluable|0|||
124617089|NCT02883049|448215942|FG009|Induction|Inevaluable|0|||
124617090|NCT02883049|448215943|FG010|Induction|Inevaluable|0|||
124617091|NCT02883049|448215944|FG011|Induction|Inevaluable|0|||
124617092|NCT02883049|448215945|FG012|Induction|Inevaluable|0|||
124617093|NCT02883049|448215946|FG013|Induction|Inevaluable|0|||
124617094|NCT02883049|448215947|FG014|Induction|Inevaluable|0|||
124617095|NCT02883049|448215948|FG015|Induction|Inevaluable|0|||
124617096|NCT02883049|448215933|FG000|Induction|Identified as VHR at end of Induction|244|||
124617097|NCT02883049|448215934|FG001|Induction|Identified as VHR at end of Induction|0|||
124617098|NCT02883049|448215935|FG002|Induction|Identified as VHR at end of Induction|0|||
124617099|NCT02883049|448215936|FG003|Induction|Identified as VHR at end of Induction|0|||
124617100|NCT02883049|448215937|FG004|Induction|Identified as VHR at end of Induction|0|||
124617101|NCT02883049|448215938|FG005|Induction|Identified as VHR at end of Induction|0|||
124617102|NCT02883049|448215939|FG006|Induction|Identified as VHR at end of Induction|0|||
124617103|NCT02883049|448215940|FG007|Induction|Identified as VHR at end of Induction|0|||
124617104|NCT02883049|448215941|FG008|Induction|Identified as VHR at end of Induction|0|||
124617105|NCT02883049|448215942|FG009|Induction|Identified as VHR at end of Induction|0|||
124617106|NCT02883049|448215943|FG010|Induction|Identified as VHR at end of Induction|0|||
124617107|NCT02883049|448215944|FG011|Induction|Identified as VHR at end of Induction|0|||
124617108|NCT02883049|448215945|FG012|Induction|Identified as VHR at end of Induction|0|||
124617109|NCT02883049|448215946|FG013|Induction|Identified as VHR at end of Induction|0|||
124617110|NCT02883049|448215947|FG014|Induction|Identified as VHR at end of Induction|0|||
124617111|NCT02883049|448215948|FG015|Induction|Identified as VHR at end of Induction|0|||
124617112|NCT02883049|448215933|FG000|Induction|Moved to another non-COG institution|3|||
124617113|NCT02883049|448215934|FG001|Induction|Moved to another non-COG institution|0|||
124617114|NCT02883049|448215935|FG002|Induction|Moved to another non-COG institution|0|||
124617115|NCT02883049|448215936|FG003|Induction|Moved to another non-COG institution|0|||
124617116|NCT02883049|448215937|FG004|Induction|Moved to another non-COG institution|0|||
124617117|NCT02883049|448215938|FG005|Induction|Moved to another non-COG institution|0|||
124617118|NCT02883049|448215939|FG006|Induction|Moved to another non-COG institution|0|||
124617119|NCT02883049|448215940|FG007|Induction|Moved to another non-COG institution|0|||
124617120|NCT02883049|448215941|FG008|Induction|Moved to another non-COG institution|0|||
124617121|NCT02883049|448215942|FG009|Induction|Moved to another non-COG institution|0|||
124617122|NCT02883049|448215943|FG010|Induction|Moved to another non-COG institution|0|||
124617123|NCT02883049|448215944|FG011|Induction|Moved to another non-COG institution|0|||
124617124|NCT02883049|448215945|FG012|Induction|Moved to another non-COG institution|0|||
124617125|NCT02883049|448215946|FG013|Induction|Moved to another non-COG institution|0|||
124617126|NCT02883049|448215947|FG014|Induction|Moved to another non-COG institution|0|||
124617127|NCT02883049|448215948|FG015|Induction|Moved to another non-COG institution|0|||
124617128|NCT02883049|448215933|FG000|Induction|Randomization closed|41|||
124617129|NCT02883049|448215934|FG001|Induction|Randomization closed|0|||
124617130|NCT02883049|448215935|FG002|Induction|Randomization closed|0|||
124617131|NCT02883049|448215936|FG003|Induction|Randomization closed|0|||
124617132|NCT02883049|448215937|FG004|Induction|Randomization closed|0|||
124617133|NCT02883049|448215938|FG005|Induction|Randomization closed|0|||
124617134|NCT02883049|448215939|FG006|Induction|Randomization closed|0|||
124617135|NCT02883049|448215940|FG007|Induction|Randomization closed|0|||
124617136|NCT02883049|448215941|FG008|Induction|Randomization closed|0|||
124617137|NCT02883049|448215942|FG009|Induction|Randomization closed|0|||
124617138|NCT02883049|448215943|FG010|Induction|Randomization closed|0|||
124617139|NCT02883049|448215944|FG011|Induction|Randomization closed|0|||
124617140|NCT02883049|448215945|FG012|Induction|Randomization closed|0|||
124617141|NCT02883049|448215946|FG013|Induction|Randomization closed|0|||
124617142|NCT02883049|448215947|FG014|Induction|Randomization closed|0|||
124617143|NCT02883049|448215948|FG015|Induction|Randomization closed|0|||
124617144|NCT02883049|448215933|FG000|Induction|MRD negative|36|||
124617145|NCT02883049|448215934|FG001|Induction|MRD negative|0|||
124617146|NCT02883049|448215935|FG002|Induction|MRD negative|0|||
124617147|NCT02883049|448215936|FG003|Induction|MRD negative|0|||
124617148|NCT02883049|448215937|FG004|Induction|MRD negative|0|||
124617149|NCT02883049|448215938|FG005|Induction|MRD negative|0|||
124617150|NCT02883049|448215939|FG006|Induction|MRD negative|0|||
124617151|NCT02883049|448215940|FG007|Induction|MRD negative|0|||
124617152|NCT02883049|448215941|FG008|Induction|MRD negative|0|||
124617153|NCT02883049|448215942|FG009|Induction|MRD negative|0|||
124617154|NCT02883049|448215943|FG010|Induction|MRD negative|0|||
124617155|NCT02883049|448215944|FG011|Induction|MRD negative|0|||
124617156|NCT02883049|448215945|FG012|Induction|MRD negative|0|||
124617157|NCT02883049|448215946|FG013|Induction|MRD negative|0|||
124617158|NCT02883049|448215947|FG014|Induction|MRD negative|0|||
124617159|NCT02883049|448215948|FG015|Induction|MRD negative|0|||
124617160|NCT02883049|448215933|FG000|Induction|Identified as HR patients|165|||
124617161|NCT02883049|448215934|FG001|Induction|Identified as HR patients|0|||
124617162|NCT02883049|448215935|FG002|Induction|Identified as HR patients|0|||
124617163|NCT02883049|448215936|FG003|Induction|Identified as HR patients|0|||
124617164|NCT02883049|448215937|FG004|Induction|Identified as HR patients|0|||
124617165|NCT02883049|448215938|FG005|Induction|Identified as HR patients|0|||
124617166|NCT02883049|448215939|FG006|Induction|Identified as HR patients|0|||
124617167|NCT02883049|448215940|FG007|Induction|Identified as HR patients|0|||
124617168|NCT02883049|448215941|FG008|Induction|Identified as HR patients|0|||
124617169|NCT02883049|448215942|FG009|Induction|Identified as HR patients|0|||
124617170|NCT02883049|448215943|FG010|Induction|Identified as HR patients|0|||
124617171|NCT02883049|448215944|FG011|Induction|Identified as HR patients|0|||
124617172|NCT02883049|448215945|FG012|Induction|Identified as HR patients|0|||
124617173|NCT02883049|448215946|FG013|Induction|Identified as HR patients|0|||
124617174|NCT02883049|448215947|FG014|Induction|Identified as HR patients|0|||
124617175|NCT02883049|448215948|FG015|Induction|Identified as HR patients|0|||
124617176|NCT02883049|448215933|FG000|Induction|Developed SMN|0|||
124617177|NCT02883049|448215934|FG001|Induction|Developed SMN|1|||
124617178|NCT02883049|448215935|FG002|Induction|Developed SMN|0|||
124617179|NCT02883049|448215936|FG003|Induction|Developed SMN|0|||
124782037|NCT02923921|448832739|FG000|Overall Study|Lost to Follow-up|1|||
124617180|NCT02883049|448215937|FG004|Induction|Developed SMN|0|||
124617181|NCT02883049|448215938|FG005|Induction|Developed SMN|0|||
124617182|NCT02883049|448215939|FG006|Induction|Developed SMN|0|||
124617183|NCT02883049|448215940|FG007|Induction|Developed SMN|0|||
124617184|NCT02883049|448215941|FG008|Induction|Developed SMN|0|||
124617185|NCT02883049|448215942|FG009|Induction|Developed SMN|0|||
124617186|NCT02883049|448215943|FG010|Induction|Developed SMN|0|||
124617187|NCT02883049|448215944|FG011|Induction|Developed SMN|0|||
124617188|NCT02883049|448215945|FG012|Induction|Developed SMN|0|||
124617189|NCT02883049|448215946|FG013|Induction|Developed SMN|0|||
124617190|NCT02883049|448215947|FG014|Induction|Developed SMN|0|||
124617191|NCT02883049|448215948|FG015|Induction|Developed SMN|0|||
124617192|NCT02883049|448215933|FG000|Induction|Enrolled onto another COG study|72|||
124617193|NCT02883049|448215934|FG001|Induction|Enrolled onto another COG study|0|||
124617194|NCT02883049|448215935|FG002|Induction|Enrolled onto another COG study|0|||
124617195|NCT02883049|448215936|FG003|Induction|Enrolled onto another COG study|0|||
124617196|NCT02883049|448215937|FG004|Induction|Enrolled onto another COG study|0|||
124617197|NCT02883049|448215938|FG005|Induction|Enrolled onto another COG study|0|||
124617198|NCT02883049|448215939|FG006|Induction|Enrolled onto another COG study|0|||
124617199|NCT02883049|448215940|FG007|Induction|Enrolled onto another COG study|0|||
124617200|NCT02883049|448215941|FG008|Induction|Enrolled onto another COG study|0|||
124617201|NCT02883049|448215942|FG009|Induction|Enrolled onto another COG study|0|||
124617202|NCT02883049|448215943|FG010|Induction|Enrolled onto another COG study|0|||
124617203|NCT02883049|448215944|FG011|Induction|Enrolled onto another COG study|0|||
124617204|NCT02883049|448215945|FG012|Induction|Enrolled onto another COG study|0|||
124617205|NCT02883049|448215946|FG013|Induction|Enrolled onto another COG study|0|||
124617206|NCT02883049|448215947|FG014|Induction|Enrolled onto another COG study|0|||
124617207|NCT02883049|448215948|FG015|Induction|Enrolled onto another COG study|0|||
124617208|NCT02883049|448215933|FG000|Induction|Incomplete induction data|17|||
124617209|NCT02883049|448215934|FG001|Induction|Incomplete induction data|0|||
124617210|NCT02883049|448215935|FG002|Induction|Incomplete induction data|0|||
124617211|NCT02883049|448215936|FG003|Induction|Incomplete induction data|0|||
124617212|NCT02883049|448215937|FG004|Induction|Incomplete induction data|0|||
124617213|NCT02883049|448215938|FG005|Induction|Incomplete induction data|0|||
124617214|NCT02883049|448215939|FG006|Induction|Incomplete induction data|0|||
124617215|NCT02883049|448215940|FG007|Induction|Incomplete induction data|0|||
124617216|NCT02883049|448215941|FG008|Induction|Incomplete induction data|0|||
124617217|NCT02883049|448215942|FG009|Induction|Incomplete induction data|0|||
124617218|NCT02883049|448215943|FG010|Induction|Incomplete induction data|0|||
124617219|NCT02883049|448215944|FG011|Induction|Incomplete induction data|0|||
124617220|NCT02883049|448215945|FG012|Induction|Incomplete induction data|0|||
124617221|NCT02883049|448215946|FG013|Induction|Incomplete induction data|0|||
124617222|NCT02883049|448215947|FG014|Induction|Incomplete induction data|0|||
124617223|NCT02883049|448215948|FG015|Induction|Incomplete induction data|0|||
124617224|NCT02883049|448215933|FG000|Post Induction|Adverse Event|0|||
124617225|NCT02883049|448215934|FG001|Post Induction|Adverse Event|0|||
124617226|NCT02883049|448215935|FG002|Post Induction|Adverse Event|0|||
124617227|NCT02883049|448215936|FG003|Post Induction|Adverse Event|7|||
124617228|NCT02883049|448215937|FG004|Post Induction|Adverse Event|8|||
124617229|NCT02883049|448215938|FG005|Post Induction|Adverse Event|3|||
124617230|NCT02883049|448215939|FG006|Post Induction|Adverse Event|4|||
124617231|NCT02883049|448215940|FG007|Post Induction|Adverse Event|5|||
124617232|NCT02883049|448215941|FG008|Post Induction|Adverse Event|6|||
124617233|NCT02883049|448215942|FG009|Post Induction|Adverse Event|7|||
124617234|NCT02883049|448215943|FG010|Post Induction|Adverse Event|2|||
124617235|NCT02883049|448215944|FG011|Post Induction|Adverse Event|2|||
124617236|NCT02883049|448215945|FG012|Post Induction|Adverse Event|0|||
124617237|NCT02883049|448215946|FG013|Post Induction|Adverse Event|0|||
124617238|NCT02883049|448215947|FG014|Post Induction|Adverse Event|5|||
124617239|NCT02883049|448215948|FG015|Post Induction|Adverse Event|2|||
124617240|NCT02883049|448215933|FG000|Post Induction|Death|0|||
124617241|NCT02883049|448215934|FG001|Post Induction|Death|0|||
124617242|NCT02883049|448215935|FG002|Post Induction|Death|0|||
124617243|NCT02883049|448215936|FG003|Post Induction|Death|9|||
124617244|NCT02883049|448215937|FG004|Post Induction|Death|9|||
124617245|NCT02883049|448215938|FG005|Post Induction|Death|0|||
124617246|NCT02883049|448215939|FG006|Post Induction|Death|1|||
124617247|NCT02883049|448215940|FG007|Post Induction|Death|6|||
124617248|NCT02883049|448215941|FG008|Post Induction|Death|5|||
124617249|NCT02883049|448215942|FG009|Post Induction|Death|3|||
124617250|NCT02883049|448215943|FG010|Post Induction|Death|1|||
124617251|NCT02883049|448215944|FG011|Post Induction|Death|0|||
124617252|NCT02883049|448215945|FG012|Post Induction|Death|1|||
124617253|NCT02883049|448215946|FG013|Post Induction|Death|1|||
124617254|NCT02883049|448215947|FG014|Post Induction|Death|10|||
124617255|NCT02883049|448215948|FG015|Post Induction|Death|2|||
124617256|NCT02883049|448215933|FG000|Post Induction|Lost to Follow-up|0|||
124617257|NCT02883049|448215934|FG001|Post Induction|Lost to Follow-up|0|||
124617258|NCT02883049|448215935|FG002|Post Induction|Lost to Follow-up|0|||
124617259|NCT02883049|448215936|FG003|Post Induction|Lost to Follow-up|0|||
124617260|NCT02883049|448215937|FG004|Post Induction|Lost to Follow-up|1|||
124617261|NCT02883049|448215938|FG005|Post Induction|Lost to Follow-up|1|||
124617262|NCT02883049|448215939|FG006|Post Induction|Lost to Follow-up|0|||
124617263|NCT02883049|448215940|FG007|Post Induction|Lost to Follow-up|0|||
124617264|NCT02883049|448215941|FG008|Post Induction|Lost to Follow-up|3|||
124617265|NCT02883049|448215942|FG009|Post Induction|Lost to Follow-up|0|||
124617266|NCT02883049|448215943|FG010|Post Induction|Lost to Follow-up|1|||
124617267|NCT02883049|448215944|FG011|Post Induction|Lost to Follow-up|0|||
124617268|NCT02883049|448215945|FG012|Post Induction|Lost to Follow-up|0|||
124617269|NCT02883049|448215946|FG013|Post Induction|Lost to Follow-up|0|||
124617270|NCT02883049|448215947|FG014|Post Induction|Lost to Follow-up|0|||
124782038|NCT02923921|448832740|FG001|Overall Study|Lost to Follow-up|0|||
124617271|NCT02883049|448215948|FG015|Post Induction|Lost to Follow-up|0|||
124617272|NCT02883049|448215933|FG000|Post Induction|Physician Decision|0|||
124617273|NCT02883049|448215934|FG001|Post Induction|Physician Decision|0|||
124617274|NCT02883049|448215935|FG002|Post Induction|Physician Decision|0|||
124617275|NCT02883049|448215936|FG003|Post Induction|Physician Decision|27|||
124617276|NCT02883049|448215937|FG004|Post Induction|Physician Decision|27|||
124617277|NCT02883049|448215938|FG005|Post Induction|Physician Decision|23|||
124617278|NCT02883049|448215939|FG006|Post Induction|Physician Decision|30|||
124617279|NCT02883049|448215940|FG007|Post Induction|Physician Decision|56|||
124617280|NCT02883049|448215941|FG008|Post Induction|Physician Decision|85|||
124617281|NCT02883049|448215942|FG009|Post Induction|Physician Decision|12|||
124617282|NCT02883049|448215943|FG010|Post Induction|Physician Decision|5|||
124617283|NCT02883049|448215944|FG011|Post Induction|Physician Decision|14|||
124617284|NCT02883049|448215945|FG012|Post Induction|Physician Decision|1|||
124617285|NCT02883049|448215946|FG013|Post Induction|Physician Decision|11|||
124782039|NCT02923921|448832739|FG000|Overall Study|Withdrawal by Subject|6|||
124782040|NCT02923921|448832740|FG001|Overall Study|Withdrawal by Subject|13|||
124782041|NCT02923921|448832739|FG000|Overall Study|Unknown, Not Collected|7|||
124782042|NCT02923921|448832740|FG001|Overall Study|Unknown, Not Collected|6|||
124782043|NCT00479687|448832741|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
124782044|NCT00479687|448832742|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
124782045|NCT00479687|448832743|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
124782046|NCT00479687|448832741|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
124782047|NCT00479687|448832742|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
124782048|NCT00479687|448832743|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
124782049|NCT00479687|448832741|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
124782050|NCT00479687|448832742|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
124782051|NCT00479687|448832743|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
124782052|NCT00479687|448832741|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
124782053|NCT00479687|448832742|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
124782054|NCT00479687|448832743|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
124782055|NCT00479687|448832741|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
124782056|NCT00479687|448832742|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
124782057|NCT00479687|448832743|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
124782058|NCT00479687|448832741|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
124782059|NCT00479687|448832742|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
124782060|NCT00479687|448832743|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
124782061|NCT00479687|448832741|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
124782062|NCT00479687|448832742|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
124782063|NCT00479687|448832743|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
124782064|NCT00479687|448832741|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
124782065|NCT00479687|448832742|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
124782066|NCT00479687|448832743|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
124782067|NCT00479687|448832741|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
124782068|NCT00479687|448832742|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
124782069|NCT00479687|448832743|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
124782070|NCT01474239|448832744|FG000|Overall Study|Disease Progression|37|||
124782071|NCT01474239|448832745|FG001|Overall Study|Disease Progression|25|||
124782072|NCT01474239|448832744|FG000|Overall Study|Adverse Event|12|||
124782073|NCT01474239|448832745|FG001|Overall Study|Adverse Event|3|||
124782074|NCT01474239|448832744|FG000|Overall Study|Withdrawal by Subject|1|||
124782075|NCT01474239|448832745|FG001|Overall Study|Withdrawal by Subject|2|||
124782076|NCT01474239|448832744|FG000|Overall Study|Death|1|||
124782077|NCT01474239|448832745|FG001|Overall Study|Death|1|||
124782078|NCT01474239|448832744|FG000|Overall Study|Clinical Disease Progression|7|||
124782079|NCT01474239|448832745|FG001|Overall Study|Clinical Disease Progression|1|||
124782080|NCT01474239|448832744|FG000|Overall Study|Withdrawal for Economic Reason|1|||
124782081|NCT01474239|448832745|FG001|Overall Study|Withdrawal for Economic Reason|0|||
124782082|NCT02175199|448832748|FG000|Overall Study|Withdrawal by Subject|1|||
124782083|NCT02175199|448832749|FG001|Overall Study|Withdrawal by Subject|5|||
124782084|NCT02175199|448832748|FG000|Overall Study|Randomized in Error|1|||
124782085|NCT02175199|448832749|FG001|Overall Study|Randomized in Error|0|||
124782086|NCT02175199|448832748|FG000|Overall Study|Sponsor Decision|1|||
124782087|NCT02175199|448832749|FG001|Overall Study|Sponsor Decision|0|||
124782088|NCT03983317|448832754|FG000|Overall Study|Physician Decision|5|||
124782089|NCT01349049|448832755|FG000|Overall Study|Disease progression|3|||
124782090|NCT01349049|448832756|FG001|Overall Study|Disease progression|5|||
124782091|NCT01349049|448832757|FG002|Overall Study|Disease progression|3|||
124782092|NCT01349049|448832758|FG003|Overall Study|Disease progression|2|||
124782093|NCT01349049|448832759|FG004|Overall Study|Disease progression|2|||
124782094|NCT01349049|448832760|FG005|Overall Study|Disease progression|2|||
124782095|NCT01349049|448832761|FG006|Overall Study|Disease progression|3|||
124782096|NCT01349049|448832762|FG007|Overall Study|Disease progression|2|||
124782097|NCT01349049|448832763|FG008|Overall Study|Disease progression|33|||
124782098|NCT01349049|448832755|FG000|Overall Study|Adverse Event|0|||
124782099|NCT01349049|448832756|FG001|Overall Study|Adverse Event|1|||
124782100|NCT01349049|448832757|FG002|Overall Study|Adverse Event|0|||
124782101|NCT01349049|448832758|FG003|Overall Study|Adverse Event|0|||
124782102|NCT01349049|448832759|FG004|Overall Study|Adverse Event|0|||
124782103|NCT01349049|448832760|FG005|Overall Study|Adverse Event|3|||
124782104|NCT01349049|448832761|FG006|Overall Study|Adverse Event|1|||
124782105|NCT01349049|448832762|FG007|Overall Study|Adverse Event|0|||
124782106|NCT01349049|448832763|FG008|Overall Study|Adverse Event|4|||
124782107|NCT01349049|448832755|FG000|Overall Study|Physician Decision|0|||
124782108|NCT01349049|448832756|FG001|Overall Study|Physician Decision|1|||
124782109|NCT01349049|448832757|FG002|Overall Study|Physician Decision|0|||
124782110|NCT01349049|448832758|FG003|Overall Study|Physician Decision|0|||
124782111|NCT01349049|448832759|FG004|Overall Study|Physician Decision|0|||
124617286|NCT02883049|448215947|FG014|Post Induction|Physician Decision|19|||
124782112|NCT01349049|448832760|FG005|Overall Study|Physician Decision|0|||
124617287|NCT02883049|448215948|FG015|Post Induction|Physician Decision|5|||
124617288|NCT02883049|448215933|FG000|Post Induction|Protocol Violation|0|||
124617289|NCT02883049|448215934|FG001|Post Induction|Protocol Violation|0|||
124617290|NCT02883049|448215935|FG002|Post Induction|Protocol Violation|0|||
124617291|NCT02883049|448215936|FG003|Post Induction|Protocol Violation|0|||
124617292|NCT02883049|448215937|FG004|Post Induction|Protocol Violation|0|||
124617293|NCT02883049|448215938|FG005|Post Induction|Protocol Violation|0|||
124617294|NCT02883049|448215939|FG006|Post Induction|Protocol Violation|0|||
124617295|NCT02883049|448215940|FG007|Post Induction|Protocol Violation|1|||
124617296|NCT02883049|448215941|FG008|Post Induction|Protocol Violation|0|||
124617297|NCT02883049|448215942|FG009|Post Induction|Protocol Violation|0|||
124617298|NCT02883049|448215943|FG010|Post Induction|Protocol Violation|0|||
124617299|NCT02883049|448215944|FG011|Post Induction|Protocol Violation|0|||
124617300|NCT02883049|448215945|FG012|Post Induction|Protocol Violation|0|||
124617301|NCT02883049|448215946|FG013|Post Induction|Protocol Violation|0|||
124617302|NCT02883049|448215947|FG014|Post Induction|Protocol Violation|0|||
124617303|NCT02883049|448215948|FG015|Post Induction|Protocol Violation|0|||
124617304|NCT02883049|448215933|FG000|Post Induction|Withdrawal by Subject|0|||
124617305|NCT02883049|448215934|FG001|Post Induction|Withdrawal by Subject|0|||
124617306|NCT02883049|448215935|FG002|Post Induction|Withdrawal by Subject|0|||
124617307|NCT02883049|448215936|FG003|Post Induction|Withdrawal by Subject|5|||
124617308|NCT02883049|448215937|FG004|Post Induction|Withdrawal by Subject|2|||
124617309|NCT02883049|448215938|FG005|Post Induction|Withdrawal by Subject|1|||
124617310|NCT02883049|448215939|FG006|Post Induction|Withdrawal by Subject|0|||
124617311|NCT02883049|448215940|FG007|Post Induction|Withdrawal by Subject|0|||
124617312|NCT02883049|448215941|FG008|Post Induction|Withdrawal by Subject|2|||
124617313|NCT02883049|448215942|FG009|Post Induction|Withdrawal by Subject|0|||
124617314|NCT02883049|448215943|FG010|Post Induction|Withdrawal by Subject|1|||
124617315|NCT02883049|448215944|FG011|Post Induction|Withdrawal by Subject|1|||
124617316|NCT02883049|448215945|FG012|Post Induction|Withdrawal by Subject|0|||
124617317|NCT02883049|448215946|FG013|Post Induction|Withdrawal by Subject|0|||
124744300|NCT00129961|448684886|FG000|Overall Study|Physician Decision|1|||
124744301|NCT00129961|448684887|FG001|Overall Study|Physician Decision|0|||
124744302|NCT00129961|448684886|FG000|Overall Study|Withdrawal by Subject|2|||
124744303|NCT00129961|448684887|FG001|Overall Study|Withdrawal by Subject|1|||
124744304|NCT00129961|448684886|FG000|Overall Study|Missing Record|0|||
124744305|NCT00129961|448684887|FG001|Overall Study|Missing Record|1|||
124744306|NCT03178669|448684888|FG000|Overall Study|Adverse Event|4|||
124744307|NCT03178669|448684889|FG001|Overall Study|Adverse Event|1|||
124744308|NCT03178669|448684890|FG002|Overall Study|Adverse Event|4|||
124744309|NCT03178669|448684891|FG003|Overall Study|Adverse Event|2|||
124744310|NCT03178669|448684892|FG004|Overall Study|Adverse Event|2|||
124744311|NCT03178669|448684888|FG000|Overall Study|Lack of Efficacy|0|||
124744312|NCT03178669|448684889|FG001|Overall Study|Lack of Efficacy|0|||
124744313|NCT03178669|448684890|FG002|Overall Study|Lack of Efficacy|2|||
124744314|NCT03178669|448684891|FG003|Overall Study|Lack of Efficacy|0|||
124744315|NCT03178669|448684892|FG004|Overall Study|Lack of Efficacy|1|||
124744316|NCT03178669|448684888|FG000|Overall Study|Physician Decision|0|||
124744317|NCT03178669|448684889|FG001|Overall Study|Physician Decision|0|||
124744318|NCT03178669|448684890|FG002|Overall Study|Physician Decision|0|||
124744319|NCT03178669|448684891|FG003|Overall Study|Physician Decision|0|||
124744320|NCT03178669|448684892|FG004|Overall Study|Physician Decision|1|||
124744321|NCT03178669|448684888|FG000|Overall Study|Withdrawal by Subject|1|||
124744322|NCT03178669|448684889|FG001|Overall Study|Withdrawal by Subject|0|||
124744323|NCT03178669|448684890|FG002|Overall Study|Withdrawal by Subject|1|||
124744324|NCT03178669|448684891|FG003|Overall Study|Withdrawal by Subject|1|||
124744325|NCT03178669|448684892|FG004|Overall Study|Withdrawal by Subject|0|||
124744326|NCT03178669|448684888|FG000|Overall Study|Lost to Follow-up|0|||
124744327|NCT03178669|448684889|FG001|Overall Study|Lost to Follow-up|0|||
124744328|NCT03178669|448684890|FG002|Overall Study|Lost to Follow-up|0|||
124744329|NCT03178669|448684891|FG003|Overall Study|Lost to Follow-up|1|||
124744330|NCT03178669|448684892|FG004|Overall Study|Lost to Follow-up|0|||
124744331|NCT01600092|448684893|FG000|Overall Study|Adverse Event|2|||
124617318|NCT02883049|448215947|FG014|Post Induction|Withdrawal by Subject|1|||
124617319|NCT02883049|448215948|FG015|Post Induction|Withdrawal by Subject|0|||
124744332|NCT01600092|448684894|FG001|Overall Study|Adverse Event|0|||
124744333|NCT01600092|448684893|FG000|Overall Study|Lost to Follow-up|4|||
124744334|NCT01600092|448684894|FG001|Overall Study|Lost to Follow-up|6|||
124744335|NCT01600092|448684893|FG000|Overall Study|Withdrawal by parent/guardian|8|||
124617320|NCT02883049|448215933|FG000|Post Induction|Ineligible|0|||
124617321|NCT02883049|448215934|FG001|Post Induction|Ineligible|0|||
124617322|NCT02883049|448215935|FG002|Post Induction|Ineligible|2|||
124617323|NCT02883049|448215936|FG003|Post Induction|Ineligible|0|||
124617324|NCT02883049|448215937|FG004|Post Induction|Ineligible|0|||
124744336|NCT01600092|448684894|FG001|Overall Study|Withdrawal by parent/guardian|6|||
124744337|NCT01600092|448684893|FG000|Overall Study|Physician Decision|1|||
124744338|NCT01600092|448684894|FG001|Overall Study|Physician Decision|1|||
124744339|NCT01600092|448684893|FG000|Overall Study|Randomized but not vaccinated|3|||
124744340|NCT01600092|448684894|FG001|Overall Study|Randomized but not vaccinated|3|||
124782113|NCT01349049|448832761|FG006|Overall Study|Physician Decision|0|||
124782114|NCT01349049|448832762|FG007|Overall Study|Physician Decision|0|||
124782115|NCT01349049|448832763|FG008|Overall Study|Physician Decision|2|||
124782116|NCT01349049|448832755|FG000|Overall Study|Protocol Violation|0|||
124782117|NCT01349049|448832756|FG001|Overall Study|Protocol Violation|0|||
124782118|NCT01349049|448832757|FG002|Overall Study|Protocol Violation|0|||
124782119|NCT01349049|448832758|FG003|Overall Study|Protocol Violation|0|||
124782120|NCT01349049|448832759|FG004|Overall Study|Protocol Violation|0|||
124782121|NCT01349049|448832760|FG005|Overall Study|Protocol Violation|0|||
124782122|NCT01349049|448832761|FG006|Overall Study|Protocol Violation|0|||
124782123|NCT01349049|448832762|FG007|Overall Study|Protocol Violation|0|||
124782124|NCT01349049|448832763|FG008|Overall Study|Protocol Violation|1|||
124782125|NCT01349049|448832755|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
124617325|NCT02883049|448215938|FG005|Post Induction|Ineligible|0|||
124617326|NCT02883049|448215939|FG006|Post Induction|Ineligible|1|||
124617327|NCT02883049|448215940|FG007|Post Induction|Ineligible|0|||
124617328|NCT02883049|448215941|FG008|Post Induction|Ineligible|0|||
124617329|NCT02883049|448215942|FG009|Post Induction|Ineligible|0|||
124617330|NCT02883049|448215943|FG010|Post Induction|Ineligible|1|||
124617331|NCT02883049|448215944|FG011|Post Induction|Ineligible|0|||
124617332|NCT02883049|448215945|FG012|Post Induction|Ineligible|0|||
124617333|NCT02883049|448215946|FG013|Post Induction|Ineligible|0|||
124617334|NCT02883049|448215947|FG014|Post Induction|Ineligible|0|||
124617335|NCT02883049|448215948|FG015|Post Induction|Ineligible|1|||
124617336|NCT02883049|448215933|FG000|Post Induction|Refusal of further protocol therapy|0|||
124617337|NCT02883049|448215934|FG001|Post Induction|Refusal of further protocol therapy|0|||
124617338|NCT02883049|448215935|FG002|Post Induction|Refusal of further protocol therapy|0|||
124617339|NCT02883049|448215936|FG003|Post Induction|Refusal of further protocol therapy|11|||
124617340|NCT02883049|448215937|FG004|Post Induction|Refusal of further protocol therapy|15|||
124617341|NCT02883049|448215938|FG005|Post Induction|Refusal of further protocol therapy|9|||
124617342|NCT02883049|448215939|FG006|Post Induction|Refusal of further protocol therapy|13|||
124617343|NCT02883049|448215940|FG007|Post Induction|Refusal of further protocol therapy|5|||
124617344|NCT02883049|448215941|FG008|Post Induction|Refusal of further protocol therapy|21|||
124617345|NCT02883049|448215942|FG009|Post Induction|Refusal of further protocol therapy|7|||
124617346|NCT02883049|448215943|FG010|Post Induction|Refusal of further protocol therapy|0|||
124617347|NCT02883049|448215944|FG011|Post Induction|Refusal of further protocol therapy|7|||
124617348|NCT02883049|448215945|FG012|Post Induction|Refusal of further protocol therapy|3|||
124617349|NCT02883049|448215946|FG013|Post Induction|Refusal of further protocol therapy|0|||
124617350|NCT02883049|448215947|FG014|Post Induction|Refusal of further protocol therapy|4|||
124617351|NCT02883049|448215948|FG015|Post Induction|Refusal of further protocol therapy|1|||
124617352|NCT02883049|448215933|FG000|Post Induction|Inevaluable|0|||
124617353|NCT02883049|448215934|FG001|Post Induction|Inevaluable|0|||
124617354|NCT02883049|448215935|FG002|Post Induction|Inevaluable|0|||
124617355|NCT02883049|448215936|FG003|Post Induction|Inevaluable|1|||
124617356|NCT02883049|448215937|FG004|Post Induction|Inevaluable|1|||
124617357|NCT02883049|448215938|FG005|Post Induction|Inevaluable|2|||
124617358|NCT02883049|448215939|FG006|Post Induction|Inevaluable|7|||
124617359|NCT02883049|448215940|FG007|Post Induction|Inevaluable|6|||
124617360|NCT02883049|448215941|FG008|Post Induction|Inevaluable|4|||
124617361|NCT02883049|448215942|FG009|Post Induction|Inevaluable|4|||
124617362|NCT02883049|448215943|FG010|Post Induction|Inevaluable|1|||
124617363|NCT02883049|448215944|FG011|Post Induction|Inevaluable|1|||
124617364|NCT02883049|448215945|FG012|Post Induction|Inevaluable|2|||
124617365|NCT02883049|448215946|FG013|Post Induction|Inevaluable|0|||
124617366|NCT02883049|448215947|FG014|Post Induction|Inevaluable|0|||
124617367|NCT02883049|448215948|FG015|Post Induction|Inevaluable|1|||
124617368|NCT02883049|448215933|FG000|Post Induction|Moved to another non-COG institution|0|||
124617369|NCT02883049|448215934|FG001|Post Induction|Moved to another non-COG institution|0|||
124617370|NCT02883049|448215935|FG002|Post Induction|Moved to another non-COG institution|0|||
124617371|NCT02883049|448215936|FG003|Post Induction|Moved to another non-COG institution|0|||
124617372|NCT02883049|448215937|FG004|Post Induction|Moved to another non-COG institution|0|||
124782126|NCT01349049|448832756|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
124782127|NCT01349049|448832757|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
124617373|NCT02883049|448215938|FG005|Post Induction|Moved to another non-COG institution|0|||
124782128|NCT01349049|448832758|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
124782129|NCT01349049|448832759|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
124782130|NCT01349049|448832760|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
124782131|NCT01349049|448832761|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
124782132|NCT01349049|448832762|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
124617374|NCT02883049|448215939|FG006|Post Induction|Moved to another non-COG institution|0|||
124617375|NCT02883049|448215940|FG007|Post Induction|Moved to another non-COG institution|2|||
124617376|NCT02883049|448215941|FG008|Post Induction|Moved to another non-COG institution|2|||
124617377|NCT02883049|448215942|FG009|Post Induction|Moved to another non-COG institution|0|||
124617378|NCT02883049|448215943|FG010|Post Induction|Moved to another non-COG institution|0|||
124617379|NCT02883049|448215944|FG011|Post Induction|Moved to another non-COG institution|1|||
124617380|NCT02883049|448215945|FG012|Post Induction|Moved to another non-COG institution|0|||
124617381|NCT02883049|448215946|FG013|Post Induction|Moved to another non-COG institution|0|||
124617382|NCT02883049|448215947|FG014|Post Induction|Moved to another non-COG institution|0|||
124617383|NCT02883049|448215948|FG015|Post Induction|Moved to another non-COG institution|0|||
124617384|NCT02883049|448215933|FG000|Post Induction|Randomization closed|0|||
124617385|NCT02883049|448215934|FG001|Post Induction|Randomization closed|0|||
124617386|NCT02883049|448215935|FG002|Post Induction|Randomization closed|0|||
124617387|NCT02883049|448215936|FG003|Post Induction|Randomization closed|0|||
124617388|NCT02883049|448215937|FG004|Post Induction|Randomization closed|0|||
124617389|NCT02883049|448215938|FG005|Post Induction|Randomization closed|0|||
124617390|NCT02883049|448215939|FG006|Post Induction|Randomization closed|0|||
124617391|NCT02883049|448215940|FG007|Post Induction|Randomization closed|20|||
124617392|NCT02883049|448215941|FG008|Post Induction|Randomization closed|0|||
124617393|NCT02883049|448215942|FG009|Post Induction|Randomization closed|0|||
124617394|NCT02883049|448215943|FG010|Post Induction|Randomization closed|0|||
124617395|NCT02883049|448215944|FG011|Post Induction|Randomization closed|0|||
124617396|NCT02883049|448215945|FG012|Post Induction|Randomization closed|0|||
124617397|NCT02883049|448215946|FG013|Post Induction|Randomization closed|0|||
124617398|NCT02883049|448215947|FG014|Post Induction|Randomization closed|0|||
124617399|NCT02883049|448215948|FG015|Post Induction|Randomization closed|0|||
124617400|NCT02883049|448215933|FG000|Post Induction|MRD negative|0|||
124744341|NCT00079677|448684895|FG000|Overall Study|Adverse Event|5|||
124744342|NCT00079677|448684896|FG001|Overall Study|Adverse Event|6|||
124744343|NCT00079677|448684895|FG000|Overall Study|Lack of Efficacy|1|||
124744344|NCT00079677|448684896|FG001|Overall Study|Lack of Efficacy|0|||
124744345|NCT00079677|448684895|FG000|Overall Study|Lost to Follow-up|2|||
124744346|NCT00079677|448684896|FG001|Overall Study|Lost to Follow-up|2|||
124744347|NCT00079677|448684895|FG000|Overall Study|Physician Decision|3|||
124744348|NCT00079677|448684896|FG001|Overall Study|Physician Decision|0|||
124744349|NCT00079677|448684895|FG000|Overall Study|Protocol Violation|2|||
124744350|NCT00079677|448684896|FG001|Overall Study|Protocol Violation|3|||
124744351|NCT00079677|448684895|FG000|Overall Study|Withdrawal by Subject|5|||
124744352|NCT00079677|448684896|FG001|Overall Study|Withdrawal by Subject|3|||
124744353|NCT00079677|448684895|FG000|Overall Study|Miscellaneous|2|||
124744354|NCT00079677|448684896|FG001|Overall Study|Miscellaneous|0|||
124744355|NCT00565136|448684897|FG000|Overall Study|Lost to Follow-up|1|||
124744356|NCT00565136|448684897|FG000|Overall Study|Withdrawal by Subject|1|||
124744357|NCT00565136|448684897|FG000|Overall Study|Protocol Violation|1|||
124744358|NCT04284774|448684899|FG000|Overall Study|Progressive disease|5|||
124744359|NCT01270256|448684900|FG000|Overall Study|Withdrawal by Subject|1|||
124744360|NCT01270256|448684901|FG001|Overall Study|Withdrawal by Subject|0|||
124744361|NCT02879578|448684902|FG000|Overall Study|Adverse Event|1|||
124744362|NCT02879578|448684903|FG001|Overall Study|Adverse Event|2|||
124744363|NCT02879578|448684904|FG002|Overall Study|Adverse Event|14|||
124744364|NCT02879578|448684902|FG000|Overall Study|Protocol Violation|0|||
124744365|NCT02879578|448684903|FG001|Overall Study|Protocol Violation|1|||
124744366|NCT02879578|448684904|FG002|Overall Study|Protocol Violation|1|||
124744367|NCT02879578|448684902|FG000|Overall Study|Withdrawal by Subject|8|||
124744368|NCT02879578|448684903|FG001|Overall Study|Withdrawal by Subject|6|||
124744369|NCT02879578|448684904|FG002|Overall Study|Withdrawal by Subject|9|||
124744370|NCT02879578|448684902|FG000|Overall Study|Lost to Follow-up|1|||
124744371|NCT02879578|448684903|FG001|Overall Study|Lost to Follow-up|0|||
124744372|NCT02879578|448684904|FG002|Overall Study|Lost to Follow-up|4|||
124744373|NCT02879578|448684902|FG000|Overall Study|Physician Decision|0|||
124744374|NCT02879578|448684903|FG001|Overall Study|Physician Decision|0|||
124744375|NCT02879578|448684904|FG002|Overall Study|Physician Decision|4|||
124744376|NCT02925728|448684910|FG000|Overall Study|Death|3|||
124744377|NCT02925728|448684911|FG001|Overall Study|Death|5|||
124744378|NCT02925728|448684910|FG000|Overall Study|Physician Decision|1|||
124744379|NCT02925728|448684911|FG001|Overall Study|Physician Decision|0|||
124744380|NCT02925728|448684910|FG000|Overall Study|Withdrawal by Subject|1|||
124744381|NCT02925728|448684911|FG001|Overall Study|Withdrawal by Subject|0|||
124744382|NCT05098509|448684912|FG000|Overall Study|Withdrawal by Subject|0|||
124744383|NCT05098509|448684913|FG001|Overall Study|Withdrawal by Subject|0|||
124617401|NCT02883049|448215934|FG001|Post Induction|MRD negative|0|||
124617402|NCT02883049|448215935|FG002|Post Induction|MRD negative|0|||
124744384|NCT05098509|448684914|FG002|Overall Study|Withdrawal by Subject|1|||
124744385|NCT05098509|448684915|FG003|Overall Study|Withdrawal by Subject|0|||
124744386|NCT05098509|448684912|FG000|Overall Study|Early study termination|1|||
124744387|NCT05098509|448684913|FG001|Overall Study|Early study termination|1|||
124744388|NCT05098509|448684914|FG002|Overall Study|Early study termination|1|||
124744389|NCT05098509|448684915|FG003|Overall Study|Early study termination|0|||
124744390|NCT02986854|448684917|FG000|Overall Study|Withdrawal by Subject|0|||
124744391|NCT02986854|448684918|FG001|Overall Study|Withdrawal by Subject|1|||
124744392|NCT02986854|448684919|FG002|Overall Study|Withdrawal by Subject|1|||
124744393|NCT02986854|448684917|FG000|Overall Study|Lost to Follow-up|3|||
124617403|NCT02883049|448215936|FG003|Post Induction|MRD negative|0|||
124617404|NCT02883049|448215937|FG004|Post Induction|MRD negative|0|||
124617405|NCT02883049|448215938|FG005|Post Induction|MRD negative|0|||
124744394|NCT02986854|448684918|FG001|Overall Study|Lost to Follow-up|11|||
124744395|NCT02986854|448684919|FG002|Overall Study|Lost to Follow-up|2|||
124744396|NCT00324233|448684922|FG000|First Period|unable to insert catheter|1|||
124744397|NCT00324233|448684923|FG001|First Period|unable to insert catheter|0|||
124617406|NCT02883049|448215939|FG006|Post Induction|MRD negative|0|||
124617407|NCT02883049|448215940|FG007|Post Induction|MRD negative|11|||
124617408|NCT02883049|448215941|FG008|Post Induction|MRD negative|0|||
124617409|NCT02883049|448215942|FG009|Post Induction|MRD negative|0|||
124617410|NCT02883049|448215943|FG010|Post Induction|MRD negative|0|||
124617411|NCT02883049|448215944|FG011|Post Induction|MRD negative|0|||
124617412|NCT02883049|448215945|FG012|Post Induction|MRD negative|0|||
124617413|NCT02883049|448215946|FG013|Post Induction|MRD negative|0|||
124617414|NCT02883049|448215947|FG014|Post Induction|MRD negative|0|||
124617415|NCT02883049|448215948|FG015|Post Induction|MRD negative|0|||
124617416|NCT02883049|448215933|FG000|Post Induction|Developed SMN|0|||
124617417|NCT02883049|448215934|FG001|Post Induction|Developed SMN|0|||
124617418|NCT02883049|448215935|FG002|Post Induction|Developed SMN|0|||
124617419|NCT02883049|448215936|FG003|Post Induction|Developed SMN|0|||
124617420|NCT02883049|448215937|FG004|Post Induction|Developed SMN|1|||
124617421|NCT02883049|448215938|FG005|Post Induction|Developed SMN|0|||
124617422|NCT02883049|448215939|FG006|Post Induction|Developed SMN|1|||
124617423|NCT02883049|448215940|FG007|Post Induction|Developed SMN|0|||
124617424|NCT02883049|448215941|FG008|Post Induction|Developed SMN|0|||
124617425|NCT02883049|448215942|FG009|Post Induction|Developed SMN|0|||
124617426|NCT02883049|448215943|FG010|Post Induction|Developed SMN|1|||
124617427|NCT02883049|448215944|FG011|Post Induction|Developed SMN|1|||
124617428|NCT02883049|448215945|FG012|Post Induction|Developed SMN|0|||
124617429|NCT02883049|448215946|FG013|Post Induction|Developed SMN|0|||
124617430|NCT02883049|448215947|FG014|Post Induction|Developed SMN|1|||
124617431|NCT02883049|448215948|FG015|Post Induction|Developed SMN|0|||
124617432|NCT02883049|448215933|FG000|Post Induction|Enrolled onto another COG study|0|||
124617433|NCT02883049|448215934|FG001|Post Induction|Enrolled onto another COG study|0|||
124617434|NCT02883049|448215935|FG002|Post Induction|Enrolled onto another COG study|0|||
124617435|NCT02883049|448215936|FG003|Post Induction|Enrolled onto another COG study|1|||
124617436|NCT02883049|448215937|FG004|Post Induction|Enrolled onto another COG study|1|||
124617437|NCT02883049|448215938|FG005|Post Induction|Enrolled onto another COG study|0|||
124617438|NCT02883049|448215939|FG006|Post Induction|Enrolled onto another COG study|0|||
124617439|NCT02883049|448215940|FG007|Post Induction|Enrolled onto another COG study|4|||
124617440|NCT02883049|448215941|FG008|Post Induction|Enrolled onto another COG study|0|||
124617441|NCT02883049|448215942|FG009|Post Induction|Enrolled onto another COG study|0|||
124617442|NCT02883049|448215943|FG010|Post Induction|Enrolled onto another COG study|0|||
124617443|NCT02883049|448215944|FG011|Post Induction|Enrolled onto another COG study|2|||
124617444|NCT02883049|448215945|FG012|Post Induction|Enrolled onto another COG study|0|||
124617445|NCT02883049|448215946|FG013|Post Induction|Enrolled onto another COG study|1|||
124617446|NCT02883049|448215947|FG014|Post Induction|Enrolled onto another COG study|0|||
124617447|NCT02883049|448215948|FG015|Post Induction|Enrolled onto another COG study|0|||
124617448|NCT02883049|448215933|FG000|Post Induction|Recurrent leukemia|0|||
124617449|NCT02883049|448215934|FG001|Post Induction|Recurrent leukemia|0|||
124617450|NCT02883049|448215935|FG002|Post Induction|Recurrent leukemia|0|||
124617451|NCT02883049|448215936|FG003|Post Induction|Recurrent leukemia|17|||
124617452|NCT02883049|448215937|FG004|Post Induction|Recurrent leukemia|12|||
124617453|NCT02883049|448215938|FG005|Post Induction|Recurrent leukemia|4|||
124617454|NCT02883049|448215939|FG006|Post Induction|Recurrent leukemia|1|||
124617455|NCT02883049|448215940|FG007|Post Induction|Recurrent leukemia|13|||
124617456|NCT02883049|448215941|FG008|Post Induction|Recurrent leukemia|27|||
124617457|NCT02883049|448215942|FG009|Post Induction|Recurrent leukemia|5|||
124617458|NCT02883049|448215943|FG010|Post Induction|Recurrent leukemia|3|||
124617459|NCT02883049|448215944|FG011|Post Induction|Recurrent leukemia|12|||
124744398|NCT00324233|448684922|FG000|Second Period|unable to insert catheter|1|||
124744399|NCT00324233|448684923|FG001|Second Period|unable to insert catheter|1|||
124617460|NCT02883049|448215945|FG012|Post Induction|Recurrent leukemia|1|||
124617461|NCT02883049|448215946|FG013|Post Induction|Recurrent leukemia|1|||
124617462|NCT02883049|448215947|FG014|Post Induction|Recurrent leukemia|9|||
124617463|NCT02883049|448215948|FG015|Post Induction|Recurrent leukemia|3|||
124617464|NCT02883049|448215933|FG000|Post Induction|Induction Failure|0|||
124617465|NCT02883049|448215934|FG001|Post Induction|Induction Failure|0|||
124617466|NCT02883049|448215935|FG002|Post Induction|Induction Failure|0|||
124617467|NCT02883049|448215936|FG003|Post Induction|Induction Failure|0|||
124617468|NCT02883049|448215937|FG004|Post Induction|Induction Failure|0|||
124617469|NCT02883049|448215938|FG005|Post Induction|Induction Failure|0|||
124617470|NCT02883049|448215939|FG006|Post Induction|Induction Failure|0|||
124617471|NCT02883049|448215940|FG007|Post Induction|Induction Failure|2|||
124617472|NCT02883049|448215941|FG008|Post Induction|Induction Failure|2|||
124744400|NCT00324233|448684922|FG000|Second Period|Protocol Violation|4|||
124744401|NCT00324233|448684923|FG001|Second Period|Protocol Violation|6|||
124617473|NCT02883049|448215942|FG009|Post Induction|Induction Failure|0|||
124617474|NCT02883049|448215943|FG010|Post Induction|Induction Failure|0|||
124617475|NCT02883049|448215944|FG011|Post Induction|Induction Failure|0|||
124617476|NCT02883049|448215945|FG012|Post Induction|Induction Failure|0|||
124617477|NCT02883049|448215946|FG013|Post Induction|Induction Failure|2|||
124617478|NCT02883049|448215947|FG014|Post Induction|Induction Failure|0|||
124617479|NCT02883049|448215948|FG015|Post Induction|Induction Failure|0|||
124617480|NCT01924754|448215952|FG000|Overall Study|Lost to Follow-up|1|||
124617481|NCT01924754|448215953|FG001|Overall Study|Lost to Follow-up|2|||
124617482|NCT01924754|448215954|FG002|Overall Study|Lost to Follow-up|1|||
124617483|NCT01924754|448215952|FG000|Overall Study|Pregnancy|0|||
124617484|NCT01924754|448215953|FG001|Overall Study|Pregnancy|1|||
124617485|NCT01924754|448215954|FG002|Overall Study|Pregnancy|2|||
124617486|NCT02245412|448215957|FG000|Treatment Period|Death|1|||
124617487|NCT02245412|448215958|FG001|Treatment Period|Death|1|||
124617488|NCT02245412|448215959|FG002|Treatment Period|Death|0|||
124617489|NCT02245412|448215957|FG000|Treatment Period|Physician Decision|1|||
124617490|NCT02245412|448215958|FG001|Treatment Period|Physician Decision|1|||
124617491|NCT02245412|448215959|FG002|Treatment Period|Physician Decision|0|||
124617492|NCT02245412|448215957|FG000|Treatment Period|Withdrawal by Subject|2|||
124617493|NCT02245412|448215958|FG001|Treatment Period|Withdrawal by Subject|1|||
124617494|NCT02245412|448215959|FG002|Treatment Period|Withdrawal by Subject|0|||
124617495|NCT02245412|448215957|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
124617496|NCT02245412|448215958|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
124617497|NCT02245412|448215959|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
124617498|NCT02245412|448215957|FG000|Follow-Up Period|Death|4|||
124617499|NCT02245412|448215958|FG001|Follow-Up Period|Death|2|||
124617500|NCT02245412|448215959|FG002|Follow-Up Period|Death|1|||
124617501|NCT02245412|448215957|FG000|Follow-Up Period|Physician Decision|1|||
124617502|NCT02245412|448215958|FG001|Follow-Up Period|Physician Decision|0|||
124617503|NCT02245412|448215959|FG002|Follow-Up Period|Physician Decision|0|||
124617504|NCT02245412|448215957|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
124617505|NCT02245412|448215958|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
124617506|NCT02245412|448215959|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
124617507|NCT01392963|448215960|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
124617508|NCT01392963|448215961|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
124617509|NCT01392963|448215960|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
124617510|NCT01392963|448215961|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
124617511|NCT01392963|448215960|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
124617512|NCT01392963|448215961|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
124617513|NCT00369486|448215962|FG000|4-Week Visit|Missed visit|2|||
124617514|NCT00369486|448215963|FG001|4-Week Visit|Missed visit|2|||
124617515|NCT00369486|448215964|FG002|4-Week Visit|Missed visit|0|||
124617516|NCT00369486|448215965|FG003|4-Week Visit|Missed visit|2|||
124617517|NCT00369486|448215966|FG004|4-Week Visit|Missed visit|1|||
124617518|NCT00369486|448215962|FG000|4-Week Visit|Dropped|0|||
124617519|NCT00369486|448215963|FG001|4-Week Visit|Dropped|0|||
124617520|NCT00369486|448215964|FG002|4-Week Visit|Dropped|1|||
124617521|NCT00369486|448215965|FG003|4-Week Visit|Dropped|0|||
124617522|NCT00369486|448215966|FG004|4-Week Visit|Dropped|0|||
124617523|NCT00369486|448215962|FG000|8-Week Visit|Missed visit|0|||
124617524|NCT00369486|448215963|FG001|8-Week Visit|Missed visit|1|||
124617525|NCT00369486|448215964|FG002|8-Week Visit|Missed visit|0|||
124617526|NCT00369486|448215965|FG003|8-Week Visit|Missed visit|0|||
124617527|NCT00369486|448215966|FG004|8-Week Visit|Missed visit|1|||
124617528|NCT00369486|448215962|FG000|8-Week Visit|Dropped|0|||
124617529|NCT00369486|448215963|FG001|8-Week Visit|Dropped|0|||
124617530|NCT00369486|448215964|FG002|8-Week Visit|Dropped|0|||
124617531|NCT00369486|448215965|FG003|8-Week Visit|Dropped|1|||
124617532|NCT00369486|448215966|FG004|8-Week Visit|Dropped|0|||
124617533|NCT00369486|448215962|FG000|17-Week Visit|Missed visit|0|||
124617534|NCT00369486|448215963|FG001|17-Week Visit|Missed visit|0|||
124617535|NCT00369486|448215964|FG002|17-Week Visit|Missed visit|1|||
124617536|NCT00369486|448215965|FG003|17-Week Visit|Missed visit|1|||
124617537|NCT00369486|448215966|FG004|17-Week Visit|Missed visit|1|||
124617538|NCT00369486|448215962|FG000|34-Week Visit|Dropped|0|||
124617539|NCT00369486|448215963|FG001|34-Week Visit|Dropped|1|||
124617540|NCT00369486|448215964|FG002|34-Week Visit|Dropped|1|||
124617541|NCT00369486|448215965|FG003|34-Week Visit|Dropped|3|||
124617542|NCT00369486|448215966|FG004|34-Week Visit|Dropped|3|||
124617543|NCT00402116|448215967|FG000|Overall Study|Jaw infection after surgery-other|1|||
124617544|NCT00402116|448215968|FG001|Overall Study|Jaw infection after surgery-other|0|||
124617545|NCT00402116|448215969|FG002|Overall Study|Jaw infection after surgery-other|0|||
124617546|NCT00402116|448215967|FG000|Overall Study|Withdrawal by Subject|1|||
124617547|NCT00402116|448215968|FG001|Overall Study|Withdrawal by Subject|0|||
124617548|NCT00402116|448215969|FG002|Overall Study|Withdrawal by Subject|5|||
124617549|NCT00402116|448215967|FG000|Overall Study|Treatment completed per protocol|1|||
124617550|NCT00402116|448215968|FG001|Overall Study|Treatment completed per protocol|1|||
124617551|NCT00402116|448215969|FG002|Overall Study|Treatment completed per protocol|2|||
124617552|NCT00402116|448215967|FG000|Overall Study|other complicating disease|0|||
124617553|NCT00402116|448215968|FG001|Overall Study|other complicating disease|0|||
124617554|NCT00402116|448215969|FG002|Overall Study|other complicating disease|2|||
124617555|NCT00402116|448215967|FG000|Overall Study|Disease Progression|0|||
124617556|NCT00402116|448215968|FG001|Overall Study|Disease Progression|4|||
124617557|NCT00402116|448215969|FG002|Overall Study|Disease Progression|38|||
124617558|NCT00402116|448215967|FG000|Overall Study|mistaken thrombocytopenia|0|||
124617559|NCT00402116|448215968|FG001|Overall Study|mistaken thrombocytopenia|0|||
124617560|NCT00402116|448215969|FG002|Overall Study|mistaken thrombocytopenia|1|||
124617561|NCT00402116|448215967|FG000|Overall Study|decline related hyponatremia/tumor|0|||
124617562|NCT00402116|448215968|FG001|Overall Study|decline related hyponatremia/tumor|0|||
124617563|NCT00402116|448215969|FG002|Overall Study|decline related hyponatremia/tumor|1|||
124617564|NCT00402116|448215967|FG000|Overall Study|Adverse Event|0|||
124617565|NCT00402116|448215968|FG001|Overall Study|Adverse Event|1|||
124617566|NCT00402116|448215969|FG002|Overall Study|Adverse Event|6|||
124617567|NCT04778904|448215970|FG000|Overall Study|Protocol Violation|1|||
124617568|NCT04778904|448215971|FG001|Overall Study|Protocol Violation|0|||
124617569|NCT04778904|448215972|FG002|Overall Study|Protocol Violation|0|||
124617570|NCT04778904|448215973|FG003|Overall Study|Protocol Violation|0|||
124617571|NCT04778904|448215970|FG000|Overall Study|Withdrawal by Subject|0|||
124617572|NCT04778904|448215971|FG001|Overall Study|Withdrawal by Subject|0|||
124617573|NCT04778904|448215972|FG002|Overall Study|Withdrawal by Subject|1|||
124617574|NCT04778904|448215973|FG003|Overall Study|Withdrawal by Subject|0|||
124617575|NCT03772717|448215980|FG000|Overall Study|Withdrawal by Subject|2|||
124617576|NCT04138043|448215981|FG000|Overall Study|Withdrawal by Subject|0|||
124617577|NCT04138043|448215982|FG001|Overall Study|Withdrawal by Subject|1|||
124617578|NCT02856802|448215983|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
124617579|NCT02856802|448215984|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
124617580|NCT02856802|448215983|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
124617581|NCT02856802|448215984|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
124617582|NCT02856802|448215983|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
124617583|NCT02856802|448215984|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
124617584|NCT02856802|448215983|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
124617585|NCT02856802|448215984|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
124617586|NCT02856802|448215983|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
124617587|NCT02856802|448215984|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
124617588|NCT02856802|448215983|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
124617589|NCT02856802|448215984|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
124617590|NCT01810302|448215985|FG000|Overall Study|Death|1|||
124617591|NCT01810302|448215986|FG001|Overall Study|Death|0|||
124617592|NCT01810302|448215985|FG000|Overall Study|Physician Decision|0|||
124617593|NCT01810302|448215986|FG001|Overall Study|Physician Decision|1|||
124617594|NCT03092219|448215992|FG000|Overall Study|Protocol Violation|7|||
124617595|NCT03092219|448215993|FG001|Overall Study|Protocol Violation|4|||
124617596|NCT00580788|448215996|FG000|Overall Study|Adverse Event|0|||
124617597|NCT00580788|448215997|FG001|Overall Study|Adverse Event|0|||
124617598|NCT00580788|448215998|FG002|Overall Study|Adverse Event|0|||
124617599|NCT00580788|448215999|FG003|Overall Study|Adverse Event|1|||
124617600|NCT01443728|448216000|FG000|Overall Study|Lost to Follow-up|2|||
124617601|NCT01443728|448216001|FG001|Overall Study|Lost to Follow-up|0|||
124617602|NCT01443728|448216000|FG000|Overall Study|Withdrawal by Subject|1|||
124617603|NCT01443728|448216001|FG001|Overall Study|Withdrawal by Subject|1|||
124617604|NCT01443728|448216000|FG000|Overall Study|Adverse Event|0|||
124617605|NCT01443728|448216001|FG001|Overall Study|Adverse Event|2|||
124617606|NCT04971187|448216002|FG000|Overall Study|Screen failures|2|||
124617607|NCT03743415|448216008|FG000|Overall Study|Death|5|||
124617608|NCT03743415|448216009|FG001|Overall Study|Death|3|||
124617609|NCT03743415|448216010|FG002|Overall Study|Death|1|||
124617610|NCT03743415|448216011|FG003|Overall Study|Death|4|||
124617611|NCT03743415|448216012|FG004|Overall Study|Death|0|||
124617612|NCT03743415|448216013|FG005|Overall Study|Death|0|||
124617613|NCT03743415|448216014|FG006|Overall Study|Death|0|||
124617614|NCT03743415|448216015|FG007|Overall Study|Death|0|||
124617615|NCT03743415|448216016|FG008|Overall Study|Death|1|||
124617616|NCT03743415|448216017|FG009|Overall Study|Death|0|||
124617617|NCT03743415|448216008|FG000|Overall Study|Withdrawal by Subject|1|||
124617618|NCT03743415|448216009|FG001|Overall Study|Withdrawal by Subject|0|||
124617619|NCT03743415|448216010|FG002|Overall Study|Withdrawal by Subject|4|||
124617620|NCT03743415|448216011|FG003|Overall Study|Withdrawal by Subject|5|||
124617621|NCT03743415|448216012|FG004|Overall Study|Withdrawal by Subject|5|||
124744402|NCT01972789|448684926|FG000|Overall Study|Adverse Event|11|||
124744403|NCT01972789|448684927|FG001|Overall Study|Adverse Event|4|||
124744404|NCT01972789|448684926|FG000|Overall Study|Subject withdrew consent|14|||
124617622|NCT03743415|448216013|FG005|Overall Study|Withdrawal by Subject|2|||
124617623|NCT03743415|448216014|FG006|Overall Study|Withdrawal by Subject|2|||
124617624|NCT03743415|448216015|FG007|Overall Study|Withdrawal by Subject|5|||
124617625|NCT03743415|448216016|FG008|Overall Study|Withdrawal by Subject|9|||
124617626|NCT03743415|448216017|FG009|Overall Study|Withdrawal by Subject|10|||
124617627|NCT03743415|448216008|FG000|Overall Study|Lost to Follow-up|2|||
124617628|NCT03743415|448216009|FG001|Overall Study|Lost to Follow-up|0|||
124617629|NCT03743415|448216010|FG002|Overall Study|Lost to Follow-up|2|||
124617630|NCT03743415|448216011|FG003|Overall Study|Lost to Follow-up|1|||
124617631|NCT03743415|448216012|FG004|Overall Study|Lost to Follow-up|1|||
124617632|NCT03743415|448216013|FG005|Overall Study|Lost to Follow-up|0|||
124617633|NCT03743415|448216014|FG006|Overall Study|Lost to Follow-up|1|||
124617634|NCT03743415|448216015|FG007|Overall Study|Lost to Follow-up|4|||
124617635|NCT03743415|448216016|FG008|Overall Study|Lost to Follow-up|13|||
124617636|NCT03743415|448216017|FG009|Overall Study|Lost to Follow-up|13|||
124617637|NCT04497948|448216023|FG000|Overall Study|Death|2|||
124617638|NCT02242045|448216027|FG000|Overall Study|Investigator's Discretion|1|||
124617639|NCT02242045|448216027|FG000|Overall Study|Progressive Disease|2|||
124617640|NCT02242045|448216027|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
124617641|NCT02242045|448216027|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
124617642|NCT02648932|448216028|FG000|Overall Study|No transplant|3|||
124617643|NCT02648932|448216029|FG001|Overall Study|No transplant|1|||
124617644|NCT01266031|448216030|FG000|Overall Study|Not treated|0|||
124617645|NCT01266031|448216031|FG001|Overall Study|Not treated|3|||
124617646|NCT01266031|448216032|FG002|Overall Study|Not treated|2|||
124617647|NCT02842073|448216039|FG000|Overall Study|Withdrawal by Subject|1|||
124617648|NCT00195338|448216040|FG000|Overall Study|Lost to Follow-up|2|||
124617649|NCT00195338|448216040|FG000|Overall Study|Adverse Event|5|||
124617650|NCT00195338|448216040|FG000|Overall Study|Lack of Efficacy|1|||
124617651|NCT00195338|448216040|FG000|Overall Study|Early closure of the site|4|||
124617652|NCT00005957|448216043|FG000|Overall Study|No treated|3|||
124617653|NCT00005957|448216044|FG001|Overall Study|No treated|9|||
124617654|NCT00005957|448216043|FG000|Overall Study|Crossover to the other arm|5|||
124617655|NCT00005957|448216044|FG001|Overall Study|Crossover to the other arm|19|||
124617656|NCT03717012|448216045|FG000|Overall Study|Due to trial termination|1|||
124617657|NCT03717012|448216046|FG001|Overall Study|Due to trial termination|2|||
124617658|NCT03717012|448216045|FG000|Overall Study|Protocol Violation|0|||
124617659|NCT03717012|448216046|FG001|Overall Study|Protocol Violation|2|||
124617660|NCT03717012|448216045|FG000|Overall Study|Adverse Event|0|||
124617661|NCT03717012|448216046|FG001|Overall Study|Adverse Event|1|||
124617662|NCT03717012|448216045|FG000|Overall Study|Lung transplant|0|||
124617663|NCT03717012|448216046|FG001|Overall Study|Lung transplant|1|||
124617664|NCT01721317|448216048|FG000|Overall Study|Study Closed / Terminated|2|||
124617665|NCT01721317|448216049|FG001|Overall Study|Study Closed / Terminated|2|||
124617666|NCT01721317|448216048|FG000|Overall Study|Physician Decision|0|||
124617667|NCT01721317|448216049|FG001|Overall Study|Physician Decision|1|||
124617668|NCT01721317|448216048|FG000|Overall Study|Withdrawal by Subject|0|||
124617669|NCT01721317|448216049|FG001|Overall Study|Withdrawal by Subject|1|||
124617670|NCT03713632|448216059|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
124617671|NCT03713632|448216060|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
124617672|NCT03713632|448216061|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
124617673|NCT03713632|448216062|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
124617674|NCT03713632|448216063|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
124617675|NCT03713632|448216059|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
124617676|NCT03713632|448216060|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
124617677|NCT03713632|448216061|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
124617678|NCT03713632|448216062|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
124617679|NCT03713632|448216063|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
124617680|NCT03713632|448216059|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
124617681|NCT03713632|448216060|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
124617682|NCT03713632|448216061|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
124617683|NCT03713632|448216062|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
124617684|NCT03713632|448216063|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
124617685|NCT03713632|448216059|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
124617686|NCT03713632|448216060|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
124617687|NCT03713632|448216061|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
124617688|NCT03713632|448216062|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
124617689|NCT03713632|448216063|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
124617690|NCT03713632|448216059|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
124617691|NCT03713632|448216060|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
124617692|NCT03713632|448216061|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
124617693|NCT03713632|448216062|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
124617694|NCT03713632|448216063|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
124617695|NCT03713632|448216059|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
124617696|NCT03713632|448216060|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
124617697|NCT03713632|448216061|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
124617698|NCT03713632|448216062|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
124617699|NCT03713632|448216063|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
124637419|NCT02589639|448290532|FG000|Overall Study|Protocol Violation|1|||
124617700|NCT03713632|448216059|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
124617701|NCT03713632|448216060|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
124617702|NCT03713632|448216061|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
124617703|NCT03713632|448216062|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
124617704|NCT03713632|448216063|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
124617705|NCT03713632|448216059|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
124617706|NCT03713632|448216060|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
124617707|NCT03713632|448216061|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
124617708|NCT03713632|448216062|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
124617709|NCT03713632|448216063|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
124617710|NCT03713632|448216059|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
124617711|NCT03713632|448216060|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
124617712|NCT03713632|448216061|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
124617713|NCT03713632|448216062|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
124617714|NCT03713632|448216063|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
124617715|NCT03713632|448216059|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
124617716|NCT03713632|448216060|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
124617717|NCT03713632|448216061|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
124617718|NCT03713632|448216062|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
124617719|NCT03713632|448216063|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
124617720|NCT03713632|448216059|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
124617721|NCT03713632|448216060|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
124617722|NCT03713632|448216061|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
124617723|NCT03713632|448216062|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
124617724|NCT03713632|448216063|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
124617725|NCT03713632|448216059|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
124617726|NCT03713632|448216060|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
124617727|NCT03713632|448216061|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
124617728|NCT03713632|448216062|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
124617729|NCT03713632|448216063|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
124617730|NCT03713632|448216059|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
124617731|NCT03713632|448216060|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
124617732|NCT03713632|448216061|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
124617733|NCT03713632|448216062|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
124617734|NCT03713632|448216063|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
124617735|NCT03713632|448216059|FG000|Treatment Period 2 (After Week 16)|Death|0|||
124617736|NCT03713632|448216060|FG001|Treatment Period 2 (After Week 16)|Death|1|||
124617737|NCT03713632|448216061|FG002|Treatment Period 2 (After Week 16)|Death|0|||
124617738|NCT03713632|448216062|FG003|Treatment Period 2 (After Week 16)|Death|0|||
124617739|NCT03713632|448216063|FG004|Treatment Period 2 (After Week 16)|Death|0|||
124617740|NCT03713632|448216059|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
124617741|NCT03713632|448216060|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
124617742|NCT03713632|448216061|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
124617743|NCT03713632|448216062|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
124617744|NCT03713632|448216063|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
124617745|NCT02806024|448216064|FG000|Overall Study|Night Delivery|1|||
124617746|NCT02806024|448216065|FG001|Overall Study|Night Delivery|1|||
124617747|NCT02806024|448216064|FG000|Overall Study|DVT during antepartum admission|0|||
124617748|NCT02806024|448216065|FG001|Overall Study|DVT during antepartum admission|1|||
124617749|NCT02892149|448216066|FG000|Overall Study|Death|262|||
124617750|NCT02892149|448216067|FG001|Overall Study|Death|278|||
124617751|NCT02892149|448216066|FG000|Overall Study|Withdrawal by Subject|53|||
124617752|NCT02892149|448216067|FG001|Overall Study|Withdrawal by Subject|47|||
124617753|NCT02892149|448216066|FG000|Overall Study|Lost to Follow-up|37|||
124617754|NCT02892149|448216067|FG001|Overall Study|Lost to Follow-up|31|||
124617755|NCT01994850|448216068|FG000|Overall Study|Physician Decision|1|||
124617756|NCT01994850|448216068|FG000|Overall Study|Withdrawal by Subject|1|||
124617757|NCT00442962|448216069|FG000|Overall Study|Pregnancy|1|||
124617758|NCT00442962|448216069|FG000|Overall Study|Lost to Follow-up|7|||
124617759|NCT02756208|448216073|FG000|Overall Study|Withdrawal by Subject|1|||
124617760|NCT02756208|448216074|FG001|Overall Study|Withdrawal by Subject|0|||
124617761|NCT02756208|448216075|FG002|Overall Study|Withdrawal by Subject|1|||
124617762|NCT02756208|448216076|FG003|Overall Study|Withdrawal by Subject|3|||
124617763|NCT02756208|448216073|FG000|Overall Study|Lost to Follow-up|3|||
124617764|NCT02756208|448216074|FG001|Overall Study|Lost to Follow-up|1|||
124617765|NCT02756208|448216075|FG002|Overall Study|Lost to Follow-up|1|||
124617766|NCT02756208|448216076|FG003|Overall Study|Lost to Follow-up|1|||
124617767|NCT02756208|448216073|FG000|Overall Study|Physician Decision|1|||
124617768|NCT02756208|448216074|FG001|Overall Study|Physician Decision|0|||
124617769|NCT02756208|448216075|FG002|Overall Study|Physician Decision|0|||
124617770|NCT02756208|448216076|FG003|Overall Study|Physician Decision|0|||
124617771|NCT02756208|448216073|FG000|Overall Study|Protocol Violation|0|||
124617772|NCT02756208|448216074|FG001|Overall Study|Protocol Violation|1|||
124617773|NCT02756208|448216075|FG002|Overall Study|Protocol Violation|0|||
124617774|NCT02756208|448216076|FG003|Overall Study|Protocol Violation|0|||
124617775|NCT04841577|448216078|FG000|Overall Study|Adverse Event|5|||
124617776|NCT04841577|448216079|FG001|Overall Study|Adverse Event|10|||
124617777|NCT04841577|448216078|FG000|Overall Study|Lost to Follow-up|8|||
124617778|NCT04841577|448216079|FG001|Overall Study|Lost to Follow-up|7|||
124617779|NCT04841577|448216078|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
124617780|NCT04841577|448216079|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
124617781|NCT04841577|448216078|FG000|Overall Study|Other|0|||
124617782|NCT04841577|448216079|FG001|Overall Study|Other|1|||
124617783|NCT01420965|448216084|FG000|Overall Study|Withdrawal by Subject|1|||
124617784|NCT01420965|448216085|FG001|Overall Study|Withdrawal by Subject|0|||
124617785|NCT01420965|448216086|FG002|Overall Study|Withdrawal by Subject|0|||
124617786|NCT01420965|448216084|FG000|Overall Study|Adverse Event|0|||
124617787|NCT01420965|448216085|FG001|Overall Study|Adverse Event|1|||
124617788|NCT01420965|448216086|FG002|Overall Study|Adverse Event|0|||
124617789|NCT00339144|448216091|FG000|Overall Study|Disease progression|5|||
124617790|NCT00339144|448216092|FG001|Overall Study|Disease progression|2|||
124617791|NCT00339144|448216093|FG002|Overall Study|Disease progression|2|||
124617792|NCT00339144|448216091|FG000|Overall Study|Study drug toxicity|3|||
124617793|NCT00339144|448216092|FG001|Overall Study|Study drug toxicity|1|||
124617794|NCT00339144|448216093|FG002|Overall Study|Study drug toxicity|1|||
124617795|NCT00339144|448216091|FG000|Overall Study|Participant's request to discontinuation|1|||
124617796|NCT00339144|448216092|FG001|Overall Study|Participant's request to discontinuation|0|||
124617797|NCT00339144|448216093|FG002|Overall Study|Participant's request to discontinuation|1|||
124617798|NCT03280381|448216094|FG000|Overall Study|Physician Decision|0|||
124617799|NCT03280381|448216095|FG001|Overall Study|Physician Decision|2|||
124617800|NCT02257385|448216096|FG000|Overall Study|Adverse Event|12|||
124617801|NCT02257385|448216097|FG001|Overall Study|Adverse Event|8|||
124617802|NCT02257385|448216096|FG000|Overall Study|Lack of Efficacy|1|||
124617803|NCT02257385|448216097|FG001|Overall Study|Lack of Efficacy|2|||
124617804|NCT02257385|448216096|FG000|Overall Study|Protocol Violation|5|||
124617805|NCT02257385|448216097|FG001|Overall Study|Protocol Violation|7|||
124617806|NCT02257385|448216096|FG000|Overall Study|Lost to Follow-up|0|||
124617807|NCT02257385|448216097|FG001|Overall Study|Lost to Follow-up|1|||
124617808|NCT02257385|448216096|FG000|Overall Study|Withdrawal by Subject|4|||
124617809|NCT02257385|448216097|FG001|Overall Study|Withdrawal by Subject|4|||
124617810|NCT03279692|448216098|FG000|Overall Study|Withdrawal by Subject|1|||
124617811|NCT02458287|448216100|FG000|Overall Study|Adverse Event|0|||
124617812|NCT02458287|448216101|FG001|Overall Study|Adverse Event|0|||
124617813|NCT02458287|448216102|FG002|Overall Study|Adverse Event|0|||
124617814|NCT02458287|448216103|FG003|Overall Study|Adverse Event|1|||
124617815|NCT02458287|448216100|FG000|Overall Study|Lost to Follow-up|0|||
124617816|NCT02458287|448216101|FG001|Overall Study|Lost to Follow-up|1|||
124617817|NCT02458287|448216102|FG002|Overall Study|Lost to Follow-up|1|||
124617818|NCT02458287|448216103|FG003|Overall Study|Lost to Follow-up|0|||
124617819|NCT02458287|448216100|FG000|Overall Study|Protocol Violation|0|||
124617820|NCT02458287|448216101|FG001|Overall Study|Protocol Violation|1|||
124617821|NCT02458287|448216102|FG002|Overall Study|Protocol Violation|0|||
124617822|NCT02458287|448216103|FG003|Overall Study|Protocol Violation|0|||
124617823|NCT02458287|448216100|FG000|Overall Study|Withdrawal by Subject|0|||
124617824|NCT02458287|448216101|FG001|Overall Study|Withdrawal by Subject|2|||
124617825|NCT02458287|448216102|FG002|Overall Study|Withdrawal by Subject|2|||
124617826|NCT02458287|448216103|FG003|Overall Study|Withdrawal by Subject|1|||
124617827|NCT02458287|448216100|FG000|Overall Study|Relocated Out of State|0|||
124617828|NCT02458287|448216101|FG001|Overall Study|Relocated Out of State|0|||
124617829|NCT02458287|448216102|FG002|Overall Study|Relocated Out of State|0|||
124617830|NCT02458287|448216103|FG003|Overall Study|Relocated Out of State|1|||
124617831|NCT02800642|448216106|FG000|Overall Study|Death|3|||
124617832|NCT02800642|448216106|FG000|Overall Study|Other|10|||
124617833|NCT02800642|448216106|FG000|Overall Study|Physician Decision|2|||
124617834|NCT02800642|448216106|FG000|Overall Study|Adverse Event|6|||
124617835|NCT02800642|448216106|FG000|Overall Study|Withdrawal by Subject|3|||
124617836|NCT02800642|448216106|FG000|Overall Study|Lost to Follow-up|1|||
124617837|NCT02027428|448216107|FG000|Induction|Never treated|7|||
124617838|NCT02027428|448216108|FG001|Induction|Never treated|0|||
124617839|NCT02027428|448216109|FG002|Induction|Never treated|0|||
124617840|NCT02027428|448216107|FG000|Induction|Progressive disease|77|||
124617841|NCT02027428|448216108|FG001|Induction|Progressive disease|0|||
124617842|NCT02027428|448216109|FG002|Induction|Progressive disease|0|||
124617843|NCT02027428|448216107|FG000|Induction|Adverse Event|51|||
124617844|NCT02027428|448216108|FG001|Induction|Adverse Event|0|||
124617845|NCT02027428|448216109|FG002|Induction|Adverse Event|0|||
124617846|NCT02027428|448216107|FG000|Induction|Withdrawal by Subject|22|||
124617847|NCT02027428|448216108|FG001|Induction|Withdrawal by Subject|0|||
124617848|NCT02027428|448216109|FG002|Induction|Withdrawal by Subject|0|||
124617849|NCT02027428|448216107|FG000|Induction|Death|21|||
124617850|NCT02027428|448216108|FG001|Induction|Death|0|||
124617851|NCT02027428|448216109|FG002|Induction|Death|0|||
124617852|NCT02027428|448216107|FG000|Induction|Symptomatic deterioration|16|||
124617853|NCT02027428|448216108|FG001|Induction|Symptomatic deterioration|0|||
124617854|NCT02027428|448216109|FG002|Induction|Symptomatic deterioration|0|||
124617855|NCT02027428|448216107|FG000|Induction|Study terminated by sponsor|12|||
124617856|NCT02027428|448216108|FG001|Induction|Study terminated by sponsor|0|||
124617857|NCT02027428|448216109|FG002|Induction|Study terminated by sponsor|0|||
124617858|NCT02027428|448216107|FG000|Induction|Protocol Violation|1|||
124617859|NCT02027428|448216108|FG001|Induction|Protocol Violation|0|||
124617860|NCT02027428|448216109|FG002|Induction|Protocol Violation|0|||
124617861|NCT02027428|448216107|FG000|Induction|Miscellaneous|14|||
124617862|NCT02027428|448216108|FG001|Induction|Miscellaneous|0|||
124617863|NCT02027428|448216109|FG002|Induction|Miscellaneous|0|||
124617864|NCT02027428|448216107|FG000|Induction|Induction Treatment Ongoing|4|||
124617865|NCT02027428|448216108|FG001|Induction|Induction Treatment Ongoing|0|||
124617866|NCT02027428|448216109|FG002|Induction|Induction Treatment Ongoing|0|||
124617867|NCT02027428|448216107|FG000|Maintenance|Death|0|||
124617868|NCT02027428|448216108|FG001|Maintenance|Death|3|||
124617869|NCT02027428|448216109|FG002|Maintenance|Death|2|||
124617870|NCT02027428|448216107|FG000|Maintenance|Adverse Event|0|||
124617871|NCT02027428|448216108|FG001|Maintenance|Adverse Event|21|||
124617872|NCT02027428|448216109|FG002|Maintenance|Adverse Event|1|||
124617873|NCT02027428|448216107|FG000|Maintenance|Progressive disease|0|||
124617874|NCT02027428|448216108|FG001|Maintenance|Progressive disease|84|||
124617875|NCT02027428|448216109|FG002|Maintenance|Progressive disease|47|||
124617876|NCT02027428|448216107|FG000|Maintenance|Symptomatic deterioration|0|||
124617877|NCT02027428|448216108|FG001|Maintenance|Symptomatic deterioration|4|||
124617878|NCT02027428|448216109|FG002|Maintenance|Symptomatic deterioration|1|||
124617879|NCT02027428|448216107|FG000|Maintenance|Withdrawal by Subject|0|||
124617880|NCT02027428|448216108|FG001|Maintenance|Withdrawal by Subject|6|||
124617881|NCT02027428|448216109|FG002|Maintenance|Withdrawal by Subject|5|||
124617882|NCT02027428|448216107|FG000|Maintenance|Protocol Violation|0|||
124617883|NCT02027428|448216108|FG001|Maintenance|Protocol Violation|0|||
124617884|NCT02027428|448216109|FG002|Maintenance|Protocol Violation|1|||
124617885|NCT02027428|448216107|FG000|Maintenance|Other|0|||
124617886|NCT02027428|448216108|FG001|Maintenance|Other|6|||
124617887|NCT02027428|448216109|FG002|Maintenance|Other|3|||
124617888|NCT02027428|448216107|FG000|Survival Follow-up|Death|0|||
124617889|NCT02027428|448216108|FG001|Survival Follow-up|Death|78|||
124617890|NCT02027428|448216109|FG002|Survival Follow-up|Death|45|||
124617891|NCT02027428|448216107|FG000|Survival Follow-up|Lost to Follow-up|0|||
124617892|NCT02027428|448216108|FG001|Survival Follow-up|Lost to Follow-up|1|||
124617893|NCT02027428|448216109|FG002|Survival Follow-up|Lost to Follow-up|1|||
124617894|NCT03371459|448216112|FG000|Washout|Lost to Follow-up|0|||
124617895|NCT03371459|448216113|FG001|Washout|Lost to Follow-up|1|||
124617896|NCT01589497|448216114|FG000|Overall Study|Withdrawal by Subject|0|||
124617897|NCT01589497|448216115|FG001|Overall Study|Withdrawal by Subject|1|||
124617898|NCT01589497|448216116|FG002|Overall Study|Withdrawal by Subject|0|||
124617899|NCT01589497|448216117|FG003|Overall Study|Withdrawal by Subject|1|||
124617900|NCT01589497|448216114|FG000|Overall Study|Death|1|||
124617901|NCT01589497|448216115|FG001|Overall Study|Death|0|||
124617902|NCT01589497|448216116|FG002|Overall Study|Death|0|||
124617903|NCT01589497|448216117|FG003|Overall Study|Death|0|||
124617904|NCT01589497|448216114|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
124617905|NCT01589497|448216115|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
124617906|NCT01589497|448216116|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
124617907|NCT01589497|448216117|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
124617908|NCT02542605|448216124|FG000|Part B: Challenge Phase|Sponsor decision|1|||
124617909|NCT02542605|448216125|FG001|Part B: Challenge Phase|Sponsor decision|0|||
124617910|NCT02542605|448216126|FG002|Part B: Challenge Phase|Sponsor decision|0|||
124617911|NCT02542605|448216124|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
124617912|NCT02542605|448216125|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
124617913|NCT02542605|448216126|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
124617914|NCT02682927|448216128|FG000|Overall Study|Adverse Event|0|||
124617915|NCT02682927|448216129|FG001|Overall Study|Adverse Event|0|||
124617916|NCT02682927|448216130|FG002|Overall Study|Adverse Event|5|||
124617917|NCT02682927|448216131|FG003|Overall Study|Adverse Event|1|||
124617918|NCT02682927|448216132|FG004|Overall Study|Adverse Event|0|||
124617919|NCT02682927|448216133|FG005|Overall Study|Adverse Event|2|||
124617920|NCT02682927|448216128|FG000|Overall Study|Death|0|||
124617921|NCT02682927|448216129|FG001|Overall Study|Death|0|||
124617922|NCT02682927|448216130|FG002|Overall Study|Death|0|||
124617923|NCT02682927|448216131|FG003|Overall Study|Death|1|||
124617924|NCT02682927|448216132|FG004|Overall Study|Death|0|||
124617925|NCT02682927|448216133|FG005|Overall Study|Death|0|||
124617926|NCT02682927|448216128|FG000|Overall Study|Lack of Efficacy|1|||
124617927|NCT02682927|448216129|FG001|Overall Study|Lack of Efficacy|0|||
124617928|NCT02682927|448216130|FG002|Overall Study|Lack of Efficacy|0|||
124617929|NCT02682927|448216131|FG003|Overall Study|Lack of Efficacy|1|||
124617930|NCT02682927|448216132|FG004|Overall Study|Lack of Efficacy|0|||
124617931|NCT02682927|448216133|FG005|Overall Study|Lack of Efficacy|0|||
124617932|NCT02682927|448216128|FG000|Overall Study|Other|0|||
124617933|NCT02682927|448216129|FG001|Overall Study|Other|0|||
124617934|NCT02682927|448216130|FG002|Overall Study|Other|0|||
124617935|NCT02682927|448216131|FG003|Overall Study|Other|2|||
124617936|NCT02682927|448216132|FG004|Overall Study|Other|0|||
124617937|NCT02682927|448216133|FG005|Overall Study|Other|0|||
124617938|NCT02682927|448216128|FG000|Overall Study|Withdrawal by Subject|2|||
124617939|NCT02682927|448216129|FG001|Overall Study|Withdrawal by Subject|0|||
124617940|NCT02682927|448216130|FG002|Overall Study|Withdrawal by Subject|1|||
124617941|NCT02682927|448216131|FG003|Overall Study|Withdrawal by Subject|0|||
124617942|NCT02682927|448216132|FG004|Overall Study|Withdrawal by Subject|1|||
124617943|NCT02682927|448216133|FG005|Overall Study|Withdrawal by Subject|1|||
124617944|NCT02766283|448216138|FG000|Overall Study|Lost to Follow-up|27|||
124617945|NCT04007991|448216139|FG000|Overall Study|Withdrawal by Subject|1|||
124617946|NCT04007991|448216140|FG001|Overall Study|Withdrawal by Subject|1|||
124617947|NCT04007991|448216139|FG000|Overall Study|Physician Decision|1|||
124617948|NCT04007991|448216140|FG001|Overall Study|Physician Decision|1|||
124617949|NCT04007991|448216139|FG000|Overall Study|Non-compliance with Study Drug|0|||
124617950|NCT04007991|448216140|FG001|Overall Study|Non-compliance with Study Drug|1|||
124617951|NCT04007991|448216139|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
124617952|NCT04007991|448216140|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
124617953|NCT04007991|448216139|FG000|Overall Study|Adverse event, non-fatal|5|||
124617954|NCT04007991|448216140|FG001|Overall Study|Adverse event, non-fatal|0|||
124617955|NCT04007991|448216139|FG000|Overall Study|Lost to Follow-up|2|||
124617956|NCT04007991|448216140|FG001|Overall Study|Lost to Follow-up|1|||
124617957|NCT05314816|448216141|FG000|Overall Study|Lost to Follow-up|5|||
124617958|NCT05314816|448216142|FG001|Overall Study|Lost to Follow-up|0|||
124617959|NCT05314816|448216143|FG002|Overall Study|Lost to Follow-up|1|||
124617960|NCT05314816|448216141|FG000|Overall Study|Protocol Violation|13|||
124617961|NCT05314816|448216142|FG001|Overall Study|Protocol Violation|8|||
124617962|NCT05314816|448216143|FG002|Overall Study|Protocol Violation|0|||
124617963|NCT03278626|448217762|FG000|Overall Study|Death|2|||
124617964|NCT03278626|448217762|FG000|Overall Study|Toxicity|1|||
124617965|NCT03278626|448217762|FG000|Overall Study|Disease Progression|2|||
124617966|NCT05013008|448217763|FG000|Overall Study|Exclusion from mBFAS|5|||
124617967|NCT05013008|448217764|FG001|Overall Study|Exclusion from mBFAS|25|||
124617968|NCT04981717|448217765|FG000|Overall Study|Protocol Violation|0|||
124617969|NCT04981717|448217766|FG001|Overall Study|Protocol Violation|3|||
124617970|NCT04981717|448217765|FG000|Overall Study|Adverse Event|1|||
124617971|NCT04981717|448217766|FG001|Overall Study|Adverse Event|3|||
124617972|NCT04981717|448217765|FG000|Overall Study|Pregnancy|1|||
124617973|NCT04981717|448217766|FG001|Overall Study|Pregnancy|0|||
124617974|NCT04981717|448217765|FG000|Overall Study|Physician Decision|1|||
124617975|NCT04981717|448217766|FG001|Overall Study|Physician Decision|0|||
124617976|NCT04981717|448217765|FG000|Overall Study|Sponsor Request|157|||
124617977|NCT04981717|448217766|FG001|Overall Study|Sponsor Request|172|||
124617978|NCT04981717|448217765|FG000|Overall Study|Lost to Follow-up|4|||
124617979|NCT04981717|448217766|FG001|Overall Study|Lost to Follow-up|5|||
124617980|NCT04981717|448217765|FG000|Overall Study|Withdrawal by Subject|50|||
124617981|NCT04981717|448217766|FG001|Overall Study|Withdrawal by Subject|37|||
124617982|NCT02207634|448217767|FG000|Overall Study|Withdrawal by Subject|21|||
124617983|NCT02207634|448217768|FG001|Overall Study|Withdrawal by Subject|31|||
124617984|NCT02207634|448217767|FG000|Overall Study|Lost to Follow-up|1|||
124617985|NCT02207634|448217768|FG001|Overall Study|Lost to Follow-up|0|||
124617986|NCT00887289|448217769|FG000|Overall Study|Lack of Efficacy|14|||
124617987|NCT00887289|448217769|FG000|Overall Study|Adverse Event|27|||
124617988|NCT00887289|448217769|FG000|Overall Study|Withdrawal by Subject|26|||
124617989|NCT00887289|448217769|FG000|Overall Study|Lost to Follow-up|8|||
124617990|NCT00887289|448217769|FG000|Overall Study|Other|20|||
124617991|NCT00459355|448217770|FG000|Overall Study|Subject no longer met inc criteria|20|||
124617992|NCT00459355|448217771|FG001|Overall Study|Subject no longer met inc criteria|18|||
124617993|NCT00287586|448217772|FG000|Overall Study|Withdrew Consent|19|||
124617994|NCT00287586|448217773|FG001|Overall Study|Withdrew Consent|30|||
124782133|NCT01349049|448832763|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
124617995|NCT00287586|448217772|FG000|Overall Study|Lost to Follow-up|5|||
124617996|NCT00287586|448217773|FG001|Overall Study|Lost to Follow-up|4|||
124617997|NCT00287586|448217772|FG000|Overall Study|Death|2|||
124617998|NCT00287586|448217773|FG001|Overall Study|Death|3|||
124617999|NCT00287586|448217772|FG000|Overall Study|Elevated Hematocrit|3|||
124618000|NCT00287586|448217773|FG001|Overall Study|Elevated Hematocrit|0|||
124618001|NCT00287586|448217772|FG000|Overall Study|Rash|3|||
124618002|NCT00287586|448217773|FG001|Overall Study|Rash|0|||
124618003|NCT00287586|448217772|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
124618004|NCT00287586|448217773|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
124618005|NCT00287586|448217772|FG000|Overall Study|Stroke|2|||
124618006|NCT00287586|448217773|FG001|Overall Study|Stroke|0|||
124618007|NCT00287586|448217772|FG000|Overall Study|Myocardial Infarction|1|||
124618008|NCT00287586|448217773|FG001|Overall Study|Myocardial Infarction|0|||
124618009|NCT00287586|448217772|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
124782134|NCT01349049|448832755|FG000|Overall Study|Other|0|||
124618010|NCT00287586|448217773|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
124618011|NCT00287586|448217772|FG000|Overall Study|Cognitive Impairment|1|||
124618012|NCT00287586|448217773|FG001|Overall Study|Cognitive Impairment|0|||
124618013|NCT00287586|448217772|FG000|Overall Study|Pancreatic Cancer|1|||
124618014|NCT00287586|448217773|FG001|Overall Study|Pancreatic Cancer|3|||
124618015|NCT00287586|448217772|FG000|Overall Study|Sleep Apnea|1|||
124618016|NCT00287586|448217773|FG001|Overall Study|Sleep Apnea|0|||
124618017|NCT00287586|448217772|FG000|Overall Study|Shoulder Pain|1|||
124618018|NCT00287586|448217773|FG001|Overall Study|Shoulder Pain|0|||
124618019|NCT00287586|448217772|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
124618020|NCT00287586|448217773|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
124618021|NCT00287586|448217772|FG000|Overall Study|Nonadherence|1|||
124618022|NCT00287586|448217773|FG001|Overall Study|Nonadherence|1|||
124618023|NCT00287586|448217772|FG000|Overall Study|Enrolled in Another Study|1|||
124618024|NCT00287586|448217773|FG001|Overall Study|Enrolled in Another Study|0|||
124618025|NCT00287586|448217772|FG000|Overall Study|Major Depression|0|||
124618026|NCT00287586|448217773|FG001|Overall Study|Major Depression|2|||
124618027|NCT00287586|448217772|FG000|Overall Study|Lung Cancer|0|||
124618028|NCT00287586|448217773|FG001|Overall Study|Lung Cancer|2|||
124618029|NCT00287586|448217772|FG000|Overall Study|Elevated IPSS Score|0|||
124618030|NCT00287586|448217773|FG001|Overall Study|Elevated IPSS Score|1|||
124618031|NCT00287586|448217772|FG000|Overall Study|Retroperitoneal Cancer|0|||
124618032|NCT00287586|448217773|FG001|Overall Study|Retroperitoneal Cancer|1|||
124618033|NCT00287586|448217772|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
124618034|NCT00287586|448217773|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
124618035|NCT00287586|448217772|FG000|Overall Study|Mood Swings and Irritability|0|||
124618036|NCT00287586|448217773|FG001|Overall Study|Mood Swings and Irritability|1|||
124618037|NCT00287586|448217772|FG000|Overall Study|Bradycardia|0|||
124618038|NCT00287586|448217773|FG001|Overall Study|Bradycardia|1|||
124618039|NCT00287586|448217772|FG000|Overall Study|Itchy Swollen Eyes|0|||
124618040|NCT00287586|448217773|FG001|Overall Study|Itchy Swollen Eyes|1|||
124618041|NCT00287586|448217772|FG000|Overall Study|Recurrent Melanoma|0|||
124618042|NCT00287586|448217773|FG001|Overall Study|Recurrent Melanoma|1|||
124618043|NCT03106987|448217779|FG000|Overall Study|Death|37|||
124618044|NCT03106987|448217780|FG001|Overall Study|Death|22|||
124618045|NCT03106987|448217781|FG002|Overall Study|Death|12|||
124618046|NCT03106987|448217782|FG003|Overall Study|Death|8|||
124618047|NCT03106987|448217779|FG000|Overall Study|Lost to Follow-up|2|||
124618048|NCT03106987|448217780|FG001|Overall Study|Lost to Follow-up|0|||
124618049|NCT03106987|448217781|FG002|Overall Study|Lost to Follow-up|2|||
124618050|NCT03106987|448217782|FG003|Overall Study|Lost to Follow-up|2|||
124618051|NCT03106987|448217779|FG000|Overall Study|Withdrawal by Subject|5|||
124618052|NCT03106987|448217780|FG001|Overall Study|Withdrawal by Subject|1|||
124618053|NCT03106987|448217781|FG002|Overall Study|Withdrawal by Subject|4|||
124618054|NCT03106987|448217782|FG003|Overall Study|Withdrawal by Subject|1|||
124618055|NCT02114385|448217783|FG000|Overall Study|Withdrawal by Subject|3|||
124618056|NCT02114385|448217784|FG001|Overall Study|Withdrawal by Subject|2|||
124618057|NCT02114385|448217783|FG000|Overall Study|Lost to Follow-up|0|||
124618058|NCT02114385|448217784|FG001|Overall Study|Lost to Follow-up|6|||
124618059|NCT01275729|448217785|FG000|Overall Study|Death|3|||
124618060|NCT01275729|448217785|FG000|Overall Study|Withdrawal by Subject|1|||
124618061|NCT00799825|448217788|FG000|Overall Study|Adverse Event|1|||
124618062|NCT00799825|448217788|FG000|Overall Study|Withdrawal by Subject|6|||
124618063|NCT00799825|448217788|FG000|Overall Study|Lost to Follow-up|38|||
124618064|NCT00799825|448217788|FG000|Overall Study|Pregnancy|3|||
124618065|NCT00582010|448217789|FG000|Overall Study|Death|0|||
124618066|NCT00582010|448217790|FG001|Overall Study|Death|1|||
124744405|NCT01972789|448684927|FG001|Overall Study|Subject withdrew consent|12|||
124744406|NCT01972789|448684926|FG000|Overall Study|Lost to Follow-up|4|||
124744407|NCT01972789|448684927|FG001|Overall Study|Lost to Follow-up|7|||
124744408|NCT01972789|448684926|FG000|Overall Study|Death|7|||
124744409|NCT01972789|448684927|FG001|Overall Study|Death|5|||
124744410|NCT01972789|448684926|FG000|Overall Study|Protocol deviation|1|||
124618067|NCT02439970|448217791|FG000|Overall Study|Study Terminated|2|||
124618068|NCT02439970|448217792|FG001|Overall Study|Study Terminated|3|||
124618069|NCT02640690|448217793|FG000|Overall Study|Lost to Follow-up|7|||
124618070|NCT02640690|448217794|FG001|Overall Study|Lost to Follow-up|7|||
124618071|NCT02640690|448217793|FG000|Overall Study|Withdrawal by Subject|16|||
124618072|NCT02640690|448217794|FG001|Overall Study|Withdrawal by Subject|20|||
124618073|NCT02640690|448217793|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
124618074|NCT02640690|448217794|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
124618075|NCT01520870|448217795|FG000|Overall Study|Withdrawal by Subject|2|||
124618076|NCT02910011|448217798|FG000|Overall Study|Physician Decision|2|||
124744411|NCT01972789|448684927|FG001|Overall Study|Protocol deviation|0|||
124744412|NCT01972789|448684926|FG000|Overall Study|Physician Decision|3|||
124744413|NCT01972789|448684927|FG001|Overall Study|Physician Decision|2|||
124618077|NCT02463357|448217799|FG000|Overall Study|Withdrawal by Subject|1|||
124618078|NCT02463357|448217800|FG001|Overall Study|Withdrawal by Subject|0|||
124618079|NCT02463357|448217801|FG002|Overall Study|Withdrawal by Subject|0|||
124618080|NCT02463357|448217802|FG003|Overall Study|Withdrawal by Subject|0|||
124618081|NCT02463357|448217803|FG004|Overall Study|Withdrawal by Subject|0|||
124618082|NCT02463357|448217799|FG000|Overall Study|Withdrawal by Subject|0|||
124618083|NCT02463357|448217800|FG001|Overall Study|Withdrawal by Subject|0|||
124618084|NCT02463357|448217801|FG002|Overall Study|Withdrawal by Subject|0|||
124618085|NCT02463357|448217802|FG003|Overall Study|Withdrawal by Subject|0|||
124618086|NCT02463357|448217803|FG004|Overall Study|Withdrawal by Subject|1|||
124618087|NCT01399658|448217806|FG000|Overall Study|Ineligible|1|||
124618088|NCT01399658|448217806|FG000|Overall Study|Machine Technical Issue|3|||
124618089|NCT01399658|448217806|FG000|Overall Study|Alternative therapy|1|||
124618090|NCT01399658|448217806|FG000|Overall Study|No reason given|1|||
124618091|NCT02460679|448217807|FG000|Overall Study|Investigator Decision|1|||
124618092|NCT02460679|448217807|FG000|Overall Study|Withdrawal by Subject|4|||
124618093|NCT02620579|448217808|FG000|Overall Study|Physician Decision|0|||
124618094|NCT02620579|448217809|FG001|Overall Study|Physician Decision|0|||
124618095|NCT02620579|448217810|FG002|Overall Study|Physician Decision|0|||
124618096|NCT02620579|448217811|FG003|Overall Study|Physician Decision|1|||
124618097|NCT02620579|448217808|FG000|Overall Study|Withdrawal by Subject|0|||
124618098|NCT02620579|448217809|FG001|Overall Study|Withdrawal by Subject|1|||
124618099|NCT02620579|448217810|FG002|Overall Study|Withdrawal by Subject|1|||
124618100|NCT02620579|448217811|FG003|Overall Study|Withdrawal by Subject|0|||
124618101|NCT00796107|448217817|FG000|Overall Study|Lack of Efficacy|1|||
124618102|NCT00796107|448217817|FG000|Overall Study|Progressive Disease|5|||
124618103|NCT02681510|448217818|FG000|Overall Study|Withdrawal by Subject|1|||
124618104|NCT02681510|448217818|FG000|Overall Study|Lost to Follow-up|9|||
124618105|NCT04315506|448217819|FG000|Overall Study|Lost to Follow-up|74|||
124618106|NCT04315506|448217820|FG001|Overall Study|Lost to Follow-up|82|||
124618107|NCT04315506|448217819|FG000|Overall Study|Withdrawal by Subject|8|||
124618108|NCT04315506|448217820|FG001|Overall Study|Withdrawal by Subject|8|||
124618109|NCT04315506|448217819|FG000|Overall Study|Physician Decision|0|||
124618110|NCT04315506|448217820|FG001|Overall Study|Physician Decision|1|||
124618111|NCT00958893|448217821|FG000|Overall Study|Study prematurely terminated|4|||
124618112|NCT03593395|448217822|FG000|Overall Study|Lost to Follow-up|48|||
124618113|NCT03593395|448217823|FG001|Overall Study|Lost to Follow-up|3|||
124618114|NCT03593395|448217822|FG000|Overall Study|Withdrawal by Subject|5|||
124618115|NCT03593395|448217823|FG001|Overall Study|Withdrawal by Subject|24|||
124618116|NCT03593395|448217822|FG000|Overall Study|Death|2|||
124618117|NCT03593395|448217823|FG001|Overall Study|Death|3|||
124618118|NCT03593395|448217822|FG000|Overall Study|Physician Decision|0|||
124618119|NCT03593395|448217823|FG001|Overall Study|Physician Decision|6|||
124618120|NCT03593395|448217822|FG000|Overall Study|Participant Relocated|19|||
124618121|NCT03593395|448217823|FG001|Overall Study|Participant Relocated|3|||
124618122|NCT03593395|448217822|FG000|Overall Study|No Information|1|||
124618123|NCT03593395|448217823|FG001|Overall Study|No Information|7|||
124618124|NCT00741338|448217824|FG000|Overall Study|Adverse Event|0|||
124618125|NCT00741338|448217825|FG001|Overall Study|Adverse Event|1|||
124618126|NCT01098474|448217828|FG000|Active Phase|Other|0|||
124618127|NCT01098474|448217829|FG001|Active Phase|Other|0|||
124618128|NCT01098474|448217830|FG002|Active Phase|Other|3|||
124618129|NCT01098474|448217831|FG003|Active Phase|Other|0|||
124618130|NCT01098474|448217832|FG004|Active Phase|Other|0|||
124618131|NCT01098474|448217833|FG005|Active Phase|Other|0|||
124618132|NCT01098474|448217828|FG000|Active Phase|Withdrawal by Subject|1|||
124618133|NCT01098474|448217829|FG001|Active Phase|Withdrawal by Subject|1|||
124618134|NCT01098474|448217830|FG002|Active Phase|Withdrawal by Subject|2|||
124618135|NCT01098474|448217831|FG003|Active Phase|Withdrawal by Subject|0|||
124618136|NCT01098474|448217832|FG004|Active Phase|Withdrawal by Subject|0|||
124618137|NCT01098474|448217833|FG005|Active Phase|Withdrawal by Subject|0|||
124618138|NCT01098474|448217828|FG000|Active Phase|Lost to Follow-up|1|||
124618139|NCT01098474|448217829|FG001|Active Phase|Lost to Follow-up|0|||
124618140|NCT01098474|448217830|FG002|Active Phase|Lost to Follow-up|0|||
124618141|NCT01098474|448217831|FG003|Active Phase|Lost to Follow-up|0|||
124618142|NCT01098474|448217832|FG004|Active Phase|Lost to Follow-up|0|||
124618143|NCT01098474|448217833|FG005|Active Phase|Lost to Follow-up|0|||
124618144|NCT01098474|448217828|FG000|Follow Up Phase|Travelled out of study area|0|||
124618145|NCT01098474|448217829|FG001|Follow Up Phase|Travelled out of study area|0|||
124618146|NCT01098474|448217830|FG002|Follow Up Phase|Travelled out of study area|0|||
124618147|NCT01098474|448217831|FG003|Follow Up Phase|Travelled out of study area|0|||
124618148|NCT01098474|448217832|FG004|Follow Up Phase|Travelled out of study area|1|||
124618149|NCT01098474|448217833|FG005|Follow Up Phase|Travelled out of study area|0|||
124618150|NCT01098474|448217828|FG000|Follow Up Phase|Other|0|||
124618151|NCT01098474|448217829|FG001|Follow Up Phase|Other|0|||
124782135|NCT01349049|448832756|FG001|Overall Study|Other|0|||
124782136|NCT01349049|448832757|FG002|Overall Study|Other|0|||
124618152|NCT01098474|448217830|FG002|Follow Up Phase|Other|0|||
124618153|NCT01098474|448217831|FG003|Follow Up Phase|Other|0|||
124618154|NCT01098474|448217832|FG004|Follow Up Phase|Other|0|||
124618155|NCT01098474|448217833|FG005|Follow Up Phase|Other|4|||
124618156|NCT01098474|448217828|FG000|Follow Up Phase|Withdrawal by Subject|0|||
124618157|NCT01098474|448217829|FG001|Follow Up Phase|Withdrawal by Subject|0|||
124618158|NCT01098474|448217830|FG002|Follow Up Phase|Withdrawal by Subject|0|||
124618159|NCT01098474|448217831|FG003|Follow Up Phase|Withdrawal by Subject|2|||
124618160|NCT01098474|448217832|FG004|Follow Up Phase|Withdrawal by Subject|0|||
124618161|NCT01098474|448217833|FG005|Follow Up Phase|Withdrawal by Subject|1|||
124618162|NCT01098474|448217828|FG000|Follow Up Phase|Lost to Follow-up|0|||
124618163|NCT01098474|448217829|FG001|Follow Up Phase|Lost to Follow-up|0|||
124618164|NCT01098474|448217830|FG002|Follow Up Phase|Lost to Follow-up|0|||
124618165|NCT01098474|448217831|FG003|Follow Up Phase|Lost to Follow-up|0|||
124618166|NCT01098474|448217832|FG004|Follow Up Phase|Lost to Follow-up|1|||
124618167|NCT01098474|448217833|FG005|Follow Up Phase|Lost to Follow-up|0|||
124618168|NCT00704132|448217844|FG000|Overall Study|Clinical Adverse Experience|1|||
124618169|NCT00704132|448217845|FG001|Overall Study|Clinical Adverse Experience|0|||
124618170|NCT00704132|448217844|FG000|Overall Study|Lack of Efficacy|0|||
124618171|NCT00704132|448217845|FG001|Overall Study|Lack of Efficacy|1|||
124618172|NCT00704132|448217844|FG000|Overall Study|Withdrawal by Subject|0|||
124618173|NCT00704132|448217845|FG001|Overall Study|Withdrawal by Subject|1|||
124618174|NCT00182325|448217846|FG000|Overall Study|Lost to Follow-up|7|||
124618175|NCT00182325|448217847|FG001|Overall Study|Lost to Follow-up|7|||
124618176|NCT00182325|448217846|FG000|Overall Study|Miscarriage|5|||
124618177|NCT00182325|448217847|FG001|Overall Study|Miscarriage|3|||
124618178|NCT00182325|448217846|FG000|Overall Study|Did not complete survey|22|||
124618179|NCT00182325|448217847|FG001|Overall Study|Did not complete survey|43|||
124618180|NCT03607487|448217850|FG000|Overall Study|Withdrawal by Subject|2|||
124618181|NCT03607487|448217851|FG001|Overall Study|Withdrawal by Subject|0|||
124618182|NCT03607487|448217852|FG002|Overall Study|Withdrawal by Subject|0|||
124618183|NCT03607487|448217853|FG003|Overall Study|Withdrawal by Subject|1|||
124618184|NCT01141205|448217854|FG000|Overall Study|Physician Decision|1|||
124618185|NCT01141205|448217855|FG001|Overall Study|Physician Decision|1|||
124618186|NCT01141205|448217854|FG000|Overall Study|Lost to Follow-up|1|||
124618187|NCT01141205|448217855|FG001|Overall Study|Lost to Follow-up|0|||
124618188|NCT01141205|448217854|FG000|Overall Study|Withdrawal by Subject|1|||
124618189|NCT01141205|448217855|FG001|Overall Study|Withdrawal by Subject|1|||
124618190|NCT01822366|448217859|FG000|Overall Study|Lost to Follow-up|5|||
124618191|NCT01822366|448217860|FG001|Overall Study|Lost to Follow-up|1|||
124618192|NCT01822366|448217861|FG002|Overall Study|Lost to Follow-up|5|||
124618193|NCT01822366|448217862|FG003|Overall Study|Lost to Follow-up|1|||
124618194|NCT01822366|448217859|FG000|Overall Study|Withdrawal by Subject|0|||
124618195|NCT01822366|448217860|FG001|Overall Study|Withdrawal by Subject|6|||
124618196|NCT01822366|448217861|FG002|Overall Study|Withdrawal by Subject|0|||
124618197|NCT01822366|448217862|FG003|Overall Study|Withdrawal by Subject|6|||
124618198|NCT01822366|448217859|FG000|Overall Study|Partial Intervention Completion|0|||
124618199|NCT01822366|448217860|FG001|Overall Study|Partial Intervention Completion|15|||
124618200|NCT01822366|448217861|FG002|Overall Study|Partial Intervention Completion|0|||
124618201|NCT01822366|448217862|FG003|Overall Study|Partial Intervention Completion|15|||
124618202|NCT05199090|448217863|FG000|Overall Study|Adverse Event|1|||
124618203|NCT05199090|448217864|FG001|Overall Study|Adverse Event|4|||
124618204|NCT05199090|448217865|FG002|Overall Study|Adverse Event|0|||
124618205|NCT05199090|448217866|FG003|Overall Study|Adverse Event|0|||
124618206|NCT05199090|448217867|FG004|Overall Study|Adverse Event|0|||
124618207|NCT05199090|448217868|FG005|Overall Study|Adverse Event|0|||
124618208|NCT05199090|448217863|FG000|Overall Study|Lost to Follow-up|1|||
124618209|NCT05199090|448217864|FG001|Overall Study|Lost to Follow-up|0|||
124618210|NCT05199090|448217865|FG002|Overall Study|Lost to Follow-up|1|||
124618211|NCT05199090|448217866|FG003|Overall Study|Lost to Follow-up|4|||
124618212|NCT05199090|448217867|FG004|Overall Study|Lost to Follow-up|0|||
124618213|NCT05199090|448217868|FG005|Overall Study|Lost to Follow-up|5|||
124618214|NCT05199090|448217863|FG000|Overall Study|Physician Decision|0|||
124618215|NCT05199090|448217864|FG001|Overall Study|Physician Decision|0|||
124618216|NCT05199090|448217865|FG002|Overall Study|Physician Decision|0|||
124618217|NCT05199090|448217866|FG003|Overall Study|Physician Decision|0|||
124618218|NCT05199090|448217867|FG004|Overall Study|Physician Decision|0|||
124618219|NCT05199090|448217868|FG005|Overall Study|Physician Decision|1|||
124618220|NCT05199090|448217863|FG000|Overall Study|Study terminated by sponsor|0|||
124618221|NCT05199090|448217864|FG001|Overall Study|Study terminated by sponsor|6|||
124618222|NCT05199090|448217865|FG002|Overall Study|Study terminated by sponsor|0|||
124618223|NCT05199090|448217866|FG003|Overall Study|Study terminated by sponsor|0|||
124618224|NCT05199090|448217867|FG004|Overall Study|Study terminated by sponsor|0|||
124618225|NCT05199090|448217868|FG005|Overall Study|Study terminated by sponsor|5|||
124618226|NCT05199090|448217863|FG000|Overall Study|Subject decision|0|||
124618227|NCT05199090|448217864|FG001|Overall Study|Subject decision|4|||
124618228|NCT05199090|448217865|FG002|Overall Study|Subject decision|0|||
124618229|NCT05199090|448217866|FG003|Overall Study|Subject decision|2|||
124618230|NCT05199090|448217867|FG004|Overall Study|Subject decision|5|||
124618231|NCT05199090|448217868|FG005|Overall Study|Subject decision|2|||
124618232|NCT03276078|448217869|FG000|Overall Study|Adverse Event|1|||
124618233|NCT02552732|448217870|FG000|Overall Study|Lost to Follow-up|2|||
124618234|NCT02552732|448217870|FG000|Overall Study|Physician Decision|1|||
124618235|NCT02552732|448217870|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
124618236|NCT02552732|448217870|FG000|Overall Study|Withdrawal by Subject|6|||
124618237|NCT02290223|448217874|FG000|6 Months|Lost to Follow-up|9|||
124618238|NCT02290223|448217875|FG001|6 Months|Lost to Follow-up|6|||
124618239|NCT02290223|448217874|FG000|6 Months|Withdrawal by Subject|5|||
124618240|NCT02290223|448217875|FG001|6 Months|Withdrawal by Subject|0|||
124618241|NCT02290223|448217874|FG000|6 Months|deceased (not related to study)|2|||
124618242|NCT02290223|448217875|FG001|6 Months|deceased (not related to study)|0|||
124618243|NCT02290223|448217874|FG000|12 Months|Lost to Follow-up|16|||
124618244|NCT02290223|448217875|FG001|12 Months|Lost to Follow-up|10|||
124618245|NCT02290223|448217874|FG000|12 Months|Refusal|0|||
124618246|NCT02290223|448217875|FG001|12 Months|Refusal|1|||
124618247|NCT01004003|448217878|FG000|Overall Study|Progressive disease|2|||
124618248|NCT01004003|448217879|FG001|Overall Study|Progressive disease|1|||
124618249|NCT01004003|448217880|FG002|Overall Study|Progressive disease|1|||
124618250|NCT01004003|448217881|FG003|Overall Study|Progressive disease|0|||
124618251|NCT01004003|448217882|FG004|Overall Study|Progressive disease|2|||
124618252|NCT01004003|448217883|FG005|Overall Study|Progressive disease|1|||
124618253|NCT01004003|448217884|FG006|Overall Study|Progressive disease|1|||
124618254|NCT01004003|448217885|FG007|Overall Study|Progressive disease|39|||
124618255|NCT01004003|448217886|FG008|Overall Study|Progressive disease|22|||
124618256|NCT01004003|448217878|FG000|Overall Study|Adverse Event|4|||
124618257|NCT01004003|448217879|FG001|Overall Study|Adverse Event|2|||
124618258|NCT01004003|448217880|FG002|Overall Study|Adverse Event|3|||
124618259|NCT01004003|448217881|FG003|Overall Study|Adverse Event|3|||
124618260|NCT01004003|448217882|FG004|Overall Study|Adverse Event|2|||
124618261|NCT01004003|448217883|FG005|Overall Study|Adverse Event|2|||
124618262|NCT01004003|448217884|FG006|Overall Study|Adverse Event|7|||
124618263|NCT01004003|448217885|FG007|Overall Study|Adverse Event|21|||
124618264|NCT01004003|448217886|FG008|Overall Study|Adverse Event|6|||
124618265|NCT01004003|448217878|FG000|Overall Study|Refused to continue taking trial med.|0|||
124618266|NCT01004003|448217879|FG001|Overall Study|Refused to continue taking trial med.|0|||
124618267|NCT01004003|448217880|FG002|Overall Study|Refused to continue taking trial med.|0|||
124618268|NCT01004003|448217881|FG003|Overall Study|Refused to continue taking trial med.|0|||
124618269|NCT01004003|448217882|FG004|Overall Study|Refused to continue taking trial med.|0|||
124618270|NCT01004003|448217883|FG005|Overall Study|Refused to continue taking trial med.|0|||
124618271|NCT01004003|448217884|FG006|Overall Study|Refused to continue taking trial med.|0|||
124618272|NCT01004003|448217885|FG007|Overall Study|Refused to continue taking trial med.|0|||
124618273|NCT01004003|448217886|FG008|Overall Study|Refused to continue taking trial med.|2|||
124618274|NCT01004003|448217878|FG000|Overall Study|Other|0|||
124618275|NCT01004003|448217879|FG001|Overall Study|Other|0|||
124618276|NCT01004003|448217880|FG002|Overall Study|Other|0|||
124618277|NCT01004003|448217881|FG003|Overall Study|Other|0|||
124618278|NCT01004003|448217882|FG004|Overall Study|Other|0|||
124618279|NCT01004003|448217883|FG005|Overall Study|Other|1|||
124618280|NCT01004003|448217884|FG006|Overall Study|Other|0|||
124618281|NCT01004003|448217885|FG007|Overall Study|Other|0|||
124618282|NCT01004003|448217886|FG008|Overall Study|Other|0|||
124618283|NCT05819203|448217889|FG000|Overall Study|Protocol Violation|1|||
124618284|NCT05819203|448217890|FG001|Overall Study|Protocol Violation|2|||
124618285|NCT05819203|448217889|FG000|Overall Study|Withdrawal by Subject|1|||
124618286|NCT05819203|448217890|FG001|Overall Study|Withdrawal by Subject|0|||
124618287|NCT02185053|448217891|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
124618288|NCT02185053|448217892|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
124618289|NCT02185053|448217893|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
124618290|NCT02185053|448217891|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
124618291|NCT02185053|448217892|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
124618292|NCT02185053|448217893|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
124618293|NCT02185053|448217891|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
124618294|NCT02185053|448217892|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
124618295|NCT02185053|448217893|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
124618296|NCT02185053|448217891|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
124618297|NCT02185053|448217892|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
124618298|NCT02185053|448217893|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
124618299|NCT02185053|448217891|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
124618300|NCT02185053|448217892|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
124618301|NCT02185053|448217893|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
124618302|NCT02185053|448217891|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
124618303|NCT02185053|448217892|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
124618304|NCT02185053|448217893|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
124618305|NCT02185053|448217891|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
124618306|NCT02185053|448217892|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
124618307|NCT02185053|448217893|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
124618308|NCT02185053|448217891|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
124618309|NCT02185053|448217892|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
124618310|NCT02185053|448217893|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
124618311|NCT02521376|448217896|FG000|Overall Study|Enrolled, But Not Treated|1|||
124618312|NCT02521376|448217897|FG001|Overall Study|Enrolled, But Not Treated|0|||
124618313|NCT02521376|448217898|FG002|Overall Study|Enrolled, But Not Treated|0|||
124618314|NCT02521376|448217899|FG003|Overall Study|Enrolled, But Not Treated|0|||
124618315|NCT03597464|448217905|FG000|Overall Study|Withdrawal by Subject|4|||
124618316|NCT03597464|448217906|FG001|Overall Study|Withdrawal by Subject|5|||
124618317|NCT03597464|448217905|FG000|Overall Study|Lost to Follow-up|3|||
124618318|NCT03597464|448217906|FG001|Overall Study|Lost to Follow-up|1|||
124618319|NCT03597464|448217905|FG000|Overall Study|Pregnancy|3|||
124618320|NCT03597464|448217906|FG001|Overall Study|Pregnancy|1|||
124618321|NCT03597464|448217905|FG000|Overall Study|Lack of Efficacy|2|||
124618322|NCT03597464|448217906|FG001|Overall Study|Lack of Efficacy|0|||
124618323|NCT03597464|448217905|FG000|Overall Study|Physician Decision|2|||
124618324|NCT03597464|448217906|FG001|Overall Study|Physician Decision|2|||
124618325|NCT03597464|448217905|FG000|Overall Study|Protocol Violation|1|||
124618326|NCT03597464|448217906|FG001|Overall Study|Protocol Violation|1|||
124618327|NCT03597464|448217905|FG000|Overall Study|Adverse Event|0|||
124618328|NCT03597464|448217906|FG001|Overall Study|Adverse Event|2|||
124618329|NCT03597464|448217905|FG000|Overall Study|Death|0|||
124618330|NCT03597464|448217906|FG001|Overall Study|Death|3|||
124618331|NCT00143247|448217911|FG000|Overall Study|Death|8|||
124618332|NCT00143247|448217911|FG000|Overall Study|Adverse Event|19|||
124618333|NCT00143247|448217911|FG000|Overall Study|Lack of Efficacy|3|||
124618334|NCT00143247|448217911|FG000|Overall Study|Withdrawal by Subject|55|||
124618335|NCT00143247|448217911|FG000|Overall Study|Study terminated by sponsor|31|||
124618336|NCT00143247|448217911|FG000|Overall Study|Protocol Violation|15|||
124618337|NCT00143247|448217911|FG000|Overall Study|Lost to Follow-up|12|||
124618338|NCT00143247|448217911|FG000|Overall Study|following inaccurate lab adverse event|1|||
124618339|NCT00143247|448217911|FG000|Overall Study|Other|12|||
124618340|NCT00340678|448217912|FG000|Overall Study|Lost to Follow-up|1|||
124618341|NCT00340678|448217913|FG001|Overall Study|Lost to Follow-up|0|||
124618342|NCT00340678|448217914|FG002|Overall Study|Lost to Follow-up|0|||
124618343|NCT00340678|448217915|FG003|Overall Study|Lost to Follow-up|0|||
124618344|NCT05048329|448219304|FG000|Overall Study|Withdrawal by Subject|1|||
124618345|NCT05048329|448219304|FG000|Overall Study|Screenfail|1|||
124618346|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criterion #1|24|||
124618347|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criterion #1|0|||
124618348|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
124618349|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
124618350|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
124618351|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
124618352|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
124618353|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
124618354|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
124618355|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
124618356|NCT03888066|448219305|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
124618357|NCT03888066|448219306|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
124618358|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
124618359|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
124618360|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
124618361|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
124618362|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
124618363|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
124618364|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
124618365|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
124618366|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criterion #2|5|||
124618367|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criterion #2|0|||
124618368|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
124618369|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
124618370|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
124618371|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
124618372|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
124618373|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
124618374|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criterion #3|11|||
124618375|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criterion #3|0|||
124618376|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
124618377|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
124618378|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
124637420|NCT02589639|448290533|FG001|Overall Study|Protocol Violation|0|||
124782137|NCT01349049|448832758|FG003|Overall Study|Other|0|||
124782138|NCT01349049|448832759|FG004|Overall Study|Other|0|||
124782139|NCT01349049|448832760|FG005|Overall Study|Other|1|||
124782140|NCT01349049|448832761|FG006|Overall Study|Other|0|||
124782141|NCT01349049|448832762|FG007|Overall Study|Other|0|||
124782142|NCT01349049|448832763|FG008|Overall Study|Other|4|||
124782143|NCT01349049|448832755|FG000|Overall Study|Death|0|||
124782144|NCT01349049|448832756|FG001|Overall Study|Death|0|||
124782145|NCT01349049|448832757|FG002|Overall Study|Death|0|||
124782146|NCT01349049|448832758|FG003|Overall Study|Death|0|||
124782147|NCT01349049|448832759|FG004|Overall Study|Death|0|||
124782148|NCT01349049|448832760|FG005|Overall Study|Death|0|||
124782149|NCT01349049|448832761|FG006|Overall Study|Death|0|||
124782150|NCT01349049|448832762|FG007|Overall Study|Death|1|||
124782151|NCT01349049|448832763|FG008|Overall Study|Death|5|||
124782152|NCT01349049|448832755|FG000|Overall Study|Non-compliance|0|||
124782153|NCT01349049|448832756|FG001|Overall Study|Non-compliance|0|||
124782154|NCT01349049|448832757|FG002|Overall Study|Non-compliance|0|||
124782155|NCT01349049|448832758|FG003|Overall Study|Non-compliance|1|||
124782156|NCT01349049|448832759|FG004|Overall Study|Non-compliance|0|||
124782157|NCT01349049|448832760|FG005|Overall Study|Non-compliance|0|||
124782158|NCT01349049|448832761|FG006|Overall Study|Non-compliance|0|||
124782159|NCT01349049|448832762|FG007|Overall Study|Non-compliance|0|||
124782160|NCT01349049|448832763|FG008|Overall Study|Non-compliance|0|||
124782161|NCT01349049|448832755|FG000|Overall Study|Withdrawal by Subject|0|||
124782162|NCT01349049|448832756|FG001|Overall Study|Withdrawal by Subject|0|||
124618379|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
124618380|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
124618381|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
124744414|NCT00086411|448684935|FG000|Overall Study|Lost to Follow-up|11|||
124744415|NCT00086411|448684936|FG001|Overall Study|Lost to Follow-up|11|||
124744416|NCT00086411|448684937|FG002|Overall Study|Lost to Follow-up|13|||
124744417|NCT00086411|448684938|FG003|Overall Study|Lost to Follow-up|12|||
124744418|NCT03667690|448687369|FG000|Overall Study|Adverse Event|0|||
124744419|NCT03667690|448687370|FG001|Overall Study|Adverse Event|3|||
124744420|NCT03667690|448687369|FG000|Overall Study|Death|22|||
124744421|NCT03667690|448687370|FG001|Overall Study|Death|21|||
124744422|NCT03667690|448687369|FG000|Overall Study|Lost to Follow-up|4|||
124744423|NCT03667690|448687370|FG001|Overall Study|Lost to Follow-up|5|||
124744424|NCT03667690|448687369|FG000|Overall Study|Withdrawal by Subject|7|||
124744425|NCT03667690|448687370|FG001|Overall Study|Withdrawal by Subject|8|||
124744426|NCT03667690|448687369|FG000|Overall Study|Subject could not return for additional investigational product|1|||
124744427|NCT03667690|448687370|FG001|Overall Study|Subject could not return for additional investigational product|0|||
124744428|NCT03667690|448687369|FG000|Overall Study|Subject discharged to hospice care|2|||
124744429|NCT03667690|448687370|FG001|Overall Study|Subject discharged to hospice care|0|||
124744430|NCT03667690|448687369|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
124744431|NCT03667690|448687370|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
124744432|NCT03667690|448687369|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
124744433|NCT03667690|448687370|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
124744434|NCT03667690|448687369|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
124744435|NCT03667690|448687370|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
124744436|NCT03667690|448687369|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
124744437|NCT03667690|448687370|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
124744438|NCT03667690|448687369|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
124744439|NCT03667690|448687370|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
124744440|NCT00321464|448687374|FG000|Overall Study|Death|169|||
124744441|NCT00321464|448687375|FG001|Overall Study|Death|174|||
124744442|NCT00321464|448687374|FG000|Overall Study|Disease progression|124|||
124744443|NCT00321464|448687375|FG001|Overall Study|Disease progression|124|||
124744444|NCT00321464|448687374|FG000|Overall Study|Withdrawal by Subject|117|||
124744445|NCT00321464|448687375|FG001|Overall Study|Withdrawal by Subject|118|||
124744446|NCT00321464|448687374|FG000|Overall Study|Participant request|57|||
124744447|NCT00321464|448687375|FG001|Overall Study|Participant request|61|||
124782163|NCT01349049|448832757|FG002|Overall Study|Withdrawal by Subject|0|||
124782164|NCT01349049|448832758|FG003|Overall Study|Withdrawal by Subject|0|||
124782165|NCT01349049|448832759|FG004|Overall Study|Withdrawal by Subject|0|||
124782166|NCT01349049|448832760|FG005|Overall Study|Withdrawal by Subject|0|||
124782167|NCT01349049|448832761|FG006|Overall Study|Withdrawal by Subject|0|||
124782168|NCT01349049|448832762|FG007|Overall Study|Withdrawal by Subject|0|||
124782169|NCT01349049|448832763|FG008|Overall Study|Withdrawal by Subject|6|||
124782170|NCT02810444|448832768|FG000|Overall Study|Screen Failures|14|||
124782171|NCT02810444|448832768|FG000|Overall Study|Withdrawal by Subject|4|||
124744448|NCT00321464|448687374|FG000|Overall Study|Adverse Event|43|||
124744449|NCT00321464|448687375|FG001|Overall Study|Adverse Event|28|||
124744450|NCT00321464|448687374|FG000|Overall Study|Physician Decision|15|||
124744451|NCT00321464|448687375|FG001|Overall Study|Physician Decision|14|||
124744452|NCT00321464|448687374|FG000|Overall Study|Noncompliance|4|||
124744453|NCT00321464|448687375|FG001|Overall Study|Noncompliance|10|||
124744454|NCT00321464|448687374|FG000|Overall Study|Lost to Follow-up|7|||
124744455|NCT00321464|448687375|FG001|Overall Study|Lost to Follow-up|8|||
124744456|NCT00321464|448687374|FG000|Overall Study|Protocol deviation|0|||
124744457|NCT00321464|448687375|FG001|Overall Study|Protocol deviation|2|||
124744458|NCT00321464|448687374|FG000|Overall Study|Ineligibility determined|2|||
124744459|NCT00321464|448687375|FG001|Overall Study|Ineligibility determined|1|||
124744460|NCT00321464|448687374|FG000|Overall Study|Other|21|||
124744461|NCT00321464|448687375|FG001|Overall Study|Other|18|||
124782172|NCT02810444|448832768|FG000|Overall Study|Adverse Event|3|||
124618382|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criterion #4|3|||
124618383|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criterion #4|0|||
124618384|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
124618385|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
124618386|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
124618387|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
124618388|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
124618389|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
124618390|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
124618391|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
124618392|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
124618393|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
124618394|NCT03888066|448219305|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
124618395|NCT03888066|448219306|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
124618396|NCT03888066|448219305|FG000|Run-in Phase|AE (Adverse Event)|17|||
124618397|NCT03888066|448219306|FG001|Run-in Phase|AE (Adverse Event)|0|||
124618398|NCT03888066|448219305|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
124618399|NCT03888066|448219306|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
124618400|NCT03888066|448219305|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
124618401|NCT03888066|448219306|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
124618402|NCT03888066|448219305|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
124618403|NCT03888066|448219306|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
124618404|NCT03888066|448219305|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
124618405|NCT03888066|448219306|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
124618406|NCT03888066|448219305|FG000|Run-in Phase|Withdrawal by Subject|43|||
124618407|NCT03888066|448219306|FG001|Run-in Phase|Withdrawal by Subject|0|||
124618408|NCT03888066|448219305|FG000|Run-in Phase|AE; Physician Decision|1|||
124618409|NCT03888066|448219306|FG001|Run-in Phase|AE; Physician Decision|0|||
124618410|NCT03888066|448219305|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
124618411|NCT03888066|448219306|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
124618412|NCT03888066|448219305|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
124618413|NCT03888066|448219306|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
124618414|NCT03888066|448219305|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
124618415|NCT03888066|448219306|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
124618416|NCT03888066|448219305|FG000|Run-in Phase|Death|1|||
124618417|NCT03888066|448219306|FG001|Run-in Phase|Death|0|||
124618418|NCT03888066|448219305|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
124618419|NCT03888066|448219306|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
124618420|NCT03888066|448219305|FG000|Run-in Phase|Physician Decision|1|||
124618421|NCT03888066|448219306|FG001|Run-in Phase|Physician Decision|0|||
124618422|NCT03888066|448219305|FG000|Run-in Phase|Protocol Violation|13|||
124618423|NCT03888066|448219306|FG001|Run-in Phase|Protocol Violation|0|||
124618424|NCT03888066|448219305|FG000|Run-in Phase|Sponsor Request|34|||
124618425|NCT03888066|448219306|FG001|Run-in Phase|Sponsor Request|0|||
124618426|NCT03888066|448219305|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
124618427|NCT03888066|448219306|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
124618428|NCT03888066|448219305|FG000|Run-in Phase|Withdrawal Of Consent|1|||
124618429|NCT03888066|448219306|FG001|Run-in Phase|Withdrawal Of Consent|0|||
124618430|NCT03888066|448219305|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
124618431|NCT03888066|448219306|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
124744462|NCT04327024|448687376|FG000|Overall Study|Death|1|||
124744463|NCT04327024|448687377|FG001|Overall Study|Death|2|||
124782173|NCT02881567|448832774|FG000|Overall Study|Adverse Event|1|||
124744464|NCT04327024|448687378|FG002|Overall Study|Death|1|||
124782174|NCT02881567|448832774|FG000|Overall Study|Lost to Follow-up|3|||
124744465|NCT04327024|448687376|FG000|Overall Study|Non-compliance with study drug|0|||
124744466|NCT04327024|448687377|FG001|Overall Study|Non-compliance with study drug|1|||
124744467|NCT04327024|448687378|FG002|Overall Study|Non-compliance with study drug|0|||
124744468|NCT04327024|448687376|FG000|Overall Study|Withdrawal by Subject|1|||
124744469|NCT04327024|448687377|FG001|Overall Study|Withdrawal by Subject|1|||
124744470|NCT04327024|448687378|FG002|Overall Study|Withdrawal by Subject|2|||
124744471|NCT01192568|448687382|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
124744472|NCT01192568|448687383|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
124744473|NCT01192568|448687384|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
124744474|NCT01192568|448687385|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
124744475|NCT01192568|448687382|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
124744476|NCT01192568|448687383|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
124744477|NCT01192568|448687384|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
124744478|NCT01192568|448687385|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
124744479|NCT00652951|448687386|FG000|Booster Phase|Adverse event, non-fatal|0|||
124744480|NCT00652951|448687387|FG001|Booster Phase|Adverse event, non-fatal|1|||
124744481|NCT00652951|448687388|FG002|Booster Phase|Adverse event, non-fatal|0|||
124618432|NCT03888066|448219305|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
124618433|NCT03888066|448219306|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
124618434|NCT03888066|448219305|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
124618435|NCT03888066|448219306|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
124618436|NCT03888066|448219305|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
124618437|NCT03888066|448219306|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
124618438|NCT03888066|448219305|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
124618439|NCT03888066|448219306|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
124618440|NCT03888066|448219305|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
124618441|NCT03888066|448219306|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
124618442|NCT03888066|448219305|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
124618443|NCT03888066|448219306|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
124618444|NCT03888066|448219305|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
124618445|NCT03888066|448219306|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
124618446|NCT03888066|448219305|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
124618447|NCT03888066|448219306|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
124618448|NCT03888066|448219305|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
124618449|NCT03888066|448219306|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
124618450|NCT03888066|448219305|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
124618451|NCT03888066|448219306|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
124618452|NCT03888066|448219305|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
124618453|NCT03888066|448219306|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
124618454|NCT00591773|448219313|FG000|Overall Study|Adverse Event|9|||
124618455|NCT00591773|448219314|FG001|Overall Study|Adverse Event|9|||
124618456|NCT00591773|448219315|FG002|Overall Study|Adverse Event|6|||
124618457|NCT00591773|448219313|FG000|Overall Study|Protocol Violation|2|||
124618458|NCT00591773|448219314|FG001|Overall Study|Protocol Violation|3|||
124618459|NCT00591773|448219315|FG002|Overall Study|Protocol Violation|0|||
124618460|NCT00591773|448219313|FG000|Overall Study|Lost to Follow-up|1|||
124618461|NCT00591773|448219314|FG001|Overall Study|Lost to Follow-up|4|||
124618462|NCT00591773|448219315|FG002|Overall Study|Lost to Follow-up|1|||
124618463|NCT00591773|448219313|FG000|Overall Study|Withdrawal by Subject|2|||
124618464|NCT00591773|448219314|FG001|Overall Study|Withdrawal by Subject|5|||
124618465|NCT00591773|448219315|FG002|Overall Study|Withdrawal by Subject|3|||
124618466|NCT00591773|448219313|FG000|Overall Study|Lack of Efficacy|1|||
124618467|NCT00591773|448219314|FG001|Overall Study|Lack of Efficacy|2|||
124618468|NCT00591773|448219315|FG002|Overall Study|Lack of Efficacy|2|||
124618469|NCT00591773|448219313|FG000|Overall Study|Other|1|||
124618470|NCT00591773|448219314|FG001|Overall Study|Other|1|||
124618471|NCT00591773|448219315|FG002|Overall Study|Other|4|||
124618472|NCT02135614|448219316|FG000|Overall Study|Randomized but Not Treated|2|||
124618473|NCT02135614|448219317|FG001|Overall Study|Randomized but Not Treated|1|||
124618474|NCT02135614|448219316|FG000|Overall Study|Adverse Event|0|||
124618475|NCT02135614|448219317|FG001|Overall Study|Adverse Event|1|||
124618476|NCT02135614|448219316|FG000|Overall Study|Death|1|||
124618477|NCT02135614|448219317|FG001|Overall Study|Death|0|||
124618478|NCT02135614|448219316|FG000|Overall Study|Investigator's Discretion|0|||
124618479|NCT02135614|448219317|FG001|Overall Study|Investigator's Discretion|1|||
124618480|NCT02135614|448219316|FG000|Overall Study|Withdrew Consent|2|||
124618481|NCT02135614|448219317|FG001|Overall Study|Withdrew Consent|2|||
124618482|NCT02135614|448219316|FG000|Overall Study|Lost to Follow-up|3|||
124618483|NCT02135614|448219317|FG001|Overall Study|Lost to Follow-up|0|||
124618484|NCT01762800|448219324|FG000|Overall Study|Adverse Event|8|||
124618485|NCT01762800|448219325|FG001|Overall Study|Adverse Event|13|||
124744482|NCT00652951|448687386|FG000|Booster Phase|Other|1|||
124744483|NCT00652951|448687387|FG001|Booster Phase|Other|0|||
124744484|NCT00652951|448687388|FG002|Booster Phase|Other|0|||
124618486|NCT01762800|448219324|FG000|Overall Study|Lack of Efficacy|3|||
124618487|NCT01762800|448219325|FG001|Overall Study|Lack of Efficacy|2|||
124637421|NCT02589639|448290534|FG002|Overall Study|Protocol Violation|0|||
124637422|NCT02589639|448290532|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
124637423|NCT02589639|448290533|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
124637424|NCT02589639|448290534|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
124637425|NCT02589639|448290532|FG000|Overall Study|Adverse Event|4|||
124637426|NCT02589639|448290533|FG001|Overall Study|Adverse Event|5|||
124637427|NCT02589639|448290534|FG002|Overall Study|Adverse Event|3|||
124637428|NCT02589639|448290532|FG000|Overall Study|Other reason than specified above|1|||
124637429|NCT02589639|448290533|FG001|Overall Study|Other reason than specified above|2|||
124637430|NCT02589639|448290534|FG002|Overall Study|Other reason than specified above|1|||
124637431|NCT02589639|448290532|FG000|Overall Study|Not Treated|0|||
124637432|NCT02589639|448290533|FG001|Overall Study|Not Treated|3|||
124637433|NCT02589639|448290534|FG002|Overall Study|Not Treated|0|||
124637434|NCT02203721|448290535|FG000|Overall Study|Lost to Follow-up|1|||
124637435|NCT02203721|448290536|FG001|Overall Study|Lost to Follow-up|0|||
124637436|NCT02203721|448290535|FG000|Overall Study|Death|0|||
124637437|NCT02203721|448290536|FG001|Overall Study|Death|2|||
124637438|NCT02203721|448290535|FG000|Overall Study|Illness|0|||
124637439|NCT02203721|448290536|FG001|Overall Study|Illness|1|||
124637440|NCT01276756|448290537|FG000|Overall Study|Lost to Follow-up|2|||
124637441|NCT01276756|448290538|FG001|Overall Study|Lost to Follow-up|0|||
124637442|NCT01276756|448290537|FG000|Overall Study|Adverse Event|3|||
124637443|NCT01276756|448290538|FG001|Overall Study|Adverse Event|2|||
124637444|NCT02593097|448290546|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
124637445|NCT02593097|448290547|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
124637446|NCT02593097|448290546|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
124637447|NCT02593097|448290547|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
124637448|NCT02593097|448290546|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
124637449|NCT02593097|448290547|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
124637450|NCT02593097|448290546|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
124637451|NCT02593097|448290547|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
124637452|NCT02593097|448290546|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
124637453|NCT02593097|448290547|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
124637454|NCT00703157|448290548|FG000|Overall Study|Lost to Follow-up|0|||
124637455|NCT00703157|448290549|FG001|Overall Study|Lost to Follow-up|1|||
124637456|NCT00703157|448290548|FG000|Overall Study|source data permanently lost/ other|4|||
124637457|NCT00703157|448290549|FG001|Overall Study|source data permanently lost/ other|1|||
124637458|NCT02968173|448290550|FG000|Overall Study|Withdrawal by Subject|1|||
124637459|NCT02670525|448290551|FG000|Overall Study|Death|94|||
124637460|NCT02670525|448290552|FG001|Overall Study|Death|14|||
124637461|NCT02670525|448290551|FG000|Overall Study|Lost to Follow-up|4|||
124637462|NCT02670525|448290552|FG001|Overall Study|Lost to Follow-up|1|||
124637463|NCT02670525|448290551|FG000|Overall Study|Subject withdrew consent|1|||
124637464|NCT02670525|448290552|FG001|Overall Study|Subject withdrew consent|0|||
124637465|NCT02670525|448290551|FG000|Overall Study|Unknown, data entry delayed|123|||
124637466|NCT02670525|448290552|FG001|Overall Study|Unknown, data entry delayed|78|||
124637467|NCT00591565|448290553|FG000|Overall Study|lost follow up, withdrawn|5|||
124637468|NCT03564119|448290557|FG000|Overall Study|Adverse Event|4|||
124637469|NCT03564119|448290558|FG001|Overall Study|Adverse Event|0|||
124637470|NCT03564119|448290557|FG000|Overall Study|Lost to Follow-up|1|||
124637471|NCT03564119|448290558|FG001|Overall Study|Lost to Follow-up|4|||
124637472|NCT03564119|448290557|FG000|Overall Study|Protocol Violation|1|||
124637473|NCT03564119|448290558|FG001|Overall Study|Protocol Violation|0|||
124637474|NCT03564119|448290557|FG000|Overall Study|Withdrawal by Subject|9|||
124637475|NCT03564119|448290558|FG001|Overall Study|Withdrawal by Subject|4|||
124637476|NCT03564119|448290557|FG000|Overall Study|Other Than Specified|0|||
124637477|NCT03564119|448290558|FG001|Overall Study|Other Than Specified|1|||
124637478|NCT00634036|448290559|FG000|Overall Study|Lost to Follow-up|1|||
124637479|NCT00634036|448290560|FG001|Overall Study|Lost to Follow-up|1|||
124637480|NCT00634036|448290559|FG000|Overall Study|Withdrawal by Subject|1|||
124637481|NCT00634036|448290560|FG001|Overall Study|Withdrawal by Subject|1|||
124637482|NCT03896022|448290566|FG000|Overall Study|Withdrawal by Subject|1|||
124637483|NCT03896022|448290567|FG001|Overall Study|Withdrawal by Subject|0|||
124637484|NCT03896022|448290568|FG002|Overall Study|Withdrawal by Subject|0|||
124637485|NCT03896022|448290566|FG000|Overall Study|Did not have procedure|3|||
124637486|NCT03896022|448290567|FG001|Overall Study|Did not have procedure|0|||
124637487|NCT03896022|448290568|FG002|Overall Study|Did not have procedure|0|||
124637488|NCT01554527|448290573|FG000|Overall Study|Withdrawal by Subject|1|||
124637489|NCT01554527|448290574|FG001|Overall Study|Withdrawal by Subject|0|||
124637490|NCT01554527|448290575|FG002|Overall Study|Withdrawal by Subject|3|||
124637491|NCT01554527|448290573|FG000|Overall Study|Lost to Follow-up|0|||
124637492|NCT01554527|448290574|FG001|Overall Study|Lost to Follow-up|0|||
124744485|NCT02593825|448687389|FG000|Intervention|Lost to Follow-up|10|||
124744486|NCT02593825|448687390|FG001|Intervention|Lost to Follow-up|12|||
124744487|NCT01206582|448687391|FG000|Overall Study|Withdrew prior to study|1|||
124744488|NCT01206582|448687392|FG001|Overall Study|Withdrew prior to study|0|||
124744489|NCT01206582|448687391|FG000|Overall Study|Discontinued intervention before week 8|1|||
124744490|NCT01206582|448687392|FG001|Overall Study|Discontinued intervention before week 8|2|||
124744491|NCT02522325|448687393|FG000|Overall Study|Adverse Event|0|||
124744492|NCT02522325|448687394|FG001|Overall Study|Adverse Event|1|||
124744493|NCT01209078|448687395|FG000|Overall Study|Adverse Event|5|||
124744494|NCT01209078|448687396|FG001|Overall Study|Adverse Event|0|||
124744495|NCT01209078|448687395|FG000|Overall Study|Lost to Follow-up|4|||
124744496|NCT01209078|448687396|FG001|Overall Study|Lost to Follow-up|0|||
124744497|NCT01209078|448687395|FG000|Overall Study|Physician Decision|5|||
124744498|NCT01209078|448687396|FG001|Overall Study|Physician Decision|2|||
124744499|NCT01209078|448687395|FG000|Overall Study|Withdrawal by Subject|2|||
124744500|NCT01209078|448687396|FG001|Overall Study|Withdrawal by Subject|1|||
124744501|NCT00924508|448687397|FG000|Overall Study|Withdrawal by Subject|3|||
124744502|NCT00495625|448687398|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
124744503|NCT01912339|448687399|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
124744504|NCT01912339|448687400|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
124744505|NCT01912339|448687401|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
124744506|NCT01912339|448687399|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
124744507|NCT01912339|448687400|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
124744508|NCT01912339|448687401|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
124744509|NCT01912339|448687399|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
124744510|NCT01912339|448687400|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
124744511|NCT01912339|448687401|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
124744512|NCT01912339|448687399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
124744513|NCT01912339|448687400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
124744514|NCT01912339|448687401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
124744515|NCT01912339|448687399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
124744516|NCT01912339|448687400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
124744517|NCT01912339|448687401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
124744518|NCT01912339|448687399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
124744519|NCT01912339|448687400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
124744520|NCT01912339|448687401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
124744521|NCT01912339|448687399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
124744522|NCT01912339|448687400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
124744523|NCT01912339|448687401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
124744524|NCT01912339|448687399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
124744525|NCT01912339|448687400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
124744526|NCT01912339|448687401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
124744527|NCT01912339|448687399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
124744528|NCT01912339|448687400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
124744529|NCT01912339|448687401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
124744530|NCT01912339|448687399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
124744531|NCT01912339|448687400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
124744532|NCT01912339|448687401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
124744533|NCT01912339|448687399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
124744534|NCT01912339|448687400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
124744535|NCT01912339|448687401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
124744536|NCT01912339|448687399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
124744537|NCT01912339|448687400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
124744538|NCT01912339|448687401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
124744539|NCT01912339|448687399|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
124744540|NCT01912339|448687400|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
124744541|NCT01912339|448687401|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
124782175|NCT02881567|448832774|FG000|Overall Study|Consent withdrawn|1|||
124782176|NCT02881567|448832774|FG000|Overall Study|Investigator decision|1|||
124782177|NCT02881567|448832774|FG000|Overall Study|Study terminated by sponsor|9|||
124782178|NCT02881567|448832774|FG000|Overall Study|Reason not Specified|3|||
124782179|NCT02078960|448832778|FG000|Treatment Period|Other|0|||
124744542|NCT01754493|448687402|FG000|Overall Study|Adverse Event|1|||
124744543|NCT01754493|448687402|FG000|Overall Study|Lost to Follow-up|3|||
124744544|NCT01754493|448687402|FG000|Overall Study|Withdrawal by Subject|1|||
124744545|NCT01754493|448687402|FG000|Overall Study|Moved out of town|1|||
124744546|NCT01754493|448687402|FG000|Overall Study|Scheduling conflict|1|||
124744547|NCT01543776|448687403|FG000|Overall Study|Withdrawal by Subject|2|||
124782180|NCT02078960|448832779|FG001|Treatment Period|Other|0|||
124782181|NCT02078960|448832780|FG002|Treatment Period|Other|1|||
124744548|NCT01543776|448687404|FG001|Overall Study|Withdrawal by Subject|2|||
124744549|NCT03055013|448687406|FG000|Overall Study|Adverse Event|78|||
124744550|NCT03055013|448687407|FG001|Overall Study|Adverse Event|0|||
124744551|NCT03055013|448687406|FG000|Overall Study|Death|6|||
124744552|NCT03055013|448687407|FG001|Overall Study|Death|0|||
124744553|NCT03055013|448687406|FG000|Overall Study|Disease relapse|33|||
124744554|NCT03055013|448687407|FG001|Overall Study|Disease relapse|0|||
124744555|NCT03055013|448687406|FG000|Overall Study|Withdrawal by Subject|28|||
124744556|NCT03055013|448687407|FG001|Overall Study|Withdrawal by Subject|0|||
124744557|NCT03055013|448687406|FG000|Overall Study|Other complicating disease|5|||
124744558|NCT03055013|448687407|FG001|Overall Study|Other complicating disease|0|||
124744559|NCT03055013|448687406|FG000|Overall Study|Physician Decision|1|||
124744560|NCT03055013|448687407|FG001|Overall Study|Physician Decision|0|||
124744561|NCT03055013|448687406|FG000|Overall Study|Benign mass/non-RCC|4|||
124744562|NCT03055013|448687407|FG001|Overall Study|Benign mass/non-RCC|0|||
124744563|NCT03055013|448687406|FG000|Overall Study|Enrolled in another trial|1|||
124744564|NCT03055013|448687407|FG001|Overall Study|Enrolled in another trial|0|||
124744565|NCT03055013|448687406|FG000|Overall Study|Non-protocol therapy|1|||
124744566|NCT03055013|448687407|FG001|Overall Study|Non-protocol therapy|0|||
124744567|NCT03055013|448687406|FG000|Overall Study|Incompliance|1|||
124744568|NCT03055013|448687407|FG001|Overall Study|Incompliance|0|||
124744569|NCT03055013|448687406|FG000|Overall Study|Insurance issues|1|||
124744570|NCT03055013|448687407|FG001|Overall Study|Insurance issues|0|||
124744571|NCT03055013|448687406|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
124744572|NCT03055013|448687407|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
124744573|NCT03055013|448687406|FG000|Overall Study|Did not receive nivolumab|10|||
124744574|NCT03055013|448687407|FG001|Overall Study|Did not receive nivolumab|0|||
124744575|NCT03055013|448687406|FG000|Overall Study|Did not receive surgery|0|||
124744576|NCT03055013|448687407|FG001|Overall Study|Did not receive surgery|28|||
124744577|NCT02207491|448687408|FG000|Overall Study|Adverse Event|20|||
124744578|NCT02207491|448687409|FG001|Overall Study|Adverse Event|4|||
124744579|NCT02207491|448687408|FG000|Overall Study|Withdrawal by Subject|3|||
124744580|NCT02207491|448687409|FG001|Overall Study|Withdrawal by Subject|2|||
124744581|NCT02207491|448687408|FG000|Overall Study|Non-compliant|0|||
124744582|NCT02207491|448687409|FG001|Overall Study|Non-compliant|1|||
124744583|NCT02207491|448687408|FG000|Overall Study|Lost to Follow-up|0|||
124744584|NCT02207491|448687409|FG001|Overall Study|Lost to Follow-up|1|||
124744585|NCT02207491|448687408|FG000|Overall Study|Lack of Efficacy|3|||
124744586|NCT02207491|448687409|FG001|Overall Study|Lack of Efficacy|0|||
124744587|NCT02207491|448687408|FG000|Overall Study|Physician Decision|2|||
124744588|NCT02207491|448687409|FG001|Overall Study|Physician Decision|0|||
124744589|NCT02207491|448687408|FG000|Overall Study|Protocol Violation|3|||
124744590|NCT02207491|448687409|FG001|Overall Study|Protocol Violation|5|||
124744591|NCT00126776|448687410|FG000|Overall Study|follow up complete on all patients|0|||
124744592|NCT00126776|448687411|FG001|Overall Study|follow up complete on all patients|0|||
124744593|NCT00599755|448687412|FG000|Overall Study|Adverse Event|11|||
124744594|NCT00599755|448687412|FG000|Overall Study|Withdrawal by Subject|2|||
124744595|NCT00599755|448687412|FG000|Overall Study|Progression of Disease|3|||
124744596|NCT00599755|448687412|FG000|Overall Study|Other Reason|2|||
124744597|NCT00599755|448687412|FG000|Overall Study|No data available|1|||
124744598|NCT03626545|448687414|FG000|Overall Study|Progressive disease|3|||
124744599|NCT03626545|448687415|FG001|Overall Study|Progressive disease|82|||
124744600|NCT03626545|448687416|FG002|Overall Study|Progressive disease|85|||
124744601|NCT03626545|448687414|FG000|Overall Study|Adverse Event|3|||
124744602|NCT03626545|448687415|FG001|Overall Study|Adverse Event|13|||
124744603|NCT03626545|448687416|FG002|Overall Study|Adverse Event|10|||
124744604|NCT03626545|448687414|FG000|Overall Study|Physician Decision|1|||
124744605|NCT03626545|448687415|FG001|Overall Study|Physician Decision|18|||
124744606|NCT03626545|448687416|FG002|Overall Study|Physician Decision|14|||
124744607|NCT03626545|448687414|FG000|Overall Study|Subject Decision|0|||
124744608|NCT03626545|448687415|FG001|Overall Study|Subject Decision|5|||
124744609|NCT03626545|448687416|FG002|Overall Study|Subject Decision|5|||
124744610|NCT03626545|448687414|FG000|Overall Study|Death|1|||
124744611|NCT03626545|448687415|FG001|Overall Study|Death|1|||
124744612|NCT03626545|448687416|FG002|Overall Study|Death|1|||
124744613|NCT03626545|448687414|FG000|Overall Study|Protocol Deviation|0|||
124744614|NCT03626545|448687415|FG001|Overall Study|Protocol Deviation|1|||
124744615|NCT03626545|448687416|FG002|Overall Study|Protocol Deviation|1|||
124744616|NCT03626545|448687414|FG000|Overall Study|Guardian Decision|0|||
124744617|NCT03626545|448687415|FG001|Overall Study|Guardian Decision|0|||
124744618|NCT03626545|448687416|FG002|Overall Study|Guardian Decision|1|||
124744619|NCT01939366|448687417|FG000|Overall Study|Adverse Event|8|||
124744620|NCT01939366|448687418|FG001|Overall Study|Adverse Event|17|||
124744621|NCT01939366|448687419|FG002|Overall Study|Adverse Event|30|||
124744622|NCT01939366|448687420|FG003|Overall Study|Adverse Event|8|||
124744623|NCT01939366|448687421|FG004|Overall Study|Adverse Event|5|||
124744624|NCT01939366|448687417|FG000|Overall Study|Lack of Efficacy|2|||
124744625|NCT01939366|448687418|FG001|Overall Study|Lack of Efficacy|1|||
124744626|NCT01939366|448687419|FG002|Overall Study|Lack of Efficacy|1|||
124618488|NCT01762800|448219324|FG000|Overall Study|Study Closed/Terminated|0|||
124618489|NCT01762800|448219325|FG001|Overall Study|Study Closed/Terminated|1|||
124618490|NCT01762800|448219324|FG000|Overall Study|Physician Decision|1|||
124618491|NCT01762800|448219325|FG001|Overall Study|Physician Decision|1|||
124618492|NCT01762800|448219324|FG000|Overall Study|Withdrawal by Subject|7|||
124618493|NCT01762800|448219325|FG001|Overall Study|Withdrawal by Subject|4|||
124618494|NCT02111603|448219327|FG000|Overall Study|Withdrawal by Subject|1|||
124618495|NCT01753297|448219330|FG000|Overall Study|Lost to Follow-up|7|||
124618496|NCT01753297|448219331|FG001|Overall Study|Lost to Follow-up|2|||
124618497|NCT01753297|448219330|FG000|Overall Study|Withdrawal by Subject|26|||
124618498|NCT01753297|448219331|FG001|Overall Study|Withdrawal by Subject|23|||
124618499|NCT01753297|448219330|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
124618500|NCT01753297|448219331|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
124618501|NCT01753297|448219330|FG000|Overall Study|Death|0|||
124618502|NCT01753297|448219331|FG001|Overall Study|Death|2|||
124618503|NCT01753297|448219330|FG000|Overall Study|Did not attend end of study visit|7|||
124618504|NCT01753297|448219331|FG001|Overall Study|Did not attend end of study visit|8|||
124618505|NCT01174043|448219334|FG000|Overall Study|Disease progression|5|||
124618506|NCT01174043|448219334|FG000|Overall Study|Adverse Event|3|||
124618507|NCT01174043|448219334|FG000|Overall Study|Death|1|||
124618508|NCT01174043|448219334|FG000|Overall Study|Withdrawal by Subject|2|||
124618509|NCT01645787|448219340|FG000|Washout (2 Weeks)|Adverse Event|1|||
124618510|NCT01645787|448219341|FG001|Washout (2 Weeks)|Adverse Event|0|||
124618511|NCT01371539|448219342|FG000|Period One: One Week|Lost to Follow-up|0|||
124618512|NCT01371539|448219343|FG001|Period One: One Week|Lost to Follow-up|1|||
124618513|NCT01371539|448219342|FG000|Period Two: One Week|Lost to Follow-up|0|||
124618514|NCT01371539|448219343|FG001|Period Two: One Week|Lost to Follow-up|1|||
124618515|NCT01371539|448219342|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
124618516|NCT01371539|448219343|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
124618517|NCT01371539|448219342|FG000|Period Two: One Week|Time/job conflict|0|||
124618518|NCT01371539|448219343|FG001|Period Two: One Week|Time/job conflict|1|||
124618519|NCT02784795|448219359|FG000|Overall Study|Progressive Disease|2|||
124618520|NCT02784795|448219360|FG001|Overall Study|Progressive Disease|1|||
124618521|NCT02784795|448219361|FG002|Overall Study|Progressive Disease|1|||
124618522|NCT02784795|448219362|FG003|Overall Study|Progressive Disease|0|||
124618523|NCT02784795|448219363|FG004|Overall Study|Progressive Disease|2|||
124618524|NCT02784795|448219364|FG005|Overall Study|Progressive Disease|0|||
124618525|NCT02784795|448219365|FG006|Overall Study|Progressive Disease|2|||
124618526|NCT02784795|448219366|FG007|Overall Study|Progressive Disease|0|||
124618527|NCT02784795|448219367|FG008|Overall Study|Progressive Disease|0|||
124618528|NCT02784795|448219368|FG009|Overall Study|Progressive Disease|0|||
124618529|NCT02784795|448219369|FG010|Overall Study|Progressive Disease|1|||
124618530|NCT02784795|448219370|FG011|Overall Study|Progressive Disease|0|||
124618531|NCT02784795|448219359|FG000|Overall Study|Adverse Event|1|||
124618532|NCT02784795|448219360|FG001|Overall Study|Adverse Event|0|||
124618533|NCT02784795|448219361|FG002|Overall Study|Adverse Event|0|||
124618534|NCT02784795|448219362|FG003|Overall Study|Adverse Event|1|||
124618535|NCT02784795|448219363|FG004|Overall Study|Adverse Event|0|||
124618536|NCT02784795|448219364|FG005|Overall Study|Adverse Event|0|||
124618537|NCT02784795|448219365|FG006|Overall Study|Adverse Event|1|||
124618538|NCT02784795|448219366|FG007|Overall Study|Adverse Event|0|||
124618539|NCT02784795|448219367|FG008|Overall Study|Adverse Event|0|||
124618540|NCT02784795|448219368|FG009|Overall Study|Adverse Event|0|||
124618541|NCT02784795|448219369|FG010|Overall Study|Adverse Event|0|||
124618542|NCT02784795|448219370|FG011|Overall Study|Adverse Event|2|||
124618543|NCT02784795|448219359|FG000|Overall Study|Withdrawal by Subject|1|||
124618544|NCT02784795|448219360|FG001|Overall Study|Withdrawal by Subject|0|||
124618545|NCT02784795|448219361|FG002|Overall Study|Withdrawal by Subject|2|||
124618546|NCT02784795|448219362|FG003|Overall Study|Withdrawal by Subject|1|||
124618547|NCT02784795|448219363|FG004|Overall Study|Withdrawal by Subject|3|||
124618548|NCT02784795|448219364|FG005|Overall Study|Withdrawal by Subject|0|||
124618549|NCT02784795|448219365|FG006|Overall Study|Withdrawal by Subject|0|||
124618550|NCT02784795|448219366|FG007|Overall Study|Withdrawal by Subject|1|||
124618551|NCT02784795|448219367|FG008|Overall Study|Withdrawal by Subject|0|||
124618552|NCT02784795|448219368|FG009|Overall Study|Withdrawal by Subject|0|||
124618553|NCT02784795|448219369|FG010|Overall Study|Withdrawal by Subject|0|||
124618554|NCT02784795|448219370|FG011|Overall Study|Withdrawal by Subject|2|||
124618555|NCT02784795|448219359|FG000|Overall Study|Death|0|||
124618556|NCT02784795|448219360|FG001|Overall Study|Death|0|||
124618557|NCT02784795|448219361|FG002|Overall Study|Death|0|||
124618558|NCT02784795|448219362|FG003|Overall Study|Death|0|||
124618559|NCT02784795|448219363|FG004|Overall Study|Death|1|||
124618560|NCT02784795|448219364|FG005|Overall Study|Death|0|||
124618561|NCT02784795|448219365|FG006|Overall Study|Death|0|||
124618562|NCT02784795|448219366|FG007|Overall Study|Death|0|||
124618563|NCT02784795|448219367|FG008|Overall Study|Death|0|||
124618564|NCT02784795|448219368|FG009|Overall Study|Death|0|||
124618565|NCT02784795|448219369|FG010|Overall Study|Death|0|||
124618566|NCT02784795|448219370|FG011|Overall Study|Death|0|||
124618567|NCT02784795|448219359|FG000|Overall Study|Physician Decision|0|||
124618568|NCT02784795|448219360|FG001|Overall Study|Physician Decision|0|||
124618569|NCT02784795|448219361|FG002|Overall Study|Physician Decision|0|||
124618570|NCT02784795|448219362|FG003|Overall Study|Physician Decision|0|||
124618571|NCT02784795|448219363|FG004|Overall Study|Physician Decision|0|||
124618572|NCT02784795|448219364|FG005|Overall Study|Physician Decision|0|||
124618573|NCT02784795|448219365|FG006|Overall Study|Physician Decision|1|||
124618574|NCT02784795|448219366|FG007|Overall Study|Physician Decision|0|||
124618575|NCT02784795|448219367|FG008|Overall Study|Physician Decision|0|||
124618576|NCT02784795|448219368|FG009|Overall Study|Physician Decision|0|||
124618577|NCT02784795|448219369|FG010|Overall Study|Physician Decision|0|||
124618578|NCT02784795|448219370|FG011|Overall Study|Physician Decision|0|||
124618579|NCT00595309|448219373|FG000|Overall Study|Lost to Follow-up|1|||
124618580|NCT00595309|448219373|FG000|Overall Study|planned vaccination against yellow fever|1|||
124618581|NCT00595309|448219373|FG000|Overall Study|acute infection after V0|1|||
124618582|NCT00595309|448219373|FG000|Overall Study|personal reason|1|||
124618583|NCT05445492|448219374|FG000|Overall Study|Physician Decision|1|||
124618584|NCT00191191|448219375|FG000|Overall Study|Entry Criteria Exclusion|2|||
124618585|NCT00191191|448219376|FG001|Overall Study|Entry Criteria Exclusion|0|||
124618586|NCT00191191|448219375|FG000|Overall Study|Treated with Another Systemic Agent|1|||
124618587|NCT00191191|448219376|FG001|Overall Study|Treated with Another Systemic Agent|1|||
124618588|NCT00191191|448219375|FG000|Overall Study|Adverse Event|11|||
124618589|NCT00191191|448219376|FG001|Overall Study|Adverse Event|21|||
124618590|NCT00191191|448219375|FG000|Overall Study|Progressive Disease|84|||
124618591|NCT00191191|448219376|FG001|Overall Study|Progressive Disease|72|||
124618592|NCT00191191|448219375|FG000|Overall Study|Toxicity After Dose Reduction|7|||
124618593|NCT00191191|448219376|FG001|Overall Study|Toxicity After Dose Reduction|8|||
124618594|NCT00191191|448219375|FG000|Overall Study|Family/Caregiver Decision|5|||
124618595|NCT00191191|448219376|FG001|Overall Study|Family/Caregiver Decision|7|||
124618596|NCT00191191|448219375|FG000|Overall Study|Lost to Follow-up|1|||
124618597|NCT00191191|448219376|FG001|Overall Study|Lost to Follow-up|0|||
124618598|NCT00191191|448219375|FG000|Overall Study|Physician Decision|3|||
124618599|NCT00191191|448219376|FG001|Overall Study|Physician Decision|2|||
124618600|NCT00191191|448219375|FG000|Overall Study|Good Clinical Practice Violation|0|||
124618601|NCT00191191|448219376|FG001|Overall Study|Good Clinical Practice Violation|1|||
124618602|NCT03633825|448219377|FG000|Enrollment|Did not post on network|5066|||
124618603|NCT03633825|448219378|FG001|Enrollment|Did not post on network|5080|||
124618604|NCT03633825|448219377|FG000|Enrollment|Post not classified as crisis|13967|||
124618605|NCT03633825|448219378|FG001|Enrollment|Post not classified as crisis|13757|||
124618606|NCT03633825|448219377|FG000|Follow up|Lost to Follow-up|478|||
124618607|NCT03633825|448219378|FG001|Follow up|Lost to Follow-up|450|||
124618608|NCT03348163|448219379|FG000|Overall Study|Withdrawal by Subject|2|||
124618609|NCT03348163|448219380|FG001|Overall Study|Withdrawal by Subject|0|||
124618610|NCT00652340|448219381|FG000|Overall Study|Had not progressed.|4|||
124618611|NCT00652340|448219382|FG001|Overall Study|Had not progressed.|3|||
124618612|NCT03682107|448219383|FG000|Overall Study|Withdrawal by Subject|0|||
124618613|NCT03682107|448219384|FG001|Overall Study|Withdrawal by Subject|1|||
124618614|NCT03682107|448219385|FG002|Overall Study|Withdrawal by Subject|0|||
124618615|NCT03682107|448219386|FG003|Overall Study|Withdrawal by Subject|0|||
124618616|NCT03682107|448219387|FG004|Overall Study|Withdrawal by Subject|0|||
124618617|NCT00214383|448219388|FG000|Overall Study|Lost to Follow-up|16|||
124618618|NCT00214383|448219389|FG001|Overall Study|Lost to Follow-up|26|||
124618619|NCT01890434|448219390|FG000|Overall Study|Adverse Event|8|||
124618620|NCT01890434|448219390|FG000|Overall Study|PCI at external hospital|1|||
124618621|NCT01890434|448219390|FG000|Overall Study|Assessment discrepancy|1|||
124618622|NCT01890434|448219390|FG000|Overall Study|CRC didn't contact participant for FU|1|||
124618623|NCT01890434|448219390|FG000|Overall Study|Could not get whole set of images|1|||
124618624|NCT01890434|448219390|FG000|Overall Study|Decline to return for GSPECT|1|||
124618625|NCT01890434|448219390|FG000|Overall Study|GSPECT at rest was not done|1|||
124618626|NCT01890434|448219390|FG000|Overall Study|Participant didn't complete MRI|1|||
124618627|NCT01890434|448219390|FG000|Overall Study|Uncontactable by phone|1|||
124618628|NCT01890434|448219390|FG000|Overall Study|Moved out of position|1|||
124744627|NCT01939366|448687420|FG003|Overall Study|Lack of Efficacy|1|||
124744628|NCT01939366|448687421|FG004|Overall Study|Lack of Efficacy|3|||
124618629|NCT01890434|448219390|FG000|Overall Study|Unable to contact|1|||
124618630|NCT01890434|448219390|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
124618631|NCT02655666|448219394|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
124618632|NCT01267994|448219395|FG000|Overall Study|Adverse Event|2|||
124618633|NCT03837743|448219396|FG000|Overall Study|Adverse Event|1|||
124618634|NCT03837743|448219396|FG000|Overall Study|Withdrawal by Subject|2|||
124618635|NCT01275430|448219398|FG000|Overall Study|Adverse Event|1|||
124618636|NCT01275430|448219398|FG000|Overall Study|No Contrast Injection|6|||
124618637|NCT01275430|448219398|FG000|Overall Study|Device Malfunction|1|||
124618638|NCT01275430|448219398|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
124618639|NCT04759768|448219399|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
124618640|NCT04759768|448219400|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
124618641|NCT04759768|448219399|FG000|Washout (7 Days)|Physician Decision|0|||
124744629|NCT01939366|448687417|FG000|Overall Study|Lost to Follow-up|1|||
124744630|NCT01939366|448687418|FG001|Overall Study|Lost to Follow-up|1|||
124744631|NCT01939366|448687419|FG002|Overall Study|Lost to Follow-up|0|||
124744632|NCT01939366|448687420|FG003|Overall Study|Lost to Follow-up|0|||
124744633|NCT01939366|448687421|FG004|Overall Study|Lost to Follow-up|0|||
124744634|NCT01939366|448687417|FG000|Overall Study|Withdrawal by Subject|1|||
124744635|NCT01939366|448687418|FG001|Overall Study|Withdrawal by Subject|0|||
124744636|NCT01939366|448687419|FG002|Overall Study|Withdrawal by Subject|2|||
124744637|NCT01939366|448687420|FG003|Overall Study|Withdrawal by Subject|2|||
124744638|NCT01939366|448687421|FG004|Overall Study|Withdrawal by Subject|3|||
124744639|NCT01939366|448687417|FG000|Overall Study|Inclusion criteria not met|0|||
124744640|NCT01939366|448687418|FG001|Overall Study|Inclusion criteria not met|1|||
124744641|NCT01939366|448687419|FG002|Overall Study|Inclusion criteria not met|1|||
124744642|NCT01939366|448687420|FG003|Overall Study|Inclusion criteria not met|0|||
124744643|NCT01939366|448687421|FG004|Overall Study|Inclusion criteria not met|1|||
124744644|NCT01939366|448687417|FG000|Overall Study|Other|0|||
124744645|NCT01939366|448687418|FG001|Overall Study|Other|0|||
124744646|NCT01939366|448687419|FG002|Overall Study|Other|2|||
124744647|NCT01939366|448687420|FG003|Overall Study|Other|2|||
124744648|NCT01939366|448687421|FG004|Overall Study|Other|1|||
124744649|NCT01939366|448687417|FG000|Overall Study|Protocol Violation|0|||
124744650|NCT01939366|448687418|FG001|Overall Study|Protocol Violation|0|||
124744651|NCT01939366|448687419|FG002|Overall Study|Protocol Violation|0|||
124744652|NCT01939366|448687420|FG003|Overall Study|Protocol Violation|1|||
124744653|NCT01939366|448687421|FG004|Overall Study|Protocol Violation|0|||
124744654|NCT01939366|448687417|FG000|Overall Study|Sponsor decision|0|||
124744655|NCT01939366|448687418|FG001|Overall Study|Sponsor decision|0|||
124744656|NCT01939366|448687419|FG002|Overall Study|Sponsor decision|0|||
124744657|NCT01939366|448687420|FG003|Overall Study|Sponsor decision|0|||
124744658|NCT01939366|448687421|FG004|Overall Study|Sponsor decision|2|||
124744659|NCT01939366|448687417|FG000|Overall Study|GCP non-compliance at site|2|||
124744660|NCT01939366|448687418|FG001|Overall Study|GCP non-compliance at site|3|||
124744661|NCT01939366|448687419|FG002|Overall Study|GCP non-compliance at site|2|||
124744662|NCT01939366|448687420|FG003|Overall Study|GCP non-compliance at site|3|||
124744663|NCT01939366|448687421|FG004|Overall Study|GCP non-compliance at site|3|||
124744664|NCT03909152|448687422|FG000|Overall Study|Adverse Event|14|||
124744665|NCT03909152|448687423|FG001|Overall Study|Adverse Event|5|||
124744666|NCT03909152|448687424|FG002|Overall Study|Adverse Event|1|||
124744667|NCT03909152|448687425|FG003|Overall Study|Adverse Event|14|||
124744668|NCT02615691|448687426|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
124744669|NCT02615691|448687426|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
124744670|NCT02615691|448687426|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
124744671|NCT02615691|448687426|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
124744672|NCT02017522|448687427|FG000|Overall Study|Withdrawal by Subject|1|||
124744673|NCT00615030|448687429|FG000|Period I|Administrative problem|0|||
124744674|NCT00615030|448687430|FG001|Period I|Administrative problem|0|||
124744675|NCT00615030|448687431|FG002|Period I|Administrative problem|0|||
124744676|NCT00615030|448687432|FG003|Period I|Administrative problem|0|||
124744677|NCT00615030|448687433|FG004|Period I|Administrative problem|1|||
124744678|NCT00615030|448687434|FG005|Period I|Administrative problem|0|||
124744679|NCT00615030|448687435|FG006|Period I|Administrative problem|0|||
124744680|NCT00615030|448687436|FG007|Period I|Administrative problem|0|||
124744681|NCT00615030|448687437|FG008|Period I|Administrative problem|0|||
124744682|NCT00615030|448687438|FG009|Period I|Administrative problem|0|||
124744683|NCT00615030|448687439|FG010|Period I|Administrative problem|0|||
124744684|NCT00615030|448687440|FG011|Period I|Administrative problem|0|||
124744685|NCT00615030|448687429|FG000|Period I|Protocol deviation|1|||
124744686|NCT00615030|448687430|FG001|Period I|Protocol deviation|0|||
124744687|NCT00615030|448687431|FG002|Period I|Protocol deviation|0|||
124744688|NCT00615030|448687432|FG003|Period I|Protocol deviation|0|||
124744689|NCT00615030|448687433|FG004|Period I|Protocol deviation|0|||
124744690|NCT00615030|448687434|FG005|Period I|Protocol deviation|0|||
124744691|NCT00615030|448687435|FG006|Period I|Protocol deviation|0|||
124744692|NCT00615030|448687436|FG007|Period I|Protocol deviation|0|||
124744693|NCT00615030|448687437|FG008|Period I|Protocol deviation|0|||
124744694|NCT00615030|448687438|FG009|Period I|Protocol deviation|0|||
124744695|NCT00615030|448687439|FG010|Period I|Protocol deviation|0|||
124744696|NCT00615030|448687440|FG011|Period I|Protocol deviation|0|||
124744697|NCT00615030|448687429|FG000|Period I|Subject withdrew consent|0|||
124744698|NCT00615030|448687430|FG001|Period I|Subject withdrew consent|0|||
124744699|NCT00615030|448687431|FG002|Period I|Subject withdrew consent|0|||
124744700|NCT00615030|448687432|FG003|Period I|Subject withdrew consent|0|||
124744701|NCT00615030|448687433|FG004|Period I|Subject withdrew consent|0|||
124744702|NCT00615030|448687434|FG005|Period I|Subject withdrew consent|0|||
124744703|NCT00615030|448687435|FG006|Period I|Subject withdrew consent|0|||
124744704|NCT00615030|448687436|FG007|Period I|Subject withdrew consent|0|||
124744705|NCT00615030|448687437|FG008|Period I|Subject withdrew consent|1|||
124744706|NCT00615030|448687438|FG009|Period I|Subject withdrew consent|0|||
124744707|NCT00615030|448687439|FG010|Period I|Subject withdrew consent|1|||
124744708|NCT00615030|448687440|FG011|Period I|Subject withdrew consent|1|||
124744709|NCT00615030|448687429|FG000|Period I|Abnormal laboratory value(s)|0|||
124744710|NCT00615030|448687430|FG001|Period I|Abnormal laboratory value(s)|0|||
124744711|NCT00615030|448687431|FG002|Period I|Abnormal laboratory value(s)|0|||
124744712|NCT00615030|448687432|FG003|Period I|Abnormal laboratory value(s)|0|||
124744713|NCT00615030|448687433|FG004|Period I|Abnormal laboratory value(s)|0|||
124744714|NCT00615030|448687434|FG005|Period I|Abnormal laboratory value(s)|1|||
124744715|NCT00615030|448687435|FG006|Period I|Abnormal laboratory value(s)|0|||
124744716|NCT00615030|448687436|FG007|Period I|Abnormal laboratory value(s)|0|||
124744717|NCT00615030|448687437|FG008|Period I|Abnormal laboratory value(s)|0|||
124744718|NCT00615030|448687438|FG009|Period I|Abnormal laboratory value(s)|0|||
124744719|NCT00615030|448687439|FG010|Period I|Abnormal laboratory value(s)|0|||
124744720|NCT00615030|448687440|FG011|Period I|Abnormal laboratory value(s)|0|||
124744721|NCT00615030|448687429|FG000|Period II|Adverse Event|0|||
124744722|NCT00615030|448687430|FG001|Period II|Adverse Event|0|||
124782182|NCT02078960|448832778|FG000|Treatment Period|Lack of Efficacy|0|||
124782183|NCT02078960|448832779|FG001|Treatment Period|Lack of Efficacy|1|||
124618642|NCT04759768|448219400|FG001|Washout (7 Days)|Physician Decision|1|||
124618643|NCT02996487|448219401|FG000|Overall Study|Lost to Follow-up|1|||
124618644|NCT02996487|448219402|FG001|Overall Study|Lost to Follow-up|1|||
124618645|NCT02996487|448219403|FG002|Overall Study|Lost to Follow-up|0|||
124618646|NCT02996487|448219401|FG000|Overall Study|Death|0|||
124618647|NCT02996487|448219402|FG001|Overall Study|Death|1|||
124618648|NCT02996487|448219403|FG002|Overall Study|Death|0|||
124618649|NCT02996487|448219401|FG000|Overall Study|Withdrawal by Subject|2|||
124618650|NCT02996487|448219402|FG001|Overall Study|Withdrawal by Subject|3|||
124618651|NCT02996487|448219403|FG002|Overall Study|Withdrawal by Subject|0|||
124618652|NCT01130597|448219404|FG000|Overall Study|Protocol-specified (High K+)|1|||
124618653|NCT01130597|448219404|FG000|Overall Study|Adverse Event|4|||
124618654|NCT01130597|448219404|FG000|Overall Study|Death|1|||
124618655|NCT01130597|448219404|FG000|Overall Study|Protocol Violation|1|||
124618656|NCT01301729|448219405|FG000|Overall Study|Withdrawal by Subject|2|||
124618657|NCT01301729|448219405|FG000|Overall Study|Participant did not Return for Treatment|1|||
124618658|NCT01301729|448219405|FG000|Overall Study|Violated Selection Criteria|1|||
124618659|NCT04873934|448219406|FG000|Overall Study|Adverse Event|0|||
124618660|NCT04873934|448219407|FG001|Overall Study|Adverse Event|1|||
124618661|NCT04873934|448219406|FG000|Overall Study|Death|0|||
124618662|NCT04873934|448219407|FG001|Overall Study|Death|2|||
124618663|NCT04873934|448219406|FG000|Overall Study|Lost to Follow-up|13|||
124618664|NCT04873934|448219407|FG001|Overall Study|Lost to Follow-up|9|||
124618665|NCT04873934|448219406|FG000|Overall Study|Physician Decision|1|||
124618666|NCT04873934|448219407|FG001|Overall Study|Physician Decision|1|||
124618667|NCT04873934|448219406|FG000|Overall Study|Protocol deviation|2|||
124618668|NCT04873934|448219407|FG001|Overall Study|Protocol deviation|1|||
124618669|NCT04873934|448219406|FG000|Overall Study|Subject decision|1|||
124618670|NCT04873934|448219407|FG001|Overall Study|Subject decision|8|||
124618671|NCT04873934|448219406|FG000|Overall Study|Withdrew consent|0|||
124618672|NCT04873934|448219407|FG001|Overall Study|Withdrew consent|4|||
124618673|NCT04873934|448219406|FG000|Overall Study|Missing|1|||
124618674|NCT04873934|448219407|FG001|Overall Study|Missing|0|||
124618675|NCT05794503|448219408|FG000|Overall Study|Operation Cancelled|2|||
124618676|NCT05794503|448219409|FG001|Overall Study|Operation Cancelled|0|||
124618677|NCT05794503|448219408|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
124618678|NCT05794503|448219409|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
124618679|NCT05794503|448219408|FG000|Overall Study|Protocol Violation|1|||
124618680|NCT05794503|448219409|FG001|Overall Study|Protocol Violation|0|||
124618681|NCT01464931|448219411|FG000|Overall Study|Withdrawal by Subject|1|||
124618682|NCT01464931|448219412|FG001|Overall Study|Withdrawal by Subject|0|||
124618683|NCT00338728|448219415|FG000|Overall Study|Screen Failure|14|||
124618684|NCT04102189|448219416|FG000|Overall Study|Withdrawal by Subject|1|||
124618685|NCT04102189|448219417|FG001|Overall Study|Withdrawal by Subject|2|||
124618686|NCT04102189|448219416|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124618687|NCT04102189|448219417|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124618688|NCT04102189|448219416|FG000|Overall Study|Lost to Follow-up|1|||
124618689|NCT04102189|448219417|FG001|Overall Study|Lost to Follow-up|0|||
124618690|NCT02933255|448219420|FG000|Overall Study|Discontinued due to study closure.|1|||
124618691|NCT02933255|448219421|FG001|Overall Study|Discontinued due to study closure.|0|||
124782184|NCT02078960|448832780|FG002|Treatment Period|Lack of Efficacy|0|||
124618692|NCT04803305|448219424|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
124618693|NCT04803305|448219425|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
124744723|NCT00615030|448687431|FG002|Period II|Adverse Event|1|||
124618694|NCT04803305|448219424|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
124618695|NCT04803305|448219425|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
124618696|NCT04803305|448219424|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
124618697|NCT04803305|448219425|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
124618698|NCT04803305|448219424|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
124744724|NCT00615030|448687432|FG003|Period II|Adverse Event|0|||
124744725|NCT00615030|448687433|FG004|Period II|Adverse Event|0|||
124744726|NCT00615030|448687434|FG005|Period II|Adverse Event|0|||
124744727|NCT00615030|448687435|FG006|Period II|Adverse Event|0|||
124744728|NCT00615030|448687436|FG007|Period II|Adverse Event|0|||
124744729|NCT00615030|448687437|FG008|Period II|Adverse Event|1|||
124744730|NCT00615030|448687438|FG009|Period II|Adverse Event|0|||
124744731|NCT00615030|448687439|FG010|Period II|Adverse Event|0|||
124744732|NCT00615030|448687440|FG011|Period II|Adverse Event|0|||
124744733|NCT00615030|448687429|FG000|Period II|Subject withdrew consent|0|||
124744734|NCT00615030|448687430|FG001|Period II|Subject withdrew consent|0|||
124744735|NCT00615030|448687431|FG002|Period II|Subject withdrew consent|0|||
124782185|NCT02078960|448832778|FG000|Treatment Period|Disease progression - accelerated phase|0|||
124782186|NCT02078960|448832779|FG001|Treatment Period|Disease progression - accelerated phase|1|||
124782187|NCT02078960|448832780|FG002|Treatment Period|Disease progression - accelerated phase|0|||
124782188|NCT02078960|448832778|FG000|Treatment Period|Disease progression - blast phase|1|||
124782189|NCT02078960|448832779|FG001|Treatment Period|Disease progression - blast phase|0|||
124782190|NCT02078960|448832780|FG002|Treatment Period|Disease progression - blast phase|0|||
124782191|NCT02078960|448832778|FG000|Treatment Period|Withdrawal by Subject|0|||
124782192|NCT02078960|448832779|FG001|Treatment Period|Withdrawal by Subject|1|||
124782193|NCT02078960|448832780|FG002|Treatment Period|Withdrawal by Subject|1|||
124782194|NCT02078960|448832778|FG000|Treatment Period|Adverse Event|1|||
124782195|NCT02078960|448832779|FG001|Treatment Period|Adverse Event|0|||
124782196|NCT02078960|448832780|FG002|Treatment Period|Adverse Event|0|||
124782197|NCT02078960|448832778|FG000|Treatment Period|Death|0|||
124782198|NCT02078960|448832779|FG001|Treatment Period|Death|0|||
124782199|NCT02078960|448832780|FG002|Treatment Period|Death|1|||
124782200|NCT02078960|448832778|FG000|Follow-up Period|Death|2|||
124782201|NCT02078960|448832779|FG001|Follow-up Period|Death|0|||
124782202|NCT02078960|448832780|FG002|Follow-up Period|Death|0|||
124782203|NCT02078960|448832778|FG000|Follow-up Period|Lost to Follow-up|0|||
124782204|NCT02078960|448832779|FG001|Follow-up Period|Lost to Follow-up|1|||
124782205|NCT02078960|448832780|FG002|Follow-up Period|Lost to Follow-up|0|||
124782206|NCT00975689|448832786|FG000|Overall Study|Adverse Event|0|||
124782207|NCT00975689|448832787|FG001|Overall Study|Adverse Event|3|||
124782208|NCT00975689|448832786|FG000|Overall Study|Withdrawal by Subject|1|||
124782209|NCT00975689|448832787|FG001|Overall Study|Withdrawal by Subject|0|||
124782210|NCT00975689|448832786|FG000|Overall Study|Physician Decision|1|||
124782211|NCT00975689|448832787|FG001|Overall Study|Physician Decision|0|||
124782212|NCT04335136|448832788|FG000|Overall Study|Death|8|||
124782213|NCT04335136|448832789|FG001|Overall Study|Death|4|||
124782214|NCT04335136|448832788|FG000|Overall Study|Lost to Follow-up|2|||
124782215|NCT04335136|448832789|FG001|Overall Study|Lost to Follow-up|0|||
124782216|NCT04335136|448832788|FG000|Overall Study|Protocol Violation|1|||
124782217|NCT04335136|448832789|FG001|Overall Study|Protocol Violation|0|||
124782218|NCT04335136|448832788|FG000|Overall Study|Withdrawal by Subject|1|||
124782219|NCT04335136|448832789|FG001|Overall Study|Withdrawal by Subject|1|||
124782220|NCT04335136|448832788|FG000|Overall Study|Health-threatening condition|0|||
124782221|NCT04335136|448832789|FG001|Overall Study|Health-threatening condition|1|||
124782222|NCT04335136|448832788|FG000|Overall Study|Adverse Event|0|||
124782223|NCT04335136|448832789|FG001|Overall Study|Adverse Event|1|||
124782224|NCT04335136|448832788|FG000|Overall Study|Erroneously randomized|2|||
124782225|NCT04335136|448832789|FG001|Overall Study|Erroneously randomized|0|||
124782226|NCT01305577|448832793|FG000|Overall Study|Adverse Event|2|||
124782227|NCT01305577|448832794|FG001|Overall Study|Adverse Event|2|||
124782228|NCT01305577|448832795|FG002|Overall Study|Adverse Event|1|||
124782229|NCT01305577|448832793|FG000|Overall Study|Withdrawal by Subject|7|||
124782230|NCT01305577|448832794|FG001|Overall Study|Withdrawal by Subject|5|||
124782231|NCT01305577|448832795|FG002|Overall Study|Withdrawal by Subject|6|||
124782232|NCT01305577|448832793|FG000|Overall Study|Lost to Follow-up|4|||
124782233|NCT01305577|448832794|FG001|Overall Study|Lost to Follow-up|3|||
124782234|NCT01305577|448832795|FG002|Overall Study|Lost to Follow-up|2|||
124782235|NCT01305577|448832793|FG000|Overall Study|Protocol Deviation|0|||
124782236|NCT01305577|448832794|FG001|Overall Study|Protocol Deviation|1|||
124782237|NCT01305577|448832795|FG002|Overall Study|Protocol Deviation|1|||
124618699|NCT04803305|448219425|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
124744736|NCT00615030|448687432|FG003|Period II|Subject withdrew consent|1|||
124782238|NCT00796978|448832796|FG000|Overall Study|Cardiac adverse event|5|||
124782239|NCT00796978|448832796|FG000|Overall Study|Adverse Event|4|||
124782240|NCT00796978|448832796|FG000|Overall Study|Withdrawal by Subject|3|||
124782241|NCT02364336|448832797|FG000|Overall Study|Adverse Event|0|||
124782242|NCT02364336|448832798|FG001|Overall Study|Adverse Event|1|||
124782243|NCT05246514|448832799|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
124744737|NCT00615030|448687433|FG004|Period II|Subject withdrew consent|0|||
124744738|NCT00615030|448687434|FG005|Period II|Subject withdrew consent|0|||
124744739|NCT00615030|448687435|FG006|Period II|Subject withdrew consent|1|||
124782244|NCT05246514|448832799|FG000|Overall Study|Withdrawal by Subject|1|||
124782245|NCT05246514|448832799|FG000|Overall Study|Death|13|||
124782246|NCT02910986|448832800|FG000|Overall Study|non-Latina|14|||
124782247|NCT02910986|448832801|FG001|Overall Study|non-Latina|13|||
124782248|NCT02910986|448832802|FG002|Overall Study|non-Latina|12|||
124744740|NCT00615030|448687436|FG007|Period II|Subject withdrew consent|0|||
124744741|NCT00615030|448687437|FG008|Period II|Subject withdrew consent|0|||
124744742|NCT00615030|448687438|FG009|Period II|Subject withdrew consent|0|||
124744743|NCT00615030|448687439|FG010|Period II|Subject withdrew consent|0|||
124744744|NCT00615030|448687440|FG011|Period II|Subject withdrew consent|0|||
124744745|NCT00615030|448687429|FG000|Period III|Administrative problems|1|||
124744746|NCT00615030|448687430|FG001|Period III|Administrative problems|0|||
124744747|NCT00615030|448687431|FG002|Period III|Administrative problems|0|||
124744748|NCT00615030|448687432|FG003|Period III|Administrative problems|1|||
124744749|NCT00615030|448687433|FG004|Period III|Administrative problems|0|||
124744750|NCT00615030|448687434|FG005|Period III|Administrative problems|0|||
124744751|NCT00615030|448687435|FG006|Period III|Administrative problems|0|||
124744752|NCT00615030|448687436|FG007|Period III|Administrative problems|0|||
124744753|NCT00615030|448687437|FG008|Period III|Administrative problems|0|||
124744754|NCT00615030|448687438|FG009|Period III|Administrative problems|0|||
124744755|NCT00615030|448687439|FG010|Period III|Administrative problems|0|||
124744756|NCT00615030|448687440|FG011|Period III|Administrative problems|0|||
124744757|NCT00151476|448687441|FG000|FAP Identified Subjects|Protocol Violation|0|||
124744758|NCT00151476|448687442|FG001|FAP Identified Subjects|Protocol Violation|1|||
124744759|NCT00151476|448687441|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
124744760|NCT00151476|448687442|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
124744761|NCT00151476|448687441|FG000|FAP Analyzed Subjects|Other study participation|0|||
124744762|NCT00151476|448687442|FG001|FAP Analyzed Subjects|Other study participation|1|||
124744763|NCT03446456|448687443|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
124744764|NCT03446456|448687444|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
124744765|NCT03446456|448687443|FG000|Overall Study|Lost to Follow-up|1|||
124744766|NCT03446456|448687444|FG001|Overall Study|Lost to Follow-up|3|||
124744767|NCT03446456|448687443|FG000|Overall Study|Participant failed the toxicology test|1|||
124744768|NCT03446456|448687444|FG001|Overall Study|Participant failed the toxicology test|0|||
124744769|NCT03446456|448687443|FG000|Overall Study|Break down of the experimental equipment|1|||
124744770|NCT03446456|448687444|FG001|Overall Study|Break down of the experimental equipment|0|||
124744771|NCT04099511|448687451|FG000|Overall Study|Lost to Follow-up|2|||
124744772|NCT04099511|448687452|FG001|Overall Study|Lost to Follow-up|2|||
124744773|NCT04099511|448687451|FG000|Overall Study|Withdrawal by Subject|8|||
124744774|NCT04099511|448687452|FG001|Overall Study|Withdrawal by Subject|4|||
124744775|NCT03002311|448687457|FG000|Overall Study|Lost to Follow-up|13|||
124744776|NCT03002311|448687458|FG001|Overall Study|Lost to Follow-up|26|||
124744777|NCT03002311|448687457|FG000|Overall Study|Referral provider called to schedule app|3|||
124744778|NCT03002311|448687458|FG001|Overall Study|Referral provider called to schedule app|3|||
124744779|NCT03002311|448687457|FG000|Overall Study|Physician Decision|3|||
124744780|NCT03002311|448687458|FG001|Overall Study|Physician Decision|1|||
124744781|NCT03908476|448687459|FG000|Overall Study|Death|3|||
124744782|NCT03908476|448687460|FG001|Overall Study|Death|0|||
124744783|NCT03908476|448687459|FG000|Overall Study|Lost to Follow-up|3|||
124744784|NCT03908476|448687460|FG001|Overall Study|Lost to Follow-up|1|||
124744785|NCT03908476|448687459|FG000|Overall Study|Withdrawal by Subject|7|||
124744786|NCT03908476|448687460|FG001|Overall Study|Withdrawal by Subject|1|||
124744787|NCT03908476|448687459|FG000|Overall Study|Physician Decision|2|||
124744788|NCT03908476|448687460|FG001|Overall Study|Physician Decision|0|||
124744789|NCT03908476|448687459|FG000|Overall Study|System Explanted and not Replaced|4|||
124744790|NCT03908476|448687460|FG001|Overall Study|System Explanted and not Replaced|0|||
124744791|NCT03908476|448687459|FG000|Overall Study|Intrathecal Pump|1|||
124744792|NCT03908476|448687460|FG001|Overall Study|Intrathecal Pump|0|||
124744793|NCT03908476|448687459|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
124744794|NCT03908476|448687460|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
124744795|NCT05194267|448687461|FG000|Overall Study|Withdrawal by Subject|2|||
124744796|NCT00802893|448687462|FG000|Overall Study|study terminated|3|||
124744797|NCT02868229|448687463|FG000|Overall Study|Adverse Event|1|||
124744798|NCT02868229|448687464|FG001|Overall Study|Adverse Event|0|||
124744799|NCT02868229|448687465|FG002|Overall Study|Adverse Event|0|||
124744800|NCT02868229|448687466|FG003|Overall Study|Adverse Event|1|||
124744801|NCT02868229|448687463|FG000|Overall Study|Death|0|||
124744802|NCT02868229|448687464|FG001|Overall Study|Death|0|||
124744803|NCT02868229|448687465|FG002|Overall Study|Death|1|||
124744804|NCT02868229|448687466|FG003|Overall Study|Death|1|||
124744805|NCT02868229|448687463|FG000|Overall Study|Missed dose|0|||
124744806|NCT02868229|448687464|FG001|Overall Study|Missed dose|0|||
124744807|NCT02868229|448687465|FG002|Overall Study|Missed dose|0|||
124744808|NCT02868229|448687466|FG003|Overall Study|Missed dose|3|||
124744809|NCT00320424|448687467|FG000|Overall Study|Adverse Event|3|||
124744810|NCT00320424|448687467|FG000|Overall Study|Other|3|||
124744811|NCT06151288|448687468|FG000|Overall Study|Lost to Follow-up|4|||
124744812|NCT06151288|448687469|FG001|Overall Study|Lost to Follow-up|2|||
124744813|NCT06151288|448687470|FG002|Overall Study|Lost to Follow-up|4|||
124744814|NCT06151288|448687471|FG003|Overall Study|Lost to Follow-up|3|||
124744815|NCT06151288|448687468|FG000|Overall Study|Withdrawal by Subject|4|||
124744816|NCT06151288|448687469|FG001|Overall Study|Withdrawal by Subject|5|||
124744817|NCT06151288|448687470|FG002|Overall Study|Withdrawal by Subject|1|||
124744818|NCT06151288|448687471|FG003|Overall Study|Withdrawal by Subject|1|||
124744819|NCT00658814|448687472|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
124744820|NCT00658814|448687473|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
124744821|NCT00658814|448687472|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
124744822|NCT00658814|448687473|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
124744823|NCT00658814|448687472|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
124744824|NCT00658814|448687473|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
124744825|NCT00658814|448687472|FG000|Remission Induction Chemotherapy|Death|1|||
124744826|NCT00658814|448687473|FG001|Remission Induction Chemotherapy|Death|4|||
124744827|NCT00658814|448687472|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
124744828|NCT00658814|448687473|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
124744829|NCT00658814|448687472|FG000|Remission Induction Chemotherapy|Not eligible|1|||
124744830|NCT00658814|448687473|FG001|Remission Induction Chemotherapy|Not eligible|2|||
124744831|NCT00658814|448687472|FG000|Consolidation Therapy|Not protocol specified|0|||
124744832|NCT00658814|448687473|FG001|Consolidation Therapy|Not protocol specified|1|||
124744833|NCT00658814|448687472|FG000|Consolidation Therapy|Not eligible|2|||
124744834|NCT00658814|448687473|FG001|Consolidation Therapy|Not eligible|2|||
124744835|NCT00658814|448687472|FG000|Maintenance Therapy|Adverse Event|1|||
124744836|NCT00658814|448687473|FG001|Maintenance Therapy|Adverse Event|1|||
124744837|NCT00658814|448687472|FG000|Maintenance Therapy|Not protocol specified|1|||
124744838|NCT00658814|448687473|FG001|Maintenance Therapy|Not protocol specified|0|||
124744839|NCT00658814|448687472|FG000|Maintenance Therapy|Not eligible|1|||
124744840|NCT00658814|448687473|FG001|Maintenance Therapy|Not eligible|0|||
124744841|NCT00231413|448687481|FG000|Overall Study|Non-serious AE|0|||
124744842|NCT00231413|448687482|FG001|Overall Study|Non-serious AE|0|||
124744843|NCT00231413|448687483|FG002|Overall Study|Non-serious AE|1|||
124744844|NCT00231413|448687484|FG003|Overall Study|Non-serious AE|0|||
124744845|NCT00231413|448687485|FG004|Overall Study|Non-serious AE|0|||
124744846|NCT00231413|448687486|FG005|Overall Study|Non-serious AE|0|||
124744847|NCT00231413|448687487|FG006|Overall Study|Non-serious AE|1|||
124744848|NCT00231413|448687481|FG000|Overall Study|Withdrawal by Subject|3|||
124744849|NCT00231413|448687482|FG001|Overall Study|Withdrawal by Subject|1|||
124744850|NCT00231413|448687483|FG002|Overall Study|Withdrawal by Subject|4|||
124744851|NCT00231413|448687484|FG003|Overall Study|Withdrawal by Subject|2|||
124744852|NCT00231413|448687485|FG004|Overall Study|Withdrawal by Subject|2|||
124744853|NCT00231413|448687486|FG005|Overall Study|Withdrawal by Subject|0|||
124744854|NCT00231413|448687487|FG006|Overall Study|Withdrawal by Subject|3|||
124744855|NCT00231413|448687481|FG000|Overall Study|Migrated/moved from study area|0|||
124744856|NCT00231413|448687482|FG001|Overall Study|Migrated/moved from study area|0|||
124744857|NCT00231413|448687483|FG002|Overall Study|Migrated/moved from study area|1|||
124744858|NCT00231413|448687484|FG003|Overall Study|Migrated/moved from study area|0|||
124744859|NCT00231413|448687485|FG004|Overall Study|Migrated/moved from study area|0|||
124744860|NCT00231413|448687486|FG005|Overall Study|Migrated/moved from study area|1|||
124744861|NCT00231413|448687487|FG006|Overall Study|Migrated/moved from study area|0|||
124744862|NCT00231413|448687481|FG000|Overall Study|Lost to Follow-up|4|||
124744863|NCT00231413|448687482|FG001|Overall Study|Lost to Follow-up|4|||
124744864|NCT00231413|448687483|FG002|Overall Study|Lost to Follow-up|1|||
124744865|NCT00231413|448687484|FG003|Overall Study|Lost to Follow-up|1|||
124744866|NCT00231413|448687485|FG004|Overall Study|Lost to Follow-up|1|||
124744867|NCT00231413|448687486|FG005|Overall Study|Lost to Follow-up|4|||
124744868|NCT00231413|448687487|FG006|Overall Study|Lost to Follow-up|0|||
124744869|NCT00231413|448687481|FG000|Overall Study|Pregnancy|1|||
124744870|NCT00231413|448687482|FG001|Overall Study|Pregnancy|0|||
124744871|NCT00231413|448687483|FG002|Overall Study|Pregnancy|0|||
124744872|NCT00231413|448687484|FG003|Overall Study|Pregnancy|0|||
124744873|NCT00231413|448687485|FG004|Overall Study|Pregnancy|0|||
124744874|NCT00231413|448687486|FG005|Overall Study|Pregnancy|0|||
124744875|NCT00231413|448687487|FG006|Overall Study|Pregnancy|0|||
124744876|NCT02708485|448687488|FG000|Overall Study|Withdrawal by Subject|3|||
124637493|NCT01554527|448290575|FG002|Overall Study|Lost to Follow-up|4|||
124637494|NCT01554527|448290573|FG000|Overall Study|Physician Decision|0|||
124637495|NCT01554527|448290574|FG001|Overall Study|Physician Decision|0|||
124637496|NCT01554527|448290575|FG002|Overall Study|Physician Decision|1|||
124637497|NCT01052480|448290576|FG000|Overall Study|Lost to Follow-up|3|||
124637498|NCT01052480|448290577|FG001|Overall Study|Lost to Follow-up|3|||
124637499|NCT01052480|448290576|FG000|Overall Study|Protocol Violation|1|||
124637500|NCT01052480|448290577|FG001|Overall Study|Protocol Violation|0|||
124637501|NCT01052480|448290576|FG000|Overall Study|Withdrawal by Subject|3|||
124637502|NCT01052480|448290577|FG001|Overall Study|Withdrawal by Subject|7|||
124637503|NCT01052480|448290576|FG000|Overall Study|Physician Decision|0|||
124637504|NCT01052480|448290577|FG001|Overall Study|Physician Decision|2|||
124744877|NCT02708485|448687489|FG001|Overall Study|Withdrawal by Subject|2|||
124744878|NCT03266172|448687490|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
124744879|NCT03266172|448687491|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
124744880|NCT03266172|448687492|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
124744881|NCT03266172|448687490|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
124744882|NCT03266172|448687491|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
124744883|NCT03266172|448687492|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
124744884|NCT03266172|448687490|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
124744885|NCT03266172|448687491|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
124744886|NCT03266172|448687492|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
124744887|NCT03266172|448687490|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
124744888|NCT03266172|448687491|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
124744889|NCT03266172|448687492|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
124744890|NCT03266172|448687490|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
124744891|NCT03266172|448687491|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
124744892|NCT03266172|448687492|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
124744893|NCT03266172|448687490|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
124744894|NCT03266172|448687491|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
124744895|NCT03266172|448687492|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
124744896|NCT01554514|448687495|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
124744897|NCT01554514|448687495|FG000|Overall Study|Physician Decision|1|||
124744898|NCT05222555|448687496|FG000|Overall Study|Ongoing|2|||
124744899|NCT05222555|448687497|FG001|Overall Study|Ongoing|18|||
124744900|NCT05222555|448687496|FG000|Overall Study|Adverse Event|1|||
124744901|NCT05222555|448687497|FG001|Overall Study|Adverse Event|1|||
124744902|NCT05222555|448687496|FG000|Overall Study|Death|0|||
124744903|NCT05222555|448687497|FG001|Overall Study|Death|6|||
124744904|NCT05222555|448687496|FG000|Overall Study|Withdrawal by Subject|0|||
124744905|NCT05222555|448687497|FG001|Overall Study|Withdrawal by Subject|11|||
124744906|NCT00300365|448687500|FG000|Overall Study|Lost to Follow-up|1|||
124744907|NCT00300365|448687501|FG001|Overall Study|Lost to Follow-up|0|||
124744908|NCT00300365|448687500|FG000|Overall Study|Physician Decision|2|||
124744909|NCT00300365|448687501|FG001|Overall Study|Physician Decision|0|||
124744910|NCT00300365|448687500|FG000|Overall Study|Withdrawal by Subject|1|||
124744911|NCT00300365|448687501|FG001|Overall Study|Withdrawal by Subject|0|||
124744912|NCT00300365|448687500|FG000|Overall Study|Adverse Event|0|||
124744913|NCT00300365|448687501|FG001|Overall Study|Adverse Event|2|||
124744914|NCT01422824|448687502|FG000|Overall Study|Case record form not evaluated|1|||
124744915|NCT01422824|448687502|FG000|Overall Study|Lost to Follow-up|37|||
124744916|NCT01581619|448687503|FG000|Overall Study|Withdrawal by Subject|1|||
124744917|NCT01581619|448687503|FG000|Overall Study|Lost to Follow-up|1|||
124744918|NCT01818492|448687504|FG000|Overall Study|Adverse Event|2|||
124744919|NCT01818492|448687504|FG000|Overall Study|Death|3|||
124744920|NCT01818492|448687504|FG000|Overall Study|Withdrawal by Subject|1|||
124744921|NCT01818492|448687504|FG000|Overall Study|Additional therapy when not allowed PP|4|||
124744922|NCT00109577|448687506|FG000|Overall Study|Withdrawal by Subject|3|||
124744923|NCT00109577|448687507|FG001|Overall Study|Withdrawal by Subject|3|||
124744924|NCT00587847|448687508|FG000|Overall Study|Lack of Efficacy|5|||
124744925|NCT00587847|448687508|FG000|Overall Study|Adverse Event|2|||
124744926|NCT03729245|448687509|FG000|Overall Study|Lost to Follow-up|5|||
124744927|NCT03729245|448687510|FG001|Overall Study|Lost to Follow-up|6|||
124744928|NCT03729245|448687509|FG000|Overall Study|Withdrawal by Subject|16|||
124744929|NCT03729245|448687510|FG001|Overall Study|Withdrawal by Subject|19|||
124744930|NCT03729245|448687509|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
124744931|NCT03729245|448687510|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
124744932|NCT00695864|448687511|FG000|Placebo|Withdrawal by Subject|1|||
124744933|NCT00695864|448687511|FG000|Placebo|Physician Decision|4|||
124744934|NCT00718770|448687512|FG000|Overall Study|Adverse Event|1|||
124744935|NCT00718770|448687512|FG000|Overall Study|Lack of Efficacy|1|||
124744936|NCT00718770|448687512|FG000|Overall Study|Lack of Efficacy|1|||
124744937|NCT00718770|448687512|FG000|Overall Study|Adverse Event|1|||
124744938|NCT00718770|448687512|FG000|Overall Study|Lack of Efficacy|1|||
124744939|NCT00718770|448687512|FG000|Overall Study|Adverse Event|1|||
124744940|NCT00718770|448687512|FG000|Overall Study|Lack of Efficacy|1|||
124744941|NCT00718770|448687512|FG000|Overall Study|Adverse Event|1|||
124744942|NCT01704456|448687513|FG000|Overall Study|Lost to Follow-up|8|||
124744943|NCT01704456|448687514|FG001|Overall Study|Lost to Follow-up|14|||
124744944|NCT00498355|448687515|FG000|Overall Study|Lost to Follow-up|1|||
124744945|NCT03268941|448689142|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
124744946|NCT03268941|448689143|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
124744947|NCT03268941|448689144|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
124744948|NCT03268941|448689145|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
124744949|NCT03268941|448689146|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
124744950|NCT03268941|448689147|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
124744951|NCT03268941|448689148|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
124744952|NCT03268941|448689142|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
124744953|NCT03268941|448689143|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
124744954|NCT03268941|448689144|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
124744955|NCT03268941|448689145|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
124744956|NCT03268941|448689146|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
124744957|NCT03268941|448689147|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
124744958|NCT03268941|448689148|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
124744959|NCT03268941|448689142|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
124744960|NCT03268941|448689143|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
124744961|NCT03268941|448689144|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
124744962|NCT03268941|448689145|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
124744963|NCT03268941|448689146|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
124744964|NCT03268941|448689147|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
124744965|NCT03268941|448689148|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
124744966|NCT03268941|448689142|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
124744967|NCT03268941|448689143|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
124744968|NCT03268941|448689144|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
124744969|NCT03268941|448689145|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
124744970|NCT03268941|448689146|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
124744971|NCT03268941|448689147|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
124744972|NCT03268941|448689148|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
124744973|NCT03268941|448689142|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
124744974|NCT03268941|448689143|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
124744975|NCT03268941|448689144|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
124744976|NCT03268941|448689145|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
124744977|NCT03268941|448689146|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
124744978|NCT03268941|448689147|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
124744979|NCT03268941|448689148|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
124744980|NCT01216683|448689149|FG000|Induction|Never started treatment|0|||
124744981|NCT01216683|448689150|FG001|Induction|Never started treatment|6|||
124744982|NCT01216683|448689151|FG002|Induction|Never started treatment|3|||
124744983|NCT01216683|448689149|FG000|Induction|Lack of Efficacy|4|||
124744984|NCT01216683|448689150|FG001|Induction|Lack of Efficacy|3|||
124744985|NCT01216683|448689151|FG002|Induction|Lack of Efficacy|7|||
124744986|NCT01216683|448689149|FG000|Induction|Adverse Event|0|||
124744987|NCT01216683|448689150|FG001|Induction|Adverse Event|5|||
124744988|NCT01216683|448689151|FG002|Induction|Adverse Event|5|||
124744989|NCT01216683|448689149|FG000|Induction|Death|0|||
124744990|NCT01216683|448689150|FG001|Induction|Death|0|||
124744991|NCT01216683|448689151|FG002|Induction|Death|2|||
124744992|NCT01216683|448689149|FG000|Induction|Withdrawal by Subject|0|||
124744993|NCT01216683|448689150|FG001|Induction|Withdrawal by Subject|4|||
124744994|NCT01216683|448689151|FG002|Induction|Withdrawal by Subject|2|||
124744995|NCT01216683|448689149|FG000|Induction|Other disease|0|||
124744996|NCT01216683|448689150|FG001|Induction|Other disease|1|||
124744997|NCT01216683|448689151|FG002|Induction|Other disease|2|||
124744998|NCT01216683|448689149|FG000|Continuation|Lack of Efficacy|3|||
124744999|NCT01216683|448689150|FG001|Continuation|Lack of Efficacy|2|||
124745000|NCT01216683|448689151|FG002|Continuation|Lack of Efficacy|7|||
124745001|NCT01216683|448689149|FG000|Continuation|Adverse Event|5|||
124745002|NCT01216683|448689150|FG001|Continuation|Adverse Event|3|||
124745003|NCT01216683|448689151|FG002|Continuation|Adverse Event|16|||
124745004|NCT01216683|448689149|FG000|Continuation|Death|1|||
124745005|NCT01216683|448689150|FG001|Continuation|Death|0|||
124745006|NCT01216683|448689151|FG002|Continuation|Death|2|||
124745007|NCT01216683|448689149|FG000|Continuation|Withdrawal by Subject|4|||
124745008|NCT01216683|448689150|FG001|Continuation|Withdrawal by Subject|5|||
124745009|NCT01216683|448689151|FG002|Continuation|Withdrawal by Subject|9|||
124745010|NCT01216683|448689149|FG000|Continuation|Other diseases|0|||
124745011|NCT01216683|448689150|FG001|Continuation|Other diseases|2|||
124745012|NCT01216683|448689151|FG002|Continuation|Other diseases|1|||
124745013|NCT01216683|448689149|FG000|Continuation|Physician Decision|1|||
124745014|NCT01216683|448689150|FG001|Continuation|Physician Decision|0|||
124745015|NCT01216683|448689151|FG002|Continuation|Physician Decision|1|||
124745016|NCT01216683|448689149|FG000|Continuation|Non-compliance|1|||
124745017|NCT01216683|448689150|FG001|Continuation|Non-compliance|0|||
124745018|NCT01216683|448689151|FG002|Continuation|Non-compliance|1|||
124745019|NCT01216683|448689149|FG000|Continuation|Insurance change|0|||
124745020|NCT01216683|448689150|FG001|Continuation|Insurance change|1|||
124745021|NCT01216683|448689151|FG002|Continuation|Insurance change|0|||
124745022|NCT01216683|448689149|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
124745023|NCT01216683|448689150|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
124745024|NCT01216683|448689151|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
124745025|NCT01216683|448689149|FG000|Continuation|Not reported|0|||
124745026|NCT01216683|448689150|FG001|Continuation|Not reported|0|||
124745027|NCT01216683|448689151|FG002|Continuation|Not reported|1|||
124745028|NCT01216683|448689149|FG000|Continuation|Never started treatment|0|||
124745029|NCT01216683|448689150|FG001|Continuation|Never started treatment|1|||
124745030|NCT01216683|448689151|FG002|Continuation|Never started treatment|5|||
124745031|NCT02503501|448689153|FG000|Overall Study|Physician Decision|1|||
124745032|NCT02503501|448689154|FG001|Overall Study|Physician Decision|0|||
124745033|NCT02503501|448689153|FG000|Overall Study|Protocol Violation|0|||
124745034|NCT02503501|448689154|FG001|Overall Study|Protocol Violation|1|||
124745035|NCT02503501|448689153|FG000|Overall Study|Withdrawal by Subject|0|||
124745036|NCT02503501|448689154|FG001|Overall Study|Withdrawal by Subject|2|||
124745037|NCT01740401|448689155|FG000|Overall Study|Progression of disease|6|||
124745038|NCT01740401|448689155|FG000|Overall Study|Adverse Event|2|||
124745039|NCT01740401|448689155|FG000|Overall Study|Did not reach primary endpoint|2|||
124745040|NCT02806960|448689156|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
124745041|NCT02806960|448689157|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
124745042|NCT02806960|448689158|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
124745043|NCT02806960|448689159|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
124745044|NCT03495102|448689160|FG000|Overall Study|Adverse Event|5|||
124745045|NCT03495102|448689161|FG001|Overall Study|Adverse Event|7|||
124745046|NCT03495102|448689162|FG002|Overall Study|Adverse Event|10|||
124745047|NCT03495102|448689160|FG000|Overall Study|Death|3|||
124745048|NCT03495102|448689161|FG001|Overall Study|Death|4|||
124745049|NCT03495102|448689162|FG002|Overall Study|Death|4|||
124745050|NCT03495102|448689160|FG000|Overall Study|Lost to Follow-up|15|||
124745051|NCT03495102|448689161|FG001|Overall Study|Lost to Follow-up|16|||
124745052|NCT03495102|448689162|FG002|Overall Study|Lost to Follow-up|17|||
124745053|NCT03495102|448689160|FG000|Overall Study|Physician Decision|2|||
124745054|NCT03495102|448689161|FG001|Overall Study|Physician Decision|0|||
124745055|NCT03495102|448689162|FG002|Overall Study|Physician Decision|2|||
124745056|NCT03495102|448689160|FG000|Overall Study|Withdrawal by Subject|25|||
124745057|NCT03495102|448689161|FG001|Overall Study|Withdrawal by Subject|36|||
124745058|NCT03495102|448689162|FG002|Overall Study|Withdrawal by Subject|18|||
124745059|NCT03495102|448689160|FG000|Overall Study|Protocol Violation|1|||
124745060|NCT03495102|448689161|FG001|Overall Study|Protocol Violation|1|||
124745061|NCT03495102|448689162|FG002|Overall Study|Protocol Violation|0|||
124745062|NCT03495102|448689160|FG000|Overall Study|Site Closure|3|||
124745063|NCT03495102|448689161|FG001|Overall Study|Site Closure|1|||
124745064|NCT03495102|448689162|FG002|Overall Study|Site Closure|2|||
124745065|NCT03495102|448689160|FG000|Overall Study|Non-compliance|1|||
124745066|NCT03495102|448689161|FG001|Overall Study|Non-compliance|0|||
124745067|NCT03495102|448689162|FG002|Overall Study|Non-compliance|0|||
124745068|NCT03495102|448689160|FG000|Overall Study|Participant Duplicated at Another Site|0|||
124745069|NCT03495102|448689161|FG001|Overall Study|Participant Duplicated at Another Site|0|||
124745070|NCT03495102|448689162|FG002|Overall Study|Participant Duplicated at Another Site|1|||
124745071|NCT03495102|448689160|FG000|Overall Study|Primary Care Physician Recommendation|0|||
124745072|NCT03495102|448689161|FG001|Overall Study|Primary Care Physician Recommendation|1|||
124745073|NCT03495102|448689162|FG002|Overall Study|Primary Care Physician Recommendation|0|||
124745074|NCT03495102|448689160|FG000|Overall Study|Relocated to Another Country|0|||
124745075|NCT03495102|448689161|FG001|Overall Study|Relocated to Another Country|1|||
124745076|NCT03495102|448689162|FG002|Overall Study|Relocated to Another Country|0|||
124745077|NCT03495102|448689160|FG000|Overall Study|Participant was in Rehabilitation|1|||
124745078|NCT03495102|448689161|FG001|Overall Study|Participant was in Rehabilitation|0|||
124745079|NCT03495102|448689162|FG002|Overall Study|Participant was in Rehabilitation|0|||
124745080|NCT01161537|448689168|FG000|Part B|Withdrawal by Subject|2|||
124745081|NCT03464019|448689172|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
124745082|NCT03464019|448689173|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
124745083|NCT03464019|448689174|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
124745084|NCT03464019|448689172|FG000|NODE-301 Part 1|Ablation|0|||
124745085|NCT03464019|448689173|FG001|NODE-301 Part 1|Ablation|0|||
124745086|NCT03464019|448689174|FG002|NODE-301 Part 1|Ablation|16|||
124745087|NCT03464019|448689172|FG000|NODE-301 Part 1|Test Dose Failure|0|||
124745088|NCT03464019|448689173|FG001|NODE-301 Part 1|Test Dose Failure|0|||
124745089|NCT03464019|448689174|FG002|NODE-301 Part 1|Test Dose Failure|8|||
124745090|NCT03464019|448689172|FG000|NODE-301 Part 1|Adverse Event|0|||
124745091|NCT03464019|448689173|FG001|NODE-301 Part 1|Adverse Event|0|||
124745092|NCT03464019|448689174|FG002|NODE-301 Part 1|Adverse Event|5|||
124745093|NCT03464019|448689172|FG000|NODE-301 Part 1|Physician Decision|0|||
124745094|NCT03464019|448689173|FG001|NODE-301 Part 1|Physician Decision|0|||
124745095|NCT03464019|448689174|FG002|NODE-301 Part 1|Physician Decision|4|||
124745096|NCT03464019|448689172|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
124745097|NCT03464019|448689173|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
124745098|NCT03464019|448689174|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
124745099|NCT03464019|448689172|FG000|NODE-301 Part 1|Protocol Violation|0|||
124745100|NCT03464019|448689173|FG001|NODE-301 Part 1|Protocol Violation|0|||
124782249|NCT02910986|448832800|FG000|Overall Study|Failure to return T! survey|72|||
124618700|NCT04803305|448219424|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
124618701|NCT04803305|448219425|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
124618702|NCT04803305|448219424|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
124745101|NCT03464019|448689174|FG002|NODE-301 Part 1|Protocol Violation|2|||
124745102|NCT03464019|448689172|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
124745103|NCT03464019|448689173|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
124745104|NCT03464019|448689174|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
124745105|NCT03464019|448689172|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
124745106|NCT03464019|448689173|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
124745107|NCT03464019|448689174|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
124745108|NCT03464019|448689172|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
124745109|NCT03464019|448689173|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
124745110|NCT03464019|448689174|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
124745111|NCT03464019|448689172|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
124745112|NCT03464019|448689173|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
124745113|NCT03464019|448689174|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
124745114|NCT03464019|448689172|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
124745115|NCT03464019|448689173|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
124745116|NCT03464019|448689174|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
124745117|NCT03464019|448689172|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
124745118|NCT03464019|448689173|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
124745119|NCT03464019|448689174|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
124745120|NCT03464019|448689172|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
124745121|NCT03464019|448689173|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
124745122|NCT03464019|448689174|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
124745123|NCT03464019|448689172|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
124745124|NCT03464019|448689173|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
124745125|NCT03464019|448689174|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
124745126|NCT03464019|448689172|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
124745127|NCT03464019|448689173|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
124745128|NCT03464019|448689174|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
124745129|NCT03464019|448689172|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
124745130|NCT03464019|448689173|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
124745131|NCT03464019|448689174|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
124745132|NCT03464019|448689172|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
124745133|NCT03464019|448689173|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
124745134|NCT03464019|448689174|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
124745135|NCT03464019|448689172|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
124745136|NCT03464019|448689173|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
124745137|NCT03464019|448689174|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
124745138|NCT03464019|448689172|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
124745139|NCT03464019|448689173|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
124745140|NCT03464019|448689174|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
124745141|NCT03464019|448689172|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
124745142|NCT03464019|448689173|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
124745143|NCT03464019|448689174|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
124745144|NCT00511134|448689175|FG000|Overall Study|Withdrawal by Subject|0|||
124745145|NCT00511134|448689176|FG001|Overall Study|Withdrawal by Subject|2|||
124745146|NCT01949090|448689177|FG000|Overall Study|Serious Adverse Event|0|||
124745147|NCT01949090|448689178|FG001|Overall Study|Serious Adverse Event|1|||
124745148|NCT01949090|448689179|FG002|Overall Study|Serious Adverse Event|2|||
124745149|NCT01949090|448689180|FG003|Overall Study|Serious Adverse Event|0|||
124745150|NCT01949090|448689181|FG004|Overall Study|Serious Adverse Event|1|||
124745151|NCT01949090|448689177|FG000|Overall Study|Withdrawal by Subject|2|||
124745152|NCT01949090|448689178|FG001|Overall Study|Withdrawal by Subject|0|||
124745153|NCT01949090|448689179|FG002|Overall Study|Withdrawal by Subject|0|||
124745154|NCT01949090|448689180|FG003|Overall Study|Withdrawal by Subject|0|||
124745155|NCT01949090|448689181|FG004|Overall Study|Withdrawal by Subject|1|||
124745156|NCT01949090|448689177|FG000|Overall Study|Protocol non-compliance|0|||
124745157|NCT01949090|448689178|FG001|Overall Study|Protocol non-compliance|0|||
124745158|NCT01949090|448689179|FG002|Overall Study|Protocol non-compliance|0|||
124745159|NCT01949090|448689180|FG003|Overall Study|Protocol non-compliance|0|||
124745160|NCT01949090|448689181|FG004|Overall Study|Protocol non-compliance|1|||
124745161|NCT01949090|448689177|FG000|Overall Study|Lost to Follow-up|2|||
124745162|NCT01949090|448689178|FG001|Overall Study|Lost to Follow-up|1|||
124745163|NCT01949090|448689179|FG002|Overall Study|Lost to Follow-up|0|||
124745164|NCT01949090|448689180|FG003|Overall Study|Lost to Follow-up|1|||
124745165|NCT01949090|448689181|FG004|Overall Study|Lost to Follow-up|1|||
124618703|NCT04803305|448219425|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
124618704|NCT04803305|448219424|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
124745166|NCT03459365|448689182|FG000|Overall Study|Withdrawal by Subject|6|||
124745167|NCT03459365|448689182|FG000|Overall Study|Protocol Violation|8|||
124745168|NCT00567359|448689185|FG000|Overall Study|Withdrawal by Subject|1|||
124745169|NCT00785980|448689186|FG000|7 Day Washout Period|Protocol Violation|3|||
124745170|NCT00528801|448689187|FG000|Overall Study|Withdrawal by Subject|1|||
124745171|NCT00528801|448689188|FG001|Overall Study|Withdrawal by Subject|1|||
124745172|NCT00528801|448689187|FG000|Overall Study|Protocol Violation|11|||
124782250|NCT02910986|448832801|FG001|Overall Study|Failure to return T! survey|84|||
124637505|NCT01052480|448290576|FG000|Overall Study|Death|1|||
124637506|NCT01052480|448290577|FG001|Overall Study|Death|5|||
124637507|NCT00529373|448290584|FG000|Base Study|Adverse Event|525|||
124637508|NCT00529373|448290585|FG001|Base Study|Adverse Event|470|||
124637509|NCT00529373|448290584|FG000|Base Study|Lack of Efficacy|16|||
124637510|NCT00529373|448290585|FG001|Base Study|Lack of Efficacy|75|||
124637511|NCT00529373|448290584|FG000|Base Study|Lost to Follow-up|221|||
124637512|NCT00529373|448290585|FG001|Base Study|Lost to Follow-up|208|||
124637513|NCT00529373|448290584|FG000|Base Study|Other Protocol Specified Criteria|19|||
124637514|NCT00529373|448290585|FG001|Base Study|Other Protocol Specified Criteria|20|||
124637515|NCT00529373|448290584|FG000|Base Study|Physician Decision|60|||
124637516|NCT00529373|448290585|FG001|Base Study|Physician Decision|52|||
124637517|NCT00529373|448290584|FG000|Base Study|Protocol Violation|48|||
124637518|NCT00529373|448290585|FG001|Base Study|Protocol Violation|38|||
124637519|NCT00529373|448290584|FG000|Base Study|Withdrawal by Subject|1062|||
124637520|NCT00529373|448290585|FG001|Base Study|Withdrawal by Subject|967|||
124637521|NCT00529373|448290584|FG000|Base Study|Did not continue into Extension|1795|||
124637522|NCT00529373|448290585|FG001|Base Study|Did not continue into Extension|2238|||
124637523|NCT00529373|448290584|FG000|First Extension Study|Adverse Event|162|||
124637524|NCT00529373|448290585|FG001|First Extension Study|Adverse Event|142|||
124637525|NCT00529373|448290584|FG000|First Extension Study|Lack of Efficacy|65|||
124637526|NCT00529373|448290585|FG001|First Extension Study|Lack of Efficacy|427|||
124637527|NCT00529373|448290584|FG000|First Extension Study|Lost to Follow-up|41|||
124637528|NCT00529373|448290585|FG001|First Extension Study|Lost to Follow-up|37|||
124637529|NCT00529373|448290584|FG000|First Extension Study|Other|27|||
124637530|NCT00529373|448290585|FG001|First Extension Study|Other|47|||
124637531|NCT00529373|448290584|FG000|First Extension Study|Physician Decision|50|||
124637532|NCT00529373|448290585|FG001|First Extension Study|Physician Decision|45|||
124637533|NCT00529373|448290584|FG000|First Extension Study|Protocol Violation|16|||
124637534|NCT00529373|448290585|FG001|First Extension Study|Protocol Violation|13|||
124637535|NCT00529373|448290584|FG000|First Extension Study|Withdrawal by Subject|296|||
124637536|NCT00529373|448290585|FG001|First Extension Study|Withdrawal by Subject|287|||
124637537|NCT00529373|448290584|FG000|First Extension Study|Disposition record non-existing|0|||
124637538|NCT00529373|448290585|FG001|First Extension Study|Disposition record non-existing|1|||
124637539|NCT00529373|448290584|FG000|First Extension Study|Discontinued after 5 years completion|208|||
124637540|NCT00529373|448290585|FG001|First Extension Study|Discontinued after 5 years completion|346|||
124637541|NCT00529373|448290584|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
124637542|NCT00529373|448290585|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
124637543|NCT00529373|448290584|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
124637544|NCT00529373|448290585|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
124637545|NCT00529373|448290584|FG000|Second Extension Study|Adverse Event|101|||
124637546|NCT00529373|448290585|FG001|Second Extension Study|Adverse Event|51|||
124637547|NCT00529373|448290584|FG000|Second Extension Study|Lack of Efficacy|7|||
124637548|NCT00529373|448290585|FG001|Second Extension Study|Lack of Efficacy|15|||
124637549|NCT00529373|448290584|FG000|Second Extension Study|Lost to Follow-up|18|||
124637550|NCT00529373|448290585|FG001|Second Extension Study|Lost to Follow-up|12|||
124637551|NCT00529373|448290584|FG000|Second Extension Study|Other|7|||
124637552|NCT00529373|448290585|FG001|Second Extension Study|Other|12|||
124637553|NCT00529373|448290584|FG000|Second Extension Study|Physician Decision|63|||
124637554|NCT00529373|448290585|FG001|Second Extension Study|Physician Decision|26|||
124637555|NCT00529373|448290584|FG000|Second Extension Study|Protocol Violation|2|||
124637556|NCT00529373|448290585|FG001|Second Extension Study|Protocol Violation|1|||
124637557|NCT00529373|448290584|FG000|Second Extension Study|Withdrawal by Subject|97|||
124637558|NCT00529373|448290585|FG001|Second Extension Study|Withdrawal by Subject|75|||
124637559|NCT00529373|448290584|FG000|Second Extension Study|Status Missing|5|||
124637560|NCT00529373|448290585|FG001|Second Extension Study|Status Missing|5|||
124637561|NCT01863667|448290586|FG000|Overall Study|Adverse Event|1|||
124637562|NCT01863667|448290587|FG001|Overall Study|Adverse Event|0|||
124637563|NCT01863667|448290586|FG000|Overall Study|Study terminated by Sponsor|30|||
124637564|NCT01863667|448290587|FG001|Overall Study|Study terminated by Sponsor|30|||
124637565|NCT01863667|448290586|FG000|Overall Study|Withdrawal by Subject|2|||
124637566|NCT01863667|448290587|FG001|Overall Study|Withdrawal by Subject|2|||
124637567|NCT03627546|448290588|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
124637568|NCT03627546|448290589|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
124637569|NCT03627546|448290590|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
124637570|NCT03627546|448290588|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
124637571|NCT03627546|448290589|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
124637572|NCT03627546|448290590|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
124637573|NCT02965573|448290593|FG000|Overall Study|Lack of Efficacy|1|||
124637574|NCT02965573|448290594|FG001|Overall Study|Lack of Efficacy|0|||
124618705|NCT04803305|448219425|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
124618706|NCT04803305|448219424|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
124618707|NCT04803305|448219425|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
124618708|NCT00708227|448219430|FG000|Overall Study|Physician Decision|0|||
124618709|NCT00708227|448219431|FG001|Overall Study|Physician Decision|3|||
124618710|NCT00708227|448219432|FG002|Overall Study|Physician Decision|1|||
124618711|NCT00708227|448219433|FG003|Overall Study|Physician Decision|2|||
124618712|NCT00708227|448219430|FG000|Overall Study|Withdrawal by Subject|1|||
124618713|NCT00708227|448219431|FG001|Overall Study|Withdrawal by Subject|2|||
124618714|NCT00708227|448219432|FG002|Overall Study|Withdrawal by Subject|0|||
124618715|NCT00708227|448219433|FG003|Overall Study|Withdrawal by Subject|1|||
124618716|NCT03654599|448219435|FG000|Overall Study|Lost to Follow-up|14|||
124618717|NCT03654599|448219436|FG001|Overall Study|Lost to Follow-up|12|||
124618718|NCT03654599|448219435|FG000|Overall Study|Death|8|||
124618719|NCT03654599|448219436|FG001|Overall Study|Death|6|||
124618720|NCT03654599|448219435|FG000|Overall Study|Withdrawal by Subject|6|||
124618721|NCT03654599|448219436|FG001|Overall Study|Withdrawal by Subject|4|||
124618722|NCT02017015|448221526|FG000|Overall Study|Adverse Event|9|||
124618723|NCT02017015|448221526|FG000|Overall Study|Withdrawal by Subject|21|||
124618724|NCT02017015|448221526|FG000|Overall Study|Death|4|||
124618725|NCT02017015|448221526|FG000|Overall Study|Progressive Disease|31|||
124618726|NCT02017015|448221526|FG000|Overall Study|Non-compliance with study drug|2|||
124618727|NCT02017015|448221526|FG000|Overall Study|Physician Decision|2|||
124618728|NCT02291510|448221534|FG000|Overall Study|Adverse Event|0|||
124618729|NCT02291510|448221535|FG001|Overall Study|Adverse Event|0|||
124618730|NCT02291510|448221536|FG002|Overall Study|Adverse Event|0|||
124618731|NCT02291510|448221537|FG003|Overall Study|Adverse Event|1|||
124618732|NCT03765788|448221538|FG000|Overall Study|Subject decision|2|||
124618733|NCT03765788|448221539|FG001|Overall Study|Subject decision|3|||
124618734|NCT03765788|448221538|FG000|Overall Study|Physician Decision|2|||
124618735|NCT03765788|448221539|FG001|Overall Study|Physician Decision|4|||
124618736|NCT03765788|448221538|FG000|Overall Study|Death|0|||
124618737|NCT03765788|448221539|FG001|Overall Study|Death|1|||
124618738|NCT03765788|448221538|FG000|Overall Study|Lost to Follow-up|1|||
124618739|NCT03765788|448221539|FG001|Overall Study|Lost to Follow-up|0|||
124618740|NCT03203850|448221540|FG000|Overall Study|Subject/guardian decision|4|||
124618741|NCT03203850|448221541|FG001|Overall Study|Subject/guardian decision|3|||
124618742|NCT03203850|448221540|FG000|Overall Study|Adverse Event|3|||
124618743|NCT03203850|448221541|FG001|Overall Study|Adverse Event|0|||
124618744|NCT03203850|448221540|FG000|Overall Study|Death|1|||
124618745|NCT03203850|448221541|FG001|Overall Study|Death|0|||
124618746|NCT01659125|448221542|FG000|Overall Study|Withdrawal by Subject|2|||
124618747|NCT01659125|448221542|FG000|Overall Study|Lost to Follow-up|7|||
124618748|NCT01659125|448221542|FG000|Overall Study|Technical Problem|1|||
124618749|NCT01659125|448221542|FG000|Overall Study|Time Constraints|2|||
124618750|NCT01659125|448221542|FG000|Overall Study|Failed to Start Treatment|2|||
124618751|NCT02126826|448221543|FG000|Overall Study|Withdrawal by Subject|0|||
124618752|NCT02126826|448221544|FG001|Overall Study|Withdrawal by Subject|0|||
124618753|NCT02126826|448221545|FG002|Overall Study|Withdrawal by Subject|0|||
124618754|NCT02126826|448221546|FG003|Overall Study|Withdrawal by Subject|1|||
124618755|NCT02126826|448221547|FG004|Overall Study|Withdrawal by Subject|0|||
124618756|NCT02126826|448221548|FG005|Overall Study|Withdrawal by Subject|0|||
124618757|NCT02126826|448221549|FG006|Overall Study|Withdrawal by Subject|0|||
124618758|NCT02640482|448221550|FG000|Overall Study|Lost to Follow-up|3|||
124618759|NCT02640482|448221551|FG001|Overall Study|Lost to Follow-up|0|||
124618760|NCT01173120|448221552|FG000|Overall Study|Lack of Efficacy|2|||
124618761|NCT01173120|448221552|FG000|Overall Study|Lost to Follow-up|1|||
124618762|NCT01173120|448221552|FG000|Overall Study|Participant Decision|2|||
124618763|NCT01173120|448221552|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
124618764|NCT01173120|448221552|FG000|Overall Study|Switch-Participant Decision|12|||
124618765|NCT01173120|448221552|FG000|Overall Study|Switch-Difficulty With Device|12|||
124618766|NCT00113763|448221553|FG000|Overall Study|Adverse Event|5|||
124618767|NCT00113763|448221554|FG001|Overall Study|Adverse Event|2|||
124618768|NCT00113763|448221553|FG000|Overall Study|Disease Progression|28|||
124618769|NCT00113763|448221554|FG001|Overall Study|Disease Progression|14|||
124618770|NCT00113763|448221553|FG000|Overall Study|Lost to Follow-up|10|||
124618771|NCT00113763|448221554|FG001|Overall Study|Lost to Follow-up|0|||
124618772|NCT00113763|448221553|FG000|Overall Study|Withdrawal by Subject|1|||
124618773|NCT00113763|448221554|FG001|Overall Study|Withdrawal by Subject|4|||
124618774|NCT00113763|448221553|FG000|Overall Study|Other|27|||
124618775|NCT00113763|448221554|FG001|Overall Study|Other|6|||
124618776|NCT00113763|448221553|FG000|Overall Study|Non-compliance|1|||
124618777|NCT00113763|448221554|FG001|Overall Study|Non-compliance|0|||
124618778|NCT00113763|448221553|FG000|Overall Study|Ongoing|1|||
124618779|NCT00113763|448221554|FG001|Overall Study|Ongoing|0|||
124618780|NCT02013817|448221555|FG000|Overall Study|Adverse Event|12|||
124618781|NCT02013817|448221555|FG000|Overall Study|Withdrawal by Subject|4|||
124618782|NCT02013817|448221555|FG000|Overall Study|Death|2|||
124618783|NCT02013817|448221555|FG000|Overall Study|Other|9|||
124745173|NCT00528801|448689188|FG001|Overall Study|Protocol Violation|5|||
124745174|NCT00528801|448689187|FG000|Overall Study|Lost to Follow-up|15|||
124745175|NCT00528801|448689188|FG001|Overall Study|Lost to Follow-up|4|||
124745176|NCT00528801|448689187|FG000|Overall Study|Administrative Reasons|0|||
124745177|NCT00528801|448689188|FG001|Overall Study|Administrative Reasons|1|||
124745178|NCT00344500|448689189|FG000|Overall Study|Adverse Event|6|||
124745179|NCT00344500|448689190|FG001|Overall Study|Adverse Event|2|||
124745180|NCT00344500|448689191|FG002|Overall Study|Adverse Event|0|||
124745181|NCT00344500|448689189|FG000|Overall Study|Lost to Follow-up|5|||
124745182|NCT00344500|448689190|FG001|Overall Study|Lost to Follow-up|13|||
124745183|NCT00344500|448689191|FG002|Overall Study|Lost to Follow-up|1|||
124745184|NCT00344500|448689189|FG000|Overall Study|Withdrawal by Subject|7|||
124745185|NCT00344500|448689190|FG001|Overall Study|Withdrawal by Subject|10|||
124745186|NCT00344500|448689191|FG002|Overall Study|Withdrawal by Subject|0|||
124745187|NCT00344500|448689189|FG000|Overall Study|Protocol Violation|4|||
124745188|NCT00344500|448689190|FG001|Overall Study|Protocol Violation|7|||
124745189|NCT00344500|448689191|FG002|Overall Study|Protocol Violation|1|||
124745190|NCT00344500|448689189|FG000|Overall Study|Not Noted|1|||
124745191|NCT00344500|448689190|FG001|Overall Study|Not Noted|3|||
124745192|NCT00344500|448689191|FG002|Overall Study|Not Noted|0|||
124745193|NCT04680975|448689197|FG000|Overall Study|Adverse Event|3|||
124745194|NCT04680975|448689197|FG000|Overall Study|Death|1|||
124745195|NCT04680975|448689197|FG000|Overall Study|Progressive Disease|1|||
124745196|NCT04680975|448689197|FG000|Overall Study|Withdrawal by Subject|1|||
124745197|NCT02702414|448689198|FG000|Overall Study|Death|96|||
124745198|NCT02702414|448689199|FG001|Overall Study|Death|42|||
124745199|NCT02702414|448689198|FG000|Overall Study|Lost to Follow-up|0|||
124745200|NCT02702414|448689199|FG001|Overall Study|Lost to Follow-up|1|||
124745201|NCT02702414|448689198|FG000|Overall Study|Withdrawal by Subject|0|||
124745202|NCT02702414|448689199|FG001|Overall Study|Withdrawal by Subject|1|||
124745203|NCT02702414|448689198|FG000|Overall Study|Protocol Violation|1|||
124745204|NCT02702414|448689199|FG001|Overall Study|Protocol Violation|0|||
124745205|NCT02702414|448689198|FG000|Overall Study|Sponsor Decision|8|||
124745206|NCT02702414|448689199|FG001|Overall Study|Sponsor Decision|7|||
124745207|NCT02596230|448689200|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
124745208|NCT02596230|448689201|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
124745209|NCT02596230|448689202|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
124745210|NCT02596230|448689203|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
124745211|NCT02596230|448689204|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
124745212|NCT02596230|448689200|FG000|Objective 2, One Year|Lost to Follow-up|0|||
124745213|NCT02596230|448689201|FG001|Objective 2, One Year|Lost to Follow-up|41|||
124745214|NCT02596230|448689202|FG002|Objective 2, One Year|Lost to Follow-up|41|||
124745215|NCT02596230|448689203|FG003|Objective 2, One Year|Lost to Follow-up|32|||
124745216|NCT02596230|448689204|FG004|Objective 2, One Year|Lost to Follow-up|46|||
124745217|NCT02596230|448689200|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
124745218|NCT02596230|448689201|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
124745219|NCT02596230|448689202|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
124745220|NCT02596230|448689203|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
124745221|NCT02596230|448689204|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
124745222|NCT02596230|448689200|FG000|Objective 2, One Year|Adverse drug reaction|0|||
124745223|NCT02596230|448689201|FG001|Objective 2, One Year|Adverse drug reaction|1|||
124745224|NCT02596230|448689202|FG002|Objective 2, One Year|Adverse drug reaction|0|||
124745225|NCT02596230|448689203|FG003|Objective 2, One Year|Adverse drug reaction|0|||
124745226|NCT02596230|448689204|FG004|Objective 2, One Year|Adverse drug reaction|0|||
124745227|NCT02596230|448689200|FG000|Objective 2, One Year|Death|0|||
124745228|NCT02596230|448689201|FG001|Objective 2, One Year|Death|12|||
124745229|NCT02596230|448689202|FG002|Objective 2, One Year|Death|41|||
124618784|NCT00451204|448221562|FG000|Overall Study|Adverse Event|4|||
124745230|NCT02596230|448689203|FG003|Objective 2, One Year|Death|21|||
124745231|NCT02596230|448689204|FG004|Objective 2, One Year|Death|30|||
124745232|NCT02596230|448689200|FG000|Objective 2, One Year|Other|0|||
124745233|NCT02596230|448689201|FG001|Objective 2, One Year|Other|3|||
124745234|NCT02596230|448689202|FG002|Objective 2, One Year|Other|2|||
124745235|NCT02596230|448689203|FG003|Objective 2, One Year|Other|0|||
124745236|NCT02596230|448689204|FG004|Objective 2, One Year|Other|0|||
124618785|NCT00451204|448221563|FG001|Overall Study|Adverse Event|6|||
124745237|NCT02271945|448689205|FG000|Overall Study|Death|3|||
124745238|NCT02271945|448689206|FG001|Overall Study|Death|3|||
124745239|NCT02271945|448689205|FG000|Overall Study|Withdrawal by Subject|1|||
124745240|NCT02271945|448689206|FG001|Overall Study|Withdrawal by Subject|1|||
124745241|NCT02271945|448689205|FG000|Overall Study|Other|1|||
124745242|NCT02271945|448689206|FG001|Overall Study|Other|1|||
124745243|NCT00290498|448689207|FG000|Overall Study|Death|2|||
124745244|NCT00290498|448689208|FG001|Overall Study|Death|0|||
124745245|NCT00290498|448689207|FG000|Overall Study|Physician Decision|1|||
124745246|NCT00290498|448689208|FG001|Overall Study|Physician Decision|0|||
124745247|NCT00290498|448689207|FG000|Overall Study|Withdrawal by Subject|1|||
124745248|NCT00290498|448689208|FG001|Overall Study|Withdrawal by Subject|0|||
124745249|NCT00290498|448689207|FG000|Overall Study|Ineligible|3|||
124745250|NCT00290498|448689208|FG001|Overall Study|Ineligible|0|||
124745251|NCT00290498|448689207|FG000|Overall Study|Non-Compliance|1|||
124745252|NCT00290498|448689208|FG001|Overall Study|Non-Compliance|0|||
124745253|NCT01716104|448689210|FG000|Overall Study|Do not meet inclusion criteria|6|||
124745254|NCT01716104|448689211|FG001|Overall Study|Do not meet inclusion criteria|7|||
124745255|NCT03129360|448689212|FG000|Overall Study|Did not meet entry criteria|0|||
124745256|NCT03129360|448689213|FG001|Overall Study|Did not meet entry criteria|2|||
124745257|NCT03129360|448689214|FG002|Overall Study|Did not meet entry criteria|1|||
124745258|NCT03129360|448689212|FG000|Overall Study|Excluded due to motion in scanner|1|||
124745259|NCT03129360|448689213|FG001|Overall Study|Excluded due to motion in scanner|0|||
124745260|NCT03129360|448689214|FG002|Overall Study|Excluded due to motion in scanner|0|||
124745261|NCT05026853|448689215|FG000|Overall Study|Cancelled appointment|1|||
124745262|NCT05026853|448689216|FG001|Overall Study|Cancelled appointment|0|||
124745263|NCT05026853|448689215|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
124745264|NCT05026853|448689216|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
124745265|NCT05026853|448689215|FG000|Overall Study|Did not complete 12-week survey|16|||
124745266|NCT05026853|448689216|FG001|Overall Study|Did not complete 12-week survey|16|||
124745267|NCT03006887|448689217|FG000|Overall Study|Adverse Event|1|||
124745268|NCT03836677|448689218|FG000|Period 1|Adverse Event|0|||
124745269|NCT03836677|448689219|FG001|Period 1|Adverse Event|1|||
124745270|NCT03836677|448689218|FG000|Period 2|Severe non-compliance to protocol|1|||
124745271|NCT03836677|448689219|FG001|Period 2|Severe non-compliance to protocol|0|||
124745272|NCT01729208|448689220|FG000|Baseline|Physician Decision|5|||
124745273|NCT01729208|448689221|FG001|Baseline|Physician Decision|4|||
124745274|NCT01729208|448689220|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
124745275|NCT01729208|448689221|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
124745276|NCT01729208|448689220|FG000|12 Months Follow-up|Lost to Follow-up|3|||
124745277|NCT01729208|448689221|FG001|12 Months Follow-up|Lost to Follow-up|3|||
124745278|NCT01729208|448689220|FG000|24 Months Follow-up|Lost to Follow-up|3|||
124745279|NCT01729208|448689221|FG001|24 Months Follow-up|Lost to Follow-up|0|||
124745280|NCT01729208|448689220|FG000|36 Months Follow-up|Physician Decision|1|||
124745281|NCT01729208|448689221|FG001|36 Months Follow-up|Physician Decision|0|||
124745282|NCT01729208|448689220|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
124745283|NCT01729208|448689221|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
124745284|NCT02428413|448689223|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
124745285|NCT02428413|448689224|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
124745286|NCT02428413|448689223|FG000|Overall Study|Protocol Violation|1|||
124745287|NCT02428413|448689224|FG001|Overall Study|Protocol Violation|2|||
124745288|NCT02428413|448689223|FG000|Overall Study|Case Cancelled|2|||
124745289|NCT02428413|448689224|FG001|Overall Study|Case Cancelled|0|||
124745290|NCT02428413|448689223|FG000|Overall Study|Missed Cases|1|||
124745291|NCT02428413|448689224|FG001|Overall Study|Missed Cases|2|||
124745292|NCT02428413|448689223|FG000|Overall Study|Nurse Refusal|1|||
124745293|NCT02428413|448689224|FG001|Overall Study|Nurse Refusal|0|||
124745294|NCT03688100|448689227|FG000|Overall Study|Lost to Follow-up|21|||
124745295|NCT03688100|448689228|FG001|Overall Study|Lost to Follow-up|15|||
124745296|NCT03688100|448689229|FG002|Overall Study|Lost to Follow-up|15|||
124745297|NCT03688100|448689230|FG003|Overall Study|Lost to Follow-up|18|||
124745298|NCT03688100|448689227|FG000|Overall Study|Withdrawal by Subject|19|||
124745299|NCT03688100|448689228|FG001|Overall Study|Withdrawal by Subject|16|||
124745300|NCT03688100|448689229|FG002|Overall Study|Withdrawal by Subject|0|||
124745301|NCT03688100|448689230|FG003|Overall Study|Withdrawal by Subject|0|||
124745302|NCT03688100|448689227|FG000|Overall Study|Death|36|||
124745303|NCT03688100|448689228|FG001|Overall Study|Death|27|||
124745304|NCT03688100|448689229|FG002|Overall Study|Death|0|||
124745305|NCT03688100|448689230|FG003|Overall Study|Death|0|||
124745306|NCT02345330|448689233|FG000|Overall Study|Death|1|||
124745307|NCT02345330|448689233|FG000|Overall Study|Progressive Disease|2|||
124745308|NCT00494507|448689234|FG000|Double-Blind Phase|Adverse Event|2|||
124745309|NCT00494507|448689235|FG001|Double-Blind Phase|Adverse Event|0|||
124745310|NCT00494507|448689236|FG002|Double-Blind Phase|Adverse Event|1|||
124618786|NCT00451204|448221562|FG000|Overall Study|Lack of Efficacy|4|||
124618787|NCT00451204|448221563|FG001|Overall Study|Lack of Efficacy|4|||
124745311|NCT00494507|448689237|FG003|Double-Blind Phase|Adverse Event|0|||
124745312|NCT00494507|448689234|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
124745313|NCT00494507|448689235|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
124745314|NCT00494507|448689236|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
124745315|NCT00494507|448689237|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
124745316|NCT00494507|448689234|FG000|Double-Blind Phase|Subject Non-compliance|0|||
124745317|NCT00494507|448689235|FG001|Double-Blind Phase|Subject Non-compliance|0|||
124745318|NCT00494507|448689236|FG002|Double-Blind Phase|Subject Non-compliance|1|||
124745319|NCT00494507|448689237|FG003|Double-Blind Phase|Subject Non-compliance|0|||
124745320|NCT00494507|448689234|FG000|Double-Blind Phase|Negative DNA test|0|||
124745321|NCT00494507|448689235|FG001|Double-Blind Phase|Negative DNA test|0|||
124745322|NCT00494507|448689236|FG002|Double-Blind Phase|Negative DNA test|0|||
124745323|NCT00494507|448689237|FG003|Double-Blind Phase|Negative DNA test|1|||
124745324|NCT00494507|448689234|FG000|Open-Label Phase|Adverse Event|0|||
124745325|NCT00494507|448689235|FG001|Open-Label Phase|Adverse Event|1|||
124745326|NCT00494507|448689236|FG002|Open-Label Phase|Adverse Event|5|||
124745327|NCT00494507|448689237|FG003|Open-Label Phase|Adverse Event|3|||
124745328|NCT00494507|448689234|FG000|Open-Label Phase|Worsening Disease|0|||
124745329|NCT00494507|448689235|FG001|Open-Label Phase|Worsening Disease|0|||
124745330|NCT00494507|448689236|FG002|Open-Label Phase|Worsening Disease|0|||
124745331|NCT00494507|448689237|FG003|Open-Label Phase|Worsening Disease|2|||
124745332|NCT02437084|448689238|FG000|Overall Study|Withdrawal by Subject|2|||
124745333|NCT02437084|448689238|FG000|Overall Study|Physician Decision|1|||
124745334|NCT00989781|448689242|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
124745335|NCT00989781|448689243|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
124745336|NCT00694304|448689244|FG000|Overall Study|Adverse Event|42|||
124745337|NCT00694304|448689244|FG000|Overall Study|Lack of Efficacy|35|||
124745338|NCT00694304|448689244|FG000|Overall Study|Non-compliance With Study Product|16|||
124745339|NCT00694304|448689244|FG000|Overall Study|Protocol Violation|6|||
124745340|NCT00694304|448689244|FG000|Overall Study|Withdrawal of Consent|61|||
124745341|NCT00694304|448689244|FG000|Overall Study|Lost to Follow-up|15|||
124745342|NCT00694304|448689244|FG000|Overall Study|Administrative or Other Reasons|32|||
124745343|NCT04566692|448689245|FG000|Overall Study|Adverse Event|2|||
124745344|NCT04566692|448689246|FG001|Overall Study|Adverse Event|0|||
124745345|NCT04566692|448689245|FG000|Overall Study|Withdrawal by Subject|1|||
124745346|NCT04566692|448689246|FG001|Overall Study|Withdrawal by Subject|1|||
124745347|NCT00671437|448689247|FG000|Overall Study|Progressive disease before C1 week 8|8|||
124745348|NCT00671437|448689247|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
124745349|NCT00671437|448689247|FG000|Overall Study|Adverse Event|3|||
124745350|NCT00671437|448689247|FG000|Overall Study|Ineligible post-hoc|1|||
124745351|NCT03203291|448689250|FG000|Overall Study|Withdrawal by Subject|1|||
124745352|NCT00377364|448689255|FG000|Overall Study|Lost to Follow-up|1|||
124745353|NCT00377364|448689256|FG001|Overall Study|Lost to Follow-up|0|||
124745354|NCT00377364|448689255|FG000|Overall Study|Withdrawal by Subject|1|||
124745355|NCT00377364|448689256|FG001|Overall Study|Withdrawal by Subject|0|||
124745356|NCT02540265|448689259|FG000|Overall Study|Lost to Follow-up|0|||
124745357|NCT02540265|448689260|FG001|Overall Study|Lost to Follow-up|0|||
124745358|NCT02540265|448689261|FG002|Overall Study|Lost to Follow-up|1|||
124745359|NCT03157037|448689267|FG000|Overall Study|Death|1|||
124745360|NCT02102399|448689268|FG000|Overall Study|Withdrawal by Subject|6|||
124745361|NCT02102399|448689269|FG001|Overall Study|Withdrawal by Subject|4|||
124745362|NCT03101085|448689270|FG000|Overall Study|Lost to Follow-up|0|||
124745363|NCT03101085|448689271|FG001|Overall Study|Lost to Follow-up|1|||
124745364|NCT03596450|448689272|FG000|Overall Study|Death|9|||
124745365|NCT03596450|448689273|FG001|Overall Study|Death|9|||
124745366|NCT03596450|448689272|FG000|Overall Study|Protocol Violation|18|||
124745367|NCT03596450|448689273|FG001|Overall Study|Protocol Violation|26|||
124745368|NCT03596450|448689272|FG000|Overall Study|Lost to Follow-up|50|||
124745369|NCT03596450|448689273|FG001|Overall Study|Lost to Follow-up|56|||
124745370|NCT03596450|448689272|FG000|Overall Study|Adverse Event|14|||
124745371|NCT03596450|448689273|FG001|Overall Study|Adverse Event|7|||
124745372|NCT03596450|448689272|FG000|Overall Study|Withdrawal by Subject|38|||
124745373|NCT03596450|448689273|FG001|Overall Study|Withdrawal by Subject|36|||
124745374|NCT03596450|448689272|FG000|Overall Study|Accidentally Randomized|2|||
124745375|NCT03596450|448689273|FG001|Overall Study|Accidentally Randomized|0|||
124745376|NCT03596450|448689272|FG000|Overall Study|Other reasons|48|||
124745377|NCT03596450|448689273|FG001|Overall Study|Other reasons|53|||
124745378|NCT03596450|448689272|FG000|Overall Study|Pregnancy|2|||
124745379|NCT03596450|448689273|FG001|Overall Study|Pregnancy|0|||
124745380|NCT04583956|448689274|FG000|Overall Study|Death|9|||
124745381|NCT04583956|448689275|FG001|Overall Study|Death|11|||
124745382|NCT04583956|448689274|FG000|Overall Study|Lost to Follow-up|7|||
124745383|NCT04583956|448689275|FG001|Overall Study|Lost to Follow-up|9|||
124745384|NCT04583956|448689274|FG000|Overall Study|Protocol Violation|2|||
124745385|NCT04583956|448689275|FG001|Overall Study|Protocol Violation|0|||
124745386|NCT04583956|448689274|FG000|Overall Study|Withdrawal by Subject|0|||
124745387|NCT04583956|448689275|FG001|Overall Study|Withdrawal by Subject|2|||
124745388|NCT04583956|448689274|FG000|Overall Study|Randomized but not dosed|2|||
124745389|NCT04583956|448689275|FG001|Overall Study|Randomized but not dosed|3|||
124745390|NCT04583956|448689274|FG000|Overall Study|Withdrawal of consent before product administration|1|||
124745391|NCT04583956|448689275|FG001|Overall Study|Withdrawal of consent before product administration|0|||
124745392|NCT02332291|448689276|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
124618788|NCT00451204|448221562|FG000|Overall Study|Lost to Follow-up|4|||
124618789|NCT00451204|448221563|FG001|Overall Study|Lost to Follow-up|4|||
124745393|NCT02332291|448689277|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
124745394|NCT02332291|448689276|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
124618790|NCT00451204|448221562|FG000|Overall Study|Protocol Violation|1|||
124745395|NCT02332291|448689277|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
124745396|NCT02332291|448689276|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
124745397|NCT02332291|448689277|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
124745398|NCT02332291|448689276|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
124745399|NCT02332291|448689277|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
124745400|NCT02332291|448689276|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
124745401|NCT02332291|448689277|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
124745402|NCT02332291|448689276|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
124745403|NCT02332291|448689277|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
124745404|NCT04407234|448689278|FG000|Overall Study|Adverse Event|3|||
124745405|NCT04407234|448689279|FG001|Overall Study|Adverse Event|3|||
124745406|NCT00727558|448689287|FG000|Overall Study|Lens issue|0|||
124745407|NCT00727558|448689288|FG001|Overall Study|Lens issue|1|||
124745408|NCT00727558|448689287|FG000|Overall Study|Adverse Event|0|||
124745409|NCT00727558|448689288|FG001|Overall Study|Adverse Event|1|||
124745410|NCT00727558|448689287|FG000|Overall Study|Subject unable to return for follow-up|1|||
124745411|NCT00727558|448689288|FG001|Overall Study|Subject unable to return for follow-up|1|||
124745412|NCT00727558|448689287|FG000|Overall Study|Lost to Follow-up|1|||
124745413|NCT00727558|448689288|FG001|Overall Study|Lost to Follow-up|0|||
124745414|NCT02100475|448691118|FG000|Overall Study|Unclassified|1|||
124745415|NCT02100475|448691119|FG001|Overall Study|Unclassified|2|||
124745416|NCT02100475|448691118|FG000|Overall Study|Withdrawal criteria|1|||
124745417|NCT02100475|448691119|FG001|Overall Study|Withdrawal criteria|0|||
124745418|NCT04599465|448691120|FG000|Overall Study|Physician Decision|1|||
124745419|NCT04599465|448691120|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
124745420|NCT02814175|448691123|FG000|Part 1|Adverse Event|2|||
124745421|NCT02814175|448691124|FG001|Part 1|Adverse Event|3|||
124745422|NCT02814175|448691125|FG002|Part 1|Adverse Event|0|||
124745423|NCT02814175|448691126|FG003|Part 1|Adverse Event|0|||
124745424|NCT02814175|448691127|FG004|Part 1|Adverse Event|0|||
124745425|NCT02814175|448691128|FG005|Part 1|Adverse Event|0|||
124745426|NCT02814175|448691123|FG000|Part 1|Withdrawal Consent|8|||
124745427|NCT02814175|448691124|FG001|Part 1|Withdrawal Consent|1|||
124745428|NCT02814175|448691125|FG002|Part 1|Withdrawal Consent|0|||
124745429|NCT02814175|448691126|FG003|Part 1|Withdrawal Consent|0|||
124745430|NCT02814175|448691127|FG004|Part 1|Withdrawal Consent|0|||
124745431|NCT02814175|448691128|FG005|Part 1|Withdrawal Consent|0|||
124745432|NCT02814175|448691123|FG000|Part 1|Lost to Follow-up|1|||
124745433|NCT02814175|448691124|FG001|Part 1|Lost to Follow-up|0|||
124745434|NCT02814175|448691125|FG002|Part 1|Lost to Follow-up|0|||
124745435|NCT02814175|448691126|FG003|Part 1|Lost to Follow-up|0|||
124745436|NCT02814175|448691127|FG004|Part 1|Lost to Follow-up|0|||
124745437|NCT02814175|448691128|FG005|Part 1|Lost to Follow-up|0|||
124745438|NCT02814175|448691123|FG000|Part 1|Lack of Efficacy|1|||
124745439|NCT02814175|448691124|FG001|Part 1|Lack of Efficacy|2|||
124745440|NCT02814175|448691125|FG002|Part 1|Lack of Efficacy|0|||
124745441|NCT02814175|448691126|FG003|Part 1|Lack of Efficacy|0|||
124745442|NCT02814175|448691127|FG004|Part 1|Lack of Efficacy|0|||
124745443|NCT02814175|448691128|FG005|Part 1|Lack of Efficacy|0|||
124745444|NCT02814175|448691123|FG000|Part 2|Adverse Event|0|||
124745445|NCT02814175|448691124|FG001|Part 2|Adverse Event|0|||
124745446|NCT02814175|448691125|FG002|Part 2|Adverse Event|0|||
124745447|NCT02814175|448691126|FG003|Part 2|Adverse Event|1|||
124745448|NCT02814175|448691127|FG004|Part 2|Adverse Event|1|||
124745449|NCT02814175|448691128|FG005|Part 2|Adverse Event|2|||
124745450|NCT02814175|448691123|FG000|Part 2|Withdrawal Consent|0|||
124745451|NCT02814175|448691124|FG001|Part 2|Withdrawal Consent|0|||
124745452|NCT02814175|448691125|FG002|Part 2|Withdrawal Consent|0|||
124745453|NCT02814175|448691126|FG003|Part 2|Withdrawal Consent|2|||
124745454|NCT02814175|448691127|FG004|Part 2|Withdrawal Consent|1|||
124745455|NCT02814175|448691128|FG005|Part 2|Withdrawal Consent|1|||
124745456|NCT02814175|448691123|FG000|Part 2|Lost to Follow-up|0|||
124745457|NCT02814175|448691124|FG001|Part 2|Lost to Follow-up|0|||
124745458|NCT02814175|448691125|FG002|Part 2|Lost to Follow-up|0|||
124745459|NCT02814175|448691126|FG003|Part 2|Lost to Follow-up|1|||
124618791|NCT00451204|448221563|FG001|Overall Study|Protocol Violation|0|||
124618792|NCT00451204|448221562|FG000|Overall Study|Patient refusal|8|||
124745460|NCT02814175|448691127|FG004|Part 2|Lost to Follow-up|0|||
124745461|NCT02814175|448691128|FG005|Part 2|Lost to Follow-up|0|||
124745462|NCT02814175|448691123|FG000|Part 2|Lack of Efficacy|0|||
124618793|NCT00451204|448221563|FG001|Overall Study|Patient refusal|4|||
124618794|NCT00451204|448221562|FG000|Overall Study|Other|1|||
124745463|NCT02814175|448691124|FG001|Part 2|Lack of Efficacy|0|||
124745464|NCT02814175|448691125|FG002|Part 2|Lack of Efficacy|0|||
124618795|NCT00451204|448221563|FG001|Overall Study|Other|2|||
124745465|NCT02814175|448691126|FG003|Part 2|Lack of Efficacy|0|||
124745466|NCT02814175|448691127|FG004|Part 2|Lack of Efficacy|0|||
124745467|NCT02814175|448691128|FG005|Part 2|Lack of Efficacy|3|||
124745468|NCT03416127|448691129|FG000|Overall Study|Withdrawal by Subject|0|||
124745469|NCT03416127|448691130|FG001|Overall Study|Withdrawal by Subject|1|||
124745470|NCT03416127|448691131|FG002|Overall Study|Withdrawal by Subject|1|||
124618796|NCT03055624|448221564|FG000|Overall Study|Study closed|9|||
124745471|NCT02702180|448691132|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
124745472|NCT02702180|448691133|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
124618797|NCT01582152|448221565|FG000|Overall Study|Disease Progression|4|||
124618798|NCT01582152|448221566|FG001|Overall Study|Disease Progression|5|||
124618799|NCT01582152|448221565|FG000|Overall Study|Adverse Event|2|||
124618800|NCT01582152|448221566|FG001|Overall Study|Adverse Event|1|||
124618801|NCT02794870|448221572|FG000|Overall Study|Withdrawal by Subject|2|||
124618802|NCT02794870|448221573|FG001|Overall Study|Withdrawal by Subject|0|||
124618803|NCT01524978|448221580|FG000|Overall Study|Other|16|||
124618804|NCT01524978|448221581|FG001|Overall Study|Other|2|||
124618805|NCT01524978|448221582|FG002|Overall Study|Other|1|||
124618806|NCT01524978|448221583|FG003|Overall Study|Other|2|||
124618807|NCT01524978|448221584|FG004|Overall Study|Other|1|||
124618808|NCT01524978|448221585|FG005|Overall Study|Other|3|||
124618809|NCT01524978|448221586|FG006|Overall Study|Other|17|||
124618810|NCT01524978|448221587|FG007|Overall Study|Other|1|||
124618811|NCT01524978|448221588|FG008|Overall Study|Other|2|||
124618812|NCT01524978|448221589|FG009|Overall Study|Other|2|||
124618813|NCT01524978|448221590|FG010|Overall Study|Other|5|||
124618814|NCT01524978|448221580|FG000|Overall Study|Withdrawal by Subject|12|||
124618815|NCT01524978|448221581|FG001|Overall Study|Withdrawal by Subject|0|||
124618816|NCT01524978|448221582|FG002|Overall Study|Withdrawal by Subject|1|||
124618817|NCT01524978|448221583|FG003|Overall Study|Withdrawal by Subject|1|||
124618818|NCT01524978|448221584|FG004|Overall Study|Withdrawal by Subject|3|||
124618819|NCT01524978|448221585|FG005|Overall Study|Withdrawal by Subject|1|||
124618820|NCT01524978|448221586|FG006|Overall Study|Withdrawal by Subject|6|||
124618821|NCT01524978|448221587|FG007|Overall Study|Withdrawal by Subject|2|||
124618822|NCT01524978|448221588|FG008|Overall Study|Withdrawal by Subject|4|||
124618823|NCT01524978|448221589|FG009|Overall Study|Withdrawal by Subject|0|||
124618824|NCT01524978|448221590|FG010|Overall Study|Withdrawal by Subject|5|||
124618825|NCT01524978|448221580|FG000|Overall Study|Lost to Follow-up|0|||
124618826|NCT01524978|448221581|FG001|Overall Study|Lost to Follow-up|0|||
124618827|NCT01524978|448221582|FG002|Overall Study|Lost to Follow-up|3|||
124618828|NCT01524978|448221583|FG003|Overall Study|Lost to Follow-up|0|||
124618829|NCT01524978|448221584|FG004|Overall Study|Lost to Follow-up|1|||
124618830|NCT01524978|448221585|FG005|Overall Study|Lost to Follow-up|1|||
124618831|NCT01524978|448221586|FG006|Overall Study|Lost to Follow-up|2|||
124618832|NCT01524978|448221587|FG007|Overall Study|Lost to Follow-up|0|||
124618833|NCT01524978|448221588|FG008|Overall Study|Lost to Follow-up|1|||
124618834|NCT01524978|448221589|FG009|Overall Study|Lost to Follow-up|1|||
124618835|NCT01524978|448221590|FG010|Overall Study|Lost to Follow-up|1|||
124618836|NCT01524978|448221580|FG000|Overall Study|Death|34|||
124618837|NCT01524978|448221581|FG001|Overall Study|Death|2|||
124618838|NCT01524978|448221582|FG002|Overall Study|Death|5|||
124618839|NCT01524978|448221583|FG003|Overall Study|Death|24|||
124618840|NCT01524978|448221584|FG004|Overall Study|Death|4|||
124618841|NCT01524978|448221585|FG005|Overall Study|Death|4|||
124618842|NCT01524978|448221586|FG006|Overall Study|Death|1|||
124618843|NCT01524978|448221587|FG007|Overall Study|Death|9|||
124618844|NCT01524978|448221588|FG008|Overall Study|Death|5|||
124618845|NCT01524978|448221589|FG009|Overall Study|Death|6|||
124618846|NCT01524978|448221590|FG010|Overall Study|Death|17|||
124618847|NCT03066258|448221591|FG000|Overall Study|Death|1|||
124618848|NCT03066258|448221592|FG001|Overall Study|Death|0|||
124618849|NCT03066258|448221593|FG002|Overall Study|Death|0|||
124618850|NCT03066258|448221594|FG003|Overall Study|Death|0|||
124618851|NCT03066258|448221595|FG004|Overall Study|Death|1|||
124618852|NCT02165735|448221596|FG000|Overall Study|Lost to Follow-up|12|||
124618853|NCT02165735|448221597|FG001|Overall Study|Lost to Follow-up|10|||
124618854|NCT02165735|448221596|FG000|Overall Study|Withdrawal by Subject|3|||
124618855|NCT02165735|448221597|FG001|Overall Study|Withdrawal by Subject|0|||
124618856|NCT02165735|448221596|FG000|Overall Study|Participant indicated lack of time|1|||
124618857|NCT02165735|448221597|FG001|Overall Study|Participant indicated lack of time|3|||
124618858|NCT02165735|448221596|FG000|Overall Study|Protocol Violation|0|||
124618859|NCT02165735|448221597|FG001|Overall Study|Protocol Violation|1|||
124618860|NCT00626561|448221598|FG000|Overall Study|Withdrawal by Subject|2|||
124618861|NCT00626561|448221598|FG000|Overall Study|Disease Progression|2|||
124618862|NCT00101283|448221599|FG000|Overall Study|Withdrawal by Subject|0|||
124618863|NCT00101283|448221600|FG001|Overall Study|Withdrawal by Subject|1|||
124618864|NCT00101283|448221599|FG000|Overall Study|Insurance Refusal|0|||
124618865|NCT00101283|448221600|FG001|Overall Study|Insurance Refusal|1|||
124618866|NCT00101283|448221599|FG000|Overall Study|Prostate Cancer Recurrence|0|||
124618867|NCT00101283|448221600|FG001|Overall Study|Prostate Cancer Recurrence|1|||
124618868|NCT00185588|448221601|FG000|Overall Study|Adverse Event|3|||
124618869|NCT00185588|448221602|FG001|Overall Study|Adverse Event|1|||
124618870|NCT00185588|448221603|FG002|Overall Study|Adverse Event|4|||
124618871|NCT00185588|448221604|FG003|Overall Study|Adverse Event|2|||
124618872|NCT00185588|448221601|FG000|Overall Study|Lost to Follow-up|0|||
124618873|NCT00185588|448221602|FG001|Overall Study|Lost to Follow-up|0|||
124618874|NCT00185588|448221603|FG002|Overall Study|Lost to Follow-up|1|||
124618875|NCT00185588|448221604|FG003|Overall Study|Lost to Follow-up|2|||
124618876|NCT00185588|448221601|FG000|Overall Study|Withdrawal by Subject|0|||
124618877|NCT00185588|448221602|FG001|Overall Study|Withdrawal by Subject|1|||
124745473|NCT02702180|448691134|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
124745474|NCT02702180|448691132|FG000|Double-blind Treatment Period|Adverse Event|0|||
124745475|NCT02702180|448691133|FG001|Double-blind Treatment Period|Adverse Event|0|||
124745476|NCT02702180|448691134|FG002|Double-blind Treatment Period|Adverse Event|1|||
124745477|NCT02702180|448691132|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
124745478|NCT02702180|448691133|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
124745479|NCT02702180|448691134|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
124745480|NCT02702180|448691132|FG000|Double-blind Treatment Period|Protocol Violation|0|||
124745481|NCT02702180|448691133|FG001|Double-blind Treatment Period|Protocol Violation|0|||
124745482|NCT02702180|448691134|FG002|Double-blind Treatment Period|Protocol Violation|2|||
124745483|NCT02702180|448691132|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
124745484|NCT02702180|448691133|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
124745485|NCT02702180|448691134|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
124745486|NCT02702180|448691132|FG000|Open-label Treatment Period|Withdrawn in error|0|||
124745487|NCT02702180|448691133|FG001|Open-label Treatment Period|Withdrawn in error|0|||
124745488|NCT02702180|448691134|FG002|Open-label Treatment Period|Withdrawn in error|1|||
124745489|NCT02397057|448691135|FG000|Overall Study|Withdrawal by Subject|6|||
124745490|NCT02397057|448691136|FG001|Overall Study|Withdrawal by Subject|7|||
124745491|NCT02397057|448691135|FG000|Overall Study|Lost to Follow-up|4|||
124745492|NCT02397057|448691136|FG001|Overall Study|Lost to Follow-up|3|||
124745493|NCT02397057|448691135|FG000|Overall Study|Death|1|||
124745494|NCT02397057|448691136|FG001|Overall Study|Death|0|||
124745495|NCT02397057|448691135|FG000|Overall Study|Adverse Event|0|||
124745496|NCT02397057|448691136|FG001|Overall Study|Adverse Event|1|||
124745497|NCT02397057|448691135|FG000|Overall Study|Physician Decision|0|||
124745498|NCT02397057|448691136|FG001|Overall Study|Physician Decision|1|||
124745499|NCT02397057|448691135|FG000|Overall Study|Subject did not receive study drug|0|||
124745500|NCT02397057|448691136|FG001|Overall Study|Subject did not receive study drug|1|||
124745501|NCT00753454|448691141|FG000|Overall Study|Adverse Event|4|||
124745502|NCT00753454|448691141|FG000|Overall Study|Lack of Efficacy|1|||
124745503|NCT00753454|448691141|FG000|Overall Study|Lost to Follow-up|3|||
124745504|NCT00753454|448691141|FG000|Overall Study|Withdrawal by Subject|5|||
124745505|NCT00753454|448691141|FG000|Overall Study|Investigator Decision|1|||
124745506|NCT03927144|448691142|FG000|Core Phase|Adverse Event|9|||
124618878|NCT00185588|448221603|FG002|Overall Study|Withdrawal by Subject|0|||
124618879|NCT00185588|448221604|FG003|Overall Study|Withdrawal by Subject|0|||
124618880|NCT00185588|448221601|FG000|Overall Study|Physician Decision|0|||
124618881|NCT00185588|448221602|FG001|Overall Study|Physician Decision|0|||
124618882|NCT00185588|448221603|FG002|Overall Study|Physician Decision|1|||
124618883|NCT00185588|448221604|FG003|Overall Study|Physician Decision|0|||
124618884|NCT02604407|448221605|FG000|Overall Study|Adverse Event|0|||
124618885|NCT02604407|448221606|FG001|Overall Study|Adverse Event|7|||
124618886|NCT02604407|448221607|FG002|Overall Study|Adverse Event|5|||
124618887|NCT02604407|448221605|FG000|Overall Study|Protocol Violation|2|||
124618888|NCT02604407|448221606|FG001|Overall Study|Protocol Violation|0|||
124618889|NCT02604407|448221607|FG002|Overall Study|Protocol Violation|0|||
124618890|NCT02604407|448221605|FG000|Overall Study|Withdrawal by Subject|3|||
124618891|NCT02604407|448221606|FG001|Overall Study|Withdrawal by Subject|3|||
124618892|NCT02604407|448221607|FG002|Overall Study|Withdrawal by Subject|5|||
124618893|NCT02604407|448221605|FG000|Overall Study|Lost to Follow-up|2|||
124618894|NCT02604407|448221606|FG001|Overall Study|Lost to Follow-up|1|||
124618895|NCT02604407|448221607|FG002|Overall Study|Lost to Follow-up|2|||
124618896|NCT02604407|448221605|FG000|Overall Study|Lack of Efficacy|1|||
124618897|NCT02604407|448221606|FG001|Overall Study|Lack of Efficacy|0|||
124618898|NCT02604407|448221607|FG002|Overall Study|Lack of Efficacy|0|||
124618899|NCT02604407|448221605|FG000|Overall Study|Other|3|||
124618900|NCT02604407|448221606|FG001|Overall Study|Other|1|||
124618901|NCT02604407|448221607|FG002|Overall Study|Other|4|||
124618902|NCT00398866|448221609|FG000|Overall Study|Adverse Event|1|||
124618903|NCT00398866|448221610|FG001|Overall Study|Adverse Event|0|||
124618904|NCT00398866|448221611|FG002|Overall Study|Adverse Event|0|||
124618905|NCT00398866|448221609|FG000|Overall Study|Lack of Efficacy|0|||
124618906|NCT00398866|448221610|FG001|Overall Study|Lack of Efficacy|0|||
124618907|NCT00398866|448221611|FG002|Overall Study|Lack of Efficacy|1|||
124618908|NCT00398866|448221609|FG000|Overall Study|Lost to Follow-up|7|||
124618909|NCT00398866|448221610|FG001|Overall Study|Lost to Follow-up|6|||
124618910|NCT00398866|448221611|FG002|Overall Study|Lost to Follow-up|4|||
124618911|NCT00398866|448221609|FG000|Overall Study|Withdrawal by Subject|5|||
124618912|NCT00398866|448221610|FG001|Overall Study|Withdrawal by Subject|1|||
124618913|NCT00398866|448221611|FG002|Overall Study|Withdrawal by Subject|2|||
124618914|NCT00398866|448221609|FG000|Overall Study|Unable to complete requirements of study|1|||
124618915|NCT00398866|448221610|FG001|Overall Study|Unable to complete requirements of study|1|||
124745507|NCT03927144|448691143|FG001|Core Phase|Adverse Event|5|||
124745508|NCT03927144|448691142|FG000|Core Phase|Lost to Follow-up|3|||
124745509|NCT03927144|448691143|FG001|Core Phase|Lost to Follow-up|2|||
124745510|NCT03927144|448691142|FG000|Core Phase|New Therapy for Study Indication|0|||
124745511|NCT03927144|448691143|FG001|Core Phase|New Therapy for Study Indication|1|||
124745512|NCT03927144|448691142|FG000|Core Phase|No Longer Clinically Benefiting|4|||
124745513|NCT03927144|448691143|FG001|Core Phase|No Longer Clinically Benefiting|4|||
124745514|NCT03927144|448691142|FG000|Core Phase|Physician Decision|2|||
124745515|NCT03927144|448691143|FG001|Core Phase|Physician Decision|8|||
124745516|NCT03927144|448691142|FG000|Core Phase|Protocol Violation|2|||
124745517|NCT03927144|448691143|FG001|Core Phase|Protocol Violation|2|||
124745518|NCT03927144|448691142|FG000|Core Phase|Withdrawal by Subject|16|||
124745519|NCT03927144|448691143|FG001|Core Phase|Withdrawal by Subject|40|||
124745520|NCT03927144|448691142|FG000|Extension Phase|Adverse Event|2|||
124745521|NCT03927144|448691143|FG001|Extension Phase|Adverse Event|1|||
124745522|NCT03927144|448691142|FG000|Extension Phase|No longer clinically benefiting|4|||
124745523|NCT03927144|448691143|FG001|Extension Phase|No longer clinically benefiting|5|||
124745524|NCT03927144|448691142|FG000|Extension Phase|Pregnancy|1|||
124745525|NCT03927144|448691143|FG001|Extension Phase|Pregnancy|0|||
124745526|NCT03927144|448691142|FG000|Extension Phase|Protocol Violation|0|||
124745527|NCT03927144|448691143|FG001|Extension Phase|Protocol Violation|1|||
124745528|NCT03927144|448691142|FG000|Extension Phase|Withdrawal by Subject|8|||
124745529|NCT03927144|448691143|FG001|Extension Phase|Withdrawal by Subject|3|||
124745530|NCT01452919|448691146|FG000|Open-Label Treatment|Adverse Event|5|||
124745531|NCT01452919|448691147|FG001|Open-Label Treatment|Adverse Event|0|||
124745532|NCT01452919|448691148|FG002|Open-Label Treatment|Adverse Event|0|||
124745533|NCT01452919|448691146|FG000|Open-Label Treatment|Lost to Follow-up|4|||
124745534|NCT01452919|448691147|FG001|Open-Label Treatment|Lost to Follow-up|0|||
124745535|NCT01452919|448691148|FG002|Open-Label Treatment|Lost to Follow-up|0|||
124745536|NCT01452919|448691146|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
124745537|NCT01452919|448691147|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
124745538|NCT01452919|448691148|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
124745539|NCT01452919|448691146|FG000|Open-Label Treatment|Protocol Violation|4|||
124745540|NCT01452919|448691147|FG001|Open-Label Treatment|Protocol Violation|0|||
124745541|NCT01452919|448691148|FG002|Open-Label Treatment|Protocol Violation|0|||
124745542|NCT01452919|448691146|FG000|Open-Label Treatment|Sponsor Decision|1|||
124745543|NCT01452919|448691147|FG001|Open-Label Treatment|Sponsor Decision|0|||
124745544|NCT01452919|448691148|FG002|Open-Label Treatment|Sponsor Decision|0|||
124745545|NCT01452919|448691146|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
124745546|NCT01452919|448691147|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
124745547|NCT01452919|448691148|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
124745548|NCT01452919|448691146|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
124745549|NCT01452919|448691147|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
124745550|NCT01452919|448691148|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
124745551|NCT01452919|448691146|FG000|Randomization Treatment|Adverse Event|0|||
124745552|NCT01452919|448691147|FG001|Randomization Treatment|Adverse Event|0|||
124745553|NCT01452919|448691148|FG002|Randomization Treatment|Adverse Event|2|||
124745554|NCT01452919|448691146|FG000|Randomization Treatment|Sponsor Decision|0|||
124745555|NCT01452919|448691147|FG001|Randomization Treatment|Sponsor Decision|1|||
124745556|NCT01452919|448691148|FG002|Randomization Treatment|Sponsor Decision|0|||
124745557|NCT01452919|448691146|FG000|Randomization Treatment|Withdrawal by Subject|0|||
124745558|NCT01452919|448691147|FG001|Randomization Treatment|Withdrawal by Subject|1|||
124745559|NCT01452919|448691148|FG002|Randomization Treatment|Withdrawal by Subject|0|||
124745560|NCT01452919|448691146|FG000|Randomization Treatment|Subject is moving or has moved|0|||
124745561|NCT01452919|448691147|FG001|Randomization Treatment|Subject is moving or has moved|1|||
124745562|NCT01452919|448691148|FG002|Randomization Treatment|Subject is moving or has moved|0|||
124745563|NCT02421588|448691149|FG000|Overall Study|Non-treatment-related AE|8|||
124745564|NCT02421588|448691150|FG001|Overall Study|Non-treatment-related AE|8|||
124745565|NCT02421588|448691149|FG000|Overall Study|Progressive disease|152|||
124745566|NCT02421588|448691150|FG001|Overall Study|Progressive disease|135|||
124745567|NCT02421588|448691149|FG000|Overall Study|Death|11|||
124745568|NCT02421588|448691150|FG001|Overall Study|Death|3|||
124745569|NCT02421588|448691149|FG000|Overall Study|Physician Decision|8|||
124745570|NCT02421588|448691150|FG001|Overall Study|Physician Decision|17|||
124745571|NCT02421588|448691149|FG000|Overall Study|Other reason not specified|3|||
124745572|NCT02421588|448691150|FG001|Overall Study|Other reason not specified|1|||
124745573|NCT02421588|448691149|FG000|Overall Study|Symptomatic deterioration|13|||
124745574|NCT02421588|448691150|FG001|Overall Study|Symptomatic deterioration|19|||
124782251|NCT02910986|448832802|FG002|Overall Study|Failure to return T! survey|72|||
124782252|NCT02910986|448832800|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
124618916|NCT00398866|448221611|FG002|Overall Study|Unable to complete requirements of study|1|||
124618917|NCT00606632|448221614|FG000|Overall Study|Withdrawal by Subject|13|||
124618918|NCT00606632|448221614|FG000|Overall Study|Miscellaneous reasons|9|||
124618919|NCT02481869|448221615|FG000|Overall Study|Lost to Follow-up|3|||
124618920|NCT02481869|448221616|FG001|Overall Study|Lost to Follow-up|4|||
124618921|NCT02481869|448221615|FG000|Overall Study|Withdrawal by Subject|2|||
124618922|NCT02481869|448221616|FG001|Overall Study|Withdrawal by Subject|0|||
124618923|NCT00711880|448221617|FG000|Overall Study|Adverse Event|11|||
124782253|NCT02910986|448832801|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
124782254|NCT02910986|448832802|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
124745575|NCT02421588|448691149|FG000|Overall Study|Treatment-related AE|10|||
124745576|NCT02421588|448691150|FG001|Overall Study|Treatment-related AE|14|||
124745577|NCT02421588|448691149|FG000|Overall Study|Withdrawal by Subject|14|||
124745578|NCT02421588|448691150|FG001|Overall Study|Withdrawal by Subject|16|||
124745579|NCT02421588|448691149|FG000|Overall Study|Not treated|2|||
124745580|NCT02421588|448691150|FG001|Overall Study|Not treated|8|||
124745581|NCT01359943|448691151|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
124745582|NCT01359943|448691152|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
124745583|NCT01359943|448691153|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
124745584|NCT01359943|448691151|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
124745585|NCT01359943|448691152|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
124745586|NCT01359943|448691153|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
124745587|NCT01359943|448691151|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
124745588|NCT01359943|448691152|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
124745589|NCT01359943|448691153|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
124745590|NCT01359943|448691151|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
124745591|NCT01359943|448691152|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
124745592|NCT01359943|448691153|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
124745593|NCT01359943|448691151|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
124745594|NCT01359943|448691152|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
124745595|NCT01359943|448691153|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
124745596|NCT01359943|448691151|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
124745597|NCT01359943|448691152|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
124745598|NCT01359943|448691153|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
124745599|NCT01359943|448691151|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
124745600|NCT01359943|448691152|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
124745601|NCT01359943|448691153|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
124745602|NCT01359943|448691151|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
124745603|NCT01359943|448691152|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
124745604|NCT01359943|448691153|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
124745605|NCT01359943|448691151|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
124745606|NCT01359943|448691152|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
124745607|NCT01359943|448691153|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
124745608|NCT01359943|448691151|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
124745609|NCT01359943|448691152|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
124745610|NCT01359943|448691153|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
124745611|NCT01359943|448691151|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
124745612|NCT01359943|448691152|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
124745613|NCT01359943|448691153|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
124745614|NCT01359943|448691151|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
124745615|NCT01359943|448691152|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
124745616|NCT01359943|448691153|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
124745617|NCT01359943|448691151|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
124745618|NCT01359943|448691152|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
124745619|NCT01359943|448691153|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
124745620|NCT01359943|448691151|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
124745621|NCT01359943|448691152|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
124745622|NCT01359943|448691153|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
124745623|NCT01359943|448691151|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
124745624|NCT01359943|448691152|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
124745625|NCT01359943|448691153|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
124745626|NCT02446600|448691164|FG000|Overall Study|Never treated|20|||
124745627|NCT02446600|448691165|FG001|Overall Study|Never treated|2|||
124745628|NCT02446600|448691166|FG002|Overall Study|Never treated|6|||
124745629|NCT02446600|448691167|FG003|Overall Study|Never treated|0|||
124745630|NCT02446600|448691164|FG000|Overall Study|Withdrawal by Subject|19|||
124745631|NCT02446600|448691165|FG001|Overall Study|Withdrawal by Subject|5|||
124745632|NCT02446600|448691166|FG002|Overall Study|Withdrawal by Subject|17|||
124745633|NCT02446600|448691167|FG003|Overall Study|Withdrawal by Subject|0|||
124745634|NCT02446600|448691164|FG000|Overall Study|Ineligible|1|||
124745635|NCT02446600|448691165|FG001|Overall Study|Ineligible|4|||
124745636|NCT02446600|448691166|FG002|Overall Study|Ineligible|4|||
124745637|NCT02446600|448691167|FG003|Overall Study|Ineligible|1|||
124745638|NCT02446600|448691164|FG000|Overall Study|Duplicate Enrollment|0|||
124745639|NCT02446600|448691165|FG001|Overall Study|Duplicate Enrollment|1|||
124745640|NCT02446600|448691166|FG002|Overall Study|Duplicate Enrollment|0|||
124745641|NCT02446600|448691167|FG003|Overall Study|Duplicate Enrollment|0|||
124745642|NCT02540668|448691168|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
124745643|NCT02540668|448691169|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
124745644|NCT03270891|448691170|FG000|Overall Study|Lost to Follow-up|3|||
124745645|NCT03270891|448691171|FG001|Overall Study|Lost to Follow-up|6|||
124618924|NCT00711880|448221618|FG001|Overall Study|Adverse Event|2|||
124618925|NCT00711880|448221617|FG000|Overall Study|Patient non-compliance|1|||
124618926|NCT00711880|448221618|FG001|Overall Study|Patient non-compliance|0|||
124618927|NCT00711880|448221617|FG000|Overall Study|Lack of Efficacy|1|||
124618928|NCT00711880|448221618|FG001|Overall Study|Lack of Efficacy|5|||
124618929|NCT03908437|448221621|FG000|Overall Study|Death|0|||
124618930|NCT03908437|448221622|FG001|Overall Study|Death|1|||
124618931|NCT03908437|448221621|FG000|Overall Study|Lost to Follow-up|31|||
124618932|NCT03908437|448221622|FG001|Overall Study|Lost to Follow-up|24|||
124618933|NCT02370238|448221623|FG000|Overall Study|Death|42|||
124618934|NCT02370238|448221624|FG001|Overall Study|Death|35|||
124618935|NCT02370238|448221623|FG000|Overall Study|Lost to Follow-up|1|||
124618936|NCT02370238|448221624|FG001|Overall Study|Lost to Follow-up|3|||
124618937|NCT02370238|448221623|FG000|Overall Study|Withdrawal by Subject|2|||
124618938|NCT02370238|448221624|FG001|Overall Study|Withdrawal by Subject|6|||
124618939|NCT02370238|448221623|FG000|Overall Study|Other|2|||
124618940|NCT02370238|448221624|FG001|Overall Study|Other|1|||
124618941|NCT04342819|448221627|FG000|Overall Study|Declined|4|||
124618942|NCT04342819|448221627|FG000|Overall Study|Not meeeting selection criteria|1|||
124618943|NCT01569295|448221628|FG000|Overall Study|Progressive Disease|75|||
124618944|NCT01569295|448221629|FG001|Overall Study|Progressive Disease|139|||
124618945|NCT01569295|448221628|FG000|Overall Study|Adverse Event|39|||
124618946|NCT01569295|448221629|FG001|Overall Study|Adverse Event|14|||
124618947|NCT01569295|448221628|FG000|Overall Study|Withdrawal by Subject|25|||
124618948|NCT01569295|448221629|FG001|Overall Study|Withdrawal by Subject|12|||
124618949|NCT01569295|448221628|FG000|Overall Study|Death|19|||
124618950|NCT01569295|448221629|FG001|Overall Study|Death|15|||
124618951|NCT01569295|448221628|FG000|Overall Study|Physician Decision|13|||
124618952|NCT01569295|448221629|FG001|Overall Study|Physician Decision|18|||
124618953|NCT01569295|448221628|FG000|Overall Study|Study Terminated by Sponsor|24|||
124618954|NCT01569295|448221629|FG001|Overall Study|Study Terminated by Sponsor|2|||
124618955|NCT01569295|448221628|FG000|Overall Study|Other Reason not Specified|3|||
124618956|NCT01569295|448221629|FG001|Overall Study|Other Reason not Specified|5|||
124618957|NCT01569295|448221628|FG000|Overall Study|Non-Compliance with Study Drug|6|||
124618958|NCT01569295|448221629|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124618959|NCT01569295|448221628|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
124618960|NCT01569295|448221629|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
124618961|NCT01569295|448221628|FG000|Overall Study|Lost to Follow-up|1|||
124618962|NCT01569295|448221629|FG001|Overall Study|Lost to Follow-up|1|||
124618963|NCT03597295|448221630|FG000|Overall Study|Death|70|||
124618964|NCT03597295|448221630|FG000|Overall Study|Lost to Follow-up|7|||
124618965|NCT00879411|448221631|FG000|Overall Study|lost to follow-up (non-AE)|162|||
124618966|NCT01884337|448221632|FG000|Treatment|Adverse Event|2|||
124618967|NCT01884337|448221633|FG001|Treatment|Adverse Event|2|||
124618968|NCT01884337|448221632|FG000|Treatment|Subj. request to discont. treatment|2|||
124618969|NCT01884337|448221633|FG001|Treatment|Subj. request to discont. treatment|0|||
124618970|NCT01884337|448221632|FG000|Follow-up Period|Lost to Follow-up|1|||
124618971|NCT01884337|448221633|FG001|Follow-up Period|Lost to Follow-up|1|||
124618972|NCT00428116|448221634|FG000|Overall Study|Death|1|||
124618973|NCT00428116|448221635|FG001|Overall Study|Death|0|||
124618974|NCT00428116|448221634|FG000|Overall Study|Withdrawal by Subject|1|||
124618975|NCT00428116|448221635|FG001|Overall Study|Withdrawal by Subject|0|||
124618976|NCT00428116|448221634|FG000|Overall Study|Lost to Follow-up|1|||
124618977|NCT00428116|448221635|FG001|Overall Study|Lost to Follow-up|0|||
124618978|NCT02455518|448221636|FG000|Overall Study|Protocol Violation|0|||
124618979|NCT02455518|448221637|FG001|Overall Study|Protocol Violation|1|||
124618980|NCT02455518|448221638|FG002|Overall Study|Protocol Violation|1|||
124618981|NCT02455518|448221639|FG003|Overall Study|Protocol Violation|3|||
124618982|NCT01038297|448221640|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
124618983|NCT01038297|448221641|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
124618984|NCT01038297|448221642|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
124618985|NCT02125877|448221643|FG000|Overall Study|Physician Decision|1|||
124618986|NCT02125877|448221644|FG001|Overall Study|Physician Decision|0|||
124618987|NCT02125877|448221643|FG000|Overall Study|Death|0|||
124618988|NCT02125877|448221644|FG001|Overall Study|Death|1|||
124618989|NCT02125877|448221643|FG000|Overall Study|Administrative problems|0|||
124618990|NCT02125877|448221644|FG001|Overall Study|Administrative problems|1|||
124618991|NCT02125877|448221643|FG000|Overall Study|Participant/guardian decision|0|||
124618992|NCT02125877|448221644|FG001|Overall Study|Participant/guardian decision|2|||
124618993|NCT02125877|448221643|FG000|Overall Study|Withdrawal by Subject|2|||
124618994|NCT02125877|448221644|FG001|Overall Study|Withdrawal by Subject|1|||
124618995|NCT02125877|448221643|FG000|Overall Study|Protocol deviation|4|||
124618996|NCT02125877|448221644|FG001|Overall Study|Protocol deviation|1|||
124618997|NCT02125877|448221643|FG000|Overall Study|Adverse Event|6|||
124618998|NCT02125877|448221644|FG001|Overall Study|Adverse Event|4|||
124618999|NCT02508935|448221648|FG000|Overall Study|Withdrawal by Subject|1|||
124619000|NCT02508935|448221648|FG000|Overall Study|Withdrawal by Caregiver|8|||
124619001|NCT02508935|448221648|FG000|Overall Study|Pain Score <4|1|||
124745646|NCT03270891|448691172|FG002|Overall Study|Lost to Follow-up|0|||
124745647|NCT03270891|448691170|FG000|Overall Study|Withdrawal by Subject|1|||
124745648|NCT03270891|448691171|FG001|Overall Study|Withdrawal by Subject|0|||
124745649|NCT03270891|448691172|FG002|Overall Study|Withdrawal by Subject|0|||
124745650|NCT03270891|448691170|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
124745651|NCT03270891|448691171|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
124745652|NCT03270891|448691172|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
124745653|NCT02516592|448691174|FG000|Overall Study|Patient withdrew consent|5|||
124745654|NCT02516592|448691175|FG001|Overall Study|Patient withdrew consent|2|||
124745655|NCT02516592|448691174|FG000|Overall Study|Protocol deviation|4|||
124745656|NCT02516592|448691175|FG001|Overall Study|Protocol deviation|4|||
124745657|NCT02516592|448691174|FG000|Overall Study|Lost to Follow-up|2|||
124745658|NCT02516592|448691175|FG001|Overall Study|Lost to Follow-up|3|||
124745659|NCT02516592|448691174|FG000|Overall Study|Patient/guardian decision|2|||
124745660|NCT02516592|448691175|FG001|Overall Study|Patient/guardian decision|1|||
124745661|NCT02516592|448691174|FG000|Overall Study|Adverse Event|1|||
124745662|NCT02516592|448691175|FG001|Overall Study|Adverse Event|2|||
124745663|NCT02516592|448691174|FG000|Overall Study|Abnormal test procedure result|1|||
124745664|NCT02516592|448691175|FG001|Overall Study|Abnormal test procedure result|0|||
124745665|NCT02516592|448691174|FG000|Overall Study|Death|1|||
124745666|NCT02516592|448691175|FG001|Overall Study|Death|1|||
124745667|NCT01286740|448691176|FG000|Overall Study|Enrolled but not treated|1|||
124745668|NCT01286740|448691176|FG000|Overall Study|Protocol Violation|1|||
124745669|NCT01110382|448691178|FG000|Overall Study|Withdrawal by Subject|0|||
124745670|NCT01110382|448691179|FG001|Overall Study|Withdrawal by Subject|1|||
124745671|NCT01110382|448691178|FG000|Overall Study|Protocol Violation|0|||
124745672|NCT01110382|448691179|FG001|Overall Study|Protocol Violation|1|||
124745673|NCT01641822|448691181|FG000|Run-in Phase|Noncompliance with study drug|1|||
124745674|NCT01641822|448691182|FG001|Run-in Phase|Noncompliance with study drug|0|||
124745675|NCT01641822|448691183|FG002|Run-in Phase|Noncompliance with study drug|0|||
124745676|NCT01641822|448691181|FG000|Run-in Phase|Adverse Event|3|||
124745677|NCT01641822|448691182|FG001|Run-in Phase|Adverse Event|0|||
124745678|NCT01641822|448691183|FG002|Run-in Phase|Adverse Event|0|||
124745679|NCT01641822|448691181|FG000|Run-in Phase|Withdrew consent|1|||
124745680|NCT01641822|448691182|FG001|Run-in Phase|Withdrew consent|0|||
124745681|NCT01641822|448691183|FG002|Run-in Phase|Withdrew consent|0|||
124745682|NCT01641822|448691181|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
124745683|NCT01641822|448691182|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
124745684|NCT01641822|448691183|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
124745685|NCT01641822|448691181|FG000|Comparative Phase|Noncompliance with study drug|0|||
124745686|NCT01641822|448691182|FG001|Comparative Phase|Noncompliance with study drug|1|||
124745687|NCT01641822|448691183|FG002|Comparative Phase|Noncompliance with study drug|0|||
124745688|NCT01641822|448691181|FG000|Comparative Phase|Investigator's discretion|0|||
124745689|NCT01641822|448691182|FG001|Comparative Phase|Investigator's discretion|0|||
124745690|NCT01641822|448691183|FG002|Comparative Phase|Investigator's discretion|1|||
124745691|NCT01641822|448691181|FG000|Comparative Phase|Pregnancy|0|||
124745692|NCT01641822|448691182|FG001|Comparative Phase|Pregnancy|0|||
124745693|NCT01641822|448691183|FG002|Comparative Phase|Pregnancy|1|||
124745694|NCT01641822|448691181|FG000|Comparative Phase|Adverse event, serious fatal|0|||
124745695|NCT01641822|448691182|FG001|Comparative Phase|Adverse event, serious fatal|1|||
124745696|NCT01641822|448691183|FG002|Comparative Phase|Adverse event, serious fatal|0|||
124745697|NCT01641822|448691181|FG000|Comparative Phase|Withdrew consent|0|||
124745698|NCT01641822|448691182|FG001|Comparative Phase|Withdrew consent|3|||
124745699|NCT01641822|448691183|FG002|Comparative Phase|Withdrew consent|7|||
124745700|NCT01641822|448691181|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
124745701|NCT01641822|448691182|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
124745702|NCT01641822|448691183|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
124745703|NCT00454584|448691184|FG000|Controlled Period|Adverse Event|5|||
124745704|NCT00454584|448691185|FG001|Controlled Period|Adverse Event|2|||
124745705|NCT00454584|448691186|FG002|Controlled Period|Adverse Event|1|||
124745706|NCT00454584|448691187|FG003|Controlled Period|Adverse Event|0|||
124745707|NCT00454584|448691188|FG004|Controlled Period|Adverse Event|0|||
124745708|NCT00454584|448691189|FG005|Controlled Period|Adverse Event|0|||
124745709|NCT00454584|448691184|FG000|Controlled Period|Lost to Follow-up|1|||
124745710|NCT00454584|448691185|FG001|Controlled Period|Lost to Follow-up|2|||
124745711|NCT00454584|448691186|FG002|Controlled Period|Lost to Follow-up|2|||
124745712|NCT00454584|448691187|FG003|Controlled Period|Lost to Follow-up|0|||
124745713|NCT00454584|448691188|FG004|Controlled Period|Lost to Follow-up|0|||
124745714|NCT00454584|448691189|FG005|Controlled Period|Lost to Follow-up|0|||
124745715|NCT00454584|448691184|FG000|Controlled Period|Other|5|||
124745716|NCT00454584|448691185|FG001|Controlled Period|Other|4|||
124745717|NCT00454584|448691186|FG002|Controlled Period|Other|2|||
124745718|NCT00454584|448691187|FG003|Controlled Period|Other|0|||
124745719|NCT00454584|448691188|FG004|Controlled Period|Other|0|||
124745720|NCT00454584|448691189|FG005|Controlled Period|Other|0|||
124745721|NCT00454584|448691184|FG000|After Controlled Period|Adverse Event|0|||
124745722|NCT00454584|448691185|FG001|After Controlled Period|Adverse Event|0|||
124745723|NCT00454584|448691186|FG002|After Controlled Period|Adverse Event|0|||
124745724|NCT00454584|448691187|FG003|After Controlled Period|Adverse Event|9|||
124745725|NCT00454584|448691188|FG004|After Controlled Period|Adverse Event|3|||
124745726|NCT00454584|448691189|FG005|After Controlled Period|Adverse Event|9|||
124745727|NCT00454584|448691184|FG000|After Controlled Period|Lack of Efficacy|0|||
124745728|NCT00454584|448691185|FG001|After Controlled Period|Lack of Efficacy|0|||
124745729|NCT00454584|448691186|FG002|After Controlled Period|Lack of Efficacy|0|||
124745730|NCT00454584|448691187|FG003|After Controlled Period|Lack of Efficacy|1|||
124745731|NCT00454584|448691188|FG004|After Controlled Period|Lack of Efficacy|0|||
124745732|NCT00454584|448691189|FG005|After Controlled Period|Lack of Efficacy|0|||
124745733|NCT00454584|448691184|FG000|After Controlled Period|Lost to Follow-up|0|||
124745734|NCT00454584|448691185|FG001|After Controlled Period|Lost to Follow-up|0|||
124745735|NCT00454584|448691186|FG002|After Controlled Period|Lost to Follow-up|0|||
124745736|NCT00454584|448691187|FG003|After Controlled Period|Lost to Follow-up|2|||
124745737|NCT00454584|448691188|FG004|After Controlled Period|Lost to Follow-up|4|||
124745738|NCT00454584|448691189|FG005|After Controlled Period|Lost to Follow-up|6|||
124745739|NCT00454584|448691184|FG000|After Controlled Period|Other|0|||
124745740|NCT00454584|448691185|FG001|After Controlled Period|Other|0|||
124745741|NCT00454584|448691186|FG002|After Controlled Period|Other|0|||
124745742|NCT00454584|448691187|FG003|After Controlled Period|Other|1|||
124745743|NCT00454584|448691188|FG004|After Controlled Period|Other|0|||
124745744|NCT00454584|448691189|FG005|After Controlled Period|Other|0|||
124745745|NCT00454584|448691184|FG000|After Controlled Period|Other|0|||
124745746|NCT00454584|448691185|FG001|After Controlled Period|Other|0|||
124745747|NCT00454584|448691186|FG002|After Controlled Period|Other|0|||
124745748|NCT00454584|448691187|FG003|After Controlled Period|Other|13|||
124745749|NCT00454584|448691188|FG004|After Controlled Period|Other|5|||
124745750|NCT00454584|448691189|FG005|After Controlled Period|Other|17|||
124745751|NCT02421601|448691190|FG000|Overall Study|Adverse Event|4|||
124745752|NCT02421601|448691190|FG000|Overall Study|Lack of Efficacy|5|||
124745753|NCT02421601|448691190|FG000|Overall Study|Physician Decision|1|||
124745754|NCT02421601|448691190|FG000|Overall Study|Withdrawal by Subject|31|||
124745755|NCT02421601|448691190|FG000|Overall Study|Others|41|||
124745756|NCT01753401|448691193|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
124745757|NCT01753401|448691194|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
124745758|NCT01753401|448691195|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
124745759|NCT01753401|448691196|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
124745760|NCT01753401|448691193|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
124745761|NCT01753401|448691194|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
124745762|NCT01753401|448691195|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
124745763|NCT01753401|448691196|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
124745764|NCT01753401|448691193|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
124745765|NCT01753401|448691194|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
124745766|NCT01753401|448691195|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
124745767|NCT01753401|448691196|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
124745768|NCT01753401|448691193|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
124745769|NCT01753401|448691194|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
124745770|NCT01753401|448691195|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
124745771|NCT01753401|448691196|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
124745772|NCT01753401|448691193|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
124745773|NCT01753401|448691194|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
124745774|NCT01753401|448691195|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
124745775|NCT01753401|448691196|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
124619002|NCT02508935|448221648|FG000|Overall Study|Emesis|3|||
124619003|NCT02508935|448221648|FG000|Overall Study|Adverse Event|3|||
124619004|NCT02508935|448221648|FG000|Overall Study|Protocol Violation|1|||
124619005|NCT02508935|448221648|FG000|Overall Study|Physician Decision|1|||
124619006|NCT02508935|448221648|FG000|Overall Study|Trial terminated by sponsor|5|||
124619007|NCT01973595|448221649|FG000|Washout|Withdrawal by Subject|1|||
124619008|NCT01973595|448221650|FG001|Washout|Withdrawal by Subject|0|||
124619009|NCT01973595|448221651|FG002|Washout|Withdrawal by Subject|1|||
124619010|NCT01973595|448221652|FG003|Washout|Withdrawal by Subject|0|||
124619011|NCT01210612|448221660|FG000|Overall Study|Withdrawal by Subject|0|||
124619012|NCT01210612|448221661|FG001|Overall Study|Withdrawal by Subject|2|||
124619013|NCT00710866|448221664|FG000|Overall Study|Protocol Violation|5|||
124619014|NCT00710866|448221665|FG001|Overall Study|Protocol Violation|4|||
124619015|NCT00710866|448221664|FG000|Overall Study|Withdrawal by Subject|2|||
124619016|NCT00710866|448221665|FG001|Overall Study|Withdrawal by Subject|1|||
124619017|NCT00710866|448221664|FG000|Overall Study|Lost to Follow-up|1|||
124619018|NCT00710866|448221665|FG001|Overall Study|Lost to Follow-up|0|||
124745776|NCT01753401|448691193|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
124745777|NCT01753401|448691194|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
124745778|NCT01753401|448691195|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
124745779|NCT01753401|448691196|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
124745780|NCT01753401|448691193|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
124745781|NCT01753401|448691194|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
124745782|NCT01753401|448691195|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
124745783|NCT01753401|448691196|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
124745784|NCT00470418|448691197|FG000|Overall Study|Withdrawal by Subject|1|||
124745785|NCT00470418|448691198|FG001|Overall Study|Withdrawal by Subject|0|||
124745786|NCT00599638|448691199|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
124745787|NCT00599638|448691200|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
124745788|NCT00599638|448691201|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
124745789|NCT00599638|448691202|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
124745790|NCT00599638|448691199|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
124745791|NCT00599638|448691200|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
124745792|NCT00599638|448691201|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
124745793|NCT00599638|448691202|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
124745794|NCT00599638|448691199|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
124745795|NCT00599638|448691200|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
124745796|NCT00599638|448691201|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
124745797|NCT00599638|448691202|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
124745798|NCT00599638|448691199|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
124745799|NCT00599638|448691200|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
124745800|NCT00599638|448691201|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
124745801|NCT00599638|448691202|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
124745802|NCT00599638|448691199|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
124745803|NCT00599638|448691200|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
124745804|NCT00599638|448691201|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
124745805|NCT00599638|448691202|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
124745806|NCT00599638|448691199|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
124745807|NCT00599638|448691200|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
124745808|NCT00599638|448691201|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
124745809|NCT00599638|448691202|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
124745810|NCT00599638|448691199|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
124745811|NCT00599638|448691200|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
124745812|NCT00599638|448691201|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
124745813|NCT00599638|448691202|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
124745814|NCT00599638|448691199|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
124745815|NCT00599638|448691200|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
124745816|NCT00599638|448691201|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
124745817|NCT00599638|448691202|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
124745818|NCT00599638|448691199|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
124745819|NCT00599638|448691200|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
124745820|NCT00599638|448691201|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
124745821|NCT00599638|448691202|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
124745822|NCT01353911|448691205|FG000|Overall Study|Lost to Follow-up|2|||
124745823|NCT01353911|448691206|FG001|Overall Study|Lost to Follow-up|6|||
124745824|NCT01353911|448691207|FG002|Overall Study|Lost to Follow-up|4|||
124745825|NCT01353911|448691208|FG003|Overall Study|Lost to Follow-up|0|||
124745826|NCT01353911|448691209|FG004|Overall Study|Lost to Follow-up|4|||
124745827|NCT01353911|448691210|FG005|Overall Study|Lost to Follow-up|4|||
124745828|NCT01353911|448691211|FG006|Overall Study|Lost to Follow-up|3|||
124745829|NCT01353911|448691212|FG007|Overall Study|Lost to Follow-up|6|||
124745830|NCT01353911|448691205|FG000|Overall Study|Withdrawal by Subject|2|||
124745831|NCT01353911|448691206|FG001|Overall Study|Withdrawal by Subject|3|||
124745832|NCT01353911|448691207|FG002|Overall Study|Withdrawal by Subject|4|||
124745833|NCT01353911|448691208|FG003|Overall Study|Withdrawal by Subject|2|||
124745834|NCT01353911|448691209|FG004|Overall Study|Withdrawal by Subject|2|||
124745835|NCT01353911|448691210|FG005|Overall Study|Withdrawal by Subject|3|||
124745836|NCT01353911|448691211|FG006|Overall Study|Withdrawal by Subject|3|||
124745837|NCT01353911|448691212|FG007|Overall Study|Withdrawal by Subject|9|||
124745838|NCT01353911|448691205|FG000|Overall Study|Status Not Recorded|4|||
124745839|NCT01353911|448691206|FG001|Overall Study|Status Not Recorded|0|||
124745840|NCT01353911|448691207|FG002|Overall Study|Status Not Recorded|1|||
124745841|NCT01353911|448691208|FG003|Overall Study|Status Not Recorded|0|||
124745842|NCT01353911|448691209|FG004|Overall Study|Status Not Recorded|0|||
124745843|NCT01353911|448691210|FG005|Overall Study|Status Not Recorded|0|||
124745844|NCT01353911|448691211|FG006|Overall Study|Status Not Recorded|0|||
124745845|NCT01353911|448691212|FG007|Overall Study|Status Not Recorded|0|||
124745846|NCT00462748|448691217|FG000|Overall Study|Adverse Event|7|||
124745847|NCT00462748|448691218|FG001|Overall Study|Adverse Event|5|||
124745848|NCT00462748|448691219|FG002|Overall Study|Adverse Event|9|||
124745849|NCT00462748|448691217|FG000|Overall Study|Protocol Violation|0|||
124745850|NCT00462748|448691218|FG001|Overall Study|Protocol Violation|2|||
124745851|NCT00462748|448691219|FG002|Overall Study|Protocol Violation|1|||
124745852|NCT00462748|448691217|FG000|Overall Study|Withdrew consent|3|||
124745853|NCT00462748|448691218|FG001|Overall Study|Withdrew consent|3|||
124745854|NCT00462748|448691219|FG002|Overall Study|Withdrew consent|0|||
124745855|NCT00462748|448691217|FG000|Overall Study|Lost to Follow-up|1|||
124745856|NCT00462748|448691218|FG001|Overall Study|Lost to Follow-up|1|||
124745857|NCT00462748|448691219|FG002|Overall Study|Lost to Follow-up|1|||
124745858|NCT00462748|448691217|FG000|Overall Study|Discontinued after 41 days Rx|1|||
124745859|NCT00462748|448691218|FG001|Overall Study|Discontinued after 41 days Rx|0|||
124745860|NCT00462748|448691219|FG002|Overall Study|Discontinued after 41 days Rx|0|||
124745861|NCT03233438|448691220|FG000|Overall Study|Lost to Follow-up|4|||
124745862|NCT03233438|448691221|FG001|Overall Study|Lost to Follow-up|9|||
124745863|NCT03233438|448691220|FG000|Overall Study|Withdrawal by Subject|2|||
124745864|NCT03233438|448691221|FG001|Overall Study|Withdrawal by Subject|1|||
124745865|NCT03233438|448691220|FG000|Overall Study|No recording of dalbavancin|0|||
124745866|NCT03233438|448691221|FG001|Overall Study|No recording of dalbavancin|1|||
124745867|NCT03429543|448691222|FG000|Overall Study|Adverse Event|1|||
124745868|NCT03429543|448691223|FG001|Overall Study|Adverse Event|1|||
124745869|NCT03429543|448691224|FG002|Overall Study|Adverse Event|0|||
124745870|NCT03429543|448691225|FG003|Overall Study|Adverse Event|0|||
124745871|NCT03429543|448691226|FG004|Overall Study|Adverse Event|0|||
124745872|NCT03429543|448691227|FG005|Overall Study|Adverse Event|2|||
124745873|NCT03429543|448691228|FG006|Overall Study|Adverse Event|0|||
124745874|NCT03429543|448691222|FG000|Overall Study|Lost to Follow-up|1|||
124745875|NCT03429543|448691223|FG001|Overall Study|Lost to Follow-up|0|||
124745876|NCT03429543|448691224|FG002|Overall Study|Lost to Follow-up|0|||
124745877|NCT03429543|448691225|FG003|Overall Study|Lost to Follow-up|0|||
124745878|NCT03429543|448691226|FG004|Overall Study|Lost to Follow-up|1|||
124745879|NCT03429543|448691227|FG005|Overall Study|Lost to Follow-up|0|||
124745880|NCT03429543|448691228|FG006|Overall Study|Lost to Follow-up|0|||
124745881|NCT03429543|448691222|FG000|Overall Study|Withdrawal by Subject|5|||
124745882|NCT03429543|448691223|FG001|Overall Study|Withdrawal by Subject|0|||
124745883|NCT03429543|448691224|FG002|Overall Study|Withdrawal by Subject|1|||
124745884|NCT03429543|448691225|FG003|Overall Study|Withdrawal by Subject|2|||
124745885|NCT03429543|448691226|FG004|Overall Study|Withdrawal by Subject|6|||
124745886|NCT03429543|448691227|FG005|Overall Study|Withdrawal by Subject|3|||
124745887|NCT03429543|448691228|FG006|Overall Study|Withdrawal by Subject|1|||
124745888|NCT03429543|448691222|FG000|Overall Study|Other reason than listed|0|||
124745889|NCT03429543|448691223|FG001|Overall Study|Other reason than listed|1|||
124745890|NCT03429543|448691224|FG002|Overall Study|Other reason than listed|0|||
124745891|NCT03429543|448691225|FG003|Overall Study|Other reason than listed|0|||
124745892|NCT03429543|448691226|FG004|Overall Study|Other reason than listed|4|||
124745893|NCT03429543|448691227|FG005|Overall Study|Other reason than listed|4|||
124745894|NCT03429543|448691228|FG006|Overall Study|Other reason than listed|0|||
124745895|NCT03429543|448691222|FG000|Overall Study|Not treated|0|||
124745896|NCT03429543|448691223|FG001|Overall Study|Not treated|0|||
124745897|NCT03429543|448691224|FG002|Overall Study|Not treated|0|||
124745898|NCT03429543|448691225|FG003|Overall Study|Not treated|0|||
124745899|NCT03429543|448691226|FG004|Overall Study|Not treated|1|||
124745900|NCT03429543|448691227|FG005|Overall Study|Not treated|0|||
124745901|NCT03429543|448691228|FG006|Overall Study|Not treated|0|||
124745902|NCT03615066|448691229|FG000|Main Study|Withdrew Consent|0|||
124745903|NCT03615066|448691230|FG001|Main Study|Withdrew Consent|1|||
124745904|NCT03615066|448691231|FG002|Main Study|Withdrew Consent|1|||
124745905|NCT03615066|448691229|FG000|Main Study|Lost to Follow-up|0|||
124745906|NCT03615066|448691230|FG001|Main Study|Lost to Follow-up|0|||
124745907|NCT03615066|448691231|FG002|Main Study|Lost to Follow-up|1|||
124745908|NCT03615066|448691229|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
124745909|NCT03615066|448691230|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
124745910|NCT03615066|448691231|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
124745911|NCT03615066|448691229|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
124745912|NCT03615066|448691230|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
124745913|NCT03615066|448691231|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
124745914|NCT03615066|448691229|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
124745915|NCT03615066|448691230|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
124745916|NCT03615066|448691231|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
124745917|NCT00576576|448691245|FG000|Overall Study|Lost to Follow-up|6|||
124745918|NCT00576576|448691245|FG000|Overall Study|Protocol Violation|1|||
124745919|NCT01805037|448691251|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
124745920|NCT01805037|448691252|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
124745921|NCT01805037|448691251|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
124745922|NCT01805037|448691252|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
124745923|NCT01805037|448691251|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
124745924|NCT01805037|448691252|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
124745925|NCT01805037|448691251|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
124745926|NCT01805037|448691252|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
124745927|NCT01805037|448691251|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
124745928|NCT01805037|448691252|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
124745929|NCT01805037|448691251|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
124745930|NCT01805037|448691252|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
124745931|NCT01805037|448691251|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
124745932|NCT01805037|448691252|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
124745933|NCT01805037|448691251|FG000|Follow Up (up to 3 Years)|Death|0|||
124745934|NCT01805037|448691252|FG001|Follow Up (up to 3 Years)|Death|2|||
124745935|NCT01805037|448691251|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
124745936|NCT01805037|448691252|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
124745937|NCT01805037|448691251|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
124745938|NCT01805037|448691252|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
124745939|NCT02177838|448691256|FG000|Overall Study|Withdrawal by Subject|1|||
124745940|NCT02177838|448691256|FG000|Overall Study|Physician Decision|1|||
124745941|NCT02177838|448691256|FG000|Overall Study|Death|1|||
124745942|NCT03517566|448691259|FG000|Overall Study|Adverse Event|5|||
124745943|NCT03517566|448691260|FG001|Overall Study|Adverse Event|2|||
124745944|NCT03517566|448691261|FG002|Overall Study|Adverse Event|2|||
124745945|NCT03517566|448691262|FG003|Overall Study|Adverse Event|8|||
124745946|NCT03517566|448691263|FG004|Overall Study|Adverse Event|7|||
124745947|NCT03517566|448691259|FG000|Overall Study|Lack of Efficacy|3|||
124745948|NCT03517566|448691260|FG001|Overall Study|Lack of Efficacy|2|||
124745949|NCT03517566|448691261|FG002|Overall Study|Lack of Efficacy|1|||
124745950|NCT03517566|448691262|FG003|Overall Study|Lack of Efficacy|1|||
124745951|NCT03517566|448691263|FG004|Overall Study|Lack of Efficacy|4|||
124745952|NCT03517566|448691259|FG000|Overall Study|Lost to Follow-up|3|||
124745953|NCT03517566|448691260|FG001|Overall Study|Lost to Follow-up|1|||
124745954|NCT03517566|448691261|FG002|Overall Study|Lost to Follow-up|1|||
124745955|NCT03517566|448691262|FG003|Overall Study|Lost to Follow-up|1|||
124745956|NCT03517566|448691263|FG004|Overall Study|Lost to Follow-up|0|||
124745957|NCT03517566|448691259|FG000|Overall Study|Physician Decision|1|||
124745958|NCT03517566|448691260|FG001|Overall Study|Physician Decision|1|||
124745959|NCT03517566|448691261|FG002|Overall Study|Physician Decision|0|||
124745960|NCT03517566|448691262|FG003|Overall Study|Physician Decision|1|||
124745961|NCT03517566|448691263|FG004|Overall Study|Physician Decision|0|||
124745962|NCT03517566|448691259|FG000|Overall Study|Pregnancy|0|||
124745963|NCT03517566|448691260|FG001|Overall Study|Pregnancy|1|||
124745964|NCT03517566|448691261|FG002|Overall Study|Pregnancy|0|||
124745965|NCT03517566|448691262|FG003|Overall Study|Pregnancy|0|||
124745966|NCT03517566|448691263|FG004|Overall Study|Pregnancy|0|||
124745967|NCT03517566|448691259|FG000|Overall Study|Protocol Deviation|0|||
124745968|NCT03517566|448691260|FG001|Overall Study|Protocol Deviation|1|||
124745969|NCT03517566|448691261|FG002|Overall Study|Protocol Deviation|0|||
124745970|NCT03517566|448691262|FG003|Overall Study|Protocol Deviation|1|||
124745971|NCT03517566|448691263|FG004|Overall Study|Protocol Deviation|1|||
124745972|NCT03517566|448691259|FG000|Overall Study|Study terminated by Sponsor|11|||
124745973|NCT03517566|448691260|FG001|Overall Study|Study terminated by Sponsor|5|||
124745974|NCT03517566|448691261|FG002|Overall Study|Study terminated by Sponsor|6|||
124745975|NCT03517566|448691262|FG003|Overall Study|Study terminated by Sponsor|14|||
124745976|NCT03517566|448691263|FG004|Overall Study|Study terminated by Sponsor|12|||
124745977|NCT03517566|448691259|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
124745978|NCT03517566|448691260|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
124745979|NCT03517566|448691261|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
124745980|NCT03517566|448691262|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
124745981|NCT03517566|448691263|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
124745982|NCT03927404|448691266|FG000|Overall Study|Withdrawal by Subject|1|||
124745983|NCT04311463|448691267|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
124745984|NCT04311463|448691268|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
124745985|NCT04311463|448691267|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
124745986|NCT04311463|448691268|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
124745987|NCT04311463|448691267|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
124745988|NCT04311463|448691268|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
124745989|NCT00737633|448691274|FG000|Overall Study|Study terminated by sponsor|44|||
124745990|NCT00737633|448691275|FG001|Overall Study|Study terminated by sponsor|55|||
124745991|NCT00737633|448691274|FG000|Overall Study|Lost to Follow-up|0|||
124745992|NCT00737633|448691275|FG001|Overall Study|Lost to Follow-up|1|||
124745993|NCT00737633|448691274|FG000|Overall Study|protocol non-compliance|0|||
124745994|NCT00737633|448691275|FG001|Overall Study|protocol non-compliance|1|||
124745995|NCT01300260|448691276|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
124745996|NCT01300260|448691277|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
124745997|NCT01300260|448691276|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
124745998|NCT01300260|448691277|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
124745999|NCT01300260|448691276|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
124619019|NCT00710866|448221664|FG000|Overall Study|Failed to meet eligibility|1|||
124619020|NCT00710866|448221665|FG001|Overall Study|Failed to meet eligibility|1|||
124619021|NCT00086281|448221666|FG000|Phase 1|Adverse Event|0|||
124619022|NCT00086281|448221667|FG001|Phase 1|Adverse Event|0|||
124619023|NCT00086281|448221668|FG002|Phase 1|Adverse Event|0|||
124619024|NCT00086281|448221669|FG003|Phase 1|Adverse Event|0|||
124619025|NCT00086281|448221670|FG004|Phase 1|Adverse Event|0|||
124619026|NCT00086281|448221671|FG005|Phase 1|Adverse Event|0|||
124619027|NCT00086281|448221672|FG006|Phase 1|Adverse Event|0|||
124619028|NCT00086281|448221673|FG007|Phase 1|Adverse Event|0|||
124619029|NCT00086281|448221674|FG008|Phase 1|Adverse Event|0|||
124619030|NCT00086281|448221675|FG009|Phase 1|Adverse Event|1|||
124619031|NCT00086281|448221676|FG010|Phase 1|Adverse Event|2|||
124619032|NCT00086281|448221677|FG011|Phase 1|Adverse Event|1|||
124619033|NCT00086281|448221678|FG012|Phase 1|Adverse Event|1|||
124619034|NCT00086281|448221679|FG013|Phase 1|Adverse Event|1|||
124619035|NCT00086281|448221680|FG014|Phase 1|Adverse Event|2|||
124619036|NCT00086281|448221666|FG000|Phase 1|Protocol Violation|0|||
124619037|NCT00086281|448221667|FG001|Phase 1|Protocol Violation|0|||
124619038|NCT00086281|448221668|FG002|Phase 1|Protocol Violation|0|||
124619039|NCT00086281|448221669|FG003|Phase 1|Protocol Violation|0|||
124619040|NCT00086281|448221670|FG004|Phase 1|Protocol Violation|0|||
124619041|NCT00086281|448221671|FG005|Phase 1|Protocol Violation|0|||
124619042|NCT00086281|448221672|FG006|Phase 1|Protocol Violation|0|||
124619043|NCT00086281|448221673|FG007|Phase 1|Protocol Violation|0|||
124619044|NCT00086281|448221674|FG008|Phase 1|Protocol Violation|0|||
124619045|NCT00086281|448221675|FG009|Phase 1|Protocol Violation|0|||
124619046|NCT00086281|448221676|FG010|Phase 1|Protocol Violation|1|||
124619047|NCT00086281|448221677|FG011|Phase 1|Protocol Violation|0|||
124619048|NCT00086281|448221678|FG012|Phase 1|Protocol Violation|0|||
124619049|NCT00086281|448221679|FG013|Phase 1|Protocol Violation|0|||
124619050|NCT00086281|448221680|FG014|Phase 1|Protocol Violation|0|||
124619051|NCT00086281|448221666|FG000|Phase 1|Serious Adverse Event|0|||
124619052|NCT00086281|448221667|FG001|Phase 1|Serious Adverse Event|0|||
124619053|NCT00086281|448221668|FG002|Phase 1|Serious Adverse Event|0|||
124619054|NCT00086281|448221669|FG003|Phase 1|Serious Adverse Event|0|||
124619055|NCT00086281|448221670|FG004|Phase 1|Serious Adverse Event|0|||
124619056|NCT00086281|448221671|FG005|Phase 1|Serious Adverse Event|0|||
124619057|NCT00086281|448221672|FG006|Phase 1|Serious Adverse Event|0|||
124619058|NCT00086281|448221673|FG007|Phase 1|Serious Adverse Event|0|||
124619059|NCT00086281|448221674|FG008|Phase 1|Serious Adverse Event|0|||
124619060|NCT00086281|448221675|FG009|Phase 1|Serious Adverse Event|0|||
124619061|NCT00086281|448221676|FG010|Phase 1|Serious Adverse Event|0|||
124619062|NCT00086281|448221677|FG011|Phase 1|Serious Adverse Event|0|||
124619063|NCT00086281|448221678|FG012|Phase 1|Serious Adverse Event|0|||
124619064|NCT00086281|448221679|FG013|Phase 1|Serious Adverse Event|0|||
124619065|NCT00086281|448221680|FG014|Phase 1|Serious Adverse Event|1|||
124619066|NCT00086281|448221666|FG000|Phase 2|Adverse Event|0|||
124619067|NCT00086281|448221667|FG001|Phase 2|Adverse Event|0|||
124619068|NCT00086281|448221668|FG002|Phase 2|Adverse Event|0|||
124619069|NCT00086281|448221669|FG003|Phase 2|Adverse Event|0|||
124619070|NCT00086281|448221670|FG004|Phase 2|Adverse Event|0|||
124619071|NCT00086281|448221671|FG005|Phase 2|Adverse Event|0|||
124619072|NCT00086281|448221672|FG006|Phase 2|Adverse Event|0|||
124619073|NCT00086281|448221673|FG007|Phase 2|Adverse Event|0|||
124619074|NCT00086281|448221674|FG008|Phase 2|Adverse Event|0|||
124619075|NCT00086281|448221675|FG009|Phase 2|Adverse Event|0|||
124619076|NCT00086281|448221676|FG010|Phase 2|Adverse Event|0|||
124619077|NCT00086281|448221677|FG011|Phase 2|Adverse Event|0|||
124619078|NCT00086281|448221678|FG012|Phase 2|Adverse Event|1|||
124619079|NCT00086281|448221679|FG013|Phase 2|Adverse Event|1|||
124619080|NCT00086281|448221680|FG014|Phase 2|Adverse Event|0|||
124619081|NCT03071276|448221682|FG000|Overall Study|Adverse Event|1|||
124619082|NCT03071276|448221682|FG000|Overall Study|Lack of Efficacy|14|||
124619083|NCT03390426|448221683|FG000|Overall Study|Protocol Violation|0|||
124619084|NCT03390426|448221684|FG001|Overall Study|Protocol Violation|1|||
124619085|NCT02516553|448221689|FG000|Overall Study|Progressive disease|2|||
124619086|NCT02516553|448221690|FG001|Overall Study|Progressive disease|2|||
124619087|NCT02516553|448221691|FG002|Overall Study|Progressive disease|3|||
124619088|NCT02516553|448221692|FG003|Overall Study|Progressive disease|5|||
124619089|NCT02516553|448221693|FG004|Overall Study|Progressive disease|3|||
124619090|NCT02516553|448221694|FG005|Overall Study|Progressive disease|0|||
124619091|NCT02516553|448221695|FG006|Overall Study|Progressive disease|5|||
124619092|NCT02516553|448221696|FG007|Overall Study|Progressive disease|5|||
124619093|NCT02516553|448221697|FG008|Overall Study|Progressive disease|11|||
124619094|NCT02516553|448221698|FG009|Overall Study|Progressive disease|3|||
124619095|NCT02516553|448221699|FG010|Overall Study|Progressive disease|10|||
124619096|NCT02516553|448221700|FG011|Overall Study|Progressive disease|8|||
124619097|NCT02516553|448221701|FG012|Overall Study|Progressive disease|8|||
124619098|NCT02516553|448221702|FG013|Overall Study|Progressive disease|2|||
124619099|NCT02516553|448221703|FG014|Overall Study|Progressive disease|2|||
124619100|NCT02516553|448221704|FG015|Overall Study|Progressive disease|2|||
124619101|NCT02516553|448221705|FG016|Overall Study|Progressive disease|1|||
124746000|NCT01300260|448691277|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
124746001|NCT00293020|448691286|FG000|Overall Study|Withdrawal by Subject|34|||
124746002|NCT00293020|448691286|FG000|Overall Study|Adverse Event|30|||
124746003|NCT00293020|448691286|FG000|Overall Study|Death|32|||
124746004|NCT00293020|448691286|FG000|Overall Study|Lack of Efficacy|12|||
124746005|NCT00293020|448691286|FG000|Overall Study|Lost to Follow-up|4|||
124746006|NCT00293020|448691286|FG000|Overall Study|Protocol Violation|6|||
124746007|NCT00293020|448691286|FG000|Overall Study|Physician Decision|21|||
124746008|NCT00293020|448691286|FG000|Overall Study|Other Reason|22|||
124746009|NCT00293020|448691286|FG000|Overall Study|No dose taken|1|||
124746010|NCT01147848|448691287|FG000|Run-in Period|Screen Failure|623|||
124746011|NCT01147848|448691288|FG001|Run-in Period|Screen Failure|0|||
124746012|NCT01147848|448691289|FG002|Run-in Period|Screen Failure|0|||
124746013|NCT01147848|448691287|FG000|Run-in Period|Run-in Failure|135|||
124746014|NCT01147848|448691288|FG001|Run-in Period|Run-in Failure|0|||
124746015|NCT01147848|448691289|FG002|Run-in Period|Run-in Failure|0|||
124746016|NCT01147848|448691287|FG000|Randomized Phase|Adverse Event|0|||
124746017|NCT01147848|448691288|FG001|Randomized Phase|Adverse Event|6|||
124746018|NCT01147848|448691289|FG002|Randomized Phase|Adverse Event|8|||
124746019|NCT01147848|448691287|FG000|Randomized Phase|Lack of Efficacy|0|||
124746020|NCT01147848|448691288|FG001|Randomized Phase|Lack of Efficacy|20|||
124746021|NCT01147848|448691289|FG002|Randomized Phase|Lack of Efficacy|11|||
124746022|NCT01147848|448691287|FG000|Randomized Phase|Protocol Violation|0|||
124746023|NCT01147848|448691288|FG001|Randomized Phase|Protocol Violation|7|||
124746024|NCT01147848|448691289|FG002|Randomized Phase|Protocol Violation|10|||
124746025|NCT01147848|448691287|FG000|Randomized Phase|Lost to Follow-up|0|||
124746026|NCT01147848|448691288|FG001|Randomized Phase|Lost to Follow-up|5|||
124746027|NCT01147848|448691289|FG002|Randomized Phase|Lost to Follow-up|7|||
124746028|NCT01147848|448691287|FG000|Randomized Phase|Physician Decision|0|||
124746029|NCT01147848|448691288|FG001|Randomized Phase|Physician Decision|0|||
124746030|NCT01147848|448691289|FG002|Randomized Phase|Physician Decision|1|||
124746031|NCT01147848|448691287|FG000|Randomized Phase|Withdrawal by Subject|0|||
124746032|NCT01147848|448691288|FG001|Randomized Phase|Withdrawal by Subject|7|||
124746033|NCT01147848|448691289|FG002|Randomized Phase|Withdrawal by Subject|9|||
124746034|NCT03180307|448691290|FG000|Overall Study|Lost to Follow-up|2|||
124746035|NCT03180307|448691291|FG001|Overall Study|Lost to Follow-up|0|||
124746036|NCT03180307|448691290|FG000|Overall Study|Death|1|||
124746037|NCT03180307|448691291|FG001|Overall Study|Death|0|||
124746038|NCT03180307|448691290|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
124746039|NCT03180307|448691291|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
124746040|NCT04349033|448691293|FG000|Overall Study|Lost to Follow-up|3|||
124746041|NCT04349033|448691294|FG001|Overall Study|Lost to Follow-up|1|||
124746042|NCT04349033|448691295|FG002|Overall Study|Lost to Follow-up|1|||
124746043|NCT01990859|448691296|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
124746044|NCT01990859|448691296|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
124746045|NCT02262754|448691298|FG000|Overall Study|Adverse Event|3|||
124746046|NCT02262754|448691299|FG001|Overall Study|Adverse Event|4|||
124746047|NCT02262754|448691300|FG002|Overall Study|Adverse Event|0|||
124746048|NCT02262754|448691298|FG000|Overall Study|Lack of Efficacy|2|||
124746049|NCT02262754|448691299|FG001|Overall Study|Lack of Efficacy|0|||
124746050|NCT02262754|448691300|FG002|Overall Study|Lack of Efficacy|1|||
124746051|NCT02262754|448691298|FG000|Overall Study|Lost to Follow-up|0|||
124746052|NCT02262754|448691299|FG001|Overall Study|Lost to Follow-up|0|||
124746053|NCT02262754|448691300|FG002|Overall Study|Lost to Follow-up|1|||
124746054|NCT02262754|448691298|FG000|Overall Study|No longer meets eligibility criteria|0|||
124746055|NCT02262754|448691299|FG001|Overall Study|No longer meets eligibility criteria|1|||
124746056|NCT02262754|448691300|FG002|Overall Study|No longer meets eligibility criteria|0|||
124746057|NCT02262754|448691298|FG000|Overall Study|Study terminated by sponsor|5|||
124746058|NCT02262754|448691299|FG001|Overall Study|Study terminated by sponsor|4|||
124746059|NCT02262754|448691300|FG002|Overall Study|Study terminated by sponsor|4|||
124782255|NCT02910986|448832800|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
124746060|NCT02262754|448691298|FG000|Overall Study|Protocol Violation|1|||
124746061|NCT02262754|448691299|FG001|Overall Study|Protocol Violation|0|||
124746062|NCT02262754|448691300|FG002|Overall Study|Protocol Violation|0|||
124746063|NCT02262754|448691298|FG000|Overall Study|Withdrawal by Subject|1|||
124746064|NCT02262754|448691299|FG001|Overall Study|Withdrawal by Subject|0|||
124746065|NCT02262754|448691300|FG002|Overall Study|Withdrawal by Subject|1|||
124746066|NCT02262754|448691298|FG000|Overall Study|Other|4|||
124746067|NCT02262754|448691299|FG001|Overall Study|Other|0|||
124746068|NCT02262754|448691300|FG002|Overall Study|Other|2|||
124746069|NCT02577016|448691301|FG000|Overall Study|Adverse Event|2|||
124619102|NCT02516553|448221706|FG017|Overall Study|Progressive disease|9|||
124746070|NCT02577016|448691302|FG001|Overall Study|Adverse Event|1|||
124746071|NCT02577016|448691301|FG000|Overall Study|Physician Decision|0|||
124619103|NCT02516553|448221707|FG018|Overall Study|Progressive disease|12|||
124746072|NCT02577016|448691302|FG001|Overall Study|Physician Decision|1|||
124746073|NCT02126839|448691303|FG000|Overall Study|Adverse Event|0|||
124746074|NCT02126839|448691304|FG001|Overall Study|Adverse Event|1|||
124746075|NCT02126839|448691303|FG000|Overall Study|Withdrawal by Subject|1|||
124746076|NCT02126839|448691304|FG001|Overall Study|Withdrawal by Subject|0|||
124746077|NCT02126839|448691303|FG000|Overall Study|Withdrawal by parent/guardian|1|||
124746078|NCT02126839|448691304|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124746079|NCT02126839|448691303|FG000|Overall Study|Protocol Violation|2|||
124746080|NCT02126839|448691304|FG001|Overall Study|Protocol Violation|3|||
124746081|NCT02126839|448691303|FG000|Overall Study|Sponsor request|0|||
124746082|NCT02126839|448691304|FG001|Overall Study|Sponsor request|1|||
124746083|NCT02126839|448691303|FG000|Overall Study|Lost to Follow-up|1|||
124746084|NCT02126839|448691304|FG001|Overall Study|Lost to Follow-up|4|||
124746085|NCT02126839|448691303|FG000|Overall Study|Other|5|||
124746086|NCT02126839|448691304|FG001|Overall Study|Other|5|||
124746087|NCT00812565|448691305|FG000|Overall Study|Did Not Receive Study Medication|1|||
124746088|NCT00812565|448691306|FG001|Overall Study|Did Not Receive Study Medication|1|||
124746089|NCT00812565|448691307|FG002|Overall Study|Did Not Receive Study Medication|0|||
124746090|NCT00812565|448691308|FG003|Overall Study|Did Not Receive Study Medication|0|||
124746091|NCT00812565|448691309|FG004|Overall Study|Did Not Receive Study Medication|0|||
124746092|NCT00812565|448691310|FG005|Overall Study|Did Not Receive Study Medication|0|||
124746093|NCT00812565|448691311|FG006|Overall Study|Did Not Receive Study Medication|0|||
124746094|NCT00812565|448691312|FG007|Overall Study|Did Not Receive Study Medication|0|||
124746095|NCT00812565|448691305|FG000|Overall Study|Adverse Event|0|||
124746096|NCT00812565|448691306|FG001|Overall Study|Adverse Event|0|||
124746097|NCT00812565|448691307|FG002|Overall Study|Adverse Event|0|||
124746098|NCT00812565|448691308|FG003|Overall Study|Adverse Event|2|||
124746099|NCT00812565|448691309|FG004|Overall Study|Adverse Event|0|||
124746100|NCT00812565|448691310|FG005|Overall Study|Adverse Event|0|||
124746101|NCT00812565|448691311|FG006|Overall Study|Adverse Event|0|||
124746102|NCT00812565|448691312|FG007|Overall Study|Adverse Event|1|||
124746103|NCT00812565|448691305|FG000|Overall Study|Did Not Come to Study Visit|1|||
124746104|NCT00812565|448691306|FG001|Overall Study|Did Not Come to Study Visit|0|||
124746105|NCT00812565|448691307|FG002|Overall Study|Did Not Come to Study Visit|0|||
124746106|NCT00812565|448691308|FG003|Overall Study|Did Not Come to Study Visit|0|||
124746107|NCT00812565|448691309|FG004|Overall Study|Did Not Come to Study Visit|0|||
124746108|NCT00812565|448691310|FG005|Overall Study|Did Not Come to Study Visit|0|||
124746109|NCT00812565|448691311|FG006|Overall Study|Did Not Come to Study Visit|0|||
124746110|NCT00812565|448691312|FG007|Overall Study|Did Not Come to Study Visit|0|||
124746111|NCT00812565|448691305|FG000|Overall Study|Withdrawal of Consent|1|||
124746112|NCT00812565|448691306|FG001|Overall Study|Withdrawal of Consent|0|||
124746113|NCT00812565|448691307|FG002|Overall Study|Withdrawal of Consent|0|||
124746114|NCT00812565|448691308|FG003|Overall Study|Withdrawal of Consent|0|||
124746115|NCT00812565|448691309|FG004|Overall Study|Withdrawal of Consent|1|||
124746116|NCT00812565|448691310|FG005|Overall Study|Withdrawal of Consent|0|||
124746117|NCT00812565|448691311|FG006|Overall Study|Withdrawal of Consent|0|||
124746118|NCT00812565|448691312|FG007|Overall Study|Withdrawal of Consent|0|||
124746119|NCT00812565|448691305|FG000|Overall Study|Reason Not Specified|0|||
124746120|NCT00812565|448691306|FG001|Overall Study|Reason Not Specified|0|||
124746121|NCT00812565|448691307|FG002|Overall Study|Reason Not Specified|0|||
124746122|NCT00812565|448691308|FG003|Overall Study|Reason Not Specified|0|||
124746123|NCT00812565|448691309|FG004|Overall Study|Reason Not Specified|0|||
124746124|NCT00812565|448691310|FG005|Overall Study|Reason Not Specified|1|||
124746125|NCT00812565|448691311|FG006|Overall Study|Reason Not Specified|0|||
124746126|NCT00812565|448691312|FG007|Overall Study|Reason Not Specified|0|||
124619104|NCT02516553|448221708|FG019|Overall Study|Progressive disease|7|||
124619105|NCT02516553|448221709|FG020|Overall Study|Progressive disease|16|||
124619106|NCT02516553|448221710|FG021|Overall Study|Progressive disease|18|||
124619107|NCT02516553|448221689|FG000|Overall Study|Dose limiting toxicity|0|||
124619108|NCT02516553|448221690|FG001|Overall Study|Dose limiting toxicity|0|||
124619109|NCT02516553|448221691|FG002|Overall Study|Dose limiting toxicity|0|||
124619110|NCT02516553|448221692|FG003|Overall Study|Dose limiting toxicity|0|||
124619111|NCT02516553|448221693|FG004|Overall Study|Dose limiting toxicity|3|||
124619112|NCT02516553|448221694|FG005|Overall Study|Dose limiting toxicity|1|||
124619113|NCT02516553|448221695|FG006|Overall Study|Dose limiting toxicity|1|||
124619114|NCT02516553|448221696|FG007|Overall Study|Dose limiting toxicity|0|||
124619115|NCT02516553|448221697|FG008|Overall Study|Dose limiting toxicity|1|||
124746127|NCT00765063|448693448|FG000|Overall Study|Lack of Efficacy|5|||
124746128|NCT00765063|448693448|FG000|Overall Study|Withdrawal by Subject|1|||
124746129|NCT00765063|448693448|FG000|Overall Study|Other|16|||
124746130|NCT00765063|448693448|FG000|Overall Study|Protocol Violation|6|||
124746131|NCT00765063|448693448|FG000|Overall Study|Adverse Event|4|||
124619116|NCT02516553|448221698|FG009|Overall Study|Dose limiting toxicity|0|||
124619117|NCT02516553|448221699|FG010|Overall Study|Dose limiting toxicity|0|||
124619118|NCT02516553|448221700|FG011|Overall Study|Dose limiting toxicity|1|||
124746132|NCT03614325|448693449|FG000|Overall Study|Withdrawal by Subject|0|||
124746133|NCT03614325|448693450|FG001|Overall Study|Withdrawal by Subject|2|||
124746134|NCT03614325|448693449|FG000|Overall Study|Surgery Cancelled|2|||
124746135|NCT03614325|448693450|FG001|Overall Study|Surgery Cancelled|1|||
124619119|NCT02516553|448221701|FG012|Overall Study|Dose limiting toxicity|0|||
124619120|NCT02516553|448221702|FG013|Overall Study|Dose limiting toxicity|1|||
124619121|NCT02516553|448221703|FG014|Overall Study|Dose limiting toxicity|0|||
124746136|NCT03614325|448693449|FG000|Overall Study|Lost to Follow-up|2|||
124746137|NCT03614325|448693450|FG001|Overall Study|Lost to Follow-up|1|||
124746138|NCT03614325|448693449|FG000|Overall Study|Surgery never scheduled|1|||
124746139|NCT03614325|448693450|FG001|Overall Study|Surgery never scheduled|0|||
124746140|NCT01041287|448693451|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
124746141|NCT01041287|448693452|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
124746142|NCT01041287|448693451|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
124746143|NCT01041287|448693452|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
124746144|NCT01673620|448693458|FG000|Overall Study|Adverse Event|1|||
124746145|NCT01673620|448693459|FG001|Overall Study|Adverse Event|0|||
124746146|NCT01597635|448693461|FG000|Part A|Adverse Event|3|||
124746147|NCT01597635|448693462|FG001|Part A|Adverse Event|0|||
124746148|NCT01597635|448693463|FG002|Part A|Adverse Event|0|||
124746149|NCT01597635|448693461|FG000|Part B|Adverse Event|0|||
124746150|NCT01597635|448693462|FG001|Part B|Adverse Event|0|||
124746151|NCT01597635|448693463|FG002|Part B|Adverse Event|1|||
124746152|NCT01597635|448693461|FG000|Part B|Protocol Violation|0|||
124746153|NCT01597635|448693462|FG001|Part B|Protocol Violation|1|||
124746154|NCT01597635|448693463|FG002|Part B|Protocol Violation|0|||
124746155|NCT01597635|448693461|FG000|Part B|Protocol-defined stopping criteria|0|||
124746156|NCT01597635|448693462|FG001|Part B|Protocol-defined stopping criteria|4|||
124746157|NCT01597635|448693463|FG002|Part B|Protocol-defined stopping criteria|3|||
124746158|NCT01597635|448693461|FG000|Part B|Withdrawal by Subject|0|||
124746159|NCT01597635|448693462|FG001|Part B|Withdrawal by Subject|1|||
124746160|NCT01597635|448693463|FG002|Part B|Withdrawal by Subject|0|||
124746161|NCT01363661|448693464|FG000|Overall Study|Adverse Event|9|||
124746162|NCT01363661|448693465|FG001|Overall Study|Adverse Event|2|||
124746163|NCT01363661|448693464|FG000|Overall Study|Withdrawal by Subject|1|||
124746164|NCT01363661|448693465|FG001|Overall Study|Withdrawal by Subject|1|||
124746165|NCT01363661|448693464|FG000|Overall Study|Protocol Violation|1|||
124746166|NCT01363661|448693465|FG001|Overall Study|Protocol Violation|0|||
124746167|NCT01363661|448693464|FG000|Overall Study|Lost to Follow-up|3|||
124746168|NCT01363661|448693465|FG001|Overall Study|Lost to Follow-up|1|||
124746169|NCT01971008|448693466|FG000|Overall Study|Protocol Violation|2|||
124746170|NCT01971008|448693467|FG001|Overall Study|Protocol Violation|1|||
124746171|NCT03775512|448693468|FG000|Overall Study|Death|1|||
124746172|NCT03775512|448693469|FG001|Overall Study|Death|1|||
124746173|NCT03775512|448693468|FG000|Overall Study|Withdrawal by Subject|7|||
124746174|NCT03775512|448693469|FG001|Overall Study|Withdrawal by Subject|4|||
124746175|NCT03775512|448693468|FG000|Overall Study|Lost to Follow-up|5|||
124746176|NCT03775512|448693469|FG001|Overall Study|Lost to Follow-up|5|||
124746177|NCT03775512|448693468|FG000|Overall Study|Excluded before Catheter insertion|14|||
124746178|NCT03775512|448693469|FG001|Overall Study|Excluded before Catheter insertion|5|||
124746179|NCT03775512|448693468|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
124746180|NCT03775512|448693469|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
124746181|NCT03775512|448693468|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
124746182|NCT03775512|448693469|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
124746183|NCT01378325|448693470|FG000|Overall Study|Protocol Violation|0|||
124746184|NCT01378325|448693471|FG001|Overall Study|Protocol Violation|1|||
124746185|NCT00767806|448693474|FG000|Overall Study|Adverse Event|30|||
124746186|NCT00767806|448693475|FG001|Overall Study|Adverse Event|11|||
124746187|NCT00767806|448693474|FG000|Overall Study|Withdrawal by Subject|8|||
124746188|NCT00767806|448693475|FG001|Overall Study|Withdrawal by Subject|13|||
124746189|NCT00767806|448693474|FG000|Overall Study|Protocol Violation|6|||
124746190|NCT00767806|448693475|FG001|Overall Study|Protocol Violation|5|||
124746191|NCT00767806|448693474|FG000|Overall Study|Lack of Efficacy|1|||
124746192|NCT00767806|448693475|FG001|Overall Study|Lack of Efficacy|9|||
124746193|NCT00767806|448693474|FG000|Overall Study|Physician Decision|4|||
124746194|NCT00767806|448693475|FG001|Overall Study|Physician Decision|3|||
124619122|NCT02516553|448221704|FG015|Overall Study|Dose limiting toxicity|0|||
124619123|NCT02516553|448221705|FG016|Overall Study|Dose limiting toxicity|1|||
124746195|NCT00767806|448693474|FG000|Overall Study|Lost to Follow-up|1|||
124746196|NCT00767806|448693475|FG001|Overall Study|Lost to Follow-up|4|||
124746197|NCT00767806|448693474|FG000|Overall Study|Entry Criteria Not Met|1|||
124746198|NCT00767806|448693475|FG001|Overall Study|Entry Criteria Not Met|1|||
124619124|NCT02516553|448221706|FG017|Overall Study|Dose limiting toxicity|1|||
124746199|NCT00767806|448693474|FG000|Overall Study|Sponsor Decision|0|||
124746200|NCT00767806|448693475|FG001|Overall Study|Sponsor Decision|1|||
124746201|NCT02489942|448693476|FG000|Overall Study|Request by patient|602|||
124746202|NCT02489942|448693476|FG000|Overall Study|Improvement/remission|157|||
124746203|NCT02489942|448693476|FG000|Overall Study|No change/Progressive disease|263|||
124746204|NCT02489942|448693476|FG000|Overall Study|Adverse Event|522|||
124746205|NCT02489942|448693476|FG000|Overall Study|Other personal reasons|1218|||
124746206|NCT02489942|448693476|FG000|Overall Study|Lost to Follow-up|456|||
124619125|NCT02516553|448221707|FG018|Overall Study|Dose limiting toxicity|0|||
124746207|NCT02489942|448693476|FG000|Overall Study|Not continuously investigated|7|||
124619126|NCT02516553|448221708|FG019|Overall Study|Dose limiting toxicity|2|||
124619127|NCT02516553|448221709|FG020|Overall Study|Dose limiting toxicity|0|||
124619128|NCT02516553|448221710|FG021|Overall Study|Dose limiting toxicity|0|||
124619129|NCT02516553|448221689|FG000|Overall Study|Other Adverse Events|0|||
124619130|NCT02516553|448221690|FG001|Overall Study|Other Adverse Events|0|||
124619131|NCT02516553|448221691|FG002|Overall Study|Other Adverse Events|0|||
124619132|NCT02516553|448221692|FG003|Overall Study|Other Adverse Events|1|||
124619133|NCT02516553|448221693|FG004|Overall Study|Other Adverse Events|0|||
124619134|NCT02516553|448221694|FG005|Overall Study|Other Adverse Events|1|||
124619135|NCT02516553|448221695|FG006|Overall Study|Other Adverse Events|0|||
124619136|NCT02516553|448221696|FG007|Overall Study|Other Adverse Events|0|||
124619137|NCT02516553|448221697|FG008|Overall Study|Other Adverse Events|0|||
124619138|NCT02516553|448221698|FG009|Overall Study|Other Adverse Events|1|||
124619139|NCT02516553|448221699|FG010|Overall Study|Other Adverse Events|3|||
124619140|NCT02516553|448221700|FG011|Overall Study|Other Adverse Events|2|||
124619141|NCT02516553|448221701|FG012|Overall Study|Other Adverse Events|0|||
124619142|NCT02516553|448221702|FG013|Overall Study|Other Adverse Events|1|||
124619143|NCT02516553|448221703|FG014|Overall Study|Other Adverse Events|0|||
124619144|NCT02516553|448221704|FG015|Overall Study|Other Adverse Events|0|||
124619145|NCT02516553|448221705|FG016|Overall Study|Other Adverse Events|0|||
124619146|NCT02516553|448221706|FG017|Overall Study|Other Adverse Events|2|||
124619147|NCT02516553|448221707|FG018|Overall Study|Other Adverse Events|1|||
124619148|NCT02516553|448221708|FG019|Overall Study|Other Adverse Events|2|||
124619149|NCT02516553|448221709|FG020|Overall Study|Other Adverse Events|2|||
124619150|NCT02516553|448221710|FG021|Overall Study|Other Adverse Events|1|||
124619151|NCT02516553|448221689|FG000|Overall Study|Refused to continue trial medication|0|||
124619152|NCT02516553|448221690|FG001|Overall Study|Refused to continue trial medication|0|||
124619153|NCT02516553|448221691|FG002|Overall Study|Refused to continue trial medication|0|||
124619154|NCT02516553|448221692|FG003|Overall Study|Refused to continue trial medication|0|||
124619155|NCT02516553|448221693|FG004|Overall Study|Refused to continue trial medication|0|||
124619156|NCT02516553|448221694|FG005|Overall Study|Refused to continue trial medication|0|||
124619157|NCT02516553|448221695|FG006|Overall Study|Refused to continue trial medication|0|||
124619158|NCT02516553|448221696|FG007|Overall Study|Refused to continue trial medication|0|||
124619159|NCT02516553|448221697|FG008|Overall Study|Refused to continue trial medication|0|||
124619160|NCT02516553|448221698|FG009|Overall Study|Refused to continue trial medication|0|||
124619161|NCT02516553|448221699|FG010|Overall Study|Refused to continue trial medication|1|||
124619162|NCT02516553|448221700|FG011|Overall Study|Refused to continue trial medication|0|||
124619163|NCT02516553|448221701|FG012|Overall Study|Refused to continue trial medication|0|||
124619164|NCT02516553|448221702|FG013|Overall Study|Refused to continue trial medication|0|||
124619165|NCT02516553|448221703|FG014|Overall Study|Refused to continue trial medication|0|||
124619166|NCT02516553|448221704|FG015|Overall Study|Refused to continue trial medication|0|||
124619167|NCT02516553|448221705|FG016|Overall Study|Refused to continue trial medication|0|||
124619168|NCT02516553|448221706|FG017|Overall Study|Refused to continue trial medication|0|||
124619169|NCT02516553|448221707|FG018|Overall Study|Refused to continue trial medication|1|||
124619170|NCT02516553|448221708|FG019|Overall Study|Refused to continue trial medication|0|||
124619171|NCT02516553|448221709|FG020|Overall Study|Refused to continue trial medication|0|||
124619172|NCT02516553|448221710|FG021|Overall Study|Refused to continue trial medication|1|||
124619173|NCT02516553|448221689|FG000|Overall Study|other reasons than listed|0|||
124619174|NCT02516553|448221690|FG001|Overall Study|other reasons than listed|0|||
124619175|NCT02516553|448221691|FG002|Overall Study|other reasons than listed|0|||
124619176|NCT02516553|448221692|FG003|Overall Study|other reasons than listed|0|||
124619177|NCT02516553|448221693|FG004|Overall Study|other reasons than listed|0|||
124619178|NCT02516553|448221694|FG005|Overall Study|other reasons than listed|0|||
124619179|NCT02516553|448221695|FG006|Overall Study|other reasons than listed|0|||
124619180|NCT02516553|448221696|FG007|Overall Study|other reasons than listed|1|||
124619181|NCT02516553|448221697|FG008|Overall Study|other reasons than listed|1|||
124619182|NCT02516553|448221698|FG009|Overall Study|other reasons than listed|0|||
124619183|NCT02516553|448221699|FG010|Overall Study|other reasons than listed|1|||
124619184|NCT02516553|448221700|FG011|Overall Study|other reasons than listed|1|||
124619185|NCT02516553|448221701|FG012|Overall Study|other reasons than listed|0|||
124619186|NCT02516553|448221702|FG013|Overall Study|other reasons than listed|0|||
124619187|NCT02516553|448221703|FG014|Overall Study|other reasons than listed|0|||
124619188|NCT02516553|448221704|FG015|Overall Study|other reasons than listed|0|||
124619189|NCT02516553|448221705|FG016|Overall Study|other reasons than listed|0|||
124619190|NCT02516553|448221706|FG017|Overall Study|other reasons than listed|0|||
124619191|NCT02516553|448221707|FG018|Overall Study|other reasons than listed|0|||
124746208|NCT02489942|448693476|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
124619192|NCT02516553|448221708|FG019|Overall Study|other reasons than listed|0|||
124619193|NCT02516553|448221709|FG020|Overall Study|other reasons than listed|2|||
124619194|NCT02516553|448221710|FG021|Overall Study|other reasons than listed|2|||
124746209|NCT02489942|448693476|FG000|Overall Study|Multiple registration|1|||
124746210|NCT02489942|448693476|FG000|Overall Study|No patient visit after entry|100|||
124746211|NCT02489942|448693476|FG000|Overall Study|No treatment with Jardiance|2|||
124746212|NCT02489942|448693476|FG000|Overall Study|Patient received Jardiance before registration|1|||
124746213|NCT02489942|448693476|FG000|Overall Study|No CRF collected|86|||
124746214|NCT00858208|448693477|FG000|Overall Study|Adverse Event|3|||
124746215|NCT00858208|448693477|FG000|Overall Study|Lost to Follow-up|26|||
124746216|NCT00858208|448693477|FG000|Overall Study|Participant refused|40|||
124746217|NCT00858208|448693477|FG000|Overall Study|Other|10|||
124746218|NCT01393639|448693478|FG000|Overall Study|Protocol Violation|0|||
124746219|NCT01393639|448693479|FG001|Overall Study|Protocol Violation|0|||
124746220|NCT01393639|448693480|FG002|Overall Study|Protocol Violation|0|||
124746221|NCT01393639|448693481|FG003|Overall Study|Protocol Violation|1|||
124746222|NCT01393639|448693482|FG004|Overall Study|Protocol Violation|0|||
124746223|NCT01393639|448693483|FG005|Overall Study|Protocol Violation|0|||
124746224|NCT01393639|448693484|FG006|Overall Study|Protocol Violation|0|||
124746225|NCT01393639|448693478|FG000|Overall Study|Other|0|||
124746226|NCT01393639|448693479|FG001|Overall Study|Other|2|||
124746227|NCT01393639|448693480|FG002|Overall Study|Other|0|||
124746228|NCT01393639|448693481|FG003|Overall Study|Other|2|||
124746229|NCT01393639|448693482|FG004|Overall Study|Other|1|||
124746230|NCT01393639|448693483|FG005|Overall Study|Other|0|||
124746231|NCT01393639|448693484|FG006|Overall Study|Other|1|||
124746232|NCT01393639|448693478|FG000|Overall Study|Withdrawal by Subject|1|||
124746233|NCT01393639|448693479|FG001|Overall Study|Withdrawal by Subject|1|||
124746234|NCT01393639|448693480|FG002|Overall Study|Withdrawal by Subject|0|||
124746235|NCT01393639|448693481|FG003|Overall Study|Withdrawal by Subject|0|||
124746236|NCT01393639|448693482|FG004|Overall Study|Withdrawal by Subject|0|||
124746237|NCT01393639|448693483|FG005|Overall Study|Withdrawal by Subject|0|||
124746238|NCT01393639|448693484|FG006|Overall Study|Withdrawal by Subject|1|||
124746239|NCT01393639|448693478|FG000|Overall Study|Medication error without associated AE|0|||
124746240|NCT01393639|448693479|FG001|Overall Study|Medication error without associated AE|0|||
124746241|NCT01393639|448693480|FG002|Overall Study|Medication error without associated AE|0|||
124746242|NCT01393639|448693481|FG003|Overall Study|Medication error without associated AE|0|||
124746243|NCT01393639|448693482|FG004|Overall Study|Medication error without associated AE|0|||
124746244|NCT01393639|448693483|FG005|Overall Study|Medication error without associated AE|0|||
124746245|NCT01393639|448693484|FG006|Overall Study|Medication error without associated AE|1|||
124746246|NCT01393639|448693478|FG000|Overall Study|Lost to Follow-up|0|||
124746247|NCT01393639|448693479|FG001|Overall Study|Lost to Follow-up|1|||
124746248|NCT01393639|448693480|FG002|Overall Study|Lost to Follow-up|0|||
124746249|NCT01393639|448693481|FG003|Overall Study|Lost to Follow-up|0|||
124746250|NCT01393639|448693482|FG004|Overall Study|Lost to Follow-up|0|||
124746251|NCT01393639|448693483|FG005|Overall Study|Lost to Follow-up|0|||
124746252|NCT01393639|448693484|FG006|Overall Study|Lost to Follow-up|1|||
124746253|NCT01393639|448693478|FG000|Overall Study|Lack of Efficacy|0|||
124746254|NCT01393639|448693479|FG001|Overall Study|Lack of Efficacy|0|||
124746255|NCT01393639|448693480|FG002|Overall Study|Lack of Efficacy|0|||
124746256|NCT01393639|448693481|FG003|Overall Study|Lack of Efficacy|0|||
124746257|NCT01393639|448693482|FG004|Overall Study|Lack of Efficacy|0|||
124746258|NCT01393639|448693483|FG005|Overall Study|Lack of Efficacy|0|||
124746259|NCT01393639|448693484|FG006|Overall Study|Lack of Efficacy|1|||
124746260|NCT01393639|448693478|FG000|Overall Study|Adverse Event|2|||
124746261|NCT01393639|448693479|FG001|Overall Study|Adverse Event|3|||
124746262|NCT01393639|448693480|FG002|Overall Study|Adverse Event|1|||
124782256|NCT02910986|448832801|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
124746263|NCT01393639|448693481|FG003|Overall Study|Adverse Event|2|||
124746264|NCT01393639|448693482|FG004|Overall Study|Adverse Event|0|||
124746265|NCT01393639|448693483|FG005|Overall Study|Adverse Event|2|||
124746266|NCT01393639|448693484|FG006|Overall Study|Adverse Event|3|||
124746267|NCT00679172|448693485|FG000|Overall Study|Non-compliance|1|||
124746268|NCT00679172|448693486|FG001|Overall Study|Non-compliance|1|||
124746269|NCT00679172|448693487|FG002|Overall Study|Non-compliance|0|||
124746270|NCT00679172|448693488|FG003|Overall Study|Non-compliance|1|||
124746271|NCT00679172|448693489|FG004|Overall Study|Non-compliance|0|||
124746272|NCT00679172|448693485|FG000|Overall Study|Other not specified|0|||
124746273|NCT00679172|448693486|FG001|Overall Study|Other not specified|0|||
124746274|NCT00679172|448693487|FG002|Overall Study|Other not specified|1|||
124746275|NCT00679172|448693488|FG003|Overall Study|Other not specified|0|||
124746276|NCT00679172|448693489|FG004|Overall Study|Other not specified|0|||
124746277|NCT00793325|448693490|FG000|Overall Study|Protocol Violation|18|||
124746278|NCT00793325|448693490|FG000|Overall Study|Lost to Follow-up|1|||
124746279|NCT01815840|448693491|FG000|Overall Study|Missing|1|||
124746280|NCT01815840|448693492|FG001|Overall Study|Missing|0|||
124746281|NCT01815840|448693491|FG000|Overall Study|Withdrew Consent|31|||
124746282|NCT01815840|448693492|FG001|Overall Study|Withdrew Consent|30|||
124782257|NCT02910986|448832802|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
124746283|NCT01815840|448693491|FG000|Overall Study|Administrative/Other|1|||
124746284|NCT01815840|448693492|FG001|Overall Study|Administrative/Other|3|||
124746285|NCT01815840|448693491|FG000|Overall Study|Adverse Event|10|||
124746286|NCT01815840|448693492|FG001|Overall Study|Adverse Event|16|||
124746287|NCT01815840|448693491|FG000|Overall Study|Death|2|||
124746288|NCT01815840|448693492|FG001|Overall Study|Death|2|||
124746289|NCT01815840|448693491|FG000|Overall Study|Disease progression|3|||
124746290|NCT01815840|448693492|FG001|Overall Study|Disease progression|2|||
124746291|NCT01815840|448693491|FG000|Overall Study|Investigators Decision|2|||
124746292|NCT01815840|448693492|FG001|Overall Study|Investigators Decision|3|||
124746293|NCT01815840|448693491|FG000|Overall Study|Lost to Follow-up|3|||
124746294|NCT01815840|448693492|FG001|Overall Study|Lost to Follow-up|6|||
124746295|NCT01815840|448693491|FG000|Overall Study|Refused Treatment|5|||
124746296|NCT01815840|448693492|FG001|Overall Study|Refused Treatment|1|||
124746297|NCT01815840|448693491|FG000|Overall Study|Sponsor Termination Treatment|1|||
124746298|NCT01815840|448693492|FG001|Overall Study|Sponsor Termination Treatment|0|||
124746299|NCT03221842|448693494|FG000|Period 1 (Open-label)|Adverse Event|4|||
124746300|NCT03221842|448693495|FG001|Period 1 (Open-label)|Adverse Event|0|||
124746301|NCT03221842|448693494|FG000|Period 1 (Open-label)|Physician Decision|2|||
124746302|NCT03221842|448693495|FG001|Period 1 (Open-label)|Physician Decision|0|||
124746303|NCT03221842|448693494|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
124746304|NCT03221842|448693495|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
124746305|NCT03221842|448693494|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
124746306|NCT03221842|448693495|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
124746307|NCT03221842|448693494|FG000|Period 1 (Open-label)|Other|2|||
124746308|NCT03221842|448693495|FG001|Period 1 (Open-label)|Other|0|||
124746309|NCT03221842|448693494|FG000|Period 2 (Randomized, Blinded)|Death|0|||
124746310|NCT03221842|448693495|FG001|Period 2 (Randomized, Blinded)|Death|1|||
124746311|NCT03221842|448693494|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
124746312|NCT03221842|448693495|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
124746313|NCT00704288|448693496|FG000|Overall Treatment Period|Adverse Event|11|||
124746314|NCT00704288|448693497|FG001|Overall Treatment Period|Adverse Event|8|||
124746315|NCT00704288|448693498|FG002|Overall Treatment Period|Adverse Event|22|||
124746316|NCT00704288|448693496|FG000|Overall Treatment Period|Death|0|||
124746317|NCT00704288|448693497|FG001|Overall Treatment Period|Death|0|||
124746318|NCT00704288|448693498|FG002|Overall Treatment Period|Death|1|||
124746319|NCT00704288|448693496|FG000|Overall Treatment Period|Physician Decision|0|||
124746320|NCT00704288|448693497|FG001|Overall Treatment Period|Physician Decision|2|||
124746321|NCT00704288|448693498|FG002|Overall Treatment Period|Physician Decision|0|||
124746322|NCT00704288|448693496|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
124746323|NCT00704288|448693497|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
124746324|NCT00704288|448693498|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
124746325|NCT00704288|448693496|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
124746326|NCT00704288|448693497|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
124746327|NCT00704288|448693498|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
124746328|NCT00704288|448693496|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
124746329|NCT00704288|448693497|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
124746330|NCT00704288|448693498|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
124746331|NCT00704288|448693496|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
124746332|NCT00704288|448693497|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
124746333|NCT00704288|448693498|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
124746334|NCT00704288|448693496|FG000|Overall Treatment Period|Roll-over to another study|1|||
124746335|NCT00704288|448693497|FG001|Overall Treatment Period|Roll-over to another study|0|||
124746336|NCT00704288|448693498|FG002|Overall Treatment Period|Roll-over to another study|4|||
124746337|NCT00704288|448693496|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
124746338|NCT00704288|448693497|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
124746339|NCT00704288|448693498|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
124746340|NCT00704288|448693496|FG000|Extended Post Treatment Follow Up Period|Death|41|||
124746341|NCT00704288|448693497|FG001|Extended Post Treatment Follow Up Period|Death|50|||
124746342|NCT00704288|448693498|FG002|Extended Post Treatment Follow Up Period|Death|93|||
124746343|NCT00704288|448693496|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
124746344|NCT00704288|448693497|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
124746345|NCT00704288|448693498|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
124746346|NCT00704288|448693496|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
124746347|NCT00704288|448693497|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
124746348|NCT00704288|448693498|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
124746349|NCT00704288|448693496|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
124746350|NCT00704288|448693497|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
124746351|NCT00704288|448693498|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
124746352|NCT04395690|448693499|FG000|Overall Study|Lost to Follow-up|1|||
124746353|NCT04395690|448693500|FG001|Overall Study|Lost to Follow-up|1|||
124746354|NCT03387020|448693502|FG000|Overall Study|Adverse Event|0|||
124746355|NCT03387020|448693503|FG001|Overall Study|Adverse Event|2|||
124746356|NCT03387020|448693504|FG002|Overall Study|Adverse Event|0|||
124746357|NCT03387020|448693502|FG000|Overall Study|Withdrawal by Subject|2|||
124746358|NCT03387020|448693503|FG001|Overall Study|Withdrawal by Subject|0|||
124746359|NCT03387020|448693504|FG002|Overall Study|Withdrawal by Subject|0|||
124746360|NCT00434642|448693505|FG000|Blinded Treatment Phase|Adverse Event|12|||
124746361|NCT00434642|448693506|FG001|Blinded Treatment Phase|Adverse Event|58|||
124746362|NCT00434642|448693505|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
124746363|NCT00434642|448693506|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
124746364|NCT00434642|448693505|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
124746365|NCT00434642|448693506|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
124746366|NCT00434642|448693505|FG000|Blinded Treatment Phase|Physician Decision|19|||
124746367|NCT00434642|448693506|FG001|Blinded Treatment Phase|Physician Decision|27|||
124746368|NCT00434642|448693505|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
124746369|NCT00434642|448693506|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
124746370|NCT00434642|448693505|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
124746371|NCT00434642|448693506|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
124746372|NCT00434642|448693505|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
124746373|NCT00434642|448693506|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
124746374|NCT00434642|448693505|FG000|Open-label Treatment Phase|Adverse Event|0|||
124746375|NCT00434642|448693506|FG001|Open-label Treatment Phase|Adverse Event|5|||
124746376|NCT00434642|448693505|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
124746377|NCT00434642|448693506|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
124746378|NCT04512976|448693511|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
124746379|NCT04512976|448693512|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
124746380|NCT04512976|448693513|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
124746381|NCT04512976|448693514|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
124746382|NCT04512976|448693515|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
124746383|NCT04512976|448693516|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
124746384|NCT00527982|448693517|FG000|Overall Study|Physician Decision|1|||
124746385|NCT00527982|448693518|FG001|Overall Study|Physician Decision|0|||
124746386|NCT02241343|448693523|FG000|Overall Study|Adverse Event|1|||
124746387|NCT04541628|448693526|FG000|Overall Study|Study Terminated|1|||
124746388|NCT04541628|448693527|FG001|Overall Study|Study Terminated|1|||
124746389|NCT04541628|448693528|FG002|Overall Study|Study Terminated|1|||
124746390|NCT05011058|448693532|FG000|Overall Study|Sponsor Decision|2|||
124746391|NCT05011058|448693533|FG001|Overall Study|Sponsor Decision|0|||
124746392|NCT05011058|448693534|FG002|Overall Study|Sponsor Decision|14|||
124746393|NCT05011058|448693535|FG003|Overall Study|Sponsor Decision|0|||
124746394|NCT05011058|448693536|FG004|Overall Study|Sponsor Decision|0|||
124746395|NCT05011058|448693537|FG005|Overall Study|Sponsor Decision|1|||
124746396|NCT05011058|448693538|FG006|Overall Study|Sponsor Decision|0|||
124746397|NCT05011058|448693539|FG007|Overall Study|Sponsor Decision|5|||
124746398|NCT01192412|448693540|FG000|Overall Study|Lost to Follow-up|2|||
124746399|NCT01192412|448693541|FG001|Overall Study|Lost to Follow-up|1|||
124746400|NCT01192412|448693540|FG000|Overall Study|Withdrawal by Subject|2|||
124746401|NCT01192412|448693541|FG001|Overall Study|Withdrawal by Subject|1|||
124746402|NCT00308074|448693545|FG000|Overall Study|Withdrawal by Subject|1|||
124746403|NCT01329939|448693548|FG000|Overall Study|Lost to Follow-up|3|||
124746404|NCT01329939|448693549|FG001|Overall Study|Lost to Follow-up|0|||
124746405|NCT01329939|448693550|FG002|Overall Study|Lost to Follow-up|1|||
124746406|NCT01329939|448693551|FG003|Overall Study|Lost to Follow-up|2|||
124746407|NCT01329939|448693548|FG000|Overall Study|Withdrawal by Subject|0|||
124746408|NCT01329939|448693549|FG001|Overall Study|Withdrawal by Subject|1|||
124782258|NCT01068600|448832803|FG000|Overall Study|Withdrawal by Subject|5|||
124619195|NCT02924727|448221715|FG000|Overall Study|Withdrawal by Subject|2|||
124746409|NCT01329939|448693550|FG002|Overall Study|Withdrawal by Subject|0|||
124746410|NCT01329939|448693551|FG003|Overall Study|Withdrawal by Subject|0|||
124746411|NCT01329939|448693548|FG000|Overall Study|Adverse Event|0|||
124746412|NCT01329939|448693549|FG001|Overall Study|Adverse Event|0|||
124746413|NCT01329939|448693550|FG002|Overall Study|Adverse Event|0|||
124746414|NCT01329939|448693551|FG003|Overall Study|Adverse Event|3|||
124746415|NCT02942485|448693552|FG000|Overall Study|Lost to Follow-up|1|||
124746416|NCT02942485|448693553|FG001|Overall Study|Lost to Follow-up|0|||
124746417|NCT04369950|448693555|FG000|Overall Study|Protocol Violation|2|||
124746418|NCT04369950|448693556|FG001|Overall Study|Protocol Violation|2|||
124746419|NCT00989963|448693557|FG000|Overall Study|Adverse Event|1|||
124746420|NCT00989963|448693558|FG001|Overall Study|Adverse Event|1|||
124746421|NCT00989963|448693559|FG002|Overall Study|Adverse Event|1|||
124746422|NCT01240200|448693560|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
124746423|NCT01240200|448693561|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
124746424|NCT01529034|448693562|FG000|Overall Study|Discontinued prior to study treatment|14|||
124746425|NCT01529034|448693562|FG000|Overall Study|Site closure|62|||
124746426|NCT01529034|448693562|FG000|Overall Study|Study termination|29|||
124746427|NCT01529034|448693562|FG000|Overall Study|Withdrawal by Subject|25|||
124746428|NCT01529034|448693562|FG000|Overall Study|No treated SCs within protocol window|13|||
124746429|NCT01529034|448693562|FG000|Overall Study|Noncompliance|8|||
124746430|NCT01529034|448693562|FG000|Overall Study|Caregiver no longer available|7|||
124746431|NCT01529034|448693562|FG000|Overall Study|Adverse Event|4|||
124746432|NCT01529034|448693562|FG000|Overall Study|Protocol Violation|4|||
124746433|NCT01529034|448693562|FG000|Overall Study|Lack of Efficacy|4|||
124746434|NCT01529034|448693562|FG000|Overall Study|Investigator no longer available|2|||
124746435|NCT01529034|448693562|FG000|Overall Study|Study drug not available|2|||
124746436|NCT03194646|448693566|FG000|Overall Study|Adverse Event|24|||
124746437|NCT03194646|448693567|FG001|Overall Study|Adverse Event|25|||
124746438|NCT03194646|448693568|FG002|Overall Study|Adverse Event|14|||
124746439|NCT03194646|448693569|FG003|Overall Study|Adverse Event|17|||
124746440|NCT03194646|448693566|FG000|Overall Study|Lack of Efficacy|4|||
124746441|NCT03194646|448693567|FG001|Overall Study|Lack of Efficacy|2|||
124746442|NCT03194646|448693568|FG002|Overall Study|Lack of Efficacy|2|||
124746443|NCT03194646|448693569|FG003|Overall Study|Lack of Efficacy|12|||
124746444|NCT03194646|448693566|FG000|Overall Study|Lost to Follow-up|30|||
124746445|NCT03194646|448693567|FG001|Overall Study|Lost to Follow-up|22|||
124746446|NCT03194646|448693568|FG002|Overall Study|Lost to Follow-up|12|||
124746447|NCT03194646|448693569|FG003|Overall Study|Lost to Follow-up|35|||
124746448|NCT03194646|448693566|FG000|Overall Study|Non-compliance with study drug|4|||
124746449|NCT03194646|448693567|FG001|Overall Study|Non-compliance with study drug|0|||
124746450|NCT03194646|448693568|FG002|Overall Study|Non-compliance with study drug|1|||
124746451|NCT03194646|448693569|FG003|Overall Study|Non-compliance with study drug|1|||
124746452|NCT03194646|448693566|FG000|Overall Study|Other|89|||
124746453|NCT03194646|448693567|FG001|Overall Study|Other|68|||
124746454|NCT03194646|448693568|FG002|Overall Study|Other|34|||
124746455|NCT03194646|448693569|FG003|Overall Study|Other|31|||
124746456|NCT03194646|448693566|FG000|Overall Study|Physician Decision|7|||
124746457|NCT03194646|448693567|FG001|Overall Study|Physician Decision|9|||
124746458|NCT03194646|448693568|FG002|Overall Study|Physician Decision|5|||
124746459|NCT03194646|448693569|FG003|Overall Study|Physician Decision|4|||
124746460|NCT03194646|448693566|FG000|Overall Study|Pregnancy|4|||
124746461|NCT03194646|448693567|FG001|Overall Study|Pregnancy|5|||
124746462|NCT03194646|448693568|FG002|Overall Study|Pregnancy|1|||
124746463|NCT03194646|448693569|FG003|Overall Study|Pregnancy|2|||
124746464|NCT03194646|448693566|FG000|Overall Study|Protocol Violation|4|||
124746465|NCT03194646|448693567|FG001|Overall Study|Protocol Violation|2|||
124746466|NCT03194646|448693568|FG002|Overall Study|Protocol Violation|1|||
124746467|NCT03194646|448693569|FG003|Overall Study|Protocol Violation|1|||
124746468|NCT03194646|448693566|FG000|Overall Study|Site terminated by sponsor|0|||
124746469|NCT03194646|448693567|FG001|Overall Study|Site terminated by sponsor|0|||
124746470|NCT03194646|448693568|FG002|Overall Study|Site terminated by sponsor|2|||
124746471|NCT03194646|448693569|FG003|Overall Study|Site terminated by sponsor|0|||
124746472|NCT03194646|448693566|FG000|Overall Study|Study terminated by sponsor|62|||
124746473|NCT03194646|448693567|FG001|Overall Study|Study terminated by sponsor|61|||
124746474|NCT03194646|448693568|FG002|Overall Study|Study terminated by sponsor|30|||
124746475|NCT03194646|448693569|FG003|Overall Study|Study terminated by sponsor|34|||
124746476|NCT03194646|448693566|FG000|Overall Study|Withdrawal by Subject|75|||
124746477|NCT03194646|448693567|FG001|Overall Study|Withdrawal by Subject|74|||
124746478|NCT03194646|448693568|FG002|Overall Study|Withdrawal by Subject|36|||
124746479|NCT03194646|448693569|FG003|Overall Study|Withdrawal by Subject|131|||
124746480|NCT03194646|448693566|FG000|Overall Study|Missing|1|||
124746481|NCT03194646|448693567|FG001|Overall Study|Missing|0|||
124746482|NCT03194646|448693568|FG002|Overall Study|Missing|1|||
124746483|NCT03194646|448693569|FG003|Overall Study|Missing|12|||
124746484|NCT02649894|448693570|FG000|Overall Study|Adverse Event|1|||
124782259|NCT01068600|448832804|FG001|Overall Study|Withdrawal by Subject|6|||
124782260|NCT01068600|448832803|FG000|Overall Study|Adverse Event|3|||
124746485|NCT02649894|448693571|FG001|Overall Study|Adverse Event|0|||
124746486|NCT02649894|448693570|FG000|Overall Study|Physician Decision|0|||
124746487|NCT02649894|448693571|FG001|Overall Study|Physician Decision|1|||
124746488|NCT02649894|448693570|FG000|Overall Study|Withdrawal by Subject|5|||
124746489|NCT02649894|448693571|FG001|Overall Study|Withdrawal by Subject|2|||
124746490|NCT02649894|448693570|FG000|Overall Study|Lost to Follow-up|2|||
124746491|NCT02649894|448693571|FG001|Overall Study|Lost to Follow-up|1|||
124746492|NCT02649894|448693570|FG000|Overall Study|Death|30|||
124746493|NCT02649894|448693571|FG001|Overall Study|Death|7|||
124746494|NCT02649894|448693570|FG000|Overall Study|Other, not specified|6|||
124746495|NCT02649894|448693571|FG001|Overall Study|Other, not specified|0|||
124746496|NCT00719680|448693572|FG000|Overall Study|Adverse Event|1|||
124746497|NCT00719680|448693572|FG000|Overall Study|Lost to Follow-up|1|||
124746498|NCT00719680|448693572|FG000|Overall Study|Withdrawal by Subject|3|||
124746499|NCT02141360|448693573|FG000|Overall Study|Withdrawal by Subject|6|||
124746500|NCT02141360|448693574|FG001|Overall Study|Withdrawal by Subject|0|||
124746501|NCT02141360|448693575|FG002|Overall Study|Withdrawal by Subject|0|||
124637575|NCT00315458|448290595|FG000|Overall Study|Administrative|0|||
124637576|NCT00315458|448290596|FG001|Overall Study|Administrative|3|||
124637577|NCT00315458|448290597|FG002|Overall Study|Administrative|8|||
124637578|NCT00315458|448290598|FG003|Overall Study|Administrative|21|||
124637579|NCT00315458|448290595|FG000|Overall Study|Adverse Event|2|||
124637580|NCT00315458|448290596|FG001|Overall Study|Adverse Event|4|||
124637581|NCT00315458|448290597|FG002|Overall Study|Adverse Event|23|||
124637582|NCT00315458|448290598|FG003|Overall Study|Adverse Event|3|||
124637583|NCT00315458|448290595|FG000|Overall Study|Lost to Follow-up|1|||
124637584|NCT00315458|448290596|FG001|Overall Study|Lost to Follow-up|2|||
124637585|NCT00315458|448290597|FG002|Overall Study|Lost to Follow-up|0|||
124637586|NCT00315458|448290598|FG003|Overall Study|Lost to Follow-up|2|||
124637587|NCT00315458|448290595|FG000|Overall Study|Withdrawal by Subject|0|||
124637588|NCT00315458|448290596|FG001|Overall Study|Withdrawal by Subject|3|||
124637589|NCT00315458|448290597|FG002|Overall Study|Withdrawal by Subject|0|||
124637590|NCT00315458|448290598|FG003|Overall Study|Withdrawal by Subject|2|||
124637591|NCT00315458|448290595|FG000|Overall Study|Lack of Efficacy|0|||
124637592|NCT00315458|448290596|FG001|Overall Study|Lack of Efficacy|0|||
124637593|NCT00315458|448290597|FG002|Overall Study|Lack of Efficacy|20|||
124637594|NCT00315458|448290598|FG003|Overall Study|Lack of Efficacy|1|||
124637595|NCT00315458|448290595|FG000|Overall Study|Did not qualify|0|||
124637596|NCT00315458|448290596|FG001|Overall Study|Did not qualify|0|||
124637597|NCT00315458|448290597|FG002|Overall Study|Did not qualify|1|||
124637598|NCT00315458|448290598|FG003|Overall Study|Did not qualify|0|||
124637599|NCT00987337|448290599|FG000|Overall Study|Adverse Event|10|||
124637600|NCT00987337|448290600|FG001|Overall Study|Adverse Event|9|||
124637601|NCT00987337|448290601|FG002|Overall Study|Adverse Event|8|||
124637602|NCT00987337|448290599|FG000|Overall Study|Insufficient Virologic Response|10|||
124637603|NCT00987337|448290600|FG001|Overall Study|Insufficient Virologic Response|7|||
124637604|NCT00987337|448290601|FG002|Overall Study|Insufficient Virologic Response|12|||
124637605|NCT00987337|448290599|FG000|Overall Study|Virologic Breakthrough|2|||
124637606|NCT00987337|448290600|FG001|Overall Study|Virologic Breakthrough|2|||
124637607|NCT00987337|448290601|FG002|Overall Study|Virologic Breakthrough|8|||
124637608|NCT00987337|448290599|FG000|Overall Study|Lost to Follow-up|10|||
124637609|NCT00987337|448290600|FG001|Overall Study|Lost to Follow-up|6|||
124637610|NCT00987337|448290601|FG002|Overall Study|Lost to Follow-up|2|||
124637611|NCT00987337|448290599|FG000|Overall Study|Withdrawal by Subject|6|||
124637612|NCT00987337|448290600|FG001|Overall Study|Withdrawal by Subject|9|||
124637613|NCT00987337|448290601|FG002|Overall Study|Withdrawal by Subject|9|||
124637614|NCT00987337|448290599|FG000|Overall Study|Other|0|||
124637615|NCT00987337|448290600|FG001|Overall Study|Other|2|||
124637616|NCT00987337|448290601|FG002|Overall Study|Other|5|||
124637617|NCT00987337|448290599|FG000|Overall Study|Protocol Violation|1|||
124637618|NCT00987337|448290600|FG001|Overall Study|Protocol Violation|0|||
124637619|NCT00987337|448290601|FG002|Overall Study|Protocol Violation|2|||
124637620|NCT00987337|448290599|FG000|Overall Study|Participant Relapsed|18|||
124637621|NCT00987337|448290600|FG001|Overall Study|Participant Relapsed|20|||
124637622|NCT00987337|448290601|FG002|Overall Study|Participant Relapsed|5|||
124637623|NCT00086619|448290603|FG000|Overall Study|Withdrawal by Subject|6|||
124637624|NCT00086619|448290604|FG001|Overall Study|Withdrawal by Subject|6|||
124637625|NCT00086619|448290603|FG000|Overall Study|Adverse Event|8|||
124637626|NCT00086619|448290604|FG001|Overall Study|Adverse Event|10|||
124637627|NCT00086619|448290603|FG000|Overall Study|Protocol Violation|1|||
124637628|NCT00086619|448290604|FG001|Overall Study|Protocol Violation|1|||
124637629|NCT00489918|448290605|FG000|Overall Study|Withdrawal by Subject|2|||
124637630|NCT00489918|448290606|FG001|Overall Study|Withdrawal by Subject|1|||
124637631|NCT00489918|448290607|FG002|Overall Study|Withdrawal by Subject|1|||
124637632|NCT00489918|448290608|FG003|Overall Study|Withdrawal by Subject|0|||
124637633|NCT00489918|448290609|FG004|Overall Study|Withdrawal by Subject|1|||
124637634|NCT00489918|448290605|FG000|Overall Study|Adverse Event|0|||
124637635|NCT00489918|448290606|FG001|Overall Study|Adverse Event|1|||
124637636|NCT00489918|448290607|FG002|Overall Study|Adverse Event|1|||
124637637|NCT00489918|448290608|FG003|Overall Study|Adverse Event|0|||
124637638|NCT00489918|448290609|FG004|Overall Study|Adverse Event|0|||
124637639|NCT00489918|448290605|FG000|Overall Study|Lost to Follow-up|0|||
124637640|NCT00489918|448290606|FG001|Overall Study|Lost to Follow-up|0|||
124637641|NCT00489918|448290607|FG002|Overall Study|Lost to Follow-up|1|||
124637642|NCT00489918|448290608|FG003|Overall Study|Lost to Follow-up|1|||
124637643|NCT00489918|448290609|FG004|Overall Study|Lost to Follow-up|0|||
124637644|NCT00489918|448290605|FG000|Overall Study|Physician Decision|0|||
124637645|NCT00489918|448290606|FG001|Overall Study|Physician Decision|0|||
124637646|NCT00489918|448290607|FG002|Overall Study|Physician Decision|1|||
124637647|NCT00489918|448290608|FG003|Overall Study|Physician Decision|0|||
124637648|NCT00489918|448290609|FG004|Overall Study|Physician Decision|0|||
124637649|NCT03225105|448290611|FG000|Overall Study|Withdrawal by Subject|1|||
124637650|NCT03225105|448290612|FG001|Overall Study|Withdrawal by Subject|0|||
124746502|NCT02141360|448693573|FG000|Overall Study|Study Terminated before Visit|1|||
124746503|NCT02141360|448693574|FG001|Overall Study|Study Terminated before Visit|0|||
124746504|NCT02141360|448693575|FG002|Overall Study|Study Terminated before Visit|0|||
124746505|NCT04071158|448693576|FG000|Overall Study|Lost to Follow-up|1|||
124746506|NCT04071158|448693577|FG001|Overall Study|Lost to Follow-up|2|||
124746507|NCT04071158|448693578|FG002|Overall Study|Lost to Follow-up|3|||
124746508|NCT04071158|448693579|FG003|Overall Study|Lost to Follow-up|3|||
124746509|NCT04071158|448693580|FG004|Overall Study|Lost to Follow-up|5|||
124746510|NCT04071158|448693576|FG000|Overall Study|Randomized but not treated|2|||
124746511|NCT04071158|448693577|FG001|Overall Study|Randomized but not treated|2|||
124746512|NCT04071158|448693578|FG002|Overall Study|Randomized but not treated|0|||
124746513|NCT04071158|448693579|FG003|Overall Study|Randomized but not treated|0|||
124746514|NCT04071158|448693580|FG004|Overall Study|Randomized but not treated|0|||
124746515|NCT01178099|448693581|FG000|Overall Study|Physician Decision|0|||
124746516|NCT01178099|448693582|FG001|Overall Study|Physician Decision|1|||
124746517|NCT05198843|448693583|FG000|Overall Study|Lack of Efficacy|1|||
124746518|NCT04058886|448693596|FG000|Overall Study|Withdrawal by Subject|4|||
124746519|NCT04058886|448693596|FG000|Overall Study|Inadequate deafness interpreter service|1|||
124746520|NCT02220712|448693604|FG000|Overall Study|Adverse Event|1|||
124746521|NCT02220712|448693604|FG000|Overall Study|Withdrawal by Subject|2|||
124746522|NCT02220712|448693604|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
124746523|NCT00760838|448693606|FG000|Overall Study|Adverse Event|1|||
124746524|NCT00760838|448693607|FG001|Overall Study|Adverse Event|1|||
124746525|NCT00760838|448693606|FG000|Overall Study|Lack of Efficacy|1|||
124746526|NCT00760838|448693607|FG001|Overall Study|Lack of Efficacy|0|||
124746527|NCT00760838|448693606|FG000|Overall Study|Lost to Follow-up|2|||
124746528|NCT00760838|448693607|FG001|Overall Study|Lost to Follow-up|0|||
124746529|NCT00760838|448693606|FG000|Overall Study|Withdrawal by Subject|1|||
124746530|NCT00760838|448693607|FG001|Overall Study|Withdrawal by Subject|1|||
124746531|NCT03624127|448693608|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
124746532|NCT03624127|448693609|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
124746533|NCT03624127|448693610|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
124746534|NCT03624127|448693608|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
124746535|NCT03624127|448693609|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
124746536|NCT03624127|448693610|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
124746537|NCT03624127|448693608|FG000|Treatment Week 0 - Week 16|Death|0|||
124746538|NCT03624127|448693609|FG001|Treatment Week 0 - Week 16|Death|1|||
124746539|NCT03624127|448693610|FG002|Treatment Week 0 - Week 16|Death|0|||
124746540|NCT03624127|448693608|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
124746541|NCT03624127|448693609|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
124746542|NCT03624127|448693610|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
124746543|NCT03624127|448693608|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
124746544|NCT03624127|448693609|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
124746545|NCT03624127|448693610|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
124746546|NCT03624127|448693608|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
124746547|NCT03624127|448693609|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
124746548|NCT03624127|448693610|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
124746549|NCT03624127|448693608|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
124746550|NCT03624127|448693609|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
124746551|NCT03624127|448693610|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
124746552|NCT03624127|448693608|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
124746553|NCT03624127|448693609|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
124746554|NCT03624127|448693610|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
124746555|NCT03624127|448693608|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
124746556|NCT03624127|448693609|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
124746557|NCT03624127|448693610|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
124746558|NCT03624127|448693608|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
124746559|NCT03624127|448693609|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
124746560|NCT03624127|448693610|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
124746561|NCT03624127|448693608|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
124746562|NCT03624127|448693609|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
124746563|NCT03624127|448693610|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
124746564|NCT03624127|448693608|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
124746565|NCT03624127|448693609|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
124746566|NCT03624127|448693610|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
124746567|NCT03624127|448693608|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
124746568|NCT03624127|448693609|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
124746569|NCT03624127|448693610|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
124746570|NCT03624127|448693608|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
124746571|NCT03624127|448693609|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
124746572|NCT03624127|448693610|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
124746573|NCT03624127|448693608|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
124746574|NCT03624127|448693609|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
124746575|NCT03624127|448693610|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
124746576|NCT03624127|448693608|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
124746577|NCT03624127|448693609|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
124746578|NCT03624127|448693610|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
124746579|NCT03624127|448693608|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
124746580|NCT03624127|448693609|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
124746581|NCT03624127|448693610|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
124746582|NCT03624127|448693608|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
124746583|NCT03624127|448693609|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
124746584|NCT03624127|448693610|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
124746585|NCT03624127|448693608|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
124746586|NCT03624127|448693609|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
124746587|NCT03624127|448693610|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
124746588|NCT03624127|448693608|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
124746589|NCT03624127|448693609|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
124746590|NCT03624127|448693610|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
124746591|NCT03624127|448693608|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
124746592|NCT03624127|448693609|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
124746593|NCT03624127|448693610|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
124746594|NCT02999633|448693611|FG000|Overall Study|Adverse Event|2|||
124746595|NCT02999633|448693611|FG000|Overall Study|Progressive disease|12|||
124746596|NCT02607228|448693612|FG000|Overall Study|Progressive Disease|4|||
124746597|NCT02607228|448693613|FG001|Overall Study|Progressive Disease|3|||
124746598|NCT02607228|448693614|FG002|Overall Study|Progressive Disease|1|||
124746599|NCT02607228|448693615|FG003|Overall Study|Progressive Disease|5|||
124746600|NCT02607228|448693616|FG004|Overall Study|Progressive Disease|4|||
124746601|NCT02607228|448693617|FG005|Overall Study|Progressive Disease|3|||
124746602|NCT02607228|448693618|FG006|Overall Study|Progressive Disease|1|||
124746603|NCT02607228|448693612|FG000|Overall Study|Adverse Event|1|||
124746604|NCT02607228|448693613|FG001|Overall Study|Adverse Event|0|||
124746605|NCT02607228|448693614|FG002|Overall Study|Adverse Event|1|||
124746606|NCT02607228|448693615|FG003|Overall Study|Adverse Event|0|||
124746607|NCT02607228|448693616|FG004|Overall Study|Adverse Event|1|||
124746608|NCT02607228|448693617|FG005|Overall Study|Adverse Event|1|||
124746609|NCT02607228|448693618|FG006|Overall Study|Adverse Event|1|||
124746610|NCT02607228|448693612|FG000|Overall Study|Investigator's Discretion|0|||
124746611|NCT02607228|448693613|FG001|Overall Study|Investigator's Discretion|0|||
124746612|NCT02607228|448693614|FG002|Overall Study|Investigator's Discretion|1|||
124746613|NCT02607228|448693615|FG003|Overall Study|Investigator's Discretion|0|||
124746614|NCT02607228|448693616|FG004|Overall Study|Investigator's Discretion|0|||
124746615|NCT02607228|448693617|FG005|Overall Study|Investigator's Discretion|1|||
124746616|NCT02607228|448693618|FG006|Overall Study|Investigator's Discretion|0|||
124746617|NCT02607228|448693612|FG000|Overall Study|Withdrew Consent|0|||
124746618|NCT02607228|448693613|FG001|Overall Study|Withdrew Consent|1|||
124746619|NCT02607228|448693614|FG002|Overall Study|Withdrew Consent|0|||
124746620|NCT02607228|448693615|FG003|Overall Study|Withdrew Consent|0|||
124746621|NCT02607228|448693616|FG004|Overall Study|Withdrew Consent|0|||
124746622|NCT02607228|448693617|FG005|Overall Study|Withdrew Consent|1|||
124746623|NCT02607228|448693618|FG006|Overall Study|Withdrew Consent|0|||
124746624|NCT02607228|448693612|FG000|Overall Study|Study Terminated by Sponsor|0|||
124746625|NCT02607228|448693613|FG001|Overall Study|Study Terminated by Sponsor|0|||
124746626|NCT02607228|448693614|FG002|Overall Study|Study Terminated by Sponsor|0|||
124746627|NCT02607228|448693615|FG003|Overall Study|Study Terminated by Sponsor|1|||
124746628|NCT02607228|448693616|FG004|Overall Study|Study Terminated by Sponsor|0|||
124746629|NCT02607228|448693617|FG005|Overall Study|Study Terminated by Sponsor|0|||
124746630|NCT02607228|448693618|FG006|Overall Study|Study Terminated by Sponsor|0|||
124746631|NCT00788710|448693619|FG000|Overall Study|Adverse Event|1|||
124746632|NCT00788710|448693620|FG001|Overall Study|Adverse Event|3|||
124746633|NCT00788710|448693621|FG002|Overall Study|Adverse Event|4|||
124746634|NCT00788710|448693619|FG000|Overall Study|Lack of Efficacy|0|||
124746635|NCT00788710|448693620|FG001|Overall Study|Lack of Efficacy|0|||
124746636|NCT00788710|448693621|FG002|Overall Study|Lack of Efficacy|1|||
124746637|NCT00788710|448693619|FG000|Overall Study|Lost to Follow-up|0|||
124746638|NCT00788710|448693620|FG001|Overall Study|Lost to Follow-up|1|||
124746639|NCT00788710|448693621|FG002|Overall Study|Lost to Follow-up|0|||
124746640|NCT00788710|448693619|FG000|Overall Study|Physician Decision|2|||
124746641|NCT00788710|448693620|FG001|Overall Study|Physician Decision|1|||
124746642|NCT00788710|448693621|FG002|Overall Study|Physician Decision|0|||
124746643|NCT00788710|448693619|FG000|Overall Study|Protocol Violation|0|||
124746644|NCT00788710|448693620|FG001|Overall Study|Protocol Violation|1|||
124746645|NCT00788710|448693621|FG002|Overall Study|Protocol Violation|1|||
124746646|NCT00788710|448693619|FG000|Overall Study|Withdrawal by Subject|2|||
124746647|NCT00788710|448693620|FG001|Overall Study|Withdrawal by Subject|2|||
124746648|NCT00788710|448693621|FG002|Overall Study|Withdrawal by Subject|0|||
124746649|NCT00605345|448693626|FG000|Overall Study|Withdrawal by Subject|1|||
124619196|NCT02924727|448221716|FG001|Overall Study|Withdrawal by Subject|4|||
124746650|NCT00605345|448693627|FG001|Overall Study|Withdrawal by Subject|0|||
124746651|NCT00605345|448693626|FG000|Overall Study|Adverse Event|0|||
124746652|NCT00605345|448693627|FG001|Overall Study|Adverse Event|1|||
124746653|NCT00605345|448693626|FG000|Overall Study|Protocol Violation|0|||
124746654|NCT00605345|448693627|FG001|Overall Study|Protocol Violation|2|||
124746655|NCT02596945|448693630|FG000|Overall Study|No documentation of study drug dosing|3|||
124746656|NCT02596945|448693630|FG000|Overall Study|Other|32|||
124746657|NCT02596945|448693630|FG000|Overall Study|Change to hemodialysis|15|||
124746658|NCT02596945|448693630|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
124746659|NCT02596945|448693630|FG000|Overall Study|Withdrawal by Subject|1|||
124746660|NCT02596945|448693630|FG000|Overall Study|Missing|1|||
124746661|NCT00422383|448693631|FG000|Overall Study|Adverse Event|5|||
124746662|NCT00422383|448693632|FG001|Overall Study|Adverse Event|3|||
124746663|NCT00422383|448693633|FG002|Overall Study|Adverse Event|1|||
124746664|NCT00422383|448693634|FG003|Overall Study|Adverse Event|1|||
124746665|NCT00422383|448693635|FG004|Overall Study|Adverse Event|0|||
124746666|NCT00422383|448693631|FG000|Overall Study|Lack of Efficacy|4|||
124746667|NCT00422383|448693632|FG001|Overall Study|Lack of Efficacy|4|||
124746668|NCT00422383|448693633|FG002|Overall Study|Lack of Efficacy|2|||
124746669|NCT00422383|448693634|FG003|Overall Study|Lack of Efficacy|1|||
124746670|NCT00422383|448693635|FG004|Overall Study|Lack of Efficacy|1|||
124746671|NCT00422383|448693631|FG000|Overall Study|Lost to Follow-up|0|||
124746672|NCT00422383|448693632|FG001|Overall Study|Lost to Follow-up|1|||
124746673|NCT00422383|448693633|FG002|Overall Study|Lost to Follow-up|0|||
124746674|NCT00422383|448693634|FG003|Overall Study|Lost to Follow-up|0|||
124746675|NCT00422383|448693635|FG004|Overall Study|Lost to Follow-up|1|||
124746676|NCT00422383|448693631|FG000|Overall Study|Protocol Violation|1|||
124746677|NCT00422383|448693632|FG001|Overall Study|Protocol Violation|1|||
124746678|NCT00422383|448693633|FG002|Overall Study|Protocol Violation|1|||
124746679|NCT00422383|448693634|FG003|Overall Study|Protocol Violation|0|||
124746680|NCT00422383|448693635|FG004|Overall Study|Protocol Violation|0|||
124746681|NCT00422383|448693631|FG000|Overall Study|Withdrawal by Subject|5|||
124746682|NCT00422383|448693632|FG001|Overall Study|Withdrawal by Subject|5|||
124746683|NCT00422383|448693633|FG002|Overall Study|Withdrawal by Subject|0|||
124746684|NCT00422383|448693634|FG003|Overall Study|Withdrawal by Subject|0|||
124746685|NCT00422383|448693635|FG004|Overall Study|Withdrawal by Subject|1|||
124746686|NCT05066165|448695709|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
124746687|NCT05066165|448695710|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
124746688|NCT05066165|448695709|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
124746689|NCT05066165|448695710|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
124746690|NCT00742417|448695711|FG000|Randomized|Withdrawal by legal representative|0|||
124746691|NCT00742417|448695712|FG001|Randomized|Withdrawal by legal representative|1|||
124746692|NCT00742417|448695711|FG000|Randomized|Withdrawal by Subject|1|||
124746693|NCT00742417|448695712|FG001|Randomized|Withdrawal by Subject|0|||
124746694|NCT00742417|448695711|FG000|Randomized|Physician Decision|1|||
124746695|NCT00742417|448695712|FG001|Randomized|Physician Decision|0|||
124746696|NCT00742417|448695711|FG000|Intensive Period|Withdrawal by Subject|1|||
124746697|NCT00742417|448695712|FG001|Intensive Period|Withdrawal by Subject|1|||
124746698|NCT00742417|448695711|FG000|Intensive Period|Adverse Event|2|||
124746699|NCT00742417|448695712|FG001|Intensive Period|Adverse Event|0|||
124746700|NCT04566601|448695717|FG000|Overall Study|Other than listed|13|||
124746701|NCT04566601|448695718|FG001|Overall Study|Other than listed|4|||
124746702|NCT04566601|448695719|FG002|Overall Study|Other than listed|2|||
124746703|NCT04566601|448695720|FG003|Overall Study|Other than listed|1|||
124746704|NCT04566601|448695721|FG004|Overall Study|Other than listed|4|||
124746705|NCT04566601|448695717|FG000|Overall Study|Protocol deviation|3|||
124746706|NCT04566601|448695718|FG001|Overall Study|Protocol deviation|0|||
124746707|NCT04566601|448695719|FG002|Overall Study|Protocol deviation|1|||
124746708|NCT04566601|448695720|FG003|Overall Study|Protocol deviation|1|||
124746709|NCT04566601|448695721|FG004|Overall Study|Protocol deviation|1|||
124746710|NCT04566601|448695717|FG000|Overall Study|Technical problems|0|||
124746711|NCT04566601|448695718|FG001|Overall Study|Technical problems|0|||
124746712|NCT04566601|448695719|FG002|Overall Study|Technical problems|1|||
124746713|NCT04566601|448695720|FG003|Overall Study|Technical problems|0|||
124746714|NCT04566601|448695721|FG004|Overall Study|Technical problems|0|||
124746715|NCT04566601|448695717|FG000|Overall Study|No reason available|3|||
124746716|NCT04566601|448695718|FG001|Overall Study|No reason available|2|||
124746717|NCT04566601|448695719|FG002|Overall Study|No reason available|7|||
124746718|NCT04566601|448695720|FG003|Overall Study|No reason available|1|||
124746719|NCT04566601|448695721|FG004|Overall Study|No reason available|5|||
124746720|NCT04566601|448695717|FG000|Overall Study|Burden of study procedures|3|||
124746721|NCT04566601|448695718|FG001|Overall Study|Burden of study procedures|0|||
124746722|NCT04566601|448695719|FG002|Overall Study|Burden of study procedures|0|||
124746723|NCT04566601|448695720|FG003|Overall Study|Burden of study procedures|3|||
124746724|NCT04566601|448695721|FG004|Overall Study|Burden of study procedures|1|||
124746725|NCT04566601|448695717|FG000|Overall Study|Change of residence|2|||
124746726|NCT04566601|448695718|FG001|Overall Study|Change of residence|2|||
124746727|NCT04566601|448695719|FG002|Overall Study|Change of residence|0|||
124746728|NCT04566601|448695720|FG003|Overall Study|Change of residence|1|||
124746729|NCT04566601|448695721|FG004|Overall Study|Change of residence|2|||
124746730|NCT04566601|448695717|FG000|Overall Study|Perceived lack of efficacy|2|||
124746731|NCT04566601|448695718|FG001|Overall Study|Perceived lack of efficacy|0|||
124746732|NCT04566601|448695719|FG002|Overall Study|Perceived lack of efficacy|1|||
124746733|NCT04566601|448695720|FG003|Overall Study|Perceived lack of efficacy|1|||
124619197|NCT02924727|448221715|FG000|Overall Study|Lost to Follow-up|2|||
124619198|NCT02924727|448221716|FG001|Overall Study|Lost to Follow-up|5|||
124619199|NCT02924727|448221715|FG000|Overall Study|Death|221|||
124619200|NCT02924727|448221716|FG001|Overall Study|Death|247|||
124619201|NCT02924727|448221715|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
124619202|NCT02924727|448221716|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
124619203|NCT03052127|448221717|FG000|Overall Study|Withdrawal by Subject|0|||
124619204|NCT03052127|448221718|FG001|Overall Study|Withdrawal by Subject|0|||
124619205|NCT03052127|448221719|FG002|Overall Study|Withdrawal by Subject|0|||
124619206|NCT03052127|448221720|FG003|Overall Study|Withdrawal by Subject|0|||
124619207|NCT03052127|448221721|FG004|Overall Study|Withdrawal by Subject|0|||
124619208|NCT03052127|448221722|FG005|Overall Study|Withdrawal by Subject|0|||
124619209|NCT03052127|448221723|FG006|Overall Study|Withdrawal by Subject|0|||
124619210|NCT03052127|448221724|FG007|Overall Study|Withdrawal by Subject|1|||
124619211|NCT03052127|448221725|FG008|Overall Study|Withdrawal by Subject|1|||
124619212|NCT03052127|448221726|FG009|Overall Study|Withdrawal by Subject|1|||
124619213|NCT03052127|448221727|FG010|Overall Study|Withdrawal by Subject|0|||
124619214|NCT03052127|448221728|FG011|Overall Study|Withdrawal by Subject|0|||
124619215|NCT03052127|448221717|FG000|Overall Study|Discontinuation by Sponsor|0|||
124619216|NCT03052127|448221718|FG001|Overall Study|Discontinuation by Sponsor|0|||
124619217|NCT03052127|448221719|FG002|Overall Study|Discontinuation by Sponsor|0|||
124619218|NCT03052127|448221720|FG003|Overall Study|Discontinuation by Sponsor|0|||
124619219|NCT03052127|448221721|FG004|Overall Study|Discontinuation by Sponsor|0|||
124619220|NCT03052127|448221722|FG005|Overall Study|Discontinuation by Sponsor|0|||
124619221|NCT03052127|448221723|FG006|Overall Study|Discontinuation by Sponsor|0|||
124619222|NCT03052127|448221724|FG007|Overall Study|Discontinuation by Sponsor|0|||
124619223|NCT03052127|448221725|FG008|Overall Study|Discontinuation by Sponsor|4|||
124619224|NCT03052127|448221726|FG009|Overall Study|Discontinuation by Sponsor|2|||
124619225|NCT03052127|448221727|FG010|Overall Study|Discontinuation by Sponsor|5|||
124619226|NCT03052127|448221728|FG011|Overall Study|Discontinuation by Sponsor|13|||
124619227|NCT03052127|448221717|FG000|Overall Study|Inability to comply with trial requirements|0|||
124619228|NCT03052127|448221718|FG001|Overall Study|Inability to comply with trial requirements|0|||
124619229|NCT03052127|448221719|FG002|Overall Study|Inability to comply with trial requirements|1|||
124619230|NCT03052127|448221720|FG003|Overall Study|Inability to comply with trial requirements|0|||
124619231|NCT03052127|448221721|FG004|Overall Study|Inability to comply with trial requirements|0|||
124619232|NCT03052127|448221722|FG005|Overall Study|Inability to comply with trial requirements|0|||
124619233|NCT03052127|448221723|FG006|Overall Study|Inability to comply with trial requirements|0|||
124619234|NCT03052127|448221724|FG007|Overall Study|Inability to comply with trial requirements|0|||
124619235|NCT03052127|448221725|FG008|Overall Study|Inability to comply with trial requirements|0|||
124619236|NCT03052127|448221726|FG009|Overall Study|Inability to comply with trial requirements|0|||
124619237|NCT03052127|448221727|FG010|Overall Study|Inability to comply with trial requirements|0|||
124619238|NCT03052127|448221728|FG011|Overall Study|Inability to comply with trial requirements|0|||
124619239|NCT03052127|448221717|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
124619240|NCT03052127|448221718|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
124619241|NCT03052127|448221719|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
124619242|NCT03052127|448221720|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
124619243|NCT03052127|448221721|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
124619244|NCT03052127|448221722|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
124619245|NCT03052127|448221723|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
124619246|NCT03052127|448221724|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
124619247|NCT03052127|448221725|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
124619248|NCT03052127|448221726|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
124619249|NCT03052127|448221727|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
124619250|NCT03052127|448221728|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
124619251|NCT03694327|448221731|FG000|Overall Study|Lost to Follow-up|13|||
124619252|NCT03694327|448221732|FG001|Overall Study|Lost to Follow-up|23|||
124619253|NCT01982812|448221733|FG000|Overall Study|Death|1|||
124619254|NCT01982812|448221734|FG001|Overall Study|Death|5|||
124619255|NCT01982812|448221733|FG000|Overall Study|Adverse Event|0|||
124619256|NCT01982812|448221734|FG001|Overall Study|Adverse Event|5|||
124619257|NCT04784533|448221735|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
124746734|NCT04566601|448695721|FG004|Overall Study|Perceived lack of efficacy|2|||
124746735|NCT04566601|448695717|FG000|Overall Study|Adverse Event|7|||
124746736|NCT04566601|448695718|FG001|Overall Study|Adverse Event|4|||
124746737|NCT04566601|448695719|FG002|Overall Study|Adverse Event|6|||
124746738|NCT04566601|448695720|FG003|Overall Study|Adverse Event|5|||
124746739|NCT04566601|448695721|FG004|Overall Study|Adverse Event|12|||
124746740|NCT00372697|448695724|FG000|Overall Study|Protocol Violation|1|||
124746741|NCT00372697|448695725|FG001|Overall Study|Protocol Violation|1|||
124746742|NCT01055314|448695726|FG000|Overall Study|Adverse Event|7|||
124746743|NCT01055314|448695727|FG001|Overall Study|Adverse Event|4|||
124746744|NCT01055314|448695726|FG000|Overall Study|Death|2|||
124746745|NCT01055314|448695727|FG001|Overall Study|Death|1|||
124746746|NCT01055314|448695726|FG000|Overall Study|Lack of Efficacy|11|||
124746747|NCT01055314|448695727|FG001|Overall Study|Lack of Efficacy|19|||
124746748|NCT01055314|448695726|FG000|Overall Study|Physician Decision|10|||
124746749|NCT01055314|448695727|FG001|Overall Study|Physician Decision|5|||
124746750|NCT01055314|448695726|FG000|Overall Study|Withdrawal by Subject|1|||
124746751|NCT01055314|448695727|FG001|Overall Study|Withdrawal by Subject|0|||
124746752|NCT01055314|448695726|FG000|Overall Study|Ineligible|3|||
124746753|NCT01055314|448695727|FG001|Overall Study|Ineligible|5|||
124746754|NCT01055314|448695726|FG000|Overall Study|Refusal of further protocol therapy|10|||
124746755|NCT01055314|448695727|FG001|Overall Study|Refusal of further protocol therapy|4|||
124746756|NCT01055314|448695726|FG000|Overall Study|No treatment|1|||
124746757|NCT01055314|448695727|FG001|Overall Study|No treatment|0|||
124746758|NCT01279616|448695728|FG000|Overall Study|donor could not be located|5|||
124746759|NCT01279616|448695728|FG000|Overall Study|no signs of sickle cell disease|2|||
124746760|NCT02462720|448695729|FG000|Part 2|Withdrawal by Subject|1|||
124746761|NCT02462720|448695730|FG001|Part 2|Withdrawal by Subject|0|||
124746762|NCT02462720|448695729|FG000|Part 2|Protocol Violation|0|||
124746763|NCT02462720|448695730|FG001|Part 2|Protocol Violation|1|||
124746764|NCT00183625|448695733|FG000|Overall Study|Withdrawal by Subject|18|||
124746765|NCT00183625|448695734|FG001|Overall Study|Withdrawal by Subject|18|||
124746766|NCT00183625|448695735|FG002|Overall Study|Withdrawal by Subject|19|||
124746767|NCT00183625|448695736|FG003|Overall Study|Withdrawal by Subject|14|||
124746768|NCT05249569|448695739|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
124746769|NCT03722524|448695740|FG000|Overall Study|Protocol Violation|86|||
124746770|NCT03722524|448695740|FG000|Overall Study|Adverse Event|7|||
124746771|NCT03722524|448695740|FG000|Overall Study|Lost to Follow-up|1|||
124746772|NCT03722524|448695740|FG000|Overall Study|Reason is not stated|1|||
124746773|NCT03722524|448695740|FG000|Overall Study|Physician Decision|1|||
124746774|NCT03722524|448695740|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
124746775|NCT00646399|448695744|FG000|Overall Study|Death|63|||
124746776|NCT00646399|448695745|FG001|Overall Study|Death|53|||
124746777|NCT00646399|448695744|FG000|Overall Study|Withdrawal by Subject|9|||
124746778|NCT00646399|448695745|FG001|Overall Study|Withdrawal by Subject|10|||
124746779|NCT00646399|448695744|FG000|Overall Study|Other Reason|11|||
124746780|NCT00646399|448695745|FG001|Overall Study|Other Reason|11|||
124746781|NCT02473367|448695748|FG000|Wait 1|Withdrawal by Subject|1|||
124746782|NCT02473367|448695748|FG000|Period 4|Lost to Follow-up|1|||
124746783|NCT02678923|448695749|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
124746784|NCT02678923|448695750|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
124746785|NCT02678923|448695749|FG000|Overall Study|Withdrawal by Subject|3|||
124746786|NCT02678923|448695750|FG001|Overall Study|Withdrawal by Subject|2|||
124746787|NCT02678923|448695749|FG000|Overall Study|Lost to Follow-up|1|||
124746788|NCT02678923|448695750|FG001|Overall Study|Lost to Follow-up|0|||
124746789|NCT02678923|448695749|FG000|Overall Study|Did Not Return for Study Visits|1|||
124746790|NCT02678923|448695750|FG001|Overall Study|Did Not Return for Study Visits|0|||
124746791|NCT00455143|448695751|FG000|Overall Study|Physician Decision|1|||
124746792|NCT00455143|448695751|FG000|Overall Study|Withdrawal by Subject|1|||
124746793|NCT00455143|448695751|FG000|Overall Study|Staff was not avail to follow patient|2|||
124746794|NCT00455143|448695751|FG000|Overall Study|No longer met Inclusion Criteria|1|||
124746795|NCT00455143|448695751|FG000|Overall Study|Surgical time, staff not available|1|||
124746796|NCT01423916|448695754|FG000|Overall Study|Adverse Event|5|||
124746797|NCT01423916|448695755|FG001|Overall Study|Adverse Event|9|||
124619258|NCT04784533|448221736|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
124619259|NCT04784533|448221737|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
124746798|NCT01423916|448695756|FG002|Overall Study|Adverse Event|2|||
124746799|NCT01423916|448695754|FG000|Overall Study|Met Withdrawal Criteria|1|||
124746800|NCT01423916|448695755|FG001|Overall Study|Met Withdrawal Criteria|1|||
124746801|NCT01423916|448695756|FG002|Overall Study|Met Withdrawal Criteria|1|||
124746802|NCT01423916|448695754|FG000|Overall Study|Physician Decision|1|||
124746803|NCT01423916|448695755|FG001|Overall Study|Physician Decision|0|||
124746804|NCT01423916|448695756|FG002|Overall Study|Physician Decision|1|||
124746805|NCT01423916|448695754|FG000|Overall Study|Withdrawal by Subject|3|||
124619260|NCT04784533|448221738|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
124746806|NCT01423916|448695755|FG001|Overall Study|Withdrawal by Subject|10|||
124746807|NCT01423916|448695756|FG002|Overall Study|Withdrawal by Subject|3|||
124746808|NCT01423916|448695754|FG000|Overall Study|Protocol Deviation|1|||
124746809|NCT01423916|448695755|FG001|Overall Study|Protocol Deviation|0|||
124746810|NCT01423916|448695756|FG002|Overall Study|Protocol Deviation|0|||
124619261|NCT04784533|448221739|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
124619262|NCT04784533|448221740|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
124619263|NCT04784533|448221741|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
124619264|NCT04784533|448221742|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
124619265|NCT04784533|448221743|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
124619266|NCT04784533|448221744|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
124619267|NCT04784533|448221735|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
124619268|NCT04784533|448221736|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
124619269|NCT04784533|448221737|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
124619270|NCT04784533|448221738|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
124619271|NCT04784533|448221739|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
124619272|NCT04784533|448221740|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
124619273|NCT04784533|448221741|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
124619274|NCT04784533|448221742|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
124619275|NCT04784533|448221743|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
124619276|NCT04784533|448221744|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
124619277|NCT04784533|448221735|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
124619278|NCT04784533|448221736|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
124619279|NCT04784533|448221737|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
124619280|NCT04784533|448221738|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
124619281|NCT04784533|448221739|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
124619282|NCT04784533|448221740|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
124619283|NCT04784533|448221741|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
124619284|NCT04784533|448221742|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
124619285|NCT04784533|448221743|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
124619286|NCT04784533|448221744|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
124619287|NCT04784533|448221735|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
124619288|NCT04784533|448221736|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
124619289|NCT04784533|448221737|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
124619290|NCT04784533|448221738|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
124619291|NCT04784533|448221739|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
124619292|NCT04784533|448221740|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
124619293|NCT04784533|448221741|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
124619294|NCT04784533|448221742|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
124619295|NCT04784533|448221743|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
124619296|NCT04784533|448221744|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
124619297|NCT04784533|448221735|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
124619298|NCT04784533|448221736|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
124619299|NCT04784533|448221737|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
124619300|NCT04784533|448221738|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
124619301|NCT04784533|448221739|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
124619302|NCT04784533|448221740|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
124619303|NCT04784533|448221741|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
124619304|NCT04784533|448221742|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
124619305|NCT04784533|448221743|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
124619306|NCT04784533|448221744|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
124619307|NCT04784533|448221735|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
124619308|NCT04784533|448221736|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
124619309|NCT04784533|448221737|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
124619310|NCT04784533|448221738|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
124619311|NCT04784533|448221739|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
124619312|NCT04784533|448221740|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
124619313|NCT04784533|448221741|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
124619314|NCT04784533|448221742|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
124619315|NCT04784533|448221743|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
124619316|NCT04784533|448221744|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
124619317|NCT04784533|448221735|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
124619318|NCT04784533|448221736|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
124619319|NCT04784533|448221737|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
124619320|NCT04784533|448221738|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
124619321|NCT04784533|448221739|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
124619322|NCT04784533|448221740|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
124619323|NCT04784533|448221741|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
124746811|NCT01966445|448695761|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
124746812|NCT01966445|448695762|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
124746813|NCT01966445|448695763|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
124746814|NCT01966445|448695764|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
124746815|NCT01966445|448695765|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
124746816|NCT01966445|448695766|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
124746817|NCT01966445|448695767|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
124746818|NCT01966445|448695761|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
124746819|NCT01966445|448695762|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
124746820|NCT01966445|448695763|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
124746821|NCT01966445|448695764|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
124746822|NCT01966445|448695765|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
124746823|NCT01966445|448695766|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
124746824|NCT01966445|448695767|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
124746825|NCT01966445|448695761|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
124746826|NCT01966445|448695762|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
124746827|NCT01966445|448695763|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
124746828|NCT01966445|448695764|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
124746829|NCT01966445|448695765|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
124746830|NCT01966445|448695766|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
124746831|NCT01966445|448695767|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
124746832|NCT01966445|448695761|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
124746833|NCT01966445|448695762|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
124746834|NCT01966445|448695763|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
124746835|NCT01966445|448695764|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
124746836|NCT01966445|448695765|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
124746837|NCT01966445|448695766|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
124746838|NCT01966445|448695767|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
124746839|NCT01966445|448695761|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
124746840|NCT01966445|448695762|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
124746841|NCT01966445|448695763|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
124746842|NCT01966445|448695764|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
124746843|NCT01966445|448695765|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
124746844|NCT01966445|448695766|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
124746845|NCT01966445|448695767|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
124746846|NCT01374178|448695768|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
124746847|NCT01374178|448695769|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
124746848|NCT01374178|448695768|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
124746849|NCT01374178|448695769|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
124746850|NCT04856904|448695772|FG000|Overall Study|Physician Decision|1|||
124746851|NCT04856904|448695773|FG001|Overall Study|Physician Decision|1|||
124746852|NCT04856904|448695772|FG000|Overall Study|Withdrawal by Subject|13|||
124746853|NCT04856904|448695773|FG001|Overall Study|Withdrawal by Subject|13|||
124746854|NCT04856904|448695772|FG000|Overall Study|Adverse Event|1|||
124746855|NCT04856904|448695773|FG001|Overall Study|Adverse Event|1|||
124746856|NCT04856904|448695772|FG000|Overall Study|Non-compliance with study drug|1|||
124746857|NCT04856904|448695773|FG001|Overall Study|Non-compliance with study drug|1|||
124746858|NCT04856904|448695772|FG000|Overall Study|Lost to Follow-up|4|||
124746859|NCT04856904|448695773|FG001|Overall Study|Lost to Follow-up|4|||
124746860|NCT04856904|448695772|FG000|Overall Study|Withdrawal by Subject|1|||
124746861|NCT04856904|448695773|FG001|Overall Study|Withdrawal by Subject|1|||
124746862|NCT04856904|448695772|FG000|Overall Study|Protocol Violation|1|||
124746863|NCT04856904|448695773|FG001|Overall Study|Protocol Violation|1|||
124746864|NCT00902174|448695774|FG000|Overall Study|Adverse Event|27|||
124746865|NCT00902174|448695775|FG001|Overall Study|Adverse Event|7|||
124746866|NCT00902174|448695774|FG000|Overall Study|Lack of Efficacy|1|||
124746867|NCT00902174|448695775|FG001|Overall Study|Lack of Efficacy|5|||
124746868|NCT00902174|448695774|FG000|Overall Study|Death|2|||
124746869|NCT00902174|448695775|FG001|Overall Study|Death|2|||
124746870|NCT00902174|448695774|FG000|Overall Study|Withdrawal by Subject|2|||
124746871|NCT00902174|448695775|FG001|Overall Study|Withdrawal by Subject|1|||
124746872|NCT00902174|448695774|FG000|Overall Study|Abnormal labs|1|||
124746873|NCT00902174|448695775|FG001|Overall Study|Abnormal labs|1|||
124746874|NCT00902174|448695774|FG000|Overall Study|Protocol Violation|1|||
124746875|NCT00902174|448695775|FG001|Overall Study|Protocol Violation|1|||
124746876|NCT00902174|448695774|FG000|Overall Study|Administration problem|0|||
124746877|NCT00902174|448695775|FG001|Overall Study|Administration problem|1|||
124746878|NCT00077649|448695776|FG000|Overall Study|Adverse Event|5|||
124746879|NCT00077649|448695777|FG001|Overall Study|Adverse Event|1|||
124746880|NCT00077649|448695778|FG002|Overall Study|Adverse Event|7|||
124746881|NCT00077649|448695779|FG003|Overall Study|Adverse Event|9|||
124746882|NCT00077649|448695776|FG000|Overall Study|Lack of Efficacy|5|||
124746883|NCT00077649|448695777|FG001|Overall Study|Lack of Efficacy|3|||
124746884|NCT00077649|448695778|FG002|Overall Study|Lack of Efficacy|3|||
124746885|NCT00077649|448695779|FG003|Overall Study|Lack of Efficacy|2|||
124746886|NCT00077649|448695776|FG000|Overall Study|Withdrawal by Subject|0|||
124746887|NCT00077649|448695777|FG001|Overall Study|Withdrawal by Subject|1|||
124746888|NCT00077649|448695778|FG002|Overall Study|Withdrawal by Subject|1|||
124746889|NCT00077649|448695779|FG003|Overall Study|Withdrawal by Subject|2|||
124746890|NCT00077649|448695776|FG000|Overall Study|Lost to Follow-up|2|||
124746891|NCT00077649|448695777|FG001|Overall Study|Lost to Follow-up|2|||
124746892|NCT00077649|448695778|FG002|Overall Study|Lost to Follow-up|3|||
124746893|NCT00077649|448695779|FG003|Overall Study|Lost to Follow-up|2|||
124746894|NCT00077649|448695776|FG000|Overall Study|Abnormality of Laboratory Test|1|||
124746895|NCT00077649|448695777|FG001|Overall Study|Abnormality of Laboratory Test|2|||
124746896|NCT00077649|448695778|FG002|Overall Study|Abnormality of Laboratory Test|1|||
124746897|NCT00077649|448695779|FG003|Overall Study|Abnormality of Laboratory Test|2|||
124746898|NCT00077649|448695776|FG000|Overall Study|Randomized but never dosed|1|||
124746899|NCT00077649|448695777|FG001|Overall Study|Randomized but never dosed|0|||
124746900|NCT00077649|448695778|FG002|Overall Study|Randomized but never dosed|0|||
124746901|NCT00077649|448695779|FG003|Overall Study|Randomized but never dosed|0|||
124746902|NCT02895945|448695781|FG000|Overall Study|Physician Decision|2|||
124746903|NCT02895945|448695782|FG001|Overall Study|Physician Decision|1|||
124746904|NCT00454181|448695786|FG000|Overall Study|Adverse Event|1|||
124746905|NCT00454181|448695787|FG001|Overall Study|Adverse Event|1|||
124746906|NCT00454181|448695786|FG000|Overall Study|Lost to Follow-up|11|||
124746907|NCT00454181|448695787|FG001|Overall Study|Lost to Follow-up|1|||
124746908|NCT00454181|448695786|FG000|Overall Study|Protocol Violation|1|||
124746909|NCT00454181|448695787|FG001|Overall Study|Protocol Violation|1|||
124746910|NCT00454181|448695786|FG000|Overall Study|Withdrawal by Subject|2|||
124746911|NCT00454181|448695787|FG001|Overall Study|Withdrawal by Subject|0|||
124746912|NCT04032080|448695788|FG000|Overall Study|Death|6|||
124746913|NCT03689855|448695793|FG000|Overall Study|Adverse Event|3|||
124746914|NCT03689855|448695793|FG000|Overall Study|Withdrawal by Subject|1|||
124746915|NCT00764673|448695794|FG000|Overall Study|Death|1|||
124746916|NCT00764673|448695794|FG000|Overall Study|Lost to Follow-up|3|||
124746917|NCT00764673|448695794|FG000|Overall Study|Withdrawal by Subject|6|||
124746918|NCT00764673|448695794|FG000|Overall Study|Revision of Device|2|||
124746919|NCT01438177|448695795|FG000|Overall Study|Withdrawal by Subject|1|||
124746920|NCT01438177|448695795|FG000|Overall Study|Initiation of new therapy|1|||
124746921|NCT01727336|448695796|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
124746922|NCT01727336|448695797|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
124746923|NCT01727336|448695798|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
124746924|NCT01727336|448695799|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
124746925|NCT01727336|448695800|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
124746926|NCT01727336|448695801|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
124746927|NCT01727336|448695796|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
124746928|NCT01727336|448695797|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
124746929|NCT01727336|448695798|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
124746930|NCT01727336|448695799|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
124746931|NCT01727336|448695800|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
124746932|NCT01727336|448695801|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
124746933|NCT01727336|448695796|FG000|Part 2 Blinded|Death|0|||
124746934|NCT01727336|448695797|FG001|Part 2 Blinded|Death|0|||
124746935|NCT01727336|448695798|FG002|Part 2 Blinded|Death|0|||
124746936|NCT01727336|448695799|FG003|Part 2 Blinded|Death|0|||
124746937|NCT01727336|448695800|FG004|Part 2 Blinded|Death|20|||
124746938|NCT01727336|448695801|FG005|Part 2 Blinded|Death|16|||
124746939|NCT01727336|448695796|FG000|Part 2 Blinded|Lack of Efficacy|0|||
124782261|NCT01068600|448832804|FG001|Overall Study|Adverse Event|3|||
124619324|NCT04784533|448221742|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
124619325|NCT04784533|448221743|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
124619326|NCT04784533|448221744|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
124746940|NCT01727336|448695797|FG001|Part 2 Blinded|Lack of Efficacy|0|||
124746941|NCT01727336|448695798|FG002|Part 2 Blinded|Lack of Efficacy|0|||
124746942|NCT01727336|448695799|FG003|Part 2 Blinded|Lack of Efficacy|0|||
124746943|NCT01727336|448695800|FG004|Part 2 Blinded|Lack of Efficacy|42|||
124746944|NCT01727336|448695801|FG005|Part 2 Blinded|Lack of Efficacy|44|||
124746945|NCT01727336|448695796|FG000|Part 2 Blinded|Lost to Follow-up|0|||
124746946|NCT01727336|448695797|FG001|Part 2 Blinded|Lost to Follow-up|0|||
124746947|NCT01727336|448695798|FG002|Part 2 Blinded|Lost to Follow-up|0|||
124746948|NCT01727336|448695799|FG003|Part 2 Blinded|Lost to Follow-up|0|||
124746949|NCT01727336|448695800|FG004|Part 2 Blinded|Lost to Follow-up|0|||
124746950|NCT01727336|448695801|FG005|Part 2 Blinded|Lost to Follow-up|1|||
124746951|NCT01727336|448695796|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
124746952|NCT01727336|448695797|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
124782262|NCT01068600|448832803|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124746953|NCT01727336|448695798|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
124746954|NCT01727336|448695799|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
124746955|NCT01727336|448695800|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
124746956|NCT01727336|448695801|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
124746957|NCT01727336|448695796|FG000|Part 2 Blinded|use of prohibited medications|0|||
124746958|NCT01727336|448695797|FG001|Part 2 Blinded|use of prohibited medications|0|||
124746959|NCT01727336|448695798|FG002|Part 2 Blinded|use of prohibited medications|0|||
124746960|NCT01727336|448695799|FG003|Part 2 Blinded|use of prohibited medications|0|||
124746961|NCT01727336|448695800|FG004|Part 2 Blinded|use of prohibited medications|1|||
124746962|NCT01727336|448695801|FG005|Part 2 Blinded|use of prohibited medications|3|||
124746963|NCT00619099|448695804|FG000|Overall Study|Progressive Disease|7|||
124746964|NCT00619099|448695805|FG001|Overall Study|Progressive Disease|5|||
124746965|NCT00619099|448695804|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
124746966|NCT00619099|448695805|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
124746967|NCT00619099|448695804|FG000|Overall Study|Adverse Event|4|||
124746968|NCT00619099|448695805|FG001|Overall Study|Adverse Event|3|||
124746969|NCT00619099|448695804|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
124746970|NCT00619099|448695805|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
124746971|NCT00619099|448695804|FG000|Overall Study|Withdrawal by Subject|10|||
124746972|NCT00619099|448695805|FG001|Overall Study|Withdrawal by Subject|2|||
124746973|NCT00619099|448695804|FG000|Overall Study|Physician Decision|9|||
124746974|NCT00619099|448695805|FG001|Overall Study|Physician Decision|6|||
124746975|NCT00885482|448695806|FG000|Overall Study|Pregnancy|1|||
124746976|NCT00885482|448695806|FG000|Overall Study|Lack of Efficacy|1|||
124746977|NCT00885482|448695806|FG000|Overall Study|Death|1|||
124746978|NCT00885482|448695806|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
124746979|NCT00084656|448695807|FG000|Overall Study|Other reasons|0|||
124746980|NCT00084656|448695808|FG001|Overall Study|Other reasons|12|||
124746981|NCT00084656|448695809|FG002|Overall Study|Other reasons|11|||
124746982|NCT00084656|448695807|FG000|Overall Study|Withdrawal by Subject|15|||
124746983|NCT00084656|448695808|FG001|Overall Study|Withdrawal by Subject|4|||
124746984|NCT00084656|448695809|FG002|Overall Study|Withdrawal by Subject|4|||
124746985|NCT00084656|448695807|FG000|Overall Study|Disease relapse|0|||
124746986|NCT00084656|448695808|FG001|Overall Study|Disease relapse|9|||
124746987|NCT00084656|448695809|FG002|Overall Study|Disease relapse|10|||
124746988|NCT00084656|448695807|FG000|Overall Study|Disease progression|9|||
124746989|NCT00084656|448695808|FG001|Overall Study|Disease progression|0|||
124746990|NCT00084656|448695809|FG002|Overall Study|Disease progression|0|||
124746991|NCT00084656|448695807|FG000|Overall Study|Lost to Follow-up|1|||
124746992|NCT00084656|448695808|FG001|Overall Study|Lost to Follow-up|0|||
124746993|NCT00084656|448695809|FG002|Overall Study|Lost to Follow-up|1|||
124746994|NCT02772978|448695810|FG000|Overall Study|Withdrawal by Subject|1|||
124746995|NCT02772978|448695811|FG001|Overall Study|Withdrawal by Subject|1|||
124746996|NCT00129467|448695812|FG000|Received Intervention|Death|1|||
124746997|NCT00129467|448695813|FG001|Received Intervention|Death|1|||
124746998|NCT00129467|448695812|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
124746999|NCT00129467|448695813|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
124747000|NCT00129467|448695812|FG000|Received Intervention|Delirium|2|||
124747001|NCT00129467|448695813|FG001|Received Intervention|Delirium|0|||
124747002|NCT00129467|448695812|FG000|Received Intervention|Withdrawal by Subject|1|||
124747003|NCT00129467|448695813|FG001|Received Intervention|Withdrawal by Subject|0|||
124747004|NCT00129467|448695812|FG000|Received Intervention|Nausea|1|||
124747005|NCT00129467|448695813|FG001|Received Intervention|Nausea|0|||
124747006|NCT00129467|448695812|FG000|Received Intervention|Intolerance to citalopram|0|||
124747007|NCT00129467|448695813|FG001|Received Intervention|Intolerance to citalopram|1|||
124747008|NCT00129467|448695812|FG000|Received Intervention|Dizzyness, fatigue|0|||
124747009|NCT00129467|448695813|FG001|Received Intervention|Dizzyness, fatigue|1|||
124747010|NCT00129467|448695812|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
124747011|NCT00129467|448695813|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
124782263|NCT01068600|448832804|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124782264|NCT01068600|448832803|FG000|Overall Study|Lost to Follow-up|1|||
124782265|NCT01068600|448832804|FG001|Overall Study|Lost to Follow-up|2|||
124782266|NCT01068600|448832803|FG000|Overall Study|Protocol deviation|1|||
124782267|NCT01068600|448832804|FG001|Overall Study|Protocol deviation|1|||
124782268|NCT01068600|448832803|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124782269|NCT01068600|448832804|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
124747012|NCT00129467|448695812|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
124747013|NCT00129467|448695813|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
124747014|NCT01532869|448695814|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
124747015|NCT01532869|448695815|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
124747016|NCT01532869|448695814|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
124747017|NCT01532869|448695815|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
124747018|NCT01532869|448695814|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
124747019|NCT01532869|448695815|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
124782270|NCT01068600|448832803|FG000|Overall Study|Administrative problems|0|||
124747020|NCT01532869|448695814|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
124747021|NCT01532869|448695815|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
124747022|NCT01532869|448695814|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
124747023|NCT01532869|448695815|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
124747024|NCT01532869|448695814|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
124747025|NCT01532869|448695815|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
124747026|NCT01532869|448695814|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
124747027|NCT01532869|448695815|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
124747028|NCT01532869|448695814|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
124747029|NCT01532869|448695815|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
124747030|NCT01532869|448695814|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
124747031|NCT01532869|448695815|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
124747032|NCT01532869|448695814|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
124747033|NCT01532869|448695815|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
124747034|NCT01532869|448695814|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
124747035|NCT01532869|448695815|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
124747036|NCT01532869|448695814|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
124747037|NCT01532869|448695815|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
124747038|NCT01532869|448695814|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
124747039|NCT01532869|448695815|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
124747040|NCT01532869|448695814|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
124747041|NCT01532869|448695815|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
124747042|NCT01532869|448695814|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
124747043|NCT01532869|448695815|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
124747044|NCT01532869|448695814|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
124747045|NCT01532869|448695815|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
124747046|NCT01532869|448695814|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
124747047|NCT01532869|448695815|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
124747048|NCT01331291|448695816|FG000|Overall Study|Lack of Efficacy|2|||
124747049|NCT01331291|448695817|FG001|Overall Study|Lack of Efficacy|8|||
124747050|NCT01331291|448695816|FG000|Overall Study|Death|0|||
124747051|NCT01331291|448695817|FG001|Overall Study|Death|1|||
124747052|NCT01026220|448695818|FG000|Induction|Death|1|||
124747053|NCT01026220|448695819|FG001|Induction|Death|0|||
124747054|NCT01026220|448695820|FG002|Induction|Death|0|||
124747055|NCT01026220|448695818|FG000|Induction|Lack of Efficacy|2|||
124747056|NCT01026220|448695819|FG001|Induction|Lack of Efficacy|0|||
124747057|NCT01026220|448695820|FG002|Induction|Lack of Efficacy|0|||
124747058|NCT01026220|448695818|FG000|Induction|Physician Decision|12|||
124747059|NCT01026220|448695819|FG001|Induction|Physician Decision|0|||
124747060|NCT01026220|448695820|FG002|Induction|Physician Decision|0|||
124747061|NCT01026220|448695818|FG000|Induction|Withdrawal by Subject|9|||
124747062|NCT01026220|448695819|FG001|Induction|Withdrawal by Subject|0|||
124747063|NCT01026220|448695820|FG002|Induction|Withdrawal by Subject|0|||
124747064|NCT01026220|448695818|FG000|Induction|Ineligible|1|||
124747065|NCT01026220|448695819|FG001|Induction|Ineligible|0|||
124747066|NCT01026220|448695820|FG002|Induction|Ineligible|0|||
124747067|NCT01026220|448695818|FG000|Consolidation Maintenance|Death|0|||
124747068|NCT01026220|448695819|FG001|Consolidation Maintenance|Death|1|||
124747069|NCT01026220|448695820|FG002|Consolidation Maintenance|Death|0|||
124747070|NCT01026220|448695818|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
124747071|NCT01026220|448695819|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
124747072|NCT01026220|448695820|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
124747073|NCT01026220|448695818|FG000|Consolidation Maintenance|Physician Decision|0|||
124747074|NCT01026220|448695819|FG001|Consolidation Maintenance|Physician Decision|2|||
124747075|NCT01026220|448695820|FG002|Consolidation Maintenance|Physician Decision|7|||
124747076|NCT01026220|448695818|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
124747077|NCT01026220|448695819|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
124747078|NCT01026220|448695820|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
124747079|NCT00409344|448695822|FG000|Overall Study|no enrollment|0|||
124747080|NCT00409344|448695823|FG001|Overall Study|no enrollment|0|||
124747081|NCT01389323|448695824|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
124747082|NCT01389323|448695824|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
124747083|NCT01389323|448695824|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
124747084|NCT01389323|448695824|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
124747085|NCT01389323|448695824|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
124747086|NCT01389323|448695824|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
124747087|NCT01389323|448695824|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
124747088|NCT01389323|448695824|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
124747089|NCT01389323|448695824|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
124747090|NCT01389323|448695824|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
124747091|NCT01389323|448695824|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
124747092|NCT01424228|448695825|FG000|Overall Study|Withdrawal by Subject|27|||
124747093|NCT01424228|448695826|FG001|Overall Study|Withdrawal by Subject|11|||
124747094|NCT01424228|448695825|FG000|Overall Study|Adverse Event|10|||
124747095|NCT01424228|448695826|FG001|Overall Study|Adverse Event|14|||
124747096|NCT01424228|448695825|FG000|Overall Study|Sponsor's decision|9|||
124747097|NCT01424228|448695826|FG001|Overall Study|Sponsor's decision|12|||
124747098|NCT01424228|448695825|FG000|Overall Study|Lack of Efficacy|5|||
124747099|NCT01424228|448695826|FG001|Overall Study|Lack of Efficacy|7|||
124747100|NCT01424228|448695825|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
124747101|NCT01424228|448695826|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
124747102|NCT01424228|448695825|FG000|Overall Study|Non-compliance|2|||
124747103|NCT01424228|448695826|FG001|Overall Study|Non-compliance|0|||
124747104|NCT01424228|448695825|FG000|Overall Study|Worsening of symptoms|1|||
124747105|NCT01424228|448695826|FG001|Overall Study|Worsening of symptoms|0|||
124747106|NCT01424228|448695825|FG000|Overall Study|Unplanned journey|0|||
124747107|NCT01424228|448695826|FG001|Overall Study|Unplanned journey|1|||
124747108|NCT00844558|448695827|FG000|Overall Study|Withdrawal by Subject|9|||
124747109|NCT00844558|448695828|FG001|Overall Study|Withdrawal by Subject|2|||
124747110|NCT00844558|448695827|FG000|Overall Study|Death|1|||
124747111|NCT00844558|448695828|FG001|Overall Study|Death|0|||
124747112|NCT00844558|448695827|FG000|Overall Study|Protocol Violation|1|||
124747113|NCT00844558|448695828|FG001|Overall Study|Protocol Violation|1|||
124747114|NCT00844558|448695827|FG000|Overall Study|Lost to Follow-up|0|||
124747115|NCT00844558|448695828|FG001|Overall Study|Lost to Follow-up|1|||
124747116|NCT00844558|448695827|FG000|Overall Study|Physician Decision|1|||
124747117|NCT00844558|448695828|FG001|Overall Study|Physician Decision|0|||
124747118|NCT01894022|448695830|FG000|Overall Study|Death|1|||
124747119|NCT01894022|448695831|FG001|Overall Study|Death|0|||
124747120|NCT01894022|448695830|FG000|Overall Study|Adverse Event, non-fatal|1|||
124747121|NCT01894022|448695831|FG001|Overall Study|Adverse Event, non-fatal|0|||
124747122|NCT01894022|448695830|FG000|Overall Study|Study Closed/terminated|7|||
124747123|NCT01894022|448695831|FG001|Overall Study|Study Closed/terminated|10|||
124747124|NCT04496453|448695833|FG000|Overall Study|Lost to Follow-up|6|||
124747125|NCT00410605|448695834|FG000|Overall Study|Adverse Event|12|||
124747126|NCT00410605|448695834|FG000|Overall Study|Physician Decision|3|||
124747127|NCT00410605|448695834|FG000|Overall Study|Withdrawal by Subject|5|||
124747128|NCT00410605|448695834|FG000|Overall Study|Started Non-Protocol Therapy|3|||
124747129|NCT00410605|448695834|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
124747130|NCT00410605|448695834|FG000|Overall Study|Transferred to another Institution|1|||
124747131|NCT03235089|448695844|FG000|Overall Study|Lost to Follow-up|1|||
124747132|NCT03235089|448695845|FG001|Overall Study|Lost to Follow-up|1|||
124747133|NCT03235089|448695844|FG000|Overall Study|Physician Decision|2|||
124747134|NCT03235089|448695845|FG001|Overall Study|Physician Decision|2|||
124747135|NCT03238924|448695846|FG000|Overall Study|Withdrawal by Subject|2|||
124747136|NCT03238924|448695847|FG001|Overall Study|Withdrawal by Subject|2|||
124747137|NCT03576716|448695848|FG000|Overall Study|Withdrawal by Subject|0|||
124747138|NCT03576716|448695849|FG001|Overall Study|Withdrawal by Subject|1|||
124747139|NCT04356040|448695850|FG000|Overall Study|Death|2|||
124747140|NCT04356040|448695851|FG001|Overall Study|Death|0|||
124747141|NCT04356040|448695850|FG000|Overall Study|Lost to Follow-up|1|||
124747142|NCT04356040|448695851|FG001|Overall Study|Lost to Follow-up|0|||
124747143|NCT04356040|448695850|FG000|Overall Study|Physician Decision|0|||
124747144|NCT04356040|448695851|FG001|Overall Study|Physician Decision|1|||
124747145|NCT04356040|448695850|FG000|Overall Study|Withdrawal by Subject|13|||
124747146|NCT04356040|448695851|FG001|Overall Study|Withdrawal by Subject|1|||
124747147|NCT04356040|448695850|FG000|Overall Study|Enrollment Pause|10|||
124747148|NCT04356040|448695851|FG001|Overall Study|Enrollment Pause|0|||
124747149|NCT04356040|448695850|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
124747150|NCT04356040|448695851|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
124619327|NCT04784533|448221735|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
124747151|NCT04356040|448695850|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
124747152|NCT04356040|448695851|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
124747153|NCT04356040|448695850|FG000|Overall Study|PI left institution|3|||
124747154|NCT04356040|448695851|FG001|Overall Study|PI left institution|0|||
124747155|NCT03688620|448695852|FG000|Overall Study|Other|0|||
124747156|NCT03688620|448695853|FG001|Overall Study|Other|0|||
124747157|NCT03688620|448695854|FG002|Overall Study|Other|1|||
124747158|NCT03688620|448695852|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
124619328|NCT04784533|448221736|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
124747159|NCT03688620|448695853|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
124747160|NCT03688620|448695854|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
124747161|NCT03688620|448695852|FG000|Overall Study|Lost to Follow-up|16|||
124747162|NCT03688620|448695853|FG001|Overall Study|Lost to Follow-up|0|||
124747163|NCT03688620|448695854|FG002|Overall Study|Lost to Follow-up|1|||
124747164|NCT03688620|448695852|FG000|Overall Study|Withdrawal by Subject|0|||
124747165|NCT03688620|448695853|FG001|Overall Study|Withdrawal by Subject|0|||
124747166|NCT03688620|448695854|FG002|Overall Study|Withdrawal by Subject|6|||
124747167|NCT01008904|448695855|FG000|Overall Study|Lost to Follow-up|1|||
124747168|NCT01008904|448695855|FG000|Overall Study|Adverse Event|2|||
124747169|NCT01008904|448695855|FG000|Overall Study|unexpected unrelated surgery|1|||
124747170|NCT00781859|448695856|FG000|Overall Study|Adverse Event|2|||
124747171|NCT00781859|448695857|FG001|Overall Study|Adverse Event|2|||
124747172|NCT00781859|448695856|FG000|Overall Study|Withdrawal by Subject|8|||
124747173|NCT00781859|448695857|FG001|Overall Study|Withdrawal by Subject|4|||
124747174|NCT00781859|448695856|FG000|Overall Study|Lost to Follow-up|6|||
124747175|NCT00781859|448695857|FG001|Overall Study|Lost to Follow-up|3|||
124747176|NCT00781859|448695856|FG000|Overall Study|Death|3|||
124747177|NCT00781859|448695857|FG001|Overall Study|Death|0|||
124747178|NCT01717326|448695858|FG000|Overall Study|Death|0|||
124747179|NCT01717326|448695859|FG001|Overall Study|Death|0|||
124747180|NCT01717326|448695860|FG002|Overall Study|Death|0|||
124747181|NCT01717326|448695861|FG003|Overall Study|Death|0|||
124747182|NCT01717326|448695862|FG004|Overall Study|Death|0|||
124747183|NCT01717326|448695863|FG005|Overall Study|Death|0|||
124747184|NCT01717326|448695864|FG006|Overall Study|Death|0|||
124747185|NCT01717326|448695865|FG007|Overall Study|Death|0|||
124747186|NCT01717326|448695866|FG008|Overall Study|Death|0|||
124747187|NCT01717326|448695867|FG009|Overall Study|Death|0|||
124747188|NCT01717326|448695868|FG010|Overall Study|Death|1|||
124747189|NCT01717326|448695869|FG011|Overall Study|Death|0|||
124747190|NCT01717326|448695870|FG012|Overall Study|Death|0|||
124747191|NCT01717326|448695871|FG013|Overall Study|Death|0|||
124747192|NCT01717326|448695872|FG014|Overall Study|Death|0|||
124747193|NCT01717326|448695873|FG015|Overall Study|Death|0|||
124747194|NCT01717326|448695874|FG016|Overall Study|Death|0|||
124747195|NCT01717326|448695875|FG017|Overall Study|Death|0|||
124747196|NCT01717326|448695876|FG018|Overall Study|Death|0|||
124747197|NCT01717326|448695877|FG019|Overall Study|Death|0|||
124747198|NCT01717326|448695858|FG000|Overall Study|Lost to Follow-up|3|||
124747199|NCT01717326|448695859|FG001|Overall Study|Lost to Follow-up|0|||
124747200|NCT01717326|448695860|FG002|Overall Study|Lost to Follow-up|0|||
124747201|NCT01717326|448695861|FG003|Overall Study|Lost to Follow-up|2|||
124747202|NCT01717326|448695862|FG004|Overall Study|Lost to Follow-up|1|||
124747203|NCT01717326|448695863|FG005|Overall Study|Lost to Follow-up|0|||
124747204|NCT01717326|448695864|FG006|Overall Study|Lost to Follow-up|1|||
124747205|NCT01717326|448695865|FG007|Overall Study|Lost to Follow-up|0|||
124747206|NCT01717326|448695866|FG008|Overall Study|Lost to Follow-up|0|||
124747207|NCT01717326|448695867|FG009|Overall Study|Lost to Follow-up|0|||
124747208|NCT01717326|448695868|FG010|Overall Study|Lost to Follow-up|1|||
124747209|NCT01717326|448695869|FG011|Overall Study|Lost to Follow-up|0|||
124747210|NCT01717326|448695870|FG012|Overall Study|Lost to Follow-up|0|||
124747211|NCT01717326|448695871|FG013|Overall Study|Lost to Follow-up|0|||
124747212|NCT01717326|448695872|FG014|Overall Study|Lost to Follow-up|0|||
124747213|NCT01717326|448695873|FG015|Overall Study|Lost to Follow-up|2|||
124747214|NCT01717326|448695874|FG016|Overall Study|Lost to Follow-up|1|||
124747215|NCT01717326|448695875|FG017|Overall Study|Lost to Follow-up|0|||
124747216|NCT01717326|448695876|FG018|Overall Study|Lost to Follow-up|2|||
124747217|NCT01717326|448695877|FG019|Overall Study|Lost to Follow-up|3|||
124747218|NCT01717326|448695858|FG000|Overall Study|Physician Decision|0|||
124747219|NCT01717326|448695859|FG001|Overall Study|Physician Decision|0|||
124747220|NCT01717326|448695860|FG002|Overall Study|Physician Decision|0|||
124747221|NCT01717326|448695861|FG003|Overall Study|Physician Decision|0|||
124747222|NCT01717326|448695862|FG004|Overall Study|Physician Decision|0|||
124782271|NCT01068600|448832804|FG001|Overall Study|Administrative problems|1|||
124619329|NCT04784533|448221737|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
124747223|NCT01717326|448695863|FG005|Overall Study|Physician Decision|0|||
124747224|NCT01717326|448695864|FG006|Overall Study|Physician Decision|0|||
124747225|NCT01717326|448695865|FG007|Overall Study|Physician Decision|0|||
124747226|NCT01717326|448695866|FG008|Overall Study|Physician Decision|0|||
124747227|NCT01717326|448695867|FG009|Overall Study|Physician Decision|1|||
124782272|NCT01727024|448832805|FG000|Period 1|Lost to Follow-up|1|||
124747228|NCT01717326|448695868|FG010|Overall Study|Physician Decision|0|||
124747229|NCT01717326|448695869|FG011|Overall Study|Physician Decision|0|||
124747230|NCT01717326|448695870|FG012|Overall Study|Physician Decision|0|||
124747231|NCT01717326|448695871|FG013|Overall Study|Physician Decision|0|||
124747232|NCT01717326|448695872|FG014|Overall Study|Physician Decision|0|||
124747233|NCT01717326|448695873|FG015|Overall Study|Physician Decision|0|||
124747234|NCT01717326|448695874|FG016|Overall Study|Physician Decision|0|||
124747235|NCT01717326|448695875|FG017|Overall Study|Physician Decision|0|||
124747236|NCT01717326|448695876|FG018|Overall Study|Physician Decision|0|||
124747237|NCT01717326|448695877|FG019|Overall Study|Physician Decision|0|||
124747238|NCT01717326|448695858|FG000|Overall Study|Protocol Violation|0|||
124747239|NCT01717326|448695859|FG001|Overall Study|Protocol Violation|0|||
124747240|NCT01717326|448695860|FG002|Overall Study|Protocol Violation|0|||
124747241|NCT01717326|448695861|FG003|Overall Study|Protocol Violation|0|||
124747242|NCT01717326|448695862|FG004|Overall Study|Protocol Violation|1|||
124747243|NCT01717326|448695863|FG005|Overall Study|Protocol Violation|0|||
124747244|NCT01717326|448695864|FG006|Overall Study|Protocol Violation|0|||
124747245|NCT01717326|448695865|FG007|Overall Study|Protocol Violation|0|||
124747246|NCT01717326|448695866|FG008|Overall Study|Protocol Violation|0|||
124747247|NCT01717326|448695867|FG009|Overall Study|Protocol Violation|0|||
124747248|NCT01717326|448695868|FG010|Overall Study|Protocol Violation|0|||
124747249|NCT01717326|448695869|FG011|Overall Study|Protocol Violation|0|||
124747250|NCT01717326|448695870|FG012|Overall Study|Protocol Violation|0|||
124747251|NCT01717326|448695871|FG013|Overall Study|Protocol Violation|0|||
124747252|NCT01717326|448695872|FG014|Overall Study|Protocol Violation|0|||
124747253|NCT01717326|448695873|FG015|Overall Study|Protocol Violation|0|||
124747254|NCT01717326|448695874|FG016|Overall Study|Protocol Violation|0|||
124747255|NCT01717326|448695875|FG017|Overall Study|Protocol Violation|0|||
124747256|NCT01717326|448695876|FG018|Overall Study|Protocol Violation|0|||
124747257|NCT01717326|448695877|FG019|Overall Study|Protocol Violation|0|||
124747258|NCT01717326|448695858|FG000|Overall Study|Withdrawal by Subject|0|||
124747259|NCT01717326|448695859|FG001|Overall Study|Withdrawal by Subject|1|||
124747260|NCT01717326|448695860|FG002|Overall Study|Withdrawal by Subject|0|||
124747261|NCT01717326|448695861|FG003|Overall Study|Withdrawal by Subject|0|||
124747262|NCT01717326|448695862|FG004|Overall Study|Withdrawal by Subject|0|||
124747263|NCT01717326|448695863|FG005|Overall Study|Withdrawal by Subject|0|||
124747264|NCT01717326|448695864|FG006|Overall Study|Withdrawal by Subject|0|||
124747265|NCT01717326|448695865|FG007|Overall Study|Withdrawal by Subject|0|||
124747266|NCT01717326|448695866|FG008|Overall Study|Withdrawal by Subject|0|||
124747267|NCT01717326|448695867|FG009|Overall Study|Withdrawal by Subject|1|||
124747268|NCT01717326|448695868|FG010|Overall Study|Withdrawal by Subject|0|||
124747269|NCT01717326|448695869|FG011|Overall Study|Withdrawal by Subject|0|||
124747270|NCT01717326|448695870|FG012|Overall Study|Withdrawal by Subject|1|||
124747271|NCT01717326|448695871|FG013|Overall Study|Withdrawal by Subject|0|||
124747272|NCT01717326|448695872|FG014|Overall Study|Withdrawal by Subject|0|||
124747273|NCT01717326|448695873|FG015|Overall Study|Withdrawal by Subject|1|||
124747274|NCT01717326|448695874|FG016|Overall Study|Withdrawal by Subject|0|||
124747275|NCT01717326|448695875|FG017|Overall Study|Withdrawal by Subject|0|||
124747276|NCT01717326|448695876|FG018|Overall Study|Withdrawal by Subject|2|||
124747277|NCT01717326|448695877|FG019|Overall Study|Withdrawal by Subject|3|||
124747278|NCT03738618|448697691|FG000|Overall Study|Protocol deviation|23|||
124747279|NCT03738618|448697692|FG001|Overall Study|Protocol deviation|0|||
124747280|NCT03738618|448697691|FG000|Overall Study|Adverse Event|4|||
124747281|NCT03738618|448697692|FG001|Overall Study|Adverse Event|0|||
124747282|NCT03738618|448697691|FG000|Overall Study|Lost to Follow-up|2|||
124747283|NCT03738618|448697692|FG001|Overall Study|Lost to Follow-up|0|||
124747284|NCT03738618|448697691|FG000|Overall Study|Randomization failure|1|||
124747285|NCT03738618|448697692|FG001|Overall Study|Randomization failure|0|||
124747286|NCT03738618|448697691|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
124747287|NCT03738618|448697692|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
124747288|NCT03738618|448697691|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
124747289|NCT03738618|448697692|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
124747290|NCT00649428|448697693|FG000|Overall Study|Adverse Event|2|||
124747291|NCT00649428|448697694|FG001|Overall Study|Adverse Event|2|||
124747292|NCT00649428|448697693|FG000|Overall Study|Withdrawal by Subject|6|||
124747293|NCT00649428|448697694|FG001|Overall Study|Withdrawal by Subject|6|||
124747294|NCT00649428|448697693|FG000|Overall Study|Lost to Follow-up|1|||
124747295|NCT00649428|448697694|FG001|Overall Study|Lost to Follow-up|3|||
124619330|NCT04784533|448221738|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
124747296|NCT00649428|448697693|FG000|Overall Study|Insufficient manufacturing yield|5|||
124782273|NCT01727024|448832806|FG001|Period 1|Lost to Follow-up|1|||
124619331|NCT04784533|448221739|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
124747297|NCT00649428|448697694|FG001|Overall Study|Insufficient manufacturing yield|1|||
124747298|NCT00649428|448697693|FG000|Overall Study|Protocol Violation|6|||
124747299|NCT00649428|448697694|FG001|Overall Study|Protocol Violation|2|||
124747300|NCT00649428|448697693|FG000|Overall Study|Physician Decision|0|||
124747301|NCT00649428|448697694|FG001|Overall Study|Physician Decision|1|||
124747302|NCT01450098|448697695|FG000|Period 3|Protocol Violation|0|||
124747303|NCT01450098|448697696|FG001|Period 3|Protocol Violation|1|||
124747304|NCT01450098|448697695|FG000|Period 3|Withdrawal by Subject|0|||
124747305|NCT01450098|448697696|FG001|Period 3|Withdrawal by Subject|2|||
124782274|NCT01727024|448832805|FG000|Period 1|Withdrawal by Subject|2|||
124619332|NCT04784533|448221740|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
124747306|NCT01272635|448697699|FG000|Overall Study|Lost to Follow-up|31|||
124747307|NCT01272635|448697700|FG001|Overall Study|Lost to Follow-up|20|||
124747308|NCT01272635|448697701|FG002|Overall Study|Lost to Follow-up|31|||
124747309|NCT01272635|448697702|FG003|Overall Study|Lost to Follow-up|23|||
124747310|NCT01832155|448697703|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
124747311|NCT01832155|448697704|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
124747312|NCT01832155|448697703|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
124782275|NCT01727024|448832806|FG001|Period 1|Withdrawal by Subject|3|||
124782276|NCT02167139|448832807|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
124619333|NCT04784533|448221741|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
124747313|NCT01832155|448697704|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
124747314|NCT02409719|448697712|FG000|Overall Study|Lost to Follow-up|3|||
124747315|NCT02409719|448697713|FG001|Overall Study|Lost to Follow-up|3|||
124747316|NCT02479139|448697714|FG000|Overall Study|Lost to Follow-up|2|||
124747317|NCT02479139|448697715|FG001|Overall Study|Lost to Follow-up|4|||
124747318|NCT02479139|448697716|FG002|Overall Study|Lost to Follow-up|4|||
124747319|NCT02479139|448697717|FG003|Overall Study|Lost to Follow-up|2|||
124747320|NCT02479139|448697718|FG004|Overall Study|Lost to Follow-up|3|||
124747321|NCT02479139|448697719|FG005|Overall Study|Lost to Follow-up|5|||
124747322|NCT02479139|448697714|FG000|Overall Study|Withdrew Consent|5|||
124747323|NCT02479139|448697715|FG001|Overall Study|Withdrew Consent|6|||
124747324|NCT02479139|448697716|FG002|Overall Study|Withdrew Consent|1|||
124747325|NCT02479139|448697717|FG003|Overall Study|Withdrew Consent|4|||
124747326|NCT02479139|448697718|FG004|Overall Study|Withdrew Consent|1|||
124747327|NCT02479139|448697719|FG005|Overall Study|Withdrew Consent|1|||
124747328|NCT02479139|448697714|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
124747329|NCT02479139|448697715|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
124747330|NCT02479139|448697716|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
124747331|NCT02479139|448697717|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
124747332|NCT02479139|448697718|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
124747333|NCT02479139|448697719|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
124747334|NCT02479139|448697714|FG000|Overall Study|Other Miscellaneous Reasons|1|||
124747335|NCT02479139|448697715|FG001|Overall Study|Other Miscellaneous Reasons|0|||
124747336|NCT02479139|448697716|FG002|Overall Study|Other Miscellaneous Reasons|1|||
124747337|NCT02479139|448697717|FG003|Overall Study|Other Miscellaneous Reasons|1|||
124747338|NCT02479139|448697718|FG004|Overall Study|Other Miscellaneous Reasons|1|||
124619334|NCT04784533|448221742|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
124619335|NCT04784533|448221743|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
124619336|NCT04784533|448221744|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
124619337|NCT04784533|448221735|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
124619338|NCT04784533|448221736|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
124747339|NCT02479139|448697719|FG005|Overall Study|Other Miscellaneous Reasons|0|||
124747340|NCT00778895|448697720|FG000|Active Phase|Adverse Event|3|||
124747341|NCT00778895|448697721|FG001|Active Phase|Adverse Event|1|||
124747342|NCT00778895|448697722|FG002|Active Phase|Adverse Event|0|||
124747343|NCT00778895|448697720|FG000|Active Phase|Withdrawal by Subject|1|||
124747344|NCT00778895|448697721|FG001|Active Phase|Withdrawal by Subject|4|||
124747345|NCT00778895|448697722|FG002|Active Phase|Withdrawal by Subject|0|||
124747346|NCT00778895|448697720|FG000|Active Phase|Lost to Follow-up|1|||
124747347|NCT00778895|448697721|FG001|Active Phase|Lost to Follow-up|1|||
124747348|NCT00778895|448697722|FG002|Active Phase|Lost to Follow-up|0|||
124747349|NCT00778895|448697720|FG000|Active Phase|Other|2|||
124747350|NCT00778895|448697721|FG001|Active Phase|Other|0|||
124619339|NCT04784533|448221737|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
124619340|NCT04784533|448221738|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
124619341|NCT04784533|448221739|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
124619342|NCT04784533|448221740|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
124619343|NCT04784533|448221741|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
124619344|NCT04784533|448221742|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
124619345|NCT04784533|448221743|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
124619346|NCT04784533|448221744|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
124619347|NCT00307437|448221745|FG000|Controlled Period|Adverse Event|7|||
124619348|NCT00307437|448221746|FG001|Controlled Period|Adverse Event|2|||
124619349|NCT00307437|448221747|FG002|Controlled Period|Adverse Event|5|||
124619350|NCT00307437|448221748|FG003|Controlled Period|Adverse Event|0|||
124747351|NCT00778895|448697722|FG002|Active Phase|Other|0|||
124747352|NCT00778895|448697720|FG000|ESFU Phase|Adverse Event|2|||
124747353|NCT00778895|448697721|FG001|ESFU Phase|Adverse Event|1|||
124747354|NCT00778895|448697722|FG002|ESFU Phase|Adverse Event|0|||
124747355|NCT00778895|448697720|FG000|ESFU Phase|Withdrawal by Subject|1|||
124747356|NCT00778895|448697721|FG001|ESFU Phase|Withdrawal by Subject|4|||
124747357|NCT00778895|448697722|FG002|ESFU Phase|Withdrawal by Subject|0|||
124747358|NCT00778895|448697720|FG000|ESFU Phase|Lost to Follow-up|6|||
124747359|NCT00778895|448697721|FG001|ESFU Phase|Lost to Follow-up|7|||
124747360|NCT00778895|448697722|FG002|ESFU Phase|Lost to Follow-up|2|||
124747361|NCT00778895|448697720|FG000|ESFU Phase|Other|2|||
124747362|NCT00778895|448697721|FG001|ESFU Phase|Other|0|||
124747363|NCT00778895|448697722|FG002|ESFU Phase|Other|0|||
124747364|NCT02540993|448697723|FG000|Overall Study|Lost to Follow-up|5|||
124747365|NCT02540993|448697724|FG001|Overall Study|Lost to Follow-up|3|||
124747366|NCT02540993|448697723|FG000|Overall Study|Withdrawal by Subject|4|||
124747367|NCT02540993|448697724|FG001|Overall Study|Withdrawal by Subject|6|||
124747368|NCT02540993|448697723|FG000|Overall Study|GCP violations|33|||
124747369|NCT02540993|448697724|FG001|Overall Study|GCP violations|27|||
124747370|NCT03550404|448697725|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
124747371|NCT03550404|448697726|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
124747372|NCT03550404|448697727|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
124747373|NCT03550404|448697725|FG000|Phase 2|Vacated position|1|||
124747374|NCT03550404|448697726|FG001|Phase 2|Vacated position|0|||
124747375|NCT03550404|448697727|FG002|Phase 2|Vacated position|0|||
124747376|NCT01009086|448697729|FG000|Overall Study|Lack of Efficacy|16|||
124747377|NCT01009086|448697730|FG001|Overall Study|Lack of Efficacy|15|||
124747378|NCT01009086|448697731|FG002|Overall Study|Lack of Efficacy|9|||
124747379|NCT01009086|448697729|FG000|Overall Study|Lost to Follow-up|4|||
124747380|NCT01009086|448697730|FG001|Overall Study|Lost to Follow-up|5|||
124747381|NCT01009086|448697731|FG002|Overall Study|Lost to Follow-up|3|||
124747382|NCT01009086|448697729|FG000|Overall Study|Adverse Event|12|||
124747383|NCT01009086|448697730|FG001|Overall Study|Adverse Event|11|||
124747384|NCT01009086|448697731|FG002|Overall Study|Adverse Event|8|||
124747385|NCT01009086|448697729|FG000|Overall Study|Withdrawal by Subject|9|||
124747386|NCT01009086|448697730|FG001|Overall Study|Withdrawal by Subject|11|||
124747387|NCT01009086|448697731|FG002|Overall Study|Withdrawal by Subject|13|||
124747388|NCT01009086|448697729|FG000|Overall Study|Other|3|||
124747389|NCT01009086|448697730|FG001|Overall Study|Other|5|||
124747390|NCT01009086|448697731|FG002|Overall Study|Other|1|||
124619351|NCT00307437|448221749|FG004|Controlled Period|Adverse Event|0|||
124619352|NCT00307437|448221750|FG005|Controlled Period|Adverse Event|0|||
124747391|NCT05096312|448697732|FG000|Overall Study|Lost to Follow-up|2|||
124747392|NCT05096312|448697733|FG001|Overall Study|Lost to Follow-up|4|||
124747393|NCT05096312|448697732|FG000|Overall Study|Adverse Event|1|||
124747394|NCT05096312|448697733|FG001|Overall Study|Adverse Event|0|||
124747395|NCT03135210|448697734|FG000|Overall Study|Death|0|||
124747396|NCT03135210|448697735|FG001|Overall Study|Death|1|||
124747397|NCT00820222|448697738|FG000|Overall Study|Lost to Follow-up|10|||
124747398|NCT00820222|448697739|FG001|Overall Study|Lost to Follow-up|9|||
124747399|NCT00820222|448697738|FG000|Overall Study|Withdrawal by Subject|19|||
124747400|NCT00820222|448697739|FG001|Overall Study|Withdrawal by Subject|21|||
124747401|NCT00820222|448697738|FG000|Overall Study|Physician Decision|93|||
124747402|NCT00820222|448697739|FG001|Overall Study|Physician Decision|88|||
124747403|NCT00820222|448697738|FG000|Overall Study|Sponsor Terminated Study|43|||
124747404|NCT00820222|448697739|FG001|Overall Study|Sponsor Terminated Study|65|||
124747405|NCT00820222|448697738|FG000|Overall Study|Unkown|11|||
124747406|NCT00820222|448697739|FG001|Overall Study|Unkown|7|||
124747407|NCT00590577|448697740|FG000|Overall Study|Lack of Efficacy|31|||
124747408|NCT00590577|448697741|FG001|Overall Study|Lack of Efficacy|28|||
124747409|NCT00590577|448697742|FG002|Overall Study|Lack of Efficacy|23|||
124747410|NCT00590577|448697743|FG003|Overall Study|Lack of Efficacy|45|||
124747411|NCT00590577|448697740|FG000|Overall Study|Withdrawal by Subject|23|||
124747412|NCT00590577|448697741|FG001|Overall Study|Withdrawal by Subject|28|||
124747413|NCT00590577|448697742|FG002|Overall Study|Withdrawal by Subject|30|||
124747414|NCT00590577|448697743|FG003|Overall Study|Withdrawal by Subject|26|||
124747415|NCT00590577|448697740|FG000|Overall Study|Adverse Event|10|||
124747416|NCT00590577|448697741|FG001|Overall Study|Adverse Event|10|||
124747417|NCT00590577|448697742|FG002|Overall Study|Adverse Event|13|||
124747418|NCT00590577|448697743|FG003|Overall Study|Adverse Event|11|||
124747419|NCT00590577|448697740|FG000|Overall Study|Lost to Follow-up|12|||
124747420|NCT00590577|448697741|FG001|Overall Study|Lost to Follow-up|6|||
124747421|NCT00590577|448697742|FG002|Overall Study|Lost to Follow-up|6|||
124747422|NCT00590577|448697743|FG003|Overall Study|Lost to Follow-up|9|||
124747423|NCT00590577|448697740|FG000|Overall Study|Pregnancy|0|||
124747424|NCT00590577|448697741|FG001|Overall Study|Pregnancy|1|||
124747425|NCT00590577|448697742|FG002|Overall Study|Pregnancy|0|||
124747426|NCT00590577|448697743|FG003|Overall Study|Pregnancy|0|||
124747427|NCT00590577|448697740|FG000|Overall Study|Various reasons|1|||
124747428|NCT00590577|448697741|FG001|Overall Study|Various reasons|3|||
124747429|NCT00590577|448697742|FG002|Overall Study|Various reasons|1|||
124747430|NCT00590577|448697743|FG003|Overall Study|Various reasons|2|||
124747431|NCT01229449|448697744|FG000|Overall Study|Withdrawal by Subject|0|||
124747432|NCT01229449|448697745|FG001|Overall Study|Withdrawal by Subject|3|||
124747433|NCT01229449|448697746|FG002|Overall Study|Withdrawal by Subject|0|||
124747434|NCT01229449|448697747|FG003|Overall Study|Withdrawal by Subject|1|||
124782277|NCT02167139|448832808|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
124619353|NCT00307437|448221751|FG006|Controlled Period|Adverse Event|0|||
124747435|NCT01229449|448697748|FG004|Overall Study|Withdrawal by Subject|1|||
124747436|NCT01229449|448697744|FG000|Overall Study|Lost to Follow-up|1|||
124747437|NCT01229449|448697745|FG001|Overall Study|Lost to Follow-up|1|||
124747438|NCT01229449|448697746|FG002|Overall Study|Lost to Follow-up|1|||
124747439|NCT01229449|448697747|FG003|Overall Study|Lost to Follow-up|0|||
124747440|NCT01229449|448697748|FG004|Overall Study|Lost to Follow-up|0|||
124747441|NCT01229449|448697744|FG000|Overall Study|Physician Decision|0|||
124747442|NCT01229449|448697745|FG001|Overall Study|Physician Decision|0|||
124747443|NCT01229449|448697746|FG002|Overall Study|Physician Decision|1|||
124747444|NCT01229449|448697747|FG003|Overall Study|Physician Decision|0|||
124747445|NCT01229449|448697748|FG004|Overall Study|Physician Decision|0|||
124747446|NCT05392803|448697761|FG000|Overall Study|Lost to Follow-up|0|||
124747447|NCT05392803|448697762|FG001|Overall Study|Lost to Follow-up|2|||
124747448|NCT00699335|448697765|FG000|Overall Study|Combination of multiple reasons|176|||
124747449|NCT00699335|448697765|FG000|Overall Study|Missing data|52|||
124747450|NCT01887353|448697766|FG000|Overall Study|Study stopped early|4|||
124747451|NCT01887353|448697767|FG001|Overall Study|Study stopped early|3|||
124747452|NCT03262441|448697768|FG000|Overall Study|Withdrawal by Subject|1|||
124747453|NCT01545050|448697769|FG000|Overall Study|Lack of Efficacy|0|||
124747454|NCT01545050|448697770|FG001|Overall Study|Lack of Efficacy|0|||
124747455|NCT01545050|448697771|FG002|Overall Study|Lack of Efficacy|0|||
124747456|NCT01545050|448697772|FG003|Overall Study|Lack of Efficacy|3|||
124747457|NCT01545050|448697773|FG004|Overall Study|Lack of Efficacy|2|||
124782278|NCT02167139|448832809|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
124782279|NCT02167139|448832810|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
124782280|NCT02167139|448832807|FG000|Randomised, Double-blind|Adverse Event|2|||
124782281|NCT02167139|448832808|FG001|Randomised, Double-blind|Adverse Event|9|||
124782282|NCT02167139|448832809|FG002|Randomised, Double-blind|Adverse Event|0|||
124782283|NCT02167139|448832810|FG003|Randomised, Double-blind|Adverse Event|0|||
124782284|NCT02167139|448832807|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
124782285|NCT02167139|448832808|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
124782286|NCT02167139|448832809|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
124782287|NCT02167139|448832810|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
124782288|NCT02167139|448832807|FG000|Randomised, Double-blind|Other|3|||
124782289|NCT02167139|448832808|FG001|Randomised, Double-blind|Other|0|||
124782290|NCT02167139|448832809|FG002|Randomised, Double-blind|Other|0|||
124782291|NCT02167139|448832810|FG003|Randomised, Double-blind|Other|0|||
124782292|NCT02167139|448832807|FG000|Transition-extension|Adverse Event|2|||
124782293|NCT02167139|448832808|FG001|Transition-extension|Adverse Event|0|||
124782294|NCT02167139|448832809|FG002|Transition-extension|Adverse Event|2|||
124782295|NCT02167139|448832810|FG003|Transition-extension|Adverse Event|3|||
124782296|NCT02167139|448832807|FG000|Transition-extension|Withdrawal by Subject|2|||
124782297|NCT02167139|448832808|FG001|Transition-extension|Withdrawal by Subject|0|||
124782298|NCT02167139|448832809|FG002|Transition-extension|Withdrawal by Subject|4|||
124782299|NCT02167139|448832810|FG003|Transition-extension|Withdrawal by Subject|1|||
124782300|NCT02167139|448832807|FG000|Transition-extension|Lack of Efficacy|0|||
124782301|NCT02167139|448832808|FG001|Transition-extension|Lack of Efficacy|0|||
124782302|NCT02167139|448832809|FG002|Transition-extension|Lack of Efficacy|1|||
124782303|NCT02167139|448832810|FG003|Transition-extension|Lack of Efficacy|1|||
124782304|NCT02167139|448832807|FG000|Transition-extension|Other|1|||
124782305|NCT02167139|448832808|FG001|Transition-extension|Other|0|||
124782306|NCT02167139|448832809|FG002|Transition-extension|Other|1|||
124782307|NCT02167139|448832810|FG003|Transition-extension|Other|0|||
124782308|NCT02167139|448832807|FG000|Transition-extension|Lost to Follow-up|1|||
124782309|NCT02167139|448832808|FG001|Transition-extension|Lost to Follow-up|0|||
124782310|NCT02167139|448832809|FG002|Transition-extension|Lost to Follow-up|0|||
124782311|NCT02167139|448832810|FG003|Transition-extension|Lost to Follow-up|0|||
124782312|NCT00329797|448832811|FG000|Overall Study|Protocol Violation|1|||
124782313|NCT00329797|448832812|FG001|Overall Study|Protocol Violation|0|||
124782314|NCT00329797|448832811|FG000|Overall Study|Withdrawal by Subject|6|||
124782315|NCT00329797|448832812|FG001|Overall Study|Withdrawal by Subject|6|||
124782316|NCT00104520|448832813|FG000|Overall Study|Unrelated adverse event|34|||
124782317|NCT00104520|448832814|FG001|Overall Study|Unrelated adverse event|47|||
124782318|NCT00104520|448832813|FG000|Overall Study|Study drug intolerance|0|||
124782319|NCT00104520|448832814|FG001|Overall Study|Study drug intolerance|1|||
124782320|NCT00104520|448832813|FG000|Overall Study|Related adverse event|13|||
124782321|NCT00104520|448832814|FG001|Overall Study|Related adverse event|15|||
124782322|NCT00104520|448832813|FG000|Overall Study|Lost to Follow-up|1|||
124782323|NCT00104520|448832814|FG001|Overall Study|Lost to Follow-up|0|||
124782324|NCT00104520|448832813|FG000|Overall Study|Noncompliance|0|||
124782325|NCT00104520|448832814|FG001|Overall Study|Noncompliance|2|||
124782326|NCT00104520|448832813|FG000|Overall Study|Personal/administrative|1|||
124782327|NCT00104520|448832814|FG001|Overall Study|Personal/administrative|1|||
124782328|NCT00104520|448832813|FG000|Overall Study|Other|1|||
124782329|NCT00104520|448832814|FG001|Overall Study|Other|5|||
124619354|NCT00307437|448221745|FG000|Controlled Period|Death|0|||
124619355|NCT00307437|448221746|FG001|Controlled Period|Death|0|||
124747458|NCT01545050|448697769|FG000|Overall Study|Adverse Event|1|||
124619356|NCT00307437|448221747|FG002|Controlled Period|Death|1|||
124782330|NCT01026324|448832816|FG000|Follow up/Survival|Withdrawal by Subject|1|||
124782331|NCT01026324|448832817|FG001|Follow up/Survival|Withdrawal by Subject|0|||
124782332|NCT01026324|448832818|FG002|Follow up/Survival|Withdrawal by Subject|0|||
124782333|NCT05188053|448832819|FG000|Overall Study|Lost to Follow-up|23|||
124782334|NCT05188053|448832820|FG001|Overall Study|Lost to Follow-up|30|||
124782335|NCT05188053|448832819|FG000|Overall Study|Protocol Violation|16|||
124782336|NCT05188053|448832820|FG001|Overall Study|Protocol Violation|16|||
124782337|NCT05188053|448832819|FG000|Overall Study|Physician Decision|3|||
124782338|NCT05188053|448832820|FG001|Overall Study|Physician Decision|0|||
124782339|NCT05188053|448832819|FG000|Overall Study|Withdrawal by Subject|0|||
124782340|NCT05188053|448832820|FG001|Overall Study|Withdrawal by Subject|1|||
124747459|NCT01545050|448697770|FG001|Overall Study|Adverse Event|1|||
124747460|NCT01545050|448697771|FG002|Overall Study|Adverse Event|2|||
124782341|NCT02447302|448832824|FG000|Overall Study|Physician Decision|1|||
124747461|NCT01545050|448697772|FG003|Overall Study|Adverse Event|2|||
124747462|NCT01545050|448697773|FG004|Overall Study|Adverse Event|0|||
124747463|NCT01545050|448697769|FG000|Overall Study|Discontinued study treatment|1|||
124747464|NCT01545050|448697770|FG001|Overall Study|Discontinued study treatment|0|||
124747465|NCT01545050|448697771|FG002|Overall Study|Discontinued study treatment|0|||
124747466|NCT01545050|448697772|FG003|Overall Study|Discontinued study treatment|0|||
124747467|NCT01545050|448697773|FG004|Overall Study|Discontinued study treatment|0|||
124747468|NCT01545050|448697769|FG000|Overall Study|Withdrawal by Subject|1|||
124747469|NCT01545050|448697770|FG001|Overall Study|Withdrawal by Subject|0|||
124747470|NCT01545050|448697771|FG002|Overall Study|Withdrawal by Subject|0|||
124747471|NCT01545050|448697772|FG003|Overall Study|Withdrawal by Subject|2|||
124747472|NCT01545050|448697773|FG004|Overall Study|Withdrawal by Subject|1|||
124747473|NCT01545050|448697769|FG000|Overall Study|Participant no longer meets study criteria|0|||
124747474|NCT01545050|448697770|FG001|Overall Study|Participant no longer meets study criteria|2|||
124747475|NCT01545050|448697771|FG002|Overall Study|Participant no longer meets study criteria|0|||
124747476|NCT01545050|448697772|FG003|Overall Study|Participant no longer meets study criteria|0|||
124747477|NCT01545050|448697773|FG004|Overall Study|Participant no longer meets study criteria|1|||
124747478|NCT01545050|448697769|FG000|Overall Study|Administrative reason by sponsor|4|||
124747479|NCT01545050|448697770|FG001|Overall Study|Administrative reason by sponsor|2|||
124747480|NCT01545050|448697771|FG002|Overall Study|Administrative reason by sponsor|3|||
124747481|NCT01545050|448697772|FG003|Overall Study|Administrative reason by sponsor|5|||
124747482|NCT01545050|448697773|FG004|Overall Study|Administrative reason by sponsor|5|||
124747483|NCT00559988|448697779|FG000|Overall Study|Death|147|||
124747484|NCT00559988|448697780|FG001|Overall Study|Death|140|||
124747485|NCT00559988|448697779|FG000|Overall Study|Withdrawal by Subject|152|||
124747486|NCT00559988|448697780|FG001|Overall Study|Withdrawal by Subject|139|||
124747487|NCT00559988|448697779|FG000|Overall Study|Lost to Follow-up|42|||
124747488|NCT00559988|448697780|FG001|Overall Study|Lost to Follow-up|56|||
124747489|NCT00559988|448697779|FG000|Overall Study|ICD device explanted|10|||
124747490|NCT00559988|448697780|FG001|Overall Study|ICD device explanted|17|||
124747491|NCT01455194|448697781|FG000|Overall Study|Screen Failure|20|||
124747492|NCT01455194|448697782|FG001|Overall Study|Screen Failure|0|||
124747493|NCT01455194|448697783|FG002|Overall Study|Screen Failure|0|||
124747494|NCT01455194|448697784|FG003|Overall Study|Screen Failure|0|||
124747495|NCT01455194|448697781|FG000|Overall Study|Randomisation Failure|90|||
124747496|NCT01455194|448697782|FG001|Overall Study|Randomisation Failure|0|||
124747497|NCT01455194|448697783|FG002|Overall Study|Randomisation Failure|0|||
124747498|NCT01455194|448697784|FG003|Overall Study|Randomisation Failure|0|||
124747499|NCT01455194|448697781|FG000|Overall Study|Deterioration in asthma|12|||
124747500|NCT01455194|448697782|FG001|Overall Study|Deterioration in asthma|6|||
124747501|NCT01455194|448697783|FG002|Overall Study|Deterioration in asthma|14|||
124747502|NCT01455194|448697784|FG003|Overall Study|Deterioration in asthma|9|||
124747503|NCT01455194|448697781|FG000|Overall Study|Adverse Event|1|||
124747504|NCT01455194|448697782|FG001|Overall Study|Adverse Event|1|||
124747505|NCT01455194|448697783|FG002|Overall Study|Adverse Event|1|||
124747506|NCT01455194|448697784|FG003|Overall Study|Adverse Event|3|||
124747507|NCT01455194|448697781|FG000|Overall Study|Withdrawal by Subject|21|||
124747508|NCT01455194|448697782|FG001|Overall Study|Withdrawal by Subject|16|||
124747509|NCT01455194|448697783|FG002|Overall Study|Withdrawal by Subject|12|||
124747510|NCT01455194|448697784|FG003|Overall Study|Withdrawal by Subject|9|||
124747511|NCT01455194|448697781|FG000|Overall Study|Lost to Follow-up|2|||
124747512|NCT01455194|448697782|FG001|Overall Study|Lost to Follow-up|0|||
124747513|NCT01455194|448697783|FG002|Overall Study|Lost to Follow-up|1|||
124747514|NCT01455194|448697784|FG003|Overall Study|Lost to Follow-up|1|||
124747515|NCT01455194|448697781|FG000|Overall Study|Pregnancy|0|||
124747516|NCT01455194|448697782|FG001|Overall Study|Pregnancy|1|||
124747517|NCT01455194|448697783|FG002|Overall Study|Pregnancy|1|||
124747518|NCT01455194|448697784|FG003|Overall Study|Pregnancy|0|||
124747519|NCT01455194|448697781|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
124747520|NCT01455194|448697782|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
124747521|NCT01455194|448697783|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
124747522|NCT01455194|448697784|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
124747523|NCT01455194|448697781|FG000|Overall Study|Miscellaneous|4|||
124747524|NCT01455194|448697782|FG001|Overall Study|Miscellaneous|5|||
124747525|NCT01455194|448697783|FG002|Overall Study|Miscellaneous|1|||
124747526|NCT01455194|448697784|FG003|Overall Study|Miscellaneous|4|||
124747527|NCT02249182|448697785|FG000|Treatment Phase|Lost to Follow-up|4|||
124747528|NCT02249182|448697786|FG001|Treatment Phase|Lost to Follow-up|0|||
124747529|NCT02249182|448697787|FG002|Treatment Phase|Lost to Follow-up|0|||
124747530|NCT02249182|448697788|FG003|Treatment Phase|Lost to Follow-up|0|||
124747531|NCT02249182|448697789|FG004|Treatment Phase|Lost to Follow-up|0|||
124747532|NCT02516228|448697792|FG000|Overall Study|Lost to Follow-up|1|||
124747533|NCT02516228|448697792|FG000|Overall Study|Withdrawal by Subject|1|||
124747534|NCT02516228|448697792|FG000|Overall Study|Physician Decision|1|||
124747535|NCT03916484|448697793|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
124747536|NCT03916484|448697794|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
124747537|NCT03916484|448697795|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
124747538|NCT03916484|448697796|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
124747539|NCT03916484|448697793|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
124747540|NCT03916484|448697794|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
124747541|NCT03916484|448697795|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
124747542|NCT03916484|448697796|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
124747543|NCT01092663|448697799|FG000|Overall Study|Withdrawal by Subject|3|||
124747544|NCT01092663|448697800|FG001|Overall Study|Withdrawal by Subject|2|||
124747545|NCT01092663|448697799|FG000|Overall Study|Glucose >300mg/dL|1|||
124747546|NCT01092663|448697800|FG001|Overall Study|Glucose >300mg/dL|0|||
124747547|NCT01092663|448697799|FG000|Overall Study|High fasting triglyceride|2|||
124747548|NCT01092663|448697800|FG001|Overall Study|High fasting triglyceride|0|||
124747549|NCT01092663|448697799|FG000|Overall Study|Adverse Event|1|||
124747550|NCT01092663|448697800|FG001|Overall Study|Adverse Event|1|||
124747551|NCT01092663|448697799|FG000|Overall Study|Protocol Violation|0|||
124747552|NCT01092663|448697800|FG001|Overall Study|Protocol Violation|1|||
124747553|NCT01183065|448697801|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
124747554|NCT02456857|448697802|FG000|Overall Study|Disease Progression|4|||
124747555|NCT01983774|448697806|FG000|Overall Study|Lung Transplant|0|||
124747556|NCT01983774|448697807|FG001|Overall Study|Lung Transplant|1|||
124747557|NCT01983774|448697806|FG000|Overall Study|Lost to Follow-up|1|||
124747558|NCT01983774|448697807|FG001|Overall Study|Lost to Follow-up|0|||
124747559|NCT01008449|448697808|FG000|Overall Study|Lost to Follow-up|29|||
124747560|NCT01008449|448697809|FG001|Overall Study|Lost to Follow-up|19|||
124747561|NCT01220180|448697810|FG000|Overall Study|Lost to Follow-up|76|||
124747562|NCT01220180|448697810|FG000|Overall Study|Other|72|||
124747563|NCT01220180|448697810|FG000|Overall Study|Adverse Event|35|||
124747564|NCT01220180|448697810|FG000|Overall Study|Lack of Efficacy|22|||
124747565|NCT01220180|448697810|FG000|Overall Study|Death|1|||
124747566|NCT01220180|448697810|FG000|Overall Study|Randomized but not treated|1|||
124747567|NCT01067469|448697816|FG000|Overall Study|Withdrawal by Subject|0|||
124747568|NCT01067469|448697817|FG001|Overall Study|Withdrawal by Subject|1|||
124747569|NCT01067469|448697816|FG000|Overall Study|Disease Progression|0|||
124747570|NCT01067469|448697817|FG001|Overall Study|Disease Progression|1|||
124747571|NCT01299116|448697819|FG000|Overall Study|Lost to Follow-up|65|||
124747572|NCT01299116|448697820|FG001|Overall Study|Lost to Follow-up|9|||
124747573|NCT01299116|448697821|FG002|Overall Study|Lost to Follow-up|11|||
124747574|NCT01123707|448697822|FG000|Overall Study|Lost to Follow-up|3|||
124747575|NCT01123707|448697823|FG001|Overall Study|Lost to Follow-up|1|||
124747576|NCT01123707|448697824|FG002|Overall Study|Lost to Follow-up|3|||
124747577|NCT01123707|448697825|FG003|Overall Study|Lost to Follow-up|2|||
124747578|NCT01123707|448697822|FG000|Overall Study|Adverse Event|5|||
124747579|NCT01123707|448697823|FG001|Overall Study|Adverse Event|7|||
124747580|NCT01123707|448697824|FG002|Overall Study|Adverse Event|5|||
124747581|NCT01123707|448697825|FG003|Overall Study|Adverse Event|3|||
124747582|NCT01123707|448697822|FG000|Overall Study|Sponsor Discontinued Study|30|||
124747583|NCT01123707|448697823|FG001|Overall Study|Sponsor Discontinued Study|24|||
124747584|NCT01123707|448697824|FG002|Overall Study|Sponsor Discontinued Study|25|||
124747585|NCT01123707|448697825|FG003|Overall Study|Sponsor Discontinued Study|40|||
124747586|NCT01123707|448697822|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
124747587|NCT01123707|448697823|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
124747588|NCT01123707|448697824|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
124747589|NCT01123707|448697825|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
124747590|NCT01123707|448697822|FG000|Overall Study|Investigator Withdrew Participant|0|||
124747591|NCT01123707|448697823|FG001|Overall Study|Investigator Withdrew Participant|1|||
124747592|NCT01123707|448697824|FG002|Overall Study|Investigator Withdrew Participant|1|||
124747593|NCT01123707|448697825|FG003|Overall Study|Investigator Withdrew Participant|1|||
124747594|NCT01123707|448697822|FG000|Overall Study|Subject Withdrew Consent|4|||
124747595|NCT01123707|448697823|FG001|Overall Study|Subject Withdrew Consent|5|||
124747596|NCT01123707|448697824|FG002|Overall Study|Subject Withdrew Consent|1|||
124747597|NCT01123707|448697825|FG003|Overall Study|Subject Withdrew Consent|2|||
124747598|NCT01123707|448697822|FG000|Overall Study|Lack of Efficacy|1|||
124747599|NCT01123707|448697823|FG001|Overall Study|Lack of Efficacy|2|||
124747600|NCT01123707|448697824|FG002|Overall Study|Lack of Efficacy|1|||
124747601|NCT01123707|448697825|FG003|Overall Study|Lack of Efficacy|0|||
124747602|NCT01123707|448697822|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
124747603|NCT01123707|448697823|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
124747604|NCT01123707|448697824|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
124747605|NCT01123707|448697825|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
124747606|NCT04378114|448697828|FG000|Overall Study|Withdrawal by Subject|5|||
124747607|NCT04079114|448697829|FG000|Overall Study|Study prematuely terminated.|166|||
124747608|NCT00629798|448697830|FG000|Overall Study|Not Treated|4|||
124747609|NCT01959243|448697833|FG000|Overall Study|Investigator Decision|3|||
124747610|NCT01959243|448697834|FG001|Overall Study|Investigator Decision|0|||
124747611|NCT01959243|448697833|FG000|Overall Study|Adverse Event|5|||
124782342|NCT02447302|448832825|FG001|Overall Study|Physician Decision|0|||
124782343|NCT02447302|448832826|FG002|Overall Study|Physician Decision|0|||
124782344|NCT02447302|448832824|FG000|Overall Study|Adverse Event|4|||
124782345|NCT02447302|448832825|FG001|Overall Study|Adverse Event|3|||
124782346|NCT02447302|448832826|FG002|Overall Study|Adverse Event|0|||
124782347|NCT02447302|448832824|FG000|Overall Study|Withdrawal by Subject|0|||
124782348|NCT02447302|448832825|FG001|Overall Study|Withdrawal by Subject|1|||
124782349|NCT02447302|448832826|FG002|Overall Study|Withdrawal by Subject|5|||
124782350|NCT02447302|448832824|FG000|Overall Study|Sponsor Decision|0|||
124782351|NCT02447302|448832825|FG001|Overall Study|Sponsor Decision|0|||
124782352|NCT02447302|448832826|FG002|Overall Study|Sponsor Decision|1|||
124782353|NCT01456897|448832831|FG000|Overall Study|Adverse Event|19|||
124782354|NCT01456897|448832832|FG001|Overall Study|Adverse Event|22|||
124782355|NCT01456897|448832831|FG000|Overall Study|Protocol Violation|3|||
124782356|NCT01456897|448832832|FG001|Overall Study|Protocol Violation|4|||
124782357|NCT01456897|448832831|FG000|Overall Study|Physician Decision|5|||
124782358|NCT01456897|448832832|FG001|Overall Study|Physician Decision|3|||
124782359|NCT01456897|448832831|FG000|Overall Study|Withdrawal by Subject|44|||
124782360|NCT01456897|448832832|FG001|Overall Study|Withdrawal by Subject|17|||
124782361|NCT01456897|448832831|FG000|Overall Study|Lack of Efficacy|4|||
124782362|NCT01456897|448832832|FG001|Overall Study|Lack of Efficacy|11|||
124782363|NCT01396070|448832839|FG000|Overall Study|Withdrawal by Subject|2|||
124782364|NCT01396070|448832839|FG000|Overall Study|Death|2|||
124782365|NCT01396070|448832839|FG000|Overall Study|Adverse Event|8|||
124782366|NCT01396070|448832839|FG000|Overall Study|Physician Decision|3|||
124782367|NCT01396070|448832839|FG000|Overall Study|Lack of Efficacy|4|||
124782368|NCT01561313|448832840|FG000|Overall Study|Withdrawal by Subject|1|||
124782369|NCT01561313|448832841|FG001|Overall Study|Withdrawal by Subject|0|||
124782370|NCT01561313|448832840|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
124782371|NCT01561313|448832841|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
124782372|NCT04254913|448832842|FG000|Overall Study|Adverse Event|1|||
124782373|NCT02695420|448832843|FG000|Overall Study|Death|0|||
124782374|NCT02695420|448832844|FG001|Overall Study|Death|1|||
124782375|NCT02695420|448832845|FG002|Overall Study|Death|0|||
124782376|NCT02695420|448832846|FG003|Overall Study|Death|0|||
124782377|NCT04535453|448832847|FG000|Overall Study|Death|0|||
124782378|NCT04535453|448832848|FG001|Overall Study|Death|1|||
124782379|NCT04535453|448832849|FG002|Overall Study|Death|0|||
124782380|NCT04535453|448832850|FG003|Overall Study|Death|0|||
124782381|NCT04535453|448832851|FG004|Overall Study|Death|0|||
124782382|NCT04535453|448832852|FG005|Overall Study|Death|0|||
124782383|NCT04535453|448832853|FG006|Overall Study|Death|0|||
124782384|NCT04535453|448832854|FG007|Overall Study|Death|0|||
124782385|NCT04535453|448832855|FG008|Overall Study|Death|0|||
124782386|NCT04535453|448832856|FG009|Overall Study|Death|0|||
124782387|NCT04535453|448832857|FG010|Overall Study|Death|0|||
124782388|NCT04535453|448832858|FG011|Overall Study|Death|0|||
124782389|NCT04535453|448832847|FG000|Overall Study|Lost to Follow-up|1|||
124782390|NCT04535453|448832848|FG001|Overall Study|Lost to Follow-up|1|||
124782391|NCT04535453|448832849|FG002|Overall Study|Lost to Follow-up|1|||
124782392|NCT04535453|448832850|FG003|Overall Study|Lost to Follow-up|0|||
124782393|NCT04535453|448832851|FG004|Overall Study|Lost to Follow-up|3|||
124747612|NCT01959243|448697834|FG001|Overall Study|Adverse Event|2|||
124747613|NCT01959243|448697833|FG000|Overall Study|Administrative reasons|2|||
124747614|NCT01959243|448697834|FG001|Overall Study|Administrative reasons|1|||
124747615|NCT01959243|448697833|FG000|Overall Study|Lost to Follow-up|3|||
124747616|NCT01959243|448697834|FG001|Overall Study|Lost to Follow-up|1|||
124747617|NCT00428844|448697837|FG000|Completed Study Drug Treatment|Adverse Event|2|||
124747618|NCT00428844|448697838|FG001|Completed Study Drug Treatment|Adverse Event|4|||
124747619|NCT00428844|448697839|FG002|Completed Study Drug Treatment|Adverse Event|4|||
124747620|NCT00428844|448697837|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
124747621|NCT00428844|448697838|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
124747622|NCT00428844|448697839|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
124782394|NCT04535453|448832852|FG005|Overall Study|Lost to Follow-up|1|||
124782395|NCT04535453|448832853|FG006|Overall Study|Lost to Follow-up|0|||
124782396|NCT04535453|448832854|FG007|Overall Study|Lost to Follow-up|0|||
124747623|NCT00428844|448697837|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
124782397|NCT04535453|448832855|FG008|Overall Study|Lost to Follow-up|1|||
124782398|NCT04535453|448832856|FG009|Overall Study|Lost to Follow-up|1|||
124782399|NCT04535453|448832857|FG010|Overall Study|Lost to Follow-up|0|||
124782400|NCT04535453|448832858|FG011|Overall Study|Lost to Follow-up|0|||
124747624|NCT00428844|448697838|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
124782401|NCT04535453|448832847|FG000|Overall Study|Physician Decision|0|||
124782402|NCT04535453|448832848|FG001|Overall Study|Physician Decision|0|||
124782403|NCT04535453|448832849|FG002|Overall Study|Physician Decision|0|||
124782404|NCT04535453|448832850|FG003|Overall Study|Physician Decision|1|||
124782405|NCT04535453|448832851|FG004|Overall Study|Physician Decision|0|||
124782406|NCT04535453|448832852|FG005|Overall Study|Physician Decision|0|||
124782407|NCT04535453|448832853|FG006|Overall Study|Physician Decision|0|||
124782408|NCT04535453|448832854|FG007|Overall Study|Physician Decision|0|||
124782409|NCT04535453|448832855|FG008|Overall Study|Physician Decision|0|||
124747625|NCT00428844|448697839|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
124747626|NCT00428844|448697837|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
124747627|NCT00428844|448697838|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
124747628|NCT00428844|448697839|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
124747629|NCT00428844|448697837|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
124747630|NCT00428844|448697838|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
124747631|NCT00428844|448697839|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
124747632|NCT00428844|448697837|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
124747633|NCT00428844|448697838|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
124747634|NCT00428844|448697839|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
124747635|NCT00428844|448697837|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
124747636|NCT00428844|448697838|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
124747637|NCT00428844|448697839|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
124747638|NCT00428844|448697837|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
124747639|NCT00428844|448697838|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
124747640|NCT00428844|448697839|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
124747641|NCT00428844|448697837|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
124747642|NCT00428844|448697838|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
124747643|NCT00428844|448697839|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
124747644|NCT00488826|448697840|FG000|Overall Study|Withdrawal by Subject|40|||
124747645|NCT00488826|448697841|FG001|Overall Study|Withdrawal by Subject|35|||
124747646|NCT00488826|448697842|FG002|Overall Study|Withdrawal by Subject|19|||
124747647|NCT00488826|448697840|FG000|Overall Study|Protocol Violation|0|||
124747648|NCT00488826|448697841|FG001|Overall Study|Protocol Violation|0|||
124747649|NCT00488826|448697842|FG002|Overall Study|Protocol Violation|2|||
124747650|NCT00488826|448697840|FG000|Overall Study|Adverse Event|9|||
124747651|NCT00488826|448697841|FG001|Overall Study|Adverse Event|15|||
124747652|NCT00488826|448697842|FG002|Overall Study|Adverse Event|4|||
124747653|NCT00488826|448697840|FG000|Overall Study|Lost to Follow-up|5|||
124747654|NCT00488826|448697841|FG001|Overall Study|Lost to Follow-up|1|||
124747655|NCT00488826|448697842|FG002|Overall Study|Lost to Follow-up|0|||
124747656|NCT00488826|448697840|FG000|Overall Study|Protocol Deviations|2|||
124747657|NCT00488826|448697841|FG001|Overall Study|Protocol Deviations|1|||
124747658|NCT00488826|448697842|FG002|Overall Study|Protocol Deviations|1|||
124747659|NCT02292706|448697844|FG000|Overall Study|Lost to Follow-up|20|||
124747660|NCT02292706|448697845|FG001|Overall Study|Lost to Follow-up|44|||
124747661|NCT02292706|448697846|FG002|Overall Study|Lost to Follow-up|24|||
124747662|NCT02292706|448697847|FG003|Overall Study|Lost to Follow-up|61|||
124747663|NCT02292706|448697848|FG004|Overall Study|Lost to Follow-up|21|||
124747664|NCT02292706|448697849|FG005|Overall Study|Lost to Follow-up|52|||
124747665|NCT02292706|448697850|FG006|Overall Study|Lost to Follow-up|25|||
124747666|NCT02292706|448697851|FG007|Overall Study|Lost to Follow-up|0|||
124747667|NCT02292706|448697844|FG000|Overall Study|Withdrew consent|15|||
124747668|NCT02292706|448697845|FG001|Overall Study|Withdrew consent|56|||
124747669|NCT02292706|448697846|FG002|Overall Study|Withdrew consent|43|||
124747670|NCT02292706|448697847|FG003|Overall Study|Withdrew consent|36|||
124747671|NCT02292706|448697848|FG004|Overall Study|Withdrew consent|13|||
124747672|NCT02292706|448697849|FG005|Overall Study|Withdrew consent|51|||
124747673|NCT02292706|448697850|FG006|Overall Study|Withdrew consent|20|||
124747674|NCT02292706|448697851|FG007|Overall Study|Withdrew consent|0|||
124747675|NCT02292706|448697844|FG000|Overall Study|Death|3|||
124747676|NCT02292706|448697845|FG001|Overall Study|Death|11|||
124747677|NCT02292706|448697846|FG002|Overall Study|Death|16|||
124747678|NCT02292706|448697847|FG003|Overall Study|Death|22|||
124747679|NCT02292706|448697848|FG004|Overall Study|Death|8|||
124747680|NCT02292706|448697849|FG005|Overall Study|Death|17|||
124747681|NCT02292706|448697850|FG006|Overall Study|Death|3|||
124747682|NCT02292706|448697851|FG007|Overall Study|Death|0|||
124747683|NCT02292706|448697844|FG000|Overall Study|Study terminated by sponsor|0|||
124747684|NCT02292706|448697845|FG001|Overall Study|Study terminated by sponsor|9|||
124747685|NCT02292706|448697846|FG002|Overall Study|Study terminated by sponsor|4|||
124747686|NCT02292706|448697847|FG003|Overall Study|Study terminated by sponsor|21|||
124747687|NCT02292706|448697848|FG004|Overall Study|Study terminated by sponsor|11|||
124747688|NCT02292706|448697849|FG005|Overall Study|Study terminated by sponsor|13|||
124747689|NCT02292706|448697850|FG006|Overall Study|Study terminated by sponsor|3|||
124747690|NCT02292706|448697851|FG007|Overall Study|Study terminated by sponsor|0|||
124747691|NCT02292706|448697844|FG000|Overall Study|Investigator's discretion|4|||
124782410|NCT04535453|448832856|FG009|Overall Study|Physician Decision|0|||
124782411|NCT04535453|448832857|FG010|Overall Study|Physician Decision|0|||
124747692|NCT02292706|448697845|FG001|Overall Study|Investigator's discretion|9|||
124747693|NCT02292706|448697846|FG002|Overall Study|Investigator's discretion|7|||
124747694|NCT02292706|448697847|FG003|Overall Study|Investigator's discretion|11|||
124747695|NCT02292706|448697848|FG004|Overall Study|Investigator's discretion|4|||
124747696|NCT02292706|448697849|FG005|Overall Study|Investigator's discretion|10|||
124747697|NCT02292706|448697850|FG006|Overall Study|Investigator's discretion|1|||
124782412|NCT04535453|448832858|FG011|Overall Study|Physician Decision|0|||
124747698|NCT02292706|448697851|FG007|Overall Study|Investigator's discretion|0|||
124747699|NCT02292706|448697844|FG000|Overall Study|Liver transplant|1|||
124747700|NCT02292706|448697845|FG001|Overall Study|Liver transplant|1|||
124747701|NCT02292706|448697846|FG002|Overall Study|Liver transplant|11|||
124747702|NCT02292706|448697847|FG003|Overall Study|Liver transplant|16|||
124747703|NCT02292706|448697848|FG004|Overall Study|Liver transplant|5|||
124747704|NCT02292706|448697849|FG005|Overall Study|Liver transplant|6|||
124747705|NCT02292706|448697850|FG006|Overall Study|Liver transplant|5|||
124747706|NCT02292706|448697851|FG007|Overall Study|Liver transplant|0|||
124747707|NCT02292706|448697844|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
124747708|NCT02292706|448697845|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
124747709|NCT02292706|448697846|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
124747710|NCT02292706|448697847|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
124747711|NCT02292706|448697848|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
124747712|NCT02292706|448697849|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
124747713|NCT02292706|448697850|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
124747714|NCT02292706|448697851|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
124747715|NCT02292706|448697844|FG000|Overall Study|Subject terminated by sponsor|1|||
124747716|NCT02292706|448697845|FG001|Overall Study|Subject terminated by sponsor|0|||
124747717|NCT02292706|448697846|FG002|Overall Study|Subject terminated by sponsor|0|||
124747718|NCT02292706|448697847|FG003|Overall Study|Subject terminated by sponsor|2|||
124747719|NCT02292706|448697848|FG004|Overall Study|Subject terminated by sponsor|1|||
124747720|NCT02292706|448697849|FG005|Overall Study|Subject terminated by sponsor|0|||
124747721|NCT02292706|448697850|FG006|Overall Study|Subject terminated by sponsor|0|||
124747722|NCT02292706|448697851|FG007|Overall Study|Subject terminated by sponsor|0|||
124747723|NCT02292706|448697844|FG000|Overall Study|Missing|0|||
124747724|NCT02292706|448697845|FG001|Overall Study|Missing|0|||
124747725|NCT02292706|448697846|FG002|Overall Study|Missing|1|||
124747726|NCT02292706|448697847|FG003|Overall Study|Missing|1|||
124747727|NCT02292706|448697848|FG004|Overall Study|Missing|0|||
124747728|NCT02292706|448697849|FG005|Overall Study|Missing|1|||
124747729|NCT02292706|448697850|FG006|Overall Study|Missing|0|||
124747730|NCT02292706|448697851|FG007|Overall Study|Missing|0|||
124747731|NCT02292706|448697844|FG000|Overall Study|Virologic relapse or reinfection|1|||
124747732|NCT02292706|448697845|FG001|Overall Study|Virologic relapse or reinfection|0|||
124747733|NCT02292706|448697846|FG002|Overall Study|Virologic relapse or reinfection|0|||
124747734|NCT02292706|448697847|FG003|Overall Study|Virologic relapse or reinfection|1|||
124747735|NCT02292706|448697848|FG004|Overall Study|Virologic relapse or reinfection|0|||
124747736|NCT02292706|448697849|FG005|Overall Study|Virologic relapse or reinfection|1|||
124747737|NCT02292706|448697850|FG006|Overall Study|Virologic relapse or reinfection|0|||
124747738|NCT02292706|448697851|FG007|Overall Study|Virologic relapse or reinfection|0|||
124747739|NCT02725866|448697854|FG000|Overall Study|Failure to return|6|||
124747740|NCT02725866|448697854|FG000|Overall Study|Withdrew consent|3|||
124747741|NCT02725866|448697854|FG000|Overall Study|Insufficient virological response|1|||
124747742|NCT02725866|448697854|FG000|Overall Study|Other, not specified|4|||
124747743|NCT04667104|448697860|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
124747744|NCT04667104|448697861|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
124747745|NCT04667104|448697862|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
124747746|NCT03043651|448697863|FG000|Overall Study|Death|1|||
124747747|NCT03043651|448697863|FG000|Overall Study|Progressive Disease|2|||
124619357|NCT00307437|448221748|FG003|Controlled Period|Death|0|||
124619358|NCT00307437|448221749|FG004|Controlled Period|Death|0|||
124619359|NCT00307437|448221750|FG005|Controlled Period|Death|0|||
124619360|NCT00307437|448221751|FG006|Controlled Period|Death|0|||
124619361|NCT00307437|448221745|FG000|Controlled Period|Lack of Efficacy|2|||
124619362|NCT00307437|448221746|FG001|Controlled Period|Lack of Efficacy|0|||
124619363|NCT00307437|448221747|FG002|Controlled Period|Lack of Efficacy|0|||
124619364|NCT00307437|448221748|FG003|Controlled Period|Lack of Efficacy|0|||
124619365|NCT00307437|448221749|FG004|Controlled Period|Lack of Efficacy|0|||
124619366|NCT00307437|448221750|FG005|Controlled Period|Lack of Efficacy|0|||
124619367|NCT00307437|448221751|FG006|Controlled Period|Lack of Efficacy|0|||
124619368|NCT00307437|448221745|FG000|Controlled Period|Lost to Follow-up|2|||
124619369|NCT00307437|448221746|FG001|Controlled Period|Lost to Follow-up|3|||
124619370|NCT00307437|448221747|FG002|Controlled Period|Lost to Follow-up|0|||
124619371|NCT00307437|448221748|FG003|Controlled Period|Lost to Follow-up|0|||
124747748|NCT03043651|448697863|FG000|Overall Study|Adverse Event|2|||
124747749|NCT03043651|448697863|FG000|Overall Study|Withdrawal by Subject|4|||
124747750|NCT03043651|448697863|FG000|Overall Study|Study Terminated by Sponsor|39|||
124747751|NCT01630889|448697864|FG000|Overall Study|Death|2|||
124747752|NCT01630889|448697864|FG000|Overall Study|Withdrawal by Subject|1|||
124747753|NCT01630889|448697864|FG000|Overall Study|Other than Specified|2|||
124747754|NCT01630889|448697864|FG000|Overall Study|Lost to Follow-up|4|||
124747755|NCT01630889|448697864|FG000|Overall Study|Other|1|||
124747756|NCT03208088|448697869|FG000|Period 2|Withdrawal by Subject|0|||
124747757|NCT03208088|448697870|FG001|Period 2|Withdrawal by Subject|0|||
124747758|NCT03208088|448697871|FG002|Period 2|Withdrawal by Subject|0|||
124619372|NCT00307437|448221749|FG004|Controlled Period|Lost to Follow-up|0|||
124619373|NCT00307437|448221750|FG005|Controlled Period|Lost to Follow-up|0|||
124619374|NCT00307437|448221751|FG006|Controlled Period|Lost to Follow-up|0|||
124619375|NCT00307437|448221745|FG000|Controlled Period|Other|5|||
124619376|NCT00307437|448221746|FG001|Controlled Period|Other|1|||
124619377|NCT00307437|448221747|FG002|Controlled Period|Other|3|||
124619378|NCT00307437|448221748|FG003|Controlled Period|Other|0|||
124619379|NCT00307437|448221749|FG004|Controlled Period|Other|0|||
124619380|NCT00307437|448221750|FG005|Controlled Period|Other|0|||
124619381|NCT00307437|448221751|FG006|Controlled Period|Other|0|||
124619382|NCT00307437|448221745|FG000|After Controlled Period|Adverse Event|0|||
124619383|NCT00307437|448221746|FG001|After Controlled Period|Adverse Event|0|||
124619384|NCT00307437|448221747|FG002|After Controlled Period|Adverse Event|0|||
124619385|NCT00307437|448221748|FG003|After Controlled Period|Adverse Event|18|||
124619386|NCT00307437|448221749|FG004|After Controlled Period|Adverse Event|16|||
124619387|NCT00307437|448221750|FG005|After Controlled Period|Adverse Event|31|||
124619388|NCT00307437|448221751|FG006|After Controlled Period|Adverse Event|40|||
124619389|NCT00307437|448221745|FG000|After Controlled Period|Death|0|||
124619390|NCT00307437|448221746|FG001|After Controlled Period|Death|0|||
124747759|NCT03208088|448697872|FG003|Period 2|Withdrawal by Subject|0|||
124747760|NCT03208088|448697873|FG004|Period 2|Withdrawal by Subject|0|||
124747761|NCT03208088|448697874|FG005|Period 2|Withdrawal by Subject|0|||
124747762|NCT03208088|448697875|FG006|Period 2|Withdrawal by Subject|0|||
124747763|NCT03208088|448697876|FG007|Period 2|Withdrawal by Subject|0|||
124747764|NCT03208088|448697877|FG008|Period 2|Withdrawal by Subject|1|||
124747765|NCT03208088|448697878|FG009|Period 2|Withdrawal by Subject|0|||
124747766|NCT03208088|448697869|FG000|Period 3|Unsatisfactory Test Article|0|||
124747767|NCT03208088|448697870|FG001|Period 3|Unsatisfactory Test Article|0|||
124747768|NCT03208088|448697871|FG002|Period 3|Unsatisfactory Test Article|0|||
124747769|NCT03208088|448697872|FG003|Period 3|Unsatisfactory Test Article|1|||
124747770|NCT03208088|448697873|FG004|Period 3|Unsatisfactory Test Article|0|||
124747771|NCT03208088|448697874|FG005|Period 3|Unsatisfactory Test Article|0|||
124747772|NCT03208088|448697875|FG006|Period 3|Unsatisfactory Test Article|0|||
124747773|NCT03208088|448697876|FG007|Period 3|Unsatisfactory Test Article|0|||
124747774|NCT03208088|448697877|FG008|Period 3|Unsatisfactory Test Article|0|||
124747775|NCT03208088|448697878|FG009|Period 3|Unsatisfactory Test Article|0|||
124747776|NCT03208088|448697869|FG000|Period 4|Unsatisfactory Test Article|0|||
124747777|NCT03208088|448697870|FG001|Period 4|Unsatisfactory Test Article|0|||
124747778|NCT03208088|448697871|FG002|Period 4|Unsatisfactory Test Article|0|||
124747779|NCT03208088|448697872|FG003|Period 4|Unsatisfactory Test Article|1|||
124747780|NCT03208088|448697873|FG004|Period 4|Unsatisfactory Test Article|0|||
124747781|NCT03208088|448697874|FG005|Period 4|Unsatisfactory Test Article|0|||
124747782|NCT03208088|448697875|FG006|Period 4|Unsatisfactory Test Article|0|||
124747783|NCT03208088|448697876|FG007|Period 4|Unsatisfactory Test Article|0|||
124747784|NCT03208088|448697877|FG008|Period 4|Unsatisfactory Test Article|0|||
124747785|NCT03208088|448697878|FG009|Period 4|Unsatisfactory Test Article|0|||
124747786|NCT00566254|448697879|FG000|Overall Study|Adverse Event|3|||
124747787|NCT00566254|448697880|FG001|Overall Study|Adverse Event|1|||
124747788|NCT00566254|448697879|FG000|Overall Study|Protocol Violation|1|||
124747789|NCT00566254|448697880|FG001|Overall Study|Protocol Violation|3|||
124747790|NCT00566254|448697879|FG000|Overall Study|Withdrawal by Subject|1|||
124747791|NCT00566254|448697880|FG001|Overall Study|Withdrawal by Subject|2|||
124747792|NCT00566254|448697879|FG000|Overall Study|Lack of Efficacy|5|||
124747793|NCT00566254|448697880|FG001|Overall Study|Lack of Efficacy|6|||
124747794|NCT00566254|448697879|FG000|Overall Study|Other|0|||
124747795|NCT00566254|448697880|FG001|Overall Study|Other|2|||
124747796|NCT00238238|448697882|FG000|Overall Study|Withdrawal by Subject|0|||
124747797|NCT00238238|448697883|FG001|Overall Study|Withdrawal by Subject|3|||
124747798|NCT00238238|448697884|FG002|Overall Study|Withdrawal by Subject|0|||
124747799|NCT01345669|448697885|FG000|Overall Study|Primary tumour recurrence|53|||
124747800|NCT01345669|448697886|FG001|Overall Study|Primary tumour recurrence|32|||
124747801|NCT01345669|448697885|FG000|Overall Study|Second primary tumour|4|||
124747802|NCT01345669|448697886|FG001|Overall Study|Second primary tumour|3|||
124747803|NCT01345669|448697885|FG000|Overall Study|Adverse Event|63|||
124747804|NCT01345669|448697886|FG001|Overall Study|Adverse Event|9|||
124747805|NCT01345669|448697885|FG000|Overall Study|Protocol Violation|3|||
124747806|NCT01345669|448697886|FG001|Overall Study|Protocol Violation|1|||
124747807|NCT01345669|448697885|FG000|Overall Study|Lost to Follow-up|1|||
124747808|NCT01345669|448697886|FG001|Overall Study|Lost to Follow-up|1|||
124747809|NCT01345669|448697885|FG000|Overall Study|Withdrawal by Subject|52|||
124747810|NCT01345669|448697886|FG001|Overall Study|Withdrawal by Subject|13|||
124747811|NCT01345669|448697885|FG000|Overall Study|Other Reasons|111|||
124747812|NCT01345669|448697886|FG001|Overall Study|Other Reasons|60|||
124747813|NCT01793883|448697887|FG000|Overall Study|Withdrawal by Subject|3|||
124747814|NCT01793883|448697888|FG001|Overall Study|Withdrawal by Subject|7|||
124747815|NCT01793883|448697889|FG002|Overall Study|Withdrawal by Subject|3|||
124619391|NCT00307437|448221747|FG002|After Controlled Period|Death|0|||
124619392|NCT00307437|448221748|FG003|After Controlled Period|Death|3|||
124619393|NCT00307437|448221749|FG004|After Controlled Period|Death|1|||
124619394|NCT00307437|448221750|FG005|After Controlled Period|Death|1|||
124619395|NCT00307437|448221751|FG006|After Controlled Period|Death|3|||
124619396|NCT00307437|448221745|FG000|After Controlled Period|Lack of Efficacy|0|||
124619397|NCT00307437|448221746|FG001|After Controlled Period|Lack of Efficacy|0|||
124619398|NCT00307437|448221747|FG002|After Controlled Period|Lack of Efficacy|0|||
124619399|NCT00307437|448221748|FG003|After Controlled Period|Lack of Efficacy|15|||
124619400|NCT00307437|448221749|FG004|After Controlled Period|Lack of Efficacy|17|||
124619401|NCT00307437|448221750|FG005|After Controlled Period|Lack of Efficacy|37|||
124619402|NCT00307437|448221751|FG006|After Controlled Period|Lack of Efficacy|24|||
124619403|NCT00307437|448221745|FG000|After Controlled Period|Lost to Follow-up|0|||
124619404|NCT00307437|448221746|FG001|After Controlled Period|Lost to Follow-up|0|||
124619405|NCT00307437|448221747|FG002|After Controlled Period|Lost to Follow-up|0|||
124619406|NCT00307437|448221748|FG003|After Controlled Period|Lost to Follow-up|7|||
124619407|NCT00307437|448221749|FG004|After Controlled Period|Lost to Follow-up|12|||
124619408|NCT00307437|448221750|FG005|After Controlled Period|Lost to Follow-up|13|||
124619409|NCT00307437|448221751|FG006|After Controlled Period|Lost to Follow-up|18|||
124619410|NCT00307437|448221745|FG000|After Controlled Period|Other|0|||
124619411|NCT00307437|448221746|FG001|After Controlled Period|Other|0|||
124619412|NCT00307437|448221747|FG002|After Controlled Period|Other|0|||
124619413|NCT00307437|448221748|FG003|After Controlled Period|Other|15|||
124619414|NCT00307437|448221749|FG004|After Controlled Period|Other|9|||
124619415|NCT00307437|448221750|FG005|After Controlled Period|Other|40|||
124619416|NCT00307437|448221751|FG006|After Controlled Period|Other|28|||
124619417|NCT03316547|448221760|FG000|Overall Study|Death|3|||
124619418|NCT03316547|448221761|FG001|Overall Study|Death|1|||
124619419|NCT03316547|448221760|FG000|Overall Study|Lost to Follow-up|6|||
124619420|NCT03316547|448221761|FG001|Overall Study|Lost to Follow-up|6|||
124619421|NCT03316547|448221760|FG000|Overall Study|Withdrawal by Subject|3|||
124619422|NCT03316547|448221761|FG001|Overall Study|Withdrawal by Subject|2|||
124619423|NCT03316547|448221760|FG000|Overall Study|Transfer to another hospital|6|||
124619424|NCT03316547|448221761|FG001|Overall Study|Transfer to another hospital|4|||
124619425|NCT00721227|448221762|FG000|Overall Study|Lost to Follow-up|3|||
124619426|NCT00721227|448221763|FG001|Overall Study|Lost to Follow-up|0|||
124619427|NCT00721227|448221762|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
124619428|NCT00721227|448221763|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
124619429|NCT02759692|448221764|FG000|Period 1|Test article no longer available|1|||
124619430|NCT02759692|448221765|FG001|Period 1|Test article no longer available|1|||
124619431|NCT02759692|448221764|FG000|Period 1|No longer meets eligibility criteria.|1|||
124619432|NCT02759692|448221765|FG001|Period 1|No longer meets eligibility criteria.|0|||
124619433|NCT02759692|448221764|FG000|Period 1|Miss-Randomized|1|||
124619434|NCT02759692|448221765|FG001|Period 1|Miss-Randomized|1|||
124619435|NCT02759692|448221764|FG000|Period 2|Lost to Follow-up|1|||
124782413|NCT04535453|448832847|FG000|Overall Study|Withdrawal by Subject|3|||
124782414|NCT04535453|448832848|FG001|Overall Study|Withdrawal by Subject|6|||
124782415|NCT04535453|448832849|FG002|Overall Study|Withdrawal by Subject|3|||
124782416|NCT04535453|448832850|FG003|Overall Study|Withdrawal by Subject|3|||
124782417|NCT04535453|448832851|FG004|Overall Study|Withdrawal by Subject|2|||
124782418|NCT04535453|448832852|FG005|Overall Study|Withdrawal by Subject|1|||
124782419|NCT04535453|448832853|FG006|Overall Study|Withdrawal by Subject|1|||
124782420|NCT04535453|448832854|FG007|Overall Study|Withdrawal by Subject|1|||
124782421|NCT04535453|448832855|FG008|Overall Study|Withdrawal by Subject|1|||
124782422|NCT04535453|448832856|FG009|Overall Study|Withdrawal by Subject|1|||
124782423|NCT04535453|448832857|FG010|Overall Study|Withdrawal by Subject|0|||
124782424|NCT04535453|448832858|FG011|Overall Study|Withdrawal by Subject|1|||
124782425|NCT04535453|448832847|FG000|Overall Study|Other|0|||
124782426|NCT04535453|448832848|FG001|Overall Study|Other|0|||
124782427|NCT04535453|448832849|FG002|Overall Study|Other|1|||
124782428|NCT04535453|448832850|FG003|Overall Study|Other|0|||
124782429|NCT04535453|448832851|FG004|Overall Study|Other|1|||
124782430|NCT04535453|448832852|FG005|Overall Study|Other|0|||
124782431|NCT04535453|448832853|FG006|Overall Study|Other|1|||
124782432|NCT04535453|448832854|FG007|Overall Study|Other|1|||
124782433|NCT04535453|448832855|FG008|Overall Study|Other|1|||
124782434|NCT04535453|448832856|FG009|Overall Study|Other|0|||
124619436|NCT02759692|448221765|FG001|Period 2|Lost to Follow-up|0|||
124619437|NCT02759692|448221764|FG000|Period 2|Test article no longer available|0|||
124782435|NCT04535453|448832857|FG010|Overall Study|Other|0|||
124782436|NCT04535453|448832858|FG011|Overall Study|Other|0|||
124782437|NCT00916929|448832859|FG000|Overall Study|Lost to Follow-up|1|||
124782438|NCT00916929|448832860|FG001|Overall Study|Lost to Follow-up|3|||
124619438|NCT02759692|448221765|FG001|Period 2|Test article no longer available|1|||
124619439|NCT00451178|448221766|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
124619440|NCT00451178|448221767|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
124619441|NCT00451178|448221766|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
124782439|NCT00916929|448832859|FG000|Overall Study|Death|5|||
124782440|NCT00916929|448832860|FG001|Overall Study|Death|10|||
124782441|NCT00916929|448832859|FG000|Overall Study|Withdrawal by Subject|1|||
124619442|NCT00451178|448221767|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
124619443|NCT00451178|448221766|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
124619444|NCT00451178|448221767|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
124619445|NCT00451178|448221766|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
124619446|NCT00451178|448221767|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
124619447|NCT00451178|448221766|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
124619448|NCT00451178|448221767|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
124619449|NCT00451178|448221766|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
124619450|NCT00451178|448221767|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
124619451|NCT00451178|448221766|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
124619452|NCT00451178|448221767|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
124619453|NCT00451178|448221766|FG000|Prior to Maintenance Therapy|PD|2|||
124619454|NCT00451178|448221767|FG001|Prior to Maintenance Therapy|PD|0|||
124619455|NCT00451178|448221766|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
124619456|NCT00451178|448221767|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
124619457|NCT00451178|448221766|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
124619458|NCT00451178|448221767|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
124619459|NCT00451178|448221766|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
124619460|NCT00451178|448221767|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
124619461|NCT00451178|448221766|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
124619462|NCT00451178|448221767|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
124619463|NCT00451178|448221766|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
124619464|NCT00451178|448221767|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
124619465|NCT00451178|448221766|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
124619466|NCT00451178|448221767|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
124619467|NCT00451178|448221766|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
124619468|NCT00451178|448221767|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
124619469|NCT01243775|448221768|FG000|Overall Study|Withdrawal by Subject|2|||
124619470|NCT03207867|448221769|FG000|Overall Study|Adverse Event|1|||
124619471|NCT03207867|448221770|FG001|Overall Study|Adverse Event|0|||
124619472|NCT03207867|448221771|FG002|Overall Study|Adverse Event|1|||
124619473|NCT03207867|448221772|FG003|Overall Study|Adverse Event|0|||
124619474|NCT03207867|448221773|FG004|Overall Study|Adverse Event|0|||
124619475|NCT03207867|448221774|FG005|Overall Study|Adverse Event|2|||
124619476|NCT03207867|448221775|FG006|Overall Study|Adverse Event|1|||
124619477|NCT03207867|448221776|FG007|Overall Study|Adverse Event|1|||
124619478|NCT03207867|448221777|FG008|Overall Study|Adverse Event|2|||
124619479|NCT03207867|448221778|FG009|Overall Study|Adverse Event|2|||
124619480|NCT03207867|448221779|FG010|Overall Study|Adverse Event|0|||
124619481|NCT03207867|448221780|FG011|Overall Study|Adverse Event|0|||
124619482|NCT03207867|448221781|FG012|Overall Study|Adverse Event|0|||
124619483|NCT03207867|448221782|FG013|Overall Study|Adverse Event|0|||
124619484|NCT03207867|448221783|FG014|Overall Study|Adverse Event|0|||
124619485|NCT03207867|448221784|FG015|Overall Study|Adverse Event|0|||
124619486|NCT03207867|448221785|FG016|Overall Study|Adverse Event|3|||
124619487|NCT03207867|448221786|FG017|Overall Study|Adverse Event|1|||
124619488|NCT03207867|448221787|FG018|Overall Study|Adverse Event|2|||
124619489|NCT03207867|448221788|FG019|Overall Study|Adverse Event|1|||
124619490|NCT03207867|448221789|FG020|Overall Study|Adverse Event|0|||
124619491|NCT03207867|448221790|FG021|Overall Study|Adverse Event|0|||
124619492|NCT03207867|448221791|FG022|Overall Study|Adverse Event|0|||
124619493|NCT03207867|448221792|FG023|Overall Study|Adverse Event|0|||
124619494|NCT03207867|448221769|FG000|Overall Study|Death|0|||
124619495|NCT03207867|448221770|FG001|Overall Study|Death|0|||
124619496|NCT03207867|448221771|FG002|Overall Study|Death|0|||
124619497|NCT03207867|448221772|FG003|Overall Study|Death|0|||
124619498|NCT03207867|448221773|FG004|Overall Study|Death|0|||
124619499|NCT03207867|448221774|FG005|Overall Study|Death|1|||
124619500|NCT03207867|448221775|FG006|Overall Study|Death|0|||
124619501|NCT03207867|448221776|FG007|Overall Study|Death|3|||
124619502|NCT03207867|448221777|FG008|Overall Study|Death|1|||
124619503|NCT03207867|448221778|FG009|Overall Study|Death|2|||
124747816|NCT01793883|448697887|FG000|Overall Study|Subject noncompliance|0|||
124747817|NCT01793883|448697888|FG001|Overall Study|Subject noncompliance|1|||
124747818|NCT01793883|448697889|FG002|Overall Study|Subject noncompliance|1|||
124747819|NCT01793883|448697887|FG000|Overall Study|Lost to Follow-up|5|||
124747820|NCT01793883|448697888|FG001|Overall Study|Lost to Follow-up|1|||
124747821|NCT01793883|448697889|FG002|Overall Study|Lost to Follow-up|3|||
124747822|NCT01793883|448697887|FG000|Overall Study|Randomized in error|1|||
124747823|NCT01793883|448697888|FG001|Overall Study|Randomized in error|0|||
124747824|NCT01793883|448697889|FG002|Overall Study|Randomized in error|0|||
124619504|NCT03207867|448221779|FG010|Overall Study|Death|0|||
124619505|NCT03207867|448221780|FG011|Overall Study|Death|1|||
124619506|NCT03207867|448221781|FG012|Overall Study|Death|0|||
124619507|NCT03207867|448221782|FG013|Overall Study|Death|1|||
124619508|NCT03207867|448221783|FG014|Overall Study|Death|0|||
124619509|NCT03207867|448221784|FG015|Overall Study|Death|0|||
124747825|NCT01793883|448697887|FG000|Overall Study|Unable to complete spriometry|1|||
124747826|NCT01793883|448697888|FG001|Overall Study|Unable to complete spriometry|0|||
124747827|NCT01793883|448697889|FG002|Overall Study|Unable to complete spriometry|0|||
124747828|NCT01793883|448697887|FG000|Overall Study|Unable to complete measurements|1|||
124747829|NCT01793883|448697888|FG001|Overall Study|Unable to complete measurements|0|||
124747830|NCT01793883|448697889|FG002|Overall Study|Unable to complete measurements|0|||
124747831|NCT01793883|448697887|FG000|Overall Study|Met exclusion criteria|1|||
124747832|NCT01793883|448697888|FG001|Overall Study|Met exclusion criteria|0|||
124747833|NCT01793883|448697889|FG002|Overall Study|Met exclusion criteria|0|||
124747834|NCT01793883|448697887|FG000|Overall Study|Dosing error|0|||
124747835|NCT01793883|448697888|FG001|Overall Study|Dosing error|1|||
124747836|NCT01793883|448697889|FG002|Overall Study|Dosing error|0|||
124747837|NCT01793883|448697887|FG000|Overall Study|Respiratory distress during spirometry|0|||
124747838|NCT01793883|448697888|FG001|Overall Study|Respiratory distress during spirometry|0|||
124747839|NCT01793883|448697889|FG002|Overall Study|Respiratory distress during spirometry|1|||
124747840|NCT02478255|448697890|FG000|Overall Study|Physician Decision|6|||
124747841|NCT02478255|448697891|FG001|Overall Study|Physician Decision|0|||
124747842|NCT02478255|448697890|FG000|Overall Study|Withdrawal by Subject|2|||
124747843|NCT02478255|448697891|FG001|Overall Study|Withdrawal by Subject|0|||
124747844|NCT00761527|448697892|FG000|Overall Study|Adverse Event|3|||
124747845|NCT00761527|448697892|FG000|Overall Study|Poor Compliance|8|||
124747846|NCT00761527|448697892|FG000|Overall Study|Lost to Follow-up|9|||
124747847|NCT00761527|448697892|FG000|Overall Study|Unknown reason|2|||
124747848|NCT01730586|448697893|FG000|Overall Study|Progressive Disease|2|||
124747849|NCT01730586|448697893|FG000|Overall Study|Inadequate Trial|8|||
124747850|NCT01730586|448697893|FG000|Overall Study|Adverse Event|2|||
124747851|NCT01730586|448697893|FG000|Overall Study|Hospice|1|||
124747852|NCT01431963|448697894|FG000|Overall Study|Adverse Event|18|||
124747853|NCT01431963|448697894|FG000|Overall Study|Lack of Efficacy|7|||
124747854|NCT01431963|448697894|FG000|Overall Study|Protocol Violation|1|||
124747855|NCT01431963|448697894|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
124747856|NCT01431963|448697894|FG000|Overall Study|Physician Decision|4|||
124747857|NCT01431963|448697894|FG000|Overall Study|Withdrawal by Subject|3|||
124747858|NCT00619307|448697895|FG000|Overall Study|Adverse Event|0|||
124747859|NCT00619307|448697896|FG001|Overall Study|Adverse Event|1|||
124747860|NCT00619307|448697895|FG000|Overall Study|Lost to Follow-up|0|||
124747861|NCT00619307|448697896|FG001|Overall Study|Lost to Follow-up|1|||
124747862|NCT00619307|448697895|FG000|Overall Study|Protocol Violation|3|||
124747863|NCT00619307|448697896|FG001|Overall Study|Protocol Violation|0|||
124747864|NCT00619307|448697895|FG000|Overall Study|Withdrew consent|1|||
124747865|NCT00619307|448697896|FG001|Overall Study|Withdrew consent|0|||
124747866|NCT00619307|448697895|FG000|Overall Study|Severe migraine|0|||
124747867|NCT00619307|448697896|FG001|Overall Study|Severe migraine|1|||
124747868|NCT00619307|448697895|FG000|Overall Study|MS attack plus steroids|0|||
124747869|NCT00619307|448697896|FG001|Overall Study|MS attack plus steroids|1|||
124747870|NCT00547521|448697897|FG000|Short Term Study (4 Months)|Adverse Event|1|||
124747871|NCT00547521|448697898|FG001|Short Term Study (4 Months)|Adverse Event|0|||
124747872|NCT00547521|448697897|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
124747873|NCT00547521|448697898|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
124747874|NCT00547521|448697897|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
124747875|NCT00547521|448697898|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
124747876|NCT00547521|448697897|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
124747877|NCT00547521|448697898|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
124747878|NCT00547521|448697897|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
124747879|NCT00547521|448697898|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
124747880|NCT00547521|448697897|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
124747881|NCT00547521|448697898|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
124747882|NCT00547521|448697897|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
124747883|NCT00547521|448697898|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
124747884|NCT00547521|448697897|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
124747885|NCT00547521|448697898|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
124747886|NCT00547521|448697897|FG000|Long Term Extension (LTE) Study|Other|0|||
124747887|NCT00547521|448697898|FG001|Long Term Extension (LTE) Study|Other|2|||
124747888|NCT00547521|448697897|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
124747889|NCT00547521|448697898|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
124747890|NCT01769196|448699361|FG000|Overall Study|Adverse Event|24|||
124747891|NCT01769196|448699362|FG001|Overall Study|Adverse Event|20|||
124782442|NCT00916929|448832860|FG001|Overall Study|Withdrawal by Subject|5|||
124747892|NCT01769196|448699361|FG000|Overall Study|Death|21|||
124782443|NCT00916929|448832859|FG000|Overall Study|Left ventricular epicardial lead|1|||
124747893|NCT01769196|448699362|FG001|Overall Study|Death|26|||
124747894|NCT01769196|448699361|FG000|Overall Study|Investigator Discretion|7|||
124747895|NCT01769196|448699362|FG001|Overall Study|Investigator Discretion|3|||
124747896|NCT01769196|448699361|FG000|Overall Study|Lack of Efficacy|3|||
124747897|NCT01769196|448699362|FG001|Overall Study|Lack of Efficacy|2|||
124619510|NCT03207867|448221785|FG016|Overall Study|Death|0|||
124619511|NCT03207867|448221786|FG017|Overall Study|Death|2|||
124619512|NCT03207867|448221787|FG018|Overall Study|Death|0|||
124619513|NCT03207867|448221788|FG019|Overall Study|Death|1|||
124619514|NCT03207867|448221789|FG020|Overall Study|Death|0|||
124619515|NCT03207867|448221790|FG021|Overall Study|Death|0|||
124619516|NCT03207867|448221791|FG022|Overall Study|Death|0|||
124619517|NCT03207867|448221792|FG023|Overall Study|Death|0|||
124619518|NCT03207867|448221769|FG000|Overall Study|Physician Decision|3|||
124619519|NCT03207867|448221770|FG001|Overall Study|Physician Decision|5|||
124619520|NCT03207867|448221771|FG002|Overall Study|Physician Decision|0|||
124619521|NCT03207867|448221772|FG003|Overall Study|Physician Decision|3|||
124619522|NCT03207867|448221773|FG004|Overall Study|Physician Decision|2|||
124619523|NCT03207867|448221774|FG005|Overall Study|Physician Decision|0|||
124619524|NCT03207867|448221775|FG006|Overall Study|Physician Decision|0|||
124619525|NCT03207867|448221776|FG007|Overall Study|Physician Decision|0|||
124619526|NCT03207867|448221777|FG008|Overall Study|Physician Decision|4|||
124619527|NCT03207867|448221778|FG009|Overall Study|Physician Decision|2|||
124619528|NCT03207867|448221779|FG010|Overall Study|Physician Decision|0|||
124619529|NCT03207867|448221780|FG011|Overall Study|Physician Decision|4|||
124619530|NCT03207867|448221781|FG012|Overall Study|Physician Decision|0|||
124619531|NCT03207867|448221782|FG013|Overall Study|Physician Decision|0|||
124619532|NCT03207867|448221783|FG014|Overall Study|Physician Decision|2|||
124619533|NCT03207867|448221784|FG015|Overall Study|Physician Decision|1|||
124619534|NCT03207867|448221785|FG016|Overall Study|Physician Decision|1|||
124619535|NCT03207867|448221786|FG017|Overall Study|Physician Decision|2|||
124619536|NCT03207867|448221787|FG018|Overall Study|Physician Decision|1|||
124619537|NCT03207867|448221788|FG019|Overall Study|Physician Decision|3|||
124619538|NCT03207867|448221789|FG020|Overall Study|Physician Decision|0|||
124619539|NCT03207867|448221790|FG021|Overall Study|Physician Decision|0|||
124619540|NCT03207867|448221791|FG022|Overall Study|Physician Decision|0|||
124619541|NCT03207867|448221792|FG023|Overall Study|Physician Decision|0|||
124619542|NCT03207867|448221769|FG000|Overall Study|Progressive Disease|7|||
124619543|NCT03207867|448221770|FG001|Overall Study|Progressive Disease|7|||
124619544|NCT03207867|448221771|FG002|Overall Study|Progressive Disease|9|||
124619545|NCT03207867|448221772|FG003|Overall Study|Progressive Disease|10|||
124619546|NCT03207867|448221773|FG004|Overall Study|Progressive Disease|11|||
124619547|NCT03207867|448221774|FG005|Overall Study|Progressive Disease|10|||
124619548|NCT03207867|448221775|FG006|Overall Study|Progressive Disease|9|||
124619549|NCT03207867|448221776|FG007|Overall Study|Progressive Disease|8|||
124619550|NCT03207867|448221777|FG008|Overall Study|Progressive Disease|19|||
124619551|NCT03207867|448221778|FG009|Overall Study|Progressive Disease|23|||
124619552|NCT03207867|448221779|FG010|Overall Study|Progressive Disease|2|||
124619553|NCT03207867|448221780|FG011|Overall Study|Progressive Disease|24|||
124619554|NCT03207867|448221781|FG012|Overall Study|Progressive Disease|3|||
124619555|NCT03207867|448221782|FG013|Overall Study|Progressive Disease|11|||
124619556|NCT03207867|448221783|FG014|Overall Study|Progressive Disease|9|||
124619557|NCT03207867|448221784|FG015|Overall Study|Progressive Disease|5|||
124619558|NCT03207867|448221785|FG016|Overall Study|Progressive Disease|10|||
124619559|NCT03207867|448221786|FG017|Overall Study|Progressive Disease|14|||
124619560|NCT03207867|448221787|FG018|Overall Study|Progressive Disease|13|||
124619561|NCT03207867|448221788|FG019|Overall Study|Progressive Disease|14|||
124619562|NCT03207867|448221789|FG020|Overall Study|Progressive Disease|6|||
124619563|NCT03207867|448221790|FG021|Overall Study|Progressive Disease|3|||
124619564|NCT03207867|448221791|FG022|Overall Study|Progressive Disease|3|||
124619565|NCT03207867|448221792|FG023|Overall Study|Progressive Disease|3|||
124619566|NCT03207867|448221769|FG000|Overall Study|Patient/guardian Decision|0|||
124619567|NCT03207867|448221770|FG001|Overall Study|Patient/guardian Decision|0|||
124619568|NCT03207867|448221771|FG002|Overall Study|Patient/guardian Decision|1|||
124619569|NCT03207867|448221772|FG003|Overall Study|Patient/guardian Decision|1|||
124619570|NCT03207867|448221773|FG004|Overall Study|Patient/guardian Decision|1|||
124619571|NCT03207867|448221774|FG005|Overall Study|Patient/guardian Decision|2|||
124619572|NCT03207867|448221775|FG006|Overall Study|Patient/guardian Decision|1|||
124619573|NCT03207867|448221776|FG007|Overall Study|Patient/guardian Decision|0|||
124619574|NCT03207867|448221777|FG008|Overall Study|Patient/guardian Decision|1|||
124619575|NCT03207867|448221778|FG009|Overall Study|Patient/guardian Decision|0|||
124619576|NCT03207867|448221779|FG010|Overall Study|Patient/guardian Decision|0|||
124782444|NCT00916929|448832860|FG001|Overall Study|Left ventricular epicardial lead|2|||
124619577|NCT03207867|448221780|FG011|Overall Study|Patient/guardian Decision|1|||
124782445|NCT00916929|448832859|FG000|Overall Study|Transferred to hospice care|1|||
124619578|NCT03207867|448221781|FG012|Overall Study|Patient/guardian Decision|0|||
124619579|NCT03207867|448221782|FG013|Overall Study|Patient/guardian Decision|1|||
124619580|NCT03207867|448221783|FG014|Overall Study|Patient/guardian Decision|2|||
124619581|NCT03207867|448221784|FG015|Overall Study|Patient/guardian Decision|0|||
124619582|NCT03207867|448221785|FG016|Overall Study|Patient/guardian Decision|1|||
124619583|NCT03207867|448221786|FG017|Overall Study|Patient/guardian Decision|3|||
124619584|NCT03207867|448221787|FG018|Overall Study|Patient/guardian Decision|4|||
124619585|NCT03207867|448221788|FG019|Overall Study|Patient/guardian Decision|1|||
124619586|NCT03207867|448221789|FG020|Overall Study|Patient/guardian Decision|0|||
124619587|NCT03207867|448221790|FG021|Overall Study|Patient/guardian Decision|0|||
124747898|NCT01769196|448699361|FG000|Overall Study|Progressive disease|11|||
124747899|NCT01769196|448699362|FG001|Overall Study|Progressive disease|6|||
124747900|NCT01769196|448699361|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
124747901|NCT01769196|448699362|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
124747902|NCT01769196|448699361|FG000|Overall Study|Protocol Violation|0|||
124747903|NCT01769196|448699362|FG001|Overall Study|Protocol Violation|3|||
124747904|NCT01769196|448699361|FG000|Overall Study|Study terminated by sponsor|160|||
124747905|NCT01769196|448699362|FG001|Overall Study|Study terminated by sponsor|161|||
124747906|NCT01769196|448699361|FG000|Overall Study|Participant never dosed with study drug|1|||
124747907|NCT01769196|448699362|FG001|Overall Study|Participant never dosed with study drug|0|||
124747908|NCT01769196|448699361|FG000|Overall Study|Withdrew consent|36|||
124747909|NCT01769196|448699362|FG001|Overall Study|Withdrew consent|40|||
124747910|NCT03499314|448699363|FG000|Overall Study|Time Commitment|1|||
124747911|NCT03499314|448699364|FG001|Overall Study|Time Commitment|2|||
124747912|NCT03499314|448699363|FG000|Overall Study|Medical issue unrelated to research study|1|||
124747913|NCT03499314|448699364|FG001|Overall Study|Medical issue unrelated to research study|1|||
124747914|NCT00655629|448699367|FG000|Overall Study|Adverse Event|4|||
124747915|NCT00655629|448699368|FG001|Overall Study|Adverse Event|1|||
124747916|NCT00655629|448699367|FG000|Overall Study|Lack of Efficacy|2|||
124747917|NCT00655629|448699368|FG001|Overall Study|Lack of Efficacy|12|||
124747918|NCT00655629|448699367|FG000|Overall Study|Lost to Follow-up|4|||
124747919|NCT00655629|448699368|FG001|Overall Study|Lost to Follow-up|3|||
124747920|NCT00655629|448699367|FG000|Overall Study|Protocol Violation|5|||
124747921|NCT00655629|448699368|FG001|Overall Study|Protocol Violation|3|||
124747922|NCT00655629|448699367|FG000|Overall Study|consent withdrawn|6|||
124747923|NCT00655629|448699368|FG001|Overall Study|consent withdrawn|4|||
124747924|NCT00705367|448699371|FG000|Long-term Extension Period|Adverse Event|2|||
124747925|NCT00705367|448699372|FG001|Long-term Extension Period|Adverse Event|0|||
124747926|NCT00705367|448699371|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
124747927|NCT00705367|448699372|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
124747928|NCT00705367|448699371|FG000|Long-term Extension Period|Lack of Efficacy|1|||
124747929|NCT00705367|448699372|FG001|Long-term Extension Period|Lack of Efficacy|0|||
124747930|NCT00705367|448699371|FG000|Long-term Extension Period|No longer met study criteria|1|||
124747931|NCT00705367|448699372|FG001|Long-term Extension Period|No longer met study criteria|0|||
124747932|NCT00705367|448699371|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
124747933|NCT00705367|448699372|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
124747934|NCT03149055|448699377|FG000|Overall Study|Not treated|4|||
124747935|NCT04440813|448699378|FG000|Overall Study|Lost to Follow-up|5|||
124747936|NCT04440813|448699379|FG001|Overall Study|Lost to Follow-up|5|||
124747937|NCT02629822|448699380|FG000|Base Study|Lost to Follow-up|2|||
124747938|NCT02629822|448699380|FG000|Base Study|Non-Compliance With Study Drug|1|||
124747939|NCT02629822|448699380|FG000|Extension Study|Adverse Event|1|||
124747940|NCT02629822|448699380|FG000|Extension Study|Lost to Follow-up|1|||
124747941|NCT00741013|448699381|FG000|Overall Study|Adverse Event|1|||
124747942|NCT00741013|448699382|FG001|Overall Study|Adverse Event|0|||
124747943|NCT00741013|448699383|FG002|Overall Study|Adverse Event|0|||
124747944|NCT00741013|448699381|FG000|Overall Study|Withdrawal by Subject|0|||
124747945|NCT00741013|448699382|FG001|Overall Study|Withdrawal by Subject|0|||
124747946|NCT00741013|448699383|FG002|Overall Study|Withdrawal by Subject|1|||
124747947|NCT00741013|448699381|FG000|Overall Study|Discovered failed screen after enrolled|0|||
124747948|NCT00741013|448699382|FG001|Overall Study|Discovered failed screen after enrolled|2|||
124747949|NCT00741013|448699383|FG002|Overall Study|Discovered failed screen after enrolled|0|||
124747950|NCT00193180|448699387|FG000|Overall Study|Lack of Efficacy|1|||
124747951|NCT00193180|448699387|FG000|Overall Study|Adverse Event|8|||
124747952|NCT00193180|448699387|FG000|Overall Study|Protocol Violation|1|||
124747953|NCT00539305|448699388|FG000|Overall Study|Adverse Event|1|||
124747954|NCT00539305|448699389|FG001|Overall Study|Adverse Event|0|||
124747955|NCT00539305|448699388|FG000|Overall Study|Substance Use|0|||
124747956|NCT00539305|448699389|FG001|Overall Study|Substance Use|1|||
124747957|NCT00539305|448699388|FG000|Overall Study|Withdrawal by Subject|0|||
124747958|NCT00539305|448699389|FG001|Overall Study|Withdrawal by Subject|1|||
124747959|NCT01331109|448699401|FG000|Overall Study|Adverse Event|6|||
124747960|NCT01331109|448699401|FG000|Overall Study|Lack of Efficacy|2|||
124747961|NCT01331109|448699401|FG000|Overall Study|Protocol Violation|3|||
124747962|NCT01331109|448699401|FG000|Overall Study|Withdrawal by Subject|7|||
124747963|NCT01331109|448699401|FG000|Overall Study|Lost to Follow-up|1|||
124747964|NCT01331109|448699401|FG000|Overall Study|Study Terminated by Sponsor|38|||
124747965|NCT00661622|448699404|FG000|Overall Study|Protocol Violation|1|||
124747966|NCT00661622|448699405|FG001|Overall Study|Protocol Violation|0|||
124747967|NCT00098306|448699410|FG000|Double Blind|Randomized, not treated|9|||
124747968|NCT00098306|448699411|FG001|Double Blind|Randomized, not treated|5|||
124747969|NCT00098306|448699412|FG002|Double Blind|Randomized, not treated|2|||
124747970|NCT00098306|448699413|FG003|Double Blind|Randomized, not treated|0|||
124747971|NCT00098306|448699414|FG004|Double Blind|Randomized, not treated|0|||
124782446|NCT00916929|448832860|FG001|Overall Study|Transferred to hospice care|1|||
124747972|NCT00098306|448699415|FG005|Double Blind|Randomized, not treated|0|||
124782447|NCT00916929|448832859|FG000|Overall Study|System explant|1|||
124782448|NCT00916929|448832860|FG001|Overall Study|System explant|0|||
124782449|NCT00916929|448832859|FG000|Overall Study|Moved to another state|0|||
124782450|NCT00916929|448832860|FG001|Overall Study|Moved to another state|1|||
124782451|NCT00916929|448832859|FG000|Overall Study|Device unable to process impedance data|0|||
124782452|NCT00916929|448832860|FG001|Overall Study|Device unable to process impedance data|7|||
124782453|NCT02929407|448832861|FG000|Overall Study|Adverse Event|1|||
124782454|NCT02442804|448832865|FG000|Overall Study|Withdrawal by Subject|0|||
124782455|NCT02442804|448832866|FG001|Overall Study|Withdrawal by Subject|1|||
124782456|NCT02442804|448832865|FG000|Overall Study|Adverse Event|1|||
124782457|NCT02442804|448832866|FG001|Overall Study|Adverse Event|0|||
124782458|NCT02036853|448832867|FG000|Overall Study|Adverse Event|0|||
124782459|NCT02036853|448832868|FG001|Overall Study|Adverse Event|2|||
124782460|NCT02036853|448832867|FG000|Overall Study|Lack of Efficacy|0|||
124782461|NCT02036853|448832868|FG001|Overall Study|Lack of Efficacy|2|||
124782462|NCT02036853|448832867|FG000|Overall Study|Physician Decision|0|||
124782463|NCT02036853|448832868|FG001|Overall Study|Physician Decision|1|||
124782464|NCT02036853|448832867|FG000|Overall Study|Withdrawal by Subject|0|||
124782465|NCT02036853|448832868|FG001|Overall Study|Withdrawal by Subject|1|||
124782466|NCT01742286|448832869|FG000|Escalation Phase|Administrative problems|1|||
124782467|NCT01742286|448832870|FG001|Escalation Phase|Administrative problems|1|||
124782468|NCT01742286|448832871|FG002|Escalation Phase|Administrative problems|0|||
124782469|NCT01742286|448832872|FG003|Escalation Phase|Administrative problems|0|||
124782470|NCT01742286|448832873|FG004|Escalation Phase|Administrative problems|0|||
124782471|NCT01742286|448832874|FG005|Escalation Phase|Administrative problems|0|||
124782472|NCT01742286|448832875|FG006|Escalation Phase|Administrative problems|2|||
124782473|NCT01742286|448832869|FG000|Escalation Phase|Adverse Event|0|||
124782474|NCT01742286|448832870|FG001|Escalation Phase|Adverse Event|1|||
124782475|NCT01742286|448832871|FG002|Escalation Phase|Adverse Event|2|||
124782476|NCT01742286|448832872|FG003|Escalation Phase|Adverse Event|0|||
124782477|NCT01742286|448832873|FG004|Escalation Phase|Adverse Event|0|||
124782478|NCT01742286|448832874|FG005|Escalation Phase|Adverse Event|1|||
124782479|NCT01742286|448832875|FG006|Escalation Phase|Adverse Event|0|||
124782480|NCT01742286|448832869|FG000|Escalation Phase|Disease progression|3|||
124782481|NCT01742286|448832870|FG001|Escalation Phase|Disease progression|7|||
124782482|NCT01742286|448832871|FG002|Escalation Phase|Disease progression|4|||
124782483|NCT01742286|448832872|FG003|Escalation Phase|Disease progression|1|||
124782484|NCT01742286|448832873|FG004|Escalation Phase|Disease progression|4|||
124782485|NCT01742286|448832874|FG005|Escalation Phase|Disease progression|3|||
124782486|NCT01742286|448832875|FG006|Escalation Phase|Disease progression|2|||
124782487|NCT01742286|448832869|FG000|Escalation Phase|Death|0|||
124782488|NCT01742286|448832870|FG001|Escalation Phase|Death|0|||
124782489|NCT01742286|448832871|FG002|Escalation Phase|Death|0|||
124782490|NCT01742286|448832872|FG003|Escalation Phase|Death|0|||
124782491|NCT01742286|448832873|FG004|Escalation Phase|Death|0|||
124782492|NCT01742286|448832874|FG005|Escalation Phase|Death|1|||
124782493|NCT01742286|448832875|FG006|Escalation Phase|Death|0|||
124782494|NCT01742286|448832869|FG000|Escalation Phase|Physician Decision|0|||
124782495|NCT01742286|448832870|FG001|Escalation Phase|Physician Decision|3|||
124782496|NCT01742286|448832871|FG002|Escalation Phase|Physician Decision|0|||
124782497|NCT01742286|448832872|FG003|Escalation Phase|Physician Decision|1|||
124619588|NCT03207867|448221791|FG022|Overall Study|Patient/guardian Decision|0|||
124619589|NCT03207867|448221792|FG023|Overall Study|Patient/guardian Decision|0|||
124619590|NCT02447744|448221793|FG000|Overall Study|Withdrawal by Subject|3|||
124619591|NCT02447744|448221794|FG001|Overall Study|Withdrawal by Subject|1|||
124619592|NCT02447744|448221793|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
124619593|NCT02447744|448221794|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
124619594|NCT05422625|448221795|FG000|Overall Study|Withdrawal by Subject|1|||
124619595|NCT05422625|448221796|FG001|Overall Study|Withdrawal by Subject|0|||
124619596|NCT00678210|448223655|FG000|Overall Study|Adverse Event|1|||
124619597|NCT00678210|448223656|FG001|Overall Study|Adverse Event|2|||
124619598|NCT00678210|448223657|FG002|Overall Study|Adverse Event|3|||
124619599|NCT00678210|448223658|FG003|Overall Study|Adverse Event|3|||
124619600|NCT00678210|448223655|FG000|Overall Study|Lack of Efficacy|2|||
124619601|NCT00678210|448223656|FG001|Overall Study|Lack of Efficacy|3|||
124619602|NCT00678210|448223657|FG002|Overall Study|Lack of Efficacy|1|||
124619603|NCT00678210|448223658|FG003|Overall Study|Lack of Efficacy|9|||
124619604|NCT00678210|448223655|FG000|Overall Study|Lost to Follow-up|4|||
124619605|NCT00678210|448223656|FG001|Overall Study|Lost to Follow-up|2|||
124619606|NCT00678210|448223657|FG002|Overall Study|Lost to Follow-up|0|||
124619607|NCT00678210|448223658|FG003|Overall Study|Lost to Follow-up|1|||
124619608|NCT00678210|448223655|FG000|Overall Study|Withdrawal by Subject|3|||
124782498|NCT01742286|448832873|FG004|Escalation Phase|Physician Decision|0|||
124619609|NCT00678210|448223656|FG001|Overall Study|Withdrawal by Subject|4|||
124782499|NCT01742286|448832874|FG005|Escalation Phase|Physician Decision|0|||
124782500|NCT01742286|448832875|FG006|Escalation Phase|Physician Decision|2|||
124782501|NCT01742286|448832869|FG000|Escalation Phase|Subject/guardian decision|1|||
124782502|NCT01742286|448832870|FG001|Escalation Phase|Subject/guardian decision|0|||
124619610|NCT00678210|448223657|FG002|Overall Study|Withdrawal by Subject|1|||
124619611|NCT00678210|448223658|FG003|Overall Study|Withdrawal by Subject|7|||
124619612|NCT00678210|448223655|FG000|Overall Study|Other|1|||
124619613|NCT00678210|448223656|FG001|Overall Study|Other|0|||
124619614|NCT00678210|448223657|FG002|Overall Study|Other|1|||
124619615|NCT00678210|448223658|FG003|Overall Study|Other|0|||
124619616|NCT04825912|448223659|FG000|Overall Study|Death|3|||
124619617|NCT04825912|448223659|FG000|Overall Study|Withdrawal by Subject|1|||
124619618|NCT02077140|448223660|FG000|Overall Study|Lost to Follow-up|4|||
124619619|NCT02077140|448223661|FG001|Overall Study|Lost to Follow-up|1|||
124619620|NCT02077140|448223662|FG002|Overall Study|Lost to Follow-up|2|||
124619621|NCT02077140|448223663|FG003|Overall Study|Lost to Follow-up|2|||
124619622|NCT02077140|448223664|FG004|Overall Study|Lost to Follow-up|3|||
124619623|NCT02077140|448223660|FG000|Overall Study|Withdrawal by Subject|0|||
124619624|NCT02077140|448223661|FG001|Overall Study|Withdrawal by Subject|1|||
124619625|NCT02077140|448223662|FG002|Overall Study|Withdrawal by Subject|0|||
124619626|NCT02077140|448223663|FG003|Overall Study|Withdrawal by Subject|2|||
124619627|NCT02077140|448223664|FG004|Overall Study|Withdrawal by Subject|2|||
124619628|NCT01009814|448223667|FG000|Overall Study|No longer met study criteria|1|||
124619629|NCT01009814|448223668|FG001|Overall Study|No longer met study criteria|1|||
124619630|NCT01009814|448223669|FG002|Overall Study|No longer met study criteria|0|||
124619631|NCT01009814|448223670|FG003|Overall Study|No longer met study criteria|0|||
124619632|NCT01009814|448223671|FG004|Overall Study|No longer met study criteria|0|||
124619633|NCT00618371|448223672|FG000|Overall Study|Withdrawal by Subject|2|||
124619634|NCT03022084|448223675|FG000|Overall Study|Lost to Follow-up|2|||
124619635|NCT03022084|448223676|FG001|Overall Study|Lost to Follow-up|3|||
124619636|NCT00517881|448223677|FG000|Overall Study|Protocol Violation|2|||
124619637|NCT00517881|448223677|FG000|Overall Study|Adverse Event|1|||
124619638|NCT00517881|448223677|FG000|Overall Study|Renal transplantation|2|||
124619639|NCT01207583|448223678|FG000|Overall Study|Withdrawal by Subject|0|||
124619640|NCT01207583|448223679|FG001|Overall Study|Withdrawal by Subject|3|||
124619641|NCT01207583|448223680|FG002|Overall Study|Withdrawal by Subject|1|||
124619642|NCT01207583|448223678|FG000|Overall Study|Participant failed to return|1|||
124619643|NCT01207583|448223679|FG001|Overall Study|Participant failed to return|0|||
124619644|NCT01207583|448223680|FG002|Overall Study|Participant failed to return|0|||
124619645|NCT01207583|448223678|FG000|Overall Study|Lost to Follow-up|0|||
124619646|NCT01207583|448223679|FG001|Overall Study|Lost to Follow-up|2|||
124619647|NCT01207583|448223680|FG002|Overall Study|Lost to Follow-up|0|||
124619648|NCT01383707|448223685|FG000|Overall Study|Consent withdrawal|6|||
124619649|NCT01383707|448223685|FG000|Overall Study|Death|19|||
124619650|NCT01383707|448223685|FG000|Overall Study|Other|8|||
124619651|NCT01383707|448223685|FG000|Overall Study|Sponsor's decision|2|||
124619652|NCT01383707|448223685|FG000|Overall Study|Adverse Event|14|||
124619653|NCT01383707|448223685|FG000|Overall Study|Progressive disease|23|||
124619654|NCT02129608|448223688|FG000|Overall Study|Lost to Follow-up|0|||
124619655|NCT02129608|448223689|FG001|Overall Study|Lost to Follow-up|1|||
124619656|NCT02129608|448223690|FG002|Overall Study|Lost to Follow-up|1|||
124619657|NCT02129608|448223688|FG000|Overall Study|Withdrawal by Subject|0|||
124619658|NCT02129608|448223689|FG001|Overall Study|Withdrawal by Subject|0|||
124619659|NCT02129608|448223690|FG002|Overall Study|Withdrawal by Subject|2|||
124619660|NCT03336528|448223691|FG000|Overall Study|Protocol Violation|1|||
124619661|NCT03336528|448223692|FG001|Overall Study|Protocol Violation|1|||
124619662|NCT03336528|448223691|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
124619663|NCT03336528|448223692|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
124619664|NCT03336528|448223691|FG000|Overall Study|Did not receive study medication|1|||
124619665|NCT03336528|448223692|FG001|Overall Study|Did not receive study medication|2|||
124619666|NCT02437903|448223693|FG000|Overall Study|Adverse Event|1|||
124619667|NCT02437903|448223693|FG000|Overall Study|Withdrawal by Subject|1|||
124619668|NCT02437903|448223693|FG000|Overall Study|Lost to Follow-up|3|||
124619669|NCT00230178|448223696|FG000|Overall Study|Adverse Event|1|||
124619670|NCT00230178|448223697|FG001|Overall Study|Adverse Event|5|||
124619671|NCT00230178|448223698|FG002|Overall Study|Adverse Event|2|||
124619672|NCT00230178|448223696|FG000|Overall Study|Withdrawal by Subject|0|||
124619673|NCT00230178|448223697|FG001|Overall Study|Withdrawal by Subject|0|||
124619674|NCT00230178|448223698|FG002|Overall Study|Withdrawal by Subject|1|||
124619675|NCT00230178|448223696|FG000|Overall Study|Various other reasons|3|||
124619676|NCT00230178|448223697|FG001|Overall Study|Various other reasons|2|||
124619677|NCT00230178|448223698|FG002|Overall Study|Various other reasons|4|||
124619678|NCT04172597|448223705|FG000|Overall Study|Disease Progression|0|||
124619679|NCT04172597|448223706|FG001|Overall Study|Disease Progression|0|||
124619680|NCT04172597|448223707|FG002|Overall Study|Disease Progression|0|||
124619681|NCT04172597|448223708|FG003|Overall Study|Disease Progression|0|||
124619682|NCT04172597|448223709|FG004|Overall Study|Disease Progression|1|||
124619683|NCT00794339|448223710|FG000|Overall Study|Withdrawal by Subject|3|||
124619684|NCT00794339|448223710|FG000|Overall Study|Ineligible|4|||
124619685|NCT00794339|448223710|FG000|Overall Study|Tx prior to ATSM|3|||
124619686|NCT00794339|448223710|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
124747973|NCT00098306|448699416|FG006|Double Blind|Randomized, not treated|0|||
124747974|NCT00098306|448699410|FG000|Double Blind|Ongoing at cut-off date|151|||
124747975|NCT00098306|448699411|FG001|Double Blind|Ongoing at cut-off date|166|||
124747976|NCT00098306|448699412|FG002|Double Blind|Ongoing at cut-off date|72|||
124747977|NCT00098306|448699413|FG003|Double Blind|Ongoing at cut-off date|0|||
124747978|NCT00098306|448699414|FG004|Double Blind|Ongoing at cut-off date|0|||
124747979|NCT00098306|448699415|FG005|Double Blind|Ongoing at cut-off date|0|||
124747980|NCT00098306|448699416|FG006|Double Blind|Ongoing at cut-off date|0|||
124747981|NCT00098306|448699410|FG000|Double Blind|Adverse Event|11|||
124747982|NCT00098306|448699411|FG001|Double Blind|Adverse Event|10|||
124747983|NCT00098306|448699412|FG002|Double Blind|Adverse Event|6|||
124747984|NCT00098306|448699413|FG003|Double Blind|Adverse Event|0|||
124747985|NCT00098306|448699414|FG004|Double Blind|Adverse Event|0|||
124747986|NCT00098306|448699415|FG005|Double Blind|Adverse Event|0|||
124747987|NCT00098306|448699416|FG006|Double Blind|Adverse Event|0|||
124747988|NCT00098306|448699410|FG000|Double Blind|Lack of Efficacy|43|||
124747989|NCT00098306|448699411|FG001|Double Blind|Lack of Efficacy|34|||
124747990|NCT00098306|448699412|FG002|Double Blind|Lack of Efficacy|17|||
124747991|NCT00098306|448699413|FG003|Double Blind|Lack of Efficacy|0|||
124747992|NCT00098306|448699414|FG004|Double Blind|Lack of Efficacy|0|||
124747993|NCT00098306|448699415|FG005|Double Blind|Lack of Efficacy|0|||
124747994|NCT00098306|448699416|FG006|Double Blind|Lack of Efficacy|0|||
124747995|NCT00098306|448699410|FG000|Double Blind|Death|1|||
124747996|NCT00098306|448699411|FG001|Double Blind|Death|4|||
124747997|NCT00098306|448699412|FG002|Double Blind|Death|1|||
124747998|NCT00098306|448699413|FG003|Double Blind|Death|0|||
124747999|NCT00098306|448699414|FG004|Double Blind|Death|0|||
124748000|NCT00098306|448699415|FG005|Double Blind|Death|0|||
124748001|NCT00098306|448699416|FG006|Double Blind|Death|0|||
124748002|NCT00098306|448699410|FG000|Double Blind|Participant defaulted|19|||
124748003|NCT00098306|448699411|FG001|Double Blind|Participant defaulted|18|||
124748004|NCT00098306|448699412|FG002|Double Blind|Participant defaulted|11|||
124748005|NCT00098306|448699413|FG003|Double Blind|Participant defaulted|0|||
124748006|NCT00098306|448699414|FG004|Double Blind|Participant defaulted|0|||
124748007|NCT00098306|448699415|FG005|Double Blind|Participant defaulted|0|||
124748008|NCT00098306|448699416|FG006|Double Blind|Participant defaulted|0|||
124748009|NCT00098306|448699410|FG000|Double Blind|Un-specified|7|||
124748010|NCT00098306|448699411|FG001|Double Blind|Un-specified|3|||
124748011|NCT00098306|448699412|FG002|Double Blind|Un-specified|11|||
124748012|NCT00098306|448699413|FG003|Double Blind|Un-specified|0|||
124748013|NCT00098306|448699414|FG004|Double Blind|Un-specified|0|||
124748014|NCT00098306|448699415|FG005|Double Blind|Un-specified|0|||
124748015|NCT00098306|448699416|FG006|Double Blind|Un-specified|0|||
124748016|NCT00098306|448699410|FG000|Open Label|Lack of Efficacy|0|||
124748017|NCT00098306|448699411|FG001|Open Label|Lack of Efficacy|0|||
124748018|NCT00098306|448699412|FG002|Open Label|Lack of Efficacy|0|||
124748019|NCT00098306|448699413|FG003|Open Label|Lack of Efficacy|13|||
124748020|NCT00098306|448699414|FG004|Open Label|Lack of Efficacy|0|||
124748021|NCT00098306|448699415|FG005|Open Label|Lack of Efficacy|0|||
124748022|NCT00098306|448699416|FG006|Open Label|Lack of Efficacy|0|||
124748023|NCT00098306|448699410|FG000|Open Label|Adverse Event|0|||
124748024|NCT00098306|448699411|FG001|Open Label|Adverse Event|0|||
124748025|NCT00098306|448699412|FG002|Open Label|Adverse Event|0|||
124748026|NCT00098306|448699413|FG003|Open Label|Adverse Event|2|||
124748027|NCT00098306|448699414|FG004|Open Label|Adverse Event|0|||
124748028|NCT00098306|448699415|FG005|Open Label|Adverse Event|0|||
124748029|NCT00098306|448699416|FG006|Open Label|Adverse Event|0|||
124748030|NCT00098306|448699410|FG000|Open Label|Death|0|||
124748031|NCT00098306|448699411|FG001|Open Label|Death|0|||
124748032|NCT00098306|448699412|FG002|Open Label|Death|0|||
124748033|NCT00098306|448699413|FG003|Open Label|Death|4|||
124748034|NCT00098306|448699414|FG004|Open Label|Death|0|||
124748035|NCT00098306|448699415|FG005|Open Label|Death|0|||
124748036|NCT00098306|448699416|FG006|Open Label|Death|0|||
124748037|NCT00098306|448699410|FG000|Open Label|Participant defaulted|0|||
124748038|NCT00098306|448699411|FG001|Open Label|Participant defaulted|0|||
124748039|NCT00098306|448699412|FG002|Open Label|Participant defaulted|0|||
124748040|NCT00098306|448699413|FG003|Open Label|Participant defaulted|24|||
124748041|NCT00098306|448699414|FG004|Open Label|Participant defaulted|0|||
124748042|NCT00098306|448699415|FG005|Open Label|Participant defaulted|0|||
124748043|NCT00098306|448699416|FG006|Open Label|Participant defaulted|0|||
124748044|NCT00098306|448699410|FG000|Open Label|Un-specified|0|||
124748045|NCT00098306|448699411|FG001|Open Label|Un-specified|0|||
124748046|NCT00098306|448699412|FG002|Open Label|Un-specified|0|||
124748047|NCT00098306|448699413|FG003|Open Label|Un-specified|15|||
124748048|NCT00098306|448699414|FG004|Open Label|Un-specified|0|||
124748049|NCT00098306|448699415|FG005|Open Label|Un-specified|0|||
124748050|NCT00098306|448699416|FG006|Open Label|Un-specified|0|||
124748051|NCT00098306|448699410|FG000|Open Label|Ongoing at cut-off date|0|||
124748052|NCT00098306|448699411|FG001|Open Label|Ongoing at cut-off date|0|||
124748053|NCT00098306|448699412|FG002|Open Label|Ongoing at cut-off date|0|||
124748054|NCT00098306|448699413|FG003|Open Label|Ongoing at cut-off date|269|||
124748055|NCT00098306|448699414|FG004|Open Label|Ongoing at cut-off date|62|||
124748056|NCT00098306|448699415|FG005|Open Label|Ongoing at cut-off date|0|||
124748057|NCT00098306|448699416|FG006|Open Label|Ongoing at cut-off date|0|||
124748058|NCT00098306|448699410|FG000|Observational Phase|Death|0|||
124748059|NCT00098306|448699411|FG001|Observational Phase|Death|0|||
124748060|NCT00098306|448699412|FG002|Observational Phase|Death|0|||
124748061|NCT00098306|448699413|FG003|Observational Phase|Death|0|||
124748062|NCT00098306|448699414|FG004|Observational Phase|Death|0|||
124748063|NCT00098306|448699415|FG005|Observational Phase|Death|5|||
124748064|NCT00098306|448699416|FG006|Observational Phase|Death|4|||
124748065|NCT00098306|448699410|FG000|Observational Phase|Participant defaulted|0|||
124748066|NCT00098306|448699411|FG001|Observational Phase|Participant defaulted|0|||
124748067|NCT00098306|448699412|FG002|Observational Phase|Participant defaulted|0|||
124748068|NCT00098306|448699413|FG003|Observational Phase|Participant defaulted|0|||
124748069|NCT00098306|448699414|FG004|Observational Phase|Participant defaulted|0|||
124748070|NCT00098306|448699415|FG005|Observational Phase|Participant defaulted|34|||
124748071|NCT00098306|448699416|FG006|Observational Phase|Participant defaulted|18|||
124748072|NCT00098306|448699410|FG000|Observational Phase|Un-specified|0|||
124748073|NCT00098306|448699411|FG001|Observational Phase|Un-specified|0|||
124748074|NCT00098306|448699412|FG002|Observational Phase|Un-specified|0|||
124748075|NCT00098306|448699413|FG003|Observational Phase|Un-specified|0|||
124748076|NCT00098306|448699414|FG004|Observational Phase|Un-specified|0|||
124748077|NCT00098306|448699415|FG005|Observational Phase|Un-specified|7|||
124748078|NCT00098306|448699416|FG006|Observational Phase|Un-specified|4|||
124748079|NCT00932165|448699417|FG000|Overall Study|Lost to Follow-up|1|||
124748080|NCT00588094|448699418|FG000|Overall Study|Adverse Event|3|||
124748081|NCT00588094|448699418|FG000|Overall Study|Progression of Disease|2|||
124748082|NCT01336023|448699419|FG000|Week 0 to Week 26|Adverse Event|8|||
124748083|NCT01336023|448699420|FG001|Week 0 to Week 26|Adverse Event|10|||
124748084|NCT01336023|448699421|FG002|Week 0 to Week 26|Adverse Event|24|||
124748085|NCT01336023|448699419|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
124748086|NCT01336023|448699420|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
124748087|NCT01336023|448699421|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
124748088|NCT01336023|448699419|FG000|Week 0 to Week 26|Protocol Violation|1|||
124748089|NCT01336023|448699420|FG001|Week 0 to Week 26|Protocol Violation|2|||
124748090|NCT01336023|448699421|FG002|Week 0 to Week 26|Protocol Violation|0|||
124748091|NCT01336023|448699419|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
124748092|NCT01336023|448699420|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
124748093|NCT01336023|448699421|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
124748094|NCT01336023|448699419|FG000|Week 0 to Week 26|Unclassified|5|||
124748095|NCT01336023|448699420|FG001|Week 0 to Week 26|Unclassified|16|||
124748096|NCT01336023|448699421|FG002|Week 0 to Week 26|Unclassified|9|||
124748097|NCT01336023|448699419|FG000|Week 27 to 52|Adverse Event|1|||
124748098|NCT01336023|448699420|FG001|Week 27 to 52|Adverse Event|5|||
124748099|NCT01336023|448699421|FG002|Week 27 to 52|Adverse Event|2|||
124748100|NCT01336023|448699419|FG000|Week 27 to 52|Protocol Violation|0|||
124748101|NCT01336023|448699420|FG001|Week 27 to 52|Protocol Violation|2|||
124748102|NCT01336023|448699421|FG002|Week 27 to 52|Protocol Violation|1|||
124748103|NCT01336023|448699419|FG000|Week 27 to 52|Withdrawal Criteria|14|||
124748104|NCT01336023|448699420|FG001|Week 27 to 52|Withdrawal Criteria|19|||
124748105|NCT01336023|448699421|FG002|Week 27 to 52|Withdrawal Criteria|16|||
124748106|NCT01336023|448699419|FG000|Week 27 to 52|Unclassified|13|||
124748107|NCT01336023|448699420|FG001|Week 27 to 52|Unclassified|18|||
124748108|NCT01336023|448699421|FG002|Week 27 to 52|Unclassified|9|||
124748109|NCT02202538|448699427|FG000|Overall Study|Withdrawal by Subject|5|||
124748110|NCT02202538|448699427|FG000|Overall Study|Did not meet all inclusion criteria|2|||
124748111|NCT02202538|448699427|FG000|Overall Study|Investigator Decision|1|||
124748112|NCT01853878|448699428|FG000|Overall Study|Recurrence|2|||
124748113|NCT01853878|448699429|FG001|Overall Study|Recurrence|0|||
124748114|NCT01853878|448699428|FG000|Overall Study|Adverse Event|2|||
124748115|NCT01853878|448699429|FG001|Overall Study|Adverse Event|0|||
124748116|NCT01853878|448699428|FG000|Overall Study|Withdrawal by Subject|3|||
124748117|NCT01853878|448699429|FG001|Overall Study|Withdrawal by Subject|1|||
124748118|NCT01853878|448699428|FG000|Overall Study|Migrated/moved from the study area|1|||
124748119|NCT01853878|448699429|FG001|Overall Study|Migrated/moved from the study area|0|||
124748120|NCT01853878|448699428|FG000|Overall Study|Other|55|||
124748121|NCT01853878|448699429|FG001|Overall Study|Other|43|||
124748122|NCT02161757|448699430|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
124748123|NCT02161757|448699431|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
124748124|NCT02161757|448699432|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
124748125|NCT02161757|448699430|FG000|Treatment Through Study Completion|Adverse Event|1|||
124748126|NCT02161757|448699431|FG001|Treatment Through Study Completion|Adverse Event|1|||
124748127|NCT02161757|448699432|FG002|Treatment Through Study Completion|Adverse Event|0|||
124748128|NCT02161757|448699430|FG000|Treatment Through Study Completion|Protocol Violation|0|||
124748129|NCT02161757|448699431|FG001|Treatment Through Study Completion|Protocol Violation|1|||
124782503|NCT01742286|448832871|FG002|Escalation Phase|Subject/guardian decision|0|||
124748130|NCT02161757|448699432|FG002|Treatment Through Study Completion|Protocol Violation|2|||
124748131|NCT02161757|448699430|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
124748132|NCT02161757|448699431|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
124748133|NCT02161757|448699432|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
124748134|NCT02161757|448699430|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
124748135|NCT02161757|448699431|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
124748136|NCT02161757|448699432|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
124748137|NCT02161757|448699430|FG000|Treatment Through Study Completion|Other|20|||
124748138|NCT02161757|448699431|FG001|Treatment Through Study Completion|Other|19|||
124748139|NCT02161757|448699432|FG002|Treatment Through Study Completion|Other|12|||
124748140|NCT02161757|448699430|FG000|Treatment Through Study Completion|Death|2|||
124748141|NCT02161757|448699431|FG001|Treatment Through Study Completion|Death|1|||
124748142|NCT02161757|448699432|FG002|Treatment Through Study Completion|Death|1|||
124748143|NCT03997825|448699433|FG000|Overall Study|Death|3|||
124748144|NCT03997825|448699433|FG000|Overall Study|Lost to Follow-up|10|||
124748145|NCT03997825|448699433|FG000|Overall Study|Withdrawal by Subject|3|||
124748146|NCT03997825|448699433|FG000|Overall Study|Refused participation|1|||
124748147|NCT01361178|448699434|FG000|Overall Study|Death|13|||
124748148|NCT01361178|448699435|FG001|Overall Study|Death|0|||
124748149|NCT00391625|448699436|FG000|Month 14|Withdrawal by Subject|1|||
124748150|NCT00391625|448699436|FG000|Month 50|Physician Decision|1|||
124748151|NCT00383162|448699437|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
124748152|NCT00383162|448699438|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
124748153|NCT00383162|448699437|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
124748154|NCT00383162|448699438|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
124748155|NCT00383162|448699437|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
124748156|NCT00383162|448699438|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
124748157|NCT00383162|448699437|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
124748158|NCT00383162|448699438|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
124748159|NCT00383162|448699437|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
124748160|NCT00383162|448699438|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
124748161|NCT00383162|448699437|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
124748162|NCT00383162|448699438|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
124748163|NCT00383162|448699437|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
124619687|NCT00794339|448223710|FG000|Overall Study|Tx not per protocol|1|||
124619688|NCT01611857|448223711|FG000|Overall Study|Withdrawal by Subject|0|||
124619689|NCT01611857|448223712|FG001|Overall Study|Withdrawal by Subject|2|||
124619690|NCT00658879|448223727|FG000|Overall Study|Protocol Violation|1|||
124619691|NCT00616421|448223728|FG000|Overall Study|Withdrawal by Subject|9|||
124619692|NCT00616421|448223729|FG001|Overall Study|Withdrawal by Subject|11|||
124619693|NCT00616421|448223730|FG002|Overall Study|Withdrawal by Subject|8|||
124619694|NCT00616421|448223728|FG000|Overall Study|Lost to Follow-up|12|||
124619695|NCT00616421|448223729|FG001|Overall Study|Lost to Follow-up|26|||
124619696|NCT00616421|448223730|FG002|Overall Study|Lost to Follow-up|30|||
124619697|NCT00616421|448223728|FG000|Overall Study|Inappropriate enrollment|3|||
124619698|NCT00616421|448223729|FG001|Overall Study|Inappropriate enrollment|0|||
124619699|NCT00616421|448223730|FG002|Overall Study|Inappropriate enrollment|1|||
124619700|NCT00616421|448223728|FG000|Overall Study|Administrative reason|1|||
124619701|NCT00616421|448223729|FG001|Overall Study|Administrative reason|0|||
124619702|NCT00616421|448223730|FG002|Overall Study|Administrative reason|0|||
124619703|NCT00616421|448223728|FG000|Overall Study|Protocol Violation|0|||
124619704|NCT00616421|448223729|FG001|Overall Study|Protocol Violation|1|||
124619705|NCT00616421|448223730|FG002|Overall Study|Protocol Violation|2|||
124619706|NCT00616421|448223728|FG000|Overall Study|Unable to classify|1|||
124619707|NCT00616421|448223729|FG001|Overall Study|Unable to classify|0|||
124619708|NCT00616421|448223730|FG002|Overall Study|Unable to classify|0|||
124619709|NCT02661217|448223731|FG000|Overall Study|Physician Decision|12|||
124619710|NCT02661217|448223732|FG001|Overall Study|Physician Decision|15|||
124619711|NCT02661217|448223731|FG000|Overall Study|Lost to Follow-up|1|||
124619712|NCT02661217|448223732|FG001|Overall Study|Lost to Follow-up|4|||
124619713|NCT02661217|448223731|FG000|Overall Study|Protocol Deviation|0|||
124619714|NCT02661217|448223732|FG001|Overall Study|Protocol Deviation|4|||
124619715|NCT02661217|448223731|FG000|Overall Study|Non-compliance with study treatment|5|||
124619716|NCT02661217|448223732|FG001|Overall Study|Non-compliance with study treatment|5|||
124619717|NCT02661217|448223731|FG000|Overall Study|Death|21|||
124619718|NCT02661217|448223732|FG001|Overall Study|Death|15|||
124619719|NCT02661217|448223731|FG000|Overall Study|Adverse Event|10|||
124748164|NCT00383162|448699438|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
124748165|NCT00383162|448699437|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
124782504|NCT01742286|448832872|FG003|Escalation Phase|Subject/guardian decision|0|||
124619720|NCT02661217|448223732|FG001|Overall Study|Adverse Event|8|||
124619721|NCT02661217|448223731|FG000|Overall Study|Withdrawal by Subject|15|||
124619722|NCT02661217|448223732|FG001|Overall Study|Withdrawal by Subject|19|||
124619723|NCT02661217|448223731|FG000|Overall Study|Did not enter follow-up epoch|7|||
124619724|NCT02661217|448223732|FG001|Overall Study|Did not enter follow-up epoch|10|||
124619725|NCT02661217|448223731|FG000|Overall Study|Death - no study drug received|1|||
124748166|NCT00383162|448699438|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
124748167|NCT00383162|448699437|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
124748168|NCT00383162|448699438|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
124748169|NCT01069705|448699441|FG000|Overall Study|Adverse Event|1|||
124748170|NCT01069705|448699441|FG000|Overall Study|Withdrawal by Subject|2|||
124748171|NCT02726022|448699442|FG000|Overall Study|Adverse Event|14|||
124748172|NCT02726022|448699442|FG000|Overall Study|Treatment Failure|8|||
124748173|NCT02726022|448699442|FG000|Overall Study|Poor Compliance|13|||
124748174|NCT02726022|448699442|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
124748175|NCT00915551|448699443|FG000|Overall Study|Withdrawal by Subject|0|||
124748176|NCT00915551|448699444|FG001|Overall Study|Withdrawal by Subject|1|||
124748177|NCT00235716|448699445|FG000|Overall Study|Death|26|||
124748178|NCT00235716|448699446|FG001|Overall Study|Death|39|||
124748179|NCT00235716|448699447|FG002|Overall Study|Death|32|||
124748180|NCT00235716|448699448|FG003|Overall Study|Death|31|||
124748181|NCT00235716|448699445|FG000|Overall Study|Withdrawal by Subject|23|||
124748182|NCT00235716|448699446|FG001|Overall Study|Withdrawal by Subject|19|||
124748183|NCT00235716|448699447|FG002|Overall Study|Withdrawal by Subject|17|||
124748184|NCT00235716|448699448|FG003|Overall Study|Withdrawal by Subject|18|||
124748185|NCT00235716|448699445|FG000|Overall Study|Lost to Follow-up|12|||
124748186|NCT00235716|448699446|FG001|Overall Study|Lost to Follow-up|7|||
124748187|NCT00235716|448699447|FG002|Overall Study|Lost to Follow-up|14|||
124748188|NCT00235716|448699448|FG003|Overall Study|Lost to Follow-up|10|||
124748189|NCT00235716|448699445|FG000|Overall Study|Adverse Event|1|||
124748190|NCT00235716|448699446|FG001|Overall Study|Adverse Event|1|||
124748191|NCT00235716|448699447|FG002|Overall Study|Adverse Event|1|||
124748192|NCT00235716|448699448|FG003|Overall Study|Adverse Event|0|||
124748193|NCT00235716|448699445|FG000|Overall Study|Physician Decision|0|||
124748194|NCT00235716|448699446|FG001|Overall Study|Physician Decision|1|||
124748195|NCT00235716|448699447|FG002|Overall Study|Physician Decision|1|||
124748196|NCT00235716|448699448|FG003|Overall Study|Physician Decision|3|||
124748197|NCT04390841|448699449|FG000|Overall Study|Withdrawal by Subject|2|||
124748198|NCT02188849|448699458|FG000|Overall Study|Lost to Follow-up|3|||
124748199|NCT02188849|448699459|FG001|Overall Study|Lost to Follow-up|8|||
124748200|NCT05090852|448699468|FG000|Overall Study|Physician Decision|5|||
124748201|NCT00504894|448699469|FG000|Overall Study|fMRI technical problems|1|||
124748202|NCT00504894|448699470|FG001|Overall Study|fMRI technical problems|1|||
124748203|NCT00504894|448699471|FG002|Overall Study|fMRI technical problems|0|||
124748204|NCT00504894|448699469|FG000|Overall Study|Withdrawal by Subject|0|||
124748205|NCT00504894|448699470|FG001|Overall Study|Withdrawal by Subject|1|||
124748206|NCT00504894|448699471|FG002|Overall Study|Withdrawal by Subject|0|||
124748207|NCT00504894|448699469|FG000|Overall Study|Infusion technical problems|0|||
124748208|NCT00504894|448699470|FG001|Overall Study|Infusion technical problems|1|||
124748209|NCT00504894|448699471|FG002|Overall Study|Infusion technical problems|0|||
124748210|NCT00504894|448699469|FG000|Overall Study|poor subject data|2|||
124748211|NCT00504894|448699470|FG001|Overall Study|poor subject data|0|||
124748212|NCT00504894|448699471|FG002|Overall Study|poor subject data|0|||
124748213|NCT01196416|448699474|FG000|Overall Study|Withdrawal by Subject|2|||
124748214|NCT00148941|448699475|FG000|Overall Study|Lost to Follow-up|17|||
124748215|NCT00148941|448699476|FG001|Overall Study|Lost to Follow-up|24|||
124748216|NCT00148941|448699477|FG002|Overall Study|Lost to Follow-up|18|||
124748217|NCT00148941|448699478|FG003|Overall Study|Lost to Follow-up|22|||
124748218|NCT00148941|448699475|FG000|Overall Study|Withdrawal by Subject|1|||
124748219|NCT00148941|448699476|FG001|Overall Study|Withdrawal by Subject|0|||
124748220|NCT00148941|448699477|FG002|Overall Study|Withdrawal by Subject|1|||
124748221|NCT00148941|448699478|FG003|Overall Study|Withdrawal by Subject|0|||
124748222|NCT00148941|448699475|FG000|Overall Study|Other|0|||
124748223|NCT00148941|448699476|FG001|Overall Study|Other|0|||
124748224|NCT00148941|448699477|FG002|Overall Study|Other|1|||
124748225|NCT00148941|448699478|FG003|Overall Study|Other|2|||
124748226|NCT03244826|448699480|FG000|Overall Study|Withdrawal by Subject|2|||
124748227|NCT03244826|448699481|FG001|Overall Study|Withdrawal by Subject|0|||
124748228|NCT03244826|448699480|FG000|Overall Study|Transplant delayed or withdrawn|12|||
124748229|NCT03244826|448699481|FG001|Overall Study|Transplant delayed or withdrawn|10|||
124748230|NCT02673684|448699482|FG000|Overall Study|Study not completed d/t loss of funding|9|||
124748231|NCT02673684|448699483|FG001|Overall Study|Study not completed d/t loss of funding|8|||
124748232|NCT00416455|448699490|FG000|Overall Study|PET / CT not done|3|||
124782505|NCT01742286|448832873|FG004|Escalation Phase|Subject/guardian decision|0|||
124782506|NCT01742286|448832874|FG005|Escalation Phase|Subject/guardian decision|0|||
124748233|NCT00416455|448699491|FG001|Overall Study|PET / CT not done|5|||
124748234|NCT00416455|448699490|FG000|Overall Study|PET / CT poor quality|2|||
124748235|NCT00416455|448699491|FG001|Overall Study|PET / CT poor quality|1|||
124748236|NCT00416455|448699490|FG000|Overall Study|Inadequate pathology|11|||
124748237|NCT00416455|448699491|FG001|Overall Study|Inadequate pathology|2|||
124748238|NCT04699461|448699498|FG000|Overall Study|Withdrawal by Subject|1|||
124748239|NCT04699461|448699499|FG001|Overall Study|Withdrawal by Subject|0|||
124748240|NCT04699461|448699498|FG000|Overall Study|Study termination by sponsor|2|||
124782507|NCT01742286|448832875|FG006|Escalation Phase|Subject/guardian decision|0|||
124782508|NCT01742286|448832869|FG000|Expansion Phase|Administrative problems|0|||
124782509|NCT01742286|448832870|FG001|Expansion Phase|Administrative problems|0|||
124782510|NCT01742286|448832871|FG002|Expansion Phase|Administrative problems|0|||
124782511|NCT01742286|448832872|FG003|Expansion Phase|Administrative problems|0|||
124782512|NCT01742286|448832873|FG004|Expansion Phase|Administrative problems|0|||
124782513|NCT01742286|448832874|FG005|Expansion Phase|Administrative problems|0|||
124782514|NCT01742286|448832875|FG006|Expansion Phase|Administrative problems|5|||
124782515|NCT01742286|448832869|FG000|Expansion Phase|Physician Decision|0|||
124782516|NCT01742286|448832870|FG001|Expansion Phase|Physician Decision|0|||
124782517|NCT01742286|448832871|FG002|Expansion Phase|Physician Decision|4|||
124782518|NCT01742286|448832872|FG003|Expansion Phase|Physician Decision|0|||
124782519|NCT01742286|448832873|FG004|Expansion Phase|Physician Decision|0|||
124782520|NCT01742286|448832874|FG005|Expansion Phase|Physician Decision|0|||
124782521|NCT01742286|448832875|FG006|Expansion Phase|Physician Decision|9|||
124782522|NCT01742286|448832869|FG000|Expansion Phase|Adverse Event|0|||
124782523|NCT01742286|448832870|FG001|Expansion Phase|Adverse Event|0|||
124782524|NCT01742286|448832871|FG002|Expansion Phase|Adverse Event|0|||
124782525|NCT01742286|448832872|FG003|Expansion Phase|Adverse Event|0|||
124782526|NCT01742286|448832873|FG004|Expansion Phase|Adverse Event|0|||
124782527|NCT01742286|448832874|FG005|Expansion Phase|Adverse Event|0|||
124782528|NCT01742286|448832875|FG006|Expansion Phase|Adverse Event|6|||
124782529|NCT01742286|448832869|FG000|Expansion Phase|Disease progression|0|||
124782530|NCT01742286|448832870|FG001|Expansion Phase|Disease progression|0|||
124782531|NCT01742286|448832871|FG002|Expansion Phase|Disease progression|3|||
124782532|NCT01742286|448832872|FG003|Expansion Phase|Disease progression|0|||
124782533|NCT01742286|448832873|FG004|Expansion Phase|Disease progression|0|||
124782534|NCT01742286|448832874|FG005|Expansion Phase|Disease progression|0|||
124782535|NCT01742286|448832875|FG006|Expansion Phase|Disease progression|15|||
124782536|NCT01742286|448832869|FG000|Expansion Phase|Withdrawal by Subject|0|||
124782537|NCT01742286|448832870|FG001|Expansion Phase|Withdrawal by Subject|0|||
124782538|NCT01742286|448832871|FG002|Expansion Phase|Withdrawal by Subject|0|||
124782539|NCT01742286|448832872|FG003|Expansion Phase|Withdrawal by Subject|0|||
124782540|NCT01742286|448832873|FG004|Expansion Phase|Withdrawal by Subject|0|||
124782541|NCT01742286|448832874|FG005|Expansion Phase|Withdrawal by Subject|0|||
124782542|NCT01742286|448832875|FG006|Expansion Phase|Withdrawal by Subject|1|||
124782543|NCT02633020|448832876|FG000|Overall Study|Adverse Event|1|||
124782544|NCT02633020|448832877|FG001|Overall Study|Adverse Event|0|||
124782545|NCT01136785|448832878|FG000|Overall Study|Protocol Violation|2|||
124782546|NCT01136785|448832879|FG001|Overall Study|Protocol Violation|1|||
124782547|NCT02954172|448832882|FG000|Overall Study|Protocol Violation|3|||
124782548|NCT02954172|448832883|FG001|Overall Study|Protocol Violation|0|||
124782549|NCT02954172|448832882|FG000|Overall Study|allergic reaction|2|||
124782550|NCT02954172|448832883|FG001|Overall Study|allergic reaction|1|||
124782551|NCT02954172|448832882|FG000|Overall Study|non-measurable lesions at baseline|1|||
124782552|NCT02954172|448832883|FG001|Overall Study|non-measurable lesions at baseline|2|||
124782553|NCT00853567|448832884|FG000|Overall Study|Study prematurely terminated|71|||
124782554|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
124782555|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
124782556|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
124782557|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
124782558|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
124782559|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
124782560|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
124619726|NCT02661217|448223732|FG001|Overall Study|Death - no study drug received|2|||
124619727|NCT02661217|448223731|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
124619728|NCT02661217|448223732|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
124619729|NCT02075515|448223733|FG000|Overall Study|Serious Adverse Event|1|||
124619730|NCT02075515|448223734|FG001|Overall Study|Serious Adverse Event|1|||
124782561|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
124782562|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
124782563|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
124782564|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
124782565|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
124782566|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
124782567|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
124782568|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
124782569|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
124782570|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
124619731|NCT02075515|448223735|FG002|Overall Study|Serious Adverse Event|1|||
124619732|NCT02075515|448223733|FG000|Overall Study|Non-Serious Adverse Event|0|||
124619733|NCT02075515|448223734|FG001|Overall Study|Non-Serious Adverse Event|1|||
124782571|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
124782572|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
124782573|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
124748241|NCT04699461|448699499|FG001|Overall Study|Study termination by sponsor|1|||
124748242|NCT04699461|448699498|FG000|Overall Study|Death|1|||
124748243|NCT04699461|448699499|FG001|Overall Study|Death|0|||
124748244|NCT04699461|448699498|FG000|Overall Study|Radiographic progression|0|||
124748245|NCT04699461|448699499|FG001|Overall Study|Radiographic progression|1|||
124748246|NCT03068767|448699501|FG000|Overall Study|Lost to Follow-up|7|||
124748247|NCT03068767|448699502|FG001|Overall Study|Lost to Follow-up|3|||
124748248|NCT03068767|448699501|FG000|Overall Study|Protocol Violation|3|||
124748249|NCT03068767|448699502|FG001|Overall Study|Protocol Violation|0|||
124748250|NCT00061633|448699503|FG000|Overall Study|Adverse Event|1|||
124748251|NCT00061633|448699504|FG001|Overall Study|Adverse Event|2|||
124748252|NCT00061633|448699503|FG000|Overall Study|Withdrawal by Subject|2|||
124748253|NCT00061633|448699504|FG001|Overall Study|Withdrawal by Subject|2|||
124748254|NCT00061633|448699503|FG000|Overall Study|Lost to Follow-up|1|||
124748255|NCT00061633|448699504|FG001|Overall Study|Lost to Follow-up|4|||
124748256|NCT00061633|448699503|FG000|Overall Study|Other|1|||
124748257|NCT00061633|448699504|FG001|Overall Study|Other|1|||
124748258|NCT00061633|448699503|FG000|Overall Study|Never received study treatment|0|||
124748259|NCT00061633|448699504|FG001|Overall Study|Never received study treatment|2|||
124748260|NCT02921087|448699507|FG000|Overall Study|Withdrawal by Subject|0|||
124748261|NCT02921087|448699508|FG001|Overall Study|Withdrawal by Subject|1|||
124748262|NCT00687531|448699509|FG000|Overall Study|Did not meet protocol eligibility|104|||
124748263|NCT00687531|448699509|FG000|Overall Study|Adverse Event|5|||
124748264|NCT00687531|448699509|FG000|Overall Study|Lost to Follow-up|26|||
124748265|NCT03848949|448699510|FG000|Overall Study|Lost to Follow-up|5|||
124748266|NCT03848949|448699511|FG001|Overall Study|Lost to Follow-up|7|||
124748267|NCT02353728|448699512|FG000|Overall Study|Subject non-compliance|1|||
124748268|NCT02301624|448699515|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
124748269|NCT02301624|448699516|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
124748270|NCT02301624|448699515|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
124748271|NCT02301624|448699516|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
124748272|NCT02301624|448699515|FG000|Open-label Maintenance Phase|Adverse Event|2|||
124748273|NCT02301624|448699516|FG001|Open-label Maintenance Phase|Adverse Event|5|||
124748274|NCT02301624|448699515|FG000|Open-label Maintenance Phase|Physician Decision|3|||
124748275|NCT02301624|448699516|FG001|Open-label Maintenance Phase|Physician Decision|3|||
124748276|NCT02301624|448699515|FG000|Open-label Maintenance Phase|Death|2|||
124748277|NCT02301624|448699516|FG001|Open-label Maintenance Phase|Death|1|||
124748278|NCT02301624|448699515|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
124748279|NCT02301624|448699516|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
124748280|NCT00895310|448699517|FG000|Overall Study|Withdrawal by Subject|1|||
124748281|NCT03109184|448701366|FG000|Overall Study|Lost to Follow-up|6|||
124748282|NCT03109184|448701367|FG001|Overall Study|Lost to Follow-up|6|||
124748283|NCT03109184|448701366|FG000|Overall Study|Withdrawal by Subject|1|||
124748284|NCT03109184|448701367|FG001|Overall Study|Withdrawal by Subject|1|||
124748285|NCT00602420|448701368|FG000|Overall Study|Death|1|||
124748286|NCT00602420|448701369|FG001|Overall Study|Death|4|||
124748287|NCT00602420|448701368|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
124748288|NCT00602420|448701369|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
124748289|NCT00602420|448701368|FG000|Overall Study|Withdrawal by Subject|18|||
124748290|NCT00602420|448701369|FG001|Overall Study|Withdrawal by Subject|17|||
124748291|NCT00602420|448701368|FG000|Overall Study|Adverse Event|1|||
124748292|NCT00602420|448701369|FG001|Overall Study|Adverse Event|0|||
124748293|NCT00703924|448701378|FG000|Overall Study|Withdrawal by Subject|1|||
124748294|NCT00703924|448701379|FG001|Overall Study|Withdrawal by Subject|1|||
124748295|NCT03077919|448701380|FG000|Overall Study|Lost to Follow-up|4|||
124748296|NCT03077919|448701381|FG001|Overall Study|Lost to Follow-up|1|||
124748297|NCT01031979|448701384|FG000|Overall Study|Lost to Follow-up|5|||
124748298|NCT01031979|448701385|FG001|Overall Study|Lost to Follow-up|4|||
124748299|NCT03592368|448701387|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
124748300|NCT03592368|448701388|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
124748301|NCT03592368|448701389|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
124748302|NCT03592368|448701390|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
124748303|NCT03592368|448701387|FG000|Overall Study|Adverse Event|0|||
124748304|NCT03592368|448701388|FG001|Overall Study|Adverse Event|0|||
124748305|NCT03592368|448701389|FG002|Overall Study|Adverse Event|0|||
124748306|NCT03592368|448701390|FG003|Overall Study|Adverse Event|1|||
124748307|NCT03592368|448701387|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
124748308|NCT03592368|448701388|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
124748309|NCT03592368|448701389|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
124748310|NCT03592368|448701390|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
124748311|NCT03831100|448701391|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
124748312|NCT03831100|448701392|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
124748313|NCT02008227|448701396|FG000|Overall Study|Lost to Follow-up|7|||
124748314|NCT02008227|448701397|FG001|Overall Study|Lost to Follow-up|9|||
124748315|NCT02008227|448701396|FG000|Overall Study|Death|494|||
124748316|NCT02008227|448701397|FG001|Overall Study|Death|485|||
124748317|NCT02008227|448701396|FG000|Overall Study|Withdrawal by Subject|67|||
124748318|NCT02008227|448701397|FG001|Overall Study|Withdrawal by Subject|36|||
124748319|NCT02008227|448701396|FG000|Overall Study|Study Terminated By Sponsor|44|||
124748320|NCT02008227|448701397|FG001|Overall Study|Study Terminated By Sponsor|83|||
124748321|NCT01618695|448701401|FG000|Core Phase|Adverse Event|4|||
124748322|NCT01618695|448701402|FG001|Core Phase|Adverse Event|5|||
124748323|NCT01618695|448701403|FG002|Core Phase|Adverse Event|15|||
124748324|NCT01618695|448701404|FG003|Core Phase|Adverse Event|20|||
124748325|NCT01618695|448701401|FG000|Core Phase|Lost to Follow-up|0|||
124748326|NCT01618695|448701402|FG001|Core Phase|Lost to Follow-up|0|||
124748327|NCT01618695|448701403|FG002|Core Phase|Lost to Follow-up|1|||
124748328|NCT01618695|448701404|FG003|Core Phase|Lost to Follow-up|0|||
124748329|NCT01618695|448701401|FG000|Core Phase|Withdrawal by Subject|16|||
124748330|NCT01618695|448701402|FG001|Core Phase|Withdrawal by Subject|11|||
124748331|NCT01618695|448701403|FG002|Core Phase|Withdrawal by Subject|9|||
124748332|NCT01618695|448701404|FG003|Core Phase|Withdrawal by Subject|13|||
124748333|NCT01618695|448701401|FG000|Core Phase|Pregnancy|2|||
124748334|NCT01618695|448701402|FG001|Core Phase|Pregnancy|0|||
124748335|NCT01618695|448701403|FG002|Core Phase|Pregnancy|0|||
124748336|NCT01618695|448701404|FG003|Core Phase|Pregnancy|0|||
124748337|NCT01618695|448701401|FG000|Core Phase|Lack of Efficacy|1|||
124748338|NCT01618695|448701402|FG001|Core Phase|Lack of Efficacy|2|||
124748339|NCT01618695|448701403|FG002|Core Phase|Lack of Efficacy|1|||
124748340|NCT01618695|448701404|FG003|Core Phase|Lack of Efficacy|1|||
124748341|NCT01618695|448701401|FG000|Core Phase|Other than specified|1|||
124748342|NCT01618695|448701402|FG001|Core Phase|Other than specified|2|||
124748343|NCT01618695|448701403|FG002|Core Phase|Other than specified|2|||
124748344|NCT01618695|448701404|FG003|Core Phase|Other than specified|2|||
124748345|NCT01618695|448701401|FG000|Core Phase|Not treated|1|||
124748346|NCT01618695|448701402|FG001|Core Phase|Not treated|0|||
124748347|NCT01618695|448701403|FG002|Core Phase|Not treated|2|||
124748348|NCT01618695|448701404|FG003|Core Phase|Not treated|0|||
124748349|NCT01618695|448701401|FG000|Extension Phase|Lack of Efficacy|17|||
124748350|NCT01618695|448701402|FG001|Extension Phase|Lack of Efficacy|33|||
124748351|NCT01618695|448701403|FG002|Extension Phase|Lack of Efficacy|26|||
124748352|NCT01618695|448701404|FG003|Extension Phase|Lack of Efficacy|24|||
124748353|NCT01618695|448701401|FG000|Extension Phase|Pregnancy|2|||
124748354|NCT01618695|448701402|FG001|Extension Phase|Pregnancy|0|||
124748355|NCT01618695|448701403|FG002|Extension Phase|Pregnancy|1|||
124748356|NCT01618695|448701404|FG003|Extension Phase|Pregnancy|1|||
124748357|NCT01618695|448701401|FG000|Extension Phase|Withdrawal by Subject|43|||
124748358|NCT01618695|448701402|FG001|Extension Phase|Withdrawal by Subject|48|||
124748359|NCT01618695|448701403|FG002|Extension Phase|Withdrawal by Subject|42|||
124748360|NCT01618695|448701404|FG003|Extension Phase|Withdrawal by Subject|33|||
124748361|NCT01618695|448701401|FG000|Extension Phase|Adverse Event|18|||
124748362|NCT01618695|448701402|FG001|Extension Phase|Adverse Event|16|||
124748363|NCT01618695|448701403|FG002|Extension Phase|Adverse Event|9|||
124748364|NCT01618695|448701404|FG003|Extension Phase|Adverse Event|20|||
124748365|NCT01618695|448701401|FG000|Extension Phase|Lost to Follow-up|2|||
124748366|NCT01618695|448701402|FG001|Extension Phase|Lost to Follow-up|1|||
124748367|NCT01618695|448701403|FG002|Extension Phase|Lost to Follow-up|1|||
124748368|NCT01618695|448701404|FG003|Extension Phase|Lost to Follow-up|1|||
124748369|NCT01618695|448701401|FG000|Extension Phase|Other than specified|13|||
124748370|NCT01618695|448701402|FG001|Extension Phase|Other than specified|18|||
124748371|NCT01618695|448701403|FG002|Extension Phase|Other than specified|13|||
124748372|NCT01618695|448701404|FG003|Extension Phase|Other than specified|18|||
124748373|NCT02454478|448701406|FG000|Overall Study|Incomplete DLT Evaluation|1|||
124748374|NCT01271725|448701410|FG000|Part A|Progressive disease according to RECIST|8|||
124748375|NCT01271725|448701411|FG001|Part A|Progressive disease according to RECIST|0|||
124748376|NCT01271725|448701410|FG000|Part A|Clinical signs/symptoms of progression|2|||
124748377|NCT01271725|448701411|FG001|Part A|Clinical signs/symptoms of progression|0|||
124782574|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
124748378|NCT01271725|448701410|FG000|Part A|Other Adverse Event|8|||
124748379|NCT01271725|448701411|FG001|Part A|Other Adverse Event|0|||
124748380|NCT01271725|448701410|FG000|Part A|Lost to Follow-up|1|||
124748381|NCT01271725|448701411|FG001|Part A|Lost to Follow-up|0|||
124748382|NCT01271725|448701410|FG000|Part A|Withdrawal by Subject|12|||
124782575|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
124748383|NCT01271725|448701411|FG001|Part A|Withdrawal by Subject|0|||
124748384|NCT01271725|448701410|FG000|Part A|Other than specified|3|||
124782576|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
124748385|NCT01271725|448701411|FG001|Part A|Other than specified|0|||
124748386|NCT01271725|448701410|FG000|Part A|Protocol Violation|1|||
124748387|NCT01271725|448701411|FG001|Part A|Protocol Violation|0|||
124748388|NCT01271725|448701410|FG000|Part B|Other than specified|0|||
124619734|NCT02075515|448223735|FG002|Overall Study|Non-Serious Adverse Event|0|||
124619735|NCT02075515|448223733|FG000|Overall Study|Withdrawal by Subject|2|||
124619736|NCT02075515|448223734|FG001|Overall Study|Withdrawal by Subject|0|||
124619737|NCT02075515|448223735|FG002|Overall Study|Withdrawal by Subject|1|||
124619738|NCT02075515|448223733|FG000|Overall Study|Lost to Follow-up|1|||
124619739|NCT02075515|448223734|FG001|Overall Study|Lost to Follow-up|3|||
124619740|NCT02075515|448223735|FG002|Overall Study|Lost to Follow-up|6|||
124619741|NCT00378573|448223736|FG000|Treatment Period|Adverse Event|9|||
124619742|NCT00378573|448223736|FG000|Treatment Period|Physician Decision|1|||
124619743|NCT00378573|448223736|FG000|Treatment Period|Withdrawal by Subject|2|||
124619744|NCT00378573|448223736|FG000|Treatment Period|Disease Progression|4|||
124619745|NCT00378573|448223736|FG000|Treatment Period|Sponsor decision to close study|1|||
124619746|NCT00378573|448223736|FG000|Follow-up|Death|12|||
124619747|NCT00378573|448223736|FG000|Follow-up|Lost to Follow-up|1|||
124619748|NCT00378573|448223736|FG000|Follow-up|Withdrawal by Subject|1|||
124619749|NCT01372748|448223741|FG000|Overall Study|Lost to Follow-up|16|||
124619750|NCT01372748|448223742|FG001|Overall Study|Lost to Follow-up|34|||
124619751|NCT01372748|448223741|FG000|Overall Study|Withdrawal by Subject|7|||
124619752|NCT01372748|448223742|FG001|Overall Study|Withdrawal by Subject|5|||
124619753|NCT00134901|448223743|FG000|Overall Study|Lost to Follow-up|5|||
124619754|NCT00134901|448223744|FG001|Overall Study|Lost to Follow-up|5|||
124619755|NCT00134901|448223743|FG000|Overall Study|discontinued intervention|12|||
124619756|NCT00134901|448223744|FG001|Overall Study|discontinued intervention|10|||
124619757|NCT04238650|448223747|FG000|Overall Study|Withdrawal by Subject|0|||
124619758|NCT04238650|448223748|FG001|Overall Study|Withdrawal by Subject|1|||
124619759|NCT01807065|448223749|FG000|Overall Study|Receive no sip-T due to IV access|1|||
124619760|NCT01807065|448223750|FG001|Overall Study|Receive no sip-T due to IV access|1|||
124619761|NCT02789137|448223751|FG000|Overall Study|Dropped out/Died|58|||
124619762|NCT00462904|448223752|FG000|Overall Study|Lost to Follow-up|1|||
124619763|NCT01685840|448223753|FG000|Overall Study|Death|77|||
124619764|NCT01685840|448223754|FG001|Overall Study|Death|66|||
124619765|NCT01685840|448223753|FG000|Overall Study|Lost to Follow-up|27|||
124619766|NCT01685840|448223754|FG001|Overall Study|Lost to Follow-up|25|||
124619767|NCT01685840|448223753|FG000|Overall Study|Physician Decision|3|||
124619768|NCT01685840|448223754|FG001|Overall Study|Physician Decision|7|||
124619769|NCT01685840|448223753|FG000|Overall Study|Withdrawal by Subject|14|||
124619770|NCT01685840|448223754|FG001|Overall Study|Withdrawal by Subject|17|||
124619771|NCT01685840|448223753|FG000|Overall Study|Futility|197|||
124619772|NCT01685840|448223754|FG001|Overall Study|Futility|200|||
124619773|NCT01685840|448223753|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
124619774|NCT01685840|448223754|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
124619775|NCT04036110|448223761|FG000|Overall Study|Lost to Follow-up|3|||
124619776|NCT04036110|448223762|FG001|Overall Study|Lost to Follow-up|2|||
124619777|NCT04036110|448223763|FG002|Overall Study|Lost to Follow-up|1|||
124619778|NCT04036110|448223761|FG000|Overall Study|Study Suspended|4|||
124619779|NCT04036110|448223762|FG001|Overall Study|Study Suspended|5|||
124619780|NCT04036110|448223763|FG002|Overall Study|Study Suspended|1|||
124619781|NCT00246324|448223768|FG000|Overall Study|Withdrawal by Subject|1|||
124619782|NCT02006732|448223769|FG000|Overall Study|Adverse Event|10|||
124619783|NCT02006732|448223770|FG001|Overall Study|Adverse Event|7|||
124619784|NCT02006732|448223771|FG002|Overall Study|Adverse Event|4|||
124619785|NCT02006732|448223772|FG003|Overall Study|Adverse Event|2|||
124619786|NCT02006732|448223769|FG000|Overall Study|Lack of Efficacy|6|||
124619787|NCT02006732|448223770|FG001|Overall Study|Lack of Efficacy|3|||
124619788|NCT02006732|448223771|FG002|Overall Study|Lack of Efficacy|1|||
124619789|NCT02006732|448223772|FG003|Overall Study|Lack of Efficacy|1|||
124619790|NCT02006732|448223769|FG000|Overall Study|Protocol Violation|1|||
124619791|NCT02006732|448223770|FG001|Overall Study|Protocol Violation|1|||
124619792|NCT02006732|448223771|FG002|Overall Study|Protocol Violation|0|||
124619793|NCT02006732|448223772|FG003|Overall Study|Protocol Violation|0|||
124619794|NCT02006732|448223769|FG000|Overall Study|Lost to Follow-up|0|||
124619795|NCT02006732|448223770|FG001|Overall Study|Lost to Follow-up|1|||
124619796|NCT02006732|448223771|FG002|Overall Study|Lost to Follow-up|0|||
124619797|NCT02006732|448223772|FG003|Overall Study|Lost to Follow-up|0|||
124619798|NCT02006732|448223769|FG000|Overall Study|Withdrawal by Subject|3|||
124619799|NCT02006732|448223770|FG001|Overall Study|Withdrawal by Subject|0|||
124619800|NCT02006732|448223771|FG002|Overall Study|Withdrawal by Subject|4|||
124619801|NCT02006732|448223772|FG003|Overall Study|Withdrawal by Subject|1|||
124619802|NCT03516513|448223773|FG000|Overall Study|Withdrawal by Subject|2|||
124619803|NCT03516513|448223774|FG001|Overall Study|Withdrawal by Subject|2|||
124619804|NCT03516513|448223775|FG002|Overall Study|Withdrawal by Subject|0|||
124619805|NCT03516513|448223776|FG003|Overall Study|Withdrawal by Subject|0|||
124619806|NCT01098487|448223777|FG000|Overall Study|Adverse Event|22|||
124619807|NCT01098487|448223777|FG000|Overall Study|Lack of Efficacy|11|||
124619808|NCT01098487|448223777|FG000|Overall Study|Withdrawal by Subject|7|||
124619809|NCT01098487|448223777|FG000|Overall Study|Lost to Follow-up|3|||
124619810|NCT01098487|448223777|FG000|Overall Study|Physician Decision|1|||
124619811|NCT00345631|448223778|FG000|Overall Study|Withdrawal by Subject|1|||
124619812|NCT00345631|448223779|FG001|Overall Study|Withdrawal by Subject|0|||
124748389|NCT01271725|448701411|FG001|Part B|Other than specified|2|||
124748390|NCT01271725|448701410|FG000|Part B|Clinical signs/symptoms of progression|0|||
124748391|NCT01271725|448701411|FG001|Part B|Clinical signs/symptoms of progression|2|||
124748392|NCT01271725|448701410|FG000|Part B|Other Adverse Event|0|||
124748393|NCT01271725|448701411|FG001|Part B|Other Adverse Event|1|||
124748394|NCT01271725|448701410|FG000|Part B|Protocol Violation|0|||
124748395|NCT01271725|448701411|FG001|Part B|Protocol Violation|1|||
124748396|NCT01271725|448701410|FG000|Part B|Withdrawal by Subject|0|||
124748397|NCT01271725|448701411|FG001|Part B|Withdrawal by Subject|6|||
124748398|NCT03354273|448701412|FG000|Overall Study|Adverse Event|5|||
124748399|NCT03354273|448701412|FG000|Overall Study|Screen Failure|21|||
124748400|NCT03354273|448701412|FG000|Overall Study|Withdrawal by Subject|34|||
124748401|NCT03354273|448701412|FG000|Overall Study|Technical Problems|30|||
124748402|NCT03354273|448701412|FG000|Overall Study|Lost to Follow-up|4|||
124748403|NCT03354273|448701412|FG000|Overall Study|Investigator Decision|3|||
124748404|NCT03354273|448701412|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
124748405|NCT03354273|448701412|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
124748406|NCT03354273|448701412|FG000|Overall Study|COVID-19 Restrictions|9|||
124748407|NCT03354273|448701412|FG000|Overall Study|Other|5|||
124748408|NCT02950480|448701418|FG000|Overall Study|Withdrawal by Subject|1|||
124748409|NCT02950480|448701419|FG001|Overall Study|Withdrawal by Subject|0|||
124748410|NCT03229109|448701424|FG000|Overall Study|Withdrawal by Subject|0|||
124748411|NCT03229109|448701425|FG001|Overall Study|Withdrawal by Subject|0|||
124748412|NCT03229109|448701426|FG002|Overall Study|Withdrawal by Subject|0|||
124748413|NCT03229109|448701427|FG003|Overall Study|Withdrawal by Subject|1|||
124748414|NCT01835223|448701428|FG000|Overall Study|Adverse Event|1|||
124748415|NCT01835223|448701429|FG001|Overall Study|Adverse Event|0|||
124748416|NCT01835223|448701428|FG000|Overall Study|Withdrawal by Subject|2|||
124748417|NCT01835223|448701429|FG001|Overall Study|Withdrawal by Subject|0|||
124748418|NCT01835223|448701428|FG000|Overall Study|Disease progression|2|||
124748419|NCT01835223|448701429|FG001|Overall Study|Disease progression|1|||
124748420|NCT01835223|448701428|FG000|Overall Study|Became Inelligible|4|||
124748421|NCT01835223|448701429|FG001|Overall Study|Became Inelligible|0|||
124748422|NCT01504841|448701430|FG000|Overall Study|Withdrawal by Subject|1|||
124748423|NCT01504841|448701431|FG001|Overall Study|Withdrawal by Subject|1|||
124748424|NCT01504841|448701432|FG002|Overall Study|Withdrawal by Subject|0|||
124748425|NCT01610336|448701433|FG000|Overall Study|Progressive Disease|4|||
124748426|NCT01610336|448701434|FG001|Overall Study|Progressive Disease|6|||
124748427|NCT01610336|448701435|FG002|Overall Study|Progressive Disease|6|||
124748428|NCT01610336|448701436|FG003|Overall Study|Progressive Disease|5|||
124748429|NCT01610336|448701437|FG004|Overall Study|Progressive Disease|3|||
124748430|NCT01610336|448701438|FG005|Overall Study|Progressive Disease|10|||
124748431|NCT01610336|448701439|FG006|Overall Study|Progressive Disease|1|||
124748432|NCT01610336|448701440|FG007|Overall Study|Progressive Disease|6|||
124748433|NCT01610336|448701441|FG008|Overall Study|Progressive Disease|6|||
124748434|NCT01610336|448701442|FG009|Overall Study|Progressive Disease|40|||
124748435|NCT01610336|448701443|FG010|Overall Study|Progressive Disease|36|||
124748436|NCT01610336|448701433|FG000|Overall Study|Adverse Event|0|||
124748437|NCT01610336|448701434|FG001|Overall Study|Adverse Event|0|||
124748438|NCT01610336|448701435|FG002|Overall Study|Adverse Event|0|||
124748439|NCT01610336|448701436|FG003|Overall Study|Adverse Event|1|||
124748440|NCT01610336|448701437|FG004|Overall Study|Adverse Event|1|||
124748441|NCT01610336|448701438|FG005|Overall Study|Adverse Event|1|||
124748442|NCT01610336|448701439|FG006|Overall Study|Adverse Event|0|||
124748443|NCT01610336|448701440|FG007|Overall Study|Adverse Event|0|||
124748444|NCT01610336|448701441|FG008|Overall Study|Adverse Event|2|||
124748445|NCT01610336|448701442|FG009|Overall Study|Adverse Event|8|||
124748446|NCT01610336|448701443|FG010|Overall Study|Adverse Event|6|||
124748447|NCT01610336|448701433|FG000|Overall Study|Subject/Guardian decision|1|||
124748448|NCT01610336|448701434|FG001|Overall Study|Subject/Guardian decision|1|||
124782577|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
124782578|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
124782579|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
124782580|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
124748449|NCT01610336|448701435|FG002|Overall Study|Subject/Guardian decision|0|||
124748450|NCT01610336|448701436|FG003|Overall Study|Subject/Guardian decision|1|||
124782581|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
124748451|NCT01610336|448701437|FG004|Overall Study|Subject/Guardian decision|0|||
124748452|NCT01610336|448701438|FG005|Overall Study|Subject/Guardian decision|0|||
124782582|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
124748453|NCT01610336|448701439|FG006|Overall Study|Subject/Guardian decision|0|||
124748454|NCT01610336|448701440|FG007|Overall Study|Subject/Guardian decision|1|||
124748455|NCT01610336|448701441|FG008|Overall Study|Subject/Guardian decision|0|||
124748456|NCT01610336|448701442|FG009|Overall Study|Subject/Guardian decision|2|||
124748457|NCT01610336|448701443|FG010|Overall Study|Subject/Guardian decision|2|||
124748458|NCT01610336|448701433|FG000|Overall Study|Death|0|||
124748459|NCT01610336|448701434|FG001|Overall Study|Death|0|||
124748460|NCT01610336|448701435|FG002|Overall Study|Death|0|||
124748461|NCT01610336|448701436|FG003|Overall Study|Death|0|||
124748462|NCT01610336|448701437|FG004|Overall Study|Death|0|||
124748463|NCT01610336|448701438|FG005|Overall Study|Death|1|||
124748464|NCT01610336|448701439|FG006|Overall Study|Death|3|||
124748465|NCT01610336|448701440|FG007|Overall Study|Death|0|||
124748466|NCT01610336|448701441|FG008|Overall Study|Death|0|||
124748467|NCT01610336|448701442|FG009|Overall Study|Death|1|||
124748468|NCT01610336|448701443|FG010|Overall Study|Death|2|||
124748469|NCT01610336|448701433|FG000|Overall Study|Non-Compliance with study treatment|0|||
124748470|NCT01610336|448701434|FG001|Overall Study|Non-Compliance with study treatment|0|||
124748471|NCT01610336|448701435|FG002|Overall Study|Non-Compliance with study treatment|0|||
124748472|NCT01610336|448701436|FG003|Overall Study|Non-Compliance with study treatment|0|||
124748473|NCT01610336|448701437|FG004|Overall Study|Non-Compliance with study treatment|0|||
124748474|NCT01610336|448701438|FG005|Overall Study|Non-Compliance with study treatment|0|||
124748475|NCT01610336|448701439|FG006|Overall Study|Non-Compliance with study treatment|0|||
124748476|NCT01610336|448701440|FG007|Overall Study|Non-Compliance with study treatment|0|||
124748477|NCT01610336|448701441|FG008|Overall Study|Non-Compliance with study treatment|0|||
124748478|NCT01610336|448701442|FG009|Overall Study|Non-Compliance with study treatment|1|||
124748479|NCT01610336|448701443|FG010|Overall Study|Non-Compliance with study treatment|0|||
124748480|NCT01610336|448701433|FG000|Overall Study|Physician Decision|0|||
124748481|NCT01610336|448701434|FG001|Overall Study|Physician Decision|0|||
124748482|NCT01610336|448701435|FG002|Overall Study|Physician Decision|0|||
124748483|NCT01610336|448701436|FG003|Overall Study|Physician Decision|0|||
124748484|NCT01610336|448701437|FG004|Overall Study|Physician Decision|0|||
124748485|NCT01610336|448701438|FG005|Overall Study|Physician Decision|0|||
124748486|NCT01610336|448701439|FG006|Overall Study|Physician Decision|1|||
124619813|NCT00345631|448223780|FG002|Overall Study|Withdrawal by Subject|1|||
124619814|NCT00345631|448223778|FG000|Overall Study|Adverse Event|0|||
124619815|NCT00345631|448223779|FG001|Overall Study|Adverse Event|1|||
124619816|NCT00345631|448223780|FG002|Overall Study|Adverse Event|0|||
124619817|NCT00345631|448223778|FG000|Overall Study|Lost to Follow-up|3|||
124619818|NCT00345631|448223779|FG001|Overall Study|Lost to Follow-up|7|||
124619819|NCT00345631|448223780|FG002|Overall Study|Lost to Follow-up|4|||
124619820|NCT00345631|448223778|FG000|Overall Study|Other reasons|0|||
124619821|NCT00345631|448223779|FG001|Overall Study|Other reasons|0|||
124619822|NCT00345631|448223780|FG002|Overall Study|Other reasons|1|||
124619823|NCT00447993|448223781|FG000|Overall Study|Lost to Follow-up|0|||
124619824|NCT00447993|448223782|FG001|Overall Study|Lost to Follow-up|0|||
124748487|NCT01610336|448701440|FG007|Overall Study|Physician Decision|0|||
124748488|NCT01610336|448701441|FG008|Overall Study|Physician Decision|0|||
124748489|NCT01610336|448701442|FG009|Overall Study|Physician Decision|0|||
124748490|NCT01610336|448701443|FG010|Overall Study|Physician Decision|0|||
124748491|NCT01610336|448701433|FG000|Overall Study|Protocol Deviation|0|||
124748492|NCT01610336|448701434|FG001|Overall Study|Protocol Deviation|0|||
124748493|NCT01610336|448701435|FG002|Overall Study|Protocol Deviation|0|||
124748494|NCT01610336|448701436|FG003|Overall Study|Protocol Deviation|0|||
124748495|NCT01610336|448701437|FG004|Overall Study|Protocol Deviation|0|||
124748496|NCT01610336|448701438|FG005|Overall Study|Protocol Deviation|0|||
124748497|NCT01610336|448701439|FG006|Overall Study|Protocol Deviation|0|||
124748498|NCT01610336|448701440|FG007|Overall Study|Protocol Deviation|0|||
124748499|NCT01610336|448701441|FG008|Overall Study|Protocol Deviation|0|||
124748500|NCT01610336|448701442|FG009|Overall Study|Protocol Deviation|1|||
124748501|NCT01610336|448701443|FG010|Overall Study|Protocol Deviation|0|||
124748502|NCT01610336|448701433|FG000|Overall Study|Transfer to another trial|0|||
124748503|NCT01610336|448701434|FG001|Overall Study|Transfer to another trial|0|||
124748504|NCT01610336|448701435|FG002|Overall Study|Transfer to another trial|0|||
124748505|NCT01610336|448701436|FG003|Overall Study|Transfer to another trial|0|||
124748506|NCT01610336|448701437|FG004|Overall Study|Transfer to another trial|0|||
124748507|NCT01610336|448701438|FG005|Overall Study|Transfer to another trial|0|||
124619825|NCT00447993|448223783|FG002|Overall Study|Lost to Follow-up|2|||
124619826|NCT00447993|448223784|FG003|Overall Study|Lost to Follow-up|2|||
124619827|NCT00447993|448223781|FG000|Overall Study|Withdrawal by Subject|0|||
124619828|NCT00447993|448223782|FG001|Overall Study|Withdrawal by Subject|0|||
124748508|NCT01610336|448701439|FG006|Overall Study|Transfer to another trial|0|||
124748509|NCT01610336|448701440|FG007|Overall Study|Transfer to another trial|0|||
124748510|NCT01610336|448701441|FG008|Overall Study|Transfer to another trial|0|||
124748511|NCT01610336|448701442|FG009|Overall Study|Transfer to another trial|0|||
124748512|NCT01610336|448701443|FG010|Overall Study|Transfer to another trial|1|||
124748513|NCT03679624|448701444|FG000|Overall Study|Adverse Event|1|||
124748514|NCT03679624|448701445|FG001|Overall Study|Adverse Event|0|||
124748515|NCT01559675|448701448|FG000|Overall Study|Protocol Violation|1|||
124748516|NCT01559675|448701449|FG001|Overall Study|Protocol Violation|2|||
124748517|NCT01559675|448701448|FG000|Overall Study|2nd operation on same patient excluded|14|||
124748518|NCT01559675|448701449|FG001|Overall Study|2nd operation on same patient excluded|12|||
124748519|NCT01496469|448701450|FG000|Overall Study|Adverse Event|1|||
124748520|NCT01496469|448701451|FG001|Overall Study|Adverse Event|0|||
124619829|NCT00447993|448223783|FG002|Overall Study|Withdrawal by Subject|2|||
124748521|NCT01496469|448701450|FG000|Overall Study|Protocol Violation|2|||
124748522|NCT01496469|448701451|FG001|Overall Study|Protocol Violation|0|||
124748523|NCT01496469|448701450|FG000|Overall Study|Lost to Follow-up|1|||
124748524|NCT01496469|448701451|FG001|Overall Study|Lost to Follow-up|1|||
124748525|NCT01496469|448701450|FG000|Overall Study|Withdrawal by Subject|4|||
124748526|NCT01496469|448701451|FG001|Overall Study|Withdrawal by Subject|4|||
124748527|NCT01496469|448701450|FG000|Overall Study|BP exceeds protocol limits|1|||
124748528|NCT01496469|448701451|FG001|Overall Study|BP exceeds protocol limits|2|||
124748529|NCT01496469|448701450|FG000|Overall Study|Other|1|||
124748530|NCT01496469|448701451|FG001|Overall Study|Other|1|||
124748531|NCT00291018|448701452|FG000|Overall Study|Not Consented or Declined PAS|12|||
124748532|NCT00291018|448701453|FG001|Overall Study|Not Consented or Declined PAS|15|||
124748533|NCT00291018|448701454|FG002|Overall Study|Not Consented or Declined PAS|15|||
124748534|NCT00291018|448701452|FG000|Overall Study|Death|3|||
124748535|NCT00291018|448701453|FG001|Overall Study|Death|3|||
124748536|NCT00291018|448701454|FG002|Overall Study|Death|4|||
124748537|NCT00291018|448701452|FG000|Overall Study|Withdrawal by Subject|2|||
124748538|NCT00291018|448701453|FG001|Overall Study|Withdrawal by Subject|8|||
124748539|NCT00291018|448701454|FG002|Overall Study|Withdrawal by Subject|1|||
124748540|NCT00291018|448701452|FG000|Overall Study|Failures|5|||
124748541|NCT00291018|448701453|FG001|Overall Study|Failures|12|||
124748542|NCT00291018|448701454|FG002|Overall Study|Failures|5|||
124748543|NCT00291018|448701452|FG000|Overall Study|Lost to Follow-up|3|||
124748544|NCT00291018|448701453|FG001|Overall Study|Lost to Follow-up|4|||
124748545|NCT00291018|448701454|FG002|Overall Study|Lost to Follow-up|18|||
124748546|NCT00630344|448701455|FG000|Overall Study|Adverse Event|5|||
124748547|NCT00630344|448701455|FG000|Overall Study|Progressive Disease|19|||
124748548|NCT00630344|448701455|FG000|Overall Study|Physician Decision|9|||
124748549|NCT00630344|448701455|FG000|Overall Study|Withdrawal by Subject|1|||
124748550|NCT00630344|448701455|FG000|Overall Study|Intercurrent Illness|1|||
124748551|NCT00630344|448701455|FG000|Overall Study|Other|1|||
124748552|NCT01357551|448701456|FG000|Overall Study|Withdrawal by Subject|6|||
124748553|NCT01357551|448701457|FG001|Overall Study|Withdrawal by Subject|4|||
124748554|NCT01357551|448701456|FG000|Overall Study|Death|0|||
124748555|NCT01357551|448701457|FG001|Overall Study|Death|1|||
124748556|NCT01357551|448701456|FG000|Overall Study|Lost to Follow-up|16|||
124748557|NCT01357551|448701457|FG001|Overall Study|Lost to Follow-up|6|||
124748558|NCT00774800|448701458|FG000|Intervention 4|Withdrawal by Subject|1|||
124748559|NCT03068754|448701465|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
124748560|NCT03068754|448701466|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
124748561|NCT03068754|448701467|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
124748562|NCT03068754|448701468|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
124748563|NCT03068754|448701465|FG000|Randomized Treatment Period (RTP)|Death|2|||
124748564|NCT03068754|448701466|FG001|Randomized Treatment Period (RTP)|Death|2|||
124748565|NCT03068754|448701467|FG002|Randomized Treatment Period (RTP)|Death|0|||
124748566|NCT03068754|448701468|FG003|Randomized Treatment Period (RTP)|Death|0|||
124748567|NCT03068754|448701465|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
124748568|NCT03068754|448701466|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
124748569|NCT03068754|448701467|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
124748570|NCT03068754|448701468|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
124748571|NCT03068754|448701465|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
124748572|NCT03068754|448701466|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
124748573|NCT03068754|448701467|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
124748574|NCT03068754|448701468|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
124748575|NCT03068754|448701465|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
124748576|NCT03068754|448701466|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
124748577|NCT03068754|448701467|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
124748578|NCT03068754|448701468|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
124748579|NCT03068754|448701465|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
124748580|NCT03068754|448701466|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
124748581|NCT03068754|448701467|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
124748582|NCT03068754|448701468|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
124748583|NCT03068754|448701465|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
124748584|NCT03068754|448701466|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
124748585|NCT03068754|448701467|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
124748586|NCT03068754|448701468|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
124748587|NCT03068754|448701465|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
124748588|NCT03068754|448701466|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
124748589|NCT03068754|448701467|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
124748590|NCT03068754|448701468|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
124748591|NCT03068754|448701465|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
124748592|NCT03068754|448701466|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
124748593|NCT03068754|448701467|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
124748594|NCT03068754|448701468|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
124748595|NCT03068754|448701465|FG000|Open Label Extension Period (OLE)|Death|0|||
124748596|NCT03068754|448701466|FG001|Open Label Extension Period (OLE)|Death|0|||
124748597|NCT03068754|448701467|FG002|Open Label Extension Period (OLE)|Death|0|||
124748598|NCT03068754|448701468|FG003|Open Label Extension Period (OLE)|Death|1|||
124748599|NCT03068754|448701465|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
124748600|NCT03068754|448701466|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
124748601|NCT03068754|448701467|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
124748602|NCT03068754|448701468|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
124748603|NCT03068754|448701465|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
124748604|NCT03068754|448701466|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
124748605|NCT03068754|448701467|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
124748606|NCT03068754|448701468|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
124748607|NCT03068754|448701465|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
124748608|NCT03068754|448701466|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
124748609|NCT03068754|448701467|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
124748610|NCT03068754|448701468|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
124748611|NCT03068754|448701465|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
124748612|NCT03068754|448701466|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
124748613|NCT03068754|448701467|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
124748614|NCT03068754|448701468|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
124748615|NCT00666965|448701469|FG000|Overall Study|Adverse Event|0|||
124748616|NCT00666965|448701470|FG001|Overall Study|Adverse Event|2|||
124748617|NCT00666965|448701471|FG002|Overall Study|Adverse Event|1|||
124748618|NCT00666965|448701472|FG003|Overall Study|Adverse Event|9|||
124748619|NCT00666965|448701469|FG000|Overall Study|Lack of Efficacy|1|||
124748620|NCT00666965|448701470|FG001|Overall Study|Lack of Efficacy|1|||
124748621|NCT00666965|448701471|FG002|Overall Study|Lack of Efficacy|0|||
124748622|NCT00666965|448701472|FG003|Overall Study|Lack of Efficacy|0|||
124748623|NCT00666965|448701469|FG000|Overall Study|Protocol Violation|0|||
124748624|NCT00666965|448701470|FG001|Overall Study|Protocol Violation|0|||
124748625|NCT00666965|448701471|FG002|Overall Study|Protocol Violation|0|||
124748626|NCT00666965|448701472|FG003|Overall Study|Protocol Violation|2|||
124748627|NCT00666965|448701469|FG000|Overall Study|Discontinuation criteria|2|||
124748628|NCT00666965|448701470|FG001|Overall Study|Discontinuation criteria|1|||
124748629|NCT00666965|448701471|FG002|Overall Study|Discontinuation criteria|1|||
124748630|NCT00666965|448701472|FG003|Overall Study|Discontinuation criteria|2|||
124748631|NCT00666965|448701469|FG000|Overall Study|Withdrawal by Subject|0|||
124748632|NCT00666965|448701470|FG001|Overall Study|Withdrawal by Subject|0|||
124748633|NCT00666965|448701471|FG002|Overall Study|Withdrawal by Subject|0|||
124748634|NCT00666965|448701472|FG003|Overall Study|Withdrawal by Subject|2|||
124748635|NCT00767819|448701476|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
124748636|NCT00767819|448701477|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
124748637|NCT00767819|448701478|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
124748638|NCT00767819|448701476|FG000|Overall Study|Withdrawal by Subject|1|||
124748639|NCT00767819|448701477|FG001|Overall Study|Withdrawal by Subject|1|||
124748640|NCT00767819|448701478|FG002|Overall Study|Withdrawal by Subject|0|||
124748641|NCT00767819|448701476|FG000|Overall Study|Administrative problems|0|||
124748642|NCT00767819|448701477|FG001|Overall Study|Administrative problems|1|||
124748643|NCT00767819|448701478|FG002|Overall Study|Administrative problems|0|||
124748644|NCT00767819|448701476|FG000|Overall Study|Death|2|||
124748645|NCT00767819|448701477|FG001|Overall Study|Death|3|||
124748646|NCT00767819|448701478|FG002|Overall Study|Death|0|||
124748647|NCT00767819|448701476|FG000|Overall Study|Adverse Event|2|||
124748648|NCT00767819|448701477|FG001|Overall Study|Adverse Event|0|||
124748649|NCT00767819|448701478|FG002|Overall Study|Adverse Event|0|||
124748650|NCT00767819|448701476|FG000|Overall Study|Abnormal lab values|1|||
124782583|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
124782584|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
124782585|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
124782586|NCT03818035|448832885|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
124782587|NCT03818035|448832886|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
124748651|NCT00767819|448701477|FG001|Overall Study|Abnormal lab values|0|||
124748652|NCT00767819|448701478|FG002|Overall Study|Abnormal lab values|0|||
124748653|NCT00767819|448701476|FG000|Overall Study|Lost to Follow-up|1|||
124748654|NCT00767819|448701477|FG001|Overall Study|Lost to Follow-up|0|||
124748655|NCT00767819|448701478|FG002|Overall Study|Lost to Follow-up|0|||
124748656|NCT03916081|448701483|FG000|Overall Study|Adverse Event|1|||
124748657|NCT03916081|448701484|FG001|Overall Study|Adverse Event|0|||
124748658|NCT03916081|448701485|FG002|Overall Study|Adverse Event|0|||
124748659|NCT03916081|448701483|FG000|Overall Study|Physician Decision|0|||
124748660|NCT03916081|448701484|FG001|Overall Study|Physician Decision|0|||
124782588|NCT03818035|448832887|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
124782589|NCT03818035|448832888|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
124782590|NCT03818035|448832885|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
124782591|NCT03818035|448832886|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
124782592|NCT03818035|448832887|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
124782593|NCT03818035|448832888|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
124782594|NCT03818035|448832885|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
124782595|NCT03818035|448832886|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
124782596|NCT03818035|448832887|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
124782597|NCT03818035|448832888|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
124782598|NCT03818035|448832885|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
124782599|NCT03818035|448832886|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
124782600|NCT03818035|448832887|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
124782601|NCT03818035|448832888|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
124782602|NCT03818035|448832885|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
124782603|NCT03818035|448832886|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
124782604|NCT03818035|448832887|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
124782605|NCT03818035|448832888|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
124782606|NCT03818035|448832885|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
124782607|NCT03818035|448832886|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
124782608|NCT03818035|448832887|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
124782609|NCT03818035|448832888|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
124782610|NCT03818035|448832885|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
124782611|NCT03818035|448832886|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
124782612|NCT03818035|448832887|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
124782613|NCT03818035|448832888|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
124782614|NCT03374202|448832891|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
124782615|NCT03374202|448832892|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
124782616|NCT03374202|448832893|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
124782617|NCT03374202|448832891|FG000|Five Year Long Term Follow Up|Death|0|||
124782618|NCT03374202|448832892|FG001|Five Year Long Term Follow Up|Death|1|||
124782619|NCT03374202|448832893|FG002|Five Year Long Term Follow Up|Death|0|||
124782620|NCT01395524|448834236|FG000|Overall Study|Non-compliance with study schedule|1|||
124782621|NCT01395524|448834237|FG001|Overall Study|Non-compliance with study schedule|0|||
124782622|NCT01395524|448834238|FG002|Overall Study|Non-compliance with study schedule|1|||
124782623|NCT01395524|448834236|FG000|Overall Study|Lost to Follow-up|3|||
124782624|NCT01395524|448834237|FG001|Overall Study|Lost to Follow-up|1|||
124782625|NCT01395524|448834238|FG002|Overall Study|Lost to Follow-up|1|||
124782626|NCT01395524|448834236|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
124782627|NCT01395524|448834237|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
124782628|NCT01395524|448834238|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
124782629|NCT01395524|448834236|FG000|Overall Study|Severe noncompliance with protocol|1|||
124782630|NCT01395524|448834237|FG001|Overall Study|Severe noncompliance with protocol|0|||
124782631|NCT01395524|448834238|FG002|Overall Study|Severe noncompliance with protocol|0|||
124782632|NCT01395524|448834236|FG000|Overall Study|Adverse Event|4|||
124782633|NCT01395524|448834237|FG001|Overall Study|Adverse Event|4|||
124782634|NCT01395524|448834238|FG002|Overall Study|Adverse Event|3|||
124782635|NCT01395524|448834236|FG000|Overall Study|Death|1|||
124782636|NCT01395524|448834237|FG001|Overall Study|Death|0|||
124782637|NCT01395524|448834238|FG002|Overall Study|Death|0|||
124782638|NCT01395524|448834236|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
124782639|NCT01395524|448834237|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
124782640|NCT01395524|448834238|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
124782641|NCT01395524|448834236|FG000|Overall Study|Withdrawal by Subject|4|||
124782642|NCT01395524|448834237|FG001|Overall Study|Withdrawal by Subject|8|||
124782643|NCT01395524|448834238|FG002|Overall Study|Withdrawal by Subject|8|||
124782644|NCT01395524|448834236|FG000|Overall Study|Did not receive treatment|1|||
124782645|NCT01395524|448834237|FG001|Overall Study|Did not receive treatment|1|||
124782646|NCT01395524|448834238|FG002|Overall Study|Did not receive treatment|3|||
124782647|NCT01395524|448834236|FG000|Overall Study|Subject had spinal surgery|0|||
124782648|NCT01395524|448834237|FG001|Overall Study|Subject had spinal surgery|0|||
124782649|NCT01395524|448834238|FG002|Overall Study|Subject had spinal surgery|1|||
124782650|NCT01657461|448834239|FG000|Overall Study|Death|9|||
124782651|NCT01657461|448834240|FG001|Overall Study|Death|12|||
124782652|NCT01657461|448834239|FG000|Overall Study|Lost to Follow-up|0|||
124782653|NCT01657461|448834240|FG001|Overall Study|Lost to Follow-up|3|||
124782654|NCT01657461|448834239|FG000|Overall Study|Physician Decision|0|||
124782655|NCT01657461|448834240|FG001|Overall Study|Physician Decision|2|||
124782656|NCT01657461|448834239|FG000|Overall Study|Withdrawal by Subject|1|||
124782657|NCT01657461|448834240|FG001|Overall Study|Withdrawal by Subject|3|||
124782658|NCT00295880|448834249|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
124782659|NCT00295880|448834249|FG000|Overall Study|Unit randomization did not occur|1|||
124782660|NCT00843284|448834250|FG000|Overall Study|Adverse Event|39|||
124782661|NCT00843284|448834250|FG000|Overall Study|Lack of Efficacy|5|||
124748661|NCT03916081|448701485|FG002|Overall Study|Physician Decision|1|||
124748662|NCT03916081|448701483|FG000|Overall Study|Lost to Follow-up|0|||
124748663|NCT03916081|448701484|FG001|Overall Study|Lost to Follow-up|1|||
124748664|NCT03916081|448701485|FG002|Overall Study|Lost to Follow-up|0|||
124748665|NCT03916081|448701483|FG000|Overall Study|Withdrawal by Subject|3|||
124748666|NCT03916081|448701484|FG001|Overall Study|Withdrawal by Subject|0|||
124748667|NCT03916081|448701485|FG002|Overall Study|Withdrawal by Subject|1|||
124748668|NCT03916081|448701483|FG000|Overall Study|Worsening of AD|0|||
124748669|NCT03916081|448701484|FG001|Overall Study|Worsening of AD|0|||
124748670|NCT03916081|448701485|FG002|Overall Study|Worsening of AD|1|||
124748671|NCT00465647|448701486|FG000|Overall Study|Administrative|2|||
124748672|NCT00465647|448701487|FG001|Overall Study|Administrative|2|||
124748673|NCT00465647|448701488|FG002|Overall Study|Administrative|3|||
124748674|NCT00465647|448701489|FG003|Overall Study|Administrative|2|||
124748675|NCT00465647|448701486|FG000|Overall Study|Adverse Event|2|||
124748676|NCT00465647|448701487|FG001|Overall Study|Adverse Event|0|||
124748677|NCT00465647|448701488|FG002|Overall Study|Adverse Event|3|||
124748678|NCT00465647|448701489|FG003|Overall Study|Adverse Event|2|||
124748679|NCT00465647|448701486|FG000|Overall Study|Withdrawal by Subject|1|||
124748680|NCT00465647|448701487|FG001|Overall Study|Withdrawal by Subject|2|||
124748681|NCT00465647|448701488|FG002|Overall Study|Withdrawal by Subject|2|||
124748682|NCT00465647|448701489|FG003|Overall Study|Withdrawal by Subject|7|||
124748683|NCT00465647|448701486|FG000|Overall Study|"The other reasons included loss of IV"|8|||
124748684|NCT00465647|448701487|FG001|Overall Study|"The other reasons included loss of IV"|4|||
124748685|NCT00465647|448701488|FG002|Overall Study|"The other reasons included loss of IV"|3|||
124748686|NCT00465647|448701489|FG003|Overall Study|"The other reasons included loss of IV"|2|||
124748687|NCT01339897|448701490|FG000|Overall Study|Adverse Event|1|||
124748688|NCT01339897|448701491|FG001|Overall Study|Adverse Event|0|||
124748689|NCT01339897|448701492|FG002|Overall Study|Adverse Event|0|||
124748690|NCT01339897|448701493|FG003|Overall Study|Adverse Event|1|||
124748691|NCT00847197|448701496|FG000|Overall Study|Adverse Event|21|||
124748692|NCT00847197|448701497|FG001|Overall Study|Adverse Event|3|||
124748693|NCT00847197|448701496|FG000|Overall Study|Protocol Violation|0|||
124748694|NCT00847197|448701497|FG001|Overall Study|Protocol Violation|1|||
124748695|NCT00847197|448701496|FG000|Overall Study|Withdrawal by Subject|3|||
124748696|NCT00847197|448701497|FG001|Overall Study|Withdrawal by Subject|1|||
124748697|NCT00622388|448701498|FG000|Overall Study|Disease Progression|47|||
124748698|NCT00622388|448701498|FG000|Overall Study|Adverse Event|6|||
124748699|NCT00622388|448701498|FG000|Overall Study|Protocol Violation|3|||
124748700|NCT00622388|448701498|FG000|Overall Study|Participant Refusal|1|||
124748701|NCT00622388|448701498|FG000|Overall Study|Death|3|||
124748702|NCT00622388|448701498|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
124748703|NCT00622388|448701498|FG000|Overall Study|Took Prohibited Medication|2|||
124748704|NCT00622388|448701498|FG000|Overall Study|Withdrew Consent|1|||
124748705|NCT00622388|448701498|FG000|Overall Study|Insurance Expired|1|||
124748706|NCT00348309|448701499|FG000|Overall Study|Adverse Event|56|||
124748707|NCT00348309|448701500|FG001|Overall Study|Adverse Event|28|||
124748708|NCT00348309|448701501|FG002|Overall Study|Adverse Event|63|||
124748709|NCT00348309|448701499|FG000|Overall Study|Lost to Follow-up|6|||
124748710|NCT00348309|448701500|FG001|Overall Study|Lost to Follow-up|7|||
124748711|NCT00348309|448701501|FG002|Overall Study|Lost to Follow-up|4|||
124748712|NCT00348309|448701499|FG000|Overall Study|Protocol Violation|7|||
124748713|NCT00348309|448701500|FG001|Overall Study|Protocol Violation|12|||
124748714|NCT00348309|448701501|FG002|Overall Study|Protocol Violation|7|||
124748715|NCT00348309|448701499|FG000|Overall Study|Withdrawal by Subject|33|||
124748716|NCT00348309|448701500|FG001|Overall Study|Withdrawal by Subject|37|||
124748717|NCT00348309|448701501|FG002|Overall Study|Withdrawal by Subject|40|||
124748718|NCT00348309|448701499|FG000|Overall Study|Non-compliance|8|||
124748719|NCT00348309|448701500|FG001|Overall Study|Non-compliance|6|||
124748720|NCT00348309|448701501|FG002|Overall Study|Non-compliance|8|||
124748721|NCT00348309|448701499|FG000|Overall Study|Death of caregiver|1|||
124748722|NCT00348309|448701500|FG001|Overall Study|Death of caregiver|0|||
124748723|NCT00348309|448701501|FG002|Overall Study|Death of caregiver|1|||
124748724|NCT00348309|448701499|FG000|Overall Study|Lack of insight, dementia|1|||
124748725|NCT00348309|448701500|FG001|Overall Study|Lack of insight, dementia|0|||
124748726|NCT00348309|448701501|FG002|Overall Study|Lack of insight, dementia|0|||
124748727|NCT00348309|448701499|FG000|Overall Study|Wrong bottle allocated|1|||
124748728|NCT00348309|448701500|FG001|Overall Study|Wrong bottle allocated|0|||
124748729|NCT00348309|448701501|FG002|Overall Study|Wrong bottle allocated|0|||
124748730|NCT00348309|448701499|FG000|Overall Study|Caregiver sick|1|||
124748731|NCT00348309|448701500|FG001|Overall Study|Caregiver sick|0|||
124748732|NCT00348309|448701501|FG002|Overall Study|Caregiver sick|0|||
124748733|NCT00348309|448701499|FG000|Overall Study|Use of prohibited medication|5|||
124748734|NCT00348309|448701500|FG001|Overall Study|Use of prohibited medication|2|||
124782662|NCT00843284|448834250|FG000|Overall Study|Lost to Follow-up|11|||
124748735|NCT00348309|448701501|FG002|Overall Study|Use of prohibited medication|2|||
124748736|NCT00348309|448701499|FG000|Overall Study|Caregiver withdrawal|3|||
124748737|NCT00348309|448701500|FG001|Overall Study|Caregiver withdrawal|0|||
124748738|NCT00348309|448701501|FG002|Overall Study|Caregiver withdrawal|7|||
124748739|NCT00348309|448701499|FG000|Overall Study|Unable to complete ET visit|1|||
124748740|NCT00348309|448701500|FG001|Overall Study|Unable to complete ET visit|0|||
124748741|NCT00348309|448701501|FG002|Overall Study|Unable to complete ET visit|0|||
124748742|NCT00348309|448701499|FG000|Overall Study|PI closing medical practice|1|||
124748743|NCT00348309|448701500|FG001|Overall Study|PI closing medical practice|0|||
124748744|NCT00348309|448701501|FG002|Overall Study|PI closing medical practice|0|||
124748745|NCT00348309|448701499|FG000|Overall Study|Principal investigator's decision|1|||
124748746|NCT00348309|448701500|FG001|Overall Study|Principal investigator's decision|0|||
124748747|NCT00348309|448701501|FG002|Overall Study|Principal investigator's decision|0|||
124748748|NCT00348309|448701499|FG000|Overall Study|No disponibility of medication|1|||
124748749|NCT00348309|448701500|FG001|Overall Study|No disponibility of medication|0|||
124748750|NCT00348309|448701501|FG002|Overall Study|No disponibility of medication|0|||
124748751|NCT00348309|448701499|FG000|Overall Study|Worsened neurodegenerative disease|1|||
124748752|NCT00348309|448701500|FG001|Overall Study|Worsened neurodegenerative disease|0|||
124748753|NCT00348309|448701501|FG002|Overall Study|Worsened neurodegenerative disease|0|||
124748754|NCT00348309|448701499|FG000|Overall Study|Cognitive and behaviour worsening|2|||
124748755|NCT00348309|448701500|FG001|Overall Study|Cognitive and behaviour worsening|0|||
124748756|NCT00348309|448701501|FG002|Overall Study|Cognitive and behaviour worsening|0|||
124748757|NCT00348309|448701499|FG000|Overall Study|Worsening of alzheimer|1|||
124748758|NCT00348309|448701500|FG001|Overall Study|Worsening of alzheimer|0|||
124748759|NCT00348309|448701501|FG002|Overall Study|Worsening of alzheimer|1|||
124748760|NCT00348309|448701499|FG000|Overall Study|Did not appear in time for Visit 3|1|||
124748761|NCT00348309|448701500|FG001|Overall Study|Did not appear in time for Visit 3|0|||
124748762|NCT00348309|448701501|FG002|Overall Study|Did not appear in time for Visit 3|0|||
124748763|NCT00348309|448701499|FG000|Overall Study|Participant died|2|||
124748764|NCT00348309|448701500|FG001|Overall Study|Participant died|1|||
124748765|NCT00348309|448701501|FG002|Overall Study|Participant died|1|||
124748766|NCT00348309|448701499|FG000|Overall Study|Decision of sponsor|1|||
124748767|NCT00348309|448701500|FG001|Overall Study|Decision of sponsor|0|||
124748768|NCT00348309|448701501|FG002|Overall Study|Decision of sponsor|0|||
124748769|NCT00348309|448701499|FG000|Overall Study|Ineffectiveness of treatment|0|||
124748770|NCT00348309|448701500|FG001|Overall Study|Ineffectiveness of treatment|1|||
124748771|NCT00348309|448701501|FG002|Overall Study|Ineffectiveness of treatment|0|||
124748772|NCT00348309|448701499|FG000|Overall Study|A foul of exclusion criteria|0|||
124748773|NCT00348309|448701500|FG001|Overall Study|A foul of exclusion criteria|1|||
124748774|NCT00348309|448701501|FG002|Overall Study|A foul of exclusion criteria|0|||
124748775|NCT00348309|448701499|FG000|Overall Study|Participant was hospitalized|0|||
124748776|NCT00348309|448701500|FG001|Overall Study|Participant was hospitalized|1|||
124748777|NCT00348309|448701501|FG002|Overall Study|Participant was hospitalized|0|||
124748778|NCT00348309|448701499|FG000|Overall Study|Sponsor refuseal|0|||
124748779|NCT00348309|448701500|FG001|Overall Study|Sponsor refuseal|1|||
124748780|NCT00348309|448701501|FG002|Overall Study|Sponsor refuseal|1|||
124748781|NCT00348309|448701499|FG000|Overall Study|Forgot often medication|0|||
124748782|NCT00348309|448701500|FG001|Overall Study|Forgot often medication|1|||
124748783|NCT00348309|448701501|FG002|Overall Study|Forgot often medication|0|||
124748784|NCT00348309|448701499|FG000|Overall Study|Medical Monitor decision|0|||
124748785|NCT00348309|448701500|FG001|Overall Study|Medical Monitor decision|0|||
124748786|NCT00348309|448701501|FG002|Overall Study|Medical Monitor decision|1|||
124748787|NCT00348309|448701499|FG000|Overall Study|Increased dose of Aricept|0|||
124748788|NCT00348309|448701500|FG001|Overall Study|Increased dose of Aricept|0|||
124748789|NCT00348309|448701501|FG002|Overall Study|Increased dose of Aricept|1|||
124748790|NCT00348309|448701499|FG000|Overall Study|Site closure|0|||
124748791|NCT00348309|448701500|FG001|Overall Study|Site closure|0|||
124748792|NCT00348309|448701501|FG002|Overall Study|Site closure|1|||
124748793|NCT00348309|448701499|FG000|Overall Study|Adverse event not attended|0|||
124748794|NCT00348309|448701500|FG001|Overall Study|Adverse event not attended|0|||
124748795|NCT00348309|448701501|FG002|Overall Study|Adverse event not attended|1|||
124748796|NCT00348309|448701499|FG000|Overall Study|ECG abnormal|0|||
124748797|NCT00348309|448701500|FG001|Overall Study|ECG abnormal|0|||
124748798|NCT00348309|448701501|FG002|Overall Study|ECG abnormal|2|||
124748799|NCT00348309|448701499|FG000|Overall Study|Cardiologist recommendations|0|||
124748800|NCT00348309|448701500|FG001|Overall Study|Cardiologist recommendations|0|||
124748801|NCT00348309|448701501|FG002|Overall Study|Cardiologist recommendations|1|||
124748802|NCT00348309|448701499|FG000|Overall Study|HCV career|0|||
124748803|NCT00348309|448701500|FG001|Overall Study|HCV career|0|||
124748804|NCT00348309|448701501|FG002|Overall Study|HCV career|1|||
124748805|NCT01894243|448701502|FG000|Overall Study|Adverse Event|0|||
124748806|NCT01894243|448701503|FG001|Overall Study|Adverse Event|1|||
124748807|NCT01894243|448701504|FG002|Overall Study|Adverse Event|2|||
124748808|NCT01894243|448701502|FG000|Overall Study|Death|0|||
124748809|NCT01894243|448701503|FG001|Overall Study|Death|0|||
124748810|NCT01894243|448701504|FG002|Overall Study|Death|3|||
124748811|NCT01894243|448701502|FG000|Overall Study|Lack of Efficacy|3|||
124748812|NCT01894243|448701503|FG001|Overall Study|Lack of Efficacy|3|||
124748813|NCT01894243|448701504|FG002|Overall Study|Lack of Efficacy|1|||
124748814|NCT01894243|448701502|FG000|Overall Study|Condition under investigation worsened|8|||
124748815|NCT01894243|448701503|FG001|Overall Study|Condition under investigation worsened|6|||
124748816|NCT01894243|448701504|FG002|Overall Study|Condition under investigation worsened|2|||
124748817|NCT01894243|448701502|FG000|Overall Study|Subject decision|1|||
124748818|NCT01894243|448701503|FG001|Overall Study|Subject decision|0|||
124748819|NCT01894243|448701504|FG002|Overall Study|Subject decision|0|||
124748820|NCT01894243|448701502|FG000|Overall Study|Other|1|||
124748821|NCT01894243|448701503|FG001|Overall Study|Other|0|||
124748822|NCT01894243|448701504|FG002|Overall Study|Other|0|||
124748823|NCT01620944|448701508|FG000|Overall Study|Early termination of Study|2|||
124748824|NCT01620944|448701509|FG001|Overall Study|Early termination of Study|1|||
124748825|NCT01364389|448701511|FG000|Overall Study|Withdrawal by Subject|0|||
124748826|NCT01364389|448701512|FG001|Overall Study|Withdrawal by Subject|1|||
124748827|NCT01364389|448701513|FG002|Overall Study|Withdrawal by Subject|0|||
124748828|NCT01364389|448701511|FG000|Overall Study|Protocol deviation|0|||
124748829|NCT01364389|448701512|FG001|Overall Study|Protocol deviation|0|||
124748830|NCT01364389|448701513|FG002|Overall Study|Protocol deviation|1|||
124748831|NCT01364389|448701511|FG000|Overall Study|Administrative problems|1|||
124748832|NCT01364389|448701512|FG001|Overall Study|Administrative problems|0|||
124748833|NCT01364389|448701513|FG002|Overall Study|Administrative problems|0|||
124748834|NCT01364389|448701511|FG000|Overall Study|Adverse Event|1|||
124748835|NCT01364389|448701512|FG001|Overall Study|Adverse Event|0|||
124748836|NCT01364389|448701513|FG002|Overall Study|Adverse Event|0|||
124748837|NCT02687581|448701514|FG000|Overall Study|Withdrawal by Subject|1|||
124748838|NCT02687581|448701515|FG001|Overall Study|Withdrawal by Subject|0|||
124748839|NCT02687581|448701516|FG002|Overall Study|Withdrawal by Subject|0|||
124748840|NCT02687581|448701517|FG003|Overall Study|Withdrawal by Subject|1|||
124748841|NCT02687581|448701514|FG000|Overall Study|Lost to Follow-up|2|||
124748842|NCT02687581|448701515|FG001|Overall Study|Lost to Follow-up|2|||
124748843|NCT02687581|448701516|FG002|Overall Study|Lost to Follow-up|0|||
124748844|NCT02687581|448701517|FG003|Overall Study|Lost to Follow-up|0|||
124748845|NCT02687581|448701514|FG000|Overall Study|the device is too small for the patient.|1|||
124748846|NCT02687581|448701515|FG001|Overall Study|the device is too small for the patient.|0|||
124748847|NCT02687581|448701516|FG002|Overall Study|the device is too small for the patient.|0|||
124748848|NCT02687581|448701517|FG003|Overall Study|the device is too small for the patient.|0|||
124748849|NCT02554981|448701520|FG000|Overall Study|Adverse Event|1|||
124748850|NCT02554981|448701520|FG000|Overall Study|Administrative Reasons|1|||
124748851|NCT02554981|448701520|FG000|Overall Study|Other Miscellaneous Reasons|3|||
124748852|NCT01114438|448701521|FG000|Overall Study|Adverse Event|10|||
124748853|NCT01114438|448701521|FG000|Overall Study|concomitant medication|1|||
124748854|NCT01114438|448701521|FG000|Overall Study|Physician Decision|1|||
124748855|NCT01114438|448701521|FG000|Overall Study|Withdrawal by Subject|2|||
124748856|NCT00991406|448701526|FG000|Overall Study|One participant did not respond to FES.|1|||
124748857|NCT03597061|448701527|FG000|Overall Study|Lost to Follow-up|1|||
124748858|NCT03597061|448701528|FG001|Overall Study|Lost to Follow-up|0|||
124748859|NCT03597061|448701527|FG000|Overall Study|Protocol Violation|0|||
124748860|NCT03597061|448701528|FG001|Overall Study|Protocol Violation|1|||
124748861|NCT02160145|448701529|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
124748862|NCT02160145|448701530|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
124748863|NCT02160145|448701531|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
124748864|NCT02160145|448701529|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
124748865|NCT02160145|448701530|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
124748866|NCT02160145|448701531|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
124748867|NCT02160145|448701529|FG000|Randomized Double-blind Period|Subject decision|0|||
124748868|NCT02160145|448701530|FG001|Randomized Double-blind Period|Subject decision|21|||
124748869|NCT02160145|448701531|FG002|Randomized Double-blind Period|Subject decision|20|||
124748870|NCT02160145|448701529|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
124748871|NCT02160145|448701530|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
124748872|NCT02160145|448701531|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
124748873|NCT02160145|448701529|FG000|Randomized Double-blind Period|Physician Decision|0|||
124748874|NCT02160145|448701530|FG001|Randomized Double-blind Period|Physician Decision|7|||
124748875|NCT02160145|448701531|FG002|Randomized Double-blind Period|Physician Decision|5|||
124748876|NCT00375518|448701532|FG000|Overall Study|Withdrawal by Subject|2|||
124748877|NCT00375518|448701533|FG001|Overall Study|Withdrawal by Subject|10|||
124748878|NCT00375518|448701532|FG000|Overall Study|Patient Not Treated|6|||
124748879|NCT00375518|448701533|FG001|Overall Study|Patient Not Treated|6|||
124748880|NCT00375518|448701532|FG000|Overall Study|Death|0|||
124748881|NCT00375518|448701533|FG001|Overall Study|Death|1|||
124748882|NCT01108523|448701534|FG000|Overall Study|Protocol Violation|4|||
124748883|NCT03755661|448701539|FG000|Overall Study|Lost to Follow-up|1|||
124748884|NCT03755661|448701540|FG001|Overall Study|Lost to Follow-up|0|||
124748885|NCT02277119|448701541|FG000|Overall Study|Lack of Efficacy|1|||
124748886|NCT02277119|448701542|FG001|Overall Study|Lack of Efficacy|1|||
124748887|NCT02277119|448701543|FG002|Overall Study|Lack of Efficacy|1|||
124748888|NCT02277119|448701541|FG000|Overall Study|Protocol Violation|2|||
124619830|NCT00447993|448223784|FG003|Overall Study|Withdrawal by Subject|2|||
124619831|NCT01885195|448223785|FG000|Overall Study|Adverse Event|29|||
124619832|NCT01885195|448223785|FG000|Overall Study|Death|1|||
124619833|NCT01885195|448223785|FG000|Overall Study|Disease Progression|67|||
124619834|NCT01885195|448223785|FG000|Overall Study|Protocol Deviation|2|||
124619835|NCT01885195|448223785|FG000|Overall Study|Physician Decision|3|||
124619836|NCT01885195|448223785|FG000|Overall Study|Patient/guardian decision|8|||
124619837|NCT00548093|448223786|FG000|Overall Study|Death|33|||
124619838|NCT00548093|448223787|FG001|Overall Study|Death|13|||
124619839|NCT00548093|448223786|FG000|Overall Study|Lost to Follow-up|3|||
124619840|NCT00548093|448223787|FG001|Overall Study|Lost to Follow-up|1|||
124619841|NCT00548093|448223786|FG000|Overall Study|Objective progression or relapse|1|||
124619842|NCT00548093|448223787|FG001|Overall Study|Objective progression or relapse|1|||
124619843|NCT00548093|448223786|FG000|Overall Study|Other|11|||
124619844|NCT00548093|448223787|FG001|Overall Study|Other|1|||
124619845|NCT00548093|448223786|FG000|Overall Study|Withdrawal by Subject|1|||
124619846|NCT00548093|448223787|FG001|Overall Study|Withdrawal by Subject|0|||
124619847|NCT00548093|448223786|FG000|Overall Study|Completed post-treatment follow-up|1|||
124619848|NCT00548093|448223787|FG001|Overall Study|Completed post-treatment follow-up|0|||
124619849|NCT00509795|448223791|FG000|Overall Study|Adverse Event|4|||
124619850|NCT00509795|448223792|FG001|Overall Study|Adverse Event|3|||
124619851|NCT00509795|448223793|FG002|Overall Study|Adverse Event|5|||
124619852|NCT00509795|448223794|FG003|Overall Study|Adverse Event|4|||
124619853|NCT00509795|448223791|FG000|Overall Study|Death|3|||
124619854|NCT00509795|448223792|FG001|Overall Study|Death|1|||
124619855|NCT00509795|448223793|FG002|Overall Study|Death|2|||
124619856|NCT00509795|448223794|FG003|Overall Study|Death|7|||
124619857|NCT00509795|448223791|FG000|Overall Study|Lack of Efficacy|0|||
124619858|NCT00509795|448223792|FG001|Overall Study|Lack of Efficacy|0|||
124619859|NCT00509795|448223793|FG002|Overall Study|Lack of Efficacy|2|||
124619860|NCT00509795|448223794|FG003|Overall Study|Lack of Efficacy|2|||
124619861|NCT00509795|448223791|FG000|Overall Study|Lost to Follow-up|1|||
124619862|NCT00509795|448223792|FG001|Overall Study|Lost to Follow-up|2|||
124619863|NCT00509795|448223793|FG002|Overall Study|Lost to Follow-up|4|||
124619864|NCT00509795|448223794|FG003|Overall Study|Lost to Follow-up|4|||
124619865|NCT00509795|448223791|FG000|Overall Study|OTHER|1|||
124619866|NCT00509795|448223792|FG001|Overall Study|OTHER|0|||
124619867|NCT00509795|448223793|FG002|Overall Study|OTHER|4|||
124619868|NCT00509795|448223794|FG003|Overall Study|OTHER|1|||
124619869|NCT00509795|448223791|FG000|Overall Study|Protocol Violation|3|||
124619870|NCT00509795|448223792|FG001|Overall Study|Protocol Violation|0|||
124619871|NCT00509795|448223793|FG002|Overall Study|Protocol Violation|3|||
124619872|NCT00509795|448223794|FG003|Overall Study|Protocol Violation|1|||
124619873|NCT00509795|448223791|FG000|Overall Study|Withdrawal by Subject|10|||
124619874|NCT00509795|448223792|FG001|Overall Study|Withdrawal by Subject|5|||
124619875|NCT00509795|448223793|FG002|Overall Study|Withdrawal by Subject|7|||
124619876|NCT00509795|448223794|FG003|Overall Study|Withdrawal by Subject|8|||
124619877|NCT00912912|448223798|FG000|Overall Study|Withdrawal by Subject|1|||
124619878|NCT00912912|448223798|FG000|Overall Study|Disease Progression|3|||
124619879|NCT00306995|448223799|FG000|Study Part I|Withdrawal by Subject|0|||
124619880|NCT00306995|448223800|FG001|Study Part I|Withdrawal by Subject|0|||
124619881|NCT00306995|448223801|FG002|Study Part I|Withdrawal by Subject|0|||
124619882|NCT00306995|448223802|FG003|Study Part I|Withdrawal by Subject|0|||
124619883|NCT00306995|448223803|FG004|Study Part I|Withdrawal by Subject|0|||
124619884|NCT00306995|448223804|FG005|Study Part I|Withdrawal by Subject|0|||
124619885|NCT00306995|448223805|FG006|Study Part I|Withdrawal by Subject|1|||
124619886|NCT00306995|448223799|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
124619887|NCT00306995|448223800|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
124619888|NCT00306995|448223801|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
124619889|NCT00306995|448223802|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
124619890|NCT00306995|448223803|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
124619891|NCT00306995|448223804|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
124619892|NCT00306995|448223805|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
124619893|NCT01277601|448226115|FG000|Overall Study|Adverse Event|5|||
124619894|NCT01277601|448226116|FG001|Overall Study|Adverse Event|3|||
124619895|NCT01277601|448226117|FG002|Overall Study|Adverse Event|0|||
124619896|NCT01277601|448226118|FG003|Overall Study|Adverse Event|7|||
124619897|NCT01277601|448226115|FG000|Overall Study|Withdrawal by Subject|18|||
124619898|NCT01277601|448226116|FG001|Overall Study|Withdrawal by Subject|21|||
124619899|NCT01277601|448226117|FG002|Overall Study|Withdrawal by Subject|8|||
124619900|NCT01277601|448226118|FG003|Overall Study|Withdrawal by Subject|17|||
124619901|NCT01277601|448226115|FG000|Overall Study|Lost to Follow-up|7|||
124619902|NCT01277601|448226116|FG001|Overall Study|Lost to Follow-up|9|||
124619903|NCT01277601|448226117|FG002|Overall Study|Lost to Follow-up|4|||
124619904|NCT01277601|448226118|FG003|Overall Study|Lost to Follow-up|2|||
124619905|NCT01277601|448226115|FG000|Overall Study|Physician Decision|3|||
124619906|NCT01277601|448226116|FG001|Overall Study|Physician Decision|5|||
124619907|NCT01277601|448226117|FG002|Overall Study|Physician Decision|1|||
124619908|NCT01277601|448226118|FG003|Overall Study|Physician Decision|6|||
124782663|NCT00843284|448834250|FG000|Overall Study|Other|10|||
124782664|NCT00843284|448834250|FG000|Overall Study|Withdrawal by Subject|4|||
124782665|NCT00843284|448834250|FG000|Overall Study|Death|3|||
124782666|NCT01761162|448834257|FG000|Overall Study|Withdrawal by Subject|3|||
124748889|NCT02277119|448701542|FG001|Overall Study|Protocol Violation|3|||
124748890|NCT02277119|448701543|FG002|Overall Study|Protocol Violation|7|||
124748891|NCT00852241|448701546|FG000|Overall Study|Physician Decision|18|||
124748892|NCT02069392|448701548|FG000|Overall Study|Withdrawal by Subject|4|||
124748893|NCT02069392|448701549|FG001|Overall Study|Withdrawal by Subject|2|||
124748894|NCT03521141|448704102|FG000|Overall Study|Death|1|||
124748895|NCT03521141|448704103|FG001|Overall Study|Death|0|||
124748896|NCT03521141|448704104|FG002|Overall Study|Death|1|||
124748897|NCT01702025|448704107|FG000|Overall Study|Equipment failure|1|||
124748898|NCT01702025|448704108|FG001|Overall Study|Equipment failure|0|||
124748899|NCT01702025|448704109|FG002|Overall Study|Equipment failure|0|||
124748900|NCT01702025|448704110|FG003|Overall Study|Equipment failure|0|||
124748901|NCT01702025|448704107|FG000|Overall Study|Adverse Event|1|||
124748902|NCT01702025|448704108|FG001|Overall Study|Adverse Event|1|||
124748903|NCT01702025|448704109|FG002|Overall Study|Adverse Event|1|||
124748904|NCT01702025|448704110|FG003|Overall Study|Adverse Event|0|||
124748905|NCT04207749|448704113|FG000|Overall Study|Lost to Follow-up|0|||
124748906|NCT04207749|448704114|FG001|Overall Study|Lost to Follow-up|2|||
124748907|NCT04207749|448704113|FG000|Overall Study|Protocol Violation|0|||
124748908|NCT04207749|448704114|FG001|Overall Study|Protocol Violation|1|||
124748909|NCT04207749|448704113|FG000|Overall Study|Withdrawal by Subject|3|||
124748910|NCT04207749|448704114|FG001|Overall Study|Withdrawal by Subject|0|||
124748911|NCT04207749|448704113|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
124748912|NCT04207749|448704114|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
124748913|NCT05362058|448704115|FG000|Treatment Period|Adverse Event|3|||
124748914|NCT05362058|448704116|FG001|Treatment Period|Adverse Event|3|||
124748915|NCT05362058|448704115|FG000|Treatment Period|Assigned treatment by mistake|3|||
124748916|NCT05362058|448704116|FG001|Treatment Period|Assigned treatment by mistake|4|||
124748917|NCT05362058|448704115|FG000|Treatment Period|Death|1|||
124748918|NCT05362058|448704116|FG001|Treatment Period|Death|1|||
124748919|NCT05362058|448704115|FG000|Treatment Period|Lost to Follow-up|6|||
124748920|NCT05362058|448704116|FG001|Treatment Period|Lost to Follow-up|3|||
124748921|NCT05362058|448704115|FG000|Treatment Period|Non-compliance with study drug|0|||
124748922|NCT05362058|448704116|FG001|Treatment Period|Non-compliance with study drug|1|||
124748923|NCT05362058|448704115|FG000|Treatment Period|Physician Decision|1|||
124748924|NCT05362058|448704116|FG001|Treatment Period|Physician Decision|0|||
124748925|NCT05362058|448704115|FG000|Treatment Period|Protocol deviation|1|||
124748926|NCT05362058|448704116|FG001|Treatment Period|Protocol deviation|0|||
124748927|NCT05362058|448704115|FG000|Treatment Period|Withdrawal by Subject|10|||
124748928|NCT05362058|448704116|FG001|Treatment Period|Withdrawal by Subject|11|||
124748929|NCT05362058|448704115|FG000|Follow-Up Period|Death|1|||
124748930|NCT05362058|448704116|FG001|Follow-Up Period|Death|0|||
124748931|NCT05362058|448704115|FG000|Follow-Up Period|Lost to Follow-up|2|||
124748932|NCT05362058|448704116|FG001|Follow-Up Period|Lost to Follow-up|1|||
124748933|NCT05362058|448704115|FG000|Follow-Up Period|Protocol deviation|1|||
124748934|NCT05362058|448704116|FG001|Follow-Up Period|Protocol deviation|1|||
124748935|NCT05362058|448704115|FG000|Follow-Up Period|Withdrawal by Subject|0|||
124748936|NCT05362058|448704116|FG001|Follow-Up Period|Withdrawal by Subject|3|||
124748937|NCT00930553|448704119|FG000|Overall Study|Adverse Event|1|||
124748938|NCT00930553|448704119|FG000|Overall Study|Lack of Efficacy|7|||
124748939|NCT00930553|448704119|FG000|Overall Study|Physician Decision|39|||
124748940|NCT00930553|448704119|FG000|Overall Study|Protocol Violation|1|||
124748941|NCT00930553|448704119|FG000|Overall Study|Pregnancy|1|||
124748942|NCT00930553|448704119|FG000|Overall Study|Withdrawal by Subject|88|||
124748943|NCT00930553|448704119|FG000|Overall Study|Lost to Follow-up|25|||
124782667|NCT02160899|448834266|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
124782668|NCT02160899|448834267|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
124782669|NCT02160899|448834268|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
124619909|NCT01277601|448226115|FG000|Overall Study|Pregnancy|2|||
124619910|NCT01277601|448226116|FG001|Overall Study|Pregnancy|2|||
124619911|NCT01277601|448226117|FG002|Overall Study|Pregnancy|4|||
124782670|NCT02160899|448834269|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
124619912|NCT01277601|448226118|FG003|Overall Study|Pregnancy|1|||
124748944|NCT00930553|448704119|FG000|Overall Study|Death|9|||
124748945|NCT00930553|448704119|FG000|Overall Study|Study terminated by sponsor|24|||
124748946|NCT00930553|448704119|FG000|Overall Study|Other than specified above|28|||
124748947|NCT00413036|448704120|FG000|Overall Study|Adverse Event|44|||
124748948|NCT00413036|448704120|FG000|Overall Study|Lack of Efficacy|129|||
124748949|NCT00413036|448704120|FG000|Overall Study|Withdrawal by Subject|7|||
124748950|NCT00413036|448704120|FG000|Overall Study|Death|9|||
124748951|NCT00413036|448704120|FG000|Overall Study|Other|26|||
124748952|NCT00413036|448704120|FG000|Overall Study|Missing|2|||
124748953|NCT04042909|448704121|FG000|Overall Study|Withdrawal by Subject|1|||
124619913|NCT01277601|448226115|FG000|Overall Study|Noncompliance with Study Drug|1|||
124748954|NCT04042909|448704122|FG001|Overall Study|Withdrawal by Subject|0|||
124748955|NCT04042909|448704123|FG002|Overall Study|Withdrawal by Subject|0|||
124748956|NCT04042909|448704121|FG000|Overall Study|duplicate cases|2|||
124748957|NCT04042909|448704122|FG001|Overall Study|duplicate cases|0|||
124748958|NCT04042909|448704123|FG002|Overall Study|duplicate cases|0|||
124748959|NCT04042909|448704121|FG000|Overall Study|technical problem|0|||
124748960|NCT04042909|448704122|FG001|Overall Study|technical problem|1|||
124748961|NCT04042909|448704123|FG002|Overall Study|technical problem|0|||
124748962|NCT01369641|448704124|FG000|Overall Study|Withdrawal by Subject|1|||
124748963|NCT00842543|448704125|FG000|Overall Study|Withdrawal by Subject|2|||
124748964|NCT00842543|448704126|FG001|Overall Study|Withdrawal by Subject|0|||
124748965|NCT00842543|448704127|FG002|Overall Study|Withdrawal by Subject|3|||
124748966|NCT00842543|448704128|FG003|Overall Study|Withdrawal by Subject|4|||
124748967|NCT01483183|448704133|FG000|Overall Study|Physician Decision|0|||
124748968|NCT01483183|448704134|FG001|Overall Study|Physician Decision|0|||
124748969|NCT01483183|448704135|FG002|Overall Study|Physician Decision|0|||
124748970|NCT01483183|448704136|FG003|Overall Study|Physician Decision|0|||
124748971|NCT01483183|448704137|FG004|Overall Study|Physician Decision|0|||
124748972|NCT01483183|448704138|FG005|Overall Study|Physician Decision|0|||
124748973|NCT01483183|448704139|FG006|Overall Study|Physician Decision|2|||
124748974|NCT01483183|448704140|FG007|Overall Study|Physician Decision|0|||
124748975|NCT01483183|448704141|FG008|Overall Study|Physician Decision|0|||
124748976|NCT01483183|448704142|FG009|Overall Study|Physician Decision|0|||
124748977|NCT01483183|448704133|FG000|Overall Study|Withdrawal by Subject|0|||
124748978|NCT01483183|448704134|FG001|Overall Study|Withdrawal by Subject|0|||
124748979|NCT01483183|448704135|FG002|Overall Study|Withdrawal by Subject|0|||
124748980|NCT01483183|448704136|FG003|Overall Study|Withdrawal by Subject|0|||
124748981|NCT01483183|448704137|FG004|Overall Study|Withdrawal by Subject|0|||
124748982|NCT01483183|448704138|FG005|Overall Study|Withdrawal by Subject|0|||
124748983|NCT01483183|448704139|FG006|Overall Study|Withdrawal by Subject|0|||
124748984|NCT01483183|448704140|FG007|Overall Study|Withdrawal by Subject|0|||
124748985|NCT01483183|448704141|FG008|Overall Study|Withdrawal by Subject|0|||
124748986|NCT01483183|448704142|FG009|Overall Study|Withdrawal by Subject|1|||
124748987|NCT00239928|448704143|FG000|Overall Study|Lack of Efficacy|1|||
124748988|NCT00239928|448704143|FG000|Overall Study|Adverse Event|4|||
124748989|NCT00239928|448704143|FG000|Overall Study|Not need to continue study|3|||
124748990|NCT00239928|448704143|FG000|Overall Study|Withdrawal by Subject|2|||
124748991|NCT00286494|448704144|FG000|Overall Study|Hyperglycemic rescue|12|||
124748992|NCT00286494|448704145|FG001|Overall Study|Hyperglycemic rescue|19|||
124748993|NCT00286494|448704146|FG002|Overall Study|Hyperglycemic rescue|18|||
124748994|NCT00286494|448704144|FG000|Overall Study|Withdrawal by Subject|2|||
124748995|NCT00286494|448704145|FG001|Overall Study|Withdrawal by Subject|10|||
124748996|NCT00286494|448704146|FG002|Overall Study|Withdrawal by Subject|9|||
124748997|NCT00286494|448704144|FG000|Overall Study|Adverse Event|3|||
124748998|NCT00286494|448704145|FG001|Overall Study|Adverse Event|8|||
124748999|NCT00286494|448704146|FG002|Overall Study|Adverse Event|6|||
124749000|NCT00286494|448704144|FG000|Overall Study|Physician Decision|5|||
124749001|NCT00286494|448704145|FG001|Overall Study|Physician Decision|5|||
124749002|NCT00286494|448704146|FG002|Overall Study|Physician Decision|1|||
124749003|NCT00286494|448704144|FG000|Overall Study|Lost to Follow-up|3|||
124749004|NCT00286494|448704145|FG001|Overall Study|Lost to Follow-up|1|||
124749005|NCT00286494|448704146|FG002|Overall Study|Lost to Follow-up|3|||
124749006|NCT00286494|448704144|FG000|Overall Study|Protocol Violation|1|||
124749007|NCT00286494|448704145|FG001|Overall Study|Protocol Violation|1|||
124749008|NCT00286494|448704146|FG002|Overall Study|Protocol Violation|2|||
124749009|NCT04776317|448704147|FG000|Overall Study|Physician Decision|0|||
124749010|NCT04776317|448704148|FG001|Overall Study|Physician Decision|1|||
124749011|NCT04776317|448704149|FG002|Overall Study|Physician Decision|0|||
124749012|NCT04776317|448704150|FG003|Overall Study|Physician Decision|0|||
124749013|NCT04776317|448704151|FG004|Overall Study|Physician Decision|0|||
124749014|NCT04776317|448704152|FG005|Overall Study|Physician Decision|0|||
124749015|NCT04776317|448704153|FG006|Overall Study|Physician Decision|0|||
124749016|NCT04776317|448704154|FG007|Overall Study|Physician Decision|0|||
124749017|NCT04776317|448704155|FG008|Overall Study|Physician Decision|0|||
124749018|NCT04776317|448704156|FG009|Overall Study|Physician Decision|0|||
124749019|NCT04776317|448704157|FG010|Overall Study|Physician Decision|0|||
124749020|NCT04776317|448704158|FG011|Overall Study|Physician Decision|0|||
124749021|NCT04776317|448704159|FG012|Overall Study|Physician Decision|0|||
124749022|NCT04776317|448704160|FG013|Overall Study|Physician Decision|0|||
124749023|NCT04776317|448704161|FG014|Overall Study|Physician Decision|0|||
124749024|NCT04776317|448704147|FG000|Overall Study|Protocol Violation|0|||
124749025|NCT04776317|448704148|FG001|Overall Study|Protocol Violation|0|||
124749026|NCT04776317|448704149|FG002|Overall Study|Protocol Violation|1|||
124749027|NCT04776317|448704150|FG003|Overall Study|Protocol Violation|0|||
124749028|NCT04776317|448704151|FG004|Overall Study|Protocol Violation|0|||
124749029|NCT04776317|448704152|FG005|Overall Study|Protocol Violation|0|||
124749030|NCT04776317|448704153|FG006|Overall Study|Protocol Violation|0|||
124749031|NCT04776317|448704154|FG007|Overall Study|Protocol Violation|0|||
124749032|NCT04776317|448704155|FG008|Overall Study|Protocol Violation|0|||
124782671|NCT02160899|448834270|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
124782672|NCT02160899|448834271|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
124782673|NCT00798759|448834272|FG000|Overall Study|Adverse Event|3|||
124782674|NCT00798759|448834273|FG001|Overall Study|Adverse Event|3|||
124782675|NCT00798759|448834272|FG000|Overall Study|Lost to Follow-up|1|||
124782676|NCT00798759|448834273|FG001|Overall Study|Lost to Follow-up|1|||
124782677|NCT00798759|448834272|FG000|Overall Study|Protocol Violation|4|||
124782678|NCT00798759|448834273|FG001|Overall Study|Protocol Violation|8|||
124782679|NCT00798759|448834272|FG000|Overall Study|Other|0|||
124782680|NCT00798759|448834273|FG001|Overall Study|Other|1|||
124782681|NCT01754727|448834274|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
124782682|NCT04518995|448834277|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
124782683|NCT04518995|448834278|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
124782684|NCT04518995|448834279|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
124782685|NCT04518995|448834277|FG000|Overall Study|Lack of Efficacy|2|||
124782686|NCT04518995|448834278|FG001|Overall Study|Lack of Efficacy|1|||
124782687|NCT04518995|448834279|FG002|Overall Study|Lack of Efficacy|0|||
124782688|NCT04518995|448834277|FG000|Overall Study|Non-compliance With Study Drug|0|||
124782689|NCT04518995|448834278|FG001|Overall Study|Non-compliance With Study Drug|3|||
124782690|NCT04518995|448834279|FG002|Overall Study|Non-compliance With Study Drug|2|||
124782691|NCT04518995|448834277|FG000|Overall Study|Pregnancy|0|||
124782692|NCT04518995|448834278|FG001|Overall Study|Pregnancy|0|||
124782693|NCT04518995|448834279|FG002|Overall Study|Pregnancy|1|||
124782694|NCT04518995|448834277|FG000|Overall Study|Protocol Violation|2|||
124782695|NCT04518995|448834278|FG001|Overall Study|Protocol Violation|0|||
124782696|NCT04518995|448834279|FG002|Overall Study|Protocol Violation|1|||
124782697|NCT04518995|448834277|FG000|Overall Study|Reason not Specified|4|||
124782698|NCT04518995|448834278|FG001|Overall Study|Reason not Specified|11|||
124782699|NCT04518995|448834279|FG002|Overall Study|Reason not Specified|2|||
124782700|NCT04518995|448834277|FG000|Overall Study|Lost to Follow-up|1|||
124782701|NCT04518995|448834278|FG001|Overall Study|Lost to Follow-up|10|||
124782702|NCT04518995|448834279|FG002|Overall Study|Lost to Follow-up|6|||
124782703|NCT02891070|448834281|FG000|Overall Study|Adverse Event|1|||
124782704|NCT02891070|448834282|FG001|Overall Study|Adverse Event|0|||
124782705|NCT02891070|448834281|FG000|Overall Study|Physician Decision|0|||
124782706|NCT02891070|448834282|FG001|Overall Study|Physician Decision|1|||
124782707|NCT02891070|448834281|FG000|Overall Study|Lost to Follow-up|4|||
124782708|NCT02891070|448834282|FG001|Overall Study|Lost to Follow-up|4|||
124782709|NCT02891070|448834281|FG000|Overall Study|Other|1|||
124782710|NCT02891070|448834282|FG001|Overall Study|Other|0|||
124782711|NCT02891070|448834281|FG000|Overall Study|Protocol Violation|0|||
124782712|NCT02891070|448834282|FG001|Overall Study|Protocol Violation|1|||
124782713|NCT02891070|448834281|FG000|Overall Study|Withdrawal by Subject|1|||
124782714|NCT02891070|448834282|FG001|Overall Study|Withdrawal by Subject|2|||
124782715|NCT02891070|448834281|FG000|Overall Study|Death|3|||
124782716|NCT02891070|448834282|FG001|Overall Study|Death|0|||
124782717|NCT04491604|448834283|FG000|Overall Study|Withdrawal by Subject|3|||
124782718|NCT02934503|448834284|FG000|Overall Study|progression of disease|3|||
124782719|NCT02934503|448834284|FG000|Overall Study|Withdrawal by Subject|1|||
124782720|NCT04248491|448834285|FG000|Overall Study|Lost to Follow-up|1|||
124782721|NCT04248491|448834286|FG001|Overall Study|Lost to Follow-up|0|||
124782722|NCT02597478|448834287|FG000|Overall Study|Withdrawal by Subject|2|||
124782723|NCT02597478|448834288|FG001|Overall Study|Withdrawal by Subject|0|||
124782724|NCT02597478|448834287|FG000|Overall Study|Change of opioid dose|1|||
124782725|NCT02597478|448834288|FG001|Overall Study|Change of opioid dose|0|||
124782726|NCT02597478|448834287|FG000|Overall Study|Insufficient exertional dyspnea|0|||
124782727|NCT02597478|448834288|FG001|Overall Study|Insufficient exertional dyspnea|1|||
124782728|NCT01536067|448834289|FG000|Overall Study|Disease Progression|1|||
124619914|NCT01277601|448226116|FG001|Overall Study|Noncompliance with Study Drug|3|||
124619915|NCT01277601|448226117|FG002|Overall Study|Noncompliance with Study Drug|2|||
124782729|NCT01652469|448834290|FG000|Overall Study|Withdrawal by Subject|1|||
124782730|NCT01652469|448834291|FG001|Overall Study|Withdrawal by Subject|4|||
124782731|NCT01652469|448834290|FG000|Overall Study|Lost to Follow-up|0|||
124782732|NCT01652469|448834291|FG001|Overall Study|Lost to Follow-up|2|||
124782733|NCT01402102|448834292|FG000|Overall Study|Protocol Violation|1|||
124782734|NCT01402102|448834293|FG001|Overall Study|Protocol Violation|0|||
124782735|NCT01402102|448834292|FG000|Overall Study|Insufficiency of compliance|1|||
124782736|NCT01402102|448834293|FG001|Overall Study|Insufficiency of compliance|1|||
124782737|NCT01402102|448834292|FG000|Overall Study|Withdrawal by Subject|0|||
124782738|NCT01402102|448834293|FG001|Overall Study|Withdrawal by Subject|2|||
124782739|NCT00905645|448834295|FG000|Overall Study|Death (not device related)|10|||
124782740|NCT00905645|448834296|FG001|Overall Study|Death (not device related)|4|||
124782741|NCT00905645|448834297|FG002|Overall Study|Death (not device related)|15|||
124782742|NCT00905645|448834298|FG003|Overall Study|Death (not device related)|8|||
124782743|NCT00905645|448834295|FG000|Overall Study|Explantation of study device(s)|78|||
124782744|NCT00905645|448834296|FG001|Overall Study|Explantation of study device(s)|47|||
124782745|NCT00905645|448834297|FG002|Overall Study|Explantation of study device(s)|28|||
124619916|NCT01277601|448226118|FG003|Overall Study|Noncompliance with Study Drug|0|||
124619917|NCT01277601|448226115|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
124619918|NCT01277601|448226116|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
124619919|NCT01277601|448226117|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
124619920|NCT01277601|448226118|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
124619921|NCT01277601|448226115|FG000|Overall Study|Protocol Violation|0|||
124619922|NCT01277601|448226116|FG001|Overall Study|Protocol Violation|2|||
124619923|NCT01277601|448226117|FG002|Overall Study|Protocol Violation|5|||
124619924|NCT01277601|448226118|FG003|Overall Study|Protocol Violation|0|||
124619925|NCT01277601|448226115|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
124619926|NCT01277601|448226116|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
124619927|NCT01277601|448226117|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
124619928|NCT01277601|448226118|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
124619929|NCT00974922|448226119|FG000|Overall Study|study terminated|24|||
124619930|NCT04974749|448226122|FG000|Overall Study|Withdrawal by Subject|2|||
124619931|NCT04974749|448226122|FG000|Overall Study|Gestation|1|||
124619932|NCT00362336|448226123|FG000|Overall Study|Serious Adverse Event|1|||
124619933|NCT00362336|448226124|FG001|Overall Study|Serious Adverse Event|0|||
124619934|NCT00362336|448226125|FG002|Overall Study|Serious Adverse Event|1|||
124619935|NCT00362336|448226123|FG000|Overall Study|Protocol Violation|0|||
124619936|NCT00362336|448226124|FG001|Overall Study|Protocol Violation|0|||
124619937|NCT00362336|448226125|FG002|Overall Study|Protocol Violation|1|||
124619938|NCT00362336|448226123|FG000|Overall Study|Lost to Follow-up|6|||
124619939|NCT00362336|448226124|FG001|Overall Study|Lost to Follow-up|4|||
124619940|NCT00362336|448226125|FG002|Overall Study|Lost to Follow-up|0|||
124619941|NCT00362336|448226123|FG000|Overall Study|Withdrawal by Subject|3|||
124619942|NCT00362336|448226124|FG001|Overall Study|Withdrawal by Subject|3|||
124619943|NCT00362336|448226125|FG002|Overall Study|Withdrawal by Subject|1|||
124619944|NCT04414618|448226126|FG000|Overall Study|Death|3|||
124619945|NCT04414618|448226127|FG001|Overall Study|Death|3|||
124619946|NCT04414618|448226126|FG000|Overall Study|Withdrawal by Subject|2|||
124619947|NCT04414618|448226127|FG001|Overall Study|Withdrawal by Subject|1|||
124619948|NCT04414618|448226126|FG000|Overall Study|Lost to Follow-up|2|||
124619949|NCT04414618|448226127|FG001|Overall Study|Lost to Follow-up|3|||
124619950|NCT04414618|448226126|FG000|Overall Study|Physician Decision|1|||
124619951|NCT04414618|448226127|FG001|Overall Study|Physician Decision|0|||
124619952|NCT01121562|448226130|FG000|Overall Study|Objective progression or relapse|8|||
124619953|NCT01121562|448226130|FG000|Overall Study|Withdrawal by Subject|1|||
124619954|NCT01121562|448226130|FG000|Overall Study|Adverse Event|1|||
124619955|NCT01121562|448226130|FG000|Overall Study|Sponsor Decision|1|||
124619956|NCT01121562|448226130|FG000|Overall Study|Met study discontinuation criteria|1|||
124619957|NCT04152863|448226131|FG000|Overall Study|Death|13|||
124619958|NCT04152863|448226132|FG001|Overall Study|Death|12|||
124619959|NCT04152863|448226133|FG002|Overall Study|Death|7|||
124619960|NCT04152863|448226131|FG000|Overall Study|Physician Decision|1|||
124619961|NCT04152863|448226132|FG001|Overall Study|Physician Decision|1|||
124619962|NCT04152863|448226133|FG002|Overall Study|Physician Decision|1|||
124619963|NCT04152863|448226131|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
124619964|NCT04152863|448226132|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
124619965|NCT04152863|448226133|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
124619966|NCT04152863|448226131|FG000|Overall Study|Withdrawal by Subject|2|||
124619967|NCT04152863|448226132|FG001|Overall Study|Withdrawal by Subject|1|||
124619968|NCT04152863|448226133|FG002|Overall Study|Withdrawal by Subject|3|||
124619969|NCT00196326|448226136|FG000|Overall Study|Did not meet protocol requirements|64|||
124619970|NCT00196326|448226136|FG000|Overall Study|Non-compliance with the protocol|81|||
124619971|NCT00196326|448226136|FG000|Overall Study|Physician Decision|3|||
124619972|NCT00196326|448226136|FG000|Overall Study|Withdrawal by Subject|225|||
124619973|NCT00196326|448226136|FG000|Overall Study|Adverse Event|253|||
124619974|NCT00196326|448226136|FG000|Overall Study|Pregnancy|34|||
124619975|NCT00196326|448226136|FG000|Overall Study|Lost to Follow-up|304|||
124749033|NCT04776317|448704156|FG009|Overall Study|Protocol Violation|0|||
124619976|NCT00196326|448226136|FG000|Overall Study|Other|22|||
124619977|NCT02797171|448226140|FG000|Overall Study|Lost to Follow-up|2|||
124619978|NCT02797171|448226141|FG001|Overall Study|Lost to Follow-up|0|||
124619979|NCT02797171|448226142|FG002|Overall Study|Lost to Follow-up|2|||
124749034|NCT04776317|448704157|FG010|Overall Study|Protocol Violation|0|||
124619980|NCT02797171|448226143|FG003|Overall Study|Lost to Follow-up|1|||
124619981|NCT02797171|448226144|FG004|Overall Study|Lost to Follow-up|2|||
124619982|NCT02797171|448226145|FG005|Overall Study|Lost to Follow-up|0|||
124619983|NCT02797171|448226140|FG000|Overall Study|Withdrawal by Subject|1|||
124619984|NCT02797171|448226141|FG001|Overall Study|Withdrawal by Subject|1|||
124619985|NCT02797171|448226142|FG002|Overall Study|Withdrawal by Subject|0|||
124619986|NCT02797171|448226143|FG003|Overall Study|Withdrawal by Subject|0|||
124619987|NCT02797171|448226144|FG004|Overall Study|Withdrawal by Subject|0|||
124619988|NCT02797171|448226145|FG005|Overall Study|Withdrawal by Subject|0|||
124619989|NCT02797171|448226140|FG000|Overall Study|Protocol Violation|1|||
124619990|NCT02797171|448226141|FG001|Overall Study|Protocol Violation|0|||
124782746|NCT00905645|448834298|FG003|Overall Study|Explantation of study device(s)|21|||
124782747|NCT00905645|448834295|FG000|Overall Study|Subject Request|41|||
124782748|NCT00905645|448834296|FG001|Overall Study|Subject Request|17|||
124782749|NCT00905645|448834297|FG002|Overall Study|Subject Request|13|||
124782750|NCT00905645|448834298|FG003|Overall Study|Subject Request|11|||
124782751|NCT00905645|448834295|FG000|Overall Study|Lost to Follow-up|299|||
124782752|NCT00905645|448834296|FG001|Overall Study|Lost to Follow-up|103|||
124782753|NCT00905645|448834297|FG002|Overall Study|Lost to Follow-up|51|||
124782754|NCT00905645|448834298|FG003|Overall Study|Lost to Follow-up|12|||
124782755|NCT01731938|448834299|FG000|Preliminary Part I|Withdrawal by Subject|2|||
124782756|NCT01731938|448834300|FG001|Preliminary Part I|Withdrawal by Subject|2|||
124782757|NCT01731938|448834299|FG000|Preliminary Part I|Physician Decision|1|||
124782758|NCT01731938|448834300|FG001|Preliminary Part I|Physician Decision|0|||
124782759|NCT01731938|448834299|FG000|Preliminary Part I|Lost to Follow-up|0|||
124782760|NCT01731938|448834300|FG001|Preliminary Part I|Lost to Follow-up|3|||
124782761|NCT01731938|448834299|FG000|Preliminary Part I|Missed Week 6 visit|0|||
124782762|NCT01731938|448834300|FG001|Preliminary Part I|Missed Week 6 visit|3|||
124782763|NCT01731938|448834299|FG000|Primary Part II|Withdrawal by Subject|5|||
124782764|NCT01731938|448834300|FG001|Primary Part II|Withdrawal by Subject|4|||
124782765|NCT01731938|448834299|FG000|Primary Part II|Lost to Follow-up|4|||
124782766|NCT01731938|448834300|FG001|Primary Part II|Lost to Follow-up|5|||
124782767|NCT01731938|448834299|FG000|Primary Part II|Death|2|||
124782768|NCT01731938|448834300|FG001|Primary Part II|Death|1|||
124782769|NCT01731938|448834299|FG000|Primary Part II|Missed Week 6 visit|2|||
124782770|NCT01731938|448834300|FG001|Primary Part II|Missed Week 6 visit|3|||
124782771|NCT04931888|448834301|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
124782772|NCT04931888|448834302|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
124782773|NCT04931888|448834303|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
124782774|NCT04931888|448834304|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
124782775|NCT04538144|448834305|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
124782776|NCT04538144|448834306|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
124782777|NCT04538144|448834307|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
124782778|NCT04538144|448834308|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
124782779|NCT02350478|448834309|FG000|Overall Study|Lost to Follow-up|5|||
124782780|NCT02350478|448834310|FG001|Overall Study|Lost to Follow-up|1|||
124782781|NCT00771953|448834311|FG000|Overall Study|Adverse Event|5|||
124782782|NCT00771953|448834312|FG001|Overall Study|Adverse Event|3|||
124782783|NCT00771953|448834311|FG000|Overall Study|Death|2|||
124782784|NCT00771953|448834312|FG001|Overall Study|Death|2|||
124782785|NCT00771953|448834311|FG000|Overall Study|Progression before active Tx|1|||
124782786|NCT00771953|448834312|FG001|Overall Study|Progression before active Tx|2|||
124782787|NCT00771953|448834311|FG000|Overall Study|Sponsor decision|1|||
124782788|NCT00771953|448834312|FG001|Overall Study|Sponsor decision|0|||
124782789|NCT00771953|448834311|FG000|Overall Study|Other complicating disease|1|||
124782790|NCT00771953|448834312|FG001|Overall Study|Other complicating disease|0|||
124749035|NCT04776317|448704158|FG011|Overall Study|Protocol Violation|0|||
124749036|NCT04776317|448704159|FG012|Overall Study|Protocol Violation|0|||
124749037|NCT04776317|448704160|FG013|Overall Study|Protocol Violation|0|||
124749038|NCT04776317|448704161|FG014|Overall Study|Protocol Violation|0|||
124749039|NCT04776317|448704147|FG000|Overall Study|Withdrawal by Subject|0|||
124749040|NCT04776317|448704148|FG001|Overall Study|Withdrawal by Subject|0|||
124749041|NCT04776317|448704149|FG002|Overall Study|Withdrawal by Subject|0|||
124749042|NCT04776317|448704150|FG003|Overall Study|Withdrawal by Subject|0|||
124749043|NCT04776317|448704151|FG004|Overall Study|Withdrawal by Subject|1|||
124749044|NCT04776317|448704152|FG005|Overall Study|Withdrawal by Subject|0|||
124749045|NCT04776317|448704153|FG006|Overall Study|Withdrawal by Subject|0|||
124749046|NCT04776317|448704154|FG007|Overall Study|Withdrawal by Subject|0|||
124749047|NCT04776317|448704155|FG008|Overall Study|Withdrawal by Subject|0|||
124749048|NCT04776317|448704156|FG009|Overall Study|Withdrawal by Subject|0|||
124749049|NCT04776317|448704157|FG010|Overall Study|Withdrawal by Subject|0|||
124749050|NCT04776317|448704158|FG011|Overall Study|Withdrawal by Subject|0|||
124749051|NCT04776317|448704159|FG012|Overall Study|Withdrawal by Subject|0|||
124749052|NCT04776317|448704160|FG013|Overall Study|Withdrawal by Subject|0|||
124749053|NCT04776317|448704161|FG014|Overall Study|Withdrawal by Subject|0|||
124782791|NCT00771953|448834311|FG000|Overall Study|Withdrawal by Subject|0|||
124782792|NCT00771953|448834312|FG001|Overall Study|Withdrawal by Subject|3|||
124782793|NCT02722304|448834317|FG000|Overall Study|Study Terminated by Sponsor|1|||
124749054|NCT02524158|448704163|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
124782794|NCT02722304|448834318|FG001|Overall Study|Study Terminated by Sponsor|0|||
124782795|NCT02722304|448834319|FG002|Overall Study|Study Terminated by Sponsor|2|||
124782796|NCT02722304|448834320|FG003|Overall Study|Study Terminated by Sponsor|1|||
124782797|NCT02722304|448834321|FG004|Overall Study|Study Terminated by Sponsor|1|||
124749055|NCT02524158|448704164|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
124749056|NCT02524158|448704163|FG000|12-weeks Assessment|Lost to Follow-up|18|||
124749057|NCT02524158|448704164|FG001|12-weeks Assessment|Lost to Follow-up|12|||
124782798|NCT02722304|448834317|FG000|Overall Study|Other|0|||
124782799|NCT02722304|448834318|FG001|Overall Study|Other|0|||
124782800|NCT02722304|448834319|FG002|Overall Study|Other|0|||
124782801|NCT02722304|448834320|FG003|Overall Study|Other|1|||
124782802|NCT02722304|448834321|FG004|Overall Study|Other|1|||
124782803|NCT02644109|448834322|FG000|Overall Study|Adverse Event|0|||
124782804|NCT02644109|448834323|FG001|Overall Study|Adverse Event|4|||
124782805|NCT01519869|448834326|FG000|Overall Study|Lost to Follow-up|1|||
124782806|NCT03023813|448834327|FG000|Overall Study|Lost to Follow-up|1|||
124782807|NCT03023813|448834328|FG001|Overall Study|Lost to Follow-up|2|||
124782808|NCT03023813|448834329|FG002|Overall Study|Lost to Follow-up|0|||
124782809|NCT02433080|448834331|FG000|Overall Study|Lost to Follow-up|1|||
124782810|NCT02433080|448834332|FG001|Overall Study|Lost to Follow-up|2|||
124782811|NCT02433080|448834331|FG000|Overall Study|Withdrawal by Subject|0|||
124782812|NCT02433080|448834332|FG001|Overall Study|Withdrawal by Subject|2|||
124782813|NCT04530136|448834333|FG000|Overall Study|Lost to Follow-up|2|||
124782814|NCT04530136|448834334|FG001|Overall Study|Lost to Follow-up|3|||
124782815|NCT04530136|448834333|FG000|Overall Study|Withdrawal by Subject|1|||
124782816|NCT04530136|448834334|FG001|Overall Study|Withdrawal by Subject|0|||
124782817|NCT04530136|448834333|FG000|Overall Study|Death|0|||
124782818|NCT04530136|448834334|FG001|Overall Study|Death|1|||
124782819|NCT01309282|448834335|FG000|Overall Study|Lost to Follow-up|1|||
124782820|NCT01387542|448834336|FG000|Overall Study|Adverse Event|3|||
124782821|NCT01387542|448834336|FG000|Overall Study|Withdrawal by Subject|1|||
124782822|NCT01387542|448834336|FG000|Overall Study|Changed diagnosis|1|||
124782823|NCT01387542|448834336|FG000|Overall Study|Insufficient response|1|||
124782824|NCT01387542|448834336|FG000|Overall Study|Non-compliant|1|||
124782825|NCT01387542|448834336|FG000|Overall Study|Lost to Follow-up|1|||
124782826|NCT01010867|448834339|FG000|Overall Study|< 50% adherence to probiotic|1|||
124782827|NCT00884741|448834340|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
124782828|NCT00884741|448834341|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
124782829|NCT00884741|448834342|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
124782830|NCT00884741|448834343|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
124782831|NCT00884741|448834340|FG000|Step 1 Registration: Tissue Screening|Death|3|||
124782832|NCT00884741|448834341|FG001|Step 1 Registration: Tissue Screening|Death|0|||
124782833|NCT00884741|448834342|FG002|Step 1 Registration: Tissue Screening|Death|0|||
124749058|NCT02524158|448704163|FG000|6-month Assessment|Withdrawal by Subject|1|||
124749059|NCT02524158|448704164|FG001|6-month Assessment|Withdrawal by Subject|1|||
124749060|NCT02524158|448704163|FG000|6-month Assessment|Lost to Follow-up|21|||
124749061|NCT02524158|448704164|FG001|6-month Assessment|Lost to Follow-up|20|||
124749062|NCT03100058|448704165|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
124749063|NCT03100058|448704166|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
124749064|NCT03100058|448704167|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
124749065|NCT03100058|448704168|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
124749066|NCT03100058|448704169|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
124749067|NCT03100058|448704170|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
124749068|NCT03100058|448704171|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
124749069|NCT03100058|448704172|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
124749070|NCT03100058|448704173|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
124749071|NCT03100058|448704174|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
124749072|NCT03100058|448704175|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
124749073|NCT03100058|448704176|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
124749074|NCT03100058|448704177|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
124749075|NCT03100058|448704165|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
124749076|NCT03100058|448704166|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
124749077|NCT03100058|448704167|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
124749078|NCT03100058|448704168|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
124749079|NCT03100058|448704169|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
124749080|NCT03100058|448704170|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
124749081|NCT03100058|448704171|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
124749082|NCT03100058|448704172|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
124749083|NCT03100058|448704173|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
124749084|NCT03100058|448704174|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
124749085|NCT03100058|448704175|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
124749086|NCT03100058|448704176|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
124749087|NCT03100058|448704177|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
124749088|NCT03100058|448704165|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
124749089|NCT03100058|448704166|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
124782834|NCT00884741|448834343|FG003|Step 1 Registration: Tissue Screening|Death|0|||
124782835|NCT00884741|448834340|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
124782836|NCT00884741|448834341|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
124782837|NCT00884741|448834342|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
124782838|NCT00884741|448834343|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
124749090|NCT03100058|448704167|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
124749091|NCT03100058|448704168|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
124749092|NCT03100058|448704169|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
124749093|NCT03100058|448704170|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
124749094|NCT03100058|448704171|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
124749095|NCT03100058|448704172|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
124749096|NCT03100058|448704173|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
124749097|NCT03100058|448704174|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
124749098|NCT03100058|448704175|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
124749099|NCT03100058|448704176|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
124749100|NCT03100058|448704177|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
124749101|NCT03100058|448704165|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
124749102|NCT03100058|448704166|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
124749103|NCT03100058|448704167|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
124749104|NCT03100058|448704168|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
124749105|NCT03100058|448704169|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
124749106|NCT03100058|448704170|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
124749107|NCT03100058|448704171|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
124749108|NCT03100058|448704172|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
124749109|NCT03100058|448704173|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
124749110|NCT03100058|448704174|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
124749111|NCT03100058|448704175|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
124749112|NCT03100058|448704176|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
124749113|NCT03100058|448704177|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
124749114|NCT03100058|448704165|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
124749115|NCT03100058|448704166|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
124749116|NCT03100058|448704167|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
124749117|NCT03100058|448704168|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
124749118|NCT03100058|448704169|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
124749119|NCT03100058|448704170|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
124749120|NCT03100058|448704171|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
124749121|NCT03100058|448704172|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
124749122|NCT03100058|448704173|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
124749123|NCT03100058|448704174|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
124749124|NCT03100058|448704175|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
124749125|NCT03100058|448704176|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
124749126|NCT03100058|448704177|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
124749127|NCT03100058|448704165|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
124749128|NCT03100058|448704166|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
124749129|NCT03100058|448704167|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
124749130|NCT03100058|448704168|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
124749131|NCT03100058|448704169|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
124749132|NCT03100058|448704170|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
124749133|NCT03100058|448704171|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
124749134|NCT03100058|448704172|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
124749135|NCT03100058|448704173|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
124749136|NCT03100058|448704174|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
124749137|NCT03100058|448704175|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
124749138|NCT03100058|448704176|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
124749139|NCT03100058|448704177|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
124749140|NCT03100058|448704165|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
124749141|NCT03100058|448704166|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
124749142|NCT03100058|448704167|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
124749143|NCT03100058|448704168|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
124749144|NCT03100058|448704169|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
124749145|NCT03100058|448704170|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
124749146|NCT03100058|448704171|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
124749147|NCT03100058|448704172|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
124749148|NCT03100058|448704173|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
124749149|NCT03100058|448704174|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
124749150|NCT03100058|448704175|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
124782839|NCT00884741|448834340|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
124749151|NCT03100058|448704176|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
124749152|NCT03100058|448704177|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
124749153|NCT03100058|448704165|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
124619991|NCT02797171|448226142|FG002|Overall Study|Protocol Violation|0|||
124782840|NCT00884741|448834341|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
124782841|NCT00884741|448834342|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
124782842|NCT00884741|448834343|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
124782843|NCT00884741|448834340|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
124782844|NCT00884741|448834341|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
124782845|NCT00884741|448834342|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
124782846|NCT00884741|448834343|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
124782847|NCT00884741|448834340|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
124782848|NCT00884741|448834341|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
124782849|NCT00884741|448834342|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
124782850|NCT00884741|448834343|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
124782851|NCT00884741|448834340|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
124782852|NCT00884741|448834341|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
124782853|NCT00884741|448834342|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
124782854|NCT00884741|448834343|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
124782855|NCT00884741|448834340|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
124782856|NCT00884741|448834341|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
124782857|NCT00884741|448834342|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
124782858|NCT00884741|448834343|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
124782859|NCT00884741|448834340|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
124782860|NCT00884741|448834341|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
124782861|NCT00884741|448834342|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
124782862|NCT00884741|448834343|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
124782863|NCT00884741|448834340|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
124782864|NCT00884741|448834341|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
124782865|NCT00884741|448834342|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
124782866|NCT00884741|448834343|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
124782867|NCT00884741|448834340|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
124782868|NCT00884741|448834341|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
124782869|NCT00884741|448834342|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
124782870|NCT00884741|448834343|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
124782871|NCT00884741|448834340|FG000|Randomization|Protocol Violation|0|||
124782872|NCT00884741|448834341|FG001|Randomization|Protocol Violation|0|||
124782873|NCT00884741|448834342|FG002|Randomization|Protocol Violation|8|||
124782874|NCT00884741|448834343|FG003|Randomization|Protocol Violation|8|||
124782875|NCT01233232|448834344|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
124782876|NCT01233232|448834345|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
124782877|NCT01233232|448834346|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
124782878|NCT02762370|448834347|FG000|Overall Study|Protocol Violation|1|||
124782879|NCT02762370|448834348|FG001|Overall Study|Protocol Violation|0|||
124782880|NCT00101452|448834353|FG000|Overall Study|Adverse Event|2|||
124782881|NCT00101452|448834354|FG001|Overall Study|Adverse Event|0|||
124782882|NCT00101452|448834355|FG002|Overall Study|Adverse Event|1|||
124782883|NCT00101452|448834353|FG000|Overall Study|Lost to Follow-up|13|||
124782884|NCT00101452|448834354|FG001|Overall Study|Lost to Follow-up|8|||
124782885|NCT00101452|448834355|FG002|Overall Study|Lost to Follow-up|14|||
124749154|NCT03100058|448704166|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
124749155|NCT03100058|448704167|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
124749156|NCT03100058|448704168|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
124749157|NCT03100058|448704169|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
124749158|NCT03100058|448704170|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
124749159|NCT03100058|448704171|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
124749160|NCT03100058|448704172|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
124749161|NCT03100058|448704173|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
124749162|NCT03100058|448704174|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
124749163|NCT03100058|448704175|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
124749164|NCT03100058|448704176|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
124749165|NCT03100058|448704177|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
124749166|NCT03100058|448704165|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
124749167|NCT03100058|448704166|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
124782886|NCT00101452|448834353|FG000|Overall Study|Withdrawal by Subject|10|||
124782887|NCT00101452|448834354|FG001|Overall Study|Withdrawal by Subject|14|||
124782888|NCT00101452|448834355|FG002|Overall Study|Withdrawal by Subject|9|||
124782889|NCT00101452|448834353|FG000|Overall Study|Baseline Fail|2|||
124782890|NCT00101452|448834354|FG001|Overall Study|Baseline Fail|1|||
124749168|NCT03100058|448704167|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
124749169|NCT03100058|448704168|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
124782891|NCT00101452|448834355|FG002|Overall Study|Baseline Fail|2|||
124782892|NCT00101452|448834353|FG000|Overall Study|Physician Decision|0|||
124749170|NCT03100058|448704169|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
124749171|NCT03100058|448704170|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
124619992|NCT02797171|448226143|FG003|Overall Study|Protocol Violation|0|||
124619993|NCT02797171|448226144|FG004|Overall Study|Protocol Violation|0|||
124619994|NCT02797171|448226145|FG005|Overall Study|Protocol Violation|0|||
124619995|NCT02797171|448226140|FG000|Overall Study|Participant unable to adhere|0|||
124619996|NCT02797171|448226141|FG001|Overall Study|Participant unable to adhere|1|||
124619997|NCT02797171|448226142|FG002|Overall Study|Participant unable to adhere|0|||
124619998|NCT02797171|448226143|FG003|Overall Study|Participant unable to adhere|0|||
124619999|NCT02797171|448226144|FG004|Overall Study|Participant unable to adhere|0|||
124620000|NCT02797171|448226145|FG005|Overall Study|Participant unable to adhere|0|||
124620001|NCT02797171|448226140|FG000|Overall Study|Not Randomized|0|||
124620002|NCT02797171|448226141|FG001|Overall Study|Not Randomized|0|||
124620003|NCT02797171|448226142|FG002|Overall Study|Not Randomized|0|||
124620004|NCT02797171|448226143|FG003|Overall Study|Not Randomized|0|||
124620005|NCT02797171|448226144|FG004|Overall Study|Not Randomized|0|||
124620006|NCT02797171|448226145|FG005|Overall Study|Not Randomized|1|||
124620007|NCT02540083|448226146|FG000|Overall Study|Withdrawal by Subject|16|||
124620008|NCT01427608|448226147|FG000|Overall Study|Death|1|||
124620009|NCT01427608|448226148|FG001|Overall Study|Death|0|||
124620010|NCT01427608|448226147|FG000|Overall Study|Withdrawal by Subject|7|||
124620011|NCT01427608|448226148|FG001|Overall Study|Withdrawal by Subject|3|||
124620012|NCT01427608|448226147|FG000|Overall Study|Relapsed-all cause|13|||
124620013|NCT01427608|448226148|FG001|Overall Study|Relapsed-all cause|34|||
124620014|NCT01427608|448226147|FG000|Overall Study|Events not attributed to study meds|0|||
124620015|NCT01427608|448226148|FG001|Overall Study|Events not attributed to study meds|1|||
124620016|NCT03993379|448226149|FG000|Overall Study|The study was terminated early due to business decision.|0|||
124620017|NCT03993379|448226150|FG001|Overall Study|The study was terminated early due to business decision.|2|||
124620018|NCT03993379|448226151|FG002|Overall Study|The study was terminated early due to business decision.|0|||
124620019|NCT03993379|448226152|FG003|Overall Study|The study was terminated early due to business decision.|0|||
124620020|NCT03993379|448226149|FG000|Overall Study|Withdrawal by Subject|0|||
124620021|NCT03993379|448226150|FG001|Overall Study|Withdrawal by Subject|1|||
124620022|NCT03993379|448226151|FG002|Overall Study|Withdrawal by Subject|0|||
124620023|NCT03993379|448226152|FG003|Overall Study|Withdrawal by Subject|0|||
124620024|NCT04289363|448226157|FG000|Overall Study|Lost to Follow-up|14|||
124620025|NCT04289363|448226158|FG001|Overall Study|Lost to Follow-up|0|||
124620026|NCT02585778|448226159|FG000|Overall Study|Adverse Event|17|||
124620027|NCT02585778|448226160|FG001|Overall Study|Adverse Event|4|||
124620028|NCT02585778|448226159|FG000|Overall Study|Participant did not wish to continue|9|||
124620029|NCT02585778|448226160|FG001|Overall Study|Participant did not wish to continue|4|||
124620030|NCT02585778|448226159|FG000|Overall Study|Poor compliance to study protocol|0|||
124620031|NCT02585778|448226160|FG001|Overall Study|Poor compliance to study protocol|2|||
124620032|NCT02585778|448226159|FG000|Overall Study|Death|0|||
124620033|NCT02585778|448226160|FG001|Overall Study|Death|1|||
124620034|NCT02585778|448226159|FG000|Overall Study|Randomized but not treated|1|||
124620035|NCT02585778|448226160|FG001|Overall Study|Randomized but not treated|2|||
124620036|NCT02585778|448226159|FG000|Overall Study|Other than specified above|6|||
124620037|NCT02585778|448226160|FG001|Overall Study|Other than specified above|2|||
124620038|NCT00445432|448226162|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
124620039|NCT00445432|448226163|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
124620040|NCT00445432|448226164|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
124620041|NCT00445432|448226165|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
124620042|NCT00445432|448226162|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
124620043|NCT00445432|448226163|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
124620044|NCT00445432|448226164|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
124620045|NCT00445432|448226165|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
124620046|NCT00445432|448226162|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
124620047|NCT00445432|448226163|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
124620048|NCT00445432|448226164|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
124620049|NCT00445432|448226165|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
124620050|NCT00445432|448226162|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
124620051|NCT00445432|448226163|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
124620052|NCT00445432|448226164|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
124620053|NCT00445432|448226165|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
124620054|NCT00445432|448226162|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
124620055|NCT00445432|448226163|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
124620056|NCT00445432|448226164|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
124749172|NCT03100058|448704171|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
124749173|NCT03100058|448704172|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
124620057|NCT00445432|448226165|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
124620058|NCT00445432|448226162|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
124620059|NCT00445432|448226163|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
124749174|NCT03100058|448704173|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
124620060|NCT00445432|448226164|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
124620061|NCT00445432|448226165|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
124620062|NCT00445432|448226162|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
124620063|NCT00445432|448226163|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
124620064|NCT00445432|448226164|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
124620065|NCT00445432|448226165|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
124620066|NCT01482312|448226168|FG000|Period 1, 90 Minutes of Wear|Other|1|||
124620067|NCT01482312|448226169|FG001|Period 1, 90 Minutes of Wear|Other|0|||
124620068|NCT01482312|448226170|FG002|Period 1, 90 Minutes of Wear|Other|0|||
124620069|NCT01482312|448226168|FG000|Period 2, 90 Minutes of Wear|Other|1|||
124620070|NCT01482312|448226169|FG001|Period 2, 90 Minutes of Wear|Other|0|||
124620071|NCT01482312|448226170|FG002|Period 2, 90 Minutes of Wear|Other|0|||
124620072|NCT01699815|448226171|FG000|Overall Study|Protocol Violation|4|||
124620073|NCT01699815|448226172|FG001|Overall Study|Protocol Violation|7|||
124620074|NCT01699815|448226171|FG000|Overall Study|record could not be located|1|||
124620075|NCT01699815|448226172|FG001|Overall Study|record could not be located|0|||
124620076|NCT01699815|448226171|FG000|Overall Study|Adverse Event|0|||
124620077|NCT01699815|448226172|FG001|Overall Study|Adverse Event|1|||
124620078|NCT00356525|448226183|FG000|Overall Study|Progressive Disease|8|||
124620079|NCT00356525|448226184|FG001|Overall Study|Progressive Disease|5|||
124620080|NCT00356525|448226185|FG002|Overall Study|Progressive Disease|4|||
124620081|NCT00356525|448226186|FG003|Overall Study|Progressive Disease|2|||
124620082|NCT00356525|448226183|FG000|Overall Study|Adverse Event|1|||
124620083|NCT00356525|448226184|FG001|Overall Study|Adverse Event|3|||
124620084|NCT00356525|448226185|FG002|Overall Study|Adverse Event|1|||
124620085|NCT00356525|448226186|FG003|Overall Study|Adverse Event|1|||
124620086|NCT00356525|448226183|FG000|Overall Study|Lost to Follow-up|1|||
124620087|NCT00356525|448226184|FG001|Overall Study|Lost to Follow-up|0|||
124620088|NCT00356525|448226185|FG002|Overall Study|Lost to Follow-up|0|||
124620089|NCT00356525|448226186|FG003|Overall Study|Lost to Follow-up|0|||
124620090|NCT00356525|448226183|FG000|Overall Study|Physician Decision|2|||
124620091|NCT00356525|448226184|FG001|Overall Study|Physician Decision|2|||
124620092|NCT00356525|448226185|FG002|Overall Study|Physician Decision|2|||
124620093|NCT00356525|448226186|FG003|Overall Study|Physician Decision|1|||
124620094|NCT00356525|448226183|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
124620095|NCT00356525|448226184|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
124620096|NCT00356525|448226185|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
124620097|NCT00356525|448226186|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
124620098|NCT00356525|448226183|FG000|Overall Study|Withdrawal by Subject|1|||
124620099|NCT00356525|448226184|FG001|Overall Study|Withdrawal by Subject|1|||
124620100|NCT00356525|448226185|FG002|Overall Study|Withdrawal by Subject|0|||
124620101|NCT00356525|448226186|FG003|Overall Study|Withdrawal by Subject|3|||
124620102|NCT00356525|448226183|FG000|Overall Study|Death|0|||
124620103|NCT00356525|448226184|FG001|Overall Study|Death|0|||
124620104|NCT00356525|448226185|FG002|Overall Study|Death|0|||
124620105|NCT00356525|448226186|FG003|Overall Study|Death|1|||
124620106|NCT00356525|448226183|FG000|Overall Study|Sponsor Decision|0|||
124620107|NCT00356525|448226184|FG001|Overall Study|Sponsor Decision|0|||
124620108|NCT00356525|448226185|FG002|Overall Study|Sponsor Decision|0|||
124620109|NCT00356525|448226186|FG003|Overall Study|Sponsor Decision|1|||
124620110|NCT00799058|448226187|FG000|Overall Study|Withdrawal by Subject|2|||
124620111|NCT00799058|448226188|FG001|Overall Study|Withdrawal by Subject|2|||
124620112|NCT00799058|448226189|FG002|Overall Study|Withdrawal by Subject|2|||
124620113|NCT00799058|448226187|FG000|Overall Study|Lost to Follow-up|1|||
124620114|NCT00799058|448226188|FG001|Overall Study|Lost to Follow-up|2|||
124620115|NCT00799058|448226189|FG002|Overall Study|Lost to Follow-up|1|||
124620116|NCT00799058|448226187|FG000|Overall Study|Adverse Event|0|||
124620117|NCT00799058|448226188|FG001|Overall Study|Adverse Event|2|||
124620118|NCT00799058|448226189|FG002|Overall Study|Adverse Event|0|||
124620119|NCT00799058|448226187|FG000|Overall Study|Pregnancy|1|||
124620120|NCT00799058|448226188|FG001|Overall Study|Pregnancy|0|||
124620121|NCT00799058|448226189|FG002|Overall Study|Pregnancy|0|||
124620122|NCT00799058|448226187|FG000|Overall Study|Not adherent|3|||
124749175|NCT03100058|448704174|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
124749176|NCT03100058|448704175|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
124749177|NCT03100058|448704176|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
124620123|NCT00799058|448226188|FG001|Overall Study|Not adherent|2|||
124620124|NCT00799058|448226189|FG002|Overall Study|Not adherent|1|||
124620125|NCT00799058|448226187|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
124620126|NCT00799058|448226188|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
124620127|NCT00799058|448226189|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
124620128|NCT00799058|448226187|FG000|Overall Study|IP dispensing error|1|||
124620129|NCT00799058|448226188|FG001|Overall Study|IP dispensing error|0|||
124620130|NCT00799058|448226189|FG002|Overall Study|IP dispensing error|0|||
124749178|NCT03100058|448704177|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
124620131|NCT00799058|448226187|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
124637651|NCT03225105|448290613|FG002|Overall Study|Withdrawal by Subject|0|||
124749179|NCT03100058|448704165|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
124749180|NCT03100058|448704166|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
124749181|NCT03100058|448704167|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
124749182|NCT03100058|448704168|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
124749183|NCT03100058|448704169|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
124749184|NCT03100058|448704170|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
124749185|NCT03100058|448704171|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
124749186|NCT03100058|448704172|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
124749187|NCT03100058|448704173|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
124749188|NCT03100058|448704174|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
124749189|NCT03100058|448704175|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
124749190|NCT03100058|448704176|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
124749191|NCT03100058|448704177|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
124749192|NCT03100058|448704165|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
124749193|NCT03100058|448704166|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
124749194|NCT03100058|448704167|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
124749195|NCT03100058|448704168|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
124749196|NCT03100058|448704169|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
124749197|NCT03100058|448704170|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
124749198|NCT03100058|448704171|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
124749199|NCT03100058|448704172|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
124749200|NCT03100058|448704173|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
124749201|NCT03100058|448704174|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
124749202|NCT03100058|448704175|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
124749203|NCT03100058|448704176|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
124749204|NCT03100058|448704177|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
124749205|NCT03100058|448704165|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
124749206|NCT03100058|448704166|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
124749207|NCT03100058|448704167|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
124749208|NCT03100058|448704168|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
124749209|NCT03100058|448704169|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
124749210|NCT03100058|448704170|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
124749211|NCT03100058|448704171|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
124749212|NCT03100058|448704172|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
124749213|NCT03100058|448704173|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
124749214|NCT03100058|448704174|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
124749215|NCT03100058|448704175|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
124749216|NCT03100058|448704176|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
124749217|NCT03100058|448704177|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
124749218|NCT03100058|448704165|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124749219|NCT03100058|448704166|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124749220|NCT03100058|448704167|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124749221|NCT03100058|448704168|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124749222|NCT03100058|448704169|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124749223|NCT03100058|448704170|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124749224|NCT03100058|448704171|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124749225|NCT03100058|448704172|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124749226|NCT03100058|448704173|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124749227|NCT03100058|448704174|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124749228|NCT03100058|448704175|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
124749229|NCT03100058|448704176|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124749230|NCT03100058|448704177|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
124749231|NCT03100058|448704165|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
124749232|NCT03100058|448704166|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
124749233|NCT03100058|448704167|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
124749234|NCT03100058|448704168|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
124749235|NCT03100058|448704169|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
124749236|NCT03100058|448704170|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
124749237|NCT03100058|448704171|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
124749238|NCT03100058|448704172|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
124749239|NCT03100058|448704173|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
124749240|NCT03100058|448704174|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
124749241|NCT03100058|448704175|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
124749242|NCT03100058|448704176|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
124782893|NCT00101452|448834354|FG001|Overall Study|Physician Decision|3|||
124782894|NCT00101452|448834355|FG002|Overall Study|Physician Decision|2|||
124782895|NCT00101452|448834353|FG000|Overall Study|Protocol Violation|2|||
124749243|NCT03100058|448704177|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
124749244|NCT03100058|448704165|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
124749245|NCT03100058|448704166|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
124749246|NCT03100058|448704167|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
124749247|NCT03100058|448704168|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
124749248|NCT03100058|448704169|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
124749249|NCT03100058|448704170|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
124749250|NCT03100058|448704171|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
124749251|NCT03100058|448704172|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
124749252|NCT03100058|448704173|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
124749253|NCT03100058|448704174|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
124749254|NCT03100058|448704175|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
124749255|NCT03100058|448704176|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
124749256|NCT03100058|448704177|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
124749257|NCT03671304|448704179|FG000|Overall Study|study terminated|7|||
124749258|NCT00479856|448704181|FG000|Overall Study|Adverse Event|1|||
124749259|NCT00479856|448704181|FG000|Overall Study|Withdrawal by Subject|1|||
124749260|NCT00479856|448704181|FG000|Overall Study|Physician Decision|1|||
124749261|NCT02760810|448704182|FG000|Overall Study|Protocol Violation|1|||
124749262|NCT02690714|448704183|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
124749263|NCT02690714|448704183|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
124749264|NCT04294147|448704184|FG000|Overall Study|Protocol Violation|2|||
124749265|NCT04294147|448704185|FG001|Overall Study|Protocol Violation|0|||
124749266|NCT01240135|448704186|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
124749267|NCT01240135|448704187|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
124749268|NCT01240135|448704186|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
124749269|NCT01240135|448704187|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
124749270|NCT01371305|448704188|FG000|Overall Study|Adverse Event|0|||
124749271|NCT01371305|448704189|FG001|Overall Study|Adverse Event|0|||
124749272|NCT01371305|448704190|FG002|Overall Study|Adverse Event|0|||
124749273|NCT01371305|448704191|FG003|Overall Study|Adverse Event|2|||
124749274|NCT01371305|448704192|FG004|Overall Study|Adverse Event|1|||
124749275|NCT01371305|448704193|FG005|Overall Study|Adverse Event|0|||
124749276|NCT01371305|448704188|FG000|Overall Study|Study terminated by sponsor|0|||
124749277|NCT01371305|448704189|FG001|Overall Study|Study terminated by sponsor|0|||
124749278|NCT01371305|448704190|FG002|Overall Study|Study terminated by sponsor|0|||
124749279|NCT01371305|448704191|FG003|Overall Study|Study terminated by sponsor|0|||
124749280|NCT01371305|448704192|FG004|Overall Study|Study terminated by sponsor|3|||
124749281|NCT01371305|448704193|FG005|Overall Study|Study terminated by sponsor|1|||
124749282|NCT01371305|448704188|FG000|Overall Study|Subject request|0|||
124749283|NCT01371305|448704189|FG001|Overall Study|Subject request|0|||
124749284|NCT01371305|448704190|FG002|Overall Study|Subject request|0|||
124749285|NCT01371305|448704191|FG003|Overall Study|Subject request|0|||
124749286|NCT01371305|448704192|FG004|Overall Study|Subject request|0|||
124749287|NCT01371305|448704193|FG005|Overall Study|Subject request|1|||
124749288|NCT02891382|448704196|FG000|Overall Study|Lost to Follow-up|3|||
124749289|NCT02891382|448704197|FG001|Overall Study|Lost to Follow-up|4|||
124749290|NCT02891382|448704198|FG002|Overall Study|Lost to Follow-up|5|||
124749291|NCT02891382|448704199|FG003|Overall Study|Lost to Follow-up|3|||
124749292|NCT02891382|448704200|FG004|Overall Study|Lost to Follow-up|4|||
124749293|NCT01628965|448704201|FG000|Overall Study|Adverse Event|30|||
124749294|NCT01628965|448704201|FG000|Overall Study|Lack of Efficacy|7|||
124749295|NCT01628965|448704201|FG000|Overall Study|Withdrawal by Subject|3|||
124749296|NCT01628965|448704201|FG000|Overall Study|Lost to Follow-up|1|||
124749297|NCT01628965|448704201|FG000|Overall Study|Discontinuation criteria|8|||
124749298|NCT02828020|448704202|FG000|Treatment Period|Adverse Event|3|||
124749299|NCT02828020|448704203|FG001|Treatment Period|Adverse Event|1|||
124749300|NCT02828020|448704204|FG002|Treatment Period|Adverse Event|1|||
124749301|NCT02828020|448704202|FG000|Treatment Period|Withdrawal of Consent|10|||
124749302|NCT02828020|448704203|FG001|Treatment Period|Withdrawal of Consent|14|||
124749303|NCT02828020|448704204|FG002|Treatment Period|Withdrawal of Consent|9|||
124749304|NCT02828020|448704202|FG000|Treatment Period|Lost to Follow-up|21|||
124749305|NCT02828020|448704203|FG001|Treatment Period|Lost to Follow-up|24|||
124749306|NCT02828020|448704204|FG002|Treatment Period|Lost to Follow-up|18|||
124749307|NCT02828020|448704202|FG000|Treatment Period|Lack of Qualifying Event|44|||
124749308|NCT02828020|448704203|FG001|Treatment Period|Lack of Qualifying Event|53|||
124749309|NCT02828020|448704204|FG002|Treatment Period|Lack of Qualifying Event|43|||
124749310|NCT02828020|448704202|FG000|Treatment Period|Pregnancy|0|||
124749311|NCT02828020|448704203|FG001|Treatment Period|Pregnancy|2|||
124749312|NCT02828020|448704204|FG002|Treatment Period|Pregnancy|0|||
124749313|NCT02828020|448704202|FG000|Treatment Period|Protocol Violation|2|||
124749314|NCT02828020|448704203|FG001|Treatment Period|Protocol Violation|4|||
124749315|NCT02828020|448704204|FG002|Treatment Period|Protocol Violation|7|||
124620132|NCT00799058|448226188|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
124620133|NCT00799058|448226189|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
124620134|NCT00799058|448226187|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
124620135|NCT00799058|448226188|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
124620136|NCT00799058|448226189|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
124620137|NCT00799058|448226187|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
124620138|NCT00799058|448226188|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
124620139|NCT00799058|448226189|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
124620140|NCT00799058|448226187|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
124620141|NCT00799058|448226188|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
124620142|NCT00799058|448226189|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
124620143|NCT03639779|448226190|FG000|Overall Study|Lost to Follow-up|1|||
124620144|NCT02088697|448226191|FG000|Period I|Physician Decision|1|||
124620145|NCT02088697|448226192|FG001|Period I|Physician Decision|4|||
124620146|NCT02088697|448226191|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
124620147|NCT02088697|448226192|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
124620148|NCT00810511|448226193|FG000|Overall Study|Protocol Violation|0|||
124620149|NCT00810511|448226194|FG001|Overall Study|Protocol Violation|1|||
124620150|NCT00810511|448226193|FG000|Overall Study|Lack of Efficacy|9|||
124620151|NCT00810511|448226194|FG001|Overall Study|Lack of Efficacy|1|||
124620152|NCT00810511|448226193|FG000|Overall Study|death in the family|0|||
124620153|NCT00810511|448226194|FG001|Overall Study|death in the family|1|||
124620154|NCT00810511|448226193|FG000|Overall Study|Lost to Follow-up|1|||
124620155|NCT00810511|448226194|FG001|Overall Study|Lost to Follow-up|0|||
124620156|NCT00810511|448226193|FG000|Overall Study|deposits on contact lens|0|||
124620157|NCT00810511|448226194|FG001|Overall Study|deposits on contact lens|1|||
124620158|NCT01295320|448226195|FG000|Overall Study|Adverse Event|2|||
124620159|NCT01295320|448226195|FG000|Overall Study|Lost to Follow-up|4|||
124620160|NCT01295320|448226195|FG000|Overall Study|Withdrawal by Subject|2|||
124620161|NCT01295320|448226195|FG000|Overall Study|Subject was bedridden|1|||
124620162|NCT01295320|448226195|FG000|Overall Study|Unable to travel|1|||
124620163|NCT00911300|448226199|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
124620164|NCT00911300|448226200|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
124620165|NCT00911300|448226199|FG000|Overall Study|Death|1|||
124620166|NCT00911300|448226200|FG001|Overall Study|Death|0|||
124620167|NCT00911300|448226199|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
124620168|NCT00911300|448226200|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
124620169|NCT00911300|448226199|FG000|Overall Study|Adverse Event|14|||
124620170|NCT00911300|448226200|FG001|Overall Study|Adverse Event|6|||
124620171|NCT00911300|448226199|FG000|Overall Study|Protocol Violation|3|||
124620172|NCT00911300|448226200|FG001|Overall Study|Protocol Violation|2|||
124620173|NCT00911300|448226199|FG000|Overall Study|Consent Withdrawn|4|||
124620174|NCT00911300|448226200|FG001|Overall Study|Consent Withdrawn|12|||
124620175|NCT00911300|448226199|FG000|Overall Study|Coronary Angiography Performed|1|||
124620176|NCT00911300|448226200|FG001|Overall Study|Coronary Angiography Performed|0|||
124620177|NCT00911300|448226199|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
124620178|NCT00911300|448226200|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
124620179|NCT00911300|448226199|FG000|Overall Study|Received Commercial Treatment|1|||
124620180|NCT00911300|448226200|FG001|Overall Study|Received Commercial Treatment|0|||
124620181|NCT00911300|448226199|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
124620182|NCT00911300|448226200|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
124620183|NCT00911300|448226199|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
124620184|NCT00911300|448226200|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
124620185|NCT00911300|448226199|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
124620186|NCT00911300|448226200|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
124620187|NCT00911300|448226199|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
124620188|NCT00911300|448226200|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
124620189|NCT00911300|448226199|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
124620190|NCT00911300|448226200|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
124620191|NCT00911300|448226199|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
124620192|NCT00911300|448226200|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
124620193|NCT00911300|448226199|FG000|Overall Study|International Normalized Ratio Too High|0|||
124620194|NCT00911300|448226200|FG001|Overall Study|International Normalized Ratio Too High|1|||
124620195|NCT00911300|448226199|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
124749316|NCT02828020|448704202|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
124749317|NCT02828020|448704203|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
124749318|NCT02828020|448704204|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
124782896|NCT00101452|448834354|FG001|Overall Study|Protocol Violation|1|||
124620196|NCT00911300|448226200|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
124620197|NCT00911300|448226199|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
124620198|NCT00911300|448226200|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
124620199|NCT00911300|448226199|FG000|Overall Study|Physician Decision|0|||
124620200|NCT00911300|448226200|FG001|Overall Study|Physician Decision|1|||
124620201|NCT00911300|448226199|FG000|Overall Study|Treatment Stopped by Mistake|0|||
124620202|NCT00911300|448226200|FG001|Overall Study|Treatment Stopped by Mistake|1|||
124620203|NCT00911300|448226199|FG000|Overall Study|Randomized; No Study Medication Received|0|||
124620204|NCT00911300|448226200|FG001|Overall Study|Randomized; No Study Medication Received|2|||
124620205|NCT01128543|448226205|FG000|Overall Study|Withdrawal by Subject|3|||
124620206|NCT01128543|448226205|FG000|Overall Study|Protocol Violation|1|||
124620207|NCT01941498|448226206|FG000|Overall Study|Relocated out of state|1|||
124620208|NCT00396565|448226207|FG000|Overall Study|Physician Decision|3|||
124620209|NCT00396565|448226208|FG001|Overall Study|Physician Decision|1|||
124620210|NCT00396565|448226209|FG002|Overall Study|Physician Decision|2|||
124620211|NCT00396565|448226207|FG000|Overall Study|Adverse Event|5|||
124620212|NCT00396565|448226208|FG001|Overall Study|Adverse Event|13|||
124620213|NCT00396565|448226209|FG002|Overall Study|Adverse Event|3|||
124620214|NCT00396565|448226207|FG000|Overall Study|Withdrawal by Subject|8|||
124620215|NCT00396565|448226208|FG001|Overall Study|Withdrawal by Subject|13|||
124620216|NCT00396565|448226209|FG002|Overall Study|Withdrawal by Subject|1|||
124620217|NCT00396565|448226207|FG000|Overall Study|Lack of Efficacy|32|||
124620218|NCT00396565|448226208|FG001|Overall Study|Lack of Efficacy|64|||
124620219|NCT00396565|448226209|FG002|Overall Study|Lack of Efficacy|11|||
124620220|NCT04324021|448226210|FG000|Overall Study|Adverse Event|1|||
124620221|NCT04324021|448226211|FG001|Overall Study|Adverse Event|0|||
124620222|NCT04324021|448226212|FG002|Overall Study|Adverse Event|0|||
124620223|NCT04324021|448226210|FG000|Overall Study|Lack of Efficacy|0|||
124620224|NCT04324021|448226211|FG001|Overall Study|Lack of Efficacy|0|||
124620225|NCT04324021|448226212|FG002|Overall Study|Lack of Efficacy|1|||
124620226|NCT04324021|448226210|FG000|Overall Study|Death|1|||
124620227|NCT04324021|448226211|FG001|Overall Study|Death|1|||
124620228|NCT04324021|448226212|FG002|Overall Study|Death|0|||
124620229|NCT03097991|448226213|FG000|Overall Study|Didn't meet study criteria|8|||
124620230|NCT03097991|448226214|FG001|Overall Study|Didn't meet study criteria|0|||
124620231|NCT03097991|448226213|FG000|Overall Study|Withdrawal by Subject|12|||
124620232|NCT03097991|448226214|FG001|Overall Study|Withdrawal by Subject|6|||
124620233|NCT03097991|448226213|FG000|Overall Study|Death of Baby|3|||
124620234|NCT03097991|448226214|FG001|Overall Study|Death of Baby|1|||
124620235|NCT03097991|448226213|FG000|Overall Study|Lost to Follow-up|24|||
124620236|NCT03097991|448226214|FG001|Overall Study|Lost to Follow-up|38|||
124620237|NCT03097991|448226213|FG000|Overall Study|Adverse Event|3|||
124620238|NCT03097991|448226214|FG001|Overall Study|Adverse Event|5|||
124620239|NCT00299130|448226215|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
124620240|NCT00299130|448226216|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
124620241|NCT00299130|448226217|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
124620242|NCT00299130|448226215|FG000|Treatment Period (up to 5 Years)|Death|1|||
124620243|NCT00299130|448226216|FG001|Treatment Period (up to 5 Years)|Death|3|||
124620244|NCT00299130|448226217|FG002|Treatment Period (up to 5 Years)|Death|1|||
124620245|NCT00299130|448226215|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
124620246|NCT00299130|448226216|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
124620247|NCT00299130|448226217|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
124620248|NCT00299130|448226215|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
124620249|NCT00299130|448226216|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
124620250|NCT00299130|448226217|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
124620251|NCT00299130|448226215|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
124620252|NCT00299130|448226216|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
124620253|NCT00299130|448226217|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
124620254|NCT00299130|448226215|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
124620255|NCT00299130|448226216|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
124620256|NCT00299130|448226217|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
124620257|NCT00299130|448226215|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
124620258|NCT00299130|448226216|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
124620259|NCT00299130|448226217|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
124620260|NCT00299130|448226215|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
124620261|NCT00299130|448226216|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
124620262|NCT00299130|448226217|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
124620263|NCT00299130|448226215|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
124620264|NCT00299130|448226216|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
124620265|NCT00299130|448226217|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
124620266|NCT00299130|448226215|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
124620267|NCT00299130|448226216|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
124620268|NCT00299130|448226217|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
124620269|NCT00299130|448226215|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
124620270|NCT00299130|448226216|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
124620271|NCT00299130|448226217|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
124749319|NCT02828020|448704202|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
124749320|NCT02828020|448704203|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
124620272|NCT00299130|448226215|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
124620273|NCT00299130|448226216|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
124620274|NCT00299130|448226217|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
124620275|NCT00299130|448226215|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
124620276|NCT00299130|448226216|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
124620277|NCT00299130|448226217|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
124620278|NCT00299130|448226215|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
124620279|NCT00299130|448226216|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
124620280|NCT00299130|448226217|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
124620281|NCT00299130|448226215|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
124620282|NCT00299130|448226216|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
124620283|NCT00299130|448226217|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
124620284|NCT00299130|448226215|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
124620285|NCT00299130|448226216|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
124620286|NCT00299130|448226217|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
124620287|NCT00299130|448226215|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
124620288|NCT00299130|448226216|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
124620289|NCT00299130|448226217|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
124620290|NCT02211417|448226218|FG000|Overall Study|Withdrawal by Subject|11|||
124620291|NCT02211417|448226219|FG001|Overall Study|Withdrawal by Subject|8|||
124620292|NCT02211417|448226218|FG000|Overall Study|Protocol Violation|1|||
124620293|NCT02211417|448226219|FG001|Overall Study|Protocol Violation|0|||
124620294|NCT02211417|448226218|FG000|Overall Study|Pregnancy|0|||
124620295|NCT02211417|448226219|FG001|Overall Study|Pregnancy|1|||
124620296|NCT02211417|448226218|FG000|Overall Study|Lost to Follow-up|2|||
124620297|NCT02211417|448226219|FG001|Overall Study|Lost to Follow-up|3|||
124620298|NCT02211417|448226218|FG000|Overall Study|Adverse Event|1|||
124620299|NCT02211417|448226219|FG001|Overall Study|Adverse Event|4|||
124620300|NCT01198132|448226220|FG000|Overall Study|Withdrawal by Subject|4|||
124620301|NCT01198132|448226221|FG001|Overall Study|Withdrawal by Subject|5|||
124620302|NCT01198132|448226220|FG000|Overall Study|Physician Decision|5|||
124620303|NCT01198132|448226221|FG001|Overall Study|Physician Decision|4|||
124620304|NCT01198132|448226220|FG000|Overall Study|Other Unspecified|3|||
124620305|NCT01198132|448226221|FG001|Overall Study|Other Unspecified|6|||
124620306|NCT01198132|448226220|FG000|Overall Study|Lack of Efficacy|2|||
124620307|NCT01198132|448226221|FG001|Overall Study|Lack of Efficacy|3|||
124620308|NCT01198132|448226220|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
124620309|NCT01198132|448226221|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
124620310|NCT01198132|448226220|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
124620311|NCT01198132|448226221|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
124620312|NCT01198132|448226220|FG000|Overall Study|Adverse Event|0|||
124620313|NCT01198132|448226221|FG001|Overall Study|Adverse Event|1|||
124620314|NCT01198132|448226220|FG000|Overall Study|Protocol Violation|1|||
124620315|NCT01198132|448226221|FG001|Overall Study|Protocol Violation|0|||
124620316|NCT01755091|448226222|FG000|Overall Study|Withdrawal by Subject|6|||
124620317|NCT01755091|448226223|FG001|Overall Study|Withdrawal by Subject|1|||
124620318|NCT01755091|448226224|FG002|Overall Study|Withdrawal by Subject|3|||
124620319|NCT01755091|448226222|FG000|Overall Study|Adverse Event|1|||
124620320|NCT01755091|448226223|FG001|Overall Study|Adverse Event|1|||
124620321|NCT01755091|448226224|FG002|Overall Study|Adverse Event|1|||
124620322|NCT01755091|448226222|FG000|Overall Study|Lost to Follow-up|1|||
124620323|NCT01755091|448226223|FG001|Overall Study|Lost to Follow-up|0|||
124620324|NCT01755091|448226224|FG002|Overall Study|Lost to Follow-up|1|||
124620325|NCT01755091|448226222|FG000|Overall Study|Physician Decision|1|||
124620326|NCT01755091|448226223|FG001|Overall Study|Physician Decision|1|||
124620327|NCT01755091|448226224|FG002|Overall Study|Physician Decision|2|||
124620328|NCT04700137|448226231|FG000|Overall Study|Lost to Follow-up|1|||
124620329|NCT04700137|448226232|FG001|Overall Study|Lost to Follow-up|6|||
124620330|NCT04700137|448226233|FG002|Overall Study|Lost to Follow-up|1|||
124749321|NCT02828020|448704204|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
124749322|NCT02828020|448704202|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
124749323|NCT02828020|448704203|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
124620331|NCT04700137|448226234|FG003|Overall Study|Lost to Follow-up|1|||
124620332|NCT04700137|448226231|FG000|Overall Study|Withdrawal by Subject|0|||
124620333|NCT04700137|448226232|FG001|Overall Study|Withdrawal by Subject|0|||
124620334|NCT04700137|448226233|FG002|Overall Study|Withdrawal by Subject|1|||
124620335|NCT04700137|448226234|FG003|Overall Study|Withdrawal by Subject|0|||
124620336|NCT04700137|448226231|FG000|Overall Study|Death|0|||
124620337|NCT04700137|448226232|FG001|Overall Study|Death|0|||
124620338|NCT04700137|448226233|FG002|Overall Study|Death|1|||
124620339|NCT04700137|448226234|FG003|Overall Study|Death|0|||
124620340|NCT00839254|448226235|FG000|Overall Study|Protocol Violation|0|||
124620341|NCT00839254|448226236|FG001|Overall Study|Protocol Violation|1|||
124620342|NCT00839254|448226237|FG002|Overall Study|Protocol Violation|1|||
124620343|NCT00839254|448226238|FG003|Overall Study|Protocol Violation|1|||
124620344|NCT00839254|448226239|FG004|Overall Study|Protocol Violation|0|||
124620345|NCT00839254|448226240|FG005|Overall Study|Protocol Violation|0|||
124620346|NCT00839254|448226241|FG006|Overall Study|Protocol Violation|1|||
124620347|NCT00839254|448226242|FG007|Overall Study|Protocol Violation|2|||
124620348|NCT00839254|448226235|FG000|Overall Study|Physician Decision|0|||
124620349|NCT00839254|448226236|FG001|Overall Study|Physician Decision|1|||
124620350|NCT00839254|448226237|FG002|Overall Study|Physician Decision|0|||
124620351|NCT00839254|448226238|FG003|Overall Study|Physician Decision|0|||
124620352|NCT00839254|448226239|FG004|Overall Study|Physician Decision|0|||
124620353|NCT00839254|448226240|FG005|Overall Study|Physician Decision|0|||
124620354|NCT00839254|448226241|FG006|Overall Study|Physician Decision|0|||
124620355|NCT00839254|448226242|FG007|Overall Study|Physician Decision|1|||
124620356|NCT00839254|448226235|FG000|Overall Study|Wrong treatment number allocation|0|||
124620357|NCT00839254|448226236|FG001|Overall Study|Wrong treatment number allocation|1|||
124620358|NCT00839254|448226237|FG002|Overall Study|Wrong treatment number allocation|0|||
124620359|NCT00839254|448226238|FG003|Overall Study|Wrong treatment number allocation|0|||
124620360|NCT00839254|448226239|FG004|Overall Study|Wrong treatment number allocation|0|||
124620361|NCT00839254|448226240|FG005|Overall Study|Wrong treatment number allocation|1|||
124620362|NCT00839254|448226241|FG006|Overall Study|Wrong treatment number allocation|0|||
124620363|NCT00839254|448226242|FG007|Overall Study|Wrong treatment number allocation|0|||
124620364|NCT00839254|448226235|FG000|Overall Study|Adverse Event|12|||
124620365|NCT00839254|448226236|FG001|Overall Study|Adverse Event|6|||
124620366|NCT00839254|448226237|FG002|Overall Study|Adverse Event|3|||
124620367|NCT00839254|448226238|FG003|Overall Study|Adverse Event|5|||
124620368|NCT00839254|448226239|FG004|Overall Study|Adverse Event|2|||
124620369|NCT00839254|448226240|FG005|Overall Study|Adverse Event|1|||
124620370|NCT00839254|448226241|FG006|Overall Study|Adverse Event|0|||
124620371|NCT00839254|448226242|FG007|Overall Study|Adverse Event|1|||
124620372|NCT00839254|448226235|FG000|Overall Study|Withdrawal by Subject|87|||
124620373|NCT00839254|448226236|FG001|Overall Study|Withdrawal by Subject|53|||
124620374|NCT00839254|448226237|FG002|Overall Study|Withdrawal by Subject|54|||
124620375|NCT00839254|448226238|FG003|Overall Study|Withdrawal by Subject|32|||
124620376|NCT00839254|448226239|FG004|Overall Study|Withdrawal by Subject|27|||
124620377|NCT00839254|448226240|FG005|Overall Study|Withdrawal by Subject|15|||
124620378|NCT00839254|448226241|FG006|Overall Study|Withdrawal by Subject|22|||
124620379|NCT00839254|448226242|FG007|Overall Study|Withdrawal by Subject|9|||
124620380|NCT00839254|448226235|FG000|Overall Study|Wrong group allocation|0|||
124749324|NCT02828020|448704204|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
124749325|NCT02828020|448704202|FG000|Safety Follow-up Period|Protocol Violation|0|||
124749326|NCT02828020|448704203|FG001|Safety Follow-up Period|Protocol Violation|2|||
124749327|NCT02828020|448704204|FG002|Safety Follow-up Period|Protocol Violation|1|||
124749328|NCT02828020|448704202|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
124749329|NCT02828020|448704203|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
124749330|NCT02828020|448704204|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
124749331|NCT00379912|448704207|FG000|Overall Study|Lack of Efficacy|1|||
124749332|NCT00379912|448704208|FG001|Overall Study|Lack of Efficacy|0|||
124749333|NCT01128946|448704209|FG000|Period I|Protocol Violation|0|||
124749334|NCT01128946|448704210|FG001|Period I|Protocol Violation|1|||
124749335|NCT01128946|448704211|FG002|Period I|Protocol Violation|0|||
124749336|NCT01128946|448704212|FG003|Period I|Protocol Violation|0|||
124749337|NCT01128946|448704209|FG000|Period I|Withdrawal by Subject|0|||
124749338|NCT01128946|448704210|FG001|Period I|Withdrawal by Subject|0|||
124749339|NCT01128946|448704211|FG002|Period I|Withdrawal by Subject|1|||
124749340|NCT01128946|448704212|FG003|Period I|Withdrawal by Subject|1|||
124749341|NCT01128946|448704209|FG000|Period II|Protocol Violation|0|||
124749342|NCT01128946|448704210|FG001|Period II|Protocol Violation|1|||
124749343|NCT01128946|448704211|FG002|Period II|Protocol Violation|0|||
124749344|NCT01128946|448704212|FG003|Period II|Protocol Violation|0|||
124749345|NCT01128946|448704209|FG000|Period II|Withdrawal by Subject|0|||
124749346|NCT01128946|448704210|FG001|Period II|Withdrawal by Subject|0|||
124749347|NCT01128946|448704211|FG002|Period II|Withdrawal by Subject|0|||
124749348|NCT01128946|448704212|FG003|Period II|Withdrawal by Subject|1|||
124749349|NCT01128946|448704209|FG000|Period III|Protocol Violation|1|||
124749350|NCT01128946|448704210|FG001|Period III|Protocol Violation|0|||
124749351|NCT01128946|448704211|FG002|Period III|Protocol Violation|0|||
124749352|NCT01128946|448704212|FG003|Period III|Protocol Violation|0|||
124749353|NCT00621140|448704213|FG000|Overall Study|Adverse Event|4|||
124749354|NCT00621140|448704214|FG001|Overall Study|Adverse Event|5|||
124749355|NCT00621140|448704213|FG000|Overall Study|Lost to Follow-up|1|||
124749356|NCT00621140|448704214|FG001|Overall Study|Lost to Follow-up|2|||
124749357|NCT00621140|448704213|FG000|Overall Study|Withdrawal by Subject|4|||
124749358|NCT00621140|448704214|FG001|Overall Study|Withdrawal by Subject|6|||
124749359|NCT00621140|448704213|FG000|Overall Study|Other incl. lack of efficacy|6|||
124749360|NCT00621140|448704214|FG001|Overall Study|Other incl. lack of efficacy|5|||
124749361|NCT01138501|448704215|FG000|Overall Study|Protocol Violation|2|||
124749362|NCT01138501|448704215|FG000|Overall Study|Withdrawal by Subject|3|||
124749363|NCT00360568|448704217|FG000|Overall Study|Adverse Event|1|||
124749364|NCT00360568|448704218|FG001|Overall Study|Adverse Event|2|||
124749365|NCT00360568|448704217|FG000|Overall Study|Lack of Efficacy|1|||
124749366|NCT00360568|448704218|FG001|Overall Study|Lack of Efficacy|0|||
124749367|NCT00360568|448704217|FG000|Overall Study|Withdrawal by Subject|0|||
124749368|NCT00360568|448704218|FG001|Overall Study|Withdrawal by Subject|3|||
124749369|NCT02873338|448704223|FG000|Overall Study|Adverse Event|0|||
124749370|NCT02873338|448704224|FG001|Overall Study|Adverse Event|2|||
124749371|NCT02873338|448704225|FG002|Overall Study|Adverse Event|1|||
124749372|NCT02873338|448704223|FG000|Overall Study|Death|2|||
124749373|NCT02873338|448704224|FG001|Overall Study|Death|1|||
124749374|NCT02873338|448704225|FG002|Overall Study|Death|1|||
124749375|NCT02873338|448704223|FG000|Overall Study|Withdrawal by Subject|2|||
124749376|NCT02873338|448704224|FG001|Overall Study|Withdrawal by Subject|1|||
124749377|NCT02873338|448704225|FG002|Overall Study|Withdrawal by Subject|3|||
124749378|NCT02873338|448704223|FG000|Overall Study|Lack of Efficacy|0|||
124749379|NCT02873338|448704224|FG001|Overall Study|Lack of Efficacy|2|||
124749380|NCT02873338|448704225|FG002|Overall Study|Lack of Efficacy|0|||
124749381|NCT02873338|448704223|FG000|Overall Study|Other or Missing|14|||
124749382|NCT02873338|448704224|FG001|Overall Study|Other or Missing|15|||
124749383|NCT02873338|448704225|FG002|Overall Study|Other or Missing|13|||
124749384|NCT03657095|448704226|FG000|Overall Study|Withdrawal by Subject|1|||
124749385|NCT03657095|448704227|FG001|Overall Study|Withdrawal by Subject|1|||
124749386|NCT03657095|448704226|FG000|Overall Study|Adverse Event|0|||
124749387|NCT03657095|448704227|FG001|Overall Study|Adverse Event|3|||
124749388|NCT03657095|448704226|FG000|Overall Study|Study Terminated by Sponsor|58|||
124749389|NCT03657095|448704227|FG001|Overall Study|Study Terminated by Sponsor|49|||
124749390|NCT00830180|448704228|FG000|Overall Study|Adverse Event|6|||
124749391|NCT00830180|448704228|FG000|Overall Study|Death|11|||
124749392|NCT00830180|448704228|FG000|Overall Study|Insufficient clinical response|1|||
124749393|NCT00830180|448704228|FG000|Overall Study|Withdrawal by Subject|5|||
124749394|NCT00830180|448704228|FG000|Overall Study|Progressive disease|2|||
124749395|NCT00830180|448704228|FG000|Overall Study|Other - Unspecified|1|||
124749396|NCT01990612|448704229|FG000|Overall Study|Lost to Follow-up|2|||
124749397|NCT01990612|448704230|FG001|Overall Study|Lost to Follow-up|1|||
124749398|NCT01990612|448704229|FG000|Overall Study|Withdrawal by Subject|5|||
124749399|NCT01990612|448704230|FG001|Overall Study|Withdrawal by Subject|2|||
124749400|NCT01068158|448704238|FG000|Overall Study|Withdrawal by Subject|1|||
124749401|NCT01068158|448704239|FG001|Overall Study|Withdrawal by Subject|2|||
124749402|NCT01068158|448704238|FG000|Overall Study|Lost to Follow-up|7|||
124749403|NCT01068158|448704239|FG001|Overall Study|Lost to Follow-up|0|||
124749404|NCT01068158|448704238|FG000|Overall Study|Protocol Violation|0|||
124749405|NCT01068158|448704239|FG001|Overall Study|Protocol Violation|2|||
124749406|NCT03824587|448704240|FG000|Run-in Period|Screen Failure|0|||
124749407|NCT03824587|448704241|FG001|Run-in Period|Screen Failure|275|||
124749408|NCT03824587|448704240|FG000|Treatment Period|Adverse Event|4|||
124749409|NCT03824587|448704241|FG001|Treatment Period|Adverse Event|1|||
124749410|NCT03824587|448704240|FG000|Treatment Period|Withdrawal by Subject|0|||
124749411|NCT03824587|448704241|FG001|Treatment Period|Withdrawal by Subject|1|||
124749412|NCT03824587|448704240|FG000|Treatment Period|Kidney Transplant|1|||
124749413|NCT03824587|448704241|FG001|Treatment Period|Kidney Transplant|1|||
124749414|NCT01300572|448704242|FG000|Overall Study|HAMA + post dosimetry|1|||
124749415|NCT00986362|448704243|FG000|Overall Study|Death|2|||
124749416|NCT00986362|448704244|FG001|Overall Study|Death|0|||
124749417|NCT00986362|448704243|FG000|Overall Study|Lost to Follow-up|0|||
124749418|NCT00986362|448704244|FG001|Overall Study|Lost to Follow-up|1|||
124749419|NCT00384332|448704246|FG000|Overall Study|Lost to Follow-up|4|||
124749420|NCT00384332|448704247|FG001|Overall Study|Lost to Follow-up|0|||
124749421|NCT03170193|448704248|FG000|Overall Study|Withdrawal by Subject|0|||
124749422|NCT03170193|448704249|FG001|Overall Study|Withdrawal by Subject|0|||
124749423|NCT03170193|448704250|FG002|Overall Study|Withdrawal by Subject|0|||
124749424|NCT03170193|448704251|FG003|Overall Study|Withdrawal by Subject|1|||
124749425|NCT03170193|448704252|FG004|Overall Study|Withdrawal by Subject|0|||
124749426|NCT03170193|448704253|FG005|Overall Study|Withdrawal by Subject|0|||
124749427|NCT03170193|448704254|FG006|Overall Study|Withdrawal by Subject|0|||
124749428|NCT03170193|448704248|FG000|Overall Study|Lost to Follow-up|1|||
124749429|NCT03170193|448704249|FG001|Overall Study|Lost to Follow-up|1|||
124749430|NCT03170193|448704250|FG002|Overall Study|Lost to Follow-up|0|||
124749431|NCT03170193|448704251|FG003|Overall Study|Lost to Follow-up|0|||
124749432|NCT03170193|448704252|FG004|Overall Study|Lost to Follow-up|0|||
124749433|NCT03170193|448704253|FG005|Overall Study|Lost to Follow-up|0|||
124782897|NCT00101452|448834355|FG002|Overall Study|Protocol Violation|3|||
124749434|NCT03170193|448704254|FG006|Overall Study|Lost to Follow-up|0|||
124749435|NCT00411632|448704255|FG000|Overall Study|Death|1|||
124749436|NCT02560012|448704256|FG000|Overall Study|Study Terminated|2|||
124749437|NCT01007838|448704259|FG000|Overall Study|Withdrawal by Subject|1|||
124749438|NCT01007838|448704260|FG001|Overall Study|Withdrawal by Subject|0|||
124749439|NCT01007838|448704261|FG002|Overall Study|Withdrawal by Subject|0|||
124749440|NCT01007838|448704262|FG003|Overall Study|Withdrawal by Subject|0|||
124749441|NCT01007838|448704259|FG000|Overall Study|Physician Decision|1|||
124749442|NCT01007838|448704260|FG001|Overall Study|Physician Decision|0|||
124749443|NCT01007838|448704261|FG002|Overall Study|Physician Decision|0|||
124749444|NCT01007838|448704262|FG003|Overall Study|Physician Decision|0|||
124749445|NCT01007838|448704259|FG000|Overall Study|Started home haemodialysis|1|||
124749446|NCT01007838|448704260|FG001|Overall Study|Started home haemodialysis|0|||
124749447|NCT01007838|448704261|FG002|Overall Study|Started home haemodialysis|0|||
124749448|NCT01007838|448704262|FG003|Overall Study|Started home haemodialysis|0|||
124749449|NCT01748825|448704275|FG000|Dose Escalation|Refused further treatment|2|||
124749450|NCT01748825|448704276|FG001|Dose Escalation|Refused further treatment|2|||
124749451|NCT01748825|448704277|FG002|Dose Escalation|Refused further treatment|0|||
124749452|NCT01748825|448704278|FG003|Dose Escalation|Refused further treatment|0|||
124749453|NCT01748825|448704279|FG004|Dose Escalation|Refused further treatment|1|||
124749454|NCT01748825|448704280|FG005|Dose Escalation|Refused further treatment|2|||
124749455|NCT01748825|448704281|FG006|Dose Escalation|Refused further treatment|0|||
124749456|NCT01748825|448704282|FG007|Dose Escalation|Refused further treatment|0|||
124749457|NCT01748825|448704283|FG008|Dose Escalation|Refused further treatment|0|||
124749458|NCT01748825|448704284|FG009|Dose Escalation|Refused further treatment|0|||
124749459|NCT01748825|448704275|FG000|Dose Escalation|Switched to alternative treatment|0|||
124749460|NCT01748825|448704276|FG001|Dose Escalation|Switched to alternative treatment|0|||
124749461|NCT01748825|448704277|FG002|Dose Escalation|Switched to alternative treatment|0|||
124749462|NCT01748825|448704278|FG003|Dose Escalation|Switched to alternative treatment|1|||
124749463|NCT01748825|448704279|FG004|Dose Escalation|Switched to alternative treatment|0|||
124749464|NCT01748825|448704280|FG005|Dose Escalation|Switched to alternative treatment|0|||
124749465|NCT01748825|448704281|FG006|Dose Escalation|Switched to alternative treatment|0|||
124749466|NCT01748825|448704282|FG007|Dose Escalation|Switched to alternative treatment|0|||
124749467|NCT01748825|448704283|FG008|Dose Escalation|Switched to alternative treatment|0|||
124749468|NCT01748825|448704284|FG009|Dose Escalation|Switched to alternative treatment|0|||
124749469|NCT01748825|448704275|FG000|Dose Escalation|Adverse Event|0|||
124749470|NCT01748825|448704276|FG001|Dose Escalation|Adverse Event|0|||
124749471|NCT01748825|448704277|FG002|Dose Escalation|Adverse Event|0|||
124749472|NCT01748825|448704278|FG003|Dose Escalation|Adverse Event|0|||
124749473|NCT01748825|448704279|FG004|Dose Escalation|Adverse Event|0|||
124749474|NCT01748825|448704280|FG005|Dose Escalation|Adverse Event|0|||
124749475|NCT01748825|448704281|FG006|Dose Escalation|Adverse Event|1|||
124749476|NCT01748825|448704282|FG007|Dose Escalation|Adverse Event|0|||
124749477|NCT01748825|448704283|FG008|Dose Escalation|Adverse Event|0|||
124749478|NCT01748825|448704284|FG009|Dose Escalation|Adverse Event|0|||
124749479|NCT01748825|448704275|FG000|Dose Expansion|Refused further treatment|0|||
124749480|NCT01748825|448704276|FG001|Dose Expansion|Refused further treatment|0|||
124749481|NCT01748825|448704277|FG002|Dose Expansion|Refused further treatment|0|||
124749482|NCT01748825|448704278|FG003|Dose Expansion|Refused further treatment|0|||
124749483|NCT01748825|448704279|FG004|Dose Expansion|Refused further treatment|0|||
124749484|NCT01748825|448704280|FG005|Dose Expansion|Refused further treatment|0|||
124749485|NCT01748825|448704281|FG006|Dose Expansion|Refused further treatment|0|||
124749486|NCT01748825|448704282|FG007|Dose Expansion|Refused further treatment|0|||
124749487|NCT01748825|448704283|FG008|Dose Expansion|Refused further treatment|1|||
124749488|NCT01748825|448704284|FG009|Dose Expansion|Refused further treatment|1|||
124749489|NCT01748825|448704275|FG000|Dose Expansion|Switched to alternative treatment|0|||
124749490|NCT01748825|448704276|FG001|Dose Expansion|Switched to alternative treatment|0|||
124749491|NCT01748825|448704277|FG002|Dose Expansion|Switched to alternative treatment|0|||
124749492|NCT01748825|448704278|FG003|Dose Expansion|Switched to alternative treatment|0|||
124749493|NCT01748825|448704279|FG004|Dose Expansion|Switched to alternative treatment|0|||
124749494|NCT01748825|448704280|FG005|Dose Expansion|Switched to alternative treatment|0|||
124749495|NCT01748825|448704281|FG006|Dose Expansion|Switched to alternative treatment|0|||
124749496|NCT01748825|448704282|FG007|Dose Expansion|Switched to alternative treatment|0|||
124749497|NCT01748825|448704283|FG008|Dose Expansion|Switched to alternative treatment|0|||
124749498|NCT01748825|448704284|FG009|Dose Expansion|Switched to alternative treatment|1|||
124749499|NCT01748825|448704275|FG000|Dose Expansion|Adverse Event|0|||
124749500|NCT01748825|448704276|FG001|Dose Expansion|Adverse Event|0|||
124749501|NCT01748825|448704277|FG002|Dose Expansion|Adverse Event|0|||
124749502|NCT01748825|448704278|FG003|Dose Expansion|Adverse Event|0|||
124782898|NCT00101452|448834353|FG000|Overall Study|Other|15|||
124782899|NCT00101452|448834354|FG001|Overall Study|Other|16|||
124749503|NCT01748825|448704279|FG004|Dose Expansion|Adverse Event|0|||
124749504|NCT01748825|448704280|FG005|Dose Expansion|Adverse Event|0|||
124749505|NCT01748825|448704281|FG006|Dose Expansion|Adverse Event|0|||
124749506|NCT01748825|448704282|FG007|Dose Expansion|Adverse Event|0|||
124749507|NCT01748825|448704283|FG008|Dose Expansion|Adverse Event|0|||
124749508|NCT01748825|448704284|FG009|Dose Expansion|Adverse Event|3|||
124749509|NCT01748825|448704275|FG000|Dose Expansion|Physician Decision|0|||
124620381|NCT00839254|448226236|FG001|Overall Study|Wrong group allocation|0|||
124782900|NCT00101452|448834355|FG002|Overall Study|Other|12|||
124749510|NCT01748825|448704276|FG001|Dose Expansion|Physician Decision|0|||
124749511|NCT01748825|448704277|FG002|Dose Expansion|Physician Decision|0|||
124749512|NCT01748825|448704278|FG003|Dose Expansion|Physician Decision|0|||
124749513|NCT01748825|448704279|FG004|Dose Expansion|Physician Decision|0|||
124749514|NCT01748825|448704280|FG005|Dose Expansion|Physician Decision|0|||
124749515|NCT01748825|448704281|FG006|Dose Expansion|Physician Decision|0|||
124749516|NCT01748825|448704282|FG007|Dose Expansion|Physician Decision|0|||
124749517|NCT01748825|448704283|FG008|Dose Expansion|Physician Decision|1|||
124749518|NCT01748825|448704284|FG009|Dose Expansion|Physician Decision|0|||
124749519|NCT00118430|448704286|FG000|Overall Study|Withdrawal by Subject|6|||
124749520|NCT00118430|448704287|FG001|Overall Study|Withdrawal by Subject|2|||
124749521|NCT00118430|448704288|FG002|Overall Study|Withdrawal by Subject|0|||
124749522|NCT00118430|448704286|FG000|Overall Study|Lost to Follow-up|15|||
124749523|NCT00118430|448704287|FG001|Overall Study|Lost to Follow-up|22|||
124749524|NCT00118430|448704288|FG002|Overall Study|Lost to Follow-up|28|||
124749525|NCT00659230|448704289|FG000|Overall Study|Lost to Follow-up|2|||
124749526|NCT00659230|448704290|FG001|Overall Study|Lost to Follow-up|5|||
124749527|NCT00659230|448704289|FG000|Overall Study|Lost source documentation|5|||
124749528|NCT00659230|448704290|FG001|Overall Study|Lost source documentation|4|||
124749529|NCT00659230|448704289|FG000|Overall Study|Did not return post-randomization|2|||
124749530|NCT00659230|448704290|FG001|Overall Study|Did not return post-randomization|3|||
124749531|NCT02147288|448704291|FG000|Overall Study|post-operative hematoma|1|||
124749532|NCT02147288|448704292|FG001|Overall Study|post-operative hematoma|1|||
124749533|NCT02147288|448704293|FG002|Overall Study|post-operative hematoma|0|||
124749534|NCT02147288|448704294|FG003|Overall Study|post-operative hematoma|0|||
124749535|NCT02147288|448704295|FG004|Overall Study|post-operative hematoma|0|||
124749536|NCT02147288|448704296|FG005|Overall Study|post-operative hematoma|0|||
124749537|NCT02147288|448704297|FG006|Overall Study|post-operative hematoma|0|||
124749538|NCT02147288|448704298|FG007|Overall Study|post-operative hematoma|0|||
124749539|NCT02147288|448704299|FG008|Overall Study|post-operative hematoma|0|||
124749540|NCT02147288|448704300|FG009|Overall Study|post-operative hematoma|0|||
124749541|NCT02147288|448704291|FG000|Overall Study|complications from concurrent hernia rep|0|||
124749542|NCT02147288|448704292|FG001|Overall Study|complications from concurrent hernia rep|1|||
124749543|NCT02147288|448704293|FG002|Overall Study|complications from concurrent hernia rep|0|||
124749544|NCT02147288|448704294|FG003|Overall Study|complications from concurrent hernia rep|0|||
124749545|NCT02147288|448704295|FG004|Overall Study|complications from concurrent hernia rep|0|||
124749546|NCT02147288|448704296|FG005|Overall Study|complications from concurrent hernia rep|0|||
124749547|NCT02147288|448704297|FG006|Overall Study|complications from concurrent hernia rep|0|||
124749548|NCT02147288|448704298|FG007|Overall Study|complications from concurrent hernia rep|0|||
124749549|NCT02147288|448704299|FG008|Overall Study|complications from concurrent hernia rep|0|||
124749550|NCT02147288|448704300|FG009|Overall Study|complications from concurrent hernia rep|0|||
124749551|NCT00269633|448704303|FG000|Overall Study|Withdrawal by Subject|1|||
124749552|NCT00269633|448704304|FG001|Overall Study|Withdrawal by Subject|0|||
124749553|NCT04412707|448704305|FG000|Cycle 1|Death|0|||
124749554|NCT04412707|448704306|FG001|Cycle 1|Death|3|||
124749555|NCT04412707|448704305|FG000|Cycle 1|Disease progression|1|||
124749556|NCT04412707|448704306|FG001|Cycle 1|Disease progression|2|||
124749557|NCT04412707|448704305|FG000|Cycle 2|Death|0|||
124749558|NCT04412707|448704306|FG001|Cycle 2|Death|1|||
124749559|NCT04412707|448704305|FG000|Cycle 2|Disease progression|3|||
124749560|NCT04412707|448704306|FG001|Cycle 2|Disease progression|0|||
124749561|NCT04412707|448704305|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
124749562|NCT04412707|448704306|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
124749563|NCT04412707|448704305|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
124749564|NCT04412707|448704306|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
124782901|NCT00499590|448834356|FG000|Overall Study|Study Terminated|112|||
124782902|NCT00499590|448834357|FG001|Overall Study|Study Terminated|112|||
124782903|NCT00499590|448834358|FG002|Overall Study|Study Terminated|112|||
124782904|NCT00499590|448834356|FG000|Overall Study|Not treated|1|||
124782905|NCT00499590|448834357|FG001|Overall Study|Not treated|0|||
124782906|NCT00499590|448834358|FG002|Overall Study|Not treated|1|||
124749565|NCT04412707|448704305|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
124749566|NCT04412707|448704306|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
124749567|NCT04412707|448704305|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
124749568|NCT04412707|448704306|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
124749569|NCT02476006|448704307|FG000|Overall Study|Death|4|||
124782907|NCT05661851|448834359|FG000|Overall Study|Protocol Violation|1|||
124749570|NCT02476006|448704307|FG000|Overall Study|Lack of treatment efficacy|2|||
124782908|NCT05661851|448834360|FG001|Overall Study|Protocol Violation|1|||
124749571|NCT02476006|448704307|FG000|Overall Study|Pregnancy|1|||
124782909|NCT05661851|448834359|FG000|Overall Study|Covid-19 Related|3|||
124782910|NCT05661851|448834360|FG001|Overall Study|Covid-19 Related|4|||
124782911|NCT05661851|448834359|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
124749572|NCT02476006|448704307|FG000|Overall Study|Participant did not wish to continue|39|||
124749573|NCT02476006|448704307|FG000|Overall Study|Adverse Event|41|||
124782912|NCT05661851|448834360|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
124749574|NCT02476006|448704307|FG000|Overall Study|Poor compliance to study protocol|3|||
124620382|NCT00839254|448226237|FG002|Overall Study|Wrong group allocation|0|||
124620383|NCT00839254|448226238|FG003|Overall Study|Wrong group allocation|0|||
124620384|NCT00839254|448226239|FG004|Overall Study|Wrong group allocation|0|||
124620385|NCT00839254|448226240|FG005|Overall Study|Wrong group allocation|0|||
124620386|NCT00839254|448226241|FG006|Overall Study|Wrong group allocation|1|||
124620387|NCT00839254|448226242|FG007|Overall Study|Wrong group allocation|0|||
124620388|NCT00839254|448226235|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
124620389|NCT00839254|448226236|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
124620390|NCT00839254|448226237|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
124620391|NCT00839254|448226238|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
124620392|NCT00839254|448226239|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
124620393|NCT00839254|448226240|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
124620394|NCT00839254|448226241|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
124620395|NCT00839254|448226242|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
124620396|NCT00839254|448226235|FG000|Overall Study|Withdrawn due to non-compliance|2|||
124620397|NCT00839254|448226236|FG001|Overall Study|Withdrawn due to non-compliance|0|||
124620398|NCT00839254|448226237|FG002|Overall Study|Withdrawn due to non-compliance|0|||
124620399|NCT00839254|448226238|FG003|Overall Study|Withdrawn due to non-compliance|0|||
124620400|NCT00839254|448226239|FG004|Overall Study|Withdrawn due to non-compliance|0|||
124620401|NCT00839254|448226240|FG005|Overall Study|Withdrawn due to non-compliance|0|||
124620402|NCT00839254|448226241|FG006|Overall Study|Withdrawn due to non-compliance|0|||
124620403|NCT00839254|448226242|FG007|Overall Study|Withdrawn due to non-compliance|0|||
124620404|NCT00839254|448226235|FG000|Overall Study|Lost to Follow-up|51|||
124620405|NCT00839254|448226236|FG001|Overall Study|Lost to Follow-up|30|||
124620406|NCT00839254|448226237|FG002|Overall Study|Lost to Follow-up|32|||
124620407|NCT00839254|448226238|FG003|Overall Study|Lost to Follow-up|24|||
124620408|NCT00839254|448226239|FG004|Overall Study|Lost to Follow-up|8|||
124620409|NCT00839254|448226240|FG005|Overall Study|Lost to Follow-up|8|||
124620410|NCT00839254|448226241|FG006|Overall Study|Lost to Follow-up|4|||
124620411|NCT00839254|448226242|FG007|Overall Study|Lost to Follow-up|2|||
124620412|NCT00489827|448226252|FG000|Overall Study|Intraoperative exclusion criteria|1|||
124620413|NCT00489827|448226253|FG001|Overall Study|Intraoperative exclusion criteria|1|||
124620414|NCT00489827|448226252|FG000|Overall Study|Intraoperative exclusion criteria|1|||
124620415|NCT00489827|448226253|FG001|Overall Study|Intraoperative exclusion criteria|1|||
124620416|NCT02296931|448226254|FG000|Overall Study|Protocol Violation|0|||
124620417|NCT02296931|448226255|FG001|Overall Study|Protocol Violation|2|||
124620418|NCT01590277|448226256|FG000|Overall Study|Withdrawal by Subject|3|||
124620419|NCT01590277|448226256|FG000|Overall Study|Withdrawal by Subject|2|||
124620420|NCT01590277|448226256|FG000|Overall Study|Withdrawal by Subject|1|||
124620421|NCT01590277|448226256|FG000|Overall Study|Withdrawal by Subject|1|||
124620422|NCT04386616|448226257|FG000|Overall Study|Death|22|||
124620423|NCT04386616|448226258|FG001|Overall Study|Death|22|||
124620424|NCT04386616|448226259|FG002|Overall Study|Death|21|||
124620425|NCT04386616|448226257|FG000|Overall Study|Lost to Follow-up|5|||
124620426|NCT04386616|448226258|FG001|Overall Study|Lost to Follow-up|8|||
124620427|NCT04386616|448226259|FG002|Overall Study|Lost to Follow-up|6|||
124620428|NCT04386616|448226257|FG000|Overall Study|Withdrawal by Subject|2|||
124620429|NCT04386616|448226258|FG001|Overall Study|Withdrawal by Subject|4|||
124620430|NCT04386616|448226259|FG002|Overall Study|Withdrawal by Subject|1|||
124620431|NCT04386616|448226257|FG000|Overall Study|Adverse Event|1|||
124620432|NCT04386616|448226258|FG001|Overall Study|Adverse Event|1|||
124620433|NCT04386616|448226259|FG002|Overall Study|Adverse Event|0|||
124620434|NCT01377012|448226260|FG000|Core Study|Study terminated by Sponsor|47|||
124620435|NCT01377012|448226261|FG001|Core Study|Study terminated by Sponsor|54|||
124620436|NCT01377012|448226262|FG002|Core Study|Study terminated by Sponsor|46|||
124620437|NCT01377012|448226260|FG000|Core Study|Technical problems|1|||
124620438|NCT01377012|448226261|FG001|Core Study|Technical problems|0|||
124620439|NCT01377012|448226262|FG002|Core Study|Technical problems|0|||
124620440|NCT01377012|448226260|FG000|Core Study|Withdrawal by Subject|15|||
124620441|NCT01377012|448226261|FG001|Core Study|Withdrawal by Subject|23|||
124620442|NCT01377012|448226262|FG002|Core Study|Withdrawal by Subject|18|||
124620443|NCT01377012|448226260|FG000|Core Study|Protocol Violation|7|||
124620444|NCT01377012|448226261|FG001|Core Study|Protocol Violation|3|||
124620445|NCT01377012|448226262|FG002|Core Study|Protocol Violation|2|||
124749575|NCT02476006|448704307|FG000|Overall Study|Sponsor decision|6|||
124620446|NCT01377012|448226260|FG000|Core Study|Pregnancy|0|||
124620447|NCT01377012|448226261|FG001|Core Study|Pregnancy|0|||
124620448|NCT01377012|448226262|FG002|Core Study|Pregnancy|1|||
124620449|NCT01377012|448226260|FG000|Core Study|Physician Decision|5|||
124620450|NCT01377012|448226261|FG001|Core Study|Physician Decision|4|||
124620451|NCT01377012|448226262|FG002|Core Study|Physician Decision|10|||
124620452|NCT01377012|448226260|FG000|Core Study|Non-Compliant with study treatment|0|||
124620453|NCT01377012|448226261|FG001|Core Study|Non-Compliant with study treatment|0|||
124620454|NCT01377012|448226262|FG002|Core Study|Non-Compliant with study treatment|1|||
124620455|NCT01377012|448226260|FG000|Core Study|No Longer require treatment|0|||
124749576|NCT02476006|448704307|FG000|Overall Study|Lost to Follow-up|5|||
124749577|NCT02476006|448704307|FG000|Overall Study|Physician Decision|5|||
124749578|NCT02476006|448704307|FG000|Overall Study|Study ended treatment not available|4|||
124749579|NCT02476006|448704307|FG000|Overall Study|Switched to commercial drug|4|||
124749580|NCT02476006|448704307|FG000|Overall Study|Excluded from study|1|||
124749581|NCT02476006|448704307|FG000|Overall Study|Protocol Violation|1|||
124749582|NCT02476006|448704307|FG000|Overall Study|Enrolled but not treated|4|||
124749583|NCT03210961|448706991|FG000|Overall Study|Adverse Event|0|||
124749584|NCT03210961|448706992|FG001|Overall Study|Adverse Event|0|||
124749585|NCT03210961|448706993|FG002|Overall Study|Adverse Event|0|||
124749586|NCT03210961|448706994|FG003|Overall Study|Adverse Event|0|||
124749587|NCT03210961|448706995|FG004|Overall Study|Adverse Event|0|||
124749588|NCT03210961|448706996|FG005|Overall Study|Adverse Event|0|||
124749589|NCT03210961|448706997|FG006|Overall Study|Adverse Event|0|||
124749590|NCT03210961|448706998|FG007|Overall Study|Adverse Event|0|||
124749591|NCT03210961|448706999|FG008|Overall Study|Adverse Event|0|||
124749592|NCT03210961|448707000|FG009|Overall Study|Adverse Event|0|||
124749593|NCT03210961|448707001|FG010|Overall Study|Adverse Event|0|||
124749594|NCT03210961|448707002|FG011|Overall Study|Adverse Event|0|||
124749595|NCT03210961|448707003|FG012|Overall Study|Adverse Event|0|||
124749596|NCT03210961|448707004|FG013|Overall Study|Adverse Event|1|||
124749597|NCT03210961|448707005|FG014|Overall Study|Adverse Event|0|||
124749598|NCT03210961|448706991|FG000|Overall Study|Lost to Follow-up|0|||
124749599|NCT03210961|448706992|FG001|Overall Study|Lost to Follow-up|0|||
124749600|NCT03210961|448706993|FG002|Overall Study|Lost to Follow-up|0|||
124749601|NCT03210961|448706994|FG003|Overall Study|Lost to Follow-up|0|||
124749602|NCT03210961|448706995|FG004|Overall Study|Lost to Follow-up|0|||
124749603|NCT03210961|448706996|FG005|Overall Study|Lost to Follow-up|0|||
124749604|NCT03210961|448706997|FG006|Overall Study|Lost to Follow-up|0|||
124749605|NCT03210961|448706998|FG007|Overall Study|Lost to Follow-up|0|||
124749606|NCT03210961|448706999|FG008|Overall Study|Lost to Follow-up|0|||
124749607|NCT03210961|448707000|FG009|Overall Study|Lost to Follow-up|0|||
124749608|NCT03210961|448707001|FG010|Overall Study|Lost to Follow-up|0|||
124749609|NCT03210961|448707002|FG011|Overall Study|Lost to Follow-up|0|||
124749610|NCT03210961|448707003|FG012|Overall Study|Lost to Follow-up|0|||
124749611|NCT03210961|448707004|FG013|Overall Study|Lost to Follow-up|0|||
124749612|NCT03210961|448707005|FG014|Overall Study|Lost to Follow-up|1|||
124749613|NCT03210961|448706991|FG000|Overall Study|Withdrawal by Subject|0|||
124749614|NCT03210961|448706992|FG001|Overall Study|Withdrawal by Subject|0|||
124749615|NCT03210961|448706993|FG002|Overall Study|Withdrawal by Subject|0|||
124749616|NCT03210961|448706994|FG003|Overall Study|Withdrawal by Subject|0|||
124749617|NCT03210961|448706995|FG004|Overall Study|Withdrawal by Subject|0|||
124749618|NCT03210961|448706996|FG005|Overall Study|Withdrawal by Subject|0|||
124749619|NCT03210961|448706997|FG006|Overall Study|Withdrawal by Subject|0|||
124749620|NCT03210961|448706998|FG007|Overall Study|Withdrawal by Subject|0|||
124749621|NCT03210961|448706999|FG008|Overall Study|Withdrawal by Subject|0|||
124749622|NCT03210961|448707000|FG009|Overall Study|Withdrawal by Subject|0|||
124749623|NCT03210961|448707001|FG010|Overall Study|Withdrawal by Subject|0|||
124749624|NCT03210961|448707002|FG011|Overall Study|Withdrawal by Subject|0|||
124749625|NCT03210961|448707003|FG012|Overall Study|Withdrawal by Subject|0|||
124749626|NCT03210961|448707004|FG013|Overall Study|Withdrawal by Subject|0|||
124749627|NCT03210961|448707005|FG014|Overall Study|Withdrawal by Subject|1|||
124749628|NCT03210961|448706991|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
124749629|NCT03210961|448706992|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
124749630|NCT03210961|448706993|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
124749631|NCT03210961|448706994|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
124749632|NCT03210961|448706995|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
124749633|NCT03210961|448706996|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
124749634|NCT03210961|448706997|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
124749635|NCT03210961|448706998|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
124749636|NCT03210961|448706999|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
124749637|NCT03210961|448707000|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
124749638|NCT03210961|448707001|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
124749639|NCT03210961|448707002|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
124749640|NCT03210961|448707003|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
124749641|NCT03210961|448707004|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
124749642|NCT03210961|448707005|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
124749643|NCT03210961|448706991|FG000|Overall Study|Other|0|||
124749644|NCT03210961|448706992|FG001|Overall Study|Other|0|||
124749645|NCT03210961|448706993|FG002|Overall Study|Other|0|||
124749646|NCT03210961|448706994|FG003|Overall Study|Other|1|||
124749647|NCT03210961|448706995|FG004|Overall Study|Other|0|||
124749648|NCT03210961|448706996|FG005|Overall Study|Other|0|||
124749649|NCT03210961|448706997|FG006|Overall Study|Other|1|||
124819524|NCT03902574|448965743|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
124749650|NCT03210961|448706998|FG007|Overall Study|Other|0|||
124749651|NCT03210961|448706999|FG008|Overall Study|Other|0|||
124749652|NCT03210961|448707000|FG009|Overall Study|Other|0|||
124749653|NCT03210961|448707001|FG010|Overall Study|Other|1|||
124749654|NCT03210961|448707002|FG011|Overall Study|Other|0|||
124749655|NCT03210961|448707003|FG012|Overall Study|Other|2|||
124749656|NCT03210961|448707004|FG013|Overall Study|Other|2|||
124749657|NCT03210961|448707005|FG014|Overall Study|Other|0|||
124749658|NCT01487265|448707006|FG000|Overall Study|Adverse Event|8|||
124749659|NCT01487265|448707006|FG000|Overall Study|Withdrawal by Subject|5|||
124749660|NCT01487265|448707006|FG000|Overall Study|Disease Progression|21|||
124749661|NCT01487265|448707006|FG000|Overall Study|Death|2|||
124749662|NCT01487265|448707006|FG000|Overall Study|Still on Treatment|1|||
124749663|NCT02291419|448707007|FG000|Overall Study|Early study termination|1|||
124749664|NCT02291419|448707008|FG001|Overall Study|Early study termination|5|||
124749665|NCT00965575|448707012|FG000|Overall Study|subject unwillingness to swallow study c|1|||
124749666|NCT00965575|448707013|FG001|Overall Study|subject unwillingness to swallow study c|0|||
124749667|NCT01732770|448707020|FG000|Overall Study|Lost to Follow-up|2|||
124749668|NCT01732770|448707021|FG001|Overall Study|Lost to Follow-up|3|||
124749669|NCT01732770|448707020|FG000|Overall Study|Withdrawal by Subject|5|||
124749670|NCT01732770|448707021|FG001|Overall Study|Withdrawal by Subject|3|||
124749671|NCT01732770|448707020|FG000|Overall Study|Decision by Sponsor|2|||
124749672|NCT01732770|448707021|FG001|Overall Study|Decision by Sponsor|2|||
124749673|NCT01732770|448707020|FG000|Overall Study|Death|1|||
124749674|NCT01732770|448707021|FG001|Overall Study|Death|0|||
124749675|NCT03047031|448707022|FG000|Overall Study|Other than listed|1|||
124749676|NCT03047031|448707023|FG001|Overall Study|Other than listed|0|||
124749677|NCT03047031|448707024|FG002|Overall Study|Other than listed|0|||
124749678|NCT03047031|448707022|FG000|Overall Study|Lost to Follow-up|4|||
124749679|NCT03047031|448707023|FG001|Overall Study|Lost to Follow-up|0|||
124749680|NCT03047031|448707024|FG002|Overall Study|Lost to Follow-up|0|||
124749681|NCT03047031|448707022|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
124749682|NCT03047031|448707023|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
124749683|NCT03047031|448707024|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
124749684|NCT03047031|448707022|FG000|Overall Study|Adverse Event|1|||
124749685|NCT03047031|448707023|FG001|Overall Study|Adverse Event|0|||
124749686|NCT03047031|448707024|FG002|Overall Study|Adverse Event|0|||
124749687|NCT03047031|448707022|FG000|Overall Study|Withdrawal by Subject|2|||
124749688|NCT03047031|448707023|FG001|Overall Study|Withdrawal by Subject|0|||
124749689|NCT03047031|448707024|FG002|Overall Study|Withdrawal by Subject|0|||
124749690|NCT03047031|448707022|FG000|Overall Study|Change to other medication|2|||
124749691|NCT03047031|448707023|FG001|Overall Study|Change to other medication|0|||
124749692|NCT03047031|448707024|FG002|Overall Study|Change to other medication|0|||
124749693|NCT03047031|448707022|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
124749694|NCT03047031|448707023|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
124749695|NCT03047031|448707024|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
124749696|NCT01959841|448707025|FG000|Overall Study|Adverse Event|1|||
124749697|NCT01959841|448707026|FG001|Overall Study|Adverse Event|3|||
124749698|NCT01959841|448707027|FG002|Overall Study|Adverse Event|2|||
124749699|NCT01959841|448707025|FG000|Overall Study|Lack of Efficacy|5|||
124749700|NCT01959841|448707026|FG001|Overall Study|Lack of Efficacy|0|||
124749701|NCT01959841|448707027|FG002|Overall Study|Lack of Efficacy|0|||
124749702|NCT01959841|448707025|FG000|Overall Study|Lost to Follow-up|1|||
124749703|NCT01959841|448707026|FG001|Overall Study|Lost to Follow-up|1|||
124749704|NCT01959841|448707027|FG002|Overall Study|Lost to Follow-up|0|||
124749705|NCT01959841|448707025|FG000|Overall Study|Physician Decision|0|||
124749706|NCT01959841|448707026|FG001|Overall Study|Physician Decision|2|||
124749707|NCT01959841|448707027|FG002|Overall Study|Physician Decision|3|||
124749708|NCT01959841|448707025|FG000|Overall Study|Protocol Violation|16|||
124749709|NCT01959841|448707026|FG001|Overall Study|Protocol Violation|23|||
124749710|NCT01959841|448707027|FG002|Overall Study|Protocol Violation|16|||
124749711|NCT01959841|448707025|FG000|Overall Study|Withdrawal by Subject|7|||
124749712|NCT01959841|448707026|FG001|Overall Study|Withdrawal by Subject|7|||
124749713|NCT01959841|448707027|FG002|Overall Study|Withdrawal by Subject|5|||
124749714|NCT01959841|448707025|FG000|Overall Study|Clinical laboratory value|2|||
124749715|NCT01959841|448707026|FG001|Overall Study|Clinical laboratory value|6|||
124749716|NCT01959841|448707027|FG002|Overall Study|Clinical laboratory value|6|||
124749717|NCT01959841|448707025|FG000|Overall Study|Platelet count below on day1 or 4|11|||
124749718|NCT01959841|448707026|FG001|Overall Study|Platelet count below on day1 or 4|15|||
124749719|NCT01959841|448707027|FG002|Overall Study|Platelet count below on day1 or 4|11|||
124749720|NCT00780416|448707028|FG000|Overall Study|Physician Decision|3|||
124749721|NCT00780416|448707029|FG001|Overall Study|Physician Decision|3|||
124749722|NCT00780416|448707028|FG000|Overall Study|Protocol Violation|1|||
124749723|NCT00780416|448707029|FG001|Overall Study|Protocol Violation|0|||
124749724|NCT00780416|448707028|FG000|Overall Study|Withdrawal by Subject|8|||
124749725|NCT00780416|448707029|FG001|Overall Study|Withdrawal by Subject|6|||
124749726|NCT00666224|448707032|FG000|Double-Blind|Adverse Event|15|||
124749727|NCT00666224|448707033|FG001|Double-Blind|Adverse Event|5|||
124749728|NCT00666224|448707032|FG000|Double-Blind|Lost to Follow-up|2|||
124749729|NCT00666224|448707033|FG001|Double-Blind|Lost to Follow-up|2|||
124749730|NCT00666224|448707032|FG000|Double-Blind|Withdrawal by Subject|18|||
124749731|NCT00666224|448707033|FG001|Double-Blind|Withdrawal by Subject|14|||
124749732|NCT00666224|448707032|FG000|Double-Blind|Physician Decision|0|||
124749733|NCT00666224|448707033|FG001|Double-Blind|Physician Decision|3|||
124749734|NCT00666224|448707032|FG000|Double-Blind|Sponsor decision|1|||
124749735|NCT00666224|448707033|FG001|Double-Blind|Sponsor decision|0|||
124749736|NCT00666224|448707032|FG000|Double-Blind|Pregnancy|3|||
124749737|NCT00666224|448707033|FG001|Double-Blind|Pregnancy|2|||
124749738|NCT00666224|448707032|FG000|Double-Blind|Noncompliance|1|||
124749739|NCT00666224|448707033|FG001|Double-Blind|Noncompliance|0|||
124749740|NCT00666224|448707032|FG000|Double-Blind|Death|1|||
124749741|NCT00666224|448707033|FG001|Double-Blind|Death|0|||
124749742|NCT00666224|448707032|FG000|Double-Blind|Undefined/Unknown|4|||
124749743|NCT00666224|448707033|FG001|Double-Blind|Undefined/Unknown|1|||
124749744|NCT00666224|448707032|FG000|Open-Label|Adverse Event|8|||
124749745|NCT00666224|448707033|FG001|Open-Label|Adverse Event|43|||
124749746|NCT00666224|448707032|FG000|Open-Label|Lost to Follow-up|4|||
124749747|NCT00666224|448707033|FG001|Open-Label|Lost to Follow-up|5|||
124749748|NCT00666224|448707032|FG000|Open-Label|Withdrawal by Subject|12|||
124749749|NCT00666224|448707033|FG001|Open-Label|Withdrawal by Subject|25|||
124749750|NCT00666224|448707032|FG000|Open-Label|Physician Decision|7|||
124749751|NCT00666224|448707033|FG001|Open-Label|Physician Decision|5|||
124749752|NCT00666224|448707032|FG000|Open-Label|Pregnancy|1|||
124749753|NCT00666224|448707033|FG001|Open-Label|Pregnancy|5|||
124749754|NCT00666224|448707032|FG000|Open-Label|Noncompliance|2|||
124749755|NCT00666224|448707033|FG001|Open-Label|Noncompliance|1|||
124749756|NCT00666224|448707032|FG000|Open-Label|Undefined/Unknown|1|||
124749757|NCT00666224|448707033|FG001|Open-Label|Undefined/Unknown|1|||
124749758|NCT00871338|448707037|FG000|Prior to Booster|Withdrawal by Subject|1|||
124749759|NCT00871338|448707038|FG001|Prior to Booster|Withdrawal by Subject|3|||
124749760|NCT00871338|448707037|FG000|Prior to Booster|Lost to Follow-up|1|||
124749761|NCT00871338|448707038|FG001|Prior to Booster|Lost to Follow-up|0|||
124749762|NCT01959139|448707046|FG000|Phase II|Disease progression|0|||
124749763|NCT01959139|448707047|FG001|Phase II|Disease progression|0|||
124749764|NCT01959139|448707048|FG002|Phase II|Disease progression|26|||
124749765|NCT01959139|448707049|FG003|Phase II|Disease progression|34|||
124749766|NCT01959139|448707046|FG000|Phase II|Adverse Event|0|||
124749767|NCT01959139|448707047|FG001|Phase II|Adverse Event|0|||
124749768|NCT01959139|448707048|FG002|Phase II|Adverse Event|10|||
124749769|NCT01959139|448707049|FG003|Phase II|Adverse Event|11|||
124749770|NCT01959139|448707046|FG000|Phase II|Patient Refusal|0|||
124749771|NCT01959139|448707047|FG001|Phase II|Patient Refusal|0|||
124749772|NCT01959139|448707048|FG002|Phase II|Patient Refusal|5|||
124749773|NCT01959139|448707049|FG003|Phase II|Patient Refusal|4|||
124749774|NCT01959139|448707046|FG000|Phase II|Death|0|||
124749775|NCT01959139|448707047|FG001|Phase II|Death|0|||
124749776|NCT01959139|448707048|FG002|Phase II|Death|3|||
124749777|NCT01959139|448707049|FG003|Phase II|Death|1|||
124749778|NCT01959139|448707046|FG000|Phase II|Other/Unknown|0|||
124749779|NCT01959139|448707047|FG001|Phase II|Other/Unknown|0|||
124749780|NCT01959139|448707048|FG002|Phase II|Other/Unknown|8|||
124749781|NCT01959139|448707049|FG003|Phase II|Other/Unknown|5|||
124749782|NCT01959139|448707046|FG000|Phase II|On treatment|0|||
124749783|NCT01959139|448707047|FG001|Phase II|On treatment|0|||
124749784|NCT01959139|448707048|FG002|Phase II|On treatment|4|||
124749785|NCT01959139|448707049|FG003|Phase II|On treatment|0|||
124749786|NCT01964963|448707054|FG000|Overall Study|Case Report Forms Uncollected|888|||
124749787|NCT01964963|448707054|FG000|Overall Study|Protocol Deviation|50|||
124749788|NCT01964963|448707054|FG000|Overall Study|Data Reliability was not Assured|5|||
124749789|NCT01235234|448707055|FG000|Overall Study|Adverse Event|2|||
124749790|NCT01235234|448707056|FG001|Overall Study|Adverse Event|2|||
124749791|NCT01235234|448707057|FG002|Overall Study|Adverse Event|1|||
124749792|NCT02352753|448707058|FG000|6-Month Dosing Period|Decision by sponsor|2|||
124749793|NCT02352753|448707058|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
124749794|NCT02352753|448707058|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
124749795|NCT02352753|448707058|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
124749796|NCT02352753|448707058|FG000|3-Month Dosing Period|Decision by sponsor|14|||
124749797|NCT02352753|448707058|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
124749798|NCT01363908|448707061|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
124749799|NCT01363908|448707062|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
124749800|NCT01363908|448707061|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
124749801|NCT01363908|448707062|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
124749802|NCT01363908|448707061|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
124749803|NCT01363908|448707062|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
124749804|NCT01363908|448707061|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
124749805|NCT01363908|448707062|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
124749806|NCT00711971|448707063|FG000|Overall Study|Lost to Follow-up|3|||
124749807|NCT00711971|448707064|FG001|Overall Study|Lost to Follow-up|4|||
124749808|NCT00711971|448707065|FG002|Overall Study|Lost to Follow-up|1|||
124749809|NCT02644343|448707066|FG000|Overall Study|Withdrawal by Subject|1|||
124749810|NCT03437577|448707071|FG000|Pre-Randomization|Withdrawal by Subject|0|||
124749811|NCT03437577|448707072|FG001|Pre-Randomization|Withdrawal by Subject|0|||
124620456|NCT01377012|448226261|FG001|Core Study|No Longer require treatment|0|||
124620457|NCT01377012|448226262|FG002|Core Study|No Longer require treatment|1|||
124620458|NCT01377012|448226260|FG000|Core Study|Lost to Follow-up|7|||
124620459|NCT01377012|448226261|FG001|Core Study|Lost to Follow-up|5|||
124620460|NCT01377012|448226262|FG002|Core Study|Lost to Follow-up|4|||
124620461|NCT01377012|448226260|FG000|Core Study|Lack of Efficacy|41|||
124620462|NCT01377012|448226261|FG001|Core Study|Lack of Efficacy|28|||
124620463|NCT01377012|448226262|FG002|Core Study|Lack of Efficacy|37|||
124620464|NCT01377012|448226260|FG000|Core Study|Death|1|||
124620465|NCT01377012|448226261|FG001|Core Study|Death|1|||
124620466|NCT01377012|448226262|FG002|Core Study|Death|1|||
124620467|NCT01377012|448226260|FG000|Core Study|Adverse Event|10|||
124620468|NCT01377012|448226261|FG001|Core Study|Adverse Event|14|||
124620469|NCT01377012|448226262|FG002|Core Study|Adverse Event|13|||
124620470|NCT01377012|448226260|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
124620471|NCT01377012|448226261|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
124620472|NCT01377012|448226262|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
124620473|NCT01377012|448226260|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
124620474|NCT01377012|448226261|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
124620475|NCT01377012|448226262|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
124620476|NCT01377012|448226260|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
124620477|NCT01377012|448226261|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
124620478|NCT01377012|448226262|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
124620479|NCT01377012|448226260|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
124620480|NCT01377012|448226261|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
124620481|NCT01377012|448226262|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
124620482|NCT01377012|448226260|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
124620483|NCT01377012|448226261|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
124620484|NCT01377012|448226262|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
124620485|NCT01377012|448226260|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
124620486|NCT01377012|448226261|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
124620487|NCT01377012|448226262|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
124620488|NCT04380961|448226265|FG000|Overall Study|Lost to Follow-up|17|||
124620489|NCT04380961|448226266|FG001|Overall Study|Lost to Follow-up|11|||
124620490|NCT04380961|448226265|FG000|Overall Study|Withdrawal by Subject|3|||
124620491|NCT04380961|448226266|FG001|Overall Study|Withdrawal by Subject|0|||
124620492|NCT04380961|448226265|FG000|Overall Study|Death|22|||
124620493|NCT04380961|448226266|FG001|Overall Study|Death|16|||
124620494|NCT04380961|448226265|FG000|Overall Study|Other|1|||
124620495|NCT04380961|448226266|FG001|Overall Study|Other|0|||
124620496|NCT04380961|448226265|FG000|Overall Study|Randomized but Not Treated|1|||
124620497|NCT04380961|448226266|FG001|Overall Study|Randomized but Not Treated|2|||
124620498|NCT00805961|448226267|FG000|Modality Therapy|Withdrawal by Subject|1|||
124620499|NCT00805961|448226267|FG000|Modality Therapy|Adverse Event|1|||
124620500|NCT00805961|448226267|FG000|Modality Therapy|Disease Progression|2|||
124620501|NCT00805961|448226267|FG000|Treatment-Free Interval|Adverse Event|3|||
124620502|NCT00805961|448226267|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
124620503|NCT00805961|448226267|FG000|Treatment-Free Interval|Physician Decision|1|||
124620504|NCT00805961|448226267|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
124620505|NCT00805961|448226267|FG000|Maintenance Treatment|Lack of Efficacy|13|||
124620506|NCT00805961|448226267|FG000|Maintenance Treatment|Intercurrent Illness|7|||
124620507|NCT00805961|448226267|FG000|Maintenance Treatment|Adverse Event|6|||
124620508|NCT00805961|448226267|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
124620509|NCT00805961|448226267|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
124620510|NCT00805961|448226267|FG000|Maintenance Treatment|Withdrawn Consent|1|||
124620511|NCT01862484|448226268|FG000|Overall Study|Lack of Efficacy|1|||
124620512|NCT01862484|448226269|FG001|Overall Study|Lack of Efficacy|1|||
124620513|NCT01862484|448226268|FG000|Overall Study|Lost to Follow-up|1|||
124620514|NCT01862484|448226269|FG001|Overall Study|Lost to Follow-up|2|||
124620515|NCT01862484|448226268|FG000|Overall Study|Protocol Violation|0|||
124620516|NCT01862484|448226269|FG001|Overall Study|Protocol Violation|2|||
124620517|NCT01862484|448226268|FG000|Overall Study|Withdrawal by Subject|0|||
124620518|NCT01862484|448226269|FG001|Overall Study|Withdrawal by Subject|3|||
124620519|NCT01632280|448226270|FG000|Overall Study|Withdrawal by Subject|1|||
124620520|NCT01632280|448226271|FG001|Overall Study|Withdrawal by Subject|0|||
124620521|NCT00993421|448226272|FG000|Overall Study|Adverse Event|2|||
124620522|NCT00993421|448226273|FG001|Overall Study|Adverse Event|7|||
124620523|NCT00993421|448226274|FG002|Overall Study|Adverse Event|6|||
124620524|NCT00993421|448226275|FG003|Overall Study|Adverse Event|9|||
124620525|NCT00993421|448226276|FG004|Overall Study|Adverse Event|5|||
124620526|NCT00993421|448226277|FG005|Overall Study|Adverse Event|7|||
124620527|NCT00993421|448226278|FG006|Overall Study|Adverse Event|1|||
124620528|NCT00993421|448226272|FG000|Overall Study|Sponsor Decision|36|||
124620529|NCT00993421|448226273|FG001|Overall Study|Sponsor Decision|31|||
124620530|NCT00993421|448226274|FG002|Overall Study|Sponsor Decision|28|||
124620531|NCT00993421|448226275|FG003|Overall Study|Sponsor Decision|30|||
124749812|NCT03437577|448707073|FG002|Pre-Randomization|Withdrawal by Subject|10|||
124749813|NCT03437577|448707071|FG000|Post-Randomization|Physician Decision|0|||
124749814|NCT03437577|448707072|FG001|Post-Randomization|Physician Decision|2|||
124749815|NCT03437577|448707073|FG002|Post-Randomization|Physician Decision|0|||
124749816|NCT00536471|448707074|FG000|Overall Study|Lost to Follow-up|48|||
124749817|NCT00536471|448707075|FG001|Overall Study|Lost to Follow-up|23|||
124749818|NCT00536471|448707076|FG002|Overall Study|Lost to Follow-up|48|||
124749819|NCT00536471|448707077|FG003|Overall Study|Lost to Follow-up|22|||
124749820|NCT00536471|448707074|FG000|Overall Study|Adverse Event|32|||
124749821|NCT00536471|448707075|FG001|Overall Study|Adverse Event|16|||
124749822|NCT00536471|448707076|FG002|Overall Study|Adverse Event|28|||
124749823|NCT00536471|448707077|FG003|Overall Study|Adverse Event|13|||
124749824|NCT00536471|448707074|FG000|Overall Study|Withdrawal by Subject|40|||
124749825|NCT00536471|448707075|FG001|Overall Study|Withdrawal by Subject|24|||
124749826|NCT00536471|448707076|FG002|Overall Study|Withdrawal by Subject|43|||
124749827|NCT00536471|448707077|FG003|Overall Study|Withdrawal by Subject|21|||
124749828|NCT00536471|448707074|FG000|Overall Study|Lack of Efficacy|17|||
124749829|NCT00536471|448707075|FG001|Overall Study|Lack of Efficacy|18|||
124749830|NCT00536471|448707076|FG002|Overall Study|Lack of Efficacy|11|||
124749831|NCT00536471|448707077|FG003|Overall Study|Lack of Efficacy|9|||
124749832|NCT00536471|448707074|FG000|Overall Study|Protocol Violation|8|||
124749833|NCT00536471|448707075|FG001|Overall Study|Protocol Violation|1|||
124749834|NCT00536471|448707076|FG002|Overall Study|Protocol Violation|2|||
124749835|NCT00536471|448707077|FG003|Overall Study|Protocol Violation|3|||
124749836|NCT00536471|448707074|FG000|Overall Study|Physician Decision|11|||
124749837|NCT00536471|448707075|FG001|Overall Study|Physician Decision|1|||
124749838|NCT00536471|448707076|FG002|Overall Study|Physician Decision|3|||
124749839|NCT00536471|448707077|FG003|Overall Study|Physician Decision|2|||
124749840|NCT00536471|448707074|FG000|Overall Study|Death|0|||
124749841|NCT00536471|448707075|FG001|Overall Study|Death|0|||
124749842|NCT00536471|448707076|FG002|Overall Study|Death|1|||
124749843|NCT00536471|448707077|FG003|Overall Study|Death|2|||
124749844|NCT00536471|448707074|FG000|Overall Study|Sponsor Decision|0|||
124749845|NCT00536471|448707075|FG001|Overall Study|Sponsor Decision|1|||
124749846|NCT00536471|448707076|FG002|Overall Study|Sponsor Decision|3|||
124749847|NCT00536471|448707077|FG003|Overall Study|Sponsor Decision|2|||
124749848|NCT04774926|448707086|FG000|Overall Study|Adverse Event|15|||
124782913|NCT05661851|448834359|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
124782914|NCT05661851|448834360|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
124782915|NCT01014910|448834361|FG000|Overall Study|Withdrawal by Subject|0|||
124782916|NCT01014910|448834362|FG001|Overall Study|Withdrawal by Subject|2|||
124782917|NCT00612807|448834363|FG000|Overall Study|Withdrawal by Subject|2|||
124782918|NCT00612807|448834364|FG001|Overall Study|Withdrawal by Subject|0|||
124782919|NCT02252939|448834365|FG000|Overall Study|Lost to Follow-up|3|||
124749849|NCT04774926|448707086|FG000|Overall Study|Lost to Follow-up|3|||
124749850|NCT04774926|448707086|FG000|Overall Study|Physician Decision|6|||
124749851|NCT04774926|448707086|FG000|Overall Study|Withdrawal by Subject|3|||
124749852|NCT04774926|448707086|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
124749853|NCT01440816|448707089|FG000|Overall Study|Disease Progression|0|||
124749854|NCT01440816|448707090|FG001|Overall Study|Disease Progression|9|||
124749855|NCT01440816|448707089|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
124749856|NCT01440816|448707090|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
124749857|NCT01687101|448707091|FG000|Overall Study|Lost to Follow-up|7|||
124782920|NCT00870584|448834369|FG000|Overall Study|Adverse Event|3|||
124782921|NCT00870584|448834370|FG001|Overall Study|Adverse Event|3|||
124782922|NCT00870584|448834369|FG000|Overall Study|Withdrawal by Subject|6|||
124749858|NCT03250182|448707094|FG000|Overall Study|Withdrawal by Subject|1|||
124749859|NCT01858740|448707095|FG000|Overall Study|Death|4|||
124749860|NCT00894361|448707102|FG000|Overall Study|deaths and less than 2 years followup|24|||
124749861|NCT00894361|448707103|FG001|Overall Study|deaths and less than 2 years followup|64|||
124749862|NCT04207060|448707108|FG000|Overall Study|Lost to Follow-up|2|||
124749863|NCT04207060|448707109|FG001|Overall Study|Lost to Follow-up|0|||
124749864|NCT02718716|448707111|FG000|Overall Study|Lack of Efficacy|1|||
124749865|NCT02718716|448707112|FG001|Overall Study|Lack of Efficacy|0|||
124749866|NCT02718716|448707113|FG002|Overall Study|Lack of Efficacy|0|||
124749867|NCT02718716|448707114|FG003|Overall Study|Lack of Efficacy|0|||
124749868|NCT02718716|448707115|FG004|Overall Study|Lack of Efficacy|0|||
124749869|NCT00296140|448707119|FG000|Overall Study|Lost to Follow-up|1|||
124749870|NCT00296140|448707120|FG001|Overall Study|Lost to Follow-up|0|||
124782923|NCT00870584|448834370|FG001|Overall Study|Withdrawal by Subject|7|||
124749871|NCT00296140|448707119|FG000|Overall Study|Withdrawal by Subject|1|||
124749872|NCT00296140|448707120|FG001|Overall Study|Withdrawal by Subject|0|||
124749873|NCT00296140|448707119|FG000|Overall Study|Discharge to Nursing Home|1|||
124749874|NCT00296140|448707120|FG001|Overall Study|Discharge to Nursing Home|0|||
124749875|NCT01856582|448707121|FG000|Overall Study|Died prior to Boost infusion|1|||
124782924|NCT00870584|448834369|FG000|Overall Study|Lost to Follow-up|5|||
124782925|NCT00870584|448834370|FG001|Overall Study|Lost to Follow-up|1|||
124749876|NCT03245398|448707126|FG000|Overall Study|Travelled to another island|1|||
124749877|NCT03245398|448707127|FG001|Overall Study|Travelled to another island|0|||
124749878|NCT00596830|448707130|FG000|Overall Study|Death|258|||
124749879|NCT00596830|448707131|FG001|Overall Study|Death|247|||
124749880|NCT00596830|448707130|FG000|Overall Study|Lost to Follow-up|7|||
124749881|NCT00596830|448707131|FG001|Overall Study|Lost to Follow-up|11|||
124749882|NCT00596830|448707130|FG000|Overall Study|Withdrawal by Subject|22|||
124749883|NCT00596830|448707131|FG001|Overall Study|Withdrawal by Subject|12|||
124749884|NCT00596830|448707130|FG000|Overall Study|Study terminated by sponsor|51|||
124749885|NCT00596830|448707131|FG001|Overall Study|Study terminated by sponsor|62|||
124749886|NCT00596830|448707130|FG000|Overall Study|Follow-up was discontinued|1|||
124749887|NCT00596830|448707131|FG001|Overall Study|Follow-up was discontinued|0|||
124749888|NCT00596830|448707130|FG000|Overall Study|Randomized but not treated|3|||
124749889|NCT00596830|448707131|FG001|Overall Study|Randomized but not treated|7|||
124749890|NCT00887926|448707132|FG000|Overall Study|Withdrawal by Subject|0|||
124749891|NCT00887926|448707133|FG001|Overall Study|Withdrawal by Subject|1|||
124749892|NCT00887926|448707134|FG002|Overall Study|Withdrawal by Subject|0|||
124749893|NCT00887926|448707135|FG003|Overall Study|Withdrawal by Subject|0|||
124749894|NCT00880191|448707136|FG000|Overall Study|Refused further treatment|4|||
124749895|NCT00880191|448707137|FG001|Overall Study|Refused further treatment|1|||
124749896|NCT00880191|448707136|FG000|Overall Study|Adverse Event|8|||
124749897|NCT00880191|448707137|FG001|Overall Study|Adverse Event|6|||
124749898|NCT00880191|448707136|FG000|Overall Study|Hospitalization/efficacy|1|||
124749899|NCT00880191|448707137|FG001|Overall Study|Hospitalization/efficacy|1|||
124749900|NCT02097030|448707138|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
124749901|NCT02097030|448707139|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
124749902|NCT02097030|448707138|FG000|First Intervention (3 Days)|Visual Acuity|0|||
124749903|NCT02097030|448707139|FG001|First Intervention (3 Days)|Visual Acuity|1|||
124749904|NCT01919801|448707140|FG000|Overall Study|Withdrawal by Subject|1|||
124749905|NCT01919801|448707141|FG001|Overall Study|Withdrawal by Subject|0|||
124749906|NCT01919801|448707140|FG000|Overall Study|Physician Decision|0|||
124749907|NCT01919801|448707141|FG001|Overall Study|Physician Decision|1|||
124749908|NCT01919801|448707140|FG000|Overall Study|Lost to Follow-up|0|||
124749909|NCT01919801|448707141|FG001|Overall Study|Lost to Follow-up|1|||
124749910|NCT01919801|448707140|FG000|Overall Study|Other|0|||
124749911|NCT01919801|448707141|FG001|Overall Study|Other|1|||
124749912|NCT01843062|448707142|FG000|Overall Study|Protocol Violation|1|||
124749913|NCT01843062|448707143|FG001|Overall Study|Protocol Violation|0|||
124749914|NCT01843062|448707142|FG000|Overall Study|New treatment following progression|2|||
124749915|NCT01843062|448707143|FG001|Overall Study|New treatment following progression|0|||
124749916|NCT01843062|448707142|FG000|Overall Study|Pregnancy|1|||
124749917|NCT01843062|448707143|FG001|Overall Study|Pregnancy|0|||
124749918|NCT01843062|448707142|FG000|Overall Study|Adverse Event|2|||
124749919|NCT01843062|448707143|FG001|Overall Study|Adverse Event|0|||
124749920|NCT01843062|448707142|FG000|Overall Study|Incorrect randomisation|1|||
124749921|NCT01843062|448707143|FG001|Overall Study|Incorrect randomisation|0|||
124749922|NCT01843062|448707142|FG000|Overall Study|Withdrawal by Subject|12|||
124749923|NCT01843062|448707143|FG001|Overall Study|Withdrawal by Subject|3|||
124749924|NCT01843062|448707142|FG000|Overall Study|Death|1|||
124749925|NCT01843062|448707143|FG001|Overall Study|Death|2|||
124749926|NCT01843062|448707142|FG000|Overall Study|Lost to Follow-up|2|||
124749927|NCT01843062|448707143|FG001|Overall Study|Lost to Follow-up|4|||
124749928|NCT01677858|448707144|FG000|Overall Study|Adverse Event|0|||
124749929|NCT01677858|448707145|FG001|Overall Study|Adverse Event|0|||
124749930|NCT01677858|448707146|FG002|Overall Study|Adverse Event|2|||
124749931|NCT01677858|448707147|FG003|Overall Study|Adverse Event|3|||
124749932|NCT01677858|448707148|FG004|Overall Study|Adverse Event|13|||
124749933|NCT01677858|448707144|FG000|Overall Study|Death|0|||
124749934|NCT01677858|448707145|FG001|Overall Study|Death|0|||
124749935|NCT01677858|448707146|FG002|Overall Study|Death|0|||
124749936|NCT01677858|448707147|FG003|Overall Study|Death|0|||
124749937|NCT01677858|448707148|FG004|Overall Study|Death|1|||
124749938|NCT01677858|448707144|FG000|Overall Study|Physician Decision|1|||
124749939|NCT01677858|448707145|FG001|Overall Study|Physician Decision|0|||
124749940|NCT01677858|448707146|FG002|Overall Study|Physician Decision|2|||
124749941|NCT01677858|448707147|FG003|Overall Study|Physician Decision|0|||
124782926|NCT00870584|448834369|FG000|Overall Study|Protocol Deviation|2|||
124782927|NCT00870584|448834370|FG001|Overall Study|Protocol Deviation|2|||
124749942|NCT01677858|448707148|FG004|Overall Study|Physician Decision|12|||
124749943|NCT01677858|448707144|FG000|Overall Study|Progressive Disease|2|||
124749944|NCT01677858|448707145|FG001|Overall Study|Progressive Disease|1|||
124749945|NCT01677858|448707146|FG002|Overall Study|Progressive Disease|9|||
124620532|NCT00993421|448226276|FG004|Overall Study|Sponsor Decision|38|||
124749946|NCT01677858|448707147|FG003|Overall Study|Progressive Disease|3|||
124749947|NCT01677858|448707148|FG004|Overall Study|Progressive Disease|43|||
124749948|NCT01677858|448707144|FG000|Overall Study|Withdrawal by Subject|0|||
124749949|NCT01677858|448707145|FG001|Overall Study|Withdrawal by Subject|1|||
124749950|NCT01677858|448707146|FG002|Overall Study|Withdrawal by Subject|1|||
124749951|NCT01677858|448707147|FG003|Overall Study|Withdrawal by Subject|0|||
124749952|NCT01677858|448707148|FG004|Overall Study|Withdrawal by Subject|15|||
124749953|NCT01677858|448707144|FG000|Overall Study|Lost to Follow-up|0|||
124749954|NCT01677858|448707145|FG001|Overall Study|Lost to Follow-up|0|||
124749955|NCT01677858|448707146|FG002|Overall Study|Lost to Follow-up|0|||
124749956|NCT01677858|448707147|FG003|Overall Study|Lost to Follow-up|0|||
124749957|NCT01677858|448707148|FG004|Overall Study|Lost to Follow-up|1|||
124749958|NCT00773747|448707149|FG000|Overall Study|Lack of Efficacy|112|||
124749959|NCT00773747|448707150|FG001|Overall Study|Lack of Efficacy|144|||
124749960|NCT00773747|448707149|FG000|Overall Study|Physician Decision|26|||
124749961|NCT00773747|448707150|FG001|Overall Study|Physician Decision|18|||
124749962|NCT00773747|448707149|FG000|Overall Study|Lost to Follow-up|0|||
124749963|NCT00773747|448707150|FG001|Overall Study|Lost to Follow-up|1|||
124749964|NCT00773747|448707149|FG000|Overall Study|Protocol Violation|2|||
124749965|NCT00773747|448707150|FG001|Overall Study|Protocol Violation|2|||
124749966|NCT00773747|448707149|FG000|Overall Study|Withdrawal by Subject|89|||
124749967|NCT00773747|448707150|FG001|Overall Study|Withdrawal by Subject|61|||
124749968|NCT00773747|448707149|FG000|Overall Study|Adverse Event|61|||
124749969|NCT00773747|448707150|FG001|Overall Study|Adverse Event|62|||
124749970|NCT00773747|448707149|FG000|Overall Study|Death|5|||
124749971|NCT00773747|448707150|FG001|Overall Study|Death|8|||
124749972|NCT00773747|448707149|FG000|Overall Study|Not Treated|2|||
124749973|NCT00773747|448707150|FG001|Overall Study|Not Treated|0|||
124749974|NCT02669212|448707153|FG000|Overall Study|Lost to Follow-up|1|||
124749975|NCT02669212|448707154|FG001|Overall Study|Lost to Follow-up|0|||
124749976|NCT02669212|448707153|FG000|Overall Study|Medical Condition|3|||
124749977|NCT02669212|448707154|FG001|Overall Study|Medical Condition|4|||
124749978|NCT02669212|448707153|FG000|Overall Study|Withdrawal by Subject|0|||
124749979|NCT02669212|448707154|FG001|Overall Study|Withdrawal by Subject|2|||
124749980|NCT02669212|448707153|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
124749981|NCT02669212|448707154|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
124749982|NCT03549104|448707155|FG000|Overall Study|Withdrawal by Subject|5|||
124749983|NCT03549104|448707156|FG001|Overall Study|Withdrawal by Subject|2|||
124749984|NCT03549104|448707155|FG000|Overall Study|Covid shelter in place|1|||
124749985|NCT03549104|448707156|FG001|Overall Study|Covid shelter in place|2|||
124749986|NCT04869358|448707157|FG000|Overall Study|Wish to have children.|1|||
124749987|NCT04869358|448707158|FG001|Overall Study|Wish to have children.|0|||
124749988|NCT04869358|448707159|FG002|Overall Study|Wish to have children.|0|||
124749989|NCT04869358|448707160|FG003|Overall Study|Wish to have children.|0|||
124749990|NCT04164732|448707161|FG000|Treatment run-in Period|Adverse Event|4|||
124749991|NCT04164732|448707162|FG001|Treatment run-in Period|Adverse Event|0|||
124749992|NCT04164732|448707163|FG002|Treatment run-in Period|Adverse Event|0|||
124749993|NCT04164732|448707161|FG000|Treatment run-in Period|Physician Decision|1|||
124749994|NCT04164732|448707162|FG001|Treatment run-in Period|Physician Decision|0|||
124749995|NCT04164732|448707163|FG002|Treatment run-in Period|Physician Decision|0|||
124749996|NCT04164732|448707161|FG000|Treatment run-in Period|Screen Failure|1|||
124749997|NCT04164732|448707162|FG001|Treatment run-in Period|Screen Failure|0|||
124749998|NCT04164732|448707163|FG002|Treatment run-in Period|Screen Failure|0|||
124749999|NCT04164732|448707161|FG000|Randomized Treatment Period|Adverse Event|0|||
124750000|NCT04164732|448707162|FG001|Randomized Treatment Period|Adverse Event|1|||
124750001|NCT04164732|448707163|FG002|Randomized Treatment Period|Adverse Event|0|||
124750002|NCT04164732|448707161|FG000|Randomized Treatment Period|Protocol Deviation|0|||
124750003|NCT04164732|448707162|FG001|Randomized Treatment Period|Protocol Deviation|1|||
124750004|NCT04164732|448707163|FG002|Randomized Treatment Period|Protocol Deviation|1|||
124750005|NCT04164732|448707161|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
124750006|NCT04164732|448707162|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
124750007|NCT04164732|448707163|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
124750008|NCT01844778|448707169|FG000|Overall Study|Protocol deviation|0|||
124750009|NCT01844778|448707170|FG001|Overall Study|Protocol deviation|1|||
124750010|NCT01844778|448707171|FG002|Overall Study|Protocol deviation|2|||
124750011|NCT01844778|448707169|FG000|Overall Study|Withdrawal by Subject|2|||
124750012|NCT01844778|448707170|FG001|Overall Study|Withdrawal by Subject|0|||
124750013|NCT01844778|448707171|FG002|Overall Study|Withdrawal by Subject|0|||
124750014|NCT01844778|448707169|FG000|Overall Study|Adverse Event|0|||
124750015|NCT01844778|448707170|FG001|Overall Study|Adverse Event|2|||
124750016|NCT01844778|448707171|FG002|Overall Study|Adverse Event|2|||
124750017|NCT02951429|448707177|FG000|Overall Study|Adverse Event|3|||
124750018|NCT02951429|448707178|FG001|Overall Study|Adverse Event|7|||
124750019|NCT02951429|448707177|FG000|Overall Study|Death|28|||
124750020|NCT02951429|448707178|FG001|Overall Study|Death|36|||
124750021|NCT02951429|448707177|FG000|Overall Study|Lack of Efficacy|0|||
124750022|NCT02951429|448707178|FG001|Overall Study|Lack of Efficacy|1|||
124750023|NCT02951429|448707177|FG000|Overall Study|Lost to Follow-up|0|||
124750024|NCT02951429|448707178|FG001|Overall Study|Lost to Follow-up|1|||
124620533|NCT00993421|448226277|FG005|Overall Study|Sponsor Decision|30|||
124750025|NCT02951429|448707177|FG000|Overall Study|Lung Transplantation|9|||
124782928|NCT01497366|448834371|FG000|Overall Study|Virologic failure|2|||
124620534|NCT00993421|448226278|FG006|Overall Study|Sponsor Decision|29|||
124620535|NCT00993421|448226272|FG000|Overall Study|Lost to Follow-up|3|||
124750026|NCT02951429|448707178|FG001|Overall Study|Lung Transplantation|6|||
124750027|NCT02951429|448707177|FG000|Overall Study|Other|1|||
124750028|NCT02951429|448707178|FG001|Overall Study|Other|3|||
124750029|NCT02951429|448707177|FG000|Overall Study|Progressive Disease|1|||
124750030|NCT02951429|448707178|FG001|Overall Study|Progressive Disease|1|||
124750031|NCT02951429|448707177|FG000|Overall Study|Withdrawal by Subject|7|||
124750032|NCT02951429|448707178|FG001|Overall Study|Withdrawal by Subject|11|||
124750033|NCT02951429|448707177|FG000|Overall Study|Participant ongoing in the study|23|||
124750034|NCT02951429|448707178|FG001|Overall Study|Participant ongoing in the study|17|||
124750035|NCT01620528|448707179|FG000|Treatment Period|Did Not Receive Study Drug|0|||
124750036|NCT01620528|448707180|FG001|Treatment Period|Did Not Receive Study Drug|0|||
124750037|NCT01620528|448707181|FG002|Treatment Period|Did Not Receive Study Drug|1|||
124750038|NCT01620528|448707179|FG000|Treatment Period|Withdrawal by Subject|35|||
124750039|NCT01620528|448707180|FG001|Treatment Period|Withdrawal by Subject|21|||
124750040|NCT01620528|448707181|FG002|Treatment Period|Withdrawal by Subject|16|||
124750041|NCT01620528|448707179|FG000|Treatment Period|Adverse Event|17|||
124750042|NCT01620528|448707180|FG001|Treatment Period|Adverse Event|13|||
124750043|NCT01620528|448707181|FG002|Treatment Period|Adverse Event|21|||
124750044|NCT01620528|448707179|FG000|Treatment Period|Lost to Follow-up|16|||
124750045|NCT01620528|448707180|FG001|Treatment Period|Lost to Follow-up|8|||
124750046|NCT01620528|448707181|FG002|Treatment Period|Lost to Follow-up|14|||
124750047|NCT01620528|448707179|FG000|Treatment Period|Other|9|||
124750048|NCT01620528|448707180|FG001|Treatment Period|Other|5|||
124750049|NCT01620528|448707181|FG002|Treatment Period|Other|7|||
124750050|NCT01620528|448707179|FG000|Treatment Period|Subject Noncompliant|11|||
124750051|NCT01620528|448707180|FG001|Treatment Period|Subject Noncompliant|2|||
124750052|NCT01620528|448707181|FG002|Treatment Period|Subject Noncompliant|2|||
124750053|NCT01620528|448707179|FG000|Treatment Period|Pregnancy|7|||
124750054|NCT01620528|448707180|FG001|Treatment Period|Pregnancy|2|||
124750055|NCT01620528|448707181|FG002|Treatment Period|Pregnancy|2|||
124750056|NCT01620528|448707179|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
124750057|NCT01620528|448707180|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
124750058|NCT01620528|448707181|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
124750059|NCT01620528|448707179|FG000|Treatment Period|Exclusionary Medication Received|0|||
124750060|NCT01620528|448707180|FG001|Treatment Period|Exclusionary Medication Received|1|||
124750061|NCT01620528|448707181|FG002|Treatment Period|Exclusionary Medication Received|0|||
124750062|NCT01620528|448707179|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
124750063|NCT01620528|448707180|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
124750064|NCT01620528|448707181|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
124750065|NCT01620528|448707179|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
124750066|NCT01620528|448707180|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
124750067|NCT01620528|448707181|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
124750068|NCT01620528|448707179|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
124750069|NCT01620528|448707180|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
124750070|NCT01620528|448707181|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
124750071|NCT01620528|448707179|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
124750072|NCT01620528|448707180|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
124750073|NCT01620528|448707181|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
124750074|NCT01620528|448707179|FG000|Post-Treatment Follow-Up Period|Other|6|||
124750075|NCT01620528|448707180|FG001|Post-Treatment Follow-Up Period|Other|4|||
124750076|NCT01620528|448707181|FG002|Post-Treatment Follow-Up Period|Other|2|||
124750077|NCT01457846|448707182|FG000|Overall Study|Death before treatment|1|||
124750078|NCT01457846|448707183|FG001|Overall Study|Death before treatment|2|||
124750079|NCT01457846|448707182|FG000|Overall Study|Did not receive treatment|0|||
124750080|NCT01457846|448707183|FG001|Overall Study|Did not receive treatment|1|||
124750081|NCT01457846|448707182|FG000|Overall Study|Death|27|||
124750082|NCT01457846|448707183|FG001|Overall Study|Death|16|||
124750083|NCT01457846|448707182|FG000|Overall Study|Unclassified reason for not completed|11|||
124750084|NCT01457846|448707183|FG001|Overall Study|Unclassified reason for not completed|10|||
124750085|NCT01457846|448707182|FG000|Overall Study|Withdrawal by Subject|1|||
124750086|NCT01457846|448707183|FG001|Overall Study|Withdrawal by Subject|1|||
124750087|NCT01457846|448707182|FG000|Overall Study|Lost to Follow-up|1|||
124750088|NCT01457846|448707183|FG001|Overall Study|Lost to Follow-up|0|||
124750089|NCT01743040|448707184|FG000|Overall Study|Death|1|||
124750090|NCT01743040|448707184|FG000|Overall Study|Lost to Follow-up|66|||
124750091|NCT01743040|448707184|FG000|Overall Study|Physician Decision|40|||
124750092|NCT01743040|448707184|FG000|Overall Study|Protocol Violation|1|||
124750093|NCT01743040|448707184|FG000|Overall Study|Withdrawal by Subject|121|||
124750094|NCT02974842|448707185|FG000|Overall Study|Withdrawal by Subject|4|||
124750095|NCT02974842|448707185|FG000|Overall Study|Screen failures|4|||
124750096|NCT02006979|448707186|FG000|Overall Study|Withdrawal by Subject|1|||
124750097|NCT02006979|448707187|FG001|Overall Study|Withdrawal by Subject|1|||
124750098|NCT02006979|448707186|FG000|Overall Study|Protocol Violation|0|||
124750099|NCT02006979|448707187|FG001|Overall Study|Protocol Violation|1|||
124750100|NCT04167137|448707188|FG000|Overall Study|Disease progression|1|||
124750101|NCT04167137|448707189|FG001|Overall Study|Disease progression|1|||
124750102|NCT04167137|448707190|FG002|Overall Study|Disease progression|3|||
124750103|NCT04167137|448707191|FG003|Overall Study|Disease progression|3|||
124750104|NCT04167137|448707192|FG004|Overall Study|Disease progression|2|||
124750105|NCT04167137|448707193|FG005|Overall Study|Disease progression|3|||
124750106|NCT04167137|448707194|FG006|Overall Study|Disease progression|2|||
124750107|NCT04167137|448707195|FG007|Overall Study|Disease progression|2|||
124750108|NCT04167137|448707188|FG000|Overall Study|Withdrawal by Subject|1|||
124750109|NCT04167137|448707189|FG001|Overall Study|Withdrawal by Subject|0|||
124750110|NCT04167137|448707190|FG002|Overall Study|Withdrawal by Subject|0|||
124750111|NCT04167137|448707191|FG003|Overall Study|Withdrawal by Subject|1|||
124750112|NCT04167137|448707192|FG004|Overall Study|Withdrawal by Subject|0|||
124750113|NCT04167137|448707193|FG005|Overall Study|Withdrawal by Subject|2|||
124750114|NCT04167137|448707194|FG006|Overall Study|Withdrawal by Subject|1|||
124750115|NCT04167137|448707195|FG007|Overall Study|Withdrawal by Subject|0|||
124750116|NCT04167137|448707188|FG000|Overall Study|Adverse Event|0|||
124750117|NCT04167137|448707189|FG001|Overall Study|Adverse Event|0|||
124750118|NCT04167137|448707190|FG002|Overall Study|Adverse Event|0|||
124750119|NCT04167137|448707191|FG003|Overall Study|Adverse Event|0|||
124750120|NCT04167137|448707192|FG004|Overall Study|Adverse Event|0|||
124750121|NCT04167137|448707193|FG005|Overall Study|Adverse Event|1|||
124750122|NCT04167137|448707194|FG006|Overall Study|Adverse Event|0|||
124750123|NCT04167137|448707195|FG007|Overall Study|Adverse Event|1|||
124750124|NCT04167137|448707188|FG000|Overall Study|Physician Decision|0|||
124750125|NCT04167137|448707189|FG001|Overall Study|Physician Decision|0|||
124750126|NCT04167137|448707190|FG002|Overall Study|Physician Decision|0|||
124750127|NCT04167137|448707191|FG003|Overall Study|Physician Decision|1|||
124750128|NCT04167137|448707192|FG004|Overall Study|Physician Decision|0|||
124750129|NCT04167137|448707193|FG005|Overall Study|Physician Decision|0|||
124750130|NCT04167137|448707194|FG006|Overall Study|Physician Decision|1|||
124750131|NCT04167137|448707195|FG007|Overall Study|Physician Decision|0|||
124750132|NCT04167137|448707188|FG000|Overall Study|Death|0|||
124750133|NCT04167137|448707189|FG001|Overall Study|Death|1|||
124750134|NCT04167137|448707190|FG002|Overall Study|Death|0|||
124750135|NCT04167137|448707191|FG003|Overall Study|Death|0|||
124750136|NCT04167137|448707192|FG004|Overall Study|Death|0|||
124750137|NCT04167137|448707193|FG005|Overall Study|Death|0|||
124750138|NCT04167137|448707194|FG006|Overall Study|Death|0|||
124750139|NCT04167137|448707195|FG007|Overall Study|Death|0|||
124750140|NCT04167137|448707188|FG000|Overall Study|Study terminated by Sponsor|0|||
124750141|NCT04167137|448707189|FG001|Overall Study|Study terminated by Sponsor|0|||
124750142|NCT04167137|448707190|FG002|Overall Study|Study terminated by Sponsor|0|||
124750143|NCT04167137|448707191|FG003|Overall Study|Study terminated by Sponsor|0|||
124750144|NCT04167137|448707192|FG004|Overall Study|Study terminated by Sponsor|0|||
124750145|NCT04167137|448707193|FG005|Overall Study|Study terminated by Sponsor|0|||
124750146|NCT04167137|448707194|FG006|Overall Study|Study terminated by Sponsor|0|||
124750147|NCT04167137|448707195|FG007|Overall Study|Study terminated by Sponsor|1|||
124750148|NCT02467582|448708698|FG000|Allocation|Withdrawal by Subject|1|||
124750149|NCT02467582|448708699|FG001|Allocation|Withdrawal by Subject|0|||
124750150|NCT02467582|448708698|FG000|Follow-up|Death|5|||
124750151|NCT02467582|448708699|FG001|Follow-up|Death|4|||
124750152|NCT02467582|448708698|FG000|Follow-up|Lost to Follow-up|6|||
124750153|NCT02467582|448708699|FG001|Follow-up|Lost to Follow-up|5|||
124750154|NCT01370265|448708700|FG000|First Intervention|Adverse Event|1|||
124750155|NCT01370265|448708701|FG001|First Intervention|Adverse Event|1|||
124750156|NCT02611817|448708702|FG000|Open-label Induction Phase|Reason not Specified|9|||
124750157|NCT02611817|448708703|FG001|Open-label Induction Phase|Reason not Specified|0|||
124750158|NCT02611817|448708704|FG002|Open-label Induction Phase|Reason not Specified|0|||
124750159|NCT02611817|448708702|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
124750160|NCT02611817|448708703|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
124750161|NCT02611817|448708704|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
124750162|NCT02611817|448708702|FG000|Open-label Induction Phase|Pregnancy|1|||
124750163|NCT02611817|448708703|FG001|Open-label Induction Phase|Pregnancy|0|||
124750164|NCT02611817|448708704|FG002|Open-label Induction Phase|Pregnancy|0|||
124750165|NCT02611817|448708702|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
124750166|NCT02611817|448708703|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
124750167|NCT02611817|448708704|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
124750168|NCT02611817|448708702|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
124750169|NCT02611817|448708703|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
124750170|NCT02611817|448708704|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
124750171|NCT02611817|448708702|FG000|Open-label Induction Phase|Protocol Violation|5|||
124750172|NCT02611817|448708703|FG001|Open-label Induction Phase|Protocol Violation|0|||
124750173|NCT02611817|448708704|FG002|Open-label Induction Phase|Protocol Violation|0|||
124750174|NCT02611817|448708702|FG000|Open-label Induction Phase|Adverse Event|16|||
124750175|NCT02611817|448708703|FG001|Open-label Induction Phase|Adverse Event|0|||
124750176|NCT02611817|448708704|FG002|Open-label Induction Phase|Adverse Event|0|||
124750177|NCT02611817|448708702|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
124620536|NCT00993421|448226273|FG001|Overall Study|Lost to Follow-up|5|||
124620537|NCT00993421|448226274|FG002|Overall Study|Lost to Follow-up|5|||
124620538|NCT00993421|448226275|FG003|Overall Study|Lost to Follow-up|0|||
124620539|NCT00993421|448226276|FG004|Overall Study|Lost to Follow-up|0|||
124620540|NCT00993421|448226277|FG005|Overall Study|Lost to Follow-up|0|||
124620541|NCT00993421|448226278|FG006|Overall Study|Lost to Follow-up|6|||
124620542|NCT00993421|448226272|FG000|Overall Study|Withdrawal by Subject|3|||
124620543|NCT00993421|448226273|FG001|Overall Study|Withdrawal by Subject|2|||
124620544|NCT00993421|448226274|FG002|Overall Study|Withdrawal by Subject|3|||
124620545|NCT00993421|448226275|FG003|Overall Study|Withdrawal by Subject|3|||
124620546|NCT00993421|448226276|FG004|Overall Study|Withdrawal by Subject|3|||
124620547|NCT00993421|448226277|FG005|Overall Study|Withdrawal by Subject|5|||
124620548|NCT00993421|448226278|FG006|Overall Study|Withdrawal by Subject|3|||
124620549|NCT00993421|448226272|FG000|Overall Study|Death|0|||
124620550|NCT00993421|448226273|FG001|Overall Study|Death|0|||
124620551|NCT00993421|448226274|FG002|Overall Study|Death|0|||
124620552|NCT00993421|448226275|FG003|Overall Study|Death|0|||
124620553|NCT00993421|448226276|FG004|Overall Study|Death|0|||
124620554|NCT00993421|448226277|FG005|Overall Study|Death|0|||
124620555|NCT00993421|448226278|FG006|Overall Study|Death|1|||
124620556|NCT00993421|448226272|FG000|Overall Study|Entry Criteria Exclusion|0|||
124620557|NCT00993421|448226273|FG001|Overall Study|Entry Criteria Exclusion|0|||
124620558|NCT00993421|448226274|FG002|Overall Study|Entry Criteria Exclusion|1|||
124620559|NCT00993421|448226275|FG003|Overall Study|Entry Criteria Exclusion|3|||
124620560|NCT00993421|448226276|FG004|Overall Study|Entry Criteria Exclusion|0|||
124620561|NCT00993421|448226277|FG005|Overall Study|Entry Criteria Exclusion|1|||
124620562|NCT00993421|448226278|FG006|Overall Study|Entry Criteria Exclusion|0|||
124620563|NCT00993421|448226272|FG000|Overall Study|Physician Decision|0|||
124620564|NCT00993421|448226273|FG001|Overall Study|Physician Decision|0|||
124620565|NCT00993421|448226274|FG002|Overall Study|Physician Decision|0|||
124620566|NCT00993421|448226275|FG003|Overall Study|Physician Decision|0|||
124620567|NCT00993421|448226276|FG004|Overall Study|Physician Decision|0|||
124620568|NCT00993421|448226277|FG005|Overall Study|Physician Decision|1|||
124620569|NCT00993421|448226278|FG006|Overall Study|Physician Decision|1|||
124620570|NCT00993421|448226272|FG000|Overall Study|Protocol Violation|0|||
124620571|NCT00993421|448226273|FG001|Overall Study|Protocol Violation|0|||
124620572|NCT00993421|448226274|FG002|Overall Study|Protocol Violation|0|||
124620573|NCT00993421|448226275|FG003|Overall Study|Protocol Violation|0|||
124620574|NCT00993421|448226276|FG004|Overall Study|Protocol Violation|0|||
124620575|NCT00993421|448226277|FG005|Overall Study|Protocol Violation|2|||
124620576|NCT00993421|448226278|FG006|Overall Study|Protocol Violation|1|||
124620577|NCT03736031|448226280|FG000|Overall Study|Death|2|||
124620578|NCT03736031|448226281|FG001|Overall Study|Death|4|||
124620579|NCT03736031|448226280|FG000|Overall Study|Lost to Follow-up|21|||
124620580|NCT03736031|448226281|FG001|Overall Study|Lost to Follow-up|2|||
124620581|NCT03736031|448226280|FG000|Overall Study|Withdrawal by Subject|9|||
124620582|NCT03736031|448226281|FG001|Overall Study|Withdrawal by Subject|0|||
124620583|NCT02215967|448226282|FG000|Overall Study|Patient became ineligible for treatment|0|||
124620584|NCT02215967|448226283|FG001|Overall Study|Patient became ineligible for treatment|0|||
124620585|NCT02215967|448226284|FG002|Overall Study|Patient became ineligible for treatment|0|||
124620586|NCT02215967|448226285|FG003|Overall Study|Patient became ineligible for treatment|3|||
124620587|NCT02215967|448226282|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
124620588|NCT02215967|448226283|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
124620589|NCT02215967|448226284|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
124620590|NCT02215967|448226285|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
124620591|NCT01954745|448226289|FG000|Overall Study|Radiological Progression|11|||
124620592|NCT01954745|448226289|FG000|Overall Study|Clinical Progression|5|||
124620593|NCT01954745|448226289|FG000|Overall Study|Adverse Event|2|||
124620594|NCT01954745|448226289|FG000|Overall Study|Death|1|||
124620595|NCT00352417|448226290|FG000|Overall Study|Adverse Event|1|||
124620596|NCT00352417|448226291|FG001|Overall Study|Adverse Event|0|||
124620597|NCT00352417|448226290|FG000|Overall Study|Protocol Violation|0|||
124620598|NCT00352417|448226291|FG001|Overall Study|Protocol Violation|2|||
124620599|NCT00352417|448226290|FG000|Overall Study|Withdrawal by Subject|1|||
124620600|NCT00352417|448226291|FG001|Overall Study|Withdrawal by Subject|2|||
124620601|NCT00352417|448226290|FG000|Overall Study|Lost to Follow-up|1|||
124620602|NCT00352417|448226291|FG001|Overall Study|Lost to Follow-up|0|||
124620603|NCT00352417|448226290|FG000|Overall Study|Schedule Change|2|||
124620604|NCT00352417|448226291|FG001|Overall Study|Schedule Change|1|||
124620605|NCT01496976|448227888|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
124620606|NCT05938621|448227889|FG000|Overall Study|Lost to Follow-up|1|||
124620607|NCT05938621|448227890|FG001|Overall Study|Lost to Follow-up|5|||
124620608|NCT05938621|448227891|FG002|Overall Study|Lost to Follow-up|2|||
124620609|NCT05938621|448227892|FG003|Overall Study|Lost to Follow-up|2|||
124620610|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
124620611|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
124620612|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
124620613|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
124750178|NCT02611817|448708703|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
124750179|NCT02611817|448708704|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
124750180|NCT02611817|448708702|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
124750181|NCT02611817|448708703|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
124750182|NCT02611817|448708704|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
124750183|NCT02611817|448708702|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
124750184|NCT02611817|448708703|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
124750185|NCT02611817|448708704|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
124750186|NCT02611817|448708702|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
124750187|NCT02611817|448708703|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
124750188|NCT02611817|448708704|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
124750189|NCT02611817|448708702|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
124750190|NCT02611817|448708703|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
124750191|NCT02611817|448708704|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
124750192|NCT02611817|448708702|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
124750193|NCT02611817|448708703|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
124750194|NCT02611817|448708704|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
124750195|NCT02611817|448708702|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
124750196|NCT02611817|448708703|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
124750197|NCT02611817|448708704|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
124750198|NCT00265317|448708705|FG000|Lead-In|Objective progression or relapse|6|||
124750199|NCT00265317|448708706|FG001|Lead-In|Objective progression or relapse|11|||
124750200|NCT00265317|448708707|FG002|Lead-In|Objective progression or relapse|0|||
124750201|NCT00265317|448708708|FG003|Lead-In|Objective progression or relapse|0|||
124750202|NCT00265317|448708705|FG000|Lead-In|Adverse Event|2|||
124750203|NCT00265317|448708706|FG001|Lead-In|Adverse Event|1|||
124750204|NCT00265317|448708707|FG002|Lead-In|Adverse Event|0|||
124750205|NCT00265317|448708708|FG003|Lead-In|Adverse Event|0|||
124750206|NCT00265317|448708705|FG000|Lead-In|Death|3|||
124750207|NCT00265317|448708706|FG001|Lead-In|Death|5|||
124750208|NCT00265317|448708707|FG002|Lead-In|Death|0|||
124750209|NCT00265317|448708708|FG003|Lead-In|Death|0|||
124750210|NCT00265317|448708705|FG000|Lead-In|Withdrawal/other than adverse event|1|||
124750211|NCT00265317|448708706|FG001|Lead-In|Withdrawal/other than adverse event|0|||
124750212|NCT00265317|448708707|FG002|Lead-In|Withdrawal/other than adverse event|0|||
124750213|NCT00265317|448708708|FG003|Lead-In|Withdrawal/other than adverse event|0|||
124750214|NCT00265317|448708705|FG000|Phase 2|Objective progression or relapse|0|||
124750215|NCT00265317|448708706|FG001|Phase 2|Objective progression or relapse|0|||
124750216|NCT00265317|448708707|FG002|Phase 2|Objective progression or relapse|37|||
124750217|NCT00265317|448708708|FG003|Phase 2|Objective progression or relapse|38|||
124750218|NCT00265317|448708705|FG000|Phase 2|Global deterioration of health status|0|||
124750219|NCT00265317|448708706|FG001|Phase 2|Global deterioration of health status|0|||
124750220|NCT00265317|448708707|FG002|Phase 2|Global deterioration of health status|3|||
124750221|NCT00265317|448708708|FG003|Phase 2|Global deterioration of health status|0|||
124750222|NCT00265317|448708705|FG000|Phase 2|Adverse Event|0|||
124750223|NCT00265317|448708706|FG001|Phase 2|Adverse Event|0|||
124750224|NCT00265317|448708707|FG002|Phase 2|Adverse Event|7|||
124750225|NCT00265317|448708708|FG003|Phase 2|Adverse Event|5|||
124750226|NCT00265317|448708705|FG000|Phase 2|Death|0|||
124750227|NCT00265317|448708706|FG001|Phase 2|Death|0|||
124750228|NCT00265317|448708707|FG002|Phase 2|Death|12|||
124750229|NCT00265317|448708708|FG003|Phase 2|Death|15|||
124750230|NCT00265317|448708705|FG000|Phase 2|Protocol Violation|0|||
124750231|NCT00265317|448708706|FG001|Phase 2|Protocol Violation|0|||
124750232|NCT00265317|448708707|FG002|Phase 2|Protocol Violation|1|||
124750233|NCT00265317|448708708|FG003|Phase 2|Protocol Violation|4|||
124750234|NCT00265317|448708705|FG000|Phase 2|Lost to Follow-up|0|||
124750235|NCT00265317|448708706|FG001|Phase 2|Lost to Follow-up|0|||
124750236|NCT00265317|448708707|FG002|Phase 2|Lost to Follow-up|0|||
124750237|NCT00265317|448708708|FG003|Phase 2|Lost to Follow-up|1|||
124750238|NCT00265317|448708705|FG000|Phase 2|Withdrawal/other than adverse event|0|||
124750239|NCT00265317|448708706|FG001|Phase 2|Withdrawal/other than adverse event|0|||
124750240|NCT00265317|448708707|FG002|Phase 2|Withdrawal/other than adverse event|2|||
124750241|NCT00265317|448708708|FG003|Phase 2|Withdrawal/other than adverse event|1|||
124750242|NCT00265317|448708705|FG000|Phase 2|Study terminated by sponsor|0|||
124750243|NCT00265317|448708706|FG001|Phase 2|Study terminated by sponsor|0|||
124750244|NCT00265317|448708707|FG002|Phase 2|Study terminated by sponsor|1|||
124750245|NCT00265317|448708708|FG003|Phase 2|Study terminated by sponsor|0|||
124750246|NCT00265317|448708705|FG000|Phase 2|Other|0|||
124750247|NCT00265317|448708706|FG001|Phase 2|Other|0|||
124750248|NCT00265317|448708707|FG002|Phase 2|Other|1|||
124750249|NCT00265317|448708708|FG003|Phase 2|Other|1|||
124750250|NCT02510001|448708709|FG000|Overall Study|Early disease progression|0|||
124750251|NCT02510001|448708710|FG001|Overall Study|Early disease progression|0|||
124750252|NCT02510001|448708711|FG002|Overall Study|Early disease progression|0|||
124750253|NCT02510001|448708712|FG003|Overall Study|Early disease progression|1|||
124750254|NCT02510001|448708713|FG004|Overall Study|Early disease progression|1|||
124750255|NCT02510001|448708714|FG005|Overall Study|Early disease progression|1|||
124750256|NCT02510001|448708715|FG006|Overall Study|Early disease progression|0|||
124750257|NCT02510001|448708716|FG007|Overall Study|Early disease progression|0|||
124750258|NCT02510001|448708709|FG000|Overall Study|Adverse Event|0|||
124750259|NCT02510001|448708710|FG001|Overall Study|Adverse Event|0|||
124750260|NCT02510001|448708711|FG002|Overall Study|Adverse Event|0|||
124750261|NCT02510001|448708712|FG003|Overall Study|Adverse Event|1|||
124750262|NCT02510001|448708713|FG004|Overall Study|Adverse Event|2|||
124750263|NCT02510001|448708714|FG005|Overall Study|Adverse Event|1|||
124750264|NCT02510001|448708715|FG006|Overall Study|Adverse Event|2|||
124750265|NCT02510001|448708716|FG007|Overall Study|Adverse Event|5|||
124750266|NCT02510001|448708709|FG000|Overall Study|Physician Decision|0|||
124750267|NCT02510001|448708710|FG001|Overall Study|Physician Decision|0|||
124750268|NCT02510001|448708711|FG002|Overall Study|Physician Decision|0|||
124750269|NCT02510001|448708712|FG003|Overall Study|Physician Decision|0|||
124750270|NCT02510001|448708713|FG004|Overall Study|Physician Decision|1|||
124750271|NCT02510001|448708714|FG005|Overall Study|Physician Decision|0|||
124750272|NCT02510001|448708715|FG006|Overall Study|Physician Decision|0|||
124750273|NCT02510001|448708716|FG007|Overall Study|Physician Decision|0|||
124750274|NCT02510001|448708709|FG000|Overall Study|Withdrawal by Subject|0|||
124750275|NCT02510001|448708710|FG001|Overall Study|Withdrawal by Subject|0|||
124750276|NCT02510001|448708711|FG002|Overall Study|Withdrawal by Subject|0|||
124750277|NCT02510001|448708712|FG003|Overall Study|Withdrawal by Subject|0|||
124750278|NCT02510001|448708713|FG004|Overall Study|Withdrawal by Subject|0|||
124750279|NCT02510001|448708714|FG005|Overall Study|Withdrawal by Subject|0|||
124750280|NCT02510001|448708715|FG006|Overall Study|Withdrawal by Subject|0|||
124750281|NCT02510001|448708716|FG007|Overall Study|Withdrawal by Subject|2|||
124750282|NCT00303485|448708720|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
124750283|NCT00303485|448708721|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
124750284|NCT00303485|448708720|FG000|Overall Study|Failure to return|0|||
124750285|NCT00303485|448708721|FG001|Overall Study|Failure to return|1|||
124750286|NCT00303485|448708720|FG000|Overall Study|Withdrawal by Subject|1|||
124750287|NCT00303485|448708721|FG001|Overall Study|Withdrawal by Subject|0|||
124750288|NCT03078855|448708728|FG000|Overall Study|Lack of Efficacy|62|||
124750289|NCT03078855|448708729|FG001|Overall Study|Lack of Efficacy|31|||
124750290|NCT03078855|448708728|FG000|Overall Study|Death|1|||
124750291|NCT03078855|448708729|FG001|Overall Study|Death|0|||
124750292|NCT03078855|448708728|FG000|Overall Study|Withdrawal by Subject|12|||
124750293|NCT03078855|448708729|FG001|Overall Study|Withdrawal by Subject|6|||
124750294|NCT03078855|448708728|FG000|Overall Study|Physician Decision|3|||
124750295|NCT03078855|448708729|FG001|Overall Study|Physician Decision|2|||
124750296|NCT03078855|448708728|FG000|Overall Study|Second Malignancy|4|||
124750297|NCT03078855|448708729|FG001|Overall Study|Second Malignancy|0|||
124750298|NCT03078855|448708728|FG000|Overall Study|Ineligible|2|||
124750299|NCT03078855|448708729|FG001|Overall Study|Ineligible|0|||
124750300|NCT03078855|448708728|FG000|Overall Study|Withdrew before day 1 treatment|2|||
124750301|NCT03078855|448708729|FG001|Overall Study|Withdrew before day 1 treatment|1|||
124750302|NCT00391027|448708731|FG000|Overall Study|Adverse Event|8|||
124750303|NCT00391027|448708732|FG001|Overall Study|Adverse Event|8|||
124750304|NCT00391027|448708731|FG000|Overall Study|Lack of Efficacy|3|||
124750305|NCT00391027|448708732|FG001|Overall Study|Lack of Efficacy|0|||
124750306|NCT00391027|448708731|FG000|Overall Study|Withdrawal by Subject|10|||
124750307|NCT00391027|448708732|FG001|Overall Study|Withdrawal by Subject|1|||
124750308|NCT00391027|448708731|FG000|Overall Study|Other|4|||
124620614|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
124750309|NCT00391027|448708732|FG001|Overall Study|Other|3|||
124750310|NCT04124705|448708735|FG000|Titration Period|Adverse Event|9|||
124750311|NCT04124705|448708736|FG001|Titration Period|Adverse Event|5|||
124750312|NCT04124705|448708735|FG000|Titration Period|Withdrawal by Subject|6|||
124750313|NCT04124705|448708736|FG001|Titration Period|Withdrawal by Subject|3|||
124750314|NCT04124705|448708735|FG000|Titration Period|Lost to Follow-up|0|||
124750315|NCT04124705|448708736|FG001|Titration Period|Lost to Follow-up|1|||
124750316|NCT04124705|448708735|FG000|Titration Period|Death|1|||
124620615|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
124620616|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
124620617|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
124750317|NCT04124705|448708736|FG001|Titration Period|Death|1|||
124750318|NCT04124705|448708735|FG000|Titration Period|Lack of Efficacy|2|||
124750319|NCT04124705|448708736|FG001|Titration Period|Lack of Efficacy|0|||
124750320|NCT04124705|448708735|FG000|Titration Period|Physician Decision|2|||
124750321|NCT04124705|448708736|FG001|Titration Period|Physician Decision|0|||
124750322|NCT04124705|448708735|FG000|Titration Period|Non-compliance with Study Drug|2|||
124750323|NCT04124705|448708736|FG001|Titration Period|Non-compliance with Study Drug|0|||
124750324|NCT04124705|448708735|FG000|Titration Period|Other|4|||
124750325|NCT04124705|448708736|FG001|Titration Period|Other|9|||
124750326|NCT04124705|448708735|FG000|Stabilization Period|Adverse Event|4|||
124750327|NCT04124705|448708736|FG001|Stabilization Period|Adverse Event|2|||
124750328|NCT04124705|448708735|FG000|Stabilization Period|Withdrawal by Subject|1|||
124750329|NCT04124705|448708736|FG001|Stabilization Period|Withdrawal by Subject|1|||
124750330|NCT04124705|448708735|FG000|Stabilization Period|Lost to Follow-up|0|||
124750331|NCT04124705|448708736|FG001|Stabilization Period|Lost to Follow-up|1|||
124750332|NCT04124705|448708735|FG000|Stabilization Period|Lack of Efficacy|4|||
124750333|NCT04124705|448708736|FG001|Stabilization Period|Lack of Efficacy|2|||
124750334|NCT04124705|448708735|FG000|Stabilization Period|Protocol Deviation|0|||
124750335|NCT04124705|448708736|FG001|Stabilization Period|Protocol Deviation|2|||
124750336|NCT04124705|448708735|FG000|Stabilization Period|Other|2|||
124750337|NCT04124705|448708736|FG001|Stabilization Period|Other|2|||
124750338|NCT01973998|448708737|FG000|Overall Study|Death|2|||
124750339|NCT01973998|448708738|FG001|Overall Study|Death|2|||
124620618|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
124620619|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
124620620|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
124620621|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
124620622|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
124620623|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
124620624|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
124620625|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
124620626|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
124620627|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
124620628|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
124620629|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
124620630|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
124620631|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
124620632|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
124620633|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
124620634|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
124620635|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
124620636|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
124620637|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
124620638|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
124620639|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
124620640|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
124620641|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
124620642|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
124620643|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
124620644|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
124620645|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
124620646|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
124620647|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
124620648|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
124620649|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
124620650|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
124620651|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
124620652|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
124620653|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
124620654|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
124620655|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
124620656|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
124620657|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
124620658|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
124620659|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
124620660|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
124620661|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
124620662|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
124620663|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
124620664|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
124620665|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
124620666|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
124620667|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
124620668|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
124620669|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
124620670|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
124750340|NCT04302545|448708741|FG000|Overall Study|Lost to Follow-up|3|||
124750341|NCT04302545|448708742|FG001|Overall Study|Lost to Follow-up|4|||
124750342|NCT01636986|448708746|FG000|Overall Study|Withdrawal by Subject|0|||
124750343|NCT01636986|448708747|FG001|Overall Study|Withdrawal by Subject|1|||
124750344|NCT01636986|448708746|FG000|Overall Study|Corneal Staining|0|||
124750345|NCT01636986|448708747|FG001|Overall Study|Corneal Staining|1|||
124750346|NCT02106403|448708752|FG000|Follow-Up Visit 3|Other Reason|0|||
124750347|NCT02106403|448708753|FG001|Follow-Up Visit 3|Other Reason|0|||
124750348|NCT02106403|448708754|FG002|Follow-Up Visit 3|Other Reason|0|||
124750349|NCT02106403|448708755|FG003|Follow-Up Visit 3|Other Reason|0|||
124750350|NCT02106403|448708756|FG004|Follow-Up Visit 3|Other Reason|0|||
124750351|NCT02106403|448708757|FG005|Follow-Up Visit 3|Other Reason|1|||
124750352|NCT04038567|448708759|FG000|Overall Study|Lost to Follow-up|6|||
124750353|NCT04038567|448708760|FG001|Overall Study|Lost to Follow-up|4|||
124750354|NCT04038567|448708761|FG002|Overall Study|Lost to Follow-up|5|||
124750355|NCT04038567|448708762|FG003|Overall Study|Lost to Follow-up|4|||
124750356|NCT04038567|448708763|FG004|Overall Study|Lost to Follow-up|6|||
124750357|NCT04038567|448708764|FG005|Overall Study|Lost to Follow-up|4|||
124750358|NCT04038567|448708765|FG006|Overall Study|Lost to Follow-up|4|||
124750359|NCT04038567|448708766|FG007|Overall Study|Lost to Follow-up|1|||
124750360|NCT04038567|448708759|FG000|Overall Study|Withdrawal by Subject|2|||
124750361|NCT04038567|448708760|FG001|Overall Study|Withdrawal by Subject|1|||
124750362|NCT04038567|448708761|FG002|Overall Study|Withdrawal by Subject|1|||
124750363|NCT04038567|448708762|FG003|Overall Study|Withdrawal by Subject|1|||
124750364|NCT04038567|448708763|FG004|Overall Study|Withdrawal by Subject|4|||
124750365|NCT04038567|448708764|FG005|Overall Study|Withdrawal by Subject|1|||
124750366|NCT04038567|448708765|FG006|Overall Study|Withdrawal by Subject|1|||
124750367|NCT04038567|448708766|FG007|Overall Study|Withdrawal by Subject|1|||
124750368|NCT04038567|448708759|FG000|Overall Study|missed survey window|1|||
124750369|NCT04038567|448708760|FG001|Overall Study|missed survey window|2|||
124750370|NCT04038567|448708761|FG002|Overall Study|missed survey window|0|||
124750371|NCT04038567|448708762|FG003|Overall Study|missed survey window|0|||
124750372|NCT04038567|448708763|FG004|Overall Study|missed survey window|1|||
124750373|NCT04038567|448708764|FG005|Overall Study|missed survey window|1|||
124750374|NCT04038567|448708765|FG006|Overall Study|missed survey window|2|||
124750375|NCT04038567|448708766|FG007|Overall Study|missed survey window|2|||
124750376|NCT04038567|448708759|FG000|Overall Study|technical issues|0|||
124750377|NCT04038567|448708760|FG001|Overall Study|technical issues|0|||
124750378|NCT04038567|448708761|FG002|Overall Study|technical issues|0|||
124750379|NCT04038567|448708762|FG003|Overall Study|technical issues|0|||
124750380|NCT04038567|448708763|FG004|Overall Study|technical issues|0|||
124750381|NCT04038567|448708764|FG005|Overall Study|technical issues|0|||
124750382|NCT04038567|448708765|FG006|Overall Study|technical issues|1|||
124750383|NCT04038567|448708766|FG007|Overall Study|technical issues|0|||
124750384|NCT04038567|448708759|FG000|Overall Study|Medical issues (i.e., illness)|0|||
124750385|NCT04038567|448708760|FG001|Overall Study|Medical issues (i.e., illness)|1|||
124750386|NCT04038567|448708761|FG002|Overall Study|Medical issues (i.e., illness)|2|||
124750387|NCT04038567|448708762|FG003|Overall Study|Medical issues (i.e., illness)|1|||
124750388|NCT04038567|448708763|FG004|Overall Study|Medical issues (i.e., illness)|1|||
124750389|NCT04038567|448708764|FG005|Overall Study|Medical issues (i.e., illness)|1|||
124750390|NCT04038567|448708765|FG006|Overall Study|Medical issues (i.e., illness)|0|||
124750391|NCT04038567|448708766|FG007|Overall Study|Medical issues (i.e., illness)|0|||
124750392|NCT04038567|448708759|FG000|Overall Study|Death|0|||
124750393|NCT04038567|448708760|FG001|Overall Study|Death|0|||
124750394|NCT04038567|448708761|FG002|Overall Study|Death|0|||
124750395|NCT04038567|448708762|FG003|Overall Study|Death|1|||
124750396|NCT04038567|448708763|FG004|Overall Study|Death|1|||
124750397|NCT04038567|448708764|FG005|Overall Study|Death|0|||
124750398|NCT04038567|448708765|FG006|Overall Study|Death|0|||
124750399|NCT04038567|448708766|FG007|Overall Study|Death|1|||
124750400|NCT01496846|448708770|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
124750401|NCT01496846|448708771|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
124750402|NCT01496846|448708772|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
124750403|NCT01496846|448708773|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
124750404|NCT01496846|448708774|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
124750405|NCT01496846|448708775|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
124750406|NCT01817959|448708778|FG000|Overall Study|Graft loss|1|||
124750407|NCT01817959|448708779|FG001|Overall Study|Graft loss|1|||
124750408|NCT01817959|448708778|FG000|Overall Study|forbidden medication|1|||
124750409|NCT01817959|448708779|FG001|Overall Study|forbidden medication|1|||
124750410|NCT01817959|448708778|FG000|Overall Study|Adverse Event|1|||
124750411|NCT01817959|448708779|FG001|Overall Study|Adverse Event|0|||
124750412|NCT01817959|448708778|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
124750413|NCT01817959|448708779|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
124750414|NCT01772576|448708780|FG000|Overall Study|Death|15|||
124750415|NCT01772576|448708780|FG000|Overall Study|Protocol Violation|1|||
124750416|NCT01772576|448708780|FG000|Overall Study|Lost to Follow-up|3|||
124750417|NCT01772576|448708780|FG000|Overall Study|Study device not used|3|||
124750418|NCT01772576|448708780|FG000|Overall Study|Adverse Event|6|||
124750419|NCT01772576|448708780|FG000|Overall Study|Withdrawal by Subject|6|||
124782929|NCT01497366|448834372|FG001|Overall Study|Virologic failure|50|||
124782930|NCT01497366|448834371|FG000|Overall Study|Lost to Follow-up|11|||
124782931|NCT01497366|448834372|FG001|Overall Study|Lost to Follow-up|10|||
124782932|NCT01497366|448834371|FG000|Overall Study|Withdrawal by Subject|6|||
124782933|NCT01497366|448834372|FG001|Overall Study|Withdrawal by Subject|6|||
124782934|NCT01497366|448834371|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
124782935|NCT01497366|448834372|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
124782936|NCT01497366|448834371|FG000|Overall Study|Other|5|||
124782937|NCT01497366|448834372|FG001|Overall Study|Other|0|||
124782938|NCT01497366|448834371|FG000|Overall Study|Death|1|||
124782939|NCT01497366|448834372|FG001|Overall Study|Death|1|||
124782940|NCT01497366|448834371|FG000|Overall Study|Randomized but not treated|7|||
124782941|NCT01497366|448834372|FG001|Overall Study|Randomized but not treated|21|||
124782942|NCT02745080|448834386|FG000|Overall Study|Adverse Event|13|||
124782943|NCT02745080|448834387|FG001|Overall Study|Adverse Event|21|||
124782944|NCT02745080|448834386|FG000|Overall Study|Lack of Efficacy|11|||
124782945|NCT02745080|448834387|FG001|Overall Study|Lack of Efficacy|23|||
124782946|NCT02745080|448834386|FG000|Overall Study|Lost to Follow-up|3|||
124782947|NCT02745080|448834387|FG001|Overall Study|Lost to Follow-up|3|||
124782948|NCT02745080|448834386|FG000|Overall Study|Physician Decision|3|||
124782949|NCT02745080|448834387|FG001|Overall Study|Physician Decision|0|||
124782950|NCT02745080|448834386|FG000|Overall Study|Protocol Violation|3|||
124782951|NCT02745080|448834387|FG001|Overall Study|Protocol Violation|1|||
124782952|NCT02745080|448834386|FG000|Overall Study|Withdrawal by Subject|22|||
124782953|NCT02745080|448834387|FG001|Overall Study|Withdrawal by Subject|41|||
124782954|NCT01821560|448834388|FG000|Overall Study|Lost to Follow-up|5|||
124782955|NCT01821560|448834389|FG001|Overall Study|Lost to Follow-up|5|||
124782956|NCT01821560|448834388|FG000|Overall Study|Withdrawal by Subject|1|||
124782957|NCT01821560|448834389|FG001|Overall Study|Withdrawal by Subject|1|||
124782958|NCT01821560|448834388|FG000|Overall Study|Protocol Violation|0|||
124782959|NCT01821560|448834389|FG001|Overall Study|Protocol Violation|1|||
124782960|NCT01338298|448834392|FG000|Overall Study|Withdrawal by Subject|1|||
124782961|NCT01338298|448834393|FG001|Overall Study|Withdrawal by Subject|1|||
124782962|NCT01338298|448834392|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
124782963|NCT01338298|448834393|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
124782964|NCT01338298|448834392|FG000|Overall Study|Administrative error|0|||
124782965|NCT01338298|448834393|FG001|Overall Study|Administrative error|1|||
124782966|NCT01338298|448834392|FG000|Overall Study|Positive symptom worsening|1|||
124620671|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
124620672|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
124620673|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
124620674|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
124620675|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
124620676|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
124620677|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
124620678|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
124620679|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
124620680|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
124620681|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
124620682|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
124620683|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
124620684|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
124620685|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
124620686|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
124620687|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
124620688|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
124620689|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
124620690|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
124620691|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
124620692|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
124620693|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
124620694|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
124620695|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
124620696|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
124620697|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
124782967|NCT01338298|448834393|FG001|Overall Study|Positive symptom worsening|0|||
124782968|NCT01338298|448834392|FG000|Overall Study|Depressive symptoms and nausea|1|||
124782969|NCT01338298|448834393|FG001|Overall Study|Depressive symptoms and nausea|0|||
124782970|NCT01338298|448834392|FG000|Overall Study|Non-adherence|1|||
124782971|NCT01338298|448834393|FG001|Overall Study|Non-adherence|0|||
124750420|NCT00923845|448708781|FG000|Induction Therapy|Poor performance status|0|||
124750421|NCT00923845|448708782|FG001|Induction Therapy|Poor performance status|2|||
124750422|NCT04356352|448708790|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
124750423|NCT04356352|448708791|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
124750424|NCT04356352|448708792|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
124750425|NCT04356352|448708790|FG000|Overall Study|Protocol Violation|0|||
124750426|NCT04356352|448708791|FG001|Overall Study|Protocol Violation|3|||
124750427|NCT04356352|448708792|FG002|Overall Study|Protocol Violation|1|||
124750428|NCT01371734|448708795|FG000|Overall Study|Other|2|||
124750429|NCT01371734|448708796|FG001|Overall Study|Other|1|||
124750430|NCT01371734|448708797|FG002|Overall Study|Other|2|||
124750431|NCT01371734|448708795|FG000|Overall Study|Withdrawal by Subject|3|||
124750432|NCT01371734|448708796|FG001|Overall Study|Withdrawal by Subject|4|||
124750433|NCT01371734|448708797|FG002|Overall Study|Withdrawal by Subject|9|||
124750434|NCT01371734|448708795|FG000|Overall Study|Lost to Follow-up|5|||
124750435|NCT01371734|448708796|FG001|Overall Study|Lost to Follow-up|3|||
124750436|NCT01371734|448708797|FG002|Overall Study|Lost to Follow-up|1|||
124750437|NCT01371734|448708795|FG000|Overall Study|Protocol Violation|3|||
124750438|NCT01371734|448708796|FG001|Overall Study|Protocol Violation|1|||
124750439|NCT01371734|448708797|FG002|Overall Study|Protocol Violation|2|||
124750440|NCT01371734|448708795|FG000|Overall Study|Adverse Event|8|||
124750441|NCT01371734|448708796|FG001|Overall Study|Adverse Event|8|||
124750442|NCT01371734|448708797|FG002|Overall Study|Adverse Event|3|||
124750443|NCT01371734|448708795|FG000|Overall Study|Lack of Efficacy|2|||
124750444|NCT01371734|448708796|FG001|Overall Study|Lack of Efficacy|2|||
124750445|NCT01371734|448708797|FG002|Overall Study|Lack of Efficacy|0|||
124750446|NCT02578186|448708798|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
124750447|NCT02578186|448708799|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
124750448|NCT02578186|448708798|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
124750449|NCT02578186|448708799|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
124750450|NCT03565237|448708800|FG000|Overall Study|Non-compliance of Investigational Product|1|||
124750451|NCT03565237|448708800|FG000|Overall Study|Physician Decision|1|||
124750452|NCT01140061|448708801|FG000|Part I|Adverse Event|1|||
124750453|NCT01140061|448708802|FG001|Part I|Adverse Event|0|||
124750454|NCT01140061|448708803|FG002|Part I|Adverse Event|0|||
124750455|NCT01140061|448708804|FG003|Part I|Adverse Event|0|||
124750456|NCT01140061|448708805|FG004|Part I|Adverse Event|0|||
124750457|NCT01140061|448708806|FG005|Part I|Adverse Event|0|||
124750458|NCT01140061|448708807|FG006|Part I|Adverse Event|0|||
124750459|NCT01140061|448708808|FG007|Part I|Adverse Event|0|||
124750460|NCT01140061|448708809|FG008|Part I|Adverse Event|0|||
124750461|NCT01140061|448708810|FG009|Part I|Adverse Event|0|||
124750462|NCT01140061|448708801|FG000|Extension|Laboratory Adverse Event|0|||
124750463|NCT01140061|448708802|FG001|Extension|Laboratory Adverse Event|0|||
124750464|NCT01140061|448708803|FG002|Extension|Laboratory Adverse Event|0|||
124750465|NCT01140061|448708804|FG003|Extension|Laboratory Adverse Event|0|||
124750466|NCT01140061|448708805|FG004|Extension|Laboratory Adverse Event|0|||
124750467|NCT01140061|448708806|FG005|Extension|Laboratory Adverse Event|0|||
124750468|NCT01140061|448708807|FG006|Extension|Laboratory Adverse Event|0|||
124750469|NCT01140061|448708808|FG007|Extension|Laboratory Adverse Event|0|||
124750470|NCT01140061|448708809|FG008|Extension|Laboratory Adverse Event|0|||
124750471|NCT01140061|448708810|FG009|Extension|Laboratory Adverse Event|1|||
124750472|NCT00828750|448708811|FG000|Overall Study|Lack of Efficacy|3|||
124750473|NCT00828750|448708811|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
124750474|NCT04006392|448708812|FG000|Overall Study|Lost to Follow-up|0|||
124750475|NCT04006392|448708813|FG001|Overall Study|Lost to Follow-up|1|||
124750476|NCT01832532|448708814|FG000|Overall Study|Withdrawal by Subject|5|||
124750477|NCT01832532|448708815|FG001|Overall Study|Withdrawal by Subject|2|||
124750478|NCT01534195|448708816|FG000|Overall Study|Withdrawal by Subject|1|||
124750479|NCT01534195|448708817|FG001|Overall Study|Withdrawal by Subject|1|||
124750480|NCT01368081|448708818|FG000|Overall Study|Adverse Event|4|||
124750481|NCT01368081|448708819|FG001|Overall Study|Adverse Event|4|||
124750482|NCT01368081|448708820|FG002|Overall Study|Adverse Event|3|||
124750483|NCT01368081|448708821|FG003|Overall Study|Adverse Event|2|||
124750484|NCT01368081|448708822|FG004|Overall Study|Adverse Event|2|||
124750485|NCT01368081|448708823|FG005|Overall Study|Adverse Event|5|||
124750486|NCT01368081|448708824|FG006|Overall Study|Adverse Event|6|||
124750487|NCT01368081|448708825|FG007|Overall Study|Adverse Event|2|||
124750488|NCT01368081|448708826|FG008|Overall Study|Adverse Event|3|||
124750489|NCT01368081|448708827|FG009|Overall Study|Adverse Event|5|||
124750490|NCT01368081|448708828|FG010|Overall Study|Adverse Event|6|||
124750491|NCT01368081|448708829|FG011|Overall Study|Adverse Event|1|||
124750492|NCT01368081|448708830|FG012|Overall Study|Adverse Event|3|||
124750493|NCT01368081|448708818|FG000|Overall Study|Lack of Efficacy|0|||
124750494|NCT01368081|448708819|FG001|Overall Study|Lack of Efficacy|1|||
124750495|NCT01368081|448708820|FG002|Overall Study|Lack of Efficacy|0|||
124750496|NCT01368081|448708821|FG003|Overall Study|Lack of Efficacy|1|||
124750497|NCT01368081|448708822|FG004|Overall Study|Lack of Efficacy|0|||
124750498|NCT01368081|448708823|FG005|Overall Study|Lack of Efficacy|0|||
124750499|NCT01368081|448708824|FG006|Overall Study|Lack of Efficacy|0|||
124750500|NCT01368081|448708825|FG007|Overall Study|Lack of Efficacy|2|||
124750501|NCT01368081|448708826|FG008|Overall Study|Lack of Efficacy|0|||
124750502|NCT01368081|448708827|FG009|Overall Study|Lack of Efficacy|0|||
124750503|NCT01368081|448708828|FG010|Overall Study|Lack of Efficacy|0|||
124750504|NCT01368081|448708829|FG011|Overall Study|Lack of Efficacy|0|||
124750505|NCT01368081|448708830|FG012|Overall Study|Lack of Efficacy|0|||
124750506|NCT01368081|448708818|FG000|Overall Study|Protocol Violation|0|||
124750507|NCT01368081|448708819|FG001|Overall Study|Protocol Violation|0|||
124750508|NCT01368081|448708820|FG002|Overall Study|Protocol Violation|0|||
124750509|NCT01368081|448708821|FG003|Overall Study|Protocol Violation|0|||
124750510|NCT01368081|448708822|FG004|Overall Study|Protocol Violation|0|||
124750511|NCT01368081|448708823|FG005|Overall Study|Protocol Violation|1|||
124750512|NCT01368081|448708824|FG006|Overall Study|Protocol Violation|0|||
124750513|NCT01368081|448708825|FG007|Overall Study|Protocol Violation|1|||
124750514|NCT01368081|448708826|FG008|Overall Study|Protocol Violation|0|||
124750515|NCT01368081|448708827|FG009|Overall Study|Protocol Violation|0|||
124750516|NCT01368081|448708828|FG010|Overall Study|Protocol Violation|0|||
124750517|NCT01368081|448708829|FG011|Overall Study|Protocol Violation|0|||
124750518|NCT01368081|448708830|FG012|Overall Study|Protocol Violation|0|||
124750519|NCT01368081|448708818|FG000|Overall Study|Lost to Follow-up|0|||
124750520|NCT01368081|448708819|FG001|Overall Study|Lost to Follow-up|0|||
124750521|NCT01368081|448708820|FG002|Overall Study|Lost to Follow-up|0|||
124750522|NCT01368081|448708821|FG003|Overall Study|Lost to Follow-up|0|||
124750523|NCT01368081|448708822|FG004|Overall Study|Lost to Follow-up|0|||
124750524|NCT01368081|448708823|FG005|Overall Study|Lost to Follow-up|0|||
124750525|NCT01368081|448708824|FG006|Overall Study|Lost to Follow-up|0|||
124750526|NCT01368081|448708825|FG007|Overall Study|Lost to Follow-up|0|||
124750527|NCT01368081|448708826|FG008|Overall Study|Lost to Follow-up|0|||
124750528|NCT01368081|448708827|FG009|Overall Study|Lost to Follow-up|0|||
124750529|NCT01368081|448708828|FG010|Overall Study|Lost to Follow-up|0|||
124750530|NCT01368081|448708829|FG011|Overall Study|Lost to Follow-up|0|||
124750531|NCT01368081|448708830|FG012|Overall Study|Lost to Follow-up|1|||
124750532|NCT01368081|448708818|FG000|Overall Study|Withdrawal by Subject|4|||
124750533|NCT01368081|448708819|FG001|Overall Study|Withdrawal by Subject|4|||
124750534|NCT01368081|448708820|FG002|Overall Study|Withdrawal by Subject|1|||
124750535|NCT01368081|448708821|FG003|Overall Study|Withdrawal by Subject|1|||
124750536|NCT01368081|448708822|FG004|Overall Study|Withdrawal by Subject|0|||
124750537|NCT01368081|448708823|FG005|Overall Study|Withdrawal by Subject|3|||
124750538|NCT01368081|448708824|FG006|Overall Study|Withdrawal by Subject|4|||
124750539|NCT01368081|448708825|FG007|Overall Study|Withdrawal by Subject|2|||
124750540|NCT01368081|448708826|FG008|Overall Study|Withdrawal by Subject|5|||
124750541|NCT01368081|448708827|FG009|Overall Study|Withdrawal by Subject|4|||
124750542|NCT01368081|448708828|FG010|Overall Study|Withdrawal by Subject|3|||
124750543|NCT01368081|448708829|FG011|Overall Study|Withdrawal by Subject|2|||
124750544|NCT01368081|448708830|FG012|Overall Study|Withdrawal by Subject|0|||
124750545|NCT01368081|448708818|FG000|Overall Study|Other reason not defined above|2|||
124750546|NCT01368081|448708819|FG001|Overall Study|Other reason not defined above|0|||
124750547|NCT01368081|448708820|FG002|Overall Study|Other reason not defined above|0|||
124750548|NCT01368081|448708821|FG003|Overall Study|Other reason not defined above|1|||
124750549|NCT01368081|448708822|FG004|Overall Study|Other reason not defined above|0|||
124750550|NCT01368081|448708823|FG005|Overall Study|Other reason not defined above|1|||
124750551|NCT01368081|448708824|FG006|Overall Study|Other reason not defined above|2|||
124750552|NCT01368081|448708825|FG007|Overall Study|Other reason not defined above|0|||
124750553|NCT01368081|448708826|FG008|Overall Study|Other reason not defined above|0|||
124750554|NCT01368081|448708827|FG009|Overall Study|Other reason not defined above|1|||
124750555|NCT01368081|448708828|FG010|Overall Study|Other reason not defined above|0|||
124750556|NCT01368081|448708829|FG011|Overall Study|Other reason not defined above|0|||
124750557|NCT01368081|448708830|FG012|Overall Study|Other reason not defined above|3|||
124750558|NCT01736618|448708833|FG000|Overall Study|Death|294|||
124750559|NCT01736618|448708833|FG000|Overall Study|Lost to Follow-up|193|||
124750560|NCT01736618|448708833|FG000|Overall Study|Withdrawal by Subject|54|||
124750561|NCT01736618|448708833|FG000|Overall Study|Subject unable to be followed at study location|223|||
124750562|NCT01736618|448708833|FG000|Overall Study|Physician Decision|33|||
124750563|NCT01736618|448708833|FG000|Overall Study|Transplant or removal of target organ|19|||
124750564|NCT01736618|448708833|FG000|Overall Study|Change in indication or condition|78|||
124750565|NCT01736618|448708833|FG000|Overall Study|Study device explant|103|||
124750566|NCT01736618|448708833|FG000|Overall Study|Unable to complete implant|2|||
124750567|NCT00400569|448708838|FG000|Overall Study|Death|1|||
124750568|NCT00620113|448708841|FG000|Overall Study|Adverse Event|3|||
124750569|NCT00620113|448708842|FG001|Overall Study|Adverse Event|2|||
124750570|NCT00620113|448708843|FG002|Overall Study|Adverse Event|2|||
124750571|NCT00620113|448708844|FG003|Overall Study|Adverse Event|1|||
124750572|NCT00620113|448708841|FG000|Overall Study|Lack of Efficacy|2|||
124750573|NCT00620113|448708842|FG001|Overall Study|Lack of Efficacy|3|||
124750574|NCT00620113|448708843|FG002|Overall Study|Lack of Efficacy|0|||
124782972|NCT05601544|448834394|FG000|Phase 2 Period 1|Adverse Event|0|||
124782973|NCT05601544|448834395|FG001|Phase 2 Period 1|Adverse Event|1|||
124782974|NCT05601544|448834396|FG002|Phase 2 Period 1|Adverse Event|0|||
124782975|NCT05601544|448834397|FG003|Phase 2 Period 1|Adverse Event|0|||
124782976|NCT05601544|448834398|FG004|Phase 2 Period 1|Adverse Event|0|||
124782977|NCT05601544|448834399|FG005|Phase 2 Period 1|Adverse Event|0|||
124782978|NCT01256294|448835817|FG000|Overall Study|Adverse Event|1|||
124782979|NCT01256294|448835818|FG001|Overall Study|Adverse Event|0|||
124782980|NCT01256294|448835817|FG000|Overall Study|Withdrawal by Subject|1|||
124782981|NCT01256294|448835818|FG001|Overall Study|Withdrawal by Subject|1|||
124782982|NCT01256294|448835817|FG000|Overall Study|Protocol deviation|2|||
124782983|NCT01256294|448835818|FG001|Overall Study|Protocol deviation|1|||
124782984|NCT04681352|448835819|FG000|Overall Study|Lost to Follow-up|2|||
124782985|NCT04681352|448835819|FG000|Overall Study|Withdrawal by Subject|22|||
124782986|NCT01643772|448835821|FG000|Overall Study|Protocol Violation|0|||
124782987|NCT01643772|448835822|FG001|Overall Study|Protocol Violation|0|||
124782988|NCT01643772|448835823|FG002|Overall Study|Protocol Violation|0|||
124782989|NCT01643772|448835824|FG003|Overall Study|Protocol Violation|1|||
124782990|NCT01643772|448835821|FG000|Overall Study|Adverse Event|0|||
124782991|NCT01643772|448835822|FG001|Overall Study|Adverse Event|0|||
124782992|NCT01643772|448835823|FG002|Overall Study|Adverse Event|0|||
124782993|NCT01643772|448835824|FG003|Overall Study|Adverse Event|1|||
124782994|NCT02338882|448835825|FG000|Overall Study|Death|1|||
124782995|NCT02338882|448835826|FG001|Overall Study|Death|0|||
124782996|NCT02338882|448835825|FG000|Overall Study|Lost to Follow-up|6|||
124782997|NCT02338882|448835826|FG001|Overall Study|Lost to Follow-up|3|||
124782998|NCT04838977|448835829|FG000|Overall Study|Lost to Follow-up|2|||
124782999|NCT04838977|448835830|FG001|Overall Study|Lost to Follow-up|3|||
124783000|NCT04838977|448835829|FG000|Overall Study|Withdrawal by Subject|1|||
124783001|NCT04838977|448835830|FG001|Overall Study|Withdrawal by Subject|1|||
124783002|NCT02314637|448835833|FG000|Overall Study|Adverse Event|4|||
124783003|NCT02314637|448835834|FG001|Overall Study|Adverse Event|8|||
124783004|NCT02314637|448835833|FG000|Overall Study|Lack of Efficacy|1|||
124783005|NCT02314637|448835834|FG001|Overall Study|Lack of Efficacy|0|||
124783006|NCT02314637|448835833|FG000|Overall Study|Physician Decision|5|||
124783007|NCT02314637|448835834|FG001|Overall Study|Physician Decision|2|||
124783008|NCT02314637|448835833|FG000|Overall Study|Withdrawal by Subject|5|||
124783009|NCT02314637|448835834|FG001|Overall Study|Withdrawal by Subject|4|||
124783010|NCT02314637|448835833|FG000|Overall Study|Other Reason|1|||
124783011|NCT02314637|448835834|FG001|Overall Study|Other Reason|0|||
124783012|NCT00724867|448835837|FG000|Overall Study|Adverse Event|25|||
124783013|NCT00724867|448835837|FG000|Overall Study|Lack of Efficacy|14|||
124783014|NCT00724867|448835837|FG000|Overall Study|Lost to Follow-up|12|||
124783015|NCT00724867|448835837|FG000|Overall Study|Non-compliance with study drug|6|||
124783016|NCT00724867|448835837|FG000|Overall Study|Physician Decision|17|||
124783017|NCT00724867|448835837|FG000|Overall Study|Protocol Violation|1|||
124783018|NCT00724867|448835837|FG000|Overall Study|Withdrawal by Subject|31|||
124783019|NCT00724867|448835837|FG000|Overall Study|Sponsor decision to end study|14|||
124783020|NCT00724867|448835837|FG000|Overall Study|Subject incarcerated|1|||
124783021|NCT00724867|448835837|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
124783022|NCT00724867|448835837|FG000|Overall Study|Subject moved out of state|1|||
124783023|NCT00724867|448835837|FG000|Overall Study|Elected to exit due to site closure|2|||
124783024|NCT00373113|448835838|FG000|Overall Study|Death|1|||
124783025|NCT00373113|448835839|FG001|Overall Study|Death|7|||
124783026|NCT00373113|448835838|FG000|Overall Study|Adverse Event|38|||
124783027|NCT00373113|448835839|FG001|Overall Study|Adverse Event|24|||
124783028|NCT00373113|448835838|FG000|Overall Study|Study terminated by sponsor|9|||
124783029|NCT00373113|448835839|FG001|Overall Study|Study terminated by sponsor|1|||
124783030|NCT00373113|448835838|FG000|Overall Study|Global deterioration of health status|10|||
124783031|NCT00373113|448835839|FG001|Overall Study|Global deterioration of health status|7|||
124783032|NCT00373113|448835838|FG000|Overall Study|Lost to Follow-up|1|||
124783033|NCT00373113|448835839|FG001|Overall Study|Lost to Follow-up|3|||
124783034|NCT00373113|448835838|FG000|Overall Study|Objective progression or relapse|150|||
124783035|NCT00373113|448835839|FG001|Overall Study|Objective progression or relapse|169|||
124783036|NCT00373113|448835838|FG000|Overall Study|Other|14|||
124783037|NCT00373113|448835839|FG001|Overall Study|Other|17|||
124783038|NCT00373113|448835838|FG000|Overall Study|Protocol Violation|5|||
124783039|NCT00373113|448835839|FG001|Overall Study|Protocol Violation|1|||
124783040|NCT00373113|448835838|FG000|Overall Study|Withdrawal by Subject|10|||
124783041|NCT00373113|448835839|FG001|Overall Study|Withdrawal by Subject|15|||
124783042|NCT03120351|448835848|FG000|Overall Study|Physician Decision|1|||
124783043|NCT03120351|448835849|FG001|Overall Study|Physician Decision|1|||
124783044|NCT01256190|448835850|FG000|Overall Study|Lost to Follow-up|2|||
124783045|NCT01256190|448835851|FG001|Overall Study|Lost to Follow-up|0|||
124620698|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
124783046|NCT02834793|448835852|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
124783047|NCT02834793|448835853|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
124783048|NCT02834793|448835854|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
124750575|NCT00620113|448708844|FG003|Overall Study|Lack of Efficacy|2|||
124750576|NCT00620113|448708841|FG000|Overall Study|Physician Decision|1|||
124750577|NCT00620113|448708842|FG001|Overall Study|Physician Decision|0|||
124750578|NCT00620113|448708843|FG002|Overall Study|Physician Decision|0|||
124750579|NCT00620113|448708844|FG003|Overall Study|Physician Decision|2|||
124750580|NCT00620113|448708841|FG000|Overall Study|Protocol Violation|2|||
124750581|NCT00620113|448708842|FG001|Overall Study|Protocol Violation|1|||
124750582|NCT00620113|448708843|FG002|Overall Study|Protocol Violation|0|||
124750583|NCT00620113|448708844|FG003|Overall Study|Protocol Violation|0|||
124750584|NCT00620113|448708841|FG000|Overall Study|Withdrawal by Subject|5|||
124750585|NCT00620113|448708842|FG001|Overall Study|Withdrawal by Subject|1|||
124750586|NCT00620113|448708843|FG002|Overall Study|Withdrawal by Subject|3|||
124750587|NCT00620113|448708844|FG003|Overall Study|Withdrawal by Subject|5|||
124750588|NCT02461745|448708847|FG000|Overall Study|Lack of Efficacy|9|||
124750589|NCT02461745|448708848|FG001|Overall Study|Lack of Efficacy|1|||
124750590|NCT02461745|448708847|FG000|Overall Study|Lost to Follow-up|2|||
124750591|NCT02461745|448708848|FG001|Overall Study|Lost to Follow-up|2|||
124750592|NCT02461745|448708847|FG000|Overall Study|Withdrawal by Subject|3|||
124750593|NCT02461745|448708848|FG001|Overall Study|Withdrawal by Subject|1|||
124750594|NCT00211887|448708851|FG000|Overall Study|Adverse Event|8|||
124750595|NCT00211887|448708852|FG001|Overall Study|Adverse Event|4|||
124750596|NCT00211887|448708853|FG002|Overall Study|Adverse Event|6|||
124750597|NCT00211887|448708851|FG000|Overall Study|Death|1|||
124750598|NCT00211887|448708852|FG001|Overall Study|Death|1|||
124750599|NCT00211887|448708853|FG002|Overall Study|Death|1|||
124750600|NCT00211887|448708851|FG000|Overall Study|Lost to Follow-up|28|||
124750601|NCT00211887|448708852|FG001|Overall Study|Lost to Follow-up|13|||
124750602|NCT00211887|448708853|FG002|Overall Study|Lost to Follow-up|9|||
124750603|NCT00211887|448708851|FG000|Overall Study|Non-medical reason|31|||
124750604|NCT00211887|448708852|FG001|Overall Study|Non-medical reason|14|||
124750605|NCT00211887|448708853|FG002|Overall Study|Non-medical reason|8|||
124750606|NCT00211887|448708851|FG000|Overall Study|Other medical reason|15|||
124750607|NCT00211887|448708852|FG001|Overall Study|Other medical reason|11|||
124750608|NCT00211887|448708853|FG002|Overall Study|Other medical reason|7|||
124750609|NCT00211887|448708851|FG000|Overall Study|Side effects|19|||
124750610|NCT00211887|448708852|FG001|Overall Study|Side effects|13|||
124750611|NCT00211887|448708853|FG002|Overall Study|Side effects|5|||
124750612|NCT00965419|448708857|FG000|Open Label Treatment for Responders|Adverse Event|33|||
124750613|NCT00965419|448708857|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
124750614|NCT00965419|448708857|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
124750615|NCT00965419|448708857|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
124750616|NCT00965419|448708857|FG000|Open Label Treatment for Responders|Physician Decision|6|||
124750617|NCT00965419|448708857|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
124750618|NCT00965419|448708857|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
124750619|NCT00965419|448708857|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
124750620|NCT00965419|448708857|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
124750621|NCT00965419|448708857|FG000|Follow-up Phase|Adverse Event|9|||
124750622|NCT00965419|448708857|FG000|Follow-up Phase|Protocol Violation|4|||
124750623|NCT00965419|448708857|FG000|Follow-up Phase|Withdrawal by Subject|8|||
124750624|NCT00965419|448708857|FG000|Follow-up Phase|Physician Decision|4|||
124750625|NCT00965419|448708857|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
124750626|NCT00965419|448708857|FG000|Follow-up Phase|Lack of Efficacy|28|||
124750627|NCT02927938|448708858|FG000|Overall Study|Death|0|||
124750628|NCT02927938|448708859|FG001|Overall Study|Death|1|||
124750629|NCT02927938|448708860|FG002|Overall Study|Death|0|||
124750630|NCT02927938|448708861|FG003|Overall Study|Death|4|||
124750631|NCT02927938|448708858|FG000|Overall Study|Early Study Termination|1|||
124750632|NCT02927938|448708859|FG001|Overall Study|Early Study Termination|5|||
124750633|NCT02927938|448708860|FG002|Overall Study|Early Study Termination|4|||
124750634|NCT02927938|448708861|FG003|Overall Study|Early Study Termination|3|||
124750635|NCT00082407|448710335|FG000|Overall Study|Adverse Event|20|||
124750636|NCT00082407|448710336|FG001|Overall Study|Adverse Event|0|||
124750637|NCT00082407|448710335|FG000|Overall Study|Protocol Violation|14|||
124750638|NCT00082407|448710336|FG001|Overall Study|Protocol Violation|12|||
124783049|NCT02834793|448835855|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
124783050|NCT02834793|448835852|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
124783051|NCT02834793|448835853|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
124750639|NCT00082407|448710335|FG000|Overall Study|Patient Decision|13|||
124750640|NCT00082407|448710336|FG001|Overall Study|Patient Decision|6|||
124750641|NCT00082407|448710335|FG000|Overall Study|Physician Decision|5|||
124750642|NCT00082407|448710336|FG001|Overall Study|Physician Decision|3|||
124750643|NCT00082407|448710335|FG000|Overall Study|Loss of Glucose Control|2|||
124750644|NCT00082407|448710336|FG001|Overall Study|Loss of Glucose Control|2|||
124750645|NCT00082407|448710335|FG000|Overall Study|Death|2|||
124750646|NCT00082407|448710336|FG001|Overall Study|Death|1|||
124750647|NCT00082407|448710335|FG000|Overall Study|Lost to Follow-up|0|||
124750648|NCT00082407|448710336|FG001|Overall Study|Lost to Follow-up|3|||
124750649|NCT00891228|448710338|FG000|Overall Study|Adverse Event|0|||
124620699|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
124620700|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
124620701|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
124620702|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
124620703|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
124620704|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
124620705|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
124620706|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
124620707|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
124620708|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
124620709|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
124620710|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
124620711|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
124620712|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
124620713|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
124620714|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
124620715|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
124620716|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
124620717|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
124620718|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
124620719|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
124620720|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
124620721|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
124620722|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
124620723|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
124620724|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
124620725|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
124620726|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
124620727|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
124620728|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
124620729|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
124620730|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
124620731|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
124620732|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
124620733|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
124620734|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
124620735|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
124620736|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
124620737|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
124620738|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
124620739|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
124620740|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
124620741|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
124620742|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
124620743|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
124620744|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
124620745|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
124620746|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
124620747|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
124620748|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
124620749|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
124620750|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
124620751|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
124620752|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
124620753|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
124620754|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
124620755|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
124620756|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
124620757|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
124750650|NCT00891228|448710339|FG001|Overall Study|Adverse Event|2|||
124750651|NCT00891228|448710340|FG002|Overall Study|Adverse Event|3|||
124750652|NCT00891228|448710338|FG000|Overall Study|Withdrawal by Subject|2|||
124750653|NCT00891228|448710339|FG001|Overall Study|Withdrawal by Subject|4|||
124750654|NCT00891228|448710340|FG002|Overall Study|Withdrawal by Subject|5|||
124750655|NCT00891228|448710338|FG000|Overall Study|Protocol Violation|3|||
124750656|NCT00891228|448710339|FG001|Overall Study|Protocol Violation|1|||
124750657|NCT00891228|448710340|FG002|Overall Study|Protocol Violation|2|||
124750658|NCT00891228|448710338|FG000|Overall Study|Physician Decision|2|||
124750659|NCT00891228|448710339|FG001|Overall Study|Physician Decision|1|||
124750660|NCT00891228|448710340|FG002|Overall Study|Physician Decision|0|||
124750661|NCT00891228|448710338|FG000|Overall Study|Lost to Follow-up|4|||
124750662|NCT00891228|448710339|FG001|Overall Study|Lost to Follow-up|4|||
124750663|NCT00891228|448710340|FG002|Overall Study|Lost to Follow-up|5|||
124750664|NCT00891228|448710338|FG000|Overall Study|Pregnancy|0|||
124750665|NCT00891228|448710339|FG001|Overall Study|Pregnancy|1|||
124750666|NCT00891228|448710340|FG002|Overall Study|Pregnancy|0|||
124750667|NCT02688985|448710343|FG000|Overall Study|Adverse Event|1|||
124750668|NCT02688985|448710344|FG001|Overall Study|Adverse Event|2|||
124750669|NCT02688985|448710345|FG002|Overall Study|Adverse Event|2|||
124750670|NCT02688985|448710346|FG003|Overall Study|Adverse Event|0|||
124750671|NCT02688985|448710347|FG004|Overall Study|Adverse Event|0|||
124750672|NCT02688985|448710343|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
124750673|NCT02688985|448710344|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
124750674|NCT02688985|448710345|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
124750675|NCT02688985|448710346|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
124750676|NCT02688985|448710347|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
124750677|NCT02688985|448710343|FG000|Overall Study|Death|0|||
124750678|NCT02688985|448710344|FG001|Overall Study|Death|0|||
124750679|NCT02688985|448710345|FG002|Overall Study|Death|0|||
124750680|NCT02688985|448710346|FG003|Overall Study|Death|0|||
124750681|NCT02688985|448710347|FG004|Overall Study|Death|1|||
124750682|NCT02688985|448710343|FG000|Overall Study|Lack of Efficacy|0|||
124750683|NCT02688985|448710344|FG001|Overall Study|Lack of Efficacy|0|||
124750684|NCT02688985|448710345|FG002|Overall Study|Lack of Efficacy|0|||
124750685|NCT02688985|448710346|FG003|Overall Study|Lack of Efficacy|0|||
124750686|NCT02688985|448710347|FG004|Overall Study|Lack of Efficacy|1|||
124750687|NCT02688985|448710343|FG000|Overall Study|Lost to Follow-up|2|||
124750688|NCT02688985|448710344|FG001|Overall Study|Lost to Follow-up|0|||
124750689|NCT02688985|448710345|FG002|Overall Study|Lost to Follow-up|1|||
124750690|NCT02688985|448710346|FG003|Overall Study|Lost to Follow-up|1|||
124750691|NCT02688985|448710347|FG004|Overall Study|Lost to Follow-up|1|||
124750692|NCT02688985|448710343|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124750693|NCT02688985|448710344|FG001|Overall Study|Non-Compliance With Study Drug|3|||
124750694|NCT02688985|448710345|FG002|Overall Study|Non-Compliance With Study Drug|1|||
124750695|NCT02688985|448710346|FG003|Overall Study|Non-Compliance With Study Drug|0|||
124750696|NCT02688985|448710347|FG004|Overall Study|Non-Compliance With Study Drug|1|||
124750697|NCT02688985|448710343|FG000|Overall Study|Other|3|||
124750698|NCT02688985|448710344|FG001|Overall Study|Other|4|||
124750699|NCT02688985|448710345|FG002|Overall Study|Other|1|||
124750700|NCT02688985|448710346|FG003|Overall Study|Other|0|||
124750701|NCT02688985|448710347|FG004|Overall Study|Other|0|||
124750702|NCT02688985|448710343|FG000|Overall Study|Physician Decision|2|||
124750703|NCT02688985|448710344|FG001|Overall Study|Physician Decision|2|||
124750704|NCT02688985|448710345|FG002|Overall Study|Physician Decision|0|||
124750705|NCT02688985|448710346|FG003|Overall Study|Physician Decision|0|||
124750706|NCT02688985|448710347|FG004|Overall Study|Physician Decision|1|||
124750707|NCT02688985|448710343|FG000|Overall Study|Pregnancy|0|||
124750708|NCT02688985|448710344|FG001|Overall Study|Pregnancy|0|||
124750709|NCT02688985|448710345|FG002|Overall Study|Pregnancy|2|||
124750710|NCT02688985|448710346|FG003|Overall Study|Pregnancy|1|||
124750711|NCT02688985|448710347|FG004|Overall Study|Pregnancy|0|||
124750712|NCT02688985|448710343|FG000|Overall Study|Study Terminated By Sponsor|0|||
124750713|NCT02688985|448710344|FG001|Overall Study|Study Terminated By Sponsor|0|||
124750714|NCT02688985|448710345|FG002|Overall Study|Study Terminated By Sponsor|0|||
124750715|NCT02688985|448710346|FG003|Overall Study|Study Terminated By Sponsor|1|||
124750716|NCT02688985|448710347|FG004|Overall Study|Study Terminated By Sponsor|0|||
124750717|NCT02688985|448710343|FG000|Overall Study|Withdrawal by Subject|2|||
124750718|NCT02688985|448710344|FG001|Overall Study|Withdrawal by Subject|8|||
124750719|NCT02688985|448710345|FG002|Overall Study|Withdrawal by Subject|7|||
124750720|NCT02688985|448710346|FG003|Overall Study|Withdrawal by Subject|1|||
124750721|NCT02688985|448710347|FG004|Overall Study|Withdrawal by Subject|4|||
124750722|NCT01726582|448710348|FG000|Overall Study|Physician Decision|99|||
124750723|NCT01726582|448710348|FG000|Overall Study|Death|85|||
124750724|NCT03704688|448710353|FG000|Overall Study|Adverse Event|0|||
124750725|NCT03704688|448710354|FG001|Overall Study|Adverse Event|0|||
124750726|NCT03704688|448710355|FG002|Overall Study|Adverse Event|0|||
124750727|NCT03704688|448710356|FG003|Overall Study|Adverse Event|4|||
124750728|NCT03704688|448710357|FG004|Overall Study|Adverse Event|1|||
124750729|NCT03704688|448710358|FG005|Overall Study|Adverse Event|0|||
124750730|NCT03704688|448710353|FG000|Overall Study|Disease Progression|0|||
124750731|NCT03704688|448710354|FG001|Overall Study|Disease Progression|0|||
124750732|NCT03704688|448710355|FG002|Overall Study|Disease Progression|0|||
124750733|NCT03704688|448710356|FG003|Overall Study|Disease Progression|3|||
124750734|NCT03704688|448710357|FG004|Overall Study|Disease Progression|1|||
124750735|NCT03704688|448710358|FG005|Overall Study|Disease Progression|0|||
124750736|NCT03704688|448710353|FG000|Overall Study|Death|0|||
124750737|NCT03704688|448710354|FG001|Overall Study|Death|0|||
124750738|NCT03704688|448710355|FG002|Overall Study|Death|0|||
124750739|NCT03704688|448710356|FG003|Overall Study|Death|0|||
124750740|NCT03704688|448710357|FG004|Overall Study|Death|3|||
124750741|NCT03704688|448710358|FG005|Overall Study|Death|0|||
124750742|NCT04878211|448710360|FG000|Overall Study|Lost to Follow-up|0|||
124750743|NCT04878211|448710361|FG001|Overall Study|Lost to Follow-up|0|||
124750744|NCT04878211|448710362|FG002|Overall Study|Lost to Follow-up|0|||
124750745|NCT04878211|448710363|FG003|Overall Study|Lost to Follow-up|1|||
124750746|NCT04878211|448710364|FG004|Overall Study|Lost to Follow-up|0|||
124750747|NCT04878211|448710365|FG005|Overall Study|Lost to Follow-up|1|||
124750748|NCT04878211|448710360|FG000|Overall Study|Protocol deviation|1|||
124750749|NCT04878211|448710361|FG001|Overall Study|Protocol deviation|0|||
124750750|NCT04878211|448710362|FG002|Overall Study|Protocol deviation|0|||
124750751|NCT04878211|448710363|FG003|Overall Study|Protocol deviation|0|||
124750752|NCT04878211|448710364|FG004|Overall Study|Protocol deviation|0|||
124750753|NCT04878211|448710365|FG005|Overall Study|Protocol deviation|0|||
124750754|NCT04878211|448710360|FG000|Overall Study|Study terminated by sponsor|0|||
124750755|NCT04878211|448710361|FG001|Overall Study|Study terminated by sponsor|0|||
124750756|NCT04878211|448710362|FG002|Overall Study|Study terminated by sponsor|0|||
124750757|NCT04878211|448710363|FG003|Overall Study|Study terminated by sponsor|0|||
124750758|NCT04878211|448710364|FG004|Overall Study|Study terminated by sponsor|9|||
124750759|NCT04878211|448710365|FG005|Overall Study|Study terminated by sponsor|4|||
124750760|NCT04878211|448710360|FG000|Overall Study|Subject decision|0|||
124750761|NCT04878211|448710361|FG001|Overall Study|Subject decision|0|||
124750762|NCT04878211|448710362|FG002|Overall Study|Subject decision|0|||
124750763|NCT04878211|448710363|FG003|Overall Study|Subject decision|0|||
124750764|NCT04878211|448710364|FG004|Overall Study|Subject decision|1|||
124750765|NCT04878211|448710365|FG005|Overall Study|Subject decision|0|||
124750766|NCT02783599|448710366|FG000|Overall Study|Progressive disease|23|||
124750767|NCT02783599|448710366|FG000|Overall Study|Surgical Resection|10|||
124750768|NCT02783599|448710366|FG000|Overall Study|Adverse Event|4|||
124750769|NCT02783599|448710366|FG000|Overall Study|Physician Decision|2|||
124750770|NCT02783599|448710366|FG000|Overall Study|Death|1|||
124750771|NCT00856544|448710367|FG000|Overall Study|Randomized but not treated|3|||
124750772|NCT00856544|448710368|FG001|Overall Study|Randomized but not treated|0|||
124750773|NCT00856544|448710369|FG002|Overall Study|Randomized but not treated|0|||
124750774|NCT00856544|448710370|FG003|Overall Study|Randomized but not treated|0|||
124750775|NCT00856544|448710367|FG000|Overall Study|Death|0|||
124750776|NCT00856544|448710368|FG001|Overall Study|Death|2|||
124750777|NCT00856544|448710369|FG002|Overall Study|Death|0|||
124750778|NCT00856544|448710370|FG003|Overall Study|Death|0|||
124750779|NCT00856544|448710367|FG000|Overall Study|Adverse Event|20|||
124750780|NCT00856544|448710368|FG001|Overall Study|Adverse Event|29|||
124750781|NCT00856544|448710369|FG002|Overall Study|Adverse Event|2|||
124750782|NCT00856544|448710370|FG003|Overall Study|Adverse Event|3|||
124750783|NCT00856544|448710367|FG000|Overall Study|Lack of Efficacy|16|||
124750784|NCT00856544|448710368|FG001|Overall Study|Lack of Efficacy|12|||
124750785|NCT00856544|448710369|FG002|Overall Study|Lack of Efficacy|3|||
124750786|NCT00856544|448710370|FG003|Overall Study|Lack of Efficacy|3|||
124750787|NCT00856544|448710367|FG000|Overall Study|Other|9|||
124750788|NCT00856544|448710368|FG001|Overall Study|Other|16|||
124750789|NCT00856544|448710369|FG002|Overall Study|Other|1|||
124750790|NCT00856544|448710370|FG003|Overall Study|Other|6|||
124750791|NCT00856544|448710367|FG000|Overall Study|Lost to Follow-up|1|||
124750792|NCT00856544|448710368|FG001|Overall Study|Lost to Follow-up|2|||
124750793|NCT00856544|448710369|FG002|Overall Study|Lost to Follow-up|2|||
124750794|NCT00856544|448710370|FG003|Overall Study|Lost to Follow-up|0|||
124750795|NCT00856544|448710367|FG000|Overall Study|Withdrawal by Subject|8|||
124750796|NCT00856544|448710368|FG001|Overall Study|Withdrawal by Subject|5|||
124750797|NCT00856544|448710369|FG002|Overall Study|Withdrawal by Subject|0|||
124750798|NCT00856544|448710370|FG003|Overall Study|Withdrawal by Subject|1|||
124750799|NCT00787189|448710371|FG000|Overall Study|Lost to Follow-up|2|||
124750800|NCT00787189|448710372|FG001|Overall Study|Lost to Follow-up|2|||
124750801|NCT00847886|448710373|FG000|Overall Study|Adverse Event|0|||
124750802|NCT00847886|448710374|FG001|Overall Study|Adverse Event|1|||
124750803|NCT03920254|448710379|FG000|Overall Study|Adverse Event|1|||
124750804|NCT03920254|448710380|FG001|Overall Study|Adverse Event|0|||
124750805|NCT03920254|448710381|FG002|Overall Study|Adverse Event|0|||
124750806|NCT03920254|448710379|FG000|Overall Study|Physician Decision|0|||
124750807|NCT03920254|448710380|FG001|Overall Study|Physician Decision|1|||
124750808|NCT03920254|448710381|FG002|Overall Study|Physician Decision|2|||
124750809|NCT03920254|448710379|FG000|Overall Study|Study Terminated By Sponsor|12|||
124750810|NCT03920254|448710380|FG001|Overall Study|Study Terminated By Sponsor|17|||
124750811|NCT03920254|448710381|FG002|Overall Study|Study Terminated By Sponsor|12|||
124750812|NCT03920254|448710379|FG000|Overall Study|Withdrawal by Subject|0|||
124750813|NCT03920254|448710380|FG001|Overall Study|Withdrawal by Subject|0|||
124750814|NCT03920254|448710381|FG002|Overall Study|Withdrawal by Subject|1|||
124750815|NCT05274269|448710382|FG000|Overall Study|Adverse Event|0|||
124750816|NCT05274269|448710383|FG001|Overall Study|Adverse Event|3|||
124750817|NCT05274269|448710382|FG000|Overall Study|Death|0|||
124750818|NCT05274269|448710383|FG001|Overall Study|Death|1|||
124750819|NCT05274269|448710382|FG000|Overall Study|Other|0|||
124750820|NCT05274269|448710383|FG001|Overall Study|Other|2|||
124750821|NCT05274269|448710382|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
124750822|NCT05274269|448710383|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
124750823|NCT02206035|448710384|FG000|Overall Study|Physician Decision|10|||
124750824|NCT02206035|448710385|FG001|Overall Study|Physician Decision|0|||
124750825|NCT02206035|448710386|FG002|Overall Study|Physician Decision|175|||
124750826|NCT05173012|448710388|FG000|Overall Study|Adverse Event|2|||
124750827|NCT05173012|448710389|FG001|Overall Study|Adverse Event|3|||
124750828|NCT05173012|448710390|FG002|Overall Study|Adverse Event|4|||
124750829|NCT05173012|448710391|FG003|Overall Study|Adverse Event|13|||
124750830|NCT05173012|448710392|FG004|Overall Study|Adverse Event|0|||
124750831|NCT05173012|448710393|FG005|Overall Study|Adverse Event|0|||
124750832|NCT05173012|448710394|FG006|Overall Study|Adverse Event|2|||
124750833|NCT05173012|448710395|FG007|Overall Study|Adverse Event|4|||
124750834|NCT05173012|448710388|FG000|Overall Study|Lost to Follow-up|0|||
124750835|NCT05173012|448710389|FG001|Overall Study|Lost to Follow-up|0|||
124750836|NCT05173012|448710390|FG002|Overall Study|Lost to Follow-up|0|||
124750837|NCT05173012|448710391|FG003|Overall Study|Lost to Follow-up|1|||
124750838|NCT05173012|448710392|FG004|Overall Study|Lost to Follow-up|0|||
124750839|NCT05173012|448710393|FG005|Overall Study|Lost to Follow-up|0|||
124750840|NCT05173012|448710394|FG006|Overall Study|Lost to Follow-up|0|||
124750841|NCT05173012|448710395|FG007|Overall Study|Lost to Follow-up|0|||
124750842|NCT05173012|448710388|FG000|Overall Study|Withdrawal by Subject|1|||
124750843|NCT05173012|448710389|FG001|Overall Study|Withdrawal by Subject|0|||
124750844|NCT05173012|448710390|FG002|Overall Study|Withdrawal by Subject|1|||
124750845|NCT05173012|448710391|FG003|Overall Study|Withdrawal by Subject|3|||
124750846|NCT05173012|448710392|FG004|Overall Study|Withdrawal by Subject|1|||
124750847|NCT05173012|448710393|FG005|Overall Study|Withdrawal by Subject|0|||
124750848|NCT05173012|448710394|FG006|Overall Study|Withdrawal by Subject|1|||
124750849|NCT05173012|448710395|FG007|Overall Study|Withdrawal by Subject|0|||
124750850|NCT05173012|448710388|FG000|Overall Study|Protocol Deviation|0|||
124750851|NCT05173012|448710389|FG001|Overall Study|Protocol Deviation|0|||
124750852|NCT05173012|448710390|FG002|Overall Study|Protocol Deviation|0|||
124750853|NCT05173012|448710391|FG003|Overall Study|Protocol Deviation|1|||
124750854|NCT05173012|448710392|FG004|Overall Study|Protocol Deviation|0|||
124750855|NCT05173012|448710393|FG005|Overall Study|Protocol Deviation|0|||
124750856|NCT05173012|448710394|FG006|Overall Study|Protocol Deviation|0|||
124750857|NCT05173012|448710395|FG007|Overall Study|Protocol Deviation|0|||
124750858|NCT05173012|448710388|FG000|Overall Study|Other|0|||
124750859|NCT05173012|448710389|FG001|Overall Study|Other|0|||
124750860|NCT05173012|448710390|FG002|Overall Study|Other|0|||
124750861|NCT05173012|448710391|FG003|Overall Study|Other|2|||
124750862|NCT05173012|448710392|FG004|Overall Study|Other|0|||
124750863|NCT05173012|448710393|FG005|Overall Study|Other|0|||
124750864|NCT05173012|448710394|FG006|Overall Study|Other|0|||
124750865|NCT05173012|448710395|FG007|Overall Study|Other|0|||
124750866|NCT03668613|448710396|FG000|Overall Study|Adverse Event|1|||
124750867|NCT03668613|448710397|FG001|Overall Study|Adverse Event|2|||
124750868|NCT03668613|448710396|FG000|Overall Study|Lack of Efficacy|5|||
124750869|NCT03668613|448710397|FG001|Overall Study|Lack of Efficacy|1|||
124750870|NCT03668613|448710396|FG000|Overall Study|Pregnancy|0|||
124750871|NCT03668613|448710397|FG001|Overall Study|Pregnancy|2|||
124750872|NCT03668613|448710396|FG000|Overall Study|Protocol Violation|1|||
124750873|NCT03668613|448710397|FG001|Overall Study|Protocol Violation|0|||
124750874|NCT03668613|448710396|FG000|Overall Study|Physician Decision|1|||
124750875|NCT03668613|448710397|FG001|Overall Study|Physician Decision|0|||
124750876|NCT03668613|448710396|FG000|Overall Study|Withdrawal by Subject|2|||
124750877|NCT03668613|448710397|FG001|Overall Study|Withdrawal by Subject|1|||
124750878|NCT03668613|448710396|FG000|Overall Study|Guardian decision|1|||
124750879|NCT03668613|448710397|FG001|Overall Study|Guardian decision|0|||
124750880|NCT01068769|448710400|FG000|Overall Study|Ineligible|1|||
124750881|NCT00709618|448710401|FG000|Overall Study|Withdrawal by Subject|4|||
124750882|NCT00709618|448710401|FG000|Overall Study|Lost to Follow-up|1|||
124750883|NCT00709618|448710401|FG000|Overall Study|Study Closed/Terminated|25|||
124750884|NCT01948063|448710404|FG000|Overall Study|Boston MCI halted research protocol|0|||
124750885|NCT01948063|448710405|FG001|Overall Study|Boston MCI halted research protocol|1|||
124750886|NCT01948063|448710404|FG000|Overall Study|Discovered an enrollment in other study|0|||
124750887|NCT01948063|448710405|FG001|Overall Study|Discovered an enrollment in other study|1|||
124750888|NCT01948063|448710404|FG000|Overall Study|Blood samples were accidentally thawed|1|||
124750889|NCT01948063|448710405|FG001|Overall Study|Blood samples were accidentally thawed|0|||
124750890|NCT03781414|448710408|FG000|Overall Study|Study terminated by sponsor|39|||
124750891|NCT03781414|448710409|FG001|Overall Study|Study terminated by sponsor|34|||
124750892|NCT03781414|448710410|FG002|Overall Study|Study terminated by sponsor|25|||
124750893|NCT03781414|448710408|FG000|Overall Study|Adverse Event|3|||
124750894|NCT03781414|448710409|FG001|Overall Study|Adverse Event|6|||
124750895|NCT03781414|448710410|FG002|Overall Study|Adverse Event|3|||
124750896|NCT03781414|448710408|FG000|Overall Study|Physician Decision|2|||
124750897|NCT03781414|448710409|FG001|Overall Study|Physician Decision|0|||
124750898|NCT03781414|448710410|FG002|Overall Study|Physician Decision|1|||
124750899|NCT03781414|448710408|FG000|Overall Study|Withdrawal by Subject|2|||
124750900|NCT03781414|448710409|FG001|Overall Study|Withdrawal by Subject|3|||
124750901|NCT03781414|448710410|FG002|Overall Study|Withdrawal by Subject|3|||
124750902|NCT03781414|448710408|FG000|Overall Study|Death|1|||
124750903|NCT03781414|448710409|FG001|Overall Study|Death|4|||
124750904|NCT03781414|448710410|FG002|Overall Study|Death|0|||
124750905|NCT03781414|448710408|FG000|Overall Study|Lost to Follow-up|1|||
124750906|NCT03781414|448710409|FG001|Overall Study|Lost to Follow-up|1|||
124750907|NCT03781414|448710410|FG002|Overall Study|Lost to Follow-up|0|||
124750908|NCT04752358|448710411|FG000|Overall Study|Death|2|||
124750909|NCT04752358|448710412|FG001|Overall Study|Death|1|||
124750910|NCT00719355|448710413|FG000|Overall Study|Death|0|||
124750911|NCT00719355|448710414|FG001|Overall Study|Death|1|||
124750912|NCT00719355|448710413|FG000|Overall Study|Medical|14|||
124750913|NCT00719355|448710414|FG001|Overall Study|Medical|5|||
124750914|NCT00719355|448710413|FG000|Overall Study|Compliance|4|||
124750915|NCT00719355|448710414|FG001|Overall Study|Compliance|6|||
124750916|NCT00719355|448710413|FG000|Overall Study|Moved|0|||
124750917|NCT00719355|448710414|FG001|Overall Study|Moved|1|||
124750918|NCT03364738|448710416|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
124750919|NCT03364738|448710416|FG000|Overall Study|Withdrawal by Subject|1|||
124750920|NCT03364738|448710416|FG000|Overall Study|Adverse Event|1|||
124750921|NCT00988091|448710423|FG000|Double-blind Period|Withdrawal by Subject|15|||
124750922|NCT00988091|448710424|FG001|Double-blind Period|Withdrawal by Subject|13|||
124750923|NCT00988091|448710423|FG000|Double-blind Period|Lost to Follow-up|12|||
124750924|NCT00988091|448710424|FG001|Double-blind Period|Lost to Follow-up|14|||
124750925|NCT00988091|448710423|FG000|Double-blind Period|Other|8|||
124750926|NCT00988091|448710424|FG001|Double-blind Period|Other|8|||
124750927|NCT00988091|448710423|FG000|Double-blind Period|Adverse Event|6|||
124750928|NCT00988091|448710424|FG001|Double-blind Period|Adverse Event|9|||
124750929|NCT00988091|448710423|FG000|Double-blind Period|Use of exclusionary medication|2|||
124750930|NCT00988091|448710424|FG001|Double-blind Period|Use of exclusionary medication|3|||
124750931|NCT00988091|448710423|FG000|Open-label Period|Adverse Event|4|||
124750932|NCT00988091|448710424|FG001|Open-label Period|Adverse Event|7|||
124750933|NCT00988091|448710423|FG000|Open-label Period|Use of exclusionary medication|1|||
124750934|NCT00988091|448710424|FG001|Open-label Period|Use of exclusionary medication|1|||
124750935|NCT00988091|448710423|FG000|Open-label Period|Protocol Violation|1|||
124750936|NCT00988091|448710424|FG001|Open-label Period|Protocol Violation|1|||
124750937|NCT00988091|448710423|FG000|Open-label Period|Withdrawal by Subject|10|||
124750938|NCT00988091|448710424|FG001|Open-label Period|Withdrawal by Subject|16|||
124750939|NCT00988091|448710423|FG000|Open-label Period|Lost to Follow-up|3|||
124750940|NCT00988091|448710424|FG001|Open-label Period|Lost to Follow-up|5|||
124750941|NCT00988091|448710423|FG000|Open-label Period|Other|2|||
124750942|NCT00988091|448710424|FG001|Open-label Period|Other|3|||
124750943|NCT00994422|448710425|FG000|Overall Study|Lost to Follow-up|7|||
124750944|NCT00994422|448710426|FG001|Overall Study|Lost to Follow-up|1|||
124750945|NCT01846741|448710428|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
124750946|NCT03664765|448710429|FG000|Overall Study|Withdrawal by Subject|4|||
124750947|NCT03664765|448710430|FG001|Overall Study|Withdrawal by Subject|1|||
124750948|NCT03664765|448710429|FG000|Overall Study|Lost to Follow-up|0|||
124750949|NCT03664765|448710430|FG001|Overall Study|Lost to Follow-up|1|||
124750950|NCT01153698|448710431|FG000|Overall Study|Adverse Event|12|||
124750951|NCT01153698|448710431|FG000|Overall Study|Lost to Follow-up|4|||
124750952|NCT01153698|448710431|FG000|Overall Study|Withdrawal by Subject|2|||
124750953|NCT01153698|448710431|FG000|Overall Study|Switch to other anticoagulants|4|||
124750954|NCT01153698|448710431|FG000|Overall Study|Other|2|||
124750955|NCT01153698|448710431|FG000|Overall Study|Not treated with Pradaxa|5|||
124750956|NCT01090063|448710432|FG000|Screen|Screen Failed|4|||
124750957|NCT01090063|448710432|FG000|Treatment|Withdrawal by Subject|4|||
124750958|NCT00330681|448710437|FG000|Overall Study|Adverse Event|3|||
124750959|NCT00330681|448710438|FG001|Overall Study|Adverse Event|6|||
124750960|NCT00330681|448710437|FG000|Overall Study|Protocol Violation|0|||
124750961|NCT00330681|448710438|FG001|Overall Study|Protocol Violation|1|||
124750962|NCT00330681|448710437|FG000|Overall Study|Withdrawal by Subject|5|||
124750963|NCT00330681|448710438|FG001|Overall Study|Withdrawal by Subject|5|||
124750964|NCT00330681|448710437|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
124750965|NCT00330681|448710438|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
124750966|NCT00428389|448710439|FG000|Core Phase|Adverse Event|6|||
124750967|NCT00428389|448710440|FG001|Core Phase|Adverse Event|4|||
124750968|NCT00428389|448710439|FG000|Core Phase|Lack of Efficacy|2|||
124750969|NCT00428389|448710440|FG001|Core Phase|Lack of Efficacy|0|||
124750970|NCT00428389|448710439|FG000|Core Phase|Abnormal test procedure result(s)|0|||
124750971|NCT00428389|448710440|FG001|Core Phase|Abnormal test procedure result(s)|1|||
124750972|NCT00428389|448710439|FG000|Core Phase|Withdrawal by Subject|3|||
124750973|NCT00428389|448710440|FG001|Core Phase|Withdrawal by Subject|4|||
124750974|NCT00428389|448710439|FG000|Core Phase|Protocol deviation|0|||
124750975|NCT00428389|448710440|FG001|Core Phase|Protocol deviation|2|||
124750976|NCT00428389|448710439|FG000|Extension Phase|Adverse Event|17|||
124750977|NCT00428389|448710440|FG001|Extension Phase|Adverse Event|11|||
124750978|NCT00428389|448710439|FG000|Extension Phase|Lack of Efficacy|4|||
124750979|NCT00428389|448710440|FG001|Extension Phase|Lack of Efficacy|3|||
124750980|NCT00428389|448710439|FG000|Extension Phase|Withdrawal by Subject|6|||
124750981|NCT00428389|448710440|FG001|Extension Phase|Withdrawal by Subject|6|||
124750982|NCT00428389|448710439|FG000|Extension Phase|Lost to Follow-up|0|||
124750983|NCT00428389|448710440|FG001|Extension Phase|Lost to Follow-up|3|||
124750984|NCT00428389|448710439|FG000|Extension Phase|Death|1|||
124750985|NCT00428389|448710440|FG001|Extension Phase|Death|0|||
124750986|NCT00428389|448710439|FG000|Extension Phase|Protocol Violation|3|||
124750987|NCT00428389|448710440|FG001|Extension Phase|Protocol Violation|2|||
124750988|NCT00428389|448710439|FG000|Extension Phase|Administrative problems|1|||
124750989|NCT00428389|448710440|FG001|Extension Phase|Administrative problems|1|||
124750990|NCT04384523|448710441|FG000|Overall Study|Lost to Follow-up|0|||
124750991|NCT04384523|448710442|FG001|Overall Study|Lost to Follow-up|0|||
124750992|NCT04384523|448710443|FG002|Overall Study|Lost to Follow-up|0|||
124750993|NCT04384523|448710444|FG003|Overall Study|Lost to Follow-up|0|||
124750994|NCT04384523|448710445|FG004|Overall Study|Lost to Follow-up|0|||
124750995|NCT04384523|448710446|FG005|Overall Study|Lost to Follow-up|1|||
124750996|NCT04384523|448710441|FG000|Overall Study|Protocol Violation|0|||
124750997|NCT04384523|448710442|FG001|Overall Study|Protocol Violation|1|||
124750998|NCT04384523|448710443|FG002|Overall Study|Protocol Violation|0|||
124750999|NCT04384523|448710444|FG003|Overall Study|Protocol Violation|0|||
124751000|NCT04384523|448710445|FG004|Overall Study|Protocol Violation|0|||
124751001|NCT04384523|448710446|FG005|Overall Study|Protocol Violation|0|||
124751002|NCT04384523|448710441|FG000|Overall Study|Withdrawal by Subject|1|||
124751003|NCT04384523|448710442|FG001|Overall Study|Withdrawal by Subject|0|||
124751004|NCT04384523|448710443|FG002|Overall Study|Withdrawal by Subject|0|||
124751005|NCT04384523|448710444|FG003|Overall Study|Withdrawal by Subject|0|||
124751006|NCT04384523|448710445|FG004|Overall Study|Withdrawal by Subject|0|||
124751007|NCT04384523|448710446|FG005|Overall Study|Withdrawal by Subject|0|||
124751008|NCT03216746|448710447|FG000|Overall Study|Lost to Follow-up|6|||
124751009|NCT03216746|448710448|FG001|Overall Study|Lost to Follow-up|8|||
124751010|NCT03216746|448710449|FG002|Overall Study|Lost to Follow-up|5|||
124751011|NCT03216746|448710450|FG003|Overall Study|Lost to Follow-up|6|||
124751012|NCT04405076|448710451|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
124751013|NCT04405076|448710452|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
124751014|NCT04405076|448710453|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
124751015|NCT04405076|448710454|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
124751016|NCT04405076|448710455|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
124751017|NCT04405076|448710456|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
124751018|NCT04405076|448710457|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
124751019|NCT04405076|448710458|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
124751020|NCT04405076|448710459|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
124751021|NCT04405076|448710451|FG000|Part A (Blinded Phase)|Physician Decision|1|||
124751022|NCT04405076|448710452|FG001|Part A (Blinded Phase)|Physician Decision|2|||
124751023|NCT04405076|448710453|FG002|Part A (Blinded Phase)|Physician Decision|0|||
124751024|NCT04405076|448710454|FG003|Part A (Blinded Phase)|Physician Decision|0|||
124751025|NCT04405076|448710455|FG004|Part A (Blinded Phase)|Physician Decision|0|||
124751026|NCT04405076|448710456|FG005|Part A (Blinded Phase)|Physician Decision|0|||
124751027|NCT04405076|448710457|FG006|Part A (Blinded Phase)|Physician Decision|0|||
124751028|NCT04405076|448710458|FG007|Part A (Blinded Phase)|Physician Decision|0|||
124751029|NCT04405076|448710459|FG008|Part A (Blinded Phase)|Physician Decision|0|||
124751030|NCT04405076|448710451|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
124751031|NCT04405076|448710452|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
124751032|NCT04405076|448710453|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
124751033|NCT04405076|448710454|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
124751034|NCT04405076|448710455|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
124751035|NCT04405076|448710456|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
124751036|NCT04405076|448710457|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
124751037|NCT04405076|448710458|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
124751038|NCT04405076|448710459|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
124751039|NCT04405076|448710451|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
124751040|NCT04405076|448710452|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
124751041|NCT04405076|448710453|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
124751042|NCT04405076|448710454|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
124751043|NCT04405076|448710455|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
124751044|NCT04405076|448710456|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
124751045|NCT04405076|448710457|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
124751046|NCT04405076|448710458|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
124751047|NCT04405076|448710459|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
124751048|NCT04405076|448710451|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
124751049|NCT04405076|448710452|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
124751050|NCT04405076|448710453|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
124751051|NCT04405076|448710454|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
124751052|NCT04405076|448710455|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
124751053|NCT04405076|448710456|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
124751054|NCT04405076|448710457|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
124751055|NCT04405076|448710458|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
124751056|NCT04405076|448710459|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
124751057|NCT04405076|448710451|FG000|Part A (Blinded Phase)|Other than Specified|0|||
124751058|NCT04405076|448710452|FG001|Part A (Blinded Phase)|Other than Specified|0|||
124751059|NCT04405076|448710453|FG002|Part A (Blinded Phase)|Other than Specified|3|||
124751060|NCT04405076|448710454|FG003|Part A (Blinded Phase)|Other than Specified|0|||
124751061|NCT04405076|448710455|FG004|Part A (Blinded Phase)|Other than Specified|0|||
124751062|NCT04405076|448710456|FG005|Part A (Blinded Phase)|Other than Specified|0|||
124751063|NCT04405076|448710457|FG006|Part A (Blinded Phase)|Other than Specified|0|||
124751064|NCT04405076|448710458|FG007|Part A (Blinded Phase)|Other than Specified|0|||
124751065|NCT04405076|448710459|FG008|Part A (Blinded Phase)|Other than Specified|0|||
124751066|NCT04405076|448710451|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
124751067|NCT04405076|448710452|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
124751068|NCT04405076|448710453|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
124751069|NCT04405076|448710454|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
124751070|NCT04405076|448710455|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
124751071|NCT04405076|448710456|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
124751072|NCT04405076|448710457|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
124751073|NCT04405076|448710458|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
124751074|NCT04405076|448710459|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
124751075|NCT04405076|448710451|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
124751076|NCT04405076|448710452|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
124751077|NCT04405076|448710453|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
124751078|NCT04405076|448710454|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
124751079|NCT04405076|448710455|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
124751080|NCT04405076|448710456|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
124751081|NCT04405076|448710457|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
124751082|NCT04405076|448710458|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
124751083|NCT04405076|448710459|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
124751084|NCT04405076|448710451|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
124751085|NCT04405076|448710452|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
124751086|NCT04405076|448710453|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
124751087|NCT04405076|448710454|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
124751088|NCT04405076|448710455|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
124751089|NCT04405076|448710456|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
124751090|NCT04405076|448710457|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
124751091|NCT04405076|448710458|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
124751092|NCT04405076|448710459|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
124751093|NCT04405076|448710451|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
124751094|NCT04405076|448710452|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
124751095|NCT04405076|448710453|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
124751096|NCT04405076|448710454|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
124751097|NCT04405076|448710455|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
124751098|NCT04405076|448710456|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
124751099|NCT04405076|448710457|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
124751100|NCT04405076|448710458|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
124751101|NCT04405076|448710459|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
124783052|NCT02834793|448835854|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
124620758|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
124620759|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
124620760|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
124620761|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
124620762|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
124751102|NCT04405076|448710451|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
124751103|NCT04405076|448710452|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
124751104|NCT04405076|448710453|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
124751105|NCT04405076|448710454|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
124751106|NCT04405076|448710455|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
124751107|NCT04405076|448710456|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
124751108|NCT04405076|448710457|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
124751109|NCT04405076|448710458|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
124751110|NCT04405076|448710459|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
124751111|NCT00392990|448710460|FG000|Treatment on Study|Adverse Event|3|||
124751112|NCT00392990|448710461|FG001|Treatment on Study|Adverse Event|1|||
124751113|NCT00392990|448710460|FG000|Follow up for 2 Years|Death|4|||
124751114|NCT00392990|448710461|FG001|Follow up for 2 Years|Death|0|||
124751115|NCT02980133|448710462|FG000|Overall Study|Other than specified|1|||
124751116|NCT02980133|448710463|FG001|Overall Study|Other than specified|1|||
124751117|NCT02980133|448710464|FG002|Overall Study|Other than specified|2|||
124751118|NCT02980133|448710465|FG003|Overall Study|Other than specified|2|||
124751119|NCT02980133|448710462|FG000|Overall Study|Lost to Follow-up|0|||
124751120|NCT02980133|448710463|FG001|Overall Study|Lost to Follow-up|0|||
124751121|NCT02980133|448710464|FG002|Overall Study|Lost to Follow-up|1|||
124751122|NCT02980133|448710465|FG003|Overall Study|Lost to Follow-up|3|||
124751123|NCT02980133|448710462|FG000|Overall Study|Protocol Violation|0|||
124751124|NCT02980133|448710463|FG001|Overall Study|Protocol Violation|1|||
124751125|NCT02980133|448710464|FG002|Overall Study|Protocol Violation|0|||
124751126|NCT02980133|448710465|FG003|Overall Study|Protocol Violation|0|||
124751127|NCT02980133|448710462|FG000|Overall Study|Withdrawal by parent/guardian|6|||
124751128|NCT02980133|448710463|FG001|Overall Study|Withdrawal by parent/guardian|3|||
124751129|NCT02980133|448710464|FG002|Overall Study|Withdrawal by parent/guardian|3|||
124751130|NCT02980133|448710465|FG003|Overall Study|Withdrawal by parent/guardian|1|||
124751131|NCT02980133|448710462|FG000|Overall Study|Withdrawal by Subject|0|||
124751132|NCT02980133|448710463|FG001|Overall Study|Withdrawal by Subject|0|||
124751133|NCT02980133|448710464|FG002|Overall Study|Withdrawal by Subject|1|||
124751134|NCT02980133|448710465|FG003|Overall Study|Withdrawal by Subject|0|||
124751135|NCT00172042|448710466|FG000|Overall Study|Adverse Event|27|||
124751136|NCT00172042|448710467|FG001|Overall Study|Adverse Event|13|||
124751137|NCT00172042|448710466|FG000|Overall Study|Abnormal laboratory value(s)|5|||
124751138|NCT00172042|448710467|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124751139|NCT00172042|448710466|FG000|Overall Study|Abnormal test procedure(s)|0|||
124751140|NCT00172042|448710467|FG001|Overall Study|Abnormal test procedure(s)|3|||
124751141|NCT00172042|448710466|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
124751142|NCT00172042|448710467|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
124751143|NCT00172042|448710466|FG000|Overall Study|Patient no longer requires study drug|10|||
124751144|NCT00172042|448710467|FG001|Overall Study|Patient no longer requires study drug|8|||
124751145|NCT00172042|448710466|FG000|Overall Study|Protocol Violation|8|||
124751146|NCT00172042|448710467|FG001|Overall Study|Protocol Violation|7|||
124751147|NCT00172042|448710466|FG000|Overall Study|Withdrawal by Subject|37|||
124751148|NCT00172042|448710467|FG001|Overall Study|Withdrawal by Subject|25|||
124751149|NCT00172042|448710466|FG000|Overall Study|Lost to Follow-up|3|||
124751150|NCT00172042|448710467|FG001|Overall Study|Lost to Follow-up|5|||
124751151|NCT00172042|448710466|FG000|Overall Study|Administrative problems|13|||
124751152|NCT00172042|448710467|FG001|Overall Study|Administrative problems|10|||
124751153|NCT00172042|448710466|FG000|Overall Study|Death|42|||
124751154|NCT00172042|448710467|FG001|Overall Study|Death|42|||
124751155|NCT03052816|448710468|FG000|Overall Study|Withdrawal by Subject|1|||
124751156|NCT03052816|448710469|FG001|Overall Study|Withdrawal by Subject|0|||
124751157|NCT03052816|448710468|FG000|Overall Study|Desired opioids|2|||
124751158|NCT03052816|448710469|FG001|Overall Study|Desired opioids|0|||
124751159|NCT00408434|448710470|FG000|Overall Study|Adverse Event|0|||
124751160|NCT00408434|448710471|FG001|Overall Study|Adverse Event|0|||
124751161|NCT00408434|448710472|FG002|Overall Study|Adverse Event|1|||
124751162|NCT00408434|448710473|FG003|Overall Study|Adverse Event|0|||
124751163|NCT00408434|448710474|FG004|Overall Study|Adverse Event|0|||
124751164|NCT00408434|448710475|FG005|Overall Study|Adverse Event|0|||
124751165|NCT00408434|448710476|FG006|Overall Study|Adverse Event|0|||
124751166|NCT00408434|448710470|FG000|Overall Study|Progressive disease|6|||
124751167|NCT00408434|448710471|FG001|Overall Study|Progressive disease|3|||
124751168|NCT00408434|448710472|FG002|Overall Study|Progressive disease|4|||
124751169|NCT00408434|448710473|FG003|Overall Study|Progressive disease|3|||
124751170|NCT00408434|448710474|FG004|Overall Study|Progressive disease|3|||
124751171|NCT00408434|448710475|FG005|Overall Study|Progressive disease|1|||
124751172|NCT00408434|448710476|FG006|Overall Study|Progressive disease|4|||
124751173|NCT00408434|448710470|FG000|Overall Study|Other|0|||
124751174|NCT00408434|448710471|FG001|Overall Study|Other|0|||
124751175|NCT00408434|448710472|FG002|Overall Study|Other|1|||
124751176|NCT00408434|448710473|FG003|Overall Study|Other|0|||
124751177|NCT00408434|448710474|FG004|Overall Study|Other|2|||
124751178|NCT00408434|448710475|FG005|Overall Study|Other|1|||
124751179|NCT00408434|448710476|FG006|Overall Study|Other|0|||
124751180|NCT00408434|448710470|FG000|Overall Study|Terminated by Investigator|0|||
124751181|NCT00408434|448710471|FG001|Overall Study|Terminated by Investigator|0|||
124751182|NCT00408434|448710472|FG002|Overall Study|Terminated by Investigator|0|||
124751183|NCT00408434|448710473|FG003|Overall Study|Terminated by Investigator|0|||
124751184|NCT00408434|448710474|FG004|Overall Study|Terminated by Investigator|1|||
124751185|NCT00408434|448710475|FG005|Overall Study|Terminated by Investigator|1|||
124751186|NCT00408434|448710476|FG006|Overall Study|Terminated by Investigator|0|||
124751187|NCT01278797|448710477|FG000|Period 1|Adverse Event|0|||
124751188|NCT01278797|448710478|FG001|Period 1|Adverse Event|1|||
124751189|NCT01278797|448710477|FG000|Period 1|Protocol Violation|1|||
124751190|NCT01278797|448710478|FG001|Period 1|Protocol Violation|0|||
124751191|NCT00895453|448710479|FG000|Overall Study|Lost to Follow-up|25|||
124751192|NCT00895453|448710480|FG001|Overall Study|Lost to Follow-up|25|||
124751193|NCT00895453|448710481|FG002|Overall Study|Lost to Follow-up|23|||
124751194|NCT03188510|448710483|FG000|Overall Study|Inappropriate behavior with site staff|0|||
124751195|NCT03188510|448710484|FG001|Overall Study|Inappropriate behavior with site staff|1|||
124751196|NCT03188510|448710485|FG002|Overall Study|Inappropriate behavior with site staff|0|||
124751197|NCT03052049|448710487|FG000|Overall Study|Withdrawal by Subject|2|||
124751198|NCT00999518|448710488|FG000|Overall Study|Adverse Event|1|||
124751199|NCT00999518|448710489|FG001|Overall Study|Adverse Event|6|||
124751200|NCT00999518|448710490|FG002|Overall Study|Adverse Event|3|||
124751201|NCT00999518|448710491|FG003|Overall Study|Adverse Event|1|||
124751202|NCT00999518|448710492|FG004|Overall Study|Adverse Event|2|||
124751203|NCT00999518|448710488|FG000|Overall Study|Lack of Efficacy|2|||
124751204|NCT00999518|448710489|FG001|Overall Study|Lack of Efficacy|0|||
124751205|NCT00999518|448710490|FG002|Overall Study|Lack of Efficacy|0|||
124751206|NCT00999518|448710491|FG003|Overall Study|Lack of Efficacy|2|||
124751207|NCT00999518|448710492|FG004|Overall Study|Lack of Efficacy|2|||
124751208|NCT00999518|448710488|FG000|Overall Study|Lost to Follow-up|0|||
124751209|NCT00999518|448710489|FG001|Overall Study|Lost to Follow-up|0|||
124751210|NCT00999518|448710490|FG002|Overall Study|Lost to Follow-up|0|||
124751211|NCT00999518|448710491|FG003|Overall Study|Lost to Follow-up|4|||
124751212|NCT00999518|448710492|FG004|Overall Study|Lost to Follow-up|1|||
124751213|NCT00999518|448710488|FG000|Overall Study|Did not meet entrance criteria|0|||
124751214|NCT00999518|448710489|FG001|Overall Study|Did not meet entrance criteria|0|||
124751215|NCT00999518|448710490|FG002|Overall Study|Did not meet entrance criteria|0|||
124751216|NCT00999518|448710491|FG003|Overall Study|Did not meet entrance criteria|0|||
124751217|NCT00999518|448710492|FG004|Overall Study|Did not meet entrance criteria|1|||
124751218|NCT00999518|448710488|FG000|Overall Study|Study terminated by sponsor|10|||
124751219|NCT00999518|448710489|FG001|Overall Study|Study terminated by sponsor|6|||
124751220|NCT00999518|448710490|FG002|Overall Study|Study terminated by sponsor|5|||
124751221|NCT00999518|448710491|FG003|Overall Study|Study terminated by sponsor|5|||
124751222|NCT00999518|448710492|FG004|Overall Study|Study terminated by sponsor|9|||
124751223|NCT00999518|448710488|FG000|Overall Study|Pregnancy|0|||
124751224|NCT00999518|448710489|FG001|Overall Study|Pregnancy|0|||
124751225|NCT00999518|448710490|FG002|Overall Study|Pregnancy|1|||
124751226|NCT00999518|448710491|FG003|Overall Study|Pregnancy|0|||
124751227|NCT00999518|448710492|FG004|Overall Study|Pregnancy|0|||
124751228|NCT00999518|448710488|FG000|Overall Study|Protocol Violation|0|||
124751229|NCT00999518|448710489|FG001|Overall Study|Protocol Violation|1|||
124751230|NCT00999518|448710490|FG002|Overall Study|Protocol Violation|0|||
124751231|NCT00999518|448710491|FG003|Overall Study|Protocol Violation|0|||
124751232|NCT00999518|448710492|FG004|Overall Study|Protocol Violation|2|||
124751233|NCT00999518|448710488|FG000|Overall Study|Withdrawal by Subject|5|||
124751234|NCT00999518|448710489|FG001|Overall Study|Withdrawal by Subject|4|||
124751235|NCT00999518|448710490|FG002|Overall Study|Withdrawal by Subject|10|||
124751236|NCT00999518|448710491|FG003|Overall Study|Withdrawal by Subject|6|||
124783053|NCT02834793|448835855|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
124783054|NCT02834793|448835852|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
124783055|NCT02834793|448835853|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
124751237|NCT00999518|448710492|FG004|Overall Study|Withdrawal by Subject|1|||
124751238|NCT00999518|448710488|FG000|Overall Study|Other|5|||
124751239|NCT00999518|448710489|FG001|Overall Study|Other|7|||
124751240|NCT00999518|448710490|FG002|Overall Study|Other|1|||
124751241|NCT00999518|448710491|FG003|Overall Study|Other|4|||
124751242|NCT00999518|448710492|FG004|Overall Study|Other|5|||
124751243|NCT00999518|448710488|FG000|Overall Study|Randomized but not Treated|1|||
124751244|NCT00999518|448710489|FG001|Overall Study|Randomized but not Treated|1|||
124751245|NCT00999518|448710490|FG002|Overall Study|Randomized but not Treated|2|||
124751246|NCT00999518|448710491|FG003|Overall Study|Randomized but not Treated|0|||
124751247|NCT00999518|448710492|FG004|Overall Study|Randomized but not Treated|1|||
124751248|NCT03319212|448710493|FG000|Overall Study|Discontinued as moving out of local area|0|||
124751249|NCT03319212|448710494|FG001|Overall Study|Discontinued as moving out of local area|1|||
124751250|NCT03319212|448710493|FG000|Overall Study|Adverse Event|2|||
124751251|NCT03319212|448710494|FG001|Overall Study|Adverse Event|2|||
124751252|NCT03319212|448710493|FG000|Overall Study|Withdrawal by Subject|0|||
124751253|NCT03319212|448710494|FG001|Overall Study|Withdrawal by Subject|1|||
124751254|NCT03319212|448710493|FG000|Overall Study|Lost to Follow-up|0|||
124751255|NCT03319212|448710494|FG001|Overall Study|Lost to Follow-up|1|||
124751256|NCT03319212|448710493|FG000|Overall Study|Physician Decision|1|||
124751257|NCT03319212|448710494|FG001|Overall Study|Physician Decision|0|||
124751258|NCT03343626|448712421|FG000|Overall Study|Lost to Follow-up|4|||
124751259|NCT03343626|448712422|FG001|Overall Study|Lost to Follow-up|3|||
124751260|NCT03343626|448712423|FG002|Overall Study|Lost to Follow-up|2|||
124751261|NCT03343626|448712424|FG003|Overall Study|Lost to Follow-up|5|||
124751262|NCT03343626|448712425|FG004|Overall Study|Lost to Follow-up|4|||
124751263|NCT03343626|448712426|FG005|Overall Study|Lost to Follow-up|4|||
124751264|NCT03343626|448712427|FG006|Overall Study|Lost to Follow-up|4|||
124751265|NCT03343626|448712428|FG007|Overall Study|Lost to Follow-up|7|||
124751266|NCT03343626|448712421|FG000|Overall Study|Withdrawal of Consent|2|||
124751267|NCT03343626|448712422|FG001|Overall Study|Withdrawal of Consent|1|||
124751268|NCT03343626|448712423|FG002|Overall Study|Withdrawal of Consent|0|||
124751269|NCT03343626|448712424|FG003|Overall Study|Withdrawal of Consent|3|||
124751270|NCT03343626|448712425|FG004|Overall Study|Withdrawal of Consent|3|||
124751271|NCT03343626|448712426|FG005|Overall Study|Withdrawal of Consent|1|||
124751272|NCT03343626|448712427|FG006|Overall Study|Withdrawal of Consent|1|||
124751273|NCT03343626|448712428|FG007|Overall Study|Withdrawal of Consent|2|||
124751274|NCT03343626|448712421|FG000|Overall Study|Reason not Specified|0|||
124751275|NCT03343626|448712422|FG001|Overall Study|Reason not Specified|1|||
124751276|NCT03343626|448712423|FG002|Overall Study|Reason not Specified|0|||
124751277|NCT03343626|448712424|FG003|Overall Study|Reason not Specified|0|||
124751278|NCT03343626|448712425|FG004|Overall Study|Reason not Specified|0|||
124751279|NCT03343626|448712426|FG005|Overall Study|Reason not Specified|0|||
124751280|NCT03343626|448712427|FG006|Overall Study|Reason not Specified|0|||
124751281|NCT03343626|448712428|FG007|Overall Study|Reason not Specified|1|||
124751282|NCT03343626|448712421|FG000|Overall Study|Data Entry Error|0|||
124751283|NCT03343626|448712422|FG001|Overall Study|Data Entry Error|0|||
124751284|NCT03343626|448712423|FG002|Overall Study|Data Entry Error|0|||
124751285|NCT03343626|448712424|FG003|Overall Study|Data Entry Error|0|||
124751286|NCT03343626|448712425|FG004|Overall Study|Data Entry Error|0|||
124751287|NCT03343626|448712426|FG005|Overall Study|Data Entry Error|0|||
124751288|NCT03343626|448712427|FG006|Overall Study|Data Entry Error|0|||
124751289|NCT03343626|448712428|FG007|Overall Study|Data Entry Error|1|||
124751290|NCT02475278|448712436|FG000|Overall Study|Lost to Follow-up|1|||
124751291|NCT02475278|448712436|FG000|Overall Study|Reason Not Specified|1|||
124751292|NCT00826618|448712437|FG000|Overall Study|Withdrawal by Subject|1|||
124751293|NCT03712787|448712438|FG000|Overall Study|Adverse Event|2|||
124751294|NCT03712787|448712439|FG001|Overall Study|Adverse Event|3|||
124751295|NCT03712787|448712440|FG002|Overall Study|Adverse Event|0|||
124751296|NCT03712787|448712441|FG003|Overall Study|Adverse Event|4|||
124751297|NCT03712787|448712438|FG000|Overall Study|Withdrawal by Subject|4|||
124751298|NCT03712787|448712439|FG001|Overall Study|Withdrawal by Subject|14|||
124751299|NCT03712787|448712440|FG002|Overall Study|Withdrawal by Subject|12|||
124751300|NCT03712787|448712441|FG003|Overall Study|Withdrawal by Subject|8|||
124751301|NCT03712787|448712438|FG000|Overall Study|Lost to Follow-up|1|||
124751302|NCT03712787|448712439|FG001|Overall Study|Lost to Follow-up|1|||
124620763|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
124620764|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
124751303|NCT03712787|448712440|FG002|Overall Study|Lost to Follow-up|2|||
124751304|NCT03712787|448712441|FG003|Overall Study|Lost to Follow-up|1|||
124751305|NCT03712787|448712438|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
124751306|NCT03712787|448712439|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
124751307|NCT03712787|448712440|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
124751308|NCT03712787|448712441|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
124751309|NCT03712787|448712438|FG000|Overall Study|COVID-19 Infection|0|||
124751310|NCT03712787|448712439|FG001|Overall Study|COVID-19 Infection|1|||
124751311|NCT03712787|448712440|FG002|Overall Study|COVID-19 Infection|0|||
124751312|NCT03712787|448712441|FG003|Overall Study|COVID-19 Infection|0|||
124751313|NCT03712787|448712438|FG000|Overall Study|Other, Not Specified|79|||
124751314|NCT03712787|448712439|FG001|Overall Study|Other, Not Specified|77|||
124751315|NCT03712787|448712440|FG002|Overall Study|Other, Not Specified|74|||
124751316|NCT03712787|448712441|FG003|Overall Study|Other, Not Specified|78|||
124751317|NCT00931606|448712443|FG000|Overall Study|Death|1|||
124751318|NCT00931606|448712444|FG001|Overall Study|Death|3|||
124751319|NCT00931606|448712445|FG002|Overall Study|Death|2|||
124751320|NCT00931606|448712446|FG003|Overall Study|Death|0|||
124751321|NCT00931606|448712443|FG000|Overall Study|Lost to Follow-up|0|||
124751322|NCT00931606|448712444|FG001|Overall Study|Lost to Follow-up|1|||
124751323|NCT00931606|448712445|FG002|Overall Study|Lost to Follow-up|0|||
124751324|NCT00931606|448712446|FG003|Overall Study|Lost to Follow-up|0|||
124751325|NCT00931606|448712443|FG000|Overall Study|Physician Decision|0|||
124751326|NCT00931606|448712444|FG001|Overall Study|Physician Decision|0|||
124751327|NCT00931606|448712445|FG002|Overall Study|Physician Decision|3|||
124751328|NCT00931606|448712446|FG003|Overall Study|Physician Decision|0|||
124751329|NCT00931606|448712443|FG000|Overall Study|Sponsor Decision|1|||
124751330|NCT00931606|448712444|FG001|Overall Study|Sponsor Decision|4|||
124751331|NCT00931606|448712445|FG002|Overall Study|Sponsor Decision|0|||
124751332|NCT00931606|448712446|FG003|Overall Study|Sponsor Decision|2|||
124751333|NCT00931606|448712443|FG000|Overall Study|Withdrawal by Subject|3|||
124751334|NCT00931606|448712444|FG001|Overall Study|Withdrawal by Subject|1|||
124751335|NCT00931606|448712445|FG002|Overall Study|Withdrawal by Subject|1|||
124751336|NCT00931606|448712446|FG003|Overall Study|Withdrawal by Subject|1|||
124751337|NCT03412812|448712454|FG000|Level 1|Death|3|||
124751338|NCT03412812|448712455|FG001|Level 1|Death|0|||
124751339|NCT03412812|448712454|FG000|Level 1|Adverse Event|0|||
124751340|NCT03412812|448712455|FG001|Level 1|Adverse Event|1|||
124751341|NCT02391363|448712461|FG000|Overall Study|Lost to Follow-up|5|||
124751342|NCT02391363|448712462|FG001|Overall Study|Lost to Follow-up|5|||
124751343|NCT02391363|448712461|FG000|Overall Study|Withdrawal by Subject|6|||
124751344|NCT02391363|448712462|FG001|Overall Study|Withdrawal by Subject|3|||
124751345|NCT03828617|448712463|FG000|Overall Study|Lost to Follow-up|22|||
124751346|NCT03828617|448712464|FG001|Overall Study|Lost to Follow-up|12|||
124751347|NCT03828617|448712465|FG002|Overall Study|Lost to Follow-up|23|||
124751348|NCT03828617|448712466|FG003|Overall Study|Lost to Follow-up|7|||
124751349|NCT03828617|448712463|FG000|Overall Study|No longer met eligibility criteria|0|||
124751350|NCT03828617|448712464|FG001|Overall Study|No longer met eligibility criteria|1|||
124751351|NCT03828617|448712465|FG002|Overall Study|No longer met eligibility criteria|1|||
124751352|NCT03828617|448712466|FG003|Overall Study|No longer met eligibility criteria|3|||
124751353|NCT03828617|448712463|FG000|Overall Study|Protocol Violation|0|||
124751354|NCT03828617|448712464|FG001|Overall Study|Protocol Violation|2|||
124751355|NCT03828617|448712465|FG002|Overall Study|Protocol Violation|0|||
124751356|NCT03828617|448712466|FG003|Overall Study|Protocol Violation|0|||
124751357|NCT03828617|448712463|FG000|Overall Study|Withdrawal by Subject|2|||
124751358|NCT03828617|448712464|FG001|Overall Study|Withdrawal by Subject|0|||
124783056|NCT02834793|448835854|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
124783057|NCT02834793|448835855|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
124783058|NCT02834793|448835852|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
124783059|NCT02834793|448835853|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
124783060|NCT02834793|448835854|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
124783061|NCT02834793|448835855|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
124783062|NCT02834793|448835852|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
124783063|NCT02834793|448835853|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
124783064|NCT02834793|448835854|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
124783065|NCT02834793|448835855|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
124783066|NCT02834793|448835852|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
124783067|NCT02834793|448835853|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
124783068|NCT02834793|448835854|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
124783069|NCT02834793|448835855|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
124783070|NCT02834793|448835852|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
124783071|NCT02834793|448835853|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
124783072|NCT02834793|448835854|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
124783073|NCT02834793|448835855|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
124783074|NCT02834793|448835852|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
124783075|NCT02834793|448835853|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
124783076|NCT02834793|448835854|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
124783077|NCT02834793|448835855|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
124620765|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
124783078|NCT02834793|448835852|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
124620766|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
124620767|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
124751359|NCT03828617|448712465|FG002|Overall Study|Withdrawal by Subject|2|||
124751360|NCT03828617|448712466|FG003|Overall Study|Withdrawal by Subject|0|||
124751361|NCT04794270|448712468|FG000|Period 1|Non Compliance|1|||
124751362|NCT04794270|448712469|FG001|Period 1|Non Compliance|0|||
124751363|NCT04794270|448712468|FG000|Period 1|Adverse Event|1|||
124751364|NCT04794270|448712469|FG001|Period 1|Adverse Event|0|||
124751365|NCT04794270|448712468|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
124751366|NCT04794270|448712469|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
124751367|NCT00732875|448712474|FG000|Overall Study|Adverse Event|16|||
124751368|NCT00732875|448712474|FG000|Overall Study|Withdrawal by Subject|6|||
124751369|NCT00732875|448712474|FG000|Overall Study|Lack of Efficacy|13|||
124751370|NCT03826186|448712475|FG000|Overall Study|Protocol Violation|2|||
124751371|NCT03826186|448712476|FG001|Overall Study|Protocol Violation|0|||
124751372|NCT03826186|448712475|FG000|Overall Study|Withdrawal by Subject|1|||
124751373|NCT03826186|448712476|FG001|Overall Study|Withdrawal by Subject|0|||
124751374|NCT03688074|448712478|FG000|Overall Study|Adverse Event|0|||
124751375|NCT03688074|448712479|FG001|Overall Study|Adverse Event|1|||
124751376|NCT03688074|448712478|FG000|Overall Study|Other|1|||
124751377|NCT03688074|448712479|FG001|Overall Study|Other|0|||
124751378|NCT03056339|448712493|FG000|Overall Study|Failed Requirements|0|||
124751379|NCT03056339|448712494|FG001|Overall Study|Failed Requirements|2|||
124751380|NCT03056339|448712495|FG002|Overall Study|Failed Requirements|7|||
124751381|NCT03056339|448712496|FG003|Overall Study|Failed Requirements|1|||
124751382|NCT01128244|448712502|FG000|Overall Study|Adverse Event|1|||
124751383|NCT01128244|448712502|FG000|Overall Study|Scheduling conflict|2|||
124751384|NCT02219334|448712503|FG000|Overall Study|Withdrawal by Subject|1|||
124751385|NCT02219334|448712504|FG001|Overall Study|Withdrawal by Subject|0|||
124751386|NCT02219334|448712503|FG000|Overall Study|Protocol Violation|7|||
124751387|NCT02219334|448712504|FG001|Overall Study|Protocol Violation|3|||
124751388|NCT04171219|448712507|FG000|Overall Study|Adverse Event|1|||
124751389|NCT04171219|448712508|FG001|Overall Study|Adverse Event|0|||
124751390|NCT04171219|448712507|FG000|Overall Study|Death|0|||
124751391|NCT04171219|448712508|FG001|Overall Study|Death|1|||
124751392|NCT04171219|448712507|FG000|Overall Study|Lack of Efficacy|9|||
124751393|NCT04171219|448712508|FG001|Overall Study|Lack of Efficacy|13|||
124751394|NCT04171219|448712507|FG000|Overall Study|Withdrawal by Subject|1|||
124751395|NCT04171219|448712508|FG001|Overall Study|Withdrawal by Subject|2|||
124751396|NCT04171219|448712507|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
124751397|NCT04171219|448712508|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
124751398|NCT04171219|448712507|FG000|Overall Study|Clinical PD/Patient choice|1|||
124751399|NCT04171219|448712508|FG001|Overall Study|Clinical PD/Patient choice|0|||
124751400|NCT04171219|448712507|FG000|Overall Study|Toxicity/ Patient choice|1|||
124751401|NCT04171219|448712508|FG001|Overall Study|Toxicity/ Patient choice|0|||
124751402|NCT04838626|448712509|FG000|Overall Study|Adverse Event|2|||
124751403|NCT04838626|448712509|FG000|Overall Study|Physician Decision|6|||
124751404|NCT04838626|448712509|FG000|Overall Study|Protocol Violation|3|||
124751405|NCT04838626|448712509|FG000|Overall Study|Withdrawal by Subject|9|||
124751406|NCT04838626|448712509|FG000|Overall Study|Technical Problems|2|||
124751407|NCT01934010|448712514|FG000|Overall Study|Adverse Event|1|||
124751408|NCT01934010|448712515|FG001|Overall Study|Adverse Event|1|||
124751409|NCT01934010|448712516|FG002|Overall Study|Adverse Event|0|||
124751410|NCT01934010|448712514|FG000|Overall Study|Withdrawal by Subject|15|||
124751411|NCT01934010|448712515|FG001|Overall Study|Withdrawal by Subject|6|||
124751412|NCT01934010|448712516|FG002|Overall Study|Withdrawal by Subject|2|||
124751413|NCT01934010|448712514|FG000|Overall Study|Lost to Follow-up|7|||
124751414|NCT01934010|448712515|FG001|Overall Study|Lost to Follow-up|4|||
124751415|NCT01934010|448712516|FG002|Overall Study|Lost to Follow-up|0|||
124751416|NCT01393821|448712517|FG000|Overall Study|Cancel|1|||
124751417|NCT01393821|448712518|FG001|Overall Study|Cancel|1|||
124751418|NCT01393821|448712517|FG000|Overall Study|not evaluable for primary endpoint|4|||
124751419|NCT01393821|448712518|FG001|Overall Study|not evaluable for primary endpoint|2|||
124751420|NCT03386487|448712519|FG000|Overall Study|Lost to Follow-up|5|||
124751421|NCT03386487|448712520|FG001|Overall Study|Lost to Follow-up|6|||
124751422|NCT03386487|448712519|FG000|Overall Study|Withdrawal by Subject|11|||
124751423|NCT03386487|448712520|FG001|Overall Study|Withdrawal by Subject|7|||
124751424|NCT03386487|448712519|FG000|Overall Study|Physician Decision|11|||
124751425|NCT03386487|448712520|FG001|Overall Study|Physician Decision|8|||
124751426|NCT03422536|448712521|FG000|Randomized|Physician Decision|1|||
124751427|NCT03422536|448712522|FG001|Randomized|Physician Decision|1|||
124751428|NCT03422536|448712521|FG000|Allocation - Received Intervention|Disease progression|19|||
124751429|NCT03422536|448712522|FG001|Allocation - Received Intervention|Disease progression|25|||
124751430|NCT03422536|448712521|FG000|Allocation - Received Intervention|Death|1|||
124751431|NCT03422536|448712522|FG001|Allocation - Received Intervention|Death|3|||
124751432|NCT03422536|448712521|FG000|Allocation - Received Intervention|Adverse Event|1|||
124751433|NCT03422536|448712522|FG001|Allocation - Received Intervention|Adverse Event|0|||
124751434|NCT03422536|448712521|FG000|Allocation - Received Intervention|Physician Decision|1|||
124783079|NCT02834793|448835853|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
124783080|NCT02834793|448835854|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
124751435|NCT03422536|448712522|FG001|Allocation - Received Intervention|Physician Decision|1|||
124751436|NCT03422536|448712521|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
124751437|NCT03422536|448712522|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
124751438|NCT03422536|448712521|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
124751439|NCT03422536|448712522|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
124751440|NCT04929249|448712523|FG000|Overall Study|Adverse Event|2|||
124751441|NCT04929249|448712524|FG001|Overall Study|Adverse Event|1|||
124751442|NCT04929249|448712523|FG000|Overall Study|Death|2|||
124751443|NCT04929249|448712524|FG001|Overall Study|Death|1|||
124751444|NCT04929249|448712523|FG000|Overall Study|Lost to Follow-up|3|||
124751445|NCT04929249|448712524|FG001|Overall Study|Lost to Follow-up|11|||
124751446|NCT04929249|448712523|FG000|Overall Study|Technical problems|0|||
124751447|NCT04929249|448712524|FG001|Overall Study|Technical problems|1|||
124751448|NCT04929249|448712523|FG000|Overall Study|Subject decision|6|||
124751449|NCT04929249|448712524|FG001|Overall Study|Subject decision|8|||
124751450|NCT04929249|448712523|FG000|Overall Study|Withdrew consent|0|||
124751451|NCT04929249|448712524|FG001|Overall Study|Withdrew consent|8|||
124751452|NCT00395850|448712535|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
124751453|NCT00395850|448712536|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
124751454|NCT00395850|448712537|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
124751455|NCT00395850|448712538|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
124751456|NCT00395850|448712535|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
124751457|NCT00395850|448712536|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
124751458|NCT00395850|448712537|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
124751459|NCT00395850|448712538|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
124751460|NCT00395850|448712535|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
124751461|NCT00395850|448712536|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
124751462|NCT00395850|448712537|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
124751463|NCT00395850|448712538|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
124751464|NCT00395850|448712535|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
124751465|NCT00395850|448712536|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
124751466|NCT00395850|448712537|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
124751467|NCT00395850|448712538|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
124751468|NCT00395850|448712535|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
124751469|NCT00395850|448712536|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
124751470|NCT00395850|448712537|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
124751471|NCT00395850|448712538|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
124751472|NCT00395850|448712535|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
124751473|NCT00395850|448712536|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
124751474|NCT00395850|448712537|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
124751475|NCT00395850|448712538|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
124751476|NCT00395850|448712535|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
124751477|NCT00395850|448712536|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
124751478|NCT00395850|448712537|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
124751479|NCT00395850|448712538|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
124751480|NCT01620762|448712540|FG000|Overall Study|Protocol Violation|1|||
124751481|NCT01620762|448712541|FG001|Overall Study|Protocol Violation|1|||
124751482|NCT01620762|448712542|FG002|Overall Study|Protocol Violation|1|||
124751483|NCT01620762|448712540|FG000|Overall Study|Adverse Event|9|||
124751484|NCT01620762|448712541|FG001|Overall Study|Adverse Event|5|||
124751485|NCT01620762|448712542|FG002|Overall Study|Adverse Event|2|||
124751486|NCT01620762|448712540|FG000|Overall Study|Withdrawal by Subject|23|||
124751487|NCT01620762|448712541|FG001|Overall Study|Withdrawal by Subject|26|||
124751488|NCT01620762|448712542|FG002|Overall Study|Withdrawal by Subject|27|||
124751489|NCT01620762|448712540|FG000|Overall Study|Lost to Follow-up|11|||
124751490|NCT01620762|448712541|FG001|Overall Study|Lost to Follow-up|17|||
124751491|NCT01620762|448712542|FG002|Overall Study|Lost to Follow-up|10|||
124751492|NCT01620762|448712540|FG000|Overall Study|Protocol deviation|1|||
124751493|NCT01620762|448712541|FG001|Overall Study|Protocol deviation|1|||
124751494|NCT01620762|448712542|FG002|Overall Study|Protocol deviation|6|||
124751495|NCT01620762|448712540|FG000|Overall Study|Subject deterioration|0|||
124751496|NCT01620762|448712541|FG001|Overall Study|Subject deterioration|1|||
124751497|NCT01620762|448712542|FG002|Overall Study|Subject deterioration|1|||
124751498|NCT01620762|448712540|FG000|Overall Study|Non-specified|3|||
124751499|NCT01620762|448712541|FG001|Overall Study|Non-specified|6|||
124751500|NCT01620762|448712542|FG002|Overall Study|Non-specified|5|||
124751501|NCT01620762|448712540|FG000|Overall Study|Use of prohibted therapies|0|||
124751502|NCT01620762|448712541|FG001|Overall Study|Use of prohibted therapies|1|||
124751503|NCT01620762|448712542|FG002|Overall Study|Use of prohibted therapies|1|||
124751504|NCT00705146|448712547|FG000|Overall Study|Lost to Follow-up|1|||
124751505|NCT00705146|448712548|FG001|Overall Study|Lost to Follow-up|1|||
124751506|NCT02669121|448712551|FG000|Overall Study|Adverse Event|4|||
124751507|NCT02669121|448712552|FG001|Overall Study|Adverse Event|5|||
124751508|NCT02669121|448712551|FG000|Overall Study|Lost to Follow-up|15|||
124751509|NCT02669121|448712552|FG001|Overall Study|Lost to Follow-up|27|||
124751510|NCT02669121|448712551|FG000|Overall Study|Withdrawal by Subject|132|||
124751511|NCT02669121|448712552|FG001|Overall Study|Withdrawal by Subject|140|||
124751512|NCT02669121|448712551|FG000|Overall Study|Pregnancy|0|||
124751513|NCT02669121|448712552|FG001|Overall Study|Pregnancy|1|||
124751514|NCT02669121|448712551|FG000|Overall Study|Discharged from US Military Active Service|117|||
124751515|NCT02669121|448712552|FG001|Overall Study|Discharged from US Military Active Service|91|||
124751516|NCT02669121|448712551|FG000|Overall Study|Reason not Specified|22|||
124751517|NCT02669121|448712552|FG001|Overall Study|Reason not Specified|18|||
124751518|NCT00825812|448712559|FG000|Overall Study|Never entered follow up|0|||
124751519|NCT00825812|448712560|FG001|Overall Study|Never entered follow up|0|||
124620768|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
124620769|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
124620770|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
124620771|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
124620772|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
124620773|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
124620774|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
124620775|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
124620776|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
124620777|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
124620778|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
124620779|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
124620780|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
124620781|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
124620782|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
124620783|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
124620784|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
124620785|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
124620786|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
124620787|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
124620788|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
124620789|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
124620790|NCT03598790|448227893|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
124620791|NCT03598790|448227894|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
124620792|NCT03598790|448227895|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
124620793|NCT03598790|448227896|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
124620794|NCT03598790|448227897|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
124620795|NCT03598790|448227898|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
124620796|NCT03598790|448227899|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
124620797|NCT03598790|448227900|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
124620798|NCT03598790|448227901|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
124620799|NCT03598790|448227893|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124620800|NCT03598790|448227894|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124620801|NCT03598790|448227895|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124620802|NCT03598790|448227896|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
124620803|NCT03598790|448227897|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
124620804|NCT03598790|448227898|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
124620805|NCT03598790|448227899|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124620806|NCT03598790|448227900|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124620807|NCT03598790|448227901|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
124620808|NCT03598790|448227893|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
124620809|NCT03598790|448227894|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
124620810|NCT03598790|448227895|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
124620811|NCT03598790|448227896|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
124620812|NCT03598790|448227897|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
124620813|NCT03598790|448227898|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
124620814|NCT03598790|448227899|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
124620815|NCT03598790|448227900|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
124620816|NCT03598790|448227901|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
124620817|NCT03598790|448227893|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124620818|NCT03598790|448227894|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124620819|NCT03598790|448227895|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124620820|NCT03598790|448227896|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
124620821|NCT03598790|448227897|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124620822|NCT03598790|448227898|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124620823|NCT03598790|448227899|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124620824|NCT03598790|448227900|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124620825|NCT03598790|448227901|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
124620826|NCT03598790|448227893|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
124620827|NCT03598790|448227894|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
124620828|NCT03598790|448227895|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
124620829|NCT03598790|448227896|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
124620830|NCT03598790|448227897|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
124620831|NCT03598790|448227898|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
124620832|NCT03598790|448227899|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
124620833|NCT03598790|448227900|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
124620834|NCT03598790|448227901|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
124620835|NCT03598790|448227893|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
124751520|NCT00825812|448712561|FG002|Overall Study|Never entered follow up|0|||
124751521|NCT00825812|448712562|FG003|Overall Study|Never entered follow up|1|||
124751522|NCT00825812|448712559|FG000|Overall Study|Adverse Event|0|||
124751523|NCT00825812|448712560|FG001|Overall Study|Adverse Event|0|||
124751524|NCT00825812|448712561|FG002|Overall Study|Adverse Event|0|||
124751525|NCT00825812|448712562|FG003|Overall Study|Adverse Event|1|||
124751526|NCT00825812|448712559|FG000|Overall Study|Subject withdrew consent|0|||
124751527|NCT00825812|448712560|FG001|Overall Study|Subject withdrew consent|0|||
124751528|NCT00825812|448712561|FG002|Overall Study|Subject withdrew consent|3|||
124751529|NCT00825812|448712562|FG003|Overall Study|Subject withdrew consent|2|||
124751530|NCT00825812|448712559|FG000|Overall Study|Non-compliance with protocol|0|||
124751531|NCT00825812|448712560|FG001|Overall Study|Non-compliance with protocol|0|||
124751532|NCT00825812|448712561|FG002|Overall Study|Non-compliance with protocol|0|||
124751533|NCT00825812|448712562|FG003|Overall Study|Non-compliance with protocol|1|||
124751534|NCT00825812|448712559|FG000|Overall Study|Administrative|0|||
124751535|NCT00825812|448712560|FG001|Overall Study|Administrative|1|||
124751536|NCT00825812|448712561|FG002|Overall Study|Administrative|3|||
124751537|NCT00825812|448712562|FG003|Overall Study|Administrative|5|||
124751538|NCT00483938|448712563|FG000|Overall Study|Protocol Violation|0|||
124751539|NCT00483938|448712564|FG001|Overall Study|Protocol Violation|0|||
124751540|NCT00483938|448712565|FG002|Overall Study|Protocol Violation|0|||
124751541|NCT00483938|448712566|FG003|Overall Study|Protocol Violation|0|||
124751542|NCT00483938|448712567|FG004|Overall Study|Protocol Violation|0|||
124751543|NCT00483938|448712568|FG005|Overall Study|Protocol Violation|0|||
124751544|NCT00483938|448712569|FG006|Overall Study|Protocol Violation|3|||
124751545|NCT00483938|448712563|FG000|Overall Study|Withdrawal by Subject|1|||
124751546|NCT00483938|448712564|FG001|Overall Study|Withdrawal by Subject|6|||
124751547|NCT00483938|448712565|FG002|Overall Study|Withdrawal by Subject|0|||
124751548|NCT00483938|448712566|FG003|Overall Study|Withdrawal by Subject|0|||
124751549|NCT00483938|448712567|FG004|Overall Study|Withdrawal by Subject|1|||
124751550|NCT00483938|448712568|FG005|Overall Study|Withdrawal by Subject|3|||
124751551|NCT00483938|448712569|FG006|Overall Study|Withdrawal by Subject|2|||
124751552|NCT00483938|448712563|FG000|Overall Study|Lost to Follow-up|1|||
124751553|NCT00483938|448712564|FG001|Overall Study|Lost to Follow-up|2|||
124751554|NCT00483938|448712565|FG002|Overall Study|Lost to Follow-up|0|||
124751555|NCT00483938|448712566|FG003|Overall Study|Lost to Follow-up|2|||
124751556|NCT00483938|448712567|FG004|Overall Study|Lost to Follow-up|1|||
124751557|NCT00483938|448712568|FG005|Overall Study|Lost to Follow-up|1|||
124751558|NCT00483938|448712569|FG006|Overall Study|Lost to Follow-up|3|||
124751559|NCT00483938|448712563|FG000|Overall Study|Death|0|||
124751560|NCT00483938|448712564|FG001|Overall Study|Death|2|||
124751561|NCT00483938|448712565|FG002|Overall Study|Death|0|||
124751562|NCT00483938|448712566|FG003|Overall Study|Death|0|||
124751563|NCT00483938|448712567|FG004|Overall Study|Death|0|||
124751564|NCT00483938|448712568|FG005|Overall Study|Death|0|||
124751565|NCT00483938|448712569|FG006|Overall Study|Death|0|||
124751566|NCT00483938|448712563|FG000|Overall Study|Other|3|||
124751567|NCT00483938|448712564|FG001|Overall Study|Other|9|||
124751568|NCT00483938|448712565|FG002|Overall Study|Other|0|||
124783081|NCT02834793|448835855|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
124783082|NCT02834793|448835852|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
124620836|NCT03598790|448227894|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
124620837|NCT03598790|448227895|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
124620838|NCT03598790|448227896|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
124620839|NCT03598790|448227897|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
124751569|NCT00483938|448712566|FG003|Overall Study|Other|4|||
124751570|NCT00483938|448712567|FG004|Overall Study|Other|0|||
124751571|NCT00483938|448712568|FG005|Overall Study|Other|4|||
124751572|NCT00483938|448712569|FG006|Overall Study|Other|32|||
124751573|NCT02218008|448712570|FG000|Stage 1 (S1)|Adverse Event|6|||
124751574|NCT02218008|448712571|FG001|Stage 1 (S1)|Adverse Event|5|||
124751575|NCT02218008|448712572|FG002|Stage 1 (S1)|Adverse Event|11|||
124751576|NCT02218008|448712573|FG003|Stage 1 (S1)|Adverse Event|0|||
124751577|NCT02218008|448712574|FG004|Stage 1 (S1)|Adverse Event|0|||
124751578|NCT02218008|448712575|FG005|Stage 1 (S1)|Adverse Event|0|||
124751579|NCT02218008|448712570|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
124783083|NCT02834793|448835853|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
124783084|NCT02834793|448835854|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
124783085|NCT02834793|448835855|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
124783086|NCT02834793|448835852|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
124783087|NCT02834793|448835853|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
124783088|NCT02834793|448835854|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
124783089|NCT02834793|448835855|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
124783090|NCT02834793|448835852|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
124783091|NCT02834793|448835853|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
124783092|NCT02834793|448835854|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
124783093|NCT02834793|448835855|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
124783094|NCT02834793|448835852|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
124783095|NCT02834793|448835853|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
124783096|NCT02834793|448835854|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
124783097|NCT02834793|448835855|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
124783098|NCT02834793|448835852|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
124783099|NCT02834793|448835853|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
124783100|NCT02834793|448835854|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
124783101|NCT02834793|448835855|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
124783102|NCT02834793|448835852|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
124783103|NCT02834793|448835853|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
124783104|NCT02834793|448835854|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
124783105|NCT02834793|448835855|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
124783106|NCT01049009|448835856|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
124783107|NCT01049009|448835857|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
124783108|NCT01049009|448835856|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124783109|NCT01049009|448835857|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
124783110|NCT01049009|448835856|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
124783111|NCT01049009|448835857|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
124783112|NCT01049009|448835856|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
124783113|NCT01049009|448835857|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
124783114|NCT02423902|448835858|FG000|Overall Study|Disease progression|1|||
124783115|NCT02423902|448835859|FG001|Overall Study|Disease progression|4|||
124783116|NCT00622440|448835872|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
124783117|NCT00622440|448835873|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
124783118|NCT00622440|448835872|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
124783119|NCT00622440|448835873|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
124783120|NCT00622440|448835872|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
124783121|NCT00622440|448835873|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
124783122|NCT00622440|448835872|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
124783123|NCT00622440|448835873|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
124783124|NCT04195893|448835882|FG000|Second Intervention|Withdrawal by Subject|1|||
124783125|NCT04195893|448835883|FG001|Second Intervention|Withdrawal by Subject|0|||
124783126|NCT01802073|448835886|FG000|Overall Study|Lost to Follow-up|0|||
124783127|NCT01802073|448835887|FG001|Overall Study|Lost to Follow-up|1|||
124783128|NCT01802073|448835886|FG000|Overall Study|Non-compliant|4|||
124783129|NCT01802073|448835887|FG001|Overall Study|Non-compliant|2|||
124783130|NCT01802073|448835886|FG000|Overall Study|Withdrawal by Subject|1|||
124783131|NCT01802073|448835887|FG001|Overall Study|Withdrawal by Subject|1|||
124783132|NCT01802073|448835886|FG000|Overall Study|Physician Decision|0|||
124783133|NCT01802073|448835887|FG001|Overall Study|Physician Decision|7|||
124783134|NCT02123472|448835891|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
124783135|NCT02123472|448835892|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
124783136|NCT00918736|448835893|FG000|Overall Study|Withdrawal by Subject|4|||
124783137|NCT01474018|448835894|FG000|Overall Study|Lost to Follow-up|0|||
124783138|NCT01474018|448835895|FG001|Overall Study|Lost to Follow-up|1|||
124783139|NCT01474018|448835894|FG000|Overall Study|Withdrawal by Subject|0|||
124783140|NCT01474018|448835895|FG001|Overall Study|Withdrawal by Subject|2|||
124783141|NCT01137604|448835896|FG000|Overall Study|Adverse Event|3|||
124783142|NCT01137604|448835897|FG001|Overall Study|Adverse Event|6|||
124783143|NCT01137604|448835898|FG002|Overall Study|Adverse Event|9|||
124783144|NCT01137604|448835899|FG003|Overall Study|Adverse Event|9|||
124783145|NCT01137604|448835896|FG000|Overall Study|Participant Choice|0|||
124783146|NCT01137604|448835897|FG001|Overall Study|Participant Choice|2|||
124783147|NCT01137604|448835898|FG002|Overall Study|Participant Choice|2|||
124783148|NCT01137604|448835899|FG003|Overall Study|Participant Choice|0|||
124783149|NCT01137604|448835896|FG000|Overall Study|Withdrawal of consent|0|||
124783150|NCT01137604|448835897|FG001|Overall Study|Withdrawal of consent|0|||
124783151|NCT01137604|448835898|FG002|Overall Study|Withdrawal of consent|0|||
124783152|NCT01137604|448835899|FG003|Overall Study|Withdrawal of consent|2|||
124783153|NCT01137604|448835896|FG000|Overall Study|Clinical progression/deterioration|1|||
124783154|NCT01137604|448835897|FG001|Overall Study|Clinical progression/deterioration|2|||
124783155|NCT01137604|448835898|FG002|Overall Study|Clinical progression/deterioration|2|||
124783156|NCT01137604|448835899|FG003|Overall Study|Clinical progression/deterioration|0|||
124783157|NCT01297491|448835900|FG000|Overall Study|Adverse Event|11|||
124783158|NCT01297491|448835901|FG001|Overall Study|Adverse Event|6|||
124783159|NCT01297491|448835900|FG000|Overall Study|Physician Decision|3|||
124783160|NCT01297491|448835901|FG001|Overall Study|Physician Decision|2|||
124783161|NCT01297491|448835900|FG000|Overall Study|Progressive disease|11|||
124783162|NCT01297491|448835901|FG001|Overall Study|Progressive disease|20|||
124783163|NCT01297491|448835900|FG000|Overall Study|Patient/Guardian decision|3|||
124783164|NCT01297491|448835901|FG001|Overall Study|Patient/Guardian decision|4|||
124783165|NCT01297491|448835900|FG000|Overall Study|Death|2|||
124783166|NCT01297491|448835901|FG001|Overall Study|Death|1|||
124783167|NCT02511106|448835902|FG000|Overall Study|Lost to Follow-up|6|||
124783168|NCT02511106|448835903|FG001|Overall Study|Lost to Follow-up|4|||
124783169|NCT02511106|448835902|FG000|Overall Study|Withdrawal by Subject|24|||
124783170|NCT02511106|448835903|FG001|Overall Study|Withdrawal by Subject|21|||
124783171|NCT02511106|448835902|FG000|Overall Study|Death|42|||
124783172|NCT02511106|448835903|FG001|Overall Study|Death|82|||
124783173|NCT02511106|448835902|FG000|Overall Study|Ongoing study at data cut-off|3|||
124783174|NCT02511106|448835903|FG001|Overall Study|Ongoing study at data cut-off|2|||
124783175|NCT02511106|448835902|FG000|Overall Study|Without specified reason|3|||
124783176|NCT02511106|448835903|FG001|Overall Study|Without specified reason|0|||
124783177|NCT00344487|448835907|FG000|Overall Study|immunologic failure|1|||
124751580|NCT02218008|448712571|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
124751581|NCT02218008|448712572|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
124751582|NCT02218008|448712573|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
124751583|NCT02218008|448712574|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
124751584|NCT02218008|448712575|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
124751585|NCT02218008|448712570|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
124751586|NCT02218008|448712571|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
124751587|NCT02218008|448712572|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
124751588|NCT02218008|448712573|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
124751589|NCT02218008|448712574|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
124751590|NCT02218008|448712575|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
124751591|NCT02218008|448712570|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
124751592|NCT02218008|448712571|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
124751593|NCT02218008|448712572|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
124751594|NCT02218008|448712573|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
124751595|NCT02218008|448712574|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
124751596|NCT02218008|448712575|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
124751597|NCT02218008|448712570|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
124751598|NCT02218008|448712571|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
124751599|NCT02218008|448712572|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
124751600|NCT02218008|448712573|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
124751601|NCT02218008|448712574|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
124751602|NCT02218008|448712575|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
124751603|NCT02218008|448712570|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
124751604|NCT02218008|448712571|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
124751605|NCT02218008|448712572|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
124751606|NCT02218008|448712573|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
124751607|NCT02218008|448712574|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
124751608|NCT02218008|448712575|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
124751609|NCT02218008|448712570|FG000|Stage 1 (S1)|Pregnancy|0|||
124751610|NCT02218008|448712571|FG001|Stage 1 (S1)|Pregnancy|0|||
124751611|NCT02218008|448712572|FG002|Stage 1 (S1)|Pregnancy|1|||
124751612|NCT02218008|448712573|FG003|Stage 1 (S1)|Pregnancy|0|||
124751613|NCT02218008|448712574|FG004|Stage 1 (S1)|Pregnancy|0|||
124783178|NCT03679754|448835910|FG000|Overall Study|Investigator request|1|||
124783179|NCT01262820|448835911|FG000|Overall Study|Adverse Event|5|||
124783180|NCT01262820|448835911|FG000|Overall Study|Lack of Efficacy|9|||
124783181|NCT01262820|448835911|FG000|Overall Study|Drug held for 21+ days|1|||
124783182|NCT00711477|448835912|FG000|Overall Study|Adverse Event|3|||
124783183|NCT00711477|448835913|FG001|Overall Study|Adverse Event|1|||
124751614|NCT02218008|448712575|FG005|Stage 1 (S1)|Pregnancy|0|||
124751615|NCT02218008|448712570|FG000|Stage 1 (S1)|Protocol Violation|0|||
124751616|NCT02218008|448712571|FG001|Stage 1 (S1)|Protocol Violation|0|||
124751617|NCT02218008|448712572|FG002|Stage 1 (S1)|Protocol Violation|1|||
124751618|NCT02218008|448712573|FG003|Stage 1 (S1)|Protocol Violation|0|||
124751619|NCT02218008|448712574|FG004|Stage 1 (S1)|Protocol Violation|0|||
124751620|NCT02218008|448712575|FG005|Stage 1 (S1)|Protocol Violation|0|||
124751621|NCT02218008|448712570|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
124751622|NCT02218008|448712571|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
124783184|NCT00711477|448835912|FG000|Overall Study|Lost to Follow-up|0|||
124783185|NCT00711477|448835913|FG001|Overall Study|Lost to Follow-up|1|||
124783186|NCT00711477|448835912|FG000|Overall Study|Noncompliance|0|||
124783187|NCT00711477|448835913|FG001|Overall Study|Noncompliance|1|||
124783188|NCT00145977|448835919|FG000|Overall Study|Lack of Efficacy|0|||
124783189|NCT00145977|448835920|FG001|Overall Study|Lack of Efficacy|4|||
124783190|NCT00145977|448835919|FG000|Overall Study|Lost to Follow-up|1|||
124783191|NCT00145977|448835920|FG001|Overall Study|Lost to Follow-up|0|||
124751623|NCT02218008|448712572|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
124751624|NCT02218008|448712573|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
124751625|NCT02218008|448712574|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
124751626|NCT02218008|448712575|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
124751627|NCT02218008|448712570|FG000|Stage 2 (S2)|Adverse Event|0|||
124751628|NCT02218008|448712571|FG001|Stage 2 (S2)|Adverse Event|0|||
124751629|NCT02218008|448712572|FG002|Stage 2 (S2)|Adverse Event|0|||
124751630|NCT02218008|448712573|FG003|Stage 2 (S2)|Adverse Event|2|||
124751631|NCT02218008|448712574|FG004|Stage 2 (S2)|Adverse Event|3|||
124751632|NCT02218008|448712575|FG005|Stage 2 (S2)|Adverse Event|3|||
124751633|NCT02218008|448712570|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
124751634|NCT02218008|448712571|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
124751635|NCT02218008|448712572|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
124751636|NCT02218008|448712573|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
124751637|NCT02218008|448712574|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
124751638|NCT02218008|448712575|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
124751639|NCT02218008|448712570|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
124751640|NCT02218008|448712571|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
124751641|NCT02218008|448712572|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
124751642|NCT02218008|448712573|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
124751643|NCT02218008|448712574|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
124751644|NCT02218008|448712575|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
124751645|NCT02218008|448712570|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
124751646|NCT02218008|448712571|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
124751647|NCT02218008|448712572|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
124751648|NCT02218008|448712573|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
124751649|NCT02218008|448712574|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
124751650|NCT02218008|448712575|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
124751651|NCT02218008|448712570|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
124751652|NCT02218008|448712571|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
124751653|NCT02218008|448712572|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
124751654|NCT02218008|448712573|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
124751655|NCT02218008|448712574|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
124751656|NCT02218008|448712575|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
124751657|NCT00106353|448712576|FG000|Part 1|Disease progression|3|||
124751658|NCT00106353|448712577|FG001|Part 1|Disease progression|4|||
124751659|NCT00106353|448712578|FG002|Part 1|Disease progression|1|||
124751660|NCT00106353|448712579|FG003|Part 1|Disease progression|3|||
124751661|NCT00106353|448712580|FG004|Part 1|Disease progression|0|||
124751662|NCT00106353|448712581|FG005|Part 1|Disease progression|0|||
124751663|NCT00106353|448712582|FG006|Part 1|Disease progression|0|||
124751664|NCT00106353|448712576|FG000|Part 1|Withdrawal by Subject|0|||
124751665|NCT00106353|448712577|FG001|Part 1|Withdrawal by Subject|0|||
124751666|NCT00106353|448712578|FG002|Part 1|Withdrawal by Subject|1|||
124751667|NCT00106353|448712579|FG003|Part 1|Withdrawal by Subject|2|||
124751668|NCT00106353|448712580|FG004|Part 1|Withdrawal by Subject|0|||
124751669|NCT00106353|448712581|FG005|Part 1|Withdrawal by Subject|0|||
124751670|NCT00106353|448712582|FG006|Part 1|Withdrawal by Subject|0|||
124751671|NCT00106353|448712576|FG000|Part 1|Symptomatic deterioration|0|||
124751672|NCT00106353|448712577|FG001|Part 1|Symptomatic deterioration|0|||
124751673|NCT00106353|448712578|FG002|Part 1|Symptomatic deterioration|1|||
124751674|NCT00106353|448712579|FG003|Part 1|Symptomatic deterioration|0|||
124751675|NCT00106353|448712580|FG004|Part 1|Symptomatic deterioration|0|||
124751676|NCT00106353|448712581|FG005|Part 1|Symptomatic deterioration|0|||
124751677|NCT00106353|448712582|FG006|Part 1|Symptomatic deterioration|0|||
124751678|NCT00106353|448712576|FG000|Part 1|Entered follow-up phase|1|||
124751679|NCT00106353|448712577|FG001|Part 1|Entered follow-up phase|1|||
124751680|NCT00106353|448712578|FG002|Part 1|Entered follow-up phase|0|||
124751681|NCT00106353|448712579|FG003|Part 1|Entered follow-up phase|1|||
124751682|NCT00106353|448712580|FG004|Part 1|Entered follow-up phase|0|||
124620840|NCT03598790|448227898|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
124751683|NCT00106353|448712581|FG005|Part 1|Entered follow-up phase|0|||
124751684|NCT00106353|448712582|FG006|Part 1|Entered follow-up phase|0|||
124751685|NCT00106353|448712576|FG000|Part 1|Adverse Event|0|||
124751686|NCT00106353|448712577|FG001|Part 1|Adverse Event|0|||
124751687|NCT00106353|448712578|FG002|Part 1|Adverse Event|0|||
124751688|NCT00106353|448712579|FG003|Part 1|Adverse Event|1|||
124751689|NCT00106353|448712580|FG004|Part 1|Adverse Event|0|||
124751690|NCT00106353|448712581|FG005|Part 1|Adverse Event|0|||
124751691|NCT00106353|448712582|FG006|Part 1|Adverse Event|0|||
124751692|NCT00106353|448712576|FG000|Part 2|Disease progression|0|||
124751693|NCT00106353|448712577|FG001|Part 2|Disease progression|0|||
124751694|NCT00106353|448712578|FG002|Part 2|Disease progression|0|||
124751695|NCT00106353|448712579|FG003|Part 2|Disease progression|0|||
124751696|NCT00106353|448712580|FG004|Part 2|Disease progression|8|||
124751697|NCT00106353|448712581|FG005|Part 2|Disease progression|14|||
124751698|NCT00106353|448712582|FG006|Part 2|Disease progression|13|||
124751699|NCT00106353|448712576|FG000|Part 2|Death|0|||
124751700|NCT00106353|448712577|FG001|Part 2|Death|0|||
124751701|NCT00106353|448712578|FG002|Part 2|Death|0|||
124620841|NCT03598790|448227899|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
124620842|NCT03598790|448227900|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
124620843|NCT03598790|448227901|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
124751702|NCT00106353|448712579|FG003|Part 2|Death|0|||
124751703|NCT00106353|448712580|FG004|Part 2|Death|3|||
124751704|NCT00106353|448712581|FG005|Part 2|Death|0|||
124751705|NCT00106353|448712582|FG006|Part 2|Death|1|||
124751706|NCT00106353|448712576|FG000|Part 2|Symptomatic deterioration|0|||
124751707|NCT00106353|448712577|FG001|Part 2|Symptomatic deterioration|0|||
124751708|NCT00106353|448712578|FG002|Part 2|Symptomatic deterioration|0|||
124751709|NCT00106353|448712579|FG003|Part 2|Symptomatic deterioration|0|||
124751710|NCT00106353|448712580|FG004|Part 2|Symptomatic deterioration|3|||
124751711|NCT00106353|448712581|FG005|Part 2|Symptomatic deterioration|0|||
124751712|NCT00106353|448712582|FG006|Part 2|Symptomatic deterioration|0|||
124751713|NCT00106353|448712576|FG000|Part 2|Adverse Event|0|||
124751714|NCT00106353|448712577|FG001|Part 2|Adverse Event|0|||
124751715|NCT00106353|448712578|FG002|Part 2|Adverse Event|0|||
124751716|NCT00106353|448712579|FG003|Part 2|Adverse Event|0|||
124751717|NCT00106353|448712580|FG004|Part 2|Adverse Event|0|||
124751718|NCT00106353|448712581|FG005|Part 2|Adverse Event|2|||
124751719|NCT00106353|448712582|FG006|Part 2|Adverse Event|1|||
124751720|NCT00106353|448712576|FG000|Part 2|Other|0|||
124751721|NCT00106353|448712577|FG001|Part 2|Other|0|||
124751722|NCT00106353|448712578|FG002|Part 2|Other|0|||
124751723|NCT00106353|448712579|FG003|Part 2|Other|0|||
124751724|NCT00106353|448712580|FG004|Part 2|Other|1|||
124751725|NCT00106353|448712581|FG005|Part 2|Other|1|||
124751726|NCT00106353|448712582|FG006|Part 2|Other|1|||
124751727|NCT00106353|448712576|FG000|Part 2|Withdrawal by Subject|0|||
124751728|NCT00106353|448712577|FG001|Part 2|Withdrawal by Subject|0|||
124751729|NCT00106353|448712578|FG002|Part 2|Withdrawal by Subject|0|||
124751730|NCT00106353|448712579|FG003|Part 2|Withdrawal by Subject|0|||
124751731|NCT00106353|448712580|FG004|Part 2|Withdrawal by Subject|1|||
124751732|NCT00106353|448712581|FG005|Part 2|Withdrawal by Subject|0|||
124751733|NCT00106353|448712582|FG006|Part 2|Withdrawal by Subject|0|||
124751734|NCT00106353|448712576|FG000|Part 2|Physician Decision|0|||
124751735|NCT00106353|448712577|FG001|Part 2|Physician Decision|0|||
124751736|NCT00106353|448712578|FG002|Part 2|Physician Decision|0|||
124751737|NCT00106353|448712579|FG003|Part 2|Physician Decision|0|||
124751738|NCT00106353|448712580|FG004|Part 2|Physician Decision|0|||
124751739|NCT00106353|448712581|FG005|Part 2|Physician Decision|1|||
124751740|NCT00106353|448712582|FG006|Part 2|Physician Decision|0|||
124751741|NCT02038075|448712583|FG000|Overall Study|Withdrawal by Subject|3|||
124751742|NCT02038075|448712584|FG001|Overall Study|Withdrawal by Subject|0|||
124751743|NCT00588354|448712585|FG000|Baseline to 2 Weeks|Adverse Event|1|||
124751744|NCT00588354|448712586|FG001|Baseline to 2 Weeks|Adverse Event|0|||
124751745|NCT00588354|448712585|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
124751746|NCT00588354|448712586|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
124751747|NCT00588354|448712585|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
124751748|NCT00588354|448712586|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
124751749|NCT04000581|448712587|FG000|Overall Study|Withdrawal by Subject|0|||
124751750|NCT04000581|448712588|FG001|Overall Study|Withdrawal by Subject|1|||
124751751|NCT03477838|448712589|FG000|Overall Study|Lost to Follow-up|14|||
124751752|NCT02519595|448712590|FG000|Overall Study|Protocol Violation|8|||
124751753|NCT02519595|448712591|FG001|Overall Study|Protocol Violation|22|||
124751754|NCT02519595|448712592|FG002|Overall Study|Protocol Violation|16|||
124751755|NCT00850538|448712593|FG000|Overall Study|unable/unwilling to complete MRI|13|||
124751756|NCT00850538|448712593|FG000|Overall Study|specimen missed due to scheduling error|14|||
124751757|NCT00850538|448712593|FG000|Overall Study|specimen unusable|7|||
124751758|NCT00850538|448712593|FG000|Overall Study|Withdrawal by Subject|3|||
124751759|NCT00850538|448712593|FG000|Overall Study|radiology error|2|||
124751760|NCT00850538|448712593|FG000|Overall Study|Protocol Violation|2|||
124751761|NCT02328027|448712601|FG000|Overall Study|Withdrawal by Subject|0|||
124620904|NCT05292183|448227918|FG000|Overall Study|Adverse Event|1|||
124620905|NCT04324073|448227921|FG000|Overall Study|withdrew consent|0|||
124620906|NCT04324073|448227922|FG001|Overall Study|withdrew consent|4|||
124620907|NCT04324073|448227923|FG002|Overall Study|withdrew consent|2|||
124620908|NCT04324073|448227924|FG003|Overall Study|withdrew consent|8|||
124620909|NCT05833139|448227927|FG000|Study Period 2|Adverse Event|1|||
124620910|NCT00371033|448227928|FG000|Overall Study|Lost to Follow-up|3|||
124620911|NCT00371033|448227929|FG001|Overall Study|Lost to Follow-up|2|||
124620912|NCT00371033|448227928|FG000|Overall Study|No longer interested|2|||
124620913|NCT00371033|448227929|FG001|Overall Study|No longer interested|0|||
124620914|NCT00371033|448227928|FG000|Overall Study|Uknown|3|||
124620915|NCT00371033|448227929|FG001|Overall Study|Uknown|1|||
124620916|NCT03922529|448227930|FG000|Overall Study|Withdrawal by Subject|13|||
124620917|NCT03922529|448227931|FG001|Overall Study|Withdrawal by Subject|12|||
124620918|NCT03922529|448227930|FG000|Overall Study|Death|7|||
124751762|NCT02328027|448712602|FG001|Overall Study|Withdrawal by Subject|1|||
124751763|NCT00250276|448712606|FG000|Overall Study|Serious Adverse Event|0|||
124751764|NCT00250276|448712607|FG001|Overall Study|Serious Adverse Event|0|||
124751765|NCT00250276|448712608|FG002|Overall Study|Serious Adverse Event|1|||
124751766|NCT00250276|448712609|FG003|Overall Study|Serious Adverse Event|0|||
124751767|NCT00250276|448712606|FG000|Overall Study|Non-serious Adverse Event|2|||
124751768|NCT00250276|448712607|FG001|Overall Study|Non-serious Adverse Event|0|||
124751769|NCT00250276|448712608|FG002|Overall Study|Non-serious Adverse Event|0|||
124751770|NCT00250276|448712609|FG003|Overall Study|Non-serious Adverse Event|2|||
124751771|NCT00250276|448712606|FG000|Overall Study|Protocol Violation|0|||
124751772|NCT00250276|448712607|FG001|Overall Study|Protocol Violation|1|||
124751773|NCT00250276|448712608|FG002|Overall Study|Protocol Violation|0|||
124751774|NCT00250276|448712609|FG003|Overall Study|Protocol Violation|0|||
124751775|NCT00250276|448712606|FG000|Overall Study|Withdrawal by Subject|1|||
124751776|NCT00250276|448712607|FG001|Overall Study|Withdrawal by Subject|2|||
124751777|NCT00250276|448712608|FG002|Overall Study|Withdrawal by Subject|3|||
124751778|NCT00250276|448712609|FG003|Overall Study|Withdrawal by Subject|2|||
124751779|NCT00250276|448712606|FG000|Overall Study|Migrated/moved from study area|3|||
124751780|NCT00250276|448712607|FG001|Overall Study|Migrated/moved from study area|0|||
124751781|NCT00250276|448712608|FG002|Overall Study|Migrated/moved from study area|2|||
124751782|NCT00250276|448712609|FG003|Overall Study|Migrated/moved from study area|7|||
124751783|NCT00250276|448712606|FG000|Overall Study|Lost to Follow-up|11|||
124751784|NCT00250276|448712607|FG001|Overall Study|Lost to Follow-up|18|||
124751785|NCT00250276|448712608|FG002|Overall Study|Lost to Follow-up|13|||
124751786|NCT00250276|448712609|FG003|Overall Study|Lost to Follow-up|8|||
124751787|NCT01088399|448712610|FG000|Overall Study|Adverse Event|211|||
124751788|NCT01088399|448712611|FG001|Overall Study|Adverse Event|16|||
124751789|NCT01088399|448712612|FG002|Overall Study|Adverse Event|0|||
124751790|NCT01088399|448712610|FG000|Overall Study|Death|204|||
124751791|NCT01088399|448712611|FG001|Overall Study|Death|45|||
124751792|NCT01088399|448712612|FG002|Overall Study|Death|0|||
124751793|NCT01088399|448712610|FG000|Overall Study|Lack of Efficacy|298|||
124751794|NCT01088399|448712611|FG001|Overall Study|Lack of Efficacy|7|||
124751795|NCT01088399|448712612|FG002|Overall Study|Lack of Efficacy|5|||
124751796|NCT01088399|448712610|FG000|Overall Study|Lost to Follow-up|1070|||
124751797|NCT01088399|448712611|FG001|Overall Study|Lost to Follow-up|278|||
124751798|NCT01088399|448712612|FG002|Overall Study|Lost to Follow-up|58|||
124751799|NCT01088399|448712610|FG000|Overall Study|Physician Decision|531|||
124751800|NCT01088399|448712611|FG001|Overall Study|Physician Decision|88|||
124751801|NCT01088399|448712612|FG002|Overall Study|Physician Decision|16|||
124751802|NCT01088399|448712610|FG000|Overall Study|Withdrawal by Subject|544|||
124751803|NCT01088399|448712611|FG001|Overall Study|Withdrawal by Subject|195|||
124751804|NCT01088399|448712612|FG002|Overall Study|Withdrawal by Subject|33|||
124751805|NCT01088399|448712610|FG000|Overall Study|Change to or start of somatropin therapy|234|||
124751806|NCT01088399|448712611|FG001|Overall Study|Change to or start of somatropin therapy|17|||
124751807|NCT01088399|448712612|FG002|Overall Study|Change to or start of somatropin therapy|12|||
124751808|NCT01088399|448712610|FG000|Overall Study|Sponsor decision|1573|||
124751809|NCT01088399|448712611|FG001|Overall Study|Sponsor decision|298|||
124751810|NCT01088399|448712612|FG002|Overall Study|Sponsor decision|7|||
124751811|NCT01088399|448712610|FG000|Overall Study|Protocol Violation|10|||
124751812|NCT01088399|448712611|FG001|Overall Study|Protocol Violation|1|||
124751813|NCT01088399|448712612|FG002|Overall Study|Protocol Violation|0|||
124751814|NCT01088399|448712610|FG000|Overall Study|Enrollment criteria not met|48|||
124751815|NCT01088399|448712611|FG001|Overall Study|Enrollment criteria not met|119|||
124751816|NCT01088399|448712612|FG002|Overall Study|Enrollment criteria not met|70|||
124751817|NCT01088399|448712610|FG000|Overall Study|Study summary visit not completed|2398|||
124751818|NCT01088399|448712611|FG001|Overall Study|Study summary visit not completed|283|||
124783192|NCT00145977|448835919|FG000|Overall Study|Withdrawal by Subject|1|||
124783193|NCT00145977|448835920|FG001|Overall Study|Withdrawal by Subject|0|||
124783194|NCT00782834|448835927|FG000|Treatment Phase|fibrous tumor not GIST|1|||
124783195|NCT02055118|448835928|FG000|Overall Study|Withdrawal by Subject|0|||
124751819|NCT01088399|448712612|FG002|Overall Study|Study summary visit not completed|80|||
124751820|NCT00782483|448712613|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
124751821|NCT01811186|448712615|FG000|Overall Study|Adverse Event|54|||
124751822|NCT01811186|448712616|FG001|Overall Study|Adverse Event|38|||
124751823|NCT01811186|448712615|FG000|Overall Study|Protocol Violation|5|||
124751824|NCT01811186|448712616|FG001|Overall Study|Protocol Violation|6|||
124751825|NCT01811186|448712615|FG000|Overall Study|Withdrawal by Subject|5|||
124751826|NCT01811186|448712616|FG001|Overall Study|Withdrawal by Subject|10|||
124751827|NCT01811186|448712615|FG000|Overall Study|Lack of Efficacy|3|||
124751828|NCT01811186|448712616|FG001|Overall Study|Lack of Efficacy|6|||
124751829|NCT01811186|448712615|FG000|Overall Study|Lost to Follow-up|4|||
124751830|NCT01811186|448712616|FG001|Overall Study|Lost to Follow-up|2|||
124751831|NCT03369236|448712619|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
124751832|NCT03369236|448712620|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
124751833|NCT03369236|448712619|FG000|Open-label Extension Period|Lack of Efficacy|2|||
124751834|NCT03369236|448712620|FG001|Open-label Extension Period|Lack of Efficacy|1|||
124751835|NCT03369236|448712619|FG000|Open-label Extension Period|Adverse Event|0|||
124783196|NCT02055118|448835929|FG001|Overall Study|Withdrawal by Subject|2|||
124751836|NCT03369236|448712620|FG001|Open-label Extension Period|Adverse Event|1|||
124620919|NCT03922529|448227931|FG001|Overall Study|Death|12|||
124620920|NCT03922529|448227930|FG000|Overall Study|Lost to Follow-up|12|||
124620921|NCT03922529|448227931|FG001|Overall Study|Lost to Follow-up|19|||
124620922|NCT03922529|448227930|FG000|Overall Study|Adverse Event|1|||
124620923|NCT03922529|448227931|FG001|Overall Study|Adverse Event|0|||
124620924|NCT03922529|448227930|FG000|Overall Study|Death after withdrawal|1|||
124620925|NCT03922529|448227931|FG001|Overall Study|Death after withdrawal|0|||
124620926|NCT03922529|448227930|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
124620927|NCT03922529|448227931|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
124620928|NCT03922529|448227930|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
124620929|NCT03922529|448227931|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
124620930|NCT02506153|448227932|FG000|Overall Study|Adverse Event|359|||
124620931|NCT02506153|448227933|FG001|Overall Study|Adverse Event|114|||
124620932|NCT02506153|448227932|FG000|Overall Study|Refused unrelated to adverse event|127|||
124620933|NCT02506153|448227933|FG001|Overall Study|Refused unrelated to adverse event|18|||
124620934|NCT02506153|448227932|FG000|Overall Study|Progression/relapse|91|||
124620935|NCT02506153|448227933|FG001|Overall Study|Progression/relapse|136|||
124620936|NCT02506153|448227932|FG000|Overall Study|Death|2|||
124620937|NCT02506153|448227933|FG001|Overall Study|Death|1|||
124620938|NCT02506153|448227932|FG000|Overall Study|Other - not protocol specified|23|||
124620939|NCT02506153|448227933|FG001|Overall Study|Other - not protocol specified|12|||
124620940|NCT06400238|448227938|FG000|Overall Study|Started Protocol Therapy|2|||
124620941|NCT06400238|448227938|FG000|Overall Study|Adverse Event|1|||
124620942|NCT06400238|448227938|FG000|Overall Study|Death|1|||
124620943|NCT06400238|448227938|FG000|Overall Study|Disease Progression|27|||
124620944|NCT06400238|448227938|FG000|Overall Study|Withdrawal by Subject|2|||
124620945|NCT06400238|448227938|FG000|Overall Study|Physician Decision|2|||
124620946|NCT06419907|448227939|FG000|Overall Study|Protocol Violation|0|||
124620947|NCT06419907|448227940|FG001|Overall Study|Protocol Violation|3|||
124620948|NCT06419907|448227941|FG002|Overall Study|Protocol Violation|0|||
124620949|NCT06419907|448227942|FG003|Overall Study|Protocol Violation|1|||
124620950|NCT06419907|448227939|FG000|Overall Study|Lost to Follow-up|0|||
124620951|NCT06419907|448227940|FG001|Overall Study|Lost to Follow-up|0|||
124620952|NCT06419907|448227941|FG002|Overall Study|Lost to Follow-up|2|||
124620953|NCT06419907|448227942|FG003|Overall Study|Lost to Follow-up|1|||
124620954|NCT05929651|448227945|FG000|Overall Study|Protocol Deviation|1|||
124620955|NCT05929651|448227945|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
124620956|NCT02260570|448227946|FG000|Overall Study|Withdrawal by Subject|2|||
124620957|NCT02260570|448227947|FG001|Overall Study|Withdrawal by Subject|1|||
124620958|NCT02260570|448227946|FG000|Overall Study|Physician Decision|1|||
124620959|NCT02260570|448227947|FG001|Overall Study|Physician Decision|1|||
124620960|NCT05026177|448227948|FG000|Overall Study|Adverse Event|33|||
124620961|NCT05026177|448227949|FG001|Overall Study|Adverse Event|33|||
124620962|NCT05026177|448227950|FG002|Overall Study|Adverse Event|17|||
124620963|NCT05026177|448227948|FG000|Overall Study|Lost to Follow-up|7|||
124620964|NCT05026177|448227949|FG001|Overall Study|Lost to Follow-up|6|||
124620965|NCT05026177|448227950|FG002|Overall Study|Lost to Follow-up|8|||
124620966|NCT05026177|448227948|FG000|Overall Study|Noncompliance with study drug|6|||
124620967|NCT05026177|448227949|FG001|Overall Study|Noncompliance with study drug|2|||
124620968|NCT05026177|448227950|FG002|Overall Study|Noncompliance with study drug|1|||
124620969|NCT05026177|448227948|FG000|Overall Study|Physician Decision|4|||
124620970|NCT05026177|448227949|FG001|Overall Study|Physician Decision|1|||
124620971|NCT05026177|448227950|FG002|Overall Study|Physician Decision|0|||
124620972|NCT05026177|448227948|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
124620973|NCT05026177|448227949|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
124620974|NCT05026177|448227950|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
124620975|NCT05026177|448227948|FG000|Overall Study|Withdrawal by Subject|53|||
124620976|NCT05026177|448227949|FG001|Overall Study|Withdrawal by Subject|51|||
124620977|NCT05026177|448227950|FG002|Overall Study|Withdrawal by Subject|55|||
124620978|NCT05026177|448227948|FG000|Overall Study|Protocol Violation|0|||
124620979|NCT05026177|448227949|FG001|Overall Study|Protocol Violation|1|||
124620980|NCT05026177|448227950|FG002|Overall Study|Protocol Violation|0|||
124751837|NCT03369236|448712619|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
124620981|NCT05026177|448227948|FG000|Overall Study|Study terminated by sponsor|70|||
124620982|NCT05026177|448227949|FG001|Overall Study|Study terminated by sponsor|74|||
124751838|NCT03369236|448712620|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
124620983|NCT05026177|448227950|FG002|Overall Study|Study terminated by sponsor|67|||
124620984|NCT05026177|448227948|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
124620985|NCT05026177|448227949|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
124620986|NCT05026177|448227950|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
124620987|NCT05026177|448227948|FG000|Overall Study|Starting alternative treatment|0|||
124620988|NCT05026177|448227949|FG001|Overall Study|Starting alternative treatment|1|||
124751839|NCT01865448|448714180|FG000|Overall Study|Adverse Event|1|||
124620989|NCT05026177|448227950|FG002|Overall Study|Starting alternative treatment|1|||
124620990|NCT05026177|448227948|FG000|Overall Study|Noncompliance with study procedures|0|||
124620991|NCT05026177|448227949|FG001|Overall Study|Noncompliance with study procedures|1|||
124620992|NCT05026177|448227950|FG002|Overall Study|Noncompliance with study procedures|1|||
124620993|NCT05026177|448227948|FG000|Overall Study|Met stopping criteria|0|||
124620994|NCT05026177|448227949|FG001|Overall Study|Met stopping criteria|0|||
124620995|NCT05026177|448227950|FG002|Overall Study|Met stopping criteria|1|||
124620996|NCT05026177|448227948|FG000|Overall Study|Health issues preventing continuation|0|||
124620997|NCT05026177|448227949|FG001|Overall Study|Health issues preventing continuation|0|||
124620998|NCT05026177|448227950|FG002|Overall Study|Health issues preventing continuation|1|||
124620999|NCT05026177|448227948|FG000|Overall Study|Randomized in error, not treated|0|||
124621000|NCT05026177|448227949|FG001|Overall Study|Randomized in error, not treated|0|||
124621001|NCT05026177|448227950|FG002|Overall Study|Randomized in error, not treated|2|||
124621002|NCT04856917|448227951|FG000|Overall Study|Withdrawal by Subject|4|||
124621003|NCT04856917|448227952|FG001|Overall Study|Withdrawal by Subject|3|||
124621004|NCT04856917|448227953|FG002|Overall Study|Withdrawal by Subject|1|||
124621005|NCT04856917|448227951|FG000|Overall Study|Lost to Follow-up|3|||
124621006|NCT04856917|448227952|FG001|Overall Study|Lost to Follow-up|1|||
124621007|NCT04856917|448227953|FG002|Overall Study|Lost to Follow-up|1|||
124621008|NCT04856917|448227951|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
124621009|NCT04856917|448227952|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
124621010|NCT04856917|448227953|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
124621011|NCT04856917|448227951|FG000|Overall Study|Other|1|||
124621012|NCT04856917|448227952|FG001|Overall Study|Other|1|||
124621013|NCT04856917|448227953|FG002|Overall Study|Other|0|||
124621014|NCT01169337|448227954|FG000|Overall Study|Lack of Efficacy|5|||
124621015|NCT01169337|448227955|FG001|Overall Study|Lack of Efficacy|7|||
124621016|NCT01169337|448227956|FG002|Overall Study|Lack of Efficacy|0|||
124621017|NCT01169337|448227954|FG000|Overall Study|Adverse Event|12|||
124621018|NCT01169337|448227955|FG001|Overall Study|Adverse Event|18|||
124621019|NCT01169337|448227956|FG002|Overall Study|Adverse Event|0|||
124621020|NCT01169337|448227954|FG000|Overall Study|Death|2|||
124621021|NCT01169337|448227955|FG001|Overall Study|Death|0|||
124621022|NCT01169337|448227956|FG002|Overall Study|Death|0|||
124621023|NCT01169337|448227954|FG000|Overall Study|Withdrawal by Subject|11|||
124621024|NCT01169337|448227955|FG001|Overall Study|Withdrawal by Subject|11|||
124621025|NCT01169337|448227956|FG002|Overall Study|Withdrawal by Subject|6|||
124621026|NCT01169337|448227954|FG000|Overall Study|Noncompliance|2|||
124621027|NCT01169337|448227955|FG001|Overall Study|Noncompliance|0|||
124621028|NCT01169337|448227956|FG002|Overall Study|Noncompliance|0|||
124621029|NCT01169337|448227954|FG000|Overall Study|Other complicating disease|1|||
124621030|NCT01169337|448227955|FG001|Overall Study|Other complicating disease|1|||
124621031|NCT01169337|448227956|FG002|Overall Study|Other complicating disease|0|||
124621032|NCT01169337|448227954|FG000|Overall Study|Physician Decision|1|||
124621033|NCT01169337|448227955|FG001|Overall Study|Physician Decision|5|||
124621034|NCT01169337|448227956|FG002|Overall Study|Physician Decision|0|||
124621035|NCT01169337|448227954|FG000|Overall Study|Alternative therapy|0|||
124621036|NCT01169337|448227955|FG001|Overall Study|Alternative therapy|2|||
124621037|NCT01169337|448227956|FG002|Overall Study|Alternative therapy|0|||
124621038|NCT01169337|448227954|FG000|Overall Study|Changed hospital|0|||
124621039|NCT01169337|448227955|FG001|Overall Study|Changed hospital|1|||
124621040|NCT01169337|448227956|FG002|Overall Study|Changed hospital|0|||
124621041|NCT01169337|448227954|FG000|Overall Study|Never started treatment|0|||
124621042|NCT01169337|448227955|FG001|Overall Study|Never started treatment|2|||
124621043|NCT01169337|448227956|FG002|Overall Study|Never started treatment|0|||
124621044|NCT01169337|448227954|FG000|Overall Study|Reason not reported|1|||
124621045|NCT01169337|448227955|FG001|Overall Study|Reason not reported|0|||
124621046|NCT01169337|448227956|FG002|Overall Study|Reason not reported|0|||
124621047|NCT01169337|448227954|FG000|Overall Study|Continuing lenalidomide|9|||
124621048|NCT01169337|448227955|FG001|Overall Study|Continuing lenalidomide|43|||
124621049|NCT01169337|448227956|FG002|Overall Study|Continuing lenalidomide|0|||
124621050|NCT04008030|448227957|FG000|Pre-Treatment|Withdrawal by Subject|0|||
124621051|NCT04008030|448227958|FG001|Pre-Treatment|Withdrawal by Subject|0|||
124621052|NCT04008030|448227959|FG002|Pre-Treatment|Withdrawal by Subject|9|||
124621053|NCT04008030|448227957|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
124621054|NCT04008030|448227958|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
124621055|NCT04008030|448227959|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
124621056|NCT04008030|448227957|FG000|Pre-Treatment|Other reasons|0|||
124621057|NCT04008030|448227958|FG001|Pre-Treatment|Other reasons|1|||
124621058|NCT04008030|448227959|FG002|Pre-Treatment|Other reasons|6|||
124621059|NCT04008030|448227957|FG000|Treatment|Withdrawal by Subject|1|||
124621060|NCT04008030|448227958|FG001|Treatment|Withdrawal by Subject|1|||
124621061|NCT04008030|448227959|FG002|Treatment|Withdrawal by Subject|1|||
124621062|NCT04008030|448227957|FG000|Treatment|Death|2|||
124621063|NCT04008030|448227958|FG001|Treatment|Death|4|||
124621064|NCT04008030|448227959|FG002|Treatment|Death|0|||
124621065|NCT04008030|448227957|FG000|Treatment|Pregnancy|0|||
124621066|NCT04008030|448227958|FG001|Treatment|Pregnancy|1|||
124621067|NCT04008030|448227959|FG002|Treatment|Pregnancy|0|||
124621068|NCT04008030|448227957|FG000|Treatment|Participant no longer meets study criteria|0|||
124621069|NCT04008030|448227958|FG001|Treatment|Participant no longer meets study criteria|1|||
124621070|NCT04008030|448227959|FG002|Treatment|Participant no longer meets study criteria|0|||
124621071|NCT04008030|448227957|FG000|Treatment|Other reasons|5|||
124621072|NCT04008030|448227958|FG001|Treatment|Other reasons|13|||
124621073|NCT04008030|448227959|FG002|Treatment|Other reasons|6|||
124621074|NCT04008030|448227957|FG000|Treatment|Disease Progression|137|||
124621075|NCT04008030|448227958|FG001|Treatment|Disease Progression|82|||
124621076|NCT04008030|448227959|FG002|Treatment|Disease Progression|85|||
124621077|NCT04008030|448227957|FG000|Treatment|Study drug toxicity|28|||
124621078|NCT04008030|448227958|FG001|Treatment|Study drug toxicity|48|||
124621079|NCT04008030|448227959|FG002|Treatment|Study drug toxicity|8|||
124621080|NCT04008030|448227957|FG000|Treatment|Adverse Event unrelated to study drug|28|||
124621081|NCT04008030|448227958|FG001|Treatment|Adverse Event unrelated to study drug|22|||
124621082|NCT04008030|448227959|FG002|Treatment|Adverse Event unrelated to study drug|6|||
124621083|NCT04008030|448227957|FG000|Treatment|Maximum Clinical Benefit|0|||
124621084|NCT04008030|448227958|FG001|Treatment|Maximum Clinical Benefit|1|||
124621085|NCT04008030|448227959|FG002|Treatment|Maximum Clinical Benefit|9|||
124621086|NCT04008030|448227957|FG000|Treatment|On-going treatment|13|||
124621087|NCT04008030|448227958|FG001|Treatment|On-going treatment|20|||
124621088|NCT04008030|448227959|FG002|Treatment|On-going treatment|0|||
124621089|NCT03560037|448227960|FG000|Overall Study|Protocol Violation|1|||
124621090|NCT03560037|448227961|FG001|Overall Study|Protocol Violation|0|||
124621091|NCT03560037|448227960|FG000|Overall Study|Physician Decision|0|||
124621092|NCT03560037|448227961|FG001|Overall Study|Physician Decision|1|||
124621093|NCT04034927|448227962|FG000|Overall Study|Adverse Event|4|||
124621094|NCT04034927|448227963|FG001|Overall Study|Adverse Event|9|||
124621095|NCT04034927|448227962|FG000|Overall Study|Death|0|||
124751840|NCT01865448|448714181|FG001|Overall Study|Adverse Event|1|||
124751841|NCT01865448|448714180|FG000|Overall Study|Pregnancy|0|||
124751842|NCT01865448|448714181|FG001|Overall Study|Pregnancy|1|||
124751843|NCT01865448|448714180|FG000|Overall Study|dropout unrelated to study|1|||
124751844|NCT01865448|448714181|FG001|Overall Study|dropout unrelated to study|1|||
124751845|NCT00872599|448714182|FG000|Second Washout Period|Adverse Event|1|||
124751846|NCT00872599|448714183|FG001|Second Washout Period|Adverse Event|1|||
124751847|NCT00801229|448714184|FG000|Signed Consent|Withdrawal by Subject|2|||
124751848|NCT00801229|448714185|FG001|Signed Consent|Withdrawal by Subject|2|||
124751849|NCT00801229|448714184|FG000|Signed Consent|Found Ineligible|1|||
124751850|NCT00801229|448714185|FG001|Signed Consent|Found Ineligible|1|||
124751851|NCT00801229|448714184|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
124751852|NCT00801229|448714185|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
124751853|NCT00801229|448714184|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
124751854|NCT00801229|448714185|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
124751855|NCT00801229|448714184|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
124751856|NCT00801229|448714185|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
124751857|NCT00801229|448714184|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
124751858|NCT00801229|448714185|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
124751859|NCT00801229|448714184|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
124751860|NCT00801229|448714185|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
124751861|NCT00801229|448714184|FG000|Received Study Drug/Placebo|Adverse Event|1|||
124751862|NCT00801229|448714185|FG001|Received Study Drug/Placebo|Adverse Event|1|||
124751863|NCT02255461|448714186|FG000|Overall Study|Adverse Event|0|||
124751864|NCT02255461|448714187|FG001|Overall Study|Adverse Event|1|||
124751865|NCT02255461|448714188|FG002|Overall Study|Adverse Event|0|||
124751866|NCT02255461|448714189|FG003|Overall Study|Adverse Event|0|||
124751867|NCT02255461|448714190|FG004|Overall Study|Adverse Event|1|||
124751868|NCT02255461|448714186|FG000|Overall Study|Withdrawal by Subject|0|||
124751869|NCT02255461|448714187|FG001|Overall Study|Withdrawal by Subject|0|||
124751870|NCT02255461|448714188|FG002|Overall Study|Withdrawal by Subject|1|||
124751871|NCT02255461|448714189|FG003|Overall Study|Withdrawal by Subject|0|||
124751872|NCT02255461|448714190|FG004|Overall Study|Withdrawal by Subject|1|||
124751873|NCT02255461|448714186|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
124751874|NCT02255461|448714187|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
124751875|NCT02255461|448714188|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
124621096|NCT04034927|448227963|FG001|Overall Study|Death|1|||
124621097|NCT04034927|448227962|FG000|Overall Study|Withdrawal by Subject|0|||
124621098|NCT04034927|448227963|FG001|Overall Study|Withdrawal by Subject|3|||
124751876|NCT02255461|448714189|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
124621099|NCT04034927|448227962|FG000|Overall Study|Still on Treatment|2|||
124621100|NCT04034927|448227963|FG001|Overall Study|Still on Treatment|1|||
124621101|NCT04034927|448227962|FG000|Overall Study|Other|1|||
124751877|NCT02255461|448714190|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
124751878|NCT04809285|448714193|FG000|Phase 1|Lost to Follow-up|6|||
124751879|NCT04809285|448714193|FG000|Phase 1|Protocol Violation|2|||
124751880|NCT04809285|448714193|FG000|Phase 1|Physician Decision|3|||
124751881|NCT04809285|448714193|FG000|Phase 1|Withdrawal by Subject|29|||
124621102|NCT04034927|448227963|FG001|Overall Study|Other|1|||
124621103|NCT03996447|448227966|FG000|First MRI Examination|Adverse Event|2|||
124621104|NCT03996447|448227967|FG001|First MRI Examination|Adverse Event|0|||
124621105|NCT03996447|448227966|FG000|First MRI Examination|Withdrawal by Subject|1|||
124621106|NCT03996447|448227967|FG001|First MRI Examination|Withdrawal by Subject|2|||
124621107|NCT03996447|448227966|FG000|First MRI Examination|Protocol Violation|0|||
124621108|NCT03996447|448227967|FG001|First MRI Examination|Protocol Violation|1|||
124621109|NCT03996447|448227966|FG000|Washout|Adverse Event|2|||
124621110|NCT03996447|448227967|FG001|Washout|Adverse Event|0|||
124621111|NCT03996447|448227966|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
124621112|NCT03996447|448227967|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
124621113|NCT03996447|448227966|FG000|Washout|Withdrawal by Subject|0|||
124621114|NCT03996447|448227967|FG001|Washout|Withdrawal by Subject|1|||
124621115|NCT03996447|448227966|FG000|Washout|Other reason|1|||
124621116|NCT03996447|448227967|FG001|Washout|Other reason|1|||
124621117|NCT03816878|448227968|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
124621118|NCT03816878|448227969|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
124621119|NCT03816878|448227968|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
124621120|NCT03816878|448227969|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
124621121|NCT03355469|448227970|FG000|Overall Study|COVID-19|3|||
124621122|NCT03355469|448227971|FG001|Overall Study|COVID-19|2|||
124621123|NCT03355469|448227972|FG002|Overall Study|COVID-19|3|||
124621124|NCT03355469|448227973|FG003|Overall Study|COVID-19|3|||
124621125|NCT03355469|448227970|FG000|Overall Study|Lost to Follow-up|1|||
124621126|NCT03355469|448227971|FG001|Overall Study|Lost to Follow-up|0|||
124621127|NCT03355469|448227972|FG002|Overall Study|Lost to Follow-up|1|||
124621128|NCT03355469|448227973|FG003|Overall Study|Lost to Follow-up|0|||
124621129|NCT03355469|448227970|FG000|Overall Study|Withdrawal by Subject|2|||
124621130|NCT03355469|448227971|FG001|Overall Study|Withdrawal by Subject|1|||
124621131|NCT03355469|448227972|FG002|Overall Study|Withdrawal by Subject|0|||
124621132|NCT03355469|448227973|FG003|Overall Study|Withdrawal by Subject|3|||
124621133|NCT01708941|448227974|FG000|Overall Study|Adverse Event|4|||
124621134|NCT01708941|448227975|FG001|Overall Study|Adverse Event|6|||
124621135|NCT01708941|448227976|FG002|Overall Study|Adverse Event|1|||
124621136|NCT01708941|448227977|FG003|Overall Study|Adverse Event|0|||
124621137|NCT01708941|448227974|FG000|Overall Study|Death|1|||
124621138|NCT01708941|448227975|FG001|Overall Study|Death|1|||
124621139|NCT01708941|448227976|FG002|Overall Study|Death|2|||
124621140|NCT01708941|448227977|FG003|Overall Study|Death|14|||
124621141|NCT01708941|448227974|FG000|Overall Study|Withdrawal by Subject|1|||
124621142|NCT01708941|448227975|FG001|Overall Study|Withdrawal by Subject|0|||
124621143|NCT01708941|448227976|FG002|Overall Study|Withdrawal by Subject|3|||
124621144|NCT01708941|448227977|FG003|Overall Study|Withdrawal by Subject|4|||
124621145|NCT01708941|448227974|FG000|Overall Study|Disease progression|9|||
124621146|NCT01708941|448227975|FG001|Overall Study|Disease progression|10|||
124621147|NCT01708941|448227976|FG002|Overall Study|Disease progression|8|||
124621148|NCT01708941|448227977|FG003|Overall Study|Disease progression|0|||
124621149|NCT01708941|448227974|FG000|Overall Study|Alternative therapy|0|||
124621150|NCT01708941|448227975|FG001|Overall Study|Alternative therapy|0|||
124621151|NCT01708941|448227976|FG002|Overall Study|Alternative therapy|2|||
124621152|NCT01708941|448227977|FG003|Overall Study|Alternative therapy|0|||
124621153|NCT01708941|448227974|FG000|Overall Study|Ineligible and never started treatment|1|||
124621154|NCT01708941|448227975|FG001|Overall Study|Ineligible and never started treatment|0|||
124621155|NCT01708941|448227976|FG002|Overall Study|Ineligible and never started treatment|1|||
124621156|NCT01708941|448227977|FG003|Overall Study|Ineligible and never started treatment|0|||
124621157|NCT01708941|448227974|FG000|Overall Study|Never started treatment|2|||
124621158|NCT01708941|448227975|FG001|Overall Study|Never started treatment|1|||
124621159|NCT01708941|448227976|FG002|Overall Study|Never started treatment|0|||
124621160|NCT01708941|448227977|FG003|Overall Study|Never started treatment|0|||
124621161|NCT01708941|448227974|FG000|Overall Study|Ineligible|0|||
124621162|NCT01708941|448227975|FG001|Overall Study|Ineligible|0|||
124621163|NCT01708941|448227976|FG002|Overall Study|Ineligible|2|||
124621164|NCT01708941|448227977|FG003|Overall Study|Ineligible|0|||
124621165|NCT01575548|448227978|FG000|Overall Study|Adverse Event|15|||
124783197|NCT02055118|448835930|FG002|Overall Study|Withdrawal by Subject|0|||
124621166|NCT01575548|448227979|FG001|Overall Study|Adverse Event|2|||
124621167|NCT01575548|448227978|FG000|Overall Study|Disease progression|12|||
124621168|NCT01575548|448227979|FG001|Overall Study|Disease progression|25|||
124621169|NCT01575548|448227978|FG000|Overall Study|Death|1|||
124621170|NCT01575548|448227979|FG001|Overall Study|Death|0|||
124621171|NCT01575548|448227978|FG000|Overall Study|Other complicating disease|1|||
124621172|NCT01575548|448227979|FG001|Overall Study|Other complicating disease|0|||
124621173|NCT01575548|448227978|FG000|Overall Study|Withdrawal by Subject|7|||
124621174|NCT01575548|448227979|FG001|Overall Study|Withdrawal by Subject|3|||
124621175|NCT01575548|448227978|FG000|Overall Study|Noncompliance|1|||
124621176|NCT01575548|448227979|FG001|Overall Study|Noncompliance|0|||
124783198|NCT02281383|448835931|FG000|Overall Study|Progressive Disease|1|||
124621177|NCT01575548|448227978|FG000|Overall Study|Anticipated surgery|0|||
124621178|NCT01575548|448227979|FG001|Overall Study|Anticipated surgery|1|||
124783199|NCT02281383|448835931|FG000|Overall Study|Withdrawal by Subject|6|||
124783200|NCT02281383|448835931|FG000|Overall Study|Protocol Violation|2|||
124783201|NCT02281383|448835931|FG000|Overall Study|Death|1|||
124783202|NCT02281383|448835931|FG000|Overall Study|Adverse Event|2|||
124783203|NCT01215097|448835932|FG000|Overall Study|Adverse Event|1|||
124783204|NCT01215097|448835933|FG001|Overall Study|Adverse Event|3|||
124783205|NCT01215097|448835932|FG000|Overall Study|Protocol Violation|0|||
124783206|NCT01215097|448835933|FG001|Overall Study|Protocol Violation|2|||
124783207|NCT01215097|448835932|FG000|Overall Study|Lost to Follow-up|2|||
124783208|NCT01215097|448835933|FG001|Overall Study|Lost to Follow-up|0|||
124783209|NCT01215097|448835932|FG000|Overall Study|Withdrawal by Subject|6|||
124783210|NCT01215097|448835933|FG001|Overall Study|Withdrawal by Subject|3|||
124783211|NCT01215097|448835932|FG000|Overall Study|Lack of Efficacy|0|||
124783212|NCT01215097|448835933|FG001|Overall Study|Lack of Efficacy|3|||
124783213|NCT01215097|448835932|FG000|Overall Study|patient's refusal to come|2|||
124783214|NCT01215097|448835933|FG001|Overall Study|patient's refusal to come|2|||
124783215|NCT01215097|448835932|FG000|Overall Study|patient's private reason|1|||
124783216|NCT01215097|448835933|FG001|Overall Study|patient's private reason|1|||
124783217|NCT02560025|448835936|FG000|Overall Study|Ineligible after consent/ registration|3|||
124783218|NCT02703337|448835937|FG000|Period One (Part A)|Withdrawal by Subject|0|||
124783219|NCT02703337|448835938|FG001|Period One (Part A)|Withdrawal by Subject|0|||
124783220|NCT02703337|448835939|FG002|Period One (Part A)|Withdrawal by Subject|0|||
124783221|NCT02703337|448835940|FG003|Period One (Part A)|Withdrawal by Subject|0|||
124783222|NCT02703337|448835941|FG004|Period One (Part A)|Withdrawal by Subject|1|||
124783223|NCT02703337|448835942|FG005|Period One (Part A)|Withdrawal by Subject|0|||
124783224|NCT02703337|448835943|FG006|Period One (Part A)|Withdrawal by Subject|0|||
124783225|NCT02703337|448835944|FG007|Period One (Part A)|Withdrawal by Subject|0|||
124783226|NCT00282308|448835945|FG000|Treatment Period|Lost to Follow-up|1|||
124783227|NCT00282308|448835946|FG001|Treatment Period|Lost to Follow-up|0|||
124783228|NCT00282308|448835947|FG002|Treatment Period|Lost to Follow-up|0|||
124783229|NCT00282308|448835945|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
124621179|NCT01575548|448227978|FG000|Overall Study|Never started protocol therapy|3|||
124621180|NCT01575548|448227979|FG001|Overall Study|Never started protocol therapy|2|||
124621181|NCT04175912|448227980|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
124621182|NCT04175912|448227981|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
124621183|NCT04175912|448227980|FG000|Overall Study|Adverse Event|0|||
124621184|NCT04175912|448227981|FG001|Overall Study|Adverse Event|3|||
124621185|NCT04175912|448227980|FG000|Overall Study|Never started treatment|3|||
124621186|NCT04175912|448227981|FG001|Overall Study|Never started treatment|3|||
124621187|NCT04175912|448227980|FG000|Overall Study|Death|0|||
124621188|NCT04175912|448227981|FG001|Overall Study|Death|1|||
124621189|NCT02048813|448227985|FG000|Overall Study|Still on treatment|279|||
124621190|NCT02048813|448227986|FG001|Overall Study|Still on treatment|0|||
124621191|NCT02048813|448227985|FG000|Overall Study|Adverse Event|40|||
124621192|NCT02048813|448227986|FG001|Overall Study|Adverse Event|38|||
124621193|NCT02048813|448227985|FG000|Overall Study|Disease progression|13|||
124621194|NCT02048813|448227986|FG001|Overall Study|Disease progression|3|||
124621195|NCT02048813|448227985|FG000|Overall Study|Withdrawal by Subject|7|||
124621196|NCT02048813|448227986|FG001|Overall Study|Withdrawal by Subject|8|||
124621197|NCT02048813|448227985|FG000|Overall Study|Death|2|||
124621198|NCT02048813|448227986|FG001|Overall Study|Death|1|||
124621199|NCT02048813|448227985|FG000|Overall Study|Complication|2|||
124621200|NCT02048813|448227986|FG001|Overall Study|Complication|2|||
124621201|NCT02048813|448227985|FG000|Overall Study|Non-protocol therapy|0|||
124621202|NCT02048813|448227986|FG001|Overall Study|Non-protocol therapy|1|||
124621203|NCT02048813|448227985|FG000|Overall Study|Second primary cancer|2|||
124621204|NCT02048813|448227986|FG001|Overall Study|Second primary cancer|0|||
124621205|NCT02048813|448227985|FG000|Overall Study|Insurance|2|||
124621206|NCT02048813|448227986|FG001|Overall Study|Insurance|0|||
124621207|NCT02048813|448227985|FG000|Overall Study|Wound infection/healing|2|||
124621208|NCT02048813|448227986|FG001|Overall Study|Wound infection/healing|0|||
124621209|NCT02048813|448227985|FG000|Overall Study|Missed appointment|3|||
124783230|NCT00282308|448835946|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
124621210|NCT02048813|448227986|FG001|Overall Study|Missed appointment|0|||
124621211|NCT02048813|448227985|FG000|Overall Study|Never started treatment|2|||
124621212|NCT02048813|448227986|FG001|Overall Study|Never started treatment|17|||
124621213|NCT01708954|448227987|FG000|Step 1|Disease progression|26|||
124783231|NCT00282308|448835947|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
124783232|NCT00282308|448835945|FG000|Treatment Period|Adverse Event|0|||
124783233|NCT00282308|448835946|FG001|Treatment Period|Adverse Event|2|||
124783234|NCT00282308|448835947|FG002|Treatment Period|Adverse Event|0|||
124783235|NCT00282308|448835945|FG000|Treatment Period|Not Treated with Study Drug|1|||
124621214|NCT01708954|448227988|FG001|Step 1|Disease progression|17|||
124621215|NCT01708954|448227989|FG002|Step 1|Disease progression|14|||
124621216|NCT01708954|448227987|FG000|Step 1|Adverse Event|3|||
124621217|NCT01708954|448227988|FG001|Step 1|Adverse Event|11|||
124621218|NCT01708954|448227989|FG002|Step 1|Adverse Event|13|||
124621219|NCT01708954|448227987|FG000|Step 1|Death|3|||
124621220|NCT01708954|448227988|FG001|Step 1|Death|2|||
124621221|NCT01708954|448227989|FG002|Step 1|Death|3|||
124621222|NCT01708954|448227987|FG000|Step 1|Withdrawal by Subject|2|||
124621223|NCT01708954|448227988|FG001|Step 1|Withdrawal by Subject|5|||
124621224|NCT01708954|448227989|FG002|Step 1|Withdrawal by Subject|3|||
124621225|NCT01708954|448227987|FG000|Step 1|Other complicating disease|0|||
124621226|NCT01708954|448227988|FG001|Step 1|Other complicating disease|2|||
124621227|NCT01708954|448227989|FG002|Step 1|Other complicating disease|0|||
124621228|NCT01708954|448227987|FG000|Step 1|Crossed over to Step 2|2|||
124621229|NCT01708954|448227988|FG001|Step 1|Crossed over to Step 2|0|||
124621230|NCT01708954|448227989|FG002|Step 1|Crossed over to Step 2|0|||
124621231|NCT01708954|448227987|FG000|Step 1|Symptomatic deterioration|1|||
124621232|NCT01708954|448227988|FG001|Step 1|Symptomatic deterioration|0|||
124621233|NCT01708954|448227989|FG002|Step 1|Symptomatic deterioration|1|||
124621234|NCT01708954|448227987|FG000|Step 1|Off-treatment reason not submitted|1|||
124621235|NCT01708954|448227988|FG001|Step 1|Off-treatment reason not submitted|1|||
124621236|NCT01708954|448227989|FG002|Step 1|Off-treatment reason not submitted|1|||
124621237|NCT01708954|448227987|FG000|Step 1|Ineligible or never received treatment|4|||
124621238|NCT01708954|448227988|FG001|Step 1|Ineligible or never received treatment|2|||
124621239|NCT01708954|448227989|FG002|Step 1|Ineligible or never received treatment|8|||
124621240|NCT01708954|448227987|FG000|Step 2|Disease progression|9|||
124621241|NCT01708954|448227988|FG001|Step 2|Disease progression|4|||
124621242|NCT01708954|448227989|FG002|Step 2|Disease progression|0|||
124621243|NCT01708954|448227987|FG000|Step 2|Adverse Event|3|||
124621244|NCT01708954|448227988|FG001|Step 2|Adverse Event|2|||
124621245|NCT01708954|448227989|FG002|Step 2|Adverse Event|0|||
124621246|NCT01708954|448227987|FG000|Step 2|Withdrawal by Subject|1|||
124621247|NCT01708954|448227988|FG001|Step 2|Withdrawal by Subject|1|||
124621248|NCT01708954|448227989|FG002|Step 2|Withdrawal by Subject|0|||
124621249|NCT06400251|448227990|FG000|Overall Study|Never Start Protocol Therapy|1|||
124621250|NCT06400251|448227990|FG000|Overall Study|Ineligible|2|||
124621251|NCT06400251|448227990|FG000|Overall Study|Mutation Status Not Confirmed|3|||
124621252|NCT06400251|448227990|FG000|Overall Study|Disease Progression|25|||
124621253|NCT06400251|448227990|FG000|Overall Study|Adverse Event|1|||
124621254|NCT06400251|448227990|FG000|Overall Study|Complicating Disease|1|||
124621255|NCT06400251|448227990|FG000|Overall Study|Physician Decision|2|||
124621256|NCT04158245|448227991|FG000|Overall Study|Lost to Follow-up|1|||
124621257|NCT03631199|448227992|FG000|Overall Study|Progressive disease|9|||
124621258|NCT03631199|448227993|FG001|Overall Study|Progressive disease|5|||
124621259|NCT03631199|448227994|FG002|Overall Study|Progressive disease|5|||
124621260|NCT03631199|448227995|FG003|Overall Study|Progressive disease|149|||
124621261|NCT03631199|448227996|FG004|Overall Study|Progressive disease|148|||
124621262|NCT03631199|448227992|FG000|Overall Study|Physician Decision|0|||
124621263|NCT03631199|448227993|FG001|Overall Study|Physician Decision|2|||
124621264|NCT03631199|448227994|FG002|Overall Study|Physician Decision|3|||
124621265|NCT03631199|448227995|FG003|Overall Study|Physician Decision|19|||
124621266|NCT03631199|448227996|FG004|Overall Study|Physician Decision|13|||
124621267|NCT03631199|448227992|FG000|Overall Study|Adverse Event|1|||
124621268|NCT03631199|448227993|FG001|Overall Study|Adverse Event|1|||
124621269|NCT03631199|448227994|FG002|Overall Study|Adverse Event|0|||
124621270|NCT03631199|448227995|FG003|Overall Study|Adverse Event|28|||
124621271|NCT03631199|448227996|FG004|Overall Study|Adverse Event|29|||
124621272|NCT03631199|448227992|FG000|Overall Study|Death|0|||
124621273|NCT03631199|448227993|FG001|Overall Study|Death|1|||
124621274|NCT03631199|448227994|FG002|Overall Study|Death|0|||
124621275|NCT03631199|448227995|FG003|Overall Study|Death|35|||
124621276|NCT03631199|448227996|FG004|Overall Study|Death|48|||
124621277|NCT03631199|448227992|FG000|Overall Study|Subject decision|0|||
124621278|NCT03631199|448227993|FG001|Overall Study|Subject decision|1|||
124621279|NCT03631199|448227994|FG002|Overall Study|Subject decision|0|||
124621280|NCT03631199|448227995|FG003|Overall Study|Subject decision|12|||
124621281|NCT03631199|448227996|FG004|Overall Study|Subject decision|12|||
124621282|NCT03631199|448227992|FG000|Overall Study|No treated|0|||
124621283|NCT03631199|448227993|FG001|Overall Study|No treated|0|||
124621284|NCT03631199|448227994|FG002|Overall Study|No treated|0|||
124621285|NCT03631199|448227995|FG003|Overall Study|No treated|0|||
124621286|NCT03631199|448227996|FG004|Overall Study|No treated|1|||
124621287|NCT03631199|448227992|FG000|Overall Study|Treatment ongoing|0|||
124621288|NCT03631199|448227993|FG001|Overall Study|Treatment ongoing|1|||
124621289|NCT03631199|448227994|FG002|Overall Study|Treatment ongoing|1|||
124621290|NCT03631199|448227995|FG003|Overall Study|Treatment ongoing|76|||
124621291|NCT03631199|448227996|FG004|Overall Study|Treatment ongoing|71|||
124621292|NCT03631199|448227992|FG000|Overall Study|Guardian decision|0|||
124621293|NCT03631199|448227993|FG001|Overall Study|Guardian decision|0|||
124621294|NCT03631199|448227994|FG002|Overall Study|Guardian decision|0|||
124621295|NCT03631199|448227995|FG003|Overall Study|Guardian decision|1|||
124621296|NCT03631199|448227996|FG004|Overall Study|Guardian decision|1|||
124621297|NCT03842228|448227999|FG000|Overall Study|Adverse Event|1|||
124621298|NCT03842228|448228000|FG001|Overall Study|Adverse Event|1|||
124621299|NCT03842228|448228001|FG002|Overall Study|Adverse Event|1|||
124621300|NCT03842228|448228002|FG003|Overall Study|Adverse Event|0|||
124621301|NCT03842228|448228003|FG004|Overall Study|Adverse Event|0|||
124621302|NCT03842228|448228004|FG005|Overall Study|Adverse Event|0|||
124621303|NCT03842228|448228005|FG006|Overall Study|Adverse Event|0|||
124621304|NCT03842228|448227999|FG000|Overall Study|Death|0|||
124621305|NCT03842228|448228000|FG001|Overall Study|Death|1|||
124621306|NCT03842228|448228001|FG002|Overall Study|Death|0|||
124621307|NCT03842228|448228002|FG003|Overall Study|Death|0|||
124621308|NCT03842228|448228003|FG004|Overall Study|Death|0|||
124621309|NCT03842228|448228004|FG005|Overall Study|Death|0|||
124621310|NCT03842228|448228005|FG006|Overall Study|Death|0|||
124621311|NCT03842228|448227999|FG000|Overall Study|Withdrawal by Subject|0|||
124621312|NCT03842228|448228000|FG001|Overall Study|Withdrawal by Subject|0|||
124621313|NCT03842228|448228001|FG002|Overall Study|Withdrawal by Subject|2|||
124621314|NCT03842228|448228002|FG003|Overall Study|Withdrawal by Subject|1|||
124621315|NCT03842228|448228003|FG004|Overall Study|Withdrawal by Subject|0|||
124621316|NCT03842228|448228004|FG005|Overall Study|Withdrawal by Subject|0|||
124621317|NCT03842228|448228005|FG006|Overall Study|Withdrawal by Subject|2|||
124621318|NCT03842228|448227999|FG000|Overall Study|Progression|8|||
124621319|NCT03842228|448228000|FG001|Overall Study|Progression|1|||
124621320|NCT03842228|448228001|FG002|Overall Study|Progression|7|||
124621321|NCT03842228|448228002|FG003|Overall Study|Progression|5|||
124621322|NCT03842228|448228003|FG004|Overall Study|Progression|4|||
124621323|NCT03842228|448228004|FG005|Overall Study|Progression|2|||
124621324|NCT03842228|448228005|FG006|Overall Study|Progression|3|||
124621325|NCT02567435|448228006|FG000|Overall Study|Death|1|||
124621326|NCT02567435|448228007|FG001|Overall Study|Death|1|||
124621327|NCT02567435|448228008|FG002|Overall Study|Death|0|||
124621328|NCT02567435|448228009|FG003|Overall Study|Death|0|||
124621329|NCT02567435|448228006|FG000|Overall Study|Ineligible|1|||
124621330|NCT02567435|448228007|FG001|Overall Study|Ineligible|3|||
124621331|NCT02567435|448228008|FG002|Overall Study|Ineligible|0|||
124621332|NCT02567435|448228009|FG003|Overall Study|Ineligible|0|||
124621333|NCT02567435|448228006|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
124621334|NCT02567435|448228007|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
124621335|NCT02567435|448228008|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
124621336|NCT02567435|448228009|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
124621337|NCT06390826|448228010|FG000|Overall Study|Never Start Protocol Therapy|1|||
124621338|NCT06390826|448228010|FG000|Overall Study|Adverse Event|1|||
124621339|NCT06390826|448228010|FG000|Overall Study|Disease Progression|8|||
124621340|NCT06390839|448228012|FG000|Overall Study|Ineligible|2|||
124621341|NCT06390839|448228012|FG000|Overall Study|Never start protocol therapy|3|||
124621342|NCT06390839|448228012|FG000|Overall Study|Adverse Event|1|||
124621343|NCT06390839|448228012|FG000|Overall Study|Alternative therapy|2|||
124621344|NCT06390839|448228012|FG000|Overall Study|Death|3|||
124621345|NCT06390839|448228012|FG000|Overall Study|Disease progression|28|||
124621346|NCT06390839|448228012|FG000|Overall Study|Withdrawal by Subject|2|||
124621347|NCT06390839|448228012|FG000|Overall Study|Complicating disease|1|||
124621348|NCT06390839|448228012|FG000|Overall Study|Noncompliance|1|||
124621349|NCT04458922|448228013|FG000|Overall Study|Withdrawal by Subject|1|||
124621350|NCT04458922|448228014|FG001|Overall Study|Withdrawal by Subject|0|||
124621351|NCT04458922|448228015|FG002|Overall Study|Withdrawal by Subject|2|||
124621352|NCT04458922|448228013|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
124621353|NCT04458922|448228014|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
124621354|NCT04458922|448228015|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
124621355|NCT04458922|448228013|FG000|Overall Study|Adverse Event|1|||
124751882|NCT04809285|448714193|FG000|Phase 2|Protocol Violation|3|||
124621356|NCT04458922|448228014|FG001|Overall Study|Adverse Event|0|||
124621357|NCT04458922|448228015|FG002|Overall Study|Adverse Event|0|||
124621358|NCT04458922|448228013|FG000|Overall Study|Started new study|0|||
124621359|NCT04458922|448228014|FG001|Overall Study|Started new study|0|||
124621360|NCT04458922|448228015|FG002|Overall Study|Started new study|1|||
124621361|NCT04458922|448228013|FG000|Overall Study|Progressive disease|6|||
124621362|NCT04458922|448228014|FG001|Overall Study|Progressive disease|8|||
124621363|NCT04458922|448228015|FG002|Overall Study|Progressive disease|2|||
124751883|NCT04809285|448714193|FG000|Phase 2|Withdrawal by Subject|4|||
124751884|NCT03350815|448714195|FG000|Period 1|Adverse Event|10|||
124621364|NCT04458922|448228013|FG000|Overall Study|Death|1|||
124621365|NCT04458922|448228014|FG001|Overall Study|Death|0|||
124621366|NCT04458922|448228015|FG002|Overall Study|Death|2|||
124621367|NCT04458922|448228013|FG000|Overall Study|Participant started chemotherapy|0|||
124621368|NCT04458922|448228014|FG001|Overall Study|Participant started chemotherapy|1|||
124621369|NCT04458922|448228015|FG002|Overall Study|Participant started chemotherapy|0|||
124621370|NCT06351371|448228017|FG000|Overall Study|Mutation Status Not Confirmed|9|||
124621371|NCT06351371|448228017|FG000|Overall Study|Ineligible|1|||
124621372|NCT06351371|448228017|FG000|Overall Study|Adverse Event|4|||
124621373|NCT06351371|448228017|FG000|Overall Study|Death|1|||
124751885|NCT03350815|448714196|FG001|Period 1|Adverse Event|0|||
124621374|NCT06351371|448228017|FG000|Overall Study|Disease progression|14|||
124621375|NCT06351371|448228017|FG000|Overall Study|Withdrawal by Subject|3|||
124621376|NCT06351371|448228017|FG000|Overall Study|Physician Decision|3|||
124621377|NCT03651700|448228018|FG000|Overall Study|Withdrawal by Subject|1|||
124621378|NCT03651700|448228019|FG001|Overall Study|Withdrawal by Subject|0|||
124751886|NCT03350815|448714197|FG002|Period 1|Adverse Event|0|||
124751887|NCT03350815|448714198|FG003|Period 1|Adverse Event|0|||
124751888|NCT03350815|448714195|FG000|Period 1|Technical problems|1|||
124621382|NCT01272037|448228024|FG000|Overall Study|Death|25|||
124621383|NCT01272037|448228025|FG001|Overall Study|Death|28|||
124621384|NCT01272037|448228024|FG000|Overall Study|Adverse Event|12|||
124621385|NCT01272037|448228025|FG001|Overall Study|Adverse Event|7|||
124621386|NCT01272037|448228024|FG000|Overall Study|Withdrawal by Subject|175|||
124621387|NCT01272037|448228025|FG001|Overall Study|Withdrawal by Subject|93|||
124621388|NCT01272037|448228024|FG000|Overall Study|Disease progression|70|||
124621389|NCT01272037|448228025|FG001|Overall Study|Disease progression|111|||
124621390|NCT01272037|448228024|FG000|Overall Study|Other reason|42|||
124621391|NCT01272037|448228025|FG001|Overall Study|Other reason|41|||
124621392|NCT01272037|448228024|FG000|Overall Study|Delinquent data|24|||
124621393|NCT01272037|448228025|FG001|Overall Study|Delinquent data|19|||
124621394|NCT01272037|448228024|FG000|Overall Study|Reason under review|33|||
124621395|NCT01272037|448228025|FG001|Overall Study|Reason under review|29|||
124621396|NCT01272037|448228024|FG000|Overall Study|On treatment|626|||
124621397|NCT01272037|448228025|FG001|Overall Study|On treatment|632|||
124621398|NCT04856930|448228026|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
124621399|NCT04856930|448228027|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
124621400|NCT04856930|448228028|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
124621401|NCT04856930|448228026|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
124621402|NCT04856930|448228027|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
124621403|NCT04856930|448228028|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
124621404|NCT04856930|448228026|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
124621405|NCT04856930|448228027|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
124621406|NCT04856930|448228028|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
124621407|NCT04856930|448228026|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
124621408|NCT04856930|448228027|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
124621409|NCT04856930|448228028|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
124621410|NCT04856930|448228026|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
124621411|NCT04856930|448228027|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
124621412|NCT04856930|448228028|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
124621413|NCT04856930|448228026|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
124621414|NCT04856930|448228027|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
124621415|NCT04856930|448228028|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
124621416|NCT04856930|448228026|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
124621417|NCT04856930|448228027|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
124621418|NCT04856930|448228028|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
124621419|NCT04856930|448228026|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
124621420|NCT04856930|448228027|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
124621421|NCT04856930|448228028|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
124621422|NCT04856930|448228026|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
124621423|NCT04856930|448228027|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
124621424|NCT04856930|448228028|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
124621425|NCT04856930|448228026|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
124621426|NCT04856930|448228027|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
124621427|NCT04856930|448228028|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
124621428|NCT04856930|448228026|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
124621429|NCT04856930|448228027|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
124751889|NCT03350815|448714196|FG001|Period 1|Technical problems|0|||
124621430|NCT04856930|448228028|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
124621431|NCT04856930|448228026|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
124621432|NCT04856930|448228027|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
124621433|NCT04856930|448228028|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
124751890|NCT03350815|448714197|FG002|Period 1|Technical problems|0|||
124621434|NCT04856930|448228026|FG000|Extension Period (16 Weeks)|Other than specified|0|||
124621435|NCT04856930|448228027|FG001|Extension Period (16 Weeks)|Other than specified|0|||
124621436|NCT04856930|448228028|FG002|Extension Period (16 Weeks)|Other than specified|1|||
124621437|NCT04856930|448228026|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
124621438|NCT04856930|448228027|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
124621439|NCT04856930|448228028|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
124621440|NCT04856930|448228026|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
124621441|NCT04856930|448228027|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
124621442|NCT04856930|448228028|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
124621443|NCT04856930|448228026|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
124621444|NCT04856930|448228027|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
124621445|NCT04856930|448228028|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
124621446|NCT04856930|448228026|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
124621447|NCT04856930|448228027|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
124621448|NCT04856930|448228028|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
124621449|NCT03965689|448228029|FG000|Overall Study|Too sick to get study intervention|2|||
124621450|NCT03104400|448228030|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
124621451|NCT03104400|448228031|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
124621452|NCT03104400|448228032|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
124621453|NCT03104400|448228033|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
124621454|NCT03104400|448228034|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
124621455|NCT03104400|448228035|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
124621456|NCT03104400|448228036|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
124621457|NCT03104400|448228037|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
124621458|NCT03104400|448228038|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
124621459|NCT03104400|448228039|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
124621460|NCT03104400|448228030|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
124621461|NCT03104400|448228031|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
124621462|NCT03104400|448228032|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
124621463|NCT03104400|448228033|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
124621464|NCT03104400|448228034|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
124621465|NCT03104400|448228035|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
124621466|NCT03104400|448228036|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
124621467|NCT03104400|448228037|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
124621468|NCT03104400|448228038|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
124621469|NCT03104400|448228039|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
124621470|NCT03104400|448228030|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
124621471|NCT03104400|448228031|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
124621472|NCT03104400|448228032|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
124621473|NCT03104400|448228033|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
124621474|NCT03104400|448228034|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
124621475|NCT03104400|448228035|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
124621476|NCT03104400|448228036|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
124621477|NCT03104400|448228037|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
124621478|NCT03104400|448228038|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
124621479|NCT03104400|448228039|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
124621480|NCT03104400|448228030|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
124621481|NCT03104400|448228031|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
124621482|NCT03104400|448228032|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
124621483|NCT03104400|448228033|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
124621484|NCT03104400|448228034|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
124621485|NCT03104400|448228035|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
124621486|NCT03104400|448228036|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
124621487|NCT03104400|448228037|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
124621488|NCT03104400|448228038|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
124621489|NCT03104400|448228039|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
124621490|NCT03104400|448228030|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
124621491|NCT03104400|448228031|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
124621492|NCT03104400|448228032|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
124621493|NCT03104400|448228033|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
124621494|NCT03104400|448228034|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
124621495|NCT03104400|448228035|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
124621496|NCT03104400|448228036|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
124621497|NCT03104400|448228037|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
124621498|NCT03104400|448228038|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
124621499|NCT03104400|448228039|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
124621500|NCT03104400|448228030|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
124621501|NCT03104400|448228031|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
124621502|NCT03104400|448228032|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
124621503|NCT03104400|448228033|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
124621504|NCT03104400|448228034|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
124621505|NCT03104400|448228035|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
124621506|NCT03104400|448228036|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
124783236|NCT00282308|448835946|FG001|Treatment Period|Not Treated with Study Drug|0|||
124621507|NCT03104400|448228037|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
124621508|NCT03104400|448228038|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
124621509|NCT03104400|448228039|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
124621510|NCT03104400|448228030|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
124783237|NCT00282308|448835947|FG002|Treatment Period|Not Treated with Study Drug|0|||
124783238|NCT00282308|448835945|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
124783239|NCT00282308|448835946|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
124783240|NCT00282308|448835947|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
124783241|NCT00282308|448835945|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
124783242|NCT00282308|448835946|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
124783243|NCT00282308|448835947|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
124783244|NCT00282308|448835945|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
124783245|NCT00282308|448835946|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
124783246|NCT00282308|448835947|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
124783247|NCT00282308|448835945|FG000|Safety Follow-up Period|Adverse Event|0|||
124783248|NCT00282308|448835946|FG001|Safety Follow-up Period|Adverse Event|0|||
124783249|NCT00282308|448835947|FG002|Safety Follow-up Period|Adverse Event|1|||
124783250|NCT00282308|448835945|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
124783251|NCT00282308|448835946|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
124783252|NCT00282308|448835947|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
124783253|NCT00282308|448835945|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
124783254|NCT00282308|448835946|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
124783255|NCT00282308|448835947|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
124783256|NCT00282308|448835945|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
124783257|NCT00282308|448835946|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
124783258|NCT00282308|448835947|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
124783259|NCT01001325|448835950|FG000|Overall Study|Lost to Follow-up|16|||
124783260|NCT01001325|448835951|FG001|Overall Study|Lost to Follow-up|10|||
124783261|NCT01001325|448835950|FG000|Overall Study|Protocol Violation|2|||
124783262|NCT01001325|448835951|FG001|Overall Study|Protocol Violation|0|||
124783263|NCT01584440|448835952|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
124783264|NCT01584440|448835953|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
124783265|NCT01584440|448835954|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
124783266|NCT01584440|448835955|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
124783267|NCT01584440|448835956|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
124783268|NCT01584440|448835952|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
124783269|NCT01584440|448835953|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
124783270|NCT01584440|448835954|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
124783271|NCT01584440|448835955|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
124783272|NCT01584440|448835956|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
124783273|NCT01584440|448835952|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
124783274|NCT01584440|448835953|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
124783275|NCT01584440|448835954|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
124783276|NCT01584440|448835955|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
124783277|NCT01584440|448835956|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
124783278|NCT01584440|448835952|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
124783279|NCT01584440|448835953|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
124783280|NCT01584440|448835954|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
124621511|NCT03104400|448228031|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
124621512|NCT03104400|448228032|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
124621513|NCT03104400|448228033|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
124621514|NCT03104400|448228034|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
124621515|NCT03104400|448228035|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
124621516|NCT03104400|448228036|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
124621517|NCT03104400|448228037|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
124621518|NCT03104400|448228038|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
124621519|NCT03104400|448228039|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
124621520|NCT03104400|448228030|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
124621521|NCT03104400|448228031|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
124621522|NCT03104400|448228032|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
124621523|NCT03104400|448228033|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
124621524|NCT03104400|448228034|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
124621525|NCT03104400|448228035|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
124621526|NCT03104400|448228036|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
124621527|NCT03104400|448228037|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
124621528|NCT03104400|448228038|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
124621529|NCT03104400|448228039|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
124621530|NCT03104400|448228030|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
124621531|NCT03104400|448228031|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
124621532|NCT03104400|448228032|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
124621533|NCT03104400|448228033|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
124621534|NCT03104400|448228034|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
124621535|NCT03104400|448228035|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
124783281|NCT01584440|448835955|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
124783282|NCT01584440|448835956|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
124783283|NCT01584440|448835952|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
124783284|NCT01584440|448835953|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
124621536|NCT03104400|448228036|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
124621537|NCT03104400|448228037|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
124621538|NCT03104400|448228038|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
124621539|NCT03104400|448228039|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
124621540|NCT03104400|448228030|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
124621541|NCT03104400|448228031|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
124621542|NCT03104400|448228032|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
124621543|NCT03104400|448228033|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
124621544|NCT03104400|448228034|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
124621545|NCT03104400|448228035|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
124621546|NCT03104400|448228036|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
124621547|NCT03104400|448228037|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
124621548|NCT03104400|448228038|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
124621549|NCT03104400|448228039|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
124621550|NCT03104400|448228030|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
124621551|NCT03104400|448228031|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
124621552|NCT03104400|448228032|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
124621553|NCT03104400|448228033|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
124621554|NCT03104400|448228034|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
124621555|NCT03104400|448228035|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
124621556|NCT03104400|448228036|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
124621557|NCT03104400|448228037|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
124621558|NCT03104400|448228038|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
124621559|NCT03104400|448228039|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
124621560|NCT03104400|448228030|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
124621561|NCT03104400|448228031|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
124621562|NCT03104400|448228032|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
124621563|NCT03104400|448228033|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
124621564|NCT03104400|448228034|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
124621565|NCT03104400|448228035|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
124621566|NCT03104400|448228036|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
124621567|NCT03104400|448228037|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
124621568|NCT03104400|448228038|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
124621569|NCT03104400|448228039|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
124621570|NCT03104400|448228030|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
124621571|NCT03104400|448228031|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
124621572|NCT03104400|448228032|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
124621573|NCT03104400|448228033|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
124621574|NCT03104400|448228034|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
124621575|NCT03104400|448228035|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
124621576|NCT03104400|448228036|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
124621577|NCT03104400|448228037|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
124621578|NCT03104400|448228038|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
124621579|NCT03104400|448228039|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
124621580|NCT03104400|448228030|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
124621581|NCT03104400|448228031|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
124621582|NCT03104400|448228032|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
124621583|NCT03104400|448228033|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
124621584|NCT03104400|448228034|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
124621585|NCT03104400|448228035|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
124621586|NCT03104400|448228036|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
124621587|NCT03104400|448228037|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
124621588|NCT03104400|448228038|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
124621589|NCT03104400|448228039|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
124621590|NCT03104400|448228030|FG000|Period 2 Week 56 - 260)|Other|0|||
124621591|NCT03104400|448228031|FG001|Period 2 Week 56 - 260)|Other|0|||
124621592|NCT03104400|448228032|FG002|Period 2 Week 56 - 260)|Other|0|||
124621593|NCT03104400|448228033|FG003|Period 2 Week 56 - 260)|Other|0|||
124621594|NCT03104400|448228034|FG004|Period 2 Week 56 - 260)|Other|0|||
124621595|NCT03104400|448228035|FG005|Period 2 Week 56 - 260)|Other|0|||
124621596|NCT03104400|448228036|FG006|Period 2 Week 56 - 260)|Other|0|||
124621597|NCT03104400|448228037|FG007|Period 2 Week 56 - 260)|Other|0|||
124621598|NCT03104400|448228038|FG008|Period 2 Week 56 - 260)|Other|1|||
124621599|NCT03104400|448228039|FG009|Period 2 Week 56 - 260)|Other|1|||
124621600|NCT04948333|448228040|FG000|Overall Study|Adverse Event|6|||
124621601|NCT04948333|448228041|FG001|Overall Study|Adverse Event|4|||
124621602|NCT04948333|448228042|FG002|Overall Study|Adverse Event|0|||
124621603|NCT04948333|448228043|FG003|Overall Study|Adverse Event|2|||
124621604|NCT04948333|448228040|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
124621605|NCT04948333|448228041|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
124621606|NCT04948333|448228042|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124621607|NCT04948333|448228043|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124621608|NCT04948333|448228040|FG000|Overall Study|Progressive Disease|1|||
124621609|NCT04948333|448228041|FG001|Overall Study|Progressive Disease|5|||
124621610|NCT04948333|448228042|FG002|Overall Study|Progressive Disease|0|||
124621611|NCT04948333|448228043|FG003|Overall Study|Progressive Disease|0|||
124621612|NCT04948333|448228040|FG000|Overall Study|Physician Decision|2|||
124621613|NCT04948333|448228041|FG001|Overall Study|Physician Decision|2|||
124621614|NCT04948333|448228042|FG002|Overall Study|Physician Decision|0|||
124621615|NCT04948333|448228043|FG003|Overall Study|Physician Decision|0|||
124621616|NCT04948333|448228040|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
124621617|NCT04948333|448228041|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
124621618|NCT04948333|448228042|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
124621619|NCT04948333|448228043|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
124621620|NCT04948333|448228040|FG000|Overall Study|Withdrawal by Subject|2|||
124621621|NCT04948333|448228041|FG001|Overall Study|Withdrawal by Subject|0|||
124621622|NCT04948333|448228042|FG002|Overall Study|Withdrawal by Subject|0|||
124621623|NCT04948333|448228043|FG003|Overall Study|Withdrawal by Subject|1|||
124621624|NCT04948333|448228040|FG000|Overall Study|Protocol Violation|0|||
124621625|NCT04948333|448228041|FG001|Overall Study|Protocol Violation|1|||
124621626|NCT04948333|448228042|FG002|Overall Study|Protocol Violation|0|||
124621627|NCT04948333|448228043|FG003|Overall Study|Protocol Violation|0|||
124621628|NCT04948333|448228040|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
124621629|NCT04948333|448228041|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
124621630|NCT04948333|448228042|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
124621631|NCT04948333|448228043|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
124621632|NCT01625988|448228044|FG000|Overall Study|Lost to Follow-up|5|||
124621633|NCT01625988|448228045|FG001|Overall Study|Lost to Follow-up|6|||
124621634|NCT01625988|448228044|FG000|Overall Study|Withdrawal by Subject|8|||
124621635|NCT01625988|448228045|FG001|Overall Study|Withdrawal by Subject|3|||
124621636|NCT01625988|448228044|FG000|Overall Study|Adverse Event|0|||
124751891|NCT03350815|448714198|FG003|Period 1|Technical problems|0|||
124751892|NCT03350815|448714195|FG000|Period 1|Lost to Follow-up|3|||
124751893|NCT03350815|448714196|FG001|Period 1|Lost to Follow-up|0|||
124751894|NCT03350815|448714197|FG002|Period 1|Lost to Follow-up|0|||
124751895|NCT03350815|448714198|FG003|Period 1|Lost to Follow-up|0|||
124751896|NCT03350815|448714195|FG000|Period 1|Physician Decision|1|||
124751897|NCT03350815|448714196|FG001|Period 1|Physician Decision|0|||
124751898|NCT03350815|448714197|FG002|Period 1|Physician Decision|0|||
124751899|NCT03350815|448714198|FG003|Period 1|Physician Decision|0|||
124751900|NCT03350815|448714195|FG000|Period 1|Withdrawal by Subject|8|||
124751901|NCT03350815|448714196|FG001|Period 1|Withdrawal by Subject|0|||
124751902|NCT03350815|448714197|FG002|Period 1|Withdrawal by Subject|0|||
124751903|NCT03350815|448714198|FG003|Period 1|Withdrawal by Subject|0|||
124751904|NCT03350815|448714195|FG000|Period 1|Lack of Efficacy|15|||
124751905|NCT03350815|448714196|FG001|Period 1|Lack of Efficacy|0|||
124751906|NCT03350815|448714197|FG002|Period 1|Lack of Efficacy|0|||
124751907|NCT03350815|448714198|FG003|Period 1|Lack of Efficacy|0|||
124751908|NCT03350815|448714195|FG000|Period 1|Non-compliance with study treatment|2|||
124751909|NCT03350815|448714196|FG001|Period 1|Non-compliance with study treatment|0|||
124751910|NCT03350815|448714197|FG002|Period 1|Non-compliance with study treatment|0|||
124751911|NCT03350815|448714198|FG003|Period 1|Non-compliance with study treatment|0|||
124751912|NCT03350815|448714195|FG000|Period 1|Protocol Violation|3|||
124751913|NCT03350815|448714196|FG001|Period 1|Protocol Violation|0|||
124751914|NCT03350815|448714197|FG002|Period 1|Protocol Violation|0|||
124751915|NCT03350815|448714198|FG003|Period 1|Protocol Violation|0|||
124751916|NCT03350815|448714195|FG000|Period 2|Adverse Event|0|||
124751917|NCT03350815|448714196|FG001|Period 2|Adverse Event|3|||
124751918|NCT03350815|448714197|FG002|Period 2|Adverse Event|5|||
124751919|NCT03350815|448714198|FG003|Period 2|Adverse Event|0|||
124751920|NCT03350815|448714195|FG000|Period 2|Technical problem|0|||
124751921|NCT03350815|448714196|FG001|Period 2|Technical problem|1|||
124751922|NCT03350815|448714197|FG002|Period 2|Technical problem|0|||
124751923|NCT03350815|448714198|FG003|Period 2|Technical problem|0|||
124751924|NCT03350815|448714195|FG000|Period 2|Lost to Follow-up|0|||
124751925|NCT03350815|448714196|FG001|Period 2|Lost to Follow-up|3|||
124751926|NCT03350815|448714197|FG002|Period 2|Lost to Follow-up|3|||
124621637|NCT01625988|448228045|FG001|Overall Study|Adverse Event|1|||
124621638|NCT01625988|448228044|FG000|Overall Study|Lack of Efficacy|0|||
124621639|NCT01625988|448228045|FG001|Overall Study|Lack of Efficacy|1|||
124621640|NCT01625988|448228044|FG000|Overall Study|Randomized Inappropriately|1|||
124621641|NCT01625988|448228045|FG001|Overall Study|Randomized Inappropriately|0|||
124751927|NCT03350815|448714198|FG003|Period 2|Lost to Follow-up|0|||
124751928|NCT03350815|448714195|FG000|Period 2|Physician Decision|0|||
124751929|NCT03350815|448714196|FG001|Period 2|Physician Decision|0|||
124751930|NCT03350815|448714197|FG002|Period 2|Physician Decision|1|||
124751931|NCT03350815|448714198|FG003|Period 2|Physician Decision|0|||
124751932|NCT03350815|448714195|FG000|Period 2|Withdrawal by Subject|0|||
124751933|NCT03350815|448714196|FG001|Period 2|Withdrawal by Subject|3|||
124751934|NCT03350815|448714197|FG002|Period 2|Withdrawal by Subject|4|||
124751935|NCT03350815|448714198|FG003|Period 2|Withdrawal by Subject|0|||
124621642|NCT01625988|448228044|FG000|Overall Study|Protocol Violation|0|||
124621643|NCT01625988|448228045|FG001|Overall Study|Protocol Violation|2|||
124621644|NCT01495702|448228046|FG000|Randomized Phase|Randomized But Not Treated|1|||
124621645|NCT01495702|448228047|FG001|Randomized Phase|Randomized But Not Treated|4|||
124621646|NCT01495702|448228046|FG000|Randomized Phase|Adverse Event|2|||
124621647|NCT01495702|448228047|FG001|Randomized Phase|Adverse Event|2|||
124621648|NCT01495702|448228046|FG000|Randomized Phase|Death|1|||
124621649|NCT01495702|448228047|FG001|Randomized Phase|Death|0|||
124621650|NCT01495702|448228046|FG000|Randomized Phase|Lack of Efficacy|2|||
124621651|NCT01495702|448228047|FG001|Randomized Phase|Lack of Efficacy|0|||
124621652|NCT01495702|448228046|FG000|Randomized Phase|Investigators Discretion|2|||
124621653|NCT01495702|448228047|FG001|Randomized Phase|Investigators Discretion|0|||
124621654|NCT01495702|448228046|FG000|Randomized Phase|Withdrew Consent|10|||
124621655|NCT01495702|448228047|FG001|Randomized Phase|Withdrew Consent|18|||
124621656|NCT01495702|448228046|FG000|Randomized Phase|Lost to Follow-up|4|||
124621657|NCT01495702|448228047|FG001|Randomized Phase|Lost to Follow-up|3|||
124621658|NCT01495702|448228046|FG000|Randomized Phase|Participant Noncompliance|1|||
124621659|NCT01495702|448228047|FG001|Randomized Phase|Participant Noncompliance|0|||
124621660|NCT01495702|448228046|FG000|Randomized Phase|Protocol Violation|3|||
124621661|NCT01495702|448228047|FG001|Randomized Phase|Protocol Violation|1|||
124621662|NCT01644617|448228048|FG000|Overall Study|Withdrawal by Subject|3|||
124621663|NCT01644617|448228049|FG001|Overall Study|Withdrawal by Subject|4|||
124621664|NCT01644617|448228050|FG002|Overall Study|Withdrawal by Subject|1|||
124621665|NCT01644617|448228048|FG000|Overall Study|Lost to Follow-up|0|||
124621666|NCT01644617|448228049|FG001|Overall Study|Lost to Follow-up|1|||
124621667|NCT01644617|448228050|FG002|Overall Study|Lost to Follow-up|0|||
124621668|NCT01644617|448228048|FG000|Overall Study|Adverse Event|3|||
124621669|NCT01644617|448228049|FG001|Overall Study|Adverse Event|0|||
124621670|NCT01644617|448228050|FG002|Overall Study|Adverse Event|6|||
124621671|NCT05246670|448228051|FG000|Overall Study|Withdrawal by Subject|2|||
124621672|NCT05246670|448228052|FG001|Overall Study|Withdrawal by Subject|3|||
124621673|NCT05246670|448228053|FG002|Overall Study|Withdrawal by Subject|0|||
124621674|NCT05246670|448228054|FG003|Overall Study|Withdrawal by Subject|1|||
124621675|NCT05246670|448228051|FG000|Overall Study|Adverse Event|0|||
124621676|NCT05246670|448228052|FG001|Overall Study|Adverse Event|0|||
124621677|NCT05246670|448228053|FG002|Overall Study|Adverse Event|1|||
124621678|NCT05246670|448228054|FG003|Overall Study|Adverse Event|0|||
124621679|NCT05246670|448228051|FG000|Overall Study|Physician Decision|1|||
124621680|NCT05246670|448228052|FG001|Overall Study|Physician Decision|0|||
124621681|NCT05246670|448228053|FG002|Overall Study|Physician Decision|0|||
124621682|NCT05246670|448228054|FG003|Overall Study|Physician Decision|0|||
124621683|NCT05246670|448228051|FG000|Overall Study|Protocol Violation|1|||
124621684|NCT05246670|448228052|FG001|Overall Study|Protocol Violation|0|||
124621685|NCT05246670|448228053|FG002|Overall Study|Protocol Violation|0|||
124621686|NCT05246670|448228054|FG003|Overall Study|Protocol Violation|0|||
124621687|NCT04152291|448228057|FG000|Overall Study|Covid-19 restrictions|27|||
124621688|NCT04152291|448228057|FG000|Overall Study|Withdrawal by Subject|3|||
124621689|NCT05124691|448228058|FG000|Phase II|Eligibility criteria|0|||
124621690|NCT05124691|448228059|FG001|Phase II|Eligibility criteria|1|||
124621691|NCT05124691|448228060|FG002|Phase II|Eligibility criteria|0|||
124621692|NCT05124691|448228058|FG000|Phase II|Withdrawal by Subject|6|||
124621693|NCT05124691|448228059|FG001|Phase II|Withdrawal by Subject|2|||
124621694|NCT05124691|448228060|FG002|Phase II|Withdrawal by Subject|3|||
124621695|NCT05124691|448228058|FG000|Phase III|Withdrawal by Subject|6|||
124621696|NCT05124691|448228059|FG001|Phase III|Withdrawal by Subject|4|||
124621697|NCT05124691|448228060|FG002|Phase III|Withdrawal by Subject|4|||
124621698|NCT05124691|448228058|FG000|Phase III|Lost to Follow-up|1|||
124621699|NCT05124691|448228059|FG001|Phase III|Lost to Follow-up|0|||
124621700|NCT05124691|448228060|FG002|Phase III|Lost to Follow-up|0|||
124621701|NCT04223752|448228063|FG000|Overall Study|Participant enrolled in error|0|||
124621702|NCT04223752|448228064|FG001|Overall Study|Participant enrolled in error|0|||
124621703|NCT04223752|448228065|FG002|Overall Study|Participant enrolled in error|0|||
124621704|NCT04223752|448228066|FG003|Overall Study|Participant enrolled in error|0|||
124621705|NCT04223752|448228067|FG004|Overall Study|Participant enrolled in error|1|||
124621706|NCT04223752|448228063|FG000|Overall Study|Death|0|||
124621707|NCT04223752|448228064|FG001|Overall Study|Death|0|||
124621708|NCT04223752|448228065|FG002|Overall Study|Death|0|||
124621709|NCT04223752|448228066|FG003|Overall Study|Death|2|||
124621710|NCT04223752|448228067|FG004|Overall Study|Death|1|||
124621711|NCT04759703|448228068|FG000|Overall Study|Withdrawal by Subject|4|||
124621712|NCT04759703|448228069|FG001|Overall Study|Withdrawal by Subject|9|||
124621713|NCT04759703|448228068|FG000|Overall Study|Adverse Event|1|||
124621714|NCT04759703|448228069|FG001|Overall Study|Adverse Event|0|||
124621715|NCT04759703|448228068|FG000|Overall Study|Lost to Follow-up|2|||
124621716|NCT04759703|448228069|FG001|Overall Study|Lost to Follow-up|0|||
124621717|NCT04877457|448228076|FG000|Overall Study|Early termination of study due to low enrollment|2|||
124621718|NCT04877457|448228077|FG001|Overall Study|Early termination of study due to low enrollment|1|||
124621719|NCT00490841|448228078|FG000|Overall Study|Death|5|||
124621720|NCT00490841|448228078|FG000|Overall Study|Withdrawal by Subject|4|||
124621721|NCT00490841|448228078|FG000|Overall Study|Lost to Follow-up|1|||
124621722|NCT00490841|448228078|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
124621723|NCT02503787|448228079|FG000|Enrollment|Withdrawal by Subject|6|||
124621724|NCT02503787|448228079|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
124621725|NCT02503787|448228079|FG000|Enrollment|Physician Decision|2|||
124621726|NCT02503787|448228079|FG000|Enrollment|Insurance issue|2|||
124621727|NCT02503787|448228079|FG000|Enrollment|Lost to Follow-up|1|||
124621728|NCT02503787|448228079|FG000|Enrollment|Study closure|1|||
124621729|NCT02503787|448228079|FG000|Enrollment|Adverse Event|1|||
124621730|NCT02503787|448228079|FG000|Enrollment|Protocol Violation|1|||
124621731|NCT02503787|448228079|FG000|Enrollment|Inability to implant system|1|||
124783285|NCT01584440|448835954|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
124783286|NCT01584440|448835955|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
124783287|NCT01584440|448835956|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
124783288|NCT01584440|448835952|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
124783289|NCT01584440|448835953|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
124783290|NCT01584440|448835954|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
124783291|NCT01584440|448835955|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
124783292|NCT01584440|448835956|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
124783293|NCT01584440|448835952|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
124783294|NCT01584440|448835953|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
124783295|NCT01584440|448835954|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
124783296|NCT01584440|448835955|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
124783297|NCT01584440|448835956|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
124783298|NCT01584440|448835952|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
124783299|NCT01584440|448835953|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
124783300|NCT01584440|448835954|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
124783301|NCT01584440|448835955|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
124783302|NCT01584440|448835956|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
124783303|NCT01584440|448835952|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
124783304|NCT01584440|448835953|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
124783305|NCT01584440|448835954|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
124783306|NCT01584440|448835955|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
124783307|NCT01584440|448835956|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
124783308|NCT00531427|448835957|FG000|Overall Study|Withdrawal by Subject|7|||
124783309|NCT00531427|448835958|FG001|Overall Study|Withdrawal by Subject|13|||
124783310|NCT00531427|448835957|FG000|Overall Study|Adverse Event|44|||
124783311|NCT00531427|448835958|FG001|Overall Study|Adverse Event|30|||
124783312|NCT00531427|448835957|FG000|Overall Study|Lost to Follow-up|4|||
124783313|NCT00531427|448835958|FG001|Overall Study|Lost to Follow-up|3|||
124783314|NCT00531427|448835957|FG000|Overall Study|Lack of Efficacy|14|||
124783315|NCT00531427|448835958|FG001|Overall Study|Lack of Efficacy|39|||
124783316|NCT00531427|448835957|FG000|Overall Study|Administrative|4|||
124783317|NCT00531427|448835958|FG001|Overall Study|Administrative|9|||
124783318|NCT02626624|448835973|FG000|Overall Study|Adverse Event|1|||
124783319|NCT02626624|448835973|FG000|Overall Study|Lost to Follow-up|3|||
124783320|NCT02626624|448835973|FG000|Overall Study|Protocol Violation|4|||
124783321|NCT02626624|448835973|FG000|Overall Study|Death|2|||
124783322|NCT00122980|448838080|FG000|Overall Study|Death|0|||
124783323|NCT00122980|448838081|FG001|Overall Study|Death|1|||
124783324|NCT00122980|448838080|FG000|Overall Study|Physician Decision|2|||
124783325|NCT00122980|448838081|FG001|Overall Study|Physician Decision|0|||
124783326|NCT00122980|448838080|FG000|Overall Study|Protocol Violation|5|||
124783327|NCT00122980|448838081|FG001|Overall Study|Protocol Violation|1|||
124783328|NCT00122980|448838080|FG000|Overall Study|Withdrawal by Subject|2|||
124783329|NCT00122980|448838081|FG001|Overall Study|Withdrawal by Subject|3|||
124783330|NCT00122980|448838080|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
124783331|NCT00122980|448838081|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
124783332|NCT00122980|448838080|FG000|Overall Study|Study termination|27|||
124783333|NCT00122980|448838081|FG001|Overall Study|Study termination|35|||
124783334|NCT01124864|448838082|FG000|Overall Study|Follow up phase competed as per protocol|18|||
124783335|NCT01124864|448838083|FG001|Overall Study|Follow up phase competed as per protocol|22|||
124783336|NCT01124864|448838084|FG002|Overall Study|Follow up phase competed as per protocol|24|||
124783337|NCT01124864|448838085|FG003|Overall Study|Follow up phase competed as per protocol|18|||
124621732|NCT02503787|448228079|FG000|Enrollment|Unable to be programmed|1|||
124621733|NCT02503787|448228079|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
124783338|NCT01124864|448838086|FG004|Overall Study|Follow up phase competed as per protocol|26|||
124783339|NCT01124864|448838087|FG005|Overall Study|Follow up phase competed as per protocol|2|||
124621734|NCT02503787|448228079|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
124621735|NCT02503787|448228079|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
124783340|NCT01124864|448838082|FG000|Overall Study|Death|6|||
124783341|NCT01124864|448838083|FG001|Overall Study|Death|9|||
124783342|NCT01124864|448838084|FG002|Overall Study|Death|6|||
124621736|NCT02503787|448228079|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
124621737|NCT02503787|448228079|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
124783343|NCT01124864|448838085|FG003|Overall Study|Death|2|||
124783344|NCT01124864|448838086|FG004|Overall Study|Death|1|||
124621738|NCT02503787|448228079|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
124621739|NCT00174954|448228081|FG000|Overall Study|Adverse Event|2|||
124621740|NCT00174954|448228081|FG000|Overall Study|No tophi found in MRI|1|||
124621741|NCT00174954|448228081|FG000|Overall Study|Physician Decision|1|||
124621742|NCT01320150|448228082|FG000|Overall Study|Protocol Violation|15|||
124621743|NCT01320150|448228082|FG000|Overall Study|Withdrawal by Subject|5|||
124621744|NCT01320150|448228082|FG000|Overall Study|Death|2|||
124621745|NCT01320150|448228082|FG000|Overall Study|Lost to Follow-up|44|||
124621746|NCT00919854|448228083|FG000|Overall Study|Adverse Event|1|||
124621747|NCT03698019|448229159|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
124621748|NCT03698019|448229160|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
124621749|NCT03698019|448229159|FG000|Step 1: Registration|Withdrawal by Subject|7|||
124621750|NCT03698019|448229160|FG001|Step 1: Registration|Withdrawal by Subject|2|||
124621751|NCT03698019|448229159|FG000|Step 1: Registration|Toxicity|0|||
124621752|NCT03698019|448229160|FG001|Step 1: Registration|Toxicity|1|||
124621753|NCT03698019|448229159|FG000|Step 1: Registration|Disease Progression|0|||
124621754|NCT03698019|448229160|FG001|Step 1: Registration|Disease Progression|12|||
124621755|NCT03698019|448229159|FG000|Step 1: Registration|Co-morbidities|0|||
124621756|NCT03698019|448229160|FG001|Step 1: Registration|Co-morbidities|1|||
124621757|NCT03698019|448229159|FG000|Step 1: Registration|Scheduling Issues|1|||
124621758|NCT03698019|448229160|FG001|Step 1: Registration|Scheduling Issues|0|||
124621759|NCT03698019|448229159|FG000|Step 1: Registration|Participant Refusal|0|||
124621760|NCT03698019|448229160|FG001|Step 1: Registration|Participant Refusal|1|||
124621761|NCT03698019|448229159|FG000|Step 2: Surgery|Participant Refusal|2|||
124621762|NCT03698019|448229160|FG001|Step 2: Surgery|Participant Refusal|1|||
124621763|NCT03698019|448229159|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
124621764|NCT03698019|448229160|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
124621765|NCT03698019|448229159|FG000|Step 2: Surgery|Metastatic Disease|16|||
124621766|NCT03698019|448229160|FG001|Step 2: Surgery|Metastatic Disease|9|||
124621767|NCT03698019|448229159|FG000|Step 2: Surgery|Residual Disease|2|||
124621768|NCT03698019|448229160|FG001|Step 2: Surgery|Residual Disease|1|||
124621769|NCT03698019|448229159|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
124621770|NCT03698019|448229160|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
124621771|NCT03698019|448229159|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
124621772|NCT03698019|448229160|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
124621773|NCT03698019|448229159|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
124621774|NCT03698019|448229160|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
124621775|NCT03698019|448229159|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
124621776|NCT03698019|448229160|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
124621777|NCT03698019|448229159|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
124621778|NCT03698019|448229160|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
124621779|NCT03698019|448229159|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
124783345|NCT01124864|448838087|FG005|Overall Study|Death|0|||
124783346|NCT01124864|448838082|FG000|Overall Study|Withdrawal by Subject|2|||
124783347|NCT01124864|448838083|FG001|Overall Study|Withdrawal by Subject|3|||
124783348|NCT01124864|448838084|FG002|Overall Study|Withdrawal by Subject|4|||
124783349|NCT01124864|448838085|FG003|Overall Study|Withdrawal by Subject|0|||
124783350|NCT01124864|448838086|FG004|Overall Study|Withdrawal by Subject|2|||
124783351|NCT01124864|448838087|FG005|Overall Study|Withdrawal by Subject|1|||
124783352|NCT01124864|448838082|FG000|Overall Study|Lost to Follow-up|1|||
124783353|NCT01124864|448838083|FG001|Overall Study|Lost to Follow-up|1|||
124783354|NCT01124864|448838084|FG002|Overall Study|Lost to Follow-up|0|||
124783355|NCT01124864|448838085|FG003|Overall Study|Lost to Follow-up|1|||
124621780|NCT03698019|448229160|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
124621781|NCT03698019|448229159|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
124621782|NCT03698019|448229160|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
124621783|NCT03698019|448229159|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
124621784|NCT03698019|448229160|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
124621785|NCT00588770|448229161|FG000|Overall Study|Disease progression|85|||
124621786|NCT00588770|448229162|FG001|Overall Study|Disease progression|68|||
124783356|NCT01124864|448838086|FG004|Overall Study|Lost to Follow-up|0|||
124783357|NCT01124864|448838087|FG005|Overall Study|Lost to Follow-up|0|||
124783358|NCT01124864|448838082|FG000|Overall Study|Protocol Violation|1|||
124783359|NCT01124864|448838083|FG001|Overall Study|Protocol Violation|0|||
124621787|NCT00588770|448229161|FG000|Overall Study|Adverse Event|29|||
124621788|NCT00588770|448229162|FG001|Overall Study|Adverse Event|58|||
124621789|NCT00588770|448229161|FG000|Overall Study|Death|13|||
124621790|NCT00588770|448229162|FG001|Overall Study|Death|22|||
124621791|NCT00588770|448229161|FG000|Overall Study|Withdrawal by Subject|15|||
124621792|NCT00588770|448229162|FG001|Overall Study|Withdrawal by Subject|25|||
124621793|NCT00588770|448229161|FG000|Overall Study|Alternative therapy|2|||
124783360|NCT01124864|448838084|FG002|Overall Study|Protocol Violation|0|||
124621794|NCT00588770|448229162|FG001|Overall Study|Alternative therapy|4|||
124621795|NCT00588770|448229161|FG000|Overall Study|Other complicating disease|3|||
124621796|NCT00588770|448229162|FG001|Overall Study|Other complicating disease|2|||
124621797|NCT00588770|448229161|FG000|Overall Study|Not start protocol therapy|0|||
124621798|NCT00588770|448229162|FG001|Overall Study|Not start protocol therapy|9|||
124621799|NCT00588770|448229161|FG000|Overall Study|Lack of Efficacy|8|||
124621800|NCT00588770|448229162|FG001|Overall Study|Lack of Efficacy|10|||
124621801|NCT00588770|448229161|FG000|Overall Study|Physician discretion|2|||
124621802|NCT00588770|448229162|FG001|Overall Study|Physician discretion|0|||
124621803|NCT00588770|448229161|FG000|Overall Study|Patient non-compliance|2|||
124621804|NCT00588770|448229162|FG001|Overall Study|Patient non-compliance|2|||
124621805|NCT01856192|448229163|FG000|Overall Study|Adverse Event|12|||
124621806|NCT01856192|448229164|FG001|Overall Study|Adverse Event|4|||
124621807|NCT01856192|448229163|FG000|Overall Study|Alternative therapy|0|||
124621808|NCT01856192|448229164|FG001|Overall Study|Alternative therapy|3|||
124621809|NCT01856192|448229163|FG000|Overall Study|Death|3|||
124621810|NCT01856192|448229164|FG001|Overall Study|Death|5|||
124621811|NCT01856192|448229163|FG000|Overall Study|Lack of Efficacy|0|||
124621812|NCT01856192|448229164|FG001|Overall Study|Lack of Efficacy|5|||
124621813|NCT01856192|448229163|FG000|Overall Study|Withdrawal by Subject|1|||
124621814|NCT01856192|448229164|FG001|Overall Study|Withdrawal by Subject|1|||
124621815|NCT01856192|448229163|FG000|Overall Study|Other diseases|1|||
124621816|NCT01856192|448229164|FG001|Overall Study|Other diseases|0|||
124621817|NCT01856192|448229163|FG000|Overall Study|Never started treatment|7|||
124621818|NCT01856192|448229164|FG001|Overall Study|Never started treatment|5|||
124621819|NCT01856192|448229163|FG000|Overall Study|Path ineligible|20|||
124621820|NCT01856192|448229164|FG001|Overall Study|Path ineligible|34|||
124621821|NCT01856192|448229163|FG000|Overall Study|Non-path ineligible|2|||
124621822|NCT01856192|448229164|FG001|Overall Study|Non-path ineligible|2|||
124621823|NCT01856192|448229163|FG000|Overall Study|Physician Decision|1|||
124621824|NCT01856192|448229164|FG001|Overall Study|Physician Decision|1|||
124621825|NCT01856192|448229163|FG000|Overall Study|Suspicion of progressive disease|1|||
124621826|NCT01856192|448229164|FG001|Overall Study|Suspicion of progressive disease|0|||
124621827|NCT01856192|448229163|FG000|Overall Study|Non-compliance|1|||
124621828|NCT01856192|448229164|FG001|Overall Study|Non-compliance|0|||
124621829|NCT02642042|448229165|FG000|Overall Study|Adverse Event|22|||
124621830|NCT02642042|448229165|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
124621831|NCT02642042|448229165|FG000|Overall Study|Progression/Relapse|28|||
124621832|NCT02642042|448229165|FG000|Overall Study|Death|1|||
124621833|NCT02642042|448229165|FG000|Overall Study|Not Protocol Specified|2|||
124621834|NCT04976621|448229166|FG000|Overall Study|Lost to Follow-up|2|||
124621835|NCT04976621|448229167|FG001|Overall Study|Lost to Follow-up|1|||
124621836|NCT04976621|448229166|FG000|Overall Study|Withdrawal by Subject|1|||
124621837|NCT04976621|448229167|FG001|Overall Study|Withdrawal by Subject|0|||
124621838|NCT03348631|448229170|FG000|Overall Study|Not Eligible, No treatment|0|||
124621839|NCT03348631|448229171|FG001|Overall Study|Not Eligible, No treatment|1|||
124621840|NCT03348631|448229170|FG000|Overall Study|Not Eligible, Treated|2|||
124621841|NCT03348631|448229171|FG001|Overall Study|Not Eligible, Treated|0|||
124621842|NCT03348631|448229170|FG000|Overall Study|Eligible, No Treatment|1|||
124621843|NCT03348631|448229171|FG001|Overall Study|Eligible, No Treatment|0|||
124621844|NCT05223920|448229179|FG000|Overall Study|Adverse Event|6|||
124621845|NCT05223920|448229180|FG001|Overall Study|Adverse Event|3|||
124621846|NCT05223920|448229179|FG000|Overall Study|Death|2|||
124621847|NCT05223920|448229180|FG001|Overall Study|Death|0|||
124621848|NCT05223920|448229179|FG000|Overall Study|Disease Progression|1|||
124621849|NCT05223920|448229180|FG001|Overall Study|Disease Progression|2|||
124621850|NCT05223920|448229179|FG000|Overall Study|Physician Decision|1|||
124621851|NCT05223920|448229180|FG001|Overall Study|Physician Decision|2|||
124621852|NCT05223920|448229179|FG000|Overall Study|Sponsor decision|11|||
124621853|NCT05223920|448229180|FG001|Overall Study|Sponsor decision|9|||
124621854|NCT05223920|448229179|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
124621855|NCT05223920|448229180|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
124621856|NCT05223920|448229179|FG000|Overall Study|Subject decision|1|||
124621857|NCT05223920|448229180|FG001|Overall Study|Subject decision|0|||
124621858|NCT05223920|448229179|FG000|Overall Study|Withdrawal by Subject|1|||
124621859|NCT05223920|448229180|FG001|Overall Study|Withdrawal by Subject|6|||
124783361|NCT01124864|448838085|FG003|Overall Study|Protocol Violation|0|||
124783362|NCT01124864|448838086|FG004|Overall Study|Protocol Violation|1|||
124621860|NCT03790657|448229181|FG000|Overall Study|Adverse Event|1|||
124621861|NCT03790657|448229182|FG001|Overall Study|Adverse Event|1|||
124621862|NCT03790657|448229181|FG000|Overall Study|Withdrawal by Subject|1|||
124621863|NCT03790657|448229182|FG001|Overall Study|Withdrawal by Subject|1|||
124621864|NCT03509467|448229183|FG000|Overall Study|Withdrawal by Subject|5|||
124621865|NCT03509467|448229184|FG001|Overall Study|Withdrawal by Subject|1|||
124621866|NCT03509467|448229185|FG002|Overall Study|Withdrawal by Subject|6|||
124621867|NCT03509467|448229186|FG003|Overall Study|Withdrawal by Subject|7|||
124621868|NCT03509467|448229187|FG004|Overall Study|Withdrawal by Subject|10|||
124621869|NCT03509467|448229188|FG005|Overall Study|Withdrawal by Subject|10|||
124621870|NCT03509467|448229189|FG006|Overall Study|Withdrawal by Subject|10|||
124621871|NCT03509467|448229190|FG007|Overall Study|Withdrawal by Subject|10|||
124621872|NCT03509467|448229183|FG000|Overall Study|Death|0|||
124621873|NCT03509467|448229184|FG001|Overall Study|Death|0|||
124621874|NCT03509467|448229185|FG002|Overall Study|Death|2|||
124621875|NCT03509467|448229186|FG003|Overall Study|Death|2|||
124621876|NCT03509467|448229187|FG004|Overall Study|Death|1|||
124621877|NCT03509467|448229188|FG005|Overall Study|Death|0|||
124621878|NCT03509467|448229189|FG006|Overall Study|Death|1|||
124621879|NCT03509467|448229190|FG007|Overall Study|Death|0|||
124621880|NCT03509467|448229183|FG000|Overall Study|Proxy Withdrawal|0|||
124621881|NCT03509467|448229184|FG001|Overall Study|Proxy Withdrawal|0|||
124621882|NCT03509467|448229185|FG002|Overall Study|Proxy Withdrawal|0|||
124621883|NCT03509467|448229186|FG003|Overall Study|Proxy Withdrawal|0|||
124621884|NCT03509467|448229187|FG004|Overall Study|Proxy Withdrawal|0|||
124621885|NCT03509467|448229188|FG005|Overall Study|Proxy Withdrawal|0|||
124621886|NCT03509467|448229189|FG006|Overall Study|Proxy Withdrawal|0|||
124621887|NCT03509467|448229190|FG007|Overall Study|Proxy Withdrawal|1|||
124621888|NCT02829918|448229191|FG000|Overall Study|Death|2|||
124621889|NCT02829918|448229191|FG000|Overall Study|Withdrawal by Subject|4|||
124621890|NCT02829918|448229191|FG000|Overall Study|Adverse Event|1|||
124621891|NCT02829918|448229191|FG000|Overall Study|Progression|1|||
124621892|NCT04186845|448229210|FG000|Overall Study|Death|2|||
124621893|NCT04186845|448229210|FG000|Overall Study|Lost to Follow-up|1|||
124621894|NCT04186845|448229210|FG000|Overall Study|Physician Decision|1|||
124621895|NCT04186845|448229210|FG000|Overall Study|Protocol Violation|1|||
124621896|NCT04186845|448229210|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
124621897|NCT04186845|448229210|FG000|Overall Study|Biopsy ordered but not done|1|||
124621898|NCT04186845|448229210|FG000|Overall Study|It was previously confirmed|1|||
124621899|NCT04186845|448229210|FG000|Overall Study|Patient cancelled scheduled scans|2|||
124621900|NCT04186845|448229210|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
124621901|NCT04186845|448229210|FG000|Overall Study|Subject refused confirmatory imaging|1|||
124621902|NCT04186845|448229210|FG000|Overall Study|Too small to biopsy|1|||
124621903|NCT03290079|448229213|FG000|Overall Study|Death|2|||
124621904|NCT04487067|448229214|FG000|Overall Study|Adverse Event|3|||
124621905|NCT04487067|448229214|FG000|Overall Study|Death Other Than Progressive Disease|60|||
124621906|NCT04487067|448229214|FG000|Overall Study|Death Due To Progressive Disease|40|||
124621907|NCT04487067|448229214|FG000|Overall Study|Lost to Follow-up|3|||
124621908|NCT04487067|448229214|FG000|Overall Study|Progressive Disease|1|||
124621909|NCT04487067|448229214|FG000|Overall Study|Protocol Violation|3|||
124621910|NCT04487067|448229214|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
124621911|NCT04487067|448229214|FG000|Overall Study|Withdrawal by Subject|15|||
124621912|NCT06385483|448229215|FG000|Overall Study|Withdrawal by Subject|2|||
124621913|NCT06385483|448229215|FG000|Overall Study|Never start protocol therapy|2|||
124621914|NCT06385483|448229215|FG000|Overall Study|Disease progression|15|||
124621915|NCT04697069|448229216|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
124621916|NCT04697069|448229217|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
124621917|NCT04697069|448229216|FG000|Overall Study|Study termination|2|||
124621918|NCT04697069|448229217|FG001|Overall Study|Study termination|1|||
124621919|NCT05180227|448229218|FG000|Overall Study|Hypertension at screening|1|||
124621920|NCT05180227|448229218|FG000|Overall Study|Lost to Follow-up|1|||
124621921|NCT04739800|448229219|FG000|Overall Study|Adverse Event|2|||
124621922|NCT04739800|448229220|FG001|Overall Study|Adverse Event|1|||
124621923|NCT04739800|448229221|FG002|Overall Study|Adverse Event|4|||
124621924|NCT04739800|448229222|FG003|Overall Study|Adverse Event|5|||
124621925|NCT04739800|448229219|FG000|Overall Study|Never Treated|2|||
124621926|NCT04739800|448229220|FG001|Overall Study|Never Treated|0|||
124621927|NCT04739800|448229221|FG002|Overall Study|Never Treated|1|||
124621928|NCT04739800|448229222|FG003|Overall Study|Never Treated|1|||
124621929|NCT04739800|448229219|FG000|Overall Study|On Treatment|5|||
124621930|NCT04739800|448229220|FG001|Overall Study|On Treatment|9|||
124621931|NCT04739800|448229221|FG002|Overall Study|On Treatment|9|||
124621932|NCT04739800|448229222|FG003|Overall Study|On Treatment|9|||
124621933|NCT04739800|448229219|FG000|Overall Study|Symptomatic Deterioration|1|||
124621934|NCT04739800|448229220|FG001|Overall Study|Symptomatic Deterioration|1|||
124621935|NCT04739800|448229221|FG002|Overall Study|Symptomatic Deterioration|3|||
124621936|NCT04739800|448229222|FG003|Overall Study|Symptomatic Deterioration|0|||
124621937|NCT04739800|448229219|FG000|Overall Study|Withdrawal by Subject|1|||
124621938|NCT04739800|448229220|FG001|Overall Study|Withdrawal by Subject|2|||
124621939|NCT04739800|448229221|FG002|Overall Study|Withdrawal by Subject|1|||
124621940|NCT04739800|448229222|FG003|Overall Study|Withdrawal by Subject|3|||
124621941|NCT04739800|448229219|FG000|Overall Study|Other Reason|1|||
124621942|NCT04739800|448229220|FG001|Overall Study|Other Reason|3|||
124621943|NCT04739800|448229221|FG002|Overall Study|Other Reason|5|||
124621944|NCT04739800|448229222|FG003|Overall Study|Other Reason|4|||
124621945|NCT02779855|448229223|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
124751936|NCT03350815|448714195|FG000|Period 2|Lack of Efficacy|0|||
124751937|NCT03350815|448714196|FG001|Period 2|Lack of Efficacy|6|||
124621946|NCT02779855|448229224|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
124621947|NCT02779855|448229225|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
124621948|NCT04787627|448229229|FG000|Overall Study|Withdrawal by Subject|3|||
124621949|NCT04787627|448229230|FG001|Overall Study|Withdrawal by Subject|0|||
124621950|NCT04787627|448229229|FG000|Overall Study|Physician Decision|2|||
124621951|NCT04787627|448229230|FG001|Overall Study|Physician Decision|0|||
124621952|NCT04787627|448229229|FG000|Overall Study|Excluded|0|||
124621953|NCT04787627|448229230|FG001|Overall Study|Excluded|1|||
124621954|NCT00985491|448229231|FG000|Overall Study|Adverse Event|8|||
124621955|NCT00985491|448229231|FG000|Overall Study|device migration|7|||
124621956|NCT00985491|448229231|FG000|Overall Study|Withdrawal by Subject|1|||
124621957|NCT00985491|448229231|FG000|Overall Study|implant failure|3|||
124621958|NCT03514017|448229232|FG000|Overall Study|Death|1|||
124621959|NCT03514017|448229232|FG000|Overall Study|Adverse Event|1|||
124621960|NCT05192889|448229237|FG000|Block 1: All Eligible Patients|Death|2|||
124621961|NCT05192889|448229238|FG001|Block 1: All Eligible Patients|Death|0|||
124621962|NCT05192889|448229239|FG002|Block 1: All Eligible Patients|Death|0|||
124621963|NCT05192889|448229237|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
124621964|NCT05192889|448229238|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
124621965|NCT05192889|448229239|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
124621966|NCT05192889|448229237|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
124621967|NCT05192889|448229238|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
124621968|NCT05192889|448229239|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
124621969|NCT01290302|448230500|FG000|Overall Study|Adverse Event|2|||
124621970|NCT01290302|448230501|FG001|Overall Study|Adverse Event|0|||
124621971|NCT01290302|448230500|FG000|Overall Study|Withdrawal by Subject|1|||
124621972|NCT01290302|448230501|FG001|Overall Study|Withdrawal by Subject|0|||
124621973|NCT01290302|448230500|FG000|Overall Study|Physician Decision|0|||
124621974|NCT01290302|448230501|FG001|Overall Study|Physician Decision|2|||
124621975|NCT01290302|448230500|FG000|Overall Study|Expiration of time for screening window|1|||
124621976|NCT01290302|448230501|FG001|Overall Study|Expiration of time for screening window|0|||
124621977|NCT01769456|448230506|FG000|Overall Study|Lost to Follow-up|19|||
124621978|NCT01769456|448230506|FG000|Overall Study|Withdrawal by Subject|3|||
124621979|NCT01769456|448230506|FG000|Overall Study|Did not receive PCC intervention|6|||
124621980|NCT01769456|448230506|FG000|Overall Study|Moved out of the area|3|||
124621981|NCT01769456|448230506|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
124621982|NCT01769456|448230506|FG000|Overall Study|Parental request to youth to withdraw|1|||
124621983|NCT05490771|448230508|FG000|Overall Study|Disease progression|18|||
124621984|NCT05490771|448230508|FG000|Overall Study|Adverse Event|3|||
124621985|NCT05490771|448230508|FG000|Overall Study|Other complicating disease|1|||
124621986|NCT05490771|448230508|FG000|Overall Study|Withdrawal by Subject|3|||
124621987|NCT05490771|448230508|FG000|Overall Study|Physician Decision|1|||
124621988|NCT05490771|448230508|FG000|Overall Study|Still on treatment|2|||
124621989|NCT05490771|448230508|FG000|Overall Study|Never start protocol therapy|5|||
124621990|NCT05490771|448230508|FG000|Overall Study|Ineligible|2|||
124621991|NCT00661193|448230512|FG000|Overall Study|Adverse Event|2|||
124621992|NCT00661193|448230513|FG001|Overall Study|Adverse Event|1|||
124621993|NCT00661193|448230512|FG000|Overall Study|Withdrawal by Subject|3|||
124621994|NCT00661193|448230513|FG001|Overall Study|Withdrawal by Subject|1|||
124751938|NCT03350815|448714197|FG002|Period 2|Lack of Efficacy|2|||
124751939|NCT03350815|448714198|FG003|Period 2|Lack of Efficacy|0|||
124751940|NCT03350815|448714195|FG000|Period 2|Protocol Violation|0|||
124751941|NCT03350815|448714196|FG001|Period 2|Protocol Violation|0|||
124751942|NCT03350815|448714197|FG002|Period 2|Protocol Violation|1|||
124751943|NCT03350815|448714198|FG003|Period 2|Protocol Violation|0|||
124751944|NCT03350815|448714195|FG000|Period 2|New therapy for study indication|0|||
124751945|NCT03350815|448714196|FG001|Period 2|New therapy for study indication|0|||
124751946|NCT03350815|448714197|FG002|Period 2|New therapy for study indication|1|||
124751947|NCT03350815|448714198|FG003|Period 2|New therapy for study indication|0|||
124751948|NCT02630472|448714199|FG000|Overall Study|Physician Decision|10|||
124751949|NCT02630472|448714200|FG001|Overall Study|Physician Decision|0|||
124751950|NCT03040674|448714203|FG000|Overall Study|Lost to Follow-up|225|||
124751951|NCT03040674|448714203|FG000|Overall Study|Death|23|||
124751952|NCT02936843|448714204|FG000|Overall Study|Lost to Follow-up|3|||
124751953|NCT02936843|448714205|FG001|Overall Study|Lost to Follow-up|1|||
124751954|NCT02936843|448714204|FG000|Overall Study|Withdrawal by Subject|1|||
124751955|NCT02936843|448714205|FG001|Overall Study|Withdrawal by Subject|1|||
124751956|NCT02703324|448714206|FG000|Period Two|Withdrawal by Subject|0|||
124751957|NCT02703324|448714207|FG001|Period Two|Withdrawal by Subject|0|||
124751958|NCT02703324|448714208|FG002|Period Two|Withdrawal by Subject|1|||
124751959|NCT02703324|448714209|FG003|Period Two|Withdrawal by Subject|0|||
124751960|NCT02703324|448714210|FG004|Period Two|Withdrawal by Subject|0|||
124751961|NCT02703324|448714211|FG005|Period Two|Withdrawal by Subject|0|||
124621995|NCT00661193|448230512|FG000|Overall Study|Progression|27|||
124621996|NCT00661193|448230513|FG001|Overall Study|Progression|24|||
124621997|NCT00661193|448230512|FG000|Overall Study|Not protocol specified|1|||
124751962|NCT04303572|448714212|FG000|Overall Study|Study closed due to poor enrollment|1|||
124751963|NCT06312592|448714213|FG000|Overall Study|Lost to Follow-up|29|||
124621998|NCT00661193|448230513|FG001|Overall Study|Not protocol specified|0|||
124621999|NCT02862730|448230516|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
124622000|NCT02862730|448230517|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
124622001|NCT02862730|448230518|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
124622002|NCT02862730|448230519|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
124622003|NCT02862730|448230520|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
124622004|NCT02862730|448230521|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
124622005|NCT02862730|448230522|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
124622006|NCT02862730|448230516|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
124622007|NCT02862730|448230517|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
124622008|NCT02862730|448230518|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
124622009|NCT02862730|448230519|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
124622010|NCT02862730|448230520|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
124622011|NCT02862730|448230521|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
124622012|NCT02862730|448230522|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
124622013|NCT02862730|448230516|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
124622014|NCT02862730|448230517|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
124622015|NCT02862730|448230518|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
124622016|NCT02862730|448230519|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
124622017|NCT02862730|448230520|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
124622018|NCT02862730|448230521|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
124622019|NCT02862730|448230522|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
124622020|NCT02862730|448230516|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
124622021|NCT02862730|448230517|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
124622022|NCT02862730|448230518|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
124622023|NCT02862730|448230519|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
124622024|NCT02862730|448230520|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
124622025|NCT02862730|448230521|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
124622026|NCT02862730|448230522|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
124622027|NCT03685344|448230523|FG000|Overall Study|Withdrawal by Subject|1|||
124622028|NCT03685344|448230524|FG001|Overall Study|Withdrawal by Subject|1|||
124622029|NCT03685344|448230525|FG002|Overall Study|Withdrawal by Subject|2|||
124622030|NCT03685344|448230526|FG003|Overall Study|Withdrawal by Subject|0|||
124622031|NCT03685344|448230523|FG000|Overall Study|Physician Decision|1|||
124622032|NCT03685344|448230524|FG001|Overall Study|Physician Decision|1|||
124622033|NCT03685344|448230525|FG002|Overall Study|Physician Decision|5|||
124622034|NCT03685344|448230526|FG003|Overall Study|Physician Decision|0|||
124622035|NCT03685344|448230523|FG000|Overall Study|Death|1|||
124622036|NCT03685344|448230524|FG001|Overall Study|Death|1|||
124622037|NCT03685344|448230525|FG002|Overall Study|Death|0|||
124622038|NCT03685344|448230526|FG003|Overall Study|Death|0|||
124622039|NCT03126435|448230528|FG000|Overall Study|Death|90|||
124622040|NCT03126435|448230529|FG001|Overall Study|Death|84|||
124622041|NCT03126435|448230528|FG000|Overall Study|Lost to Follow-up|4|||
124622042|NCT03126435|448230529|FG001|Overall Study|Lost to Follow-up|3|||
124622043|NCT03126435|448230528|FG000|Overall Study|Physician Decision|0|||
124622044|NCT03126435|448230529|FG001|Overall Study|Physician Decision|1|||
124622045|NCT03126435|448230528|FG000|Overall Study|Withdrawal by Subject|6|||
124622046|NCT03126435|448230529|FG001|Overall Study|Withdrawal by Subject|12|||
124622047|NCT03126435|448230528|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
124622048|NCT03126435|448230529|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
124622049|NCT03971474|448230532|FG000|Overall Study|Adverse Event|11|||
124622050|NCT03971474|448230533|FG001|Overall Study|Adverse Event|7|||
124622051|NCT03971474|448230532|FG000|Overall Study|Refusal unrelated to adverse event|5|||
124622052|NCT03971474|448230533|FG001|Overall Study|Refusal unrelated to adverse event|1|||
124622053|NCT03971474|448230532|FG000|Overall Study|Progression/relapse|40|||
124622054|NCT03971474|448230533|FG001|Overall Study|Progression/relapse|47|||
124622055|NCT03971474|448230532|FG000|Overall Study|Death|6|||
124622056|NCT03971474|448230533|FG001|Overall Study|Death|3|||
124622057|NCT03971474|448230532|FG000|Overall Study|Other - not protocol specified|5|||
124622058|NCT03971474|448230533|FG001|Overall Study|Other - not protocol specified|4|||
124622059|NCT03971474|448230532|FG000|Overall Study|On treatment|0|||
124622060|NCT03971474|448230533|FG001|Overall Study|On treatment|7|||
124622061|NCT00261950|448230534|FG000|Overall Study|Lost to Follow-up|2|||
124622062|NCT00261950|448230534|FG000|Overall Study|Death|6|||
124622063|NCT00261950|448230534|FG000|Overall Study|Withdrawal by Subject|5|||
124622064|NCT00261950|448230534|FG000|Overall Study|Other|1|||
124622065|NCT00261950|448230534|FG000|Overall Study|Physician Decision|1|||
124622066|NCT00261950|448230534|FG000|Overall Study|Protocol specified Criteria|11|||
124622067|NCT01937871|448230541|FG000|Overall Study|Adverse Event|6|||
124622068|NCT01937871|448230542|FG001|Overall Study|Adverse Event|6|||
124622069|NCT01937871|448230543|FG002|Overall Study|Adverse Event|2|||
124622070|NCT01937871|448230541|FG000|Overall Study|Lost to Follow-up|8|||
124622071|NCT01937871|448230542|FG001|Overall Study|Lost to Follow-up|2|||
124622072|NCT01937871|448230543|FG002|Overall Study|Lost to Follow-up|4|||
124622073|NCT01937871|448230541|FG000|Overall Study|Withdrawal by Subject|9|||
124622074|NCT01937871|448230542|FG001|Overall Study|Withdrawal by Subject|6|||
124622075|NCT01937871|448230543|FG002|Overall Study|Withdrawal by Subject|4|||
124622076|NCT01937871|448230541|FG000|Overall Study|Physician Decision|0|||
124622077|NCT01937871|448230542|FG001|Overall Study|Physician Decision|1|||
124622078|NCT01937871|448230543|FG002|Overall Study|Physician Decision|0|||
124622079|NCT01937871|448230541|FG000|Overall Study|Entry Criteria Not Met|1|||
124622080|NCT01937871|448230542|FG001|Overall Study|Entry Criteria Not Met|2|||
124622081|NCT01937871|448230543|FG002|Overall Study|Entry Criteria Not Met|1|||
124622082|NCT00577863|448230550|FG000|Overall Study|Adverse Event|4|||
124622083|NCT00577863|448230551|FG001|Overall Study|Adverse Event|2|||
124622084|NCT00577863|448230550|FG000|Overall Study|Death|1|||
124622085|NCT00577863|448230551|FG001|Overall Study|Death|0|||
124622086|NCT00577863|448230550|FG000|Overall Study|Lost to Follow-up|2|||
124622087|NCT00577863|448230551|FG001|Overall Study|Lost to Follow-up|2|||
124622088|NCT00577863|448230550|FG000|Overall Study|Entry Criteria Exclusion|1|||
124622089|NCT00577863|448230551|FG001|Overall Study|Entry Criteria Exclusion|0|||
124622090|NCT00577863|448230550|FG000|Overall Study|Withdrawal by Subject|0|||
124622091|NCT00577863|448230551|FG001|Overall Study|Withdrawal by Subject|2|||
124622092|NCT00577863|448230550|FG000|Overall Study|Sponsor Decision|2|||
124622093|NCT00577863|448230551|FG001|Overall Study|Sponsor Decision|7|||
124622094|NCT00577863|448230550|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
124622095|NCT00577863|448230551|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
124622096|NCT03154125|448230552|FG000|Overall Study|Lost to Follow-up|11|||
124622097|NCT03154125|448230553|FG001|Overall Study|Lost to Follow-up|11|||
124622098|NCT03154125|448230554|FG002|Overall Study|Lost to Follow-up|0|||
124622099|NCT03154125|448230552|FG000|Overall Study|Withdrawal by Subject|49|||
124622100|NCT03154125|448230553|FG001|Overall Study|Withdrawal by Subject|55|||
124622101|NCT03154125|448230554|FG002|Overall Study|Withdrawal by Subject|8|||
124622102|NCT03154125|448230552|FG000|Overall Study|Physician Decision|13|||
124622103|NCT03154125|448230553|FG001|Overall Study|Physician Decision|6|||
124622104|NCT03154125|448230554|FG002|Overall Study|Physician Decision|0|||
124622105|NCT03154125|448230552|FG000|Overall Study|Protocol Violation|3|||
124622106|NCT03154125|448230553|FG001|Overall Study|Protocol Violation|5|||
124622107|NCT03154125|448230554|FG002|Overall Study|Protocol Violation|0|||
124622108|NCT05061420|448230556|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
124622109|NCT05061420|448230557|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
124622110|NCT05061420|448230558|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
124622111|NCT05061420|448230556|FG000|Overall Study|Progressive disease|11|||
124622112|NCT05061420|448230557|FG001|Overall Study|Progressive disease|15|||
124622113|NCT05061420|448230558|FG002|Overall Study|Progressive disease|14|||
124622114|NCT05061420|448230556|FG000|Overall Study|Withdrawal by Subject|2|||
124622115|NCT05061420|448230557|FG001|Overall Study|Withdrawal by Subject|0|||
124622116|NCT05061420|448230558|FG002|Overall Study|Withdrawal by Subject|1|||
124622117|NCT05061420|448230556|FG000|Overall Study|Not related to COVID-19|2|||
124622118|NCT05061420|448230557|FG001|Overall Study|Not related to COVID-19|0|||
124622119|NCT05061420|448230558|FG002|Overall Study|Not related to COVID-19|0|||
124622120|NCT02859142|448230559|FG000|Overall Study|Adverse Event|1|||
124622121|NCT02859142|448230560|FG001|Overall Study|Adverse Event|2|||
124622122|NCT02859142|448230559|FG000|Overall Study|Lost to Follow-up|1|||
124622123|NCT02859142|448230560|FG001|Overall Study|Lost to Follow-up|4|||
124622124|NCT02859142|448230559|FG000|Overall Study|Withdrawal by Subject|2|||
124622125|NCT02859142|448230560|FG001|Overall Study|Withdrawal by Subject|0|||
124622126|NCT02859142|448230559|FG000|Overall Study|Scheduling difficulties|0|||
124622127|NCT02859142|448230560|FG001|Overall Study|Scheduling difficulties|3|||
124622128|NCT02466685|448230561|FG000|Overall Study|Adverse Event|5|||
124622129|NCT02466685|448230562|FG001|Overall Study|Adverse Event|2|||
124622130|NCT02466685|448230561|FG000|Overall Study|Lost to Follow-up|1|||
124622131|NCT02466685|448230562|FG001|Overall Study|Lost to Follow-up|1|||
124622132|NCT02466685|448230561|FG000|Overall Study|Withdrawal by Subject|1|||
124622133|NCT02466685|448230562|FG001|Overall Study|Withdrawal by Subject|0|||
124622134|NCT02466685|448230561|FG000|Overall Study|Physician Decision|1|||
124622135|NCT02466685|448230562|FG001|Overall Study|Physician Decision|1|||
124622136|NCT05299528|448230566|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
124622137|NCT05299528|448230567|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
124622138|NCT05299528|448230568|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
124622139|NCT05299528|448230569|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
124622140|NCT05299528|448230570|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
124622141|NCT05299528|448230571|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
124622142|NCT05299528|448230572|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
124622143|NCT05299528|448230566|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
124622144|NCT05299528|448230567|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
124622145|NCT05299528|448230568|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
124622146|NCT05299528|448230569|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
124622147|NCT05299528|448230570|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
124622148|NCT05299528|448230571|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
124622149|NCT05299528|448230572|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
124622150|NCT05299528|448230566|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
124622151|NCT05299528|448230567|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
124622152|NCT05299528|448230568|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
124622153|NCT05299528|448230569|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
124622154|NCT05299528|448230570|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
124622155|NCT05299528|448230571|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
124622156|NCT05299528|448230572|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
124622157|NCT01070953|448230576|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
124622158|NCT01070953|448230576|FG000|Participants for Safety Evaluation|Off-label use|283|||
124622159|NCT01070953|448230576|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
124622160|NCT01070953|448230576|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
124622161|NCT01070953|448230576|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
124622162|NCT01070953|448230576|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
124622163|NCT01070953|448230576|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
124622164|NCT01070953|448230576|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
124622165|NCT01070953|448230576|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
124622166|NCT01070953|448230576|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
124622167|NCT02445963|448230577|FG000|Overall Study|Lost to Follow-up|1|||
124622168|NCT02445963|448230578|FG001|Overall Study|Lost to Follow-up|0|||
124622169|NCT02445963|448230579|FG002|Overall Study|Lost to Follow-up|0|||
124622170|NCT02445963|448230580|FG003|Overall Study|Lost to Follow-up|0|||
124622171|NCT02445963|448230577|FG000|Overall Study|Change in employment|1|||
124622172|NCT02445963|448230578|FG001|Overall Study|Change in employment|0|||
124622173|NCT02445963|448230579|FG002|Overall Study|Change in employment|0|||
124622174|NCT02445963|448230580|FG003|Overall Study|Change in employment|0|||
124622175|NCT02445963|448230577|FG000|Overall Study|Symptoms post-vaccination|0|||
124622176|NCT02445963|448230578|FG001|Overall Study|Symptoms post-vaccination|0|||
124622177|NCT02445963|448230579|FG002|Overall Study|Symptoms post-vaccination|1|||
124622178|NCT02445963|448230580|FG003|Overall Study|Symptoms post-vaccination|0|||
124622179|NCT01957176|448230581|FG000|Overall Study|Adverse Event|2|||
124622180|NCT01957176|448230582|FG001|Overall Study|Adverse Event|0|||
124622181|NCT01957176|448230581|FG000|Overall Study|Physician Decision|2|||
124622182|NCT01957176|448230582|FG001|Overall Study|Physician Decision|1|||
124622183|NCT01957176|448230581|FG000|Overall Study|Withdrawal by Subject|1|||
124622184|NCT01957176|448230582|FG001|Overall Study|Withdrawal by Subject|0|||
124622185|NCT02359994|448230583|FG000|Overall Population Study|Adverse Event|1|||
124622186|NCT02359994|448230584|FG001|Overall Population Study|Adverse Event|1|||
124622187|NCT02359994|448230583|FG000|Overall Population Study|Death|1|||
124622188|NCT02359994|448230584|FG001|Overall Population Study|Death|5|||
124622189|NCT02359994|448230583|FG000|Overall Population Study|Lost to Follow-up|1|||
124622190|NCT02359994|448230584|FG001|Overall Population Study|Lost to Follow-up|1|||
124622191|NCT02359994|448230583|FG000|Overall Population Study|Withdrawal by Subject|1|||
124622192|NCT02359994|448230584|FG001|Overall Population Study|Withdrawal by Subject|0|||
124622193|NCT02359994|448230583|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
124622194|NCT02359994|448230584|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
124622195|NCT02359994|448230583|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
124622196|NCT02359994|448230584|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
124622197|NCT02359994|448230583|FG000|Extended Oncology 24-Month Survival|Death|19|||
124622198|NCT02359994|448230584|FG001|Extended Oncology 24-Month Survival|Death|21|||
124622199|NCT02359994|448230583|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
124622200|NCT02359994|448230584|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
124622201|NCT04597632|448230587|FG000|Overall Study|Withdrawal by Subject|10|||
124622202|NCT04597632|448230587|FG000|Overall Study|Lost to Follow-up|1|||
124622203|NCT04597632|448230587|FG000|Overall Study|Death|1|||
124622204|NCT04597632|448230587|FG000|Overall Study|Adverse Event|5|||
124622205|NCT01823835|448230588|FG000|Overall Study|Adverse Event|0|||
124622206|NCT01823835|448230589|FG001|Overall Study|Adverse Event|0|||
124622207|NCT01823835|448230590|FG002|Overall Study|Adverse Event|0|||
124622208|NCT01823835|448230591|FG003|Overall Study|Adverse Event|0|||
124622209|NCT01823835|448230592|FG004|Overall Study|Adverse Event|1|||
124622210|NCT01823835|448230593|FG005|Overall Study|Adverse Event|0|||
124622211|NCT01823835|448230594|FG006|Overall Study|Adverse Event|1|||
124622212|NCT01823835|448230595|FG007|Overall Study|Adverse Event|0|||
124622213|NCT01823835|448230596|FG008|Overall Study|Adverse Event|0|||
124622214|NCT01823835|448230597|FG009|Overall Study|Adverse Event|0|||
124622215|NCT01823835|448230598|FG010|Overall Study|Adverse Event|1|||
124622216|NCT01823835|448230599|FG011|Overall Study|Adverse Event|2|||
124622217|NCT01823835|448230600|FG012|Overall Study|Adverse Event|0|||
124622218|NCT01823835|448230601|FG013|Overall Study|Adverse Event|0|||
124622219|NCT01823835|448230602|FG014|Overall Study|Adverse Event|0|||
124622220|NCT01823835|448230588|FG000|Overall Study|Physician Decision|0|||
124622221|NCT01823835|448230589|FG001|Overall Study|Physician Decision|0|||
124622222|NCT01823835|448230590|FG002|Overall Study|Physician Decision|0|||
124622223|NCT01823835|448230591|FG003|Overall Study|Physician Decision|0|||
124622224|NCT01823835|448230592|FG004|Overall Study|Physician Decision|0|||
124622225|NCT01823835|448230593|FG005|Overall Study|Physician Decision|0|||
124622226|NCT01823835|448230594|FG006|Overall Study|Physician Decision|0|||
124622227|NCT01823835|448230595|FG007|Overall Study|Physician Decision|0|||
124622228|NCT01823835|448230596|FG008|Overall Study|Physician Decision|0|||
124622229|NCT01823835|448230597|FG009|Overall Study|Physician Decision|0|||
124622230|NCT01823835|448230598|FG010|Overall Study|Physician Decision|0|||
124622231|NCT01823835|448230599|FG011|Overall Study|Physician Decision|2|||
124622232|NCT01823835|448230600|FG012|Overall Study|Physician Decision|0|||
124622233|NCT01823835|448230601|FG013|Overall Study|Physician Decision|0|||
124622234|NCT01823835|448230602|FG014|Overall Study|Physician Decision|0|||
124622235|NCT01823835|448230588|FG000|Overall Study|Progressive Disease|3|||
124622236|NCT01823835|448230589|FG001|Overall Study|Progressive Disease|4|||
124622237|NCT01823835|448230590|FG002|Overall Study|Progressive Disease|3|||
124622238|NCT01823835|448230591|FG003|Overall Study|Progressive Disease|6|||
124622239|NCT01823835|448230592|FG004|Overall Study|Progressive Disease|4|||
124622240|NCT01823835|448230593|FG005|Overall Study|Progressive Disease|6|||
124622241|NCT01823835|448230594|FG006|Overall Study|Progressive Disease|5|||
124622242|NCT01823835|448230595|FG007|Overall Study|Progressive Disease|3|||
124622243|NCT01823835|448230596|FG008|Overall Study|Progressive Disease|3|||
124622244|NCT01823835|448230597|FG009|Overall Study|Progressive Disease|18|||
124622245|NCT01823835|448230598|FG010|Overall Study|Progressive Disease|8|||
124622246|NCT01823835|448230599|FG011|Overall Study|Progressive Disease|46|||
124622247|NCT01823835|448230600|FG012|Overall Study|Progressive Disease|18|||
124622248|NCT01823835|448230601|FG013|Overall Study|Progressive Disease|4|||
124622249|NCT01823835|448230602|FG014|Overall Study|Progressive Disease|6|||
124622250|NCT01823835|448230588|FG000|Overall Study|Study Termination|0|||
124622251|NCT01823835|448230589|FG001|Overall Study|Study Termination|0|||
124622252|NCT01823835|448230590|FG002|Overall Study|Study Termination|0|||
124622253|NCT01823835|448230591|FG003|Overall Study|Study Termination|0|||
124622254|NCT01823835|448230592|FG004|Overall Study|Study Termination|1|||
124622255|NCT01823835|448230593|FG005|Overall Study|Study Termination|0|||
124622256|NCT01823835|448230594|FG006|Overall Study|Study Termination|0|||
124622257|NCT01823835|448230595|FG007|Overall Study|Study Termination|0|||
124622258|NCT01823835|448230596|FG008|Overall Study|Study Termination|0|||
124622259|NCT01823835|448230597|FG009|Overall Study|Study Termination|0|||
124622260|NCT01823835|448230598|FG010|Overall Study|Study Termination|0|||
124622261|NCT01823835|448230599|FG011|Overall Study|Study Termination|1|||
124622262|NCT01823835|448230600|FG012|Overall Study|Study Termination|0|||
124622263|NCT01823835|448230601|FG013|Overall Study|Study Termination|0|||
124622264|NCT01823835|448230602|FG014|Overall Study|Study Termination|0|||
124622265|NCT01823835|448230588|FG000|Overall Study|Withdrawal by Subject|0|||
124622266|NCT01823835|448230589|FG001|Overall Study|Withdrawal by Subject|0|||
124622267|NCT01823835|448230590|FG002|Overall Study|Withdrawal by Subject|1|||
124622268|NCT01823835|448230591|FG003|Overall Study|Withdrawal by Subject|0|||
124622269|NCT01823835|448230592|FG004|Overall Study|Withdrawal by Subject|0|||
124622270|NCT01823835|448230593|FG005|Overall Study|Withdrawal by Subject|0|||
124622271|NCT01823835|448230594|FG006|Overall Study|Withdrawal by Subject|0|||
124622272|NCT01823835|448230595|FG007|Overall Study|Withdrawal by Subject|0|||
124622273|NCT01823835|448230596|FG008|Overall Study|Withdrawal by Subject|0|||
124622274|NCT01823835|448230597|FG009|Overall Study|Withdrawal by Subject|1|||
124622275|NCT01823835|448230598|FG010|Overall Study|Withdrawal by Subject|1|||
124622276|NCT01823835|448230599|FG011|Overall Study|Withdrawal by Subject|2|||
124622277|NCT01823835|448230600|FG012|Overall Study|Withdrawal by Subject|1|||
124622278|NCT01823835|448230601|FG013|Overall Study|Withdrawal by Subject|0|||
124622279|NCT01823835|448230602|FG014|Overall Study|Withdrawal by Subject|0|||
124622280|NCT03017612|448230603|FG000|Overall Study|Adverse Event|2|||
124622281|NCT04895982|448230604|FG000|Overall Study|Withdrawal by Subject|0|||
124622282|NCT04895982|448230605|FG001|Overall Study|Withdrawal by Subject|0|||
124622283|NCT04895982|448230606|FG002|Overall Study|Withdrawal by Subject|0|||
124622284|NCT04895982|448230607|FG003|Overall Study|Withdrawal by Subject|0|||
124622285|NCT04895982|448230608|FG004|Overall Study|Withdrawal by Subject|0|||
124622286|NCT04895982|448230609|FG005|Overall Study|Withdrawal by Subject|1|||
124622287|NCT04895982|448230610|FG006|Overall Study|Withdrawal by Subject|1|||
124622288|NCT04895982|448230611|FG007|Overall Study|Withdrawal by Subject|0|||
124622289|NCT04895982|448230612|FG008|Overall Study|Withdrawal by Subject|0|||
124622290|NCT04895982|448230613|FG009|Overall Study|Withdrawal by Subject|1|||
124622291|NCT04895982|448230614|FG010|Overall Study|Withdrawal by Subject|0|||
124622292|NCT04895982|448230615|FG011|Overall Study|Withdrawal by Subject|1|||
124622293|NCT04895982|448230604|FG000|Overall Study|Withdrawal by parent/guardian|2|||
124622294|NCT04895982|448230605|FG001|Overall Study|Withdrawal by parent/guardian|3|||
124622295|NCT04895982|448230606|FG002|Overall Study|Withdrawal by parent/guardian|3|||
124622296|NCT04895982|448230607|FG003|Overall Study|Withdrawal by parent/guardian|1|||
124622297|NCT04895982|448230608|FG004|Overall Study|Withdrawal by parent/guardian|3|||
124622298|NCT04895982|448230609|FG005|Overall Study|Withdrawal by parent/guardian|2|||
124622299|NCT04895982|448230610|FG006|Overall Study|Withdrawal by parent/guardian|1|||
124622300|NCT04895982|448230611|FG007|Overall Study|Withdrawal by parent/guardian|0|||
124622301|NCT04895982|448230612|FG008|Overall Study|Withdrawal by parent/guardian|3|||
124622302|NCT04895982|448230613|FG009|Overall Study|Withdrawal by parent/guardian|0|||
124622303|NCT04895982|448230614|FG010|Overall Study|Withdrawal by parent/guardian|0|||
124622304|NCT04895982|448230615|FG011|Overall Study|Withdrawal by parent/guardian|0|||
124622305|NCT04895982|448230604|FG000|Overall Study|Other|0|||
124622306|NCT04895982|448230605|FG001|Overall Study|Other|0|||
124622307|NCT04895982|448230606|FG002|Overall Study|Other|1|||
124622308|NCT04895982|448230607|FG003|Overall Study|Other|1|||
124622309|NCT04895982|448230608|FG004|Overall Study|Other|0|||
124622310|NCT04895982|448230609|FG005|Overall Study|Other|0|||
124622311|NCT04895982|448230610|FG006|Overall Study|Other|0|||
124622312|NCT04895982|448230611|FG007|Overall Study|Other|0|||
124622313|NCT04895982|448230612|FG008|Overall Study|Other|0|||
124622314|NCT04895982|448230613|FG009|Overall Study|Other|1|||
124622315|NCT04895982|448230614|FG010|Overall Study|Other|0|||
124622316|NCT04895982|448230615|FG011|Overall Study|Other|0|||
124622317|NCT04895982|448230604|FG000|Overall Study|Protocol Violation|0|||
124622318|NCT04895982|448230605|FG001|Overall Study|Protocol Violation|0|||
124622319|NCT04895982|448230606|FG002|Overall Study|Protocol Violation|1|||
124622320|NCT04895982|448230607|FG003|Overall Study|Protocol Violation|1|||
124622321|NCT04895982|448230608|FG004|Overall Study|Protocol Violation|1|||
124622322|NCT04895982|448230609|FG005|Overall Study|Protocol Violation|0|||
124622323|NCT04895982|448230610|FG006|Overall Study|Protocol Violation|0|||
124622324|NCT04895982|448230611|FG007|Overall Study|Protocol Violation|1|||
124622325|NCT04895982|448230612|FG008|Overall Study|Protocol Violation|0|||
124622326|NCT04895982|448230613|FG009|Overall Study|Protocol Violation|0|||
124622327|NCT04895982|448230614|FG010|Overall Study|Protocol Violation|0|||
124622328|NCT04895982|448230615|FG011|Overall Study|Protocol Violation|0|||
124622329|NCT04895982|448230604|FG000|Overall Study|Lost to Follow-up|0|||
124622330|NCT04895982|448230605|FG001|Overall Study|Lost to Follow-up|0|||
124622331|NCT04895982|448230606|FG002|Overall Study|Lost to Follow-up|1|||
124622332|NCT04895982|448230607|FG003|Overall Study|Lost to Follow-up|0|||
124622333|NCT04895982|448230608|FG004|Overall Study|Lost to Follow-up|0|||
124622334|NCT04895982|448230609|FG005|Overall Study|Lost to Follow-up|1|||
124622335|NCT04895982|448230610|FG006|Overall Study|Lost to Follow-up|0|||
124622336|NCT04895982|448230611|FG007|Overall Study|Lost to Follow-up|0|||
124622337|NCT04895982|448230612|FG008|Overall Study|Lost to Follow-up|1|||
124622338|NCT04895982|448230613|FG009|Overall Study|Lost to Follow-up|0|||
124622339|NCT04895982|448230614|FG010|Overall Study|Lost to Follow-up|0|||
124622340|NCT04895982|448230615|FG011|Overall Study|Lost to Follow-up|0|||
124622341|NCT04895982|448230604|FG000|Overall Study|Refused further study procedures|0|||
124622342|NCT04895982|448230605|FG001|Overall Study|Refused further study procedures|0|||
124622343|NCT04895982|448230606|FG002|Overall Study|Refused further study procedures|1|||
124622344|NCT04895982|448230607|FG003|Overall Study|Refused further study procedures|0|||
124622345|NCT04895982|448230608|FG004|Overall Study|Refused further study procedures|0|||
124622346|NCT04895982|448230609|FG005|Overall Study|Refused further study procedures|0|||
124622347|NCT04895982|448230610|FG006|Overall Study|Refused further study procedures|0|||
124622348|NCT04895982|448230611|FG007|Overall Study|Refused further study procedures|0|||
124622349|NCT04895982|448230612|FG008|Overall Study|Refused further study procedures|0|||
124622350|NCT04895982|448230613|FG009|Overall Study|Refused further study procedures|0|||
124622351|NCT04895982|448230614|FG010|Overall Study|Refused further study procedures|0|||
124622352|NCT04895982|448230615|FG011|Overall Study|Refused further study procedures|0|||
124622353|NCT01893346|448230616|FG000|Overall Study|Lost to Follow-up|0|||
124622354|NCT01893346|448230617|FG001|Overall Study|Lost to Follow-up|1|||
124622355|NCT01893346|448230618|FG002|Overall Study|Lost to Follow-up|0|||
124622356|NCT01893346|448230619|FG003|Overall Study|Lost to Follow-up|0|||
124622357|NCT01893346|448230616|FG000|Overall Study|Protocol Violation|1|||
124622358|NCT01893346|448230617|FG001|Overall Study|Protocol Violation|0|||
124622359|NCT01893346|448230618|FG002|Overall Study|Protocol Violation|0|||
124622360|NCT01893346|448230619|FG003|Overall Study|Protocol Violation|0|||
124622361|NCT01893346|448230616|FG000|Overall Study|Withdrawal by Subject|2|||
124622362|NCT01893346|448230617|FG001|Overall Study|Withdrawal by Subject|0|||
124622363|NCT01893346|448230618|FG002|Overall Study|Withdrawal by Subject|0|||
124622364|NCT01893346|448230619|FG003|Overall Study|Withdrawal by Subject|0|||
124622365|NCT01449812|448230622|FG000|Overall Study|Migrated/moved from study area|1|||
124622366|NCT01449812|448230623|FG001|Overall Study|Migrated/moved from study area|0|||
124622367|NCT01449812|448230624|FG002|Overall Study|Migrated/moved from study area|0|||
124622368|NCT01449812|448230622|FG000|Overall Study|Withdrawal by Subject|0|||
124622369|NCT01449812|448230623|FG001|Overall Study|Withdrawal by Subject|0|||
124622370|NCT01449812|448230624|FG002|Overall Study|Withdrawal by Subject|1|||
124622371|NCT01449812|448230622|FG000|Overall Study|Lost to Follow-up|1|||
124622372|NCT01449812|448230623|FG001|Overall Study|Lost to Follow-up|0|||
124622373|NCT01449812|448230624|FG002|Overall Study|Lost to Follow-up|0|||
124622374|NCT01866098|448230625|FG000|Overall Study|Lost to Follow-up|11|||
124622375|NCT01866098|448230626|FG001|Overall Study|Lost to Follow-up|18|||
124622376|NCT01866098|448230627|FG002|Overall Study|Lost to Follow-up|13|||
124622377|NCT01866098|448230625|FG000|Overall Study|Physician Decision|0|||
124622378|NCT01866098|448230626|FG001|Overall Study|Physician Decision|1|||
124622379|NCT01866098|448230627|FG002|Overall Study|Physician Decision|2|||
124622380|NCT01866098|448230625|FG000|Overall Study|Adverse Event|1|||
124622381|NCT01866098|448230626|FG001|Overall Study|Adverse Event|5|||
124622382|NCT01866098|448230627|FG002|Overall Study|Adverse Event|4|||
124622383|NCT01866098|448230625|FG000|Overall Study|Protocol Violation|1|||
124622384|NCT01866098|448230626|FG001|Overall Study|Protocol Violation|0|||
124622385|NCT01866098|448230627|FG002|Overall Study|Protocol Violation|0|||
124622386|NCT01866098|448230625|FG000|Overall Study|Withdrawal by Subject|1|||
124622387|NCT01866098|448230626|FG001|Overall Study|Withdrawal by Subject|2|||
124622388|NCT01866098|448230627|FG002|Overall Study|Withdrawal by Subject|0|||
124622389|NCT01866098|448230625|FG000|Overall Study|Unrelated Hospitalization|2|||
124622390|NCT01866098|448230626|FG001|Overall Study|Unrelated Hospitalization|0|||
124622391|NCT01866098|448230627|FG002|Overall Study|Unrelated Hospitalization|1|||
124622392|NCT01866098|448230625|FG000|Overall Study|Non-compliance|1|||
124622393|NCT01866098|448230626|FG001|Overall Study|Non-compliance|0|||
124622394|NCT01866098|448230627|FG002|Overall Study|Non-compliance|1|||
124622395|NCT01866098|448230625|FG000|Overall Study|Pregnancy|2|||
124622396|NCT01866098|448230626|FG001|Overall Study|Pregnancy|0|||
124622397|NCT01866098|448230627|FG002|Overall Study|Pregnancy|0|||
124622398|NCT01866098|448230625|FG000|Overall Study|Death|0|||
124622399|NCT01866098|448230626|FG001|Overall Study|Death|1|||
124622400|NCT01866098|448230627|FG002|Overall Study|Death|0|||
124622401|NCT04239027|448230628|FG000|Overall Study|Adverse Event|4|||
124622402|NCT04239027|448230628|FG000|Overall Study|Withdrawal by Subject|9|||
124622403|NCT04239027|448230628|FG000|Overall Study|Death|1|||
124622404|NCT04239027|448230628|FG000|Overall Study|Physician Decision|9|||
124622405|NCT04239027|448230628|FG000|Overall Study|Lost to Follow-up|2|||
124622406|NCT04239027|448230628|FG000|Overall Study|Lack of Efficacy|1|||
124622407|NCT03449446|448230629|FG000|Overall Study|Randomized but Never Treated|0|||
124622408|NCT03449446|448230630|FG001|Overall Study|Randomized but Never Treated|0|||
124622409|NCT03449446|448230631|FG002|Overall Study|Randomized but Never Treated|1|||
124622410|NCT03449446|448230632|FG003|Overall Study|Randomized but Never Treated|1|||
124622411|NCT03449446|448230633|FG004|Overall Study|Randomized but Never Treated|1|||
124622412|NCT03449446|448230634|FG005|Overall Study|Randomized but Never Treated|0|||
124622413|NCT03449446|448230635|FG006|Overall Study|Randomized but Never Treated|0|||
124622414|NCT03449446|448230629|FG000|Overall Study|Unknown Reason|33|||
124622415|NCT03449446|448230630|FG001|Overall Study|Unknown Reason|1|||
124622416|NCT03449446|448230631|FG002|Overall Study|Unknown Reason|1|||
124622417|NCT03449446|448230632|FG003|Overall Study|Unknown Reason|1|||
124751964|NCT06312592|448714214|FG001|Overall Study|Lost to Follow-up|13|||
124751965|NCT01858766|448714215|FG000|Overall Study|Randomized but Never Treated|0|||
124751966|NCT01858766|448714216|FG001|Overall Study|Randomized but Never Treated|0|||
124751967|NCT01858766|448714217|FG002|Overall Study|Randomized but Never Treated|0|||
124751968|NCT01858766|448714218|FG003|Overall Study|Randomized but Never Treated|0|||
124751969|NCT01858766|448714219|FG004|Overall Study|Randomized but Never Treated|0|||
124751970|NCT01858766|448714220|FG005|Overall Study|Randomized but Never Treated|1|||
124751971|NCT01858766|448714221|FG006|Overall Study|Randomized but Never Treated|0|||
124751972|NCT01858766|448714222|FG007|Overall Study|Randomized but Never Treated|0|||
124751973|NCT01858766|448714223|FG008|Overall Study|Randomized but Never Treated|0|||
124751974|NCT01858766|448714224|FG009|Overall Study|Randomized but Never Treated|0|||
124751975|NCT01858766|448714225|FG010|Overall Study|Randomized but Never Treated|0|||
124751976|NCT01858766|448714226|FG011|Overall Study|Randomized but Never Treated|0|||
124751977|NCT01858766|448714227|FG012|Overall Study|Randomized but Never Treated|0|||
124751978|NCT01858766|448714228|FG013|Overall Study|Randomized but Never Treated|0|||
124751979|NCT01858766|448714229|FG014|Overall Study|Randomized but Never Treated|0|||
124751980|NCT01858766|448714230|FG015|Overall Study|Randomized but Never Treated|0|||
124751981|NCT01858766|448714231|FG016|Overall Study|Randomized but Never Treated|0|||
124783363|NCT01124864|448838087|FG005|Overall Study|Protocol Violation|0|||
124622418|NCT03449446|448230633|FG004|Overall Study|Unknown Reason|2|||
124783364|NCT01243242|448838088|FG000|Overall Study|Adverse Event|1|||
124622419|NCT03449446|448230634|FG005|Overall Study|Unknown Reason|2|||
124622420|NCT03449446|448230635|FG006|Overall Study|Unknown Reason|0|||
124622421|NCT03449446|448230629|FG000|Overall Study|Withdrew Consent|1|||
124622422|NCT03449446|448230630|FG001|Overall Study|Withdrew Consent|3|||
124622423|NCT03449446|448230631|FG002|Overall Study|Withdrew Consent|1|||
124622424|NCT03449446|448230632|FG003|Overall Study|Withdrew Consent|4|||
124622425|NCT03449446|448230633|FG004|Overall Study|Withdrew Consent|4|||
124622426|NCT03449446|448230634|FG005|Overall Study|Withdrew Consent|4|||
124622427|NCT03449446|448230635|FG006|Overall Study|Withdrew Consent|1|||
124622428|NCT03449446|448230629|FG000|Overall Study|Adverse Event|1|||
124622429|NCT03449446|448230630|FG001|Overall Study|Adverse Event|2|||
124622430|NCT03449446|448230631|FG002|Overall Study|Adverse Event|1|||
124622431|NCT03449446|448230632|FG003|Overall Study|Adverse Event|0|||
124622432|NCT03449446|448230633|FG004|Overall Study|Adverse Event|0|||
124622433|NCT03449446|448230634|FG005|Overall Study|Adverse Event|2|||
124622434|NCT03449446|448230635|FG006|Overall Study|Adverse Event|0|||
124622435|NCT03449446|448230629|FG000|Overall Study|Lost to Follow-up|0|||
124622436|NCT03449446|448230630|FG001|Overall Study|Lost to Follow-up|0|||
124622437|NCT03449446|448230631|FG002|Overall Study|Lost to Follow-up|2|||
124622438|NCT03449446|448230632|FG003|Overall Study|Lost to Follow-up|1|||
124622439|NCT03449446|448230633|FG004|Overall Study|Lost to Follow-up|3|||
124622440|NCT03449446|448230634|FG005|Overall Study|Lost to Follow-up|0|||
124622441|NCT03449446|448230635|FG006|Overall Study|Lost to Follow-up|0|||
124622442|NCT03449446|448230629|FG000|Overall Study|Investigator's Discretion|0|||
124622443|NCT03449446|448230630|FG001|Overall Study|Investigator's Discretion|1|||
124622444|NCT03449446|448230631|FG002|Overall Study|Investigator's Discretion|1|||
124622445|NCT03449446|448230632|FG003|Overall Study|Investigator's Discretion|2|||
124622446|NCT03449446|448230633|FG004|Overall Study|Investigator's Discretion|0|||
124622447|NCT03449446|448230634|FG005|Overall Study|Investigator's Discretion|0|||
124622448|NCT03449446|448230635|FG006|Overall Study|Investigator's Discretion|0|||
124622449|NCT03449446|448230629|FG000|Overall Study|Non Compliance with Study Drug|1|||
124622450|NCT03449446|448230630|FG001|Overall Study|Non Compliance with Study Drug|0|||
124622451|NCT03449446|448230631|FG002|Overall Study|Non Compliance with Study Drug|0|||
124622452|NCT03449446|448230632|FG003|Overall Study|Non Compliance with Study Drug|0|||
124622453|NCT03449446|448230633|FG004|Overall Study|Non Compliance with Study Drug|0|||
124622454|NCT03449446|448230634|FG005|Overall Study|Non Compliance with Study Drug|0|||
124622455|NCT03449446|448230635|FG006|Overall Study|Non Compliance with Study Drug|0|||
124622456|NCT03449446|448230629|FG000|Overall Study|Protocol Violation|0|||
124622457|NCT03449446|448230630|FG001|Overall Study|Protocol Violation|0|||
124622458|NCT03449446|448230631|FG002|Overall Study|Protocol Violation|0|||
124622459|NCT03449446|448230632|FG003|Overall Study|Protocol Violation|0|||
124622460|NCT03449446|448230633|FG004|Overall Study|Protocol Violation|1|||
124622461|NCT03449446|448230634|FG005|Overall Study|Protocol Violation|1|||
124622462|NCT03449446|448230635|FG006|Overall Study|Protocol Violation|0|||
124622463|NCT03449446|448230629|FG000|Overall Study|Death|0|||
124622464|NCT03449446|448230630|FG001|Overall Study|Death|0|||
124622465|NCT03449446|448230631|FG002|Overall Study|Death|0|||
124622466|NCT03449446|448230632|FG003|Overall Study|Death|0|||
124622467|NCT03449446|448230633|FG004|Overall Study|Death|1|||
124622468|NCT03449446|448230634|FG005|Overall Study|Death|0|||
124622469|NCT03449446|448230635|FG006|Overall Study|Death|0|||
124622470|NCT02839707|448230642|FG000|Phase I|Not eligible for analysis|9|||
124622471|NCT02839707|448230643|FG001|Phase I|Not eligible for analysis|0|||
124622472|NCT02839707|448230644|FG002|Phase I|Not eligible for analysis|0|||
124622473|NCT02839707|448230642|FG000|Phase II|Not treated according to protocol|4|||
124622474|NCT02839707|448230643|FG001|Phase II|Not treated according to protocol|0|||
124622475|NCT02839707|448230644|FG002|Phase II|Not treated according to protocol|2|||
124622476|NCT02839707|448230642|FG000|Phase III|Not treated according to protocol|0|||
124622477|NCT02839707|448230643|FG001|Phase III|Not treated according to protocol|0|||
124622478|NCT02839707|448230644|FG002|Phase III|Not treated according to protocol|4|||
124622479|NCT01950390|448230645|FG000|Overall Study|Never started treatment|3|||
124622480|NCT01950390|448230646|FG001|Overall Study|Never started treatment|2|||
124622481|NCT01950390|448230645|FG000|Overall Study|Disease progression|45|||
124622482|NCT01950390|448230646|FG001|Overall Study|Disease progression|52|||
124622483|NCT01950390|448230645|FG000|Overall Study|Adverse Event|22|||
124622484|NCT01950390|448230646|FG001|Overall Study|Adverse Event|16|||
124622485|NCT01950390|448230645|FG000|Overall Study|Death|5|||
124622486|NCT01950390|448230646|FG001|Overall Study|Death|3|||
124622487|NCT01950390|448230645|FG000|Overall Study|Withdrawal by Subject|5|||
124622488|NCT01950390|448230646|FG001|Overall Study|Withdrawal by Subject|1|||
124622489|NCT01950390|448230645|FG000|Overall Study|Alternative therapy|0|||
124622490|NCT01950390|448230646|FG001|Overall Study|Alternative therapy|3|||
124622491|NCT01950390|448230645|FG000|Overall Study|Complicating disease|1|||
124622492|NCT01950390|448230646|FG001|Overall Study|Complicating disease|0|||
124622493|NCT01950390|448230645|FG000|Overall Study|On treatment|1|||
124622494|NCT01950390|448230646|FG001|Overall Study|On treatment|0|||
124622495|NCT01950390|448230645|FG000|Overall Study|Symptomatic deterioration|2|||
124622496|NCT01950390|448230646|FG001|Overall Study|Symptomatic deterioration|1|||
124622497|NCT01950390|448230645|FG000|Overall Study|Physician Decision|0|||
124622498|NCT01950390|448230646|FG001|Overall Study|Physician Decision|4|||
124622499|NCT01950390|448230645|FG000|Overall Study|Lack of clinical benefit|0|||
124622500|NCT01950390|448230646|FG001|Overall Study|Lack of clinical benefit|1|||
124622501|NCT01950390|448230645|FG000|Overall Study|Maintained PR and moved to observation only|0|||
124622502|NCT01950390|448230646|FG001|Overall Study|Maintained PR and moved to observation only|1|||
124622503|NCT01059786|448232355|FG000|Overall Study|Did not receive 6 cycles.|0|||
124622504|NCT01059786|448232356|FG001|Overall Study|Did not receive 6 cycles.|0|||
124622505|NCT01059786|448232357|FG002|Overall Study|Did not receive 6 cycles.|4|||
124622506|NCT01059786|448232358|FG003|Overall Study|Did not receive 6 cycles.|1|||
124622507|NCT01059786|448232359|FG004|Overall Study|Did not receive 6 cycles.|0|||
124622508|NCT02586688|448232361|FG000|Overall Study|Lost to Follow-up|2|||
124622509|NCT02586688|448232362|FG001|Overall Study|Lost to Follow-up|1|||
124622510|NCT02586688|448232361|FG000|Overall Study|Withdrawal by Subject|1|||
124622511|NCT02586688|448232362|FG001|Overall Study|Withdrawal by Subject|1|||
124622512|NCT02586688|448232361|FG000|Overall Study|Adverse Event|3|||
124622513|NCT02586688|448232362|FG001|Overall Study|Adverse Event|1|||
124622514|NCT02454608|448232363|FG000|Double-Blind Period|Lack of Efficacy|0|||
124622515|NCT02454608|448232364|FG001|Double-Blind Period|Lack of Efficacy|2|||
124622516|NCT02454608|448232365|FG002|Double-Blind Period|Lack of Efficacy|0|||
124622517|NCT02454608|448232363|FG000|Open Label Period|Lost to Follow-up|0|||
124622518|NCT02454608|448232364|FG001|Open Label Period|Lost to Follow-up|0|||
124622519|NCT02454608|448232365|FG002|Open Label Period|Lost to Follow-up|11|||
124622520|NCT02454608|448232363|FG000|Open Label Period|Withdrawal by Subject|0|||
124622521|NCT02454608|448232364|FG001|Open Label Period|Withdrawal by Subject|0|||
124622522|NCT02454608|448232365|FG002|Open Label Period|Withdrawal by Subject|8|||
124622523|NCT02969382|448232377|FG000|Overall Study|Adverse Event|8|||
124622524|NCT02969382|448232378|FG001|Overall Study|Adverse Event|10|||
124622525|NCT02969382|448232377|FG000|Overall Study|Lack of Efficacy|4|||
124622526|NCT02969382|448232378|FG001|Overall Study|Lack of Efficacy|5|||
124622527|NCT02969382|448232377|FG000|Overall Study|Death|0|||
124622528|NCT02969382|448232378|FG001|Overall Study|Death|1|||
124622529|NCT02969382|448232377|FG000|Overall Study|PROTOCOL DEVIATION|0|||
124622530|NCT02969382|448232378|FG001|Overall Study|PROTOCOL DEVIATION|1|||
124622531|NCT02969382|448232377|FG000|Overall Study|Withdrawal by Subject|14|||
124622532|NCT02969382|448232378|FG001|Overall Study|Withdrawal by Subject|9|||
124622533|NCT02847260|448232382|FG000|Overall Study|Adverse Event|3|||
124622534|NCT02847260|448232382|FG000|Overall Study|Withdrawal by Subject|2|||
124622535|NCT02847260|448232382|FG000|Overall Study|Clinical Deterioration|1|||
124622536|NCT02847260|448232382|FG000|Overall Study|Physician Decision|1|||
124622537|NCT00886015|448232385|FG000|Overall Study|Death|0|||
124622538|NCT00886015|448232386|FG001|Overall Study|Death|2|||
124622539|NCT01692626|448232387|FG000|Overall Study|Death|0|||
124622540|NCT01692626|448232388|FG001|Overall Study|Death|1|||
124622541|NCT01692626|448232387|FG000|Overall Study|Adverse Event|2|||
124622542|NCT01692626|448232388|FG001|Overall Study|Adverse Event|3|||
124622543|NCT01692626|448232387|FG000|Overall Study|Protocol Violation|1|||
124622544|NCT01692626|448232388|FG001|Overall Study|Protocol Violation|2|||
124622545|NCT01692626|448232387|FG000|Overall Study|Withdrawal by Subject|1|||
124622546|NCT01692626|448232388|FG001|Overall Study|Withdrawal by Subject|0|||
124622547|NCT00855894|448232389|FG000|Overall Study|Death|31|||
124622548|NCT00855894|448232389|FG000|Overall Study|Patient's decision|1|||
124622549|NCT00855894|448232389|FG000|Overall Study|Disease progression|1|||
124622550|NCT00444587|448232399|FG000|Overall Study|Death|2|||
124622551|NCT00444587|448232400|FG001|Overall Study|Death|1|||
124622552|NCT00444587|448232399|FG000|Overall Study|Progression of the disease|73|||
124622553|NCT00444587|448232400|FG001|Overall Study|Progression of the disease|8|||
124622554|NCT00444587|448232399|FG000|Overall Study|Refused treatment/did not cooperate|4|||
124622555|NCT00444587|448232400|FG001|Overall Study|Refused treatment/did not cooperate|1|||
124622556|NCT00444587|448232399|FG000|Overall Study|Investigator decision|3|||
124622557|NCT00444587|448232400|FG001|Overall Study|Investigator decision|0|||
124622558|NCT00444587|448232399|FG000|Overall Study|Protocol Violation|1|||
124622559|NCT00444587|448232400|FG001|Overall Study|Protocol Violation|0|||
124622560|NCT00444587|448232399|FG000|Overall Study|Missing|0|||
124622561|NCT00444587|448232400|FG001|Overall Study|Missing|5|||
124622562|NCT01720225|448232409|FG000|Overall Study|Withdrawal by Subject|0|||
124622563|NCT01720225|448232410|FG001|Overall Study|Withdrawal by Subject|1|||
124622564|NCT01720225|448232409|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
124622565|NCT01720225|448232410|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
124622566|NCT01473407|448232411|FG000|Overall Study|Physician Decision|1|||
124622567|NCT01473407|448232412|FG001|Overall Study|Physician Decision|4|||
124622568|NCT01473407|448232411|FG000|Overall Study|Lost to Follow-up|10|||
124622569|NCT01473407|448232412|FG001|Overall Study|Lost to Follow-up|4|||
124622570|NCT01473407|448232411|FG000|Overall Study|Adverse Event|8|||
124783365|NCT01243242|448838089|FG001|Overall Study|Adverse Event|1|||
124622571|NCT01473407|448232412|FG001|Overall Study|Adverse Event|8|||
124622572|NCT01473407|448232411|FG000|Overall Study|Randomization Error|3|||
124783366|NCT01243242|448838088|FG000|Overall Study|Withdrawal by Subject|1|||
124622573|NCT01473407|448232412|FG001|Overall Study|Randomization Error|1|||
124622574|NCT01473407|448232411|FG000|Overall Study|Withdrawal by Subject|4|||
124783367|NCT01243242|448838089|FG001|Overall Study|Withdrawal by Subject|1|||
124622575|NCT01473407|448232412|FG001|Overall Study|Withdrawal by Subject|7|||
124622576|NCT01473407|448232411|FG000|Overall Study|Kidney Transplant|7|||
124622577|NCT01473407|448232412|FG001|Overall Study|Kidney Transplant|6|||
124622578|NCT01473407|448232411|FG000|Overall Study|Vacation/Travel|1|||
124622579|NCT01473407|448232412|FG001|Overall Study|Vacation/Travel|1|||
124622580|NCT01473407|448232411|FG000|Overall Study|Elevated Hemoglobin|1|||
124622581|NCT01473407|448232412|FG001|Overall Study|Elevated Hemoglobin|0|||
124622582|NCT01473407|448232411|FG000|Overall Study|Patient Received Aranesp|1|||
124622583|NCT01473407|448232412|FG001|Overall Study|Patient Received Aranesp|0|||
124622584|NCT01473407|448232411|FG000|Overall Study|Patient Lost Green Card Status|1|||
124622585|NCT01473407|448232412|FG001|Overall Study|Patient Lost Green Card Status|0|||
124622586|NCT01473407|448232411|FG000|Overall Study|Temperature Excursion|2|||
124622587|NCT01473407|448232412|FG001|Overall Study|Temperature Excursion|3|||
124622588|NCT01473407|448232411|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
124622589|NCT01473407|448232412|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
124622590|NCT01473407|448232411|FG000|Overall Study|Sponsor's Decision|10|||
124622591|NCT01473407|448232412|FG001|Overall Study|Sponsor's Decision|10|||
124622592|NCT01473407|448232411|FG000|Overall Study|Site Closure|1|||
124622593|NCT01473407|448232412|FG001|Overall Study|Site Closure|0|||
124622594|NCT04071405|448232413|FG000|Overall Study|Protocol Violation|3|||
124622595|NCT02422797|448232414|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
124622596|NCT02422797|448232415|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
124622597|NCT02422797|448232414|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
124622598|NCT02422797|448232415|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
124622599|NCT02422797|448232414|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
124622600|NCT02422797|448232415|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
124622601|NCT02422797|448232414|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
124622602|NCT02422797|448232415|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
124622603|NCT02422797|448232414|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
124622604|NCT02422797|448232415|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
124622605|NCT02422797|448232414|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
124622606|NCT02422797|448232415|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
124622607|NCT02422797|448232414|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
124622608|NCT02422797|448232415|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
124622609|NCT02422797|448232414|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
124622610|NCT02422797|448232415|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
124622611|NCT02422797|448232414|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
124622612|NCT02422797|448232415|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
124622613|NCT02422797|448232414|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
124622614|NCT02422797|448232415|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
124622615|NCT02422797|448232414|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
124622616|NCT02422797|448232415|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
124622617|NCT02422797|448232414|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
124622618|NCT02422797|448232415|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
124622619|NCT02422797|448232414|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
124622620|NCT02422797|448232415|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
124622621|NCT02422797|448232414|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
124622622|NCT02422797|448232415|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
124622623|NCT02422797|448232414|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
124622624|NCT02422797|448232415|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
124622625|NCT02422797|448232414|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
124783368|NCT01243242|448838088|FG000|Overall Study|Physician Decision|0|||
124783369|NCT01243242|448838089|FG001|Overall Study|Physician Decision|1|||
124783370|NCT01243242|448838088|FG000|Overall Study|sponsor decision|0|||
124783371|NCT01243242|448838089|FG001|Overall Study|sponsor decision|1|||
124783372|NCT01243242|448838088|FG000|Overall Study|non compliance|1|||
124783373|NCT01243242|448838089|FG001|Overall Study|non compliance|0|||
124783374|NCT00724711|448838090|FG000|Overall Study|Adverse Event|7|||
124783375|NCT00724711|448838091|FG001|Overall Study|Adverse Event|3|||
124783376|NCT00724711|448838090|FG000|Overall Study|Pregnancy|0|||
124783377|NCT00724711|448838091|FG001|Overall Study|Pregnancy|1|||
124783378|NCT00724711|448838090|FG000|Overall Study|Lack of Efficacy|0|||
124783379|NCT00724711|448838091|FG001|Overall Study|Lack of Efficacy|1|||
124783380|NCT00724711|448838090|FG000|Overall Study|Physician Decision|0|||
124783381|NCT00724711|448838091|FG001|Overall Study|Physician Decision|3|||
124783382|NCT00724711|448838090|FG000|Overall Study|Withdrawal by Subject|5|||
124783383|NCT00724711|448838091|FG001|Overall Study|Withdrawal by Subject|4|||
124783384|NCT00724711|448838090|FG000|Overall Study|Lost to Follow-up|4|||
124783385|NCT00724711|448838091|FG001|Overall Study|Lost to Follow-up|5|||
124783386|NCT00724711|448838090|FG000|Overall Study|Protocol Violation|1|||
124783387|NCT00724711|448838091|FG001|Overall Study|Protocol Violation|0|||
124783388|NCT01945710|448838092|FG000|Overall Study|Progressive Disease|5|||
124783389|NCT01945710|448838093|FG001|Overall Study|Progressive Disease|4|||
124783390|NCT01945710|448838094|FG002|Overall Study|Progressive Disease|3|||
124783391|NCT01945710|448838095|FG003|Overall Study|Progressive Disease|2|||
124783392|NCT01945710|448838096|FG004|Overall Study|Progressive Disease|7|||
124622626|NCT02422797|448232415|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
124622627|NCT02422797|448232414|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
124622628|NCT02422797|448232415|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
124622629|NCT02422797|448232414|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
124622630|NCT02422797|448232415|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
124622631|NCT02422797|448232414|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
124622632|NCT02422797|448232415|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
124622633|NCT02422797|448232414|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
124622634|NCT02422797|448232415|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
124622635|NCT02422797|448232414|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
124622636|NCT02422797|448232415|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
124622637|NCT00369941|448232416|FG000|Overall Study|Never Treated|1|||
124622638|NCT00369941|448232417|FG001|Overall Study|Never Treated|2|||
124622639|NCT00369941|448232416|FG000|Overall Study|Adverse Event|14|||
124622640|NCT00369941|448232417|FG001|Overall Study|Adverse Event|28|||
124622641|NCT00369941|448232416|FG000|Overall Study|Lack of Efficacy|6|||
124622642|NCT00369941|448232417|FG001|Overall Study|Lack of Efficacy|10|||
124622643|NCT00369941|448232416|FG000|Overall Study|Lost to Follow-up|12|||
124622644|NCT00369941|448232417|FG001|Overall Study|Lost to Follow-up|22|||
124622645|NCT00369941|448232416|FG000|Overall Study|Protocol Violation|5|||
124622646|NCT00369941|448232417|FG001|Overall Study|Protocol Violation|3|||
124622647|NCT00369941|448232416|FG000|Overall Study|Withdrawal by Subject|5|||
124622648|NCT00369941|448232417|FG001|Overall Study|Withdrawal by Subject|18|||
124622649|NCT00369941|448232416|FG000|Overall Study|Pregnancy|4|||
124622650|NCT00369941|448232417|FG001|Overall Study|Pregnancy|2|||
124622651|NCT00369941|448232416|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
124622652|NCT00369941|448232417|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
124622653|NCT00369941|448232416|FG000|Overall Study|Moved|11|||
124622654|NCT00369941|448232417|FG001|Overall Study|Moved|5|||
124622655|NCT00369941|448232416|FG000|Overall Study|Treatment with Prohibited Medication|3|||
124622656|NCT00369941|448232417|FG001|Overall Study|Treatment with Prohibited Medication|1|||
124622657|NCT00369941|448232416|FG000|Overall Study|Employment Interfered with Study Visits|1|||
124622658|NCT00369941|448232417|FG001|Overall Study|Employment Interfered with Study Visits|0|||
124622659|NCT00369941|448232416|FG000|Overall Study|Study Site Terminated|2|||
124622660|NCT00369941|448232417|FG001|Overall Study|Study Site Terminated|0|||
124622661|NCT00369941|448232416|FG000|Overall Study|Miscellaneous|3|||
124622662|NCT00369941|448232417|FG001|Overall Study|Miscellaneous|3|||
124622663|NCT01027702|448232418|FG000|Overall Study|Received subsequent therapy|1|||
124622664|NCT01027702|448232419|FG001|Overall Study|Received subsequent therapy|2|||
124622665|NCT01027702|448232420|FG002|Overall Study|Received subsequent therapy|0|||
124622666|NCT01027702|448232421|FG003|Overall Study|Received subsequent therapy|4|||
124622667|NCT01027702|448232422|FG004|Overall Study|Received subsequent therapy|1|||
124622668|NCT01027702|448232423|FG005|Overall Study|Received subsequent therapy|0|||
124622669|NCT01027702|448232424|FG006|Overall Study|Received subsequent therapy|1|||
124622670|NCT01027702|448232418|FG000|Overall Study|Death|0|||
124622671|NCT01027702|448232419|FG001|Overall Study|Death|0|||
124622672|NCT01027702|448232420|FG002|Overall Study|Death|1|||
124622673|NCT01027702|448232421|FG003|Overall Study|Death|0|||
124622674|NCT01027702|448232422|FG004|Overall Study|Death|0|||
124622675|NCT01027702|448232423|FG005|Overall Study|Death|0|||
124622676|NCT01027702|448232424|FG006|Overall Study|Death|0|||
124622677|NCT00403585|448232425|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
124622678|NCT00403585|448232425|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
124622679|NCT00403585|448232425|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
124622680|NCT02964312|448232434|FG000|Overall Study|Lost to Follow-up|28|||
124622681|NCT02964312|448232434|FG000|Overall Study|Withdrawal by Subject|11|||
124622682|NCT02964312|448232434|FG000|Overall Study|Lack of Efficacy|10|||
124622683|NCT02964312|448232434|FG000|Overall Study|Did not consent to long-term FU|14|||
124622684|NCT02964312|448232434|FG000|Overall Study|Death|1|||
124622685|NCT02276807|448232435|FG000|Overall Study|Withdrawal by Subject|8|||
124622686|NCT02276807|448232436|FG001|Overall Study|Withdrawal by Subject|7|||
124622687|NCT02276807|448232435|FG000|Overall Study|Lost to Follow-up|10|||
124622688|NCT02276807|448232436|FG001|Overall Study|Lost to Follow-up|10|||
124622689|NCT01023035|448232438|FG000|Treatment Period|Adverse Event|27|||
124622690|NCT01023035|448232439|FG001|Treatment Period|Adverse Event|32|||
124622691|NCT01023035|448232440|FG002|Treatment Period|Adverse Event|50|||
124622692|NCT01023035|448232438|FG000|Treatment Period|Non-Medical Reasons|19|||
124622693|NCT01023035|448232439|FG001|Treatment Period|Non-Medical Reasons|22|||
124622694|NCT01023035|448232440|FG002|Treatment Period|Non-Medical Reasons|44|||
124622695|NCT01023035|448232438|FG000|Treatment Period|Treatment Failure|26|||
124622696|NCT01023035|448232439|FG001|Treatment Period|Treatment Failure|31|||
124622697|NCT01023035|448232440|FG002|Treatment Period|Treatment Failure|24|||
124622698|NCT01023035|448232438|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
124622699|NCT01023035|448232439|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
124622700|NCT01023035|448232440|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
124622701|NCT01023035|448232438|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
124622702|NCT01023035|448232439|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
124622703|NCT01023035|448232440|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
124622704|NCT00524420|448232441|FG000|Overall Study|Lack of Efficacy|1|||
124622705|NCT00524420|448232442|FG001|Overall Study|Lack of Efficacy|0|||
124622706|NCT01090414|448232443|FG000|Study 101-99|Progressive Disease|28|||
124622707|NCT01090414|448232444|FG001|Study 101-99|Progressive Disease|48|||
124622708|NCT01090414|448232445|FG002|Study 101-99|Progressive Disease|10|||
124622709|NCT01090414|448232446|FG003|Study 101-99|Progressive Disease|4|||
124622710|NCT01090414|448232443|FG000|Study 101-99|Adverse Event|10|||
124622711|NCT01090414|448232444|FG001|Study 101-99|Adverse Event|28|||
124622712|NCT01090414|448232445|FG002|Study 101-99|Adverse Event|18|||
124622713|NCT01090414|448232446|FG003|Study 101-99|Adverse Event|0|||
124622714|NCT01090414|448232443|FG000|Study 101-99|Investigator Request|1|||
124622715|NCT01090414|448232444|FG001|Study 101-99|Investigator Request|11|||
124622716|NCT01090414|448232445|FG002|Study 101-99|Investigator Request|4|||
124622717|NCT01090414|448232446|FG003|Study 101-99|Investigator Request|0|||
124622718|NCT01090414|448232443|FG000|Study 101-99|Death|3|||
124622719|NCT01090414|448232444|FG001|Study 101-99|Death|8|||
124622720|NCT01090414|448232445|FG002|Study 101-99|Death|1|||
124622721|NCT01090414|448232446|FG003|Study 101-99|Death|0|||
124622722|NCT01090414|448232443|FG000|Study 101-99|Sponsor Discontinued Study|0|||
124622723|NCT01090414|448232444|FG001|Study 101-99|Sponsor Discontinued Study|7|||
124622724|NCT01090414|448232445|FG002|Study 101-99|Sponsor Discontinued Study|5|||
124622725|NCT01090414|448232446|FG003|Study 101-99|Sponsor Discontinued Study|0|||
124622726|NCT01090414|448232443|FG000|Study 101-99|Other (Unknown Reasons)|3|||
124622727|NCT01090414|448232444|FG001|Study 101-99|Other (Unknown Reasons)|3|||
124622728|NCT01090414|448232445|FG002|Study 101-99|Other (Unknown Reasons)|0|||
124622729|NCT01090414|448232446|FG003|Study 101-99|Other (Unknown Reasons)|0|||
124622730|NCT01090414|448232443|FG000|Study 101-99|Withdrew Consent|0|||
124622731|NCT01090414|448232444|FG001|Study 101-99|Withdrew Consent|2|||
124622732|NCT01090414|448232445|FG002|Study 101-99|Withdrew Consent|3|||
124622733|NCT01090414|448232446|FG003|Study 101-99|Withdrew Consent|1|||
124622734|NCT01090414|448232443|FG000|Study 101-99|Participant Request|3|||
124622735|NCT01090414|448232444|FG001|Study 101-99|Participant Request|1|||
124622736|NCT01090414|448232445|FG002|Study 101-99|Participant Request|0|||
124622737|NCT01090414|448232446|FG003|Study 101-99|Participant Request|0|||
124622738|NCT02413229|448232456|FG000|Overall Study|Adverse Event|0|||
124622739|NCT02413229|448232457|FG001|Overall Study|Adverse Event|0|||
124622740|NCT02413229|448232458|FG002|Overall Study|Adverse Event|0|||
124622741|NCT02413229|448232459|FG003|Overall Study|Adverse Event|1|||
124622742|NCT02413229|448232460|FG004|Overall Study|Adverse Event|0|||
124622743|NCT02413229|448232461|FG005|Overall Study|Adverse Event|0|||
124622744|NCT02413229|448232462|FG006|Overall Study|Adverse Event|0|||
124622745|NCT02413229|448232463|FG007|Overall Study|Adverse Event|1|||
124622746|NCT02413229|448232456|FG000|Overall Study|Lost to Follow-up|0|||
124622747|NCT02413229|448232457|FG001|Overall Study|Lost to Follow-up|0|||
124622748|NCT02413229|448232458|FG002|Overall Study|Lost to Follow-up|1|||
124622749|NCT02413229|448232459|FG003|Overall Study|Lost to Follow-up|0|||
124622750|NCT02413229|448232460|FG004|Overall Study|Lost to Follow-up|2|||
124622751|NCT02413229|448232461|FG005|Overall Study|Lost to Follow-up|0|||
124622752|NCT02413229|448232462|FG006|Overall Study|Lost to Follow-up|0|||
124622753|NCT02413229|448232463|FG007|Overall Study|Lost to Follow-up|0|||
124622754|NCT02413229|448232456|FG000|Overall Study|Withdrawal by Subject|1|||
124622755|NCT02413229|448232457|FG001|Overall Study|Withdrawal by Subject|1|||
124622756|NCT02413229|448232458|FG002|Overall Study|Withdrawal by Subject|0|||
124622757|NCT02413229|448232459|FG003|Overall Study|Withdrawal by Subject|0|||
124622758|NCT02413229|448232460|FG004|Overall Study|Withdrawal by Subject|1|||
124622759|NCT02413229|448232461|FG005|Overall Study|Withdrawal by Subject|0|||
124622760|NCT02413229|448232462|FG006|Overall Study|Withdrawal by Subject|0|||
124622761|NCT02413229|448232463|FG007|Overall Study|Withdrawal by Subject|2|||
124622762|NCT02413229|448232456|FG000|Overall Study|Progressive Disease|0|||
124622763|NCT02413229|448232457|FG001|Overall Study|Progressive Disease|0|||
124622764|NCT02413229|448232458|FG002|Overall Study|Progressive Disease|0|||
124622765|NCT02413229|448232459|FG003|Overall Study|Progressive Disease|0|||
124622766|NCT02413229|448232460|FG004|Overall Study|Progressive Disease|0|||
124622767|NCT02413229|448232461|FG005|Overall Study|Progressive Disease|0|||
124622768|NCT02413229|448232462|FG006|Overall Study|Progressive Disease|0|||
124622769|NCT02413229|448232463|FG007|Overall Study|Progressive Disease|1|||
124622770|NCT02932462|448232464|FG000|Overall Study|Adverse Event|1|||
124622771|NCT02932462|448232465|FG001|Overall Study|Adverse Event|2|||
124622772|NCT02932462|448232464|FG000|Overall Study|Lost to Follow-up|4|||
124622773|NCT02932462|448232465|FG001|Overall Study|Lost to Follow-up|1|||
124622774|NCT02932462|448232464|FG000|Overall Study|Protocol Violation|0|||
124622775|NCT02932462|448232465|FG001|Overall Study|Protocol Violation|5|||
124622776|NCT02932462|448232464|FG000|Overall Study|Withdrawal by Subject|1|||
124622777|NCT02932462|448232465|FG001|Overall Study|Withdrawal by Subject|4|||
124622778|NCT02932462|448232464|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124622779|NCT02932462|448232465|FG001|Overall Study|Non-Compliance With Study Drug|1|||
124622780|NCT02932462|448232464|FG000|Overall Study|Progressive Disease|1|||
124622781|NCT02932462|448232465|FG001|Overall Study|Progressive Disease|0|||
124622782|NCT02652949|448232466|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
124622783|NCT02652949|448232466|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
124622784|NCT02652949|448232466|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
124622785|NCT02652949|448232466|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
124622786|NCT02652949|448232466|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
124622787|NCT02652949|448232466|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
124622788|NCT02652949|448232466|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
124622789|NCT02652949|448232466|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
124622790|NCT02652949|448232466|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
124622791|NCT02652949|448232466|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
124622792|NCT02652949|448232466|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
124622793|NCT02652949|448232466|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
124622794|NCT02652949|448232466|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
124622795|NCT02652949|448232466|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
124622796|NCT02652949|448232466|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
124622797|NCT02652949|448232466|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
124622798|NCT02652949|448232466|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
124622799|NCT05219448|448232467|FG000|Overall Study|Lost to Follow-up|9|||
124622800|NCT05219448|448232468|FG001|Overall Study|Lost to Follow-up|0|||
124622801|NCT02287922|448232469|FG000|Overall Study|Adverse Event|1|||
124622802|NCT02287922|448232470|FG001|Overall Study|Adverse Event|1|||
124622803|NCT02287922|448232471|FG002|Overall Study|Adverse Event|3|||
124622804|NCT02287922|448232472|FG003|Overall Study|Adverse Event|4|||
124622805|NCT02287922|448232469|FG000|Overall Study|Withdrawal by Subject|1|||
124622806|NCT02287922|448232470|FG001|Overall Study|Withdrawal by Subject|1|||
124622807|NCT02287922|448232471|FG002|Overall Study|Withdrawal by Subject|1|||
124622808|NCT02287922|448232472|FG003|Overall Study|Withdrawal by Subject|2|||
124622809|NCT02287922|448232469|FG000|Overall Study|Lost to Follow-up|0|||
124622810|NCT02287922|448232470|FG001|Overall Study|Lost to Follow-up|0|||
124622811|NCT02287922|448232471|FG002|Overall Study|Lost to Follow-up|1|||
124622812|NCT02287922|448232472|FG003|Overall Study|Lost to Follow-up|0|||
124622813|NCT02287922|448232469|FG000|Overall Study|Sponsor's decision|0|||
124622814|NCT02287922|448232470|FG001|Overall Study|Sponsor's decision|0|||
124622815|NCT02287922|448232471|FG002|Overall Study|Sponsor's decision|0|||
124622816|NCT02287922|448232472|FG003|Overall Study|Sponsor's decision|1|||
124622817|NCT02287922|448232469|FG000|Overall Study|Other|1|||
124622818|NCT02287922|448232470|FG001|Overall Study|Other|0|||
124622819|NCT02287922|448232471|FG002|Overall Study|Other|2|||
124622820|NCT02287922|448232472|FG003|Overall Study|Other|0|||
124622821|NCT00668317|448232473|FG000|Overall Study|Adverse Event|2|||
124622822|NCT01814553|448232483|FG000|Overall Study|PD per clinical progression|6|||
124622823|NCT01814553|448232484|FG001|Overall Study|PD per clinical progression|8|||
124622824|NCT01814553|448232483|FG000|Overall Study|Other Adverse Event|4|||
124622825|NCT01814553|448232484|FG001|Overall Study|Other Adverse Event|5|||
124622826|NCT01814553|448232483|FG000|Overall Study|Withdrawal by Subject|1|||
124622827|NCT01814553|448232484|FG001|Overall Study|Withdrawal by Subject|1|||
124622828|NCT01814553|448232483|FG000|Overall Study|Other than stated|7|||
124622829|NCT01814553|448232484|FG001|Overall Study|Other than stated|8|||
124622830|NCT04138823|448232485|FG000|Overall Study|Clinical disease progression|0|||
124622831|NCT04138823|448232486|FG001|Overall Study|Clinical disease progression|0|||
124622832|NCT04138823|448232487|FG002|Overall Study|Clinical disease progression|1|||
124622833|NCT04138823|448232485|FG000|Overall Study|Objective disease progression|3|||
124622834|NCT04138823|448232486|FG001|Overall Study|Objective disease progression|2|||
124622835|NCT04138823|448232487|FG002|Overall Study|Objective disease progression|5|||
124622836|NCT04868500|448232488|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
124622837|NCT04868500|448232489|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
124622838|NCT04868500|448232488|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
124622839|NCT04868500|448232489|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
124622840|NCT02676765|448232490|FG000|Overall Study|Lost to Follow-up|0|||
124622841|NCT02676765|448232491|FG001|Overall Study|Lost to Follow-up|1|||
124622842|NCT03340974|448232492|FG000|Completion of Study -Long Term Follow up|Death|8|||
124622843|NCT03340974|448232493|FG001|Completion of Study -Long Term Follow up|Death|5|||
124622844|NCT03340974|448232494|FG002|Completion of Study -Long Term Follow up|Death|5|||
124622845|NCT03340974|448232495|FG003|Completion of Study -Long Term Follow up|Death|7|||
124622846|NCT03340974|448232492|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
124622847|NCT03340974|448232493|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
124622848|NCT03340974|448232494|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
124622849|NCT03340974|448232495|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
124622850|NCT03340974|448232492|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
124622851|NCT03340974|448232493|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
124622852|NCT03340974|448232494|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
124622853|NCT03340974|448232495|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
124622854|NCT03340974|448232492|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
124622855|NCT03340974|448232493|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
124622856|NCT03340974|448232494|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
124622857|NCT03340974|448232495|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
124622858|NCT01330303|448232502|FG000|Period 1|Adverse Event|1|||
124622859|NCT01330303|448232503|FG001|Period 1|Adverse Event|0|||
124622860|NCT01330303|448232502|FG000|Period 1|Protocol Violation|0|||
124622861|NCT01330303|448232503|FG001|Period 1|Protocol Violation|1|||
124622862|NCT01330303|448232502|FG000|Period 1|Withdrawal by Subject|0|||
124622863|NCT01330303|448232503|FG001|Period 1|Withdrawal by Subject|1|||
124622864|NCT01107197|448232504|FG000|Overall Study|Death|12|||
124622865|NCT01107197|448232505|FG001|Overall Study|Death|10|||
124622866|NCT01107197|448232504|FG000|Overall Study|Lost to Follow-up|5|||
124622867|NCT01107197|448232505|FG001|Overall Study|Lost to Follow-up|8|||
124622868|NCT01107197|448232504|FG000|Overall Study|Withdrawal by Subject|3|||
124622869|NCT01107197|448232505|FG001|Overall Study|Withdrawal by Subject|5|||
124622870|NCT03548337|448232506|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
124622871|NCT03548337|448232507|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
124622872|NCT03548337|448232506|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
124622873|NCT03548337|448232507|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
124622874|NCT03548337|448232506|FG000|Infant Series|Lost to Follow-up|2|||
124622875|NCT03548337|448232507|FG001|Infant Series|Lost to Follow-up|1|||
124622876|NCT03548337|448232506|FG000|Infant Series|Adverse Event|0|||
124622877|NCT03548337|448232507|FG001|Infant Series|Adverse Event|2|||
124622878|NCT03548337|448232506|FG000|Infant Series|Randomized but Not Vaccinated|1|||
124622879|NCT03548337|448232507|FG001|Infant Series|Randomized but Not Vaccinated|0|||
124622880|NCT03548337|448232506|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
124622881|NCT03548337|448232507|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
124622882|NCT01911273|448232508|FG000|Overall Study|Progression of Disease|1|||
124622883|NCT01911273|448232509|FG001|Overall Study|Progression of Disease|0|||
124622884|NCT01911273|448232508|FG000|Overall Study|Withdrawal by Subject|0|||
124622885|NCT01911273|448232509|FG001|Overall Study|Withdrawal by Subject|2|||
124622886|NCT01855828|448232510|FG000|Overall Study|Adverse Event|1|||
124622887|NCT01855828|448232510|FG000|Overall Study|Withdrawal by Subject|1|||
124622888|NCT02517463|448232522|FG000|Overall Study|Lost to Follow-up|5|||
124622889|NCT02517463|448232523|FG001|Overall Study|Lost to Follow-up|2|||
124622890|NCT02890355|448232526|FG000|Overall Study|Adverse Event|5|||
124622891|NCT02890355|448232527|FG001|Overall Study|Adverse Event|5|||
124622892|NCT02890355|448232526|FG000|Overall Study|Refusal unrelated to adverse event|5|||
124622893|NCT02890355|448232527|FG001|Overall Study|Refusal unrelated to adverse event|10|||
124622894|NCT02890355|448232526|FG000|Overall Study|Progression/relapse|46|||
124622895|NCT02890355|448232527|FG001|Overall Study|Progression/relapse|39|||
124622896|NCT02890355|448232526|FG000|Overall Study|Not protocol specified|3|||
124622897|NCT02890355|448232527|FG001|Overall Study|Not protocol specified|4|||
124622898|NCT01128179|448232528|FG000|Overall Study|Death|1|||
124622899|NCT01128179|448232529|FG001|Overall Study|Death|0|||
124622900|NCT01128179|448232528|FG000|Overall Study|Protocol Violation|1|||
124622901|NCT01128179|448232529|FG001|Overall Study|Protocol Violation|0|||
124622902|NCT00720382|448232532|FG000|Overall Study|Adverse Event|54|||
124622903|NCT00720382|448232533|FG001|Overall Study|Adverse Event|17|||
124622904|NCT00720382|448232532|FG000|Overall Study|Lack of Efficacy|18|||
124622905|NCT00720382|448232533|FG001|Overall Study|Lack of Efficacy|7|||
124622906|NCT00720382|448232532|FG000|Overall Study|Non-Compliance|15|||
124622907|NCT00720382|448232533|FG001|Overall Study|Non-Compliance|5|||
124622908|NCT00720382|448232532|FG000|Overall Study|Withdrawal by Subject|47|||
124622909|NCT00720382|448232533|FG001|Overall Study|Withdrawal by Subject|11|||
124622910|NCT00720382|448232532|FG000|Overall Study|Lost to Follow-up|28|||
124622911|NCT00720382|448232533|FG001|Overall Study|Lost to Follow-up|14|||
124783393|NCT01945710|448838097|FG005|Overall Study|Progressive Disease|3|||
124783394|NCT01945710|448838098|FG006|Overall Study|Progressive Disease|19|||
124783395|NCT01945710|448838092|FG000|Overall Study|Adverse Event|0|||
124783396|NCT01945710|448838093|FG001|Overall Study|Adverse Event|1|||
124783397|NCT01945710|448838094|FG002|Overall Study|Adverse Event|0|||
124622912|NCT00720382|448232532|FG000|Overall Study|administrative|14|||
124622913|NCT00720382|448232533|FG001|Overall Study|administrative|5|||
124622914|NCT03999996|448234636|FG000|Prior to Booster|Adverse Event|2|||
124622915|NCT03999996|448234637|FG001|Prior to Booster|Adverse Event|0|||
124622916|NCT03999996|448234638|FG002|Prior to Booster|Adverse Event|0|||
124622917|NCT03999996|448234639|FG003|Prior to Booster|Adverse Event|0|||
124622918|NCT03999996|448234636|FG000|Prior to Booster|Lost to Follow-up|17|||
124622919|NCT03999996|448234637|FG001|Prior to Booster|Lost to Follow-up|22|||
124622920|NCT03999996|448234638|FG002|Prior to Booster|Lost to Follow-up|0|||
124622921|NCT03999996|448234639|FG003|Prior to Booster|Lost to Follow-up|0|||
124622922|NCT03999996|448234636|FG000|Prior to Booster|Withdrawal of Consent|51|||
124622923|NCT03999996|448234637|FG001|Prior to Booster|Withdrawal of Consent|8|||
124622924|NCT03999996|448234638|FG002|Prior to Booster|Withdrawal of Consent|0|||
124622925|NCT03999996|448234639|FG003|Prior to Booster|Withdrawal of Consent|0|||
124622926|NCT03999996|448234636|FG000|Prior to Booster|Death|0|||
124622927|NCT03999996|448234637|FG001|Prior to Booster|Death|1|||
124622928|NCT03999996|448234638|FG002|Prior to Booster|Death|0|||
124622929|NCT03999996|448234639|FG003|Prior to Booster|Death|0|||
124622930|NCT03999996|448234636|FG000|Prior to Booster|Reason Not Specified|27|||
124622931|NCT03999996|448234637|FG001|Prior to Booster|Reason Not Specified|4|||
124622932|NCT03999996|448234638|FG002|Prior to Booster|Reason Not Specified|0|||
124622933|NCT03999996|448234639|FG003|Prior to Booster|Reason Not Specified|0|||
124622934|NCT03999996|448234636|FG000|Booster Phase|Lost to Follow-up|0|||
124622935|NCT03999996|448234637|FG001|Booster Phase|Lost to Follow-up|0|||
124622936|NCT03999996|448234638|FG002|Booster Phase|Lost to Follow-up|3|||
124622937|NCT03999996|448234639|FG003|Booster Phase|Lost to Follow-up|3|||
124622938|NCT03999996|448234636|FG000|Booster Phase|Withdrawal of Consent|0|||
124622939|NCT03999996|448234637|FG001|Booster Phase|Withdrawal of Consent|0|||
124622940|NCT03999996|448234638|FG002|Booster Phase|Withdrawal of Consent|0|||
124622941|NCT03999996|448234639|FG003|Booster Phase|Withdrawal of Consent|1|||
124622942|NCT03999996|448234636|FG000|Booster Phase|Reason Not Specified|0|||
124622943|NCT03999996|448234637|FG001|Booster Phase|Reason Not Specified|0|||
124622944|NCT03999996|448234638|FG002|Booster Phase|Reason Not Specified|0|||
124622945|NCT03999996|448234639|FG003|Booster Phase|Reason Not Specified|1|||
124622946|NCT01433055|448234640|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
124622947|NCT01433055|448234641|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
124622948|NCT01433055|448234640|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
124622949|NCT01433055|448234641|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
124622950|NCT02717455|448234642|FG000|Overall Study|Adverse Event|1|||
124622951|NCT02717455|448234643|FG001|Overall Study|Adverse Event|0|||
124622952|NCT02717455|448234644|FG002|Overall Study|Adverse Event|0|||
124622953|NCT02717455|448234645|FG003|Overall Study|Adverse Event|2|||
124622954|NCT02717455|448234646|FG004|Overall Study|Adverse Event|2|||
124622955|NCT02717455|448234647|FG005|Overall Study|Adverse Event|2|||
124622956|NCT02717455|448234642|FG000|Overall Study|Withdrawal by Subject|1|||
124622957|NCT02717455|448234643|FG001|Overall Study|Withdrawal by Subject|1|||
124622958|NCT02717455|448234644|FG002|Overall Study|Withdrawal by Subject|0|||
124622959|NCT02717455|448234645|FG003|Overall Study|Withdrawal by Subject|2|||
124622960|NCT02717455|448234646|FG004|Overall Study|Withdrawal by Subject|2|||
124622961|NCT02717455|448234647|FG005|Overall Study|Withdrawal by Subject|1|||
124622962|NCT02717455|448234642|FG000|Overall Study|Death|1|||
124622963|NCT02717455|448234643|FG001|Overall Study|Death|0|||
124622964|NCT02717455|448234644|FG002|Overall Study|Death|0|||
124622965|NCT02717455|448234645|FG003|Overall Study|Death|0|||
124622966|NCT02717455|448234646|FG004|Overall Study|Death|1|||
124622967|NCT02717455|448234647|FG005|Overall Study|Death|0|||
124622968|NCT02717455|448234642|FG000|Overall Study|Did not receive study drug|0|||
124622969|NCT02717455|448234643|FG001|Overall Study|Did not receive study drug|0|||
124622970|NCT02717455|448234644|FG002|Overall Study|Did not receive study drug|0|||
124622971|NCT02717455|448234645|FG003|Overall Study|Did not receive study drug|1|||
124622972|NCT02717455|448234646|FG004|Overall Study|Did not receive study drug|0|||
124622973|NCT02717455|448234647|FG005|Overall Study|Did not receive study drug|1|||
124622974|NCT02717455|448234642|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
124622975|NCT02717455|448234643|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
124622976|NCT02717455|448234644|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
124622977|NCT02717455|448234645|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
124622978|NCT02717455|448234646|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
124622979|NCT02717455|448234647|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
124622980|NCT02717455|448234642|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
124622981|NCT02717455|448234643|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
124622982|NCT02717455|448234644|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
124622983|NCT02717455|448234645|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
124622984|NCT02717455|448234646|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
124622985|NCT02717455|448234647|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
124622986|NCT00233948|448234650|FG000|Overall Study|Adverse Event|1|||
124622987|NCT00233948|448234651|FG001|Overall Study|Adverse Event|0|||
124622988|NCT00233948|448234652|FG002|Overall Study|Adverse Event|0|||
124622989|NCT00233948|448234653|FG003|Overall Study|Adverse Event|0|||
124622990|NCT00233948|448234654|FG004|Overall Study|Adverse Event|0|||
124622991|NCT00233948|448234655|FG005|Overall Study|Adverse Event|0|||
124622992|NCT03573830|448234660|FG000|Overall Study|Dropped without completing treatment|0|||
124622993|NCT03573830|448234661|FG001|Overall Study|Dropped without completing treatment|7|||
124622994|NCT03573830|448234660|FG000|Overall Study|Lost to Follow-up|4|||
124622995|NCT03573830|448234661|FG001|Overall Study|Lost to Follow-up|0|||
124622996|NCT00733005|448234662|FG000|Overall Study|Adverse Event|0|||
124622997|NCT00733005|448234663|FG001|Overall Study|Adverse Event|1|||
124622998|NCT00733005|448234662|FG000|Overall Study|Treatment Failure|0|||
124622999|NCT00733005|448234663|FG001|Overall Study|Treatment Failure|1|||
124623000|NCT00733005|448234662|FG000|Overall Study|Withdrawal by Subject|0|||
124623001|NCT00733005|448234663|FG001|Overall Study|Withdrawal by Subject|1|||
124623002|NCT00733005|448234662|FG000|Overall Study|Protocol Violation|2|||
124623003|NCT00733005|448234663|FG001|Overall Study|Protocol Violation|0|||
124623004|NCT02465398|448234666|FG000|Overall Study|Death|7|||
124623005|NCT02465398|448234666|FG000|Overall Study|Revision|7|||
124623006|NCT02465398|448234666|FG000|Overall Study|did not receive study device|1|||
124623007|NCT02465398|448234666|FG000|Overall Study|Withdrawal by Subject|1|||
124623008|NCT02465398|448234666|FG000|Overall Study|Lost to Follow-up|14|||
124623009|NCT05244122|448234667|FG000|Overall Study|Withdrawal by Subject|318|||
124623010|NCT03410056|448234668|FG000|Overall Study|Decision by Sponsor|0|||
124623011|NCT03410056|448234669|FG001|Overall Study|Decision by Sponsor|0|||
124623012|NCT03410056|448234670|FG002|Overall Study|Decision by Sponsor|3|||
124623013|NCT03410056|448234671|FG003|Overall Study|Decision by Sponsor|0|||
124623014|NCT03410056|448234672|FG004|Overall Study|Decision by Sponsor|0|||
124623015|NCT03410056|448234673|FG005|Overall Study|Decision by Sponsor|0|||
124623016|NCT03410056|448234674|FG006|Overall Study|Decision by Sponsor|0|||
124623017|NCT03410056|448234668|FG000|Overall Study|Withdrawal by Subject|0|||
124623018|NCT03410056|448234669|FG001|Overall Study|Withdrawal by Subject|2|||
124623019|NCT03410056|448234670|FG002|Overall Study|Withdrawal by Subject|5|||
124623020|NCT03410056|448234671|FG003|Overall Study|Withdrawal by Subject|5|||
124623021|NCT03410056|448234672|FG004|Overall Study|Withdrawal by Subject|0|||
124623022|NCT03410056|448234673|FG005|Overall Study|Withdrawal by Subject|0|||
124623023|NCT03410056|448234674|FG006|Overall Study|Withdrawal by Subject|0|||
124623024|NCT00266630|448234675|FG000|Overall Study|Adverse Event|8|||
124623025|NCT00266630|448234676|FG001|Overall Study|Adverse Event|6|||
124623026|NCT00266630|448234675|FG000|Overall Study|Lack of Efficacy|1|||
124623027|NCT00266630|448234676|FG001|Overall Study|Lack of Efficacy|4|||
124623028|NCT00266630|448234675|FG000|Overall Study|Entry Criteria not met|1|||
124623029|NCT00266630|448234676|FG001|Overall Study|Entry Criteria not met|0|||
124623030|NCT00266630|448234675|FG000|Overall Study|Protocol Violation|1|||
124623031|NCT00266630|448234676|FG001|Overall Study|Protocol Violation|3|||
124623032|NCT00266630|448234675|FG000|Overall Study|Physician Decision|1|||
124623033|NCT00266630|448234676|FG001|Overall Study|Physician Decision|2|||
124623034|NCT00266630|448234675|FG000|Overall Study|Withdrawal by Subject|10|||
124623035|NCT00266630|448234676|FG001|Overall Study|Withdrawal by Subject|2|||
124623036|NCT00266630|448234675|FG000|Overall Study|Lost to Follow-up|1|||
124623037|NCT00266630|448234676|FG001|Overall Study|Lost to Follow-up|0|||
124623038|NCT00266630|448234675|FG000|Overall Study|Other|19|||
124623039|NCT00266630|448234676|FG001|Overall Study|Other|11|||
124623040|NCT03284723|448234681|FG000|Overall Study|Death|0|||
124623041|NCT03284723|448234682|FG001|Overall Study|Death|0|||
124623042|NCT03284723|448234683|FG002|Overall Study|Death|0|||
124623043|NCT03284723|448234684|FG003|Overall Study|Death|1|||
124623044|NCT03284723|448234685|FG004|Overall Study|Death|0|||
124623045|NCT03284723|448234686|FG005|Overall Study|Death|0|||
124623046|NCT03284723|448234687|FG006|Overall Study|Death|1|||
124623047|NCT03284723|448234688|FG007|Overall Study|Death|0|||
124623048|NCT03284723|448234689|FG008|Overall Study|Death|0|||
124623049|NCT03284723|448234690|FG009|Overall Study|Death|2|||
124623050|NCT03284723|448234691|FG010|Overall Study|Death|1|||
124623051|NCT03284723|448234692|FG011|Overall Study|Death|0|||
124623052|NCT03284723|448234681|FG000|Overall Study|Lost to Follow-up|0|||
124623053|NCT03284723|448234682|FG001|Overall Study|Lost to Follow-up|0|||
124623054|NCT03284723|448234683|FG002|Overall Study|Lost to Follow-up|0|||
124623055|NCT03284723|448234684|FG003|Overall Study|Lost to Follow-up|0|||
124623056|NCT03284723|448234685|FG004|Overall Study|Lost to Follow-up|0|||
124623057|NCT03284723|448234686|FG005|Overall Study|Lost to Follow-up|2|||
124623058|NCT03284723|448234687|FG006|Overall Study|Lost to Follow-up|1|||
124623059|NCT03284723|448234688|FG007|Overall Study|Lost to Follow-up|0|||
124623060|NCT03284723|448234689|FG008|Overall Study|Lost to Follow-up|0|||
124623061|NCT03284723|448234690|FG009|Overall Study|Lost to Follow-up|2|||
124623062|NCT03284723|448234691|FG010|Overall Study|Lost to Follow-up|0|||
124623063|NCT03284723|448234692|FG011|Overall Study|Lost to Follow-up|0|||
124623064|NCT03284723|448234681|FG000|Overall Study|Study Terminated By Sponsor|0|||
124783398|NCT01945710|448838095|FG003|Overall Study|Adverse Event|0|||
124783399|NCT01945710|448838096|FG004|Overall Study|Adverse Event|0|||
124623065|NCT03284723|448234682|FG001|Overall Study|Study Terminated By Sponsor|0|||
124623066|NCT03284723|448234683|FG002|Overall Study|Study Terminated By Sponsor|0|||
124623067|NCT03284723|448234684|FG003|Overall Study|Study Terminated By Sponsor|0|||
124623068|NCT03284723|448234685|FG004|Overall Study|Study Terminated By Sponsor|1|||
124623069|NCT03284723|448234686|FG005|Overall Study|Study Terminated By Sponsor|0|||
124623070|NCT03284723|448234687|FG006|Overall Study|Study Terminated By Sponsor|0|||
124623071|NCT03284723|448234688|FG007|Overall Study|Study Terminated By Sponsor|0|||
124623072|NCT03284723|448234689|FG008|Overall Study|Study Terminated By Sponsor|1|||
124623073|NCT03284723|448234690|FG009|Overall Study|Study Terminated By Sponsor|1|||
124783400|NCT01945710|448838097|FG005|Overall Study|Adverse Event|0|||
124783401|NCT01945710|448838098|FG006|Overall Study|Adverse Event|0|||
124783402|NCT01945710|448838092|FG000|Overall Study|Other|2|||
124783403|NCT01945710|448838093|FG001|Overall Study|Other|0|||
124783404|NCT01945710|448838094|FG002|Overall Study|Other|3|||
124783405|NCT01945710|448838095|FG003|Overall Study|Other|1|||
124783406|NCT01945710|448838096|FG004|Overall Study|Other|1|||
124783407|NCT01945710|448838097|FG005|Overall Study|Other|0|||
124783408|NCT01945710|448838098|FG006|Overall Study|Other|4|||
124783409|NCT01945710|448838092|FG000|Overall Study|Withdrawal by Subject|0|||
124783410|NCT01945710|448838093|FG001|Overall Study|Withdrawal by Subject|1|||
124783411|NCT01945710|448838094|FG002|Overall Study|Withdrawal by Subject|1|||
124783412|NCT01945710|448838095|FG003|Overall Study|Withdrawal by Subject|0|||
124783413|NCT01945710|448838096|FG004|Overall Study|Withdrawal by Subject|1|||
124783414|NCT01945710|448838097|FG005|Overall Study|Withdrawal by Subject|0|||
124783415|NCT01945710|448838098|FG006|Overall Study|Withdrawal by Subject|0|||
124783416|NCT00375609|448838099|FG000|Overall Study|Did not receive treatment|1|||
124783417|NCT00375609|448838100|FG001|Overall Study|Did not receive treatment|0|||
124783418|NCT00375609|448838101|FG002|Overall Study|Did not receive treatment|0|||
124783419|NCT00375609|448838099|FG000|Overall Study|Adverse Event|0|||
124783420|NCT00375609|448838100|FG001|Overall Study|Adverse Event|3|||
124783421|NCT00375609|448838101|FG002|Overall Study|Adverse Event|0|||
124783422|NCT00375609|448838099|FG000|Overall Study|Lost to Follow-up|1|||
124783423|NCT00375609|448838100|FG001|Overall Study|Lost to Follow-up|0|||
124783424|NCT00375609|448838101|FG002|Overall Study|Lost to Follow-up|0|||
124783425|NCT00375609|448838099|FG000|Overall Study|Physician Decision|0|||
124783426|NCT00375609|448838100|FG001|Overall Study|Physician Decision|0|||
124783427|NCT00375609|448838101|FG002|Overall Study|Physician Decision|1|||
124783428|NCT00375609|448838099|FG000|Overall Study|Withdrawal by Subject|1|||
124783429|NCT00375609|448838100|FG001|Overall Study|Withdrawal by Subject|4|||
124783430|NCT00375609|448838101|FG002|Overall Study|Withdrawal by Subject|0|||
124783431|NCT00375609|448838099|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
124783432|NCT00375609|448838100|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
124783433|NCT00375609|448838101|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
124783434|NCT01368562|448838102|FG000|Overall Study|Adverse Event|1|||
124783435|NCT01368562|448838102|FG000|Overall Study|Disease progression|1|||
124783436|NCT01368562|448838102|FG000|Overall Study|Lost to Follow-up|1|||
124783437|NCT01368562|448838102|FG000|Overall Study|Death|6|||
124783438|NCT01368562|448838102|FG000|Overall Study|Unresponsive to treatment|5|||
124783439|NCT01368562|448838102|FG000|Overall Study|Other|3|||
124783440|NCT01368562|448838102|FG000|Overall Study|Other than specified|2|||
124783441|NCT00669409|448838105|FG000|Part 2|Withdrawal by Subject|0|||
124783442|NCT00669409|448838106|FG001|Part 2|Withdrawal by Subject|0|||
124783443|NCT00669409|448838107|FG002|Part 2|Withdrawal by Subject|0|||
124783444|NCT00669409|448838108|FG003|Part 2|Withdrawal by Subject|0|||
124783445|NCT00669409|448838109|FG004|Part 2|Withdrawal by Subject|0|||
124783446|NCT00669409|448838110|FG005|Part 2|Withdrawal by Subject|0|||
124783447|NCT00669409|448838111|FG006|Part 2|Withdrawal by Subject|0|||
124783448|NCT00669409|448838112|FG007|Part 2|Withdrawal by Subject|0|||
124783449|NCT00669409|448838113|FG008|Part 2|Withdrawal by Subject|0|||
124783450|NCT00669409|448838114|FG009|Part 2|Withdrawal by Subject|1|||
124783451|NCT00669409|448838115|FG010|Part 2|Withdrawal by Subject|0|||
124783452|NCT03583385|448838120|FG000|Treatment Period 1|Withdrawal by Subject|1|||
124783453|NCT03583385|448838121|FG001|Treatment Period 1|Withdrawal by Subject|1|||
124783454|NCT03583385|448838120|FG000|Treatment Period 2|Adverse Event|1|||
124783455|NCT03583385|448838121|FG001|Treatment Period 2|Adverse Event|0|||
124783456|NCT00095940|448838122|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
124783457|NCT00095940|448838123|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
124783458|NCT00095940|448838124|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
124783459|NCT00095940|448838125|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
124783460|NCT00095940|448838126|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
124783461|NCT00095940|448838127|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
124783462|NCT00095940|448838128|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
124783463|NCT00095940|448838129|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
124783464|NCT00095940|448838130|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
124783465|NCT00095940|448838122|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
124783466|NCT00095940|448838123|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
124783467|NCT00095940|448838124|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
124783468|NCT00095940|448838125|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
124783469|NCT00095940|448838126|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
124783470|NCT00095940|448838127|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
124783471|NCT00095940|448838128|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
124783472|NCT00095940|448838129|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
124783473|NCT00095940|448838130|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
124783474|NCT00095940|448838122|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
124623074|NCT03284723|448234691|FG010|Overall Study|Study Terminated By Sponsor|1|||
124623075|NCT03284723|448234692|FG011|Overall Study|Study Terminated By Sponsor|1|||
124623076|NCT03284723|448234681|FG000|Overall Study|Withdrawal by Subject|0|||
124623077|NCT03284723|448234682|FG001|Overall Study|Withdrawal by Subject|0|||
124623078|NCT03284723|448234683|FG002|Overall Study|Withdrawal by Subject|0|||
124623079|NCT03284723|448234684|FG003|Overall Study|Withdrawal by Subject|0|||
124623080|NCT03284723|448234685|FG004|Overall Study|Withdrawal by Subject|5|||
124623081|NCT03284723|448234686|FG005|Overall Study|Withdrawal by Subject|3|||
124623082|NCT03284723|448234687|FG006|Overall Study|Withdrawal by Subject|1|||
124623083|NCT03284723|448234688|FG007|Overall Study|Withdrawal by Subject|0|||
124623084|NCT03284723|448234689|FG008|Overall Study|Withdrawal by Subject|6|||
124623085|NCT03284723|448234690|FG009|Overall Study|Withdrawal by Subject|0|||
124623086|NCT03284723|448234691|FG010|Overall Study|Withdrawal by Subject|3|||
124623087|NCT03284723|448234692|FG011|Overall Study|Withdrawal by Subject|1|||
124623088|NCT03284723|448234681|FG000|Overall Study|Other|1|||
124623089|NCT03284723|448234682|FG001|Overall Study|Other|0|||
124623090|NCT03284723|448234683|FG002|Overall Study|Other|1|||
124623091|NCT03284723|448234684|FG003|Overall Study|Other|0|||
124623092|NCT03284723|448234685|FG004|Overall Study|Other|1|||
124623093|NCT03284723|448234686|FG005|Overall Study|Other|0|||
124623094|NCT03284723|448234687|FG006|Overall Study|Other|0|||
124623095|NCT03284723|448234688|FG007|Overall Study|Other|0|||
124623096|NCT03284723|448234689|FG008|Overall Study|Other|0|||
124623097|NCT03284723|448234690|FG009|Overall Study|Other|0|||
124623098|NCT03284723|448234691|FG010|Overall Study|Other|1|||
124623099|NCT03284723|448234692|FG011|Overall Study|Other|0|||
124623100|NCT03284723|448234681|FG000|Overall Study|Adverse Event|0|||
124623101|NCT03284723|448234682|FG001|Overall Study|Adverse Event|0|||
124623102|NCT03284723|448234683|FG002|Overall Study|Adverse Event|0|||
124623103|NCT03284723|448234684|FG003|Overall Study|Adverse Event|0|||
124623104|NCT03284723|448234685|FG004|Overall Study|Adverse Event|0|||
124623105|NCT03284723|448234686|FG005|Overall Study|Adverse Event|0|||
124623106|NCT03284723|448234687|FG006|Overall Study|Adverse Event|0|||
124623107|NCT03284723|448234688|FG007|Overall Study|Adverse Event|0|||
124623108|NCT03284723|448234689|FG008|Overall Study|Adverse Event|1|||
124623109|NCT03284723|448234690|FG009|Overall Study|Adverse Event|0|||
124623110|NCT03284723|448234691|FG010|Overall Study|Adverse Event|0|||
124623111|NCT03284723|448234692|FG011|Overall Study|Adverse Event|0|||
124623112|NCT00615199|448234693|FG000|Overall Study|Adverse Event|3|||
124623113|NCT00615199|448234694|FG001|Overall Study|Adverse Event|1|||
124623114|NCT00615199|448234695|FG002|Overall Study|Adverse Event|1|||
124623115|NCT00615199|448234696|FG003|Overall Study|Adverse Event|0|||
124623116|NCT00615199|448234693|FG000|Overall Study|Lack of Efficacy|2|||
124623117|NCT00615199|448234694|FG001|Overall Study|Lack of Efficacy|0|||
124623118|NCT00615199|448234695|FG002|Overall Study|Lack of Efficacy|0|||
124623119|NCT00615199|448234696|FG003|Overall Study|Lack of Efficacy|1|||
124623120|NCT00615199|448234693|FG000|Overall Study|Lost to Follow-up|1|||
124623121|NCT00615199|448234694|FG001|Overall Study|Lost to Follow-up|0|||
124623122|NCT00615199|448234695|FG002|Overall Study|Lost to Follow-up|0|||
124623123|NCT00615199|448234696|FG003|Overall Study|Lost to Follow-up|0|||
124623124|NCT00615199|448234693|FG000|Overall Study|Other|0|||
124623125|NCT00615199|448234694|FG001|Overall Study|Other|0|||
124623126|NCT00615199|448234695|FG002|Overall Study|Other|0|||
124623127|NCT00615199|448234696|FG003|Overall Study|Other|1|||
124623128|NCT00615199|448234693|FG000|Overall Study|Withdrawal by Subject|2|||
124623129|NCT00615199|448234694|FG001|Overall Study|Withdrawal by Subject|1|||
124623130|NCT00615199|448234695|FG002|Overall Study|Withdrawal by Subject|0|||
124623131|NCT00615199|448234696|FG003|Overall Study|Withdrawal by Subject|0|||
124623132|NCT00764881|448234701|FG000|Overall Study|Adverse Event|5|||
124623133|NCT00764881|448234702|FG001|Overall Study|Adverse Event|1|||
124623134|NCT00764881|448234701|FG000|Overall Study|Withdrawal by Subject|1|||
124623135|NCT00764881|448234702|FG001|Overall Study|Withdrawal by Subject|3|||
124623136|NCT00764881|448234701|FG000|Overall Study|Protocol Violation|2|||
124623137|NCT00764881|448234702|FG001|Overall Study|Protocol Violation|2|||
124623138|NCT00764881|448234701|FG000|Overall Study|Lost to Follow-up|2|||
124623139|NCT00764881|448234702|FG001|Overall Study|Lost to Follow-up|0|||
124623140|NCT00764881|448234701|FG000|Overall Study|Noncompliant|1|||
124623141|NCT00764881|448234702|FG001|Overall Study|Noncompliant|0|||
124623142|NCT00764881|448234701|FG000|Overall Study|Accidentally discontinued study drug|1|||
124623143|NCT00764881|448234702|FG001|Overall Study|Accidentally discontinued study drug|0|||
124623144|NCT00764881|448234701|FG000|Overall Study|Wished to become pregnant|1|||
124623145|NCT00764881|448234702|FG001|Overall Study|Wished to become pregnant|0|||
124623146|NCT00764881|448234701|FG000|Overall Study|Carcinoma detected|1|||
124623147|NCT00764881|448234702|FG001|Overall Study|Carcinoma detected|0|||
124623148|NCT00764881|448234701|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
124623149|NCT00764881|448234702|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
124623150|NCT00764881|448234701|FG000|Overall Study|no treatment or no observation|2|||
124623151|NCT00764881|448234702|FG001|Overall Study|no treatment or no observation|2|||
124623152|NCT01153425|448234704|FG000|Overall Study|Withdrawal by Subject|3|||
124783475|NCT00095940|448838123|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
124783476|NCT00095940|448838124|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
124783477|NCT00095940|448838125|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
124783478|NCT00095940|448838126|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
124783479|NCT00095940|448838127|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
124783480|NCT00095940|448838128|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
124783481|NCT00095940|448838129|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
124783482|NCT00095940|448838130|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
124783483|NCT03539549|448838132|FG000|Overall Study|Adverse Event|12|||
124783484|NCT03539549|448838132|FG000|Overall Study|Lost to Follow-up|1|||
124783485|NCT03539549|448838132|FG000|Overall Study|Death|2|||
124783486|NCT03539549|448838132|FG000|Overall Study|Progressive Disease|1|||
124783487|NCT03539549|448838132|FG000|Overall Study|Reason not Specified|1|||
124783488|NCT02864862|448838133|FG000|Overall Study|Lost to Follow-up|1|||
124783489|NCT02864862|448838134|FG001|Overall Study|Lost to Follow-up|0|||
124783490|NCT02864862|448838135|FG002|Overall Study|Lost to Follow-up|1|||
124783491|NCT02864862|448838133|FG000|Overall Study|Protocol Violation|0|||
124783492|NCT02864862|448838134|FG001|Overall Study|Protocol Violation|0|||
124783493|NCT02864862|448838135|FG002|Overall Study|Protocol Violation|1|||
124783494|NCT04693234|448838139|FG000|Overall Study|Death|79|||
124783495|NCT04693234|448838140|FG001|Overall Study|Death|19|||
124783496|NCT04693234|448838139|FG000|Overall Study|Sponsor Ended Study|47|||
124783497|NCT04693234|448838140|FG001|Overall Study|Sponsor Ended Study|18|||
124783498|NCT04693234|448838139|FG000|Overall Study|Withdrawal by Subject|10|||
124783499|NCT04693234|448838140|FG001|Overall Study|Withdrawal by Subject|2|||
124783500|NCT04693234|448838139|FG000|Overall Study|Lost to Follow-up|2|||
124783501|NCT04693234|448838140|FG001|Overall Study|Lost to Follow-up|1|||
124783502|NCT04643158|448838141|FG000|Overall Study|Study terminated by sponsor|0|||
124783503|NCT04643158|448838142|FG001|Overall Study|Study terminated by sponsor|0|||
124783504|NCT04643158|448838143|FG002|Overall Study|Study terminated by sponsor|1|||
124783505|NCT04643158|448838144|FG003|Overall Study|Study terminated by sponsor|0|||
124783506|NCT04643158|448838145|FG004|Overall Study|Study terminated by sponsor|0|||
124783507|NCT04643158|448838146|FG005|Overall Study|Study terminated by sponsor|1|||
124783508|NCT04643158|448838147|FG006|Overall Study|Study terminated by sponsor|0|||
124783509|NCT04643158|448838141|FG000|Overall Study|Global/country situation|0|||
124783510|NCT04643158|448838142|FG001|Overall Study|Global/country situation|0|||
124783511|NCT04643158|448838143|FG002|Overall Study|Global/country situation|1|||
124783512|NCT04643158|448838144|FG003|Overall Study|Global/country situation|0|||
124783513|NCT04643158|448838145|FG004|Overall Study|Global/country situation|0|||
124783514|NCT04643158|448838146|FG005|Overall Study|Global/country situation|0|||
124623153|NCT01153425|448234705|FG001|Overall Study|Withdrawal by Subject|3|||
124623154|NCT01232452|448234706|FG000|Overall Study|Adverse Event|17|||
124623155|NCT01232452|448234707|FG001|Overall Study|Adverse Event|15|||
124623156|NCT01232452|448234706|FG000|Overall Study|Withdrawal by Subject|11|||
124623157|NCT01232452|448234707|FG001|Overall Study|Withdrawal by Subject|8|||
124623158|NCT01232452|448234706|FG000|Overall Study|Physician Decision|8|||
124623159|NCT01232452|448234707|FG001|Overall Study|Physician Decision|12|||
124623160|NCT01232452|448234706|FG000|Overall Study|Protocol entry criterion not met|0|||
124623161|NCT01232452|448234707|FG001|Overall Study|Protocol entry criterion not met|2|||
124623162|NCT01232452|448234706|FG000|Overall Study|Sponsor Decision|3|||
124623163|NCT01232452|448234707|FG001|Overall Study|Sponsor Decision|1|||
124623164|NCT01232452|448234706|FG000|Overall Study|Protocol Violation|0|||
124623165|NCT01232452|448234707|FG001|Overall Study|Protocol Violation|1|||
124623166|NCT05024747|448234708|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
124623167|NCT05024747|448234709|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
124623168|NCT05024747|448234708|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
124623169|NCT05024747|448234709|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
124623170|NCT05024747|448234708|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
124623171|NCT05024747|448234709|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
124623172|NCT03022370|448234710|FG000|Overall Study|Death|6|||
124623173|NCT03022370|448234711|FG001|Overall Study|Death|12|||
124623174|NCT03022370|448234710|FG000|Overall Study|Lost to Follow-up|174|||
124623175|NCT03022370|448234711|FG001|Overall Study|Lost to Follow-up|109|||
124623176|NCT00699816|448234712|FG000|Overall Study|Protocol Violation|1|||
124623177|NCT00699816|448234713|FG001|Overall Study|Protocol Violation|3|||
124623178|NCT02454933|448234716|FG000|Overall Study|Progressive disease|10|||
124623179|NCT02454933|448234717|FG001|Overall Study|Progressive disease|7|||
124623180|NCT02454933|448234716|FG000|Overall Study|Adverse Event|1|||
124623181|NCT02454933|448234717|FG001|Overall Study|Adverse Event|1|||
124783515|NCT04643158|448838147|FG006|Overall Study|Global/country situation|0|||
124783516|NCT04643158|448838141|FG000|Overall Study|Withdrawal by Subject|0|||
124783517|NCT04643158|448838142|FG001|Overall Study|Withdrawal by Subject|0|||
124783518|NCT04643158|448838143|FG002|Overall Study|Withdrawal by Subject|0|||
124623182|NCT02454933|448234716|FG000|Overall Study|Withdrawal by Subject|0|||
124783519|NCT04643158|448838144|FG003|Overall Study|Withdrawal by Subject|0|||
124783520|NCT04643158|448838145|FG004|Overall Study|Withdrawal by Subject|0|||
124623183|NCT02454933|448234717|FG001|Overall Study|Withdrawal by Subject|3|||
124623184|NCT02454933|448234716|FG000|Overall Study|Lost to Follow-up|1|||
124623185|NCT02454933|448234717|FG001|Overall Study|Lost to Follow-up|0|||
124623186|NCT01526655|448234720|FG000|Overall Study|Withdrawal by Subject|0|||
124623187|NCT01526655|448234721|FG001|Overall Study|Withdrawal by Subject|1|||
124623188|NCT04753216|448234722|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
124623189|NCT04753216|448234722|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
124623190|NCT04753216|448234722|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
124623191|NCT05211726|448234727|FG000|Overall Study|Withdrawal by Subject|2|||
124623192|NCT05211726|448234728|FG001|Overall Study|Withdrawal by Subject|3|||
124623193|NCT05211726|448234727|FG000|Overall Study|Protocol Violation|0|||
124623194|NCT05211726|448234728|FG001|Overall Study|Protocol Violation|1|||
124623195|NCT00344448|448234736|FG000|Screening|Withdrawal by Subject|0|||
124623196|NCT00344448|448234737|FG001|Screening|Withdrawal by Subject|1|||
124623197|NCT00344448|448234736|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
124623198|NCT00344448|448234737|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
124623199|NCT00344448|448234736|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
124623200|NCT00344448|448234737|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
124623201|NCT00344448|448234736|FG000|Open Label|Withdrawal by Subject|1|||
124623202|NCT00344448|448234737|FG001|Open Label|Withdrawal by Subject|1|||
124623203|NCT00344448|448234736|FG000|Open Label|Study terminated|1|||
124623204|NCT00344448|448234737|FG001|Open Label|Study terminated|0|||
124623205|NCT02565511|448234738|FG000|Overall Study|Study terminated by Sponsor|35|||
124623206|NCT02565511|448234739|FG001|Overall Study|Study terminated by Sponsor|22|||
124623207|NCT02565511|448234740|FG002|Overall Study|Study terminated by Sponsor|235|||
124623208|NCT02565511|448234741|FG003|Overall Study|Study terminated by Sponsor|156|||
124623209|NCT02565511|448234738|FG000|Overall Study|Withdrawal by Subject|3|||
124623210|NCT02565511|448234739|FG001|Overall Study|Withdrawal by Subject|0|||
124623211|NCT02565511|448234740|FG002|Overall Study|Withdrawal by Subject|12|||
124623212|NCT02565511|448234741|FG003|Overall Study|Withdrawal by Subject|5|||
124623213|NCT02565511|448234738|FG000|Overall Study|Adverse Event|0|||
124623214|NCT02565511|448234739|FG001|Overall Study|Adverse Event|0|||
124623215|NCT02565511|448234740|FG002|Overall Study|Adverse Event|1|||
124623216|NCT02565511|448234741|FG003|Overall Study|Adverse Event|1|||
124623217|NCT02565511|448234738|FG000|Overall Study|Lost to Follow-up|4|||
124623218|NCT02565511|448234739|FG001|Overall Study|Lost to Follow-up|1|||
124623219|NCT02565511|448234740|FG002|Overall Study|Lost to Follow-up|0|||
124623220|NCT02565511|448234741|FG003|Overall Study|Lost to Follow-up|1|||
124623221|NCT02565511|448234738|FG000|Overall Study|Physician Decision|0|||
124623222|NCT02565511|448234739|FG001|Overall Study|Physician Decision|0|||
124623223|NCT02565511|448234740|FG002|Overall Study|Physician Decision|0|||
124623224|NCT02565511|448234741|FG003|Overall Study|Physician Decision|1|||
124623225|NCT02565511|448234738|FG000|Overall Study|Protocol deviation|0|||
124623226|NCT02565511|448234739|FG001|Overall Study|Protocol deviation|0|||
124623227|NCT02565511|448234740|FG002|Overall Study|Protocol deviation|3|||
124623228|NCT02565511|448234741|FG003|Overall Study|Protocol deviation|0|||
124623229|NCT04807400|448234742|FG000|Overall Study|Adverse Event|2|||
124623230|NCT04807400|448234743|FG001|Overall Study|Adverse Event|3|||
124623231|NCT04807400|448234744|FG002|Overall Study|Adverse Event|3|||
124623232|NCT04807400|448234742|FG000|Overall Study|Death|2|||
124623233|NCT04807400|448234743|FG001|Overall Study|Death|0|||
124623234|NCT04807400|448234744|FG002|Overall Study|Death|0|||
124623235|NCT04807400|448234742|FG000|Overall Study|Lost to Follow-up|8|||
124623236|NCT04807400|448234743|FG001|Overall Study|Lost to Follow-up|6|||
124623237|NCT04807400|448234744|FG002|Overall Study|Lost to Follow-up|6|||
124623238|NCT04807400|448234742|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124623239|NCT04807400|448234743|FG001|Overall Study|Non-Compliance With Study Drug|4|||
124623240|NCT04807400|448234744|FG002|Overall Study|Non-Compliance With Study Drug|1|||
124623241|NCT04807400|448234742|FG000|Overall Study|Participant Decision|20|||
124623242|NCT04807400|448234743|FG001|Overall Study|Participant Decision|19|||
124623243|NCT04807400|448234744|FG002|Overall Study|Participant Decision|26|||
124623244|NCT04807400|448234742|FG000|Overall Study|Physician Decision|0|||
124623245|NCT04807400|448234743|FG001|Overall Study|Physician Decision|1|||
124623246|NCT04807400|448234744|FG002|Overall Study|Physician Decision|0|||
124623247|NCT04807400|448234742|FG000|Overall Study|Protocol Violation|4|||
124623248|NCT04807400|448234743|FG001|Overall Study|Protocol Violation|3|||
124623249|NCT04807400|448234744|FG002|Overall Study|Protocol Violation|7|||
124623250|NCT04807400|448234742|FG000|Overall Study|Withdrawal by Subject|13|||
124623251|NCT04807400|448234743|FG001|Overall Study|Withdrawal by Subject|9|||
124623252|NCT04807400|448234744|FG002|Overall Study|Withdrawal by Subject|20|||
124623253|NCT04807400|448234742|FG000|Overall Study|Mis-randomized|1|||
124623254|NCT04807400|448234743|FG001|Overall Study|Mis-randomized|0|||
124623255|NCT04807400|448234744|FG002|Overall Study|Mis-randomized|0|||
124623256|NCT03076775|448234749|FG000|Overall Study|Lost to Follow-up|1|||
124623257|NCT03076775|448234750|FG001|Overall Study|Lost to Follow-up|0|||
124623258|NCT01332292|448234753|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
124623259|NCT01332292|448234754|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
124623260|NCT01332292|448234753|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
124623261|NCT01332292|448234754|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
124623262|NCT01332292|448234753|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
124623263|NCT01332292|448234754|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
124623264|NCT02324582|448234756|FG000|Overall Study|Screen Failures|0|||
124623265|NCT02324582|448234757|FG001|Overall Study|Screen Failures|5|||
124623266|NCT03541317|448234758|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
124623267|NCT03541317|448234759|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
124623268|NCT03541317|448234760|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
124623269|NCT03541317|448234761|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
124623270|NCT03541317|448234762|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
124623271|NCT03541317|448234763|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
124623272|NCT01487525|448234764|FG000|Overall Study|Withdrawal by Subject|0|||
124623273|NCT01487525|448234765|FG001|Overall Study|Withdrawal by Subject|1|||
124623274|NCT04650204|448234766|FG000|Overall Study|Study was Terminated|2|||
124623275|NCT04650204|448234767|FG001|Overall Study|Study was Terminated|1|||
124623276|NCT04388553|448234769|FG000|Overall Study|Protocol Violation|1|||
124623277|NCT04388553|448234770|FG001|Overall Study|Protocol Violation|0|||
124623278|NCT02123446|448234771|FG000|Washout Period (1 Day)|Physician Decision|1|||
124623279|NCT02123446|448234772|FG001|Washout Period (1 Day)|Physician Decision|0|||
124623280|NCT04502212|448234775|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
124623281|NCT04502212|448234775|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
124623282|NCT04208750|448234807|FG000|Overall Study|Lost to Follow-up|16|||
124623283|NCT04208750|448234808|FG001|Overall Study|Lost to Follow-up|15|||
124623284|NCT04460885|448237045|FG000|Overall Study|Withdrawal by Subject|6|||
124623285|NCT04460885|448237046|FG001|Overall Study|Withdrawal by Subject|8|||
124623286|NCT04460885|448237045|FG000|Overall Study|Site closure|1|||
124623287|NCT04460885|448237046|FG001|Overall Study|Site closure|0|||
124623288|NCT04460885|448237045|FG000|Overall Study|Death|5|||
124623289|NCT04460885|448237046|FG001|Overall Study|Death|4|||
124623290|NCT04460885|448237045|FG000|Overall Study|Physician Decision|2|||
124623291|NCT04460885|448237046|FG001|Overall Study|Physician Decision|1|||
124623292|NCT04460885|448237045|FG000|Overall Study|Lost to Follow-up|4|||
124623293|NCT04460885|448237046|FG001|Overall Study|Lost to Follow-up|4|||
124623294|NCT04559347|448237047|FG000|Overall Study|Death|1|||
124623295|NCT04559347|448237048|FG001|Overall Study|Death|0|||
124623296|NCT04559347|448237047|FG000|Overall Study|Thoracotomy conversion|1|||
124623297|NCT04559347|448237048|FG001|Overall Study|Thoracotomy conversion|1|||
124623298|NCT04559347|448237047|FG000|Overall Study|Provider unavailable|2|||
124623299|NCT04559347|448237048|FG001|Overall Study|Provider unavailable|1|||
124623300|NCT04559347|448237047|FG000|Overall Study|Other|2|||
124623301|NCT04559347|448237048|FG001|Overall Study|Other|1|||
124623302|NCT05377749|448237049|FG000|3 Weeks|Lost to Follow-up|2|||
124623303|NCT05377749|448237050|FG001|3 Weeks|Lost to Follow-up|4|||
124623304|NCT05377749|448237049|FG000|3 Weeks|Withdrawal by Subject|1|||
124623305|NCT05377749|448237050|FG001|3 Weeks|Withdrawal by Subject|1|||
124623306|NCT00064987|448237051|FG000|Overall Study|Physician Decision|3|||
124623307|NCT00064987|448237052|FG001|Overall Study|Physician Decision|0|||
124623308|NCT01214655|448237053|FG000|Part A|Progressive Disease|7|||
124623309|NCT01214655|448237054|FG001|Part A|Progressive Disease|0|||
124623310|NCT01214655|448237055|FG002|Part A|Progressive Disease|0|||
124623311|NCT01214655|448237053|FG000|Part A|Physician Decision|1|||
124623312|NCT01214655|448237054|FG001|Part A|Physician Decision|0|||
124623313|NCT01214655|448237055|FG002|Part A|Physician Decision|0|||
124623314|NCT01214655|448237053|FG000|Part B|Progressive disease|0|||
124623315|NCT01214655|448237054|FG001|Part B|Progressive disease|10|||
124623316|NCT01214655|448237055|FG002|Part B|Progressive disease|0|||
124623317|NCT01214655|448237053|FG000|Part B|Death|0|||
124623318|NCT01214655|448237054|FG001|Part B|Death|1|||
124623319|NCT01214655|448237055|FG002|Part B|Death|0|||
124623320|NCT01214655|448237053|FG000|Part B|Withdrawal by Subject|0|||
124623321|NCT01214655|448237054|FG001|Part B|Withdrawal by Subject|2|||
124623322|NCT01214655|448237055|FG002|Part B|Withdrawal by Subject|0|||
124623323|NCT01214655|448237053|FG000|Part C|Progressive Disease|0|||
124623324|NCT01214655|448237054|FG001|Part C|Progressive Disease|0|||
124623325|NCT01214655|448237055|FG002|Part C|Progressive Disease|5|||
124623326|NCT01214655|448237053|FG000|Part C|Death|0|||
124623327|NCT01214655|448237054|FG001|Part C|Death|0|||
124783521|NCT04643158|448838146|FG005|Overall Study|Withdrawal by Subject|1|||
124623328|NCT01214655|448237055|FG002|Part C|Death|1|||
124783522|NCT04643158|448838147|FG006|Overall Study|Withdrawal by Subject|0|||
124623329|NCT01214655|448237053|FG000|Part C|Physician Decision|0|||
124623330|NCT01214655|448237054|FG001|Part C|Physician Decision|0|||
124623331|NCT01214655|448237055|FG002|Part C|Physician Decision|1|||
124623332|NCT05256134|448237056|FG000|Overall Study|Study Terminated by Sponsor|11|||
124623333|NCT05256134|448237057|FG001|Overall Study|Study Terminated by Sponsor|10|||
124623334|NCT05256134|448237056|FG000|Overall Study|Withdrawal by Subject|1|||
124623335|NCT05256134|448237057|FG001|Overall Study|Withdrawal by Subject|3|||
124623336|NCT01567462|448237064|FG000|Overall Study|Withdrawal by Subject|4|||
124623337|NCT01567462|448237065|FG001|Overall Study|Withdrawal by Subject|7|||
124623338|NCT01977417|448237066|FG000|Overall Study|Adverse Event|1|||
124623339|NCT01977417|448237067|FG001|Overall Study|Adverse Event|0|||
124623340|NCT01977417|448237066|FG000|Overall Study|Withdrawal by Subject|2|||
124623341|NCT01977417|448237067|FG001|Overall Study|Withdrawal by Subject|4|||
124623342|NCT01977417|448237066|FG000|Overall Study|Female enrollment goal met|0|||
124623343|NCT01977417|448237067|FG001|Overall Study|Female enrollment goal met|2|||
124623344|NCT02548156|448237073|FG000|Washout Period 1|Lost to Follow-up|0|||
124623345|NCT02548156|448237074|FG001|Washout Period 1|Lost to Follow-up|0|||
124623346|NCT02548156|448237075|FG002|Washout Period 1|Lost to Follow-up|0|||
124623347|NCT02548156|448237076|FG003|Washout Period 1|Lost to Follow-up|0|||
124623348|NCT02548156|448237077|FG004|Washout Period 1|Lost to Follow-up|1|||
124623349|NCT02548156|448237078|FG005|Washout Period 1|Lost to Follow-up|0|||
124623350|NCT01068262|448237079|FG000|Overall Study|Adverse Event|2|||
124623351|NCT01068262|448237080|FG001|Overall Study|Adverse Event|0|||
124623352|NCT01068262|448237081|FG002|Overall Study|Adverse Event|1|||
124623353|NCT01068262|448237082|FG003|Overall Study|Adverse Event|0|||
124623354|NCT01068262|448237079|FG000|Overall Study|Protocol Violation|1|||
124623355|NCT01068262|448237080|FG001|Overall Study|Protocol Violation|0|||
124623356|NCT01068262|448237081|FG002|Overall Study|Protocol Violation|0|||
124623357|NCT01068262|448237082|FG003|Overall Study|Protocol Violation|0|||
124623358|NCT01068262|448237079|FG000|Overall Study|Withdrawal by Subject|0|||
124623359|NCT01068262|448237080|FG001|Overall Study|Withdrawal by Subject|1|||
124623360|NCT01068262|448237081|FG002|Overall Study|Withdrawal by Subject|0|||
124623361|NCT01068262|448237082|FG003|Overall Study|Withdrawal by Subject|0|||
124623362|NCT02301390|448237085|FG000|Overall Study|Withdrawal by Subject|3|||
124623363|NCT02301390|448237086|FG001|Overall Study|Withdrawal by Subject|5|||
124623364|NCT02301390|448237085|FG000|Overall Study|Protocol Violation|1|||
124623365|NCT02301390|448237086|FG001|Overall Study|Protocol Violation|0|||
124623366|NCT02301390|448237085|FG000|Overall Study|Physician Decision|1|||
124623367|NCT02301390|448237086|FG001|Overall Study|Physician Decision|0|||
124623368|NCT02301390|448237085|FG000|Overall Study|Lost to Follow-up|0|||
124623369|NCT02301390|448237086|FG001|Overall Study|Lost to Follow-up|1|||
124623370|NCT02301390|448237085|FG000|Overall Study|Death|2|||
124623371|NCT02301390|448237086|FG001|Overall Study|Death|2|||
124623372|NCT02301390|448237085|FG000|Overall Study|Procedure not completed|0|||
124623373|NCT02301390|448237086|FG001|Overall Study|Procedure not completed|4|||
124623374|NCT02301390|448237085|FG000|Overall Study|Missed multiple visits|1|||
124623375|NCT02301390|448237086|FG001|Overall Study|Missed multiple visits|1|||
124623376|NCT02301390|448237085|FG000|Overall Study|study terminated|2|||
124623377|NCT02301390|448237086|FG001|Overall Study|study terminated|0|||
124623378|NCT02121652|448237087|FG000|Overall Study|Lost to Follow-up|2|||
124623379|NCT02121652|448237088|FG001|Overall Study|Lost to Follow-up|1|||
124623380|NCT02121652|448237087|FG000|Overall Study|Death|1|||
124623381|NCT02121652|448237088|FG001|Overall Study|Death|0|||
124623382|NCT02121652|448237087|FG000|Overall Study|Withdrawal by Subject|3|||
124623383|NCT02121652|448237088|FG001|Overall Study|Withdrawal by Subject|3|||
124623384|NCT04108299|448237095|FG000|Overall Study|Not interested in participating|2|||
124623385|NCT04108299|448237096|FG001|Overall Study|Not interested in participating|1|||
124623386|NCT04108299|448237097|FG002|Overall Study|Not interested in participating|2|||
124623387|NCT04108299|448237098|FG003|Overall Study|Not interested in participating|1|||
124623388|NCT04123405|448237099|FG000|Overall Study|Adverse Event|1|||
124623389|NCT04123405|448237100|FG001|Overall Study|Adverse Event|2|||
124623390|NCT04123405|448237101|FG002|Overall Study|Adverse Event|3|||
124623391|NCT04123405|448237102|FG003|Overall Study|Adverse Event|3|||
124623392|NCT04123405|448237099|FG000|Overall Study|Exclusion criteria met|1|||
124623393|NCT04123405|448237100|FG001|Overall Study|Exclusion criteria met|2|||
124623394|NCT04123405|448237101|FG002|Overall Study|Exclusion criteria met|0|||
124623395|NCT04123405|448237102|FG003|Overall Study|Exclusion criteria met|2|||
124623396|NCT04123405|448237099|FG000|Overall Study|Withdrawal by Subject|1|||
124623397|NCT04123405|448237100|FG001|Overall Study|Withdrawal by Subject|3|||
124623398|NCT04123405|448237101|FG002|Overall Study|Withdrawal by Subject|0|||
124623399|NCT04123405|448237102|FG003|Overall Study|Withdrawal by Subject|2|||
124623400|NCT04123405|448237099|FG000|Overall Study|Contact to subject lost|0|||
124623401|NCT04123405|448237100|FG001|Overall Study|Contact to subject lost|0|||
124623402|NCT04123405|448237101|FG002|Overall Study|Contact to subject lost|0|||
124623403|NCT04123405|448237102|FG003|Overall Study|Contact to subject lost|1|||
124623404|NCT04123405|448237099|FG000|Overall Study|screening failure|1|||
124623405|NCT04123405|448237100|FG001|Overall Study|screening failure|0|||
124783523|NCT04540198|448838148|FG000|Overall Study|Lost to Follow-up|25|||
124783524|NCT04540198|448838149|FG001|Overall Study|Lost to Follow-up|23|||
124623406|NCT04123405|448237101|FG002|Overall Study|screening failure|0|||
124623407|NCT04123405|448237102|FG003|Overall Study|screening failure|0|||
124783525|NCT04540198|448838148|FG000|Overall Study|Withdrawal by Subject|15|||
124623408|NCT00247676|448237103|FG000|Overall Study|Death|5|||
124623409|NCT00247676|448237103|FG000|Overall Study|Adverse Event|11|||
124623410|NCT00247676|448237103|FG000|Overall Study|Lack of Efficacy|15|||
124623411|NCT00247676|448237103|FG000|Overall Study|Other|3|||
124623412|NCT00247676|448237103|FG000|Overall Study|Withdrawal by Subject|2|||
124623413|NCT00662649|448237104|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
124623414|NCT00662649|448237105|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
124623415|NCT00662649|448237106|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
124623416|NCT00662649|448237107|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
124623417|NCT00662649|448237108|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
124623418|NCT00662649|448237104|FG000|Core Study (24 Months)|Adverse Event|22|||
124623419|NCT00662649|448237105|FG001|Core Study (24 Months)|Adverse Event|13|||
124623420|NCT00662649|448237106|FG002|Core Study (24 Months)|Adverse Event|18|||
124623421|NCT00662649|448237107|FG003|Core Study (24 Months)|Adverse Event|0|||
124623422|NCT00662649|448237108|FG004|Core Study (24 Months)|Adverse Event|0|||
124623423|NCT00662649|448237104|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
124623424|NCT00662649|448237105|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
124623425|NCT00662649|448237106|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
124623426|NCT00662649|448237107|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
124623427|NCT00662649|448237108|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
124623428|NCT00662649|448237104|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
124623429|NCT00662649|448237105|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
124623430|NCT00662649|448237106|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
124623431|NCT00662649|448237107|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
124623432|NCT00662649|448237108|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
124623433|NCT00662649|448237104|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
124623434|NCT00662649|448237105|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
124623435|NCT00662649|448237106|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
124623436|NCT00662649|448237107|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
124623437|NCT00662649|448237108|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
124623438|NCT00662649|448237104|FG000|Core Study (24 Months)|Protocol Violation|5|||
124623439|NCT00662649|448237105|FG001|Core Study (24 Months)|Protocol Violation|5|||
124623440|NCT00662649|448237106|FG002|Core Study (24 Months)|Protocol Violation|4|||
124623441|NCT00662649|448237107|FG003|Core Study (24 Months)|Protocol Violation|0|||
124623442|NCT00662649|448237108|FG004|Core Study (24 Months)|Protocol Violation|0|||
124623443|NCT00662649|448237104|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
124623444|NCT00662649|448237105|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
124623445|NCT00662649|448237106|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
124623446|NCT00662649|448237107|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
124623447|NCT00662649|448237108|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
124623448|NCT00662649|448237104|FG000|Core Study (24 Months)|Death|1|||
124623449|NCT00662649|448237105|FG001|Core Study (24 Months)|Death|0|||
124623450|NCT00662649|448237106|FG002|Core Study (24 Months)|Death|2|||
124623451|NCT00662649|448237107|FG003|Core Study (24 Months)|Death|0|||
124623452|NCT00662649|448237108|FG004|Core Study (24 Months)|Death|0|||
124623453|NCT00662649|448237104|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
124623454|NCT00662649|448237105|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
124623455|NCT00662649|448237106|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
124623456|NCT00662649|448237107|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
124623457|NCT00662649|448237108|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
124623458|NCT00662649|448237104|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
124623459|NCT00662649|448237105|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
124623460|NCT00662649|448237106|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
124623461|NCT00662649|448237107|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
124623462|NCT00662649|448237108|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
124623463|NCT00662649|448237104|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
124623464|NCT00662649|448237105|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
124623465|NCT00662649|448237106|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
124623466|NCT00662649|448237107|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
124623467|NCT00662649|448237108|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
124623468|NCT00662649|448237104|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
124623469|NCT00662649|448237105|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
124623470|NCT00662649|448237106|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
124623471|NCT00662649|448237107|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
124623472|NCT00662649|448237108|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
124623473|NCT00662649|448237104|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
124623474|NCT00662649|448237105|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
124623475|NCT00662649|448237106|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
124623476|NCT00662649|448237107|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
124623477|NCT00662649|448237108|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
124623478|NCT00662649|448237104|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
124623479|NCT00662649|448237105|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
124623480|NCT00662649|448237106|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
124623481|NCT00662649|448237107|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
124623482|NCT00662649|448237108|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
124623483|NCT00662649|448237104|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
124623484|NCT00662649|448237105|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
124623485|NCT00662649|448237106|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
124623486|NCT00662649|448237107|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
124623487|NCT00662649|448237108|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
124623488|NCT00662649|448237104|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
124623489|NCT00662649|448237105|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
124623490|NCT00662649|448237106|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
124623491|NCT00662649|448237107|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
124623492|NCT00662649|448237108|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
124623493|NCT00662649|448237104|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
124623494|NCT00662649|448237105|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
124623495|NCT00662649|448237106|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
124623496|NCT00662649|448237107|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
124623497|NCT00662649|448237108|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
124623498|NCT03594071|448237109|FG000|Overall Study|Re-operation|3|||
124623499|NCT03594071|448237109|FG000|Overall Study|Missed visit|2|||
124623500|NCT01026194|448237110|FG000|Period 1：Double Blind Period|Adverse Event|2|||
124623501|NCT01026194|448237111|FG001|Period 1：Double Blind Period|Adverse Event|1|||
124623502|NCT01026194|448237110|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
124623503|NCT01026194|448237111|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
124623504|NCT01026194|448237110|FG000|Period 1：Double Blind Period|Physician Decision|0|||
124623505|NCT01026194|448237111|FG001|Period 1：Double Blind Period|Physician Decision|4|||
124623506|NCT01026194|448237110|FG000|Period 2：Open-label Period|Adverse Event|4|||
124623507|NCT01026194|448237111|FG001|Period 2：Open-label Period|Adverse Event|5|||
124623508|NCT01026194|448237110|FG000|Period 2：Open-label Period|Physician Decision|3|||
124623509|NCT01026194|448237111|FG001|Period 2：Open-label Period|Physician Decision|1|||
124623510|NCT01026194|448237110|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
124623511|NCT01026194|448237111|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
124623512|NCT01750190|448237112|FG000|Overall Study|Adverse Event|47|||
124623513|NCT01750190|448237113|FG001|Overall Study|Adverse Event|19|||
124623514|NCT01750190|448237112|FG000|Overall Study|Death|38|||
124623515|NCT01750190|448237113|FG001|Overall Study|Death|11|||
124623516|NCT01750190|448237112|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
124623517|NCT01750190|448237113|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
124623518|NCT01750190|448237112|FG000|Overall Study|Lost to Follow-up|28|||
124623519|NCT01750190|448237113|FG001|Overall Study|Lost to Follow-up|7|||
124623520|NCT01750190|448237112|FG000|Overall Study|Physician Decision|16|||
124623521|NCT01750190|448237113|FG001|Overall Study|Physician Decision|17|||
124623522|NCT01750190|448237112|FG000|Overall Study|Protocol Violation|6|||
124623523|NCT01750190|448237113|FG001|Overall Study|Protocol Violation|5|||
124623524|NCT01750190|448237112|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
124623525|NCT01750190|448237113|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
124623526|NCT01750190|448237112|FG000|Overall Study|Withdrawal by Subject|83|||
124623527|NCT01750190|448237113|FG001|Overall Study|Withdrawal by Subject|89|||
124623528|NCT01750190|448237112|FG000|Overall Study|Kidney Transplant|8|||
124623529|NCT01750190|448237113|FG001|Overall Study|Kidney Transplant|4|||
124623530|NCT01750190|448237112|FG000|Overall Study|Dialysis|22|||
124623531|NCT01750190|448237113|FG001|Overall Study|Dialysis|8|||
124623532|NCT01750190|448237112|FG000|Overall Study|Other than Specified|13|||
124623533|NCT01750190|448237113|FG001|Overall Study|Other than Specified|4|||
124623534|NCT02955212|448237120|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
124623535|NCT02955212|448237121|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
124623536|NCT02955212|448237120|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
124623537|NCT02955212|448237121|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
124623538|NCT02955212|448237120|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
124623539|NCT02955212|448237121|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
124623540|NCT02955212|448237120|FG000|Period 1: Double-blind Treatment Period|Other|3|||
124623541|NCT02955212|448237121|FG001|Period 1: Double-blind Treatment Period|Other|2|||
124623542|NCT02955212|448237120|FG000|Period 2: Open-label Extension|Adverse Event|11|||
124783526|NCT04540198|448838149|FG001|Overall Study|Withdrawal by Subject|9|||
124783527|NCT04540198|448838148|FG000|Overall Study|Discontinued|1|||
124623543|NCT02955212|448237121|FG001|Period 2: Open-label Extension|Adverse Event|7|||
124623544|NCT02955212|448237120|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
124623545|NCT02955212|448237121|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
124623546|NCT02955212|448237120|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
124623547|NCT02955212|448237121|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
124623548|NCT02955212|448237120|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
124623549|NCT02955212|448237121|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
124623550|NCT02955212|448237120|FG000|Period 2: Open-label Extension|Other|2|||
124623551|NCT02955212|448237121|FG001|Period 2: Open-label Extension|Other|4|||
124623552|NCT02009722|448237122|FG000|Overall Study|Protocol Violation|1|||
124623553|NCT02009722|448237123|FG001|Overall Study|Protocol Violation|2|||
124623554|NCT02009722|448237122|FG000|Overall Study|Did not receive intervention|0|||
124623555|NCT02009722|448237123|FG001|Overall Study|Did not receive intervention|1|||
124623556|NCT00545714|448237124|FG000|Induction Phase (6 Months)|Physician Decision|3|||
124623557|NCT00545714|448237124|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
124623558|NCT00545714|448237124|FG000|Induction Phase (6 Months)|Disease Progression|1|||
124623559|NCT00545714|448237124|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
124623560|NCT00545714|448237124|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
124623561|NCT00545714|448237124|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
124623562|NCT00545714|448237124|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
124623563|NCT00545714|448237124|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
124623564|NCT00545714|448237124|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
124623565|NCT00545714|448237124|FG000|Maintenance Phase (36 Months)|Death|2|||
124623566|NCT04428034|448237129|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
124623567|NCT00560391|448237132|FG000|Overall Study|Still on treatment|0|||
124623568|NCT00560391|448237133|FG001|Overall Study|Still on treatment|0|||
124623569|NCT00560391|448237134|FG002|Overall Study|Still on treatment|0|||
124623570|NCT00560391|448237135|FG003|Overall Study|Still on treatment|1|||
124623571|NCT00560391|448237136|FG004|Overall Study|Still on treatment|2|||
124623572|NCT02556801|448237137|FG000|Overall Study|Lost to Follow-up|1|||
124623573|NCT02556801|448237138|FG001|Overall Study|Lost to Follow-up|0|||
124623574|NCT02556801|448237139|FG002|Overall Study|Lost to Follow-up|2|||
124623575|NCT02556801|448237140|FG003|Overall Study|Lost to Follow-up|0|||
124623576|NCT02556801|448237137|FG000|Overall Study|Withdrawal by Subject|1|||
124623577|NCT02556801|448237138|FG001|Overall Study|Withdrawal by Subject|1|||
124623578|NCT02556801|448237139|FG002|Overall Study|Withdrawal by Subject|1|||
124623579|NCT02556801|448237140|FG003|Overall Study|Withdrawal by Subject|0|||
124623580|NCT02556801|448237137|FG000|Overall Study|Protocol Violation|0|||
124623581|NCT02556801|448237138|FG001|Overall Study|Protocol Violation|3|||
124623582|NCT02556801|448237139|FG002|Overall Study|Protocol Violation|1|||
124623583|NCT02556801|448237140|FG003|Overall Study|Protocol Violation|1|||
124623584|NCT02556801|448237137|FG000|Overall Study|Adverse Event|0|||
124623585|NCT02556801|448237138|FG001|Overall Study|Adverse Event|2|||
124623586|NCT02556801|448237139|FG002|Overall Study|Adverse Event|0|||
124623587|NCT02556801|448237140|FG003|Overall Study|Adverse Event|3|||
124623588|NCT02556801|448237137|FG000|Overall Study|Pregnancy|0|||
124623589|NCT02556801|448237138|FG001|Overall Study|Pregnancy|1|||
124623590|NCT02556801|448237139|FG002|Overall Study|Pregnancy|0|||
124623591|NCT02556801|448237140|FG003|Overall Study|Pregnancy|0|||
124623592|NCT02556801|448237137|FG000|Overall Study|Personal reasons patient|0|||
124623593|NCT02556801|448237138|FG001|Overall Study|Personal reasons patient|0|||
124623594|NCT02556801|448237139|FG002|Overall Study|Personal reasons patient|0|||
124623595|NCT02556801|448237140|FG003|Overall Study|Personal reasons patient|1|||
124623596|NCT03668808|448237141|FG000|First Intervention|Withdrawal by Subject|2|||
124623597|NCT03668808|448237142|FG001|First Intervention|Withdrawal by Subject|2|||
124623598|NCT02001987|448237152|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
124623599|NCT02001987|448237152|FG000|Core Study Period (24 Weeks)|Death|1|||
124623600|NCT02001987|448237152|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
124623601|NCT02001987|448237152|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
124623602|NCT02001987|448237152|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
124623603|NCT02001987|448237152|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
124623604|NCT02001987|448237152|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
124623605|NCT02001987|448237152|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
124623606|NCT02001987|448237152|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
124623607|NCT02001987|448237152|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
124623608|NCT02001987|448237152|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
124623609|NCT02001987|448237152|FG000|LTE Period (52 Weeks)|Other|3|||
124623610|NCT01965860|448237153|FG000|Overall Study|Pregnancy|1|||
124623611|NCT01965860|448237154|FG001|Overall Study|Pregnancy|0|||
124783528|NCT04540198|448838149|FG001|Overall Study|Discontinued|0|||
124783529|NCT02888119|448838150|FG000|Overall Study|Lost to Follow-up|5|||
124623612|NCT01965860|448237155|FG002|Overall Study|Pregnancy|1|||
124783530|NCT02888119|448838151|FG001|Overall Study|Lost to Follow-up|4|||
124783531|NCT02888119|448838152|FG002|Overall Study|Lost to Follow-up|0|||
124783532|NCT05573386|448838153|FG000|Overall Study|Withdrawal by Subject|3|||
124623613|NCT01965860|448237153|FG000|Overall Study|Logistics|1|||
124623614|NCT01965860|448237154|FG001|Overall Study|Logistics|0|||
124783533|NCT05573386|448838154|FG001|Overall Study|Withdrawal by Subject|2|||
124623615|NCT01965860|448237155|FG002|Overall Study|Logistics|0|||
124623616|NCT02288325|448237162|FG000|Run-in Period|Adverse Event|48|||
124623617|NCT02288325|448237163|FG001|Run-in Period|Adverse Event|0|||
124623618|NCT02288325|448237164|FG002|Run-in Period|Adverse Event|0|||
124623619|NCT02288325|448237162|FG000|Run-in Period|Lack of Efficacy|16|||
124623620|NCT02288325|448237163|FG001|Run-in Period|Lack of Efficacy|0|||
124623621|NCT02288325|448237164|FG002|Run-in Period|Lack of Efficacy|0|||
124623622|NCT02288325|448237162|FG000|Run-in Period|Withdrawal of Consent|28|||
124623623|NCT02288325|448237163|FG001|Run-in Period|Withdrawal of Consent|0|||
124623624|NCT02288325|448237164|FG002|Run-in Period|Withdrawal of Consent|0|||
124623625|NCT02288325|448237162|FG000|Run-in Period|Lost to Follow-up|25|||
124623626|NCT02288325|448237163|FG001|Run-in Period|Lost to Follow-up|0|||
124623627|NCT02288325|448237164|FG002|Run-in Period|Lost to Follow-up|0|||
124623628|NCT02288325|448237162|FG000|Run-in Period|Protocol Violation|17|||
124623629|NCT02288325|448237163|FG001|Run-in Period|Protocol Violation|0|||
124623630|NCT02288325|448237164|FG002|Run-in Period|Protocol Violation|0|||
124623631|NCT02288325|448237162|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
124623632|NCT02288325|448237163|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
124623633|NCT02288325|448237164|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
124623634|NCT02288325|448237162|FG000|Run-in Period|Reason not Specified|8|||
124623635|NCT02288325|448237163|FG001|Run-in Period|Reason not Specified|0|||
124623636|NCT02288325|448237164|FG002|Run-in Period|Reason not Specified|0|||
124623637|NCT02288325|448237162|FG000|Stabilization Period|Adverse Event|13|||
124623638|NCT02288325|448237163|FG001|Stabilization Period|Adverse Event|0|||
124623639|NCT02288325|448237164|FG002|Stabilization Period|Adverse Event|0|||
124623640|NCT02288325|448237162|FG000|Stabilization Period|Lack of Efficacy|22|||
124623641|NCT02288325|448237163|FG001|Stabilization Period|Lack of Efficacy|0|||
124623642|NCT02288325|448237164|FG002|Stabilization Period|Lack of Efficacy|0|||
124623643|NCT02288325|448237162|FG000|Stabilization Period|Withdrawal of Consent|23|||
124623644|NCT02288325|448237163|FG001|Stabilization Period|Withdrawal of Consent|0|||
124623645|NCT02288325|448237164|FG002|Stabilization Period|Withdrawal of Consent|0|||
124623646|NCT02288325|448237162|FG000|Stabilization Period|Lost to Follow-up|12|||
124623647|NCT02288325|448237163|FG001|Stabilization Period|Lost to Follow-up|0|||
124623648|NCT02288325|448237164|FG002|Stabilization Period|Lost to Follow-up|0|||
124623649|NCT02288325|448237162|FG000|Stabilization Period|Protocol Violation|8|||
124623650|NCT02288325|448237163|FG001|Stabilization Period|Protocol Violation|0|||
124623651|NCT02288325|448237164|FG002|Stabilization Period|Protocol Violation|0|||
124623652|NCT02288325|448237162|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
124623653|NCT02288325|448237163|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
124623654|NCT02288325|448237164|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
124623655|NCT02288325|448237162|FG000|Stabilization Period|Reason not Specified|15|||
124623656|NCT02288325|448237163|FG001|Stabilization Period|Reason not Specified|0|||
124623657|NCT02288325|448237164|FG002|Stabilization Period|Reason not Specified|0|||
124623658|NCT02288325|448237162|FG000|Double-blind Treatment Period|Adverse Event|0|||
124623659|NCT02288325|448237163|FG001|Double-blind Treatment Period|Adverse Event|2|||
124623660|NCT02288325|448237164|FG002|Double-blind Treatment Period|Adverse Event|5|||
124623661|NCT02288325|448237162|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
124623662|NCT02288325|448237163|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
124623663|NCT02288325|448237164|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
124623664|NCT02288325|448237162|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
124623665|NCT02288325|448237163|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
124623666|NCT02288325|448237164|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
124623667|NCT02288325|448237162|FG000|Double-blind Treatment Period|Protocol Violation|0|||
124623668|NCT02288325|448237163|FG001|Double-blind Treatment Period|Protocol Violation|1|||
124623669|NCT02288325|448237164|FG002|Double-blind Treatment Period|Protocol Violation|2|||
124623670|NCT02288325|448237162|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
124623671|NCT02288325|448237163|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
124623672|NCT02288325|448237164|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
124623673|NCT02288325|448237162|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
124623674|NCT02288325|448237163|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
124623675|NCT02288325|448237164|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
124623676|NCT03519087|448237171|FG000|Clinic Evaluation|Physician Decision|15|||
124623677|NCT03519087|448237172|FG001|Clinic Evaluation|Physician Decision|18|||
124623678|NCT03519087|448237173|FG002|Clinic Evaluation|Physician Decision|0|||
124623679|NCT03519087|448237174|FG003|Clinic Evaluation|Physician Decision|0|||
124623680|NCT03519087|448237175|FG004|Clinic Evaluation|Physician Decision|0|||
124623681|NCT03519087|448237171|FG000|Clinic Evaluation|Protocol Violation|1|||
124623682|NCT03519087|448237172|FG001|Clinic Evaluation|Protocol Violation|0|||
124623683|NCT03519087|448237173|FG002|Clinic Evaluation|Protocol Violation|0|||
124623684|NCT03519087|448237174|FG003|Clinic Evaluation|Protocol Violation|0|||
124623685|NCT03519087|448237175|FG004|Clinic Evaluation|Protocol Violation|0|||
124623686|NCT03519087|448237171|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
124623687|NCT03519087|448237172|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
124623688|NCT03519087|448237173|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
124783534|NCT03646123|448838155|FG000|Overall Study|Withdrawal by Subject|2|||
124783535|NCT03646123|448838156|FG001|Overall Study|Withdrawal by Subject|2|||
124783536|NCT03646123|448838157|FG002|Overall Study|Withdrawal by Subject|3|||
124623689|NCT03519087|448237174|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
124623690|NCT03519087|448237175|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
124623691|NCT03519087|448237171|FG000|Re-randomization for Treatment|Not appropriate|2|||
124623692|NCT03519087|448237172|FG001|Re-randomization for Treatment|Not appropriate|3|||
124623693|NCT03519087|448237173|FG002|Re-randomization for Treatment|Not appropriate|0|||
124623694|NCT03519087|448237174|FG003|Re-randomization for Treatment|Not appropriate|0|||
124623695|NCT03519087|448237175|FG004|Re-randomization for Treatment|Not appropriate|0|||
124623696|NCT03519087|448237171|FG000|Laboratory Testing|Lost to Follow-up|0|||
124623697|NCT03519087|448237172|FG001|Laboratory Testing|Lost to Follow-up|0|||
124623698|NCT03519087|448237173|FG002|Laboratory Testing|Lost to Follow-up|2|||
124623699|NCT03519087|448237174|FG003|Laboratory Testing|Lost to Follow-up|3|||
124623700|NCT03519087|448237175|FG004|Laboratory Testing|Lost to Follow-up|6|||
124623701|NCT03519087|448237171|FG000|Laboratory Testing|Protocol Violation|0|||
124623702|NCT03519087|448237172|FG001|Laboratory Testing|Protocol Violation|0|||
124623703|NCT03519087|448237173|FG002|Laboratory Testing|Protocol Violation|0|||
124623704|NCT03519087|448237174|FG003|Laboratory Testing|Protocol Violation|1|||
124623705|NCT03519087|448237175|FG004|Laboratory Testing|Protocol Violation|0|||
124623706|NCT02374346|448237177|FG000|Overall Study|operated or discharged during weekend|48|||
124623707|NCT01137071|448237178|FG000|Overall Study|Disease Progression|11|||
124623708|NCT01137071|448237178|FG000|Overall Study|Withdrawal by Subject|2|||
124623709|NCT01137071|448237178|FG000|Overall Study|Wrongly Included|1|||
124623710|NCT04194645|448237179|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
124623711|NCT04194645|448237180|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
124623712|NCT04194645|448237181|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
124623713|NCT04194645|448237182|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
124623714|NCT04194645|448237183|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
124623715|NCT04194645|448237184|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
124623716|NCT04194645|448237185|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
124623717|NCT04194645|448237186|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
124623718|NCT04194645|448237187|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
124623719|NCT04194645|448237188|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
124623720|NCT04194645|448237189|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
124623721|NCT04194645|448237190|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
124623722|NCT04194645|448237191|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
124623723|NCT04194645|448237192|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
124623724|NCT04194645|448237193|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
124623725|NCT03656744|448237194|FG000|Overall Study|Adverse Event|1|||
124623726|NCT03656744|448237195|FG001|Overall Study|Adverse Event|4|||
124623727|NCT03656744|448237196|FG002|Overall Study|Adverse Event|1|||
124623728|NCT03656744|448237194|FG000|Overall Study|Protocol Violation|1|||
124623729|NCT03656744|448237195|FG001|Overall Study|Protocol Violation|0|||
124623730|NCT03656744|448237196|FG002|Overall Study|Protocol Violation|0|||
124623731|NCT03656744|448237194|FG000|Overall Study|Lost to Follow-up|2|||
124623732|NCT03656744|448237195|FG001|Overall Study|Lost to Follow-up|2|||
124623733|NCT03656744|448237196|FG002|Overall Study|Lost to Follow-up|0|||
124623734|NCT03656744|448237194|FG000|Overall Study|Withdrawal by Subject|0|||
124623735|NCT03656744|448237195|FG001|Overall Study|Withdrawal by Subject|1|||
124623736|NCT03656744|448237196|FG002|Overall Study|Withdrawal by Subject|0|||
124623737|NCT03656744|448237194|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
124623738|NCT03656744|448237195|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
124623739|NCT03656744|448237196|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
124623740|NCT03910673|448237199|FG000|Overall Study|Adverse Event|0|||
124623741|NCT03910673|448237200|FG001|Overall Study|Adverse Event|0|||
124623742|NCT03910673|448237201|FG002|Overall Study|Adverse Event|0|||
124623743|NCT03910673|448237202|FG003|Overall Study|Adverse Event|2|||
124623744|NCT03910673|448237203|FG004|Overall Study|Adverse Event|0|||
124623745|NCT00098774|448237204|FG000|Overall Study|Adverse Event|2|||
124623746|NCT00098774|448237204|FG000|Overall Study|Disease Progression|9|||
124623747|NCT00098774|448237204|FG000|Overall Study|Withdrawal by Subject|1|||
124623748|NCT00098774|448237204|FG000|Overall Study|Failed (to respond) during induction|4|||
124623749|NCT00098774|448237204|FG000|Overall Study|Physician Decision|2|||
124623750|NCT02290405|448237205|FG000|Overall Study|Withdrawal by Subject|1|||
124623751|NCT02290405|448237206|FG001|Overall Study|Withdrawal by Subject|0|||
124623752|NCT03142191|448237207|FG000|Placebo Controlled Period|Death|0|||
124623753|NCT03142191|448237208|FG001|Placebo Controlled Period|Death|1|||
124623754|NCT03142191|448237209|FG002|Placebo Controlled Period|Death|1|||
124623755|NCT03142191|448237210|FG003|Placebo Controlled Period|Death|0|||
124623756|NCT03142191|448237211|FG004|Placebo Controlled Period|Death|0|||
124623757|NCT03142191|448237207|FG000|Placebo Controlled Period|Adverse Event|4|||
124623758|NCT03142191|448237208|FG001|Placebo Controlled Period|Adverse Event|5|||
124623759|NCT03142191|448237209|FG002|Placebo Controlled Period|Adverse Event|1|||
124623760|NCT03142191|448237210|FG003|Placebo Controlled Period|Adverse Event|0|||
124623761|NCT03142191|448237211|FG004|Placebo Controlled Period|Adverse Event|0|||
124623762|NCT03142191|448237207|FG000|Placebo Controlled Period|Progressive Disease|1|||
124623763|NCT03142191|448237208|FG001|Placebo Controlled Period|Progressive Disease|0|||
124623764|NCT03142191|448237209|FG002|Placebo Controlled Period|Progressive Disease|1|||
124623765|NCT03142191|448237210|FG003|Placebo Controlled Period|Progressive Disease|0|||
124623766|NCT03142191|448237211|FG004|Placebo Controlled Period|Progressive Disease|0|||
124623767|NCT03142191|448237207|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
124623768|NCT03142191|448237208|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
124623769|NCT03142191|448237209|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
124623770|NCT03142191|448237210|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
124623771|NCT03142191|448237211|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
124623772|NCT03142191|448237207|FG000|Placebo Controlled Period|Other Reasons|1|||
124623773|NCT03142191|448237208|FG001|Placebo Controlled Period|Other Reasons|0|||
124623774|NCT03142191|448237209|FG002|Placebo Controlled Period|Other Reasons|0|||
124623775|NCT03142191|448237210|FG003|Placebo Controlled Period|Other Reasons|0|||
124623776|NCT03142191|448237211|FG004|Placebo Controlled Period|Other Reasons|0|||
124623777|NCT03142191|448237207|FG000|Active Treatment Extension Period|Death|2|||
124623778|NCT03142191|448237208|FG001|Active Treatment Extension Period|Death|1|||
124623779|NCT03142191|448237209|FG002|Active Treatment Extension Period|Death|1|||
124623780|NCT03142191|448237210|FG003|Active Treatment Extension Period|Death|1|||
124623781|NCT03142191|448237211|FG004|Active Treatment Extension Period|Death|0|||
124623782|NCT03142191|448237207|FG000|Active Treatment Extension Period|Adverse Event|6|||
124623783|NCT03142191|448237208|FG001|Active Treatment Extension Period|Adverse Event|5|||
124623784|NCT03142191|448237209|FG002|Active Treatment Extension Period|Adverse Event|4|||
124623785|NCT03142191|448237210|FG003|Active Treatment Extension Period|Adverse Event|1|||
124623786|NCT03142191|448237211|FG004|Active Treatment Extension Period|Adverse Event|0|||
124623787|NCT03142191|448237207|FG000|Active Treatment Extension Period|Progressive Disease|10|||
124623788|NCT03142191|448237208|FG001|Active Treatment Extension Period|Progressive Disease|5|||
124623789|NCT03142191|448237209|FG002|Active Treatment Extension Period|Progressive Disease|4|||
124623790|NCT03142191|448237210|FG003|Active Treatment Extension Period|Progressive Disease|1|||
124623791|NCT03142191|448237211|FG004|Active Treatment Extension Period|Progressive Disease|2|||
124623792|NCT03142191|448237207|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
124623793|NCT03142191|448237208|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
124623794|NCT03142191|448237209|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
124623795|NCT03142191|448237210|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
124623796|NCT03142191|448237211|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
124623797|NCT03142191|448237207|FG000|Active Treatment Extension Period|Physician Decision|2|||
124623798|NCT03142191|448237208|FG001|Active Treatment Extension Period|Physician Decision|0|||
124623799|NCT03142191|448237209|FG002|Active Treatment Extension Period|Physician Decision|0|||
124623800|NCT03142191|448237210|FG003|Active Treatment Extension Period|Physician Decision|0|||
124623801|NCT03142191|448237211|FG004|Active Treatment Extension Period|Physician Decision|0|||
124623802|NCT03142191|448237207|FG000|Active Treatment Extension Period|Other Reasons|3|||
124623803|NCT03142191|448237208|FG001|Active Treatment Extension Period|Other Reasons|3|||
124623804|NCT03142191|448237209|FG002|Active Treatment Extension Period|Other Reasons|3|||
124623805|NCT03142191|448237210|FG003|Active Treatment Extension Period|Other Reasons|8|||
124623806|NCT03142191|448237211|FG004|Active Treatment Extension Period|Other Reasons|3|||
124623807|NCT03142191|448237207|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
124623808|NCT03142191|448237208|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
124623809|NCT03142191|448237209|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
124623810|NCT03142191|448237210|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
124623811|NCT03142191|448237211|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
124623812|NCT01277211|448237212|FG000|Overall Study|Adverse Event|60|||
124623813|NCT01277211|448237213|FG001|Overall Study|Adverse Event|22|||
124623814|NCT01277211|448237212|FG000|Overall Study|Pregnancy|9|||
124623815|NCT01277211|448237213|FG001|Overall Study|Pregnancy|4|||
124623816|NCT01277211|448237212|FG000|Overall Study|Lost to Follow-up|14|||
124623817|NCT01277211|448237213|FG001|Overall Study|Lost to Follow-up|9|||
124623818|NCT01277211|448237212|FG000|Overall Study|Did not wish to continue|17|||
124623819|NCT01277211|448237213|FG001|Overall Study|Did not wish to continue|0|||
124623820|NCT01277211|448237212|FG000|Overall Study|Withdrew Consent|9|||
124623821|NCT01277211|448237213|FG001|Overall Study|Withdrew Consent|9|||
124623822|NCT01277211|448237212|FG000|Overall Study|Non-compliance with protocol|13|||
124623823|NCT01277211|448237213|FG001|Overall Study|Non-compliance with protocol|4|||
124783537|NCT03646123|448838155|FG000|Overall Study|Study termination by sponsor|0|||
124623824|NCT01277211|448237212|FG000|Overall Study|Did not meet protocol eligibility|1|||
124623825|NCT01277211|448237213|FG001|Overall Study|Did not meet protocol eligibility|0|||
124623826|NCT01277211|448237212|FG000|Overall Study|Administrative|3|||
124783538|NCT03646123|448838156|FG001|Overall Study|Study termination by sponsor|45|||
124623827|NCT01277211|448237213|FG001|Overall Study|Administrative|0|||
124623828|NCT01277211|448237212|FG000|Overall Study|Pregnancy wish|0|||
124623829|NCT01277211|448237213|FG001|Overall Study|Pregnancy wish|2|||
124623830|NCT01277211|448237212|FG000|Overall Study|Discontinued prior to treatment|24|||
124623831|NCT01277211|448237213|FG001|Overall Study|Discontinued prior to treatment|13|||
124623832|NCT02536846|448237214|FG000|Overall Study|Withdrawal by Subject|1|||
124623833|NCT02593110|448237215|FG000|Overall Study|Withdrawal by Subject|0|||
124623834|NCT02593110|448237216|FG001|Overall Study|Withdrawal by Subject|3|||
124623835|NCT02593110|448237217|FG002|Overall Study|Withdrawal by Subject|3|||
124623836|NCT02593110|448237218|FG003|Overall Study|Withdrawal by Subject|2|||
124623837|NCT02593110|448237215|FG000|Overall Study|Death|0|||
124623838|NCT02593110|448237216|FG001|Overall Study|Death|0|||
124623839|NCT02593110|448237217|FG002|Overall Study|Death|1|||
124623840|NCT02593110|448237218|FG003|Overall Study|Death|0|||
124623841|NCT04604795|448237219|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
124623842|NCT04604795|448237220|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
124623843|NCT04604795|448237221|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
124623844|NCT04604795|448237222|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
124623845|NCT04604795|448237223|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
124623846|NCT04604795|448237224|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
124623847|NCT04604795|448237225|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
124623848|NCT04604795|448237226|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
124623849|NCT04604795|448237227|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
124623850|NCT04604795|448237228|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
124623851|NCT04604795|448237219|FG000|Part B: Up to Day 14|Adverse Event|0|||
124623852|NCT04604795|448237220|FG001|Part B: Up to Day 14|Adverse Event|0|||
124623853|NCT04604795|448237221|FG002|Part B: Up to Day 14|Adverse Event|0|||
124623854|NCT04604795|448237222|FG003|Part B: Up to Day 14|Adverse Event|0|||
124623855|NCT04604795|448237223|FG004|Part B: Up to Day 14|Adverse Event|2|||
124623856|NCT04604795|448237224|FG005|Part B: Up to Day 14|Adverse Event|1|||
124623857|NCT04604795|448237225|FG006|Part B: Up to Day 14|Adverse Event|0|||
124623858|NCT04604795|448237226|FG007|Part B: Up to Day 14|Adverse Event|0|||
124623859|NCT04604795|448237227|FG008|Part B: Up to Day 14|Adverse Event|0|||
124623860|NCT04604795|448237228|FG009|Part B: Up to Day 14|Adverse Event|0|||
124623861|NCT04604795|448237219|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
124623862|NCT04604795|448237220|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
124623863|NCT04604795|448237221|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
124623864|NCT04604795|448237222|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
124623865|NCT04604795|448237223|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
124623866|NCT04604795|448237224|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
124623867|NCT04604795|448237225|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
124623868|NCT04604795|448237226|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
124623869|NCT04604795|448237227|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
124623870|NCT04604795|448237228|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
124623871|NCT04604795|448237219|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
124623872|NCT04604795|448237220|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
124623873|NCT04604795|448237221|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
124623874|NCT04604795|448237222|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
124623875|NCT04604795|448237223|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
124623876|NCT04604795|448237224|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
124623877|NCT04604795|448237225|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
124623878|NCT04604795|448237226|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
124623879|NCT04604795|448237227|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
124623880|NCT04604795|448237228|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
124623881|NCT04604795|448237219|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
124783539|NCT03646123|448838157|FG002|Overall Study|Study termination by sponsor|139|||
124783540|NCT03646123|448838155|FG000|Overall Study|Lost to Follow-up|4|||
124783541|NCT03646123|448838156|FG001|Overall Study|Lost to Follow-up|10|||
124783542|NCT03646123|448838157|FG002|Overall Study|Lost to Follow-up|10|||
124783543|NCT03646123|448838155|FG000|Overall Study|Death|2|||
124783544|NCT03646123|448838156|FG001|Overall Study|Death|1|||
124783545|NCT03646123|448838157|FG002|Overall Study|Death|1|||
124783546|NCT03646123|448838155|FG000|Overall Study|Other|2|||
124623882|NCT04604795|448237220|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
124623883|NCT04604795|448237221|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
124623884|NCT04604795|448237222|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
124623885|NCT04604795|448237223|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
124623886|NCT04604795|448237224|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
124623887|NCT04604795|448237225|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
124623888|NCT04604795|448237226|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
124623889|NCT04604795|448237227|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
124623890|NCT04604795|448237228|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
124623891|NCT04604795|448237219|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
124623892|NCT04604795|448237220|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
124623893|NCT04604795|448237221|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
124623894|NCT04604795|448237222|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
124623895|NCT04604795|448237223|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
124623896|NCT04604795|448237224|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
124623897|NCT04604795|448237225|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
124623898|NCT04604795|448237226|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
124623899|NCT04604795|448237227|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
124623900|NCT04604795|448237228|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
124623901|NCT00111241|448237236|FG000|Overall Study|Lost to Follow-up|1|||
124623902|NCT00111241|448237237|FG001|Overall Study|Lost to Follow-up|0|||
124623903|NCT00111241|448237236|FG000|Overall Study|Withdrawal by Subject|4|||
124623904|NCT00111241|448237237|FG001|Overall Study|Withdrawal by Subject|0|||
124623905|NCT00111241|448237236|FG000|Overall Study|Protocol Violation|9|||
124623906|NCT00111241|448237237|FG001|Overall Study|Protocol Violation|8|||
124623907|NCT00111241|448237236|FG000|Overall Study|Adverse Event|1|||
124623908|NCT00111241|448237237|FG001|Overall Study|Adverse Event|0|||
124623909|NCT02096744|448237238|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
124623910|NCT02096744|448237239|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
124623911|NCT02096744|448237238|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
124623912|NCT02096744|448237239|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
124623913|NCT02096744|448237238|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
124623914|NCT02096744|448237239|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
124623915|NCT00952731|448237245|FG000|Overall Study|Drug supply expired|1|||
124623916|NCT00952731|448237246|FG001|Overall Study|Drug supply expired|0|||
124623917|NCT01450683|448237247|FG000|Overall Study|Adverse Event|2|||
124623918|NCT02108912|448237248|FG000|Overall Study|Lost to Follow-up|1|||
124623919|NCT02108912|448237249|FG001|Overall Study|Lost to Follow-up|1|||
124623920|NCT02108912|448237248|FG000|Overall Study|lack of transportation|1|||
124623921|NCT02108912|448237249|FG001|Overall Study|lack of transportation|0|||
124623922|NCT02108912|448237248|FG000|Overall Study|high blood pressure|1|||
124623923|NCT02108912|448237249|FG001|Overall Study|high blood pressure|0|||
124623924|NCT00625872|448237250|FG000|Overall Study|Withdrawal by Subject|1|||
124623925|NCT00625872|448237251|FG001|Overall Study|Withdrawal by Subject|0|||
124623926|NCT00625872|448237250|FG000|Overall Study|Does not meet inclusion criteria|1|||
124623927|NCT00625872|448237251|FG001|Overall Study|Does not meet inclusion criteria|0|||
124623928|NCT00625872|448237250|FG000|Overall Study|Terminated by sponsor|2|||
124623929|NCT00625872|448237251|FG001|Overall Study|Terminated by sponsor|5|||
124623930|NCT00625872|448237250|FG000|Overall Study|Randomized but not treated|0|||
124623931|NCT00625872|448237251|FG001|Overall Study|Randomized but not treated|1|||
124623932|NCT00852202|448237252|FG000|Overall Study|Adverse Event|2|||
124623933|NCT00852202|448237253|FG001|Overall Study|Adverse Event|3|||
124623934|NCT00852202|448237254|FG002|Overall Study|Adverse Event|7|||
124623935|NCT00852202|448237252|FG000|Overall Study|Lack of Efficacy|4|||
124623936|NCT00852202|448237253|FG001|Overall Study|Lack of Efficacy|1|||
124623937|NCT00852202|448237254|FG002|Overall Study|Lack of Efficacy|2|||
124623938|NCT00852202|448237252|FG000|Overall Study|Protocol Violation|2|||
124623939|NCT00852202|448237253|FG001|Overall Study|Protocol Violation|2|||
124623940|NCT00852202|448237254|FG002|Overall Study|Protocol Violation|7|||
124623941|NCT00852202|448237252|FG000|Overall Study|Withdrawal by Subject|3|||
124623942|NCT00852202|448237253|FG001|Overall Study|Withdrawal by Subject|1|||
124623943|NCT00852202|448237254|FG002|Overall Study|Withdrawal by Subject|2|||
124623944|NCT00852202|448237252|FG000|Overall Study|Lost to Follow-up|5|||
124623945|NCT00852202|448237253|FG001|Overall Study|Lost to Follow-up|5|||
124623946|NCT00852202|448237254|FG002|Overall Study|Lost to Follow-up|6|||
124623947|NCT00852202|448237252|FG000|Overall Study|pregnancy,moving away and surgery|1|||
124623948|NCT00852202|448237253|FG001|Overall Study|pregnancy,moving away and surgery|0|||
124623949|NCT00852202|448237254|FG002|Overall Study|pregnancy,moving away and surgery|2|||
124623950|NCT05022212|448237257|FG000|Overall Study|Lost to Follow-up|0|||
124623951|NCT05022212|448237258|FG001|Overall Study|Lost to Follow-up|2|||
124623952|NCT01682811|448237259|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
124623953|NCT01682811|448237260|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
124623954|NCT01682811|448237261|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
124623955|NCT01682811|448237262|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
124783547|NCT03646123|448838156|FG001|Overall Study|Other|0|||
124783548|NCT03646123|448838157|FG002|Overall Study|Other|2|||
124623956|NCT01682811|448237263|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
124623957|NCT01682811|448237264|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
124623958|NCT01682811|448237265|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
124623959|NCT01682811|448237259|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
124783549|NCT03462511|448838163|FG000|Overall Study|Withdrawal by Subject|2|||
124623960|NCT01682811|448237260|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
124623961|NCT01682811|448237261|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
124623962|NCT01682811|448237262|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
124623963|NCT01682811|448237263|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
124623964|NCT01682811|448237264|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
124623965|NCT01682811|448237265|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
124623966|NCT01682811|448237259|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
124623967|NCT01682811|448237260|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
124623968|NCT01682811|448237261|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
124623969|NCT01682811|448237262|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
124623970|NCT01682811|448237263|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
124623971|NCT01682811|448237264|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
124623972|NCT01682811|448237265|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
124623973|NCT01682811|448237259|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
124623974|NCT01682811|448237260|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
124623975|NCT01682811|448237261|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
124623976|NCT01682811|448237262|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
124623977|NCT01682811|448237263|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
124623978|NCT01682811|448237264|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
124623979|NCT01682811|448237265|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
124623980|NCT02694328|448237266|FG000|Overall Study|Adverse Event|27|||
124623981|NCT02694328|448237267|FG001|Overall Study|Adverse Event|33|||
124623982|NCT02694328|448237266|FG000|Overall Study|Withdrawal by Subject|27|||
124623983|NCT02694328|448237267|FG001|Overall Study|Withdrawal by Subject|23|||
124623984|NCT02694328|448237266|FG000|Overall Study|Lost to Follow-up|26|||
124623985|NCT02694328|448237267|FG001|Overall Study|Lost to Follow-up|22|||
124623986|NCT02694328|448237266|FG000|Overall Study|Noncompliant with study drug|11|||
124623987|NCT02694328|448237267|FG001|Overall Study|Noncompliant with study drug|8|||
124623988|NCT02694328|448237266|FG000|Overall Study|Incarceration|1|||
124623989|NCT02694328|448237267|FG001|Overall Study|Incarceration|1|||
124623990|NCT02694328|448237266|FG000|Overall Study|Lack of Efficacy|1|||
124623991|NCT02694328|448237267|FG001|Overall Study|Lack of Efficacy|2|||
124623992|NCT02694328|448237266|FG000|Overall Study|Pregnancy|1|||
124623993|NCT02694328|448237267|FG001|Overall Study|Pregnancy|1|||
124623994|NCT02694328|448237266|FG000|Overall Study|Protocol Violation|6|||
124623995|NCT02694328|448237267|FG001|Overall Study|Protocol Violation|5|||
124623996|NCT02694328|448237266|FG000|Overall Study|Abnormal Laboratory Value|0|||
124623997|NCT02694328|448237267|FG001|Overall Study|Abnormal Laboratory Value|3|||
124623998|NCT04100018|448239183|FG000|Pre-Treatment Period|Not Reported|0|||
124623999|NCT04100018|448239184|FG001|Pre-Treatment Period|Not Reported|4|||
124624000|NCT04100018|448239183|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
124624001|NCT04100018|448239184|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
124624002|NCT04100018|448239183|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
124624003|NCT04100018|448239184|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
124624004|NCT04100018|448239183|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
124624005|NCT04100018|448239184|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
124624006|NCT04100018|448239183|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
124624007|NCT04100018|448239184|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
124624008|NCT04100018|448239183|FG000|Treatment Period|Ongoing Treatment|1|||
124624009|NCT04100018|448239184|FG001|Treatment Period|Ongoing Treatment|0|||
124783550|NCT03462511|448838164|FG001|Overall Study|Withdrawal by Subject|3|||
124783551|NCT02925416|448838165|FG000|Overall Study|Adverse Event|2|||
124783552|NCT02925416|448838166|FG001|Overall Study|Adverse Event|0|||
124783553|NCT03595228|448838167|FG000|Overall Study|Death|2|||
124783554|NCT03595228|448838167|FG000|Overall Study|Lack of Efficacy|13|||
124783555|NCT03595228|448838167|FG000|Overall Study|Withdrawal by Subject|3|||
124783556|NCT03595228|448838167|FG000|Overall Study|Withdrawal by Sponsor|1|||
124783557|NCT00200356|448838168|FG000|Overall Study|Lack of Efficacy|3|||
124783558|NCT00200356|448838169|FG001|Overall Study|Lack of Efficacy|3|||
124783559|NCT00200356|448838168|FG000|Overall Study|Protocol Violation|4|||
124783560|NCT00200356|448838169|FG001|Overall Study|Protocol Violation|4|||
124783561|NCT00200356|448838168|FG000|Overall Study|Nontreatment|1|||
124783562|NCT00200356|448838169|FG001|Overall Study|Nontreatment|0|||
124783563|NCT00435045|448838171|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
124783564|NCT00435045|448838172|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
124783565|NCT00435045|448838171|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
124783566|NCT00435045|448838172|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
124783567|NCT00435045|448838171|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
124624010|NCT04100018|448239183|FG000|Treatment Period|Other Reason|26|||
124624011|NCT04100018|448239184|FG001|Treatment Period|Other Reason|37|||
124624012|NCT04100018|448239183|FG000|Treatment Period|Completed treatment as per protocol|1|||
124624013|NCT04100018|448239184|FG001|Treatment Period|Completed treatment as per protocol|2|||
124624014|NCT04100018|448239183|FG000|Treatment Period|Maximum clinical benefit|3|||
124624015|NCT04100018|448239184|FG001|Treatment Period|Maximum clinical benefit|0|||
124624016|NCT04100018|448239183|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
124624017|NCT04100018|448239184|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
124783568|NCT00435045|448838172|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
124624018|NCT04100018|448239183|FG000|Treatment Period|Study drug toxicity|67|||
124624019|NCT04100018|448239184|FG001|Treatment Period|Study drug toxicity|28|||
124624020|NCT04100018|448239183|FG000|Treatment Period|Disease Progression|284|||
124624021|NCT04100018|448239184|FG001|Treatment Period|Disease Progression|327|||
124624022|NCT04100018|448239183|FG000|Treatment Period|Administrative reasons by sponsor|16|||
124624023|NCT04100018|448239184|FG001|Treatment Period|Administrative reasons by sponsor|30|||
124624024|NCT04100018|448239183|FG000|Treatment Period|Poor/Non-Compliance|1|||
124624025|NCT04100018|448239184|FG001|Treatment Period|Poor/Non-Compliance|0|||
124624026|NCT04100018|448239183|FG000|Treatment Period|Lost to Follow-up|2|||
124624027|NCT04100018|448239184|FG001|Treatment Period|Lost to Follow-up|2|||
124624028|NCT04100018|448239183|FG000|Treatment Period|Death|16|||
124624029|NCT04100018|448239184|FG001|Treatment Period|Death|11|||
124624030|NCT04100018|448239183|FG000|Treatment Period|Participant withdrew consent|10|||
124624031|NCT04100018|448239184|FG001|Treatment Period|Participant withdrew consent|10|||
124624032|NCT04100018|448239183|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
124624033|NCT04100018|448239184|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
124624034|NCT04100018|448239183|FG000|Treatment Period|Adverse Event|14|||
124624035|NCT04100018|448239184|FG001|Treatment Period|Adverse Event|6|||
124624036|NCT04100018|448239183|FG000|Treatment Period|Lack of Efficacy|4|||
124624037|NCT04100018|448239184|FG001|Treatment Period|Lack of Efficacy|2|||
124624038|NCT02653625|448239191|FG000|Overall Study|Adverse Event|1|||
124624039|NCT02653625|448239191|FG000|Overall Study|Non-compliance with Study Drug|1|||
124624040|NCT02653625|448239191|FG000|Overall Study|Protocol Violation|1|||
124624041|NCT02653625|448239191|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
124624042|NCT02090725|448239192|FG000|Overall Study|Withdrawal by Subject|1|||
124624043|NCT02090725|448239192|FG000|Overall Study|participants moved from area|3|||
124624044|NCT01499095|448239193|FG000|Overall Study|Randomized But Not Treated|1|||
124624045|NCT01499095|448239194|FG001|Overall Study|Randomized But Not Treated|1|||
124624046|NCT01499095|448239193|FG000|Overall Study|Adverse Event|12|||
124624047|NCT01499095|448239194|FG001|Overall Study|Adverse Event|7|||
124624048|NCT01499095|448239193|FG000|Overall Study|Lack of Efficacy|2|||
124624049|NCT01499095|448239194|FG001|Overall Study|Lack of Efficacy|1|||
124624050|NCT01499095|448239193|FG000|Overall Study|Protocol Violation|6|||
124624051|NCT01499095|448239194|FG001|Overall Study|Protocol Violation|7|||
124624052|NCT01499095|448239193|FG000|Overall Study|Received Rescue Therapy|32|||
124624053|NCT01499095|448239194|FG001|Overall Study|Received Rescue Therapy|40|||
124624054|NCT01499095|448239193|FG000|Overall Study|Diverse Reasons|22|||
124624055|NCT01499095|448239194|FG001|Overall Study|Diverse Reasons|25|||
124624056|NCT01499095|448239193|FG000|Overall Study|Lost to Follow-up|6|||
124624057|NCT01499095|448239194|FG001|Overall Study|Lost to Follow-up|4|||
124624058|NCT01499095|448239193|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
124624059|NCT01499095|448239194|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
124624060|NCT01499095|448239193|FG000|Overall Study|Hypoglycemia|3|||
124624061|NCT01499095|448239194|FG001|Overall Study|Hypoglycemia|1|||
124624062|NCT01499095|448239193|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
124624063|NCT01499095|448239194|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
124624064|NCT01499095|448239193|FG000|Overall Study|Change in Injection Schedule|2|||
124624065|NCT01499095|448239194|FG001|Overall Study|Change in Injection Schedule|0|||
124624066|NCT01499095|448239193|FG000|Overall Study|Perceived Lack of Efficacy|1|||
124624067|NCT01499095|448239194|FG001|Overall Study|Perceived Lack of Efficacy|1|||
124624068|NCT04358081|448239198|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
124624069|NCT04358081|448239199|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
124624070|NCT04358081|448239200|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
124624071|NCT04358081|448239198|FG000|Treatment Phase of Study|Adverse Event|1|||
124624072|NCT04358081|448239199|FG001|Treatment Phase of Study|Adverse Event|0|||
124624073|NCT04358081|448239200|FG002|Treatment Phase of Study|Adverse Event|1|||
124624074|NCT04358081|448239198|FG000|Treatment Phase of Study|Physician Decision|2|||
124624075|NCT04358081|448239199|FG001|Treatment Phase of Study|Physician Decision|0|||
124624076|NCT04358081|448239200|FG002|Treatment Phase of Study|Physician Decision|1|||
124624077|NCT04358081|448239198|FG000|Treatment Phase of Study|Protocol Violation|1|||
124624078|NCT04358081|448239199|FG001|Treatment Phase of Study|Protocol Violation|0|||
124624079|NCT04358081|448239200|FG002|Treatment Phase of Study|Protocol Violation|0|||
124624080|NCT04358081|448239198|FG000|Study Completion Phase|Death|0|||
124624081|NCT04358081|448239199|FG001|Study Completion Phase|Death|0|||
124624082|NCT04358081|448239200|FG002|Study Completion Phase|Death|1|||
124624083|NCT04358081|448239198|FG000|Study Completion Phase|Lost to Follow-up|1|||
124624084|NCT04358081|448239199|FG001|Study Completion Phase|Lost to Follow-up|0|||
124624085|NCT04358081|448239200|FG002|Study Completion Phase|Lost to Follow-up|1|||
124624086|NCT01130532|448239201|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
124624087|NCT01130532|448239202|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
124624088|NCT01130532|448239203|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
124624089|NCT01130532|448239204|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
124624090|NCT01130532|448239201|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
124624091|NCT01130532|448239202|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
124624092|NCT01130532|448239203|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
124624093|NCT01130532|448239204|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
124624094|NCT01130532|448239201|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
124624095|NCT01130532|448239202|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
124624096|NCT01130532|448239203|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
124624097|NCT01130532|448239204|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
124624098|NCT01130532|448239201|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
124624099|NCT01130532|448239202|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
124624100|NCT01130532|448239203|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
124624101|NCT01130532|448239204|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
124624102|NCT01130532|448239201|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
124624103|NCT01130532|448239202|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
124624104|NCT01130532|448239203|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
124624105|NCT01130532|448239204|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
124624106|NCT01130532|448239201|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
124624107|NCT01130532|448239202|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
124624108|NCT01130532|448239203|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
124624109|NCT01130532|448239204|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
124624110|NCT01130532|448239201|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
124624111|NCT01130532|448239202|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
124624112|NCT01130532|448239203|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
124624113|NCT01130532|448239204|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
124624114|NCT01130532|448239201|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
124624115|NCT01130532|448239202|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
124624116|NCT01130532|448239203|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
124624117|NCT01130532|448239204|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
124624118|NCT01130532|448239201|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
124624119|NCT01130532|448239202|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
124624120|NCT01130532|448239203|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
124624121|NCT01130532|448239204|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
124624122|NCT01130532|448239201|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
124624123|NCT01130532|448239202|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
124624124|NCT01130532|448239203|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
124624125|NCT01130532|448239204|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
124624126|NCT01130532|448239201|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
124624127|NCT01130532|448239202|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
124624128|NCT01130532|448239203|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
124624129|NCT01130532|448239204|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
124624130|NCT02762929|448239205|FG000|Overall Study|Adverse Event|0|||
124624131|NCT02762929|448239206|FG001|Overall Study|Adverse Event|0|||
124624132|NCT02762929|448239207|FG002|Overall Study|Adverse Event|0|||
124624133|NCT02762929|448239208|FG003|Overall Study|Adverse Event|1|||
124624134|NCT02762929|448239209|FG004|Overall Study|Adverse Event|0|||
124624135|NCT02762929|448239210|FG005|Overall Study|Adverse Event|0|||
124624136|NCT02762929|448239205|FG000|Overall Study|Lost to Follow-up|1|||
124624137|NCT02762929|448239206|FG001|Overall Study|Lost to Follow-up|2|||
124624138|NCT02762929|448239207|FG002|Overall Study|Lost to Follow-up|0|||
124624139|NCT02762929|448239208|FG003|Overall Study|Lost to Follow-up|1|||
124624140|NCT02762929|448239209|FG004|Overall Study|Lost to Follow-up|0|||
124624141|NCT02762929|448239210|FG005|Overall Study|Lost to Follow-up|0|||
124624142|NCT02762929|448239205|FG000|Overall Study|Withdrawal by Subject|0|||
124624143|NCT02762929|448239206|FG001|Overall Study|Withdrawal by Subject|1|||
124624144|NCT02762929|448239207|FG002|Overall Study|Withdrawal by Subject|0|||
124624145|NCT02762929|448239208|FG003|Overall Study|Withdrawal by Subject|0|||
124624146|NCT02762929|448239209|FG004|Overall Study|Withdrawal by Subject|0|||
124624147|NCT02762929|448239210|FG005|Overall Study|Withdrawal by Subject|0|||
124624148|NCT02762929|448239205|FG000|Overall Study|exclusionary medication disclosed late|0|||
124624149|NCT02762929|448239206|FG001|Overall Study|exclusionary medication disclosed late|0|||
124624150|NCT02762929|448239207|FG002|Overall Study|exclusionary medication disclosed late|0|||
124624151|NCT02762929|448239208|FG003|Overall Study|exclusionary medication disclosed late|1|||
124624152|NCT02762929|448239209|FG004|Overall Study|exclusionary medication disclosed late|0|||
124624153|NCT02762929|448239210|FG005|Overall Study|exclusionary medication disclosed late|0|||
124624154|NCT02656303|448239211|FG000|Overall Study|Adverse Event|3|||
124624155|NCT02656303|448239212|FG001|Overall Study|Adverse Event|2|||
124624156|NCT02656303|448239213|FG002|Overall Study|Adverse Event|0|||
124624157|NCT02656303|448239211|FG000|Overall Study|Death|12|||
124624158|NCT02656303|448239212|FG001|Overall Study|Death|4|||
124624159|NCT02656303|448239213|FG002|Overall Study|Death|1|||
124624160|NCT02656303|448239211|FG000|Overall Study|Lack of Efficacy|1|||
124624161|NCT02656303|448239212|FG001|Overall Study|Lack of Efficacy|0|||
124624162|NCT02656303|448239213|FG002|Overall Study|Lack of Efficacy|0|||
124624163|NCT02656303|448239211|FG000|Overall Study|Non-Compliance with Study|1|||
124624164|NCT02656303|448239212|FG001|Overall Study|Non-Compliance with Study|1|||
124624165|NCT02656303|448239213|FG002|Overall Study|Non-Compliance with Study|0|||
124624166|NCT02656303|448239211|FG000|Overall Study|Investigator Decision|2|||
124624167|NCT02656303|448239212|FG001|Overall Study|Investigator Decision|1|||
124624168|NCT02656303|448239213|FG002|Overall Study|Investigator Decision|0|||
124624169|NCT02656303|448239211|FG000|Overall Study|Progressive Disease|25|||
124624170|NCT02656303|448239212|FG001|Overall Study|Progressive Disease|14|||
124624171|NCT02656303|448239213|FG002|Overall Study|Progressive Disease|10|||
124624172|NCT02656303|448239211|FG000|Overall Study|Study Terminated by Sponsor|20|||
124624173|NCT02656303|448239212|FG001|Overall Study|Study Terminated by Sponsor|7|||
124624174|NCT02656303|448239213|FG002|Overall Study|Study Terminated by Sponsor|5|||
124624175|NCT02656303|448239211|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
124624176|NCT02656303|448239212|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
124624177|NCT02656303|448239213|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
124624178|NCT02656303|448239211|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
124624179|NCT02656303|448239212|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
124624180|NCT02656303|448239213|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
124624181|NCT02656303|448239211|FG000|Overall Study|Reason not Specified|1|||
124624182|NCT02656303|448239212|FG001|Overall Study|Reason not Specified|1|||
124624183|NCT02656303|448239213|FG002|Overall Study|Reason not Specified|2|||
124624184|NCT01842438|448239216|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
124624185|NCT01842438|448239217|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
124624186|NCT01842438|448239216|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
124624187|NCT01842438|448239217|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
124624188|NCT01842438|448239216|FG000|T2: 6month Follow-up|Death|0|||
124624189|NCT01842438|448239217|FG001|T2: 6month Follow-up|Death|1|||
124624190|NCT00782626|448239221|FG000|Overall Study|Adverse Event|1|||
124624191|NCT00782626|448239221|FG000|Overall Study|Progressive Disease|5|||
124624192|NCT00782626|448239221|FG000|Overall Study|Other Complicating Disease|1|||
124624193|NCT04909853|448239222|FG000|Part 1|Assigned but not treated|0|||
124624194|NCT04909853|448239223|FG001|Part 1|Assigned but not treated|0|||
124624195|NCT04909853|448239224|FG002|Part 1|Assigned but not treated|1|||
124624196|NCT04909853|448239225|FG003|Part 1|Assigned but not treated|0|||
124624197|NCT04909853|448239222|FG000|Part 2|Adverse Event|0|||
124624198|NCT04909853|448239223|FG001|Part 2|Adverse Event|0|||
124624199|NCT04909853|448239224|FG002|Part 2|Adverse Event|0|||
124624200|NCT04909853|448239225|FG003|Part 2|Adverse Event|1|||
124624201|NCT04054765|448239226|FG000|Baseline|Withdrawal by Subject|5|||
124624202|NCT04054765|448239227|FG001|Baseline|Withdrawal by Subject|3|||
124624203|NCT04054765|448239226|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
124624204|NCT04054765|448239227|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
124624205|NCT04054765|448239226|FG000|3-month Follow up|Withdrawal by Subject|0|||
124624206|NCT04054765|448239227|FG001|3-month Follow up|Withdrawal by Subject|3|||
124624207|NCT04054765|448239226|FG000|6-month Follow up|Lost to Follow-up|32|||
124624208|NCT04054765|448239227|FG001|6-month Follow up|Lost to Follow-up|32|||
124624209|NCT00077207|448239229|FG000|Overall Study|Adverse Event|5|||
124624210|NCT00077207|448239229|FG000|Overall Study|Lack of Efficacy|12|||
124624211|NCT00077207|448239229|FG000|Overall Study|Physician Decision|6|||
124624212|NCT00077207|448239229|FG000|Overall Study|Withdrawal by Subject|6|||
124624213|NCT00077207|448239229|FG000|Overall Study|Ineligible|1|||
124624214|NCT00853099|448239230|FG000|Double-blind Period|Adverse Event|7|||
124624215|NCT00853099|448239231|FG001|Double-blind Period|Adverse Event|9|||
124624216|NCT00853099|448239232|FG002|Double-blind Period|Adverse Event|13|||
124624217|NCT00853099|448239233|FG003|Double-blind Period|Adverse Event|0|||
124624218|NCT00853099|448239230|FG000|Double-blind Period|Withdrawal by Subject|2|||
124624219|NCT00853099|448239231|FG001|Double-blind Period|Withdrawal by Subject|3|||
124624220|NCT00853099|448239232|FG002|Double-blind Period|Withdrawal by Subject|0|||
124624221|NCT00853099|448239233|FG003|Double-blind Period|Withdrawal by Subject|0|||
124624222|NCT00853099|448239230|FG000|Double-blind Period|Lack of Efficacy|14|||
124624223|NCT00853099|448239231|FG001|Double-blind Period|Lack of Efficacy|17|||
124624224|NCT00853099|448239232|FG002|Double-blind Period|Lack of Efficacy|16|||
124624225|NCT00853099|448239233|FG003|Double-blind Period|Lack of Efficacy|0|||
124624226|NCT00853099|448239230|FG000|Double-blind Period|Other|0|||
124624227|NCT00853099|448239231|FG001|Double-blind Period|Other|0|||
124624228|NCT00853099|448239232|FG002|Double-blind Period|Other|1|||
124624229|NCT00853099|448239233|FG003|Double-blind Period|Other|0|||
124624230|NCT00853099|448239230|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
124624231|NCT00853099|448239231|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
124624232|NCT00853099|448239232|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
124624233|NCT00853099|448239233|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
124624234|NCT00853099|448239230|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
124624235|NCT00853099|448239231|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
124624236|NCT00853099|448239232|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
124624237|NCT00853099|448239233|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
124624238|NCT00853099|448239230|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
124624239|NCT00853099|448239231|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
124624240|NCT00853099|448239232|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
124624241|NCT00853099|448239233|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
124624242|NCT00853099|448239230|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
124624243|NCT00853099|448239231|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
124624244|NCT00853099|448239232|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
124624245|NCT00853099|448239233|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
124624246|NCT00853099|448239230|FG000|Double-blind + Open-label Periods|Other|0|||
124624247|NCT00853099|448239231|FG001|Double-blind + Open-label Periods|Other|0|||
124624248|NCT00853099|448239232|FG002|Double-blind + Open-label Periods|Other|0|||
124624249|NCT00853099|448239233|FG003|Double-blind + Open-label Periods|Other|6|||
124624250|NCT01811472|448239234|FG000|Overall Study|Adverse Event|1|||
124624251|NCT01811472|448239235|FG001|Overall Study|Adverse Event|0|||
124624252|NCT01811472|448239236|FG002|Overall Study|Adverse Event|4|||
124624253|NCT01811472|448239234|FG000|Overall Study|Lost to Follow-up|0|||
124624254|NCT01811472|448239235|FG001|Overall Study|Lost to Follow-up|0|||
124624255|NCT01811472|448239236|FG002|Overall Study|Lost to Follow-up|1|||
124624256|NCT01811472|448239234|FG000|Overall Study|Subject/guardian decision|1|||
124624257|NCT01811472|448239235|FG001|Overall Study|Subject/guardian decision|0|||
124624258|NCT01811472|448239236|FG002|Overall Study|Subject/guardian decision|0|||
124624259|NCT03280264|448239237|FG000|Overall Study|Adverse Event|1|||
124624260|NCT03280264|448239237|FG000|Overall Study|Physician Decision|1|||
124624261|NCT03280264|448239237|FG000|Overall Study|Withdrawal by Subject|1|||
124624262|NCT02738138|448239239|FG000|Overall Study|Adverse Event|0|||
124624263|NCT02738138|448239240|FG001|Overall Study|Adverse Event|1|||
124624264|NCT02738138|448239239|FG000|Overall Study|Lost to Follow-up|2|||
124624265|NCT02738138|448239240|FG001|Overall Study|Lost to Follow-up|0|||
124624266|NCT02738138|448239239|FG000|Overall Study|Other - not further specified|1|||
124624267|NCT02738138|448239240|FG001|Overall Study|Other - not further specified|0|||
124624268|NCT01995513|448239243|FG000|Period 1: First Open Label Treatment|Other|34|||
124624269|NCT01995513|448239244|FG001|Period 1: First Open Label Treatment|Other|0|||
124624270|NCT01995513|448239245|FG002|Period 1: First Open Label Treatment|Other|0|||
124624271|NCT01995513|448239246|FG003|Period 1: First Open Label Treatment|Other|0|||
124624272|NCT01995513|448239243|FG000|Period 1: First Open Label Treatment|Death|14|||
124783569|NCT00435045|448838171|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
124783570|NCT00435045|448838172|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
124783571|NCT00435045|448838171|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
124783572|NCT00435045|448838172|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
124783573|NCT00435045|448838171|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
124783574|NCT00435045|448838172|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
124783575|NCT00435045|448838171|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
124783576|NCT00435045|448838172|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
124783577|NCT00435045|448838171|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
124783578|NCT00435045|448838172|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
124783579|NCT00435045|448838171|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
124783580|NCT00435045|448838172|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
124783581|NCT00435045|448838171|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
124783582|NCT00435045|448838172|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
124783583|NCT00435045|448838171|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
124783584|NCT00435045|448838172|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
124783585|NCT00312195|448838173|FG000|Overall Study|Adverse Event|4|||
124783586|NCT00312195|448838174|FG001|Overall Study|Adverse Event|6|||
124783587|NCT00312195|448838173|FG000|Overall Study|Lost to Follow-up|1|||
124783588|NCT00312195|448838174|FG001|Overall Study|Lost to Follow-up|0|||
124783589|NCT00312195|448838173|FG000|Overall Study|Protocol Violation|1|||
124783590|NCT00312195|448838174|FG001|Overall Study|Protocol Violation|0|||
124783591|NCT01015638|448838177|FG000|Overall Study|Withdrawal by Subject|1|||
124783592|NCT01015638|448838178|FG001|Overall Study|Withdrawal by Subject|0|||
124783593|NCT01703754|448838182|FG000|Overall Study|Clinically significant disease progression|2|||
124783594|NCT01703754|448838183|FG001|Overall Study|Clinically significant disease progression|2|||
124783595|NCT01703754|448838184|FG002|Overall Study|Clinically significant disease progression|1|||
124783596|NCT01703754|448838182|FG000|Overall Study|Adverse Event|1|||
124783597|NCT01703754|448838183|FG001|Overall Study|Adverse Event|1|||
124783598|NCT01703754|448838184|FG002|Overall Study|Adverse Event|0|||
124783599|NCT01703754|448838182|FG000|Overall Study|Withdrawal by Subject|2|||
124783600|NCT01703754|448838183|FG001|Overall Study|Withdrawal by Subject|0|||
124783601|NCT01703754|448838184|FG002|Overall Study|Withdrawal by Subject|0|||
124783602|NCT00964171|448838187|FG000|Overall Study|Death|5|||
124783603|NCT02872935|448838193|FG000|Overall Study|Other|0|||
124783604|NCT02872935|448838194|FG001|Overall Study|Other|1|||
124783605|NCT02792829|448838195|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
124783606|NCT02792829|448838196|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
124783607|NCT02792829|448838197|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
124624273|NCT01995513|448239244|FG001|Period 1: First Open Label Treatment|Death|0|||
124624274|NCT01995513|448239245|FG002|Period 1: First Open Label Treatment|Death|0|||
124624275|NCT01995513|448239246|FG003|Period 1: First Open Label Treatment|Death|0|||
124624276|NCT01995513|448239243|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
124624277|NCT01995513|448239244|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
124624278|NCT01995513|448239245|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
124624279|NCT01995513|448239246|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
124624280|NCT01995513|448239243|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
124624281|NCT01995513|448239244|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
124624282|NCT01995513|448239245|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
124624283|NCT01995513|448239246|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
124624284|NCT01995513|448239243|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
124624285|NCT01995513|448239244|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
124624286|NCT01995513|448239245|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
124624287|NCT01995513|448239246|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
124624288|NCT01995513|448239243|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
124624289|NCT01995513|448239244|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
124624290|NCT01995513|448239245|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
124624291|NCT01995513|448239246|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
124624292|NCT01995513|448239243|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
124624293|NCT01995513|448239244|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
124624294|NCT01995513|448239245|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
124624295|NCT01995513|448239246|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
124624296|NCT01995513|448239243|FG000|Period 1: Second Open Label Treatment|Other|0|||
124624297|NCT01995513|448239244|FG001|Period 1: Second Open Label Treatment|Other|2|||
124624298|NCT01995513|448239245|FG002|Period 1: Second Open Label Treatment|Other|0|||
124624299|NCT01995513|448239246|FG003|Period 1: Second Open Label Treatment|Other|0|||
124624300|NCT01995513|448239243|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
124624301|NCT01995513|448239244|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
124624302|NCT01995513|448239245|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
124624303|NCT01995513|448239246|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
124624304|NCT01995513|448239243|FG000|Period 2: Double Blind Treatment|Death|0|||
124624305|NCT01995513|448239244|FG001|Period 2: Double Blind Treatment|Death|0|||
124624306|NCT01995513|448239245|FG002|Period 2: Double Blind Treatment|Death|0|||
124624307|NCT01995513|448239246|FG003|Period 2: Double Blind Treatment|Death|1|||
124624308|NCT01995513|448239243|FG000|Period 2: Double Blind Treatment|Other|0|||
124624309|NCT01995513|448239244|FG001|Period 2: Double Blind Treatment|Other|0|||
124624310|NCT01995513|448239245|FG002|Period 2: Double Blind Treatment|Other|3|||
124624311|NCT01995513|448239246|FG003|Period 2: Double Blind Treatment|Other|3|||
124624312|NCT01995513|448239243|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
124624313|NCT01995513|448239244|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
124624314|NCT01995513|448239245|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
124624315|NCT01995513|448239246|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
124624316|NCT01995513|448239243|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
124624317|NCT01995513|448239244|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
124624318|NCT01995513|448239245|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
124624319|NCT01995513|448239246|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
124624320|NCT01995513|448239243|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
124624321|NCT01995513|448239244|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
124624322|NCT01995513|448239245|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
124624323|NCT01995513|448239246|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
124624324|NCT01995513|448239243|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
124624325|NCT01995513|448239244|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
124624326|NCT01995513|448239245|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
124624327|NCT01995513|448239246|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
124624328|NCT02071225|448239254|FG000|Overall Study|Withdrawal of Consent|2|||
124624329|NCT02071225|448239254|FG000|Overall Study|Protocol Deviation|1|||
124624330|NCT02071225|448239254|FG000|Overall Study|Lost to Follow-up|2|||
124783608|NCT02792829|448838198|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
124783609|NCT02792829|448838199|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
124783610|NCT02792829|448838200|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
124783611|NCT02792829|448838201|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
124783612|NCT02792829|448838202|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
124783613|NCT02792829|448838195|FG000|Treatment Period 2|Adverse Event|0|||
124783614|NCT02792829|448838196|FG001|Treatment Period 2|Adverse Event|0|||
124783615|NCT02792829|448838197|FG002|Treatment Period 2|Adverse Event|0|||
124783616|NCT02792829|448838198|FG003|Treatment Period 2|Adverse Event|0|||
124783617|NCT02792829|448838199|FG004|Treatment Period 2|Adverse Event|1|||
124783618|NCT02792829|448838200|FG005|Treatment Period 2|Adverse Event|0|||
124624331|NCT02071225|448239254|FG000|Overall Study|Death|25|||
124624332|NCT00280735|448239259|FG000|Overall Study|Adverse Event|5|||
124624333|NCT00280735|448239259|FG000|Overall Study|Lack of Efficacy|3|||
124624334|NCT00280735|448239259|FG000|Overall Study|Withdrawal by Subject|8|||
124624335|NCT00280735|448239259|FG000|Overall Study|Intercurrent Illness|2|||
124624336|NCT01895777|448239260|FG000|Overall Study|Adverse Event|1|||
124624337|NCT01895777|448239261|FG001|Overall Study|Adverse Event|2|||
124624338|NCT01895777|448239260|FG000|Overall Study|Lost to Follow-up|2|||
124624339|NCT01895777|448239261|FG001|Overall Study|Lost to Follow-up|0|||
124624340|NCT01895777|448239260|FG000|Overall Study|Not treated|1|||
124624341|NCT01895777|448239261|FG001|Overall Study|Not treated|0|||
124624342|NCT01895777|448239260|FG000|Overall Study|Other reasons|3|||
124624343|NCT01895777|448239261|FG001|Overall Study|Other reasons|2|||
124624344|NCT01895777|448239260|FG000|Overall Study|Non-compliance with the CTP|2|||
124624345|NCT01895777|448239261|FG001|Overall Study|Non-compliance with the CTP|1|||
124624346|NCT02064296|448239262|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
124624347|NCT02064296|448239263|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
124624348|NCT02064296|448239264|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
124624349|NCT02064296|448239262|FG000|Intervention|Withdrawal by Subject|0|||
124624350|NCT02064296|448239263|FG001|Intervention|Withdrawal by Subject|1|||
124624351|NCT02064296|448239264|FG002|Intervention|Withdrawal by Subject|2|||
124624352|NCT03885661|448239276|FG000|Overall Study|Withdrawal by Subject|0|||
124624353|NCT03885661|448239277|FG001|Overall Study|Withdrawal by Subject|1|||
124624354|NCT03885661|448239276|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
124624355|NCT03885661|448239277|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
124624356|NCT03735121|448239282|FG000|Overall Study|Death|3|||
124624357|NCT03735121|448239283|FG001|Overall Study|Death|6|||
124624358|NCT03735121|448239284|FG002|Overall Study|Death|8|||
124624359|NCT03735121|448239285|FG003|Overall Study|Death|37|||
124624360|NCT03735121|448239286|FG004|Overall Study|Death|86|||
124624361|NCT03735121|448239282|FG000|Overall Study|Withdrawal by Subject|1|||
124624362|NCT03735121|448239283|FG001|Overall Study|Withdrawal by Subject|1|||
124624363|NCT03735121|448239284|FG002|Overall Study|Withdrawal by Subject|3|||
124624364|NCT03735121|448239285|FG003|Overall Study|Withdrawal by Subject|4|||
124624365|NCT03735121|448239286|FG004|Overall Study|Withdrawal by Subject|2|||
124624366|NCT03735121|448239282|FG000|Overall Study|Progressive Disease|0|||
124624367|NCT03735121|448239283|FG001|Overall Study|Progressive Disease|0|||
124624368|NCT03735121|448239284|FG002|Overall Study|Progressive Disease|1|||
124624369|NCT03735121|448239285|FG003|Overall Study|Progressive Disease|0|||
124624370|NCT03735121|448239286|FG004|Overall Study|Progressive Disease|0|||
124624371|NCT03735121|448239282|FG000|Overall Study|Lost to Follow-up|0|||
124624372|NCT03735121|448239283|FG001|Overall Study|Lost to Follow-up|0|||
124624373|NCT03735121|448239284|FG002|Overall Study|Lost to Follow-up|0|||
124624374|NCT03735121|448239285|FG003|Overall Study|Lost to Follow-up|0|||
124624375|NCT03735121|448239286|FG004|Overall Study|Lost to Follow-up|1|||
124624376|NCT03735121|448239282|FG000|Overall Study|Ongoing|3|||
124624377|NCT03735121|448239283|FG001|Overall Study|Ongoing|3|||
124624378|NCT03735121|448239284|FG002|Overall Study|Ongoing|26|||
124624379|NCT03735121|448239285|FG003|Overall Study|Ongoing|83|||
124624380|NCT03735121|448239286|FG004|Overall Study|Ongoing|158|||
124624381|NCT03138655|448239287|FG000|Overall Study|Adverse Event|2|||
124624382|NCT03138655|448239288|FG001|Overall Study|Adverse Event|1|||
124624383|NCT03138655|448239289|FG002|Overall Study|Adverse Event|2|||
124624384|NCT03138655|448239290|FG003|Overall Study|Adverse Event|1|||
124624385|NCT03138655|448239291|FG004|Overall Study|Adverse Event|1|||
124624386|NCT03138655|448239292|FG005|Overall Study|Adverse Event|4|||
124624387|NCT03138655|448239293|FG006|Overall Study|Adverse Event|2|||
124624388|NCT03138655|448239294|FG007|Overall Study|Adverse Event|2|||
124624389|NCT03138655|448239287|FG000|Overall Study|Withdrawal by Subject|0|||
124624390|NCT03138655|448239288|FG001|Overall Study|Withdrawal by Subject|1|||
124624391|NCT03138655|448239289|FG002|Overall Study|Withdrawal by Subject|0|||
124624392|NCT03138655|448239290|FG003|Overall Study|Withdrawal by Subject|0|||
124624393|NCT03138655|448239291|FG004|Overall Study|Withdrawal by Subject|0|||
124624394|NCT03138655|448239292|FG005|Overall Study|Withdrawal by Subject|0|||
124624395|NCT03138655|448239293|FG006|Overall Study|Withdrawal by Subject|1|||
124624396|NCT03138655|448239294|FG007|Overall Study|Withdrawal by Subject|0|||
124624397|NCT03138655|448239287|FG000|Overall Study|Reason not Specified|1|||
124624398|NCT03138655|448239288|FG001|Overall Study|Reason not Specified|0|||
124624399|NCT03138655|448239289|FG002|Overall Study|Reason not Specified|0|||
124624400|NCT03138655|448239290|FG003|Overall Study|Reason not Specified|2|||
124624401|NCT03138655|448239291|FG004|Overall Study|Reason not Specified|1|||
124624402|NCT03138655|448239292|FG005|Overall Study|Reason not Specified|1|||
124624403|NCT03138655|448239293|FG006|Overall Study|Reason not Specified|0|||
124624404|NCT03138655|448239294|FG007|Overall Study|Reason not Specified|0|||
124624405|NCT03151304|448239295|FG000|Overall Study|Termination of study by Sponsor|23|||
124624406|NCT03151304|448239295|FG000|Overall Study|missing|3|||
124624407|NCT03151304|448239295|FG000|Overall Study|Withdrawal by Subject|8|||
124624408|NCT03151304|448239295|FG000|Overall Study|multiple reasons|30|||
124783619|NCT02792829|448838201|FG006|Treatment Period 2|Adverse Event|1|||
124783620|NCT02792829|448838202|FG007|Treatment Period 2|Adverse Event|1|||
124783621|NCT02792829|448838195|FG000|Treatment Period 2|Use of proscribed medications|0|||
124783622|NCT02792829|448838196|FG001|Treatment Period 2|Use of proscribed medications|0|||
124783623|NCT02792829|448838197|FG002|Treatment Period 2|Use of proscribed medications|0|||
124783624|NCT02792829|448838198|FG003|Treatment Period 2|Use of proscribed medications|0|||
124783625|NCT02792829|448838199|FG004|Treatment Period 2|Use of proscribed medications|0|||
124783626|NCT02792829|448838200|FG005|Treatment Period 2|Use of proscribed medications|0|||
124783627|NCT02792829|448838201|FG006|Treatment Period 2|Use of proscribed medications|0|||
124783628|NCT02792829|448838202|FG007|Treatment Period 2|Use of proscribed medications|1|||
124783629|NCT02873429|448838203|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
124783630|NCT02873429|448838204|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
124783631|NCT02873429|448838203|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
124783632|NCT02873429|448838204|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
124783633|NCT02873429|448838203|FG000|16 Weeks|Lost to Follow-up|3|||
124783634|NCT02873429|448838204|FG001|16 Weeks|Lost to Follow-up|0|||
124783635|NCT04270370|448838205|FG000|Overall Study|Lost to Follow-up|1|||
124783636|NCT04270370|448838206|FG001|Overall Study|Lost to Follow-up|0|||
124783637|NCT04270370|448838207|FG002|Overall Study|Lost to Follow-up|0|||
124783638|NCT04270370|448838208|FG003|Overall Study|Lost to Follow-up|0|||
124783639|NCT04270370|448838209|FG004|Overall Study|Lost to Follow-up|0|||
124624409|NCT01783886|448239296|FG000|Overall Study|Lost to Follow-up|0|||
124624410|NCT01783886|448239297|FG001|Overall Study|Lost to Follow-up|3|||
124624411|NCT01783886|448239298|FG002|Overall Study|Lost to Follow-up|0|||
124624412|NCT01783886|448239296|FG000|Overall Study|Protocol deviation|0|||
124624413|NCT01783886|448239297|FG001|Overall Study|Protocol deviation|0|||
124624414|NCT01783886|448239298|FG002|Overall Study|Protocol deviation|2|||
124624415|NCT01783886|448239296|FG000|Overall Study|Withdrawal of consent by participant|1|||
124624416|NCT01783886|448239297|FG001|Overall Study|Withdrawal of consent by participant|3|||
124624417|NCT01783886|448239298|FG002|Overall Study|Withdrawal of consent by participant|4|||
124624418|NCT01783886|448239296|FG000|Overall Study|Adverse Event|4|||
124624419|NCT01783886|448239297|FG001|Overall Study|Adverse Event|5|||
124624420|NCT01783886|448239298|FG002|Overall Study|Adverse Event|4|||
124624421|NCT04542057|448239299|FG000|Overall Study|Death|3|||
124624422|NCT04542057|448239300|FG001|Overall Study|Death|1|||
124624423|NCT04542057|448239299|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
124624424|NCT04542057|448239300|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
124624425|NCT04542057|448239299|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
124624426|NCT04542057|448239300|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
124624427|NCT04542057|448239299|FG000|Overall Study|Adverse Event|15|||
124624428|NCT04542057|448239300|FG001|Overall Study|Adverse Event|6|||
124624429|NCT04542057|448239299|FG000|Overall Study|COVID-19 adverse event|6|||
124624430|NCT04542057|448239300|FG001|Overall Study|COVID-19 adverse event|4|||
124624431|NCT04542057|448239299|FG000|Overall Study|Lack of Efficacy|2|||
124624432|NCT04542057|448239300|FG001|Overall Study|Lack of Efficacy|5|||
124624433|NCT04542057|448239299|FG000|Overall Study|Study terminated by sponsor|1|||
124624434|NCT04542057|448239300|FG001|Overall Study|Study terminated by sponsor|0|||
124624435|NCT04542057|448239299|FG000|Overall Study|Investigator discretion|2|||
124624436|NCT04542057|448239300|FG001|Overall Study|Investigator discretion|1|||
124624437|NCT04542057|448239299|FG000|Overall Study|Withdrawal by Subject|52|||
124624438|NCT04542057|448239300|FG001|Overall Study|Withdrawal by Subject|30|||
124624439|NCT04542057|448239299|FG000|Overall Study|Lost to Follow-up|8|||
124624440|NCT04542057|448239300|FG001|Overall Study|Lost to Follow-up|11|||
124624441|NCT04542057|448239299|FG000|Overall Study|Other|2|||
124624442|NCT04542057|448239300|FG001|Overall Study|Other|2|||
124624443|NCT00104572|448239301|FG000|Overall Study|Withdrawal by Subject|3|||
124624444|NCT00104572|448239302|FG001|Overall Study|Withdrawal by Subject|3|||
124624445|NCT00104572|448239303|FG002|Overall Study|Withdrawal by Subject|0|||
124624446|NCT00940316|448239304|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
124624447|NCT00940316|448239305|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
124624448|NCT00940316|448239306|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
124783640|NCT04270370|448838210|FG005|Overall Study|Lost to Follow-up|0|||
124783641|NCT04270370|448838211|FG006|Overall Study|Lost to Follow-up|0|||
124783642|NCT04270370|448838212|FG007|Overall Study|Lost to Follow-up|0|||
124783643|NCT04270370|448838213|FG008|Overall Study|Lost to Follow-up|1|||
124783644|NCT04270370|448838214|FG009|Overall Study|Lost to Follow-up|0|||
124624449|NCT00940316|448239304|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
124624450|NCT00940316|448239305|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
124783645|NCT04270370|448838215|FG010|Overall Study|Lost to Follow-up|0|||
124783646|NCT04270370|448838216|FG011|Overall Study|Lost to Follow-up|0|||
124783647|NCT00530504|448838219|FG000|Overall Study|Death|54|||
124783648|NCT00530504|448838219|FG000|Overall Study|Lost to Follow-up|26|||
124624451|NCT00940316|448239306|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
124624452|NCT00940316|448239304|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
124624453|NCT00940316|448239305|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
124624454|NCT00940316|448239306|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
124783649|NCT00530504|448838219|FG000|Overall Study|Withdrawal by Subject|39|||
124783650|NCT00530504|448838219|FG000|Overall Study|Exited study due to other reasons|33|||
124783651|NCT02872285|448838222|FG000|Overall Study|Withdrawal by Subject|2|||
124783652|NCT02872285|448838223|FG001|Overall Study|Withdrawal by Subject|0|||
124783653|NCT02872285|448838222|FG000|Overall Study|Lost to Follow-up|2|||
124783654|NCT02872285|448838223|FG001|Overall Study|Lost to Follow-up|2|||
124783655|NCT02872285|448838222|FG000|Overall Study|Discontinued due to back surgery|1|||
124783656|NCT02872285|448838223|FG001|Overall Study|Discontinued due to back surgery|0|||
124783657|NCT05477108|448838224|FG000|Overall Study|Participants randomized, not treated|1|||
124783658|NCT05477108|448838225|FG001|Overall Study|Participants randomized, not treated|1|||
124783659|NCT05477108|448838226|FG002|Overall Study|Participants randomized, not treated|1|||
124783660|NCT05477108|448838224|FG000|Overall Study|Physician Decision|0|||
124783661|NCT05477108|448838225|FG001|Overall Study|Physician Decision|0|||
124783662|NCT05477108|448838226|FG002|Overall Study|Physician Decision|1|||
124783663|NCT05477108|448838224|FG000|Overall Study|withdrawn from study|0|||
124783664|NCT05477108|448838225|FG001|Overall Study|withdrawn from study|0|||
124783665|NCT05477108|448838226|FG002|Overall Study|withdrawn from study|1|||
124783666|NCT02660983|448838227|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
124783667|NCT02660983|448838228|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
124783668|NCT02660983|448838227|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
124783669|NCT02660983|448838228|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
124783670|NCT02660983|448838227|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
124783671|NCT02660983|448838228|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
124783672|NCT02660983|448838227|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
124783673|NCT02660983|448838228|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
124783674|NCT02660983|448838227|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
124783675|NCT02660983|448838228|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
124783676|NCT02660983|448838227|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
124783677|NCT02660983|448838228|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
124783678|NCT02660983|448838227|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
124783679|NCT02660983|448838228|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
124783680|NCT04303195|448838233|FG000|Overall Study|Adverse Event|1|||
124783681|NCT04303195|448838234|FG001|Overall Study|Adverse Event|3|||
124783682|NCT04303195|448838235|FG002|Overall Study|Adverse Event|7|||
124783683|NCT04303195|448838236|FG003|Overall Study|Adverse Event|0|||
124783684|NCT04303195|448838233|FG000|Overall Study|Lost to Follow-up|1|||
124783685|NCT04303195|448838234|FG001|Overall Study|Lost to Follow-up|0|||
124783686|NCT04303195|448838235|FG002|Overall Study|Lost to Follow-up|1|||
124783687|NCT04303195|448838236|FG003|Overall Study|Lost to Follow-up|4|||
124783688|NCT04303195|448838233|FG000|Overall Study|Withdrawal by Subject|3|||
124783689|NCT04303195|448838234|FG001|Overall Study|Withdrawal by Subject|1|||
124783690|NCT04303195|448838235|FG002|Overall Study|Withdrawal by Subject|1|||
124783691|NCT04303195|448838236|FG003|Overall Study|Withdrawal by Subject|1|||
124783692|NCT04303195|448838233|FG000|Overall Study|No study drug administered or protocol deviation|0|||
124783693|NCT04303195|448838234|FG001|Overall Study|No study drug administered or protocol deviation|2|||
124783694|NCT04303195|448838235|FG002|Overall Study|No study drug administered or protocol deviation|0|||
124783695|NCT04303195|448838236|FG003|Overall Study|No study drug administered or protocol deviation|2|||
124783696|NCT01065454|448838237|FG000|Treatment|Adverse Event|7|||
124783697|NCT01065454|448838238|FG001|Treatment|Adverse Event|4|||
124783698|NCT01065454|448838239|FG002|Treatment|Adverse Event|3|||
124783699|NCT01065454|448838240|FG003|Treatment|Adverse Event|6|||
124783700|NCT01065454|448838237|FG000|Treatment|Death|1|||
124783701|NCT01065454|448838238|FG001|Treatment|Death|0|||
124783702|NCT01065454|448838239|FG002|Treatment|Death|0|||
124783703|NCT01065454|448838240|FG003|Treatment|Death|0|||
124783704|NCT01065454|448838237|FG000|Treatment|Non-compliance|1|||
124783705|NCT01065454|448838238|FG001|Treatment|Non-compliance|0|||
124783706|NCT01065454|448838239|FG002|Treatment|Non-compliance|0|||
124783707|NCT01065454|448838240|FG003|Treatment|Non-compliance|1|||
124783708|NCT01065454|448838237|FG000|Treatment|Protocol Decision|0|||
124783709|NCT01065454|448838238|FG001|Treatment|Protocol Decision|0|||
124783710|NCT01065454|448838239|FG002|Treatment|Protocol Decision|3|||
124783711|NCT01065454|448838240|FG003|Treatment|Protocol Decision|2|||
124783712|NCT01065454|448838237|FG000|Treatment|Protocol Violation|1|||
124624455|NCT00940316|448239304|FG000|Treated After Cycle 5|Adverse Event|0|||
124624456|NCT00940316|448239305|FG001|Treated After Cycle 5|Adverse Event|0|||
124783713|NCT01065454|448838238|FG001|Treatment|Protocol Violation|0|||
124783714|NCT01065454|448838239|FG002|Treatment|Protocol Violation|1|||
124783715|NCT01065454|448838240|FG003|Treatment|Protocol Violation|0|||
124783716|NCT01065454|448838237|FG000|Treatment|Withdrawal by Subject|3|||
124783717|NCT01065454|448838238|FG001|Treatment|Withdrawal by Subject|1|||
124783718|NCT01065454|448838239|FG002|Treatment|Withdrawal by Subject|2|||
124783719|NCT01065454|448838240|FG003|Treatment|Withdrawal by Subject|3|||
124783720|NCT01065454|448838237|FG000|Follow up|Adverse Event|1|||
124783721|NCT01065454|448838238|FG001|Follow up|Adverse Event|0|||
124783722|NCT01065454|448838239|FG002|Follow up|Adverse Event|0|||
124783723|NCT01065454|448838240|FG003|Follow up|Adverse Event|1|||
124783724|NCT01065454|448838237|FG000|Follow up|Death|0|||
124783725|NCT01065454|448838238|FG001|Follow up|Death|1|||
124783726|NCT01065454|448838239|FG002|Follow up|Death|1|||
124783727|NCT01065454|448838240|FG003|Follow up|Death|0|||
124783728|NCT01065454|448838237|FG000|Follow up|Lost to Follow-up|0|||
124783729|NCT01065454|448838238|FG001|Follow up|Lost to Follow-up|0|||
124783730|NCT01065454|448838239|FG002|Follow up|Lost to Follow-up|0|||
124783731|NCT01065454|448838240|FG003|Follow up|Lost to Follow-up|1|||
124783732|NCT01065454|448838237|FG000|Follow up|Progressive disease|0|||
124783733|NCT01065454|448838238|FG001|Follow up|Progressive disease|0|||
124783734|NCT01065454|448838239|FG002|Follow up|Progressive disease|0|||
124783735|NCT01065454|448838240|FG003|Follow up|Progressive disease|1|||
124783736|NCT01065454|448838237|FG000|Follow up|Withdrawal by Subject|1|||
124783737|NCT01065454|448838238|FG001|Follow up|Withdrawal by Subject|1|||
124783738|NCT01065454|448838239|FG002|Follow up|Withdrawal by Subject|1|||
124783739|NCT01065454|448838240|FG003|Follow up|Withdrawal by Subject|0|||
124783740|NCT01065454|448838237|FG000|Follow up|study ongoing|37|||
124783741|NCT01065454|448838238|FG001|Follow up|study ongoing|22|||
124783742|NCT01065454|448838239|FG002|Follow up|study ongoing|15|||
124783743|NCT01065454|448838240|FG003|Follow up|study ongoing|41|||
124783744|NCT01601652|448838241|FG000|Overall Study|Death|1|||
124783745|NCT05688670|448838242|FG000|Overall Study|Change in surgery plan|1|||
124783746|NCT05688670|448838243|FG001|Overall Study|Change in surgery plan|4|||
124783747|NCT05688670|448838242|FG000|Overall Study|Inability to extubate|1|||
124783748|NCT05688670|448838243|FG001|Overall Study|Inability to extubate|2|||
124783749|NCT05688670|448838242|FG000|Overall Study|Day of surgery cancellation|0|||
124783750|NCT05688670|448838243|FG001|Overall Study|Day of surgery cancellation|1|||
124783751|NCT05688670|448838242|FG000|Overall Study|Reintubated on PCICU arrival|0|||
124783752|NCT05688670|448838243|FG001|Overall Study|Reintubated on PCICU arrival|1|||
124783753|NCT03425253|448838244|FG000|Overall Study|Adverse Event|2|||
124783754|NCT03425253|448838244|FG000|Overall Study|Lost to Follow-up|3|||
124783755|NCT03425253|448838244|FG000|Overall Study|Withdrew Consent|6|||
124783756|NCT03425253|448838244|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
124783757|NCT05009979|448838245|FG000|Overall Study|Withdrawal by Subject|1|||
124783758|NCT03844945|448839931|FG000|Overall Study|Adverse Event|1|||
124783759|NCT03844945|448839932|FG001|Overall Study|Adverse Event|1|||
124783760|NCT03844945|448839933|FG002|Overall Study|Adverse Event|4|||
124783761|NCT03844945|448839934|FG003|Overall Study|Adverse Event|0|||
124783762|NCT03844945|448839931|FG000|Overall Study|Withdrawal by Subject|0|||
124783763|NCT03844945|448839932|FG001|Overall Study|Withdrawal by Subject|0|||
124783764|NCT03844945|448839933|FG002|Overall Study|Withdrawal by Subject|1|||
124783765|NCT03844945|448839934|FG003|Overall Study|Withdrawal by Subject|0|||
124783766|NCT03844945|448839931|FG000|Overall Study|Lack of Efficacy|0|||
124783767|NCT03844945|448839932|FG001|Overall Study|Lack of Efficacy|0|||
124783768|NCT03844945|448839933|FG002|Overall Study|Lack of Efficacy|0|||
124783769|NCT03844945|448839934|FG003|Overall Study|Lack of Efficacy|1|||
124783770|NCT04129151|448839941|FG000|Overall Study|Adverse Event|1|||
124783771|NCT04129151|448839941|FG000|Overall Study|Disease Progression|7|||
124624457|NCT00940316|448239306|FG002|Treated After Cycle 5|Adverse Event|1|||
124624458|NCT00940316|448239304|FG000|Treated After Cycle 5|Progressive disease|0|||
124624459|NCT00940316|448239305|FG001|Treated After Cycle 5|Progressive disease|1|||
124624460|NCT00940316|448239306|FG002|Treated After Cycle 5|Progressive disease|0|||
124624461|NCT00796757|448239308|FG000|Overall Study|Withdrawal by Subject|14|||
124624462|NCT00796757|448239308|FG000|Overall Study|Death|61|||
124624463|NCT00796757|448239308|FG000|Overall Study|Protocol Violation|1|||
124624464|NCT00796757|448239308|FG000|Overall Study|Participant noncompliance|1|||
124624465|NCT00796757|448239308|FG000|Overall Study|Investigator's decision|2|||
124624466|NCT00796757|448239308|FG000|Overall Study|Other|7|||
124624467|NCT02016183|448239311|FG000|Overall Study|Case Report Forms Uncollected|13|||
124624468|NCT02016183|448239311|FG000|Overall Study|Protocol Violation|52|||
124624469|NCT00996489|448239312|FG000|Overall Study|Device failure|45|||
124783772|NCT04129151|448839941|FG000|Overall Study|Study closure|1|||
124783773|NCT02051933|448839942|FG000|Overall Study|Physician Decision|0|||
124783774|NCT02051933|448839943|FG001|Overall Study|Physician Decision|1|||
124783775|NCT00588861|448839947|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
124783776|NCT00588861|448839948|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
124783777|NCT00588861|448839947|FG000|6 Months|Patients did not return for follow-up|98|||
124783778|NCT00588861|448839948|FG001|6 Months|Patients did not return for follow-up|73|||
124783779|NCT00588861|448839947|FG000|1 Year|Patients did not return for follow-up|89|||
124783780|NCT00588861|448839948|FG001|1 Year|Patients did not return for follow-up|82|||
124783781|NCT00588861|448839947|FG000|2 Years|Patients did not return for follow-up|92|||
124624470|NCT00996489|448239312|FG000|Overall Study|Discontinued|116|||
124624471|NCT00770328|448239315|FG000|Overall Study|Adverse Event|11|||
124624472|NCT00770328|448239316|FG001|Overall Study|Adverse Event|2|||
124624473|NCT00770328|448239315|FG000|Overall Study|Lost to Follow-up|2|||
124783782|NCT00588861|448839948|FG001|2 Years|Patients did not return for follow-up|87|||
124783783|NCT00588861|448839947|FG000|4 Years|Patients did not return for follow-up|91|||
124624474|NCT00770328|448239316|FG001|Overall Study|Lost to Follow-up|2|||
124624475|NCT01130493|448239317|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
124624476|NCT01130493|448239318|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
124624477|NCT01130493|448239319|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
124624478|NCT01130493|448239317|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
124624479|NCT01130493|448239318|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
124624480|NCT01130493|448239319|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
124624481|NCT01130493|448239317|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
124624482|NCT01130493|448239318|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
124624483|NCT01130493|448239319|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
124624484|NCT01130493|448239317|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
124624485|NCT01130493|448239318|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
124624486|NCT01130493|448239319|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
124624487|NCT01130493|448239317|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
124624488|NCT01130493|448239318|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
124624489|NCT01130493|448239319|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
124624490|NCT01130493|448239317|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
124624491|NCT01130493|448239318|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
124624492|NCT01130493|448239319|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
124624493|NCT01130493|448239317|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
124624494|NCT01130493|448239318|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
124624495|NCT01130493|448239319|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
124624496|NCT01130493|448239317|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
124624497|NCT01130493|448239318|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
124624498|NCT01130493|448239319|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
124624499|NCT01130493|448239317|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
124624500|NCT01130493|448239318|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
124624501|NCT01130493|448239319|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
124624502|NCT01130493|448239317|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
124624503|NCT01130493|448239318|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
124624504|NCT01130493|448239319|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
124624505|NCT01130493|448239317|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
124624506|NCT01130493|448239318|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
124624507|NCT01130493|448239319|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
124624508|NCT01130493|448239317|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
124624509|NCT01130493|448239318|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
124624510|NCT01130493|448239319|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
124624511|NCT01130493|448239317|FG000|Part 2: OLE|Adverse Event|0|||
124624512|NCT01130493|448239318|FG001|Part 2: OLE|Adverse Event|2|||
124624513|NCT01130493|448239319|FG002|Part 2: OLE|Adverse Event|1|||
124624514|NCT01130493|448239317|FG000|Part 2: OLE|Withdrawal by Subject|0|||
124624515|NCT01130493|448239318|FG001|Part 2: OLE|Withdrawal by Subject|1|||
124624516|NCT01130493|448239319|FG002|Part 2: OLE|Withdrawal by Subject|4|||
124624517|NCT03452943|448239320|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
124624518|NCT03452943|448239321|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
124624519|NCT03452943|448239320|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
124624520|NCT03452943|448239321|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
124624521|NCT03452943|448239320|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
124624522|NCT03452943|448239321|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
124624523|NCT03452943|448239320|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
124624524|NCT03452943|448239321|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
124624525|NCT03452943|448239320|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
124624526|NCT03452943|448239321|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
124624527|NCT03452943|448239320|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
124624528|NCT03452943|448239321|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
124624529|NCT00879086|448239324|FG000|Overall Study|Adverse Event|3|||
124783784|NCT00588861|448839948|FG001|4 Years|Patients did not return for follow-up|103|||
124783785|NCT00588861|448839947|FG000|6 Years|Patients did not return for follow-up|104|||
124783786|NCT00588861|448839948|FG001|6 Years|Patients did not return for follow-up|109|||
124783787|NCT00588861|448839947|FG000|8 Years|Patients did not return for follow-up|105|||
124783788|NCT00588861|448839948|FG001|8 Years|Patients did not return for follow-up|114|||
124783789|NCT00588861|448839947|FG000|10 Years|Incomplete due to study termination|107|||
124624530|NCT00879086|448239325|FG001|Overall Study|Adverse Event|15|||
124624531|NCT00879086|448239324|FG000|Overall Study|Participant choice|2|||
124624532|NCT00879086|448239325|FG001|Overall Study|Participant choice|2|||
124624533|NCT00879086|448239324|FG000|Overall Study|Progression of disease|40|||
124624534|NCT00879086|448239325|FG001|Overall Study|Progression of disease|26|||
124624535|NCT00879086|448239324|FG000|Overall Study|Withdrawal of consent|2|||
124624536|NCT00879086|448239325|FG001|Overall Study|Withdrawal of consent|1|||
124624537|NCT00879086|448239324|FG000|Overall Study|Other|4|||
124624538|NCT00879086|448239325|FG001|Overall Study|Other|6|||
124624539|NCT00879086|448239324|FG000|Overall Study|Death|1|||
124624540|NCT00879086|448239325|FG001|Overall Study|Death|2|||
124624541|NCT02286843|448239326|FG000|Overall Study|Not Treated|4|||
124624542|NCT02286843|448239326|FG000|Overall Study|Protocol Violation|1|||
124624543|NCT02286843|448239326|FG000|Overall Study|Withdrawal by Subject|1|||
124624544|NCT03172494|448239327|FG000|Overall Study|Adverse Event|5|||
124624545|NCT03172494|448239328|FG001|Overall Study|Adverse Event|1|||
124624546|NCT03172494|448239329|FG002|Overall Study|Adverse Event|15|||
124624547|NCT03172494|448239327|FG000|Overall Study|Protocol Violation|3|||
124624548|NCT03172494|448239328|FG001|Overall Study|Protocol Violation|2|||
124624549|NCT03172494|448239329|FG002|Overall Study|Protocol Violation|1|||
124624550|NCT03172494|448239327|FG000|Overall Study|Lack of Efficacy|0|||
124624551|NCT03172494|448239328|FG001|Overall Study|Lack of Efficacy|0|||
124624552|NCT03172494|448239329|FG002|Overall Study|Lack of Efficacy|4|||
124624553|NCT03172494|448239327|FG000|Overall Study|Pregnancy|0|||
124624554|NCT03172494|448239328|FG001|Overall Study|Pregnancy|1|||
124624555|NCT03172494|448239329|FG002|Overall Study|Pregnancy|0|||
124624556|NCT03172494|448239327|FG000|Overall Study|Withdrawal by Subject|10|||
124624557|NCT03172494|448239328|FG001|Overall Study|Withdrawal by Subject|8|||
124624558|NCT03172494|448239329|FG002|Overall Study|Withdrawal by Subject|8|||
124624559|NCT03172494|448239327|FG000|Overall Study|Severe hypoglycaemic episode|0|||
124624560|NCT03172494|448239328|FG001|Overall Study|Severe hypoglycaemic episode|0|||
124624561|NCT03172494|448239329|FG002|Overall Study|Severe hypoglycaemic episode|1|||
124624562|NCT03172494|448239327|FG000|Overall Study|Non-compliance towards treatment|2|||
124624563|NCT03172494|448239328|FG001|Overall Study|Non-compliance towards treatment|0|||
124624564|NCT03172494|448239329|FG002|Overall Study|Non-compliance towards treatment|0|||
124624565|NCT02764151|448239330|FG000|Overall Study|Subject refused further follow-up|0|||
124624566|NCT02764151|448239331|FG001|Overall Study|Subject refused further follow-up|0|||
124624567|NCT02764151|448239332|FG002|Overall Study|Subject refused further follow-up|0|||
124624568|NCT02764151|448239333|FG003|Overall Study|Subject refused further follow-up|1|||
124624569|NCT02764151|448239330|FG000|Overall Study|Other|0|||
124624570|NCT02764151|448239331|FG001|Overall Study|Other|0|||
124624571|NCT02764151|448239332|FG002|Overall Study|Other|0|||
124624572|NCT02764151|448239333|FG003|Overall Study|Other|2|||
124624573|NCT03086551|448239334|FG000|First Intervention|Failure to meet inclusion criterion|1|||
124624574|NCT03086551|448239335|FG001|First Intervention|Failure to meet inclusion criterion|0|||
124624575|NCT03086551|448239334|FG000|First Intervention|Lost to Follow-up|0|||
124624576|NCT03086551|448239335|FG001|First Intervention|Lost to Follow-up|1|||
124624577|NCT03086551|448239334|FG000|Washout|Lost to Follow-up|1|||
124624578|NCT03086551|448239335|FG001|Washout|Lost to Follow-up|2|||
124624579|NCT03086551|448239334|FG000|Washout|Withdrawal by Subject|2|||
124624580|NCT03086551|448239335|FG001|Washout|Withdrawal by Subject|1|||
124624581|NCT02201277|448239337|FG000|Overall Study|Death|3|||
124624582|NCT02201277|448239338|FG001|Overall Study|Death|4|||
124624583|NCT02201277|448239337|FG000|Overall Study|Lost to Follow-up|2|||
124624584|NCT02201277|448239338|FG001|Overall Study|Lost to Follow-up|1|||
124624585|NCT02201277|448239337|FG000|Overall Study|Failed retrieval|1|||
124624586|NCT02201277|448239338|FG001|Overall Study|Failed retrieval|0|||
124624587|NCT02201277|448239337|FG000|Overall Study|Physician Decision|1|||
124624588|NCT02201277|448239338|FG001|Overall Study|Physician Decision|0|||
124624589|NCT00489255|448239339|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
124624590|NCT00489255|448239340|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
124624591|NCT00489255|448239339|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
124624592|NCT00489255|448239340|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
124624593|NCT00489255|448239339|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
124624594|NCT00489255|448239340|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
124624595|NCT00489255|448239339|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
124624596|NCT00489255|448239340|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
124624597|NCT00489255|448239339|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
124624598|NCT00489255|448239340|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
124624599|NCT00489255|448239339|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
124624600|NCT00489255|448239340|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
124624601|NCT00489255|448239339|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
124624602|NCT00489255|448239340|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
124624603|NCT00489255|448239339|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
124624604|NCT00489255|448239340|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
124624605|NCT00489255|448239339|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
124624606|NCT00489255|448239340|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
124624607|NCT00489255|448239339|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
124624608|NCT00489255|448239340|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
124624609|NCT03485352|448239341|FG000|Overall Study|Lost to Follow-up|9|||
124624610|NCT01512160|448239342|FG000|Overall Study|Lost to Follow-up|1|||
124624611|NCT01512160|448239343|FG001|Overall Study|Lost to Follow-up|0|||
124624612|NCT01512160|448239344|FG002|Overall Study|Lost to Follow-up|0|||
124624613|NCT01512160|448239345|FG003|Overall Study|Lost to Follow-up|0|||
124624614|NCT01512160|448239342|FG000|Overall Study|Withdrawal by Subject|1|||
124624615|NCT01512160|448239343|FG001|Overall Study|Withdrawal by Subject|0|||
124624616|NCT01512160|448239344|FG002|Overall Study|Withdrawal by Subject|0|||
124624617|NCT01512160|448239345|FG003|Overall Study|Withdrawal by Subject|1|||
124624618|NCT01260701|448239347|FG000|Overall Study|Adverse Event|9|||
124624619|NCT01260701|448239347|FG000|Overall Study|Withdrawal by Subject|2|||
124624620|NCT01260701|448239347|FG000|Overall Study|Progression|53|||
124624621|NCT01260701|448239347|FG000|Overall Study|Death|2|||
124624622|NCT01260701|448239347|FG000|Overall Study|Not protocol specified|3|||
124624623|NCT01260701|448239347|FG000|Overall Study|Under review|1|||
124624624|NCT01260701|448239347|FG000|Overall Study|Ineligible|4|||
124624625|NCT01260701|448239347|FG000|Overall Study|Did not begin protocol therapy|1|||
124783790|NCT00588861|448839948|FG001|10 Years|Incomplete due to study termination|114|||
124783791|NCT02730195|448839949|FG000|Overall Study|Withdrawal by Subject|1|||
124783792|NCT00265148|448839950|FG000|Overall Study|Adverse Event|2|||
124783793|NCT00265148|448839951|FG001|Overall Study|Adverse Event|2|||
124783794|NCT00265148|448839950|FG000|Overall Study|Lack of Efficacy|0|||
124783795|NCT00265148|448839951|FG001|Overall Study|Lack of Efficacy|2|||
124783796|NCT00265148|448839950|FG000|Overall Study|Protocol Violation|3|||
124783797|NCT00265148|448839951|FG001|Overall Study|Protocol Violation|2|||
124783798|NCT00265148|448839950|FG000|Overall Study|Lost to Follow-up|0|||
124783799|NCT00265148|448839951|FG001|Overall Study|Lost to Follow-up|1|||
124783800|NCT00265148|448839950|FG000|Overall Study|Withdrawal by Subject|2|||
124783801|NCT00265148|448839951|FG001|Overall Study|Withdrawal by Subject|1|||
124783802|NCT00265148|448839950|FG000|Overall Study|Physician Decision|1|||
124783803|NCT00265148|448839951|FG001|Overall Study|Physician Decision|0|||
124783804|NCT00265148|448839950|FG000|Overall Study|Increasing frailty|0|||
124783805|NCT00265148|448839951|FG001|Overall Study|Increasing frailty|1|||
124783806|NCT00265148|448839950|FG000|Overall Study|Subject chose to change of the dose|1|||
124783807|NCT00265148|448839951|FG001|Overall Study|Subject chose to change of the dose|0|||
124783808|NCT00942994|448839956|FG000|Overall Study|Adverse Event|7|||
124783809|NCT00942994|448839957|FG001|Overall Study|Adverse Event|4|||
124783810|NCT00942994|448839956|FG000|Overall Study|Abnormal laboratory value(s)|1|||
124783811|NCT00942994|448839957|FG001|Overall Study|Abnormal laboratory value(s)|0|||
124783812|NCT00942994|448839956|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124783813|NCT00942994|448839957|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124783814|NCT00942994|448839956|FG000|Overall Study|Patient withdrew consent|5|||
124783815|NCT00942994|448839957|FG001|Overall Study|Patient withdrew consent|8|||
124783816|NCT00942994|448839956|FG000|Overall Study|Lost to Follow-up|1|||
124783817|NCT00942994|448839957|FG001|Overall Study|Lost to Follow-up|4|||
124783818|NCT00942994|448839956|FG000|Overall Study|Protocol deviation|1|||
124783819|NCT00942994|448839957|FG001|Overall Study|Protocol deviation|2|||
124783820|NCT01874340|448839960|FG000|Overall Study|Study terminated by Sponsor|6|||
124783821|NCT01874340|448839961|FG001|Overall Study|Study terminated by Sponsor|8|||
124783822|NCT01874340|448839962|FG002|Overall Study|Study terminated by Sponsor|8|||
124783823|NCT01874340|448839963|FG003|Overall Study|Study terminated by Sponsor|4|||
124783824|NCT01874340|448839960|FG000|Overall Study|Withdrawal by Subject|0|||
124783825|NCT01874340|448839961|FG001|Overall Study|Withdrawal by Subject|0|||
124783826|NCT01874340|448839962|FG002|Overall Study|Withdrawal by Subject|0|||
124783827|NCT01874340|448839963|FG003|Overall Study|Withdrawal by Subject|1|||
124783828|NCT01311024|448839971|FG000|Overall Study|Protocol Violation|35|||
124783829|NCT01311024|448839972|FG001|Overall Study|Protocol Violation|22|||
124783830|NCT01523275|448839975|FG000|Overall Study|Lost to Follow-up|1|||
124783831|NCT01523275|448839976|FG001|Overall Study|Lost to Follow-up|2|||
124783832|NCT01523275|448839975|FG000|Overall Study|Withdrawal by Subject|1|||
124783833|NCT01523275|448839976|FG001|Overall Study|Withdrawal by Subject|0|||
124783834|NCT01206322|448839977|FG000|Overall Study|Adverse Event|0|||
124783835|NCT01206322|448839978|FG001|Overall Study|Adverse Event|0|||
124783836|NCT01206322|448839979|FG002|Overall Study|Adverse Event|0|||
124783837|NCT01206322|448839980|FG003|Overall Study|Adverse Event|1|||
124783838|NCT00689117|448839981|FG000|Overall Study|Adverse Event|6|||
124783839|NCT00689117|448839982|FG001|Overall Study|Adverse Event|0|||
124783840|NCT00689117|448839983|FG002|Overall Study|Adverse Event|5|||
124783841|NCT00689117|448839984|FG003|Overall Study|Adverse Event|0|||
124783842|NCT00689117|448839981|FG000|Overall Study|Lost to Follow-up|26|||
124783843|NCT00689117|448839982|FG001|Overall Study|Lost to Follow-up|19|||
124783844|NCT00689117|448839983|FG002|Overall Study|Lost to Follow-up|17|||
124783845|NCT00689117|448839984|FG003|Overall Study|Lost to Follow-up|11|||
124783846|NCT00689117|448839981|FG000|Overall Study|Lack of Efficacy|1|||
124783847|NCT00689117|448839982|FG001|Overall Study|Lack of Efficacy|2|||
124783848|NCT00689117|448839983|FG002|Overall Study|Lack of Efficacy|2|||
124783849|NCT00689117|448839984|FG003|Overall Study|Lack of Efficacy|2|||
124783850|NCT00689117|448839981|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
124783851|NCT00689117|448839982|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
124783852|NCT00689117|448839983|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
124783853|NCT00689117|448839984|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
124783854|NCT00689117|448839981|FG000|Overall Study|Withdrawal by Subject|19|||
124783855|NCT00689117|448839982|FG001|Overall Study|Withdrawal by Subject|18|||
124783856|NCT00689117|448839983|FG002|Overall Study|Withdrawal by Subject|26|||
124783857|NCT00689117|448839984|FG003|Overall Study|Withdrawal by Subject|13|||
124783858|NCT00689117|448839981|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
124783859|NCT00689117|448839982|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
124783860|NCT00689117|448839983|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
124783861|NCT00689117|448839984|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
124783862|NCT00689117|448839981|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
124783863|NCT00689117|448839982|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
124783864|NCT00689117|448839983|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124783865|NCT00689117|448839984|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
124783866|NCT00689117|448839981|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
124783867|NCT00689117|448839982|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
124783868|NCT00689117|448839983|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
124783869|NCT00689117|448839984|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
124783870|NCT00689117|448839981|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
124783871|NCT00689117|448839982|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
124783872|NCT00689117|448839983|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
124783873|NCT00689117|448839984|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
124783874|NCT00689117|448839981|FG000|Overall Study|Use of Prohibitive Medication|2|||
124783875|NCT00689117|448839982|FG001|Overall Study|Use of Prohibitive Medication|1|||
124783876|NCT00689117|448839983|FG002|Overall Study|Use of Prohibitive Medication|3|||
124783877|NCT00689117|448839984|FG003|Overall Study|Use of Prohibitive Medication|0|||
124783878|NCT00689117|448839981|FG000|Overall Study|Pregnancy|0|||
124783879|NCT00689117|448839982|FG001|Overall Study|Pregnancy|2|||
124624722|NCT04205812|448241529|FG000|Randomized Treatment Period|Ongoing|28|||
124624723|NCT04205812|448241530|FG001|Randomized Treatment Period|Ongoing|138|||
124624724|NCT04205812|448241529|FG000|Randomized Treatment Period|Death|94|||
124624725|NCT04205812|448241530|FG001|Randomized Treatment Period|Death|226|||
124624726|NCT04205812|448241529|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
124624727|NCT04205812|448241530|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
124624728|NCT04205812|448241529|FG000|Randomized Treatment Period|Physician Decision|1|||
124624729|NCT04205812|448241530|FG001|Randomized Treatment Period|Physician Decision|4|||
124624730|NCT04205812|448241529|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
124624731|NCT04205812|448241530|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
124624732|NCT04205812|448241529|FG000|Randomized Treatment Period|Progressive Disease|0|||
124624733|NCT04205812|448241530|FG001|Randomized Treatment Period|Progressive Disease|1|||
124624734|NCT04205812|448241529|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
124624735|NCT04205812|448241530|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
124624736|NCT04205812|448241529|FG000|Monotherapy Treatment Period|Ongoing|17|||
124624737|NCT04205812|448241530|FG001|Monotherapy Treatment Period|Ongoing|0|||
124624738|NCT04205812|448241529|FG000|Monotherapy Treatment Period|Death|39|||
124624739|NCT04205812|448241530|FG001|Monotherapy Treatment Period|Death|0|||
124624740|NCT04205812|448241529|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
124624741|NCT04205812|448241530|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
124624742|NCT04205812|448241529|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
124624743|NCT04205812|448241530|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
124624744|NCT05221320|448241533|FG000|Overall Study|Lack of Efficacy|3|||
124624745|NCT05221320|448241534|FG001|Overall Study|Lack of Efficacy|7|||
124624746|NCT05221320|448241535|FG002|Overall Study|Lack of Efficacy|10|||
124624747|NCT05221320|448241536|FG003|Overall Study|Lack of Efficacy|1|||
124624748|NCT05221320|448241537|FG004|Overall Study|Lack of Efficacy|0|||
124624749|NCT05221320|448241538|FG005|Overall Study|Lack of Efficacy|0|||
124624750|NCT05221320|448241533|FG000|Overall Study|Physician Decision|1|||
124624751|NCT05221320|448241534|FG001|Overall Study|Physician Decision|0|||
124624752|NCT05221320|448241535|FG002|Overall Study|Physician Decision|3|||
124624753|NCT05221320|448241536|FG003|Overall Study|Physician Decision|1|||
124624754|NCT05221320|448241537|FG004|Overall Study|Physician Decision|0|||
124624755|NCT05221320|448241538|FG005|Overall Study|Physician Decision|0|||
124624756|NCT05221320|448241533|FG000|Overall Study|Withdrawal by Subject|0|||
124624757|NCT05221320|448241534|FG001|Overall Study|Withdrawal by Subject|3|||
124624758|NCT05221320|448241535|FG002|Overall Study|Withdrawal by Subject|1|||
124624759|NCT05221320|448241536|FG003|Overall Study|Withdrawal by Subject|0|||
124624760|NCT05221320|448241537|FG004|Overall Study|Withdrawal by Subject|0|||
124624761|NCT05221320|448241538|FG005|Overall Study|Withdrawal by Subject|0|||
124624762|NCT05221320|448241533|FG000|Overall Study|Death|0|||
124624763|NCT05221320|448241534|FG001|Overall Study|Death|5|||
124624764|NCT05221320|448241535|FG002|Overall Study|Death|6|||
124624765|NCT05221320|448241536|FG003|Overall Study|Death|0|||
124624766|NCT05221320|448241537|FG004|Overall Study|Death|1|||
124624767|NCT05221320|448241538|FG005|Overall Study|Death|0|||
124624768|NCT06473519|448241539|FG000|Overall Study|Lost to Follow-up|2|||
124624769|NCT06473519|448241540|FG001|Overall Study|Lost to Follow-up|5|||
124624770|NCT06473519|448241539|FG000|Overall Study|Withdrawal by Subject|1|||
124624771|NCT06473519|448241540|FG001|Overall Study|Withdrawal by Subject|4|||
124624772|NCT06473519|448241539|FG000|Overall Study|Randomized but not vaccinated|1|||
124624773|NCT06473519|448241540|FG001|Overall Study|Randomized but not vaccinated|2|||
124624774|NCT02514447|448241553|FG000|Overall Study|Withdrawal by Subject|3|||
124624775|NCT02514447|448241554|FG001|Overall Study|Withdrawal by Subject|1|||
124624776|NCT02514447|448241555|FG002|Overall Study|Withdrawal by Subject|1|||
124624777|NCT02514447|448241556|FG003|Overall Study|Withdrawal by Subject|0|||
124624778|NCT02514447|448241557|FG004|Overall Study|Withdrawal by Subject|0|||
124624779|NCT02514447|448241558|FG005|Overall Study|Withdrawal by Subject|0|||
124624780|NCT02514447|448241559|FG006|Overall Study|Withdrawal by Subject|0|||
124624781|NCT02514447|448241560|FG007|Overall Study|Withdrawal by Subject|1|||
124624782|NCT02514447|448241561|FG008|Overall Study|Withdrawal by Subject|1|||
124624783|NCT02514447|448241553|FG000|Overall Study|Death|24|||
124624784|NCT02514447|448241554|FG001|Overall Study|Death|28|||
124624785|NCT02514447|448241555|FG002|Overall Study|Death|29|||
124624786|NCT02514447|448241556|FG003|Overall Study|Death|0|||
124624787|NCT02514447|448241557|FG004|Overall Study|Death|3|||
124624788|NCT02514447|448241558|FG005|Overall Study|Death|4|||
124624789|NCT02514447|448241559|FG006|Overall Study|Death|8|||
124624790|NCT02514447|448241560|FG007|Overall Study|Death|6|||
124624791|NCT02514447|448241561|FG008|Overall Study|Death|5|||
124624792|NCT02514447|448241553|FG000|Overall Study|Lost to Follow-up|1|||
124624793|NCT02514447|448241554|FG001|Overall Study|Lost to Follow-up|0|||
124624794|NCT02514447|448241555|FG002|Overall Study|Lost to Follow-up|0|||
124624795|NCT02514447|448241556|FG003|Overall Study|Lost to Follow-up|0|||
124624796|NCT02514447|448241557|FG004|Overall Study|Lost to Follow-up|0|||
124624797|NCT02514447|448241558|FG005|Overall Study|Lost to Follow-up|0|||
124624798|NCT02514447|448241559|FG006|Overall Study|Lost to Follow-up|0|||
124624799|NCT02514447|448241560|FG007|Overall Study|Lost to Follow-up|0|||
124624800|NCT02514447|448241561|FG008|Overall Study|Lost to Follow-up|1|||
124624801|NCT02514447|448241553|FG000|Overall Study|Sponsor Termination of Study|0|||
124624802|NCT02514447|448241554|FG001|Overall Study|Sponsor Termination of Study|1|||
124624803|NCT02514447|448241555|FG002|Overall Study|Sponsor Termination of Study|1|||
124624804|NCT02514447|448241556|FG003|Overall Study|Sponsor Termination of Study|0|||
124624805|NCT02514447|448241557|FG004|Overall Study|Sponsor Termination of Study|0|||
124624806|NCT02514447|448241558|FG005|Overall Study|Sponsor Termination of Study|0|||
124624807|NCT02514447|448241559|FG006|Overall Study|Sponsor Termination of Study|0|||
124624808|NCT02514447|448241560|FG007|Overall Study|Sponsor Termination of Study|0|||
124624809|NCT02514447|448241561|FG008|Overall Study|Sponsor Termination of Study|0|||
124624810|NCT02514447|448241553|FG000|Overall Study|Study completion per Investigator|1|||
124783880|NCT00689117|448839983|FG002|Overall Study|Pregnancy|0|||
124783881|NCT00689117|448839984|FG003|Overall Study|Pregnancy|2|||
124624811|NCT02514447|448241554|FG001|Overall Study|Study completion per Investigator|0|||
124624812|NCT02514447|448241555|FG002|Overall Study|Study completion per Investigator|1|||
124624813|NCT02514447|448241556|FG003|Overall Study|Study completion per Investigator|2|||
124624814|NCT02514447|448241557|FG004|Overall Study|Study completion per Investigator|0|||
124624815|NCT02514447|448241558|FG005|Overall Study|Study completion per Investigator|0|||
124624816|NCT02514447|448241559|FG006|Overall Study|Study completion per Investigator|0|||
124624817|NCT02514447|448241560|FG007|Overall Study|Study completion per Investigator|0|||
124624818|NCT02514447|448241561|FG008|Overall Study|Study completion per Investigator|1|||
124624861|NCT04903288|448241574|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
124624862|NCT04903288|448241574|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
124624863|NCT04903288|448241574|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
124624864|NCT04903288|448241574|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
124624865|NCT03713593|448241575|FG000|Overall Study|Sponsor Decision|73|||
124624866|NCT03713593|448241576|FG001|Overall Study|Sponsor Decision|41|||
124624867|NCT03713593|448241575|FG000|Overall Study|Lost to Follow-up|2|||
124624868|NCT03713593|448241576|FG001|Overall Study|Lost to Follow-up|1|||
124624869|NCT03713593|448241575|FG000|Overall Study|Death|314|||
124624870|NCT03713593|448241576|FG001|Overall Study|Death|349|||
124624871|NCT03713593|448241575|FG000|Overall Study|Withdrawal by Subject|6|||
124624872|NCT03713593|448241576|FG001|Overall Study|Withdrawal by Subject|8|||
124624873|NCT04776148|448241577|FG000|Overall Study|Death|249|||
124624874|NCT04776148|448241578|FG001|Overall Study|Death|260|||
124624875|NCT04776148|448241577|FG000|Overall Study|Lost to Follow-up|0|||
124624876|NCT04776148|448241578|FG001|Overall Study|Lost to Follow-up|1|||
124624877|NCT04776148|448241577|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124624878|NCT04776148|448241578|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
124624879|NCT04776148|448241577|FG000|Overall Study|Withdrawal by Subject|3|||
124624880|NCT04776148|448241578|FG001|Overall Study|Withdrawal by Subject|4|||
124624881|NCT04776148|448241577|FG000|Overall Study|Sponsor Decision|30|||
124624882|NCT04776148|448241578|FG001|Overall Study|Sponsor Decision|15|||
124624883|NCT03130777|448241579|FG000|Overall Study|Death|0|||
124624884|NCT03130777|448241580|FG001|Overall Study|Death|1|||
124624885|NCT03130777|448241579|FG000|Overall Study|Did not meet eligibility criteria|1|||
124624886|NCT03130777|448241580|FG001|Overall Study|Did not meet eligibility criteria|0|||
124624908|NCT02498613|448241599|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
124624909|NCT02498613|448241600|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
124624910|NCT02498613|448241601|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
124624911|NCT02498613|448241602|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
124624912|NCT02498613|448241599|FG000|Overall Study|Withdrawal by Subject|3|||
124624913|NCT02498613|448241600|FG001|Overall Study|Withdrawal by Subject|1|||
124624914|NCT02498613|448241601|FG002|Overall Study|Withdrawal by Subject|0|||
124624915|NCT02498613|448241602|FG003|Overall Study|Withdrawal by Subject|0|||
124624916|NCT05168202|448241603|FG000|Overall Study|Progressive Disease|4|||
124624917|NCT05168202|448241604|FG001|Overall Study|Progressive Disease|4|||
124624918|NCT05168202|448241605|FG002|Overall Study|Progressive Disease|2|||
124624919|NCT05168202|448241606|FG003|Overall Study|Progressive Disease|3|||
124624920|NCT05168202|448241607|FG004|Overall Study|Progressive Disease|2|||
124624921|NCT05168202|448241608|FG005|Overall Study|Progressive Disease|3|||
124624922|NCT05168202|448241609|FG006|Overall Study|Progressive Disease|2|||
124624923|NCT05168202|448241603|FG000|Overall Study|Adverse Event|2|||
124624924|NCT05168202|448241604|FG001|Overall Study|Adverse Event|1|||
124624925|NCT05168202|448241605|FG002|Overall Study|Adverse Event|4|||
124624926|NCT05168202|448241606|FG003|Overall Study|Adverse Event|4|||
124624927|NCT05168202|448241607|FG004|Overall Study|Adverse Event|3|||
124624928|NCT05168202|448241608|FG005|Overall Study|Adverse Event|2|||
124624929|NCT05168202|448241609|FG006|Overall Study|Adverse Event|0|||
124624930|NCT05168202|448241603|FG000|Overall Study|Lack of Efficacy|0|||
124624931|NCT05168202|448241604|FG001|Overall Study|Lack of Efficacy|1|||
124624932|NCT05168202|448241605|FG002|Overall Study|Lack of Efficacy|1|||
124624933|NCT05168202|448241606|FG003|Overall Study|Lack of Efficacy|0|||
124624934|NCT05168202|448241607|FG004|Overall Study|Lack of Efficacy|1|||
124624935|NCT05168202|448241608|FG005|Overall Study|Lack of Efficacy|2|||
124624936|NCT05168202|448241609|FG006|Overall Study|Lack of Efficacy|2|||
124624937|NCT05168202|448241603|FG000|Overall Study|Withdrawal by Subject|0|||
124624938|NCT05168202|448241604|FG001|Overall Study|Withdrawal by Subject|0|||
124624939|NCT05168202|448241605|FG002|Overall Study|Withdrawal by Subject|1|||
124624940|NCT05168202|448241606|FG003|Overall Study|Withdrawal by Subject|1|||
124624941|NCT05168202|448241607|FG004|Overall Study|Withdrawal by Subject|1|||
124624942|NCT05168202|448241608|FG005|Overall Study|Withdrawal by Subject|1|||
124624943|NCT05168202|448241609|FG006|Overall Study|Withdrawal by Subject|0|||
124624944|NCT05168202|448241603|FG000|Overall Study|Disease Relapse|0|||
124624945|NCT05168202|448241604|FG001|Overall Study|Disease Relapse|1|||
124624946|NCT05168202|448241605|FG002|Overall Study|Disease Relapse|0|||
124624947|NCT05168202|448241606|FG003|Overall Study|Disease Relapse|1|||
124624948|NCT05168202|448241607|FG004|Overall Study|Disease Relapse|1|||
124624949|NCT05168202|448241608|FG005|Overall Study|Disease Relapse|0|||
124624950|NCT05168202|448241609|FG006|Overall Study|Disease Relapse|0|||
124624951|NCT05168202|448241603|FG000|Overall Study|Other Reasons|0|||
124624952|NCT05168202|448241604|FG001|Overall Study|Other Reasons|0|||
124624953|NCT05168202|448241605|FG002|Overall Study|Other Reasons|0|||
124624954|NCT05168202|448241606|FG003|Overall Study|Other Reasons|0|||
124624955|NCT05168202|448241607|FG004|Overall Study|Other Reasons|0|||
124624956|NCT05168202|448241608|FG005|Overall Study|Other Reasons|2|||
124624957|NCT05168202|448241609|FG006|Overall Study|Other Reasons|1|||
124624958|NCT05168202|448241603|FG000|Overall Study|Physician Decision|0|||
124624959|NCT05168202|448241604|FG001|Overall Study|Physician Decision|1|||
124624960|NCT05168202|448241605|FG002|Overall Study|Physician Decision|1|||
124624961|NCT05168202|448241606|FG003|Overall Study|Physician Decision|0|||
124624962|NCT05168202|448241607|FG004|Overall Study|Physician Decision|0|||
124624963|NCT05168202|448241608|FG005|Overall Study|Physician Decision|0|||
124624964|NCT05168202|448241609|FG006|Overall Study|Physician Decision|0|||
124624965|NCT05168202|448241603|FG000|Overall Study|Study Terminated by Sponsor|0|||
124624966|NCT05168202|448241604|FG001|Overall Study|Study Terminated by Sponsor|0|||
124624967|NCT05168202|448241605|FG002|Overall Study|Study Terminated by Sponsor|0|||
124624968|NCT05168202|448241606|FG003|Overall Study|Study Terminated by Sponsor|1|||
124624969|NCT05168202|448241607|FG004|Overall Study|Study Terminated by Sponsor|0|||
124624970|NCT05168202|448241608|FG005|Overall Study|Study Terminated by Sponsor|0|||
124624971|NCT05168202|448241609|FG006|Overall Study|Study Terminated by Sponsor|0|||
124624972|NCT05109611|448241610|FG000|Overall Study|Adverse Event|13|||
124624973|NCT05109611|448241611|FG001|Overall Study|Adverse Event|10|||
124624974|NCT05109611|448241610|FG000|Overall Study|Withdrawal by Subject|1|||
124624975|NCT05109611|448241611|FG001|Overall Study|Withdrawal by Subject|0|||
124624976|NCT05109611|448241610|FG000|Overall Study|Lost to Follow-up|1|||
124624977|NCT05109611|448241611|FG001|Overall Study|Lost to Follow-up|2|||
124624978|NCT05109611|448241610|FG000|Overall Study|Protocol Violation|0|||
124624979|NCT05109611|448241611|FG001|Overall Study|Protocol Violation|4|||
124624980|NCT05109611|448241610|FG000|Overall Study|Information unavailable|1|||
124624981|NCT05109611|448241611|FG001|Overall Study|Information unavailable|1|||
124624992|NCT02731638|448241617|FG000|Overall Study|Lost to Follow-up|6|||
124624993|NCT02731638|448241618|FG001|Overall Study|Lost to Follow-up|9|||
124625004|NCT05626231|448241621|FG000|Provider Enrollment|Worked part-time|4|||
124625005|NCT05626231|448241621|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
124625006|NCT05626231|448241621|FG000|Provider Enrollment|Non-clinical employee|1|||
124625007|NCT05626231|448241621|FG000|Provider Enrollment|Provider does not see clients|3|||
124625008|NCT05626231|448241621|FG000|Provider Enrollment|Other|5|||
124625013|NCT06195930|448241624|FG000|Overall Study|Adverse Event|4|||
124625116|NCT05878093|448241645|FG000|Overall Study|Withdrawal by Subject|3|||
124625117|NCT05878093|448241646|FG001|Overall Study|Withdrawal by Subject|1|||
124625118|NCT04995029|448241647|FG000|Induction Phase|Did not meet eligibility criteria|5|||
124625119|NCT04995029|448241648|FG001|Induction Phase|Did not meet eligibility criteria|2|||
124625120|NCT04995029|448241649|FG002|Induction Phase|Did not meet eligibility criteria|0|||
124625121|NCT04995029|448241650|FG003|Induction Phase|Did not meet eligibility criteria|0|||
124625122|NCT04995029|448241647|FG000|Induction Phase|Withdrawal by Subject|85|||
124625123|NCT04995029|448241648|FG001|Induction Phase|Withdrawal by Subject|42|||
124625124|NCT04995029|448241649|FG002|Induction Phase|Withdrawal by Subject|0|||
124625125|NCT04995029|448241650|FG003|Induction Phase|Withdrawal by Subject|0|||
124625126|NCT04995029|448241647|FG000|Induction Phase|Lost to Follow-up|103|||
124625127|NCT04995029|448241648|FG001|Induction Phase|Lost to Follow-up|67|||
124625128|NCT04995029|448241649|FG002|Induction Phase|Lost to Follow-up|0|||
124625129|NCT04995029|448241650|FG003|Induction Phase|Lost to Follow-up|0|||
124625130|NCT04995029|448241647|FG000|Induction Phase|Adverse Event|5|||
124625131|NCT04995029|448241648|FG001|Induction Phase|Adverse Event|3|||
124625132|NCT04995029|448241649|FG002|Induction Phase|Adverse Event|0|||
124625133|NCT04995029|448241650|FG003|Induction Phase|Adverse Event|0|||
124625134|NCT04995029|448241647|FG000|Induction Phase|Physician Decision|11|||
124625135|NCT04995029|448241648|FG001|Induction Phase|Physician Decision|8|||
124625136|NCT04995029|448241649|FG002|Induction Phase|Physician Decision|0|||
124625137|NCT04995029|448241650|FG003|Induction Phase|Physician Decision|0|||
124625138|NCT04995029|448241647|FG000|Induction Phase|Incarceration|6|||
124625139|NCT04995029|448241648|FG001|Induction Phase|Incarceration|3|||
124625140|NCT04995029|448241649|FG002|Induction Phase|Incarceration|0|||
124625141|NCT04995029|448241650|FG003|Induction Phase|Incarceration|0|||
124625142|NCT04995029|448241647|FG000|Induction Phase|Not otherwise described|5|||
124625143|NCT04995029|448241648|FG001|Induction Phase|Not otherwise described|5|||
124625144|NCT04995029|448241649|FG002|Induction Phase|Not otherwise described|0|||
124625145|NCT04995029|448241650|FG003|Induction Phase|Not otherwise described|0|||
124625146|NCT04995029|448241647|FG000|Maintenance Phase|Lost to Follow-up|0|||
124625147|NCT04995029|448241648|FG001|Maintenance Phase|Lost to Follow-up|0|||
124625148|NCT04995029|448241649|FG002|Maintenance Phase|Lost to Follow-up|51|||
124625149|NCT04995029|448241650|FG003|Maintenance Phase|Lost to Follow-up|44|||
124625150|NCT04995029|448241647|FG000|Maintenance Phase|Did not meet eligibility criteria|0|||
124625151|NCT04995029|448241648|FG001|Maintenance Phase|Did not meet eligibility criteria|0|||
124625152|NCT04995029|448241649|FG002|Maintenance Phase|Did not meet eligibility criteria|0|||
124625153|NCT04995029|448241650|FG003|Maintenance Phase|Did not meet eligibility criteria|1|||
124625154|NCT04995029|448241647|FG000|Maintenance Phase|Adverse Event|0|||
124625155|NCT04995029|448241648|FG001|Maintenance Phase|Adverse Event|0|||
124625156|NCT04995029|448241649|FG002|Maintenance Phase|Adverse Event|0|||
124625157|NCT04995029|448241650|FG003|Maintenance Phase|Adverse Event|1|||
124625158|NCT04995029|448241647|FG000|Maintenance Phase|Physician Decision|0|||
124625159|NCT04995029|448241648|FG001|Maintenance Phase|Physician Decision|0|||
124625160|NCT04995029|448241649|FG002|Maintenance Phase|Physician Decision|8|||
124625161|NCT04995029|448241650|FG003|Maintenance Phase|Physician Decision|4|||
124625162|NCT04995029|448241647|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124625163|NCT04995029|448241648|FG001|Maintenance Phase|Withdrawal by Subject|0|||
124625164|NCT04995029|448241649|FG002|Maintenance Phase|Withdrawal by Subject|17|||
124625165|NCT04995029|448241650|FG003|Maintenance Phase|Withdrawal by Subject|31|||
124625166|NCT04995029|448241647|FG000|Maintenance Phase|Incarceration|0|||
124625167|NCT04995029|448241648|FG001|Maintenance Phase|Incarceration|0|||
124625168|NCT04995029|448241649|FG002|Maintenance Phase|Incarceration|4|||
124625169|NCT04995029|448241650|FG003|Maintenance Phase|Incarceration|3|||
124625170|NCT04995029|448241647|FG000|Maintenance Phase|Not otherwise described|0|||
124625171|NCT04995029|448241648|FG001|Maintenance Phase|Not otherwise described|0|||
124625172|NCT04995029|448241649|FG002|Maintenance Phase|Not otherwise described|2|||
124625173|NCT04995029|448241650|FG003|Maintenance Phase|Not otherwise described|3|||
124625174|NCT04995029|448241647|FG000|Maintenance Phase|Pregnancy|0|||
124625175|NCT04995029|448241648|FG001|Maintenance Phase|Pregnancy|0|||
124625176|NCT04995029|448241649|FG002|Maintenance Phase|Pregnancy|2|||
124625177|NCT04995029|448241650|FG003|Maintenance Phase|Pregnancy|2|||
124625178|NCT03690388|448241655|FG000|Overall Study|Adverse Event|8|||
124625179|NCT03690388|448241656|FG001|Overall Study|Adverse Event|1|||
124625180|NCT03690388|448241655|FG000|Overall Study|Radiographic Progression|14|||
124625181|NCT03690388|448241656|FG001|Overall Study|Radiographic Progression|29|||
124625182|NCT03690388|448241655|FG000|Overall Study|Clinical deterioration|10|||
124625183|NCT03690388|448241656|FG001|Overall Study|Clinical deterioration|6|||
124625184|NCT03690388|448241655|FG000|Overall Study|Withdrawal by Subject|2|||
124625185|NCT03690388|448241656|FG001|Overall Study|Withdrawal by Subject|0|||
124625186|NCT03690388|448241655|FG000|Overall Study|Lack of Efficacy|1|||
124625187|NCT03690388|448241656|FG001|Overall Study|Lack of Efficacy|0|||
124625188|NCT03690388|448241655|FG000|Overall Study|Lost to Follow-up|1|||
124625189|NCT03690388|448241656|FG001|Overall Study|Lost to Follow-up|0|||
124625199|NCT03041311|448241671|FG000|Overall Study|Death|39|||
124625200|NCT03041311|448241672|FG001|Overall Study|Death|42|||
124625201|NCT03041311|448241671|FG000|Overall Study|Lost to Follow-up|0|||
124783882|NCT00689117|448839981|FG000|Overall Study|Incarceration|2|||
124625202|NCT03041311|448241672|FG001|Overall Study|Lost to Follow-up|1|||
124625203|NCT03041311|448241671|FG000|Overall Study|Withdrawal by Subject|8|||
124625204|NCT03041311|448241672|FG001|Overall Study|Withdrawal by Subject|5|||
124625205|NCT03041311|448241671|FG000|Overall Study|Sponsor Terminated Study|2|||
124625206|NCT03041311|448241672|FG001|Overall Study|Sponsor Terminated Study|4|||
124625207|NCT03041311|448241671|FG000|Overall Study|Disease Progression|3|||
124625208|NCT03041311|448241672|FG001|Overall Study|Disease Progression|1|||
124625209|NCT03041311|448241671|FG000|Overall Study|Randomized in error, did not receive drug|2|||
124625210|NCT03041311|448241672|FG001|Overall Study|Randomized in error, did not receive drug|0|||
124625243|NCT04182490|448241690|FG000|Overall Study|Withdrawal by Subject|3|||
124625244|NCT04182490|448241691|FG001|Overall Study|Withdrawal by Subject|3|||
124625245|NCT04182490|448241690|FG000|Overall Study|Lost to Follow-up|0|||
124625246|NCT04182490|448241691|FG001|Overall Study|Lost to Follow-up|1|||
124625247|NCT04182490|448241690|FG000|Overall Study|Physician Decision|0|||
124625248|NCT04182490|448241691|FG001|Overall Study|Physician Decision|1|||
124625258|NCT03934541|448243234|FG000|Overall Study|Study Terminated by Sponsor|0|||
124625259|NCT03934541|448243235|FG001|Overall Study|Study Terminated by Sponsor|1|||
124625260|NCT03934541|448243236|FG002|Overall Study|Study Terminated by Sponsor|0|||
124625261|NCT03934541|448243237|FG003|Overall Study|Study Terminated by Sponsor|0|||
124783883|NCT00689117|448839982|FG001|Overall Study|Incarceration|0|||
124783884|NCT00689117|448839983|FG002|Overall Study|Incarceration|0|||
124625277|NCT02673775|448243243|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
124625278|NCT02673775|448243244|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
124625279|NCT02673775|448243243|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
124783885|NCT00689117|448839984|FG003|Overall Study|Incarceration|0|||
124783886|NCT00689117|448839981|FG000|Overall Study|Fear of Birth Defects|0|||
124625280|NCT02673775|448243244|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
124625281|NCT02673775|448243243|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
124625282|NCT02673775|448243244|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
124625283|NCT02673775|448243243|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
124625284|NCT02673775|448243244|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
124625285|NCT02441686|448243246|FG000|Induction|Adverse Event|4|||
124625286|NCT02441686|448243246|FG000|Induction|Complicating disease|1|||
124625287|NCT02441686|448243246|FG000|Induction|Physician Decision|1|||
124625288|NCT02441686|448243246|FG000|Induction|Withdrawal by Subject|1|||
124625289|NCT02441686|448243246|FG000|Induction|Did not receive treatment|1|||
124625290|NCT02441686|448243246|FG000|Maintenance|Remaining on Treatment|23|||
124625291|NCT02441686|448243246|FG000|Maintenance|Physician Decision|1|||
124625292|NCT02441686|448243246|FG000|Maintenance|Adverse Event|3|||
124625293|NCT02441686|448243246|FG000|Maintenance|Progressive Disease|10|||
124625294|NCT02441686|448243246|FG000|Maintenance|Withdrawal by Subject|1|||
124783887|NCT00689117|448839982|FG001|Overall Study|Fear of Birth Defects|0|||
124783888|NCT00689117|448839983|FG002|Overall Study|Fear of Birth Defects|1|||
124783889|NCT00689117|448839984|FG003|Overall Study|Fear of Birth Defects|0|||
124783890|NCT00689117|448839981|FG000|Overall Study|Transportation|1|||
124783891|NCT00689117|448839982|FG001|Overall Study|Transportation|0|||
124783892|NCT00689117|448839983|FG002|Overall Study|Transportation|0|||
124783893|NCT00689117|448839984|FG003|Overall Study|Transportation|0|||
124783894|NCT00689117|448839981|FG000|Overall Study|Patient Withdrew from Study|0|||
124783895|NCT00689117|448839982|FG001|Overall Study|Patient Withdrew from Study|0|||
124783896|NCT00689117|448839983|FG002|Overall Study|Patient Withdrew from Study|0|||
124783897|NCT00689117|448839984|FG003|Overall Study|Patient Withdrew from Study|1|||
124783898|NCT00689117|448839981|FG000|Overall Study|Personal Reason|0|||
124783899|NCT00689117|448839982|FG001|Overall Study|Personal Reason|1|||
124783900|NCT00689117|448839983|FG002|Overall Study|Personal Reason|0|||
124783901|NCT00689117|448839984|FG003|Overall Study|Personal Reason|0|||
124783902|NCT00689117|448839981|FG000|Overall Study|Dispensing Error|0|||
124783903|NCT00689117|448839982|FG001|Overall Study|Dispensing Error|1|||
124783904|NCT00689117|448839983|FG002|Overall Study|Dispensing Error|0|||
124783905|NCT00689117|448839984|FG003|Overall Study|Dispensing Error|0|||
124783906|NCT01086358|448839987|FG000|First Intervention|Lost to Follow-up|9|||
124783907|NCT01086358|448839988|FG001|First Intervention|Lost to Follow-up|4|||
124783908|NCT01086358|448839987|FG000|First Intervention|Withdrawal by Subject|0|||
124783909|NCT01086358|448839988|FG001|First Intervention|Withdrawal by Subject|1|||
124783910|NCT01086358|448839987|FG000|Second Intervention|Lost to Follow-up|4|||
124783911|NCT01086358|448839988|FG001|Second Intervention|Lost to Follow-up|4|||
124783912|NCT03206788|448839991|FG000|Overall Study|Withdrawal by Subject|0|||
124783913|NCT03206788|448839992|FG001|Overall Study|Withdrawal by Subject|1|||
124783914|NCT03206788|448839991|FG000|Overall Study|Adverse Event|0|||
124783915|NCT03206788|448839992|FG001|Overall Study|Adverse Event|1|||
124783916|NCT03206788|448839991|FG000|Overall Study|Physician Decision|0|||
124783917|NCT03206788|448839992|FG001|Overall Study|Physician Decision|1|||
124783918|NCT02471612|448839993|FG000|Overall Study|Lost to Follow-up|2|||
124783919|NCT03899805|448839994|FG000|Overall Study|Physician Decision|3|||
124783920|NCT03899805|448839995|FG001|Overall Study|Physician Decision|0|||
124783921|NCT03899805|448839996|FG002|Overall Study|Physician Decision|2|||
124783922|NCT03899805|448839994|FG000|Overall Study|Withdrawal by Subject|1|||
124783923|NCT03899805|448839995|FG001|Overall Study|Withdrawal by Subject|0|||
124783924|NCT03899805|448839996|FG002|Overall Study|Withdrawal by Subject|2|||
124783925|NCT03899805|448839994|FG000|Overall Study|Progressive Disease|10|||
124625339|NCT03164616|448243264|FG000|Overall Study|Death|250|||
124625340|NCT03164616|448243265|FG001|Overall Study|Death|264|||
124625341|NCT03164616|448243266|FG002|Overall Study|Death|279|||
124625342|NCT03164616|448243264|FG000|Overall Study|Lost to Follow-up|2|||
124625343|NCT03164616|448243265|FG001|Overall Study|Lost to Follow-up|2|||
124625344|NCT03164616|448243266|FG002|Overall Study|Lost to Follow-up|2|||
124625345|NCT03164616|448243264|FG000|Overall Study|Withdrawal by Subject|6|||
124625346|NCT03164616|448243265|FG001|Overall Study|Withdrawal by Subject|7|||
124625347|NCT03164616|448243266|FG002|Overall Study|Withdrawal by Subject|16|||
124783926|NCT03899805|448839995|FG001|Overall Study|Progressive Disease|18|||
124783927|NCT03899805|448839996|FG002|Overall Study|Progressive Disease|12|||
124783928|NCT03899805|448839994|FG000|Overall Study|Adverse Event|3|||
124783929|NCT03899805|448839995|FG001|Overall Study|Adverse Event|1|||
124783930|NCT03899805|448839996|FG002|Overall Study|Adverse Event|0|||
124783931|NCT03899805|448839994|FG000|Overall Study|Death|2|||
124783932|NCT03899805|448839995|FG001|Overall Study|Death|0|||
124783933|NCT03899805|448839996|FG002|Overall Study|Death|0|||
124783934|NCT03899805|448839994|FG000|Overall Study|Came off for surgery|0|||
124783935|NCT03899805|448839995|FG001|Overall Study|Came off for surgery|0|||
124783936|NCT03899805|448839996|FG002|Overall Study|Came off for surgery|1|||
124783937|NCT03317405|448839997|FG000|Overall Study|Withdrawal by Subject|1|||
124783938|NCT03317405|448839998|FG001|Overall Study|Withdrawal by Subject|0|||
124783939|NCT03317405|448839999|FG002|Overall Study|Withdrawal by Subject|0|||
124783940|NCT03317405|448839997|FG000|Overall Study|Physician Decision|0|||
124783941|NCT03317405|448839998|FG001|Overall Study|Physician Decision|0|||
124783942|NCT03317405|448839999|FG002|Overall Study|Physician Decision|1|||
124783943|NCT03317405|448839997|FG000|Overall Study|Surgery Rescheduled|0|||
124783944|NCT03317405|448839998|FG001|Overall Study|Surgery Rescheduled|1|||
124783945|NCT03317405|448839999|FG002|Overall Study|Surgery Rescheduled|0|||
124783946|NCT01018810|448840002|FG000|Overall Study|Withdrawal by Subject|0|||
124783947|NCT01018810|448840003|FG001|Overall Study|Withdrawal by Subject|1|||
124783948|NCT01018810|448840004|FG002|Overall Study|Withdrawal by Subject|0|||
124783949|NCT01018810|448840005|FG003|Overall Study|Withdrawal by Subject|0|||
124783950|NCT01018810|448840006|FG004|Overall Study|Withdrawal by Subject|0|||
124783951|NCT01018810|448840002|FG000|Overall Study|Sponsor Decision|2|||
124783952|NCT01018810|448840003|FG001|Overall Study|Sponsor Decision|0|||
124783953|NCT01018810|448840004|FG002|Overall Study|Sponsor Decision|1|||
124783954|NCT01018810|448840005|FG003|Overall Study|Sponsor Decision|1|||
124783955|NCT01018810|448840006|FG004|Overall Study|Sponsor Decision|1|||
124751982|NCT01858766|448714232|FG017|Overall Study|Randomized but Never Treated|1|||
124751983|NCT01858766|448714233|FG018|Overall Study|Randomized but Never Treated|0|||
124751984|NCT01858766|448714215|FG000|Overall Study|Death|0|||
124751985|NCT01858766|448714216|FG001|Overall Study|Death|0|||
124751986|NCT01858766|448714217|FG002|Overall Study|Death|1|||
124751987|NCT01858766|448714218|FG003|Overall Study|Death|0|||
124751988|NCT01858766|448714219|FG004|Overall Study|Death|0|||
124751989|NCT01858766|448714220|FG005|Overall Study|Death|0|||
124751990|NCT01858766|448714221|FG006|Overall Study|Death|0|||
124751991|NCT01858766|448714222|FG007|Overall Study|Death|0|||
124751992|NCT01858766|448714223|FG008|Overall Study|Death|0|||
124751993|NCT01858766|448714224|FG009|Overall Study|Death|0|||
124783956|NCT01640314|448840007|FG000|Overall Study|Protocol Violation|0|||
124783957|NCT01640314|448840008|FG001|Overall Study|Protocol Violation|1|||
124783958|NCT04450381|448840009|FG000|Overall Study|Protocol Violation|4|||
124783959|NCT04450381|448840009|FG000|Overall Study|Wrong device setting|2|||
124783960|NCT01989208|448840010|FG000|200 mg (7 Days)|Protocol Violation|0|||
124783961|NCT01989208|448840011|FG001|200 mg (7 Days)|Protocol Violation|1|||
124783962|NCT04973436|448840012|FG000|Overall Study|Lost to Follow-up|3|||
124783963|NCT04973436|448840012|FG000|Overall Study|Withdrawal by Subject|1|||
124783964|NCT04973436|448840012|FG000|Overall Study|Death|2|||
124783965|NCT00566696|448840013|FG000|Overall Study|Met Exclusion Criteria|2|||
124783966|NCT00566696|448840013|FG000|Overall Study|Muromonab not available|1|||
124625429|NCT06018129|448243311|FG000|Overall Study|Death|1|||
124625430|NCT06018129|448243312|FG001|Overall Study|Death|1|||
124625431|NCT06018129|448243313|FG002|Overall Study|Death|2|||
124625432|NCT06018129|448243311|FG000|Overall Study|Sponsor Decision|2|||
124625433|NCT06018129|448243312|FG001|Overall Study|Sponsor Decision|2|||
124625434|NCT06018129|448243313|FG002|Overall Study|Sponsor Decision|1|||
124625435|NCT04917861|448243314|FG000|Main Study (196 Days)|Adverse Event|0|||
124625436|NCT04917861|448243315|FG001|Main Study (196 Days)|Adverse Event|1|||
124625437|NCT04917861|448243316|FG002|Main Study (196 Days)|Adverse Event|0|||
124625438|NCT04917861|448243317|FG003|Main Study (196 Days)|Adverse Event|0|||
124625439|NCT04917861|448243314|FG000|Main Study (196 Days)|Death|0|||
124625440|NCT04917861|448243315|FG001|Main Study (196 Days)|Death|0|||
124625441|NCT04917861|448243316|FG002|Main Study (196 Days)|Death|0|||
124625442|NCT04917861|448243317|FG003|Main Study (196 Days)|Death|1|||
124625443|NCT04917861|448243314|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
124625444|NCT04917861|448243315|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
124625445|NCT04917861|448243316|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
124625446|NCT04917861|448243317|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
124625447|NCT04917861|448243314|FG000|Main Study (196 Days)|Physician Decision|0|||
124625448|NCT04917861|448243315|FG001|Main Study (196 Days)|Physician Decision|0|||
124625449|NCT04917861|448243316|FG002|Main Study (196 Days)|Physician Decision|0|||
124625450|NCT04917861|448243317|FG003|Main Study (196 Days)|Physician Decision|1|||
124625451|NCT04917861|448243314|FG000|Main Study (196 Days)|Pregnancy|1|||
124625452|NCT04917861|448243315|FG001|Main Study (196 Days)|Pregnancy|1|||
124625453|NCT04917861|448243316|FG002|Main Study (196 Days)|Pregnancy|0|||
124625454|NCT04917861|448243317|FG003|Main Study (196 Days)|Pregnancy|0|||
124625455|NCT04917861|448243314|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
124625456|NCT04917861|448243315|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
124625457|NCT04917861|448243316|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
124625458|NCT04917861|448243317|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
124625459|NCT04917861|448243314|FG000|Main Study (196 Days)|Other Than Specified|1|||
124625460|NCT04917861|448243315|FG001|Main Study (196 Days)|Other Than Specified|0|||
124625461|NCT04917861|448243316|FG002|Main Study (196 Days)|Other Than Specified|1|||
124625462|NCT04917861|448243317|FG003|Main Study (196 Days)|Other Than Specified|2|||
124625463|NCT04917861|448243314|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
124625464|NCT04917861|448243315|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
124625465|NCT04917861|448243316|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
124625466|NCT04917861|448243317|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
124625467|NCT04917861|448243314|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
124625468|NCT04917861|448243315|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
124625469|NCT04917861|448243316|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
124625470|NCT04917861|448243317|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
124625471|NCT04917861|448243314|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
124625472|NCT04917861|448243315|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
124625473|NCT04917861|448243316|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
124625474|NCT04917861|448243317|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
124625475|NCT04917861|448243314|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
124625476|NCT04917861|448243315|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
124625477|NCT04917861|448243316|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
124625478|NCT04917861|448243317|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
124625479|NCT04917861|448243314|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
124625480|NCT04917861|448243315|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
124625481|NCT04917861|448243316|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
124625482|NCT04917861|448243317|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
124625483|NCT04917861|448243314|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
124625484|NCT04917861|448243315|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
124625485|NCT04917861|448243316|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
124625486|NCT04917861|448243317|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
124783967|NCT00566696|448840013|FG000|Overall Study|Health Status Change|1|||
124783968|NCT00566696|448840013|FG000|Overall Study|Physician Decision|1|||
124625487|NCT06389487|448243318|FG000|Overall Study|Lost to Follow-up|9|||
124625488|NCT06389487|448243319|FG001|Overall Study|Lost to Follow-up|5|||
124625489|NCT06389487|448243320|FG002|Overall Study|Lost to Follow-up|13|||
124625490|NCT06389487|448243318|FG000|Overall Study|Protocol Violation|0|||
124625491|NCT06389487|448243319|FG001|Overall Study|Protocol Violation|0|||
124625492|NCT06389487|448243320|FG002|Overall Study|Protocol Violation|2|||
124625493|NCT06389487|448243318|FG000|Overall Study|Withdrawal by Subject|2|||
124625494|NCT06389487|448243319|FG001|Overall Study|Withdrawal by Subject|2|||
124625495|NCT06389487|448243320|FG002|Overall Study|Withdrawal by Subject|1|||
124625496|NCT06389487|448243318|FG000|Overall Study|Other|1|||
124625497|NCT06389487|448243319|FG001|Overall Study|Other|0|||
124625498|NCT06389487|448243320|FG002|Overall Study|Other|1|||
124637652|NCT03225105|448290614|FG003|Overall Study|Withdrawal by Subject|0|||
124637653|NCT03225105|448290611|FG000|Overall Study|Death|0|||
124637654|NCT03225105|448290612|FG001|Overall Study|Death|4|||
124637655|NCT03225105|448290613|FG002|Overall Study|Death|2|||
124637656|NCT03225105|448290614|FG003|Overall Study|Death|0|||
124637657|NCT03225105|448290611|FG000|Overall Study|Study termination per Sponsor Decision|2|||
124637658|NCT03225105|448290612|FG001|Overall Study|Study termination per Sponsor Decision|0|||
124637659|NCT03225105|448290613|FG002|Overall Study|Study termination per Sponsor Decision|3|||
124637660|NCT03225105|448290614|FG003|Overall Study|Study termination per Sponsor Decision|3|||
124637661|NCT01209520|448290615|FG000|Overall Study|Withdrawal by Subject|3|||
124637662|NCT00961350|448290616|FG000|Overall Study|Adverse Event|18|||
124637663|NCT00961350|448290617|FG001|Overall Study|Adverse Event|33|||
124637664|NCT00961350|448290616|FG000|Overall Study|Withdrawal by Subject|10|||
124637665|NCT00961350|448290617|FG001|Overall Study|Withdrawal by Subject|10|||
124637666|NCT00961350|448290616|FG000|Overall Study|Lost to Follow-up|3|||
124637667|NCT00961350|448290617|FG001|Overall Study|Lost to Follow-up|3|||
124637668|NCT00961350|448290616|FG000|Overall Study|Misc|16|||
124637669|NCT00961350|448290617|FG001|Overall Study|Misc|21|||
124637670|NCT02134015|448290618|FG000|Overall Study|Protocol Violation|0|||
124637671|NCT02134015|448290619|FG001|Overall Study|Protocol Violation|1|||
124637672|NCT02134015|448290618|FG000|Overall Study|Death|2|||
124637673|NCT02134015|448290619|FG001|Overall Study|Death|1|||
124637674|NCT02134015|448290618|FG000|Overall Study|Reason not provided|1|||
124637675|NCT02134015|448290619|FG001|Overall Study|Reason not provided|2|||
124637676|NCT02134015|448290618|FG000|Overall Study|Clinical progression|14|||
124637677|NCT02134015|448290619|FG001|Overall Study|Clinical progression|7|||
124637678|NCT02134015|448290618|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
124637679|NCT02134015|448290619|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
124637680|NCT02134015|448290618|FG000|Overall Study|Study terminated by sponsor|2|||
124637681|NCT02134015|448290619|FG001|Overall Study|Study terminated by sponsor|3|||
124637682|NCT02134015|448290618|FG000|Overall Study|Adverse Event|9|||
124637683|NCT02134015|448290619|FG001|Overall Study|Adverse Event|10|||
124637684|NCT02134015|448290618|FG000|Overall Study|Withdrawal by Subject|3|||
124637685|NCT02134015|448290619|FG001|Overall Study|Withdrawal by Subject|7|||
124637686|NCT00617890|448292398|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
124637687|NCT00617890|448292399|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
124637688|NCT00617890|448292400|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
124637689|NCT00617890|448292401|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
124637690|NCT00617890|448292398|FG000|Overall Study|Lack of Efficacy|23|||
124637691|NCT00617890|448292399|FG001|Overall Study|Lack of Efficacy|26|||
124637692|NCT00617890|448292400|FG002|Overall Study|Lack of Efficacy|30|||
124637693|NCT00617890|448292401|FG003|Overall Study|Lack of Efficacy|97|||
124637694|NCT00617890|448292398|FG000|Overall Study|Lost to Follow-up|0|||
124637695|NCT00617890|448292399|FG001|Overall Study|Lost to Follow-up|0|||
124637696|NCT00617890|448292400|FG002|Overall Study|Lost to Follow-up|1|||
124637697|NCT00617890|448292401|FG003|Overall Study|Lost to Follow-up|2|||
124637698|NCT00617890|448292398|FG000|Overall Study|Withdrawal by Subject|4|||
124637699|NCT00617890|448292399|FG001|Overall Study|Withdrawal by Subject|1|||
124637700|NCT00617890|448292400|FG002|Overall Study|Withdrawal by Subject|0|||
124637701|NCT00617890|448292401|FG003|Overall Study|Withdrawal by Subject|2|||
124637702|NCT00617890|448292398|FG000|Overall Study|Protocol Violation|2|||
124637703|NCT00617890|448292399|FG001|Overall Study|Protocol Violation|1|||
124637704|NCT00617890|448292400|FG002|Overall Study|Protocol Violation|0|||
124637705|NCT00617890|448292401|FG003|Overall Study|Protocol Violation|0|||
124637706|NCT00617890|448292398|FG000|Overall Study|Adverse Event|1|||
124637707|NCT00617890|448292399|FG001|Overall Study|Adverse Event|0|||
124637708|NCT00617890|448292400|FG002|Overall Study|Adverse Event|3|||
124637709|NCT00617890|448292401|FG003|Overall Study|Adverse Event|8|||
124637710|NCT00617890|448292398|FG000|Overall Study|Not treated|1|||
124637711|NCT00617890|448292399|FG001|Overall Study|Not treated|0|||
124637712|NCT00617890|448292400|FG002|Overall Study|Not treated|1|||
124637713|NCT00617890|448292401|FG003|Overall Study|Not treated|1|||
124637714|NCT00915018|448292403|FG000|Overall Study|Death|75|||
124637715|NCT00915018|448292404|FG001|Overall Study|Death|70|||
124637716|NCT00915018|448292403|FG000|Overall Study|Lost to Follow-up|10|||
124637717|NCT00915018|448292404|FG001|Overall Study|Lost to Follow-up|5|||
124637718|NCT00915018|448292403|FG000|Overall Study|Withdrawal by Subject|38|||
124751994|NCT01858766|448714225|FG010|Overall Study|Death|0|||
124751995|NCT01858766|448714226|FG011|Overall Study|Death|0|||
124751996|NCT01858766|448714227|FG012|Overall Study|Death|0|||
124751997|NCT01858766|448714228|FG013|Overall Study|Death|0|||
124751998|NCT01858766|448714229|FG014|Overall Study|Death|0|||
124751999|NCT01858766|448714230|FG015|Overall Study|Death|0|||
124752000|NCT01858766|448714231|FG016|Overall Study|Death|0|||
124625501|NCT00001521|448245339|FG000|Overall Study|Withdrawal by Subject|3|||
124625502|NCT00001521|448245340|FG001|Overall Study|Withdrawal by Subject|3|||
124625503|NCT00001521|448245339|FG000|Overall Study|Physician Decision|1|||
124625504|NCT00001521|448245340|FG001|Overall Study|Physician Decision|1|||
124625505|NCT00001521|448245339|FG000|Overall Study|Noncompliant|6|||
124625506|NCT00001521|448245340|FG001|Overall Study|Noncompliant|3|||
124625507|NCT00970593|448245342|FG000|Overall Study|Adverse Event|1|||
124625508|NCT00970593|448245343|FG001|Overall Study|Adverse Event|1|||
124625509|NCT00970593|448245344|FG002|Overall Study|Adverse Event|0|||
124625510|NCT00970593|448245345|FG003|Overall Study|Adverse Event|0|||
124625511|NCT00970593|448245346|FG004|Overall Study|Adverse Event|0|||
124625512|NCT00970593|448245347|FG005|Overall Study|Adverse Event|0|||
124625513|NCT00970593|448245348|FG006|Overall Study|Adverse Event|0|||
124625514|NCT00970593|448245342|FG000|Overall Study|Discontinuation of study by sponsor|0|||
124625515|NCT00970593|448245343|FG001|Overall Study|Discontinuation of study by sponsor|0|||
124625516|NCT00970593|448245344|FG002|Overall Study|Discontinuation of study by sponsor|5|||
124625517|NCT00970593|448245345|FG003|Overall Study|Discontinuation of study by sponsor|0|||
124625518|NCT00970593|448245346|FG004|Overall Study|Discontinuation of study by sponsor|0|||
124625519|NCT00970593|448245347|FG005|Overall Study|Discontinuation of study by sponsor|0|||
124752001|NCT01858766|448714232|FG017|Overall Study|Death|0|||
124752002|NCT01858766|448714233|FG018|Overall Study|Death|0|||
124752003|NCT01858766|448714215|FG000|Overall Study|Lack of Efficacy|1|||
124752004|NCT01858766|448714216|FG001|Overall Study|Lack of Efficacy|0|||
124752005|NCT01858766|448714217|FG002|Overall Study|Lack of Efficacy|0|||
124752006|NCT01858766|448714218|FG003|Overall Study|Lack of Efficacy|0|||
124752007|NCT01858766|448714219|FG004|Overall Study|Lack of Efficacy|1|||
124752008|NCT01858766|448714220|FG005|Overall Study|Lack of Efficacy|2|||
124752009|NCT01858766|448714221|FG006|Overall Study|Lack of Efficacy|0|||
124752010|NCT01858766|448714222|FG007|Overall Study|Lack of Efficacy|0|||
124752011|NCT01858766|448714223|FG008|Overall Study|Lack of Efficacy|0|||
124752012|NCT01858766|448714224|FG009|Overall Study|Lack of Efficacy|0|||
124752013|NCT01858766|448714225|FG010|Overall Study|Lack of Efficacy|0|||
124752014|NCT01858766|448714226|FG011|Overall Study|Lack of Efficacy|3|||
124752015|NCT01858766|448714227|FG012|Overall Study|Lack of Efficacy|5|||
124752016|NCT01858766|448714228|FG013|Overall Study|Lack of Efficacy|3|||
124752017|NCT01858766|448714229|FG014|Overall Study|Lack of Efficacy|5|||
124752018|NCT01858766|448714230|FG015|Overall Study|Lack of Efficacy|5|||
124752019|NCT01858766|448714231|FG016|Overall Study|Lack of Efficacy|2|||
124752020|NCT01858766|448714232|FG017|Overall Study|Lack of Efficacy|3|||
124752021|NCT01858766|448714233|FG018|Overall Study|Lack of Efficacy|3|||
124752022|NCT01858766|448714215|FG000|Overall Study|Lost to Follow-up|0|||
124752023|NCT01858766|448714216|FG001|Overall Study|Lost to Follow-up|0|||
124752024|NCT01858766|448714217|FG002|Overall Study|Lost to Follow-up|0|||
124752025|NCT01858766|448714218|FG003|Overall Study|Lost to Follow-up|0|||
124752026|NCT01858766|448714219|FG004|Overall Study|Lost to Follow-up|0|||
124752027|NCT01858766|448714220|FG005|Overall Study|Lost to Follow-up|1|||
124752028|NCT01858766|448714221|FG006|Overall Study|Lost to Follow-up|0|||
124752029|NCT01858766|448714222|FG007|Overall Study|Lost to Follow-up|2|||
124752030|NCT01858766|448714223|FG008|Overall Study|Lost to Follow-up|0|||
124752031|NCT01858766|448714224|FG009|Overall Study|Lost to Follow-up|0|||
124752032|NCT01858766|448714225|FG010|Overall Study|Lost to Follow-up|0|||
124752033|NCT01858766|448714226|FG011|Overall Study|Lost to Follow-up|1|||
124752034|NCT01858766|448714227|FG012|Overall Study|Lost to Follow-up|0|||
124752035|NCT01858766|448714228|FG013|Overall Study|Lost to Follow-up|0|||
124752036|NCT01858766|448714229|FG014|Overall Study|Lost to Follow-up|3|||
124752037|NCT01858766|448714230|FG015|Overall Study|Lost to Follow-up|1|||
124752038|NCT01858766|448714231|FG016|Overall Study|Lost to Follow-up|1|||
124752039|NCT01858766|448714232|FG017|Overall Study|Lost to Follow-up|0|||
124752040|NCT01858766|448714233|FG018|Overall Study|Lost to Follow-up|1|||
124752041|NCT01858766|448714215|FG000|Overall Study|Withdrew Consent|0|||
124752042|NCT01858766|448714216|FG001|Overall Study|Withdrew Consent|0|||
124752043|NCT01858766|448714217|FG002|Overall Study|Withdrew Consent|0|||
124752044|NCT01858766|448714218|FG003|Overall Study|Withdrew Consent|0|||
124752045|NCT01858766|448714219|FG004|Overall Study|Withdrew Consent|0|||
124752046|NCT01858766|448714220|FG005|Overall Study|Withdrew Consent|0|||
124752047|NCT01858766|448714221|FG006|Overall Study|Withdrew Consent|0|||
124783969|NCT00566696|448840013|FG000|Overall Study|Non-Patient Donors|37|||
124625520|NCT00970593|448245348|FG006|Overall Study|Discontinuation of study by sponsor|2|||
124625521|NCT00970593|448245342|FG000|Overall Study|Withdrawal by Subject|0|||
124625522|NCT00970593|448245343|FG001|Overall Study|Withdrawal by Subject|0|||
124752048|NCT01858766|448714222|FG007|Overall Study|Withdrew Consent|0|||
124752049|NCT01858766|448714223|FG008|Overall Study|Withdrew Consent|0|||
124752050|NCT01858766|448714224|FG009|Overall Study|Withdrew Consent|0|||
124752051|NCT01858766|448714225|FG010|Overall Study|Withdrew Consent|0|||
124752052|NCT01858766|448714226|FG011|Overall Study|Withdrew Consent|1|||
124752053|NCT01858766|448714227|FG012|Overall Study|Withdrew Consent|0|||
124752054|NCT01858766|448714228|FG013|Overall Study|Withdrew Consent|0|||
124752055|NCT01858766|448714229|FG014|Overall Study|Withdrew Consent|0|||
124752056|NCT01858766|448714230|FG015|Overall Study|Withdrew Consent|0|||
124752057|NCT01858766|448714231|FG016|Overall Study|Withdrew Consent|0|||
124625523|NCT00970593|448245344|FG002|Overall Study|Withdrawal by Subject|1|||
124625524|NCT00970593|448245345|FG003|Overall Study|Withdrawal by Subject|0|||
124625525|NCT00970593|448245346|FG004|Overall Study|Withdrawal by Subject|0|||
124625526|NCT00970593|448245347|FG005|Overall Study|Withdrawal by Subject|0|||
124625527|NCT00970593|448245348|FG006|Overall Study|Withdrawal by Subject|0|||
124625528|NCT04176250|448245349|FG000|Overall Study|Adverse Event|0|||
124625529|NCT04176250|448245350|FG001|Overall Study|Adverse Event|1|||
124625530|NCT04176250|448245351|FG002|Overall Study|Adverse Event|0|||
124625531|NCT04176250|448245352|FG003|Overall Study|Adverse Event|1|||
124625532|NCT04176250|448245353|FG004|Overall Study|Adverse Event|0|||
124625533|NCT04176250|448245354|FG005|Overall Study|Adverse Event|1|||
124625534|NCT04176250|448245349|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
124625535|NCT04176250|448245350|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
124625536|NCT04176250|448245351|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
124625537|NCT04176250|448245352|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
124625538|NCT04176250|448245353|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
124625539|NCT04176250|448245354|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
124625540|NCT04176250|448245349|FG000|Overall Study|Withdrawal by Subject|0|||
124625541|NCT04176250|448245350|FG001|Overall Study|Withdrawal by Subject|0|||
124625542|NCT04176250|448245351|FG002|Overall Study|Withdrawal by Subject|0|||
124625543|NCT04176250|448245352|FG003|Overall Study|Withdrawal by Subject|0|||
124625544|NCT04176250|448245353|FG004|Overall Study|Withdrawal by Subject|0|||
124625545|NCT04176250|448245354|FG005|Overall Study|Withdrawal by Subject|1|||
124625546|NCT04176250|448245349|FG000|Overall Study|Randomized in error|0|||
124625547|NCT04176250|448245350|FG001|Overall Study|Randomized in error|0|||
124625548|NCT04176250|448245351|FG002|Overall Study|Randomized in error|0|||
124625549|NCT04176250|448245352|FG003|Overall Study|Randomized in error|0|||
124625550|NCT04176250|448245353|FG004|Overall Study|Randomized in error|1|||
124625551|NCT04176250|448245354|FG005|Overall Study|Randomized in error|0|||
124625552|NCT01342081|448245360|FG000|Overall Study|Did not receive allocated intervention|0|||
124625553|NCT01342081|448245361|FG001|Overall Study|Did not receive allocated intervention|0|||
124625554|NCT01342081|448245362|FG002|Overall Study|Did not receive allocated intervention|1|||
124625555|NCT01342081|448245360|FG000|Overall Study|Adverse Event|1|||
124625556|NCT01342081|448245361|FG001|Overall Study|Adverse Event|0|||
124625557|NCT01342081|448245362|FG002|Overall Study|Adverse Event|0|||
124625558|NCT01342081|448245360|FG000|Overall Study|Physician Decision|0|||
124625559|NCT01342081|448245361|FG001|Overall Study|Physician Decision|1|||
124625560|NCT01342081|448245362|FG002|Overall Study|Physician Decision|0|||
124625561|NCT01342081|448245360|FG000|Overall Study|Withdrawal by Subject|1|||
124625562|NCT01342081|448245361|FG001|Overall Study|Withdrawal by Subject|1|||
124625563|NCT01342081|448245362|FG002|Overall Study|Withdrawal by Subject|0|||
124625564|NCT02790437|448245363|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
124625565|NCT02790437|448245364|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
124625566|NCT02790437|448245363|FG000|Overall Study|Adverse Event|1|||
124625567|NCT02790437|448245364|FG001|Overall Study|Adverse Event|0|||
124625568|NCT02790437|448245363|FG000|Overall Study|Withdrawal by Subject|1|||
124625569|NCT02790437|448245364|FG001|Overall Study|Withdrawal by Subject|0|||
124625570|NCT01202175|448245366|FG000|Overall Study|Lost to Follow-up|2|||
124625571|NCT01202175|448245366|FG000|Overall Study|Withdrawal by Subject|1|||
124625572|NCT01202175|448245366|FG000|Overall Study|Adverse Event|2|||
124625573|NCT04720053|448245370|FG000|Overall Study|Lost to Follow-up|12|||
124625574|NCT01942993|448245371|FG000|Overall Study|Lost to Follow-up|1|||
124625575|NCT01942993|448245371|FG000|Overall Study|Physician Decision|1|||
124625576|NCT01350271|448245375|FG000|Overall Study|Lost to Follow-up|21|||
124625577|NCT01350271|448245376|FG001|Overall Study|Lost to Follow-up|17|||
124625578|NCT01350271|448245377|FG002|Overall Study|Lost to Follow-up|26|||
124625579|NCT02906670|448245378|FG000|Cohort 1, QW|Radiological Progression|1|||
124625580|NCT02906670|448245379|FG001|Cohort 1, QW|Radiological Progression|0|||
124625581|NCT02906670|448245380|FG002|Cohort 1, QW|Radiological Progression|0|||
124625582|NCT02906670|448245381|FG003|Cohort 1, QW|Radiological Progression|0|||
124625583|NCT02906670|448245382|FG004|Cohort 1, QW|Radiological Progression|0|||
124625584|NCT02906670|448245383|FG005|Cohort 1, QW|Radiological Progression|0|||
124625585|NCT02906670|448245384|FG006|Cohort 1, QW|Radiological Progression|0|||
124625586|NCT02906670|448245385|FG007|Cohort 1, QW|Radiological Progression|0|||
124625587|NCT02906670|448245386|FG008|Cohort 1, QW|Radiological Progression|0|||
124625588|NCT02906670|448245387|FG009|Cohort 1, QW|Radiological Progression|0|||
124625589|NCT02906670|448245378|FG000|Cohort 2, QW|Radiological Progression|0|||
124752058|NCT01858766|448714232|FG017|Overall Study|Withdrew Consent|0|||
124752059|NCT01858766|448714233|FG018|Overall Study|Withdrew Consent|0|||
124625590|NCT02906670|448245379|FG001|Cohort 2, QW|Radiological Progression|1|||
124625591|NCT02906670|448245380|FG002|Cohort 2, QW|Radiological Progression|0|||
124752060|NCT03517228|448714234|FG000|Overall Study|Withdrawal by Subject|2|||
124625592|NCT02906670|448245381|FG003|Cohort 2, QW|Radiological Progression|0|||
124625593|NCT02906670|448245382|FG004|Cohort 2, QW|Radiological Progression|0|||
124625594|NCT02906670|448245383|FG005|Cohort 2, QW|Radiological Progression|0|||
124625595|NCT02906670|448245384|FG006|Cohort 2, QW|Radiological Progression|0|||
124625596|NCT02906670|448245385|FG007|Cohort 2, QW|Radiological Progression|0|||
124625597|NCT02906670|448245386|FG008|Cohort 2, QW|Radiological Progression|0|||
124625598|NCT02906670|448245387|FG009|Cohort 2, QW|Radiological Progression|0|||
124625599|NCT02906670|448245378|FG000|Cohort 3, QW|Radiological Progression|0|||
124625600|NCT02906670|448245379|FG001|Cohort 3, QW|Radiological Progression|0|||
124625601|NCT02906670|448245380|FG002|Cohort 3, QW|Radiological Progression|2|||
124625602|NCT02906670|448245381|FG003|Cohort 3, QW|Radiological Progression|0|||
124625603|NCT02906670|448245382|FG004|Cohort 3, QW|Radiological Progression|0|||
124625604|NCT02906670|448245383|FG005|Cohort 3, QW|Radiological Progression|0|||
124625605|NCT02906670|448245384|FG006|Cohort 3, QW|Radiological Progression|0|||
124625606|NCT02906670|448245385|FG007|Cohort 3, QW|Radiological Progression|0|||
124625607|NCT02906670|448245386|FG008|Cohort 3, QW|Radiological Progression|0|||
124625608|NCT02906670|448245387|FG009|Cohort 3, QW|Radiological Progression|0|||
124625609|NCT02906670|448245378|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
124625610|NCT02906670|448245379|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
124625611|NCT02906670|448245380|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
124625612|NCT02906670|448245381|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
124625613|NCT02906670|448245382|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
124625614|NCT02906670|448245383|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
124625615|NCT02906670|448245384|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
124625616|NCT02906670|448245385|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
124625617|NCT02906670|448245386|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
124625618|NCT02906670|448245387|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
124625619|NCT02906670|448245378|FG000|Cohort 4, Q2W|Radiological Progression|0|||
124625620|NCT02906670|448245379|FG001|Cohort 4, Q2W|Radiological Progression|0|||
124625621|NCT02906670|448245380|FG002|Cohort 4, Q2W|Radiological Progression|0|||
124625622|NCT02906670|448245381|FG003|Cohort 4, Q2W|Radiological Progression|0|||
124625623|NCT02906670|448245382|FG004|Cohort 4, Q2W|Radiological Progression|0|||
124625624|NCT02906670|448245383|FG005|Cohort 4, Q2W|Radiological Progression|1|||
124625625|NCT02906670|448245384|FG006|Cohort 4, Q2W|Radiological Progression|0|||
124625626|NCT02906670|448245385|FG007|Cohort 4, Q2W|Radiological Progression|0|||
124625627|NCT02906670|448245386|FG008|Cohort 4, Q2W|Radiological Progression|0|||
124625628|NCT02906670|448245387|FG009|Cohort 4, Q2W|Radiological Progression|0|||
124625629|NCT02906670|448245378|FG000|Cohort 4, Q2W|Clinical Progression|0|||
124625630|NCT02906670|448245379|FG001|Cohort 4, Q2W|Clinical Progression|0|||
124625631|NCT02906670|448245380|FG002|Cohort 4, Q2W|Clinical Progression|0|||
124625632|NCT02906670|448245381|FG003|Cohort 4, Q2W|Clinical Progression|0|||
124625633|NCT02906670|448245382|FG004|Cohort 4, Q2W|Clinical Progression|0|||
124625634|NCT02906670|448245383|FG005|Cohort 4, Q2W|Clinical Progression|2|||
124625635|NCT02906670|448245384|FG006|Cohort 4, Q2W|Clinical Progression|0|||
124625636|NCT02906670|448245385|FG007|Cohort 4, Q2W|Clinical Progression|0|||
124625637|NCT02906670|448245386|FG008|Cohort 4, Q2W|Clinical Progression|0|||
124625638|NCT02906670|448245387|FG009|Cohort 4, Q2W|Clinical Progression|0|||
124625639|NCT02906670|448245378|FG000|Cohort 5, Q2W|Radiological Progression|0|||
124625640|NCT02906670|448245379|FG001|Cohort 5, Q2W|Radiological Progression|0|||
124625641|NCT02906670|448245380|FG002|Cohort 5, Q2W|Radiological Progression|0|||
124625642|NCT02906670|448245381|FG003|Cohort 5, Q2W|Radiological Progression|0|||
124625643|NCT02906670|448245382|FG004|Cohort 5, Q2W|Radiological Progression|0|||
124625644|NCT02906670|448245383|FG005|Cohort 5, Q2W|Radiological Progression|0|||
124625645|NCT02906670|448245384|FG006|Cohort 5, Q2W|Radiological Progression|4|||
124625646|NCT02906670|448245385|FG007|Cohort 5, Q2W|Radiological Progression|0|||
124625647|NCT02906670|448245386|FG008|Cohort 5, Q2W|Radiological Progression|0|||
124625648|NCT02906670|448245387|FG009|Cohort 5, Q2W|Radiological Progression|0|||
124625649|NCT02906670|448245378|FG000|Cohort 5, Q2W|Clinical Progression|0|||
124625650|NCT02906670|448245379|FG001|Cohort 5, Q2W|Clinical Progression|0|||
124625651|NCT02906670|448245380|FG002|Cohort 5, Q2W|Clinical Progression|0|||
124625652|NCT02906670|448245381|FG003|Cohort 5, Q2W|Clinical Progression|0|||
124625653|NCT02906670|448245382|FG004|Cohort 5, Q2W|Clinical Progression|0|||
124625654|NCT02906670|448245383|FG005|Cohort 5, Q2W|Clinical Progression|0|||
124625655|NCT02906670|448245384|FG006|Cohort 5, Q2W|Clinical Progression|1|||
124625656|NCT02906670|448245385|FG007|Cohort 5, Q2W|Clinical Progression|0|||
124625657|NCT02906670|448245386|FG008|Cohort 5, Q2W|Clinical Progression|0|||
124625658|NCT02906670|448245387|FG009|Cohort 5, Q2W|Clinical Progression|0|||
124625659|NCT02906670|448245378|FG000|Cohort 5, Q2W|Adverse Event|0|||
124625660|NCT02906670|448245379|FG001|Cohort 5, Q2W|Adverse Event|0|||
124625661|NCT02906670|448245380|FG002|Cohort 5, Q2W|Adverse Event|0|||
124625662|NCT02906670|448245381|FG003|Cohort 5, Q2W|Adverse Event|0|||
124625663|NCT02906670|448245382|FG004|Cohort 5, Q2W|Adverse Event|0|||
124625664|NCT02906670|448245383|FG005|Cohort 5, Q2W|Adverse Event|0|||
124625665|NCT02906670|448245384|FG006|Cohort 5, Q2W|Adverse Event|1|||
124625666|NCT02906670|448245385|FG007|Cohort 5, Q2W|Adverse Event|0|||
124625667|NCT02906670|448245386|FG008|Cohort 5, Q2W|Adverse Event|0|||
124783970|NCT06338462|448840014|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
124783971|NCT00452361|448840017|FG000|Overall Study|Adverse Event|8|||
124783972|NCT00452361|448840018|FG001|Overall Study|Adverse Event|0|||
124783973|NCT00452361|448840017|FG000|Overall Study|Withdrawal by Subject|0|||
124783974|NCT00452361|448840018|FG001|Overall Study|Withdrawal by Subject|1|||
124783975|NCT00452361|448840017|FG000|Overall Study|Premature termination|13|||
124783976|NCT00452361|448840018|FG001|Overall Study|Premature termination|9|||
124783977|NCT03116152|448840021|FG000|Overall Study|Disease Progression|49|||
124783978|NCT03116152|448840022|FG001|Overall Study|Disease Progression|47|||
124783979|NCT03116152|448840021|FG000|Overall Study|Death|5|||
124783980|NCT03116152|448840022|FG001|Overall Study|Death|2|||
124783981|NCT03116152|448840021|FG000|Overall Study|Adverse Event|21|||
124783982|NCT03116152|448840022|FG001|Overall Study|Adverse Event|7|||
124783983|NCT03116152|448840021|FG000|Overall Study|Protocol Violation|2|||
124783984|NCT03116152|448840022|FG001|Overall Study|Protocol Violation|2|||
124783985|NCT03116152|448840021|FG000|Overall Study|Withdrawal by Subject|0|||
124783986|NCT03116152|448840022|FG001|Overall Study|Withdrawal by Subject|1|||
124783987|NCT03116152|448840021|FG000|Overall Study|Physician Decision|3|||
124783988|NCT03116152|448840022|FG001|Overall Study|Physician Decision|2|||
124783989|NCT03116152|448840021|FG000|Overall Study|other|11|||
124783990|NCT03116152|448840022|FG001|Overall Study|other|34|||
124783991|NCT03179605|448840023|FG000|Overall Study|Withdrawal by Subject|1|||
124783992|NCT00910299|448840024|FG000|Overall Study|Withdrawal by Subject|16|||
124783993|NCT00910299|448840025|FG001|Overall Study|Withdrawal by Subject|13|||
124783994|NCT00910299|448840024|FG000|Overall Study|Sponsor Decision|58|||
124783995|NCT00910299|448840025|FG001|Overall Study|Sponsor Decision|60|||
124783996|NCT00910299|448840024|FG000|Overall Study|Didn't receive any study drug|2|||
124783997|NCT00910299|448840025|FG001|Overall Study|Didn't receive any study drug|1|||
124783998|NCT00635999|448840026|FG000|Overall Study|Withdrawal by Subject|4|||
124783999|NCT00635999|448840027|FG001|Overall Study|Withdrawal by Subject|2|||
124784000|NCT00635999|448840028|FG002|Overall Study|Withdrawal by Subject|1|||
124784001|NCT00228553|448840033|FG000|Overall Study|Adverse Event|112|||
124784002|NCT00228553|448840033|FG000|Overall Study|Lack of Efficacy|34|||
124784003|NCT00228553|448840033|FG000|Overall Study|Lost to Follow-up|67|||
124784004|NCT00228553|448840033|FG000|Overall Study|Physician Decision|48|||
124784005|NCT00228553|448840033|FG000|Overall Study|Protocol Violation|6|||
124784006|NCT00228553|448840033|FG000|Overall Study|Withdrawal by Subject|115|||
124784007|NCT00228553|448840033|FG000|Overall Study|Pregnancy|2|||
124784008|NCT00228553|448840033|FG000|Overall Study|Miscellaneous|46|||
124784009|NCT01536392|448840034|FG000|Overall Study|Adverse Event|2|||
124784010|NCT01536392|448840035|FG001|Overall Study|Adverse Event|2|||
124784011|NCT01536392|448840034|FG000|Overall Study|Physician Decision|2|||
124784012|NCT01536392|448840035|FG001|Overall Study|Physician Decision|3|||
124784013|NCT01536392|448840034|FG000|Overall Study|Withdrawal by Subject|3|||
124784014|NCT01536392|448840035|FG001|Overall Study|Withdrawal by Subject|6|||
124784015|NCT01536392|448840034|FG000|Overall Study|Non Compliance|3|||
124784016|NCT01536392|448840035|FG001|Overall Study|Non Compliance|4|||
124784017|NCT01536392|448840034|FG000|Overall Study|Completed therapy early|3|||
124784018|NCT01536392|448840035|FG001|Overall Study|Completed therapy early|0|||
124784019|NCT02259088|448840037|FG000|Overall Study|Adverse Event|6|||
124784020|NCT02259088|448840038|FG001|Overall Study|Adverse Event|4|||
124784021|NCT02259088|448840037|FG000|Overall Study|Lost to Follow-up|2|||
124784022|NCT02259088|448840038|FG001|Overall Study|Lost to Follow-up|0|||
124784023|NCT02259088|448840037|FG000|Overall Study|Death|2|||
124784024|NCT02259088|448840038|FG001|Overall Study|Death|0|||
124784025|NCT02259088|448840037|FG000|Overall Study|Physician Decision|5|||
124784026|NCT02259088|448840038|FG001|Overall Study|Physician Decision|2|||
124784027|NCT02259088|448840037|FG000|Overall Study|Protocol deviation|5|||
124784028|NCT02259088|448840038|FG001|Overall Study|Protocol deviation|0|||
124784029|NCT02259088|448840037|FG000|Overall Study|Subject/guardian decision|8|||
124784030|NCT02259088|448840038|FG001|Overall Study|Subject/guardian decision|8|||
124784031|NCT01033448|448840040|FG000|Overall Study|Withdrawal by Subject|4|||
124784032|NCT01033448|448840040|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
124784033|NCT01033448|448840040|FG000|Overall Study|Lost to Follow-up|3|||
124784034|NCT01033448|448840040|FG000|Overall Study|Withdrew due to other reasons|3|||
124784035|NCT01033448|448840040|FG000|Overall Study|Unknown disposition|1|||
124625668|NCT02906670|448245387|FG009|Cohort 5, Q2W|Adverse Event|0|||
124625669|NCT02906670|448245378|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
124784036|NCT01818752|448840041|FG000|Overall Study|Adverse Event|64|||
124784037|NCT01818752|448840042|FG001|Overall Study|Adverse Event|74|||
124784038|NCT01818752|448840041|FG000|Overall Study|Death|14|||
124784039|NCT01818752|448840042|FG001|Overall Study|Death|18|||
124784040|NCT01818752|448840041|FG000|Overall Study|Non-compliance|16|||
124784041|NCT01818752|448840042|FG001|Overall Study|Non-compliance|20|||
124784042|NCT01818752|448840041|FG000|Overall Study|Withdrawal by Subject|15|||
124784043|NCT01818752|448840042|FG001|Overall Study|Withdrawal by Subject|14|||
124784044|NCT01818752|448840041|FG000|Overall Study|Physician Decision|9|||
124784045|NCT01818752|448840042|FG001|Overall Study|Physician Decision|8|||
124784046|NCT01818752|448840041|FG000|Overall Study|Disease Progression|54|||
124625670|NCT02906670|448245379|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
124625671|NCT02906670|448245380|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
124625672|NCT02906670|448245381|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
124625673|NCT02906670|448245382|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
124625674|NCT02906670|448245383|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
124625675|NCT02906670|448245384|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
124625676|NCT02906670|448245385|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
124625677|NCT02906670|448245386|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
124625678|NCT02906670|448245387|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
124625679|NCT02906670|448245378|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
124625680|NCT02906670|448245379|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
124625681|NCT02906670|448245380|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
124625682|NCT02906670|448245381|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
124625683|NCT02906670|448245382|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
124625684|NCT02906670|448245383|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
124625685|NCT02906670|448245384|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
124625686|NCT02906670|448245385|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
124625687|NCT02906670|448245386|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
124625688|NCT02906670|448245387|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
124625689|NCT02906670|448245378|FG000|Cohort 5P, Q2W|Adverse Event|0|||
124625690|NCT02906670|448245379|FG001|Cohort 5P, Q2W|Adverse Event|0|||
124625691|NCT02906670|448245380|FG002|Cohort 5P, Q2W|Adverse Event|0|||
124625692|NCT02906670|448245381|FG003|Cohort 5P, Q2W|Adverse Event|0|||
124625693|NCT02906670|448245382|FG004|Cohort 5P, Q2W|Adverse Event|0|||
124625694|NCT02906670|448245383|FG005|Cohort 5P, Q2W|Adverse Event|0|||
124625695|NCT02906670|448245384|FG006|Cohort 5P, Q2W|Adverse Event|0|||
124625696|NCT02906670|448245385|FG007|Cohort 5P, Q2W|Adverse Event|1|||
124625697|NCT02906670|448245386|FG008|Cohort 5P, Q2W|Adverse Event|0|||
124625698|NCT02906670|448245387|FG009|Cohort 5P, Q2W|Adverse Event|0|||
124625699|NCT02906670|448245378|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
124625700|NCT02906670|448245379|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
124625701|NCT02906670|448245380|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
124625702|NCT02906670|448245381|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
124625703|NCT02906670|448245382|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
124625704|NCT02906670|448245383|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
124625705|NCT02906670|448245384|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
124625706|NCT02906670|448245385|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
124625707|NCT02906670|448245386|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
124625708|NCT02906670|448245387|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
124625709|NCT02906670|448245378|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
124625710|NCT02906670|448245379|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
124625711|NCT02906670|448245380|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
124625712|NCT02906670|448245381|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
124625713|NCT02906670|448245382|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
124625714|NCT02906670|448245383|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
124625715|NCT02906670|448245384|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
124625716|NCT02906670|448245385|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
124625717|NCT02906670|448245386|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
124625718|NCT02906670|448245387|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
124625719|NCT02906670|448245378|FG000|Cohort 4P, QW|Radiological Progression|0|||
124625720|NCT02906670|448245379|FG001|Cohort 4P, QW|Radiological Progression|0|||
124625721|NCT02906670|448245380|FG002|Cohort 4P, QW|Radiological Progression|0|||
124625722|NCT02906670|448245381|FG003|Cohort 4P, QW|Radiological Progression|3|||
124625723|NCT02906670|448245382|FG004|Cohort 4P, QW|Radiological Progression|0|||
124625724|NCT02906670|448245383|FG005|Cohort 4P, QW|Radiological Progression|0|||
124625725|NCT02906670|448245384|FG006|Cohort 4P, QW|Radiological Progression|0|||
124625726|NCT02906670|448245385|FG007|Cohort 4P, QW|Radiological Progression|0|||
124625727|NCT02906670|448245386|FG008|Cohort 4P, QW|Radiological Progression|0|||
124625728|NCT02906670|448245387|FG009|Cohort 4P, QW|Radiological Progression|0|||
124625729|NCT02906670|448245378|FG000|Cohort 7P, Q2W|Adverse Event|0|||
124625730|NCT02906670|448245379|FG001|Cohort 7P, Q2W|Adverse Event|0|||
124625731|NCT02906670|448245380|FG002|Cohort 7P, Q2W|Adverse Event|0|||
124625732|NCT02906670|448245381|FG003|Cohort 7P, Q2W|Adverse Event|0|||
124625733|NCT02906670|448245382|FG004|Cohort 7P, Q2W|Adverse Event|0|||
124625734|NCT02906670|448245383|FG005|Cohort 7P, Q2W|Adverse Event|0|||
124625735|NCT02906670|448245384|FG006|Cohort 7P, Q2W|Adverse Event|0|||
124625736|NCT02906670|448245385|FG007|Cohort 7P, Q2W|Adverse Event|0|||
124625737|NCT02906670|448245386|FG008|Cohort 7P, Q2W|Adverse Event|0|||
124625738|NCT02906670|448245387|FG009|Cohort 7P, Q2W|Adverse Event|1|||
124625739|NCT02906670|448245378|FG000|Cohort 7P, Q2W|Physician Decision|0|||
124625740|NCT02906670|448245379|FG001|Cohort 7P, Q2W|Physician Decision|0|||
124625741|NCT02906670|448245380|FG002|Cohort 7P, Q2W|Physician Decision|0|||
124625742|NCT02906670|448245381|FG003|Cohort 7P, Q2W|Physician Decision|0|||
124625743|NCT02906670|448245382|FG004|Cohort 7P, Q2W|Physician Decision|0|||
124625744|NCT02906670|448245383|FG005|Cohort 7P, Q2W|Physician Decision|0|||
124625745|NCT02906670|448245384|FG006|Cohort 7P, Q2W|Physician Decision|0|||
124625746|NCT02906670|448245385|FG007|Cohort 7P, Q2W|Physician Decision|0|||
124784047|NCT01818752|448840042|FG001|Overall Study|Disease Progression|48|||
124784048|NCT01818752|448840041|FG000|Overall Study|Other|7|||
124784049|NCT01818752|448840042|FG001|Overall Study|Other|8|||
124784050|NCT01818752|448840041|FG000|Overall Study|Continuing Treatment|1|||
124784051|NCT01818752|448840042|FG001|Overall Study|Continuing Treatment|4|||
124784052|NCT01818752|448840041|FG000|Overall Study|Randomized but not Dosed|7|||
124784053|NCT01818752|448840042|FG001|Overall Study|Randomized but not Dosed|4|||
124784054|NCT01324141|448840043|FG000|Overall Study|Declined to participate before treatment started|1|||
124784055|NCT01324141|448840043|FG000|Overall Study|Disease progression on study|1|||
124784056|NCT01165216|448840049|FG000|Overall Study|Adverse Event|6|||
124784057|NCT01165216|448840050|FG001|Overall Study|Adverse Event|3|||
124784058|NCT01165216|448840049|FG000|Overall Study|Withdrawal by Subject|1|||
124784059|NCT01165216|448840050|FG001|Overall Study|Withdrawal by Subject|1|||
124784060|NCT01165216|448840049|FG000|Overall Study|Disease progression|1|||
124784061|NCT01165216|448840050|FG001|Overall Study|Disease progression|3|||
124784078|NCT06457204|448840060|FG000|Washout|Adverse Event|0|||
124784079|NCT06457204|448840061|FG001|Washout|Adverse Event|2|||
124784080|NCT01808092|448840062|FG000|Overall Study|Death|39|||
124784081|NCT01808092|448840063|FG001|Overall Study|Death|29|||
124784082|NCT01808092|448840062|FG000|Overall Study|Lost to Follow-up|3|||
124784083|NCT01808092|448840063|FG001|Overall Study|Lost to Follow-up|7|||
124784084|NCT01808092|448840062|FG000|Overall Study|Withdrawal by Subject|9|||
124784085|NCT01808092|448840063|FG001|Overall Study|Withdrawal by Subject|4|||
124784086|NCT01808092|448840062|FG000|Overall Study|Other Eligibility criteria|3|||
124784087|NCT01808092|448840063|FG001|Overall Study|Other Eligibility criteria|5|||
124784088|NCT01097005|448840064|FG000|Overall Study|Case Report Form not collected|18|||
124784089|NCT01097005|448840064|FG000|Overall Study|Subjects cannot visit the hospital|1|||
124784090|NCT01097005|448840064|FG000|Overall Study|Poor medication compliance|1|||
124784091|NCT01097005|448840064|FG000|Overall Study|No examination data available|244|||
124784092|NCT01097005|448840064|FG000|Overall Study|Deviation from exclusion criteria|37|||
124784093|NCT01097005|448840064|FG000|Overall Study|Adverse Event|14|||
124784094|NCT01097005|448840064|FG000|Overall Study|Discontinuance by complication|50|||
124784095|NCT05289037|448840069|FG000|Overall Study|Withdrawal by Subject|7|||
124784096|NCT05289037|448840070|FG001|Overall Study|Withdrawal by Subject|0|||
124784097|NCT05289037|448840071|FG002|Overall Study|Withdrawal by Subject|3|||
124784098|NCT05289037|448840072|FG003|Overall Study|Withdrawal by Subject|3|||
124784099|NCT05289037|448840073|FG004|Overall Study|Withdrawal by Subject|1|||
124784100|NCT05289037|448840074|FG005|Overall Study|Withdrawal by Subject|5|||
124784101|NCT05289037|448840075|FG006|Overall Study|Withdrawal by Subject|2|||
124784102|NCT05289037|448840076|FG007|Overall Study|Withdrawal by Subject|1|||
124784103|NCT05289037|448840077|FG008|Overall Study|Withdrawal by Subject|2|||
124784104|NCT05289037|448840078|FG009|Overall Study|Withdrawal by Subject|2|||
124784105|NCT05289037|448840079|FG010|Overall Study|Withdrawal by Subject|1|||
124784106|NCT05289037|448840080|FG011|Overall Study|Withdrawal by Subject|0|||
124784107|NCT05289037|448840081|FG012|Overall Study|Withdrawal by Subject|1|||
124784108|NCT05289037|448840082|FG013|Overall Study|Withdrawal by Subject|2|||
124784109|NCT05289037|448840083|FG014|Overall Study|Withdrawal by Subject|0|||
124784110|NCT05289037|448840084|FG015|Overall Study|Withdrawal by Subject|3|||
124784111|NCT05289037|448840085|FG016|Overall Study|Withdrawal by Subject|3|||
124784112|NCT05289037|448840069|FG000|Overall Study|Lost to Follow-up|1|||
124784113|NCT05289037|448840070|FG001|Overall Study|Lost to Follow-up|4|||
124784114|NCT05289037|448840071|FG002|Overall Study|Lost to Follow-up|3|||
124784115|NCT05289037|448840072|FG003|Overall Study|Lost to Follow-up|3|||
124784116|NCT05289037|448840073|FG004|Overall Study|Lost to Follow-up|3|||
124784117|NCT05289037|448840074|FG005|Overall Study|Lost to Follow-up|2|||
124784118|NCT05289037|448840075|FG006|Overall Study|Lost to Follow-up|3|||
124784119|NCT05289037|448840076|FG007|Overall Study|Lost to Follow-up|2|||
124784120|NCT05289037|448840077|FG008|Overall Study|Lost to Follow-up|2|||
124784121|NCT05289037|448840078|FG009|Overall Study|Lost to Follow-up|1|||
124784122|NCT05289037|448840079|FG010|Overall Study|Lost to Follow-up|3|||
124784123|NCT05289037|448840080|FG011|Overall Study|Lost to Follow-up|4|||
124784124|NCT05289037|448840081|FG012|Overall Study|Lost to Follow-up|2|||
124784125|NCT05289037|448840082|FG013|Overall Study|Lost to Follow-up|7|||
124625747|NCT02906670|448245386|FG008|Cohort 7P, Q2W|Physician Decision|0|||
124625748|NCT02906670|448245387|FG009|Cohort 7P, Q2W|Physician Decision|1|||
124625749|NCT02906670|448245378|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
124625750|NCT02906670|448245379|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
124625751|NCT02906670|448245380|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
124625752|NCT02906670|448245381|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
124625753|NCT02906670|448245382|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
124625754|NCT02906670|448245383|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
124625755|NCT02906670|448245384|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
124625756|NCT02906670|448245385|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
124625757|NCT02906670|448245386|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
124625758|NCT02906670|448245387|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
124625759|NCT02906670|448245378|FG000|Cohort 5P, QW|Radiological Progression|0|||
124625760|NCT02906670|448245379|FG001|Cohort 5P, QW|Radiological Progression|0|||
124625761|NCT02906670|448245380|FG002|Cohort 5P, QW|Radiological Progression|0|||
124625762|NCT02906670|448245381|FG003|Cohort 5P, QW|Radiological Progression|0|||
124625763|NCT02906670|448245382|FG004|Cohort 5P, QW|Radiological Progression|3|||
124625764|NCT02906670|448245383|FG005|Cohort 5P, QW|Radiological Progression|0|||
124625765|NCT02906670|448245384|FG006|Cohort 5P, QW|Radiological Progression|0|||
124625766|NCT02906670|448245385|FG007|Cohort 5P, QW|Radiological Progression|0|||
124625767|NCT02906670|448245386|FG008|Cohort 5P, QW|Radiological Progression|0|||
124625768|NCT02906670|448245387|FG009|Cohort 5P, QW|Radiological Progression|0|||
124625769|NCT01349192|448245388|FG000|Overall Study|Protocol Violation|0|||
124625770|NCT01349192|448245389|FG001|Overall Study|Protocol Violation|1|||
124625771|NCT01349192|448245388|FG000|Overall Study|Withdrawal by Subject|0|||
124625772|NCT01349192|448245389|FG001|Overall Study|Withdrawal by Subject|2|||
124625773|NCT01349192|448245388|FG000|Overall Study|Lost to Follow-up|1|||
124625774|NCT01349192|448245389|FG001|Overall Study|Lost to Follow-up|3|||
124625775|NCT01349192|448245388|FG000|Overall Study|Failure to adhere to Protocol|2|||
124625776|NCT01349192|448245389|FG001|Overall Study|Failure to adhere to Protocol|0|||
124625777|NCT03749330|448245390|FG000|Overall Study|Clinicians left work in the CICU|0|||
124625778|NCT03749330|448245391|FG001|Overall Study|Clinicians left work in the CICU|2|||
124625779|NCT03749330|448245392|FG002|Overall Study|Clinicians left work in the CICU|0|||
124625780|NCT03749330|448245393|FG003|Overall Study|Clinicians left work in the CICU|0|||
124625781|NCT03749330|448245394|FG004|Overall Study|Clinicians left work in the CICU|0|||
124625782|NCT03749330|448245395|FG005|Overall Study|Clinicians left work in the CICU|0|||
124625783|NCT01973439|448245396|FG000|Overall Study|Lost samples from one PK Day|2|||
124625784|NCT01973439|448245396|FG000|Overall Study|Vomiting after commencing once daily|1|||
124625785|NCT01973439|448245396|FG000|Overall Study|PK curve incomplete|2|||
124625786|NCT02038010|448245398|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
124625787|NCT02038010|448245399|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
124625788|NCT02038010|448245400|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
124625789|NCT02038010|448245401|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
124625790|NCT02038010|448245398|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
124625791|NCT02038010|448245399|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
124625792|NCT02038010|448245400|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
124625793|NCT02038010|448245401|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
124625794|NCT02038010|448245398|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
124625795|NCT02038010|448245399|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
124625796|NCT02038010|448245400|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
124625797|NCT02038010|448245401|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
124625798|NCT02038010|448245398|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
124625799|NCT02038010|448245399|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
124625800|NCT02038010|448245400|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
124625801|NCT02038010|448245401|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
124625802|NCT02038010|448245398|FG000|Follow Up|Death|4|||
124625803|NCT02038010|448245399|FG001|Follow Up|Death|3|||
124625804|NCT02038010|448245400|FG002|Follow Up|Death|0|||
124625805|NCT02038010|448245401|FG003|Follow Up|Death|0|||
124625806|NCT02038010|448245398|FG000|Follow Up|Other|3|||
124625807|NCT02038010|448245399|FG001|Follow Up|Other|0|||
124625808|NCT02038010|448245400|FG002|Follow Up|Other|0|||
124625809|NCT02038010|448245401|FG003|Follow Up|Other|0|||
124625810|NCT03908125|448245406|FG000|Overall Study|Withdrawal by Subject|92|||
124625811|NCT03908125|448245406|FG000|Overall Study|Lost to Follow-up|8|||
124625812|NCT02262325|448245407|FG000|Overall Study|Death|16|||
124625813|NCT02262325|448245407|FG000|Overall Study|Lost to Follow-up|1|||
124625814|NCT02815995|448245408|FG000|Overall Study|Disease Progression|3|||
124625815|NCT02815995|448245409|FG001|Overall Study|Disease Progression|7|||
124625816|NCT02815995|448245410|FG002|Overall Study|Disease Progression|2|||
124625817|NCT02815995|448245411|FG003|Overall Study|Disease Progression|4|||
124625818|NCT02815995|448245412|FG004|Overall Study|Disease Progression|3|||
124784126|NCT05289037|448840083|FG014|Overall Study|Lost to Follow-up|4|||
124784127|NCT05289037|448840084|FG015|Overall Study|Lost to Follow-up|6|||
124784128|NCT05289037|448840085|FG016|Overall Study|Lost to Follow-up|4|||
124784129|NCT05289037|448840069|FG000|Overall Study|Death|0|||
124784130|NCT05289037|448840070|FG001|Overall Study|Death|0|||
124784131|NCT05289037|448840071|FG002|Overall Study|Death|0|||
124784132|NCT05289037|448840072|FG003|Overall Study|Death|0|||
124784133|NCT05289037|448840073|FG004|Overall Study|Death|0|||
124784134|NCT05289037|448840074|FG005|Overall Study|Death|1|||
124784135|NCT05289037|448840075|FG006|Overall Study|Death|0|||
124784136|NCT05289037|448840076|FG007|Overall Study|Death|0|||
124784137|NCT05289037|448840077|FG008|Overall Study|Death|0|||
124784138|NCT05289037|448840078|FG009|Overall Study|Death|0|||
124784139|NCT05289037|448840079|FG010|Overall Study|Death|0|||
124784140|NCT05289037|448840080|FG011|Overall Study|Death|0|||
124784141|NCT05289037|448840081|FG012|Overall Study|Death|0|||
124784142|NCT05289037|448840082|FG013|Overall Study|Death|0|||
124784143|NCT05289037|448840083|FG014|Overall Study|Death|1|||
124784144|NCT05289037|448840084|FG015|Overall Study|Death|0|||
124784145|NCT05289037|448840085|FG016|Overall Study|Death|0|||
124784146|NCT05289037|448840069|FG000|Overall Study|Did not receive vaccine|0|||
124784147|NCT05289037|448840070|FG001|Overall Study|Did not receive vaccine|3|||
124784148|NCT05289037|448840071|FG002|Overall Study|Did not receive vaccine|0|||
124784149|NCT05289037|448840072|FG003|Overall Study|Did not receive vaccine|0|||
124784150|NCT05289037|448840073|FG004|Overall Study|Did not receive vaccine|1|||
124784151|NCT05289037|448840074|FG005|Overall Study|Did not receive vaccine|1|||
124784152|NCT05289037|448840075|FG006|Overall Study|Did not receive vaccine|1|||
124625819|NCT02815995|448245413|FG005|Overall Study|Disease Progression|9|||
124625820|NCT02815995|448245414|FG006|Overall Study|Disease Progression|3|||
124625821|NCT02815995|448245415|FG007|Overall Study|Disease Progression|1|||
124625822|NCT02815995|448245408|FG000|Overall Study|Adverse Event|1|||
124625823|NCT02815995|448245409|FG001|Overall Study|Adverse Event|2|||
124625824|NCT02815995|448245410|FG002|Overall Study|Adverse Event|2|||
124625825|NCT02815995|448245411|FG003|Overall Study|Adverse Event|0|||
124625826|NCT02815995|448245412|FG004|Overall Study|Adverse Event|0|||
124625827|NCT02815995|448245413|FG005|Overall Study|Adverse Event|1|||
124625828|NCT02815995|448245414|FG006|Overall Study|Adverse Event|0|||
124625829|NCT02815995|448245415|FG007|Overall Study|Adverse Event|0|||
124625830|NCT02815995|448245408|FG000|Overall Study|Pregnancy|0|||
124625831|NCT02815995|448245409|FG001|Overall Study|Pregnancy|0|||
124625832|NCT02815995|448245410|FG002|Overall Study|Pregnancy|0|||
124625833|NCT02815995|448245411|FG003|Overall Study|Pregnancy|0|||
124625834|NCT02815995|448245412|FG004|Overall Study|Pregnancy|0|||
124625835|NCT02815995|448245413|FG005|Overall Study|Pregnancy|0|||
124625836|NCT02815995|448245414|FG006|Overall Study|Pregnancy|1|||
124625837|NCT02815995|448245415|FG007|Overall Study|Pregnancy|0|||
124625838|NCT01071915|448245416|FG000|Overall Study|Adverse Event|3|||
124625839|NCT01071915|448245416|FG000|Overall Study|Physician Decision|2|||
124625840|NCT01071915|448245416|FG000|Overall Study|Withdrawal by Subject|2|||
124625841|NCT01071915|448245416|FG000|Overall Study|Miscellaneous Reasons|2|||
124625842|NCT00114140|448245417|FG000|Overall Study|Protocol Violation|7|||
124625843|NCT00666328|448245420|FG000|Overall Study|Death|2|||
124625844|NCT00666328|448245420|FG000|Overall Study|Lost to Follow-up|2|||
124625845|NCT00666328|448245420|FG000|Overall Study|No longer met eligibility criteria|1|||
124625846|NCT05064397|448245421|FG000|Overall Study|Adverse Event|4|||
124625847|NCT05064397|448245421|FG000|Overall Study|Lack of Efficacy|12|||
124625848|NCT05064397|448245421|FG000|Overall Study|Withdrawal by Subject|3|||
124625849|NCT05064397|448245421|FG000|Overall Study|Lost to Follow-up|1|||
124625850|NCT05064397|448245421|FG000|Overall Study|Other reasons|3|||
124625851|NCT02232984|448245422|FG000|Overall Study|Withdrawal by Subject|5|||
124625852|NCT02232984|448245422|FG000|Overall Study|Death|1|||
124625853|NCT02232984|448245422|FG000|Overall Study|Investigator withdrawal|10|||
124625854|NCT02232984|448245422|FG000|Overall Study|Device implant unsuccessful|53|||
124625855|NCT02232984|448245422|FG000|Overall Study|not disclosed by site|7|||
124625856|NCT02232984|448245422|FG000|Overall Study|Protocol Violation|1|||
124625857|NCT00535405|448245425|FG000|Overall Study|Adverse Event|6|||
124625858|NCT00535405|448245426|FG001|Overall Study|Adverse Event|8|||
124625859|NCT00535405|448245427|FG002|Overall Study|Adverse Event|3|||
124625860|NCT00535405|448245428|FG003|Overall Study|Adverse Event|8|||
124625861|NCT00535405|448245429|FG004|Overall Study|Adverse Event|6|||
124625862|NCT00535405|448245425|FG000|Overall Study|Lost to Follow-up|1|||
124784153|NCT05289037|448840076|FG007|Overall Study|Did not receive vaccine|0|||
124625863|NCT00535405|448245426|FG001|Overall Study|Lost to Follow-up|3|||
124625864|NCT00535405|448245427|FG002|Overall Study|Lost to Follow-up|3|||
124625865|NCT00535405|448245428|FG003|Overall Study|Lost to Follow-up|2|||
124625866|NCT00535405|448245429|FG004|Overall Study|Lost to Follow-up|1|||
124625867|NCT00535405|448245425|FG000|Overall Study|Physician Decision|3|||
124625868|NCT00535405|448245426|FG001|Overall Study|Physician Decision|2|||
124625869|NCT00535405|448245427|FG002|Overall Study|Physician Decision|0|||
124784154|NCT05289037|448840077|FG008|Overall Study|Did not receive vaccine|0|||
124784155|NCT05289037|448840078|FG009|Overall Study|Did not receive vaccine|0|||
124784156|NCT05289037|448840079|FG010|Overall Study|Did not receive vaccine|0|||
124625870|NCT00535405|448245428|FG003|Overall Study|Physician Decision|1|||
124625871|NCT00535405|448245429|FG004|Overall Study|Physician Decision|1|||
124625872|NCT00535405|448245425|FG000|Overall Study|Protocol Violation|2|||
124625873|NCT00535405|448245426|FG001|Overall Study|Protocol Violation|2|||
124625874|NCT00535405|448245427|FG002|Overall Study|Protocol Violation|2|||
124625875|NCT00535405|448245428|FG003|Overall Study|Protocol Violation|1|||
124625876|NCT00535405|448245429|FG004|Overall Study|Protocol Violation|0|||
124625877|NCT00535405|448245425|FG000|Overall Study|Withdrawal by Subject|5|||
124625878|NCT00535405|448245426|FG001|Overall Study|Withdrawal by Subject|11|||
124625879|NCT00535405|448245427|FG002|Overall Study|Withdrawal by Subject|10|||
124625880|NCT00535405|448245428|FG003|Overall Study|Withdrawal by Subject|10|||
124625881|NCT00535405|448245429|FG004|Overall Study|Withdrawal by Subject|8|||
124625882|NCT03404674|448245430|FG000|Overall Study|Inability to Attend Future Visits|0|||
124625883|NCT03404674|448245431|FG001|Overall Study|Inability to Attend Future Visits|1|||
124625884|NCT03404674|448245432|FG002|Overall Study|Inability to Attend Future Visits|1|||
124625885|NCT03404674|448245433|FG003|Overall Study|Inability to Attend Future Visits|0|||
124625886|NCT03404674|448245434|FG004|Overall Study|Inability to Attend Future Visits|0|||
124625887|NCT03404674|448245435|FG005|Overall Study|Inability to Attend Future Visits|0|||
124625888|NCT03404674|448245430|FG000|Overall Study|Behavioral Problems|0|||
124625889|NCT03404674|448245431|FG001|Overall Study|Behavioral Problems|0|||
124625890|NCT03404674|448245432|FG002|Overall Study|Behavioral Problems|1|||
124625891|NCT03404674|448245433|FG003|Overall Study|Behavioral Problems|0|||
124625892|NCT03404674|448245434|FG004|Overall Study|Behavioral Problems|0|||
124625893|NCT03404674|448245435|FG005|Overall Study|Behavioral Problems|0|||
124625894|NCT03404674|448245430|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
124625895|NCT03404674|448245431|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
124625896|NCT03404674|448245432|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
124625897|NCT03404674|448245433|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
124625898|NCT03404674|448245434|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
124625899|NCT03404674|448245435|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
124625900|NCT00129545|448245438|FG000|Overall Study|Death|5|||
124625901|NCT00129545|448245439|FG001|Overall Study|Death|60|||
124625902|NCT00129545|448245440|FG002|Overall Study|Death|44|||
124625903|NCT00129545|448245438|FG000|Overall Study|Withdrawal by Subject|3|||
124625904|NCT00129545|448245439|FG001|Overall Study|Withdrawal by Subject|18|||
124625905|NCT00129545|448245440|FG002|Overall Study|Withdrawal by Subject|44|||
124625906|NCT00129545|448245438|FG000|Overall Study|Lost to Follow-up|2|||
124625907|NCT00129545|448245439|FG001|Overall Study|Lost to Follow-up|22|||
124625908|NCT00129545|448245440|FG002|Overall Study|Lost to Follow-up|13|||
124625909|NCT00129545|448245438|FG000|Overall Study|Physician Decision|0|||
124625910|NCT00129545|448245439|FG001|Overall Study|Physician Decision|3|||
124625911|NCT00129545|448245440|FG002|Overall Study|Physician Decision|10|||
124625912|NCT00129545|448245438|FG000|Overall Study|Device not implanted|16|||
124625913|NCT00129545|448245439|FG001|Overall Study|Device not implanted|61|||
124625914|NCT00129545|448245440|FG002|Overall Study|Device not implanted|0|||
124625915|NCT02969044|448245445|FG000|Overall Study|Withdrawal by Subject|2|||
124625916|NCT02969044|448245446|FG001|Overall Study|Withdrawal by Subject|6|||
124625917|NCT02969044|448245445|FG000|Overall Study|Adverse Event|3|||
124625918|NCT02969044|448245446|FG001|Overall Study|Adverse Event|0|||
124625919|NCT04728802|448245449|FG000|Overall Study|Withdrawal by Subject|4|||
124625920|NCT04728802|448245450|FG001|Overall Study|Withdrawal by Subject|20|||
124625921|NCT04728802|448245449|FG000|Overall Study|Physician Decision|7|||
124625922|NCT04728802|448245450|FG001|Overall Study|Physician Decision|7|||
124625923|NCT04728802|448245449|FG000|Overall Study|Protocol Violation|10|||
124625924|NCT04728802|448245450|FG001|Overall Study|Protocol Violation|4|||
124625925|NCT04728802|448245449|FG000|Overall Study|Transfer|1|||
124625926|NCT04728802|448245450|FG001|Overall Study|Transfer|0|||
124625927|NCT04728802|448245449|FG000|Overall Study|Death|4|||
124625928|NCT04728802|448245450|FG001|Overall Study|Death|5|||
124625929|NCT04728802|448245449|FG000|Overall Study|Other|3|||
124625930|NCT04728802|448245450|FG001|Overall Study|Other|0|||
124625931|NCT00262028|448245451|FG000|Overall Study|Withdrawal by Subject|6|||
124625932|NCT00262028|448245452|FG001|Overall Study|Withdrawal by Subject|3|||
124625933|NCT00262028|448245453|FG002|Overall Study|Withdrawal by Subject|6|||
124625934|NCT00262028|448245454|FG003|Overall Study|Withdrawal by Subject|5|||
124625935|NCT00262028|448245455|FG004|Overall Study|Withdrawal by Subject|2|||
124625936|NCT00262028|448245456|FG005|Overall Study|Withdrawal by Subject|3|||
124625937|NCT00262028|448245457|FG006|Overall Study|Withdrawal by Subject|5|||
124625938|NCT00262028|448245458|FG007|Overall Study|Withdrawal by Subject|7|||
124625939|NCT00262028|448245459|FG008|Overall Study|Withdrawal by Subject|2|||
124625940|NCT00262028|448245451|FG000|Overall Study|Lost to Follow-up|7|||
124625941|NCT00262028|448245452|FG001|Overall Study|Lost to Follow-up|7|||
124625942|NCT00262028|448245453|FG002|Overall Study|Lost to Follow-up|5|||
124625943|NCT00262028|448245454|FG003|Overall Study|Lost to Follow-up|5|||
124625944|NCT00262028|448245455|FG004|Overall Study|Lost to Follow-up|4|||
124625945|NCT00262028|448245456|FG005|Overall Study|Lost to Follow-up|3|||
124625946|NCT00262028|448245457|FG006|Overall Study|Lost to Follow-up|3|||
124625947|NCT00262028|448245458|FG007|Overall Study|Lost to Follow-up|5|||
124625948|NCT00262028|448245459|FG008|Overall Study|Lost to Follow-up|6|||
124625949|NCT00262028|448245451|FG000|Overall Study|Administrative Reason|11|||
124625950|NCT00262028|448245452|FG001|Overall Study|Administrative Reason|14|||
124625951|NCT00262028|448245453|FG002|Overall Study|Administrative Reason|9|||
124625952|NCT00262028|448245454|FG003|Overall Study|Administrative Reason|12|||
124625953|NCT00262028|448245455|FG004|Overall Study|Administrative Reason|6|||
124625954|NCT00262028|448245456|FG005|Overall Study|Administrative Reason|7|||
124625955|NCT00262028|448245457|FG006|Overall Study|Administrative Reason|4|||
124625956|NCT00262028|448245458|FG007|Overall Study|Administrative Reason|6|||
124625957|NCT00262028|448245459|FG008|Overall Study|Administrative Reason|10|||
124625958|NCT00262028|448245451|FG000|Overall Study|Protocol Violation|0|||
124625959|NCT00262028|448245452|FG001|Overall Study|Protocol Violation|0|||
124625960|NCT00262028|448245453|FG002|Overall Study|Protocol Violation|0|||
124625961|NCT00262028|448245454|FG003|Overall Study|Protocol Violation|1|||
124625962|NCT00262028|448245455|FG004|Overall Study|Protocol Violation|0|||
124625963|NCT00262028|448245456|FG005|Overall Study|Protocol Violation|0|||
124625964|NCT00262028|448245457|FG006|Overall Study|Protocol Violation|0|||
124625965|NCT00262028|448245458|FG007|Overall Study|Protocol Violation|0|||
124625966|NCT00262028|448245459|FG008|Overall Study|Protocol Violation|0|||
124625967|NCT00262028|448245451|FG000|Overall Study|Unable to classify|0|||
124625968|NCT00262028|448245452|FG001|Overall Study|Unable to classify|3|||
124625969|NCT00262028|448245453|FG002|Overall Study|Unable to classify|0|||
124625970|NCT00262028|448245454|FG003|Overall Study|Unable to classify|0|||
124625971|NCT00262028|448245455|FG004|Overall Study|Unable to classify|0|||
124625972|NCT00262028|448245456|FG005|Overall Study|Unable to classify|0|||
124625973|NCT00262028|448245457|FG006|Overall Study|Unable to classify|0|||
124625974|NCT00262028|448245458|FG007|Overall Study|Unable to classify|0|||
124625975|NCT00262028|448245459|FG008|Overall Study|Unable to classify|1|||
124625976|NCT01176513|448245460|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
124625977|NCT02308124|448245462|FG000|Overall Study|Lost to Follow-up|6|||
124625978|NCT02308124|448245463|FG001|Overall Study|Lost to Follow-up|6|||
124625979|NCT02308124|448245464|FG002|Overall Study|Lost to Follow-up|6|||
124625980|NCT02308124|448245462|FG000|Overall Study|Adverse Event|0|||
124625981|NCT02308124|448245463|FG001|Overall Study|Adverse Event|2|||
124625982|NCT02308124|448245464|FG002|Overall Study|Adverse Event|2|||
124625983|NCT01329900|448245465|FG000|Overall Study|Elevated creatinine/renal function|1|||
124625984|NCT04233073|448245469|FG000|Overall Study|Death|5|||
124625985|NCT00143390|448245470|FG000|Overall Study|Death|2|||
124625986|NCT00143390|448245471|FG001|Overall Study|Death|0|||
124625987|NCT00143390|448245470|FG000|Overall Study|Not meeting entry criteria|2|||
124625988|NCT00143390|448245471|FG001|Overall Study|Not meeting entry criteria|5|||
124625989|NCT00143390|448245470|FG000|Overall Study|Withdrawal by Subject|4|||
124625990|NCT00143390|448245471|FG001|Overall Study|Withdrawal by Subject|4|||
124625991|NCT00143390|448245470|FG000|Overall Study|Progressive disease|119|||
124625992|NCT00143390|448245471|FG001|Overall Study|Progressive disease|115|||
124625993|NCT00143390|448245470|FG000|Overall Study|Protocol Violation|2|||
124625994|NCT00143390|448245471|FG001|Overall Study|Protocol Violation|0|||
124625995|NCT00143390|448245470|FG000|Overall Study|Study termination|10|||
124625996|NCT00143390|448245471|FG001|Overall Study|Study termination|15|||
124625997|NCT00143390|448245470|FG000|Overall Study|Adverse Event|9|||
124625998|NCT00143390|448245471|FG001|Overall Study|Adverse Event|8|||
124625999|NCT00143390|448245470|FG000|Overall Study|Other|1|||
124626000|NCT00143390|448245471|FG001|Overall Study|Other|2|||
124626001|NCT00041132|448245472|FG000|Overall Study|Adverse Event|19|||
124626002|NCT00041132|448245472|FG000|Overall Study|Death|1|||
124626003|NCT00041132|448245472|FG000|Overall Study|Not Eligible|7|||
124626004|NCT00041132|448245472|FG000|Overall Study|Withdrawal by Subject|1|||
124626005|NCT00041132|448245472|FG000|Overall Study|Physician Decision|2|||
124626006|NCT00995774|448245477|FG000|Training Period 2|Withdrawal by Subject|2|||
124626007|NCT00995774|448245478|FG001|Training Period 2|Withdrawal by Subject|0|||
124626008|NCT03953612|448245480|FG000|Overall Study|Randomized but did not start|1|||
124626009|NCT03953612|448245481|FG001|Overall Study|Randomized but did not start|1|||
124626010|NCT03953612|448245482|FG002|Overall Study|Randomized but did not start|1|||
124626011|NCT03953612|448245480|FG000|Overall Study|Withdrawal by Subject|2|||
124752061|NCT03517228|448714234|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
124626012|NCT03953612|448245481|FG001|Overall Study|Withdrawal by Subject|1|||
124626013|NCT03953612|448245482|FG002|Overall Study|Withdrawal by Subject|0|||
124626014|NCT03200717|448245500|FG000|Overall Study|Progressive disease|24|||
124626015|NCT03200717|448245501|FG001|Overall Study|Progressive disease|5|||
124626016|NCT03200717|448245500|FG000|Overall Study|Adverse Event|11|||
124626017|NCT03200717|448245501|FG001|Overall Study|Adverse Event|8|||
124626018|NCT03200717|448245500|FG000|Overall Study|Physician Decision|3|||
124626019|NCT03200717|448245501|FG001|Overall Study|Physician Decision|2|||
124626020|NCT03200717|448245500|FG000|Overall Study|Death|2|||
124626021|NCT03200717|448245501|FG001|Overall Study|Death|0|||
124626022|NCT03200717|448245500|FG000|Overall Study|Subject/Guardian Decision|1|||
124626023|NCT03200717|448245501|FG001|Overall Study|Subject/Guardian Decision|0|||
124626024|NCT04211831|448245506|FG000|Overall Study|Withdrawal by Subject|4|||
124626025|NCT04211831|448245507|FG001|Overall Study|Withdrawal by Subject|1|||
124626026|NCT04211831|448245508|FG002|Overall Study|Withdrawal by Subject|1|||
124626027|NCT04211831|448245506|FG000|Overall Study|Protocol Violation|0|||
124626028|NCT04211831|448245507|FG001|Overall Study|Protocol Violation|0|||
124626029|NCT04211831|448245508|FG002|Overall Study|Protocol Violation|1|||
124626030|NCT04211831|448245506|FG000|Overall Study|Adverse Event|0|||
124626031|NCT04211831|448245507|FG001|Overall Study|Adverse Event|1|||
124626032|NCT04211831|448245508|FG002|Overall Study|Adverse Event|0|||
124626033|NCT04211831|448245506|FG000|Overall Study|Lack of Efficacy|0|||
124626034|NCT04211831|448245507|FG001|Overall Study|Lack of Efficacy|0|||
124626035|NCT04211831|448245508|FG002|Overall Study|Lack of Efficacy|1|||
124626036|NCT04211831|448245506|FG000|Overall Study|Lost to Follow-up|0|||
124626037|NCT04211831|448245507|FG001|Overall Study|Lost to Follow-up|0|||
124626038|NCT04211831|448245508|FG002|Overall Study|Lost to Follow-up|2|||
124626039|NCT04211831|448245506|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
124626040|NCT04211831|448245507|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
124626041|NCT04211831|448245508|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
124626042|NCT04211831|448245506|FG000|Overall Study|Other|0|||
124626043|NCT04211831|448245507|FG001|Overall Study|Other|1|||
124626044|NCT04211831|448245508|FG002|Overall Study|Other|0|||
124626045|NCT00397514|448245509|FG000|Overall Study|Withdrawal by Subject|1|||
124626046|NCT00397514|448245509|FG000|Overall Study|Pacing wire malfunction|1|||
124626047|NCT00397514|448245509|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
124626048|NCT00397514|448245509|FG000|Overall Study|early extubation|2|||
124626049|NCT00397514|448245509|FG000|Overall Study|poor echocardiographic windows|1|||
124626050|NCT01256879|448245511|FG000|Overall Study|Withdrawal by Subject|1|||
124626051|NCT01959295|448245513|FG000|Overall Study|Adverse Event|2|||
124626052|NCT01959295|448245514|FG001|Overall Study|Adverse Event|0|||
124626053|NCT01959295|448245513|FG000|Overall Study|Lost to Follow-up|0|||
124626054|NCT01959295|448245514|FG001|Overall Study|Lost to Follow-up|2|||
124626055|NCT01959295|448245513|FG000|Overall Study|Physician Decision|2|||
124626056|NCT01959295|448245514|FG001|Overall Study|Physician Decision|3|||
124626057|NCT01959295|448245513|FG000|Overall Study|Protocol Violation|16|||
124626058|NCT01959295|448245514|FG001|Overall Study|Protocol Violation|5|||
124626059|NCT01959295|448245513|FG000|Overall Study|Withdrawal by Subject|3|||
124626060|NCT01959295|448245514|FG001|Overall Study|Withdrawal by Subject|1|||
124626061|NCT01959295|448245513|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
124626062|NCT01959295|448245514|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
124626063|NCT03493685|448247934|FG000|Overall Study|Death|4|||
124626064|NCT03493685|448247935|FG001|Overall Study|Death|3|||
124626065|NCT03493685|448247934|FG000|Overall Study|Lost to Follow-up|3|||
124626066|NCT03493685|448247935|FG001|Overall Study|Lost to Follow-up|2|||
124626067|NCT03493685|448247934|FG000|Overall Study|Physician Decision|2|||
124626068|NCT03493685|448247935|FG001|Overall Study|Physician Decision|0|||
124626069|NCT03493685|448247934|FG000|Overall Study|Withdrawal by Subject|7|||
124626070|NCT03493685|448247935|FG001|Overall Study|Withdrawal by Subject|11|||
124626071|NCT03300817|448247936|FG000|Overall Study|Withdrawal by Subject|1|||
124626072|NCT03300817|448247936|FG000|Overall Study|Adverse Event|1|||
124626073|NCT03300817|448247936|FG000|Overall Study|Subject Found to be Ineligible|2|||
124626074|NCT00265759|448247937|FG000|Overall Study|Withdrawal by Subject|0|||
124626075|NCT00265759|448247938|FG001|Overall Study|Withdrawal by Subject|1|||
124626076|NCT00265759|448247939|FG002|Overall Study|Withdrawal by Subject|2|||
124626077|NCT00265759|448247940|FG003|Overall Study|Withdrawal by Subject|2|||
124626078|NCT00265759|448247937|FG000|Overall Study|Cancel|0|||
124626079|NCT00265759|448247938|FG001|Overall Study|Cancel|0|||
124626080|NCT00265759|448247939|FG002|Overall Study|Cancel|0|||
124626081|NCT00265759|448247940|FG003|Overall Study|Cancel|3|||
124626082|NCT00265759|448247937|FG000|Overall Study|Ineligible|0|||
124626083|NCT00265759|448247938|FG001|Overall Study|Ineligible|0|||
124626084|NCT00265759|448247939|FG002|Overall Study|Ineligible|0|||
124752062|NCT03517228|448714234|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
124626085|NCT00265759|448247940|FG003|Overall Study|Ineligible|1|||
124626086|NCT00265759|448247937|FG000|Overall Study|Bilateral disease|0|||
124626087|NCT00265759|448247938|FG001|Overall Study|Bilateral disease|0|||
124626088|NCT00265759|448247939|FG002|Overall Study|Bilateral disease|0|||
124626089|NCT00265759|448247940|FG003|Overall Study|Bilateral disease|2|||
124626090|NCT00265759|448247937|FG000|Overall Study|Discontinued due to intolerability|0|||
124626091|NCT00265759|448247938|FG001|Overall Study|Discontinued due to intolerability|0|||
124626092|NCT00265759|448247939|FG002|Overall Study|Discontinued due to intolerability|0|||
124626093|NCT00265759|448247940|FG003|Overall Study|Discontinued due to intolerability|1|||
124626094|NCT03729596|448247943|FG000|Overall Study|Death|3|||
124626095|NCT03729596|448247944|FG001|Overall Study|Death|5|||
124626096|NCT03729596|448247945|FG002|Overall Study|Death|4|||
124626097|NCT03729596|448247946|FG003|Overall Study|Death|1|||
124626098|NCT03729596|448247947|FG004|Overall Study|Death|0|||
124626099|NCT03729596|448247948|FG005|Overall Study|Death|34|||
124626100|NCT03729596|448247949|FG006|Overall Study|Death|18|||
124626101|NCT03729596|448247950|FG007|Overall Study|Death|14|||
124626102|NCT03729596|448247951|FG008|Overall Study|Death|19|||
124626103|NCT03729596|448247952|FG009|Overall Study|Death|9|||
124626104|NCT03729596|448247943|FG000|Overall Study|Lost to Follow-up|0|||
124626105|NCT03729596|448247944|FG001|Overall Study|Lost to Follow-up|0|||
124626106|NCT03729596|448247945|FG002|Overall Study|Lost to Follow-up|0|||
124626107|NCT03729596|448247946|FG003|Overall Study|Lost to Follow-up|0|||
124626108|NCT03729596|448247947|FG004|Overall Study|Lost to Follow-up|0|||
124626109|NCT03729596|448247948|FG005|Overall Study|Lost to Follow-up|0|||
124626110|NCT03729596|448247949|FG006|Overall Study|Lost to Follow-up|1|||
124626111|NCT03729596|448247950|FG007|Overall Study|Lost to Follow-up|0|||
124626112|NCT03729596|448247951|FG008|Overall Study|Lost to Follow-up|0|||
124626113|NCT03729596|448247952|FG009|Overall Study|Lost to Follow-up|1|||
124626114|NCT03729596|448247943|FG000|Overall Study|protocol amendment|0|||
124626115|NCT03729596|448247944|FG001|Overall Study|protocol amendment|1|||
124626116|NCT03729596|448247945|FG002|Overall Study|protocol amendment|3|||
124626117|NCT03729596|448247946|FG003|Overall Study|protocol amendment|6|||
124626118|NCT03729596|448247947|FG004|Overall Study|protocol amendment|5|||
124626119|NCT03729596|448247948|FG005|Overall Study|protocol amendment|0|||
124626120|NCT03729596|448247949|FG006|Overall Study|protocol amendment|0|||
124626121|NCT03729596|448247950|FG007|Overall Study|protocol amendment|0|||
124626122|NCT03729596|448247951|FG008|Overall Study|protocol amendment|0|||
124626123|NCT03729596|448247952|FG009|Overall Study|protocol amendment|0|||
124626124|NCT03729596|448247943|FG000|Overall Study|Withdrawal by Subject|0|||
124626125|NCT03729596|448247944|FG001|Overall Study|Withdrawal by Subject|0|||
124626126|NCT03729596|448247945|FG002|Overall Study|Withdrawal by Subject|0|||
124626127|NCT03729596|448247946|FG003|Overall Study|Withdrawal by Subject|0|||
124626128|NCT03729596|448247947|FG004|Overall Study|Withdrawal by Subject|0|||
124626129|NCT03729596|448247948|FG005|Overall Study|Withdrawal by Subject|4|||
124626130|NCT03729596|448247949|FG006|Overall Study|Withdrawal by Subject|2|||
124626131|NCT03729596|448247950|FG007|Overall Study|Withdrawal by Subject|3|||
124626132|NCT03729596|448247951|FG008|Overall Study|Withdrawal by Subject|2|||
124626133|NCT03729596|448247952|FG009|Overall Study|Withdrawal by Subject|3|||
124626134|NCT03729596|448247943|FG000|Overall Study|study terminated by sponsor|0|||
124626135|NCT03729596|448247944|FG001|Overall Study|study terminated by sponsor|0|||
124626136|NCT03729596|448247945|FG002|Overall Study|study terminated by sponsor|0|||
124626137|NCT03729596|448247946|FG003|Overall Study|study terminated by sponsor|0|||
124626138|NCT03729596|448247947|FG004|Overall Study|study terminated by sponsor|1|||
124626139|NCT03729596|448247948|FG005|Overall Study|study terminated by sponsor|3|||
124626140|NCT03729596|448247949|FG006|Overall Study|study terminated by sponsor|0|||
124626141|NCT03729596|448247950|FG007|Overall Study|study terminated by sponsor|1|||
124626142|NCT03729596|448247951|FG008|Overall Study|study terminated by sponsor|0|||
124626143|NCT03729596|448247952|FG009|Overall Study|study terminated by sponsor|0|||
124626144|NCT04467840|448247953|FG000|Overall Study|Death|35|||
124626145|NCT04467840|448247954|FG001|Overall Study|Death|39|||
124626146|NCT04467840|448247953|FG000|Overall Study|Withdrawal by Subject|8|||
124626147|NCT04467840|448247954|FG001|Overall Study|Withdrawal by Subject|4|||
124626148|NCT04467840|448247953|FG000|Overall Study|Adverse Event|2|||
124626149|NCT04467840|448247954|FG001|Overall Study|Adverse Event|0|||
124626150|NCT04467840|448247953|FG000|Overall Study|Lost to Follow-up|1|||
124626151|NCT04467840|448247954|FG001|Overall Study|Lost to Follow-up|3|||
124626152|NCT04467840|448247953|FG000|Overall Study|Physician Decision|1|||
124626153|NCT04467840|448247954|FG001|Overall Study|Physician Decision|0|||
124626154|NCT04467840|448247953|FG000|Overall Study|Other|1|||
124626155|NCT04467840|448247954|FG001|Overall Study|Other|5|||
124626156|NCT04467840|448247953|FG000|Overall Study|Missing study completion status|3|||
124626157|NCT04467840|448247954|FG001|Overall Study|Missing study completion status|1|||
124784157|NCT05289037|448840080|FG011|Overall Study|Did not receive vaccine|0|||
124784158|NCT05289037|448840081|FG012|Overall Study|Did not receive vaccine|0|||
124784159|NCT05289037|448840082|FG013|Overall Study|Did not receive vaccine|0|||
124626158|NCT05126693|448247957|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
124784160|NCT05289037|448840083|FG014|Overall Study|Did not receive vaccine|1|||
124784161|NCT05289037|448840084|FG015|Overall Study|Did not receive vaccine|0|||
124784162|NCT05289037|448840085|FG016|Overall Study|Did not receive vaccine|0|||
124626159|NCT05126693|448247958|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
124626160|NCT05126693|448247957|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
124626161|NCT05126693|448247958|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
124626162|NCT05126693|448247957|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
124626163|NCT05126693|448247958|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
124626164|NCT04011722|448247963|FG000|30 Days|Death|5|||
124626165|NCT04011722|448247964|FG001|30 Days|Death|1|||
124784163|NCT05289037|448840069|FG000|Overall Study|Unable to make last visit|0|||
124626166|NCT04011722|448247963|FG000|1 Year|Death|13|||
124626167|NCT04011722|448247964|FG001|1 Year|Death|5|||
124626168|NCT04011722|448247963|FG000|1 Year|Withdrawal by Subject|8|||
124626169|NCT04011722|448247964|FG001|1 Year|Withdrawal by Subject|2|||
124626170|NCT04011722|448247963|FG000|1 Year|Missed Visit|6|||
124626171|NCT04011722|448247964|FG001|1 Year|Missed Visit|1|||
124626172|NCT04011722|448247963|FG000|1 Year|Pending Visit|0|||
124626173|NCT04011722|448247964|FG001|1 Year|Pending Visit|11|||
124626174|NCT04011722|448247963|FG000|1 Year|Not Yet Due|0|||
124626175|NCT04011722|448247964|FG001|1 Year|Not Yet Due|9|||
124626176|NCT04011722|448247963|FG000|2 Year|Death|16|||
124626177|NCT04011722|448247964|FG001|2 Year|Death|1|||
124626178|NCT04011722|448247963|FG000|2 Year|Withdrawal by Subject|10|||
124626179|NCT04011722|448247964|FG001|2 Year|Withdrawal by Subject|1|||
124626180|NCT04011722|448247963|FG000|2 Year|Missed Visit|9|||
124626181|NCT04011722|448247964|FG001|2 Year|Missed Visit|0|||
124626182|NCT04011722|448247963|FG000|2 Year|Visit Pending|1|||
124626183|NCT04011722|448247964|FG001|2 Year|Visit Pending|3|||
124626184|NCT04011722|448247963|FG000|2 Year|Not Yet Due|43|||
124626185|NCT04011722|448247964|FG001|2 Year|Not Yet Due|54|||
124626186|NCT04011722|448247963|FG000|3 Year|Death|10|||
124626187|NCT04011722|448247964|FG001|3 Year|Death|0|||
124626188|NCT04011722|448247963|FG000|3 Year|Withdrawal by Subject|2|||
124626189|NCT04011722|448247964|FG001|3 Year|Withdrawal by Subject|0|||
124626190|NCT04011722|448247963|FG000|3 Year|Missed Visit|2|||
124626191|NCT04011722|448247964|FG001|3 Year|Missed Visit|0|||
124626192|NCT04011722|448247963|FG000|3 Year|Pending Visit|34|||
124626193|NCT04011722|448247964|FG001|3 Year|Pending Visit|0|||
124626194|NCT04011722|448247963|FG000|3 Year|Not Yet Due|99|||
124626195|NCT04011722|448247964|FG001|3 Year|Not Yet Due|0|||
124626196|NCT05061134|448247965|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
124626197|NCT05061134|448247966|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
124626198|NCT05061134|448247967|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
124626199|NCT05061134|448247965|FG000|Overall Study|Subject not treated|0|||
124626200|NCT05061134|448247966|FG001|Overall Study|Subject not treated|0|||
124626201|NCT05061134|448247967|FG002|Overall Study|Subject not treated|2|||
124626202|NCT05061134|448247965|FG000|Overall Study|Other|0|||
124626203|NCT05061134|448247966|FG001|Overall Study|Other|0|||
124626204|NCT05061134|448247967|FG002|Overall Study|Other|9|||
124752063|NCT03517228|448714234|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
124752064|NCT03517228|448714234|FG000|Overall Study|Canceled due to device being updated|1|||
124752065|NCT03517228|448714234|FG000|Overall Study|No V Cares in stock|1|||
124752066|NCT03517228|448714234|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
124752067|NCT00475709|448714242|FG000|Overall Study|Did not meet eligibility criteria|8|||
124752068|NCT00475709|448714242|FG000|Overall Study|Death|41|||
124752069|NCT00475709|448714242|FG000|Overall Study|Device Explant|6|||
124752070|NCT00475709|448714242|FG000|Overall Study|Lost to Follow-up|21|||
124752071|NCT01835158|448714245|FG000|Overall Study|Withdrawal by Subject|1|||
124752072|NCT01835158|448714246|FG001|Overall Study|Withdrawal by Subject|6|||
124752073|NCT01415401|448714247|FG000|Overall Study|Adverse Event|5|||
124752074|NCT01415401|448714247|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
124752075|NCT01415401|448714247|FG000|Overall Study|Terminated by Sponsor|1|||
124752076|NCT00532298|448714258|FG000|Overall Study|Adverse Event|1|||
124752077|NCT00532298|448714259|FG001|Overall Study|Adverse Event|0|||
124752078|NCT00532298|448714260|FG002|Overall Study|Adverse Event|0|||
124752079|NCT00532298|448714261|FG003|Overall Study|Adverse Event|0|||
124752080|NCT00532298|448714262|FG004|Overall Study|Adverse Event|1|||
124752081|NCT00532298|448714263|FG005|Overall Study|Adverse Event|1|||
124752082|NCT00532298|448714258|FG000|Overall Study|Lost to Follow-up|1|||
124752083|NCT00532298|448714259|FG001|Overall Study|Lost to Follow-up|1|||
124752084|NCT00532298|448714260|FG002|Overall Study|Lost to Follow-up|1|||
124752085|NCT00532298|448714261|FG003|Overall Study|Lost to Follow-up|0|||
124752086|NCT00532298|448714262|FG004|Overall Study|Lost to Follow-up|0|||
124752087|NCT00532298|448714263|FG005|Overall Study|Lost to Follow-up|1|||
124752088|NCT02023996|448714264|FG000|Overall Study|Protocol Violation|6|||
124752089|NCT00095173|448714268|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
124752090|NCT00095173|448714269|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
124752091|NCT00095173|448714270|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
124752092|NCT00095173|448714271|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
124752093|NCT00095173|448714272|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
124752094|NCT00095173|448714273|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
124752095|NCT00095173|448714268|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
124752096|NCT00095173|448714269|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
124752097|NCT00095173|448714270|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
124752098|NCT00095173|448714271|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
124752099|NCT00095173|448714272|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
124626205|NCT05061134|448247965|FG000|Overall Study|Withdrawal by Subject|9|||
124752100|NCT00095173|448714273|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
124752101|NCT00095173|448714268|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
124626206|NCT05061134|448247966|FG001|Overall Study|Withdrawal by Subject|8|||
124626207|NCT05061134|448247967|FG002|Overall Study|Withdrawal by Subject|5|||
124626208|NCT05061134|448247965|FG000|Overall Study|Study Terminated by Sponsor|22|||
124626209|NCT05061134|448247966|FG001|Overall Study|Study Terminated by Sponsor|14|||
124626210|NCT05061134|448247967|FG002|Overall Study|Study Terminated by Sponsor|7|||
124626211|NCT05061134|448247965|FG000|Overall Study|Progressive Disease|1|||
124626212|NCT05061134|448247966|FG001|Overall Study|Progressive Disease|2|||
124626213|NCT05061134|448247967|FG002|Overall Study|Progressive Disease|0|||
124626214|NCT05061134|448247965|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
124626215|NCT05061134|448247966|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
124626216|NCT05061134|448247967|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
124626217|NCT05061134|448247965|FG000|Overall Study|Lost to Follow-up|1|||
124626218|NCT05061134|448247966|FG001|Overall Study|Lost to Follow-up|0|||
124626219|NCT05061134|448247967|FG002|Overall Study|Lost to Follow-up|0|||
124626220|NCT05061134|448247965|FG000|Overall Study|Physician Decision|1|||
124626221|NCT05061134|448247966|FG001|Overall Study|Physician Decision|1|||
124626222|NCT05061134|448247967|FG002|Overall Study|Physician Decision|0|||
124626223|NCT05061134|448247965|FG000|Overall Study|Disease progression|1|||
124626224|NCT05061134|448247966|FG001|Overall Study|Disease progression|0|||
124626225|NCT05061134|448247967|FG002|Overall Study|Disease progression|0|||
124626226|NCT05061134|448247965|FG000|Overall Study|Death|43|||
124626227|NCT05061134|448247966|FG001|Overall Study|Death|23|||
124626228|NCT05061134|448247967|FG002|Overall Study|Death|14|||
124626229|NCT05061134|448247965|FG000|Overall Study|Database lock|2|||
124626230|NCT05061134|448247966|FG001|Overall Study|Database lock|0|||
124626231|NCT05061134|448247967|FG002|Overall Study|Database lock|0|||
124626232|NCT04848480|448247971|FG000|Main Phase (26 Weeks)|Death|1|||
124626233|NCT04848480|448247972|FG001|Main Phase (26 Weeks)|Death|0|||
124626234|NCT04848480|448247971|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
124626235|NCT04848480|448247972|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
124626236|NCT04848480|448247971|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
124626237|NCT04848480|448247972|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
124626238|NCT04848480|448247971|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
124626239|NCT04848480|448247972|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
124626240|NCT04848480|448247971|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
124626241|NCT04848480|448247972|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
124626242|NCT04848480|448247971|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
124626243|NCT04848480|448247972|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
124626244|NCT01368497|448247973|FG000|Overall Study|Lost to Follow-up|2|||
124626245|NCT02366689|448247975|FG000|Overall Study|Withdrawal by Subject|1|||
124626246|NCT02366689|448247976|FG001|Overall Study|Withdrawal by Subject|0|||
124626247|NCT02366689|448247977|FG002|Overall Study|Withdrawal by Subject|1|||
124626248|NCT02366689|448247975|FG000|Overall Study|Lost to Follow-up|3|||
124626249|NCT02366689|448247976|FG001|Overall Study|Lost to Follow-up|2|||
124626250|NCT02366689|448247977|FG002|Overall Study|Lost to Follow-up|0|||
124626251|NCT02366689|448247975|FG000|Overall Study|Pregnancy|0|||
124626252|NCT02366689|448247976|FG001|Overall Study|Pregnancy|1|||
124626253|NCT02366689|448247977|FG002|Overall Study|Pregnancy|1|||
124626254|NCT03283566|448247978|FG000|Overall Study|Lost to Follow-up|1|||
124626255|NCT03283566|448247979|FG001|Overall Study|Lost to Follow-up|2|||
124626256|NCT03718832|448247980|FG000|Analysis Sample|Withdrawal by Subject|18|||
124626257|NCT03718832|448247981|FG001|Analysis Sample|Withdrawal by Subject|15|||
124626258|NCT03718832|448247980|FG000|Analysis Sample|Legal hold on data|1|||
124626259|NCT03718832|448247981|FG001|Analysis Sample|Legal hold on data|0|||
124626260|NCT03718832|448247980|FG000|Analysis Sample|Participant from treated household|0|||
124626261|NCT03718832|448247981|FG001|Analysis Sample|Participant from treated household|1|||
124626262|NCT03718832|448247980|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
124626263|NCT03718832|448247981|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
124626264|NCT03288714|448247986|FG000|Overall Study|Lost to Follow-up|2|||
124626265|NCT03288714|448247987|FG001|Overall Study|Lost to Follow-up|1|||
124626266|NCT03288714|448247986|FG000|Overall Study|Non-compliance with study schedule|2|||
124626267|NCT03288714|448247987|FG001|Overall Study|Non-compliance with study schedule|0|||
124626268|NCT03288714|448247986|FG000|Overall Study|Withdrawal by Subject|3|||
124626269|NCT03288714|448247987|FG001|Overall Study|Withdrawal by Subject|1|||
124626270|NCT03288714|448247986|FG000|Overall Study|Clinical Worsening|2|||
124626271|NCT03288714|448247987|FG001|Overall Study|Clinical Worsening|1|||
124626272|NCT03288714|448247986|FG000|Overall Study|Adverse Event|1|||
124626273|NCT03288714|448247987|FG001|Overall Study|Adverse Event|0|||
124626274|NCT04882241|448247988|FG000|Overall Study|Ongoing in study|46|||
124626275|NCT04882241|448247989|FG001|Overall Study|Ongoing in study|48|||
124752102|NCT00095173|448714269|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
124752103|NCT00095173|448714270|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
124752104|NCT00095173|448714271|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
124752105|NCT00095173|448714272|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
124752106|NCT00095173|448714273|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
124752107|NCT00095173|448714268|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
124752108|NCT00095173|448714269|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
124626276|NCT04882241|448247990|FG002|Overall Study|Ongoing in study|0|||
124626277|NCT04882241|448247991|FG003|Overall Study|Ongoing in study|0|||
124626278|NCT04882241|448247988|FG000|Overall Study|Death|13|||
124626279|NCT04882241|448247989|FG001|Overall Study|Death|13|||
124752109|NCT00095173|448714270|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
124626280|NCT04882241|448247990|FG002|Overall Study|Death|0|||
124626281|NCT04882241|448247991|FG003|Overall Study|Death|0|||
124626282|NCT02203357|448248001|FG000|Overall Study|Lost to Follow-up|58|||
124752110|NCT00095173|448714271|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
124752111|NCT00095173|448714272|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
124752112|NCT00095173|448714273|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
124752113|NCT00095173|448714268|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
124752114|NCT00095173|448714269|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
124752115|NCT00095173|448714270|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
124752116|NCT00095173|448714271|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
124752117|NCT00095173|448714272|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
124752118|NCT00095173|448714273|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
124752119|NCT00095173|448714268|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
124752120|NCT00095173|448714269|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
124752121|NCT00095173|448714270|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
124752122|NCT00095173|448714271|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
124752123|NCT00095173|448714272|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
124752124|NCT00095173|448714273|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
124752125|NCT00095173|448714268|FG000|Open-Label Extension Phase (Period C)|Death|0|||
124752126|NCT00095173|448714269|FG001|Open-Label Extension Phase (Period C)|Death|0|||
124752127|NCT00095173|448714270|FG002|Open-Label Extension Phase (Period C)|Death|0|||
124752128|NCT00095173|448714271|FG003|Open-Label Extension Phase (Period C)|Death|0|||
124752129|NCT00095173|448714272|FG004|Open-Label Extension Phase (Period C)|Death|0|||
124752130|NCT00095173|448714273|FG005|Open-Label Extension Phase (Period C)|Death|1|||
124752131|NCT00095173|448714268|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
124784164|NCT05289037|448840070|FG001|Overall Study|Unable to make last visit|0|||
124784165|NCT05289037|448840071|FG002|Overall Study|Unable to make last visit|1|||
124784166|NCT05289037|448840072|FG003|Overall Study|Unable to make last visit|0|||
124784167|NCT05289037|448840073|FG004|Overall Study|Unable to make last visit|0|||
124784168|NCT05289037|448840074|FG005|Overall Study|Unable to make last visit|0|||
124784169|NCT05289037|448840075|FG006|Overall Study|Unable to make last visit|0|||
124784170|NCT05289037|448840076|FG007|Overall Study|Unable to make last visit|0|||
124784171|NCT05289037|448840077|FG008|Overall Study|Unable to make last visit|0|||
124784172|NCT05289037|448840078|FG009|Overall Study|Unable to make last visit|0|||
124784173|NCT05289037|448840079|FG010|Overall Study|Unable to make last visit|0|||
124784174|NCT05289037|448840080|FG011|Overall Study|Unable to make last visit|0|||
124784175|NCT05289037|448840081|FG012|Overall Study|Unable to make last visit|0|||
124784176|NCT05289037|448840082|FG013|Overall Study|Unable to make last visit|0|||
124784177|NCT05289037|448840083|FG014|Overall Study|Unable to make last visit|0|||
124784178|NCT05289037|448840084|FG015|Overall Study|Unable to make last visit|0|||
124784179|NCT05289037|448840085|FG016|Overall Study|Unable to make last visit|0|||
124784180|NCT05289037|448840069|FG000|Overall Study|Protocol deviation|0|||
124784181|NCT05289037|448840070|FG001|Overall Study|Protocol deviation|0|||
124784182|NCT05289037|448840071|FG002|Overall Study|Protocol deviation|0|||
124784183|NCT05289037|448840072|FG003|Overall Study|Protocol deviation|0|||
124784184|NCT05289037|448840073|FG004|Overall Study|Protocol deviation|0|||
124784185|NCT05289037|448840074|FG005|Overall Study|Protocol deviation|0|||
124784186|NCT05289037|448840075|FG006|Overall Study|Protocol deviation|0|||
124784187|NCT05289037|448840076|FG007|Overall Study|Protocol deviation|0|||
124784188|NCT05289037|448840077|FG008|Overall Study|Protocol deviation|0|||
124784189|NCT05289037|448840078|FG009|Overall Study|Protocol deviation|0|||
124784190|NCT05289037|448840079|FG010|Overall Study|Protocol deviation|0|||
124784191|NCT05289037|448840080|FG011|Overall Study|Protocol deviation|0|||
124784192|NCT05289037|448840081|FG012|Overall Study|Protocol deviation|0|||
124784193|NCT05289037|448840082|FG013|Overall Study|Protocol deviation|0|||
124784194|NCT05289037|448840083|FG014|Overall Study|Protocol deviation|0|||
124784195|NCT05289037|448840084|FG015|Overall Study|Protocol deviation|1|||
124784196|NCT05289037|448840085|FG016|Overall Study|Protocol deviation|0|||
124784197|NCT05141448|448840086|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
124784198|NCT05141448|448840087|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
124784199|NCT05141448|448840088|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
124784200|NCT05141448|448840089|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
124784201|NCT05141448|448840090|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
124784202|NCT05141448|448840091|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
124784203|NCT05141448|448840086|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
124784204|NCT05141448|448840087|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
124784205|NCT05141448|448840088|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
124626283|NCT02203357|448248002|FG001|Overall Study|Lost to Follow-up|66|||
124784206|NCT05141448|448840089|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
124784207|NCT05141448|448840090|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
124784208|NCT05141448|448840091|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
124784209|NCT05141448|448840086|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
124784210|NCT05141448|448840087|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
124752132|NCT00095173|448714269|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
124752133|NCT00095173|448714270|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
124784211|NCT05141448|448840088|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
124784212|NCT05141448|448840089|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
124784213|NCT05141448|448840090|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
124784214|NCT05141448|448840091|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
124784215|NCT05141448|448840086|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
124784216|NCT05141448|448840087|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
124784217|NCT05141448|448840088|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
124784218|NCT05141448|448840089|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
124784219|NCT05141448|448840090|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
124784220|NCT05141448|448840091|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
124784221|NCT05141448|448840086|FG000|Period 2|COVID-19 Related|0|||
124784222|NCT05141448|448840087|FG001|Period 2|COVID-19 Related|0|||
124784223|NCT05141448|448840088|FG002|Period 2|COVID-19 Related|0|||
124784224|NCT05141448|448840089|FG003|Period 2|COVID-19 Related|1|||
124784225|NCT05141448|448840090|FG004|Period 2|COVID-19 Related|0|||
124784226|NCT05141448|448840091|FG005|Period 2|COVID-19 Related|1|||
124784227|NCT05141448|448840086|FG000|3|Covid-19 related|2|||
124784228|NCT05141448|448840087|FG001|3|Covid-19 related|0|||
124784229|NCT05141448|448840088|FG002|3|Covid-19 related|0|||
124784230|NCT05141448|448840089|FG003|3|Covid-19 related|0|||
124784231|NCT05141448|448840090|FG004|3|Covid-19 related|0|||
124784232|NCT05141448|448840091|FG005|3|Covid-19 related|1|||
124784233|NCT05141448|448840086|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
124784234|NCT05141448|448840087|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
124784235|NCT05141448|448840088|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
124784236|NCT05141448|448840089|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
124784237|NCT05141448|448840090|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
124784238|NCT05141448|448840091|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
124819525|NCT03902574|448965744|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
124819526|NCT05147350|448965747|FG000|Overall Study|Death|2|||
124819527|NCT05147350|448965748|FG001|Overall Study|Death|3|||
124819528|NCT05147350|448965749|FG002|Overall Study|Death|3|||
124819529|NCT05147350|448965750|FG003|Overall Study|Death|2|||
124819530|NCT05147350|448965751|FG004|Overall Study|Death|2|||
124819531|NCT05147350|448965752|FG005|Overall Study|Death|1|||
124819532|NCT05147350|448965753|FG006|Overall Study|Death|1|||
124819533|NCT05147350|448965754|FG007|Overall Study|Death|3|||
124626284|NCT02203357|448248003|FG002|Overall Study|Lost to Follow-up|70|||
124626285|NCT00470535|448248016|FG000|Overall Study|Disease Progression|13|||
124626286|NCT00470535|448248016|FG000|Overall Study|Withdrawal by Subject|1|||
124626287|NCT00470535|448248016|FG000|Overall Study|Adverse Event|1|||
124626288|NCT00470535|448248016|FG000|Overall Study|Death|1|||
124626289|NCT00470535|448248016|FG000|Overall Study|Other|2|||
124626290|NCT02070965|448248021|FG000|Overall Study|Lost to Follow-up|0|||
124626291|NCT02070965|448248022|FG001|Overall Study|Lost to Follow-up|1|||
124626292|NCT02070965|448248023|FG002|Overall Study|Lost to Follow-up|0|||
124626293|NCT02070965|448248021|FG000|Overall Study|Withdrawal by Subject|1|||
124626294|NCT02070965|448248022|FG001|Overall Study|Withdrawal by Subject|1|||
124626295|NCT02070965|448248023|FG002|Overall Study|Withdrawal by Subject|1|||
124626296|NCT02070965|448248021|FG000|Overall Study|Subject moved|1|||
124626297|NCT02070965|448248022|FG001|Overall Study|Subject moved|0|||
124626298|NCT02070965|448248023|FG002|Overall Study|Subject moved|0|||
124626299|NCT02515331|448248024|FG000|Overall Study|Withdrawal by Subject|0|||
124626300|NCT02515331|448248025|FG001|Overall Study|Withdrawal by Subject|0|||
124626301|NCT02515331|448248026|FG002|Overall Study|Withdrawal by Subject|1|||
124626302|NCT02515331|448248024|FG000|Overall Study|Protocol deviation|0|||
124626303|NCT02515331|448248025|FG001|Overall Study|Protocol deviation|0|||
124626304|NCT02515331|448248026|FG002|Overall Study|Protocol deviation|3|||
124626305|NCT02515331|448248024|FG000|Overall Study|Adverse Event|2|||
124626306|NCT02515331|448248025|FG001|Overall Study|Adverse Event|0|||
124626307|NCT02515331|448248026|FG002|Overall Study|Adverse Event|0|||
124626308|NCT00124748|448248027|FG000|Overall Study|Adverse Event|8|||
124819534|NCT05147350|448965747|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
124819535|NCT05147350|448965748|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
124626309|NCT00124748|448248028|FG001|Overall Study|Adverse Event|39|||
124626310|NCT00124748|448248027|FG000|Overall Study|Abnormal laboratory Value|2|||
124626311|NCT00124748|448248028|FG001|Overall Study|Abnormal laboratory Value|2|||
124819536|NCT05147350|448965749|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
124819537|NCT05147350|448965750|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
124819538|NCT05147350|448965751|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
124626312|NCT00124748|448248027|FG000|Overall Study|Abnormal Procedure|0|||
124626313|NCT00124748|448248028|FG001|Overall Study|Abnormal Procedure|1|||
124626314|NCT00124748|448248027|FG000|Overall Study|Lack of Efficacy|20|||
124626315|NCT00124748|448248028|FG001|Overall Study|Lack of Efficacy|41|||
124626316|NCT00124748|448248027|FG000|Overall Study|No longer requires study drug|1|||
124626317|NCT00124748|448248028|FG001|Overall Study|No longer requires study drug|1|||
124784239|NCT01217307|448841413|FG000|Overall Study|Withdrawal by Subject|0|||
124784240|NCT01217307|448841414|FG001|Overall Study|Withdrawal by Subject|1|||
124784241|NCT01868542|448841415|FG000|Overall Study|Protocol Violation|0|||
124784242|NCT01868542|448841416|FG001|Overall Study|Protocol Violation|1|||
124784243|NCT01868542|448841415|FG000|Overall Study|Unclassified|0|||
124784244|NCT01868542|448841416|FG001|Overall Study|Unclassified|1|||
124784245|NCT02248675|448841417|FG000|Overall Study|Lost to Follow-up|3|||
124784246|NCT02248675|448841418|FG001|Overall Study|Lost to Follow-up|1|||
124784247|NCT00813943|448841426|FG000|Overall Study|Ongoing at cut-off date|5|||
124784248|NCT00813943|448841427|FG001|Overall Study|Ongoing at cut-off date|5|||
124784249|NCT00813943|448841428|FG002|Overall Study|Ongoing at cut-off date|3|||
124784250|NCT02551991|448841429|FG000|Overall Study|Death|5|||
124784251|NCT02551991|448841430|FG001|Overall Study|Death|7|||
124784252|NCT02551991|448841431|FG002|Overall Study|Death|8|||
124784253|NCT02551991|448841432|FG003|Overall Study|Death|7|||
124784254|NCT02551991|448841433|FG004|Overall Study|Death|17|||
124784255|NCT02551991|448841429|FG000|Overall Study|Withdrawal by Subject|1|||
124784256|NCT02551991|448841430|FG001|Overall Study|Withdrawal by Subject|0|||
124784257|NCT02551991|448841431|FG002|Overall Study|Withdrawal by Subject|0|||
124784258|NCT02551991|448841432|FG003|Overall Study|Withdrawal by Subject|0|||
124784259|NCT02551991|448841433|FG004|Overall Study|Withdrawal by Subject|2|||
124784260|NCT02551991|448841429|FG000|Overall Study|Lost to Follow-up|0|||
124784261|NCT02551991|448841430|FG001|Overall Study|Lost to Follow-up|0|||
124784262|NCT02551991|448841431|FG002|Overall Study|Lost to Follow-up|1|||
124784263|NCT02551991|448841432|FG003|Overall Study|Lost to Follow-up|0|||
124784264|NCT02551991|448841433|FG004|Overall Study|Lost to Follow-up|0|||
124784265|NCT02551991|448841429|FG000|Overall Study|Sponsor Decision|1|||
124784266|NCT02551991|448841430|FG001|Overall Study|Sponsor Decision|0|||
124784267|NCT02551991|448841431|FG002|Overall Study|Sponsor Decision|1|||
124784268|NCT02551991|448841432|FG003|Overall Study|Sponsor Decision|0|||
124784269|NCT02551991|448841433|FG004|Overall Study|Sponsor Decision|5|||
124784270|NCT02551991|448841429|FG000|Overall Study|Other|0|||
124784271|NCT02551991|448841430|FG001|Overall Study|Other|0|||
124784272|NCT02551991|448841431|FG002|Overall Study|Other|0|||
124784273|NCT02551991|448841432|FG003|Overall Study|Other|0|||
124784274|NCT02551991|448841433|FG004|Overall Study|Other|1|||
124784275|NCT00984620|448841434|FG000|Overall Study|Adverse Event|5|||
124784276|NCT00984620|448841435|FG001|Overall Study|Adverse Event|5|||
124784277|NCT00984620|448841434|FG000|Overall Study|Lost to Follow-up|1|||
124784278|NCT00984620|448841435|FG001|Overall Study|Lost to Follow-up|1|||
124784279|NCT00984620|448841434|FG000|Overall Study|Withdrawal by Subject|0|||
124784280|NCT00984620|448841435|FG001|Overall Study|Withdrawal by Subject|2|||
124784281|NCT00984620|448841434|FG000|Overall Study|reason other than listed above|0|||
124784282|NCT00984620|448841435|FG001|Overall Study|reason other than listed above|4|||
124784283|NCT02424578|448841437|FG000|Overall Study|Withdrawal by Subject|0|||
124784284|NCT02424578|448841438|FG001|Overall Study|Withdrawal by Subject|1|||
124784285|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
124784286|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
124784287|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Adverse Event|7|||
124784288|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Adverse Event|6|||
124784289|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
124784290|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
124784291|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Physician Decision|4|||
124784292|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Physician Decision|4|||
124784293|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
124784294|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
124626318|NCT00124748|448248027|FG000|Overall Study|Protocol Violation|3|||
124626319|NCT00124748|448248028|FG001|Overall Study|Protocol Violation|1|||
124784295|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
124784296|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
124784297|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
124784298|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
124784299|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Non-compliance|1|||
124784300|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Non-compliance|0|||
124784301|NCT00470834|448841441|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
124784302|NCT00470834|448841442|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
124784303|NCT00470834|448841441|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
124784304|NCT00470834|448841442|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
124784305|NCT00470834|448841441|FG000|Extension Period (24 Months)|Adverse Event|3|||
124784306|NCT00470834|448841442|FG001|Extension Period (24 Months)|Adverse Event|4|||
124784307|NCT00470834|448841441|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
124784308|NCT00470834|448841442|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
124784309|NCT00470834|448841441|FG000|Extension Period (24 Months)|Physician Decision|4|||
124784310|NCT00470834|448841442|FG001|Extension Period (24 Months)|Physician Decision|3|||
124784311|NCT00470834|448841441|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
124784312|NCT00470834|448841442|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
124784313|NCT00470834|448841441|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
124784314|NCT00470834|448841442|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
124784315|NCT00470834|448841441|FG000|Extension Period (24 Months)|Non-compliance|0|||
124784316|NCT00470834|448841442|FG001|Extension Period (24 Months)|Non-compliance|1|||
124784317|NCT00470834|448841441|FG000|Extension Period (24 Months)|Disease Progression|0|||
124784318|NCT00470834|448841442|FG001|Extension Period (24 Months)|Disease Progression|1|||
124784319|NCT04975438|448841446|FG000|Overall Study|Lost to Follow-up|1|||
124784320|NCT04975438|448841447|FG001|Overall Study|Lost to Follow-up|0|||
124784321|NCT04975438|448841448|FG002|Overall Study|Lost to Follow-up|1|||
124784322|NCT04975438|448841449|FG003|Overall Study|Lost to Follow-up|0|||
124752134|NCT00095173|448714271|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
124784323|NCT04975438|448841446|FG000|Overall Study|Withdrawal by Subject|1|||
124784324|NCT04975438|448841447|FG001|Overall Study|Withdrawal by Subject|0|||
124784325|NCT04975438|448841448|FG002|Overall Study|Withdrawal by Subject|0|||
124784326|NCT04975438|448841449|FG003|Overall Study|Withdrawal by Subject|0|||
124784327|NCT01276054|448841454|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
124784328|NCT01276054|448841455|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
124784329|NCT02640508|448841456|FG000|Overall Study|Death|19|||
124784330|NCT02640508|448841456|FG000|Overall Study|Withdrawal by Subject|8|||
124784331|NCT02640508|448841456|FG000|Overall Study|Physician Decision|1|||
124784332|NCT02640508|448841456|FG000|Overall Study|Lost to Follow-up|1|||
124784333|NCT05405257|448841460|FG000|Overall Study|Withdrawal by Subject|1|||
124784334|NCT00776919|448841461|FG000|Overall Study|Withdrawal by Subject|16|||
124784335|NCT00776919|448841462|FG001|Overall Study|Withdrawal by Subject|14|||
124784336|NCT00776919|448841463|FG002|Overall Study|Withdrawal by Subject|15|||
124784337|NCT00776919|448841464|FG003|Overall Study|Withdrawal by Subject|26|||
124784338|NCT00776919|448841461|FG000|Overall Study|Lost to Follow-up|8|||
124784339|NCT00776919|448841462|FG001|Overall Study|Lost to Follow-up|12|||
124784340|NCT00776919|448841463|FG002|Overall Study|Lost to Follow-up|11|||
124784341|NCT00776919|448841464|FG003|Overall Study|Lost to Follow-up|8|||
124784342|NCT00776919|448841461|FG000|Overall Study|Adverse Event|1|||
124784343|NCT00776919|448841462|FG001|Overall Study|Adverse Event|0|||
124784344|NCT00776919|448841463|FG002|Overall Study|Adverse Event|2|||
124784345|NCT00776919|448841464|FG003|Overall Study|Adverse Event|2|||
124784346|NCT00776919|448841461|FG000|Overall Study|Protocol Violation|1|||
124784347|NCT00776919|448841462|FG001|Overall Study|Protocol Violation|2|||
124784348|NCT00776919|448841463|FG002|Overall Study|Protocol Violation|0|||
124784349|NCT00776919|448841464|FG003|Overall Study|Protocol Violation|1|||
124784350|NCT00776919|448841461|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
124784351|NCT00776919|448841462|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
124784352|NCT00776919|448841463|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
124784353|NCT00776919|448841464|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
124784354|NCT00275340|448841465|FG000|Overall Study|Lost to Follow-up|2|||
124784355|NCT00275340|448841466|FG001|Overall Study|Lost to Follow-up|4|||
124784356|NCT02379637|448841470|FG000|Overall Study|Protocol Violation|0|||
124784357|NCT02379637|448841471|FG001|Overall Study|Protocol Violation|1|||
124784358|NCT02379637|448841470|FG000|Overall Study|Adverse Event|1|||
124784359|NCT02379637|448841471|FG001|Overall Study|Adverse Event|0|||
124784360|NCT02379637|448841470|FG000|Overall Study|Withdrawal by Subject|1|||
124784361|NCT02379637|448841471|FG001|Overall Study|Withdrawal by Subject|0|||
124784362|NCT00862641|448841472|FG000|Overall Study|Randomized, but drug not received|1|||
124784363|NCT00862641|448841473|FG001|Overall Study|Randomized, but drug not received|4|||
124784364|NCT00862641|448841474|FG002|Overall Study|Randomized, but drug not received|1|||
124784365|NCT00862641|448841475|FG003|Overall Study|Randomized, but drug not received|4|||
124784366|NCT02365480|448841476|FG000|Overall Study|Withdrawal by Subject|2|||
124784367|NCT02365480|448841477|FG001|Overall Study|Withdrawal by Subject|0|||
124752135|NCT00095173|448714272|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
124752136|NCT00095173|448714273|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
124752137|NCT00095173|448714268|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
124752138|NCT00095173|448714269|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
124752139|NCT00095173|448714270|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
124752140|NCT00095173|448714271|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
124752141|NCT00095173|448714272|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
124752142|NCT00095173|448714273|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
124752143|NCT00095173|448714268|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
124752144|NCT00095173|448714269|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
124752145|NCT00095173|448714270|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
124752146|NCT00095173|448714271|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
124752147|NCT00095173|448714272|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
124752148|NCT00095173|448714273|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
124784368|NCT03091348|448841478|FG000|Overall Study|Lost to Follow-up|2|||
124784369|NCT03091348|448841479|FG001|Overall Study|Lost to Follow-up|1|||
124784370|NCT02791763|448841480|FG000|Overall Study|Protocol Violation|0|||
124784371|NCT02791763|448841481|FG001|Overall Study|Protocol Violation|0|||
124784372|NCT02791763|448841482|FG002|Overall Study|Protocol Violation|1|||
124784373|NCT02791763|448841480|FG000|Overall Study|Withdrawal by Subject|5|||
124784374|NCT02791763|448841481|FG001|Overall Study|Withdrawal by Subject|1|||
124784375|NCT02791763|448841482|FG002|Overall Study|Withdrawal by Subject|0|||
124784376|NCT02791763|448841480|FG000|Overall Study|Physician Decision|0|||
124784377|NCT02791763|448841481|FG001|Overall Study|Physician Decision|1|||
124626320|NCT00124748|448248027|FG000|Overall Study|Withdrawal by Subject|5|||
124626321|NCT00124748|448248028|FG001|Overall Study|Withdrawal by Subject|15|||
124626322|NCT00124748|448248027|FG000|Overall Study|Lost to Follow-up|2|||
124626323|NCT00124748|448248028|FG001|Overall Study|Lost to Follow-up|7|||
124626324|NCT00124748|448248027|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
124626325|NCT00124748|448248028|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
124626326|NCT00124748|448248027|FG000|Overall Study|Death|1|||
124626327|NCT00124748|448248028|FG001|Overall Study|Death|3|||
124626328|NCT00322712|448248029|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
124626329|NCT03889886|448248030|FG000|Overall Study|Other|0|||
124626330|NCT03889886|448248031|FG001|Overall Study|Other|1|||
124626331|NCT03889886|448248032|FG002|Overall Study|Other|0|||
124626332|NCT03889886|448248033|FG003|Overall Study|Other|1|||
124626333|NCT03889886|448248030|FG000|Overall Study|Withdrawal by Subject|0|||
124626334|NCT03889886|448248031|FG001|Overall Study|Withdrawal by Subject|0|||
124626335|NCT03889886|448248032|FG002|Overall Study|Withdrawal by Subject|1|||
124626336|NCT03889886|448248033|FG003|Overall Study|Withdrawal by Subject|0|||
124626337|NCT03889886|448248030|FG000|Overall Study|Adverse Event|0|||
124626338|NCT03889886|448248031|FG001|Overall Study|Adverse Event|0|||
124626339|NCT03889886|448248032|FG002|Overall Study|Adverse Event|0|||
124626340|NCT03889886|448248033|FG003|Overall Study|Adverse Event|6|||
124626341|NCT00758524|448248035|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
124626342|NCT00758524|448248036|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
124626343|NCT00758524|448248037|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
124626344|NCT00758524|448248038|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
124626345|NCT00758524|448248039|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
124784378|NCT02791763|448841482|FG002|Overall Study|Physician Decision|0|||
124784379|NCT02791763|448841480|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
124784380|NCT02791763|448841481|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
124784381|NCT02791763|448841482|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
124784382|NCT02791763|448841480|FG000|Overall Study|Cancer event|1|||
124784383|NCT02791763|448841481|FG001|Overall Study|Cancer event|3|||
124784384|NCT02791763|448841482|FG002|Overall Study|Cancer event|0|||
124784385|NCT02791763|448841480|FG000|Overall Study|Participant had renal transplant|3|||
124784386|NCT02791763|448841481|FG001|Overall Study|Participant had renal transplant|0|||
124784387|NCT02791763|448841482|FG002|Overall Study|Participant had renal transplant|0|||
124784388|NCT02791763|448841480|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
124784389|NCT02791763|448841481|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
124784390|NCT02791763|448841482|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
124784391|NCT02791763|448841480|FG000|Overall Study|Adverse Event|12|||
124784392|NCT02791763|448841481|FG001|Overall Study|Adverse Event|13|||
124784393|NCT02791763|448841482|FG002|Overall Study|Adverse Event|7|||
124784394|NCT04534686|448841483|FG000|Baseline Measurement|Lost to Follow-up|4|||
124784395|NCT04534686|448841484|FG001|Baseline Measurement|Lost to Follow-up|6|||
124784396|NCT04534686|448841483|FG000|Baseline Measurement|Withdrawal by Subject|3|||
124784397|NCT04534686|448841484|FG001|Baseline Measurement|Withdrawal by Subject|1|||
124784398|NCT04534686|448841483|FG000|Intervention|Withdrawal by Subject|2|||
124784399|NCT04534686|448841484|FG001|Intervention|Withdrawal by Subject|2|||
124784400|NCT00706342|448841485|FG000|Overall Study|Adverse Event|3|||
124784401|NCT00706342|448841485|FG000|Overall Study|Not responding to treatment|2|||
124784402|NCT00706342|448841485|FG000|Overall Study|Withdrawn due to failure to respond|1|||
124784403|NCT00706342|448841485|FG000|Overall Study|Death|1|||
124784404|NCT00706342|448841485|FG000|Overall Study|Withdrew from the study on his own.|1|||
124784405|NCT00706342|448841485|FG000|Overall Study|Investigator discretion|2|||
124784406|NCT00706342|448841485|FG000|Overall Study|Non-responder Week 12|1|||
124784407|NCT00706342|448841485|FG000|Overall Study|Ongoing|6|||
124784408|NCT00706342|448841485|FG000|Overall Study|WIthdrawal of consent|1|||
124784409|NCT01419197|448841490|FG000|Overall Study|Death|247|||
124784410|NCT01419197|448841491|FG001|Overall Study|Death|122|||
124784411|NCT01419197|448841490|FG000|Overall Study|Physician Decision|4|||
124784412|NCT01419197|448841491|FG001|Overall Study|Physician Decision|4|||
124784413|NCT01419197|448841490|FG000|Overall Study|Non-compliance|3|||
124784414|NCT01419197|448841491|FG001|Overall Study|Non-compliance|1|||
124784415|NCT01419197|448841490|FG000|Overall Study|Withdrawal by Subject|33|||
124784416|NCT01419197|448841491|FG001|Overall Study|Withdrawal by Subject|32|||
124784417|NCT01419197|448841490|FG000|Overall Study|Study Completed by Sponsor|103|||
124784418|NCT01419197|448841491|FG001|Overall Study|Study Completed by Sponsor|34|||
124784419|NCT01419197|448841490|FG000|Overall Study|Reason Not Specified|0|||
124784420|NCT01419197|448841491|FG001|Overall Study|Reason Not Specified|1|||
124784421|NCT01419197|448841490|FG000|Overall Study|Lost to Follow-up|14|||
124784422|NCT01419197|448841491|FG001|Overall Study|Lost to Follow-up|4|||
124784423|NCT02410343|448841492|FG000|Core Period (24 Weeks)|Adverse Event|1|||
124784424|NCT02410343|448841493|FG001|Core Period (24 Weeks)|Adverse Event|0|||
124784425|NCT02410343|448841492|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
124784426|NCT02410343|448841493|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
124784427|NCT02410343|448841492|FG000|Extension Period (12 Months)|Adverse Event|1|||
124784428|NCT02410343|448841493|FG001|Extension Period (12 Months)|Adverse Event|0|||
124784429|NCT02410343|448841492|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
124784430|NCT02410343|448841493|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
124784431|NCT02878798|448841498|FG000|Overall Study|Withdrawal by Subject|5|||
124784432|NCT02878798|448841499|FG001|Overall Study|Withdrawal by Subject|4|||
124784433|NCT02878798|448841498|FG000|Overall Study|Lost to Follow-up|2|||
124784434|NCT02878798|448841499|FG001|Overall Study|Lost to Follow-up|2|||
124784435|NCT02878798|448841498|FG000|Overall Study|Protocol Violation|0|||
124784436|NCT02878798|448841499|FG001|Overall Study|Protocol Violation|1|||
124784437|NCT00246740|448841500|FG000|Initial Enrollment|Death|1|||
124784438|NCT00246740|448841501|FG001|Initial Enrollment|Death|0|||
124784439|NCT00246740|448841500|FG000|Initial Enrollment|Additional surgery scheduled|0|||
124784440|NCT00246740|448841501|FG001|Initial Enrollment|Additional surgery scheduled|2|||
124784441|NCT00246740|448841500|FG000|Initial Enrollment|Surgery schedule change|4|||
124784442|NCT00246740|448841501|FG001|Initial Enrollment|Surgery schedule change|4|||
124784443|NCT00246740|448841500|FG000|Initial Enrollment|Other|1|||
124784444|NCT00246740|448841501|FG001|Initial Enrollment|Other|2|||
124784445|NCT01510769|448841502|FG000|Overall Study|Adverse Event|7|||
124784446|NCT01510769|448841503|FG001|Overall Study|Adverse Event|6|||
124784447|NCT01510769|448841504|FG002|Overall Study|Adverse Event|4|||
124784448|NCT01510769|448841502|FG000|Overall Study|Gout Flare|0|||
124784449|NCT01510769|448841503|FG001|Overall Study|Gout Flare|3|||
124784450|NCT01510769|448841504|FG002|Overall Study|Gout Flare|1|||
124784451|NCT01510769|448841502|FG000|Overall Study|Protocol Violation|11|||
124784452|NCT01510769|448841503|FG001|Overall Study|Protocol Violation|10|||
124784453|NCT01510769|448841504|FG002|Overall Study|Protocol Violation|9|||
124784454|NCT01510769|448841502|FG000|Overall Study|Lost to Follow-up|5|||
124784455|NCT01510769|448841503|FG001|Overall Study|Lost to Follow-up|1|||
124784456|NCT01510769|448841504|FG002|Overall Study|Lost to Follow-up|5|||
124784457|NCT01510769|448841502|FG000|Overall Study|Withdrawal by Subject|3|||
124784458|NCT01510769|448841503|FG001|Overall Study|Withdrawal by Subject|4|||
124784459|NCT01510769|448841504|FG002|Overall Study|Withdrawal by Subject|3|||
124784460|NCT01510769|448841502|FG000|Overall Study|Death|1|||
124784461|NCT01510769|448841503|FG001|Overall Study|Death|1|||
124784462|NCT01510769|448841504|FG002|Overall Study|Death|0|||
124784463|NCT00335764|448841505|FG000|Overall Study|wrong histology|1|||
124784464|NCT00335764|448841506|FG001|Overall Study|wrong histology|0|||
124784465|NCT00335764|448841507|FG002|Overall Study|wrong histology|0|||
124784466|NCT00335764|448841508|FG003|Overall Study|wrong histology|0|||
124784467|NCT00335764|448841509|FG004|Overall Study|wrong histology|1|||
124784468|NCT02466659|448841512|FG000|Overall Study|Lost to Follow-up|5|||
124784469|NCT02466659|448841513|FG001|Overall Study|Lost to Follow-up|2|||
124784470|NCT00929643|448841514|FG000|Overall Study|Protocol Violation|2|||
124784471|NCT00934440|448841517|FG000|Overall Study|Lost to Follow-up|1|||
124784472|NCT00744042|448841518|FG000|Overall Study|Withdrawal by Subject|1|||
124784473|NCT00750152|448841519|FG000|Overall Study|Adverse Event|2|||
124784474|NCT00750152|448841520|FG001|Overall Study|Adverse Event|1|||
124784475|NCT00750152|448841519|FG000|Overall Study|Lost to Follow-up|8|||
124784476|NCT00750152|448841520|FG001|Overall Study|Lost to Follow-up|13|||
124784477|NCT00750152|448841519|FG000|Overall Study|Withdrawal by Subject|3|||
124784478|NCT00750152|448841520|FG001|Overall Study|Withdrawal by Subject|3|||
124784479|NCT00750152|448841519|FG000|Overall Study|Physician Decision|1|||
124784480|NCT00750152|448841520|FG001|Overall Study|Physician Decision|1|||
124784481|NCT00750152|448841519|FG000|Overall Study|Non-compliance|0|||
124784482|NCT00750152|448841520|FG001|Overall Study|Non-compliance|1|||
124784483|NCT00750152|448841519|FG000|Overall Study|Termination by sponsor|1|||
124784484|NCT00750152|448841520|FG001|Overall Study|Termination by sponsor|0|||
124784485|NCT00750152|448841519|FG000|Overall Study|Other|7|||
124784486|NCT00750152|448841520|FG001|Overall Study|Other|8|||
124784487|NCT04629066|448841523|FG000|Overall Study|Lost to Follow-up|3|||
124784488|NCT04629066|448841524|FG001|Overall Study|Lost to Follow-up|2|||
124784489|NCT01028300|448841525|FG000|Overall Study|Study Terminated|4|||
124784490|NCT01214395|448841528|FG000|Overall Study|All patients had infection|5|||
124784491|NCT00715910|448841532|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
124784492|NCT00715910|448841533|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
124784493|NCT00715910|448841534|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
124784494|NCT00715910|448841535|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
124784495|NCT00715910|448841536|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
124784496|NCT00715910|448841537|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
124784497|NCT00715910|448841532|FG000|Booster and ESFU Phase|Other|0|||
124784498|NCT00715910|448841533|FG001|Booster and ESFU Phase|Other|0|||
124784499|NCT00715910|448841534|FG002|Booster and ESFU Phase|Other|0|||
124784500|NCT00715910|448841535|FG003|Booster and ESFU Phase|Other|5|||
124784501|NCT00715910|448841536|FG004|Booster and ESFU Phase|Other|1|||
124784502|NCT00715910|448841537|FG005|Booster and ESFU Phase|Other|0|||
124784503|NCT02034409|448841538|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
124784504|NCT02034409|448841539|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
124784505|NCT02034409|448841538|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
124784506|NCT02034409|448841539|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
124784507|NCT02034409|448841538|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
124784508|NCT02034409|448841539|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
124784509|NCT02034409|448841538|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
124784510|NCT02034409|448841539|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
124784511|NCT02034409|448841538|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
124784512|NCT02034409|448841539|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
124784513|NCT02034409|448841538|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
124784514|NCT02034409|448841539|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
124784515|NCT05092360|448841540|FG000|Overall Study|Withdrawal by Subject|21|||
124784516|NCT05092360|448841541|FG001|Overall Study|Withdrawal by Subject|4|||
124784517|NCT05092360|448841542|FG002|Overall Study|Withdrawal by Subject|9|||
124784518|NCT05092360|448841543|FG003|Overall Study|Withdrawal by Subject|26|||
124784519|NCT05092360|448841540|FG000|Overall Study|Death|97|||
124784520|NCT05092360|448841541|FG001|Overall Study|Death|14|||
124784521|NCT05092360|448841542|FG002|Overall Study|Death|31|||
124784522|NCT05092360|448841543|FG003|Overall Study|Death|101|||
124784523|NCT05092360|448841540|FG000|Overall Study|Lost to Follow-up|1|||
124784524|NCT05092360|448841541|FG001|Overall Study|Lost to Follow-up|2|||
124784525|NCT05092360|448841542|FG002|Overall Study|Lost to Follow-up|2|||
124784526|NCT05092360|448841543|FG003|Overall Study|Lost to Follow-up|2|||
124784527|NCT05092360|448841540|FG000|Overall Study|Study terminated by sponsor|65|||
124784528|NCT05092360|448841541|FG001|Overall Study|Study terminated by sponsor|7|||
124784529|NCT05092360|448841542|FG002|Overall Study|Study terminated by sponsor|13|||
124784530|NCT05092360|448841543|FG003|Overall Study|Study terminated by sponsor|61|||
124784531|NCT03952039|448841546|FG000|Overall Study|Adverse Event|22|||
124784532|NCT03952039|448841547|FG001|Overall Study|Adverse Event|8|||
124784533|NCT03952039|448841546|FG000|Overall Study|Withdrawal by Participant|17|||
124784534|NCT03952039|448841547|FG001|Overall Study|Withdrawal by Participant|12|||
124784535|NCT03952039|448841546|FG000|Overall Study|Death|13|||
124784536|NCT03952039|448841547|FG001|Overall Study|Death|6|||
124784537|NCT03952039|448841546|FG000|Overall Study|Lack of Efficacy|12|||
124784538|NCT03952039|448841547|FG001|Overall Study|Lack of Efficacy|2|||
124784539|NCT03952039|448841546|FG000|Overall Study|Physician Decision|9|||
124784540|NCT03952039|448841547|FG001|Overall Study|Physician Decision|3|||
124784541|NCT03952039|448841546|FG000|Overall Study|Progressive Disease|6|||
124784542|NCT03952039|448841547|FG001|Overall Study|Progressive Disease|4|||
124784543|NCT03952039|448841546|FG000|Overall Study|Other Reasons|12|||
124784544|NCT03952039|448841547|FG001|Overall Study|Other Reasons|4|||
124784545|NCT04614324|448841553|FG000|Overall Study|Lost to Follow-up|3|||
124784546|NCT04614324|448841553|FG000|Overall Study|Physician Decision|1|||
124784547|NCT04614324|448841553|FG000|Overall Study|Withdrawal by Subject|2|||
124784548|NCT04614324|448841553|FG000|Overall Study|Remaining in Follow up|123|||
124784549|NCT04627285|448841554|FG000|Overall Study|Adverse Event|0|||
124784550|NCT04627285|448841555|FG001|Overall Study|Adverse Event|2|||
124784551|NCT04627285|448841554|FG000|Overall Study|Lost to Follow-up|1|||
124784552|NCT04627285|448841555|FG001|Overall Study|Lost to Follow-up|0|||
124784553|NCT04627285|448841554|FG000|Overall Study|Withdrawal by Subject|1|||
124784554|NCT04627285|448841555|FG001|Overall Study|Withdrawal by Subject|1|||
124784555|NCT04627285|448841554|FG000|Overall Study|Sponsor decision|5|||
124626346|NCT00758524|448248040|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
124626347|NCT00758524|448248041|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
124784556|NCT04627285|448841555|FG001|Overall Study|Sponsor decision|0|||
124784557|NCT04627285|448841554|FG000|Overall Study|Participant left country; aunt informed the site|0|||
124784558|NCT04627285|448841555|FG001|Overall Study|Participant left country; aunt informed the site|1|||
124784559|NCT04473235|448843613|FG000|Overall Study|Lost to Follow-up|6|||
124784560|NCT04473235|448843614|FG001|Overall Study|Lost to Follow-up|5|||
124784561|NCT04473235|448843613|FG000|Overall Study|Declined continuation|2|||
124784562|NCT04473235|448843614|FG001|Overall Study|Declined continuation|0|||
124784563|NCT04473235|448843613|FG000|Overall Study|Physician Decision|1|||
124784564|NCT04473235|448843614|FG001|Overall Study|Physician Decision|1|||
124784565|NCT04473235|448843613|FG000|Overall Study|Protocol Violation|10|||
124784566|NCT04473235|448843614|FG001|Overall Study|Protocol Violation|6|||
124784567|NCT01754402|448843615|FG000|Overall Study|Death|0|||
124784568|NCT01754402|448843616|FG001|Overall Study|Death|0|||
124784569|NCT01754402|448843617|FG002|Overall Study|Death|1|||
124784570|NCT01754402|448843615|FG000|Overall Study|Adverse Event|2|||
124784571|NCT01754402|448843616|FG001|Overall Study|Adverse Event|2|||
124626348|NCT00758524|448248042|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
124626349|NCT00758524|448248043|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
124626350|NCT00758524|448248044|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
124626351|NCT00758524|448248045|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
124626352|NCT00758524|448248046|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
124626353|NCT00758524|448248047|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
124626354|NCT00758524|448248048|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
124626355|NCT00758524|448248049|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
124626356|NCT00758524|448248050|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
124626357|NCT00758524|448248051|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
124626358|NCT00758524|448248035|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
124626359|NCT00758524|448248036|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
124626360|NCT00758524|448248037|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
124626361|NCT00758524|448248038|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
124626362|NCT00758524|448248039|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
124626363|NCT00758524|448248040|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
124626364|NCT00758524|448248041|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
124626365|NCT00758524|448248042|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
124626366|NCT00758524|448248043|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
124626367|NCT00758524|448248044|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
124626368|NCT00758524|448248045|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
124626369|NCT00758524|448248046|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
124626370|NCT00758524|448248047|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
124626371|NCT00758524|448248048|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
124626372|NCT00758524|448248049|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
124626373|NCT00758524|448248050|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
124626374|NCT00758524|448248051|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
124626375|NCT00758524|448248035|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
124626376|NCT00758524|448248036|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
124626377|NCT00758524|448248037|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
124626378|NCT00758524|448248038|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
124626379|NCT00758524|448248039|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
124626380|NCT00758524|448248040|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
124626381|NCT00758524|448248041|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
124626382|NCT00758524|448248042|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
124626383|NCT00758524|448248043|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
124626384|NCT00758524|448248044|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
124626385|NCT00758524|448248045|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
124626386|NCT00758524|448248046|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
124626387|NCT00758524|448248047|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
124626388|NCT00758524|448248048|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
124626389|NCT00758524|448248049|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
124626390|NCT00758524|448248050|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
124626391|NCT00758524|448248051|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
124626392|NCT00758524|448248035|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
124626393|NCT00758524|448248036|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
124626394|NCT00758524|448248037|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
124626395|NCT00758524|448248038|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
124626396|NCT00758524|448248039|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
124626397|NCT00758524|448248040|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
124626398|NCT00758524|448248041|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
124626399|NCT00758524|448248042|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
124626400|NCT00758524|448248043|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
124626401|NCT00758524|448248044|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
124626402|NCT00758524|448248045|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
124626403|NCT00758524|448248046|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
124626404|NCT00758524|448248047|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
124626405|NCT00758524|448248048|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
124626406|NCT00758524|448248049|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
124626407|NCT00758524|448248050|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
124626408|NCT00758524|448248051|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
124626409|NCT00758524|448248035|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
124626410|NCT00758524|448248036|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
124626411|NCT00758524|448248037|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
124626412|NCT00758524|448248038|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
124626413|NCT00758524|448248039|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
124626414|NCT00758524|448248040|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
124626415|NCT00758524|448248041|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
124784572|NCT01754402|448843617|FG002|Overall Study|Adverse Event|1|||
124784573|NCT01754402|448843615|FG000|Overall Study|Withdrawal by Subject|0|||
124784574|NCT01754402|448843616|FG001|Overall Study|Withdrawal by Subject|0|||
124784575|NCT01754402|448843617|FG002|Overall Study|Withdrawal by Subject|1|||
124784576|NCT01754402|448843615|FG000|Overall Study|Lack of Efficacy|0|||
124784577|NCT01754402|448843616|FG001|Overall Study|Lack of Efficacy|0|||
124784578|NCT01754402|448843617|FG002|Overall Study|Lack of Efficacy|1|||
124784579|NCT01282463|448843618|FG000|Overall Study|Lost to Follow-up|1|||
124784580|NCT01282463|448843619|FG001|Overall Study|Lost to Follow-up|0|||
124784581|NCT01282463|448843620|FG002|Overall Study|Lost to Follow-up|0|||
124784582|NCT01282463|448843618|FG000|Overall Study|Withdrawal by Subject|6|||
124784583|NCT01282463|448843619|FG001|Overall Study|Withdrawal by Subject|2|||
124784584|NCT01282463|448843620|FG002|Overall Study|Withdrawal by Subject|3|||
124784585|NCT01282463|448843618|FG000|Overall Study|"Never Treated Death"|0|||
124784586|NCT01282463|448843619|FG001|Overall Study|"Never Treated Death"|1|||
124784587|NCT01282463|448843620|FG002|Overall Study|"Never Treated Death"|0|||
124784588|NCT01282463|448843618|FG000|Overall Study|"Never Treated PD"|0|||
124784589|NCT01282463|448843619|FG001|Overall Study|"Never Treated PD"|1|||
124784590|NCT01282463|448843620|FG002|Overall Study|"Never Treated PD"|0|||
124784591|NCT01282463|448843618|FG000|Overall Study|Protocol Violation|0|||
124784592|NCT01282463|448843619|FG001|Overall Study|Protocol Violation|0|||
124784593|NCT01282463|448843620|FG002|Overall Study|Protocol Violation|1|||
124784594|NCT01282463|448843618|FG000|Overall Study|Physician Decision|1|||
124784595|NCT01282463|448843619|FG001|Overall Study|Physician Decision|0|||
124784596|NCT01282463|448843620|FG002|Overall Study|Physician Decision|0|||
124784597|NCT01221285|448843623|FG000|Overall Study|Withdrawal by Subject|1|||
124784598|NCT01239992|448843625|FG000|Overall Study|Withdrawal by Subject|2|||
124784599|NCT00220779|448843631|FG000|Overall Study|Adverse Event|1|||
124784600|NCT00220779|448843632|FG001|Overall Study|Adverse Event|0|||
124784601|NCT00220779|448843633|FG002|Overall Study|Adverse Event|0|||
124784602|NCT00220779|448843631|FG000|Overall Study|Withdrawal by Subject|1|||
124784603|NCT00220779|448843632|FG001|Overall Study|Withdrawal by Subject|4|||
124784604|NCT00220779|448843633|FG002|Overall Study|Withdrawal by Subject|1|||
124784605|NCT00220779|448843631|FG000|Overall Study|Non-compliance|1|||
124784606|NCT00220779|448843632|FG001|Overall Study|Non-compliance|0|||
124784607|NCT00220779|448843633|FG002|Overall Study|Non-compliance|0|||
124784608|NCT00220779|448843631|FG000|Overall Study|Too time consuming|1|||
124784609|NCT00220779|448843632|FG001|Overall Study|Too time consuming|0|||
124784610|NCT00220779|448843633|FG002|Overall Study|Too time consuming|0|||
124784611|NCT00220779|448843631|FG000|Overall Study|Pregnancy|0|||
124784612|NCT00220779|448843632|FG001|Overall Study|Pregnancy|0|||
124784613|NCT00220779|448843633|FG002|Overall Study|Pregnancy|2|||
124784614|NCT00220779|448843631|FG000|Overall Study|Lack of Efficacy|3|||
124784615|NCT00220779|448843632|FG001|Overall Study|Lack of Efficacy|0|||
124784616|NCT00220779|448843633|FG002|Overall Study|Lack of Efficacy|1|||
124784617|NCT03390101|448843634|FG000|Weeks 0-12|Withdrawal by Subject|0|||
124784618|NCT03390101|448843635|FG001|Weeks 0-12|Withdrawal by Subject|1|||
124784619|NCT03390101|448843636|FG002|Weeks 0-12|Withdrawal by Subject|1|||
124784620|NCT03390101|448843634|FG000|Weeks 0-12|Lost to Follow-up|0|||
124784621|NCT03390101|448843635|FG001|Weeks 0-12|Lost to Follow-up|1|||
124784622|NCT03390101|448843636|FG002|Weeks 0-12|Lost to Follow-up|0|||
124784623|NCT03390101|448843634|FG000|Weeks 12-54|Withdrawal by Subject|0|||
124784624|NCT03390101|448843635|FG001|Weeks 12-54|Withdrawal by Subject|3|||
124784625|NCT03390101|448843636|FG002|Weeks 12-54|Withdrawal by Subject|1|||
124784626|NCT03390101|448843634|FG000|Weeks 12-54|Pregnancy|1|||
124784627|NCT03390101|448843635|FG001|Weeks 12-54|Pregnancy|0|||
124784628|NCT03390101|448843636|FG002|Weeks 12-54|Pregnancy|0|||
124784629|NCT03390101|448843634|FG000|Weeks 12-54|Adverse Event|2|||
124784630|NCT03390101|448843635|FG001|Weeks 12-54|Adverse Event|1|||
124784631|NCT03390101|448843636|FG002|Weeks 12-54|Adverse Event|1|||
124784632|NCT00281658|448843637|FG000|Randomized Phase|Adverse Event|0|||
124784633|NCT00281658|448843638|FG001|Randomized Phase|Adverse Event|2|||
124784634|NCT00281658|448843639|FG002|Randomized Phase|Adverse Event|0|||
124784635|NCT00281658|448843640|FG003|Randomized Phase|Adverse Event|0|||
124784636|NCT00281658|448843637|FG000|Randomized Phase|Lost to Follow-up|34|||
124784637|NCT00281658|448843638|FG001|Randomized Phase|Lost to Follow-up|27|||
124784638|NCT00281658|448843639|FG002|Randomized Phase|Lost to Follow-up|0|||
124784639|NCT00281658|448843640|FG003|Randomized Phase|Lost to Follow-up|0|||
124784640|NCT00281658|448843637|FG000|Randomized Phase|Withdrawal by Subject|8|||
124784641|NCT00281658|448843638|FG001|Randomized Phase|Withdrawal by Subject|7|||
124784642|NCT00281658|448843639|FG002|Randomized Phase|Withdrawal by Subject|0|||
124784643|NCT00281658|448843640|FG003|Randomized Phase|Withdrawal by Subject|0|||
124784644|NCT00281658|448843637|FG000|Randomized Phase|Study closed/terminated|1|||
124784645|NCT00281658|448843638|FG001|Randomized Phase|Study closed/terminated|1|||
124784646|NCT00281658|448843639|FG002|Randomized Phase|Study closed/terminated|0|||
124784647|NCT00281658|448843640|FG003|Randomized Phase|Study closed/terminated|0|||
124784648|NCT00281658|448843637|FG000|Randomized Phase|Disease progression|36|||
124784649|NCT00281658|448843638|FG001|Randomized Phase|Disease progression|27|||
124784650|NCT00281658|448843639|FG002|Randomized Phase|Disease progression|0|||
124784651|NCT00281658|448843640|FG003|Randomized Phase|Disease progression|0|||
124784652|NCT00281658|448843637|FG000|Randomized Phase|Physician Decision|1|||
124784653|NCT00281658|448843638|FG001|Randomized Phase|Physician Decision|1|||
124784654|NCT00281658|448843639|FG002|Randomized Phase|Physician Decision|0|||
124784655|NCT00281658|448843640|FG003|Randomized Phase|Physician Decision|0|||
124784656|NCT00281658|448843637|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
124784657|NCT00281658|448843638|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
124784658|NCT00281658|448843639|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
124784659|NCT00281658|448843640|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
124784660|NCT00281658|448843637|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
124784661|NCT00281658|448843638|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
124784662|NCT00281658|448843639|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
124784663|NCT00281658|448843640|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
124784664|NCT00281658|448843637|FG000|Randomized Phase|Treatment ongoing|1|||
124784665|NCT00281658|448843638|FG001|Randomized Phase|Treatment ongoing|0|||
124784666|NCT00281658|448843639|FG002|Randomized Phase|Treatment ongoing|0|||
124784667|NCT00281658|448843640|FG003|Randomized Phase|Treatment ongoing|0|||
124784668|NCT00281658|448843637|FG000|Open Label Phase|Adverse Event|0|||
124784669|NCT00281658|448843638|FG001|Open Label Phase|Adverse Event|0|||
124784670|NCT00281658|448843639|FG002|Open Label Phase|Adverse Event|1|||
124784671|NCT00281658|448843640|FG003|Open Label Phase|Adverse Event|0|||
124784672|NCT00281658|448843637|FG000|Open Label Phase|Lost to Follow-up|0|||
124784673|NCT00281658|448843638|FG001|Open Label Phase|Lost to Follow-up|0|||
124784674|NCT00281658|448843639|FG002|Open Label Phase|Lost to Follow-up|16|||
124784675|NCT00281658|448843640|FG003|Open Label Phase|Lost to Follow-up|2|||
124784676|NCT00281658|448843637|FG000|Open Label Phase|Withdrawal by Subject|0|||
124784677|NCT00281658|448843638|FG001|Open Label Phase|Withdrawal by Subject|0|||
124784678|NCT00281658|448843639|FG002|Open Label Phase|Withdrawal by Subject|3|||
124784679|NCT00281658|448843640|FG003|Open Label Phase|Withdrawal by Subject|2|||
124784680|NCT00281658|448843637|FG000|Open Label Phase|Disease progression|0|||
124784681|NCT00281658|448843638|FG001|Open Label Phase|Disease progression|0|||
124784682|NCT00281658|448843639|FG002|Open Label Phase|Disease progression|18|||
124784683|NCT00281658|448843640|FG003|Open Label Phase|Disease progression|0|||
124784684|NCT00281658|448843637|FG000|Open Label Phase|Physician Decision|0|||
124784685|NCT00281658|448843638|FG001|Open Label Phase|Physician Decision|0|||
124784686|NCT00281658|448843639|FG002|Open Label Phase|Physician Decision|1|||
124784687|NCT00281658|448843640|FG003|Open Label Phase|Physician Decision|0|||
124784688|NCT00281658|448843637|FG000|Open Label Phase|Relocation of patient|0|||
124784689|NCT00281658|448843638|FG001|Open Label Phase|Relocation of patient|0|||
124784690|NCT00281658|448843639|FG002|Open Label Phase|Relocation of patient|1|||
124784691|NCT00281658|448843640|FG003|Open Label Phase|Relocation of patient|0|||
124784692|NCT00281658|448843637|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
124784693|NCT00281658|448843638|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
124784694|NCT00281658|448843639|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
124784695|NCT00281658|448843640|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
124784696|NCT01343693|448843641|FG000|Overall Study|Lost to Follow-up|9|||
124784697|NCT02704143|448843642|FG000|Overall Study|disease progression|10|||
124784698|NCT01235598|448843643|FG000|Overall Study|Adverse Event|0|||
124784699|NCT01235598|448843644|FG001|Overall Study|Adverse Event|3|||
124784700|NCT01235598|448843643|FG000|Overall Study|Lack of Efficacy|0|||
124784701|NCT01235598|448843644|FG001|Overall Study|Lack of Efficacy|1|||
124784702|NCT01235598|448843643|FG000|Overall Study|Withdrawal by Subject|1|||
124784703|NCT01235598|448843644|FG001|Overall Study|Withdrawal by Subject|0|||
124784704|NCT02151773|448843645|FG000|Overall Study|Protocol Deviation|64|||
124784705|NCT00395343|448843646|FG000|Overall Study|Adverse Event|13|||
124784706|NCT00395343|448843647|FG001|Overall Study|Adverse Event|5|||
124784707|NCT00395343|448843646|FG000|Overall Study|Lack of Efficacy|0|||
124784708|NCT00395343|448843647|FG001|Overall Study|Lack of Efficacy|1|||
124784709|NCT00395343|448843646|FG000|Overall Study|Lost to Follow-up|4|||
124626416|NCT00758524|448248042|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
124626417|NCT00758524|448248043|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
124626418|NCT00758524|448248044|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
124626419|NCT00758524|448248045|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
124626420|NCT00758524|448248046|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
124626421|NCT00758524|448248047|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
124626422|NCT00758524|448248048|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
124626423|NCT00758524|448248049|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
124626424|NCT00758524|448248050|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
124784710|NCT00395343|448843647|FG001|Overall Study|Lost to Follow-up|4|||
124784711|NCT00395343|448843646|FG000|Overall Study|Physician Decision|2|||
124784712|NCT00395343|448843647|FG001|Overall Study|Physician Decision|4|||
124784713|NCT00395343|448843646|FG000|Overall Study|Protocol Violation|6|||
124784714|NCT00395343|448843647|FG001|Overall Study|Protocol Violation|8|||
124784715|NCT00395343|448843646|FG000|Overall Study|Withdrawal by Subject|11|||
124784716|NCT00395343|448843647|FG001|Overall Study|Withdrawal by Subject|12|||
124626425|NCT00758524|448248051|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
124626426|NCT00758524|448248035|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
124626427|NCT00758524|448248036|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
124626428|NCT00758524|448248037|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
124626429|NCT00758524|448248038|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
124626430|NCT00758524|448248039|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
124626431|NCT00758524|448248040|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
124626432|NCT00758524|448248041|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
124626433|NCT00758524|448248042|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
124626434|NCT00758524|448248043|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
124784717|NCT00395343|448843646|FG000|Overall Study|Other|5|||
124784718|NCT00395343|448843647|FG001|Overall Study|Other|2|||
124784719|NCT01463007|448843649|FG000|Overall Study|Physician Decision|1|||
124784720|NCT00387790|448843650|FG000|Overall Study|Adverse Event|5|||
124784721|NCT00387790|448843650|FG000|Overall Study|Lack of Efficacy|2|||
124784722|NCT00387790|448843650|FG000|Overall Study|Physician Decision|2|||
124784723|NCT00387790|448843650|FG000|Overall Study|Withdrawal by Subject|3|||
124784724|NCT00387790|448843650|FG000|Overall Study|Ineligible for study|2|||
124784725|NCT00444678|448843651|FG000|Overall Study|Toxicity|11|||
124784726|NCT00444678|448843651|FG000|Overall Study|Disease Progression|12|||
124784727|NCT00444678|448843651|FG000|Overall Study|Death|3|||
124784728|NCT00444678|448843651|FG000|Overall Study|Physician Decision|3|||
124784729|NCT00444678|448843651|FG000|Overall Study|Withdrawal by Subject|2|||
124784730|NCT02779556|448843654|FG000|Baseline|Partial baseline interview completed|1|||
124784731|NCT02779556|448843655|FG001|Baseline|Partial baseline interview completed|0|||
124784732|NCT02779556|448843654|FG000|3 Months|Lost to Follow-up|40|||
124784733|NCT02779556|448843655|FG001|3 Months|Lost to Follow-up|29|||
124784734|NCT02779556|448843654|FG000|3 Months|Missed 3 month clinic visit|27|||
124784735|NCT02779556|448843655|FG001|3 Months|Missed 3 month clinic visit|19|||
124784736|NCT02779556|448843654|FG000|6 Month|Lost to Follow-up|33|||
124784737|NCT02779556|448843655|FG001|6 Month|Lost to Follow-up|39|||
124784738|NCT02779556|448843654|FG000|6 Month HbA1c|No value collected during window|69|||
124784739|NCT02779556|448843655|FG001|6 Month HbA1c|No value collected during window|50|||
124784740|NCT02779556|448843654|FG000|12 Month HbA1c|No value collected during window|138|||
124784741|NCT02779556|448843655|FG001|12 Month HbA1c|No value collected during window|102|||
124784742|NCT03110770|448843659|FG000|Overall Study|Death|1|||
124784743|NCT03110770|448843660|FG001|Overall Study|Death|0|||
124784744|NCT03110770|448843661|FG002|Overall Study|Death|0|||
124784745|NCT03110770|448843662|FG003|Overall Study|Death|1|||
124784746|NCT03110770|448843663|FG004|Overall Study|Death|0|||
124784747|NCT03110770|448843659|FG000|Overall Study|Enrolled but did not receive product|0|||
124784748|NCT03110770|448843660|FG001|Overall Study|Enrolled but did not receive product|0|||
124784749|NCT03110770|448843661|FG002|Overall Study|Enrolled but did not receive product|0|||
124784750|NCT03110770|448843662|FG003|Overall Study|Enrolled but did not receive product|8|||
124784751|NCT03110770|448843663|FG004|Overall Study|Enrolled but did not receive product|7|||
124784752|NCT03110770|448843659|FG000|Overall Study|Lost to Follow-up|0|||
124784753|NCT03110770|448843660|FG001|Overall Study|Lost to Follow-up|0|||
124784754|NCT03110770|448843661|FG002|Overall Study|Lost to Follow-up|0|||
124784755|NCT03110770|448843662|FG003|Overall Study|Lost to Follow-up|53|||
124784756|NCT03110770|448843663|FG004|Overall Study|Lost to Follow-up|45|||
124784757|NCT03110770|448843659|FG000|Overall Study|Investigator Decision|0|||
124784758|NCT03110770|448843660|FG001|Overall Study|Investigator Decision|0|||
124784759|NCT03110770|448843661|FG002|Overall Study|Investigator Decision|0|||
124784760|NCT03110770|448843662|FG003|Overall Study|Investigator Decision|5|||
124784761|NCT03110770|448843663|FG004|Overall Study|Investigator Decision|3|||
124784762|NCT03110770|448843659|FG000|Overall Study|Withdrawal by Subject|0|||
124784763|NCT03110770|448843660|FG001|Overall Study|Withdrawal by Subject|0|||
124784764|NCT03110770|448843661|FG002|Overall Study|Withdrawal by Subject|0|||
124784765|NCT03110770|448843662|FG003|Overall Study|Withdrawal by Subject|24|||
124784766|NCT03110770|448843663|FG004|Overall Study|Withdrawal by Subject|24|||
124784767|NCT03110770|448843659|FG000|Overall Study|Moved from area|5|||
124784768|NCT03110770|448843660|FG001|Overall Study|Moved from area|0|||
124784769|NCT03110770|448843661|FG002|Overall Study|Moved from area|2|||
124784770|NCT03110770|448843662|FG003|Overall Study|Moved from area|42|||
124784771|NCT03110770|448843663|FG004|Overall Study|Moved from area|43|||
124784772|NCT03110770|448843659|FG000|Overall Study|Illness/Injury unrelated to product|0|||
124784773|NCT03110770|448843660|FG001|Overall Study|Illness/Injury unrelated to product|0|||
124784774|NCT03110770|448843661|FG002|Overall Study|Illness/Injury unrelated to product|0|||
124784775|NCT03110770|448843662|FG003|Overall Study|Illness/Injury unrelated to product|0|||
124626435|NCT00758524|448248044|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
124626436|NCT00758524|448248045|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
124626437|NCT00758524|448248046|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
124626438|NCT00758524|448248047|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
124784776|NCT03110770|448843663|FG004|Overall Study|Illness/Injury unrelated to product|1|||
124784777|NCT02082340|448843671|FG000|Overall Study|Lost to Follow-up|1|||
124784778|NCT02082340|448843672|FG001|Overall Study|Lost to Follow-up|1|||
124784779|NCT01625260|448843673|FG000|Overall Study|Adverse Event|3|||
124784780|NCT01625260|448843674|FG001|Overall Study|Adverse Event|0|||
124784781|NCT01625260|448843673|FG000|Overall Study|Study Terminated by Investigator|2|||
124784782|NCT01625260|448843674|FG001|Overall Study|Study Terminated by Investigator|0|||
124784783|NCT01625260|448843673|FG000|Overall Study|Disease Progression|2|||
124784784|NCT01625260|448843674|FG001|Overall Study|Disease Progression|0|||
124784785|NCT01625260|448843673|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
124784786|NCT01625260|448843674|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
124784787|NCT02937584|448843675|FG000|Period 1|Adverse Event|1|||
124784788|NCT02937584|448843676|FG001|Period 1|Adverse Event|2|||
124784789|NCT02937584|448843675|FG000|Washout|Adverse Event|0|||
124784790|NCT02937584|448843676|FG001|Washout|Adverse Event|1|||
124784791|NCT00635219|448843677|FG000|Overall Study|Adverse Event|12|||
124784792|NCT00635219|448843678|FG001|Overall Study|Adverse Event|10|||
124784793|NCT00635219|448843679|FG002|Overall Study|Adverse Event|18|||
124784794|NCT00635219|448843680|FG003|Overall Study|Adverse Event|15|||
124784795|NCT00635219|448843681|FG004|Overall Study|Adverse Event|19|||
124784796|NCT00635219|448843677|FG000|Overall Study|Lack of Efficacy|5|||
124784797|NCT00635219|448843678|FG001|Overall Study|Lack of Efficacy|6|||
124784798|NCT00635219|448843679|FG002|Overall Study|Lack of Efficacy|3|||
124784799|NCT00635219|448843680|FG003|Overall Study|Lack of Efficacy|4|||
124784800|NCT00635219|448843681|FG004|Overall Study|Lack of Efficacy|6|||
124784801|NCT00635219|448843677|FG000|Overall Study|Non-compliance With Study Product|0|||
124784802|NCT00635219|448843678|FG001|Overall Study|Non-compliance With Study Product|0|||
124784803|NCT00635219|448843679|FG002|Overall Study|Non-compliance With Study Product|0|||
124784804|NCT00635219|448843680|FG003|Overall Study|Non-compliance With Study Product|2|||
124784805|NCT00635219|448843681|FG004|Overall Study|Non-compliance With Study Product|1|||
124784806|NCT00635219|448843677|FG000|Overall Study|Protocol Violation|0|||
124784807|NCT00635219|448843678|FG001|Overall Study|Protocol Violation|2|||
124784808|NCT00635219|448843679|FG002|Overall Study|Protocol Violation|3|||
124784809|NCT00635219|448843680|FG003|Overall Study|Protocol Violation|2|||
124784810|NCT00635219|448843681|FG004|Overall Study|Protocol Violation|4|||
124784811|NCT00635219|448843677|FG000|Overall Study|Withdrawal of Consent|8|||
124784812|NCT00635219|448843678|FG001|Overall Study|Withdrawal of Consent|6|||
124784813|NCT00635219|448843679|FG002|Overall Study|Withdrawal of Consent|8|||
124784814|NCT00635219|448843680|FG003|Overall Study|Withdrawal of Consent|11|||
124784815|NCT00635219|448843681|FG004|Overall Study|Withdrawal of Consent|8|||
124784816|NCT00635219|448843677|FG000|Overall Study|Lost to Follow-up|0|||
124784817|NCT00635219|448843678|FG001|Overall Study|Lost to Follow-up|0|||
124784818|NCT00635219|448843679|FG002|Overall Study|Lost to Follow-up|2|||
124784819|NCT00635219|448843680|FG003|Overall Study|Lost to Follow-up|0|||
124784820|NCT00635219|448843681|FG004|Overall Study|Lost to Follow-up|3|||
124784821|NCT00635219|448843677|FG000|Overall Study|Administrative or Other Reasons|0|||
124784822|NCT00635219|448843678|FG001|Overall Study|Administrative or Other Reasons|1|||
124784823|NCT00635219|448843679|FG002|Overall Study|Administrative or Other Reasons|1|||
124784824|NCT00635219|448843680|FG003|Overall Study|Administrative or Other Reasons|0|||
124784825|NCT00635219|448843681|FG004|Overall Study|Administrative or Other Reasons|1|||
124784826|NCT01598129|448843690|FG000|Overall Study|Disease progression|6|||
124784827|NCT01598129|448843690|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
124784828|NCT01598129|448843690|FG000|Overall Study|Withdrawal by Subject|1|||
124784829|NCT00591318|448843691|FG000|Overall Study|Lack of Efficacy|2|||
124784830|NCT00591318|448843692|FG001|Overall Study|Lack of Efficacy|0|||
124784831|NCT00591318|448843691|FG000|Overall Study|Adverse Event|2|||
124784832|NCT00591318|448843692|FG001|Overall Study|Adverse Event|0|||
124784833|NCT04074161|448843695|FG000|Overall Study|Withdrawal by Subject|2|||
124784834|NCT04074161|448843696|FG001|Overall Study|Withdrawal by Subject|4|||
124784835|NCT04074161|448843697|FG002|Overall Study|Withdrawal by Subject|1|||
124784836|NCT04074161|448843695|FG000|Overall Study|Lost to Follow-up|4|||
124784837|NCT04074161|448843696|FG001|Overall Study|Lost to Follow-up|5|||
124784838|NCT04074161|448843697|FG002|Overall Study|Lost to Follow-up|3|||
124784839|NCT03890666|448843702|FG000|Overall Study|Withdrawal by Subject|0|||
124784840|NCT03890666|448843703|FG001|Overall Study|Withdrawal by Subject|1|||
124784841|NCT03890666|448843702|FG000|Overall Study|Protocol deviation|1|||
124784842|NCT03890666|448843703|FG001|Overall Study|Protocol deviation|4|||
124784843|NCT03890666|448843702|FG000|Overall Study|Lost to Follow-up|2|||
124784844|NCT03890666|448843703|FG001|Overall Study|Lost to Follow-up|5|||
124784845|NCT03890666|448843702|FG000|Overall Study|Other than specified|1|||
124784846|NCT03890666|448843703|FG001|Overall Study|Other than specified|8|||
124784847|NCT01639729|448843704|FG000|Overall Study|Withdrawal by Subject|1|||
124784848|NCT01639729|448843705|FG001|Overall Study|Withdrawal by Subject|0|||
124784849|NCT01639729|448843706|FG002|Overall Study|Withdrawal by Subject|1|||
124784850|NCT01639729|448843707|FG003|Overall Study|Withdrawal by Subject|1|||
124784851|NCT01639729|448843708|FG004|Overall Study|Withdrawal by Subject|0|||
124784852|NCT01639729|448843709|FG005|Overall Study|Withdrawal by Subject|0|||
124784853|NCT03052426|448843710|FG000|Overall Study|Withdrawal by Subject|0|||
124784854|NCT03052426|448843711|FG001|Overall Study|Withdrawal by Subject|1|||
124784855|NCT03052426|448843712|FG002|Overall Study|Withdrawal by Subject|0|||
124784856|NCT03052426|448843710|FG000|Overall Study|Lost to Follow-up|2|||
124784857|NCT03052426|448843711|FG001|Overall Study|Lost to Follow-up|0|||
124784858|NCT03052426|448843712|FG002|Overall Study|Lost to Follow-up|1|||
124784859|NCT03083990|448843715|FG000|Overall Study|Adverse Event|1|||
124784860|NCT03083990|448843716|FG001|Overall Study|Adverse Event|0|||
124784861|NCT03672097|448843717|FG000|Period 1|Withdrawal by Subject|2|||
124784862|NCT03672097|448843717|FG000|Period 1|Adverse Event|1|||
124784863|NCT03672097|448843717|FG000|Period 1|Did not receive treatment|1|||
124784864|NCT03672097|448843717|FG000|Period 2|Withdrawal by Subject|3|||
124784865|NCT03672097|448843717|FG000|Period 2|Other|1|||
124784866|NCT01781299|448843718|FG000|Overall Study|Withdrawal by Subject|0|||
124784867|NCT01781299|448843719|FG001|Overall Study|Withdrawal by Subject|1|||
124784868|NCT00146848|448843720|FG000|Pre-randomization|Death|19|||
124784869|NCT00146848|448843721|FG001|Pre-randomization|Death|0|||
124784870|NCT00146848|448843722|FG002|Pre-randomization|Death|0|||
124784871|NCT00146848|448843720|FG000|Pre-randomization|Lost to Follow-up|70|||
124784872|NCT00146848|448843721|FG001|Pre-randomization|Lost to Follow-up|0|||
124784873|NCT00146848|448843722|FG002|Pre-randomization|Lost to Follow-up|0|||
124784874|NCT00146848|448843720|FG000|Pre-randomization|Physician Decision|8|||
124784875|NCT00146848|448843721|FG001|Pre-randomization|Physician Decision|0|||
124784876|NCT00146848|448843722|FG002|Pre-randomization|Physician Decision|0|||
124784877|NCT00146848|448843720|FG000|Pre-randomization|Protocol Violation|172|||
124784878|NCT00146848|448843721|FG001|Pre-randomization|Protocol Violation|0|||
124784879|NCT00146848|448843722|FG002|Pre-randomization|Protocol Violation|0|||
124784880|NCT00146848|448843720|FG000|Pre-randomization|Withdrawal by Subject|40|||
124784881|NCT00146848|448843721|FG001|Pre-randomization|Withdrawal by Subject|0|||
124784882|NCT00146848|448843722|FG002|Pre-randomization|Withdrawal by Subject|0|||
124784883|NCT00146848|448843720|FG000|Post-randomization|Lost to Follow-up|12|||
124784884|NCT00146848|448843721|FG001|Post-randomization|Lost to Follow-up|15|||
124784885|NCT00146848|448843722|FG002|Post-randomization|Lost to Follow-up|12|||
124784886|NCT00146848|448843720|FG000|Post-randomization|Withdrawn|26|||
124784887|NCT00146848|448843721|FG001|Post-randomization|Withdrawn|32|||
124784888|NCT00146848|448843722|FG002|Post-randomization|Withdrawn|27|||
124784889|NCT01798849|448843723|FG000|Overall Study|Physician Decision|0|||
124784890|NCT01798849|448843724|FG001|Overall Study|Physician Decision|0|||
124784891|NCT01798849|448843725|FG002|Overall Study|Physician Decision|1|||
124784892|NCT02636361|448843726|FG000|Period 4|Physician Decision|0|||
124784893|NCT02636361|448843727|FG001|Period 4|Physician Decision|0|||
124784894|NCT02636361|448843728|FG002|Period 4|Physician Decision|0|||
124784895|NCT02636361|448843729|FG003|Period 4|Physician Decision|1|||
124784896|NCT02636361|448843730|FG004|Period 4|Physician Decision|0|||
124784897|NCT02032238|448843731|FG000|Overall Study|Lost to Follow-up|2|||
124784898|NCT02032238|448843732|FG001|Overall Study|Lost to Follow-up|0|||
124784899|NCT03158285|448843737|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
124784900|NCT03158285|448843738|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
124784901|NCT03158285|448843739|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
124784902|NCT03158285|448843737|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
124784903|NCT03158285|448843738|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
124784904|NCT03158285|448843739|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
124784905|NCT03158285|448843737|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
124784906|NCT03158285|448843738|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
124784907|NCT03158285|448843739|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
124784908|NCT03158285|448843737|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
124784909|NCT03158285|448843738|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
124784910|NCT03158285|448843739|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
124784911|NCT03158285|448843737|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
124784912|NCT03158285|448843738|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
124784913|NCT03158285|448843739|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
124784914|NCT03158285|448843737|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
124784915|NCT03158285|448843738|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
124784916|NCT03158285|448843739|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
124784917|NCT03158285|448843737|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
124784918|NCT03158285|448843738|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
124784919|NCT03158285|448843739|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
124784920|NCT03158285|448843737|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
124784921|NCT03158285|448843738|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
124784922|NCT03158285|448843739|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
124784923|NCT03158285|448843737|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
124784924|NCT03158285|448843738|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
124784925|NCT03158285|448843739|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
124784926|NCT03158285|448843737|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
124784927|NCT03158285|448843738|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
124784928|NCT03158285|448843739|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
124784929|NCT03158285|448843737|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
124784930|NCT03158285|448843738|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
124784931|NCT03158285|448843739|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
124784932|NCT03158285|448843737|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
124784933|NCT03158285|448843738|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
124784934|NCT03158285|448843739|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
124784935|NCT03158285|448843737|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
124784936|NCT03158285|448843738|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
124784937|NCT03158285|448843739|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
124784938|NCT03158285|448843737|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
124784939|NCT03158285|448843738|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
124784940|NCT03158285|448843739|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
124784941|NCT03158285|448843737|FG000|Active Treatment Period: Week 52-100|Death|1|||
124784942|NCT03158285|448843738|FG001|Active Treatment Period: Week 52-100|Death|0|||
124784943|NCT03158285|448843739|FG002|Active Treatment Period: Week 52-100|Death|0|||
124784944|NCT03158285|448843737|FG000|Active Treatment Period: Week 52-100|Other|4|||
124784945|NCT03158285|448843738|FG001|Active Treatment Period: Week 52-100|Other|1|||
124784946|NCT03158285|448843739|FG002|Active Treatment Period: Week 52-100|Other|0|||
124784947|NCT02228980|448843740|FG000|Overall Study|Adverse Event|14|||
124784948|NCT02228980|448843741|FG001|Overall Study|Adverse Event|0|||
124784949|NCT02228980|448843742|FG002|Overall Study|Adverse Event|0|||
124784950|NCT02228980|448843743|FG003|Overall Study|Adverse Event|0|||
124784951|NCT02228980|448843740|FG000|Overall Study|Protocol Violation|7|||
124784952|NCT02228980|448843741|FG001|Overall Study|Protocol Violation|0|||
124784953|NCT02228980|448843742|FG002|Overall Study|Protocol Violation|0|||
124784954|NCT02228980|448843743|FG003|Overall Study|Protocol Violation|0|||
124784955|NCT02228980|448843740|FG000|Overall Study|Withdrawal by Subject|3|||
124784956|NCT02228980|448843741|FG001|Overall Study|Withdrawal by Subject|3|||
124784957|NCT02228980|448843742|FG002|Overall Study|Withdrawal by Subject|2|||
124784958|NCT02228980|448843743|FG003|Overall Study|Withdrawal by Subject|3|||
124784959|NCT01642615|448843744|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
124784960|NCT01642615|448843745|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
124784961|NCT01642615|448843746|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
124784962|NCT01642615|448843744|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
124784963|NCT01642615|448843745|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
124784964|NCT01642615|448843746|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
124784965|NCT01642615|448843744|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
124784966|NCT01642615|448843745|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
124784967|NCT01642615|448843746|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
124784968|NCT01642615|448843744|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
124784969|NCT01642615|448843745|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
124784970|NCT01642615|448843746|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
124784971|NCT01642615|448843744|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
124784972|NCT01642615|448843745|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
124784973|NCT01642615|448843746|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
124784974|NCT01642615|448843744|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
124784975|NCT01642615|448843745|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
124784976|NCT01642615|448843746|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
124784977|NCT01642615|448843744|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
124784978|NCT01642615|448843745|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
124784979|NCT01642615|448843746|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
124784980|NCT01642615|448843744|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
124784981|NCT01642615|448843745|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
124784982|NCT01642615|448843746|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
124784983|NCT01642615|448843744|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
124784984|NCT01642615|448843745|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
124784985|NCT01642615|448843746|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
124784986|NCT01699867|448843747|FG000|Overall Study|Screening Failure|3|||
124784987|NCT04002908|448843750|FG000|Overall Study|Death|41|||
124784988|NCT04002908|448843751|FG001|Overall Study|Death|0|||
124784989|NCT04002908|448843752|FG002|Overall Study|Death|0|||
124784990|NCT04002908|448843753|FG003|Overall Study|Death|0|||
124784991|NCT04002908|448843750|FG000|Overall Study|Withdrawal by Subject|112|||
124784992|NCT04002908|448843751|FG001|Overall Study|Withdrawal by Subject|0|||
124784993|NCT04002908|448843752|FG002|Overall Study|Withdrawal by Subject|0|||
124784994|NCT04002908|448843753|FG003|Overall Study|Withdrawal by Subject|0|||
124784995|NCT04002908|448843750|FG000|Overall Study|Lost to Follow-up|72|||
124784996|NCT04002908|448843751|FG001|Overall Study|Lost to Follow-up|0|||
124784997|NCT04002908|448843752|FG002|Overall Study|Lost to Follow-up|0|||
124784998|NCT04002908|448843753|FG003|Overall Study|Lost to Follow-up|0|||
124784999|NCT04002908|448843750|FG000|Overall Study|Infant died, so mother withdrawn|34|||
124785000|NCT04002908|448843751|FG001|Overall Study|Infant died, so mother withdrawn|0|||
124785001|NCT04002908|448843752|FG002|Overall Study|Infant died, so mother withdrawn|0|||
124785002|NCT04002908|448843753|FG003|Overall Study|Infant died, so mother withdrawn|0|||
124785003|NCT00006289|448843756|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
124785004|NCT00006289|448843757|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
124785005|NCT00006289|448843756|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
124785006|NCT00006289|448843757|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
124785007|NCT04359901|448843767|FG000|Overall Study|Withdrawal by Subject|0|||
124785008|NCT04359901|448843768|FG001|Overall Study|Withdrawal by Subject|1|||
124785009|NCT04359901|448843767|FG000|Overall Study|Death|6|||
124785010|NCT04359901|448843768|FG001|Overall Study|Death|2|||
124785011|NCT03703297|448843771|FG000|Overall Study|Death|115|||
124785012|NCT03703297|448843772|FG001|Overall Study|Death|0|||
124785013|NCT03703297|448843773|FG002|Overall Study|Death|144|||
124785014|NCT03703297|448843771|FG000|Overall Study|Withdrawal by Subject|9|||
124785015|NCT03703297|448843772|FG001|Overall Study|Withdrawal by Subject|0|||
124785016|NCT03703297|448843773|FG002|Overall Study|Withdrawal by Subject|11|||
124785017|NCT03703297|448843771|FG000|Overall Study|Ongoing at the time of DCO|140|||
124785018|NCT03703297|448843772|FG001|Overall Study|Ongoing at the time of DCO|200|||
124785019|NCT03703297|448843773|FG002|Overall Study|Ongoing at the time of DCO|111|||
124785020|NCT01888432|448845134|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
124785021|NCT01888432|448845135|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
124785022|NCT01888432|448845134|FG000|12-month Analysis (FAS)|Physician Decision|1|||
124785023|NCT01888432|448845135|FG001|12-month Analysis (FAS)|Physician Decision|1|||
124785024|NCT01888432|448845134|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
124785025|NCT01888432|448845135|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
124785026|NCT01888432|448845134|FG000|12-month Analysis (FAS)|Death|4|||
124785027|NCT01888432|448845135|FG001|12-month Analysis (FAS)|Death|3|||
124785028|NCT01888432|448845134|FG000|24-month Analysis (FAS)|Graft loss|0|||
124785029|NCT01888432|448845135|FG001|24-month Analysis (FAS)|Graft loss|1|||
124785030|NCT01888432|448845134|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
124785031|NCT01888432|448845135|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
124785032|NCT01888432|448845134|FG000|24-month Analysis (FAS)|Physician Decision|2|||
124785033|NCT01888432|448845135|FG001|24-month Analysis (FAS)|Physician Decision|4|||
124785034|NCT01888432|448845134|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
124785035|NCT01888432|448845135|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
124785036|NCT01888432|448845134|FG000|24-month Analysis (FAS)|Death|8|||
124785037|NCT01888432|448845135|FG001|24-month Analysis (FAS)|Death|4|||
124785038|NCT01888432|448845134|FG000|36-month Analysis (Extension)|Death|1|||
124785039|NCT01888432|448845135|FG001|36-month Analysis (Extension)|Death|0|||
124785040|NCT00130247|448845138|FG000|Overall Study|Pregnancy|1|||
124785041|NCT00130247|448845139|FG001|Overall Study|Pregnancy|0|||
124785042|NCT00130247|448845138|FG000|Overall Study|Post-randomization exclusion|1|||
124785043|NCT00130247|448845139|FG001|Overall Study|Post-randomization exclusion|2|||
124785044|NCT00130247|448845138|FG000|Overall Study|Not compliant with DOT|0|||
124785045|NCT00130247|448845139|FG001|Overall Study|Not compliant with DOT|2|||
124785046|NCT02848729|448845140|FG000|Overall Study|Withdrawal by Subject|1|||
124785047|NCT02848729|448845141|FG001|Overall Study|Withdrawal by Subject|0|||
124785048|NCT02848729|448845140|FG000|Overall Study|Emesis|15|||
124785049|NCT02848729|448845141|FG001|Overall Study|Emesis|11|||
124785050|NCT01904773|448845142|FG000|Screen|Screen failure|3|||
124785051|NCT01904773|448845143|FG001|Screen|Screen failure|0|||
124785052|NCT01904773|448845144|FG002|Screen|Screen failure|0|||
124785053|NCT01904773|448845145|FG003|Screen|Screen failure|0|||
124785054|NCT01904773|448845146|FG004|Screen|Screen failure|0|||
124785055|NCT01904773|448845147|FG005|Screen|Screen failure|0|||
124785056|NCT01904773|448845148|FG006|Screen|Screen failure|0|||
124785057|NCT01904773|448845149|FG007|Screen|Screen failure|0|||
124785058|NCT01904773|448845150|FG008|Screen|Screen failure|0|||
124785059|NCT01904773|448845142|FG000|Screen|Withdrawal by Subject|1|||
124785060|NCT01904773|448845143|FG001|Screen|Withdrawal by Subject|0|||
124785061|NCT01904773|448845144|FG002|Screen|Withdrawal by Subject|0|||
124785062|NCT01904773|448845145|FG003|Screen|Withdrawal by Subject|0|||
124785063|NCT01904773|448845146|FG004|Screen|Withdrawal by Subject|0|||
124785064|NCT01904773|448845147|FG005|Screen|Withdrawal by Subject|0|||
124785065|NCT01904773|448845148|FG006|Screen|Withdrawal by Subject|0|||
124785066|NCT01904773|448845149|FG007|Screen|Withdrawal by Subject|0|||
124785067|NCT01904773|448845150|FG008|Screen|Withdrawal by Subject|0|||
124626439|NCT00758524|448248048|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
124785068|NCT01904773|448845142|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
124785069|NCT01904773|448845143|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
124785070|NCT01904773|448845144|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
124785071|NCT01904773|448845145|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
124785072|NCT01904773|448845146|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
124785073|NCT01904773|448845147|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
124785074|NCT01904773|448845148|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
124785075|NCT01904773|448845149|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
124785076|NCT01904773|448845150|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
124785077|NCT01904773|448845142|FG000|First Intervention|Adverse Event|0|||
124785078|NCT01904773|448845143|FG001|First Intervention|Adverse Event|0|||
124785079|NCT01904773|448845144|FG002|First Intervention|Adverse Event|0|||
124785080|NCT01904773|448845145|FG003|First Intervention|Adverse Event|0|||
124785081|NCT01904773|448845146|FG004|First Intervention|Adverse Event|0|||
124785082|NCT01904773|448845147|FG005|First Intervention|Adverse Event|0|||
124785083|NCT01904773|448845148|FG006|First Intervention|Adverse Event|1|||
124785084|NCT01904773|448845149|FG007|First Intervention|Adverse Event|0|||
124785085|NCT01904773|448845150|FG008|First Intervention|Adverse Event|0|||
124785086|NCT01904773|448845142|FG000|Placebo Washout First Intervention|Condition worsened|0|||
124785087|NCT01904773|448845143|FG001|Placebo Washout First Intervention|Condition worsened|1|||
124785088|NCT01904773|448845144|FG002|Placebo Washout First Intervention|Condition worsened|0|||
124785089|NCT01904773|448845145|FG003|Placebo Washout First Intervention|Condition worsened|0|||
124785090|NCT01904773|448845146|FG004|Placebo Washout First Intervention|Condition worsened|0|||
124785091|NCT01904773|448845147|FG005|Placebo Washout First Intervention|Condition worsened|0|||
124785092|NCT01904773|448845148|FG006|Placebo Washout First Intervention|Condition worsened|0|||
124785093|NCT01904773|448845149|FG007|Placebo Washout First Intervention|Condition worsened|0|||
124785094|NCT01904773|448845150|FG008|Placebo Washout First Intervention|Condition worsened|0|||
124785095|NCT01904773|448845142|FG000|Fifth Intervention|Adverse Event|0|||
124785096|NCT01904773|448845143|FG001|Fifth Intervention|Adverse Event|0|||
124785097|NCT01904773|448845144|FG002|Fifth Intervention|Adverse Event|0|||
124785098|NCT01904773|448845145|FG003|Fifth Intervention|Adverse Event|0|||
124785099|NCT01904773|448845146|FG004|Fifth Intervention|Adverse Event|0|||
124785100|NCT01904773|448845147|FG005|Fifth Intervention|Adverse Event|0|||
124785101|NCT01904773|448845148|FG006|Fifth Intervention|Adverse Event|0|||
124785102|NCT01904773|448845149|FG007|Fifth Intervention|Adverse Event|1|||
124785103|NCT01904773|448845150|FG008|Fifth Intervention|Adverse Event|0|||
124785104|NCT01904773|448845142|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
124785105|NCT01904773|448845143|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
124785106|NCT01904773|448845144|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
124785107|NCT01904773|448845145|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
124785108|NCT01904773|448845146|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
124785109|NCT01904773|448845147|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
124785110|NCT01904773|448845148|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
124785111|NCT01904773|448845149|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
124785112|NCT01904773|448845150|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
124785113|NCT00791076|448845151|FG000|Overall Study|Study was terminated,PI left institution|8|||
124785114|NCT00606905|448845154|FG000|Overall Study|No Pregnancy|9|||
124785115|NCT00606905|448845155|FG001|Overall Study|No Pregnancy|6|||
124785116|NCT00606905|448845154|FG000|Overall Study|Non-Index Pregnancy|1|||
124785117|NCT00606905|448845155|FG001|Overall Study|Non-Index Pregnancy|4|||
124785118|NCT00606905|448845154|FG000|Overall Study|Withdrew|5|||
124785119|NCT00606905|448845155|FG001|Overall Study|Withdrew|5|||
124785120|NCT03700684|448845156|FG000|Overall Study|COVID-19|0|||
124785121|NCT03700684|448845157|FG001|Overall Study|COVID-19|0|||
124785122|NCT03700684|448845158|FG002|Overall Study|COVID-19|2|||
124785123|NCT03319745|448845159|FG000|Overall Study|Death|1|||
124785124|NCT03319745|448845159|FG000|Overall Study|Toxicity Precluding Surgery|1|||
124785125|NCT00870103|448845160|FG000|Overall Study|Physician Decision|2|||
124785126|NCT00870103|448845160|FG000|Overall Study|Lost to Follow-up|2|||
124785127|NCT03255629|448845161|FG000|Overall Study|Adverse Event|1|||
124785128|NCT03255629|448845162|FG001|Overall Study|Adverse Event|0|||
124785129|NCT03255629|448845161|FG000|Overall Study|did not experience hypoglycemia|2|||
124785130|NCT03255629|448845162|FG001|Overall Study|did not experience hypoglycemia|1|||
124785131|NCT00859638|448845163|FG000|Overall Study|Lost to Follow-up|6|||
124785132|NCT00859638|448845164|FG001|Overall Study|Lost to Follow-up|1|||
124785133|NCT00859638|448845163|FG000|Overall Study|Withdrawal by Subject|3|||
124785134|NCT00859638|448845164|FG001|Overall Study|Withdrawal by Subject|2|||
124785135|NCT00859638|448845163|FG000|Overall Study|Ill health|1|||
124785136|NCT00859638|448845164|FG001|Overall Study|Ill health|1|||
124785137|NCT02969408|448845166|FG000|Overall Study|Adverse Event|2|||
124785138|NCT02969408|448845166|FG000|Overall Study|Withdrawal by Subject|8|||
124785139|NCT02969408|448845166|FG000|Overall Study|Lost to Follow-up|4|||
124785140|NCT02969408|448845166|FG000|Overall Study|Protocol Violation|1|||
124785141|NCT02969408|448845166|FG000|Overall Study|Other than specified|1|||
124785142|NCT01767142|448845167|FG000|Overall Study|Lost to Follow-up|3|||
124785143|NCT04075734|448845170|FG000|Overall Study|Lost to Follow-up|1|||
124785144|NCT04075734|448845171|FG001|Overall Study|Lost to Follow-up|1|||
124785145|NCT04075734|448845172|FG002|Overall Study|Lost to Follow-up|0|||
124785146|NCT04075734|448845170|FG000|Overall Study|Withdrawal by Subject|3|||
124785147|NCT04075734|448845171|FG001|Overall Study|Withdrawal by Subject|0|||
124785148|NCT04075734|448845172|FG002|Overall Study|Withdrawal by Subject|0|||
124785149|NCT01776307|448845175|FG000|Overall Study|Not dosed|0|||
124785150|NCT01776307|448845176|FG001|Overall Study|Not dosed|0|||
124785151|NCT01776307|448845177|FG002|Overall Study|Not dosed|1|||
124785152|NCT03615040|448845178|FG000|Overall Study|Withdrawal by Subject|2|||
124785153|NCT03615040|448845179|FG001|Overall Study|Withdrawal by Subject|1|||
124785154|NCT03615040|448845178|FG000|Overall Study|Physician Decision|2|||
124785155|NCT03615040|448845179|FG001|Overall Study|Physician Decision|2|||
124785156|NCT03615040|448845178|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
124785157|NCT03615040|448845179|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
124785158|NCT03615040|448845178|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
124785159|NCT03615040|448845179|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
124785160|NCT03615040|448845178|FG000|Overall Study|Death|0|||
124785161|NCT03615040|448845179|FG001|Overall Study|Death|2|||
124785162|NCT05194579|448845184|FG000|Overall Study|Lost to Follow-up|2|||
124785163|NCT05194579|448845185|FG001|Overall Study|Lost to Follow-up|3|||
124785164|NCT05194579|448845184|FG000|Overall Study|Withdrawal by Subject|3|||
124785165|NCT05194579|448845185|FG001|Overall Study|Withdrawal by Subject|4|||
124785166|NCT05194579|448845184|FG000|Overall Study|Refused further study procedures|0|||
124785167|NCT05194579|448845185|FG001|Overall Study|Refused further study procedures|1|||
124785168|NCT05194579|448845184|FG000|Overall Study|Protocol deviation|1|||
124785169|NCT05194579|448845185|FG001|Overall Study|Protocol deviation|0|||
124785170|NCT04145219|448845186|FG000|Overall Study|Adverse Event|18|||
124785171|NCT04145219|448845187|FG001|Overall Study|Adverse Event|6|||
124785172|NCT04145219|448845186|FG000|Overall Study|Lost to Follow-up|2|||
124785173|NCT04145219|448845187|FG001|Overall Study|Lost to Follow-up|3|||
124785174|NCT04145219|448845186|FG000|Overall Study|Physician Decision|0|||
124785175|NCT04145219|448845187|FG001|Overall Study|Physician Decision|2|||
124785176|NCT04145219|448845186|FG000|Overall Study|Withdrawal by Subject|12|||
124785177|NCT04145219|448845187|FG001|Overall Study|Withdrawal by Subject|8|||
124785178|NCT04145219|448845186|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
124785179|NCT04145219|448845187|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
124785180|NCT01788215|448845193|FG000|Overall Study|Withdrawal by Subject|0|||
124785181|NCT01788215|448845194|FG001|Overall Study|Withdrawal by Subject|1|||
124785182|NCT01788215|448845193|FG000|Overall Study|Lost to Follow-up|2|||
124785183|NCT01788215|448845194|FG001|Overall Study|Lost to Follow-up|0|||
124785184|NCT01950013|448845195|FG000|Overall Study|Withdrawal by Subject|0|||
124785185|NCT01950013|448845196|FG001|Overall Study|Withdrawal by Subject|2|||
124785186|NCT01950013|448845197|FG002|Overall Study|Withdrawal by Subject|0|||
124785187|NCT00612105|448845206|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
124785188|NCT00612105|448845207|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
124785189|NCT00612105|448845206|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
124785190|NCT00612105|448845207|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
124785191|NCT00612105|448845206|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
124785192|NCT00612105|448845207|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
124785193|NCT00612105|448845206|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
124785194|NCT00612105|448845207|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
124785195|NCT00612105|448845206|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
124785196|NCT00612105|448845207|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
124785197|NCT00612105|448845206|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
124785198|NCT00612105|448845207|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
124785199|NCT00612105|448845206|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
124785200|NCT00612105|448845207|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
124785201|NCT00612105|448845206|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
124785202|NCT00612105|448845207|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
124785203|NCT00612105|448845206|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
124785204|NCT00612105|448845207|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
124785205|NCT00612105|448845206|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
124785206|NCT00612105|448845207|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
124785207|NCT00612105|448845206|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
124785208|NCT00612105|448845207|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
124785209|NCT00612105|448845206|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
124785210|NCT00612105|448845207|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
124785211|NCT00271505|448845209|FG000|Overall Study|Screen Failure|3|||
124785212|NCT00271505|448845209|FG000|Overall Study|Adverse Event|1|||
124626440|NCT00758524|448248049|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
124626441|NCT00758524|448248050|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
124785213|NCT00271505|448845209|FG000|Overall Study|Death|1|||
124785214|NCT04556383|448845210|FG000|PCP|Lack of Efficacy|28|||
124785215|NCT04556383|448845211|FG001|PCP|Lack of Efficacy|23|||
124785216|NCT04556383|448845212|FG002|PCP|Lack of Efficacy|23|||
124785217|NCT04556383|448845213|FG003|PCP|Lack of Efficacy|0|||
124785218|NCT04556383|448845210|FG000|PCP|Study terminated by sponsor|15|||
124785219|NCT04556383|448845211|FG001|PCP|Study terminated by sponsor|13|||
124785220|NCT04556383|448845212|FG002|PCP|Study terminated by sponsor|16|||
124785221|NCT04556383|448845213|FG003|PCP|Study terminated by sponsor|0|||
124785222|NCT04556383|448845210|FG000|PCP|Withdrawal by Subject|8|||
124785223|NCT04556383|448845211|FG001|PCP|Withdrawal by Subject|6|||
124785224|NCT04556383|448845212|FG002|PCP|Withdrawal by Subject|6|||
124785225|NCT04556383|448845213|FG003|PCP|Withdrawal by Subject|0|||
124785226|NCT04556383|448845210|FG000|PCP|Adverse Event|1|||
124785227|NCT04556383|448845211|FG001|PCP|Adverse Event|7|||
124785228|NCT04556383|448845212|FG002|PCP|Adverse Event|7|||
124785229|NCT04556383|448845213|FG003|PCP|Adverse Event|0|||
124785230|NCT04556383|448845210|FG000|PCP|Other, Not Specified|1|||
124785231|NCT04556383|448845211|FG001|PCP|Other, Not Specified|2|||
124785232|NCT04556383|448845212|FG002|PCP|Other, Not Specified|1|||
124785233|NCT04556383|448845213|FG003|PCP|Other, Not Specified|0|||
124785234|NCT04556383|448845210|FG000|PCP|Protocol Violation|1|||
124785235|NCT04556383|448845211|FG001|PCP|Protocol Violation|0|||
124785236|NCT04556383|448845212|FG002|PCP|Protocol Violation|1|||
124785237|NCT04556383|448845213|FG003|PCP|Protocol Violation|0|||
124785238|NCT04556383|448845210|FG000|PCP|Lost to Follow-up|1|||
124785239|NCT04556383|448845211|FG001|PCP|Lost to Follow-up|0|||
124785240|NCT04556383|448845212|FG002|PCP|Lost to Follow-up|0|||
124785241|NCT04556383|448845213|FG003|PCP|Lost to Follow-up|0|||
124785242|NCT04556383|448845210|FG000|PCP|Physician Decision|0|||
124785243|NCT04556383|448845211|FG001|PCP|Physician Decision|1|||
124785244|NCT04556383|448845212|FG002|PCP|Physician Decision|0|||
124785245|NCT04556383|448845213|FG003|PCP|Physician Decision|0|||
124785246|NCT04556383|448845210|FG000|PCP|Site terminated by sponsor|0|||
124785247|NCT04556383|448845211|FG001|PCP|Site terminated by sponsor|1|||
124785248|NCT04556383|448845212|FG002|PCP|Site terminated by sponsor|0|||
124785249|NCT04556383|448845213|FG003|PCP|Site terminated by sponsor|0|||
124785250|NCT04556383|448845210|FG000|OLE|Study terminated by sponsor|0|||
124785251|NCT04556383|448845211|FG001|OLE|Study terminated by sponsor|0|||
124785252|NCT04556383|448845212|FG002|OLE|Study terminated by sponsor|0|||
124785253|NCT04556383|448845213|FG003|OLE|Study terminated by sponsor|68|||
124785254|NCT04556383|448845210|FG000|OLE|Withdrawal by Subject|0|||
124785255|NCT04556383|448845211|FG001|OLE|Withdrawal by Subject|0|||
124785256|NCT04556383|448845212|FG002|OLE|Withdrawal by Subject|0|||
124785257|NCT04556383|448845213|FG003|OLE|Withdrawal by Subject|10|||
124785258|NCT04556383|448845210|FG000|OLE|Lack of Efficacy|0|||
124785259|NCT04556383|448845211|FG001|OLE|Lack of Efficacy|0|||
124785260|NCT04556383|448845212|FG002|OLE|Lack of Efficacy|0|||
124785261|NCT04556383|448845213|FG003|OLE|Lack of Efficacy|7|||
124785262|NCT04556383|448845210|FG000|OLE|Adverse Event|0|||
124785263|NCT04556383|448845211|FG001|OLE|Adverse Event|0|||
124785264|NCT04556383|448845212|FG002|OLE|Adverse Event|0|||
124785265|NCT04556383|448845213|FG003|OLE|Adverse Event|2|||
124785266|NCT04556383|448845210|FG000|OLE|Other, Not Specified|0|||
124785267|NCT04556383|448845211|FG001|OLE|Other, Not Specified|0|||
124785268|NCT04556383|448845212|FG002|OLE|Other, Not Specified|0|||
124785269|NCT04556383|448845213|FG003|OLE|Other, Not Specified|2|||
124785270|NCT04556383|448845210|FG000|OLE|Death|0|||
124785271|NCT04556383|448845211|FG001|OLE|Death|0|||
124785272|NCT04556383|448845212|FG002|OLE|Death|0|||
124785273|NCT04556383|448845213|FG003|OLE|Death|1|||
124785274|NCT04556383|448845210|FG000|OLE|Lost to Follow-up|0|||
124785275|NCT04556383|448845211|FG001|OLE|Lost to Follow-up|0|||
124785276|NCT04556383|448845212|FG002|OLE|Lost to Follow-up|0|||
124785277|NCT04556383|448845213|FG003|OLE|Lost to Follow-up|1|||
124785278|NCT00119678|448845214|FG000|Double-blind Treatment Period|Death|1|||
124785279|NCT00119678|448845215|FG001|Double-blind Treatment Period|Death|0|||
124785280|NCT00119678|448845214|FG000|Double-blind Treatment Period|Adverse Event|7|||
124785281|NCT00119678|448845215|FG001|Double-blind Treatment Period|Adverse Event|1|||
124785282|NCT00119678|448845214|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
124785283|NCT00119678|448845215|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
124785284|NCT00119678|448845214|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
124785285|NCT00119678|448845215|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
124785286|NCT00119678|448845214|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
124785287|NCT00119678|448845215|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
124785288|NCT00119678|448845214|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
124785289|NCT00119678|448845215|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
124785290|NCT00119678|448845214|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
124785291|NCT00119678|448845215|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
124785292|NCT00119678|448845214|FG000|Double-blind Treatment Period|Pregnancy|0|||
124785293|NCT00119678|448845215|FG001|Double-blind Treatment Period|Pregnancy|2|||
124785294|NCT00119678|448845214|FG000|Double-blind Treatment Period|Not treated|1|||
124785295|NCT00119678|448845215|FG001|Double-blind Treatment Period|Not treated|2|||
124785296|NCT00119678|448845214|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
124785297|NCT00119678|448845215|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
124785298|NCT00119678|448845214|FG000|Open-label Treatment Period|Death|1|||
124785299|NCT00119678|448845215|FG001|Open-label Treatment Period|Death|0|||
124785300|NCT00119678|448845214|FG000|Open-label Treatment Period|Adverse Event|3|||
124785301|NCT00119678|448845215|FG001|Open-label Treatment Period|Adverse Event|0|||
124785302|NCT00119678|448845214|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
124785303|NCT00119678|448845215|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
124785304|NCT00119678|448845214|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
124785305|NCT00119678|448845215|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
124785306|NCT00119678|448845214|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
124785307|NCT00119678|448845215|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
124785308|NCT00119678|448845214|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
124785309|NCT00119678|448845215|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
124785310|NCT00119678|448845214|FG000|Open-label Treatment Period|Pregnancy|1|||
124785311|NCT00119678|448845215|FG001|Open-label Treatment Period|Pregnancy|0|||
124785312|NCT00119678|448845214|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
124785313|NCT00119678|448845215|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
124785314|NCT02720042|448845223|FG000|Overall Study|Death|3|||
124785315|NCT02720042|448845223|FG000|Overall Study|Lost to Follow-up|4|||
124785316|NCT02720042|448845223|FG000|Overall Study|Withdrawal by Subject|1|||
124785317|NCT02720042|448845223|FG000|Overall Study|Physician Decision|3|||
124785318|NCT02720042|448845223|FG000|Overall Study|Phasix Mesh explanted|1|||
124785319|NCT02720042|448845223|FG000|Overall Study|unable due to non-study-related illness|3|||
124785320|NCT01761240|448845224|FG000|Overall Study|Progressive disease:radiology assessment|3|||
124785321|NCT01761240|448845225|FG001|Overall Study|Progressive disease:radiology assessment|3|||
124785322|NCT01761240|448845226|FG002|Overall Study|Progressive disease:radiology assessment|0|||
124785323|NCT01761240|448845227|FG003|Overall Study|Progressive disease:radiology assessment|0|||
124785324|NCT01761240|448845228|FG004|Overall Study|Progressive disease:radiology assessment|0|||
124785325|NCT01761240|448845224|FG000|Overall Study|Progressive disease:clinical assessment|0|||
124785326|NCT01761240|448845225|FG001|Overall Study|Progressive disease:clinical assessment|0|||
124785327|NCT01761240|448845226|FG002|Overall Study|Progressive disease:clinical assessment|3|||
124785328|NCT01761240|448845227|FG003|Overall Study|Progressive disease:clinical assessment|1|||
124785329|NCT01761240|448845228|FG004|Overall Study|Progressive disease:clinical assessment|0|||
124785330|NCT01761240|448845224|FG000|Overall Study|Withdrawal by Subject|0|||
124785331|NCT01761240|448845225|FG001|Overall Study|Withdrawal by Subject|0|||
124785332|NCT01761240|448845226|FG002|Overall Study|Withdrawal by Subject|0|||
124785333|NCT01761240|448845227|FG003|Overall Study|Withdrawal by Subject|3|||
124785334|NCT01761240|448845228|FG004|Overall Study|Withdrawal by Subject|1|||
124785335|NCT01761240|448845224|FG000|Overall Study|Adverse Event|0|||
124785336|NCT01761240|448845225|FG001|Overall Study|Adverse Event|0|||
124785337|NCT01761240|448845226|FG002|Overall Study|Adverse Event|0|||
124785338|NCT01761240|448845227|FG003|Overall Study|Adverse Event|1|||
124785339|NCT01761240|448845228|FG004|Overall Study|Adverse Event|6|||
124785340|NCT01761240|448845224|FG000|Overall Study|Death|0|||
124785341|NCT01761240|448845225|FG001|Overall Study|Death|1|||
124785342|NCT01761240|448845226|FG002|Overall Study|Death|1|||
124785343|NCT01761240|448845227|FG003|Overall Study|Death|2|||
124785344|NCT01761240|448845228|FG004|Overall Study|Death|1|||
124785345|NCT01761240|448845224|FG000|Overall Study|Non-compliance|0|||
124785346|NCT01761240|448845225|FG001|Overall Study|Non-compliance|0|||
124785347|NCT01761240|448845226|FG002|Overall Study|Non-compliance|1|||
124785348|NCT01761240|448845227|FG003|Overall Study|Non-compliance|0|||
124785349|NCT01761240|448845228|FG004|Overall Study|Non-compliance|0|||
124785350|NCT00509145|448845231|FG000|Overall Study|Death|0|||
124785351|NCT00509145|448845232|FG001|Overall Study|Death|2|||
124785352|NCT00509145|448845231|FG000|Overall Study|Adverse Event|42|||
124785353|NCT00509145|448845232|FG001|Overall Study|Adverse Event|28|||
124785354|NCT00509145|448845231|FG000|Overall Study|Withdrawal by Subject|32|||
124785355|NCT00509145|448845232|FG001|Overall Study|Withdrawal by Subject|38|||
124785356|NCT00509145|448845231|FG000|Overall Study|Physician Decision|11|||
124785357|NCT00509145|448845232|FG001|Overall Study|Physician Decision|14|||
124785358|NCT00509145|448845231|FG000|Overall Study|Protocol Violation|1|||
124785359|NCT00509145|448845232|FG001|Overall Study|Protocol Violation|6|||
124785360|NCT00509145|448845231|FG000|Overall Study|Pregnancy|3|||
124785361|NCT00509145|448845232|FG001|Overall Study|Pregnancy|8|||
124785362|NCT00509145|448845231|FG000|Overall Study|Lost to Follow-up|6|||
124785363|NCT00509145|448845232|FG001|Overall Study|Lost to Follow-up|5|||
124785364|NCT00509145|448845231|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
124785365|NCT00509145|448845232|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
124785366|NCT00509145|448845231|FG000|Overall Study|Other|6|||
124785367|NCT00509145|448845232|FG001|Overall Study|Other|6|||
124785368|NCT01994889|448845233|FG000|Overall Study|Adverse Event|5|||
124785369|NCT01994889|448845234|FG001|Overall Study|Adverse Event|12|||
124785370|NCT01994889|448845235|FG002|Overall Study|Adverse Event|11|||
124785371|NCT01994889|448845233|FG000|Overall Study|Cardiac Device Implantation|0|||
124785372|NCT01994889|448845234|FG001|Overall Study|Cardiac Device Implantation|2|||
124785373|NCT01994889|448845235|FG002|Overall Study|Cardiac Device Implantation|0|||
124785374|NCT01994889|448845233|FG000|Overall Study|Organ Transplantation|1|||
124785375|NCT01994889|448845234|FG001|Overall Study|Organ Transplantation|5|||
124785376|NCT01994889|448845235|FG002|Overall Study|Organ Transplantation|5|||
124785377|NCT01994889|448845233|FG000|Overall Study|No longer willing to participate|8|||
124785378|NCT01994889|448845234|FG001|Overall Study|No longer willing to participate|17|||
124785379|NCT01994889|448845235|FG002|Overall Study|No longer willing to participate|37|||
124785380|NCT01994889|448845233|FG000|Overall Study|Lost to Follow-up|0|||
124785381|NCT01994889|448845234|FG001|Overall Study|Lost to Follow-up|1|||
124785382|NCT01994889|448845235|FG002|Overall Study|Lost to Follow-up|0|||
124785383|NCT01994889|448845233|FG000|Overall Study|Protocol Violation|0|||
124785384|NCT01994889|448845234|FG001|Overall Study|Protocol Violation|1|||
124785385|NCT01994889|448845235|FG002|Overall Study|Protocol Violation|1|||
124785386|NCT01994889|448845233|FG000|Overall Study|Death|14|||
124785387|NCT01994889|448845234|FG001|Overall Study|Death|25|||
124785388|NCT01994889|448845235|FG002|Overall Study|Death|38|||
124785389|NCT02969655|448845237|FG000|Overall Study|Withdrawal by Subject|3|||
124785390|NCT02969655|448845238|FG001|Overall Study|Withdrawal by Subject|2|||
124785391|NCT02969655|448845237|FG000|Overall Study|Physician Decision|4|||
124785392|NCT02969655|448845238|FG001|Overall Study|Physician Decision|3|||
124785393|NCT02969655|448845237|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
124785394|NCT02969655|448845238|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
124785395|NCT02969655|448845237|FG000|Overall Study|Adverse Event|10|||
124785396|NCT02969655|448845238|FG001|Overall Study|Adverse Event|8|||
124785397|NCT02674204|448845239|FG000|Overall Study|Adverse Event|1|||
124785398|NCT02674204|448845240|FG001|Overall Study|Adverse Event|0|||
124785399|NCT01516034|448845244|FG000|Overall Study|Physician Decision|1|||
124785400|NCT01516034|448845244|FG000|Overall Study|Lack of Efficacy|7|||
124785401|NCT03060551|448845245|FG000|Overall Study|Withdrawal by Subject|1|||
124785402|NCT03060551|448845245|FG000|Overall Study|Adverse Event|1|||
124785403|NCT01525225|448845250|FG000|Enrollment|No longer met study criteria|1|||
124785404|NCT01525225|448845250|FG000|Enrollment|Other|1|||
124785405|NCT00363545|448845251|FG000|Overall Study|Serious Adverse Event|0|||
124785406|NCT00363545|448845252|FG001|Overall Study|Serious Adverse Event|1|||
124785407|NCT00363545|448845251|FG000|Overall Study|Withdrawal by Subject|12|||
124785408|NCT00363545|448845252|FG001|Overall Study|Withdrawal by Subject|15|||
124785409|NCT00363545|448845251|FG000|Overall Study|Migrated/moved from study area|3|||
124785410|NCT00363545|448845252|FG001|Overall Study|Migrated/moved from study area|6|||
124785411|NCT00363545|448845251|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
124785412|NCT00363545|448845252|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
124785413|NCT00363545|448845251|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
124785414|NCT00363545|448845252|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
124785415|NCT00363545|448845251|FG000|Overall Study|Others|1|||
124785416|NCT00363545|448845252|FG001|Overall Study|Others|0|||
124785417|NCT01379508|448845253|FG000|Treatment to Week 104|Adverse Event|2|||
124785418|NCT01379508|448845254|FG001|Treatment to Week 104|Adverse Event|0|||
124785419|NCT01379508|448845255|FG002|Treatment to Week 104|Adverse Event|5|||
124785420|NCT01379508|448845256|FG003|Treatment to Week 104|Adverse Event|0|||
124785421|NCT01379508|448845253|FG000|Treatment to Week 104|Abnormal lab value|1|||
124785422|NCT01379508|448845254|FG001|Treatment to Week 104|Abnormal lab value|0|||
124785423|NCT01379508|448845255|FG002|Treatment to Week 104|Abnormal lab value|0|||
124785424|NCT01379508|448845256|FG003|Treatment to Week 104|Abnormal lab value|0|||
124785425|NCT01379508|448845253|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
124785426|NCT01379508|448845254|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
124785427|NCT01379508|448845255|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
124785428|NCT01379508|448845256|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
124785429|NCT01379508|448845253|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
124785430|NCT01379508|448845254|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
124785431|NCT01379508|448845255|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
124785432|NCT01379508|448845256|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
124785433|NCT01379508|448845253|FG000|Treatment to Week 104|Lost to Follow-up|5|||
124785434|NCT01379508|448845254|FG001|Treatment to Week 104|Lost to Follow-up|0|||
124785435|NCT01379508|448845255|FG002|Treatment to Week 104|Lost to Follow-up|3|||
124785436|NCT01379508|448845256|FG003|Treatment to Week 104|Lost to Follow-up|0|||
124785437|NCT01379508|448845253|FG000|Treatment to Week 104|Administrative problems|3|||
124785438|NCT01379508|448845254|FG001|Treatment to Week 104|Administrative problems|1|||
124785439|NCT01379508|448845255|FG002|Treatment to Week 104|Administrative problems|0|||
124785440|NCT01379508|448845256|FG003|Treatment to Week 104|Administrative problems|0|||
124785441|NCT01379508|448845253|FG000|Treatment to Week 104|Protocol Violation|1|||
124785442|NCT01379508|448845254|FG001|Treatment to Week 104|Protocol Violation|1|||
124785443|NCT01379508|448845255|FG002|Treatment to Week 104|Protocol Violation|1|||
124785444|NCT01379508|448845256|FG003|Treatment to Week 104|Protocol Violation|0|||
124785445|NCT01379508|448845253|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
124785446|NCT01379508|448845254|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
124785447|NCT01379508|448845255|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
124785448|NCT01379508|448845256|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
124785449|NCT01379508|448845253|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
124785450|NCT01379508|448845254|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
124785451|NCT01379508|448845255|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
124785452|NCT01379508|448845256|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
124785453|NCT01379508|448845253|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
124785454|NCT01379508|448845254|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
124785455|NCT01379508|448845255|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
124785456|NCT01379508|448845256|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
124785457|NCT01379508|448845253|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
124785458|NCT01379508|448845254|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
124785459|NCT01379508|448845255|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
124785460|NCT01379508|448845256|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
124785461|NCT01457352|448845257|FG000|Period 1|Adverse Event|2|||
124785462|NCT01457352|448845258|FG001|Period 1|Adverse Event|0|||
124785463|NCT01457352|448845257|FG000|Period 1|Withdrawal by Subject|2|||
124785464|NCT01457352|448845258|FG001|Period 1|Withdrawal by Subject|0|||
124785465|NCT01457352|448845257|FG000|Period 1|Physician Decision|2|||
124785466|NCT01457352|448845258|FG001|Period 1|Physician Decision|0|||
124785467|NCT01457352|448845257|FG000|Period 1|MS related disease progression|1|||
124785468|NCT01457352|448845258|FG001|Period 1|MS related disease progression|0|||
124785469|NCT01457352|448845257|FG000|Period 1|Withdrawn|1|||
124785470|NCT01457352|448845258|FG001|Period 1|Withdrawn|0|||
124785471|NCT01457352|448845257|FG000|Period 1|withdrew per sponsor|1|||
124785472|NCT01457352|448845258|FG001|Period 1|withdrew per sponsor|0|||
124785473|NCT01457352|448845257|FG000|Period 1|Protocol Violation|4|||
124785474|NCT01457352|448845258|FG001|Period 1|Protocol Violation|0|||
124785475|NCT01457352|448845257|FG000|Period 1|Did not meet eligibility criteria|3|||
124785476|NCT01457352|448845258|FG001|Period 1|Did not meet eligibility criteria|0|||
124785477|NCT01457352|448845257|FG000|Period 2|Withdrawal by Subject|23|||
124785478|NCT01457352|448845258|FG001|Period 2|Withdrawal by Subject|0|||
124785479|NCT01457352|448845257|FG000|Period 2|Adverse Event|22|||
124785480|NCT01457352|448845258|FG001|Period 2|Adverse Event|0|||
124785481|NCT01457352|448845257|FG000|Period 2|no analysis|10|||
124785482|NCT01457352|448845258|FG001|Period 2|no analysis|0|||
124785483|NCT01457352|448845257|FG000|Period 2|Lack of Efficacy|8|||
124785484|NCT01457352|448845258|FG001|Period 2|Lack of Efficacy|0|||
124785485|NCT01457352|448845257|FG000|Period 2|Protocol Violation|4|||
124785486|NCT01457352|448845258|FG001|Period 2|Protocol Violation|0|||
124785487|NCT01457352|448845257|FG000|Period 2|Sponsor's withdrawal|7|||
124785488|NCT01457352|448845258|FG001|Period 2|Sponsor's withdrawal|0|||
124785489|NCT01457352|448845257|FG000|Period 2|Lost to Follow-up|1|||
124785490|NCT01457352|448845258|FG001|Period 2|Lost to Follow-up|0|||
124785491|NCT01457352|448845257|FG000|Period 2|dose change|1|||
124785492|NCT01457352|448845258|FG001|Period 2|dose change|0|||
124785493|NCT01457352|448845257|FG000|Period 2|Physician Decision|1|||
124785494|NCT01457352|448845258|FG001|Period 2|Physician Decision|0|||
124785495|NCT01457352|448845257|FG000|Period 2|Did not meet eligibility criteria|3|||
124785496|NCT01457352|448845258|FG001|Period 2|Did not meet eligibility criteria|0|||
124785497|NCT01457352|448845257|FG000|Period 3|Adverse Event|1|||
124785498|NCT01457352|448845258|FG001|Period 3|Adverse Event|1|||
124785499|NCT01457352|448845257|FG000|Period 3|Withdrawal by Subject|0|||
124785500|NCT01457352|448845258|FG001|Period 3|Withdrawal by Subject|2|||
124785501|NCT01457352|448845257|FG000|Period 3|incorrect treatment|0|||
124785502|NCT01457352|448845258|FG001|Period 3|incorrect treatment|1|||
124785503|NCT01457352|448845257|FG000|Period 3|Sponsor's withdrawal|0|||
124785504|NCT01457352|448845258|FG001|Period 3|Sponsor's withdrawal|1|||
124785505|NCT02537015|448845259|FG000|Overall Study|Adverse Event|3|||
124785506|NCT02537015|448845259|FG000|Overall Study|Withdrawal by Subject|2|||
124785507|NCT02537015|448845259|FG000|Overall Study|Other Miscellaneous Reasons|1|||
124785508|NCT04174365|448845260|FG000|Overall Study|Lost to Follow-up|1|||
124785509|NCT04174365|448845261|FG001|Overall Study|Lost to Follow-up|2|||
124626442|NCT00758524|448248051|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
124626443|NCT00758524|448248035|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
124626444|NCT00758524|448248036|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
124785510|NCT04174365|448845260|FG000|Overall Study|Adverse Event|2|||
124785511|NCT04174365|448845261|FG001|Overall Study|Adverse Event|1|||
124785512|NCT04174365|448845260|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
124785513|NCT04174365|448845261|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
124785514|NCT04174365|448845260|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
124785515|NCT04174365|448845261|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
124785516|NCT04174365|448845260|FG000|Overall Study|Protocol Deviation|1|||
124785517|NCT04174365|448845261|FG001|Overall Study|Protocol Deviation|0|||
124785518|NCT04174365|448845260|FG000|Overall Study|Lack of Efficacy|0|||
124785519|NCT04174365|448845261|FG001|Overall Study|Lack of Efficacy|2|||
124785520|NCT04174365|448845260|FG000|Overall Study|Disease Relapse|1|||
124785521|NCT04174365|448845261|FG001|Overall Study|Disease Relapse|0|||
124785522|NCT04174365|448845260|FG000|Overall Study|Reason Not Specified|0|||
124785523|NCT04174365|448845261|FG001|Overall Study|Reason Not Specified|1|||
124785524|NCT02156271|448847889|FG000|Overall Study|Physician Decision|4|||
124785525|NCT02156271|448847890|FG001|Overall Study|Physician Decision|3|||
124785526|NCT00109590|448847891|FG000|Overall Study|Lost to Follow-up|1|||
124785527|NCT00109590|448847892|FG001|Overall Study|Lost to Follow-up|0|||
124785528|NCT00109590|448847893|FG002|Overall Study|Lost to Follow-up|1|||
124785529|NCT00109590|448847891|FG000|Overall Study|Never Started Treatment|1|||
124785530|NCT00109590|448847892|FG001|Overall Study|Never Started Treatment|2|||
124785531|NCT00109590|448847893|FG002|Overall Study|Never Started Treatment|3|||
124785532|NCT00409331|448847897|FG000|Overall Study|Physician Decision|1|||
124785533|NCT01511055|448847902|FG000|Overall Study|Withdrawal by Subject|6|||
124785534|NCT04590248|448847904|FG000|Overall Study|Lost to Follow-up|1|||
124785535|NCT04590248|448847904|FG000|Overall Study|Withdrawal by Subject|16|||
124785536|NCT04590248|448847904|FG000|Overall Study|Other|2|||
124785537|NCT02052414|448847907|FG000|Overall Study|Adverse Event|12|||
124785538|NCT02052414|448847907|FG000|Overall Study|Lack of Efficacy|2|||
124785539|NCT02052414|448847907|FG000|Overall Study|Withdrawal by Subject|3|||
124785540|NCT03263702|448847911|FG000|Overall Study|Lost to Follow-up|2|||
124785541|NCT03263702|448847912|FG001|Overall Study|Lost to Follow-up|2|||
124785542|NCT03263702|448847911|FG000|Overall Study|Withdrawal by Subject|1|||
124785543|NCT03263702|448847912|FG001|Overall Study|Withdrawal by Subject|2|||
124785544|NCT02527200|448847913|FG000|Overall Study|Withdrawal by Subject|3|||
124785545|NCT02527200|448847914|FG001|Overall Study|Withdrawal by Subject|2|||
124785546|NCT02527200|448847915|FG002|Overall Study|Withdrawal by Subject|1|||
124785547|NCT02527200|448847916|FG003|Overall Study|Withdrawal by Subject|0|||
124785548|NCT02527200|448847913|FG000|Overall Study|Unclassified|0|||
124785549|NCT02527200|448847914|FG001|Overall Study|Unclassified|1|||
124785550|NCT02527200|448847915|FG002|Overall Study|Unclassified|0|||
124785551|NCT02527200|448847916|FG003|Overall Study|Unclassified|0|||
124785552|NCT02527200|448847913|FG000|Overall Study|Lost to Follow-up|0|||
124785553|NCT02527200|448847914|FG001|Overall Study|Lost to Follow-up|0|||
124785554|NCT02527200|448847915|FG002|Overall Study|Lost to Follow-up|1|||
124785555|NCT02527200|448847916|FG003|Overall Study|Lost to Follow-up|0|||
124785556|NCT00966875|448847918|FG000|Part A|Adverse Event|2|||
124785557|NCT00966875|448847919|FG001|Part A|Adverse Event|1|||
124785558|NCT00966875|448847920|FG002|Part A|Adverse Event|0|||
124785559|NCT00966875|448847921|FG003|Part A|Adverse Event|1|||
124785560|NCT00966875|448847922|FG004|Part A|Adverse Event|0|||
124785561|NCT00966875|448847923|FG005|Part A|Adverse Event|1|||
124785562|NCT00966875|448847924|FG006|Part A|Adverse Event|0|||
124785563|NCT00966875|448847925|FG007|Part A|Adverse Event|3|||
124785564|NCT00966875|448847926|FG008|Part A|Adverse Event|3|||
124785565|NCT00966875|448847918|FG000|Part A|Entry Criteria|0|||
124785566|NCT00966875|448847919|FG001|Part A|Entry Criteria|0|||
124785567|NCT00966875|448847920|FG002|Part A|Entry Criteria|0|||
124785568|NCT00966875|448847921|FG003|Part A|Entry Criteria|0|||
124785569|NCT00966875|448847922|FG004|Part A|Entry Criteria|0|||
124785570|NCT00966875|448847923|FG005|Part A|Entry Criteria|2|||
124785571|NCT00966875|448847924|FG006|Part A|Entry Criteria|0|||
124785572|NCT00966875|448847925|FG007|Part A|Entry Criteria|0|||
124785573|NCT00966875|448847926|FG008|Part A|Entry Criteria|0|||
124785574|NCT00966875|448847918|FG000|Part A|Lack of Efficacy|0|||
124785575|NCT00966875|448847919|FG001|Part A|Lack of Efficacy|1|||
124785576|NCT00966875|448847920|FG002|Part A|Lack of Efficacy|0|||
124785577|NCT00966875|448847921|FG003|Part A|Lack of Efficacy|0|||
124785578|NCT00966875|448847922|FG004|Part A|Lack of Efficacy|0|||
124785579|NCT00966875|448847923|FG005|Part A|Lack of Efficacy|0|||
124785580|NCT00966875|448847924|FG006|Part A|Lack of Efficacy|4|||
124785581|NCT00966875|448847925|FG007|Part A|Lack of Efficacy|0|||
124785582|NCT00966875|448847926|FG008|Part A|Lack of Efficacy|0|||
124785583|NCT00966875|448847918|FG000|Part A|Lost to Follow-up|2|||
124785584|NCT00966875|448847919|FG001|Part A|Lost to Follow-up|0|||
124785585|NCT00966875|448847920|FG002|Part A|Lost to Follow-up|0|||
124785586|NCT00966875|448847921|FG003|Part A|Lost to Follow-up|0|||
124785587|NCT00966875|448847922|FG004|Part A|Lost to Follow-up|0|||
124785588|NCT00966875|448847923|FG005|Part A|Lost to Follow-up|1|||
124785589|NCT00966875|448847924|FG006|Part A|Lost to Follow-up|0|||
124785590|NCT00966875|448847925|FG007|Part A|Lost to Follow-up|0|||
124785591|NCT00966875|448847926|FG008|Part A|Lost to Follow-up|0|||
124785592|NCT00966875|448847918|FG000|Part A|Parent/Caregiver Decision|0|||
124785593|NCT00966875|448847919|FG001|Part A|Parent/Caregiver Decision|0|||
124785594|NCT00966875|448847920|FG002|Part A|Parent/Caregiver Decision|0|||
124785595|NCT00966875|448847921|FG003|Part A|Parent/Caregiver Decision|1|||
124785596|NCT00966875|448847922|FG004|Part A|Parent/Caregiver Decision|0|||
124785597|NCT00966875|448847923|FG005|Part A|Parent/Caregiver Decision|0|||
124785598|NCT00966875|448847924|FG006|Part A|Parent/Caregiver Decision|0|||
124785599|NCT00966875|448847925|FG007|Part A|Parent/Caregiver Decision|0|||
124785600|NCT00966875|448847926|FG008|Part A|Parent/Caregiver Decision|0|||
124785601|NCT00966875|448847918|FG000|Part A|Physician Decision|0|||
124785602|NCT00966875|448847919|FG001|Part A|Physician Decision|0|||
124785603|NCT00966875|448847920|FG002|Part A|Physician Decision|0|||
124785604|NCT00966875|448847921|FG003|Part A|Physician Decision|0|||
124785605|NCT00966875|448847922|FG004|Part A|Physician Decision|1|||
124785606|NCT00966875|448847923|FG005|Part A|Physician Decision|0|||
124785607|NCT00966875|448847924|FG006|Part A|Physician Decision|1|||
124785608|NCT00966875|448847925|FG007|Part A|Physician Decision|0|||
124785609|NCT00966875|448847926|FG008|Part A|Physician Decision|2|||
124785610|NCT00966875|448847918|FG000|Part A|Sponsor Decision|0|||
124785611|NCT00966875|448847919|FG001|Part A|Sponsor Decision|0|||
124785612|NCT00966875|448847920|FG002|Part A|Sponsor Decision|1|||
124785613|NCT00966875|448847921|FG003|Part A|Sponsor Decision|0|||
124785614|NCT00966875|448847922|FG004|Part A|Sponsor Decision|1|||
124785615|NCT00966875|448847923|FG005|Part A|Sponsor Decision|0|||
124785616|NCT00966875|448847924|FG006|Part A|Sponsor Decision|0|||
124785617|NCT00966875|448847925|FG007|Part A|Sponsor Decision|2|||
124785618|NCT00966875|448847926|FG008|Part A|Sponsor Decision|1|||
124785619|NCT00966875|448847918|FG000|Part A|Withdrawal by Subject|2|||
124785620|NCT00966875|448847919|FG001|Part A|Withdrawal by Subject|2|||
124785621|NCT00966875|448847920|FG002|Part A|Withdrawal by Subject|1|||
124785622|NCT00966875|448847921|FG003|Part A|Withdrawal by Subject|1|||
124785623|NCT00966875|448847922|FG004|Part A|Withdrawal by Subject|3|||
124785624|NCT00966875|448847923|FG005|Part A|Withdrawal by Subject|0|||
124785625|NCT00966875|448847924|FG006|Part A|Withdrawal by Subject|5|||
124785626|NCT00966875|448847925|FG007|Part A|Withdrawal by Subject|1|||
124785627|NCT00966875|448847926|FG008|Part A|Withdrawal by Subject|1|||
124785628|NCT00966875|448847918|FG000|Part A|Protocol Violation|0|||
124785629|NCT00966875|448847919|FG001|Part A|Protocol Violation|0|||
124785630|NCT00966875|448847920|FG002|Part A|Protocol Violation|0|||
124785631|NCT00966875|448847921|FG003|Part A|Protocol Violation|0|||
124785632|NCT00966875|448847922|FG004|Part A|Protocol Violation|0|||
124785633|NCT00966875|448847923|FG005|Part A|Protocol Violation|0|||
124785634|NCT00966875|448847924|FG006|Part A|Protocol Violation|2|||
124785635|NCT00966875|448847925|FG007|Part A|Protocol Violation|1|||
124785636|NCT00966875|448847926|FG008|Part A|Protocol Violation|1|||
124785637|NCT00966875|448847918|FG000|Part B|Adverse Event|0|||
124785638|NCT00966875|448847919|FG001|Part B|Adverse Event|1|||
124785639|NCT00966875|448847920|FG002|Part B|Adverse Event|1|||
124785640|NCT00966875|448847921|FG003|Part B|Adverse Event|0|||
124785641|NCT00966875|448847922|FG004|Part B|Adverse Event|1|||
124785642|NCT00966875|448847923|FG005|Part B|Adverse Event|0|||
124785643|NCT00966875|448847924|FG006|Part B|Adverse Event|5|||
124785644|NCT00966875|448847925|FG007|Part B|Adverse Event|2|||
124785645|NCT00966875|448847926|FG008|Part B|Adverse Event|2|||
124785646|NCT00966875|448847918|FG000|Part B|Death|0|||
124785647|NCT00966875|448847919|FG001|Part B|Death|0|||
124785648|NCT00966875|448847920|FG002|Part B|Death|1|||
124785649|NCT00966875|448847921|FG003|Part B|Death|0|||
124785650|NCT00966875|448847922|FG004|Part B|Death|0|||
124785651|NCT00966875|448847923|FG005|Part B|Death|0|||
124785652|NCT00966875|448847924|FG006|Part B|Death|0|||
124785653|NCT00966875|448847925|FG007|Part B|Death|1|||
124785654|NCT00966875|448847926|FG008|Part B|Death|0|||
124785655|NCT00966875|448847918|FG000|Part B|Lack of Efficacy|2|||
124785656|NCT00966875|448847919|FG001|Part B|Lack of Efficacy|1|||
124785657|NCT00966875|448847920|FG002|Part B|Lack of Efficacy|1|||
124785658|NCT00966875|448847921|FG003|Part B|Lack of Efficacy|1|||
124785659|NCT00966875|448847922|FG004|Part B|Lack of Efficacy|2|||
124785660|NCT00966875|448847923|FG005|Part B|Lack of Efficacy|3|||
124785661|NCT00966875|448847924|FG006|Part B|Lack of Efficacy|12|||
124785662|NCT00966875|448847925|FG007|Part B|Lack of Efficacy|9|||
124785663|NCT00966875|448847926|FG008|Part B|Lack of Efficacy|6|||
124785664|NCT00966875|448847918|FG000|Part B|Lost to Follow-up|0|||
124785665|NCT00966875|448847919|FG001|Part B|Lost to Follow-up|0|||
124785666|NCT00966875|448847920|FG002|Part B|Lost to Follow-up|0|||
124785667|NCT00966875|448847921|FG003|Part B|Lost to Follow-up|1|||
124785668|NCT00966875|448847922|FG004|Part B|Lost to Follow-up|0|||
124785669|NCT00966875|448847923|FG005|Part B|Lost to Follow-up|0|||
124785670|NCT00966875|448847924|FG006|Part B|Lost to Follow-up|0|||
124785671|NCT00966875|448847925|FG007|Part B|Lost to Follow-up|0|||
124785672|NCT00966875|448847926|FG008|Part B|Lost to Follow-up|1|||
124785673|NCT00966875|448847918|FG000|Part B|Physician Decision|0|||
124785674|NCT00966875|448847919|FG001|Part B|Physician Decision|0|||
124785675|NCT00966875|448847920|FG002|Part B|Physician Decision|1|||
124785676|NCT00966875|448847921|FG003|Part B|Physician Decision|0|||
124785677|NCT00966875|448847922|FG004|Part B|Physician Decision|2|||
124785678|NCT00966875|448847923|FG005|Part B|Physician Decision|1|||
124785679|NCT00966875|448847924|FG006|Part B|Physician Decision|0|||
124785680|NCT00966875|448847925|FG007|Part B|Physician Decision|0|||
124785681|NCT00966875|448847926|FG008|Part B|Physician Decision|2|||
124626445|NCT00758524|448248037|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
124785682|NCT00966875|448847918|FG000|Part B|Sponsor Decision|1|||
124785683|NCT00966875|448847919|FG001|Part B|Sponsor Decision|0|||
124785684|NCT00966875|448847920|FG002|Part B|Sponsor Decision|0|||
124785685|NCT00966875|448847921|FG003|Part B|Sponsor Decision|0|||
124785686|NCT00966875|448847922|FG004|Part B|Sponsor Decision|0|||
124785687|NCT00966875|448847923|FG005|Part B|Sponsor Decision|1|||
124785688|NCT00966875|448847924|FG006|Part B|Sponsor Decision|0|||
124785689|NCT00966875|448847925|FG007|Part B|Sponsor Decision|2|||
124785690|NCT00966875|448847926|FG008|Part B|Sponsor Decision|1|||
124785691|NCT00966875|448847918|FG000|Part B|Withdrawal by Subject|2|||
124785692|NCT00966875|448847919|FG001|Part B|Withdrawal by Subject|1|||
124785693|NCT00966875|448847920|FG002|Part B|Withdrawal by Subject|2|||
124785694|NCT00966875|448847921|FG003|Part B|Withdrawal by Subject|1|||
124785695|NCT00966875|448847922|FG004|Part B|Withdrawal by Subject|2|||
124785696|NCT00966875|448847923|FG005|Part B|Withdrawal by Subject|1|||
124785697|NCT00966875|448847924|FG006|Part B|Withdrawal by Subject|4|||
124785698|NCT00966875|448847925|FG007|Part B|Withdrawal by Subject|5|||
124785699|NCT00966875|448847926|FG008|Part B|Withdrawal by Subject|5|||
124785700|NCT00966875|448847918|FG000|Part B|Entry Criteria|0|||
124785701|NCT00966875|448847919|FG001|Part B|Entry Criteria|0|||
124785702|NCT00966875|448847920|FG002|Part B|Entry Criteria|0|||
124785703|NCT00966875|448847921|FG003|Part B|Entry Criteria|0|||
124785704|NCT00966875|448847922|FG004|Part B|Entry Criteria|0|||
124785705|NCT00966875|448847923|FG005|Part B|Entry Criteria|0|||
124785706|NCT00966875|448847924|FG006|Part B|Entry Criteria|1|||
124785707|NCT00966875|448847925|FG007|Part B|Entry Criteria|0|||
124785708|NCT00966875|448847926|FG008|Part B|Entry Criteria|1|||
124785709|NCT04657666|448847929|FG000|Period 1|Withdrawal of participant consent|2|||
124785710|NCT04657666|448847930|FG001|Period 1|Withdrawal of participant consent|1|||
124785711|NCT04657666|448847929|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
124785712|NCT04657666|448847930|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
124785713|NCT04657666|448847929|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
124785714|NCT04657666|448847930|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
124785715|NCT04657666|448847929|FG000|Period 2|Other|2|||
124785716|NCT04657666|448847930|FG001|Period 2|Other|0|||
124785717|NCT04657666|448847929|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
124785718|NCT04657666|448847930|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
124785719|NCT02386189|448847931|FG000|Overall Study|Lost to Follow-up|2|||
124785720|NCT02386189|448847932|FG001|Overall Study|Lost to Follow-up|3|||
124785721|NCT02386189|448847931|FG000|Overall Study|Withdrawal by Subject|1|||
124785722|NCT02386189|448847932|FG001|Overall Study|Withdrawal by Subject|0|||
124785723|NCT02386189|448847931|FG000|Overall Study|Death|1|||
124785724|NCT02386189|448847932|FG001|Overall Study|Death|0|||
124785725|NCT01659554|448847938|FG000|Overall Study|Study Termination|4|||
124785726|NCT01022398|448847941|FG000|Overall Study|Study terminated|2|||
124785727|NCT01022398|448847942|FG001|Overall Study|Study terminated|2|||
124785728|NCT01317550|448847943|FG000|Overall Study|Withdrawal by Subject|1|||
124785729|NCT01317550|448847944|FG001|Overall Study|Withdrawal by Subject|0|||
124785730|NCT01317550|448847945|FG002|Overall Study|Withdrawal by Subject|0|||
124785731|NCT01317550|448847946|FG003|Overall Study|Withdrawal by Subject|0|||
124785732|NCT01317550|448847943|FG000|Overall Study|Lack of compliance study med|1|||
124785733|NCT01317550|448847944|FG001|Overall Study|Lack of compliance study med|0|||
124785734|NCT01317550|448847945|FG002|Overall Study|Lack of compliance study med|0|||
124785735|NCT01317550|448847946|FG003|Overall Study|Lack of compliance study med|0|||
124785736|NCT03179202|448847947|FG000|Overall Study|Screen Failure|67|||
124785737|NCT03179202|448847947|FG000|Overall Study|Subject Lost to Follow Up|12|||
124785738|NCT03179202|448847947|FG000|Overall Study|Withdrawal by Subject|7|||
124785739|NCT03179202|448847947|FG000|Overall Study|Adverse Event|3|||
124785740|NCT03179202|448847947|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
124785741|NCT03179202|448847947|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
124785742|NCT01120782|448847948|FG000|Overall Study|Test article shipping error|11|||
124785743|NCT00640224|448847952|FG000|Overall Study|Lost to Follow-up|5|||
124785744|NCT00640224|448847953|FG001|Overall Study|Lost to Follow-up|2|||
124785745|NCT00640224|448847954|FG002|Overall Study|Lost to Follow-up|0|||
124785746|NCT00640224|448847955|FG003|Overall Study|Lost to Follow-up|0|||
124785747|NCT00640224|448847952|FG000|Overall Study|Withdrawal by Subject|1|||
124785748|NCT00640224|448847953|FG001|Overall Study|Withdrawal by Subject|0|||
124785749|NCT00640224|448847954|FG002|Overall Study|Withdrawal by Subject|0|||
124785750|NCT00640224|448847955|FG003|Overall Study|Withdrawal by Subject|0|||
124785751|NCT00640224|448847952|FG000|Overall Study|Headaches|0|||
124785752|NCT00640224|448847953|FG001|Overall Study|Headaches|1|||
124785753|NCT00640224|448847954|FG002|Overall Study|Headaches|0|||
124785754|NCT00640224|448847955|FG003|Overall Study|Headaches|0|||
124785755|NCT04224688|448847959|FG000|Overall Study|Withdrawal by Subject|1|||
124785756|NCT04224688|448847960|FG001|Overall Study|Withdrawal by Subject|3|||
124785757|NCT04224688|448847959|FG000|Overall Study|Lack of Efficacy|1|||
124785758|NCT04224688|448847960|FG001|Overall Study|Lack of Efficacy|1|||
124785759|NCT04224688|448847959|FG000|Overall Study|Adverse event, not fatal|0|||
124785760|NCT04224688|448847960|FG001|Overall Study|Adverse event, not fatal|2|||
124785761|NCT04224688|448847959|FG000|Overall Study|COVID-19|0|||
124785762|NCT04224688|448847960|FG001|Overall Study|COVID-19|1|||
124785763|NCT01024309|448847966|FG000|Overall Study|Physician Decision|4|||
124785764|NCT01024309|448847967|FG001|Overall Study|Physician Decision|0|||
124785765|NCT01024309|448847966|FG000|Overall Study|Withdrawal by Subject|4|||
124785766|NCT01024309|448847967|FG001|Overall Study|Withdrawal by Subject|4|||
124785767|NCT03232333|448847973|FG000|Overall Study|Infection or Osteomyelitis|9|||
124785768|NCT03232333|448847973|FG000|Overall Study|Lost to Follow-up|4|||
124785769|NCT03232333|448847973|FG000|Overall Study|Withdrawal by Subject|2|||
124785770|NCT00653432|448847977|FG000|Overall Study|Adverse Event|4|||
124785771|NCT00653432|448847978|FG001|Overall Study|Adverse Event|1|||
124626446|NCT00758524|448248038|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
124785772|NCT00653432|448847977|FG000|Overall Study|Withdrawal by Subject|4|||
124785773|NCT00653432|448847978|FG001|Overall Study|Withdrawal by Subject|5|||
124785774|NCT00653432|448847977|FG000|Overall Study|Lost to Follow-up|7|||
124785775|NCT00653432|448847978|FG001|Overall Study|Lost to Follow-up|6|||
124785776|NCT00653432|448847977|FG000|Overall Study|Use/Need of Con Therapy|2|||
124785777|NCT00653432|448847978|FG001|Overall Study|Use/Need of Con Therapy|1|||
124785778|NCT00653432|448847977|FG000|Overall Study|Other - Reason Not Provided|5|||
124785779|NCT00653432|448847978|FG001|Overall Study|Other - Reason Not Provided|3|||
124785780|NCT00567255|448847979|FG000|Overall Study|Adverse Event|241|||
124785781|NCT00567255|448847980|FG001|Overall Study|Adverse Event|68|||
124785782|NCT00567255|448847979|FG000|Overall Study|Lost to Follow-up|77|||
124785783|NCT00567255|448847980|FG001|Overall Study|Lost to Follow-up|48|||
124785784|NCT00567255|448847979|FG000|Overall Study|Withdrawal by Subject|75|||
124785785|NCT00567255|448847980|FG001|Overall Study|Withdrawal by Subject|56|||
124785786|NCT00567255|448847979|FG000|Overall Study|Lack of Efficacy|19|||
124785787|NCT00567255|448847980|FG001|Overall Study|Lack of Efficacy|33|||
124785788|NCT00567255|448847979|FG000|Overall Study|Protocol Violation|20|||
124785789|NCT00567255|448847980|FG001|Overall Study|Protocol Violation|8|||
124785790|NCT00567255|448847979|FG000|Overall Study|Pregnancy|6|||
124785791|NCT00567255|448847980|FG001|Overall Study|Pregnancy|0|||
124785792|NCT00567255|448847979|FG000|Overall Study|Drug noncompliance,moved,other|25|||
124785793|NCT00567255|448847980|FG001|Overall Study|Drug noncompliance,moved,other|15|||
124785794|NCT01290796|448847985|FG000|Overall Study|Lost to Follow-up|21|||
124785795|NCT01290796|448847985|FG000|Overall Study|Withdrawal by Subject|4|||
124785796|NCT01290796|448847985|FG000|Overall Study|Physician Decision|2|||
124785797|NCT01290796|448847985|FG000|Overall Study|Secondary Surgical Intervention|2|||
124785798|NCT01290796|448847985|FG000|Overall Study|Withdrawal by Sponsor|1|||
124785799|NCT02343549|448847986|FG000|Overall Study|Death|11|||
124785800|NCT02343549|448847986|FG000|Overall Study|Withdrawal by Subject|2|||
124785801|NCT03087617|448847987|FG000|Overall Study|Lost to Follow-up|32|||
124785802|NCT03087617|448847988|FG001|Overall Study|Lost to Follow-up|30|||
124785803|NCT03087617|448847989|FG002|Overall Study|Lost to Follow-up|30|||
124785804|NCT03087617|448847990|FG003|Overall Study|Lost to Follow-up|39|||
124785805|NCT01090323|448847992|FG000|Overall Study|Adverse Event|12|||
124785806|NCT01090323|448847993|FG001|Overall Study|Adverse Event|2|||
124785807|NCT01090323|448847992|FG000|Overall Study|Abnormal Lab Values|3|||
124785808|NCT01090323|448847993|FG001|Overall Study|Abnormal Lab Values|1|||
124785809|NCT01090323|448847992|FG000|Overall Study|Abnormal Test Procedure Results|2|||
124785810|NCT01090323|448847993|FG001|Overall Study|Abnormal Test Procedure Results|0|||
124785811|NCT01090323|448847992|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
124785812|NCT01090323|448847993|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124785813|NCT01090323|448847992|FG000|Overall Study|Condition no longer requires drug|5|||
124785814|NCT01090323|448847993|FG001|Overall Study|Condition no longer requires drug|4|||
124785815|NCT01090323|448847992|FG000|Overall Study|Protocol Violation|2|||
124785816|NCT01090323|448847993|FG001|Overall Study|Protocol Violation|1|||
124785817|NCT01090323|448847992|FG000|Overall Study|Withdrew consent|33|||
124785818|NCT01090323|448847993|FG001|Overall Study|Withdrew consent|11|||
124785819|NCT01090323|448847992|FG000|Overall Study|Lost to Follow-up|11|||
124785820|NCT01090323|448847993|FG001|Overall Study|Lost to Follow-up|6|||
124785821|NCT01090323|448847992|FG000|Overall Study|Administrative problems|6|||
124785822|NCT01090323|448847993|FG001|Overall Study|Administrative problems|4|||
124785823|NCT01090323|448847992|FG000|Overall Study|Death|1|||
124785824|NCT01090323|448847993|FG001|Overall Study|Death|2|||
124785825|NCT01090323|448847992|FG000|Overall Study|Stopped end of core|7|||
124785826|NCT01090323|448847993|FG001|Overall Study|Stopped end of core|0|||
124785827|NCT01090323|448847992|FG000|Overall Study|Stopped end of extension 1#|3|||
124785828|NCT01090323|448847993|FG001|Overall Study|Stopped end of extension 1#|1|||
124785829|NCT01864005|448847994|FG000|Overall Study|Protocol Violation|0|||
124785830|NCT01864005|448847995|FG001|Overall Study|Protocol Violation|1|||
124785831|NCT01864005|448847994|FG000|Overall Study|Withdrawal by Subject|0|||
124785832|NCT01864005|448847995|FG001|Overall Study|Withdrawal by Subject|1|||
124785833|NCT01864005|448847994|FG000|Overall Study|Incorrect enrolment|1|||
124785834|NCT01864005|448847995|FG001|Overall Study|Incorrect enrolment|0|||
124785835|NCT01864005|448847994|FG000|Overall Study|Disease need|1|||
124785836|NCT01864005|448847995|FG001|Overall Study|Disease need|1|||
124785837|NCT01864005|448847994|FG000|Overall Study|Need GP IIb/IIIa|1|||
124785838|NCT01864005|448847995|FG001|Overall Study|Need GP IIb/IIIa|3|||
124785839|NCT00763698|448847996|FG000|Overall Study|Unsuccessful Implant|5|||
124785840|NCT00763698|448847996|FG000|Overall Study|Death|4|||
124785841|NCT00763698|448847996|FG000|Overall Study|Withdrawal by Subject|1|||
124785842|NCT02059291|448847997|FG000|Epoch 2|Lack of Efficacy|0|||
124785843|NCT02059291|448847998|FG001|Epoch 2|Lack of Efficacy|0|||
124785844|NCT02059291|448847999|FG002|Epoch 2|Lack of Efficacy|0|||
124785845|NCT02059291|448848000|FG003|Epoch 2|Lack of Efficacy|1|||
124785846|NCT02059291|448848001|FG004|Epoch 2|Lack of Efficacy|0|||
124785847|NCT02059291|448848002|FG005|Epoch 2|Lack of Efficacy|1|||
124785848|NCT02059291|448848003|FG006|Epoch 2|Lack of Efficacy|0|||
124785849|NCT02059291|448848004|FG007|Epoch 2|Lack of Efficacy|0|||
124785850|NCT02059291|448848005|FG008|Epoch 2|Lack of Efficacy|0|||
124785851|NCT02059291|448848006|FG009|Epoch 2|Lack of Efficacy|0|||
124785852|NCT02059291|448848007|FG010|Epoch 2|Lack of Efficacy|0|||
124785853|NCT02059291|448848008|FG011|Epoch 2|Lack of Efficacy|0|||
124785854|NCT02059291|448848009|FG012|Epoch 2|Lack of Efficacy|0|||
124785855|NCT02059291|448848010|FG013|Epoch 2|Lack of Efficacy|0|||
124785856|NCT02059291|448848011|FG014|Epoch 2|Lack of Efficacy|0|||
124785857|NCT02059291|448848012|FG015|Epoch 2|Lack of Efficacy|0|||
124785858|NCT02059291|448848013|FG016|Epoch 2|Lack of Efficacy|0|||
124785859|NCT02059291|448848014|FG017|Epoch 2|Lack of Efficacy|0|||
124785860|NCT02059291|448848015|FG018|Epoch 2|Lack of Efficacy|0|||
124785861|NCT02059291|448848016|FG019|Epoch 2|Lack of Efficacy|0|||
124785862|NCT02059291|448848017|FG020|Epoch 2|Lack of Efficacy|0|||
124785863|NCT02059291|448848018|FG021|Epoch 2|Lack of Efficacy|0|||
124785864|NCT02059291|448848019|FG022|Epoch 2|Lack of Efficacy|0|||
124785865|NCT02059291|448848020|FG023|Epoch 2|Lack of Efficacy|0|||
124785866|NCT02059291|448848021|FG024|Epoch 2|Lack of Efficacy|0|||
124785867|NCT02059291|448847997|FG000|Epoch 2|Adverse Event|0|||
124785868|NCT02059291|448847998|FG001|Epoch 2|Adverse Event|0|||
124785869|NCT02059291|448847999|FG002|Epoch 2|Adverse Event|1|||
124785870|NCT02059291|448848000|FG003|Epoch 2|Adverse Event|1|||
124785871|NCT02059291|448848001|FG004|Epoch 2|Adverse Event|0|||
124785872|NCT02059291|448848002|FG005|Epoch 2|Adverse Event|0|||
124785873|NCT02059291|448848003|FG006|Epoch 2|Adverse Event|0|||
124785874|NCT02059291|448848004|FG007|Epoch 2|Adverse Event|1|||
124785875|NCT02059291|448848005|FG008|Epoch 2|Adverse Event|1|||
124785876|NCT02059291|448848006|FG009|Epoch 2|Adverse Event|0|||
124785877|NCT02059291|448848007|FG010|Epoch 2|Adverse Event|0|||
124785878|NCT02059291|448848008|FG011|Epoch 2|Adverse Event|0|||
124785879|NCT02059291|448848009|FG012|Epoch 2|Adverse Event|0|||
124785880|NCT02059291|448848010|FG013|Epoch 2|Adverse Event|0|||
124785881|NCT02059291|448848011|FG014|Epoch 2|Adverse Event|0|||
124785882|NCT02059291|448848012|FG015|Epoch 2|Adverse Event|0|||
124785883|NCT02059291|448848013|FG016|Epoch 2|Adverse Event|0|||
124785884|NCT02059291|448848014|FG017|Epoch 2|Adverse Event|0|||
124785885|NCT02059291|448848015|FG018|Epoch 2|Adverse Event|0|||
124785886|NCT02059291|448848016|FG019|Epoch 2|Adverse Event|0|||
124785887|NCT02059291|448848017|FG020|Epoch 2|Adverse Event|0|||
124785888|NCT02059291|448848018|FG021|Epoch 2|Adverse Event|0|||
124785889|NCT02059291|448848019|FG022|Epoch 2|Adverse Event|0|||
124785890|NCT02059291|448848020|FG023|Epoch 2|Adverse Event|0|||
124785891|NCT02059291|448848021|FG024|Epoch 2|Adverse Event|0|||
124785892|NCT02059291|448847997|FG000|Epoch 2|Withdrawal by Subject|0|||
124785893|NCT02059291|448847998|FG001|Epoch 2|Withdrawal by Subject|1|||
124785894|NCT02059291|448847999|FG002|Epoch 2|Withdrawal by Subject|0|||
124785895|NCT02059291|448848000|FG003|Epoch 2|Withdrawal by Subject|0|||
124785896|NCT02059291|448848001|FG004|Epoch 2|Withdrawal by Subject|0|||
124785897|NCT02059291|448848002|FG005|Epoch 2|Withdrawal by Subject|1|||
124785898|NCT02059291|448848003|FG006|Epoch 2|Withdrawal by Subject|0|||
124785899|NCT02059291|448848004|FG007|Epoch 2|Withdrawal by Subject|0|||
124785900|NCT02059291|448848005|FG008|Epoch 2|Withdrawal by Subject|1|||
124785901|NCT02059291|448848006|FG009|Epoch 2|Withdrawal by Subject|0|||
124785902|NCT02059291|448848007|FG010|Epoch 2|Withdrawal by Subject|0|||
124785903|NCT02059291|448848008|FG011|Epoch 2|Withdrawal by Subject|0|||
124785904|NCT02059291|448848009|FG012|Epoch 2|Withdrawal by Subject|0|||
124785905|NCT02059291|448848010|FG013|Epoch 2|Withdrawal by Subject|0|||
124785906|NCT02059291|448848011|FG014|Epoch 2|Withdrawal by Subject|0|||
124785907|NCT02059291|448848012|FG015|Epoch 2|Withdrawal by Subject|0|||
124785908|NCT02059291|448848013|FG016|Epoch 2|Withdrawal by Subject|0|||
124785909|NCT02059291|448848014|FG017|Epoch 2|Withdrawal by Subject|0|||
124785910|NCT02059291|448848015|FG018|Epoch 2|Withdrawal by Subject|0|||
124785911|NCT02059291|448848016|FG019|Epoch 2|Withdrawal by Subject|0|||
124785912|NCT02059291|448848017|FG020|Epoch 2|Withdrawal by Subject|0|||
124785913|NCT02059291|448848018|FG021|Epoch 2|Withdrawal by Subject|0|||
124785914|NCT02059291|448848019|FG022|Epoch 2|Withdrawal by Subject|0|||
124785915|NCT02059291|448848020|FG023|Epoch 2|Withdrawal by Subject|0|||
124785916|NCT02059291|448848021|FG024|Epoch 2|Withdrawal by Subject|0|||
124785917|NCT02059291|448847997|FG000|Epoch 3|Physician Decision|0|||
124785918|NCT02059291|448847998|FG001|Epoch 3|Physician Decision|0|||
124785919|NCT02059291|448847999|FG002|Epoch 3|Physician Decision|0|||
124785920|NCT02059291|448848000|FG003|Epoch 3|Physician Decision|0|||
124785921|NCT02059291|448848001|FG004|Epoch 3|Physician Decision|0|||
124785922|NCT02059291|448848002|FG005|Epoch 3|Physician Decision|0|||
124785923|NCT02059291|448848003|FG006|Epoch 3|Physician Decision|0|||
124785924|NCT02059291|448848004|FG007|Epoch 3|Physician Decision|0|||
124785925|NCT02059291|448848005|FG008|Epoch 3|Physician Decision|0|||
124785926|NCT02059291|448848006|FG009|Epoch 3|Physician Decision|0|||
124785927|NCT02059291|448848007|FG010|Epoch 3|Physician Decision|0|||
124785928|NCT02059291|448848008|FG011|Epoch 3|Physician Decision|0|||
124785929|NCT02059291|448848009|FG012|Epoch 3|Physician Decision|0|||
124785930|NCT02059291|448848010|FG013|Epoch 3|Physician Decision|1|||
124785931|NCT02059291|448848011|FG014|Epoch 3|Physician Decision|0|||
124785932|NCT02059291|448848012|FG015|Epoch 3|Physician Decision|1|||
124785933|NCT02059291|448848013|FG016|Epoch 3|Physician Decision|0|||
124785934|NCT02059291|448848014|FG017|Epoch 3|Physician Decision|0|||
124785935|NCT02059291|448848015|FG018|Epoch 3|Physician Decision|0|||
124785936|NCT02059291|448848016|FG019|Epoch 3|Physician Decision|0|||
124785937|NCT02059291|448848017|FG020|Epoch 3|Physician Decision|0|||
124785938|NCT02059291|448848018|FG021|Epoch 3|Physician Decision|0|||
124785939|NCT02059291|448848019|FG022|Epoch 3|Physician Decision|0|||
124785940|NCT02059291|448848020|FG023|Epoch 3|Physician Decision|0|||
124785941|NCT02059291|448848021|FG024|Epoch 3|Physician Decision|0|||
124785942|NCT02059291|448847997|FG000|Epoch 3|Adverse Event|0|||
124785943|NCT02059291|448847998|FG001|Epoch 3|Adverse Event|0|||
124785944|NCT02059291|448847999|FG002|Epoch 3|Adverse Event|0|||
124785945|NCT02059291|448848000|FG003|Epoch 3|Adverse Event|0|||
124785946|NCT02059291|448848001|FG004|Epoch 3|Adverse Event|0|||
124785947|NCT02059291|448848002|FG005|Epoch 3|Adverse Event|0|||
124785948|NCT02059291|448848003|FG006|Epoch 3|Adverse Event|0|||
124785949|NCT02059291|448848004|FG007|Epoch 3|Adverse Event|0|||
124785950|NCT02059291|448848005|FG008|Epoch 3|Adverse Event|0|||
124785951|NCT02059291|448848006|FG009|Epoch 3|Adverse Event|0|||
124785952|NCT02059291|448848007|FG010|Epoch 3|Adverse Event|0|||
124785953|NCT02059291|448848008|FG011|Epoch 3|Adverse Event|0|||
124785954|NCT02059291|448848009|FG012|Epoch 3|Adverse Event|0|||
124785955|NCT02059291|448848010|FG013|Epoch 3|Adverse Event|0|||
124785956|NCT02059291|448848011|FG014|Epoch 3|Adverse Event|0|||
124785957|NCT02059291|448848012|FG015|Epoch 3|Adverse Event|1|||
124785958|NCT02059291|448848013|FG016|Epoch 3|Adverse Event|0|||
124785959|NCT02059291|448848014|FG017|Epoch 3|Adverse Event|0|||
124785960|NCT02059291|448848015|FG018|Epoch 3|Adverse Event|0|||
124785961|NCT02059291|448848016|FG019|Epoch 3|Adverse Event|0|||
124785962|NCT02059291|448848017|FG020|Epoch 3|Adverse Event|0|||
124785963|NCT02059291|448848018|FG021|Epoch 3|Adverse Event|0|||
124785964|NCT02059291|448848019|FG022|Epoch 3|Adverse Event|0|||
124785965|NCT02059291|448848020|FG023|Epoch 3|Adverse Event|0|||
124785966|NCT02059291|448848021|FG024|Epoch 3|Adverse Event|0|||
124785967|NCT02059291|448847997|FG000|Epoch 3|Lack of Efficacy|0|||
124785968|NCT02059291|448847998|FG001|Epoch 3|Lack of Efficacy|0|||
124785969|NCT02059291|448847999|FG002|Epoch 3|Lack of Efficacy|0|||
124785970|NCT02059291|448848000|FG003|Epoch 3|Lack of Efficacy|0|||
124785971|NCT02059291|448848001|FG004|Epoch 3|Lack of Efficacy|0|||
124785972|NCT02059291|448848002|FG005|Epoch 3|Lack of Efficacy|0|||
124785973|NCT02059291|448848003|FG006|Epoch 3|Lack of Efficacy|0|||
124785974|NCT02059291|448848004|FG007|Epoch 3|Lack of Efficacy|0|||
124785975|NCT02059291|448848005|FG008|Epoch 3|Lack of Efficacy|0|||
124785976|NCT02059291|448848006|FG009|Epoch 3|Lack of Efficacy|0|||
124785977|NCT02059291|448848007|FG010|Epoch 3|Lack of Efficacy|0|||
124785978|NCT02059291|448848008|FG011|Epoch 3|Lack of Efficacy|0|||
124785979|NCT02059291|448848009|FG012|Epoch 3|Lack of Efficacy|0|||
124785980|NCT02059291|448848010|FG013|Epoch 3|Lack of Efficacy|0|||
124785981|NCT02059291|448848011|FG014|Epoch 3|Lack of Efficacy|0|||
124785982|NCT02059291|448848012|FG015|Epoch 3|Lack of Efficacy|3|||
124785983|NCT02059291|448848013|FG016|Epoch 3|Lack of Efficacy|0|||
124785984|NCT02059291|448848014|FG017|Epoch 3|Lack of Efficacy|0|||
124785985|NCT02059291|448848015|FG018|Epoch 3|Lack of Efficacy|0|||
124785986|NCT02059291|448848016|FG019|Epoch 3|Lack of Efficacy|0|||
124785987|NCT02059291|448848017|FG020|Epoch 3|Lack of Efficacy|0|||
124785988|NCT02059291|448848018|FG021|Epoch 3|Lack of Efficacy|0|||
124785989|NCT02059291|448848019|FG022|Epoch 3|Lack of Efficacy|0|||
124785990|NCT02059291|448848020|FG023|Epoch 3|Lack of Efficacy|0|||
124785991|NCT02059291|448848021|FG024|Epoch 3|Lack of Efficacy|0|||
124785992|NCT02059291|448847997|FG000|Epoch 3|Withdrawal by Subject|0|||
124785993|NCT02059291|448847998|FG001|Epoch 3|Withdrawal by Subject|0|||
124626447|NCT00758524|448248039|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
124785994|NCT02059291|448847999|FG002|Epoch 3|Withdrawal by Subject|0|||
124785995|NCT02059291|448848000|FG003|Epoch 3|Withdrawal by Subject|0|||
124785996|NCT02059291|448848001|FG004|Epoch 3|Withdrawal by Subject|0|||
124785997|NCT02059291|448848002|FG005|Epoch 3|Withdrawal by Subject|0|||
124626448|NCT00758524|448248040|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
124785998|NCT02059291|448848003|FG006|Epoch 3|Withdrawal by Subject|0|||
124785999|NCT02059291|448848004|FG007|Epoch 3|Withdrawal by Subject|0|||
124786000|NCT02059291|448848005|FG008|Epoch 3|Withdrawal by Subject|0|||
124786001|NCT02059291|448848006|FG009|Epoch 3|Withdrawal by Subject|0|||
124786002|NCT02059291|448848007|FG010|Epoch 3|Withdrawal by Subject|0|||
124786003|NCT02059291|448848008|FG011|Epoch 3|Withdrawal by Subject|0|||
124786004|NCT02059291|448848009|FG012|Epoch 3|Withdrawal by Subject|0|||
124786005|NCT02059291|448848010|FG013|Epoch 3|Withdrawal by Subject|0|||
124786006|NCT02059291|448848011|FG014|Epoch 3|Withdrawal by Subject|0|||
124786007|NCT02059291|448848012|FG015|Epoch 3|Withdrawal by Subject|1|||
124786008|NCT02059291|448848013|FG016|Epoch 3|Withdrawal by Subject|0|||
124786009|NCT02059291|448848014|FG017|Epoch 3|Withdrawal by Subject|0|||
124786010|NCT02059291|448848015|FG018|Epoch 3|Withdrawal by Subject|0|||
124786011|NCT02059291|448848016|FG019|Epoch 3|Withdrawal by Subject|0|||
124786012|NCT02059291|448848017|FG020|Epoch 3|Withdrawal by Subject|0|||
124786013|NCT02059291|448848018|FG021|Epoch 3|Withdrawal by Subject|0|||
124786014|NCT02059291|448848019|FG022|Epoch 3|Withdrawal by Subject|0|||
124786015|NCT02059291|448848020|FG023|Epoch 3|Withdrawal by Subject|0|||
124786016|NCT02059291|448848021|FG024|Epoch 3|Withdrawal by Subject|0|||
124786017|NCT02059291|448847997|FG000|Epoch 4|Adverse Event|0|||
124786018|NCT02059291|448847998|FG001|Epoch 4|Adverse Event|0|||
124786019|NCT02059291|448847999|FG002|Epoch 4|Adverse Event|0|||
124786020|NCT02059291|448848000|FG003|Epoch 4|Adverse Event|0|||
124786021|NCT02059291|448848001|FG004|Epoch 4|Adverse Event|0|||
124786022|NCT02059291|448848002|FG005|Epoch 4|Adverse Event|0|||
124786023|NCT02059291|448848003|FG006|Epoch 4|Adverse Event|0|||
124786024|NCT02059291|448848004|FG007|Epoch 4|Adverse Event|0|||
124786025|NCT02059291|448848005|FG008|Epoch 4|Adverse Event|0|||
124786026|NCT02059291|448848006|FG009|Epoch 4|Adverse Event|0|||
124786027|NCT02059291|448848007|FG010|Epoch 4|Adverse Event|0|||
124786028|NCT02059291|448848008|FG011|Epoch 4|Adverse Event|0|||
124786029|NCT02059291|448848009|FG012|Epoch 4|Adverse Event|0|||
124786030|NCT02059291|448848010|FG013|Epoch 4|Adverse Event|0|||
124786031|NCT02059291|448848011|FG014|Epoch 4|Adverse Event|0|||
124786032|NCT02059291|448848012|FG015|Epoch 4|Adverse Event|0|||
124786033|NCT02059291|448848013|FG016|Epoch 4|Adverse Event|1|||
124786034|NCT02059291|448848014|FG017|Epoch 4|Adverse Event|0|||
124786035|NCT02059291|448848015|FG018|Epoch 4|Adverse Event|0|||
124786036|NCT02059291|448848016|FG019|Epoch 4|Adverse Event|0|||
124786037|NCT02059291|448848017|FG020|Epoch 4|Adverse Event|0|||
124786038|NCT02059291|448848018|FG021|Epoch 4|Adverse Event|0|||
124786039|NCT02059291|448848019|FG022|Epoch 4|Adverse Event|1|||
124786040|NCT02059291|448848020|FG023|Epoch 4|Adverse Event|0|||
124786041|NCT02059291|448848021|FG024|Epoch 4|Adverse Event|0|||
124786042|NCT02059291|448847997|FG000|Epoch 4|Pregnancy|0|||
124786043|NCT02059291|448847998|FG001|Epoch 4|Pregnancy|0|||
124786044|NCT02059291|448847999|FG002|Epoch 4|Pregnancy|0|||
124786045|NCT02059291|448848000|FG003|Epoch 4|Pregnancy|0|||
124786046|NCT02059291|448848001|FG004|Epoch 4|Pregnancy|0|||
124786047|NCT02059291|448848002|FG005|Epoch 4|Pregnancy|0|||
124786048|NCT02059291|448848003|FG006|Epoch 4|Pregnancy|0|||
124786049|NCT02059291|448848004|FG007|Epoch 4|Pregnancy|0|||
124786050|NCT02059291|448848005|FG008|Epoch 4|Pregnancy|0|||
124786051|NCT02059291|448848006|FG009|Epoch 4|Pregnancy|0|||
124786052|NCT02059291|448848007|FG010|Epoch 4|Pregnancy|0|||
124786053|NCT02059291|448848008|FG011|Epoch 4|Pregnancy|0|||
124786054|NCT02059291|448848009|FG012|Epoch 4|Pregnancy|0|||
124786055|NCT02059291|448848010|FG013|Epoch 4|Pregnancy|0|||
124786056|NCT02059291|448848011|FG014|Epoch 4|Pregnancy|0|||
124786057|NCT02059291|448848012|FG015|Epoch 4|Pregnancy|0|||
124786058|NCT02059291|448848013|FG016|Epoch 4|Pregnancy|1|||
124786059|NCT02059291|448848014|FG017|Epoch 4|Pregnancy|0|||
124786060|NCT02059291|448848015|FG018|Epoch 4|Pregnancy|0|||
124786061|NCT02059291|448848016|FG019|Epoch 4|Pregnancy|0|||
124786062|NCT02059291|448848017|FG020|Epoch 4|Pregnancy|0|||
124786063|NCT02059291|448848018|FG021|Epoch 4|Pregnancy|0|||
124786064|NCT02059291|448848019|FG022|Epoch 4|Pregnancy|0|||
124786065|NCT02059291|448848020|FG023|Epoch 4|Pregnancy|0|||
124786066|NCT02059291|448848021|FG024|Epoch 4|Pregnancy|0|||
124786067|NCT02059291|448847997|FG000|Epoch 4|Withdrawal by Subject|0|||
124786068|NCT02059291|448847998|FG001|Epoch 4|Withdrawal by Subject|0|||
124786069|NCT02059291|448847999|FG002|Epoch 4|Withdrawal by Subject|0|||
124786070|NCT02059291|448848000|FG003|Epoch 4|Withdrawal by Subject|0|||
124786071|NCT02059291|448848001|FG004|Epoch 4|Withdrawal by Subject|0|||
124786072|NCT02059291|448848002|FG005|Epoch 4|Withdrawal by Subject|0|||
124786073|NCT02059291|448848003|FG006|Epoch 4|Withdrawal by Subject|0|||
124786074|NCT02059291|448848004|FG007|Epoch 4|Withdrawal by Subject|0|||
124786075|NCT02059291|448848005|FG008|Epoch 4|Withdrawal by Subject|0|||
124786076|NCT02059291|448848006|FG009|Epoch 4|Withdrawal by Subject|0|||
124786077|NCT02059291|448848007|FG010|Epoch 4|Withdrawal by Subject|0|||
124786078|NCT02059291|448848008|FG011|Epoch 4|Withdrawal by Subject|0|||
124786079|NCT02059291|448848009|FG012|Epoch 4|Withdrawal by Subject|0|||
124786080|NCT02059291|448848010|FG013|Epoch 4|Withdrawal by Subject|0|||
124786081|NCT02059291|448848011|FG014|Epoch 4|Withdrawal by Subject|0|||
124786082|NCT02059291|448848012|FG015|Epoch 4|Withdrawal by Subject|0|||
124786083|NCT02059291|448848013|FG016|Epoch 4|Withdrawal by Subject|0|||
124786084|NCT02059291|448848014|FG017|Epoch 4|Withdrawal by Subject|0|||
124786085|NCT02059291|448848015|FG018|Epoch 4|Withdrawal by Subject|0|||
124786086|NCT02059291|448848016|FG019|Epoch 4|Withdrawal by Subject|0|||
124786087|NCT02059291|448848017|FG020|Epoch 4|Withdrawal by Subject|1|||
124786088|NCT02059291|448848018|FG021|Epoch 4|Withdrawal by Subject|0|||
124786089|NCT02059291|448848019|FG022|Epoch 4|Withdrawal by Subject|0|||
124786090|NCT02059291|448848020|FG023|Epoch 4|Withdrawal by Subject|0|||
124786091|NCT02059291|448848021|FG024|Epoch 4|Withdrawal by Subject|0|||
124786092|NCT02059291|448847997|FG000|Epoch 4|Lack of Efficacy|0|||
124786093|NCT02059291|448847998|FG001|Epoch 4|Lack of Efficacy|0|||
124786094|NCT02059291|448847999|FG002|Epoch 4|Lack of Efficacy|0|||
124786095|NCT02059291|448848000|FG003|Epoch 4|Lack of Efficacy|0|||
124786096|NCT02059291|448848001|FG004|Epoch 4|Lack of Efficacy|0|||
124786097|NCT02059291|448848002|FG005|Epoch 4|Lack of Efficacy|0|||
124786098|NCT02059291|448848003|FG006|Epoch 4|Lack of Efficacy|0|||
124786099|NCT02059291|448848004|FG007|Epoch 4|Lack of Efficacy|0|||
124786100|NCT02059291|448848005|FG008|Epoch 4|Lack of Efficacy|0|||
124786101|NCT02059291|448848006|FG009|Epoch 4|Lack of Efficacy|0|||
124786102|NCT02059291|448848007|FG010|Epoch 4|Lack of Efficacy|0|||
124786103|NCT02059291|448848008|FG011|Epoch 4|Lack of Efficacy|0|||
124786104|NCT02059291|448848009|FG012|Epoch 4|Lack of Efficacy|0|||
124786105|NCT02059291|448848010|FG013|Epoch 4|Lack of Efficacy|0|||
124786106|NCT02059291|448848011|FG014|Epoch 4|Lack of Efficacy|0|||
124786107|NCT02059291|448848012|FG015|Epoch 4|Lack of Efficacy|0|||
124786108|NCT02059291|448848013|FG016|Epoch 4|Lack of Efficacy|0|||
124786109|NCT02059291|448848014|FG017|Epoch 4|Lack of Efficacy|0|||
124786110|NCT02059291|448848015|FG018|Epoch 4|Lack of Efficacy|0|||
124786111|NCT02059291|448848016|FG019|Epoch 4|Lack of Efficacy|0|||
124786112|NCT02059291|448848017|FG020|Epoch 4|Lack of Efficacy|0|||
124786113|NCT02059291|448848018|FG021|Epoch 4|Lack of Efficacy|0|||
124786114|NCT02059291|448848019|FG022|Epoch 4|Lack of Efficacy|0|||
124786115|NCT02059291|448848020|FG023|Epoch 4|Lack of Efficacy|1|||
124786116|NCT02059291|448848021|FG024|Epoch 4|Lack of Efficacy|0|||
124786117|NCT01433289|448848022|FG000|Overall Study|Pregnancy|0|||
124786118|NCT01433289|448848023|FG001|Overall Study|Pregnancy|1|||
124786119|NCT01433289|448848024|FG002|Overall Study|Pregnancy|0|||
124786120|NCT01433289|448848025|FG003|Overall Study|Pregnancy|0|||
124786121|NCT03241368|448848026|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
124786122|NCT03241368|448848026|FG000|Overall Study|Lost to Follow-up|1|||
124786123|NCT03241368|448848026|FG000|Overall Study|Physician Decision|6|||
124786124|NCT03241368|448848026|FG000|Overall Study|Withdrawal by Subject|6|||
124786125|NCT03241368|448848026|FG000|Overall Study|Protocol Violation|1|||
124786126|NCT00080899|448848029|FG000|Overall Study|Adverse Event|1|||
124786127|NCT00787267|448848031|FG000|Overall Study|Screen failure/Ineligible|10|||
124786128|NCT00787267|448848031|FG000|Overall Study|No Reason Provided|1|||
124786129|NCT00787267|448848031|FG000|Overall Study|Withdrawal by Subject|1|||
124786130|NCT04343235|448848032|FG000|Overall Study|Lost to Follow-up|3|||
124786131|NCT04343235|448848033|FG001|Overall Study|Lost to Follow-up|2|||
124786132|NCT00865280|448848034|FG000|Overall Study|Withdrawal by Subject|4|||
124786133|NCT00865280|448848035|FG001|Overall Study|Withdrawal by Subject|1|||
124786134|NCT00865280|448848034|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
124786135|NCT00865280|448848035|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
124786136|NCT00865280|448848034|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
124786137|NCT00865280|448848035|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
124786138|NCT00865280|448848034|FG000|Overall Study|Exclusion Condition|1|||
124786139|NCT00865280|448848035|FG001|Overall Study|Exclusion Condition|0|||
124786140|NCT00865280|448848034|FG000|Overall Study|Adverse Event|0|||
124786141|NCT00865280|448848035|FG001|Overall Study|Adverse Event|1|||
124786142|NCT01616693|448848036|FG000|Evaluated for Safety|Physician Decision|1|||
124786143|NCT01616693|448848037|FG001|Evaluated for Safety|Physician Decision|0|||
124786144|NCT01616693|448848038|FG002|Evaluated for Safety|Physician Decision|1|||
124786145|NCT01616693|448848039|FG003|Evaluated for Safety|Physician Decision|0|||
124786146|NCT01616693|448848036|FG000|Received Both Vaccines|Adverse Event|2|||
124786147|NCT01616693|448848037|FG001|Received Both Vaccines|Adverse Event|0|||
124786148|NCT01616693|448848038|FG002|Received Both Vaccines|Adverse Event|0|||
124786149|NCT01616693|448848039|FG003|Received Both Vaccines|Adverse Event|0|||
124786150|NCT01616693|448848036|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
124786151|NCT01616693|448848037|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
124786152|NCT01616693|448848038|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
124786153|NCT01616693|448848039|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
124786154|NCT01616693|448848036|FG000|Received Both Vaccines|Lost to Follow-up|4|||
124786155|NCT01616693|448848037|FG001|Received Both Vaccines|Lost to Follow-up|3|||
124786156|NCT01616693|448848038|FG002|Received Both Vaccines|Lost to Follow-up|4|||
124786157|NCT01616693|448848039|FG003|Received Both Vaccines|Lost to Follow-up|4|||
124786158|NCT01616693|448848036|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
124786159|NCT01616693|448848037|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
124786160|NCT01616693|448848038|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
124786161|NCT01616693|448848039|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
124786162|NCT00653939|448848040|FG000|Overall Study|Adverse Event|1|||
124786163|NCT00653939|448848041|FG001|Overall Study|Adverse Event|3|||
124786164|NCT00653939|448848040|FG000|Overall Study|Withdrawal by Subject|3|||
124786165|NCT00653939|448848041|FG001|Overall Study|Withdrawal by Subject|3|||
124786166|NCT00653939|448848040|FG000|Overall Study|Physician Decision|4|||
124786167|NCT00653939|448848041|FG001|Overall Study|Physician Decision|0|||
124786168|NCT00653939|448848040|FG000|Overall Study|Disease Progression|2|||
124786169|NCT00653939|448848041|FG001|Overall Study|Disease Progression|3|||
124786170|NCT00653939|448848040|FG000|Overall Study|Other|2|||
124786171|NCT00653939|448848041|FG001|Overall Study|Other|6|||
124786172|NCT01105767|448848042|FG000|Overall Study|Lost to Follow-up|1160|||
124786173|NCT01105767|448848043|FG001|Overall Study|Lost to Follow-up|1614|||
124786174|NCT01105767|448848044|FG002|Overall Study|Lost to Follow-up|1184|||
124786175|NCT00743106|448848045|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
124786176|NCT00743106|448848046|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
124786177|NCT02874144|448848051|FG000|Overall Study|Lost to Follow-up|3|||
124786178|NCT02874144|448848052|FG001|Overall Study|Lost to Follow-up|5|||
124786179|NCT00486811|448848053|FG000|Overall Study|Adverse Event|28|||
124786180|NCT00486811|448848054|FG001|Overall Study|Adverse Event|60|||
124786181|NCT00486811|448848055|FG002|Overall Study|Adverse Event|135|||
124786182|NCT00486811|448848053|FG000|Overall Study|Lack of Efficacy|34|||
124786183|NCT00486811|448848054|FG001|Overall Study|Lack of Efficacy|14|||
124786184|NCT00486811|448848055|FG002|Overall Study|Lack of Efficacy|7|||
124786185|NCT00486811|448848053|FG000|Overall Study|Lost to Follow-up|4|||
124786186|NCT00486811|448848054|FG001|Overall Study|Lost to Follow-up|6|||
124786187|NCT00486811|448848055|FG002|Overall Study|Lost to Follow-up|4|||
124786188|NCT00486811|448848053|FG000|Overall Study|Withdrawal by Subject|33|||
124786189|NCT00486811|448848054|FG001|Overall Study|Withdrawal by Subject|44|||
124786190|NCT00486811|448848055|FG002|Overall Study|Withdrawal by Subject|58|||
124786191|NCT00486811|448848053|FG000|Overall Study|Study drug non-compliant|5|||
124786192|NCT00486811|448848054|FG001|Overall Study|Study drug non-compliant|6|||
124786193|NCT00486811|448848055|FG002|Overall Study|Study drug non-compliant|3|||
124786194|NCT00486811|448848053|FG000|Overall Study|All other|18|||
124786195|NCT00486811|448848054|FG001|Overall Study|All other|11|||
124786196|NCT00486811|448848055|FG002|Overall Study|All other|7|||
124786197|NCT03753789|448848058|FG000|Overall Study|Withdrawal by Subject|2|||
124786198|NCT01711216|448848065|FG000|Overall Study|Adverse Event|4|||
124786199|NCT01711216|448848065|FG000|Overall Study|Pregnancy|56|||
124786200|NCT01711216|448848065|FG000|Overall Study|Withdrawal by Subject|6|||
124786201|NCT01711216|448848065|FG000|Overall Study|Lost to Follow-up|46|||
124786202|NCT01711216|448848065|FG000|Overall Study|variety of other minor reasons|83|||
124786203|NCT01711216|448848065|FG000|Overall Study|no reason specified|22|||
124786204|NCT00946153|448848067|FG000|Phase 2|Adverse Event|0|||
124786205|NCT00946153|448848068|FG001|Phase 2|Adverse Event|0|||
124786206|NCT00946153|448848069|FG002|Phase 2|Adverse Event|0|||
124786207|NCT00946153|448848070|FG003|Phase 2|Adverse Event|0|||
124786208|NCT00946153|448848071|FG004|Phase 2|Adverse Event|6|||
124786209|NCT00946153|448848067|FG000|Phase 2|Need more reduction of dose|0|||
124786210|NCT00946153|448848068|FG001|Phase 2|Need more reduction of dose|0|||
124786211|NCT00946153|448848069|FG002|Phase 2|Need more reduction of dose|0|||
124786212|NCT00946153|448848070|FG003|Phase 2|Need more reduction of dose|0|||
124786213|NCT00946153|448848071|FG004|Phase 2|Need more reduction of dose|2|||
124786214|NCT00946153|448848067|FG000|Phase 2|Physician Decision|0|||
124786215|NCT00946153|448848068|FG001|Phase 2|Physician Decision|0|||
124786216|NCT00946153|448848069|FG002|Phase 2|Physician Decision|0|||
124786217|NCT00946153|448848070|FG003|Phase 2|Physician Decision|0|||
124786218|NCT00946153|448848071|FG004|Phase 2|Physician Decision|1|||
124786219|NCT00946153|448848067|FG000|Phase 2|14 days washout for recovery due to AE|0|||
124786220|NCT00946153|448848068|FG001|Phase 2|14 days washout for recovery due to AE|0|||
124786221|NCT00946153|448848069|FG002|Phase 2|14 days washout for recovery due to AE|0|||
124786222|NCT00946153|448848070|FG003|Phase 2|14 days washout for recovery due to AE|0|||
124786223|NCT00946153|448848071|FG004|Phase 2|14 days washout for recovery due to AE|4|||
124786224|NCT01030666|448848072|FG000|Overall Study|Lost to Follow-up|3|||
124786225|NCT01030666|448848073|FG001|Overall Study|Lost to Follow-up|2|||
124786226|NCT03698591|448848075|FG000|Overall Study|Withdrawal by Subject|2|||
124786227|NCT03698591|448848076|FG001|Overall Study|Withdrawal by Subject|2|||
124786228|NCT03698591|448848075|FG000|Overall Study|Failed drug screen|1|||
124786229|NCT03698591|448848076|FG001|Overall Study|Failed drug screen|1|||
124786230|NCT03698591|448848075|FG000|Overall Study|Failed health screen|0|||
124786231|NCT03698591|448848076|FG001|Overall Study|Failed health screen|1|||
124786232|NCT03698591|448848075|FG000|Overall Study|Ineligible for financial compensation|1|||
124786233|NCT03698591|448848076|FG001|Overall Study|Ineligible for financial compensation|0|||
124786234|NCT03698591|448848075|FG000|Overall Study|Equipment Error|1|||
124786235|NCT03698591|448848076|FG001|Overall Study|Equipment Error|0|||
124786236|NCT03698591|448848075|FG000|Overall Study|Could not establish TMS dosage|0|||
124786237|NCT03698591|448848076|FG001|Overall Study|Could not establish TMS dosage|1|||
124786238|NCT00831493|448848080|FG000|Overall Study|Intractable nausea and vomiting|1|||
124786239|NCT00557856|448848087|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
124786240|NCT00557856|448848088|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
124786241|NCT00557856|448848089|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
124786242|NCT00557856|448848090|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
124786243|NCT00557856|448848091|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
124786244|NCT00557856|448848092|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
124786245|NCT00557856|448848093|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
124786246|NCT00557856|448848094|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
124786247|NCT00557856|448848095|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
124786248|NCT00557856|448848087|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
124786249|NCT00557856|448848088|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
124786250|NCT00557856|448848089|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
124786251|NCT00557856|448848090|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
124786252|NCT00557856|448848091|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
124786253|NCT00557856|448848092|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
124786254|NCT00557856|448848093|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
124786255|NCT00557856|448848094|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
124786256|NCT00557856|448848095|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
124786257|NCT00557856|448848087|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
124786258|NCT00557856|448848088|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
124786259|NCT00557856|448848089|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
124786260|NCT00557856|448848090|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
124786261|NCT00557856|448848091|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
124786262|NCT00557856|448848092|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
124786263|NCT00557856|448848093|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
124786264|NCT00557856|448848094|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
124786265|NCT00557856|448848095|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
124786266|NCT00557856|448848087|FG000|Part 1: Dose Escalation Phase|Other|0|||
124786267|NCT00557856|448848088|FG001|Part 1: Dose Escalation Phase|Other|0|||
124786268|NCT00557856|448848089|FG002|Part 1: Dose Escalation Phase|Other|1|||
124786269|NCT00557856|448848090|FG003|Part 1: Dose Escalation Phase|Other|1|||
124786270|NCT00557856|448848091|FG004|Part 1: Dose Escalation Phase|Other|0|||
124786271|NCT00557856|448848092|FG005|Part 1: Dose Escalation Phase|Other|0|||
124786272|NCT00557856|448848093|FG006|Part 1: Dose Escalation Phase|Other|0|||
124786273|NCT00557856|448848094|FG007|Part 1: Dose Escalation Phase|Other|1|||
124786274|NCT00557856|448848095|FG008|Part 1: Dose Escalation Phase|Other|0|||
124786275|NCT00557856|448848087|FG000|Part 1: Dose Escalation Phase|Death|0|||
124786276|NCT00557856|448848088|FG001|Part 1: Dose Escalation Phase|Death|0|||
124786277|NCT00557856|448848089|FG002|Part 1: Dose Escalation Phase|Death|0|||
124786278|NCT00557856|448848090|FG003|Part 1: Dose Escalation Phase|Death|0|||
124786279|NCT00557856|448848091|FG004|Part 1: Dose Escalation Phase|Death|0|||
124786280|NCT00557856|448848092|FG005|Part 1: Dose Escalation Phase|Death|1|||
124786281|NCT00557856|448848093|FG006|Part 1: Dose Escalation Phase|Death|0|||
124786282|NCT00557856|448848094|FG007|Part 1: Dose Escalation Phase|Death|0|||
124786283|NCT00557856|448848095|FG008|Part 1: Dose Escalation Phase|Death|0|||
124786284|NCT00557856|448848087|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
124786285|NCT00557856|448848088|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
124786286|NCT00557856|448848089|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
124786287|NCT00557856|448848090|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
124786288|NCT00557856|448848091|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
124786289|NCT00557856|448848092|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
124786290|NCT00557856|448848093|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
124786291|NCT00557856|448848094|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
124786292|NCT00557856|448848095|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
124786293|NCT00557856|448848087|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
124786294|NCT00557856|448848088|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
124786295|NCT00557856|448848089|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
124786296|NCT00557856|448848090|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
124786297|NCT00557856|448848091|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
124786298|NCT00557856|448848092|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
124786299|NCT00557856|448848093|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
124786300|NCT00557856|448848094|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
124786301|NCT00557856|448848095|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
124786302|NCT00557856|448848087|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
124786303|NCT00557856|448848088|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
124786304|NCT00557856|448848089|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
124786305|NCT00557856|448848090|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
124786306|NCT00557856|448848091|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
124786307|NCT00557856|448848092|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
124786308|NCT00557856|448848093|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
124786309|NCT00557856|448848094|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
124786310|NCT00557856|448848095|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
124786311|NCT00557856|448848087|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
124786312|NCT00557856|448848088|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
124786313|NCT00557856|448848089|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
124786314|NCT00557856|448848090|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
124786315|NCT00557856|448848091|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
124786316|NCT00557856|448848092|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
124786317|NCT00557856|448848093|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
124786318|NCT00557856|448848094|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
124786319|NCT00557856|448848095|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
124786320|NCT00557856|448848087|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
124786321|NCT00557856|448848088|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
124786322|NCT00557856|448848089|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
124786323|NCT00557856|448848090|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
124786324|NCT00557856|448848091|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
124786325|NCT00557856|448848092|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
124786326|NCT00557856|448848093|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
124786327|NCT00557856|448848094|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
124786328|NCT00557856|448848095|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
124786329|NCT00557856|448848087|FG000|Part 2: Exploratory Phase|Other|0|||
124786330|NCT00557856|448848088|FG001|Part 2: Exploratory Phase|Other|0|||
124786331|NCT00557856|448848089|FG002|Part 2: Exploratory Phase|Other|0|||
124786332|NCT00557856|448848090|FG003|Part 2: Exploratory Phase|Other|0|||
124786333|NCT00557856|448848091|FG004|Part 2: Exploratory Phase|Other|0|||
124786334|NCT00557856|448848092|FG005|Part 2: Exploratory Phase|Other|0|||
124786335|NCT00557856|448848093|FG006|Part 2: Exploratory Phase|Other|0|||
124786336|NCT00557856|448848094|FG007|Part 2: Exploratory Phase|Other|0|||
124786337|NCT00557856|448848095|FG008|Part 2: Exploratory Phase|Other|1|||
124786338|NCT00557856|448848087|FG000|Part 2: Exploratory Phase|Death|0|||
124786339|NCT00557856|448848088|FG001|Part 2: Exploratory Phase|Death|0|||
124786340|NCT00557856|448848089|FG002|Part 2: Exploratory Phase|Death|0|||
124786341|NCT00557856|448848090|FG003|Part 2: Exploratory Phase|Death|0|||
124786342|NCT00557856|448848091|FG004|Part 2: Exploratory Phase|Death|0|||
124786343|NCT00557856|448848092|FG005|Part 2: Exploratory Phase|Death|0|||
124786344|NCT00557856|448848093|FG006|Part 2: Exploratory Phase|Death|0|||
124786345|NCT00557856|448848094|FG007|Part 2: Exploratory Phase|Death|0|||
124786346|NCT00557856|448848095|FG008|Part 2: Exploratory Phase|Death|2|||
124786347|NCT00557856|448848087|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
124786348|NCT00557856|448848088|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
124786349|NCT00557856|448848089|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
124786350|NCT00557856|448848090|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
124786351|NCT00557856|448848091|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
124786352|NCT00557856|448848092|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
124786353|NCT00557856|448848093|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
124786354|NCT00557856|448848094|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
124786355|NCT00557856|448848095|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
124786356|NCT01675167|448848096|FG000|Open-label Titration Phase|Adverse Event|81|||
124786357|NCT01675167|448848097|FG001|Open-label Titration Phase|Adverse Event|0|||
124786358|NCT01675167|448848098|FG002|Open-label Titration Phase|Adverse Event|0|||
124786359|NCT01675167|448848096|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
124786360|NCT01675167|448848097|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
124786361|NCT01675167|448848098|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
124786362|NCT01675167|448848096|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
124786363|NCT01675167|448848097|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
124786364|NCT01675167|448848098|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
124786365|NCT01675167|448848096|FG000|Open-label Titration Phase|Protocol Violation|43|||
124786366|NCT01675167|448848097|FG001|Open-label Titration Phase|Protocol Violation|0|||
124786367|NCT01675167|448848098|FG002|Open-label Titration Phase|Protocol Violation|0|||
124786368|NCT01675167|448848096|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
124786369|NCT01675167|448848097|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
124786370|NCT01675167|448848098|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
124786371|NCT01675167|448848096|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
124786372|NCT01675167|448848097|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
124786373|NCT01675167|448848098|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
124786374|NCT01675167|448848096|FG000|Open-label Titration Phase|Other|55|||
124786375|NCT01675167|448848097|FG001|Open-label Titration Phase|Other|0|||
124786376|NCT01675167|448848098|FG002|Open-label Titration Phase|Other|0|||
124786377|NCT01675167|448848096|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
124786378|NCT01675167|448848097|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
124786379|NCT01675167|448848098|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
124786380|NCT01675167|448848096|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124786381|NCT01675167|448848097|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
124786382|NCT01675167|448848098|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
124786383|NCT01675167|448848096|FG000|Double-blind Treatment Phase|Adverse Event|0|||
124786384|NCT01675167|448848097|FG001|Double-blind Treatment Phase|Adverse Event|5|||
124786385|NCT01675167|448848098|FG002|Double-blind Treatment Phase|Adverse Event|13|||
124786386|NCT01675167|448848096|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
124786387|NCT01675167|448848097|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
124786388|NCT01675167|448848098|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
124786389|NCT01675167|448848096|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
124786390|NCT01675167|448848097|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
124786391|NCT01675167|448848098|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
124786392|NCT01675167|448848096|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
124786393|NCT01675167|448848097|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
124786394|NCT01675167|448848098|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
124786395|NCT01675167|448848096|FG000|Double-blind Treatment Phase|Other|0|||
124786396|NCT01675167|448848097|FG001|Double-blind Treatment Phase|Other|7|||
124786397|NCT01675167|448848098|FG002|Double-blind Treatment Phase|Other|5|||
124786398|NCT01925131|448850166|FG000|Overall Study|Death|0|||
124786399|NCT01925131|448850167|FG001|Overall Study|Death|0|||
124786400|NCT01925131|448850168|FG002|Overall Study|Death|1|||
124786401|NCT01925131|448850169|FG003|Overall Study|Death|0|||
124786402|NCT01925131|448850170|FG004|Overall Study|Death|0|||
124786403|NCT01925131|448850171|FG005|Overall Study|Death|0|||
124786404|NCT01925131|448850166|FG000|Overall Study|Progression/Relapse|1|||
124786405|NCT01925131|448850167|FG001|Overall Study|Progression/Relapse|1|||
124786406|NCT01925131|448850168|FG002|Overall Study|Progression/Relapse|4|||
124786407|NCT01925131|448850169|FG003|Overall Study|Progression/Relapse|0|||
124786408|NCT01925131|448850170|FG004|Overall Study|Progression/Relapse|0|||
124786409|NCT01925131|448850171|FG005|Overall Study|Progression/Relapse|1|||
124786410|NCT01925131|448850166|FG000|Overall Study|Patient Refusal|1|||
124786411|NCT01925131|448850167|FG001|Overall Study|Patient Refusal|0|||
124786412|NCT01925131|448850168|FG002|Overall Study|Patient Refusal|0|||
124786413|NCT01925131|448850169|FG003|Overall Study|Patient Refusal|0|||
124786414|NCT01925131|448850170|FG004|Overall Study|Patient Refusal|0|||
124786415|NCT01925131|448850171|FG005|Overall Study|Patient Refusal|0|||
124786416|NCT01925131|448850166|FG000|Overall Study|Adverse Event|0|||
124786417|NCT01925131|448850167|FG001|Overall Study|Adverse Event|0|||
124786418|NCT01925131|448850168|FG002|Overall Study|Adverse Event|2|||
124786419|NCT01925131|448850169|FG003|Overall Study|Adverse Event|0|||
124786420|NCT01925131|448850170|FG004|Overall Study|Adverse Event|1|||
124786421|NCT01925131|448850171|FG005|Overall Study|Adverse Event|3|||
124786422|NCT01925131|448850166|FG000|Overall Study|Other - Not Protocol Specified|3|||
124786423|NCT01925131|448850167|FG001|Overall Study|Other - Not Protocol Specified|1|||
124786424|NCT01925131|448850168|FG002|Overall Study|Other - Not Protocol Specified|2|||
124786425|NCT01925131|448850169|FG003|Overall Study|Other - Not Protocol Specified|5|||
124786426|NCT01925131|448850170|FG004|Overall Study|Other - Not Protocol Specified|10|||
124786427|NCT01925131|448850171|FG005|Overall Study|Other - Not Protocol Specified|6|||
124786428|NCT01696929|448850175|FG000|Overall Study|Physician Decision|1|||
124786429|NCT01794338|448850176|FG000|Overall Study|Death|2|||
124786430|NCT01794338|448850177|FG001|Overall Study|Death|0|||
124786431|NCT01794338|448850176|FG000|Overall Study|Lost to Follow-up|6|||
124786432|NCT01794338|448850177|FG001|Overall Study|Lost to Follow-up|9|||
124786433|NCT02522624|448850178|FG000|Overall Study|Technical failure|1|||
124786434|NCT02522624|448850179|FG001|Overall Study|Technical failure|0|||
124786435|NCT02123251|448850180|FG000|Overall Study|Death|1|||
124786436|NCT02123251|448850181|FG001|Overall Study|Death|1|||
124786437|NCT02123251|448850180|FG000|Overall Study|Withdrawal by Subject|0|||
124786438|NCT02123251|448850181|FG001|Overall Study|Withdrawal by Subject|3|||
124786439|NCT02123251|448850180|FG000|Overall Study|Lost Medicaid eligibility|29|||
124786440|NCT02123251|448850181|FG001|Overall Study|Lost Medicaid eligibility|22|||
124786441|NCT02123251|448850180|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
124786442|NCT02123251|448850181|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
124786443|NCT02617485|448850196|FG000|Treatment and Observation Period|Adverse Event|9|||
124786444|NCT02617485|448850197|FG001|Treatment and Observation Period|Adverse Event|1|||
124786445|NCT02617485|448850196|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
124786446|NCT02617485|448850197|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
124786447|NCT02617485|448850196|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
124786448|NCT02617485|448850197|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
124786449|NCT02617485|448850196|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
124786450|NCT02617485|448850197|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
124786451|NCT02617485|448850196|FG000|Treatment and Observation Period|Physician Decision|0|||
124786452|NCT02617485|448850197|FG001|Treatment and Observation Period|Physician Decision|1|||
124786453|NCT02617485|448850196|FG000|Follow-up Period|Adverse Event|1|||
124786454|NCT02617485|448850197|FG001|Follow-up Period|Adverse Event|0|||
124786455|NCT02617485|448850196|FG000|Follow-up Period|Withdrawal by Subject|1|||
124786456|NCT02617485|448850197|FG001|Follow-up Period|Withdrawal by Subject|0|||
124786457|NCT02617485|448850196|FG000|Follow-up Period|Disease progression|2|||
124786458|NCT02617485|448850197|FG001|Follow-up Period|Disease progression|1|||
124786459|NCT02617485|448850196|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
124786460|NCT02617485|448850197|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
124786461|NCT02617485|448850196|FG000|Follow-up Period|Patient needed radiotherapy|9|||
124786462|NCT02617485|448850197|FG001|Follow-up Period|Patient needed radiotherapy|5|||
124786463|NCT02617485|448850196|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
124786464|NCT02617485|448850197|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
124786465|NCT00617669|448850199|FG000|Overall Study|Withdrawal by Subject|71|||
124786466|NCT00617669|448850200|FG001|Overall Study|Withdrawal by Subject|77|||
124786467|NCT00617669|448850199|FG000|Overall Study|Lost to Follow-up|3|||
124786468|NCT00617669|448850200|FG001|Overall Study|Lost to Follow-up|2|||
124786469|NCT00617669|448850199|FG000|Overall Study|Adverse Event|87|||
124786470|NCT00617669|448850200|FG001|Overall Study|Adverse Event|76|||
124786471|NCT00617669|448850199|FG000|Overall Study|Protocol Violation|2|||
124786472|NCT00617669|448850200|FG001|Overall Study|Protocol Violation|3|||
124786473|NCT00617669|448850199|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
124786474|NCT00617669|448850200|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
124786475|NCT00617669|448850199|FG000|Overall Study|Patients randomized but not treated|2|||
124786476|NCT00617669|448850200|FG001|Overall Study|Patients randomized but not treated|3|||
124786477|NCT03680742|448850201|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
124786478|NCT02894502|448850204|FG000|Baseline|Withdrawal by Subject|24|||
124786479|NCT02894502|448850205|FG001|Baseline|Withdrawal by Subject|31|||
124786480|NCT02894502|448850206|FG002|Baseline|Withdrawal by Subject|36|||
124786481|NCT02894502|448850204|FG000|Baseline|Death|3|||
124786482|NCT02894502|448850205|FG001|Baseline|Death|1|||
124786483|NCT02894502|448850206|FG002|Baseline|Death|9|||
124786484|NCT02894502|448850204|FG000|First Follow up|Withdrawal by Subject|32|||
124786485|NCT02894502|448850205|FG001|First Follow up|Withdrawal by Subject|29|||
124786486|NCT02894502|448850206|FG002|First Follow up|Withdrawal by Subject|37|||
124786487|NCT02894502|448850204|FG000|First Follow up|Death|2|||
124786488|NCT02894502|448850205|FG001|First Follow up|Death|2|||
124786489|NCT02894502|448850206|FG002|First Follow up|Death|3|||
124786490|NCT02894502|448850204|FG000|Second Follow up|Withdrawal by Subject|13|||
124786491|NCT02894502|448850205|FG001|Second Follow up|Withdrawal by Subject|15|||
124786492|NCT02894502|448850206|FG002|Second Follow up|Withdrawal by Subject|13|||
124786493|NCT02894502|448850204|FG000|Second Follow up|Death|2|||
124786494|NCT02894502|448850205|FG001|Second Follow up|Death|3|||
124786495|NCT02894502|448850206|FG002|Second Follow up|Death|1|||
124786496|NCT02894502|448850204|FG000|Third Follow up|Withdrawal by Subject|5|||
124786497|NCT02894502|448850205|FG001|Third Follow up|Withdrawal by Subject|6|||
124786498|NCT02894502|448850206|FG002|Third Follow up|Withdrawal by Subject|3|||
124786499|NCT02894502|448850204|FG000|Third Follow up|Death|1|||
124786500|NCT02894502|448850205|FG001|Third Follow up|Death|1|||
124786501|NCT02894502|448850206|FG002|Third Follow up|Death|0|||
124786502|NCT04605991|448850207|FG000|Overall Study|Adverse Event|5|||
124786503|NCT04605991|448850207|FG000|Overall Study|Lack of Efficacy|1|||
124786504|NCT04605991|448850207|FG000|Overall Study|Lost to Follow-up|8|||
124786505|NCT04605991|448850207|FG000|Overall Study|Physician Decision|4|||
124786506|NCT04605991|448850207|FG000|Overall Study|Withdrawal by Subject|14|||
124786507|NCT04605991|448850207|FG000|Overall Study|Non-compliance with study|1|||
124786508|NCT01410357|448850208|FG000|Overall Study|Death|2|||
124786509|NCT01410357|448850209|FG001|Overall Study|Death|1|||
124786510|NCT01410357|448850208|FG000|Overall Study|Withdrawal by Subject|1|||
124786511|NCT01410357|448850209|FG001|Overall Study|Withdrawal by Subject|2|||
124786512|NCT01410357|448850208|FG000|Overall Study|Lost to Follow-up|23|||
124786513|NCT01410357|448850209|FG001|Overall Study|Lost to Follow-up|21|||
124786514|NCT00615901|448850210|FG000|Overall Study|Withdrawal by Subject|2|||
124786515|NCT00615901|448850210|FG000|Overall Study|Adverse Event|7|||
124786516|NCT03598114|448850211|FG000|Overall Study|Staff turnover/left the program|3|||
124786517|NCT03598114|448850212|FG001|Overall Study|Staff turnover/left the program|39|||
124786518|NCT01589653|448850213|FG000|Overall Study|Protocol Violation|3|||
124786519|NCT01589653|448850214|FG001|Overall Study|Protocol Violation|1|||
124786520|NCT01589653|448850213|FG000|Overall Study|Withdrawal criteria|4|||
124786521|NCT01589653|448850214|FG001|Overall Study|Withdrawal criteria|7|||
124786522|NCT01589653|448850213|FG000|Overall Study|Unclassified|0|||
124786523|NCT01589653|448850214|FG001|Overall Study|Unclassified|3|||
124786524|NCT00361634|448850216|FG000|Overall Study|Lost to Follow-up|1|||
124786525|NCT00361634|448850216|FG000|Overall Study|Withdrawal by Subject|1|||
124786526|NCT00833417|448850217|FG000|Overall Study|Adverse Event|5|||
124786527|NCT00833417|448850218|FG001|Overall Study|Adverse Event|16|||
124786528|NCT00833417|448850217|FG000|Overall Study|Death|1|||
124786529|NCT00833417|448850218|FG001|Overall Study|Death|3|||
124786530|NCT00833417|448850217|FG000|Overall Study|Lost to Follow-up|1|||
124786531|NCT00833417|448850218|FG001|Overall Study|Lost to Follow-up|2|||
124786532|NCT00833417|448850217|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
124786533|NCT00833417|448850218|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
124786534|NCT00833417|448850217|FG000|Overall Study|Patient Decision to Withdraw|4|||
124786535|NCT00833417|448850218|FG001|Overall Study|Patient Decision to Withdraw|23|||
124786536|NCT00833417|448850217|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
124786537|NCT00833417|448850218|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
124786538|NCT00833417|448850217|FG000|Overall Study|Disease Progression|18|||
124786539|NCT00833417|448850218|FG001|Overall Study|Disease Progression|17|||
124786540|NCT00833417|448850217|FG000|Overall Study|Reason Not Specified|0|||
124786541|NCT00833417|448850218|FG001|Overall Study|Reason Not Specified|1|||
124786542|NCT03330002|448850219|FG000|Overall Study|Lost to Follow-up|15|||
124786543|NCT03330002|448850219|FG000|Overall Study|Death|7|||
124786544|NCT01883453|448850220|FG000|Overall Study|No episode of common cold|25|||
124786545|NCT01883453|448850221|FG001|Overall Study|No episode of common cold|23|||
124786546|NCT00505076|448850222|FG000|Overall Study|Adverse Event|1|||
124786547|NCT00505076|448850223|FG001|Overall Study|Adverse Event|0|||
124786548|NCT00505076|448850224|FG002|Overall Study|Adverse Event|1|||
124786549|NCT00505076|448850222|FG000|Overall Study|Protocol Violation|2|||
124786550|NCT00505076|448850223|FG001|Overall Study|Protocol Violation|1|||
124786551|NCT00505076|448850224|FG002|Overall Study|Protocol Violation|2|||
124786552|NCT00505076|448850222|FG000|Overall Study|Withdrawal by Subject|0|||
124786553|NCT00505076|448850223|FG001|Overall Study|Withdrawal by Subject|1|||
124786554|NCT00505076|448850224|FG002|Overall Study|Withdrawal by Subject|2|||
124786555|NCT00647270|448850225|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
124786556|NCT00647270|448850226|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
124786557|NCT00647270|448850227|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
124786558|NCT00647270|448850225|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
124786559|NCT00647270|448850226|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
124786560|NCT00647270|448850227|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
124786561|NCT00647270|448850225|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
124786562|NCT00647270|448850226|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
124786563|NCT00647270|448850227|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
124786564|NCT00647270|448850225|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
124786565|NCT00647270|448850226|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
124786566|NCT00647270|448850227|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
124786567|NCT00647270|448850225|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
124786568|NCT00647270|448850226|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
124786569|NCT00647270|448850227|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
124786570|NCT00647270|448850225|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
124786571|NCT00647270|448850226|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
124786572|NCT00647270|448850227|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
124786573|NCT00647270|448850225|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
124786574|NCT00647270|448850226|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
124786575|NCT00647270|448850227|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
124786576|NCT03337490|448850228|FG000|Overall Study|Withdrawal by Subject|1|||
124786577|NCT03337490|448850229|FG001|Overall Study|Withdrawal by Subject|0|||
124786578|NCT03337490|448850230|FG002|Overall Study|Withdrawal by Subject|0|||
124786579|NCT03337490|448850228|FG000|Overall Study|Lack of Efficacy|10|||
124786580|NCT03337490|448850229|FG001|Overall Study|Lack of Efficacy|12|||
124786581|NCT03337490|448850230|FG002|Overall Study|Lack of Efficacy|35|||
124786582|NCT03337490|448850228|FG000|Overall Study|Physician Decision|0|||
124786583|NCT03337490|448850229|FG001|Overall Study|Physician Decision|1|||
124786584|NCT03337490|448850230|FG002|Overall Study|Physician Decision|0|||
124786585|NCT03337490|448850228|FG000|Overall Study|Lost to Follow-up|0|||
124786586|NCT03337490|448850229|FG001|Overall Study|Lost to Follow-up|1|||
124786587|NCT03337490|448850230|FG002|Overall Study|Lost to Follow-up|0|||
124786588|NCT02745145|448850231|FG000|Overall Study|Adverse Event|1|||
124786589|NCT02745145|448850232|FG001|Overall Study|Adverse Event|0|||
124786590|NCT02745145|448850233|FG002|Overall Study|Adverse Event|0|||
124786591|NCT02745145|448850231|FG000|Overall Study|Death|0|||
124786592|NCT02745145|448850232|FG001|Overall Study|Death|1|||
124786593|NCT02745145|448850233|FG002|Overall Study|Death|0|||
124786594|NCT02745145|448850231|FG000|Overall Study|Progressive disease|0|||
124786595|NCT02745145|448850232|FG001|Overall Study|Progressive disease|0|||
124786596|NCT02745145|448850233|FG002|Overall Study|Progressive disease|1|||
124786597|NCT02745145|448850231|FG000|Overall Study|Withdrew consent|1|||
124786598|NCT02745145|448850232|FG001|Overall Study|Withdrew consent|1|||
124786599|NCT02745145|448850233|FG002|Overall Study|Withdrew consent|1|||
124786600|NCT02745145|448850231|FG000|Overall Study|Study Termination|8|||
124786601|NCT02745145|448850232|FG001|Overall Study|Study Termination|3|||
124786602|NCT02745145|448850233|FG002|Overall Study|Study Termination|7|||
124786603|NCT00388583|448850234|FG000|Overall Study|Protocol Violation|1|||
124786604|NCT00388583|448850235|FG001|Overall Study|Protocol Violation|0|||
124786605|NCT00388583|448850234|FG000|Overall Study|Withdrawal by Subject|3|||
124786606|NCT00388583|448850235|FG001|Overall Study|Withdrawal by Subject|3|||
124786607|NCT00388583|448850234|FG000|Overall Study|Serious Adverse Event|2|||
124786608|NCT00388583|448850235|FG001|Overall Study|Serious Adverse Event|0|||
124786609|NCT00388583|448850234|FG000|Overall Study|Did not receive vaccine|0|||
124786610|NCT00388583|448850235|FG001|Overall Study|Did not receive vaccine|1|||
124786611|NCT02709538|448850240|FG000|Overall Study|Adverse Event|13|||
124786612|NCT02709538|448850241|FG001|Overall Study|Adverse Event|2|||
124786613|NCT02709538|448850242|FG002|Overall Study|Adverse Event|3|||
124786614|NCT02709538|448850240|FG000|Overall Study|Lack of Efficacy|1|||
124786615|NCT02709538|448850241|FG001|Overall Study|Lack of Efficacy|0|||
124786616|NCT02709538|448850242|FG002|Overall Study|Lack of Efficacy|0|||
124786617|NCT02709538|448850240|FG000|Overall Study|Lost to Follow-up|24|||
124786618|NCT02709538|448850241|FG001|Overall Study|Lost to Follow-up|8|||
124786619|NCT02709538|448850242|FG002|Overall Study|Lost to Follow-up|4|||
124786620|NCT02709538|448850240|FG000|Overall Study|Physician Decision|1|||
124786621|NCT02709538|448850241|FG001|Overall Study|Physician Decision|0|||
124786622|NCT02709538|448850242|FG002|Overall Study|Physician Decision|0|||
124786623|NCT02709538|448850240|FG000|Overall Study|Withdrawal by Subject|40|||
124786624|NCT02709538|448850241|FG001|Overall Study|Withdrawal by Subject|7|||
124786625|NCT02709538|448850242|FG002|Overall Study|Withdrawal by Subject|4|||
124786626|NCT02709538|448850240|FG000|Overall Study|Non-compliance with study procedures|5|||
124786627|NCT02709538|448850241|FG001|Overall Study|Non-compliance with study procedures|0|||
124786628|NCT02709538|448850242|FG002|Overall Study|Non-compliance with study procedures|0|||
124786629|NCT02709538|448850240|FG000|Overall Study|Non-compliance with study drug|2|||
124786630|NCT02709538|448850241|FG001|Overall Study|Non-compliance with study drug|0|||
124786631|NCT02709538|448850242|FG002|Overall Study|Non-compliance with study drug|0|||
124786632|NCT02709538|448850240|FG000|Overall Study|Protocol deviation|10|||
124786633|NCT02709538|448850241|FG001|Overall Study|Protocol deviation|4|||
124786634|NCT02709538|448850242|FG002|Overall Study|Protocol deviation|4|||
124786635|NCT02709538|448850240|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
124786636|NCT02709538|448850241|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
124786637|NCT02709538|448850242|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
124786638|NCT02709538|448850240|FG000|Overall Study|Other|16|||
124786639|NCT02709538|448850241|FG001|Overall Study|Other|7|||
124786640|NCT02709538|448850242|FG002|Overall Study|Other|5|||
124786641|NCT00835211|448850243|FG000|First Intervention|Withdrawal by Subject|0|||
124786642|NCT00835211|448850244|FG001|First Intervention|Withdrawal by Subject|1|||
124786643|NCT00835211|448850243|FG000|Washout: 7 Days|Adverse Event|2|||
124786644|NCT00835211|448850244|FG001|Washout: 7 Days|Adverse Event|1|||
124786645|NCT00835211|448850243|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
124786646|NCT00835211|448850244|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
124786647|NCT02160041|448850245|FG000|Overall Study|Adverse Event|11|||
124786648|NCT02160041|448850245|FG000|Overall Study|Death|2|||
124786649|NCT02160041|448850245|FG000|Overall Study|disease progression|57|||
124786650|NCT02160041|448850245|FG000|Overall Study|Protocol Violation|1|||
124786651|NCT02160041|448850245|FG000|Overall Study|non-compliance with study|1|||
124786652|NCT02160041|448850245|FG000|Overall Study|Physician Decision|3|||
124786653|NCT02160041|448850245|FG000|Overall Study|Withdrawal by Subject|8|||
124786654|NCT02160041|448850245|FG000|Overall Study|study terminated by by sponsor|1|||
124786655|NCT01403948|448850246|FG000|Overall Study|Progressive disease|0|||
124786656|NCT01403948|448850247|FG001|Overall Study|Progressive disease|2|||
124786657|NCT01403948|448850248|FG002|Overall Study|Progressive disease|2|||
124786658|NCT01403948|448850249|FG003|Overall Study|Progressive disease|4|||
124786659|NCT01403948|448850250|FG004|Overall Study|Progressive disease|2|||
124786660|NCT01403948|448850251|FG005|Overall Study|Progressive disease|6|||
124786661|NCT01403948|448850252|FG006|Overall Study|Progressive disease|2|||
124786662|NCT01403948|448850253|FG007|Overall Study|Progressive disease|4|||
124786663|NCT01403948|448850254|FG008|Overall Study|Progressive disease|5|||
124786664|NCT01403948|448850255|FG009|Overall Study|Progressive disease|5|||
124786665|NCT01403948|448850246|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
124786666|NCT01403948|448850247|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
124786667|NCT01403948|448850248|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
124786668|NCT01403948|448850249|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
124786669|NCT01403948|448850250|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
124786670|NCT01403948|448850251|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
124786671|NCT01403948|448850252|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
124786672|NCT01403948|448850253|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
124786673|NCT01403948|448850254|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
124786674|NCT01403948|448850255|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
124786675|NCT01403948|448850246|FG000|Overall Study|Lost to Follow-up|0|||
124786676|NCT01403948|448850247|FG001|Overall Study|Lost to Follow-up|0|||
124786677|NCT01403948|448850248|FG002|Overall Study|Lost to Follow-up|0|||
124786678|NCT01403948|448850249|FG003|Overall Study|Lost to Follow-up|0|||
124786679|NCT01403948|448850250|FG004|Overall Study|Lost to Follow-up|0|||
124786680|NCT01403948|448850251|FG005|Overall Study|Lost to Follow-up|0|||
124786681|NCT01403948|448850252|FG006|Overall Study|Lost to Follow-up|0|||
124786682|NCT01403948|448850253|FG007|Overall Study|Lost to Follow-up|0|||
124786683|NCT01403948|448850254|FG008|Overall Study|Lost to Follow-up|0|||
124786684|NCT01403948|448850255|FG009|Overall Study|Lost to Follow-up|1|||
124786685|NCT01403948|448850246|FG000|Overall Study|Refused cont. medication|0|||
124786686|NCT01403948|448850247|FG001|Overall Study|Refused cont. medication|0|||
124786687|NCT01403948|448850248|FG002|Overall Study|Refused cont. medication|0|||
124786688|NCT01403948|448850249|FG003|Overall Study|Refused cont. medication|0|||
124786689|NCT01403948|448850250|FG004|Overall Study|Refused cont. medication|1|||
124786690|NCT01403948|448850251|FG005|Overall Study|Refused cont. medication|0|||
124786691|NCT01403948|448850252|FG006|Overall Study|Refused cont. medication|0|||
124786692|NCT01403948|448850253|FG007|Overall Study|Refused cont. medication|0|||
124786693|NCT01403948|448850254|FG008|Overall Study|Refused cont. medication|0|||
124786694|NCT01403948|448850255|FG009|Overall Study|Refused cont. medication|1|||
124786695|NCT01403948|448850246|FG000|Overall Study|other than above|1|||
124786696|NCT01403948|448850247|FG001|Overall Study|other than above|2|||
124786697|NCT01403948|448850248|FG002|Overall Study|other than above|1|||
124786698|NCT01403948|448850249|FG003|Overall Study|other than above|0|||
124786699|NCT01403948|448850250|FG004|Overall Study|other than above|1|||
124786700|NCT01403948|448850251|FG005|Overall Study|other than above|1|||
124786701|NCT01403948|448850252|FG006|Overall Study|other than above|2|||
124786702|NCT01403948|448850253|FG007|Overall Study|other than above|0|||
124786703|NCT01403948|448850254|FG008|Overall Study|other than above|0|||
124786704|NCT01403948|448850255|FG009|Overall Study|other than above|0|||
124786705|NCT05498701|448850256|FG000|Period 3|Adverse Event|1|||
124786706|NCT05498701|448850257|FG001|Period 3|Adverse Event|0|||
124786707|NCT00006409|448850261|FG000|Baseline|Protocol Violation|48|||
124786708|NCT00006409|448850262|FG001|Baseline|Protocol Violation|70|||
124786709|NCT00006409|448850263|FG002|Baseline|Protocol Violation|0|||
124786710|NCT00006409|448850264|FG003|Baseline|Protocol Violation|0|||
124786711|NCT00006409|448850265|FG004|Baseline|Protocol Violation|0|||
124786712|NCT00006409|448850266|FG005|Baseline|Protocol Violation|0|||
124786713|NCT00006409|448850261|FG000|Post-2 Year Intervention|Protocol Violation|0|||
124786714|NCT00006409|448850262|FG001|Post-2 Year Intervention|Protocol Violation|0|||
124786715|NCT00006409|448850263|FG002|Post-2 Year Intervention|Protocol Violation|251|||
124786716|NCT00006409|448850264|FG003|Post-2 Year Intervention|Protocol Violation|168|||
124786717|NCT00006409|448850265|FG004|Post-2 Year Intervention|Protocol Violation|0|||
124786718|NCT00006409|448850266|FG005|Post-2 Year Intervention|Protocol Violation|0|||
124786719|NCT00006409|448850261|FG000|Post-3 Year Intervention|Protocol Violation|0|||
124786720|NCT00006409|448850262|FG001|Post-3 Year Intervention|Protocol Violation|0|||
124786721|NCT00006409|448850263|FG002|Post-3 Year Intervention|Protocol Violation|0|||
124786722|NCT00006409|448850264|FG003|Post-3 Year Intervention|Protocol Violation|0|||
124786723|NCT00006409|448850265|FG004|Post-3 Year Intervention|Protocol Violation|62|||
124786724|NCT00006409|448850266|FG005|Post-3 Year Intervention|Protocol Violation|62|||
124786725|NCT00638183|448850267|FG000|Overall Study|Adverse Event|23|||
124786726|NCT00638183|448850267|FG000|Overall Study|Lack of Efficacy|14|||
124786727|NCT00638183|448850267|FG000|Overall Study|Physician Decision|9|||
124786728|NCT00638183|448850267|FG000|Overall Study|Lost to Follow-up|46|||
124786729|NCT00638183|448850267|FG000|Overall Study|Other reason not defined above|27|||
124786730|NCT01763996|448850270|FG000|Treatment Period 2|Adverse Event|0|||
124786731|NCT01763996|448850271|FG001|Treatment Period 2|Adverse Event|1|||
124786732|NCT03704636|448850275|FG000|Overall Study|Inadequate Venous Flow|3|||
124786733|NCT00539188|448850278|FG000|Overall Study|Withdrawal by Subject|1|||
124786734|NCT00539188|448850279|FG001|Overall Study|Withdrawal by Subject|0|||
124786735|NCT00539188|448850278|FG000|Overall Study|Lost to Follow-up|2|||
124786736|NCT00539188|448850279|FG001|Overall Study|Lost to Follow-up|1|||
124786737|NCT01546623|448850280|FG000|Overall Study|Adverse Event|2|||
124786738|NCT01546623|448850281|FG001|Overall Study|Adverse Event|3|||
124786739|NCT01546623|448850280|FG000|Overall Study|Major Protocol Deviation|1|||
124786740|NCT01546623|448850281|FG001|Overall Study|Major Protocol Deviation|1|||
124786741|NCT01546623|448850280|FG000|Overall Study|High Prostate specific antigen|2|||
124786742|NCT01546623|448850281|FG001|Overall Study|High Prostate specific antigen|1|||
124786743|NCT01546623|448850280|FG000|Overall Study|Did Not Receive Study Drug|1|||
124786744|NCT01546623|448850281|FG001|Overall Study|Did Not Receive Study Drug|1|||
124786745|NCT01134705|448850282|FG000|Overall Study|Adverse Event|1|||
124786746|NCT01134705|448850283|FG001|Overall Study|Adverse Event|7|||
124786747|NCT01134705|448850282|FG000|Overall Study|Withdrawal by Subject|6|||
124786748|NCT01134705|448850283|FG001|Overall Study|Withdrawal by Subject|6|||
124786749|NCT01134705|448850282|FG000|Overall Study|Pregnancy|1|||
124786750|NCT01134705|448850283|FG001|Overall Study|Pregnancy|0|||
124786751|NCT01134705|448850282|FG000|Overall Study|Lost to Follow-up|5|||
124786752|NCT01134705|448850283|FG001|Overall Study|Lost to Follow-up|2|||
124786753|NCT01134705|448850282|FG000|Overall Study|Protocol Violation|1|||
124786754|NCT01134705|448850283|FG001|Overall Study|Protocol Violation|1|||
124786755|NCT01134705|448850282|FG000|Overall Study|Other|1|||
124786756|NCT01134705|448850283|FG001|Overall Study|Other|6|||
124786757|NCT04784442|448850284|FG000|Overall Study|Adverse Event|1|||
124786758|NCT04784442|448850285|FG001|Overall Study|Adverse Event|0|||
124786759|NCT04784442|448850286|FG002|Overall Study|Adverse Event|2|||
124786760|NCT04784442|448850287|FG003|Overall Study|Adverse Event|1|||
124786761|NCT04784442|448850284|FG000|Overall Study|Protocol Violation|1|||
124786762|NCT04784442|448850285|FG001|Overall Study|Protocol Violation|0|||
124786763|NCT04784442|448850286|FG002|Overall Study|Protocol Violation|0|||
124786764|NCT04784442|448850287|FG003|Overall Study|Protocol Violation|0|||
124786765|NCT04784442|448850284|FG000|Overall Study|Non-compliance with study drug|1|||
124786766|NCT04784442|448850285|FG001|Overall Study|Non-compliance with study drug|0|||
124786767|NCT04784442|448850286|FG002|Overall Study|Non-compliance with study drug|0|||
124786768|NCT04784442|448850287|FG003|Overall Study|Non-compliance with study drug|0|||
124786769|NCT01590758|448850290|FG000|Overall Study|Withdrawal by Subject|0|||
124786770|NCT01590758|448850291|FG001|Overall Study|Withdrawal by Subject|3|||
124786771|NCT01590758|448850290|FG000|Overall Study|Physician Decision|1|||
124786772|NCT01590758|448850291|FG001|Overall Study|Physician Decision|2|||
124786773|NCT01590758|448850290|FG000|Overall Study|Lost to Follow-up|4|||
124786774|NCT01590758|448850291|FG001|Overall Study|Lost to Follow-up|2|||
124786775|NCT01578850|448850292|FG000|Period 1|Insufficient Clinical Response|1|||
124786776|NCT01578850|448850293|FG001|Period 1|Insufficient Clinical Response|0|||
124786777|NCT01578850|448850294|FG002|Period 1|Insufficient Clinical Response|0|||
124786778|NCT01578850|448850292|FG000|Period 1|Adverse Event|11|||
124786779|NCT01578850|448850293|FG001|Period 1|Adverse Event|0|||
124786780|NCT01578850|448850294|FG002|Period 1|Adverse Event|0|||
124786781|NCT01578850|448850292|FG000|Period 1|Death|1|||
124786782|NCT01578850|448850293|FG001|Period 1|Death|0|||
124786783|NCT01578850|448850294|FG002|Period 1|Death|0|||
124786784|NCT01578850|448850292|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
124786785|NCT01578850|448850293|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
124786786|NCT01578850|448850294|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
124786787|NCT01578850|448850292|FG000|Period 1|Withdrawal by Subject|9|||
124786788|NCT01578850|448850293|FG001|Period 1|Withdrawal by Subject|0|||
124786789|NCT01578850|448850294|FG002|Period 1|Withdrawal by Subject|0|||
124786790|NCT01578850|448850292|FG000|Period 1|Study Terminated by Sponsor|3|||
124786791|NCT01578850|448850293|FG001|Period 1|Study Terminated by Sponsor|0|||
124786792|NCT01578850|448850294|FG002|Period 1|Study Terminated by Sponsor|0|||
124786793|NCT01578850|448850292|FG000|Period 2|Insufficient Clinical Response|0|||
124786794|NCT01578850|448850293|FG001|Period 2|Insufficient Clinical Response|1|||
124786795|NCT01578850|448850294|FG002|Period 2|Insufficient Clinical Response|0|||
124786796|NCT01578850|448850292|FG000|Period 2|Adverse Event|0|||
124786797|NCT01578850|448850293|FG001|Period 2|Adverse Event|3|||
124786798|NCT01578850|448850294|FG002|Period 2|Adverse Event|6|||
124786799|NCT01578850|448850292|FG000|Period 2|Lost to Follow-up|0|||
124786800|NCT01578850|448850293|FG001|Period 2|Lost to Follow-up|1|||
124786801|NCT01578850|448850294|FG002|Period 2|Lost to Follow-up|2|||
124786802|NCT01578850|448850292|FG000|Period 2|Withdrawal by Subject|0|||
124786803|NCT01578850|448850293|FG001|Period 2|Withdrawal by Subject|2|||
124786804|NCT01578850|448850294|FG002|Period 2|Withdrawal by Subject|2|||
124786805|NCT01578850|448850292|FG000|Period 2|Study Terminated by Sponsor|0|||
124786806|NCT01578850|448850293|FG001|Period 2|Study Terminated by Sponsor|5|||
124786807|NCT01578850|448850294|FG002|Period 2|Study Terminated by Sponsor|4|||
124786808|NCT01578850|448850292|FG000|Period 2|Unspecified Reasons|0|||
124786809|NCT01578850|448850293|FG001|Period 2|Unspecified Reasons|1|||
124786810|NCT01578850|448850294|FG002|Period 2|Unspecified Reasons|0|||
124786811|NCT02756806|448850295|FG000|Overall Study|Study terminated early|5|||
124786812|NCT02717832|448850296|FG000|Overall Study|Inability to place IV|3|||
124786813|NCT02929498|448850297|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
124786814|NCT02929498|448850298|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
124786815|NCT02929498|448850299|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
124786816|NCT02929498|448850297|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
124786817|NCT02929498|448850298|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
124786818|NCT02929498|448850299|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
124786819|NCT02744040|448850300|FG000|Overall Study|Withdrawal by Subject|3|||
124786820|NCT02744040|448850301|FG001|Overall Study|Withdrawal by Subject|2|||
124786821|NCT02744040|448850302|FG002|Overall Study|Withdrawal by Subject|2|||
124786822|NCT02744040|448850300|FG000|Overall Study|Physician Decision|0|||
124786823|NCT02744040|448850301|FG001|Overall Study|Physician Decision|8|||
124786824|NCT02744040|448850302|FG002|Overall Study|Physician Decision|13|||
124786825|NCT02744040|448850300|FG000|Overall Study|Lost to Follow-up|3|||
124786826|NCT02744040|448850301|FG001|Overall Study|Lost to Follow-up|1|||
124786827|NCT02744040|448850302|FG002|Overall Study|Lost to Follow-up|7|||
124786828|NCT00096356|448850303|FG000|Overall Study|Adverse Event|11|||
124786829|NCT00096356|448850304|FG001|Overall Study|Adverse Event|9|||
124786830|NCT00096356|448850303|FG000|Overall Study|Physician Decision|5|||
124786831|NCT00096356|448850304|FG001|Overall Study|Physician Decision|3|||
124786832|NCT00096356|448850303|FG000|Overall Study|Withdrawal by Subject|17|||
124786833|NCT00096356|448850304|FG001|Overall Study|Withdrawal by Subject|23|||
124786834|NCT00096356|448850303|FG000|Overall Study|Lack of Efficacy|1|||
124786835|NCT00096356|448850304|FG001|Overall Study|Lack of Efficacy|0|||
124786836|NCT00096356|448850303|FG000|Overall Study|multiple reasons|10|||
124786837|NCT00096356|448850304|FG001|Overall Study|multiple reasons|18|||
124786838|NCT01008423|448850305|FG000|Overall Study|Adverse Event|13|||
124786839|NCT01008423|448850306|FG001|Overall Study|Adverse Event|6|||
124786840|NCT01008423|448850305|FG000|Overall Study|Withdrawal by Subject|4|||
124786841|NCT01008423|448850306|FG001|Overall Study|Withdrawal by Subject|7|||
124786842|NCT01008423|448850305|FG000|Overall Study|Lost to Follow-up|0|||
124786843|NCT01008423|448850306|FG001|Overall Study|Lost to Follow-up|2|||
124786844|NCT01008423|448850305|FG000|Overall Study|Low Cortisol|0|||
124786845|NCT01008423|448850306|FG001|Overall Study|Low Cortisol|1|||
124786846|NCT01008423|448850305|FG000|Overall Study|Lack of Efficacy|0|||
124786847|NCT01008423|448850306|FG001|Overall Study|Lack of Efficacy|5|||
124786848|NCT01008423|448850305|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
124786849|NCT01008423|448850306|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
124786850|NCT01008423|448850305|FG000|Overall Study|Personal Conflict|1|||
124786851|NCT01008423|448850306|FG001|Overall Study|Personal Conflict|0|||
124786852|NCT01008423|448850305|FG000|Overall Study|Other|0|||
124786853|NCT01008423|448850306|FG001|Overall Study|Other|1|||
124786854|NCT03288142|448850308|FG000|Overall Study|Lost to Follow-up|22|||
124786855|NCT03288142|448850309|FG001|Overall Study|Lost to Follow-up|15|||
124786856|NCT00934843|448850310|FG000|Overall Study|Protocol Violation|0|||
124786857|NCT00934843|448850311|FG001|Overall Study|Protocol Violation|1|||
124786858|NCT01144299|448850314|FG000|Overall Study|Lost to Follow-up|1|||
124786859|NCT01144299|448850315|FG001|Overall Study|Lost to Follow-up|0|||
124786860|NCT01144299|448850314|FG000|Overall Study|Withdrawal by Subject|1|||
124786861|NCT01144299|448850315|FG001|Overall Study|Withdrawal by Subject|0|||
124786862|NCT03976648|448850324|FG000|Overall Study|Adverse Event|0|||
124786863|NCT03976648|448850325|FG001|Overall Study|Adverse Event|2|||
124786864|NCT03976648|448850324|FG000|Overall Study|Study terminated by sponsor|21|||
124786865|NCT03976648|448850325|FG001|Overall Study|Study terminated by sponsor|8|||
124786866|NCT00243841|448850326|FG000|Overall Study|Physician Decision|0|||
124786867|NCT00243841|448850327|FG001|Overall Study|Physician Decision|0|||
124786868|NCT00243841|448850328|FG002|Overall Study|Physician Decision|1|||
124786869|NCT00243841|448850329|FG003|Overall Study|Physician Decision|0|||
124786870|NCT00243841|448850330|FG004|Overall Study|Physician Decision|0|||
124786871|NCT00243841|448850331|FG005|Overall Study|Physician Decision|2|||
124786872|NCT00881868|448850332|FG000|Overall Study|Adverse Event|0|||
124786873|NCT00881868|448850333|FG001|Overall Study|Adverse Event|1|||
124786874|NCT00881868|448850332|FG000|Overall Study|Lost to Follow-up|2|||
124786875|NCT00881868|448850333|FG001|Overall Study|Lost to Follow-up|1|||
124786876|NCT00881868|448850332|FG000|Overall Study|Physician Decision|4|||
124786877|NCT00881868|448850333|FG001|Overall Study|Physician Decision|0|||
124786878|NCT00881868|448850332|FG000|Overall Study|Protocol Violation|2|||
124786879|NCT00881868|448850333|FG001|Overall Study|Protocol Violation|0|||
124786880|NCT01981551|448850334|FG000|Overall Study|Refused further treatment|8|||
124786881|NCT01981551|448850334|FG000|Overall Study|Adverse Event|1|||
124786882|NCT03255083|448850335|FG000|Overall Study|Clinical progression|1|||
124786883|NCT03255083|448850336|FG001|Overall Study|Clinical progression|0|||
124786884|NCT03255083|448850337|FG002|Overall Study|Clinical progression|0|||
124786885|NCT03255083|448850338|FG003|Overall Study|Clinical progression|0|||
124786886|NCT03255083|448850335|FG000|Overall Study|Adverse Event|0|||
124786887|NCT03255083|448850336|FG001|Overall Study|Adverse Event|1|||
124786888|NCT03255083|448850337|FG002|Overall Study|Adverse Event|0|||
124786889|NCT03255083|448850338|FG003|Overall Study|Adverse Event|0|||
124786890|NCT03255083|448850335|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
124786891|NCT03255083|448850336|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
124786892|NCT03255083|448850337|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
124786893|NCT03255083|448850338|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
124786894|NCT03255083|448850335|FG000|Overall Study|Withdrawal by Subject|1|||
124786895|NCT03255083|448850336|FG001|Overall Study|Withdrawal by Subject|1|||
124786896|NCT03255083|448850337|FG002|Overall Study|Withdrawal by Subject|1|||
124786897|NCT03255083|448850338|FG003|Overall Study|Withdrawal by Subject|0|||
124786898|NCT01182844|448850339|FG000|Overall Study|Withdrawal by Subject|0|||
124786899|NCT01182844|448850340|FG001|Overall Study|Withdrawal by Subject|2|||
124786900|NCT00960570|448850341|FG000|21 Day Washout Period|Adverse Event|1|||
124786901|NCT00960570|448850341|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
124786902|NCT00960570|448850341|FG000|1 Day Period Between Dosing|Adverse Event|2|||
124786903|NCT00960570|448850341|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
124786904|NCT01451437|448850342|FG000|Overall Study|Adverse Event|0|||
124786905|NCT01451437|448850343|FG001|Overall Study|Adverse Event|0|||
124786906|NCT01451437|448850344|FG002|Overall Study|Adverse Event|0|||
124786907|NCT01451437|448850345|FG003|Overall Study|Adverse Event|0|||
124786908|NCT01451437|448850346|FG004|Overall Study|Adverse Event|0|||
124786909|NCT01451437|448850347|FG005|Overall Study|Adverse Event|1|||
124786910|NCT01451437|448850348|FG006|Overall Study|Adverse Event|1|||
124786911|NCT01451437|448850349|FG007|Overall Study|Adverse Event|2|||
124786912|NCT01451437|448850350|FG008|Overall Study|Adverse Event|1|||
124786913|NCT01451437|448850342|FG000|Overall Study|Physician Decision|1|||
124786914|NCT01451437|448850343|FG001|Overall Study|Physician Decision|1|||
124786915|NCT01451437|448850344|FG002|Overall Study|Physician Decision|2|||
124786916|NCT01451437|448850345|FG003|Overall Study|Physician Decision|0|||
124786917|NCT01451437|448850346|FG004|Overall Study|Physician Decision|0|||
124786918|NCT01451437|448850347|FG005|Overall Study|Physician Decision|0|||
124786919|NCT01451437|448850348|FG006|Overall Study|Physician Decision|0|||
124786920|NCT01451437|448850349|FG007|Overall Study|Physician Decision|0|||
124786921|NCT01451437|448850350|FG008|Overall Study|Physician Decision|0|||
124786922|NCT01451437|448850342|FG000|Overall Study|Disease Progression|0|||
124786923|NCT01451437|448850343|FG001|Overall Study|Disease Progression|0|||
124786924|NCT01451437|448850344|FG002|Overall Study|Disease Progression|1|||
124786925|NCT01451437|448850345|FG003|Overall Study|Disease Progression|1|||
124786926|NCT01451437|448850346|FG004|Overall Study|Disease Progression|3|||
124786927|NCT01451437|448850347|FG005|Overall Study|Disease Progression|2|||
124786928|NCT01451437|448850348|FG006|Overall Study|Disease Progression|3|||
124786929|NCT01451437|448850349|FG007|Overall Study|Disease Progression|1|||
124786930|NCT01451437|448850350|FG008|Overall Study|Disease Progression|3|||
124786931|NCT01451437|448850342|FG000|Overall Study|Protocol Violation|0|||
124786932|NCT01451437|448850343|FG001|Overall Study|Protocol Violation|0|||
124786933|NCT01451437|448850344|FG002|Overall Study|Protocol Violation|0|||
124786934|NCT01451437|448850345|FG003|Overall Study|Protocol Violation|0|||
124786935|NCT01451437|448850346|FG004|Overall Study|Protocol Violation|0|||
124786936|NCT01451437|448850347|FG005|Overall Study|Protocol Violation|0|||
124786937|NCT01451437|448850348|FG006|Overall Study|Protocol Violation|1|||
124786938|NCT01451437|448850349|FG007|Overall Study|Protocol Violation|0|||
124786939|NCT01451437|448850350|FG008|Overall Study|Protocol Violation|0|||
124786940|NCT01451437|448850342|FG000|Overall Study|Withdrawal by Subject|0|||
124786941|NCT01451437|448850343|FG001|Overall Study|Withdrawal by Subject|0|||
124786942|NCT01451437|448850344|FG002|Overall Study|Withdrawal by Subject|0|||
124786943|NCT01451437|448850345|FG003|Overall Study|Withdrawal by Subject|0|||
124786944|NCT01451437|448850346|FG004|Overall Study|Withdrawal by Subject|1|||
124786945|NCT01451437|448850347|FG005|Overall Study|Withdrawal by Subject|0|||
124786946|NCT01451437|448850348|FG006|Overall Study|Withdrawal by Subject|1|||
124786947|NCT01451437|448850349|FG007|Overall Study|Withdrawal by Subject|0|||
124786948|NCT01451437|448850350|FG008|Overall Study|Withdrawal by Subject|0|||
124786949|NCT03254108|448852334|FG000|Overall Study|Adverse Event|0|||
124786950|NCT03254108|448852335|FG001|Overall Study|Adverse Event|2|||
124786951|NCT03254108|448852336|FG002|Overall Study|Adverse Event|0|||
124786952|NCT03254108|448852337|FG003|Overall Study|Adverse Event|1|||
124786953|NCT03254108|448852338|FG004|Overall Study|Adverse Event|1|||
124786954|NCT03254108|448852334|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
124786955|NCT03254108|448852335|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
124786956|NCT03254108|448852336|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
124786957|NCT03254108|448852337|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
124786958|NCT03254108|448852338|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
124786959|NCT00490529|448852340|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
124786960|NCT00490529|448852340|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
124786961|NCT00490529|448852340|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
124786962|NCT00490529|448852340|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
124786963|NCT00490529|448852340|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
124786964|NCT00490529|448852340|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
124786965|NCT03254459|448852341|FG000|Overall Study|Adverse Event|7|||
124786966|NCT03254459|448852342|FG001|Overall Study|Adverse Event|20|||
124786967|NCT03254459|448852341|FG000|Overall Study|Withdrawal by Subject Consent|3|||
124786968|NCT03254459|448852342|FG001|Overall Study|Withdrawal by Subject Consent|1|||
124786969|NCT03254459|448852341|FG000|Overall Study|Lost to Follow-up|0|||
124786970|NCT03254459|448852342|FG001|Overall Study|Lost to Follow-up|1|||
124786971|NCT03254459|448852341|FG000|Overall Study|Miscellaneous|0|||
124786972|NCT03254459|448852342|FG001|Overall Study|Miscellaneous|1|||
124786973|NCT00727441|448852343|FG000|Overall Study|Disease Progression|11|||
124786974|NCT00727441|448852344|FG001|Overall Study|Disease Progression|14|||
124786975|NCT00727441|448852345|FG002|Overall Study|Disease Progression|17|||
124786976|NCT00727441|448852343|FG000|Overall Study|Eligibility|7|||
124786977|NCT00727441|448852344|FG001|Overall Study|Eligibility|5|||
124786978|NCT00727441|448852345|FG002|Overall Study|Eligibility|7|||
124786979|NCT00727441|448852343|FG000|Overall Study|Death|0|||
124786980|NCT00727441|448852344|FG001|Overall Study|Death|1|||
124786981|NCT00727441|448852345|FG002|Overall Study|Death|1|||
124786982|NCT00727441|448852343|FG000|Overall Study|Physician Decision|0|||
124786983|NCT00727441|448852344|FG001|Overall Study|Physician Decision|1|||
124786984|NCT00727441|448852345|FG002|Overall Study|Physician Decision|0|||
124786985|NCT00727441|448852343|FG000|Overall Study|Withdrawal by Subject|0|||
124786986|NCT00727441|448852344|FG001|Overall Study|Withdrawal by Subject|1|||
124786987|NCT00727441|448852345|FG002|Overall Study|Withdrawal by Subject|0|||
124786988|NCT00535288|448852346|FG000|Overall Study|Adverse Event|20|||
124786989|NCT00535288|448852347|FG001|Overall Study|Adverse Event|19|||
124786990|NCT00535288|448852348|FG002|Overall Study|Adverse Event|25|||
124786991|NCT00535288|448852349|FG003|Overall Study|Adverse Event|20|||
124786992|NCT00535288|448852350|FG004|Overall Study|Adverse Event|30|||
124786993|NCT00535288|448852346|FG000|Overall Study|Lost to Follow-up|0|||
124786994|NCT00535288|448852347|FG001|Overall Study|Lost to Follow-up|3|||
124786995|NCT00535288|448852348|FG002|Overall Study|Lost to Follow-up|0|||
124786996|NCT00535288|448852349|FG003|Overall Study|Lost to Follow-up|0|||
124786997|NCT00535288|448852350|FG004|Overall Study|Lost to Follow-up|0|||
124786998|NCT00535288|448852346|FG000|Overall Study|Lack of Efficacy|26|||
124786999|NCT00535288|448852347|FG001|Overall Study|Lack of Efficacy|3|||
124787000|NCT00535288|448852348|FG002|Overall Study|Lack of Efficacy|4|||
124787001|NCT00535288|448852349|FG003|Overall Study|Lack of Efficacy|4|||
124787002|NCT00535288|448852350|FG004|Overall Study|Lack of Efficacy|7|||
124787003|NCT00535288|448852346|FG000|Overall Study|Unwilling to cooperate|6|||
124787004|NCT00535288|448852347|FG001|Overall Study|Unwilling to cooperate|6|||
124787005|NCT00535288|448852348|FG002|Overall Study|Unwilling to cooperate|3|||
124787006|NCT00535288|448852349|FG003|Overall Study|Unwilling to cooperate|3|||
124787007|NCT00535288|448852350|FG004|Overall Study|Unwilling to cooperate|4|||
124787008|NCT00535288|448852346|FG000|Overall Study|Other|2|||
124787009|NCT00535288|448852347|FG001|Overall Study|Other|1|||
124787010|NCT00535288|448852348|FG002|Overall Study|Other|1|||
124787011|NCT00535288|448852349|FG003|Overall Study|Other|2|||
124787012|NCT00535288|448852350|FG004|Overall Study|Other|1|||
124787013|NCT00745849|448852351|FG000|First Intervention|Withdrawal by Subject|0|||
124787014|NCT00745849|448852352|FG001|First Intervention|Withdrawal by Subject|1|||
124787015|NCT00745849|448852351|FG000|First Intervention|Lost to Follow-up|1|||
124787016|NCT00745849|448852352|FG001|First Intervention|Lost to Follow-up|1|||
124787017|NCT00745849|448852351|FG000|Second Intervention|Lost to Follow-up|2|||
124787018|NCT00745849|448852352|FG001|Second Intervention|Lost to Follow-up|1|||
124787019|NCT01129583|448852353|FG000|Overall Study|Death|1|||
124787020|NCT01129583|448852354|FG001|Overall Study|Death|0|||
124787021|NCT01129583|448852353|FG000|Overall Study|Lost to Follow-up|1|||
124787022|NCT01129583|448852354|FG001|Overall Study|Lost to Follow-up|1|||
124787023|NCT01129583|448852353|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
124787024|NCT01129583|448852354|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
124787025|NCT02600871|448852355|FG000|Overall Study|Lost to Follow-up|13|||
124787026|NCT02600871|448852356|FG001|Overall Study|Lost to Follow-up|10|||
124787027|NCT00830869|448852359|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
124787028|NCT00830869|448852360|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
124787029|NCT00830869|448852361|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
124787030|NCT00830869|448852362|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
124787031|NCT00830869|448852363|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
124787032|NCT00830869|448852364|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
124787033|NCT00830869|448852365|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
124787034|NCT00830869|448852366|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
124787035|NCT00830869|448852367|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
124787036|NCT00830869|448852368|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
124787037|NCT00830869|448852369|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
124787038|NCT00830869|448852370|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
124787039|NCT00830869|448852359|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
124787040|NCT00830869|448852360|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
124787041|NCT00830869|448852361|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
124787042|NCT00830869|448852362|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
124787043|NCT00830869|448852363|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
124787044|NCT00830869|448852364|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
124787045|NCT00830869|448852365|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
124787046|NCT00830869|448852366|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
124787047|NCT00830869|448852367|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
124787048|NCT00830869|448852368|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
124787049|NCT00830869|448852369|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
124787050|NCT00830869|448852370|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
124787051|NCT00830869|448852359|FG000|Period 1: Part 1|Adverse Event|0|||
124787052|NCT00830869|448852360|FG001|Period 1: Part 1|Adverse Event|0|||
124787053|NCT00830869|448852361|FG002|Period 1: Part 1|Adverse Event|0|||
124787054|NCT00830869|448852362|FG003|Period 1: Part 1|Adverse Event|0|||
124787055|NCT00830869|448852363|FG004|Period 1: Part 1|Adverse Event|0|||
124787056|NCT00830869|448852364|FG005|Period 1: Part 1|Adverse Event|1|||
124787057|NCT00830869|448852365|FG006|Period 1: Part 1|Adverse Event|1|||
124787058|NCT00830869|448852366|FG007|Period 1: Part 1|Adverse Event|0|||
124787059|NCT00830869|448852367|FG008|Period 1: Part 1|Adverse Event|0|||
124787060|NCT00830869|448852368|FG009|Period 1: Part 1|Adverse Event|0|||
124787061|NCT00830869|448852369|FG010|Period 1: Part 1|Adverse Event|0|||
124787062|NCT00830869|448852370|FG011|Period 1: Part 1|Adverse Event|0|||
124787063|NCT00830869|448852359|FG000|Period 1: Part 1|Progressive disease|1|||
124787064|NCT00830869|448852360|FG001|Period 1: Part 1|Progressive disease|0|||
124787065|NCT00830869|448852361|FG002|Period 1: Part 1|Progressive disease|1|||
124787066|NCT00830869|448852362|FG003|Period 1: Part 1|Progressive disease|6|||
124787067|NCT00830869|448852363|FG004|Period 1: Part 1|Progressive disease|4|||
124787068|NCT00830869|448852364|FG005|Period 1: Part 1|Progressive disease|4|||
124787069|NCT00830869|448852365|FG006|Period 1: Part 1|Progressive disease|1|||
124787070|NCT00830869|448852366|FG007|Period 1: Part 1|Progressive disease|0|||
124787071|NCT00830869|448852367|FG008|Period 1: Part 1|Progressive disease|0|||
124787072|NCT00830869|448852368|FG009|Period 1: Part 1|Progressive disease|0|||
124787073|NCT00830869|448852369|FG010|Period 1: Part 1|Progressive disease|0|||
124787074|NCT00830869|448852370|FG011|Period 1: Part 1|Progressive disease|0|||
124787075|NCT00830869|448852359|FG000|Period 2: Part 2|Protocol Violation|0|||
124787076|NCT00830869|448852360|FG001|Period 2: Part 2|Protocol Violation|0|||
124787077|NCT00830869|448852361|FG002|Period 2: Part 2|Protocol Violation|0|||
124787078|NCT00830869|448852362|FG003|Period 2: Part 2|Protocol Violation|0|||
124787079|NCT00830869|448852363|FG004|Period 2: Part 2|Protocol Violation|0|||
124787080|NCT00830869|448852364|FG005|Period 2: Part 2|Protocol Violation|0|||
124787081|NCT00830869|448852365|FG006|Period 2: Part 2|Protocol Violation|0|||
124787082|NCT00830869|448852366|FG007|Period 2: Part 2|Protocol Violation|1|||
124787083|NCT00830869|448852367|FG008|Period 2: Part 2|Protocol Violation|0|||
124787084|NCT00830869|448852368|FG009|Period 2: Part 2|Protocol Violation|1|||
124787085|NCT00830869|448852369|FG010|Period 2: Part 2|Protocol Violation|0|||
124787086|NCT00830869|448852370|FG011|Period 2: Part 2|Protocol Violation|0|||
124787087|NCT00830869|448852359|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
124787088|NCT00830869|448852360|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
124787089|NCT00830869|448852361|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
124787090|NCT00830869|448852362|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
124787091|NCT00830869|448852363|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
124787092|NCT00830869|448852364|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
124787093|NCT00830869|448852365|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
124787094|NCT00830869|448852366|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
124787095|NCT00830869|448852367|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
124787096|NCT00830869|448852368|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
124787097|NCT00830869|448852369|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
124787098|NCT00830869|448852370|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
124787099|NCT00830869|448852359|FG000|Period 2: Part 2|Adverse Event|0|||
124787100|NCT00830869|448852360|FG001|Period 2: Part 2|Adverse Event|0|||
124787101|NCT00830869|448852361|FG002|Period 2: Part 2|Adverse Event|0|||
124787102|NCT00830869|448852362|FG003|Period 2: Part 2|Adverse Event|0|||
124787103|NCT00830869|448852363|FG004|Period 2: Part 2|Adverse Event|0|||
124787104|NCT00830869|448852364|FG005|Period 2: Part 2|Adverse Event|0|||
124787105|NCT00830869|448852365|FG006|Period 2: Part 2|Adverse Event|0|||
124787106|NCT00830869|448852366|FG007|Period 2: Part 2|Adverse Event|4|||
124787107|NCT00830869|448852367|FG008|Period 2: Part 2|Adverse Event|3|||
124787108|NCT00830869|448852368|FG009|Period 2: Part 2|Adverse Event|2|||
124787109|NCT00830869|448852369|FG010|Period 2: Part 2|Adverse Event|2|||
124787110|NCT00830869|448852370|FG011|Period 2: Part 2|Adverse Event|0|||
124787111|NCT00830869|448852359|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
124787112|NCT00830869|448852360|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
124787113|NCT00830869|448852361|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
124787114|NCT00830869|448852362|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
124787115|NCT00830869|448852363|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
124787116|NCT00830869|448852364|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
124787117|NCT00830869|448852365|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
124787118|NCT00830869|448852366|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
124787119|NCT00830869|448852367|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
124787120|NCT00830869|448852368|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
124787121|NCT00830869|448852369|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
124787122|NCT00830869|448852370|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
124787123|NCT00830869|448852359|FG000|Period 2: Part 2|Progressive disease|0|||
124787124|NCT00830869|448852360|FG001|Period 2: Part 2|Progressive disease|0|||
124787125|NCT00830869|448852361|FG002|Period 2: Part 2|Progressive disease|0|||
124787126|NCT00830869|448852362|FG003|Period 2: Part 2|Progressive disease|0|||
124787127|NCT00830869|448852363|FG004|Period 2: Part 2|Progressive disease|0|||
124787128|NCT00830869|448852364|FG005|Period 2: Part 2|Progressive disease|0|||
124787129|NCT00830869|448852365|FG006|Period 2: Part 2|Progressive disease|0|||
124787130|NCT00830869|448852366|FG007|Period 2: Part 2|Progressive disease|14|||
124787131|NCT00830869|448852367|FG008|Period 2: Part 2|Progressive disease|11|||
124787132|NCT00830869|448852368|FG009|Period 2: Part 2|Progressive disease|12|||
124626449|NCT00758524|448248041|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
124626450|NCT00758524|448248042|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
124787133|NCT00830869|448852369|FG010|Period 2: Part 2|Progressive disease|8|||
124787134|NCT00830869|448852370|FG011|Period 2: Part 2|Progressive disease|15|||
124787135|NCT00830869|448852359|FG000|Period 2: Part 2|Other|0|||
124787136|NCT00830869|448852360|FG001|Period 2: Part 2|Other|0|||
124787137|NCT00830869|448852361|FG002|Period 2: Part 2|Other|0|||
124787138|NCT00830869|448852362|FG003|Period 2: Part 2|Other|0|||
124787139|NCT00830869|448852363|FG004|Period 2: Part 2|Other|0|||
124787140|NCT00830869|448852364|FG005|Period 2: Part 2|Other|0|||
124787141|NCT00830869|448852365|FG006|Period 2: Part 2|Other|0|||
124787142|NCT00830869|448852366|FG007|Period 2: Part 2|Other|0|||
124787143|NCT00830869|448852367|FG008|Period 2: Part 2|Other|0|||
124787144|NCT00830869|448852368|FG009|Period 2: Part 2|Other|1|||
124787145|NCT00830869|448852369|FG010|Period 2: Part 2|Other|0|||
124787146|NCT00830869|448852370|FG011|Period 2: Part 2|Other|0|||
124787147|NCT03745820|448852371|FG000|Overall Study|Adverse Event|0|||
124787148|NCT03745820|448852372|FG001|Overall Study|Adverse Event|3|||
124787149|NCT03745820|448852373|FG002|Overall Study|Adverse Event|2|||
124787150|NCT03745820|448852371|FG000|Overall Study|Non-Compliance with Study Drug|4|||
124787151|NCT03745820|448852372|FG001|Overall Study|Non-Compliance with Study Drug|3|||
124787152|NCT03745820|448852373|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124787153|NCT03745820|448852371|FG000|Overall Study|Withdrawal by Subject|4|||
124787154|NCT03745820|448852372|FG001|Overall Study|Withdrawal by Subject|4|||
124626451|NCT00758524|448248043|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
124787155|NCT03745820|448852373|FG002|Overall Study|Withdrawal by Subject|4|||
124787156|NCT03745820|448852371|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
124787157|NCT03745820|448852372|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
124787158|NCT03745820|448852373|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
124787159|NCT03745820|448852371|FG000|Overall Study|Lost to Follow-up|2|||
124787160|NCT03745820|448852372|FG001|Overall Study|Lost to Follow-up|0|||
124787161|NCT03745820|448852373|FG002|Overall Study|Lost to Follow-up|3|||
124787162|NCT03745820|448852371|FG000|Overall Study|Reason not Specified|2|||
124787163|NCT03745820|448852372|FG001|Overall Study|Reason not Specified|4|||
124787164|NCT03745820|448852373|FG002|Overall Study|Reason not Specified|1|||
124787165|NCT00668733|448852377|FG000|Overall Study|Lost to Follow-up|2|||
124787166|NCT00668733|448852378|FG001|Overall Study|Lost to Follow-up|3|||
124787167|NCT00668733|448852377|FG000|Overall Study|Withdrawal by Subject|0|||
124787168|NCT00668733|448852378|FG001|Overall Study|Withdrawal by Subject|4|||
124787169|NCT00945906|448852382|FG000|Overall Study|Withdrawal by Subject|1|||
124787170|NCT00945906|448852382|FG000|Overall Study|Did not want to return for last visit|2|||
124787171|NCT00945906|448852382|FG000|Overall Study|Unable to return for last visit|2|||
124787172|NCT00945906|448852382|FG000|Overall Study|Moved to another country|2|||
124787173|NCT00797966|448852383|FG000|Phase A|Lost to Follow-up|0|||
124787174|NCT00797966|448852384|FG001|Phase A|Lost to Follow-up|0|||
124787175|NCT00797966|448852385|FG002|Phase A|Lost to Follow-up|0|||
124787176|NCT00797966|448852386|FG003|Phase A|Lost to Follow-up|0|||
124787177|NCT00797966|448852387|FG004|Phase A|Lost to Follow-up|33|||
124787178|NCT00797966|448852388|FG005|Phase A|Lost to Follow-up|0|||
124787179|NCT00797966|448852383|FG000|Phase A|Adverse Event|0|||
124787180|NCT00797966|448852384|FG001|Phase A|Adverse Event|0|||
124787181|NCT00797966|448852385|FG002|Phase A|Adverse Event|0|||
124787182|NCT00797966|448852386|FG003|Phase A|Adverse Event|0|||
124787183|NCT00797966|448852387|FG004|Phase A|Adverse Event|46|||
124787184|NCT00797966|448852388|FG005|Phase A|Adverse Event|0|||
124787185|NCT00797966|448852383|FG000|Phase A|Met withdrawal criteria|0|||
124787186|NCT00797966|448852384|FG001|Phase A|Met withdrawal criteria|0|||
124787187|NCT00797966|448852385|FG002|Phase A|Met withdrawal criteria|0|||
124787188|NCT00797966|448852386|FG003|Phase A|Met withdrawal criteria|0|||
124787189|NCT00797966|448852387|FG004|Phase A|Met withdrawal criteria|4|||
124787190|NCT00797966|448852388|FG005|Phase A|Met withdrawal criteria|0|||
124787191|NCT00797966|448852383|FG000|Phase A|Physician Decision|0|||
124787192|NCT00797966|448852384|FG001|Phase A|Physician Decision|0|||
124787193|NCT00797966|448852385|FG002|Phase A|Physician Decision|0|||
124787194|NCT00797966|448852386|FG003|Phase A|Physician Decision|0|||
124787195|NCT00797966|448852387|FG004|Phase A|Physician Decision|13|||
124787196|NCT00797966|448852388|FG005|Phase A|Physician Decision|0|||
124787197|NCT00797966|448852383|FG000|Phase A|Withdrawal by Subject|0|||
124787198|NCT00797966|448852384|FG001|Phase A|Withdrawal by Subject|0|||
124787199|NCT00797966|448852385|FG002|Phase A|Withdrawal by Subject|0|||
124787200|NCT00797966|448852386|FG003|Phase A|Withdrawal by Subject|0|||
124787201|NCT00797966|448852387|FG004|Phase A|Withdrawal by Subject|33|||
124787202|NCT00797966|448852388|FG005|Phase A|Withdrawal by Subject|0|||
124787203|NCT00797966|448852383|FG000|Phase A|Protocol deviation|0|||
124787204|NCT00797966|448852384|FG001|Phase A|Protocol deviation|0|||
124787205|NCT00797966|448852385|FG002|Phase A|Protocol deviation|0|||
124787206|NCT00797966|448852386|FG003|Phase A|Protocol deviation|0|||
124787207|NCT00797966|448852387|FG004|Phase A|Protocol deviation|56|||
124787208|NCT00797966|448852388|FG005|Phase A|Protocol deviation|0|||
124787209|NCT00797966|448852383|FG000|Phase B|Lost to Follow-up|0|||
124787210|NCT00797966|448852384|FG001|Phase B|Lost to Follow-up|1|||
124787211|NCT00797966|448852385|FG002|Phase B|Lost to Follow-up|3|||
124787212|NCT00797966|448852386|FG003|Phase B|Lost to Follow-up|0|||
124787213|NCT00797966|448852387|FG004|Phase B|Lost to Follow-up|0|||
124787214|NCT00797966|448852388|FG005|Phase B|Lost to Follow-up|0|||
124787215|NCT00797966|448852383|FG000|Phase B|Adverse Event|2|||
124787216|NCT00797966|448852384|FG001|Phase B|Adverse Event|1|||
124787217|NCT00797966|448852385|FG002|Phase B|Adverse Event|3|||
124787218|NCT00797966|448852386|FG003|Phase B|Adverse Event|1|||
124787219|NCT00797966|448852387|FG004|Phase B|Adverse Event|0|||
124787220|NCT00797966|448852388|FG005|Phase B|Adverse Event|0|||
124787221|NCT00797966|448852383|FG000|Phase B|Met Withdrawal Criteria|3|||
124787222|NCT00797966|448852384|FG001|Phase B|Met Withdrawal Criteria|3|||
124787223|NCT00797966|448852385|FG002|Phase B|Met Withdrawal Criteria|6|||
124787224|NCT00797966|448852386|FG003|Phase B|Met Withdrawal Criteria|1|||
124787225|NCT00797966|448852387|FG004|Phase B|Met Withdrawal Criteria|0|||
124787226|NCT00797966|448852388|FG005|Phase B|Met Withdrawal Criteria|0|||
124787227|NCT00797966|448852383|FG000|Phase B|Physician Decision|1|||
124787228|NCT00797966|448852384|FG001|Phase B|Physician Decision|0|||
124787229|NCT00797966|448852385|FG002|Phase B|Physician Decision|3|||
124787230|NCT00797966|448852386|FG003|Phase B|Physician Decision|1|||
124787231|NCT00797966|448852387|FG004|Phase B|Physician Decision|0|||
124787232|NCT00797966|448852388|FG005|Phase B|Physician Decision|0|||
124787233|NCT00797966|448852383|FG000|Phase B|Withdrawal by Subject|1|||
124787234|NCT00797966|448852384|FG001|Phase B|Withdrawal by Subject|4|||
124787235|NCT00797966|448852385|FG002|Phase B|Withdrawal by Subject|3|||
124787236|NCT00797966|448852386|FG003|Phase B|Withdrawal by Subject|3|||
124787237|NCT00797966|448852387|FG004|Phase B|Withdrawal by Subject|0|||
124787238|NCT00797966|448852388|FG005|Phase B|Withdrawal by Subject|0|||
124787239|NCT00797966|448852383|FG000|Phase B|Protocol Deviation|4|||
124787240|NCT00797966|448852384|FG001|Phase B|Protocol Deviation|8|||
124787241|NCT00797966|448852385|FG002|Phase B|Protocol Deviation|2|||
124787242|NCT00797966|448852386|FG003|Phase B|Protocol Deviation|6|||
124787243|NCT00797966|448852387|FG004|Phase B|Protocol Deviation|0|||
124787244|NCT00797966|448852388|FG005|Phase B|Protocol Deviation|0|||
124787245|NCT00797966|448852383|FG000|Phase B|Lack of Efficacy|0|||
124787246|NCT00797966|448852384|FG001|Phase B|Lack of Efficacy|1|||
124787247|NCT00797966|448852385|FG002|Phase B|Lack of Efficacy|1|||
124787248|NCT00797966|448852386|FG003|Phase B|Lack of Efficacy|4|||
124787249|NCT00797966|448852387|FG004|Phase B|Lack of Efficacy|0|||
124787250|NCT00797966|448852388|FG005|Phase B|Lack of Efficacy|0|||
124787251|NCT00797966|448852383|FG000|Phase A+|Lost to Follow-up|0|||
124787252|NCT00797966|448852384|FG001|Phase A+|Lost to Follow-up|0|||
124787253|NCT00797966|448852385|FG002|Phase A+|Lost to Follow-up|0|||
124787254|NCT00797966|448852386|FG003|Phase A+|Lost to Follow-up|0|||
124787255|NCT00797966|448852387|FG004|Phase A+|Lost to Follow-up|0|||
124787256|NCT00797966|448852388|FG005|Phase A+|Lost to Follow-up|9|||
124787257|NCT00797966|448852383|FG000|Phase A+|Met withdrawal criteria|0|||
124787258|NCT00797966|448852384|FG001|Phase A+|Met withdrawal criteria|0|||
124787259|NCT00797966|448852385|FG002|Phase A+|Met withdrawal criteria|0|||
124787260|NCT00797966|448852386|FG003|Phase A+|Met withdrawal criteria|0|||
124787261|NCT00797966|448852387|FG004|Phase A+|Met withdrawal criteria|0|||
124787262|NCT00797966|448852388|FG005|Phase A+|Met withdrawal criteria|5|||
124787263|NCT00797966|448852383|FG000|Phase A+|Withdrawal by Subject|0|||
124787264|NCT00797966|448852384|FG001|Phase A+|Withdrawal by Subject|0|||
124787265|NCT00797966|448852385|FG002|Phase A+|Withdrawal by Subject|0|||
124787266|NCT00797966|448852386|FG003|Phase A+|Withdrawal by Subject|0|||
124787267|NCT00797966|448852387|FG004|Phase A+|Withdrawal by Subject|0|||
124787268|NCT00797966|448852388|FG005|Phase A+|Withdrawal by Subject|6|||
124787269|NCT00797966|448852383|FG000|Phase A+|Adverse Event|0|||
124787270|NCT00797966|448852384|FG001|Phase A+|Adverse Event|0|||
124787271|NCT00797966|448852385|FG002|Phase A+|Adverse Event|0|||
124787272|NCT00797966|448852386|FG003|Phase A+|Adverse Event|0|||
124787273|NCT00797966|448852387|FG004|Phase A+|Adverse Event|0|||
124787274|NCT00797966|448852388|FG005|Phase A+|Adverse Event|4|||
124787275|NCT00797966|448852383|FG000|Phase A+|Protocol deviation|0|||
124787276|NCT00797966|448852384|FG001|Phase A+|Protocol deviation|0|||
124787277|NCT00797966|448852385|FG002|Phase A+|Protocol deviation|0|||
124787278|NCT00797966|448852386|FG003|Phase A+|Protocol deviation|0|||
124787279|NCT00797966|448852387|FG004|Phase A+|Protocol deviation|0|||
124787280|NCT00797966|448852388|FG005|Phase A+|Protocol deviation|4|||
124787281|NCT03859973|448852389|FG000|Overall Study|Other reason than listed|3|||
124787282|NCT03859973|448852390|FG001|Overall Study|Other reason than listed|2|||
124787283|NCT03859973|448852389|FG000|Overall Study|COVID-19 related, not due to AE|3|||
124787284|NCT03859973|448852390|FG001|Overall Study|COVID-19 related, not due to AE|4|||
124787285|NCT03859973|448852389|FG000|Overall Study|Withdrawal by Subject|8|||
124787286|NCT03859973|448852390|FG001|Overall Study|Withdrawal by Subject|9|||
124787287|NCT03859973|448852389|FG000|Overall Study|Lost to Follow-up|2|||
124787288|NCT03859973|448852390|FG001|Overall Study|Lost to Follow-up|3|||
124787289|NCT03859973|448852389|FG000|Overall Study|Protocol Violation|1|||
124787290|NCT03859973|448852390|FG001|Overall Study|Protocol Violation|3|||
124787291|NCT03859973|448852389|FG000|Overall Study|Adverse Event|3|||
124787292|NCT03859973|448852390|FG001|Overall Study|Adverse Event|5|||
124787293|NCT01478048|448852391|FG000|Overall Study|Disease Progression|52|||
124787294|NCT01478048|448852392|FG001|Overall Study|Disease Progression|35|||
124787295|NCT01478048|448852391|FG000|Overall Study|study drug toxicity|11|||
124787296|NCT01478048|448852392|FG001|Overall Study|study drug toxicity|14|||
124787297|NCT01478048|448852391|FG000|Overall Study|Adverse Event|2|||
124787298|NCT01478048|448852392|FG001|Overall Study|Adverse Event|11|||
124787299|NCT01478048|448852391|FG000|Overall Study|subject request to discontinue treatment|3|||
124787300|NCT01478048|448852392|FG001|Overall Study|subject request to discontinue treatment|5|||
124787301|NCT01478048|448852391|FG000|Overall Study|Withdrawal by Subject|2|||
124787302|NCT01478048|448852392|FG001|Overall Study|Withdrawal by Subject|5|||
124787303|NCT01478048|448852391|FG000|Overall Study|non-specified|6|||
124787304|NCT01478048|448852392|FG001|Overall Study|non-specified|4|||
124787305|NCT01478048|448852391|FG000|Overall Study|poor/non-compliance|0|||
124787306|NCT01478048|448852392|FG001|Overall Study|poor/non-compliance|1|||
124787307|NCT01478048|448852391|FG000|Overall Study|no longer meets study criteria|1|||
124787308|NCT01478048|448852392|FG001|Overall Study|no longer meets study criteria|0|||
124787309|NCT03032380|448852401|FG000|Overall Study|Adverse Event|0|||
124787310|NCT03032380|448852402|FG001|Overall Study|Adverse Event|1|||
124787311|NCT03032380|448852401|FG000|Overall Study|Lack of Efficacy|1|||
124787312|NCT03032380|448852402|FG001|Overall Study|Lack of Efficacy|0|||
124787313|NCT03032380|448852401|FG000|Overall Study|Withdrawal by Subject|2|||
124787314|NCT03032380|448852402|FG001|Overall Study|Withdrawal by Subject|3|||
124787315|NCT03032380|448852401|FG000|Overall Study|Recovery|0|||
124787316|NCT03032380|448852402|FG001|Overall Study|Recovery|1|||
124787317|NCT03032380|448852401|FG000|Overall Study|Death|39|||
124787318|NCT03032380|448852402|FG001|Overall Study|Death|34|||
124787319|NCT03032380|448852401|FG000|Overall Study|Other - Miscellaneous|0|||
124787320|NCT03032380|448852402|FG001|Overall Study|Other - Miscellaneous|1|||
124787321|NCT01561898|448852403|FG000|Overall Study|Withdrawal by Subject|0|||
124787322|NCT01561898|448852404|FG001|Overall Study|Withdrawal by Subject|8|||
124787323|NCT01561898|448852405|FG002|Overall Study|Withdrawal by Subject|12|||
124787324|NCT01561898|448852406|FG003|Overall Study|Withdrawal by Subject|5|||
124787325|NCT01561898|448852403|FG000|Overall Study|Lack of Efficacy|0|||
124787326|NCT01561898|448852404|FG001|Overall Study|Lack of Efficacy|8|||
124787327|NCT01561898|448852405|FG002|Overall Study|Lack of Efficacy|10|||
124787328|NCT01561898|448852406|FG003|Overall Study|Lack of Efficacy|5|||
124787329|NCT01561898|448852403|FG000|Overall Study|Worsening of complications|0|||
124787330|NCT01561898|448852404|FG001|Overall Study|Worsening of complications|1|||
124787331|NCT01561898|448852405|FG002|Overall Study|Worsening of complications|0|||
124787332|NCT01561898|448852406|FG003|Overall Study|Worsening of complications|0|||
124787333|NCT01561898|448852403|FG000|Overall Study|Lost to Follow-up|0|||
124787334|NCT01561898|448852404|FG001|Overall Study|Lost to Follow-up|0|||
124752149|NCT00095173|448714268|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
124752150|NCT00095173|448714269|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
124752151|NCT00095173|448714270|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
124752152|NCT00095173|448714271|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
124752153|NCT00095173|448714272|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
124752154|NCT00095173|448714273|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
124752155|NCT00095173|448714268|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
124752156|NCT00095173|448714269|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
124752157|NCT00095173|448714270|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
124752158|NCT00095173|448714271|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
124752159|NCT00095173|448714272|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
124752160|NCT00095173|448714273|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
124752161|NCT00095173|448714268|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
124752162|NCT00095173|448714269|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
124752163|NCT00095173|448714270|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
124752164|NCT00095173|448714271|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
124752165|NCT00095173|448714272|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
124752166|NCT00095173|448714273|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
124752167|NCT00095173|448714268|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
124752168|NCT00095173|448714269|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
124752169|NCT00095173|448714270|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
124752170|NCT00095173|448714271|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
124752171|NCT00095173|448714272|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
124752172|NCT00095173|448714273|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
124752173|NCT00095173|448714268|FG000|Open-Label Extension Phase (Period C)|Other|0|||
124752174|NCT00095173|448714269|FG001|Open-Label Extension Phase (Period C)|Other|0|||
124752175|NCT00095173|448714270|FG002|Open-Label Extension Phase (Period C)|Other|0|||
124752176|NCT00095173|448714271|FG003|Open-Label Extension Phase (Period C)|Other|4|||
124752177|NCT00095173|448714272|FG004|Open-Label Extension Phase (Period C)|Other|6|||
124752178|NCT00095173|448714273|FG005|Open-Label Extension Phase (Period C)|Other|8|||
124752179|NCT00145574|448714275|FG000|Double Blind|Adverse Event|0|||
124752180|NCT00145574|448714276|FG001|Double Blind|Adverse Event|3|||
124752181|NCT00145574|448714277|FG002|Double Blind|Adverse Event|1|||
124752182|NCT00145574|448714275|FG000|Double Blind|Withdrawal by Subject|1|||
124752183|NCT00145574|448714276|FG001|Double Blind|Withdrawal by Subject|1|||
124752184|NCT00145574|448714277|FG002|Double Blind|Withdrawal by Subject|1|||
124752185|NCT00145574|448714275|FG000|Double Blind|required restricted medicine|0|||
124752186|NCT00145574|448714276|FG001|Double Blind|required restricted medicine|1|||
124752187|NCT00145574|448714277|FG002|Double Blind|required restricted medicine|0|||
124752188|NCT00145574|448714275|FG000|Open Label Long-term Extension|Adverse Event|0|||
124752189|NCT00145574|448714276|FG001|Open Label Long-term Extension|Adverse Event|0|||
124752190|NCT00145574|448714277|FG002|Open Label Long-term Extension|Adverse Event|5|||
124752191|NCT00145574|448714275|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
124752192|NCT00145574|448714276|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
124752193|NCT00145574|448714277|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
124752194|NCT00145574|448714275|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
124752195|NCT00145574|448714276|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
124752196|NCT00145574|448714277|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
124752197|NCT00145574|448714275|FG000|Open Label Long-term Extension|required restricted medicine|0|||
124752198|NCT00145574|448714276|FG001|Open Label Long-term Extension|required restricted medicine|0|||
124752199|NCT00145574|448714277|FG002|Open Label Long-term Extension|required restricted medicine|1|||
124752200|NCT00527904|448714278|FG000|Overall Study|Adverse Event|45|||
124752201|NCT00527904|448714278|FG000|Overall Study|Withdrawal by Subject|21|||
124752202|NCT00527904|448714278|FG000|Overall Study|Lost to Follow-up|8|||
124752203|NCT00527904|448714278|FG000|Overall Study|misc|22|||
124752204|NCT02708355|448714280|FG000|Overall Study|Adverse Event|1|||
124752205|NCT02708355|448714281|FG001|Overall Study|Adverse Event|0|||
124787335|NCT01561898|448852405|FG002|Overall Study|Lost to Follow-up|1|||
124787336|NCT01561898|448852406|FG003|Overall Study|Lost to Follow-up|0|||
124787337|NCT01561898|448852403|FG000|Overall Study|Adverse Event|1|||
124787338|NCT01561898|448852404|FG001|Overall Study|Adverse Event|19|||
124787339|NCT01561898|448852405|FG002|Overall Study|Adverse Event|14|||
124787340|NCT01561898|448852406|FG003|Overall Study|Adverse Event|9|||
124787341|NCT01561898|448852403|FG000|Overall Study|Physician Decision|1|||
124787342|NCT01561898|448852404|FG001|Overall Study|Physician Decision|5|||
124787343|NCT01561898|448852405|FG002|Overall Study|Physician Decision|7|||
124787344|NCT01561898|448852406|FG003|Overall Study|Physician Decision|1|||
124787345|NCT00294762|448852407|FG000|Overall Study|Did not receive study treatment|3|||
124787346|NCT00294762|448852408|FG001|Overall Study|Did not receive study treatment|3|||
124787347|NCT02238080|448852409|FG000|Overall Study|Death|13|||
124787348|NCT02238080|448852409|FG000|Overall Study|Treatment interrupted|6|||
124787349|NCT02238080|448852409|FG000|Overall Study|Withdrawal by Subject|2|||
124787350|NCT02238080|448852409|FG000|Overall Study|Other|4|||
124787351|NCT01738646|448852410|FG000|Overall Study|Still Receiving Treatment|2|||
124787352|NCT04093024|448852413|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
124787353|NCT04093024|448852414|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
124787354|NCT04093024|448852413|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
124787355|NCT04093024|448852414|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
124787356|NCT04093024|448852413|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
124787357|NCT04093024|448852414|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
124787358|NCT04093024|448852413|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
124787359|NCT04093024|448852414|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
124787360|NCT00233454|448852417|FG000|Overall Study|Death|6|||
124787361|NCT00796445|448852418|FG000|Overall Study|Protocol Violation|5|||
124787362|NCT00796445|448852419|FG001|Overall Study|Protocol Violation|3|||
124787363|NCT00796445|448852418|FG000|Overall Study|Adverse event, serious fatal|10|||
124787364|NCT00796445|448852419|FG001|Overall Study|Adverse event, serious fatal|5|||
124787365|NCT00796445|448852418|FG000|Overall Study|Adverse event, non-fatal|4|||
124787366|NCT00796445|448852419|FG001|Overall Study|Adverse event, non-fatal|0|||
124787367|NCT00796445|448852418|FG000|Overall Study|Disease progression/recurrence|537|||
124787368|NCT00796445|448852419|FG001|Overall Study|Disease progression/recurrence|268|||
124787369|NCT00796445|448852418|FG000|Overall Study|Other|10|||
124787370|NCT00796445|448852419|FG001|Overall Study|Other|7|||
124787371|NCT00796445|448852418|FG000|Overall Study|Withdrawal by Subject|18|||
124787372|NCT00796445|448852419|FG001|Overall Study|Withdrawal by Subject|9|||
124787373|NCT00796445|448852418|FG000|Overall Study|Invalid Informed Consent Form|1|||
124787374|NCT00796445|448852419|FG001|Overall Study|Invalid Informed Consent Form|0|||
124787375|NCT02366091|448852420|FG000|Overall Study|Withdrawal by Subject|3|||
124787376|NCT02366091|448852421|FG001|Overall Study|Withdrawal by Subject|7|||
124787377|NCT02366091|448852422|FG002|Overall Study|Withdrawal by Subject|3|||
124787378|NCT02366091|448852423|FG003|Overall Study|Withdrawal by Subject|1|||
124787379|NCT00322621|448852424|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
124787380|NCT00322621|448852425|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
124787381|NCT00322621|448852426|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
124787382|NCT00322621|448852424|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
124787383|NCT00322621|448852425|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
124787384|NCT00322621|448852426|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
124787385|NCT00322621|448852424|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
124787386|NCT00322621|448852425|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
124787387|NCT00322621|448852426|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
124787388|NCT00322621|448852424|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
124787389|NCT00322621|448852425|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
124787390|NCT00322621|448852426|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
124787391|NCT00322621|448852424|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
124787392|NCT00322621|448852425|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
124787393|NCT00322621|448852426|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
124787394|NCT00322621|448852424|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
124787395|NCT00322621|448852425|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
124787396|NCT00322621|448852426|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
124787397|NCT00322621|448852424|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
124787398|NCT00322621|448852425|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
124787399|NCT00322621|448852426|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
124787400|NCT00322621|448852424|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
124787401|NCT00322621|448852425|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
124787402|NCT00322621|448852426|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
124787403|NCT00322621|448852424|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
124787404|NCT00322621|448852425|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
124787405|NCT00322621|448852426|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
124787406|NCT00322621|448852424|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
124787407|NCT00322621|448852425|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
124787408|NCT00322621|448852426|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
124787409|NCT00322621|448852424|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
124787410|NCT00322621|448852425|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
124787411|NCT00322621|448852426|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
124787412|NCT01743001|448852427|FG000|Overall Study|Physician Decision|1|||
124787413|NCT01743001|448852428|FG001|Overall Study|Physician Decision|0|||
124787414|NCT01743001|448852427|FG000|Overall Study|Pregnancy|1|||
124787415|NCT01743001|448852428|FG001|Overall Study|Pregnancy|0|||
124787416|NCT01743001|448852427|FG000|Overall Study|Death|1|||
124787417|NCT01743001|448852428|FG001|Overall Study|Death|0|||
124787418|NCT01565343|448852429|FG000|Overall Study|Administrative decision/technical issues|1|||
124787419|NCT01565343|448852430|FG001|Overall Study|Administrative decision/technical issues|0|||
124787420|NCT01565343|448852431|FG002|Overall Study|Administrative decision/technical issues|0|||
124787421|NCT01853839|448852433|FG000|Overall Study|Violated inclusion criteria|2|||
124787422|NCT01853839|448852433|FG000|Overall Study|Not meet ITT population definition|58|||
124787423|NCT01853839|448852433|FG000|Overall Study|End of treatment visit too early|33|||
124787424|NCT01853839|448852433|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
124787425|NCT02350764|448852434|FG000|Overall Study|Adverse Event|4|||
124787426|NCT02350764|448852434|FG000|Overall Study|Death|3|||
124787427|NCT02350764|448852434|FG000|Overall Study|Physician Decision|2|||
124787428|NCT02350764|448852434|FG000|Overall Study|Withdrawal by Subject|2|||
124787429|NCT03531632|448852435|FG000|Overall Study|Adverse Event|0|||
124787430|NCT03531632|448852436|FG001|Overall Study|Adverse Event|0|||
124787431|NCT03531632|448852437|FG002|Overall Study|Adverse Event|1|||
124787432|NCT03531632|448852435|FG000|Overall Study|Death|4|||
124787433|NCT03531632|448852436|FG001|Overall Study|Death|0|||
124787434|NCT03531632|448852437|FG002|Overall Study|Death|14|||
124787435|NCT03531632|448852435|FG000|Overall Study|Study Terminated|1|||
124787436|NCT03531632|448852436|FG001|Overall Study|Study Terminated|3|||
124787437|NCT03531632|448852437|FG002|Overall Study|Study Terminated|11|||
124787438|NCT00600119|448852438|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
124787439|NCT00600119|448852439|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
124787440|NCT00600119|448852440|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
124787441|NCT00600119|448852441|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
124787442|NCT00600119|448852442|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
124787443|NCT00600119|448852443|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
124787444|NCT00600119|448852438|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
124787445|NCT00600119|448852439|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
124787446|NCT00600119|448852440|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
124787447|NCT00600119|448852441|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
124787448|NCT00600119|448852442|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
124787449|NCT00600119|448852443|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
124787450|NCT00600119|448852438|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
124787451|NCT00600119|448852439|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
124787452|NCT00600119|448852440|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
124787453|NCT00600119|448852441|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
124787454|NCT00600119|448852442|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
124787455|NCT00600119|448852443|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
124787456|NCT00600119|448852438|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
124787457|NCT00600119|448852439|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
124787458|NCT00600119|448852440|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
124787459|NCT00600119|448852441|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
124787460|NCT00600119|448852442|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
124787461|NCT00600119|448852443|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
124787462|NCT00600119|448852438|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
124787463|NCT00600119|448852439|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
124787464|NCT00600119|448852440|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
124787465|NCT00600119|448852441|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
124787466|NCT00600119|448852442|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
124787467|NCT00600119|448852443|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
124787468|NCT00600119|448852438|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
124787469|NCT00600119|448852439|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
124787470|NCT00600119|448852440|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
124787471|NCT00600119|448852441|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
124787472|NCT00600119|448852442|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
124626452|NCT00758524|448248044|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
124787473|NCT00600119|448852443|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
124787474|NCT00600119|448852438|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
124752206|NCT02708355|448714282|FG002|Overall Study|Adverse Event|0|||
124752207|NCT01320202|448714283|FG000|Overall Study|Adverse Event|5|||
124752208|NCT01320202|448714284|FG001|Overall Study|Adverse Event|5|||
124752209|NCT01320202|448714283|FG000|Overall Study|Death|5|||
124752210|NCT01320202|448714284|FG001|Overall Study|Death|3|||
124752211|NCT01320202|448714283|FG000|Overall Study|Lost to Follow-up|1|||
124752212|NCT01320202|448714284|FG001|Overall Study|Lost to Follow-up|0|||
124752213|NCT01320202|448714283|FG000|Overall Study|Physician Decision|3|||
124752214|NCT01320202|448714284|FG001|Overall Study|Physician Decision|1|||
124752215|NCT01320202|448714283|FG000|Overall Study|Protocol Violation|2|||
124752216|NCT01320202|448714284|FG001|Overall Study|Protocol Violation|1|||
124752217|NCT01320202|448714283|FG000|Overall Study|Withdrawal by Subject|10|||
124752218|NCT01320202|448714284|FG001|Overall Study|Withdrawal by Subject|3|||
124752219|NCT01320202|448714283|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
124752220|NCT01320202|448714284|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
124752221|NCT01320202|448714283|FG000|Overall Study|kidney transplant|1|||
124752222|NCT01320202|448714284|FG001|Overall Study|kidney transplant|2|||
124752223|NCT01320202|448714283|FG000|Overall Study|blood transfusion|1|||
124752224|NCT01320202|448714284|FG001|Overall Study|blood transfusion|7|||
124752225|NCT01320202|448714283|FG000|Overall Study|moved/changed dialysis|5|||
124752226|NCT01320202|448714284|FG001|Overall Study|moved/changed dialysis|2|||
124752227|NCT01320202|448714283|FG000|Overall Study|sponsor request|2|||
124752228|NCT01320202|448714284|FG001|Overall Study|sponsor request|0|||
124752229|NCT01320202|448714283|FG000|Overall Study|ineligible|3|||
124752230|NCT01320202|448714284|FG001|Overall Study|ineligible|0|||
124752231|NCT01320202|448714283|FG000|Overall Study|regained renal function|1|||
124752232|NCT01320202|448714284|FG001|Overall Study|regained renal function|0|||
124752233|NCT01019369|448714286|FG000|Overall Study|Lost to Follow-up|10|||
124752234|NCT01019369|448714287|FG001|Overall Study|Lost to Follow-up|6|||
124752235|NCT01019369|448714286|FG000|Overall Study|Withdrawal by Subject|0|||
124752236|NCT01019369|448714287|FG001|Overall Study|Withdrawal by Subject|1|||
124752237|NCT01380834|448714288|FG000|Overall Study|Physician Decision|1|||
124752238|NCT01380834|448714289|FG001|Overall Study|Physician Decision|0|||
124752239|NCT04310566|448714290|FG000|Period 1|Study Termination due to COVID-19|15|||
124752240|NCT04310566|448714291|FG001|Period 1|Study Termination due to COVID-19|17|||
124752241|NCT04310566|448714290|FG000|Period 1|Protocol Violation|0|||
124752242|NCT04310566|448714291|FG001|Period 1|Protocol Violation|1|||
124752243|NCT04310566|448714290|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
124752244|NCT04310566|448714291|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
124752245|NCT04310566|448714290|FG000|Period 1|Lost to Follow-up|1|||
124752246|NCT04310566|448714291|FG001|Period 1|Lost to Follow-up|0|||
124752247|NCT04310566|448714290|FG000|Period 1|Withdrawal by Subject|0|||
124752248|NCT04310566|448714291|FG001|Period 1|Withdrawal by Subject|1|||
124752249|NCT04310566|448714290|FG000|Period 2|Study Termination|7|||
124752250|NCT04310566|448714291|FG001|Period 2|Study Termination|5|||
124752251|NCT01711645|448714292|FG000|Overall Study|Withdrawal by Subject|8|||
124752252|NCT01711645|448714292|FG000|Overall Study|Lost to Follow-up|6|||
124752253|NCT01711645|448714292|FG000|Overall Study|Physician Decision|5|||
124752254|NCT01746173|448714298|FG000|Overall Study|Disease Progression|2|||
124752255|NCT01771250|448714300|FG000|Period 1|Met exclusion criteria|1|||
124752256|NCT01771250|448714301|FG001|Period 1|Met exclusion criteria|0|||
124752257|NCT03543137|448714305|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
124752258|NCT03543137|448714306|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
124752259|NCT03543137|448714305|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
124752260|NCT03543137|448714306|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
124752261|NCT03543137|448714305|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
124752262|NCT03543137|448714306|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
124752263|NCT01153724|448714309|FG000|Treatment Period 1|Withdrawal by Subject|1|||
124752264|NCT01153724|448714309|FG000|Treatment Period 2|Adverse Event|1|||
124752265|NCT01153724|448714309|FG000|Treatment Period 2|Other reason not defined above|1|||
124752266|NCT04230213|448714315|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
124752267|NCT04230213|448714316|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
124752268|NCT04230213|448714317|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
124752269|NCT04230213|448714315|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
124752270|NCT04230213|448714316|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
124752271|NCT04230213|448714317|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
124752272|NCT04230213|448714315|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
124752273|NCT04230213|448714316|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
124752274|NCT04230213|448714317|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
124752275|NCT04230213|448714315|FG000|TP2: Week 10 to Week 16|Other|0|||
124752276|NCT04230213|448714316|FG001|TP2: Week 10 to Week 16|Other|2|||
124752277|NCT04230213|448714317|FG002|TP2: Week 10 to Week 16|Other|1|||
124752278|NCT04230213|448714315|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
124752279|NCT04230213|448714316|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
124787475|NCT00600119|448852439|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
124787476|NCT00600119|448852440|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
124787477|NCT00600119|448852441|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
124787478|NCT00600119|448852442|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
124787479|NCT00600119|448852443|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
124787480|NCT00600119|448852438|FG000|Double-blind Treatment Period|Other|0|||
124787481|NCT00600119|448852439|FG001|Double-blind Treatment Period|Other|0|||
124787482|NCT00600119|448852440|FG002|Double-blind Treatment Period|Other|0|||
124787483|NCT00600119|448852441|FG003|Double-blind Treatment Period|Other|0|||
124787484|NCT00600119|448852442|FG004|Double-blind Treatment Period|Other|2|||
124787485|NCT00600119|448852443|FG005|Double-blind Treatment Period|Other|1|||
124787486|NCT00600119|448852438|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
124787487|NCT00600119|448852439|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
124787488|NCT00600119|448852440|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
124787489|NCT00600119|448852441|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
124787490|NCT00600119|448852442|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
124787491|NCT00600119|448852443|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
124787492|NCT00600119|448852438|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
124787493|NCT00600119|448852439|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
124787494|NCT00600119|448852440|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
124787495|NCT00600119|448852441|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
124787496|NCT00600119|448852442|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
124787497|NCT00600119|448852443|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
124787498|NCT00600119|448852438|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
124787499|NCT00600119|448852439|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
124787500|NCT00600119|448852440|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
124787501|NCT00600119|448852441|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
124787502|NCT00600119|448852442|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
124787503|NCT00600119|448852443|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
124787504|NCT00600119|448852438|FG000|Double-blind Treatment Period|Physician Decision|2|||
124787505|NCT00600119|448852439|FG001|Double-blind Treatment Period|Physician Decision|0|||
124787506|NCT00600119|448852440|FG002|Double-blind Treatment Period|Physician Decision|0|||
124787507|NCT00600119|448852441|FG003|Double-blind Treatment Period|Physician Decision|0|||
124787508|NCT00600119|448852442|FG004|Double-blind Treatment Period|Physician Decision|0|||
124787509|NCT00600119|448852443|FG005|Double-blind Treatment Period|Physician Decision|0|||
124787510|NCT00600119|448852438|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
124787511|NCT00600119|448852439|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
124787512|NCT00600119|448852440|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
124787513|NCT00600119|448852441|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
124787514|NCT00600119|448852442|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
124787515|NCT00600119|448852443|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
124787516|NCT00600119|448852438|FG000|Double-blind Treatment Period|Adverse Event|1|||
124787517|NCT00600119|448852439|FG001|Double-blind Treatment Period|Adverse Event|1|||
124787518|NCT00600119|448852440|FG002|Double-blind Treatment Period|Adverse Event|0|||
124787519|NCT00600119|448852441|FG003|Double-blind Treatment Period|Adverse Event|1|||
124787520|NCT00600119|448852442|FG004|Double-blind Treatment Period|Adverse Event|2|||
124787521|NCT00600119|448852443|FG005|Double-blind Treatment Period|Adverse Event|10|||
124787522|NCT00600119|448852438|FG000|Follow-up Period|Adverse Event|0|||
124787523|NCT00600119|448852439|FG001|Follow-up Period|Adverse Event|0|||
124787524|NCT00600119|448852440|FG002|Follow-up Period|Adverse Event|0|||
124787525|NCT00600119|448852441|FG003|Follow-up Period|Adverse Event|0|||
124787526|NCT00600119|448852442|FG004|Follow-up Period|Adverse Event|0|||
124787527|NCT00600119|448852443|FG005|Follow-up Period|Adverse Event|1|||
124787528|NCT00600119|448852438|FG000|Follow-up Period|Other|1|||
124787529|NCT00600119|448852439|FG001|Follow-up Period|Other|0|||
124787530|NCT00600119|448852440|FG002|Follow-up Period|Other|0|||
124787531|NCT00600119|448852441|FG003|Follow-up Period|Other|0|||
124787532|NCT00600119|448852442|FG004|Follow-up Period|Other|0|||
124787533|NCT00600119|448852443|FG005|Follow-up Period|Other|0|||
124787534|NCT00729469|448852444|FG000|Overall Study|Adverse Event|14|||
124787535|NCT00729469|448852445|FG001|Overall Study|Adverse Event|25|||
124787536|NCT00729469|448852444|FG000|Overall Study|Lost to Follow-up|9|||
124787537|NCT00729469|448852445|FG001|Overall Study|Lost to Follow-up|9|||
124787538|NCT00729469|448852444|FG000|Overall Study|Protocol Violation|2|||
124787539|NCT00729469|448852445|FG001|Overall Study|Protocol Violation|1|||
124787540|NCT00729469|448852444|FG000|Overall Study|Withdrawal by Subject|19|||
124787541|NCT00729469|448852445|FG001|Overall Study|Withdrawal by Subject|8|||
124787542|NCT00729469|448852444|FG000|Overall Study|Other-Not mentioned|9|||
124787543|NCT00729469|448852445|FG001|Overall Study|Other-Not mentioned|4|||
124787544|NCT01270802|448852448|FG000|Overall Study|Withdrawal by Subject|1|||
124787545|NCT01270802|448852449|FG001|Overall Study|Withdrawal by Subject|0|||
124787546|NCT01270802|448852448|FG000|Overall Study|Adverse Event|1|||
124787547|NCT01270802|448852449|FG001|Overall Study|Adverse Event|0|||
124787548|NCT01270802|448852448|FG000|Overall Study|Lost to Follow-up|0|||
124787549|NCT01270802|448852449|FG001|Overall Study|Lost to Follow-up|1|||
124787550|NCT04620798|448852452|FG000|Overall Study|Lost to Follow-up|126|||
124787551|NCT04620798|448852453|FG001|Overall Study|Lost to Follow-up|138|||
124787552|NCT01960907|448852456|FG000|Overall Study|Death|4|||
124787553|NCT01960907|448852457|FG001|Overall Study|Death|3|||
124787554|NCT01960907|448852456|FG000|Overall Study|Withdrawal by Subject|32|||
124787555|NCT01960907|448852457|FG001|Overall Study|Withdrawal by Subject|42|||
124787556|NCT00439738|448852463|FG000|Overall Study|Withdrawal by Subject|16|||
124787557|NCT00439738|448852464|FG001|Overall Study|Withdrawal by Subject|13|||
124787558|NCT00439738|448852463|FG000|Overall Study|Adverse Event|6|||
124787559|NCT00439738|448852464|FG001|Overall Study|Adverse Event|4|||
124787560|NCT00439738|448852463|FG000|Overall Study|Lost to Follow-up|5|||
124787561|NCT00439738|448852464|FG001|Overall Study|Lost to Follow-up|6|||
124787562|NCT00439738|448852463|FG000|Overall Study|Protocol Violation|6|||
124787563|NCT00439738|448852464|FG001|Overall Study|Protocol Violation|3|||
124787564|NCT00439738|448852463|FG000|Overall Study|Lack of Efficacy|2|||
124787565|NCT00439738|448852464|FG001|Overall Study|Lack of Efficacy|2|||
124787566|NCT00439738|448852463|FG000|Overall Study|Abnormal Lab Values|1|||
124787567|NCT00439738|448852464|FG001|Overall Study|Abnormal Lab Values|0|||
124787568|NCT00402740|448852468|FG000|Overall Study|Withdrawal by Subject|18|||
124787569|NCT00402740|448852468|FG000|Overall Study|Death|50|||
124787570|NCT00402740|448852468|FG000|Overall Study|Lost to Follow-up|6|||
124787571|NCT00402740|448852468|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
124787572|NCT00402740|448852468|FG000|Overall Study|Subject disposition unknown.|1|||
124787573|NCT01185353|448852470|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
124787574|NCT01185353|448852471|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
124787575|NCT01185353|448852472|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
124787576|NCT01185353|448852473|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
124787577|NCT01185353|448852474|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
124787578|NCT01185353|448852475|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
124787579|NCT01185353|448852476|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
124787580|NCT01185353|448852477|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
124787581|NCT01185353|448852478|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
124787582|NCT01185353|448852479|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
124787583|NCT01185353|448852470|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787584|NCT01185353|448852471|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787585|NCT01185353|448852472|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787586|NCT01185353|448852473|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787587|NCT01185353|448852474|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
124787588|NCT01185353|448852475|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787589|NCT01185353|448852476|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787590|NCT01185353|448852477|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787591|NCT01185353|448852478|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787592|NCT01185353|448852479|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
124787593|NCT01185353|448852470|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
124787594|NCT01185353|448852471|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
124787595|NCT01185353|448852472|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
124787596|NCT01185353|448852473|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
124787597|NCT01185353|448852474|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
124787598|NCT01185353|448852475|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
124787599|NCT01185353|448852476|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
124787600|NCT01185353|448852477|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
124787601|NCT01185353|448852478|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
124787602|NCT01185353|448852479|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
124787603|NCT01185353|448852470|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
124787604|NCT01185353|448852471|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
124787605|NCT01185353|448852472|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
124787606|NCT01185353|448852473|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
124787607|NCT01185353|448852474|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
124787608|NCT01185353|448852475|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
124787609|NCT01185353|448852476|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
124787610|NCT01185353|448852477|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
124787611|NCT01185353|448852478|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
124787612|NCT01185353|448852479|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
124787613|NCT01185353|448852470|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787614|NCT01185353|448852471|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787615|NCT01185353|448852472|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787616|NCT01185353|448852473|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787617|NCT01185353|448852474|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
124787618|NCT01185353|448852475|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787619|NCT01185353|448852476|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787620|NCT01185353|448852477|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787621|NCT01185353|448852478|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787622|NCT01185353|448852479|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
124787623|NCT01185353|448852470|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
124787624|NCT01185353|448852471|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
124787625|NCT01185353|448852472|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
124787626|NCT01185353|448852473|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
124787627|NCT01185353|448852474|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
124787628|NCT01185353|448852475|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
124787629|NCT01185353|448852476|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
124787630|NCT01185353|448852477|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
124787631|NCT01185353|448852478|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
124787632|NCT01185353|448852479|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
124787633|NCT01185353|448852470|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
124787634|NCT01185353|448852471|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
124787635|NCT01185353|448852472|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
124787636|NCT01185353|448852473|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
124787637|NCT01185353|448852474|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
124787638|NCT01185353|448852475|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
124787639|NCT01185353|448852476|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
124787640|NCT01185353|448852477|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
124787641|NCT01185353|448852478|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
124787642|NCT01185353|448852479|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
124787643|NCT01185353|448852470|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
124787644|NCT01185353|448852471|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
124787645|NCT01185353|448852472|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
124787646|NCT01185353|448852473|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
124787647|NCT01185353|448852474|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
124787648|NCT01185353|448852475|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
124787649|NCT01185353|448852476|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
124787650|NCT01185353|448852477|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
124787651|NCT01185353|448852478|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
124787652|NCT01185353|448852479|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
124787653|NCT01185353|448852470|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
124787654|NCT01185353|448852471|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
124787655|NCT01185353|448852472|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
124787656|NCT01185353|448852473|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
124787657|NCT01185353|448852474|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
124787658|NCT01185353|448852475|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
124787659|NCT01185353|448852476|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
124787660|NCT01185353|448852477|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
124787661|NCT01185353|448852478|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
124787662|NCT01185353|448852479|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
124787663|NCT01185353|448852470|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
124787664|NCT01185353|448852471|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
124787665|NCT01185353|448852472|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
124787666|NCT01185353|448852473|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
124787667|NCT01185353|448852474|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
124787668|NCT01185353|448852475|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
124787669|NCT01185353|448852476|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
124787670|NCT01185353|448852477|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
124787671|NCT01185353|448852478|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
124787672|NCT01185353|448852479|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
124787673|NCT01185353|448852470|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787674|NCT01185353|448852471|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787675|NCT01185353|448852472|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787676|NCT01185353|448852473|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787677|NCT01185353|448852474|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787678|NCT01185353|448852475|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787679|NCT01185353|448852476|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
124787680|NCT01185353|448852477|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787681|NCT01185353|448852478|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787682|NCT01185353|448852479|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
124787683|NCT01185353|448852470|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
124787684|NCT01185353|448852471|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
124787685|NCT01185353|448852472|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
124787686|NCT01185353|448852473|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
124787687|NCT01185353|448852474|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
124787688|NCT01185353|448852475|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
124787689|NCT01185353|448852476|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
124787690|NCT01185353|448852477|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
124787691|NCT01185353|448852478|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
124787692|NCT01185353|448852479|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
124787693|NCT01185353|448852470|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
124787694|NCT01185353|448852471|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
124787695|NCT01185353|448852472|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
124787696|NCT01185353|448852473|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
124787697|NCT01185353|448852474|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
124787698|NCT01185353|448852475|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
124787699|NCT01185353|448852476|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
124787700|NCT01185353|448852477|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
124787701|NCT01185353|448852478|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
124787702|NCT01185353|448852479|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
124787703|NCT01185353|448852470|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
124787704|NCT01185353|448852471|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
124787705|NCT01185353|448852472|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
124787706|NCT01185353|448852473|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
124787707|NCT01185353|448852474|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
124787708|NCT01185353|448852475|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
124787709|NCT01185353|448852476|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
124787710|NCT01185353|448852477|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
124787711|NCT01185353|448852478|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
124787712|NCT01185353|448852479|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
124787713|NCT01185353|448852470|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787714|NCT01185353|448852471|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787715|NCT01185353|448852472|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787716|NCT01185353|448852473|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787717|NCT01185353|448852474|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787718|NCT01185353|448852475|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787719|NCT01185353|448852476|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787720|NCT01185353|448852477|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787721|NCT01185353|448852478|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
124787722|NCT01185353|448852479|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
124787723|NCT01185353|448852470|FG000|Part C (Weeks 24 Through 76)|Death|0|||
124787724|NCT01185353|448852471|FG001|Part C (Weeks 24 Through 76)|Death|0|||
124787725|NCT01185353|448852472|FG002|Part C (Weeks 24 Through 76)|Death|0|||
124787726|NCT01185353|448852473|FG003|Part C (Weeks 24 Through 76)|Death|0|||
124787727|NCT01185353|448852474|FG004|Part C (Weeks 24 Through 76)|Death|0|||
124787728|NCT01185353|448852475|FG005|Part C (Weeks 24 Through 76)|Death|0|||
124787729|NCT01185353|448852476|FG006|Part C (Weeks 24 Through 76)|Death|0|||
124787730|NCT01185353|448852477|FG007|Part C (Weeks 24 Through 76)|Death|0|||
124787731|NCT01185353|448852478|FG008|Part C (Weeks 24 Through 76)|Death|0|||
124787732|NCT01185353|448852479|FG009|Part C (Weeks 24 Through 76)|Death|1|||
124787733|NCT01185353|448852470|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787734|NCT01185353|448852471|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787735|NCT01185353|448852472|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787736|NCT01185353|448852473|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787737|NCT01185353|448852474|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787738|NCT01185353|448852475|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787739|NCT01185353|448852476|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787740|NCT01185353|448852477|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787741|NCT01185353|448852478|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
124787742|NCT01185353|448852479|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
124787743|NCT01185353|448852470|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787744|NCT01185353|448852471|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787745|NCT01185353|448852472|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787746|NCT01185353|448852473|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787747|NCT01185353|448852474|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787748|NCT01185353|448852475|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787749|NCT01185353|448852476|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787750|NCT01185353|448852477|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787751|NCT01185353|448852478|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
124787752|NCT01185353|448852479|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
124787753|NCT01185353|448852470|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
124787754|NCT01185353|448852471|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
124787755|NCT01185353|448852472|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
124626453|NCT00758524|448248045|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
124787756|NCT01185353|448852473|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
124787757|NCT01185353|448852474|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
124626454|NCT00758524|448248046|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
124626455|NCT00758524|448248047|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
124626456|NCT00758524|448248048|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
124626457|NCT00758524|448248049|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
124626458|NCT00758524|448248050|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
124626459|NCT00758524|448248051|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
124626460|NCT00758524|448248035|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
124626461|NCT00758524|448248036|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
124626462|NCT00758524|448248037|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
124626463|NCT00758524|448248038|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
124626464|NCT00758524|448248039|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
124626465|NCT00758524|448248040|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
124626466|NCT00758524|448248041|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
124626467|NCT00758524|448248042|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
124626468|NCT00758524|448248043|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
124626469|NCT00758524|448248044|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
124626470|NCT00758524|448248045|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
124626471|NCT00758524|448248046|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
124626472|NCT00758524|448248047|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
124626473|NCT00758524|448248048|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
124626474|NCT00758524|448248049|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
124626475|NCT00758524|448248050|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
124626476|NCT00758524|448248051|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
124626477|NCT00758524|448248035|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
124626478|NCT00758524|448248036|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
124626479|NCT00758524|448248037|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
124626480|NCT00758524|448248038|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
124626481|NCT00758524|448248039|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
124626482|NCT00758524|448248040|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
124787758|NCT01185353|448852475|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
124787759|NCT01185353|448852476|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
124787760|NCT01185353|448852477|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
124787761|NCT01185353|448852478|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
124787762|NCT01185353|448852479|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
124787763|NCT01185353|448852470|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
124787764|NCT01185353|448852471|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
124787765|NCT01185353|448852472|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
124787766|NCT01185353|448852473|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
124787767|NCT01185353|448852474|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
124787768|NCT01185353|448852475|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
124787769|NCT01185353|448852476|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
124787770|NCT01185353|448852477|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
124787771|NCT01185353|448852478|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
124787772|NCT01185353|448852479|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
124787773|NCT01185353|448852470|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
124787774|NCT01185353|448852471|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
124787775|NCT01185353|448852472|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
124787776|NCT01185353|448852473|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
124787777|NCT01185353|448852474|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
124787778|NCT01185353|448852475|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
124787779|NCT01185353|448852476|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
124787780|NCT01185353|448852477|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
124787781|NCT01185353|448852478|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
124787782|NCT01185353|448852479|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
124787783|NCT01185353|448852470|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
124787784|NCT01185353|448852471|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
124787785|NCT01185353|448852472|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
124787786|NCT01185353|448852473|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
124787787|NCT01185353|448852474|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
124787788|NCT01185353|448852475|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
124626483|NCT00758524|448248041|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
124626484|NCT00758524|448248042|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
124626485|NCT00758524|448248043|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
124787789|NCT01185353|448852476|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
124787790|NCT01185353|448852477|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
124787791|NCT01185353|448852478|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
124787792|NCT01185353|448852479|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
124787793|NCT02270944|448852480|FG000|Overall Study|Lost to Follow-up|9|||
124787794|NCT02270944|448852481|FG001|Overall Study|Lost to Follow-up|4|||
124787795|NCT02270944|448852480|FG000|Overall Study|Withdrawal by Subject|2|||
124787796|NCT02270944|448852481|FG001|Overall Study|Withdrawal by Subject|1|||
124787797|NCT00095147|448852482|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
124787798|NCT00095147|448852483|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
124787799|NCT00095147|448852484|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
124787800|NCT00095147|448852485|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
124787801|NCT00095147|448852486|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
124787802|NCT00095147|448852482|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
124787803|NCT00095147|448852483|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
124787804|NCT00095147|448852484|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
124787805|NCT00095147|448852485|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
124787806|NCT00095147|448852486|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
124787807|NCT00095147|448852482|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
124787808|NCT00095147|448852483|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
124787809|NCT00095147|448852484|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
124787810|NCT00095147|448852485|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
124787811|NCT00095147|448852486|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
124787812|NCT00095147|448852482|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
124787813|NCT00095147|448852483|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
124787814|NCT00095147|448852484|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
124787815|NCT00095147|448852485|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
124787816|NCT00095147|448852486|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
124787817|NCT00095147|448852482|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
124787818|NCT00095147|448852483|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
124787819|NCT00095147|448852484|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
124787820|NCT00095147|448852485|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
124787821|NCT00095147|448852486|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
124787822|NCT00095147|448852482|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
124787823|NCT00095147|448852483|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
124787824|NCT00095147|448852484|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
124787825|NCT00095147|448852485|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
124787826|NCT00095147|448852486|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
124787827|NCT00095147|448852482|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
124787828|NCT00095147|448852483|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
124787829|NCT00095147|448852484|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
124787830|NCT00095147|448852485|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
124787831|NCT00095147|448852486|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
124787832|NCT00095147|448852482|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
124787833|NCT00095147|448852483|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
124787834|NCT00095147|448852484|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
124787835|NCT00095147|448852485|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
124787836|NCT00095147|448852486|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
124787837|NCT00095147|448852482|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
124787838|NCT00095147|448852483|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
124787839|NCT00095147|448852484|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
124787840|NCT00095147|448852485|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
124787841|NCT00095147|448852486|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
124787842|NCT00095147|448852482|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
124787843|NCT00095147|448852483|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
124787844|NCT00095147|448852484|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
124787845|NCT00095147|448852485|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
124787846|NCT00095147|448852486|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
124787847|NCT00095147|448852482|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
124787848|NCT00095147|448852483|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
124787849|NCT00095147|448852484|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
124787850|NCT00095147|448852485|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
124787851|NCT00095147|448852486|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
124787852|NCT00095147|448852482|FG000|Long-term Extension Period|Death|0|||
124787853|NCT00095147|448852483|FG001|Long-term Extension Period|Death|0|||
124787854|NCT00095147|448852484|FG002|Long-term Extension Period|Death|0|||
124787855|NCT00095147|448852485|FG003|Long-term Extension Period|Death|0|||
124787856|NCT00095147|448852486|FG004|Long-term Extension Period|Death|3|||
124787857|NCT00095147|448852482|FG000|Long-term Extension Period|Adverse Event|0|||
124787858|NCT00095147|448852483|FG001|Long-term Extension Period|Adverse Event|0|||
124787859|NCT00095147|448852484|FG002|Long-term Extension Period|Adverse Event|0|||
124787860|NCT00095147|448852485|FG003|Long-term Extension Period|Adverse Event|0|||
124787861|NCT00095147|448852486|FG004|Long-term Extension Period|Adverse Event|11|||
124787862|NCT00095147|448852482|FG000|Long-term Extension Period|Lack of Efficacy|0|||
124787863|NCT00095147|448852483|FG001|Long-term Extension Period|Lack of Efficacy|0|||
124787864|NCT00095147|448852484|FG002|Long-term Extension Period|Lack of Efficacy|0|||
124787865|NCT00095147|448852485|FG003|Long-term Extension Period|Lack of Efficacy|0|||
124787866|NCT00095147|448852486|FG004|Long-term Extension Period|Lack of Efficacy|9|||
124787867|NCT00095147|448852482|FG000|Long-term Extension Period|Lost to Follow-up|0|||
124787868|NCT00095147|448852483|FG001|Long-term Extension Period|Lost to Follow-up|0|||
124787869|NCT00095147|448852484|FG002|Long-term Extension Period|Lost to Follow-up|0|||
124787870|NCT00095147|448852485|FG003|Long-term Extension Period|Lost to Follow-up|0|||
124787871|NCT00095147|448852486|FG004|Long-term Extension Period|Lost to Follow-up|6|||
124787872|NCT00095147|448852482|FG000|Long-term Extension Period|Withdrawal of consent|0|||
124787873|NCT00095147|448852483|FG001|Long-term Extension Period|Withdrawal of consent|0|||
124787874|NCT00095147|448852484|FG002|Long-term Extension Period|Withdrawal of consent|0|||
124787875|NCT00095147|448852485|FG003|Long-term Extension Period|Withdrawal of consent|0|||
124787876|NCT00095147|448852486|FG004|Long-term Extension Period|Withdrawal of consent|12|||
124787877|NCT00095147|448852482|FG000|Long-term Extension Period|Pregnancy|0|||
124787878|NCT00095147|448852483|FG001|Long-term Extension Period|Pregnancy|0|||
124787879|NCT00095147|448852484|FG002|Long-term Extension Period|Pregnancy|0|||
124787880|NCT00095147|448852485|FG003|Long-term Extension Period|Pregnancy|0|||
124787881|NCT00095147|448852486|FG004|Long-term Extension Period|Pregnancy|1|||
124787882|NCT00095147|448852482|FG000|Long-term Extension Period|No longer meets study criteria|0|||
124787883|NCT00095147|448852483|FG001|Long-term Extension Period|No longer meets study criteria|0|||
124787884|NCT00095147|448852484|FG002|Long-term Extension Period|No longer meets study criteria|0|||
124787885|NCT00095147|448852485|FG003|Long-term Extension Period|No longer meets study criteria|0|||
124787886|NCT00095147|448852486|FG004|Long-term Extension Period|No longer meets study criteria|1|||
124787887|NCT00095147|448852482|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
124787888|NCT00095147|448852483|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
124787889|NCT00095147|448852484|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
124787890|NCT00095147|448852485|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
124787891|NCT00095147|448852486|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
124787892|NCT00095147|448852482|FG000|Long-term Extension Period|Leaving country|0|||
124787893|NCT00095147|448852483|FG001|Long-term Extension Period|Leaving country|0|||
124787894|NCT00095147|448852484|FG002|Long-term Extension Period|Leaving country|0|||
124787895|NCT00095147|448852485|FG003|Long-term Extension Period|Leaving country|0|||
124787896|NCT00095147|448852486|FG004|Long-term Extension Period|Leaving country|1|||
124787897|NCT01375075|448852489|FG000|Overall Study|Adverse Event|0|||
124787898|NCT01375075|448852490|FG001|Overall Study|Adverse Event|0|||
124787899|NCT01375075|448852491|FG002|Overall Study|Adverse Event|3|||
124787900|NCT01375075|448852492|FG003|Overall Study|Adverse Event|1|||
124787901|NCT01375075|448852493|FG004|Overall Study|Adverse Event|0|||
124787902|NCT01375075|448852494|FG005|Overall Study|Adverse Event|1|||
124787903|NCT01375075|448852489|FG000|Overall Study|Entry Criterion Not Met|1|||
124787904|NCT01375075|448852490|FG001|Overall Study|Entry Criterion Not Met|0|||
124787905|NCT01375075|448852491|FG002|Overall Study|Entry Criterion Not Met|0|||
124787906|NCT01375075|448852492|FG003|Overall Study|Entry Criterion Not Met|0|||
124787907|NCT01375075|448852493|FG004|Overall Study|Entry Criterion Not Met|0|||
124787908|NCT01375075|448852494|FG005|Overall Study|Entry Criterion Not Met|1|||
124787909|NCT01375075|448852489|FG000|Overall Study|Withdrawal by Subject|0|||
124787910|NCT01375075|448852490|FG001|Overall Study|Withdrawal by Subject|1|||
124787911|NCT01375075|448852491|FG002|Overall Study|Withdrawal by Subject|0|||
124787912|NCT01375075|448852492|FG003|Overall Study|Withdrawal by Subject|0|||
124787913|NCT01375075|448852493|FG004|Overall Study|Withdrawal by Subject|0|||
124787914|NCT01375075|448852494|FG005|Overall Study|Withdrawal by Subject|1|||
124787915|NCT01011309|448852495|FG000|Overall Study|Adverse Event|2|||
124787916|NCT01011309|448852496|FG001|Overall Study|Adverse Event|1|||
124787917|NCT01011309|448852497|FG002|Overall Study|Adverse Event|2|||
124787918|NCT01011309|448852495|FG000|Overall Study|Lack of Efficacy|0|||
124787919|NCT01011309|448852496|FG001|Overall Study|Lack of Efficacy|1|||
124787920|NCT01011309|448852497|FG002|Overall Study|Lack of Efficacy|0|||
124787921|NCT01011309|448852495|FG000|Overall Study|Protocol Violation|0|||
124787922|NCT01011309|448852496|FG001|Overall Study|Protocol Violation|1|||
124787923|NCT01011309|448852497|FG002|Overall Study|Protocol Violation|3|||
124787924|NCT03472547|448852506|FG000|Overall Study|Withdrawal by Subject|30|||
124787925|NCT04236141|448854209|FG000|Overall Study|Death|18|||
124787926|NCT04236141|448854210|FG001|Overall Study|Death|10|||
124787927|NCT04236141|448854209|FG000|Overall Study|Withdrawal by Participant|1|||
124787928|NCT04236141|448854210|FG001|Overall Study|Withdrawal by Participant|0|||
124787929|NCT04236141|448854209|FG000|Overall Study|Reason not Specified|1|||
124787930|NCT04236141|448854210|FG001|Overall Study|Reason not Specified|0|||
124787931|NCT04236141|448854209|FG000|Overall Study|Study terminated by Sponsor|8|||
124787932|NCT04236141|448854210|FG001|Overall Study|Study terminated by Sponsor|4|||
124787933|NCT01948193|448854211|FG000|Overall Study|Serious event|2|||
124787934|NCT01948193|448854211|FG000|Overall Study|Lost to Follow-up|7|||
124787935|NCT00507728|448854220|FG000|Randomization to Month 3|Lost to Follow-up|15|||
124787936|NCT00507728|448854221|FG001|Randomization to Month 3|Lost to Follow-up|14|||
124787937|NCT00507728|448854222|FG002|Randomization to Month 3|Lost to Follow-up|20|||
124787938|NCT00507728|448854220|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
124787939|NCT00507728|448854221|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
124787940|NCT00507728|448854222|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
124787941|NCT01964755|448854223|FG000|Overall Study|Death|2|||
124787942|NCT01332799|448854227|FG000|Overall Study|Insufficient funding|10|||
124787943|NCT01332799|448854228|FG001|Overall Study|Insufficient funding|10|||
124787944|NCT01909791|448854229|FG000|Overall Study|Death|9|||
124787945|NCT01909791|448854230|FG001|Overall Study|Death|8|||
124787946|NCT01909791|448854231|FG002|Overall Study|Death|4|||
124787947|NCT01909791|448854229|FG000|Overall Study|Withdrawal by Subject|5|||
124787948|NCT01909791|448854230|FG001|Overall Study|Withdrawal by Subject|9|||
124787949|NCT01909791|448854231|FG002|Overall Study|Withdrawal by Subject|13|||
124787950|NCT01909791|448854229|FG000|Overall Study|Lost to Follow-up|5|||
124787951|NCT01909791|448854230|FG001|Overall Study|Lost to Follow-up|11|||
124787952|NCT01909791|448854231|FG002|Overall Study|Lost to Follow-up|10|||
124787953|NCT01909791|448854229|FG000|Overall Study|Missed Visit|2|||
124787954|NCT01909791|448854230|FG001|Overall Study|Missed Visit|0|||
124787955|NCT01909791|448854231|FG002|Overall Study|Missed Visit|1|||
124787956|NCT02168387|448854234|FG000|Overall Study|Planned exubation|6|||
124787957|NCT02168387|448854235|FG001|Overall Study|Planned exubation|3|||
124787958|NCT02168387|448854234|FG000|Overall Study|Death|1|||
124787959|NCT02168387|448854235|FG001|Overall Study|Death|0|||
124787960|NCT03467152|448854236|FG000|Overall Study|Adverse Event|4|||
124787961|NCT03467152|448854237|FG001|Overall Study|Adverse Event|5|||
124787962|NCT03467152|448854238|FG002|Overall Study|Adverse Event|0|||
124787963|NCT03467152|448854236|FG000|Overall Study|Subject Choice|1|||
124787964|NCT03467152|448854237|FG001|Overall Study|Subject Choice|3|||
124787965|NCT03467152|448854238|FG002|Overall Study|Subject Choice|0|||
124787966|NCT03467152|448854236|FG000|Overall Study|Lost to Follow-up|1|||
124787967|NCT03467152|448854237|FG001|Overall Study|Lost to Follow-up|0|||
124787968|NCT03467152|448854238|FG002|Overall Study|Lost to Follow-up|0|||
124787969|NCT03467152|448854236|FG000|Overall Study|Withdrawal by Subject|4|||
124787970|NCT03467152|448854237|FG001|Overall Study|Withdrawal by Subject|2|||
124787971|NCT03467152|448854238|FG002|Overall Study|Withdrawal by Subject|0|||
124787972|NCT03467152|448854236|FG000|Overall Study|Others|3|||
124787973|NCT03467152|448854237|FG001|Overall Study|Others|0|||
124787974|NCT03467152|448854238|FG002|Overall Study|Others|0|||
124787975|NCT03467152|448854236|FG000|Overall Study|Not treated|3|||
124787976|NCT03467152|448854237|FG001|Overall Study|Not treated|1|||
124787977|NCT03467152|448854238|FG002|Overall Study|Not treated|6|||
124787978|NCT01236547|448854239|FG000|Overall Study|Protocol Violation|0|||
124787979|NCT01236547|448854240|FG001|Overall Study|Protocol Violation|1|||
124787980|NCT01236547|448854241|FG002|Overall Study|Protocol Violation|1|||
124787981|NCT01236547|448854242|FG003|Overall Study|Protocol Violation|6|||
124787982|NCT01236547|448854243|FG004|Overall Study|Protocol Violation|12|||
124787983|NCT04250077|448854244|FG000|Overall Study|Withdrawal by Subject|0|||
124787984|NCT04250077|448854245|FG001|Overall Study|Withdrawal by Subject|1|||
124787985|NCT04250077|448854246|FG002|Overall Study|Withdrawal by Subject|0|||
124787986|NCT04250077|448854244|FG000|Overall Study|Lost to Follow-up|2|||
124787987|NCT04250077|448854245|FG001|Overall Study|Lost to Follow-up|3|||
124787988|NCT04250077|448854246|FG002|Overall Study|Lost to Follow-up|0|||
124787989|NCT00910624|448854247|FG000|Treatment Phase|Adverse Event|2|||
124787990|NCT00910624|448854248|FG001|Treatment Phase|Adverse Event|6|||
124787991|NCT00910624|448854249|FG002|Treatment Phase|Adverse Event|6|||
124787992|NCT00910624|448854250|FG003|Treatment Phase|Adverse Event|0|||
124787993|NCT00910624|448854247|FG000|Treatment Phase|Treatment Failure|23|||
124787994|NCT00910624|448854248|FG001|Treatment Phase|Treatment Failure|10|||
124787995|NCT00910624|448854249|FG002|Treatment Phase|Treatment Failure|0|||
124787996|NCT00910624|448854250|FG003|Treatment Phase|Treatment Failure|0|||
124787997|NCT00910624|448854247|FG000|Treatment Phase|Lost to Follow-up|0|||
124787998|NCT00910624|448854248|FG001|Treatment Phase|Lost to Follow-up|0|||
124787999|NCT00910624|448854249|FG002|Treatment Phase|Lost to Follow-up|1|||
124788000|NCT00910624|448854250|FG003|Treatment Phase|Lost to Follow-up|0|||
124788001|NCT00910624|448854247|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
124788002|NCT00910624|448854248|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
124788003|NCT00910624|448854249|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
124788004|NCT00910624|448854250|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
124788005|NCT00910624|448854247|FG000|Treatment Phase|Withdrawal by Subject|2|||
124788006|NCT00910624|448854248|FG001|Treatment Phase|Withdrawal by Subject|1|||
124788007|NCT00910624|448854249|FG002|Treatment Phase|Withdrawal by Subject|0|||
124788008|NCT00910624|448854250|FG003|Treatment Phase|Withdrawal by Subject|0|||
124788009|NCT00910624|448854247|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
124788010|NCT00910624|448854248|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
124788011|NCT00910624|448854249|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
124788012|NCT00910624|448854250|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
124788013|NCT00910624|448854247|FG000|Follow-Up Phase|Adverse Event|0|||
124788014|NCT00910624|448854248|FG001|Follow-Up Phase|Adverse Event|0|||
124788015|NCT00910624|448854249|FG002|Follow-Up Phase|Adverse Event|1|||
124788016|NCT00910624|448854250|FG003|Follow-Up Phase|Adverse Event|0|||
124788017|NCT00910624|448854247|FG000|Follow-Up Phase|Lost to Follow-up|3|||
124788018|NCT00910624|448854248|FG001|Follow-Up Phase|Lost to Follow-up|1|||
124788019|NCT00910624|448854249|FG002|Follow-Up Phase|Lost to Follow-up|2|||
124788020|NCT00910624|448854250|FG003|Follow-Up Phase|Lost to Follow-up|0|||
124788021|NCT00910624|448854247|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
124788022|NCT00910624|448854248|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
124788023|NCT00910624|448854249|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
124788024|NCT00910624|448854250|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
124788025|NCT00910624|448854247|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
124788026|NCT00910624|448854248|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
124788027|NCT00910624|448854249|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
124788028|NCT00910624|448854250|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
124788029|NCT00910624|448854247|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
124788030|NCT00910624|448854248|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
124788031|NCT00910624|448854249|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
124788032|NCT00910624|448854250|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
124788033|NCT00910624|448854247|FG000|Follow-Up Phase|Administrative|0|||
124788034|NCT00910624|448854248|FG001|Follow-Up Phase|Administrative|1|||
124788035|NCT00910624|448854249|FG002|Follow-Up Phase|Administrative|1|||
124788036|NCT00910624|448854250|FG003|Follow-Up Phase|Administrative|0|||
124788037|NCT04140227|448854251|FG000|Overall Study|Withdrawal by Subject|26|||
124788038|NCT04140227|448854251|FG000|Overall Study|Lost to Follow-up|8|||
124788039|NCT04140227|448854251|FG000|Overall Study|Adverse Event|8|||
124788040|NCT04140227|448854251|FG000|Overall Study|Death|1|||
124788041|NCT04140227|448854251|FG000|Overall Study|Other|3|||
124788042|NCT04140227|448854251|FG000|Overall Study|Protocol Violation|2|||
124788043|NCT01713933|448854252|FG000|Overall Study|Lost to Follow-up|2|||
124788044|NCT01713933|448854252|FG000|Overall Study|Withdrawal by Subject|3|||
124788045|NCT01713933|448854252|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
124788046|NCT00412373|448854253|FG000|Overall Study|Adverse Event|8|||
124788047|NCT00412373|448854254|FG001|Overall Study|Adverse Event|13|||
124788048|NCT00412373|448854253|FG000|Overall Study|Lack of Efficacy|16|||
124788049|NCT00412373|448854254|FG001|Overall Study|Lack of Efficacy|22|||
124788050|NCT00412373|448854253|FG000|Overall Study|Lost to Follow-up|7|||
124788051|NCT00412373|448854254|FG001|Overall Study|Lost to Follow-up|13|||
124788052|NCT00412373|448854253|FG000|Overall Study|Withdrawal by Subject|8|||
124788053|NCT00412373|448854254|FG001|Overall Study|Withdrawal by Subject|27|||
124788054|NCT00412373|448854253|FG000|Overall Study|Other|2|||
124788055|NCT00412373|448854254|FG001|Overall Study|Other|2|||
124788056|NCT04022733|448854258|FG000|Overall Study|conversion to open surgery|3|||
124788057|NCT04022733|448854259|FG001|Overall Study|conversion to open surgery|2|||
124788058|NCT04022733|448854258|FG000|Overall Study|bradycardia|0|||
124788059|NCT04022733|448854259|FG001|Overall Study|bradycardia|1|||
124788060|NCT02855541|448854261|FG000|Overall Study|Change in health status|2|||
124788061|NCT02855541|448854261|FG000|Overall Study|Withdrawal by Subject|2|||
124788062|NCT00422513|448854262|FG000|Overall Study|Lack of Efficacy|4|||
124788063|NCT00422513|448854263|FG001|Overall Study|Lack of Efficacy|5|||
124788064|NCT00422513|448854262|FG000|Overall Study|Protocol Violation|23|||
124788065|NCT00422513|448854263|FG001|Overall Study|Protocol Violation|7|||
124788066|NCT00422513|448854262|FG000|Overall Study|Refused Treatment|4|||
124788067|NCT00422513|448854263|FG001|Overall Study|Refused Treatment|2|||
124788068|NCT00422513|448854262|FG000|Overall Study|Withdrawal by Subject|2|||
124788069|NCT00422513|448854263|FG001|Overall Study|Withdrawal by Subject|1|||
124788070|NCT00422513|448854262|FG000|Overall Study|early termination of the study|67|||
124788071|NCT00422513|448854263|FG001|Overall Study|early termination of the study|80|||
124788072|NCT00422513|448854262|FG000|Overall Study|Adverse Event|4|||
124788073|NCT00422513|448854263|FG001|Overall Study|Adverse Event|4|||
124788074|NCT00422513|448854262|FG000|Overall Study|Death|3|||
124788075|NCT00422513|448854263|FG001|Overall Study|Death|7|||
124788076|NCT03135119|448854264|FG000|Overall Study|Lost to Follow-up|2|||
124788077|NCT03135119|448854265|FG001|Overall Study|Lost to Follow-up|0|||
124788078|NCT03135119|448854264|FG000|Overall Study|Physician Decision|1|||
124788079|NCT03135119|448854265|FG001|Overall Study|Physician Decision|1|||
124788080|NCT03135119|448854264|FG000|Overall Study|COVID-19 Shutdown|2|||
124788081|NCT03135119|448854265|FG001|Overall Study|COVID-19 Shutdown|2|||
124788082|NCT01541397|448854266|FG000|Overall Study|Study ended prior to data collection|4|||
124788083|NCT01541397|448854267|FG001|Overall Study|Study ended prior to data collection|2|||
124788084|NCT02267317|448854268|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
124788085|NCT02267317|448854269|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
124788086|NCT02267317|448854270|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
124788087|NCT02267317|448854271|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
124788088|NCT02267317|448854272|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
124788089|NCT02267317|448854273|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
124788090|NCT02267317|448854268|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
124788091|NCT02267317|448854269|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
124788092|NCT02267317|448854270|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
124788093|NCT02267317|448854271|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
124788094|NCT02267317|448854272|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
124788095|NCT02267317|448854273|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
124788096|NCT01689532|448854276|FG000|Overall Study|Adverse Event|9|||
124788097|NCT01689532|448854277|FG001|Overall Study|Adverse Event|5|||
124788098|NCT01689532|448854276|FG000|Overall Study|Lack of Efficacy|2|||
124788099|NCT01689532|448854277|FG001|Overall Study|Lack of Efficacy|2|||
124788100|NCT01689532|448854276|FG000|Overall Study|Withdrawal by Subject|1|||
124788101|NCT01689532|448854277|FG001|Overall Study|Withdrawal by Subject|2|||
124788102|NCT01689532|448854276|FG000|Overall Study|Physician Decision|2|||
124788103|NCT01689532|448854277|FG001|Overall Study|Physician Decision|0|||
124788104|NCT01363349|448854278|FG000|Overall Study|Adverse Event|6|||
124788105|NCT01363349|448854279|FG001|Overall Study|Adverse Event|7|||
124788106|NCT01363349|448854278|FG000|Overall Study|Lack of Efficacy|3|||
124788107|NCT01363349|448854279|FG001|Overall Study|Lack of Efficacy|10|||
124788108|NCT01363349|448854278|FG000|Overall Study|Non compliance/Protocol deviations|2|||
124788109|NCT01363349|448854279|FG001|Overall Study|Non compliance/Protocol deviations|2|||
124788110|NCT01363349|448854278|FG000|Overall Study|Withdrawal by Subject|14|||
124788111|NCT01363349|448854279|FG001|Overall Study|Withdrawal by Subject|6|||
124788112|NCT01363349|448854278|FG000|Overall Study|Lost to Follow-up|5|||
124788113|NCT01363349|448854279|FG001|Overall Study|Lost to Follow-up|6|||
124788114|NCT01363349|448854278|FG000|Overall Study|Not reported|36|||
124788115|NCT01363349|448854279|FG001|Overall Study|Not reported|37|||
124788116|NCT01363349|448854278|FG000|Overall Study|missing|1|||
124788117|NCT01363349|448854279|FG001|Overall Study|missing|2|||
124788118|NCT02208063|448854280|FG000|Overall Study|Death|3|||
124788119|NCT02208063|448854281|FG001|Overall Study|Death|5|||
124788120|NCT02208063|448854280|FG000|Overall Study|Not Specified in report|3|||
124788121|NCT02208063|448854281|FG001|Overall Study|Not Specified in report|4|||
124788122|NCT02208063|448854280|FG000|Overall Study|Withdrawal by Subject|5|||
124788123|NCT02208063|448854281|FG001|Overall Study|Withdrawal by Subject|2|||
124788124|NCT02208063|448854280|FG000|Overall Study|Lost to Follow-up|1|||
124788125|NCT02208063|448854281|FG001|Overall Study|Lost to Follow-up|0|||
124788126|NCT00913458|448854282|FG000|Phase 1|Non-Responder|54|||
124788127|NCT00913458|448854283|FG001|Phase 1|Non-Responder|0|||
124788128|NCT00913458|448854284|FG002|Phase 1|Non-Responder|0|||
124788129|NCT00913458|448854285|FG003|Phase 1|Non-Responder|0|||
124788130|NCT00913458|448854286|FG004|Phase 1|Non-Responder|0|||
124788131|NCT00913458|448854287|FG005|Phase 1|Non-Responder|0|||
124788132|NCT00913458|448854288|FG006|Phase 1|Non-Responder|0|||
124788133|NCT00913458|448854282|FG000|Phase 1|Subject Request|17|||
124788134|NCT00913458|448854283|FG001|Phase 1|Subject Request|0|||
124788135|NCT00913458|448854284|FG002|Phase 1|Subject Request|0|||
124788136|NCT00913458|448854285|FG003|Phase 1|Subject Request|0|||
124788137|NCT00913458|448854286|FG004|Phase 1|Subject Request|0|||
124788138|NCT00913458|448854287|FG005|Phase 1|Subject Request|0|||
124788139|NCT00913458|448854288|FG006|Phase 1|Subject Request|0|||
124788140|NCT00913458|448854282|FG000|Phase 1|Adverse Event|20|||
124788141|NCT00913458|448854283|FG001|Phase 1|Adverse Event|0|||
124788142|NCT00913458|448854284|FG002|Phase 1|Adverse Event|0|||
124788143|NCT00913458|448854285|FG003|Phase 1|Adverse Event|0|||
124788144|NCT00913458|448854286|FG004|Phase 1|Adverse Event|0|||
124788145|NCT00913458|448854287|FG005|Phase 1|Adverse Event|0|||
124788146|NCT00913458|448854288|FG006|Phase 1|Adverse Event|0|||
124788147|NCT00913458|448854282|FG000|Phase 1|Lost to Follow-up|2|||
124788148|NCT00913458|448854283|FG001|Phase 1|Lost to Follow-up|0|||
124788149|NCT00913458|448854284|FG002|Phase 1|Lost to Follow-up|0|||
124788150|NCT00913458|448854285|FG003|Phase 1|Lost to Follow-up|0|||
124788151|NCT00913458|448854286|FG004|Phase 1|Lost to Follow-up|0|||
124788152|NCT00913458|448854287|FG005|Phase 1|Lost to Follow-up|0|||
124788153|NCT00913458|448854288|FG006|Phase 1|Lost to Follow-up|0|||
124788154|NCT00913458|448854282|FG000|Phase 1|Protocol Violation|10|||
124788155|NCT00913458|448854283|FG001|Phase 1|Protocol Violation|0|||
124788156|NCT00913458|448854284|FG002|Phase 1|Protocol Violation|0|||
124788157|NCT00913458|448854285|FG003|Phase 1|Protocol Violation|0|||
124788158|NCT00913458|448854286|FG004|Phase 1|Protocol Violation|0|||
124788159|NCT00913458|448854287|FG005|Phase 1|Protocol Violation|0|||
124788160|NCT00913458|448854288|FG006|Phase 1|Protocol Violation|0|||
124788161|NCT00913458|448854282|FG000|Phase 1|Sponsor|2|||
124788162|NCT00913458|448854283|FG001|Phase 1|Sponsor|0|||
124788163|NCT00913458|448854284|FG002|Phase 1|Sponsor|0|||
124788164|NCT00913458|448854285|FG003|Phase 1|Sponsor|0|||
124788165|NCT00913458|448854286|FG004|Phase 1|Sponsor|0|||
124788166|NCT00913458|448854287|FG005|Phase 1|Sponsor|0|||
124788167|NCT00913458|448854288|FG006|Phase 1|Sponsor|0|||
124788168|NCT00913458|448854282|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
124788169|NCT00913458|448854283|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
124788170|NCT00913458|448854284|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
124788171|NCT00913458|448854285|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
124788172|NCT00913458|448854286|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
124788173|NCT00913458|448854287|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
124788174|NCT00913458|448854288|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
124788175|NCT00913458|448854282|FG000|Phase 2|Non-Responder|0|||
124788176|NCT00913458|448854283|FG001|Phase 2|Non-Responder|5|||
124788177|NCT00913458|448854284|FG002|Phase 2|Non-Responder|7|||
124788178|NCT00913458|448854285|FG003|Phase 2|Non-Responder|12|||
124788179|NCT00913458|448854286|FG004|Phase 2|Non-Responder|0|||
124788180|NCT00913458|448854287|FG005|Phase 2|Non-Responder|0|||
124788181|NCT00913458|448854288|FG006|Phase 2|Non-Responder|0|||
124788182|NCT00913458|448854282|FG000|Phase 2|Subject Request|0|||
124788183|NCT00913458|448854283|FG001|Phase 2|Subject Request|0|||
124788184|NCT00913458|448854284|FG002|Phase 2|Subject Request|1|||
124788185|NCT00913458|448854285|FG003|Phase 2|Subject Request|2|||
124788186|NCT00913458|448854286|FG004|Phase 2|Subject Request|0|||
124788187|NCT00913458|448854287|FG005|Phase 2|Subject Request|0|||
124788188|NCT00913458|448854288|FG006|Phase 2|Subject Request|0|||
124788189|NCT00913458|448854282|FG000|Phase 2|Adverse Event|0|||
124788190|NCT00913458|448854283|FG001|Phase 2|Adverse Event|3|||
124788191|NCT00913458|448854284|FG002|Phase 2|Adverse Event|0|||
124788192|NCT00913458|448854285|FG003|Phase 2|Adverse Event|1|||
124788193|NCT00913458|448854286|FG004|Phase 2|Adverse Event|0|||
124788194|NCT00913458|448854287|FG005|Phase 2|Adverse Event|0|||
124788195|NCT00913458|448854288|FG006|Phase 2|Adverse Event|0|||
124788196|NCT00913458|448854282|FG000|Phase 2|Lost to Follow-up|0|||
124788197|NCT00913458|448854283|FG001|Phase 2|Lost to Follow-up|0|||
124788198|NCT00913458|448854284|FG002|Phase 2|Lost to Follow-up|0|||
124788199|NCT00913458|448854285|FG003|Phase 2|Lost to Follow-up|1|||
124788200|NCT00913458|448854286|FG004|Phase 2|Lost to Follow-up|0|||
124788201|NCT00913458|448854287|FG005|Phase 2|Lost to Follow-up|0|||
124788202|NCT00913458|448854288|FG006|Phase 2|Lost to Follow-up|0|||
124788203|NCT00913458|448854282|FG000|Phase 2|Protocol Violation|0|||
124788204|NCT00913458|448854283|FG001|Phase 2|Protocol Violation|2|||
124788205|NCT00913458|448854284|FG002|Phase 2|Protocol Violation|0|||
124788206|NCT00913458|448854285|FG003|Phase 2|Protocol Violation|0|||
124788207|NCT00913458|448854286|FG004|Phase 2|Protocol Violation|0|||
124788208|NCT00913458|448854287|FG005|Phase 2|Protocol Violation|0|||
124788209|NCT00913458|448854288|FG006|Phase 2|Protocol Violation|0|||
124788210|NCT00913458|448854282|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
124788211|NCT00913458|448854283|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
124788212|NCT00913458|448854284|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
124788213|NCT00913458|448854285|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
124788214|NCT00913458|448854286|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
124788215|NCT00913458|448854287|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
124788216|NCT00913458|448854288|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
124788217|NCT00913458|448854282|FG000|Phase 3|Adverse Event|0|||
124788218|NCT00913458|448854283|FG001|Phase 3|Adverse Event|0|||
124788219|NCT00913458|448854284|FG002|Phase 3|Adverse Event|0|||
124788220|NCT00913458|448854285|FG003|Phase 3|Adverse Event|0|||
124788221|NCT00913458|448854286|FG004|Phase 3|Adverse Event|5|||
124788222|NCT00913458|448854287|FG005|Phase 3|Adverse Event|4|||
124788223|NCT00913458|448854288|FG006|Phase 3|Adverse Event|1|||
124788224|NCT00913458|448854282|FG000|Phase 3|Lost to Follow-up|0|||
124788225|NCT00913458|448854283|FG001|Phase 3|Lost to Follow-up|0|||
124788226|NCT00913458|448854284|FG002|Phase 3|Lost to Follow-up|0|||
124788227|NCT00913458|448854285|FG003|Phase 3|Lost to Follow-up|0|||
124788228|NCT00913458|448854286|FG004|Phase 3|Lost to Follow-up|2|||
124788229|NCT00913458|448854287|FG005|Phase 3|Lost to Follow-up|0|||
124788230|NCT00913458|448854288|FG006|Phase 3|Lost to Follow-up|0|||
124788231|NCT00913458|448854282|FG000|Phase 3|Non-Responder|0|||
124788232|NCT00913458|448854283|FG001|Phase 3|Non-Responder|0|||
124788233|NCT00913458|448854284|FG002|Phase 3|Non-Responder|0|||
124788234|NCT00913458|448854285|FG003|Phase 3|Non-Responder|0|||
124788235|NCT00913458|448854286|FG004|Phase 3|Non-Responder|0|||
124788236|NCT00913458|448854287|FG005|Phase 3|Non-Responder|1|||
124788237|NCT00913458|448854288|FG006|Phase 3|Non-Responder|3|||
124788238|NCT00913458|448854282|FG000|Phase 3|Withdrawal by Subject|0|||
124788239|NCT00913458|448854283|FG001|Phase 3|Withdrawal by Subject|0|||
124788240|NCT00913458|448854284|FG002|Phase 3|Withdrawal by Subject|0|||
124788241|NCT00913458|448854285|FG003|Phase 3|Withdrawal by Subject|0|||
124788242|NCT00913458|448854286|FG004|Phase 3|Withdrawal by Subject|1|||
124788243|NCT00913458|448854287|FG005|Phase 3|Withdrawal by Subject|2|||
124788244|NCT00913458|448854288|FG006|Phase 3|Withdrawal by Subject|0|||
124788245|NCT00913458|448854282|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
124788246|NCT00913458|448854283|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
124788247|NCT00913458|448854284|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
124788248|NCT00913458|448854285|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
124752280|NCT04230213|448714317|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
124752281|NCT04230213|448714315|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
124752282|NCT04230213|448714316|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
124752283|NCT04230213|448714317|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
124752284|NCT04230213|448714315|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
124752285|NCT04230213|448714316|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
124752286|NCT04230213|448714317|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
124752287|NCT04230213|448714315|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
124752288|NCT04230213|448714316|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
124752289|NCT04230213|448714317|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
124752290|NCT04230213|448714315|FG000|TP3: Week 16 to Week 22|Other|0|||
124752291|NCT04230213|448714316|FG001|TP3: Week 16 to Week 22|Other|1|||
124752292|NCT04230213|448714317|FG002|TP3: Week 16 to Week 22|Other|3|||
124752293|NCT04230213|448714315|FG000|TP4: Week 22 to Week 32|Other|0|||
124752294|NCT04230213|448714316|FG001|TP4: Week 22 to Week 32|Other|5|||
124752295|NCT04230213|448714317|FG002|TP4: Week 22 to Week 32|Other|5|||
124752296|NCT04230213|448714315|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
124752297|NCT04230213|448714316|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
124752298|NCT04230213|448714317|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
124752299|NCT04230213|448714315|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
124752300|NCT04230213|448714316|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
124752301|NCT04230213|448714317|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
124752302|NCT04230213|448714315|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
124752303|NCT04230213|448714316|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
124752304|NCT04230213|448714317|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
124752305|NCT04230213|448714315|FG000|Follow up: Week 32 to Week 36|Other|0|||
124752306|NCT04230213|448714316|FG001|Follow up: Week 32 to Week 36|Other|1|||
124752307|NCT04230213|448714317|FG002|Follow up: Week 32 to Week 36|Other|1|||
124752308|NCT02508428|448714322|FG000|Overall Study|Death|32|||
124752309|NCT02508428|448714323|FG001|Overall Study|Death|33|||
124752310|NCT02508428|448714322|FG000|Overall Study|Liner revised|3|||
124752311|NCT02508428|448714323|FG001|Overall Study|Liner revised|19|||
124752312|NCT02508428|448714322|FG000|Overall Study|Incomplete follow-up|17|||
124752313|NCT02508428|448714323|FG001|Overall Study|Incomplete follow-up|15|||
124752314|NCT00534976|448714329|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
124752315|NCT00534976|448714330|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
124752316|NCT00534976|448714329|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
124752317|NCT00534976|448714330|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
124752318|NCT00534976|448714329|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
124752319|NCT00534976|448714330|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
124752320|NCT00861471|448714331|FG000|Overall Study|Withdrawal by Subject|1|||
124752321|NCT00861471|448714331|FG000|Overall Study|Adverse Event|2|||
124752322|NCT00861471|448714331|FG000|Overall Study|Lack of Efficacy|3|||
124752323|NCT00861471|448714331|FG000|Overall Study|treatment for lumbar laminectomy|1|||
124752324|NCT00861471|448714331|FG000|Overall Study|Physician Decision|2|||
124752325|NCT02834247|448714332|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
124752326|NCT02834247|448714333|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
124752327|NCT02834247|448714334|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
124752328|NCT02834247|448714335|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
124752329|NCT02834247|448714332|FG000|Dose Escalation Phase|Death|5|||
124752330|NCT02834247|448714333|FG001|Dose Escalation Phase|Death|6|||
124752331|NCT02834247|448714334|FG002|Dose Escalation Phase|Death|5|||
124752332|NCT02834247|448714335|FG003|Dose Escalation Phase|Death|0|||
124752333|NCT02834247|448714332|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
124752334|NCT02834247|448714333|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
124752335|NCT02834247|448714334|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
124752336|NCT02834247|448714335|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
124752337|NCT02834247|448714332|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
124752338|NCT02834247|448714333|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
124752339|NCT02834247|448714334|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
124752340|NCT02834247|448714335|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
124752341|NCT02834247|448714332|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
124752342|NCT02834247|448714333|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
124752343|NCT02834247|448714334|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
124752344|NCT02834247|448714335|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
124752345|NCT02834247|448714332|FG000|Dose Expansion Phase|Death|0|||
124752346|NCT02834247|448714333|FG001|Dose Expansion Phase|Death|0|||
124752347|NCT02834247|448714334|FG002|Dose Expansion Phase|Death|0|||
124752348|NCT02834247|448714335|FG003|Dose Expansion Phase|Death|8|||
124752349|NCT02834247|448714332|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
124752350|NCT02834247|448714333|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
124752351|NCT02834247|448714334|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
124752352|NCT02834247|448714335|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
124788249|NCT00913458|448854286|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
124788250|NCT00913458|448854287|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
124788251|NCT00913458|448854288|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
124788252|NCT02279407|448854289|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
124788253|NCT02279407|448854290|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
124788254|NCT02279407|448854291|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
124788255|NCT02279407|448854292|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
124788256|NCT02279407|448854289|FG000|Overall Study|Withdrawal by Subject|1|||
124788257|NCT02279407|448854290|FG001|Overall Study|Withdrawal by Subject|0|||
124788258|NCT02279407|448854291|FG002|Overall Study|Withdrawal by Subject|1|||
124788259|NCT02279407|448854292|FG003|Overall Study|Withdrawal by Subject|1|||
124788260|NCT02279407|448854289|FG000|Overall Study|Adverse Event|1|||
124788261|NCT02279407|448854290|FG001|Overall Study|Adverse Event|1|||
124788262|NCT02279407|448854291|FG002|Overall Study|Adverse Event|2|||
124788263|NCT02279407|448854292|FG003|Overall Study|Adverse Event|0|||
124788264|NCT01155011|448854297|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
124788265|NCT01155011|448854298|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
124788266|NCT01155011|448854297|FG000|Baseline to 6 Months|investigator decision, moved|4|||
124788267|NCT01155011|448854298|FG001|Baseline to 6 Months|investigator decision, moved|5|||
124788268|NCT01155011|448854297|FG000|Baseline to 6 Months|Death|0|||
124788269|NCT01155011|448854298|FG001|Baseline to 6 Months|Death|1|||
124788270|NCT01155011|448854297|FG000|6 to 12 Months|Withdrawal by Subject|8|||
124788271|NCT01155011|448854298|FG001|6 to 12 Months|Withdrawal by Subject|5|||
124788272|NCT01155011|448854297|FG000|6 to 12 Months|Death|1|||
124788273|NCT01155011|448854298|FG001|6 to 12 Months|Death|5|||
124788274|NCT00422084|448854299|FG000|Overall Study|Adverse Event|21|||
124788275|NCT00422084|448854300|FG001|Overall Study|Adverse Event|7|||
124788276|NCT00422084|448854299|FG000|Overall Study|Withdrawal by Subject|12|||
124788277|NCT00422084|448854300|FG001|Overall Study|Withdrawal by Subject|9|||
124788278|NCT00422084|448854299|FG000|Overall Study|Lost to Follow-up|14|||
124788279|NCT00422084|448854300|FG001|Overall Study|Lost to Follow-up|9|||
124788280|NCT00422084|448854299|FG000|Overall Study|Protocol Violation|4|||
124788281|NCT00422084|448854300|FG001|Overall Study|Protocol Violation|1|||
124788282|NCT00422084|448854299|FG000|Overall Study|Lack of Efficacy|40|||
124788283|NCT00422084|448854300|FG001|Overall Study|Lack of Efficacy|42|||
124788284|NCT00422084|448854299|FG000|Overall Study|P. vivax infection|3|||
124788285|NCT00422084|448854300|FG001|Overall Study|P. vivax infection|6|||
124788286|NCT00422084|448854299|FG000|Overall Study|Cyesis|1|||
124788287|NCT00422084|448854300|FG001|Overall Study|Cyesis|0|||
124788288|NCT00422084|448854299|FG000|Overall Study|Withdrawn from study accidentally|1|||
124788289|NCT00422084|448854300|FG001|Overall Study|Withdrawn from study accidentally|0|||
124788290|NCT00422084|448854299|FG000|Overall Study|Non-compliance|1|||
124788291|NCT00422084|448854300|FG001|Overall Study|Non-compliance|0|||
124788292|NCT00422084|448854299|FG000|Overall Study|Re-location|0|||
124788293|NCT00422084|448854300|FG001|Overall Study|Re-location|1|||
124788294|NCT00422084|448854299|FG000|Overall Study|Not defined|1|||
124788295|NCT00422084|448854300|FG001|Overall Study|Not defined|1|||
124788296|NCT03774823|448854303|FG000|Overall Study|Withdrawal by Subject|1|||
124788297|NCT03774823|448854304|FG001|Overall Study|Withdrawal by Subject|1|||
124788298|NCT00958438|448854305|FG000|Overall Study|Protocol Violation|3|||
124788299|NCT00958438|448854306|FG001|Overall Study|Protocol Violation|2|||
124788300|NCT00958438|448854307|FG002|Overall Study|Protocol Violation|2|||
124788301|NCT00958438|448854305|FG000|Overall Study|Withdrawal by Subject|4|||
124788302|NCT00958438|448854306|FG001|Overall Study|Withdrawal by Subject|2|||
124788303|NCT00958438|448854307|FG002|Overall Study|Withdrawal by Subject|1|||
124788304|NCT00958438|448854305|FG000|Overall Study|Adverse Event|0|||
124788305|NCT00958438|448854306|FG001|Overall Study|Adverse Event|3|||
124788306|NCT00958438|448854307|FG002|Overall Study|Adverse Event|0|||
124788307|NCT00958438|448854305|FG000|Overall Study|Physician Decision|1|||
124788308|NCT00958438|448854306|FG001|Overall Study|Physician Decision|0|||
124788309|NCT00958438|448854307|FG002|Overall Study|Physician Decision|1|||
124788310|NCT00958438|448854305|FG000|Overall Study|Other than specified above|2|||
124788311|NCT00958438|448854306|FG001|Overall Study|Other than specified above|3|||
124788312|NCT00958438|448854307|FG002|Overall Study|Other than specified above|2|||
124788313|NCT00759564|448854308|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
124788314|NCT00759564|448854309|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
124788315|NCT00759564|448854310|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
124788316|NCT00759564|448854311|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
124788317|NCT00759564|448854312|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
124788318|NCT02788279|448854314|FG000|Overall Study|Death|62|||
124788319|NCT02788279|448854315|FG001|Overall Study|Death|136|||
124788320|NCT02788279|448854316|FG002|Overall Study|Death|72|||
124788321|NCT02788279|448854314|FG000|Overall Study|Withdrawal by Subject|10|||
124788322|NCT02788279|448854315|FG001|Overall Study|Withdrawal by Subject|15|||
124788323|NCT02788279|448854316|FG002|Overall Study|Withdrawal by Subject|5|||
124788324|NCT02788279|448854314|FG000|Overall Study|Lost to Follow-up|0|||
124788325|NCT02788279|448854315|FG001|Overall Study|Lost to Follow-up|3|||
124788326|NCT02788279|448854316|FG002|Overall Study|Lost to Follow-up|2|||
124788327|NCT02788279|448854314|FG000|Overall Study|Sponsor decision|18|||
124788328|NCT02788279|448854315|FG001|Overall Study|Sponsor decision|29|||
124788329|NCT02788279|448854316|FG002|Overall Study|Sponsor decision|11|||
124788330|NCT00329849|448854317|FG000|Overall Study|Withdrawal by Subject|6|||
124788331|NCT00329849|448854318|FG001|Overall Study|Withdrawal by Subject|4|||
124788332|NCT03996369|448854319|FG000|Overall Study|Protocol deviation|1|||
124788333|NCT03996369|448854320|FG001|Overall Study|Protocol deviation|1|||
124788334|NCT03996369|448854319|FG000|Overall Study|Physician Decision|4|||
124788335|NCT03996369|448854320|FG001|Overall Study|Physician Decision|2|||
124788336|NCT03996369|448854319|FG000|Overall Study|Participant decision|0|||
124788337|NCT03996369|448854320|FG001|Overall Study|Participant decision|1|||
124788338|NCT03996369|448854319|FG000|Overall Study|Lack of Efficacy|4|||
124788339|NCT03996369|448854320|FG001|Overall Study|Lack of Efficacy|0|||
124788340|NCT03996369|448854319|FG000|Overall Study|Adverse Event|9|||
124788341|NCT03996369|448854320|FG001|Overall Study|Adverse Event|0|||
124788342|NCT03996369|448854319|FG000|Overall Study|Withdrawal by Subject|6|||
124788343|NCT03996369|448854320|FG001|Overall Study|Withdrawal by Subject|8|||
124788344|NCT03996369|448854319|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
124788345|NCT03996369|448854320|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
124788346|NCT03996369|448854319|FG000|Overall Study|Lost to Follow-up|0|||
124788347|NCT03996369|448854320|FG001|Overall Study|Lost to Follow-up|1|||
124788348|NCT02238067|448854321|FG000|Overall Study|Not completed survey at Month 6|45|||
124788349|NCT01566214|448854323|FG000|Overall Study|Lost to Follow-up|3|||
124788350|NCT01566214|448854324|FG001|Overall Study|Lost to Follow-up|0|||
124788351|NCT00832624|448854328|FG000|Overall Study|Study Terminated|10|||
124788352|NCT02395172|448854329|FG000|Overall Study|Participants randomized but not treated|3|||
124788353|NCT02395172|448854330|FG001|Overall Study|Participants randomized but not treated|31|||
124788354|NCT00717236|448854331|FG000|Double-Blind Period|Adverse Event|33|||
124788355|NCT00717236|448854332|FG001|Double-Blind Period|Adverse Event|6|||
124788356|NCT00717236|448854331|FG000|Double-Blind Period|Lack of Efficacy|6|||
124788357|NCT00717236|448854332|FG001|Double-Blind Period|Lack of Efficacy|6|||
124788358|NCT00717236|448854331|FG000|Double-Blind Period|Lost to Follow-up|3|||
124788359|NCT00717236|448854332|FG001|Double-Blind Period|Lost to Follow-up|5|||
124788360|NCT00717236|448854331|FG000|Double-Blind Period|Withdrawal by Subject|10|||
124788361|NCT00717236|448854332|FG001|Double-Blind Period|Withdrawal by Subject|2|||
124788362|NCT00717236|448854331|FG000|Double-Blind Period|Loss of efficacy|3|||
124788363|NCT00717236|448854332|FG001|Double-Blind Period|Loss of efficacy|0|||
124788364|NCT00717236|448854331|FG000|Double-Blind Period|Other: Death|1|||
124788365|NCT00717236|448854332|FG001|Double-Blind Period|Other: Death|0|||
124788366|NCT00717236|448854331|FG000|Double-Blind Period|Other: Pregnancy|1|||
124788367|NCT00717236|448854332|FG001|Double-Blind Period|Other: Pregnancy|0|||
124788368|NCT00717236|448854331|FG000|Double-Blind Period|Other: Protocol Violation|2|||
124788369|NCT00717236|448854332|FG001|Double-Blind Period|Other: Protocol Violation|0|||
124788370|NCT00717236|448854331|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
124788371|NCT00717236|448854332|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
124788372|NCT00717236|448854331|FG000|Double-Blind Period|Other: Site withdrew|2|||
124788373|NCT00717236|448854332|FG001|Double-Blind Period|Other: Site withdrew|0|||
124788374|NCT00717236|448854331|FG000|Double-Blind Period|Other: Screening failure|1|||
124788375|NCT00717236|448854332|FG001|Double-Blind Period|Other: Screening failure|0|||
124788376|NCT00717236|448854331|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
124788377|NCT00717236|448854332|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
124788378|NCT00717236|448854331|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
124788379|NCT00717236|448854332|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
124788380|NCT00717236|448854331|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
124788381|NCT00717236|448854332|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
124788382|NCT00717236|448854331|FG000|Double-Blind Period|Other: History of cancer|1|||
124788383|NCT00717236|448854332|FG001|Double-Blind Period|Other: History of cancer|0|||
124788384|NCT00717236|448854331|FG000|Double-Blind Period|Other: Sponsor request|1|||
124788385|NCT00717236|448854332|FG001|Double-Blind Period|Other: Sponsor request|0|||
124788386|NCT00717236|448854331|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
124788387|NCT00717236|448854332|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
124788388|NCT00717236|448854331|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
124788389|NCT00717236|448854332|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
124788390|NCT00717236|448854331|FG000|Double-Blind Period|Other: Subject moved|1|||
124788391|NCT00717236|448854332|FG001|Double-Blind Period|Other: Subject moved|1|||
124788392|NCT00717236|448854331|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
124788393|NCT00717236|448854332|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
124788394|NCT00717236|448854331|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
124788395|NCT00717236|448854332|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
124788396|NCT00717236|448854331|FG000|Double-Blind Period|Other: Transportation problems|0|||
124788397|NCT00717236|448854332|FG001|Double-Blind Period|Other: Transportation problems|1|||
124788398|NCT00717236|448854331|FG000|Double-Blind Period|Other: Investigator Decision|0|||
124788399|NCT00717236|448854332|FG001|Double-Blind Period|Other: Investigator Decision|1|||
124788400|NCT00717236|448854331|FG000|Open-Label Period|Adverse Event|29|||
124788401|NCT00717236|448854332|FG001|Open-Label Period|Adverse Event|4|||
124788402|NCT00717236|448854331|FG000|Open-Label Period|Lack of Efficacy|30|||
124788403|NCT00717236|448854332|FG001|Open-Label Period|Lack of Efficacy|8|||
124788404|NCT00717236|448854331|FG000|Open-Label Period|Lost to Follow-up|28|||
124788405|NCT00717236|448854332|FG001|Open-Label Period|Lost to Follow-up|4|||
124788406|NCT00717236|448854331|FG000|Open-Label Period|Withdrawal by Subject|20|||
124788407|NCT00717236|448854332|FG001|Open-Label Period|Withdrawal by Subject|2|||
124788408|NCT00717236|448854331|FG000|Open-Label Period|Loss of Efficacy|6|||
124788409|NCT00717236|448854332|FG001|Open-Label Period|Loss of Efficacy|1|||
124788410|NCT00717236|448854331|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
124788411|NCT00717236|448854332|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
124788412|NCT00717236|448854331|FG000|Open-Label Period|Other: Lack of Compliance|1|||
124788413|NCT00717236|448854332|FG001|Open-Label Period|Other: Lack of Compliance|1|||
124788414|NCT00717236|448854331|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
124788415|NCT00717236|448854332|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
124788416|NCT00717236|448854331|FG000|Open-Label Period|Other: Moved|1|||
124788417|NCT00717236|448854332|FG001|Open-Label Period|Other: Moved|0|||
124788418|NCT00717236|448854331|FG000|Open-Label Period|Other: Investigator Decision|1|||
124788419|NCT00717236|448854332|FG001|Open-Label Period|Other: Investigator Decision|0|||
124788420|NCT00717236|448854331|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
124788421|NCT00717236|448854332|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
124788422|NCT00717236|448854331|FG000|Open-Label Period|Other: Sponsor Request|3|||
124788423|NCT00717236|448854332|FG001|Open-Label Period|Other: Sponsor Request|0|||
124788424|NCT00717236|448854331|FG000|Open-Label Period|Other: Cataract Surgery|1|||
124788425|NCT00717236|448854332|FG001|Open-Label Period|Other: Cataract Surgery|0|||
124788426|NCT00717236|448854331|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
124788427|NCT00717236|448854332|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
124788428|NCT00717236|448854331|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
124788429|NCT00717236|448854332|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
124788430|NCT00717236|448854331|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
124788431|NCT00717236|448854332|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
124788432|NCT00475982|448854333|FG000|Overall Study|surgery rescheduled|7|||
124788433|NCT00475982|448854334|FG001|Overall Study|surgery rescheduled|3|||
124788434|NCT00783198|448854339|FG000|Overall Study|Adverse Event|15|||
124788435|NCT00783198|448854340|FG001|Overall Study|Adverse Event|19|||
124788436|NCT00783198|448854341|FG002|Overall Study|Adverse Event|3|||
124788437|NCT00783198|448854339|FG000|Overall Study|Lost to Follow-up|11|||
124788438|NCT00783198|448854340|FG001|Overall Study|Lost to Follow-up|1|||
124788439|NCT00783198|448854341|FG002|Overall Study|Lost to Follow-up|7|||
124788440|NCT00783198|448854339|FG000|Overall Study|Withdrawal by Subject|22|||
124788441|NCT00783198|448854340|FG001|Overall Study|Withdrawal by Subject|14|||
124788442|NCT00783198|448854341|FG002|Overall Study|Withdrawal by Subject|20|||
124788443|NCT00783198|448854339|FG000|Overall Study|Noncompliance with protocol|7|||
124788444|NCT00783198|448854340|FG001|Overall Study|Noncompliance with protocol|7|||
124788445|NCT00783198|448854341|FG002|Overall Study|Noncompliance with protocol|10|||
124788446|NCT00783198|448854339|FG000|Overall Study|Did not meet protocol eligibility|0|||
124788447|NCT00783198|448854340|FG001|Overall Study|Did not meet protocol eligibility|1|||
124788448|NCT00783198|448854341|FG002|Overall Study|Did not meet protocol eligibility|0|||
124788449|NCT00783198|448854339|FG000|Overall Study|Administrative|2|||
124788450|NCT00783198|448854340|FG001|Overall Study|Administrative|1|||
124788451|NCT00783198|448854341|FG002|Overall Study|Administrative|2|||
124788452|NCT00946985|448854342|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
124788453|NCT00946985|448854342|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
124788454|NCT00946985|448854342|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
124788455|NCT00946985|448854342|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
124788456|NCT00946985|448854342|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
124788457|NCT00946985|448854342|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
124788458|NCT00946985|448854342|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
124788459|NCT00946985|448854342|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
124788460|NCT00946985|448854342|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
124788461|NCT04345367|448854343|FG000|Overall Study|Other|3|||
124788462|NCT04345367|448854344|FG001|Overall Study|Other|4|||
124788463|NCT04345367|448854343|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
124788464|NCT04345367|448854344|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
124788465|NCT04345367|448854343|FG000|Overall Study|Withdrawal by Subject|11|||
124788466|NCT04345367|448854344|FG001|Overall Study|Withdrawal by Subject|11|||
124788467|NCT04345367|448854343|FG000|Overall Study|Protocol Violation|4|||
124788468|NCT04345367|448854344|FG001|Overall Study|Protocol Violation|3|||
124788469|NCT04345367|448854343|FG000|Overall Study|Lost to Follow-up|2|||
124626486|NCT00758524|448248044|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
124626487|NCT00758524|448248045|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
124788470|NCT04345367|448854344|FG001|Overall Study|Lost to Follow-up|4|||
124788471|NCT04345367|448854343|FG000|Overall Study|Lack of Efficacy|2|||
124788472|NCT04345367|448854344|FG001|Overall Study|Lack of Efficacy|0|||
124788473|NCT04345367|448854343|FG000|Overall Study|Death|2|||
124788474|NCT04345367|448854344|FG001|Overall Study|Death|0|||
124788475|NCT04345367|448854343|FG000|Overall Study|Adverse Event|10|||
124788476|NCT04345367|448854344|FG001|Overall Study|Adverse Event|9|||
124788477|NCT00852371|448854345|FG000|Overall Study|Lost to Follow-up|2|||
124788478|NCT00852371|448854346|FG001|Overall Study|Lost to Follow-up|3|||
124788479|NCT00852371|448854347|FG002|Overall Study|Lost to Follow-up|4|||
124788480|NCT00852371|448854348|FG003|Overall Study|Lost to Follow-up|2|||
124788481|NCT00796523|448854349|FG000|Overall Study|Lost to Follow-up|9|||
124788482|NCT00796523|448854350|FG001|Overall Study|Lost to Follow-up|7|||
124788483|NCT04525885|448854351|FG000|Overall Study|Screen Failure|1|||
124788484|NCT04525885|448854352|FG001|Overall Study|Screen Failure|0|||
124788485|NCT04525885|448854353|FG002|Overall Study|Screen Failure|0|||
124788486|NCT04525885|448854351|FG000|Overall Study|Withdrawal by Subject|14|||
124788487|NCT04525885|448854352|FG001|Overall Study|Withdrawal by Subject|6|||
124788488|NCT04525885|448854353|FG002|Overall Study|Withdrawal by Subject|20|||
124788489|NCT04525885|448854351|FG000|Overall Study|Physician Decision|1|||
124788490|NCT04525885|448854352|FG001|Overall Study|Physician Decision|0|||
124788491|NCT04525885|448854353|FG002|Overall Study|Physician Decision|1|||
124788492|NCT00978757|448854362|FG000|Overall Study|Physician Decision|1|||
124788493|NCT00978757|448854363|FG001|Overall Study|Physician Decision|3|||
124788494|NCT01700387|448854364|FG000|Overall Study|Withdrawal by Subject|1|||
124788495|NCT01700387|448854365|FG001|Overall Study|Withdrawal by Subject|2|||
124788496|NCT01700387|448854364|FG000|Overall Study|Adverse Event|1|||
124788497|NCT01700387|448854365|FG001|Overall Study|Adverse Event|1|||
124788498|NCT01700387|448854364|FG000|Overall Study|Lost to Follow-up|2|||
124788499|NCT01700387|448854365|FG001|Overall Study|Lost to Follow-up|1|||
124788500|NCT01031836|448855840|FG000|Stage I|Adverse Event|1|||
124788501|NCT01031836|448855841|FG001|Stage I|Adverse Event|1|||
124788502|NCT01031836|448855842|FG002|Stage I|Adverse Event|0|||
124788503|NCT01031836|448855843|FG003|Stage I|Adverse Event|0|||
124626488|NCT00758524|448248046|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
124626489|NCT00758524|448248047|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
124626490|NCT00758524|448248048|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
124626491|NCT00758524|448248049|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
124626492|NCT00758524|448248050|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
124626493|NCT00758524|448248051|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
124626494|NCT00758524|448248035|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
124626495|NCT00758524|448248036|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
124626496|NCT00758524|448248037|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
124626497|NCT00758524|448248038|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
124626498|NCT00758524|448248039|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
124626499|NCT00758524|448248040|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
124626500|NCT00758524|448248041|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
124626501|NCT00758524|448248042|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
124626502|NCT00758524|448248043|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
124626503|NCT00758524|448248044|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
124626504|NCT00758524|448248045|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
124626505|NCT00758524|448248046|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
124626506|NCT00758524|448248047|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
124626507|NCT00758524|448248048|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
124626508|NCT00758524|448248049|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
124788504|NCT01031836|448855844|FG004|Stage I|Adverse Event|0|||
124788505|NCT01031836|448855845|FG005|Stage I|Adverse Event|0|||
124788506|NCT01031836|448855840|FG000|Stage I|Other|0|||
124788507|NCT01031836|448855841|FG001|Stage I|Other|1|||
124788508|NCT01031836|448855842|FG002|Stage I|Other|0|||
124788509|NCT01031836|448855843|FG003|Stage I|Other|0|||
124626509|NCT00758524|448248050|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
124626510|NCT00758524|448248051|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
124788510|NCT01031836|448855844|FG004|Stage I|Other|0|||
124788511|NCT01031836|448855845|FG005|Stage I|Other|1|||
124788512|NCT01031836|448855840|FG000|Stage II|Adverse Event|0|||
124788513|NCT01031836|448855841|FG001|Stage II|Adverse Event|0|||
124788514|NCT01031836|448855842|FG002|Stage II|Adverse Event|2|||
124788515|NCT01031836|448855843|FG003|Stage II|Adverse Event|2|||
124788516|NCT01031836|448855844|FG004|Stage II|Adverse Event|1|||
124788517|NCT01031836|448855845|FG005|Stage II|Adverse Event|1|||
124788518|NCT01031836|448855840|FG000|Stage II|Other|2|||
124788519|NCT01031836|448855841|FG001|Stage II|Other|0|||
124788520|NCT01031836|448855842|FG002|Stage II|Other|0|||
124788521|NCT01031836|448855843|FG003|Stage II|Other|1|||
124788522|NCT01031836|448855844|FG004|Stage II|Other|1|||
124788523|NCT01031836|448855845|FG005|Stage II|Other|0|||
124626511|NCT04747470|448248063|FG000|Overall Study|Death|0|||
124626512|NCT04747470|448248064|FG001|Overall Study|Death|3|||
124626513|NCT04747470|448248065|FG002|Overall Study|Death|2|||
124626514|NCT04747470|448248066|FG003|Overall Study|Death|2|||
124626515|NCT04747470|448248067|FG004|Overall Study|Death|2|||
124626516|NCT04747470|448248068|FG005|Overall Study|Death|0|||
124626517|NCT04747470|448248069|FG006|Overall Study|Death|0|||
124626518|NCT04747470|448248070|FG007|Overall Study|Death|0|||
124626519|NCT04747470|448248071|FG008|Overall Study|Death|0|||
124626520|NCT04747470|448248072|FG009|Overall Study|Death|0|||
124626521|NCT04747470|448248073|FG010|Overall Study|Death|0|||
124626522|NCT04747470|448248063|FG000|Overall Study|Withdrew Consent|0|||
124626523|NCT04747470|448248064|FG001|Overall Study|Withdrew Consent|0|||
124626524|NCT04747470|448248065|FG002|Overall Study|Withdrew Consent|0|||
124626525|NCT04747470|448248066|FG003|Overall Study|Withdrew Consent|1|||
124626526|NCT04747470|448248067|FG004|Overall Study|Withdrew Consent|0|||
124626527|NCT04747470|448248068|FG005|Overall Study|Withdrew Consent|0|||
124626528|NCT04747470|448248069|FG006|Overall Study|Withdrew Consent|0|||
124626529|NCT04747470|448248070|FG007|Overall Study|Withdrew Consent|0|||
124626530|NCT04747470|448248071|FG008|Overall Study|Withdrew Consent|0|||
124626531|NCT04747470|448248072|FG009|Overall Study|Withdrew Consent|0|||
124626532|NCT04747470|448248073|FG010|Overall Study|Withdrew Consent|0|||
124626533|NCT04747470|448248063|FG000|Overall Study|Study Terminated by Sponsor|0|||
124788524|NCT03137069|448855846|FG000|Overall Study|Withdrawal by Subject|1|||
124788525|NCT03137069|448855847|FG001|Overall Study|Withdrawal by Subject|2|||
124788526|NCT03137069|448855848|FG002|Overall Study|Withdrawal by Subject|2|||
124788527|NCT03137069|448855849|FG003|Overall Study|Withdrawal by Subject|2|||
124788528|NCT03137069|448855850|FG004|Overall Study|Withdrawal by Subject|0|||
124788529|NCT03137069|448855851|FG005|Overall Study|Withdrawal by Subject|0|||
124788530|NCT03137069|448855846|FG000|Overall Study|Adverse Event|0|||
124788531|NCT03137069|448855847|FG001|Overall Study|Adverse Event|3|||
124788532|NCT03137069|448855848|FG002|Overall Study|Adverse Event|1|||
124788533|NCT03137069|448855849|FG003|Overall Study|Adverse Event|1|||
124626534|NCT04747470|448248064|FG001|Overall Study|Study Terminated by Sponsor|0|||
124626535|NCT04747470|448248065|FG002|Overall Study|Study Terminated by Sponsor|1|||
124626536|NCT04747470|448248066|FG003|Overall Study|Study Terminated by Sponsor|0|||
124626537|NCT04747470|448248067|FG004|Overall Study|Study Terminated by Sponsor|2|||
124626538|NCT04747470|448248068|FG005|Overall Study|Study Terminated by Sponsor|0|||
124626539|NCT04747470|448248069|FG006|Overall Study|Study Terminated by Sponsor|0|||
124626540|NCT04747470|448248070|FG007|Overall Study|Study Terminated by Sponsor|0|||
124788534|NCT03137069|448855850|FG004|Overall Study|Adverse Event|0|||
124788535|NCT03137069|448855851|FG005|Overall Study|Adverse Event|1|||
124626541|NCT04747470|448248071|FG008|Overall Study|Study Terminated by Sponsor|0|||
124626542|NCT04747470|448248072|FG009|Overall Study|Study Terminated by Sponsor|0|||
124626543|NCT04747470|448248073|FG010|Overall Study|Study Terminated by Sponsor|0|||
124626544|NCT00769379|448248076|FG000|Overall Study|No follow up data mapped to Other.|3|||
124626545|NCT00769379|448248077|FG001|Overall Study|No follow up data mapped to Other.|13|||
124626546|NCT01928472|448248078|FG000|Overall Study|Death|0|||
124626547|NCT01928472|448248079|FG001|Overall Study|Death|0|||
124626548|NCT01928472|448248080|FG002|Overall Study|Death|1|||
124626549|NCT01928472|448248081|FG003|Overall Study|Death|0|||
124626550|NCT01928472|448248078|FG000|Overall Study|Withdrawal by Subject|4|||
124626551|NCT01928472|448248079|FG001|Overall Study|Withdrawal by Subject|4|||
124626552|NCT01928472|448248080|FG002|Overall Study|Withdrawal by Subject|1|||
124626553|NCT01928472|448248081|FG003|Overall Study|Withdrawal by Subject|2|||
124626554|NCT01928472|448248078|FG000|Overall Study|Lost to Follow-up|2|||
124626555|NCT01928472|448248079|FG001|Overall Study|Lost to Follow-up|3|||
124626556|NCT01928472|448248080|FG002|Overall Study|Lost to Follow-up|4|||
124788536|NCT03137069|448855846|FG000|Overall Study|Protocol Violation|0|||
124626557|NCT01928472|448248081|FG003|Overall Study|Lost to Follow-up|0|||
124626558|NCT01928472|448248078|FG000|Overall Study|Administrative Reason|2|||
124626559|NCT01928472|448248079|FG001|Overall Study|Administrative Reason|1|||
124626560|NCT01928472|448248080|FG002|Overall Study|Administrative Reason|0|||
124626561|NCT01928472|448248081|FG003|Overall Study|Administrative Reason|0|||
124626562|NCT01928472|448248078|FG000|Overall Study|Unclassified|0|||
124626563|NCT01928472|448248079|FG001|Overall Study|Unclassified|0|||
124626564|NCT01928472|448248080|FG002|Overall Study|Unclassified|1|||
124626565|NCT01928472|448248081|FG003|Overall Study|Unclassified|0|||
124626566|NCT01308424|448248082|FG000|Baseline Eligibility|Screen Failures|71|||
124626567|NCT01308424|448248083|FG001|Baseline Eligibility|Screen Failures|0|||
124626568|NCT01308424|448248084|FG002|Baseline Eligibility|Screen Failures|0|||
124626569|NCT01308424|448248082|FG000|Randomization|Adverse Event|0|||
124626570|NCT01308424|448248083|FG001|Randomization|Adverse Event|1|||
124626571|NCT01308424|448248084|FG002|Randomization|Adverse Event|1|||
124626572|NCT01308424|448248082|FG000|Randomization|Lost to Follow-up|0|||
124626573|NCT01308424|448248083|FG001|Randomization|Lost to Follow-up|1|||
124788537|NCT03137069|448855847|FG001|Overall Study|Protocol Violation|1|||
124788538|NCT03137069|448855848|FG002|Overall Study|Protocol Violation|0|||
124788539|NCT03137069|448855849|FG003|Overall Study|Protocol Violation|1|||
124626574|NCT01308424|448248084|FG002|Randomization|Lost to Follow-up|0|||
124626575|NCT01308424|448248082|FG000|Randomization|Physician Decision|0|||
124626576|NCT01308424|448248083|FG001|Randomization|Physician Decision|1|||
124626577|NCT01308424|448248084|FG002|Randomization|Physician Decision|1|||
124626578|NCT01841593|448248088|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
124626579|NCT01841593|448248089|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
124626580|NCT01841593|448248088|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
124626581|NCT01841593|448248089|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
124626582|NCT00307086|448248090|FG000|Overall Study|ineligible|5|||
124626583|NCT00312338|448248091|FG000|Overall Study|Adverse Event|7|||
124626584|NCT00312338|448248092|FG001|Overall Study|Adverse Event|2|||
124626585|NCT00312338|448248091|FG000|Overall Study|Lost to Follow-up|9|||
124626586|NCT00312338|448248092|FG001|Overall Study|Lost to Follow-up|1|||
124626587|NCT00312338|448248091|FG000|Overall Study|Withdrawal by Subject|4|||
124626588|NCT00312338|448248092|FG001|Overall Study|Withdrawal by Subject|0|||
124626589|NCT00312338|448248091|FG000|Overall Study|Subsequent infection|2|||
124626590|NCT00312338|448248092|FG001|Overall Study|Subsequent infection|0|||
124626591|NCT02553772|448248093|FG000|Overall Study|Adverse Event|2|||
124626592|NCT02553772|448248094|FG001|Overall Study|Adverse Event|3|||
124626593|NCT02553772|448248093|FG000|Overall Study|Lost to Follow-up|2|||
124626594|NCT02553772|448248094|FG001|Overall Study|Lost to Follow-up|1|||
124626595|NCT02553772|448248093|FG000|Overall Study|Withdrawal of Consent|1|||
124626596|NCT02553772|448248094|FG001|Overall Study|Withdrawal of Consent|1|||
124626597|NCT02553772|448248093|FG000|Overall Study|Lack of Efficacy|1|||
124626598|NCT02553772|448248094|FG001|Overall Study|Lack of Efficacy|0|||
124626599|NCT02553772|448248093|FG000|Overall Study|Other Miscellaneous Reasons|0|||
124626600|NCT02553772|448248094|FG001|Overall Study|Other Miscellaneous Reasons|1|||
124626601|NCT02198963|448248101|FG000|Overall Study|Adverse Event|1|||
124626602|NCT02198963|448248101|FG000|Overall Study|Withdrawal by Subject|6|||
124626603|NCT00281957|448248105|FG000|Overall Study|Adverse Event|7|||
124626604|NCT00281957|448248106|FG001|Overall Study|Adverse Event|2|||
124626605|NCT00281957|448248105|FG000|Overall Study|Death|1|||
124626606|NCT00281957|448248106|FG001|Overall Study|Death|0|||
124626607|NCT00281957|448248105|FG000|Overall Study|Progression/relapse|47|||
124626608|NCT00281957|448248106|FG001|Overall Study|Progression/relapse|35|||
124626609|NCT00281957|448248105|FG000|Overall Study|Not protocol specified|8|||
124626610|NCT00281957|448248106|FG001|Overall Study|Not protocol specified|1|||
124626611|NCT00281957|448248105|FG000|Overall Study|Not eligible|1|||
124626612|NCT00281957|448248106|FG001|Overall Study|Not eligible|2|||
124626613|NCT00281957|448248105|FG000|Overall Study|Did not start treatment|3|||
124626614|NCT00281957|448248106|FG001|Overall Study|Did not start treatment|1|||
124626615|NCT00281957|448248105|FG000|Overall Study|Refusal unrelated to adverse events|0|||
124626616|NCT00281957|448248106|FG001|Overall Study|Refusal unrelated to adverse events|1|||
124626617|NCT01876446|448248107|FG000|Overall Study|Death|0|||
124626618|NCT01876446|448248108|FG001|Overall Study|Death|1|||
124626619|NCT01876446|448248107|FG000|Overall Study|Withdrawal by Subject|1|||
124626620|NCT01876446|448248108|FG001|Overall Study|Withdrawal by Subject|2|||
124626621|NCT01876446|448248107|FG000|Overall Study|Physician Decision|1|||
124626622|NCT01876446|448248108|FG001|Overall Study|Physician Decision|3|||
124626623|NCT03180645|448248110|FG000|Overall Study|Adverse Event|0|||
124626624|NCT03180645|448248111|FG001|Overall Study|Adverse Event|1|||
124626625|NCT03180645|448248112|FG002|Overall Study|Adverse Event|2|||
124626626|NCT01808573|448248113|FG000|Overall Study|Death|212|||
124626627|NCT01808573|448248114|FG001|Overall Study|Death|240|||
124626628|NCT01808573|448248113|FG000|Overall Study|Withdrawal by Subject|12|||
124626629|NCT01808573|448248114|FG001|Overall Study|Withdrawal by Subject|10|||
124626630|NCT01808573|448248113|FG000|Overall Study|Lost to Follow-up|3|||
124626631|NCT01808573|448248114|FG001|Overall Study|Lost to Follow-up|0|||
124626632|NCT01808573|448248113|FG000|Overall Study|Discontinuation of study by sponsor|79|||
124626633|NCT01808573|448248114|FG001|Overall Study|Discontinuation of study by sponsor|64|||
124626634|NCT01808573|448248113|FG000|Overall Study|Randomized in Error|1|||
124626635|NCT01808573|448248114|FG001|Overall Study|Randomized in Error|0|||
124788540|NCT03137069|448855850|FG004|Overall Study|Protocol Violation|1|||
124788541|NCT03137069|448855851|FG005|Overall Study|Protocol Violation|1|||
124626636|NCT02208089|448248115|FG000|Overall Study|Withdrawal by Subject|1|||
124626637|NCT02208089|448248116|FG001|Overall Study|Withdrawal by Subject|0|||
124626638|NCT02208089|448248115|FG000|Overall Study|Lost to Follow-up|6|||
124626639|NCT02208089|448248116|FG001|Overall Study|Lost to Follow-up|0|||
124626640|NCT00972595|448248118|FG000|Period 1|Adverse Event|1|||
124626641|NCT00972595|448248119|FG001|Period 1|Adverse Event|0|||
124626642|NCT03629184|448248120|FG000|Overall Study|Withdrawal by Subject|2|||
124626643|NCT03629184|448248121|FG001|Overall Study|Withdrawal by Subject|1|||
124626644|NCT03629184|448248120|FG000|Overall Study|Physician Decision|1|||
124626645|NCT03629184|448248121|FG001|Overall Study|Physician Decision|0|||
124626646|NCT01461538|448248122|FG000|Overall Study|Death|15|||
124626647|NCT01461538|448248123|FG001|Overall Study|Death|6|||
124788542|NCT03137069|448855846|FG000|Overall Study|Physician Decision|0|||
124626648|NCT01461538|448248124|FG002|Overall Study|Death|2|||
124626649|NCT01461538|448248122|FG000|Overall Study|Study Stopped by Sponsor|2|||
124626650|NCT01461538|448248123|FG001|Overall Study|Study Stopped by Sponsor|1|||
124626651|NCT01461538|448248124|FG002|Overall Study|Study Stopped by Sponsor|0|||
124626652|NCT01461538|448248122|FG000|Overall Study|Withdrawal by Subject|1|||
124626653|NCT01461538|448248123|FG001|Overall Study|Withdrawal by Subject|1|||
124626654|NCT01461538|448248124|FG002|Overall Study|Withdrawal by Subject|0|||
124626655|NCT00141778|448248125|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
124626656|NCT00141778|448248126|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
124626657|NCT00141778|448248127|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
124626658|NCT00141778|448248125|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
124626659|NCT00141778|448248126|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
124626660|NCT00141778|448248127|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
124626661|NCT00141778|448248125|FG000|Started Study Medication|Withdrawal by Subject|0|||
124626662|NCT00141778|448248126|FG001|Started Study Medication|Withdrawal by Subject|2|||
124626663|NCT00141778|448248127|FG002|Started Study Medication|Withdrawal by Subject|0|||
124626664|NCT00141778|448248125|FG000|Started Study Medication|Difficulty Swallowing|0|||
124626665|NCT00141778|448248126|FG001|Started Study Medication|Difficulty Swallowing|1|||
124626666|NCT00141778|448248127|FG002|Started Study Medication|Difficulty Swallowing|0|||
124626667|NCT00141778|448248125|FG000|Started Study Medication|Chest Discomfort|0|||
124626668|NCT00141778|448248126|FG001|Started Study Medication|Chest Discomfort|0|||
124626669|NCT00141778|448248127|FG002|Started Study Medication|Chest Discomfort|1|||
124626670|NCT02729909|448248128|FG000|Overall Study|Lost to Follow-up|0|||
124626671|NCT02729909|448248129|FG001|Overall Study|Lost to Follow-up|1|||
124626672|NCT02729909|448248128|FG000|Overall Study|Lack of Efficacy|0|||
124626673|NCT02729909|448248129|FG001|Overall Study|Lack of Efficacy|2|||
124626674|NCT02729909|448248128|FG000|Overall Study|Significant Protocol Deviation|0|||
124626675|NCT02729909|448248129|FG001|Overall Study|Significant Protocol Deviation|2|||
124626676|NCT02729909|448248128|FG000|Overall Study|Voluntary Withdrawal|1|||
124626677|NCT02729909|448248129|FG001|Overall Study|Voluntary Withdrawal|0|||
124626678|NCT02046603|448248131|FG000|Overall Study|Other|11|||
124626679|NCT02046603|448248132|FG001|Overall Study|Other|66|||
124626680|NCT02046603|448248131|FG000|Overall Study|Protocol Violation|0|||
124626681|NCT02046603|448248132|FG001|Overall Study|Protocol Violation|1|||
124626682|NCT02046603|448248131|FG000|Overall Study|Participant/legal guardian decision|1|||
124626683|NCT02046603|448248132|FG001|Overall Study|Participant/legal guardian decision|3|||
124626684|NCT02046603|448248131|FG000|Overall Study|Physician Decision|2|||
124626685|NCT02046603|448248132|FG001|Overall Study|Physician Decision|1|||
124626686|NCT02046603|448248131|FG000|Overall Study|Lost to Follow-up|1|||
124626687|NCT02046603|448248132|FG001|Overall Study|Lost to Follow-up|2|||
124626688|NCT02046603|448248131|FG000|Overall Study|Death|0|||
124626689|NCT02046603|448248132|FG001|Overall Study|Death|1|||
124626690|NCT02046603|448248131|FG000|Overall Study|Adverse Event|0|||
124626691|NCT02046603|448248132|FG001|Overall Study|Adverse Event|1|||
124626692|NCT05101343|448248133|FG000|Overall Study|Withdrawal by Subject|2|||
124626693|NCT05101343|448248134|FG001|Overall Study|Withdrawal by Subject|1|||
124626694|NCT02461160|448248135|FG000|Overall Study|Lost to Follow-up|0|||
124626695|NCT02461160|448248136|FG001|Overall Study|Lost to Follow-up|0|||
124626696|NCT02461160|448248137|FG002|Overall Study|Lost to Follow-up|0|||
124626697|NCT02461160|448248138|FG003|Overall Study|Lost to Follow-up|0|||
124626698|NCT02461160|448248139|FG004|Overall Study|Lost to Follow-up|0|||
124626699|NCT02461160|448248140|FG005|Overall Study|Lost to Follow-up|0|||
124626700|NCT02461160|448248141|FG006|Overall Study|Lost to Follow-up|0|||
124626701|NCT02461160|448248142|FG007|Overall Study|Lost to Follow-up|1|||
124626702|NCT02461160|448248143|FG008|Overall Study|Lost to Follow-up|0|||
124626703|NCT02461160|448248144|FG009|Overall Study|Lost to Follow-up|0|||
124626704|NCT02461160|448248145|FG010|Overall Study|Lost to Follow-up|0|||
124626705|NCT02461160|448248146|FG011|Overall Study|Lost to Follow-up|0|||
124626706|NCT02461160|448248147|FG012|Overall Study|Lost to Follow-up|0|||
124626707|NCT00061932|448248148|FG000|Overall Study|Withdrawal by Subject|13|||
124626708|NCT00061932|448248149|FG001|Overall Study|Withdrawal by Subject|4|||
124626709|NCT02899962|448248150|FG000|Open-label Phase|Adverse Event|2|||
124626710|NCT02899962|448248151|FG001|Open-label Phase|Adverse Event|0|||
124626711|NCT02899962|448248152|FG002|Open-label Phase|Adverse Event|0|||
124788543|NCT03137069|448855847|FG001|Overall Study|Physician Decision|0|||
124788544|NCT03137069|448855848|FG002|Overall Study|Physician Decision|0|||
124626712|NCT02899962|448248150|FG000|Open-label Phase|Lost to Follow-up|9|||
124626713|NCT02899962|448248151|FG001|Open-label Phase|Lost to Follow-up|0|||
124626714|NCT02899962|448248152|FG002|Open-label Phase|Lost to Follow-up|0|||
124626715|NCT02899962|448248150|FG000|Open-label Phase|Other reasons|9|||
124626716|NCT02899962|448248151|FG001|Open-label Phase|Other reasons|0|||
124626717|NCT02899962|448248152|FG002|Open-label Phase|Other reasons|0|||
124626718|NCT02899962|448248150|FG000|Open-label Phase|Withdrawal by Subject|7|||
124626719|NCT02899962|448248151|FG001|Open-label Phase|Withdrawal by Subject|0|||
124626720|NCT02899962|448248152|FG002|Open-label Phase|Withdrawal by Subject|0|||
124626721|NCT02899962|448248150|FG000|Maintenance Phase|Adverse Event|0|||
124626722|NCT02899962|448248151|FG001|Maintenance Phase|Adverse Event|2|||
124626723|NCT02899962|448248152|FG002|Maintenance Phase|Adverse Event|1|||
124626724|NCT02899962|448248150|FG000|Maintenance Phase|Death|0|||
124626725|NCT02899962|448248151|FG001|Maintenance Phase|Death|0|||
124626726|NCT02899962|448248152|FG002|Maintenance Phase|Death|1|||
124626727|NCT02899962|448248150|FG000|Maintenance Phase|Lack of Efficacy|0|||
124626728|NCT02899962|448248151|FG001|Maintenance Phase|Lack of Efficacy|20|||
124626729|NCT02899962|448248152|FG002|Maintenance Phase|Lack of Efficacy|16|||
124626730|NCT02899962|448248150|FG000|Maintenance Phase|Lost to Follow-up|0|||
124626731|NCT02899962|448248151|FG001|Maintenance Phase|Lost to Follow-up|12|||
124626732|NCT02899962|448248152|FG002|Maintenance Phase|Lost to Follow-up|14|||
124626733|NCT02899962|448248150|FG000|Maintenance Phase|Other reasons|0|||
124626734|NCT02899962|448248151|FG001|Maintenance Phase|Other reasons|9|||
124626735|NCT02899962|448248152|FG002|Maintenance Phase|Other reasons|13|||
124626736|NCT02899962|448248150|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
124626737|NCT02899962|448248151|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
124626738|NCT02899962|448248152|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
124626739|NCT02899962|448248150|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
124626740|NCT02899962|448248151|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
124626741|NCT02899962|448248152|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
124626742|NCT02899962|448248150|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124626743|NCT02899962|448248151|FG001|Maintenance Phase|Withdrawal by Subject|30|||
124626744|NCT02899962|448248152|FG002|Maintenance Phase|Withdrawal by Subject|36|||
124626745|NCT01245283|448248153|FG000|Overall Study|Lost to Follow-up|14|||
124626746|NCT01245283|448248154|FG001|Overall Study|Lost to Follow-up|11|||
124626747|NCT01245283|448248155|FG002|Overall Study|Lost to Follow-up|11|||
124626748|NCT01610492|448248162|FG000|Overall Study|Adverse Event|1|||
124626749|NCT01610492|448248162|FG000|Overall Study|Lack of Efficacy|3|||
124626750|NCT01610492|448248162|FG000|Overall Study|Other: Reached stopping criteria|1|||
124626751|NCT01610492|448248162|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
124626752|NCT01982955|448248163|FG000|Overall Study|Randomized but not treated|0|||
124626753|NCT01982955|448248164|FG001|Overall Study|Randomized but not treated|0|||
124626754|NCT01982955|448248165|FG002|Overall Study|Randomized but not treated|0|||
124626755|NCT01982955|448248166|FG003|Overall Study|Randomized but not treated|1|||
124626756|NCT01982955|448248167|FG004|Overall Study|Randomized but not treated|0|||
124626757|NCT00768248|448248170|FG000|Overall Study|Research coordinator didn't collect data|1|||
124626758|NCT00768248|448248171|FG001|Overall Study|Research coordinator didn't collect data|1|||
124626759|NCT01547390|448248172|FG000|Overall Study|Withdrawal by Subject|10|||
124626760|NCT01547390|448248173|FG001|Overall Study|Withdrawal by Subject|7|||
124626761|NCT01547390|448248172|FG000|Overall Study|termination of pregnancy|0|||
124626762|NCT01547390|448248173|FG001|Overall Study|termination of pregnancy|1|||
124626763|NCT01547390|448248172|FG000|Overall Study|Lost to Follow-up|0|||
124626764|NCT01547390|448248173|FG001|Overall Study|Lost to Follow-up|2|||
124626765|NCT01547390|448248172|FG000|Overall Study|Adverse Event|3|||
124626766|NCT01547390|448248173|FG001|Overall Study|Adverse Event|0|||
124626767|NCT01459783|448248174|FG000|Baseline to 6 Months|Death|1|||
124626768|NCT01459783|448248175|FG001|Baseline to 6 Months|Death|0|||
124626769|NCT01459783|448248174|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
124626770|NCT01459783|448248175|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
124626771|NCT01459783|448248174|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
124626772|NCT01459783|448248175|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
124626773|NCT01459783|448248174|FG000|6 Months to 12 Months|Death|0|||
124626774|NCT01459783|448248175|FG001|6 Months to 12 Months|Death|1|||
124626775|NCT01459783|448248174|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
124626776|NCT01459783|448248175|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
124626777|NCT01459783|448248174|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
124626778|NCT01459783|448248175|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
124626779|NCT01459783|448248174|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
124626780|NCT01459783|448248175|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
124626781|NCT00640315|448248176|FG000|Overall Study|Withdrawal by Subject|0|||
124626782|NCT00640315|448248177|FG001|Overall Study|Withdrawal by Subject|1|||
124626783|NCT05201794|448249911|FG000|Overall Study|Withdrawal by Subject|13|||
124626784|NCT05201794|448249912|FG001|Overall Study|Withdrawal by Subject|12|||
124626785|NCT05201794|448249913|FG002|Overall Study|Withdrawal by Subject|14|||
124626786|NCT05201794|448249914|FG003|Overall Study|Withdrawal by Subject|0|||
124626787|NCT05201794|448249911|FG000|Overall Study|Adverse Event|5|||
124626788|NCT05201794|448249912|FG001|Overall Study|Adverse Event|5|||
124626789|NCT05201794|448249913|FG002|Overall Study|Adverse Event|4|||
124626790|NCT05201794|448249914|FG003|Overall Study|Adverse Event|0|||
124626791|NCT05201794|448249911|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
124626792|NCT05201794|448249912|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
124626793|NCT05201794|448249913|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
124626794|NCT05201794|448249914|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
124626795|NCT05201794|448249911|FG000|Overall Study|Non-Compliance With Study Drug|2|||
124626796|NCT05201794|448249912|FG001|Overall Study|Non-Compliance With Study Drug|3|||
124626797|NCT05201794|448249913|FG002|Overall Study|Non-Compliance With Study Drug|3|||
124626798|NCT05201794|448249914|FG003|Overall Study|Non-Compliance With Study Drug|0|||
124626799|NCT05201794|448249911|FG000|Overall Study|Physician Decision|1|||
124626800|NCT05201794|448249912|FG001|Overall Study|Physician Decision|3|||
124626801|NCT05201794|448249913|FG002|Overall Study|Physician Decision|2|||
124626802|NCT05201794|448249914|FG003|Overall Study|Physician Decision|0|||
124626803|NCT05201794|448249911|FG000|Overall Study|Lost to Follow-up|2|||
124626804|NCT05201794|448249912|FG001|Overall Study|Lost to Follow-up|2|||
124626805|NCT05201794|448249913|FG002|Overall Study|Lost to Follow-up|0|||
124626806|NCT05201794|448249914|FG003|Overall Study|Lost to Follow-up|0|||
124626807|NCT05201794|448249911|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
124626808|NCT05201794|448249912|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
124626809|NCT05201794|448249913|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
124626810|NCT05201794|448249914|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
124626811|NCT05201794|448249911|FG000|Overall Study|Protocol Violation|2|||
124626812|NCT05201794|448249912|FG001|Overall Study|Protocol Violation|0|||
124626813|NCT05201794|448249913|FG002|Overall Study|Protocol Violation|1|||
124626814|NCT05201794|448249914|FG003|Overall Study|Protocol Violation|0|||
124626815|NCT05201794|448249911|FG000|Overall Study|Death|1|||
124626816|NCT05201794|448249912|FG001|Overall Study|Death|0|||
124626817|NCT05201794|448249913|FG002|Overall Study|Death|0|||
124626818|NCT05201794|448249914|FG003|Overall Study|Death|0|||
124626819|NCT05201794|448249911|FG000|Overall Study|Site Terminated By Sponsor|0|||
124626820|NCT05201794|448249912|FG001|Overall Study|Site Terminated By Sponsor|1|||
124626821|NCT05201794|448249913|FG002|Overall Study|Site Terminated By Sponsor|0|||
124626822|NCT05201794|448249914|FG003|Overall Study|Site Terminated By Sponsor|0|||
124626823|NCT05201794|448249911|FG000|Overall Study|Other|3|||
124626824|NCT05201794|448249912|FG001|Overall Study|Other|3|||
124626825|NCT05201794|448249913|FG002|Overall Study|Other|3|||
124626826|NCT05201794|448249914|FG003|Overall Study|Other|0|||
124626827|NCT05201794|448249911|FG000|Overall Study|Randomized But Not Treated|1|||
124626828|NCT05201794|448249912|FG001|Overall Study|Randomized But Not Treated|2|||
124626829|NCT05201794|448249913|FG002|Overall Study|Randomized But Not Treated|1|||
124626830|NCT05201794|448249914|FG003|Overall Study|Randomized But Not Treated|0|||
124626831|NCT06082843|448249915|FG000|Overall Study|Withdrawal by Subject|0|||
124626832|NCT06082843|448249916|FG001|Overall Study|Withdrawal by Subject|2|||
124626833|NCT06082843|448249915|FG000|Overall Study|Study terminated by sponsor|12|||
124626834|NCT06082843|448249916|FG001|Overall Study|Study terminated by sponsor|8|||
124626835|NCT00118157|448249920|FG000|Overall Study|Adverse Event|2|||
124626836|NCT00118157|448249920|FG000|Overall Study|Death|8|||
124626837|NCT00118157|448249920|FG000|Overall Study|Withdrawal by Subject|2|||
124626838|NCT05989672|448249921|FG000|Overall Study|Adverse Event|3|||
124626839|NCT05989672|448249922|FG001|Overall Study|Adverse Event|0|||
124626840|NCT05989672|448249923|FG002|Overall Study|Adverse Event|0|||
124626841|NCT00696423|448249924|FG000|Overall Study|Lost to Follow-up|0|||
124626842|NCT00696423|448249925|FG001|Overall Study|Lost to Follow-up|5|||
124626843|NCT00443729|448249926|FG000|Overall Study|Never Treated|0|||
124626844|NCT00443729|448249927|FG001|Overall Study|Never Treated|1|||
124626845|NCT00443729|448249926|FG000|Overall Study|Lack of Efficacy|4|||
124626846|NCT00443729|448249927|FG001|Overall Study|Lack of Efficacy|2|||
124626847|NCT00443729|448249926|FG000|Overall Study|Lost to Follow-up|0|||
124626848|NCT00443729|448249927|FG001|Overall Study|Lost to Follow-up|1|||
124626849|NCT00443729|448249926|FG000|Overall Study|Physician Decision|2|||
124626850|NCT00443729|448249927|FG001|Overall Study|Physician Decision|1|||
124626851|NCT00443729|448249926|FG000|Overall Study|Protocol Violation|1|||
124626852|NCT00443729|448249927|FG001|Overall Study|Protocol Violation|1|||
124626853|NCT00443729|448249926|FG000|Overall Study|Withdrawal by Subject|3|||
124626854|NCT00443729|448249927|FG001|Overall Study|Withdrawal by Subject|1|||
124626855|NCT03989102|448249928|FG000|Year 1|Withdrawal by Subject|6|||
124626856|NCT03989102|448249929|FG001|Year 1|Withdrawal by Subject|2|||
124788545|NCT03137069|448855849|FG003|Overall Study|Physician Decision|1|||
124788546|NCT03137069|448855850|FG004|Overall Study|Physician Decision|0|||
124788547|NCT03137069|448855851|FG005|Overall Study|Physician Decision|0|||
124788548|NCT03137069|448855846|FG000|Overall Study|Study Terminated by Sponsor|0|||
124626857|NCT03989102|448249930|FG002|Year 1|Withdrawal by Subject|7|||
124626858|NCT03989102|448249928|FG000|Year 1|Lost to Follow-up|5|||
124626859|NCT03989102|448249929|FG001|Year 1|Lost to Follow-up|2|||
124626860|NCT03989102|448249930|FG002|Year 1|Lost to Follow-up|5|||
124626861|NCT03989102|448249928|FG000|Year 1|Subject met withdrawal criteria|1|||
124626862|NCT03989102|448249929|FG001|Year 1|Subject met withdrawal criteria|0|||
124788549|NCT03137069|448855847|FG001|Overall Study|Study Terminated by Sponsor|0|||
124626863|NCT03989102|448249930|FG002|Year 1|Subject met withdrawal criteria|1|||
124626864|NCT03989102|448249928|FG000|Year 2|Lost to Follow-up|7|||
124626865|NCT03989102|448249929|FG001|Year 2|Lost to Follow-up|3|||
124626866|NCT03989102|448249930|FG002|Year 2|Lost to Follow-up|4|||
124626867|NCT03989102|448249928|FG000|Year 2|Withdrawal by Subject|3|||
124626868|NCT03989102|448249929|FG001|Year 2|Withdrawal by Subject|1|||
124626869|NCT03989102|448249930|FG002|Year 2|Withdrawal by Subject|2|||
124626870|NCT03989102|448249928|FG000|Year 2|Subject non-compliant|3|||
124626871|NCT03989102|448249929|FG001|Year 2|Subject non-compliant|2|||
124626872|NCT03989102|448249930|FG002|Year 2|Subject non-compliant|0|||
124626873|NCT03989102|448249928|FG000|Year 2|Travel|1|||
124626874|NCT03989102|448249929|FG001|Year 2|Travel|0|||
124626875|NCT03989102|448249930|FG002|Year 2|Travel|1|||
124626876|NCT03989102|448249928|FG000|Year 2|P16 missing|4|||
124626877|NCT03989102|448249929|FG001|Year 2|P16 missing|2|||
124626878|NCT03989102|448249930|FG002|Year 2|P16 missing|1|||
124626879|NCT03989102|448249928|FG000|Year 2|P11 missing|1|||
124626880|NCT03989102|448249929|FG001|Year 2|P11 missing|3|||
124626881|NCT03989102|448249930|FG002|Year 2|P11 missing|7|||
124626882|NCT03989102|448249928|FG000|Year 2|Definitive displacement outside the study site|0|||
124626883|NCT03989102|448249929|FG001|Year 2|Definitive displacement outside the study site|1|||
124626884|NCT03989102|448249930|FG002|Year 2|Definitive displacement outside the study site|0|||
124626885|NCT03989102|448249928|FG000|Year 2|Subject missed last study visit|0|||
124626886|NCT03989102|448249929|FG001|Year 2|Subject missed last study visit|1|||
124626887|NCT03989102|448249930|FG002|Year 2|Subject missed last study visit|0|||
124626888|NCT03989102|448249928|FG000|Year 2|Death|0|||
124626889|NCT03989102|448249929|FG001|Year 2|Death|1|||
124626890|NCT03989102|448249930|FG002|Year 2|Death|0|||
124626891|NCT03989102|448249928|FG000|Year 2|Subject not reachable|0|||
124626892|NCT03989102|448249929|FG001|Year 2|Subject not reachable|0|||
124626893|NCT03989102|448249930|FG002|Year 2|Subject not reachable|1|||
124626894|NCT03989102|448249928|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
124626895|NCT03989102|448249929|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
124626896|NCT03989102|448249930|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
124626897|NCT03989102|448249928|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
124626898|NCT03989102|448249929|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
124626899|NCT03989102|448249930|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
124626900|NCT03989102|448249928|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
124626901|NCT03989102|448249929|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
124626902|NCT03989102|448249930|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
124626903|NCT03989102|448249928|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
124626904|NCT03989102|448249929|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
124626905|NCT03989102|448249930|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
124626906|NCT03989102|448249928|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
124626907|NCT03989102|448249929|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
124626908|NCT03989102|448249930|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
124626909|NCT03989102|448249928|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
124626910|NCT03989102|448249929|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
124626911|NCT03989102|448249930|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
124626912|NCT03642262|448249931|FG000|Period 1|Withdrawal by Subject|1|||
124626913|NCT03642262|448249932|FG001|Period 1|Withdrawal by Subject|1|||
124626914|NCT03642262|448249931|FG000|Period 1|Adverse Event|0|||
124626915|NCT03642262|448249932|FG001|Period 1|Adverse Event|1|||
124626916|NCT01050530|448249942|FG000|Overall Study|Adverse Event|6|||
124626917|NCT01050530|448249943|FG001|Overall Study|Adverse Event|3|||
124626918|NCT01050530|448249942|FG000|Overall Study|Lack of Efficacy|1|||
124626919|NCT01050530|448249943|FG001|Overall Study|Lack of Efficacy|4|||
124626920|NCT01050530|448249942|FG000|Overall Study|Withdrawal by Subject|0|||
124626921|NCT01050530|448249943|FG001|Overall Study|Withdrawal by Subject|3|||
124626922|NCT01050530|448249942|FG000|Overall Study|Protocol Violation|1|||
124626923|NCT01050530|448249943|FG001|Overall Study|Protocol Violation|0|||
124626924|NCT02288312|448249944|FG000|Overall Study|Pregnancy|1|||
124626925|NCT02288312|448249945|FG001|Overall Study|Pregnancy|0|||
124626926|NCT02288312|448249946|FG002|Overall Study|Pregnancy|0|||
124626927|NCT01276041|448249947|FG000|Overall Study|Adverse Event|2|||
124626928|NCT01276041|448249947|FG000|Overall Study|Protocol Violation|1|||
124788550|NCT03137069|448855848|FG002|Overall Study|Study Terminated by Sponsor|0|||
124788551|NCT03137069|448855849|FG003|Overall Study|Study Terminated by Sponsor|0|||
124788552|NCT03137069|448855850|FG004|Overall Study|Study Terminated by Sponsor|1|||
124626929|NCT00485264|448249948|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
124626930|NCT00485264|448249949|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
124626931|NCT00485264|448249950|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
124626932|NCT00485264|448249951|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
124626933|NCT00485264|448249952|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
124626934|NCT00485264|448249953|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
124626935|NCT00485264|448249948|FG000|Overall Study|Death|1|||
124626936|NCT00485264|448249949|FG001|Overall Study|Death|0|||
124626937|NCT00485264|448249950|FG002|Overall Study|Death|0|||
124626938|NCT00485264|448249951|FG003|Overall Study|Death|0|||
124626939|NCT00485264|448249952|FG004|Overall Study|Death|1|||
124626940|NCT00485264|448249953|FG005|Overall Study|Death|0|||
124788553|NCT03137069|448855851|FG005|Overall Study|Study Terminated by Sponsor|0|||
124626941|NCT00485264|448249948|FG000|Overall Study|Adverse Event|1|||
124626942|NCT00485264|448249949|FG001|Overall Study|Adverse Event|0|||
124626943|NCT00485264|448249950|FG002|Overall Study|Adverse Event|2|||
124626944|NCT00485264|448249951|FG003|Overall Study|Adverse Event|3|||
124626945|NCT00485264|448249952|FG004|Overall Study|Adverse Event|1|||
124626946|NCT00485264|448249953|FG005|Overall Study|Adverse Event|3|||
124626947|NCT00485264|448249948|FG000|Overall Study|Pregnancy|4|||
124626948|NCT00485264|448249949|FG001|Overall Study|Pregnancy|0|||
124788554|NCT03137069|448855846|FG000|Overall Study|Data Entry Error|0|||
124788555|NCT03137069|448855847|FG001|Overall Study|Data Entry Error|0|||
124788556|NCT03137069|448855848|FG002|Overall Study|Data Entry Error|0|||
124788557|NCT03137069|448855849|FG003|Overall Study|Data Entry Error|1|||
124788558|NCT03137069|448855850|FG004|Overall Study|Data Entry Error|0|||
124788559|NCT03137069|448855851|FG005|Overall Study|Data Entry Error|0|||
124788560|NCT02043899|448855853|FG000|Overall Study|Adverse Event|3|||
124788561|NCT02043899|448855853|FG000|Overall Study|Physician Decision|1|||
124788562|NCT02043899|448855853|FG000|Overall Study|Withdrawal by Subject|2|||
124788563|NCT02043899|448855853|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
124788564|NCT02043899|448855853|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
124788565|NCT02043899|448855853|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
124788566|NCT02043899|448855853|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
124788567|NCT02043899|448855853|FG000|Overall Study|Treatment delayed|1|||
124788568|NCT01954927|448855854|FG000|Overall Study|Withdrawal by Subject|3|||
124788569|NCT01954927|448855855|FG001|Overall Study|Withdrawal by Subject|1|||
124788570|NCT03320824|448855856|FG000|Overall Study|Withdrawal by Subject|8|||
124626949|NCT00485264|448249950|FG002|Overall Study|Pregnancy|0|||
124626950|NCT00485264|448249951|FG003|Overall Study|Pregnancy|0|||
124626951|NCT00485264|448249952|FG004|Overall Study|Pregnancy|0|||
124626952|NCT00485264|448249953|FG005|Overall Study|Pregnancy|0|||
124626953|NCT00485264|448249948|FG000|Overall Study|Disallowed Medication|0|||
124626954|NCT00485264|448249949|FG001|Overall Study|Disallowed Medication|0|||
124626955|NCT00485264|448249950|FG002|Overall Study|Disallowed Medication|0|||
124626956|NCT00485264|448249951|FG003|Overall Study|Disallowed Medication|0|||
124626957|NCT00485264|448249952|FG004|Overall Study|Disallowed Medication|0|||
124626958|NCT00485264|448249953|FG005|Overall Study|Disallowed Medication|1|||
124626959|NCT00485264|448249948|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
124626960|NCT00485264|448249949|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
124626961|NCT00485264|448249950|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
124626962|NCT00485264|448249951|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
124626963|NCT00485264|448249952|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
124626964|NCT00485264|448249953|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
124626965|NCT00485264|448249948|FG000|Overall Study|Lack of Efficacy|0|||
124626966|NCT00485264|448249949|FG001|Overall Study|Lack of Efficacy|1|||
124626967|NCT00485264|448249950|FG002|Overall Study|Lack of Efficacy|0|||
124626968|NCT00485264|448249951|FG003|Overall Study|Lack of Efficacy|0|||
124626969|NCT00485264|448249952|FG004|Overall Study|Lack of Efficacy|0|||
124626970|NCT00485264|448249953|FG005|Overall Study|Lack of Efficacy|0|||
124626971|NCT00485264|448249948|FG000|Overall Study|Guardian Consent Withdrawn|1|||
124626972|NCT00485264|448249949|FG001|Overall Study|Guardian Consent Withdrawn|0|||
124626973|NCT00485264|448249950|FG002|Overall Study|Guardian Consent Withdrawn|0|||
124626974|NCT00485264|448249951|FG003|Overall Study|Guardian Consent Withdrawn|0|||
124626975|NCT00485264|448249952|FG004|Overall Study|Guardian Consent Withdrawn|1|||
124626976|NCT00485264|448249953|FG005|Overall Study|Guardian Consent Withdrawn|0|||
124626977|NCT00485264|448249948|FG000|Overall Study|Physician Decision|0|||
124626978|NCT00485264|448249949|FG001|Overall Study|Physician Decision|2|||
124626979|NCT00485264|448249950|FG002|Overall Study|Physician Decision|0|||
124626980|NCT00485264|448249951|FG003|Overall Study|Physician Decision|0|||
124626981|NCT00485264|448249952|FG004|Overall Study|Physician Decision|0|||
124626982|NCT00485264|448249953|FG005|Overall Study|Physician Decision|0|||
124626983|NCT00485264|448249948|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
124626984|NCT00485264|448249949|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
124626985|NCT00485264|448249950|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
124626986|NCT00485264|448249951|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
124626987|NCT00485264|448249952|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
124626988|NCT00485264|448249953|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
124626989|NCT00485264|448249948|FG000|Overall Study|Not Able to Attend Clinic|5|||
124626990|NCT00485264|448249949|FG001|Overall Study|Not Able to Attend Clinic|0|||
124626991|NCT00485264|448249950|FG002|Overall Study|Not Able to Attend Clinic|0|||
124626992|NCT00485264|448249951|FG003|Overall Study|Not Able to Attend Clinic|1|||
124626993|NCT00485264|448249952|FG004|Overall Study|Not Able to Attend Clinic|1|||
124626994|NCT00485264|448249953|FG005|Overall Study|Not Able to Attend Clinic|2|||
124626995|NCT00485264|448249948|FG000|Overall Study|Non-Compliant|17|||
124626996|NCT00485264|448249949|FG001|Overall Study|Non-Compliant|2|||
124626997|NCT00485264|448249950|FG002|Overall Study|Non-Compliant|1|||
124626998|NCT00485264|448249951|FG003|Overall Study|Non-Compliant|0|||
124626999|NCT00485264|448249952|FG004|Overall Study|Non-Compliant|1|||
124627000|NCT00485264|448249953|FG005|Overall Study|Non-Compliant|0|||
124627001|NCT00485264|448249948|FG000|Overall Study|Lost to Follow-up|2|||
124627002|NCT00485264|448249949|FG001|Overall Study|Lost to Follow-up|1|||
124627003|NCT00485264|448249950|FG002|Overall Study|Lost to Follow-up|1|||
124627004|NCT00485264|448249951|FG003|Overall Study|Lost to Follow-up|0|||
124627005|NCT00485264|448249952|FG004|Overall Study|Lost to Follow-up|0|||
124627006|NCT00485264|448249953|FG005|Overall Study|Lost to Follow-up|1|||
124627007|NCT00485264|448249948|FG000|Overall Study|Other Reason|3|||
124627008|NCT00485264|448249949|FG001|Overall Study|Other Reason|0|||
124627009|NCT00485264|448249950|FG002|Overall Study|Other Reason|0|||
124627010|NCT00485264|448249951|FG003|Overall Study|Other Reason|0|||
124627011|NCT00485264|448249952|FG004|Overall Study|Other Reason|0|||
124627012|NCT00485264|448249953|FG005|Overall Study|Other Reason|0|||
124627013|NCT00276484|448249954|FG000|Overall Study|Adverse Event|4|||
124627014|NCT00276484|448249955|FG001|Overall Study|Adverse Event|7|||
124627015|NCT00276484|448249954|FG000|Overall Study|Lost to Follow-up|1|||
124627016|NCT00276484|448249955|FG001|Overall Study|Lost to Follow-up|1|||
124627017|NCT00276484|448249954|FG000|Overall Study|Protocol Violation|0|||
124627018|NCT00276484|448249955|FG001|Overall Study|Protocol Violation|1|||
124627019|NCT00276484|448249954|FG000|Overall Study|Withdrawal by Subject|4|||
124627020|NCT00276484|448249955|FG001|Overall Study|Withdrawal by Subject|3|||
124627021|NCT00276484|448249954|FG000|Overall Study|Could not take time off work|0|||
124627022|NCT00276484|448249955|FG001|Overall Study|Could not take time off work|1|||
124627023|NCT02440464|448249956|FG000|Overall Study|Withdrawal by Subject|3|||
124627024|NCT02440464|448249957|FG001|Overall Study|Withdrawal by Subject|2|||
124627025|NCT01626690|448249958|FG000|Overall Study|Protocol Violation|1|||
124627026|NCT01626690|448249959|FG001|Overall Study|Protocol Violation|0|||
124627027|NCT01626690|448249958|FG000|Overall Study|Adverse Event|1|||
124627028|NCT01626690|448249959|FG001|Overall Study|Adverse Event|0|||
124627029|NCT04688671|448249960|FG000|Overall Study|Adverse Event|3|||
124627030|NCT04688671|448249961|FG001|Overall Study|Adverse Event|1|||
124627031|NCT04688671|448249960|FG000|Overall Study|Withdrawal by Subject|3|||
124627032|NCT04688671|448249961|FG001|Overall Study|Withdrawal by Subject|1|||
124627033|NCT04688671|448249960|FG000|Overall Study|Lack of Efficacy|1|||
124627034|NCT04688671|448249961|FG001|Overall Study|Lack of Efficacy|1|||
124627035|NCT04688671|448249960|FG000|Overall Study|Protocol Violation|1|||
124627036|NCT04688671|448249961|FG001|Overall Study|Protocol Violation|0|||
124627037|NCT04688671|448249960|FG000|Overall Study|Lost to Follow-up|0|||
124627038|NCT04688671|448249961|FG001|Overall Study|Lost to Follow-up|1|||
124627039|NCT02414958|448249964|FG000|Overall Study|Adverse Event|6|||
124627040|NCT02414958|448249965|FG001|Overall Study|Adverse Event|6|||
124627041|NCT02414958|448249966|FG002|Overall Study|Adverse Event|3|||
124627042|NCT02414958|448249964|FG000|Overall Study|Protocol Violation|10|||
124627043|NCT02414958|448249965|FG001|Overall Study|Protocol Violation|3|||
124627044|NCT02414958|448249966|FG002|Overall Study|Protocol Violation|1|||
124627045|NCT02414958|448249964|FG000|Overall Study|Lost to Follow-up|7|||
124627046|NCT02414958|448249965|FG001|Overall Study|Lost to Follow-up|4|||
124627047|NCT02414958|448249966|FG002|Overall Study|Lost to Follow-up|0|||
124627048|NCT02414958|448249964|FG000|Overall Study|Withdrawal by Subject|5|||
124627049|NCT02414958|448249965|FG001|Overall Study|Withdrawal by Subject|3|||
124627050|NCT02414958|448249966|FG002|Overall Study|Withdrawal by Subject|5|||
124627051|NCT02414958|448249964|FG000|Overall Study|Other than specified|4|||
124627052|NCT02414958|448249965|FG001|Overall Study|Other than specified|4|||
124627053|NCT02414958|448249966|FG002|Overall Study|Other than specified|5|||
124627054|NCT01269918|448249967|FG000|Overall Study|Did not receive study drug|0|||
124627055|NCT01269918|448249968|FG001|Overall Study|Did not receive study drug|3|||
124627056|NCT03571828|448249969|FG000|Overall Study|Withdrawal by Subject|1|||
124627057|NCT03571828|448249970|FG001|Overall Study|Withdrawal by Subject|0|||
124627058|NCT03571828|448249969|FG000|Overall Study|Decision by sponsor|5|||
124627059|NCT03571828|448249970|FG001|Overall Study|Decision by sponsor|1|||
124627060|NCT03571828|448249969|FG000|Overall Study|Death|2|||
124627061|NCT03571828|448249970|FG001|Overall Study|Death|0|||
124627062|NCT05767905|448249973|FG000|Overall Study|Adverse Event|0|||
124788571|NCT03320824|448855857|FG001|Overall Study|Withdrawal by Subject|1|||
124788572|NCT03320824|448855856|FG000|Overall Study|Lost to Follow-up|10|||
124627063|NCT05767905|448249974|FG001|Overall Study|Adverse Event|0|||
124627064|NCT05767905|448249975|FG002|Overall Study|Adverse Event|1|||
124627065|NCT03762239|448249976|FG000|Overall Study|Appointment to the doctor|1|||
124627066|NCT03762239|448249977|FG001|Overall Study|Appointment to the doctor|1|||
124627067|NCT04471428|448249978|FG000|Overall Study|Withdrawal by Subject|29|||
124627068|NCT04471428|448249979|FG001|Overall Study|Withdrawal by Subject|1|||
124627069|NCT04471428|448249978|FG000|Overall Study|Physician Decision|0|||
124627070|NCT04471428|448249979|FG001|Overall Study|Physician Decision|1|||
124627071|NCT04471428|448249978|FG000|Overall Study|Reason Not Specified|0|||
124627072|NCT04471428|448249979|FG001|Overall Study|Reason Not Specified|2|||
124627073|NCT04471428|448249978|FG000|Overall Study|Death|106|||
124627074|NCT04471428|448249979|FG001|Overall Study|Death|114|||
124627075|NCT04471428|448249978|FG000|Overall Study|Ongoing in the study|45|||
124627076|NCT04471428|448249979|FG001|Overall Study|Ongoing in the study|68|||
124627077|NCT03645863|448249980|FG000|Overall Study|Withdrawal by Subject|1|||
124627078|NCT03645863|448249981|FG001|Overall Study|Withdrawal by Subject|0|||
124627079|NCT03645863|448249982|FG002|Overall Study|Withdrawal by Subject|0|||
124627080|NCT04660331|448249994|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
124627081|NCT04660331|448249995|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
124627082|NCT04660331|448249996|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
124627083|NCT03624192|448250001|FG000|Overall Study|Lost to Follow-up|1|||
124627084|NCT03624192|448250002|FG001|Overall Study|Lost to Follow-up|1|||
124627085|NCT02635984|448250003|FG000|Overall Study|Lost to Follow-up|2|||
124627086|NCT02635984|448250004|FG001|Overall Study|Lost to Follow-up|4|||
124627087|NCT02635984|448250003|FG000|Overall Study|Study Arm Closed|1|||
124627088|NCT02635984|448250004|FG001|Overall Study|Study Arm Closed|0|||
124627089|NCT01640249|448250005|FG000|Period 1|Withdrawal by Subject|1|||
124627090|NCT01640249|448250006|FG001|Period 1|Withdrawal by Subject|0|||
124627091|NCT01640249|448250007|FG002|Period 1|Withdrawal by Subject|0|||
124627092|NCT01640249|448250008|FG003|Period 1|Withdrawal by Subject|0|||
124627093|NCT01640249|448250009|FG004|Period 1|Withdrawal by Subject|0|||
124627094|NCT01640249|448250010|FG005|Period 1|Withdrawal by Subject|1|||
124627095|NCT01640249|448250011|FG006|Period 1|Withdrawal by Subject|0|||
124627096|NCT01870778|448250016|FG000|Overall Study|Withdrawal by Subject|8|||
124627097|NCT01870778|448250017|FG001|Overall Study|Withdrawal by Subject|7|||
124627098|NCT01870778|448250016|FG000|Overall Study|Lost to Follow-up|0|||
124627099|NCT01870778|448250017|FG001|Overall Study|Lost to Follow-up|2|||
124627100|NCT00613171|448250022|FG000|Overall Study|Adverse Event|7|||
124627101|NCT00613171|448250022|FG000|Overall Study|Withdrawal by Subject|3|||
124627102|NCT00613171|448250022|FG000|Overall Study|Reason not Specified|4|||
124627103|NCT00951496|448250023|FG000|Overall Study|Did not initiate study treatment|10|||
124627104|NCT00951496|448250024|FG001|Overall Study|Did not initiate study treatment|8|||
124627105|NCT00951496|448250025|FG002|Overall Study|Did not initiate study treatment|13|||
124627106|NCT00786409|448250029|FG000|Overall Study|Withdrawal by Subject|2|||
124627107|NCT00786409|448250029|FG000|Overall Study|Adverse Event|2|||
124627108|NCT00786409|448250029|FG000|Overall Study|Pregnancy|2|||
124627109|NCT00786409|448250029|FG000|Overall Study|Lost to Follow-up|1|||
124627110|NCT00610129|448250030|FG000|Overall Study|Not treated since patients ineligible|3|||
124627111|NCT01184079|448250036|FG000|Overall Study|Lost to Follow-up|14|||
124627112|NCT01184079|448250037|FG001|Overall Study|Lost to Follow-up|2|||
124627113|NCT02905032|448250039|FG000|Overall Study|Withdrawal by Subject|2|||
124627114|NCT02905032|448250040|FG001|Overall Study|Withdrawal by Subject|0|||
124627115|NCT02905032|448250041|FG002|Overall Study|Withdrawal by Subject|0|||
124627116|NCT02905032|448250039|FG000|Overall Study|Protocol Violation|6|||
124627117|NCT02905032|448250040|FG001|Overall Study|Protocol Violation|12|||
124627118|NCT02905032|448250041|FG002|Overall Study|Protocol Violation|0|||
124627119|NCT00193050|448250047|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
124627120|NCT00193050|448250047|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
124627121|NCT00193050|448250047|FG000|Neoadjuvant Treatment|Physician Decision|2|||
124627122|NCT00193050|448250047|FG000|Neoadjuvant Treatment|Adverse Event|2|||
124627123|NCT00193050|448250047|FG000|Adjuvant|Physician Decision|5|||
124627124|NCT00193050|448250047|FG000|Adjuvant|Intercurrent Hospitalization|3|||
124627125|NCT00193050|448250047|FG000|Adjuvant|Lack of Efficacy|2|||
124627126|NCT00866359|448250050|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
124627127|NCT00866359|448250051|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
124627128|NCT00866359|448250052|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
124627129|NCT00866359|448250053|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
124627130|NCT00866359|448250050|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
124627131|NCT00866359|448250051|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
124627132|NCT00866359|448250052|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
124627133|NCT00866359|448250053|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
124627134|NCT00866359|448250050|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
124627135|NCT00866359|448250051|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
124627136|NCT00866359|448250052|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
124627137|NCT00866359|448250053|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
124627138|NCT00866359|448250050|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
124627139|NCT00866359|448250051|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
124627140|NCT00866359|448250052|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
124627141|NCT00866359|448250053|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
124627142|NCT00866359|448250050|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
124627143|NCT00866359|448250051|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
124627144|NCT00866359|448250052|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
124627145|NCT00866359|448250053|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
124788573|NCT03320824|448855857|FG001|Overall Study|Lost to Follow-up|1|||
124627146|NCT00866359|448250050|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
124627147|NCT00866359|448250051|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
124627148|NCT00866359|448250052|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
124788574|NCT03320824|448855856|FG000|Overall Study|moved out of state|0|||
124627149|NCT00866359|448250053|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
124627150|NCT00550459|448250054|FG000|Overall Study|Adverse Event|0|||
124627151|NCT00550459|448250055|FG001|Overall Study|Adverse Event|2|||
124627152|NCT00550459|448250054|FG000|Overall Study|Withdrawal by Subject|1|||
124627153|NCT00550459|448250055|FG001|Overall Study|Withdrawal by Subject|1|||
124627154|NCT01625091|448250056|FG000|Intervention|Death|1|||
124627155|NCT01625091|448250057|FG001|Intervention|Death|1|||
124627156|NCT01625091|448250056|FG000|Intervention|Withdrawal by Subject|4|||
124788575|NCT03320824|448855857|FG001|Overall Study|moved out of state|1|||
124627157|NCT01625091|448250057|FG001|Intervention|Withdrawal by Subject|1|||
124627158|NCT01625091|448250056|FG000|Intervention|Adverse Event|0|||
124627159|NCT01625091|448250057|FG001|Intervention|Adverse Event|2|||
124627160|NCT01625091|448250056|FG000|Intervention|Lost to Follow-up|4|||
124627161|NCT01625091|448250057|FG001|Intervention|Lost to Follow-up|4|||
124627162|NCT01625091|448250056|FG000|Intervention|Study termination|2|||
124627163|NCT01625091|448250057|FG001|Intervention|Study termination|3|||
124627164|NCT01625091|448250056|FG000|Post-intervention|Death|0|||
124627165|NCT01625091|448250057|FG001|Post-intervention|Death|1|||
124627166|NCT01625091|448250056|FG000|Post-intervention|Lost to Follow-up|2|||
124627167|NCT01625091|448250057|FG001|Post-intervention|Lost to Follow-up|0|||
124627168|NCT01625091|448250056|FG000|Post-intervention|Study termination|2|||
124627169|NCT01625091|448250057|FG001|Post-intervention|Study termination|1|||
124627170|NCT02163057|448250058|FG000|Overall Study|Participant Refusal to Continue|2|||
124627171|NCT02163057|448250059|FG001|Overall Study|Participant Refusal to Continue|2|||
124627172|NCT02163057|448250058|FG000|Overall Study|Participant Significant Noncompliance|0|||
124627173|NCT02163057|448250059|FG001|Overall Study|Participant Significant Noncompliance|1|||
124627174|NCT02163057|448250058|FG000|Overall Study|Progression of Disease|1|||
124627175|NCT02163057|448250059|FG001|Overall Study|Progression of Disease|2|||
124627176|NCT00445146|448250060|FG000|Overall Study|Withdrew Consent|29|||
124627177|NCT00445146|448250060|FG000|Overall Study|Lack of Efficacy|28|||
124627178|NCT00445146|448250060|FG000|Overall Study|Investigator's Discretion|22|||
124627179|NCT00445146|448250060|FG000|Overall Study|Adverse Event|13|||
124627180|NCT00445146|448250060|FG000|Overall Study|Lost to Follow-up|13|||
124627181|NCT00445146|448250060|FG000|Overall Study|Death|9|||
124627182|NCT00445146|448250060|FG000|Overall Study|Protocol Violation|4|||
124627183|NCT00445146|448250060|FG000|Overall Study|Pregnancy|1|||
124627184|NCT00625820|448250061|FG000|Overall Study|Withdrawal by Subject|1|||
124627185|NCT03759392|448250063|FG000|Overall Study|Adverse Event|12|||
124627186|NCT03759392|448250064|FG001|Overall Study|Adverse Event|4|||
124627187|NCT03759392|448250063|FG000|Overall Study|Death|2|||
124627188|NCT03759392|448250064|FG001|Overall Study|Death|1|||
124627189|NCT03759392|448250063|FG000|Overall Study|Withdrawal by Subject|2|||
124627190|NCT03759392|448250064|FG001|Overall Study|Withdrawal by Subject|0|||
124627191|NCT03759392|448250063|FG000|Overall Study|Protocol Violation|2|||
124627192|NCT03759392|448250064|FG001|Overall Study|Protocol Violation|0|||
124627193|NCT03759392|448250063|FG000|Overall Study|Physician Decision|0|||
124627194|NCT03759392|448250064|FG001|Overall Study|Physician Decision|1|||
124627195|NCT03759392|448250063|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
124627196|NCT03759392|448250064|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
124627197|NCT03759392|448250063|FG000|Overall Study|No longer able to take medicines|1|||
124627198|NCT03759392|448250064|FG001|Overall Study|No longer able to take medicines|0|||
124627199|NCT03759392|448250063|FG000|Overall Study|Stopped taking study drug|1|||
124627200|NCT03759392|448250064|FG001|Overall Study|Stopped taking study drug|0|||
124627201|NCT02623725|448250065|FG000|Overall Study|Non compliance with protocol|9|||
124627202|NCT02623725|448250066|FG001|Overall Study|Non compliance with protocol|3|||
124627203|NCT02623725|448250065|FG000|Overall Study|Serious adverse event|0|||
124627204|NCT02623725|448250066|FG001|Overall Study|Serious adverse event|2|||
124627205|NCT02623725|448250065|FG000|Overall Study|Withdrawal by Subject|7|||
124627206|NCT02623725|448250066|FG001|Overall Study|Withdrawal by Subject|1|||
124627207|NCT02548143|448250067|FG000|Overall Study|Adverse Event|1|||
124627208|NCT02548143|448250068|FG001|Overall Study|Adverse Event|0|||
124627209|NCT02548143|448250067|FG000|Overall Study|Withdrawal by Subject|0|||
124627210|NCT02548143|448250068|FG001|Overall Study|Withdrawal by Subject|1|||
124627211|NCT02603146|448252123|FG000|Overall Study|Lost to Follow-up|5|||
124627212|NCT02603146|448252124|FG001|Overall Study|Lost to Follow-up|6|||
124627213|NCT02603146|448252123|FG000|Overall Study|Withdrawal by Subject|8|||
124627214|NCT02603146|448252124|FG001|Overall Study|Withdrawal by Subject|10|||
124627215|NCT02603146|448252123|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
124627216|NCT02603146|448252124|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
124627217|NCT02603146|448252123|FG000|Overall Study|Participant moved|2|||
124627218|NCT02603146|448252124|FG001|Overall Study|Participant moved|0|||
124627219|NCT02603146|448252123|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
124627220|NCT02603146|448252124|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
124627221|NCT04452669|448252126|FG000|Overall Study|Death|1|||
124627222|NCT04452669|448252127|FG001|Overall Study|Death|4|||
124627223|NCT04653454|448252132|FG000|Overall Study|Withdrawal by Subject|1|||
124627224|NCT04653454|448252132|FG000|Overall Study|Physician Decision|40|||
124627225|NCT03620708|448252133|FG000|Overall Study|Lost to Follow-up|1|||
124627226|NCT03620708|448252134|FG001|Overall Study|Lost to Follow-up|1|||
124627227|NCT03620708|448252135|FG002|Overall Study|Lost to Follow-up|2|||
124627228|NCT03620708|448252133|FG000|Overall Study|Withdrawal by Subject|0|||
124627229|NCT03620708|448252134|FG001|Overall Study|Withdrawal by Subject|0|||
124627230|NCT03620708|448252135|FG002|Overall Study|Withdrawal by Subject|1|||
124627231|NCT05525520|448252136|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
124627232|NCT05525520|448252137|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
124627233|NCT05525520|448252136|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
124627234|NCT05525520|448252137|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
124627235|NCT03176134|448252138|FG000|Overall Study|Lost to Follow-up|0|||
124627236|NCT03176134|448252139|FG001|Overall Study|Lost to Follow-up|2|||
124627237|NCT03176134|448252140|FG002|Overall Study|Lost to Follow-up|0|||
124627238|NCT03176134|448252141|FG003|Overall Study|Lost to Follow-up|0|||
124627239|NCT03176134|448252142|FG004|Overall Study|Lost to Follow-up|0|||
124627240|NCT03176134|448252143|FG005|Overall Study|Lost to Follow-up|0|||
124627241|NCT03176134|448252144|FG006|Overall Study|Lost to Follow-up|0|||
124627242|NCT03176134|448252145|FG007|Overall Study|Lost to Follow-up|0|||
124627243|NCT03176134|448252138|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
124627244|NCT03176134|448252139|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124627245|NCT03176134|448252140|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
124627246|NCT03176134|448252141|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
124627247|NCT03176134|448252142|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
124627248|NCT03176134|448252143|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
124627249|NCT03176134|448252144|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
124627250|NCT03176134|448252145|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
124627251|NCT03657797|448252146|FG000|Overall Study|Lost to Follow-up|0|||
124627252|NCT03657797|448252147|FG001|Overall Study|Lost to Follow-up|1|||
124627253|NCT03657797|448252148|FG002|Overall Study|Lost to Follow-up|1|||
124627254|NCT03657797|448252149|FG003|Overall Study|Lost to Follow-up|0|||
124627255|NCT03657797|448252146|FG000|Overall Study|Physician Decision|0|||
124627256|NCT03657797|448252147|FG001|Overall Study|Physician Decision|1|||
124627257|NCT03657797|448252148|FG002|Overall Study|Physician Decision|0|||
124627258|NCT03657797|448252149|FG003|Overall Study|Physician Decision|0|||
124788576|NCT03320824|448855856|FG000|Overall Study|could not complete final visit|0|||
124788577|NCT03320824|448855857|FG001|Overall Study|could not complete final visit|1|||
124788578|NCT00955305|448855858|FG000|Overall Study|Disease progression|39|||
124788579|NCT00955305|448855859|FG001|Overall Study|Disease progression|41|||
124788580|NCT00955305|448855858|FG000|Overall Study|Adverse Event|22|||
124788581|NCT00955305|448855859|FG001|Overall Study|Adverse Event|22|||
124627259|NCT03657797|448252146|FG000|Overall Study|Withdrawal by Subject|0|||
124627260|NCT03657797|448252147|FG001|Overall Study|Withdrawal by Subject|1|||
124627261|NCT03657797|448252148|FG002|Overall Study|Withdrawal by Subject|2|||
124627262|NCT03657797|448252149|FG003|Overall Study|Withdrawal by Subject|0|||
124627263|NCT03657797|448252146|FG000|Overall Study|Adverse Event|0|||
124627264|NCT03657797|448252147|FG001|Overall Study|Adverse Event|0|||
124627265|NCT03657797|448252148|FG002|Overall Study|Adverse Event|2|||
124627266|NCT03657797|448252149|FG003|Overall Study|Adverse Event|0|||
124627267|NCT02760004|448252150|FG000|Overall Study|Lost to Follow-up|13|||
124627268|NCT02760004|448252151|FG001|Overall Study|Lost to Follow-up|22|||
124627269|NCT00654095|448252158|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
124627270|NCT00654095|448252158|FG000|Overall Study|Elevated triglyceride level (2)|1|||
124627271|NCT00654095|448252158|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
124627272|NCT00654095|448252158|FG000|Overall Study|Adverse Event|11|||
124627273|NCT00654095|448252158|FG000|Overall Study|Withdrawal by Subject|5|||
124627274|NCT00654095|448252158|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
124627275|NCT00654095|448252158|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
124627276|NCT00654095|448252158|FG000|Overall Study|Did not meet inclusion criteria|1|||
124627277|NCT01431079|448252159|FG000|Overall Study|Lost to Follow-up|35|||
124627278|NCT01431079|448252160|FG001|Overall Study|Lost to Follow-up|39|||
124627279|NCT03565900|448252161|FG000|Overall Study|Disposition Unknown|4|||
124627280|NCT03565900|448252162|FG001|Overall Study|Disposition Unknown|1|||
124627281|NCT03565900|448252161|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
124627282|NCT03565900|448252162|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
124627283|NCT03565900|448252161|FG000|Overall Study|Withdrawal by Subject|4|||
124788582|NCT00955305|448855858|FG000|Overall Study|Death|2|||
124788583|NCT00955305|448855859|FG001|Overall Study|Death|1|||
124788584|NCT00955305|448855858|FG000|Overall Study|Withdrawal by Subject|5|||
124788585|NCT00955305|448855859|FG001|Overall Study|Withdrawal by Subject|4|||
124627284|NCT03565900|448252162|FG001|Overall Study|Withdrawal by Subject|5|||
124627285|NCT03565900|448252161|FG000|Overall Study|Randomized By Mistake|0|||
124627286|NCT03565900|448252162|FG001|Overall Study|Randomized By Mistake|2|||
124627287|NCT03565900|448252161|FG000|Overall Study|Physician Decision|7|||
124627288|NCT03565900|448252162|FG001|Overall Study|Physician Decision|11|||
124627289|NCT03565900|448252161|FG000|Overall Study|Death|9|||
124627290|NCT03565900|448252162|FG001|Overall Study|Death|7|||
124627291|NCT00100828|448252172|FG000|Overall Study|Physician Decision|6|||
124627292|NCT01215136|448252173|FG000|Overall Study|Adverse Event|2|||
124627293|NCT01215136|448252174|FG001|Overall Study|Adverse Event|9|||
124627294|NCT01215136|448252173|FG000|Overall Study|Disease Progression|3|||
124627295|NCT01215136|448252174|FG001|Overall Study|Disease Progression|14|||
124627296|NCT01215136|448252173|FG000|Overall Study|Symptomatic Deterioration|1|||
124788586|NCT00955305|448855858|FG000|Overall Study|Alternative therapy|4|||
124788587|NCT00955305|448855859|FG001|Overall Study|Alternative therapy|0|||
124788588|NCT00955305|448855858|FG000|Overall Study|Other complicating disease|2|||
124788589|NCT00955305|448855859|FG001|Overall Study|Other complicating disease|4|||
124788590|NCT00955305|448855858|FG000|Overall Study|Physician Decision|1|||
124788591|NCT00955305|448855859|FG001|Overall Study|Physician Decision|0|||
124788592|NCT00955305|448855858|FG000|Overall Study|Continued presence of residual disease|0|||
124788593|NCT00955305|448855859|FG001|Overall Study|Continued presence of residual disease|1|||
124788594|NCT00955305|448855858|FG000|Overall Study|Functional decline|2|||
124788595|NCT00955305|448855859|FG001|Overall Study|Functional decline|0|||
124788596|NCT00955305|448855858|FG000|Overall Study|Maximum response achieved|0|||
124788597|NCT00955305|448855859|FG001|Overall Study|Maximum response achieved|1|||
124788598|NCT00955305|448855858|FG000|Overall Study|Lost to Follow-up|0|||
124788599|NCT00955305|448855859|FG001|Overall Study|Lost to Follow-up|1|||
124788600|NCT00955305|448855858|FG000|Overall Study|No off-treatment reason submitted|1|||
124788601|NCT00955305|448855859|FG001|Overall Study|No off-treatment reason submitted|0|||
124788602|NCT00955305|448855858|FG000|Overall Study|Never started protocol treatment|5|||
124788603|NCT00955305|448855859|FG001|Overall Study|Never started protocol treatment|5|||
124788604|NCT00955305|448855858|FG000|Overall Study|Ineligible|5|||
124788605|NCT00955305|448855859|FG001|Overall Study|Ineligible|7|||
124788606|NCT03387111|448855860|FG000|Overall Study|Progressive Disease|3|||
124788607|NCT03387111|448855860|FG000|Overall Study|Other|1|||
124788608|NCT01325337|448855870|FG000|Overall Study|Adverse Event|0|||
124788609|NCT01325337|448855871|FG001|Overall Study|Adverse Event|2|||
124788610|NCT01325337|448855872|FG002|Overall Study|Adverse Event|2|||
124788611|NCT01325337|448855873|FG003|Overall Study|Adverse Event|1|||
124788612|NCT01325337|448855874|FG004|Overall Study|Adverse Event|2|||
124627297|NCT01215136|448252174|FG001|Overall Study|Symptomatic Deterioration|1|||
124627298|NCT01215136|448252173|FG000|Overall Study|Death|0|||
124627299|NCT01215136|448252174|FG001|Overall Study|Death|2|||
124627300|NCT01215136|448252173|FG000|Overall Study|Withdrawal by Subject|0|||
124627301|NCT01215136|448252174|FG001|Overall Study|Withdrawal by Subject|1|||
124627302|NCT01197911|448252175|FG000|Overall Study|Adverse Event|0|||
124627303|NCT01197911|448252176|FG001|Overall Study|Adverse Event|0|||
124627304|NCT01197911|448252177|FG002|Overall Study|Adverse Event|1|||
124627305|NCT01526057|448252179|FG000|Overall Study|Withdrawal by Subject|3|||
124627306|NCT01526057|448252180|FG001|Overall Study|Withdrawal by Subject|2|||
124627307|NCT01526057|448252181|FG002|Overall Study|Withdrawal by Subject|2|||
124627308|NCT01526057|448252179|FG000|Overall Study|Adverse Event|3|||
124627309|NCT01526057|448252180|FG001|Overall Study|Adverse Event|1|||
124788613|NCT01325337|448855870|FG000|Overall Study|Lost to Follow-up|2|||
124788614|NCT01325337|448855871|FG001|Overall Study|Lost to Follow-up|2|||
124788615|NCT01325337|448855872|FG002|Overall Study|Lost to Follow-up|2|||
124788616|NCT01325337|448855873|FG003|Overall Study|Lost to Follow-up|1|||
124788617|NCT01325337|448855874|FG004|Overall Study|Lost to Follow-up|2|||
124788618|NCT01325337|448855870|FG000|Overall Study|Personal Reasons|2|||
124788619|NCT01325337|448855871|FG001|Overall Study|Personal Reasons|5|||
124788620|NCT01325337|448855872|FG002|Overall Study|Personal Reasons|4|||
124788621|NCT01325337|448855873|FG003|Overall Study|Personal Reasons|8|||
124788622|NCT01325337|448855874|FG004|Overall Study|Personal Reasons|3|||
124788623|NCT01325337|448855870|FG000|Overall Study|Withdrawal by Subject|1|||
124788624|NCT01325337|448855871|FG001|Overall Study|Withdrawal by Subject|0|||
124788625|NCT01325337|448855872|FG002|Overall Study|Withdrawal by Subject|1|||
124788626|NCT01325337|448855873|FG003|Overall Study|Withdrawal by Subject|0|||
124788627|NCT01325337|448855874|FG004|Overall Study|Withdrawal by Subject|1|||
124788628|NCT00362180|448855875|FG000|Treated Period|Withdrawal by Subject|1|||
124788629|NCT00362180|448855876|FG001|Treated Period|Withdrawal by Subject|0|||
124788630|NCT00362180|448855877|FG002|Treated Period|Withdrawal by Subject|0|||
124788631|NCT00362180|448855878|FG003|Treated Period|Withdrawal by Subject|0|||
124788632|NCT00362180|448855879|FG004|Treated Period|Withdrawal by Subject|0|||
124788633|NCT00362180|448855880|FG005|Treated Period|Withdrawal by Subject|0|||
124788634|NCT00362180|448855881|FG006|Treated Period|Withdrawal by Subject|0|||
124788635|NCT00362180|448855882|FG007|Treated Period|Withdrawal by Subject|0|||
124788636|NCT00362180|448855883|FG008|Treated Period|Withdrawal by Subject|0|||
124788637|NCT00362180|448855875|FG000|Treated Period|Adverse Event|0|||
124788638|NCT00362180|448855876|FG001|Treated Period|Adverse Event|0|||
124627310|NCT01526057|448252181|FG002|Overall Study|Adverse Event|1|||
124788639|NCT00362180|448855877|FG002|Treated Period|Adverse Event|0|||
124788640|NCT00362180|448855878|FG003|Treated Period|Adverse Event|0|||
124788641|NCT00362180|448855879|FG004|Treated Period|Adverse Event|0|||
124788642|NCT00362180|448855880|FG005|Treated Period|Adverse Event|1|||
124788643|NCT00362180|448855881|FG006|Treated Period|Adverse Event|0|||
124788644|NCT00362180|448855882|FG007|Treated Period|Adverse Event|1|||
124788645|NCT00362180|448855883|FG008|Treated Period|Adverse Event|0|||
124627311|NCT01526057|448252179|FG000|Overall Study|Death|1|||
124627312|NCT01526057|448252180|FG001|Overall Study|Death|0|||
124627313|NCT01526057|448252181|FG002|Overall Study|Death|0|||
124627314|NCT01526057|448252179|FG000|Overall Study|Lost to Follow-up|1|||
124788646|NCT02434471|448855893|FG000|Overall Study|Physician Decision|9|||
124627315|NCT01526057|448252180|FG001|Overall Study|Lost to Follow-up|0|||
124788647|NCT00369629|448855894|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
124788648|NCT00369629|448855895|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
124788649|NCT00369629|448855896|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
124788650|NCT00369629|448855897|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
124788651|NCT00369629|448855894|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
124788652|NCT00369629|448855895|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
124788653|NCT00369629|448855896|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
124627316|NCT01526057|448252181|FG002|Overall Study|Lost to Follow-up|1|||
124627317|NCT01526057|448252179|FG000|Overall Study|Other|1|||
124627318|NCT01526057|448252180|FG001|Overall Study|Other|0|||
124627319|NCT01526057|448252181|FG002|Overall Study|Other|1|||
124627320|NCT01526057|448252179|FG000|Overall Study|Protocol Violation|0|||
124627321|NCT01526057|448252180|FG001|Overall Study|Protocol Violation|0|||
124627322|NCT01526057|448252181|FG002|Overall Study|Protocol Violation|1|||
124627323|NCT02289729|448252192|FG000|Overall Study|Lack of Efficacy|3|||
124627324|NCT02289729|448252192|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
124627325|NCT02289729|448252192|FG000|Overall Study|Withdrawal by Subject|1|||
124627326|NCT02289729|448252192|FG000|Overall Study|Death|1|||
124627327|NCT04870710|448252197|FG000|Overall Study|Lost to Follow-up|3|||
124627328|NCT05724589|448252198|FG000|Overall Study|Lost to Follow-up|1|||
124627329|NCT01042093|448252204|FG000|Overall Study|Protocol Violation|2|||
124627330|NCT01042093|448252205|FG001|Overall Study|Protocol Violation|2|||
124627331|NCT01042093|448252206|FG002|Overall Study|Protocol Violation|2|||
124627332|NCT01042093|448252207|FG003|Overall Study|Protocol Violation|3|||
124627333|NCT01042093|448252204|FG000|Overall Study|Withdrawal by Subject|0|||
124627334|NCT01042093|448252205|FG001|Overall Study|Withdrawal by Subject|0|||
124752353|NCT02834247|448714332|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
124752354|NCT02834247|448714333|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
124752355|NCT02834247|448714334|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
124752356|NCT02834247|448714335|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
124752357|NCT05111249|448716721|FG000|Overall Study|Lost to Follow-up|0|||
124752358|NCT05111249|448716722|FG001|Overall Study|Lost to Follow-up|2|||
124752359|NCT05111249|448716721|FG000|Overall Study|Physician Decision|0|||
124752360|NCT05111249|448716722|FG001|Overall Study|Physician Decision|1|||
124752361|NCT05111249|448716721|FG000|Overall Study|Participant decision|1|||
124752362|NCT05111249|448716722|FG001|Overall Study|Participant decision|5|||
124752363|NCT05128578|448716723|FG000|Overall Study|Withdrawal by Subject|9|||
124752364|NCT05128578|448716723|FG000|Overall Study|Lost to Follow-up|5|||
124752365|NCT01016600|448716726|FG000|Overall Study|Did not start treatment|1|||
124752366|NCT01016600|448716727|FG001|Overall Study|Did not start treatment|0|||
124752367|NCT01016600|448716728|FG002|Overall Study|Did not start treatment|0|||
124752368|NCT01016600|448716729|FG003|Overall Study|Did not start treatment|0|||
124752369|NCT02679755|448716730|FG000|Overall Study|Death|0|||
124752370|NCT02679755|448716731|FG001|Overall Study|Death|3|||
124752371|NCT02679755|448716730|FG000|Overall Study|Global deterioration of health status|1|||
124752372|NCT02679755|448716731|FG001|Overall Study|Global deterioration of health status|8|||
124752373|NCT02679755|448716730|FG000|Overall Study|Lost to Follow-up|1|||
124752374|NCT02679755|448716731|FG001|Overall Study|Lost to Follow-up|0|||
124752375|NCT02679755|448716730|FG000|Overall Study|Objective progression or relapse|24|||
124752376|NCT02679755|448716731|FG001|Overall Study|Objective progression or relapse|83|||
124752377|NCT02679755|448716730|FG000|Overall Study|Not defined|0|||
124752378|NCT02679755|448716731|FG001|Overall Study|Not defined|2|||
124752379|NCT02679755|448716730|FG000|Overall Study|Withdrawal by participant|6|||
124752380|NCT02679755|448716731|FG001|Overall Study|Withdrawal by participant|3|||
124752381|NCT02679755|448716730|FG000|Overall Study|Adverse Event|1|||
124752382|NCT02679755|448716731|FG001|Overall Study|Adverse Event|4|||
124752383|NCT02679755|448716730|FG000|Overall Study|Adverse events not related to study drug|1|||
124752384|NCT02679755|448716731|FG001|Overall Study|Adverse events not related to study drug|2|||
124752385|NCT02451917|448716734|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
124752386|NCT02451917|448716735|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
124752387|NCT02451917|448716734|FG000|First Intervention (24 Weeks)|Death|0|||
124752388|NCT02451917|448716735|FG001|First Intervention (24 Weeks)|Death|1|||
124752389|NCT02451917|448716734|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
124752390|NCT02451917|448716735|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
124752391|NCT01724866|448716736|FG000|Overall Study|Adverse Event|0|||
124752392|NCT01724866|448716737|FG001|Overall Study|Adverse Event|0|||
124752393|NCT01724866|448716738|FG002|Overall Study|Adverse Event|1|||
124752394|NCT01724866|448716739|FG003|Overall Study|Adverse Event|1|||
124752395|NCT01724866|448716736|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
124752396|NCT01724866|448716737|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
124752397|NCT01724866|448716738|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
124752398|NCT01724866|448716739|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
124752399|NCT01724866|448716736|FG000|Overall Study|Investigator's Discretion|0|||
124627335|NCT01042093|448252206|FG002|Overall Study|Withdrawal by Subject|0|||
124627336|NCT01042093|448252207|FG003|Overall Study|Withdrawal by Subject|1|||
124627337|NCT02273388|448252210|FG000|Overall Study|Adverse Event|0|||
124627338|NCT02273388|448252211|FG001|Overall Study|Adverse Event|0|||
124627339|NCT02273388|448252212|FG002|Overall Study|Adverse Event|0|||
124627340|NCT02273388|448252213|FG003|Overall Study|Adverse Event|0|||
124627341|NCT02273388|448252214|FG004|Overall Study|Adverse Event|0|||
124627342|NCT02273388|448252215|FG005|Overall Study|Adverse Event|0|||
124627343|NCT02273388|448252216|FG006|Overall Study|Adverse Event|1|||
124627344|NCT02273388|448252217|FG007|Overall Study|Adverse Event|2|||
124627345|NCT02273388|448252218|FG008|Overall Study|Adverse Event|0|||
124627346|NCT02273388|448252219|FG009|Overall Study|Adverse Event|0|||
124627347|NCT02273388|448252220|FG010|Overall Study|Adverse Event|0|||
124627348|NCT02273388|448252221|FG011|Overall Study|Adverse Event|0|||
124627349|NCT02273388|448252210|FG000|Overall Study|Adverse Event study disease worse|4|||
124627350|NCT02273388|448252211|FG001|Overall Study|Adverse Event study disease worse|3|||
124627351|NCT02273388|448252212|FG002|Overall Study|Adverse Event study disease worse|3|||
124627352|NCT02273388|448252213|FG003|Overall Study|Adverse Event study disease worse|2|||
124627353|NCT02273388|448252214|FG004|Overall Study|Adverse Event study disease worse|4|||
124627354|NCT02273388|448252215|FG005|Overall Study|Adverse Event study disease worse|3|||
124627355|NCT02273388|448252216|FG006|Overall Study|Adverse Event study disease worse|14|||
124627356|NCT02273388|448252217|FG007|Overall Study|Adverse Event study disease worse|6|||
124627357|NCT02273388|448252218|FG008|Overall Study|Adverse Event study disease worse|6|||
124627358|NCT02273388|448252219|FG009|Overall Study|Adverse Event study disease worse|5|||
124627359|NCT02273388|448252220|FG010|Overall Study|Adverse Event study disease worse|10|||
124627360|NCT02273388|448252221|FG011|Overall Study|Adverse Event study disease worse|1|||
124627361|NCT02273388|448252210|FG000|Overall Study|Sponsor decision|0|||
124627362|NCT02273388|448252211|FG001|Overall Study|Sponsor decision|0|||
124627363|NCT02273388|448252212|FG002|Overall Study|Sponsor decision|0|||
124627364|NCT02273388|448252213|FG003|Overall Study|Sponsor decision|0|||
124627365|NCT02273388|448252214|FG004|Overall Study|Sponsor decision|0|||
124627366|NCT02273388|448252215|FG005|Overall Study|Sponsor decision|0|||
124627367|NCT02273388|448252216|FG006|Overall Study|Sponsor decision|0|||
124627368|NCT02273388|448252217|FG007|Overall Study|Sponsor decision|0|||
124627369|NCT02273388|448252218|FG008|Overall Study|Sponsor decision|0|||
124627370|NCT02273388|448252219|FG009|Overall Study|Sponsor decision|0|||
124627371|NCT02273388|448252220|FG010|Overall Study|Sponsor decision|0|||
124627372|NCT02273388|448252221|FG011|Overall Study|Sponsor decision|1|||
124627373|NCT01256502|448252225|FG000|Overall Study|Had scaffold removed|4|||
124627374|NCT01256502|448252225|FG000|Overall Study|Personal reasons|5|||
124627375|NCT01256502|448252225|FG000|Overall Study|Protocol deviation|1|||
124627376|NCT01523002|448252226|FG000|Period 1|Withdrawal by Subject|1|||
124627377|NCT01523002|448252227|FG001|Period 1|Withdrawal by Subject|3|||
124627378|NCT01523002|448252226|FG000|Period 1|Lost to Follow-up|1|||
124627379|NCT01523002|448252227|FG001|Period 1|Lost to Follow-up|0|||
124627380|NCT01523002|448252226|FG000|Period 1|Adverse Event|0|||
124627381|NCT01523002|448252227|FG001|Period 1|Adverse Event|8|||
124627382|NCT01523002|448252226|FG000|Period 2|Withdrawal by Subject|4|||
124627383|NCT01523002|448252227|FG001|Period 2|Withdrawal by Subject|1|||
124627384|NCT01523002|448252226|FG000|Period 2|Adverse Event|2|||
124627385|NCT01523002|448252227|FG001|Period 2|Adverse Event|5|||
124627386|NCT01523002|448252226|FG000|Period 3|Withdrawal by Subject|1|||
124627387|NCT01523002|448252227|FG001|Period 3|Withdrawal by Subject|0|||
124627388|NCT01523002|448252226|FG000|Period 3|Adverse Event|3|||
124627389|NCT01523002|448252227|FG001|Period 3|Adverse Event|0|||
124627390|NCT03281876|448252228|FG000|Overall Study|Adverse Event|4|||
124627391|NCT03281876|448252229|FG001|Overall Study|Adverse Event|15|||
124627392|NCT03281876|448252228|FG000|Overall Study|Lost to Follow-up|1|||
124627393|NCT03281876|448252229|FG001|Overall Study|Lost to Follow-up|4|||
124627394|NCT03281876|448252228|FG000|Overall Study|Withdrawal by Subject|11|||
124627395|NCT03281876|448252229|FG001|Overall Study|Withdrawal by Subject|15|||
124627396|NCT03281876|448252228|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
124627397|NCT03281876|448252229|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124627398|NCT03281876|448252228|FG000|Overall Study|OTHER|5|||
124627399|NCT03281876|448252229|FG001|Overall Study|OTHER|5|||
124627400|NCT01478373|448252230|FG000|Treatment Phase|Protocol Violation|1|||
124627401|NCT01478373|448252230|FG000|Survival Phase|Adverse Event|8|||
124627402|NCT01478373|448252230|FG000|Survival Phase|Protocol Violation|1|||
124627403|NCT01478373|448252230|FG000|Survival Phase|crossover to another study|2|||
124627404|NCT01478373|448252230|FG000|Survival Phase|Progressive Disease|27|||
124627405|NCT01074944|448252232|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
124627406|NCT01074944|448252233|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
124627407|NCT01074944|448252234|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
124627408|NCT01074944|448252235|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
124627409|NCT01074944|448252236|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
124627410|NCT01074944|448252232|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
124627411|NCT01074944|448252233|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
124627412|NCT01074944|448252234|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
124627413|NCT01074944|448252235|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
124627414|NCT01074944|448252236|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
124627415|NCT01074944|448252232|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
124627416|NCT01074944|448252233|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
124627417|NCT01074944|448252234|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
124627418|NCT01074944|448252235|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
124627419|NCT01074944|448252236|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
124627420|NCT01074944|448252232|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
124627421|NCT01074944|448252233|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
124627422|NCT01074944|448252234|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
124627423|NCT01074944|448252235|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
124627424|NCT01074944|448252236|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
124627425|NCT01074944|448252232|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
124627426|NCT01074944|448252233|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
124627427|NCT01074944|448252234|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
124627428|NCT01074944|448252235|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
124627429|NCT01074944|448252236|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
124627430|NCT01074944|448252232|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
124627431|NCT01074944|448252233|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
124627432|NCT01074944|448252234|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
124627433|NCT01074944|448252235|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
124627434|NCT01074944|448252236|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
124627435|NCT01074944|448252232|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
124627436|NCT01074944|448252233|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
124627437|NCT01074944|448252234|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
124627438|NCT01074944|448252235|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
124627439|NCT01074944|448252236|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
124627440|NCT01074944|448252232|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
124627441|NCT01074944|448252233|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
124627442|NCT01074944|448252234|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
124627443|NCT01074944|448252235|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
124627444|NCT01074944|448252236|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
124627445|NCT01074944|448252232|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
124627446|NCT01074944|448252233|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
124627447|NCT01074944|448252234|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
124627448|NCT01074944|448252235|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
124627449|NCT01074944|448252236|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
124627450|NCT01074944|448252232|FG000|Long Term Treatment|Adverse Event|0|||
124627451|NCT01074944|448252233|FG001|Long Term Treatment|Adverse Event|0|||
124627452|NCT01074944|448252234|FG002|Long Term Treatment|Adverse Event|0|||
124627453|NCT01074944|448252235|FG003|Long Term Treatment|Adverse Event|3|||
124627454|NCT01074944|448252236|FG004|Long Term Treatment|Adverse Event|0|||
124627455|NCT01074944|448252232|FG000|Long Term Treatment|Lost to Follow-up|0|||
124627456|NCT01074944|448252233|FG001|Long Term Treatment|Lost to Follow-up|0|||
124788654|NCT00369629|448855897|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
124627457|NCT01074944|448252234|FG002|Long Term Treatment|Lost to Follow-up|0|||
124627458|NCT01074944|448252235|FG003|Long Term Treatment|Lost to Follow-up|2|||
124627459|NCT01074944|448252236|FG004|Long Term Treatment|Lost to Follow-up|0|||
124627460|NCT01074944|448252232|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
124627461|NCT01074944|448252233|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
124627462|NCT01074944|448252234|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
124627463|NCT01074944|448252235|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
124627464|NCT01074944|448252236|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
124788655|NCT00369629|448855894|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
124788656|NCT00369629|448855895|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
124788657|NCT00369629|448855896|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
124627465|NCT01074944|448252232|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
124627466|NCT01074944|448252233|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
124627467|NCT01074944|448252234|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
124627468|NCT01074944|448252235|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
124627469|NCT01074944|448252236|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
124627470|NCT01074944|448252232|FG000|Long Term Treatment|Withdrawal by Subject|0|||
124627471|NCT01074944|448252233|FG001|Long Term Treatment|Withdrawal by Subject|0|||
124627472|NCT01074944|448252234|FG002|Long Term Treatment|Withdrawal by Subject|0|||
124627473|NCT01074944|448252235|FG003|Long Term Treatment|Withdrawal by Subject|2|||
124627474|NCT01074944|448252236|FG004|Long Term Treatment|Withdrawal by Subject|0|||
124627475|NCT01074944|448252232|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
124627476|NCT01074944|448252233|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
124627477|NCT01074944|448252234|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
124627478|NCT01074944|448252235|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
124627479|NCT01074944|448252236|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
124627480|NCT01074944|448252232|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
124627481|NCT01074944|448252233|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
124627482|NCT01074944|448252234|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
124627483|NCT01074944|448252235|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
124627484|NCT01074944|448252236|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
124627485|NCT02348112|448252238|FG000|Overall Study|Withdrawal by Subject|32|||
124627486|NCT02348112|448252239|FG001|Overall Study|Withdrawal by Subject|29|||
124627487|NCT02348112|448252238|FG000|Overall Study|Lost to Follow-up|24|||
124627488|NCT02348112|448252239|FG001|Overall Study|Lost to Follow-up|20|||
124627489|NCT02348112|448252238|FG000|Overall Study|Physician Decision|17|||
124627490|NCT02348112|448252239|FG001|Overall Study|Physician Decision|15|||
124627491|NCT02348112|448252238|FG000|Overall Study|Site closed due to PI leaving|0|||
124627492|NCT02348112|448252239|FG001|Overall Study|Site closed due to PI leaving|30|||
124627493|NCT02348112|448252238|FG000|Overall Study|Sponsor withdrawal|0|||
124627494|NCT02348112|448252239|FG001|Overall Study|Sponsor withdrawal|7|||
124627495|NCT02348112|448252238|FG000|Overall Study|Death|0|||
124627496|NCT02348112|448252239|FG001|Overall Study|Death|1|||
124627497|NCT01998841|448252244|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
124627498|NCT01998841|448252245|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
124627499|NCT01998841|448252246|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
124627500|NCT01998841|448252247|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
124627501|NCT01998841|448252248|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
124627502|NCT01998841|448252244|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
124627503|NCT01998841|448252245|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
124627504|NCT01998841|448252246|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
124627505|NCT01998841|448252247|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
124627506|NCT01998841|448252248|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
124627507|NCT02552121|448252249|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
124627508|NCT02552121|448252250|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
124627509|NCT02552121|448252251|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
124627510|NCT02552121|448252252|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
124627511|NCT02552121|448252253|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
124627512|NCT02552121|448252254|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
124627513|NCT02552121|448252255|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
124627514|NCT02552121|448252256|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
124627515|NCT02552121|448252249|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
124627516|NCT02552121|448252250|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
124627517|NCT02552121|448252251|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
124627518|NCT02552121|448252252|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
124627519|NCT02552121|448252253|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
124627520|NCT02552121|448252254|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
124627521|NCT02552121|448252255|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
124627522|NCT02552121|448252256|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
124627523|NCT02552121|448252249|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
124627524|NCT02552121|448252250|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
124627525|NCT02552121|448252251|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
124788658|NCT00369629|448855897|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
124788659|NCT00369629|448855894|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
124627526|NCT02552121|448252252|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
124627527|NCT02552121|448252253|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
124627528|NCT02552121|448252254|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
124627529|NCT02552121|448252255|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
124627530|NCT02552121|448252256|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
124627531|NCT02552121|448252249|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
124627532|NCT02552121|448252250|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
124627533|NCT02552121|448252251|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
124627534|NCT02552121|448252252|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
124627535|NCT02552121|448252253|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
124627536|NCT02552121|448252254|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
124627537|NCT02552121|448252255|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
124627538|NCT02552121|448252256|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
124788660|NCT00369629|448855895|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
124627539|NCT02552121|448252249|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
124627540|NCT02552121|448252250|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
124627541|NCT02552121|448252251|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
124627542|NCT02552121|448252252|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
124627543|NCT02552121|448252253|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
124627544|NCT02552121|448252254|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
124627545|NCT02552121|448252255|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
124627546|NCT02552121|448252256|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
124627547|NCT02552121|448252249|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
124627548|NCT02552121|448252250|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
124627549|NCT02552121|448252251|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
124627550|NCT02552121|448252252|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
124627551|NCT02552121|448252253|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
124627552|NCT02552121|448252254|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
124627553|NCT02552121|448252255|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
124627554|NCT02552121|448252256|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
124627555|NCT02552121|448252249|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
124627556|NCT02552121|448252250|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
124627557|NCT02552121|448252251|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
124627558|NCT02552121|448252252|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
124627559|NCT02552121|448252253|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
124627560|NCT02552121|448252254|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
124627561|NCT02552121|448252255|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
124627562|NCT02552121|448252256|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
124627563|NCT02552121|448252249|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
124627564|NCT02552121|448252250|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
124627565|NCT02552121|448252251|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
124627566|NCT02552121|448252252|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
124627567|NCT02552121|448252253|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
124627568|NCT02552121|448252254|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
124627569|NCT02552121|448252255|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
124627570|NCT02552121|448252256|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
124627571|NCT02552121|448252249|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
124627572|NCT02552121|448252250|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
124627573|NCT02552121|448252251|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
124627574|NCT02552121|448252252|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
124627575|NCT02552121|448252253|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
124627576|NCT02552121|448252254|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
124627577|NCT02552121|448252255|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
124627578|NCT02552121|448252256|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
124627579|NCT02552121|448252249|FG000|Part 2: Cohort Expansion|Death|0|||
124627580|NCT02552121|448252250|FG001|Part 2: Cohort Expansion|Death|0|||
124627581|NCT02552121|448252251|FG002|Part 2: Cohort Expansion|Death|1|||
124627582|NCT02552121|448252252|FG003|Part 2: Cohort Expansion|Death|0|||
124627583|NCT02552121|448252253|FG004|Part 2: Cohort Expansion|Death|0|||
124627584|NCT02552121|448252254|FG005|Part 2: Cohort Expansion|Death|0|||
124627585|NCT02552121|448252255|FG006|Part 2: Cohort Expansion|Death|0|||
124627586|NCT02552121|448252256|FG007|Part 2: Cohort Expansion|Death|0|||
124627587|NCT02854527|448252257|FG000|Overall Study|Adverse Event|0|||
124627588|NCT02854527|448252258|FG001|Overall Study|Adverse Event|0|||
124627589|NCT02854527|448252259|FG002|Overall Study|Adverse Event|0|||
124627590|NCT02854527|448252260|FG003|Overall Study|Adverse Event|0|||
124627591|NCT02854527|448252261|FG004|Overall Study|Adverse Event|1|||
124627592|NCT02854527|448252262|FG005|Overall Study|Adverse Event|0|||
124627593|NCT02854527|448252263|FG006|Overall Study|Adverse Event|0|||
124627594|NCT02854527|448252264|FG007|Overall Study|Adverse Event|0|||
124627595|NCT02854527|448252265|FG008|Overall Study|Adverse Event|0|||
124627596|NCT02854527|448252266|FG009|Overall Study|Adverse Event|0|||
124627597|NCT02854527|448252257|FG000|Overall Study|Lost to Follow-up|0|||
124627598|NCT02854527|448252258|FG001|Overall Study|Lost to Follow-up|0|||
124627599|NCT02854527|448252259|FG002|Overall Study|Lost to Follow-up|0|||
124627600|NCT02854527|448252260|FG003|Overall Study|Lost to Follow-up|1|||
124627601|NCT02854527|448252261|FG004|Overall Study|Lost to Follow-up|0|||
124627602|NCT02854527|448252262|FG005|Overall Study|Lost to Follow-up|0|||
124627603|NCT02854527|448252263|FG006|Overall Study|Lost to Follow-up|0|||
124627604|NCT02854527|448252264|FG007|Overall Study|Lost to Follow-up|0|||
124627605|NCT02854527|448252265|FG008|Overall Study|Lost to Follow-up|0|||
124627606|NCT02854527|448252266|FG009|Overall Study|Lost to Follow-up|0|||
124627607|NCT02575833|448252268|FG000|Overall Study|Withdrawal by Subject|0|||
124627608|NCT02575833|448252269|FG001|Overall Study|Withdrawal by Subject|1|||
124627609|NCT02575833|448252268|FG000|Overall Study|Lost to Follow-up|1|||
124627610|NCT02575833|448252269|FG001|Overall Study|Lost to Follow-up|0|||
124627611|NCT01821807|448252270|FG000|Overall Study|Lost to Follow-up|3|||
124627612|NCT01821807|448252271|FG001|Overall Study|Lost to Follow-up|1|||
124627613|NCT02633787|448252273|FG000|Overall Study|Withdrawal by Subject|1|||
124627614|NCT01742897|448252274|FG000|Overall Study|Adverse Event|3|||
124627615|NCT01742897|448252274|FG000|Overall Study|Withdrawal by Subject|1|||
124627616|NCT01742897|448252274|FG000|Overall Study|Other|1|||
124627617|NCT02404805|448252275|FG000|Overall Study|Withdrawal by Subject|1|||
124627618|NCT02404805|448252276|FG001|Overall Study|Withdrawal by Subject|0|||
124627619|NCT02404805|448252277|FG002|Overall Study|Withdrawal by Subject|0|||
124627620|NCT02404805|448252278|FG003|Overall Study|Withdrawal by Subject|0|||
124627621|NCT02404805|448252279|FG004|Overall Study|Withdrawal by Subject|0|||
124627622|NCT02404805|448252280|FG005|Overall Study|Withdrawal by Subject|0|||
124627623|NCT02601014|448252281|FG000|Overall Study|Adverse Event|3|||
124627624|NCT02601014|448252282|FG001|Overall Study|Adverse Event|3|||
124627625|NCT02601014|448252281|FG000|Overall Study|Death|3|||
124627626|NCT02601014|448252282|FG001|Overall Study|Death|1|||
124627627|NCT02601014|448252281|FG000|Overall Study|Disease progression|4|||
124627628|NCT02601014|448252282|FG001|Overall Study|Disease progression|8|||
124627629|NCT01168427|448252283|FG000|Overall Study|Patient exited prior to implant|1|||
124627630|NCT02456740|448252284|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
124627631|NCT02456740|448252285|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
124627632|NCT02456740|448252286|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
124627633|NCT02456740|448252287|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
124627634|NCT02456740|448252288|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
124627635|NCT02456740|448252289|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
124627636|NCT02456740|448252290|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
124627637|NCT02456740|448252291|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
124627638|NCT02456740|448252292|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
124788661|NCT00369629|448855896|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
124788662|NCT00369629|448855897|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
124788663|NCT00369629|448855894|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
124788664|NCT00369629|448855895|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
124627639|NCT02456740|448252284|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
124627640|NCT02456740|448252285|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
124627641|NCT02456740|448252286|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
124627642|NCT02456740|448252287|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
124627643|NCT02456740|448252288|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
124627644|NCT02456740|448252289|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
124627645|NCT02456740|448252290|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
124627646|NCT02456740|448252291|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
124627647|NCT02456740|448252292|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
124627648|NCT02456740|448252284|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
124627649|NCT02456740|448252285|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
124627650|NCT02456740|448252286|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
124627651|NCT02456740|448252287|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
124627652|NCT02456740|448252288|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
124627653|NCT02456740|448252289|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
124788665|NCT00369629|448855896|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
124627654|NCT02456740|448252290|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
124627655|NCT02456740|448252291|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
124627656|NCT02456740|448252292|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
124627657|NCT02456740|448252284|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
124627658|NCT02456740|448252285|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
124627659|NCT02456740|448252286|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
124627660|NCT02456740|448252287|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
124627661|NCT02456740|448252288|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
124627662|NCT02456740|448252289|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
124627663|NCT02456740|448252290|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
124627664|NCT02456740|448252291|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
124788666|NCT00369629|448855897|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
124788667|NCT00369629|448855894|FG000|Completed 4 More Cycles|Progressive disease|2|||
124788668|NCT00369629|448855895|FG001|Completed 4 More Cycles|Progressive disease|1|||
124788669|NCT00369629|448855896|FG002|Completed 4 More Cycles|Progressive disease|2|||
124788670|NCT00369629|448855897|FG003|Completed 4 More Cycles|Progressive disease|0|||
124627665|NCT02456740|448252292|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
124627666|NCT02456740|448252284|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
124627667|NCT02456740|448252285|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
124627668|NCT02456740|448252286|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
124788671|NCT00369629|448855894|FG000|Follow up for 1 Year|Death|2|||
124788672|NCT00369629|448855895|FG001|Follow up for 1 Year|Death|1|||
124627669|NCT02456740|448252287|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
124627670|NCT02456740|448252288|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
124627671|NCT02456740|448252289|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
124627672|NCT02456740|448252290|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
124627673|NCT02456740|448252291|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
124627674|NCT02456740|448252292|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
124627675|NCT02456740|448252284|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
124627676|NCT02456740|448252285|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
124627677|NCT02456740|448252286|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
124627678|NCT02456740|448252287|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
124627679|NCT02456740|448252288|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
124627680|NCT02456740|448252289|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
124627681|NCT02456740|448252290|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
124627682|NCT02456740|448252291|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
124627683|NCT02456740|448252292|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
124627684|NCT02456740|448252284|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
124627685|NCT02456740|448252285|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
124627686|NCT02456740|448252286|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
124627687|NCT02456740|448252287|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
124627688|NCT02456740|448252288|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
124627689|NCT02456740|448252289|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
124627690|NCT02456740|448252290|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
124627691|NCT02456740|448252291|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
124627692|NCT02456740|448252292|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
124627693|NCT00967330|448252293|FG000|Overall Study|Protocol Violation|3|||
124627694|NCT00967330|448252294|FG001|Overall Study|Protocol Violation|4|||
124627695|NCT00967330|448252293|FG000|Overall Study|Regular|10|||
124627696|NCT00967330|448252294|FG001|Overall Study|Regular|3|||
124627697|NCT00967330|448252293|FG000|Overall Study|Withdrawal by Subject|6|||
124627698|NCT00967330|448252294|FG001|Overall Study|Withdrawal by Subject|0|||
124627699|NCT00967330|448252293|FG000|Overall Study|Lost to Follow-up|1|||
124627700|NCT00967330|448252294|FG001|Overall Study|Lost to Follow-up|1|||
124627701|NCT00967330|448252293|FG000|Overall Study|Death|102|||
124627702|NCT00967330|448252294|FG001|Overall Study|Death|51|||
124627703|NCT00967330|448252293|FG000|Overall Study|Severe protocol deviation|0|||
124627704|NCT00967330|448252294|FG001|Overall Study|Severe protocol deviation|1|||
124627705|NCT05620082|448252300|FG000|Overall Study|Discharged before study end|1|||
124627706|NCT05620082|448252301|FG001|Overall Study|Discharged before study end|4|||
124627707|NCT05620082|448252302|FG002|Overall Study|Discharged before study end|0|||
124627708|NCT05620082|448252300|FG000|Overall Study|Moved to a different ward|1|||
124627709|NCT05620082|448252301|FG001|Overall Study|Moved to a different ward|0|||
124627710|NCT05620082|448252302|FG002|Overall Study|Moved to a different ward|0|||
124627711|NCT05620082|448252300|FG000|Overall Study|Feeling too unwell|1|||
124627712|NCT05620082|448252301|FG001|Overall Study|Feeling too unwell|0|||
124627713|NCT05620082|448252302|FG002|Overall Study|Feeling too unwell|0|||
124627714|NCT00942357|448253699|FG000|Overall Study|Ineligible|37|||
124627715|NCT00942357|448253700|FG001|Overall Study|Ineligible|40|||
124627716|NCT01960257|448253703|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
124627717|NCT01960257|448253704|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
124627718|NCT01960257|448253705|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
124627719|NCT01960257|448253703|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
124627720|NCT01960257|448253704|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
124627721|NCT01960257|448253705|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
124627722|NCT01960257|448253703|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
124627723|NCT01960257|448253704|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
124627724|NCT01960257|448253705|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
124627725|NCT02002221|448253706|FG000|Overall Study|Adverse Event|2|||
124627726|NCT02002221|448253707|FG001|Overall Study|Adverse Event|1|||
124627727|NCT02002221|448253706|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124627728|NCT02002221|448253707|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124627729|NCT02002221|448253706|FG000|Overall Study|Patient withdrew consent|0|||
124627730|NCT02002221|448253707|FG001|Overall Study|Patient withdrew consent|1|||
124627731|NCT03347110|448253708|FG000|Overall Study|Other (Participant is incarcerated)|1|||
124627732|NCT03347110|448253708|FG000|Overall Study|Withdrawal by Subject|9|||
124627733|NCT03347110|448253708|FG000|Overall Study|Lost to Follow-up|1|||
124627734|NCT03347110|448253708|FG000|Overall Study|Lack of Efficacy|2|||
124627735|NCT03347110|448253708|FG000|Overall Study|Adverse Event, non-fatal|9|||
124627736|NCT01518322|448253709|FG000|Overall Study|FeNO measurement was missing|13|||
124627737|NCT00110396|448253714|FG000|Overall Study|Adverse Event|15|||
124627738|NCT00110396|448253714|FG000|Overall Study|Lost to Follow-up|1|||
124627739|NCT00110396|448253714|FG000|Overall Study|Administration of plasmapheresis|1|||
124627740|NCT00110396|448253714|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
124627741|NCT00110396|448253714|FG000|Overall Study|Lack of Efficacy|1|||
124627742|NCT00110396|448253714|FG000|Overall Study|Decided not to continue treatment|1|||
124627743|NCT00110396|448253714|FG000|Overall Study|Patient non-compliance|1|||
124627744|NCT00110396|448253714|FG000|Overall Study|Patient refused to continue|1|||
124627745|NCT00110396|448253714|FG000|Overall Study|Patient refused to participate|1|||
124627746|NCT00110396|448253714|FG000|Overall Study|Patient will|1|||
124627747|NCT00110396|448253714|FG000|Overall Study|Patient's decision|1|||
124627748|NCT00110396|448253714|FG000|Overall Study|Participation in MS vaccine study|1|||
124627749|NCT00110396|448253714|FG000|Overall Study|Pregnancy|1|||
124627750|NCT00110396|448253714|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
124627751|NCT00110396|448253714|FG000|Overall Study|Protocol Violation|2|||
124627752|NCT00110396|448253714|FG000|Overall Study|Patient refused to come back|1|||
124627753|NCT00110396|448253714|FG000|Overall Study|The patient has refused|2|||
124627754|NCT00110396|448253714|FG000|Overall Study|The patient has refused to visit site|1|||
124627755|NCT00110396|448253714|FG000|Overall Study|Patient is to be administered copaxone|1|||
124627756|NCT00882518|448253715|FG000|Overall Study|Adverse Event|9|||
124627757|NCT00882518|448253716|FG001|Overall Study|Adverse Event|18|||
124627758|NCT00882518|448253715|FG000|Overall Study|Withdrawal by Subject|9|||
124627759|NCT00882518|448253716|FG001|Overall Study|Withdrawal by Subject|13|||
124627760|NCT00882518|448253715|FG000|Overall Study|Lack of Efficacy|12|||
124627761|NCT00882518|448253716|FG001|Overall Study|Lack of Efficacy|9|||
124627762|NCT00882518|448253715|FG000|Overall Study|Severe non-compliance to protocol|3|||
124788673|NCT00369629|448855896|FG002|Follow up for 1 Year|Death|1|||
124788674|NCT00369629|448855897|FG003|Follow up for 1 Year|Death|0|||
124788675|NCT00369629|448855894|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
124788676|NCT00369629|448855895|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
124788677|NCT00369629|448855896|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
124788678|NCT00369629|448855897|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
124788679|NCT00369629|448855894|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
124788680|NCT00369629|448855895|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
124788681|NCT00369629|448855896|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
124788682|NCT00369629|448855897|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
124788683|NCT00874939|448855898|FG000|Overall Study|Study terminated|4|||
124788684|NCT01250496|448855901|FG000|Overall Study|Study terminated|124|||
124788685|NCT01250496|448855902|FG001|Overall Study|Study terminated|124|||
124788686|NCT00883688|448855905|FG000|Overall Study|Ineligible|2|||
124788687|NCT01104376|448855911|FG000|Overall Study|Withdrawal by Subject|15|||
124788688|NCT01104376|448855911|FG000|Overall Study|Consented but excluded after labs|13|||
124788689|NCT03085914|448855919|FG000|Overall Study|Death|6|||
124788690|NCT03085914|448855920|FG001|Overall Study|Death|6|||
124788691|NCT03085914|448855921|FG002|Overall Study|Death|4|||
124788692|NCT03085914|448855922|FG003|Overall Study|Death|1|||
124627763|NCT00882518|448253716|FG001|Overall Study|Severe non-compliance to protocol|1|||
124627764|NCT00882518|448253715|FG000|Overall Study|Incorrect enrolment|4|||
124627765|NCT00882518|448253716|FG001|Overall Study|Incorrect enrolment|2|||
124627766|NCT00882518|448253715|FG000|Overall Study|Central lab closure for National day|1|||
124627767|NCT00882518|448253716|FG001|Overall Study|Central lab closure for National day|0|||
124627768|NCT00882518|448253715|FG000|Overall Study|Allocating random number by mistake|0|||
124627769|NCT00882518|448253716|FG001|Overall Study|Allocating random number by mistake|1|||
124627770|NCT02137252|448253718|FG000|Overall Study|trial terminated early|2|||
124627771|NCT02137252|448253719|FG001|Overall Study|trial terminated early|1|||
124627772|NCT00245466|448253720|FG000|Overall Study|Adverse Event|2|||
124788693|NCT03085914|448855923|FG004|Overall Study|Death|5|||
124788694|NCT03085914|448855924|FG005|Overall Study|Death|2|||
124627773|NCT00245466|448253721|FG001|Overall Study|Adverse Event|8|||
124627774|NCT00245466|448253722|FG002|Overall Study|Adverse Event|4|||
124627775|NCT00245466|448253720|FG000|Overall Study|Low prostate specific antigen suppr|16|||
124627776|NCT00245466|448253721|FG001|Overall Study|Low prostate specific antigen suppr|14|||
124627777|NCT00245466|448253722|FG002|Overall Study|Low prostate specific antigen suppr|5|||
124627778|NCT00245466|448253720|FG000|Overall Study|Insufficient testosterone suppr|12|||
124627779|NCT00245466|448253721|FG001|Overall Study|Insufficient testosterone suppr|12|||
124788695|NCT03085914|448855925|FG006|Overall Study|Death|2|||
124788696|NCT03085914|448855919|FG000|Overall Study|Withdrawal by Subject|1|||
124788697|NCT03085914|448855920|FG001|Overall Study|Withdrawal by Subject|1|||
124788698|NCT03085914|448855921|FG002|Overall Study|Withdrawal by Subject|2|||
124788699|NCT03085914|448855922|FG003|Overall Study|Withdrawal by Subject|2|||
124627780|NCT00245466|448253722|FG002|Overall Study|Insufficient testosterone suppr|21|||
124627781|NCT00245466|448253720|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
124627782|NCT00245466|448253721|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
124627783|NCT00245466|448253722|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
124788700|NCT03085914|448855923|FG004|Overall Study|Withdrawal by Subject|2|||
124788701|NCT03085914|448855924|FG005|Overall Study|Withdrawal by Subject|0|||
124627784|NCT00245466|448253720|FG000|Overall Study|Withdrawal by Subject|2|||
124627785|NCT00245466|448253721|FG001|Overall Study|Withdrawal by Subject|2|||
124788702|NCT03085914|448855925|FG006|Overall Study|Withdrawal by Subject|1|||
124788703|NCT03085914|448855919|FG000|Overall Study|Lost to Follow-up|0|||
124627786|NCT00245466|448253722|FG002|Overall Study|Withdrawal by Subject|1|||
124627787|NCT00245466|448253720|FG000|Overall Study|Lost to Follow-up|3|||
124627788|NCT00245466|448253721|FG001|Overall Study|Lost to Follow-up|0|||
124627789|NCT00245466|448253722|FG002|Overall Study|Lost to Follow-up|0|||
124627790|NCT00245466|448253720|FG000|Overall Study|Disease progression|0|||
124627791|NCT00245466|448253721|FG001|Overall Study|Disease progression|3|||
124627792|NCT00245466|448253722|FG002|Overall Study|Disease progression|1|||
124627793|NCT00245466|448253720|FG000|Overall Study|Protocol Violation|1|||
124627794|NCT00245466|448253721|FG001|Overall Study|Protocol Violation|2|||
124627795|NCT00245466|448253722|FG002|Overall Study|Protocol Violation|2|||
124627796|NCT00245466|448253720|FG000|Overall Study|Death|0|||
124627797|NCT00245466|448253721|FG001|Overall Study|Death|2|||
124627798|NCT00245466|448253722|FG002|Overall Study|Death|0|||
124627799|NCT00245466|448253720|FG000|Overall Study|Administrative reasons|0|||
124627800|NCT00245466|448253721|FG001|Overall Study|Administrative reasons|1|||
124627801|NCT00245466|448253722|FG002|Overall Study|Administrative reasons|0|||
124627802|NCT01958437|448253723|FG000|Overall Study|Incidental MRI findings|0|||
124627803|NCT01958437|448253724|FG001|Overall Study|Incidental MRI findings|0|||
124627804|NCT01958437|448253725|FG002|Overall Study|Incidental MRI findings|1|||
124627805|NCT01958437|448253726|FG003|Overall Study|Incidental MRI findings|1|||
124627806|NCT04886596|448253729|FG000|Overall Study|Adverse Event|442|||
124627807|NCT04886596|448253730|FG001|Overall Study|Adverse Event|441|||
124627808|NCT04886596|448253729|FG000|Overall Study|Lost to Follow-up|448|||
124627809|NCT04886596|448253730|FG001|Overall Study|Lost to Follow-up|465|||
124627810|NCT04886596|448253729|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
124627811|NCT04886596|448253730|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
124627812|NCT04886596|448253729|FG000|Overall Study|Migrated/moved from the study area|201|||
124627813|NCT04886596|448253730|FG001|Overall Study|Migrated/moved from the study area|184|||
124627814|NCT04886596|448253729|FG000|Overall Study|Other|298|||
124627815|NCT04886596|448253730|FG001|Overall Study|Other|326|||
124627816|NCT00948155|448253732|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
124627817|NCT00948155|448253733|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
124627818|NCT00948155|448253732|FG000|Washout 14 Days|Lost to Follow-up|1|||
124627819|NCT00948155|448253733|FG001|Washout 14 Days|Lost to Follow-up|2|||
124627820|NCT04620746|448253734|FG000|Overall Study|Adverse Event|2|||
124627821|NCT04620746|448253735|FG001|Overall Study|Adverse Event|0|||
124627822|NCT04620746|448253734|FG000|Overall Study|Uniterpretable skin test|1|||
124627823|NCT04620746|448253735|FG001|Overall Study|Uniterpretable skin test|0|||
124627824|NCT04620746|448253734|FG000|Overall Study|Withdrawal by Subject|0|||
124627825|NCT04620746|448253735|FG001|Overall Study|Withdrawal by Subject|1|||
124627826|NCT03473925|448253736|FG000|Overall Study|Death|48|||
124627827|NCT03473925|448253737|FG001|Overall Study|Death|44|||
124627828|NCT03473925|448253736|FG000|Overall Study|Sponsor Decision|2|||
124627829|NCT03473925|448253737|FG001|Overall Study|Sponsor Decision|7|||
124627830|NCT03473925|448253736|FG000|Overall Study|Withdrawal by Subject|1|||
124627831|NCT03473925|448253737|FG001|Overall Study|Withdrawal by Subject|3|||
124627832|NCT03473925|448253736|FG000|Overall Study|Not Treated|1|||
124627833|NCT03473925|448253737|FG001|Overall Study|Not Treated|1|||
124788704|NCT03085914|448855920|FG001|Overall Study|Lost to Follow-up|0|||
124788705|NCT03085914|448855921|FG002|Overall Study|Lost to Follow-up|1|||
124788706|NCT03085914|448855922|FG003|Overall Study|Lost to Follow-up|0|||
124788707|NCT03085914|448855923|FG004|Overall Study|Lost to Follow-up|0|||
124788708|NCT03085914|448855924|FG005|Overall Study|Lost to Follow-up|1|||
124788709|NCT03085914|448855925|FG006|Overall Study|Lost to Follow-up|1|||
124788710|NCT03085914|448855919|FG000|Overall Study|Reason was not specified,|2|||
124788711|NCT03085914|448855920|FG001|Overall Study|Reason was not specified,|2|||
124788712|NCT03085914|448855921|FG002|Overall Study|Reason was not specified,|2|||
124788713|NCT03085914|448855922|FG003|Overall Study|Reason was not specified,|3|||
124788714|NCT03085914|448855923|FG004|Overall Study|Reason was not specified,|3|||
124627834|NCT03411863|448253738|FG000|Overall Study|Withdrawal by Subject|3|||
124627835|NCT03411863|448253739|FG001|Overall Study|Withdrawal by Subject|1|||
124627836|NCT03411863|448253738|FG000|Overall Study|Physician Decision|0|||
124627837|NCT03411863|448253739|FG001|Overall Study|Physician Decision|1|||
124627838|NCT04661150|448253744|FG000|Overall Study|Ongoing in study|19|||
124627839|NCT04661150|448253745|FG001|Overall Study|Ongoing in study|20|||
124627840|NCT04661150|448253744|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
124627841|NCT04661150|448253745|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
124627842|NCT04661150|448253744|FG000|Overall Study|Death|2|||
124788715|NCT03085914|448855924|FG005|Overall Study|Reason was not specified,|3|||
124788716|NCT03085914|448855925|FG006|Overall Study|Reason was not specified,|6|||
124627843|NCT04661150|448253745|FG001|Overall Study|Death|0|||
124627844|NCT03535740|448253746|FG000|Overall Study|Death|44|||
124627845|NCT03535740|448253746|FG000|Overall Study|Lost to Follow-up|1|||
124788717|NCT03085914|448855919|FG000|Overall Study|Progressive Disease|0|||
124627846|NCT03535740|448253746|FG000|Overall Study|Withdrawal by Subject|13|||
124627847|NCT03535740|448253746|FG000|Overall Study|Site terminated by Sponsor|45|||
124627848|NCT05198518|448253751|FG000|Screening Visit|Deemed unable to participate|58|||
124627849|NCT05198518|448253752|FG001|Screening Visit|Deemed unable to participate|0|||
124788718|NCT03085914|448855920|FG001|Overall Study|Progressive Disease|0|||
124788719|NCT03085914|448855921|FG002|Overall Study|Progressive Disease|2|||
124788720|NCT03085914|448855922|FG003|Overall Study|Progressive Disease|2|||
124788721|NCT03085914|448855923|FG004|Overall Study|Progressive Disease|1|||
124788722|NCT03085914|448855924|FG005|Overall Study|Progressive Disease|1|||
124788723|NCT03085914|448855925|FG006|Overall Study|Progressive Disease|1|||
124788724|NCT03085914|448855919|FG000|Overall Study|Study Terminated by the Sponsor|0|||
124788725|NCT03085914|448855920|FG001|Overall Study|Study Terminated by the Sponsor|0|||
124788726|NCT03085914|448855921|FG002|Overall Study|Study Terminated by the Sponsor|0|||
124788727|NCT03085914|448855922|FG003|Overall Study|Study Terminated by the Sponsor|1|||
124788728|NCT03085914|448855923|FG004|Overall Study|Study Terminated by the Sponsor|2|||
124788729|NCT03085914|448855924|FG005|Overall Study|Study Terminated by the Sponsor|1|||
124788730|NCT03085914|448855925|FG006|Overall Study|Study Terminated by the Sponsor|0|||
124788731|NCT04644315|448855926|FG000|Overall Study|Subject withdrawal of consent|1|||
124788732|NCT05315908|448855927|FG000|Overall Study|Lost to Follow-up|4477|||
124788733|NCT05315908|448855928|FG001|Overall Study|Lost to Follow-up|4606|||
124788734|NCT01445548|448855929|FG000|Overall Study|Adverse Event|1|||
124788735|NCT03642132|448855931|FG000|Chemotherapy Period|Adverse Event|1|||
124788736|NCT03642132|448855932|FG001|Chemotherapy Period|Adverse Event|1|||
124788737|NCT03642132|448855933|FG002|Chemotherapy Period|Adverse Event|0|||
124788738|NCT03642132|448855931|FG000|Chemotherapy Period|Physician's decision|4|||
124788739|NCT03642132|448855932|FG001|Chemotherapy Period|Physician's decision|1|||
124788740|NCT03642132|448855933|FG002|Chemotherapy Period|Physician's decision|0|||
124788741|NCT03642132|448855931|FG000|Chemotherapy Period|Progressive disease|0|||
124788742|NCT03642132|448855932|FG001|Chemotherapy Period|Progressive disease|0|||
124788743|NCT03642132|448855933|FG002|Chemotherapy Period|Progressive disease|1|||
124788744|NCT03642132|448855931|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
124788745|NCT03642132|448855932|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
124788746|NCT03642132|448855933|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
124788747|NCT03642132|448855931|FG000|Chemotherapy Period|Other|1|||
124788748|NCT03642132|448855932|FG001|Chemotherapy Period|Other|0|||
124788749|NCT03642132|448855933|FG002|Chemotherapy Period|Other|2|||
124627850|NCT05198518|448253753|FG002|Screening Visit|Deemed unable to participate|0|||
124627851|NCT02756611|448253756|FG000|Overall Study|Death|70|||
124627852|NCT02756611|448253756|FG000|Overall Study|Withdrawal by Subject|2|||
124627853|NCT02756611|448253756|FG000|Overall Study|Lost to Follow-up|3|||
124627854|NCT02756611|448253756|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
124627855|NCT02756611|448253756|FG000|Overall Study|Other|10|||
124627856|NCT03125798|448253758|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
124627857|NCT03125798|448253759|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
124627858|NCT03125798|448253758|FG000|Overall Study|Conversion to thoracotomy|7|||
124627859|NCT03125798|448253759|FG001|Overall Study|Conversion to thoracotomy|7|||
124627860|NCT00065156|448253763|FG000|Overall Study|Adverse Event|37|||
124627861|NCT00065156|448253763|FG000|Overall Study|Lack of Efficacy|52|||
124627862|NCT00065156|448253763|FG000|Overall Study|Withdrawal by Subject|8|||
124627863|NCT00065156|448253763|FG000|Overall Study|Lost to Follow-up|1|||
124627864|NCT00065156|448253763|FG000|Overall Study|Death|11|||
124627865|NCT00065156|448253763|FG000|Overall Study|Study Closed by Sponsor|2|||
124627866|NCT00065156|448253763|FG000|Overall Study|Disease Progression|7|||
124627867|NCT00065156|448253763|FG000|Overall Study|Investigator Decision|2|||
124627868|NCT00065156|448253763|FG000|Overall Study|Non-Compliance|2|||
124627869|NCT00065156|448253763|FG000|Overall Study|Loss of Response|1|||
124627870|NCT00065156|448253763|FG000|Overall Study|Secondary Malign Disease|1|||
124627871|NCT04583735|448253764|FG000|Double-masked Treatment Period|Adverse Event|0|||
124627872|NCT04583735|448253765|FG001|Double-masked Treatment Period|Adverse Event|1|||
124627873|NCT04583735|448253764|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
124627874|NCT04583735|448253765|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
124627875|NCT04583735|448253764|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
124627876|NCT04583735|448253765|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
124788750|NCT03642132|448855931|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
124788751|NCT03642132|448855932|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
124788752|NCT03642132|448855933|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
124627877|NCT04583735|448253764|FG000|Open-label Treatment Period|Adverse Event|1|||
124627878|NCT04583735|448253765|FG001|Open-label Treatment Period|Adverse Event|1|||
124627879|NCT04583735|448253764|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
124627880|NCT04583735|448253765|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
124627881|NCT04583735|448253764|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
124627882|NCT04583735|448253765|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
124627883|NCT00124917|448253766|FG000|Overall Study|Physician Decision|3|||
124788753|NCT03642132|448855931|FG000|Maintenance Period|Adverse Event|1|||
124788754|NCT03642132|448855932|FG001|Maintenance Period|Adverse Event|2|||
124627884|NCT03518008|448253767|FG000|Period 2, Second Week of Wear|Family emergency|0|||
124788755|NCT03642132|448855933|FG002|Maintenance Period|Adverse Event|0|||
124788756|NCT03642132|448855931|FG000|Maintenance Period|Non-compliance with study drug|0|||
124788757|NCT03642132|448855932|FG001|Maintenance Period|Non-compliance with study drug|0|||
124627885|NCT03518008|448253768|FG001|Period 2, Second Week of Wear|Family emergency|1|||
124627886|NCT01169350|448253769|FG000|Overall Study|Physician Decision|3|||
124627887|NCT01169350|448253769|FG000|Overall Study|Lost to Follow-up|2|||
124627888|NCT00931411|448253770|FG000|First Intervention - 42 Days|Adverse Event|2|||
124627889|NCT00931411|448253771|FG001|First Intervention - 42 Days|Adverse Event|3|||
124627890|NCT00931411|448253770|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
124627891|NCT00931411|448253771|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
124627892|NCT00931411|448253770|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
124627893|NCT00931411|448253771|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
124627894|NCT00476190|448253775|FG000|Overall Study|Ineligible|1|||
124627895|NCT00476190|448253776|FG001|Overall Study|Ineligible|1|||
124627896|NCT00476190|448253775|FG000|Overall Study|Induction Death|2|||
124627897|NCT00476190|448253776|FG001|Overall Study|Induction Death|0|||
124627898|NCT00476190|448253775|FG000|Overall Study|Induction Failure|2|||
124627899|NCT00476190|448253776|FG001|Overall Study|Induction Failure|4|||
124627900|NCT00476190|448253775|FG000|Overall Study|Lost to Follow-up|1|||
124627901|NCT00476190|448253776|FG001|Overall Study|Lost to Follow-up|0|||
124627902|NCT00476190|448253775|FG000|Overall Study|Relapse/Progression|5|||
124627903|NCT00476190|448253776|FG001|Overall Study|Relapse/Progression|2|||
124627904|NCT00476190|448253775|FG000|Overall Study|Remission Death|0|||
124627905|NCT00476190|448253776|FG001|Overall Study|Remission Death|1|||
124627906|NCT00476190|448253775|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
124627907|NCT00476190|448253776|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
124627908|NCT00476190|448253775|FG000|Overall Study|Withdrawal by Subject|6|||
124627909|NCT00476190|448253776|FG001|Overall Study|Withdrawal by Subject|2|||
124627910|NCT00476190|448253775|FG000|Overall Study|Other|9|||
124627911|NCT00476190|448253776|FG001|Overall Study|Other|10|||
124788758|NCT03642132|448855933|FG002|Maintenance Period|Non-compliance with study drug|1|||
124788759|NCT03642132|448855931|FG000|Maintenance Period|Physician's decision|2|||
124788760|NCT03642132|448855932|FG001|Maintenance Period|Physician's decision|2|||
124788761|NCT03642132|448855933|FG002|Maintenance Period|Physician's decision|2|||
124788762|NCT03642132|448855931|FG000|Maintenance Period|Progressive disease|9|||
124788763|NCT03642132|448855932|FG001|Maintenance Period|Progressive disease|3|||
124788764|NCT03642132|448855933|FG002|Maintenance Period|Progressive disease|6|||
124788765|NCT03642132|448855931|FG000|Maintenance Period|Other|0|||
124788766|NCT03642132|448855932|FG001|Maintenance Period|Other|0|||
124788767|NCT03642132|448855933|FG002|Maintenance Period|Other|3|||
124788768|NCT03642132|448855931|FG000|Maintenance Period|Withdrawal by Subject|1|||
124788769|NCT03642132|448855932|FG001|Maintenance Period|Withdrawal by Subject|1|||
124788770|NCT03642132|448855933|FG002|Maintenance Period|Withdrawal by Subject|2|||
124627912|NCT02466321|448253777|FG000|Overall Study|Death|26|||
124627913|NCT02466321|448253777|FG000|Overall Study|Revision|6|||
124627914|NCT02466321|448253777|FG000|Overall Study|Lost to Follow-up|60|||
124627915|NCT02466321|448253777|FG000|Overall Study|Did not receive study device|1|||
124627916|NCT06071754|448253779|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
124627917|NCT04331808|448253780|FG000|Overall Study|Withdrew consent|1|||
124627918|NCT04331808|448253781|FG001|Overall Study|Withdrew consent|0|||
124627919|NCT04331808|448253782|FG002|Overall Study|Withdrew consent|2|||
124627920|NCT04331808|448253783|FG003|Overall Study|Withdrew consent|3|||
124627921|NCT02189837|448253784|FG000|Overall Study|Withdrawal by Subject|2|||
124627922|NCT02189837|448253785|FG001|Overall Study|Withdrawal by Subject|1|||
124627923|NCT02189837|448253786|FG002|Overall Study|Withdrawal by Subject|3|||
124627924|NCT02189837|448253787|FG003|Overall Study|Withdrawal by Subject|1|||
124627925|NCT02189837|448253784|FG000|Overall Study|Sponsor Decision|0|||
124627926|NCT02189837|448253785|FG001|Overall Study|Sponsor Decision|0|||
124627927|NCT02189837|448253786|FG002|Overall Study|Sponsor Decision|0|||
124627928|NCT02189837|448253787|FG003|Overall Study|Sponsor Decision|1|||
124627929|NCT00822692|448253793|FG000|Overall Study|Lost to Follow-up|17|||
124788771|NCT03642132|448855931|FG000|Follow-up Period|Other|0|||
124627930|NCT00822692|448253794|FG001|Overall Study|Lost to Follow-up|25|||
124627931|NCT02443740|448253795|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
124627932|NCT02443740|448253796|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
124627933|NCT02443740|448253797|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
124627934|NCT02443740|448253798|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
124627935|NCT02443740|448253799|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
124627936|NCT02443740|448253800|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
124627937|NCT02443740|448253801|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
124627938|NCT02443740|448253802|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
124627939|NCT02443740|448253803|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
124627940|NCT02443740|448253804|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
124788772|NCT03642132|448855932|FG001|Follow-up Period|Other|0|||
124627941|NCT02443740|448253805|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
124627942|NCT02443740|448253795|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
124627943|NCT02443740|448253796|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
124788773|NCT03642132|448855933|FG002|Follow-up Period|Other|1|||
124788774|NCT03642132|448855931|FG000|Follow-up Period|Withdrawal by Subject|1|||
124627944|NCT02443740|448253797|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
124627945|NCT02443740|448253798|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
124627946|NCT02443740|448253799|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
124627947|NCT02443740|448253800|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
124627948|NCT02443740|448253801|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
124627949|NCT02443740|448253802|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
124627950|NCT02443740|448253803|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
124627951|NCT02443740|448253804|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
124627952|NCT02443740|448253805|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
124627953|NCT02443740|448253795|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
124627954|NCT02443740|448253796|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
124627955|NCT02443740|448253797|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
124627956|NCT02443740|448253798|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
124627957|NCT02443740|448253799|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
124627958|NCT02443740|448253800|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
124627959|NCT02443740|448253801|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
124627960|NCT02443740|448253802|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
124627961|NCT02443740|448253803|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
124627962|NCT02443740|448253804|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
124627963|NCT02443740|448253805|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
124627964|NCT00456300|448253806|FG000|Overall Study|Adverse Event|1|||
124627965|NCT00456300|448253807|FG001|Overall Study|Adverse Event|0|||
124627966|NCT00683657|448253812|FG000|Overall Study|Adverse Event|0|||
124627967|NCT00683657|448253813|FG001|Overall Study|Adverse Event|1|||
124627968|NCT00683657|448253812|FG000|Overall Study|Subject Withdrew Consent|1|||
124627969|NCT00683657|448253813|FG001|Overall Study|Subject Withdrew Consent|0|||
124627970|NCT01408043|448253818|FG000|Overall Study|unable to collect cells|1|||
124627971|NCT00739063|448253822|FG000|Overall Study|Screen failures|8|||
124627972|NCT03447743|448253823|FG000|Overall Study|Withdrawal by Subject|2|||
124627973|NCT03447743|448253823|FG000|Overall Study|Lost to Follow-up|3|||
124627974|NCT03447743|448253823|FG000|Overall Study|Adverse Event|1|||
124627975|NCT03447743|448253823|FG000|Overall Study|Did not meet criteria to continue|1|||
124627976|NCT03567980|448253824|FG000|Overall Study|Adverse Event|1|||
124627977|NCT03093259|448253825|FG000|Overall Study|Adverse Event|1|||
124627978|NCT03093259|448253826|FG001|Overall Study|Adverse Event|0|||
124627979|NCT03093259|448253825|FG000|Overall Study|Withdrawal by Subject|1|||
124627980|NCT03093259|448253826|FG001|Overall Study|Withdrawal by Subject|0|||
124627981|NCT04871776|448253829|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
124627982|NCT04871776|448253830|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
124627983|NCT04871776|448253831|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
124627984|NCT04871776|448253829|FG000|Overall Study|Did not meet eligibility criteria|1|||
124627985|NCT04871776|448253830|FG001|Overall Study|Did not meet eligibility criteria|1|||
124627986|NCT04871776|448253831|FG002|Overall Study|Did not meet eligibility criteria|1|||
124627987|NCT04075487|448256027|FG000|Overall Study|Withdrawal by Subject|1|||
124627988|NCT02848001|448256030|FG000|Overall Study|other reasons|0|||
124627989|NCT02848001|448256031|FG001|Overall Study|other reasons|0|||
124627990|NCT02848001|448256032|FG002|Overall Study|other reasons|1|||
124627991|NCT02848001|448256033|FG003|Overall Study|other reasons|0|||
124627992|NCT02848001|448256034|FG004|Overall Study|other reasons|4|||
124627993|NCT02848001|448256035|FG005|Overall Study|other reasons|1|||
124627994|NCT02848001|448256036|FG006|Overall Study|other reasons|0|||
124627995|NCT02848001|448256037|FG007|Overall Study|other reasons|2|||
124627996|NCT02848001|448256038|FG008|Overall Study|other reasons|2|||
124627997|NCT02848001|448256039|FG009|Overall Study|other reasons|3|||
124627998|NCT02848001|448256040|FG010|Overall Study|other reasons|0|||
124627999|NCT02848001|448256041|FG011|Overall Study|other reasons|1|||
124628000|NCT02848001|448256042|FG012|Overall Study|other reasons|1|||
124628001|NCT02848001|448256043|FG013|Overall Study|other reasons|0|||
124628002|NCT02848001|448256044|FG014|Overall Study|other reasons|0|||
124628003|NCT02848001|448256045|FG015|Overall Study|other reasons|2|||
124628004|NCT02848001|448256046|FG016|Overall Study|other reasons|1|||
124628005|NCT02848001|448256030|FG000|Overall Study|Lack of Efficacy|0|||
124628006|NCT02848001|448256031|FG001|Overall Study|Lack of Efficacy|1|||
124628007|NCT02848001|448256032|FG002|Overall Study|Lack of Efficacy|1|||
124628008|NCT02848001|448256033|FG003|Overall Study|Lack of Efficacy|2|||
124628009|NCT02848001|448256034|FG004|Overall Study|Lack of Efficacy|3|||
124628010|NCT02848001|448256035|FG005|Overall Study|Lack of Efficacy|0|||
124628011|NCT02848001|448256036|FG006|Overall Study|Lack of Efficacy|1|||
124628012|NCT02848001|448256037|FG007|Overall Study|Lack of Efficacy|0|||
124628013|NCT02848001|448256038|FG008|Overall Study|Lack of Efficacy|0|||
124628014|NCT02848001|448256039|FG009|Overall Study|Lack of Efficacy|1|||
124628015|NCT02848001|448256040|FG010|Overall Study|Lack of Efficacy|0|||
124628016|NCT02848001|448256041|FG011|Overall Study|Lack of Efficacy|2|||
124628017|NCT02848001|448256042|FG012|Overall Study|Lack of Efficacy|0|||
124628018|NCT02848001|448256043|FG013|Overall Study|Lack of Efficacy|2|||
124628019|NCT02848001|448256044|FG014|Overall Study|Lack of Efficacy|2|||
124628020|NCT02848001|448256045|FG015|Overall Study|Lack of Efficacy|0|||
124628021|NCT02848001|448256046|FG016|Overall Study|Lack of Efficacy|0|||
124628022|NCT02848001|448256030|FG000|Overall Study|Progressive Disease|2|||
124628023|NCT02848001|448256031|FG001|Overall Study|Progressive Disease|1|||
124628024|NCT02848001|448256032|FG002|Overall Study|Progressive Disease|0|||
124628025|NCT02848001|448256033|FG003|Overall Study|Progressive Disease|4|||
124628026|NCT02848001|448256034|FG004|Overall Study|Progressive Disease|3|||
124628027|NCT02848001|448256035|FG005|Overall Study|Progressive Disease|0|||
124628028|NCT02848001|448256036|FG006|Overall Study|Progressive Disease|4|||
124628029|NCT02848001|448256037|FG007|Overall Study|Progressive Disease|1|||
124628030|NCT02848001|448256038|FG008|Overall Study|Progressive Disease|0|||
124628031|NCT02848001|448256039|FG009|Overall Study|Progressive Disease|2|||
124628032|NCT02848001|448256040|FG010|Overall Study|Progressive Disease|3|||
124628033|NCT02848001|448256041|FG011|Overall Study|Progressive Disease|2|||
124628034|NCT02848001|448256042|FG012|Overall Study|Progressive Disease|1|||
124628035|NCT02848001|448256043|FG013|Overall Study|Progressive Disease|0|||
124628036|NCT02848001|448256044|FG014|Overall Study|Progressive Disease|2|||
124628037|NCT02848001|448256045|FG015|Overall Study|Progressive Disease|4|||
124628038|NCT02848001|448256046|FG016|Overall Study|Progressive Disease|0|||
124628039|NCT02848001|448256030|FG000|Overall Study|Adverse Event|0|||
124628040|NCT02848001|448256031|FG001|Overall Study|Adverse Event|0|||
124628041|NCT02848001|448256032|FG002|Overall Study|Adverse Event|0|||
124628042|NCT02848001|448256033|FG003|Overall Study|Adverse Event|0|||
124628043|NCT02848001|448256034|FG004|Overall Study|Adverse Event|2|||
124628044|NCT02848001|448256035|FG005|Overall Study|Adverse Event|0|||
124628045|NCT02848001|448256036|FG006|Overall Study|Adverse Event|0|||
124628046|NCT02848001|448256037|FG007|Overall Study|Adverse Event|0|||
124628047|NCT02848001|448256038|FG008|Overall Study|Adverse Event|0|||
124628048|NCT02848001|448256039|FG009|Overall Study|Adverse Event|1|||
124628049|NCT02848001|448256040|FG010|Overall Study|Adverse Event|0|||
124628050|NCT02848001|448256041|FG011|Overall Study|Adverse Event|1|||
124628051|NCT02848001|448256042|FG012|Overall Study|Adverse Event|1|||
124628052|NCT02848001|448256043|FG013|Overall Study|Adverse Event|0|||
124628053|NCT02848001|448256044|FG014|Overall Study|Adverse Event|2|||
124628054|NCT02848001|448256045|FG015|Overall Study|Adverse Event|0|||
124628055|NCT02848001|448256046|FG016|Overall Study|Adverse Event|0|||
124628056|NCT02848001|448256030|FG000|Overall Study|Death|0|||
124628057|NCT02848001|448256031|FG001|Overall Study|Death|0|||
124628058|NCT02848001|448256032|FG002|Overall Study|Death|0|||
124628059|NCT02848001|448256033|FG003|Overall Study|Death|1|||
124628060|NCT02848001|448256034|FG004|Overall Study|Death|3|||
124628061|NCT02848001|448256035|FG005|Overall Study|Death|1|||
124628062|NCT02848001|448256036|FG006|Overall Study|Death|2|||
124628063|NCT02848001|448256037|FG007|Overall Study|Death|3|||
124628064|NCT02848001|448256038|FG008|Overall Study|Death|4|||
124628065|NCT02848001|448256039|FG009|Overall Study|Death|1|||
124628066|NCT02848001|448256040|FG010|Overall Study|Death|0|||
124628067|NCT02848001|448256041|FG011|Overall Study|Death|1|||
124628068|NCT02848001|448256042|FG012|Overall Study|Death|3|||
124628069|NCT02848001|448256043|FG013|Overall Study|Death|0|||
124628070|NCT02848001|448256044|FG014|Overall Study|Death|2|||
124628071|NCT02848001|448256045|FG015|Overall Study|Death|3|||
124628072|NCT02848001|448256046|FG016|Overall Study|Death|0|||
124628073|NCT02848001|448256030|FG000|Overall Study|Physician Decision|0|||
124628074|NCT02848001|448256031|FG001|Overall Study|Physician Decision|0|||
124628075|NCT02848001|448256032|FG002|Overall Study|Physician Decision|0|||
124628076|NCT02848001|448256033|FG003|Overall Study|Physician Decision|0|||
124628077|NCT02848001|448256034|FG004|Overall Study|Physician Decision|0|||
124628078|NCT02848001|448256035|FG005|Overall Study|Physician Decision|0|||
124628079|NCT02848001|448256036|FG006|Overall Study|Physician Decision|0|||
124628080|NCT02848001|448256037|FG007|Overall Study|Physician Decision|0|||
124628081|NCT02848001|448256038|FG008|Overall Study|Physician Decision|1|||
124788775|NCT03642132|448855932|FG001|Follow-up Period|Withdrawal by Subject|2|||
124788776|NCT03642132|448855933|FG002|Follow-up Period|Withdrawal by Subject|0|||
124788777|NCT03642132|448855931|FG000|Follow-up Period|Study terminated by sponsor|1|||
124628082|NCT02848001|448256039|FG009|Overall Study|Physician Decision|1|||
124628083|NCT02848001|448256040|FG010|Overall Study|Physician Decision|0|||
124788778|NCT03642132|448855932|FG001|Follow-up Period|Study terminated by sponsor|0|||
124628084|NCT02848001|448256041|FG011|Overall Study|Physician Decision|0|||
124628085|NCT02848001|448256042|FG012|Overall Study|Physician Decision|2|||
124628086|NCT02848001|448256043|FG013|Overall Study|Physician Decision|0|||
124628087|NCT02848001|448256044|FG014|Overall Study|Physician Decision|0|||
124628088|NCT02848001|448256045|FG015|Overall Study|Physician Decision|0|||
124628089|NCT02848001|448256046|FG016|Overall Study|Physician Decision|0|||
124628090|NCT02848001|448256030|FG000|Overall Study|Withdrawal by Subject|0|||
124628091|NCT02848001|448256031|FG001|Overall Study|Withdrawal by Subject|0|||
124628092|NCT02848001|448256032|FG002|Overall Study|Withdrawal by Subject|0|||
124628093|NCT02848001|448256033|FG003|Overall Study|Withdrawal by Subject|0|||
124628094|NCT02848001|448256034|FG004|Overall Study|Withdrawal by Subject|0|||
124628095|NCT02848001|448256035|FG005|Overall Study|Withdrawal by Subject|1|||
124628096|NCT02848001|448256036|FG006|Overall Study|Withdrawal by Subject|1|||
124628097|NCT02848001|448256037|FG007|Overall Study|Withdrawal by Subject|1|||
124628098|NCT02848001|448256038|FG008|Overall Study|Withdrawal by Subject|0|||
124628099|NCT02848001|448256039|FG009|Overall Study|Withdrawal by Subject|0|||
124628100|NCT02848001|448256040|FG010|Overall Study|Withdrawal by Subject|0|||
124628101|NCT02848001|448256041|FG011|Overall Study|Withdrawal by Subject|0|||
124628102|NCT02848001|448256042|FG012|Overall Study|Withdrawal by Subject|0|||
124628103|NCT02848001|448256043|FG013|Overall Study|Withdrawal by Subject|0|||
124628104|NCT02848001|448256044|FG014|Overall Study|Withdrawal by Subject|0|||
124628105|NCT02848001|448256045|FG015|Overall Study|Withdrawal by Subject|0|||
124628106|NCT02848001|448256046|FG016|Overall Study|Withdrawal by Subject|0|||
124628107|NCT00725283|448256049|FG000|Overall Study|Missing Code|3|||
124628108|NCT00725283|448256049|FG000|Overall Study|Death|5|||
124628109|NCT00725283|448256049|FG000|Overall Study|Other|6|||
124628110|NCT00725283|448256049|FG000|Overall Study|Withdrawal by Subject|10|||
124628111|NCT02115269|448256050|FG000|Overall Study|Lost to Follow-up|43|||
124628112|NCT02115269|448256050|FG000|Overall Study|Did not complete patient diary|3|||
124628113|NCT02115269|448256050|FG000|Overall Study|Moved to another city|7|||
124628114|NCT02115269|448256050|FG000|Overall Study|Withdrawal by Subject|2|||
124628115|NCT02115269|448256050|FG000|Overall Study|Didn't take study drug|2|||
124628116|NCT01402570|448256051|FG000|Overall Study|Adverse Event|1|||
124628117|NCT04179838|448256058|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
124628118|NCT04179838|448256059|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
124628119|NCT04179838|448256058|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
124628120|NCT04179838|448256059|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
124628121|NCT01290068|448256064|FG000|Overall Study|Adverse Event|1|||
124628122|NCT01290068|448256065|FG001|Overall Study|Adverse Event|3|||
124628123|NCT01290068|448256064|FG000|Overall Study|Lost to Follow-up|3|||
124628124|NCT01290068|448256065|FG001|Overall Study|Lost to Follow-up|0|||
124628125|NCT01290068|448256064|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
124628126|NCT01290068|448256065|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
124628127|NCT01290068|448256064|FG000|Overall Study|Other|3|||
124628128|NCT01290068|448256065|FG001|Overall Study|Other|1|||
124628129|NCT00513695|448256066|FG000|Overall Study|Discontinued therapy|2|||
124628130|NCT00513695|448256066|FG000|Overall Study|Progression prior to surgery|3|||
124628131|NCT01417156|448256072|FG000|Overall Study|Adverse Event|12|||
124628132|NCT01417156|448256072|FG000|Overall Study|Protocol Violation|2|||
124628133|NCT00818766|448256073|FG000|Overall Study|Could not be Contacted on Day 28|11|||
124628134|NCT00818766|448256074|FG001|Overall Study|Could not be Contacted on Day 28|10|||
124628135|NCT00818766|448256073|FG000|Overall Study|Death|1|||
124628136|NCT00818766|448256074|FG001|Overall Study|Death|0|||
124628137|NCT00818766|448256073|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
124628138|NCT00818766|448256074|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
124628139|NCT00086684|448256075|FG000|Overall Study|Adverse Event|12|||
124628140|NCT00086684|448256076|FG001|Overall Study|Adverse Event|17|||
124628141|NCT00086684|448256077|FG002|Overall Study|Adverse Event|14|||
124628142|NCT00086684|448256075|FG000|Overall Study|Lack of Efficacy|6|||
124628143|NCT00086684|448256076|FG001|Overall Study|Lack of Efficacy|6|||
124628144|NCT00086684|448256077|FG002|Overall Study|Lack of Efficacy|5|||
124628145|NCT00086684|448256075|FG000|Overall Study|Lost to Follow-up|15|||
124628146|NCT00086684|448256076|FG001|Overall Study|Lost to Follow-up|8|||
124628147|NCT00086684|448256077|FG002|Overall Study|Lost to Follow-up|10|||
124628148|NCT00086684|448256075|FG000|Overall Study|Protocol Violation|8|||
124628149|NCT00086684|448256076|FG001|Overall Study|Protocol Violation|3|||
124628150|NCT00086684|448256077|FG002|Overall Study|Protocol Violation|0|||
124628151|NCT00086684|448256075|FG000|Overall Study|Withdrawal by Subject|0|||
124628152|NCT00086684|448256076|FG001|Overall Study|Withdrawal by Subject|4|||
124628153|NCT00086684|448256077|FG002|Overall Study|Withdrawal by Subject|10|||
124628154|NCT00086684|448256075|FG000|Overall Study|NONCOMPLIANCE|5|||
124628155|NCT00086684|448256076|FG001|Overall Study|NONCOMPLIANCE|7|||
124628156|NCT00086684|448256077|FG002|Overall Study|NONCOMPLIANCE|6|||
124628157|NCT00086684|448256075|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
124628158|NCT00086684|448256076|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
124628159|NCT00086684|448256077|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
124628160|NCT00086684|448256075|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
124628161|NCT00086684|448256076|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
124628162|NCT00086684|448256077|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
124628163|NCT00086684|448256075|FG000|Overall Study|Other|4|||
124628164|NCT00086684|448256076|FG001|Overall Study|Other|2|||
124628165|NCT00086684|448256077|FG002|Overall Study|Other|3|||
124628166|NCT01996241|448256078|FG000|Overall Study|Lost to Follow-up|252|||
124628167|NCT01996241|448256079|FG001|Overall Study|Lost to Follow-up|235|||
124628168|NCT04515147|448256081|FG000|Overall Study|Withdrawal by Subject|1|||
124628169|NCT04515147|448256082|FG001|Overall Study|Withdrawal by Subject|0|||
124628170|NCT04515147|448256083|FG002|Overall Study|Withdrawal by Subject|10|||
124628171|NCT04515147|448256084|FG003|Overall Study|Withdrawal by Subject|18|||
124628172|NCT04515147|448256085|FG004|Overall Study|Withdrawal by Subject|1|||
124628173|NCT04515147|448256086|FG005|Overall Study|Withdrawal by Subject|8|||
124628174|NCT04515147|448256081|FG000|Overall Study|Lost to Follow-up|0|||
124628175|NCT04515147|448256082|FG001|Overall Study|Lost to Follow-up|1|||
124628176|NCT04515147|448256083|FG002|Overall Study|Lost to Follow-up|5|||
124628177|NCT04515147|448256084|FG003|Overall Study|Lost to Follow-up|6|||
124628178|NCT04515147|448256085|FG004|Overall Study|Lost to Follow-up|2|||
124628179|NCT04515147|448256086|FG005|Overall Study|Lost to Follow-up|1|||
124788779|NCT03642132|448855933|FG002|Follow-up Period|Study terminated by sponsor|1|||
124788780|NCT03642132|448855931|FG000|Follow-up Period|Lack of Efficacy|1|||
124788781|NCT03642132|448855932|FG001|Follow-up Period|Lack of Efficacy|0|||
124788782|NCT03642132|448855933|FG002|Follow-up Period|Lack of Efficacy|0|||
124788783|NCT03642132|448855931|FG000|Follow-up Period|Death|1|||
124788784|NCT03642132|448855932|FG001|Follow-up Period|Death|0|||
124788785|NCT03642132|448855933|FG002|Follow-up Period|Death|2|||
124788786|NCT03642132|448855931|FG000|Follow-up Period|Adverse Event|1|||
124788787|NCT03642132|448855932|FG001|Follow-up Period|Adverse Event|0|||
124628180|NCT04515147|448256081|FG000|Overall Study|Adverse Event|0|||
124628181|NCT04515147|448256082|FG001|Overall Study|Adverse Event|0|||
124628182|NCT04515147|448256083|FG002|Overall Study|Adverse Event|0|||
124628183|NCT04515147|448256084|FG003|Overall Study|Adverse Event|2|||
124628184|NCT04515147|448256085|FG004|Overall Study|Adverse Event|0|||
124628185|NCT04515147|448256086|FG005|Overall Study|Adverse Event|0|||
124628186|NCT04515147|448256081|FG000|Overall Study|Miscellaneous|0|||
124628187|NCT04515147|448256082|FG001|Overall Study|Miscellaneous|0|||
124628188|NCT04515147|448256083|FG002|Overall Study|Miscellaneous|0|||
124628189|NCT04515147|448256084|FG003|Overall Study|Miscellaneous|1|||
124628190|NCT04515147|448256085|FG004|Overall Study|Miscellaneous|0|||
124628191|NCT04515147|448256086|FG005|Overall Study|Miscellaneous|1|||
124628192|NCT02094300|448256091|FG000|Overall Study|Death|7|||
124628193|NCT02094300|448256091|FG000|Overall Study|Lost to Follow-up|10|||
124628194|NCT02094300|448256091|FG000|Overall Study|Still be eligible for follow-up|3|||
124628195|NCT00725491|448256097|FG000|Overall Study|Adverse Event|3|||
124628196|NCT00725491|448256098|FG001|Overall Study|Adverse Event|2|||
124628197|NCT00725491|448256097|FG000|Overall Study|Pregnancy|0|||
124628198|NCT00725491|448256098|FG001|Overall Study|Pregnancy|3|||
124628199|NCT00725491|448256097|FG000|Overall Study|Risk for hyperstimulation|2|||
124628200|NCT00725491|448256098|FG001|Overall Study|Risk for hyperstimulation|9|||
124628201|NCT00725491|448256097|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
124628202|NCT00725491|448256098|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
124628203|NCT00725491|448256097|FG000|Overall Study|Fertilization failure|0|||
124628204|NCT00725491|448256098|FG001|Overall Study|Fertilization failure|1|||
124628205|NCT00725491|448256097|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
124628206|NCT00725491|448256098|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
124628207|NCT01495000|448256099|FG000|Overall Study|Lost to Follow-up|2|||
124628208|NCT01495000|448256100|FG001|Overall Study|Lost to Follow-up|2|||
124628209|NCT01495000|448256099|FG000|Overall Study|Protocol Violation|1|||
124628210|NCT01495000|448256100|FG001|Overall Study|Protocol Violation|0|||
124628211|NCT01495000|448256099|FG000|Overall Study|Withdrawal by Subject|10|||
124628212|NCT01495000|448256100|FG001|Overall Study|Withdrawal by Subject|10|||
124628213|NCT01514461|448256101|FG000|Overall Study|Adverse Event|2|||
124628214|NCT01514461|448256102|FG001|Overall Study|Adverse Event|1|||
124628215|NCT01514461|448256103|FG002|Overall Study|Adverse Event|3|||
124628216|NCT01514461|448256101|FG000|Overall Study|Physician Decision|1|||
124628217|NCT01514461|448256102|FG001|Overall Study|Physician Decision|1|||
124628218|NCT01514461|448256103|FG002|Overall Study|Physician Decision|0|||
124628219|NCT01514461|448256101|FG000|Overall Study|Patient/guardian decision|1|||
124628220|NCT01514461|448256102|FG001|Overall Study|Patient/guardian decision|1|||
124788788|NCT03642132|448855933|FG002|Follow-up Period|Adverse Event|0|||
124788789|NCT04493892|448855944|FG000|Overall Study|Withdrawal by Subject|15|||
124788790|NCT01128621|448855945|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
124788791|NCT01128621|448855946|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
124628221|NCT01514461|448256103|FG002|Overall Study|Patient/guardian decision|1|||
124628222|NCT01514461|448256101|FG000|Overall Study|Death|1|||
124628223|NCT01514461|448256102|FG001|Overall Study|Death|0|||
124628224|NCT01514461|448256103|FG002|Overall Study|Death|0|||
124628225|NCT03499067|448256104|FG000|First Intervention|Physician Decision|2|||
124628226|NCT03499067|448256105|FG001|First Intervention|Physician Decision|1|||
124788792|NCT03595618|448855947|FG000|Overall Study|Adverse Event|16|||
124628227|NCT03499067|448256104|FG000|First Intervention|Withdrawal by Subject|3|||
124628228|NCT03499067|448256105|FG001|First Intervention|Withdrawal by Subject|6|||
124628229|NCT02548832|448256106|FG000|Overall Study|Lost to Follow-up|2|||
124628230|NCT02548832|448256107|FG001|Overall Study|Lost to Follow-up|2|||
124628231|NCT02548832|448256108|FG002|Overall Study|Lost to Follow-up|2|||
124788793|NCT03595618|448855948|FG001|Overall Study|Adverse Event|17|||
124788794|NCT03595618|448855949|FG002|Overall Study|Adverse Event|20|||
124628232|NCT03345420|448256109|FG000|Overall Study|Withdrawal by Subject|1|||
124628233|NCT02058069|448256110|FG000|Overall Study|Exclusion due to implant size|5|||
124628234|NCT02058069|448256110|FG000|Overall Study|Withdrawal by Subject|6|||
124628235|NCT01320293|448256132|FG000|Overall Study|Lack of Efficacy|1|||
124628236|NCT01320293|448256132|FG000|Overall Study|Adverse Event|1|||
124628237|NCT00470470|448256133|FG000|Overall Study|Adverse Event|2|||
124628238|NCT00470470|448256133|FG000|Overall Study|Death|2|||
124628239|NCT00470470|448256133|FG000|Overall Study|Not treated|1|||
124628240|NCT04338022|448256136|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
124628241|NCT04338022|448256137|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
124628242|NCT04338022|448256136|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
124628243|NCT04338022|448256137|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
124628244|NCT04338022|448256136|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
124628245|NCT04338022|448256137|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
124628246|NCT04338022|448256136|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
124628247|NCT04338022|448256137|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
124628248|NCT04338022|448256136|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
124628249|NCT04338022|448256137|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
124628250|NCT04338022|448256136|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
124628251|NCT04338022|448256137|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
124628252|NCT04338022|448256136|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
124628253|NCT04338022|448256137|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
124628254|NCT04338022|448256136|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
124628255|NCT04338022|448256137|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
124628256|NCT04338022|448256136|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
124628257|NCT04338022|448256137|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
124628258|NCT04338022|448256136|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
124628259|NCT04338022|448256137|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
124628260|NCT04338022|448256136|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
124628261|NCT04338022|448256137|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
124628262|NCT04338022|448256136|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
124628263|NCT04338022|448256137|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
124628264|NCT04338022|448256136|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
124628265|NCT04338022|448256137|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
124628266|NCT04338022|448256136|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
124628267|NCT04338022|448256137|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
124628268|NCT04782076|448256139|FG000|Overall Study|Family Emergency|1|||
124628269|NCT02860546|448256146|FG000|Overall Study|Clinical Progression|6|||
124628270|NCT02860546|448256146|FG000|Overall Study|Radiological Progression|12|||
124628271|NCT01949662|448256151|FG000|Overall Study|Death|9|||
124628272|NCT01949662|448256152|FG001|Overall Study|Death|7|||
124628273|NCT01949662|448256151|FG000|Overall Study|Discharged before an agitation event|8|||
124628274|NCT01949662|448256152|FG001|Overall Study|Discharged before an agitation event|3|||
124628275|NCT01949662|448256151|FG000|Overall Study|Dropped out|1|||
124628276|NCT01949662|448256152|FG001|Overall Study|Dropped out|3|||
124628277|NCT01949662|448256151|FG000|Overall Study|Ineligible|0|||
124628278|NCT01949662|448256152|FG001|Overall Study|Ineligible|1|||
124628279|NCT00729937|448256155|FG000|Overall Study|Lost to Follow-up|49|||
124628280|NCT00729937|448256156|FG001|Overall Study|Lost to Follow-up|58|||
124628281|NCT00729937|448256157|FG002|Overall Study|Lost to Follow-up|18|||
124628282|NCT00729937|448256158|FG003|Overall Study|Lost to Follow-up|33|||
124628283|NCT00729937|448256159|FG004|Overall Study|Lost to Follow-up|18|||
124628284|NCT00729937|448256160|FG005|Overall Study|Lost to Follow-up|23|||
124628285|NCT00729937|448256155|FG000|Overall Study|Physician Decision|7|||
124628286|NCT00729937|448256156|FG001|Overall Study|Physician Decision|16|||
124628287|NCT00729937|448256157|FG002|Overall Study|Physician Decision|2|||
124628288|NCT00729937|448256158|FG003|Overall Study|Physician Decision|0|||
124628289|NCT00729937|448256159|FG004|Overall Study|Physician Decision|5|||
124628290|NCT00729937|448256160|FG005|Overall Study|Physician Decision|8|||
124628291|NCT00729937|448256155|FG000|Overall Study|Death|1|||
124628292|NCT00729937|448256156|FG001|Overall Study|Death|0|||
124628293|NCT00729937|448256157|FG002|Overall Study|Death|1|||
124628294|NCT00729937|448256158|FG003|Overall Study|Death|0|||
124628295|NCT00729937|448256159|FG004|Overall Study|Death|0|||
124628296|NCT00729937|448256160|FG005|Overall Study|Death|1|||
124628297|NCT00729937|448256155|FG000|Overall Study|Withdrawal by Subject|3|||
124628298|NCT00729937|448256156|FG001|Overall Study|Withdrawal by Subject|5|||
124628299|NCT00729937|448256157|FG002|Overall Study|Withdrawal by Subject|6|||
124628300|NCT00729937|448256158|FG003|Overall Study|Withdrawal by Subject|0|||
124628301|NCT00729937|448256159|FG004|Overall Study|Withdrawal by Subject|4|||
124628302|NCT00729937|448256160|FG005|Overall Study|Withdrawal by Subject|2|||
124628303|NCT00729937|448256155|FG000|Overall Study|Randomized but not treated|12|||
124788795|NCT03595618|448855950|FG003|Overall Study|Adverse Event|8|||
124788796|NCT03595618|448855947|FG000|Overall Study|Withdrawal by Subject|12|||
124788797|NCT03595618|448855948|FG001|Overall Study|Withdrawal by Subject|14|||
124628304|NCT00729937|448256156|FG001|Overall Study|Randomized but not treated|6|||
124628305|NCT00729937|448256157|FG002|Overall Study|Randomized but not treated|1|||
124628306|NCT00729937|448256158|FG003|Overall Study|Randomized but not treated|0|||
124628307|NCT00729937|448256159|FG004|Overall Study|Randomized but not treated|1|||
124628308|NCT00729937|448256160|FG005|Overall Study|Randomized but not treated|3|||
124628309|NCT00729937|448256155|FG000|Overall Study|Did not meet eligibility criteria|2|||
124628310|NCT00729937|448256156|FG001|Overall Study|Did not meet eligibility criteria|1|||
124628311|NCT00729937|448256157|FG002|Overall Study|Did not meet eligibility criteria|0|||
124628312|NCT00729937|448256158|FG003|Overall Study|Did not meet eligibility criteria|0|||
124628313|NCT00729937|448256159|FG004|Overall Study|Did not meet eligibility criteria|0|||
124628314|NCT00729937|448256160|FG005|Overall Study|Did not meet eligibility criteria|0|||
124788798|NCT03595618|448855949|FG002|Overall Study|Withdrawal by Subject|14|||
124788799|NCT03595618|448855950|FG003|Overall Study|Withdrawal by Subject|10|||
124788800|NCT03595618|448855947|FG000|Overall Study|Lost to Follow-up|6|||
124788801|NCT03595618|448855948|FG001|Overall Study|Lost to Follow-up|4|||
124788802|NCT03595618|448855949|FG002|Overall Study|Lost to Follow-up|5|||
124788803|NCT03595618|448855950|FG003|Overall Study|Lost to Follow-up|6|||
124788804|NCT03595618|448855947|FG000|Overall Study|Protocol Violation|2|||
124788805|NCT03595618|448855948|FG001|Overall Study|Protocol Violation|0|||
124788806|NCT03595618|448855949|FG002|Overall Study|Protocol Violation|6|||
124788807|NCT03595618|448855950|FG003|Overall Study|Protocol Violation|2|||
124788808|NCT03595618|448855947|FG000|Overall Study|Physician Decision|0|||
124788809|NCT03595618|448855948|FG001|Overall Study|Physician Decision|0|||
124788810|NCT03595618|448855949|FG002|Overall Study|Physician Decision|1|||
124788811|NCT03595618|448855950|FG003|Overall Study|Physician Decision|2|||
124788812|NCT03595618|448855947|FG000|Overall Study|Miscellaneous|7|||
124788813|NCT03595618|448855948|FG001|Overall Study|Miscellaneous|5|||
124788814|NCT03595618|448855949|FG002|Overall Study|Miscellaneous|10|||
124788815|NCT03595618|448855950|FG003|Overall Study|Miscellaneous|6|||
124788816|NCT01253811|448855951|FG000|Overall Study|Withdrawal criteria|1|||
124788817|NCT01782469|448855954|FG000|Overall Study|Lost to Follow-up|1|||
124788818|NCT00357760|448855961|FG000|Overall Study|Disease progression|44|||
124788819|NCT00357760|448855962|FG001|Overall Study|Disease progression|17|||
124788820|NCT00357760|448855961|FG000|Overall Study|Adverse Event|10|||
124788821|NCT00357760|448855962|FG001|Overall Study|Adverse Event|7|||
124788822|NCT00357760|448855961|FG000|Overall Study|Death|0|||
124788823|NCT00357760|448855962|FG001|Overall Study|Death|3|||
124788824|NCT00357760|448855961|FG000|Overall Study|Alternative therapy|1|||
124788825|NCT00357760|448855962|FG001|Overall Study|Alternative therapy|0|||
124788826|NCT00357760|448855961|FG000|Overall Study|Withdrawal by Subject|0|||
124788827|NCT00357760|448855962|FG001|Overall Study|Withdrawal by Subject|2|||
124788828|NCT00357760|448855961|FG000|Overall Study|Never started treatment|2|||
124788829|NCT00357760|448855962|FG001|Overall Study|Never started treatment|1|||
124788830|NCT00357760|448855961|FG000|Overall Study|Ineligible|0|||
124788831|NCT00357760|448855962|FG001|Overall Study|Ineligible|2|||
124788832|NCT00357760|448855961|FG000|Overall Study|Physician Decision|2|||
124788833|NCT00357760|448855962|FG001|Overall Study|Physician Decision|1|||
124788834|NCT00357760|448855961|FG000|Overall Study|Protocol Violation|0|||
124788835|NCT00357760|448855962|FG001|Overall Study|Protocol Violation|1|||
124788836|NCT00357760|448855961|FG000|Overall Study|To receive hospice care|0|||
124788837|NCT00357760|448855962|FG001|Overall Study|To receive hospice care|1|||
124788838|NCT04136444|448855963|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
124788839|NCT04136444|448855964|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
124788840|NCT02184572|448855970|FG000|Overall Study|Lost to Follow-up|29|||
124788841|NCT02184572|448855971|FG001|Overall Study|Lost to Follow-up|21|||
124788842|NCT02184572|448855970|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
124788843|NCT02184572|448855971|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
124788844|NCT02184572|448855970|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
124788845|NCT02184572|448855971|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
124788846|NCT02184572|448855970|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
124788847|NCT02184572|448855971|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
124788848|NCT02184572|448855970|FG000|Overall Study|Traveling Outside The Country|1|||
124788849|NCT02184572|448855971|FG001|Overall Study|Traveling Outside The Country|0|||
124788850|NCT02184572|448855970|FG000|Overall Study|Withdrawal by Subject|14|||
124788851|NCT02184572|448855971|FG001|Overall Study|Withdrawal by Subject|9|||
124628315|NCT00729937|448256155|FG000|Overall Study|Incarcerated|0|||
124788852|NCT03726996|448855972|FG000|Overall Study|Parent's decision|2|||
124788853|NCT03726996|448855972|FG000|Overall Study|Study early termination|2|||
124788854|NCT01328444|448855973|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
124788855|NCT01328444|448855974|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
124788856|NCT01328444|448855975|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
124788857|NCT01328444|448855976|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
124628316|NCT00729937|448256156|FG001|Overall Study|Incarcerated|2|||
124788858|NCT01328444|448855977|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
124788859|NCT01328444|448855978|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
124788860|NCT01328444|448855973|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
124788861|NCT01328444|448855974|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
124788862|NCT01328444|448855975|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
124788863|NCT01328444|448855976|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
124788864|NCT01328444|448855977|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
124788865|NCT01328444|448855978|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
124788866|NCT01328444|448855973|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
124788867|NCT01328444|448855974|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
124788868|NCT01328444|448855975|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
124788869|NCT01328444|448855976|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
124788870|NCT01328444|448855977|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
124788871|NCT01328444|448855978|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
124788872|NCT01328444|448855973|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
124788873|NCT01328444|448855974|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
124788874|NCT01328444|448855975|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
124788875|NCT01328444|448855976|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
124788876|NCT01328444|448855977|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
124788877|NCT01328444|448855978|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
124788878|NCT01328444|448855973|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
124788879|NCT01328444|448855974|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124788880|NCT01328444|448855975|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124788881|NCT01328444|448855976|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
124788882|NCT01328444|448855977|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124788883|NCT01328444|448855978|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
124788884|NCT01328444|448855973|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
124788885|NCT01328444|448855974|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
124788886|NCT01328444|448855975|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
124788887|NCT01328444|448855976|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
124788888|NCT01328444|448855977|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
124788889|NCT01328444|448855978|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
124788890|NCT01328444|448855973|FG000|Washout Period (14 Days)|Adverse Event|1|||
124788891|NCT01328444|448855974|FG001|Washout Period (14 Days)|Adverse Event|1|||
124788892|NCT01328444|448855975|FG002|Washout Period (14 Days)|Adverse Event|0|||
124788893|NCT01328444|448855976|FG003|Washout Period (14 Days)|Adverse Event|1|||
124788894|NCT01328444|448855977|FG004|Washout Period (14 Days)|Adverse Event|1|||
124788895|NCT01328444|448855978|FG005|Washout Period (14 Days)|Adverse Event|2|||
124788896|NCT01328444|448855973|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
124788897|NCT01328444|448855974|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
124788898|NCT01328444|448855975|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
124788899|NCT01328444|448855976|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
124788900|NCT01328444|448855977|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
124788901|NCT01328444|448855978|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
124788902|NCT01328444|448855973|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
124788903|NCT01328444|448855974|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
124788904|NCT01328444|448855975|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
124788905|NCT01328444|448855976|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
124788906|NCT01328444|448855977|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
124788907|NCT01328444|448855978|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
124788908|NCT01328444|448855973|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
124788909|NCT01328444|448855974|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
124788910|NCT01328444|448855975|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
124788911|NCT01328444|448855976|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
124788912|NCT01328444|448855977|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
124788913|NCT01328444|448855978|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
124788914|NCT01328444|448855973|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
124788915|NCT01328444|448855974|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
124788916|NCT01328444|448855975|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
124788917|NCT01328444|448855976|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
124788918|NCT01328444|448855977|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
124788919|NCT01328444|448855978|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
124788920|NCT01328444|448855973|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
124788921|NCT01328444|448855974|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
124788922|NCT01328444|448855975|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
124788923|NCT01328444|448855976|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
124788924|NCT01328444|448855977|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
124788925|NCT01328444|448855978|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
124788926|NCT01328444|448855973|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
124788927|NCT01328444|448855974|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
124788928|NCT01328444|448855975|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
124628317|NCT00729937|448256157|FG002|Overall Study|Incarcerated|1|||
124628318|NCT00729937|448256158|FG003|Overall Study|Incarcerated|1|||
124788929|NCT01328444|448855976|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
124788930|NCT01328444|448855977|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
124788931|NCT01328444|448855978|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
124788932|NCT01328444|448855973|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
124788933|NCT01328444|448855974|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
124788934|NCT01328444|448855975|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
124788935|NCT01328444|448855976|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
124788936|NCT01328444|448855977|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
124788937|NCT01328444|448855978|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
124788938|NCT01328444|448855973|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124788939|NCT01328444|448855974|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124788940|NCT01328444|448855975|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124788941|NCT01328444|448855976|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124788942|NCT01328444|448855977|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
124788943|NCT01328444|448855978|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
124788944|NCT03180619|448855979|FG000|Overall Study|Withdrew Consent|5|||
124788945|NCT03180619|448855980|FG001|Overall Study|Withdrew Consent|0|||
124788946|NCT03180619|448855981|FG002|Overall Study|Withdrew Consent|2|||
124788947|NCT03180619|448855979|FG000|Overall Study|Death|2|||
124788948|NCT03180619|448855980|FG001|Overall Study|Death|1|||
124788949|NCT03180619|448855981|FG002|Overall Study|Death|2|||
124788950|NCT03180619|448855979|FG000|Overall Study|Adverse Event|2|||
124788951|NCT03180619|448855980|FG001|Overall Study|Adverse Event|0|||
124788952|NCT03180619|448855981|FG002|Overall Study|Adverse Event|1|||
124788953|NCT03180619|448855979|FG000|Overall Study|Investigator's discretion|2|||
124788954|NCT03180619|448855980|FG001|Overall Study|Investigator's discretion|0|||
124788955|NCT03180619|448855981|FG002|Overall Study|Investigator's discretion|1|||
124788956|NCT02743611|448855982|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
124788957|NCT02743611|448855983|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
124788958|NCT02743611|448855984|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
124788959|NCT02743611|448855985|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
124788960|NCT00561977|448855986|FG000|Overall Study|Withdrawal by Subject|0|||
124788961|NCT00561977|448855987|FG001|Overall Study|Withdrawal by Subject|2|||
124788962|NCT00561977|448855988|FG002|Overall Study|Withdrawal by Subject|1|||
124788963|NCT00561977|448855986|FG000|Overall Study|Pregnancy|0|||
124788964|NCT00561977|448855987|FG001|Overall Study|Pregnancy|1|||
124788965|NCT00561977|448855988|FG002|Overall Study|Pregnancy|1|||
124788966|NCT00781885|448855989|FG000|Overall Study|Physician Decision|1|||
124788967|NCT01755026|448855990|FG000|Overall Study|Adverse Event|1|||
124788968|NCT01755026|448855991|FG001|Overall Study|Adverse Event|0|||
124788969|NCT01755026|448855990|FG000|Overall Study|Withdrawal by Subject|1|||
124788970|NCT01755026|448855991|FG001|Overall Study|Withdrawal by Subject|1|||
124788971|NCT00392379|448855992|FG000|Overall Study|Withdrawal by Subject|17|||
124788972|NCT00392379|448855993|FG001|Overall Study|Withdrawal by Subject|28|||
124788973|NCT00392379|448855992|FG000|Overall Study|Lost to Follow-up|4|||
124788974|NCT00392379|448855993|FG001|Overall Study|Lost to Follow-up|9|||
124788975|NCT00392379|448855992|FG000|Overall Study|Adverse Event|1|||
124788976|NCT00392379|448855993|FG001|Overall Study|Adverse Event|1|||
124788977|NCT03041129|448855994|FG000|Overall Study|Withdrawal by Subject|2|||
124788978|NCT03041129|448855995|FG001|Overall Study|Withdrawal by Subject|0|||
124788979|NCT03041129|448855996|FG002|Overall Study|Withdrawal by Subject|0|||
124788980|NCT03041129|448855997|FG003|Overall Study|Withdrawal by Subject|0|||
124788981|NCT03678870|448855998|FG000|Overall Study|prescribed non- protocol medications|10|||
124788982|NCT03678870|448855999|FG001|Overall Study|prescribed non- protocol medications|6|||
124788983|NCT03678870|448855998|FG000|Overall Study|Lost to Follow-up|3|||
124788984|NCT03678870|448855999|FG001|Overall Study|Lost to Follow-up|2|||
124788985|NCT03104816|448856000|FG000|Overall Study|Lack of Efficacy|0|||
124788986|NCT03104816|448856001|FG001|Overall Study|Lack of Efficacy|2|||
124788987|NCT03104816|448856002|FG002|Overall Study|Lack of Efficacy|0|||
124788988|NCT03104816|448856000|FG000|Overall Study|Protocol Violation|2|||
124788989|NCT03104816|448856001|FG001|Overall Study|Protocol Violation|0|||
124788990|NCT03104816|448856002|FG002|Overall Study|Protocol Violation|2|||
124788991|NCT01159431|448856004|FG000|Overall Study|Adverse Event|1|||
124788992|NCT01159431|448856005|FG001|Overall Study|Adverse Event|2|||
124788993|NCT01159431|448856004|FG000|Overall Study|non-compliance|1|||
124788994|NCT01159431|448856005|FG001|Overall Study|non-compliance|1|||
124788995|NCT01159431|448856004|FG000|Overall Study|Lack of Efficacy|0|||
124788996|NCT01159431|448856005|FG001|Overall Study|Lack of Efficacy|3|||
124788997|NCT03645434|448856008|FG000|Period 1|Adverse Event|0|||
124788998|NCT03645434|448856009|FG001|Period 1|Adverse Event|0|||
124788999|NCT03645434|448856010|FG002|Period 1|Adverse Event|0|||
124789000|NCT03645434|448856011|FG003|Period 1|Adverse Event|1|||
124789001|NCT03645434|448856012|FG004|Period 1|Adverse Event|0|||
124789002|NCT03645434|448856013|FG005|Period 1|Adverse Event|0|||
124789003|NCT03645434|448856008|FG000|Period 1|COPD exacerbation|0|||
124628319|NCT00729937|448256159|FG004|Overall Study|Incarcerated|0|||
124789004|NCT03645434|448856009|FG001|Period 1|COPD exacerbation|0|||
124789005|NCT03645434|448856010|FG002|Period 1|COPD exacerbation|0|||
124789006|NCT03645434|448856011|FG003|Period 1|COPD exacerbation|0|||
124789007|NCT03645434|448856012|FG004|Period 1|COPD exacerbation|1|||
124789008|NCT03645434|448856013|FG005|Period 1|COPD exacerbation|0|||
124789009|NCT03658876|448857847|FG000|Overall Study|Protocol Violation|3|||
124789010|NCT03658876|448857848|FG001|Overall Study|Protocol Violation|2|||
124789011|NCT03658876|448857847|FG000|Overall Study|Withdrawal by Subject|2|||
124789012|NCT03658876|448857848|FG001|Overall Study|Withdrawal by Subject|0|||
124789013|NCT03658876|448857847|FG000|Overall Study|Death|0|||
124789014|NCT03658876|448857848|FG001|Overall Study|Death|1|||
124789015|NCT03658876|448857847|FG000|Overall Study|Intercurrent illness|6|||
124789016|NCT03658876|448857848|FG001|Overall Study|Intercurrent illness|4|||
124789017|NCT03658876|448857847|FG000|Overall Study|Transplantation/other operation|1|||
124789018|NCT03658876|448857848|FG001|Overall Study|Transplantation/other operation|5|||
124789019|NCT01330017|448857849|FG000|Overall Study|Adverse Event|0|||
124789020|NCT01330017|448857850|FG001|Overall Study|Adverse Event|1|||
124789021|NCT01330017|448857851|FG002|Overall Study|Adverse Event|1|||
124789022|NCT01330017|448857852|FG003|Overall Study|Adverse Event|4|||
124789023|NCT01330017|448857853|FG004|Overall Study|Adverse Event|0|||
124789024|NCT01330017|448857849|FG000|Overall Study|Withdrawal by Subject|0|||
124789025|NCT01330017|448857850|FG001|Overall Study|Withdrawal by Subject|0|||
124789026|NCT01330017|448857851|FG002|Overall Study|Withdrawal by Subject|1|||
124789027|NCT01330017|448857852|FG003|Overall Study|Withdrawal by Subject|0|||
124789028|NCT01330017|448857853|FG004|Overall Study|Withdrawal by Subject|1|||
124789029|NCT01330017|448857849|FG000|Overall Study|Lost to Follow-up|0|||
124789030|NCT01330017|448857850|FG001|Overall Study|Lost to Follow-up|0|||
124789031|NCT01330017|448857851|FG002|Overall Study|Lost to Follow-up|1|||
124789032|NCT01330017|448857852|FG003|Overall Study|Lost to Follow-up|0|||
124789033|NCT01330017|448857853|FG004|Overall Study|Lost to Follow-up|0|||
124789034|NCT01330017|448857849|FG000|Overall Study|Protocol Violation|0|||
124789035|NCT01330017|448857850|FG001|Overall Study|Protocol Violation|0|||
124789036|NCT01330017|448857851|FG002|Overall Study|Protocol Violation|0|||
124789037|NCT01330017|448857852|FG003|Overall Study|Protocol Violation|1|||
124789038|NCT01330017|448857853|FG004|Overall Study|Protocol Violation|0|||
124789039|NCT01330017|448857849|FG000|Overall Study|Unknown Reason|5|||
124789040|NCT01330017|448857850|FG001|Overall Study|Unknown Reason|3|||
124789041|NCT01330017|448857851|FG002|Overall Study|Unknown Reason|5|||
124789042|NCT01330017|448857852|FG003|Overall Study|Unknown Reason|7|||
124789043|NCT01330017|448857853|FG004|Overall Study|Unknown Reason|2|||
124789044|NCT01106092|448857854|FG000|Overall Study|Withdrawal by Subject|0|||
124789045|NCT01106092|448857855|FG001|Overall Study|Withdrawal by Subject|0|||
124789046|NCT01106092|448857856|FG002|Overall Study|Withdrawal by Subject|0|||
124789047|NCT01106092|448857857|FG003|Overall Study|Withdrawal by Subject|1|||
124789048|NCT00843778|448857858|FG000|Overall Study|Adverse Event|15|||
124789049|NCT00843778|448857858|FG000|Overall Study|Lack of Efficacy|14|||
124789050|NCT00843778|448857858|FG000|Overall Study|Loss of efficacy|2|||
124789051|NCT00843778|448857858|FG000|Overall Study|Withdrawal by Subject|4|||
124789052|NCT03338959|448857863|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
124789053|NCT03338959|448857863|FG000|Overall Study|Physician Decision|1|||
124789054|NCT03328182|448857866|FG000|Overall Study|Withdrawal by Subject|1|||
124789055|NCT03328182|448857866|FG000|Overall Study|Protocol Violation|2|||
124789056|NCT03328182|448857866|FG000|Overall Study|No Product Evaluated|1|||
124789057|NCT01347580|448857870|FG000|Overall Study|Withdrawal by Subject|13|||
124789058|NCT01347580|448857871|FG001|Overall Study|Withdrawal by Subject|23|||
124789059|NCT01347580|448857870|FG000|Overall Study|Death|30|||
124789060|NCT01347580|448857871|FG001|Overall Study|Death|19|||
124789061|NCT01347580|448857870|FG000|Overall Study|Protocol Violation|10|||
124789062|NCT01347580|448857871|FG001|Overall Study|Protocol Violation|7|||
124789063|NCT01347580|448857870|FG000|Overall Study|Lost to Follow-up|3|||
124789064|NCT01347580|448857871|FG001|Overall Study|Lost to Follow-up|1|||
124789065|NCT01347580|448857870|FG000|Overall Study|Had other reason|9|||
124789066|NCT01347580|448857871|FG001|Overall Study|Had other reason|6|||
124789067|NCT02870933|448857872|FG000|Overall Study|Death|2|||
124789068|NCT02870933|448857873|FG001|Overall Study|Death|1|||
124789069|NCT02870933|448857872|FG000|Overall Study|Withdrawal by Subject|0|||
124789070|NCT02870933|448857873|FG001|Overall Study|Withdrawal by Subject|1|||
124789071|NCT00003590|448857874|FG000|Overall Study|Ineligible Patient|1|||
124789072|NCT00003590|448857874|FG000|Overall Study|Adverse Event|7|||
124789073|NCT00003590|448857874|FG000|Overall Study|Withdrawal by Subject|1|||
124789074|NCT00003590|448857874|FG000|Overall Study|Lack of Efficacy|11|||
124789075|NCT00003590|448857874|FG000|Overall Study|Death|1|||
124789076|NCT00003590|448857874|FG000|Overall Study|Physician Decision|1|||
124789077|NCT01425463|448857875|FG000|Overall Study|Adverse Event|5|||
124789078|NCT01425463|448857876|FG001|Overall Study|Adverse Event|7|||
124789079|NCT01425463|448857875|FG000|Overall Study|Lack of Efficacy|1|||
124789080|NCT01425463|448857876|FG001|Overall Study|Lack of Efficacy|1|||
124789081|NCT01425463|448857875|FG000|Overall Study|Protocol Violation|2|||
124789082|NCT01425463|448857876|FG001|Overall Study|Protocol Violation|2|||
124789083|NCT01425463|448857875|FG000|Overall Study|Lost to Follow-up|5|||
124789084|NCT01425463|448857876|FG001|Overall Study|Lost to Follow-up|2|||
124789085|NCT01425463|448857875|FG000|Overall Study|Withdrawal by Subject|7|||
124789086|NCT01425463|448857876|FG001|Overall Study|Withdrawal by Subject|5|||
124789087|NCT01425463|448857875|FG000|Overall Study|Unknown Reason|4|||
124789088|NCT01425463|448857876|FG001|Overall Study|Unknown Reason|7|||
124789089|NCT01009840|448857877|FG000|Overall Study|Lost to Follow-up|1|||
124789090|NCT01009840|448857877|FG000|Overall Study|Adverse Event|4|||
124789091|NCT01009840|448857877|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
124789092|NCT01009840|448857877|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
124789093|NCT01009840|448857877|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
124789094|NCT01958489|448857888|FG000|Period 2|Adverse Event|0|||
124789095|NCT01958489|448857889|FG001|Period 2|Adverse Event|1|||
124789096|NCT00917644|448857890|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
124789097|NCT00917644|448857891|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
124789098|NCT00917644|448857890|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
124789099|NCT00917644|448857891|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
124789100|NCT00917644|448857890|FG000|Period 2: Second Intervention|family emergency|1|||
124789101|NCT00917644|448857891|FG001|Period 2: Second Intervention|family emergency|0|||
124789102|NCT02338232|448857892|FG000|Overall Study|Screen Failure|3|||
124789103|NCT02338232|448857892|FG000|Overall Study|Withdrawal by Subject|6|||
124789104|NCT02338232|448857892|FG000|Overall Study|Adverse Event|2|||
124789105|NCT02500056|448857893|FG000|Overall Study|Lost to Follow-up|3|||
124789106|NCT02500056|448857894|FG001|Overall Study|Lost to Follow-up|7|||
124789107|NCT02500056|448857893|FG000|Overall Study|Recurrence|1|||
124789108|NCT02500056|448857894|FG001|Overall Study|Recurrence|0|||
124789109|NCT02500056|448857893|FG000|Overall Study|Death|3|||
124789110|NCT02500056|448857894|FG001|Overall Study|Death|1|||
124789111|NCT00864916|448857895|FG000|Overall Study|Lost to Follow-up|4|||
124789112|NCT00864916|448857896|FG001|Overall Study|Lost to Follow-up|4|||
124789113|NCT00864916|448857895|FG000|Overall Study|Protocol Violation|1|||
124789114|NCT00864916|448857896|FG001|Overall Study|Protocol Violation|0|||
124789115|NCT00864916|448857895|FG000|Overall Study|Withdrawal by Subject|1|||
124789116|NCT00864916|448857896|FG001|Overall Study|Withdrawal by Subject|0|||
124789117|NCT01087736|448857899|FG000|Overall Study|Lost to Follow-up|1|||
124789118|NCT01087736|448857900|FG001|Overall Study|Lost to Follow-up|0|||
124789119|NCT01087736|448857899|FG000|Overall Study|Death|0|||
124789120|NCT01087736|448857900|FG001|Overall Study|Death|1|||
124789121|NCT01087736|448857899|FG000|Overall Study|Withdrawal by Subject|0|||
124789122|NCT01087736|448857900|FG001|Overall Study|Withdrawal by Subject|1|||
124789123|NCT02122783|448857909|FG000|Overall Study|Adverse Event|0|||
124789124|NCT02122783|448857910|FG001|Overall Study|Adverse Event|1|||
124789125|NCT01579812|448857913|FG000|Overall Study|Ineligible after treatment start|40|||
124789126|NCT01579812|448857913|FG000|Overall Study|Patient choice|3|||
124789127|NCT01579812|448857913|FG000|Overall Study|Noncompliance|3|||
124789128|NCT01579812|448857913|FG000|Overall Study|Withdrawal by Subject|6|||
124789129|NCT01101308|448857914|FG000|Period 1|Adverse Event|2|||
124789130|NCT01101308|448857915|FG001|Period 1|Adverse Event|1|||
124789131|NCT01101308|448857914|FG000|Period 1|Positive for cotinine|1|||
124789132|NCT01101308|448857915|FG001|Period 1|Positive for cotinine|0|||
124789133|NCT04905498|448857920|FG000|Overall Study|Lost to Follow-up|0|||
124789134|NCT04905498|448857921|FG001|Overall Study|Lost to Follow-up|2|||
124789135|NCT04905498|448857920|FG000|Overall Study|COVID lockdown|1|||
124789136|NCT04905498|448857921|FG001|Overall Study|COVID lockdown|0|||
124789137|NCT00869778|448857924|FG000|Overall Study|Adverse Event|2|||
124789138|NCT00869778|448857925|FG001|Overall Study|Adverse Event|0|||
124789139|NCT00869778|448857926|FG002|Overall Study|Adverse Event|0|||
124789140|NCT00869778|448857924|FG000|Overall Study|Withdrawal by Subject|3|||
124789141|NCT00869778|448857925|FG001|Overall Study|Withdrawal by Subject|4|||
124789142|NCT00869778|448857926|FG002|Overall Study|Withdrawal by Subject|5|||
124789143|NCT00869778|448857924|FG000|Overall Study|Pregnancy|1|||
124789144|NCT00869778|448857925|FG001|Overall Study|Pregnancy|0|||
124789145|NCT00869778|448857926|FG002|Overall Study|Pregnancy|0|||
124789146|NCT00869778|448857924|FG000|Overall Study|Protocol Violation|5|||
124789147|NCT00869778|448857925|FG001|Overall Study|Protocol Violation|3|||
124789148|NCT00869778|448857926|FG002|Overall Study|Protocol Violation|5|||
124789149|NCT00869778|448857924|FG000|Overall Study|Unblinding|1|||
124789150|NCT00869778|448857925|FG001|Overall Study|Unblinding|0|||
124789151|NCT00869778|448857926|FG002|Overall Study|Unblinding|0|||
124789152|NCT03339297|448857927|FG000|Overall Study|Relapse of Hematologic Disease|1|||
124789153|NCT03339297|448857928|FG001|Overall Study|Relapse of Hematologic Disease|0|||
124789154|NCT03339297|448857927|FG000|Overall Study|Death|10|||
124789155|NCT03339297|448857928|FG001|Overall Study|Death|7|||
124789156|NCT03339297|448857927|FG000|Overall Study|Hepatic Candidosis|1|||
124789157|NCT03339297|448857928|FG001|Overall Study|Hepatic Candidosis|0|||
124789158|NCT03339297|448857927|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
124789159|NCT03339297|448857928|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
124789160|NCT03339297|448857927|FG000|Overall Study|Consent Withdrawn by Participant|3|||
124789161|NCT03339297|448857928|FG001|Overall Study|Consent Withdrawn by Participant|3|||
124789162|NCT03339297|448857927|FG000|Overall Study|Disease Relapse|2|||
124789163|NCT03339297|448857928|FG001|Overall Study|Disease Relapse|0|||
124789164|NCT03339297|448857927|FG000|Overall Study|Physician Decision|1|||
124789165|NCT03339297|448857928|FG001|Overall Study|Physician Decision|1|||
124789166|NCT03339297|448857927|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
124789167|NCT03339297|448857928|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
124789168|NCT03339297|448857927|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
124789169|NCT03339297|448857928|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
124789170|NCT03339297|448857927|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
124789171|NCT03339297|448857928|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
124789172|NCT03339297|448857927|FG000|Overall Study|Adverse Event, Non-fatal|1|||
124789173|NCT03339297|448857928|FG001|Overall Study|Adverse Event, Non-fatal|0|||
124789174|NCT03339297|448857927|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
124789175|NCT03339297|448857928|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
124789176|NCT03339297|448857927|FG000|Overall Study|Patient Was Not Eligible|1|||
124789177|NCT03339297|448857928|FG001|Overall Study|Patient Was Not Eligible|0|||
124789178|NCT03051620|448857929|FG000|Overall Study|Lost to Follow-up|6|||
124789179|NCT03051620|448857929|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
124789180|NCT00393510|448857930|FG000|Overall Study|Physician Decision|3|||
124789181|NCT00393510|448857931|FG001|Overall Study|Physician Decision|9|||
124789182|NCT03077087|448857932|FG000|Overall Study|Physician Decision|2|||
124789183|NCT02112045|448857935|FG000|Overall Study|Withdrawal by Subject|1|||
124789184|NCT02112045|448857936|FG001|Overall Study|Withdrawal by Subject|0|||
124789185|NCT00977080|448857938|FG000|Overall Study|Adverse Event|2|||
124789186|NCT00977080|448857939|FG001|Overall Study|Adverse Event|7|||
124789187|NCT00977080|448857940|FG002|Overall Study|Adverse Event|7|||
124789188|NCT00977080|448857941|FG003|Overall Study|Adverse Event|7|||
124789189|NCT00977080|448857938|FG000|Overall Study|Withdrawal by Subject|1|||
124789190|NCT00977080|448857939|FG001|Overall Study|Withdrawal by Subject|5|||
124789191|NCT00977080|448857940|FG002|Overall Study|Withdrawal by Subject|1|||
124789192|NCT00977080|448857941|FG003|Overall Study|Withdrawal by Subject|5|||
124789193|NCT00977080|448857938|FG000|Overall Study|Protocol Violation|7|||
124789194|NCT00977080|448857939|FG001|Overall Study|Protocol Violation|3|||
124789195|NCT00977080|448857940|FG002|Overall Study|Protocol Violation|4|||
124789196|NCT00977080|448857941|FG003|Overall Study|Protocol Violation|3|||
124789197|NCT00977080|448857938|FG000|Overall Study|Noncompliance|0|||
124789198|NCT00977080|448857939|FG001|Overall Study|Noncompliance|2|||
124789199|NCT00977080|448857940|FG002|Overall Study|Noncompliance|1|||
124789200|NCT00977080|448857941|FG003|Overall Study|Noncompliance|0|||
124789201|NCT00977080|448857938|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
124789202|NCT00977080|448857939|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
124789203|NCT00977080|448857940|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
124789204|NCT00977080|448857941|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
124789205|NCT00977080|448857938|FG000|Overall Study|Required kidney transplantation|1|||
124789206|NCT00977080|448857939|FG001|Overall Study|Required kidney transplantation|3|||
124789207|NCT00977080|448857940|FG002|Overall Study|Required kidney transplantation|3|||
124789208|NCT00977080|448857941|FG003|Overall Study|Required kidney transplantation|1|||
124789209|NCT00977080|448857938|FG000|Overall Study|Travel for family reasons|1|||
124789210|NCT00977080|448857939|FG001|Overall Study|Travel for family reasons|0|||
124789211|NCT00977080|448857940|FG002|Overall Study|Travel for family reasons|0|||
124789212|NCT00977080|448857941|FG003|Overall Study|Travel for family reasons|0|||
124789213|NCT00441116|448857944|FG000|Overall Study|Adverse Event|1|||
124789214|NCT00441116|448857945|FG001|Overall Study|Adverse Event|1|||
124789215|NCT00441116|448857944|FG000|Overall Study|Withdrawal by Subject|1|||
124789216|NCT00441116|448857945|FG001|Overall Study|Withdrawal by Subject|0|||
124789217|NCT00441116|448857944|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
124789218|NCT00441116|448857945|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
124789219|NCT00796991|448857957|FG000|Overall Study|Adverse Event|0|||
124789220|NCT00796991|448857958|FG001|Overall Study|Adverse Event|0|||
124789221|NCT00796991|448857959|FG002|Overall Study|Adverse Event|1|||
124789222|NCT00796991|448857957|FG000|Overall Study|Death|2|||
124789223|NCT00796991|448857958|FG001|Overall Study|Death|0|||
124789224|NCT00796991|448857959|FG002|Overall Study|Death|0|||
124628320|NCT00729937|448256160|FG005|Overall Study|Incarcerated|0|||
124789225|NCT00796991|448857957|FG000|Overall Study|Disease Progression|10|||
124789226|NCT00796991|448857958|FG001|Overall Study|Disease Progression|9|||
124628321|NCT00243412|448256162|FG000|Overall Study|Death|0|||
124628322|NCT00243412|448256163|FG001|Overall Study|Death|1|||
124789227|NCT00796991|448857959|FG002|Overall Study|Disease Progression|7|||
124789228|NCT00796991|448857957|FG000|Overall Study|Study Drug Toxicity|3|||
124789229|NCT00796991|448857958|FG001|Overall Study|Study Drug Toxicity|3|||
124789230|NCT00796991|448857959|FG002|Overall Study|Study Drug Toxicity|5|||
124789231|NCT00796991|448857957|FG000|Overall Study|Withdrawal by Subject|0|||
124628323|NCT00243412|448256162|FG000|Overall Study|Adverse Event|4|||
124789232|NCT00796991|448857958|FG001|Overall Study|Withdrawal by Subject|0|||
124789233|NCT00796991|448857959|FG002|Overall Study|Withdrawal by Subject|1|||
124789234|NCT01765218|448857960|FG000|Overall Study|Protocol Violation|1|||
124789235|NCT01765218|448857961|FG001|Overall Study|Protocol Violation|2|||
124789236|NCT03148691|448857962|FG000|Overall Study|Protocol Violation|1|||
124789237|NCT03148691|448857963|FG001|Overall Study|Protocol Violation|2|||
124789238|NCT03148691|448857964|FG002|Overall Study|Protocol Violation|7|||
124789239|NCT03148691|448857962|FG000|Overall Study|Lost to Follow-up|0|||
124789240|NCT03148691|448857963|FG001|Overall Study|Lost to Follow-up|0|||
124789241|NCT03148691|448857964|FG002|Overall Study|Lost to Follow-up|1|||
124789242|NCT03148691|448857962|FG000|Overall Study|Other|1|||
124789243|NCT03148691|448857963|FG001|Overall Study|Other|0|||
124789244|NCT03148691|448857964|FG002|Overall Study|Other|0|||
124789245|NCT03148691|448857962|FG000|Overall Study|Withdrawal by Subject|1|||
124789246|NCT03148691|448857963|FG001|Overall Study|Withdrawal by Subject|0|||
124789247|NCT03148691|448857964|FG002|Overall Study|Withdrawal by Subject|0|||
124789248|NCT00171834|448857965|FG000|Overall Study|Adverse Event|2|||
124789249|NCT00171834|448857966|FG001|Overall Study|Adverse Event|1|||
124789250|NCT00171834|448857967|FG002|Overall Study|Adverse Event|3|||
124789251|NCT00171834|448857968|FG003|Overall Study|Adverse Event|2|||
124789252|NCT00171834|448857969|FG004|Overall Study|Adverse Event|2|||
124789253|NCT00171834|448857970|FG005|Overall Study|Adverse Event|15|||
124789254|NCT00171834|448857971|FG006|Overall Study|Adverse Event|1|||
124789255|NCT00171834|448857965|FG000|Overall Study|Withdrawal by Subject|0|||
124789256|NCT00171834|448857966|FG001|Overall Study|Withdrawal by Subject|2|||
124789257|NCT00171834|448857967|FG002|Overall Study|Withdrawal by Subject|0|||
124789258|NCT00171834|448857968|FG003|Overall Study|Withdrawal by Subject|1|||
124789259|NCT00171834|448857969|FG004|Overall Study|Withdrawal by Subject|1|||
124789260|NCT00171834|448857970|FG005|Overall Study|Withdrawal by Subject|1|||
124789261|NCT00171834|448857971|FG006|Overall Study|Withdrawal by Subject|0|||
124789262|NCT00171834|448857965|FG000|Overall Study|Death from study indication|0|||
124789263|NCT00171834|448857966|FG001|Overall Study|Death from study indication|1|||
124789264|NCT00171834|448857967|FG002|Overall Study|Death from study indication|0|||
124789265|NCT00171834|448857968|FG003|Overall Study|Death from study indication|0|||
124789266|NCT00171834|448857969|FG004|Overall Study|Death from study indication|1|||
124789267|NCT00171834|448857970|FG005|Overall Study|Death from study indication|0|||
124789268|NCT00171834|448857971|FG006|Overall Study|Death from study indication|0|||
124789269|NCT00171834|448857965|FG000|Overall Study|Disease Progression|4|||
124789270|NCT00171834|448857966|FG001|Overall Study|Disease Progression|8|||
124789271|NCT00171834|448857967|FG002|Overall Study|Disease Progression|8|||
124789272|NCT00171834|448857968|FG003|Overall Study|Disease Progression|9|||
124789273|NCT00171834|448857969|FG004|Overall Study|Disease Progression|2|||
124789274|NCT00171834|448857970|FG005|Overall Study|Disease Progression|18|||
124789275|NCT00171834|448857971|FG006|Overall Study|Disease Progression|3|||
124789276|NCT00171834|448857965|FG000|Overall Study|Treatment Duration Completed|0|||
124789277|NCT00171834|448857966|FG001|Overall Study|Treatment Duration Completed|0|||
124789278|NCT00171834|448857967|FG002|Overall Study|Treatment Duration Completed|1|||
124789279|NCT00171834|448857968|FG003|Overall Study|Treatment Duration Completed|0|||
124789280|NCT00171834|448857969|FG004|Overall Study|Treatment Duration Completed|2|||
124789281|NCT00171834|448857970|FG005|Overall Study|Treatment Duration Completed|1|||
124789282|NCT00171834|448857971|FG006|Overall Study|Treatment Duration Completed|0|||
124789283|NCT02365233|448857981|FG000|Overall Study|IRB withheld the data|1|||
124789284|NCT02365233|448857982|FG001|Overall Study|IRB withheld the data|2|||
124789285|NCT02365233|448857983|FG002|Overall Study|IRB withheld the data|2|||
124789286|NCT01978938|448857984|FG000|Overall Study|Lost to Follow-up|12|||
124789287|NCT01978938|448857985|FG001|Overall Study|Lost to Follow-up|6|||
124789288|NCT01978938|448857984|FG000|Overall Study|Withdrawal by Subject|8|||
124789289|NCT01978938|448857985|FG001|Overall Study|Withdrawal by Subject|4|||
124789290|NCT01978938|448857984|FG000|Overall Study|Adverse Event, non-fatal|2|||
124789291|NCT01978938|448857985|FG001|Overall Study|Adverse Event, non-fatal|1|||
124789292|NCT01978938|448857984|FG000|Overall Study|Participant noncompliance|1|||
124789293|NCT01978938|448857985|FG001|Overall Study|Participant noncompliance|1|||
124789294|NCT01978938|448857984|FG000|Overall Study|Did not meet inclusion criteria|0|||
124789295|NCT01978938|448857985|FG001|Overall Study|Did not meet inclusion criteria|1|||
124789296|NCT01978938|448857984|FG000|Overall Study|Previously scheduled procedure|0|||
124789297|NCT01978938|448857985|FG001|Overall Study|Previously scheduled procedure|1|||
124789298|NCT02342418|448857986|FG000|Overall Study|Adverse Event|0|||
124789299|NCT02342418|448857987|FG001|Overall Study|Adverse Event|1|||
124789300|NCT04255394|448857988|FG000|Overall Study|Death|35|||
124789301|NCT04255394|448857989|FG001|Overall Study|Death|25|||
124789302|NCT04255394|448857988|FG000|Overall Study|Device removed|2|||
124789303|NCT04255394|448857989|FG001|Overall Study|Device removed|10|||
124789304|NCT04255394|448857988|FG000|Overall Study|Withdrawal by Subject|9|||
124789305|NCT04255394|448857989|FG001|Overall Study|Withdrawal by Subject|8|||
124789306|NCT04255394|448857988|FG000|Overall Study|Screen Failure/Not treated|12|||
124789307|NCT04255394|448857989|FG001|Overall Study|Screen Failure/Not treated|8|||
124789308|NCT04255394|448857988|FG000|Overall Study|Lost to Follow-up|123|||
124789309|NCT04255394|448857989|FG001|Overall Study|Lost to Follow-up|265|||
124789310|NCT04255394|448857988|FG000|Overall Study|Adverse Event|1|||
124789311|NCT04255394|448857989|FG001|Overall Study|Adverse Event|3|||
124789312|NCT02285062|448857995|FG000|Pre-Treatment Period|Protocol Violation|0|||
124789313|NCT02285062|448857996|FG001|Pre-Treatment Period|Protocol Violation|2|||
124789314|NCT02285062|448857995|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
124789315|NCT02285062|448857996|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
124789316|NCT00821509|448857997|FG000|Overall Study|Withdrawal by Subject|12|||
124789317|NCT00821509|448857998|FG001|Overall Study|Withdrawal by Subject|11|||
124789318|NCT00821509|448857999|FG002|Overall Study|Withdrawal by Subject|34|||
124789319|NCT01227629|448858001|FG000|Overall Study|Adverse Event|2|||
124789320|NCT01227629|448858002|FG001|Overall Study|Adverse Event|2|||
124789321|NCT01227629|448858003|FG002|Overall Study|Adverse Event|1|||
124789322|NCT01227629|448858004|FG003|Overall Study|Adverse Event|6|||
124789323|NCT01227629|448858005|FG004|Overall Study|Adverse Event|1|||
124789324|NCT01227629|448858006|FG005|Overall Study|Adverse Event|1|||
124789325|NCT01227629|448858007|FG006|Overall Study|Adverse Event|6|||
124789326|NCT01227629|448858008|FG007|Overall Study|Adverse Event|6|||
124789327|NCT01227629|448858009|FG008|Overall Study|Adverse Event|4|||
124789328|NCT01227629|448858010|FG009|Overall Study|Adverse Event|0|||
124789329|NCT01227629|448858001|FG000|Overall Study|Protocol Violation|0|||
124789330|NCT01227629|448858002|FG001|Overall Study|Protocol Violation|0|||
124789331|NCT01227629|448858003|FG002|Overall Study|Protocol Violation|0|||
124789332|NCT01227629|448858004|FG003|Overall Study|Protocol Violation|1|||
124789333|NCT01227629|448858005|FG004|Overall Study|Protocol Violation|0|||
124789334|NCT01227629|448858006|FG005|Overall Study|Protocol Violation|0|||
124789335|NCT01227629|448858007|FG006|Overall Study|Protocol Violation|0|||
124789336|NCT01227629|448858008|FG007|Overall Study|Protocol Violation|0|||
124789337|NCT01227629|448858009|FG008|Overall Study|Protocol Violation|0|||
124789338|NCT01227629|448858010|FG009|Overall Study|Protocol Violation|0|||
124789339|NCT01227629|448858001|FG000|Overall Study|Lost to Follow-up|0|||
124789340|NCT01227629|448858002|FG001|Overall Study|Lost to Follow-up|0|||
124789341|NCT01227629|448858003|FG002|Overall Study|Lost to Follow-up|0|||
124789342|NCT01227629|448858004|FG003|Overall Study|Lost to Follow-up|0|||
124789343|NCT01227629|448858005|FG004|Overall Study|Lost to Follow-up|1|||
124789344|NCT01227629|448858006|FG005|Overall Study|Lost to Follow-up|0|||
124789345|NCT01227629|448858007|FG006|Overall Study|Lost to Follow-up|0|||
124789346|NCT01227629|448858008|FG007|Overall Study|Lost to Follow-up|0|||
124789347|NCT01227629|448858009|FG008|Overall Study|Lost to Follow-up|0|||
124789348|NCT01227629|448858010|FG009|Overall Study|Lost to Follow-up|0|||
124789349|NCT01227629|448858001|FG000|Overall Study|Withdrawal by Subject|0|||
124789350|NCT01227629|448858002|FG001|Overall Study|Withdrawal by Subject|0|||
124789351|NCT01227629|448858003|FG002|Overall Study|Withdrawal by Subject|0|||
124789352|NCT01227629|448858004|FG003|Overall Study|Withdrawal by Subject|0|||
124789353|NCT01227629|448858005|FG004|Overall Study|Withdrawal by Subject|0|||
124789354|NCT01227629|448858006|FG005|Overall Study|Withdrawal by Subject|0|||
124789355|NCT01227629|448858007|FG006|Overall Study|Withdrawal by Subject|2|||
124789356|NCT01227629|448858008|FG007|Overall Study|Withdrawal by Subject|0|||
124789357|NCT01227629|448858009|FG008|Overall Study|Withdrawal by Subject|0|||
124789358|NCT01227629|448858010|FG009|Overall Study|Withdrawal by Subject|1|||
124789359|NCT01227629|448858001|FG000|Overall Study|Other|0|||
124789360|NCT01227629|448858002|FG001|Overall Study|Other|0|||
124789361|NCT01227629|448858003|FG002|Overall Study|Other|0|||
124789362|NCT01227629|448858004|FG003|Overall Study|Other|1|||
124789363|NCT01227629|448858005|FG004|Overall Study|Other|0|||
124789364|NCT01227629|448858006|FG005|Overall Study|Other|0|||
124789365|NCT01227629|448858007|FG006|Overall Study|Other|0|||
124789366|NCT01227629|448858008|FG007|Overall Study|Other|0|||
124789367|NCT01227629|448858009|FG008|Overall Study|Other|2|||
124789368|NCT01227629|448858010|FG009|Overall Study|Other|1|||
124789369|NCT00534599|448858016|FG000|Overall Study|Adverse Event|25|||
124789370|NCT00534599|448858017|FG001|Overall Study|Adverse Event|4|||
124789371|NCT00534599|448858016|FG000|Overall Study|Incorrect enrollment|2|||
124789372|NCT00534599|448858017|FG001|Overall Study|Incorrect enrollment|1|||
124789373|NCT00534599|448858016|FG000|Overall Study|Mis-randomization|2|||
124789374|NCT00534599|448858017|FG001|Overall Study|Mis-randomization|2|||
124789375|NCT00534599|448858016|FG000|Overall Study|Developed study-specific d/c criteria|5|||
124789376|NCT00534599|448858017|FG001|Overall Study|Developed study-specific d/c criteria|0|||
124789377|NCT00534599|448858016|FG000|Overall Study|Lack of Efficacy|0|||
124789378|NCT00534599|448858017|FG001|Overall Study|Lack of Efficacy|1|||
124789379|NCT00534599|448858016|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
124789380|NCT00534599|448858017|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
124789381|NCT00534599|448858016|FG000|Overall Study|Protocol Violation|1|||
124789382|NCT00534599|448858017|FG001|Overall Study|Protocol Violation|3|||
124789383|NCT00534599|448858016|FG000|Overall Study|Lost to Follow-up|11|||
124789384|NCT00534599|448858017|FG001|Overall Study|Lost to Follow-up|14|||
124789385|NCT00534599|448858016|FG000|Overall Study|Withdrawal by Subject|4|||
124789386|NCT00534599|448858017|FG001|Overall Study|Withdrawal by Subject|6|||
124789387|NCT00534599|448858016|FG000|Overall Study|Other|7|||
124789388|NCT00534599|448858017|FG001|Overall Study|Other|0|||
124789389|NCT03865316|448859970|FG000|Overall Study|Procedure Cancelled|4|||
124789390|NCT03865316|448859970|FG000|Overall Study|Equipment failure|4|||
124789391|NCT02616146|448859971|FG000|Overall Study|Adverse Event|64|||
124789392|NCT02616146|448859972|FG001|Overall Study|Adverse Event|24|||
124789393|NCT02616146|448859971|FG000|Overall Study|Lost to Follow-up|23|||
124789394|NCT02616146|448859972|FG001|Overall Study|Lost to Follow-up|13|||
124789395|NCT02616146|448859971|FG000|Overall Study|Non-compliance with study protocol|2|||
124789396|NCT02616146|448859972|FG001|Overall Study|Non-compliance with study protocol|0|||
124789397|NCT02616146|448859971|FG000|Overall Study|Non-compliance with study drug|4|||
124789398|NCT02616146|448859972|FG001|Overall Study|Non-compliance with study drug|2|||
124789399|NCT02616146|448859971|FG000|Overall Study|Pregnancy|2|||
124789400|NCT02616146|448859972|FG001|Overall Study|Pregnancy|2|||
124789401|NCT02616146|448859971|FG000|Overall Study|Pregnancy wish|3|||
124789402|NCT02616146|448859972|FG001|Overall Study|Pregnancy wish|0|||
124789403|NCT02616146|448859971|FG000|Overall Study|Protocol Violation|6|||
124789404|NCT02616146|448859972|FG001|Overall Study|Protocol Violation|3|||
124789405|NCT02616146|448859971|FG000|Overall Study|Study terminated by sponsor|1372|||
124789406|NCT02616146|448859972|FG001|Overall Study|Study terminated by sponsor|432|||
124789407|NCT02616146|448859971|FG000|Overall Study|Participant moved|4|||
124789408|NCT02616146|448859972|FG001|Overall Study|Participant moved|3|||
124789409|NCT02616146|448859971|FG000|Overall Study|Withdrawal by Subject|30|||
124789410|NCT02616146|448859972|FG001|Overall Study|Withdrawal by Subject|24|||
124789411|NCT02616146|448859971|FG000|Overall Study|Physician Decision|2|||
124789412|NCT02616146|448859972|FG001|Overall Study|Physician Decision|1|||
124789413|NCT00336856|448859973|FG000|Overall Study|Withdrawal by Subject|3|||
124789414|NCT00336856|448859973|FG000|Overall Study|Found ineligible at time of analysis|1|||
124789415|NCT01604278|448859974|FG000|Overall Study|Lack of Efficacy|0|||
124789416|NCT01604278|448859975|FG001|Overall Study|Lack of Efficacy|1|||
124789417|NCT01604278|448859974|FG000|Overall Study|Lost to Follow-up|1|||
124789418|NCT01604278|448859975|FG001|Overall Study|Lost to Follow-up|0|||
124789419|NCT01604278|448859974|FG000|Overall Study|Administrative problems|2|||
124789420|NCT01604278|448859975|FG001|Overall Study|Administrative problems|1|||
124789421|NCT01604278|448859974|FG000|Overall Study|Withdrawal by Subject|3|||
124789422|NCT01604278|448859975|FG001|Overall Study|Withdrawal by Subject|3|||
124789423|NCT01604278|448859974|FG000|Overall Study|Adverse Event|3|||
124789424|NCT01604278|448859975|FG001|Overall Study|Adverse Event|5|||
124789425|NCT01604278|448859974|FG000|Overall Study|Protocol Deviation|5|||
124789426|NCT01604278|448859975|FG001|Overall Study|Protocol Deviation|3|||
124789427|NCT02184455|448859976|FG000|Overall Study|Lost to Follow-up|1|||
124789428|NCT01012219|448859977|FG000|Period 1|Withdrawal by Subject|1|||
124789429|NCT01012219|448859977|FG000|Period 2|Withdrawal by Subject|1|||
124789430|NCT01444092|448859988|FG000|Overall Study|Adverse Event|8|||
124789431|NCT01444092|448859988|FG000|Overall Study|Protocol Violation|1|||
124789432|NCT01444092|448859988|FG000|Overall Study|Withdrawal by Subject|1|||
124789433|NCT01444092|448859988|FG000|Overall Study|Other Eligibility criteria|7|||
124789434|NCT01328366|448859989|FG000|Overall Study|Death|1|||
124789435|NCT01328366|448859989|FG000|Overall Study|Withdrawal by Subject|2|||
124789436|NCT01328366|448859989|FG000|Overall Study|Lost to Follow-up|7|||
124789437|NCT01122264|448859993|FG000|Overall Study|Adverse Event|6|||
124789438|NCT01122264|448859994|FG001|Overall Study|Adverse Event|5|||
124789439|NCT01122264|448859995|FG002|Overall Study|Adverse Event|7|||
124789440|NCT01122264|448859993|FG000|Overall Study|Death|1|||
124789441|NCT01122264|448859994|FG001|Overall Study|Death|0|||
124789442|NCT01122264|448859995|FG002|Overall Study|Death|0|||
124789443|NCT01122264|448859993|FG000|Overall Study|Lost to Follow-up|5|||
124789444|NCT01122264|448859994|FG001|Overall Study|Lost to Follow-up|9|||
124789445|NCT01122264|448859995|FG002|Overall Study|Lost to Follow-up|13|||
124789446|NCT01122264|448859993|FG000|Overall Study|Entry Criteria Not Met|1|||
124789447|NCT01122264|448859994|FG001|Overall Study|Entry Criteria Not Met|0|||
124789448|NCT01122264|448859995|FG002|Overall Study|Entry Criteria Not Met|0|||
124789449|NCT01122264|448859993|FG000|Overall Study|Protocol Violation|7|||
124789450|NCT01122264|448859994|FG001|Overall Study|Protocol Violation|7|||
124789451|NCT01122264|448859995|FG002|Overall Study|Protocol Violation|9|||
124789452|NCT01122264|448859993|FG000|Overall Study|Withdrawal by Subject|6|||
124789453|NCT01122264|448859994|FG001|Overall Study|Withdrawal by Subject|6|||
124789454|NCT01122264|448859995|FG002|Overall Study|Withdrawal by Subject|16|||
124789455|NCT01122264|448859993|FG000|Overall Study|Physician Decision|3|||
124789456|NCT01122264|448859994|FG001|Overall Study|Physician Decision|1|||
124789457|NCT01122264|448859995|FG002|Overall Study|Physician Decision|1|||
124789458|NCT01122264|448859993|FG000|Overall Study|Lack of Efficacy|3|||
124789459|NCT01122264|448859994|FG001|Overall Study|Lack of Efficacy|1|||
124789460|NCT01122264|448859995|FG002|Overall Study|Lack of Efficacy|1|||
124789461|NCT03005873|448859996|FG000|Overall Study|Prohibited medication use post radnomization|1|||
124789462|NCT03005873|448859997|FG001|Overall Study|Prohibited medication use post radnomization|1|||
124789463|NCT03005873|448859998|FG002|Overall Study|Prohibited medication use post radnomization|1|||
124789464|NCT03005873|448859996|FG000|Overall Study|Withdrew consent|0|||
124789465|NCT03005873|448859997|FG001|Overall Study|Withdrew consent|1|||
124789466|NCT03005873|448859998|FG002|Overall Study|Withdrew consent|2|||
124789467|NCT03005873|448859996|FG000|Overall Study|Lost to Follow-up|0|||
124789468|NCT03005873|448859997|FG001|Overall Study|Lost to Follow-up|1|||
124789469|NCT03005873|448859998|FG002|Overall Study|Lost to Follow-up|0|||
124789470|NCT03005873|448859996|FG000|Overall Study|Ineligible post randomization|0|||
124789471|NCT03005873|448859997|FG001|Overall Study|Ineligible post randomization|0|||
124789472|NCT03005873|448859998|FG002|Overall Study|Ineligible post randomization|1|||
124789473|NCT04585009|448859999|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
124789474|NCT04585009|448860000|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789475|NCT04585009|448860001|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789476|NCT04585009|448860002|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789477|NCT04585009|448860003|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789478|NCT04585009|448860004|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789479|NCT04585009|448860005|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789480|NCT04585009|448860006|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789481|NCT04585009|448860007|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789482|NCT04585009|448860008|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789483|NCT04585009|448860009|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789484|NCT04585009|448860010|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
124789485|NCT04585009|448859999|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
124789486|NCT04585009|448860000|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789487|NCT04585009|448860001|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789488|NCT04585009|448860002|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789489|NCT04585009|448860003|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789490|NCT04585009|448860004|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789491|NCT04585009|448860005|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789492|NCT04585009|448860006|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789493|NCT04585009|448860007|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789494|NCT04585009|448860008|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789495|NCT04585009|448860009|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789496|NCT04585009|448860010|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
124789497|NCT04585009|448859999|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789498|NCT04585009|448860000|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789499|NCT04585009|448860001|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789500|NCT04585009|448860002|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789501|NCT04585009|448860003|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789502|NCT04585009|448860004|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789503|NCT04585009|448860005|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789504|NCT04585009|448860006|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
124789505|NCT04585009|448860007|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789506|NCT04585009|448860008|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789507|NCT04585009|448860009|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789508|NCT04585009|448860010|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
124789509|NCT04585009|448859999|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789510|NCT04585009|448860000|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789511|NCT04585009|448860001|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789512|NCT04585009|448860002|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789513|NCT04585009|448860003|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
124789514|NCT04585009|448860004|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789515|NCT04585009|448860005|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789516|NCT04585009|448860006|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789517|NCT04585009|448860007|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789518|NCT04585009|448860008|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789519|NCT04585009|448860009|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789520|NCT04585009|448860010|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
124789521|NCT04585009|448859999|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789522|NCT04585009|448860000|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789523|NCT04585009|448860001|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789524|NCT04585009|448860002|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789525|NCT04585009|448860003|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789526|NCT04585009|448860004|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789527|NCT04585009|448860005|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789528|NCT04585009|448860006|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789529|NCT04585009|448860007|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789530|NCT04585009|448860008|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
124789531|NCT04585009|448860009|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789532|NCT04585009|448860010|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
124789533|NCT04585009|448859999|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789534|NCT04585009|448860000|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789535|NCT04585009|448860001|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789536|NCT04585009|448860002|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789537|NCT04585009|448860003|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789538|NCT04585009|448860004|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789539|NCT04585009|448860005|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789540|NCT04585009|448860006|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789541|NCT04585009|448860007|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789542|NCT04585009|448860008|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789543|NCT04585009|448860009|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
124789544|NCT04585009|448860010|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
124789545|NCT00097981|448860019|FG000|Overall Study|Adverse Event|31|||
124789546|NCT00097981|448860020|FG001|Overall Study|Adverse Event|44|||
124789547|NCT00097981|448860019|FG000|Overall Study|Withdrawal by Subject|10|||
124789548|NCT00097981|448860020|FG001|Overall Study|Withdrawal by Subject|8|||
124789549|NCT00097981|448860019|FG000|Overall Study|Protocol Violation|1|||
124789550|NCT00097981|448860020|FG001|Overall Study|Protocol Violation|1|||
124789551|NCT00097981|448860019|FG000|Overall Study|Death|2|||
124789552|NCT00097981|448860020|FG001|Overall Study|Death|4|||
124789553|NCT00097981|448860019|FG000|Overall Study|Physician Decision|7|||
124789554|NCT00097981|448860020|FG001|Overall Study|Physician Decision|1|||
124789555|NCT00097981|448860019|FG000|Overall Study|Disease Progression|8|||
124789556|NCT00097981|448860020|FG001|Overall Study|Disease Progression|2|||
124789557|NCT00097981|448860019|FG000|Overall Study|Transplant planned|28|||
124789558|NCT00097981|448860020|FG001|Overall Study|Transplant planned|27|||
124789559|NCT00097981|448860019|FG000|Overall Study|Other|19|||
124789560|NCT00097981|448860020|FG001|Overall Study|Other|13|||
124789561|NCT00895011|448860022|FG000|Overall Study|Withdrawal by Subject|14|||
124789562|NCT00895011|448860023|FG001|Overall Study|Withdrawal by Subject|7|||
124789563|NCT00895011|448860024|FG002|Overall Study|Withdrawal by Subject|2|||
124789564|NCT00895011|448860022|FG000|Overall Study|Lost to Follow-up|5|||
124789565|NCT00895011|448860023|FG001|Overall Study|Lost to Follow-up|4|||
124789566|NCT00895011|448860024|FG002|Overall Study|Lost to Follow-up|1|||
124789567|NCT00895011|448860022|FG000|Overall Study|Protocol Violation|3|||
124789568|NCT00895011|448860023|FG001|Overall Study|Protocol Violation|1|||
124789569|NCT00895011|448860024|FG002|Overall Study|Protocol Violation|3|||
124789570|NCT00895011|448860022|FG000|Overall Study|Adverse Event|1|||
124789571|NCT00895011|448860023|FG001|Overall Study|Adverse Event|2|||
124789572|NCT00895011|448860024|FG002|Overall Study|Adverse Event|2|||
124789573|NCT00895011|448860022|FG000|Overall Study|schedule conflict|1|||
124789574|NCT00895011|448860023|FG001|Overall Study|schedule conflict|0|||
124789575|NCT00895011|448860024|FG002|Overall Study|schedule conflict|0|||
124789576|NCT02230527|448860026|FG000|Overall Study|Withdrawal by Subject|1|||
124789577|NCT02230527|448860027|FG001|Overall Study|Withdrawal by Subject|1|||
124789578|NCT02230527|448860026|FG000|Overall Study|Death|1|||
124789579|NCT02230527|448860027|FG001|Overall Study|Death|0|||
124789580|NCT02230527|448860026|FG000|Overall Study|Lost to Follow-up|2|||
124789581|NCT02230527|448860027|FG001|Overall Study|Lost to Follow-up|1|||
124789582|NCT02230527|448860026|FG000|Overall Study|Other|1|||
124789583|NCT02230527|448860027|FG001|Overall Study|Other|0|||
124789584|NCT04461600|448860029|FG000|Overall Study|Death|6|||
124789585|NCT04461600|448860030|FG001|Overall Study|Death|5|||
124789586|NCT04461600|448860029|FG000|Overall Study|Withdrawal by Subject|0|||
124789587|NCT04461600|448860030|FG001|Overall Study|Withdrawal by Subject|1|||
124789588|NCT01242813|448860031|FG000|Overall Study|Lost to Follow-up|2|||
124789589|NCT01369329|448860034|FG000|Overall Study|Withdrawal by Subject|8|||
124789590|NCT01369329|448860035|FG001|Overall Study|Withdrawal by Subject|6|||
124789591|NCT01369329|448860036|FG002|Overall Study|Withdrawal by Subject|10|||
124789592|NCT01369329|448860034|FG000|Overall Study|Lost to Follow-up|2|||
124789593|NCT01369329|448860035|FG001|Overall Study|Lost to Follow-up|2|||
124789594|NCT01369329|448860036|FG002|Overall Study|Lost to Follow-up|2|||
124789595|NCT01369329|448860034|FG000|Overall Study|Other|2|||
124789596|NCT01369329|448860035|FG001|Overall Study|Other|3|||
124789597|NCT01369329|448860036|FG002|Overall Study|Other|2|||
124789598|NCT01252667|448860037|FG000|Overall Study|Transplant aborted post-conditioning|0|||
124789599|NCT01252667|448860038|FG001|Overall Study|Transplant aborted post-conditioning|0|||
124789600|NCT01252667|448860039|FG002|Overall Study|Transplant aborted post-conditioning|0|||
124789601|NCT01252667|448860040|FG003|Overall Study|Transplant aborted post-conditioning|0|||
124789602|NCT01252667|448860041|FG004|Overall Study|Transplant aborted post-conditioning|0|||
124789603|NCT01252667|448860042|FG005|Overall Study|Transplant aborted post-conditioning|1|||
124789604|NCT01836276|448860043|FG000|Overall Study|Lost to Follow-up|28|||
124789605|NCT01836276|448860044|FG001|Overall Study|Lost to Follow-up|51|||
124789606|NCT00331552|448860047|FG000|Period 3: Phase II|Neurological Symptoms|1|||
124789607|NCT00331552|448860048|FG001|Period 3: Phase II|Neurological Symptoms|0|||
124789608|NCT00331552|448860047|FG000|Period 3: Phase II|Severe Nausea|1|||
124789609|NCT00331552|448860048|FG001|Period 3: Phase II|Severe Nausea|0|||
124789610|NCT02577887|448860050|FG000|Overall Study|Death|93|||
124789611|NCT02577887|448860050|FG000|Overall Study|Protocol Violation|125|||
124789612|NCT02577887|448860050|FG000|Overall Study|Withdrawal by Subject|80|||
124789613|NCT03560518|448860051|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
124789614|NCT03560518|448860052|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
124789615|NCT03560518|448860053|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
124789616|NCT03560518|448860051|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
124789617|NCT03560518|448860052|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
124789618|NCT03560518|448860053|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
124789619|NCT03560518|448860051|FG000|Double Blind Treatment Period|Protocol Violation|1|||
124789620|NCT03560518|448860052|FG001|Double Blind Treatment Period|Protocol Violation|2|||
124789621|NCT03560518|448860053|FG002|Double Blind Treatment Period|Protocol Violation|0|||
124789622|NCT03560518|448860051|FG000|Double Blind Treatment Period|Pregnancy|0|||
124789623|NCT03560518|448860052|FG001|Double Blind Treatment Period|Pregnancy|2|||
124789624|NCT03560518|448860053|FG002|Double Blind Treatment Period|Pregnancy|0|||
124789625|NCT03560518|448860051|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
124789626|NCT03560518|448860052|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
124789627|NCT03560518|448860053|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
124789628|NCT03560518|448860051|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
124789629|NCT03560518|448860052|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
124789630|NCT03560518|448860053|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
124789631|NCT03560518|448860051|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
124789632|NCT03560518|448860052|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
124789633|NCT03560518|448860053|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
124789634|NCT03560518|448860051|FG000|Double Blind Treatment Period|Adverse Event|0|||
124789635|NCT03560518|448860052|FG001|Double Blind Treatment Period|Adverse Event|3|||
124789636|NCT03560518|448860053|FG002|Double Blind Treatment Period|Adverse Event|1|||
124789637|NCT02984943|448860055|FG000|Overall Study|Withdrawal by Subject|3|||
124789638|NCT02984943|448860055|FG000|Overall Study|Physician Decision|1|||
124789639|NCT01133990|448860056|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
124789640|NCT01133990|448860057|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124789641|NCT01133990|448860058|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124789642|NCT01133990|448860059|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124789643|NCT01133990|448860060|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124789644|NCT01133990|448860061|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
124789645|NCT01133990|448860056|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
124789646|NCT01133990|448860057|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
124789647|NCT01133990|448860058|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
124789648|NCT01133990|448860059|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
124789649|NCT01133990|448860060|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
124789650|NCT01133990|448860061|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
124789651|NCT01133990|448860056|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
124789652|NCT01133990|448860057|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
124789653|NCT01133990|448860058|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
124789654|NCT01133990|448860059|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
124789655|NCT01133990|448860060|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
124789656|NCT01133990|448860061|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
124789657|NCT01133990|448860056|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
124789658|NCT01133990|448860057|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
124789659|NCT01133990|448860058|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
124789660|NCT01133990|448860059|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
124789661|NCT01133990|448860060|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
124789662|NCT01133990|448860061|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
124789663|NCT05277337|448860062|FG000|Overall Study|Lost to Follow-up|2|||
124789664|NCT05277337|448860063|FG001|Overall Study|Lost to Follow-up|0|||
124789665|NCT05277337|448860062|FG000|Overall Study|Withdrawal by Subject|1|||
124789666|NCT05277337|448860063|FG001|Overall Study|Withdrawal by Subject|0|||
124789667|NCT02282345|448860065|FG000|Overall Study|Progression|0|||
124789668|NCT02282345|448860066|FG001|Overall Study|Progression|1|||
124789669|NCT01185301|448860067|FG000|Overall Study|Adverse Event|3|||
124789670|NCT01185301|448860068|FG001|Overall Study|Adverse Event|0|||
124789671|NCT01185301|448860069|FG002|Overall Study|Adverse Event|2|||
124789672|NCT01185301|448860070|FG003|Overall Study|Adverse Event|3|||
124789673|NCT01185301|448860067|FG000|Overall Study|Withdrawal by Subject|7|||
124789674|NCT01185301|448860068|FG001|Overall Study|Withdrawal by Subject|5|||
124789675|NCT01185301|448860069|FG002|Overall Study|Withdrawal by Subject|2|||
124789676|NCT01185301|448860070|FG003|Overall Study|Withdrawal by Subject|3|||
124789677|NCT01185301|448860067|FG000|Overall Study|Lost to Follow-up|2|||
124789678|NCT01185301|448860068|FG001|Overall Study|Lost to Follow-up|0|||
124789679|NCT01185301|448860069|FG002|Overall Study|Lost to Follow-up|0|||
124789680|NCT01185301|448860070|FG003|Overall Study|Lost to Follow-up|1|||
124789681|NCT01185301|448860067|FG000|Overall Study|Other Reason|3|||
124789682|NCT01185301|448860068|FG001|Overall Study|Other Reason|2|||
124789683|NCT01185301|448860069|FG002|Overall Study|Other Reason|2|||
124789684|NCT01185301|448860070|FG003|Overall Study|Other Reason|2|||
124789685|NCT02683746|448860071|FG000|Overall Study|Adverse Event|3|||
124789686|NCT02683746|448860072|FG001|Overall Study|Adverse Event|2|||
124789687|NCT02683746|448860071|FG000|Overall Study|Lost to Follow-up|5|||
124789688|NCT02683746|448860072|FG001|Overall Study|Lost to Follow-up|6|||
124789689|NCT02683746|448860071|FG000|Overall Study|Withdrawal by Subject|6|||
124789690|NCT02683746|448860072|FG001|Overall Study|Withdrawal by Subject|5|||
124789691|NCT02683746|448860071|FG000|Overall Study|Physician Decision|2|||
124789692|NCT02683746|448860072|FG001|Overall Study|Physician Decision|1|||
124789693|NCT04987944|448860073|FG000|Overall Study|Adverse Event|0|||
124789694|NCT04987944|448860074|FG001|Overall Study|Adverse Event|1|||
124789695|NCT04987944|448860073|FG000|Overall Study|Withdrawal by Subject|0|||
124789696|NCT04987944|448860074|FG001|Overall Study|Withdrawal by Subject|1|||
124789697|NCT02353143|448860079|FG000|Overall Study|Withdrawal by Subject|1|||
124789698|NCT02353143|448860080|FG001|Overall Study|Withdrawal by Subject|0|||
124789699|NCT02353143|448860081|FG002|Overall Study|Withdrawal by Subject|0|||
124789700|NCT02353143|448860082|FG003|Overall Study|Withdrawal by Subject|0|||
124789701|NCT02353143|448860083|FG004|Overall Study|Withdrawal by Subject|1|||
124789702|NCT02353143|448860084|FG005|Overall Study|Withdrawal by Subject|0|||
124789703|NCT02353143|448860085|FG006|Overall Study|Withdrawal by Subject|0|||
124789704|NCT02353143|448860086|FG007|Overall Study|Withdrawal by Subject|1|||
124789705|NCT02353143|448860087|FG008|Overall Study|Withdrawal by Subject|1|||
124789706|NCT02353143|448860079|FG000|Overall Study|Lack of Efficacy|2|||
124789707|NCT02353143|448860080|FG001|Overall Study|Lack of Efficacy|1|||
124789708|NCT02353143|448860081|FG002|Overall Study|Lack of Efficacy|2|||
124789709|NCT02353143|448860082|FG003|Overall Study|Lack of Efficacy|4|||
124789710|NCT02353143|448860083|FG004|Overall Study|Lack of Efficacy|13|||
124789711|NCT02353143|448860084|FG005|Overall Study|Lack of Efficacy|2|||
124789712|NCT02353143|448860085|FG006|Overall Study|Lack of Efficacy|2|||
124789713|NCT02353143|448860086|FG007|Overall Study|Lack of Efficacy|2|||
124789714|NCT02353143|448860087|FG008|Overall Study|Lack of Efficacy|1|||
124789715|NCT02353143|448860079|FG000|Overall Study|reason not specified|1|||
124789716|NCT02353143|448860080|FG001|Overall Study|reason not specified|2|||
124789717|NCT02353143|448860081|FG002|Overall Study|reason not specified|0|||
124789718|NCT02353143|448860082|FG003|Overall Study|reason not specified|0|||
124789719|NCT02353143|448860083|FG004|Overall Study|reason not specified|6|||
124789720|NCT02353143|448860084|FG005|Overall Study|reason not specified|1|||
124789721|NCT02353143|448860085|FG006|Overall Study|reason not specified|0|||
124789722|NCT02353143|448860086|FG007|Overall Study|reason not specified|3|||
124628324|NCT00243412|448256163|FG001|Overall Study|Adverse Event|2|||
124628325|NCT00243412|448256162|FG000|Overall Study|Lost to Follow-up|0|||
124628326|NCT00243412|448256163|FG001|Overall Study|Lost to Follow-up|1|||
124628327|NCT00243412|448256162|FG000|Overall Study|Physician Decision|1|||
124628328|NCT00243412|448256163|FG001|Overall Study|Physician Decision|1|||
124628329|NCT00243412|448256162|FG000|Overall Study|Withdrawal by Subject|4|||
124628330|NCT00243412|448256163|FG001|Overall Study|Withdrawal by Subject|5|||
124628331|NCT00243412|448256162|FG000|Overall Study|Other|1|||
124628332|NCT00243412|448256163|FG001|Overall Study|Other|1|||
124628333|NCT02586155|448256172|FG000|Overall Study|Adverse Event|2|||
124628334|NCT02586155|448256173|FG001|Overall Study|Adverse Event|3|||
124628335|NCT02586155|448256172|FG000|Overall Study|Withdrawal by Subject|31|||
124628336|NCT02586155|448256173|FG001|Overall Study|Withdrawal by Subject|24|||
124628337|NCT02586155|448256172|FG000|Overall Study|Lost to Follow-up|7|||
124628338|NCT02586155|448256173|FG001|Overall Study|Lost to Follow-up|13|||
124628339|NCT02586155|448256172|FG000|Overall Study|Death|61|||
124628340|NCT02586155|448256173|FG001|Overall Study|Death|72|||
124628341|NCT02586155|448256172|FG000|Overall Study|Other reasons|26|||
124628342|NCT02586155|448256173|FG001|Overall Study|Other reasons|15|||
124628343|NCT04779879|448256174|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
124628344|NCT04779879|448256175|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
124628345|NCT04779879|448256176|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
124628346|NCT04779879|448256177|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
124628347|NCT04779879|448256178|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
124628348|NCT04779879|448256179|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
124789723|NCT02353143|448860087|FG008|Overall Study|reason not specified|1|||
124789724|NCT02353143|448860079|FG000|Overall Study|Physician Decision|0|||
124789725|NCT02353143|448860080|FG001|Overall Study|Physician Decision|4|||
124789726|NCT02353143|448860081|FG002|Overall Study|Physician Decision|2|||
124789727|NCT02353143|448860082|FG003|Overall Study|Physician Decision|3|||
124789728|NCT02353143|448860083|FG004|Overall Study|Physician Decision|4|||
124789729|NCT02353143|448860084|FG005|Overall Study|Physician Decision|0|||
124789730|NCT02353143|448860085|FG006|Overall Study|Physician Decision|1|||
124789731|NCT02353143|448860086|FG007|Overall Study|Physician Decision|2|||
124789732|NCT02353143|448860087|FG008|Overall Study|Physician Decision|0|||
124789733|NCT02353143|448860079|FG000|Overall Study|Adverse Event|0|||
124789734|NCT02353143|448860080|FG001|Overall Study|Adverse Event|0|||
124789735|NCT02353143|448860081|FG002|Overall Study|Adverse Event|1|||
124789736|NCT02353143|448860082|FG003|Overall Study|Adverse Event|0|||
124789737|NCT02353143|448860083|FG004|Overall Study|Adverse Event|1|||
124789738|NCT02353143|448860084|FG005|Overall Study|Adverse Event|1|||
124789739|NCT02353143|448860085|FG006|Overall Study|Adverse Event|0|||
124789740|NCT02353143|448860086|FG007|Overall Study|Adverse Event|0|||
124789741|NCT02353143|448860087|FG008|Overall Study|Adverse Event|0|||
124789742|NCT02353143|448860079|FG000|Overall Study|patient receiving other treatment for AML|0|||
124789743|NCT02353143|448860080|FG001|Overall Study|patient receiving other treatment for AML|0|||
124789744|NCT02353143|448860081|FG002|Overall Study|patient receiving other treatment for AML|1|||
124789745|NCT02353143|448860082|FG003|Overall Study|patient receiving other treatment for AML|0|||
124789746|NCT02353143|448860083|FG004|Overall Study|patient receiving other treatment for AML|0|||
124789747|NCT02353143|448860084|FG005|Overall Study|patient receiving other treatment for AML|0|||
124789748|NCT02353143|448860085|FG006|Overall Study|patient receiving other treatment for AML|0|||
124789749|NCT02353143|448860086|FG007|Overall Study|patient receiving other treatment for AML|0|||
124789750|NCT02353143|448860087|FG008|Overall Study|patient receiving other treatment for AML|0|||
124789751|NCT02353143|448860079|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
124789752|NCT02353143|448860080|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
124789753|NCT02353143|448860081|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
124789754|NCT02353143|448860082|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
124789755|NCT02353143|448860083|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
124789756|NCT02353143|448860084|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
124789757|NCT02353143|448860085|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
124789758|NCT02353143|448860086|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
124789759|NCT02353143|448860087|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
124789760|NCT02946931|448860090|FG000|Overall Study|Did not require collection of CRFs|588|||
124789761|NCT02946931|448860090|FG000|Overall Study|Other than listed|37|||
124789762|NCT02946931|448860090|FG000|Overall Study|Discharge from hospital|118|||
124789763|NCT02946931|448860090|FG000|Overall Study|Adverse Event|81|||
124789764|NCT02946931|448860090|FG000|Overall Study|CRFs not valid|1|||
124789765|NCT02946931|448860090|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
124789766|NCT02213133|448860091|FG000|Overall Study|Participant discontinued study therapy|2|||
124789767|NCT02213133|448860092|FG001|Overall Study|Participant discontinued study therapy|0|||
124789768|NCT02213133|448860093|FG002|Overall Study|Participant discontinued study therapy|0|||
124789769|NCT02213133|448860091|FG000|Overall Study|Participant withdrew informed consent|2|||
124789770|NCT02213133|448860092|FG001|Overall Study|Participant withdrew informed consent|1|||
124789771|NCT02213133|448860093|FG002|Overall Study|Participant withdrew informed consent|2|||
124789772|NCT02213133|448860091|FG000|Overall Study|Disease progression|11|||
124789773|NCT02213133|448860092|FG001|Overall Study|Disease progression|2|||
124789774|NCT02213133|448860093|FG002|Overall Study|Disease progression|0|||
124789775|NCT02213133|448860091|FG000|Overall Study|Adverse Event (AE)|1|||
124789776|NCT02213133|448860092|FG001|Overall Study|Adverse Event (AE)|0|||
124789777|NCT02213133|448860093|FG002|Overall Study|Adverse Event (AE)|0|||
124789778|NCT02213133|448860091|FG000|Overall Study|Death|16|||
124789779|NCT02213133|448860092|FG001|Overall Study|Death|2|||
124789780|NCT02213133|448860093|FG002|Overall Study|Death|1|||
124789781|NCT02213133|448860091|FG000|Overall Study|Other|5|||
124789782|NCT02213133|448860092|FG001|Overall Study|Other|0|||
124789783|NCT02213133|448860093|FG002|Overall Study|Other|0|||
124789784|NCT04740905|448860102|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
124789785|NCT04740905|448860103|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
124789786|NCT04740905|448860102|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
124789787|NCT04740905|448860103|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
124789788|NCT04740905|448860102|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
124789789|NCT04740905|448860103|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
124789790|NCT04740905|448860102|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
124789791|NCT04740905|448860103|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
124789792|NCT04740905|448860102|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
124789793|NCT04740905|448860103|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
124789794|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
124789795|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
124789796|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
124789797|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
124789798|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
124789799|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
124789800|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
124789801|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
124789802|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
124789803|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
124789804|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
124789805|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
124789806|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
124789807|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
124789808|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
124789809|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
124789810|NCT04740905|448860102|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
124789811|NCT04740905|448860103|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
124789812|NCT02412488|448860108|FG000|Overall Study|Lost to Follow-up|10|||
124789813|NCT02412488|448860108|FG000|Overall Study|Withdrawal by Subject|5|||
124789814|NCT02412488|448860108|FG000|Overall Study|Physician Decision|1|||
124789815|NCT02412488|448860108|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
124789816|NCT02412488|448860108|FG000|Overall Study|Reveal LINQ explant|1|||
124789817|NCT01989468|448860109|FG000|Overall Study|Adverse Event|10|||
124789818|NCT01989468|448860110|FG001|Overall Study|Adverse Event|15|||
124789819|NCT01989468|448860111|FG002|Overall Study|Adverse Event|4|||
124789820|NCT01989468|448860112|FG003|Overall Study|Adverse Event|5|||
124789821|NCT01989468|448860113|FG004|Overall Study|Adverse Event|4|||
124789822|NCT01989468|448860109|FG000|Overall Study|Lack of Efficacy|11|||
124789823|NCT01989468|448860110|FG001|Overall Study|Lack of Efficacy|11|||
124789824|NCT01989468|448860111|FG002|Overall Study|Lack of Efficacy|7|||
124789825|NCT01989468|448860112|FG003|Overall Study|Lack of Efficacy|4|||
124789826|NCT01989468|448860113|FG004|Overall Study|Lack of Efficacy|2|||
124789827|NCT01989468|448860109|FG000|Overall Study|Lost to Follow-up|5|||
124789828|NCT01989468|448860110|FG001|Overall Study|Lost to Follow-up|2|||
124789829|NCT01989468|448860111|FG002|Overall Study|Lost to Follow-up|0|||
124789830|NCT01989468|448860112|FG003|Overall Study|Lost to Follow-up|1|||
124789831|NCT01989468|448860113|FG004|Overall Study|Lost to Follow-up|1|||
124789832|NCT01989468|448860109|FG000|Overall Study|Physician Decision|4|||
124789833|NCT01989468|448860110|FG001|Overall Study|Physician Decision|1|||
124789834|NCT01989468|448860111|FG002|Overall Study|Physician Decision|0|||
124789835|NCT01989468|448860112|FG003|Overall Study|Physician Decision|1|||
124789836|NCT01989468|448860113|FG004|Overall Study|Physician Decision|0|||
124789837|NCT01989468|448860109|FG000|Overall Study|Pregnancy|0|||
124789838|NCT01989468|448860110|FG001|Overall Study|Pregnancy|1|||
124789839|NCT01989468|448860111|FG002|Overall Study|Pregnancy|0|||
124789840|NCT01989468|448860112|FG003|Overall Study|Pregnancy|0|||
124789841|NCT01989468|448860113|FG004|Overall Study|Pregnancy|0|||
124789842|NCT01989468|448860109|FG000|Overall Study|Technical Problems|3|||
124789843|NCT01989468|448860110|FG001|Overall Study|Technical Problems|1|||
124789844|NCT01989468|448860111|FG002|Overall Study|Technical Problems|3|||
124789845|NCT01989468|448860112|FG003|Overall Study|Technical Problems|1|||
124789846|NCT01989468|448860113|FG004|Overall Study|Technical Problems|0|||
124789847|NCT01989468|448860109|FG000|Overall Study|Subject Guardian Decision|11|||
124789848|NCT01989468|448860110|FG001|Overall Study|Subject Guardian Decision|6|||
124789849|NCT01989468|448860111|FG002|Overall Study|Subject Guardian Decision|4|||
124789850|NCT01989468|448860112|FG003|Overall Study|Subject Guardian Decision|4|||
124789851|NCT01989468|448860113|FG004|Overall Study|Subject Guardian Decision|1|||
124789852|NCT01989468|448860109|FG000|Overall Study|Death|3|||
124789853|NCT01989468|448860110|FG001|Overall Study|Death|0|||
124789854|NCT01989468|448860111|FG002|Overall Study|Death|1|||
124789855|NCT01989468|448860112|FG003|Overall Study|Death|0|||
124789856|NCT01989468|448860113|FG004|Overall Study|Death|0|||
124789857|NCT03222492|448860116|FG000|Overall Study|Withdrawal by Subject|0|||
124789858|NCT03222492|448860117|FG001|Overall Study|Withdrawal by Subject|0|||
124789859|NCT03222492|448860118|FG002|Overall Study|Withdrawal by Subject|1|||
124789860|NCT03222492|448860119|FG003|Overall Study|Withdrawal by Subject|0|||
124789861|NCT03222492|448860116|FG000|Overall Study|COVID-19 related|0|||
124789862|NCT03222492|448860117|FG001|Overall Study|COVID-19 related|0|||
124789863|NCT03222492|448860118|FG002|Overall Study|COVID-19 related|1|||
124789864|NCT03222492|448860119|FG003|Overall Study|COVID-19 related|0|||
124789865|NCT01224782|448860125|FG000|Overall Study|Lost to Follow-up|177|||
124789866|NCT01224782|448860125|FG000|Overall Study|Withdrawal by Subject|16|||
124789867|NCT01224782|448860125|FG000|Overall Study|Death|14|||
124789868|NCT01224782|448860125|FG000|Overall Study|Improvement|13|||
124789869|NCT01224782|448860125|FG000|Overall Study|Adverse Event|12|||
124789870|NCT01224782|448860125|FG000|Overall Study|Adverse Reaction|11|||
124789871|NCT01224782|448860125|FG000|Overall Study|Noncompliance|10|||
124789872|NCT01224782|448860125|FG000|Overall Study|Other|4|||
124789873|NCT01224782|448860125|FG000|Overall Study|Start of Dialysis|3|||
124789874|NCT01224782|448860125|FG000|Overall Study|Change of Treatment|1|||
124789875|NCT01224782|448860125|FG000|Overall Study|Financial Reasons|1|||
124789876|NCT01224782|448860125|FG000|Overall Study|Deterioration|1|||
124789877|NCT01224782|448860125|FG000|Overall Study|Transplantation|1|||
124789878|NCT00065429|448860128|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
124789879|NCT00065429|448860129|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
124789880|NCT00065429|448860130|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
124789881|NCT00065429|448860131|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
124789882|NCT00065429|448860132|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
124789883|NCT00065429|448860133|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
124789884|NCT00065429|448860134|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
124789885|NCT00065429|448860128|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
124789886|NCT00065429|448860129|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
124789887|NCT00065429|448860130|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
124789888|NCT00065429|448860131|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
124789889|NCT00065429|448860132|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
124789890|NCT00065429|448860133|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
124789891|NCT00065429|448860134|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
124789892|NCT00065429|448860128|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
124789893|NCT00065429|448860129|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
124789894|NCT00065429|448860130|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
124789895|NCT00065429|448860131|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
124789896|NCT00065429|448860132|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
124789897|NCT00065429|448860133|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
124789898|NCT00065429|448860134|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
124789899|NCT00065429|448860128|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
124789900|NCT00065429|448860129|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
124789901|NCT00065429|448860130|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
124789902|NCT00065429|448860131|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
124789903|NCT00065429|448860132|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
124789904|NCT00065429|448860133|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
124789905|NCT00065429|448860134|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
124789906|NCT00065429|448860128|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
124789907|NCT00065429|448860129|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
124789908|NCT00065429|448860130|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
124789909|NCT00065429|448860131|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
124789910|NCT00065429|448860132|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
124789911|NCT00065429|448860133|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
124789912|NCT00065429|448860134|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
124789913|NCT00065429|448860128|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
124789914|NCT00065429|448860129|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
124789915|NCT00065429|448860130|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
124789916|NCT00065429|448860131|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
124789917|NCT00065429|448860132|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
124789918|NCT00065429|448860133|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
124789919|NCT00065429|448860134|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
124789920|NCT00065429|448860128|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
124789921|NCT00065429|448860129|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
124789922|NCT00065429|448860130|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
124789923|NCT00065429|448860131|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
124628349|NCT04779879|448256174|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
124628350|NCT04779879|448256175|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
124628351|NCT04779879|448256176|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
124628352|NCT04779879|448256177|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
124628353|NCT04779879|448256178|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
124628354|NCT04779879|448256179|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
124628355|NCT04779879|448256174|FG000|Part C: Up to Week 36|Death|0|||
124628356|NCT04779879|448256175|FG001|Part C: Up to Week 36|Death|0|||
124628357|NCT04779879|448256176|FG002|Part C: Up to Week 36|Death|0|||
124628358|NCT04779879|448256177|FG003|Part C: Up to Week 36|Death|0|||
124628359|NCT04779879|448256178|FG004|Part C: Up to Week 36|Death|0|||
124628360|NCT04779879|448256179|FG005|Part C: Up to Week 36|Death|1|||
124628361|NCT04779879|448256174|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
124628362|NCT04779879|448256175|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
124628363|NCT04779879|448256176|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
124628364|NCT04779879|448256177|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
124628365|NCT04779879|448256178|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
124628366|NCT04779879|448256179|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
124628367|NCT02072980|448256180|FG000|Period 2, Second Wear|Adverse Event|0|||
124789924|NCT00065429|448860132|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
124789925|NCT00065429|448860133|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
124789926|NCT00065429|448860134|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
124789927|NCT02015221|448860137|FG000|Overall Study|Withdrawal by Subject|8|||
124789928|NCT02015221|448860138|FG001|Overall Study|Withdrawal by Subject|6|||
124628368|NCT02072980|448256181|FG001|Period 2, Second Wear|Adverse Event|1|||
124628369|NCT00955617|448256187|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
124628370|NCT00955617|448256188|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
124789929|NCT02015221|448860137|FG000|Overall Study|Lost to Follow-up|1|||
124789930|NCT02015221|448860138|FG001|Overall Study|Lost to Follow-up|0|||
124789931|NCT00995566|448860139|FG000|Overall Study|Adverse Event|2|||
124789932|NCT00995566|448860139|FG000|Overall Study|Early study termination|52|||
124628371|NCT00955617|448256187|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
124628372|NCT00955617|448256188|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
124628373|NCT00955617|448256187|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
124628374|NCT00955617|448256188|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
124628375|NCT00955617|448256187|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
124628376|NCT00955617|448256188|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
124628377|NCT00070564|448257564|FG000|Overall Study|Progression|2|||
124628378|NCT00070564|448257565|FG001|Overall Study|Progression|4|||
124628379|NCT00070564|448257566|FG002|Overall Study|Progression|7|||
124628380|NCT00070564|448257567|FG003|Overall Study|Progression|7|||
124628381|NCT00070564|448257568|FG004|Overall Study|Progression|1|||
124628382|NCT00070564|448257569|FG005|Overall Study|Progression|0|||
124628383|NCT00070564|448257564|FG000|Overall Study|Delinquent|1|||
124628384|NCT00070564|448257565|FG001|Overall Study|Delinquent|4|||
124628385|NCT00070564|448257566|FG002|Overall Study|Delinquent|2|||
124628386|NCT00070564|448257567|FG003|Overall Study|Delinquent|0|||
124628387|NCT00070564|448257568|FG004|Overall Study|Delinquent|0|||
124628388|NCT00070564|448257569|FG005|Overall Study|Delinquent|0|||
124628389|NCT00070564|448257564|FG000|Overall Study|Adverse Event|150|||
124628390|NCT00070564|448257565|FG001|Overall Study|Adverse Event|142|||
124628391|NCT00070564|448257566|FG002|Overall Study|Adverse Event|120|||
124628392|NCT00070564|448257567|FG003|Overall Study|Adverse Event|108|||
124628393|NCT00070564|448257568|FG004|Overall Study|Adverse Event|63|||
124628394|NCT00070564|448257569|FG005|Overall Study|Adverse Event|36|||
124628395|NCT00070564|448257564|FG000|Overall Study|Death|4|||
124628396|NCT00070564|448257565|FG001|Overall Study|Death|1|||
124628397|NCT00070564|448257566|FG002|Overall Study|Death|5|||
124628398|NCT00070564|448257567|FG003|Overall Study|Death|3|||
124628399|NCT00070564|448257568|FG004|Overall Study|Death|0|||
124628400|NCT00070564|448257569|FG005|Overall Study|Death|1|||
124628401|NCT00070564|448257564|FG000|Overall Study|Other, not protocol specified|17|||
124628402|NCT00070564|448257565|FG001|Overall Study|Other, not protocol specified|15|||
124628403|NCT00070564|448257566|FG002|Overall Study|Other, not protocol specified|14|||
124628404|NCT00070564|448257567|FG003|Overall Study|Other, not protocol specified|19|||
124628405|NCT00070564|448257568|FG004|Overall Study|Other, not protocol specified|6|||
124628406|NCT00070564|448257569|FG005|Overall Study|Other, not protocol specified|7|||
124628407|NCT00070564|448257564|FG000|Overall Study|Withdrawal by Subject|26|||
124628408|NCT00070564|448257565|FG001|Overall Study|Withdrawal by Subject|37|||
124628409|NCT00070564|448257566|FG002|Overall Study|Withdrawal by Subject|23|||
124628410|NCT00070564|448257567|FG003|Overall Study|Withdrawal by Subject|30|||
124628411|NCT00070564|448257568|FG004|Overall Study|Withdrawal by Subject|8|||
124628412|NCT00070564|448257569|FG005|Overall Study|Withdrawal by Subject|8|||
124628413|NCT00070564|448257564|FG000|Overall Study|Not reported|0|||
124628414|NCT00070564|448257565|FG001|Overall Study|Not reported|0|||
124628415|NCT00070564|448257566|FG002|Overall Study|Not reported|0|||
124628416|NCT00070564|448257567|FG003|Overall Study|Not reported|0|||
124628417|NCT00070564|448257568|FG004|Overall Study|Not reported|1|||
124628418|NCT00070564|448257569|FG005|Overall Study|Not reported|0|||
124628419|NCT04576507|448257573|FG000|Overall Study|Adverse Event|4|||
124628420|NCT04576507|448257573|FG000|Overall Study|Withdrawal by Subject|1|||
124628421|NCT00931528|448257578|FG000|Overall Study|Protocol Violation|9|||
124628422|NCT00931528|448257579|FG001|Overall Study|Protocol Violation|12|||
124628423|NCT00931528|448257578|FG000|Overall Study|Withdrawal by Subject|4|||
124628424|NCT00931528|448257579|FG001|Overall Study|Withdrawal by Subject|12|||
124628425|NCT00931528|448257578|FG000|Overall Study|Lost to Follow-up|6|||
124628426|NCT00931528|448257579|FG001|Overall Study|Lost to Follow-up|13|||
124628427|NCT00931528|448257578|FG000|Overall Study|Assessment outside of Time Frame|22|||
124628428|NCT00931528|448257579|FG001|Overall Study|Assessment outside of Time Frame|23|||
124628429|NCT00711243|448257583|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
124628430|NCT00711243|448257584|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
124789933|NCT01576159|448860140|FG000|Overall Study|Withdrawal by Subject|0|||
124628431|NCT00711243|448257585|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
124628432|NCT00711243|448257586|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
124628433|NCT00711243|448257587|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
124628434|NCT00711243|448257588|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
124628435|NCT00711243|448257583|FG000|Reached First Response/4 Cycles|Death|0|||
124628436|NCT00711243|448257584|FG001|Reached First Response/4 Cycles|Death|0|||
124628437|NCT00711243|448257585|FG002|Reached First Response/4 Cycles|Death|0|||
124628438|NCT00711243|448257586|FG003|Reached First Response/4 Cycles|Death|0|||
124628439|NCT00711243|448257587|FG004|Reached First Response/4 Cycles|Death|0|||
124628440|NCT00711243|448257588|FG005|Reached First Response/4 Cycles|Death|2|||
124628441|NCT00711243|448257583|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
124628442|NCT00711243|448257584|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
124628443|NCT00711243|448257585|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
124628444|NCT00711243|448257586|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
124628445|NCT00711243|448257587|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
124628446|NCT00711243|448257588|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
124628447|NCT00711243|448257583|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
124628448|NCT00711243|448257584|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
124628449|NCT00711243|448257585|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
124628450|NCT00711243|448257586|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
124628451|NCT00711243|448257587|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
124628452|NCT00711243|448257588|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
124628453|NCT00711243|448257583|FG000|Treated Cycle 5 After First Response|Death|0|||
124628454|NCT00711243|448257584|FG001|Treated Cycle 5 After First Response|Death|0|||
124628455|NCT00711243|448257585|FG002|Treated Cycle 5 After First Response|Death|0|||
124628456|NCT00711243|448257586|FG003|Treated Cycle 5 After First Response|Death|0|||
124628457|NCT00711243|448257587|FG004|Treated Cycle 5 After First Response|Death|0|||
124628458|NCT00711243|448257588|FG005|Treated Cycle 5 After First Response|Death|2|||
124628459|NCT00711243|448257583|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
124628460|NCT00711243|448257584|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
124628461|NCT00711243|448257585|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
124628462|NCT00711243|448257586|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
124628463|NCT00711243|448257587|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
124628464|NCT00711243|448257588|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
124628465|NCT00711243|448257583|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
124628466|NCT00711243|448257584|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
124628467|NCT00711243|448257585|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
124628468|NCT00711243|448257586|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
124628469|NCT00711243|448257587|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
124628470|NCT00711243|448257588|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
124628471|NCT01557504|448257591|FG000|Overall Study|Physician Decision|1|||
124628472|NCT01557504|448257592|FG001|Overall Study|Physician Decision|0|||
124628473|NCT01962103|448257593|FG000|Phase 1|Adverse Event|4|||
124628474|NCT01962103|448257594|FG001|Phase 1|Adverse Event|0|||
124628475|NCT01962103|448257595|FG002|Phase 1|Adverse Event|2|||
124628476|NCT01962103|448257596|FG003|Phase 1|Adverse Event|1|||
124628477|NCT01962103|448257597|FG004|Phase 1|Adverse Event|2|||
124628478|NCT01962103|448257598|FG005|Phase 1|Adverse Event|2|||
124628479|NCT01962103|448257599|FG006|Phase 1|Adverse Event|0|||
124628480|NCT01962103|448257600|FG007|Phase 1|Adverse Event|0|||
124628481|NCT01962103|448257601|FG008|Phase 1|Adverse Event|0|||
124628482|NCT01962103|448257593|FG000|Phase 1|Progressive Disease|8|||
124628483|NCT01962103|448257594|FG001|Phase 1|Progressive Disease|6|||
124628484|NCT01962103|448257595|FG002|Phase 1|Progressive Disease|8|||
124628485|NCT01962103|448257596|FG003|Phase 1|Progressive Disease|4|||
124628486|NCT01962103|448257597|FG004|Phase 1|Progressive Disease|5|||
124628487|NCT01962103|448257598|FG005|Phase 1|Progressive Disease|4|||
124628488|NCT01962103|448257599|FG006|Phase 1|Progressive Disease|0|||
124628489|NCT01962103|448257600|FG007|Phase 1|Progressive Disease|0|||
124628490|NCT01962103|448257601|FG008|Phase 1|Progressive Disease|0|||
124628491|NCT01962103|448257593|FG000|Phase 1|Withdrawal by Subject|0|||
124628492|NCT01962103|448257594|FG001|Phase 1|Withdrawal by Subject|0|||
124628493|NCT01962103|448257595|FG002|Phase 1|Withdrawal by Subject|0|||
124628494|NCT01962103|448257596|FG003|Phase 1|Withdrawal by Subject|2|||
124628495|NCT01962103|448257597|FG004|Phase 1|Withdrawal by Subject|0|||
124628496|NCT01962103|448257598|FG005|Phase 1|Withdrawal by Subject|0|||
124628497|NCT01962103|448257599|FG006|Phase 1|Withdrawal by Subject|0|||
124628498|NCT01962103|448257600|FG007|Phase 1|Withdrawal by Subject|0|||
124628499|NCT01962103|448257601|FG008|Phase 1|Withdrawal by Subject|0|||
124628500|NCT01962103|448257593|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
124628501|NCT01962103|448257594|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
124628502|NCT01962103|448257595|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
124628503|NCT01962103|448257596|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
124628504|NCT01962103|448257597|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
124628505|NCT01962103|448257598|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
124628506|NCT01962103|448257599|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
124628507|NCT01962103|448257600|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
124628508|NCT01962103|448257601|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
124628509|NCT01962103|448257593|FG000|Phase 1|Physician Decision|0|||
124628510|NCT01962103|448257594|FG001|Phase 1|Physician Decision|0|||
124628511|NCT01962103|448257595|FG002|Phase 1|Physician Decision|0|||
124628512|NCT01962103|448257596|FG003|Phase 1|Physician Decision|1|||
124628513|NCT01962103|448257597|FG004|Phase 1|Physician Decision|0|||
124628514|NCT01962103|448257598|FG005|Phase 1|Physician Decision|0|||
124628515|NCT01962103|448257599|FG006|Phase 1|Physician Decision|0|||
124628516|NCT01962103|448257600|FG007|Phase 1|Physician Decision|0|||
124628517|NCT01962103|448257601|FG008|Phase 1|Physician Decision|0|||
124628518|NCT01962103|448257593|FG000|Phase 1|Symptomatic Deterioration|3|||
124628519|NCT01962103|448257594|FG001|Phase 1|Symptomatic Deterioration|2|||
124628520|NCT01962103|448257595|FG002|Phase 1|Symptomatic Deterioration|2|||
124628521|NCT01962103|448257596|FG003|Phase 1|Symptomatic Deterioration|2|||
124628522|NCT01962103|448257597|FG004|Phase 1|Symptomatic Deterioration|1|||
124628523|NCT01962103|448257598|FG005|Phase 1|Symptomatic Deterioration|1|||
124628524|NCT01962103|448257599|FG006|Phase 1|Symptomatic Deterioration|0|||
124628525|NCT01962103|448257600|FG007|Phase 1|Symptomatic Deterioration|0|||
124628526|NCT01962103|448257601|FG008|Phase 1|Symptomatic Deterioration|0|||
124628527|NCT01962103|448257593|FG000|Phase 1|Miscellaneous|1|||
124628528|NCT01962103|448257594|FG001|Phase 1|Miscellaneous|0|||
124628529|NCT01962103|448257595|FG002|Phase 1|Miscellaneous|0|||
124628530|NCT01962103|448257596|FG003|Phase 1|Miscellaneous|0|||
124628531|NCT01962103|448257597|FG004|Phase 1|Miscellaneous|0|||
124628532|NCT01962103|448257598|FG005|Phase 1|Miscellaneous|0|||
124628533|NCT01962103|448257599|FG006|Phase 1|Miscellaneous|0|||
124628534|NCT01962103|448257600|FG007|Phase 1|Miscellaneous|0|||
124628535|NCT01962103|448257601|FG008|Phase 1|Miscellaneous|0|||
124628536|NCT01962103|448257593|FG000|Phase 2|Adverse Event|0|||
124628537|NCT01962103|448257594|FG001|Phase 2|Adverse Event|0|||
124628538|NCT01962103|448257595|FG002|Phase 2|Adverse Event|0|||
124628539|NCT01962103|448257596|FG003|Phase 2|Adverse Event|0|||
124628540|NCT01962103|448257597|FG004|Phase 2|Adverse Event|0|||
124628541|NCT01962103|448257598|FG005|Phase 2|Adverse Event|0|||
124628542|NCT01962103|448257599|FG006|Phase 2|Adverse Event|1|||
124628543|NCT01962103|448257600|FG007|Phase 2|Adverse Event|0|||
124628544|NCT01962103|448257601|FG008|Phase 2|Adverse Event|3|||
124628545|NCT01962103|448257593|FG000|Phase 2|Progressive Disease|0|||
124628546|NCT01962103|448257594|FG001|Phase 2|Progressive Disease|0|||
124628547|NCT01962103|448257595|FG002|Phase 2|Progressive Disease|0|||
124628548|NCT01962103|448257596|FG003|Phase 2|Progressive Disease|0|||
124628549|NCT01962103|448257597|FG004|Phase 2|Progressive Disease|0|||
124628550|NCT01962103|448257598|FG005|Phase 2|Progressive Disease|0|||
124628551|NCT01962103|448257599|FG006|Phase 2|Progressive Disease|11|||
124628552|NCT01962103|448257600|FG007|Phase 2|Progressive Disease|12|||
124628553|NCT01962103|448257601|FG008|Phase 2|Progressive Disease|11|||
124628554|NCT01962103|448257593|FG000|Phase 2|Symptomatic Deterioration|0|||
124628555|NCT01962103|448257594|FG001|Phase 2|Symptomatic Deterioration|0|||
124628556|NCT01962103|448257595|FG002|Phase 2|Symptomatic Deterioration|0|||
124628557|NCT01962103|448257596|FG003|Phase 2|Symptomatic Deterioration|0|||
124628558|NCT01962103|448257597|FG004|Phase 2|Symptomatic Deterioration|0|||
124628559|NCT01962103|448257598|FG005|Phase 2|Symptomatic Deterioration|0|||
124628560|NCT01962103|448257599|FG006|Phase 2|Symptomatic Deterioration|2|||
124628561|NCT01962103|448257600|FG007|Phase 2|Symptomatic Deterioration|2|||
124628562|NCT01962103|448257601|FG008|Phase 2|Symptomatic Deterioration|0|||
124628563|NCT01321749|448257602|FG000|Overall Study|Lost to Follow-up|4|||
124628564|NCT01321749|448257603|FG001|Overall Study|Lost to Follow-up|11|||
124628565|NCT01321749|448257602|FG000|Overall Study|Protocol Violation|4|||
124628566|NCT01321749|448257603|FG001|Overall Study|Protocol Violation|7|||
124628567|NCT01321749|448257602|FG000|Overall Study|Withdrawal by Subject|5|||
124628568|NCT01321749|448257603|FG001|Overall Study|Withdrawal by Subject|4|||
124628569|NCT02750618|448257604|FG000|Overall Study|Withdrawal by Subject|1|||
124628570|NCT01067105|448257607|FG000|Overall Study|Adverse Event|14|||
124628571|NCT01067105|448257607|FG000|Overall Study|Protocol Violation|48|||
124628572|NCT01067105|448257607|FG000|Overall Study|Withdrawal by Subject|36|||
124628573|NCT01067105|448257607|FG000|Overall Study|Lost to Follow-up|6|||
124628574|NCT01067105|448257607|FG000|Overall Study|Physician Decision|6|||
124628575|NCT01067105|448257607|FG000|Overall Study|Other|31|||
124628576|NCT02302833|448257610|FG000|Overall Study|Lost to Follow-up|3|||
124628577|NCT04878432|448257611|FG000|Overall Study|Adverse Event|1|||
124628578|NCT04878432|448257611|FG000|Overall Study|Death|2|||
124628579|NCT04878432|448257611|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
124628580|NCT04878432|448257611|FG000|Overall Study|Withdrawal by Subject|6|||
124628581|NCT04878432|448257611|FG000|Overall Study|Progressive Disease|7|||
124789934|NCT01576159|448860141|FG001|Overall Study|Withdrawal by Subject|1|||
124789935|NCT01576159|448860142|FG002|Overall Study|Withdrawal by Subject|0|||
124789936|NCT01576159|448860143|FG003|Overall Study|Withdrawal by Subject|0|||
124789937|NCT01576159|448860140|FG000|Overall Study|Physician Decision|0|||
124789938|NCT01576159|448860141|FG001|Overall Study|Physician Decision|0|||
124789939|NCT01576159|448860142|FG002|Overall Study|Physician Decision|1|||
124789940|NCT01576159|448860143|FG003|Overall Study|Physician Decision|0|||
124789941|NCT01576159|448860140|FG000|Overall Study|Lost to Follow-up|0|||
124628582|NCT04878432|448257611|FG000|Overall Study|New Therapy for Study Indication|7|||
124628583|NCT04878432|448257611|FG000|Overall Study|Physician Decision|11|||
124628584|NCT05017246|448257612|FG000|Overall Study|Withdrawal by Subject|5|||
124628585|NCT05017246|448257613|FG001|Overall Study|Withdrawal by Subject|3|||
124628586|NCT05017246|448257612|FG000|Overall Study|Determined to be ineligible|0|||
124628587|NCT05017246|448257613|FG001|Overall Study|Determined to be ineligible|1|||
124628588|NCT05017246|448257612|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
124628589|NCT05017246|448257613|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
124628590|NCT05017246|448257612|FG000|Overall Study|Technical failure|1|||
124628591|NCT05017246|448257613|FG001|Overall Study|Technical failure|3|||
124789942|NCT01576159|448860141|FG001|Overall Study|Lost to Follow-up|0|||
124789943|NCT01576159|448860142|FG002|Overall Study|Lost to Follow-up|0|||
124628592|NCT02719184|448257616|FG000|Overall Study|Other than listed|1|||
124628593|NCT02719184|448257617|FG001|Overall Study|Other than listed|12|||
124628594|NCT02719184|448257618|FG002|Overall Study|Other than listed|13|||
124628595|NCT02719184|448257619|FG003|Overall Study|Other than listed|22|||
124628596|NCT02719184|448257620|FG004|Overall Study|Other than listed|9|||
124628597|NCT02719184|448257616|FG000|Overall Study|Withdrawal by Subject|5|||
124628598|NCT02719184|448257617|FG001|Overall Study|Withdrawal by Subject|3|||
124628599|NCT02719184|448257618|FG002|Overall Study|Withdrawal by Subject|6|||
124628600|NCT02719184|448257619|FG003|Overall Study|Withdrawal by Subject|6|||
124628601|NCT02719184|448257620|FG004|Overall Study|Withdrawal by Subject|0|||
124628602|NCT02719184|448257616|FG000|Overall Study|Lost to Follow-up|0|||
124628603|NCT02719184|448257617|FG001|Overall Study|Lost to Follow-up|4|||
124628604|NCT02719184|448257618|FG002|Overall Study|Lost to Follow-up|1|||
124628605|NCT02719184|448257619|FG003|Overall Study|Lost to Follow-up|3|||
124628606|NCT02719184|448257620|FG004|Overall Study|Lost to Follow-up|0|||
124628607|NCT02719184|448257616|FG000|Overall Study|Protocol Violation|0|||
124628608|NCT02719184|448257617|FG001|Overall Study|Protocol Violation|3|||
124628609|NCT02719184|448257618|FG002|Overall Study|Protocol Violation|0|||
124628610|NCT02719184|448257619|FG003|Overall Study|Protocol Violation|2|||
124628611|NCT02719184|448257620|FG004|Overall Study|Protocol Violation|0|||
124628612|NCT02719184|448257616|FG000|Overall Study|Adverse Event|0|||
124628613|NCT02719184|448257617|FG001|Overall Study|Adverse Event|0|||
124628614|NCT02719184|448257618|FG002|Overall Study|Adverse Event|0|||
124628615|NCT02719184|448257619|FG003|Overall Study|Adverse Event|3|||
124628616|NCT02719184|448257620|FG004|Overall Study|Adverse Event|0|||
124628617|NCT02439216|448257621|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
124628618|NCT02439216|448257622|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
124628619|NCT02439216|448257623|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
124628620|NCT02439216|448257624|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
124628621|NCT02439216|448257625|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
124628622|NCT02439216|448257626|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
124628623|NCT02439216|448257627|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
124628624|NCT02439216|448257628|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
124628625|NCT02439216|448257629|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
124628626|NCT02439216|448257621|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
124628627|NCT02439216|448257622|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
124628628|NCT02439216|448257623|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
124628629|NCT02439216|448257624|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
124628630|NCT02439216|448257625|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
124628631|NCT02439216|448257626|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
124628632|NCT02439216|448257627|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
124628633|NCT02439216|448257628|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
124628634|NCT02439216|448257629|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
124628635|NCT02439216|448257621|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
124628636|NCT02439216|448257622|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
124628637|NCT02439216|448257623|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
124628638|NCT02439216|448257624|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
124628639|NCT02439216|448257625|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
124628640|NCT02439216|448257626|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
124628641|NCT02439216|448257627|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
124628642|NCT02439216|448257628|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
124628643|NCT02439216|448257629|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
124628644|NCT02439216|448257621|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
124628645|NCT02439216|448257622|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
124789944|NCT01576159|448860143|FG003|Overall Study|Lost to Follow-up|1|||
124789945|NCT01576159|448860140|FG000|Overall Study|Protocol Violation|1|||
124789946|NCT01576159|448860141|FG001|Overall Study|Protocol Violation|0|||
124789947|NCT01576159|448860142|FG002|Overall Study|Protocol Violation|0|||
124789948|NCT01576159|448860143|FG003|Overall Study|Protocol Violation|0|||
124789949|NCT01181986|448860146|FG000|Phase 1|Lost to Follow-up|0|||
124789950|NCT01181986|448860147|FG001|Phase 1|Lost to Follow-up|1|||
124789951|NCT01181986|448860148|FG002|Phase 1|Lost to Follow-up|1|||
124789952|NCT01181986|448860146|FG000|Phase 1|Adverse Event|0|||
124628646|NCT02439216|448257623|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
124628647|NCT02439216|448257624|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
124628648|NCT02439216|448257625|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
124628649|NCT02439216|448257626|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
124628650|NCT02439216|448257627|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
124789953|NCT01181986|448860147|FG001|Phase 1|Adverse Event|0|||
124789954|NCT01181986|448860148|FG002|Phase 1|Adverse Event|1|||
124789955|NCT01181986|448860146|FG000|Phase 1|Protocol Violation|1|||
124789956|NCT01181986|448860147|FG001|Phase 1|Protocol Violation|0|||
124789957|NCT01181986|448860148|FG002|Phase 1|Protocol Violation|0|||
124789958|NCT01181986|448860146|FG000|Phase 2|Adverse Event|0|||
124789959|NCT01181986|448860147|FG001|Phase 2|Adverse Event|3|||
124789960|NCT01181986|448860148|FG002|Phase 2|Adverse Event|0|||
124789961|NCT01181986|448860146|FG000|Phase 2|Medical condition|0|||
124789962|NCT01181986|448860147|FG001|Phase 2|Medical condition|1|||
124789963|NCT01181986|448860148|FG002|Phase 2|Medical condition|0|||
124789964|NCT03720652|448860149|FG000|Overall Study|Withdrawal by Subject|2|||
124789965|NCT03720652|448860150|FG001|Overall Study|Withdrawal by Subject|7|||
124789966|NCT03720652|448860149|FG000|Overall Study|Lost to Follow-up|0|||
124789967|NCT03720652|448860150|FG001|Overall Study|Lost to Follow-up|4|||
124789968|NCT03073733|448860151|FG000|Overall Study|Lost to Follow-up|1|||
124789969|NCT03073733|448860152|FG001|Overall Study|Lost to Follow-up|0|||
124789970|NCT03073733|448860153|FG002|Overall Study|Lost to Follow-up|0|||
124789971|NCT03073733|448860151|FG000|Overall Study|Physician Decision|0|||
124789972|NCT03073733|448860152|FG001|Overall Study|Physician Decision|1|||
124789973|NCT03073733|448860153|FG002|Overall Study|Physician Decision|0|||
124789974|NCT03073733|448860151|FG000|Overall Study|Withdrawal by Subject|0|||
124789975|NCT03073733|448860152|FG001|Overall Study|Withdrawal by Subject|0|||
124789976|NCT03073733|448860153|FG002|Overall Study|Withdrawal by Subject|1|||
124789977|NCT01454778|448860154|FG000|Overall Study|Lost to Follow-up|2|||
124789978|NCT01454778|448860154|FG000|Overall Study|Death|1|||
124789979|NCT00835731|448860155|FG000|Overall Study|Withdrawal by Subject|1|||
124789980|NCT00835731|448860156|FG001|Overall Study|Withdrawal by Subject|0|||
124789981|NCT00835731|448860155|FG000|Overall Study|Physician Decision|1|||
124789982|NCT00835731|448860156|FG001|Overall Study|Physician Decision|1|||
124789983|NCT00348881|448860157|FG000|Overall Study|Lost to Follow-up|12|||
124789984|NCT00348881|448860158|FG001|Overall Study|Lost to Follow-up|6|||
124789985|NCT00348881|448860157|FG000|Overall Study|Withdrawal by Subject|3|||
124628651|NCT02439216|448257628|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
124789986|NCT00348881|448860158|FG001|Overall Study|Withdrawal by Subject|4|||
124789987|NCT00348881|448860157|FG000|Overall Study|Adverse Event|2|||
124628652|NCT02439216|448257629|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
124628653|NCT02439216|448257621|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
124628654|NCT02439216|448257622|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
124628655|NCT02439216|448257623|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
124789988|NCT00348881|448860158|FG001|Overall Study|Adverse Event|0|||
124789989|NCT00348881|448860157|FG000|Overall Study|Serious Adverse Event|0|||
124789990|NCT00348881|448860158|FG001|Overall Study|Serious Adverse Event|2|||
124789991|NCT01221272|448862017|FG000|Period 1|Adverse Event|2|||
124789992|NCT01221272|448862018|FG001|Period 1|Adverse Event|0|||
124789993|NCT01221272|448862017|FG000|Period 1|Consent Withdrawal|0|||
124789994|NCT01221272|448862018|FG001|Period 1|Consent Withdrawal|1|||
124789995|NCT01221272|448862017|FG000|Period 1|Significant Dosing Noncompliance|0|||
124789996|NCT01221272|448862018|FG001|Period 1|Significant Dosing Noncompliance|1|||
124789997|NCT01221272|448862017|FG000|Period 2|Adverse Event|0|||
124789998|NCT01221272|448862018|FG001|Period 2|Adverse Event|2|||
124628656|NCT02439216|448257624|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
124628657|NCT02439216|448257625|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
124628658|NCT02439216|448257626|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
124628659|NCT02439216|448257627|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
124628660|NCT02439216|448257628|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
124628661|NCT02439216|448257629|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
124628662|NCT03359850|448257630|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
124628663|NCT03359850|448257631|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
124628664|NCT03359850|448257630|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
124628665|NCT03359850|448257631|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
124628666|NCT03359850|448257630|FG000|Extension Phase (Up to 28 Months)|Death|2|||
124628667|NCT03359850|448257631|FG001|Extension Phase (Up to 28 Months)|Death|4|||
124628668|NCT03359850|448257630|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
124628669|NCT03359850|448257631|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
124789999|NCT04839562|448862019|FG000|Overall Study|Withdrawal by Subject|0|||
124790000|NCT04839562|448862020|FG001|Overall Study|Withdrawal by Subject|1|||
124790001|NCT04839562|448862019|FG000|Overall Study|Physician Decision|0|||
124790002|NCT04839562|448862020|FG001|Overall Study|Physician Decision|1|||
124790003|NCT01246466|448862021|FG000|Overall Study|Death|1|||
124790004|NCT01246466|448862021|FG000|Overall Study|Withdrawal by Subject|1|||
124790005|NCT00877773|448862022|FG000|Overall Study|Disease Progression|44|||
124790006|NCT00003472|448862027|FG000|Overall Study|Not evaluable|3|||
124790007|NCT01350544|448862028|FG000|Overall Study|Administrative Withdrawal|0|||
124790008|NCT01350544|448862029|FG001|Overall Study|Administrative Withdrawal|1|||
124790009|NCT01350544|448862028|FG000|Overall Study|Death|1|||
124790010|NCT01350544|448862029|FG001|Overall Study|Death|2|||
124790011|NCT01350544|448862028|FG000|Overall Study|Moved out of LA County|2|||
124790012|NCT01350544|448862029|FG001|Overall Study|Moved out of LA County|2|||
124790013|NCT01350544|448862028|FG000|Overall Study|Medical Issues|1|||
124790014|NCT01350544|448862029|FG001|Overall Study|Medical Issues|1|||
124790015|NCT01350544|448862028|FG000|Overall Study|Withdrawal by Subject|0|||
124790016|NCT01350544|448862029|FG001|Overall Study|Withdrawal by Subject|1|||
124790017|NCT01350544|448862028|FG000|Overall Study|Incarceration|1|||
124790018|NCT01350544|448862029|FG001|Overall Study|Incarceration|0|||
124790019|NCT01350544|448862028|FG000|Overall Study|Lost to Follow-up|18|||
124790020|NCT01350544|448862029|FG001|Overall Study|Lost to Follow-up|15|||
124790021|NCT00538785|448862030|FG000|Overall Study|Death|9|||
124790022|NCT00538785|448862031|FG001|Overall Study|Death|10|||
124790023|NCT00538785|448862030|FG000|Overall Study|Withdrawal of consent|9|||
124790024|NCT00538785|448862031|FG001|Overall Study|Withdrawal of consent|7|||
124790025|NCT00538785|448862030|FG000|Overall Study|Lost to Follow-up|1|||
124790026|NCT00538785|448862031|FG001|Overall Study|Lost to Follow-up|0|||
124790027|NCT01002820|448862032|FG000|Overall Study|Adverse Event|1|||
124790028|NCT01002820|448862032|FG000|Overall Study|Withdrawal by Subject|2|||
124790029|NCT01002820|448862032|FG000|Overall Study|Lack of Efficacy|1|||
124790030|NCT01673347|448862033|FG000|Overall Study|failure of allograft|7|||
124790031|NCT03086967|448862034|FG000|Overall Study|Screen Failure|2|||
124790032|NCT03086967|448862035|FG001|Overall Study|Screen Failure|2|||
124790033|NCT02661178|448862040|FG000|Part 1|Protocol Violation|1|||
124790034|NCT02661178|448862041|FG001|Part 1|Protocol Violation|0|||
124790035|NCT02661178|448862042|FG002|Part 1|Protocol Violation|0|||
124790036|NCT02661178|448862043|FG003|Part 1|Protocol Violation|0|||
124790037|NCT02661178|448862044|FG004|Part 1|Protocol Violation|0|||
124790038|NCT02661178|448862045|FG005|Part 1|Protocol Violation|0|||
124790039|NCT02661178|448862046|FG006|Part 1|Protocol Violation|0|||
124790040|NCT02661178|448862047|FG007|Part 1|Protocol Violation|0|||
124790041|NCT02661178|448862048|FG008|Part 1|Protocol Violation|0|||
124790042|NCT02661178|448862049|FG009|Part 1|Protocol Violation|0|||
124790043|NCT02661178|448862050|FG010|Part 1|Protocol Violation|0|||
124790044|NCT02661178|448862051|FG011|Part 1|Protocol Violation|0|||
124790045|NCT02661178|448862052|FG012|Part 1|Protocol Violation|0|||
124790046|NCT02661178|448862053|FG013|Part 1|Protocol Violation|0|||
124790047|NCT02661178|448862054|FG014|Part 1|Protocol Violation|0|||
124790048|NCT00775203|448862057|FG000|Overall Study|Adverse Event|25|||
124790049|NCT00775203|448862058|FG001|Overall Study|Adverse Event|6|||
124790050|NCT00775203|448862057|FG000|Overall Study|Lack of Efficacy|8|||
124790051|NCT00775203|448862058|FG001|Overall Study|Lack of Efficacy|9|||
124790052|NCT00775203|448862057|FG000|Overall Study|Withdrawal by Subject|11|||
124790053|NCT00775203|448862058|FG001|Overall Study|Withdrawal by Subject|9|||
124790054|NCT00775203|448862057|FG000|Overall Study|Lost to Follow-up|11|||
124790055|NCT00775203|448862058|FG001|Overall Study|Lost to Follow-up|15|||
124790056|NCT00775203|448862057|FG000|Overall Study|Administrative reason|2|||
124790057|NCT00775203|448862058|FG001|Overall Study|Administrative reason|0|||
124790058|NCT00775203|448862057|FG000|Overall Study|Noncompliance|4|||
124790059|NCT00775203|448862058|FG001|Overall Study|Noncompliance|2|||
124790060|NCT00775203|448862057|FG000|Overall Study|Protocol Violation|0|||
124790061|NCT00775203|448862058|FG001|Overall Study|Protocol Violation|1|||
124790062|NCT00775203|448862057|FG000|Overall Study|Entered other study|1|||
124790063|NCT00775203|448862058|FG001|Overall Study|Entered other study|0|||
124790064|NCT00775203|448862057|FG000|Overall Study|Physician Decision|0|||
124790065|NCT00775203|448862058|FG001|Overall Study|Physician Decision|1|||
124790066|NCT00704522|448862059|FG000|Overall Study|Lack of Efficacy|65|||
124790067|NCT00704522|448862060|FG001|Overall Study|Lack of Efficacy|17|||
124790068|NCT00704522|448862059|FG000|Overall Study|Failure to appear again at hospital|56|||
124790069|NCT00704522|448862060|FG001|Overall Study|Failure to appear again at hospital|10|||
124790070|NCT00704522|448862059|FG000|Overall Study|Withdrawal by Subject|17|||
124790071|NCT00704522|448862060|FG001|Overall Study|Withdrawal by Subject|8|||
124790072|NCT00704522|448862059|FG000|Overall Study|Adverse Event|9|||
124790073|NCT00704522|448862060|FG001|Overall Study|Adverse Event|1|||
124790074|NCT00704522|448862059|FG000|Overall Study|Undefined causes|9|||
124790075|NCT00704522|448862060|FG001|Overall Study|Undefined causes|7|||
124790076|NCT00704522|448862059|FG000|Overall Study|No information on therapy end|27|||
124790077|NCT00704522|448862060|FG001|Overall Study|No information on therapy end|2|||
124790078|NCT01525901|448862065|FG000|Period 2: 12 Weeks|Adverse Event|0|||
124790079|NCT01525901|448862066|FG001|Period 2: 12 Weeks|Adverse Event|1|||
124790080|NCT01525901|448862067|FG002|Period 2: 12 Weeks|Adverse Event|0|||
124790081|NCT01525901|448862068|FG003|Period 2: 12 Weeks|Adverse Event|0|||
124790082|NCT02486627|448862073|FG000|Overall Study|Death|1|||
124790083|NCT02486627|448862074|FG001|Overall Study|Death|0|||
124790084|NCT02486627|448862073|FG000|Overall Study|Other Unspecified|0|||
124790085|NCT02486627|448862074|FG001|Overall Study|Other Unspecified|2|||
124790086|NCT02486627|448862073|FG000|Overall Study|Consent Withdrawn by Participant|4|||
124790087|NCT02486627|448862074|FG001|Overall Study|Consent Withdrawn by Participant|3|||
124790088|NCT02486627|448862073|FG000|Overall Study|Significant Participant Noncompliance|1|||
124790089|NCT02486627|448862074|FG001|Overall Study|Significant Participant Noncompliance|1|||
124790090|NCT02486627|448862073|FG000|Overall Study|Lost to Follow-up|1|||
124790091|NCT02486627|448862074|FG001|Overall Study|Lost to Follow-up|3|||
124790092|NCT01073462|448862075|FG000|Overall Study|Death|14|||
124790093|NCT01073462|448862075|FG000|Overall Study|Kidney transplant|10|||
124790094|NCT01073462|448862075|FG000|Overall Study|Low parathyroid hormone levels|8|||
124790095|NCT01073462|448862075|FG000|Overall Study|Serious adverse event|2|||
124790096|NCT01073462|448862075|FG000|Overall Study|Lost to Follow-up|7|||
124790097|NCT03554486|448862079|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
124790098|NCT03554486|448862080|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
124790099|NCT03554486|448862081|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
124790100|NCT03554486|448862079|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
124790101|NCT03554486|448862080|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
124790102|NCT03554486|448862081|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
124790103|NCT03554486|448862079|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
124790104|NCT03554486|448862080|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
124790105|NCT03554486|448862081|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
124790106|NCT01509053|448862082|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
124790107|NCT01509053|448862082|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
124790108|NCT01509053|448862082|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
124790109|NCT01509053|448862082|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
124790110|NCT01509053|448862082|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
124790111|NCT01509053|448862082|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
124790112|NCT01738477|448862084|FG000|Overall Study|Lost to Follow-up|1|||
124790113|NCT01738477|448862085|FG001|Overall Study|Lost to Follow-up|4|||
124790114|NCT01915303|448862086|FG000|Core Phase|Adverse Event|7|||
124790115|NCT01915303|448862086|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
124790116|NCT01915303|448862086|FG000|Core Phase|Death|2|||
124790117|NCT01915303|448862086|FG000|Core Phase|Protocol Violation|2|||
124790118|NCT01915303|448862086|FG000|Core Phase|Abnormal lab value|1|||
124790119|NCT01915303|448862086|FG000|Core Phase|Withdrawal by Subject|1|||
124790120|NCT01915303|448862086|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
124790121|NCT01915303|448862086|FG000|Extension Phase|Withdrawal by Subject|4|||
124790122|NCT01915303|448862086|FG000|Extension Phase|Adverse Event|3|||
124790123|NCT01915303|448862086|FG000|Extension Phase|Death|1|||
124790124|NCT01915303|448862086|FG000|Extension Phase|Protocol Violation|1|||
124790125|NCT02925338|448862087|FG000|Overall Study|Death|0|||
124628670|NCT03359850|448257630|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
124628671|NCT03359850|448257631|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
124628672|NCT03472014|448257643|FG000|Overall Study|Lost to Follow-up|4|||
124628673|NCT02792517|448257644|FG000|Overall Study|Withdrawal by Subject|10|||
124628674|NCT02792517|448257644|FG000|Overall Study|Decision by Sponsor|7|||
124628675|NCT02792517|448257644|FG000|Overall Study|Lost to Follow-up|3|||
124628676|NCT00711087|448257645|FG000|Overall Study|Lost to Follow-up|1|||
124628677|NCT00711087|448257646|FG001|Overall Study|Lost to Follow-up|0|||
124628678|NCT00856193|448257649|FG000|Period 2|Abnormal test procedure results|0|||
124628679|NCT00856193|448257650|FG001|Period 2|Abnormal test procedure results|1|||
124628680|NCT00856193|448257649|FG000|Period 2|Lost to Follow-up|0|||
124628681|NCT00856193|448257650|FG001|Period 2|Lost to Follow-up|1|||
124628682|NCT00428246|448257651|FG000|Overall Study|Withdrawal by Subject|0|||
124628683|NCT00428246|448257652|FG001|Overall Study|Withdrawal by Subject|0|||
124628684|NCT00428246|448257653|FG002|Overall Study|Withdrawal by Subject|1|||
124628685|NCT00428246|448257651|FG000|Overall Study|Adverse Event|1|||
124628686|NCT00428246|448257652|FG001|Overall Study|Adverse Event|0|||
124628687|NCT00428246|448257653|FG002|Overall Study|Adverse Event|0|||
124628688|NCT02569801|448257654|FG000|Overall Study|Withdrawal by Subject|9|||
124628689|NCT02569801|448257655|FG001|Overall Study|Withdrawal by Subject|9|||
124628690|NCT02569801|448257654|FG000|Overall Study|Sponsor Decision|13|||
124628691|NCT02569801|448257655|FG001|Overall Study|Sponsor Decision|14|||
124628692|NCT02569801|448257654|FG000|Overall Study|Progressive Disease|2|||
124628693|NCT02569801|448257655|FG001|Overall Study|Progressive Disease|7|||
124628694|NCT02569801|448257654|FG000|Overall Study|Lost to Follow-up|0|||
124628695|NCT02569801|448257655|FG001|Overall Study|Lost to Follow-up|1|||
124628696|NCT02569801|448257654|FG000|Overall Study|Death|12|||
124628697|NCT02569801|448257655|FG001|Overall Study|Death|4|||
124628698|NCT01125917|448257665|FG000|Overall Study|Adverse Event|43|||
124628699|NCT01125917|448257665|FG000|Overall Study|Lost to Follow-up|23|||
124628700|NCT01125917|448257665|FG000|Overall Study|Withdrawal by Subject|31|||
124628701|NCT01125917|448257665|FG000|Overall Study|Administrative|223|||
124628702|NCT01125917|448257665|FG000|Overall Study|Lack of Efficacy|19|||
124628703|NCT02501928|448257666|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
124628704|NCT02501928|448257667|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
124628705|NCT02501928|448257668|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
124628706|NCT02501928|448257669|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
124790126|NCT02925338|448862088|FG001|Overall Study|Death|2|||
124628707|NCT02501928|448257670|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
124790127|NCT02925338|448862089|FG002|Overall Study|Death|1|||
124790128|NCT02925338|448862090|FG003|Overall Study|Death|0|||
124790129|NCT02925338|448862091|FG004|Overall Study|Death|0|||
124790130|NCT02925338|448862087|FG000|Overall Study|Lost to Follow-up|30|||
124790131|NCT02925338|448862088|FG001|Overall Study|Lost to Follow-up|10|||
124790132|NCT02925338|448862089|FG002|Overall Study|Lost to Follow-up|1|||
124790133|NCT02925338|448862090|FG003|Overall Study|Lost to Follow-up|16|||
124790134|NCT02925338|448862091|FG004|Overall Study|Lost to Follow-up|3|||
124790135|NCT02925338|448862087|FG000|Overall Study|Withdrawal by Subject|3|||
124790136|NCT02925338|448862088|FG001|Overall Study|Withdrawal by Subject|0|||
124790137|NCT02925338|448862089|FG002|Overall Study|Withdrawal by Subject|3|||
124790138|NCT02925338|448862090|FG003|Overall Study|Withdrawal by Subject|2|||
124790139|NCT02925338|448862091|FG004|Overall Study|Withdrawal by Subject|2|||
124790140|NCT02925338|448862087|FG000|Overall Study|Missing|38|||
124790141|NCT02925338|448862088|FG001|Overall Study|Missing|27|||
124790142|NCT02925338|448862089|FG002|Overall Study|Missing|0|||
124790143|NCT02925338|448862090|FG003|Overall Study|Missing|3|||
124790144|NCT02925338|448862091|FG004|Overall Study|Missing|2|||
124790145|NCT02925338|448862087|FG000|Overall Study|Participant's Decision|11|||
124790146|NCT02925338|448862088|FG001|Overall Study|Participant's Decision|7|||
124790147|NCT02925338|448862089|FG002|Overall Study|Participant's Decision|3|||
124790148|NCT02925338|448862090|FG003|Overall Study|Participant's Decision|8|||
124790149|NCT02925338|448862091|FG004|Overall Study|Participant's Decision|1|||
124790150|NCT02925338|448862087|FG000|Overall Study|Treatment Discontinuation|144|||
124790151|NCT02925338|448862088|FG001|Overall Study|Treatment Discontinuation|65|||
124790152|NCT02925338|448862089|FG002|Overall Study|Treatment Discontinuation|56|||
124628708|NCT02501928|448257671|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
124628711|NCT00838526|448257679|FG000|Overall Study|Adverse Event|3|||
124628712|NCT00838526|448257680|FG001|Overall Study|Adverse Event|12|||
124628713|NCT00838526|448257679|FG000|Overall Study|Lost to Follow-up|4|||
124628714|NCT00838526|448257680|FG001|Overall Study|Lost to Follow-up|12|||
124628715|NCT00838526|448257679|FG000|Overall Study|Withdrawal by Subject|4|||
124628716|NCT00838526|448257680|FG001|Overall Study|Withdrawal by Subject|5|||
124790153|NCT02925338|448862090|FG003|Overall Study|Treatment Discontinuation|131|||
124790154|NCT02925338|448862091|FG004|Overall Study|Treatment Discontinuation|22|||
124790155|NCT02509117|448862092|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790156|NCT02509117|448862093|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
124790157|NCT02509117|448862094|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790158|NCT02509117|448862095|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790159|NCT02509117|448862096|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790160|NCT02509117|448862097|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790161|NCT02509117|448862098|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790162|NCT02509117|448862099|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790163|NCT02509117|448862100|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790164|NCT02509117|448862101|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
124790165|NCT02509117|448862092|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790166|NCT02509117|448862093|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790167|NCT02509117|448862094|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790168|NCT02509117|448862095|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790169|NCT02509117|448862096|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790170|NCT02509117|448862097|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790171|NCT02509117|448862098|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790172|NCT02509117|448862099|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790173|NCT02509117|448862100|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
124790174|NCT02509117|448862101|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
124790175|NCT02509117|448862092|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
124790176|NCT02509117|448862093|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
124790177|NCT02509117|448862094|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
124790178|NCT02509117|448862095|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
124790179|NCT02509117|448862096|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
124790180|NCT02509117|448862097|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
124628717|NCT00838526|448257679|FG000|Overall Study|Lack of Efficacy|2|||
124628718|NCT00838526|448257680|FG001|Overall Study|Lack of Efficacy|3|||
124790181|NCT02509117|448862098|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
124790182|NCT02509117|448862099|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
124790183|NCT02509117|448862100|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
124790184|NCT02509117|448862101|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
124790185|NCT00548184|448862104|FG000|Overall Study|Adverse Event|3|||
124628719|NCT00838526|448257679|FG000|Overall Study|Other|11|||
124628720|NCT00838526|448257680|FG001|Overall Study|Other|7|||
124628721|NCT03483012|448257681|FG000|Overall Study|Lack of Efficacy|6|||
124790186|NCT00548184|448862104|FG000|Overall Study|took other drug|1|||
124790187|NCT00548184|448862104|FG000|Overall Study|Found Her2 negative|1|||
124628722|NCT02452476|448257684|FG000|Overall Study|Death|4|||
124628723|NCT02452476|448257685|FG001|Overall Study|Death|7|||
124628724|NCT02452476|448257684|FG000|Overall Study|Lost to Follow-up|1|||
124628725|NCT02452476|448257685|FG001|Overall Study|Lost to Follow-up|1|||
124628726|NCT02452476|448257684|FG000|Overall Study|Physician Decision|1|||
124628727|NCT02452476|448257685|FG001|Overall Study|Physician Decision|1|||
124628728|NCT02452476|448257684|FG000|Overall Study|Not treated|5|||
124628729|NCT02452476|448257685|FG001|Overall Study|Not treated|1|||
124628730|NCT02201784|448257686|FG000|Overall Study|Failure to achieve adequate block|2|||
124628731|NCT02201784|448257687|FG001|Overall Study|Failure to achieve adequate block|0|||
124628732|NCT01757275|448257688|FG000|Overall Study|Lost to Follow-up|1|||
124628733|NCT01757275|448257689|FG001|Overall Study|Lost to Follow-up|2|||
124628734|NCT01757275|448257688|FG000|Overall Study|Adverse Event|3|||
124628735|NCT01757275|448257689|FG001|Overall Study|Adverse Event|3|||
124628736|NCT01757275|448257688|FG000|Overall Study|Withdrawal by Subject|2|||
124628737|NCT01757275|448257689|FG001|Overall Study|Withdrawal by Subject|4|||
124628738|NCT01757275|448257688|FG000|Overall Study|Not treated|3|||
124628739|NCT01757275|448257689|FG001|Overall Study|Not treated|4|||
124628740|NCT01749826|448259333|FG000|Overall Study|Study Terminated|20|||
124790188|NCT00636363|448862105|FG000|Overall Study|Conjunctivitis|0|||
124790189|NCT00636363|448862106|FG001|Overall Study|Conjunctivitis|0|||
124790190|NCT00636363|448862107|FG002|Overall Study|Conjunctivitis|1|||
124790191|NCT00636363|448862105|FG000|Overall Study|Adverse Event|0|||
124790192|NCT00636363|448862106|FG001|Overall Study|Adverse Event|0|||
124790193|NCT00636363|448862107|FG002|Overall Study|Adverse Event|1|||
124790194|NCT00636363|448862105|FG000|Overall Study|Positive slit lamp finding|0|||
124790195|NCT00636363|448862106|FG001|Overall Study|Positive slit lamp finding|2|||
124790196|NCT00636363|448862107|FG002|Overall Study|Positive slit lamp finding|1|||
124790197|NCT00636363|448862105|FG000|Overall Study|Study related symptoms/complaints|8|||
124790198|NCT00636363|448862106|FG001|Overall Study|Study related symptoms/complaints|7|||
124790199|NCT00636363|448862107|FG002|Overall Study|Study related symptoms/complaints|4|||
124790200|NCT00636363|448862105|FG000|Overall Study|Met ineligibility criteria|0|||
124790201|NCT00636363|448862106|FG001|Overall Study|Met ineligibility criteria|0|||
124790202|NCT00636363|448862107|FG002|Overall Study|Met ineligibility criteria|3|||
124790203|NCT00636363|448862105|FG000|Overall Study|Missed > 1 visit|0|||
124790204|NCT00636363|448862106|FG001|Overall Study|Missed > 1 visit|1|||
124790205|NCT00636363|448862107|FG002|Overall Study|Missed > 1 visit|3|||
124790206|NCT00636363|448862105|FG000|Overall Study|Lack of motivation|1|||
124790207|NCT00636363|448862106|FG001|Overall Study|Lack of motivation|0|||
124790208|NCT00636363|448862107|FG002|Overall Study|Lack of motivation|1|||
124790209|NCT00636363|448862105|FG000|Overall Study|Protocol Violation|0|||
124790210|NCT00636363|448862106|FG001|Overall Study|Protocol Violation|3|||
124790211|NCT00636363|448862107|FG002|Overall Study|Protocol Violation|0|||
124790212|NCT00636363|448862105|FG000|Overall Study|Lost to Follow-up|3|||
124790213|NCT00636363|448862106|FG001|Overall Study|Lost to Follow-up|4|||
124790214|NCT00636363|448862107|FG002|Overall Study|Lost to Follow-up|2|||
124790215|NCT00636363|448862105|FG000|Overall Study|Withdrawal by Subject|1|||
124790216|NCT00636363|448862106|FG001|Overall Study|Withdrawal by Subject|3|||
124790217|NCT00636363|448862107|FG002|Overall Study|Withdrawal by Subject|2|||
124790218|NCT00280748|448862109|FG000|Overall Study|Decline in performance|3|||
124790219|NCT00280748|448862109|FG000|Overall Study|Extra-cranial disease progression|1|||
124790220|NCT00029146|448862110|FG000|Overall Study|Lost to Follow-up|2|||
124790221|NCT00029146|448862111|FG001|Overall Study|Lost to Follow-up|1|||
124790222|NCT03567343|448862113|FG000|Overall Study|Lost to Follow-up|2|||
124790223|NCT03567343|448862114|FG001|Overall Study|Lost to Follow-up|1|||
124790224|NCT03567343|448862113|FG000|Overall Study|No longer eligible|2|||
124790225|NCT03567343|448862114|FG001|Overall Study|No longer eligible|1|||
124790226|NCT03567343|448862113|FG000|Overall Study|Adverse Event|1|||
124790227|NCT03567343|448862114|FG001|Overall Study|Adverse Event|0|||
124628741|NCT01749826|448259334|FG001|Overall Study|Study Terminated|0|||
124628742|NCT02721732|448259335|FG000|Overall Study|Adverse Event|2|||
124790228|NCT03567343|448862113|FG000|Overall Study|Protocol Violation|1|||
124790229|NCT03567343|448862114|FG001|Overall Study|Protocol Violation|1|||
124790230|NCT03007888|448862118|FG000|First Intervention (14 Days)|Adverse Event|1|||
124790231|NCT03007888|448862119|FG001|First Intervention (14 Days)|Adverse Event|0|||
124790232|NCT01806662|448862120|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
124628743|NCT02721732|448259336|FG001|Overall Study|Adverse Event|0|||
124628744|NCT02721732|448259337|FG002|Overall Study|Adverse Event|2|||
124628745|NCT02721732|448259338|FG003|Overall Study|Adverse Event|0|||
124790233|NCT01806662|448862121|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
124790234|NCT01806662|448862120|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
124790235|NCT01806662|448862121|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
124790236|NCT01806662|448862120|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
124790237|NCT01806662|448862121|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
124790238|NCT01806662|448862120|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
124790239|NCT01806662|448862121|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
124790240|NCT00043550|448862124|FG000|Overall Study|Withdrawal by Subject|22|||
124790241|NCT00043550|448862125|FG001|Overall Study|Withdrawal by Subject|12|||
124790242|NCT00043550|448862126|FG002|Overall Study|Withdrawal by Subject|20|||
124790243|NCT00827931|448862130|FG000|Overall Study|Death|3|||
124790244|NCT00827931|448862131|FG001|Overall Study|Death|5|||
124790245|NCT00827931|448862130|FG000|Overall Study|Adverse Event|1|||
124790246|NCT00827931|448862131|FG001|Overall Study|Adverse Event|0|||
124790247|NCT00827931|448862130|FG000|Overall Study|Lost to Follow-up|1|||
124790248|NCT00827931|448862131|FG001|Overall Study|Lost to Follow-up|0|||
124790249|NCT00827931|448862130|FG000|Overall Study|Withdrawal by Subject|0|||
124790250|NCT00827931|448862131|FG001|Overall Study|Withdrawal by Subject|1|||
124628746|NCT02721732|448259339|FG004|Overall Study|Adverse Event|1|||
124628747|NCT02721732|448259340|FG005|Overall Study|Adverse Event|0|||
124628748|NCT02721732|448259341|FG006|Overall Study|Adverse Event|1|||
124628749|NCT02721732|448259342|FG007|Overall Study|Adverse Event|0|||
124628750|NCT02721732|448259343|FG008|Overall Study|Adverse Event|1|||
124628751|NCT02721732|448259344|FG009|Overall Study|Adverse Event|1|||
124628752|NCT02721732|448259335|FG000|Overall Study|Death|0|||
124628753|NCT02721732|448259336|FG001|Overall Study|Death|0|||
124628754|NCT02721732|448259337|FG002|Overall Study|Death|0|||
124628755|NCT02721732|448259338|FG003|Overall Study|Death|0|||
124628756|NCT02721732|448259339|FG004|Overall Study|Death|1|||
124628757|NCT02721732|448259340|FG005|Overall Study|Death|0|||
124628758|NCT02721732|448259341|FG006|Overall Study|Death|1|||
124628759|NCT02721732|448259342|FG007|Overall Study|Death|0|||
124628760|NCT02721732|448259343|FG008|Overall Study|Death|0|||
124628761|NCT02721732|448259344|FG009|Overall Study|Death|1|||
124628762|NCT02721732|448259335|FG000|Overall Study|Lack of Efficacy|12|||
124628763|NCT02721732|448259336|FG001|Overall Study|Lack of Efficacy|11|||
124628764|NCT02721732|448259337|FG002|Overall Study|Lack of Efficacy|18|||
124628765|NCT02721732|448259338|FG003|Overall Study|Lack of Efficacy|5|||
124628766|NCT02721732|448259339|FG004|Overall Study|Lack of Efficacy|21|||
124628767|NCT02721732|448259340|FG005|Overall Study|Lack of Efficacy|2|||
124628768|NCT02721732|448259341|FG006|Overall Study|Lack of Efficacy|8|||
124628769|NCT02721732|448259342|FG007|Overall Study|Lack of Efficacy|11|||
124628770|NCT02721732|448259343|FG008|Overall Study|Lack of Efficacy|10|||
124628771|NCT02721732|448259344|FG009|Overall Study|Lack of Efficacy|20|||
124628772|NCT02721732|448259335|FG000|Overall Study|Physician Decision|0|||
124628773|NCT02721732|448259336|FG001|Overall Study|Physician Decision|0|||
124628774|NCT02721732|448259337|FG002|Overall Study|Physician Decision|1|||
124628775|NCT02721732|448259338|FG003|Overall Study|Physician Decision|0|||
124628776|NCT02721732|448259339|FG004|Overall Study|Physician Decision|0|||
124628777|NCT02721732|448259340|FG005|Overall Study|Physician Decision|0|||
124628778|NCT02721732|448259341|FG006|Overall Study|Physician Decision|0|||
124628779|NCT02721732|448259342|FG007|Overall Study|Physician Decision|0|||
124628780|NCT02721732|448259343|FG008|Overall Study|Physician Decision|0|||
124628781|NCT02721732|448259344|FG009|Overall Study|Physician Decision|0|||
124628782|NCT02721732|448259335|FG000|Overall Study|Withdrawal by Subject|1|||
124628783|NCT02721732|448259336|FG001|Overall Study|Withdrawal by Subject|0|||
124628784|NCT02721732|448259337|FG002|Overall Study|Withdrawal by Subject|0|||
124628785|NCT02721732|448259338|FG003|Overall Study|Withdrawal by Subject|0|||
124628786|NCT02721732|448259339|FG004|Overall Study|Withdrawal by Subject|3|||
124628787|NCT02721732|448259340|FG005|Overall Study|Withdrawal by Subject|0|||
124628788|NCT02721732|448259341|FG006|Overall Study|Withdrawal by Subject|1|||
124628789|NCT02721732|448259342|FG007|Overall Study|Withdrawal by Subject|1|||
124628790|NCT02721732|448259343|FG008|Overall Study|Withdrawal by Subject|0|||
124628791|NCT02721732|448259344|FG009|Overall Study|Withdrawal by Subject|1|||
124628792|NCT02721732|448259335|FG000|Overall Study|Participant Choice|1|||
124628793|NCT02721732|448259336|FG001|Overall Study|Participant Choice|0|||
124628794|NCT02721732|448259337|FG002|Overall Study|Participant Choice|0|||
124628795|NCT02721732|448259338|FG003|Overall Study|Participant Choice|0|||
124628796|NCT02721732|448259339|FG004|Overall Study|Participant Choice|0|||
124628797|NCT02721732|448259340|FG005|Overall Study|Participant Choice|0|||
124628798|NCT02721732|448259341|FG006|Overall Study|Participant Choice|0|||
124628799|NCT02721732|448259342|FG007|Overall Study|Participant Choice|0|||
124628800|NCT02721732|448259343|FG008|Overall Study|Participant Choice|0|||
124790251|NCT00827931|448862130|FG000|Overall Study|Other|1|||
124790252|NCT00827931|448862131|FG001|Overall Study|Other|0|||
124790253|NCT01917656|448862135|FG000|Overall Study|Adverse Event|11|||
124628801|NCT02721732|448259344|FG009|Overall Study|Participant Choice|1|||
124628802|NCT02721732|448259335|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
124628803|NCT02721732|448259336|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
124790254|NCT01917656|448862136|FG001|Overall Study|Adverse Event|0|||
124790255|NCT01917656|448862135|FG000|Overall Study|Withdrawal criteria|8|||
124628804|NCT02721732|448259337|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
124628805|NCT02721732|448259338|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
124628806|NCT02721732|448259339|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
124628807|NCT02721732|448259340|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
124628808|NCT02721732|448259341|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
124790256|NCT01917656|448862136|FG001|Overall Study|Withdrawal criteria|14|||
124628809|NCT02721732|448259342|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
124628810|NCT02721732|448259343|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
124628811|NCT02721732|448259344|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
124628812|NCT02721732|448259335|FG000|Overall Study|Progression and withdrew consent|1|||
124628813|NCT02721732|448259336|FG001|Overall Study|Progression and withdrew consent|1|||
124628814|NCT02721732|448259337|FG002|Overall Study|Progression and withdrew consent|0|||
124628815|NCT02721732|448259338|FG003|Overall Study|Progression and withdrew consent|0|||
124628816|NCT02721732|448259339|FG004|Overall Study|Progression and withdrew consent|0|||
124628817|NCT02721732|448259340|FG005|Overall Study|Progression and withdrew consent|0|||
124628818|NCT02721732|448259341|FG006|Overall Study|Progression and withdrew consent|0|||
124628819|NCT02721732|448259342|FG007|Overall Study|Progression and withdrew consent|0|||
124628820|NCT02721732|448259343|FG008|Overall Study|Progression and withdrew consent|0|||
124628821|NCT02721732|448259344|FG009|Overall Study|Progression and withdrew consent|1|||
124628822|NCT02721732|448259335|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
124628823|NCT02721732|448259336|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
124628824|NCT02721732|448259337|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
124628825|NCT02721732|448259338|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
124628826|NCT02721732|448259339|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
124628827|NCT02721732|448259340|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
124628828|NCT02721732|448259341|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
124628829|NCT02721732|448259342|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
124628830|NCT02721732|448259343|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
124628831|NCT02721732|448259344|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
124628832|NCT02572570|448259351|FG000|Overall Study|Study Terminated|27|||
124628833|NCT02763046|448259352|FG000|Overall Study|Adverse Event|5|||
124790257|NCT01917656|448862135|FG000|Overall Study|Unclassified|0|||
124790258|NCT01917656|448862136|FG001|Overall Study|Unclassified|3|||
124790259|NCT01917656|448862135|FG000|Overall Study|Withdrawal by Subject|4|||
124790260|NCT01917656|448862136|FG001|Overall Study|Withdrawal by Subject|3|||
124628834|NCT02763046|448259353|FG001|Overall Study|Adverse Event|4|||
124628835|NCT02763046|448259354|FG002|Overall Study|Adverse Event|0|||
124628836|NCT02763046|448259352|FG000|Overall Study|Lack of Efficacy|1|||
124628837|NCT02763046|448259353|FG001|Overall Study|Lack of Efficacy|1|||
124628838|NCT02763046|448259354|FG002|Overall Study|Lack of Efficacy|3|||
124628839|NCT02763046|448259352|FG000|Overall Study|Physician Decision|1|||
124628840|NCT02763046|448259353|FG001|Overall Study|Physician Decision|0|||
124628841|NCT02763046|448259354|FG002|Overall Study|Physician Decision|1|||
124628842|NCT02763046|448259352|FG000|Overall Study|Subject/guardian decision|2|||
124628843|NCT02763046|448259353|FG001|Overall Study|Subject/guardian decision|0|||
124628844|NCT02763046|448259354|FG002|Overall Study|Subject/guardian decision|4|||
124628845|NCT03052751|448259358|FG000|Dosing Period 1|Adverse Event|0|||
124628846|NCT03052751|448259359|FG001|Dosing Period 1|Adverse Event|1|||
124628847|NCT03052751|448259360|FG002|Dosing Period 1|Adverse Event|0|||
124628848|NCT03052751|448259361|FG003|Dosing Period 1|Adverse Event|0|||
124628849|NCT03052751|448259362|FG004|Dosing Period 1|Adverse Event|0|||
124628850|NCT03052751|448259363|FG005|Dosing Period 1|Adverse Event|0|||
124628851|NCT03052751|448259358|FG000|Dosing Period 2|Adverse Event|0|||
124628852|NCT03052751|448259359|FG001|Dosing Period 2|Adverse Event|0|||
124628853|NCT03052751|448259360|FG002|Dosing Period 2|Adverse Event|3|||
124628854|NCT03052751|448259361|FG003|Dosing Period 2|Adverse Event|0|||
124790261|NCT01917656|448862135|FG000|Overall Study|Lost to Follow-up|3|||
124790262|NCT01917656|448862136|FG001|Overall Study|Lost to Follow-up|4|||
124790263|NCT02081859|448862137|FG000|Overall Study|No fertilization|2|||
124790264|NCT02081859|448862138|FG001|Overall Study|No fertilization|2|||
124790265|NCT02081859|448862137|FG000|Overall Study|No sperm|1|||
124790266|NCT02081859|448862138|FG001|Overall Study|No sperm|0|||
124790267|NCT02081859|448862137|FG000|Overall Study|Unanticipated freeze all cycle|2|||
124790268|NCT02081859|448862138|FG001|Overall Study|Unanticipated freeze all cycle|6|||
124790269|NCT02081859|448862137|FG000|Overall Study|< 4 embryos|27|||
124790270|NCT02081859|448862138|FG001|Overall Study|< 4 embryos|23|||
124790271|NCT02081859|448862137|FG000|Overall Study|Other reasons|2|||
124790272|NCT02081859|448862138|FG001|Overall Study|Other reasons|0|||
124790273|NCT01870076|448862139|FG000|Overall Study|Withdrawal by Subject|1|||
124790274|NCT01870076|448862140|FG001|Overall Study|Withdrawal by Subject|0|||
124790275|NCT01870076|448862141|FG002|Overall Study|Withdrawal by Subject|1|||
124628855|NCT03052751|448259362|FG004|Dosing Period 2|Adverse Event|0|||
124628856|NCT03052751|448259363|FG005|Dosing Period 2|Adverse Event|0|||
124628857|NCT03052751|448259358|FG000|Observation Period|Adverse Event|0|||
124628858|NCT03052751|448259359|FG001|Observation Period|Adverse Event|0|||
124628859|NCT03052751|448259360|FG002|Observation Period|Adverse Event|0|||
124790276|NCT01870076|448862142|FG003|Overall Study|Withdrawal by Subject|0|||
124790277|NCT00492063|448862143|FG000|Overall Study|Death|0|||
124790278|NCT00492063|448862144|FG001|Overall Study|Death|0|||
124790279|NCT00492063|448862145|FG002|Overall Study|Death|1|||
124790280|NCT00492063|448862146|FG003|Overall Study|Death|2|||
124790281|NCT00492063|448862143|FG000|Overall Study|Withdrawal by Subject|4|||
124790282|NCT00492063|448862144|FG001|Overall Study|Withdrawal by Subject|3|||
124790283|NCT00492063|448862145|FG002|Overall Study|Withdrawal by Subject|5|||
124790284|NCT00492063|448862146|FG003|Overall Study|Withdrawal by Subject|4|||
124790285|NCT00492063|448862143|FG000|Overall Study|Lost to Follow-up|6|||
124790286|NCT00492063|448862144|FG001|Overall Study|Lost to Follow-up|11|||
124790287|NCT00492063|448862145|FG002|Overall Study|Lost to Follow-up|5|||
124790288|NCT00492063|448862146|FG003|Overall Study|Lost to Follow-up|3|||
124790289|NCT00492063|448862143|FG000|Overall Study|Protocol Violation|0|||
124790290|NCT00492063|448862144|FG001|Overall Study|Protocol Violation|0|||
124790291|NCT00492063|448862145|FG002|Overall Study|Protocol Violation|0|||
124790292|NCT00492063|448862146|FG003|Overall Study|Protocol Violation|1|||
124790293|NCT00510653|448862157|FG000|Overall Study|Withdrawal by Subject|8|||
124790294|NCT00510653|448862157|FG000|Overall Study|Monetary|3|||
124790295|NCT02312687|448862159|FG000|Overall Study|Other, Not Specified|1|||
124790296|NCT00217464|448862162|FG000|Overall Study|Progression|15|||
124790297|NCT00217464|448862162|FG000|Overall Study|Other|2|||
124790298|NCT00169442|448862163|FG000|Overall Study|Withdrawal by Subject|0|||
124790299|NCT00169442|448862164|FG001|Overall Study|Withdrawal by Subject|0|||
124790300|NCT00169442|448862165|FG002|Overall Study|Withdrawal by Subject|1|||
124790301|NCT00169442|448862166|FG003|Overall Study|Withdrawal by Subject|0|||
124790302|NCT00169442|448862167|FG004|Overall Study|Withdrawal by Subject|0|||
124790303|NCT00169442|448862168|FG005|Overall Study|Withdrawal by Subject|0|||
124790304|NCT00169442|448862163|FG000|Overall Study|Migrated/moved from study area|0|||
124790305|NCT00169442|448862164|FG001|Overall Study|Migrated/moved from study area|0|||
124790306|NCT00169442|448862165|FG002|Overall Study|Migrated/moved from study area|0|||
124790307|NCT00169442|448862166|FG003|Overall Study|Migrated/moved from study area|0|||
124790308|NCT00169442|448862167|FG004|Overall Study|Migrated/moved from study area|0|||
124790309|NCT00169442|448862168|FG005|Overall Study|Migrated/moved from study area|2|||
124790310|NCT00169442|448862163|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
124790311|NCT00169442|448862164|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
124790312|NCT00169442|448862165|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
124790313|NCT00169442|448862166|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
124790314|NCT00169442|448862167|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
124790315|NCT00169442|448862168|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
124790316|NCT00169442|448862163|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
124790317|NCT00169442|448862164|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
124790318|NCT00169442|448862165|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
124790319|NCT00169442|448862166|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
124790320|NCT00169442|448862167|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
124790321|NCT00169442|448862168|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
124790322|NCT01426789|448862169|FG000|Part 1|Protocol deviation|0|||
124790323|NCT01426789|448862170|FG001|Part 1|Protocol deviation|1|||
124790324|NCT01426789|448862171|FG002|Part 1|Protocol deviation|0|||
124790325|NCT01426789|448862172|FG003|Part 1|Protocol deviation|0|||
124790326|NCT01426789|448862173|FG004|Part 1|Protocol deviation|0|||
124790327|NCT01426789|448862174|FG005|Part 1|Protocol deviation|0|||
124790328|NCT01426789|448862169|FG000|Part 1|Lost to Follow-up|1|||
124790329|NCT01426789|448862170|FG001|Part 1|Lost to Follow-up|2|||
124790330|NCT01426789|448862171|FG002|Part 1|Lost to Follow-up|0|||
124790331|NCT01426789|448862172|FG003|Part 1|Lost to Follow-up|0|||
124790332|NCT01426789|448862173|FG004|Part 1|Lost to Follow-up|0|||
124790333|NCT01426789|448862174|FG005|Part 1|Lost to Follow-up|0|||
124790334|NCT01426789|448862169|FG000|Part 1|Lack of Efficacy|2|||
124628860|NCT03052751|448259361|FG003|Observation Period|Adverse Event|0|||
124790335|NCT01426789|448862170|FG001|Part 1|Lack of Efficacy|1|||
124790336|NCT01426789|448862171|FG002|Part 1|Lack of Efficacy|0|||
124790337|NCT01426789|448862172|FG003|Part 1|Lack of Efficacy|0|||
124790338|NCT01426789|448862173|FG004|Part 1|Lack of Efficacy|0|||
124790339|NCT01426789|448862174|FG005|Part 1|Lack of Efficacy|0|||
124790340|NCT01426789|448862169|FG000|Part 1|Adverse Event|3|||
124790341|NCT01426789|448862170|FG001|Part 1|Adverse Event|0|||
124790342|NCT01426789|448862171|FG002|Part 1|Adverse Event|0|||
124790343|NCT01426789|448862172|FG003|Part 1|Adverse Event|0|||
124790344|NCT01426789|448862173|FG004|Part 1|Adverse Event|0|||
124790345|NCT01426789|448862174|FG005|Part 1|Adverse Event|0|||
124790346|NCT01426789|448862169|FG000|Part 2|Protocol deviation|0|||
124628861|NCT03052751|448259362|FG004|Observation Period|Adverse Event|1|||
124628862|NCT03052751|448259363|FG005|Observation Period|Adverse Event|0|||
124628863|NCT01103180|448259364|FG000|Overall Study|Withdrawal by Subject|8|||
124790347|NCT01426789|448862170|FG001|Part 2|Protocol deviation|0|||
124790348|NCT01426789|448862171|FG002|Part 2|Protocol deviation|1|||
124790349|NCT01426789|448862172|FG003|Part 2|Protocol deviation|0|||
124790350|NCT01426789|448862173|FG004|Part 2|Protocol deviation|0|||
124790351|NCT01426789|448862174|FG005|Part 2|Protocol deviation|0|||
124790352|NCT01426789|448862169|FG000|Part 2|Death|0|||
124790353|NCT01426789|448862170|FG001|Part 2|Death|0|||
124790354|NCT01426789|448862171|FG002|Part 2|Death|1|||
124790355|NCT01426789|448862172|FG003|Part 2|Death|0|||
124790356|NCT01426789|448862173|FG004|Part 2|Death|1|||
124790357|NCT01426789|448862174|FG005|Part 2|Death|0|||
124790358|NCT01426789|448862169|FG000|Part 2|Administrative problems|0|||
124628864|NCT01103180|448259365|FG001|Overall Study|Withdrawal by Subject|13|||
124628865|NCT01103180|448259364|FG000|Overall Study|Lost to Follow-up|13|||
124628866|NCT01103180|448259365|FG001|Overall Study|Lost to Follow-up|7|||
124628867|NCT01103180|448259364|FG000|Overall Study|Physician Decision|1|||
124628868|NCT01103180|448259365|FG001|Overall Study|Physician Decision|0|||
124628869|NCT01103180|448259364|FG000|Overall Study|Protocol Violation|0|||
124628870|NCT01103180|448259365|FG001|Overall Study|Protocol Violation|1|||
124628871|NCT01173523|448259366|FG000|Overall Study|Clinical Progression|1|||
124628872|NCT01173523|448259367|FG001|Overall Study|Clinical Progression|1|||
124628873|NCT01173523|448259366|FG000|Overall Study|Progressive Disease|10|||
124628874|NCT01173523|448259367|FG001|Overall Study|Progressive Disease|8|||
124790359|NCT01426789|448862170|FG001|Part 2|Administrative problems|0|||
124790360|NCT01426789|448862171|FG002|Part 2|Administrative problems|2|||
124790361|NCT01426789|448862172|FG003|Part 2|Administrative problems|0|||
124790362|NCT01426789|448862173|FG004|Part 2|Administrative problems|1|||
124790363|NCT01426789|448862174|FG005|Part 2|Administrative problems|0|||
124790364|NCT01426789|448862169|FG000|Part 2|Lost to Follow-up|0|||
124790365|NCT01426789|448862170|FG001|Part 2|Lost to Follow-up|0|||
124790366|NCT01426789|448862171|FG002|Part 2|Lost to Follow-up|4|||
124790367|NCT01426789|448862172|FG003|Part 2|Lost to Follow-up|0|||
124790368|NCT01426789|448862173|FG004|Part 2|Lost to Follow-up|1|||
124790369|NCT01426789|448862174|FG005|Part 2|Lost to Follow-up|0|||
124628875|NCT01173523|448259366|FG000|Overall Study|Other|2|||
124628876|NCT01173523|448259367|FG001|Overall Study|Other|3|||
124628877|NCT01439802|448259372|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
124628878|NCT01439802|448259372|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
124628879|NCT01866826|448259374|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
124628880|NCT01866826|448259375|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
124628881|NCT01866826|448259374|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
124628882|NCT01866826|448259375|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
124628883|NCT01866826|448259374|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
124628884|NCT01866826|448259375|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
124628885|NCT02493660|448259376|FG000|Overall Study|Physician Decision|0|||
124628886|NCT02493660|448259377|FG001|Overall Study|Physician Decision|1|||
124628887|NCT02493660|448259376|FG000|Overall Study|Adverse Event|4|||
124628888|NCT02493660|448259377|FG001|Overall Study|Adverse Event|2|||
124628889|NCT02493660|448259376|FG000|Overall Study|Withdrawal by Subject|2|||
124628890|NCT02493660|448259377|FG001|Overall Study|Withdrawal by Subject|3|||
124628891|NCT02493660|448259376|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
124628892|NCT02493660|448259377|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
124628893|NCT02493660|448259376|FG000|Overall Study|Protocol Violation|0|||
124628894|NCT02493660|448259377|FG001|Overall Study|Protocol Violation|1|||
124628895|NCT02493660|448259376|FG000|Overall Study|Death|0|||
124628896|NCT02493660|448259377|FG001|Overall Study|Death|1|||
124628897|NCT02493660|448259376|FG000|Overall Study|Lost to Follow-up|2|||
124628898|NCT02493660|448259377|FG001|Overall Study|Lost to Follow-up|4|||
124628899|NCT02502149|448259381|FG000|Intermediate|Discontinued prematurely|1|||
124628900|NCT02502149|448259382|FG001|Intermediate|Discontinued prematurely|0|||
124628901|NCT02502149|448259383|FG002|Intermediate|Discontinued prematurely|0|||
124628902|NCT02502149|448259384|FG003|Intermediate|Discontinued prematurely|0|||
124628903|NCT02502149|448259385|FG004|Intermediate|Discontinued prematurely|0|||
124628904|NCT02968576|448259386|FG000|Overall Study|Pregnancy|0|||
124628905|NCT02968576|448259387|FG001|Overall Study|Pregnancy|1|||
124628906|NCT02222922|448259388|FG000|Overall Study|Death|0|||
124628907|NCT02222922|448259389|FG001|Overall Study|Death|0|||
124790370|NCT01426789|448862169|FG000|Part 2|Withdrawal by Subject|0|||
124790371|NCT01426789|448862170|FG001|Part 2|Withdrawal by Subject|0|||
124790372|NCT01426789|448862171|FG002|Part 2|Withdrawal by Subject|0|||
124628908|NCT02222922|448259390|FG002|Overall Study|Death|0|||
124628909|NCT02222922|448259391|FG003|Overall Study|Death|0|||
124628910|NCT02222922|448259392|FG004|Overall Study|Death|13|||
124628911|NCT02222922|448259393|FG005|Overall Study|Death|0|||
124628912|NCT02222922|448259394|FG006|Overall Study|Death|0|||
124790373|NCT01426789|448862172|FG003|Part 2|Withdrawal by Subject|1|||
124628913|NCT02222922|448259395|FG007|Overall Study|Death|0|||
124628914|NCT02222922|448259396|FG008|Overall Study|Death|2|||
124628915|NCT02222922|448259388|FG000|Overall Study|Lost to Follow-up|0|||
124628916|NCT02222922|448259389|FG001|Overall Study|Lost to Follow-up|0|||
124628917|NCT02222922|448259390|FG002|Overall Study|Lost to Follow-up|1|||
124628918|NCT02222922|448259391|FG003|Overall Study|Lost to Follow-up|0|||
124628919|NCT02222922|448259392|FG004|Overall Study|Lost to Follow-up|9|||
124628920|NCT02222922|448259393|FG005|Overall Study|Lost to Follow-up|1|||
124628921|NCT02222922|448259394|FG006|Overall Study|Lost to Follow-up|0|||
124628922|NCT02222922|448259395|FG007|Overall Study|Lost to Follow-up|0|||
124790374|NCT01426789|448862173|FG004|Part 2|Withdrawal by Subject|2|||
124790375|NCT01426789|448862174|FG005|Part 2|Withdrawal by Subject|0|||
124790376|NCT01426789|448862169|FG000|Part 2|Lack of Efficacy|0|||
124790377|NCT01426789|448862170|FG001|Part 2|Lack of Efficacy|0|||
124628923|NCT02222922|448259396|FG008|Overall Study|Lost to Follow-up|0|||
124628924|NCT02222922|448259388|FG000|Overall Study|Other|0|||
124628925|NCT02222922|448259389|FG001|Overall Study|Other|0|||
124628926|NCT02222922|448259390|FG002|Overall Study|Other|0|||
124628927|NCT02222922|448259391|FG003|Overall Study|Other|2|||
124628928|NCT02222922|448259392|FG004|Overall Study|Other|10|||
124628929|NCT02222922|448259393|FG005|Overall Study|Other|2|||
124628930|NCT02222922|448259394|FG006|Overall Study|Other|2|||
124628931|NCT02222922|448259395|FG007|Overall Study|Other|4|||
124628932|NCT02222922|448259396|FG008|Overall Study|Other|1|||
124628933|NCT02222922|448259388|FG000|Overall Study|Participant refused further follow-up|1|||
124628934|NCT02222922|448259389|FG001|Overall Study|Participant refused further follow-up|0|||
124628935|NCT02222922|448259390|FG002|Overall Study|Participant refused further follow-up|0|||
124628936|NCT02222922|448259391|FG003|Overall Study|Participant refused further follow-up|1|||
124628937|NCT02222922|448259392|FG004|Overall Study|Participant refused further follow-up|6|||
124628938|NCT02222922|448259393|FG005|Overall Study|Participant refused further follow-up|0|||
124628939|NCT02222922|448259394|FG006|Overall Study|Participant refused further follow-up|0|||
124628940|NCT02222922|448259395|FG007|Overall Study|Participant refused further follow-up|0|||
124628941|NCT02222922|448259396|FG008|Overall Study|Participant refused further follow-up|3|||
124628942|NCT00116779|448259400|FG000|Overall Study|Adverse Event|4|||
124628943|NCT00116779|448259401|FG001|Overall Study|Adverse Event|2|||
124628944|NCT00116779|448259400|FG000|Overall Study|Protocol Violation|1|||
124628945|NCT00116779|448259401|FG001|Overall Study|Protocol Violation|4|||
124628946|NCT00116779|448259400|FG000|Overall Study|Withdrawal by Subject|4|||
124628947|NCT00116779|448259401|FG001|Overall Study|Withdrawal by Subject|1|||
124628948|NCT00116779|448259400|FG000|Overall Study|Inadequate testosterone suppression|7|||
124628949|NCT00116779|448259401|FG001|Overall Study|Inadequate testosterone suppression|9|||
124628950|NCT00116779|448259400|FG000|Overall Study|Physician Decision|3|||
124628951|NCT00116779|448259401|FG001|Overall Study|Physician Decision|1|||
124628952|NCT00116779|448259400|FG000|Overall Study|Elevated PSA levels|2|||
124790378|NCT01426789|448862171|FG002|Part 2|Lack of Efficacy|5|||
124790379|NCT01426789|448862172|FG003|Part 2|Lack of Efficacy|0|||
124790380|NCT01426789|448862173|FG004|Part 2|Lack of Efficacy|2|||
124790381|NCT01426789|448862174|FG005|Part 2|Lack of Efficacy|0|||
124790382|NCT01426789|448862169|FG000|Part 2|Adverse Event|0|||
124790383|NCT01426789|448862170|FG001|Part 2|Adverse Event|0|||
124790384|NCT01426789|448862171|FG002|Part 2|Adverse Event|2|||
124790385|NCT01426789|448862172|FG003|Part 2|Adverse Event|0|||
124790386|NCT01426789|448862173|FG004|Part 2|Adverse Event|1|||
124790387|NCT01426789|448862174|FG005|Part 2|Adverse Event|0|||
124790388|NCT00311584|448862177|FG000|Overall Study|Death|1|||
124790389|NCT00311584|448862178|FG001|Overall Study|Death|0|||
124790390|NCT00311584|448862177|FG000|Overall Study|Lack of Efficacy|12|||
124790391|NCT00311584|448862178|FG001|Overall Study|Lack of Efficacy|15|||
124790392|NCT00311584|448862177|FG000|Overall Study|Physician Decision|4|||
124790393|NCT00311584|448862178|FG001|Overall Study|Physician Decision|5|||
124790394|NCT00311584|448862177|FG000|Overall Study|Withdrawal by Subject|1|||
124752400|NCT01724866|448716737|FG001|Overall Study|Investigator's Discretion|1|||
124752401|NCT01724866|448716738|FG002|Overall Study|Investigator's Discretion|1|||
124752402|NCT01724866|448716739|FG003|Overall Study|Investigator's Discretion|0|||
124752403|NCT01724866|448716736|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
124790395|NCT00311584|448862178|FG001|Overall Study|Withdrawal by Subject|1|||
124790396|NCT00311584|448862177|FG000|Overall Study|ineligible|2|||
124790397|NCT00311584|448862178|FG001|Overall Study|ineligible|2|||
124790398|NCT00167778|448862183|FG000|Overall Study|Withdrawal by Subject|1|||
124790399|NCT02654717|448862184|FG000|Overall Study|Adverse Event|2|||
124790400|NCT02654717|448862185|FG001|Overall Study|Adverse Event|2|||
124790401|NCT02654717|448862184|FG000|Overall Study|Protocol Violation|1|||
124790402|NCT02654717|448862185|FG001|Overall Study|Protocol Violation|2|||
124790403|NCT02654717|448862184|FG000|Overall Study|Withdrawal by Subject|0|||
124790404|NCT02654717|448862185|FG001|Overall Study|Withdrawal by Subject|1|||
124790405|NCT02654717|448862184|FG000|Overall Study|Non-permitted medication|3|||
124790406|NCT02654717|448862185|FG001|Overall Study|Non-permitted medication|0|||
124790407|NCT05395091|448863664|FG000|Baseline to Month 12|Adverse Event|7|||
124790408|NCT05395091|448863665|FG001|Baseline to Month 12|Adverse Event|2|||
124790409|NCT05395091|448863666|FG002|Baseline to Month 12|Adverse Event|0|||
124628953|NCT00116779|448259401|FG001|Overall Study|Elevated PSA levels|2|||
124628954|NCT02714218|448259402|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124628955|NCT02714218|448259403|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
124628956|NCT02714218|448259404|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
124628957|NCT02714218|448259402|FG000|Pre-Treatment Period|Other reasons|0|||
124752404|NCT01724866|448716737|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
124752405|NCT01724866|448716738|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
124790410|NCT05395091|448863664|FG000|Baseline to Month 12|Death|3|||
124790411|NCT05395091|448863665|FG001|Baseline to Month 12|Death|1|||
124790412|NCT05395091|448863666|FG002|Baseline to Month 12|Death|0|||
124790413|NCT05395091|448863664|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
124790414|NCT05395091|448863665|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
124790415|NCT05395091|448863666|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
124790416|NCT05395091|448863664|FG000|Baseline to Month 12|Protocol Violation|2|||
124790417|NCT05395091|448863665|FG001|Baseline to Month 12|Protocol Violation|3|||
124790418|NCT05395091|448863666|FG002|Baseline to Month 12|Protocol Violation|0|||
124790419|NCT05395091|448863664|FG000|Baseline to Month 12|Physician Decision|1|||
124790420|NCT05395091|448863665|FG001|Baseline to Month 12|Physician Decision|0|||
124790421|NCT05395091|448863666|FG002|Baseline to Month 12|Physician Decision|0|||
124790422|NCT05395091|448863664|FG000|Month 12 to Month 18|Death|1|||
124790423|NCT05395091|448863665|FG001|Month 12 to Month 18|Death|0|||
124790424|NCT05395091|448863666|FG002|Month 12 to Month 18|Death|0|||
124790425|NCT05395091|448863664|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
124790426|NCT05395091|448863665|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
124790427|NCT05395091|448863666|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
124790428|NCT05395091|448863664|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
124790429|NCT05395091|448863665|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
124790430|NCT05395091|448863666|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
124790431|NCT05395091|448863664|FG000|Month 12 to Month 18|Other reasons|0|||
124790432|NCT05395091|448863665|FG001|Month 12 to Month 18|Other reasons|0|||
124790433|NCT05395091|448863666|FG002|Month 12 to Month 18|Other reasons|1|||
124790434|NCT00313781|448863669|FG000|Before Crossover|Death|22|||
124790435|NCT00313781|448863670|FG001|Before Crossover|Death|8|||
124628958|NCT02714218|448259403|FG001|Pre-Treatment Period|Other reasons|1|||
124628959|NCT02714218|448259404|FG002|Pre-Treatment Period|Other reasons|0|||
124628960|NCT02714218|448259402|FG000|Treatment Period|Disease Progression|55|||
124628961|NCT02714218|448259403|FG001|Treatment Period|Disease Progression|52|||
124628962|NCT02714218|448259404|FG002|Treatment Period|Disease Progression|14|||
124628963|NCT02714218|448259402|FG000|Treatment Period|Study drug toxicity|46|||
124628964|NCT02714218|448259403|FG001|Treatment Period|Study drug toxicity|70|||
124628965|NCT02714218|448259404|FG002|Treatment Period|Study drug toxicity|6|||
124628966|NCT02714218|448259402|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
124628967|NCT02714218|448259403|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
124628968|NCT02714218|448259404|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
124628969|NCT02714218|448259402|FG000|Treatment Period|Request to discontinue treatment|1|||
124628970|NCT02714218|448259403|FG001|Treatment Period|Request to discontinue treatment|4|||
124628971|NCT02714218|448259404|FG002|Treatment Period|Request to discontinue treatment|1|||
124628972|NCT02714218|448259402|FG000|Treatment Period|Participant withdrew consent|2|||
124628973|NCT02714218|448259403|FG001|Treatment Period|Participant withdrew consent|2|||
124628974|NCT02714218|448259404|FG002|Treatment Period|Participant withdrew consent|0|||
124628975|NCT02714218|448259402|FG000|Treatment Period|Maximum clinical benefit|4|||
124628976|NCT02714218|448259403|FG001|Treatment Period|Maximum clinical benefit|2|||
124628977|NCT02714218|448259404|FG002|Treatment Period|Maximum clinical benefit|0|||
124628978|NCT02714218|448259402|FG000|Treatment Period|Administrative reason by sponsor|2|||
124628979|NCT02714218|448259403|FG001|Treatment Period|Administrative reason by sponsor|1|||
124628980|NCT02714218|448259404|FG002|Treatment Period|Administrative reason by sponsor|0|||
124628981|NCT02714218|448259402|FG000|Treatment Period|Other reasons|6|||
124628982|NCT02714218|448259403|FG001|Treatment Period|Other reasons|6|||
124628983|NCT02714218|448259404|FG002|Treatment Period|Other reasons|0|||
124628984|NCT02714218|448259402|FG000|Treatment Period|Completed treatment as per protocol|36|||
124628985|NCT02714218|448259403|FG001|Treatment Period|Completed treatment as per protocol|27|||
124628986|NCT02714218|448259404|FG002|Treatment Period|Completed treatment as per protocol|3|||
124628987|NCT02714218|448259402|FG000|Treatment Period|Not reported|9|||
124628988|NCT02714218|448259403|FG001|Treatment Period|Not reported|6|||
124628989|NCT02714218|448259404|FG002|Treatment Period|Not reported|0|||
124628990|NCT03743051|448259409|FG000|Overall Study|Adverse Event|5|||
124628991|NCT03743051|448259410|FG001|Overall Study|Adverse Event|9|||
124628992|NCT03743051|448259409|FG000|Overall Study|Death|27|||
124628993|NCT03743051|448259410|FG001|Overall Study|Death|26|||
124790436|NCT00313781|448863671|FG002|Before Crossover|Death|0|||
124790437|NCT00313781|448863669|FG000|Before Crossover|Lost to Follow-up|0|||
124790438|NCT00313781|448863670|FG001|Before Crossover|Lost to Follow-up|3|||
124790439|NCT00313781|448863671|FG002|Before Crossover|Lost to Follow-up|0|||
124790440|NCT00313781|448863669|FG000|Before Crossover|Withdrawal by Subject|3|||
124790441|NCT00313781|448863670|FG001|Before Crossover|Withdrawal by Subject|1|||
124790442|NCT00313781|448863671|FG002|Before Crossover|Withdrawal by Subject|0|||
124790443|NCT00313781|448863669|FG000|Before Crossover|Other|45|||
124790444|NCT00313781|448863670|FG001|Before Crossover|Other|30|||
124790445|NCT00313781|448863671|FG002|Before Crossover|Other|0|||
124628994|NCT03743051|448259409|FG000|Overall Study|Lost to Follow-up|4|||
124628995|NCT03743051|448259410|FG001|Overall Study|Lost to Follow-up|8|||
124628996|NCT03743051|448259409|FG000|Overall Study|Withdrawal by Subject|32|||
124628997|NCT03743051|448259410|FG001|Overall Study|Withdrawal by Subject|19|||
124628998|NCT03743051|448259409|FG000|Overall Study|Physician Decision|10|||
124790446|NCT00313781|448863669|FG000|Before Crossover|Crossover|0|||
124790447|NCT00313781|448863670|FG001|Before Crossover|Crossover|37|||
124628999|NCT03743051|448259410|FG001|Overall Study|Physician Decision|15|||
124629000|NCT03743051|448259409|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
124629001|NCT03743051|448259410|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
124629002|NCT00811733|448259411|FG000|Overall Study|Investigator Discretion|10|||
124629003|NCT00811733|448259412|FG001|Overall Study|Investigator Discretion|8|||
124629004|NCT00811733|448259411|FG000|Overall Study|Withdrawal by Subject|1|||
124629005|NCT00811733|448259412|FG001|Overall Study|Withdrawal by Subject|2|||
124629006|NCT00793871|448259414|FG000|Overall Study|Death|50|||
124629007|NCT00793871|448259414|FG000|Overall Study|Lost to Follow-up|3|||
124629008|NCT00793871|448259414|FG000|Overall Study|Study terminated by the Sponsor|7|||
124629009|NCT02500589|448259415|FG000|Overall Study|Withdrawal by Subject|11|||
124790448|NCT00313781|448863671|FG002|Before Crossover|Crossover|0|||
124790449|NCT00313781|448863669|FG000|Before Crossover|Randomized, not treated|5|||
124790450|NCT00313781|448863670|FG001|Before Crossover|Randomized, not treated|0|||
124790451|NCT00313781|448863671|FG002|Before Crossover|Randomized, not treated|0|||
124790452|NCT00313781|448863669|FG000|After Crossover|Death|0|||
124790453|NCT00313781|448863670|FG001|After Crossover|Death|0|||
124790454|NCT00313781|448863671|FG002|After Crossover|Death|6|||
124790455|NCT00313781|448863669|FG000|After Crossover|Withdrawal by Subject|0|||
124790456|NCT00313781|448863670|FG001|After Crossover|Withdrawal by Subject|0|||
124790457|NCT00313781|448863671|FG002|After Crossover|Withdrawal by Subject|3|||
124629010|NCT02500589|448259416|FG001|Overall Study|Withdrawal by Subject|14|||
124629011|NCT02500589|448259415|FG000|Overall Study|Lost to Follow-up|10|||
124629012|NCT02500589|448259416|FG001|Overall Study|Lost to Follow-up|12|||
124629013|NCT02500589|448259415|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
124629014|NCT02500589|448259416|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
124629015|NCT02500589|448259415|FG000|Overall Study|Death|7|||
124629016|NCT02500589|448259416|FG001|Overall Study|Death|5|||
124629017|NCT03652051|448259417|FG000|Stage 1|Adverse Event|0|||
124629018|NCT03652051|448259418|FG001|Stage 1|Adverse Event|5|||
124629019|NCT03652051|448259419|FG002|Stage 1|Adverse Event|7|||
124629020|NCT03652051|448259420|FG003|Stage 1|Adverse Event|1|||
124629021|NCT03652051|448259417|FG000|Stage 1|Withdrawal by Subject|0|||
124629022|NCT03652051|448259418|FG001|Stage 1|Withdrawal by Subject|0|||
124629023|NCT03652051|448259419|FG002|Stage 1|Withdrawal by Subject|1|||
124629024|NCT03652051|448259420|FG003|Stage 1|Withdrawal by Subject|0|||
124629025|NCT03652051|448259417|FG000|Stage 2|Adverse Event|0|||
124629026|NCT03652051|448259418|FG001|Stage 2|Adverse Event|2|||
124629027|NCT03652051|448259419|FG002|Stage 2|Adverse Event|1|||
124629028|NCT03652051|448259420|FG003|Stage 2|Adverse Event|0|||
124629029|NCT03652051|448259417|FG000|Stage 2|Protocol Violation|0|||
124629030|NCT03652051|448259418|FG001|Stage 2|Protocol Violation|1|||
124629031|NCT03652051|448259419|FG002|Stage 2|Protocol Violation|6|||
124629032|NCT03652051|448259420|FG003|Stage 2|Protocol Violation|0|||
124629033|NCT03652051|448259417|FG000|Stage 2|Lost to Follow-up|0|||
124629034|NCT03652051|448259418|FG001|Stage 2|Lost to Follow-up|2|||
124629035|NCT03652051|448259419|FG002|Stage 2|Lost to Follow-up|0|||
124629036|NCT03652051|448259420|FG003|Stage 2|Lost to Follow-up|3|||
124629037|NCT03652051|448259417|FG000|Stage 2|Withdrawal by Subject|0|||
124629038|NCT03652051|448259418|FG001|Stage 2|Withdrawal by Subject|11|||
124629039|NCT03652051|448259419|FG002|Stage 2|Withdrawal by Subject|9|||
124629040|NCT03652051|448259420|FG003|Stage 2|Withdrawal by Subject|3|||
124629041|NCT03442751|448259424|FG000|Overall Study|Withdrawal by Subject|3|||
124629042|NCT03442751|448259425|FG001|Overall Study|Withdrawal by Subject|1|||
124629043|NCT03442751|448259424|FG000|Overall Study|Lost to Follow-up|3|||
124629044|NCT03442751|448259425|FG001|Overall Study|Lost to Follow-up|0|||
124629045|NCT02603887|448259426|FG000|Stage 1|Adverse Event|4|||
124629046|NCT02603887|448259426|FG000|Stage 1|Disease progression|1|||
124629047|NCT02603887|448259426|FG000|Stage 2|FDA guidance|1|||
124629048|NCT02766335|448259428|FG000|Initial Registration|Adverse Event|6|||
124629049|NCT02766335|448259429|FG001|Initial Registration|Adverse Event|3|||
124629050|NCT02766335|448259430|FG002|Initial Registration|Adverse Event|0|||
124629051|NCT02766335|448259428|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
124629052|NCT02766335|448259429|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
124629053|NCT02766335|448259430|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
124629054|NCT02766335|448259428|FG000|Initial Registration|Progression/relapse|49|||
124629055|NCT02766335|448259429|FG001|Initial Registration|Progression/relapse|15|||
124629056|NCT02766335|448259430|FG002|Initial Registration|Progression/relapse|0|||
124629057|NCT02766335|448259428|FG000|Initial Registration|Death|1|||
124629058|NCT02766335|448259429|FG001|Initial Registration|Death|3|||
124790458|NCT00313781|448863669|FG000|After Crossover|Other|0|||
124790459|NCT00313781|448863670|FG001|After Crossover|Other|0|||
124629059|NCT02766335|448259430|FG002|Initial Registration|Death|0|||
124629060|NCT02766335|448259428|FG000|Initial Registration|not protocol specified|1|||
124629061|NCT02766335|448259429|FG001|Initial Registration|not protocol specified|9|||
124629062|NCT02766335|448259430|FG002|Initial Registration|not protocol specified|0|||
124629063|NCT02766335|448259428|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
124629064|NCT02766335|448259429|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
124790460|NCT00313781|448863671|FG002|After Crossover|Other|18|||
124629065|NCT02766335|448259430|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
124629066|NCT02766335|448259428|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
124629067|NCT02766335|448259429|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
124629068|NCT02766335|448259430|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
124629069|NCT00235755|448259439|FG000|4-Week Titration Phase|Adverse Event|6|||
124629070|NCT00235755|448259440|FG001|4-Week Titration Phase|Adverse Event|14|||
124629071|NCT00235755|448259441|FG002|4-Week Titration Phase|Adverse Event|20|||
124629072|NCT00235755|448259439|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
124790461|NCT01433250|448863672|FG000|Overall Study|Protocol Violation|0|||
124790462|NCT01433250|448863673|FG001|Overall Study|Protocol Violation|1|||
124790463|NCT01433250|448863672|FG000|Overall Study|Withdrawal by Subject|3|||
124790464|NCT01433250|448863673|FG001|Overall Study|Withdrawal by Subject|2|||
124790465|NCT00834080|448863674|FG000|Overall Study|Adverse Event|7|||
124790466|NCT00834080|448863674|FG000|Overall Study|Lost to Follow-up|7|||
124629073|NCT00235755|448259440|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
124629074|NCT00235755|448259441|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
124629075|NCT00235755|448259439|FG000|4-Week Titration Phase|Protocol Violation|2|||
124629076|NCT00235755|448259440|FG001|4-Week Titration Phase|Protocol Violation|2|||
124629077|NCT00235755|448259441|FG002|4-Week Titration Phase|Protocol Violation|1|||
124629078|NCT00235755|448259439|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
124629079|NCT00235755|448259440|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
124629080|NCT00235755|448259441|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
124629081|NCT00235755|448259439|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
124629082|NCT00235755|448259440|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
124629083|NCT00235755|448259441|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
124629084|NCT00235755|448259439|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
124629085|NCT00235755|448259440|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
124629086|NCT00235755|448259441|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
124629087|NCT00235755|448259439|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
124629088|NCT00235755|448259440|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
124629089|NCT00235755|448259441|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
124629090|NCT00235755|448259439|FG000|12-Week Maintenance Phase|Adverse Event|8|||
124629091|NCT00235755|448259440|FG001|12-Week Maintenance Phase|Adverse Event|12|||
124629092|NCT00235755|448259441|FG002|12-Week Maintenance Phase|Adverse Event|26|||
124629093|NCT00235755|448259439|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
124629094|NCT00235755|448259440|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
124629095|NCT00235755|448259441|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
124629096|NCT00235755|448259439|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
124629097|NCT00235755|448259440|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
124629098|NCT00235755|448259441|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
124629099|NCT00235755|448259439|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
124629100|NCT00235755|448259440|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
124629101|NCT00235755|448259441|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
124629102|NCT00235755|448259439|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
124629103|NCT00235755|448259440|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
124629104|NCT00235755|448259441|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
124629105|NCT00235755|448259439|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
124629106|NCT00235755|448259440|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
124629107|NCT00235755|448259441|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
124629108|NCT03164551|448259442|FG000|Overall Study|Imaging discontinued prior completion|8|||
124629109|NCT03164551|448259443|FG001|Overall Study|Imaging discontinued prior completion|0|||
124629110|NCT03164551|448259442|FG000|Overall Study|Participant was non-compliant|1|||
124629111|NCT03164551|448259443|FG001|Overall Study|Participant was non-compliant|0|||
124629112|NCT03164551|448259442|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
124629113|NCT03164551|448259443|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
124629114|NCT03164551|448259442|FG000|Overall Study|Other|8|||
124629115|NCT03164551|448259443|FG001|Overall Study|Other|2|||
124629116|NCT01515423|448259444|FG000|Open Label Phase|Adverse Event|57|||
124629117|NCT01515423|448259445|FG001|Open Label Phase|Adverse Event|0|||
124629118|NCT01515423|448259446|FG002|Open Label Phase|Adverse Event|0|||
124629119|NCT01515423|448259444|FG000|Open Label Phase|Death|2|||
124629120|NCT01515423|448259445|FG001|Open Label Phase|Death|0|||
124629121|NCT01515423|448259446|FG002|Open Label Phase|Death|0|||
124790467|NCT00834080|448863674|FG000|Overall Study|Withdrawal by Subject|5|||
124790468|NCT00834080|448863674|FG000|Overall Study|Other - Pregnancy|1|||
124790469|NCT00834080|448863674|FG000|Overall Study|Other - False positive tests of the UDS|1|||
124790470|NCT00834080|448863674|FG000|Overall Study|Physician Decision|1|||
124790471|NCT00834080|448863674|FG000|Overall Study|Subject Relocated|1|||
124790472|NCT02431260|448863675|FG000|Overall Study|Subject Decision|0|||
124790473|NCT02431260|448863676|FG001|Overall Study|Subject Decision|1|||
124790474|NCT02431260|448863677|FG002|Overall Study|Subject Decision|1|||
124790475|NCT02431260|448863678|FG003|Overall Study|Subject Decision|0|||
124790476|NCT02431260|448863679|FG004|Overall Study|Subject Decision|0|||
124629122|NCT01515423|448259444|FG000|Open Label Phase|Lack of Efficacy|117|||
124629123|NCT01515423|448259445|FG001|Open Label Phase|Lack of Efficacy|0|||
124629124|NCT01515423|448259446|FG002|Open Label Phase|Lack of Efficacy|0|||
124629125|NCT01515423|448259444|FG000|Open Label Phase|Lost to Follow-up|21|||
124629126|NCT01515423|448259445|FG001|Open Label Phase|Lost to Follow-up|0|||
124629127|NCT01515423|448259446|FG002|Open Label Phase|Lost to Follow-up|0|||
124629128|NCT01515423|448259444|FG000|Open Label Phase|Withdrawal by Subject|118|||
124629129|NCT01515423|448259445|FG001|Open Label Phase|Withdrawal by Subject|0|||
124629130|NCT01515423|448259446|FG002|Open Label Phase|Withdrawal by Subject|0|||
124629131|NCT01515423|448259444|FG000|Open Label Phase|excluded from DB Phase|70|||
124629132|NCT01515423|448259445|FG001|Open Label Phase|excluded from DB Phase|0|||
124629133|NCT01515423|448259446|FG002|Open Label Phase|excluded from DB Phase|0|||
124629134|NCT01515423|448259444|FG000|Open Label Phase|Other|28|||
124629135|NCT01515423|448259445|FG001|Open Label Phase|Other|0|||
124629136|NCT01515423|448259446|FG002|Open Label Phase|Other|0|||
124629137|NCT01515423|448259444|FG000|DOUBLE BLIND|Adverse Event|0|||
124629138|NCT01515423|448259445|FG001|DOUBLE BLIND|Adverse Event|15|||
124629139|NCT01515423|448259446|FG002|DOUBLE BLIND|Adverse Event|13|||
124629140|NCT01515423|448259444|FG000|DOUBLE BLIND|Death|0|||
124629141|NCT01515423|448259445|FG001|DOUBLE BLIND|Death|1|||
124629142|NCT01515423|448259446|FG002|DOUBLE BLIND|Death|2|||
124629143|NCT01515423|448259444|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
124790477|NCT02431260|448863680|FG005|Overall Study|Subject Decision|0|||
124790478|NCT02431260|448863681|FG006|Overall Study|Subject Decision|0|||
124790479|NCT02431260|448863682|FG007|Overall Study|Subject Decision|0|||
124790480|NCT02431260|448863683|FG008|Overall Study|Subject Decision|1|||
124629144|NCT01515423|448259445|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
124629145|NCT01515423|448259446|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
124629146|NCT01515423|448259444|FG000|DOUBLE BLIND|Pregnancy|0|||
124629147|NCT01515423|448259445|FG001|DOUBLE BLIND|Pregnancy|2|||
124629148|NCT01515423|448259446|FG002|DOUBLE BLIND|Pregnancy|0|||
124629149|NCT01515423|448259444|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
124629150|NCT01515423|448259445|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
124629151|NCT01515423|448259446|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
124790481|NCT02431260|448863684|FG009|Overall Study|Subject Decision|1|||
124790482|NCT02431260|448863685|FG010|Overall Study|Subject Decision|0|||
124790483|NCT02431260|448863686|FG011|Overall Study|Subject Decision|1|||
124790484|NCT02431260|448863687|FG012|Overall Study|Subject Decision|0|||
124790485|NCT02431260|448863688|FG013|Overall Study|Subject Decision|0|||
124790486|NCT02431260|448863675|FG000|Overall Study|Death|4|||
124790487|NCT02431260|448863676|FG001|Overall Study|Death|4|||
124790488|NCT02431260|448863677|FG002|Overall Study|Death|3|||
124790489|NCT02431260|448863678|FG003|Overall Study|Death|4|||
124790490|NCT02431260|448863679|FG004|Overall Study|Death|2|||
124790491|NCT02431260|448863680|FG005|Overall Study|Death|2|||
124790492|NCT02431260|448863681|FG006|Overall Study|Death|3|||
124790493|NCT02431260|448863682|FG007|Overall Study|Death|1|||
124790494|NCT02431260|448863683|FG008|Overall Study|Death|6|||
124790495|NCT02431260|448863684|FG009|Overall Study|Death|6|||
124790496|NCT02431260|448863685|FG010|Overall Study|Death|3|||
124629152|NCT01515423|448259444|FG000|DOUBLE BLIND|Other|0|||
124629153|NCT01515423|448259445|FG001|DOUBLE BLIND|Other|6|||
124629154|NCT01515423|448259446|FG002|DOUBLE BLIND|Other|12|||
124629155|NCT01515423|448259444|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
124790497|NCT02431260|448863686|FG011|Overall Study|Death|2|||
124790498|NCT02431260|448863687|FG012|Overall Study|Death|5|||
124629156|NCT01515423|448259445|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
124629157|NCT01515423|448259446|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
124629158|NCT02314026|448259447|FG000|Overall Study|Protocol Violation|28|||
124629159|NCT04421131|448259449|FG000|Overall Study|Lost to Follow-up|1|||
124629160|NCT04421131|448259449|FG000|Overall Study|Protocol Violation|2|||
124629161|NCT04421131|448259449|FG000|Overall Study|App crashed|5|||
124629162|NCT01401452|448259451|FG000|Overall Study|Adverse reaction|9|||
124629163|NCT01401452|448259451|FG000|Overall Study|Lost to Follow-up|12|||
124790499|NCT02431260|448863688|FG013|Overall Study|Death|1|||
124629164|NCT01401452|448259451|FG000|Overall Study|Lack of Efficacy|30|||
124629165|NCT01401452|448259451|FG000|Overall Study|Participant developed breast cancer|1|||
124629166|NCT01401452|448259451|FG000|Overall Study|Tx stopped due to financial reasons|1|||
124629167|NCT01401452|448259451|FG000|Overall Study|Tx stopped by psychiatrist|1|||
124629168|NCT01401452|448259451|FG000|Overall Study|No more visits within the 36 wk followup|4|||
124629169|NCT01401452|448259451|FG000|Overall Study|Subject did not come to follow up visits|2|||
124790500|NCT02431260|448863675|FG000|Overall Study|Lost to Follow-up|0|||
124790501|NCT02431260|448863676|FG001|Overall Study|Lost to Follow-up|0|||
124790502|NCT02431260|448863677|FG002|Overall Study|Lost to Follow-up|0|||
124790503|NCT02431260|448863678|FG003|Overall Study|Lost to Follow-up|0|||
124790504|NCT02431260|448863679|FG004|Overall Study|Lost to Follow-up|0|||
124790505|NCT02431260|448863680|FG005|Overall Study|Lost to Follow-up|1|||
124790506|NCT02431260|448863681|FG006|Overall Study|Lost to Follow-up|0|||
124790507|NCT02431260|448863682|FG007|Overall Study|Lost to Follow-up|0|||
124790508|NCT02431260|448863683|FG008|Overall Study|Lost to Follow-up|0|||
124629170|NCT01401452|448259451|FG000|Overall Study|Subject didn't return for routine visits|1|||
124629171|NCT01401452|448259451|FG000|Overall Study|Subject moved to another city|1|||
124629172|NCT01401452|448259451|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
124629173|NCT01401452|448259451|FG000|Overall Study|Psoriatic arthritis|1|||
124629174|NCT01401452|448259451|FG000|Overall Study|Participant stopped Tx|2|||
124629175|NCT01401452|448259451|FG000|Overall Study|Discontinuation for personal reasons|1|||
124629176|NCT01401452|448259451|FG000|Overall Study|Treatment failure|1|||
124629177|NCT01401452|448259451|FG000|Overall Study|Unsatisfactory output|1|||
124629178|NCT01401452|448259451|FG000|Overall Study|Subject withdrew because of Tx success|1|||
124629179|NCT01401452|448259451|FG000|Overall Study|Subject chose to discontinue treatment|1|||
124629180|NCT01401452|448259451|FG000|Overall Study|Participant withdrew consent|1|||
124629181|NCT00584454|448259452|FG000|Overall Study|Adverse Event|1|||
124629182|NCT00584454|448259452|FG000|Overall Study|Relocation|1|||
124629183|NCT00584454|448259452|FG000|Overall Study|Clinical Hold|2|||
124629184|NCT01133067|448259453|FG000|Overall Study|Death|136|||
124629185|NCT01133067|448259453|FG000|Overall Study|Lost to Follow-up|3|||
124629186|NCT04135937|448259457|FG000|Overall Study|Lost to Follow-up|2|||
124629187|NCT04135937|448259457|FG000|Overall Study|Withdrawal by Subject|1|||
124629188|NCT02654054|448259461|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
124629189|NCT02654054|448259462|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
124629190|NCT02654054|448259463|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
124629191|NCT02654054|448259461|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
124629192|NCT02654054|448259462|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
124629193|NCT02654054|448259463|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
124629194|NCT02654054|448259461|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
124629195|NCT02654054|448259462|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
124629196|NCT02654054|448259463|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
124629197|NCT02654054|448259461|FG000|Post-Treatment Follow-Up Period|Other|1|||
124629198|NCT02654054|448259462|FG001|Post-Treatment Follow-Up Period|Other|0|||
124629199|NCT02654054|448259463|FG002|Post-Treatment Follow-Up Period|Other|4|||
124629200|NCT02654054|448259461|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
124629201|NCT02654054|448259462|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
124629202|NCT02654054|448259463|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
124629203|NCT00420420|448259464|FG000|Overall Study|Adverse Event|5|||
124629204|NCT00420420|448259465|FG001|Overall Study|Adverse Event|3|||
124629205|NCT00420420|448259464|FG000|Overall Study|Protocol Violation|1|||
124629206|NCT00420420|448259465|FG001|Overall Study|Protocol Violation|1|||
124629207|NCT00420420|448259464|FG000|Overall Study|Withdrawal by Subject|1|||
124629208|NCT00420420|448259465|FG001|Overall Study|Withdrawal by Subject|0|||
124629209|NCT00420420|448259464|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
124629210|NCT00420420|448259465|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
124629211|NCT00273182|448259466|FG000|Overall Study|Death|450|||
124629212|NCT00273182|448259466|FG000|Overall Study|Lost to Follow-up|88|||
124629213|NCT00273182|448259466|FG000|Overall Study|Withdrawal by Subject|257|||
124629214|NCT00273182|448259466|FG000|Overall Study|Device/System Explant|154|||
124629215|NCT00273182|448259466|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
124629216|NCT00856492|448259467|FG000|Overall Study|Ineligible or withdrew consent|1|||
124629217|NCT00856492|448259468|FG001|Overall Study|Ineligible or withdrew consent|1|||
124629218|NCT00856492|448259469|FG002|Overall Study|Ineligible or withdrew consent|2|||
124629219|NCT05842967|448261001|FG000|Period 1: SSA|Adverse Event|1|||
124629220|NCT05842967|448261002|FG001|Period 1: SSA|Adverse Event|1|||
124629221|NCT05842967|448261003|FG002|Period 1: SSA|Adverse Event|0|||
124629222|NCT05842967|448261004|FG003|Period 1: SSA|Adverse Event|0|||
124629223|NCT05842967|448261001|FG000|Period 1: SSA|Death|1|||
124629224|NCT05842967|448261002|FG001|Period 1: SSA|Death|0|||
124629225|NCT05842967|448261003|FG002|Period 1: SSA|Death|0|||
124629226|NCT05842967|448261004|FG003|Period 1: SSA|Death|0|||
124629227|NCT05842967|448261001|FG000|Period 1: SSA|Lost to Follow-up|16|||
124629228|NCT05842967|448261002|FG001|Period 1: SSA|Lost to Follow-up|4|||
124629229|NCT05842967|448261003|FG002|Period 1: SSA|Lost to Follow-up|0|||
124629230|NCT05842967|448261004|FG003|Period 1: SSA|Lost to Follow-up|0|||
124629231|NCT05842967|448261001|FG000|Period 1: SSA|Physician Decision|1|||
124629232|NCT05842967|448261002|FG001|Period 1: SSA|Physician Decision|0|||
124629233|NCT05842967|448261003|FG002|Period 1: SSA|Physician Decision|0|||
124629234|NCT05842967|448261004|FG003|Period 1: SSA|Physician Decision|0|||
124629235|NCT05842967|448261001|FG000|Period 1: SSA|Withdrawal by Subject|2|||
124629236|NCT05842967|448261002|FG001|Period 1: SSA|Withdrawal by Subject|2|||
124629237|NCT05842967|448261003|FG002|Period 1: SSA|Withdrawal by Subject|0|||
124629238|NCT05842967|448261004|FG003|Period 1: SSA|Withdrawal by Subject|0|||
124629239|NCT05842967|448261001|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
124629240|NCT05842967|448261002|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
124629241|NCT05842967|448261003|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
124790509|NCT02431260|448863684|FG009|Overall Study|Lost to Follow-up|0|||
124629242|NCT05842967|448261004|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
124629243|NCT05842967|448261001|FG000|Period 2: SSB|Adverse Event|0|||
124629244|NCT05842967|448261002|FG001|Period 2: SSB|Adverse Event|0|||
124629245|NCT05842967|448261003|FG002|Period 2: SSB|Adverse Event|2|||
124629246|NCT05842967|448261004|FG003|Period 2: SSB|Adverse Event|0|||
124629247|NCT05842967|448261001|FG000|Period 2: SSB|Lost to Follow-up|0|||
124629248|NCT05842967|448261002|FG001|Period 2: SSB|Lost to Follow-up|0|||
124629249|NCT05842967|448261003|FG002|Period 2: SSB|Lost to Follow-up|4|||
124629250|NCT05842967|448261004|FG003|Period 2: SSB|Lost to Follow-up|3|||
124629251|NCT05842967|448261001|FG000|Period 2: SSB|Withdrawal by Subject|0|||
124629252|NCT05842967|448261002|FG001|Period 2: SSB|Withdrawal by Subject|0|||
124629253|NCT05842967|448261003|FG002|Period 2: SSB|Withdrawal by Subject|1|||
124790510|NCT02431260|448863685|FG010|Overall Study|Lost to Follow-up|0|||
124790511|NCT02431260|448863686|FG011|Overall Study|Lost to Follow-up|0|||
124629254|NCT05842967|448261004|FG003|Period 2: SSB|Withdrawal by Subject|0|||
124629255|NCT05842967|448261001|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
124629256|NCT05842967|448261002|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
124629257|NCT05842967|448261003|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
124629258|NCT05842967|448261004|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
124629259|NCT05842967|448261001|FG000|Period 2: SSB|Protocol Violation|0|||
124629260|NCT05842967|448261002|FG001|Period 2: SSB|Protocol Violation|0|||
124629261|NCT05842967|448261003|FG002|Period 2: SSB|Protocol Violation|0|||
124629262|NCT05842967|448261004|FG003|Period 2: SSB|Protocol Violation|1|||
124629263|NCT02157935|448261005|FG000|Overall Study|Withdrawal by Subject|25|||
124629264|NCT02157935|448261006|FG001|Overall Study|Withdrawal by Subject|39|||
124629265|NCT02157935|448261005|FG000|Overall Study|Screen failure|1|||
124629266|NCT02157935|448261006|FG001|Overall Study|Screen failure|2|||
124629267|NCT02157935|448261005|FG000|Overall Study|Protocol Violation|1|||
124629268|NCT02157935|448261006|FG001|Overall Study|Protocol Violation|0|||
124629269|NCT02157935|448261005|FG000|Overall Study|Progressive disease|0|||
124629270|NCT02157935|448261006|FG001|Overall Study|Progressive disease|2|||
124629271|NCT02157935|448261005|FG000|Overall Study|Other|5|||
124629272|NCT02157935|448261006|FG001|Overall Study|Other|12|||
124629273|NCT02157935|448261005|FG000|Overall Study|Lack of Efficacy|0|||
124629274|NCT02157935|448261006|FG001|Overall Study|Lack of Efficacy|1|||
124629275|NCT02157935|448261005|FG000|Overall Study|Death|4|||
124629276|NCT02157935|448261006|FG001|Overall Study|Death|4|||
124629277|NCT02157935|448261005|FG000|Overall Study|Adverse Event|3|||
124629278|NCT02157935|448261006|FG001|Overall Study|Adverse Event|5|||
124629279|NCT02764762|448261007|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
124629280|NCT02764762|448261007|FG000|Overall Study|Lost to Follow-up|4|||
124629281|NCT02764762|448261007|FG000|Overall Study|Voluntary Withdrawal|8|||
124629282|NCT02764762|448261007|FG000|Overall Study|Site Termination|1|||
124629283|NCT02764762|448261007|FG000|Overall Study|Lack of Efficacy|16|||
124629284|NCT02764762|448261007|FG000|Overall Study|Reason not Specified|1|||
124629285|NCT00742209|448261012|FG000|Overall Study|Adverse Event|11|||
124629286|NCT00742209|448261013|FG001|Overall Study|Adverse Event|4|||
124629287|NCT00742209|448261014|FG002|Overall Study|Adverse Event|17|||
124629288|NCT00742209|448261015|FG003|Overall Study|Adverse Event|16|||
124629289|NCT00742209|448261016|FG004|Overall Study|Adverse Event|13|||
124629290|NCT00742209|448261012|FG000|Overall Study|Participant Withdrew Consent|8|||
124629291|NCT00742209|448261013|FG001|Overall Study|Participant Withdrew Consent|4|||
124629292|NCT00742209|448261014|FG002|Overall Study|Participant Withdrew Consent|14|||
124790512|NCT02431260|448863687|FG012|Overall Study|Lost to Follow-up|0|||
124629293|NCT00742209|448261015|FG003|Overall Study|Participant Withdrew Consent|7|||
124790513|NCT02431260|448863688|FG013|Overall Study|Lost to Follow-up|0|||
124790514|NCT02431260|448863675|FG000|Overall Study|Study Terminated by the Sponsor|0|||
124790515|NCT02431260|448863676|FG001|Overall Study|Study Terminated by the Sponsor|0|||
124629294|NCT00742209|448261016|FG004|Overall Study|Participant Withdrew Consent|4|||
124790516|NCT02431260|448863677|FG002|Overall Study|Study Terminated by the Sponsor|2|||
124790517|NCT02431260|448863678|FG003|Overall Study|Study Terminated by the Sponsor|1|||
124790518|NCT02431260|448863679|FG004|Overall Study|Study Terminated by the Sponsor|1|||
124790519|NCT02431260|448863680|FG005|Overall Study|Study Terminated by the Sponsor|0|||
124790520|NCT02431260|448863681|FG006|Overall Study|Study Terminated by the Sponsor|1|||
124790521|NCT02431260|448863682|FG007|Overall Study|Study Terminated by the Sponsor|2|||
124629295|NCT00742209|448261012|FG000|Overall Study|Protocol Violation|6|||
124629296|NCT00742209|448261013|FG001|Overall Study|Protocol Violation|5|||
124629297|NCT00742209|448261014|FG002|Overall Study|Protocol Violation|4|||
124629298|NCT00742209|448261015|FG003|Overall Study|Protocol Violation|5|||
124629299|NCT00742209|448261016|FG004|Overall Study|Protocol Violation|3|||
124629300|NCT00742209|448261012|FG000|Overall Study|Lost to Follow-up|3|||
124629301|NCT00742209|448261013|FG001|Overall Study|Lost to Follow-up|4|||
124629302|NCT00742209|448261014|FG002|Overall Study|Lost to Follow-up|5|||
124629303|NCT00742209|448261015|FG003|Overall Study|Lost to Follow-up|5|||
124629304|NCT00742209|448261016|FG004|Overall Study|Lost to Follow-up|3|||
124629305|NCT00742209|448261012|FG000|Overall Study|Lack of Efficacy|6|||
124629306|NCT00742209|448261013|FG001|Overall Study|Lack of Efficacy|1|||
124629307|NCT00742209|448261014|FG002|Overall Study|Lack of Efficacy|1|||
124629308|NCT00742209|448261015|FG003|Overall Study|Lack of Efficacy|3|||
124629309|NCT00742209|448261016|FG004|Overall Study|Lack of Efficacy|1|||
124629310|NCT00742209|448261012|FG000|Overall Study|Investigator Discretion|0|||
124629311|NCT00742209|448261013|FG001|Overall Study|Investigator Discretion|0|||
124629312|NCT00742209|448261014|FG002|Overall Study|Investigator Discretion|5|||
124629313|NCT00742209|448261015|FG003|Overall Study|Investigator Discretion|1|||
124629314|NCT00742209|448261016|FG004|Overall Study|Investigator Discretion|1|||
124629315|NCT02003209|448261020|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
124629316|NCT02003209|448261021|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
124629317|NCT00638508|448261022|FG000|Overall Study|Physician Decision|5|||
124629318|NCT00638508|448261023|FG001|Overall Study|Physician Decision|2|||
124629319|NCT03500198|448261024|FG000|Overall Study|Lost to Follow-up|0|||
124629320|NCT03500198|448261025|FG001|Overall Study|Lost to Follow-up|1|||
124629321|NCT00324987|448261026|FG000|Overall Study|Adverse Event|2|||
124629322|NCT00324987|448261027|FG001|Overall Study|Adverse Event|1|||
124629323|NCT00324987|448261026|FG000|Overall Study|Withdrawal by Subject|1|||
124629324|NCT00324987|448261027|FG001|Overall Study|Withdrawal by Subject|1|||
124629325|NCT00324987|448261026|FG000|Overall Study|Progression|1|||
124629326|NCT00324987|448261027|FG001|Overall Study|Progression|1|||
124629327|NCT00324987|448261026|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
124629328|NCT00324987|448261027|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
124629329|NCT01254643|448261029|FG000|Overall Study|Withdrawal by Subject|1|||
124629330|NCT03817125|448261030|FG000|Overall Study|Adverse Event|1|||
124629331|NCT03817125|448261031|FG001|Overall Study|Adverse Event|0|||
124629332|NCT03817125|448261030|FG000|Overall Study|Physician Decision|0|||
124629333|NCT03817125|448261031|FG001|Overall Study|Physician Decision|1|||
124629334|NCT03817125|448261030|FG000|Overall Study|Lack of Efficacy|1|||
124629335|NCT03817125|448261031|FG001|Overall Study|Lack of Efficacy|5|||
124629336|NCT02105467|448261032|FG000|Period 1|Lost to Follow-up|1|||
124629337|NCT02105467|448261033|FG001|Period 1|Lost to Follow-up|0|||
124629338|NCT02105467|448261032|FG000|Period 1|Death|1|||
124629339|NCT02105467|448261033|FG001|Period 1|Death|0|||
124629340|NCT02105467|448261032|FG000|Period 2|Lost to Follow-up|1|||
124629341|NCT02105467|448261033|FG001|Period 2|Lost to Follow-up|0|||
124629342|NCT02105467|448261032|FG000|Period 2|Death|1|||
124629343|NCT02105467|448261033|FG001|Period 2|Death|0|||
124629344|NCT02105467|448261032|FG000|Period 2|Withdrawal by Subject|0|||
124629345|NCT02105467|448261033|FG001|Period 2|Withdrawal by Subject|2|||
124629346|NCT02105467|448261032|FG000|Period 3|Lost to Follow-up|0|||
124629347|NCT02105467|448261033|FG001|Period 3|Lost to Follow-up|1|||
124629348|NCT01037218|448261034|FG000|Overall Study|Adverse Event|4|||
124629349|NCT01037218|448261035|FG001|Overall Study|Adverse Event|2|||
124629350|NCT01037218|448261036|FG002|Overall Study|Adverse Event|2|||
124629351|NCT01037218|448261037|FG003|Overall Study|Adverse Event|1|||
124629352|NCT01037218|448261034|FG000|Overall Study|Lack of Efficacy|0|||
124629353|NCT01037218|448261035|FG001|Overall Study|Lack of Efficacy|2|||
124629354|NCT01037218|448261036|FG002|Overall Study|Lack of Efficacy|1|||
124629355|NCT01037218|448261037|FG003|Overall Study|Lack of Efficacy|5|||
124629356|NCT01037218|448261034|FG000|Overall Study|Lost to Follow-up|3|||
124629357|NCT01037218|448261035|FG001|Overall Study|Lost to Follow-up|5|||
124629358|NCT01037218|448261036|FG002|Overall Study|Lost to Follow-up|4|||
124629359|NCT01037218|448261037|FG003|Overall Study|Lost to Follow-up|2|||
124629360|NCT01037218|448261034|FG000|Overall Study|Withdrawal by Subject|6|||
124629361|NCT01037218|448261035|FG001|Overall Study|Withdrawal by Subject|7|||
124629362|NCT01037218|448261036|FG002|Overall Study|Withdrawal by Subject|7|||
124629363|NCT01037218|448261037|FG003|Overall Study|Withdrawal by Subject|4|||
124629364|NCT01037218|448261034|FG000|Overall Study|Partner Withdrew Consent|0|||
124629365|NCT01037218|448261035|FG001|Overall Study|Partner Withdrew Consent|3|||
124629366|NCT01037218|448261036|FG002|Overall Study|Partner Withdrew Consent|2|||
124629367|NCT01037218|448261037|FG003|Overall Study|Partner Withdrew Consent|1|||
124629368|NCT01037218|448261034|FG000|Overall Study|Protocol Violation|0|||
124629369|NCT01037218|448261035|FG001|Overall Study|Protocol Violation|0|||
124629370|NCT01037218|448261036|FG002|Overall Study|Protocol Violation|2|||
124629371|NCT01037218|448261037|FG003|Overall Study|Protocol Violation|2|||
124629372|NCT01037218|448261034|FG000|Overall Study|Various|3|||
124629373|NCT01037218|448261035|FG001|Overall Study|Various|2|||
124629374|NCT01037218|448261036|FG002|Overall Study|Various|3|||
124629375|NCT01037218|448261037|FG003|Overall Study|Various|1|||
124629376|NCT02676882|448261038|FG000|Overall Study|Adverse Event|1|||
124629377|NCT02676882|448261039|FG001|Overall Study|Adverse Event|0|||
124629378|NCT02676882|448261038|FG000|Overall Study|Lost to Follow-up|1|||
124629379|NCT02676882|448261039|FG001|Overall Study|Lost to Follow-up|0|||
124629380|NCT02676882|448261038|FG000|Overall Study|Withdrawal by Subject|1|||
124629381|NCT02676882|448261039|FG001|Overall Study|Withdrawal by Subject|2|||
124629382|NCT02568072|448261040|FG000|Overall Study|Unavailable for appointment|23|||
124629383|NCT02568072|448261040|FG000|Overall Study|Unable to contact|3|||
124629384|NCT02568072|448261040|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
124629385|NCT02568072|448261040|FG000|Overall Study|Withdrawal by Subject|1|||
124629386|NCT02568072|448261040|FG000|Overall Study|Sustained injury, marathon not run|24|||
124629387|NCT01321879|448261044|FG000|Overall Study|Lack of Efficacy|5|||
124629388|NCT01321879|448261044|FG000|Overall Study|Adverse Event|5|||
124629389|NCT01321879|448261044|FG000|Overall Study|Death|3|||
124629390|NCT01321879|448261044|FG000|Overall Study|Withdrawal by Subject|1|||
124629391|NCT00897715|448261045|FG000|Overall Study|Lost to Follow-up|0|||
124629392|NCT00897715|448261046|FG001|Overall Study|Lost to Follow-up|1|||
124629393|NCT00897715|448261045|FG000|Overall Study|Physician Decision|1|||
124629394|NCT00897715|448261046|FG001|Overall Study|Physician Decision|0|||
124629395|NCT00897715|448261045|FG000|Overall Study|increased risk of infection|1|||
124629396|NCT00897715|448261046|FG001|Overall Study|increased risk of infection|0|||
124629397|NCT00958828|448261047|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
124629398|NCT00958828|448261048|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
124629399|NCT00958828|448261047|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
124629400|NCT00958828|448261048|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
124629401|NCT02687451|448261056|FG000|Overall Study|Withdrawal by Subject|1|||
124629402|NCT02687451|448261057|FG001|Overall Study|Withdrawal by Subject|0|||
124629403|NCT02687451|448261058|FG002|Overall Study|Withdrawal by Subject|0|||
124629404|NCT02687451|448261059|FG003|Overall Study|Withdrawal by Subject|0|||
124629405|NCT02687451|448261060|FG004|Overall Study|Withdrawal by Subject|0|||
124629406|NCT02687451|448261061|FG005|Overall Study|Withdrawal by Subject|1|||
124629407|NCT01125189|448261062|FG000|Treatment Period|Lack of Efficacy|15|||
124629408|NCT01125189|448261063|FG001|Treatment Period|Lack of Efficacy|18|||
124629409|NCT01125189|448261064|FG002|Treatment Period|Lack of Efficacy|25|||
124629410|NCT01125189|448261062|FG000|Treatment Period|Adverse Event|7|||
124629411|NCT01125189|448261063|FG001|Treatment Period|Adverse Event|8|||
124629412|NCT01125189|448261064|FG002|Treatment Period|Adverse Event|8|||
124629413|NCT01125189|448261062|FG000|Treatment Period|Withdrawal by Subject|3|||
124629414|NCT01125189|448261063|FG001|Treatment Period|Withdrawal by Subject|1|||
124629415|NCT01125189|448261064|FG002|Treatment Period|Withdrawal by Subject|1|||
124629416|NCT01125189|448261062|FG000|Treatment Period|Death|1|||
124629417|NCT01125189|448261063|FG001|Treatment Period|Death|0|||
124629418|NCT01125189|448261064|FG002|Treatment Period|Death|0|||
124629419|NCT01125189|448261062|FG000|Treatment Period|Lost to Follow-up|1|||
124629420|NCT01125189|448261063|FG001|Treatment Period|Lost to Follow-up|2|||
124629421|NCT01125189|448261064|FG002|Treatment Period|Lost to Follow-up|1|||
124629422|NCT01125189|448261062|FG000|Treatment Period|Poor compliance/noncompliance|0|||
124629423|NCT01125189|448261063|FG001|Treatment Period|Poor compliance/noncompliance|1|||
124629424|NCT01125189|448261064|FG002|Treatment Period|Poor compliance/noncompliance|0|||
124629425|NCT01125189|448261062|FG000|Treatment Period|Participants requested to discontinue|1|||
124629426|NCT01125189|448261063|FG001|Treatment Period|Participants requested to discontinue|3|||
124629427|NCT01125189|448261064|FG002|Treatment Period|Participants requested to discontinue|4|||
124629428|NCT01125189|448261062|FG000|Treatment Period|Other reasons|1|||
124629429|NCT01125189|448261063|FG001|Treatment Period|Other reasons|1|||
124629430|NCT01125189|448261064|FG002|Treatment Period|Other reasons|0|||
124629431|NCT01125189|448261062|FG000|Treatment Period|Completed 24 week treatment period only|2|||
124629432|NCT01125189|448261063|FG001|Treatment Period|Completed 24 week treatment period only|1|||
124629433|NCT01125189|448261064|FG002|Treatment Period|Completed 24 week treatment period only|2|||
124629434|NCT01125189|448261062|FG000|Follow up Period|Withdrawal by Subject|3|||
124629435|NCT01125189|448261063|FG001|Follow up Period|Withdrawal by Subject|2|||
124629436|NCT01125189|448261064|FG002|Follow up Period|Withdrawal by Subject|5|||
124629437|NCT01125189|448261062|FG000|Follow up Period|Death|1|||
124629438|NCT01125189|448261063|FG001|Follow up Period|Death|0|||
124790522|NCT02431260|448863683|FG008|Overall Study|Study Terminated by the Sponsor|1|||
124790523|NCT02431260|448863684|FG009|Overall Study|Study Terminated by the Sponsor|1|||
124790524|NCT02431260|448863685|FG010|Overall Study|Study Terminated by the Sponsor|1|||
124790525|NCT02431260|448863686|FG011|Overall Study|Study Terminated by the Sponsor|0|||
124790526|NCT02431260|448863687|FG012|Overall Study|Study Terminated by the Sponsor|4|||
124790527|NCT02431260|448863688|FG013|Overall Study|Study Terminated by the Sponsor|0|||
124790528|NCT02431260|448863675|FG000|Overall Study|Physician Decision|0|||
124790529|NCT02431260|448863676|FG001|Overall Study|Physician Decision|0|||
124790530|NCT02431260|448863677|FG002|Overall Study|Physician Decision|0|||
124790531|NCT02431260|448863678|FG003|Overall Study|Physician Decision|0|||
124790532|NCT02431260|448863679|FG004|Overall Study|Physician Decision|0|||
124629439|NCT01125189|448261064|FG002|Follow up Period|Death|0|||
124629440|NCT01125189|448261062|FG000|Follow up Period|Lost to Follow-up|12|||
124790533|NCT02431260|448863680|FG005|Overall Study|Physician Decision|1|||
124790534|NCT02431260|448863681|FG006|Overall Study|Physician Decision|0|||
124790535|NCT02431260|448863682|FG007|Overall Study|Physician Decision|0|||
124790536|NCT02431260|448863683|FG008|Overall Study|Physician Decision|0|||
124790537|NCT02431260|448863684|FG009|Overall Study|Physician Decision|0|||
124629441|NCT01125189|448261063|FG001|Follow up Period|Lost to Follow-up|9|||
124629442|NCT01125189|448261064|FG002|Follow up Period|Lost to Follow-up|6|||
124629443|NCT01125189|448261062|FG000|Follow up Period|Other reasons|4|||
124629444|NCT01125189|448261063|FG001|Follow up Period|Other reasons|4|||
124629445|NCT01125189|448261064|FG002|Follow up Period|Other reasons|5|||
124629446|NCT00927589|448261065|FG000|Overall Study|Death|1|||
124629447|NCT00927589|448261065|FG000|Overall Study|Physician Decision|1|||
124790538|NCT02431260|448863685|FG010|Overall Study|Physician Decision|0|||
124790539|NCT02431260|448863686|FG011|Overall Study|Physician Decision|0|||
124790540|NCT02431260|448863687|FG012|Overall Study|Physician Decision|0|||
124790541|NCT02431260|448863688|FG013|Overall Study|Physician Decision|0|||
124790542|NCT02431260|448863675|FG000|Overall Study|Other Unspecified|0|||
124790543|NCT02431260|448863676|FG001|Overall Study|Other Unspecified|0|||
124790544|NCT02431260|448863677|FG002|Overall Study|Other Unspecified|0|||
124790545|NCT02431260|448863678|FG003|Overall Study|Other Unspecified|0|||
124790546|NCT02431260|448863679|FG004|Overall Study|Other Unspecified|0|||
124790547|NCT02431260|448863680|FG005|Overall Study|Other Unspecified|0|||
124790548|NCT02431260|448863681|FG006|Overall Study|Other Unspecified|0|||
124790549|NCT02431260|448863682|FG007|Overall Study|Other Unspecified|0|||
124790550|NCT02431260|448863683|FG008|Overall Study|Other Unspecified|0|||
124790551|NCT02431260|448863684|FG009|Overall Study|Other Unspecified|0|||
124790552|NCT02431260|448863685|FG010|Overall Study|Other Unspecified|0|||
124790553|NCT02431260|448863686|FG011|Overall Study|Other Unspecified|1|||
124790554|NCT02431260|448863687|FG012|Overall Study|Other Unspecified|1|||
124790555|NCT02431260|448863688|FG013|Overall Study|Other Unspecified|0|||
124790556|NCT00321646|448863689|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
124790557|NCT00321646|448863689|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
124790558|NCT00321646|448863689|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
124790559|NCT02576145|448863692|FG000|Overall Study|Adverse Event|1|||
124790560|NCT02576145|448863693|FG001|Overall Study|Adverse Event|0|||
124790561|NCT02576145|448863692|FG000|Overall Study|Withdrawal by Subject|1|||
124790562|NCT02576145|448863693|FG001|Overall Study|Withdrawal by Subject|0|||
124790563|NCT02576145|448863692|FG000|Overall Study|Acute rejection|1|||
124790564|NCT02576145|448863693|FG001|Overall Study|Acute rejection|0|||
124790565|NCT02576145|448863692|FG000|Overall Study|Tetanus Titers Decreased|0|||
124790566|NCT02576145|448863693|FG001|Overall Study|Tetanus Titers Decreased|1|||
124790567|NCT02660138|448863694|FG000|Overall Study|Adverse Event|0|||
124790568|NCT02660138|448863695|FG001|Overall Study|Adverse Event|3|||
124790569|NCT02660138|448863696|FG002|Overall Study|Adverse Event|2|||
124790570|NCT02660138|448863694|FG000|Overall Study|Lack of Efficacy|1|||
124790571|NCT02660138|448863695|FG001|Overall Study|Lack of Efficacy|2|||
124790572|NCT02660138|448863696|FG002|Overall Study|Lack of Efficacy|1|||
124790573|NCT02660138|448863694|FG000|Overall Study|Withdrawal by Subject|7|||
124790574|NCT02660138|448863695|FG001|Overall Study|Withdrawal by Subject|6|||
124790575|NCT02660138|448863696|FG002|Overall Study|Withdrawal by Subject|6|||
124790576|NCT02660138|448863694|FG000|Overall Study|Lost to Follow-up|4|||
124790577|NCT02660138|448863695|FG001|Overall Study|Lost to Follow-up|4|||
124790578|NCT02660138|448863696|FG002|Overall Study|Lost to Follow-up|1|||
124790579|NCT02660138|448863694|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
124790580|NCT02660138|448863695|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
124790581|NCT02660138|448863696|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
124790582|NCT02660138|448863694|FG000|Overall Study|Other|1|||
124790583|NCT02660138|448863695|FG001|Overall Study|Other|1|||
124790584|NCT02660138|448863696|FG002|Overall Study|Other|0|||
124790585|NCT02660138|448863694|FG000|Overall Study|Not treated|0|||
124790586|NCT02660138|448863695|FG001|Overall Study|Not treated|1|||
124790587|NCT02660138|448863696|FG002|Overall Study|Not treated|0|||
124790588|NCT00308581|448863697|FG000|Induction Phase|Adverse Event|0|||
124790589|NCT00308581|448863698|FG001|Induction Phase|Adverse Event|0|||
124790590|NCT00308581|448863699|FG002|Induction Phase|Adverse Event|37|||
124790591|NCT00308581|448863697|FG000|Induction Phase|Lack of Efficacy|0|||
124790592|NCT00308581|448863698|FG001|Induction Phase|Lack of Efficacy|0|||
124790593|NCT00308581|448863699|FG002|Induction Phase|Lack of Efficacy|121|||
124790594|NCT00308581|448863697|FG000|Induction Phase|Withdrawal by Subject|0|||
124790595|NCT00308581|448863698|FG001|Induction Phase|Withdrawal by Subject|0|||
124790596|NCT00308581|448863699|FG002|Induction Phase|Withdrawal by Subject|5|||
124790597|NCT00308581|448863697|FG000|Induction Phase|Unknown reason|0|||
124790598|NCT00308581|448863698|FG001|Induction Phase|Unknown reason|0|||
124790599|NCT00308581|448863699|FG002|Induction Phase|Unknown reason|3|||
124790600|NCT00308581|448863697|FG000|Randomized Maintenance Phase|Adverse Event|10|||
124790601|NCT00308581|448863698|FG001|Randomized Maintenance Phase|Adverse Event|17|||
124790602|NCT00308581|448863699|FG002|Randomized Maintenance Phase|Adverse Event|0|||
124790603|NCT00308581|448863697|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
124790604|NCT00308581|448863698|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
124790605|NCT00308581|448863699|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
124790606|NCT00308581|448863697|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
124790607|NCT00308581|448863698|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
124790608|NCT00308581|448863699|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
124790609|NCT00308581|448863697|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
124790610|NCT00308581|448863698|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
124790611|NCT00308581|448863699|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
124790612|NCT00308581|448863697|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
124790613|NCT00308581|448863698|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
124790614|NCT00308581|448863699|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
124790615|NCT00308581|448863697|FG000|Randomized Maintenance Phase|Unknown reason|3|||
124790616|NCT00308581|448863698|FG001|Randomized Maintenance Phase|Unknown reason|0|||
124790617|NCT00308581|448863699|FG002|Randomized Maintenance Phase|Unknown reason|0|||
124790618|NCT01087788|448863701|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
124790619|NCT01087788|448863702|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
124790620|NCT01087788|448863703|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
124790621|NCT01087788|448863701|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
124790622|NCT01087788|448863702|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
124790623|NCT01087788|448863703|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
124790624|NCT01087788|448863701|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
124790625|NCT01087788|448863702|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
124790626|NCT01087788|448863703|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
124790627|NCT01087788|448863701|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
124790628|NCT01087788|448863702|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
124790629|NCT01087788|448863703|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
124790630|NCT01087788|448863701|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
124790631|NCT01087788|448863702|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
124790632|NCT01087788|448863703|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
124790633|NCT01087788|448863701|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
124790634|NCT01087788|448863702|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
124790635|NCT01087788|448863703|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
124790636|NCT01087788|448863701|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
124790637|NCT01087788|448863702|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
124790638|NCT01087788|448863703|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
124790639|NCT01087788|448863701|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
124790640|NCT01087788|448863702|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
124790641|NCT01087788|448863703|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
124790642|NCT01087788|448863701|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
124790643|NCT01087788|448863702|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
124790644|NCT01087788|448863703|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
124790645|NCT01087788|448863701|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
124790646|NCT01087788|448863702|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
124790647|NCT01087788|448863703|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
124790648|NCT01087788|448863701|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
124790649|NCT01087788|448863702|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
124790650|NCT01087788|448863703|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
124790651|NCT01087788|448863701|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
124790652|NCT01087788|448863702|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
124790653|NCT01087788|448863703|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
124790654|NCT01087788|448863701|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
124790655|NCT01087788|448863702|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
124790656|NCT01087788|448863703|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
124790657|NCT01087788|448863701|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
124790658|NCT01087788|448863702|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
124790659|NCT01087788|448863703|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
124790660|NCT01087788|448863701|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
124790661|NCT01087788|448863702|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
124790662|NCT01087788|448863703|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
124790663|NCT01087788|448863701|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
124790664|NCT01087788|448863702|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
124790665|NCT01087788|448863703|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
124790666|NCT01087788|448863701|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
124790667|NCT01087788|448863702|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
124790668|NCT01087788|448863703|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
124790669|NCT01087788|448863701|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
124790670|NCT01087788|448863702|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
124790671|NCT01087788|448863703|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
124790672|NCT01087788|448863701|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
124790673|NCT01087788|448863702|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
124790674|NCT01087788|448863703|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
124790675|NCT01087788|448863701|FG000|24-weeks Dose-blind Period|Patient moved|0|||
124790676|NCT01087788|448863702|FG001|24-weeks Dose-blind Period|Patient moved|0|||
124790677|NCT01087788|448863703|FG002|24-weeks Dose-blind Period|Patient moved|1|||
124790678|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
124790679|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
124790680|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
124790681|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
124629448|NCT00927589|448261065|FG000|Overall Study|Withdrawal by Subject|3|||
124790682|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
124790683|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
124790684|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
124790685|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
124790686|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
124790687|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
124790688|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
124790689|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
124790690|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
124790691|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
124790692|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
124790693|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
124790694|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
124790695|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
124790696|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
124790697|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
124790698|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
124790699|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
124790700|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
124790701|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
124790702|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
124790703|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
124790704|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
124790705|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
124790706|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
124790707|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
124790708|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
124790709|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
124790710|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
124790711|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
124790712|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
124790713|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
124790714|NCT01087788|448863701|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
124790715|NCT01087788|448863702|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
124790716|NCT01087788|448863703|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
124790717|NCT00534313|448863707|FG000|Short-term Period|Adverse Event|1|||
124790718|NCT00534313|448863708|FG001|Short-term Period|Adverse Event|2|||
124790719|NCT00534313|448863709|FG002|Short-term Period|Adverse Event|1|||
124790720|NCT00534313|448863710|FG003|Short-term Period|Adverse Event|3|||
124790721|NCT00534313|448863707|FG000|Short-term Period|Lack of Efficacy|3|||
124790722|NCT00534313|448863708|FG001|Short-term Period|Lack of Efficacy|4|||
124790723|NCT00534313|448863709|FG002|Short-term Period|Lack of Efficacy|0|||
124790724|NCT00534313|448863710|FG003|Short-term Period|Lack of Efficacy|3|||
124790725|NCT00534313|448863707|FG000|Short-term Period|Participant not meeting study criteria|0|||
124790726|NCT00534313|448863708|FG001|Short-term Period|Participant not meeting study criteria|0|||
124790727|NCT00534313|448863709|FG002|Short-term Period|Participant not meeting study criteria|0|||
124790728|NCT00534313|448863710|FG003|Short-term Period|Participant not meeting study criteria|1|||
124790729|NCT00534313|448863707|FG000|Short-term Period|Participant withdrew consent|2|||
124790730|NCT00534313|448863708|FG001|Short-term Period|Participant withdrew consent|0|||
124790731|NCT00534313|448863709|FG002|Short-term Period|Participant withdrew consent|0|||
124790732|NCT00534313|448863710|FG003|Short-term Period|Participant withdrew consent|2|||
124790733|NCT00534313|448863707|FG000|Short-term Period|Pregnancy|0|||
124790734|NCT00534313|448863708|FG001|Short-term Period|Pregnancy|0|||
124790735|NCT00534313|448863709|FG002|Short-term Period|Pregnancy|1|||
124790736|NCT00534313|448863710|FG003|Short-term Period|Pregnancy|0|||
124790737|NCT00534313|448863707|FG000|Long-term Period|Adverse Event|2|||
124790738|NCT00534313|448863708|FG001|Long-term Period|Adverse Event|1|||
124790739|NCT00534313|448863709|FG002|Long-term Period|Adverse Event|0|||
124790740|NCT00534313|448863710|FG003|Long-term Period|Adverse Event|1|||
124790741|NCT00534313|448863707|FG000|Long-term Period|Lack of Efficacy|14|||
124790742|NCT00534313|448863708|FG001|Long-term Period|Lack of Efficacy|10|||
124790743|NCT00534313|448863709|FG002|Long-term Period|Lack of Efficacy|14|||
124790744|NCT00534313|448863710|FG003|Long-term Period|Lack of Efficacy|12|||
124790745|NCT00534313|448863707|FG000|Long-term Period|Lost to Follow-up|1|||
124790746|NCT00534313|448863708|FG001|Long-term Period|Lost to Follow-up|2|||
124790747|NCT00534313|448863709|FG002|Long-term Period|Lost to Follow-up|0|||
124790748|NCT00534313|448863710|FG003|Long-term Period|Lost to Follow-up|0|||
124790749|NCT00534313|448863707|FG000|Long-term Period|Withdrawal by Subject|2|||
124790750|NCT00534313|448863708|FG001|Long-term Period|Withdrawal by Subject|2|||
124790751|NCT00534313|448863709|FG002|Long-term Period|Withdrawal by Subject|0|||
124790752|NCT00534313|448863710|FG003|Long-term Period|Withdrawal by Subject|0|||
124790753|NCT00534313|448863707|FG000|Long-term Period|No longer meets study criteria|0|||
124790754|NCT00534313|448863708|FG001|Long-term Period|No longer meets study criteria|1|||
124790755|NCT00534313|448863709|FG002|Long-term Period|No longer meets study criteria|0|||
124790756|NCT00534313|448863710|FG003|Long-term Period|No longer meets study criteria|0|||
124790757|NCT00534313|448863707|FG000|Long-term Period|Poor compliance/noncompliance|0|||
124790758|NCT00534313|448863708|FG001|Long-term Period|Poor compliance/noncompliance|1|||
124790759|NCT00534313|448863709|FG002|Long-term Period|Poor compliance/noncompliance|1|||
124790760|NCT00534313|448863710|FG003|Long-term Period|Poor compliance/noncompliance|0|||
124790761|NCT00534313|448863707|FG000|Long-term Period|Administrative reason by sponsor|17|||
124790762|NCT00534313|448863708|FG001|Long-term Period|Administrative reason by sponsor|15|||
124790763|NCT00534313|448863709|FG002|Long-term Period|Administrative reason by sponsor|26|||
124790764|NCT00534313|448863710|FG003|Long-term Period|Administrative reason by sponsor|18|||
124790765|NCT00534313|448863707|FG000|Long-term Period|Other|1|||
124790766|NCT00534313|448863708|FG001|Long-term Period|Other|2|||
124790767|NCT00534313|448863709|FG002|Long-term Period|Other|2|||
124790768|NCT00534313|448863710|FG003|Long-term Period|Other|2|||
124790769|NCT03709576|448863716|FG000|Overall Study|progression prior to enrollment|1|||
124790770|NCT01947855|448863717|FG000|Overall Study|Withdrawal by Subject|1|||
124790771|NCT01947855|448863718|FG001|Overall Study|Withdrawal by Subject|0|||
124790772|NCT01947855|448863719|FG002|Overall Study|Withdrawal by Subject|0|||
124790773|NCT00436501|448863721|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
124790774|NCT00436501|448863722|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
124790775|NCT00436501|448863721|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
124790776|NCT00436501|448863722|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
124790777|NCT03011892|448863729|FG000|Double Blind (DB) Period|Adverse Event|0|||
124790778|NCT03011892|448863730|FG001|Double Blind (DB) Period|Adverse Event|1|||
124790779|NCT03011892|448863731|FG002|Double Blind (DB) Period|Adverse Event|1|||
124790780|NCT03011892|448863732|FG003|Double Blind (DB) Period|Adverse Event|0|||
124790781|NCT03011892|448863733|FG004|Double Blind (DB) Period|Adverse Event|0|||
124790782|NCT03011892|448863734|FG005|Double Blind (DB) Period|Adverse Event|0|||
124790783|NCT03011892|448863735|FG006|Double Blind (DB) Period|Adverse Event|0|||
124790784|NCT03011892|448863736|FG007|Double Blind (DB) Period|Adverse Event|0|||
124790785|NCT03011892|448863737|FG008|Double Blind (DB) Period|Adverse Event|0|||
124790786|NCT03011892|448863738|FG009|Double Blind (DB) Period|Adverse Event|0|||
124790787|NCT03011892|448863739|FG010|Double Blind (DB) Period|Adverse Event|0|||
124790788|NCT03011892|448863740|FG011|Double Blind (DB) Period|Adverse Event|0|||
124790789|NCT03011892|448863729|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
124790790|NCT03011892|448863730|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
124790791|NCT03011892|448863731|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
124790792|NCT03011892|448863732|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
124790793|NCT03011892|448863733|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
124790794|NCT03011892|448863734|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
124790795|NCT03011892|448863735|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
124790796|NCT03011892|448863736|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
124790797|NCT03011892|448863737|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
124790798|NCT03011892|448863738|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
124790799|NCT03011892|448863739|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
124790800|NCT03011892|448863740|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
124790801|NCT03011892|448863729|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
124790802|NCT03011892|448863730|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
124790803|NCT03011892|448863731|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
124790804|NCT03011892|448863732|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
124790805|NCT03011892|448863733|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
124790806|NCT03011892|448863734|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
124790807|NCT03011892|448863735|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
124790808|NCT03011892|448863736|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
124790809|NCT03011892|448863737|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
124790810|NCT03011892|448863738|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
124790811|NCT03011892|448863739|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
124790812|NCT03011892|448863740|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
124790813|NCT03011892|448863729|FG000|Double Blind (DB) Period|Other|1|||
124790814|NCT03011892|448863730|FG001|Double Blind (DB) Period|Other|1|||
124790815|NCT03011892|448863731|FG002|Double Blind (DB) Period|Other|1|||
124790816|NCT03011892|448863732|FG003|Double Blind (DB) Period|Other|0|||
124790817|NCT03011892|448863733|FG004|Double Blind (DB) Period|Other|1|||
124790818|NCT03011892|448863734|FG005|Double Blind (DB) Period|Other|0|||
124790819|NCT03011892|448863735|FG006|Double Blind (DB) Period|Other|0|||
124790820|NCT03011892|448863736|FG007|Double Blind (DB) Period|Other|0|||
124790821|NCT03011892|448863737|FG008|Double Blind (DB) Period|Other|0|||
124790822|NCT03011892|448863738|FG009|Double Blind (DB) Period|Other|0|||
124790823|NCT03011892|448863739|FG010|Double Blind (DB) Period|Other|0|||
124790824|NCT03011892|448863740|FG011|Double Blind (DB) Period|Other|0|||
124790825|NCT03011892|448863729|FG000|Double Blind (DB) Period|Physician Decision|1|||
124790826|NCT03011892|448863730|FG001|Double Blind (DB) Period|Physician Decision|0|||
124790827|NCT03011892|448863731|FG002|Double Blind (DB) Period|Physician Decision|1|||
124790828|NCT03011892|448863732|FG003|Double Blind (DB) Period|Physician Decision|0|||
124790829|NCT03011892|448863733|FG004|Double Blind (DB) Period|Physician Decision|0|||
124790830|NCT03011892|448863734|FG005|Double Blind (DB) Period|Physician Decision|0|||
124790831|NCT03011892|448863735|FG006|Double Blind (DB) Period|Physician Decision|0|||
124790832|NCT03011892|448863736|FG007|Double Blind (DB) Period|Physician Decision|0|||
124790833|NCT03011892|448863737|FG008|Double Blind (DB) Period|Physician Decision|0|||
124790834|NCT03011892|448863738|FG009|Double Blind (DB) Period|Physician Decision|0|||
124790835|NCT03011892|448863739|FG010|Double Blind (DB) Period|Physician Decision|0|||
124790836|NCT03011892|448863740|FG011|Double Blind (DB) Period|Physician Decision|0|||
124790837|NCT03011892|448863729|FG000|Double Blind (DB) Period|Pregnancy|0|||
124790838|NCT03011892|448863730|FG001|Double Blind (DB) Period|Pregnancy|0|||
124790839|NCT03011892|448863731|FG002|Double Blind (DB) Period|Pregnancy|0|||
124790840|NCT03011892|448863732|FG003|Double Blind (DB) Period|Pregnancy|0|||
124790841|NCT03011892|448863733|FG004|Double Blind (DB) Period|Pregnancy|1|||
124790842|NCT03011892|448863734|FG005|Double Blind (DB) Period|Pregnancy|0|||
124790843|NCT03011892|448863735|FG006|Double Blind (DB) Period|Pregnancy|0|||
124790844|NCT03011892|448863736|FG007|Double Blind (DB) Period|Pregnancy|0|||
124790845|NCT03011892|448863737|FG008|Double Blind (DB) Period|Pregnancy|0|||
124790846|NCT03011892|448863738|FG009|Double Blind (DB) Period|Pregnancy|0|||
124790847|NCT03011892|448863739|FG010|Double Blind (DB) Period|Pregnancy|0|||
124790848|NCT03011892|448863740|FG011|Double Blind (DB) Period|Pregnancy|0|||
124790849|NCT03011892|448863729|FG000|Double Blind (DB) Period|Protocol Violation|1|||
124790850|NCT03011892|448863730|FG001|Double Blind (DB) Period|Protocol Violation|0|||
124790851|NCT03011892|448863731|FG002|Double Blind (DB) Period|Protocol Violation|0|||
124790852|NCT03011892|448863732|FG003|Double Blind (DB) Period|Protocol Violation|0|||
124790853|NCT03011892|448863733|FG004|Double Blind (DB) Period|Protocol Violation|0|||
124790854|NCT03011892|448863734|FG005|Double Blind (DB) Period|Protocol Violation|0|||
124790855|NCT03011892|448863735|FG006|Double Blind (DB) Period|Protocol Violation|0|||
124790856|NCT03011892|448863736|FG007|Double Blind (DB) Period|Protocol Violation|0|||
124790857|NCT03011892|448863737|FG008|Double Blind (DB) Period|Protocol Violation|0|||
124790858|NCT03011892|448863738|FG009|Double Blind (DB) Period|Protocol Violation|0|||
124790859|NCT03011892|448863739|FG010|Double Blind (DB) Period|Protocol Violation|0|||
124790860|NCT03011892|448863740|FG011|Double Blind (DB) Period|Protocol Violation|0|||
124790861|NCT03011892|448863729|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
124790862|NCT03011892|448863730|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
124790863|NCT03011892|448863731|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
124790864|NCT03011892|448863732|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
124790865|NCT03011892|448863733|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
124790866|NCT03011892|448863734|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
124790867|NCT03011892|448863735|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
124790868|NCT03011892|448863736|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
124790869|NCT03011892|448863737|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
124790870|NCT03011892|448863738|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
124790871|NCT03011892|448863739|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
124790872|NCT03011892|448863740|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
124790873|NCT03011892|448863729|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
124790874|NCT03011892|448863730|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
124790875|NCT03011892|448863731|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
124790876|NCT03011892|448863732|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
124790877|NCT03011892|448863733|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
124790878|NCT03011892|448863734|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
124790879|NCT03011892|448863735|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
124790880|NCT03011892|448863736|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
124790881|NCT03011892|448863737|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
124790882|NCT03011892|448863738|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
124790883|NCT03011892|448863739|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
124790884|NCT03011892|448863740|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
124790885|NCT03011892|448863729|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
124790886|NCT03011892|448863730|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
124790887|NCT03011892|448863731|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
124790888|NCT03011892|448863732|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
124790889|NCT03011892|448863733|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
124790890|NCT03011892|448863734|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
124790891|NCT03011892|448863735|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
124790892|NCT03011892|448863736|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
124790893|NCT03011892|448863737|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
124790894|NCT03011892|448863738|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
124790895|NCT03011892|448863739|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
124790896|NCT03011892|448863740|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
124790897|NCT03011892|448863729|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
124790898|NCT03011892|448863730|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
124790899|NCT03011892|448863731|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
124790900|NCT03011892|448863732|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
124790901|NCT03011892|448863733|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
124790902|NCT03011892|448863734|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
124790903|NCT03011892|448863735|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
124790904|NCT03011892|448863736|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
124790905|NCT03011892|448863737|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
124790906|NCT03011892|448863738|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
124790907|NCT03011892|448863739|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
124790908|NCT03011892|448863740|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
124790909|NCT03011892|448863729|FG000|Open Label (OL) Period|Reason not specified|0|||
124790910|NCT03011892|448863730|FG001|Open Label (OL) Period|Reason not specified|0|||
124790911|NCT03011892|448863731|FG002|Open Label (OL) Period|Reason not specified|0|||
124790912|NCT03011892|448863732|FG003|Open Label (OL) Period|Reason not specified|0|||
124790913|NCT03011892|448863733|FG004|Open Label (OL) Period|Reason not specified|0|||
124790914|NCT03011892|448863734|FG005|Open Label (OL) Period|Reason not specified|0|||
124790915|NCT03011892|448863735|FG006|Open Label (OL) Period|Reason not specified|0|||
124790916|NCT03011892|448863736|FG007|Open Label (OL) Period|Reason not specified|1|||
124790917|NCT03011892|448863737|FG008|Open Label (OL) Period|Reason not specified|0|||
124790918|NCT03011892|448863738|FG009|Open Label (OL) Period|Reason not specified|0|||
124790919|NCT03011892|448863739|FG010|Open Label (OL) Period|Reason not specified|0|||
124790920|NCT03011892|448863740|FG011|Open Label (OL) Period|Reason not specified|0|||
124790921|NCT02282293|448863741|FG000|Overall Study|Lost to Follow-up|2|||
124790922|NCT02282293|448863742|FG001|Overall Study|Lost to Follow-up|2|||
124790923|NCT02282293|448863741|FG000|Overall Study|Unable to comply with study procedures|1|||
124790924|NCT02282293|448863742|FG001|Overall Study|Unable to comply with study procedures|0|||
124790925|NCT02282293|448863741|FG000|Overall Study|Moved out of study area|0|||
124790926|NCT02282293|448863742|FG001|Overall Study|Moved out of study area|1|||
124790927|NCT01924429|448863754|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
124790928|NCT01924429|448863755|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
124790929|NCT00384111|448863756|FG000|Overall Study|Disease Progression|3|||
124790930|NCT00384111|448863756|FG000|Overall Study|Adverse Event|1|||
124790931|NCT00384111|448863756|FG000|Overall Study|Investigator Decision|3|||
124790932|NCT00384111|448863756|FG000|Overall Study|Study Terminated by the Sponsor|19|||
124790933|NCT00807573|448863757|FG000|Overall Study|Withdrawal by Subject|1|||
124790934|NCT00807573|448863757|FG000|Overall Study|Adverse Event|1|||
124790935|NCT01089361|448863758|FG000|Overall Study|Death|1|||
124790936|NCT01089361|448863759|FG001|Overall Study|Death|0|||
124790937|NCT03612856|448863760|FG000|Pre-dose Period|Physician Decision|0|||
124790938|NCT03612856|448863761|FG001|Pre-dose Period|Physician Decision|1|||
124790939|NCT03612856|448863762|FG002|Pre-dose Period|Physician Decision|1|||
124790940|NCT03612856|448863760|FG000|Pre-dose Period|Withdrawal by Subject|0|||
124790941|NCT03612856|448863761|FG001|Pre-dose Period|Withdrawal by Subject|1|||
124790942|NCT03612856|448863762|FG002|Pre-dose Period|Withdrawal by Subject|0|||
124790943|NCT04463069|448863763|FG000|Overall Study|Withdrawal by Subject|2|||
124790944|NCT04463069|448863764|FG001|Overall Study|Withdrawal by Subject|10|||
124790945|NCT04463069|448863763|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
124790946|NCT04463069|448863764|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
124790947|NCT01155167|448863767|FG000|Overall Study|Insufficient ultrasound data|2|||
124790948|NCT01155167|448863768|FG001|Overall Study|Insufficient ultrasound data|0|||
124790949|NCT01155167|448863767|FG000|Overall Study|Access site changed to femoral artery|1|||
124790950|NCT01155167|448863768|FG001|Overall Study|Access site changed to femoral artery|0|||
124790951|NCT02880956|448863774|FG000|Overall Study|Adverse Event|3|||
124790952|NCT02880956|448863775|FG001|Overall Study|Adverse Event|6|||
124790953|NCT02880956|448863776|FG002|Overall Study|Adverse Event|5|||
124790954|NCT02880956|448863777|FG003|Overall Study|Adverse Event|4|||
124790955|NCT02880956|448863774|FG000|Overall Study|Withdrawal by Subject|9|||
124790956|NCT02880956|448863775|FG001|Overall Study|Withdrawal by Subject|4|||
124790957|NCT02880956|448863776|FG002|Overall Study|Withdrawal by Subject|6|||
124790958|NCT02880956|448863777|FG003|Overall Study|Withdrawal by Subject|11|||
124790959|NCT02880956|448863774|FG000|Overall Study|Lost to Follow-up|0|||
124790960|NCT02880956|448863775|FG001|Overall Study|Lost to Follow-up|1|||
124790961|NCT02880956|448863776|FG002|Overall Study|Lost to Follow-up|0|||
124790962|NCT02880956|448863777|FG003|Overall Study|Lost to Follow-up|0|||
124790963|NCT02880956|448863774|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
124790964|NCT02880956|448863775|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
124790965|NCT02880956|448863776|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
124790966|NCT02880956|448863777|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
124790967|NCT02880956|448863774|FG000|Overall Study|Other, Not Specified|4|||
124790968|NCT02880956|448863775|FG001|Overall Study|Other, Not Specified|2|||
124790969|NCT02880956|448863776|FG002|Overall Study|Other, Not Specified|0|||
124790970|NCT02880956|448863777|FG003|Overall Study|Other, Not Specified|3|||
124790971|NCT00853970|448863778|FG000|Overall Study|Withdrawal by Subject|2|||
124790972|NCT00853970|448863779|FG001|Overall Study|Withdrawal by Subject|1|||
124790973|NCT00853970|448863778|FG000|Overall Study|Cancelled surgery|4|||
124790974|NCT00853970|448863779|FG001|Overall Study|Cancelled surgery|2|||
124790975|NCT00576420|448865751|FG000|Overall Study|Death|0|||
124790976|NCT00576420|448865752|FG001|Overall Study|Death|0|||
124790977|NCT00576420|448865753|FG002|Overall Study|Death|1|||
124790978|NCT01771809|448865758|FG000|Overall Study|Adverse Event|4|||
124790979|NCT01771809|448865759|FG001|Overall Study|Adverse Event|12|||
124790980|NCT01771809|448865758|FG000|Overall Study|Protocol Violation|0|||
124790981|NCT01771809|448865759|FG001|Overall Study|Protocol Violation|1|||
124790982|NCT01771809|448865758|FG000|Overall Study|Withdrawal by Subject|34|||
124790983|NCT01771809|448865759|FG001|Overall Study|Withdrawal by Subject|42|||
124790984|NCT01771809|448865758|FG000|Overall Study|Lost to Follow-up|1|||
124790985|NCT01771809|448865759|FG001|Overall Study|Lost to Follow-up|3|||
124790986|NCT01771809|448865758|FG000|Overall Study|Other (Insufficient clinical response)|22|||
124790987|NCT01771809|448865759|FG001|Overall Study|Other (Insufficient clinical response)|20|||
124790988|NCT01771809|448865758|FG000|Overall Study|Death|1|||
124790989|NCT01771809|448865759|FG001|Overall Study|Death|0|||
124790990|NCT01771809|448865758|FG000|Overall Study|Other (other)|9|||
124790991|NCT01771809|448865759|FG001|Overall Study|Other (other)|5|||
124790992|NCT02656680|448865760|FG000|Overall Study|Lost to Follow-up|0|||
124790993|NCT02656680|448865761|FG001|Overall Study|Lost to Follow-up|1|||
124790994|NCT02656680|448865762|FG002|Overall Study|Lost to Follow-up|7|||
124790995|NCT01142089|448865768|FG000|Overall Study|Physician Decision|1|||
124790996|NCT01142089|448865769|FG001|Overall Study|Physician Decision|0|||
124790997|NCT01142089|448865768|FG000|Overall Study|Withdrawal by Subject|1|||
124790998|NCT01142089|448865769|FG001|Overall Study|Withdrawal by Subject|2|||
124790999|NCT01142089|448865768|FG000|Overall Study|Use of prohibited medications|0|||
124791000|NCT01142089|448865769|FG001|Overall Study|Use of prohibited medications|1|||
124791001|NCT01142089|448865768|FG000|Overall Study|Noncompliance with study procedures|2|||
124629449|NCT00927589|448261065|FG000|Overall Study|Adverse Event|2|||
124629450|NCT00927589|448261065|FG000|Overall Study|Disease Progression|8|||
124629451|NCT00927589|448261065|FG000|Overall Study|Non-compliance|1|||
124629452|NCT00707239|448261066|FG000|Overall Study|Adverse Event|5|||
124629453|NCT00707239|448261067|FG001|Overall Study|Adverse Event|3|||
124629454|NCT00707239|448261068|FG002|Overall Study|Adverse Event|2|||
124629455|NCT00707239|448261066|FG000|Overall Study|Death|3|||
124629456|NCT00707239|448261067|FG001|Overall Study|Death|1|||
124629457|NCT00707239|448261068|FG002|Overall Study|Death|3|||
124629458|NCT00707239|448261066|FG000|Overall Study|Physician Decision|1|||
124629459|NCT00707239|448261067|FG001|Overall Study|Physician Decision|1|||
124629460|NCT00707239|448261068|FG002|Overall Study|Physician Decision|2|||
124629461|NCT00707239|448261066|FG000|Overall Study|Protocol Violation|0|||
124629462|NCT00707239|448261067|FG001|Overall Study|Protocol Violation|0|||
124629463|NCT00707239|448261068|FG002|Overall Study|Protocol Violation|1|||
124629464|NCT00707239|448261066|FG000|Overall Study|Lack of Efficacy|1|||
124629465|NCT00707239|448261067|FG001|Overall Study|Lack of Efficacy|2|||
124629466|NCT00707239|448261068|FG002|Overall Study|Lack of Efficacy|0|||
124629467|NCT00707239|448261066|FG000|Overall Study|Randomized, but not treated|1|||
124629468|NCT00707239|448261067|FG001|Overall Study|Randomized, but not treated|1|||
124629469|NCT00707239|448261068|FG002|Overall Study|Randomized, but not treated|1|||
124629470|NCT00707239|448261066|FG000|Overall Study|Other|8|||
124629471|NCT00707239|448261067|FG001|Overall Study|Other|3|||
124629472|NCT00707239|448261068|FG002|Overall Study|Other|5|||
124629473|NCT01651117|448261073|FG000|Overall Study|Death|2|||
124629474|NCT01651117|448261074|FG001|Overall Study|Death|3|||
124629475|NCT01651117|448261075|FG002|Overall Study|Death|2|||
124629476|NCT01651117|448261076|FG003|Overall Study|Death|2|||
124629477|NCT01113892|448261081|FG000|Overall Study|Lost to Follow-up|2|||
124629478|NCT01113892|448261082|FG001|Overall Study|Lost to Follow-up|2|||
124629479|NCT01113892|448261081|FG000|Overall Study|Withdrawal by Subject|1|||
124791002|NCT01142089|448865769|FG001|Overall Study|Noncompliance with study procedures|1|||
124791003|NCT01142089|448865768|FG000|Overall Study|Patient required rescue medication|8|||
124791004|NCT01142089|448865769|FG001|Overall Study|Patient required rescue medication|17|||
124791005|NCT02907892|448865772|FG000|Overall Study|Lost to Follow-up|27|||
124791006|NCT02907892|448865773|FG001|Overall Study|Lost to Follow-up|40|||
124791007|NCT01974765|448865774|FG000|Overall Study|Withdrawal by Subject|1|||
124629480|NCT01113892|448261082|FG001|Overall Study|Withdrawal by Subject|1|||
124629481|NCT01113892|448261081|FG000|Overall Study|Death|2|||
124629482|NCT01113892|448261082|FG001|Overall Study|Death|4|||
124629483|NCT01113892|448261081|FG000|Overall Study|Graft no longer evaluable|9|||
124629484|NCT01113892|448261082|FG001|Overall Study|Graft no longer evaluable|9|||
124629485|NCT01532934|448261093|FG000|Overall Study|Lost to Follow-up|11|||
124629486|NCT01532934|448261094|FG001|Overall Study|Lost to Follow-up|11|||
124629487|NCT01532934|448261093|FG000|Overall Study|In controlled environment|3|||
124629488|NCT01532934|448261094|FG001|Overall Study|In controlled environment|2|||
124629489|NCT01147068|448261095|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
124791008|NCT01974765|448865774|FG000|Overall Study|Death|1|||
124791009|NCT01974765|448865774|FG000|Overall Study|Adverse Event|2|||
124791010|NCT00528970|448865775|FG000|Overall Study|Adverse Event|6|||
124791011|NCT00528970|448865776|FG001|Overall Study|Adverse Event|8|||
124791012|NCT00528970|448865777|FG002|Overall Study|Adverse Event|5|||
124791013|NCT00528970|448865775|FG000|Overall Study|Lost to Follow-up|0|||
124791014|NCT00528970|448865776|FG001|Overall Study|Lost to Follow-up|0|||
124791015|NCT00528970|448865777|FG002|Overall Study|Lost to Follow-up|1|||
124791016|NCT00528970|448865775|FG000|Overall Study|Other than specified|2|||
124791017|NCT00528970|448865776|FG001|Overall Study|Other than specified|3|||
124791018|NCT00528970|448865777|FG002|Overall Study|Other than specified|3|||
124791019|NCT00528970|448865775|FG000|Overall Study|Protocol Violation|2|||
124791020|NCT00528970|448865776|FG001|Overall Study|Protocol Violation|1|||
124791021|NCT00528970|448865777|FG002|Overall Study|Protocol Violation|4|||
124791022|NCT00528970|448865775|FG000|Overall Study|Lack of Efficacy|0|||
124791023|NCT00528970|448865776|FG001|Overall Study|Lack of Efficacy|0|||
124791024|NCT00528970|448865777|FG002|Overall Study|Lack of Efficacy|1|||
124791025|NCT00528970|448865775|FG000|Overall Study|Withdrawal by Subject|4|||
124791026|NCT00528970|448865776|FG001|Overall Study|Withdrawal by Subject|3|||
124791027|NCT00528970|448865777|FG002|Overall Study|Withdrawal by Subject|5|||
124791028|NCT00528970|448865775|FG000|Overall Study|Randomized but not treated|0|||
124791029|NCT00528970|448865776|FG001|Overall Study|Randomized but not treated|0|||
124791030|NCT00528970|448865777|FG002|Overall Study|Randomized but not treated|1|||
124791031|NCT03860935|448865778|FG000|Overall Study|Withdrawal of Consent|15|||
124791032|NCT03860935|448865779|FG001|Overall Study|Withdrawal of Consent|6|||
124629490|NCT01147068|448261096|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
124629491|NCT01147068|448261097|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
124791033|NCT03860935|448865778|FG000|Overall Study|Death|75|||
124791034|NCT03860935|448865779|FG001|Overall Study|Death|51|||
124791035|NCT01430754|448865780|FG000|Run-In Phase|Circadian Period Ineligible|24|||
124791036|NCT01430754|448865781|FG001|Run-In Phase|Circadian Period Ineligible|0|||
124791037|NCT01430754|448865780|FG000|Run-In Phase|Protocol Violation|6|||
124791038|NCT01430754|448865781|FG001|Run-In Phase|Protocol Violation|0|||
124791039|NCT01430754|448865780|FG000|Run-In Phase|Adverse Event|2|||
124791040|NCT01430754|448865781|FG001|Run-In Phase|Adverse Event|0|||
124791041|NCT01430754|448865780|FG000|Run-In Phase|Other|2|||
124791042|NCT01430754|448865781|FG001|Run-In Phase|Other|0|||
124791043|NCT01430754|448865780|FG000|Run-In Phase|Withdrawal by Subject|2|||
124791044|NCT01430754|448865781|FG001|Run-In Phase|Withdrawal by Subject|0|||
124791045|NCT01430754|448865780|FG000|Run-In Phase|Lost to Follow-up|1|||
124791046|NCT01430754|448865781|FG001|Run-In Phase|Lost to Follow-up|0|||
124791047|NCT00701662|448865785|FG000|Overall Study|Lack of Efficacy|1|||
124791048|NCT00635024|448865786|FG000|Overall Study|Adverse Event|1|||
124791049|NCT01105065|448865787|FG000|Overall Study|Adverse Event|5|||
124791050|NCT01105065|448865787|FG000|Overall Study|Technical Problems|1|||
124791051|NCT01038869|448865790|FG000|Overall Study|Withdrawal by Subject|1|||
124791052|NCT01038869|448865790|FG000|Overall Study|Lost to Follow-up|6|||
124791053|NCT04575597|448865791|FG000|Overall Study|Death|0|||
124791054|NCT04575597|448865792|FG001|Overall Study|Death|0|||
124791055|NCT04575597|448865793|FG002|Overall Study|Death|0|||
124791056|NCT04575597|448865794|FG003|Overall Study|Death|1|||
124791057|NCT04575597|448865795|FG004|Overall Study|Death|3|||
124791058|NCT04575597|448865796|FG005|Overall Study|Death|14|||
124791059|NCT04575597|448865791|FG000|Overall Study|Lost to Follow-up|2|||
124791060|NCT04575597|448865792|FG001|Overall Study|Lost to Follow-up|1|||
124791061|NCT04575597|448865793|FG002|Overall Study|Lost to Follow-up|1|||
124791062|NCT04575597|448865794|FG003|Overall Study|Lost to Follow-up|2|||
124791063|NCT04575597|448865795|FG004|Overall Study|Lost to Follow-up|10|||
124791064|NCT04575597|448865796|FG005|Overall Study|Lost to Follow-up|8|||
124791065|NCT04575597|448865791|FG000|Overall Study|Withdrawal by Subject|2|||
124791066|NCT04575597|448865792|FG001|Overall Study|Withdrawal by Subject|2|||
124791067|NCT04575597|448865793|FG002|Overall Study|Withdrawal by Subject|4|||
124791068|NCT04575597|448865794|FG003|Overall Study|Withdrawal by Subject|2|||
124791069|NCT04575597|448865795|FG004|Overall Study|Withdrawal by Subject|25|||
124791070|NCT04575597|448865796|FG005|Overall Study|Withdrawal by Subject|28|||
124791071|NCT04575597|448865791|FG000|Overall Study|Not Recorded|0|||
124629492|NCT01147068|448261098|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
124791072|NCT04575597|448865792|FG001|Overall Study|Not Recorded|0|||
124791073|NCT04575597|448865793|FG002|Overall Study|Not Recorded|0|||
124791074|NCT04575597|448865794|FG003|Overall Study|Not Recorded|0|||
124629493|NCT01147068|448261099|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
124791075|NCT04575597|448865795|FG004|Overall Study|Not Recorded|0|||
124791076|NCT04575597|448865796|FG005|Overall Study|Not Recorded|2|||
124791077|NCT04575597|448865791|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124791078|NCT04575597|448865792|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124791079|NCT04575597|448865793|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124791080|NCT04575597|448865794|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124791081|NCT04575597|448865795|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
124791082|NCT04575597|448865796|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
124791083|NCT03316911|448865801|FG000|Overall Study|Lost to Follow-up|33|||
124791084|NCT03316911|448865802|FG001|Overall Study|Lost to Follow-up|29|||
124791085|NCT01119937|448865803|FG000|Overall Study|Adverse Event|11|||
124791086|NCT01119937|448865804|FG001|Overall Study|Adverse Event|5|||
124791087|NCT01119937|448865803|FG000|Overall Study|Protocol deviation|3|||
124791088|NCT01119937|448865804|FG001|Overall Study|Protocol deviation|1|||
124791089|NCT01119937|448865803|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
124791090|NCT01119937|448865804|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124791091|NCT01119937|448865803|FG000|Overall Study|Withdrawal by Subject|2|||
124791092|NCT01119937|448865804|FG001|Overall Study|Withdrawal by Subject|1|||
124791093|NCT02536404|448865809|FG000|Overall Study|Adverse Event|5|||
124791094|NCT02536404|448865810|FG001|Overall Study|Adverse Event|0|||
124791095|NCT02536404|448865809|FG000|Overall Study|Withdrawal by Subject|4|||
124791096|NCT02536404|448865810|FG001|Overall Study|Withdrawal by Subject|1|||
124791097|NCT02536404|448865809|FG000|Overall Study|Physician Decision|10|||
124791098|NCT02536404|448865810|FG001|Overall Study|Physician Decision|0|||
124791099|NCT02536404|448865809|FG000|Overall Study|Sponsor decision|1|||
124791100|NCT02536404|448865810|FG001|Overall Study|Sponsor decision|0|||
124791101|NCT00770146|448865811|FG000|Treatment Period|Withdrawal by Subject|6|||
124791102|NCT00770146|448865812|FG001|Treatment Period|Withdrawal by Subject|13|||
124791103|NCT00770146|448865811|FG000|Treatment Period|Adverse Event|2|||
124791104|NCT00770146|448865812|FG001|Treatment Period|Adverse Event|26|||
124791105|NCT00770146|448865811|FG000|Treatment Period|Other|1|||
124791106|NCT00770146|448865812|FG001|Treatment Period|Other|5|||
124791107|NCT00770146|448865811|FG000|Treatment Period|Protocol non-compliance|0|||
124791108|NCT00770146|448865812|FG001|Treatment Period|Protocol non-compliance|1|||
124791109|NCT00770146|448865811|FG000|Follow-up Period|Withdrawal by Subject|7|||
124791110|NCT00770146|448865812|FG001|Follow-up Period|Withdrawal by Subject|13|||
124791111|NCT00770146|448865811|FG000|Follow-up Period|Adverse Event|0|||
124791112|NCT00770146|448865812|FG001|Follow-up Period|Adverse Event|2|||
124791113|NCT00770146|448865811|FG000|Follow-up Period|Other|4|||
124791114|NCT00770146|448865812|FG001|Follow-up Period|Other|5|||
124791115|NCT00816023|448865814|FG000|Overall Study|Lost to Follow-up|1|||
124791116|NCT00816023|448865815|FG001|Overall Study|Lost to Follow-up|1|||
124791117|NCT00816023|448865816|FG002|Overall Study|Lost to Follow-up|0|||
124791118|NCT00816023|448865817|FG003|Overall Study|Lost to Follow-up|0|||
124791119|NCT00816023|448865814|FG000|Overall Study|Withdrawal by Subject|1|||
124791120|NCT00816023|448865815|FG001|Overall Study|Withdrawal by Subject|0|||
124791121|NCT00816023|448865816|FG002|Overall Study|Withdrawal by Subject|0|||
124791122|NCT00816023|448865817|FG003|Overall Study|Withdrawal by Subject|0|||
124791123|NCT00816023|448865814|FG000|Overall Study|Physician Decision|0|||
124791124|NCT00816023|448865815|FG001|Overall Study|Physician Decision|0|||
124791125|NCT00816023|448865816|FG002|Overall Study|Physician Decision|1|||
124791126|NCT00816023|448865817|FG003|Overall Study|Physician Decision|0|||
124791127|NCT00816023|448865814|FG000|Overall Study|assessments complete prior to window|1|||
124791128|NCT00816023|448865815|FG001|Overall Study|assessments complete prior to window|1|||
124791129|NCT00816023|448865816|FG002|Overall Study|assessments complete prior to window|2|||
124791130|NCT00816023|448865817|FG003|Overall Study|assessments complete prior to window|1|||
124791131|NCT00816023|448865814|FG000|Overall Study|Randomized Not Treated|6|||
124791132|NCT00816023|448865815|FG001|Overall Study|Randomized Not Treated|4|||
124791133|NCT00816023|448865816|FG002|Overall Study|Randomized Not Treated|6|||
124791134|NCT00816023|448865817|FG003|Overall Study|Randomized Not Treated|11|||
124791135|NCT05027971|448865818|FG000|Overall Study|Physician Decision|7|||
124791136|NCT05027971|448865819|FG001|Overall Study|Physician Decision|3|||
124791137|NCT05027971|448865818|FG000|Overall Study|Lost to Follow-up|1|||
124791138|NCT05027971|448865819|FG001|Overall Study|Lost to Follow-up|1|||
124791139|NCT05027971|448865818|FG000|Overall Study|Withdrawal by Subject|0|||
124791140|NCT05027971|448865819|FG001|Overall Study|Withdrawal by Subject|2|||
124791141|NCT05027971|448865818|FG000|Overall Study|Non-study fiber used.|0|||
124791142|NCT05027971|448865819|FG001|Overall Study|Non-study fiber used.|1|||
124791143|NCT05027971|448865818|FG000|Overall Study|Protocol Violation|0|||
124791144|NCT05027971|448865819|FG001|Overall Study|Protocol Violation|2|||
124791145|NCT01238588|448865824|FG000|Overall Study|Withdrawal by Subject|1|||
124791146|NCT01238588|448865824|FG000|Overall Study|Physician Decision|2|||
124791147|NCT01903252|448865829|FG000|Double-Blind Induction|Adverse Event|20|||
124791148|NCT01903252|448865830|FG001|Double-Blind Induction|Adverse Event|18|||
124791149|NCT01903252|448865831|FG002|Double-Blind Induction|Adverse Event|0|||
124791150|NCT01903252|448865832|FG003|Double-Blind Induction|Adverse Event|0|||
124791151|NCT01903252|448865833|FG004|Double-Blind Induction|Adverse Event|0|||
124791152|NCT01903252|448865834|FG005|Double-Blind Induction|Adverse Event|0|||
124791153|NCT01903252|448865829|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
124791154|NCT01903252|448865830|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
124791155|NCT01903252|448865831|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
124791156|NCT01903252|448865832|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
124791157|NCT01903252|448865833|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
124791158|NCT01903252|448865834|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
124791159|NCT01903252|448865829|FG000|Double-Blind Induction|Physician Decision|2|||
124791160|NCT01903252|448865830|FG001|Double-Blind Induction|Physician Decision|3|||
124791161|NCT01903252|448865831|FG002|Double-Blind Induction|Physician Decision|0|||
124791162|NCT01903252|448865832|FG003|Double-Blind Induction|Physician Decision|0|||
124791163|NCT01903252|448865833|FG004|Double-Blind Induction|Physician Decision|0|||
124791164|NCT01903252|448865834|FG005|Double-Blind Induction|Physician Decision|0|||
124791165|NCT01903252|448865829|FG000|Double-Blind Induction|non-compliance,|7|||
124791166|NCT01903252|448865830|FG001|Double-Blind Induction|non-compliance,|7|||
124791167|NCT01903252|448865831|FG002|Double-Blind Induction|non-compliance,|0|||
124791168|NCT01903252|448865832|FG003|Double-Blind Induction|non-compliance,|0|||
124791169|NCT01903252|448865833|FG004|Double-Blind Induction|non-compliance,|0|||
124791170|NCT01903252|448865834|FG005|Double-Blind Induction|non-compliance,|0|||
124791171|NCT01903252|448865829|FG000|Extended Induction, Open-Label|Adverse Event|0|||
124791172|NCT01903252|448865830|FG001|Extended Induction, Open-Label|Adverse Event|0|||
124791173|NCT01903252|448865831|FG002|Extended Induction, Open-Label|Adverse Event|17|||
124791174|NCT01903252|448865832|FG003|Extended Induction, Open-Label|Adverse Event|0|||
124791175|NCT01903252|448865833|FG004|Extended Induction, Open-Label|Adverse Event|0|||
124791176|NCT01903252|448865834|FG005|Extended Induction, Open-Label|Adverse Event|0|||
124791177|NCT01903252|448865829|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
124791178|NCT01903252|448865830|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
124791179|NCT01903252|448865831|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
124791180|NCT01903252|448865832|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
124791181|NCT01903252|448865833|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
124791182|NCT01903252|448865834|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
124791183|NCT01903252|448865829|FG000|Extended Induction, Open-Label|Physician Decision|0|||
124791184|NCT01903252|448865830|FG001|Extended Induction, Open-Label|Physician Decision|0|||
124791185|NCT01903252|448865831|FG002|Extended Induction, Open-Label|Physician Decision|1|||
124791186|NCT01903252|448865832|FG003|Extended Induction, Open-Label|Physician Decision|0|||
124791187|NCT01903252|448865833|FG004|Extended Induction, Open-Label|Physician Decision|0|||
124791188|NCT01903252|448865834|FG005|Extended Induction, Open-Label|Physician Decision|0|||
124791189|NCT01903252|448865829|FG000|Maintenance, Open-Label|Adverse Event|0|||
124791190|NCT01903252|448865830|FG001|Maintenance, Open-Label|Adverse Event|0|||
124791191|NCT01903252|448865831|FG002|Maintenance, Open-Label|Adverse Event|0|||
124791192|NCT01903252|448865832|FG003|Maintenance, Open-Label|Adverse Event|3|||
124791193|NCT01903252|448865833|FG004|Maintenance, Open-Label|Adverse Event|9|||
124791194|NCT01903252|448865834|FG005|Maintenance, Open-Label|Adverse Event|14|||
124791195|NCT01903252|448865829|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
124791196|NCT01903252|448865830|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
124791197|NCT01903252|448865831|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
124791198|NCT01903252|448865832|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
124791199|NCT01903252|448865833|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
124791200|NCT01903252|448865834|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
124791201|NCT01903252|448865829|FG000|Maintenance, Open-Label|Other|0|||
124791202|NCT01903252|448865830|FG001|Maintenance, Open-Label|Other|0|||
124791203|NCT01903252|448865831|FG002|Maintenance, Open-Label|Other|0|||
124791204|NCT01903252|448865832|FG003|Maintenance, Open-Label|Other|2|||
124791205|NCT01903252|448865833|FG004|Maintenance, Open-Label|Other|6|||
124791206|NCT01903252|448865834|FG005|Maintenance, Open-Label|Other|2|||
124791207|NCT02437110|448865835|FG000|Screening|Lost to Follow-up|3|||
124791208|NCT02437110|448865835|FG000|Screening|Physician Decision|1|||
124791209|NCT02437110|448865835|FG000|ART|Adverse Event|3|||
124791210|NCT02437110|448865835|FG000|ART|Protocol Violation|3|||
124791211|NCT02437110|448865835|FG000|ART|Withdrawal by Subject|4|||
124791212|NCT02437110|448865835|FG000|ART|Lost to follow-up prior to start of intervention|1|||
124791213|NCT02437110|448865835|FG000|ART|Physician decision prior to start of intervention|2|||
124791214|NCT02437110|448865835|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
124791215|NCT02437110|448865835|FG000|Post-ART|Lost to Follow-up|3|||
124791216|NCT02437110|448865835|FG000|Post-ART|Protocol Violation|4|||
124791217|NCT02437110|448865835|FG000|Post-ART|Withdrawal by Subject|3|||
124791218|NCT03836001|448865838|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
124791219|NCT03836001|448865839|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
124791220|NCT03836001|448865840|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
124791221|NCT03836001|448865838|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
124791222|NCT03836001|448865839|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
124791223|NCT03836001|448865840|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
124791224|NCT03836001|448865838|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
124791225|NCT03836001|448865839|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
124791226|NCT03836001|448865840|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
124791227|NCT03836001|448865838|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
124791228|NCT03836001|448865839|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
124791229|NCT03836001|448865840|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
124791230|NCT01381562|448865841|FG000|Overall Study|Adverse Event|0|||
124791231|NCT01381562|448865842|FG001|Overall Study|Adverse Event|1|||
124791232|NCT01381562|448865843|FG002|Overall Study|Adverse Event|0|||
124791233|NCT01642732|448865848|FG000|Overall Study|Withdrawal by Subject|1|||
124791234|NCT00899353|448865851|FG000|Overall Study|Adverse Event|2|||
124791235|NCT00899353|448865851|FG000|Overall Study|Lost to Follow-up|1|||
124791236|NCT00899353|448865851|FG000|Overall Study|Withdrawal by Subject|2|||
124791237|NCT02730793|448865857|FG000|Overall Study|Physician Decision|0|||
124791238|NCT02730793|448865858|FG001|Overall Study|Physician Decision|1|||
124791239|NCT02730793|448865857|FG000|Overall Study|Withdrawal by Subject|0|||
124791240|NCT02730793|448865858|FG001|Overall Study|Withdrawal by Subject|1|||
124791241|NCT01284491|448865859|FG000|Overall Study|Study termination|13|||
124791242|NCT02694757|448865862|FG000|Overall Study|Lack of Efficacy|3|||
124791243|NCT02650921|448865863|FG000|Overall Study|Withdrawal by Subject|4|||
124791244|NCT02650921|448865863|FG000|Overall Study|Lost to Follow-up|2|||
124791245|NCT02650921|448865863|FG000|Overall Study|Adverse Event|1|||
124791246|NCT02650921|448865863|FG000|Overall Study|Due to Medical Condition|1|||
124791247|NCT00783302|448865864|FG000|Overall Study|Lost to Follow-up|17|||
124791248|NCT00783302|448865864|FG000|Overall Study|Technical Problems|11|||
124791249|NCT00783302|448865864|FG000|Overall Study|Protocol Violation|3|||
124791250|NCT00783302|448865864|FG000|Overall Study|Physician Decision|1|||
124791251|NCT00783302|448865864|FG000|Overall Study|Withdrawal by Subject|3|||
124791252|NCT04604132|448865865|FG000|Overall Study|Adverse Event|2|||
124791253|NCT04604132|448865866|FG001|Overall Study|Adverse Event|0|||
124791254|NCT04604132|448865867|FG002|Overall Study|Adverse Event|0|||
124791255|NCT04604132|448865868|FG003|Overall Study|Adverse Event|1|||
124791256|NCT04604132|448865869|FG004|Overall Study|Adverse Event|2|||
124791257|NCT04604132|448865865|FG000|Overall Study|Study terminated by sponsor|0|||
124791258|NCT04604132|448865866|FG001|Overall Study|Study terminated by sponsor|0|||
124791259|NCT04604132|448865867|FG002|Overall Study|Study terminated by sponsor|0|||
124791260|NCT04604132|448865868|FG003|Overall Study|Study terminated by sponsor|0|||
124791261|NCT04604132|448865869|FG004|Overall Study|Study terminated by sponsor|1|||
124791262|NCT04604132|448865865|FG000|Overall Study|Progressive disease: Clinical progression|0|||
124791263|NCT04604132|448865866|FG001|Overall Study|Progressive disease: Clinical progression|0|||
124791264|NCT04604132|448865867|FG002|Overall Study|Progressive disease: Clinical progression|1|||
124791265|NCT04604132|448865868|FG003|Overall Study|Progressive disease: Clinical progression|0|||
124791266|NCT04604132|448865869|FG004|Overall Study|Progressive disease: Clinical progression|0|||
124791267|NCT04604132|448865865|FG000|Overall Study|Progressive disease: Radiological progression|8|||
124791268|NCT04604132|448865866|FG001|Overall Study|Progressive disease: Radiological progression|7|||
124791269|NCT04604132|448865867|FG002|Overall Study|Progressive disease: Radiological progression|10|||
124791270|NCT04604132|448865868|FG003|Overall Study|Progressive disease: Radiological progression|4|||
124791271|NCT04604132|448865869|FG004|Overall Study|Progressive disease: Radiological progression|3|||
124791272|NCT04604132|448865865|FG000|Overall Study|Death|3|||
124791273|NCT04604132|448865866|FG001|Overall Study|Death|1|||
124791274|NCT04604132|448865867|FG002|Overall Study|Death|2|||
124791275|NCT04604132|448865868|FG003|Overall Study|Death|1|||
124791276|NCT04604132|448865869|FG004|Overall Study|Death|0|||
124791277|NCT00952380|448865870|FG000|Overall Study|Other|0|||
124791278|NCT00952380|448865871|FG001|Overall Study|Other|0|||
124791279|NCT00952380|448865872|FG002|Overall Study|Other|0|||
124791280|NCT00952380|448865873|FG003|Overall Study|Other|0|||
124791281|NCT00952380|448865874|FG004|Overall Study|Other|1|||
124791282|NCT00952380|448865870|FG000|Overall Study|Withdrawal by Subject|0|||
124791283|NCT00952380|448865871|FG001|Overall Study|Withdrawal by Subject|0|||
124791284|NCT00952380|448865872|FG002|Overall Study|Withdrawal by Subject|1|||
124791285|NCT00952380|448865873|FG003|Overall Study|Withdrawal by Subject|0|||
124791286|NCT00952380|448865874|FG004|Overall Study|Withdrawal by Subject|2|||
124791287|NCT00952380|448865870|FG000|Overall Study|Adverse Event|0|||
124791288|NCT00952380|448865871|FG001|Overall Study|Adverse Event|1|||
124791289|NCT00952380|448865872|FG002|Overall Study|Adverse Event|0|||
124791290|NCT00952380|448865873|FG003|Overall Study|Adverse Event|0|||
124791291|NCT00952380|448865874|FG004|Overall Study|Adverse Event|3|||
124791292|NCT00952380|448865870|FG000|Overall Study|Physician Decision|0|||
124791293|NCT00952380|448865871|FG001|Overall Study|Physician Decision|0|||
124629494|NCT01147068|448261100|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
124791294|NCT00952380|448865872|FG002|Overall Study|Physician Decision|1|||
124791295|NCT00952380|448865873|FG003|Overall Study|Physician Decision|2|||
124791296|NCT00952380|448865874|FG004|Overall Study|Physician Decision|0|||
124791297|NCT00952380|448865870|FG000|Overall Study|Non-compliant to protocol|0|||
124791298|NCT00952380|448865871|FG001|Overall Study|Non-compliant to protocol|0|||
124629495|NCT01147068|448261101|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
124791299|NCT00952380|448865872|FG002|Overall Study|Non-compliant to protocol|0|||
124791300|NCT00952380|448865873|FG003|Overall Study|Non-compliant to protocol|1|||
124791301|NCT00952380|448865874|FG004|Overall Study|Non-compliant to protocol|0|||
124791302|NCT03400956|448865875|FG000|Treatment Period 1|Adverse Event|0|||
124629496|NCT01147068|448261095|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
124791303|NCT03400956|448865876|FG001|Treatment Period 1|Adverse Event|1|||
124791304|NCT03400956|448865877|FG002|Treatment Period 1|Adverse Event|0|||
124791305|NCT03400956|448865875|FG000|Treatment Period 1|Lost to Follow-up|0|||
124791306|NCT03400956|448865876|FG001|Treatment Period 1|Lost to Follow-up|0|||
124791307|NCT03400956|448865877|FG002|Treatment Period 1|Lost to Follow-up|1|||
124791308|NCT03400956|448865875|FG000|Treatment Period 1|Protocol Violation|0|||
124791309|NCT03400956|448865876|FG001|Treatment Period 1|Protocol Violation|2|||
124791310|NCT03400956|448865877|FG002|Treatment Period 1|Protocol Violation|0|||
124791311|NCT03400956|448865875|FG000|Treatment Period 1|Study terminated by sponsor|3|||
124791312|NCT03400956|448865876|FG001|Treatment Period 1|Study terminated by sponsor|1|||
124791313|NCT03400956|448865877|FG002|Treatment Period 1|Study terminated by sponsor|1|||
124791314|NCT03400956|448865875|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124791315|NCT03400956|448865876|FG001|Treatment Period 1|Withdrawal by Subject|2|||
124791316|NCT03400956|448865877|FG002|Treatment Period 1|Withdrawal by Subject|4|||
124791317|NCT03400956|448865875|FG000|Treatment Period 1|Other|1|||
124791318|NCT03400956|448865876|FG001|Treatment Period 1|Other|2|||
124791319|NCT03400956|448865877|FG002|Treatment Period 1|Other|3|||
124791320|NCT03400956|448865875|FG000|Post-treatment Period 1|Adverse Event|0|||
124791321|NCT03400956|448865876|FG001|Post-treatment Period 1|Adverse Event|0|||
124791322|NCT03400956|448865877|FG002|Post-treatment Period 1|Adverse Event|1|||
124791323|NCT03400956|448865875|FG000|Post-treatment Period 1|Physician Decision|2|||
124791324|NCT03400956|448865876|FG001|Post-treatment Period 1|Physician Decision|3|||
124791325|NCT03400956|448865877|FG002|Post-treatment Period 1|Physician Decision|0|||
124791326|NCT03400956|448865875|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
124791327|NCT03400956|448865876|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
124791328|NCT03400956|448865877|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
124791329|NCT03400956|448865875|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
124791330|NCT03400956|448865876|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
124791331|NCT03400956|448865877|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
124791332|NCT03400956|448865875|FG000|Post-treatment Period 1|Other|4|||
124791333|NCT03400956|448865876|FG001|Post-treatment Period 1|Other|3|||
124791334|NCT03400956|448865877|FG002|Post-treatment Period 1|Other|4|||
124791335|NCT03400956|448865875|FG000|Treatment Period 2|Adverse Event|2|||
124791336|NCT03400956|448865876|FG001|Treatment Period 2|Adverse Event|1|||
124791337|NCT03400956|448865877|FG002|Treatment Period 2|Adverse Event|1|||
124791338|NCT03400956|448865875|FG000|Treatment Period 2|Lost to Follow-up|1|||
124791339|NCT03400956|448865876|FG001|Treatment Period 2|Lost to Follow-up|1|||
124791340|NCT03400956|448865877|FG002|Treatment Period 2|Lost to Follow-up|0|||
124791341|NCT03400956|448865875|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124791342|NCT03400956|448865876|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124791343|NCT03400956|448865877|FG002|Treatment Period 2|Withdrawal by Subject|3|||
124791344|NCT03400956|448865875|FG000|Treatment Period 2|Other|1|||
124791345|NCT03400956|448865876|FG001|Treatment Period 2|Other|1|||
124791346|NCT03400956|448865877|FG002|Treatment Period 2|Other|0|||
124791347|NCT03400956|448865875|FG000|Follow-up Period|Withdrawal by Subject|0|||
124791348|NCT03400956|448865876|FG001|Follow-up Period|Withdrawal by Subject|0|||
124791349|NCT03400956|448865877|FG002|Follow-up Period|Withdrawal by Subject|1|||
124791350|NCT03400956|448865875|FG000|Follow-up Period|Other|0|||
124791351|NCT03400956|448865876|FG001|Follow-up Period|Other|0|||
124791352|NCT03400956|448865877|FG002|Follow-up Period|Other|1|||
124791353|NCT00160667|448865878|FG000|Overall Study|Adverse Event|3|||
124791354|NCT00160667|448865879|FG001|Overall Study|Adverse Event|1|||
124791355|NCT00160667|448865880|FG002|Overall Study|Adverse Event|4|||
124791356|NCT00160667|448865878|FG000|Overall Study|Withdrawal by Subject|2|||
124791357|NCT00160667|448865879|FG001|Overall Study|Withdrawal by Subject|0|||
124791358|NCT00160667|448865880|FG002|Overall Study|Withdrawal by Subject|1|||
124791359|NCT00160667|448865878|FG000|Overall Study|Lack of Efficacy|0|||
124791360|NCT00160667|448865879|FG001|Overall Study|Lack of Efficacy|1|||
124791361|NCT00160667|448865880|FG002|Overall Study|Lack of Efficacy|0|||
124791362|NCT00160667|448865878|FG000|Overall Study|Protocol Violation|0|||
124791363|NCT00160667|448865879|FG001|Overall Study|Protocol Violation|1|||
124791364|NCT00160667|448865880|FG002|Overall Study|Protocol Violation|0|||
124791365|NCT00160667|448865878|FG000|Overall Study|Patient decision|0|||
124791366|NCT00160667|448865879|FG001|Overall Study|Patient decision|0|||
124791367|NCT00160667|448865880|FG002|Overall Study|Patient decision|1|||
124791368|NCT00927940|448865881|FG000|Overall Study|Death|1|||
124791369|NCT03044574|448865885|FG000|Overall Study|Lost to Follow-up|37|||
124791370|NCT03044574|448865886|FG001|Overall Study|Lost to Follow-up|45|||
124791371|NCT00890045|448865887|FG000|Overall Study|Death|0|||
124791372|NCT00890045|448865888|FG001|Overall Study|Death|1|||
124791373|NCT00890045|448865887|FG000|Overall Study|Did not receive HeRO Graft|0|||
124791374|NCT00890045|448865888|FG001|Overall Study|Did not receive HeRO Graft|2|||
124791375|NCT00890045|448865887|FG000|Overall Study|Lost to Follow-up|5|||
124791376|NCT00890045|448865888|FG001|Overall Study|Lost to Follow-up|7|||
124791377|NCT00483756|448865893|FG000|Overall Study|Death|2|||
124791378|NCT00483756|448865894|FG001|Overall Study|Death|0|||
124791379|NCT00483756|448865895|FG002|Overall Study|Death|1|||
124791380|NCT00483756|448865893|FG000|Overall Study|Adverse Event|19|||
124791381|NCT00483756|448865894|FG001|Overall Study|Adverse Event|38|||
124791382|NCT00483756|448865895|FG002|Overall Study|Adverse Event|40|||
124791383|NCT00483756|448865893|FG000|Overall Study|Lack of Efficacy|1|||
124791384|NCT00483756|448865894|FG001|Overall Study|Lack of Efficacy|0|||
124791385|NCT00483756|448865895|FG002|Overall Study|Lack of Efficacy|0|||
124791386|NCT00483756|448865893|FG000|Overall Study|Lost to Follow-up|3|||
124791387|NCT00483756|448865894|FG001|Overall Study|Lost to Follow-up|1|||
124791388|NCT00483756|448865895|FG002|Overall Study|Lost to Follow-up|0|||
124791389|NCT00483756|448865893|FG000|Overall Study|Withdrawal by Subject|5|||
124791390|NCT00483756|448865894|FG001|Overall Study|Withdrawal by Subject|3|||
124791391|NCT00483756|448865895|FG002|Overall Study|Withdrawal by Subject|4|||
124791392|NCT00483756|448865893|FG000|Overall Study|Other|2|||
124791393|NCT00483756|448865894|FG001|Overall Study|Other|4|||
124791394|NCT00483756|448865895|FG002|Overall Study|Other|3|||
124791395|NCT00483756|448865893|FG000|Overall Study|Randomized, Not Treated|1|||
124791396|NCT00483756|448865894|FG001|Overall Study|Randomized, Not Treated|4|||
124791397|NCT00483756|448865895|FG002|Overall Study|Randomized, Not Treated|4|||
124791398|NCT00906971|448865896|FG000|Overall Study|Withdrawal by Subject|8|||
124791399|NCT00906971|448865897|FG001|Overall Study|Withdrawal by Subject|2|||
124791400|NCT00906971|448865896|FG000|Overall Study|Lost to Follow-up|0|||
124791401|NCT00906971|448865897|FG001|Overall Study|Lost to Follow-up|1|||
124791402|NCT04054947|448865898|FG000|Overall Study|Withdrawal by Subject|1|||
124791403|NCT04054947|448865899|FG001|Overall Study|Withdrawal by Subject|0|||
124791404|NCT04054947|448865898|FG000|Overall Study|Lost to Follow-up|2|||
124791405|NCT04054947|448865899|FG001|Overall Study|Lost to Follow-up|5|||
124791406|NCT01606878|448865900|FG000|Overall Study|Adverse Event|1|||
124791407|NCT01606878|448865901|FG001|Overall Study|Adverse Event|1|||
124791408|NCT01606878|448865902|FG002|Overall Study|Adverse Event|0|||
124791409|NCT01606878|448865903|FG003|Overall Study|Adverse Event|0|||
124791410|NCT01606878|448865904|FG004|Overall Study|Adverse Event|0|||
124791411|NCT01606878|448865905|FG005|Overall Study|Adverse Event|0|||
124791412|NCT01606878|448865906|FG006|Overall Study|Adverse Event|1|||
124791413|NCT01606878|448865907|FG007|Overall Study|Adverse Event|0|||
124791414|NCT01606878|448865908|FG008|Overall Study|Adverse Event|1|||
124791415|NCT01606878|448865909|FG009|Overall Study|Adverse Event|3|||
124791416|NCT01606878|448865910|FG010|Overall Study|Adverse Event|0|||
124791417|NCT01606878|448865900|FG000|Overall Study|Lack of Efficacy|1|||
124791418|NCT01606878|448865901|FG001|Overall Study|Lack of Efficacy|1|||
124791419|NCT01606878|448865902|FG002|Overall Study|Lack of Efficacy|1|||
124791420|NCT01606878|448865903|FG003|Overall Study|Lack of Efficacy|2|||
124791421|NCT01606878|448865904|FG004|Overall Study|Lack of Efficacy|1|||
124791422|NCT01606878|448865905|FG005|Overall Study|Lack of Efficacy|2|||
124791423|NCT01606878|448865906|FG006|Overall Study|Lack of Efficacy|1|||
124791424|NCT01606878|448865907|FG007|Overall Study|Lack of Efficacy|2|||
124791425|NCT01606878|448865908|FG008|Overall Study|Lack of Efficacy|2|||
124791426|NCT01606878|448865909|FG009|Overall Study|Lack of Efficacy|0|||
124791427|NCT01606878|448865910|FG010|Overall Study|Lack of Efficacy|1|||
124791428|NCT01606878|448865900|FG000|Overall Study|Physician Decision|1|||
124791429|NCT01606878|448865901|FG001|Overall Study|Physician Decision|0|||
124791430|NCT01606878|448865902|FG002|Overall Study|Physician Decision|2|||
124791431|NCT01606878|448865903|FG003|Overall Study|Physician Decision|1|||
124791432|NCT01606878|448865904|FG004|Overall Study|Physician Decision|1|||
124791433|NCT01606878|448865905|FG005|Overall Study|Physician Decision|1|||
124791434|NCT01606878|448865906|FG006|Overall Study|Physician Decision|2|||
124791435|NCT01606878|448865907|FG007|Overall Study|Physician Decision|0|||
124791436|NCT01606878|448865908|FG008|Overall Study|Physician Decision|1|||
124791437|NCT01606878|448865909|FG009|Overall Study|Physician Decision|0|||
124791438|NCT01606878|448865910|FG010|Overall Study|Physician Decision|0|||
124791439|NCT01606878|448865900|FG000|Overall Study|Withdrawal by Subject|3|||
124791440|NCT01606878|448865901|FG001|Overall Study|Withdrawal by Subject|2|||
124791441|NCT01606878|448865902|FG002|Overall Study|Withdrawal by Subject|2|||
124791442|NCT01606878|448865903|FG003|Overall Study|Withdrawal by Subject|0|||
124791443|NCT01606878|448865904|FG004|Overall Study|Withdrawal by Subject|1|||
124791444|NCT01606878|448865905|FG005|Overall Study|Withdrawal by Subject|1|||
124791445|NCT01606878|448865906|FG006|Overall Study|Withdrawal by Subject|2|||
124791446|NCT01606878|448865907|FG007|Overall Study|Withdrawal by Subject|1|||
124791447|NCT01606878|448865908|FG008|Overall Study|Withdrawal by Subject|2|||
124791448|NCT01606878|448865909|FG009|Overall Study|Withdrawal by Subject|0|||
124791449|NCT01606878|448865910|FG010|Overall Study|Withdrawal by Subject|2|||
124791450|NCT03473548|448865911|FG000|Overall Study|Did not attempt HST testing|3|||
124791451|NCT03473548|448865912|FG001|Overall Study|Did not attempt HST testing|0|||
124791452|NCT00129311|448865913|FG000|Overall Study|Withdrawal by Subject|12|||
124791453|NCT00129311|448865914|FG001|Overall Study|Withdrawal by Subject|19|||
124791454|NCT01340872|448867415|FG000|Double-blind Phase|Adverse Event|6|||
124791455|NCT01340872|448867416|FG001|Double-blind Phase|Adverse Event|4|||
124791456|NCT01340872|448867417|FG002|Double-blind Phase|Adverse Event|0|||
124791457|NCT01340872|448867418|FG003|Double-blind Phase|Adverse Event|0|||
124791458|NCT01340872|448867415|FG000|Double-blind Phase|Withdrawal by Subject|3|||
124791459|NCT01340872|448867416|FG001|Double-blind Phase|Withdrawal by Subject|5|||
124791460|NCT01340872|448867417|FG002|Double-blind Phase|Withdrawal by Subject|0|||
124791461|NCT01340872|448867418|FG003|Double-blind Phase|Withdrawal by Subject|0|||
124791462|NCT01340872|448867415|FG000|Double-blind Phase|Lost to Follow-up|0|||
124791463|NCT01340872|448867416|FG001|Double-blind Phase|Lost to Follow-up|1|||
124791464|NCT01340872|448867417|FG002|Double-blind Phase|Lost to Follow-up|0|||
124791465|NCT01340872|448867418|FG003|Double-blind Phase|Lost to Follow-up|0|||
124791466|NCT01340872|448867415|FG000|Double-blind Phase|Protocol Violation|0|||
124791467|NCT01340872|448867416|FG001|Double-blind Phase|Protocol Violation|1|||
124791468|NCT01340872|448867417|FG002|Double-blind Phase|Protocol Violation|0|||
124791469|NCT01340872|448867418|FG003|Double-blind Phase|Protocol Violation|0|||
124791470|NCT01340872|448867415|FG000|Open-label Phase|Physician Decision|0|||
124791471|NCT01340872|448867416|FG001|Open-label Phase|Physician Decision|0|||
124791472|NCT01340872|448867417|FG002|Open-label Phase|Physician Decision|2|||
124791473|NCT01340872|448867418|FG003|Open-label Phase|Physician Decision|1|||
124791474|NCT01340872|448867415|FG000|Open-label Phase|Pregnancy|0|||
124791475|NCT01340872|448867416|FG001|Open-label Phase|Pregnancy|0|||
124791476|NCT01340872|448867417|FG002|Open-label Phase|Pregnancy|1|||
124791477|NCT01340872|448867418|FG003|Open-label Phase|Pregnancy|0|||
124791478|NCT01340872|448867415|FG000|Open-label Phase|Adverse Event|0|||
124791479|NCT01340872|448867416|FG001|Open-label Phase|Adverse Event|0|||
124791480|NCT01340872|448867417|FG002|Open-label Phase|Adverse Event|8|||
124791481|NCT01340872|448867418|FG003|Open-label Phase|Adverse Event|4|||
124791482|NCT01340872|448867415|FG000|Open-label Phase|Withdrawal by Subject|0|||
124791483|NCT01340872|448867416|FG001|Open-label Phase|Withdrawal by Subject|0|||
124791484|NCT01340872|448867417|FG002|Open-label Phase|Withdrawal by Subject|1|||
124791485|NCT01340872|448867418|FG003|Open-label Phase|Withdrawal by Subject|6|||
124791486|NCT01340872|448867415|FG000|Open-label Phase|Worsening of IBD|0|||
124791487|NCT01340872|448867416|FG001|Open-label Phase|Worsening of IBD|0|||
124791488|NCT01340872|448867417|FG002|Open-label Phase|Worsening of IBD|1|||
124791489|NCT01340872|448867418|FG003|Open-label Phase|Worsening of IBD|0|||
124791490|NCT03603509|448867419|FG000|Overall Study|Lost to Follow-up|3|||
124791491|NCT03603509|448867420|FG001|Overall Study|Lost to Follow-up|4|||
124791492|NCT01258998|448867423|FG000|Overall Study|Ineligible|1|||
124791493|NCT01143389|448867426|FG000|Overall Study|Lost to Follow-up|26|||
124791494|NCT01143389|448867427|FG001|Overall Study|Lost to Follow-up|25|||
124791495|NCT04966910|448867428|FG000|Baseline|Participant did not complete measure|0|||
124791496|NCT04966910|448867429|FG001|Baseline|Participant did not complete measure|0|||
124791497|NCT04966910|448867430|FG002|Baseline|Participant did not complete measure|1|||
124791498|NCT04966910|448867431|FG003|Baseline|Participant did not complete measure|0|||
124791499|NCT04966910|448867428|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
124791500|NCT04966910|448867429|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
124791501|NCT04966910|448867430|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
124791502|NCT04966910|448867431|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
124791503|NCT04966910|448867428|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
124791504|NCT04966910|448867429|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
124791505|NCT04966910|448867430|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
124791506|NCT04966910|448867431|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
124791507|NCT04966910|448867428|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
124791508|NCT04966910|448867429|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
124791509|NCT04966910|448867430|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
124791510|NCT04966910|448867431|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
124791511|NCT02276027|448867433|FG000|Overall Study|Death|1|||
124791512|NCT02276027|448867434|FG001|Overall Study|Death|0|||
124791513|NCT02276027|448867435|FG002|Overall Study|Death|0|||
124791514|NCT02276027|448867436|FG003|Overall Study|Death|2|||
124791515|NCT02276027|448867433|FG000|Overall Study|Physician Decision|0|||
124791516|NCT02276027|448867434|FG001|Overall Study|Physician Decision|0|||
124791517|NCT02276027|448867435|FG002|Overall Study|Physician Decision|0|||
124791518|NCT02276027|448867436|FG003|Overall Study|Physician Decision|1|||
124791519|NCT02276027|448867433|FG000|Overall Study|Progressive disease|1|||
124791520|NCT02276027|448867434|FG001|Overall Study|Progressive disease|13|||
124791521|NCT02276027|448867435|FG002|Overall Study|Progressive disease|12|||
124791522|NCT02276027|448867436|FG003|Overall Study|Progressive disease|14|||
124791523|NCT02276027|448867433|FG000|Overall Study|Subject/guardian decision|0|||
124791524|NCT02276027|448867434|FG001|Overall Study|Subject/guardian decision|1|||
124791525|NCT02276027|448867435|FG002|Overall Study|Subject/guardian decision|0|||
124791526|NCT02276027|448867436|FG003|Overall Study|Subject/guardian decision|3|||
124791527|NCT02276027|448867433|FG000|Overall Study|Adverse Event|0|||
124791528|NCT02276027|448867434|FG001|Overall Study|Adverse Event|2|||
124791529|NCT02276027|448867435|FG002|Overall Study|Adverse Event|8|||
124791530|NCT02276027|448867436|FG003|Overall Study|Adverse Event|2|||
124791531|NCT03224598|448867437|FG000|Overall Study|Lost to Follow-up|0|||
124791532|NCT03224598|448867438|FG001|Overall Study|Lost to Follow-up|2|||
124791533|NCT03224598|448867439|FG002|Overall Study|Lost to Follow-up|0|||
124791534|NCT03224598|448867437|FG000|Overall Study|Other|0|||
124791535|NCT03224598|448867438|FG001|Overall Study|Other|1|||
124791536|NCT03224598|448867439|FG002|Overall Study|Other|0|||
124791537|NCT01527357|448867449|FG000|Overall Study|Death|8|||
124791538|NCT01527357|448867450|FG001|Overall Study|Death|2|||
124791539|NCT01527357|448867449|FG000|Overall Study|Lost to Follow-up|6|||
124791540|NCT01527357|448867450|FG001|Overall Study|Lost to Follow-up|4|||
124791541|NCT01527357|448867449|FG000|Overall Study|Withdrew Consent|1|||
124791542|NCT01527357|448867450|FG001|Overall Study|Withdrew Consent|1|||
124791543|NCT01527357|448867449|FG000|Overall Study|Non-compliance|0|||
124791544|NCT01527357|448867450|FG001|Overall Study|Non-compliance|1|||
124791545|NCT01527357|448867449|FG000|Overall Study|No Day 29 Visit|0|||
124791546|NCT01527357|448867450|FG001|Overall Study|No Day 29 Visit|1|||
124791547|NCT01527357|448867449|FG000|Overall Study|Did Not Receive Treatment|2|||
124791548|NCT01527357|448867450|FG001|Overall Study|Did Not Receive Treatment|0|||
124791549|NCT02446171|448867451|FG000|Overall Study|Withdrawal by Subject|0|||
124791550|NCT02446171|448867452|FG001|Overall Study|Withdrawal by Subject|0|||
124791551|NCT02446171|448867453|FG002|Overall Study|Withdrawal by Subject|2|||
124791552|NCT02446171|448867454|FG003|Overall Study|Withdrawal by Subject|0|||
124791553|NCT04531462|448867455|FG000|Overall Study|Withdrawal by Subject|3|||
124791554|NCT04531462|448867456|FG001|Overall Study|Withdrawal by Subject|1|||
124791555|NCT04531462|448867455|FG000|Overall Study|Adverse Event|3|||
124791556|NCT04531462|448867456|FG001|Overall Study|Adverse Event|3|||
124791557|NCT00504582|448867457|FG000|Overall Study|Lost to Follow-up|1|||
124791558|NCT00504582|448867458|FG001|Overall Study|Lost to Follow-up|0|||
124791559|NCT00504582|448867459|FG002|Overall Study|Lost to Follow-up|0|||
124791560|NCT02292784|448867462|FG000|Overall Study|Lost to Follow-up|1|||
124791561|NCT02292784|448867463|FG001|Overall Study|Lost to Follow-up|17|||
124791562|NCT02292784|448867464|FG002|Overall Study|Lost to Follow-up|18|||
124791563|NCT02292784|448867462|FG000|Overall Study|Withdrawal by Subject|0|||
124791564|NCT02292784|448867463|FG001|Overall Study|Withdrawal by Subject|3|||
124791565|NCT02292784|448867464|FG002|Overall Study|Withdrawal by Subject|3|||
124791566|NCT00348933|448867465|FG000|Overall Study|Withdrawal by Subject|10|||
124791567|NCT00348933|448867465|FG000|Overall Study|Lost to Follow-up|6|||
124791568|NCT00348933|448867465|FG000|Overall Study|Protocol Violation|2|||
124791569|NCT00348933|448867465|FG000|Overall Study|Adverse Event|7|||
124791570|NCT01264081|448867466|FG000|Participants Screened|Screening failures|30|||
124791571|NCT01264081|448867466|FG000|Started Treatment|Withdrawal by Subject|1|||
124791572|NCT01264081|448867466|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
124791573|NCT01489111|448867467|FG000|Overall Study|Withdrawal criterion|1|||
124791574|NCT00134784|448867468|FG000|Overall Study|Withdrawal by Subject|2|||
124791575|NCT00134784|448867469|FG001|Overall Study|Withdrawal by Subject|2|||
124791576|NCT00134784|448867470|FG002|Overall Study|Withdrawal by Subject|2|||
124791577|NCT00134784|448867471|FG003|Overall Study|Withdrawal by Subject|1|||
124791578|NCT00730028|448867476|FG000|Overall Study|Adverse Event|23|||
124791579|NCT00730028|448867477|FG001|Overall Study|Adverse Event|26|||
124791580|NCT00730028|448867478|FG002|Overall Study|Adverse Event|16|||
124791581|NCT00730028|448867479|FG003|Overall Study|Adverse Event|20|||
124791582|NCT00730028|448867480|FG004|Overall Study|Adverse Event|43|||
124791583|NCT00730028|448867476|FG000|Overall Study|Lost to Follow-up|13|||
124791584|NCT00730028|448867477|FG001|Overall Study|Lost to Follow-up|26|||
124791585|NCT00730028|448867478|FG002|Overall Study|Lost to Follow-up|22|||
124791586|NCT00730028|448867479|FG003|Overall Study|Lost to Follow-up|26|||
124791587|NCT00730028|448867480|FG004|Overall Study|Lost to Follow-up|25|||
124791588|NCT00730028|448867476|FG000|Overall Study|Protocol Violation|6|||
124791589|NCT00730028|448867477|FG001|Overall Study|Protocol Violation|1|||
124791590|NCT00730028|448867478|FG002|Overall Study|Protocol Violation|1|||
124791591|NCT00730028|448867479|FG003|Overall Study|Protocol Violation|2|||
124791592|NCT00730028|448867480|FG004|Overall Study|Protocol Violation|0|||
124791593|NCT00730028|448867476|FG000|Overall Study|Withdrawal by Subject|9|||
124791594|NCT00730028|448867477|FG001|Overall Study|Withdrawal by Subject|5|||
124791595|NCT00730028|448867478|FG002|Overall Study|Withdrawal by Subject|4|||
124791596|NCT00730028|448867479|FG003|Overall Study|Withdrawal by Subject|5|||
124791597|NCT00730028|448867480|FG004|Overall Study|Withdrawal by Subject|9|||
124791598|NCT00730028|448867476|FG000|Overall Study|Physician Decision|3|||
124791599|NCT00730028|448867477|FG001|Overall Study|Physician Decision|3|||
124791600|NCT00730028|448867478|FG002|Overall Study|Physician Decision|2|||
124791601|NCT00730028|448867479|FG003|Overall Study|Physician Decision|3|||
124791602|NCT00730028|448867480|FG004|Overall Study|Physician Decision|2|||
124791603|NCT00730028|448867476|FG000|Overall Study|Treatment Failure|5|||
124629497|NCT01147068|448261096|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
124629498|NCT01147068|448261097|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
124629499|NCT01147068|448261098|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
124791604|NCT00730028|448867477|FG001|Overall Study|Treatment Failure|5|||
124791605|NCT00730028|448867478|FG002|Overall Study|Treatment Failure|0|||
124791606|NCT00730028|448867479|FG003|Overall Study|Treatment Failure|0|||
124791607|NCT00730028|448867480|FG004|Overall Study|Treatment Failure|1|||
124791608|NCT00730028|448867476|FG000|Overall Study|Randomization Error|1|||
124791609|NCT00730028|448867477|FG001|Overall Study|Randomization Error|0|||
124791610|NCT00730028|448867478|FG002|Overall Study|Randomization Error|0|||
124791611|NCT00730028|448867479|FG003|Overall Study|Randomization Error|0|||
124791612|NCT00730028|448867480|FG004|Overall Study|Randomization Error|2|||
124791613|NCT03811093|448867481|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
124791614|NCT03811093|448867482|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
124791615|NCT03811093|448867481|FG000|Overall Study|Unable to measure body fat percentage|2|||
124791616|NCT03811093|448867482|FG001|Overall Study|Unable to measure body fat percentage|0|||
124791617|NCT00464490|448867483|FG000|Overall Study|Physician Decision|11|||
124791618|NCT00464490|448867484|FG001|Overall Study|Physician Decision|11|||
124791619|NCT03188042|448867485|FG000|Overall Study|Withdrawal by Subject|1|||
124791620|NCT03188042|448867486|FG001|Overall Study|Withdrawal by Subject|1|||
124791621|NCT03565367|448867490|FG000|Overall Study|No scan due to technical issues|4|||
124791622|NCT03565367|448867491|FG001|Overall Study|No scan due to technical issues|0|||
124791623|NCT01227824|448867494|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
124791624|NCT01227824|448867495|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
124791625|NCT01227824|448867496|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
124791626|NCT01227824|448867494|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
124791627|NCT01227824|448867495|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
124791628|NCT01227824|448867496|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
124791629|NCT01227824|448867494|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
124791630|NCT01227824|448867495|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
124791631|NCT01227824|448867496|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
124791632|NCT01227824|448867494|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
124791633|NCT01227824|448867495|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
124791634|NCT01227824|448867496|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
124791635|NCT01227824|448867494|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
124791636|NCT01227824|448867495|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
124791637|NCT01227824|448867496|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
124791638|NCT01227824|448867494|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
124791639|NCT01227824|448867495|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
124791640|NCT01227824|448867496|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
124791641|NCT01227824|448867494|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
124791642|NCT01227824|448867495|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
124791643|NCT01227824|448867496|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
124791644|NCT01227824|448867494|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
124791645|NCT01227824|448867495|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
124791646|NCT01227824|448867496|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
124791647|NCT01227824|448867494|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
124791648|NCT01227824|448867495|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
124791649|NCT01227824|448867496|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
124791650|NCT01227824|448867494|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
124791651|NCT01227824|448867495|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
124791652|NCT01227824|448867496|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
124791653|NCT01227824|448867494|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
124791654|NCT01227824|448867495|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
124791655|NCT01227824|448867496|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
124791656|NCT01227824|448867494|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
124791657|NCT01227824|448867495|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
124791658|NCT01227824|448867496|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
124791659|NCT01227824|448867494|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
124791660|NCT01227824|448867495|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
124791661|NCT01227824|448867496|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
124791662|NCT01227824|448867494|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
124791663|NCT01227824|448867495|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
124791664|NCT01227824|448867496|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
124791665|NCT01227824|448867494|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
124791666|NCT01227824|448867495|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
124791667|NCT01227824|448867496|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
124791668|NCT02395302|448867499|FG000|Overall Study|Screen Failure|3|||
124791669|NCT02395302|448867499|FG000|Overall Study|Run In Failure|7|||
124791670|NCT02395302|448867499|FG000|Overall Study|Withdrawal by Subject|2|||
124791671|NCT02395302|448867499|FG000|Overall Study|Physician Decision|2|||
124791672|NCT01306929|448867500|FG000|Overall Study|Withdrawal by Subject|23|||
124791673|NCT01306929|448867500|FG000|Overall Study|Adverse Event|21|||
124791674|NCT01306929|448867500|FG000|Overall Study|Physician Decision|13|||
124791675|NCT01306929|448867500|FG000|Overall Study|Death|8|||
124791676|NCT01306929|448867500|FG000|Overall Study|Withdrawal by parent/guardian|5|||
124791677|NCT01306929|448867500|FG000|Overall Study|Protocol Violation|3|||
124791678|NCT01306929|448867500|FG000|Overall Study|Non-compliance with study drug|2|||
124791679|NCT01306929|448867500|FG000|Overall Study|Lost to Follow-up|2|||
124791680|NCT01306929|448867500|FG000|Overall Study|Various|17|||
124791681|NCT00710762|448867503|FG000|Overall Study|Progressive disease|27|||
124791682|NCT00710762|448867504|FG001|Overall Study|Progressive disease|30|||
124791683|NCT00710762|448867503|FG000|Overall Study|Adverse Event other disease worsening|2|||
124791684|NCT00710762|448867504|FG001|Overall Study|Adverse Event other disease worsening|1|||
124791685|NCT00710762|448867503|FG000|Overall Study|Other Adverse Event|7|||
124791686|NCT00710762|448867504|FG001|Overall Study|Other Adverse Event|7|||
124791687|NCT00710762|448867503|FG000|Overall Study|Lost to Follow-up|1|||
124791688|NCT00710762|448867504|FG001|Overall Study|Lost to Follow-up|0|||
124791689|NCT00710762|448867503|FG000|Overall Study|Reason other than listed above|2|||
124791690|NCT00710762|448867504|FG001|Overall Study|Reason other than listed above|2|||
124791691|NCT00495040|448867505|FG000|Overall Study|Withdrawal by Subject|3|||
124791692|NCT01892384|448867509|FG000|Overall Study|Withdrawal by Subject|1|||
124791693|NCT01892384|448867510|FG001|Overall Study|Withdrawal by Subject|1|||
124791694|NCT01892384|448867511|FG002|Overall Study|Withdrawal by Subject|0|||
124791695|NCT01892384|448867512|FG003|Overall Study|Withdrawal by Subject|0|||
124791696|NCT00592774|448867513|FG000|Overall Study|Adverse Event|5|||
124791697|NCT00592774|448867514|FG001|Overall Study|Adverse Event|19|||
124791698|NCT00592774|448867515|FG002|Overall Study|Adverse Event|2|||
124791699|NCT00592774|448867516|FG003|Overall Study|Adverse Event|14|||
124791700|NCT00592774|448867517|FG004|Overall Study|Adverse Event|8|||
124791701|NCT00592774|448867513|FG000|Overall Study|Protocol Violation|0|||
124791702|NCT00592774|448867514|FG001|Overall Study|Protocol Violation|1|||
124791703|NCT00592774|448867515|FG002|Overall Study|Protocol Violation|0|||
124791704|NCT00592774|448867516|FG003|Overall Study|Protocol Violation|0|||
124791705|NCT00592774|448867517|FG004|Overall Study|Protocol Violation|1|||
124791706|NCT00592774|448867513|FG000|Overall Study|Withdrawal by Subject|3|||
124791707|NCT00592774|448867514|FG001|Overall Study|Withdrawal by Subject|7|||
124791708|NCT00592774|448867515|FG002|Overall Study|Withdrawal by Subject|0|||
124791709|NCT00592774|448867516|FG003|Overall Study|Withdrawal by Subject|0|||
124791710|NCT00592774|448867517|FG004|Overall Study|Withdrawal by Subject|0|||
124791711|NCT00592774|448867513|FG000|Overall Study|Lack of Efficacy|3|||
124791712|NCT00592774|448867514|FG001|Overall Study|Lack of Efficacy|3|||
124791713|NCT00592774|448867515|FG002|Overall Study|Lack of Efficacy|0|||
124791714|NCT00592774|448867516|FG003|Overall Study|Lack of Efficacy|0|||
124791715|NCT00592774|448867517|FG004|Overall Study|Lack of Efficacy|2|||
124791716|NCT00592774|448867513|FG000|Overall Study|Physician Decision|0|||
124791717|NCT00592774|448867514|FG001|Overall Study|Physician Decision|1|||
124791718|NCT00592774|448867515|FG002|Overall Study|Physician Decision|1|||
124791719|NCT00592774|448867516|FG003|Overall Study|Physician Decision|0|||
124791720|NCT00592774|448867517|FG004|Overall Study|Physician Decision|1|||
124791721|NCT00592774|448867513|FG000|Overall Study|Other|0|||
124791722|NCT00592774|448867514|FG001|Overall Study|Other|1|||
124791723|NCT00592774|448867515|FG002|Overall Study|Other|1|||
124791724|NCT00592774|448867516|FG003|Overall Study|Other|0|||
124791725|NCT00592774|448867517|FG004|Overall Study|Other|2|||
124791726|NCT01700439|448867518|FG000|Overall Study|Lost to Follow-up|47|||
124791727|NCT01700439|448867518|FG000|Overall Study|Withdrawal by Subject|183|||
124791728|NCT01700439|448867518|FG000|Overall Study|Death|186|||
124791729|NCT00621621|448867523|FG000|Overall Study|Subjects were exited at EP study|30|||
124791730|NCT00621621|448867524|FG001|Overall Study|Subjects were exited at EP study|0|||
124791731|NCT00608569|448867530|FG000|Overall Study|Death|4|||
124791732|NCT00608569|448867531|FG001|Overall Study|Death|3|||
124791733|NCT00608569|448867530|FG000|Overall Study|Lost to Follow-up|4|||
124791734|NCT00608569|448867531|FG001|Overall Study|Lost to Follow-up|5|||
124791735|NCT00608569|448867530|FG000|Overall Study|Withdrawal by Subject|1|||
124791736|NCT00608569|448867531|FG001|Overall Study|Withdrawal by Subject|0|||
124791737|NCT00608569|448867530|FG000|Overall Study|Adverse Event|1|||
124791738|NCT00608569|448867531|FG001|Overall Study|Adverse Event|0|||
124791739|NCT00608569|448867530|FG000|Overall Study|Unable to adhere with study requirements|0|||
124791740|NCT00608569|448867531|FG001|Overall Study|Unable to adhere with study requirements|1|||
124791741|NCT00053898|448867538|FG000|Overall Study|No follow-up data from any source|9|||
124791742|NCT00053898|448867539|FG001|Overall Study|No follow-up data from any source|12|||
124791743|NCT00053898|448867538|FG000|Overall Study|Follow-up from telephone contact only|5|||
124791744|NCT00053898|448867539|FG001|Overall Study|Follow-up from telephone contact only|1|||
124791745|NCT00545129|448867542|FG000|Overall Study|Lack of Efficacy|2|||
124791746|NCT00545129|448867543|FG001|Overall Study|Lack of Efficacy|5|||
124791747|NCT00545129|448867542|FG000|Overall Study|Death|2|||
124791748|NCT00545129|448867543|FG001|Overall Study|Death|1|||
124791749|NCT00545129|448867542|FG000|Overall Study|Adverse Event|1|||
124791750|NCT00545129|448867543|FG001|Overall Study|Adverse Event|1|||
124791751|NCT00545129|448867542|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
124791752|NCT00545129|448867543|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
124791753|NCT00545129|448867542|FG000|Overall Study|Other|3|||
124791754|NCT00545129|448867543|FG001|Overall Study|Other|3|||
124791755|NCT01894568|448867544|FG000|Overall Study|Adverse Event|2|||
124791756|NCT01894568|448867545|FG001|Overall Study|Adverse Event|3|||
124791757|NCT01894568|448867544|FG000|Overall Study|Protocol required discontinuation|2|||
124791758|NCT01894568|448867545|FG001|Overall Study|Protocol required discontinuation|1|||
124791759|NCT01894568|448867544|FG000|Overall Study|Withdrawal by Subject|5|||
124791760|NCT01894568|448867545|FG001|Overall Study|Withdrawal by Subject|5|||
124791761|NCT01894568|448867544|FG000|Overall Study|Physician Decision|1|||
124791762|NCT01894568|448867545|FG001|Overall Study|Physician Decision|0|||
124791763|NCT01894568|448867544|FG000|Overall Study|Lost to Follow-up|0|||
124791764|NCT01894568|448867545|FG001|Overall Study|Lost to Follow-up|1|||
124791765|NCT01514370|448867547|FG000|Overall Study|Protocol Violation|2|||
124791766|NCT01514370|448867548|FG001|Overall Study|Protocol Violation|3|||
124791767|NCT01514370|448867547|FG000|Overall Study|Lost to Follow-up|0|||
124791768|NCT01514370|448867548|FG001|Overall Study|Lost to Follow-up|2|||
124791769|NCT01514370|448867547|FG000|Overall Study|Withdrawal by Subject|2|||
124791770|NCT01514370|448867548|FG001|Overall Study|Withdrawal by Subject|1|||
124791771|NCT01514370|448867547|FG000|Overall Study|Adverse Event|1|||
124791772|NCT01514370|448867548|FG001|Overall Study|Adverse Event|3|||
124791773|NCT01514370|448867547|FG000|Overall Study|Other|6|||
124791774|NCT01514370|448867548|FG001|Overall Study|Other|7|||
124791775|NCT01551420|448867549|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
124791776|NCT01551420|448867550|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
124791777|NCT01551420|448867549|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
124791778|NCT01551420|448867550|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
124791779|NCT01551420|448867549|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
124791780|NCT01551420|448867550|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
124791781|NCT01551420|448867549|FG000|Screened for Part B Eligibility|Declined participation|8|||
124791782|NCT01551420|448867550|FG001|Screened for Part B Eligibility|Declined participation|1|||
124791783|NCT01551420|448867549|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
124791784|NCT01551420|448867550|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
124791785|NCT01551420|448867549|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
124791786|NCT01551420|448867550|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
124791787|NCT01551420|448867549|FG000|Home Use (Part B)|Withdrawal by staff|0|||
124791788|NCT01551420|448867550|FG001|Home Use (Part B)|Withdrawal by staff|1|||
124791789|NCT03353740|448867552|FG000|Overall Study|Images for these participants not viable|52|||
124791790|NCT02232880|448867553|FG000|Overall Study|study stopped prior to randomization|1|||
124791791|NCT02545543|448867554|FG000|Overall Study|Lost to Follow-up|67|||
124791792|NCT02545543|448867555|FG001|Overall Study|Lost to Follow-up|25|||
124791793|NCT02545543|448867554|FG000|Overall Study|Physician Decision|3|||
124791794|NCT02545543|448867555|FG001|Overall Study|Physician Decision|0|||
124791795|NCT02545543|448867554|FG000|Overall Study|Withdrawal by Subject|9|||
124791796|NCT02545543|448867555|FG001|Overall Study|Withdrawal by Subject|8|||
124791797|NCT02545543|448867554|FG000|Overall Study|Noncomplaince|1|||
124791798|NCT02545543|448867555|FG001|Overall Study|Noncomplaince|0|||
124791799|NCT02545543|448867554|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
124791800|NCT02545543|448867555|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
124791801|NCT01395784|448867556|FG000|Overall Study|Lost to Follow-up|7|||
124791802|NCT01395784|448867556|FG000|Overall Study|Withdrawal by Subject|3|||
124791803|NCT01395784|448867556|FG000|Overall Study|Physician Decision|5|||
124791804|NCT04268823|448867557|FG000|Overall Study|Adverse Event|1|||
124791805|NCT04268823|448867558|FG001|Overall Study|Adverse Event|0|||
124791806|NCT04268823|448867557|FG000|Overall Study|Participant Decision|1|||
124791807|NCT04268823|448867558|FG001|Overall Study|Participant Decision|0|||
124791808|NCT02055365|448869474|FG000|Overall Study|Prematurely Withdrawn|1|||
124791809|NCT02882152|448869475|FG000|Overall Study|Lost to Follow-up|1|||
124791810|NCT02882152|448869476|FG001|Overall Study|Lost to Follow-up|0|||
124791811|NCT01343823|448869479|FG000|Overall Study|Study Terminated|1|||
124791812|NCT01343823|448869480|FG001|Overall Study|Study Terminated|0|||
124791813|NCT01343823|448869481|FG002|Overall Study|Study Terminated|0|||
124791814|NCT01343823|448869482|FG003|Overall Study|Study Terminated|1|||
124791815|NCT01343823|448869479|FG000|Overall Study|Withdrawal by Subject|1|||
124791816|NCT01343823|448869480|FG001|Overall Study|Withdrawal by Subject|0|||
124791817|NCT01343823|448869481|FG002|Overall Study|Withdrawal by Subject|0|||
124791818|NCT01343823|448869482|FG003|Overall Study|Withdrawal by Subject|0|||
124791819|NCT00923364|448869483|FG000|Overall Study|Death|3|||
124791820|NCT00923364|448869484|FG001|Overall Study|Death|0|||
124791821|NCT00923364|448869483|FG000|Overall Study|Did not go to transplant|1|||
124791822|NCT00923364|448869484|FG001|Overall Study|Did not go to transplant|0|||
124791823|NCT01752036|448869485|FG000|Overall Study|Death|2|||
124791824|NCT04352127|448869486|FG000|Overall Study|Unable to obtain readings|4|||
124791825|NCT04352127|448869487|FG001|Overall Study|Unable to obtain readings|1|||
124791826|NCT01437995|448869488|FG000|Overall Study|Lost to Follow-up|11|||
124791827|NCT01437995|448869489|FG001|Overall Study|Lost to Follow-up|18|||
124791828|NCT01437995|448869490|FG002|Overall Study|Lost to Follow-up|20|||
124791829|NCT05338671|448869491|FG000|Overall Study|Lost to Follow-up|2|||
124791830|NCT05338671|448869492|FG001|Overall Study|Lost to Follow-up|2|||
124791831|NCT05338671|448869491|FG000|Overall Study|Root canal completed in a single visit|1|||
124791832|NCT05338671|448869492|FG001|Overall Study|Root canal completed in a single visit|0|||
124791833|NCT04456673|448869493|FG000|Overall Study|Adverse Event|7|||
124791834|NCT04456673|448869494|FG001|Overall Study|Adverse Event|14|||
124791835|NCT04456673|448869493|FG000|Overall Study|Poor compliance to protocol|1|||
124791836|NCT04456673|448869494|FG001|Overall Study|Poor compliance to protocol|0|||
124791837|NCT04456673|448869493|FG000|Overall Study|Withdrawal by Subject|31|||
124791838|NCT04456673|448869494|FG001|Overall Study|Withdrawal by Subject|23|||
124791839|NCT04456673|448869493|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
124791840|NCT04456673|448869494|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
124791841|NCT04391049|448869495|FG000|Overall Study|Protocol Violation|1|||
124791842|NCT03874429|448869496|FG000|Overall Study|Adverse Event|2|||
124791843|NCT03874429|448869497|FG001|Overall Study|Adverse Event|2|||
124791844|NCT03874429|448869496|FG000|Overall Study|Lack of Efficacy|0|||
124791845|NCT03874429|448869497|FG001|Overall Study|Lack of Efficacy|1|||
124791846|NCT03874429|448869496|FG000|Overall Study|Covid-19 pandemic|4|||
124791847|NCT03874429|448869497|FG001|Overall Study|Covid-19 pandemic|2|||
124791848|NCT02160002|448869498|FG000|Overall Study|Withdrawal by Subject|2|||
124791849|NCT02160002|448869499|FG001|Overall Study|Withdrawal by Subject|1|||
124791850|NCT00246571|448869500|FG000|Overall Study|Adverse Event|7|||
124791851|NCT00246571|448869501|FG001|Overall Study|Adverse Event|0|||
124791852|NCT00246571|448869500|FG000|Overall Study|Protocol Violation|0|||
124791853|NCT00246571|448869501|FG001|Overall Study|Protocol Violation|1|||
124791854|NCT00246571|448869500|FG000|Overall Study|Withdrawal by Subject|2|||
124791855|NCT00246571|448869501|FG001|Overall Study|Withdrawal by Subject|3|||
124791856|NCT00246571|448869500|FG000|Overall Study|Lack of Efficacy|84|||
124791857|NCT00246571|448869501|FG001|Overall Study|Lack of Efficacy|21|||
124791858|NCT00246571|448869500|FG000|Overall Study|Death|17|||
124791859|NCT00246571|448869501|FG001|Overall Study|Death|3|||
124791860|NCT00246571|448869500|FG000|Overall Study|Sponsor|0|||
124791861|NCT00246571|448869501|FG001|Overall Study|Sponsor|1|||
124791862|NCT00246571|448869500|FG000|Overall Study|Did not meet entrance criteria|2|||
124791863|NCT00246571|448869501|FG001|Overall Study|Did not meet entrance criteria|1|||
124791864|NCT00246571|448869500|FG000|Overall Study|Laboratory abnormalities|1|||
124791865|NCT00246571|448869501|FG001|Overall Study|Laboratory abnormalities|0|||
124791866|NCT00246571|448869500|FG000|Overall Study|Crossover participants|0|||
124791867|NCT00246571|448869501|FG001|Overall Study|Crossover participants|74|||
124791868|NCT04896229|448869502|FG000|Overall Study|Lost to Follow-up|113|||
124791869|NCT04896229|448869503|FG001|Overall Study|Lost to Follow-up|113|||
124791870|NCT00159822|448869506|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
124791871|NCT00159822|448869506|FG000|Voriconazole Treatment Period|Adverse Event|9|||
124791872|NCT00159822|448869506|FG000|Voriconazole Treatment Period|Death|4|||
124791873|NCT00159822|448869506|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
124791874|NCT00159822|448869506|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
124791875|NCT00159822|448869506|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
124791876|NCT00159822|448869506|FG000|Post-treatment Follow-up Period|Death|1|||
124791877|NCT00159822|448869506|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
124791878|NCT00159822|448869506|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
124791879|NCT00713310|448869507|FG000|Overall Study|Adverse Event|5|||
124791880|NCT00713310|448869508|FG001|Overall Study|Adverse Event|2|||
124791881|NCT00713310|448869507|FG000|Overall Study|Lack of Efficacy|0|||
124791882|NCT00713310|448869508|FG001|Overall Study|Lack of Efficacy|2|||
124791883|NCT00713310|448869507|FG000|Overall Study|Withdrawal by Subject|0|||
124791884|NCT00713310|448869508|FG001|Overall Study|Withdrawal by Subject|2|||
124791885|NCT00275821|448869510|FG000|Overall Study|Adverse Event|4|||
124791886|NCT00275821|448869511|FG001|Overall Study|Adverse Event|12|||
124791887|NCT00275821|448869512|FG002|Overall Study|Adverse Event|5|||
124791888|NCT00275821|448869510|FG000|Overall Study|Administrative problems|3|||
124791889|NCT00275821|448869511|FG001|Overall Study|Administrative problems|4|||
124791890|NCT00275821|448869512|FG002|Overall Study|Administrative problems|4|||
124791891|NCT00275821|448869510|FG000|Overall Study|Withdrawal by Subject|0|||
124791892|NCT00275821|448869511|FG001|Overall Study|Withdrawal by Subject|2|||
124791893|NCT00275821|448869512|FG002|Overall Study|Withdrawal by Subject|1|||
124791894|NCT00275821|448869510|FG000|Overall Study|Lost to Follow-up|0|||
124629500|NCT01147068|448261099|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
124629501|NCT01147068|448261100|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
124629502|NCT01147068|448261101|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
124629503|NCT01147068|448261095|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
124629504|NCT01147068|448261096|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
124629505|NCT01147068|448261097|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
124791895|NCT00275821|448869511|FG001|Overall Study|Lost to Follow-up|1|||
124791896|NCT00275821|448869512|FG002|Overall Study|Lost to Follow-up|1|||
124791897|NCT00275821|448869510|FG000|Overall Study|Death|0|||
124791898|NCT00275821|448869511|FG001|Overall Study|Death|2|||
124791899|NCT00275821|448869512|FG002|Overall Study|Death|1|||
124791900|NCT00275821|448869510|FG000|Overall Study|Lack of Efficacy|2|||
124791901|NCT00275821|448869511|FG001|Overall Study|Lack of Efficacy|1|||
124791902|NCT00275821|448869512|FG002|Overall Study|Lack of Efficacy|0|||
124791903|NCT00275821|448869510|FG000|Overall Study|Protocol Violation|5|||
124791904|NCT00275821|448869511|FG001|Overall Study|Protocol Violation|1|||
124791905|NCT00275821|448869512|FG002|Overall Study|Protocol Violation|0|||
124791906|NCT00329901|448869513|FG000|Overall Study|Withdrawal by Subject|4|||
124791907|NCT00329901|448869514|FG001|Overall Study|Withdrawal by Subject|3|||
124791908|NCT00329901|448869515|FG002|Overall Study|Withdrawal by Subject|2|||
124791909|NCT00329901|448869513|FG000|Overall Study|Lost to Follow-up|2|||
124791910|NCT00329901|448869514|FG001|Overall Study|Lost to Follow-up|0|||
124791911|NCT00329901|448869515|FG002|Overall Study|Lost to Follow-up|1|||
124791912|NCT00329901|448869513|FG000|Overall Study|Protocol Violation|1|||
124791913|NCT00329901|448869514|FG001|Overall Study|Protocol Violation|0|||
124791914|NCT00329901|448869515|FG002|Overall Study|Protocol Violation|1|||
124791915|NCT00329901|448869513|FG000|Overall Study|Unable to classify|2|||
124791916|NCT00329901|448869514|FG001|Overall Study|Unable to classify|2|||
124791917|NCT00329901|448869515|FG002|Overall Study|Unable to classify|0|||
124791918|NCT00992589|448869516|FG000|Open-Label Phase|Adverse Event|4|||
124791919|NCT00992589|448869517|FG001|Open-Label Phase|Adverse Event|0|||
124791920|NCT00992589|448869518|FG002|Open-Label Phase|Adverse Event|0|||
124791921|NCT00992589|448869519|FG003|Open-Label Phase|Adverse Event|0|||
124791922|NCT00992589|448869516|FG000|Open-Label Phase|Withdrawal by Subject|20|||
124791923|NCT00992589|448869517|FG001|Open-Label Phase|Withdrawal by Subject|0|||
124791924|NCT00992589|448869518|FG002|Open-Label Phase|Withdrawal by Subject|0|||
124791925|NCT00992589|448869519|FG003|Open-Label Phase|Withdrawal by Subject|0|||
124791926|NCT00992589|448869516|FG000|Open-Label Phase|Lost to Follow-up|1|||
124791927|NCT00992589|448869517|FG001|Open-Label Phase|Lost to Follow-up|0|||
124791928|NCT00992589|448869518|FG002|Open-Label Phase|Lost to Follow-up|0|||
124791929|NCT00992589|448869519|FG003|Open-Label Phase|Lost to Follow-up|0|||
124791930|NCT00992589|448869516|FG000|Open-Label Phase|Protocol Violation|3|||
124791931|NCT00992589|448869517|FG001|Open-Label Phase|Protocol Violation|0|||
124791932|NCT00992589|448869518|FG002|Open-Label Phase|Protocol Violation|0|||
124791933|NCT00992589|448869519|FG003|Open-Label Phase|Protocol Violation|0|||
124791934|NCT00992589|448869516|FG000|Open-Label Phase|Physician Decision|4|||
124791935|NCT00992589|448869517|FG001|Open-Label Phase|Physician Decision|0|||
124791936|NCT00992589|448869518|FG002|Open-Label Phase|Physician Decision|0|||
124791937|NCT00992589|448869519|FG003|Open-Label Phase|Physician Decision|0|||
124791938|NCT00992589|448869516|FG000|Open-Label Phase|Other|45|||
124791939|NCT00992589|448869517|FG001|Open-Label Phase|Other|0|||
124791940|NCT00992589|448869518|FG002|Open-Label Phase|Other|0|||
124791941|NCT00992589|448869519|FG003|Open-Label Phase|Other|0|||
124791942|NCT00992589|448869516|FG000|Double-Blind Phase|Adverse Event|0|||
124791943|NCT00992589|448869517|FG001|Double-Blind Phase|Adverse Event|6|||
124791944|NCT00992589|448869518|FG002|Double-Blind Phase|Adverse Event|2|||
124791945|NCT00992589|448869519|FG003|Double-Blind Phase|Adverse Event|3|||
124791946|NCT00992589|448869516|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
124791947|NCT00992589|448869517|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
124791948|NCT00992589|448869518|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
124791949|NCT00992589|448869519|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
124791950|NCT00992589|448869516|FG000|Double-Blind Phase|Lost to Follow-up|0|||
124791951|NCT00992589|448869517|FG001|Double-Blind Phase|Lost to Follow-up|0|||
124791952|NCT00992589|448869518|FG002|Double-Blind Phase|Lost to Follow-up|0|||
124791953|NCT00992589|448869519|FG003|Double-Blind Phase|Lost to Follow-up|2|||
124791954|NCT00992589|448869516|FG000|Double-Blind Phase|Other|0|||
124791955|NCT00992589|448869517|FG001|Double-Blind Phase|Other|1|||
124791956|NCT00992589|448869518|FG002|Double-Blind Phase|Other|6|||
124791957|NCT00992589|448869519|FG003|Double-Blind Phase|Other|3|||
124791958|NCT01215916|448869520|FG000|Overall Study|Progressive Disease|0|||
124791959|NCT01215916|448869521|FG001|Overall Study|Progressive Disease|2|||
124791960|NCT01215916|448869522|FG002|Overall Study|Progressive Disease|1|||
124791961|NCT01215916|448869523|FG003|Overall Study|Progressive Disease|2|||
124791962|NCT01215916|448869524|FG004|Overall Study|Progressive Disease|5|||
124791963|NCT01215916|448869525|FG005|Overall Study|Progressive Disease|4|||
124791964|NCT01215916|448869526|FG006|Overall Study|Progressive Disease|5|||
124629506|NCT01147068|448261098|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
124629507|NCT01147068|448261099|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
124629508|NCT01147068|448261100|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
124791965|NCT01215916|448869527|FG007|Overall Study|Progressive Disease|3|||
124791966|NCT01215916|448869528|FG008|Overall Study|Progressive Disease|1|||
124791967|NCT01215916|448869520|FG000|Overall Study|Adverse Event|1|||
124791968|NCT01215916|448869521|FG001|Overall Study|Adverse Event|1|||
124791969|NCT01215916|448869522|FG002|Overall Study|Adverse Event|0|||
124791970|NCT01215916|448869523|FG003|Overall Study|Adverse Event|1|||
124791971|NCT01215916|448869524|FG004|Overall Study|Adverse Event|0|||
124791972|NCT01215916|448869525|FG005|Overall Study|Adverse Event|0|||
124791973|NCT01215916|448869526|FG006|Overall Study|Adverse Event|3|||
124791974|NCT01215916|448869527|FG007|Overall Study|Adverse Event|0|||
124791975|NCT01215916|448869528|FG008|Overall Study|Adverse Event|0|||
124791976|NCT01215916|448869520|FG000|Overall Study|Withdrawal by Subject|0|||
124791977|NCT01215916|448869521|FG001|Overall Study|Withdrawal by Subject|1|||
124791978|NCT01215916|448869522|FG002|Overall Study|Withdrawal by Subject|1|||
124791979|NCT01215916|448869523|FG003|Overall Study|Withdrawal by Subject|2|||
124791980|NCT01215916|448869524|FG004|Overall Study|Withdrawal by Subject|0|||
124791981|NCT01215916|448869525|FG005|Overall Study|Withdrawal by Subject|0|||
124791982|NCT01215916|448869526|FG006|Overall Study|Withdrawal by Subject|1|||
124791983|NCT01215916|448869527|FG007|Overall Study|Withdrawal by Subject|0|||
124791984|NCT01215916|448869528|FG008|Overall Study|Withdrawal by Subject|0|||
124791985|NCT01215916|448869520|FG000|Overall Study|Death|0|||
124791986|NCT01215916|448869521|FG001|Overall Study|Death|1|||
124791987|NCT01215916|448869522|FG002|Overall Study|Death|0|||
124791988|NCT01215916|448869523|FG003|Overall Study|Death|0|||
124791989|NCT01215916|448869524|FG004|Overall Study|Death|1|||
124791990|NCT01215916|448869525|FG005|Overall Study|Death|0|||
124791991|NCT01215916|448869526|FG006|Overall Study|Death|0|||
124791992|NCT01215916|448869527|FG007|Overall Study|Death|0|||
124791993|NCT01215916|448869528|FG008|Overall Study|Death|1|||
124791994|NCT01215916|448869520|FG000|Overall Study|Physician Decision|0|||
124791995|NCT01215916|448869521|FG001|Overall Study|Physician Decision|0|||
124791996|NCT01215916|448869522|FG002|Overall Study|Physician Decision|1|||
124791997|NCT01215916|448869523|FG003|Overall Study|Physician Decision|1|||
124791998|NCT01215916|448869524|FG004|Overall Study|Physician Decision|0|||
124791999|NCT01215916|448869525|FG005|Overall Study|Physician Decision|0|||
124792000|NCT01215916|448869526|FG006|Overall Study|Physician Decision|0|||
124792001|NCT01215916|448869527|FG007|Overall Study|Physician Decision|0|||
124792002|NCT01215916|448869528|FG008|Overall Study|Physician Decision|0|||
124792003|NCT02142387|448869529|FG000|Overall Study|<19 years old|49|||
124792004|NCT02142387|448869530|FG001|Overall Study|<19 years old|326|||
124792005|NCT02142387|448869529|FG000|Overall Study|non-cardiac etiology|504|||
124792006|NCT02142387|448869530|FG001|Overall Study|non-cardiac etiology|3431|||
124792007|NCT02142387|448869529|FG000|Overall Study|CPR not performed|74|||
124792008|NCT02142387|448869530|FG001|Overall Study|CPR not performed|473|||
124792009|NCT02142387|448869529|FG000|Overall Study|witnessed by paramedic|139|||
124792010|NCT02142387|448869530|FG001|Overall Study|witnessed by paramedic|917|||
124792011|NCT02142387|448869529|FG000|Overall Study|incomplete data|1|||
124792012|NCT02142387|448869530|FG001|Overall Study|incomplete data|9|||
124792013|NCT02142387|448869529|FG000|Overall Study|occurred not at home|298|||
124792014|NCT02142387|448869530|FG001|Overall Study|occurred not at home|2474|||
124792015|NCT05028361|448869531|FG000|Overall Study|Withdrawal by Subject|1|||
124792016|NCT05028361|448869532|FG001|Overall Study|Withdrawal by Subject|0|||
124792017|NCT00779259|448869537|FG000|Quinine Alone|Adverse Event|2|||
124792018|NCT02047318|448869541|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
124792019|NCT02047318|448869541|FG000|Core Study Period|Adverse Event|1|||
124792020|NCT02047318|448869541|FG000|Core Study Period|Withdrawal by caregiver|3|||
124792021|NCT02047318|448869541|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
124792022|NCT02296138|448869542|FG000|Overall Study|Adverse Event|348|||
124792023|NCT02296138|448869543|FG001|Overall Study|Adverse Event|259|||
124792024|NCT02296138|448869542|FG000|Overall Study|Lack of Efficacy|59|||
124792025|NCT02296138|448869543|FG001|Overall Study|Lack of Efficacy|37|||
124792026|NCT02296138|448869542|FG000|Overall Study|Protocol Violation|35|||
124792027|NCT02296138|448869543|FG001|Overall Study|Protocol Violation|36|||
124792028|NCT02296138|448869542|FG000|Overall Study|Lost to Follow-up|9|||
124792029|NCT02296138|448869543|FG001|Overall Study|Lost to Follow-up|12|||
124792030|NCT02296138|448869542|FG000|Overall Study|Withdrawal by Subject|184|||
124792031|NCT02296138|448869543|FG001|Overall Study|Withdrawal by Subject|131|||
124792032|NCT02296138|448869542|FG000|Overall Study|Not Treated|1|||
124792033|NCT02296138|448869543|FG001|Overall Study|Not Treated|1|||
124792034|NCT02296138|448869542|FG000|Overall Study|Patients with data irregularities|10|||
124792035|NCT02296138|448869543|FG001|Overall Study|Patients with data irregularities|11|||
124792036|NCT02296138|448869542|FG000|Overall Study|Other than specified|15|||
124792037|NCT02296138|448869543|FG001|Overall Study|Other than specified|13|||
124792038|NCT00711516|448869544|FG000|Overall Study|Adverse Event|1|||
124792039|NCT00711516|448869545|FG001|Overall Study|Adverse Event|1|||
124792040|NCT00711516|448869544|FG000|Overall Study|Withdrawal by Subject|0|||
124792041|NCT00711516|448869545|FG001|Overall Study|Withdrawal by Subject|1|||
124792042|NCT00711516|448869544|FG000|Overall Study|Protocol Violation|0|||
124792043|NCT00711516|448869545|FG001|Overall Study|Protocol Violation|1|||
124792044|NCT01029405|448869549|FG000|Overall Study|Withdrawal by Subject|0|||
124792045|NCT01029405|448869550|FG001|Overall Study|Withdrawal by Subject|1|||
124792046|NCT01029405|448869551|FG002|Overall Study|Withdrawal by Subject|2|||
124792047|NCT01029405|448869552|FG003|Overall Study|Withdrawal by Subject|0|||
124792048|NCT01029405|448869549|FG000|Overall Study|Protocol Violation|0|||
124792049|NCT01029405|448869550|FG001|Overall Study|Protocol Violation|0|||
124792050|NCT01029405|448869551|FG002|Overall Study|Protocol Violation|0|||
124792051|NCT01029405|448869552|FG003|Overall Study|Protocol Violation|1|||
124792052|NCT01029405|448869549|FG000|Overall Study|Adverse Event|0|||
124792053|NCT01029405|448869550|FG001|Overall Study|Adverse Event|0|||
124792054|NCT01029405|448869551|FG002|Overall Study|Adverse Event|1|||
124792055|NCT01029405|448869552|FG003|Overall Study|Adverse Event|1|||
124792056|NCT01029405|448869549|FG000|Overall Study|Lost to Follow-up|2|||
124792057|NCT01029405|448869550|FG001|Overall Study|Lost to Follow-up|1|||
124792058|NCT01029405|448869551|FG002|Overall Study|Lost to Follow-up|1|||
124792059|NCT01029405|448869552|FG003|Overall Study|Lost to Follow-up|2|||
124792060|NCT01029405|448869549|FG000|Overall Study|Other|0|||
124792061|NCT01029405|448869550|FG001|Overall Study|Other|1|||
124792062|NCT01029405|448869551|FG002|Overall Study|Other|0|||
124792063|NCT01029405|448869552|FG003|Overall Study|Other|1|||
124792064|NCT00409175|448869553|FG000|Overall Study|Adverse Event|4|||
124792065|NCT00409175|448869554|FG001|Overall Study|Adverse Event|3|||
124792066|NCT00409175|448869553|FG000|Overall Study|Withdrawal by Subject|1|||
124792067|NCT00409175|448869554|FG001|Overall Study|Withdrawal by Subject|2|||
124792068|NCT00409175|448869553|FG000|Overall Study|Negative genotype|0|||
124792069|NCT00409175|448869554|FG001|Overall Study|Negative genotype|1|||
124792070|NCT00409175|448869553|FG000|Overall Study|Liver transplantation|13|||
124792071|NCT00409175|448869554|FG001|Overall Study|Liver transplantation|13|||
124792072|NCT02108262|448869557|FG000|Overall Study|Non-compliance|0|||
124792073|NCT02108262|448869558|FG001|Overall Study|Non-compliance|2|||
124792074|NCT02108262|448869559|FG002|Overall Study|Non-compliance|1|||
124792075|NCT02108262|448869560|FG003|Overall Study|Non-compliance|1|||
124792076|NCT02108262|448869557|FG000|Overall Study|Randomized by error/screen failure|0|||
124792077|NCT02108262|448869558|FG001|Overall Study|Randomized by error/screen failure|0|||
124792078|NCT02108262|448869559|FG002|Overall Study|Randomized by error/screen failure|1|||
124792079|NCT02108262|448869560|FG003|Overall Study|Randomized by error/screen failure|0|||
124792080|NCT02108262|448869557|FG000|Overall Study|Distance to center|0|||
124792081|NCT02108262|448869558|FG001|Overall Study|Distance to center|1|||
124792082|NCT02108262|448869559|FG002|Overall Study|Distance to center|1|||
124792083|NCT02108262|448869560|FG003|Overall Study|Distance to center|0|||
124792084|NCT02108262|448869557|FG000|Overall Study|Adverse Event|0|||
124792085|NCT02108262|448869558|FG001|Overall Study|Adverse Event|11|||
124792086|NCT02108262|448869559|FG002|Overall Study|Adverse Event|6|||
124792087|NCT02108262|448869560|FG003|Overall Study|Adverse Event|12|||
124792088|NCT02108262|448869557|FG000|Overall Study|Death|0|||
124792089|NCT02108262|448869558|FG001|Overall Study|Death|2|||
124792090|NCT02108262|448869559|FG002|Overall Study|Death|2|||
124792091|NCT02108262|448869560|FG003|Overall Study|Death|1|||
124792092|NCT02108262|448869557|FG000|Overall Study|Lost to Follow-up|0|||
124792093|NCT02108262|448869558|FG001|Overall Study|Lost to Follow-up|0|||
124792094|NCT02108262|448869559|FG002|Overall Study|Lost to Follow-up|1|||
124792095|NCT02108262|448869560|FG003|Overall Study|Lost to Follow-up|0|||
124792096|NCT02108262|448869557|FG000|Overall Study|Physician Decision|0|||
124792097|NCT02108262|448869558|FG001|Overall Study|Physician Decision|0|||
124792098|NCT02108262|448869559|FG002|Overall Study|Physician Decision|2|||
124792099|NCT02108262|448869560|FG003|Overall Study|Physician Decision|0|||
124792100|NCT02108262|448869557|FG000|Overall Study|Withdrawal by Subject|0|||
124792101|NCT02108262|448869558|FG001|Overall Study|Withdrawal by Subject|7|||
124792102|NCT02108262|448869559|FG002|Overall Study|Withdrawal by Subject|3|||
124792103|NCT02108262|448869560|FG003|Overall Study|Withdrawal by Subject|4|||
124792104|NCT02108262|448869557|FG000|Overall Study|Due to key hepatic values|0|||
124792105|NCT02108262|448869558|FG001|Overall Study|Due to key hepatic values|1|||
124792106|NCT02108262|448869559|FG002|Overall Study|Due to key hepatic values|0|||
124792107|NCT02108262|448869560|FG003|Overall Study|Due to key hepatic values|0|||
124792108|NCT02108262|448869557|FG000|Overall Study|Unable to contact patient|0|||
124792109|NCT02108262|448869558|FG001|Overall Study|Unable to contact patient|3|||
124792110|NCT02108262|448869559|FG002|Overall Study|Unable to contact patient|1|||
124792111|NCT02108262|448869560|FG003|Overall Study|Unable to contact patient|2|||
124792112|NCT02108262|448869557|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
124792113|NCT02108262|448869558|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
124792114|NCT02108262|448869559|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
124792115|NCT02108262|448869560|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
124792116|NCT02108262|448869557|FG000|Overall Study|Patient did not want another infusion|0|||
124792117|NCT02108262|448869558|FG001|Overall Study|Patient did not want another infusion|3|||
124792118|NCT02108262|448869559|FG002|Overall Study|Patient did not want another infusion|3|||
124792119|NCT02108262|448869560|FG003|Overall Study|Patient did not want another infusion|2|||
124792120|NCT02108262|448869557|FG000|Overall Study|Vacation|0|||
124792121|NCT02108262|448869558|FG001|Overall Study|Vacation|1|||
124792122|NCT02108262|448869559|FG002|Overall Study|Vacation|0|||
124792123|NCT02108262|448869560|FG003|Overall Study|Vacation|0|||
124792124|NCT02108262|448869557|FG000|Overall Study|Patient decision|0|||
124792125|NCT02108262|448869558|FG001|Overall Study|Patient decision|7|||
124792126|NCT02108262|448869559|FG002|Overall Study|Patient decision|9|||
124792127|NCT02108262|448869560|FG003|Overall Study|Patient decision|14|||
124792128|NCT02108262|448869557|FG000|Overall Study|Missed IV due to pharmacy error|0|||
124792129|NCT02108262|448869558|FG001|Overall Study|Missed IV due to pharmacy error|0|||
124792130|NCT02108262|448869559|FG002|Overall Study|Missed IV due to pharmacy error|1|||
124792131|NCT02108262|448869560|FG003|Overall Study|Missed IV due to pharmacy error|0|||
124792132|NCT00761150|448869561|FG000|Open-label Period|Adverse Event|36|||
124792133|NCT00761150|448869562|FG001|Open-label Period|Adverse Event|0|||
124792134|NCT00761150|448869563|FG002|Open-label Period|Adverse Event|0|||
124792135|NCT00761150|448869561|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
124792136|NCT00761150|448869562|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
124792137|NCT00761150|448869563|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
124792138|NCT00761150|448869561|FG000|Open-label Period|Lost to Follow-up|7|||
124792139|NCT00761150|448869562|FG001|Open-label Period|Lost to Follow-up|0|||
124792140|NCT00761150|448869563|FG002|Open-label Period|Lost to Follow-up|0|||
124792141|NCT00761150|448869561|FG000|Open-label Period|Lack of Efficacy|4|||
124792142|NCT00761150|448869562|FG001|Open-label Period|Lack of Efficacy|0|||
124792143|NCT00761150|448869563|FG002|Open-label Period|Lack of Efficacy|0|||
124792144|NCT00761150|448869561|FG000|Open-label Period|Withdrawal by Subject|5|||
124792145|NCT00761150|448869562|FG001|Open-label Period|Withdrawal by Subject|0|||
124792146|NCT00761150|448869563|FG002|Open-label Period|Withdrawal by Subject|0|||
124792147|NCT00761150|448869561|FG000|Open-label Period|Noncompliance|2|||
124792148|NCT00761150|448869562|FG001|Open-label Period|Noncompliance|0|||
124792149|NCT00761150|448869563|FG002|Open-label Period|Noncompliance|0|||
124792150|NCT00761150|448869561|FG000|Open-label Period|Other|5|||
124792151|NCT00761150|448869562|FG001|Open-label Period|Other|0|||
124792152|NCT00761150|448869563|FG002|Open-label Period|Other|0|||
124792153|NCT00761150|448869561|FG000|Double-blind Period|Lack of Efficacy|0|||
124792154|NCT00761150|448869562|FG001|Double-blind Period|Lack of Efficacy|2|||
124792155|NCT00761150|448869563|FG002|Double-blind Period|Lack of Efficacy|19|||
124792156|NCT00761150|448869561|FG000|Double-blind Period|Adverse Event|0|||
124792157|NCT00761150|448869562|FG001|Double-blind Period|Adverse Event|3|||
124792158|NCT00761150|448869563|FG002|Double-blind Period|Adverse Event|3|||
124792159|NCT00761150|448869561|FG000|Double-blind Period|Withdrawal by Subject|0|||
124792160|NCT00761150|448869562|FG001|Double-blind Period|Withdrawal by Subject|3|||
124792161|NCT00761150|448869563|FG002|Double-blind Period|Withdrawal by Subject|2|||
124792162|NCT00761150|448869561|FG000|Double-blind Period|Lost to Follow-up|0|||
124792163|NCT00761150|448869562|FG001|Double-blind Period|Lost to Follow-up|2|||
124792164|NCT00761150|448869563|FG002|Double-blind Period|Lost to Follow-up|1|||
124792165|NCT00761150|448869561|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
124792166|NCT00761150|448869562|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
124792167|NCT00761150|448869563|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
124792168|NCT00761150|448869561|FG000|Double-blind Period|Noncompliance|0|||
124792169|NCT00761150|448869562|FG001|Double-blind Period|Noncompliance|1|||
124792170|NCT00761150|448869563|FG002|Double-blind Period|Noncompliance|0|||
124792171|NCT00761150|448869561|FG000|Double-blind Period|Other|0|||
124792172|NCT00761150|448869562|FG001|Double-blind Period|Other|3|||
124792173|NCT00761150|448869563|FG002|Double-blind Period|Other|3|||
124792174|NCT05463198|448869564|FG000|Overall Study|Withdrawal by Subject|19|||
124792175|NCT05463198|448869564|FG000|Overall Study|Procedure Notes Missing|18|||
124792176|NCT01860846|448869565|FG000|Overall Study|Lost to Follow-up|33|||
124792177|NCT00466687|448869568|FG000|Overall Study|Adverse Event|1|||
124792178|NCT00466687|448869568|FG000|Overall Study|Other complicating illness|3|||
124792179|NCT00466687|448869568|FG000|Overall Study|Withdrawal by Subject|1|||
124792180|NCT00466687|448869568|FG000|Overall Study|Disease progression|29|||
124792181|NCT01925989|448869569|FG000|Period 1|Sponsor Decision|1|||
124792182|NCT01925989|448869570|FG001|Period 1|Sponsor Decision|1|||
124792183|NCT01925989|448869571|FG002|Period 1|Sponsor Decision|0|||
124792184|NCT01925989|448869569|FG000|Period 1|Withdrawal by Subject|0|||
124792185|NCT01925989|448869570|FG001|Period 1|Withdrawal by Subject|1|||
124792186|NCT01925989|448869571|FG002|Period 1|Withdrawal by Subject|0|||
124792187|NCT00868517|448869576|FG000|Overall Study|Withdrawal by Subject|3|||
124792188|NCT00868517|448869577|FG001|Overall Study|Withdrawal by Subject|3|||
124792189|NCT00868517|448869578|FG002|Overall Study|Withdrawal by Subject|2|||
124792190|NCT00868517|448869576|FG000|Overall Study|Protocol Violation|1|||
124792191|NCT00868517|448869577|FG001|Overall Study|Protocol Violation|1|||
124792192|NCT00868517|448869578|FG002|Overall Study|Protocol Violation|0|||
124792193|NCT00420641|448869581|FG000|Overall Study|Adverse Event|3|||
124792194|NCT00420641|448869582|FG001|Overall Study|Adverse Event|25|||
124792195|NCT00420641|448869583|FG002|Overall Study|Adverse Event|10|||
124792196|NCT00420641|448869581|FG000|Overall Study|Lost to Follow-up|2|||
124792197|NCT00420641|448869582|FG001|Overall Study|Lost to Follow-up|4|||
124629509|NCT01147068|448261101|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
124792198|NCT00420641|448869583|FG002|Overall Study|Lost to Follow-up|2|||
124792199|NCT00420641|448869581|FG000|Overall Study|Protocol Violation|8|||
124792200|NCT00420641|448869582|FG001|Overall Study|Protocol Violation|8|||
124792201|NCT00420641|448869583|FG002|Overall Study|Protocol Violation|7|||
124792202|NCT00420641|448869581|FG000|Overall Study|Withdrawal by Subject|15|||
124792203|NCT00420641|448869582|FG001|Overall Study|Withdrawal by Subject|21|||
124792204|NCT00420641|448869583|FG002|Overall Study|Withdrawal by Subject|14|||
124792205|NCT00420641|448869581|FG000|Overall Study|Lack of Efficacy|6|||
124792206|NCT00420641|448869582|FG001|Overall Study|Lack of Efficacy|5|||
124792207|NCT00420641|448869583|FG002|Overall Study|Lack of Efficacy|4|||
124792208|NCT00420641|448869581|FG000|Overall Study|Non-compliance|7|||
124792209|NCT00420641|448869582|FG001|Overall Study|Non-compliance|5|||
124792210|NCT00420641|448869583|FG002|Overall Study|Non-compliance|4|||
124792211|NCT00420641|448869581|FG000|Overall Study|Other|4|||
124792212|NCT00420641|448869582|FG001|Overall Study|Other|4|||
124792213|NCT00420641|448869583|FG002|Overall Study|Other|3|||
124792214|NCT03459690|448869585|FG000|Overall Study|Lost to Follow-up|0|||
124792215|NCT03459690|448869586|FG001|Overall Study|Lost to Follow-up|1|||
124792216|NCT03459690|448869585|FG000|Overall Study|Withdrawal by Subject|1|||
124792217|NCT03459690|448869586|FG001|Overall Study|Withdrawal by Subject|1|||
124792218|NCT02586506|448869587|FG000|Overall Study|Protocol Violation|6|||
124792219|NCT02586506|448869587|FG000|Overall Study|Lost to Follow-up|1|||
124792220|NCT02586506|448869587|FG000|Overall Study|Other Reason|2|||
124792221|NCT02815280|448869593|FG000|Double-Blind Phase|Adverse Event|1|||
124792222|NCT02815280|448869594|FG001|Double-Blind Phase|Adverse Event|1|||
124792223|NCT02815280|448869593|FG000|Double-Blind Phase|Lost to Follow-up|10|||
124792224|NCT02815280|448869594|FG001|Double-Blind Phase|Lost to Follow-up|9|||
124792225|NCT02815280|448869593|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
124792226|NCT02815280|448869594|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
124792227|NCT02815280|448869593|FG000|Double-Blind Phase|Protocol Violation|2|||
124792228|NCT02815280|448869594|FG001|Double-Blind Phase|Protocol Violation|2|||
124792229|NCT02815280|448869593|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
124792230|NCT02815280|448869594|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
124792231|NCT02815280|448869593|FG000|Open-Label Phase|Adverse Event|2|||
124792232|NCT02815280|448869594|FG001|Open-Label Phase|Adverse Event|3|||
124792233|NCT02815280|448869593|FG000|Open-Label Phase|Lost to Follow-up|18|||
124792234|NCT02815280|448869594|FG001|Open-Label Phase|Lost to Follow-up|9|||
124792235|NCT02815280|448869593|FG000|Open-Label Phase|Withdrawal by Subject|33|||
124792236|NCT02815280|448869594|FG001|Open-Label Phase|Withdrawal by Subject|18|||
124792237|NCT02815280|448869593|FG000|Open-Label Phase|Protocol Violation|3|||
124792238|NCT02815280|448869594|FG001|Open-Label Phase|Protocol Violation|0|||
124792239|NCT02815280|448869593|FG000|Open-Label Phase|Administrative|26|||
124792240|NCT02815280|448869594|FG001|Open-Label Phase|Administrative|12|||
124792241|NCT02815280|448869593|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
124792242|NCT02815280|448869594|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
124792243|NCT01534182|448869609|FG000|Overall Study|Administrative problems|1|||
124792244|NCT01534182|448869610|FG001|Overall Study|Administrative problems|0|||
124792245|NCT01534182|448869609|FG000|Overall Study|Withdrawal by Subject|4|||
124792246|NCT01534182|448869610|FG001|Overall Study|Withdrawal by Subject|7|||
124792247|NCT01534182|448869609|FG000|Overall Study|Adverse Event|7|||
124792248|NCT01534182|448869610|FG001|Overall Study|Adverse Event|3|||
124792249|NCT01944839|448869611|FG000|Overall Study|Physician Decision|2|||
124792250|NCT01944839|448869612|FG001|Overall Study|Physician Decision|2|||
124792251|NCT01944839|448869611|FG000|Overall Study|Protocol Violation|0|||
124792252|NCT01944839|448869612|FG001|Overall Study|Protocol Violation|1|||
124792253|NCT01944839|448869611|FG000|Overall Study|Adverse Event|10|||
124792254|NCT01944839|448869612|FG001|Overall Study|Adverse Event|5|||
124792255|NCT01944839|448869611|FG000|Overall Study|Withdrawal by Subject|9|||
124792256|NCT01944839|448869612|FG001|Overall Study|Withdrawal by Subject|17|||
124792257|NCT01944839|448869611|FG000|Overall Study|Lost to Follow-up|1|||
124792258|NCT01944839|448869612|FG001|Overall Study|Lost to Follow-up|0|||
124792259|NCT01944839|448869611|FG000|Overall Study|Subject non-compliance|0|||
124792260|NCT01944839|448869612|FG001|Overall Study|Subject non-compliance|3|||
124792261|NCT05093790|448869616|FG000|Overall Study|Failure to meet continuation criteria|0|||
124792262|NCT05093790|448869617|FG001|Overall Study|Failure to meet continuation criteria|0|||
124792263|NCT05093790|448869618|FG002|Overall Study|Failure to meet continuation criteria|1|||
124792264|NCT05093790|448869619|FG003|Overall Study|Failure to meet continuation criteria|0|||
124792265|NCT05093790|448869616|FG000|Overall Study|Adverse Event|1|||
124792266|NCT05093790|448869617|FG001|Overall Study|Adverse Event|0|||
124792267|NCT05093790|448869618|FG002|Overall Study|Adverse Event|0|||
124792268|NCT05093790|448869619|FG003|Overall Study|Adverse Event|0|||
124792269|NCT00924170|448869620|FG000|Overall Study|Refused further treatment|0|||
124792270|NCT00924170|448869621|FG001|Overall Study|Refused further treatment|1|||
124792271|NCT00924170|448869620|FG000|Overall Study|Physician Decision|0|||
124792272|NCT00924170|448869621|FG001|Overall Study|Physician Decision|1|||
124792273|NCT00924170|448869620|FG000|Overall Study|Progressive disease|3|||
124792274|NCT00924170|448869621|FG001|Overall Study|Progressive disease|6|||
124792275|NCT00924170|448869620|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
124792276|NCT00924170|448869621|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
124792277|NCT00924170|448869620|FG000|Overall Study|Death|1|||
124792278|NCT00924170|448869621|FG001|Overall Study|Death|0|||
124792279|NCT04449029|448869624|FG000|Overall Study|Adverse Event|0|||
124792280|NCT04449029|448869625|FG001|Overall Study|Adverse Event|1|||
124792281|NCT04449029|448869626|FG002|Overall Study|Adverse Event|1|||
124792282|NCT04449029|448869627|FG003|Overall Study|Adverse Event|0|||
124792283|NCT04449029|448869628|FG004|Overall Study|Adverse Event|1|||
124792284|NCT04449029|448869629|FG005|Overall Study|Adverse Event|0|||
124792285|NCT04449029|448869630|FG006|Overall Study|Adverse Event|1|||
124792286|NCT04449029|448869631|FG007|Overall Study|Adverse Event|0|||
124792287|NCT04449029|448869624|FG000|Overall Study|Lost to Follow-up|0|||
124792288|NCT04449029|448869625|FG001|Overall Study|Lost to Follow-up|1|||
124792289|NCT04449029|448869626|FG002|Overall Study|Lost to Follow-up|0|||
124792290|NCT04449029|448869627|FG003|Overall Study|Lost to Follow-up|0|||
124792291|NCT04449029|448869628|FG004|Overall Study|Lost to Follow-up|0|||
124792292|NCT04449029|448869629|FG005|Overall Study|Lost to Follow-up|0|||
124792293|NCT04449029|448869630|FG006|Overall Study|Lost to Follow-up|0|||
124792294|NCT04449029|448869631|FG007|Overall Study|Lost to Follow-up|0|||
124792295|NCT04449029|448869624|FG000|Overall Study|Protocol Violation|0|||
124792296|NCT04449029|448869625|FG001|Overall Study|Protocol Violation|1|||
124792297|NCT04449029|448869626|FG002|Overall Study|Protocol Violation|0|||
124792298|NCT04449029|448869627|FG003|Overall Study|Protocol Violation|0|||
124792299|NCT04449029|448869628|FG004|Overall Study|Protocol Violation|0|||
124792300|NCT04449029|448869629|FG005|Overall Study|Protocol Violation|0|||
124792301|NCT04449029|448869630|FG006|Overall Study|Protocol Violation|0|||
124792302|NCT04449029|448869631|FG007|Overall Study|Protocol Violation|0|||
124792303|NCT04449029|448869624|FG000|Overall Study|Physician Decision|0|||
124792304|NCT04449029|448869625|FG001|Overall Study|Physician Decision|0|||
124792305|NCT04449029|448869626|FG002|Overall Study|Physician Decision|0|||
124792306|NCT04449029|448869627|FG003|Overall Study|Physician Decision|0|||
124792307|NCT04449029|448869628|FG004|Overall Study|Physician Decision|0|||
124792308|NCT04449029|448869629|FG005|Overall Study|Physician Decision|1|||
124792309|NCT04449029|448869630|FG006|Overall Study|Physician Decision|0|||
124792310|NCT04449029|448869631|FG007|Overall Study|Physician Decision|0|||
124792311|NCT04449029|448869624|FG000|Overall Study|Withdrawal by Subject|3|||
124792312|NCT04449029|448869625|FG001|Overall Study|Withdrawal by Subject|0|||
124792313|NCT04449029|448869626|FG002|Overall Study|Withdrawal by Subject|1|||
124792314|NCT04449029|448869627|FG003|Overall Study|Withdrawal by Subject|1|||
124792315|NCT04449029|448869628|FG004|Overall Study|Withdrawal by Subject|5|||
124792316|NCT04449029|448869629|FG005|Overall Study|Withdrawal by Subject|1|||
124792317|NCT04449029|448869630|FG006|Overall Study|Withdrawal by Subject|4|||
124792318|NCT04449029|448869631|FG007|Overall Study|Withdrawal by Subject|0|||
124792319|NCT02025556|448869633|FG000|Overall Study|Adverse Event|0|||
124792320|NCT02025556|448869634|FG001|Overall Study|Adverse Event|4|||
124792321|NCT02025556|448869635|FG002|Overall Study|Adverse Event|2|||
124792322|NCT02025556|448869633|FG000|Overall Study|Lack of Efficacy|2|||
124792323|NCT02025556|448869634|FG001|Overall Study|Lack of Efficacy|1|||
124792324|NCT02025556|448869635|FG002|Overall Study|Lack of Efficacy|0|||
124792325|NCT02025556|448869633|FG000|Overall Study|Protocol Violation|2|||
124792326|NCT02025556|448869634|FG001|Overall Study|Protocol Violation|1|||
124792327|NCT02025556|448869635|FG002|Overall Study|Protocol Violation|0|||
124792328|NCT02025556|448869633|FG000|Overall Study|Withdrawal by Subject|0|||
124792329|NCT02025556|448869634|FG001|Overall Study|Withdrawal by Subject|3|||
124792330|NCT02025556|448869635|FG002|Overall Study|Withdrawal by Subject|6|||
124792331|NCT02025556|448869633|FG000|Overall Study|Lost to Follow-up|2|||
124792332|NCT02025556|448869634|FG001|Overall Study|Lost to Follow-up|4|||
124792333|NCT02025556|448869635|FG002|Overall Study|Lost to Follow-up|0|||
124792334|NCT02025556|448869633|FG000|Overall Study|Reason not reported|0|||
124792335|NCT02025556|448869634|FG001|Overall Study|Reason not reported|0|||
124792336|NCT02025556|448869635|FG002|Overall Study|Reason not reported|1|||
124792337|NCT00627445|448869637|FG000|Overall Study|Adverse Event|3|||
124792338|NCT00627445|448869638|FG001|Overall Study|Adverse Event|3|||
124792339|NCT00627445|448869637|FG000|Overall Study|Lack of Efficacy|0|||
124792340|NCT00627445|448869638|FG001|Overall Study|Lack of Efficacy|1|||
124792341|NCT00627445|448869637|FG000|Overall Study|Other|6|||
124792342|NCT00627445|448869638|FG001|Overall Study|Other|8|||
124792343|NCT04098224|448869639|FG000|Overall Study|Adverse Event|1|||
124792344|NCT04098224|448869640|FG001|Overall Study|Adverse Event|0|||
124792345|NCT04098224|448869639|FG000|Overall Study|Physician Decision|1|||
124792346|NCT04098224|448869640|FG001|Overall Study|Physician Decision|0|||
124792347|NCT04098224|448869639|FG000|Overall Study|Patient not required enteral feeding|1|||
124792348|NCT04098224|448869640|FG001|Overall Study|Patient not required enteral feeding|0|||
124792349|NCT04098224|448869639|FG000|Overall Study|Patient failure nasogastric tube|1|||
124792350|NCT04098224|448869640|FG001|Overall Study|Patient failure nasogastric tube|0|||
124792351|NCT04098224|448869639|FG000|Overall Study|Patient early extubation|1|||
124792352|NCT04098224|448869640|FG001|Overall Study|Patient early extubation|3|||
124792353|NCT02217527|448869641|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
124792354|NCT02217527|448869642|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
124792355|NCT02217527|448869641|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
124792356|NCT02217527|448869642|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
124792357|NCT01203852|448869643|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
124792358|NCT01203852|448869643|FG000|Washout 2 Weeks|Physician Decision|46|||
124792359|NCT00247611|448869647|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
124792360|NCT00247611|448869648|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
124792361|NCT00247611|448869647|FG000|Baselined|Completed baseline only|9|||
124792362|NCT00247611|448869648|FG001|Baselined|Completed baseline only|8|||
124792363|NCT01587898|448869649|FG000|Overall Study|Adverse Event|1|||
124792364|NCT01587898|448869650|FG001|Overall Study|Adverse Event|1|||
124792365|NCT01587898|448869651|FG002|Overall Study|Adverse Event|0|||
124792366|NCT01587898|448869652|FG003|Overall Study|Adverse Event|0|||
124792367|NCT01587898|448869649|FG000|Overall Study|Protocol Violation|0|||
124792368|NCT01587898|448869650|FG001|Overall Study|Protocol Violation|2|||
124792369|NCT01587898|448869651|FG002|Overall Study|Protocol Violation|1|||
124792370|NCT01587898|448869652|FG003|Overall Study|Protocol Violation|1|||
124792371|NCT01587898|448869649|FG000|Overall Study|Lost to Follow-up|0|||
124792372|NCT01587898|448869650|FG001|Overall Study|Lost to Follow-up|0|||
124792373|NCT01587898|448869651|FG002|Overall Study|Lost to Follow-up|0|||
124792374|NCT01587898|448869652|FG003|Overall Study|Lost to Follow-up|1|||
124792375|NCT01587898|448869649|FG000|Overall Study|Withdrawal by Subject|2|||
124792376|NCT01587898|448869650|FG001|Overall Study|Withdrawal by Subject|1|||
124792377|NCT01587898|448869651|FG002|Overall Study|Withdrawal by Subject|0|||
124792378|NCT01587898|448869652|FG003|Overall Study|Withdrawal by Subject|0|||
124792379|NCT01587898|448869649|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
124792380|NCT01587898|448869650|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
124792381|NCT01587898|448869651|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
124792382|NCT01587898|448869652|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
124792383|NCT00502203|448869653|FG000|Overall Study|Inevaluable|1|||
124792384|NCT01829243|448869656|FG000|First Intervention|Screen Failure|4|||
124792385|NCT01829243|448869657|FG001|First Intervention|Screen Failure|2|||
124792386|NCT02829944|448869661|FG000|Overall Study|Physician Decision|0|||
124792387|NCT02829944|448869662|FG001|Overall Study|Physician Decision|1|||
124792388|NCT02829944|448869661|FG000|Overall Study|Screen Failure|2|||
124792389|NCT02829944|448869662|FG001|Overall Study|Screen Failure|2|||
124792390|NCT02829944|448869661|FG000|Overall Study|Inadequate Neuraxial Block|1|||
124792391|NCT02829944|448869662|FG001|Overall Study|Inadequate Neuraxial Block|1|||
124792392|NCT02829944|448869661|FG000|Overall Study|Withdrawal by Subject|2|||
124792393|NCT02829944|448869662|FG001|Overall Study|Withdrawal by Subject|1|||
124792394|NCT02829944|448869661|FG000|Overall Study|Catheter Displacement|1|||
124792395|NCT02829944|448869662|FG001|Overall Study|Catheter Displacement|0|||
124792396|NCT02829944|448869661|FG000|Overall Study|Catheter broke|0|||
124792397|NCT02829944|448869662|FG001|Overall Study|Catheter broke|1|||
124792398|NCT02829944|448869661|FG000|Overall Study|Staff unavailable|0|||
124792399|NCT02829944|448869662|FG001|Overall Study|Staff unavailable|1|||
124792400|NCT00336583|448871306|FG000|Overall Study|Lost to Follow-up|1|||
124792401|NCT00336583|448871306|FG000|Overall Study|Death|1|||
124792402|NCT03039621|448871307|FG000|Overall Study|Violation of inclusion criteria|3|||
124792403|NCT03039621|448871308|FG001|Overall Study|Violation of inclusion criteria|2|||
124792404|NCT03039621|448871307|FG000|Overall Study|Non-compliance with protocol requirement|4|||
124792405|NCT03039621|448871308|FG001|Overall Study|Non-compliance with protocol requirement|5|||
124792406|NCT03039621|448871307|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
124792407|NCT03039621|448871308|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
124792408|NCT03039621|448871307|FG000|Overall Study|Violation of non-inclusion criteria|1|||
124792409|NCT03039621|448871308|FG001|Overall Study|Violation of non-inclusion criteria|2|||
124792410|NCT00814333|448871311|FG000|Enrollment|Lost to Follow-up|1|||
124792411|NCT00814333|448871312|FG001|Enrollment|Lost to Follow-up|0|||
124792412|NCT02927067|448871313|FG000|Overall Study|Withdrawn Consent|20|||
124792413|NCT02927067|448871314|FG001|Overall Study|Withdrawn Consent|12|||
124792414|NCT02927067|448871313|FG000|Overall Study|Death|18|||
124792415|NCT02927067|448871314|FG001|Overall Study|Death|31|||
124792416|NCT02927067|448871313|FG000|Overall Study|Adverse Event|13|||
124792417|NCT02927067|448871314|FG001|Overall Study|Adverse Event|10|||
124792418|NCT02927067|448871313|FG000|Overall Study|Noncompliance|5|||
124792419|NCT02927067|448871314|FG001|Overall Study|Noncompliance|2|||
124792420|NCT02927067|448871313|FG000|Overall Study|Reason not Specified|4|||
124792421|NCT02927067|448871314|FG001|Overall Study|Reason not Specified|6|||
124792422|NCT02716896|448871315|FG000|Overall Study|Physician Decision|0|||
124792423|NCT02716896|448871316|FG001|Overall Study|Physician Decision|1|||
124792424|NCT01727700|448871317|FG000|Overall Study|Adverse Event|0|||
124792425|NCT01727700|448871318|FG001|Overall Study|Adverse Event|7|||
124792426|NCT01727700|448871319|FG002|Overall Study|Adverse Event|1|||
124792427|NCT01727700|448871317|FG000|Overall Study|Particpant withdrew consent|0|||
124792428|NCT01727700|448871318|FG001|Overall Study|Particpant withdrew consent|3|||
124792429|NCT01727700|448871319|FG002|Overall Study|Particpant withdrew consent|1|||
124792430|NCT01727700|448871317|FG000|Overall Study|Protocol Violation|2|||
124792431|NCT01727700|448871318|FG001|Overall Study|Protocol Violation|0|||
124792432|NCT01727700|448871319|FG002|Overall Study|Protocol Violation|0|||
124792433|NCT02519855|448871320|FG000|Overall Study|Adverse Event|0|||
124792434|NCT02519855|448871321|FG001|Overall Study|Adverse Event|1|||
124792435|NCT02519855|448871320|FG000|Overall Study|Lost to Follow-up|3|||
124792436|NCT02519855|448871321|FG001|Overall Study|Lost to Follow-up|3|||
124792437|NCT00003830|448871335|FG000|Overall Study|No follow up data|3|||
124792438|NCT00003830|448871336|FG001|Overall Study|No follow up data|0|||
124792439|NCT00003830|448871335|FG000|Overall Study|Sentinel node positive patients|829|||
124792440|NCT00003830|448871336|FG001|Overall Study|Sentinel node positive patients|793|||
124792441|NCT00603590|448871340|FG000|Overall Study|Did not attend study clinic|39|||
124792442|NCT00603590|448871341|FG001|Overall Study|Did not attend study clinic|30|||
124792443|NCT00603590|448871340|FG000|Overall Study|Refused blood test|5|||
124792444|NCT00603590|448871341|FG001|Overall Study|Refused blood test|1|||
124792445|NCT00603590|448871340|FG000|Overall Study|Patient discontinued study drug|22|||
124792446|NCT00603590|448871341|FG001|Overall Study|Patient discontinued study drug|15|||
124792447|NCT00603590|448871340|FG000|Overall Study|Adverse Event|2|||
124792448|NCT00603590|448871341|FG001|Overall Study|Adverse Event|0|||
124792449|NCT00603590|448871340|FG000|Overall Study|Lost to Follow-up|8|||
124792450|NCT00603590|448871341|FG001|Overall Study|Lost to Follow-up|4|||
124792451|NCT00603590|448871340|FG000|Overall Study|Cardiovascular event|0|||
124792452|NCT00603590|448871341|FG001|Overall Study|Cardiovascular event|1|||
124792453|NCT03699475|448871347|FG000|Overall Study|Death|1|||
124792454|NCT00137839|448871348|FG000|Overall Study|Adverse Event|7|||
124792455|NCT00137839|448871348|FG000|Overall Study|Physician Decision|7|||
124792456|NCT00137839|448871348|FG000|Overall Study|Death|8|||
124792457|NCT00137839|448871348|FG000|Overall Study|Disease Progression|60|||
124792458|NCT00137839|448871348|FG000|Overall Study|Not Start Treatment|1|||
124792459|NCT00137839|448871348|FG000|Overall Study|Prolonged Treatment Delay|1|||
124792460|NCT03739242|448871355|FG000|Overall Study|Withdrawal by Subject|1|||
124792461|NCT03739242|448871356|FG001|Overall Study|Withdrawal by Subject|1|||
124792462|NCT03739242|448871355|FG000|Overall Study|Protocol Violation|0|||
124792463|NCT03739242|448871356|FG001|Overall Study|Protocol Violation|1|||
124792464|NCT02446743|448871357|FG000|Overall Study|Withdrawal by Subject|1|||
124792465|NCT02446743|448871358|FG001|Overall Study|Withdrawal by Subject|1|||
124792466|NCT02446743|448871357|FG000|Overall Study|Lost to Follow-up|1|||
124792467|NCT02446743|448871358|FG001|Overall Study|Lost to Follow-up|0|||
124792468|NCT02446743|448871357|FG000|Overall Study|Adverse Event|1|||
124792469|NCT02446743|448871358|FG001|Overall Study|Adverse Event|1|||
124792470|NCT02446743|448871357|FG000|Overall Study|Other|2|||
124792471|NCT02446743|448871358|FG001|Overall Study|Other|3|||
124792472|NCT03718299|448871359|FG000|Overall Study|Adverse Event|1|||
124792473|NCT03718299|448871359|FG000|Overall Study|Withdrawal by Subject|6|||
124792474|NCT03718299|448871359|FG000|Overall Study|Physician Decision|2|||
124792475|NCT03718299|448871359|FG000|Overall Study|Lost to Follow-up|1|||
124792476|NCT01475071|448871364|FG000|Overall Study|Physician Decision|1|||
124792477|NCT01475071|448871364|FG000|Overall Study|Withdrawal by Subject|6|||
124792478|NCT01475071|448871364|FG000|Overall Study|Lost to Follow-up|1|||
124792479|NCT01011478|448871365|FG000|Overall Study|No follow up data|12|||
124792480|NCT01011478|448871366|FG001|Overall Study|No follow up data|7|||
124792481|NCT02158364|448871371|FG000|Overall Study|Case report forms uncollected|10|||
124792482|NCT02158364|448871371|FG000|Overall Study|Protocol Deviation|50|||
124792483|NCT02514473|448871372|FG000|Overall Study|Adverse Event|0|||
124792484|NCT02514473|448871373|FG001|Overall Study|Adverse Event|2|||
124792485|NCT02514473|448871372|FG000|Overall Study|Withdrawal by Subject|2|||
124792486|NCT02514473|448871373|FG001|Overall Study|Withdrawal by Subject|1|||
124792487|NCT02514473|448871372|FG000|Overall Study|Lost to Follow-up|0|||
124792488|NCT02514473|448871373|FG001|Overall Study|Lost to Follow-up|1|||
124792489|NCT02514473|448871372|FG000|Overall Study|Other|1|||
124792490|NCT02514473|448871373|FG001|Overall Study|Other|1|||
124792491|NCT00674154|448871376|FG000|Overall Study|Withdrawal by Subject|3|||
124792492|NCT00674154|448871377|FG001|Overall Study|Withdrawal by Subject|1|||
124792493|NCT00674154|448871376|FG000|Overall Study|Did not want parathyroidectomy|0|||
124792494|NCT00674154|448871377|FG001|Overall Study|Did not want parathyroidectomy|2|||
124792495|NCT01107379|448871378|FG000|Overall Study|Withdrawal by Subject|18|||
124792496|NCT01107379|448871378|FG000|Overall Study|Lost to Follow-up|3|||
124792497|NCT04559529|448871379|FG000|First Intervention (1 Day)|Adverse Event|0|||
124792498|NCT04559529|448871380|FG001|First Intervention (1 Day)|Adverse Event|0|||
124792499|NCT04559529|448871381|FG002|First Intervention (1 Day)|Adverse Event|0|||
124792500|NCT04559529|448871382|FG003|First Intervention (1 Day)|Adverse Event|1|||
124792501|NCT04559529|448871379|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
124792502|NCT04559529|448871380|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
124792503|NCT04559529|448871381|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
124629510|NCT01147068|448261095|FG000|Subjects That Received 2nd Dose|Other|0|||
124629511|NCT01147068|448261096|FG001|Subjects That Received 2nd Dose|Other|3|||
124629512|NCT01147068|448261097|FG002|Subjects That Received 2nd Dose|Other|3|||
124629513|NCT01147068|448261098|FG003|Subjects That Received 2nd Dose|Other|0|||
124629514|NCT01147068|448261099|FG004|Subjects That Received 2nd Dose|Other|1|||
124629515|NCT01147068|448261100|FG005|Subjects That Received 2nd Dose|Other|0|||
124629516|NCT01147068|448261101|FG006|Subjects That Received 2nd Dose|Other|0|||
124629517|NCT01147068|448261095|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
124629518|NCT01147068|448261096|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
124629519|NCT01147068|448261097|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
124792504|NCT04559529|448871382|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
124792505|NCT04559529|448871379|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
124792506|NCT04559529|448871380|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
124792507|NCT04559529|448871381|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
124792508|NCT04559529|448871382|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
124792509|NCT00609362|448871383|FG000|Overall Study|Withdrawal by Subject|2|||
124792510|NCT00609362|448871384|FG001|Overall Study|Withdrawal by Subject|1|||
124792511|NCT00609362|448871383|FG000|Overall Study|Adverse Event|1|||
124792512|NCT00609362|448871384|FG001|Overall Study|Adverse Event|0|||
124629520|NCT01147068|448261098|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
124629521|NCT01147068|448261099|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
124629522|NCT01147068|448261100|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
124629523|NCT01147068|448261101|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
124629524|NCT01147068|448261095|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
124629525|NCT01147068|448261096|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
124629526|NCT01147068|448261097|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
124629527|NCT01147068|448261098|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
124629528|NCT01147068|448261099|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
124629529|NCT01147068|448261100|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
124629530|NCT01147068|448261101|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
124629531|NCT01147068|448261095|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
124629532|NCT01147068|448261096|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
124629533|NCT01147068|448261097|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
124629534|NCT01147068|448261098|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
124629535|NCT01147068|448261099|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
124629536|NCT01147068|448261100|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
124792513|NCT01009281|448871385|FG000|Overall Study|Administrative problems|7|||
124792514|NCT00548405|448871386|FG000|Overall Study|Adverse Event|6|||
124792515|NCT00548405|448871387|FG001|Overall Study|Adverse Event|2|||
124792516|NCT00548405|448871388|FG002|Overall Study|Adverse Event|0|||
124792517|NCT00548405|448871386|FG000|Overall Study|Lack of Efficacy|6|||
124792518|NCT00548405|448871387|FG001|Overall Study|Lack of Efficacy|0|||
124792519|NCT00548405|448871388|FG002|Overall Study|Lack of Efficacy|0|||
124792520|NCT00548405|448871386|FG000|Overall Study|Physician Decision|3|||
124792521|NCT00548405|448871387|FG001|Overall Study|Physician Decision|4|||
124792522|NCT00548405|448871388|FG002|Overall Study|Physician Decision|1|||
124792523|NCT00548405|448871386|FG000|Overall Study|Pregnancy|1|||
124792524|NCT00548405|448871387|FG001|Overall Study|Pregnancy|0|||
124792525|NCT00548405|448871388|FG002|Overall Study|Pregnancy|0|||
124792526|NCT00548405|448871386|FG000|Overall Study|Protocol Violation|1|||
124792527|NCT00548405|448871387|FG001|Overall Study|Protocol Violation|0|||
124792528|NCT00548405|448871388|FG002|Overall Study|Protocol Violation|0|||
124792529|NCT00548405|448871386|FG000|Overall Study|Withdrawal by Subject|36|||
124792530|NCT00548405|448871387|FG001|Overall Study|Withdrawal by Subject|12|||
124792531|NCT00548405|448871388|FG002|Overall Study|Withdrawal by Subject|5|||
124792532|NCT00548405|448871386|FG000|Overall Study|Lost to Follow-up|1|||
124792533|NCT00548405|448871387|FG001|Overall Study|Lost to Follow-up|1|||
124792534|NCT00548405|448871388|FG002|Overall Study|Lost to Follow-up|2|||
124792535|NCT00548405|448871386|FG000|Overall Study|Death|0|||
124792536|NCT00548405|448871387|FG001|Overall Study|Death|1|||
124792537|NCT00548405|448871388|FG002|Overall Study|Death|1|||
124792538|NCT00548405|448871386|FG000|Overall Study|Sponsor decision|1|||
124792539|NCT00548405|448871387|FG001|Overall Study|Sponsor decision|0|||
124792540|NCT00548405|448871388|FG002|Overall Study|Sponsor decision|0|||
124792541|NCT00548405|448871386|FG000|Overall Study|Randomized but not treated|1|||
124792542|NCT00548405|448871387|FG001|Overall Study|Randomized but not treated|0|||
124792543|NCT00548405|448871388|FG002|Overall Study|Randomized but not treated|0|||
124792544|NCT02582684|448871389|FG000|Overall Study|Unable to contact subject/parent|4|||
124792545|NCT02582684|448871389|FG000|Overall Study|Subject not able to get to clinic|10|||
124792546|NCT02582684|448871389|FG000|Overall Study|Subject withdrew consent|1|||
124792547|NCT02582684|448871389|FG000|Overall Study|Found to be ineligible after enrollment|2|||
124792548|NCT00899392|448871399|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
124792549|NCT00899392|448871400|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
124792550|NCT01261780|448871407|FG000|Overall Study|Withdrawal by Subject|1|||
124792551|NCT01261780|448871408|FG001|Overall Study|Withdrawal by Subject|0|||
124792552|NCT01261780|448871407|FG000|Overall Study|Event not related to subject|1|||
124792553|NCT01261780|448871408|FG001|Overall Study|Event not related to subject|2|||
124792554|NCT01239732|448871409|FG000|Overall Study|Termination of study per protocol|667|||
124792555|NCT01239732|448871409|FG000|Overall Study|Death|226|||
124792556|NCT01239732|448871409|FG000|Overall Study|Withdrawal by Subject|87|||
124792557|NCT01239732|448871409|FG000|Overall Study|Adverse Event|6|||
124792558|NCT01239732|448871409|FG000|Overall Study|Protocol Violation|3|||
124792559|NCT01239732|448871409|FG000|Overall Study|Participant non compliance|5|||
124792560|NCT01239732|448871409|FG000|Overall Study|Study termination by sponsor|2|||
124629537|NCT01147068|448261101|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
124792561|NCT01239732|448871409|FG000|Overall Study|Investigator's decision|4|||
124792562|NCT01239732|448871409|FG000|Overall Study|Treatment failure|2|||
124792563|NCT01239732|448871409|FG000|Overall Study|Other|19|||
124792564|NCT00732940|448871410|FG000|Overall Study|Withdrawal by Subject|1|||
124792565|NCT00732940|448871411|FG001|Overall Study|Withdrawal by Subject|2|||
124792566|NCT00732940|448871410|FG000|Overall Study|Adverse Event|0|||
124792567|NCT00732940|448871411|FG001|Overall Study|Adverse Event|1|||
124792568|NCT00732940|448871410|FG000|Overall Study|Lost to Follow-up|1|||
124792569|NCT00732940|448871411|FG001|Overall Study|Lost to Follow-up|0|||
124792570|NCT02241889|448871412|FG000|Overall Study|device issues|0|||
124792571|NCT02241889|448871413|FG001|Overall Study|device issues|0|||
124792572|NCT02241889|448871414|FG002|Overall Study|device issues|1|||
124792573|NCT02241889|448871415|FG003|Overall Study|device issues|0|||
124792574|NCT02241889|448871416|FG004|Overall Study|device issues|0|||
124792575|NCT02241889|448871417|FG005|Overall Study|device issues|0|||
124792576|NCT02241889|448871412|FG000|Overall Study|Withdrawal by Subject|0|||
124792577|NCT02241889|448871413|FG001|Overall Study|Withdrawal by Subject|0|||
124792578|NCT02241889|448871414|FG002|Overall Study|Withdrawal by Subject|0|||
124792579|NCT02241889|448871415|FG003|Overall Study|Withdrawal by Subject|0|||
124792580|NCT02241889|448871416|FG004|Overall Study|Withdrawal by Subject|0|||
124792581|NCT02241889|448871417|FG005|Overall Study|Withdrawal by Subject|1|||
124792582|NCT00266877|448871420|FG000|Overall Study|Death|1|||
124792583|NCT00266877|448871421|FG001|Overall Study|Death|1|||
124792584|NCT00266877|448871422|FG002|Overall Study|Death|1|||
124792585|NCT00266877|448871420|FG000|Overall Study|Adverse Event|6|||
124792586|NCT00266877|448871421|FG001|Overall Study|Adverse Event|4|||
124792587|NCT00266877|448871422|FG002|Overall Study|Adverse Event|1|||
124792588|NCT00266877|448871420|FG000|Overall Study|Physician Decision|2|||
124792589|NCT00266877|448871421|FG001|Overall Study|Physician Decision|1|||
124792590|NCT00266877|448871422|FG002|Overall Study|Physician Decision|1|||
124792591|NCT00266877|448871420|FG000|Overall Study|Withdrawal by Subject|3|||
124792592|NCT00266877|448871421|FG001|Overall Study|Withdrawal by Subject|1|||
124792593|NCT00266877|448871422|FG002|Overall Study|Withdrawal by Subject|1|||
124792594|NCT00266877|448871420|FG000|Overall Study|Disease Progression|72|||
124792595|NCT00266877|448871421|FG001|Overall Study|Disease Progression|37|||
124792596|NCT00266877|448871422|FG002|Overall Study|Disease Progression|23|||
124792597|NCT00266877|448871420|FG000|Overall Study|Symptomatic Deterioration|6|||
124792598|NCT00266877|448871421|FG001|Overall Study|Symptomatic Deterioration|3|||
124792599|NCT00266877|448871422|FG002|Overall Study|Symptomatic Deterioration|1|||
124792600|NCT00266877|448871420|FG000|Overall Study|Hospitalization|1|||
124792601|NCT00266877|448871421|FG001|Overall Study|Hospitalization|0|||
124792602|NCT00266877|448871422|FG002|Overall Study|Hospitalization|0|||
124792603|NCT00266877|448871420|FG000|Overall Study|Concomitant Radiotherapy|0|||
124792604|NCT00266877|448871421|FG001|Overall Study|Concomitant Radiotherapy|1|||
124792605|NCT00266877|448871422|FG002|Overall Study|Concomitant Radiotherapy|0|||
124792606|NCT01077375|448871428|FG000|Overall Study|Adverse Event|2|||
124792607|NCT01077375|448871429|FG001|Overall Study|Adverse Event|15|||
124792608|NCT01077375|448871428|FG000|Overall Study|Lack of Efficacy|6|||
124792609|NCT01077375|448871429|FG001|Overall Study|Lack of Efficacy|8|||
124792610|NCT01077375|448871428|FG000|Overall Study|Withdrawal by Subject|0|||
124792611|NCT01077375|448871429|FG001|Overall Study|Withdrawal by Subject|6|||
124792612|NCT01077375|448871428|FG000|Overall Study|Lost to Follow-up|2|||
124792613|NCT01077375|448871429|FG001|Overall Study|Lost to Follow-up|5|||
124792614|NCT01077375|448871428|FG000|Overall Study|Other Reason|0|||
124792615|NCT01077375|448871429|FG001|Overall Study|Other Reason|1|||
124792616|NCT03985878|448871435|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
124792617|NCT03985878|448871435|FG000|Overall Study|Study Terminated by Sponsor|12|||
124792618|NCT03985878|448871435|FG000|Overall Study|Withdrawal by Subject|1|||
124792619|NCT00278915|448871439|FG000|Overall Study|Disease progression|1|||
124792620|NCT02520089|448871440|FG000|Overall Study|Lost to Follow-up|3|||
124792621|NCT02520089|448871441|FG001|Overall Study|Lost to Follow-up|4|||
124792622|NCT00002931|448872689|FG000|Overall Study|rapidly progressing disease during|2|||
124792623|NCT00910247|448872691|FG000|Overall Study|Adverse Event|15|||
124792624|NCT00910247|448872691|FG000|Overall Study|Death|2|||
124792625|NCT00910247|448872691|FG000|Overall Study|Lost to Follow-up|10|||
124792626|NCT00910247|448872691|FG000|Overall Study|Physician Decision|3|||
124792627|NCT00910247|448872691|FG000|Overall Study|Protocol Violation|10|||
124792628|NCT00910247|448872691|FG000|Overall Study|Withdrawal by Subject|25|||
124792629|NCT00910247|448872691|FG000|Overall Study|Not collected|4|||
124792630|NCT01879579|448872692|FG000|Overall Study|Phone incompatible with texting platform|3|||
124792631|NCT01879579|448872693|FG001|Overall Study|Phone incompatible with texting platform|0|||
124792632|NCT01879579|448872692|FG000|Overall Study|Did not enroll in texting platform|1|||
124792633|NCT01879579|448872693|FG001|Overall Study|Did not enroll in texting platform|0|||
124792634|NCT01879579|448872692|FG000|Overall Study|Did not initiate insulin treatment|1|||
124792635|NCT01879579|448872693|FG001|Overall Study|Did not initiate insulin treatment|0|||
124792636|NCT01879579|448872692|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
124792637|NCT01879579|448872693|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
124792638|NCT01879579|448872692|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
124792639|NCT01879579|448872693|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
124792640|NCT01757691|448872697|FG000|Overall Study|Administrative problems|2|||
124792641|NCT01757691|448872698|FG001|Overall Study|Administrative problems|0|||
124792642|NCT02919969|448872705|FG000|Overall Study|Lack of Efficacy|22|||
124792643|NCT02919969|448872705|FG000|Overall Study|Death|4|||
124792644|NCT02919969|448872705|FG000|Overall Study|Physician Decision|3|||
124792645|NCT02919969|448872705|FG000|Overall Study|Withdrawal by Subject|2|||
124792646|NCT01842633|448872706|FG000|Overall Study|Screen Failure|1|||
124792647|NCT01842633|448872707|FG001|Overall Study|Screen Failure|0|||
124792648|NCT01842633|448872708|FG002|Overall Study|Screen Failure|0|||
124792649|NCT01842633|448872706|FG000|Overall Study|Adverse Event|1|||
124792650|NCT01842633|448872707|FG001|Overall Study|Adverse Event|1|||
124792651|NCT01842633|448872708|FG002|Overall Study|Adverse Event|0|||
124792652|NCT01842633|448872706|FG000|Overall Study|Withdrawal by Subject|0|||
124792653|NCT01842633|448872707|FG001|Overall Study|Withdrawal by Subject|1|||
124792654|NCT01842633|448872708|FG002|Overall Study|Withdrawal by Subject|0|||
124792655|NCT01842633|448872706|FG000|Overall Study|Technical issues|1|||
124792656|NCT01842633|448872707|FG001|Overall Study|Technical issues|0|||
124792657|NCT01842633|448872708|FG002|Overall Study|Technical issues|0|||
124792658|NCT05347147|448872709|FG000|Overall Study|Lost to Follow-up|0|||
124792659|NCT05347147|448872710|FG001|Overall Study|Lost to Follow-up|1|||
124792660|NCT05347147|448872709|FG000|Overall Study|Sponsor request|3|||
124792661|NCT05347147|448872710|FG001|Overall Study|Sponsor request|3|||
124792662|NCT05347147|448872709|FG000|Overall Study|Study termination|2|||
124792663|NCT05347147|448872710|FG001|Overall Study|Study termination|1|||
124792664|NCT00718081|448872713|FG000|Overall Study|Adverse Event|0|||
124792665|NCT00718081|448872714|FG001|Overall Study|Adverse Event|1|||
124792666|NCT00718081|448872715|FG002|Overall Study|Adverse Event|0|||
124792667|NCT00718081|448872713|FG000|Overall Study|Lack of Efficacy|7|||
124792668|NCT00718081|448872714|FG001|Overall Study|Lack of Efficacy|3|||
124792669|NCT00718081|448872715|FG002|Overall Study|Lack of Efficacy|21|||
124792670|NCT01397825|448872716|FG000|Overall Study|Progressive Disease|10|||
124792671|NCT01397825|448872717|FG001|Overall Study|Progressive Disease|3|||
124792672|NCT01397825|448872718|FG002|Overall Study|Progressive Disease|11|||
124792673|NCT01397825|448872719|FG003|Overall Study|Progressive Disease|1|||
124792674|NCT01397825|448872720|FG004|Overall Study|Progressive Disease|0|||
124792675|NCT01397825|448872716|FG000|Overall Study|Symptomatic Deterioration|2|||
124792676|NCT01397825|448872717|FG001|Overall Study|Symptomatic Deterioration|0|||
124792677|NCT01397825|448872718|FG002|Overall Study|Symptomatic Deterioration|4|||
124792678|NCT01397825|448872719|FG003|Overall Study|Symptomatic Deterioration|0|||
124792679|NCT01397825|448872720|FG004|Overall Study|Symptomatic Deterioration|0|||
124792680|NCT01397825|448872716|FG000|Overall Study|Adverse Event|0|||
124792681|NCT01397825|448872717|FG001|Overall Study|Adverse Event|1|||
124792682|NCT01397825|448872718|FG002|Overall Study|Adverse Event|5|||
124792683|NCT01397825|448872719|FG003|Overall Study|Adverse Event|1|||
124792684|NCT01397825|448872720|FG004|Overall Study|Adverse Event|0|||
124792685|NCT01397825|448872716|FG000|Overall Study|Withdrawal by Subject|1|||
124792686|NCT01397825|448872717|FG001|Overall Study|Withdrawal by Subject|0|||
124792687|NCT01397825|448872718|FG002|Overall Study|Withdrawal by Subject|5|||
124792688|NCT01397825|448872719|FG003|Overall Study|Withdrawal by Subject|1|||
124792689|NCT01397825|448872720|FG004|Overall Study|Withdrawal by Subject|0|||
124792690|NCT01931670|448872722|FG000|Treatment Period|Exclusionary Medication Received|1|||
124792691|NCT01931670|448872723|FG001|Treatment Period|Exclusionary Medication Received|1|||
124792692|NCT01931670|448872724|FG002|Treatment Period|Exclusionary Medication Received|1|||
124792693|NCT01931670|448872722|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
124792694|NCT01931670|448872723|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
124792695|NCT01931670|448872724|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
124792696|NCT01931670|448872722|FG000|Treatment Period|Subject Noncompliant|4|||
124792697|NCT01931670|448872723|FG001|Treatment Period|Subject Noncompliant|9|||
124792698|NCT01931670|448872724|FG002|Treatment Period|Subject Noncompliant|5|||
124792699|NCT01931670|448872722|FG000|Treatment Period|Adverse Event|19|||
124792700|NCT01931670|448872723|FG001|Treatment Period|Adverse Event|8|||
124792701|NCT01931670|448872724|FG002|Treatment Period|Adverse Event|21|||
124792702|NCT01931670|448872722|FG000|Treatment Period|Lack of Efficacy|11|||
124792703|NCT01931670|448872723|FG001|Treatment Period|Lack of Efficacy|2|||
124792704|NCT01931670|448872724|FG002|Treatment Period|Lack of Efficacy|2|||
124792705|NCT01931670|448872722|FG000|Treatment Period|Pregnancy|7|||
124792706|NCT01931670|448872723|FG001|Treatment Period|Pregnancy|2|||
124792707|NCT01931670|448872724|FG002|Treatment Period|Pregnancy|0|||
124792708|NCT01931670|448872722|FG000|Treatment Period|Other|8|||
124792709|NCT01931670|448872723|FG001|Treatment Period|Other|7|||
124792710|NCT01931670|448872724|FG002|Treatment Period|Other|2|||
124792711|NCT01931670|448872722|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
124792712|NCT01931670|448872723|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
124792713|NCT01931670|448872724|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
124792714|NCT01931670|448872722|FG000|Treatment Period|Lost to Follow-up|19|||
124792715|NCT01931670|448872723|FG001|Treatment Period|Lost to Follow-up|5|||
124792716|NCT01931670|448872724|FG002|Treatment Period|Lost to Follow-up|7|||
124792717|NCT01931670|448872722|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
124792718|NCT01931670|448872723|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
124792719|NCT01931670|448872724|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
124792720|NCT01931670|448872722|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
124792721|NCT01931670|448872723|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
124792722|NCT01931670|448872724|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
124792723|NCT01931670|448872722|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
124792724|NCT01931670|448872723|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
124792725|NCT01931670|448872724|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
124792726|NCT01931670|448872722|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
124792727|NCT01931670|448872723|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
124792728|NCT01931670|448872724|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
124792729|NCT01931670|448872722|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
124792730|NCT01931670|448872723|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
124792731|NCT01931670|448872724|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
124792732|NCT01931670|448872722|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
124792733|NCT01931670|448872723|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
124792734|NCT01931670|448872724|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
124792735|NCT00976508|448872730|FG000|Overall Study|Death|7|||
124792736|NCT00976508|448872731|FG001|Overall Study|Death|1|||
124792737|NCT00976508|448872730|FG000|Overall Study|Lost to Follow-up|1|||
124792738|NCT00976508|448872731|FG001|Overall Study|Lost to Follow-up|0|||
124792739|NCT00976508|448872730|FG000|Overall Study|Withdrawal by Subject|1|||
124792740|NCT00976508|448872731|FG001|Overall Study|Withdrawal by Subject|0|||
124792741|NCT00976508|448872730|FG000|Overall Study|Disease Progression|4|||
124792742|NCT00976508|448872731|FG001|Overall Study|Disease Progression|4|||
124792743|NCT00976508|448872730|FG000|Overall Study|Subject Enrolled in Hospice|1|||
124792744|NCT00976508|448872731|FG001|Overall Study|Subject Enrolled in Hospice|0|||
124792745|NCT00976508|448872730|FG000|Overall Study|Terminated by the Sponsor|0|||
124792746|NCT00976508|448872731|FG001|Overall Study|Terminated by the Sponsor|1|||
124792747|NCT01205581|448872733|FG000|Overall Study|Withdrawal by Subject|1|||
124792748|NCT01205581|448872734|FG001|Overall Study|Withdrawal by Subject|0|||
124792749|NCT01205581|448872735|FG002|Overall Study|Withdrawal by Subject|0|||
124792750|NCT01205581|448872736|FG003|Overall Study|Withdrawal by Subject|0|||
124792751|NCT01205581|448872737|FG004|Overall Study|Withdrawal by Subject|0|||
124792752|NCT01205581|448872738|FG005|Overall Study|Withdrawal by Subject|0|||
124792753|NCT00978432|448872740|FG000|Overall Study|Withdrawal by Subject|0|||
124792754|NCT00978432|448872741|FG001|Overall Study|Withdrawal by Subject|0|||
124792755|NCT00978432|448872742|FG002|Overall Study|Withdrawal by Subject|1|||
124792756|NCT00978432|448872740|FG000|Overall Study|Lack of Efficacy|1|||
124792757|NCT00978432|448872741|FG001|Overall Study|Lack of Efficacy|1|||
124792758|NCT00978432|448872742|FG002|Overall Study|Lack of Efficacy|3|||
124792759|NCT00978432|448872740|FG000|Overall Study|Adverse Event|2|||
124792760|NCT00978432|448872741|FG001|Overall Study|Adverse Event|0|||
124792761|NCT00978432|448872742|FG002|Overall Study|Adverse Event|1|||
124792762|NCT04418661|448872743|FG000|Overall Study|Adverse Event|0|||
124792763|NCT04418661|448872744|FG001|Overall Study|Adverse Event|1|||
124792764|NCT04418661|448872745|FG002|Overall Study|Adverse Event|5|||
124792765|NCT04418661|448872746|FG003|Overall Study|Adverse Event|3|||
124792766|NCT04418661|448872747|FG004|Overall Study|Adverse Event|0|||
124792767|NCT04418661|448872748|FG005|Overall Study|Adverse Event|2|||
124792768|NCT04418661|448872743|FG000|Overall Study|Progressive disease|4|||
124792769|NCT04418661|448872744|FG001|Overall Study|Progressive disease|11|||
124792770|NCT04418661|448872745|FG002|Overall Study|Progressive disease|6|||
124792771|NCT04418661|448872746|FG003|Overall Study|Progressive disease|11|||
124792772|NCT04418661|448872747|FG004|Overall Study|Progressive disease|1|||
124792773|NCT04418661|448872748|FG005|Overall Study|Progressive disease|12|||
124792774|NCT04418661|448872743|FG000|Overall Study|Withdrawal by Subject|0|||
124792775|NCT04418661|448872744|FG001|Overall Study|Withdrawal by Subject|1|||
124792776|NCT04418661|448872745|FG002|Overall Study|Withdrawal by Subject|0|||
124792777|NCT04418661|448872746|FG003|Overall Study|Withdrawal by Subject|1|||
124792778|NCT04418661|448872747|FG004|Overall Study|Withdrawal by Subject|0|||
124792779|NCT04418661|448872748|FG005|Overall Study|Withdrawal by Subject|0|||
124792780|NCT04418661|448872743|FG000|Overall Study|Other|0|||
124792781|NCT04418661|448872744|FG001|Overall Study|Other|0|||
124792782|NCT04418661|448872745|FG002|Overall Study|Other|1|||
124792783|NCT04418661|448872746|FG003|Overall Study|Other|3|||
124792784|NCT04418661|448872747|FG004|Overall Study|Other|0|||
124792785|NCT04418661|448872748|FG005|Overall Study|Other|1|||
124792786|NCT00045942|448872751|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
124792787|NCT00045942|448872752|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
124792788|NCT00045942|448872753|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
124792789|NCT00045942|448872754|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
124792790|NCT00045942|448872755|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
124792791|NCT00045942|448872756|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
124792792|NCT00045942|448872757|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
124792793|NCT00045942|448872758|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
124792794|NCT00045942|448872759|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
124792795|NCT00045942|448872751|FG000|PKC412A2104 (Core)|Adverse Event|5|||
124792796|NCT00045942|448872752|FG001|PKC412A2104 (Core)|Adverse Event|0|||
124792797|NCT00045942|448872753|FG002|PKC412A2104 (Core)|Adverse Event|0|||
124792798|NCT00045942|448872754|FG003|PKC412A2104 (Core)|Adverse Event|0|||
124792799|NCT00045942|448872755|FG004|PKC412A2104 (Core)|Adverse Event|0|||
124792800|NCT00045942|448872756|FG005|PKC412A2104 (Core)|Adverse Event|0|||
124792801|NCT00045942|448872757|FG006|PKC412A2104 (Core)|Adverse Event|0|||
124792802|NCT00045942|448872758|FG007|PKC412A2104 (Core)|Adverse Event|0|||
124792803|NCT00045942|448872759|FG008|PKC412A2104 (Core)|Adverse Event|0|||
124792804|NCT00045942|448872751|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
124792805|NCT00045942|448872752|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
124792806|NCT00045942|448872753|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
124792807|NCT00045942|448872754|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
124792808|NCT00045942|448872755|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
124792809|NCT00045942|448872756|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
124792810|NCT00045942|448872757|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
124792811|NCT00045942|448872758|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
124792812|NCT00045942|448872759|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
124792813|NCT00045942|448872751|FG000|PKC412A2104 (Core)|Death|1|||
124792814|NCT00045942|448872752|FG001|PKC412A2104 (Core)|Death|0|||
124792815|NCT00045942|448872753|FG002|PKC412A2104 (Core)|Death|0|||
124792816|NCT00045942|448872754|FG003|PKC412A2104 (Core)|Death|0|||
124792817|NCT00045942|448872755|FG004|PKC412A2104 (Core)|Death|0|||
124792818|NCT00045942|448872756|FG005|PKC412A2104 (Core)|Death|0|||
124792819|NCT00045942|448872757|FG006|PKC412A2104 (Core)|Death|0|||
124792820|NCT00045942|448872758|FG007|PKC412A2104 (Core)|Death|0|||
124792821|NCT00045942|448872759|FG008|PKC412A2104 (Core)|Death|0|||
124792822|NCT00045942|448872751|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
124792823|NCT00045942|448872752|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
124792824|NCT00045942|448872753|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
124792825|NCT00045942|448872754|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
124792826|NCT00045942|448872755|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
124792827|NCT00045942|448872756|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
124792828|NCT00045942|448872757|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
124792829|NCT00045942|448872758|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
124792830|NCT00045942|448872759|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
124792831|NCT00045942|448872751|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
124792832|NCT00045942|448872752|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
124792833|NCT00045942|448872753|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
124792834|NCT00045942|448872754|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
124792835|NCT00045942|448872755|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
124792836|NCT00045942|448872756|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
124792837|NCT00045942|448872757|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
124792838|NCT00045942|448872758|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
124792839|NCT00045942|448872759|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
124792840|NCT00045942|448872751|FG000|PKC412A2104E1|Lack of Efficacy|0|||
124792841|NCT00045942|448872752|FG001|PKC412A2104E1|Lack of Efficacy|11|||
124792842|NCT00045942|448872753|FG002|PKC412A2104E1|Lack of Efficacy|11|||
124792843|NCT00045942|448872754|FG003|PKC412A2104E1|Lack of Efficacy|23|||
124792844|NCT00045942|448872755|FG004|PKC412A2104E1|Lack of Efficacy|17|||
124792845|NCT00045942|448872756|FG005|PKC412A2104E1|Lack of Efficacy|0|||
124792846|NCT00045942|448872757|FG006|PKC412A2104E1|Lack of Efficacy|0|||
124792847|NCT00045942|448872758|FG007|PKC412A2104E1|Lack of Efficacy|0|||
124792848|NCT00045942|448872759|FG008|PKC412A2104E1|Lack of Efficacy|0|||
124792849|NCT00045942|448872751|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
124792850|NCT00045942|448872752|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
124792851|NCT00045942|448872753|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
124792852|NCT00045942|448872754|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
124792853|NCT00045942|448872755|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
124792854|NCT00045942|448872756|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
124792855|NCT00045942|448872757|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
124792856|NCT00045942|448872758|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
124792857|NCT00045942|448872759|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
124792858|NCT00045942|448872751|FG000|PKC412A2104E1|Adverse Event|0|||
124792859|NCT00045942|448872752|FG001|PKC412A2104E1|Adverse Event|1|||
124792860|NCT00045942|448872753|FG002|PKC412A2104E1|Adverse Event|1|||
124792861|NCT00045942|448872754|FG003|PKC412A2104E1|Adverse Event|3|||
124792862|NCT00045942|448872755|FG004|PKC412A2104E1|Adverse Event|6|||
124792863|NCT00045942|448872756|FG005|PKC412A2104E1|Adverse Event|0|||
124792864|NCT00045942|448872757|FG006|PKC412A2104E1|Adverse Event|0|||
124792865|NCT00045942|448872758|FG007|PKC412A2104E1|Adverse Event|0|||
124792866|NCT00045942|448872759|FG008|PKC412A2104E1|Adverse Event|0|||
124792867|NCT00045942|448872751|FG000|PKC412A2104E1|Death|0|||
124792868|NCT00045942|448872752|FG001|PKC412A2104E1|Death|4|||
124792869|NCT00045942|448872753|FG002|PKC412A2104E1|Death|1|||
124792870|NCT00045942|448872754|FG003|PKC412A2104E1|Death|1|||
124792871|NCT00045942|448872755|FG004|PKC412A2104E1|Death|1|||
124792872|NCT00045942|448872756|FG005|PKC412A2104E1|Death|0|||
124792873|NCT00045942|448872757|FG006|PKC412A2104E1|Death|0|||
124792874|NCT00045942|448872758|FG007|PKC412A2104E1|Death|0|||
124792875|NCT00045942|448872759|FG008|PKC412A2104E1|Death|0|||
124792876|NCT00045942|448872751|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
124792877|NCT00045942|448872752|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
124792878|NCT00045942|448872753|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
124792879|NCT00045942|448872754|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
124792880|NCT00045942|448872755|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
124792881|NCT00045942|448872756|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
124792882|NCT00045942|448872757|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
124792883|NCT00045942|448872758|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
124792884|NCT00045942|448872759|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
124792885|NCT00045942|448872751|FG000|PKC412A2104E2|Lost to Follow-up|0|||
124792886|NCT00045942|448872752|FG001|PKC412A2104E2|Lost to Follow-up|0|||
124792887|NCT00045942|448872753|FG002|PKC412A2104E2|Lost to Follow-up|0|||
124792888|NCT00045942|448872754|FG003|PKC412A2104E2|Lost to Follow-up|0|||
124792889|NCT00045942|448872755|FG004|PKC412A2104E2|Lost to Follow-up|0|||
124792890|NCT00045942|448872756|FG005|PKC412A2104E2|Lost to Follow-up|0|||
124792891|NCT00045942|448872757|FG006|PKC412A2104E2|Lost to Follow-up|0|||
124792892|NCT00045942|448872758|FG007|PKC412A2104E2|Lost to Follow-up|3|||
124792893|NCT00045942|448872759|FG008|PKC412A2104E2|Lost to Follow-up|0|||
124792894|NCT00045942|448872751|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
124792895|NCT00045942|448872752|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
124792896|NCT00045942|448872753|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
124792897|NCT00045942|448872754|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
124792898|NCT00045942|448872755|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
124792899|NCT00045942|448872756|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
124792900|NCT00045942|448872757|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
124792901|NCT00045942|448872758|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
124792902|NCT00045942|448872759|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
124792903|NCT00045942|448872751|FG000|PKC412A2104E2|Lack of Efficacy|0|||
124792904|NCT00045942|448872752|FG001|PKC412A2104E2|Lack of Efficacy|0|||
124792905|NCT00045942|448872753|FG002|PKC412A2104E2|Lack of Efficacy|0|||
124792906|NCT00045942|448872754|FG003|PKC412A2104E2|Lack of Efficacy|0|||
124792907|NCT00045942|448872755|FG004|PKC412A2104E2|Lack of Efficacy|0|||
124792908|NCT00045942|448872756|FG005|PKC412A2104E2|Lack of Efficacy|3|||
124792909|NCT00045942|448872757|FG006|PKC412A2104E2|Lack of Efficacy|2|||
124792910|NCT00045942|448872758|FG007|PKC412A2104E2|Lack of Efficacy|2|||
124792911|NCT00045942|448872759|FG008|PKC412A2104E2|Lack of Efficacy|6|||
124792912|NCT00045942|448872751|FG000|PKC412A2104E2|Adverse Event|0|||
124792913|NCT00045942|448872752|FG001|PKC412A2104E2|Adverse Event|0|||
124792914|NCT00045942|448872753|FG002|PKC412A2104E2|Adverse Event|0|||
124792915|NCT00045942|448872754|FG003|PKC412A2104E2|Adverse Event|0|||
124792916|NCT00045942|448872755|FG004|PKC412A2104E2|Adverse Event|0|||
124792917|NCT00045942|448872756|FG005|PKC412A2104E2|Adverse Event|4|||
124792918|NCT00045942|448872757|FG006|PKC412A2104E2|Adverse Event|3|||
124792919|NCT00045942|448872758|FG007|PKC412A2104E2|Adverse Event|1|||
124792920|NCT00045942|448872759|FG008|PKC412A2104E2|Adverse Event|0|||
124792921|NCT00045942|448872751|FG000|PKC412A2104E2|Death|0|||
124792922|NCT00045942|448872752|FG001|PKC412A2104E2|Death|0|||
124792923|NCT00045942|448872753|FG002|PKC412A2104E2|Death|0|||
124792924|NCT00045942|448872754|FG003|PKC412A2104E2|Death|0|||
124792925|NCT00045942|448872755|FG004|PKC412A2104E2|Death|0|||
124792926|NCT00045942|448872756|FG005|PKC412A2104E2|Death|1|||
124792927|NCT00045942|448872757|FG006|PKC412A2104E2|Death|2|||
124792928|NCT00045942|448872758|FG007|PKC412A2104E2|Death|0|||
124792929|NCT00045942|448872759|FG008|PKC412A2104E2|Death|0|||
124792930|NCT02095132|448872760|FG000|Overall Study|Adverse Event|0|||
124792931|NCT02095132|448872761|FG001|Overall Study|Adverse Event|0|||
124792932|NCT02095132|448872762|FG002|Overall Study|Adverse Event|0|||
124792933|NCT02095132|448872763|FG003|Overall Study|Adverse Event|0|||
124792934|NCT02095132|448872764|FG004|Overall Study|Adverse Event|1|||
124792935|NCT02095132|448872765|FG005|Overall Study|Adverse Event|0|||
124792936|NCT02095132|448872766|FG006|Overall Study|Adverse Event|1|||
124792937|NCT02095132|448872767|FG007|Overall Study|Adverse Event|0|||
124792938|NCT02095132|448872768|FG008|Overall Study|Adverse Event|0|||
124629538|NCT02291237|448261102|FG000|Overall Study|Study Terminated by Sponsor|72|||
124792939|NCT02095132|448872760|FG000|Overall Study|Death|0|||
124629539|NCT02291237|448261103|FG001|Overall Study|Study Terminated by Sponsor|67|||
124629540|NCT02291237|448261102|FG000|Overall Study|Adverse Event|1|||
124792940|NCT02095132|448872761|FG001|Overall Study|Death|0|||
124792941|NCT02095132|448872762|FG002|Overall Study|Death|0|||
124792942|NCT02095132|448872763|FG003|Overall Study|Death|0|||
124792943|NCT02095132|448872764|FG004|Overall Study|Death|0|||
124792944|NCT02095132|448872765|FG005|Overall Study|Death|0|||
124792945|NCT02095132|448872766|FG006|Overall Study|Death|1|||
124792946|NCT02095132|448872767|FG007|Overall Study|Death|0|||
124792947|NCT02095132|448872768|FG008|Overall Study|Death|0|||
124792948|NCT02095132|448872760|FG000|Overall Study|Lack of Efficacy|3|||
124792949|NCT02095132|448872761|FG001|Overall Study|Lack of Efficacy|5|||
124792950|NCT02095132|448872762|FG002|Overall Study|Lack of Efficacy|2|||
124792951|NCT02095132|448872763|FG003|Overall Study|Lack of Efficacy|8|||
124792952|NCT02095132|448872764|FG004|Overall Study|Lack of Efficacy|3|||
124792953|NCT02095132|448872765|FG005|Overall Study|Lack of Efficacy|6|||
124792954|NCT02095132|448872766|FG006|Overall Study|Lack of Efficacy|10|||
124792955|NCT02095132|448872767|FG007|Overall Study|Lack of Efficacy|9|||
124792956|NCT02095132|448872768|FG008|Overall Study|Lack of Efficacy|8|||
124792957|NCT02095132|448872760|FG000|Overall Study|Physician Decision|1|||
124792958|NCT02095132|448872761|FG001|Overall Study|Physician Decision|0|||
124792959|NCT02095132|448872762|FG002|Overall Study|Physician Decision|0|||
124792960|NCT02095132|448872763|FG003|Overall Study|Physician Decision|0|||
124792961|NCT02095132|448872764|FG004|Overall Study|Physician Decision|0|||
124792962|NCT02095132|448872765|FG005|Overall Study|Physician Decision|0|||
124792963|NCT02095132|448872766|FG006|Overall Study|Physician Decision|1|||
124792964|NCT02095132|448872767|FG007|Overall Study|Physician Decision|0|||
124792965|NCT02095132|448872768|FG008|Overall Study|Physician Decision|2|||
124629541|NCT02291237|448261103|FG001|Overall Study|Adverse Event|3|||
124629542|NCT02291237|448261102|FG000|Overall Study|Investigator's Discretion|0|||
124629543|NCT02291237|448261103|FG001|Overall Study|Investigator's Discretion|3|||
124629544|NCT02291237|448261102|FG000|Overall Study|Withdrew Consent|11|||
124629545|NCT02291237|448261103|FG001|Overall Study|Withdrew Consent|11|||
124629546|NCT02291237|448261102|FG000|Overall Study|Lost to Follow-up|0|||
124629547|NCT02291237|448261103|FG001|Overall Study|Lost to Follow-up|2|||
124629548|NCT02291237|448261102|FG000|Overall Study|Subject Required Prohibited Medication|2|||
124792966|NCT02095132|448872760|FG000|Overall Study|Withdrawal by Subject|0|||
124792967|NCT02095132|448872761|FG001|Overall Study|Withdrawal by Subject|0|||
124792968|NCT02095132|448872762|FG002|Overall Study|Withdrawal by Subject|2|||
124792969|NCT02095132|448872763|FG003|Overall Study|Withdrawal by Subject|2|||
124792970|NCT02095132|448872764|FG004|Overall Study|Withdrawal by Subject|3|||
124792971|NCT02095132|448872765|FG005|Overall Study|Withdrawal by Subject|0|||
124792972|NCT02095132|448872766|FG006|Overall Study|Withdrawal by Subject|5|||
124792973|NCT02095132|448872767|FG007|Overall Study|Withdrawal by Subject|0|||
124792974|NCT02095132|448872768|FG008|Overall Study|Withdrawal by Subject|0|||
124792975|NCT01895361|448872772|FG000|Overall Study|Adverse Event|1|||
124792976|NCT01895361|448872773|FG001|Overall Study|Adverse Event|1|||
124792977|NCT01895361|448872774|FG002|Overall Study|Adverse Event|3|||
124792978|NCT01895361|448872772|FG000|Overall Study|Death|2|||
124792979|NCT01895361|448872773|FG001|Overall Study|Death|1|||
124792980|NCT01895361|448872774|FG002|Overall Study|Death|2|||
124792981|NCT01895361|448872772|FG000|Overall Study|Lost to Follow-up|4|||
124792982|NCT01895361|448872773|FG001|Overall Study|Lost to Follow-up|4|||
124792983|NCT01895361|448872774|FG002|Overall Study|Lost to Follow-up|6|||
124792984|NCT01895361|448872772|FG000|Overall Study|Non-compliance with study|1|||
124792985|NCT01895361|448872773|FG001|Overall Study|Non-compliance with study|3|||
124792986|NCT01895361|448872774|FG002|Overall Study|Non-compliance with study|1|||
124792987|NCT01895361|448872772|FG000|Overall Study|Physician Decision|2|||
124792988|NCT01895361|448872773|FG001|Overall Study|Physician Decision|2|||
124792989|NCT01895361|448872774|FG002|Overall Study|Physician Decision|2|||
124792990|NCT01895361|448872772|FG000|Overall Study|Withdrawal by Subject|7|||
124792991|NCT01895361|448872773|FG001|Overall Study|Withdrawal by Subject|6|||
124792992|NCT01895361|448872774|FG002|Overall Study|Withdrawal by Subject|6|||
124792993|NCT01895361|448872772|FG000|Overall Study|Lack of Efficacy|0|||
124792994|NCT01895361|448872773|FG001|Overall Study|Lack of Efficacy|1|||
124792995|NCT01895361|448872774|FG002|Overall Study|Lack of Efficacy|0|||
124792996|NCT01895361|448872772|FG000|Overall Study|Reasons different from categories above|7|||
124792997|NCT01895361|448872773|FG001|Overall Study|Reasons different from categories above|3|||
124792998|NCT01895361|448872774|FG002|Overall Study|Reasons different from categories above|4|||
124792999|NCT00761748|448872778|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
124793000|NCT00761748|448872779|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
124793001|NCT00761748|448872778|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
124793002|NCT00761748|448872779|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
124793003|NCT01209832|448872780|FG000|Period 1|Sponsor Decision and was not dosed|1|||
124793004|NCT01209832|448872780|FG000|Period 2|Sponsor Decision|1|||
124793005|NCT01268579|448872781|FG000|Overall Study|Adverse Event|1|||
124793006|NCT01268579|448872781|FG000|Overall Study|Withdrawal by Subject|2|||
124793007|NCT02692651|448872782|FG000|Study Treatment|Death|7|||
124793008|NCT02692651|448872783|FG001|Study Treatment|Death|3|||
124793009|NCT02692651|448872782|FG000|Study Treatment|comfort care|1|||
124793010|NCT02692651|448872783|FG001|Study Treatment|comfort care|1|||
124629549|NCT02291237|448261103|FG001|Overall Study|Subject Required Prohibited Medication|0|||
124629550|NCT01149863|448261104|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
124629551|NCT01306305|448261105|FG000|Overall Study|Lost to Follow-up|1|||
124629552|NCT01306305|448261106|FG001|Overall Study|Lost to Follow-up|0|||
124793011|NCT02692651|448872782|FG000|Study Treatment|Protocol violation per treating team preference|8|||
124793012|NCT02692651|448872783|FG001|Study Treatment|Protocol violation per treating team preference|6|||
124793013|NCT02692651|448872782|FG000|Post Study Treatment Follow-up|Death|4|||
124793014|NCT02692651|448872783|FG001|Post Study Treatment Follow-up|Death|4|||
124793015|NCT02480712|448872784|FG000|Overall Study|Enrolled but Never Treated|1|||
124629553|NCT01306305|448261105|FG000|Overall Study|Withdrew consent|1|||
124793016|NCT02480712|448872784|FG000|Overall Study|Lost to Follow-up|5|||
124793017|NCT02480712|448872784|FG000|Overall Study|Withdrew Consent|3|||
124629554|NCT01306305|448261106|FG001|Overall Study|Withdrew consent|0|||
124793018|NCT02480712|448872784|FG000|Overall Study|Death|1|||
124793019|NCT02480712|448872784|FG000|Overall Study|Lack of Efficacy|1|||
124793020|NCT02239120|448872785|FG000|Overall Study|Death|56|||
124793021|NCT02239120|448872786|FG001|Overall Study|Death|58|||
124793022|NCT02239120|448872785|FG000|Overall Study|Lost to Follow-up|19|||
124793023|NCT02239120|448872786|FG001|Overall Study|Lost to Follow-up|14|||
124793024|NCT01878149|448872791|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
124793025|NCT01878149|448872792|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
124793026|NCT02048241|448872793|FG000|Overall Study|Withdrawal by Subject|0|||
124793027|NCT02048241|448872794|FG001|Overall Study|Withdrawal by Subject|1|||
124793028|NCT00402233|448872795|FG000|Overall Study|Adverse Event|1|||
124793029|NCT00402233|448872796|FG001|Overall Study|Adverse Event|7|||
124793030|NCT00402233|448872797|FG002|Overall Study|Adverse Event|9|||
124793031|NCT00402233|448872798|FG003|Overall Study|Adverse Event|9|||
124793032|NCT00402233|448872795|FG000|Overall Study|Protocol Violation|0|||
124793033|NCT00402233|448872796|FG001|Overall Study|Protocol Violation|1|||
124793034|NCT00402233|448872797|FG002|Overall Study|Protocol Violation|0|||
124793035|NCT00402233|448872798|FG003|Overall Study|Protocol Violation|0|||
124793036|NCT00402233|448872795|FG000|Overall Study|Withdrawal by Subject|2|||
124793037|NCT00402233|448872796|FG001|Overall Study|Withdrawal by Subject|1|||
124793038|NCT00402233|448872797|FG002|Overall Study|Withdrawal by Subject|2|||
124793039|NCT00402233|448872798|FG003|Overall Study|Withdrawal by Subject|2|||
124793040|NCT00402233|448872795|FG000|Overall Study|Worsening of disease under study|2|||
124793041|NCT00402233|448872796|FG001|Overall Study|Worsening of disease under study|0|||
124793042|NCT00402233|448872797|FG002|Overall Study|Worsening of disease under study|0|||
124793043|NCT00402233|448872798|FG003|Overall Study|Worsening of disease under study|0|||
124793044|NCT00402233|448872795|FG000|Overall Study|Worsening of other pre-existing disease|0|||
124793045|NCT00402233|448872796|FG001|Overall Study|Worsening of other pre-existing disease|1|||
124793046|NCT00402233|448872797|FG002|Overall Study|Worsening of other pre-existing disease|0|||
124793047|NCT00402233|448872798|FG003|Overall Study|Worsening of other pre-existing disease|0|||
124793048|NCT04658940|448872802|FG000|Overall Study|Withdrawal by Subject|1|||
124793049|NCT03579602|448872803|FG000|Overall Study|Subject unable to receive study drug|0|||
124793050|NCT03579602|448872804|FG001|Overall Study|Subject unable to receive study drug|2|||
124793051|NCT03579602|448872803|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
124793052|NCT03579602|448872804|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
124793053|NCT02518464|448872805|FG000|Overall Study|Adverse Event|2|||
124793054|NCT01120067|448872808|FG000|Overall Study|Lost to Follow-up|3|||
124793055|NCT01120067|448872809|FG001|Overall Study|Lost to Follow-up|1|||
124793056|NCT01120067|448872808|FG000|Overall Study|fail to engage >3 sessions|2|||
124793057|NCT01120067|448872809|FG001|Overall Study|fail to engage >3 sessions|0|||
124793058|NCT00604214|448872829|FG000|Baseline to Day 28|Death|223|||
124793059|NCT00604214|448872830|FG001|Baseline to Day 28|Death|202|||
124793060|NCT00604214|448872829|FG000|Baseline to Day 28|Lost to Follow-up|2|||
124793061|NCT00604214|448872830|FG001|Baseline to Day 28|Lost to Follow-up|4|||
124793062|NCT00604214|448872829|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
124793063|NCT00604214|448872830|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
124793064|NCT00604214|448872829|FG000|Day 29 to Day 90|Death|64|||
124793065|NCT00604214|448872830|FG001|Day 29 to Day 90|Death|67|||
124793066|NCT00604214|448872829|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
124793067|NCT00604214|448872830|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
124793068|NCT00604214|448872829|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
124793069|NCT00604214|448872830|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
124793070|NCT00604214|448872829|FG000|Day 91 to Day 180|Death|19|||
124793071|NCT00604214|448872830|FG001|Day 91 to Day 180|Death|23|||
124793072|NCT00604214|448872829|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
124793073|NCT00604214|448872830|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
124793074|NCT00604214|448872829|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
124793075|NCT00604214|448872830|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
124793076|NCT00686998|448872831|FG000|Overall Study|Adverse Event|3|||
124793077|NCT00686998|448872832|FG001|Overall Study|Adverse Event|2|||
124793078|NCT00686998|448872833|FG002|Overall Study|Adverse Event|1|||
124793079|NCT00686998|448872831|FG000|Overall Study|Withdrawal by Subject|2|||
124793080|NCT00686998|448872832|FG001|Overall Study|Withdrawal by Subject|1|||
124793081|NCT00686998|448872833|FG002|Overall Study|Withdrawal by Subject|2|||
124793082|NCT00686998|448872831|FG000|Overall Study|Lack of Efficacy|7|||
124793083|NCT00686998|448872832|FG001|Overall Study|Lack of Efficacy|5|||
124793084|NCT00686998|448872833|FG002|Overall Study|Lack of Efficacy|0|||
124793085|NCT00686998|448872831|FG000|Overall Study|Other|0|||
124793086|NCT00686998|448872832|FG001|Overall Study|Other|0|||
124629555|NCT03326193|448261107|FG000|Overall Study|Sponsor decision|35|||
124793087|NCT00686998|448872833|FG002|Overall Study|Other|1|||
124793088|NCT00686998|448872831|FG000|Overall Study|Safety Reasons|1|||
124629556|NCT00699998|448261109|FG000|Overall Study|Withdrawal by Subject|194|||
124629557|NCT00699998|448261110|FG001|Overall Study|Withdrawal by Subject|83|||
124793089|NCT00686998|448872832|FG001|Overall Study|Safety Reasons|0|||
124793090|NCT00686998|448872833|FG002|Overall Study|Safety Reasons|0|||
124793091|NCT00130442|448874152|FG000|Overall Study|Withdrawal by Subject|0|||
124793092|NCT00130442|448874153|FG001|Overall Study|Withdrawal by Subject|1|||
124793093|NCT00130442|448874152|FG000|Overall Study|did not meet criteria|1|||
124793094|NCT00130442|448874153|FG001|Overall Study|did not meet criteria|1|||
124793095|NCT02233946|448874154|FG000|Baseline|Withdrawal by Subject|2|||
124793096|NCT02233946|448874155|FG001|Baseline|Withdrawal by Subject|0|||
124793097|NCT02233946|448874154|FG000|3-months Follow-up|Lost to Follow-up|53|||
124793098|NCT02233946|448874155|FG001|3-months Follow-up|Lost to Follow-up|29|||
124793099|NCT02233946|448874154|FG000|6-months Follow-up|Lost to Follow-up|21|||
124793100|NCT02233946|448874155|FG001|6-months Follow-up|Lost to Follow-up|2|||
124793101|NCT02233946|448874154|FG000|9-month Follow-up|Lost to Follow-up|20|||
124793102|NCT02233946|448874155|FG001|9-month Follow-up|Lost to Follow-up|11|||
124793103|NCT02233946|448874154|FG000|12-month Follow-up|Lost to Follow-up|28|||
124793104|NCT02233946|448874155|FG001|12-month Follow-up|Lost to Follow-up|11|||
124793105|NCT02054481|448874156|FG000|Overall Study|Adverse Event|1|||
124793106|NCT02054481|448874157|FG001|Overall Study|Adverse Event|1|||
124793107|NCT02054481|448874158|FG002|Overall Study|Adverse Event|0|||
124793108|NCT02054481|448874159|FG003|Overall Study|Adverse Event|1|||
124793109|NCT02054481|448874156|FG000|Overall Study|Lost to Follow-up|1|||
124793110|NCT02054481|448874157|FG001|Overall Study|Lost to Follow-up|0|||
124793111|NCT02054481|448874158|FG002|Overall Study|Lost to Follow-up|0|||
124793112|NCT02054481|448874159|FG003|Overall Study|Lost to Follow-up|0|||
124793113|NCT02054481|448874156|FG000|Overall Study|Other reason|2|||
124793114|NCT02054481|448874157|FG001|Overall Study|Other reason|1|||
124793115|NCT02054481|448874158|FG002|Overall Study|Other reason|2|||
124793116|NCT02054481|448874159|FG003|Overall Study|Other reason|0|||
124793117|NCT02320903|448874160|FG000|Overall Study|Withdrawal by Subject|0|||
124793118|NCT02320903|448874161|FG001|Overall Study|Withdrawal by Subject|9|||
124793119|NCT02320903|448874162|FG002|Overall Study|Withdrawal by Subject|9|||
124793120|NCT02320903|448874160|FG000|Overall Study|Exited therapy; no longer eligible|8|||
124793121|NCT02320903|448874161|FG001|Overall Study|Exited therapy; no longer eligible|2|||
124793122|NCT02320903|448874162|FG002|Overall Study|Exited therapy; no longer eligible|2|||
124793123|NCT02320903|448874160|FG000|Overall Study|Lost to Follow-up|0|||
124793124|NCT02320903|448874161|FG001|Overall Study|Lost to Follow-up|5|||
124793125|NCT02320903|448874162|FG002|Overall Study|Lost to Follow-up|5|||
124793126|NCT00773383|448874163|FG000|Overall Study|Adverse Event|4|||
124793127|NCT00773383|448874163|FG000|Overall Study|Death|1|||
124793128|NCT00773383|448874163|FG000|Overall Study|Progression of Disease|23|||
124793129|NCT00773383|448874163|FG000|Overall Study|Other|2|||
124793130|NCT00773383|448874163|FG000|Overall Study|No study dose received|1|||
124793131|NCT03384693|448874164|FG000|Overall Study|Adverse Event|3|||
124793132|NCT03621475|448874167|FG000|Overall Study|No longer required restraints at initiation|0|||
124793133|NCT03621475|448874168|FG001|Overall Study|No longer required restraints at initiation|1|||
124793134|NCT01095094|448874170|FG000|Overall Study|Withdrawal by Subject|1|||
124793135|NCT01095094|448874170|FG000|Overall Study|Death|1|||
124793136|NCT01095094|448874170|FG000|Overall Study|Physician Decision|1|||
124793137|NCT02093351|448874171|FG000|Part A|Adverse Event|0|||
124793138|NCT02093351|448874172|FG001|Part A|Adverse Event|1|||
124793139|NCT02093351|448874173|FG002|Part A|Adverse Event|1|||
124793140|NCT02093351|448874174|FG003|Part A|Adverse Event|0|||
124793141|NCT02093351|448874171|FG000|Part A|Condition under investigation worsened|2|||
124793142|NCT02093351|448874172|FG001|Part A|Condition under investigation worsened|0|||
124793143|NCT02093351|448874173|FG002|Part A|Condition under investigation worsened|2|||
124793144|NCT02093351|448874174|FG003|Part A|Condition under investigation worsened|0|||
124793145|NCT02093351|448874171|FG000|Part A|Death|0|||
124793146|NCT02093351|448874172|FG001|Part A|Death|1|||
124793147|NCT02093351|448874173|FG002|Part A|Death|0|||
124793148|NCT02093351|448874174|FG003|Part A|Death|0|||
124793149|NCT02093351|448874171|FG000|Part B|Patient decision|0|||
124793150|NCT02093351|448874172|FG001|Part B|Patient decision|0|||
124793151|NCT02093351|448874173|FG002|Part B|Patient decision|0|||
124793152|NCT02093351|448874174|FG003|Part B|Patient decision|3|||
124793153|NCT02093351|448874171|FG000|Part B|Disease progression|0|||
124793154|NCT02093351|448874172|FG001|Part B|Disease progression|0|||
124629558|NCT00699998|448261111|FG002|Overall Study|Withdrawal by Subject|202|||
124629559|NCT00699998|448261112|FG003|Overall Study|Withdrawal by Subject|80|||
124629560|NCT00699998|448261109|FG000|Overall Study|Physician Decision|3|||
124629561|NCT00699998|448261110|FG001|Overall Study|Physician Decision|2|||
124629562|NCT00699998|448261111|FG002|Overall Study|Physician Decision|1|||
124629563|NCT00699998|448261112|FG003|Overall Study|Physician Decision|1|||
124629564|NCT00699998|448261109|FG000|Overall Study|Lost to Follow-up|2|||
124793155|NCT02093351|448874173|FG002|Part B|Disease progression|0|||
124793156|NCT02093351|448874174|FG003|Part B|Disease progression|4|||
124793157|NCT02093351|448874171|FG000|Part B|Complete response|0|||
124793158|NCT02093351|448874172|FG001|Part B|Complete response|0|||
124793159|NCT02093351|448874173|FG002|Part B|Complete response|0|||
124793160|NCT02093351|448874174|FG003|Part B|Complete response|1|||
124793161|NCT02093351|448874171|FG000|Part B|Adverse event + disease progression|0|||
124793162|NCT02093351|448874172|FG001|Part B|Adverse event + disease progression|0|||
124793163|NCT02093351|448874173|FG002|Part B|Adverse event + disease progression|0|||
124793164|NCT02093351|448874174|FG003|Part B|Adverse event + disease progression|1|||
124793165|NCT02093351|448874171|FG000|Part B|Lack of therapeutic response|0|||
124793166|NCT02093351|448874172|FG001|Part B|Lack of therapeutic response|0|||
124793167|NCT02093351|448874173|FG002|Part B|Lack of therapeutic response|0|||
124793168|NCT02093351|448874174|FG003|Part B|Lack of therapeutic response|12|||
124793169|NCT02093351|448874171|FG000|Part B|Condition under investigation worsened|0|||
124793170|NCT02093351|448874172|FG001|Part B|Condition under investigation worsened|0|||
124793171|NCT02093351|448874173|FG002|Part B|Condition under investigation worsened|0|||
124793172|NCT02093351|448874174|FG003|Part B|Condition under investigation worsened|39|||
124793173|NCT02093351|448874171|FG000|Part B|Adverse Event|0|||
124793174|NCT02093351|448874172|FG001|Part B|Adverse Event|0|||
124793175|NCT02093351|448874173|FG002|Part B|Adverse Event|0|||
124793176|NCT02093351|448874174|FG003|Part B|Adverse Event|2|||
124793177|NCT02093351|448874171|FG000|Part B|Death|0|||
124793178|NCT02093351|448874172|FG001|Part B|Death|0|||
124793179|NCT02093351|448874173|FG002|Part B|Death|0|||
124793180|NCT02093351|448874174|FG003|Part B|Death|1|||
124793181|NCT01099709|448874175|FG000|Period 1|Withdrawal by Subject|0|||
124793182|NCT01099709|448874176|FG001|Period 1|Withdrawal by Subject|1|||
124793183|NCT01099709|448874175|FG000|Period 1|Positive cotinine test|0|||
124793184|NCT01099709|448874176|FG001|Period 1|Positive cotinine test|1|||
124793185|NCT01099709|448874175|FG000|Period 1|Adverse Event|1|||
124793186|NCT01099709|448874176|FG001|Period 1|Adverse Event|0|||
124793187|NCT01122394|448874184|FG000|Overall Study|Withdrawal by Subject|1|||
124793188|NCT01122394|448874185|FG001|Overall Study|Withdrawal by Subject|1|||
124793189|NCT01122394|448874184|FG000|Overall Study|Lost to Follow-up|2|||
124793190|NCT01122394|448874185|FG001|Overall Study|Lost to Follow-up|2|||
124793191|NCT01122394|448874184|FG000|Overall Study|Adverse Event|0|||
124793192|NCT01122394|448874185|FG001|Overall Study|Adverse Event|1|||
124793193|NCT00039871|448874186|FG000|Overall Study|Adverse Event|165|||
124793194|NCT00039871|448874186|FG000|Overall Study|Lost to Follow-up|18|||
124793195|NCT00039871|448874186|FG000|Overall Study|Protocol Violation|24|||
124793196|NCT00039871|448874186|FG000|Overall Study|Withdrawal by Subject|97|||
124793197|NCT00039871|448874186|FG000|Overall Study|Did not meet eligibility criteria|11|||
124793198|NCT00039871|448874186|FG000|Overall Study|Administrative|1|||
124793199|NCT00039871|448874186|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
124793200|NCT00039871|448874186|FG000|Overall Study|Never entered follow-up|7|||
124793201|NCT00815516|448874189|FG000|Overall Study|Death|3|||
124793202|NCT00815516|448874190|FG001|Overall Study|Death|1|||
124793203|NCT00815516|448874189|FG000|Overall Study|Physician Decision|1|||
124793204|NCT00815516|448874190|FG001|Overall Study|Physician Decision|0|||
124793205|NCT01736657|448874191|FG000|Overall Study|insufficient vascular access|1|||
124793206|NCT01992159|448874204|FG000|Overall Study|Withdrawal by Subject|4|||
124793207|NCT01992159|448874205|FG001|Overall Study|Withdrawal by Subject|7|||
124793208|NCT01992159|448874206|FG002|Overall Study|Withdrawal by Subject|0|||
124793209|NCT01992159|448874207|FG003|Overall Study|Withdrawal by Subject|3|||
124793210|NCT01992159|448874204|FG000|Overall Study|Adverse Event|0|||
124793211|NCT01992159|448874205|FG001|Overall Study|Adverse Event|1|||
124793212|NCT01992159|448874206|FG002|Overall Study|Adverse Event|0|||
124793213|NCT01992159|448874207|FG003|Overall Study|Adverse Event|1|||
124793214|NCT01992159|448874204|FG000|Overall Study|Death|0|||
124793215|NCT01992159|448874205|FG001|Overall Study|Death|0|||
124793216|NCT01992159|448874206|FG002|Overall Study|Death|1|||
124793217|NCT01992159|448874207|FG003|Overall Study|Death|0|||
124793218|NCT03023046|448874210|FG000|Overall Study|Withdrawal by Subject|1|||
124793219|NCT02278471|448874211|FG000|Overall Study|Lost to Follow-up|6|||
124793220|NCT02278471|448874212|FG001|Overall Study|Lost to Follow-up|15|||
124793221|NCT02278471|448874211|FG000|Overall Study|Death|2|||
124793222|NCT02278471|448874212|FG001|Overall Study|Death|2|||
124793223|NCT02278471|448874211|FG000|Overall Study|Withdrawal by Subject|0|||
124793224|NCT02278471|448874212|FG001|Overall Study|Withdrawal by Subject|3|||
124793225|NCT00640835|448874213|FG000|Overall Study|Adverse Event|5|||
124793226|NCT00640835|448874214|FG001|Overall Study|Adverse Event|3|||
124793227|NCT00640835|448874213|FG000|Overall Study|Withdrawal by Subject|12|||
124793228|NCT00640835|448874214|FG001|Overall Study|Withdrawal by Subject|14|||
124793229|NCT00640835|448874213|FG000|Overall Study|Physician Decision|10|||
124793230|NCT00640835|448874214|FG001|Overall Study|Physician Decision|14|||
124793231|NCT00640835|448874213|FG000|Overall Study|Sponsor's Decision|11|||
124793232|NCT00640835|448874214|FG001|Overall Study|Sponsor's Decision|7|||
124793233|NCT00640835|448874213|FG000|Overall Study|Protocol Violation|2|||
124793234|NCT00640835|448874214|FG001|Overall Study|Protocol Violation|2|||
124793235|NCT00640835|448874213|FG000|Overall Study|Lost to Follow-up|17|||
124793236|NCT00640835|448874214|FG001|Overall Study|Lost to Follow-up|13|||
124793237|NCT00640835|448874213|FG000|Overall Study|Other Reason|19|||
124793238|NCT00640835|448874214|FG001|Overall Study|Other Reason|4|||
124793239|NCT01741012|448874215|FG000|Overall Study|Lost to Follow-up|1|||
124793240|NCT01741012|448874215|FG000|Overall Study|Withdrawal by Subject|2|||
124793241|NCT03468543|448874216|FG000|Overall Study|Protocol stopping rules met|3|||
124793242|NCT04618770|448874219|FG000|Overall Study|Censored from Analysis|12|||
124793243|NCT04618770|448874219|FG000|Overall Study|Early Termination|25|||
124793244|NCT04393298|448874220|FG000|Overall Study|Adverse Event|0|||
124793245|NCT04393298|448874221|FG001|Overall Study|Adverse Event|0|||
124793246|NCT04393298|448874222|FG002|Overall Study|Adverse Event|0|||
124793247|NCT04393298|448874223|FG003|Overall Study|Adverse Event|0|||
124793248|NCT04393298|448874224|FG004|Overall Study|Adverse Event|1|||
124793249|NCT04393298|448874225|FG005|Overall Study|Adverse Event|0|||
124793250|NCT04393298|448874226|FG006|Overall Study|Adverse Event|0|||
124793251|NCT04393298|448874227|FG007|Overall Study|Adverse Event|0|||
124793252|NCT04393298|448874228|FG008|Overall Study|Adverse Event|2|||
124793253|NCT04393298|448874229|FG009|Overall Study|Adverse Event|0|||
124793254|NCT04393298|448874230|FG010|Overall Study|Adverse Event|0|||
124793255|NCT04393298|448874231|FG011|Overall Study|Adverse Event|0|||
124793256|NCT04393298|448874232|FG012|Overall Study|Adverse Event|1|||
124793257|NCT04393298|448874233|FG013|Overall Study|Adverse Event|1|||
124793258|NCT04393298|448874234|FG014|Overall Study|Adverse Event|0|||
124793259|NCT04393298|448874220|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793260|NCT04393298|448874221|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793261|NCT04393298|448874222|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
124793262|NCT04393298|448874223|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793263|NCT04393298|448874224|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793264|NCT04393298|448874225|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793265|NCT04393298|448874226|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793266|NCT04393298|448874227|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793267|NCT04393298|448874228|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793268|NCT04393298|448874229|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793269|NCT04393298|448874230|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793270|NCT04393298|448874231|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793271|NCT04393298|448874232|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793272|NCT04393298|448874233|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
124793273|NCT04393298|448874234|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
124793274|NCT04393298|448874220|FG000|Overall Study|Lack of Efficacy|0|||
124793275|NCT04393298|448874221|FG001|Overall Study|Lack of Efficacy|0|||
124793276|NCT04393298|448874222|FG002|Overall Study|Lack of Efficacy|0|||
124793277|NCT04393298|448874223|FG003|Overall Study|Lack of Efficacy|0|||
124793278|NCT04393298|448874224|FG004|Overall Study|Lack of Efficacy|0|||
124793279|NCT04393298|448874225|FG005|Overall Study|Lack of Efficacy|0|||
124793280|NCT04393298|448874226|FG006|Overall Study|Lack of Efficacy|0|||
124793281|NCT04393298|448874227|FG007|Overall Study|Lack of Efficacy|0|||
124793282|NCT04393298|448874228|FG008|Overall Study|Lack of Efficacy|0|||
124793283|NCT04393298|448874229|FG009|Overall Study|Lack of Efficacy|0|||
124793284|NCT04393298|448874230|FG010|Overall Study|Lack of Efficacy|0|||
124793285|NCT04393298|448874231|FG011|Overall Study|Lack of Efficacy|0|||
124793286|NCT04393298|448874232|FG012|Overall Study|Lack of Efficacy|0|||
124793287|NCT04393298|448874233|FG013|Overall Study|Lack of Efficacy|0|||
124793288|NCT04393298|448874234|FG014|Overall Study|Lack of Efficacy|1|||
124793289|NCT04393298|448874220|FG000|Overall Study|Progression|1|||
124793290|NCT04393298|448874221|FG001|Overall Study|Progression|0|||
124793291|NCT04393298|448874222|FG002|Overall Study|Progression|0|||
124793292|NCT04393298|448874223|FG003|Overall Study|Progression|0|||
124793293|NCT04393298|448874224|FG004|Overall Study|Progression|0|||
124793294|NCT04393298|448874225|FG005|Overall Study|Progression|0|||
124793295|NCT04393298|448874226|FG006|Overall Study|Progression|0|||
124793296|NCT04393298|448874227|FG007|Overall Study|Progression|0|||
124793297|NCT04393298|448874228|FG008|Overall Study|Progression|0|||
124793298|NCT04393298|448874229|FG009|Overall Study|Progression|0|||
124793299|NCT04393298|448874230|FG010|Overall Study|Progression|1|||
124793300|NCT04393298|448874231|FG011|Overall Study|Progression|1|||
124793301|NCT04393298|448874232|FG012|Overall Study|Progression|0|||
124793302|NCT04393298|448874233|FG013|Overall Study|Progression|0|||
124793303|NCT04393298|448874234|FG014|Overall Study|Progression|0|||
124793304|NCT04393298|448874220|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
124793305|NCT04393298|448874221|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
124629565|NCT00699998|448261110|FG001|Overall Study|Lost to Follow-up|1|||
124629566|NCT00699998|448261111|FG002|Overall Study|Lost to Follow-up|3|||
124629567|NCT00699998|448261112|FG003|Overall Study|Lost to Follow-up|1|||
124793306|NCT04393298|448874222|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793307|NCT04393298|448874223|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793308|NCT04393298|448874224|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793309|NCT04393298|448874225|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793310|NCT04393298|448874226|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793311|NCT04393298|448874227|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793312|NCT04393298|448874228|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793313|NCT04393298|448874229|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793314|NCT04393298|448874230|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
124629568|NCT04052620|448261113|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
124793315|NCT04393298|448874231|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793316|NCT04393298|448874232|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793317|NCT04393298|448874233|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793318|NCT04393298|448874234|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
124793319|NCT04393298|448874220|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793320|NCT04393298|448874221|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
124793321|NCT04393298|448874222|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793322|NCT04393298|448874223|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793323|NCT04393298|448874224|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793324|NCT04393298|448874225|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793325|NCT04393298|448874226|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793326|NCT04393298|448874227|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793327|NCT04393298|448874228|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793328|NCT04393298|448874229|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793329|NCT04393298|448874230|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793330|NCT04393298|448874231|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793331|NCT04393298|448874232|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793332|NCT04393298|448874233|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793333|NCT04393298|448874234|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
124793334|NCT04393298|448874220|FG000|Overall Study|Clinical Progression|0|||
124793335|NCT04393298|448874221|FG001|Overall Study|Clinical Progression|2|||
124793336|NCT04393298|448874222|FG002|Overall Study|Clinical Progression|0|||
124793337|NCT04393298|448874223|FG003|Overall Study|Clinical Progression|0|||
124793338|NCT04393298|448874224|FG004|Overall Study|Clinical Progression|0|||
124793339|NCT04393298|448874225|FG005|Overall Study|Clinical Progression|0|||
124793340|NCT04393298|448874226|FG006|Overall Study|Clinical Progression|0|||
124793341|NCT04393298|448874227|FG007|Overall Study|Clinical Progression|0|||
124793342|NCT04393298|448874228|FG008|Overall Study|Clinical Progression|0|||
124793343|NCT04393298|448874229|FG009|Overall Study|Clinical Progression|0|||
124793344|NCT04393298|448874230|FG010|Overall Study|Clinical Progression|0|||
124793345|NCT04393298|448874231|FG011|Overall Study|Clinical Progression|0|||
124793346|NCT04393298|448874232|FG012|Overall Study|Clinical Progression|0|||
124793347|NCT04393298|448874233|FG013|Overall Study|Clinical Progression|0|||
124793348|NCT04393298|448874234|FG014|Overall Study|Clinical Progression|0|||
124793349|NCT04393298|448874220|FG000|Overall Study|Disease Progression|0|||
124793350|NCT04393298|448874221|FG001|Overall Study|Disease Progression|1|||
124793351|NCT04393298|448874222|FG002|Overall Study|Disease Progression|0|||
124793352|NCT04393298|448874223|FG003|Overall Study|Disease Progression|0|||
124793353|NCT04393298|448874224|FG004|Overall Study|Disease Progression|0|||
124793354|NCT04393298|448874225|FG005|Overall Study|Disease Progression|3|||
124793355|NCT04393298|448874226|FG006|Overall Study|Disease Progression|2|||
124793356|NCT04393298|448874227|FG007|Overall Study|Disease Progression|1|||
124793357|NCT04393298|448874228|FG008|Overall Study|Disease Progression|2|||
124793358|NCT04393298|448874229|FG009|Overall Study|Disease Progression|1|||
124793359|NCT04393298|448874230|FG010|Overall Study|Disease Progression|0|||
124793360|NCT04393298|448874231|FG011|Overall Study|Disease Progression|3|||
124793361|NCT04393298|448874232|FG012|Overall Study|Disease Progression|0|||
124793362|NCT04393298|448874233|FG013|Overall Study|Disease Progression|0|||
124793363|NCT04393298|448874234|FG014|Overall Study|Disease Progression|1|||
124793364|NCT04393298|448874220|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793365|NCT04393298|448874221|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793366|NCT04393298|448874222|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
124793367|NCT04393298|448874223|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793368|NCT04393298|448874224|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793369|NCT04393298|448874225|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793370|NCT04393298|448874226|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793371|NCT04393298|448874227|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793372|NCT04393298|448874228|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793373|NCT04393298|448874229|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793374|NCT04393298|448874230|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793375|NCT04393298|448874231|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793376|NCT04393298|448874232|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793377|NCT04393298|448874233|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793378|NCT04393298|448874234|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
124793379|NCT04393298|448874220|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793380|NCT04393298|448874221|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793381|NCT04393298|448874222|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
124793382|NCT04393298|448874223|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793383|NCT04393298|448874224|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793384|NCT04393298|448874225|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793385|NCT04393298|448874226|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793386|NCT04393298|448874227|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793387|NCT04393298|448874228|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793388|NCT04393298|448874229|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793389|NCT04393298|448874230|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793390|NCT04393298|448874231|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793391|NCT04393298|448874232|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793392|NCT04393298|448874233|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793393|NCT04393298|448874234|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
124793394|NCT04393298|448874220|FG000|Overall Study|Progressive Disease (PD)|0|||
124793395|NCT04393298|448874221|FG001|Overall Study|Progressive Disease (PD)|0|||
124793396|NCT04393298|448874222|FG002|Overall Study|Progressive Disease (PD)|0|||
124793397|NCT04393298|448874223|FG003|Overall Study|Progressive Disease (PD)|3|||
124793398|NCT04393298|448874224|FG004|Overall Study|Progressive Disease (PD)|0|||
124793399|NCT04393298|448874225|FG005|Overall Study|Progressive Disease (PD)|0|||
124793400|NCT04393298|448874226|FG006|Overall Study|Progressive Disease (PD)|0|||
124793401|NCT04393298|448874227|FG007|Overall Study|Progressive Disease (PD)|0|||
124793402|NCT04393298|448874228|FG008|Overall Study|Progressive Disease (PD)|0|||
124793403|NCT04393298|448874229|FG009|Overall Study|Progressive Disease (PD)|0|||
124793404|NCT04393298|448874230|FG010|Overall Study|Progressive Disease (PD)|0|||
124793405|NCT04393298|448874231|FG011|Overall Study|Progressive Disease (PD)|0|||
124793406|NCT04393298|448874232|FG012|Overall Study|Progressive Disease (PD)|0|||
124793407|NCT04393298|448874233|FG013|Overall Study|Progressive Disease (PD)|0|||
124793408|NCT04393298|448874234|FG014|Overall Study|Progressive Disease (PD)|0|||
124793409|NCT04393298|448874220|FG000|Overall Study|Started a New Cancer Treatment|0|||
124793410|NCT04393298|448874221|FG001|Overall Study|Started a New Cancer Treatment|0|||
124793411|NCT04393298|448874222|FG002|Overall Study|Started a New Cancer Treatment|0|||
124793412|NCT04393298|448874223|FG003|Overall Study|Started a New Cancer Treatment|0|||
124793413|NCT04393298|448874224|FG004|Overall Study|Started a New Cancer Treatment|1|||
124793414|NCT04393298|448874225|FG005|Overall Study|Started a New Cancer Treatment|0|||
124793415|NCT04393298|448874226|FG006|Overall Study|Started a New Cancer Treatment|0|||
124629569|NCT04052620|448261114|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
124629570|NCT04052620|448261113|FG000|Overall Study|Withdrawal by Subject|1|||
124629571|NCT04052620|448261114|FG001|Overall Study|Withdrawal by Subject|0|||
124629572|NCT04052620|448261113|FG000|Overall Study|Lost to Follow-up|1|||
124629573|NCT04052620|448261114|FG001|Overall Study|Lost to Follow-up|1|||
124629574|NCT04052620|448261113|FG000|Overall Study|Adverse Event|1|||
124629575|NCT04052620|448261114|FG001|Overall Study|Adverse Event|0|||
124629576|NCT04052620|448261113|FG000|Overall Study|Subject did not meet study Criteria|0|||
124629577|NCT04052620|448261114|FG001|Overall Study|Subject did not meet study Criteria|1|||
124629578|NCT04052620|448261113|FG000|Overall Study|Screened failure, randomized by mistake|0|||
124629579|NCT04052620|448261114|FG001|Overall Study|Screened failure, randomized by mistake|1|||
124629580|NCT04052620|448261113|FG000|Overall Study|Personal reasons|2|||
124629581|NCT04052620|448261114|FG001|Overall Study|Personal reasons|4|||
124629582|NCT04052620|448261113|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
124629583|NCT04052620|448261114|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
124629584|NCT01406574|448261115|FG000|Overall Study|Adverse Event|0|||
124629585|NCT01406574|448261116|FG001|Overall Study|Adverse Event|0|||
124629586|NCT01406574|448261117|FG002|Overall Study|Adverse Event|1|||
124629587|NCT01406574|448261118|FG003|Overall Study|Adverse Event|3|||
124629588|NCT01406574|448261115|FG000|Overall Study|Physician Decision|0|||
124629589|NCT01406574|448261116|FG001|Overall Study|Physician Decision|0|||
124629590|NCT01406574|448261117|FG002|Overall Study|Physician Decision|0|||
124629591|NCT01406574|448261118|FG003|Overall Study|Physician Decision|1|||
124629592|NCT01406574|448261115|FG000|Overall Study|Withdrawal by Subject|0|||
124629593|NCT01406574|448261116|FG001|Overall Study|Withdrawal by Subject|1|||
124629594|NCT01406574|448261117|FG002|Overall Study|Withdrawal by Subject|0|||
124629595|NCT01406574|448261118|FG003|Overall Study|Withdrawal by Subject|0|||
124629596|NCT01406574|448261115|FG000|Overall Study|Definite progression of primary disease|1|||
124629597|NCT01406574|448261116|FG001|Overall Study|Definite progression of primary disease|0|||
124629598|NCT01406574|448261117|FG002|Overall Study|Definite progression of primary disease|0|||
124629599|NCT01406574|448261118|FG003|Overall Study|Definite progression of primary disease|0|||
124629600|NCT03552380|448261119|FG000|Study Treatment|Disease Progression|3|||
124629601|NCT03552380|448261120|FG001|Study Treatment|Disease Progression|4|||
124629602|NCT03552380|448261119|FG000|Study Treatment|Adverse Event|2|||
124793416|NCT04393298|448874227|FG007|Overall Study|Started a New Cancer Treatment|0|||
124793417|NCT04393298|448874228|FG008|Overall Study|Started a New Cancer Treatment|0|||
124793418|NCT04393298|448874229|FG009|Overall Study|Started a New Cancer Treatment|0|||
124629603|NCT03552380|448261120|FG001|Study Treatment|Adverse Event|2|||
124629604|NCT03552380|448261119|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
124629605|NCT03552380|448261120|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
124629606|NCT03552380|448261119|FG000|Follow up|Death|3|||
124629607|NCT03552380|448261120|FG001|Follow up|Death|4|||
124629608|NCT03552380|448261119|FG000|Follow up|Site IRB terminated|0|||
124629609|NCT03552380|448261120|FG001|Follow up|Site IRB terminated|1|||
124629610|NCT02431364|448261125|FG000|Overall Study|Adverse Event|0|||
124629611|NCT02431364|448261126|FG001|Overall Study|Adverse Event|1|||
124629612|NCT02431364|448261127|FG002|Overall Study|Adverse Event|0|||
124629613|NCT02431364|448261128|FG003|Overall Study|Adverse Event|0|||
124629614|NCT02431364|448261129|FG004|Overall Study|Adverse Event|0|||
124629615|NCT02431364|448261125|FG000|Overall Study|Randomized but never treated|0|||
124629616|NCT02431364|448261126|FG001|Overall Study|Randomized but never treated|0|||
124629617|NCT02431364|448261127|FG002|Overall Study|Randomized but never treated|0|||
124629618|NCT02431364|448261128|FG003|Overall Study|Randomized but never treated|1|||
124629619|NCT02431364|448261129|FG004|Overall Study|Randomized but never treated|0|||
124629620|NCT00916383|448261130|FG000|Overall Study|Adverse Event|1|||
124629621|NCT00916383|448261130|FG000|Overall Study|Death|1|||
124629622|NCT00916383|448261130|FG000|Overall Study|Protocol Violation|1|||
124629623|NCT00258960|448261131|FG000|Overall Study|Death|2|||
124629624|NCT00258960|448261131|FG000|Overall Study|Disease Progression|7|||
124629625|NCT00258960|448261131|FG000|Overall Study|Adverse Event|4|||
124629626|NCT00258960|448261131|FG000|Overall Study|Physician Decision|1|||
124629627|NCT00258960|448261131|FG000|Overall Study|Withdrawal by Subject|1|||
124629628|NCT00258960|448261131|FG000|Overall Study|Mistake|2|||
124629629|NCT00473590|448261132|FG000|Overall Study|Adverse Event|3|||
124629630|NCT00473590|448261133|FG001|Overall Study|Adverse Event|3|||
124629631|NCT00473590|448261132|FG000|Overall Study|Death|4|||
124629632|NCT00473590|448261133|FG001|Overall Study|Death|2|||
124629633|NCT00473590|448261132|FG000|Overall Study|Progression not resulting in death|24|||
124629634|NCT00473590|448261133|FG001|Overall Study|Progression not resulting in death|20|||
124629635|NCT00473590|448261132|FG000|Overall Study|Non-protocol-specified therapy|7|||
124629636|NCT00473590|448261133|FG001|Overall Study|Non-protocol-specified therapy|5|||
124629637|NCT00473590|448261132|FG000|Overall Study|Physician Decision|2|||
124629638|NCT00473590|448261133|FG001|Overall Study|Physician Decision|4|||
124629639|NCT00473590|448261132|FG000|Overall Study|Withdrawal by Subject|5|||
124629640|NCT00473590|448261133|FG001|Overall Study|Withdrawal by Subject|3|||
124629641|NCT00473590|448261132|FG000|Overall Study|Other|0|||
124629642|NCT00473590|448261133|FG001|Overall Study|Other|1|||
124793419|NCT04393298|448874230|FG010|Overall Study|Started a New Cancer Treatment|0|||
124793420|NCT04393298|448874231|FG011|Overall Study|Started a New Cancer Treatment|0|||
124793421|NCT04393298|448874232|FG012|Overall Study|Started a New Cancer Treatment|0|||
124793422|NCT04393298|448874233|FG013|Overall Study|Started a New Cancer Treatment|0|||
124793423|NCT04393298|448874234|FG014|Overall Study|Started a New Cancer Treatment|0|||
124793424|NCT04393298|448874220|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793425|NCT04393298|448874221|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793426|NCT04393298|448874222|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793427|NCT04393298|448874223|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793428|NCT04393298|448874224|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
124793429|NCT04393298|448874225|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793430|NCT04393298|448874226|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793431|NCT04393298|448874227|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793432|NCT04393298|448874228|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793433|NCT04393298|448874229|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793434|NCT04393298|448874230|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793435|NCT04393298|448874231|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793436|NCT04393298|448874232|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793437|NCT04393298|448874233|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124793438|NCT04393298|448874234|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
124629643|NCT01112059|448261136|FG000|Overall Study|Withdrawal by Subject|1|||
124629644|NCT01112059|448261137|FG001|Overall Study|Withdrawal by Subject|0|||
124629645|NCT03367819|448261140|FG000|Overall Study|Adverse Event|4|||
124629646|NCT03367819|448261141|FG001|Overall Study|Adverse Event|4|||
124629647|NCT03367819|448261140|FG000|Overall Study|Progressive Disease|15|||
124629648|NCT03367819|448261141|FG001|Overall Study|Progressive Disease|13|||
124629649|NCT03367819|448261140|FG000|Overall Study|Withdrawal by Subject|1|||
124629650|NCT03367819|448261141|FG001|Overall Study|Withdrawal by Subject|0|||
124629651|NCT03367819|448261140|FG000|Overall Study|Other|4|||
124629652|NCT03367819|448261141|FG001|Overall Study|Other|2|||
124629653|NCT00725920|448261142|FG000|Overall Study|Lack of Efficacy|3|||
124629654|NCT00725920|448261143|FG001|Overall Study|Lack of Efficacy|6|||
124629655|NCT03918629|448261144|FG000|Overall Study|Adverse Event|19|||
124629656|NCT03918629|448261145|FG001|Overall Study|Adverse Event|20|||
124629657|NCT03918629|448261144|FG000|Overall Study|Death|14|||
124629658|NCT03918629|448261145|FG001|Overall Study|Death|7|||
124793439|NCT04393298|448874220|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793440|NCT04393298|448874221|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793441|NCT04393298|448874222|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793442|NCT04393298|448874223|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793443|NCT04393298|448874224|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793444|NCT04393298|448874225|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
124793445|NCT04393298|448874226|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793446|NCT04393298|448874227|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793447|NCT04393298|448874228|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793448|NCT04393298|448874229|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793449|NCT04393298|448874230|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793450|NCT04393298|448874231|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793451|NCT04393298|448874232|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793452|NCT04393298|448874233|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793453|NCT04393298|448874234|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
124793454|NCT04393298|448874220|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793455|NCT04393298|448874221|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793456|NCT04393298|448874222|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793457|NCT04393298|448874223|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793458|NCT04393298|448874224|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793459|NCT04393298|448874225|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
124793460|NCT04393298|448874226|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793461|NCT04393298|448874227|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793462|NCT04393298|448874228|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793463|NCT04393298|448874229|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793464|NCT04393298|448874230|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793465|NCT04393298|448874231|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793466|NCT04393298|448874232|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793467|NCT04393298|448874233|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
124793468|NCT04393298|448874234|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
124793469|NCT04393298|448874220|FG000|Overall Study|Death|0|||
124793470|NCT04393298|448874221|FG001|Overall Study|Death|0|||
124793471|NCT04393298|448874222|FG002|Overall Study|Death|0|||
124793472|NCT04393298|448874223|FG003|Overall Study|Death|0|||
124793473|NCT04393298|448874224|FG004|Overall Study|Death|0|||
124793474|NCT04393298|448874225|FG005|Overall Study|Death|1|||
124793475|NCT04393298|448874226|FG006|Overall Study|Death|1|||
124793476|NCT04393298|448874227|FG007|Overall Study|Death|0|||
124793477|NCT04393298|448874228|FG008|Overall Study|Death|1|||
124793478|NCT04393298|448874229|FG009|Overall Study|Death|1|||
124793479|NCT04393298|448874230|FG010|Overall Study|Death|0|||
124793480|NCT04393298|448874231|FG011|Overall Study|Death|1|||
124793481|NCT04393298|448874232|FG012|Overall Study|Death|1|||
124793482|NCT04393298|448874233|FG013|Overall Study|Death|0|||
124793483|NCT04393298|448874234|FG014|Overall Study|Death|1|||
124793484|NCT04393298|448874220|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793485|NCT04393298|448874221|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793486|NCT04393298|448874222|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793487|NCT04393298|448874223|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793488|NCT04393298|448874224|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793489|NCT04393298|448874225|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
124793490|NCT04393298|448874226|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793491|NCT04393298|448874227|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793492|NCT04393298|448874228|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793493|NCT04393298|448874229|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793494|NCT04393298|448874230|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793495|NCT04393298|448874231|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793496|NCT04393298|448874232|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793497|NCT04393298|448874233|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124629659|NCT03918629|448261144|FG000|Overall Study|Lost to Follow-up|36|||
124629660|NCT03918629|448261145|FG001|Overall Study|Lost to Follow-up|28|||
124793498|NCT04393298|448874234|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
124793499|NCT04393298|448874220|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
124793500|NCT04393298|448874221|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
124793501|NCT04393298|448874222|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
124629661|NCT03918629|448261144|FG000|Overall Study|Physician Decision|1|||
124629662|NCT03918629|448261145|FG001|Overall Study|Physician Decision|0|||
124629663|NCT03918629|448261144|FG000|Overall Study|Protocol Violation|7|||
124793502|NCT04393298|448874223|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
124793503|NCT04393298|448874224|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
124793504|NCT04393298|448874225|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
124793505|NCT04393298|448874226|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
124793506|NCT04393298|448874227|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
124793507|NCT04393298|448874228|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
124793508|NCT04393298|448874229|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
124793509|NCT04393298|448874230|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
124793510|NCT04393298|448874231|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
124793511|NCT04393298|448874232|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
124793512|NCT04393298|448874233|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
124793513|NCT04393298|448874234|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
124793514|NCT04393298|448874220|FG000|Overall Study|Patient Passed Away|0|||
124793515|NCT04393298|448874221|FG001|Overall Study|Patient Passed Away|0|||
124793516|NCT04393298|448874222|FG002|Overall Study|Patient Passed Away|0|||
124793517|NCT04393298|448874223|FG003|Overall Study|Patient Passed Away|0|||
124793518|NCT04393298|448874224|FG004|Overall Study|Patient Passed Away|0|||
124793519|NCT04393298|448874225|FG005|Overall Study|Patient Passed Away|0|||
124793520|NCT04393298|448874226|FG006|Overall Study|Patient Passed Away|0|||
124793521|NCT04393298|448874227|FG007|Overall Study|Patient Passed Away|1|||
124793522|NCT04393298|448874228|FG008|Overall Study|Patient Passed Away|0|||
124793523|NCT04393298|448874229|FG009|Overall Study|Patient Passed Away|0|||
124793524|NCT04393298|448874230|FG010|Overall Study|Patient Passed Away|0|||
124793525|NCT04393298|448874231|FG011|Overall Study|Patient Passed Away|0|||
124793526|NCT04393298|448874232|FG012|Overall Study|Patient Passed Away|0|||
124793527|NCT04393298|448874233|FG013|Overall Study|Patient Passed Away|0|||
124793528|NCT04393298|448874234|FG014|Overall Study|Patient Passed Away|0|||
124793529|NCT04393298|448874220|FG000|Overall Study|Patient Deceased|0|||
124793530|NCT04393298|448874221|FG001|Overall Study|Patient Deceased|0|||
124793531|NCT04393298|448874222|FG002|Overall Study|Patient Deceased|0|||
124793532|NCT04393298|448874223|FG003|Overall Study|Patient Deceased|0|||
124793533|NCT04393298|448874224|FG004|Overall Study|Patient Deceased|0|||
124793534|NCT04393298|448874225|FG005|Overall Study|Patient Deceased|0|||
124793535|NCT04393298|448874226|FG006|Overall Study|Patient Deceased|0|||
124793536|NCT04393298|448874227|FG007|Overall Study|Patient Deceased|1|||
124793537|NCT04393298|448874228|FG008|Overall Study|Patient Deceased|0|||
124793538|NCT04393298|448874229|FG009|Overall Study|Patient Deceased|0|||
124793539|NCT04393298|448874230|FG010|Overall Study|Patient Deceased|0|||
124793540|NCT04393298|448874231|FG011|Overall Study|Patient Deceased|0|||
124793541|NCT04393298|448874232|FG012|Overall Study|Patient Deceased|0|||
124793542|NCT04393298|448874233|FG013|Overall Study|Patient Deceased|0|||
124793543|NCT04393298|448874234|FG014|Overall Study|Patient Deceased|0|||
124793544|NCT04393298|448874220|FG000|Overall Study|Patient Discharged to Hospice|0|||
124793545|NCT04393298|448874221|FG001|Overall Study|Patient Discharged to Hospice|0|||
124793546|NCT04393298|448874222|FG002|Overall Study|Patient Discharged to Hospice|0|||
124793547|NCT04393298|448874223|FG003|Overall Study|Patient Discharged to Hospice|0|||
124793548|NCT04393298|448874224|FG004|Overall Study|Patient Discharged to Hospice|0|||
124793549|NCT04393298|448874225|FG005|Overall Study|Patient Discharged to Hospice|0|||
124793550|NCT04393298|448874226|FG006|Overall Study|Patient Discharged to Hospice|0|||
124793551|NCT04393298|448874227|FG007|Overall Study|Patient Discharged to Hospice|0|||
124793552|NCT04393298|448874228|FG008|Overall Study|Patient Discharged to Hospice|1|||
124793553|NCT04393298|448874229|FG009|Overall Study|Patient Discharged to Hospice|0|||
124793554|NCT04393298|448874230|FG010|Overall Study|Patient Discharged to Hospice|0|||
124793555|NCT04393298|448874231|FG011|Overall Study|Patient Discharged to Hospice|0|||
124793556|NCT04393298|448874232|FG012|Overall Study|Patient Discharged to Hospice|0|||
124793557|NCT04393298|448874233|FG013|Overall Study|Patient Discharged to Hospice|0|||
124793558|NCT04393298|448874234|FG014|Overall Study|Patient Discharged to Hospice|0|||
124793559|NCT04393298|448874220|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793560|NCT04393298|448874221|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793561|NCT04393298|448874222|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793562|NCT04393298|448874223|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793563|NCT04393298|448874224|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124629664|NCT03918629|448261145|FG001|Overall Study|Protocol Violation|4|||
124793564|NCT04393298|448874225|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124629665|NCT03918629|448261144|FG000|Overall Study|Withdrawal by Subject|47|||
124793565|NCT04393298|448874226|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793566|NCT04393298|448874227|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793567|NCT04393298|448874228|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793568|NCT04393298|448874229|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
124793569|NCT04393298|448874230|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793570|NCT04393298|448874231|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793571|NCT04393298|448874232|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124629666|NCT03918629|448261145|FG001|Overall Study|Withdrawal by Subject|47|||
124793572|NCT04393298|448874233|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793573|NCT04393298|448874234|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
124793574|NCT04393298|448874220|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
124793575|NCT04393298|448874221|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
124793576|NCT04393298|448874222|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
124793577|NCT04393298|448874223|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
124793578|NCT04393298|448874224|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
124793579|NCT04393298|448874225|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
124793580|NCT04393298|448874226|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
124793581|NCT04393298|448874227|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
124793582|NCT04393298|448874228|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
124793583|NCT04393298|448874229|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
124793584|NCT04393298|448874230|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
124793585|NCT04393298|448874231|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
124793586|NCT04393298|448874232|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
124793587|NCT04393298|448874233|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
124793588|NCT04393298|448874234|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
124793589|NCT02311582|448874237|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
124793590|NCT02311582|448874238|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
124793591|NCT02311582|448874239|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
124793592|NCT02311582|448874240|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
124793593|NCT02311582|448874241|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
124793594|NCT04972630|448874243|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
124793595|NCT04972630|448874244|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
124793596|NCT04972630|448874245|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
124793597|NCT01129024|448874253|FG000|Overall Study|Physician Decision|5|||
124793598|NCT01129024|448874253|FG000|Overall Study|Study Terminated by Sponsor|8|||
124793599|NCT01129024|448874253|FG000|Overall Study|Withdrawal by Subject|2|||
124793600|NCT01129024|448874253|FG000|Overall Study|Lack of Efficacy|3|||
124793601|NCT01129024|448874253|FG000|Overall Study|Needed a Platelet Transfusion|1|||
124793602|NCT00686634|448874259|FG000|Overall Study|Protocol Violation|6|||
124793603|NCT00924781|448874262|FG000|Overall Study|Study terminated by sponsor|12|||
124793604|NCT00924781|448874263|FG001|Overall Study|Study terminated by sponsor|10|||
124793605|NCT01653132|448874264|FG000|First Intervention|Protocol Violation|1|||
124793606|NCT01653132|448874265|FG001|First Intervention|Protocol Violation|0|||
124793607|NCT03828370|448874266|FG000|3 Month Follow-up|Lost to Follow-up|4|||
124793608|NCT03828370|448874267|FG001|3 Month Follow-up|Lost to Follow-up|12|||
124793609|NCT03828370|448874266|FG000|9 Month Follow up|Lost to Follow-up|12|||
124793610|NCT03828370|448874267|FG001|9 Month Follow up|Lost to Follow-up|20|||
124793611|NCT02677324|448874268|FG000|Overall Study|Disease Progression|6|||
124793612|NCT02677324|448874268|FG000|Overall Study|Inability to Swallow pills|1|||
124793613|NCT02677324|448874268|FG000|Overall Study|Non-compliance|1|||
124793614|NCT02677324|448874268|FG000|Overall Study|Lack of Efficacy|1|||
124793615|NCT02677324|448874268|FG000|Overall Study|Medical insurance coverage|1|||
124793616|NCT02677324|448874268|FG000|Overall Study|Adverse Event|1|||
124793617|NCT02677324|448874268|FG000|Overall Study|IgM Myeloma diagnosis|1|||
124793618|NCT03312751|448874271|FG000|Overall Study|Death|7|||
124793619|NCT03312751|448874272|FG001|Overall Study|Death|9|||
124793620|NCT03312751|448874271|FG000|Overall Study|Study discontinuation due to other reason|0|||
124793621|NCT03312751|448874272|FG001|Overall Study|Study discontinuation due to other reason|1|||
124793622|NCT00475423|448874273|FG000|Overall Study|Protocol Violation|5|||
124793623|NCT00475423|448874273|FG000|Overall Study|Adverse Event|4|||
124793624|NCT00475423|448874273|FG000|Overall Study|Withdrawal by Subject|6|||
124793625|NCT00475423|448874273|FG000|Overall Study|Lack of Efficacy|8|||
124793626|NCT00475423|448874273|FG000|Overall Study|Death|1|||
124793627|NCT00475423|448874273|FG000|Overall Study|Reason not specified|1|||
124793628|NCT00475423|448874273|FG000|Overall Study|Lost to Follow-up|7|||
124793629|NCT00046891|448874274|FG000|Overall Study|Cancels|5|||
124793630|NCT00046891|448874275|FG001|Overall Study|Cancels|9|||
124793631|NCT00046891|448874274|FG000|Overall Study|Ineligible|1|||
124793632|NCT00046891|448874275|FG001|Overall Study|Ineligible|1|||
124793633|NCT00046891|448874274|FG000|Overall Study|Withdrawal by Subject|18|||
124793634|NCT00046891|448874275|FG001|Overall Study|Withdrawal by Subject|15|||
124793635|NCT00046891|448874274|FG000|Overall Study|Adverse Event|5|||
124793636|NCT00046891|448874275|FG001|Overall Study|Adverse Event|5|||
124793637|NCT02496676|448874276|FG000|Phase 1 - Period 1|Adverse Event|0|||
124793638|NCT02496676|448874277|FG001|Phase 1 - Period 1|Adverse Event|1|||
124793639|NCT02496676|448874276|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
124793640|NCT02496676|448874277|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
124793641|NCT01624870|448874278|FG000|Overall Study|Death|19|||
124793642|NCT01624870|448874278|FG000|Overall Study|Withdrawal by Subject|1|||
124793643|NCT01624870|448874278|FG000|Overall Study|CoreValve not implanted|6|||
124793644|NCT01624870|448874278|FG000|Overall Study|Lost to follow up|1|||
124793645|NCT04672252|448874282|FG000|Overall Study|Protocol Violation|1|||
124793646|NCT04672252|448874283|FG001|Overall Study|Protocol Violation|0|||
124793647|NCT04391569|448874284|FG000|Overall Study|Death|15|||
124793648|NCT04391569|448874285|FG001|Overall Study|Death|10|||
124793649|NCT04391569|448874284|FG000|Overall Study|Withdrawal by Subject|1|||
124793650|NCT04391569|448874285|FG001|Overall Study|Withdrawal by Subject|0|||
124793651|NCT04391569|448874284|FG000|Overall Study|Lost to Follow-up|3|||
124793652|NCT04391569|448874285|FG001|Overall Study|Lost to Follow-up|2|||
124793653|NCT04391569|448874284|FG000|Overall Study|Lack of Efficacy|0|||
124793654|NCT04391569|448874285|FG001|Overall Study|Lack of Efficacy|1|||
124793655|NCT04391569|448874284|FG000|Overall Study|Participant discharged to hospice facility|0|||
124793656|NCT04391569|448874285|FG001|Overall Study|Participant discharged to hospice facility|1|||
124793657|NCT04391569|448874284|FG000|Overall Study|Participant family decision|1|||
124793658|NCT04391569|448874285|FG001|Overall Study|Participant family decision|0|||
124793659|NCT04391569|448874284|FG000|Overall Study|Participant discharged prematurely|1|||
124793660|NCT04391569|448874285|FG001|Overall Study|Participant discharged prematurely|0|||
124793661|NCT01431638|448874286|FG000|Overall Study|Adverse Event|1|||
124793662|NCT01431638|448874287|FG001|Overall Study|Adverse Event|3|||
124793663|NCT01431638|448874288|FG002|Overall Study|Adverse Event|1|||
124793664|NCT01431638|448874286|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124793665|NCT01431638|448874287|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
124793666|NCT01431638|448874288|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
124793667|NCT01431638|448874286|FG000|Overall Study|Participants condition no longer requires study drug|0|||
124793668|NCT01431638|448874287|FG001|Overall Study|Participants condition no longer requires study drug|1|||
124793669|NCT01431638|448874288|FG002|Overall Study|Participants condition no longer requires study drug|0|||
124793670|NCT01431638|448874286|FG000|Overall Study|Participant withdrew consent|14|||
124793671|NCT01431638|448874287|FG001|Overall Study|Participant withdrew consent|5|||
124793672|NCT01431638|448874288|FG002|Overall Study|Participant withdrew consent|8|||
124793673|NCT01431638|448874286|FG000|Overall Study|Lost to Follow-up|7|||
124793674|NCT01431638|448874287|FG001|Overall Study|Lost to Follow-up|9|||
124793675|NCT01431638|448874288|FG002|Overall Study|Lost to Follow-up|7|||
124793676|NCT01431638|448874286|FG000|Overall Study|Administrative problems|1|||
124793677|NCT01431638|448874287|FG001|Overall Study|Administrative problems|4|||
124793678|NCT01431638|448874288|FG002|Overall Study|Administrative problems|6|||
124793679|NCT01431638|448874286|FG000|Overall Study|Death|1|||
124793680|NCT01431638|448874287|FG001|Overall Study|Death|0|||
124793681|NCT01431638|448874288|FG002|Overall Study|Death|0|||
124793682|NCT01431638|448874286|FG000|Overall Study|Protocol deviation|1|||
124793683|NCT01431638|448874287|FG001|Overall Study|Protocol deviation|1|||
124793684|NCT01431638|448874288|FG002|Overall Study|Protocol deviation|4|||
124793685|NCT01431638|448874286|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
124793686|NCT01431638|448874287|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
124793687|NCT01431638|448874288|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
124793688|NCT00773838|448874289|FG000|Overall Study|Adverse Event|29|||
124793689|NCT00773838|448874289|FG000|Overall Study|Lost to Follow-up|1|||
124793690|NCT00773838|448874289|FG000|Overall Study|Physician Decision|8|||
124793691|NCT00773838|448874289|FG000|Overall Study|Progressive Disease|82|||
124793692|NCT00773838|448874289|FG000|Overall Study|Protocol Violation|2|||
124793693|NCT00773838|448874289|FG000|Overall Study|Withdrawal by Subject|21|||
124793694|NCT04085367|448875689|FG000|Overall Study|Adverse Event|1|||
124793695|NCT04085367|448875690|FG001|Overall Study|Adverse Event|1|||
124793696|NCT04085367|448875689|FG000|Overall Study|Withdrawal by Subject|13|||
124793697|NCT04085367|448875690|FG001|Overall Study|Withdrawal by Subject|4|||
124793698|NCT04085367|448875689|FG000|Overall Study|Lost to Follow-up|3|||
124793699|NCT04085367|448875690|FG001|Overall Study|Lost to Follow-up|1|||
124793700|NCT04085367|448875689|FG000|Overall Study|Other unspecified|2|||
124793701|NCT04085367|448875690|FG001|Overall Study|Other unspecified|1|||
124793702|NCT04085367|448875689|FG000|Overall Study|Status Unknown|1|||
124793703|NCT04085367|448875690|FG001|Overall Study|Status Unknown|1|||
124793704|NCT00470158|448875701|FG000|Overall Study|Death|0|||
124629667|NCT03918629|448261144|FG000|Overall Study|Other|7|||
124629668|NCT03918629|448261145|FG001|Overall Study|Other|11|||
124629669|NCT03918629|448261144|FG000|Overall Study|Randomized but not vaccinated|2|||
124629670|NCT03918629|448261145|FG001|Overall Study|Randomized but not vaccinated|1|||
124793705|NCT00470158|448875702|FG001|Overall Study|Death|0|||
124793706|NCT00470158|448875703|FG002|Overall Study|Death|0|||
124793707|NCT00470158|448875704|FG003|Overall Study|Death|0|||
124793708|NCT00470158|448875705|FG004|Overall Study|Death|2|||
124793709|NCT00470158|448875701|FG000|Overall Study|Lost to Follow-up|7|||
124793710|NCT00470158|448875702|FG001|Overall Study|Lost to Follow-up|8|||
124793711|NCT00470158|448875703|FG002|Overall Study|Lost to Follow-up|8|||
124793712|NCT00470158|448875704|FG003|Overall Study|Lost to Follow-up|5|||
124793713|NCT00470158|448875705|FG004|Overall Study|Lost to Follow-up|4|||
124793714|NCT00470158|448875701|FG000|Overall Study|Protocol Violation|1|||
124793715|NCT00470158|448875702|FG001|Overall Study|Protocol Violation|0|||
124793716|NCT00470158|448875703|FG002|Overall Study|Protocol Violation|0|||
124793717|NCT00470158|448875704|FG003|Overall Study|Protocol Violation|0|||
124793718|NCT00470158|448875705|FG004|Overall Study|Protocol Violation|0|||
124793719|NCT01249118|448875706|FG000|First Washout Period|Physician Decision|0|||
124793720|NCT01249118|448875707|FG001|First Washout Period|Physician Decision|1|||
124793721|NCT01249118|448875708|FG002|First Washout Period|Physician Decision|0|||
124793722|NCT00880685|448875709|FG000|Memantine 10mg|Lost to Follow-up|2|||
124793723|NCT00880685|448875709|FG000|Memantine 20mg|Withdrawal by Subject|1|||
124793724|NCT00997438|448875710|FG000|Overall Study|Blood draw difficulty|2|||
124793725|NCT00997438|448875711|FG001|Overall Study|Blood draw difficulty|0|||
124793726|NCT00997438|448875712|FG002|Overall Study|Blood draw difficulty|1|||
124793727|NCT00997438|448875710|FG000|Overall Study|Withdrawal by Subject|1|||
124793728|NCT00997438|448875711|FG001|Overall Study|Withdrawal by Subject|1|||
124793729|NCT00997438|448875712|FG002|Overall Study|Withdrawal by Subject|0|||
124793730|NCT00997438|448875710|FG000|Overall Study|Exclusion criteria at visit 1|2|||
124793731|NCT00997438|448875711|FG001|Overall Study|Exclusion criteria at visit 1|2|||
124793732|NCT00997438|448875712|FG002|Overall Study|Exclusion criteria at visit 1|3|||
124793733|NCT01236118|448875713|FG000|Overall Study|Adverse Event|2|||
124793734|NCT01236118|448875714|FG001|Overall Study|Adverse Event|0|||
124793735|NCT01236118|448875715|FG002|Overall Study|Adverse Event|2|||
124793736|NCT01236118|448875713|FG000|Overall Study|Physician Decision|0|||
124793737|NCT01236118|448875714|FG001|Overall Study|Physician Decision|1|||
124793738|NCT01236118|448875715|FG002|Overall Study|Physician Decision|0|||
124793739|NCT01236118|448875713|FG000|Overall Study|Withdrawal by Subject|0|||
124793740|NCT01236118|448875714|FG001|Overall Study|Withdrawal by Subject|0|||
124793741|NCT01236118|448875715|FG002|Overall Study|Withdrawal by Subject|1|||
124793742|NCT00095238|448875716|FG000|Overall Study|Lack of Efficacy|9|||
124793743|NCT00095238|448875717|FG001|Overall Study|Lack of Efficacy|9|||
124793744|NCT00095238|448875716|FG000|Overall Study|Adverse Event|331|||
124793745|NCT00095238|448875717|FG001|Overall Study|Adverse Event|287|||
124793746|NCT00095238|448875716|FG000|Overall Study|Subject Withdrew Consent|208|||
124793747|NCT00095238|448875717|FG001|Overall Study|Subject Withdrew Consent|223|||
124793748|NCT00095238|448875716|FG000|Overall Study|Death|154|||
124793749|NCT00095238|448875717|FG001|Overall Study|Death|170|||
124793750|NCT00095238|448875716|FG000|Overall Study|Lost to Follow-up|19|||
124793751|NCT00095238|448875717|FG001|Overall Study|Lost to Follow-up|24|||
124793752|NCT00095238|448875716|FG000|Overall Study|Noncompliance|44|||
124793753|NCT00095238|448875717|FG001|Overall Study|Noncompliance|45|||
124793754|NCT00095238|448875716|FG000|Overall Study|No longer met study criteria|4|||
124793755|NCT00095238|448875717|FG001|Overall Study|No longer met study criteria|5|||
124793756|NCT00095238|448875716|FG000|Overall Study|Study terminated by sponsor|0|||
124793757|NCT00095238|448875717|FG001|Overall Study|Study terminated by sponsor|1|||
124793758|NCT00095238|448875716|FG000|Overall Study|Missing|1|||
124793759|NCT00095238|448875717|FG001|Overall Study|Missing|0|||
124793760|NCT00095238|448875716|FG000|Overall Study|Other Reasons|87|||
124793761|NCT00095238|448875717|FG001|Overall Study|Other Reasons|88|||
124793762|NCT03505671|448875718|FG000|Overall Study|Withdrawal by Subject|2|||
124793763|NCT03505671|448875719|FG001|Overall Study|Withdrawal by Subject|1|||
124793764|NCT03505671|448875718|FG000|Overall Study|Lost to Follow-up|1|||
124793765|NCT03505671|448875719|FG001|Overall Study|Lost to Follow-up|0|||
124793766|NCT04535167|448875722|FG000|Treatment|Adverse Event|0|||
124793767|NCT04535167|448875723|FG001|Treatment|Adverse Event|0|||
124793768|NCT04535167|448875724|FG002|Treatment|Adverse Event|0|||
124793769|NCT04535167|448875725|FG003|Treatment|Adverse Event|0|||
124793770|NCT04535167|448875726|FG004|Treatment|Adverse Event|0|||
124793771|NCT04535167|448875727|FG005|Treatment|Adverse Event|0|||
124793772|NCT04535167|448875728|FG006|Treatment|Adverse Event|1|||
124793773|NCT04535167|448875722|FG000|Follow-Up|Death|0|||
124793774|NCT04535167|448875723|FG001|Follow-Up|Death|0|||
124793775|NCT04535167|448875724|FG002|Follow-Up|Death|0|||
124793776|NCT04535167|448875725|FG003|Follow-Up|Death|0|||
124793777|NCT04535167|448875726|FG004|Follow-Up|Death|0|||
124793778|NCT04535167|448875727|FG005|Follow-Up|Death|0|||
124629671|NCT01891864|448261146|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
124793779|NCT04535167|448875728|FG006|Follow-Up|Death|1|||
124793780|NCT04535167|448875722|FG000|Follow-Up|Lost to Follow-up|0|||
124793781|NCT04535167|448875723|FG001|Follow-Up|Lost to Follow-up|0|||
124793782|NCT04535167|448875724|FG002|Follow-Up|Lost to Follow-up|0|||
124793783|NCT04535167|448875725|FG003|Follow-Up|Lost to Follow-up|1|||
124793784|NCT04535167|448875726|FG004|Follow-Up|Lost to Follow-up|0|||
124793785|NCT04535167|448875727|FG005|Follow-Up|Lost to Follow-up|0|||
124793786|NCT04535167|448875728|FG006|Follow-Up|Lost to Follow-up|0|||
124793787|NCT02038829|448875729|FG000|Washout Period 1|Death|0|||
124793788|NCT02038829|448875730|FG001|Washout Period 1|Death|0|||
124793789|NCT02038829|448875731|FG002|Washout Period 1|Death|0|||
124793790|NCT02038829|448875732|FG003|Washout Period 1|Death|0|||
124793791|NCT02038829|448875733|FG004|Washout Period 1|Death|1|||
124793792|NCT02038829|448875734|FG005|Washout Period 1|Death|0|||
124793793|NCT02038829|448875735|FG006|Washout Period 1|Death|0|||
124793794|NCT02038829|448875736|FG007|Washout Period 1|Death|0|||
124793795|NCT02038829|448875737|FG008|Washout Period 1|Death|0|||
124793796|NCT02038829|448875738|FG009|Washout Period 1|Death|0|||
124793797|NCT02038829|448875739|FG010|Washout Period 1|Death|0|||
124793798|NCT02038829|448875740|FG011|Washout Period 1|Death|0|||
124793799|NCT02038829|448875729|FG000|Treatment Period 2|Adverse Event|0|||
124793800|NCT02038829|448875730|FG001|Treatment Period 2|Adverse Event|0|||
124793801|NCT02038829|448875731|FG002|Treatment Period 2|Adverse Event|0|||
124793802|NCT02038829|448875732|FG003|Treatment Period 2|Adverse Event|0|||
124793803|NCT02038829|448875733|FG004|Treatment Period 2|Adverse Event|0|||
124793804|NCT02038829|448875734|FG005|Treatment Period 2|Adverse Event|0|||
124793805|NCT02038829|448875735|FG006|Treatment Period 2|Adverse Event|0|||
124793806|NCT02038829|448875736|FG007|Treatment Period 2|Adverse Event|0|||
124793807|NCT02038829|448875737|FG008|Treatment Period 2|Adverse Event|0|||
124793808|NCT02038829|448875738|FG009|Treatment Period 2|Adverse Event|0|||
124793809|NCT02038829|448875739|FG010|Treatment Period 2|Adverse Event|1|||
124793810|NCT02038829|448875740|FG011|Treatment Period 2|Adverse Event|0|||
124793811|NCT02038829|448875729|FG000|Treatment Period 2|Withdrawal by Subject|1|||
124793812|NCT02038829|448875730|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124793813|NCT02038829|448875731|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124793814|NCT02038829|448875732|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124793815|NCT02038829|448875733|FG004|Treatment Period 2|Withdrawal by Subject|0|||
124793816|NCT02038829|448875734|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124793817|NCT02038829|448875735|FG006|Treatment Period 2|Withdrawal by Subject|0|||
124793818|NCT02038829|448875736|FG007|Treatment Period 2|Withdrawal by Subject|0|||
124793819|NCT02038829|448875737|FG008|Treatment Period 2|Withdrawal by Subject|0|||
124793820|NCT02038829|448875738|FG009|Treatment Period 2|Withdrawal by Subject|0|||
124793821|NCT02038829|448875739|FG010|Treatment Period 2|Withdrawal by Subject|0|||
124793822|NCT02038829|448875740|FG011|Treatment Period 2|Withdrawal by Subject|0|||
124793823|NCT02038829|448875729|FG000|Washout Period 2|Adverse Event|0|||
124793824|NCT02038829|448875730|FG001|Washout Period 2|Adverse Event|0|||
124793825|NCT02038829|448875731|FG002|Washout Period 2|Adverse Event|0|||
124793826|NCT02038829|448875732|FG003|Washout Period 2|Adverse Event|0|||
124793827|NCT02038829|448875733|FG004|Washout Period 2|Adverse Event|0|||
124793828|NCT02038829|448875734|FG005|Washout Period 2|Adverse Event|0|||
124793829|NCT02038829|448875735|FG006|Washout Period 2|Adverse Event|0|||
124793830|NCT02038829|448875736|FG007|Washout Period 2|Adverse Event|0|||
124793831|NCT02038829|448875737|FG008|Washout Period 2|Adverse Event|1|||
124629672|NCT01891864|448261147|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
124629673|NCT01891864|448261148|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
124793832|NCT02038829|448875738|FG009|Washout Period 2|Adverse Event|0|||
124793833|NCT02038829|448875739|FG010|Washout Period 2|Adverse Event|0|||
124793834|NCT02038829|448875740|FG011|Washout Period 2|Adverse Event|0|||
124793835|NCT02038829|448875729|FG000|Washout Period 2|Withdrawal by Subject|0|||
124793836|NCT02038829|448875730|FG001|Washout Period 2|Withdrawal by Subject|0|||
124793837|NCT02038829|448875731|FG002|Washout Period 2|Withdrawal by Subject|0|||
124793838|NCT02038829|448875732|FG003|Washout Period 2|Withdrawal by Subject|0|||
124793839|NCT02038829|448875733|FG004|Washout Period 2|Withdrawal by Subject|0|||
124793840|NCT02038829|448875734|FG005|Washout Period 2|Withdrawal by Subject|1|||
124793841|NCT02038829|448875735|FG006|Washout Period 2|Withdrawal by Subject|0|||
124793842|NCT02038829|448875736|FG007|Washout Period 2|Withdrawal by Subject|0|||
124793843|NCT02038829|448875737|FG008|Washout Period 2|Withdrawal by Subject|0|||
124793844|NCT02038829|448875738|FG009|Washout Period 2|Withdrawal by Subject|0|||
124793845|NCT02038829|448875739|FG010|Washout Period 2|Withdrawal by Subject|0|||
124793846|NCT02038829|448875740|FG011|Washout Period 2|Withdrawal by Subject|0|||
124793847|NCT02038829|448875729|FG000|Treatment Period 4|Adverse Event|0|||
124793848|NCT02038829|448875730|FG001|Treatment Period 4|Adverse Event|1|||
124793849|NCT02038829|448875731|FG002|Treatment Period 4|Adverse Event|0|||
124793850|NCT02038829|448875732|FG003|Treatment Period 4|Adverse Event|0|||
124793851|NCT02038829|448875733|FG004|Treatment Period 4|Adverse Event|0|||
124793852|NCT02038829|448875734|FG005|Treatment Period 4|Adverse Event|0|||
124793853|NCT02038829|448875735|FG006|Treatment Period 4|Adverse Event|0|||
124793854|NCT02038829|448875736|FG007|Treatment Period 4|Adverse Event|0|||
124793855|NCT02038829|448875737|FG008|Treatment Period 4|Adverse Event|0|||
124793856|NCT02038829|448875738|FG009|Treatment Period 4|Adverse Event|0|||
124629674|NCT01891864|448261149|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
124629675|NCT01891864|448261150|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
124793857|NCT02038829|448875739|FG010|Treatment Period 4|Adverse Event|0|||
124793858|NCT02038829|448875740|FG011|Treatment Period 4|Adverse Event|0|||
124629676|NCT01891864|448261151|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
124629677|NCT01891864|448261146|FG000|Treatment Period 1|Physician Decision|0|||
124629678|NCT01891864|448261147|FG001|Treatment Period 1|Physician Decision|1|||
124793859|NCT02038829|448875729|FG000|Washout Period 4|Adverse Event|0|||
124793860|NCT02038829|448875730|FG001|Washout Period 4|Adverse Event|0|||
124793861|NCT02038829|448875731|FG002|Washout Period 4|Adverse Event|0|||
124793862|NCT02038829|448875732|FG003|Washout Period 4|Adverse Event|0|||
124793863|NCT02038829|448875733|FG004|Washout Period 4|Adverse Event|0|||
124793864|NCT02038829|448875734|FG005|Washout Period 4|Adverse Event|0|||
124793865|NCT02038829|448875735|FG006|Washout Period 4|Adverse Event|1|||
124793866|NCT02038829|448875736|FG007|Washout Period 4|Adverse Event|0|||
124793867|NCT02038829|448875737|FG008|Washout Period 4|Adverse Event|0|||
124793868|NCT02038829|448875738|FG009|Washout Period 4|Adverse Event|0|||
124793869|NCT02038829|448875739|FG010|Washout Period 4|Adverse Event|0|||
124793870|NCT02038829|448875740|FG011|Washout Period 4|Adverse Event|0|||
124793871|NCT02038829|448875729|FG000|Treatment Period 6|Adverse Event|0|||
124793872|NCT02038829|448875730|FG001|Treatment Period 6|Adverse Event|0|||
124793873|NCT02038829|448875731|FG002|Treatment Period 6|Adverse Event|1|||
124793874|NCT02038829|448875732|FG003|Treatment Period 6|Adverse Event|0|||
124793875|NCT02038829|448875733|FG004|Treatment Period 6|Adverse Event|0|||
124793876|NCT02038829|448875734|FG005|Treatment Period 6|Adverse Event|0|||
124793877|NCT02038829|448875735|FG006|Treatment Period 6|Adverse Event|0|||
124793878|NCT02038829|448875736|FG007|Treatment Period 6|Adverse Event|0|||
124793879|NCT02038829|448875737|FG008|Treatment Period 6|Adverse Event|0|||
124793880|NCT02038829|448875738|FG009|Treatment Period 6|Adverse Event|0|||
124793881|NCT02038829|448875739|FG010|Treatment Period 6|Adverse Event|0|||
124793882|NCT02038829|448875740|FG011|Treatment Period 6|Adverse Event|0|||
124793883|NCT00075270|448875741|FG000|Overall Study|Withdrawal by Subject|28|||
124793884|NCT00075270|448875742|FG001|Overall Study|Withdrawal by Subject|21|||
124793885|NCT00075270|448875741|FG000|Overall Study|Lost to Follow-up|25|||
124793886|NCT00075270|448875742|FG001|Overall Study|Lost to Follow-up|28|||
124793887|NCT00075270|448875741|FG000|Overall Study|Protocol Violation|0|||
124793888|NCT00075270|448875742|FG001|Overall Study|Protocol Violation|2|||
124793889|NCT00075270|448875741|FG000|Overall Study|Death|198|||
124793890|NCT00075270|448875742|FG001|Overall Study|Death|215|||
124793891|NCT00075270|448875741|FG000|Overall Study|Other/Unknown|9|||
124793892|NCT00075270|448875742|FG001|Overall Study|Other/Unknown|5|||
124793893|NCT00075270|448875741|FG000|Overall Study|Missing|26|||
124793894|NCT00075270|448875742|FG001|Overall Study|Missing|13|||
124793895|NCT04656275|448875744|FG000|Overall Study|Study terminated by sponsor|2|||
124793896|NCT04656275|448875745|FG001|Overall Study|Study terminated by sponsor|4|||
124793897|NCT02361580|448875747|FG000|Overall Study|Lost to Follow-up|6|||
124793898|NCT02361580|448875748|FG001|Overall Study|Lost to Follow-up|3|||
124793899|NCT03490981|448875749|FG000|Overall Study|Lost to Follow-up|1|||
124793900|NCT03490981|448875750|FG001|Overall Study|Lost to Follow-up|2|||
124793901|NCT00723203|448875759|FG000|Overall Study|Withdrawal by Subject|3|||
124793902|NCT00740051|448875760|FG000|Overall Study|Lack of Efficacy|2|||
124793903|NCT00740051|448875761|FG001|Overall Study|Lack of Efficacy|5|||
124793904|NCT00740051|448875760|FG000|Overall Study|Adverse Event|1|||
124793905|NCT00740051|448875761|FG001|Overall Study|Adverse Event|4|||
124793906|NCT00740051|448875760|FG000|Overall Study|Protocol Violation|2|||
124793907|NCT00740051|448875761|FG001|Overall Study|Protocol Violation|6|||
124793908|NCT00740051|448875760|FG000|Overall Study|Lost to Follow-up|3|||
124793909|NCT00740051|448875761|FG001|Overall Study|Lost to Follow-up|8|||
124793910|NCT00740051|448875760|FG000|Overall Study|Withdrawal by Subject|6|||
124793911|NCT00740051|448875761|FG001|Overall Study|Withdrawal by Subject|8|||
124793912|NCT00740051|448875760|FG000|Overall Study|Other reason (not specified)|4|||
124793913|NCT00740051|448875761|FG001|Overall Study|Other reason (not specified)|1|||
124793914|NCT00274924|448875762|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
124793915|NCT00274924|448875763|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
124793916|NCT00274924|448875764|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
124793917|NCT00274924|448875762|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
124793918|NCT00274924|448875763|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
124629679|NCT01891864|448261148|FG002|Treatment Period 1|Physician Decision|0|||
124629680|NCT01891864|448261149|FG003|Treatment Period 1|Physician Decision|0|||
124629681|NCT01891864|448261150|FG004|Treatment Period 1|Physician Decision|0|||
124793919|NCT00274924|448875764|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
124793920|NCT00274924|448875762|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
124793921|NCT00274924|448875763|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
124793922|NCT00274924|448875764|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
124793923|NCT00274924|448875762|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
124793924|NCT00274924|448875763|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
124793925|NCT00274924|448875764|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
124793926|NCT00274924|448875762|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
124793927|NCT00274924|448875763|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
124793928|NCT00274924|448875764|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
124793929|NCT00274924|448875762|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
124793930|NCT00274924|448875763|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
124793931|NCT00274924|448875764|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
124793932|NCT00274924|448875762|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
124793933|NCT00274924|448875763|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
124793934|NCT00274924|448875764|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
124793935|NCT00274924|448875762|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
124793936|NCT00274924|448875763|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
124793937|NCT00274924|448875764|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
124793938|NCT00274924|448875762|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
124793939|NCT00274924|448875763|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
124793940|NCT00274924|448875764|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
124793941|NCT00274924|448875762|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
124793942|NCT00274924|448875763|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
124793943|NCT00274924|448875764|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
124793944|NCT00274924|448875762|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
124793945|NCT00274924|448875763|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
124793946|NCT00274924|448875764|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
124793947|NCT00274924|448875762|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
124793948|NCT00274924|448875763|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
124793949|NCT00274924|448875764|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
124793950|NCT00274924|448875762|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
124793951|NCT00274924|448875763|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
124793952|NCT00274924|448875764|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
124793953|NCT01903525|448875766|FG000|Overall Study|Lost to Follow-up|5|||
124793954|NCT01903525|448875767|FG001|Overall Study|Lost to Follow-up|9|||
124793955|NCT01903525|448875766|FG000|Overall Study|Adverse Event|0|||
124793956|NCT01903525|448875767|FG001|Overall Study|Adverse Event|1|||
124793957|NCT04381988|448875768|FG000|Overall Study|The study was terminated|4|||
124793958|NCT04381988|448875769|FG001|Overall Study|The study was terminated|0|||
124793959|NCT03025035|448875770|FG000|Overall Study|Death|2|||
124793960|NCT03025035|448875770|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
124793961|NCT03562767|448875776|FG000|Overall Study|Physician Decision|2|||
124793962|NCT03562767|448875777|FG001|Overall Study|Physician Decision|0|||
124793963|NCT03562767|448875778|FG002|Overall Study|Physician Decision|0|||
124793964|NCT03562767|448875776|FG000|Overall Study|Logistic Reason|1|||
124793965|NCT03562767|448875777|FG001|Overall Study|Logistic Reason|3|||
124793966|NCT03562767|448875778|FG002|Overall Study|Logistic Reason|0|||
124793967|NCT01589770|448875781|FG000|Overall Study|EGFR <60ml/min|6|||
124793968|NCT01589770|448875782|FG001|Overall Study|EGFR <60ml/min|4|||
124793969|NCT01589770|448875781|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
124793970|NCT01589770|448875782|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
124793971|NCT00725842|448875783|FG000|Overall Study|Lost to Follow-up|19|||
124793972|NCT00725842|448875783|FG000|Overall Study|Death|1|||
124793973|NCT00725842|448875783|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
124793974|NCT00725842|448875783|FG000|Overall Study|Consent date prior to study start date|5|||
124793975|NCT00725842|448875783|FG000|Overall Study|Inclusion criterion not met|1|||
124793976|NCT00725842|448875783|FG000|Overall Study|No Visit 1 data|1|||
124793977|NCT01853618|448875786|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
124793978|NCT01853618|448875787|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
124793979|NCT01853618|448875788|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
124793980|NCT01853618|448875789|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
124793981|NCT01853618|448875790|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
124793982|NCT01853618|448875786|FG000|Overall Study|Progressive disease|1|||
124793983|NCT01853618|448875787|FG001|Overall Study|Progressive disease|1|||
124793984|NCT01853618|448875788|FG002|Overall Study|Progressive disease|1|||
124793985|NCT01853618|448875789|FG003|Overall Study|Progressive disease|1|||
124793986|NCT01853618|448875790|FG004|Overall Study|Progressive disease|2|||
124793987|NCT01853618|448875786|FG000|Overall Study|Physician Decision|0|||
124793988|NCT01853618|448875787|FG001|Overall Study|Physician Decision|1|||
124793989|NCT01853618|448875788|FG002|Overall Study|Physician Decision|1|||
124793990|NCT01853618|448875789|FG003|Overall Study|Physician Decision|0|||
124793991|NCT01853618|448875790|FG004|Overall Study|Physician Decision|0|||
124793992|NCT01853618|448875786|FG000|Overall Study|Refused further treatment|0|||
124793993|NCT01853618|448875787|FG001|Overall Study|Refused further treatment|0|||
124793994|NCT01853618|448875788|FG002|Overall Study|Refused further treatment|0|||
124793995|NCT01853618|448875789|FG003|Overall Study|Refused further treatment|0|||
124793996|NCT01853618|448875790|FG004|Overall Study|Refused further treatment|1|||
124793997|NCT01658813|448875791|FG000|Overall Study|Disease progression|3|||
124629682|NCT01891864|448261151|FG005|Treatment Period 1|Physician Decision|0|||
124629683|NCT01891864|448261146|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
124629684|NCT01891864|448261147|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
124629685|NCT01891864|448261148|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
124793998|NCT05615935|448875792|FG000|Overall Study|Lost to Follow-up|1|||
124793999|NCT05615935|448875793|FG001|Overall Study|Lost to Follow-up|1|||
124794000|NCT00938886|448875794|FG000|Overall Study|Death|0|||
124794001|NCT00938886|448875795|FG001|Overall Study|Death|1|||
124794002|NCT00938886|448875794|FG000|Overall Study|Withdrawal by Subject|4|||
124794003|NCT00938886|448875795|FG001|Overall Study|Withdrawal by Subject|7|||
124794004|NCT00938886|448875794|FG000|Overall Study|Lost to Follow-up|3|||
124794005|NCT00938886|448875795|FG001|Overall Study|Lost to Follow-up|2|||
124794006|NCT01075191|448875796|FG000|Overall Study|Death|1|||
124794007|NCT01075191|448875796|FG000|Overall Study|Intensification|3|||
124794008|NCT01075191|448875796|FG000|Overall Study|Co-morbidities|1|||
124794009|NCT01075191|448875796|FG000|Overall Study|Adverse Event|4|||
124794010|NCT01075191|448875796|FG000|Overall Study|Noncompliance|3|||
124794011|NCT01075191|448875796|FG000|Overall Study|Therapy Break|3|||
124794012|NCT01075191|448875796|FG000|Overall Study|Patient's Wish|2|||
124794013|NCT01075191|448875796|FG000|Overall Study|Unknown Reasons|1|||
124794014|NCT02674854|448875797|FG000|Overall Study|Adverse Event|17|||
124794015|NCT02674854|448875798|FG001|Overall Study|Adverse Event|15|||
124794016|NCT02674854|448875799|FG002|Overall Study|Adverse Event|5|||
124794017|NCT02674854|448875797|FG000|Overall Study|Withdrawal by Subject|1|||
124794018|NCT02674854|448875798|FG001|Overall Study|Withdrawal by Subject|5|||
124794019|NCT02674854|448875799|FG002|Overall Study|Withdrawal by Subject|4|||
124794020|NCT02674854|448875797|FG000|Overall Study|No-compliant subject|1|||
124794021|NCT02674854|448875798|FG001|Overall Study|No-compliant subject|0|||
124794022|NCT02674854|448875799|FG002|Overall Study|No-compliant subject|1|||
124794023|NCT02674854|448875797|FG000|Overall Study|Lost to Follow-up|1|||
124794024|NCT02674854|448875798|FG001|Overall Study|Lost to Follow-up|0|||
124794025|NCT02674854|448875799|FG002|Overall Study|Lost to Follow-up|2|||
124794026|NCT02674854|448875797|FG000|Overall Study|Lack of Efficacy|0|||
124794027|NCT02674854|448875798|FG001|Overall Study|Lack of Efficacy|3|||
124794028|NCT02674854|448875799|FG002|Overall Study|Lack of Efficacy|0|||
124794029|NCT02674854|448875797|FG000|Overall Study|Disallowed Concurrent Medication|2|||
124794030|NCT02674854|448875798|FG001|Overall Study|Disallowed Concurrent Medication|2|||
124794031|NCT02674854|448875799|FG002|Overall Study|Disallowed Concurrent Medication|0|||
124794032|NCT02674854|448875797|FG000|Overall Study|Protocol Violation|1|||
124794033|NCT02674854|448875798|FG001|Overall Study|Protocol Violation|1|||
124794034|NCT02674854|448875799|FG002|Overall Study|Protocol Violation|2|||
124794035|NCT02674854|448875797|FG000|Overall Study|Death|0|||
124794036|NCT02674854|448875798|FG001|Overall Study|Death|1|||
124794037|NCT02674854|448875799|FG002|Overall Study|Death|0|||
124794038|NCT02674854|448875797|FG000|Overall Study|Subject missed V6.2|1|||
124794039|NCT02674854|448875798|FG001|Overall Study|Subject missed V6.2|0|||
124794040|NCT02674854|448875799|FG002|Overall Study|Subject missed V6.2|0|||
124794041|NCT00913692|448875800|FG000|Screening (4 Months)|Physician Decision|3|||
124794042|NCT00913692|448875800|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
124794043|NCT00913692|448875800|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
124794044|NCT04738318|448875801|FG000|Overall Study|Protocol Violation|1|||
124794045|NCT04738318|448875802|FG001|Overall Study|Protocol Violation|0|||
124794046|NCT01226121|448875803|FG000|Overall Study|Lost to Follow-up|2|||
124794047|NCT01226121|448875804|FG001|Overall Study|Lost to Follow-up|0|||
124794048|NCT01226121|448875805|FG002|Overall Study|Lost to Follow-up|1|||
124794049|NCT04231981|448875806|FG000|Overall Study|Adverse Event|1|||
124794050|NCT04231981|448875806|FG000|Overall Study|Death|16|||
124794051|NCT04231981|448875806|FG000|Overall Study|Lost to Follow-up|1|||
124794052|NCT02889562|448875807|FG000|Overall Study|Physician Decision|0|||
124794053|NCT02889562|448875808|FG001|Overall Study|Physician Decision|1|||
124794054|NCT02889562|448875807|FG000|Overall Study|Withdrawal by Subject|0|||
124794055|NCT02889562|448875808|FG001|Overall Study|Withdrawal by Subject|1|||
124794056|NCT01470989|448875811|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
124794057|NCT01470989|448875812|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
124794058|NCT01470989|448875811|FG000|Overall Study|Adverse Event|2|||
124794059|NCT01470989|448875812|FG001|Overall Study|Adverse Event|5|||
124794060|NCT01470989|448875811|FG000|Overall Study|Abnormal laboratory value|1|||
124794061|NCT01470989|448875812|FG001|Overall Study|Abnormal laboratory value|1|||
124794062|NCT01470989|448875811|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124794063|NCT01470989|448875812|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
124794064|NCT01470989|448875811|FG000|Overall Study|Withdrawal by Subject|19|||
124794065|NCT01470989|448875812|FG001|Overall Study|Withdrawal by Subject|17|||
124794066|NCT01470989|448875811|FG000|Overall Study|Lost to Follow-up|18|||
124794067|NCT01470989|448875812|FG001|Overall Study|Lost to Follow-up|13|||
124794068|NCT01470989|448875811|FG000|Overall Study|Administrative problems|2|||
124794069|NCT01470989|448875812|FG001|Overall Study|Administrative problems|4|||
124794070|NCT01470989|448875811|FG000|Overall Study|Death|2|||
124794071|NCT01470989|448875812|FG001|Overall Study|Death|2|||
124794072|NCT01470989|448875811|FG000|Overall Study|Protocol deviation|1|||
124794073|NCT01470989|448875812|FG001|Overall Study|Protocol deviation|2|||
124794074|NCT00969280|448875813|FG000|Overall Study|Protocol Violation|2|||
124794075|NCT00969280|448875814|FG001|Overall Study|Protocol Violation|1|||
124794076|NCT00969280|448875813|FG000|Overall Study|Withdrawal by Subject|0|||
124794077|NCT00969280|448875814|FG001|Overall Study|Withdrawal by Subject|1|||
124794078|NCT00969280|448875813|FG000|Overall Study|infection of influenza A(H1N1)|0|||
124794079|NCT00969280|448875814|FG001|Overall Study|infection of influenza A(H1N1)|1|||
124794080|NCT02119676|448875815|FG000|Overall Study|Adverse Event|9|||
124794081|NCT02119676|448875816|FG001|Overall Study|Adverse Event|17|||
124794082|NCT02119676|448875817|FG002|Overall Study|Adverse Event|10|||
124794083|NCT02119676|448875818|FG003|Overall Study|Adverse Event|10|||
124794084|NCT02119676|448875815|FG000|Overall Study|Disease progression|53|||
124794085|NCT02119676|448875816|FG001|Overall Study|Disease progression|55|||
124794086|NCT02119676|448875817|FG002|Overall Study|Disease progression|68|||
124794087|NCT02119676|448875818|FG003|Overall Study|Disease progression|73|||
124794088|NCT02119676|448875815|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
124794089|NCT02119676|448875816|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
124794090|NCT02119676|448875817|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
124794091|NCT02119676|448875818|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
124794092|NCT02119676|448875815|FG000|Overall Study|Physician Decision|4|||
124794093|NCT02119676|448875816|FG001|Overall Study|Physician Decision|2|||
124794094|NCT02119676|448875817|FG002|Overall Study|Physician Decision|3|||
124794095|NCT02119676|448875818|FG003|Overall Study|Physician Decision|2|||
124794096|NCT02119676|448875815|FG000|Overall Study|Death|9|||
124794097|NCT02119676|448875816|FG001|Overall Study|Death|3|||
124794098|NCT02119676|448875817|FG002|Overall Study|Death|2|||
124794099|NCT02119676|448875818|FG003|Overall Study|Death|1|||
124794100|NCT02119676|448875815|FG000|Overall Study|Noncompliance|0|||
124794101|NCT02119676|448875816|FG001|Overall Study|Noncompliance|1|||
124794102|NCT02119676|448875817|FG002|Overall Study|Noncompliance|0|||
124794103|NCT02119676|448875818|FG003|Overall Study|Noncompliance|0|||
124794104|NCT02119676|448875815|FG000|Overall Study|Lost to Follow-up|0|||
124794105|NCT02119676|448875816|FG001|Overall Study|Lost to Follow-up|0|||
124794106|NCT02119676|448875817|FG002|Overall Study|Lost to Follow-up|1|||
124794107|NCT02119676|448875818|FG003|Overall Study|Lost to Follow-up|0|||
124794108|NCT02119676|448875815|FG000|Overall Study|Protocol deviation|0|||
124794109|NCT02119676|448875816|FG001|Overall Study|Protocol deviation|0|||
124794110|NCT02119676|448875817|FG002|Overall Study|Protocol deviation|1|||
124794111|NCT02119676|448875818|FG003|Overall Study|Protocol deviation|0|||
124794112|NCT02119676|448875815|FG000|Overall Study|Other, unspecified|2|||
124794113|NCT02119676|448875816|FG001|Overall Study|Other, unspecified|1|||
124794114|NCT02119676|448875817|FG002|Overall Study|Other, unspecified|3|||
124794115|NCT02119676|448875818|FG003|Overall Study|Other, unspecified|4|||
124794116|NCT02119676|448875815|FG000|Overall Study|Did not receive study med|2|||
124794117|NCT02119676|448875816|FG001|Overall Study|Did not receive study med|2|||
124794118|NCT02119676|448875817|FG002|Overall Study|Did not receive study med|4|||
124794119|NCT02119676|448875818|FG003|Overall Study|Did not receive study med|5|||
124794120|NCT00570232|448875819|FG000|Overall Study|Adverse Event|10|||
124794121|NCT00570232|448875819|FG000|Overall Study|discontinued due to medical condition|3|||
124794122|NCT00570232|448875819|FG000|Overall Study|discontinued due to recurrence|8|||
124794123|NCT00570232|448875819|FG000|Overall Study|discontinued due to noncompliance|2|||
124794124|NCT01037088|448875822|FG000|Overall Study|Withdrawal by Subject|3|||
124794125|NCT02216812|448875823|FG000|Overall Study|Lost to Follow-up|10|||
124794126|NCT02216812|448875824|FG001|Overall Study|Lost to Follow-up|5|||
124794127|NCT01585584|448875825|FG000|Overall Study|Lack of Efficacy|1|||
124794128|NCT01585584|448875825|FG000|Overall Study|Withdrawal by Subject|1|||
124794129|NCT01585584|448875825|FG000|Overall Study|Physician Decision|2|||
124794130|NCT00527488|448875826|FG000|Overall Study|Withdrawn prior to dosing|0|||
124794131|NCT00527488|448875827|FG001|Overall Study|Withdrawn prior to dosing|1|||
124794132|NCT00527488|448875828|FG002|Overall Study|Withdrawn prior to dosing|1|||
124794133|NCT00527488|448875829|FG003|Overall Study|Withdrawn prior to dosing|0|||
124794134|NCT01958827|448875830|FG000|Overall Study|Adverse Event|3|||
124794135|NCT01958827|448875830|FG000|Overall Study|Lack of Efficacy|6|||
124794136|NCT01958827|448875830|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
124794137|NCT00266864|448875831|FG000|Overall Study|Lost to Follow-up|4|||
124794138|NCT00266864|448875832|FG001|Overall Study|Lost to Follow-up|1|||
124794139|NCT00266864|448875831|FG000|Overall Study|Withdrawal by Subject|1|||
124794140|NCT00266864|448875832|FG001|Overall Study|Withdrawal by Subject|1|||
124794141|NCT03036800|448875833|FG000|Overall Study|Protocol Violation|1|||
124794142|NCT03036800|448875834|FG001|Overall Study|Protocol Violation|0|||
124794143|NCT03036800|448875833|FG000|Overall Study|Non-compliance|1|||
124794144|NCT03036800|448875834|FG001|Overall Study|Non-compliance|0|||
124794145|NCT03036800|448875833|FG000|Overall Study|Lost to Follow-up|1|||
124794146|NCT03036800|448875834|FG001|Overall Study|Lost to Follow-up|0|||
124794147|NCT03036800|448875833|FG000|Overall Study|Death|1|||
124629686|NCT01891864|448261149|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
124629687|NCT01891864|448261150|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
124794148|NCT03036800|448875834|FG001|Overall Study|Death|0|||
124794149|NCT03036800|448875833|FG000|Overall Study|Tolerance|5|||
124794150|NCT03036800|448875834|FG001|Overall Study|Tolerance|0|||
124794151|NCT03036800|448875833|FG000|Overall Study|Unknown/no reason given|50|||
124794152|NCT03036800|448875834|FG001|Overall Study|Unknown/no reason given|39|||
124794153|NCT01077154|448875835|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
124794154|NCT01077154|448875836|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
124794155|NCT01077154|448875835|FG000|Overall Study|Withdrawal by Subject|369|||
124794156|NCT01077154|448875836|FG001|Overall Study|Withdrawal by Subject|385|||
124794157|NCT01077154|448875835|FG000|Overall Study|Death|215|||
124794158|NCT01077154|448875836|FG001|Overall Study|Death|214|||
124794159|NCT01077154|448875835|FG000|Overall Study|Lost to Follow-up|43|||
124794160|NCT01077154|448875836|FG001|Overall Study|Lost to Follow-up|35|||
124794161|NCT01077154|448875835|FG000|Overall Study|Noncompliance|22|||
124794162|NCT01077154|448875836|FG001|Overall Study|Noncompliance|20|||
124794163|NCT01077154|448875835|FG000|Overall Study|Disease Progression|18|||
124794164|NCT01077154|448875836|FG001|Overall Study|Disease Progression|20|||
124794165|NCT01077154|448875835|FG000|Overall Study|Ineligibility Determined|10|||
124794166|NCT01077154|448875836|FG001|Overall Study|Ineligibility Determined|14|||
124794167|NCT01077154|448875835|FG000|Overall Study|Other|14|||
124794168|NCT01077154|448875836|FG001|Overall Study|Other|11|||
124794169|NCT01077154|448875835|FG000|Overall Study|Adverse Event|9|||
124794170|NCT01077154|448875836|FG001|Overall Study|Adverse Event|9|||
124794171|NCT01077154|448875835|FG000|Overall Study|Administrative Decision|1|||
124794172|NCT01077154|448875836|FG001|Overall Study|Administrative Decision|6|||
124794173|NCT01077154|448875835|FG000|Overall Study|Protocol Deviation|1|||
124794174|NCT01077154|448875836|FG001|Overall Study|Protocol Deviation|0|||
124794175|NCT05985980|448875837|FG000|Overall Study|Withdrawal by Subject|1|||
124794176|NCT05985980|448875837|FG000|Overall Study|Withdrawal by Subject|1|||
124794177|NCT05985980|448875837|FG000|Overall Study|Withdrawal by Subject|1|||
124794178|NCT05985980|448875837|FG000|Overall Study|Withdrawal by Subject|1|||
124794179|NCT02207946|448875838|FG000|Overall Study|Lost to Follow-up|1|||
124794180|NCT02207946|448875839|FG001|Overall Study|Lost to Follow-up|0|||
124794181|NCT02207946|448875838|FG000|Overall Study|Adverse Event|0|||
124794182|NCT02207946|448875839|FG001|Overall Study|Adverse Event|1|||
124794183|NCT00811642|448875840|FG000|Overall Study|Adverse Event|3|||
124794184|NCT00811642|448875840|FG000|Overall Study|Protocol Violation|1|||
124794185|NCT00811642|448875840|FG000|Overall Study|Death|2|||
124794186|NCT00811642|448875840|FG000|Overall Study|Withdrawal by Subject|7|||
124794187|NCT00811642|448875840|FG000|Overall Study|Cumulative use of antifungal agent|2|||
124794188|NCT01163318|448875848|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
124794189|NCT01163318|448875848|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
124794190|NCT01163318|448875848|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
124794191|NCT01163318|448875848|FG000|Overall Study|Participants Without Case Report Form|7|||
124794192|NCT01163318|448875848|FG000|Overall Study|Multiple Reasons Per Participant|224|||
124794193|NCT01006603|448875850|FG000|Overall Study|Withdrawal by Subject|17|||
124794194|NCT01006603|448875851|FG001|Overall Study|Withdrawal by Subject|19|||
124794195|NCT01006603|448875850|FG000|Overall Study|Lost to Follow-up|0|||
124794196|NCT01006603|448875851|FG001|Overall Study|Lost to Follow-up|1|||
124794197|NCT01006603|448875850|FG000|Overall Study|Safety reason|1|||
124794198|NCT01006603|448875851|FG001|Overall Study|Safety reason|1|||
124794199|NCT01006603|448875850|FG000|Overall Study|Protocol Violation|1|||
124794200|NCT01006603|448875851|FG001|Overall Study|Protocol Violation|3|||
124794201|NCT01006603|448875850|FG000|Overall Study|Incorrect enrolment|0|||
124794202|NCT01006603|448875851|FG001|Overall Study|Incorrect enrolment|2|||
124794203|NCT01006603|448875850|FG000|Overall Study|Adverse Event|15|||
124794204|NCT01006603|448875851|FG001|Overall Study|Adverse Event|7|||
124794205|NCT01006603|448875850|FG000|Overall Study|Death|1|||
124794206|NCT01006603|448875851|FG001|Overall Study|Death|1|||
124794207|NCT01006603|448875850|FG000|Overall Study|Study specific discontinuation criteria|33|||
124794208|NCT01006603|448875851|FG001|Overall Study|Study specific discontinuation criteria|34|||
124794209|NCT01006603|448875850|FG000|Overall Study|Other|3|||
124794210|NCT01006603|448875851|FG001|Overall Study|Other|7|||
124794211|NCT00706849|448877193|FG000|Treatment Period|Adverse Event|0|||
124794212|NCT00706849|448877194|FG001|Treatment Period|Adverse Event|9|||
124794213|NCT00706849|448877193|FG000|Treatment Period|Other|0|||
124794214|NCT00706849|448877194|FG001|Treatment Period|Other|1|||
124794215|NCT00706849|448877193|FG000|Follow-up Period|Withdrawal by Subject|0|||
124794216|NCT00706849|448877194|FG001|Follow-up Period|Withdrawal by Subject|2|||
124794217|NCT00706849|448877193|FG000|Follow-up Period|Protocol non-compliance|0|||
124794218|NCT00706849|448877194|FG001|Follow-up Period|Protocol non-compliance|1|||
124794219|NCT01611454|448877195|FG000|Overall Study|Lack of Efficacy|18|||
124794220|NCT01611454|448877196|FG001|Overall Study|Lack of Efficacy|10|||
124794221|NCT03269552|448877198|FG000|Overall Study|Adverse Event|2|||
124794222|NCT00920907|448877199|FG000|Induction Period|Adverse Event|0|||
124794223|NCT00920907|448877200|FG001|Induction Period|Adverse Event|2|||
124794224|NCT00920907|448877199|FG000|Induction Period|Death|1|||
124794225|NCT00920907|448877200|FG001|Induction Period|Death|1|||
124794226|NCT00920907|448877199|FG000|Induction Period|Disease Progression|12|||
124794227|NCT00920907|448877200|FG001|Induction Period|Disease Progression|11|||
124794228|NCT00920907|448877199|FG000|Induction Period|Study Drug Toxicity|8|||
124794229|NCT00920907|448877200|FG001|Induction Period|Study Drug Toxicity|6|||
124794230|NCT00920907|448877199|FG000|Induction Period|No longer meets study criteria|0|||
124794231|NCT00920907|448877200|FG001|Induction Period|No longer meets study criteria|1|||
124794232|NCT00920907|448877199|FG000|Induction Period|Withdrawal by Subject|1|||
124794233|NCT00920907|448877200|FG001|Induction Period|Withdrawal by Subject|1|||
124794234|NCT00920907|448877199|FG000|Maintenance Period|Disease Progression|3|||
124794235|NCT00920907|448877200|FG001|Maintenance Period|Disease Progression|7|||
124794236|NCT00920907|448877199|FG000|Maintenance Period|Administrative (study closure)|7|||
124794237|NCT00920907|448877200|FG001|Maintenance Period|Administrative (study closure)|2|||
124794238|NCT00920907|448877199|FG000|Maintenance Period|Study Drug Toxicity|0|||
124794239|NCT00920907|448877200|FG001|Maintenance Period|Study Drug Toxicity|2|||
124794240|NCT00920907|448877199|FG000|Maintenance Period|Death|1|||
124794241|NCT00920907|448877200|FG001|Maintenance Period|Death|1|||
124794242|NCT00920907|448877199|FG000|Maintenance Period|Withdrawal by Subject|1|||
124794243|NCT00920907|448877200|FG001|Maintenance Period|Withdrawal by Subject|0|||
124794244|NCT00920907|448877199|FG000|Maintenance Period|Adverse Event|0|||
124794245|NCT00920907|448877200|FG001|Maintenance Period|Adverse Event|1|||
124794246|NCT02616601|448877201|FG000|Overall Study|Withdrawal by Subject|4|||
124794247|NCT02616601|448877202|FG001|Overall Study|Withdrawal by Subject|4|||
124794248|NCT02616601|448877203|FG002|Overall Study|Withdrawal by Subject|3|||
124794249|NCT02616601|448877201|FG000|Overall Study|Adverse Event|2|||
124794250|NCT02616601|448877202|FG001|Overall Study|Adverse Event|0|||
124794251|NCT02616601|448877203|FG002|Overall Study|Adverse Event|2|||
124794252|NCT02616601|448877201|FG000|Overall Study|Death|1|||
124794253|NCT02616601|448877202|FG001|Overall Study|Death|0|||
124794254|NCT02616601|448877203|FG002|Overall Study|Death|0|||
124794255|NCT02616601|448877201|FG000|Overall Study|Lost to Follow-up|1|||
124794256|NCT02616601|448877202|FG001|Overall Study|Lost to Follow-up|0|||
124794257|NCT02616601|448877203|FG002|Overall Study|Lost to Follow-up|1|||
124794258|NCT02616601|448877201|FG000|Overall Study|Non-Compliance with Test Article|1|||
124794259|NCT02616601|448877202|FG001|Overall Study|Non-Compliance with Test Article|0|||
124794260|NCT02616601|448877203|FG002|Overall Study|Non-Compliance with Test Article|1|||
124794261|NCT04389970|448877205|FG000|Overall Study|Lost to Follow-up|1|||
124794262|NCT04179890|448877206|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
124794263|NCT04179890|448877207|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
124794264|NCT04179890|448877206|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
124794265|NCT04179890|448877207|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
124794266|NCT04179890|448877206|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
124794267|NCT04179890|448877207|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
124794268|NCT04179890|448877206|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
124794269|NCT04179890|448877207|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
124794270|NCT04179890|448877206|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
124794271|NCT04179890|448877207|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
124794272|NCT04179890|448877206|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
124794273|NCT04179890|448877207|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
124794274|NCT04179890|448877206|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
124794275|NCT04179890|448877207|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
124794276|NCT04179890|448877206|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
124794277|NCT04179890|448877207|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
124794278|NCT04179890|448877206|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
124794279|NCT04179890|448877207|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
124794280|NCT02579928|448877208|FG000|Overall Study|Withdrawal by Subject|1|||
124794281|NCT02579928|448877209|FG001|Overall Study|Withdrawal by Subject|0|||
124794282|NCT03754972|448877212|FG000|Overall Study|Protocol Violation|25|||
124794283|NCT03422627|448877213|FG000|Overall Study|Protocol-specified Criteria|1|||
124794284|NCT03422627|448877214|FG001|Overall Study|Protocol-specified Criteria|1|||
124794285|NCT03422627|448877215|FG002|Overall Study|Protocol-specified Criteria|0|||
124794286|NCT03422627|448877216|FG003|Overall Study|Protocol-specified Criteria|0|||
124794287|NCT03422627|448877217|FG004|Overall Study|Protocol-specified Criteria|2|||
124794288|NCT03422627|448877213|FG000|Overall Study|Requirement for Alternative Therapy|1|||
124794289|NCT03422627|448877214|FG001|Overall Study|Requirement for Alternative Therapy|1|||
124794290|NCT03422627|448877215|FG002|Overall Study|Requirement for Alternative Therapy|2|||
124794291|NCT03422627|448877216|FG003|Overall Study|Requirement for Alternative Therapy|0|||
124794292|NCT03422627|448877217|FG004|Overall Study|Requirement for Alternative Therapy|0|||
124794293|NCT03422627|448877213|FG000|Overall Study|Disease Progression|1|||
124794294|NCT03422627|448877214|FG001|Overall Study|Disease Progression|0|||
124794295|NCT03422627|448877215|FG002|Overall Study|Disease Progression|1|||
124794296|NCT03422627|448877216|FG003|Overall Study|Disease Progression|2|||
124794297|NCT03422627|448877217|FG004|Overall Study|Disease Progression|0|||
124794298|NCT03422627|448877213|FG000|Overall Study|Adverse Event|2|||
124794299|NCT03422627|448877214|FG001|Overall Study|Adverse Event|1|||
124794300|NCT03422627|448877215|FG002|Overall Study|Adverse Event|0|||
124794301|NCT03422627|448877216|FG003|Overall Study|Adverse Event|0|||
124794302|NCT03422627|448877217|FG004|Overall Study|Adverse Event|2|||
124794303|NCT03422627|448877213|FG000|Overall Study|Ineligibility Determined|0|||
124794304|NCT03422627|448877214|FG001|Overall Study|Ineligibility Determined|1|||
124794305|NCT03422627|448877215|FG002|Overall Study|Ineligibility Determined|0|||
124794306|NCT03422627|448877216|FG003|Overall Study|Ineligibility Determined|0|||
124794307|NCT03422627|448877217|FG004|Overall Study|Ineligibility Determined|0|||
124794308|NCT03422627|448877213|FG000|Overall Study|Death|0|||
124794309|NCT03422627|448877214|FG001|Overall Study|Death|1|||
124794310|NCT03422627|448877215|FG002|Overall Study|Death|1|||
124794311|NCT03422627|448877216|FG003|Overall Study|Death|0|||
124794312|NCT03422627|448877217|FG004|Overall Study|Death|0|||
124794313|NCT03422627|448877213|FG000|Overall Study|Withdrawal by Subject|0|||
124794314|NCT03422627|448877214|FG001|Overall Study|Withdrawal by Subject|0|||
124794315|NCT03422627|448877215|FG002|Overall Study|Withdrawal by Subject|0|||
124794316|NCT03422627|448877216|FG003|Overall Study|Withdrawal by Subject|1|||
124794317|NCT03422627|448877217|FG004|Overall Study|Withdrawal by Subject|0|||
124794318|NCT00934648|448877220|FG000|Overall Study|Failure to return|8|||
124794319|NCT00934648|448877220|FG000|Overall Study|Withdrawal by Subject|1|||
124794320|NCT01993836|448877221|FG000|Overall Study|Surgery Cancelled|3|||
124794321|NCT01993836|448877222|FG001|Overall Study|Surgery Cancelled|0|||
124794322|NCT01993836|448877223|FG002|Overall Study|Surgery Cancelled|0|||
124794323|NCT01993836|448877221|FG000|Overall Study|Physician Decision|2|||
124794324|NCT01993836|448877222|FG001|Overall Study|Physician Decision|1|||
124794325|NCT01993836|448877223|FG002|Overall Study|Physician Decision|0|||
124794326|NCT01993836|448877221|FG000|Overall Study|Death|0|||
124794327|NCT01993836|448877222|FG001|Overall Study|Death|2|||
124794328|NCT01993836|448877223|FG002|Overall Study|Death|0|||
124794329|NCT01993836|448877221|FG000|Overall Study|Withdrawal by Subject|12|||
124794330|NCT01993836|448877222|FG001|Overall Study|Withdrawal by Subject|10|||
124794331|NCT01993836|448877223|FG002|Overall Study|Withdrawal by Subject|5|||
124794332|NCT02195687|448877225|FG000|Overall Study|Personal Reasons|1|||
124794333|NCT02195687|448877226|FG001|Overall Study|Personal Reasons|1|||
124794334|NCT02195687|448877225|FG000|Overall Study|Lost to Follow-up|4|||
124794335|NCT02195687|448877226|FG001|Overall Study|Lost to Follow-up|1|||
124794336|NCT04369924|448877227|FG000|Overall Study|Lost to Follow-up|302|||
124794337|NCT04369924|448877228|FG001|Overall Study|Lost to Follow-up|339|||
124794338|NCT00708201|448877229|FG000|Overall Study|Adverse Event|4|||
124794339|NCT00708201|448877230|FG001|Overall Study|Adverse Event|4|||
124794340|NCT00708201|448877229|FG000|Overall Study|Withdrawal by Subject|1|||
124794341|NCT00708201|448877230|FG001|Overall Study|Withdrawal by Subject|1|||
124794342|NCT00708201|448877229|FG000|Overall Study|Lost to Follow-up|2|||
124794343|NCT00708201|448877230|FG001|Overall Study|Lost to Follow-up|0|||
124794344|NCT00708201|448877229|FG000|Overall Study|Protocol Violation|0|||
124794345|NCT00708201|448877230|FG001|Overall Study|Protocol Violation|1|||
124794346|NCT00282464|448877231|FG000|Overall Study|Adverse Event|26|||
124794347|NCT00282464|448877232|FG001|Overall Study|Adverse Event|20|||
124794348|NCT00282464|448877231|FG000|Overall Study|Lack of Efficacy|8|||
124794349|NCT00282464|448877232|FG001|Overall Study|Lack of Efficacy|8|||
124794350|NCT00282464|448877231|FG000|Overall Study|Lost to Follow-up|10|||
124794351|NCT00282464|448877232|FG001|Overall Study|Lost to Follow-up|10|||
124794352|NCT00282464|448877231|FG000|Overall Study|Withdrawal by Subject|24|||
124794353|NCT00282464|448877232|FG001|Overall Study|Withdrawal by Subject|10|||
124794354|NCT00282464|448877231|FG000|Overall Study|laboratory abnormality|1|||
124794355|NCT00282464|448877232|FG001|Overall Study|laboratory abnormality|2|||
124794356|NCT00282464|448877231|FG000|Overall Study|Protocol Violation|0|||
124794357|NCT00282464|448877232|FG001|Overall Study|Protocol Violation|7|||
124794358|NCT00282464|448877231|FG000|Overall Study|Patient moved|1|||
124794359|NCT00282464|448877232|FG001|Overall Study|Patient moved|0|||
124794360|NCT00282464|448877231|FG000|Overall Study|patient non-compliant|3|||
124794361|NCT00282464|448877232|FG001|Overall Study|patient non-compliant|0|||
124794362|NCT00282464|448877231|FG000|Overall Study|patient no show|0|||
124794363|NCT00282464|448877232|FG001|Overall Study|patient no show|1|||
124794364|NCT00282464|448877231|FG000|Overall Study|patient incarcerated|0|||
124794365|NCT00282464|448877232|FG001|Overall Study|patient incarcerated|1|||
124794366|NCT00282464|448877231|FG000|Overall Study|family crisis|0|||
124794367|NCT00282464|448877232|FG001|Overall Study|family crisis|1|||
124629688|NCT01891864|448261151|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
124629689|NCT01891864|448261146|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
124629690|NCT01891864|448261147|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
124629691|NCT01891864|448261148|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
124629692|NCT01891864|448261149|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
124794368|NCT00282464|448877231|FG000|Overall Study|dispensed wrong kit|0|||
124794369|NCT00282464|448877232|FG001|Overall Study|dispensed wrong kit|1|||
124794370|NCT00282464|448877231|FG000|Overall Study|dropped due to missed visits|0|||
124794371|NCT00282464|448877232|FG001|Overall Study|dropped due to missed visits|1|||
124794372|NCT00812487|448877233|FG000|Overall Study|Lost to Follow-up|2|||
124629693|NCT01891864|448261150|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
124629694|NCT01891864|448261151|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
124794373|NCT00812487|448877234|FG001|Overall Study|Lost to Follow-up|0|||
124794374|NCT00812487|448877233|FG000|Overall Study|Withdrawal by Subject|3|||
124794375|NCT00812487|448877234|FG001|Overall Study|Withdrawal by Subject|2|||
124794376|NCT00812487|448877233|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
124794377|NCT00812487|448877234|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
124794378|NCT00812487|448877233|FG000|Overall Study|Protocol Violation|0|||
124794379|NCT00812487|448877234|FG001|Overall Study|Protocol Violation|1|||
124794380|NCT02360605|448877235|FG000|Overall Study|Withdrawal by Subject|4|||
124794381|NCT02360605|448877236|FG001|Overall Study|Withdrawal by Subject|9|||
124794382|NCT02360605|448877235|FG000|Overall Study|Lost to Follow-up|7|||
124794383|NCT02360605|448877236|FG001|Overall Study|Lost to Follow-up|8|||
124794384|NCT02360605|448877235|FG000|Overall Study|Death|0|||
124794385|NCT02360605|448877236|FG001|Overall Study|Death|1|||
124794386|NCT00290407|448877237|FG000|Overall Study|Physician Decision|2|||
124794387|NCT01117792|448877239|FG000|Overall Study|Death|1|||
124794388|NCT01117792|448877239|FG000|Overall Study|Adverse Event|3|||
124794389|NCT01721577|448877240|FG000|Overall Study|Lack of Efficacy|1|||
124794390|NCT01721577|448877241|FG001|Overall Study|Lack of Efficacy|0|||
124794391|NCT01721577|448877240|FG000|Overall Study|Death|1|||
124794392|NCT01721577|448877241|FG001|Overall Study|Death|0|||
124794393|NCT01721577|448877240|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
124794394|NCT01721577|448877241|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
124794395|NCT01721577|448877240|FG000|Overall Study|Adverse Event|0|||
124794396|NCT01721577|448877241|FG001|Overall Study|Adverse Event|2|||
124794397|NCT01055496|448877249|FG000|Overall Study|Withdrawal by Subject|2|||
124794398|NCT01055496|448877250|FG001|Overall Study|Withdrawal by Subject|4|||
124794399|NCT01055496|448877249|FG000|Overall Study|Death|13|||
124794400|NCT01055496|448877250|FG001|Overall Study|Death|23|||
124794401|NCT01055496|448877249|FG000|Overall Study|Lost to Follow-up|0|||
124794402|NCT01055496|448877250|FG001|Overall Study|Lost to Follow-up|2|||
124794403|NCT01055496|448877249|FG000|Overall Study|Other - Unspecified|0|||
124794404|NCT01055496|448877250|FG001|Overall Study|Other - Unspecified|1|||
124794405|NCT01673282|448877258|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
124794406|NCT01673282|448877259|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
124794407|NCT01673282|448877258|FG000|Overall Study|Lack of Efficacy|9|||
124794408|NCT01673282|448877259|FG001|Overall Study|Lack of Efficacy|2|||
124794409|NCT01673282|448877258|FG000|Overall Study|Lost to Follow-up|11|||
124794410|NCT01673282|448877259|FG001|Overall Study|Lost to Follow-up|10|||
124794411|NCT01673282|448877258|FG000|Overall Study|Withdrawal by Subject|3|||
124794412|NCT01673282|448877259|FG001|Overall Study|Withdrawal by Subject|3|||
124794413|NCT01673282|448877258|FG000|Overall Study|Other|1|||
124794414|NCT01673282|448877259|FG001|Overall Study|Other|6|||
124794415|NCT02106923|448877265|FG000|Overall Study|Protocol Violation|0|||
124794416|NCT02106923|448877266|FG001|Overall Study|Protocol Violation|0|||
124794417|NCT02106923|448877267|FG002|Overall Study|Protocol Violation|0|||
124794418|NCT02106923|448877268|FG003|Overall Study|Protocol Violation|0|||
124794419|NCT02106923|448877269|FG004|Overall Study|Protocol Violation|0|||
124794420|NCT02106923|448877270|FG005|Overall Study|Protocol Violation|1|||
124794421|NCT03485495|448877271|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
124794422|NCT03485495|448877272|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
124794423|NCT01323920|448877273|FG000|Overall Study|Death|5|||
124794424|NCT01323920|448877273|FG000|Overall Study|Withdrawal by Subject|1|||
124794425|NCT02915874|448877274|FG000|Overall Study|Lost to Follow-up|5|||
124794426|NCT02915874|448877275|FG001|Overall Study|Lost to Follow-up|4|||
124794427|NCT02915874|448877274|FG000|Overall Study|Withdrawal by Subject|1|||
124794428|NCT02915874|448877275|FG001|Overall Study|Withdrawal by Subject|1|||
124794429|NCT02915874|448877274|FG000|Overall Study|Started New Anxiety Medication|0|||
124794430|NCT02915874|448877275|FG001|Overall Study|Started New Anxiety Medication|1|||
124629695|NCT01891864|448261146|FG000|Treatment Period 1|Withdrawal by Subject|2|||
124629696|NCT01891864|448261147|FG001|Treatment Period 1|Withdrawal by Subject|5|||
124629697|NCT01891864|448261148|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124629698|NCT01891864|448261149|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124629699|NCT01891864|448261150|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124794431|NCT01056380|448877277|FG000|Overall Study|Lost to Follow-up|2|||
124794432|NCT01056380|448877278|FG001|Overall Study|Lost to Follow-up|3|||
124794433|NCT03901456|448877279|FG000|Overall Study|Withdrawal by Subject|0|||
124794434|NCT03901456|448877280|FG001|Overall Study|Withdrawal by Subject|0|||
124794435|NCT03901456|448877281|FG002|Overall Study|Withdrawal by Subject|1|||
124794436|NCT03901456|448877279|FG000|Overall Study|Lost to Follow-up|0|||
124794437|NCT03901456|448877280|FG001|Overall Study|Lost to Follow-up|1|||
124794438|NCT03901456|448877281|FG002|Overall Study|Lost to Follow-up|0|||
124794439|NCT01715129|448877286|FG000|Overall Study|Adverse Event, fatal|1|||
124794440|NCT01715129|448877286|FG000|Overall Study|Lack of Efficacy|3|||
124794441|NCT01715129|448877286|FG000|Overall Study|Protocol Violation|1|||
124629700|NCT01891864|448261151|FG005|Treatment Period 1|Withdrawal by Subject|0|||
124629701|NCT01891864|448261146|FG000|Treatment Period 1|Lost to Follow-up|1|||
124629702|NCT01891864|448261147|FG001|Treatment Period 1|Lost to Follow-up|0|||
124794442|NCT01715129|448877286|FG000|Overall Study|Consent Withdrawn|2|||
124794443|NCT01715129|448877286|FG000|Overall Study|Lost to Follow-up|1|||
124794444|NCT01715129|448877286|FG000|Overall Study|Other|1|||
124794445|NCT02068768|448877291|FG000|Overall Study|Lost to Follow-up|5|||
124794446|NCT02068768|448877291|FG000|Overall Study|Early Termination by Sponsor|2|||
124794447|NCT00555425|448877292|FG000|Overall Study|Missed Medication > 1 wk|34|||
124794448|NCT00555425|448877293|FG001|Overall Study|Missed Medication > 1 wk|15|||
124629703|NCT01891864|448261148|FG002|Treatment Period 1|Lost to Follow-up|0|||
124794449|NCT00555425|448877292|FG000|Overall Study|Missed 3 physician management visits|1|||
124794450|NCT00555425|448877293|FG001|Overall Study|Missed 3 physician management visits|0|||
124794451|NCT00555425|448877292|FG000|Overall Study|Met criteria for protective transfer|16|||
124794452|NCT00555425|448877293|FG001|Overall Study|Met criteria for protective transfer|3|||
124794453|NCT00555425|448877292|FG000|Overall Study|Became pregnant and transferred care|0|||
124794454|NCT00555425|448877293|FG001|Overall Study|Became pregnant and transferred care|1|||
124794455|NCT00400153|448877301|FG000|Overall Study|AE due to study disease worsening|14|||
124794456|NCT00400153|448877302|FG001|Overall Study|AE due to study disease worsening|19|||
124794457|NCT00400153|448877303|FG002|Overall Study|AE due to study disease worsening|20|||
124794458|NCT00400153|448877301|FG000|Overall Study|AE due to other disease worsening|2|||
124794459|NCT00400153|448877302|FG001|Overall Study|AE due to other disease worsening|1|||
124794460|NCT00400153|448877303|FG002|Overall Study|AE due to other disease worsening|0|||
124794461|NCT00400153|448877301|FG000|Overall Study|AE due to other condition|3|||
124794462|NCT00400153|448877302|FG001|Overall Study|AE due to other condition|14|||
124794463|NCT00400153|448877303|FG002|Overall Study|AE due to other condition|15|||
124794464|NCT00400153|448877301|FG000|Overall Study|Protocol Violation|7|||
124794465|NCT00400153|448877302|FG001|Overall Study|Protocol Violation|4|||
124794466|NCT00400153|448877303|FG002|Overall Study|Protocol Violation|9|||
124794467|NCT00400153|448877301|FG000|Overall Study|Lost to Follow-up|2|||
124794468|NCT00400153|448877302|FG001|Overall Study|Lost to Follow-up|1|||
124794469|NCT00400153|448877303|FG002|Overall Study|Lost to Follow-up|4|||
124794470|NCT00400153|448877301|FG000|Overall Study|Withdrawal by Subject|12|||
124794471|NCT00400153|448877302|FG001|Overall Study|Withdrawal by Subject|11|||
124794472|NCT00400153|448877303|FG002|Overall Study|Withdrawal by Subject|10|||
124794473|NCT00400153|448877301|FG000|Overall Study|Other reasons - not mentioned above|8|||
124794474|NCT00400153|448877302|FG001|Overall Study|Other reasons - not mentioned above|5|||
124794475|NCT00400153|448877303|FG002|Overall Study|Other reasons - not mentioned above|3|||
124794476|NCT01423604|448877304|FG000|Safety Run-In|Adverse Event|3|||
124794477|NCT01423604|448877305|FG001|Safety Run-In|Adverse Event|0|||
124794478|NCT01423604|448877304|FG000|Safety Run-In|Death|1|||
124794479|NCT01423604|448877305|FG001|Safety Run-In|Death|0|||
124794480|NCT01423604|448877304|FG000|Safety Run-In|Physician Decision|1|||
124794481|NCT01423604|448877305|FG001|Safety Run-In|Physician Decision|0|||
124794482|NCT01423604|448877304|FG000|Safety Run-In|Disease progression|3|||
124794483|NCT01423604|448877305|FG001|Safety Run-In|Disease progression|0|||
124794484|NCT01423604|448877304|FG000|Safety Run-In|Patient decision|1|||
124794485|NCT01423604|448877305|FG001|Safety Run-In|Patient decision|0|||
124629704|NCT01891864|448261149|FG003|Treatment Period 1|Lost to Follow-up|0|||
124629705|NCT01891864|448261150|FG004|Treatment Period 1|Lost to Follow-up|0|||
124629706|NCT01891864|448261151|FG005|Treatment Period 1|Lost to Follow-up|0|||
124629707|NCT01891864|448261146|FG000|Treatment Period 2|Protocol Violation|0|||
124629708|NCT01891864|448261147|FG001|Treatment Period 2|Protocol Violation|0|||
124629709|NCT01891864|448261148|FG002|Treatment Period 2|Protocol Violation|0|||
124629710|NCT01891864|448261149|FG003|Treatment Period 2|Protocol Violation|1|||
124629711|NCT01891864|448261150|FG004|Treatment Period 2|Protocol Violation|0|||
124629712|NCT01891864|448261151|FG005|Treatment Period 2|Protocol Violation|0|||
124629713|NCT01891864|448261146|FG000|Treatment Period 2|Physician Decision|0|||
124629714|NCT01891864|448261147|FG001|Treatment Period 2|Physician Decision|0|||
124629715|NCT01891864|448261148|FG002|Treatment Period 2|Physician Decision|1|||
124629716|NCT01891864|448261149|FG003|Treatment Period 2|Physician Decision|0|||
124629717|NCT01891864|448261150|FG004|Treatment Period 2|Physician Decision|0|||
124629718|NCT01891864|448261151|FG005|Treatment Period 2|Physician Decision|0|||
124629719|NCT01891864|448261146|FG000|Treatment Period 2|Site Termination|0|||
124629720|NCT01891864|448261147|FG001|Treatment Period 2|Site Termination|0|||
124629721|NCT01891864|448261148|FG002|Treatment Period 2|Site Termination|1|||
124629722|NCT01891864|448261149|FG003|Treatment Period 2|Site Termination|2|||
124629723|NCT01891864|448261150|FG004|Treatment Period 2|Site Termination|0|||
124629724|NCT01891864|448261151|FG005|Treatment Period 2|Site Termination|0|||
124794486|NCT01423604|448877304|FG000|Randomized|Adverse Event|4|||
124794487|NCT01423604|448877305|FG001|Randomized|Adverse Event|10|||
124629725|NCT01891864|448261146|FG000|Treatment Period 2|Lack of Efficacy|0|||
124629726|NCT01891864|448261147|FG001|Treatment Period 2|Lack of Efficacy|0|||
124629727|NCT01891864|448261148|FG002|Treatment Period 2|Lack of Efficacy|1|||
124629728|NCT01891864|448261149|FG003|Treatment Period 2|Lack of Efficacy|0|||
124629729|NCT01891864|448261150|FG004|Treatment Period 2|Lack of Efficacy|1|||
124629730|NCT01891864|448261151|FG005|Treatment Period 2|Lack of Efficacy|0|||
124629731|NCT01891864|448261146|FG000|Treatment Period 2|Adverse Event|0|||
124629732|NCT01891864|448261147|FG001|Treatment Period 2|Adverse Event|0|||
124794488|NCT01423604|448877304|FG000|Randomized|Death|1|||
124794489|NCT01423604|448877305|FG001|Randomized|Death|0|||
124794490|NCT01423604|448877304|FG000|Randomized|Physician Decision|16|||
124629733|NCT01891864|448261148|FG002|Treatment Period 2|Adverse Event|1|||
124794491|NCT01423604|448877305|FG001|Randomized|Physician Decision|13|||
124794492|NCT01423604|448877304|FG000|Randomized|Other - unspecified|37|||
124794493|NCT01423604|448877305|FG001|Randomized|Other - unspecified|31|||
124794494|NCT01423604|448877304|FG000|Randomized|Patient decision|5|||
124794495|NCT01423604|448877305|FG001|Randomized|Patient decision|9|||
124794496|NCT00424255|448877306|FG000|Overall Study|Death|115|||
124794497|NCT00424255|448877307|FG001|Overall Study|Death|111|||
124794498|NCT00424255|448877306|FG000|Overall Study|Lost to Follow-up|26|||
124794499|NCT00424255|448877307|FG001|Overall Study|Lost to Follow-up|20|||
124794500|NCT00424255|448877306|FG000|Overall Study|Protocol Violation|0|||
124794501|NCT00424255|448877307|FG001|Overall Study|Protocol Violation|1|||
124794502|NCT00424255|448877306|FG000|Overall Study|Withdrawal by Subject|34|||
124794503|NCT00424255|448877307|FG001|Overall Study|Withdrawal by Subject|38|||
124794504|NCT00424255|448877306|FG000|Overall Study|Physician Decision|3|||
124794505|NCT00424255|448877307|FG001|Overall Study|Physician Decision|7|||
124794506|NCT00424255|448877306|FG000|Overall Study|Cognitive Disturbance|1|||
124794507|NCT00424255|448877307|FG001|Overall Study|Cognitive Disturbance|0|||
124794508|NCT00424255|448877306|FG000|Overall Study|Non-compliance by Participants|1|||
124794509|NCT00424255|448877307|FG001|Overall Study|Non-compliance by Participants|0|||
124794510|NCT00424255|448877306|FG000|Overall Study|Fatigue|1|||
124794511|NCT00424255|448877307|FG001|Overall Study|Fatigue|0|||
124794512|NCT00424255|448877306|FG000|Overall Study|Disease Progression|0|||
124794513|NCT00424255|448877307|FG001|Overall Study|Disease Progression|2|||
124794514|NCT00424255|448877306|FG000|Overall Study|Sponsor Terminated Study|161|||
124794515|NCT00424255|448877307|FG001|Overall Study|Sponsor Terminated Study|167|||
124794516|NCT02186301|448879140|FG000|Overall Study|Progressive Disease|7|||
124794517|NCT02186301|448879141|FG001|Overall Study|Progressive Disease|22|||
124794518|NCT02186301|448879142|FG002|Overall Study|Progressive Disease|27|||
124794519|NCT02186301|448879140|FG000|Overall Study|Adverse Event|5|||
124794520|NCT02186301|448879141|FG001|Overall Study|Adverse Event|5|||
124794521|NCT02186301|448879142|FG002|Overall Study|Adverse Event|5|||
124794522|NCT02186301|448879140|FG000|Overall Study|Death|1|||
124794523|NCT02186301|448879141|FG001|Overall Study|Death|0|||
124794524|NCT02186301|448879142|FG002|Overall Study|Death|0|||
124794525|NCT02186301|448879140|FG000|Overall Study|Withdrawal by Subject|5|||
124794526|NCT02186301|448879141|FG001|Overall Study|Withdrawal by Subject|1|||
124794527|NCT02186301|448879142|FG002|Overall Study|Withdrawal by Subject|3|||
124794528|NCT02186301|448879140|FG000|Overall Study|Physician Decision|1|||
124794529|NCT02186301|448879141|FG001|Overall Study|Physician Decision|0|||
124794530|NCT02186301|448879142|FG002|Overall Study|Physician Decision|1|||
124794531|NCT02186301|448879140|FG000|Overall Study|Study Terminated by Sponsor|1|||
124794532|NCT02186301|448879141|FG001|Overall Study|Study Terminated by Sponsor|0|||
124794533|NCT02186301|448879142|FG002|Overall Study|Study Terminated by Sponsor|11|||
124794534|NCT02186301|448879140|FG000|Overall Study|Protocol Deviation|0|||
124794535|NCT02186301|448879141|FG001|Overall Study|Protocol Deviation|2|||
124794536|NCT02186301|448879142|FG002|Overall Study|Protocol Deviation|0|||
124794537|NCT02186301|448879140|FG000|Overall Study|Missing|0|||
124794538|NCT02186301|448879141|FG001|Overall Study|Missing|0|||
124794539|NCT02186301|448879142|FG002|Overall Study|Missing|2|||
124794540|NCT02186301|448879140|FG000|Overall Study|Other|0|||
124794541|NCT02186301|448879141|FG001|Overall Study|Other|0|||
124794542|NCT02186301|448879142|FG002|Overall Study|Other|1|||
124794543|NCT00371761|448879143|FG000|Overall Study|Adverse Event|1|||
124794544|NCT00371761|448879144|FG001|Overall Study|Adverse Event|1|||
124794545|NCT00371761|448879143|FG000|Overall Study|Withdrawal by Subject|1|||
124794546|NCT00371761|448879144|FG001|Overall Study|Withdrawal by Subject|3|||
124794547|NCT00371761|448879143|FG000|Overall Study|Investigator Judgment|2|||
124794548|NCT00371761|448879144|FG001|Overall Study|Investigator Judgment|3|||
124794549|NCT00371761|448879143|FG000|Overall Study|Study termination|4|||
124794550|NCT00371761|448879144|FG001|Overall Study|Study termination|3|||
124794551|NCT03560739|448879145|FG000|Overall Study|Adverse Event|0|||
124794552|NCT03560739|448879146|FG001|Overall Study|Adverse Event|1|||
124629734|NCT01891864|448261149|FG003|Treatment Period 2|Adverse Event|2|||
124629735|NCT01891864|448261150|FG004|Treatment Period 2|Adverse Event|0|||
124629736|NCT01891864|448261151|FG005|Treatment Period 2|Adverse Event|4|||
124629737|NCT01891864|448261146|FG000|Treatment Period 2|Termination of Site|0|||
124794553|NCT03560739|448879147|FG002|Overall Study|Adverse Event|0|||
124794554|NCT03560739|448879148|FG003|Overall Study|Adverse Event|0|||
124794555|NCT03361176|448879149|FG000|Overall Study|Lost to Follow-up|1|||
124629738|NCT01891864|448261147|FG001|Treatment Period 2|Termination of Site|0|||
124794556|NCT03361176|448879150|FG001|Overall Study|Lost to Follow-up|2|||
124794557|NCT03361176|448879149|FG000|Overall Study|Adverse Event|0|||
124794558|NCT03361176|448879150|FG001|Overall Study|Adverse Event|2|||
124794559|NCT03361176|448879149|FG000|Overall Study|Withdrawal by Subject|0|||
124794560|NCT03361176|448879150|FG001|Overall Study|Withdrawal by Subject|1|||
124794561|NCT03123185|448879151|FG000|Overall Study|Withdrawal by Subject|0|||
124794562|NCT03123185|448879152|FG001|Overall Study|Withdrawal by Subject|0|||
124794563|NCT03123185|448879153|FG002|Overall Study|Withdrawal by Subject|0|||
124794564|NCT03123185|448879154|FG003|Overall Study|Withdrawal by Subject|0|||
124794565|NCT03123185|448879155|FG004|Overall Study|Withdrawal by Subject|0|||
124794566|NCT03123185|448879156|FG005|Overall Study|Withdrawal by Subject|0|||
124794567|NCT03123185|448879157|FG006|Overall Study|Withdrawal by Subject|0|||
124794568|NCT03123185|448879158|FG007|Overall Study|Withdrawal by Subject|0|||
124794569|NCT03123185|448879159|FG008|Overall Study|Withdrawal by Subject|0|||
124794570|NCT03123185|448879160|FG009|Overall Study|Withdrawal by Subject|0|||
124794571|NCT03123185|448879161|FG010|Overall Study|Withdrawal by Subject|0|||
124794572|NCT03123185|448879162|FG011|Overall Study|Withdrawal by Subject|0|||
124794573|NCT03123185|448879163|FG012|Overall Study|Withdrawal by Subject|1|||
124794574|NCT03123185|448879164|FG013|Overall Study|Withdrawal by Subject|0|||
124794575|NCT01083173|448879168|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
124794576|NCT01083173|448879169|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
124794577|NCT01083173|448879168|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
124794578|NCT01083173|448879169|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
124794579|NCT01083173|448879168|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
124794580|NCT01083173|448879169|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
124794581|NCT01083173|448879168|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
124794582|NCT01083173|448879169|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
124794583|NCT01083173|448879168|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
124794584|NCT01083173|448879169|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
124794585|NCT01083173|448879168|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
124794586|NCT01083173|448879169|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
124794587|NCT01083173|448879168|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
124794588|NCT01083173|448879169|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
124794589|NCT01083173|448879168|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
124794590|NCT01083173|448879169|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
124794591|NCT01083173|448879168|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
124794592|NCT01083173|448879169|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
124794593|NCT01083173|448879168|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
124794594|NCT01083173|448879169|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
124794595|NCT01083173|448879168|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
124794596|NCT01083173|448879169|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
124794597|NCT02554279|448879173|FG000|Overall Study|Adverse Event|2|||
124794598|NCT02554279|448879174|FG001|Overall Study|Adverse Event|5|||
124794599|NCT02554279|448879173|FG000|Overall Study|Lost to Follow-up|3|||
124794600|NCT02554279|448879174|FG001|Overall Study|Lost to Follow-up|2|||
124794601|NCT02554279|448879173|FG000|Overall Study|Withdrawal by Subject|6|||
124794602|NCT02554279|448879174|FG001|Overall Study|Withdrawal by Subject|4|||
124794603|NCT02554279|448879173|FG000|Overall Study|Protocol Violation|2|||
124794604|NCT02554279|448879174|FG001|Overall Study|Protocol Violation|1|||
124794605|NCT02554279|448879173|FG000|Overall Study|Other reason|19|||
124794606|NCT02554279|448879174|FG001|Overall Study|Other reason|6|||
124794607|NCT01933789|448879175|FG000|Overall Study|Death|0|||
124794608|NCT01933789|448879176|FG001|Overall Study|Death|0|||
124794609|NCT01933789|448879177|FG002|Overall Study|Death|0|||
124794610|NCT01933789|448879178|FG003|Overall Study|Death|0|||
124794611|NCT01933789|448879179|FG004|Overall Study|Death|21|||
124794612|NCT01933789|448879180|FG005|Overall Study|Death|32|||
124794613|NCT01933789|448879181|FG006|Overall Study|Death|0|||
124794614|NCT01933789|448879182|FG007|Overall Study|Death|0|||
124794615|NCT01933789|448879183|FG008|Overall Study|Death|0|||
124794616|NCT01933789|448879175|FG000|Overall Study|Lost to Follow-up|0|||
124794617|NCT01933789|448879176|FG001|Overall Study|Lost to Follow-up|0|||
124794618|NCT01933789|448879177|FG002|Overall Study|Lost to Follow-up|0|||
124794619|NCT01933789|448879178|FG003|Overall Study|Lost to Follow-up|1|||
124794620|NCT01933789|448879179|FG004|Overall Study|Lost to Follow-up|8|||
124794621|NCT01933789|448879180|FG005|Overall Study|Lost to Follow-up|9|||
124794622|NCT01933789|448879181|FG006|Overall Study|Lost to Follow-up|1|||
124794623|NCT01933789|448879182|FG007|Overall Study|Lost to Follow-up|4|||
124794624|NCT01933789|448879183|FG008|Overall Study|Lost to Follow-up|0|||
124794625|NCT01933789|448879175|FG000|Overall Study|Withdrawal by Subject|2|||
124794626|NCT01933789|448879176|FG001|Overall Study|Withdrawal by Subject|1|||
124794627|NCT01933789|448879177|FG002|Overall Study|Withdrawal by Subject|0|||
124794628|NCT01933789|448879178|FG003|Overall Study|Withdrawal by Subject|0|||
124794629|NCT01933789|448879179|FG004|Overall Study|Withdrawal by Subject|17|||
124794630|NCT01933789|448879180|FG005|Overall Study|Withdrawal by Subject|16|||
124794631|NCT01933789|448879181|FG006|Overall Study|Withdrawal by Subject|1|||
124794632|NCT01933789|448879182|FG007|Overall Study|Withdrawal by Subject|4|||
124794633|NCT01933789|448879183|FG008|Overall Study|Withdrawal by Subject|0|||
124794634|NCT01933789|448879175|FG000|Overall Study|Became Ineligible|4|||
124794635|NCT01933789|448879176|FG001|Overall Study|Became Ineligible|0|||
124794636|NCT01933789|448879177|FG002|Overall Study|Became Ineligible|0|||
124794637|NCT01933789|448879178|FG003|Overall Study|Became Ineligible|0|||
124794638|NCT01933789|448879179|FG004|Overall Study|Became Ineligible|13|||
124794639|NCT01933789|448879180|FG005|Overall Study|Became Ineligible|10|||
124794640|NCT01933789|448879181|FG006|Overall Study|Became Ineligible|13|||
124794641|NCT01933789|448879182|FG007|Overall Study|Became Ineligible|6|||
124794642|NCT01933789|448879183|FG008|Overall Study|Became Ineligible|0|||
124794643|NCT01966432|448879184|FG000|Overall Study|Lost to Follow-up|3|||
124794644|NCT01966432|448879185|FG001|Overall Study|Lost to Follow-up|2|||
124794645|NCT01966432|448879186|FG002|Overall Study|Lost to Follow-up|5|||
124794646|NCT01966432|448879184|FG000|Overall Study|Withdrawal by Subject|1|||
124794647|NCT01966432|448879185|FG001|Overall Study|Withdrawal by Subject|3|||
124794648|NCT01966432|448879186|FG002|Overall Study|Withdrawal by Subject|0|||
124794649|NCT01966432|448879184|FG000|Overall Study|Subject Incarcerated|0|||
124794650|NCT01966432|448879185|FG001|Overall Study|Subject Incarcerated|0|||
124794651|NCT01966432|448879186|FG002|Overall Study|Subject Incarcerated|1|||
124794652|NCT01966432|448879184|FG000|Overall Study|SBIRT program ended|1|||
124794653|NCT01966432|448879185|FG001|Overall Study|SBIRT program ended|8|||
124794654|NCT01966432|448879186|FG002|Overall Study|SBIRT program ended|20|||
124794655|NCT00930982|448879187|FG000|Overall Study|Adverse Event|19|||
124794656|NCT00930982|448879188|FG001|Overall Study|Adverse Event|23|||
124794657|NCT00930982|448879187|FG000|Overall Study|Protocol Violation|1|||
124794658|NCT00930982|448879188|FG001|Overall Study|Protocol Violation|5|||
124794659|NCT00930982|448879187|FG000|Overall Study|Withdrawal by Subject|1|||
124794660|NCT00930982|448879188|FG001|Overall Study|Withdrawal by Subject|1|||
124794661|NCT01609478|448879189|FG000|Overall Study|Adverse Event|3|||
124794662|NCT01609478|448879190|FG001|Overall Study|Adverse Event|1|||
124794663|NCT01609478|448879191|FG002|Overall Study|Adverse Event|5|||
124794664|NCT01609478|448879189|FG000|Overall Study|Protocol Deviation|0|||
124794665|NCT01609478|448879190|FG001|Overall Study|Protocol Deviation|1|||
124794666|NCT01609478|448879191|FG002|Overall Study|Protocol Deviation|1|||
124794667|NCT01609478|448879189|FG000|Overall Study|Non-Compliance with study treatment|1|||
124794668|NCT01609478|448879190|FG001|Overall Study|Non-Compliance with study treatment|0|||
124794669|NCT01609478|448879191|FG002|Overall Study|Non-Compliance with study treatment|0|||
124794670|NCT01609478|448879189|FG000|Overall Study|Physician Decision|1|||
124794671|NCT01609478|448879190|FG001|Overall Study|Physician Decision|0|||
124794672|NCT01609478|448879191|FG002|Overall Study|Physician Decision|1|||
124794673|NCT01609478|448879189|FG000|Overall Study|Withdrawal by Subject|2|||
124794674|NCT01609478|448879190|FG001|Overall Study|Withdrawal by Subject|0|||
124794675|NCT01609478|448879191|FG002|Overall Study|Withdrawal by Subject|2|||
124794676|NCT04966741|448879192|FG000|Overall Study|Lost to Follow-up|1|||
124794677|NCT04966741|448879193|FG001|Overall Study|Lost to Follow-up|0|||
124794678|NCT02953509|448879199|FG000|Overall Study|Death|1|||
124794679|NCT02953509|448879200|FG001|Overall Study|Death|3|||
124794680|NCT02953509|448879201|FG002|Overall Study|Death|3|||
124794681|NCT02953509|448879202|FG003|Overall Study|Death|4|||
124794682|NCT02953509|448879203|FG004|Overall Study|Death|12|||
124794683|NCT02953509|448879204|FG005|Overall Study|Death|3|||
124794684|NCT02953509|448879205|FG006|Overall Study|Death|25|||
124794685|NCT02953509|448879206|FG007|Overall Study|Death|10|||
124794686|NCT02953509|448879207|FG008|Overall Study|Death|21|||
124794687|NCT02953509|448879208|FG009|Overall Study|Death|20|||
124794688|NCT02953509|448879199|FG000|Overall Study|Reason Not Specified|0|||
124794689|NCT02953509|448879200|FG001|Overall Study|Reason Not Specified|2|||
124794690|NCT02953509|448879201|FG002|Overall Study|Reason Not Specified|8|||
124794691|NCT02953509|448879202|FG003|Overall Study|Reason Not Specified|2|||
124794692|NCT02953509|448879203|FG004|Overall Study|Reason Not Specified|11|||
124794693|NCT02953509|448879204|FG005|Overall Study|Reason Not Specified|4|||
124794694|NCT02953509|448879205|FG006|Overall Study|Reason Not Specified|12|||
124794695|NCT02953509|448879206|FG007|Overall Study|Reason Not Specified|2|||
124794696|NCT02953509|448879207|FG008|Overall Study|Reason Not Specified|7|||
124794697|NCT02953509|448879208|FG009|Overall Study|Reason Not Specified|2|||
124794698|NCT02953509|448879199|FG000|Overall Study|Consent Withdrawn|1|||
124794699|NCT02953509|448879200|FG001|Overall Study|Consent Withdrawn|1|||
124794700|NCT02953509|448879201|FG002|Overall Study|Consent Withdrawn|2|||
124794701|NCT02953509|448879202|FG003|Overall Study|Consent Withdrawn|1|||
124794702|NCT02953509|448879203|FG004|Overall Study|Consent Withdrawn|3|||
124794703|NCT02953509|448879204|FG005|Overall Study|Consent Withdrawn|0|||
124794704|NCT02953509|448879205|FG006|Overall Study|Consent Withdrawn|4|||
124794705|NCT02953509|448879206|FG007|Overall Study|Consent Withdrawn|1|||
124794706|NCT02953509|448879207|FG008|Overall Study|Consent Withdrawn|1|||
124794707|NCT02953509|448879208|FG009|Overall Study|Consent Withdrawn|4|||
124794708|NCT02953509|448879199|FG000|Overall Study|Lost to Follow-up|0|||
124794709|NCT02953509|448879200|FG001|Overall Study|Lost to Follow-up|0|||
124794710|NCT02953509|448879201|FG002|Overall Study|Lost to Follow-up|0|||
124629739|NCT01891864|448261148|FG002|Treatment Period 2|Termination of Site|0|||
124794711|NCT02953509|448879202|FG003|Overall Study|Lost to Follow-up|0|||
124794712|NCT02953509|448879203|FG004|Overall Study|Lost to Follow-up|0|||
124794713|NCT02953509|448879204|FG005|Overall Study|Lost to Follow-up|0|||
124794714|NCT02953509|448879205|FG006|Overall Study|Lost to Follow-up|1|||
124794715|NCT02953509|448879206|FG007|Overall Study|Lost to Follow-up|1|||
124794716|NCT02953509|448879207|FG008|Overall Study|Lost to Follow-up|1|||
124794717|NCT02953509|448879208|FG009|Overall Study|Lost to Follow-up|1|||
124794718|NCT02953509|448879199|FG000|Overall Study|Study terminated by sponsor|1|||
124794719|NCT02953509|448879200|FG001|Overall Study|Study terminated by sponsor|0|||
124794720|NCT02953509|448879201|FG002|Overall Study|Study terminated by sponsor|0|||
124794721|NCT02953509|448879202|FG003|Overall Study|Study terminated by sponsor|0|||
124794722|NCT02953509|448879203|FG004|Overall Study|Study terminated by sponsor|0|||
124794723|NCT02953509|448879204|FG005|Overall Study|Study terminated by sponsor|0|||
124794724|NCT02953509|448879205|FG006|Overall Study|Study terminated by sponsor|1|||
124794725|NCT02953509|448879206|FG007|Overall Study|Study terminated by sponsor|0|||
124794726|NCT02953509|448879207|FG008|Overall Study|Study terminated by sponsor|1|||
124794727|NCT02953509|448879208|FG009|Overall Study|Study terminated by sponsor|1|||
124794728|NCT00484185|448879209|FG000|Overall Study|Lost to Follow-up|44|||
124794729|NCT00484185|448879209|FG000|Overall Study|Other|20|||
124794730|NCT00484185|448879209|FG000|Overall Study|Randomized but not treated|5|||
124794731|NCT00484185|448879209|FG000|Overall Study|Death|2|||
124794732|NCT00459056|448879210|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
124794733|NCT00459056|448879211|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
124794734|NCT02522871|448879212|FG000|Overall Study|Protocol Violation|1|||
124794735|NCT02522871|448879213|FG001|Overall Study|Protocol Violation|4|||
124794736|NCT02522871|448879212|FG000|Overall Study|Treated without randomization|1|||
124794737|NCT02522871|448879213|FG001|Overall Study|Treated without randomization|0|||
124794738|NCT02522871|448879212|FG000|Overall Study|Death|9|||
124794739|NCT02522871|448879213|FG001|Overall Study|Death|9|||
124794740|NCT02522871|448879212|FG000|Overall Study|Died in operating room prior to transplant|0|||
124794741|NCT02522871|448879213|FG001|Overall Study|Died in operating room prior to transplant|1|||
124794742|NCT00509262|448879214|FG000|Overall Study|Adverse Event|16|||
124794743|NCT00509262|448879215|FG001|Overall Study|Adverse Event|18|||
124794744|NCT00509262|448879214|FG000|Overall Study|Other|2|||
124794745|NCT00509262|448879215|FG001|Overall Study|Other|2|||
124794746|NCT00509262|448879214|FG000|Overall Study|Lack of Efficacy|1|||
124794747|NCT00509262|448879215|FG001|Overall Study|Lack of Efficacy|0|||
124794748|NCT00509262|448879214|FG000|Overall Study|Lost to Follow-up|1|||
124794749|NCT00509262|448879215|FG001|Overall Study|Lost to Follow-up|6|||
124794750|NCT00509262|448879214|FG000|Overall Study|Physician Decision|1|||
124794751|NCT00509262|448879215|FG001|Overall Study|Physician Decision|3|||
124794752|NCT00509262|448879214|FG000|Overall Study|Protocol Violation|2|||
124794753|NCT00509262|448879215|FG001|Overall Study|Protocol Violation|2|||
124794754|NCT00509262|448879214|FG000|Overall Study|Withdrawal by Subject|24|||
124794755|NCT00509262|448879215|FG001|Overall Study|Withdrawal by Subject|11|||
124794756|NCT02793622|448879220|FG000|Overall Study|Lost to Follow-up|31|||
124794757|NCT02793622|448879221|FG001|Overall Study|Lost to Follow-up|19|||
124794758|NCT02793622|448879220|FG000|Overall Study|Withdrawal by Subject|21|||
124794759|NCT02793622|448879221|FG001|Overall Study|Withdrawal by Subject|17|||
124794760|NCT02793622|448879220|FG000|Overall Study|Adverse Event|0|||
124794761|NCT02793622|448879221|FG001|Overall Study|Adverse Event|1|||
124794762|NCT02793622|448879220|FG000|Overall Study|Protocol Violation|1|||
124794763|NCT02793622|448879221|FG001|Overall Study|Protocol Violation|5|||
124794764|NCT01146860|448879222|FG000|Overall Study|Withdrawal by Subject|0|||
124794765|NCT01146860|448879223|FG001|Overall Study|Withdrawal by Subject|1|||
124794766|NCT01092832|448879224|FG000|Overall Study|Other|1|||
124794767|NCT01092832|448879225|FG001|Overall Study|Other|0|||
124794768|NCT00393042|448879227|FG000|First Intervention|Withdrawal by Subject|1|||
124794769|NCT00393042|448879228|FG001|First Intervention|Withdrawal by Subject|2|||
124794770|NCT00393042|448879227|FG000|First Intervention|Lost to Follow-up|3|||
124794771|NCT00393042|448879228|FG001|First Intervention|Lost to Follow-up|3|||
124794772|NCT00393042|448879227|FG000|First Intervention|Protocol Violation|1|||
124794773|NCT00393042|448879228|FG001|First Intervention|Protocol Violation|0|||
124794774|NCT00393042|448879227|FG000|First Intervention|Adverse Event|0|||
124794775|NCT00393042|448879228|FG001|First Intervention|Adverse Event|1|||
124794776|NCT00393042|448879227|FG000|Second Intervetion|Adverse Event|0|||
124794777|NCT00393042|448879228|FG001|Second Intervetion|Adverse Event|3|||
124794778|NCT00393042|448879227|FG000|Second Intervetion|Withdrawal by Subject|0|||
124794779|NCT00393042|448879228|FG001|Second Intervetion|Withdrawal by Subject|2|||
124794780|NCT00393042|448879227|FG000|Second Intervetion|Lack of Efficacy|1|||
124794781|NCT00393042|448879228|FG001|Second Intervetion|Lack of Efficacy|0|||
124794782|NCT00393042|448879227|FG000|Second Intervetion|Lost to Follow-up|0|||
124794783|NCT00393042|448879228|FG001|Second Intervetion|Lost to Follow-up|2|||
124794784|NCT00393042|448879227|FG000|Second Intervetion|Protocol Violation|1|||
124794785|NCT00393042|448879228|FG001|Second Intervetion|Protocol Violation|1|||
124794786|NCT01150474|448879230|FG000|Overall Study|Withdrawal by Subject|5|||
124794787|NCT01150474|448879231|FG001|Overall Study|Withdrawal by Subject|2|||
124794788|NCT01150474|448879230|FG000|Overall Study|Cancer found|1|||
124794789|NCT01150474|448879231|FG001|Overall Study|Cancer found|0|||
124794790|NCT01150474|448879230|FG000|Overall Study|Multiple Studies|0|||
124794791|NCT01150474|448879231|FG001|Overall Study|Multiple Studies|1|||
124794792|NCT01150474|448879230|FG000|Overall Study|Rectotomy|1|||
124794793|NCT01150474|448879231|FG001|Overall Study|Rectotomy|0|||
124794794|NCT01150474|448879230|FG000|Overall Study|Drug did not arrive in time|1|||
124794795|NCT01150474|448879231|FG001|Overall Study|Drug did not arrive in time|0|||
124794796|NCT01150474|448879230|FG000|Overall Study|Drug not administered|1|||
124794797|NCT01150474|448879231|FG001|Overall Study|Drug not administered|0|||
124794798|NCT01150474|448879230|FG000|Overall Study|Surgery Changed|1|||
124794799|NCT01150474|448879231|FG001|Overall Study|Surgery Changed|0|||
124794800|NCT02290431|448879232|FG000|Overall Study|Adverse Event|20|||
124794801|NCT02290431|448879232|FG000|Overall Study|Progressive disease|4|||
124794802|NCT02290431|448879232|FG000|Overall Study|Study terminated by Sponsor|1|||
124794803|NCT02290431|448879232|FG000|Overall Study|Physician Decision|2|||
124794804|NCT00821327|448879235|FG000|Overall Study|Adverse Event|13|||
124794805|NCT00821327|448879235|FG000|Overall Study|Patient Request|1|||
124794806|NCT00821327|448879235|FG000|Overall Study|Investigator Request|2|||
124794807|NCT00821327|448879235|FG000|Overall Study|Sponsor Request|1|||
124794808|NCT00821327|448879235|FG000|Overall Study|Disease Progression|13|||
124794809|NCT00821327|448879235|FG000|Overall Study|Other/Unknown|5|||
124794810|NCT00459979|448879238|FG000|Overall Study|Withdrawal by Subject|1|||
124794811|NCT00459979|448879238|FG000|Overall Study|Protocol Violation|1|||
124794812|NCT01007253|448879245|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
124794813|NCT01007253|448879246|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
124794814|NCT01007253|448879247|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
124794815|NCT01007253|448879248|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
124794816|NCT00814801|448879249|FG000|Overall Study|Adverse Event|15|||
124794817|NCT00814801|448879250|FG001|Overall Study|Adverse Event|16|||
124794818|NCT00814801|448879251|FG002|Overall Study|Adverse Event|19|||
124794819|NCT00814801|448879249|FG000|Overall Study|Withdrawal by Subject|9|||
124794820|NCT00814801|448879250|FG001|Overall Study|Withdrawal by Subject|11|||
124794821|NCT00814801|448879251|FG002|Overall Study|Withdrawal by Subject|14|||
124794822|NCT00814801|448879249|FG000|Overall Study|Inappropriate as a subject|1|||
124794823|NCT00814801|448879250|FG001|Overall Study|Inappropriate as a subject|1|||
124794824|NCT00814801|448879251|FG002|Overall Study|Inappropriate as a subject|1|||
124794825|NCT00814801|448879249|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
124794826|NCT00814801|448879250|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
124794827|NCT00814801|448879251|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
124794828|NCT00814801|448879249|FG000|Overall Study|Missing or change of caregiver|6|||
124794829|NCT00814801|448879250|FG001|Overall Study|Missing or change of caregiver|2|||
124794830|NCT00814801|448879251|FG002|Overall Study|Missing or change of caregiver|4|||
124794831|NCT00814801|448879249|FG000|Overall Study|Non-compliance|0|||
124794832|NCT00814801|448879250|FG001|Overall Study|Non-compliance|1|||
124794833|NCT00814801|448879251|FG002|Overall Study|Non-compliance|1|||
124794834|NCT00814801|448879249|FG000|Overall Study|Other|2|||
124794835|NCT00814801|448879250|FG001|Overall Study|Other|6|||
124794836|NCT00814801|448879251|FG002|Overall Study|Other|4|||
124794837|NCT01163032|448879255|FG000|Randomization Phase|Withdrawal by Subject|2|||
124794838|NCT01163032|448879256|FG001|Randomization Phase|Withdrawal by Subject|3|||
124794839|NCT01163032|448879257|FG002|Randomization Phase|Withdrawal by Subject|0|||
124794840|NCT01163032|448879255|FG000|Randomization Phase|Adverse Event|3|||
124794841|NCT01163032|448879256|FG001|Randomization Phase|Adverse Event|3|||
124794842|NCT01163032|448879257|FG002|Randomization Phase|Adverse Event|0|||
124794843|NCT01163032|448879255|FG000|Randomization Phase|Protocol Violation|0|||
124794844|NCT01163032|448879256|FG001|Randomization Phase|Protocol Violation|1|||
124794845|NCT01163032|448879257|FG002|Randomization Phase|Protocol Violation|0|||
124794846|NCT01163032|448879255|FG000|Randomization Phase|Various*|5|||
124794847|NCT01163032|448879256|FG001|Randomization Phase|Various*|4|||
124794848|NCT01163032|448879257|FG002|Randomization Phase|Various*|0|||
124794849|NCT01163032|448879255|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
124794850|NCT01163032|448879256|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
124794851|NCT01163032|448879257|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
124794852|NCT01163032|448879255|FG000|Open Label Extension Phase|Adverse Event|0|||
124794853|NCT01163032|448879256|FG001|Open Label Extension Phase|Adverse Event|0|||
124794854|NCT01163032|448879257|FG002|Open Label Extension Phase|Adverse Event|3|||
124794855|NCT01163032|448879255|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
124794856|NCT01163032|448879256|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
124794857|NCT01163032|448879257|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
124794858|NCT01163032|448879255|FG000|Open Label Extension Phase|Protocol Violation|0|||
124794859|NCT01163032|448879256|FG001|Open Label Extension Phase|Protocol Violation|0|||
124794860|NCT01163032|448879257|FG002|Open Label Extension Phase|Protocol Violation|1|||
124794861|NCT01163032|448879255|FG000|Open Label Extension Phase|Study Termination|0|||
124794862|NCT01163032|448879256|FG001|Open Label Extension Phase|Study Termination|0|||
124794863|NCT01163032|448879257|FG002|Open Label Extension Phase|Study Termination|7|||
124794864|NCT01163032|448879255|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
124794865|NCT01163032|448879256|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
124794866|NCT01163032|448879257|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
124629740|NCT01891864|448261149|FG003|Treatment Period 2|Termination of Site|0|||
124794867|NCT02751931|448879258|FG000|Overall Study|Adverse Event|3|||
124794868|NCT02751931|448879259|FG001|Overall Study|Adverse Event|0|||
124794869|NCT02751931|448879258|FG000|Overall Study|Other: Miscelleneous|10|||
124794870|NCT02751931|448879259|FG001|Overall Study|Other: Miscelleneous|8|||
124794871|NCT02380690|448879260|FG000|Overall Study|Lost to Follow-up|14|||
124794872|NCT02380690|448879261|FG001|Overall Study|Lost to Follow-up|4|||
124794873|NCT02380690|448879260|FG000|Overall Study|Withdrawal by Subject|20|||
124794874|NCT02380690|448879261|FG001|Overall Study|Withdrawal by Subject|8|||
124794875|NCT00817479|448879265|FG000|Overall Study|Physician Decision|1|||
124794876|NCT00817479|448879266|FG001|Overall Study|Physician Decision|1|||
124794877|NCT04030026|448879268|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
124794878|NCT04030026|448879269|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
124794879|NCT04030026|448879268|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
124794880|NCT04030026|448879269|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
124794881|NCT04030026|448879268|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
124794882|NCT04030026|448879269|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
124794883|NCT04030026|448879268|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
124794884|NCT04030026|448879269|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
124794885|NCT04030026|448879268|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
124794886|NCT04030026|448879269|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
124794887|NCT04030026|448879268|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
124794888|NCT04030026|448879269|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
124794889|NCT04030026|448879268|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
124794890|NCT04030026|448879269|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
124794891|NCT00523367|448879270|FG000|Overall Study|19 screen failures|19|||
124794892|NCT00523367|448879270|FG000|Overall Study|4 Withdrawn by PI|4|||
124794893|NCT00282347|448879275|FG000|Treatment Period|Death|2|||
124794894|NCT00282347|448879276|FG001|Treatment Period|Death|0|||
124794895|NCT00282347|448879275|FG000|Treatment Period|Lost to Follow-up|2|||
124794896|NCT00282347|448879276|FG001|Treatment Period|Lost to Follow-up|5|||
124794897|NCT00282347|448879275|FG000|Treatment Period|Withdrawal by Subject|1|||
124794898|NCT00282347|448879276|FG001|Treatment Period|Withdrawal by Subject|3|||
124794899|NCT00282347|448879275|FG000|Treatment Period|Physician Decision|0|||
124794900|NCT00282347|448879276|FG001|Treatment Period|Physician Decision|1|||
124794901|NCT00282347|448879275|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
124794902|NCT00282347|448879276|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
124794903|NCT00282347|448879275|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
124794904|NCT00282347|448879276|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
124794905|NCT00282347|448879275|FG000|Safety Follow-up Period|Physician Decision|1|||
124794906|NCT00282347|448879276|FG001|Safety Follow-up Period|Physician Decision|1|||
124794907|NCT00282347|448879275|FG000|Safety Follow-up Period|Protocol Deviation|0|||
124794908|NCT00282347|448879276|FG001|Safety Follow-up Period|Protocol Deviation|2|||
124794909|NCT00282347|448879275|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
124794910|NCT00282347|448879276|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
124794911|NCT00282347|448879275|FG000|B Cell Follow-up Period|Physician Decision|1|||
124794912|NCT00282347|448879276|FG001|B Cell Follow-up Period|Physician Decision|0|||
124794913|NCT00282347|448879275|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
124794914|NCT00282347|448879276|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
124794915|NCT02361346|448879277|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
124794916|NCT02361346|448879278|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
124794917|NCT02361346|448879279|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
124794918|NCT02361346|448879280|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
124794919|NCT02361346|448879281|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
124794920|NCT02361346|448879282|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
124794921|NCT02361346|448879283|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
124794922|NCT02361346|448879284|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
124794923|NCT02361346|448879285|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
124794924|NCT02361346|448879277|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
124794925|NCT02361346|448879278|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
124794926|NCT02361346|448879279|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
124794927|NCT02361346|448879280|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
124794928|NCT02361346|448879281|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
124794929|NCT02361346|448879282|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
124794930|NCT02361346|448879283|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
124794931|NCT02361346|448879284|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
124794932|NCT02361346|448879285|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
124794933|NCT02361346|448879277|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
124629741|NCT01891864|448261150|FG004|Treatment Period 2|Termination of Site|2|||
124794934|NCT02361346|448879278|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
124794935|NCT02361346|448879279|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
124629742|NCT01891864|448261151|FG005|Treatment Period 2|Termination of Site|0|||
124794936|NCT02361346|448879280|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
124794937|NCT02361346|448879281|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
124794938|NCT02361346|448879282|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
124794939|NCT02361346|448879283|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
124794940|NCT02361346|448879284|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
124794941|NCT02361346|448879285|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
124794942|NCT02361346|448879277|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
124794943|NCT02361346|448879278|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
124794944|NCT02361346|448879279|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
124794945|NCT02361346|448879280|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
124794946|NCT02361346|448879281|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
124794947|NCT02361346|448879282|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
124794948|NCT02361346|448879283|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
124794949|NCT02361346|448879284|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
124794950|NCT02361346|448879285|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
124794951|NCT02361346|448879277|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
124794952|NCT02361346|448879278|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
124794953|NCT02361346|448879279|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
124794954|NCT02361346|448879280|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
124794955|NCT02361346|448879281|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
124794956|NCT02361346|448879282|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
124794957|NCT02361346|448879283|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
124794958|NCT02361346|448879284|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
124794959|NCT02361346|448879285|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
124794960|NCT02361346|448879277|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
124794961|NCT02361346|448879278|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
124794962|NCT02361346|448879279|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
124794963|NCT02361346|448879280|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
124794964|NCT02361346|448879281|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
124794965|NCT02361346|448879282|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
124794966|NCT02361346|448879283|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
124794967|NCT02361346|448879284|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
124794968|NCT02361346|448879285|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
124794969|NCT00782795|448879286|FG000|Overall Study|Withdrawal by Subject|1|||
124794970|NCT00782795|448879287|FG001|Overall Study|Withdrawal by Subject|2|||
124794971|NCT04480424|448879288|FG000|Overall Study|Withdrawal by Subject|0|||
124794972|NCT04480424|448879289|FG001|Overall Study|Withdrawal by Subject|2|||
124794973|NCT04480424|448879288|FG000|Overall Study|Lost to Follow-up|3|||
124794974|NCT04480424|448879289|FG001|Overall Study|Lost to Follow-up|3|||
124794975|NCT04480424|448879288|FG000|Overall Study|Death|14|||
124794976|NCT04480424|448879289|FG001|Overall Study|Death|16|||
124794977|NCT04480424|448879288|FG000|Overall Study|Reason not Specified|5|||
124794978|NCT04480424|448879289|FG001|Overall Study|Reason not Specified|5|||
124794979|NCT02782923|448879290|FG000|Overall Study|Lost to Follow-up|15|||
124794980|NCT00993044|448879292|FG000|Irinotecan 50 mg|Physician Decision|1|||
124794981|NCT00734747|448879293|FG000|SRS Procedure|No staples placed|3|||
124794982|NCT00734747|448879293|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
124794983|NCT01275339|448880651|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
124794984|NCT01275339|448880652|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
124794985|NCT01275339|448880653|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
124794986|NCT01275339|448880654|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
124794987|NCT01275339|448880651|FG000|Overall Study|Withdrawal by Subject|0|||
124794988|NCT01275339|448880652|FG001|Overall Study|Withdrawal by Subject|0|||
124794989|NCT01275339|448880653|FG002|Overall Study|Withdrawal by Subject|1|||
124794990|NCT01275339|448880654|FG003|Overall Study|Withdrawal by Subject|0|||
124794991|NCT02469038|448880655|FG000|Overall Study|Physician Decision|4|||
124794992|NCT02469038|448880656|FG001|Overall Study|Physician Decision|5|||
124794993|NCT01850602|448880662|FG000|Overall Study|Adverse Event|7|||
124794994|NCT01850602|448880663|FG001|Overall Study|Adverse Event|10|||
124794995|NCT01850602|448880662|FG000|Overall Study|Physician Decision|2|||
124794996|NCT01850602|448880663|FG001|Overall Study|Physician Decision|1|||
124794997|NCT01850602|448880662|FG000|Overall Study|Withdrawal by Subject|2|||
124794998|NCT01850602|448880663|FG001|Overall Study|Withdrawal by Subject|4|||
124794999|NCT01850602|448880662|FG000|Overall Study|Decrease in serum calcium|2|||
124795000|NCT01850602|448880663|FG001|Overall Study|Decrease in serum calcium|3|||
124795001|NCT01850602|448880662|FG000|Overall Study|Increase in serum ferritin|1|||
124795002|NCT01850602|448880663|FG001|Overall Study|Increase in serum ferritin|0|||
124795003|NCT01857310|448880664|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
124795004|NCT01857310|448880665|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
124795005|NCT02497976|448880666|FG000|Overall Study|Withdrawal by Subject|2|||
124795006|NCT02497976|448880667|FG001|Overall Study|Withdrawal by Subject|0|||
124795007|NCT02497976|448880666|FG000|Overall Study|Moved out of area|0|||
124795008|NCT02497976|448880667|FG001|Overall Study|Moved out of area|1|||
124795009|NCT00584740|448880668|FG000|Overall Study|Adverse Event|1|||
124795010|NCT00584740|448880669|FG001|Overall Study|Adverse Event|1|||
124795011|NCT00584740|448880668|FG000|Overall Study|Lack of Efficacy|8|||
124795012|NCT00584740|448880669|FG001|Overall Study|Lack of Efficacy|2|||
124795013|NCT00584740|448880668|FG000|Overall Study|Withdrawal by Subject|3|||
124795014|NCT00584740|448880669|FG001|Overall Study|Withdrawal by Subject|2|||
124795015|NCT00584740|448880668|FG000|Overall Study|Lost to Follow-up|0|||
124795016|NCT00584740|448880669|FG001|Overall Study|Lost to Follow-up|1|||
124795017|NCT03915860|448880673|FG000|Overall Study|Adverse Event|3|||
124795018|NCT03915860|448880673|FG000|Overall Study|Withdrawal by Subject|6|||
124795019|NCT03915860|448880673|FG000|Overall Study|Lost to Follow-up|2|||
124795020|NCT03915860|448880673|FG000|Overall Study|Other than specified|3|||
124795021|NCT02195011|448880674|FG000|Overall Study|Adverse Event|4|||
124795022|NCT02195011|448880675|FG001|Overall Study|Adverse Event|0|||
124795023|NCT02195011|448880674|FG000|Overall Study|Progressive Disease|18|||
124795024|NCT02195011|448880675|FG001|Overall Study|Progressive Disease|1|||
124795025|NCT02195011|448880674|FG000|Overall Study|Withdrawal by Subject|3|||
124795026|NCT02195011|448880675|FG001|Overall Study|Withdrawal by Subject|0|||
124795027|NCT00768469|448880678|FG000|Overall Study|Adverse Event|0|||
124795028|NCT00768469|448880679|FG001|Overall Study|Adverse Event|2|||
124795029|NCT00768469|448880678|FG000|Overall Study|Disease Progression|3|||
124795030|NCT00768469|448880679|FG001|Overall Study|Disease Progression|4|||
124795031|NCT00768469|448880678|FG000|Overall Study|Withdrawal by Subject|0|||
124795032|NCT00768469|448880679|FG001|Overall Study|Withdrawal by Subject|1|||
124795033|NCT00722371|448880682|FG000|Overall Study|Adverse Event|6|||
124795034|NCT00722371|448880683|FG001|Overall Study|Adverse Event|13|||
124795035|NCT00722371|448880684|FG002|Overall Study|Adverse Event|9|||
124795036|NCT00722371|448880685|FG003|Overall Study|Adverse Event|10|||
124795037|NCT00722371|448880686|FG004|Overall Study|Adverse Event|6|||
124795038|NCT00722371|448880687|FG005|Overall Study|Adverse Event|8|||
124795039|NCT00722371|448880688|FG006|Overall Study|Adverse Event|4|||
124795040|NCT00722371|448880682|FG000|Overall Study|Contraindication|0|||
124795041|NCT00722371|448880683|FG001|Overall Study|Contraindication|0|||
124795042|NCT00722371|448880684|FG002|Overall Study|Contraindication|1|||
124795043|NCT00722371|448880685|FG003|Overall Study|Contraindication|0|||
124795044|NCT00722371|448880686|FG004|Overall Study|Contraindication|0|||
124795045|NCT00722371|448880687|FG005|Overall Study|Contraindication|0|||
124795046|NCT00722371|448880688|FG006|Overall Study|Contraindication|0|||
124795047|NCT00722371|448880682|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
124795048|NCT00722371|448880683|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
124795049|NCT00722371|448880684|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
124795050|NCT00722371|448880685|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
124795051|NCT00722371|448880686|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
124795052|NCT00722371|448880687|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
124795053|NCT00722371|448880688|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
124795054|NCT00722371|448880682|FG000|Overall Study|Excluded medication|0|||
124795055|NCT00722371|448880683|FG001|Overall Study|Excluded medication|1|||
124795056|NCT00722371|448880684|FG002|Overall Study|Excluded medication|1|||
124795057|NCT00722371|448880685|FG003|Overall Study|Excluded medication|0|||
124795058|NCT00722371|448880686|FG004|Overall Study|Excluded medication|0|||
124795059|NCT00722371|448880687|FG005|Overall Study|Excluded medication|0|||
124795060|NCT00722371|448880688|FG006|Overall Study|Excluded medication|1|||
124795061|NCT00722371|448880682|FG000|Overall Study|Hyperglycemia|2|||
124795062|NCT00722371|448880683|FG001|Overall Study|Hyperglycemia|6|||
124795063|NCT00722371|448880684|FG002|Overall Study|Hyperglycemia|4|||
124795064|NCT00722371|448880685|FG003|Overall Study|Hyperglycemia|2|||
124795065|NCT00722371|448880686|FG004|Overall Study|Hyperglycemia|5|||
124795066|NCT00722371|448880687|FG005|Overall Study|Hyperglycemia|1|||
124795067|NCT00722371|448880688|FG006|Overall Study|Hyperglycemia|1|||
124795068|NCT00722371|448880682|FG000|Overall Study|Hypoglycemia|1|||
124795069|NCT00722371|448880683|FG001|Overall Study|Hypoglycemia|0|||
124795070|NCT00722371|448880684|FG002|Overall Study|Hypoglycemia|0|||
124795071|NCT00722371|448880685|FG003|Overall Study|Hypoglycemia|0|||
124795072|NCT00722371|448880686|FG004|Overall Study|Hypoglycemia|0|||
124795073|NCT00722371|448880687|FG005|Overall Study|Hypoglycemia|0|||
124795074|NCT00722371|448880688|FG006|Overall Study|Hypoglycemia|0|||
124795075|NCT00722371|448880682|FG000|Overall Study|Lack of Efficacy|4|||
124795076|NCT00722371|448880683|FG001|Overall Study|Lack of Efficacy|6|||
124795077|NCT00722371|448880684|FG002|Overall Study|Lack of Efficacy|6|||
124795078|NCT00722371|448880685|FG003|Overall Study|Lack of Efficacy|6|||
124795079|NCT00722371|448880686|FG004|Overall Study|Lack of Efficacy|2|||
124795080|NCT00722371|448880687|FG005|Overall Study|Lack of Efficacy|3|||
124795081|NCT00722371|448880688|FG006|Overall Study|Lack of Efficacy|0|||
124795082|NCT00722371|448880682|FG000|Overall Study|Lost to Follow-up|11|||
124795083|NCT00722371|448880683|FG001|Overall Study|Lost to Follow-up|14|||
124795084|NCT00722371|448880684|FG002|Overall Study|Lost to Follow-up|21|||
124795085|NCT00722371|448880685|FG003|Overall Study|Lost to Follow-up|13|||
124795086|NCT00722371|448880686|FG004|Overall Study|Lost to Follow-up|8|||
124795087|NCT00722371|448880687|FG005|Overall Study|Lost to Follow-up|16|||
124795088|NCT00722371|448880688|FG006|Overall Study|Lost to Follow-up|13|||
124795089|NCT00722371|448880682|FG000|Overall Study|Physician Decision|5|||
124795090|NCT00722371|448880683|FG001|Overall Study|Physician Decision|2|||
124795091|NCT00722371|448880684|FG002|Overall Study|Physician Decision|2|||
124795092|NCT00722371|448880685|FG003|Overall Study|Physician Decision|5|||
124795093|NCT00722371|448880686|FG004|Overall Study|Physician Decision|2|||
124795094|NCT00722371|448880687|FG005|Overall Study|Physician Decision|3|||
124795095|NCT00722371|448880688|FG006|Overall Study|Physician Decision|4|||
124795096|NCT00722371|448880682|FG000|Overall Study|Pregnancy|1|||
124795097|NCT00722371|448880683|FG001|Overall Study|Pregnancy|1|||
124795098|NCT00722371|448880684|FG002|Overall Study|Pregnancy|0|||
124795099|NCT00722371|448880685|FG003|Overall Study|Pregnancy|0|||
124795100|NCT00722371|448880686|FG004|Overall Study|Pregnancy|0|||
124795101|NCT00722371|448880687|FG005|Overall Study|Pregnancy|1|||
124795102|NCT00722371|448880688|FG006|Overall Study|Pregnancy|0|||
124795103|NCT00722371|448880682|FG000|Overall Study|Protocol Violation|6|||
124795104|NCT00722371|448880683|FG001|Overall Study|Protocol Violation|1|||
124795105|NCT00722371|448880684|FG002|Overall Study|Protocol Violation|0|||
124795106|NCT00722371|448880685|FG003|Overall Study|Protocol Violation|1|||
124795107|NCT00722371|448880686|FG004|Overall Study|Protocol Violation|4|||
124795108|NCT00722371|448880687|FG005|Overall Study|Protocol Violation|2|||
124795109|NCT00722371|448880688|FG006|Overall Study|Protocol Violation|1|||
124795110|NCT00722371|448880682|FG000|Overall Study|Withdrawal by Subject|18|||
124795111|NCT00722371|448880683|FG001|Overall Study|Withdrawal by Subject|27|||
124795112|NCT00722371|448880684|FG002|Overall Study|Withdrawal by Subject|19|||
124795113|NCT00722371|448880685|FG003|Overall Study|Withdrawal by Subject|23|||
124795114|NCT00722371|448880686|FG004|Overall Study|Withdrawal by Subject|19|||
124795115|NCT00722371|448880687|FG005|Overall Study|Withdrawal by Subject|18|||
124795116|NCT00722371|448880688|FG006|Overall Study|Withdrawal by Subject|26|||
124795117|NCT02635646|448880689|FG000|Overall Study|Lost to Follow-up|24|||
124795118|NCT02635646|448880690|FG001|Overall Study|Lost to Follow-up|25|||
124795119|NCT02635646|448880689|FG000|Overall Study|Pregnancy|1|||
124795120|NCT02635646|448880690|FG001|Overall Study|Pregnancy|1|||
124795121|NCT03189381|448880691|FG000|Overall Study|Death|1|||
124795122|NCT03189381|448880692|FG001|Overall Study|Death|0|||
124795123|NCT03761797|448880693|FG000|Overall Study|Changing hospital|11|||
124795124|NCT03761797|448880693|FG000|Overall Study|Improvement/remission|6|||
124629743|NCT01891864|448261146|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124629744|NCT01891864|448261147|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124629745|NCT01891864|448261148|FG002|Treatment Period 2|Withdrawal by Subject|3|||
124629746|NCT01891864|448261149|FG003|Treatment Period 2|Withdrawal by Subject|4|||
124629747|NCT01891864|448261150|FG004|Treatment Period 2|Withdrawal by Subject|1|||
124629748|NCT01891864|448261151|FG005|Treatment Period 2|Withdrawal by Subject|1|||
124629749|NCT01891864|448261146|FG000|Extension Period|Lack of Efficacy|0|||
124629750|NCT01891864|448261147|FG001|Extension Period|Lack of Efficacy|0|||
124795125|NCT03761797|448880693|FG000|Overall Study|Withdrawal by Subject|19|||
124795126|NCT03761797|448880693|FG000|Overall Study|Lost to Follow-up|33|||
124795127|NCT03761797|448880693|FG000|Overall Study|Adverse Event|37|||
124795128|NCT03761797|448880693|FG000|Overall Study|Case report form (CRF) not collected|5|||
124795129|NCT03761797|448880693|FG000|Overall Study|No patient visit after entry|13|||
124795130|NCT03761797|448880693|FG000|Overall Study|Switch to other diabetes medication|10|||
124795131|NCT03761797|448880693|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
124795132|NCT03761797|448880693|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
124795133|NCT03761797|448880693|FG000|Overall Study|Insufficient effectives|2|||
124795134|NCT03761797|448880693|FG000|Overall Study|Excessive alcohol intake|1|||
124795135|NCT00251004|448880694|FG000|Overall Study|Withdrawal by Subject|23|||
124795136|NCT00251004|448880695|FG001|Overall Study|Withdrawal by Subject|16|||
124795137|NCT00251004|448880696|FG002|Overall Study|Withdrawal by Subject|14|||
124795138|NCT00251004|448880694|FG000|Overall Study|Death|9|||
124795139|NCT00251004|448880695|FG001|Overall Study|Death|10|||
124795140|NCT00251004|448880696|FG002|Overall Study|Death|8|||
124795141|NCT00251004|448880694|FG000|Overall Study|Lost to Follow-up|1|||
124795142|NCT00251004|448880695|FG001|Overall Study|Lost to Follow-up|2|||
124629751|NCT01891864|448261148|FG002|Extension Period|Lack of Efficacy|0|||
124629752|NCT01891864|448261149|FG003|Extension Period|Lack of Efficacy|1|||
124629753|NCT01891864|448261150|FG004|Extension Period|Lack of Efficacy|1|||
124629754|NCT01891864|448261151|FG005|Extension Period|Lack of Efficacy|0|||
124629755|NCT01891864|448261146|FG000|Extension Period|Pregnancy|0|||
124629756|NCT01891864|448261147|FG001|Extension Period|Pregnancy|0|||
124629757|NCT01891864|448261148|FG002|Extension Period|Pregnancy|1|||
124629758|NCT01891864|448261149|FG003|Extension Period|Pregnancy|0|||
124629759|NCT01891864|448261150|FG004|Extension Period|Pregnancy|0|||
124629760|NCT01891864|448261151|FG005|Extension Period|Pregnancy|0|||
124629761|NCT01891864|448261146|FG000|Extension Period|Adverse Event|0|||
124795143|NCT00251004|448880696|FG002|Overall Study|Lost to Follow-up|1|||
124795144|NCT00251004|448880694|FG000|Overall Study|Graft Loss|12|||
124795145|NCT00251004|448880695|FG001|Overall Study|Graft Loss|13|||
124795146|NCT00251004|448880696|FG002|Overall Study|Graft Loss|8|||
124795147|NCT00645788|448880697|FG000|Overall Study|Did not receive study drug|1|||
124795148|NCT00645788|448880698|FG001|Overall Study|Did not receive study drug|1|||
124795149|NCT00645788|448880699|FG002|Overall Study|Did not receive study drug|0|||
124795150|NCT00645788|448880700|FG003|Overall Study|Did not receive study drug|0|||
124629762|NCT01891864|448261147|FG001|Extension Period|Adverse Event|0|||
124795151|NCT00645788|448880697|FG000|Overall Study|Adverse Event|4|||
124795152|NCT00645788|448880698|FG001|Overall Study|Adverse Event|9|||
124795153|NCT00645788|448880699|FG002|Overall Study|Adverse Event|5|||
124795154|NCT00645788|448880700|FG003|Overall Study|Adverse Event|3|||
124795155|NCT00645788|448880697|FG000|Overall Study|Lost to Follow-up|1|||
124795156|NCT00645788|448880698|FG001|Overall Study|Lost to Follow-up|0|||
124795157|NCT00645788|448880699|FG002|Overall Study|Lost to Follow-up|0|||
124795158|NCT00645788|448880700|FG003|Overall Study|Lost to Follow-up|0|||
124795159|NCT00645788|448880697|FG000|Overall Study|Protocol Violation|1|||
124795160|NCT00645788|448880698|FG001|Overall Study|Protocol Violation|0|||
124795161|NCT00645788|448880699|FG002|Overall Study|Protocol Violation|2|||
124795162|NCT00645788|448880700|FG003|Overall Study|Protocol Violation|0|||
124795163|NCT00645788|448880697|FG000|Overall Study|Withdrawal by Subject|0|||
124795164|NCT00645788|448880698|FG001|Overall Study|Withdrawal by Subject|1|||
124795165|NCT00645788|448880699|FG002|Overall Study|Withdrawal by Subject|0|||
124795166|NCT00645788|448880700|FG003|Overall Study|Withdrawal by Subject|2|||
124795167|NCT00645788|448880697|FG000|Overall Study|Pulmonary exacerbation|13|||
124795168|NCT00645788|448880698|FG001|Overall Study|Pulmonary exacerbation|16|||
124795169|NCT00645788|448880699|FG002|Overall Study|Pulmonary exacerbation|11|||
124795170|NCT00645788|448880700|FG003|Overall Study|Pulmonary exacerbation|9|||
124795171|NCT03149848|448880701|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
124795172|NCT03149848|448880701|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
124795173|NCT01244490|448880702|FG000|Overall Study|Lack of Efficacy|14|||
124795174|NCT01244490|448880703|FG001|Overall Study|Lack of Efficacy|5|||
124795175|NCT01244490|448880704|FG002|Overall Study|Lack of Efficacy|5|||
124795176|NCT01244490|448880702|FG000|Overall Study|Withdrawal by Subject|4|||
124795177|NCT01244490|448880703|FG001|Overall Study|Withdrawal by Subject|4|||
124795178|NCT01244490|448880704|FG002|Overall Study|Withdrawal by Subject|9|||
124795179|NCT01244490|448880702|FG000|Overall Study|Adverse Event|1|||
124795180|NCT01244490|448880703|FG001|Overall Study|Adverse Event|9|||
124795181|NCT01244490|448880704|FG002|Overall Study|Adverse Event|5|||
124795182|NCT01244490|448880702|FG000|Overall Study|Lost to Follow-up|0|||
124795183|NCT01244490|448880703|FG001|Overall Study|Lost to Follow-up|6|||
124795184|NCT01244490|448880704|FG002|Overall Study|Lost to Follow-up|3|||
124795185|NCT01244490|448880702|FG000|Overall Study|Other|0|||
124795186|NCT01244490|448880703|FG001|Overall Study|Other|0|||
124795187|NCT01244490|448880704|FG002|Overall Study|Other|1|||
124795188|NCT00256282|448880712|FG000|Overall Study|Disease progression, relapse during acti|12|||
124795189|NCT00256282|448880712|FG000|Overall Study|Adverse Event|3|||
124795190|NCT00256282|448880712|FG000|Overall Study|Physician Decision|1|||
124795191|NCT00327470|448880715|FG000|Overall Study|Randomized, but not treated|0|||
124795192|NCT00327470|448880716|FG001|Overall Study|Randomized, but not treated|2|||
124795193|NCT00327470|448880715|FG000|Overall Study|Adverse Event|9|||
124795194|NCT00327470|448880716|FG001|Overall Study|Adverse Event|14|||
124795195|NCT00327470|448880715|FG000|Overall Study|Lack of Efficacy|7|||
124795196|NCT00327470|448880716|FG001|Overall Study|Lack of Efficacy|19|||
124795197|NCT00327470|448880715|FG000|Overall Study|Other|5|||
124795198|NCT00327470|448880716|FG001|Overall Study|Other|9|||
124795199|NCT00327470|448880715|FG000|Overall Study|Lost to Follow-up|1|||
124795200|NCT00327470|448880716|FG001|Overall Study|Lost to Follow-up|3|||
124795201|NCT00327470|448880715|FG000|Overall Study|Withdrawal by Subject|6|||
124795202|NCT00327470|448880716|FG001|Overall Study|Withdrawal by Subject|12|||
124795203|NCT00327470|448880715|FG000|Overall Study|Death|1|||
124795204|NCT00327470|448880716|FG001|Overall Study|Death|4|||
124795205|NCT02581943|448880719|FG000|Overall Study|Death|5|||
124795206|NCT02581943|448880720|FG001|Overall Study|Death|2|||
124795207|NCT02581943|448880719|FG000|Overall Study|Disease Progression|12|||
124795208|NCT02581943|448880720|FG001|Overall Study|Disease Progression|15|||
124795209|NCT02581943|448880719|FG000|Overall Study|Withdrawal by Subject|1|||
124795210|NCT02581943|448880720|FG001|Overall Study|Withdrawal by Subject|2|||
124795211|NCT03021564|448880721|FG000|Overall Study|Death|84|||
124795212|NCT03021564|448880722|FG001|Overall Study|Death|466|||
124795213|NCT03021564|448880721|FG000|Overall Study|Lost to Follow-up|0|||
124795214|NCT03021564|448880722|FG001|Overall Study|Lost to Follow-up|2|||
124795215|NCT00219544|448880723|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
124629763|NCT01891864|448261148|FG002|Extension Period|Adverse Event|4|||
124629764|NCT01891864|448261149|FG003|Extension Period|Adverse Event|2|||
124629765|NCT01891864|448261150|FG004|Extension Period|Adverse Event|2|||
124795216|NCT00219544|448880724|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
124795217|NCT00219544|448880723|FG000|Single Blind Treatment Period|Adverse Event|9|||
124795218|NCT00219544|448880724|FG001|Single Blind Treatment Period|Adverse Event|0|||
124795219|NCT00219544|448880723|FG000|Single Blind Treatment Period|Protocol Violation|4|||
124795220|NCT00219544|448880724|FG001|Single Blind Treatment Period|Protocol Violation|0|||
124795221|NCT00219544|448880723|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
124795222|NCT00219544|448880724|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
124795223|NCT00219544|448880723|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
124629766|NCT01891864|448261151|FG005|Extension Period|Adverse Event|0|||
124795224|NCT00219544|448880724|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
124795225|NCT00219544|448880723|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
124795226|NCT00219544|448880724|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
124795227|NCT00745615|448880727|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
124795228|NCT00745615|448880728|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
124795229|NCT00745615|448880729|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
124795230|NCT00745615|448880730|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
124795231|NCT00745615|448880731|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
124795232|NCT00745615|448880732|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
124795233|NCT00745615|448880727|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
124795234|NCT00745615|448880728|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
124795235|NCT00745615|448880729|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
124795236|NCT00745615|448880730|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
124795237|NCT00745615|448880731|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
124795238|NCT00745615|448880732|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
124795239|NCT00745615|448880727|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
124795240|NCT00745615|448880728|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
124795241|NCT00745615|448880729|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
124795242|NCT00745615|448880730|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
124795243|NCT00745615|448880731|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
124795244|NCT00745615|448880732|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
124795245|NCT00745615|448880727|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
124795246|NCT00745615|448880728|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
124795247|NCT00745615|448880729|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
124795248|NCT00745615|448880730|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
124795249|NCT00745615|448880731|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
124795250|NCT00745615|448880732|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
124795251|NCT00745615|448880727|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
124795252|NCT00745615|448880728|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
124795253|NCT00745615|448880729|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
124795254|NCT00745615|448880730|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
124795255|NCT00745615|448880731|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
124795256|NCT00745615|448880732|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
124795257|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
124795258|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
124795259|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
124795260|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
124795261|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
124795262|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
124795263|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
124795264|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
124795265|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
124795266|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
124795267|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
124795268|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
124795269|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
124795270|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
124795271|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
124795272|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
124795273|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
124795274|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
124795275|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
124795276|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
124795277|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
124795278|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
124795279|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
124795280|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
124795281|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
124795282|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
124795283|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
124795284|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
124795285|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
124795286|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
124795287|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
124795288|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
124795289|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
124795290|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
124795291|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
124795292|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
124795293|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
124795294|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
124795295|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
124795296|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
124795297|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
124795298|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
124795299|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
124795300|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
124795301|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
124795302|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
124795303|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
124795304|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
124795305|NCT00745615|448880727|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
124795306|NCT00745615|448880728|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
124795307|NCT00745615|448880729|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
124795308|NCT00745615|448880730|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
124795309|NCT00745615|448880731|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
124795310|NCT00745615|448880732|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
124795311|NCT00586664|448880733|FG000|Overall Study|Withdrawal by Subject|3|||
124795312|NCT00586664|448880734|FG001|Overall Study|Withdrawal by Subject|7|||
124795313|NCT00586664|448880735|FG002|Overall Study|Withdrawal by Subject|1|||
124795314|NCT00586664|448880733|FG000|Overall Study|Exclusion criteria met|2|||
124795315|NCT00586664|448880734|FG001|Overall Study|Exclusion criteria met|0|||
124795316|NCT00586664|448880735|FG002|Overall Study|Exclusion criteria met|0|||
124795317|NCT00727532|448880737|FG000|Overall Study|Adverse Event|1|||
124795318|NCT00727532|448880737|FG000|Overall Study|Withdrawal by Subject|1|||
124795319|NCT00829933|448880738|FG000|Overall Study|Adverse Event|2|||
124795320|NCT00829933|448880739|FG001|Overall Study|Adverse Event|3|||
124795321|NCT00829933|448880740|FG002|Overall Study|Adverse Event|2|||
124795322|NCT00829933|448880741|FG003|Overall Study|Adverse Event|1|||
124795323|NCT00829933|448880738|FG000|Overall Study|Death|0|||
124795324|NCT00829933|448880739|FG001|Overall Study|Death|0|||
124795325|NCT00829933|448880740|FG002|Overall Study|Death|1|||
124795326|NCT00829933|448880741|FG003|Overall Study|Death|1|||
124795327|NCT00829933|448880738|FG000|Overall Study|Lack of Efficacy|0|||
124795328|NCT00829933|448880739|FG001|Overall Study|Lack of Efficacy|1|||
124795329|NCT00829933|448880740|FG002|Overall Study|Lack of Efficacy|0|||
124795330|NCT00829933|448880741|FG003|Overall Study|Lack of Efficacy|0|||
124795331|NCT00829933|448880738|FG000|Overall Study|Physician Decision|5|||
124795332|NCT00829933|448880739|FG001|Overall Study|Physician Decision|7|||
124795333|NCT00829933|448880740|FG002|Overall Study|Physician Decision|8|||
124795334|NCT00829933|448880741|FG003|Overall Study|Physician Decision|1|||
124795335|NCT00829933|448880738|FG000|Overall Study|Pregnancy|0|||
124795336|NCT00829933|448880739|FG001|Overall Study|Pregnancy|0|||
124795337|NCT00829933|448880740|FG002|Overall Study|Pregnancy|0|||
124795338|NCT00829933|448880741|FG003|Overall Study|Pregnancy|2|||
124795339|NCT00829933|448880738|FG000|Overall Study|Protocol Violation|2|||
124795340|NCT00829933|448880739|FG001|Overall Study|Protocol Violation|1|||
124795341|NCT00829933|448880740|FG002|Overall Study|Protocol Violation|0|||
124795342|NCT00829933|448880741|FG003|Overall Study|Protocol Violation|0|||
124795343|NCT00829933|448880738|FG000|Overall Study|withdrew before treatment started|5|||
124795344|NCT00829933|448880739|FG001|Overall Study|withdrew before treatment started|1|||
124629767|NCT01891864|448261146|FG000|Extension Period|Withdrawal by Subject|0|||
124795345|NCT00829933|448880740|FG002|Overall Study|withdrew before treatment started|2|||
124795346|NCT00829933|448880741|FG003|Overall Study|withdrew before treatment started|9|||
124795347|NCT01986933|448880746|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
124795348|NCT01986933|448880747|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
124795349|NCT01986933|448880748|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
124795350|NCT01986933|448880749|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
124795351|NCT01986933|448880750|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
124629768|NCT01891864|448261147|FG001|Extension Period|Withdrawal by Subject|0|||
124629769|NCT01891864|448261148|FG002|Extension Period|Withdrawal by Subject|1|||
124629770|NCT01891864|448261149|FG003|Extension Period|Withdrawal by Subject|2|||
124629771|NCT01891864|448261150|FG004|Extension Period|Withdrawal by Subject|4|||
124795352|NCT01986933|448880746|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
124795353|NCT01986933|448880747|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
124629772|NCT01891864|448261151|FG005|Extension Period|Withdrawal by Subject|0|||
124629773|NCT01891864|448261146|FG000|Extension Period|Lost to Follow-up|0|||
124795354|NCT01986933|448880748|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
124795355|NCT01986933|448880749|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
124795356|NCT01986933|448880750|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
124795357|NCT01986933|448880746|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
124795358|NCT01986933|448880747|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
124795359|NCT01986933|448880748|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
124795360|NCT01986933|448880749|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
124795361|NCT01986933|448880750|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
124795362|NCT01986933|448880746|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
124795363|NCT01986933|448880747|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
124795364|NCT01986933|448880748|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
124795365|NCT01986933|448880749|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
124795366|NCT01986933|448880750|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
124795367|NCT01986933|448880746|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
124795368|NCT01986933|448880747|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
124795369|NCT01986933|448880748|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
124795370|NCT01986933|448880749|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
124795371|NCT01986933|448880750|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
124795372|NCT01986933|448880746|FG000|Active-to-active (Part B)|Adverse Event|0|||
124795373|NCT01986933|448880747|FG001|Active-to-active (Part B)|Adverse Event|2|||
124795374|NCT01986933|448880748|FG002|Active-to-active (Part B)|Adverse Event|0|||
124795375|NCT01986933|448880749|FG003|Active-to-active (Part B)|Adverse Event|1|||
124795376|NCT01986933|448880750|FG004|Active-to-active (Part B)|Adverse Event|3|||
124795377|NCT01986933|448880746|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
124795378|NCT01986933|448880747|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
124795379|NCT01986933|448880748|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
124795380|NCT01986933|448880749|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
124795381|NCT01986933|448880750|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
124795382|NCT01986933|448880746|FG000|Active-to-active (Part B)|Pregnancy|0|||
124795383|NCT01986933|448880747|FG001|Active-to-active (Part B)|Pregnancy|0|||
124795384|NCT01986933|448880748|FG002|Active-to-active (Part B)|Pregnancy|0|||
124795385|NCT01986933|448880749|FG003|Active-to-active (Part B)|Pregnancy|0|||
124795386|NCT01986933|448880750|FG004|Active-to-active (Part B)|Pregnancy|1|||
124795387|NCT01986933|448880746|FG000|Active-to-active (Part B)|Physician Decision|0|||
124795388|NCT01986933|448880747|FG001|Active-to-active (Part B)|Physician Decision|0|||
124795389|NCT01986933|448880748|FG002|Active-to-active (Part B)|Physician Decision|1|||
124795390|NCT01986933|448880749|FG003|Active-to-active (Part B)|Physician Decision|1|||
124795391|NCT01986933|448880750|FG004|Active-to-active (Part B)|Physician Decision|0|||
124795392|NCT01986933|448880746|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
124795393|NCT01986933|448880747|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
124795394|NCT01986933|448880748|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
124795395|NCT01986933|448880749|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
124795396|NCT01986933|448880750|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
124795397|NCT01986933|448880746|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
124795398|NCT01986933|448880747|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
124795399|NCT01986933|448880748|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
124795400|NCT01986933|448880749|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
124795401|NCT01986933|448880750|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
124795402|NCT01986933|448880746|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
124795403|NCT01986933|448880747|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
124795404|NCT01986933|448880748|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
124795405|NCT01986933|448880749|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
124795406|NCT01986933|448880750|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
124795407|NCT01986933|448880746|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
124795408|NCT01986933|448880747|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
124795409|NCT01986933|448880748|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
124795410|NCT01986933|448880749|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
124795411|NCT01986933|448880750|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
124795412|NCT01986933|448880746|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
124795413|NCT01986933|448880747|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
124795414|NCT01986933|448880748|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
124795415|NCT01986933|448880749|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
124795416|NCT01986933|448880750|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
124795417|NCT01986933|448880746|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
124795418|NCT01986933|448880747|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
124795419|NCT01986933|448880748|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
124795420|NCT01986933|448880749|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
124795421|NCT01986933|448880750|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
124795422|NCT01986933|448880746|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
124795423|NCT01986933|448880747|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
124795424|NCT01986933|448880748|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
124795425|NCT01986933|448880749|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
124795426|NCT01986933|448880750|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
124795427|NCT01986933|448880746|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
124795428|NCT01986933|448880747|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
124795429|NCT01986933|448880748|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
124795430|NCT01986933|448880749|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
124795431|NCT01986933|448880750|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
124795432|NCT03119701|448880751|FG000|6-day Dosing|Death|4|||
124795433|NCT03119701|448880752|FG001|6-day Dosing|Death|1|||
124795434|NCT03119701|448880751|FG000|6-day Dosing|Adverse Event|3|||
124795435|NCT03119701|448880752|FG001|6-day Dosing|Adverse Event|0|||
124795436|NCT03119701|448880751|FG000|6-day Dosing|Physician Decision|0|||
124795437|NCT03119701|448880752|FG001|6-day Dosing|Physician Decision|1|||
124795438|NCT03119701|448880751|FG000|6-day Dosing|Withdrawal by Subject|0|||
124795439|NCT03119701|448880752|FG001|6-day Dosing|Withdrawal by Subject|1|||
124795440|NCT03119701|448880751|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
124795441|NCT03119701|448880752|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
124795442|NCT00596362|448880753|FG000|Overall Study|Progressive Disease|1|||
124795443|NCT00356122|448880756|FG000|TREATMENT|Lack of Efficacy|26|||
124795444|NCT00356122|448880756|FG000|TREATMENT|Adverse Event|10|||
124795445|NCT00356122|448880756|FG000|TREATMENT|Subject's request|4|||
124795446|NCT00356122|448880756|FG000|TREATMENT|Other|4|||
124795447|NCT00356122|448880756|FG000|TREATMENT|Did not receive study medication|1|||
124795448|NCT00356122|448880756|FG000|FOLLOW-UP|Death|37|||
124795449|NCT00356122|448880756|FG000|FOLLOW-UP|Lost to Follow-up|2|||
124795450|NCT00356122|448880756|FG000|FOLLOW-UP|Other|2|||
124795451|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
124795452|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
124795453|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
124795454|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
124795455|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
124795456|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
124795457|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
124795458|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
124795459|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
124795460|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
124795461|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
124795462|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
124795463|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
124795464|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
124795465|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
124795466|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
124795467|NCT00491556|448880757|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
124795468|NCT00491556|448880758|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
124795469|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
124795470|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
124795471|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
124795472|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
124795473|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
124795474|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
124795475|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
124795476|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
124795477|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
124795478|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
124795479|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
124795480|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
124795481|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
124795482|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
124795483|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
124795484|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
124795485|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
124795486|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
124795487|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
124795488|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
124795489|NCT00491556|448880757|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
124795490|NCT00491556|448880758|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
124795491|NCT02418156|448880759|FG000|Overall Study|Lost to Follow-up|12|||
124795492|NCT02418156|448880759|FG000|Overall Study|Death|2|||
124795493|NCT02418156|448880759|FG000|Overall Study|Physician Decision|1|||
124795494|NCT02418156|448880759|FG000|Overall Study|Withdrawal by Subject|1|||
124795495|NCT02418156|448880759|FG000|Overall Study|Subject refused to return|1|||
124795496|NCT05772702|448880771|FG000|Overall Study|Adverse Event|1|||
124795497|NCT01909453|448880772|FG000|Overall Study|Ongoing|118|||
124795498|NCT01909453|448880773|FG001|Overall Study|Ongoing|103|||
124795499|NCT01909453|448880774|FG002|Overall Study|Ongoing|83|||
124795500|NCT01909453|448880775|FG003|Overall Study|Ongoing|164|||
124795501|NCT01909453|448880776|FG004|Overall Study|Ongoing|50|||
124795502|NCT01909453|448880772|FG000|Overall Study|Death|69|||
124795503|NCT01909453|448880773|FG001|Overall Study|Death|74|||
124795504|NCT01909453|448880774|FG002|Overall Study|Death|88|||
124795505|NCT01909453|448880775|FG003|Overall Study|Death|86|||
124795506|NCT01909453|448880776|FG004|Overall Study|Death|29|||
124795507|NCT01909453|448880772|FG000|Overall Study|Lost to Follow-up|3|||
124795508|NCT01909453|448880773|FG001|Overall Study|Lost to Follow-up|4|||
124795509|NCT01909453|448880774|FG002|Overall Study|Lost to Follow-up|4|||
124795510|NCT01909453|448880775|FG003|Overall Study|Lost to Follow-up|3|||
124795511|NCT01909453|448880776|FG004|Overall Study|Lost to Follow-up|3|||
124795512|NCT01909453|448880772|FG000|Overall Study|Withdrawal by Subject|2|||
124795513|NCT01909453|448880773|FG001|Overall Study|Withdrawal by Subject|13|||
124795514|NCT01909453|448880774|FG002|Overall Study|Withdrawal by Subject|16|||
124795515|NCT01909453|448880775|FG003|Overall Study|Withdrawal by Subject|5|||
124795516|NCT01909453|448880776|FG004|Overall Study|Withdrawal by Subject|4|||
124795517|NCT00884377|448882408|FG000|Overall Study|Withdrawal by Subject|1|||
124795518|NCT00884377|448882409|FG001|Overall Study|Withdrawal by Subject|0|||
124795519|NCT00884377|448882408|FG000|Overall Study|Could not confirm diagnosis|1|||
124795520|NCT00884377|448882409|FG001|Overall Study|Could not confirm diagnosis|0|||
124795521|NCT00884377|448882408|FG000|Overall Study|Physician Decision|0|||
124795522|NCT00884377|448882409|FG001|Overall Study|Physician Decision|1|||
124795523|NCT02003365|448882410|FG000|Overall Study|Lost to Follow-up|0|||
124795524|NCT02003365|448882411|FG001|Overall Study|Lost to Follow-up|0|||
124795525|NCT02003365|448882412|FG002|Overall Study|Lost to Follow-up|1|||
124795526|NCT00622739|448882413|FG000|Overall Study|Physician Decision|1|||
124795527|NCT00622739|448882414|FG001|Overall Study|Physician Decision|0|||
124795528|NCT00622739|448882413|FG000|Overall Study|Adverse Event|1|||
124795529|NCT00622739|448882414|FG001|Overall Study|Adverse Event|2|||
124795530|NCT00622739|448882413|FG000|Overall Study|Lack of Efficacy|0|||
124795531|NCT00622739|448882414|FG001|Overall Study|Lack of Efficacy|2|||
124795532|NCT00622739|448882413|FG000|Overall Study|Withdrawal by Subject|0|||
124795533|NCT00622739|448882414|FG001|Overall Study|Withdrawal by Subject|1|||
124795534|NCT00622739|448882413|FG000|Overall Study|Lost to Follow-up|0|||
124795535|NCT00622739|448882414|FG001|Overall Study|Lost to Follow-up|1|||
124795536|NCT03387150|448882423|FG000|Overall Study|Withdrawal by Subject|3|||
124795537|NCT03387150|448882424|FG001|Overall Study|Withdrawal by Subject|0|||
124795538|NCT03387150|448882425|FG002|Overall Study|Withdrawal by Subject|3|||
124795539|NCT03387150|448882426|FG003|Overall Study|Withdrawal by Subject|4|||
124795540|NCT03387150|448882427|FG004|Overall Study|Withdrawal by Subject|1|||
124795541|NCT03387150|448882428|FG005|Overall Study|Withdrawal by Subject|2|||
124795542|NCT03387150|448882429|FG006|Overall Study|Withdrawal by Subject|0|||
124795543|NCT03387150|448882423|FG000|Overall Study|Lost to Follow-up|3|||
124795544|NCT03387150|448882424|FG001|Overall Study|Lost to Follow-up|2|||
124795545|NCT03387150|448882425|FG002|Overall Study|Lost to Follow-up|2|||
124795546|NCT03387150|448882426|FG003|Overall Study|Lost to Follow-up|3|||
124795547|NCT03387150|448882427|FG004|Overall Study|Lost to Follow-up|3|||
124795548|NCT03387150|448882428|FG005|Overall Study|Lost to Follow-up|3|||
124795549|NCT03387150|448882429|FG006|Overall Study|Lost to Follow-up|0|||
124795550|NCT03387150|448882423|FG000|Overall Study|Participant unable to adhere to visit|0|||
124795551|NCT03387150|448882424|FG001|Overall Study|Participant unable to adhere to visit|1|||
124795552|NCT03387150|448882425|FG002|Overall Study|Participant unable to adhere to visit|0|||
124795553|NCT03387150|448882426|FG003|Overall Study|Participant unable to adhere to visit|0|||
124795554|NCT03387150|448882427|FG004|Overall Study|Participant unable to adhere to visit|2|||
124795555|NCT03387150|448882428|FG005|Overall Study|Participant unable to adhere to visit|2|||
124795556|NCT03387150|448882429|FG006|Overall Study|Participant unable to adhere to visit|0|||
124795557|NCT04617795|448882430|FG000|Main Study|Lost to Follow-up|1|||
124795558|NCT04617795|448882431|FG001|Main Study|Lost to Follow-up|0|||
124795559|NCT03442764|448882432|FG000|Overall Study|Adverse Event|1|||
124795560|NCT03442764|448882433|FG001|Overall Study|Adverse Event|0|||
124795561|NCT03442764|448882434|FG002|Overall Study|Adverse Event|0|||
124795562|NCT04850313|448882435|FG000|Overall Study|Withdrawal by Subject|0|||
124795563|NCT04850313|448882436|FG001|Overall Study|Withdrawal by Subject|1|||
124795564|NCT02395016|448882437|FG000|Overall Study|Adverse Event|4|||
124795565|NCT02395016|448882438|FG001|Overall Study|Adverse Event|3|||
124795566|NCT02395016|448882437|FG000|Overall Study|Withdrawal by Subject|9|||
124795567|NCT02395016|448882438|FG001|Overall Study|Withdrawal by Subject|6|||
124795568|NCT02395016|448882437|FG000|Overall Study|Protocol Violation|2|||
124795569|NCT02395016|448882438|FG001|Overall Study|Protocol Violation|3|||
124795570|NCT01547780|448882439|FG000|Baseline PET Scan|Physician Decision|1|||
124795571|NCT01547780|448882440|FG001|Baseline PET Scan|Physician Decision|0|||
124795572|NCT01547780|448882441|FG002|Baseline PET Scan|Physician Decision|1|||
124795573|NCT01547780|448882442|FG003|Baseline PET Scan|Physician Decision|0|||
124795574|NCT01547780|448882439|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
124795575|NCT01547780|448882440|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
124795576|NCT01547780|448882441|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
124795577|NCT01547780|448882442|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
124795578|NCT01288976|448882444|FG000|Overall Study|Withdrawal by Subject|58|||
124795579|NCT01288976|448882445|FG001|Overall Study|Withdrawal by Subject|12|||
124795580|NCT01288976|448882446|FG002|Overall Study|Withdrawal by Subject|9|||
124795581|NCT01288976|448882444|FG000|Overall Study|Death|98|||
124795582|NCT01288976|448882445|FG001|Overall Study|Death|6|||
124795583|NCT01288976|448882446|FG002|Overall Study|Death|4|||
124795584|NCT01288976|448882444|FG000|Overall Study|Data unavailable|22|||
124795585|NCT01288976|448882445|FG001|Overall Study|Data unavailable|9|||
124795586|NCT01288976|448882446|FG002|Overall Study|Data unavailable|7|||
124795587|NCT02478398|448882455|FG000|Overall Study|Adverse Event|20|||
124795588|NCT02478398|448882456|FG001|Overall Study|Adverse Event|5|||
124795589|NCT02478398|448882455|FG000|Overall Study|Lost to Follow-up|5|||
124795590|NCT02478398|448882456|FG001|Overall Study|Lost to Follow-up|4|||
124795591|NCT02478398|448882455|FG000|Overall Study|Non-Compliance With Study Drug|5|||
124795592|NCT02478398|448882456|FG001|Overall Study|Non-Compliance With Study Drug|1|||
124795593|NCT02478398|448882455|FG000|Overall Study|Protocol Violation|3|||
124795594|NCT02478398|448882456|FG001|Overall Study|Protocol Violation|1|||
124795595|NCT02478398|448882455|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
124795596|NCT02478398|448882456|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
124795597|NCT02478398|448882455|FG000|Overall Study|Withdrawal By Participant|10|||
124795598|NCT02478398|448882456|FG001|Overall Study|Withdrawal By Participant|4|||
124795599|NCT01362595|448882458|FG000|Overall Study|Screen failure|10|||
124795600|NCT01362595|448882458|FG000|Overall Study|Withdrawal by Subject|2|||
124795601|NCT00959374|448882459|FG000|Overall Study|Withdrawal by Subject|2|||
124795602|NCT00959374|448882459|FG000|Overall Study|Lost to Follow-up|14|||
124795603|NCT00959374|448882459|FG000|Overall Study|Death|1|||
124795604|NCT00959374|448882459|FG000|Overall Study|Protocol Violation|1|||
124795605|NCT00959374|448882459|FG000|Overall Study|Implant Removed/Not Replaced|4|||
124795606|NCT00959374|448882459|FG000|Overall Study|Physician Decision|1|||
124795607|NCT02448680|448882460|FG000|Overall Study|Physician Decision|1|||
124795608|NCT02448680|448882461|FG001|Overall Study|Physician Decision|1|||
124795609|NCT02448680|448882460|FG000|Overall Study|Withdrawal by Subject|0|||
124795610|NCT02448680|448882461|FG001|Overall Study|Withdrawal by Subject|2|||
124795611|NCT00636987|448882462|FG000|Overall Study|Death|44|||
124795612|NCT00636987|448882462|FG000|Overall Study|Explanted|13|||
124795613|NCT00636987|448882462|FG000|Overall Study|Lost to Follow-up|63|||
124795614|NCT00636987|448882462|FG000|Overall Study|5 year visit window not complete|69|||
124795615|NCT01251146|448882463|FG000|Overall Study|Lost to Follow-up|3|||
124795616|NCT01251146|448882464|FG001|Overall Study|Lost to Follow-up|10|||
124795617|NCT00737464|448882473|FG000|Overall Study|Adverse Event|1|||
124795618|NCT00737464|448882473|FG000|Overall Study|Death|6|||
124795619|NCT00737464|448882473|FG000|Overall Study|Other - Failure to Return|1|||
124795620|NCT00737464|448882473|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
124795621|NCT00737464|448882473|FG000|Overall Study|Other reasons|4|||
124795622|NCT03220438|448882476|FG000|Overall Study|Lost to Follow-up|0|||
124795623|NCT03220438|448882477|FG001|Overall Study|Lost to Follow-up|0|||
124795624|NCT03220438|448882478|FG002|Overall Study|Lost to Follow-up|1|||
124795625|NCT03220438|448882479|FG003|Overall Study|Lost to Follow-up|0|||
124795626|NCT01634178|448882482|FG000|Treatment Period 1|Adverse Event|0|||
124795627|NCT01634178|448882483|FG001|Treatment Period 1|Adverse Event|1|||
124795628|NCT01634178|448882482|FG000|Treatment Period 2|Adverse Event|1|||
124795629|NCT01634178|448882483|FG001|Treatment Period 2|Adverse Event|0|||
124795630|NCT00991952|448882498|FG000|Overall Study|Adverse Event|0|||
124795631|NCT00991952|448882499|FG001|Overall Study|Adverse Event|1|||
124795632|NCT02483533|448882501|FG000|Overall Study|Lack of Efficacy|50|||
124795633|NCT02483533|448882502|FG001|Overall Study|Lack of Efficacy|50|||
124795634|NCT03452527|448882503|FG000|Overall Study|Withdrawal by Subject|1|||
124795635|NCT03452527|448882504|FG001|Overall Study|Withdrawal by Subject|1|||
124795636|NCT03452527|448882503|FG000|Overall Study|Study Terminated|2|||
124795637|NCT03452527|448882504|FG001|Overall Study|Study Terminated|3|||
124795638|NCT00582816|448882505|FG000|Overall Study|Engraftment Failure|3|||
124795639|NCT00174291|448882516|FG000|Overall Study|Lost to Follow-up|1|||
124795640|NCT00174291|448882517|FG001|Overall Study|Lost to Follow-up|1|||
124795641|NCT00174291|448882516|FG000|Overall Study|Protocol Violation|0|||
124795642|NCT00174291|448882517|FG001|Overall Study|Protocol Violation|2|||
124795643|NCT00174291|448882516|FG000|Overall Study|Study terminated by sponsor|1|||
124795644|NCT00174291|448882517|FG001|Overall Study|Study terminated by sponsor|0|||
124795645|NCT00174291|448882516|FG000|Overall Study|Withdrawal by Subject|3|||
124795646|NCT00174291|448882517|FG001|Overall Study|Withdrawal by Subject|3|||
124795647|NCT03116347|448882520|FG000|Overall Study|Withdrawal by Subject|1|||
124795648|NCT03116347|448882521|FG001|Overall Study|Withdrawal by Subject|2|||
124795649|NCT03170232|448882522|FG000|Overall Study|Adverse Event|0|||
124795650|NCT03170232|448882523|FG001|Overall Study|Adverse Event|1|||
124795651|NCT03170232|448882522|FG000|Overall Study|Protocol Violation|0|||
124795652|NCT03170232|448882523|FG001|Overall Study|Protocol Violation|1|||
124795653|NCT03170232|448882522|FG000|Overall Study|Lack of Efficacy|0|||
124795654|NCT03170232|448882523|FG001|Overall Study|Lack of Efficacy|1|||
124795655|NCT03170232|448882522|FG000|Overall Study|Study closed/terminated|26|||
124795656|NCT03170232|448882523|FG001|Overall Study|Study closed/terminated|23|||
124795657|NCT03170232|448882522|FG000|Overall Study|Lost to Follow-up|1|||
124795658|NCT03170232|448882523|FG001|Overall Study|Lost to Follow-up|0|||
124795659|NCT03170232|448882522|FG000|Overall Study|Withdrawal by Subject|0|||
124795660|NCT03170232|448882523|FG001|Overall Study|Withdrawal by Subject|1|||
124795661|NCT00586326|448882524|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
124795662|NCT00586326|448882524|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
124795663|NCT00586326|448882524|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
124795664|NCT00586326|448882524|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
124795665|NCT00586326|448882524|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
124795666|NCT00586326|448882524|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
124795667|NCT00586326|448882524|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
124795668|NCT00586326|448882524|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
124795669|NCT00586326|448882524|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
124795670|NCT00586326|448882524|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
124795671|NCT00586326|448882524|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
124795672|NCT00586326|448882524|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
124795673|NCT00586326|448882524|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
124795674|NCT00586326|448882524|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
124795675|NCT00586326|448882524|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
124795676|NCT00586326|448882524|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
124795677|NCT00586326|448882524|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
124795678|NCT01439347|448882525|FG000|Overall Study|Death|10|||
124795679|NCT01439347|448882526|FG001|Overall Study|Death|9|||
124795680|NCT01439347|448882525|FG000|Overall Study|Withdrawal by Subject|0|||
124795681|NCT01439347|448882526|FG001|Overall Study|Withdrawal by Subject|1|||
124795682|NCT01439347|448882525|FG000|Overall Study|Physician Decision|1|||
124795683|NCT01439347|448882526|FG001|Overall Study|Physician Decision|0|||
124795684|NCT01439347|448882525|FG000|Overall Study|Sponsor Terminated Study|2|||
124795685|NCT01439347|448882526|FG001|Overall Study|Sponsor Terminated Study|3|||
124795686|NCT04068896|448882528|FG000|Overall Study|Adverse Event|2|||
124795687|NCT04068896|448882529|FG001|Overall Study|Adverse Event|0|||
124795688|NCT04068896|448882530|FG002|Overall Study|Adverse Event|1|||
124795689|NCT04068896|448882531|FG003|Overall Study|Adverse Event|0|||
124795690|NCT04068896|448882532|FG004|Overall Study|Adverse Event|0|||
124795691|NCT04068896|448882533|FG005|Overall Study|Adverse Event|0|||
124795692|NCT04068896|448882528|FG000|Overall Study|Death|3|||
124795693|NCT04068896|448882529|FG001|Overall Study|Death|1|||
124795694|NCT04068896|448882530|FG002|Overall Study|Death|3|||
124795695|NCT04068896|448882531|FG003|Overall Study|Death|19|||
124795696|NCT04068896|448882532|FG004|Overall Study|Death|17|||
124795697|NCT04068896|448882533|FG005|Overall Study|Death|0|||
124795698|NCT04068896|448882528|FG000|Overall Study|Physician Decision|0|||
124795699|NCT04068896|448882529|FG001|Overall Study|Physician Decision|0|||
124795700|NCT04068896|448882530|FG002|Overall Study|Physician Decision|0|||
124795701|NCT04068896|448882531|FG003|Overall Study|Physician Decision|1|||
124795702|NCT04068896|448882532|FG004|Overall Study|Physician Decision|0|||
124795703|NCT04068896|448882533|FG005|Overall Study|Physician Decision|0|||
124795704|NCT04068896|448882528|FG000|Overall Study|progressive disease|3|||
124795705|NCT04068896|448882529|FG001|Overall Study|progressive disease|5|||
124795706|NCT04068896|448882530|FG002|Overall Study|progressive disease|3|||
124795707|NCT04068896|448882531|FG003|Overall Study|progressive disease|2|||
124795708|NCT04068896|448882532|FG004|Overall Study|progressive disease|1|||
124629774|NCT01891864|448261147|FG001|Extension Period|Lost to Follow-up|0|||
124629775|NCT01891864|448261148|FG002|Extension Period|Lost to Follow-up|2|||
124629776|NCT01891864|448261149|FG003|Extension Period|Lost to Follow-up|0|||
124629777|NCT01891864|448261150|FG004|Extension Period|Lost to Follow-up|0|||
124629778|NCT01891864|448261151|FG005|Extension Period|Lost to Follow-up|0|||
124629779|NCT04720105|448261152|FG000|Overall Study|Lack of Efficacy|1|||
124629780|NCT04720105|448261152|FG000|Overall Study|Lost to Follow-up|1|||
124629781|NCT04720105|448261152|FG000|Overall Study|Withdrawal by Subject|3|||
124629782|NCT02698163|448261155|FG000|Overall Study|Lost to Follow-up|0|||
124629783|NCT02698163|448261156|FG001|Overall Study|Lost to Follow-up|1|||
124629784|NCT05373108|448261157|FG000|Overall Study|Withdrawal by Subject|2|||
124629785|NCT02892331|448261158|FG000|Overall Study|Withdrawal by Subject|0|||
124795709|NCT04068896|448882533|FG005|Overall Study|progressive disease|2|||
124795710|NCT04068896|448882528|FG000|Overall Study|Study terminated by sponsor|0|||
124629786|NCT02892331|448261159|FG001|Overall Study|Withdrawal by Subject|1|||
124629787|NCT02892331|448261160|FG002|Overall Study|Withdrawal by Subject|1|||
124629788|NCT02892331|448261158|FG000|Overall Study|Sick family member|0|||
124629789|NCT02892331|448261159|FG001|Overall Study|Sick family member|0|||
124795711|NCT04068896|448882529|FG001|Overall Study|Study terminated by sponsor|0|||
124795712|NCT04068896|448882530|FG002|Overall Study|Study terminated by sponsor|1|||
124629790|NCT02892331|448261160|FG002|Overall Study|Sick family member|1|||
124629791|NCT02892331|448261158|FG000|Overall Study|Corona virus pandemic|1|||
124629792|NCT02892331|448261159|FG001|Overall Study|Corona virus pandemic|0|||
124629793|NCT02892331|448261160|FG002|Overall Study|Corona virus pandemic|1|||
124795713|NCT04068896|448882531|FG003|Overall Study|Study terminated by sponsor|2|||
124629794|NCT02892331|448261158|FG000|Overall Study|Lost to Follow-up|1|||
124629795|NCT02892331|448261159|FG001|Overall Study|Lost to Follow-up|0|||
124629796|NCT02892331|448261160|FG002|Overall Study|Lost to Follow-up|1|||
124629797|NCT02892331|448261158|FG000|Overall Study|Blood pressure was too elevated|0|||
124629798|NCT02892331|448261159|FG001|Overall Study|Blood pressure was too elevated|1|||
124629799|NCT02892331|448261160|FG002|Overall Study|Blood pressure was too elevated|0|||
124629800|NCT02892331|448261158|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
124629801|NCT02892331|448261159|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
124629802|NCT02892331|448261160|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
124629803|NCT00349973|448261164|FG000|Overall Study|Adverse Event|3|||
124629804|NCT00349973|448261165|FG001|Overall Study|Adverse Event|3|||
124629805|NCT00349973|448261164|FG000|Overall Study|Withdrawal by Subject|1|||
124629806|NCT00349973|448261165|FG001|Overall Study|Withdrawal by Subject|0|||
124795714|NCT04068896|448882532|FG004|Overall Study|Study terminated by sponsor|1|||
124795715|NCT04068896|448882533|FG005|Overall Study|Study terminated by sponsor|4|||
124795716|NCT04068896|448882528|FG000|Overall Study|Protocol Violation|0|||
124795717|NCT04068896|448882529|FG001|Overall Study|Protocol Violation|0|||
124795718|NCT04068896|448882530|FG002|Overall Study|Protocol Violation|0|||
124795719|NCT04068896|448882531|FG003|Overall Study|Protocol Violation|1|||
124795720|NCT04068896|448882532|FG004|Overall Study|Protocol Violation|0|||
124795721|NCT04068896|448882533|FG005|Overall Study|Protocol Violation|0|||
124795722|NCT04068896|448882528|FG000|Overall Study|Withdrawal by Subject|0|||
124795723|NCT04068896|448882529|FG001|Overall Study|Withdrawal by Subject|3|||
124795724|NCT04068896|448882530|FG002|Overall Study|Withdrawal by Subject|0|||
124795725|NCT04068896|448882531|FG003|Overall Study|Withdrawal by Subject|2|||
124795726|NCT04068896|448882532|FG004|Overall Study|Withdrawal by Subject|1|||
124795727|NCT04068896|448882533|FG005|Overall Study|Withdrawal by Subject|0|||
124629807|NCT04314037|448261166|FG000|Treatment Period 2|Adverse Event|1|||
124795728|NCT04068896|448882528|FG000|Overall Study|Symptomatic deterioration|2|||
124795729|NCT04068896|448882529|FG001|Overall Study|Symptomatic deterioration|0|||
124795730|NCT04068896|448882530|FG002|Overall Study|Symptomatic deterioration|0|||
124795731|NCT04068896|448882531|FG003|Overall Study|Symptomatic deterioration|0|||
124795732|NCT04068896|448882532|FG004|Overall Study|Symptomatic deterioration|0|||
124795733|NCT04068896|448882533|FG005|Overall Study|Symptomatic deterioration|0|||
124795734|NCT01101191|448882534|FG000|Period 1|Withdrawal by Subject|1|||
124795735|NCT01101191|448882535|FG001|Period 1|Withdrawal by Subject|0|||
124795736|NCT01101191|448882534|FG000|Period 1|Adverse Event|1|||
124795737|NCT01101191|448882535|FG001|Period 1|Adverse Event|2|||
124795738|NCT02009384|448882536|FG000|Overall Study|Death|2|||
124795739|NCT00718237|448882538|FG000|Overall Study|Adverse Event|1|||
124795740|NCT00718237|448882539|FG001|Overall Study|Adverse Event|3|||
124795741|NCT00718237|448882538|FG000|Overall Study|Lost to Follow-up|2|||
124795742|NCT00718237|448882539|FG001|Overall Study|Lost to Follow-up|2|||
124795743|NCT00718237|448882538|FG000|Overall Study|Physician Decision|1|||
124795744|NCT00718237|448882539|FG001|Overall Study|Physician Decision|0|||
124795745|NCT00718237|448882538|FG000|Overall Study|Withdrawal by Subject|9|||
124795746|NCT00718237|448882539|FG001|Overall Study|Withdrawal by Subject|10|||
124795747|NCT02694718|448882540|FG000|Overall Study|Death|1|||
124795748|NCT02694718|448882540|FG000|Overall Study|Withdrawal by Subject|1|||
124795749|NCT02925793|448882541|FG000|Overall Study|Adverse Event|3|||
124795750|NCT02925793|448882542|FG001|Overall Study|Adverse Event|3|||
124795751|NCT02925793|448882543|FG002|Overall Study|Adverse Event|6|||
124795752|NCT02925793|448882541|FG000|Overall Study|Withdrawal by Subject|16|||
124795753|NCT02925793|448882542|FG001|Overall Study|Withdrawal by Subject|15|||
124795754|NCT02925793|448882543|FG002|Overall Study|Withdrawal by Subject|13|||
124795755|NCT02925793|448882541|FG000|Overall Study|Investigator Discretion|0|||
124795756|NCT02925793|448882542|FG001|Overall Study|Investigator Discretion|1|||
124795757|NCT02925793|448882543|FG002|Overall Study|Investigator Discretion|1|||
124795758|NCT02925793|448882541|FG000|Overall Study|Lost to Follow-up|2|||
124795759|NCT02925793|448882542|FG001|Overall Study|Lost to Follow-up|3|||
124795760|NCT02925793|448882543|FG002|Overall Study|Lost to Follow-up|1|||
124795761|NCT02925793|448882541|FG000|Overall Study|Lack of Efficacy|2|||
124795762|NCT02925793|448882542|FG001|Overall Study|Lack of Efficacy|6|||
124795763|NCT02925793|448882543|FG002|Overall Study|Lack of Efficacy|4|||
124795764|NCT02925793|448882541|FG000|Overall Study|Other:|2|||
124795765|NCT02925793|448882542|FG001|Overall Study|Other:|1|||
124795766|NCT02925793|448882543|FG002|Overall Study|Other:|3|||
124795767|NCT00879879|448882544|FG000|Overall Study|Death|1|||
124795768|NCT00879879|448882544|FG000|Overall Study|Withdrawal by Subject|1|||
124795769|NCT00879879|448882544|FG000|Overall Study|Physician Decision|1|||
124795770|NCT00667446|448882546|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
124795771|NCT00667446|448882547|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
124795772|NCT00667446|448882546|FG000|Treatment Period (36 Months)|Other|2|||
124795773|NCT00667446|448882547|FG001|Treatment Period (36 Months)|Other|2|||
124795774|NCT00667446|448882546|FG000|Treatment Period (36 Months)|Personal reasons|2|||
124629808|NCT04314037|448261167|FG001|Treatment Period 2|Adverse Event|0|||
124795775|NCT00667446|448882547|FG001|Treatment Period (36 Months)|Personal reasons|2|||
124795776|NCT00667446|448882546|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
124795777|NCT00667446|448882547|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
124795778|NCT00667446|448882546|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
124795779|NCT00667446|448882547|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
124795780|NCT00667446|448882546|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
124795781|NCT00667446|448882547|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
124795782|NCT00667446|448882546|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
124795783|NCT00667446|448882547|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
124795784|NCT00667446|448882546|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
124795785|NCT00667446|448882547|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
124795786|NCT00667446|448882546|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
124795787|NCT00667446|448882547|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
124795788|NCT01343901|448882548|FG000|Overall Study|Death|85|||
124795789|NCT01343901|448882548|FG000|Overall Study|Physician Decision|4|||
124795790|NCT01343901|448882548|FG000|Overall Study|Lost to Follow-up|12|||
124795791|NCT01343901|448882548|FG000|Overall Study|Management by another medical team|11|||
124795792|NCT01343901|448882548|FG000|Overall Study|Participant decision|1|||
124795793|NCT00769483|448882551|FG000|Overall Study|Withdrawal by Subject|0|||
124795794|NCT00769483|448882552|FG001|Overall Study|Withdrawal by Subject|1|||
124795795|NCT00769483|448882553|FG002|Overall Study|Withdrawal by Subject|0|||
124795796|NCT00769483|448882554|FG003|Overall Study|Withdrawal by Subject|0|||
124795797|NCT00769483|448882555|FG004|Overall Study|Withdrawal by Subject|1|||
124795798|NCT00769483|448882556|FG005|Overall Study|Withdrawal by Subject|0|||
124795799|NCT03455764|448882557|FG000|Overall Study|Adverse Event|1|||
124795800|NCT03455764|448882558|FG001|Overall Study|Adverse Event|0|||
124795801|NCT03455764|448882559|FG002|Overall Study|Adverse Event|0|||
124795802|NCT03455764|448882560|FG003|Overall Study|Adverse Event|0|||
124795803|NCT03455764|448882561|FG004|Overall Study|Adverse Event|0|||
124795804|NCT03455764|448882557|FG000|Overall Study|Disease Progression|4|||
124795805|NCT03455764|448882558|FG001|Overall Study|Disease Progression|0|||
124795806|NCT03455764|448882559|FG002|Overall Study|Disease Progression|0|||
124795807|NCT03455764|448882560|FG003|Overall Study|Disease Progression|0|||
124795808|NCT03455764|448882561|FG004|Overall Study|Disease Progression|0|||
124795809|NCT03455764|448882557|FG000|Overall Study|On Treatment|1|||
124795810|NCT03455764|448882558|FG001|Overall Study|On Treatment|0|||
124795811|NCT03455764|448882559|FG002|Overall Study|On Treatment|0|||
124795812|NCT03455764|448882560|FG003|Overall Study|On Treatment|0|||
124795813|NCT03455764|448882561|FG004|Overall Study|On Treatment|0|||
124795814|NCT05080660|448882562|FG000|Overall Study|Adverse Event|4|||
124795815|NCT05080660|448882563|FG001|Overall Study|Adverse Event|0|||
124795816|NCT05080660|448882562|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
124795817|NCT05080660|448882563|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
124795818|NCT05080660|448882562|FG000|Overall Study|Physician Decision|1|||
124795819|NCT05080660|448882563|FG001|Overall Study|Physician Decision|0|||
124795820|NCT05080660|448882562|FG000|Overall Study|Protocol Deviation|2|||
124795821|NCT05080660|448882563|FG001|Overall Study|Protocol Deviation|0|||
124795822|NCT05080660|448882562|FG000|Overall Study|Withdrawal by Subject|5|||
124795823|NCT05080660|448882563|FG001|Overall Study|Withdrawal by Subject|2|||
124795824|NCT04221230|448882573|FG000|Overall Study|Lost to Follow-up|12|||
124795825|NCT04221230|448882574|FG001|Overall Study|Lost to Follow-up|12|||
124795826|NCT04221230|448882573|FG000|Overall Study|Protocol Violation|2|||
124795827|NCT04221230|448882574|FG001|Overall Study|Protocol Violation|2|||
124795828|NCT04221230|448882573|FG000|Overall Study|Adverse Event|0|||
124795829|NCT04221230|448882574|FG001|Overall Study|Adverse Event|8|||
124795830|NCT04221230|448882573|FG000|Overall Study|Physician Decision|1|||
124795831|NCT04221230|448882574|FG001|Overall Study|Physician Decision|0|||
124795832|NCT04221230|448882573|FG000|Overall Study|Withdrawal by Subject|13|||
124795833|NCT04221230|448882574|FG001|Overall Study|Withdrawal by Subject|11|||
124795834|NCT04221230|448882573|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124795835|NCT04221230|448882574|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124795836|NCT04221230|448882573|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124795837|NCT04221230|448882574|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
124795838|NCT04221230|448882573|FG000|Overall Study|Pregnancy|0|||
124795839|NCT04221230|448882574|FG001|Overall Study|Pregnancy|1|||
124795840|NCT04221230|448882573|FG000|Overall Study|Other|1|||
124795841|NCT04221230|448882574|FG001|Overall Study|Other|2|||
124795842|NCT01307020|448882577|FG000|Overall Study|Lost to Follow-up|0|||
124795843|NCT01307020|448882578|FG001|Overall Study|Lost to Follow-up|0|||
124795844|NCT01307020|448882579|FG002|Overall Study|Lost to Follow-up|1|||
124795845|NCT01307020|448882580|FG003|Overall Study|Lost to Follow-up|1|||
124795846|NCT01307020|448882581|FG004|Overall Study|Lost to Follow-up|0|||
124795847|NCT01307020|448882582|FG005|Overall Study|Lost to Follow-up|0|||
124795848|NCT01307020|448882583|FG006|Overall Study|Lost to Follow-up|1|||
124795849|NCT01307020|448882584|FG007|Overall Study|Lost to Follow-up|0|||
124795850|NCT01307020|448882585|FG008|Overall Study|Lost to Follow-up|0|||
124795851|NCT01307020|448882586|FG009|Overall Study|Lost to Follow-up|0|||
124795852|NCT01307020|448882577|FG000|Overall Study|Electronic data capture failure|0|||
124795853|NCT01307020|448882578|FG001|Overall Study|Electronic data capture failure|1|||
124795854|NCT01307020|448882579|FG002|Overall Study|Electronic data capture failure|0|||
124795855|NCT01307020|448882580|FG003|Overall Study|Electronic data capture failure|0|||
124795856|NCT01307020|448882581|FG004|Overall Study|Electronic data capture failure|0|||
124795857|NCT01307020|448882582|FG005|Overall Study|Electronic data capture failure|0|||
124795858|NCT01307020|448882583|FG006|Overall Study|Electronic data capture failure|0|||
124795859|NCT01307020|448882584|FG007|Overall Study|Electronic data capture failure|0|||
124795860|NCT01307020|448882585|FG008|Overall Study|Electronic data capture failure|0|||
124795861|NCT01307020|448882586|FG009|Overall Study|Electronic data capture failure|0|||
124795862|NCT02021656|448882587|FG000|Overall Study|Adverse Event|1|||
124795863|NCT02021656|448882587|FG000|Overall Study|Lack of Efficacy|2|||
124795864|NCT02021656|448882587|FG000|Overall Study|Lost to Follow-up|1|||
124795865|NCT02021656|448882587|FG000|Overall Study|Withdrew Consent|2|||
124795866|NCT03150485|448883842|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
124795867|NCT03150485|448883843|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
124795868|NCT03150485|448883844|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
124795869|NCT03150485|448883845|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
124795870|NCT03150485|448883846|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
124795871|NCT03150485|448883847|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
124795872|NCT01394718|448883848|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
124795873|NCT01394718|448883849|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
124795874|NCT00814879|448883850|FG000|By Week 24|Cancer Diagnosis|1|||
124795875|NCT00814879|448883851|FG001|By Week 24|Cancer Diagnosis|0|||
124795876|NCT00814879|448883850|FG000|By Week 24|Incarceration|0|||
124795877|NCT00814879|448883851|FG001|By Week 24|Incarceration|1|||
124795878|NCT00814879|448883850|FG000|By Week 48|Lost to Follow-up|2|||
124795879|NCT00814879|448883851|FG001|By Week 48|Lost to Follow-up|2|||
124795880|NCT00814879|448883850|FG000|By Week 48|Death|0|||
124795881|NCT00814879|448883851|FG001|By Week 48|Death|1|||
124795882|NCT01461057|448883852|FG000|Overall Study|Death|10|||
124795883|NCT01461057|448883853|FG001|Overall Study|Death|9|||
124795884|NCT01461057|448883852|FG000|Overall Study|Withdrawal by Subject|2|||
124795885|NCT01461057|448883853|FG001|Overall Study|Withdrawal by Subject|3|||
124795886|NCT01461057|448883852|FG000|Overall Study|Physician Decision|0|||
124795887|NCT01461057|448883853|FG001|Overall Study|Physician Decision|2|||
124795888|NCT01461057|448883852|FG000|Overall Study|Adverse Event|0|||
124795889|NCT01461057|448883853|FG001|Overall Study|Adverse Event|1|||
124795890|NCT01461057|448883852|FG000|Overall Study|Progression of Disease|1|||
124795891|NCT01461057|448883853|FG001|Overall Study|Progression of Disease|0|||
124795892|NCT01461057|448883852|FG000|Overall Study|Study Terminated by Sponsor|2|||
124795893|NCT01461057|448883853|FG001|Overall Study|Study Terminated by Sponsor|0|||
124795894|NCT01739400|448883854|FG000|Overall Study|Physician Decision|3|||
124795895|NCT01739400|448883855|FG001|Overall Study|Physician Decision|0|||
124795896|NCT01739400|448883854|FG000|Overall Study|Lost to Follow-up|2|||
124795897|NCT01739400|448883855|FG001|Overall Study|Lost to Follow-up|0|||
124795898|NCT01739400|448883854|FG000|Overall Study|Death|5|||
124795899|NCT01739400|448883855|FG001|Overall Study|Death|2|||
124795900|NCT01739400|448883854|FG000|Overall Study|Withdrawal by Subject|7|||
124795901|NCT01739400|448883855|FG001|Overall Study|Withdrawal by Subject|7|||
124795902|NCT03350984|448883856|FG000|Overall Study|Death|1|||
124795903|NCT03350984|448883857|FG001|Overall Study|Death|0|||
124795904|NCT03350984|448883856|FG000|Overall Study|Lost to Follow-up|5|||
124795905|NCT03350984|448883857|FG001|Overall Study|Lost to Follow-up|6|||
124795906|NCT03350984|448883856|FG000|Overall Study|Protocol Violation|1|||
124795907|NCT03350984|448883857|FG001|Overall Study|Protocol Violation|2|||
124795908|NCT03350984|448883856|FG000|Overall Study|Physician Decision|1|||
124795909|NCT03350984|448883857|FG001|Overall Study|Physician Decision|0|||
124795910|NCT00642473|448883858|FG000|Overall Study|Withdrawal by Subject|0|||
124795911|NCT00642473|448883859|FG001|Overall Study|Withdrawal by Subject|5|||
124795912|NCT00642473|448883858|FG000|Overall Study|Progression or death|2|||
124795913|NCT00642473|448883859|FG001|Overall Study|Progression or death|4|||
124795914|NCT00642473|448883858|FG000|Overall Study|Other|2|||
124795915|NCT00642473|448883859|FG001|Overall Study|Other|2|||
124629809|NCT04314037|448261166|FG000|Treatment Period 3|Protocol Violation|1|||
124795916|NCT00478881|448883862|FG000|Overall Study|Adverse Event|31|||
124795917|NCT00478881|448883863|FG001|Overall Study|Adverse Event|12|||
124795918|NCT00478881|448883862|FG000|Overall Study|Lack of Efficacy|0|||
124795919|NCT00478881|448883863|FG001|Overall Study|Lack of Efficacy|3|||
124795920|NCT00478881|448883862|FG000|Overall Study|Lost to Follow-up|0|||
124795921|NCT00478881|448883863|FG001|Overall Study|Lost to Follow-up|1|||
124795922|NCT00478881|448883862|FG000|Overall Study|Protocol Violation|2|||
124795923|NCT00478881|448883863|FG001|Overall Study|Protocol Violation|2|||
124795924|NCT00478881|448883862|FG000|Overall Study|Withdrawal by Subject|6|||
124795925|NCT00478881|448883863|FG001|Overall Study|Withdrawal by Subject|2|||
124795926|NCT00478881|448883862|FG000|Overall Study|Non-Compliance with Study Medication|0|||
124795927|NCT00478881|448883863|FG001|Overall Study|Non-Compliance with Study Medication|2|||
124795928|NCT03410823|448883864|FG000|Overall Study|Death|1|||
124795929|NCT03410823|448883864|FG000|Overall Study|Withdrawal by Subject|2|||
124795930|NCT03410823|448883864|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
124795931|NCT05128929|448883866|FG000|Overall Study|Adverse Event|0|||
124795932|NCT05128929|448883867|FG001|Overall Study|Adverse Event|1|||
124795933|NCT02742246|448883868|FG000|Overall Study|Never initiated treatment|5|||
124795934|NCT02742246|448883869|FG001|Overall Study|Never initiated treatment|3|||
124795935|NCT02742246|448883870|FG002|Overall Study|Never initiated treatment|1|||
124795936|NCT02742246|448883868|FG000|Overall Study|dropped out during treatment|7|||
124795937|NCT02742246|448883869|FG001|Overall Study|dropped out during treatment|13|||
124795938|NCT02742246|448883870|FG002|Overall Study|dropped out during treatment|10|||
124795939|NCT02742246|448883868|FG000|Overall Study|Death|1|||
124795940|NCT02742246|448883869|FG001|Overall Study|Death|0|||
124795941|NCT02742246|448883870|FG002|Overall Study|Death|0|||
124795942|NCT03584373|448883872|FG000|Overall Study|Lost to Follow-up|7|||
124795943|NCT03584373|448883873|FG001|Overall Study|Lost to Follow-up|8|||
124795944|NCT01487577|448883874|FG000|Overall Study|Became ineligible after signing consent|1|||
124795945|NCT00662532|448883877|FG000|Overall Study|Adverse Event|0|||
124795946|NCT00662532|448883878|FG001|Overall Study|Adverse Event|1|||
124795947|NCT00662532|448883877|FG000|Overall Study|Lost to Follow-up|0|||
124795948|NCT00662532|448883878|FG001|Overall Study|Lost to Follow-up|1|||
124795949|NCT00367770|448883879|FG000|Overall Study|Adverse Event|1|||
124795950|NCT00367770|448883879|FG000|Overall Study|Withdrawal by Subject|1|||
124795951|NCT01155479|448883880|FG000|Part I|Adverse Event|13|||
124795952|NCT01155479|448883881|FG001|Part I|Adverse Event|8|||
124795953|NCT01155479|448883882|FG002|Part I|Adverse Event|18|||
124795954|NCT01155479|448883883|FG003|Part I|Adverse Event|7|||
124795955|NCT01155479|448883884|FG004|Part I|Adverse Event|6|||
124795956|NCT01155479|448883880|FG000|Part I|Administrative|2|||
124795957|NCT01155479|448883881|FG001|Part I|Administrative|2|||
124795958|NCT01155479|448883882|FG002|Part I|Administrative|2|||
124795959|NCT01155479|448883883|FG003|Part I|Administrative|0|||
124795960|NCT01155479|448883884|FG004|Part I|Administrative|0|||
124795961|NCT01155479|448883880|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
124795962|NCT01155479|448883881|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
124795963|NCT01155479|448883882|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
124795964|NCT01155479|448883883|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
124795965|NCT01155479|448883884|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
124795966|NCT01155479|448883880|FG000|Part I|Withdrawal by Subject|11|||
124795967|NCT01155479|448883881|FG001|Part I|Withdrawal by Subject|13|||
124795968|NCT01155479|448883882|FG002|Part I|Withdrawal by Subject|8|||
124795969|NCT01155479|448883883|FG003|Part I|Withdrawal by Subject|8|||
124795970|NCT01155479|448883884|FG004|Part I|Withdrawal by Subject|9|||
124795971|NCT01155479|448883880|FG000|Part I|Lost to Follow-up|0|||
124795972|NCT01155479|448883881|FG001|Part I|Lost to Follow-up|0|||
124795973|NCT01155479|448883882|FG002|Part I|Lost to Follow-up|1|||
124795974|NCT01155479|448883883|FG003|Part I|Lost to Follow-up|1|||
124795975|NCT01155479|448883884|FG004|Part I|Lost to Follow-up|0|||
124795976|NCT01155479|448883880|FG000|Part I|Treatment Failure|3|||
124795977|NCT01155479|448883881|FG001|Part I|Treatment Failure|0|||
124795978|NCT01155479|448883882|FG002|Part I|Treatment Failure|3|||
124795979|NCT01155479|448883883|FG003|Part I|Treatment Failure|1|||
124795980|NCT01155479|448883884|FG004|Part I|Treatment Failure|2|||
124795981|NCT01155479|448883880|FG000|Part I|Did Not Receive Treatment|4|||
124795982|NCT01155479|448883881|FG001|Part I|Did Not Receive Treatment|2|||
124795983|NCT01155479|448883882|FG002|Part I|Did Not Receive Treatment|2|||
124795984|NCT01155479|448883883|FG003|Part I|Did Not Receive Treatment|6|||
124795985|NCT01155479|448883884|FG004|Part I|Did Not Receive Treatment|1|||
124795986|NCT01155479|448883880|FG000|Part I|Non-Compliance with Protocol|2|||
124795987|NCT01155479|448883881|FG001|Part I|Non-Compliance with Protocol|1|||
124795988|NCT01155479|448883882|FG002|Part I|Non-Compliance with Protocol|3|||
124795989|NCT01155479|448883883|FG003|Part I|Non-Compliance with Protocol|3|||
124795990|NCT01155479|448883884|FG004|Part I|Non-Compliance with Protocol|2|||
124795991|NCT01155479|448883880|FG000|Part II|Adverse Event|7|||
124795992|NCT01155479|448883881|FG001|Part II|Adverse Event|6|||
124795993|NCT01155479|448883882|FG002|Part II|Adverse Event|8|||
124795994|NCT01155479|448883883|FG003|Part II|Adverse Event|3|||
124795995|NCT01155479|448883884|FG004|Part II|Adverse Event|4|||
124795996|NCT01155479|448883880|FG000|Part II|Administrative|43|||
124795997|NCT01155479|448883881|FG001|Part II|Administrative|49|||
124795998|NCT01155479|448883882|FG002|Part II|Administrative|36|||
124795999|NCT01155479|448883883|FG003|Part II|Administrative|38|||
124796000|NCT01155479|448883884|FG004|Part II|Administrative|46|||
124796001|NCT01155479|448883880|FG000|Part II|Withdrawal by Subject|8|||
124796002|NCT01155479|448883881|FG001|Part II|Withdrawal by Subject|4|||
124796003|NCT01155479|448883882|FG002|Part II|Withdrawal by Subject|12|||
124796004|NCT01155479|448883883|FG003|Part II|Withdrawal by Subject|7|||
124796005|NCT01155479|448883884|FG004|Part II|Withdrawal by Subject|3|||
124796006|NCT01155479|448883880|FG000|Part II|Lost to Follow-up|1|||
124796007|NCT01155479|448883881|FG001|Part II|Lost to Follow-up|0|||
124796008|NCT01155479|448883882|FG002|Part II|Lost to Follow-up|0|||
124796009|NCT01155479|448883883|FG003|Part II|Lost to Follow-up|0|||
124796010|NCT01155479|448883884|FG004|Part II|Lost to Follow-up|1|||
124796011|NCT01155479|448883880|FG000|Part II|Treatment Failure|0|||
124796012|NCT01155479|448883881|FG001|Part II|Treatment Failure|1|||
124796013|NCT01155479|448883882|FG002|Part II|Treatment Failure|2|||
124796014|NCT01155479|448883883|FG003|Part II|Treatment Failure|0|||
124796015|NCT01155479|448883884|FG004|Part II|Treatment Failure|1|||
124796016|NCT01155479|448883880|FG000|Part II|Non-Compliance with Protocol|0|||
124796017|NCT01155479|448883881|FG001|Part II|Non-Compliance with Protocol|1|||
124796018|NCT01155479|448883882|FG002|Part II|Non-Compliance with Protocol|0|||
124796019|NCT01155479|448883883|FG003|Part II|Non-Compliance with Protocol|2|||
124796020|NCT01155479|448883884|FG004|Part II|Non-Compliance with Protocol|0|||
124796021|NCT00998764|448883885|FG000|Overall Study|Lack of Efficacy|3|||
124796022|NCT00998764|448883886|FG001|Overall Study|Lack of Efficacy|6|||
124796023|NCT00998764|448883885|FG000|Overall Study|Adverse Event|17|||
124796024|NCT00998764|448883886|FG001|Overall Study|Adverse Event|12|||
124796025|NCT00998764|448883885|FG000|Overall Study|Withdrawal by Subject|19|||
124796026|NCT00998764|448883886|FG001|Overall Study|Withdrawal by Subject|25|||
124796027|NCT00998764|448883885|FG000|Overall Study|Physician Decision|3|||
124796028|NCT00998764|448883886|FG001|Overall Study|Physician Decision|3|||
124796029|NCT00998764|448883885|FG000|Overall Study|Death|3|||
124796030|NCT00998764|448883886|FG001|Overall Study|Death|1|||
124796031|NCT00998764|448883885|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
124796032|NCT00998764|448883886|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
124796033|NCT00998764|448883885|FG000|Overall Study|Protocol Violation|0|||
124796034|NCT00998764|448883886|FG001|Overall Study|Protocol Violation|1|||
124796035|NCT00998764|448883885|FG000|Overall Study|Failed to Return|1|||
124796036|NCT00998764|448883886|FG001|Overall Study|Failed to Return|1|||
124796037|NCT00998764|448883885|FG000|Overall Study|Lost to Follow-up|1|||
124796038|NCT00998764|448883886|FG001|Overall Study|Lost to Follow-up|1|||
124796039|NCT00998764|448883885|FG000|Overall Study|Loss of Caregiver|0|||
124796040|NCT00998764|448883886|FG001|Overall Study|Loss of Caregiver|3|||
124796041|NCT00998764|448883885|FG000|Overall Study|Other|4|||
124796042|NCT00998764|448883886|FG001|Overall Study|Other|4|||
124796043|NCT00998764|448883885|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
124796044|NCT00998764|448883886|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
124796045|NCT04761627|448883887|FG000|Run-in Period|Death|1|||
124796046|NCT04761627|448883888|FG001|Run-in Period|Death|0|||
124796047|NCT04761627|448883889|FG002|Run-in Period|Death|0|||
124796048|NCT04761627|448883887|FG000|Run-in Period|Required alternative therapy|2|||
124796049|NCT04761627|448883888|FG001|Run-in Period|Required alternative therapy|0|||
124796050|NCT04761627|448883889|FG002|Run-in Period|Required alternative therapy|0|||
124796051|NCT04761627|448883887|FG000|Run-in Period|Lost to Follow-up|2|||
124796052|NCT04761627|448883888|FG001|Run-in Period|Lost to Follow-up|0|||
124796053|NCT04761627|448883889|FG002|Run-in Period|Lost to Follow-up|0|||
124796054|NCT04761627|448883887|FG000|Run-in Period|Protocol Violation|3|||
124796055|NCT04761627|448883888|FG001|Run-in Period|Protocol Violation|0|||
124796056|NCT04761627|448883889|FG002|Run-in Period|Protocol Violation|0|||
124796057|NCT04761627|448883887|FG000|Run-in Period|Abnormal liver function|1|||
124796058|NCT04761627|448883888|FG001|Run-in Period|Abnormal liver function|0|||
124796059|NCT04761627|448883889|FG002|Run-in Period|Abnormal liver function|0|||
124796060|NCT04761627|448883887|FG000|Run-in Period|Adverse Event|6|||
124796061|NCT04761627|448883888|FG001|Run-in Period|Adverse Event|0|||
124796062|NCT04761627|448883889|FG002|Run-in Period|Adverse Event|0|||
124796063|NCT04761627|448883887|FG000|Run-in Period|Withdrawal by Subject|7|||
124796064|NCT04761627|448883888|FG001|Run-in Period|Withdrawal by Subject|0|||
124796065|NCT04761627|448883889|FG002|Run-in Period|Withdrawal by Subject|0|||
124796066|NCT04761627|448883887|FG000|Run-in Period|Did not meet PASI 50|15|||
124796067|NCT04761627|448883888|FG001|Run-in Period|Did not meet PASI 50|0|||
124796068|NCT04761627|448883889|FG002|Run-in Period|Did not meet PASI 50|0|||
124796069|NCT04761627|448883887|FG000|Run-in Period|Study site closure|2|||
124796070|NCT04761627|448883888|FG001|Run-in Period|Study site closure|0|||
124796071|NCT04761627|448883889|FG002|Run-in Period|Study site closure|0|||
124796072|NCT04761627|448883887|FG000|Run-in Period|Pregnancy|2|||
124796073|NCT04761627|448883888|FG001|Run-in Period|Pregnancy|0|||
124796074|NCT04761627|448883889|FG002|Run-in Period|Pregnancy|0|||
124796075|NCT04761627|448883887|FG000|Post-randomization Period|Military service|0|||
124796076|NCT04761627|448883888|FG001|Post-randomization Period|Military service|1|||
124796077|NCT04761627|448883889|FG002|Post-randomization Period|Military service|0|||
124796078|NCT04761627|448883887|FG000|Post-randomization Period|Adverse Event|0|||
124796079|NCT04761627|448883888|FG001|Post-randomization Period|Adverse Event|4|||
124796080|NCT04761627|448883889|FG002|Post-randomization Period|Adverse Event|2|||
124796081|NCT04761627|448883887|FG000|Post-randomization Period|Lost to Follow-up|0|||
124796082|NCT04761627|448883888|FG001|Post-randomization Period|Lost to Follow-up|6|||
124796083|NCT04761627|448883889|FG002|Post-randomization Period|Lost to Follow-up|6|||
124796084|NCT04761627|448883887|FG000|Post-randomization Period|Withdrawal by Subject|0|||
124796085|NCT04761627|448883888|FG001|Post-randomization Period|Withdrawal by Subject|7|||
124796086|NCT04761627|448883889|FG002|Post-randomization Period|Withdrawal by Subject|6|||
124796087|NCT04761627|448883887|FG000|Post-randomization Period|Pregnancy|0|||
124796088|NCT04761627|448883888|FG001|Post-randomization Period|Pregnancy|0|||
124796089|NCT04761627|448883889|FG002|Post-randomization Period|Pregnancy|1|||
124796090|NCT04761627|448883887|FG000|Post-randomization Period|Study site closure|0|||
124796091|NCT04761627|448883888|FG001|Post-randomization Period|Study site closure|0|||
124796092|NCT04761627|448883889|FG002|Post-randomization Period|Study site closure|1|||
124796093|NCT04761627|448883887|FG000|Post-randomization Period|Family planning|0|||
124796094|NCT04761627|448883888|FG001|Post-randomization Period|Family planning|1|||
124796095|NCT04761627|448883889|FG002|Post-randomization Period|Family planning|0|||
124796096|NCT01214174|448883890|FG000|Overall Study|Withdrawal by Subject|0|||
124796097|NCT01214174|448883891|FG001|Overall Study|Withdrawal by Subject|0|||
124796098|NCT01214174|448883892|FG002|Overall Study|Withdrawal by Subject|1|||
124796099|NCT03823378|448883895|FG000|Overall Study|Adverse Event|2|||
124796100|NCT03823378|448883896|FG001|Overall Study|Adverse Event|2|||
124796101|NCT03823378|448883897|FG002|Overall Study|Adverse Event|0|||
124796102|NCT03823378|448883898|FG003|Overall Study|Adverse Event|0|||
124796103|NCT03823378|448883899|FG004|Overall Study|Adverse Event|0|||
124796104|NCT03823378|448883900|FG005|Overall Study|Adverse Event|0|||
124796105|NCT03823378|448883895|FG000|Overall Study|Lost to Follow-up|0|||
124796106|NCT03823378|448883896|FG001|Overall Study|Lost to Follow-up|1|||
124796107|NCT03823378|448883897|FG002|Overall Study|Lost to Follow-up|0|||
124796108|NCT03823378|448883898|FG003|Overall Study|Lost to Follow-up|0|||
124796109|NCT03823378|448883899|FG004|Overall Study|Lost to Follow-up|1|||
124796110|NCT03823378|448883900|FG005|Overall Study|Lost to Follow-up|0|||
124796111|NCT03823378|448883895|FG000|Overall Study|Withdrawal by Subject|0|||
124796112|NCT03823378|448883896|FG001|Overall Study|Withdrawal by Subject|1|||
124796113|NCT03823378|448883897|FG002|Overall Study|Withdrawal by Subject|4|||
124796114|NCT03823378|448883898|FG003|Overall Study|Withdrawal by Subject|2|||
124796115|NCT03823378|448883899|FG004|Overall Study|Withdrawal by Subject|0|||
124796116|NCT03823378|448883900|FG005|Overall Study|Withdrawal by Subject|1|||
124796117|NCT03823378|448883895|FG000|Overall Study|Other, not specified|19|||
124796118|NCT03823378|448883896|FG001|Overall Study|Other, not specified|12|||
124796119|NCT03823378|448883897|FG002|Overall Study|Other, not specified|6|||
124796120|NCT03823378|448883898|FG003|Overall Study|Other, not specified|8|||
124796121|NCT03823378|448883899|FG004|Overall Study|Other, not specified|17|||
124629810|NCT04314037|448261167|FG001|Treatment Period 3|Protocol Violation|0|||
124629811|NCT04314037|448261166|FG000|Treatment Period 3|Adverse Event|0|||
124629812|NCT04314037|448261167|FG001|Treatment Period 3|Adverse Event|1|||
124629813|NCT00868530|448261170|FG000|Overall Study|Adverse Event|3|||
124629814|NCT00868530|448261170|FG000|Overall Study|Lost to Follow-up|1|||
124796122|NCT03823378|448883900|FG005|Overall Study|Other, not specified|7|||
124796123|NCT02093026|448883901|FG000|Overall Study|Adverse Event|26|||
124796124|NCT02093026|448883901|FG000|Overall Study|Death|10|||
124796125|NCT02093026|448883901|FG000|Overall Study|Other|157|||
124796126|NCT02376829|448883902|FG000|Overall Study|Withdrawal by Subject|27|||
124796127|NCT02376829|448883903|FG001|Overall Study|Withdrawal by Subject|44|||
124796128|NCT01255787|448883904|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
124796129|NCT01255787|448883905|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
124796130|NCT01255787|448883906|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
124796131|NCT01255787|448883907|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
124796132|NCT01255787|448883904|FG000|Overall Study|Major Protocol Deviation|1|||
124796133|NCT01255787|448883905|FG001|Overall Study|Major Protocol Deviation|1|||
124796134|NCT01255787|448883906|FG002|Overall Study|Major Protocol Deviation|0|||
124796135|NCT01255787|448883907|FG003|Overall Study|Major Protocol Deviation|4|||
124796136|NCT01255787|448883904|FG000|Overall Study|Lost to Follow-up|1|||
124796137|NCT01255787|448883905|FG001|Overall Study|Lost to Follow-up|2|||
124796138|NCT01255787|448883906|FG002|Overall Study|Lost to Follow-up|4|||
124796139|NCT01255787|448883907|FG003|Overall Study|Lost to Follow-up|2|||
124796140|NCT01255787|448883904|FG000|Overall Study|Withdrawal of Consent|3|||
124796141|NCT01255787|448883905|FG001|Overall Study|Withdrawal of Consent|9|||
124796142|NCT01255787|448883906|FG002|Overall Study|Withdrawal of Consent|3|||
124796143|NCT01255787|448883907|FG003|Overall Study|Withdrawal of Consent|4|||
124796144|NCT01255787|448883904|FG000|Overall Study|Pregnancy|0|||
124796145|NCT01255787|448883905|FG001|Overall Study|Pregnancy|0|||
124796146|NCT01255787|448883906|FG002|Overall Study|Pregnancy|0|||
124796147|NCT01255787|448883907|FG003|Overall Study|Pregnancy|1|||
124796148|NCT01255787|448883904|FG000|Overall Study|Lack of Efficacy|2|||
124796149|NCT01255787|448883905|FG001|Overall Study|Lack of Efficacy|2|||
124796150|NCT01255787|448883906|FG002|Overall Study|Lack of Efficacy|2|||
124796151|NCT01255787|448883907|FG003|Overall Study|Lack of Efficacy|2|||
124629815|NCT00858273|448261171|FG000|Overall Study|Protocol Violation|3|||
124629816|NCT00858273|448261172|FG001|Overall Study|Protocol Violation|5|||
124629817|NCT04199104|448262825|FG000|Overall Study|Death|148|||
124796152|NCT01255787|448883904|FG000|Overall Study|Noncompliance with Study Drug|3|||
124796153|NCT01255787|448883905|FG001|Overall Study|Noncompliance with Study Drug|1|||
124796154|NCT01255787|448883906|FG002|Overall Study|Noncompliance with Study Drug|0|||
124796155|NCT01255787|448883907|FG003|Overall Study|Noncompliance with Study Drug|0|||
124796156|NCT00476047|448883908|FG000|Overall Study|Lost to Follow-up|1|||
124796157|NCT05153473|448883909|FG000|Overall Study|Death|46|||
124796158|NCT05153473|448883909|FG000|Overall Study|Lost to Follow-up|3|||
124796159|NCT02283177|448883910|FG000|Overall Study|Withdrawal by Subject|1|||
124796160|NCT02283177|448883911|FG001|Overall Study|Withdrawal by Subject|1|||
124796161|NCT02398227|448883912|FG000|Overall Study|Lost to Follow-up|21|||
124796162|NCT02398227|448883913|FG001|Overall Study|Lost to Follow-up|12|||
124796163|NCT02398227|448883912|FG000|Overall Study|Withdrawal by Subject|5|||
124796164|NCT02398227|448883913|FG001|Overall Study|Withdrawal by Subject|6|||
124796165|NCT02398227|448883912|FG000|Overall Study|Removed from treatment and dropped out|1|||
124796166|NCT02398227|448883913|FG001|Overall Study|Removed from treatment and dropped out|0|||
124796167|NCT01185834|448883914|FG000|Overall Study|Lost to Follow-up|2|||
124796168|NCT01185834|448883914|FG000|Overall Study|Discomfort|4|||
124796169|NCT01185834|448883914|FG000|Overall Study|Biomicroscopy|4|||
124796170|NCT01185834|448883914|FG000|Overall Study|Time/Job Conflict|2|||
124796171|NCT01185834|448883914|FG000|Overall Study|Early exit - Site error|2|||
124796172|NCT01975831|448883915|FG000|Overall Study|Adverse Event|1|||
124796173|NCT01975831|448883916|FG001|Overall Study|Adverse Event|2|||
124796174|NCT01975831|448883917|FG002|Overall Study|Adverse Event|2|||
124796175|NCT01975831|448883918|FG003|Overall Study|Adverse Event|0|||
124796176|NCT01975831|448883919|FG004|Overall Study|Adverse Event|1|||
124796177|NCT01975831|448883920|FG005|Overall Study|Adverse Event|1|||
124796178|NCT01975831|448883921|FG006|Overall Study|Adverse Event|3|||
124796179|NCT01975831|448883922|FG007|Overall Study|Adverse Event|4|||
124796180|NCT01975831|448883923|FG008|Overall Study|Adverse Event|1|||
124796181|NCT01975831|448883915|FG000|Overall Study|Death|1|||
124796182|NCT01975831|448883916|FG001|Overall Study|Death|1|||
124796183|NCT01975831|448883917|FG002|Overall Study|Death|0|||
124796184|NCT01975831|448883918|FG003|Overall Study|Death|0|||
124796185|NCT01975831|448883919|FG004|Overall Study|Death|1|||
124796186|NCT01975831|448883920|FG005|Overall Study|Death|0|||
124796187|NCT01975831|448883921|FG006|Overall Study|Death|1|||
124796188|NCT01975831|448883922|FG007|Overall Study|Death|0|||
124796189|NCT01975831|448883923|FG008|Overall Study|Death|0|||
124796190|NCT01975831|448883915|FG000|Overall Study|Progressive Disease|1|||
124796191|NCT01975831|448883916|FG001|Overall Study|Progressive Disease|3|||
124796192|NCT01975831|448883917|FG002|Overall Study|Progressive Disease|2|||
124796193|NCT01975831|448883918|FG003|Overall Study|Progressive Disease|4|||
124796194|NCT01975831|448883919|FG004|Overall Study|Progressive Disease|13|||
124796195|NCT01975831|448883920|FG005|Overall Study|Progressive Disease|9|||
124796196|NCT01975831|448883921|FG006|Overall Study|Progressive Disease|10|||
124796197|NCT01975831|448883922|FG007|Overall Study|Progressive Disease|8|||
124796198|NCT01975831|448883923|FG008|Overall Study|Progressive Disease|10|||
124796199|NCT01975831|448883915|FG000|Overall Study|Withdrawal by Subject|0|||
124796200|NCT01975831|448883916|FG001|Overall Study|Withdrawal by Subject|3|||
124796201|NCT01975831|448883917|FG002|Overall Study|Withdrawal by Subject|0|||
124796202|NCT01975831|448883918|FG003|Overall Study|Withdrawal by Subject|0|||
124796203|NCT01975831|448883919|FG004|Overall Study|Withdrawal by Subject|3|||
124796204|NCT01975831|448883920|FG005|Overall Study|Withdrawal by Subject|1|||
124796205|NCT01975831|448883921|FG006|Overall Study|Withdrawal by Subject|1|||
124796206|NCT01975831|448883922|FG007|Overall Study|Withdrawal by Subject|0|||
124796207|NCT01975831|448883923|FG008|Overall Study|Withdrawal by Subject|0|||
124796208|NCT01975831|448883915|FG000|Overall Study|Physician Decision|0|||
124796209|NCT01975831|448883916|FG001|Overall Study|Physician Decision|0|||
124796210|NCT01975831|448883917|FG002|Overall Study|Physician Decision|0|||
124796211|NCT01975831|448883918|FG003|Overall Study|Physician Decision|0|||
124796212|NCT01975831|448883919|FG004|Overall Study|Physician Decision|0|||
124796213|NCT01975831|448883920|FG005|Overall Study|Physician Decision|1|||
124796214|NCT01975831|448883921|FG006|Overall Study|Physician Decision|0|||
124796215|NCT01975831|448883922|FG007|Overall Study|Physician Decision|1|||
124796216|NCT01975831|448883923|FG008|Overall Study|Physician Decision|0|||
124796217|NCT01975831|448883915|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
124796218|NCT01975831|448883916|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
124796219|NCT01975831|448883917|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
124796220|NCT01975831|448883918|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
124796221|NCT01975831|448883919|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
124796222|NCT01975831|448883920|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
124796223|NCT01975831|448883921|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
124796224|NCT01975831|448883922|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
124796225|NCT01975831|448883923|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
124796226|NCT01975831|448883915|FG000|Overall Study|Entered Hospice|0|||
124796227|NCT01975831|448883916|FG001|Overall Study|Entered Hospice|0|||
124796228|NCT01975831|448883917|FG002|Overall Study|Entered Hospice|0|||
124629818|NCT04199104|448262826|FG001|Overall Study|Death|134|||
124796229|NCT01975831|448883918|FG003|Overall Study|Entered Hospice|0|||
124796230|NCT01975831|448883919|FG004|Overall Study|Entered Hospice|0|||
124796231|NCT01975831|448883920|FG005|Overall Study|Entered Hospice|1|||
124796232|NCT01975831|448883921|FG006|Overall Study|Entered Hospice|0|||
124796233|NCT01975831|448883922|FG007|Overall Study|Entered Hospice|0|||
124796234|NCT01975831|448883923|FG008|Overall Study|Entered Hospice|0|||
124796235|NCT01975831|448883915|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
124796236|NCT01975831|448883916|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
124796237|NCT01975831|448883917|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
124796238|NCT01975831|448883918|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
124796239|NCT01975831|448883919|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
124796240|NCT01975831|448883920|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
124796241|NCT01975831|448883921|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
124796242|NCT01975831|448883922|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
124796243|NCT01975831|448883923|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
124796244|NCT00887744|448883924|FG000|Overall Study|Adverse Event|3|||
124796245|NCT00887744|448883924|FG000|Overall Study|Death|1|||
124796246|NCT00887744|448883924|FG000|Overall Study|Lost to Follow-up|3|||
124796247|NCT00887744|448883924|FG000|Overall Study|Withdrawal by Subject|18|||
124796248|NCT00887744|448883924|FG000|Overall Study|Various reasons|9|||
124796249|NCT03324581|448883928|FG000|Overall Study|Adverse Event|18|||
124796250|NCT03324581|448883929|FG001|Overall Study|Adverse Event|11|||
124796251|NCT03324581|448883930|FG002|Overall Study|Adverse Event|7|||
124796252|NCT03324581|448883928|FG000|Overall Study|Lack of Efficacy|0|||
124796253|NCT03324581|448883929|FG001|Overall Study|Lack of Efficacy|1|||
124796254|NCT03324581|448883930|FG002|Overall Study|Lack of Efficacy|0|||
124796255|NCT03324581|448883928|FG000|Overall Study|Lost to Follow-up|5|||
124796256|NCT03324581|448883929|FG001|Overall Study|Lost to Follow-up|3|||
124796257|NCT03324581|448883930|FG002|Overall Study|Lost to Follow-up|6|||
124796258|NCT03324581|448883928|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
124796259|NCT03324581|448883929|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
124796260|NCT03324581|448883930|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
124796261|NCT03324581|448883928|FG000|Overall Study|Physician Decision|0|||
124796262|NCT03324581|448883929|FG001|Overall Study|Physician Decision|1|||
124796263|NCT03324581|448883930|FG002|Overall Study|Physician Decision|2|||
124796264|NCT03324581|448883928|FG000|Overall Study|Protocol Deviation|8|||
124796265|NCT03324581|448883929|FG001|Overall Study|Protocol Deviation|9|||
124796266|NCT03324581|448883930|FG002|Overall Study|Protocol Deviation|4|||
124796267|NCT03324581|448883928|FG000|Overall Study|Withdrawal by Subject|6|||
124796268|NCT03324581|448883929|FG001|Overall Study|Withdrawal by Subject|8|||
124796269|NCT03324581|448883930|FG002|Overall Study|Withdrawal by Subject|6|||
124796270|NCT03324581|448883928|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
124796271|NCT03324581|448883929|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
124796272|NCT03324581|448883930|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
124796273|NCT02274038|448883931|FG000|Overall Study|Death|1|||
124796274|NCT03783702|448883932|FG000|Overall Study|Lost to Follow-up|6|||
124796275|NCT03783702|448883933|FG001|Overall Study|Lost to Follow-up|8|||
124796276|NCT03783702|448883932|FG000|Overall Study|Protocol Violation|1|||
124796277|NCT03783702|448883933|FG001|Overall Study|Protocol Violation|3|||
124796278|NCT04473482|448883934|FG000|Overall Study|Death|0|||
124796279|NCT04473482|448883935|FG001|Overall Study|Death|3|||
124796280|NCT04473482|448883934|FG000|Overall Study|Lost to Follow-up|9|||
124796281|NCT04473482|448883935|FG001|Overall Study|Lost to Follow-up|7|||
124796282|NCT04473482|448883934|FG000|Overall Study|Withdrawal by Subject|2|||
124796283|NCT04473482|448883935|FG001|Overall Study|Withdrawal by Subject|1|||
124796284|NCT00321893|448883937|FG000|Overall Study|Non-Compliance/Refusal|16|||
124796285|NCT00321893|448883938|FG001|Overall Study|Non-Compliance/Refusal|10|||
124796286|NCT00321893|448883937|FG000|Overall Study|Lost to Follow-up|2|||
124796287|NCT00321893|448883938|FG001|Overall Study|Lost to Follow-up|1|||
124796288|NCT00321893|448883937|FG000|Overall Study|Adverse Event|6|||
124796289|NCT00321893|448883938|FG001|Overall Study|Adverse Event|3|||
124796290|NCT01306877|448883939|FG000|Overall Study|Lost to Follow-up|3|||
124796291|NCT01306877|448883940|FG001|Overall Study|Lost to Follow-up|3|||
124796292|NCT01306877|448883939|FG000|Overall Study|Physician Decision|0|||
124796293|NCT01306877|448883940|FG001|Overall Study|Physician Decision|1|||
124796294|NCT00999921|448883945|FG000|Overall Study|Lost to Follow-up|10|||
124796295|NCT00999921|448883946|FG001|Overall Study|Lost to Follow-up|19|||
124796296|NCT00989573|448883950|FG000|Overall Study|Adverse Event|8|||
124796297|NCT00989573|448883951|FG001|Overall Study|Adverse Event|12|||
124796298|NCT00989573|448883952|FG002|Overall Study|Adverse Event|4|||
124796299|NCT00989573|448883950|FG000|Overall Study|Physician Decision|0|||
124796300|NCT00989573|448883951|FG001|Overall Study|Physician Decision|2|||
124796301|NCT00989573|448883952|FG002|Overall Study|Physician Decision|0|||
124796302|NCT00989573|448883950|FG000|Overall Study|Protocol Violation|1|||
124796303|NCT00989573|448883951|FG001|Overall Study|Protocol Violation|1|||
124796304|NCT00989573|448883952|FG002|Overall Study|Protocol Violation|1|||
124796305|NCT00989573|448883950|FG000|Overall Study|Withdrawal by Subject|4|||
124796306|NCT00989573|448883951|FG001|Overall Study|Withdrawal by Subject|7|||
124796307|NCT00989573|448883952|FG002|Overall Study|Withdrawal by Subject|3|||
124796308|NCT01076075|448883954|FG000|Overall Study|Adverse Event|3|||
124796309|NCT01076075|448883955|FG001|Overall Study|Adverse Event|9|||
124796310|NCT01076075|448883954|FG000|Overall Study|Lack of Efficacy|5|||
124796311|NCT01076075|448883955|FG001|Overall Study|Lack of Efficacy|4|||
124796312|NCT01076075|448883954|FG000|Overall Study|Lost to Follow-up|6|||
124796313|NCT01076075|448883955|FG001|Overall Study|Lost to Follow-up|5|||
124796314|NCT01076075|448883954|FG000|Overall Study|other|19|||
124796315|NCT01076075|448883955|FG001|Overall Study|other|9|||
124796316|NCT01076075|448883954|FG000|Overall Study|Protocol Violation|0|||
124796317|NCT01076075|448883955|FG001|Overall Study|Protocol Violation|1|||
124796318|NCT01076075|448883954|FG000|Overall Study|Withdrawal by Subject|8|||
124796319|NCT01076075|448883955|FG001|Overall Study|Withdrawal by Subject|19|||
124796320|NCT00995865|448883958|FG000|Overall Study|Protocol Violation|2|||
124796321|NCT00995865|448883959|FG001|Overall Study|Protocol Violation|0|||
124796322|NCT00995865|448883960|FG002|Overall Study|Protocol Violation|0|||
124796323|NCT00995865|448883958|FG000|Overall Study|Lost to Follow-up|0|||
124796324|NCT00995865|448883959|FG001|Overall Study|Lost to Follow-up|0|||
124796325|NCT00995865|448883960|FG002|Overall Study|Lost to Follow-up|1|||
124796326|NCT03687970|448883962|FG000|Overall Study|visit scheduling conflicts|2|||
124796327|NCT03687970|448883963|FG001|Overall Study|visit scheduling conflicts|0|||
124796328|NCT02359851|448883966|FG000|Overall Study|Death|1|||
124796329|NCT02359851|448883966|FG000|Overall Study|Disease progression|1|||
124796330|NCT01888003|448883967|FG000|Overall Study|Study Terminated|5|||
124796331|NCT01888003|448883968|FG001|Overall Study|Study Terminated|6|||
124796332|NCT01888003|448883969|FG002|Overall Study|Study Terminated|40|||
124796333|NCT00055471|448883970|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
124796334|NCT00055471|448883971|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
124796335|NCT00055471|448883972|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
124796336|NCT00055471|448883970|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
124796337|NCT00055471|448883971|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
124796338|NCT00055471|448883972|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
124796339|NCT00055471|448883970|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
124796340|NCT00055471|448883971|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
124796341|NCT00055471|448883972|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
124796342|NCT01854944|448883973|FG000|Overall Study|Withdrawal by Subject|0|||
124796343|NCT01854944|448883974|FG001|Overall Study|Withdrawal by Subject|0|||
124796344|NCT01854944|448883975|FG002|Overall Study|Withdrawal by Subject|1|||
124796345|NCT02101112|448883976|FG000|Overall Study|Adverse Event|0|||
124796346|NCT02101112|448883977|FG001|Overall Study|Adverse Event|0|||
124796347|NCT02101112|448883978|FG002|Overall Study|Adverse Event|1|||
124796348|NCT02101112|448883979|FG003|Overall Study|Adverse Event|0|||
124796349|NCT02101112|448883980|FG004|Overall Study|Adverse Event|0|||
124796350|NCT02101112|448883981|FG005|Overall Study|Adverse Event|0|||
124796351|NCT02101112|448883976|FG000|Overall Study|Withdrawal by Subject|0|||
124796352|NCT02101112|448883977|FG001|Overall Study|Withdrawal by Subject|0|||
124796353|NCT02101112|448883978|FG002|Overall Study|Withdrawal by Subject|0|||
124796354|NCT02101112|448883979|FG003|Overall Study|Withdrawal by Subject|0|||
124796355|NCT02101112|448883980|FG004|Overall Study|Withdrawal by Subject|1|||
124796356|NCT02101112|448883981|FG005|Overall Study|Withdrawal by Subject|0|||
124796357|NCT04340063|448883982|FG000|Overall Study|Withdrawal by Subject|1|||
124796358|NCT04340063|448883983|FG001|Overall Study|Withdrawal by Subject|2|||
124796359|NCT04340063|448883982|FG000|Overall Study|Lost to Follow-up|3|||
124796360|NCT04340063|448883983|FG001|Overall Study|Lost to Follow-up|1|||
124796361|NCT04340063|448883982|FG000|Overall Study|Protocol Violation|0|||
124796362|NCT04340063|448883983|FG001|Overall Study|Protocol Violation|1|||
124796363|NCT01857583|448883984|FG000|Overall Study|Adverse Event|0|||
124796364|NCT01857583|448883985|FG001|Overall Study|Adverse Event|0|||
124796365|NCT01857583|448883986|FG002|Overall Study|Adverse Event|1|||
124796366|NCT01857583|448883987|FG003|Overall Study|Adverse Event|1|||
124796367|NCT01857583|448883984|FG000|Overall Study|Death|0|||
124796368|NCT01857583|448883985|FG001|Overall Study|Death|1|||
124796369|NCT01857583|448883986|FG002|Overall Study|Death|1|||
124796370|NCT01857583|448883987|FG003|Overall Study|Death|0|||
124796371|NCT01857583|448883984|FG000|Overall Study|Physician Decision|0|||
124796372|NCT01857583|448883985|FG001|Overall Study|Physician Decision|0|||
124796373|NCT01857583|448883986|FG002|Overall Study|Physician Decision|0|||
124796374|NCT01857583|448883987|FG003|Overall Study|Physician Decision|1|||
124796375|NCT01857583|448883984|FG000|Overall Study|Withdrawal by Subject|1|||
124796376|NCT01857583|448883985|FG001|Overall Study|Withdrawal by Subject|0|||
124796377|NCT01857583|448883986|FG002|Overall Study|Withdrawal by Subject|1|||
124796378|NCT01857583|448883987|FG003|Overall Study|Withdrawal by Subject|2|||
124796379|NCT00458536|448883990|FG000|Overall Study|Disease progression prior to treatment|7|||
124796380|NCT00458536|448883990|FG000|Overall Study|Unable to make vaccine|3|||
124796381|NCT00458536|448883990|FG000|Overall Study|No measurable disease after surgery|2|||
124796382|NCT00458536|448883990|FG000|Overall Study|Did not have renal cell carcinoma|2|||
124796383|NCT00458536|448883990|FG000|Overall Study|Patient did not have surgery|1|||
124796384|NCT00458536|448883990|FG000|Overall Study|Ineligible due to toxicity|1|||
124796385|NCT00458536|448883990|FG000|Overall Study|Withdrawal by Subject|1|||
124796386|NCT00458536|448883990|FG000|Overall Study|Progressive disease during treatment|2|||
124796387|NCT00562627|448885807|FG000|Overall Study|Protocol Violation|1|||
124796388|NCT00562627|448885808|FG001|Overall Study|Protocol Violation|1|||
124796389|NCT00562627|448885809|FG002|Overall Study|Protocol Violation|1|||
124796390|NCT00625742|448885810|FG000|Overall Study|Disease Progression|2|||
124796391|NCT00625742|448885810|FG000|Overall Study|Withdrawal by Subject|1|||
124796392|NCT00625742|448885810|FG000|Overall Study|Adverse Event|4|||
124796393|NCT00625742|448885810|FG000|Overall Study|Lost to Follow-up|4|||
124796394|NCT00625742|448885810|FG000|Overall Study|Ineligible|1|||
124796395|NCT01709578|448885811|FG000|Overall Study|Rescued and entered in long term safety|63|||
124796396|NCT01709578|448885812|FG001|Overall Study|Rescued and entered in long term safety|25|||
124796397|NCT01709578|448885813|FG002|Overall Study|Rescued and entered in long term safety|26|||
124796398|NCT01709578|448885811|FG000|Overall Study|Adverse Event|9|||
124796399|NCT01709578|448885812|FG001|Overall Study|Adverse Event|18|||
124796400|NCT01709578|448885813|FG002|Overall Study|Adverse Event|17|||
124796401|NCT01709578|448885811|FG000|Overall Study|Lack of Efficacy|5|||
124796402|NCT01709578|448885812|FG001|Overall Study|Lack of Efficacy|4|||
124796403|NCT01709578|448885813|FG002|Overall Study|Lack of Efficacy|2|||
124796404|NCT01709578|448885811|FG000|Overall Study|Poor compliance to protocol|1|||
124796405|NCT01709578|448885812|FG001|Overall Study|Poor compliance to protocol|2|||
124796406|NCT01709578|448885813|FG002|Overall Study|Poor compliance to protocol|1|||
124796407|NCT01709578|448885811|FG000|Overall Study|Other, not related to safety or efficacy|2|||
124796408|NCT01709578|448885812|FG001|Overall Study|Other, not related to safety or efficacy|7|||
124796409|NCT01709578|448885813|FG002|Overall Study|Other, not related to safety or efficacy|5|||
124796410|NCT04050371|448885814|FG000|Overall Study|Withdrawal by Subject|1|||
124796411|NCT04050371|448885815|FG001|Overall Study|Withdrawal by Subject|0|||
124796412|NCT01314911|448885817|FG000|Overall Study|Lost to Follow-up|3|||
124796413|NCT01314911|448885818|FG001|Overall Study|Lost to Follow-up|2|||
124796414|NCT01314911|448885817|FG000|Overall Study|Withdrawal by Subject|1|||
124796415|NCT01314911|448885818|FG001|Overall Study|Withdrawal by Subject|3|||
124796416|NCT01314911|448885817|FG000|Overall Study|Received Non-randomized Study Drug|0|||
124796417|NCT01314911|448885818|FG001|Overall Study|Received Non-randomized Study Drug|1|||
124796418|NCT01314911|448885817|FG000|Overall Study|Never Started Treatment|1|||
124796419|NCT01314911|448885818|FG001|Overall Study|Never Started Treatment|0|||
124796420|NCT00588952|448885820|FG000|Overall Study|Adverse Event|0|||
124796421|NCT00588952|448885821|FG001|Overall Study|Adverse Event|2|||
124796422|NCT00588952|448885820|FG000|Overall Study|Withdrawal by Subject|3|||
124796423|NCT00588952|448885821|FG001|Overall Study|Withdrawal by Subject|5|||
124796424|NCT01277042|448885822|FG000|Overall Study|Adverse Event|4|||
124796425|NCT01277042|448885823|FG001|Overall Study|Adverse Event|3|||
124796426|NCT01277042|448885822|FG000|Overall Study|Lost to Follow-up|2|||
124796427|NCT01277042|448885823|FG001|Overall Study|Lost to Follow-up|2|||
124796428|NCT01277042|448885822|FG000|Overall Study|Withdrawal by Subject|2|||
124796429|NCT01277042|448885823|FG001|Overall Study|Withdrawal by Subject|0|||
124796430|NCT02284178|448885824|FG000|Overall Study|Met exclusion criteria|49|||
124796431|NCT02284178|448885825|FG001|Overall Study|Met exclusion criteria|54|||
124796432|NCT01483690|448885828|FG000|Overall Study|Adverse Event|1|||
124796433|NCT01483690|448885829|FG001|Overall Study|Adverse Event|2|||
124796434|NCT01483690|448885828|FG000|Overall Study|clinical deterioration|1|||
124796435|NCT01483690|448885829|FG001|Overall Study|clinical deterioration|0|||
124796436|NCT01483690|448885828|FG000|Overall Study|Physician Decision|0|||
124796437|NCT01483690|448885829|FG001|Overall Study|Physician Decision|2|||
124796438|NCT01483690|448885828|FG000|Overall Study|exclusionary procedure|0|||
124796439|NCT01483690|448885829|FG001|Overall Study|exclusionary procedure|1|||
124796440|NCT03569293|448885832|FG000|Overall Study|Adverse Event|4|||
124796441|NCT03569293|448885833|FG001|Overall Study|Adverse Event|1|||
124796442|NCT03569293|448885834|FG002|Overall Study|Adverse Event|5|||
124796443|NCT03569293|448885835|FG003|Overall Study|Adverse Event|1|||
124796444|NCT03569293|448885836|FG004|Overall Study|Adverse Event|0|||
124796445|NCT03569293|448885837|FG005|Overall Study|Adverse Event|0|||
124796446|NCT03569293|448885832|FG000|Overall Study|Withdrawal by Subject|16|||
124796447|NCT03569293|448885833|FG001|Overall Study|Withdrawal by Subject|2|||
124796448|NCT03569293|448885834|FG002|Overall Study|Withdrawal by Subject|4|||
124796449|NCT03569293|448885835|FG003|Overall Study|Withdrawal by Subject|1|||
124796450|NCT03569293|448885836|FG004|Overall Study|Withdrawal by Subject|0|||
124796451|NCT03569293|448885837|FG005|Overall Study|Withdrawal by Subject|0|||
124796452|NCT03569293|448885832|FG000|Overall Study|Lost to Follow-up|1|||
124796453|NCT03569293|448885833|FG001|Overall Study|Lost to Follow-up|3|||
124796454|NCT03569293|448885834|FG002|Overall Study|Lost to Follow-up|1|||
124796455|NCT03569293|448885835|FG003|Overall Study|Lost to Follow-up|1|||
124796456|NCT03569293|448885836|FG004|Overall Study|Lost to Follow-up|0|||
124796457|NCT03569293|448885837|FG005|Overall Study|Lost to Follow-up|0|||
124796458|NCT03569293|448885832|FG000|Overall Study|Other|8|||
124796459|NCT03569293|448885833|FG001|Overall Study|Other|2|||
124796460|NCT03569293|448885834|FG002|Overall Study|Other|1|||
124796461|NCT03569293|448885835|FG003|Overall Study|Other|1|||
124796462|NCT03569293|448885836|FG004|Overall Study|Other|0|||
124796463|NCT03569293|448885837|FG005|Overall Study|Other|0|||
124796464|NCT03569293|448885832|FG000|Overall Study|Ongoing at Time of Analysis|8|||
124796465|NCT03569293|448885833|FG001|Overall Study|Ongoing at Time of Analysis|1|||
124796466|NCT03569293|448885834|FG002|Overall Study|Ongoing at Time of Analysis|3|||
124796467|NCT03569293|448885835|FG003|Overall Study|Ongoing at Time of Analysis|0|||
124796468|NCT03569293|448885836|FG004|Overall Study|Ongoing at Time of Analysis|0|||
124796469|NCT03569293|448885837|FG005|Overall Study|Ongoing at Time of Analysis|0|||
124796470|NCT03553836|448885839|FG000|Overall Study|Ongoing in Study|460|||
124796471|NCT03553836|448885840|FG001|Overall Study|Ongoing in Study|459|||
124796472|NCT03553836|448885839|FG000|Overall Study|Withdrawal by Subject|9|||
124796473|NCT03553836|448885840|FG001|Overall Study|Withdrawal by Subject|10|||
124796474|NCT03553836|448885839|FG000|Overall Study|Lost to Follow-up|1|||
124796475|NCT03553836|448885840|FG001|Overall Study|Lost to Follow-up|3|||
124796476|NCT03553836|448885839|FG000|Overall Study|Death|17|||
124796477|NCT03553836|448885840|FG001|Overall Study|Death|17|||
124796478|NCT04062123|448885841|FG000|Overall Study|Withdrawal by Subject|0|||
124796479|NCT04062123|448885842|FG001|Overall Study|Withdrawal by Subject|1|||
124796480|NCT04062123|448885843|FG002|Overall Study|Withdrawal by Subject|0|||
124796481|NCT01041495|448885844|FG000|Overall Study|Withdrawal by Subject|2|||
124796482|NCT01041495|448885845|FG001|Overall Study|Withdrawal by Subject|5|||
124796483|NCT01041495|448885844|FG000|Overall Study|Adverse Event|2|||
124796484|NCT01041495|448885845|FG001|Overall Study|Adverse Event|1|||
124796485|NCT01041495|448885844|FG000|Overall Study|Lost to Follow-up|0|||
124796486|NCT01041495|448885845|FG001|Overall Study|Lost to Follow-up|1|||
124796487|NCT03780400|448885849|FG000|Overall Study|Lost to Follow-up|5|||
124796488|NCT03780400|448885849|FG000|Overall Study|Withdrawal by Subject|2|||
124796489|NCT01479985|448885850|FG000|Overall Study|Tablet malfunction, no data saved|1|||
124796490|NCT01479985|448885851|FG001|Overall Study|Tablet malfunction, no data saved|1|||
124796491|NCT01479985|448885850|FG000|Overall Study|No decisional conflict scale responses|0|||
124796492|NCT01479985|448885851|FG001|Overall Study|No decisional conflict scale responses|2|||
124796493|NCT01479985|448885850|FG000|Overall Study|No post-visit survey|5|||
124796494|NCT01479985|448885851|FG001|Overall Study|No post-visit survey|3|||
124796495|NCT01653782|448885852|FG000|Overall Study|Withdrawal by Subject|9|||
124796496|NCT01653782|448885853|FG001|Overall Study|Withdrawal by Subject|15|||
124796497|NCT01653782|448885854|FG002|Overall Study|Withdrawal by Subject|4|||
124796498|NCT01653782|448885852|FG000|Overall Study|Lost to Follow-up|7|||
124796499|NCT01653782|448885853|FG001|Overall Study|Lost to Follow-up|3|||
124796500|NCT01653782|448885854|FG002|Overall Study|Lost to Follow-up|2|||
124796501|NCT01142128|448885855|FG000|Overall Study|Physician Decision|1|||
124796502|NCT01142128|448885855|FG000|Overall Study|Lost to Follow-up|1|||
124796503|NCT01142128|448885855|FG000|Overall Study|Withdrawal by Subject|2|||
124796504|NCT00442468|448885856|FG000|Overall Study|Adverse Event|4|||
124796505|NCT00442468|448885856|FG000|Overall Study|Withdrawal by Subject|91|||
124796506|NCT00442468|448885856|FG000|Overall Study|Did not complete all study procedures|88|||
124796507|NCT05867342|448885859|FG000|Overall Study|Investigator Decision|3|||
124796508|NCT05867342|448885860|FG001|Overall Study|Investigator Decision|3|||
124796509|NCT00470184|448885861|FG000|Overall Study|Not Treated(became ineligible)|4|||
124796510|NCT00470184|448885861|FG000|Overall Study|Not treated (other)|1|||
124796511|NCT00470184|448885861|FG000|Overall Study|disease Progression|4|||
124796512|NCT00470184|448885861|FG000|Overall Study|Adverse Event|3|||
124796513|NCT00470184|448885861|FG000|Overall Study|Withdrawal by Subject|4|||
124796514|NCT00470184|448885861|FG000|Overall Study|other|5|||
124796515|NCT00470184|448885861|FG000|Overall Study|recurrence|1|||
124796516|NCT05442775|448885862|FG000|Overall Study|Trial terminated|61|||
124796517|NCT05442775|448885862|FG000|Overall Study|Lack of Efficacy|4|||
124796518|NCT05442775|448885862|FG000|Overall Study|Withdrawal by Subject|4|||
124796519|NCT05442775|448885862|FG000|Overall Study|Death|1|||
124796520|NCT05442775|448885862|FG000|Overall Study|Participant removed at Sponsor request|1|||
124796521|NCT00058539|448885864|FG000|Overall Study|Disease progression|24|||
124796522|NCT00058539|448885864|FG000|Overall Study|Adverse Event|3|||
124796523|NCT00058539|448885864|FG000|Overall Study|Withdrawal by Subject|5|||
124796524|NCT00058539|448885864|FG000|Overall Study|Physician Decision|9|||
124796525|NCT00058539|448885864|FG000|Overall Study|Death|1|||
124796526|NCT03190369|448885865|FG000|Overall Study|Poor compliance to protocol|0|||
124796527|NCT03190369|448885866|FG001|Overall Study|Poor compliance to protocol|1|||
124796528|NCT03190369|448885865|FG000|Overall Study|Withdraw before treatment|1|||
124796529|NCT03190369|448885866|FG001|Overall Study|Withdraw before treatment|5|||
124796530|NCT03190369|448885865|FG000|Overall Study|Randomized but not treated|0|||
124796531|NCT03190369|448885866|FG001|Overall Study|Randomized but not treated|2|||
124796532|NCT02963831|448885867|FG000|Overall Study|Progressive Disease|3|||
124796533|NCT02963831|448885868|FG001|Overall Study|Progressive Disease|3|||
124796534|NCT02963831|448885869|FG002|Overall Study|Progressive Disease|16|||
124796535|NCT02963831|448885870|FG003|Overall Study|Progressive Disease|27|||
124796536|NCT02963831|448885867|FG000|Overall Study|Withdrawal by Subject|1|||
124796537|NCT02963831|448885868|FG001|Overall Study|Withdrawal by Subject|0|||
124796538|NCT02963831|448885869|FG002|Overall Study|Withdrawal by Subject|2|||
124796539|NCT02963831|448885870|FG003|Overall Study|Withdrawal by Subject|4|||
124796540|NCT02963831|448885867|FG000|Overall Study|Adverse Event|0|||
124796541|NCT02963831|448885868|FG001|Overall Study|Adverse Event|1|||
124796542|NCT02963831|448885869|FG002|Overall Study|Adverse Event|1|||
124796543|NCT02963831|448885870|FG003|Overall Study|Adverse Event|2|||
124796544|NCT02963831|448885867|FG000|Overall Study|Death|0|||
124796545|NCT02963831|448885868|FG001|Overall Study|Death|0|||
124796546|NCT02963831|448885869|FG002|Overall Study|Death|0|||
124796547|NCT02963831|448885870|FG003|Overall Study|Death|2|||
124796548|NCT04543409|448885871|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
124796549|NCT04543409|448885872|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
124796550|NCT04543409|448885871|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
124796551|NCT04543409|448885872|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
124796552|NCT04543409|448885871|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
124796553|NCT04543409|448885872|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
124796554|NCT04543409|448885871|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
124796555|NCT04543409|448885872|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
124796556|NCT04543409|448885871|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
124796557|NCT04543409|448885872|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
124796558|NCT04543409|448885871|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
124796559|NCT04543409|448885872|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
124796560|NCT04543409|448885871|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
124796561|NCT04543409|448885872|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
124796562|NCT04543409|448885871|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
124796563|NCT04543409|448885872|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
124796564|NCT04543409|448885871|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
124796565|NCT04543409|448885872|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
124796566|NCT04543409|448885871|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
124796567|NCT04543409|448885872|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
124796568|NCT04543409|448885871|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
124796569|NCT04543409|448885872|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
124796570|NCT01923168|448885873|FG000|Overall Study|Protocol Violation|1|||
124796571|NCT01923168|448885874|FG001|Overall Study|Protocol Violation|1|||
124796572|NCT01923168|448885875|FG002|Overall Study|Protocol Violation|0|||
124796573|NCT01923168|448885873|FG000|Overall Study|Subject/guardian decision|14|||
124796574|NCT01923168|448885874|FG001|Overall Study|Subject/guardian decision|14|||
124796575|NCT01923168|448885875|FG002|Overall Study|Subject/guardian decision|4|||
124796576|NCT01923168|448885873|FG000|Overall Study|Adverse Event|12|||
124796577|NCT01923168|448885874|FG001|Overall Study|Adverse Event|12|||
124796578|NCT01923168|448885875|FG002|Overall Study|Adverse Event|0|||
124796579|NCT01923168|448885873|FG000|Overall Study|Physician Decision|6|||
124796580|NCT01923168|448885874|FG001|Overall Study|Physician Decision|9|||
124796581|NCT01923168|448885875|FG002|Overall Study|Physician Decision|5|||
124796582|NCT01923168|448885873|FG000|Overall Study|Progressive disease|4|||
124796583|NCT01923168|448885874|FG001|Overall Study|Progressive disease|3|||
124796584|NCT01923168|448885875|FG002|Overall Study|Progressive disease|7|||
124796585|NCT01923168|448885873|FG000|Overall Study|Death|0|||
124796586|NCT01923168|448885874|FG001|Overall Study|Death|0|||
124796587|NCT01923168|448885875|FG002|Overall Study|Death|1|||
124796588|NCT03418571|448885876|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
124796589|NCT03418571|448885877|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
124796590|NCT03882008|448885878|FG000|Overall Study|Withdrawal by Subject|1|||
124796591|NCT03882008|448885878|FG000|Overall Study|Lost to Follow-up|1|||
124796592|NCT04341662|448885879|FG000|Overall Study|Did not have source-verified blood loss data|423|||
124796593|NCT04341662|448885880|FG001|Overall Study|Did not have source-verified blood loss data|514|||
124796594|NCT03101267|448885881|FG000|Primary Study Period|Withdrawal by Subject|1|||
124796595|NCT03101267|448885882|FG001|Primary Study Period|Withdrawal by Subject|2|||
124796596|NCT03101267|448885883|FG002|Primary Study Period|Withdrawal by Subject|3|||
124796597|NCT03101267|448885881|FG000|Primary Study Period|Miscellaneous|2|||
124796598|NCT03101267|448885882|FG001|Primary Study Period|Miscellaneous|0|||
124796599|NCT03101267|448885883|FG002|Primary Study Period|Miscellaneous|0|||
124796600|NCT01222403|448885884|FG000|Overall Study|Inappropriate enrollment|0|||
124796601|NCT01222403|448885885|FG001|Overall Study|Inappropriate enrollment|2|||
124796602|NCT01262352|448885887|FG000|Period 1|Illness after randomization|1|||
124796603|NCT01262352|448885888|FG001|Period 1|Illness after randomization|0|||
124796604|NCT01262352|448885887|FG000|Washout|Adverse Event|1|||
124796605|NCT01262352|448885888|FG001|Washout|Adverse Event|1|||
124796606|NCT01262352|448885887|FG000|Washout|Extended Washout|0|||
124796607|NCT01262352|448885888|FG001|Washout|Extended Washout|1|||
124796608|NCT02045303|448885889|FG000|Overall Study|Protocol Violation|2|||
124796609|NCT02045303|448885890|FG001|Overall Study|Protocol Violation|1|||
124796610|NCT02045303|448885891|FG002|Overall Study|Protocol Violation|0|||
124796611|NCT02045303|448885889|FG000|Overall Study|Withdrawal by Subject|0|||
124796612|NCT02045303|448885890|FG001|Overall Study|Withdrawal by Subject|2|||
124796613|NCT02045303|448885891|FG002|Overall Study|Withdrawal by Subject|0|||
124796614|NCT01642407|448885892|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
124796615|NCT01642407|448885892|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
124796616|NCT01642407|448885892|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
124796617|NCT03533686|448885893|FG000|Overall Study|Withdrawal by Subject|1|||
124796618|NCT03533686|448885894|FG001|Overall Study|Withdrawal by Subject|0|||
124796619|NCT03533686|448885895|FG002|Overall Study|Withdrawal by Subject|0|||
124796620|NCT03533686|448885896|FG003|Overall Study|Withdrawal by Subject|3|||
124796621|NCT03533686|448885897|FG004|Overall Study|Withdrawal by Subject|5|||
124796622|NCT03533686|448885898|FG005|Overall Study|Withdrawal by Subject|1|||
124796623|NCT03533686|448885893|FG000|Overall Study|Lost to Follow-up|0|||
124796624|NCT03533686|448885894|FG001|Overall Study|Lost to Follow-up|1|||
124796625|NCT03533686|448885895|FG002|Overall Study|Lost to Follow-up|0|||
124796626|NCT03533686|448885896|FG003|Overall Study|Lost to Follow-up|0|||
124796627|NCT03533686|448885897|FG004|Overall Study|Lost to Follow-up|2|||
124796628|NCT03533686|448885898|FG005|Overall Study|Lost to Follow-up|0|||
124796629|NCT03533686|448885893|FG000|Overall Study|Screen Failure|0|||
124796630|NCT03533686|448885894|FG001|Overall Study|Screen Failure|0|||
124796631|NCT03533686|448885895|FG002|Overall Study|Screen Failure|0|||
124796632|NCT03533686|448885896|FG003|Overall Study|Screen Failure|2|||
124796633|NCT03533686|448885897|FG004|Overall Study|Screen Failure|0|||
124796634|NCT03533686|448885898|FG005|Overall Study|Screen Failure|0|||
124796635|NCT00245583|448885901|FG000|Overall Study|Lost to Follow-up|1|||
124796636|NCT00245583|448885902|FG001|Overall Study|Lost to Follow-up|5|||
124796637|NCT00245583|448885901|FG000|Overall Study|Adverse Event|2|||
124796638|NCT00245583|448885902|FG001|Overall Study|Adverse Event|1|||
124796639|NCT00245583|448885901|FG000|Overall Study|Lack of Efficacy|1|||
124796640|NCT00245583|448885902|FG001|Overall Study|Lack of Efficacy|0|||
124796641|NCT00245583|448885901|FG000|Overall Study|Withdrawal by Subject|2|||
124796642|NCT00245583|448885902|FG001|Overall Study|Withdrawal by Subject|3|||
124796643|NCT00829283|448885903|FG000|Overall Study|Lost to Follow-up|7|||
124796644|NCT00829283|448885904|FG001|Overall Study|Lost to Follow-up|25|||
124796645|NCT00591578|448885907|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
124796646|NCT00591578|448885908|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
124796647|NCT00591578|448885909|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
124796648|NCT00591578|448885907|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
124796649|NCT00591578|448885908|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
124796650|NCT00591578|448885909|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
124796651|NCT00591578|448885907|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
124796652|NCT00591578|448885908|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
124796653|NCT00591578|448885909|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
124796654|NCT00591578|448885907|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
124796655|NCT00591578|448885908|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
124796656|NCT00591578|448885909|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
124796657|NCT00591578|448885907|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
124796658|NCT00591578|448885908|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
124796659|NCT00591578|448885909|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
124796660|NCT00591578|448885907|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
124796661|NCT00591578|448885908|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
124796662|NCT00591578|448885909|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
124796663|NCT00591578|448885907|FG000|Double-Blind Treatment Phase|Other|4|||
124796664|NCT00591578|448885908|FG001|Double-Blind Treatment Phase|Other|9|||
124796665|NCT00591578|448885909|FG002|Double-Blind Treatment Phase|Other|4|||
124796666|NCT00591578|448885907|FG000|Open-Label Extension Phase|Adverse Event|3|||
124796667|NCT00591578|448885908|FG001|Open-Label Extension Phase|Adverse Event|5|||
124796668|NCT00591578|448885909|FG002|Open-Label Extension Phase|Adverse Event|0|||
124796669|NCT00591578|448885907|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
124796670|NCT00591578|448885908|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
124796671|NCT00591578|448885909|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
124796672|NCT00591578|448885907|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
124796673|NCT00591578|448885908|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
124796674|NCT00591578|448885909|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
124796675|NCT00591578|448885907|FG000|Open-Label Extension Phase|Other|1|||
124796676|NCT00591578|448885908|FG001|Open-Label Extension Phase|Other|0|||
124796677|NCT00591578|448885909|FG002|Open-Label Extension Phase|Other|0|||
124796678|NCT03945175|448885910|FG000|Overall Study|Did not meet inclusion criteria|31|||
124796679|NCT03945175|448885910|FG000|Overall Study|Withdrew consent|2|||
124796680|NCT03945175|448885910|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
124796681|NCT03945175|448885910|FG000|Overall Study|Early termination during Mydayis treatment|1|||
124796682|NCT00870233|448885911|FG000|Overall Study|Withdrawal by Subject|18|||
124796683|NCT00870233|448885911|FG000|Overall Study|Did not undergo laparotomy|3|||
124796684|NCT00870233|448885911|FG000|Overall Study|Incompatible internet browser|2|||
124796685|NCT00870233|448885911|FG000|Overall Study|Death|1|||
124796686|NCT00378079|448885912|FG000|Overall Study|Lost to Follow-up|6|||
124796687|NCT00378079|448885913|FG001|Overall Study|Lost to Follow-up|1|||
124796688|NCT00378079|448885914|FG002|Overall Study|Lost to Follow-up|0|||
124796689|NCT00006389|448885915|FG000|Overall Study|Adverse Event|1|||
124796690|NCT01445886|448885924|FG000|Overall Study|Lost to Follow-up|2|||
124796691|NCT01445886|448885924|FG000|Overall Study|Protocol Violation|3|||
124796692|NCT03500679|448885925|FG000|Overall Study|Lost to Follow-up|6|||
124796693|NCT03500679|448885926|FG001|Overall Study|Lost to Follow-up|3|||
124796694|NCT03500679|448885925|FG000|Overall Study|Withdrawal by Subject|3|||
124796695|NCT03500679|448885926|FG001|Overall Study|Withdrawal by Subject|0|||
124796696|NCT01962922|448885927|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
124796697|NCT01962922|448885928|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
124796698|NCT01962922|448885927|FG000|PK Portion Day 7|non-compliance|1|||
124796699|NCT01962922|448885928|FG001|PK Portion Day 7|non-compliance|0|||
124796700|NCT01962922|448885927|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
124796701|NCT01962922|448885928|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
124796702|NCT01962922|448885927|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
124796703|NCT01962922|448885928|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
124796704|NCT03224546|448885929|FG000|Overall Study|Lost to Follow-up|9|||
124796705|NCT03224546|448885930|FG001|Overall Study|Lost to Follow-up|8|||
124796706|NCT03224546|448885931|FG002|Overall Study|Lost to Follow-up|3|||
124796707|NCT03224546|448885929|FG000|Overall Study|Withdrawal by Subject|7|||
124796708|NCT03224546|448885930|FG001|Overall Study|Withdrawal by Subject|14|||
124796709|NCT03224546|448885931|FG002|Overall Study|Withdrawal by Subject|12|||
124796710|NCT02730208|448885932|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
124796711|NCT02730208|448885933|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
124796712|NCT00510952|448885939|FG000|Overall Study|Adverse Event|1|||
124796713|NCT00510952|448885940|FG001|Overall Study|Adverse Event|0|||
124796714|NCT00510952|448885939|FG000|Overall Study|Entry Criteria Not Met|3|||
124796715|NCT00510952|448885940|FG001|Overall Study|Entry Criteria Not Met|1|||
124796716|NCT00510952|448885939|FG000|Overall Study|Lost to Follow-up|5|||
124796717|NCT00510952|448885940|FG001|Overall Study|Lost to Follow-up|3|||
124796718|NCT00510952|448885939|FG000|Overall Study|Physician Decision|1|||
124796719|NCT00510952|448885940|FG001|Overall Study|Physician Decision|1|||
124796720|NCT00510952|448885939|FG000|Overall Study|Protocol Violation|7|||
124796721|NCT00510952|448885940|FG001|Overall Study|Protocol Violation|4|||
124796722|NCT00510952|448885939|FG000|Overall Study|Sponsor Decision|1|||
124796723|NCT00510952|448885940|FG001|Overall Study|Sponsor Decision|0|||
124796724|NCT00510952|448885939|FG000|Overall Study|Withdrawal by Subject|6|||
124796725|NCT00510952|448885940|FG001|Overall Study|Withdrawal by Subject|7|||
124796726|NCT00510952|448885939|FG000|Overall Study|Did Not Receive Study Drug|2|||
124796727|NCT00510952|448885940|FG001|Overall Study|Did Not Receive Study Drug|0|||
124796728|NCT02793128|448885945|FG000|Overall Study|Death|4|||
124796729|NCT02793128|448885945|FG000|Overall Study|Withdrawal by Subject|2|||
124796730|NCT02793128|448885945|FG000|Overall Study|Physician Decision|1|||
124796731|NCT02793128|448885945|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
124796732|NCT02793128|448885945|FG000|Overall Study|Patient elected nephroureterectomy|1|||
124796733|NCT03287635|448885949|FG000|Overall Study|Lost to Follow-up|5|||
124796734|NCT03287635|448885949|FG000|Overall Study|Withdrawal by Subject|1|||
124796735|NCT03287635|448885949|FG000|Overall Study|Physician Decision|1|||
124796736|NCT03670836|448885950|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
124796737|NCT03670836|448885951|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
124796738|NCT03670836|448885950|FG000|Per Protocol Population (PP)|Physician Decision|9|||
124796739|NCT03670836|448885951|FG001|Per Protocol Population (PP)|Physician Decision|10|||
124796740|NCT03670836|448885950|FG000|Per Protocol Population (PP)|Physician Decision|4|||
124796741|NCT03670836|448885951|FG001|Per Protocol Population (PP)|Physician Decision|6|||
124796742|NCT03670836|448885950|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
124796743|NCT03670836|448885951|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
124796744|NCT04285580|448887944|FG000|Overall Study|Protocol Violation|0|||
124796745|NCT04285580|448887945|FG001|Overall Study|Protocol Violation|1|||
124796746|NCT02582255|448887946|FG000|Overall Study|Protocol Violation|0|||
124796747|NCT02582255|448887947|FG001|Overall Study|Protocol Violation|3|||
124796748|NCT04854642|448887948|FG000|Overall Study|Adverse Event|1|||
124796749|NCT04854642|448887949|FG001|Overall Study|Adverse Event|2|||
124796750|NCT04854642|448887948|FG000|Overall Study|Withdrawal by Subject|0|||
124796751|NCT04854642|448887949|FG001|Overall Study|Withdrawal by Subject|1|||
124796752|NCT01107418|448887951|FG000|Overall Study|Disease Progression|45|||
124796753|NCT01107418|448887951|FG000|Overall Study|Adverse Event|3|||
124796754|NCT01107418|448887951|FG000|Overall Study|Withdrawal by Subject|1|||
124796755|NCT01107418|448887951|FG000|Overall Study|Study Closing|1|||
124796756|NCT01107418|448887951|FG000|Overall Study|Started Other Therapy|1|||
124796757|NCT01107418|448887951|FG000|Overall Study|Entered Extension Study|1|||
124796758|NCT00597701|448887952|FG000|Overall Study|Withdrawal by Subject|5|||
124796759|NCT00597701|448887953|FG001|Overall Study|Withdrawal by Subject|5|||
124796760|NCT00597701|448887952|FG000|Overall Study|Death|0|||
124796761|NCT00597701|448887953|FG001|Overall Study|Death|1|||
124796762|NCT00597701|448887952|FG000|Overall Study|Physician Decision|2|||
124796763|NCT00597701|448887953|FG001|Overall Study|Physician Decision|0|||
124796764|NCT00597701|448887952|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
124796765|NCT00597701|448887953|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
124796766|NCT00076024|448887956|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
124796767|NCT00076024|448887957|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
124796768|NCT00076024|448887958|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
124796769|NCT00076024|448887959|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
124796770|NCT00076024|448887956|FG000|Phase 1, Lead-in|Adverse Event|1|||
124796771|NCT00076024|448887957|FG001|Phase 1, Lead-in|Adverse Event|0|||
124796772|NCT00076024|448887958|FG002|Phase 1, Lead-in|Adverse Event|0|||
124796773|NCT00076024|448887959|FG003|Phase 1, Lead-in|Adverse Event|0|||
124796774|NCT00076024|448887956|FG000|Phase 1, Lead-in|Clinical progression|1|||
124796775|NCT00076024|448887957|FG001|Phase 1, Lead-in|Clinical progression|0|||
124796776|NCT00076024|448887958|FG002|Phase 1, Lead-in|Clinical progression|0|||
124796777|NCT00076024|448887959|FG003|Phase 1, Lead-in|Clinical progression|0|||
124796778|NCT00076024|448887956|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
124796779|NCT00076024|448887957|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
124796780|NCT00076024|448887958|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
124796781|NCT00076024|448887959|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
124796782|NCT00076024|448887956|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
124796783|NCT00076024|448887957|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
124796784|NCT00076024|448887958|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
124796785|NCT00076024|448887959|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
124796786|NCT00076024|448887956|FG000|Phase 2, Double-blind|Adverse Event|0|||
124796787|NCT00076024|448887957|FG001|Phase 2, Double-blind|Adverse Event|25|||
124796788|NCT00076024|448887958|FG002|Phase 2, Double-blind|Adverse Event|6|||
124796789|NCT00076024|448887959|FG003|Phase 2, Double-blind|Adverse Event|0|||
124796790|NCT00076024|448887956|FG000|Phase 2, Double-blind|Un-specified|0|||
124796791|NCT00076024|448887957|FG001|Phase 2, Double-blind|Un-specified|14|||
124796792|NCT00076024|448887958|FG002|Phase 2, Double-blind|Un-specified|6|||
124796793|NCT00076024|448887959|FG003|Phase 2, Double-blind|Un-specified|0|||
124796794|NCT00076024|448887956|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
124796795|NCT00076024|448887957|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
124796796|NCT00076024|448887958|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
124796797|NCT00076024|448887959|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
124796798|NCT00076024|448887956|FG000|Phase 2, Open-label|Adverse Event|0|||
124796799|NCT00076024|448887957|FG001|Phase 2, Open-label|Adverse Event|0|||
124796800|NCT00076024|448887958|FG002|Phase 2, Open-label|Adverse Event|0|||
124796801|NCT00076024|448887959|FG003|Phase 2, Open-label|Adverse Event|2|||
124796802|NCT00076024|448887956|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
124796803|NCT00076024|448887957|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
124796804|NCT00076024|448887958|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
124796805|NCT00076024|448887959|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
124796806|NCT00076024|448887956|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
124796807|NCT00076024|448887957|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
124796808|NCT00076024|448887958|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
124796809|NCT00076024|448887959|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
124796810|NCT00076024|448887956|FG000|Phase 2, Open-label|Other|0|||
124796811|NCT00076024|448887957|FG001|Phase 2, Open-label|Other|0|||
124796812|NCT00076024|448887958|FG002|Phase 2, Open-label|Other|0|||
124796813|NCT00076024|448887959|FG003|Phase 2, Open-label|Other|2|||
124796814|NCT01155219|448887963|FG000|Overall Study|Adverse Event|3|||
124796815|NCT01155219|448887964|FG001|Overall Study|Adverse Event|1|||
124796816|NCT01155219|448887963|FG000|Overall Study|non-medical reason|1|||
124796817|NCT01155219|448887964|FG001|Overall Study|non-medical reason|2|||
124796818|NCT00301821|448887966|FG000|Overall Study|Ineligible|25|||
124796819|NCT00301821|448887966|FG000|Overall Study|Cancel|1|||
124796820|NCT04078178|448887971|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
124796821|NCT04078178|448887972|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
124796822|NCT04078178|448887971|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
124796823|NCT04078178|448887972|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
124796824|NCT04078178|448887971|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
124796825|NCT04078178|448887972|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
124796826|NCT04078178|448887971|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
124796827|NCT04078178|448887972|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
124796828|NCT04078178|448887971|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
124796829|NCT04078178|448887972|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
124796830|NCT04006119|448887973|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
124796831|NCT04006119|448887973|FG000|End of Treatment Veledimex|Adverse Event|2|||
124796832|NCT04006119|448887973|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
124796833|NCT04006119|448887973|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
124796834|NCT04006119|448887973|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
124796835|NCT04006119|448887973|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
124796836|NCT00472459|448887974|FG000|Overall Study|Adverse Event|13|||
124796837|NCT00472459|448887975|FG001|Overall Study|Adverse Event|13|||
124796838|NCT00472459|448887974|FG000|Overall Study|Withdrawal by Subject|5|||
124796839|NCT00472459|448887975|FG001|Overall Study|Withdrawal by Subject|5|||
124796840|NCT00472459|448887974|FG000|Overall Study|Protocol Violation|3|||
124796841|NCT00472459|448887975|FG001|Overall Study|Protocol Violation|3|||
124796842|NCT00472459|448887974|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
124796843|NCT00472459|448887975|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
124796844|NCT00472459|448887974|FG000|Overall Study|Lost to Follow-up|1|||
124796845|NCT00472459|448887975|FG001|Overall Study|Lost to Follow-up|1|||
124796846|NCT03981822|448887980|FG000|Overall Study|Lost to Follow-up|0|||
124796847|NCT03981822|448887981|FG001|Overall Study|Lost to Follow-up|1|||
124796848|NCT03981822|448887982|FG002|Overall Study|Lost to Follow-up|1|||
124796849|NCT03981822|448887983|FG003|Overall Study|Lost to Follow-up|0|||
124796850|NCT03981822|448887984|FG004|Overall Study|Lost to Follow-up|6|||
124796851|NCT03981822|448887985|FG005|Overall Study|Lost to Follow-up|4|||
124796852|NCT03981822|448887986|FG006|Overall Study|Lost to Follow-up|4|||
124796853|NCT03981822|448887987|FG007|Overall Study|Lost to Follow-up|2|||
124796854|NCT03981822|448887980|FG000|Overall Study|Withdrawal by Subject|0|||
124796855|NCT03981822|448887981|FG001|Overall Study|Withdrawal by Subject|1|||
124796856|NCT03981822|448887982|FG002|Overall Study|Withdrawal by Subject|0|||
124796857|NCT03981822|448887983|FG003|Overall Study|Withdrawal by Subject|0|||
124796858|NCT03981822|448887984|FG004|Overall Study|Withdrawal by Subject|0|||
124796859|NCT03981822|448887985|FG005|Overall Study|Withdrawal by Subject|1|||
124796860|NCT03981822|448887986|FG006|Overall Study|Withdrawal by Subject|0|||
124796861|NCT03981822|448887987|FG007|Overall Study|Withdrawal by Subject|2|||
124796862|NCT03981822|448887980|FG000|Overall Study|COVID-19 Related|0|||
124796863|NCT03981822|448887981|FG001|Overall Study|COVID-19 Related|0|||
124796864|NCT03981822|448887982|FG002|Overall Study|COVID-19 Related|0|||
124796865|NCT03981822|448887983|FG003|Overall Study|COVID-19 Related|0|||
124796866|NCT03981822|448887984|FG004|Overall Study|COVID-19 Related|2|||
124796867|NCT03981822|448887985|FG005|Overall Study|COVID-19 Related|1|||
124796868|NCT03981822|448887986|FG006|Overall Study|COVID-19 Related|2|||
124796869|NCT03981822|448887987|FG007|Overall Study|COVID-19 Related|1|||
124796870|NCT06460493|448887988|FG000|Overall Study|Withdrawal by Subject|2|||
124796871|NCT03489551|448887991|FG000|Overall Study|Withdrawal by Subject|2|||
124796872|NCT02987660|448887994|FG000|Overall Study|Study terminated by sponsor|10|||
124796873|NCT02987660|448887995|FG001|Overall Study|Study terminated by sponsor|10|||
124796874|NCT00054717|448887996|FG000|Overall Study|Randomized but not treated|2|||
124796875|NCT00054717|448887997|FG001|Overall Study|Randomized but not treated|8|||
124796876|NCT00054717|448887996|FG000|Overall Study|Adverse Event|70|||
124796877|NCT00054717|448887997|FG001|Overall Study|Adverse Event|22|||
124796878|NCT00054717|448887996|FG000|Overall Study|Protocol Violation|18|||
124796879|NCT00054717|448887997|FG001|Overall Study|Protocol Violation|19|||
124796880|NCT00054717|448887996|FG000|Overall Study|Lost to Follow-up|23|||
124796881|NCT00054717|448887997|FG001|Overall Study|Lost to Follow-up|13|||
124796882|NCT00054717|448887996|FG000|Overall Study|Withdrawal by Subject|32|||
124796883|NCT00054717|448887997|FG001|Overall Study|Withdrawal by Subject|20|||
124796884|NCT00054717|448887996|FG000|Overall Study|Other reason not defined above|117|||
124796885|NCT00054717|448887997|FG001|Overall Study|Other reason not defined above|217|||
124796886|NCT03707184|448887998|FG000|Overall Study|Withdrawal by Subject|2|||
124796887|NCT04704154|448887999|FG000|Overall Study|Adverse Event|3|||
124796888|NCT04704154|448888000|FG001|Overall Study|Adverse Event|2|||
124796889|NCT04704154|448888001|FG002|Overall Study|Adverse Event|4|||
124796890|NCT04704154|448888002|FG003|Overall Study|Adverse Event|2|||
124796891|NCT04704154|448888003|FG004|Overall Study|Adverse Event|3|||
124796892|NCT04704154|448888004|FG005|Overall Study|Adverse Event|0|||
124796893|NCT04704154|448887999|FG000|Overall Study|Death|3|||
124796894|NCT04704154|448888000|FG001|Overall Study|Death|0|||
124796895|NCT04704154|448888001|FG002|Overall Study|Death|0|||
124796896|NCT04704154|448888002|FG003|Overall Study|Death|0|||
124796897|NCT04704154|448888003|FG004|Overall Study|Death|3|||
124796898|NCT04704154|448888004|FG005|Overall Study|Death|0|||
124796899|NCT04704154|448887999|FG000|Overall Study|Physician Decision|1|||
124796900|NCT04704154|448888000|FG001|Overall Study|Physician Decision|0|||
124796901|NCT04704154|448888001|FG002|Overall Study|Physician Decision|1|||
124796902|NCT04704154|448888002|FG003|Overall Study|Physician Decision|0|||
124796903|NCT04704154|448888003|FG004|Overall Study|Physician Decision|2|||
124796904|NCT04704154|448888004|FG005|Overall Study|Physician Decision|0|||
124796905|NCT04704154|448887999|FG000|Overall Study|Participant Decision|1|||
124796906|NCT04704154|448888000|FG001|Overall Study|Participant Decision|1|||
124796907|NCT04704154|448888001|FG002|Overall Study|Participant Decision|0|||
124796908|NCT04704154|448888002|FG003|Overall Study|Participant Decision|0|||
124796909|NCT04704154|448888003|FG004|Overall Study|Participant Decision|0|||
124796910|NCT04704154|448888004|FG005|Overall Study|Participant Decision|0|||
124796911|NCT04704154|448887999|FG000|Overall Study|Progressive Disease|19|||
124796912|NCT04704154|448888000|FG001|Overall Study|Progressive Disease|17|||
124796913|NCT04704154|448888001|FG002|Overall Study|Progressive Disease|20|||
124796914|NCT04704154|448888002|FG003|Overall Study|Progressive Disease|18|||
124796915|NCT04704154|448888003|FG004|Overall Study|Progressive Disease|36|||
124796916|NCT04704154|448888004|FG005|Overall Study|Progressive Disease|30|||
124796917|NCT04704154|448887999|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
124819539|NCT05147350|448965752|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
124796918|NCT04704154|448888000|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
124796919|NCT04704154|448888001|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
124796920|NCT04704154|448888002|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
124796921|NCT04704154|448888003|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
124796922|NCT04704154|448888004|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
124796923|NCT04704154|448887999|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
124796924|NCT04704154|448888000|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
124796925|NCT04704154|448888001|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
124796926|NCT04704154|448888002|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
124796927|NCT04704154|448888003|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
124796928|NCT04704154|448888004|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
124796929|NCT04251156|448888005|FG000|Overall Study|Lost to Follow-up|1|||
124796930|NCT04251156|448888006|FG001|Overall Study|Lost to Follow-up|1|||
124796931|NCT04251156|448888005|FG000|Overall Study|Withdrawal by Subject|4|||
124796932|NCT04251156|448888006|FG001|Overall Study|Withdrawal by Subject|4|||
124796933|NCT04209426|448888007|FG000|Overall Study|Lost to Follow-up|3|||
124796934|NCT04209426|448888008|FG001|Overall Study|Lost to Follow-up|2|||
124796935|NCT04423939|448888009|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
124796936|NCT04423939|448888010|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
124796937|NCT04423939|448888009|FG000|Overall Study|Death|3|||
124796938|NCT04423939|448888010|FG001|Overall Study|Death|0|||
124796939|NCT04423939|448888009|FG000|Overall Study|Withdrawal by Subject|3|||
124796940|NCT04423939|448888010|FG001|Overall Study|Withdrawal by Subject|0|||
124796941|NCT04423939|448888009|FG000|Overall Study|Caregiver to patient who died|0|||
124796942|NCT04423939|448888010|FG001|Overall Study|Caregiver to patient who died|3|||
124796943|NCT04423939|448888009|FG000|Overall Study|Caregiver to patient who withdrew|0|||
124796944|NCT04423939|448888010|FG001|Overall Study|Caregiver to patient who withdrew|3|||
124796945|NCT04626310|448888013|FG000|Overall Study|4-miss from treatment|6|||
124796946|NCT04626310|448888014|FG001|Overall Study|4-miss from treatment|5|||
124796947|NCT04626310|448888015|FG002|Overall Study|4-miss from treatment|5|||
124796948|NCT04626310|448888013|FG000|Overall Study|Withdrawal by Subject|1|||
124796949|NCT04626310|448888014|FG001|Overall Study|Withdrawal by Subject|0|||
124796950|NCT04626310|448888015|FG002|Overall Study|Withdrawal by Subject|3|||
124796951|NCT02278341|448888016|FG000|Overall Study|Randomized but never received study drug|1|||
124796952|NCT02278341|448888017|FG001|Overall Study|Randomized but never received study drug|1|||
124796953|NCT02278341|448888016|FG000|Overall Study|Adverse Event|3|||
124796954|NCT02278341|448888017|FG001|Overall Study|Adverse Event|0|||
124796955|NCT02278341|448888016|FG000|Overall Study|Death|68|||
124796956|NCT02278341|448888017|FG001|Overall Study|Death|56|||
124796957|NCT02278341|448888016|FG000|Overall Study|Withdrawal by Subject|30|||
124796958|NCT02278341|448888017|FG001|Overall Study|Withdrawal by Subject|19|||
124796959|NCT02278341|448888016|FG000|Overall Study|Lost to Follow-up|0|||
124796960|NCT02278341|448888017|FG001|Overall Study|Lost to Follow-up|1|||
124796961|NCT02278341|448888016|FG000|Overall Study|Physician Decision|1|||
124796962|NCT02278341|448888017|FG001|Overall Study|Physician Decision|1|||
124796963|NCT02278341|448888016|FG000|Overall Study|Miscellaneous|15|||
124796964|NCT02278341|448888017|FG001|Overall Study|Miscellaneous|14|||
124796965|NCT02604017|448888018|FG000|Overall Study|Withdrew Consent|0|||
124796966|NCT02604017|448888019|FG001|Overall Study|Withdrew Consent|2|||
124796967|NCT02604017|448888018|FG000|Overall Study|Lost to Follow-up|5|||
124796968|NCT02604017|448888019|FG001|Overall Study|Lost to Follow-up|6|||
124796969|NCT02604017|448888018|FG000|Overall Study|Other|1|||
124796970|NCT02604017|448888019|FG001|Overall Study|Other|0|||
124796971|NCT00740246|448888020|FG000|Overall Study|Received Blood Transfusion|0|||
124796972|NCT00740246|448888021|FG001|Overall Study|Received Blood Transfusion|1|||
124796973|NCT00740246|448888020|FG000|Overall Study|Adverse Event|1|||
124796974|NCT00740246|448888021|FG001|Overall Study|Adverse Event|2|||
124796975|NCT00740246|448888020|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
124796976|NCT00740246|448888021|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
124796977|NCT00740246|448888020|FG000|Overall Study|Lost to Follow-up|2|||
124796978|NCT00740246|448888021|FG001|Overall Study|Lost to Follow-up|2|||
124796979|NCT00740246|448888020|FG000|Overall Study|Withdrawal by Subject|4|||
124796980|NCT00740246|448888021|FG001|Overall Study|Withdrawal by Subject|3|||
124796981|NCT00740246|448888020|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
124796982|NCT00740246|448888021|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
124796983|NCT00740246|448888020|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
124796984|NCT00740246|448888021|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
124796985|NCT00740246|448888020|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
124796986|NCT00740246|448888021|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
124796987|NCT00740246|448888020|FG000|Overall Study|Unable To Comply With Study Visits|2|||
124796988|NCT00740246|448888021|FG001|Overall Study|Unable To Comply With Study Visits|0|||
124796989|NCT00740246|448888020|FG000|Overall Study|Unable to Access Vein|0|||
124796990|NCT00740246|448888021|FG001|Overall Study|Unable to Access Vein|2|||
124796991|NCT00740246|448888020|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
124796992|NCT00740246|448888021|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
124796993|NCT01606254|448888024|FG000|Overall Study|Withdrawal by Subject|1|||
124796994|NCT01606254|448888025|FG001|Overall Study|Withdrawal by Subject|3|||
124796995|NCT01606254|448888026|FG002|Overall Study|Withdrawal by Subject|0|||
124796996|NCT01606254|448888027|FG003|Overall Study|Withdrawal by Subject|2|||
124796997|NCT01606254|448888024|FG000|Overall Study|Adverse Event|1|||
124796998|NCT01606254|448888025|FG001|Overall Study|Adverse Event|1|||
124796999|NCT01606254|448888026|FG002|Overall Study|Adverse Event|0|||
124797000|NCT01606254|448888027|FG003|Overall Study|Adverse Event|1|||
124797001|NCT02011893|448888028|FG000|Enrollment to Randomization|Adverse Event|2|||
124797002|NCT02011893|448888029|FG001|Enrollment to Randomization|Adverse Event|0|||
124797003|NCT02011893|448888030|FG002|Enrollment to Randomization|Adverse Event|0|||
124797004|NCT02011893|448888028|FG000|Enrollment to Randomization|Physician Decision|10|||
124797005|NCT02011893|448888029|FG001|Enrollment to Randomization|Physician Decision|0|||
124797006|NCT02011893|448888030|FG002|Enrollment to Randomization|Physician Decision|0|||
124797007|NCT02011893|448888028|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
124797008|NCT02011893|448888029|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
124797009|NCT02011893|448888030|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
124797010|NCT02011893|448888028|FG000|Enrollment to Randomization|Screening Failure|29|||
124797011|NCT02011893|448888029|FG001|Enrollment to Randomization|Screening Failure|0|||
124797012|NCT02011893|448888030|FG002|Enrollment to Randomization|Screening Failure|0|||
124797013|NCT02011893|448888028|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
124797014|NCT02011893|448888029|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
124797015|NCT02011893|448888030|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
124797016|NCT02011893|448888028|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
124797017|NCT02011893|448888029|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
124797018|NCT02011893|448888030|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
124797019|NCT02011893|448888028|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
124797020|NCT02011893|448888029|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
124797021|NCT02011893|448888030|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
124797022|NCT02011893|448888028|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
124797023|NCT02011893|448888029|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
124797024|NCT02011893|448888030|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
124797025|NCT02011893|448888028|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
124797026|NCT02011893|448888029|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
124797027|NCT02011893|448888030|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
124797028|NCT03977454|448888031|FG000|Overall Study|immediate postoperative revision|2|||
124797029|NCT03977454|448888032|FG001|Overall Study|immediate postoperative revision|2|||
124797030|NCT01289782|448888033|FG000|Overall Study|Lost to Follow-up|14|||
124797031|NCT01289782|448888034|FG001|Overall Study|Lost to Follow-up|7|||
124797032|NCT01289782|448888033|FG000|Overall Study|Protocol Violation|1|||
124797033|NCT01289782|448888034|FG001|Overall Study|Protocol Violation|1|||
124797034|NCT01289782|448888033|FG000|Overall Study|Withdrawal by Subject|8|||
124797035|NCT01289782|448888034|FG001|Overall Study|Withdrawal by Subject|2|||
124797036|NCT01289782|448888033|FG000|Overall Study|Sponsor's Decision|1|||
124797037|NCT01289782|448888034|FG001|Overall Study|Sponsor's Decision|0|||
124797038|NCT01289782|448888033|FG000|Overall Study|Reason not specified|1|||
124797039|NCT01289782|448888034|FG001|Overall Study|Reason not specified|2|||
124797040|NCT01241240|448888035|FG000|Overall Study|Adverse Event|5|||
124797041|NCT01241240|448888036|FG001|Overall Study|Adverse Event|4|||
124797042|NCT01241240|448888035|FG000|Overall Study|Lost to Follow-up|2|||
124797043|NCT01241240|448888036|FG001|Overall Study|Lost to Follow-up|4|||
124797044|NCT01241240|448888035|FG000|Overall Study|Personal Reasons|1|||
124797045|NCT01241240|448888036|FG001|Overall Study|Personal Reasons|1|||
124797046|NCT04365257|448888040|FG000|Overall Study|Physician Decision|1|||
124797047|NCT04365257|448888041|FG001|Overall Study|Physician Decision|0|||
124797048|NCT04365257|448888040|FG000|Overall Study|Patient Noncompliance|1|||
124797049|NCT04365257|448888041|FG001|Overall Study|Patient Noncompliance|0|||
124797050|NCT04365257|448888040|FG000|Overall Study|Withdrawal by Subject|0|||
124797051|NCT04365257|448888041|FG001|Overall Study|Withdrawal by Subject|1|||
124797052|NCT00518973|448888042|FG000|Overall Study|Withdrawal by Subject|3|||
124797053|NCT00518973|448888043|FG001|Overall Study|Withdrawal by Subject|2|||
124797054|NCT01001299|448888046|FG000|Overall Study|Insufficient Therapeutic Response|20|||
124797055|NCT01001299|448888046|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
124797056|NCT01001299|448888046|FG000|Overall Study|Death|1|||
124797057|NCT01001299|448888046|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
124797058|NCT01001299|448888046|FG000|Overall Study|Withdrew Consent|1|||
124797059|NCT01565499|448888051|FG000|Overall Study|Physician Decision|1|||
124797060|NCT01565499|448888051|FG000|Overall Study|Adverse Event|5|||
124797061|NCT01565499|448888051|FG000|Overall Study|Withdrawal by Subject|2|||
124797062|NCT03519386|448888054|FG000|Overall Study|Withdrawal by Subject|4|||
124797063|NCT03519386|448888055|FG001|Overall Study|Withdrawal by Subject|1|||
124797064|NCT03519386|448888056|FG002|Overall Study|Withdrawal by Subject|2|||
124797065|NCT03519386|448888054|FG000|Overall Study|Physician Decision|1|||
124797066|NCT03519386|448888055|FG001|Overall Study|Physician Decision|1|||
124797067|NCT03519386|448888056|FG002|Overall Study|Physician Decision|1|||
124797068|NCT03519386|448888054|FG000|Overall Study|Lost to Follow-up|0|||
124797069|NCT03519386|448888055|FG001|Overall Study|Lost to Follow-up|1|||
124797070|NCT03519386|448888056|FG002|Overall Study|Lost to Follow-up|1|||
124797071|NCT03519386|448888054|FG000|Overall Study|Death|1|||
124797072|NCT03519386|448888055|FG001|Overall Study|Death|0|||
124797073|NCT03519386|448888056|FG002|Overall Study|Death|4|||
124797074|NCT03519386|448888054|FG000|Overall Study|Adverse Event|2|||
124797075|NCT03519386|448888055|FG001|Overall Study|Adverse Event|1|||
124797076|NCT03519386|448888056|FG002|Overall Study|Adverse Event|2|||
124797077|NCT03519386|448888054|FG000|Overall Study|Explanted|2|||
124797078|NCT03519386|448888055|FG001|Overall Study|Explanted|1|||
124797079|NCT03519386|448888056|FG002|Overall Study|Explanted|0|||
124797080|NCT03519386|448888054|FG000|Overall Study|Ongoing in study|190|||
124797081|NCT03519386|448888055|FG001|Overall Study|Ongoing in study|192|||
124797082|NCT03519386|448888056|FG002|Overall Study|Ongoing in study|183|||
124797083|NCT01582854|448888058|FG000|Overall Study|Death|8|||
124797084|NCT01582854|448888059|FG001|Overall Study|Death|5|||
124797085|NCT01582854|448888058|FG000|Overall Study|Adverse Event|2|||
124797086|NCT01582854|448888059|FG001|Overall Study|Adverse Event|3|||
124797087|NCT01582854|448888058|FG000|Overall Study|Withdrawal by Participant|8|||
124797088|NCT01582854|448888059|FG001|Overall Study|Withdrawal by Participant|11|||
124797089|NCT01582854|448888058|FG000|Overall Study|Lost to Follow-up|1|||
124797090|NCT01582854|448888059|FG001|Overall Study|Lost to Follow-up|2|||
124797091|NCT01582854|448888058|FG000|Overall Study|Physician Decision|0|||
124797092|NCT01582854|448888059|FG001|Overall Study|Physician Decision|1|||
124797093|NCT01582854|448888058|FG000|Overall Study|Recurrent Stroke|13|||
124797094|NCT01582854|448888059|FG001|Overall Study|Recurrent Stroke|8|||
124797095|NCT01582854|448888058|FG000|Overall Study|Disallowed Concomitant Medication|3|||
124797096|NCT01582854|448888059|FG001|Overall Study|Disallowed Concomitant Medication|2|||
124797097|NCT01582854|448888058|FG000|Overall Study|Carotid or Neurosurgery|0|||
124797098|NCT01582854|448888059|FG001|Overall Study|Carotid or Neurosurgery|1|||
124797099|NCT01582854|448888058|FG000|Overall Study|General Anaesthesia|0|||
124797100|NCT01582854|448888059|FG001|Overall Study|General Anaesthesia|1|||
124797101|NCT01582854|448888058|FG000|Overall Study|Other Miscellaneous Reason|1|||
124797102|NCT01582854|448888059|FG001|Overall Study|Other Miscellaneous Reason|0|||
124797103|NCT02652767|448888064|FG000|Overall Study|Death|2|||
124797104|NCT02652767|448888064|FG000|Overall Study|Lost to Follow-up|1|||
124797105|NCT02652767|448888064|FG000|Overall Study|Withdrawal by Subject|1|||
124797106|NCT01028378|448888065|FG000|Overall Study|Lost to Follow-up|12|||
124797107|NCT01028378|448888065|FG000|Overall Study|Withdrawal by Subject|1|||
124797108|NCT01028378|448888065|FG000|Overall Study|Adminstrative Reasons|4|||
124797109|NCT00107952|448888069|FG000|Overall Study|Death|75|||
124797110|NCT00107952|448888070|FG001|Overall Study|Death|61|||
124797111|NCT00107952|448888069|FG000|Overall Study|Lost to Follow-up|0|||
124797112|NCT00107952|448888070|FG001|Overall Study|Lost to Follow-up|3|||
124797113|NCT00107952|448888069|FG000|Overall Study|Withdrawal by Subject|9|||
124797114|NCT00107952|448888070|FG001|Overall Study|Withdrawal by Subject|6|||
124797115|NCT00107952|448888069|FG000|Overall Study|Other|2|||
124797116|NCT00107952|448888070|FG001|Overall Study|Other|5|||
124797117|NCT00107952|448888069|FG000|Overall Study|Never received study treatment|9|||
124797118|NCT00107952|448888070|FG001|Overall Study|Never received study treatment|6|||
124797119|NCT01401959|448888071|FG000|Enrolled|Withdrawal by Subject|1|||
124797120|NCT01401959|448888072|FG001|Enrolled|Withdrawal by Subject|0|||
124797121|NCT01401959|448888073|FG002|Enrolled|Withdrawal by Subject|0|||
124797122|NCT01401959|448888071|FG000|Treated|Disease Progression|2|||
124797123|NCT01401959|448888072|FG001|Treated|Disease Progression|2|||
124797124|NCT01401959|448888073|FG002|Treated|Disease Progression|1|||
124797125|NCT01401959|448888071|FG000|Treated|Adverse Event|4|||
124797126|NCT01401959|448888072|FG001|Treated|Adverse Event|3|||
124797127|NCT01401959|448888073|FG002|Treated|Adverse Event|2|||
124629819|NCT04199104|448262825|FG000|Overall Study|Lost to Follow-up|1|||
124629820|NCT04199104|448262826|FG001|Overall Study|Lost to Follow-up|1|||
124629821|NCT04199104|448262825|FG000|Overall Study|Withdrawal by Subject|4|||
124629822|NCT04199104|448262826|FG001|Overall Study|Withdrawal by Subject|4|||
124797128|NCT01401959|448888071|FG000|Treated|Withdrawal by Subject|1|||
124797129|NCT01401959|448888072|FG001|Treated|Withdrawal by Subject|2|||
124797130|NCT01401959|448888073|FG002|Treated|Withdrawal by Subject|2|||
124797131|NCT01401959|448888071|FG000|Treated|Protocol Violation|0|||
124797132|NCT01401959|448888072|FG001|Treated|Protocol Violation|1|||
124797133|NCT01401959|448888073|FG002|Treated|Protocol Violation|0|||
124797134|NCT03614975|448888080|FG000|Overall Study|Physician Decision|7|||
124797135|NCT03614975|448888081|FG001|Overall Study|Physician Decision|5|||
124797136|NCT03614975|448888080|FG000|Overall Study|Withdrawal by Subject|2|||
124797137|NCT03614975|448888081|FG001|Overall Study|Withdrawal by Subject|2|||
124797138|NCT03614975|448888080|FG000|Overall Study|Specimens not in lab batch shipment|1|||
124797139|NCT03614975|448888081|FG001|Overall Study|Specimens not in lab batch shipment|1|||
124797140|NCT00450385|448888082|FG000|Overall Study|Death|3|||
124797141|NCT00450385|448888082|FG000|Overall Study|Protocol Violation|1|||
124797142|NCT00450385|448888082|FG000|Overall Study|Withdrawal by Subject|2|||
124797143|NCT00450385|448888082|FG000|Overall Study|Lack of Efficacy|2|||
124797144|NCT00450385|448888082|FG000|Overall Study|Adverse Event|1|||
124797145|NCT00450385|448888082|FG000|Overall Study|Physician Decision|1|||
124797146|NCT00450385|448888082|FG000|Overall Study|Other|3|||
124797147|NCT01569464|448888083|FG000|Overall Study|Adverse Event|4|||
124797148|NCT01569464|448888084|FG001|Overall Study|Adverse Event|0|||
124797149|NCT01569464|448888083|FG000|Overall Study|Lack of Efficacy|1|||
124797150|NCT01569464|448888084|FG001|Overall Study|Lack of Efficacy|0|||
124797151|NCT01569464|448888083|FG000|Overall Study|Protocol Violation|1|||
124797152|NCT01569464|448888084|FG001|Overall Study|Protocol Violation|0|||
124797153|NCT01569464|448888083|FG000|Overall Study|Lost to Follow-up|2|||
124797154|NCT01569464|448888084|FG001|Overall Study|Lost to Follow-up|3|||
124797155|NCT01569464|448888083|FG000|Overall Study|Withdrawal by Subject|1|||
124797156|NCT01569464|448888084|FG001|Overall Study|Withdrawal by Subject|1|||
124797157|NCT01569464|448888083|FG000|Overall Study|Other|1|||
124797158|NCT01569464|448888084|FG001|Overall Study|Other|1|||
124797159|NCT01390220|448888090|FG000|Test Dose Phase|Adverse Event|17|||
124797160|NCT01390220|448888091|FG001|Test Dose Phase|Adverse Event|0|||
124797161|NCT01390220|448888092|FG002|Test Dose Phase|Adverse Event|0|||
124797162|NCT01390220|448888090|FG000|Test Dose Phase|Withdrawal by Subject|8|||
124797163|NCT01390220|448888091|FG001|Test Dose Phase|Withdrawal by Subject|0|||
124797164|NCT01390220|448888092|FG002|Test Dose Phase|Withdrawal by Subject|0|||
124797165|NCT01390220|448888090|FG000|Test Dose Phase|Lost to Follow-up|2|||
124797166|NCT01390220|448888091|FG001|Test Dose Phase|Lost to Follow-up|0|||
124797167|NCT01390220|448888092|FG002|Test Dose Phase|Lost to Follow-up|0|||
124797168|NCT01390220|448888090|FG000|Test Dose Phase|Protocol Violation|8|||
124797169|NCT01390220|448888091|FG001|Test Dose Phase|Protocol Violation|0|||
124797170|NCT01390220|448888092|FG002|Test Dose Phase|Protocol Violation|0|||
124797171|NCT01390220|448888090|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
124797172|NCT01390220|448888091|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
124797173|NCT01390220|448888092|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
124797174|NCT01390220|448888090|FG000|Test Dose Phase|Study/Site closure|6|||
124797175|NCT01390220|448888091|FG001|Test Dose Phase|Study/Site closure|0|||
124797176|NCT01390220|448888092|FG002|Test Dose Phase|Study/Site closure|0|||
124797177|NCT01390220|448888090|FG000|Test Dose Phase|Caregiver no longer available|5|||
124797178|NCT01390220|448888091|FG001|Test Dose Phase|Caregiver no longer available|0|||
124797179|NCT01390220|448888092|FG002|Test Dose Phase|Caregiver no longer available|0|||
124797180|NCT01390220|448888090|FG000|Test Dose Phase|Noncompliance|2|||
124797181|NCT01390220|448888091|FG001|Test Dose Phase|Noncompliance|0|||
124797182|NCT01390220|448888092|FG002|Test Dose Phase|Noncompliance|0|||
124797183|NCT01390220|448888090|FG000|Test Dose Phase|Logistical|6|||
124797184|NCT01390220|448888091|FG001|Test Dose Phase|Logistical|0|||
124797185|NCT01390220|448888092|FG002|Test Dose Phase|Logistical|0|||
124797186|NCT01390220|448888090|FG000|Comparative Phase|Withdrawal by Subject|0|||
124629823|NCT04199104|448262825|FG000|Overall Study|Participants Ongoing|103|||
124629824|NCT04199104|448262826|FG001|Overall Study|Participants Ongoing|116|||
124797187|NCT01390220|448888091|FG001|Comparative Phase|Withdrawal by Subject|1|||
124797188|NCT01390220|448888092|FG002|Comparative Phase|Withdrawal by Subject|0|||
124797189|NCT03063203|448888093|FG000|Overall Study|Chose alternative therapy|3|||
124797190|NCT03063203|448888093|FG000|Overall Study|Death|2|||
124797191|NCT03063203|448888093|FG000|Overall Study|Disease progression|4|||
124797192|NCT03063203|448888093|FG000|Overall Study|Physician Decision|5|||
124797193|NCT04718103|448888094|FG000|Overall Study|Adverse Event|1|||
124797194|NCT04718103|448888095|FG001|Overall Study|Adverse Event|1|||
124797195|NCT04718103|448888094|FG000|Overall Study|Lack of Efficacy|4|||
124797196|NCT04718103|448888095|FG001|Overall Study|Lack of Efficacy|1|||
124797197|NCT04718103|448888094|FG000|Overall Study|Lost to Follow-up|2|||
124797198|NCT04718103|448888095|FG001|Overall Study|Lost to Follow-up|2|||
124797199|NCT04718103|448888094|FG000|Overall Study|Physician Decision|2|||
124797200|NCT04718103|448888095|FG001|Overall Study|Physician Decision|0|||
124797201|NCT04718103|448888094|FG000|Overall Study|Pregnancy|0|||
124797202|NCT04718103|448888095|FG001|Overall Study|Pregnancy|1|||
124797203|NCT04718103|448888094|FG000|Overall Study|Withdrawal by Subject|10|||
124797204|NCT04718103|448888095|FG001|Overall Study|Withdrawal by Subject|6|||
124797205|NCT04718103|448888094|FG000|Overall Study|Randomized, not treated|4|||
124797206|NCT04718103|448888095|FG001|Overall Study|Randomized, not treated|1|||
124797207|NCT04718103|448888094|FG000|Overall Study|GCP violations|7|||
124797208|NCT04718103|448888095|FG001|Overall Study|GCP violations|5|||
124797209|NCT00136604|448888096|FG000|Overall Study|Lost to Follow-up|1|||
124797210|NCT00136604|448888097|FG001|Overall Study|Lost to Follow-up|0|||
124797211|NCT00136604|448888098|FG002|Overall Study|Lost to Follow-up|0|||
124797212|NCT00136604|448888099|FG003|Overall Study|Lost to Follow-up|0|||
124797213|NCT00136604|448888100|FG004|Overall Study|Lost to Follow-up|1|||
124797214|NCT00136604|448888096|FG000|Overall Study|Migrated/moved from study area|0|||
124797215|NCT00136604|448888097|FG001|Overall Study|Migrated/moved from study area|1|||
124797216|NCT00136604|448888098|FG002|Overall Study|Migrated/moved from study area|0|||
124797217|NCT00136604|448888099|FG003|Overall Study|Migrated/moved from study area|0|||
124797218|NCT00136604|448888100|FG004|Overall Study|Migrated/moved from study area|0|||
124797219|NCT03631355|448888101|FG000|Overall Study|Lost to Follow-up|1|||
124797220|NCT03631355|448888102|FG001|Overall Study|Lost to Follow-up|2|||
124797221|NCT03640559|448888105|FG000|Overall Study|Physician Decision|1|||
124797222|NCT03640559|448888106|FG001|Overall Study|Physician Decision|1|||
124797223|NCT03640559|448888105|FG000|Overall Study|Withdrawal by Subject|1|||
124797224|NCT03640559|448888106|FG001|Overall Study|Withdrawal by Subject|0|||
124797225|NCT02125604|448888107|FG000|Overall Study|Other|4|||
124797226|NCT02125604|448888107|FG000|Overall Study|Investigator Decision|1|||
124797227|NCT02125604|448888107|FG000|Overall Study|Lost to Follow-up|2|||
124797228|NCT02125604|448888107|FG000|Overall Study|Consent Withdrawn|4|||
124797229|NCT02125604|448888107|FG000|Overall Study|Adverse Event|20|||
124797230|NCT01876810|448888110|FG000|Overall Study|Physician Decision|0|||
124797231|NCT01876810|448888111|FG001|Overall Study|Physician Decision|1|||
124797232|NCT00719264|448889733|FG000|Overall Study|Adverse Event|41|||
124797233|NCT00719264|448889734|FG001|Overall Study|Adverse Event|49|||
124797234|NCT00719264|448889733|FG000|Overall Study|Death|13|||
124797235|NCT00719264|448889734|FG001|Overall Study|Death|10|||
124797236|NCT00719264|448889733|FG000|Overall Study|Administrative Problems|6|||
124797237|NCT00719264|448889734|FG001|Overall Study|Administrative Problems|4|||
124797238|NCT00719264|448889733|FG000|Overall Study|Lost to Follow-up|1|||
124797239|NCT00719264|448889734|FG001|Overall Study|Lost to Follow-up|1|||
124797240|NCT00719264|448889733|FG000|Overall Study|Withdrawal by Subject|12|||
124797241|NCT00719264|448889734|FG001|Overall Study|Withdrawal by Subject|7|||
124797242|NCT00719264|448889733|FG000|Overall Study|Protocol Deviation|1|||
124797243|NCT00719264|448889734|FG001|Overall Study|Protocol Deviation|3|||
124797244|NCT00719264|448889733|FG000|Overall Study|New Cancer Therapy|4|||
124797245|NCT00719264|448889734|FG001|Overall Study|New Cancer Therapy|2|||
124797246|NCT00719264|448889733|FG000|Overall Study|Disease Progression|104|||
124797247|NCT00719264|448889734|FG001|Overall Study|Disease Progression|107|||
124797248|NCT03034200|448889735|FG000|Overall Study|Disease progression|8|||
124797249|NCT03034200|448889736|FG001|Overall Study|Disease progression|10|||
124797250|NCT03034200|448889737|FG002|Overall Study|Disease progression|4|||
124797251|NCT03034200|448889735|FG000|Overall Study|Physician Decision|2|||
124797252|NCT03034200|448889736|FG001|Overall Study|Physician Decision|0|||
124797253|NCT03034200|448889737|FG002|Overall Study|Physician Decision|3|||
124797254|NCT03034200|448889735|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
124797255|NCT03034200|448889736|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
124797256|NCT03034200|448889737|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
124797257|NCT03034200|448889735|FG000|Overall Study|Adjuvant Therapy|0|||
124797258|NCT03034200|448889736|FG001|Overall Study|Adjuvant Therapy|0|||
124797259|NCT03034200|448889737|FG002|Overall Study|Adjuvant Therapy|1|||
124797260|NCT05523323|448889738|FG000|Overall Study|Death|26|||
124797261|NCT05523323|448889739|FG001|Overall Study|Death|21|||
124797262|NCT05523323|448889738|FG000|Overall Study|Ongoing participants|35|||
124797263|NCT05523323|448889739|FG001|Overall Study|Ongoing participants|30|||
124797264|NCT03435640|448889740|FG000|Overall Study|Withdrawal by Subject|0|||
124797265|NCT03435640|448889741|FG001|Overall Study|Withdrawal by Subject|1|||
124797266|NCT03435640|448889742|FG002|Overall Study|Withdrawal by Subject|0|||
124797267|NCT03435640|448889743|FG003|Overall Study|Withdrawal by Subject|2|||
124797268|NCT03435640|448889744|FG004|Overall Study|Withdrawal by Subject|0|||
124797269|NCT03435640|448889745|FG005|Overall Study|Withdrawal by Subject|0|||
124797270|NCT03435640|448889746|FG006|Overall Study|Withdrawal by Subject|3|||
124797271|NCT03435640|448889747|FG007|Overall Study|Withdrawal by Subject|0|||
124797272|NCT03435640|448889748|FG008|Overall Study|Withdrawal by Subject|0|||
124797273|NCT03435640|448889749|FG009|Overall Study|Withdrawal by Subject|2|||
124797274|NCT03435640|448889750|FG010|Overall Study|Withdrawal by Subject|3|||
124797275|NCT03435640|448889740|FG000|Overall Study|Lost to Follow-up|0|||
124797276|NCT03435640|448889741|FG001|Overall Study|Lost to Follow-up|0|||
124797277|NCT03435640|448889742|FG002|Overall Study|Lost to Follow-up|1|||
124797278|NCT03435640|448889743|FG003|Overall Study|Lost to Follow-up|0|||
124797279|NCT03435640|448889744|FG004|Overall Study|Lost to Follow-up|0|||
124797280|NCT03435640|448889745|FG005|Overall Study|Lost to Follow-up|0|||
124797281|NCT03435640|448889746|FG006|Overall Study|Lost to Follow-up|0|||
124797282|NCT03435640|448889747|FG007|Overall Study|Lost to Follow-up|0|||
124797283|NCT03435640|448889748|FG008|Overall Study|Lost to Follow-up|0|||
124797284|NCT03435640|448889749|FG009|Overall Study|Lost to Follow-up|0|||
124797285|NCT03435640|448889750|FG010|Overall Study|Lost to Follow-up|0|||
124797286|NCT00920829|448889758|FG000|Allocation|No post randomization data|3|||
124797287|NCT00920829|448889759|FG001|Allocation|No post randomization data|1|||
124797288|NCT00920829|448889760|FG002|Allocation|No post randomization data|0|||
124797289|NCT00920829|448889761|FG003|Allocation|No post randomization data|2|||
124797290|NCT00920829|448889758|FG000|Available for Analysis|Withdrawal by Subject|6|||
124797291|NCT00920829|448889759|FG001|Available for Analysis|Withdrawal by Subject|6|||
124797292|NCT00920829|448889760|FG002|Available for Analysis|Withdrawal by Subject|6|||
124797293|NCT00920829|448889761|FG003|Available for Analysis|Withdrawal by Subject|10|||
124797294|NCT00920829|448889758|FG000|Available for Analysis|Required Medical Treatment|0|||
124797295|NCT00920829|448889759|FG001|Available for Analysis|Required Medical Treatment|1|||
124797296|NCT00920829|448889760|FG002|Available for Analysis|Required Medical Treatment|2|||
124797297|NCT00920829|448889761|FG003|Available for Analysis|Required Medical Treatment|0|||
124797298|NCT00920829|448889758|FG000|Available for Analysis|Adverse Event|1|||
124797299|NCT00920829|448889759|FG001|Available for Analysis|Adverse Event|2|||
124797300|NCT00920829|448889760|FG002|Available for Analysis|Adverse Event|1|||
124797301|NCT00920829|448889761|FG003|Available for Analysis|Adverse Event|0|||
124797302|NCT00920829|448889758|FG000|Available for Analysis|Death|1|||
124797303|NCT00920829|448889759|FG001|Available for Analysis|Death|0|||
124797304|NCT00920829|448889760|FG002|Available for Analysis|Death|0|||
124797305|NCT00920829|448889761|FG003|Available for Analysis|Death|0|||
124797306|NCT00920829|448889758|FG000|Available for Analysis|Protocol Violation|0|||
124797307|NCT00920829|448889759|FG001|Available for Analysis|Protocol Violation|0|||
124797308|NCT00920829|448889760|FG002|Available for Analysis|Protocol Violation|1|||
124797309|NCT00920829|448889761|FG003|Available for Analysis|Protocol Violation|0|||
124797310|NCT00920829|448889758|FG000|Available for Analysis|Required more treatment|0|||
124797311|NCT00920829|448889759|FG001|Available for Analysis|Required more treatment|2|||
124797312|NCT00920829|448889760|FG002|Available for Analysis|Required more treatment|0|||
124797313|NCT00920829|448889761|FG003|Available for Analysis|Required more treatment|1|||
124797314|NCT04533880|448889762|FG000|Overall Study|Lost to Follow-up|0|||
124797315|NCT04533880|448889763|FG001|Overall Study|Lost to Follow-up|1|||
124797316|NCT04533880|448889764|FG002|Overall Study|Lost to Follow-up|1|||
124797317|NCT01711879|448889769|FG000|Overall Study|Death|1|||
124797318|NCT01711879|448889770|FG001|Overall Study|Death|0|||
124797319|NCT02239224|448889773|FG000|Overall Study|Administrative|0|||
124797320|NCT02239224|448889774|FG001|Overall Study|Administrative|0|||
124797321|NCT02239224|448889775|FG002|Overall Study|Administrative|3|||
124797322|NCT02239224|448889776|FG003|Overall Study|Administrative|1|||
124797323|NCT03183778|448889779|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
124797324|NCT01466179|448889781|FG000|Overall Study|Ongoing in core study|2|||
124797325|NCT01466179|448889781|FG000|Overall Study|Physician Decision|46|||
124797326|NCT01466179|448889781|FG000|Overall Study|Progressive disease|43|||
124797327|NCT01466179|448889781|FG000|Overall Study|Adverse Event|32|||
124797328|NCT01466179|448889781|FG000|Overall Study|Disease relapse|23|||
124797329|NCT01466179|448889781|FG000|Overall Study|Lack of Efficacy|14|||
124797330|NCT01466179|448889781|FG000|Overall Study|Death|7|||
124797331|NCT01466179|448889781|FG000|Overall Study|Withdrawal by Subject|7|||
124797332|NCT01466179|448889781|FG000|Overall Study|Protocol Violation|2|||
124797333|NCT01466179|448889781|FG000|Overall Study|Other|3|||
124797334|NCT00749580|448889782|FG000|Overall Study|Lost to Follow-up|4|||
124797335|NCT00749580|448889783|FG001|Overall Study|Lost to Follow-up|8|||
124797336|NCT00749580|448889782|FG000|Overall Study|Adverse Event|0|||
124797337|NCT00749580|448889783|FG001|Overall Study|Adverse Event|1|||
124797338|NCT03868124|448889787|FG000|Overall Study|Withdrawal by Subject|4|||
124797339|NCT03868124|448889788|FG001|Overall Study|Withdrawal by Subject|0|||
124797340|NCT03868124|448889789|FG002|Overall Study|Withdrawal by Subject|1|||
124797341|NCT03868124|448889787|FG000|Overall Study|Physician Decision|1|||
124797342|NCT03868124|448889788|FG001|Overall Study|Physician Decision|0|||
124797343|NCT03868124|448889789|FG002|Overall Study|Physician Decision|1|||
124797344|NCT03868124|448889787|FG000|Overall Study|Lost to Follow-up|1|||
124797345|NCT03868124|448889788|FG001|Overall Study|Lost to Follow-up|1|||
124797346|NCT03868124|448889789|FG002|Overall Study|Lost to Follow-up|2|||
124797347|NCT03868124|448889787|FG000|Overall Study|Death|1|||
124797348|NCT03868124|448889788|FG001|Overall Study|Death|1|||
124797349|NCT03868124|448889789|FG002|Overall Study|Death|2|||
124797350|NCT03868124|448889787|FG000|Overall Study|Adverse Event|0|||
124797351|NCT03868124|448889788|FG001|Overall Study|Adverse Event|0|||
124797352|NCT03868124|448889789|FG002|Overall Study|Adverse Event|3|||
124797353|NCT03868124|448889787|FG000|Overall Study|Explanted|2|||
124797354|NCT03868124|448889788|FG001|Overall Study|Explanted|1|||
124797355|NCT03868124|448889789|FG002|Overall Study|Explanted|0|||
124797356|NCT03868124|448889787|FG000|Overall Study|Ongoing in study|176|||
124797357|NCT03868124|448889788|FG001|Overall Study|Ongoing in study|180|||
124797358|NCT03868124|448889789|FG002|Overall Study|Ongoing in study|183|||
124797359|NCT04565236|448889790|FG000|Overall Study|Patient/Guardian Decision|0|||
124797360|NCT04565236|448889791|FG001|Overall Study|Patient/Guardian Decision|0|||
124797361|NCT04565236|448889792|FG002|Overall Study|Patient/Guardian Decision|1|||
124797362|NCT04565236|448889793|FG003|Overall Study|Patient/Guardian Decision|0|||
124797363|NCT01117051|448889794|FG000|Overall Study|Withdrawal by Subject|5|||
124797364|NCT01117051|448889795|FG001|Overall Study|Withdrawal by Subject|3|||
124797365|NCT01117051|448889794|FG000|Overall Study|Adverse Event|4|||
124797366|NCT01117051|448889795|FG001|Overall Study|Adverse Event|3|||
124797367|NCT01117051|448889794|FG000|Overall Study|Lost to Follow-up|0|||
124797368|NCT01117051|448889795|FG001|Overall Study|Lost to Follow-up|1|||
124797369|NCT01117051|448889794|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
124797370|NCT01117051|448889795|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
124797371|NCT01117051|448889794|FG000|Overall Study|Sponsor's decision|3|||
124797372|NCT01117051|448889795|FG001|Overall Study|Sponsor's decision|1|||
124797373|NCT01117051|448889794|FG000|Overall Study|Surgical procedure|0|||
124797374|NCT01117051|448889795|FG001|Overall Study|Surgical procedure|1|||
124797375|NCT01117051|448889794|FG000|Overall Study|Randomized by mistake|0|||
124797376|NCT01117051|448889795|FG001|Overall Study|Randomized by mistake|1|||
124797377|NCT01117051|448889794|FG000|Overall Study|Convenience issue|1|||
124797378|NCT01117051|448889795|FG001|Overall Study|Convenience issue|0|||
124797379|NCT00206076|448889797|FG000|Overall Study|Physician Decision|2|||
124797380|NCT00206076|448889798|FG001|Overall Study|Physician Decision|0|||
124797381|NCT00206076|448889797|FG000|Overall Study|Withdrawal by Subject|1|||
124797382|NCT00206076|448889798|FG001|Overall Study|Withdrawal by Subject|1|||
124797383|NCT00366340|448889801|FG000|Infant Series|Protocol Violation|3|||
124797384|NCT00366340|448889802|FG001|Infant Series|Protocol Violation|4|||
124797385|NCT00366340|448889801|FG000|Infant Series|Withdrawal by Subject|3|||
124797386|NCT00366340|448889802|FG001|Infant Series|Withdrawal by Subject|3|||
124797387|NCT00366340|448889801|FG000|Infant Series|Adverse Event|0|||
124797388|NCT00366340|448889802|FG001|Infant Series|Adverse Event|2|||
124797389|NCT00366340|448889801|FG000|Infant Series|Lost to Follow-up|1|||
124797390|NCT00366340|448889802|FG001|Infant Series|Lost to Follow-up|1|||
124797391|NCT00366340|448889801|FG000|Infant Series|Failure to return|1|||
124797392|NCT00366340|448889802|FG001|Infant Series|Failure to return|0|||
124797393|NCT00366340|448889801|FG000|After the Infant Series|Parent/legal guardian request|1|||
124797394|NCT00366340|448889802|FG001|After the Infant Series|Parent/legal guardian request|1|||
124797395|NCT00366340|448889801|FG000|After the Infant Series|Failed to return|0|||
124797396|NCT00366340|448889802|FG001|After the Infant Series|Failed to return|1|||
124797397|NCT00366340|448889801|FG000|After the Infant Series|Protocol Violation|2|||
124797398|NCT00366340|448889802|FG001|After the Infant Series|Protocol Violation|2|||
124797399|NCT00366340|448889801|FG000|After the Infant Series|Adverse Event|0|||
124797400|NCT00366340|448889802|FG001|After the Infant Series|Adverse Event|1|||
124797401|NCT00366340|448889801|FG000|After the Infant Series|Lost to Follow-up|0|||
124797402|NCT00366340|448889802|FG001|After the Infant Series|Lost to Follow-up|1|||
124797403|NCT00366340|448889801|FG000|Toddler Dose|Failed to return|1|||
124797404|NCT00366340|448889802|FG001|Toddler Dose|Failed to return|0|||
124797405|NCT00366340|448889801|FG000|Toddler Dose|Parent/legal guardian request|0|||
124797406|NCT00366340|448889802|FG001|Toddler Dose|Parent/legal guardian request|1|||
124797407|NCT03355664|448889803|FG000|Overall Study|Adverse Event|1|||
124797408|NCT03355664|448889804|FG001|Overall Study|Adverse Event|2|||
124797409|NCT03355664|448889803|FG000|Overall Study|Lost to Follow-up|11|||
124797410|NCT03355664|448889804|FG001|Overall Study|Lost to Follow-up|7|||
124797411|NCT03355664|448889803|FG000|Overall Study|Protocol Violation|1|||
124797412|NCT03355664|448889804|FG001|Overall Study|Protocol Violation|2|||
124797413|NCT03355664|448889803|FG000|Overall Study|Withdrawal by Subject|2|||
124797414|NCT03355664|448889804|FG001|Overall Study|Withdrawal by Subject|1|||
124797415|NCT01315236|448889810|FG000|Double-blind Phase|Death|1|||
124797416|NCT01315236|448889811|FG001|Double-blind Phase|Death|0|||
124797417|NCT01315236|448889810|FG000|Double-blind Phase|Adverse Event|1|||
124797418|NCT01315236|448889811|FG001|Double-blind Phase|Adverse Event|0|||
124797419|NCT01315236|448889810|FG000|Double-blind Phase|Withdrawal of Consent|1|||
124797420|NCT01315236|448889811|FG001|Double-blind Phase|Withdrawal of Consent|0|||
124797421|NCT01315236|448889810|FG000|Double-blind Phase|Lost to Follow-up|1|||
124797422|NCT01315236|448889811|FG001|Double-blind Phase|Lost to Follow-up|0|||
124797423|NCT01315236|448889810|FG000|Open-label Phase|Death|1|||
124797424|NCT01315236|448889811|FG001|Open-label Phase|Death|0|||
124797425|NCT01315236|448889810|FG000|Open-label Phase|Adverse Event|0|||
124797426|NCT01315236|448889811|FG001|Open-label Phase|Adverse Event|1|||
124797427|NCT01315236|448889810|FG000|Open-label Phase|Other|0|||
124797428|NCT01315236|448889811|FG001|Open-label Phase|Other|1|||
124797429|NCT01315236|448889810|FG000|12-Month Follow-up Period|Death|0|||
124797430|NCT01315236|448889811|FG001|12-Month Follow-up Period|Death|1|||
124797431|NCT01315236|448889810|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
124797432|NCT01315236|448889811|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
124797433|NCT01751802|448889812|FG000|Overall Study|Adverse Event|4|||
124797434|NCT01751802|448889813|FG001|Overall Study|Adverse Event|2|||
124797435|NCT00589784|448889816|FG000|Overall Study|Withdrawal by Subject|0|||
124797436|NCT00589784|448889817|FG001|Overall Study|Withdrawal by Subject|6|||
124797437|NCT00589784|448889816|FG000|Overall Study|Patient inevaluable|1|||
124797438|NCT00589784|448889817|FG001|Overall Study|Patient inevaluable|0|||
124797439|NCT00589784|448889816|FG000|Overall Study|Adverse Event|0|||
124797440|NCT00589784|448889817|FG001|Overall Study|Adverse Event|4|||
124797441|NCT00521001|448889818|FG000|Overall Study|Ineligible|1|||
124797442|NCT02821910|448889820|FG000|Overall Study|Withdrawal by Subject|0|||
124797443|NCT02821910|448889821|FG001|Overall Study|Withdrawal by Subject|0|||
124797444|NCT02821910|448889822|FG002|Overall Study|Withdrawal by Subject|1|||
124797445|NCT02821910|448889823|FG003|Overall Study|Withdrawal by Subject|0|||
124797446|NCT02821910|448889824|FG004|Overall Study|Withdrawal by Subject|0|||
124797447|NCT02821910|448889825|FG005|Overall Study|Withdrawal by Subject|1|||
124797448|NCT02821910|448889820|FG000|Overall Study|Other than specified|1|||
124797449|NCT02821910|448889821|FG001|Overall Study|Other than specified|0|||
124797450|NCT02821910|448889822|FG002|Overall Study|Other than specified|1|||
124797451|NCT02821910|448889823|FG003|Overall Study|Other than specified|0|||
124797452|NCT02821910|448889824|FG004|Overall Study|Other than specified|0|||
124797453|NCT02821910|448889825|FG005|Overall Study|Other than specified|0|||
124797454|NCT00287079|448889826|FG000|Overall Study|Qualifying relapse|12|||
124797455|NCT00287079|448889827|FG001|Overall Study|Qualifying relapse|1|||
124797456|NCT00287079|448889826|FG000|Overall Study|Non-qualifying relapse|1|||
124797457|NCT00287079|448889827|FG001|Overall Study|Non-qualifying relapse|0|||
124797458|NCT00287079|448889826|FG000|Overall Study|Adverse Event|5|||
124797459|NCT00287079|448889827|FG001|Overall Study|Adverse Event|0|||
124797460|NCT00287079|448889826|FG000|Overall Study|Protocol Violation|1|||
124797461|NCT00287079|448889827|FG001|Overall Study|Protocol Violation|0|||
124797462|NCT00287079|448889826|FG000|Overall Study|Other|3|||
124797463|NCT00287079|448889827|FG001|Overall Study|Other|0|||
124797464|NCT01082640|448889830|FG000|Overall Study|Adverse Event|9|||
124797465|NCT01082640|448889831|FG001|Overall Study|Adverse Event|5|||
124797466|NCT01082640|448889832|FG002|Overall Study|Adverse Event|3|||
124797467|NCT01082640|448889830|FG000|Overall Study|Withdrawal by Subject|3|||
124797468|NCT01082640|448889831|FG001|Overall Study|Withdrawal by Subject|3|||
124797469|NCT01082640|448889832|FG002|Overall Study|Withdrawal by Subject|2|||
124797470|NCT01082640|448889830|FG000|Overall Study|Major protocol deviation|3|||
124797471|NCT01082640|448889831|FG001|Overall Study|Major protocol deviation|3|||
124797472|NCT01082640|448889832|FG002|Overall Study|Major protocol deviation|0|||
124797473|NCT01082640|448889830|FG000|Overall Study|Lost to Follow-up|0|||
124797474|NCT01082640|448889831|FG001|Overall Study|Lost to Follow-up|3|||
124797475|NCT01082640|448889832|FG002|Overall Study|Lost to Follow-up|0|||
124797476|NCT01082640|448889830|FG000|Overall Study|Other|2|||
124797477|NCT01082640|448889831|FG001|Overall Study|Other|1|||
124797478|NCT01082640|448889832|FG002|Overall Study|Other|3|||
124797479|NCT01282203|448889837|FG000|Overall Study|Adverse Event|1|||
124797480|NCT02129777|448889841|FG000|Double-Blind Period|Adverse Event|0|||
124797481|NCT02129777|448889842|FG001|Double-Blind Period|Adverse Event|0|||
124797482|NCT02129777|448889843|FG002|Double-Blind Period|Adverse Event|0|||
124797483|NCT02129777|448889844|FG003|Double-Blind Period|Adverse Event|0|||
124797484|NCT02129777|448889845|FG004|Double-Blind Period|Adverse Event|1|||
124797485|NCT02129777|448889846|FG005|Double-Blind Period|Adverse Event|0|||
124797486|NCT02129777|448889847|FG006|Double-Blind Period|Adverse Event|0|||
124797487|NCT02129777|448889841|FG000|Double-Blind Period|Lost to Follow-up|1|||
124797488|NCT02129777|448889842|FG001|Double-Blind Period|Lost to Follow-up|1|||
124797489|NCT02129777|448889843|FG002|Double-Blind Period|Lost to Follow-up|1|||
124797490|NCT02129777|448889844|FG003|Double-Blind Period|Lost to Follow-up|2|||
124797491|NCT02129777|448889845|FG004|Double-Blind Period|Lost to Follow-up|0|||
124797492|NCT02129777|448889846|FG005|Double-Blind Period|Lost to Follow-up|0|||
124797493|NCT02129777|448889847|FG006|Double-Blind Period|Lost to Follow-up|0|||
124797494|NCT02129777|448889841|FG000|Double-Blind Period|Withdrawal by Subject|2|||
124797495|NCT02129777|448889842|FG001|Double-Blind Period|Withdrawal by Subject|4|||
124797496|NCT02129777|448889843|FG002|Double-Blind Period|Withdrawal by Subject|3|||
124797497|NCT02129777|448889844|FG003|Double-Blind Period|Withdrawal by Subject|2|||
124797498|NCT02129777|448889845|FG004|Double-Blind Period|Withdrawal by Subject|3|||
124797499|NCT02129777|448889846|FG005|Double-Blind Period|Withdrawal by Subject|0|||
124797500|NCT02129777|448889847|FG006|Double-Blind Period|Withdrawal by Subject|0|||
124797501|NCT02129777|448889841|FG000|Double-Blind Period|Pregnancy|0|||
124797502|NCT02129777|448889842|FG001|Double-Blind Period|Pregnancy|0|||
124797503|NCT02129777|448889843|FG002|Double-Blind Period|Pregnancy|0|||
124797504|NCT02129777|448889844|FG003|Double-Blind Period|Pregnancy|0|||
124797505|NCT02129777|448889845|FG004|Double-Blind Period|Pregnancy|1|||
124797506|NCT02129777|448889846|FG005|Double-Blind Period|Pregnancy|0|||
124797507|NCT02129777|448889847|FG006|Double-Blind Period|Pregnancy|0|||
124797508|NCT02129777|448889841|FG000|Double-Blind Period|Lack of Efficacy|3|||
124797509|NCT02129777|448889842|FG001|Double-Blind Period|Lack of Efficacy|1|||
124797510|NCT02129777|448889843|FG002|Double-Blind Period|Lack of Efficacy|0|||
124797511|NCT02129777|448889844|FG003|Double-Blind Period|Lack of Efficacy|3|||
124797512|NCT02129777|448889845|FG004|Double-Blind Period|Lack of Efficacy|2|||
124797513|NCT02129777|448889846|FG005|Double-Blind Period|Lack of Efficacy|0|||
124797514|NCT02129777|448889847|FG006|Double-Blind Period|Lack of Efficacy|0|||
124797515|NCT02129777|448889841|FG000|Double-Blind Period|Other|1|||
124797516|NCT02129777|448889842|FG001|Double-Blind Period|Other|2|||
124797517|NCT02129777|448889843|FG002|Double-Blind Period|Other|0|||
124797518|NCT02129777|448889844|FG003|Double-Blind Period|Other|0|||
124797519|NCT02129777|448889845|FG004|Double-Blind Period|Other|0|||
124797520|NCT02129777|448889846|FG005|Double-Blind Period|Other|0|||
124797521|NCT02129777|448889847|FG006|Double-Blind Period|Other|0|||
124797522|NCT02129777|448889841|FG000|Open-Label Period|Lack of Efficacy|0|||
124797523|NCT02129777|448889842|FG001|Open-Label Period|Lack of Efficacy|0|||
124797524|NCT02129777|448889843|FG002|Open-Label Period|Lack of Efficacy|0|||
124797525|NCT02129777|448889844|FG003|Open-Label Period|Lack of Efficacy|0|||
124797526|NCT02129777|448889845|FG004|Open-Label Period|Lack of Efficacy|0|||
124797527|NCT02129777|448889846|FG005|Open-Label Period|Lack of Efficacy|0|||
124797528|NCT02129777|448889847|FG006|Open-Label Period|Lack of Efficacy|5|||
124797529|NCT02129777|448889841|FG000|Open-Label Period|Lost to Follow-up|0|||
124797530|NCT02129777|448889842|FG001|Open-Label Period|Lost to Follow-up|0|||
124797531|NCT02129777|448889843|FG002|Open-Label Period|Lost to Follow-up|0|||
124797532|NCT02129777|448889844|FG003|Open-Label Period|Lost to Follow-up|0|||
124797533|NCT02129777|448889845|FG004|Open-Label Period|Lost to Follow-up|0|||
124797534|NCT02129777|448889846|FG005|Open-Label Period|Lost to Follow-up|1|||
124797535|NCT02129777|448889847|FG006|Open-Label Period|Lost to Follow-up|1|||
124797536|NCT02129777|448889841|FG000|Open-Label Period|Withdrawal by Subject|0|||
124797537|NCT02129777|448889842|FG001|Open-Label Period|Withdrawal by Subject|0|||
124797538|NCT02129777|448889843|FG002|Open-Label Period|Withdrawal by Subject|0|||
124797539|NCT02129777|448889844|FG003|Open-Label Period|Withdrawal by Subject|0|||
124797540|NCT02129777|448889845|FG004|Open-Label Period|Withdrawal by Subject|0|||
124797541|NCT02129777|448889846|FG005|Open-Label Period|Withdrawal by Subject|1|||
124797542|NCT02129777|448889847|FG006|Open-Label Period|Withdrawal by Subject|3|||
124797543|NCT02129777|448889841|FG000|Open-Label Period|Study Termination|0|||
124797544|NCT02129777|448889842|FG001|Open-Label Period|Study Termination|0|||
124797545|NCT02129777|448889843|FG002|Open-Label Period|Study Termination|0|||
124797546|NCT02129777|448889844|FG003|Open-Label Period|Study Termination|0|||
124797547|NCT02129777|448889845|FG004|Open-Label Period|Study Termination|0|||
124797548|NCT02129777|448889846|FG005|Open-Label Period|Study Termination|10|||
124797549|NCT02129777|448889847|FG006|Open-Label Period|Study Termination|39|||
124797550|NCT00542451|448889851|FG000|Overall Study|Adverse Event|31|||
124797551|NCT00542451|448889851|FG000|Overall Study|Withdrawal by Subject|30|||
124797552|NCT00542451|448889851|FG000|Overall Study|Physician Decision|4|||
124797553|NCT00542451|448889851|FG000|Overall Study|Recurrent disease|1|||
124797554|NCT00542451|448889851|FG000|Overall Study|unknown reason|1|||
124797555|NCT00542451|448889851|FG000|Overall Study|Death|2|||
124797556|NCT00542451|448889851|FG000|Overall Study|Lost to Follow-up|10|||
124797557|NCT00064298|448889860|FG000|Overall Study|Withdrawal by Subject|2|||
124797558|NCT00064298|448889861|FG001|Overall Study|Withdrawal by Subject|1|||
124797559|NCT00064298|448889860|FG000|Overall Study|Lost to Follow-up|2|||
124797560|NCT00064298|448889861|FG001|Overall Study|Lost to Follow-up|2|||
124797561|NCT00064298|448889860|FG000|Overall Study|Death|0|||
124797562|NCT00064298|448889861|FG001|Overall Study|Death|1|||
124797563|NCT00064298|448889860|FG000|Overall Study|Disease Progression|2|||
124797564|NCT00064298|448889861|FG001|Overall Study|Disease Progression|1|||
124797565|NCT01856023|448889862|FG000|Overall Study|Death|1|||
124797566|NCT01856023|448889863|FG001|Overall Study|Death|2|||
124797567|NCT01856023|448889862|FG000|Overall Study|Adverse Event|2|||
124797568|NCT01856023|448889863|FG001|Overall Study|Adverse Event|1|||
124797569|NCT01856023|448889862|FG000|Overall Study|Lack of Efficacy|5|||
124797570|NCT01856023|448889863|FG001|Overall Study|Lack of Efficacy|5|||
124797571|NCT01856023|448889862|FG000|Overall Study|non compliance, study closure|1|||
124797572|NCT01856023|448889863|FG001|Overall Study|non compliance, study closure|3|||
124797573|NCT01856023|448889862|FG000|Overall Study|Withdrawal by Subject|1|||
124797574|NCT01856023|448889863|FG001|Overall Study|Withdrawal by Subject|1|||
124797575|NCT00322153|448889866|FG000|Overall Study|Adverse Event|21|||
124797576|NCT00322153|448889867|FG001|Overall Study|Adverse Event|34|||
124797577|NCT00322153|448889866|FG000|Overall Study|Protocol Violation|6|||
124797578|NCT00322153|448889867|FG001|Overall Study|Protocol Violation|14|||
124797579|NCT00322153|448889866|FG000|Overall Study|Withdrawal by Subject|18|||
124797580|NCT00322153|448889867|FG001|Overall Study|Withdrawal by Subject|10|||
124797581|NCT00322153|448889866|FG000|Overall Study|Lack of Efficacy|8|||
124797582|NCT00322153|448889867|FG001|Overall Study|Lack of Efficacy|3|||
124797583|NCT00322153|448889866|FG000|Overall Study|Lost to Follow-up|5|||
124797584|NCT00322153|448889867|FG001|Overall Study|Lost to Follow-up|4|||
124797585|NCT00322153|448889866|FG000|Overall Study|Withdrawn for other reasons|5|||
124797586|NCT00322153|448889867|FG001|Overall Study|Withdrawn for other reasons|4|||
124797587|NCT01309893|448889868|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
124797588|NCT01309893|448889869|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
124797589|NCT01309893|448889868|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
124797590|NCT01309893|448889869|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
124752406|NCT01724866|448716739|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
124752407|NCT01724866|448716736|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
124752408|NCT01724866|448716737|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
124752409|NCT01724866|448716738|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
124752410|NCT01724866|448716739|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
124752411|NCT02300259|448716744|FG000|Period 1|Adverse Event|0|||
124752412|NCT02300259|448716745|FG001|Period 1|Adverse Event|0|||
124752413|NCT02300259|448716746|FG002|Period 1|Adverse Event|1|||
124752414|NCT02300259|448716744|FG000|Period 1|Withdrawal by Subject|0|||
124752415|NCT02300259|448716745|FG001|Period 1|Withdrawal by Subject|0|||
124629853|NCT02325973|448262838|FG000|Overall Study|Death|5|||
124629854|NCT02325973|448262838|FG000|Overall Study|Withdrawal by subject or investigator|16|||
124629855|NCT05655546|448262839|FG000|Overall Study|Withdrawal by Subject|2|||
124629856|NCT05655546|448262840|FG001|Overall Study|Withdrawal by Subject|4|||
124629857|NCT04510090|448262841|FG000|FE-HS|Withdrawal by Subject|0|||
124629858|NCT04510090|448262842|FG001|FE-HS|Withdrawal by Subject|0|||
124629859|NCT04510090|448262843|FG002|FE-HS|Withdrawal by Subject|0|||
124629860|NCT04510090|448262844|FG003|FE-HS|Withdrawal by Subject|0|||
124629861|NCT04510090|448262845|FG004|FE-HS|Withdrawal by Subject|1|||
124629862|NCT04510090|448262846|FG005|FE-HS|Withdrawal by Subject|0|||
124629863|NCT04510090|448262847|FG006|FE-HS|Withdrawal by Subject|0|||
124629864|NCT04510090|448262848|FG007|FE-HS|Withdrawal by Subject|0|||
124629865|NCT05825404|448262849|FG000|First Intervention (Weeks 2-5)|Death|0|||
124629866|NCT05825404|448262850|FG001|First Intervention (Weeks 2-5)|Death|1|||
124629867|NCT05825404|448262849|FG000|Second Intervention (Weeks 8-11)|Death|0|||
124629868|NCT05825404|448262850|FG001|Second Intervention (Weeks 8-11)|Death|1|||
124629869|NCT01415518|448262851|FG000|Overall Study|Withdrawal by Subject|2|||
124629870|NCT01415518|448262852|FG001|Overall Study|Withdrawal by Subject|12|||
124629871|NCT01415518|448262851|FG000|Overall Study|Protocol Violation|6|||
124629872|NCT01415518|448262852|FG001|Overall Study|Protocol Violation|8|||
124629873|NCT01415518|448262851|FG000|Overall Study|Lost to Follow-up|3|||
124629874|NCT01415518|448262852|FG001|Overall Study|Lost to Follow-up|5|||
124629875|NCT01415518|448262851|FG000|Overall Study|Adverse Event|3|||
124629876|NCT01415518|448262852|FG001|Overall Study|Adverse Event|4|||
124629877|NCT01415518|448262851|FG000|Overall Study|Death|1|||
124629878|NCT01415518|448262852|FG001|Overall Study|Death|1|||
124629879|NCT01415518|448262851|FG000|Overall Study|Condition under Investigation Worsened|1|||
124629880|NCT01415518|448262852|FG001|Overall Study|Condition under Investigation Worsened|1|||
124629881|NCT00679211|448262853|FG000|Overall Study|Progressive disease|82|||
124629882|NCT00679211|448262853|FG000|Overall Study|Adverse Event|7|||
124629883|NCT00679211|448262853|FG000|Overall Study|Withdrawal by Subject|2|||
124629884|NCT00679211|448262853|FG000|Overall Study|Physician Decision|5|||
124752416|NCT02300259|448716746|FG002|Period 1|Withdrawal by Subject|1|||
124752417|NCT02300259|448716744|FG000|Period 2|Adverse Event|1|||
124752418|NCT02300259|448716745|FG001|Period 2|Adverse Event|0|||
124629885|NCT00679211|448262853|FG000|Overall Study|Refused to undergo protocol procedures|1|||
124629886|NCT00679211|448262853|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
124629887|NCT00679211|448262853|FG000|Overall Study|Other|1|||
124629888|NCT01730053|448262854|FG000|Overall Study|Participant moved|0|||
124752419|NCT02300259|448716746|FG002|Period 2|Adverse Event|0|||
124629889|NCT01730053|448262855|FG001|Overall Study|Participant moved|0|||
124629890|NCT01730053|448262856|FG002|Overall Study|Participant moved|1|||
124629891|NCT01730053|448262857|FG003|Overall Study|Participant moved|0|||
124629892|NCT01730053|448262858|FG004|Overall Study|Participant moved|0|||
124629893|NCT01730053|448262859|FG005|Overall Study|Participant moved|0|||
124752420|NCT02300259|448716744|FG000|Period 2|Withdrawal by Subject|0|||
124797591|NCT02414139|448889870|FG000|Treatment Period|Adverse Event|11|||
124629894|NCT01730053|448262854|FG000|Overall Study|Physician Decision|0|||
124797592|NCT02414139|448889871|FG001|Treatment Period|Adverse Event|6|||
124797593|NCT02414139|448889872|FG002|Treatment Period|Adverse Event|8|||
124797594|NCT02414139|448889873|FG003|Treatment Period|Adverse Event|5|||
124797595|NCT02414139|448889874|FG004|Treatment Period|Adverse Event|14|||
124797596|NCT02414139|448889875|FG005|Treatment Period|Adverse Event|3|||
124797597|NCT02414139|448889876|FG006|Treatment Period|Adverse Event|6|||
124797598|NCT02414139|448889877|FG007|Treatment Period|Adverse Event|1|||
124797599|NCT02414139|448889878|FG008|Treatment Period|Adverse Event|6|||
124797600|NCT02414139|448889879|FG009|Treatment Period|Adverse Event|8|||
124797601|NCT02414139|448889870|FG000|Treatment Period|Death|0|||
124797602|NCT02414139|448889871|FG001|Treatment Period|Death|0|||
124797603|NCT02414139|448889872|FG002|Treatment Period|Death|1|||
124797604|NCT02414139|448889873|FG003|Treatment Period|Death|1|||
124797605|NCT02414139|448889874|FG004|Treatment Period|Death|0|||
124797606|NCT02414139|448889875|FG005|Treatment Period|Death|0|||
124797607|NCT02414139|448889876|FG006|Treatment Period|Death|0|||
124797608|NCT02414139|448889877|FG007|Treatment Period|Death|0|||
124797609|NCT02414139|448889878|FG008|Treatment Period|Death|0|||
124797610|NCT02414139|448889879|FG009|Treatment Period|Death|1|||
124797611|NCT02414139|448889870|FG000|Treatment Period|Physician Decision|5|||
124797612|NCT02414139|448889871|FG001|Treatment Period|Physician Decision|4|||
124797613|NCT02414139|448889872|FG002|Treatment Period|Physician Decision|6|||
124797614|NCT02414139|448889873|FG003|Treatment Period|Physician Decision|1|||
124797615|NCT02414139|448889874|FG004|Treatment Period|Physician Decision|4|||
124797616|NCT02414139|448889875|FG005|Treatment Period|Physician Decision|0|||
124797617|NCT02414139|448889876|FG006|Treatment Period|Physician Decision|2|||
124797618|NCT02414139|448889877|FG007|Treatment Period|Physician Decision|0|||
124797619|NCT02414139|448889878|FG008|Treatment Period|Physician Decision|1|||
124797620|NCT02414139|448889879|FG009|Treatment Period|Physician Decision|4|||
124797621|NCT02414139|448889870|FG000|Treatment Period|Progressive disease|48|||
124797622|NCT02414139|448889871|FG001|Treatment Period|Progressive disease|31|||
124797623|NCT02414139|448889872|FG002|Treatment Period|Progressive disease|37|||
124797624|NCT02414139|448889873|FG003|Treatment Period|Progressive disease|21|||
124797625|NCT02414139|448889874|FG004|Treatment Period|Progressive disease|43|||
124797626|NCT02414139|448889875|FG005|Treatment Period|Progressive disease|12|||
124797627|NCT02414139|448889876|FG006|Treatment Period|Progressive disease|16|||
124797628|NCT02414139|448889877|FG007|Treatment Period|Progressive disease|2|||
124797629|NCT02414139|448889878|FG008|Treatment Period|Progressive disease|20|||
124797630|NCT02414139|448889879|FG009|Treatment Period|Progressive disease|14|||
124797631|NCT02414139|448889870|FG000|Treatment Period|Protocol deviation|0|||
124797632|NCT02414139|448889871|FG001|Treatment Period|Protocol deviation|0|||
124797633|NCT02414139|448889872|FG002|Treatment Period|Protocol deviation|1|||
124797634|NCT02414139|448889873|FG003|Treatment Period|Protocol deviation|0|||
124797635|NCT02414139|448889874|FG004|Treatment Period|Protocol deviation|0|||
124797636|NCT02414139|448889875|FG005|Treatment Period|Protocol deviation|0|||
124797637|NCT02414139|448889876|FG006|Treatment Period|Protocol deviation|0|||
124797638|NCT02414139|448889877|FG007|Treatment Period|Protocol deviation|0|||
124797639|NCT02414139|448889878|FG008|Treatment Period|Protocol deviation|0|||
124797640|NCT02414139|448889879|FG009|Treatment Period|Protocol deviation|0|||
124797641|NCT02414139|448889870|FG000|Treatment Period|Subject/Guardian decision|5|||
124797642|NCT02414139|448889871|FG001|Treatment Period|Subject/Guardian decision|1|||
124797643|NCT02414139|448889872|FG002|Treatment Period|Subject/Guardian decision|1|||
124797644|NCT02414139|448889873|FG003|Treatment Period|Subject/Guardian decision|2|||
124797645|NCT02414139|448889874|FG004|Treatment Period|Subject/Guardian decision|5|||
124797646|NCT02414139|448889875|FG005|Treatment Period|Subject/Guardian decision|0|||
124797647|NCT02414139|448889876|FG006|Treatment Period|Subject/Guardian decision|2|||
124797648|NCT02414139|448889877|FG007|Treatment Period|Subject/Guardian decision|0|||
124797649|NCT02414139|448889878|FG008|Treatment Period|Subject/Guardian decision|1|||
124797650|NCT02414139|448889879|FG009|Treatment Period|Subject/Guardian decision|1|||
124797651|NCT02414139|448889870|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
124797652|NCT02414139|448889871|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
124797653|NCT02414139|448889872|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
124797654|NCT02414139|448889873|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
124797655|NCT02414139|448889874|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
124797656|NCT02414139|448889875|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
124797657|NCT02414139|448889876|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
124797658|NCT02414139|448889877|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
124797659|NCT02414139|448889878|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
124797660|NCT02414139|448889879|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
124797661|NCT02414139|448889870|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
124797662|NCT02414139|448889871|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124797663|NCT02414139|448889872|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124797664|NCT02414139|448889873|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124797665|NCT02414139|448889874|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
124797666|NCT02414139|448889875|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124797667|NCT02414139|448889876|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124797668|NCT02414139|448889877|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124797669|NCT02414139|448889878|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124797670|NCT02414139|448889879|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
124797671|NCT02414139|448889870|FG000|Post-treatment Efficacy Follow-up|Death|0|||
124797672|NCT02414139|448889871|FG001|Post-treatment Efficacy Follow-up|Death|1|||
124797673|NCT02414139|448889872|FG002|Post-treatment Efficacy Follow-up|Death|0|||
124797674|NCT02414139|448889873|FG003|Post-treatment Efficacy Follow-up|Death|0|||
124797675|NCT02414139|448889874|FG004|Post-treatment Efficacy Follow-up|Death|1|||
124797676|NCT02414139|448889875|FG005|Post-treatment Efficacy Follow-up|Death|0|||
124797677|NCT02414139|448889876|FG006|Post-treatment Efficacy Follow-up|Death|0|||
124797678|NCT02414139|448889877|FG007|Post-treatment Efficacy Follow-up|Death|0|||
124797679|NCT02414139|448889878|FG008|Post-treatment Efficacy Follow-up|Death|0|||
124797680|NCT02414139|448889879|FG009|Post-treatment Efficacy Follow-up|Death|1|||
124797681|NCT02414139|448889870|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
124797682|NCT02414139|448889871|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797683|NCT02414139|448889872|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797684|NCT02414139|448889873|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797685|NCT02414139|448889874|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797686|NCT02414139|448889875|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797687|NCT02414139|448889876|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797688|NCT02414139|448889877|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797689|NCT02414139|448889878|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797690|NCT02414139|448889879|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
124797691|NCT02414139|448889870|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
124797692|NCT02414139|448889871|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
124797693|NCT02414139|448889872|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
124797694|NCT02414139|448889873|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
124797695|NCT02414139|448889874|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
124797696|NCT02414139|448889875|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
124797697|NCT02414139|448889876|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
124797698|NCT02414139|448889877|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
124797699|NCT02414139|448889878|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
124797700|NCT02414139|448889879|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
124797701|NCT02414139|448889870|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
124797702|NCT02414139|448889871|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
124797703|NCT02414139|448889872|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
124797704|NCT02414139|448889873|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
124797705|NCT02414139|448889874|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
124797706|NCT02414139|448889875|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
124797707|NCT02414139|448889876|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
124797708|NCT02414139|448889877|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
124797709|NCT02414139|448889878|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
124797710|NCT02414139|448889879|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
124797711|NCT02414139|448889870|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
124797712|NCT02414139|448889871|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
124797713|NCT02414139|448889872|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
124797714|NCT02414139|448889873|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
124797715|NCT02414139|448889874|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
124797716|NCT02414139|448889875|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
124797717|NCT02414139|448889876|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
124797718|NCT02414139|448889877|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
124797719|NCT02414139|448889878|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
124797720|NCT02414139|448889879|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
124797721|NCT02414139|448889870|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
124797722|NCT02414139|448889871|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
124797723|NCT02414139|448889872|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
124797724|NCT02414139|448889873|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
124629895|NCT01730053|448262855|FG001|Overall Study|Physician Decision|0|||
124629896|NCT01730053|448262856|FG002|Overall Study|Physician Decision|0|||
124797725|NCT02414139|448889874|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
124797726|NCT02414139|448889875|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
124797727|NCT02414139|448889876|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
124797728|NCT02414139|448889877|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
124797729|NCT02414139|448889878|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
124797730|NCT02414139|448889879|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
124797731|NCT02632838|448889880|FG000|Overall Study|Withdrawal by Subject|3|||
124797732|NCT02632838|448889881|FG001|Overall Study|Withdrawal by Subject|0|||
124797733|NCT02632838|448889880|FG000|Overall Study|Lost to Follow-up|0|||
124797734|NCT02632838|448889881|FG001|Overall Study|Lost to Follow-up|2|||
124797735|NCT02810340|448889882|FG000|Overall Study|Withdrawal by Subject|1|||
124797736|NCT02810340|448889883|FG001|Overall Study|Withdrawal by Subject|0|||
124797737|NCT02810340|448889884|FG002|Overall Study|Withdrawal by Subject|0|||
124797738|NCT02810340|448889882|FG000|Overall Study|Incarceration|0|||
124797739|NCT02810340|448889883|FG001|Overall Study|Incarceration|1|||
124797740|NCT02810340|448889884|FG002|Overall Study|Incarceration|0|||
124797741|NCT02810340|448889882|FG000|Overall Study|Lost to Follow-up|0|||
124797742|NCT02810340|448889883|FG001|Overall Study|Lost to Follow-up|0|||
124797743|NCT02810340|448889884|FG002|Overall Study|Lost to Follow-up|1|||
124797744|NCT01233687|448889890|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
124797745|NCT01233687|448889890|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
124797746|NCT01233687|448889890|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
124797747|NCT01484938|448889891|FG000|Overall Study|Adverse Event|2|||
124797748|NCT01484938|448889891|FG000|Overall Study|Lost to Follow-up|1|||
124797749|NCT01484938|448889891|FG000|Overall Study|Noncompliance|1|||
124797750|NCT02211638|448889892|FG000|Overall Study|Case Report Forms Uncollected|291|||
124797751|NCT02211638|448889892|FG000|Overall Study|Protocol Violation|692|||
124797752|NCT04571515|448889895|FG000|Overall Study|Physician Decision|0|||
124797753|NCT04571515|448889896|FG001|Overall Study|Physician Decision|0|||
124797754|NCT04571515|448889897|FG002|Overall Study|Physician Decision|0|||
124797755|NCT04571515|448889898|FG003|Overall Study|Physician Decision|0|||
124797756|NCT04571515|448889899|FG004|Overall Study|Physician Decision|1|||
124797757|NCT04571515|448889895|FG000|Overall Study|Withdrawal by Subject|0|||
124797758|NCT04571515|448889896|FG001|Overall Study|Withdrawal by Subject|0|||
124797759|NCT04571515|448889897|FG002|Overall Study|Withdrawal by Subject|0|||
124797760|NCT04571515|448889898|FG003|Overall Study|Withdrawal by Subject|0|||
124797761|NCT04571515|448889899|FG004|Overall Study|Withdrawal by Subject|1|||
124797762|NCT04571515|448889895|FG000|Overall Study|insufficient pain|1|||
124797763|NCT04571515|448889896|FG001|Overall Study|insufficient pain|0|||
124797764|NCT04571515|448889897|FG002|Overall Study|insufficient pain|0|||
124797765|NCT04571515|448889898|FG003|Overall Study|insufficient pain|0|||
124797766|NCT04571515|448889899|FG004|Overall Study|insufficient pain|1|||
124797767|NCT05140382|448889900|FG000|Overall Study|Death|3|||
124629897|NCT01730053|448262857|FG003|Overall Study|Physician Decision|1|||
124629898|NCT01730053|448262858|FG004|Overall Study|Physician Decision|0|||
124629899|NCT01730053|448262859|FG005|Overall Study|Physician Decision|0|||
124629900|NCT01730053|448262854|FG000|Overall Study|Adverse Event|2|||
124629901|NCT01730053|448262855|FG001|Overall Study|Adverse Event|6|||
124629902|NCT01730053|448262856|FG002|Overall Study|Adverse Event|3|||
124629903|NCT01730053|448262857|FG003|Overall Study|Adverse Event|3|||
124797768|NCT05140382|448889901|FG001|Overall Study|Death|0|||
124797769|NCT05140382|448889902|FG002|Overall Study|Death|0|||
124797770|NCT05140382|448889900|FG000|Overall Study|Investigator decision|1|||
124797771|NCT05140382|448889901|FG001|Overall Study|Investigator decision|0|||
124797772|NCT05140382|448889902|FG002|Overall Study|Investigator decision|0|||
124797773|NCT05140382|448889900|FG000|Overall Study|Other|4|||
124797774|NCT05140382|448889901|FG001|Overall Study|Other|0|||
124797775|NCT05140382|448889902|FG002|Overall Study|Other|1|||
124797776|NCT05140382|448889900|FG000|Overall Study|Progressive disease|20|||
124797777|NCT05140382|448889901|FG001|Overall Study|Progressive disease|1|||
124629904|NCT01730053|448262858|FG004|Overall Study|Adverse Event|2|||
124629905|NCT01730053|448262859|FG005|Overall Study|Adverse Event|2|||
124629906|NCT01730053|448262854|FG000|Overall Study|Poor compliance to protocol|1|||
124629907|NCT01730053|448262855|FG001|Overall Study|Poor compliance to protocol|2|||
124797778|NCT05140382|448889902|FG002|Overall Study|Progressive disease|12|||
124797779|NCT05140382|448889900|FG000|Overall Study|Subjective disease progression|2|||
124797780|NCT05140382|448889901|FG001|Overall Study|Subjective disease progression|1|||
124797781|NCT05140382|448889902|FG002|Overall Study|Subjective disease progression|0|||
124797782|NCT05140382|448889900|FG000|Overall Study|Unknown at data cut-off|0|||
124797783|NCT05140382|448889901|FG001|Overall Study|Unknown at data cut-off|0|||
124797784|NCT05140382|448889902|FG002|Overall Study|Unknown at data cut-off|1|||
124797785|NCT05140382|448889900|FG000|Overall Study|Withdrawal by Subject|1|||
124797786|NCT05140382|448889901|FG001|Overall Study|Withdrawal by Subject|0|||
124797787|NCT05140382|448889902|FG002|Overall Study|Withdrawal by Subject|4|||
124797788|NCT05140382|448889900|FG000|Overall Study|Withdrawal of consent|0|||
124797789|NCT05140382|448889901|FG001|Overall Study|Withdrawal of consent|0|||
124797790|NCT05140382|448889902|FG002|Overall Study|Withdrawal of consent|1|||
124797791|NCT00323869|448889907|FG000|Overall Study|Death|1|||
124797792|NCT04902326|448891530|FG000|Overall Study|Withdrawal by Subject|1|||
124797793|NCT04902326|448891531|FG001|Overall Study|Withdrawal by Subject|3|||
124797794|NCT04902326|448891532|FG002|Overall Study|Withdrawal by Subject|0|||
124629908|NCT01730053|448262856|FG002|Overall Study|Poor compliance to protocol|2|||
124629909|NCT01730053|448262857|FG003|Overall Study|Poor compliance to protocol|0|||
124797795|NCT04902326|448891533|FG003|Overall Study|Withdrawal by Subject|1|||
124797796|NCT04902326|448891530|FG000|Overall Study|Lost to Follow-up|14|||
124797797|NCT04902326|448891531|FG001|Overall Study|Lost to Follow-up|14|||
124797798|NCT04902326|448891532|FG002|Overall Study|Lost to Follow-up|14|||
124797799|NCT04902326|448891533|FG003|Overall Study|Lost to Follow-up|6|||
124797800|NCT00427960|448891534|FG000|Overall Study|Adverse Event|2|||
124797801|NCT00427960|448891535|FG001|Overall Study|Adverse Event|0|||
124797802|NCT00427960|448891534|FG000|Overall Study|Withdrawal by Subject|0|||
124797803|NCT00427960|448891535|FG001|Overall Study|Withdrawal by Subject|3|||
124797804|NCT00427960|448891534|FG000|Overall Study|Other|0|||
124797805|NCT00427960|448891535|FG001|Overall Study|Other|1|||
124797806|NCT00423670|448891538|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
124797807|NCT00423670|448891539|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
124797808|NCT00423670|448891540|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
124797809|NCT00423670|448891541|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
124797810|NCT00423670|448891542|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
124797811|NCT00423670|448891543|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
124797812|NCT00423670|448891544|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
124797813|NCT00423670|448891545|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
124797814|NCT00423670|448891538|FG000|Treatment Period|Adverse Event|8|||
124797815|NCT00423670|448891539|FG001|Treatment Period|Adverse Event|12|||
124797816|NCT00423670|448891540|FG002|Treatment Period|Adverse Event|15|||
124797817|NCT00423670|448891541|FG003|Treatment Period|Adverse Event|20|||
124797818|NCT00423670|448891542|FG004|Treatment Period|Adverse Event|9|||
124797819|NCT00423670|448891543|FG005|Treatment Period|Adverse Event|4|||
124797820|NCT00423670|448891544|FG006|Treatment Period|Adverse Event|7|||
124797821|NCT00423670|448891545|FG007|Treatment Period|Adverse Event|2|||
124797822|NCT00423670|448891538|FG000|Treatment Period|Protocol-defined clinical event|0|||
124797823|NCT00423670|448891539|FG001|Treatment Period|Protocol-defined clinical event|7|||
124797824|NCT00423670|448891540|FG002|Treatment Period|Protocol-defined clinical event|4|||
124797825|NCT00423670|448891541|FG003|Treatment Period|Protocol-defined clinical event|12|||
124797826|NCT00423670|448891542|FG004|Treatment Period|Protocol-defined clinical event|5|||
124797827|NCT00423670|448891543|FG005|Treatment Period|Protocol-defined clinical event|4|||
124797828|NCT00423670|448891544|FG006|Treatment Period|Protocol-defined clinical event|16|||
124797829|NCT00423670|448891545|FG007|Treatment Period|Protocol-defined clinical event|15|||
124797830|NCT00423670|448891538|FG000|Treatment Period|Lost to Follow-up|2|||
124797831|NCT00423670|448891539|FG001|Treatment Period|Lost to Follow-up|1|||
124797832|NCT00423670|448891540|FG002|Treatment Period|Lost to Follow-up|3|||
124797833|NCT00423670|448891541|FG003|Treatment Period|Lost to Follow-up|1|||
124797834|NCT00423670|448891542|FG004|Treatment Period|Lost to Follow-up|6|||
124797835|NCT00423670|448891543|FG005|Treatment Period|Lost to Follow-up|0|||
124797836|NCT00423670|448891544|FG006|Treatment Period|Lost to Follow-up|3|||
124797837|NCT00423670|448891545|FG007|Treatment Period|Lost to Follow-up|1|||
124797838|NCT00423670|448891538|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
124797839|NCT00423670|448891539|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
124797840|NCT00423670|448891540|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
124797841|NCT00423670|448891541|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
124797842|NCT00423670|448891542|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
124797843|NCT00423670|448891543|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
124797844|NCT00423670|448891544|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
124797845|NCT00423670|448891545|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
124797846|NCT00423670|448891538|FG000|Treatment Period|Investigator decision|0|||
124797847|NCT00423670|448891539|FG001|Treatment Period|Investigator decision|0|||
124797848|NCT00423670|448891540|FG002|Treatment Period|Investigator decision|0|||
124797849|NCT00423670|448891541|FG003|Treatment Period|Investigator decision|0|||
124797850|NCT00423670|448891542|FG004|Treatment Period|Investigator decision|0|||
124797851|NCT00423670|448891543|FG005|Treatment Period|Investigator decision|0|||
124797852|NCT00423670|448891544|FG006|Treatment Period|Investigator decision|0|||
124797853|NCT00423670|448891545|FG007|Treatment Period|Investigator decision|1|||
124797854|NCT00423670|448891538|FG000|Treatment Period|Non-compliance with protocol|3|||
124797855|NCT00423670|448891539|FG001|Treatment Period|Non-compliance with protocol|1|||
124797856|NCT00423670|448891540|FG002|Treatment Period|Non-compliance with protocol|1|||
124797857|NCT00423670|448891541|FG003|Treatment Period|Non-compliance with protocol|3|||
124797858|NCT00423670|448891542|FG004|Treatment Period|Non-compliance with protocol|2|||
124797859|NCT00423670|448891543|FG005|Treatment Period|Non-compliance with protocol|0|||
124797860|NCT00423670|448891544|FG006|Treatment Period|Non-compliance with protocol|2|||
124797861|NCT00423670|448891545|FG007|Treatment Period|Non-compliance with protocol|2|||
124797862|NCT00423670|448891538|FG000|Follow-up Period|Lost to Follow-up|0|||
124797863|NCT00423670|448891539|FG001|Follow-up Period|Lost to Follow-up|12|||
124797864|NCT00423670|448891540|FG002|Follow-up Period|Lost to Follow-up|8|||
124797865|NCT00423670|448891541|FG003|Follow-up Period|Lost to Follow-up|3|||
124797866|NCT00423670|448891542|FG004|Follow-up Period|Lost to Follow-up|1|||
124797867|NCT00423670|448891543|FG005|Follow-up Period|Lost to Follow-up|0|||
124797868|NCT00423670|448891544|FG006|Follow-up Period|Lost to Follow-up|5|||
124797869|NCT00423670|448891545|FG007|Follow-up Period|Lost to Follow-up|0|||
124797870|NCT00423670|448891538|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
124797871|NCT00423670|448891539|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
124797872|NCT00423670|448891540|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
124797873|NCT00423670|448891541|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
124797874|NCT00423670|448891542|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
124797875|NCT00423670|448891543|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
124797876|NCT00423670|448891544|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
124797877|NCT00423670|448891545|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
124797878|NCT00423670|448891538|FG000|Follow-up Period|Non-compliance with protocol|2|||
124797879|NCT00423670|448891539|FG001|Follow-up Period|Non-compliance with protocol|0|||
124797880|NCT00423670|448891540|FG002|Follow-up Period|Non-compliance with protocol|1|||
124797881|NCT00423670|448891541|FG003|Follow-up Period|Non-compliance with protocol|1|||
124797882|NCT00423670|448891542|FG004|Follow-up Period|Non-compliance with protocol|0|||
124797883|NCT00423670|448891543|FG005|Follow-up Period|Non-compliance with protocol|0|||
124797884|NCT00423670|448891544|FG006|Follow-up Period|Non-compliance with protocol|3|||
124797885|NCT00423670|448891545|FG007|Follow-up Period|Non-compliance with protocol|2|||
124797886|NCT04163718|448891546|FG000|Overall Study|Study terminated|12|||
124797887|NCT01025154|448891547|FG000|Overall Study|Lost to Follow-up|1|||
124797888|NCT01025154|448891547|FG000|Overall Study|Withdrawal by Subject|1|||
124797889|NCT02942576|448891549|FG000|Overall Study|Adverse Event|28|||
124797890|NCT02942576|448891550|FG001|Overall Study|Adverse Event|6|||
124797891|NCT02942576|448891549|FG000|Overall Study|Withdrawal by Subject|7|||
124797892|NCT02942576|448891550|FG001|Overall Study|Withdrawal by Subject|5|||
124797893|NCT02942576|448891549|FG000|Overall Study|Physician Decision|1|||
124797894|NCT02942576|448891550|FG001|Overall Study|Physician Decision|4|||
124797895|NCT02942576|448891549|FG000|Overall Study|Other|10|||
124629910|NCT01730053|448262858|FG004|Overall Study|Poor compliance to protocol|0|||
124629911|NCT01730053|448262859|FG005|Overall Study|Poor compliance to protocol|2|||
124629912|NCT01730053|448262854|FG000|Overall Study|Other than specified|2|||
124629913|NCT01730053|448262855|FG001|Overall Study|Other than specified|6|||
124797896|NCT02942576|448891550|FG001|Overall Study|Other|8|||
124797897|NCT00938964|448891551|FG000|Overall Study|Death|3|||
124797898|NCT00938964|448891552|FG001|Overall Study|Death|3|||
124797899|NCT00938964|448891551|FG000|Overall Study|Lost to Follow-up|2|||
124797900|NCT00938964|448891552|FG001|Overall Study|Lost to Follow-up|3|||
124797901|NCT00938964|448891551|FG000|Overall Study|Withdrawal by Subject|22|||
124797902|NCT00938964|448891552|FG001|Overall Study|Withdrawal by Subject|18|||
124797903|NCT00938964|448891551|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
124797904|NCT00938964|448891552|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
124797905|NCT01858636|448891553|FG000|Overall Study|No Device Deployment Attempted|24|||
124797906|NCT01858636|448891553|FG000|Overall Study|Physician Decision|1|||
124797907|NCT01858636|448891553|FG000|Overall Study|Death|1|||
124797908|NCT01858636|448891553|FG000|Overall Study|Lost to Follow-up|1|||
124797909|NCT01858636|448891553|FG000|Overall Study|Withdrawal by Subject|1|||
124797910|NCT03523000|448891557|FG000|Overall Study|Withdrawal by Subject|3|||
124797911|NCT03523000|448891558|FG001|Overall Study|Withdrawal by Subject|0|||
124797912|NCT03523000|448891557|FG000|Overall Study|Unsuccessful trial|2|||
124797913|NCT03523000|448891558|FG001|Overall Study|Unsuccessful trial|0|||
124797914|NCT01227564|448891561|FG000|Overall Study|No Longer Willing to Participate|4|||
124797915|NCT01227564|448891562|FG001|Overall Study|No Longer Willing to Participate|2|||
124797916|NCT01227564|448891563|FG002|Overall Study|No Longer Willing to Participate|5|||
124797917|NCT01227564|448891561|FG000|Overall Study|Participant moved to another town|0|||
124797918|NCT01227564|448891562|FG001|Overall Study|Participant moved to another town|0|||
124797919|NCT01227564|448891563|FG002|Overall Study|Participant moved to another town|1|||
124797920|NCT02862600|448891575|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
124797921|NCT02862600|448891575|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
124797922|NCT02862600|448891575|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
124797923|NCT02862600|448891575|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
124797924|NCT00772070|448891592|FG000|Overall Study|Lost to Follow-up|0|||
124797925|NCT00772070|448891593|FG001|Overall Study|Lost to Follow-up|8|||
124797926|NCT00772070|448891592|FG000|Overall Study|Withdrawal by Subject|0|||
124797927|NCT00772070|448891593|FG001|Overall Study|Withdrawal by Subject|2|||
124797928|NCT00772070|448891592|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
124629914|NCT01730053|448262856|FG002|Overall Study|Other than specified|5|||
124629915|NCT01730053|448262857|FG003|Overall Study|Other than specified|4|||
124629916|NCT01730053|448262858|FG004|Overall Study|Other than specified|7|||
124797929|NCT00772070|448891593|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
124797930|NCT01309308|448891594|FG000|Overall Study|Lost to Follow-up|6|||
124797931|NCT01309308|448891595|FG001|Overall Study|Lost to Follow-up|4|||
124797932|NCT01017575|448891596|FG000|Overall Study|Lack of Efficacy|0|||
124797933|NCT01017575|448891597|FG001|Overall Study|Lack of Efficacy|1|||
124797934|NCT01017575|448891598|FG002|Overall Study|Lack of Efficacy|0|||
124797935|NCT01017575|448891599|FG003|Overall Study|Lack of Efficacy|1|||
124797936|NCT01017575|448891600|FG004|Overall Study|Lack of Efficacy|1|||
124797937|NCT01017575|448891596|FG000|Overall Study|Adverse Event|0|||
124797938|NCT01017575|448891597|FG001|Overall Study|Adverse Event|1|||
124797939|NCT01017575|448891598|FG002|Overall Study|Adverse Event|0|||
124797940|NCT01017575|448891599|FG003|Overall Study|Adverse Event|0|||
124797941|NCT01017575|448891600|FG004|Overall Study|Adverse Event|2|||
124797942|NCT01017575|448891596|FG000|Overall Study|Withdrawal by Subject|1|||
124797943|NCT01017575|448891597|FG001|Overall Study|Withdrawal by Subject|0|||
124797944|NCT01017575|448891598|FG002|Overall Study|Withdrawal by Subject|0|||
124797945|NCT01017575|448891599|FG003|Overall Study|Withdrawal by Subject|0|||
124797946|NCT01017575|448891600|FG004|Overall Study|Withdrawal by Subject|0|||
124797947|NCT01476644|448891601|FG000|Overall Study|Death|5|||
124797948|NCT01476644|448891601|FG000|Overall Study|moved to another state|2|||
124797949|NCT01476644|448891601|FG000|Overall Study|Lost to Follow-up|19|||
124797950|NCT01476644|448891601|FG000|Overall Study|Withdrawal by Subject|13|||
124797951|NCT00095628|448891602|FG000|Overall Study|Disease progression prior to treatment|1|||
124797952|NCT04271280|448891603|FG000|Overall Study|Lost to Follow-up|300|||
124797953|NCT04271280|448891603|FG000|Overall Study|Death|153|||
124797954|NCT04271280|448891603|FG000|Overall Study|Withdrawal of consent by patient|59|||
124797955|NCT04271280|448891603|FG000|Overall Study|Other|51|||
124797956|NCT04271280|448891603|FG000|Overall Study|No end of study information|42|||
124797957|NCT00495131|448891604|FG000|Overall Study|Adverse Event|6|||
124797958|NCT00495131|448891605|FG001|Overall Study|Adverse Event|2|||
124797959|NCT00495131|448891604|FG000|Overall Study|Lack of Efficacy|0|||
124797960|NCT00495131|448891605|FG001|Overall Study|Lack of Efficacy|2|||
124797961|NCT00495131|448891604|FG000|Overall Study|Lost to Follow-up|0|||
124797962|NCT00495131|448891605|FG001|Overall Study|Lost to Follow-up|2|||
124797963|NCT00495131|448891604|FG000|Overall Study|Withdrawal by Subject|1|||
124797964|NCT00495131|448891605|FG001|Overall Study|Withdrawal by Subject|0|||
124797965|NCT00744471|448891606|FG000|Overall Study|Randomized but not treated|1|||
124797966|NCT00744471|448891607|FG001|Overall Study|Randomized but not treated|1|||
124797967|NCT00744471|448891608|FG002|Overall Study|Randomized but not treated|4|||
124797968|NCT00744471|448891609|FG003|Overall Study|Randomized but not treated|0|||
124797969|NCT00744471|448891606|FG000|Overall Study|Death|0|||
124797970|NCT00744471|448891607|FG001|Overall Study|Death|0|||
124797971|NCT00744471|448891608|FG002|Overall Study|Death|0|||
124797972|NCT00744471|448891609|FG003|Overall Study|Death|1|||
124797973|NCT00744471|448891606|FG000|Overall Study|Adverse Event|6|||
124797974|NCT00744471|448891607|FG001|Overall Study|Adverse Event|7|||
124797975|NCT00744471|448891608|FG002|Overall Study|Adverse Event|5|||
124797976|NCT00744471|448891609|FG003|Overall Study|Adverse Event|9|||
124797977|NCT00744471|448891606|FG000|Overall Study|Withdrawal by Subject|9|||
124797978|NCT00744471|448891607|FG001|Overall Study|Withdrawal by Subject|9|||
124797979|NCT00744471|448891608|FG002|Overall Study|Withdrawal by Subject|15|||
124797980|NCT00744471|448891609|FG003|Overall Study|Withdrawal by Subject|12|||
124797981|NCT00744471|448891606|FG000|Overall Study|Protocol Violation|1|||
124797982|NCT00744471|448891607|FG001|Overall Study|Protocol Violation|4|||
124797983|NCT00744471|448891608|FG002|Overall Study|Protocol Violation|1|||
124797984|NCT00744471|448891609|FG003|Overall Study|Protocol Violation|2|||
124797985|NCT00744471|448891606|FG000|Overall Study|Entered extension study|41|||
124797986|NCT00744471|448891607|FG001|Overall Study|Entered extension study|84|||
124797987|NCT00744471|448891608|FG002|Overall Study|Entered extension study|100|||
124797988|NCT00744471|448891609|FG003|Overall Study|Entered extension study|91|||
124797989|NCT00744471|448891606|FG000|Overall Study|Other|2|||
124797990|NCT00744471|448891607|FG001|Overall Study|Other|3|||
124797991|NCT00744471|448891608|FG002|Overall Study|Other|6|||
124797992|NCT00744471|448891609|FG003|Overall Study|Other|2|||
124797993|NCT00744471|448891606|FG000|Overall Study|Lack of Efficacy|83|||
124797994|NCT00744471|448891607|FG001|Overall Study|Lack of Efficacy|37|||
124797995|NCT00744471|448891608|FG002|Overall Study|Lack of Efficacy|19|||
124797996|NCT00744471|448891609|FG003|Overall Study|Lack of Efficacy|31|||
124797997|NCT00744471|448891606|FG000|Overall Study|Lost to Follow-up|0|||
124797998|NCT00744471|448891607|FG001|Overall Study|Lost to Follow-up|0|||
124797999|NCT00744471|448891608|FG002|Overall Study|Lost to Follow-up|2|||
124629917|NCT01730053|448262859|FG005|Overall Study|Other than specified|9|||
124798000|NCT00744471|448891609|FG003|Overall Study|Lost to Follow-up|0|||
124798001|NCT04706416|448891614|FG000|Overall Study|Lost to Follow-up|2|||
124798002|NCT04706416|448891615|FG001|Overall Study|Lost to Follow-up|0|||
124798003|NCT01539317|448891619|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
124798004|NCT01539317|448891620|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
124798005|NCT00976573|448891627|FG000|Overall Study|Ineligible|0|||
124798006|NCT00976573|448891628|FG001|Overall Study|Ineligible|1|||
124798007|NCT00976573|448891627|FG000|Overall Study|Cancel prior to receiving treatment|4|||
124798008|NCT00976573|448891628|FG001|Overall Study|Cancel prior to receiving treatment|2|||
124798009|NCT02117427|448891629|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
124798010|NCT02117427|448891630|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
124798011|NCT02117427|448891631|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
124798012|NCT02117427|448891629|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
124798013|NCT02117427|448891630|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
124798014|NCT02117427|448891631|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
124798015|NCT02117427|448891629|FG000|Overall Study|Physician Decision|0|||
124798016|NCT02117427|448891630|FG001|Overall Study|Physician Decision|2|||
124798017|NCT02117427|448891631|FG002|Overall Study|Physician Decision|0|||
124798018|NCT02117427|448891629|FG000|Overall Study|No longer meets inclusion criteria|0|||
124798019|NCT02117427|448891630|FG001|Overall Study|No longer meets inclusion criteria|1|||
124798020|NCT02117427|448891631|FG002|Overall Study|No longer meets inclusion criteria|0|||
124798021|NCT02117427|448891629|FG000|Overall Study|Death|0|||
124798022|NCT02117427|448891630|FG001|Overall Study|Death|1|||
124798023|NCT02117427|448891631|FG002|Overall Study|Death|0|||
124798024|NCT00937391|448891640|FG000|Stage 2|Withdrawal by Subject|1|||
124798025|NCT01436162|448891651|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
124798026|NCT01436162|448891652|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
124798027|NCT01436162|448891653|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
124798028|NCT01436162|448891651|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
124798029|NCT01436162|448891652|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
124798030|NCT01436162|448891653|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
124798031|NCT01436162|448891651|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
124798032|NCT01436162|448891652|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
124798033|NCT01436162|448891653|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
124798034|NCT01436162|448891651|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
124798035|NCT01436162|448891652|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
124798036|NCT01436162|448891653|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
124798037|NCT01436162|448891651|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
124798038|NCT01436162|448891652|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
124798039|NCT01436162|448891653|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
124798040|NCT01436162|448891651|FG000|Single-blind Lead-in Phase|Other|107|||
124798041|NCT01436162|448891652|FG001|Single-blind Lead-in Phase|Other|0|||
124798042|NCT01436162|448891653|FG002|Single-blind Lead-in Phase|Other|0|||
124798043|NCT01436162|448891651|FG000|Randomized Phase|Adverse Event|1|||
124798044|NCT01436162|448891652|FG001|Randomized Phase|Adverse Event|5|||
124798045|NCT01436162|448891653|FG002|Randomized Phase|Adverse Event|6|||
124798046|NCT01436162|448891651|FG000|Randomized Phase|Protocol Violation|4|||
124798047|NCT01436162|448891652|FG001|Randomized Phase|Protocol Violation|4|||
124798048|NCT01436162|448891653|FG002|Randomized Phase|Protocol Violation|2|||
124798049|NCT01436162|448891651|FG000|Randomized Phase|Withdrawal by Subject|16|||
124798050|NCT01436162|448891652|FG001|Randomized Phase|Withdrawal by Subject|9|||
124798051|NCT01436162|448891653|FG002|Randomized Phase|Withdrawal by Subject|8|||
124798052|NCT01436162|448891651|FG000|Randomized Phase|Lost to Follow-up|17|||
124798053|NCT01436162|448891652|FG001|Randomized Phase|Lost to Follow-up|5|||
124798054|NCT01436162|448891653|FG002|Randomized Phase|Lost to Follow-up|4|||
124798055|NCT01436162|448891651|FG000|Randomized Phase|Lack of Efficacy|0|||
124798056|NCT01436162|448891652|FG001|Randomized Phase|Lack of Efficacy|1|||
124798057|NCT01436162|448891653|FG002|Randomized Phase|Lack of Efficacy|1|||
124798058|NCT01436162|448891651|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
124798059|NCT01436162|448891652|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
124798060|NCT01436162|448891653|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
124798061|NCT01436162|448891651|FG000|Randomized Phase|Other|2|||
124798062|NCT01436162|448891652|FG001|Randomized Phase|Other|5|||
124798063|NCT01436162|448891653|FG002|Randomized Phase|Other|4|||
124798064|NCT01931202|448891657|FG000|Overall Study|Withdrawal by Subject|0|||
124798065|NCT01931202|448891658|FG001|Overall Study|Withdrawal by Subject|0|||
124798066|NCT01931202|448891659|FG002|Overall Study|Withdrawal by Subject|2|||
124798067|NCT01931202|448891657|FG000|Overall Study|Lost to Follow-up|0|||
124798068|NCT01931202|448891658|FG001|Overall Study|Lost to Follow-up|5|||
124798069|NCT01931202|448891659|FG002|Overall Study|Lost to Follow-up|2|||
124798070|NCT04597918|448891662|FG000|Overall Study|Withdrawal by Subject|6|||
124798071|NCT04597918|448891662|FG000|Overall Study|Lost to Follow-up|3|||
124798072|NCT04597918|448891662|FG000|Overall Study|Death|1|||
124798073|NCT00395538|448891663|FG000|Overall Study|Did not re-consent to revised protocol|1|||
124798074|NCT00395538|448891664|FG001|Overall Study|Did not re-consent to revised protocol|10|||
124798075|NCT00395538|448891665|FG002|Overall Study|Did not re-consent to revised protocol|0|||
124798076|NCT00395538|448891663|FG000|Overall Study|FDA partial hold on PTH|0|||
124629918|NCT01470248|448262860|FG000|Overall Study|Withdrawal by Subject|1|||
124798077|NCT00395538|448891664|FG001|Overall Study|FDA partial hold on PTH|0|||
124798078|NCT00395538|448891665|FG002|Overall Study|FDA partial hold on PTH|11|||
124798079|NCT00395538|448891663|FG000|Overall Study|Failed screening|0|||
124629919|NCT05085834|448262861|FG000|Overall Study|Lost to Follow-up|9|||
124798080|NCT00395538|448891664|FG001|Overall Study|Failed screening|0|||
124798081|NCT00395538|448891665|FG002|Overall Study|Failed screening|4|||
124798082|NCT00395538|448891663|FG000|Overall Study|Switch to Natpara|0|||
124798083|NCT00395538|448891664|FG001|Overall Study|Switch to Natpara|0|||
124798084|NCT00395538|448891665|FG002|Overall Study|Switch to Natpara|3|||
124629920|NCT05085834|448262862|FG001|Overall Study|Lost to Follow-up|2|||
124798085|NCT00395538|448891663|FG000|Overall Study|Adverse Event|1|||
124798086|NCT00395538|448891664|FG001|Overall Study|Adverse Event|0|||
124798087|NCT00395538|448891665|FG002|Overall Study|Adverse Event|2|||
124798088|NCT00395538|448891663|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
124798089|NCT00395538|448891664|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
124798090|NCT00395538|448891665|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
124798091|NCT00395538|448891663|FG000|Overall Study|Non-compliance with study protocol|0|||
124798092|NCT00395538|448891664|FG001|Overall Study|Non-compliance with study protocol|1|||
124798093|NCT00395538|448891665|FG002|Overall Study|Non-compliance with study protocol|0|||
124798094|NCT00395538|448891663|FG000|Overall Study|PTH resistance|0|||
124798095|NCT00395538|448891664|FG001|Overall Study|PTH resistance|0|||
124798096|NCT00395538|448891665|FG002|Overall Study|PTH resistance|1|||
124798097|NCT00395538|448891663|FG000|Overall Study|Pregnancy|1|||
124798098|NCT00395538|448891664|FG001|Overall Study|Pregnancy|0|||
124798099|NCT00395538|448891665|FG002|Overall Study|Pregnancy|0|||
124798100|NCT00395538|448891663|FG000|Overall Study|Partial recovery of parathyroid function|0|||
124798101|NCT00395538|448891664|FG001|Overall Study|Partial recovery of parathyroid function|0|||
124798102|NCT00395538|448891665|FG002|Overall Study|Partial recovery of parathyroid function|1|||
124798103|NCT00395538|448891663|FG000|Overall Study|Participant elected to discontinue|0|||
124798104|NCT00395538|448891664|FG001|Overall Study|Participant elected to discontinue|0|||
124798105|NCT00395538|448891665|FG002|Overall Study|Participant elected to discontinue|1|||
124798106|NCT01074047|448891666|FG000|Treatment Phase|Adverse Event|89|||
124798107|NCT01074047|448891667|FG001|Treatment Phase|Adverse Event|66|||
124798108|NCT01074047|448891666|FG000|Treatment Phase|Disease Progression|16|||
124798109|NCT01074047|448891667|FG001|Treatment Phase|Disease Progression|21|||
124798110|NCT01074047|448891666|FG000|Treatment Phase|Withdrawal by Subject|27|||
124798111|NCT01074047|448891667|FG001|Treatment Phase|Withdrawal by Subject|48|||
124798112|NCT01074047|448891666|FG000|Treatment Phase|Death|53|||
124798113|NCT01074047|448891667|FG001|Treatment Phase|Death|58|||
124798114|NCT01074047|448891666|FG000|Treatment Phase|Lost to Follow-up|0|||
124798115|NCT01074047|448891667|FG001|Treatment Phase|Lost to Follow-up|1|||
124798116|NCT01074047|448891666|FG000|Treatment Phase|Protocol Violation|0|||
124798117|NCT01074047|448891667|FG001|Treatment Phase|Protocol Violation|1|||
124798118|NCT01074047|448891666|FG000|Treatment Phase|Miscellaneous|32|||
124798119|NCT01074047|448891667|FG001|Treatment Phase|Miscellaneous|39|||
124798120|NCT01074047|448891666|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
124798121|NCT01074047|448891667|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
124798122|NCT01074047|448891666|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
124798123|NCT01074047|448891667|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
124798124|NCT01074047|448891666|FG000|Survival Follow-Up Phase|Death|116|||
124798125|NCT01074047|448891667|FG001|Survival Follow-Up Phase|Death|124|||
124798126|NCT01074047|448891666|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
124798127|NCT01074047|448891667|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
124798128|NCT01074047|448891666|FG000|Extension Phase|Physician Decision|1|||
124798129|NCT01074047|448891667|FG001|Extension Phase|Physician Decision|0|||
124798130|NCT01074047|448891666|FG000|Extension Phase|Adverse Event|5|||
124798131|NCT01074047|448891667|FG001|Extension Phase|Adverse Event|0|||
124798132|NCT01074047|448891666|FG000|Extension Phase|Disease Progression|9|||
124798133|NCT01074047|448891667|FG001|Extension Phase|Disease Progression|0|||
124798134|NCT01074047|448891666|FG000|Extension Phase|Withdrawal by Subject|2|||
124798135|NCT01074047|448891667|FG001|Extension Phase|Withdrawal by Subject|0|||
124798136|NCT01074047|448891666|FG000|Extension Phase|Death|5|||
124798137|NCT01074047|448891667|FG001|Extension Phase|Death|0|||
124798138|NCT04041700|448891672|FG000|Overall Study|Pregnancy|1|||
124798139|NCT04041700|448891672|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
124798140|NCT02775903|448891673|FG000|Overall Study|Death|7|||
124798141|NCT02775903|448891674|FG001|Overall Study|Death|11|||
124798142|NCT02775903|448891675|FG002|Overall Study|Death|12|||
124798143|NCT02775903|448891676|FG003|Overall Study|Death|11|||
124798144|NCT02775903|448891673|FG000|Overall Study|Adverse Event|0|||
124798145|NCT02775903|448891674|FG001|Overall Study|Adverse Event|1|||
124798146|NCT02775903|448891675|FG002|Overall Study|Adverse Event|12|||
124798147|NCT02775903|448891676|FG003|Overall Study|Adverse Event|3|||
124798148|NCT02775903|448891673|FG000|Overall Study|Progressive disease|15|||
124798149|NCT02775903|448891674|FG001|Overall Study|Progressive disease|14|||
124798150|NCT02775903|448891675|FG002|Overall Study|Progressive disease|30|||
124798151|NCT02775903|448891676|FG003|Overall Study|Progressive disease|20|||
124798152|NCT02775903|448891673|FG000|Overall Study|Lack of Efficacy|2|||
124798153|NCT02775903|448891674|FG001|Overall Study|Lack of Efficacy|2|||
124798154|NCT02775903|448891675|FG002|Overall Study|Lack of Efficacy|2|||
124798155|NCT02775903|448891676|FG003|Overall Study|Lack of Efficacy|6|||
124798156|NCT02775903|448891673|FG000|Overall Study|Withdrawal by Subject|7|||
124798157|NCT02775903|448891674|FG001|Overall Study|Withdrawal by Subject|5|||
124798158|NCT02775903|448891675|FG002|Overall Study|Withdrawal by Subject|5|||
124798159|NCT02775903|448891676|FG003|Overall Study|Withdrawal by Subject|8|||
124798160|NCT02775903|448891673|FG000|Overall Study|Other reasons|7|||
124798161|NCT02775903|448891674|FG001|Overall Study|Other reasons|8|||
124798162|NCT02775903|448891675|FG002|Overall Study|Other reasons|2|||
124798163|NCT02775903|448891676|FG003|Overall Study|Other reasons|12|||
124798164|NCT01683019|448893284|FG000|Overall Study|Withdrawal by Subject|2|||
124798165|NCT01683019|448893285|FG001|Overall Study|Withdrawal by Subject|1|||
124798166|NCT01683019|448893286|FG002|Overall Study|Withdrawal by Subject|4|||
124798167|NCT00543855|448893287|FG000|Overall Study|Adverse Event|3|||
124798168|NCT00543855|448893288|FG001|Overall Study|Adverse Event|1|||
124798169|NCT00543855|448893289|FG002|Overall Study|Adverse Event|3|||
124798170|NCT00543855|448893290|FG003|Overall Study|Adverse Event|4|||
124798171|NCT00543855|448893287|FG000|Overall Study|Lost to Follow-up|0|||
124798172|NCT00543855|448893288|FG001|Overall Study|Lost to Follow-up|0|||
124798173|NCT00543855|448893289|FG002|Overall Study|Lost to Follow-up|1|||
124798174|NCT00543855|448893290|FG003|Overall Study|Lost to Follow-up|0|||
124798175|NCT00543855|448893287|FG000|Overall Study|Withdrawal by Subject|0|||
124798176|NCT00543855|448893288|FG001|Overall Study|Withdrawal by Subject|1|||
124798177|NCT00543855|448893289|FG002|Overall Study|Withdrawal by Subject|2|||
124798178|NCT00543855|448893290|FG003|Overall Study|Withdrawal by Subject|0|||
124798179|NCT00543855|448893287|FG000|Overall Study|Protocol Violation|1|||
124798180|NCT00543855|448893288|FG001|Overall Study|Protocol Violation|0|||
124798181|NCT00543855|448893289|FG002|Overall Study|Protocol Violation|0|||
124798182|NCT00543855|448893290|FG003|Overall Study|Protocol Violation|0|||
124798183|NCT04444895|448893292|FG000|Overall Study|Adverse Event|2|||
124798184|NCT04444895|448893292|FG000|Overall Study|Lost to Follow-up|2|||
124798185|NCT04444895|448893292|FG000|Overall Study|Withdrawal by Subject|5|||
124798186|NCT03954041|448893295|FG000|Overall Study|Lost to Follow-up|3|||
124798187|NCT03954041|448893296|FG001|Overall Study|Lost to Follow-up|3|||
124798188|NCT03954041|448893297|FG002|Overall Study|Lost to Follow-up|6|||
124798189|NCT03954041|448893295|FG000|Overall Study|Death|4|||
124798190|NCT03954041|448893296|FG001|Overall Study|Death|0|||
124798191|NCT03954041|448893297|FG002|Overall Study|Death|1|||
124798192|NCT03954041|448893295|FG000|Overall Study|Death by neurologic criteria|0|||
124798193|NCT03954041|448893296|FG001|Overall Study|Death by neurologic criteria|0|||
124798194|NCT03954041|448893297|FG002|Overall Study|Death by neurologic criteria|1|||
124798195|NCT03954041|448893295|FG000|Overall Study|Reason not specified|7|||
124798196|NCT03954041|448893296|FG001|Overall Study|Reason not specified|4|||
124798197|NCT03954041|448893297|FG002|Overall Study|Reason not specified|2|||
124798198|NCT03954041|448893295|FG000|Overall Study|Withdrew prior to dosing|4|||
124798199|NCT03954041|448893296|FG001|Overall Study|Withdrew prior to dosing|2|||
124798200|NCT03954041|448893297|FG002|Overall Study|Withdrew prior to dosing|0|||
124798201|NCT04177355|448893298|FG000|Overall Study|Lost to Follow-up|0|||
124798202|NCT04177355|448893299|FG001|Overall Study|Lost to Follow-up|2|||
124798203|NCT04177355|448893300|FG002|Overall Study|Lost to Follow-up|0|||
124798204|NCT04177355|448893301|FG003|Overall Study|Lost to Follow-up|1|||
124798205|NCT04177355|448893302|FG004|Overall Study|Lost to Follow-up|2|||
124798206|NCT04177355|448893303|FG005|Overall Study|Lost to Follow-up|0|||
124798207|NCT04177355|448893304|FG006|Overall Study|Lost to Follow-up|1|||
124798208|NCT04177355|448893305|FG007|Overall Study|Lost to Follow-up|0|||
124798209|NCT04177355|448893306|FG008|Overall Study|Lost to Follow-up|0|||
124798210|NCT04177355|448893307|FG009|Overall Study|Lost to Follow-up|0|||
124798211|NCT04177355|448893308|FG010|Overall Study|Lost to Follow-up|0|||
124798212|NCT04177355|448893298|FG000|Overall Study|Withdrawal by Subject|0|||
124798213|NCT04177355|448893299|FG001|Overall Study|Withdrawal by Subject|0|||
124798214|NCT04177355|448893300|FG002|Overall Study|Withdrawal by Subject|0|||
124798215|NCT04177355|448893301|FG003|Overall Study|Withdrawal by Subject|1|||
124798216|NCT04177355|448893302|FG004|Overall Study|Withdrawal by Subject|1|||
124798217|NCT04177355|448893303|FG005|Overall Study|Withdrawal by Subject|0|||
124798218|NCT04177355|448893304|FG006|Overall Study|Withdrawal by Subject|0|||
124798219|NCT04177355|448893305|FG007|Overall Study|Withdrawal by Subject|0|||
124798220|NCT04177355|448893306|FG008|Overall Study|Withdrawal by Subject|1|||
124798221|NCT04177355|448893307|FG009|Overall Study|Withdrawal by Subject|0|||
124798222|NCT04177355|448893308|FG010|Overall Study|Withdrawal by Subject|0|||
124798223|NCT00397943|448893309|FG000|Overall Study|Unspecified reasons|12|||
124798224|NCT00397943|448893310|FG001|Overall Study|Unspecified reasons|9|||
124798225|NCT00397943|448893311|FG002|Overall Study|Unspecified reasons|0|||
124798226|NCT00397943|448893312|FG003|Overall Study|Unspecified reasons|0|||
124798227|NCT00397943|448893313|FG004|Overall Study|Unspecified reasons|0|||
124798228|NCT05007717|448893314|FG000|Overall Study|Death|3|||
124798229|NCT05007717|448893315|FG001|Overall Study|Death|2|||
124798230|NCT02806973|448893317|FG000|Period 1|Withdrawal by Subject|0|||
124798231|NCT02806973|448893318|FG001|Period 1|Withdrawal by Subject|2|||
124798232|NCT02806973|448893319|FG002|Period 1|Withdrawal by Subject|1|||
124798233|NCT02806973|448893320|FG003|Period 1|Withdrawal by Subject|1|||
124798234|NCT02806973|448893317|FG000|Period 1|Adverse Event|0|||
124798235|NCT02806973|448893318|FG001|Period 1|Adverse Event|0|||
124798236|NCT02806973|448893319|FG002|Period 1|Adverse Event|0|||
124798237|NCT02806973|448893320|FG003|Period 1|Adverse Event|1|||
124798238|NCT02806973|448893317|FG000|Period 3|Withdrawal by Subject|0|||
124798239|NCT02806973|448893318|FG001|Period 3|Withdrawal by Subject|0|||
124798240|NCT02806973|448893319|FG002|Period 3|Withdrawal by Subject|0|||
124798241|NCT02806973|448893320|FG003|Period 3|Withdrawal by Subject|3|||
124798242|NCT02806973|448893317|FG000|Period 3|Adverse Event|0|||
124798243|NCT02806973|448893318|FG001|Period 3|Adverse Event|0|||
124798244|NCT02806973|448893319|FG002|Period 3|Adverse Event|1|||
124798245|NCT02806973|448893320|FG003|Period 3|Adverse Event|0|||
124798246|NCT03282565|448893326|FG000|Overall Study|COVID-19 Research Shutdown|0|||
124798247|NCT03282565|448893327|FG001|Overall Study|COVID-19 Research Shutdown|2|||
124798248|NCT03282565|448893328|FG002|Overall Study|COVID-19 Research Shutdown|2|||
124798249|NCT02131532|448893329|FG000|Overall Study|Withdrawal by Subject|1|||
124798250|NCT02131532|448893329|FG000|Overall Study|Physician Decision|1|||
124798251|NCT02131532|448893329|FG000|Overall Study|Other health conditions|2|||
124798252|NCT01466595|448893330|FG000|Overall Study|Withdrawal by Subject|0|||
124798253|NCT01466595|448893331|FG001|Overall Study|Withdrawal by Subject|1|||
124798254|NCT00450112|448893332|FG000|Overall Study|Other Treatment Required|5|||
124798255|NCT00450112|448893333|FG001|Overall Study|Other Treatment Required|1|||
124798256|NCT00450112|448893332|FG000|Overall Study|Withdrawal by Subject|4|||
124798257|NCT00450112|448893333|FG001|Overall Study|Withdrawal by Subject|1|||
124798258|NCT00450112|448893332|FG000|Overall Study|Lost to Follow-up|2|||
124798259|NCT00450112|448893333|FG001|Overall Study|Lost to Follow-up|1|||
124798260|NCT00450112|448893332|FG000|Overall Study|Others|2|||
124798261|NCT00450112|448893333|FG001|Overall Study|Others|3|||
124798262|NCT01264016|448893334|FG000|Overall Study|Withdrawal by Subject|1|||
124798263|NCT01264016|448893334|FG000|Overall Study|Felt faint at sight of blood|1|||
124798264|NCT02147184|448893335|FG000|Overall Study|Lost to Follow-up|28|||
124798265|NCT02147184|448893336|FG001|Overall Study|Lost to Follow-up|15|||
124798266|NCT02147184|448893335|FG000|Overall Study|Study Burden|11|||
124798267|NCT02147184|448893336|FG001|Overall Study|Study Burden|7|||
124798268|NCT02147184|448893335|FG000|Overall Study|Pregnancy|6|||
124798269|NCT02147184|448893336|FG001|Overall Study|Pregnancy|0|||
124798270|NCT02147184|448893335|FG000|Overall Study|Moved out of state|3|||
124798271|NCT02147184|448893336|FG001|Overall Study|Moved out of state|3|||
124798272|NCT02147184|448893335|FG000|Overall Study|Physician Decision|0|||
124798273|NCT02147184|448893336|FG001|Overall Study|Physician Decision|2|||
124798274|NCT02147184|448893335|FG000|Overall Study|Other|1|||
124798275|NCT02147184|448893336|FG001|Overall Study|Other|0|||
124798276|NCT02117414|448893337|FG000|Overall Study|Death|5|||
124798277|NCT02117414|448893338|FG001|Overall Study|Death|2|||
124798278|NCT02117414|448893337|FG000|Overall Study|Withdrawal by Subject|10|||
124798279|NCT02117414|448893338|FG001|Overall Study|Withdrawal by Subject|4|||
124798280|NCT00417482|448893339|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
124798281|NCT00417482|448893340|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
124798282|NCT00417482|448893341|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
124798283|NCT00417482|448893339|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
124798284|NCT00417482|448893340|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
124798285|NCT00417482|448893341|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
124629921|NCT05085834|448262861|FG000|Overall Study|Adverse Event|6|||
124629922|NCT05085834|448262862|FG001|Overall Study|Adverse Event|0|||
124798286|NCT00417482|448893339|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
124798287|NCT00417482|448893340|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
124798288|NCT00417482|448893341|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
124798289|NCT00417482|448893339|FG000|Phase B 1st 16 Weeks|Death|1|||
124798290|NCT00417482|448893340|FG001|Phase B 1st 16 Weeks|Death|0|||
124798291|NCT00417482|448893341|FG002|Phase B 1st 16 Weeks|Death|0|||
124798292|NCT00417482|448893339|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
124798293|NCT00417482|448893340|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
124798294|NCT00417482|448893341|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
124798295|NCT00417482|448893339|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
124798296|NCT00417482|448893340|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
124798297|NCT00417482|448893341|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
124798298|NCT00417482|448893339|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
124798299|NCT00417482|448893340|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
124798300|NCT00417482|448893341|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
124798301|NCT00417482|448893339|FG000|Phase B 2nd 16 Weeks|Death|1|||
124629923|NCT05085834|448262861|FG000|Overall Study|Death|1|||
124629924|NCT05085834|448262862|FG001|Overall Study|Death|0|||
124629925|NCT05085834|448262861|FG000|Overall Study|Inability to swallow the pill|0|||
124629926|NCT05085834|448262862|FG001|Overall Study|Inability to swallow the pill|1|||
124798302|NCT00417482|448893340|FG001|Phase B 2nd 16 Weeks|Death|1|||
124629927|NCT02243605|448262863|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
124629928|NCT02243605|448262864|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
124629929|NCT02243605|448262863|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
124629930|NCT02243605|448262864|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
124629931|NCT02243605|448262863|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
124629932|NCT02243605|448262864|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
124798303|NCT00417482|448893341|FG002|Phase B 2nd 16 Weeks|Death|0|||
124798304|NCT06400979|448893344|FG000|Overall Study|Lost to Follow-up|29|||
124798305|NCT06400979|448893344|FG000|Overall Study|Withdrawal by Subject|1|||
124798306|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
124798307|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
124798308|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
124798309|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
124798310|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
124798311|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
124798312|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
124798313|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
124798314|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
124798315|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
124798316|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
124798317|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
124798318|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
124798319|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
124798320|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
124798321|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
124798322|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Program Termination|3|||
124798323|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Program Termination|0|||
124798324|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Program Termination|1|||
124798325|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Program Termination|1|||
124798326|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
124798327|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
124798328|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
124798329|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
124798330|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
124798331|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
124798332|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
124798333|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
124798334|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
124798335|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
124798336|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
124798337|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
124798338|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
124798339|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
124798340|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
124798341|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
124798342|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
124798343|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
124798344|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
124798345|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
124798346|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
124798347|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
124798348|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
124798349|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
124798350|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
124798351|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
124798352|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
124798353|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
124798354|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
124798355|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
124798356|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
124798357|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
124798358|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
124798359|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
124798360|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
124798361|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
124798362|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
124798363|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
124798364|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
124798365|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
124798366|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
124798367|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
124798368|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
124798369|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
124798370|NCT03739840|448893345|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
124798371|NCT03739840|448893346|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
124798372|NCT03739840|448893347|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
124629933|NCT02243605|448262863|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
124629934|NCT02243605|448262864|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
124629935|NCT02243605|448262863|FG000|Stage 2 - Final Analysis Population|Progression|0|||
124629936|NCT02243605|448262864|FG001|Stage 2 - Final Analysis Population|Progression|1|||
124629937|NCT01823328|448262865|FG000|Overall Study|Withdrawal by Subject|8|||
124629938|NCT01823328|448262866|FG001|Overall Study|Withdrawal by Subject|6|||
124629939|NCT04173507|448262867|FG000|Overall Study|On Treatment|3|||
124798373|NCT03739840|448893348|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
124798374|NCT03739840|448893345|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
124798375|NCT03739840|448893346|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
124798376|NCT03739840|448893347|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
124798377|NCT03739840|448893348|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
124629940|NCT04173507|448262867|FG000|Overall Study|Adverse Event|3|||
124629941|NCT04173507|448262867|FG000|Overall Study|Progression/Relapse|34|||
124629942|NCT04173507|448262867|FG000|Overall Study|Death|2|||
124629943|NCT02717507|448262870|FG000|Overall Study|Lost to Follow-up|5|||
124629944|NCT02717507|448262871|FG001|Overall Study|Lost to Follow-up|8|||
124629945|NCT02717507|448262870|FG000|Overall Study|Pregnancy|1|||
124629946|NCT02717507|448262871|FG001|Overall Study|Pregnancy|1|||
124629947|NCT02717507|448262870|FG000|Overall Study|Protocol Violation|2|||
124629948|NCT02717507|448262871|FG001|Overall Study|Protocol Violation|2|||
124629949|NCT02717507|448262870|FG000|Overall Study|Withdrawal by Subject|20|||
124629950|NCT02717507|448262871|FG001|Overall Study|Withdrawal by Subject|20|||
124629951|NCT02717507|448262870|FG000|Overall Study|Relapse|1|||
124629952|NCT02717507|448262871|FG001|Overall Study|Relapse|1|||
124629953|NCT02717507|448262870|FG000|Overall Study|Cardiac Event|2|||
124629954|NCT02717507|448262871|FG001|Overall Study|Cardiac Event|6|||
124629955|NCT00595621|448262872|FG000|Open Label Run in|Adverse Event|1|||
124629956|NCT00595621|448262873|FG001|Open Label Run in|Adverse Event|0|||
124629957|NCT00595621|448262872|FG000|Open Label Run in|Physician Decision|1|||
124629958|NCT00595621|448262873|FG001|Open Label Run in|Physician Decision|0|||
124629959|NCT00595621|448262872|FG000|Open Label Run in|Withdrawal by Subject|1|||
124629960|NCT00595621|448262873|FG001|Open Label Run in|Withdrawal by Subject|0|||
124629961|NCT00595621|448262872|FG000|Randomization and Study|Adverse Event|2|||
124629962|NCT00595621|448262873|FG001|Randomization and Study|Adverse Event|0|||
124629963|NCT00595621|448262872|FG000|Randomization and Study|Withdrawal by Subject|0|||
124798378|NCT03739840|448893345|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
124798379|NCT03739840|448893346|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
124798380|NCT03739840|448893347|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
124798381|NCT03739840|448893348|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
124798382|NCT03739840|448893345|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
124798383|NCT03739840|448893346|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
124798384|NCT03739840|448893347|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
124798385|NCT03739840|448893348|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
124798386|NCT03739840|448893345|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
124798387|NCT03739840|448893346|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
124798388|NCT03739840|448893347|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
124798389|NCT03739840|448893348|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
124798390|NCT03739840|448893345|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
124798391|NCT03739840|448893346|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
124798392|NCT03739840|448893347|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
124798393|NCT03739840|448893348|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
124798394|NCT03739840|448893345|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
124798395|NCT03739840|448893346|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
124798396|NCT03739840|448893347|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
124798397|NCT03739840|448893348|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
124629964|NCT00595621|448262873|FG001|Randomization and Study|Withdrawal by Subject|1|||
124629965|NCT02392481|448262874|FG000|Overall Study|Adverse Event|0|||
124629966|NCT02392481|448262875|FG001|Overall Study|Adverse Event|0|||
124629967|NCT02392481|448262876|FG002|Overall Study|Adverse Event|1|||
124629968|NCT02392481|448262877|FG003|Overall Study|Adverse Event|2|||
124629969|NCT02392481|448262874|FG000|Overall Study|Withdrawal by Subject|0|||
124629970|NCT02392481|448262875|FG001|Overall Study|Withdrawal by Subject|0|||
124629971|NCT02392481|448262876|FG002|Overall Study|Withdrawal by Subject|1|||
124629972|NCT02392481|448262877|FG003|Overall Study|Withdrawal by Subject|0|||
124629973|NCT01998919|448262878|FG000|Overall Study|Death|2|||
124629974|NCT01998919|448262879|FG001|Overall Study|Death|2|||
124629975|NCT01998919|448262878|FG000|Overall Study|Adverse Event|0|||
124629976|NCT01998919|448262879|FG001|Overall Study|Adverse Event|5|||
124629977|NCT01998919|448262878|FG000|Overall Study|Disease progression|31|||
124629978|NCT01998919|448262879|FG001|Overall Study|Disease progression|22|||
124629979|NCT01998919|448262878|FG000|Overall Study|Withdrawal by Subject|2|||
124629980|NCT01998919|448262879|FG001|Overall Study|Withdrawal by Subject|4|||
124629981|NCT01998919|448262878|FG000|Overall Study|Lost to Follow-up|2|||
124629982|NCT01998919|448262879|FG001|Overall Study|Lost to Follow-up|0|||
124798398|NCT03739840|448893345|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
124798399|NCT03739840|448893346|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
124798400|NCT03739840|448893347|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
124798401|NCT03739840|448893348|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
124798402|NCT03739840|448893345|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
124798403|NCT03739840|448893346|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
124798404|NCT03739840|448893347|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
124798405|NCT03739840|448893348|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
124798406|NCT01058265|448893351|FG000|Overall Study|Lost to Follow-up|11|||
124798407|NCT01058265|448893352|FG001|Overall Study|Lost to Follow-up|12|||
124798408|NCT02962765|448893353|FG000|Overall Study|Protocol Violation|9|||
124798409|NCT02962765|448893353|FG000|Overall Study|Withdrawal by Subject|3|||
124798410|NCT02962765|448893353|FG000|Overall Study|Lost to Follow-up|1|||
124798411|NCT02962765|448893353|FG000|Overall Study|Death|1|||
124798412|NCT02962765|448893353|FG000|Overall Study|Limited access to study medication|3|||
124798413|NCT00750880|448893359|FG000|Overall Study|Adverse Event|76|||
124798414|NCT00750880|448893359|FG000|Overall Study|Death|4|||
124798415|NCT00750880|448893359|FG000|Overall Study|Lack of Efficacy|46|||
124798416|NCT00750880|448893359|FG000|Overall Study|Lost to Follow-up|10|||
124798417|NCT00750880|448893359|FG000|Overall Study|Protocol Violation|15|||
124798418|NCT00750880|448893359|FG000|Overall Study|Withdrawal by Subject|33|||
124798419|NCT00750880|448893359|FG000|Overall Study|Physician Decision|20|||
124798420|NCT00750880|448893359|FG000|Overall Study|Administrative|11|||
124798421|NCT00984568|448893360|FG000|Overall Study|Withdrawal by Subject|1|||
124798422|NCT00984568|448893361|FG001|Overall Study|Withdrawal by Subject|2|||
124798423|NCT00984568|448893360|FG000|Overall Study|Lack of Efficacy|2|||
124798424|NCT00984568|448893361|FG001|Overall Study|Lack of Efficacy|0|||
124798425|NCT00984568|448893360|FG000|Overall Study|Adverse Event|2|||
124798426|NCT00984568|448893361|FG001|Overall Study|Adverse Event|0|||
124798427|NCT00984568|448893360|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
124798428|NCT00984568|448893361|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
124798429|NCT00984568|448893360|FG000|Overall Study|Lost to Follow-up|0|||
124798430|NCT00984568|448893361|FG001|Overall Study|Lost to Follow-up|1|||
124798431|NCT00984568|448893360|FG000|Overall Study|Opportunistic Infection|1|||
124798432|NCT00984568|448893361|FG001|Overall Study|Opportunistic Infection|0|||
124798433|NCT00984568|448893360|FG000|Overall Study|Unknown Reason|1|||
124798434|NCT00984568|448893361|FG001|Overall Study|Unknown Reason|3|||
124798435|NCT02964507|448893362|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
124798436|NCT02964507|448893363|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
124798437|NCT02964507|448893364|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
124798438|NCT02964507|448893365|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
124798439|NCT02964507|448893366|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
124798440|NCT02964507|448893367|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
124798441|NCT02964507|448893368|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
124798442|NCT02964507|448893369|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
124798443|NCT02964507|448893362|FG000|Overall Study|Study terminated by Sponsor|9|||
124798444|NCT02964507|448893363|FG001|Overall Study|Study terminated by Sponsor|1|||
124798445|NCT02964507|448893364|FG002|Overall Study|Study terminated by Sponsor|9|||
124798446|NCT02964507|448893365|FG003|Overall Study|Study terminated by Sponsor|3|||
124798447|NCT02964507|448893366|FG004|Overall Study|Study terminated by Sponsor|3|||
124798448|NCT02964507|448893367|FG005|Overall Study|Study terminated by Sponsor|2|||
124798449|NCT02964507|448893368|FG006|Overall Study|Study terminated by Sponsor|0|||
124798450|NCT02964507|448893369|FG007|Overall Study|Study terminated by Sponsor|0|||
124798451|NCT02964507|448893362|FG000|Overall Study|Other|3|||
124798452|NCT02964507|448893363|FG001|Overall Study|Other|0|||
124798453|NCT02964507|448893364|FG002|Overall Study|Other|0|||
124798454|NCT02964507|448893365|FG003|Overall Study|Other|0|||
124798455|NCT02964507|448893366|FG004|Overall Study|Other|1|||
124798456|NCT02964507|448893367|FG005|Overall Study|Other|0|||
124798457|NCT02964507|448893368|FG006|Overall Study|Other|0|||
124798458|NCT02964507|448893369|FG007|Overall Study|Other|0|||
124798459|NCT02964507|448893362|FG000|Overall Study|Death|11|||
124798460|NCT02964507|448893363|FG001|Overall Study|Death|9|||
124798461|NCT02964507|448893364|FG002|Overall Study|Death|12|||
124798462|NCT02964507|448893365|FG003|Overall Study|Death|2|||
124798463|NCT02964507|448893366|FG004|Overall Study|Death|10|||
124798464|NCT02964507|448893367|FG005|Overall Study|Death|5|||
124798465|NCT02964507|448893368|FG006|Overall Study|Death|0|||
124798466|NCT02964507|448893369|FG007|Overall Study|Death|0|||
124798467|NCT02964507|448893362|FG000|Overall Study|Withdrawal by Subject|1|||
124629983|NCT01998919|448262878|FG000|Overall Study|Other|5|||
124798468|NCT02964507|448893363|FG001|Overall Study|Withdrawal by Subject|0|||
124798469|NCT02964507|448893364|FG002|Overall Study|Withdrawal by Subject|1|||
124798470|NCT02964507|448893365|FG003|Overall Study|Withdrawal by Subject|1|||
124798471|NCT02964507|448893366|FG004|Overall Study|Withdrawal by Subject|0|||
124798472|NCT02964507|448893367|FG005|Overall Study|Withdrawal by Subject|1|||
124798473|NCT02964507|448893368|FG006|Overall Study|Withdrawal by Subject|0|||
124798474|NCT02964507|448893369|FG007|Overall Study|Withdrawal by Subject|0|||
124798475|NCT02964507|448893362|FG000|Overall Study|Physician Decision|2|||
124798476|NCT02964507|448893363|FG001|Overall Study|Physician Decision|0|||
124798477|NCT02964507|448893364|FG002|Overall Study|Physician Decision|3|||
124798478|NCT02964507|448893365|FG003|Overall Study|Physician Decision|0|||
124798479|NCT02964507|448893366|FG004|Overall Study|Physician Decision|1|||
124798480|NCT02964507|448893367|FG005|Overall Study|Physician Decision|0|||
124798481|NCT02964507|448893368|FG006|Overall Study|Physician Decision|0|||
124798482|NCT02964507|448893369|FG007|Overall Study|Physician Decision|0|||
124798483|NCT03880461|448893373|FG000|Overall Study|Determined ineligible after enrollment|45|||
124798484|NCT03880461|448893374|FG001|Overall Study|Determined ineligible after enrollment|44|||
124798485|NCT03880461|448893373|FG000|Overall Study|No weight measurement after enrollment|24|||
124798486|NCT03880461|448893374|FG001|Overall Study|No weight measurement after enrollment|17|||
124798487|NCT04025710|448893377|FG000|Overall Study|Death|3|||
124798488|NCT04025710|448893377|FG000|Overall Study|Lost to Follow-up|5|||
124798489|NCT04025710|448893377|FG000|Overall Study|Withdrawal by Subject|1|||
124798490|NCT04025710|448893377|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
124798491|NCT04025710|448893377|FG000|Overall Study|Drop-out according to protocol|34|||
124798492|NCT02431247|448893378|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
124798493|NCT02431247|448893379|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
124798494|NCT02431247|448893380|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
124798495|NCT02431247|448893378|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
124798496|NCT02431247|448893379|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
124798497|NCT02431247|448893380|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
124798498|NCT02431247|448893378|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
124798499|NCT02431247|448893379|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
124798500|NCT02431247|448893380|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
124798501|NCT02431247|448893378|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
124798502|NCT02431247|448893379|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
124798503|NCT02431247|448893380|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
124798504|NCT02431247|448893378|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
124798505|NCT02431247|448893379|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
124798506|NCT02431247|448893380|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
124798507|NCT02431247|448893378|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
124798508|NCT02431247|448893379|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
124798509|NCT02431247|448893380|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
124798510|NCT02431247|448893378|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
124798511|NCT02431247|448893379|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
124798512|NCT02431247|448893380|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
124798513|NCT02431247|448893378|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
124629984|NCT01998919|448262879|FG001|Overall Study|Other|2|||
124629985|NCT02088177|448262882|FG000|Overall Study|Lost to Follow-up|3|||
124629986|NCT01778530|448262884|FG000|Overall Study|Progression on study|1|||
124629987|NCT01778530|448262884|FG000|Overall Study|Adverse event/side effect|1|||
124629988|NCT01199939|448262885|FG000|Overall Study|Adverse Event|4|||
124629989|NCT01199939|448262885|FG000|Overall Study|Protocol Violation|3|||
124629990|NCT01199939|448262885|FG000|Overall Study|Lost to Follow-up|2|||
124629991|NCT01199939|448262885|FG000|Overall Study|Reached a virologic endpoint|4|||
124629992|NCT01894919|448262886|FG000|Overall Study|Withdrawal by Subject|1|||
124629993|NCT01894919|448262887|FG001|Overall Study|Withdrawal by Subject|0|||
124629994|NCT01894919|448262888|FG002|Overall Study|Withdrawal by Subject|0|||
124629995|NCT01894919|448262889|FG003|Overall Study|Withdrawal by Subject|0|||
124629996|NCT01894919|448262890|FG004|Overall Study|Withdrawal by Subject|1|||
124629997|NCT01894919|448262891|FG005|Overall Study|Withdrawal by Subject|0|||
124629998|NCT01894919|448262892|FG006|Overall Study|Withdrawal by Subject|0|||
124629999|NCT01894919|448262893|FG007|Overall Study|Withdrawal by Subject|0|||
124630000|NCT01894919|448262894|FG008|Overall Study|Withdrawal by Subject|0|||
124630001|NCT01894919|448262895|FG009|Overall Study|Withdrawal by Subject|1|||
124630002|NCT01894919|448262896|FG010|Overall Study|Withdrawal by Subject|1|||
124630003|NCT01894919|448262897|FG011|Overall Study|Withdrawal by Subject|0|||
124630004|NCT01894919|448262898|FG012|Overall Study|Withdrawal by Subject|0|||
124630005|NCT01894919|448262886|FG000|Overall Study|Adverse Event|0|||
124630006|NCT01894919|448262887|FG001|Overall Study|Adverse Event|0|||
124630007|NCT01894919|448262888|FG002|Overall Study|Adverse Event|0|||
124630008|NCT01894919|448262889|FG003|Overall Study|Adverse Event|0|||
124630009|NCT01894919|448262890|FG004|Overall Study|Adverse Event|0|||
124630010|NCT01894919|448262891|FG005|Overall Study|Adverse Event|0|||
124630011|NCT01894919|448262892|FG006|Overall Study|Adverse Event|0|||
124630012|NCT01894919|448262893|FG007|Overall Study|Adverse Event|0|||
124798514|NCT02431247|448893379|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
124798515|NCT02431247|448893380|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
124798516|NCT02431247|448893378|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
124798517|NCT02431247|448893379|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
124798518|NCT02431247|448893380|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
124798519|NCT02431247|448893378|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
124798520|NCT02431247|448893379|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
124798521|NCT02431247|448893380|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
124798522|NCT02431247|448893378|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
124798523|NCT02431247|448893379|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
124798524|NCT02431247|448893380|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
124798525|NCT02431247|448893378|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
124798526|NCT02431247|448893379|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
124630013|NCT01894919|448262894|FG008|Overall Study|Adverse Event|0|||
124630014|NCT01894919|448262895|FG009|Overall Study|Adverse Event|0|||
124630015|NCT01894919|448262896|FG010|Overall Study|Adverse Event|1|||
124630016|NCT01894919|448262897|FG011|Overall Study|Adverse Event|0|||
124630017|NCT01894919|448262898|FG012|Overall Study|Adverse Event|0|||
124630018|NCT01894919|448262886|FG000|Overall Study|Other-Unspecified|1|||
124630019|NCT01894919|448262887|FG001|Overall Study|Other-Unspecified|0|||
124630020|NCT01894919|448262888|FG002|Overall Study|Other-Unspecified|0|||
124630021|NCT01894919|448262889|FG003|Overall Study|Other-Unspecified|0|||
124630022|NCT01894919|448262890|FG004|Overall Study|Other-Unspecified|0|||
124630023|NCT01894919|448262891|FG005|Overall Study|Other-Unspecified|0|||
124630024|NCT01894919|448262892|FG006|Overall Study|Other-Unspecified|0|||
124630025|NCT01894919|448262893|FG007|Overall Study|Other-Unspecified|0|||
124630026|NCT01894919|448262894|FG008|Overall Study|Other-Unspecified|0|||
124798527|NCT02431247|448893380|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
124798528|NCT02431247|448893378|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
124798529|NCT02431247|448893379|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
124798530|NCT02431247|448893380|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
124798531|NCT02431247|448893378|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
124798532|NCT02431247|448893379|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
124798533|NCT02431247|448893380|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
124798534|NCT01562873|448893381|FG000|Overall Study|Disease Progression per RECIST|10|||
124798535|NCT01562873|448893382|FG001|Overall Study|Disease Progression per RECIST|0|||
124798536|NCT01562873|448893381|FG000|Overall Study|Adverse Event|1|||
124798537|NCT01562873|448893382|FG001|Overall Study|Adverse Event|0|||
124798538|NCT01562873|448893381|FG000|Overall Study|Clinical Disease Progression|9|||
124798539|NCT01562873|448893382|FG001|Overall Study|Clinical Disease Progression|0|||
124798540|NCT01562873|448893381|FG000|Overall Study|Clinical PD and adverse event|1|||
124798541|NCT01562873|448893382|FG001|Overall Study|Clinical PD and adverse event|0|||
124798542|NCT01369485|448893383|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
124798543|NCT01369485|448893384|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
124798544|NCT01369485|448893383|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
124798545|NCT01369485|448893384|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
124798546|NCT01369485|448893383|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
124798547|NCT01369485|448893384|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
124798548|NCT01369485|448893383|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
124798549|NCT01369485|448893384|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
124798550|NCT01369485|448893383|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
124798551|NCT01369485|448893384|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
124798552|NCT01369485|448893383|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
124798553|NCT01369485|448893384|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
124798554|NCT01369485|448893383|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
124798555|NCT01369485|448893384|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
124798556|NCT01369485|448893383|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
124798557|NCT01369485|448893384|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
124798558|NCT01369485|448893383|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
124798559|NCT01369485|448893384|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
124798560|NCT01369485|448893383|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
124798561|NCT01369485|448893384|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
124798562|NCT00194675|448893395|FG000|Overall Study|Lost to Follow-up|1|||
124630027|NCT01894919|448262895|FG009|Overall Study|Other-Unspecified|0|||
124630028|NCT01894919|448262896|FG010|Overall Study|Other-Unspecified|0|||
124630029|NCT01894919|448262897|FG011|Overall Study|Other-Unspecified|0|||
124630030|NCT01894919|448262898|FG012|Overall Study|Other-Unspecified|0|||
124630031|NCT01894919|448262886|FG000|Overall Study|Lost to Follow-up|0|||
124630032|NCT01894919|448262887|FG001|Overall Study|Lost to Follow-up|0|||
124630033|NCT01894919|448262888|FG002|Overall Study|Lost to Follow-up|0|||
124630034|NCT01894919|448262889|FG003|Overall Study|Lost to Follow-up|0|||
124798563|NCT00194675|448893396|FG001|Overall Study|Lost to Follow-up|1|||
124798564|NCT00194675|448893395|FG000|Overall Study|lack of interest|1|||
124798565|NCT00194675|448893396|FG001|Overall Study|lack of interest|1|||
124798566|NCT00194675|448893395|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
124798567|NCT00194675|448893396|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
124798568|NCT00194675|448893395|FG000|Overall Study|Protocol Violation|1|||
124798569|NCT00194675|448893396|FG001|Overall Study|Protocol Violation|0|||
124798570|NCT00194675|448893395|FG000|Overall Study|Death|1|||
124798571|NCT00194675|448893396|FG001|Overall Study|Death|0|||
124798572|NCT01285960|448893397|FG000|Overall Study|Withdrawal by Subject|2|||
124798573|NCT01285960|448893397|FG000|Overall Study|Lost to Follow-up|2|||
124798574|NCT01285960|448893397|FG000|Overall Study|2 subjects received less 10 sonications|2|||
124798575|NCT02280473|448893400|FG000|Overall Study|Adverse Event|1|||
124798576|NCT02280473|448893401|FG001|Overall Study|Adverse Event|1|||
124798577|NCT02280473|448893400|FG000|Overall Study|Lack of Efficacy|0|||
124798578|NCT02280473|448893401|FG001|Overall Study|Lack of Efficacy|1|||
124798579|NCT02280473|448893400|FG000|Overall Study|Lost to Follow-up|0|||
124798580|NCT02280473|448893401|FG001|Overall Study|Lost to Follow-up|1|||
124798581|NCT01484054|448893402|FG000|Period 1|Withdrawal by Subject|0|||
124798582|NCT01484054|448893403|FG001|Period 1|Withdrawal by Subject|1|||
124798583|NCT01610271|448893404|FG000|Overall Study|Surgery not complete|0|||
124798584|NCT01610271|448893405|FG001|Overall Study|Surgery not complete|1|||
124798585|NCT01610271|448893404|FG000|Overall Study|Prosthesis not implanted|2|||
124798586|NCT01610271|448893405|FG001|Overall Study|Prosthesis not implanted|3|||
124798587|NCT00364130|448893406|FG000|Intervention Period|Lost to Follow-up|4|||
124798588|NCT00364130|448893407|FG001|Intervention Period|Lost to Follow-up|3|||
124798589|NCT00364130|448893406|FG000|Intervention Period|Pregnancy|1|||
124798590|NCT00364130|448893407|FG001|Intervention Period|Pregnancy|0|||
124798591|NCT00364130|448893406|FG000|Intervention Period|Withdrawal by Subject|4|||
124798592|NCT00364130|448893407|FG001|Intervention Period|Withdrawal by Subject|5|||
124798593|NCT00364130|448893406|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
124798594|NCT00364130|448893407|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
124798595|NCT00410202|448893408|FG000|On-Treatment|Continuing treatment|69|||
124798596|NCT00410202|448893409|FG001|On-Treatment|Continuing treatment|71|||
124798597|NCT00410202|448893410|FG002|On-Treatment|Continuing treatment|66|||
124798598|NCT00410202|448893408|FG000|On-Treatment|Adverse Event|1|||
124798599|NCT00410202|448893409|FG001|On-Treatment|Adverse Event|3|||
124798600|NCT00410202|448893410|FG002|On-Treatment|Adverse Event|2|||
124798601|NCT00410202|448893408|FG000|On-Treatment|Death|1|||
124798602|NCT00410202|448893409|FG001|On-Treatment|Death|0|||
124798603|NCT00410202|448893410|FG002|On-Treatment|Death|0|||
124798604|NCT00410202|448893408|FG000|On-Treatment|Lost to Follow-up|1|||
124798605|NCT00410202|448893409|FG001|On-Treatment|Lost to Follow-up|0|||
124798606|NCT00410202|448893410|FG002|On-Treatment|Lost to Follow-up|1|||
124798607|NCT00410202|448893408|FG000|On-Treatment|Lack of Efficacy|1|||
124798608|NCT00410202|448893409|FG001|On-Treatment|Lack of Efficacy|4|||
124798609|NCT00410202|448893410|FG002|On-Treatment|Lack of Efficacy|0|||
124798610|NCT00410202|448893408|FG000|On-Treatment|Withdrawal by Subject|2|||
124798611|NCT00410202|448893409|FG001|On-Treatment|Withdrawal by Subject|1|||
124798612|NCT00410202|448893410|FG002|On-Treatment|Withdrawal by Subject|1|||
124798613|NCT00410202|448893408|FG000|On-Treatment|Other Reason|0|||
124798614|NCT00410202|448893409|FG001|On-Treatment|Other Reason|0|||
124798615|NCT00410202|448893410|FG002|On-Treatment|Other Reason|1|||
124798616|NCT00410202|448893408|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
124798617|NCT00410202|448893409|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
124798618|NCT00410202|448893410|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
124798619|NCT00410202|448893408|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
124798620|NCT00410202|448893409|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
124798621|NCT00410202|448893410|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
124798622|NCT00410202|448893408|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
124798623|NCT00410202|448893409|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
124798624|NCT00410202|448893410|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
124798625|NCT00144027|448893412|FG000|Overall Study|Lost to Follow-up|1|||
124798626|NCT00144027|448893413|FG001|Overall Study|Lost to Follow-up|3|||
124798627|NCT00144027|448893412|FG000|Overall Study|Withdrawal by Subject|2|||
124798628|NCT00144027|448893413|FG001|Overall Study|Withdrawal by Subject|2|||
124798629|NCT00144027|448893412|FG000|Overall Study|did not complete baseline assessment|0|||
124798630|NCT00144027|448893413|FG001|Overall Study|did not complete baseline assessment|6|||
124630035|NCT01894919|448262890|FG004|Overall Study|Lost to Follow-up|2|||
124798631|NCT03194490|448893425|FG000|Overall Study|Lost to Follow-up|1|||
124798632|NCT03194490|448893426|FG001|Overall Study|Lost to Follow-up|3|||
124798633|NCT03194490|448893425|FG000|Overall Study|participant developed specific neck pain|1|||
124798634|NCT03194490|448893426|FG001|Overall Study|participant developed specific neck pain|0|||
124798635|NCT01758289|448893427|FG000|Overall Study|Premature Study Termination|44|||
124798636|NCT01758289|448893427|FG000|Overall Study|Adverse Event|9|||
124630036|NCT01894919|448262891|FG005|Overall Study|Lost to Follow-up|0|||
124798637|NCT01574079|448893428|FG000|Overall Study|Physician Decision|0|||
124798638|NCT01574079|448893429|FG001|Overall Study|Physician Decision|2|||
124798639|NCT01574079|448893428|FG000|Overall Study|Lost to Follow-up|1|||
124798640|NCT01574079|448893429|FG001|Overall Study|Lost to Follow-up|0|||
124798641|NCT00285207|448893432|FG000|Overall Study|Lost to Follow-up|3|||
124798642|NCT00285207|448893433|FG001|Overall Study|Lost to Follow-up|2|||
124798643|NCT00285207|448893432|FG000|Overall Study|Withdrawal by Subject|5|||
124798644|NCT00285207|448893433|FG001|Overall Study|Withdrawal by Subject|2|||
124798645|NCT00285207|448893432|FG000|Overall Study|Pregnancy|1|||
124798646|NCT00285207|448893433|FG001|Overall Study|Pregnancy|1|||
124798647|NCT00285207|448893432|FG000|Overall Study|non-compliance|0|||
124798648|NCT00285207|448893433|FG001|Overall Study|non-compliance|1|||
124798649|NCT02294773|448895019|FG000|Overall Study|Withdrawal by Subject|0|||
124798650|NCT02294773|448895020|FG001|Overall Study|Withdrawal by Subject|2|||
124798651|NCT03052764|448895021|FG000|Double-Blind Treatment Period|Adverse Event|2|||
124798652|NCT03052764|448895022|FG001|Double-Blind Treatment Period|Adverse Event|0|||
124798653|NCT03052764|448895021|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
124798654|NCT03052764|448895022|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
124798655|NCT03052764|448895021|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
124798656|NCT03052764|448895022|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
124798657|NCT03052764|448895021|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
124798658|NCT03052764|448895022|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
124798659|NCT03052764|448895021|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
124798660|NCT03052764|448895022|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
124798661|NCT05828095|448895023|FG000|Overall Study|Lost to Follow-up|1|||
124798662|NCT05828095|448895024|FG001|Overall Study|Lost to Follow-up|0|||
124798663|NCT05828095|448895023|FG000|Overall Study|Reactogenicity symptom|0|||
124798664|NCT05828095|448895024|FG001|Overall Study|Reactogenicity symptom|1|||
124798665|NCT03206073|448895025|FG000|Overall Study|Participant Noncompliance|0|||
124798666|NCT03206073|448895026|FG001|Overall Study|Participant Noncompliance|1|||
124798667|NCT03206073|448895027|FG002|Overall Study|Participant Noncompliance|0|||
124798668|NCT03206073|448895028|FG003|Overall Study|Participant Noncompliance|0|||
124798669|NCT03206073|448895025|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
124798670|NCT03206073|448895026|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
124798671|NCT03206073|448895027|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
124798672|NCT03206073|448895028|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
124798673|NCT03206073|448895025|FG000|Overall Study|Death|0|||
124798674|NCT03206073|448895026|FG001|Overall Study|Death|0|||
124798675|NCT03206073|448895027|FG002|Overall Study|Death|1|||
124798676|NCT03206073|448895028|FG003|Overall Study|Death|0|||
124798677|NCT03206073|448895025|FG000|Overall Study|Taken off active treatment|0|||
124798678|NCT03206073|448895026|FG001|Overall Study|Taken off active treatment|0|||
124798679|NCT03206073|448895027|FG002|Overall Study|Taken off active treatment|3|||
124798680|NCT03206073|448895028|FG003|Overall Study|Taken off active treatment|0|||
124798681|NCT03332771|448895029|FG000|Overall Study|Adverse Event|6|||
124798682|NCT03332771|448895030|FG001|Overall Study|Adverse Event|4|||
124798683|NCT03332771|448895031|FG002|Overall Study|Adverse Event|1|||
124798684|NCT03332771|448895032|FG003|Overall Study|Adverse Event|3|||
124798685|NCT03332771|448895029|FG000|Overall Study|Poor Compliance to Protocol|0|||
124798686|NCT03332771|448895030|FG001|Overall Study|Poor Compliance to Protocol|1|||
124798687|NCT03332771|448895031|FG002|Overall Study|Poor Compliance to Protocol|0|||
124798688|NCT03332771|448895032|FG003|Overall Study|Poor Compliance to Protocol|1|||
124798689|NCT03332771|448895029|FG000|Overall Study|Lost to Follow-up|2|||
124798690|NCT03332771|448895030|FG001|Overall Study|Lost to Follow-up|2|||
124798691|NCT03332771|448895031|FG002|Overall Study|Lost to Follow-up|1|||
124798692|NCT03332771|448895032|FG003|Overall Study|Lost to Follow-up|2|||
124798693|NCT03332771|448895029|FG000|Overall Study|At the Participant's own request|20|||
124798694|NCT03332771|448895030|FG001|Overall Study|At the Participant's own request|26|||
124798695|NCT03332771|448895031|FG002|Overall Study|At the Participant's own request|14|||
124798696|NCT03332771|448895032|FG003|Overall Study|At the Participant's own request|23|||
124798697|NCT03332771|448895029|FG000|Overall Study|Reason Not Specified|6|||
124798698|NCT03332771|448895030|FG001|Overall Study|Reason Not Specified|18|||
124798699|NCT03332771|448895031|FG002|Overall Study|Reason Not Specified|16|||
124798700|NCT03332771|448895032|FG003|Overall Study|Reason Not Specified|19|||
124798701|NCT00096954|448895033|FG000|Overall Study|Adverse Event|3|||
124798702|NCT00096954|448895034|FG001|Overall Study|Adverse Event|1|||
124798703|NCT00096954|448895033|FG000|Overall Study|Withdrawal by Subject|9|||
124798704|NCT00096954|448895034|FG001|Overall Study|Withdrawal by Subject|8|||
124798705|NCT00096954|448895033|FG000|Overall Study|Physician Decision|1|||
124630037|NCT01894919|448262892|FG006|Overall Study|Lost to Follow-up|0|||
124798706|NCT00096954|448895034|FG001|Overall Study|Physician Decision|1|||
124798707|NCT00096954|448895033|FG000|Overall Study|Sponsors Decision|1|||
124798708|NCT00096954|448895034|FG001|Overall Study|Sponsors Decision|1|||
124798709|NCT00096954|448895033|FG000|Overall Study|Pregnancy|1|||
124798710|NCT00096954|448895034|FG001|Overall Study|Pregnancy|1|||
124798711|NCT00096954|448895033|FG000|Overall Study|Initiation of immunotherapy|1|||
124798712|NCT00096954|448895034|FG001|Overall Study|Initiation of immunotherapy|0|||
124798713|NCT00096954|448895033|FG000|Overall Study|Non-compliance|0|||
124798714|NCT00096954|448895034|FG001|Overall Study|Non-compliance|3|||
124798715|NCT00096954|448895033|FG000|Overall Study|Lost to Follow-up|8|||
124798716|NCT00096954|448895034|FG001|Overall Study|Lost to Follow-up|5|||
124798717|NCT04478123|448895036|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
124798718|NCT04478123|448895036|FG000|Overall Study|NE|1|||
124798719|NCT03581786|448895039|FG000|Overall Study|Death|67|||
124798720|NCT03581786|448895040|FG001|Overall Study|Death|47|||
124798721|NCT03581786|448895039|FG000|Overall Study|Withdrawal by Subject|2|||
124798722|NCT03581786|448895040|FG001|Overall Study|Withdrawal by Subject|5|||
124798723|NCT03581786|448895039|FG000|Overall Study|Lost to Follow-up|7|||
124798724|NCT03581786|448895040|FG001|Overall Study|Lost to Follow-up|4|||
124798725|NCT03581786|448895039|FG000|Overall Study|reason other than specified above|0|||
124798726|NCT03581786|448895040|FG001|Overall Study|reason other than specified above|1|||
124798727|NCT01347307|448895043|FG000|Overall Study|Death|0|||
124798728|NCT01347307|448895044|FG001|Overall Study|Death|4|||
124798729|NCT01347307|448895043|FG000|Overall Study|Physician Decision|0|||
124798730|NCT01347307|448895044|FG001|Overall Study|Physician Decision|1|||
124798731|NCT04123665|448895049|FG000|Overall Study|Withdrawal by Subject|7|||
124798732|NCT04123665|448895050|FG001|Overall Study|Withdrawal by Subject|0|||
124798733|NCT04123665|448895049|FG000|Overall Study|Lost to Follow-up|1|||
124798734|NCT04123665|448895050|FG001|Overall Study|Lost to Follow-up|0|||
124798735|NCT02237911|448895051|FG000|Overall Study|Withdrawal by Subject|4|||
124798736|NCT02237911|448895052|FG001|Overall Study|Withdrawal by Subject|7|||
124798737|NCT02237911|448895053|FG002|Overall Study|Withdrawal by Subject|2|||
124798738|NCT02237911|448895051|FG000|Overall Study|Lost to Follow-up|3|||
124798739|NCT02237911|448895052|FG001|Overall Study|Lost to Follow-up|1|||
124798740|NCT02237911|448895053|FG002|Overall Study|Lost to Follow-up|1|||
124798741|NCT00053365|448895054|FG000|Overall Study|Incorrect cell type|1|||
124798742|NCT00053365|448895054|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
124798743|NCT00053365|448895054|FG000|Overall Study|Never treated|4|||
124798744|NCT00958789|448895059|FG000|Overall Study|Death|5|||
124798745|NCT00958789|448895059|FG000|Overall Study|Lost to Follow-up|14|||
124798746|NCT00958789|448895059|FG000|Overall Study|Withdrawal by Subject|17|||
124798747|NCT00958789|448895059|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
124798748|NCT00958789|448895059|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
124798749|NCT00958789|448895059|FG000|Overall Study|Subject terminated|2|||
124798750|NCT00958789|448895059|FG000|Overall Study|Revision|7|||
124798751|NCT00721123|448895060|FG000|Overall Study|Adverse Event|96|||
124798752|NCT00721123|448895060|FG000|Overall Study|Death|10|||
124798753|NCT00721123|448895060|FG000|Overall Study|Insufficient Therapeutic Response|21|||
124798754|NCT00721123|448895060|FG000|Overall Study|Protocol Violation|1|||
124798755|NCT00721123|448895060|FG000|Overall Study|Refused Treatment|41|||
124798756|NCT00721123|448895060|FG000|Overall Study|Failure to Return|9|||
124798757|NCT00721123|448895060|FG000|Overall Study|Withdrawal by Subject|5|||
124798758|NCT00433511|448895067|FG000|Step 1|Adverse Event|50|||
124798759|NCT00433511|448895068|FG001|Step 1|Adverse Event|157|||
124798760|NCT00433511|448895069|FG002|Step 1|Adverse Event|153|||
124798761|NCT00433511|448895067|FG000|Step 1|Withdrawal by Subject|45|||
124798762|NCT00433511|448895068|FG001|Step 1|Withdrawal by Subject|143|||
124798763|NCT00433511|448895069|FG002|Step 1|Withdrawal by Subject|154|||
124798764|NCT00433511|448895067|FG000|Step 1|Death|3|||
124798765|NCT00433511|448895068|FG001|Step 1|Death|1|||
124798766|NCT00433511|448895069|FG002|Step 1|Death|1|||
124798767|NCT00433511|448895067|FG000|Step 1|Physician Decision|1|||
124798768|NCT00433511|448895068|FG001|Step 1|Physician Decision|4|||
124798769|NCT00433511|448895069|FG002|Step 1|Physician Decision|3|||
124798770|NCT00433511|448895067|FG000|Step 1|Never started protocol therapy|28|||
124798771|NCT00433511|448895068|FG001|Step 1|Never started protocol therapy|64|||
124798772|NCT00433511|448895069|FG002|Step 1|Never started protocol therapy|66|||
124798773|NCT00433511|448895067|FG000|Step 1|Alternative therapy|2|||
124630038|NCT01894919|448262893|FG007|Overall Study|Lost to Follow-up|0|||
124798774|NCT00433511|448895068|FG001|Step 1|Alternative therapy|1|||
124798775|NCT00433511|448895069|FG002|Step 1|Alternative therapy|3|||
124798776|NCT00433511|448895067|FG000|Step 1|Disease progression, relapse|5|||
124798777|NCT00433511|448895068|FG001|Step 1|Disease progression, relapse|3|||
124798778|NCT00433511|448895069|FG002|Step 1|Disease progression, relapse|3|||
124798779|NCT00433511|448895067|FG000|Step 1|Other complicating disease|2|||
124798780|NCT00433511|448895068|FG001|Step 1|Other complicating disease|6|||
124798781|NCT00433511|448895069|FG002|Step 1|Other complicating disease|3|||
124798782|NCT00433511|448895067|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
124798783|NCT00433511|448895068|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
124798784|NCT00433511|448895069|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
124798785|NCT00433511|448895067|FG000|Step 1|Suspected recurrence|0|||
124630039|NCT01894919|448262894|FG008|Overall Study|Lost to Follow-up|0|||
124798786|NCT00433511|448895068|FG001|Step 1|Suspected recurrence|1|||
124798787|NCT00433511|448895069|FG002|Step 1|Suspected recurrence|0|||
124798788|NCT00433511|448895067|FG000|Step 1|Insurance/drug distribution issues|0|||
124798789|NCT00433511|448895068|FG001|Step 1|Insurance/drug distribution issues|1|||
124798790|NCT00433511|448895069|FG002|Step 1|Insurance/drug distribution issues|2|||
124798791|NCT00433511|448895067|FG000|Step 1|Patient moved|0|||
124798792|NCT00433511|448895068|FG001|Step 1|Patient moved|0|||
124798793|NCT00433511|448895069|FG002|Step 1|Patient moved|1|||
124798794|NCT00433511|448895067|FG000|Step 2 (Arm D)|Adverse Event|0|||
124798795|NCT00433511|448895068|FG001|Step 2 (Arm D)|Adverse Event|0|||
124798796|NCT00433511|448895069|FG002|Step 2 (Arm D)|Adverse Event|135|||
124798797|NCT00433511|448895067|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
124798798|NCT00433511|448895068|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
124798799|NCT00433511|448895069|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
124798800|NCT00433511|448895067|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
124798801|NCT00433511|448895068|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
124798802|NCT00433511|448895069|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
124798803|NCT00433511|448895067|FG000|Step 2 (Arm D)|Physician Decision|0|||
124798804|NCT00433511|448895068|FG001|Step 2 (Arm D)|Physician Decision|0|||
124798805|NCT00433511|448895069|FG002|Step 2 (Arm D)|Physician Decision|9|||
124798806|NCT00433511|448895067|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
124798807|NCT00433511|448895068|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
124798808|NCT00433511|448895069|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
124798809|NCT00433511|448895067|FG000|Step 2 (Arm D)|Other complicating disease|0|||
124798810|NCT00433511|448895068|FG001|Step 2 (Arm D)|Other complicating disease|0|||
124798811|NCT00433511|448895069|FG002|Step 2 (Arm D)|Other complicating disease|3|||
124798812|NCT00433511|448895067|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
124798813|NCT00433511|448895068|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
124798814|NCT00433511|448895069|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
124798815|NCT00433511|448895067|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
124798816|NCT00433511|448895068|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
124798817|NCT00433511|448895069|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
124798818|NCT00433511|448895067|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
124798819|NCT00433511|448895068|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
124798820|NCT00433511|448895069|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
124798821|NCT00433511|448895067|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
124798822|NCT00433511|448895068|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
124798823|NCT00433511|448895069|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
124798824|NCT03139604|448895070|FG000|Overall Study|Other|7|||
124798825|NCT03139604|448895071|FG001|Overall Study|Other|3|||
124798826|NCT03139604|448895070|FG000|Overall Study|Withdrawal by Subject|16|||
124798827|NCT03139604|448895071|FG001|Overall Study|Withdrawal by Subject|17|||
124798828|NCT03139604|448895070|FG000|Overall Study|Physician Decision|1|||
124798829|NCT03139604|448895071|FG001|Overall Study|Physician Decision|2|||
124798830|NCT03139604|448895070|FG000|Overall Study|Lost to Follow-up|3|||
124798831|NCT03139604|448895071|FG001|Overall Study|Lost to Follow-up|1|||
124798832|NCT03139604|448895070|FG000|Overall Study|Death|65|||
124798833|NCT03139604|448895071|FG001|Overall Study|Death|67|||
124798834|NCT03139604|448895070|FG000|Overall Study|Study Terminated by Sponsor|122|||
124798835|NCT03139604|448895071|FG001|Overall Study|Study Terminated by Sponsor|127|||
124798836|NCT03139604|448895070|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
124798837|NCT03139604|448895071|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
124798838|NCT04950608|448895072|FG000|Overall Study|Withdrawal by Subject|2|||
124798839|NCT04950608|448895072|FG000|Overall Study|Physician Decision|3|||
124798840|NCT02007512|448895076|FG000|Double Blind Treatment Period|Adverse Event|4|||
124798841|NCT02007512|448895077|FG001|Double Blind Treatment Period|Adverse Event|6|||
124798842|NCT02007512|448895078|FG002|Double Blind Treatment Period|Adverse Event|2|||
124798843|NCT02007512|448895079|FG003|Double Blind Treatment Period|Adverse Event|2|||
124798844|NCT02007512|448895076|FG000|Double Blind Treatment Period|Death|1|||
124798845|NCT02007512|448895077|FG001|Double Blind Treatment Period|Death|0|||
124798846|NCT02007512|448895078|FG002|Double Blind Treatment Period|Death|0|||
124798847|NCT02007512|448895079|FG003|Double Blind Treatment Period|Death|0|||
124798848|NCT02007512|448895076|FG000|Double Blind Treatment Period|Disease progression|51|||
124798849|NCT02007512|448895077|FG001|Double Blind Treatment Period|Disease progression|50|||
124798850|NCT02007512|448895078|FG002|Double Blind Treatment Period|Disease progression|57|||
124798851|NCT02007512|448895079|FG003|Double Blind Treatment Period|Disease progression|52|||
124798852|NCT02007512|448895076|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
124798853|NCT02007512|448895077|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
124798854|NCT02007512|448895078|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
124798855|NCT02007512|448895079|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
124630040|NCT01894919|448262895|FG009|Overall Study|Lost to Follow-up|0|||
124630041|NCT01894919|448262896|FG010|Overall Study|Lost to Follow-up|0|||
124798856|NCT02007512|448895076|FG000|Double Blind Treatment Period|Protocol Violation|1|||
124798857|NCT02007512|448895077|FG001|Double Blind Treatment Period|Protocol Violation|0|||
124798858|NCT02007512|448895078|FG002|Double Blind Treatment Period|Protocol Violation|0|||
124798859|NCT02007512|448895079|FG003|Double Blind Treatment Period|Protocol Violation|1|||
124798860|NCT02007512|448895076|FG000|Double Blind Treatment Period|Other|2|||
124798861|NCT02007512|448895077|FG001|Double Blind Treatment Period|Other|1|||
124798862|NCT02007512|448895078|FG002|Double Blind Treatment Period|Other|1|||
124798863|NCT02007512|448895079|FG003|Double Blind Treatment Period|Other|2|||
124798864|NCT02007512|448895076|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
124798865|NCT02007512|448895077|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
124798866|NCT02007512|448895078|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
124798867|NCT02007512|448895079|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
124798868|NCT02007512|448895076|FG000|Open Label Treatment Period|Adverse Event|1|||
124798869|NCT02007512|448895077|FG001|Open Label Treatment Period|Adverse Event|0|||
124798870|NCT02007512|448895078|FG002|Open Label Treatment Period|Adverse Event|0|||
124798871|NCT02007512|448895079|FG003|Open Label Treatment Period|Adverse Event|0|||
124798872|NCT02007512|448895076|FG000|Open Label Treatment Period|Other|1|||
124798873|NCT02007512|448895077|FG001|Open Label Treatment Period|Other|1|||
124798874|NCT02007512|448895078|FG002|Open Label Treatment Period|Other|0|||
124798875|NCT02007512|448895079|FG003|Open Label Treatment Period|Other|0|||
124798876|NCT02007512|448895076|FG000|Open Label Treatment Period|Disease progression|23|||
124798877|NCT02007512|448895077|FG001|Open Label Treatment Period|Disease progression|11|||
124798878|NCT02007512|448895078|FG002|Open Label Treatment Period|Disease progression|0|||
124798879|NCT02007512|448895079|FG003|Open Label Treatment Period|Disease progression|0|||
124798880|NCT00608543|448895082|FG000|Overall Study|Adverse Event|4|||
124798881|NCT03026088|448895084|FG000|Overall Study|Study termination|20|||
124798882|NCT01869725|448895086|FG000|Overall Study|ineligible after registration|1|||
124798883|NCT01869725|448895086|FG000|Overall Study|Death|1|||
124798884|NCT01869725|448895086|FG000|Overall Study|Lost to Follow-up|2|||
124798885|NCT01143207|448895087|FG000|Overall Study|Lost to Follow-up|2|||
124798886|NCT03416374|448895100|FG000|Between Treatment Period I and II|Other|0|||
124798887|NCT03416374|448895101|FG001|Between Treatment Period I and II|Other|9|||
124798888|NCT03416374|448895100|FG000|Treatment Period II|Lack of Efficacy|3|||
124798889|NCT03416374|448895101|FG001|Treatment Period II|Lack of Efficacy|11|||
124798890|NCT03416374|448895100|FG000|Treatment Period II|Adverse Event|1|||
124798891|NCT03416374|448895101|FG001|Treatment Period II|Adverse Event|4|||
124798892|NCT03416374|448895100|FG000|Treatment Period II|Death|0|||
124798893|NCT03416374|448895101|FG001|Treatment Period II|Death|1|||
124798894|NCT03416374|448895100|FG000|Treatment Period II|Other|0|||
124798895|NCT03416374|448895101|FG001|Treatment Period II|Other|2|||
124798896|NCT01052844|448895102|FG000|Overall Study|Adverse Event|0|||
124798897|NCT01052844|448895103|FG001|Overall Study|Adverse Event|1|||
124798898|NCT03463031|448895104|FG000|Overall Study|Withdrawal by Subject|4|||
124798899|NCT03463031|448895105|FG001|Overall Study|Withdrawal by Subject|2|||
124798900|NCT03463031|448895104|FG000|Overall Study|Investigator/Sponsor Decision|0|||
124798901|NCT03463031|448895105|FG001|Overall Study|Investigator/Sponsor Decision|1|||
124798902|NCT03463031|448895104|FG000|Overall Study|Lost to Follow-up|1|||
124798903|NCT03463031|448895105|FG001|Overall Study|Lost to Follow-up|1|||
124798904|NCT03463031|448895104|FG000|Overall Study|Adverse Event|4|||
124798905|NCT03463031|448895105|FG001|Overall Study|Adverse Event|1|||
124798906|NCT03463031|448895104|FG000|Overall Study|Use of prohibited medication by subject|1|||
124798907|NCT03463031|448895105|FG001|Overall Study|Use of prohibited medication by subject|0|||
124798908|NCT02537574|448895110|FG000|Overall Study|Adverse Event|1|||
124798909|NCT02537574|448895111|FG001|Overall Study|Adverse Event|3|||
124798910|NCT02537574|448895112|FG002|Overall Study|Adverse Event|2|||
124798911|NCT02537574|448895110|FG000|Overall Study|Lost to Follow-up|40|||
124798912|NCT02537574|448895111|FG001|Overall Study|Lost to Follow-up|51|||
124798913|NCT02537574|448895112|FG002|Overall Study|Lost to Follow-up|55|||
124798914|NCT02537574|448895110|FG000|Overall Study|Noncompliance with study drug|0|||
124798915|NCT02537574|448895111|FG001|Overall Study|Noncompliance with study drug|1|||
124798916|NCT02537574|448895112|FG002|Overall Study|Noncompliance with study drug|1|||
124798917|NCT02537574|448895110|FG000|Overall Study|Physician Decision|2|||
124798918|NCT02537574|448895111|FG001|Overall Study|Physician Decision|0|||
124798919|NCT02537574|448895112|FG002|Overall Study|Physician Decision|0|||
124798920|NCT02537574|448895110|FG000|Overall Study|Protocol Violation|4|||
124798921|NCT02537574|448895111|FG001|Overall Study|Protocol Violation|2|||
124798922|NCT02537574|448895112|FG002|Overall Study|Protocol Violation|3|||
124798923|NCT02537574|448895110|FG000|Overall Study|Withdrawal by Subject|37|||
124798924|NCT02537574|448895111|FG001|Overall Study|Withdrawal by Subject|27|||
124798925|NCT02537574|448895112|FG002|Overall Study|Withdrawal by Subject|29|||
124798926|NCT02537574|448895110|FG000|Overall Study|Lack of Efficacy|14|||
124798927|NCT02537574|448895111|FG001|Overall Study|Lack of Efficacy|16|||
124798928|NCT02537574|448895112|FG002|Overall Study|Lack of Efficacy|15|||
124798929|NCT02537574|448895110|FG000|Overall Study|Duplicate Patient|1|||
124798930|NCT02537574|448895111|FG001|Overall Study|Duplicate Patient|0|||
124798931|NCT02537574|448895112|FG002|Overall Study|Duplicate Patient|0|||
124798932|NCT02537574|448895110|FG000|Overall Study|Patient not Stable|0|||
124798933|NCT02537574|448895111|FG001|Overall Study|Patient not Stable|1|||
124798934|NCT02537574|448895112|FG002|Overall Study|Patient not Stable|0|||
124798935|NCT02537574|448895110|FG000|Overall Study|Incarceration|0|||
124798936|NCT02537574|448895111|FG001|Overall Study|Incarceration|1|||
124798937|NCT02537574|448895112|FG002|Overall Study|Incarceration|0|||
124798938|NCT02537574|448895110|FG000|Overall Study|Failed Naloxone Challenge|0|||
124798939|NCT02537574|448895111|FG001|Overall Study|Failed Naloxone Challenge|1|||
124798940|NCT02537574|448895112|FG002|Overall Study|Failed Naloxone Challenge|0|||
124798941|NCT02537574|448895110|FG000|Overall Study|Transportation Issues|0|||
124798942|NCT02537574|448895111|FG001|Overall Study|Transportation Issues|0|||
124798943|NCT02537574|448895112|FG002|Overall Study|Transportation Issues|1|||
124798944|NCT02537574|448895110|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
124798945|NCT02537574|448895111|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
124798946|NCT02537574|448895112|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
124798947|NCT02537574|448895110|FG000|Overall Study|Noncompliance with Protocol|0|||
124798948|NCT02537574|448895111|FG001|Overall Study|Noncompliance with Protocol|0|||
124798949|NCT02537574|448895112|FG002|Overall Study|Noncompliance with Protocol|1|||
124798950|NCT00048061|448895113|FG000|Overall Study|Adverse Event|41|||
124798951|NCT00048061|448895114|FG001|Overall Study|Adverse Event|32|||
124798952|NCT00048061|448895115|FG002|Overall Study|Adverse Event|44|||
124798953|NCT00048061|448895116|FG003|Overall Study|Adverse Event|37|||
124798954|NCT00048061|448895113|FG000|Overall Study|Lost to Follow-up|3|||
124798955|NCT00048061|448895114|FG001|Overall Study|Lost to Follow-up|2|||
124798956|NCT00048061|448895115|FG002|Overall Study|Lost to Follow-up|4|||
124798957|NCT00048061|448895116|FG003|Overall Study|Lost to Follow-up|5|||
124798958|NCT00048061|448895113|FG000|Overall Study|Withdrawal by Subject|20|||
124798959|NCT00048061|448895114|FG001|Overall Study|Withdrawal by Subject|29|||
124798960|NCT00048061|448895115|FG002|Overall Study|Withdrawal by Subject|29|||
124798961|NCT00048061|448895116|FG003|Overall Study|Withdrawal by Subject|32|||
124798962|NCT00048061|448895113|FG000|Overall Study|Did not follow-up|5|||
124798963|NCT00048061|448895114|FG001|Overall Study|Did not follow-up|5|||
124798964|NCT00048061|448895115|FG002|Overall Study|Did not follow-up|4|||
124798965|NCT00048061|448895116|FG003|Overall Study|Did not follow-up|5|||
124798966|NCT00048061|448895113|FG000|Overall Study|Early improvement|6|||
124798967|NCT00048061|448895114|FG001|Overall Study|Early improvement|5|||
124798968|NCT00048061|448895115|FG002|Overall Study|Early improvement|3|||
124798969|NCT00048061|448895116|FG003|Overall Study|Early improvement|0|||
124798970|NCT02675231|448895117|FG000|Overall Study|Withdrawal by Subject|2|||
124798971|NCT02675231|448895118|FG001|Overall Study|Withdrawal by Subject|4|||
124798972|NCT02675231|448895119|FG002|Overall Study|Withdrawal by Subject|2|||
124798973|NCT02675231|448895117|FG000|Overall Study|Lost to Follow-up|3|||
124798974|NCT02675231|448895118|FG001|Overall Study|Lost to Follow-up|4|||
124798975|NCT02675231|448895119|FG002|Overall Study|Lost to Follow-up|3|||
124798976|NCT02495233|448895120|FG000|Overall Study|Miscellaneous|0|||
124798977|NCT02495233|448895121|FG001|Overall Study|Miscellaneous|1|||
124798978|NCT02220998|448895123|FG000|Overall Study|Randomized but Never Treated|1|||
124798979|NCT02220998|448895124|FG001|Overall Study|Randomized but Never Treated|2|||
124798980|NCT02220998|448895123|FG000|Overall Study|Death|2|||
124798981|NCT02220998|448895124|FG001|Overall Study|Death|0|||
124798982|NCT02220998|448895123|FG000|Overall Study|Lack of Efficacy|0|||
124798983|NCT02220998|448895124|FG001|Overall Study|Lack of Efficacy|5|||
124798984|NCT02220998|448895123|FG000|Overall Study|Lost to Follow-up|4|||
124798985|NCT02220998|448895124|FG001|Overall Study|Lost to Follow-up|4|||
124798986|NCT02314143|448895125|FG000|Overall Study|Adverse Event|0|||
124798987|NCT02314143|448895126|FG001|Overall Study|Adverse Event|6|||
124798988|NCT02314143|448895127|FG002|Overall Study|Adverse Event|4|||
124798989|NCT02314143|448895125|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
124798990|NCT02314143|448895126|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
124798991|NCT02314143|448895127|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
124798992|NCT02314143|448895125|FG000|Overall Study|Physician Decision|2|||
124798993|NCT02314143|448895126|FG001|Overall Study|Physician Decision|1|||
124798994|NCT02314143|448895127|FG002|Overall Study|Physician Decision|0|||
124798995|NCT02314143|448895125|FG000|Overall Study|Withdrawal by Subject|1|||
124798996|NCT02314143|448895126|FG001|Overall Study|Withdrawal by Subject|0|||
124798997|NCT02314143|448895127|FG002|Overall Study|Withdrawal by Subject|1|||
124798998|NCT00873860|448895129|FG000|Overall Study|Lost to Follow-up|1|||
124798999|NCT00873860|448895130|FG001|Overall Study|Lost to Follow-up|0|||
124799000|NCT00873860|448895131|FG002|Overall Study|Lost to Follow-up|0|||
124799001|NCT00873860|448895132|FG003|Overall Study|Lost to Follow-up|1|||
124799002|NCT00873860|448895129|FG000|Overall Study|Withdrawal by Subject|1|||
124799003|NCT00873860|448895130|FG001|Overall Study|Withdrawal by Subject|0|||
124799004|NCT00873860|448895131|FG002|Overall Study|Withdrawal by Subject|2|||
124799005|NCT00873860|448895132|FG003|Overall Study|Withdrawal by Subject|0|||
124799006|NCT00873860|448895129|FG000|Overall Study|Death|1|||
124799007|NCT00873860|448895130|FG001|Overall Study|Death|0|||
124799008|NCT00873860|448895131|FG002|Overall Study|Death|0|||
124799009|NCT00873860|448895132|FG003|Overall Study|Death|0|||
124799010|NCT00873860|448895129|FG000|Overall Study|Other|1|||
124799011|NCT00873860|448895130|FG001|Overall Study|Other|0|||
124799012|NCT00873860|448895131|FG002|Overall Study|Other|1|||
124799013|NCT00873860|448895132|FG003|Overall Study|Other|0|||
124799014|NCT02140775|448895134|FG000|Overall Study|Withdrawal by Subject|30|||
124799015|NCT02140775|448895135|FG001|Overall Study|Withdrawal by Subject|7|||
124799016|NCT04650854|448895138|FG000|Overall Study|Adverse Event|1|||
124799017|NCT04650854|448895139|FG001|Overall Study|Adverse Event|12|||
124799018|NCT04650854|448895140|FG002|Overall Study|Adverse Event|14|||
124799019|NCT04650854|448895138|FG000|Overall Study|Lack of Efficacy|1|||
124799020|NCT04650854|448895139|FG001|Overall Study|Lack of Efficacy|3|||
124799021|NCT04650854|448895140|FG002|Overall Study|Lack of Efficacy|6|||
124799022|NCT04650854|448895138|FG000|Overall Study|Lost to Follow-up|1|||
124630042|NCT01894919|448262897|FG011|Overall Study|Lost to Follow-up|0|||
124630043|NCT01894919|448262898|FG012|Overall Study|Lost to Follow-up|0|||
124630044|NCT03711188|448262899|FG000|Overall Study|Disease progression|11|||
124630045|NCT03711188|448262899|FG000|Overall Study|Adverse Event|1|||
124630046|NCT01433471|448262902|FG000|Overall Study|Withdrawal by Subject|0|||
124630047|NCT01433471|448262903|FG001|Overall Study|Withdrawal by Subject|1|||
124630048|NCT03238651|448262904|FG000|Overall Study|Other|0|||
124630049|NCT03238651|448262905|FG001|Overall Study|Other|0|||
124630050|NCT03238651|448262906|FG002|Overall Study|Other|0|||
124630051|NCT03238651|448262907|FG003|Overall Study|Other|0|||
124630052|NCT03238651|448262908|FG004|Overall Study|Other|1|||
124630053|NCT03238651|448262904|FG000|Overall Study|Progressive Disease|2|||
124630054|NCT03238651|448262905|FG001|Overall Study|Progressive Disease|2|||
124799023|NCT04650854|448895139|FG001|Overall Study|Lost to Follow-up|1|||
124799024|NCT04650854|448895140|FG002|Overall Study|Lost to Follow-up|0|||
124799025|NCT04650854|448895138|FG000|Overall Study|Withdrawal by Subject|2|||
124799026|NCT04650854|448895139|FG001|Overall Study|Withdrawal by Subject|17|||
124799027|NCT04650854|448895140|FG002|Overall Study|Withdrawal by Subject|9|||
124799028|NCT04650854|448895138|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
124799029|NCT04650854|448895139|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
124799030|NCT04650854|448895140|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
124799031|NCT04650854|448895138|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
124799032|NCT04650854|448895139|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
124799033|NCT04650854|448895140|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
124799034|NCT04650854|448895138|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
124799035|NCT04650854|448895139|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
124799036|NCT04650854|448895140|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
124799037|NCT04650854|448895138|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
124799038|NCT04650854|448895139|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
124799039|NCT04650854|448895140|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
124799040|NCT04650854|448895138|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
124799041|NCT04650854|448895139|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
124799042|NCT04650854|448895140|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
124799043|NCT04650854|448895138|FG000|Overall Study|Use of Rescue Medication|0|||
124799044|NCT04650854|448895139|FG001|Overall Study|Use of Rescue Medication|0|||
124799045|NCT04650854|448895140|FG002|Overall Study|Use of Rescue Medication|1|||
124799046|NCT04650854|448895138|FG000|Overall Study|Last Treatment Per Sponsor|0|||
124799047|NCT04650854|448895139|FG001|Overall Study|Last Treatment Per Sponsor|0|||
124799048|NCT04650854|448895140|FG002|Overall Study|Last Treatment Per Sponsor|2|||
124799049|NCT04650854|448895138|FG000|Overall Study|Rescue Medication|0|||
124630055|NCT03238651|448262906|FG002|Overall Study|Progressive Disease|2|||
124630056|NCT03238651|448262907|FG003|Overall Study|Progressive Disease|2|||
124630057|NCT03238651|448262908|FG004|Overall Study|Progressive Disease|0|||
124630058|NCT03238651|448262904|FG000|Overall Study|Withdrawal by Subject|0|||
124630059|NCT03238651|448262905|FG001|Overall Study|Withdrawal by Subject|1|||
124630060|NCT03238651|448262906|FG002|Overall Study|Withdrawal by Subject|0|||
124630061|NCT03238651|448262907|FG003|Overall Study|Withdrawal by Subject|1|||
124630062|NCT03238651|448262908|FG004|Overall Study|Withdrawal by Subject|0|||
124630063|NCT03238651|448262904|FG000|Overall Study|Adverse Event|1|||
124630064|NCT03238651|448262905|FG001|Overall Study|Adverse Event|3|||
124630065|NCT03238651|448262906|FG002|Overall Study|Adverse Event|2|||
124630066|NCT03238651|448262907|FG003|Overall Study|Adverse Event|0|||
124630067|NCT03238651|448262908|FG004|Overall Study|Adverse Event|0|||
124630068|NCT03875508|448262909|FG000|Overall Study|Adverse Event|1|||
124630069|NCT03875508|448262909|FG000|Overall Study|Lost to Follow-up|8|||
124630070|NCT03875508|448262909|FG000|Overall Study|Lack of Efficacy|1|||
124630071|NCT03875508|448262909|FG000|Overall Study|Other, not specified|2|||
124630072|NCT04341363|448262912|FG000|Overall Study|Adverse Event|1|||
124630073|NCT04341363|448262912|FG000|Overall Study|Withdrawal by Subject|1|||
124630074|NCT00063934|448262913|FG000|Overall Study|Ineligible|1|||
124630075|NCT00840749|448262917|FG000|Overall Study|Death|1|||
124630076|NCT00840749|448262918|FG001|Overall Study|Death|2|||
124630077|NCT00840749|448262917|FG000|Overall Study|not treated on study arm|11|||
124630078|NCT00840749|448262918|FG001|Overall Study|not treated on study arm|11|||
124630079|NCT00840749|448262917|FG000|Overall Study|study closed|19|||
124630080|NCT00840749|448262918|FG001|Overall Study|study closed|14|||
124630081|NCT02550561|448262919|FG000|Overall Study|Lost to Follow-up|5|||
124630082|NCT02550561|448262919|FG000|Overall Study|Withdrawal by Subject|1|||
124630083|NCT00395629|448262920|FG000|Core Study|Adverse Event|0|||
124630084|NCT00395629|448262921|FG001|Core Study|Adverse Event|3|||
124630085|NCT00395629|448262922|FG002|Core Study|Adverse Event|4|||
124630086|NCT00395629|448262920|FG000|Core Study|Abnormal laboratory value(s)|0|||
124630087|NCT00395629|448262921|FG001|Core Study|Abnormal laboratory value(s)|0|||
124630088|NCT00395629|448262922|FG002|Core Study|Abnormal laboratory value(s)|1|||
124630089|NCT00395629|448262920|FG000|Core Study|Protocol Violation|1|||
124630090|NCT00395629|448262921|FG001|Core Study|Protocol Violation|0|||
124630091|NCT00395629|448262922|FG002|Core Study|Protocol Violation|0|||
124630092|NCT00395629|448262920|FG000|Core Study|Withdrawal by Subject|0|||
124630093|NCT00395629|448262921|FG001|Core Study|Withdrawal by Subject|1|||
124630094|NCT00395629|448262922|FG002|Core Study|Withdrawal by Subject|1|||
124630095|NCT00395629|448262920|FG000|Core Study|Lost to Follow-up|0|||
124630096|NCT00395629|448262921|FG001|Core Study|Lost to Follow-up|0|||
124630097|NCT00395629|448262922|FG002|Core Study|Lost to Follow-up|1|||
124630098|NCT00395629|448262920|FG000|Extension Study|Adverse Event|0|||
124630099|NCT00395629|448262921|FG001|Extension Study|Adverse Event|0|||
124630100|NCT00395629|448262922|FG002|Extension Study|Adverse Event|2|||
124799050|NCT04650854|448895139|FG001|Overall Study|Rescue Medication|0|||
124799051|NCT04650854|448895140|FG002|Overall Study|Rescue Medication|1|||
124799052|NCT04650854|448895138|FG000|Overall Study|Participant Want to Start a Family|0|||
124799053|NCT04650854|448895139|FG001|Overall Study|Participant Want to Start a Family|0|||
124799054|NCT04650854|448895140|FG002|Overall Study|Participant Want to Start a Family|1|||
124799055|NCT04650854|448895138|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
124799056|NCT04650854|448895139|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
124799057|NCT04650854|448895140|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
124799058|NCT04650854|448895138|FG000|Overall Study|Participant Screened For MG0020|0|||
124799059|NCT04650854|448895139|FG001|Overall Study|Participant Screened For MG0020|2|||
124799060|NCT04650854|448895140|FG002|Overall Study|Participant Screened For MG0020|3|||
124799061|NCT04650854|448895138|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
124799062|NCT04650854|448895139|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
124799063|NCT04650854|448895140|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
124799064|NCT04650854|448895138|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
124799065|NCT04650854|448895139|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
124799066|NCT04650854|448895140|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
124799067|NCT04650854|448895138|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
124799068|NCT04650854|448895139|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
124799069|NCT04650854|448895140|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
124799070|NCT04650854|448895138|FG000|Overall Study|End Of Study|0|||
124799071|NCT04650854|448895139|FG001|Overall Study|End Of Study|2|||
124799072|NCT04650854|448895140|FG002|Overall Study|End Of Study|1|||
124799073|NCT04650854|448895138|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
124799074|NCT04650854|448895139|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
124799075|NCT04650854|448895140|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
124799076|NCT04650854|448895138|FG000|Overall Study|Participant Received Rescue Medication|0|||
124799077|NCT04650854|448895139|FG001|Overall Study|Participant Received Rescue Medication|1|||
124799078|NCT04650854|448895140|FG002|Overall Study|Participant Received Rescue Medication|0|||
124799079|NCT04650854|448895138|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
124799080|NCT04650854|448895139|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
124799081|NCT04650854|448895140|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
124799082|NCT04650854|448895138|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
124799083|NCT04650854|448895139|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
124799084|NCT04650854|448895140|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
124799085|NCT04650854|448895138|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
124799086|NCT04650854|448895139|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
124799087|NCT04650854|448895140|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
124799088|NCT04650854|448895138|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
124799089|NCT04650854|448895139|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
124799090|NCT04650854|448895140|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
124799091|NCT04650854|448895138|FG000|Overall Study|Enrollment Cup|0|||
124799092|NCT04650854|448895139|FG001|Overall Study|Enrollment Cup|0|||
124799093|NCT04650854|448895140|FG002|Overall Study|Enrollment Cup|1|||
124799094|NCT00704808|448895141|FG000|Overall Study|Discontinued prior to starting treatment|14|||
124799095|NCT00704808|448895141|FG000|Overall Study|Death|7|||
124799096|NCT00704808|448895141|FG000|Overall Study|Tumor progression|80|||
124630101|NCT00395629|448262920|FG000|Extension Study|Administrative problems|0|||
124630102|NCT00395629|448262921|FG001|Extension Study|Administrative problems|0|||
124630103|NCT00395629|448262922|FG002|Extension Study|Administrative problems|1|||
124630104|NCT01051960|448262923|FG000|Overall Study|Adverse Event|1|||
124630105|NCT03534687|448262924|FG000|Overall Study|Lost to Follow-up|7|||
124630106|NCT03534687|448262925|FG001|Overall Study|Lost to Follow-up|2|||
124630107|NCT02394600|448262926|FG000|Overall Study|Adverse Event|3|||
124630108|NCT02394600|448262927|FG001|Overall Study|Adverse Event|0|||
124630109|NCT02394600|448262926|FG000|Overall Study|Lost to Follow-up|0|||
124630110|NCT02394600|448262927|FG001|Overall Study|Lost to Follow-up|1|||
124630111|NCT02394600|448262926|FG000|Overall Study|Withdrawal by Subject|0|||
124630112|NCT02394600|448262927|FG001|Overall Study|Withdrawal by Subject|1|||
124630113|NCT02394600|448262926|FG000|Overall Study|Protocol Violation|1|||
124630114|NCT02394600|448262927|FG001|Overall Study|Protocol Violation|0|||
124630115|NCT01686373|448262928|FG000|Overall Study|Lost to Follow-up|3|||
124630116|NCT01686373|448262929|FG001|Overall Study|Lost to Follow-up|0|||
124630117|NCT01686373|448262928|FG000|Overall Study|Withdrawal by Subject|0|||
124630118|NCT01686373|448262929|FG001|Overall Study|Withdrawal by Subject|1|||
124630119|NCT01686373|448262928|FG000|Overall Study|Adverse Event|0|||
124630120|NCT01686373|448262929|FG001|Overall Study|Adverse Event|1|||
124630121|NCT01960413|448262940|FG000|Overall Study|Withdrawal by Subject|1|||
124630122|NCT01960413|448262941|FG001|Overall Study|Withdrawal by Subject|1|||
124630123|NCT01960413|448262940|FG000|Overall Study|Physician Decision|1|||
124630124|NCT01960413|448262941|FG001|Overall Study|Physician Decision|0|||
124630125|NCT01960413|448262940|FG000|Overall Study|Lost to Follow-up|2|||
124630126|NCT01960413|448262941|FG001|Overall Study|Lost to Follow-up|0|||
124630127|NCT01082328|448262945|FG000|Overall Study|Adverse Event|1|||
124630128|NCT00791778|448262946|FG000|Double-blind Treatment|Adverse Event|49|||
124630129|NCT00791778|448262947|FG001|Double-blind Treatment|Adverse Event|9|||
124630130|NCT00791778|448262946|FG000|Double-blind Treatment|Physician Decision|6|||
124630131|NCT00791778|448262947|FG001|Double-blind Treatment|Physician Decision|26|||
124630132|NCT00791778|448262946|FG000|Double-blind Treatment|Protocol Violation|0|||
124630133|NCT00791778|448262947|FG001|Double-blind Treatment|Protocol Violation|4|||
124630134|NCT00791778|448262946|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
124630135|NCT00791778|448262947|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
124630136|NCT00791778|448262946|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
124630137|NCT00791778|448262947|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
124630138|NCT00791778|448262946|FG000|Follow-up|Withdrawal by Subject|3|||
124630139|NCT00791778|448262947|FG001|Follow-up|Withdrawal by Subject|0|||
124630140|NCT00791778|448262946|FG000|Follow-up|Lost to Follow-up|2|||
124630141|NCT00791778|448262947|FG001|Follow-up|Lost to Follow-up|1|||
124630142|NCT02285361|448262948|FG000|Overall Study|Protocol Violation|43|||
124630143|NCT02285361|448262948|FG000|Overall Study|Lost to Follow-up|5|||
124630144|NCT02285361|448262948|FG000|Overall Study|Not taken GIOTRIF|2|||
124630145|NCT02285361|448262948|FG000|Overall Study|Consented prior to the contract date|1|||
124630146|NCT02411656|448262950|FG000|Overall Study|Adverse Event|4|||
124630147|NCT02411656|448262950|FG000|Overall Study|Clinical Progression|33|||
124630148|NCT06481709|448262951|FG000|Overall Study|Withdrawal by Subject|0|||
124630149|NCT06481709|448262952|FG001|Overall Study|Withdrawal by Subject|0|||
124630150|NCT06481709|448262953|FG002|Overall Study|Withdrawal by Subject|2|||
124630151|NCT06481709|448262954|FG003|Overall Study|Withdrawal by Subject|0|||
124630152|NCT04578535|448262957|FG000|Overall Study|Lost to Follow-up|1|||
124630153|NCT04578535|448262958|FG001|Overall Study|Lost to Follow-up|0|||
124630154|NCT04578535|448262959|FG002|Overall Study|Lost to Follow-up|0|||
124630155|NCT04578535|448262960|FG003|Overall Study|Lost to Follow-up|1|||
124630156|NCT04578535|448262961|FG004|Overall Study|Lost to Follow-up|0|||
124630157|NCT04578535|448262962|FG005|Overall Study|Lost to Follow-up|2|||
124630158|NCT04578535|448262957|FG000|Overall Study|Pregnancy|1|||
124630159|NCT04578535|448262958|FG001|Overall Study|Pregnancy|0|||
124630160|NCT04578535|448262959|FG002|Overall Study|Pregnancy|0|||
124630161|NCT04578535|448262960|FG003|Overall Study|Pregnancy|0|||
124630162|NCT04578535|448262961|FG004|Overall Study|Pregnancy|0|||
124630163|NCT04578535|448262962|FG005|Overall Study|Pregnancy|0|||
124799097|NCT00704808|448895141|FG000|Overall Study|Patient's decision|11|||
124799098|NCT00704808|448895141|FG000|Overall Study|Early therapy discontinuation|16|||
124799099|NCT00704808|448895141|FG000|Overall Study|Adverse Event|1|||
124799100|NCT00704808|448895141|FG000|Overall Study|Lost to Follow-up|1|||
124799101|NCT00704808|448895141|FG000|Overall Study|Treatment change|1|||
124799102|NCT01280955|448895145|FG000|Overall Study|Death|2|||
124799103|NCT01280955|448895145|FG000|Overall Study|Withdrawal by Subject|1|||
124799104|NCT04223232|448895146|FG000|Overall Study|Withdrawal by Subject|1|||
124799105|NCT05281601|448895147|FG000|Overall Study|Physician Decision|2|||
124799106|NCT05281601|448895148|FG001|Overall Study|Physician Decision|0|||
124799107|NCT05281601|448895147|FG000|Overall Study|Lost to Follow-up|2|||
124799108|NCT05281601|448895148|FG001|Overall Study|Lost to Follow-up|0|||
124630164|NCT04578535|448262957|FG000|Overall Study|Withdrawal by Subject|0|||
124630165|NCT04578535|448262958|FG001|Overall Study|Withdrawal by Subject|0|||
124630166|NCT04578535|448262959|FG002|Overall Study|Withdrawal by Subject|0|||
124799109|NCT05281601|448895147|FG000|Overall Study|Death|1|||
124630167|NCT04578535|448262960|FG003|Overall Study|Withdrawal by Subject|1|||
124630168|NCT04578535|448262961|FG004|Overall Study|Withdrawal by Subject|1|||
124630169|NCT04578535|448262962|FG005|Overall Study|Withdrawal by Subject|5|||
124630170|NCT04578535|448262957|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
124630171|NCT04578535|448262958|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
124799110|NCT05281601|448895148|FG001|Overall Study|Death|0|||
124799111|NCT05281601|448895147|FG000|Overall Study|Withdrawal by parent/guardian|2|||
124799112|NCT05281601|448895148|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124799113|NCT03172910|448896612|FG000|Overall Study|Adverse Event|0|||
124799114|NCT03172910|448896613|FG001|Overall Study|Adverse Event|0|||
124799115|NCT03172910|448896614|FG002|Overall Study|Adverse Event|0|||
124630172|NCT04578535|448262959|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
124630173|NCT04578535|448262960|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
124630174|NCT04578535|448262961|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
124630175|NCT04578535|448262962|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
124630176|NCT05317312|448262963|FG000|Overall Study|Withdrawal by Subject|0|||
124630177|NCT05317312|448262964|FG001|Overall Study|Withdrawal by Subject|1|||
124630178|NCT05317312|448262965|FG002|Overall Study|Withdrawal by Subject|0|||
124630179|NCT05317312|448262966|FG003|Overall Study|Withdrawal by Subject|0|||
124630180|NCT05317312|448262963|FG000|Overall Study|Lost to Follow-up|0|||
124630181|NCT05317312|448262964|FG001|Overall Study|Lost to Follow-up|0|||
124630182|NCT05317312|448262965|FG002|Overall Study|Lost to Follow-up|0|||
124630183|NCT05317312|448262966|FG003|Overall Study|Lost to Follow-up|1|||
124630184|NCT05317312|448262963|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
124630185|NCT05317312|448262964|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
124799116|NCT03172910|448896615|FG003|Overall Study|Adverse Event|0|||
124799117|NCT03172910|448896616|FG004|Overall Study|Adverse Event|1|||
124799118|NCT01659658|448896617|FG000|Overall Study|Withdrawal by Patient|18|||
124799119|NCT01659658|448896618|FG001|Overall Study|Withdrawal by Patient|4|||
124799120|NCT01659658|448896619|FG002|Overall Study|Withdrawal by Patient|2|||
124799121|NCT01659658|448896620|FG003|Overall Study|Withdrawal by Patient|0|||
124799122|NCT01659658|448896621|FG004|Overall Study|Withdrawal by Patient|11|||
124799123|NCT01659658|448896617|FG000|Overall Study|Study Terminated by Sponsor|9|||
124799124|NCT01659658|448896618|FG001|Overall Study|Study Terminated by Sponsor|7|||
124799125|NCT01659658|448896619|FG002|Overall Study|Study Terminated by Sponsor|0|||
124799126|NCT01659658|448896620|FG003|Overall Study|Study Terminated by Sponsor|1|||
124799127|NCT01659658|448896621|FG004|Overall Study|Study Terminated by Sponsor|4|||
124799128|NCT01659658|448896617|FG000|Overall Study|Reason not Specified|61|||
124799129|NCT01659658|448896618|FG001|Overall Study|Reason not Specified|15|||
124799130|NCT01659658|448896619|FG002|Overall Study|Reason not Specified|8|||
124799131|NCT01659658|448896620|FG003|Overall Study|Reason not Specified|1|||
124799132|NCT01659658|448896621|FG004|Overall Study|Reason not Specified|34|||
124799133|NCT01659658|448896617|FG000|Overall Study|Lost to Follow-up|2|||
124799134|NCT01659658|448896618|FG001|Overall Study|Lost to Follow-up|0|||
124799135|NCT01659658|448896619|FG002|Overall Study|Lost to Follow-up|0|||
124799136|NCT01659658|448896620|FG003|Overall Study|Lost to Follow-up|0|||
124799137|NCT01659658|448896621|FG004|Overall Study|Lost to Follow-up|0|||
124799138|NCT01442038|448896624|FG000|Overall Study|Death|35|||
124799139|NCT01442038|448896625|FG001|Overall Study|Death|29|||
124799140|NCT01442038|448896624|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
124799141|NCT01442038|448896625|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
124799142|NCT01442038|448896624|FG000|Overall Study|Participant Withdrew Consent|137|||
124799143|NCT01442038|448896625|FG001|Overall Study|Participant Withdrew Consent|102|||
124799144|NCT01442038|448896624|FG000|Overall Study|Lost to Follow-up|37|||
124799145|NCT01442038|448896625|FG001|Overall Study|Lost to Follow-up|51|||
124799146|NCT01442038|448896624|FG000|Overall Study|Adverse Event|26|||
124799147|NCT01442038|448896625|FG001|Overall Study|Adverse Event|15|||
124799148|NCT01442038|448896624|FG000|Overall Study|Protocol Deviation|9|||
124799149|NCT01442038|448896625|FG001|Overall Study|Protocol Deviation|20|||
124799150|NCT01442038|448896624|FG000|Overall Study|Investigator's Discretion|13|||
124799151|NCT01442038|448896625|FG001|Overall Study|Investigator's Discretion|16|||
124799152|NCT01442038|448896624|FG000|Overall Study|Study Terminated By Sponsor|2|||
124799153|NCT01442038|448896625|FG001|Overall Study|Study Terminated By Sponsor|3|||
124799154|NCT00089284|448896626|FG000|Overall Study|Adverse event before starting treatment|0|||
124799155|NCT00089284|448896627|FG001|Overall Study|Adverse event before starting treatment|0|||
124799156|NCT00089284|448896628|FG002|Overall Study|Adverse event before starting treatment|0|||
124799157|NCT00089284|448896629|FG003|Overall Study|Adverse event before starting treatment|0|||
124799158|NCT00089284|448896630|FG004|Overall Study|Adverse event before starting treatment|0|||
124799159|NCT00089284|448896631|FG005|Overall Study|Adverse event before starting treatment|0|||
124799160|NCT00089284|448896632|FG006|Overall Study|Adverse event before starting treatment|1|||
124799161|NCT02428608|448896633|FG000|Overall Study|Pregnancy|2|||
124799162|NCT02428608|448896633|FG000|Overall Study|Lost to Follow-up|37|||
124799163|NCT02428608|448896633|FG000|Overall Study|Withdrawal by Subject|2|||
124799164|NCT02428608|448896633|FG000|Overall Study|scheduling conflicts|15|||
124630186|NCT05317312|448262965|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
124630187|NCT05317312|448262966|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
124799165|NCT02428608|448896633|FG000|Overall Study|moved away|10|||
124799166|NCT02428608|448896633|FG000|Overall Study|Death|1|||
124799167|NCT02428608|448896633|FG000|Overall Study|various|16|||
124799168|NCT03646643|448896634|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
124630188|NCT00837148|448262967|FG000|Overall Study|Adverse Event|1|||
124630189|NCT00837148|448262967|FG000|Overall Study|Death|1|||
124799169|NCT03646643|448896635|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
124799170|NCT03646643|448896634|FG000|Overall Study|Lost to Follow-up|0|||
124799171|NCT03646643|448896635|FG001|Overall Study|Lost to Follow-up|1|||
124799172|NCT04521777|448896636|FG000|Overall Study|Death|2|||
124799173|NCT04521777|448896636|FG000|Overall Study|Withdrawal by Subject|2|||
124799174|NCT00900601|448896637|FG000|Overall Study|Physician Decision|1|||
124799175|NCT00214500|448896639|FG000|Treatment Period|Adverse Event|1|||
124799176|NCT00214500|448896639|FG000|Extension Period|Withdrawal by Subject|2|||
124799177|NCT00147251|448896640|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
124799178|NCT00147251|448896641|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
124799179|NCT01629706|448896642|FG000|Phase 1 PureVision|Screen Failure|4|||
124799180|NCT01629706|448896642|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
124799181|NCT01629706|448896642|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
124799182|NCT01629706|448896642|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
124799183|NCT01629706|448896642|FG000|Phase 2 Habitual|Screen Failure|6|||
124799184|NCT01629706|448896642|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
124799185|NCT01629706|448896642|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
124799186|NCT01629706|448896642|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
124799187|NCT01629706|448896642|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
124799188|NCT02663687|448896644|FG000|Overall Study|Adverse Event|1|||
124799189|NCT02663687|448896645|FG001|Overall Study|Adverse Event|0|||
124799190|NCT02663687|448896646|FG002|Overall Study|Adverse Event|0|||
124799191|NCT02663687|448896647|FG003|Overall Study|Adverse Event|0|||
124799192|NCT02663687|448896648|FG004|Overall Study|Adverse Event|0|||
124799193|NCT02663687|448896644|FG000|Overall Study|Other|1|||
124799194|NCT02663687|448896645|FG001|Overall Study|Other|0|||
124799195|NCT02663687|448896646|FG002|Overall Study|Other|1|||
124799196|NCT02663687|448896647|FG003|Overall Study|Other|0|||
124799197|NCT02663687|448896648|FG004|Overall Study|Other|0|||
124799198|NCT03595774|448896649|FG000|Overall Study|Adverse Event|1|||
124799199|NCT03595774|448896650|FG001|Overall Study|Adverse Event|0|||
124799200|NCT03595774|448896651|FG002|Overall Study|Adverse Event|1|||
124799201|NCT03595774|448896652|FG003|Overall Study|Adverse Event|0|||
124799202|NCT03595774|448896649|FG000|Overall Study|screen failure|0|||
124799203|NCT03595774|448896650|FG001|Overall Study|screen failure|1|||
124799204|NCT03595774|448896651|FG002|Overall Study|screen failure|0|||
124799205|NCT03595774|448896652|FG003|Overall Study|screen failure|1|||
124799206|NCT01151098|448896653|FG000|Overall Study|Adverse Event|82|||
124799207|NCT01151098|448896653|FG000|Overall Study|Lost to Follow-up|6|||
124799208|NCT01151098|448896653|FG000|Overall Study|Lack of Efficacy|15|||
124799209|NCT01151098|448896653|FG000|Overall Study|Protocol Violation|1|||
124799210|NCT01151098|448896653|FG000|Overall Study|Miscellaneous|13|||
124799211|NCT00116168|448896660|FG000|Overall Study|Lost to Follow-up|6|||
124799212|NCT00116168|448896661|FG001|Overall Study|Lost to Follow-up|5|||
124799213|NCT00116168|448896662|FG002|Overall Study|Lost to Follow-up|0|||
124799214|NCT00116168|448896663|FG003|Overall Study|Lost to Follow-up|0|||
124799215|NCT02788474|448896664|FG000|Double Blind Treatment Period|Not treated|1|||
124799216|NCT02788474|448896665|FG001|Double Blind Treatment Period|Not treated|0|||
124799217|NCT02788474|448896664|FG000|Double Blind Treatment Period|Patient's refusal|3|||
124799218|NCT02788474|448896665|FG001|Double Blind Treatment Period|Patient's refusal|0|||
124799219|NCT02788474|448896664|FG000|Double Blind Treatment Period|Adverse Event|6|||
124799220|NCT02788474|448896665|FG001|Double Blind Treatment Period|Adverse Event|4|||
124799221|NCT02788474|448896664|FG000|Open Label Treatment Period|Adverse Event|29|||
124799222|NCT02788474|448896665|FG001|Open Label Treatment Period|Adverse Event|9|||
124799223|NCT02788474|448896664|FG000|Open Label Treatment Period|Other than reason specified|1|||
124799224|NCT02788474|448896665|FG001|Open Label Treatment Period|Other than reason specified|0|||
124799225|NCT02788474|448896664|FG000|Open Label Treatment Period|Patient's refusal|1|||
124799226|NCT02788474|448896665|FG001|Open Label Treatment Period|Patient's refusal|3|||
124799227|NCT02788474|448896664|FG000|Open Label Treatment Period|Non-compliance|1|||
124799228|NCT02788474|448896665|FG001|Open Label Treatment Period|Non-compliance|0|||
124799229|NCT00117286|448896667|FG000|Overall Study|Adverse Event|12|||
124799230|NCT00117286|448896668|FG001|Overall Study|Adverse Event|6|||
124799231|NCT00117286|448896667|FG000|Overall Study|Lost to Follow-up|2|||
124799232|NCT00117286|448896668|FG001|Overall Study|Lost to Follow-up|0|||
124799233|NCT00117286|448896667|FG000|Overall Study|Protocol Violation|3|||
124630190|NCT03839628|448262968|FG000|Overall Study|Withdrawal by Subject|1|||
124799234|NCT00117286|448896668|FG001|Overall Study|Protocol Violation|3|||
124799235|NCT00117286|448896667|FG000|Overall Study|Withdrawal by Subject|6|||
124799236|NCT00117286|448896668|FG001|Overall Study|Withdrawal by Subject|2|||
124799237|NCT00117286|448896667|FG000|Overall Study|Physician Decision|3|||
124799238|NCT00117286|448896668|FG001|Overall Study|Physician Decision|7|||
124799239|NCT00117286|448896667|FG000|Overall Study|Lack of Efficacy|2|||
124799240|NCT00117286|448896668|FG001|Overall Study|Lack of Efficacy|1|||
124799241|NCT00117286|448896667|FG000|Overall Study|Research site closing|0|||
124799242|NCT00117286|448896668|FG001|Overall Study|Research site closing|2|||
124799243|NCT03555435|448896669|FG000|Overall Study|Lost to Follow-up|17|||
124799244|NCT03555435|448896670|FG001|Overall Study|Lost to Follow-up|19|||
124799245|NCT03555435|448896671|FG002|Overall Study|Lost to Follow-up|8|||
124799246|NCT01272661|448896675|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
124799247|NCT01272661|448896676|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
124799248|NCT01272661|448896677|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
124799249|NCT02869438|448896678|FG000|Overall Study|Lost to Follow-up|1|||
124799250|NCT02869438|448896679|FG001|Overall Study|Lost to Follow-up|0|||
124799251|NCT02869438|448896678|FG000|Overall Study|Adverse Event|1|||
124799252|NCT02869438|448896679|FG001|Overall Study|Adverse Event|0|||
124799253|NCT02869438|448896678|FG000|Overall Study|Withdrawal by Subject|1|||
124799254|NCT02869438|448896679|FG001|Overall Study|Withdrawal by Subject|2|||
124799255|NCT02169284|448896685|FG000|Overall Study|Physician Decision|0|||
124799256|NCT02169284|448896686|FG001|Overall Study|Physician Decision|1|||
124799257|NCT04505540|448896687|FG000|Baseline|Protocol Violation|10|||
124799258|NCT04505540|448896687|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
124799259|NCT04505540|448896687|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
124799260|NCT04505540|448896687|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
124799261|NCT04505540|448896687|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
124799262|NCT04505540|448896687|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
124799263|NCT04505540|448896687|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
124799264|NCT04505540|448896687|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
124799265|NCT04505540|448896687|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
124799266|NCT04505540|448896687|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
124799267|NCT04505540|448896687|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
124799268|NCT04505540|448896687|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
124799269|NCT04505540|448896687|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
124799270|NCT03583073|448896688|FG000|Overall Study|Lost to Follow-up|8|||
124799271|NCT03583073|448896689|FG001|Overall Study|Lost to Follow-up|12|||
124799272|NCT01367119|448896690|FG000|Overall Study|Adverse Event|1|||
124799273|NCT01367119|448896691|FG001|Overall Study|Adverse Event|0|||
124799274|NCT01367119|448896690|FG000|Overall Study|Withdrawal by Subject|1|||
124799275|NCT01367119|448896691|FG001|Overall Study|Withdrawal by Subject|1|||
124799276|NCT05342532|448896692|FG000|Overall Study|Adverse Event|5|||
124799277|NCT05342532|448896693|FG001|Overall Study|Adverse Event|20|||
124799278|NCT05342532|448896692|FG000|Overall Study|Lost to Follow-up|10|||
124799279|NCT05342532|448896693|FG001|Overall Study|Lost to Follow-up|15|||
124799280|NCT02057393|448896696|FG000|Overall Study|Withdrawal by Subject|1|||
124799281|NCT02057393|448896696|FG000|Overall Study|Patient did not meet criteria|1|||
124799282|NCT03180684|448896697|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
124799283|NCT03180684|448896698|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
124799284|NCT03180684|448896697|FG000|Overall Study|Physician Decision|1|||
124799285|NCT03180684|448896698|FG001|Overall Study|Physician Decision|0|||
124799286|NCT03180684|448896697|FG000|Overall Study|Lost to Follow-up|1|||
124799287|NCT03180684|448896698|FG001|Overall Study|Lost to Follow-up|0|||
124799288|NCT03180684|448896697|FG000|Overall Study|Progressive Disease|1|||
124799289|NCT03180684|448896698|FG001|Overall Study|Progressive Disease|0|||
124799290|NCT01115803|448896699|FG000|Overall Study|Withdrawal by Subject|0|||
124799291|NCT01115803|448896700|FG001|Overall Study|Withdrawal by Subject|0|||
124799292|NCT01115803|448896701|FG002|Overall Study|Withdrawal by Subject|0|||
124799293|NCT01115803|448896702|FG003|Overall Study|Withdrawal by Subject|0|||
124799294|NCT01115803|448896703|FG004|Overall Study|Withdrawal by Subject|0|||
124799295|NCT01115803|448896704|FG005|Overall Study|Withdrawal by Subject|0|||
124799296|NCT01115803|448896705|FG006|Overall Study|Withdrawal by Subject|1|||
124799297|NCT01115803|448896699|FG000|Overall Study|Lost to Follow-up|0|||
124799298|NCT01115803|448896700|FG001|Overall Study|Lost to Follow-up|0|||
124799299|NCT01115803|448896701|FG002|Overall Study|Lost to Follow-up|1|||
124799300|NCT01115803|448896702|FG003|Overall Study|Lost to Follow-up|0|||
124799301|NCT01115803|448896703|FG004|Overall Study|Lost to Follow-up|0|||
124799302|NCT01115803|448896704|FG005|Overall Study|Lost to Follow-up|0|||
124799303|NCT01115803|448896705|FG006|Overall Study|Lost to Follow-up|0|||
124799304|NCT01115803|448896699|FG000|Overall Study|Progressive Disease during Cycle1|0|||
124799305|NCT01115803|448896700|FG001|Overall Study|Progressive Disease during Cycle1|0|||
124799306|NCT01115803|448896701|FG002|Overall Study|Progressive Disease during Cycle1|0|||
124799307|NCT01115803|448896702|FG003|Overall Study|Progressive Disease during Cycle1|0|||
124799308|NCT01115803|448896703|FG004|Overall Study|Progressive Disease during Cycle1|0|||
124799309|NCT01115803|448896704|FG005|Overall Study|Progressive Disease during Cycle1|0|||
124799310|NCT01115803|448896705|FG006|Overall Study|Progressive Disease during Cycle1|1|||
124799311|NCT03475875|448896706|FG000|Period 1|Lost to Follow-up|1|||
124799312|NCT03475875|448896707|FG001|Period 1|Lost to Follow-up|0|||
124799313|NCT03475875|448896706|FG000|Period 1|Adverse Event|2|||
124799314|NCT03475875|448896707|FG001|Period 1|Adverse Event|1|||
124799315|NCT03475875|448896706|FG000|Period 2|Adverse Event|3|||
124799316|NCT03475875|448896707|FG001|Period 2|Adverse Event|0|||
124799317|NCT03475875|448896706|FG000|Period 2|Protocol Violation|0|||
124799318|NCT03475875|448896707|FG001|Period 2|Protocol Violation|1|||
124799319|NCT02017171|448896708|FG000|Overall Study|Death|10|||
124799320|NCT02017171|448896709|FG001|Overall Study|Death|4|||
124799321|NCT02017171|448896708|FG000|Overall Study|Withdrawal by Subject|23|||
124799322|NCT02017171|448896709|FG001|Overall Study|Withdrawal by Subject|17|||
124799323|NCT02017171|448896708|FG000|Overall Study|Lost to Follow-up|21|||
124799324|NCT02017171|448896709|FG001|Overall Study|Lost to Follow-up|20|||
124799325|NCT02017171|448896708|FG000|Overall Study|ESKD|6|||
124799326|NCT02017171|448896709|FG001|Overall Study|ESKD|2|||
124799327|NCT02017171|448896708|FG000|Overall Study|Miscellaneous|2|||
124799328|NCT02017171|448896709|FG001|Overall Study|Miscellaneous|3|||
124799329|NCT03091777|448896711|FG000|Overall Study|Pregnancy|2|||
124799330|NCT03091777|448896712|FG001|Overall Study|Pregnancy|1|||
124799331|NCT03091777|448896713|FG002|Overall Study|Pregnancy|0|||
124799332|NCT03091777|448896711|FG000|Overall Study|Adverse Event|2|||
124799333|NCT03091777|448896712|FG001|Overall Study|Adverse Event|1|||
124799334|NCT03091777|448896713|FG002|Overall Study|Adverse Event|4|||
124799335|NCT03091777|448896711|FG000|Overall Study|Withdrawal by Subject|4|||
124799336|NCT03091777|448896712|FG001|Overall Study|Withdrawal by Subject|2|||
124799337|NCT03091777|448896713|FG002|Overall Study|Withdrawal by Subject|6|||
124799338|NCT03091777|448896711|FG000|Overall Study|Protocol Violation|2|||
124799339|NCT03091777|448896712|FG001|Overall Study|Protocol Violation|1|||
124799340|NCT03091777|448896713|FG002|Overall Study|Protocol Violation|1|||
124799341|NCT03091777|448896711|FG000|Overall Study|Lost to Follow-up|12|||
124799342|NCT03091777|448896712|FG001|Overall Study|Lost to Follow-up|14|||
124799343|NCT03091777|448896713|FG002|Overall Study|Lost to Follow-up|7|||
124799344|NCT03091777|448896711|FG000|Overall Study|Lack of Efficacy|0|||
124799345|NCT03091777|448896712|FG001|Overall Study|Lack of Efficacy|0|||
124799346|NCT03091777|448896713|FG002|Overall Study|Lack of Efficacy|5|||
124799347|NCT03091777|448896711|FG000|Overall Study|Noncompliance with study drug|2|||
124799348|NCT03091777|448896712|FG001|Overall Study|Noncompliance with study drug|3|||
124799349|NCT03091777|448896713|FG002|Overall Study|Noncompliance with study drug|1|||
124799350|NCT03091777|448896711|FG000|Overall Study|Physician Decision|1|||
124799351|NCT03091777|448896712|FG001|Overall Study|Physician Decision|0|||
124799352|NCT03091777|448896713|FG002|Overall Study|Physician Decision|1|||
124799353|NCT03091777|448896711|FG000|Overall Study|Abnormal Laboratory Value|7|||
124799354|NCT03091777|448896712|FG001|Overall Study|Abnormal Laboratory Value|11|||
124799355|NCT03091777|448896713|FG002|Overall Study|Abnormal Laboratory Value|12|||
124799356|NCT02536833|448896714|FG000|Overall Study|Discontinued Before Treatment|0|||
124799357|NCT02536833|448896715|FG001|Overall Study|Discontinued Before Treatment|0|||
124799358|NCT02536833|448896716|FG002|Overall Study|Discontinued Before Treatment|1|||
124799359|NCT02536833|448896717|FG003|Overall Study|Discontinued Before Treatment|2|||
124799360|NCT02536833|448896714|FG000|Overall Study|Adverse Event|1|||
124799361|NCT02536833|448896715|FG001|Overall Study|Adverse Event|3|||
124799362|NCT02536833|448896716|FG002|Overall Study|Adverse Event|4|||
124799363|NCT02536833|448896717|FG003|Overall Study|Adverse Event|1|||
124799364|NCT02536833|448896714|FG000|Overall Study|Lost to Follow-up|2|||
124799365|NCT02536833|448896715|FG001|Overall Study|Lost to Follow-up|1|||
124799366|NCT02536833|448896716|FG002|Overall Study|Lost to Follow-up|2|||
124799367|NCT02536833|448896717|FG003|Overall Study|Lost to Follow-up|2|||
124799368|NCT02536833|448896714|FG000|Overall Study|Physician Decision|0|||
124799369|NCT02536833|448896715|FG001|Overall Study|Physician Decision|0|||
124799370|NCT02536833|448896716|FG002|Overall Study|Physician Decision|0|||
124799371|NCT02536833|448896717|FG003|Overall Study|Physician Decision|1|||
124799372|NCT02536833|448896714|FG000|Overall Study|Site Terminated by Sponsor|2|||
124799373|NCT02536833|448896715|FG001|Overall Study|Site Terminated by Sponsor|2|||
124799374|NCT02536833|448896716|FG002|Overall Study|Site Terminated by Sponsor|2|||
124799375|NCT02536833|448896717|FG003|Overall Study|Site Terminated by Sponsor|2|||
124799376|NCT02536833|448896714|FG000|Overall Study|Subject Non-Compliance|0|||
124799377|NCT02536833|448896715|FG001|Overall Study|Subject Non-Compliance|1|||
124799378|NCT02536833|448896716|FG002|Overall Study|Subject Non-Compliance|1|||
124799379|NCT02536833|448896717|FG003|Overall Study|Subject Non-Compliance|0|||
124799380|NCT02536833|448896714|FG000|Overall Study|Withdrawal by Subject|4|||
124799381|NCT02536833|448896715|FG001|Overall Study|Withdrawal by Subject|3|||
124799382|NCT02536833|448896716|FG002|Overall Study|Withdrawal by Subject|5|||
124799383|NCT02536833|448896717|FG003|Overall Study|Withdrawal by Subject|11|||
124799384|NCT02764190|448896719|FG000|Overall Study|Lost to Follow-up|17|||
124799385|NCT02764190|448896720|FG001|Overall Study|Lost to Follow-up|13|||
124799386|NCT01172275|448896721|FG000|Overall Study|Lost to Follow-up|1|||
124799387|NCT01172275|448896722|FG001|Overall Study|Lost to Follow-up|0|||
124799388|NCT01172275|448896721|FG000|Overall Study|Protocol Violation|1|||
124799389|NCT01172275|448896722|FG001|Overall Study|Protocol Violation|0|||
124630191|NCT00380874|448262969|FG000|Overall Study|Adverse Event|7|||
124630192|NCT00380874|448262970|FG001|Overall Study|Adverse Event|7|||
124799390|NCT05308290|448896727|FG000|Overall Study|Death|1|||
124799391|NCT05308290|448896728|FG001|Overall Study|Death|0|||
124799392|NCT05308290|448896727|FG000|Overall Study|Lost to Follow-up|2|||
124799393|NCT05308290|448896728|FG001|Overall Study|Lost to Follow-up|1|||
124799394|NCT05308290|448896727|FG000|Overall Study|still in study followup|0|||
124799395|NCT05308290|448896728|FG001|Overall Study|still in study followup|1|||
124799396|NCT04437368|448896729|FG000|Overall Study|Death|3|||
124799397|NCT04437368|448896730|FG001|Overall Study|Death|0|||
124799398|NCT04437368|448896731|FG002|Overall Study|Death|2|||
124799399|NCT04437368|448896729|FG000|Overall Study|Study terminated by sponsor|16|||
124799400|NCT04437368|448896730|FG001|Overall Study|Study terminated by sponsor|1|||
124799401|NCT04437368|448896731|FG002|Overall Study|Study terminated by sponsor|25|||
124799402|NCT04437368|448896729|FG000|Overall Study|Withdrawal by Subject|4|||
124799403|NCT04437368|448896730|FG001|Overall Study|Withdrawal by Subject|0|||
124799404|NCT04437368|448896731|FG002|Overall Study|Withdrawal by Subject|3|||
124799405|NCT04437368|448896729|FG000|Overall Study|Sponsor instructions|23|||
124799406|NCT04437368|448896730|FG001|Overall Study|Sponsor instructions|0|||
124799407|NCT04437368|448896731|FG002|Overall Study|Sponsor instructions|0|||
124799408|NCT01982331|448896732|FG000|Received Vaccination 2|Adverse Event|1|||
124799409|NCT01982331|448896733|FG001|Received Vaccination 2|Adverse Event|2|||
124799410|NCT01982331|448896732|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
124799411|NCT01982331|448896733|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
124799412|NCT01982331|448896732|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
124799413|NCT01982331|448896733|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
124799414|NCT02393690|448896743|FG000|Overall Study|Ineligible|0|||
124630193|NCT00380874|448262969|FG000|Overall Study|Death|1|||
124799415|NCT02393690|448896744|FG001|Overall Study|Ineligible|1|||
124799416|NCT00586846|448896745|FG000|Overall Study|Physician Decision|1|||
124799417|NCT00586846|448896745|FG000|Overall Study|Death|1|||
124799418|NCT00586846|448896745|FG000|Overall Study|Evaluable for Toxicity Only|4|||
124799419|NCT01674634|448896746|FG000|Overall Study|Withdrawal by Subject|3|||
124799420|NCT01674634|448896746|FG000|Overall Study|Lost to Follow-up|3|||
124799421|NCT02059005|448896747|FG000|Overall Study|Death|1|||
124799422|NCT02059005|448896748|FG001|Overall Study|Death|3|||
124799423|NCT02059005|448896747|FG000|Overall Study|Lost to Follow-up|19|||
124799424|NCT02059005|448896748|FG001|Overall Study|Lost to Follow-up|19|||
124799425|NCT02059005|448896747|FG000|Overall Study|Incarceration|0|||
124799426|NCT02059005|448896748|FG001|Overall Study|Incarceration|1|||
124799427|NCT02059005|448896747|FG000|Overall Study|Inpatient|0|||
124799428|NCT02059005|448896748|FG001|Overall Study|Inpatient|1|||
124799429|NCT02142803|448896749|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
124799430|NCT02142803|448896750|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
124799431|NCT02142803|448896751|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
124799432|NCT02142803|448896752|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
124799433|NCT02718300|448896758|FG000|Overall Study|Death|4|||
124799434|NCT02718300|448896759|FG001|Overall Study|Death|5|||
124799435|NCT02718300|448896760|FG002|Overall Study|Death|17|||
124799436|NCT02718300|448896758|FG000|Overall Study|Lost to Follow-up|1|||
124799437|NCT02718300|448896759|FG001|Overall Study|Lost to Follow-up|0|||
124799438|NCT02718300|448896760|FG002|Overall Study|Lost to Follow-up|2|||
124799439|NCT02718300|448896758|FG000|Overall Study|Physician Decision|1|||
124799440|NCT02718300|448896759|FG001|Overall Study|Physician Decision|0|||
124799441|NCT02718300|448896760|FG002|Overall Study|Physician Decision|2|||
124799442|NCT02718300|448896758|FG000|Overall Study|Study Terminated by Sponsor|6|||
124799443|NCT02718300|448896759|FG001|Overall Study|Study Terminated by Sponsor|3|||
124799444|NCT02718300|448896760|FG002|Overall Study|Study Terminated by Sponsor|4|||
124799445|NCT02718300|448896758|FG000|Overall Study|Withdrawal by Subject|0|||
124799446|NCT02718300|448896759|FG001|Overall Study|Withdrawal by Subject|4|||
124799447|NCT02718300|448896760|FG002|Overall Study|Withdrawal by Subject|3|||
124799448|NCT02718300|448896758|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
124799449|NCT02718300|448896759|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
124799450|NCT02718300|448896760|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
124799451|NCT03120624|448896761|FG000|Overall Study|Withdrawal by Subject|0|||
124799452|NCT03120624|448896762|FG001|Overall Study|Withdrawal by Subject|1|||
124799453|NCT03120624|448896763|FG002|Overall Study|Withdrawal by Subject|0|||
124799454|NCT03120624|448896764|FG003|Overall Study|Withdrawal by Subject|0|||
124799455|NCT03120624|448896765|FG004|Overall Study|Withdrawal by Subject|0|||
124799456|NCT03120624|448896766|FG005|Overall Study|Withdrawal by Subject|0|||
124799457|NCT03120624|448896767|FG006|Overall Study|Withdrawal by Subject|0|||
124799458|NCT03120624|448896768|FG007|Overall Study|Withdrawal by Subject|0|||
124799459|NCT05063318|448896769|FG000|Overall Study|Progressive disease|2|||
124799460|NCT05063318|448896770|FG001|Overall Study|Progressive disease|0|||
124799461|NCT05063318|448896771|FG002|Overall Study|Progressive disease|3|||
124799462|NCT05063318|448896769|FG000|Overall Study|Compassionate use|1|||
124799463|NCT05063318|448896770|FG001|Overall Study|Compassionate use|3|||
124799464|NCT05063318|448896771|FG002|Overall Study|Compassionate use|3|||
124799465|NCT05063318|448896769|FG000|Overall Study|Adverse Event|0|||
124799466|NCT05063318|448896770|FG001|Overall Study|Adverse Event|1|||
124630194|NCT00380874|448262970|FG001|Overall Study|Death|0|||
124799467|NCT05063318|448896771|FG002|Overall Study|Adverse Event|0|||
124799468|NCT05063318|448896769|FG000|Overall Study|Withdrawal by Subject|0|||
124799469|NCT05063318|448896770|FG001|Overall Study|Withdrawal by Subject|1|||
124630195|NCT00380874|448262969|FG000|Overall Study|Withdrawal by Subject|2|||
124799470|NCT05063318|448896771|FG002|Overall Study|Withdrawal by Subject|0|||
124799471|NCT01927341|448898627|FG000|Phase 1b|Lost to Follow-up|1|||
124799472|NCT01927341|448898628|FG001|Phase 1b|Lost to Follow-up|0|||
124799473|NCT01927341|448898629|FG002|Phase 1b|Lost to Follow-up|0|||
124799474|NCT01927341|448898630|FG003|Phase 1b|Lost to Follow-up|0|||
124799475|NCT01927341|448898631|FG004|Phase 1b|Lost to Follow-up|0|||
124799476|NCT01927341|448898627|FG000|Phase 1b|Death|2|||
124799477|NCT01927341|448898628|FG001|Phase 1b|Death|0|||
124799478|NCT01927341|448898629|FG002|Phase 1b|Death|0|||
124799479|NCT01927341|448898630|FG003|Phase 1b|Death|0|||
124799480|NCT01927341|448898631|FG004|Phase 1b|Death|0|||
124799481|NCT01927341|448898627|FG000|Phase 1b|Follow-up completed|7|||
124799482|NCT01927341|448898628|FG001|Phase 1b|Follow-up completed|0|||
124799483|NCT01927341|448898629|FG002|Phase 1b|Follow-up completed|0|||
124799484|NCT01927341|448898630|FG003|Phase 1b|Follow-up completed|0|||
124799485|NCT01927341|448898631|FG004|Phase 1b|Follow-up completed|0|||
124799486|NCT01927341|448898627|FG000|Phase 2|Lost to Follow-up|0|||
124799487|NCT01927341|448898628|FG001|Phase 2|Lost to Follow-up|1|||
124799488|NCT01927341|448898629|FG002|Phase 2|Lost to Follow-up|0|||
124799489|NCT01927341|448898630|FG003|Phase 2|Lost to Follow-up|0|||
124799490|NCT01927341|448898631|FG004|Phase 2|Lost to Follow-up|0|||
124799491|NCT01927341|448898627|FG000|Phase 2|Participant withdrew consent|0|||
124799492|NCT01927341|448898628|FG001|Phase 2|Participant withdrew consent|2|||
124799493|NCT01927341|448898629|FG002|Phase 2|Participant withdrew consent|1|||
124799494|NCT01927341|448898630|FG003|Phase 2|Participant withdrew consent|2|||
124799495|NCT01927341|448898631|FG004|Phase 2|Participant withdrew consent|3|||
124799496|NCT01927341|448898627|FG000|Phase 2|Death|0|||
124799497|NCT01927341|448898628|FG001|Phase 2|Death|4|||
124799498|NCT01927341|448898629|FG002|Phase 2|Death|0|||
124799499|NCT01927341|448898630|FG003|Phase 2|Death|3|||
124799500|NCT01927341|448898631|FG004|Phase 2|Death|2|||
124799501|NCT01927341|448898627|FG000|Phase 2|New cancer therapy|0|||
124799502|NCT01927341|448898628|FG001|Phase 2|New cancer therapy|1|||
124799503|NCT01927341|448898629|FG002|Phase 2|New cancer therapy|0|||
124799504|NCT01927341|448898630|FG003|Phase 2|New cancer therapy|4|||
124799505|NCT01927341|448898631|FG004|Phase 2|New cancer therapy|1|||
124799506|NCT01927341|448898627|FG000|Phase 2|Disease progression|0|||
124799507|NCT01927341|448898628|FG001|Phase 2|Disease progression|1|||
124799508|NCT01927341|448898629|FG002|Phase 2|Disease progression|1|||
124799509|NCT01927341|448898630|FG003|Phase 2|Disease progression|1|||
124799510|NCT01927341|448898631|FG004|Phase 2|Disease progression|0|||
124799511|NCT01927341|448898627|FG000|Phase 2|Follow-up completed|0|||
124799512|NCT01927341|448898628|FG001|Phase 2|Follow-up completed|6|||
124799513|NCT01927341|448898629|FG002|Phase 2|Follow-up completed|3|||
124799514|NCT01927341|448898630|FG003|Phase 2|Follow-up completed|5|||
124799515|NCT01927341|448898631|FG004|Phase 2|Follow-up completed|2|||
124799516|NCT00451451|448898640|FG000|Overall Study|Adverse Event|11|||
124799517|NCT00451451|448898641|FG001|Overall Study|Adverse Event|21|||
124799518|NCT00451451|448898642|FG002|Overall Study|Adverse Event|26|||
124799519|NCT00451451|448898643|FG003|Overall Study|Adverse Event|10|||
124799520|NCT00451451|448898640|FG000|Overall Study|Lost to Follow-up|11|||
124799521|NCT00451451|448898641|FG001|Overall Study|Lost to Follow-up|9|||
124799522|NCT00451451|448898642|FG002|Overall Study|Lost to Follow-up|8|||
124799523|NCT00451451|448898643|FG003|Overall Study|Lost to Follow-up|11|||
124799524|NCT00451451|448898640|FG000|Overall Study|Consent Withdrawn|14|||
124799525|NCT00451451|448898641|FG001|Overall Study|Consent Withdrawn|9|||
124799526|NCT00451451|448898642|FG002|Overall Study|Consent Withdrawn|17|||
124799527|NCT00451451|448898643|FG003|Overall Study|Consent Withdrawn|17|||
124799528|NCT00451451|448898640|FG000|Overall Study|Investigator Decision|6|||
124799529|NCT00451451|448898641|FG001|Overall Study|Investigator Decision|2|||
124799530|NCT00451451|448898642|FG002|Overall Study|Investigator Decision|1|||
124799531|NCT00451451|448898643|FG003|Overall Study|Investigator Decision|2|||
124799532|NCT00451451|448898640|FG000|Overall Study|Subject Non-Compliance|8|||
124799533|NCT00451451|448898641|FG001|Overall Study|Subject Non-Compliance|4|||
124799534|NCT00451451|448898642|FG002|Overall Study|Subject Non-Compliance|3|||
124799535|NCT00451451|448898643|FG003|Overall Study|Subject Non-Compliance|3|||
124799536|NCT00451451|448898640|FG000|Overall Study|Death|1|||
124799537|NCT00451451|448898641|FG001|Overall Study|Death|0|||
124799538|NCT00451451|448898642|FG002|Overall Study|Death|0|||
124799539|NCT00451451|448898643|FG003|Overall Study|Death|1|||
124799540|NCT00451451|448898640|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
124799541|NCT00451451|448898641|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
124799542|NCT00451451|448898642|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
124799543|NCT00451451|448898643|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
124799544|NCT00084838|448898644|FG000|Overall Study|Death|1|||
124799545|NCT00084838|448898644|FG000|Overall Study|Adverse Event|2|||
124799546|NCT00084838|448898644|FG000|Overall Study|Withdrawal by Subject|1|||
124799547|NCT00084838|448898644|FG000|Overall Study|Progressive Disease|4|||
124799548|NCT00084838|448898644|FG000|Overall Study|Pt Non-Compliance|1|||
124799549|NCT00084838|448898644|FG000|Overall Study|Ineligible|4|||
124799550|NCT00122278|448898645|FG000|Overall Study|Lost to Follow-up|2|||
124799551|NCT00122278|448898646|FG001|Overall Study|Lost to Follow-up|0|||
124799552|NCT01865084|448898647|FG000|Double Blind Period (DB)|Adverse Event|2|||
124799553|NCT01865084|448898648|FG001|Double Blind Period (DB)|Adverse Event|2|||
124799554|NCT01865084|448898649|FG002|Double Blind Period (DB)|Adverse Event|1|||
124799555|NCT01865084|448898647|FG000|Double Blind Period (DB)|Protocol Violation|0|||
124799556|NCT01865084|448898648|FG001|Double Blind Period (DB)|Protocol Violation|0|||
124799557|NCT01865084|448898649|FG002|Double Blind Period (DB)|Protocol Violation|1|||
124799558|NCT01865084|448898647|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
124799559|NCT01865084|448898648|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
124799560|NCT01865084|448898649|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
124799561|NCT01865084|448898647|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
124799562|NCT01865084|448898648|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
124799563|NCT01865084|448898649|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
124799564|NCT01865084|448898647|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
124799565|NCT01865084|448898648|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
124799566|NCT01865084|448898649|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
124799567|NCT01865084|448898647|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
124799568|NCT01865084|448898648|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
124799569|NCT01865084|448898649|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
124799570|NCT01865084|448898647|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
124799571|NCT01865084|448898648|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
124799572|NCT01865084|448898649|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
124799573|NCT01865084|448898647|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
124799574|NCT01865084|448898648|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
124799575|NCT01865084|448898649|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
124799576|NCT01865084|448898647|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
124799577|NCT01865084|448898648|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
124799578|NCT01865084|448898649|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
124799579|NCT01994590|448898650|FG000|Overall Study|Adverse Event|1|||
124799580|NCT01994590|448898650|FG000|Overall Study|Trial Terminated|1|||
124799581|NCT03607422|448898651|FG000|Overall Study|Adverse Event|7|||
124799582|NCT03607422|448898652|FG001|Overall Study|Adverse Event|3|||
124799583|NCT03607422|448898653|FG002|Overall Study|Adverse Event|2|||
124799584|NCT03607422|448898654|FG003|Overall Study|Adverse Event|0|||
124799585|NCT03607422|448898655|FG004|Overall Study|Adverse Event|2|||
124799586|NCT03607422|448898656|FG005|Overall Study|Adverse Event|0|||
124799587|NCT03607422|448898651|FG000|Overall Study|Withdrawal by Subject|11|||
124799588|NCT03607422|448898652|FG001|Overall Study|Withdrawal by Subject|3|||
124799589|NCT03607422|448898653|FG002|Overall Study|Withdrawal by Subject|6|||
124799590|NCT03607422|448898654|FG003|Overall Study|Withdrawal by Subject|2|||
124799591|NCT03607422|448898655|FG004|Overall Study|Withdrawal by Subject|0|||
124799592|NCT03607422|448898656|FG005|Overall Study|Withdrawal by Subject|0|||
124799593|NCT03607422|448898651|FG000|Overall Study|Lost to Follow-up|0|||
124799594|NCT03607422|448898652|FG001|Overall Study|Lost to Follow-up|0|||
124799595|NCT03607422|448898653|FG002|Overall Study|Lost to Follow-up|1|||
124799596|NCT03607422|448898654|FG003|Overall Study|Lost to Follow-up|0|||
124799597|NCT03607422|448898655|FG004|Overall Study|Lost to Follow-up|0|||
124799598|NCT03607422|448898656|FG005|Overall Study|Lost to Follow-up|0|||
124799599|NCT03607422|448898651|FG000|Overall Study|Other|12|||
124799600|NCT03607422|448898652|FG001|Overall Study|Other|4|||
124799601|NCT03607422|448898653|FG002|Overall Study|Other|1|||
124799602|NCT03607422|448898654|FG003|Overall Study|Other|2|||
124799603|NCT03607422|448898655|FG004|Overall Study|Other|0|||
124799604|NCT03607422|448898656|FG005|Overall Study|Other|2|||
124799605|NCT03607422|448898651|FG000|Overall Study|Ongoing at Time of Analysis|8|||
124799606|NCT03607422|448898652|FG001|Overall Study|Ongoing at Time of Analysis|0|||
124799607|NCT03607422|448898653|FG002|Overall Study|Ongoing at Time of Analysis|2|||
124799608|NCT03607422|448898654|FG003|Overall Study|Ongoing at Time of Analysis|1|||
124799609|NCT03607422|448898655|FG004|Overall Study|Ongoing at Time of Analysis|1|||
124799610|NCT03607422|448898656|FG005|Overall Study|Ongoing at Time of Analysis|1|||
124799611|NCT03693170|448898657|FG000|Overall Study|Disease Progression|48|||
124799612|NCT03693170|448898657|FG000|Overall Study|Adverse Event|16|||
124799613|NCT03693170|448898657|FG000|Overall Study|Physician Decision|6|||
124799614|NCT03693170|448898657|FG000|Overall Study|Protocol Violation|2|||
124799615|NCT03693170|448898657|FG000|Overall Study|Death|1|||
124799616|NCT03693170|448898657|FG000|Overall Study|Non compliance with study drug|1|||
124799617|NCT03693170|448898657|FG000|Overall Study|Withdrawal by Subject|1|||
124799618|NCT03875118|448898658|FG000|Overall Study|Withdrawal by Subject|4|||
124799619|NCT03875118|448898659|FG001|Overall Study|Withdrawal by Subject|4|||
124799620|NCT03228420|448898669|FG000|Overall Study|Lost to Follow-up|5|||
124799621|NCT03228420|448898670|FG001|Overall Study|Lost to Follow-up|3|||
124799622|NCT03228420|448898669|FG000|Overall Study|Withdrawal by Subject|10|||
124799623|NCT03228420|448898670|FG001|Overall Study|Withdrawal by Subject|0|||
124799624|NCT03228420|448898669|FG000|Overall Study|Adverse Event|5|||
124799625|NCT03228420|448898670|FG001|Overall Study|Adverse Event|2|||
124799626|NCT01298531|448898671|FG000|Overall Study|Lack of Efficacy|0|||
124799627|NCT01298531|448898672|FG001|Overall Study|Lack of Efficacy|1|||
124799628|NCT01298531|448898671|FG000|Overall Study|Lost to Follow-up|2|||
124799629|NCT01298531|448898672|FG001|Overall Study|Lost to Follow-up|0|||
124799630|NCT01298531|448898671|FG000|Overall Study|Protocol Violation|1|||
124799631|NCT01298531|448898672|FG001|Overall Study|Protocol Violation|1|||
124799632|NCT01298531|448898671|FG000|Overall Study|Adverse Event|4|||
124799633|NCT01298531|448898672|FG001|Overall Study|Adverse Event|3|||
124799634|NCT01298531|448898671|FG000|Overall Study|Does not meet entrance criteria|0|||
124799635|NCT01298531|448898672|FG001|Overall Study|Does not meet entrance criteria|1|||
124799636|NCT01298531|448898671|FG000|Overall Study|Other|2|||
124799637|NCT01298531|448898672|FG001|Overall Study|Other|1|||
124799638|NCT01933217|448898675|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
124799639|NCT01933217|448898676|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
124799640|NCT01933217|448898675|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
124799641|NCT01933217|448898676|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
124799642|NCT03923738|448898679|FG000|Period 1|Adverse Event|1|||
124799643|NCT03923738|448898679|FG000|Period 1|Withdrawal by Subject|1|||
124799644|NCT03583164|448898681|FG000|Overall Study|Death in Main Phase|35|||
124799645|NCT03583164|448898681|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
124799646|NCT03583164|448898681|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
124799647|NCT03583164|448898681|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
124799648|NCT03583164|448898681|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
124799649|NCT03583164|448898681|FG000|Overall Study|Physician decision in Main Phase|1|||
124799650|NCT03583164|448898681|FG000|Overall Study|Physician decision in Extended Phase|2|||
124799651|NCT03583164|448898681|FG000|Overall Study|Death in Extended Phase|13|||
124799652|NCT03583164|448898681|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
124799653|NCT03583164|448898681|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
124799654|NCT03583164|448898681|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
124799655|NCT03583164|448898681|FG000|Overall Study|Treatment failure in Main Phase|2|||
124799656|NCT03583164|448898681|FG000|Overall Study|Treatment failure in Extended Phase|4|||
124799657|NCT03583164|448898681|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
124799658|NCT03583164|448898681|FG000|Overall Study|Other not specified reason in Main Phase|2|||
124799659|NCT00735254|448898682|FG000|Overall Study|Protocol Violation|1|||
124799660|NCT00735254|448898683|FG001|Overall Study|Protocol Violation|1|||
124799661|NCT00735254|448898684|FG002|Overall Study|Protocol Violation|1|||
124799662|NCT00735254|448898685|FG003|Overall Study|Protocol Violation|0|||
124799663|NCT00057954|448898689|FG000|Overall Study|Death|1|||
124799664|NCT00057954|448898689|FG000|Overall Study|Disease progression|1|||
124799665|NCT00559754|448898690|FG000|Overall Study|Disease progression|1|||
124799666|NCT00559754|448898690|FG000|Overall Study|Adverse Event|5|||
124799667|NCT00559754|448898690|FG000|Overall Study|Protocol Violation|1|||
124799668|NCT00559754|448898690|FG000|Overall Study|Investigator criteria|2|||
124799669|NCT00559754|448898690|FG000|Overall Study|Withdrawal by Subject|2|||
124799670|NCT01251744|448898691|FG000|Overall Study|Lost to Follow-up|1|||
124799671|NCT01251744|448898692|FG001|Overall Study|Lost to Follow-up|0|||
124799672|NCT01068652|448898697|FG000|Overall Study|Adverse Event|4|||
124799673|NCT01068652|448898698|FG001|Overall Study|Adverse Event|0|||
124799674|NCT01068652|448898697|FG000|Overall Study|Lack of Efficacy|0|||
124799675|NCT01068652|448898698|FG001|Overall Study|Lack of Efficacy|2|||
124799676|NCT01068652|448898697|FG000|Overall Study|Lost to Follow-up|2|||
124799677|NCT01068652|448898698|FG001|Overall Study|Lost to Follow-up|1|||
124799678|NCT01068652|448898697|FG000|Overall Study|Protocol Violation|3|||
124799679|NCT01068652|448898698|FG001|Overall Study|Protocol Violation|6|||
124799680|NCT01068652|448898697|FG000|Overall Study|Withdrawal criteria|1|||
124799681|NCT01068652|448898698|FG001|Overall Study|Withdrawal criteria|2|||
124799682|NCT01068652|448898697|FG000|Overall Study|Patient was not eligible|1|||
124799683|NCT01068652|448898698|FG001|Overall Study|Patient was not eligible|0|||
124799684|NCT01068652|448898697|FG000|Overall Study|Unclassified|7|||
124799685|NCT01068652|448898698|FG001|Overall Study|Unclassified|4|||
124799686|NCT00751621|448898699|FG000|Overall Study|Adverse Event|1|||
124799687|NCT00751621|448898699|FG000|Overall Study|Withdrawal by Subject|1|||
124799688|NCT00751621|448898699|FG000|Overall Study|Subject moved to another country|1|||
124799689|NCT00751621|448898699|FG000|Overall Study|Poor adherence to asthma treatment|1|||
124799690|NCT03343067|448898700|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
124799691|NCT03343067|448898701|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
124799692|NCT03343067|448898702|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
124799693|NCT01323946|448898703|FG000|Overall Study|Lost to Follow-up|0|||
124799694|NCT01323946|448898704|FG001|Overall Study|Lost to Follow-up|1|||
124799695|NCT01323946|448898705|FG002|Overall Study|Lost to Follow-up|0|||
124799696|NCT01323946|448898703|FG000|Overall Study|Parents refused the last blood draw|1|||
124799697|NCT01323946|448898704|FG001|Overall Study|Parents refused the last blood draw|0|||
124799698|NCT01323946|448898705|FG002|Overall Study|Parents refused the last blood draw|0|||
124799699|NCT01323946|448898703|FG000|Overall Study|Withdrawal by Subject|2|||
124799700|NCT01323946|448898704|FG001|Overall Study|Withdrawal by Subject|2|||
124799701|NCT01323946|448898705|FG002|Overall Study|Withdrawal by Subject|0|||
124799702|NCT01243671|448898706|FG000|Overall Study|Adverse Event|3|||
124799703|NCT01243671|448898706|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
124799704|NCT01243671|448898706|FG000|Overall Study|Other|1|||
124799705|NCT00573248|448898707|FG000|Overall Study|scheduling conflicts|15|||
124799706|NCT00573248|448898708|FG001|Overall Study|scheduling conflicts|11|||
124799707|NCT01013649|448898711|FG000|First Step|Withdrawal by Subject|36|||
124799708|NCT01013649|448898712|FG001|First Step|Withdrawal by Subject|19|||
124799709|NCT01013649|448898713|FG002|First Step|Withdrawal by Subject|0|||
124799710|NCT01013649|448898714|FG003|First Step|Withdrawal by Subject|0|||
124799711|NCT01013649|448898711|FG000|First Step|Progression|58|||
124799712|NCT01013649|448898712|FG001|First Step|Progression|23|||
124799713|NCT01013649|448898713|FG002|First Step|Progression|0|||
124799714|NCT01013649|448898714|FG003|First Step|Progression|0|||
124799715|NCT01013649|448898711|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
124799716|NCT01013649|448898712|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
124799717|NCT01013649|448898713|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
124799718|NCT01013649|448898714|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
124799719|NCT01013649|448898711|FG000|First Step|Death|3|||
124799720|NCT01013649|448898712|FG001|First Step|Death|4|||
124799721|NCT01013649|448898713|FG002|First Step|Death|0|||
124799722|NCT01013649|448898714|FG003|First Step|Death|0|||
124630196|NCT00380874|448262970|FG001|Overall Study|Withdrawal by Subject|1|||
124630197|NCT00380874|448262969|FG000|Overall Study|Not related to study drug|3|||
124799723|NCT01013649|448898711|FG000|First Step|Adverse Event|9|||
124799724|NCT01013649|448898712|FG001|First Step|Adverse Event|5|||
124799725|NCT01013649|448898713|FG002|First Step|Adverse Event|0|||
124799726|NCT01013649|448898714|FG003|First Step|Adverse Event|0|||
124799727|NCT01013649|448898711|FG000|First Step|Other|4|||
124799728|NCT01013649|448898712|FG001|First Step|Other|6|||
124799729|NCT01013649|448898713|FG002|First Step|Other|0|||
124799730|NCT01013649|448898714|FG003|First Step|Other|0|||
124799731|NCT05323656|448898717|FG000|Overall Study|Still On-Treatment|6|||
124630198|NCT00380874|448262970|FG001|Overall Study|Not related to study drug|2|||
124630199|NCT01964976|448262971|FG000|Overall Study|Protocol Violation|31|||
124630200|NCT01565889|448262975|FG000|Part A|Withdrawal by Subject|1|||
124630201|NCT01565889|448262976|FG001|Part A|Withdrawal by Subject|0|||
124630202|NCT01565889|448262977|FG002|Part A|Withdrawal by Subject|0|||
124630203|NCT01565889|448262978|FG003|Part A|Withdrawal by Subject|0|||
124630204|NCT01565889|448262979|FG004|Part A|Withdrawal by Subject|0|||
124630205|NCT01565889|448262980|FG005|Part A|Withdrawal by Subject|0|||
124630206|NCT01565889|448262975|FG000|Part B|Withdrawal by Subject|0|||
124630207|NCT01565889|448262976|FG001|Part B|Withdrawal by Subject|0|||
124630208|NCT01565889|448262977|FG002|Part B|Withdrawal by Subject|0|||
124630209|NCT01565889|448262978|FG003|Part B|Withdrawal by Subject|0|||
124630210|NCT01565889|448262979|FG004|Part B|Withdrawal by Subject|0|||
124630211|NCT01565889|448262980|FG005|Part B|Withdrawal by Subject|1|||
124630212|NCT01565889|448262975|FG000|Part B|Lack of Efficacy|0|||
124630213|NCT01565889|448262976|FG001|Part B|Lack of Efficacy|0|||
124630214|NCT01565889|448262977|FG002|Part B|Lack of Efficacy|0|||
124630215|NCT01565889|448262978|FG003|Part B|Lack of Efficacy|0|||
124630216|NCT01565889|448262979|FG004|Part B|Lack of Efficacy|0|||
124799732|NCT05323656|448898718|FG001|Overall Study|Still On-Treatment|6|||
124799733|NCT05323656|448898717|FG000|Overall Study|Progressive Disease|15|||
124799734|NCT05323656|448898718|FG001|Overall Study|Progressive Disease|14|||
124799735|NCT05323656|448898717|FG000|Overall Study|Adverse Event|2|||
124799736|NCT05323656|448898718|FG001|Overall Study|Adverse Event|3|||
124799737|NCT05323656|448898717|FG000|Overall Study|Death|1|||
124799738|NCT05323656|448898718|FG001|Overall Study|Death|2|||
124799739|NCT05323656|448898717|FG000|Overall Study|Withdrawal by Subject|1|||
124799740|NCT05323656|448898718|FG001|Overall Study|Withdrawal by Subject|0|||
124799741|NCT05323656|448898717|FG000|Overall Study|Clinical disease progression|0|||
124799742|NCT05323656|448898718|FG001|Overall Study|Clinical disease progression|1|||
124630217|NCT01565889|448262980|FG005|Part B|Lack of Efficacy|2|||
124630218|NCT01565889|448262975|FG000|Part B|Lost to Follow-up|0|||
124630219|NCT01565889|448262976|FG001|Part B|Lost to Follow-up|0|||
124630220|NCT01565889|448262977|FG002|Part B|Lost to Follow-up|0|||
124630221|NCT01565889|448262978|FG003|Part B|Lost to Follow-up|0|||
124630222|NCT01565889|448262979|FG004|Part B|Lost to Follow-up|0|||
124630223|NCT01565889|448262980|FG005|Part B|Lost to Follow-up|1|||
124630224|NCT01326845|448262983|FG000|Overall Study|Administrative Problems|5|||
124630225|NCT01326845|448262984|FG001|Overall Study|Administrative Problems|2|||
124630226|NCT01326845|448262983|FG000|Overall Study|Adverse Event|1|||
124630227|NCT01326845|448262984|FG001|Overall Study|Adverse Event|0|||
124799743|NCT05323656|448898717|FG000|Overall Study|Patient and Investigator decision|1|||
124799744|NCT05323656|448898718|FG001|Overall Study|Patient and Investigator decision|0|||
124799745|NCT05323656|448898717|FG000|Overall Study|Physician Decision|0|||
124799746|NCT05323656|448898718|FG001|Overall Study|Physician Decision|1|||
124799747|NCT03370289|448898721|FG000|Overall Study|Screen Failure|1|||
124799748|NCT03370289|448898721|FG000|Overall Study|Sample Size Sufficient|4|||
124799749|NCT03309046|448898722|FG000|Overall Study|Withdrawal by Subject|4|||
124799750|NCT03309046|448898723|FG001|Overall Study|Withdrawal by Subject|17|||
124630228|NCT01326845|448262983|FG000|Overall Study|Misisng|1|||
124630229|NCT01326845|448262984|FG001|Overall Study|Misisng|3|||
124799751|NCT03963401|448898728|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
124799752|NCT03963401|448898729|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
124799753|NCT03963401|448898730|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
124799754|NCT03963401|448898731|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
124799755|NCT03963401|448898732|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
124799756|NCT03963401|448898733|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
124799757|NCT03963401|448898728|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
124799758|NCT03963401|448898729|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
124799759|NCT03963401|448898730|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
124799760|NCT03963401|448898731|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
124799761|NCT03963401|448898732|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
124799762|NCT03963401|448898733|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
124799763|NCT03963401|448898728|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
124799764|NCT03963401|448898729|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
124799765|NCT03963401|448898730|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
124799766|NCT03963401|448898731|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
124799767|NCT03963401|448898732|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
124799768|NCT03963401|448898733|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
124799769|NCT03963401|448898728|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
124799770|NCT03963401|448898729|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
124799771|NCT03963401|448898730|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
124799772|NCT03963401|448898731|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
124799773|NCT03963401|448898732|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
124799774|NCT03963401|448898733|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
124799775|NCT03963401|448898728|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
124799776|NCT03963401|448898729|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
124799777|NCT03963401|448898730|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
124799778|NCT03963401|448898731|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
124799779|NCT03963401|448898732|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
124799780|NCT03963401|448898733|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
124799781|NCT03963401|448898728|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
124799782|NCT03963401|448898729|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
124799783|NCT03963401|448898730|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
124799784|NCT03963401|448898731|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
124799785|NCT03963401|448898732|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
124799786|NCT03963401|448898733|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
124799787|NCT03963401|448898728|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
124799788|NCT03963401|448898729|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
124799789|NCT03963401|448898730|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
124799790|NCT03963401|448898731|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
124799791|NCT03963401|448898732|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
124799792|NCT03963401|448898733|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
124799793|NCT03963401|448898728|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
124799794|NCT03963401|448898729|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
124799795|NCT03963401|448898730|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
124799796|NCT03963401|448898731|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
124799797|NCT03963401|448898732|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
124799798|NCT03963401|448898733|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
124799799|NCT03963401|448898728|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
124799800|NCT03963401|448898729|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
124799801|NCT03963401|448898730|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
124799802|NCT03963401|448898731|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
124799803|NCT03963401|448898732|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
124799804|NCT03963401|448898733|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
124799805|NCT03963401|448898728|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
124799806|NCT03963401|448898729|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
124799807|NCT03963401|448898730|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
124799808|NCT03963401|448898731|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
124630230|NCT00982657|448262985|FG000|Overall Study|Death|1|||
124630231|NCT00982657|448262986|FG001|Overall Study|Death|0|||
124630232|NCT00982657|448262987|FG002|Overall Study|Death|1|||
124630233|NCT00982657|448262988|FG003|Overall Study|Death|1|||
124630234|NCT00982657|448262985|FG000|Overall Study|Withdrawal by Subject|0|||
124630235|NCT00982657|448262986|FG001|Overall Study|Withdrawal by Subject|0|||
124630236|NCT00982657|448262987|FG002|Overall Study|Withdrawal by Subject|1|||
124630237|NCT00982657|448262988|FG003|Overall Study|Withdrawal by Subject|3|||
124799809|NCT03963401|448898732|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
124799810|NCT03963401|448898733|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
124799811|NCT03963401|448898728|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
124799812|NCT03963401|448898729|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
124799813|NCT03963401|448898730|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
124799814|NCT03963401|448898731|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
124799815|NCT03963401|448898732|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
124799816|NCT03963401|448898733|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
124799817|NCT01721070|448898736|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
124799818|NCT02204007|448898737|FG000|Overall Study|Surgery Canceled|1|||
124799819|NCT02204007|448898738|FG001|Overall Study|Surgery Canceled|1|||
124799820|NCT00910988|448898739|FG000|Overall Study|Lost to Follow-up|2|||
124799821|NCT00910988|448898740|FG001|Overall Study|Lost to Follow-up|4|||
124799822|NCT00910988|448898741|FG002|Overall Study|Lost to Follow-up|3|||
124799823|NCT00910988|448898742|FG003|Overall Study|Lost to Follow-up|0|||
124799824|NCT03004443|448898743|FG000|Overall Study|Pregnancy|0|||
124799825|NCT03004443|448898744|FG001|Overall Study|Pregnancy|1|||
124799826|NCT00828854|448898745|FG000|Overall Study|Disease Progression|17|||
124799827|NCT00828854|448898745|FG000|Overall Study|Adverse Event|9|||
124799828|NCT00828854|448898745|FG000|Overall Study|Reason not Specified|1|||
124799829|NCT03911843|448898746|FG000|Overall Study|Adverse Event|2|||
124799830|NCT03911843|448898747|FG001|Overall Study|Adverse Event|0|||
124799831|NCT03911843|448898746|FG000|Overall Study|Protocol Violation|2|||
124799832|NCT03911843|448898747|FG001|Overall Study|Protocol Violation|0|||
124799833|NCT03911843|448898746|FG000|Overall Study|Lost to Follow-up|0|||
124799834|NCT03911843|448898747|FG001|Overall Study|Lost to Follow-up|1|||
124799835|NCT01907100|448898748|FG000|Overall Study|PD based on modified RECIST criteria|31|||
124799836|NCT01907100|448898749|FG001|Overall Study|PD based on modified RECIST criteria|32|||
124799837|NCT01907100|448898750|FG002|Overall Study|PD based on modified RECIST criteria|95|||
124799838|NCT01907100|448898751|FG003|Overall Study|PD based on modified RECIST criteria|92|||
124799839|NCT01907100|448898748|FG000|Overall Study|Withdrawal by Subject|2|||
124799840|NCT01907100|448898749|FG001|Overall Study|Withdrawal by Subject|5|||
124799841|NCT01907100|448898750|FG002|Overall Study|Withdrawal by Subject|10|||
124799842|NCT01907100|448898751|FG003|Overall Study|Withdrawal by Subject|13|||
124799843|NCT01907100|448898748|FG000|Overall Study|Protocol Violation|0|||
124799844|NCT01907100|448898749|FG001|Overall Study|Protocol Violation|0|||
124799845|NCT01907100|448898750|FG002|Overall Study|Protocol Violation|1|||
124799846|NCT01907100|448898751|FG003|Overall Study|Protocol Violation|1|||
124799847|NCT01907100|448898748|FG000|Overall Study|Lost to Follow-up|0|||
124799848|NCT01907100|448898749|FG001|Overall Study|Lost to Follow-up|0|||
124799849|NCT01907100|448898750|FG002|Overall Study|Lost to Follow-up|0|||
124799850|NCT01907100|448898751|FG003|Overall Study|Lost to Follow-up|1|||
124799851|NCT01907100|448898748|FG000|Overall Study|Not treated|2|||
124799852|NCT01907100|448898749|FG001|Overall Study|Not treated|0|||
124799853|NCT01907100|448898750|FG002|Overall Study|Not treated|1|||
124799854|NCT01907100|448898751|FG003|Overall Study|Not treated|2|||
124799855|NCT01907100|448898748|FG000|Overall Study|Other than reasons specified|1|||
124799856|NCT01907100|448898749|FG001|Overall Study|Other than reasons specified|0|||
124799857|NCT01907100|448898750|FG002|Overall Study|Other than reasons specified|10|||
124799858|NCT01907100|448898751|FG003|Overall Study|Other than reasons specified|6|||
124799859|NCT01907100|448898748|FG000|Overall Study|Adverse event (AE)|6|||
124799860|NCT01907100|448898749|FG001|Overall Study|Adverse event (AE)|3|||
124799861|NCT01907100|448898750|FG002|Overall Study|Adverse event (AE)|22|||
124799862|NCT01907100|448898751|FG003|Overall Study|Adverse event (AE)|23|||
124799863|NCT01907100|448898748|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
124799864|NCT01907100|448898749|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
124799865|NCT01907100|448898750|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
124799866|NCT01907100|448898751|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
124799867|NCT03635788|448898752|FG000|Step 1|Death|1|||
124799868|NCT03635788|448898753|FG001|Step 1|Death|0|||
124799869|NCT03635788|448898754|FG002|Step 1|Death|0|||
124799870|NCT03635788|448898752|FG000|Step 1|Lost to Follow-up|31|||
124799871|NCT03635788|448898753|FG001|Step 1|Lost to Follow-up|0|||
124799872|NCT03635788|448898754|FG002|Step 1|Lost to Follow-up|0|||
124799873|NCT03635788|448898752|FG000|Step 1|Pregnancy|1|||
124799874|NCT03635788|448898753|FG001|Step 1|Pregnancy|0|||
124799875|NCT03635788|448898754|FG002|Step 1|Pregnancy|0|||
124799876|NCT03635788|448898752|FG000|Step 1|Protocol Violation|8|||
124799877|NCT03635788|448898753|FG001|Step 1|Protocol Violation|0|||
124799878|NCT03635788|448898754|FG002|Step 1|Protocol Violation|0|||
124799879|NCT03635788|448898752|FG000|Step 1|Withdrawal by Subject|13|||
124799880|NCT03635788|448898753|FG001|Step 1|Withdrawal by Subject|0|||
124799881|NCT03635788|448898754|FG002|Step 1|Withdrawal by Subject|0|||
124630238|NCT00982657|448262985|FG000|Overall Study|Other|0|||
124799882|NCT03635788|448898752|FG000|Step 1|Other reasons|12|||
124799883|NCT03635788|448898753|FG001|Step 1|Other reasons|0|||
124799884|NCT03635788|448898754|FG002|Step 1|Other reasons|0|||
124799885|NCT03635788|448898752|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
124799886|NCT03635788|448898753|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
124799887|NCT03635788|448898754|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
124799888|NCT03635788|448898752|FG000|Step 2|Lost to Follow-up|0|||
124799889|NCT03635788|448898753|FG001|Step 2|Lost to Follow-up|8|||
124799890|NCT03635788|448898754|FG002|Step 2|Lost to Follow-up|15|||
124799891|NCT03635788|448898752|FG000|Step 2|Withdrawal by Subject|0|||
124799892|NCT03635788|448898753|FG001|Step 2|Withdrawal by Subject|6|||
124799893|NCT03635788|448898754|FG002|Step 2|Withdrawal by Subject|6|||
124799894|NCT03635788|448898752|FG000|Step 2|Death|0|||
124799895|NCT03635788|448898753|FG001|Step 2|Death|2|||
124799896|NCT03635788|448898754|FG002|Step 2|Death|0|||
124799897|NCT03635788|448898752|FG000|Step 2|Incarceration|0|||
124799898|NCT03635788|448898753|FG001|Step 2|Incarceration|2|||
124799899|NCT03635788|448898754|FG002|Step 2|Incarceration|0|||
124799900|NCT03635788|448898752|FG000|Step 2|Non-Compliance With Study Requirements|0|||
124799901|NCT03635788|448898753|FG001|Step 2|Non-Compliance With Study Requirements|1|||
124799902|NCT03635788|448898754|FG002|Step 2|Non-Compliance With Study Requirements|1|||
124799903|NCT03635788|448898752|FG000|Step 2|Confounding Medical Condition|0|||
124799904|NCT03635788|448898753|FG001|Step 2|Confounding Medical Condition|0|||
124799905|NCT03635788|448898754|FG002|Step 2|Confounding Medical Condition|1|||
124799906|NCT03635788|448898752|FG000|Step 2|Out Of State With No Plan To Return|0|||
124799907|NCT03635788|448898753|FG001|Step 2|Out Of State With No Plan To Return|1|||
124799908|NCT03635788|448898754|FG002|Step 2|Out Of State With No Plan To Return|0|||
124799909|NCT03635788|448898752|FG000|Step 2|Switched To Injectables|0|||
124799910|NCT03635788|448898753|FG001|Step 2|Switched To Injectables|0|||
124799911|NCT03635788|448898754|FG002|Step 2|Switched To Injectables|1|||
124799912|NCT03635788|448898752|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
124799913|NCT03635788|448898753|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
124799914|NCT03635788|448898754|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
124799915|NCT04382755|448898755|FG000|Overall Study|Withdrawal by Subject|1|||
124799916|NCT04382755|448898756|FG001|Overall Study|Withdrawal by Subject|0|||
124799917|NCT04382755|448898755|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
124799918|NCT04382755|448898756|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
124799919|NCT04382755|448898755|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
124799920|NCT04382755|448898756|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
124799921|NCT01397201|448900382|FG000|Overall Study|Not treated|0|||
124799922|NCT01397201|448900383|FG001|Overall Study|Not treated|0|||
124799923|NCT01397201|448900384|FG002|Overall Study|Not treated|1|||
124799924|NCT01397201|448900385|FG003|Overall Study|Not treated|0|||
124799925|NCT01397201|448900386|FG004|Overall Study|Not treated|0|||
124799926|NCT01397201|448900382|FG000|Overall Study|Not yet defined|3|||
124799927|NCT01397201|448900383|FG001|Overall Study|Not yet defined|6|||
124799928|NCT01397201|448900384|FG002|Overall Study|Not yet defined|5|||
124799929|NCT01397201|448900385|FG003|Overall Study|Not yet defined|5|||
124799930|NCT01397201|448900386|FG004|Overall Study|Not yet defined|4|||
124799931|NCT01397201|448900382|FG000|Overall Study|Adverse Event|2|||
124799932|NCT01397201|448900383|FG001|Overall Study|Adverse Event|0|||
124799933|NCT01397201|448900384|FG002|Overall Study|Adverse Event|0|||
124799934|NCT01397201|448900385|FG003|Overall Study|Adverse Event|0|||
124799935|NCT01397201|448900386|FG004|Overall Study|Adverse Event|0|||
124799936|NCT00215683|448900387|FG000|Overall Study|Adverse Event|15|||
124799937|NCT00215683|448900388|FG001|Overall Study|Adverse Event|16|||
124799938|NCT00215683|448900389|FG002|Overall Study|Adverse Event|15|||
124799939|NCT00215683|448900387|FG000|Overall Study|Lack of Efficacy|5|||
124799940|NCT00215683|448900388|FG001|Overall Study|Lack of Efficacy|1|||
124799941|NCT00215683|448900389|FG002|Overall Study|Lack of Efficacy|2|||
124799942|NCT00215683|448900387|FG000|Overall Study|Lost to Follow-up|0|||
124799943|NCT00215683|448900388|FG001|Overall Study|Lost to Follow-up|2|||
124799944|NCT00215683|448900389|FG002|Overall Study|Lost to Follow-up|1|||
124799945|NCT00215683|448900387|FG000|Overall Study|Withdrawal by Subject|9|||
124799946|NCT00215683|448900388|FG001|Overall Study|Withdrawal by Subject|4|||
124799947|NCT00215683|448900389|FG002|Overall Study|Withdrawal by Subject|13|||
124799948|NCT00215683|448900387|FG000|Overall Study|Physician Decision|0|||
124799949|NCT00215683|448900388|FG001|Overall Study|Physician Decision|0|||
124799950|NCT00215683|448900389|FG002|Overall Study|Physician Decision|1|||
124799951|NCT00215683|448900387|FG000|Overall Study|Difficult to attend visits|0|||
124799952|NCT00215683|448900388|FG001|Overall Study|Difficult to attend visits|1|||
124799953|NCT00215683|448900389|FG002|Overall Study|Difficult to attend visits|0|||
124799954|NCT00215683|448900387|FG000|Overall Study|No study drug available|0|||
124799955|NCT00215683|448900388|FG001|Overall Study|No study drug available|1|||
124799956|NCT00215683|448900389|FG002|Overall Study|No study drug available|0|||
124799957|NCT00215683|448900387|FG000|Overall Study|Intermittent therapy required|0|||
124799958|NCT00215683|448900388|FG001|Overall Study|Intermittent therapy required|1|||
124799959|NCT00215683|448900389|FG002|Overall Study|Intermittent therapy required|0|||
124799960|NCT01083485|448900390|FG000|Overall Study|Adverse Event|0|||
124799961|NCT01083485|448900391|FG001|Overall Study|Adverse Event|1|||
124799962|NCT01083485|448900390|FG000|Overall Study|Protocol Violation|1|||
124799963|NCT01083485|448900391|FG001|Overall Study|Protocol Violation|0|||
124799964|NCT01083485|448900390|FG000|Overall Study|Withdrawal by Subject|5|||
124799965|NCT01083485|448900391|FG001|Overall Study|Withdrawal by Subject|2|||
124799966|NCT01083485|448900390|FG000|Overall Study|Other|1|||
124799967|NCT01083485|448900391|FG001|Overall Study|Other|0|||
124799968|NCT04493333|448900392|FG000|Overall Study|Withdrawal by Subject|1|||
124799969|NCT04493333|448900393|FG001|Overall Study|Withdrawal by Subject|1|||
124799970|NCT04493333|448900392|FG000|Overall Study|Ineligible|0|||
124799971|NCT04493333|448900393|FG001|Overall Study|Ineligible|1|||
124799972|NCT04493333|448900392|FG000|Overall Study|Noncompliance|2|||
124799973|NCT04493333|448900393|FG001|Overall Study|Noncompliance|1|||
124799974|NCT02247531|448900394|FG000|Overall Study|Adverse Event|3|||
124799975|NCT02247531|448900395|FG001|Overall Study|Adverse Event|4|||
124799976|NCT02247531|448900396|FG002|Overall Study|Adverse Event|9|||
124799977|NCT02247531|448900394|FG000|Overall Study|Death|8|||
124799978|NCT02247531|448900395|FG001|Overall Study|Death|9|||
124799979|NCT02247531|448900396|FG002|Overall Study|Death|5|||
124799980|NCT02247531|448900394|FG000|Overall Study|Lost to Follow-up|1|||
124799981|NCT02247531|448900395|FG001|Overall Study|Lost to Follow-up|8|||
124799982|NCT02247531|448900396|FG002|Overall Study|Lost to Follow-up|3|||
124799983|NCT02247531|448900394|FG000|Overall Study|Non-compliance|2|||
124799984|NCT02247531|448900395|FG001|Overall Study|Non-compliance|2|||
124799985|NCT02247531|448900396|FG002|Overall Study|Non-compliance|0|||
124799986|NCT02247531|448900394|FG000|Overall Study|Withdrawal by Subject|26|||
124799987|NCT02247531|448900395|FG001|Overall Study|Withdrawal by Subject|31|||
124799988|NCT02247531|448900396|FG002|Overall Study|Withdrawal by Subject|25|||
124799989|NCT02247531|448900394|FG000|Overall Study|Study Terminated by Sponsor|64|||
124799990|NCT02247531|448900395|FG001|Overall Study|Study Terminated by Sponsor|66|||
124799991|NCT02247531|448900396|FG002|Overall Study|Study Terminated by Sponsor|62|||
124799992|NCT02247531|448900394|FG000|Overall Study|Physician Decision|0|||
124630239|NCT00982657|448262986|FG001|Overall Study|Other|0|||
124630240|NCT00982657|448262987|FG002|Overall Study|Other|0|||
124630241|NCT00982657|448262988|FG003|Overall Study|Other|4|||
124630242|NCT00982657|448262985|FG000|Overall Study|On going at date of cut-off|0|||
124630243|NCT00982657|448262986|FG001|Overall Study|On going at date of cut-off|0|||
124630244|NCT00982657|448262987|FG002|Overall Study|On going at date of cut-off|0|||
124630245|NCT00982657|448262988|FG003|Overall Study|On going at date of cut-off|1|||
124630246|NCT00752128|448262991|FG000|Overall Study|Withdrawal by Subject|4|||
124630247|NCT02286713|448262992|FG000|One Week Follow-Up|Death|1|||
124630248|NCT02286713|448262993|FG001|One Week Follow-Up|Death|0|||
124630249|NCT02286713|448262992|FG000|One Week Follow-Up|Lost to Follow-up|17|||
124630250|NCT02286713|448262993|FG001|One Week Follow-Up|Lost to Follow-up|21|||
124630251|NCT02286713|448262992|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
124630252|NCT02286713|448262993|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
124630253|NCT02286713|448262992|FG000|Three Month Follow-Up|Death|1|||
124630254|NCT02286713|448262993|FG001|Three Month Follow-Up|Death|1|||
124630255|NCT02286713|448262992|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
124630256|NCT02286713|448262993|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
124630257|NCT02286713|448262992|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
124630258|NCT02286713|448262993|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
124630259|NCT02286713|448262992|FG000|Six Month Follow-Up|Death|2|||
124630260|NCT02286713|448262993|FG001|Six Month Follow-Up|Death|0|||
124630261|NCT02286713|448262992|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
124630262|NCT02286713|448262993|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
124630263|NCT02235454|448262994|FG000|Overall Study|Withdrawal by Subject|2|||
124630264|NCT03323398|448262995|FG000|Overall Study|Other than Specified|0|||
124630265|NCT03323398|448262996|FG001|Overall Study|Other than Specified|1|||
124630266|NCT03323398|448262997|FG002|Overall Study|Other than Specified|2|||
124630267|NCT03323398|448262998|FG003|Overall Study|Other than Specified|0|||
124630268|NCT03323398|448262999|FG004|Overall Study|Other than Specified|0|||
124630269|NCT03323398|448263000|FG005|Overall Study|Other than Specified|0|||
124630270|NCT03323398|448263001|FG006|Overall Study|Other than Specified|1|||
124630271|NCT03323398|448263002|FG007|Overall Study|Other than Specified|0|||
124630272|NCT03323398|448263003|FG008|Overall Study|Other than Specified|2|||
124799993|NCT02247531|448900395|FG001|Overall Study|Physician Decision|2|||
124799994|NCT02247531|448900396|FG002|Overall Study|Physician Decision|2|||
124799995|NCT02247531|448900394|FG000|Overall Study|Unspecified Reason|2|||
124799996|NCT02247531|448900395|FG001|Overall Study|Unspecified Reason|3|||
124799997|NCT02247531|448900396|FG002|Overall Study|Unspecified Reason|4|||
124799998|NCT03468985|448900397|FG000|Overall Study|Adverse Event|0|||
124799999|NCT03468985|448900398|FG001|Overall Study|Adverse Event|2|||
124630273|NCT03323398|448262995|FG000|Overall Study|Lost to Follow-up|1|||
124630274|NCT03323398|448262996|FG001|Overall Study|Lost to Follow-up|2|||
124630275|NCT03323398|448262997|FG002|Overall Study|Lost to Follow-up|1|||
124630276|NCT03323398|448262998|FG003|Overall Study|Lost to Follow-up|0|||
124630277|NCT03323398|448262999|FG004|Overall Study|Lost to Follow-up|0|||
124630278|NCT03323398|448263000|FG005|Overall Study|Lost to Follow-up|0|||
124630279|NCT03323398|448263001|FG006|Overall Study|Lost to Follow-up|0|||
124630280|NCT03323398|448263002|FG007|Overall Study|Lost to Follow-up|0|||
124630281|NCT03323398|448263003|FG008|Overall Study|Lost to Follow-up|0|||
124630282|NCT03323398|448262995|FG000|Overall Study|Death|4|||
124630283|NCT03323398|448262996|FG001|Overall Study|Death|6|||
124630284|NCT03323398|448262997|FG002|Overall Study|Death|2|||
124630285|NCT03323398|448262998|FG003|Overall Study|Death|2|||
124630286|NCT03323398|448262999|FG004|Overall Study|Death|1|||
124630287|NCT03323398|448263000|FG005|Overall Study|Death|2|||
124630288|NCT03323398|448263001|FG006|Overall Study|Death|0|||
124630289|NCT03323398|448263002|FG007|Overall Study|Death|0|||
124630290|NCT03323398|448263003|FG008|Overall Study|Death|6|||
124630291|NCT03323398|448262995|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
124630292|NCT03323398|448262996|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
124630293|NCT03323398|448262997|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
124630294|NCT03323398|448262998|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
124630295|NCT03323398|448262999|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
124630296|NCT03323398|448263000|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
124630297|NCT03323398|448263001|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
124630298|NCT03323398|448263002|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
124630299|NCT03323398|448263003|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
124630300|NCT03323398|448262995|FG000|Overall Study|Withdrawal by Subject|2|||
124630301|NCT03323398|448262996|FG001|Overall Study|Withdrawal by Subject|1|||
124630302|NCT03323398|448262997|FG002|Overall Study|Withdrawal by Subject|3|||
124630303|NCT03323398|448262998|FG003|Overall Study|Withdrawal by Subject|0|||
124630304|NCT03323398|448262999|FG004|Overall Study|Withdrawal by Subject|0|||
124630305|NCT03323398|448263000|FG005|Overall Study|Withdrawal by Subject|1|||
124630306|NCT03323398|448263001|FG006|Overall Study|Withdrawal by Subject|0|||
124630307|NCT03323398|448263002|FG007|Overall Study|Withdrawal by Subject|0|||
124630308|NCT03323398|448263003|FG008|Overall Study|Withdrawal by Subject|0|||
124630309|NCT03323398|448262995|FG000|Overall Study|Participant was Put on Hospice|0|||
124630310|NCT03323398|448262996|FG001|Overall Study|Participant was Put on Hospice|0|||
124630311|NCT03323398|448262997|FG002|Overall Study|Participant was Put on Hospice|0|||
124630312|NCT03323398|448262998|FG003|Overall Study|Participant was Put on Hospice|0|||
124630313|NCT03323398|448262999|FG004|Overall Study|Participant was Put on Hospice|0|||
124630314|NCT03323398|448263000|FG005|Overall Study|Participant was Put on Hospice|0|||
124630315|NCT03323398|448263001|FG006|Overall Study|Participant was Put on Hospice|1|||
124630316|NCT03323398|448263002|FG007|Overall Study|Participant was Put on Hospice|0|||
124630317|NCT03323398|448263003|FG008|Overall Study|Participant was Put on Hospice|0|||
124630318|NCT03323398|448262995|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
124630319|NCT03323398|448262996|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
124630320|NCT03323398|448262997|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
124630321|NCT03323398|448262998|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
124630322|NCT03323398|448262999|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
124630323|NCT03323398|448263000|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
124630324|NCT03323398|448263001|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
124630325|NCT03323398|448263002|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
124630326|NCT03323398|448263003|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
124630327|NCT02546986|448264792|FG000|Treatment Period|Progressive Disease|20|||
124630328|NCT02546986|448264793|FG001|Treatment Period|Progressive Disease|22|||
124630329|NCT02546986|448264792|FG000|Treatment Period|Adverse Event|14|||
124630330|NCT02546986|448264793|FG001|Treatment Period|Adverse Event|6|||
124630331|NCT02546986|448264792|FG000|Treatment Period|Symptomatic Deterioration|4|||
124630332|NCT02546986|448264793|FG001|Treatment Period|Symptomatic Deterioration|3|||
124630333|NCT02546986|448264792|FG000|Treatment Period|Death|3|||
124630334|NCT02546986|448264793|FG001|Treatment Period|Death|4|||
124630335|NCT02546986|448264792|FG000|Treatment Period|Physician Decision|1|||
124630336|NCT02546986|448264793|FG001|Treatment Period|Physician Decision|2|||
124630337|NCT02546986|448264792|FG000|Treatment Period|Protocol Violation|1|||
124630338|NCT02546986|448264793|FG001|Treatment Period|Protocol Violation|0|||
124630339|NCT02546986|448264792|FG000|Treatment Period|Withdrawal by Subject|1|||
124630340|NCT02546986|448264793|FG001|Treatment Period|Withdrawal by Subject|1|||
124630341|NCT02546986|448264792|FG000|Treatment Period|Non-compliance with Study Drug|0|||
124630342|NCT02546986|448264793|FG001|Treatment Period|Non-compliance with Study Drug|1|||
124630343|NCT02546986|448264792|FG000|Treatment Period|Study Terminated by Sponsor|0|||
124630344|NCT02546986|448264793|FG001|Treatment Period|Study Terminated by Sponsor|1|||
124630345|NCT02546986|448264792|FG000|Treatment Period|Miscellaneous|7|||
124630346|NCT02546986|448264793|FG001|Treatment Period|Miscellaneous|9|||
124630347|NCT02546986|448264792|FG000|Survival Follow-Up Phase|Missing Status|3|||
124630348|NCT02546986|448264793|FG001|Survival Follow-Up Phase|Missing Status|5|||
124630349|NCT02546986|448264792|FG000|Survival Follow-Up Phase|Death|18|||
124800000|NCT03468985|448900399|FG002|Overall Study|Adverse Event|0|||
124630350|NCT02546986|448264793|FG001|Survival Follow-Up Phase|Death|12|||
124630351|NCT02546986|448264792|FG000|Survival Follow-Up Phase|Alive|13|||
124630352|NCT02546986|448264793|FG001|Survival Follow-Up Phase|Alive|16|||
124630353|NCT02546986|448264792|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
124630354|NCT02546986|448264793|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
124630355|NCT01168232|448264794|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
124630356|NCT01168232|448264794|FG000|Overall Study|Ineligible- Wrong cell type|6|||
124630357|NCT01168232|448264794|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
124630358|NCT05012098|448264797|FG000|Overall Study|Disease progression|5|||
124630359|NCT05012098|448264798|FG001|Overall Study|Disease progression|2|||
124630360|NCT05012098|448264797|FG000|Overall Study|Adverse Event|1|||
124630361|NCT05012098|448264798|FG001|Overall Study|Adverse Event|0|||
124630362|NCT05012098|448264797|FG000|Overall Study|Withdrawal by Subject|1|||
124630363|NCT05012098|448264798|FG001|Overall Study|Withdrawal by Subject|0|||
124630364|NCT05012098|448264797|FG000|Overall Study|Discontinuation per protocol|1|||
124630365|NCT05012098|448264798|FG001|Overall Study|Discontinuation per protocol|0|||
124630366|NCT05258773|448264799|FG000|Overall Study|Screen Failure|1|||
124630367|NCT05258773|448264800|FG001|Overall Study|Screen Failure|1|||
124630368|NCT05258773|448264799|FG000|Overall Study|Adverse Event|1|||
124630369|NCT05258773|448264800|FG001|Overall Study|Adverse Event|0|||
124630370|NCT05258773|448264799|FG000|Overall Study|Withdrawal by Subject|0|||
124630371|NCT05258773|448264800|FG001|Overall Study|Withdrawal by Subject|1|||
124630372|NCT03018288|448264803|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
124630373|NCT03018288|448264804|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
124630374|NCT03018288|448264805|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
124630375|NCT03018288|448264806|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
124630376|NCT03018288|448264803|FG000|Overall Study|Participant withdrew consent.|0|||
124630377|NCT03018288|448264804|FG001|Overall Study|Participant withdrew consent.|0|||
124630378|NCT03018288|448264805|FG002|Overall Study|Participant withdrew consent.|1|||
124630379|NCT03018288|448264806|FG003|Overall Study|Participant withdrew consent.|0|||
124630380|NCT03018288|448264803|FG000|Overall Study|Switched to alternative treatment.|0|||
124630381|NCT03018288|448264804|FG001|Overall Study|Switched to alternative treatment.|0|||
124630382|NCT03018288|448264805|FG002|Overall Study|Switched to alternative treatment.|1|||
124800001|NCT03468985|448900400|FG003|Overall Study|Adverse Event|0|||
124800002|NCT03468985|448900397|FG000|Overall Study|Withdrawal by Subject|0|||
124800003|NCT03468985|448900398|FG001|Overall Study|Withdrawal by Subject|0|||
124800004|NCT03468985|448900399|FG002|Overall Study|Withdrawal by Subject|0|||
124800005|NCT03468985|448900400|FG003|Overall Study|Withdrawal by Subject|1|||
124800006|NCT04131556|448900401|FG000|Overall Study|Adverse Event|1|||
124800007|NCT04131556|448900401|FG000|Overall Study|Withdrawal by Subject|1|||
124800008|NCT04060862|448900404|FG000|Overall Study|Symptomatic Deterioration|1|||
124800009|NCT04060862|448900404|FG000|Overall Study|Un-specified|6|||
124800010|NCT04060862|448900404|FG000|Overall Study|Progressive disease|12|||
124800011|NCT04060862|448900404|FG000|Overall Study|Physician Decision|1|||
124800012|NCT04629508|448900405|FG000|Overall Study|Adverse Event|1|||
124800013|NCT04629508|448900405|FG000|Overall Study|Death|2|||
124800014|NCT04629508|448900405|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
124800015|NCT00760214|448900413|FG000|Overall Study|Adverse Event|8|||
124800016|NCT00760214|448900414|FG001|Overall Study|Adverse Event|9|||
124800017|NCT00760214|448900415|FG002|Overall Study|Adverse Event|12|||
124800018|NCT00760214|448900413|FG000|Overall Study|Protocol Violation|3|||
124800019|NCT00760214|448900414|FG001|Overall Study|Protocol Violation|0|||
124800020|NCT00760214|448900415|FG002|Overall Study|Protocol Violation|3|||
124800021|NCT00760214|448900413|FG000|Overall Study|Lost to Follow-up|0|||
124800022|NCT00760214|448900414|FG001|Overall Study|Lost to Follow-up|0|||
124800023|NCT00760214|448900415|FG002|Overall Study|Lost to Follow-up|1|||
124800024|NCT00760214|448900413|FG000|Overall Study|Withdrawal by Subject|12|||
124800025|NCT00760214|448900414|FG001|Overall Study|Withdrawal by Subject|14|||
124800026|NCT00760214|448900415|FG002|Overall Study|Withdrawal by Subject|13|||
124800027|NCT00760214|448900413|FG000|Overall Study|Lack of Efficacy|3|||
124800028|NCT00760214|448900414|FG001|Overall Study|Lack of Efficacy|2|||
124800029|NCT00760214|448900415|FG002|Overall Study|Lack of Efficacy|4|||
124800030|NCT00760214|448900413|FG000|Overall Study|Pregnancy|0|||
124800031|NCT00760214|448900414|FG001|Overall Study|Pregnancy|0|||
124800032|NCT00760214|448900415|FG002|Overall Study|Pregnancy|1|||
124630383|NCT03018288|448264806|FG003|Overall Study|Switched to alternative treatment.|0|||
124630384|NCT03018288|448264803|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
124630385|NCT03018288|448264804|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
124630386|NCT03018288|448264805|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
124630387|NCT03018288|448264806|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
124630388|NCT03018288|448264803|FG000|Overall Study|Screen failures|0|||
124800033|NCT00760214|448900413|FG000|Overall Study|Physician Decision|1|||
124800034|NCT00760214|448900414|FG001|Overall Study|Physician Decision|1|||
124800035|NCT00760214|448900415|FG002|Overall Study|Physician Decision|1|||
124800036|NCT00760214|448900413|FG000|Overall Study|Other|3|||
124800037|NCT00760214|448900414|FG001|Overall Study|Other|4|||
124800038|NCT00760214|448900415|FG002|Overall Study|Other|6|||
124800039|NCT03960554|448900419|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
124800040|NCT03960554|448900420|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
124800041|NCT02545075|448900421|FG000|Randomization|Lost to Follow-up|0|||
124800042|NCT02545075|448900422|FG001|Randomization|Lost to Follow-up|1|||
124800043|NCT02545075|448900421|FG000|Randomization|Withdrawal by Subject|0|||
124800044|NCT02545075|448900422|FG001|Randomization|Withdrawal by Subject|6|||
124800045|NCT02545075|448900421|FG000|Treatment|Disease progression|71|||
124800046|NCT02545075|448900422|FG001|Treatment|Disease progression|32|||
124800047|NCT02545075|448900421|FG000|Treatment|Participant dicontinued study treatment|7|||
124800048|NCT02545075|448900422|FG001|Treatment|Participant dicontinued study treatment|9|||
124800049|NCT02545075|448900421|FG000|Treatment|Withdrawal by Subject|1|||
124800050|NCT02545075|448900422|FG001|Treatment|Withdrawal by Subject|0|||
124800051|NCT02545075|448900421|FG000|Treatment|Adverse event not related to study drug|1|||
124800052|NCT02545075|448900422|FG001|Treatment|Adverse event not related to study drug|0|||
124800053|NCT02545075|448900421|FG000|Treatment|Death|1|||
124800054|NCT02545075|448900422|FG001|Treatment|Death|0|||
124800055|NCT02545075|448900421|FG000|Treatment|Participant drug toxicity|1|||
124800056|NCT02545075|448900422|FG001|Treatment|Participant drug toxicity|0|||
124800057|NCT02545075|448900421|FG000|Treatment|Completed treatment|40|||
124800058|NCT02545075|448900422|FG001|Treatment|Completed treatment|12|||
124800059|NCT01810432|448900423|FG000|Washout|Protocol Violation|0|||
124800060|NCT01810432|448900424|FG001|Washout|Protocol Violation|1|||
124800061|NCT01810432|448900423|FG000|Washout|Adverse Event|1|||
124800062|NCT01810432|448900424|FG001|Washout|Adverse Event|0|||
124800063|NCT01810432|448900423|FG000|Period 2|Withdrawal by Subject|2|||
124800064|NCT01810432|448900424|FG001|Period 2|Withdrawal by Subject|1|||
124800065|NCT01810432|448900423|FG000|Period 2|Physician Decision|1|||
124800066|NCT01810432|448900424|FG001|Period 2|Physician Decision|0|||
124800067|NCT01810432|448900423|FG000|Period 2|Lost to Follow-up|1|||
124800068|NCT01810432|448900424|FG001|Period 2|Lost to Follow-up|1|||
124800069|NCT00736879|448900425|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
124800070|NCT00736879|448900426|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
124800071|NCT00736879|448900427|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
124800072|NCT00736879|448900428|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
124800073|NCT00736879|448900425|FG000|Double Blind Treatment Period|Adverse Event|0|||
124800074|NCT00736879|448900426|FG001|Double Blind Treatment Period|Adverse Event|1|||
124800075|NCT00736879|448900427|FG002|Double Blind Treatment Period|Adverse Event|1|||
124800076|NCT00736879|448900428|FG003|Double Blind Treatment Period|Adverse Event|0|||
124800077|NCT00736879|448900425|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
124800078|NCT00736879|448900426|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
124800079|NCT00736879|448900427|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
124630389|NCT03018288|448264804|FG001|Overall Study|Screen failures|0|||
124630390|NCT03018288|448264805|FG002|Overall Study|Screen failures|0|||
124630391|NCT03018288|448264806|FG003|Overall Study|Screen failures|51|||
124630392|NCT03018288|448264803|FG000|Overall Study|Chose treatment outside of UNC|0|||
124630393|NCT03018288|448264804|FG001|Overall Study|Chose treatment outside of UNC|0|||
124630394|NCT03018288|448264805|FG002|Overall Study|Chose treatment outside of UNC|0|||
124630395|NCT03018288|448264806|FG003|Overall Study|Chose treatment outside of UNC|1|||
124630396|NCT03018288|448264803|FG000|Overall Study|Unable to comply with protocol requirements|1|||
124630397|NCT03018288|448264804|FG001|Overall Study|Unable to comply with protocol requirements|1|||
124630398|NCT03018288|448264805|FG002|Overall Study|Unable to comply with protocol requirements|0|||
124630399|NCT03018288|448264806|FG003|Overall Study|Unable to comply with protocol requirements|1|||
124630400|NCT03018288|448264803|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
124630401|NCT03018288|448264804|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
124630402|NCT03018288|448264805|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
124630403|NCT03018288|448264806|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
124630404|NCT03018288|448264803|FG000|Overall Study|Physician Decision|0|||
124630405|NCT03018288|448264804|FG001|Overall Study|Physician Decision|0|||
124630406|NCT03018288|448264805|FG002|Overall Study|Physician Decision|0|||
124630407|NCT03018288|448264806|FG003|Overall Study|Physician Decision|1|||
124630408|NCT01490086|448264810|FG000|Overall Study|Consent withdrawn|4|||
124630409|NCT01490086|448264811|FG001|Overall Study|Consent withdrawn|4|||
124800080|NCT00736879|448900428|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
124800081|NCT00736879|448900425|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
124800082|NCT00736879|448900426|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
124800083|NCT00736879|448900427|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
124800084|NCT00736879|448900428|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
124630410|NCT01490086|448264812|FG002|Overall Study|Consent withdrawn|3|||
124630411|NCT01490086|448264813|FG003|Overall Study|Consent withdrawn|0|||
124630412|NCT01490086|448264814|FG004|Overall Study|Consent withdrawn|1|||
124800085|NCT00736879|448900425|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
124630413|NCT01490086|448264810|FG000|Overall Study|Non-compliance|0|||
124630414|NCT01490086|448264811|FG001|Overall Study|Non-compliance|1|||
124630415|NCT01490086|448264812|FG002|Overall Study|Non-compliance|0|||
124630416|NCT01490086|448264813|FG003|Overall Study|Non-compliance|0|||
124630417|NCT01490086|448264814|FG004|Overall Study|Non-compliance|0|||
124800086|NCT00736879|448900426|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
124800087|NCT00736879|448900427|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
124800088|NCT00736879|448900428|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
124800089|NCT00736879|448900425|FG000|Double Blind Treatment Period|No longer met criteria|0|||
124800090|NCT00736879|448900426|FG001|Double Blind Treatment Period|No longer met criteria|1|||
124800091|NCT00736879|448900427|FG002|Double Blind Treatment Period|No longer met criteria|0|||
124800092|NCT00736879|448900428|FG003|Double Blind Treatment Period|No longer met criteria|0|||
124800093|NCT00736879|448900425|FG000|Double Blind Treatment Period|non-specified|0|||
124800094|NCT00736879|448900426|FG001|Double Blind Treatment Period|non-specified|1|||
124800095|NCT00736879|448900427|FG002|Double Blind Treatment Period|non-specified|0|||
124800096|NCT00736879|448900428|FG003|Double Blind Treatment Period|non-specified|0|||
124800097|NCT00736879|448900425|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
124800098|NCT00736879|448900426|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
124800099|NCT00736879|448900427|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
124800100|NCT00736879|448900428|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
124800101|NCT00736879|448900425|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
124800102|NCT00736879|448900426|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
124800103|NCT00736879|448900427|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
124800104|NCT00736879|448900428|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
124800105|NCT02360111|448900431|FG000|Overall Study|Death|2|||
124800107|NCT02310321|448900435|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
124800108|NCT02310321|448900436|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
124800109|NCT02310321|448900437|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
124800110|NCT02310321|448900435|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
124800111|NCT02310321|448900436|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
124800112|NCT02310321|448900437|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
124800113|NCT02310321|448900435|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
124800114|NCT02310321|448900436|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
124800115|NCT02310321|448900437|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
124800116|NCT02310321|448900435|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
124800117|NCT02310321|448900436|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
124800118|NCT02310321|448900437|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
124800119|NCT02310321|448900435|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
124800120|NCT02310321|448900436|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
124800121|NCT02310321|448900437|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
124800122|NCT02310321|448900435|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
124800123|NCT02310321|448900436|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
124800124|NCT02310321|448900437|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
124800125|NCT02310321|448900435|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
124800126|NCT02310321|448900436|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
124800127|NCT02310321|448900437|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
124800128|NCT02310321|448900435|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
124800129|NCT02310321|448900436|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
124800130|NCT02310321|448900437|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
124800131|NCT02310321|448900435|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
124800132|NCT02310321|448900436|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
124800133|NCT02310321|448900437|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
124800134|NCT02310321|448900435|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
124800135|NCT02310321|448900436|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
124800136|NCT02310321|448900437|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
124630418|NCT01490086|448264810|FG000|Overall Study|Abnormal laboratory findings|1|||
124630419|NCT01490086|448264811|FG001|Overall Study|Abnormal laboratory findings|0|||
124630420|NCT01490086|448264812|FG002|Overall Study|Abnormal laboratory findings|0|||
124630421|NCT01490086|448264813|FG003|Overall Study|Abnormal laboratory findings|0|||
124630422|NCT01490086|448264814|FG004|Overall Study|Abnormal laboratory findings|0|||
124630423|NCT01490086|448264810|FG000|Overall Study|Lost to Follow-up|0|||
124800137|NCT02310321|448900435|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
124800138|NCT02310321|448900436|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
124800139|NCT02310321|448900437|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
124800140|NCT02310321|448900435|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
124800141|NCT02310321|448900436|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
124800142|NCT02310321|448900437|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
124800143|NCT02310321|448900435|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
124800144|NCT02310321|448900436|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
124800145|NCT02310321|448900437|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
124800146|NCT02310321|448900435|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
124800147|NCT02310321|448900436|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
124800148|NCT02310321|448900437|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
124800149|NCT02310321|448900435|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
124800150|NCT02310321|448900436|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
124800151|NCT02310321|448900437|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
124800152|NCT02310321|448900435|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
124800153|NCT02310321|448900436|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
124800154|NCT02310321|448900437|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
124800155|NCT02310321|448900435|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
124800156|NCT02310321|448900436|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
124800157|NCT02310321|448900437|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
124800158|NCT02310321|448900435|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
124800159|NCT02310321|448900436|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
124800160|NCT02310321|448900437|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
124800161|NCT02310321|448900435|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
124800162|NCT02310321|448900436|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
124800163|NCT02310321|448900437|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
124800164|NCT02310321|448900435|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
124800165|NCT02310321|448900436|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
124630424|NCT01490086|448264811|FG001|Overall Study|Lost to Follow-up|0|||
124630425|NCT01490086|448264812|FG002|Overall Study|Lost to Follow-up|0|||
124630426|NCT01490086|448264813|FG003|Overall Study|Lost to Follow-up|0|||
124630427|NCT01490086|448264814|FG004|Overall Study|Lost to Follow-up|1|||
124630428|NCT01490086|448264810|FG000|Overall Study|Physician Decision|3|||
124630429|NCT01490086|448264811|FG001|Overall Study|Physician Decision|4|||
124630430|NCT01490086|448264812|FG002|Overall Study|Physician Decision|2|||
124630431|NCT01490086|448264813|FG003|Overall Study|Physician Decision|3|||
124630432|NCT01490086|448264814|FG004|Overall Study|Physician Decision|1|||
124800166|NCT02310321|448900437|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
124800167|NCT02310321|448900435|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
124800168|NCT02310321|448900436|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
124800169|NCT02310321|448900437|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
124800170|NCT02310321|448900435|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
124800171|NCT02310321|448900436|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
124800172|NCT02310321|448900437|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
124800173|NCT02310321|448900435|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
124800174|NCT02310321|448900436|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
124800175|NCT02310321|448900437|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
124630433|NCT01490086|448264810|FG000|Overall Study|Adverse Event|0|||
124630434|NCT01490086|448264811|FG001|Overall Study|Adverse Event|0|||
124630435|NCT01490086|448264812|FG002|Overall Study|Adverse Event|1|||
124630436|NCT01490086|448264813|FG003|Overall Study|Adverse Event|2|||
124630437|NCT01490086|448264814|FG004|Overall Study|Adverse Event|0|||
124630438|NCT01490086|448264810|FG000|Overall Study|Lack of Efficacy|0|||
124630439|NCT01490086|448264811|FG001|Overall Study|Lack of Efficacy|3|||
124630440|NCT01490086|448264812|FG002|Overall Study|Lack of Efficacy|1|||
124630441|NCT01490086|448264813|FG003|Overall Study|Lack of Efficacy|0|||
124630442|NCT01490086|448264814|FG004|Overall Study|Lack of Efficacy|8|||
124630443|NCT01490086|448264810|FG000|Overall Study|Worsening of symptoms|0|||
124630444|NCT01490086|448264811|FG001|Overall Study|Worsening of symptoms|1|||
124630445|NCT01490086|448264812|FG002|Overall Study|Worsening of symptoms|0|||
124800176|NCT01698905|448900438|FG000|Overall Study|Adverse Event|4|||
124800177|NCT01698905|448900438|FG000|Overall Study|Physician Decision|2|||
124800178|NCT01698905|448900438|FG000|Overall Study|Pregnancy|1|||
124800179|NCT01698905|448900438|FG000|Overall Study|Protocol Violation|1|||
124800180|NCT01698905|448900438|FG000|Overall Study|Subject/guardian decision|2|||
124800181|NCT01698905|448900438|FG000|Overall Study|Death|1|||
124800182|NCT02325791|448900441|FG000|Overall Study|Adverse Event|0|||
124800183|NCT02325791|448900442|FG001|Overall Study|Adverse Event|1|||
124800184|NCT02325791|448900443|FG002|Overall Study|Adverse Event|1|||
124800185|NCT02325791|448900444|FG003|Overall Study|Adverse Event|0|||
124630446|NCT01490086|448264813|FG003|Overall Study|Worsening of symptoms|1|||
124630447|NCT01490086|448264814|FG004|Overall Study|Worsening of symptoms|0|||
124630448|NCT01490086|448264810|FG000|Overall Study|Subject uncontrollable and abusive|0|||
124630449|NCT01490086|448264811|FG001|Overall Study|Subject uncontrollable and abusive|1|||
124630450|NCT01490086|448264812|FG002|Overall Study|Subject uncontrollable and abusive|0|||
124800186|NCT02325791|448900441|FG000|Overall Study|Death|0|||
124800187|NCT02325791|448900442|FG001|Overall Study|Death|3|||
124800188|NCT02325791|448900443|FG002|Overall Study|Death|0|||
124800189|NCT02325791|448900444|FG003|Overall Study|Death|1|||
124800190|NCT02325791|448900441|FG000|Overall Study|Lost to Follow-up|0|||
124800191|NCT02325791|448900442|FG001|Overall Study|Lost to Follow-up|15|||
124800192|NCT02325791|448900443|FG002|Overall Study|Lost to Follow-up|14|||
124800193|NCT02325791|448900444|FG003|Overall Study|Lost to Follow-up|9|||
124800194|NCT02325791|448900441|FG000|Overall Study|Physician Decision|0|||
124800195|NCT02325791|448900442|FG001|Overall Study|Physician Decision|1|||
124800196|NCT02325791|448900443|FG002|Overall Study|Physician Decision|1|||
124800197|NCT02325791|448900444|FG003|Overall Study|Physician Decision|0|||
124800198|NCT02325791|448900441|FG000|Overall Study|Protocol Violation|0|||
124800199|NCT02325791|448900442|FG001|Overall Study|Protocol Violation|0|||
124630451|NCT01490086|448264813|FG003|Overall Study|Subject uncontrollable and abusive|0|||
124630452|NCT01490086|448264814|FG004|Overall Study|Subject uncontrollable and abusive|0|||
124630453|NCT01490086|448264810|FG000|Overall Study|Subject left hospital|0|||
124630454|NCT01490086|448264811|FG001|Overall Study|Subject left hospital|1|||
124630455|NCT01490086|448264812|FG002|Overall Study|Subject left hospital|0|||
124630456|NCT01490086|448264813|FG003|Overall Study|Subject left hospital|1|||
124630457|NCT01490086|448264814|FG004|Overall Study|Subject left hospital|0|||
124630458|NCT06025721|448264815|FG000|Overall Study|Physician Decision|1|||
124630459|NCT06025721|448264815|FG000|Overall Study|Protocol Violation|1|||
124630460|NCT06025721|448264815|FG000|Overall Study|Incarceration|1|||
124630461|NCT01127256|448264816|FG000|Overall Study|Adverse Event|13|||
124630462|NCT01127256|448264817|FG001|Overall Study|Adverse Event|13|||
124630463|NCT01127256|448264816|FG000|Overall Study|Lack of Efficacy|4|||
124630464|NCT01127256|448264817|FG001|Overall Study|Lack of Efficacy|0|||
124630465|NCT01127256|448264816|FG000|Overall Study|Lost to Follow-up|16|||
124630466|NCT01127256|448264817|FG001|Overall Study|Lost to Follow-up|17|||
124630467|NCT01127256|448264816|FG000|Overall Study|Withdrawal by Subject|5|||
124630468|NCT01127256|448264817|FG001|Overall Study|Withdrawal by Subject|9|||
124630469|NCT01127256|448264816|FG000|Overall Study|Protocol Violation|1|||
124630470|NCT01127256|448264817|FG001|Overall Study|Protocol Violation|0|||
124630471|NCT02068508|448264819|FG000|Overall Study|Case report forms uncollected|27|||
124630472|NCT02068508|448264819|FG000|Overall Study|Patient did not visit the study site|1|||
124630473|NCT02068508|448264819|FG000|Overall Study|Protocol Violation|4|||
124630474|NCT00413699|448264821|FG000|Initial Period|Death|25|||
124630475|NCT00413699|448264822|FG001|Initial Period|Death|30|||
124630476|NCT00413699|448264823|FG002|Initial Period|Death|0|||
124630477|NCT00413699|448264821|FG000|Initial Period|Lack of Efficacy|59|||
124630478|NCT00413699|448264822|FG001|Initial Period|Lack of Efficacy|115|||
124630479|NCT00413699|448264823|FG002|Initial Period|Lack of Efficacy|0|||
124630480|NCT00413699|448264821|FG000|Initial Period|Lost to Follow-up|31|||
124630481|NCT00413699|448264822|FG001|Initial Period|Lost to Follow-up|101|||
124630482|NCT00413699|448264823|FG002|Initial Period|Lost to Follow-up|0|||
124630483|NCT00413699|448264821|FG000|Initial Period|Protocol Violation|38|||
124630484|NCT00413699|448264822|FG001|Initial Period|Protocol Violation|89|||
124630485|NCT00413699|448264823|FG002|Initial Period|Protocol Violation|0|||
124630486|NCT00413699|448264821|FG000|Initial Period|Pregnancy|10|||
124630487|NCT00413699|448264822|FG001|Initial Period|Pregnancy|8|||
124630488|NCT00413699|448264823|FG002|Initial Period|Pregnancy|0|||
124630489|NCT00413699|448264821|FG000|Initial Period|Did not meet entrance criteria|2|||
124630490|NCT00413699|448264822|FG001|Initial Period|Did not meet entrance criteria|2|||
124630491|NCT00413699|448264823|FG002|Initial Period|Did not meet entrance criteria|0|||
124630492|NCT00413699|448264821|FG000|Initial Period|Medication error without adverse event|0|||
124630493|NCT00413699|448264822|FG001|Initial Period|Medication error without adverse event|1|||
124630494|NCT00413699|448264823|FG002|Initial Period|Medication error without adverse event|0|||
124630495|NCT00413699|448264821|FG000|Initial Period|Study terminated by Sponsor|0|||
124630496|NCT00413699|448264822|FG001|Initial Period|Study terminated by Sponsor|1|||
124630497|NCT00413699|448264823|FG002|Initial Period|Study terminated by Sponsor|0|||
124630498|NCT00413699|448264821|FG000|Initial Period|Other|67|||
124800200|NCT02325791|448900443|FG002|Overall Study|Protocol Violation|1|||
124800201|NCT02325791|448900444|FG003|Overall Study|Protocol Violation|0|||
124630499|NCT00413699|448264822|FG001|Initial Period|Other|211|||
124630500|NCT00413699|448264823|FG002|Initial Period|Other|0|||
124630501|NCT00413699|448264821|FG000|Initial Period|Adverse event related to study drug|178|||
124630502|NCT00413699|448264822|FG001|Initial Period|Adverse event related to study drug|527|||
124630503|NCT00413699|448264823|FG002|Initial Period|Adverse event related to study drug|0|||
124630504|NCT00413699|448264821|FG000|Initial Period|Adverse event not related to study drug|113|||
124630505|NCT00413699|448264822|FG001|Initial Period|Adverse event not related to study drug|248|||
124630506|NCT00413699|448264823|FG002|Initial Period|Adverse event not related to study drug|0|||
124630507|NCT00413699|448264821|FG000|Initial Period|Missing end of study page|0|||
124800202|NCT02325791|448900441|FG000|Overall Study|Withdrawal by Subject|0|||
124800203|NCT02325791|448900442|FG001|Overall Study|Withdrawal by Subject|5|||
124800204|NCT02325791|448900443|FG002|Overall Study|Withdrawal by Subject|8|||
124800205|NCT02325791|448900444|FG003|Overall Study|Withdrawal by Subject|16|||
124630508|NCT00413699|448264822|FG001|Initial Period|Missing end of study page|4|||
124630509|NCT00413699|448264823|FG002|Initial Period|Missing end of study page|0|||
124630510|NCT00413699|448264821|FG000|Initial Period|No longer willing to participate|116|||
124630511|NCT00413699|448264822|FG001|Initial Period|No longer willing to participate|368|||
124630512|NCT00413699|448264823|FG002|Initial Period|No longer willing to participate|0|||
124630513|NCT00413699|448264821|FG000|Extension Period|No Longer Willing to Participate|0|||
124630514|NCT00413699|448264822|FG001|Extension Period|No Longer Willing to Participate|0|||
124800206|NCT03953183|448900445|FG000|Overall Study|Physician Decision|0|||
124800207|NCT03953183|448900446|FG001|Overall Study|Physician Decision|1|||
124800208|NCT03953183|448900445|FG000|Overall Study|Withdrawal by Subject|0|||
124800209|NCT03953183|448900446|FG001|Overall Study|Withdrawal by Subject|1|||
124800210|NCT01465191|448900447|FG000|Overall Study|Protocol Violation|6|||
124800211|NCT01465191|448900448|FG001|Overall Study|Protocol Violation|3|||
124800212|NCT01465191|448900449|FG002|Overall Study|Protocol Violation|3|||
124800213|NCT01465191|448900447|FG000|Overall Study|Lost to Follow-up|3|||
124800214|NCT01465191|448900448|FG001|Overall Study|Lost to Follow-up|6|||
124800215|NCT01465191|448900449|FG002|Overall Study|Lost to Follow-up|4|||
124800216|NCT02273739|448900450|FG000|Overall Study|Progression of Disease|3|||
124800217|NCT02273739|448900451|FG001|Overall Study|Progression of Disease|4|||
124630515|NCT00413699|448264823|FG002|Extension Period|No Longer Willing to Participate|2|||
124800218|NCT02273739|448900452|FG002|Overall Study|Progression of Disease|5|||
124800219|NCT02273739|448900453|FG003|Overall Study|Progression of Disease|2|||
124800220|NCT02273739|448900450|FG000|Overall Study|Death|0|||
124800221|NCT02273739|448900451|FG001|Overall Study|Death|0|||
124800222|NCT02273739|448900452|FG002|Overall Study|Death|0|||
124800223|NCT02273739|448900453|FG003|Overall Study|Death|2|||
124800224|NCT02273739|448900450|FG000|Overall Study|Adverse Event|0|||
124800225|NCT02273739|448900451|FG001|Overall Study|Adverse Event|0|||
124800226|NCT02273739|448900452|FG002|Overall Study|Adverse Event|0|||
124800227|NCT02273739|448900453|FG003|Overall Study|Adverse Event|1|||
124800228|NCT02273739|448900450|FG000|Overall Study|Withdrawal by Subject|0|||
124800229|NCT02273739|448900451|FG001|Overall Study|Withdrawal by Subject|0|||
124800230|NCT02273739|448900452|FG002|Overall Study|Withdrawal by Subject|2|||
124800231|NCT02273739|448900453|FG003|Overall Study|Withdrawal by Subject|1|||
124800232|NCT02273739|448900450|FG000|Overall Study|Physician Decision|0|||
124800233|NCT02273739|448900451|FG001|Overall Study|Physician Decision|0|||
124800234|NCT02273739|448900452|FG002|Overall Study|Physician Decision|0|||
124800235|NCT02273739|448900453|FG003|Overall Study|Physician Decision|1|||
124630516|NCT00413699|448264821|FG000|Extension Period|Protocol Violation|0|||
124630517|NCT00413699|448264822|FG001|Extension Period|Protocol Violation|0|||
124630518|NCT00413699|448264823|FG002|Extension Period|Protocol Violation|1|||
124630519|NCT00413699|448264821|FG000|Extension Period|Adverse Event|0|||
124630520|NCT00413699|448264822|FG001|Extension Period|Adverse Event|0|||
124630521|NCT00413699|448264823|FG002|Extension Period|Adverse Event|2|||
124630522|NCT03511105|448264824|FG000|Overall Study|Adverse Event|1|||
124630523|NCT03511105|448264825|FG001|Overall Study|Adverse Event|0|||
124630524|NCT03511105|448264824|FG000|Overall Study|Withdrew consent|1|||
124630525|NCT03511105|448264825|FG001|Overall Study|Withdrew consent|0|||
124630526|NCT02810457|448264826|FG000|Overall Study|Randomised but no treatment received|2|||
124630527|NCT02810457|448264827|FG001|Overall Study|Randomised but no treatment received|1|||
124630528|NCT02810457|448264826|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
124630529|NCT02810457|448264827|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
124630530|NCT02810457|448264826|FG000|Overall Study|Adverse Event|37|||
124630531|NCT02810457|448264827|FG001|Overall Study|Adverse Event|43|||
124630532|NCT02810457|448264826|FG000|Overall Study|Patient decision|31|||
124630533|NCT02810457|448264827|FG001|Overall Study|Patient decision|35|||
124630534|NCT02810457|448264826|FG000|Overall Study|Patient lost to follow-up|2|||
124630535|NCT02810457|448264827|FG001|Overall Study|Patient lost to follow-up|2|||
124630536|NCT02810457|448264826|FG000|Overall Study|Death|39|||
124630537|NCT02810457|448264827|FG001|Overall Study|Death|28|||
124630538|NCT02810457|448264826|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
124630539|NCT02810457|448264827|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
124630540|NCT02810457|448264826|FG000|Overall Study|Clinical progression|15|||
124800236|NCT04795622|448900454|FG000|Overall Study|Adverse Event|1|||
124630541|NCT02810457|448264827|FG001|Overall Study|Clinical progression|16|||
124630542|NCT02810457|448264826|FG000|Overall Study|Investigator decision|3|||
124630543|NCT02810457|448264827|FG001|Overall Study|Investigator decision|2|||
124630544|NCT02810457|448264826|FG000|Overall Study|Patient ineligibility|3|||
124630545|NCT02810457|448264827|FG001|Overall Study|Patient ineligibility|0|||
124630546|NCT02810457|448264826|FG000|Overall Study|Miscalculated PD|1|||
124630547|NCT02810457|448264827|FG001|Overall Study|Miscalculated PD|0|||
124800237|NCT04795622|448900455|FG001|Overall Study|Adverse Event|0|||
124800238|NCT04795622|448900454|FG000|Overall Study|Withdrawal by Subject|3|||
124800239|NCT04795622|448900455|FG001|Overall Study|Withdrawal by Subject|3|||
124800240|NCT04795622|448900454|FG000|Overall Study|Protocol Violation|0|||
124800241|NCT04795622|448900455|FG001|Overall Study|Protocol Violation|2|||
124800242|NCT04795622|448900454|FG000|Overall Study|Lost to Follow-up|2|||
124630548|NCT02810457|448264826|FG000|Overall Study|Physician Decision|0|||
124630549|NCT02810457|448264827|FG001|Overall Study|Physician Decision|1|||
124800243|NCT04795622|448900455|FG001|Overall Study|Lost to Follow-up|3|||
124800244|NCT04795622|448900454|FG000|Overall Study|Other|7|||
124800245|NCT04795622|448900455|FG001|Overall Study|Other|8|||
124800246|NCT00089674|448900456|FG000|Overall Study|Physician Decision|4|||
124800247|NCT00089674|448900457|FG001|Overall Study|Physician Decision|2|||
124800248|NCT00089674|448900456|FG000|Overall Study|Adverse Event|23|||
124800249|NCT00089674|448900457|FG001|Overall Study|Adverse Event|29|||
124630550|NCT02832687|448264828|FG000|Overall Study|Adverse Event|0|||
124630551|NCT02832687|448264829|FG001|Overall Study|Adverse Event|2|||
124630552|NCT04231825|448264830|FG000|Overall Study|Protocol Violation|3|||
124630553|NCT04231825|448264831|FG001|Overall Study|Protocol Violation|3|||
124800250|NCT00089674|448900456|FG000|Overall Study|Withdrawal by Subject|143|||
124800251|NCT00089674|448900457|FG001|Overall Study|Withdrawal by Subject|127|||
124800252|NCT00089674|448900456|FG000|Overall Study|Death|43|||
124800253|NCT00089674|448900457|FG001|Overall Study|Death|43|||
124800254|NCT00089674|448900456|FG000|Overall Study|Disease progression|21|||
124800255|NCT00089674|448900457|FG001|Overall Study|Disease progression|23|||
124800256|NCT00089674|448900456|FG000|Overall Study|Ineligibility determined|8|||
124800257|NCT00089674|448900457|FG001|Overall Study|Ineligibility determined|10|||
124800258|NCT00089674|448900456|FG000|Overall Study|Lost to Follow-up|21|||
124800259|NCT00089674|448900457|FG001|Overall Study|Lost to Follow-up|17|||
124800260|NCT00089674|448900456|FG000|Overall Study|Noncompliance|7|||
124800261|NCT00089674|448900457|FG001|Overall Study|Noncompliance|3|||
124800262|NCT00089674|448900456|FG000|Overall Study|Other|5|||
124800263|NCT00089674|448900457|FG001|Overall Study|Other|9|||
124800264|NCT00089674|448900456|FG000|Overall Study|Requirement for alternative therapy|14|||
124800265|NCT00089674|448900457|FG001|Overall Study|Requirement for alternative therapy|4|||
124800266|NCT02961218|448900458|FG000|Overall Study|Lost to Follow-up|0|||
124800267|NCT02961218|448900459|FG001|Overall Study|Lost to Follow-up|2|||
124800268|NCT02961218|448900458|FG000|Overall Study|Physician Decision|0|||
124800269|NCT02961218|448900459|FG001|Overall Study|Physician Decision|2|||
124800270|NCT02961218|448900458|FG000|Overall Study|Subject/Guardian Decision|3|||
124800271|NCT02961218|448900459|FG001|Overall Study|Subject/Guardian Decision|1|||
124800272|NCT00591266|448900460|FG000|Overall Study|Adverse Event|2|||
124800273|NCT00591266|448900461|FG001|Overall Study|Adverse Event|2|||
124800274|NCT00591266|448900462|FG002|Overall Study|Adverse Event|3|||
124800275|NCT00591266|448900460|FG000|Overall Study|Lost to Follow-up|0|||
124800276|NCT00591266|448900461|FG001|Overall Study|Lost to Follow-up|1|||
124800277|NCT00591266|448900462|FG002|Overall Study|Lost to Follow-up|0|||
124800278|NCT00591266|448900460|FG000|Overall Study|Protocol Violation|0|||
124800279|NCT00591266|448900461|FG001|Overall Study|Protocol Violation|0|||
124800280|NCT00591266|448900462|FG002|Overall Study|Protocol Violation|1|||
124800281|NCT00591266|448900460|FG000|Overall Study|Withdrawal by Subject|6|||
124800282|NCT00591266|448900461|FG001|Overall Study|Withdrawal by Subject|2|||
124800283|NCT00591266|448900462|FG002|Overall Study|Withdrawal by Subject|5|||
124800284|NCT00591266|448900460|FG000|Overall Study|Lack of Efficacy|0|||
124800285|NCT00591266|448900461|FG001|Overall Study|Lack of Efficacy|2|||
124800286|NCT00591266|448900462|FG002|Overall Study|Lack of Efficacy|0|||
124800287|NCT00591266|448900460|FG000|Overall Study|Other|1|||
124800288|NCT00591266|448900461|FG001|Overall Study|Other|4|||
124800289|NCT00591266|448900462|FG002|Overall Study|Other|5|||
124800290|NCT03488927|448900463|FG000|Overall Study|Withdrawal by Subject|44|||
124800291|NCT03488927|448900464|FG001|Overall Study|Withdrawal by Subject|118|||
124800292|NCT03488927|448900465|FG002|Overall Study|Withdrawal by Subject|217|||
124800293|NCT00901927|448900466|FG000|Overall Study|Lack of Efficacy|1|||
124800294|NCT00901927|448900466|FG000|Overall Study|Protocol Violation|3|||
124800295|NCT00901927|448900466|FG000|Overall Study|Withdrawal by Subject|2|||
124800296|NCT02676466|448900469|FG000|Overall Study|Death|0|||
124800297|NCT02676466|448900470|FG001|Overall Study|Death|2|||
124800298|NCT02676466|448900471|FG002|Overall Study|Death|1|||
124800299|NCT02676466|448900472|FG003|Overall Study|Death|0|||
124800300|NCT02676466|448900473|FG004|Overall Study|Death|0|||
124630554|NCT04231825|448264830|FG000|Overall Study|Lost to Follow-up|0|||
124800301|NCT02676466|448900474|FG005|Overall Study|Death|0|||
124800302|NCT02676466|448900475|FG006|Overall Study|Death|0|||
124800303|NCT02676466|448900476|FG007|Overall Study|Death|0|||
124800304|NCT02676466|448900469|FG000|Overall Study|Withdrawal by Subject|4|||
124630555|NCT04231825|448264831|FG001|Overall Study|Lost to Follow-up|1|||
124800305|NCT02676466|448900470|FG001|Overall Study|Withdrawal by Subject|3|||
124800306|NCT02676466|448900471|FG002|Overall Study|Withdrawal by Subject|1|||
124800307|NCT02676466|448900472|FG003|Overall Study|Withdrawal by Subject|0|||
124800308|NCT02676466|448900473|FG004|Overall Study|Withdrawal by Subject|3|||
124800309|NCT02676466|448900474|FG005|Overall Study|Withdrawal by Subject|1|||
124630556|NCT02019472|448264832|FG000|Overall Study|Adverse Event|14|||
124800310|NCT02676466|448900475|FG006|Overall Study|Withdrawal by Subject|1|||
124800311|NCT02676466|448900476|FG007|Overall Study|Withdrawal by Subject|1|||
124800312|NCT01178073|448900478|FG000|Overall Study|Adverse Event|34|||
124800313|NCT01178073|448900479|FG001|Overall Study|Adverse Event|27|||
124800314|NCT01178073|448900480|FG002|Overall Study|Adverse Event|24|||
124800315|NCT01178073|448900478|FG000|Overall Study|Protocol Violation|1|||
124800316|NCT01178073|448900479|FG001|Overall Study|Protocol Violation|1|||
124800317|NCT01178073|448900480|FG002|Overall Study|Protocol Violation|1|||
124800318|NCT01178073|448900478|FG000|Overall Study|Lost to Follow-up|2|||
124800319|NCT01178073|448900479|FG001|Overall Study|Lost to Follow-up|0|||
124800320|NCT01178073|448900480|FG002|Overall Study|Lost to Follow-up|3|||
124800321|NCT01178073|448900478|FG000|Overall Study|Physician Decision|14|||
124800322|NCT01178073|448900479|FG001|Overall Study|Physician Decision|10|||
124800323|NCT01178073|448900480|FG002|Overall Study|Physician Decision|10|||
124800324|NCT01178073|448900478|FG000|Overall Study|Withdrawal by Subject|10|||
124800325|NCT01178073|448900479|FG001|Overall Study|Withdrawal by Subject|6|||
124800326|NCT01178073|448900480|FG002|Overall Study|Withdrawal by Subject|8|||
124800327|NCT01178073|448900478|FG000|Overall Study|Missing Completion Status|1|||
124800328|NCT01178073|448900479|FG001|Overall Study|Missing Completion Status|0|||
124800329|NCT01178073|448900480|FG002|Overall Study|Missing Completion Status|0|||
124800330|NCT03497676|448900483|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
124800331|NCT03497676|448900484|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
124800332|NCT03497676|448900485|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
124800333|NCT03497676|448900486|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
124800334|NCT03497676|448900483|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
124800335|NCT03497676|448900484|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
124800336|NCT03497676|448900485|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
124800337|NCT03497676|448900486|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
124800338|NCT03497676|448900483|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
124800339|NCT03497676|448900484|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
124800340|NCT03497676|448900485|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
124800341|NCT03497676|448900486|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
124800342|NCT03497676|448900483|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
124800343|NCT03497676|448900484|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
124800344|NCT03497676|448900485|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
124800345|NCT03497676|448900486|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
124800346|NCT03497676|448900483|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
124800347|NCT03497676|448900484|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
124800348|NCT03497676|448900485|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
124800349|NCT03497676|448900486|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
124800350|NCT03497676|448900483|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
124800351|NCT03497676|448900484|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
124800352|NCT03497676|448900485|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
124800353|NCT03497676|448900486|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
124800354|NCT03497676|448900483|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
124800355|NCT03497676|448900484|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
124800356|NCT03497676|448900485|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
124800357|NCT03497676|448900486|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
124800358|NCT03497676|448900483|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
124800359|NCT03497676|448900484|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
124800360|NCT03497676|448900485|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
124800361|NCT03497676|448900486|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
124800362|NCT01226043|448900496|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
124800363|NCT01226043|448900497|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
124800364|NCT01226043|448900498|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
124800365|NCT01226043|448900499|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
124800366|NCT01226043|448900496|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
124800367|NCT01226043|448900497|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
124800368|NCT01226043|448900498|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
124800369|NCT01226043|448900499|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
124800370|NCT01226043|448900496|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
124800371|NCT01226043|448900497|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
124800372|NCT01226043|448900498|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
124800373|NCT01226043|448900499|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
124800374|NCT01226043|448900496|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
124800375|NCT01226043|448900497|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
124800376|NCT01226043|448900498|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
124800377|NCT01226043|448900499|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
124800378|NCT01226043|448900496|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
124800379|NCT01226043|448900497|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
124800380|NCT01226043|448900498|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
124800381|NCT01226043|448900499|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
124800382|NCT01226043|448900496|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
124800383|NCT01226043|448900497|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
124800384|NCT01226043|448900498|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
124800385|NCT01226043|448900499|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
124800386|NCT01226043|448900496|FG000|6-week Re-randomization Phase|Adverse Event|0|||
124800387|NCT01226043|448900497|FG001|6-week Re-randomization Phase|Adverse Event|0|||
124800388|NCT01226043|448900498|FG002|6-week Re-randomization Phase|Adverse Event|1|||
124800389|NCT01226043|448900499|FG003|6-week Re-randomization Phase|Adverse Event|1|||
124800390|NCT01226043|448900496|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
124800391|NCT01226043|448900497|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
124800392|NCT01226043|448900498|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
124800393|NCT01226043|448900499|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
124800394|NCT01226043|448900496|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
124800395|NCT01226043|448900497|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
124800396|NCT01226043|448900498|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
124800397|NCT01226043|448900499|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
124800398|NCT01226043|448900496|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
124800399|NCT01226043|448900497|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
124800400|NCT01226043|448900498|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
124800401|NCT01226043|448900499|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
124800402|NCT01226043|448900496|FG000|6-week Re-randomization Phase|Physician Decision|0|||
124800403|NCT01226043|448900497|FG001|6-week Re-randomization Phase|Physician Decision|0|||
124800404|NCT01226043|448900498|FG002|6-week Re-randomization Phase|Physician Decision|3|||
124800405|NCT01226043|448900499|FG003|6-week Re-randomization Phase|Physician Decision|2|||
124800406|NCT01226043|448900496|FG000|6-week Re-randomization Phase|completed in error|0|||
124800407|NCT01226043|448900497|FG001|6-week Re-randomization Phase|completed in error|0|||
124800408|NCT01226043|448900498|FG002|6-week Re-randomization Phase|completed in error|0|||
124800409|NCT01226043|448900499|FG003|6-week Re-randomization Phase|completed in error|1|||
124800410|NCT01226043|448900496|FG000|30-week Observational Phase|Adverse Event|0|||
124800411|NCT01226043|448900497|FG001|30-week Observational Phase|Adverse Event|0|||
124800412|NCT01226043|448900498|FG002|30-week Observational Phase|Adverse Event|1|||
124800413|NCT01226043|448900499|FG003|30-week Observational Phase|Adverse Event|1|||
124800414|NCT01226043|448900496|FG000|30-week Observational Phase|Protocol Violation|0|||
124800415|NCT01226043|448900497|FG001|30-week Observational Phase|Protocol Violation|0|||
124800416|NCT01226043|448900498|FG002|30-week Observational Phase|Protocol Violation|0|||
124800417|NCT01226043|448900499|FG003|30-week Observational Phase|Protocol Violation|1|||
124800418|NCT01226043|448900496|FG000|30-week Observational Phase|Lost to Follow-up|0|||
124800419|NCT01226043|448900497|FG001|30-week Observational Phase|Lost to Follow-up|0|||
124800420|NCT01226043|448900498|FG002|30-week Observational Phase|Lost to Follow-up|2|||
124800421|NCT01226043|448900499|FG003|30-week Observational Phase|Lost to Follow-up|2|||
124800422|NCT01226043|448900496|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
124800423|NCT01226043|448900497|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
124800424|NCT01226043|448900498|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
124800425|NCT01226043|448900499|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
124800426|NCT01226043|448900496|FG000|30-week Observational Phase|Physician Decision|0|||
124800427|NCT01226043|448900497|FG001|30-week Observational Phase|Physician Decision|0|||
124800428|NCT01226043|448900498|FG002|30-week Observational Phase|Physician Decision|2|||
124800429|NCT01226043|448900499|FG003|30-week Observational Phase|Physician Decision|2|||
124800430|NCT00191646|448900501|FG000|Overall Study|Toxicity|26|||
124800431|NCT00191646|448900502|FG001|Overall Study|Toxicity|37|||
124800432|NCT00191646|448900501|FG000|Overall Study|Disease Progression|5|||
124800433|NCT00191646|448900502|FG001|Overall Study|Disease Progression|6|||
124800434|NCT00191646|448900501|FG000|Overall Study|Physician Decision|20|||
124800435|NCT00191646|448900502|FG001|Overall Study|Physician Decision|11|||
124800436|NCT00191646|448900501|FG000|Overall Study|Withdrawal by Subject|58|||
124800437|NCT00191646|448900502|FG001|Overall Study|Withdrawal by Subject|39|||
124800438|NCT00191646|448900501|FG000|Overall Study|Protocol Violation|5|||
124800439|NCT00191646|448900502|FG001|Overall Study|Protocol Violation|7|||
124800440|NCT00191646|448900501|FG000|Overall Study|Death|6|||
124800441|NCT00191646|448900502|FG001|Overall Study|Death|8|||
124800442|NCT00191646|448900501|FG000|Overall Study|Other|33|||
124800443|NCT00191646|448900502|FG001|Overall Study|Other|34|||
124800444|NCT00191646|448900501|FG000|Overall Study|Missing Data|18|||
124800445|NCT00191646|448900502|FG001|Overall Study|Missing Data|11|||
124800446|NCT05211284|448900507|FG000|Overall Study|Study Terminated|3|||
124800447|NCT05211284|448900508|FG001|Overall Study|Study Terminated|1|||
124800448|NCT00739596|448900509|FG000|Overall Study|Adverse Event|12|||
124800449|NCT00739596|448900510|FG001|Overall Study|Adverse Event|6|||
124800450|NCT00739596|448900509|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
124800451|NCT00739596|448900510|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
124800452|NCT00739596|448900509|FG000|Overall Study|Patient Withdrew Consent|8|||
124800453|NCT00739596|448900510|FG001|Overall Study|Patient Withdrew Consent|8|||
124800454|NCT00739596|448900509|FG000|Overall Study|Lost to Follow-up|0|||
124800455|NCT00739596|448900510|FG001|Overall Study|Lost to Follow-up|2|||
124800456|NCT00739596|448900509|FG000|Overall Study|Protocol Deviation|1|||
124800457|NCT00739596|448900510|FG001|Overall Study|Protocol Deviation|1|||
124800458|NCT00908011|448900515|FG000|Overall Study|Withdrawal by Subject|2|||
124800459|NCT00908011|448900516|FG001|Overall Study|Withdrawal by Subject|2|||
124800460|NCT02567552|448900517|FG000|Overall Study|Adverse Event|0|||
124800461|NCT02567552|448900518|FG001|Overall Study|Adverse Event|1|||
124800462|NCT04669535|448900522|FG000|Overall Study|Death|1|||
124800463|NCT04669535|448900523|FG001|Overall Study|Death|1|||
124800464|NCT04669535|448900524|FG002|Overall Study|Death|0|||
124800465|NCT04669535|448900525|FG003|Overall Study|Death|0|||
124800466|NCT02452697|448900526|FG000|Overall Study|Physician Decision|4|||
124800467|NCT02452697|448900527|FG001|Overall Study|Physician Decision|4|||
124800468|NCT02452697|448900528|FG002|Overall Study|Physician Decision|3|||
124800469|NCT02452697|448900529|FG003|Overall Study|Physician Decision|2|||
124800470|NCT02452697|448900526|FG000|Overall Study|Withdrawal by Subject|1|||
124800471|NCT02452697|448900527|FG001|Overall Study|Withdrawal by Subject|0|||
124800472|NCT02452697|448900528|FG002|Overall Study|Withdrawal by Subject|0|||
124800473|NCT02452697|448900529|FG003|Overall Study|Withdrawal by Subject|0|||
124800474|NCT02452697|448900526|FG000|Overall Study|still in follow-up|2|||
124800475|NCT02452697|448900527|FG001|Overall Study|still in follow-up|2|||
124800476|NCT02452697|448900528|FG002|Overall Study|still in follow-up|1|||
124800477|NCT02452697|448900529|FG003|Overall Study|still in follow-up|3|||
124800478|NCT03552965|448900531|FG000|Overall Study|Death|1|||
124800479|NCT03552965|448900532|FG001|Overall Study|Death|1|||
124800480|NCT03552965|448900531|FG000|Overall Study|Lost to Follow-up|1|||
124800481|NCT03552965|448900532|FG001|Overall Study|Lost to Follow-up|1|||
124800482|NCT03552965|448900531|FG000|Overall Study|Physician Decision|1|||
124800483|NCT03552965|448900532|FG001|Overall Study|Physician Decision|1|||
124800484|NCT03552965|448900531|FG000|Overall Study|Withdrawal by Subject|0|||
124800485|NCT03552965|448900532|FG001|Overall Study|Withdrawal by Subject|2|||
124800486|NCT03552965|448900531|FG000|Overall Study|Continuation not in patient best interest|1|||
124800487|NCT03552965|448900532|FG001|Overall Study|Continuation not in patient best interest|0|||
124800488|NCT03552965|448900531|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
124800489|NCT03552965|448900532|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
124800490|NCT02477696|448900533|FG000|Overall Study|Death|89|||
124800491|NCT02477696|448900534|FG001|Overall Study|Death|106|||
124800492|NCT02477696|448900533|FG000|Overall Study|Lost to Follow-up|7|||
124800493|NCT02477696|448900534|FG001|Overall Study|Lost to Follow-up|5|||
124800494|NCT02477696|448900533|FG000|Overall Study|Withdrawal by Subject|37|||
124800495|NCT02477696|448900534|FG001|Overall Study|Withdrawal by Subject|34|||
124800496|NCT02477696|448900533|FG000|Overall Study|Physician Decision|7|||
124800497|NCT02477696|448900534|FG001|Overall Study|Physician Decision|9|||
124800498|NCT02477696|448900533|FG000|Overall Study|Study terminated by sponsor|103|||
124800499|NCT02477696|448900534|FG001|Overall Study|Study terminated by sponsor|99|||
124800500|NCT02477696|448900533|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
124800501|NCT02477696|448900534|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
124800502|NCT02477696|448900533|FG000|Overall Study|Missing/Unknown|2|||
124800503|NCT02477696|448900534|FG001|Overall Study|Missing/Unknown|0|||
124800504|NCT05419908|448900536|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
124800505|NCT05419908|448900537|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
124800506|NCT05419908|448900536|FG000|Overall Study|Serious Adverse Event|0|||
124800507|NCT05419908|448900537|FG001|Overall Study|Serious Adverse Event|2|||
124800508|NCT05419908|448900536|FG000|Overall Study|Withdrawal by Subject|2|||
124800509|NCT05419908|448900537|FG001|Overall Study|Withdrawal by Subject|0|||
124630557|NCT02019472|448264833|FG001|Overall Study|Adverse Event|23|||
124630558|NCT02019472|448264834|FG002|Overall Study|Adverse Event|17|||
124630559|NCT02019472|448264832|FG000|Overall Study|Death|0|||
124630560|NCT02019472|448264833|FG001|Overall Study|Death|1|||
124630561|NCT02019472|448264834|FG002|Overall Study|Death|1|||
124630562|NCT02019472|448264832|FG000|Overall Study|Lack of Efficacy|7|||
124630563|NCT02019472|448264833|FG001|Overall Study|Lack of Efficacy|4|||
124630564|NCT02019472|448264834|FG002|Overall Study|Lack of Efficacy|4|||
124630565|NCT02019472|448264832|FG000|Overall Study|Lost to Follow-up|0|||
124630566|NCT02019472|448264833|FG001|Overall Study|Lost to Follow-up|2|||
124630567|NCT02019472|448264834|FG002|Overall Study|Lost to Follow-up|1|||
124630568|NCT02019472|448264832|FG000|Overall Study|Physician Decision|1|||
124800510|NCT05419908|448900536|FG000|Overall Study|Miscellaneous|1|||
124800511|NCT05419908|448900537|FG001|Overall Study|Miscellaneous|1|||
124800512|NCT00085709|448901719|FG000|Overall Study|Adverse Event|8|||
124800513|NCT00085709|448901720|FG001|Overall Study|Adverse Event|0|||
124800514|NCT00085709|448901719|FG000|Overall Study|Death|8|||
124630569|NCT02019472|448264833|FG001|Overall Study|Physician Decision|2|||
124800515|NCT00085709|448901720|FG001|Overall Study|Death|2|||
124800516|NCT00085709|448901719|FG000|Overall Study|Refusal unrelated to adverse events|1|||
124800517|NCT00085709|448901720|FG001|Overall Study|Refusal unrelated to adverse events|2|||
124800518|NCT00085709|448901719|FG000|Overall Study|Progression|3|||
124630570|NCT02019472|448264834|FG002|Overall Study|Physician Decision|0|||
124630571|NCT02019472|448264832|FG000|Overall Study|Pregnancy|1|||
124630572|NCT02019472|448264833|FG001|Overall Study|Pregnancy|2|||
124630573|NCT02019472|448264834|FG002|Overall Study|Pregnancy|2|||
124630574|NCT02019472|448264832|FG000|Overall Study|Withdrawal by Subject|11|||
124630575|NCT02019472|448264833|FG001|Overall Study|Withdrawal by Subject|10|||
124630576|NCT02019472|448264834|FG002|Overall Study|Withdrawal by Subject|11|||
124630577|NCT02019472|448264832|FG000|Overall Study|Other|3|||
124630578|NCT02019472|448264833|FG001|Overall Study|Other|8|||
124630579|NCT02019472|448264834|FG002|Overall Study|Other|6|||
124630580|NCT03192488|448264835|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
124630581|NCT03192488|448264836|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
124630582|NCT03192488|448264837|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
124630583|NCT03192488|448264838|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
124630584|NCT03192488|448264839|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
124630585|NCT03192488|448264840|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
124630586|NCT03192488|448264835|FG000|Third Intervention (d1)|Adverse Event|0|||
124630587|NCT03192488|448264836|FG001|Third Intervention (d1)|Adverse Event|0|||
124630588|NCT03192488|448264837|FG002|Third Intervention (d1)|Adverse Event|0|||
124630589|NCT03192488|448264838|FG003|Third Intervention (d1)|Adverse Event|0|||
124630590|NCT03192488|448264839|FG004|Third Intervention (d1)|Adverse Event|1|||
124630591|NCT03192488|448264840|FG005|Third Intervention (d1)|Adverse Event|0|||
124630592|NCT01401361|448264841|FG000|Overall Study|Withdrawal by Subject|16|||
124630593|NCT01401361|448264841|FG000|Overall Study|Lack of Efficacy|6|||
124630594|NCT01401361|448264841|FG000|Overall Study|Physician Decision|1|||
124630595|NCT01401361|448264841|FG000|Overall Study|Lost to Follow-up|3|||
124630596|NCT01401361|448264841|FG000|Overall Study|Subject/family decision post procedure|2|||
124630597|NCT02547428|448264852|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
124630598|NCT02547428|448264853|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
124630599|NCT02547428|448264852|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
124630600|NCT02547428|448264853|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
124630601|NCT02547428|448264852|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
124630602|NCT02547428|448264853|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
124630603|NCT02547428|448264852|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
124630604|NCT02547428|448264853|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
124630605|NCT02547428|448264852|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
124630606|NCT02547428|448264853|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
124630607|NCT02547428|448264852|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
124630608|NCT02547428|448264853|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
124630609|NCT02547428|448264852|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
124630610|NCT02547428|448264853|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
124630611|NCT02547428|448264852|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
124630612|NCT02547428|448264853|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
124630613|NCT01479465|448264854|FG000|Overall Study|Disease Progression|9|||
124630614|NCT01479465|448264855|FG001|Overall Study|Disease Progression|61|||
124630615|NCT01479465|448264856|FG002|Overall Study|Disease Progression|65|||
124630616|NCT01479465|448264857|FG003|Overall Study|Disease Progression|70|||
124630617|NCT01479465|448264854|FG000|Overall Study|Study Discontinued by Sponsor|0|||
124630618|NCT01479465|448264855|FG001|Overall Study|Study Discontinued by Sponsor|7|||
124630619|NCT01479465|448264856|FG002|Overall Study|Study Discontinued by Sponsor|5|||
124630620|NCT01479465|448264857|FG003|Overall Study|Study Discontinued by Sponsor|3|||
124630621|NCT01479465|448264854|FG000|Overall Study|Adverse Event|0|||
124630622|NCT01479465|448264855|FG001|Overall Study|Adverse Event|3|||
124630623|NCT01479465|448264856|FG002|Overall Study|Adverse Event|6|||
124630624|NCT01479465|448264857|FG003|Overall Study|Adverse Event|4|||
124630625|NCT01479465|448264854|FG000|Overall Study|Investigator Discretion|1|||
124630626|NCT01479465|448264855|FG001|Overall Study|Investigator Discretion|4|||
124630627|NCT01479465|448264856|FG002|Overall Study|Investigator Discretion|2|||
124630628|NCT01479465|448264857|FG003|Overall Study|Investigator Discretion|4|||
124630629|NCT01479465|448264854|FG000|Overall Study|Subject Request|1|||
124630630|NCT01479465|448264855|FG001|Overall Study|Subject Request|3|||
124630631|NCT01479465|448264856|FG002|Overall Study|Subject Request|4|||
124630632|NCT01479465|448264857|FG003|Overall Study|Subject Request|2|||
124630633|NCT01479465|448264854|FG000|Overall Study|Subject Withdrew Consent|0|||
124630634|NCT01479465|448264855|FG001|Overall Study|Subject Withdrew Consent|5|||
124630635|NCT01479465|448264856|FG002|Overall Study|Subject Withdrew Consent|2|||
124630636|NCT01479465|448264857|FG003|Overall Study|Subject Withdrew Consent|1|||
124630637|NCT01479465|448264854|FG000|Overall Study|Protocol Violation|0|||
124630638|NCT01479465|448264855|FG001|Overall Study|Protocol Violation|1|||
124630639|NCT01479465|448264856|FG002|Overall Study|Protocol Violation|1|||
124630640|NCT01479465|448264857|FG003|Overall Study|Protocol Violation|0|||
124800519|NCT00085709|448901720|FG001|Overall Study|Progression|4|||
124800520|NCT00085709|448901719|FG000|Overall Study|Not protocol specified|12|||
124630641|NCT01479465|448264854|FG000|Overall Study|Death|0|||
124630642|NCT01479465|448264855|FG001|Overall Study|Death|0|||
124630643|NCT01479465|448264856|FG002|Overall Study|Death|0|||
124630644|NCT01479465|448264857|FG003|Overall Study|Death|1|||
124630645|NCT01479465|448264854|FG000|Overall Study|Lost to Follow-up|0|||
124630646|NCT01479465|448264855|FG001|Overall Study|Lost to Follow-up|0|||
124630647|NCT01479465|448264856|FG002|Overall Study|Lost to Follow-up|1|||
124630648|NCT01479465|448264857|FG003|Overall Study|Lost to Follow-up|0|||
124630649|NCT04429503|448264862|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
124630650|NCT04429503|448264863|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
124630651|NCT04429503|448264864|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
124630652|NCT04429503|448264865|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
124630653|NCT04429503|448264866|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
124630654|NCT04429503|448264867|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
124630655|NCT04429503|448264862|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
124630656|NCT04429503|448264863|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
124630657|NCT04429503|448264864|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
124630658|NCT04429503|448264865|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
124630659|NCT04429503|448264866|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
124630660|NCT04429503|448264867|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
124630661|NCT04429503|448264862|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
124630662|NCT04429503|448264863|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
124630663|NCT04429503|448264864|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
124630664|NCT04429503|448264865|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
124630665|NCT04429503|448264866|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
124630666|NCT04429503|448264867|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
124630667|NCT04429503|448264862|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
124630668|NCT04429503|448264863|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
124630669|NCT04429503|448264864|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
124630670|NCT04429503|448264865|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
124630671|NCT04429503|448264866|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
124630672|NCT04429503|448264867|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
124630673|NCT04429503|448264862|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
124630674|NCT04429503|448264863|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
124630675|NCT04429503|448264864|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
124630676|NCT04429503|448264865|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
124630677|NCT04429503|448264866|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
124630678|NCT04429503|448264867|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
124630679|NCT04429503|448264862|FG000|Main Study (Up to Wk 96)|Death|9|||
124630680|NCT04429503|448264863|FG001|Main Study (Up to Wk 96)|Death|18|||
124630681|NCT04429503|448264864|FG002|Main Study (Up to Wk 96)|Death|5|||
124630682|NCT04429503|448264865|FG003|Main Study (Up to Wk 96)|Death|0|||
124630683|NCT04429503|448264866|FG004|Main Study (Up to Wk 96)|Death|0|||
124630684|NCT04429503|448264867|FG005|Main Study (Up to Wk 96)|Death|0|||
124630685|NCT04429503|448264862|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
124630686|NCT04429503|448264863|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
124630687|NCT04429503|448264864|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
124630688|NCT04429503|448264865|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
124630689|NCT04429503|448264866|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
124630690|NCT04429503|448264867|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
124630691|NCT04429503|448264862|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
124630692|NCT04429503|448264863|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
124630693|NCT04429503|448264864|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
124630694|NCT04429503|448264865|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
124630695|NCT04429503|448264866|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
124630696|NCT04429503|448264867|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
124630697|NCT04429503|448264862|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
124630698|NCT04429503|448264863|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
124630699|NCT04429503|448264864|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
124630700|NCT04429503|448264865|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
124630701|NCT04429503|448264866|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
124630702|NCT04429503|448264867|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
124630703|NCT04429503|448264862|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
124630704|NCT04429503|448264863|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
124630705|NCT04429503|448264864|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
124630706|NCT04429503|448264865|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
124630707|NCT04429503|448264866|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
124630708|NCT04429503|448264867|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
124630709|NCT04429503|448264862|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
124630710|NCT04429503|448264863|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
124630711|NCT04429503|448264864|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
124630712|NCT04429503|448264865|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
124630713|NCT04429503|448264866|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
124630714|NCT04429503|448264867|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
124630715|NCT04429503|448264862|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
124630716|NCT04429503|448264863|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
124630717|NCT04429503|448264864|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
124630718|NCT04429503|448264865|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
124630719|NCT04429503|448264866|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
124630720|NCT04429503|448264867|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
124630721|NCT05516108|448264868|FG000|Overall Study|Time Commitment|3|||
124630722|NCT05516108|448264869|FG001|Overall Study|Time Commitment|1|||
124630723|NCT05516108|448264868|FG000|Overall Study|Reason Unknown|2|||
124630724|NCT05516108|448264869|FG001|Overall Study|Reason Unknown|4|||
124630725|NCT00709995|448264870|FG000|Overall Study|Adverse Event|4|||
124630726|NCT00709995|448264871|FG001|Overall Study|Adverse Event|2|||
124630727|NCT00709995|448264870|FG000|Overall Study|Withdrawal by Subject|1|||
124630728|NCT00709995|448264871|FG001|Overall Study|Withdrawal by Subject|3|||
124630729|NCT01641640|448264872|FG000|Overall Study|Enrolled but not treated|1|||
124630730|NCT01641640|448264872|FG000|Overall Study|Efficacy failure|29|||
124630731|NCT01641640|448264872|FG000|Overall Study|Lost to Follow-up|3|||
124630732|NCT01641640|448264872|FG000|Overall Study|Withdrawal by Subject|2|||
124630733|NCT01641640|448264872|FG000|Overall Study|Adverse Event|1|||
124630734|NCT01234350|448264873|FG000|Overall Study|Adverse Event|277|||
124630735|NCT01234350|448264874|FG001|Overall Study|Adverse Event|92|||
124630736|NCT01234350|448264873|FG000|Overall Study|Withdrawal by Subject|61|||
124630737|NCT01234350|448264874|FG001|Overall Study|Withdrawal by Subject|36|||
124630738|NCT01234350|448264873|FG000|Overall Study|Lost to Follow-up|115|||
124630739|NCT01234350|448264874|FG001|Overall Study|Lost to Follow-up|47|||
124630740|NCT01234350|448264873|FG000|Overall Study|Covers a diverse set of reasons|234|||
124630741|NCT01234350|448264874|FG001|Overall Study|Covers a diverse set of reasons|92|||
124630742|NCT01836471|448264877|FG000|Overall Study|Pregnancy|1|||
124630743|NCT01836471|448264878|FG001|Overall Study|Pregnancy|0|||
124630744|NCT01836471|448264879|FG002|Overall Study|Pregnancy|0|||
124630745|NCT01836471|448264880|FG003|Overall Study|Pregnancy|0|||
124630746|NCT01836471|448264881|FG004|Overall Study|Pregnancy|0|||
124630747|NCT01836471|448264877|FG000|Overall Study|Withdrawal by Subject|3|||
124630748|NCT01836471|448264878|FG001|Overall Study|Withdrawal by Subject|4|||
124630749|NCT01836471|448264879|FG002|Overall Study|Withdrawal by Subject|1|||
124630750|NCT01836471|448264880|FG003|Overall Study|Withdrawal by Subject|0|||
124630751|NCT01836471|448264881|FG004|Overall Study|Withdrawal by Subject|2|||
124630752|NCT01836471|448264877|FG000|Overall Study|Physician Decision|0|||
124630753|NCT01836471|448264878|FG001|Overall Study|Physician Decision|1|||
124630754|NCT01836471|448264879|FG002|Overall Study|Physician Decision|0|||
124630755|NCT01836471|448264880|FG003|Overall Study|Physician Decision|0|||
124630756|NCT01836471|448264881|FG004|Overall Study|Physician Decision|0|||
124630757|NCT01836471|448264877|FG000|Overall Study|Lost to Follow-up|0|||
124630758|NCT01836471|448264878|FG001|Overall Study|Lost to Follow-up|0|||
124630759|NCT01836471|448264879|FG002|Overall Study|Lost to Follow-up|0|||
124630760|NCT01836471|448264880|FG003|Overall Study|Lost to Follow-up|1|||
124630761|NCT01836471|448264881|FG004|Overall Study|Lost to Follow-up|1|||
124630762|NCT01836471|448264877|FG000|Overall Study|Adverse Event|6|||
124630763|NCT01836471|448264878|FG001|Overall Study|Adverse Event|3|||
124630764|NCT01836471|448264879|FG002|Overall Study|Adverse Event|1|||
124630765|NCT01836471|448264880|FG003|Overall Study|Adverse Event|1|||
124630766|NCT01836471|448264881|FG004|Overall Study|Adverse Event|2|||
124630767|NCT01836471|448264877|FG000|Overall Study|Non compliance with tx|1|||
124630768|NCT01836471|448264878|FG001|Overall Study|Non compliance with tx|1|||
124630769|NCT01836471|448264879|FG002|Overall Study|Non compliance with tx|0|||
124630770|NCT01836471|448264880|FG003|Overall Study|Non compliance with tx|0|||
124630771|NCT01836471|448264881|FG004|Overall Study|Non compliance with tx|0|||
124630772|NCT02059135|448264882|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
124630773|NCT02059135|448264883|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
124630774|NCT02059135|448264882|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
124800521|NCT00085709|448901720|FG001|Overall Study|Not protocol specified|22|||
124630775|NCT02059135|448264883|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
124630776|NCT02059135|448264882|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
124630777|NCT02059135|448264883|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
124630778|NCT02059135|448264882|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
124630779|NCT02059135|448264883|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
124630780|NCT02059135|448264882|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
124630781|NCT02059135|448264883|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
124630782|NCT02059135|448264882|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
124630783|NCT02059135|448264883|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
124630784|NCT02059135|448264882|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
124630785|NCT02059135|448264883|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
124630786|NCT02059135|448264882|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
124630787|NCT02059135|448264883|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
124630788|NCT03335475|448264884|FG000|Overall Study|Did not wear accelerometer|4|||
124630789|NCT03335475|448264885|FG001|Overall Study|Did not wear accelerometer|0|||
124630790|NCT03335475|448264884|FG000|Overall Study|Withdrawal by Subject|0|||
124630791|NCT03335475|448264885|FG001|Overall Study|Withdrawal by Subject|1|||
124630792|NCT02755103|448264886|FG000|Overall Study|Lost to Follow-up|17|||
124630793|NCT02755103|448264887|FG001|Overall Study|Lost to Follow-up|15|||
124630794|NCT02755103|448264886|FG000|Overall Study|Death|0|||
124630795|NCT02755103|448264887|FG001|Overall Study|Death|1|||
124630796|NCT02755103|448264886|FG000|Overall Study|Physician Decision|0|||
124630797|NCT02755103|448264887|FG001|Overall Study|Physician Decision|1|||
124630798|NCT02755103|448264886|FG000|Overall Study|Pregnancy|0|||
124630799|NCT02755103|448264887|FG001|Overall Study|Pregnancy|1|||
124630800|NCT02755103|448264886|FG000|Overall Study|Withdrawal by Subject|3|||
124630801|NCT02755103|448264887|FG001|Overall Study|Withdrawal by Subject|0|||
124630802|NCT00658723|448264890|FG000|Overall Study|Lost to Follow-up|0|||
124630803|NCT00658723|448264891|FG001|Overall Study|Lost to Follow-up|2|||
124630804|NCT00658723|448264892|FG002|Overall Study|Lost to Follow-up|2|||
124630805|NCT00658723|448264890|FG000|Overall Study|Death|2|||
124630806|NCT00658723|448264891|FG001|Overall Study|Death|1|||
124630807|NCT00658723|448264892|FG002|Overall Study|Death|4|||
124630808|NCT00658723|448264890|FG000|Overall Study|Scheduling Issue|1|||
124630809|NCT00658723|448264891|FG001|Overall Study|Scheduling Issue|1|||
124630810|NCT00658723|448264892|FG002|Overall Study|Scheduling Issue|0|||
124630811|NCT00658723|448264890|FG000|Overall Study|Withdrawal by Subject|1|||
124630812|NCT00658723|448264891|FG001|Overall Study|Withdrawal by Subject|0|||
124630813|NCT00658723|448264892|FG002|Overall Study|Withdrawal by Subject|1|||
124630814|NCT05921903|448264893|FG000|Overall Study|Unsolicited non-SAE|0|||
124630815|NCT05921903|448264894|FG001|Overall Study|Unsolicited non-SAE|1|||
124630816|NCT05921903|448264895|FG002|Overall Study|Unsolicited non-SAE|0|||
124630817|NCT05921903|448264893|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
124630818|NCT05921903|448264894|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
124630819|NCT05921903|448264895|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
124630820|NCT05921903|448264893|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
124630821|NCT05921903|448264894|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
124630822|NCT05921903|448264895|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
124630823|NCT03305848|448264896|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
124630824|NCT03305848|448264896|FG000|Overall Study|Physician Decision|2|||
124630825|NCT00789854|448264897|FG000|Overall Study|Adverse Event|28|||
124630826|NCT00789854|448264898|FG001|Overall Study|Adverse Event|23|||
124630827|NCT00789854|448264899|FG002|Overall Study|Adverse Event|18|||
124630828|NCT00789854|448264897|FG000|Overall Study|Lost to Follow-up|1|||
124630829|NCT00789854|448264898|FG001|Overall Study|Lost to Follow-up|1|||
124630830|NCT00789854|448264899|FG002|Overall Study|Lost to Follow-up|4|||
124630831|NCT00789854|448264897|FG000|Overall Study|Withdrawal by Subject|9|||
124630832|NCT00789854|448264898|FG001|Overall Study|Withdrawal by Subject|6|||
124630833|NCT00789854|448264899|FG002|Overall Study|Withdrawal by Subject|17|||
124630834|NCT00789854|448264897|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
124630835|NCT00789854|448264898|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
124630836|NCT00789854|448264899|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
124630837|NCT00789854|448264897|FG000|Overall Study|Severe non-compliance to the protocol|3|||
124630838|NCT00789854|448264898|FG001|Overall Study|Severe non-compliance to the protocol|0|||
124630839|NCT00789854|448264899|FG002|Overall Study|Severe non-compliance to the protocol|0|||
124630840|NCT00789854|448264897|FG000|Overall Study|Safety reasons|0|||
124630841|NCT00789854|448264898|FG001|Overall Study|Safety reasons|0|||
124630842|NCT00789854|448264899|FG002|Overall Study|Safety reasons|2|||
124630843|NCT00789854|448264897|FG000|Overall Study|Other|6|||
124630844|NCT00789854|448264898|FG001|Overall Study|Other|0|||
124630845|NCT00789854|448264899|FG002|Overall Study|Other|5|||
124630846|NCT05366010|448264900|FG000|Overall Study|Withdrawal by Subject|1|||
124630847|NCT05366010|448264900|FG000|Overall Study|Protocol Violation|1|||
124630848|NCT05366010|448264900|FG000|Overall Study|Lost to Follow-up|2|||
124630849|NCT05366010|448264900|FG000|Overall Study|Screen Failure|2|||
124630850|NCT02224157|448264901|FG000|Overall Study|Severe non-compliance to protocol|2|||
124630851|NCT02224157|448264902|FG001|Overall Study|Severe non-compliance to protocol|2|||
124630852|NCT02224157|448264901|FG000|Overall Study|Other|13|||
124630853|NCT02224157|448264902|FG001|Overall Study|Other|10|||
124630854|NCT02224157|448264901|FG000|Overall Study|Subject decision|58|||
124630855|NCT02224157|448264902|FG001|Overall Study|Subject decision|50|||
124630856|NCT02224157|448264901|FG000|Overall Study|Prematurely closed site|4|||
124630857|NCT02224157|448264902|FG001|Overall Study|Prematurely closed site|2|||
124630858|NCT02224157|448264901|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
124630859|NCT02224157|448264902|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
124630860|NCT02224157|448264901|FG000|Overall Study|Lost to Follow-up|27|||
124630861|NCT02224157|448264902|FG001|Overall Study|Lost to Follow-up|35|||
124630862|NCT02224157|448264901|FG000|Overall Study|Death|1|||
124630863|NCT02224157|448264902|FG001|Overall Study|Death|1|||
124630864|NCT02224157|448264901|FG000|Overall Study|Adverse Event|1|||
124630865|NCT02224157|448264902|FG001|Overall Study|Adverse Event|3|||
124630866|NCT05906628|448264905|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
124630867|NCT05906628|448264906|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
124630868|NCT05906628|448264905|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
124630869|NCT05906628|448264906|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
124630870|NCT05906628|448264905|FG000|16-Week DBVC Period|Protocol Violation|4|||
124630871|NCT05906628|448264906|FG001|16-Week DBVC Period|Protocol Violation|2|||
124630872|NCT05906628|448264905|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
124630873|NCT05906628|448264906|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
124630874|NCT05906628|448264905|FG000|16-Week OLE Period|Death|1|||
124630875|NCT05906628|448264906|FG001|16-Week OLE Period|Death|0|||
124630876|NCT05906628|448264905|FG000|16-Week OLE Period|Lost to Follow-up|1|||
124630877|NCT05906628|448264906|FG001|16-Week OLE Period|Lost to Follow-up|1|||
124630878|NCT05906628|448264905|FG000|16-Week OLE Period|Protocol Violation|0|||
124630879|NCT05906628|448264906|FG001|16-Week OLE Period|Protocol Violation|1|||
124630880|NCT05906628|448264905|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
124630881|NCT05906628|448264906|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
124630882|NCT01060072|448264907|FG000|Overall Study|Adverse Event|1|||
124630883|NCT01060072|448264908|FG001|Overall Study|Adverse Event|1|||
124630884|NCT01060072|448264907|FG000|Overall Study|Physician Decision|0|||
124630885|NCT01060072|448264908|FG001|Overall Study|Physician Decision|2|||
124630886|NCT01060072|448264907|FG000|Overall Study|Protocol Violation|0|||
124630887|NCT01060072|448264908|FG001|Overall Study|Protocol Violation|1|||
124630888|NCT01060072|448264907|FG000|Overall Study|Acute cholecystitis|1|||
124630889|NCT01060072|448264908|FG001|Overall Study|Acute cholecystitis|0|||
124630890|NCT01060072|448264907|FG000|Overall Study|Excluded Medications|0|||
124630891|NCT01060072|448264908|FG001|Overall Study|Excluded Medications|1|||
124630892|NCT01707290|448264909|FG000|Overall Study|Adverse event (AE)|1|||
124630893|NCT01707290|448264910|FG001|Overall Study|Adverse event (AE)|0|||
124630894|NCT01707290|448264909|FG000|Overall Study|Physician Decision|1|||
124630895|NCT01707290|448264910|FG001|Overall Study|Physician Decision|0|||
124630896|NCT01707290|448264909|FG000|Overall Study|Lost to Follow-up|3|||
124630897|NCT01707290|448264910|FG001|Overall Study|Lost to Follow-up|0|||
124630898|NCT01707290|448264909|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
124630899|NCT01707290|448264910|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
124630900|NCT01707290|448264909|FG000|Overall Study|Commercial drug available|60|||
124630901|NCT01707290|448264910|FG001|Overall Study|Commercial drug available|1|||
124630902|NCT01707290|448264909|FG000|Overall Study|Other unspecified|17|||
124630903|NCT01707290|448264910|FG001|Overall Study|Other unspecified|0|||
124630904|NCT04837196|448264911|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
124630905|NCT04837196|448264912|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
124630906|NCT04837196|448264913|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
124630907|NCT04837196|448264914|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
124630908|NCT04837196|448264915|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
124630909|NCT04837196|448264911|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
124630910|NCT04837196|448264912|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
124630911|NCT04837196|448264913|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
124630912|NCT04837196|448264914|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
124630913|NCT04837196|448264915|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
124630914|NCT04837196|448264911|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
124630915|NCT04837196|448264912|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
124630916|NCT04837196|448264913|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
124630917|NCT04837196|448264914|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
124630918|NCT04837196|448264915|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
124630919|NCT04837196|448264911|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
124630920|NCT04837196|448264912|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
124630921|NCT04837196|448264913|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
124630922|NCT04837196|448264914|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
124630923|NCT04837196|448264915|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
124630924|NCT04837196|448264911|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
124630925|NCT04837196|448264912|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
124630926|NCT04837196|448264913|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
124630927|NCT04837196|448264914|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
124630928|NCT04837196|448264915|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
124630929|NCT01522456|448264916|FG000|Overall Study|Adverse Event|2|||
124630930|NCT01522456|448264916|FG000|Overall Study|Lost to Follow-up|2|||
124800522|NCT00085709|448901719|FG000|Overall Study|Not eligible|19|||
124800523|NCT00085709|448901720|FG001|Overall Study|Not eligible|19|||
124800524|NCT00085709|448901719|FG000|Overall Study|Withdrawal by Subject|2|||
124800525|NCT00085709|448901720|FG001|Overall Study|Withdrawal by Subject|1|||
124800526|NCT00293215|448901721|FG000|Overall Study|Progressive disease|3|||
124800527|NCT00293215|448901722|FG001|Overall Study|Progressive disease|1|||
124800528|NCT00293215|448901721|FG000|Overall Study|Adverse Event|2|||
124800529|NCT00293215|448901722|FG001|Overall Study|Adverse Event|2|||
124800530|NCT01229371|448901725|FG000|Overall Study|Withdrawal by Subject|0|||
124800531|NCT01229371|448901726|FG001|Overall Study|Withdrawal by Subject|1|||
124800532|NCT01229371|448901727|FG002|Overall Study|Withdrawal by Subject|0|||
124800533|NCT01229371|448901728|FG003|Overall Study|Withdrawal by Subject|0|||
124800534|NCT04622735|448901729|FG000|Overall Study|Lost to Follow-up|1|||
124800535|NCT04622735|448901730|FG001|Overall Study|Lost to Follow-up|2|||
124800536|NCT04622735|448901731|FG002|Overall Study|Lost to Follow-up|1|||
124800537|NCT04622735|448901729|FG000|Overall Study|Adverse Event|0|||
124800538|NCT04622735|448901730|FG001|Overall Study|Adverse Event|0|||
124800539|NCT04622735|448901731|FG002|Overall Study|Adverse Event|1|||
124800540|NCT04622735|448901729|FG000|Overall Study|Protocol Violation|1|||
124800541|NCT04622735|448901730|FG001|Overall Study|Protocol Violation|0|||
124800542|NCT04622735|448901731|FG002|Overall Study|Protocol Violation|0|||
124800543|NCT05314478|448901732|FG000|Overall Study|Physician Decision|1|||
124800544|NCT02923427|448901733|FG000|Overall Study|convert to laparatomy|2|||
124800545|NCT02923427|448901734|FG001|Overall Study|convert to laparatomy|2|||
124800546|NCT02923427|448901733|FG000|Overall Study|destaturation|1|||
124800547|NCT02923427|448901734|FG001|Overall Study|destaturation|0|||
124800548|NCT02923427|448901733|FG000|Overall Study|can not replace LMA|1|||
124800549|NCT02923427|448901734|FG001|Overall Study|can not replace LMA|0|||
124800550|NCT01325623|448901735|FG000|Overall Study|Withdrawal by Subject|3|||
124800551|NCT01229397|448901736|FG000|Overall Study|Withdrawal by Subject|3|||
124800552|NCT01229397|448901737|FG001|Overall Study|Withdrawal by Subject|3|||
124800553|NCT01229397|448901736|FG000|Overall Study|Lost to Follow-up|7|||
124800554|NCT01229397|448901737|FG001|Overall Study|Lost to Follow-up|6|||
124800555|NCT01229397|448901736|FG000|Overall Study|Migrated/moved from study area|1|||
124800556|NCT01229397|448901737|FG001|Overall Study|Migrated/moved from study area|0|||
124800557|NCT02694523|448901738|FG000|Part A|Adverse Event|7|||
124800558|NCT02694523|448901739|FG001|Part A|Adverse Event|3|||
124800559|NCT02694523|448901740|FG002|Part A|Adverse Event|0|||
124800560|NCT02694523|448901741|FG003|Part A|Adverse Event|0|||
124800561|NCT02694523|448901742|FG004|Part A|Adverse Event|0|||
124800562|NCT02694523|448901743|FG005|Part A|Adverse Event|0|||
124800563|NCT02694523|448901744|FG006|Part A|Adverse Event|0|||
124800564|NCT02694523|448901738|FG000|Part A|Protocol Violation|1|||
124800565|NCT02694523|448901739|FG001|Part A|Protocol Violation|0|||
124800566|NCT02694523|448901740|FG002|Part A|Protocol Violation|0|||
124800567|NCT02694523|448901741|FG003|Part A|Protocol Violation|0|||
124800568|NCT02694523|448901742|FG004|Part A|Protocol Violation|0|||
124800569|NCT02694523|448901743|FG005|Part A|Protocol Violation|0|||
124800570|NCT02694523|448901744|FG006|Part A|Protocol Violation|0|||
124800571|NCT02694523|448901738|FG000|Part A|Lost to Follow-up|1|||
124800572|NCT02694523|448901739|FG001|Part A|Lost to Follow-up|2|||
124800573|NCT02694523|448901740|FG002|Part A|Lost to Follow-up|0|||
124800574|NCT02694523|448901741|FG003|Part A|Lost to Follow-up|0|||
124800575|NCT02694523|448901742|FG004|Part A|Lost to Follow-up|0|||
124800576|NCT02694523|448901743|FG005|Part A|Lost to Follow-up|0|||
124800577|NCT02694523|448901744|FG006|Part A|Lost to Follow-up|0|||
124800578|NCT02694523|448901738|FG000|Part A|Withdrawal by Subject|3|||
124800579|NCT02694523|448901739|FG001|Part A|Withdrawal by Subject|1|||
124800580|NCT02694523|448901740|FG002|Part A|Withdrawal by Subject|0|||
124800581|NCT02694523|448901741|FG003|Part A|Withdrawal by Subject|0|||
124800582|NCT02694523|448901742|FG004|Part A|Withdrawal by Subject|0|||
124800583|NCT02694523|448901743|FG005|Part A|Withdrawal by Subject|0|||
124630931|NCT01522456|448264916|FG000|Overall Study|Withdrawal by Subject|2|||
124800584|NCT02694523|448901744|FG006|Part A|Withdrawal by Subject|0|||
124800585|NCT02694523|448901738|FG000|Part A|Other|1|||
124800586|NCT02694523|448901739|FG001|Part A|Other|1|||
124800587|NCT02694523|448901740|FG002|Part A|Other|0|||
124800588|NCT02694523|448901741|FG003|Part A|Other|0|||
124800589|NCT02694523|448901742|FG004|Part A|Other|0|||
124800590|NCT02694523|448901743|FG005|Part A|Other|0|||
124800591|NCT02694523|448901744|FG006|Part A|Other|0|||
124800592|NCT02694523|448901738|FG000|Part B|Adverse Event|0|||
124800593|NCT02694523|448901739|FG001|Part B|Adverse Event|0|||
124800594|NCT02694523|448901740|FG002|Part B|Adverse Event|7|||
124800595|NCT02694523|448901741|FG003|Part B|Adverse Event|1|||
124800596|NCT02694523|448901742|FG004|Part B|Adverse Event|1|||
124800597|NCT02694523|448901743|FG005|Part B|Adverse Event|2|||
124800598|NCT02694523|448901744|FG006|Part B|Adverse Event|0|||
124630932|NCT01522456|448264916|FG000|Overall Study|Pregnancy|1|||
124800599|NCT02694523|448901738|FG000|Part B|Protocol Violation|0|||
124800600|NCT02694523|448901739|FG001|Part B|Protocol Violation|0|||
124800601|NCT02694523|448901740|FG002|Part B|Protocol Violation|1|||
124800602|NCT02694523|448901741|FG003|Part B|Protocol Violation|0|||
124800603|NCT02694523|448901742|FG004|Part B|Protocol Violation|0|||
124800604|NCT02694523|448901743|FG005|Part B|Protocol Violation|0|||
124800605|NCT02694523|448901744|FG006|Part B|Protocol Violation|0|||
124800606|NCT02694523|448901738|FG000|Part B|Lost to Follow-up|0|||
124800607|NCT02694523|448901739|FG001|Part B|Lost to Follow-up|0|||
124800608|NCT02694523|448901740|FG002|Part B|Lost to Follow-up|2|||
124800609|NCT02694523|448901741|FG003|Part B|Lost to Follow-up|3|||
124800610|NCT02694523|448901742|FG004|Part B|Lost to Follow-up|2|||
124800611|NCT02694523|448901743|FG005|Part B|Lost to Follow-up|0|||
124800612|NCT02694523|448901744|FG006|Part B|Lost to Follow-up|1|||
124800613|NCT02694523|448901738|FG000|Part B|Withdrawal by Subject|0|||
124800614|NCT02694523|448901739|FG001|Part B|Withdrawal by Subject|0|||
124800615|NCT02694523|448901740|FG002|Part B|Withdrawal by Subject|9|||
124800616|NCT02694523|448901741|FG003|Part B|Withdrawal by Subject|0|||
124630933|NCT01522456|448264916|FG000|Overall Study|Tolerability Assessment|1|||
124630934|NCT03641469|448264917|FG000|Overall Study|Ineligible|2|||
124630935|NCT03641469|448264917|FG000|Overall Study|Withdrawal by Subject|5|||
124630936|NCT03641469|448264917|FG000|Overall Study|Physician Decision|1|||
124630937|NCT03641469|448264917|FG000|Overall Study|Protocol Violation|1|||
124630938|NCT03641469|448264917|FG000|Overall Study|Lost to Follow-up|2|||
124630939|NCT05479435|448264918|FG000|Overall Study|Withdrawal by Subject|1|||
124630940|NCT05479435|448264919|FG001|Overall Study|Withdrawal by Subject|0|||
124630941|NCT05479435|448264920|FG002|Overall Study|Withdrawal by Subject|0|||
124800617|NCT02694523|448901742|FG004|Part B|Withdrawal by Subject|1|||
124800618|NCT02694523|448901743|FG005|Part B|Withdrawal by Subject|3|||
124800619|NCT02694523|448901744|FG006|Part B|Withdrawal by Subject|0|||
124800620|NCT02694523|448901738|FG000|Part B|Other|0|||
124800621|NCT02694523|448901739|FG001|Part B|Other|0|||
124800622|NCT02694523|448901740|FG002|Part B|Other|1|||
124800623|NCT02694523|448901741|FG003|Part B|Other|0|||
124800624|NCT02694523|448901742|FG004|Part B|Other|0|||
124800625|NCT02694523|448901743|FG005|Part B|Other|0|||
124800626|NCT02694523|448901744|FG006|Part B|Other|1|||
124800627|NCT05896748|448901745|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
124800628|NCT05896748|448901745|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
124800629|NCT05896748|448901745|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
124800630|NCT05896748|448901745|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
124800631|NCT05896748|448901745|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
124800632|NCT00764504|448901746|FG000|Overall Study|Death|12|||
124800633|NCT00764504|448901747|FG001|Overall Study|Death|6|||
124800634|NCT00764504|448901748|FG002|Overall Study|Death|13|||
124800635|NCT00764504|448901746|FG000|Overall Study|Revision of Device|12|||
124800636|NCT00764504|448901747|FG001|Overall Study|Revision of Device|23|||
124800637|NCT00764504|448901748|FG002|Overall Study|Revision of Device|14|||
124800638|NCT00764504|448901746|FG000|Overall Study|Physician Decision|1|||
124800639|NCT00764504|448901747|FG001|Overall Study|Physician Decision|0|||
124800640|NCT00764504|448901748|FG002|Overall Study|Physician Decision|0|||
124800641|NCT00764504|448901746|FG000|Overall Study|Withdrawal by Subject|1|||
124800642|NCT00764504|448901747|FG001|Overall Study|Withdrawal by Subject|7|||
124800643|NCT00764504|448901748|FG002|Overall Study|Withdrawal by Subject|4|||
124800644|NCT00764504|448901746|FG000|Overall Study|Lost to Follow-up|40|||
124800645|NCT00764504|448901747|FG001|Overall Study|Lost to Follow-up|34|||
124800646|NCT00764504|448901748|FG002|Overall Study|Lost to Follow-up|72|||
124800647|NCT01298193|448901749|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
124800648|NCT01298193|448901749|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
124800649|NCT01298193|448901749|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
124800650|NCT01298193|448901749|FG000|Efficacy Phase (Second Cycle)|Death|1|||
124800651|NCT04010539|448901750|FG000|Overall Study|Withdrawal by Subject|4|||
124800652|NCT04010539|448901751|FG001|Overall Study|Withdrawal by Subject|1|||
124800653|NCT04010539|448901750|FG000|Overall Study|Physician Decision|0|||
124800654|NCT04010539|448901751|FG001|Overall Study|Physician Decision|2|||
124800655|NCT04010539|448901750|FG000|Overall Study|Lost to Follow-up|10|||
124800656|NCT04010539|448901751|FG001|Overall Study|Lost to Follow-up|14|||
124800657|NCT04010539|448901750|FG000|Overall Study|Adverse Event|3|||
124800658|NCT04010539|448901751|FG001|Overall Study|Adverse Event|0|||
124630942|NCT05479435|448264918|FG000|Overall Study|Covid 19|0|||
124800659|NCT04010539|448901750|FG000|Overall Study|Participant Did Not Receive IP|0|||
124800660|NCT04010539|448901751|FG001|Overall Study|Participant Did Not Receive IP|1|||
124800661|NCT04010539|448901750|FG000|Overall Study|Protocol Deviation|0|||
124800662|NCT04010539|448901751|FG001|Overall Study|Protocol Deviation|1|||
124800663|NCT04010539|448901750|FG000|Overall Study|Randomized in Error/ Mistake|2|||
124800664|NCT04010539|448901751|FG001|Overall Study|Randomized in Error/ Mistake|0|||
124800665|NCT04010539|448901750|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
124800666|NCT04010539|448901751|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
124800667|NCT00249288|448901752|FG000|Overall Study|Lost to Follow-up|3|||
124800668|NCT00249288|448901753|FG001|Overall Study|Lost to Follow-up|3|||
124800669|NCT00249288|448901752|FG000|Overall Study|Withdrawal by Subject|2|||
124800670|NCT00249288|448901753|FG001|Overall Study|Withdrawal by Subject|2|||
124800671|NCT03059446|448901754|FG000|Overall Study|Adverse Event|11|||
124630943|NCT05479435|448264919|FG001|Overall Study|Covid 19|0|||
124630944|NCT05479435|448264920|FG002|Overall Study|Covid 19|2|||
124800672|NCT03059446|448901754|FG000|Overall Study|Withdrawal of Consent|16|||
124800673|NCT03059446|448901754|FG000|Overall Study|Lost to Follow-up|3|||
124800674|NCT03059446|448901754|FG000|Overall Study|Protocol Violation|1|||
124800675|NCT03059446|448901754|FG000|Overall Study|Study Terminated by Sponsor|131|||
124800676|NCT03059446|448901754|FG000|Overall Study|Reason not Specified|5|||
124800677|NCT05298306|448901761|FG000|Overall Study|Physician Decision|0|||
124800678|NCT05298306|448901762|FG001|Overall Study|Physician Decision|0|||
124800679|NCT05298306|448901763|FG002|Overall Study|Physician Decision|0|||
124800680|NCT05298306|448901764|FG003|Overall Study|Physician Decision|1|||
124800681|NCT05298306|448901765|FG004|Overall Study|Physician Decision|0|||
124630945|NCT02562235|448267159|FG000|Overall Study|Adverse Event|3|||
124630946|NCT05016960|448267160|FG000|Overall Study|Withdrawal by Subject|1|||
124630947|NCT05016960|448267161|FG001|Overall Study|Withdrawal by Subject|9|||
124630948|NCT04796961|448267162|FG000|Overall Study|Lost to Follow-up|10|||
124630949|NCT04796961|448267162|FG000|Overall Study|Withdrawal by Subject|3|||
124630950|NCT04796961|448267162|FG000|Overall Study|Left Organization|10|||
124630951|NCT02513160|448267166|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
124630952|NCT02513160|448267167|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
124630953|NCT02513160|448267168|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
124630954|NCT02513160|448267169|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
124630955|NCT02513160|448267166|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
124630956|NCT02513160|448267167|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
124630957|NCT02513160|448267168|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
124630958|NCT02513160|448267169|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
124630959|NCT02513160|448267166|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
124630960|NCT02513160|448267167|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
124630961|NCT02513160|448267168|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
124630962|NCT02513160|448267169|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
124630963|NCT02513160|448267166|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
124630964|NCT02513160|448267167|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
124630965|NCT02513160|448267168|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
124630966|NCT02513160|448267169|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
124630967|NCT02513160|448267166|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
124630968|NCT02513160|448267167|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
124630969|NCT02513160|448267168|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
124630970|NCT02513160|448267169|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
124630971|NCT02513160|448267166|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
124630972|NCT02513160|448267167|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
124630973|NCT02513160|448267168|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
124630974|NCT02513160|448267169|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
124630975|NCT02513160|448267166|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
124630976|NCT02513160|448267167|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
124630977|NCT02513160|448267168|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
124630978|NCT02513160|448267169|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
124630979|NCT02513160|448267166|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
124630980|NCT02513160|448267167|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
124630981|NCT02513160|448267168|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
124630982|NCT02513160|448267169|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
124630983|NCT02513160|448267166|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
124800682|NCT05298306|448901766|FG005|Overall Study|Physician Decision|0|||
124800683|NCT03538431|448901770|FG000|Overall Study|Physician Decision|0|||
124800684|NCT03538431|448901771|FG001|Overall Study|Physician Decision|1|||
124800685|NCT03538431|448901770|FG000|Overall Study|Withdrawal by Subject|1|||
124800686|NCT03538431|448901771|FG001|Overall Study|Withdrawal by Subject|0|||
124800687|NCT00620464|448901772|FG000|Overall Study|Adverse Event|15|||
124800688|NCT00620464|448901773|FG001|Overall Study|Adverse Event|17|||
124800689|NCT00620464|448901772|FG000|Overall Study|Lost to Follow-up|1|||
124800690|NCT00620464|448901773|FG001|Overall Study|Lost to Follow-up|1|||
124800691|NCT00620464|448901772|FG000|Overall Study|Planning Pregnancy|1|||
124800692|NCT00620464|448901773|FG001|Overall Study|Planning Pregnancy|4|||
124800693|NCT00620464|448901772|FG000|Overall Study|Personal|2|||
124800694|NCT00620464|448901773|FG001|Overall Study|Personal|2|||
124800695|NCT00620464|448901772|FG000|Overall Study|Used prohibited medication|1|||
124800696|NCT00620464|448901773|FG001|Overall Study|Used prohibited medication|0|||
124800697|NCT00986479|448901776|FG000|Period 1|Improved mood|1|||
124800698|NCT00986479|448901777|FG001|Period 1|Improved mood|0|||
124800699|NCT00986479|448901776|FG000|Period 1|Administrative reasons|1|||
124800700|NCT00986479|448901777|FG001|Period 1|Administrative reasons|0|||
124800701|NCT00771316|448901782|FG000|Overall Study|Adverse Event|0|||
124800702|NCT00771316|448901783|FG001|Overall Study|Adverse Event|1|||
124800703|NCT00771316|448901782|FG000|Overall Study|Patient withdrew consent|1|||
124800704|NCT00771316|448901783|FG001|Overall Study|Patient withdrew consent|0|||
124800705|NCT00771316|448901782|FG000|Overall Study|Discontinued due to early termination|1|||
124800706|NCT00771316|448901783|FG001|Overall Study|Discontinued due to early termination|0|||
124800707|NCT02027376|448901784|FG000|Overall Study|Death|1|||
124800708|NCT02027376|448901785|FG001|Overall Study|Death|0|||
124800709|NCT02027376|448901786|FG002|Overall Study|Death|0|||
124800710|NCT00880165|448901795|FG000|Overall Study|Withdrawal by Subject|27|||
124800711|NCT00880165|448901796|FG001|Overall Study|Withdrawal by Subject|23|||
124800712|NCT00880165|448901795|FG000|Overall Study|Not diagnosed with OSA|14|||
124800713|NCT00880165|448901796|FG001|Overall Study|Not diagnosed with OSA|8|||
124800714|NCT00880165|448901795|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
124800715|NCT00880165|448901796|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
124800716|NCT00880165|448901795|FG000|Overall Study|Lost to follow|9|||
124800717|NCT00880165|448901796|FG001|Overall Study|Lost to follow|15|||
124800718|NCT00667602|448901797|FG000|Overall Study|Withdrawal by Subject|4|||
124800719|NCT00667602|448901798|FG001|Overall Study|Withdrawal by Subject|9|||
124800720|NCT00667602|448901799|FG002|Overall Study|Withdrawal by Subject|10|||
124800721|NCT00667602|448901797|FG000|Overall Study|Lost to Follow-up|4|||
124800722|NCT00667602|448901798|FG001|Overall Study|Lost to Follow-up|5|||
124800723|NCT00667602|448901799|FG002|Overall Study|Lost to Follow-up|6|||
124800724|NCT00667602|448901797|FG000|Overall Study|Administrative reason|0|||
124800725|NCT00667602|448901798|FG001|Overall Study|Administrative reason|0|||
124800726|NCT00667602|448901799|FG002|Overall Study|Administrative reason|2|||
124800727|NCT00667602|448901797|FG000|Overall Study|Protocol Violation|0|||
124800728|NCT00667602|448901798|FG001|Overall Study|Protocol Violation|1|||
124800729|NCT00667602|448901799|FG002|Overall Study|Protocol Violation|0|||
124800730|NCT00644228|448901804|FG000|Randomization & Eligibility|Ineligible|31|||
124800731|NCT00644228|448901805|FG001|Randomization & Eligibility|Ineligible|21|||
124800732|NCT00644228|448901804|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
124800733|NCT00644228|448901805|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
124800734|NCT00644228|448901804|FG000|Randomization & Eligibility|Invalid Consent|0|||
124800735|NCT00644228|448901805|FG001|Randomization & Eligibility|Invalid Consent|1|||
124800736|NCT00644228|448901804|FG000|Induction Therapy|Adverse Event|22|||
124800737|NCT00644228|448901805|FG001|Induction Therapy|Adverse Event|55|||
124800738|NCT00644228|448901804|FG000|Induction Therapy|Withdrawal by Subject|10|||
124800739|NCT00644228|448901805|FG001|Induction Therapy|Withdrawal by Subject|3|||
124800740|NCT00644228|448901804|FG000|Induction Therapy|Progression/Relapse|24|||
124800741|NCT00644228|448901805|FG001|Induction Therapy|Progression/Relapse|12|||
124800742|NCT00644228|448901804|FG000|Induction Therapy|Death|3|||
124800743|NCT00644228|448901805|FG001|Induction Therapy|Death|7|||
124800744|NCT00644228|448901804|FG000|Induction Therapy|Not Protocol-Specified|24|||
124800745|NCT00644228|448901805|FG001|Induction Therapy|Not Protocol-Specified|28|||
124800746|NCT00644228|448901804|FG000|Maintenance|Adverse Event|27|||
124800747|NCT00644228|448901805|FG001|Maintenance|Adverse Event|31|||
124800748|NCT00644228|448901804|FG000|Maintenance|Withdrawal by Subject|6|||
124800749|NCT00644228|448901805|FG001|Maintenance|Withdrawal by Subject|4|||
124800750|NCT00644228|448901804|FG000|Maintenance|Progression/Relapse|67|||
124800751|NCT00644228|448901805|FG001|Maintenance|Progression/Relapse|42|||
124800752|NCT00644228|448901804|FG000|Maintenance|Death|3|||
124800753|NCT00644228|448901805|FG001|Maintenance|Death|3|||
124800754|NCT00644228|448901804|FG000|Maintenance|Not Protocol-Specified|14|||
124800755|NCT00644228|448901805|FG001|Maintenance|Not Protocol-Specified|15|||
124800756|NCT00644228|448901804|FG000|Maintenance|On Treatment|26|||
124800757|NCT00644228|448901805|FG001|Maintenance|On Treatment|40|||
124800758|NCT00760084|448901806|FG000|Overall Study|Physician Decision|5|||
124800759|NCT00760084|448901806|FG000|Overall Study|Withdrawal by Subject|2|||
124800760|NCT00760084|448901806|FG000|Overall Study|Progressive Disease|3|||
124800761|NCT00973349|448901807|FG000|Overall Study|Adverse Event|0|||
124800762|NCT00973349|448901808|FG001|Overall Study|Adverse Event|0|||
124800763|NCT00973349|448901809|FG002|Overall Study|Adverse Event|0|||
124800764|NCT00973349|448901810|FG003|Overall Study|Adverse Event|0|||
124800765|NCT00973349|448901811|FG004|Overall Study|Adverse Event|1|||
124800766|NCT00973349|448901812|FG005|Overall Study|Adverse Event|0|||
124630984|NCT02513160|448267167|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
124630985|NCT02513160|448267168|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
124630986|NCT02513160|448267169|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
124800767|NCT00973349|448901813|FG006|Overall Study|Adverse Event|0|||
124800768|NCT00973349|448901814|FG007|Overall Study|Adverse Event|0|||
124800769|NCT00973349|448901815|FG008|Overall Study|Adverse Event|1|||
124800770|NCT00973349|448901816|FG009|Overall Study|Adverse Event|0|||
124800771|NCT00973349|448901817|FG010|Overall Study|Adverse Event|0|||
124800772|NCT00973349|448901818|FG011|Overall Study|Adverse Event|0|||
124800773|NCT00973349|448901819|FG012|Overall Study|Adverse Event|0|||
124800774|NCT00973349|448901820|FG013|Overall Study|Adverse Event|0|||
124800775|NCT00973349|448901821|FG014|Overall Study|Adverse Event|1|||
124800776|NCT00973349|448901822|FG015|Overall Study|Adverse Event|0|||
124800777|NCT00973349|448901807|FG000|Overall Study|Withdrawal by Subject|1|||
124800778|NCT00973349|448901808|FG001|Overall Study|Withdrawal by Subject|2|||
124800779|NCT00973349|448901809|FG002|Overall Study|Withdrawal by Subject|2|||
124800780|NCT00973349|448901810|FG003|Overall Study|Withdrawal by Subject|3|||
124800781|NCT00973349|448901811|FG004|Overall Study|Withdrawal by Subject|2|||
124630987|NCT02513160|448267166|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
124630988|NCT02513160|448267167|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
124630989|NCT02513160|448267168|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
124630990|NCT02513160|448267169|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
124630991|NCT02513160|448267166|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
124630992|NCT02513160|448267167|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
124630993|NCT02513160|448267168|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
124752421|NCT02300259|448716745|FG001|Period 2|Withdrawal by Subject|0|||
124752422|NCT02300259|448716746|FG002|Period 2|Withdrawal by Subject|1|||
124752423|NCT01424501|448716747|FG000|Overall Study|Withdrawal by Subject|1|||
124752424|NCT01424501|448716748|FG001|Overall Study|Withdrawal by Subject|0|||
124752425|NCT01424501|448716749|FG002|Overall Study|Withdrawal by Subject|1|||
124752426|NCT01424501|448716750|FG003|Overall Study|Withdrawal by Subject|0|||
124752427|NCT01424501|448716751|FG004|Overall Study|Withdrawal by Subject|0|||
124752428|NCT01424501|448716752|FG005|Overall Study|Withdrawal by Subject|0|||
124752429|NCT01424501|448716747|FG000|Overall Study|Lost to Follow-up|0|||
124752430|NCT01424501|448716748|FG001|Overall Study|Lost to Follow-up|1|||
124752431|NCT01424501|448716749|FG002|Overall Study|Lost to Follow-up|1|||
124752432|NCT01424501|448716750|FG003|Overall Study|Lost to Follow-up|0|||
124752433|NCT01424501|448716751|FG004|Overall Study|Lost to Follow-up|0|||
124752434|NCT01424501|448716752|FG005|Overall Study|Lost to Follow-up|0|||
124752435|NCT01980095|448716753|FG000|Overall Study|Lost to Follow-up|6|||
124752436|NCT01980095|448716754|FG001|Overall Study|Lost to Follow-up|7|||
124752437|NCT01980095|448716753|FG000|Overall Study|Withdrawal by Subject|2|||
124752438|NCT01980095|448716754|FG001|Overall Study|Withdrawal by Subject|3|||
124752439|NCT01980095|448716753|FG000|Overall Study|Poor compliance|5|||
124752440|NCT01980095|448716754|FG001|Overall Study|Poor compliance|0|||
124752441|NCT01980095|448716753|FG000|Overall Study|Safety issue|0|||
124752442|NCT01980095|448716754|FG001|Overall Study|Safety issue|1|||
124752443|NCT01980095|448716753|FG000|Overall Study|Study drug discontinued|1|||
124752444|NCT01980095|448716754|FG001|Overall Study|Study drug discontinued|0|||
124752445|NCT01980095|448716753|FG000|Overall Study|Randomized by mistake|1|||
124752446|NCT01980095|448716754|FG001|Overall Study|Randomized by mistake|0|||
124752447|NCT04737278|448716755|FG000|Overall Study|Lost to Follow-up|1|||
124752448|NCT04737278|448716756|FG001|Overall Study|Lost to Follow-up|1|||
124752449|NCT04737278|448716755|FG000|Overall Study|Withdrawal by Subject|1|||
124752450|NCT04737278|448716756|FG001|Overall Study|Withdrawal by Subject|0|||
124752451|NCT04737278|448716755|FG000|Overall Study|Protocol Violation|1|||
124752452|NCT04737278|448716756|FG001|Overall Study|Protocol Violation|1|||
124752453|NCT04737278|448716755|FG000|Overall Study|failure to complete questionnaire|1|||
124752454|NCT04737278|448716756|FG001|Overall Study|failure to complete questionnaire|1|||
124752455|NCT02737475|448716757|FG000|Overall Study|Other reasons|0|||
124752456|NCT02737475|448716758|FG001|Overall Study|Other reasons|0|||
124752457|NCT02737475|448716759|FG002|Overall Study|Other reasons|0|||
124752458|NCT02737475|448716760|FG003|Overall Study|Other reasons|0|||
124752459|NCT02737475|448716761|FG004|Overall Study|Other reasons|1|||
124752460|NCT02737475|448716762|FG005|Overall Study|Other reasons|1|||
124752461|NCT02737475|448716763|FG006|Overall Study|Other reasons|0|||
124752462|NCT02737475|448716764|FG007|Overall Study|Other reasons|0|||
124752463|NCT02737475|448716765|FG008|Overall Study|Other reasons|1|||
124752464|NCT02737475|448716766|FG009|Overall Study|Other reasons|0|||
124752465|NCT02737475|448716767|FG010|Overall Study|Other reasons|1|||
124752466|NCT02737475|448716768|FG011|Overall Study|Other reasons|0|||
124752467|NCT02737475|448716769|FG012|Overall Study|Other reasons|0|||
124752468|NCT02737475|448716770|FG013|Overall Study|Other reasons|0|||
124752469|NCT02737475|448716771|FG014|Overall Study|Other reasons|0|||
124752470|NCT02737475|448716772|FG015|Overall Study|Other reasons|0|||
124752471|NCT02737475|448716773|FG016|Overall Study|Other reasons|0|||
124752472|NCT02737475|448716774|FG017|Overall Study|Other reasons|0|||
124752473|NCT02737475|448716775|FG018|Overall Study|Other reasons|0|||
124752474|NCT02737475|448716776|FG019|Overall Study|Other reasons|0|||
124752475|NCT02737475|448716777|FG020|Overall Study|Other reasons|0|||
124752476|NCT02737475|448716778|FG021|Overall Study|Other reasons|1|||
124752477|NCT02737475|448716779|FG022|Overall Study|Other reasons|0|||
124752478|NCT02737475|448716780|FG023|Overall Study|Other reasons|1|||
124752479|NCT02737475|448716781|FG024|Overall Study|Other reasons|1|||
124752480|NCT02737475|448716782|FG025|Overall Study|Other reasons|1|||
124752481|NCT02737475|448716783|FG026|Overall Study|Other reasons|0|||
124752482|NCT02737475|448716757|FG000|Overall Study|Death|1|||
124752483|NCT02737475|448716758|FG001|Overall Study|Death|0|||
124752484|NCT02737475|448716759|FG002|Overall Study|Death|0|||
124752485|NCT02737475|448716760|FG003|Overall Study|Death|1|||
124752486|NCT02737475|448716761|FG004|Overall Study|Death|0|||
124800782|NCT00973349|448901812|FG005|Overall Study|Withdrawal by Subject|0|||
124800783|NCT00973349|448901813|FG006|Overall Study|Withdrawal by Subject|2|||
124800784|NCT00973349|448901814|FG007|Overall Study|Withdrawal by Subject|2|||
124800785|NCT00973349|448901815|FG008|Overall Study|Withdrawal by Subject|0|||
124800786|NCT00973349|448901816|FG009|Overall Study|Withdrawal by Subject|2|||
124800787|NCT00973349|448901817|FG010|Overall Study|Withdrawal by Subject|0|||
124800788|NCT00973349|448901818|FG011|Overall Study|Withdrawal by Subject|1|||
124800789|NCT00973349|448901819|FG012|Overall Study|Withdrawal by Subject|0|||
124800790|NCT00973349|448901820|FG013|Overall Study|Withdrawal by Subject|0|||
124800791|NCT00973349|448901821|FG014|Overall Study|Withdrawal by Subject|0|||
124800792|NCT00973349|448901822|FG015|Overall Study|Withdrawal by Subject|0|||
124630994|NCT02513160|448267169|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
124630995|NCT02513160|448267166|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
124630996|NCT02513160|448267167|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
124630997|NCT02513160|448267168|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
124630998|NCT02513160|448267169|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
124630999|NCT02844543|448267170|FG000|Overall Study|Withdrawal by Subject|4|||
124631000|NCT02844543|448267170|FG000|Overall Study|Did not meet eligibility criteria|1|||
124631001|NCT04710576|448267176|FG000|Overall Study|Participants still in the study|73|||
124631002|NCT04710576|448267177|FG001|Overall Study|Participants still in the study|70|||
124631003|NCT04710576|448267178|FG002|Overall Study|Participants still in the study|60|||
124631004|NCT04710576|448267176|FG000|Overall Study|Death|2|||
124631005|NCT04710576|448267177|FG001|Overall Study|Death|7|||
124631006|NCT04710576|448267178|FG002|Overall Study|Death|12|||
124631007|NCT04710576|448267176|FG000|Overall Study|Withdrawal by Subject|4|||
124631008|NCT04710576|448267177|FG001|Overall Study|Withdrawal by Subject|3|||
124631009|NCT04710576|448267178|FG002|Overall Study|Withdrawal by Subject|7|||
124631010|NCT04710576|448267176|FG000|Overall Study|Sponsor decision|1|||
124631011|NCT04710576|448267177|FG001|Overall Study|Sponsor decision|0|||
124631012|NCT04710576|448267178|FG002|Overall Study|Sponsor decision|0|||
124631013|NCT04581824|448267179|FG000|Overall Study|Lost to Follow-up|1|||
124631014|NCT04581824|448267180|FG001|Overall Study|Lost to Follow-up|0|||
124631015|NCT04581824|448267179|FG000|Overall Study|Withdrawal by Subject|2|||
124631016|NCT04581824|448267180|FG001|Overall Study|Withdrawal by Subject|7|||
124631017|NCT04581824|448267179|FG000|Overall Study|Study terminated by sponsor|37|||
124631018|NCT04581824|448267180|FG001|Overall Study|Study terminated by sponsor|23|||
124631019|NCT04796909|448267181|FG000|Overall Study|Withdrawal by Subject|1|||
124631020|NCT04796909|448267182|FG001|Overall Study|Withdrawal by Subject|1|||
124631021|NCT03879135|448267183|FG000|Overall Study|Physician Decision|0|||
124631022|NCT03879135|448267184|FG001|Overall Study|Physician Decision|0|||
124631023|NCT03879135|448267185|FG002|Overall Study|Physician Decision|0|||
124631024|NCT03879135|448267186|FG003|Overall Study|Physician Decision|1|||
124631025|NCT03879135|448267187|FG004|Overall Study|Physician Decision|0|||
124631026|NCT03879135|448267188|FG005|Overall Study|Physician Decision|0|||
124631027|NCT03879135|448267183|FG000|Overall Study|Withdrawal by Subject|0|||
124631028|NCT03879135|448267184|FG001|Overall Study|Withdrawal by Subject|0|||
124631029|NCT03879135|448267185|FG002|Overall Study|Withdrawal by Subject|0|||
124631030|NCT03879135|448267186|FG003|Overall Study|Withdrawal by Subject|0|||
124631031|NCT03879135|448267187|FG004|Overall Study|Withdrawal by Subject|0|||
124631032|NCT03879135|448267188|FG005|Overall Study|Withdrawal by Subject|1|||
124631033|NCT03879135|448267183|FG000|Overall Study|Site Closed by Sponsor|0|||
124631034|NCT03879135|448267184|FG001|Overall Study|Site Closed by Sponsor|0|||
124631035|NCT03879135|448267185|FG002|Overall Study|Site Closed by Sponsor|0|||
124631036|NCT03879135|448267186|FG003|Overall Study|Site Closed by Sponsor|1|||
124631037|NCT03879135|448267187|FG004|Overall Study|Site Closed by Sponsor|1|||
124631038|NCT03879135|448267188|FG005|Overall Study|Site Closed by Sponsor|0|||
124631039|NCT04162847|448267189|FG000|Overall Study|Withdrawal by Subject|7|||
124631040|NCT04162847|448267190|FG001|Overall Study|Withdrawal by Subject|1|||
124631041|NCT03428958|448267191|FG000|Overall Study|Adverse Event|0|||
124631042|NCT03428958|448267192|FG001|Overall Study|Adverse Event|0|||
124631043|NCT03428958|448267193|FG002|Overall Study|Adverse Event|0|||
124631044|NCT03428958|448267194|FG003|Overall Study|Adverse Event|1|||
124631045|NCT03428958|448267195|FG004|Overall Study|Adverse Event|0|||
124631046|NCT03428958|448267196|FG005|Overall Study|Adverse Event|2|||
124631047|NCT03428958|448267197|FG006|Overall Study|Adverse Event|1|||
124631048|NCT03428958|448267198|FG007|Overall Study|Adverse Event|0|||
124631049|NCT03428958|448267199|FG008|Overall Study|Adverse Event|0|||
124631050|NCT03428958|448267200|FG009|Overall Study|Adverse Event|0|||
124800793|NCT00973349|448901807|FG000|Overall Study|Lost to Follow-up|3|||
124800794|NCT00973349|448901808|FG001|Overall Study|Lost to Follow-up|1|||
124800795|NCT00973349|448901809|FG002|Overall Study|Lost to Follow-up|2|||
124800796|NCT00973349|448901810|FG003|Overall Study|Lost to Follow-up|2|||
124631051|NCT03428958|448267201|FG010|Overall Study|Adverse Event|0|||
124631052|NCT03428958|448267202|FG011|Overall Study|Adverse Event|0|||
124631053|NCT03428958|448267203|FG012|Overall Study|Adverse Event|0|||
124800797|NCT00973349|448901811|FG004|Overall Study|Lost to Follow-up|1|||
124631054|NCT03428958|448267204|FG013|Overall Study|Adverse Event|0|||
124631055|NCT03428958|448267205|FG014|Overall Study|Adverse Event|0|||
124631056|NCT03428958|448267206|FG015|Overall Study|Adverse Event|0|||
124631057|NCT03428958|448267207|FG016|Overall Study|Adverse Event|0|||
124631058|NCT03428958|448267191|FG000|Overall Study|Clinical Progression|2|||
124631059|NCT03428958|448267192|FG001|Overall Study|Clinical Progression|3|||
124631060|NCT03428958|448267193|FG002|Overall Study|Clinical Progression|2|||
124631061|NCT03428958|448267194|FG003|Overall Study|Clinical Progression|1|||
124631062|NCT03428958|448267195|FG004|Overall Study|Clinical Progression|0|||
124631063|NCT03428958|448267196|FG005|Overall Study|Clinical Progression|2|||
124631064|NCT03428958|448267197|FG006|Overall Study|Clinical Progression|0|||
124631065|NCT03428958|448267198|FG007|Overall Study|Clinical Progression|0|||
124631066|NCT03428958|448267199|FG008|Overall Study|Clinical Progression|0|||
124631067|NCT03428958|448267200|FG009|Overall Study|Clinical Progression|0|||
124631068|NCT03428958|448267201|FG010|Overall Study|Clinical Progression|0|||
124631069|NCT03428958|448267202|FG011|Overall Study|Clinical Progression|0|||
124631070|NCT03428958|448267203|FG012|Overall Study|Clinical Progression|0|||
124631071|NCT03428958|448267204|FG013|Overall Study|Clinical Progression|0|||
124631072|NCT03428958|448267205|FG014|Overall Study|Clinical Progression|0|||
124631073|NCT03428958|448267206|FG015|Overall Study|Clinical Progression|0|||
124631074|NCT03428958|448267207|FG016|Overall Study|Clinical Progression|0|||
124631075|NCT03428958|448267191|FG000|Overall Study|Progression per RECIST|6|||
124631076|NCT03428958|448267192|FG001|Overall Study|Progression per RECIST|6|||
124631077|NCT03428958|448267193|FG002|Overall Study|Progression per RECIST|7|||
124631078|NCT03428958|448267194|FG003|Overall Study|Progression per RECIST|4|||
124631079|NCT03428958|448267195|FG004|Overall Study|Progression per RECIST|0|||
124631080|NCT03428958|448267196|FG005|Overall Study|Progression per RECIST|7|||
124631081|NCT03428958|448267197|FG006|Overall Study|Progression per RECIST|8|||
124631082|NCT03428958|448267198|FG007|Overall Study|Progression per RECIST|0|||
124631083|NCT03428958|448267199|FG008|Overall Study|Progression per RECIST|0|||
124631084|NCT03428958|448267200|FG009|Overall Study|Progression per RECIST|0|||
124631085|NCT03428958|448267201|FG010|Overall Study|Progression per RECIST|0|||
124631086|NCT03428958|448267202|FG011|Overall Study|Progression per RECIST|0|||
124631087|NCT03428958|448267203|FG012|Overall Study|Progression per RECIST|1|||
124631088|NCT03428958|448267204|FG013|Overall Study|Progression per RECIST|0|||
124631089|NCT03428958|448267205|FG014|Overall Study|Progression per RECIST|0|||
124631090|NCT03428958|448267206|FG015|Overall Study|Progression per RECIST|0|||
124631091|NCT03428958|448267207|FG016|Overall Study|Progression per RECIST|0|||
124631092|NCT03428958|448267191|FG000|Overall Study|Death|2|||
124631093|NCT03428958|448267192|FG001|Overall Study|Death|2|||
124631094|NCT03428958|448267193|FG002|Overall Study|Death|0|||
124631095|NCT03428958|448267194|FG003|Overall Study|Death|0|||
124631096|NCT03428958|448267195|FG004|Overall Study|Death|0|||
124631097|NCT03428958|448267196|FG005|Overall Study|Death|7|||
124631098|NCT03428958|448267197|FG006|Overall Study|Death|9|||
124631099|NCT03428958|448267198|FG007|Overall Study|Death|6|||
124631100|NCT03428958|448267199|FG008|Overall Study|Death|0|||
124631101|NCT03428958|448267200|FG009|Overall Study|Death|0|||
124631102|NCT03428958|448267201|FG010|Overall Study|Death|3|||
124631103|NCT03428958|448267202|FG011|Overall Study|Death|0|||
124631104|NCT03428958|448267203|FG012|Overall Study|Death|4|||
124631105|NCT03428958|448267204|FG013|Overall Study|Death|0|||
124631106|NCT03428958|448267205|FG014|Overall Study|Death|0|||
124631107|NCT03428958|448267206|FG015|Overall Study|Death|0|||
124631108|NCT03428958|448267207|FG016|Overall Study|Death|0|||
124631109|NCT03428958|448267191|FG000|Overall Study|Lost to Follow-up|0|||
124631110|NCT03428958|448267192|FG001|Overall Study|Lost to Follow-up|0|||
124631111|NCT03428958|448267193|FG002|Overall Study|Lost to Follow-up|0|||
124631112|NCT03428958|448267194|FG003|Overall Study|Lost to Follow-up|0|||
124631113|NCT03428958|448267195|FG004|Overall Study|Lost to Follow-up|0|||
124631114|NCT03428958|448267196|FG005|Overall Study|Lost to Follow-up|1|||
124631115|NCT03428958|448267197|FG006|Overall Study|Lost to Follow-up|1|||
124631116|NCT03428958|448267198|FG007|Overall Study|Lost to Follow-up|0|||
124631117|NCT03428958|448267199|FG008|Overall Study|Lost to Follow-up|0|||
124631118|NCT03428958|448267200|FG009|Overall Study|Lost to Follow-up|0|||
124631119|NCT03428958|448267201|FG010|Overall Study|Lost to Follow-up|0|||
124631120|NCT03428958|448267202|FG011|Overall Study|Lost to Follow-up|0|||
124631121|NCT03428958|448267203|FG012|Overall Study|Lost to Follow-up|0|||
124631122|NCT03428958|448267204|FG013|Overall Study|Lost to Follow-up|0|||
124631123|NCT03428958|448267205|FG014|Overall Study|Lost to Follow-up|0|||
124631124|NCT03428958|448267206|FG015|Overall Study|Lost to Follow-up|0|||
124631125|NCT03428958|448267207|FG016|Overall Study|Lost to Follow-up|0|||
124631126|NCT03428958|448267191|FG000|Overall Study|Physician/Sponsor Decision|1|||
124631127|NCT03428958|448267192|FG001|Overall Study|Physician/Sponsor Decision|0|||
124631128|NCT03428958|448267193|FG002|Overall Study|Physician/Sponsor Decision|1|||
124631129|NCT03428958|448267194|FG003|Overall Study|Physician/Sponsor Decision|0|||
124631130|NCT03428958|448267195|FG004|Overall Study|Physician/Sponsor Decision|0|||
124631131|NCT03428958|448267196|FG005|Overall Study|Physician/Sponsor Decision|2|||
124631132|NCT03428958|448267197|FG006|Overall Study|Physician/Sponsor Decision|2|||
124631133|NCT03428958|448267198|FG007|Overall Study|Physician/Sponsor Decision|2|||
124631134|NCT03428958|448267199|FG008|Overall Study|Physician/Sponsor Decision|0|||
124631135|NCT03428958|448267200|FG009|Overall Study|Physician/Sponsor Decision|0|||
124631136|NCT03428958|448267201|FG010|Overall Study|Physician/Sponsor Decision|2|||
124631137|NCT03428958|448267202|FG011|Overall Study|Physician/Sponsor Decision|0|||
124631138|NCT03428958|448267203|FG012|Overall Study|Physician/Sponsor Decision|4|||
124631139|NCT03428958|448267204|FG013|Overall Study|Physician/Sponsor Decision|0|||
124631140|NCT03428958|448267205|FG014|Overall Study|Physician/Sponsor Decision|0|||
124631141|NCT03428958|448267206|FG015|Overall Study|Physician/Sponsor Decision|0|||
124631142|NCT03428958|448267207|FG016|Overall Study|Physician/Sponsor Decision|0|||
124631143|NCT03428958|448267191|FG000|Overall Study|Withdrawal by Subject|0|||
124631144|NCT03428958|448267192|FG001|Overall Study|Withdrawal by Subject|0|||
124631145|NCT03428958|448267193|FG002|Overall Study|Withdrawal by Subject|2|||
124631146|NCT03428958|448267194|FG003|Overall Study|Withdrawal by Subject|0|||
124631147|NCT03428958|448267195|FG004|Overall Study|Withdrawal by Subject|0|||
124631148|NCT03428958|448267196|FG005|Overall Study|Withdrawal by Subject|2|||
124631149|NCT03428958|448267197|FG006|Overall Study|Withdrawal by Subject|4|||
124631150|NCT03428958|448267198|FG007|Overall Study|Withdrawal by Subject|1|||
124631151|NCT03428958|448267199|FG008|Overall Study|Withdrawal by Subject|0|||
124631152|NCT03428958|448267200|FG009|Overall Study|Withdrawal by Subject|0|||
124631153|NCT03428958|448267201|FG010|Overall Study|Withdrawal by Subject|0|||
124631154|NCT03428958|448267202|FG011|Overall Study|Withdrawal by Subject|0|||
124631155|NCT03428958|448267203|FG012|Overall Study|Withdrawal by Subject|0|||
124631156|NCT03428958|448267204|FG013|Overall Study|Withdrawal by Subject|0|||
124631157|NCT03428958|448267205|FG014|Overall Study|Withdrawal by Subject|0|||
124631158|NCT03428958|448267206|FG015|Overall Study|Withdrawal by Subject|0|||
124631159|NCT03428958|448267207|FG016|Overall Study|Withdrawal by Subject|0|||
124631160|NCT03874117|448267208|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
124631161|NCT03874117|448267209|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
124631162|NCT03874117|448267208|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
124631163|NCT03874117|448267209|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
124631164|NCT03874117|448267208|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
124631165|NCT03874117|448267209|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
124631166|NCT03874117|448267208|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
124631167|NCT03874117|448267209|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
124631168|NCT03874117|448267208|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
124631169|NCT03874117|448267209|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
124631170|NCT01922037|448267210|FG000|Overall Study|Withdrawal by Subject|2|||
124631171|NCT01922037|448267211|FG001|Overall Study|Withdrawal by Subject|44|||
124631172|NCT01922037|448267210|FG000|Overall Study|Adverse Event|1|||
124631173|NCT01922037|448267211|FG001|Overall Study|Adverse Event|7|||
124631174|NCT01922037|448267210|FG000|Overall Study|Death|0|||
124631175|NCT01922037|448267211|FG001|Overall Study|Death|5|||
124631176|NCT01922037|448267210|FG000|Overall Study|Pregnancy|0|||
124631177|NCT01922037|448267211|FG001|Overall Study|Pregnancy|2|||
124631178|NCT01922037|448267210|FG000|Overall Study|Participant non-compliance|4|||
124631179|NCT01922037|448267211|FG001|Overall Study|Participant non-compliance|46|||
124631180|NCT01922037|448267210|FG000|Overall Study|Investigator/Sponsor decision|1|||
124631181|NCT01922037|448267211|FG001|Overall Study|Investigator/Sponsor decision|4|||
124631182|NCT01922037|448267210|FG000|Overall Study|Other unspecified|2|||
124631183|NCT01922037|448267211|FG001|Overall Study|Other unspecified|66|||
124631184|NCT00813150|448267214|FG000|Treatment Period|Adverse Event|16|||
124631185|NCT00813150|448267215|FG001|Treatment Period|Adverse Event|15|||
124631186|NCT00813150|448267214|FG000|Treatment Period|Death|2|||
124631187|NCT00813150|448267215|FG001|Treatment Period|Death|0|||
124631188|NCT00813150|448267214|FG000|Treatment Period|Progressive disease|1|||
124631189|NCT00813150|448267215|FG001|Treatment Period|Progressive disease|0|||
124631190|NCT00813150|448267214|FG000|Treatment Period|Complete response|0|||
124631191|NCT00813150|448267215|FG001|Treatment Period|Complete response|1|||
124631192|NCT00813150|448267214|FG000|Treatment Period|Stable disease|1|||
124631193|NCT00813150|448267215|FG001|Treatment Period|Stable disease|2|||
124631194|NCT00813150|448267214|FG000|Treatment Period|Protocol Violation|3|||
124631195|NCT00813150|448267215|FG001|Treatment Period|Protocol Violation|4|||
124631196|NCT00813150|448267214|FG000|Treatment Period|Withdrawal by Subject|5|||
124631197|NCT00813150|448267215|FG001|Treatment Period|Withdrawal by Subject|3|||
124631198|NCT00813150|448267214|FG000|Treatment Period|Non compliance|0|||
124631199|NCT00813150|448267215|FG001|Treatment Period|Non compliance|1|||
124631200|NCT00813150|448267214|FG000|Treatment Period|Reason not specified|3|||
124631201|NCT00813150|448267215|FG001|Treatment Period|Reason not specified|4|||
124631202|NCT00813150|448267214|FG000|Treatment Period|Data not available|1|||
124631203|NCT00813150|448267215|FG001|Treatment Period|Data not available|2|||
124631204|NCT00813150|448267214|FG000|Long Term Follow-up|Death|0|||
124631205|NCT00813150|448267215|FG001|Long Term Follow-up|Death|4|||
124631206|NCT00813150|448267214|FG000|Long Term Follow-up|Other|0|||
124631207|NCT00813150|448267215|FG001|Long Term Follow-up|Other|3|||
124631208|NCT00813150|448267214|FG000|Long Term Follow-up|Lost to Follow-up|2|||
124631209|NCT00813150|448267215|FG001|Long Term Follow-up|Lost to Follow-up|0|||
124631210|NCT00813150|448267214|FG000|Long Term Follow-up|Progression/Relapse|22|||
124631211|NCT00813150|448267215|FG001|Long Term Follow-up|Progression/Relapse|24|||
124631212|NCT01217112|448267220|FG000|Overall Study|Adverse Event|0|||
124631213|NCT01217112|448267221|FG001|Overall Study|Adverse Event|2|||
124631214|NCT01217112|448267222|FG002|Overall Study|Adverse Event|0|||
124631215|NCT01217112|448267223|FG003|Overall Study|Adverse Event|2|||
124631216|NCT01217112|448267224|FG004|Overall Study|Adverse Event|0|||
124631217|NCT01217112|448267220|FG000|Overall Study|Withdrawal by Subject|0|||
124631218|NCT01217112|448267221|FG001|Overall Study|Withdrawal by Subject|0|||
124631219|NCT01217112|448267222|FG002|Overall Study|Withdrawal by Subject|1|||
124631220|NCT01217112|448267223|FG003|Overall Study|Withdrawal by Subject|0|||
124631221|NCT01217112|448267224|FG004|Overall Study|Withdrawal by Subject|0|||
124631222|NCT01217112|448267220|FG000|Overall Study|Physician Decision|0|||
124631223|NCT01217112|448267221|FG001|Overall Study|Physician Decision|0|||
124631224|NCT01217112|448267222|FG002|Overall Study|Physician Decision|0|||
124631225|NCT01217112|448267223|FG003|Overall Study|Physician Decision|0|||
124631226|NCT01217112|448267224|FG004|Overall Study|Physician Decision|1|||
124631227|NCT02512302|448267225|FG000|Period 1|Adverse Event|0|||
124631228|NCT02512302|448267226|FG001|Period 1|Adverse Event|1|||
124631229|NCT02512302|448267227|FG002|Period 1|Adverse Event|0|||
124631230|NCT02512302|448267228|FG003|Period 1|Adverse Event|0|||
124631231|NCT02512302|448267229|FG004|Period 1|Adverse Event|0|||
124631232|NCT02512302|448267230|FG005|Period 1|Adverse Event|0|||
124631233|NCT02512302|448267231|FG006|Period 1|Adverse Event|0|||
124631234|NCT02512302|448267232|FG007|Period 1|Adverse Event|0|||
124631235|NCT02512302|448267233|FG008|Period 1|Adverse Event|0|||
124631236|NCT02512302|448267234|FG009|Period 1|Adverse Event|0|||
124631237|NCT02512302|448267225|FG000|Period 2|Adverse Event|0|||
124631238|NCT02512302|448267226|FG001|Period 2|Adverse Event|0|||
124631239|NCT02512302|448267227|FG002|Period 2|Adverse Event|0|||
124631240|NCT02512302|448267228|FG003|Period 2|Adverse Event|0|||
124631241|NCT02512302|448267229|FG004|Period 2|Adverse Event|0|||
124631242|NCT02512302|448267230|FG005|Period 2|Adverse Event|0|||
124631243|NCT02512302|448267231|FG006|Period 2|Adverse Event|0|||
124631244|NCT02512302|448267232|FG007|Period 2|Adverse Event|0|||
124631245|NCT02512302|448267233|FG008|Period 2|Adverse Event|0|||
124631246|NCT02512302|448267234|FG009|Period 2|Adverse Event|1|||
124631247|NCT02512302|448267225|FG000|Period 3|Lost to Follow-up|0|||
124631248|NCT02512302|448267226|FG001|Period 3|Lost to Follow-up|0|||
124631249|NCT02512302|448267227|FG002|Period 3|Lost to Follow-up|1|||
124631250|NCT02512302|448267228|FG003|Period 3|Lost to Follow-up|0|||
124631251|NCT02512302|448267229|FG004|Period 3|Lost to Follow-up|0|||
124631252|NCT02512302|448267230|FG005|Period 3|Lost to Follow-up|0|||
124631253|NCT02512302|448267231|FG006|Period 3|Lost to Follow-up|0|||
124631254|NCT02512302|448267232|FG007|Period 3|Lost to Follow-up|0|||
124631255|NCT02512302|448267233|FG008|Period 3|Lost to Follow-up|0|||
124631256|NCT02512302|448267234|FG009|Period 3|Lost to Follow-up|0|||
124631257|NCT02512302|448267225|FG000|Period 4|Adverse Event|0|||
124631258|NCT02512302|448267226|FG001|Period 4|Adverse Event|0|||
124631259|NCT02512302|448267227|FG002|Period 4|Adverse Event|0|||
124631260|NCT02512302|448267228|FG003|Period 4|Adverse Event|0|||
124631261|NCT02512302|448267229|FG004|Period 4|Adverse Event|0|||
124631262|NCT02512302|448267230|FG005|Period 4|Adverse Event|0|||
124631263|NCT02512302|448267231|FG006|Period 4|Adverse Event|1|||
124631264|NCT02512302|448267232|FG007|Period 4|Adverse Event|0|||
124631265|NCT02512302|448267233|FG008|Period 4|Adverse Event|0|||
124631266|NCT02512302|448267234|FG009|Period 4|Adverse Event|0|||
124631267|NCT01002989|448267235|FG000|Overall Study|exclusion criteria, no consent|5|||
124631268|NCT03664232|448267236|FG000|Overall Study|Withdrawal by Subject|0|||
124631269|NCT03664232|448267237|FG001|Overall Study|Withdrawal by Subject|1|||
124631270|NCT03664232|448267238|FG002|Overall Study|Withdrawal by Subject|0|||
124631271|NCT03664232|448267239|FG003|Overall Study|Withdrawal by Subject|1|||
124631272|NCT03664232|448267236|FG000|Overall Study|Adverse Event|0|||
124631273|NCT03664232|448267237|FG001|Overall Study|Adverse Event|0|||
124631274|NCT03664232|448267238|FG002|Overall Study|Adverse Event|1|||
124631275|NCT03664232|448267239|FG003|Overall Study|Adverse Event|0|||
124631276|NCT03664232|448267236|FG000|Overall Study|Other-Non-compliance with study drug|0|||
124631277|NCT03664232|448267237|FG001|Overall Study|Other-Non-compliance with study drug|1|||
124631278|NCT03664232|448267238|FG002|Overall Study|Other-Non-compliance with study drug|0|||
124631279|NCT03664232|448267239|FG003|Overall Study|Other-Non-compliance with study drug|2|||
124631280|NCT03664232|448267236|FG000|Overall Study|Other-Unspecified|0|||
124631281|NCT03664232|448267237|FG001|Overall Study|Other-Unspecified|3|||
124631282|NCT03664232|448267238|FG002|Overall Study|Other-Unspecified|0|||
124631283|NCT03664232|448267239|FG003|Overall Study|Other-Unspecified|1|||
124631284|NCT03664232|448267236|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
124631285|NCT03664232|448267237|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
124631286|NCT03664232|448267238|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
124631287|NCT03664232|448267239|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
124631288|NCT00370552|448267240|FG000|Overall Study|Adverse Event|2|||
124631289|NCT00370552|448267241|FG001|Overall Study|Adverse Event|2|||
124631290|NCT00370552|448267242|FG002|Overall Study|Adverse Event|2|||
124631291|NCT00370552|448267240|FG000|Overall Study|Disease progression|23|||
124631292|NCT00370552|448267241|FG001|Overall Study|Disease progression|23|||
124631293|NCT00370552|448267242|FG002|Overall Study|Disease progression|15|||
124631294|NCT00370552|448267240|FG000|Overall Study|Maximum clinical benefit|3|||
124631295|NCT00370552|448267241|FG001|Overall Study|Maximum clinical benefit|5|||
124631296|NCT00370552|448267242|FG002|Overall Study|Maximum clinical benefit|5|||
124631297|NCT00370552|448267240|FG000|Overall Study|Poor or noncompliance|0|||
124631298|NCT00370552|448267241|FG001|Overall Study|Poor or noncompliance|0|||
124631299|NCT00370552|448267242|FG002|Overall Study|Poor or noncompliance|1|||
124631300|NCT00370552|448267240|FG000|Overall Study|Study drug toxicity|11|||
124631301|NCT00370552|448267241|FG001|Overall Study|Study drug toxicity|8|||
124631302|NCT00370552|448267242|FG002|Overall Study|Study drug toxicity|6|||
124631303|NCT00370552|448267240|FG000|Overall Study|Withdrawal by Subject|2|||
124631304|NCT00370552|448267241|FG001|Overall Study|Withdrawal by Subject|0|||
124631305|NCT00370552|448267242|FG002|Overall Study|Withdrawal by Subject|1|||
124631306|NCT00370552|448267240|FG000|Overall Study|Still on treatment|1|||
124631307|NCT00370552|448267241|FG001|Overall Study|Still on treatment|3|||
124631308|NCT00370552|448267242|FG002|Overall Study|Still on treatment|2|||
124631309|NCT00370552|448267240|FG000|Overall Study|Never treated|1|||
124631310|NCT00370552|448267241|FG001|Overall Study|Never treated|0|||
124631311|NCT00370552|448267242|FG002|Overall Study|Never treated|0|||
124631312|NCT00370552|448267240|FG000|Overall Study|Physician Decision|1|||
124631313|NCT00370552|448267241|FG001|Overall Study|Physician Decision|1|||
124631314|NCT00370552|448267242|FG002|Overall Study|Physician Decision|0|||
124631315|NCT00370552|448267240|FG000|Overall Study|Investigator decision|2|||
124631316|NCT00370552|448267241|FG001|Overall Study|Investigator decision|1|||
124631317|NCT00370552|448267242|FG002|Overall Study|Investigator decision|0|||
124631318|NCT00370552|448267240|FG000|Overall Study|High risk of allergic reaction|0|||
124631319|NCT00370552|448267241|FG001|Overall Study|High risk of allergic reaction|1|||
124631320|NCT00370552|448267242|FG002|Overall Study|High risk of allergic reaction|0|||
124631321|NCT00370552|448267240|FG000|Overall Study|Planned radiation for palliation|0|||
124631322|NCT00370552|448267241|FG001|Overall Study|Planned radiation for palliation|1|||
124631323|NCT00370552|448267242|FG002|Overall Study|Planned radiation for palliation|0|||
124631324|NCT03334435|448267248|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
124631325|NCT03334435|448267249|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
124631326|NCT03334435|448267250|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
124631327|NCT03334435|448267251|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
124631328|NCT03334435|448267252|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
124631329|NCT03334435|448267253|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
124631330|NCT03334435|448267254|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
124631331|NCT03334435|448267255|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
124631332|NCT03334435|448267256|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
124631333|NCT03334435|448267257|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
124631334|NCT03334435|448267258|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
124631335|NCT03334435|448267259|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
124631336|NCT03334435|448267260|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
124631337|NCT03334435|448267261|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
124631338|NCT03334435|448267262|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
124631339|NCT03334435|448267248|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
124631340|NCT03334435|448267249|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
124631341|NCT03334435|448267250|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
124631342|NCT03334435|448267251|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
124631343|NCT03334435|448267252|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
124631344|NCT03334435|448267253|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
124631345|NCT03334435|448267254|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
124631346|NCT03334435|448267255|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
124631347|NCT03334435|448267256|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
124631348|NCT03334435|448267257|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
124631349|NCT03334435|448267258|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
124631350|NCT03334435|448267259|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
124631351|NCT03334435|448267260|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
124631352|NCT03334435|448267261|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
124631353|NCT03334435|448267262|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
124631354|NCT03334435|448267248|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
124631355|NCT03334435|448267249|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
124631356|NCT03334435|448267250|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
124631357|NCT03334435|448267251|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
124631358|NCT03334435|448267252|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
124631359|NCT03334435|448267253|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
124631360|NCT03334435|448267254|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
124631361|NCT03334435|448267255|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
124631362|NCT03334435|448267256|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
124631363|NCT03334435|448267257|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
124631364|NCT03334435|448267258|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
124631365|NCT03334435|448267259|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
124631366|NCT03334435|448267260|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
124631367|NCT03334435|448267261|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
124631368|NCT03334435|448267262|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
124631369|NCT03334435|448267248|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
124631370|NCT03334435|448267249|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
124631371|NCT03334435|448267250|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
124631372|NCT03334435|448267251|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
124631373|NCT03334435|448267252|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
124631374|NCT03334435|448267253|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
124631375|NCT03334435|448267254|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
124631376|NCT03334435|448267255|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
124631377|NCT03334435|448267256|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
124631378|NCT03334435|448267257|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
124631379|NCT03334435|448267258|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
124631380|NCT03334435|448267259|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
124631381|NCT03334435|448267260|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
124631382|NCT03334435|448267261|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
124631383|NCT03334435|448267262|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
124631384|NCT03334435|448267248|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
124631385|NCT03334435|448267249|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
124631386|NCT03334435|448267250|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
124631387|NCT03334435|448267251|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
124631388|NCT03334435|448267252|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
124631389|NCT03334435|448267253|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
124631390|NCT03334435|448267254|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
124631391|NCT03334435|448267255|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
124631392|NCT03334435|448267256|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
124631393|NCT03334435|448267257|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
124631394|NCT03334435|448267258|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
124631395|NCT03334435|448267259|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
124631396|NCT03334435|448267260|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
124631397|NCT03334435|448267261|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
124631398|NCT03334435|448267262|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
124631399|NCT03334435|448267248|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
124631400|NCT03334435|448267249|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
124631401|NCT03334435|448267250|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
124631402|NCT03334435|448267251|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
124631403|NCT03334435|448267252|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
124631404|NCT03334435|448267253|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
124631405|NCT03334435|448267254|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
124631406|NCT03334435|448267255|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
124631407|NCT03334435|448267256|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
124631408|NCT03334435|448267257|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
124631409|NCT03334435|448267258|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
124631410|NCT03334435|448267259|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
124631411|NCT03334435|448267260|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
124631412|NCT03334435|448267261|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
124631413|NCT03334435|448267262|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
124631414|NCT03334435|448267248|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
124631415|NCT03334435|448267249|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
124631416|NCT03334435|448267250|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
124631417|NCT03334435|448267251|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
124631418|NCT03334435|448267252|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
124631419|NCT03334435|448267253|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
124631420|NCT03334435|448267254|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
124631421|NCT03334435|448267255|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
124631422|NCT03334435|448267256|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
124631423|NCT03334435|448267257|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
124631424|NCT03334435|448267258|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
124631425|NCT03334435|448267259|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
124631426|NCT03334435|448267260|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
124631427|NCT03334435|448267261|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
124631428|NCT03334435|448267262|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
124631429|NCT03334435|448267248|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
124631430|NCT03334435|448267249|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
124631431|NCT03334435|448267250|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
124631432|NCT03334435|448267251|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
124631433|NCT03334435|448267252|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
124631434|NCT03334435|448267253|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
124631435|NCT03334435|448267254|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
124631436|NCT03334435|448267255|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
124631437|NCT03334435|448267256|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
124631438|NCT03334435|448267257|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
124631439|NCT03334435|448267258|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
124631440|NCT03334435|448267259|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
124631441|NCT03334435|448267260|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
124631442|NCT03334435|448267261|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
124631443|NCT03334435|448267262|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
124631444|NCT03334435|448267248|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
124631445|NCT03334435|448267249|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
124631446|NCT03334435|448267250|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
124631447|NCT03334435|448267251|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
124631448|NCT03334435|448267252|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
124631449|NCT03334435|448267253|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
124631450|NCT03334435|448267254|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
124631451|NCT03334435|448267255|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
124631452|NCT03334435|448267256|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
124631453|NCT03334435|448267257|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
124631454|NCT03334435|448267258|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
124631455|NCT03334435|448267259|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
124631456|NCT03334435|448267260|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
124631457|NCT03334435|448267261|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
124631458|NCT03334435|448267262|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
124631459|NCT03334435|448267248|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
124631460|NCT03334435|448267249|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
124631461|NCT03334435|448267250|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
124631462|NCT03334435|448267251|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
124631463|NCT03334435|448267252|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
124631464|NCT03334435|448267253|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
124631465|NCT03334435|448267254|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
124631466|NCT03334435|448267255|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
124631467|NCT03334435|448267256|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
124631468|NCT03334435|448267257|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
124631469|NCT03334435|448267258|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
124631470|NCT03334435|448267259|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
124631471|NCT03334435|448267260|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
124631472|NCT03334435|448267261|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
124631473|NCT03334435|448267262|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
124631474|NCT03334435|448267248|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
124631475|NCT03334435|448267249|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
124631476|NCT03334435|448267250|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
124631477|NCT03334435|448267251|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
124631478|NCT03334435|448267252|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
124752487|NCT02737475|448716762|FG005|Overall Study|Death|0|||
124631479|NCT03334435|448267253|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
124631480|NCT03334435|448267254|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
124631481|NCT03334435|448267255|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
124631482|NCT03334435|448267256|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
124631483|NCT03334435|448267257|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
124631484|NCT03334435|448267258|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
124631485|NCT03334435|448267259|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
124631486|NCT03334435|448267260|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
124631487|NCT03334435|448267261|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
124631488|NCT03334435|448267262|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
124631489|NCT03334435|448267248|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
124631490|NCT03334435|448267249|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
124631491|NCT03334435|448267250|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
124631492|NCT03334435|448267251|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
124631493|NCT03334435|448267252|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
124631494|NCT03334435|448267253|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
124631495|NCT03334435|448267254|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
124631496|NCT03334435|448267255|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
124631497|NCT03334435|448267256|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
124631498|NCT03334435|448267257|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
124631499|NCT03334435|448267258|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
124631500|NCT03334435|448267259|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
124631501|NCT03334435|448267260|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
124800798|NCT00973349|448901812|FG005|Overall Study|Lost to Follow-up|3|||
124800799|NCT00973349|448901813|FG006|Overall Study|Lost to Follow-up|0|||
124800800|NCT00973349|448901814|FG007|Overall Study|Lost to Follow-up|1|||
124800801|NCT00973349|448901815|FG008|Overall Study|Lost to Follow-up|2|||
124800802|NCT00973349|448901816|FG009|Overall Study|Lost to Follow-up|1|||
124800803|NCT00973349|448901817|FG010|Overall Study|Lost to Follow-up|0|||
124800804|NCT00973349|448901818|FG011|Overall Study|Lost to Follow-up|1|||
124800805|NCT00973349|448901819|FG012|Overall Study|Lost to Follow-up|0|||
124800806|NCT00973349|448901820|FG013|Overall Study|Lost to Follow-up|0|||
124800807|NCT00973349|448901821|FG014|Overall Study|Lost to Follow-up|0|||
124800808|NCT00973349|448901822|FG015|Overall Study|Lost to Follow-up|1|||
124800809|NCT00973349|448901807|FG000|Overall Study|Inappropriate enrolment|0|||
124800810|NCT00973349|448901808|FG001|Overall Study|Inappropriate enrolment|0|||
124800811|NCT00973349|448901809|FG002|Overall Study|Inappropriate enrolment|1|||
124800812|NCT00973349|448901810|FG003|Overall Study|Inappropriate enrolment|0|||
124800813|NCT00973349|448901811|FG004|Overall Study|Inappropriate enrolment|0|||
124800814|NCT00973349|448901812|FG005|Overall Study|Inappropriate enrolment|0|||
124800815|NCT00973349|448901813|FG006|Overall Study|Inappropriate enrolment|0|||
124800816|NCT00973349|448901814|FG007|Overall Study|Inappropriate enrolment|0|||
124800817|NCT00973349|448901815|FG008|Overall Study|Inappropriate enrolment|0|||
124800818|NCT00973349|448901816|FG009|Overall Study|Inappropriate enrolment|2|||
124800819|NCT00973349|448901817|FG010|Overall Study|Inappropriate enrolment|0|||
124800820|NCT00973349|448901818|FG011|Overall Study|Inappropriate enrolment|0|||
124800821|NCT00973349|448901819|FG012|Overall Study|Inappropriate enrolment|1|||
124800822|NCT00973349|448901820|FG013|Overall Study|Inappropriate enrolment|0|||
124800823|NCT00973349|448901821|FG014|Overall Study|Inappropriate enrolment|1|||
124800824|NCT00973349|448901822|FG015|Overall Study|Inappropriate enrolment|1|||
124800825|NCT00973349|448901807|FG000|Overall Study|Protocol Violation|0|||
124800826|NCT00973349|448901808|FG001|Overall Study|Protocol Violation|0|||
124800827|NCT00973349|448901809|FG002|Overall Study|Protocol Violation|0|||
124800828|NCT00973349|448901810|FG003|Overall Study|Protocol Violation|0|||
124800829|NCT00973349|448901811|FG004|Overall Study|Protocol Violation|0|||
124800830|NCT00973349|448901812|FG005|Overall Study|Protocol Violation|0|||
124800831|NCT00973349|448901813|FG006|Overall Study|Protocol Violation|0|||
124800832|NCT00973349|448901814|FG007|Overall Study|Protocol Violation|0|||
124800833|NCT00973349|448901815|FG008|Overall Study|Protocol Violation|1|||
124800834|NCT00973349|448901816|FG009|Overall Study|Protocol Violation|0|||
124800835|NCT00973349|448901817|FG010|Overall Study|Protocol Violation|0|||
124800836|NCT00973349|448901818|FG011|Overall Study|Protocol Violation|0|||
124800837|NCT00973349|448901819|FG012|Overall Study|Protocol Violation|0|||
124631502|NCT03334435|448267261|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
124800838|NCT00973349|448901820|FG013|Overall Study|Protocol Violation|0|||
124800839|NCT00973349|448901821|FG014|Overall Study|Protocol Violation|0|||
124800840|NCT00973349|448901822|FG015|Overall Study|Protocol Violation|0|||
124800841|NCT00973349|448901807|FG000|Overall Study|Unable to classify|0|||
124800842|NCT00973349|448901808|FG001|Overall Study|Unable to classify|0|||
124800843|NCT00973349|448901809|FG002|Overall Study|Unable to classify|0|||
124800844|NCT00973349|448901810|FG003|Overall Study|Unable to classify|0|||
124800845|NCT00973349|448901811|FG004|Overall Study|Unable to classify|1|||
124800846|NCT00973349|448901812|FG005|Overall Study|Unable to classify|1|||
124800847|NCT00973349|448901813|FG006|Overall Study|Unable to classify|0|||
124800848|NCT00973349|448901814|FG007|Overall Study|Unable to classify|0|||
124800849|NCT00973349|448901815|FG008|Overall Study|Unable to classify|0|||
124800850|NCT00973349|448901816|FG009|Overall Study|Unable to classify|1|||
124800851|NCT00973349|448901817|FG010|Overall Study|Unable to classify|0|||
124800852|NCT00973349|448901818|FG011|Overall Study|Unable to classify|0|||
124800853|NCT00973349|448901819|FG012|Overall Study|Unable to classify|0|||
124800854|NCT00973349|448901820|FG013|Overall Study|Unable to classify|0|||
124800855|NCT00973349|448901821|FG014|Overall Study|Unable to classify|0|||
124800856|NCT00973349|448901822|FG015|Overall Study|Unable to classify|0|||
124800857|NCT03187756|448901823|FG000|Overall Study|Termination of study|4|||
124800858|NCT02301988|448901824|FG000|Overall Study|Withdrawal by Subject|2|||
124800859|NCT02301988|448901825|FG001|Overall Study|Withdrawal by Subject|1|||
124800860|NCT02301988|448901824|FG000|Overall Study|Physician Decision|2|||
124800861|NCT02301988|448901825|FG001|Overall Study|Physician Decision|2|||
124800862|NCT02301988|448901824|FG000|Overall Study|Unknown Reason|1|||
124800863|NCT02301988|448901825|FG001|Overall Study|Unknown Reason|3|||
124800864|NCT02301988|448901824|FG000|Overall Study|Lack of Efficacy|3|||
124800865|NCT02301988|448901825|FG001|Overall Study|Lack of Efficacy|2|||
124800866|NCT02301988|448901824|FG000|Overall Study|Death|1|||
124800867|NCT02301988|448901825|FG001|Overall Study|Death|0|||
124800868|NCT02301988|448901824|FG000|Overall Study|Adverse Event|1|||
124800869|NCT02301988|448901825|FG001|Overall Study|Adverse Event|1|||
124800870|NCT04755283|448901826|FG000|Overall Study|Withdrawal by Subject|14|||
124800871|NCT04755283|448901827|FG001|Overall Study|Withdrawal by Subject|3|||
124800872|NCT04755283|448901828|FG002|Overall Study|Withdrawal by Subject|6|||
124800873|NCT04755283|448901826|FG000|Overall Study|Lost to Follow-up|0|||
124800874|NCT04755283|448901827|FG001|Overall Study|Lost to Follow-up|0|||
124800875|NCT04755283|448901828|FG002|Overall Study|Lost to Follow-up|1|||
124800876|NCT04755283|448901826|FG000|Overall Study|Death|31|||
124800877|NCT04755283|448901827|FG001|Overall Study|Death|36|||
124800878|NCT04755283|448901828|FG002|Overall Study|Death|34|||
124800879|NCT02750943|448901829|FG000|Overall Study|Lost to Follow-up|1|||
124800880|NCT02750943|448901830|FG001|Overall Study|Lost to Follow-up|2|||
124800881|NCT02750943|448901829|FG000|Overall Study|Withdrawal by Subject|5|||
124800882|NCT02750943|448901830|FG001|Overall Study|Withdrawal by Subject|7|||
124800883|NCT00171054|448901831|FG000|Overall Study|Protocol Violation|1|||
124800884|NCT00171054|448901832|FG001|Overall Study|Protocol Violation|2|||
124800885|NCT00171054|448901831|FG000|Overall Study|Patient withdrew consent|1|||
124800886|NCT00171054|448901832|FG001|Overall Study|Patient withdrew consent|0|||
124800887|NCT00171054|448901831|FG000|Overall Study|Lost to Follow-up|0|||
124800888|NCT00171054|448901832|FG001|Overall Study|Lost to Follow-up|1|||
124800889|NCT00171054|448901831|FG000|Overall Study|Adverse Event|8|||
124800890|NCT00171054|448901832|FG001|Overall Study|Adverse Event|8|||
124800891|NCT00171054|448901831|FG000|Overall Study|Condition no longer required study drug|0|||
124800892|NCT00171054|448901832|FG001|Overall Study|Condition no longer required study drug|1|||
124800893|NCT05098938|448901836|FG000|Overall Study|Adverse Event|4|||
124800894|NCT05098938|448901837|FG001|Overall Study|Adverse Event|3|||
124800895|NCT05098938|448901836|FG000|Overall Study|inclusion/exclusion criteria change|11|||
124800896|NCT05098938|448901837|FG001|Overall Study|inclusion/exclusion criteria change|5|||
124800897|NCT05098938|448901836|FG000|Overall Study|lack of compliance|26|||
124800898|NCT05098938|448901837|FG001|Overall Study|lack of compliance|19|||
124800899|NCT05098938|448901836|FG000|Overall Study|Lost to Follow-up|37|||
124800900|NCT05098938|448901837|FG001|Overall Study|Lost to Follow-up|40|||
124800901|NCT05098938|448901836|FG000|Overall Study|Lost in treatment period|17|||
124800902|NCT05098938|448901837|FG001|Overall Study|Lost in treatment period|13|||
124800903|NCT05098938|448901836|FG000|Overall Study|Met an exclusion criterion|0|||
124800904|NCT05098938|448901837|FG001|Overall Study|Met an exclusion criterion|3|||
124800905|NCT05098938|448901836|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
124800906|NCT05098938|448901837|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
124800907|NCT05098938|448901836|FG000|Overall Study|Physician Decision|25|||
124800908|NCT05098938|448901837|FG001|Overall Study|Physician Decision|32|||
124800909|NCT05098938|448901836|FG000|Overall Study|Run in failure in treatment phase|1|||
124800910|NCT05098938|448901837|FG001|Overall Study|Run in failure in treatment phase|1|||
124800911|NCT05098938|448901836|FG000|Overall Study|Withdrawal by Subject|0|||
124800912|NCT05098938|448901837|FG001|Overall Study|Withdrawal by Subject|3|||
124800913|NCT05098938|448901836|FG000|Overall Study|Run-in Failure in early study|505|||
124800914|NCT05098938|448901837|FG001|Overall Study|Run-in Failure in early study|514|||
124800915|NCT05098938|448901836|FG000|Overall Study|IMP delivery missed|1|||
124800916|NCT05098938|448901837|FG001|Overall Study|IMP delivery missed|5|||
124800917|NCT05098938|448901836|FG000|Overall Study|6 months visit was missed|2|||
124800918|NCT05098938|448901837|FG001|Overall Study|6 months visit was missed|0|||
124800919|NCT05098938|448901836|FG000|Overall Study|fit for use was not completed within window|3|||
124800920|NCT05098938|448901837|FG001|Overall Study|fit for use was not completed within window|0|||
124800921|NCT05098938|448901836|FG000|Overall Study|V2 visit was not completed within window|0|||
124800922|NCT05098938|448901837|FG001|Overall Study|V2 visit was not completed within window|1|||
124800923|NCT05098938|448901836|FG000|Overall Study|exclusionary medication use|1|||
124800924|NCT05098938|448901837|FG001|Overall Study|exclusionary medication use|2|||
124800925|NCT05098938|448901836|FG000|Overall Study|change in medication|1|||
124800926|NCT05098938|448901837|FG001|Overall Study|change in medication|0|||
124800927|NCT05098938|448901836|FG000|Overall Study|treatment failure|2|||
124800928|NCT05098938|448901837|FG001|Overall Study|treatment failure|1|||
124800929|NCT01828320|448901838|FG000|Overall Study|Lost to Follow-up|1|||
124800930|NCT01828320|448901839|FG001|Overall Study|Lost to Follow-up|3|||
124800931|NCT01828320|448901838|FG000|Overall Study|Withdrawal by Subject|7|||
124800932|NCT01828320|448901839|FG001|Overall Study|Withdrawal by Subject|2|||
124800933|NCT02160782|448902867|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
124800934|NCT02160782|448902868|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
124800935|NCT02160782|448902869|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
124800936|NCT02160782|448902870|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
124800937|NCT02160782|448902871|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
124800938|NCT02160782|448902867|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
124800939|NCT02160782|448902868|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
124800940|NCT02160782|448902869|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
124800941|NCT02160782|448902870|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
124800942|NCT02160782|448902871|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
124800943|NCT02160782|448902867|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
124800944|NCT02160782|448902868|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
124800945|NCT02160782|448902869|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
124800946|NCT02160782|448902870|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
124800947|NCT02160782|448902871|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
124800948|NCT02160782|448902867|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
124800949|NCT02160782|448902868|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
124800950|NCT02160782|448902869|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
124800951|NCT02160782|448902870|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
124800952|NCT02160782|448902871|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
124800953|NCT02160782|448902867|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
124800954|NCT02160782|448902868|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
124800955|NCT02160782|448902869|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
124800956|NCT02160782|448902870|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
124800957|NCT02160782|448902871|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
124800958|NCT02160782|448902867|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
124800959|NCT02160782|448902868|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
124800960|NCT02160782|448902869|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
124800961|NCT02160782|448902870|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
124800962|NCT02160782|448902871|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
124800963|NCT02160782|448902867|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
124800964|NCT02160782|448902868|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
124800965|NCT02160782|448902869|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
124800966|NCT02160782|448902870|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
124800967|NCT02160782|448902871|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
124800968|NCT00401531|448902876|FG000|Overall Study|Adverse Event|2|||
124800969|NCT00401531|448902877|FG001|Overall Study|Adverse Event|0|||
124800970|NCT00401531|448902876|FG000|Overall Study|Protocol Violation|3|||
124800971|NCT00401531|448902877|FG001|Overall Study|Protocol Violation|7|||
124800972|NCT00401531|448902876|FG000|Overall Study|Lost to Follow-up|1|||
124800973|NCT00401531|448902877|FG001|Overall Study|Lost to Follow-up|1|||
124800974|NCT00401531|448902876|FG000|Overall Study|Withdrawal by Subject|3|||
124800975|NCT00401531|448902877|FG001|Overall Study|Withdrawal by Subject|2|||
124800976|NCT01801072|448902878|FG000|Overall Study|Lost to Follow-up|17|||
124800977|NCT01801072|448902879|FG001|Overall Study|Lost to Follow-up|14|||
124800978|NCT01801072|448902878|FG000|Overall Study|Physician Decision|2|||
124800979|NCT01801072|448902879|FG001|Overall Study|Physician Decision|3|||
124800980|NCT01801072|448902878|FG000|Overall Study|Withdrawal by Subject|1|||
124800981|NCT01801072|448902879|FG001|Overall Study|Withdrawal by Subject|0|||
124800982|NCT01801072|448902878|FG000|Overall Study|Protocol Violation|2|||
124800983|NCT01801072|448902879|FG001|Overall Study|Protocol Violation|0|||
124800984|NCT01801072|448902878|FG000|Overall Study|Death|7|||
124800985|NCT01801072|448902879|FG001|Overall Study|Death|8|||
124800986|NCT03906461|448902880|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
124800987|NCT03906461|448902880|FG000|Completed 12-month Follow-up|Missed Visit|6|||
124800988|NCT00510874|448902881|FG000|Overall Study|Withdrawal by Subject|1|||
124800989|NCT00510874|448902882|FG001|Overall Study|Withdrawal by Subject|1|||
124800990|NCT00510874|448902883|FG002|Overall Study|Withdrawal by Subject|0|||
124800991|NCT00510874|448902884|FG003|Overall Study|Withdrawal by Subject|0|||
124800992|NCT00510874|448902885|FG004|Overall Study|Withdrawal by Subject|3|||
124800993|NCT00510874|448902886|FG005|Overall Study|Withdrawal by Subject|0|||
124800994|NCT00510874|448902887|FG006|Overall Study|Withdrawal by Subject|0|||
124800995|NCT00510874|448902881|FG000|Overall Study|Lost to Follow-up|2|||
124800996|NCT00510874|448902882|FG001|Overall Study|Lost to Follow-up|3|||
124800997|NCT00510874|448902883|FG002|Overall Study|Lost to Follow-up|1|||
124800998|NCT00510874|448902884|FG003|Overall Study|Lost to Follow-up|3|||
124800999|NCT00510874|448902885|FG004|Overall Study|Lost to Follow-up|4|||
124801000|NCT00510874|448902886|FG005|Overall Study|Lost to Follow-up|0|||
124801001|NCT00510874|448902887|FG006|Overall Study|Lost to Follow-up|1|||
124801002|NCT02423109|448902890|FG000|Lens 1|Adverse Event|1|||
124801003|NCT02423109|448902891|FG001|Lens 1|Adverse Event|0|||
124801004|NCT03956056|448902892|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
124801005|NCT03956056|448902892|FG000|Overall Study|Lack of Efficacy|1|||
124801006|NCT03403374|448902893|FG000|Overall Study|Lost to Follow-up|1|||
124801007|NCT00950911|448902894|FG000|Overall Study|Adverse Event|0|||
124801008|NCT00950911|448902895|FG001|Overall Study|Adverse Event|2|||
124801009|NCT00950911|448902894|FG000|Overall Study|Death|4|||
124801010|NCT00950911|448902895|FG001|Overall Study|Death|6|||
124801011|NCT00950911|448902894|FG000|Overall Study|Disease progression|2|||
124801012|NCT00950911|448902895|FG001|Overall Study|Disease progression|2|||
124801013|NCT00950911|448902894|FG000|Overall Study|Consent withdrawn|1|||
124801014|NCT00950911|448902895|FG001|Overall Study|Consent withdrawn|3|||
124801015|NCT00950911|448902894|FG000|Overall Study|Administrative decision|3|||
124801016|NCT00950911|448902895|FG001|Overall Study|Administrative decision|1|||
124801017|NCT00950911|448902894|FG000|Overall Study|Ineligibility determined|1|||
124801018|NCT00950911|448902895|FG001|Overall Study|Ineligibility determined|0|||
124801019|NCT00950911|448902894|FG000|Overall Study|Noncompliance|1|||
124801020|NCT00950911|448902895|FG001|Overall Study|Noncompliance|0|||
124801021|NCT00950911|448902894|FG000|Overall Study|Poor performance status|0|||
124801022|NCT00950911|448902895|FG001|Overall Study|Poor performance status|1|||
124801023|NCT02476422|448902898|FG000|Overall Study|Subject/guardian decision|0|||
124801024|NCT02476422|448902899|FG001|Overall Study|Subject/guardian decision|1|||
124801025|NCT01134315|448902904|FG000|Overall Study|Adverse Event|1|||
124801026|NCT01134315|448902905|FG001|Overall Study|Adverse Event|2|||
124801027|NCT01134315|448902904|FG000|Overall Study|Other Reason|8|||
124801028|NCT01134315|448902905|FG001|Overall Study|Other Reason|17|||
124801029|NCT02180165|448902908|FG000|Overall Study|Not Treated|0|||
124801030|NCT02180165|448902909|FG001|Overall Study|Not Treated|0|||
124801031|NCT02180165|448902910|FG002|Overall Study|Not Treated|1|||
124801032|NCT02180165|448902911|FG003|Overall Study|Not Treated|0|||
124801033|NCT02180165|448902908|FG000|Overall Study|Adverse Event|7|||
124801034|NCT02180165|448902909|FG001|Overall Study|Adverse Event|0|||
124801035|NCT02180165|448902910|FG002|Overall Study|Adverse Event|18|||
124801036|NCT02180165|448902911|FG003|Overall Study|Adverse Event|3|||
124801037|NCT02180165|448902908|FG000|Overall Study|Lack of Efficacy|0|||
124801038|NCT02180165|448902909|FG001|Overall Study|Lack of Efficacy|1|||
124801039|NCT02180165|448902910|FG002|Overall Study|Lack of Efficacy|3|||
124801040|NCT02180165|448902911|FG003|Overall Study|Lack of Efficacy|2|||
124801041|NCT02180165|448902908|FG000|Overall Study|Physician Decision|1|||
124801042|NCT02180165|448902909|FG001|Overall Study|Physician Decision|0|||
124801043|NCT02180165|448902910|FG002|Overall Study|Physician Decision|5|||
124801044|NCT02180165|448902911|FG003|Overall Study|Physician Decision|0|||
124801045|NCT02180165|448902908|FG000|Overall Study|Withdrawal by Subject|3|||
124801046|NCT02180165|448902909|FG001|Overall Study|Withdrawal by Subject|0|||
124801047|NCT02180165|448902910|FG002|Overall Study|Withdrawal by Subject|2|||
124801048|NCT02180165|448902911|FG003|Overall Study|Withdrawal by Subject|1|||
124801049|NCT03875768|448902912|FG000|Overall Study|Lost to Follow-up|16|||
124801050|NCT03875768|448902913|FG001|Overall Study|Lost to Follow-up|13|||
124801051|NCT03875768|448902912|FG000|Overall Study|Withdrawal by Subject|10|||
124801052|NCT03875768|448902913|FG001|Overall Study|Withdrawal by Subject|21|||
124801053|NCT03875768|448902912|FG000|Overall Study|Did not complete assessment|21|||
124631503|NCT03334435|448267262|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
124801054|NCT03875768|448902913|FG001|Overall Study|Did not complete assessment|12|||
124801055|NCT03875768|448902912|FG000|Overall Study|Became ineligible|1|||
124801056|NCT03875768|448902913|FG001|Overall Study|Became ineligible|0|||
124801057|NCT00737438|448902914|FG000|Overall Study|Withdrawal by Subject|2|||
124801058|NCT00737438|448902914|FG000|Overall Study|Patient ineligible|1|||
124801059|NCT02791594|448902915|FG000|Overall Study|Physician Decision|2|||
124801060|NCT04950166|448902918|FG000|Overall Study|Withdrawal by Subject|1|||
124801061|NCT00857415|448902919|FG000|Overall Study|Image acquisition failure|2|||
124801062|NCT00857415|448902920|FG001|Overall Study|Image acquisition failure|0|||
124801063|NCT00857415|448902919|FG000|Overall Study|Invalid image or not imaged|3|||
124801064|NCT00857415|448902920|FG001|Overall Study|Invalid image or not imaged|0|||
124801065|NCT00857415|448902919|FG000|Overall Study|Subject still living at end of study|110|||
124801066|NCT00857415|448902920|FG001|Overall Study|Subject still living at end of study|0|||
124801067|NCT00857415|448902919|FG000|Overall Study|Deceased with no autopsy|2|||
124801068|NCT00857415|448902920|FG001|Overall Study|Deceased with no autopsy|0|||
124801069|NCT04508140|448902923|FG000|Overall Study|Adverse Event|2|||
124801070|NCT04508140|448902924|FG001|Overall Study|Adverse Event|2|||
124801071|NCT04508140|448902923|FG000|Overall Study|Withdrawal by Subject|0|||
124801072|NCT04508140|448902924|FG001|Overall Study|Withdrawal by Subject|2|||
124801073|NCT04508140|448902923|FG000|Overall Study|progressive disease|9|||
124801074|NCT04508140|448902924|FG001|Overall Study|progressive disease|3|||
124801075|NCT01130103|448902925|FG000|Randomized Treatment|Adverse Event|1|||
124801076|NCT01130103|448902926|FG001|Randomized Treatment|Adverse Event|1|||
124801077|NCT01130103|448902925|FG000|Randomized Treatment|Lost to Follow-up|1|||
124801078|NCT01130103|448902926|FG001|Randomized Treatment|Lost to Follow-up|0|||
124801079|NCT01130103|448902925|FG000|Randomized Treatment|Protocol Violation|3|||
124801080|NCT01130103|448902926|FG001|Randomized Treatment|Protocol Violation|2|||
124801081|NCT01130103|448902925|FG000|Randomized Treatment|Withdrawal by Subject|1|||
124801082|NCT01130103|448902926|FG001|Randomized Treatment|Withdrawal by Subject|2|||
124801083|NCT01130103|448902925|FG000|Maintenance Treatment|Lack of Efficacy|0|||
124801084|NCT01130103|448902926|FG001|Maintenance Treatment|Lack of Efficacy|1|||
124801085|NCT01130103|448902925|FG000|Maintenance Treatment|Lost to Follow-up|1|||
124801086|NCT01130103|448902926|FG001|Maintenance Treatment|Lost to Follow-up|1|||
124801087|NCT01130103|448902925|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
124801088|NCT01130103|448902926|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
124801089|NCT01199731|448902927|FG000|Overall Study|Adverse Event|0|||
124801090|NCT01199731|448902928|FG001|Overall Study|Adverse Event|1|||
124801091|NCT01199731|448902929|FG002|Overall Study|Adverse Event|0|||
124801092|NCT01199731|448902927|FG000|Overall Study|Study closed/terminated|7|||
124801093|NCT01199731|448902928|FG001|Overall Study|Study closed/terminated|9|||
124801094|NCT01199731|448902929|FG002|Overall Study|Study closed/terminated|7|||
124801095|NCT01199731|448902927|FG000|Overall Study|Lost to Follow-up|0|||
124801096|NCT01199731|448902928|FG001|Overall Study|Lost to Follow-up|0|||
124801097|NCT01199731|448902929|FG002|Overall Study|Lost to Follow-up|2|||
124801098|NCT01199731|448902927|FG000|Overall Study|Physician Decision|0|||
124801099|NCT01199731|448902928|FG001|Overall Study|Physician Decision|1|||
124801100|NCT01199731|448902929|FG002|Overall Study|Physician Decision|1|||
124801101|NCT01199731|448902927|FG000|Overall Study|Withdrawal by Subject|2|||
124801102|NCT01199731|448902928|FG001|Overall Study|Withdrawal by Subject|0|||
124801103|NCT01199731|448902929|FG002|Overall Study|Withdrawal by Subject|0|||
124801104|NCT02992132|448902930|FG000|Overall Study|Adverse Event|4|||
124801105|NCT02992132|448902931|FG001|Overall Study|Adverse Event|1|||
124801106|NCT02992132|448902932|FG002|Overall Study|Adverse Event|3|||
124801107|NCT02992132|448902930|FG000|Overall Study|Lack of Efficacy|2|||
124801108|NCT02992132|448902931|FG001|Overall Study|Lack of Efficacy|0|||
124801109|NCT02992132|448902932|FG002|Overall Study|Lack of Efficacy|0|||
124801110|NCT02992132|448902930|FG000|Overall Study|Non-compliance with study drug|2|||
124801111|NCT02992132|448902931|FG001|Overall Study|Non-compliance with study drug|0|||
124801112|NCT02992132|448902932|FG002|Overall Study|Non-compliance with study drug|0|||
124801113|NCT02992132|448902930|FG000|Overall Study|Progressive disease|1|||
124801114|NCT02992132|448902931|FG001|Overall Study|Progressive disease|0|||
124801115|NCT02992132|448902932|FG002|Overall Study|Progressive disease|0|||
124801116|NCT02992132|448902930|FG000|Overall Study|Protocol Violation|2|||
124801117|NCT02992132|448902931|FG001|Overall Study|Protocol Violation|2|||
124801118|NCT02992132|448902932|FG002|Overall Study|Protocol Violation|0|||
124801119|NCT02992132|448902930|FG000|Overall Study|Caregiver withdrew consent|2|||
124801120|NCT02992132|448902931|FG001|Overall Study|Caregiver withdrew consent|3|||
124801121|NCT02992132|448902932|FG002|Overall Study|Caregiver withdrew consent|2|||
124801122|NCT02992132|448902930|FG000|Overall Study|Withdrawal by Subject|0|||
124801123|NCT02992132|448902931|FG001|Overall Study|Withdrawal by Subject|2|||
124801124|NCT02992132|448902932|FG002|Overall Study|Withdrawal by Subject|1|||
124801125|NCT02992132|448902930|FG000|Overall Study|Physician Decision|0|||
124801126|NCT02992132|448902931|FG001|Overall Study|Physician Decision|0|||
124801127|NCT02992132|448902932|FG002|Overall Study|Physician Decision|1|||
124801128|NCT00381381|448902938|FG000|Overall Study|Adverse Event|3|||
124801129|NCT00381381|448902938|FG000|Overall Study|Lost to Follow-up|52|||
124801130|NCT00381381|448902938|FG000|Overall Study|Withdrawal by Subject|9|||
124801131|NCT01437878|448902943|FG000|Overall Study|Withdrawal by Subject|1|||
124801132|NCT01437878|448902944|FG001|Overall Study|Withdrawal by Subject|0|||
124801133|NCT01070043|448902945|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
124801134|NCT01070043|448902946|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
124801135|NCT01070043|448902947|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
124801136|NCT01070043|448902945|FG000|Double-Blind Treatment|Adverse Event|0|||
124801137|NCT01070043|448902946|FG001|Double-Blind Treatment|Adverse Event|0|||
124801138|NCT01070043|448902947|FG002|Double-Blind Treatment|Adverse Event|2|||
124631504|NCT03334435|448267248|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
124801139|NCT00473746|448902949|FG000|Period 1 (Phase 1)|Adverse Event|1|||
124801140|NCT00473746|448902950|FG001|Period 1 (Phase 1)|Adverse Event|0|||
124801141|NCT00473746|448902951|FG002|Period 1 (Phase 1)|Adverse Event|0|||
124801142|NCT00473746|448902952|FG003|Period 1 (Phase 1)|Adverse Event|0|||
124801143|NCT00473746|448902953|FG004|Period 1 (Phase 1)|Adverse Event|0|||
124801144|NCT00473746|448902949|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
124801145|NCT00473746|448902950|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
124801146|NCT00473746|448902951|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
124631505|NCT03334435|448267249|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
124631506|NCT03334435|448267250|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
124631507|NCT03334435|448267251|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
124801147|NCT00473746|448902952|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
124801148|NCT00473746|448902953|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
124801149|NCT00473746|448902949|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
124801150|NCT00473746|448902950|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
124801151|NCT00473746|448902951|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
124801152|NCT00473746|448902952|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
124801153|NCT00473746|448902953|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
124801154|NCT00473746|448902949|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
124801155|NCT00473746|448902950|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
124801156|NCT00473746|448902951|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
124801157|NCT00473746|448902952|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
124801158|NCT00473746|448902953|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
124801159|NCT00473746|448902949|FG000|Period 1 (Phase 1)|Reason not specified|0|||
124801160|NCT00473746|448902950|FG001|Period 1 (Phase 1)|Reason not specified|1|||
124801161|NCT00473746|448902951|FG002|Period 1 (Phase 1)|Reason not specified|0|||
124801162|NCT00473746|448902952|FG003|Period 1 (Phase 1)|Reason not specified|0|||
124801163|NCT00473746|448902953|FG004|Period 1 (Phase 1)|Reason not specified|0|||
124801164|NCT00473746|448902949|FG000|Period 2 (Phase 2)|Adverse Event|0|||
124801165|NCT00473746|448902950|FG001|Period 2 (Phase 2)|Adverse Event|0|||
124801166|NCT00473746|448902951|FG002|Period 2 (Phase 2)|Adverse Event|0|||
124801167|NCT00473746|448902952|FG003|Period 2 (Phase 2)|Adverse Event|0|||
124801168|NCT00473746|448902953|FG004|Period 2 (Phase 2)|Adverse Event|3|||
124801169|NCT00473746|448902949|FG000|Period 2 (Phase 2)|Death|0|||
124801170|NCT00473746|448902950|FG001|Period 2 (Phase 2)|Death|0|||
124801171|NCT00473746|448902951|FG002|Period 2 (Phase 2)|Death|0|||
124801172|NCT00473746|448902952|FG003|Period 2 (Phase 2)|Death|0|||
124801173|NCT00473746|448902953|FG004|Period 2 (Phase 2)|Death|1|||
124801174|NCT00473746|448902949|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
124801175|NCT00473746|448902950|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
124801176|NCT00473746|448902951|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
124801177|NCT00473746|448902952|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
124801178|NCT00473746|448902953|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
124801179|NCT00473746|448902949|FG000|Period 2 (Phase 2)|Reason not specified|0|||
124801180|NCT00473746|448902950|FG001|Period 2 (Phase 2)|Reason not specified|0|||
124801181|NCT00473746|448902951|FG002|Period 2 (Phase 2)|Reason not specified|0|||
124801182|NCT00473746|448902952|FG003|Period 2 (Phase 2)|Reason not specified|0|||
124801183|NCT00473746|448902953|FG004|Period 2 (Phase 2)|Reason not specified|3|||
124801184|NCT00667420|448902957|FG000|Overall Study|Adverse Event|2|||
124801185|NCT00667420|448902957|FG000|Overall Study|Lack of Efficacy|5|||
124801186|NCT00667420|448902957|FG000|Overall Study|Physician Decision|1|||
124801187|NCT00667420|448902957|FG000|Overall Study|Withdrawal by Subject|2|||
124801188|NCT01528215|448902958|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
124801189|NCT01528215|448902959|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
124801190|NCT01528215|448902958|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
124801191|NCT01528215|448902959|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
124801192|NCT01528215|448902958|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
124801193|NCT01528215|448902959|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
124801194|NCT01528215|448902958|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
124801195|NCT01528215|448902959|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
124801196|NCT01462227|448902960|FG000|Second Assignment|Lost to Follow-up|1|||
124801197|NCT01462227|448902961|FG001|Second Assignment|Lost to Follow-up|0|||
124801198|NCT01462227|448902962|FG002|Second Assignment|Lost to Follow-up|0|||
124631508|NCT03334435|448267252|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
124631509|NCT03334435|448267253|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
124631510|NCT03334435|448267254|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
124801199|NCT01462227|448902963|FG003|Second Assignment|Lost to Follow-up|0|||
124801200|NCT01462227|448902960|FG000|Second Assignment|Protocol Violation|0|||
124631511|NCT03334435|448267255|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
124631512|NCT03334435|448267256|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
124631513|NCT03334435|448267257|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
124631514|NCT03334435|448267258|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
124631515|NCT03334435|448267259|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
124631516|NCT03334435|448267260|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
124801201|NCT01462227|448902961|FG001|Second Assignment|Protocol Violation|1|||
124801202|NCT01462227|448902962|FG002|Second Assignment|Protocol Violation|1|||
124801203|NCT01462227|448902963|FG003|Second Assignment|Protocol Violation|0|||
124801204|NCT00586066|448902966|FG000|Overall Study|Lost to Follow-up|6|||
124801205|NCT00586066|448902967|FG001|Overall Study|Lost to Follow-up|3|||
124801206|NCT00586066|448902966|FG000|Overall Study|Lack of Efficacy|5|||
124801207|NCT00586066|448902967|FG001|Overall Study|Lack of Efficacy|3|||
124801208|NCT00586066|448902966|FG000|Overall Study|Adverse Event|2|||
124801209|NCT00586066|448902967|FG001|Overall Study|Adverse Event|2|||
124801210|NCT00586066|448902966|FG000|Overall Study|Physician Decision|1|||
124801211|NCT00586066|448902967|FG001|Overall Study|Physician Decision|0|||
124801212|NCT00586066|448902966|FG000|Overall Study|Withdrawal of consent|4|||
124801213|NCT00586066|448902967|FG001|Overall Study|Withdrawal of consent|2|||
124801214|NCT00467610|448902968|FG000|Overall Study|Withdrawal by Subject|1|||
124801215|NCT01369615|448902969|FG000|Overall Study|Withdrawal by Subject|0|||
124801216|NCT01369615|448902970|FG001|Overall Study|Withdrawal by Subject|1|||
124801217|NCT01369615|448902969|FG000|Overall Study|Lost to Follow-up|0|||
124801218|NCT01369615|448902970|FG001|Overall Study|Lost to Follow-up|1|||
124801219|NCT04263454|448902971|FG000|Overall Study|Adverse Event|0|||
124801220|NCT04263454|448902972|FG001|Overall Study|Adverse Event|2|||
124801221|NCT04263454|448902971|FG000|Overall Study|Physician Decision|3|||
124801222|NCT04263454|448902972|FG001|Overall Study|Physician Decision|5|||
124801223|NCT04263454|448902971|FG000|Overall Study|Poor Data Quality|0|||
124801224|NCT04263454|448902972|FG001|Overall Study|Poor Data Quality|1|||
124801225|NCT03911154|448902973|FG000|Overall Study|Withdrawal by Subject|1|||
124801226|NCT02035475|448902974|FG000|Overall Study|Withdrawal by Subject|4|||
124801227|NCT02035475|448902974|FG000|Overall Study|Physician Decision|1|||
124801228|NCT02035475|448902974|FG000|Overall Study|Equipment Error|1|||
124801229|NCT01231347|448902975|FG000|Overall Study|Full Consent withdrawn|19|||
124801230|NCT01231347|448902976|FG001|Overall Study|Full Consent withdrawn|19|||
124801231|NCT01231347|448902977|FG002|Overall Study|Full Consent withdrawn|11|||
124801232|NCT01231347|448902975|FG000|Overall Study|Lost to Follow-up|4|||
124801233|NCT01231347|448902976|FG001|Overall Study|Lost to Follow-up|2|||
124801234|NCT01231347|448902977|FG002|Overall Study|Lost to Follow-up|2|||
124801235|NCT01231347|448902975|FG000|Overall Study|Death|202|||
124801236|NCT01231347|448902976|FG001|Overall Study|Death|210|||
124801237|NCT01231347|448902977|FG002|Overall Study|Death|101|||
124801238|NCT01231347|448902975|FG000|Overall Study|other event|7|||
124801239|NCT01231347|448902976|FG001|Overall Study|other event|9|||
124801240|NCT01231347|448902977|FG002|Overall Study|other event|3|||
124801241|NCT02322021|448902978|FG000|Core Phase|Adverse Event|1|||
124631517|NCT03334435|448267261|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
124801242|NCT02322021|448902979|FG001|Core Phase|Adverse Event|3|||
124801243|NCT02322021|448902980|FG002|Core Phase|Adverse Event|4|||
124801244|NCT02322021|448902981|FG003|Core Phase|Adverse Event|2|||
124801245|NCT02322021|448902982|FG004|Core Phase|Adverse Event|0|||
124801246|NCT02322021|448902978|FG000|Core Phase|Participant Choice|4|||
124801247|NCT02322021|448902979|FG001|Core Phase|Participant Choice|5|||
124801248|NCT02322021|448902980|FG002|Core Phase|Participant Choice|4|||
124801249|NCT02322021|448902981|FG003|Core Phase|Participant Choice|2|||
124801250|NCT02322021|448902982|FG004|Core Phase|Participant Choice|0|||
124801251|NCT02322021|448902978|FG000|Core Phase|Lost to Follow-up|0|||
124801252|NCT02322021|448902979|FG001|Core Phase|Lost to Follow-up|0|||
124801253|NCT02322021|448902980|FG002|Core Phase|Lost to Follow-up|0|||
124801254|NCT02322021|448902981|FG003|Core Phase|Lost to Follow-up|1|||
124801255|NCT02322021|448902982|FG004|Core Phase|Lost to Follow-up|0|||
124801256|NCT02322021|448902978|FG000|Core Phase|Other|0|||
124801257|NCT02322021|448902979|FG001|Core Phase|Other|0|||
124801258|NCT02322021|448902980|FG002|Core Phase|Other|1|||
124631518|NCT03334435|448267262|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
124631519|NCT03334435|448267248|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
124631520|NCT03334435|448267249|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
124631521|NCT03334435|448267250|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
124631522|NCT03334435|448267251|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
124631523|NCT03334435|448267252|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
124631524|NCT03334435|448267253|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
124631525|NCT03334435|448267254|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
124631526|NCT03334435|448267255|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
124631527|NCT03334435|448267256|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
124801259|NCT02322021|448902981|FG003|Core Phase|Other|0|||
124801260|NCT02322021|448902982|FG004|Core Phase|Other|0|||
124801261|NCT02322021|448902978|FG000|Extension Phase|Adverse Event|0|||
124801262|NCT02322021|448902979|FG001|Extension Phase|Adverse Event|0|||
124801263|NCT02322021|448902980|FG002|Extension Phase|Adverse Event|0|||
124801264|NCT02322021|448902981|FG003|Extension Phase|Adverse Event|0|||
124801265|NCT02322021|448902982|FG004|Extension Phase|Adverse Event|3|||
124801266|NCT02322021|448902978|FG000|Extension Phase|Participant Choice|0|||
124801267|NCT02322021|448902979|FG001|Extension Phase|Participant Choice|0|||
124801268|NCT02322021|448902980|FG002|Extension Phase|Participant Choice|0|||
124801269|NCT02322021|448902981|FG003|Extension Phase|Participant Choice|0|||
124801270|NCT02322021|448902982|FG004|Extension Phase|Participant Choice|6|||
124801271|NCT02322021|448902978|FG000|Extension Phase|Other|0|||
124801272|NCT02322021|448902979|FG001|Extension Phase|Other|0|||
124801273|NCT02322021|448902980|FG002|Extension Phase|Other|0|||
124801274|NCT02322021|448902981|FG003|Extension Phase|Other|0|||
124801275|NCT02322021|448902982|FG004|Extension Phase|Other|3|||
124801276|NCT02322021|448902978|FG000|Extension Phase|Lost to Follow-up|0|||
124801277|NCT02322021|448902979|FG001|Extension Phase|Lost to Follow-up|0|||
124801278|NCT02322021|448902980|FG002|Extension Phase|Lost to Follow-up|0|||
124801279|NCT02322021|448902981|FG003|Extension Phase|Lost to Follow-up|0|||
124801280|NCT02322021|448902982|FG004|Extension Phase|Lost to Follow-up|1|||
124801281|NCT02322021|448902978|FG000|Extension Phase|Study terminated by sponsor|0|||
124801282|NCT02322021|448902979|FG001|Extension Phase|Study terminated by sponsor|0|||
124801283|NCT02322021|448902980|FG002|Extension Phase|Study terminated by sponsor|0|||
124801284|NCT02322021|448902981|FG003|Extension Phase|Study terminated by sponsor|0|||
124801285|NCT02322021|448902982|FG004|Extension Phase|Study terminated by sponsor|28|||
124801286|NCT02047227|448902983|FG000|Overall Study|Adverse Event|2|||
124801287|NCT02047227|448902984|FG001|Overall Study|Adverse Event|4|||
124801288|NCT02047227|448902983|FG000|Overall Study|Lost to Follow-up|0|||
124801289|NCT02047227|448902984|FG001|Overall Study|Lost to Follow-up|3|||
124801290|NCT02047227|448902983|FG000|Overall Study|Protocol Violation|1|||
124801291|NCT02047227|448902984|FG001|Overall Study|Protocol Violation|0|||
124801292|NCT02047227|448902983|FG000|Overall Study|Spontaneous pregnancy|1|||
124801293|NCT02047227|448902984|FG001|Overall Study|Spontaneous pregnancy|0|||
124801294|NCT02047227|448902983|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
124801295|NCT02047227|448902984|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
124801296|NCT02047227|448902983|FG000|Overall Study|No oocytes retrieved|21|||
124801297|NCT02047227|448902984|FG001|Overall Study|No oocytes retrieved|20|||
124801298|NCT02047227|448902983|FG000|Overall Study|No fertilization|61|||
124801299|NCT02047227|448902984|FG001|Overall Study|No fertilization|51|||
124801300|NCT02047227|448902983|FG000|Overall Study|Intention to freeze all embryos|1|||
124801301|NCT02047227|448902984|FG001|Overall Study|Intention to freeze all embryos|0|||
124801302|NCT02047227|448902983|FG000|Overall Study|All embryos discarded|12|||
124801303|NCT02047227|448902984|FG001|Overall Study|All embryos discarded|11|||
124801304|NCT02047227|448902983|FG000|Overall Study|Other|10|||
124801305|NCT02047227|448902984|FG001|Overall Study|Other|9|||
124801306|NCT00492050|448902990|FG000|Overall Study|Adverse Event|1|||
124801307|NCT00492050|448902990|FG000|Overall Study|Lack of Efficacy|1|||
124801308|NCT00492050|448902990|FG000|Overall Study|Withdrawal by Subject|3|||
124801309|NCT00492050|448902990|FG000|Overall Study|Unable to collect SCT|2|||
124801310|NCT00492050|448902990|FG000|Overall Study|Progressive Disease|2|||
124801311|NCT01104701|448904356|FG000|Overall Study|Withdrawal by Subject|0|||
124801312|NCT01104701|448904357|FG001|Overall Study|Withdrawal by Subject|1|||
124801313|NCT01104701|448904358|FG002|Overall Study|Withdrawal by Subject|2|||
124801314|NCT01104701|448904359|FG003|Overall Study|Withdrawal by Subject|1|||
124801315|NCT01104701|448904356|FG000|Overall Study|Adverse Event|0|||
124801316|NCT01104701|448904357|FG001|Overall Study|Adverse Event|0|||
124801317|NCT01104701|448904358|FG002|Overall Study|Adverse Event|0|||
124801318|NCT01104701|448904359|FG003|Overall Study|Adverse Event|1|||
124801319|NCT01104701|448904356|FG000|Overall Study|Physician Decision|0|||
124631528|NCT03334435|448267257|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
124631529|NCT03334435|448267258|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
124631530|NCT03334435|448267259|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
124631531|NCT03334435|448267260|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
124631532|NCT03334435|448267261|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
124631533|NCT03334435|448267262|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
124631534|NCT03334435|448267248|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
124631535|NCT03334435|448267249|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
124801320|NCT01104701|448904357|FG001|Overall Study|Physician Decision|2|||
124801321|NCT01104701|448904358|FG002|Overall Study|Physician Decision|0|||
124801322|NCT01104701|448904359|FG003|Overall Study|Physician Decision|0|||
124801323|NCT03437512|448904360|FG000|Randomized|Withdrawal by Subject|0|||
124801324|NCT03437512|448904361|FG001|Randomized|Withdrawal by Subject|2|||
124801325|NCT03437512|448904360|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
124801326|NCT03437512|448904361|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
124801327|NCT00674973|448904362|FG000|Overall Study|Insufficient Therapeutic Response|77|||
124801328|NCT00674973|448904363|FG001|Overall Study|Insufficient Therapeutic Response|72|||
124801329|NCT00674973|448904362|FG000|Overall Study|Refused Treatment|1|||
124801330|NCT00674973|448904363|FG001|Overall Study|Refused Treatment|5|||
124801331|NCT00674973|448904362|FG000|Overall Study|Failure to Return|1|||
124801332|NCT00674973|448904363|FG001|Overall Study|Failure to Return|0|||
124801333|NCT00674973|448904362|FG000|Overall Study|Adverse Event|2|||
124801334|NCT00674973|448904363|FG001|Overall Study|Adverse Event|9|||
124631536|NCT03334435|448267250|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
124631537|NCT03334435|448267251|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
124801335|NCT00674973|448904362|FG000|Overall Study|Death|19|||
124801336|NCT00674973|448904363|FG001|Overall Study|Death|15|||
124801337|NCT00674973|448904362|FG000|Overall Study|Protocol Violation|0|||
124801338|NCT00674973|448904363|FG001|Overall Study|Protocol Violation|1|||
124801339|NCT01002482|448904366|FG000|Overall Study|Withdrawal by Subject|14|||
124801340|NCT01002482|448904367|FG001|Overall Study|Withdrawal by Subject|21|||
124801341|NCT01002482|448904366|FG000|Overall Study|Included twice|1|||
124801342|NCT01002482|448904367|FG001|Overall Study|Included twice|0|||
124801343|NCT05108922|448904371|FG000|Overall Study|Adverse Event|2|||
124801344|NCT05108922|448904372|FG001|Overall Study|Adverse Event|3|||
124801345|NCT05108922|448904371|FG000|Overall Study|Lost to Follow-up|2|||
124801346|NCT05108922|448904372|FG001|Overall Study|Lost to Follow-up|1|||
124801347|NCT05108922|448904371|FG000|Overall Study|Inadvertent enrollment|0|||
124801348|NCT05108922|448904372|FG001|Overall Study|Inadvertent enrollment|1|||
124801349|NCT05108922|448904371|FG000|Overall Study|Physician Decision|2|||
124801350|NCT05108922|448904372|FG001|Overall Study|Physician Decision|3|||
124801351|NCT05108922|448904371|FG000|Overall Study|Protocol deviation|1|||
124801352|NCT05108922|448904372|FG001|Overall Study|Protocol deviation|0|||
124801353|NCT05108922|448904371|FG000|Overall Study|Screen failure|1|||
124801354|NCT05108922|448904372|FG001|Overall Study|Screen failure|0|||
124801355|NCT05108922|448904371|FG000|Overall Study|Withdrawal by Subject|11|||
124801356|NCT05108922|448904372|FG001|Overall Study|Withdrawal by Subject|8|||
124801357|NCT05036369|448904373|FG000|Overall Study|Run In non compliance|1|||
124801358|NCT05036369|448904374|FG001|Overall Study|Run In non compliance|2|||
124801359|NCT05036369|448904373|FG000|Overall Study|Change in eligibility criteria|0|||
124801360|NCT05036369|448904374|FG001|Overall Study|Change in eligibility criteria|1|||
124801361|NCT00426231|448904377|FG000|Overall Study|Withdrawal by Subject|9|||
124801362|NCT00426231|448904378|FG001|Overall Study|Withdrawal by Subject|12|||
124801363|NCT01795638|448904379|FG000|Overall Study|Death|0|||
124801364|NCT01795638|448904380|FG001|Overall Study|Death|3|||
124801365|NCT01795638|448904379|FG000|Overall Study|transferred to quaternary hospital|2|||
124801366|NCT01795638|448904380|FG001|Overall Study|transferred to quaternary hospital|3|||
124801367|NCT01795638|448904379|FG000|Overall Study|Protocol Violation|3|||
124801368|NCT01795638|448904380|FG001|Overall Study|Protocol Violation|0|||
124801369|NCT01795638|448904379|FG000|Overall Study|discharged from hospital|7|||
124801370|NCT01795638|448904380|FG001|Overall Study|discharged from hospital|5|||
124801371|NCT01795638|448904379|FG000|Overall Study|Withdrawal by Subject|1|||
124801372|NCT01795638|448904380|FG001|Overall Study|Withdrawal by Subject|0|||
124801373|NCT03061097|448904381|FG000|Overall Study|Withdrawal by Subject|0|||
124801374|NCT03061097|448904382|FG001|Overall Study|Withdrawal by Subject|3|||
124801375|NCT03911713|448904383|FG000|Overall Study|Lost to Follow-up|0|||
124801376|NCT03911713|448904384|FG001|Overall Study|Lost to Follow-up|2|||
124801377|NCT03911713|448904385|FG002|Overall Study|Lost to Follow-up|0|||
124801378|NCT03911713|448904386|FG003|Overall Study|Lost to Follow-up|0|||
124801379|NCT03911713|448904387|FG004|Overall Study|Lost to Follow-up|0|||
124631538|NCT03334435|448267252|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
124631539|NCT03334435|448267253|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
124631540|NCT03334435|448267254|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
124631541|NCT03334435|448267255|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
124801380|NCT03911713|448904383|FG000|Overall Study|Other|0|||
124801381|NCT03911713|448904384|FG001|Overall Study|Other|0|||
124801382|NCT03911713|448904385|FG002|Overall Study|Other|0|||
124631542|NCT03334435|448267256|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
124631543|NCT03334435|448267257|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
124631544|NCT03334435|448267258|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
124631545|NCT03334435|448267259|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
124801383|NCT03911713|448904386|FG003|Overall Study|Other|1|||
124801384|NCT03911713|448904387|FG004|Overall Study|Other|0|||
124801385|NCT03911713|448904383|FG000|Overall Study|Randomized, Never Dosed|1|||
124801386|NCT03911713|448904384|FG001|Overall Study|Randomized, Never Dosed|0|||
124801387|NCT03911713|448904385|FG002|Overall Study|Randomized, Never Dosed|0|||
124801388|NCT03911713|448904386|FG003|Overall Study|Randomized, Never Dosed|1|||
124801389|NCT03911713|448904387|FG004|Overall Study|Randomized, Never Dosed|0|||
124801390|NCT02437513|448904388|FG000|Overall Study|Withdrawal by Subject|2|||
124801391|NCT01845818|448904389|FG000|Overall Study|Withdrawal by Subject|0|||
124801392|NCT01845818|448904390|FG001|Overall Study|Withdrawal by Subject|1|||
124801393|NCT01845818|448904389|FG000|Overall Study|Lost to Follow-up|7|||
124801394|NCT01845818|448904390|FG001|Overall Study|Lost to Follow-up|5|||
124801395|NCT01845818|448904389|FG000|Overall Study|Administrative Reasons|3|||
124801396|NCT01845818|448904390|FG001|Overall Study|Administrative Reasons|1|||
124801397|NCT01845818|448904389|FG000|Overall Study|Serious Adverse Event|1|||
124801398|NCT01845818|448904390|FG001|Overall Study|Serious Adverse Event|1|||
124801399|NCT01845818|448904389|FG000|Overall Study|Other|25|||
124801400|NCT01845818|448904390|FG001|Overall Study|Other|8|||
124801401|NCT01845818|448904389|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
124801402|NCT01845818|448904390|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
124801403|NCT01845818|448904389|FG000|Overall Study|No Follow-Up Data Available|4|||
124801404|NCT01845818|448904390|FG001|Overall Study|No Follow-Up Data Available|1|||
124801405|NCT00422097|448904391|FG000|Dose Level 2|Still on treatment|0|||
124801406|NCT00422097|448904392|FG001|Dose Level 2|Still on treatment|1|||
124801407|NCT00422097|448904393|FG002|Dose Level 2|Still on treatment|0|||
124801408|NCT00422097|448904394|FG003|Dose Level 2|Still on treatment|0|||
124801409|NCT00422097|448904395|FG004|Dose Level 2|Still on treatment|0|||
124801410|NCT00422097|448904396|FG005|Dose Level 2|Still on treatment|0|||
124631546|NCT03334435|448267260|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
124631547|NCT03334435|448267261|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
124631548|NCT03334435|448267262|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
124631549|NCT03334435|448267248|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
124631550|NCT03334435|448267249|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
124631551|NCT03334435|448267250|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
124631552|NCT03334435|448267251|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
124631553|NCT03334435|448267252|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
124631554|NCT03334435|448267253|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
124631555|NCT03334435|448267254|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
124631556|NCT03334435|448267255|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
124801411|NCT00422097|448904397|FG006|Dose Level 2|Still on treatment|0|||
124801412|NCT00422097|448904398|FG007|Dose Level 2|Still on treatment|0|||
124801413|NCT02360995|448904399|FG000|Overall Study|Lost to Follow-up|2|||
124801414|NCT02360995|448904400|FG001|Overall Study|Lost to Follow-up|0|||
124801415|NCT02360995|448904401|FG002|Overall Study|Lost to Follow-up|2|||
124801416|NCT02360995|448904399|FG000|Overall Study|Withdrawal by Subject|0|||
124801417|NCT02360995|448904400|FG001|Overall Study|Withdrawal by Subject|1|||
124801418|NCT02360995|448904401|FG002|Overall Study|Withdrawal by Subject|0|||
124801419|NCT02395666|448904402|FG000|Overall Study|Physician Decision|3|||
124801420|NCT02395666|448904403|FG001|Overall Study|Physician Decision|0|||
124801421|NCT02395666|448904402|FG000|Overall Study|Lost to Follow-up|1|||
124801422|NCT02395666|448904403|FG001|Overall Study|Lost to Follow-up|0|||
124801423|NCT02395666|448904402|FG000|Overall Study|Withdrawal by Subject|2|||
124801424|NCT02395666|448904403|FG001|Overall Study|Withdrawal by Subject|1|||
124801425|NCT02611960|448904404|FG000|Overall Study|Adverse Event|7|||
124801426|NCT02611960|448904405|FG001|Overall Study|Adverse Event|8|||
124801427|NCT02611960|448904404|FG000|Overall Study|Death|98|||
124801428|NCT02611960|448904405|FG001|Overall Study|Death|92|||
124801429|NCT02611960|448904404|FG000|Overall Study|Withdrawal by Subject|1|||
124801430|NCT02611960|448904405|FG001|Overall Study|Withdrawal by Subject|5|||
124801431|NCT02611960|448904404|FG000|Overall Study|Sponsor Decision|11|||
124801432|NCT02611960|448904405|FG001|Overall Study|Sponsor Decision|11|||
124801433|NCT01409434|448904417|FG000|Overall Study|Protocol Violation|4|||
124801434|NCT05061966|448904418|FG000|Overall Study|Lost to Follow-up|13|||
124801435|NCT05061966|448904419|FG001|Overall Study|Lost to Follow-up|13|||
124801436|NCT02213042|448904420|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
124801437|NCT02213042|448904421|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
124801438|NCT02213042|448904422|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
124801439|NCT02213042|448904420|FG000|Overall Study|Adverse Event|2|||
124801440|NCT02213042|448904421|FG001|Overall Study|Adverse Event|1|||
124801441|NCT02213042|448904422|FG002|Overall Study|Adverse Event|0|||
124801442|NCT02213042|448904420|FG000|Overall Study|Withdrawal by Subject|0|||
124801443|NCT02213042|448904421|FG001|Overall Study|Withdrawal by Subject|1|||
124801444|NCT02213042|448904422|FG002|Overall Study|Withdrawal by Subject|1|||
124801445|NCT02213042|448904420|FG000|Overall Study|Protocol Violation|1|||
124801446|NCT02213042|448904421|FG001|Overall Study|Protocol Violation|0|||
124801447|NCT02213042|448904422|FG002|Overall Study|Protocol Violation|0|||
124801448|NCT02213042|448904420|FG000|Overall Study|Investigator discretion|0|||
124801449|NCT02213042|448904421|FG001|Overall Study|Investigator discretion|0|||
124801450|NCT02213042|448904422|FG002|Overall Study|Investigator discretion|1|||
124801451|NCT00777205|448904429|FG000|Overall Study|Lost to Follow-up|25|||
124801452|NCT00777205|448904430|FG001|Overall Study|Lost to Follow-up|9|||
124801453|NCT00777205|448904429|FG000|Overall Study|Withdrawal by Subject|6|||
124801454|NCT00777205|448904430|FG001|Overall Study|Withdrawal by Subject|4|||
124801455|NCT00777205|448904429|FG000|Overall Study|Death|0|||
124801456|NCT00777205|448904430|FG001|Overall Study|Death|2|||
124801457|NCT00777205|448904429|FG000|Overall Study|Protocol Violation|0|||
124631557|NCT03334435|448267256|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
124752488|NCT02737475|448716763|FG006|Overall Study|Death|0|||
124752489|NCT02737475|448716764|FG007|Overall Study|Death|2|||
124752490|NCT02737475|448716765|FG008|Overall Study|Death|0|||
124752491|NCT02737475|448716766|FG009|Overall Study|Death|0|||
124752492|NCT02737475|448716767|FG010|Overall Study|Death|0|||
124752493|NCT02737475|448716768|FG011|Overall Study|Death|4|||
124752494|NCT02737475|448716769|FG012|Overall Study|Death|2|||
124752495|NCT02737475|448716770|FG013|Overall Study|Death|2|||
124752496|NCT02737475|448716771|FG014|Overall Study|Death|0|||
124752497|NCT02737475|448716772|FG015|Overall Study|Death|2|||
124752498|NCT02737475|448716773|FG016|Overall Study|Death|2|||
124752499|NCT02737475|448716774|FG017|Overall Study|Death|2|||
124752500|NCT02737475|448716775|FG018|Overall Study|Death|1|||
124752501|NCT02737475|448716776|FG019|Overall Study|Death|0|||
124801458|NCT00777205|448904430|FG001|Overall Study|Protocol Violation|56|||
124801459|NCT03053271|448904433|FG000|Overall Study|Did not meet randomization criteria|3|||
124801460|NCT03053271|448904433|FG000|Overall Study|Withdrawal by Subject|1|||
124801461|NCT04137224|448904435|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
124801462|NCT04137224|448904436|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
124801463|NCT04137224|448904435|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
124801464|NCT04137224|448904436|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
124801465|NCT04137224|448904435|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
124801466|NCT04137224|448904436|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
124801467|NCT01225887|448904437|FG000|Overall Study|Ineligible:required test not done|2|||
124631558|NCT03334435|448267257|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
124631559|NCT03334435|448267258|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
124631560|NCT03334435|448267259|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
124631561|NCT03334435|448267260|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
124631562|NCT03334435|448267261|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
124631563|NCT03334435|448267262|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
124801468|NCT01225887|448904437|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
124801469|NCT01225887|448904437|FG000|Overall Study|Ineligible:inadequate pathology|2|||
124801470|NCT01669928|448904438|FG000|First Intervention|Withdrawal by Subject|3|||
124801471|NCT01669928|448904439|FG001|First Intervention|Withdrawal by Subject|5|||
124801472|NCT00925990|448904443|FG000|Overall Study|Adverse Event|1|||
124801473|NCT00925990|448904444|FG001|Overall Study|Adverse Event|3|||
124801474|NCT00925990|448904443|FG000|Overall Study|Withdrawal by Subject|2|||
124801475|NCT00925990|448904444|FG001|Overall Study|Withdrawal by Subject|2|||
124801476|NCT00925990|448904443|FG000|Overall Study|Lost to Follow-up|1|||
124801477|NCT00925990|448904444|FG001|Overall Study|Lost to Follow-up|3|||
124801478|NCT00925990|448904443|FG000|Overall Study|Physician Decision|1|||
124801479|NCT00925990|448904444|FG001|Overall Study|Physician Decision|1|||
124631564|NCT03334435|448267248|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
124631565|NCT03334435|448267249|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
124631566|NCT03334435|448267250|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
124631567|NCT03334435|448267251|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
124631568|NCT03334435|448267252|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
124631569|NCT03334435|448267253|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
124801480|NCT00925990|448904443|FG000|Overall Study|moved out of state, missed medication|0|||
124801481|NCT00925990|448904444|FG001|Overall Study|moved out of state, missed medication|2|||
124801482|NCT00679055|448904445|FG000|Overall Study|Adverse Event|0|||
124801483|NCT00679055|448904446|FG001|Overall Study|Adverse Event|1|||
124631570|NCT03334435|448267254|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
124631571|NCT03334435|448267255|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
124631572|NCT03334435|448267256|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
124631573|NCT03334435|448267257|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
124631574|NCT03334435|448267258|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
124801484|NCT00679055|448904445|FG000|Overall Study|Other|0|||
124801485|NCT00679055|448904446|FG001|Overall Study|Other|3|||
124801486|NCT00679055|448904445|FG000|Overall Study|Study Terminated|2|||
124801487|NCT00679055|448904446|FG001|Overall Study|Study Terminated|1|||
124801488|NCT01822678|448904453|FG000|Overall Study|Withdrawal by Subject|5|||
124801489|NCT01822678|448904454|FG001|Overall Study|Withdrawal by Subject|4|||
124801490|NCT01822678|448904455|FG002|Overall Study|Withdrawal by Subject|4|||
124801491|NCT01822678|448904453|FG000|Overall Study|Adverse Event|4|||
124801492|NCT01822678|448904454|FG001|Overall Study|Adverse Event|3|||
124801493|NCT01822678|448904455|FG002|Overall Study|Adverse Event|1|||
124801494|NCT01822678|448904453|FG000|Overall Study|Lack of Efficacy|3|||
124801495|NCT01822678|448904454|FG001|Overall Study|Lack of Efficacy|6|||
124801496|NCT01822678|448904455|FG002|Overall Study|Lack of Efficacy|5|||
124801497|NCT01822678|448904453|FG000|Overall Study|Lost to Follow-up|0|||
124801498|NCT01822678|448904454|FG001|Overall Study|Lost to Follow-up|2|||
124801499|NCT01822678|448904455|FG002|Overall Study|Lost to Follow-up|1|||
124801500|NCT00943124|448904459|FG000|Period 1|Withdrawal by Subject|1|||
124801501|NCT00943124|448904460|FG001|Period 1|Withdrawal by Subject|1|||
124801502|NCT00943124|448904459|FG000|Period 1|Did Not Follow Study Procedures|1|||
124801503|NCT00943124|448904460|FG001|Period 1|Did Not Follow Study Procedures|0|||
124801504|NCT00943124|448904459|FG000|Period 1|Personal Reasons|0|||
124801505|NCT00943124|448904460|FG001|Period 1|Personal Reasons|1|||
124801506|NCT01916967|448904463|FG000|Overall Study|Adverse Event|0|||
124801507|NCT01916967|448904464|FG001|Overall Study|Adverse Event|0|||
124801508|NCT01916967|448904465|FG002|Overall Study|Adverse Event|2|||
124801509|NCT01916967|448904463|FG000|Overall Study|Lack of Efficacy|0|||
124801510|NCT01916967|448904464|FG001|Overall Study|Lack of Efficacy|0|||
124801511|NCT01916967|448904465|FG002|Overall Study|Lack of Efficacy|6|||
124801512|NCT01916967|448904463|FG000|Overall Study|Physician Decision|0|||
124801513|NCT01916967|448904464|FG001|Overall Study|Physician Decision|0|||
124801514|NCT01916967|448904465|FG002|Overall Study|Physician Decision|1|||
124801515|NCT01916967|448904463|FG000|Overall Study|Protocol Violation|0|||
124801516|NCT01916967|448904464|FG001|Overall Study|Protocol Violation|1|||
124801517|NCT01916967|448904465|FG002|Overall Study|Protocol Violation|0|||
124801518|NCT01912963|448904466|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
124801519|NCT01912963|448904467|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
124801520|NCT01912963|448904468|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
124801521|NCT01912963|448904466|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
124801522|NCT01912963|448904467|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
124801523|NCT01912963|448904468|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
124801524|NCT01912963|448904466|FG000|Overall Study|Adverse Event|0|||
124801525|NCT01912963|448904467|FG001|Overall Study|Adverse Event|1|||
124801526|NCT01912963|448904468|FG002|Overall Study|Adverse Event|1|||
124801527|NCT01912963|448904466|FG000|Overall Study|Withdrawal by Subject|0|||
124801528|NCT01912963|448904467|FG001|Overall Study|Withdrawal by Subject|1|||
124801529|NCT01912963|448904468|FG002|Overall Study|Withdrawal by Subject|0|||
124801530|NCT01912963|448904466|FG000|Overall Study|Sought treatment locally|0|||
124801531|NCT01912963|448904467|FG001|Overall Study|Sought treatment locally|1|||
124801532|NCT01912963|448904468|FG002|Overall Study|Sought treatment locally|0|||
124801533|NCT01702571|448904471|FG000|Overall Study|Death|1067|||
124801534|NCT01702571|448904472|FG001|Overall Study|Death|76|||
124801535|NCT01702571|448904471|FG000|Overall Study|Lost to Follow-up|144|||
124801536|NCT01702571|448904472|FG001|Overall Study|Lost to Follow-up|10|||
124801537|NCT01702571|448904471|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
124631575|NCT03334435|448267259|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
124631576|NCT03334435|448267260|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
124631577|NCT03334435|448267261|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
124631578|NCT03334435|448267262|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
124631579|NCT03334435|448267248|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
124631580|NCT03334435|448267249|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
124631581|NCT03334435|448267250|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
124631582|NCT03334435|448267251|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
124752502|NCT02737475|448716777|FG020|Overall Study|Death|0|||
124752503|NCT02737475|448716778|FG021|Overall Study|Death|0|||
124752504|NCT02737475|448716779|FG022|Overall Study|Death|0|||
124752505|NCT02737475|448716780|FG023|Overall Study|Death|0|||
124752506|NCT02737475|448716781|FG024|Overall Study|Death|0|||
124752507|NCT02737475|448716782|FG025|Overall Study|Death|0|||
124752508|NCT02737475|448716783|FG026|Overall Study|Death|0|||
124752509|NCT02737475|448716757|FG000|Overall Study|Participant withdrew consent|0|||
124752510|NCT02737475|448716758|FG001|Overall Study|Participant withdrew consent|0|||
124752511|NCT02737475|448716759|FG002|Overall Study|Participant withdrew consent|0|||
124752512|NCT02737475|448716760|FG003|Overall Study|Participant withdrew consent|0|||
124752513|NCT02737475|448716761|FG004|Overall Study|Participant withdrew consent|0|||
124752514|NCT02737475|448716762|FG005|Overall Study|Participant withdrew consent|2|||
124752515|NCT02737475|448716763|FG006|Overall Study|Participant withdrew consent|0|||
124752516|NCT02737475|448716764|FG007|Overall Study|Participant withdrew consent|0|||
124752517|NCT02737475|448716765|FG008|Overall Study|Participant withdrew consent|0|||
124752518|NCT02737475|448716766|FG009|Overall Study|Participant withdrew consent|0|||
124752519|NCT02737475|448716767|FG010|Overall Study|Participant withdrew consent|0|||
124752520|NCT02737475|448716768|FG011|Overall Study|Participant withdrew consent|0|||
124752521|NCT02737475|448716769|FG012|Overall Study|Participant withdrew consent|0|||
124752522|NCT02737475|448716770|FG013|Overall Study|Participant withdrew consent|0|||
124752523|NCT02737475|448716771|FG014|Overall Study|Participant withdrew consent|1|||
124752524|NCT02737475|448716772|FG015|Overall Study|Participant withdrew consent|0|||
124752525|NCT02737475|448716773|FG016|Overall Study|Participant withdrew consent|0|||
124752526|NCT02737475|448716774|FG017|Overall Study|Participant withdrew consent|2|||
124752527|NCT02737475|448716775|FG018|Overall Study|Participant withdrew consent|1|||
124752528|NCT02737475|448716776|FG019|Overall Study|Participant withdrew consent|0|||
124752529|NCT02737475|448716777|FG020|Overall Study|Participant withdrew consent|2|||
124752530|NCT02737475|448716778|FG021|Overall Study|Participant withdrew consent|0|||
124752531|NCT02737475|448716779|FG022|Overall Study|Participant withdrew consent|0|||
124752532|NCT02737475|448716780|FG023|Overall Study|Participant withdrew consent|0|||
124752533|NCT02737475|448716781|FG024|Overall Study|Participant withdrew consent|0|||
124752534|NCT02737475|448716782|FG025|Overall Study|Participant withdrew consent|0|||
124752535|NCT02737475|448716783|FG026|Overall Study|Participant withdrew consent|0|||
124752536|NCT02737475|448716757|FG000|Overall Study|Lost to Follow-up|0|||
124752537|NCT02737475|448716758|FG001|Overall Study|Lost to Follow-up|0|||
124752538|NCT02737475|448716759|FG002|Overall Study|Lost to Follow-up|0|||
124752539|NCT02737475|448716760|FG003|Overall Study|Lost to Follow-up|0|||
124752540|NCT02737475|448716761|FG004|Overall Study|Lost to Follow-up|0|||
124801538|NCT01702571|448904472|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
124801539|NCT01702571|448904471|FG000|Overall Study|Investigator Decision|5|||
124801540|NCT01702571|448904472|FG001|Overall Study|Investigator Decision|0|||
124801541|NCT01702571|448904471|FG000|Overall Study|Not Classifiable|1|||
124801542|NCT01702571|448904472|FG001|Overall Study|Not Classifiable|0|||
124801543|NCT01702571|448904471|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
124801544|NCT01702571|448904472|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
124801545|NCT01702571|448904471|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
124801546|NCT01702571|448904472|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
124801547|NCT01702571|448904471|FG000|Overall Study|Progressive Disease|3|||
124801548|NCT01702571|448904472|FG001|Overall Study|Progressive Disease|0|||
124801549|NCT01702571|448904471|FG000|Overall Study|Protocol Violation|2|||
124801550|NCT01702571|448904472|FG001|Overall Study|Protocol Violation|0|||
124801551|NCT01702571|448904471|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
124801552|NCT01702571|448904472|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
124801553|NCT01702571|448904471|FG000|Overall Study|Termination By Sponsor|4|||
124801554|NCT01702571|448904472|FG001|Overall Study|Termination By Sponsor|0|||
124801555|NCT01702571|448904471|FG000|Overall Study|Withdrawal by Subject|177|||
124801556|NCT01702571|448904472|FG001|Overall Study|Withdrawal by Subject|29|||
124801557|NCT01977937|448904479|FG000|Overall Study|Withdrawal by Subject|2|||
124801558|NCT01977937|448904480|FG001|Overall Study|Withdrawal by Subject|1|||
124801559|NCT01977937|448904479|FG000|Overall Study|Adverse Event|1|||
124801560|NCT01977937|448904480|FG001|Overall Study|Adverse Event|0|||
124801561|NCT01977937|448904479|FG000|Overall Study|Physician Decision|0|||
124801562|NCT01977937|448904480|FG001|Overall Study|Physician Decision|1|||
124801563|NCT00915356|448904481|FG000|Overall Study|Withdrawal by Subject|1|||
124801564|NCT00915356|448904482|FG001|Overall Study|Withdrawal by Subject|0|||
124801565|NCT00915356|448904483|FG002|Overall Study|Withdrawal by Subject|0|||
124801566|NCT00915356|448904484|FG003|Overall Study|Withdrawal by Subject|0|||
124801567|NCT00915356|448904485|FG004|Overall Study|Withdrawal by Subject|0|||
124801568|NCT02001181|448904491|FG000|Overall Study|Adverse Event|0|||
124801569|NCT02001181|448904492|FG001|Overall Study|Adverse Event|2|||
124801570|NCT02001181|448904491|FG000|Overall Study|Lost to Follow-up|1|||
124801571|NCT02001181|448904492|FG001|Overall Study|Lost to Follow-up|0|||
124801572|NCT02001181|448904491|FG000|Overall Study|Withdrawal by Subject|0|||
124801573|NCT02001181|448904492|FG001|Overall Study|Withdrawal by Subject|1|||
124801574|NCT00292318|448904493|FG000|Overall Study|Study terminated by officials|2|||
124801575|NCT00292318|448904494|FG001|Overall Study|Study terminated by officials|1|||
124801576|NCT01278160|448904495|FG000|Overall Study|Adverse Event|1|||
124801577|NCT01278160|448904496|FG001|Overall Study|Adverse Event|1|||
124801578|NCT01278160|448904495|FG000|Overall Study|Lost to Follow-up|0|||
124801579|NCT01278160|448904496|FG001|Overall Study|Lost to Follow-up|1|||
124801580|NCT01278160|448904495|FG000|Overall Study|Withdrawal by Subject|3|||
124801581|NCT01278160|448904496|FG001|Overall Study|Withdrawal by Subject|2|||
124801582|NCT01278160|448904495|FG000|Overall Study|Unclassified|1|||
124631583|NCT03334435|448267252|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
124631584|NCT03334435|448267253|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
124631585|NCT03334435|448267254|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
124631586|NCT03334435|448267255|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
124631587|NCT03334435|448267256|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
124631588|NCT03334435|448267257|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
124631589|NCT03334435|448267258|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
124631590|NCT03334435|448267259|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
124631591|NCT03334435|448267260|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
124631592|NCT03334435|448267261|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
124631593|NCT03334435|448267262|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
124631594|NCT03334435|448267248|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
124631595|NCT03334435|448267249|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
124631596|NCT03334435|448267250|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
124631597|NCT03334435|448267251|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
124631598|NCT03334435|448267252|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
124631599|NCT03334435|448267253|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
124631600|NCT03334435|448267254|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
124631601|NCT03334435|448267255|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
124801583|NCT01278160|448904496|FG001|Overall Study|Unclassified|2|||
124801584|NCT02819518|448904497|FG000|Overall Study|Death|9|||
124801585|NCT02819518|448904498|FG001|Overall Study|Death|12|||
124801586|NCT02819518|448904499|FG002|Overall Study|Death|9|||
124801587|NCT02819518|448904500|FG003|Overall Study|Death|475|||
124801588|NCT02819518|448904501|FG004|Overall Study|Death|244|||
124801589|NCT02819518|448904497|FG000|Overall Study|Withdrawal by Subject|0|||
124801590|NCT02819518|448904498|FG001|Overall Study|Withdrawal by Subject|0|||
124801591|NCT02819518|448904499|FG002|Overall Study|Withdrawal by Subject|0|||
124801592|NCT02819518|448904500|FG003|Overall Study|Withdrawal by Subject|25|||
124801593|NCT02819518|448904501|FG004|Overall Study|Withdrawal by Subject|8|||
124801594|NCT02819518|448904497|FG000|Overall Study|Lost to Follow-up|0|||
124801595|NCT02819518|448904498|FG001|Overall Study|Lost to Follow-up|0|||
124801596|NCT02819518|448904499|FG002|Overall Study|Lost to Follow-up|0|||
124801597|NCT02819518|448904500|FG003|Overall Study|Lost to Follow-up|0|||
124801598|NCT02819518|448904501|FG004|Overall Study|Lost to Follow-up|1|||
124801599|NCT02819518|448904497|FG000|Overall Study|Sponsor Decision|1|||
124801600|NCT02819518|448904498|FG001|Overall Study|Sponsor Decision|1|||
124801601|NCT02819518|448904499|FG002|Overall Study|Sponsor Decision|0|||
124801602|NCT02819518|448904500|FG003|Overall Study|Sponsor Decision|34|||
124801603|NCT02819518|448904501|FG004|Overall Study|Sponsor Decision|17|||
124801604|NCT02819518|448904497|FG000|Overall Study|Transferred to extension study|1|||
124801605|NCT02819518|448904498|FG001|Overall Study|Transferred to extension study|1|||
124801606|NCT02819518|448904499|FG002|Overall Study|Transferred to extension study|1|||
124801607|NCT02819518|448904500|FG003|Overall Study|Transferred to extension study|32|||
124801608|NCT02819518|448904501|FG004|Overall Study|Transferred to extension study|11|||
124801609|NCT01505647|448904502|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
124801610|NCT01505647|448904503|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
124801611|NCT01505647|448904502|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
124801612|NCT01505647|448904503|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
124801613|NCT01505647|448904502|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
124801614|NCT01505647|448904503|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
124801615|NCT01505647|448904502|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
124801616|NCT01505647|448904503|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
124801617|NCT01505647|448904502|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
124801618|NCT01505647|448904503|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
124801619|NCT03112590|448904504|FG000|Overall Study|Adverse Event|0|||
124801620|NCT03112590|448904505|FG001|Overall Study|Adverse Event|1|||
124801621|NCT03112590|448904506|FG002|Overall Study|Adverse Event|0|||
124801622|NCT00843726|448904507|FG000|Overall Study|Death|1|||
124801623|NCT00843726|448904508|FG001|Overall Study|Death|0|||
124801624|NCT00843726|448904507|FG000|Overall Study|Withdrawal by Subject|0|||
124801625|NCT00843726|448904508|FG001|Overall Study|Withdrawal by Subject|1|||
124801626|NCT00406718|448904509|FG000|Overall Study|Withdrawal by Subject|2|||
124801627|NCT00406718|448904510|FG001|Overall Study|Withdrawal by Subject|9|||
124801628|NCT00406718|448904511|FG002|Overall Study|Withdrawal by Subject|4|||
124801629|NCT00406718|448904509|FG000|Overall Study|Lost to Follow-up|2|||
124801630|NCT00406718|448904510|FG001|Overall Study|Lost to Follow-up|5|||
124801631|NCT00406718|448904511|FG002|Overall Study|Lost to Follow-up|4|||
124801632|NCT02898116|448904519|FG000|Overall Study|Adverse Event|1|||
124801633|NCT02898116|448904519|FG000|Overall Study|Progressive disease|1|||
124801634|NCT05597020|448904522|FG000|Washout|Forbidden medication|2|||
124801635|NCT05597020|448904523|FG001|Washout|Forbidden medication|0|||
124801636|NCT05597020|448904522|FG000|Treatment Period II|Advice from primary care physician|1|||
124801637|NCT05597020|448904523|FG001|Treatment Period II|Advice from primary care physician|0|||
124801638|NCT05597020|448904522|FG000|Treatment Period II|Subject lost investigational product|1|||
124801639|NCT05597020|448904523|FG001|Treatment Period II|Subject lost investigational product|0|||
124801640|NCT05597020|448904522|FG000|Treatment Period II|Private reasons|0|||
124801641|NCT05597020|448904523|FG001|Treatment Period II|Private reasons|1|||
124801642|NCT05169567|448904524|FG000|Overall Study|On study treatment|116|||
124801643|NCT05169567|448904525|FG001|Overall Study|On study treatment|128|||
124801644|NCT05169567|448904524|FG000|Overall Study|Lost to Follow-up|1|||
124801645|NCT05169567|448904525|FG001|Overall Study|Lost to Follow-up|0|||
124801646|NCT05169567|448904524|FG000|Overall Study|Withdrawal by Subject|25|||
124801647|NCT05169567|448904525|FG001|Overall Study|Withdrawal by Subject|21|||
124801648|NCT01015131|448904526|FG000|Overall Study|Physician Decision|1|||
124801649|NCT01015131|448904526|FG000|Overall Study|Protocol Violation|1|||
124801650|NCT01015131|448904526|FG000|Overall Study|Withdrawal by Subject|2|||
124801651|NCT01015131|448904526|FG000|Overall Study|Other Protocol Specified Criteria|4|||
124801652|NCT05430022|448904527|FG000|Overall Study|Withdrawal by Subject|4|||
124801653|NCT05430022|448904528|FG001|Overall Study|Withdrawal by Subject|4|||
124801654|NCT02445391|448904537|FG000|Overall Study|No active protocol treatment|3|||
124801655|NCT02445391|448904538|FG001|Overall Study|No active protocol treatment|0|||
124631602|NCT03334435|448267256|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
124801656|NCT02445391|448904539|FG002|Overall Study|No active protocol treatment|0|||
124801657|NCT02445391|448904537|FG000|Overall Study|Adverse Event|0|||
124801658|NCT02445391|448904538|FG001|Overall Study|Adverse Event|21|||
124801659|NCT02445391|448904539|FG002|Overall Study|Adverse Event|12|||
124801660|NCT02445391|448904537|FG000|Overall Study|Alternative therapy|0|||
124801661|NCT02445391|448904538|FG001|Overall Study|Alternative therapy|0|||
124801662|NCT02445391|448904539|FG002|Overall Study|Alternative therapy|1|||
124801663|NCT02445391|448904537|FG000|Overall Study|Disease progression|0|||
124801664|NCT02445391|448904538|FG001|Overall Study|Disease progression|7|||
124801665|NCT02445391|448904539|FG002|Overall Study|Disease progression|22|||
124631603|NCT03334435|448267257|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
124801666|NCT02445391|448904537|FG000|Overall Study|Complicating disease|0|||
124801667|NCT02445391|448904538|FG001|Overall Study|Complicating disease|2|||
124801668|NCT02445391|448904539|FG002|Overall Study|Complicating disease|1|||
124801669|NCT02445391|448904537|FG000|Overall Study|Withdrawal by Subject|0|||
124801670|NCT02445391|448904538|FG001|Overall Study|Withdrawal by Subject|4|||
124801671|NCT02445391|448904539|FG002|Overall Study|Withdrawal by Subject|9|||
124801672|NCT02445391|448904537|FG000|Overall Study|Financial issue|0|||
124801673|NCT02445391|448904538|FG001|Overall Study|Financial issue|0|||
124801674|NCT02445391|448904539|FG002|Overall Study|Financial issue|2|||
124801675|NCT02445391|448904537|FG000|Overall Study|Still on treatment|0|||
124801676|NCT02445391|448904538|FG001|Overall Study|Still on treatment|7|||
124631604|NCT03334435|448267258|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
124631605|NCT03334435|448267259|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
124631606|NCT03334435|448267260|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
124631607|NCT03334435|448267261|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
124801677|NCT02445391|448904539|FG002|Overall Study|Still on treatment|16|||
124801678|NCT02445391|448904537|FG000|Overall Study|Not start protocol therapy|0|||
124801679|NCT02445391|448904538|FG001|Overall Study|Not start protocol therapy|12|||
124801680|NCT02445391|448904539|FG002|Overall Study|Not start protocol therapy|9|||
124801681|NCT00891462|448906088|FG000|Overall Study|Withdrawal by Subject|9|||
124801682|NCT00891462|448906089|FG001|Overall Study|Withdrawal by Subject|6|||
124801683|NCT00891462|448906090|FG002|Overall Study|Withdrawal by Subject|7|||
124801684|NCT00891462|448906088|FG000|Overall Study|Adverse Event|7|||
124801685|NCT00891462|448906089|FG001|Overall Study|Adverse Event|8|||
124801686|NCT00891462|448906090|FG002|Overall Study|Adverse Event|7|||
124801687|NCT00891462|448906088|FG000|Overall Study|Lack of Efficacy|10|||
124801688|NCT00891462|448906089|FG001|Overall Study|Lack of Efficacy|5|||
124801689|NCT00891462|448906090|FG002|Overall Study|Lack of Efficacy|1|||
124801690|NCT00891462|448906088|FG000|Overall Study|COPD exacerbation|7|||
124801691|NCT00891462|448906089|FG001|Overall Study|COPD exacerbation|4|||
124801692|NCT00891462|448906090|FG002|Overall Study|COPD exacerbation|1|||
124801693|NCT00891462|448906088|FG000|Overall Study|Other Reason|2|||
124801694|NCT00891462|448906089|FG001|Overall Study|Other Reason|5|||
124801695|NCT00891462|448906090|FG002|Overall Study|Other Reason|3|||
124801696|NCT00891462|448906088|FG000|Overall Study|Protocol Violation|2|||
124801697|NCT00891462|448906089|FG001|Overall Study|Protocol Violation|1|||
124801698|NCT00891462|448906090|FG002|Overall Study|Protocol Violation|3|||
124801699|NCT00891462|448906088|FG000|Overall Study|Inclusion/exclusion criteria|0|||
124801700|NCT00891462|448906089|FG001|Overall Study|Inclusion/exclusion criteria|2|||
124801701|NCT00891462|448906090|FG002|Overall Study|Inclusion/exclusion criteria|2|||
124801702|NCT00891462|448906088|FG000|Overall Study|Lost to Follow-up|0|||
124801703|NCT00891462|448906089|FG001|Overall Study|Lost to Follow-up|2|||
124801704|NCT00891462|448906090|FG002|Overall Study|Lost to Follow-up|0|||
124801705|NCT00423722|448906094|FG000|Overall Study|Death|4|||
124801706|NCT00423722|448906095|FG001|Overall Study|Death|4|||
124801707|NCT00423722|448906094|FG000|Overall Study|Declined to participate|2|||
124801708|NCT00423722|448906095|FG001|Overall Study|Declined to participate|3|||
124801709|NCT00423722|448906094|FG000|Overall Study|Unable to complete questionnaires|4|||
124631608|NCT03334435|448267262|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
124631609|NCT04067050|448267270|FG000|One Month|Lost to Follow-up|4|||
124631610|NCT04067050|448267271|FG001|One Month|Lost to Follow-up|0|||
124631611|NCT04067050|448267270|FG000|Two Month|Lost to Follow-up|1|||
124631612|NCT04067050|448267271|FG001|Two Month|Lost to Follow-up|0|||
124631613|NCT04067050|448267270|FG000|Two Month|Adverse Event|1|||
124631614|NCT04067050|448267271|FG001|Two Month|Adverse Event|0|||
124631615|NCT00942084|448267282|FG000|Overall Study|Death|2|||
124631616|NCT02342678|448267284|FG000|Overall Study|Lost to Follow-up|0|||
124631617|NCT02342678|448267285|FG001|Overall Study|Lost to Follow-up|1|||
124631618|NCT02342678|448267284|FG000|Overall Study|Too busy to complete study|0|||
124631619|NCT02342678|448267285|FG001|Overall Study|Too busy to complete study|2|||
124631620|NCT02342678|448267284|FG000|Overall Study|Family illness/emergency|0|||
124631621|NCT02342678|448267285|FG001|Overall Study|Family illness/emergency|1|||
124631622|NCT02342678|448267284|FG000|Overall Study|Illness/medical reason|1|||
124631623|NCT02342678|448267285|FG001|Overall Study|Illness/medical reason|1|||
124631624|NCT01930162|448267288|FG000|Overall Study|Abnormal test procedure result(s)|4|||
124631625|NCT01930162|448267288|FG000|Overall Study|Death|1|||
124631626|NCT00031590|448267289|FG000|Overall Study|Adverse Event|1|||
124631627|NCT00031590|448267289|FG000|Overall Study|Withdrawal by parents|2|||
124631628|NCT05506046|448267290|FG000|Overall Study|Lost to Follow-up|89|||
124631629|NCT05506046|448267291|FG001|Overall Study|Lost to Follow-up|101|||
124631630|NCT05506046|448267292|FG002|Overall Study|Lost to Follow-up|102|||
124631631|NCT05506046|448267293|FG003|Overall Study|Lost to Follow-up|99|||
124631632|NCT03051100|448267297|FG000|Overall Study|Withdrawal by Subject|1|||
124801710|NCT00423722|448906095|FG001|Overall Study|Unable to complete questionnaires|4|||
124631633|NCT03051100|448267298|FG001|Overall Study|Withdrawal by Subject|0|||
124801711|NCT00423722|448906094|FG000|Overall Study|Withdrawal by Subject|4|||
124801712|NCT00423722|448906095|FG001|Overall Study|Withdrawal by Subject|2|||
124801713|NCT00518687|448906097|FG000|Overall Study|Adverse Event|201|||
124801714|NCT00518687|448906098|FG001|Overall Study|Adverse Event|177|||
124631634|NCT03776357|448267299|FG000|Overall Study|Lost to Follow-up|3|||
124631635|NCT01198470|448267302|FG000|Overall Study|Adverse Event|2|||
124631636|NCT02949973|448267303|FG000|Overall Study|Physician Decision|1|||
124631637|NCT01422213|448267304|FG000|Overall Study|Adverse Event|8|||
124631638|NCT01422213|448267305|FG001|Overall Study|Adverse Event|7|||
124631639|NCT01422213|448267306|FG002|Overall Study|Adverse Event|11|||
124631640|NCT01422213|448267304|FG000|Overall Study|Lack of Efficacy|10|||
124631641|NCT01422213|448267305|FG001|Overall Study|Lack of Efficacy|2|||
124631642|NCT01422213|448267306|FG002|Overall Study|Lack of Efficacy|2|||
124631643|NCT01422213|448267304|FG000|Overall Study|Non-compliance with study drug|0|||
124631644|NCT01422213|448267305|FG001|Overall Study|Non-compliance with study drug|1|||
124631645|NCT01422213|448267306|FG002|Overall Study|Non-compliance with study drug|0|||
124631646|NCT01422213|448267304|FG000|Overall Study|Protocol Violation|0|||
124631647|NCT01422213|448267305|FG001|Overall Study|Protocol Violation|2|||
124631648|NCT01422213|448267306|FG002|Overall Study|Protocol Violation|4|||
124631649|NCT01422213|448267304|FG000|Overall Study|Withdrawal of Consent|7|||
124631650|NCT01422213|448267305|FG001|Overall Study|Withdrawal of Consent|3|||
124631651|NCT01422213|448267306|FG002|Overall Study|Withdrawal of Consent|5|||
124631652|NCT01422213|448267304|FG000|Overall Study|Lost to Follow-up|3|||
124631653|NCT01422213|448267305|FG001|Overall Study|Lost to Follow-up|3|||
124631654|NCT01422213|448267306|FG002|Overall Study|Lost to Follow-up|5|||
124631655|NCT01422213|448267304|FG000|Overall Study|Administrative or Other Reason(s)|5|||
124631656|NCT01422213|448267305|FG001|Overall Study|Administrative or Other Reason(s)|4|||
124631657|NCT01422213|448267306|FG002|Overall Study|Administrative or Other Reason(s)|2|||
124631658|NCT04129125|448267313|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
124631659|NCT04129125|448267313|FG000|Overall Study|Study device was not used|3|||
124631660|NCT04484142|448267314|FG000|Overall Study|Adverse Event|13|||
124631661|NCT04484142|448267314|FG000|Overall Study|Progressive Disease|87|||
124631662|NCT04484142|448267314|FG000|Overall Study|Clinical Progression|10|||
124631663|NCT04484142|448267314|FG000|Overall Study|Withdrawal by Subject|6|||
124631664|NCT04484142|448267314|FG000|Overall Study|Physician Decision|1|||
124631665|NCT03181633|448267315|FG000|Overall Study|Withdrawal by Subject|1|||
124631666|NCT03181633|448267315|FG000|Overall Study|Missing follow-up visit|1|||
124631667|NCT05303194|448267316|FG000|Overall Study|Lost to Follow-up|1|||
124631668|NCT05303194|448267317|FG001|Overall Study|Lost to Follow-up|1|||
124631669|NCT05303194|448267316|FG000|Overall Study|Withdrawal by Subject|0|||
124631670|NCT05303194|448267317|FG001|Overall Study|Withdrawal by Subject|1|||
124631671|NCT05271175|448267327|FG000|One Week Follow up|Lost to Follow-up|10|||
124631672|NCT05271175|448267328|FG001|One Week Follow up|Lost to Follow-up|7|||
124631673|NCT05271175|448267329|FG002|One Week Follow up|Lost to Follow-up|5|||
124631674|NCT05271175|448267327|FG000|One Month Follow up|Lost to Follow-up|12|||
124631675|NCT05271175|448267328|FG001|One Month Follow up|Lost to Follow-up|7|||
124631676|NCT05271175|448267329|FG002|One Month Follow up|Lost to Follow-up|9|||
124752541|NCT02737475|448716762|FG005|Overall Study|Lost to Follow-up|0|||
124752542|NCT02737475|448716763|FG006|Overall Study|Lost to Follow-up|0|||
124752543|NCT02737475|448716764|FG007|Overall Study|Lost to Follow-up|0|||
124752544|NCT02737475|448716765|FG008|Overall Study|Lost to Follow-up|0|||
124752545|NCT02737475|448716766|FG009|Overall Study|Lost to Follow-up|0|||
124752546|NCT02737475|448716767|FG010|Overall Study|Lost to Follow-up|0|||
124752547|NCT02737475|448716768|FG011|Overall Study|Lost to Follow-up|0|||
124752548|NCT02737475|448716769|FG012|Overall Study|Lost to Follow-up|0|||
124752549|NCT02737475|448716770|FG013|Overall Study|Lost to Follow-up|0|||
124752550|NCT02737475|448716771|FG014|Overall Study|Lost to Follow-up|0|||
124752551|NCT02737475|448716772|FG015|Overall Study|Lost to Follow-up|1|||
124752552|NCT02737475|448716773|FG016|Overall Study|Lost to Follow-up|0|||
124752553|NCT02737475|448716774|FG017|Overall Study|Lost to Follow-up|0|||
124752554|NCT02737475|448716775|FG018|Overall Study|Lost to Follow-up|0|||
124752555|NCT02737475|448716776|FG019|Overall Study|Lost to Follow-up|0|||
124752556|NCT02737475|448716777|FG020|Overall Study|Lost to Follow-up|0|||
124752557|NCT02737475|448716778|FG021|Overall Study|Lost to Follow-up|0|||
124752558|NCT02737475|448716779|FG022|Overall Study|Lost to Follow-up|0|||
124752559|NCT02737475|448716780|FG023|Overall Study|Lost to Follow-up|0|||
124752560|NCT02737475|448716781|FG024|Overall Study|Lost to Follow-up|0|||
124752561|NCT02737475|448716782|FG025|Overall Study|Lost to Follow-up|0|||
124752562|NCT02737475|448716783|FG026|Overall Study|Lost to Follow-up|0|||
124752563|NCT02737475|448716757|FG000|Overall Study|Disease Progression|0|||
124752564|NCT02737475|448716758|FG001|Overall Study|Disease Progression|0|||
124752565|NCT02737475|448716759|FG002|Overall Study|Disease Progression|0|||
124752566|NCT02737475|448716760|FG003|Overall Study|Disease Progression|0|||
124752567|NCT02737475|448716761|FG004|Overall Study|Disease Progression|0|||
124752568|NCT02737475|448716762|FG005|Overall Study|Disease Progression|0|||
124752569|NCT02737475|448716763|FG006|Overall Study|Disease Progression|0|||
124752570|NCT02737475|448716764|FG007|Overall Study|Disease Progression|0|||
124752571|NCT02737475|448716765|FG008|Overall Study|Disease Progression|0|||
124752572|NCT02737475|448716766|FG009|Overall Study|Disease Progression|0|||
124752573|NCT02737475|448716767|FG010|Overall Study|Disease Progression|0|||
124752574|NCT02737475|448716768|FG011|Overall Study|Disease Progression|0|||
124801715|NCT00518687|448906097|FG000|Overall Study|Lost to Follow-up|144|||
124801716|NCT00518687|448906098|FG001|Overall Study|Lost to Follow-up|155|||
124801717|NCT00518687|448906097|FG000|Overall Study|Physician Decision|42|||
124801718|NCT00518687|448906098|FG001|Overall Study|Physician Decision|48|||
124801719|NCT00518687|448906097|FG000|Overall Study|Progressive disease|2|||
124801720|NCT00518687|448906098|FG001|Overall Study|Progressive disease|2|||
124801721|NCT00518687|448906097|FG000|Overall Study|Protocol Violation|8|||
124801722|NCT00518687|448906098|FG001|Overall Study|Protocol Violation|10|||
124801723|NCT00518687|448906097|FG000|Overall Study|Study terminated by sponsor|930|||
124801724|NCT00518687|448906098|FG001|Overall Study|Study terminated by sponsor|918|||
124801725|NCT00518687|448906097|FG000|Overall Study|Withdrawal by Subject|110|||
124801726|NCT00518687|448906098|FG001|Overall Study|Withdrawal by Subject|110|||
124801727|NCT01846104|448906099|FG000|Overall Study|Withdrawal by Subject|1|||
124801728|NCT02095223|448906100|FG000|Overall Study|Withdrawal by Subject|1|||
124801729|NCT02095223|448906101|FG001|Overall Study|Withdrawal by Subject|0|||
124801730|NCT01397162|448906102|FG000|Overall Study|Adverse Event|4|||
124801731|NCT01397162|448906103|FG001|Overall Study|Adverse Event|0|||
124801732|NCT01397162|448906104|FG002|Overall Study|Adverse Event|0|||
124801733|NCT01397162|448906105|FG003|Overall Study|Adverse Event|0|||
124801734|NCT01397162|448906106|FG004|Overall Study|Adverse Event|0|||
124801735|NCT01397162|448906102|FG000|Overall Study|Not yet defined|3|||
124801736|NCT01397162|448906103|FG001|Overall Study|Not yet defined|4|||
124801737|NCT01397162|448906104|FG002|Overall Study|Not yet defined|3|||
124801738|NCT01397162|448906105|FG003|Overall Study|Not yet defined|5|||
124801739|NCT01397162|448906106|FG004|Overall Study|Not yet defined|3|||
124801740|NCT02339285|448906107|FG000|Overall Study|Withdrawal by Subject|0|||
124801741|NCT02339285|448906108|FG001|Overall Study|Withdrawal by Subject|1|||
124801742|NCT02339285|448906109|FG002|Overall Study|Withdrawal by Subject|1|||
124801743|NCT02339285|448906107|FG000|Overall Study|Lost to Follow-up|1|||
124801744|NCT02339285|448906108|FG001|Overall Study|Lost to Follow-up|1|||
124801745|NCT02339285|448906109|FG002|Overall Study|Lost to Follow-up|1|||
124801746|NCT02339285|448906107|FG000|Overall Study|Protocol Deviation|0|||
124801747|NCT02339285|448906108|FG001|Overall Study|Protocol Deviation|1|||
124801748|NCT02339285|448906109|FG002|Overall Study|Protocol Deviation|0|||
124801749|NCT00282412|448906112|FG000|Overall Study|Death|2|||
124801750|NCT00697073|448906113|FG000|Overall Study|Withdrawal by Subject|2|||
124801751|NCT00697073|448906113|FG000|Overall Study|Pregnancy|1|||
124801752|NCT00697073|448906113|FG000|Overall Study|non compliance and other|6|||
124801753|NCT00736957|448906118|FG000|Overall Study|Adverse Event|43|||
124801754|NCT00736957|448906118|FG000|Overall Study|Withdrawal by Subject|49|||
124801755|NCT00736957|448906118|FG000|Overall Study|violation of eligibility criteria|2|||
124801756|NCT00736957|448906118|FG000|Overall Study|did not attend hospital appointments|1|||
124801757|NCT00736957|448906118|FG000|Overall Study|not eligible for Treatment Period I|22|||
124801758|NCT00736957|448906118|FG000|Overall Study|Physician Decision|5|||
124801759|NCT02231918|448906120|FG000|Overall Study|Withdrawal by Subject|0|||
124801760|NCT02231918|448906121|FG001|Overall Study|Withdrawal by Subject|1|||
124801761|NCT02231918|448906122|FG002|Overall Study|Withdrawal by Subject|0|||
124801762|NCT02231918|448906120|FG000|Overall Study|Adverse Event|0|||
124801763|NCT02231918|448906121|FG001|Overall Study|Adverse Event|0|||
124801764|NCT02231918|448906122|FG002|Overall Study|Adverse Event|1|||
124801765|NCT00331864|448906123|FG000|Overall Study|Adverse Event|30|||
124801766|NCT00331864|448906124|FG001|Overall Study|Adverse Event|1|||
124801767|NCT00331864|448906123|FG000|Overall Study|Lack of Efficacy|4|||
124801768|NCT00331864|448906124|FG001|Overall Study|Lack of Efficacy|0|||
124801769|NCT00331864|448906123|FG000|Overall Study|Protocol Violation|3|||
124801770|NCT00331864|448906124|FG001|Overall Study|Protocol Violation|0|||
124801771|NCT00331864|448906123|FG000|Overall Study|Withdrawal by Subject|10|||
124801772|NCT00331864|448906124|FG001|Overall Study|Withdrawal by Subject|0|||
124801773|NCT00331864|448906123|FG000|Overall Study|Lost to Follow-up|4|||
124801774|NCT00331864|448906124|FG001|Overall Study|Lost to Follow-up|3|||
124801775|NCT00331864|448906123|FG000|Overall Study|Administrative Problems|1|||
124801776|NCT00331864|448906124|FG001|Overall Study|Administrative Problems|0|||
124801777|NCT00331864|448906123|FG000|Overall Study|Death|6|||
124801778|NCT00331864|448906124|FG001|Overall Study|Death|0|||
124801779|NCT01092507|448906125|FG000|Overall Study|Withdrawal by Subject|2|||
124801780|NCT01092507|448906126|FG001|Overall Study|Withdrawal by Subject|0|||
124801781|NCT04073368|448906129|FG000|Overall Study|Adverse Event|2|||
124801782|NCT04073368|448906130|FG001|Overall Study|Adverse Event|0|||
124801783|NCT04073368|448906131|FG002|Overall Study|Adverse Event|1|||
124801784|NCT04073368|448906132|FG003|Overall Study|Adverse Event|1|||
124801785|NCT04073368|448906129|FG000|Overall Study|Withdrawal by Subject|2|||
124801786|NCT04073368|448906130|FG001|Overall Study|Withdrawal by Subject|2|||
124801787|NCT04073368|448906131|FG002|Overall Study|Withdrawal by Subject|1|||
124801788|NCT04073368|448906132|FG003|Overall Study|Withdrawal by Subject|1|||
124801789|NCT04073368|448906129|FG000|Overall Study|Lost to Follow-up|1|||
124801790|NCT04073368|448906130|FG001|Overall Study|Lost to Follow-up|1|||
124801791|NCT04073368|448906131|FG002|Overall Study|Lost to Follow-up|1|||
124801792|NCT04073368|448906132|FG003|Overall Study|Lost to Follow-up|0|||
124801793|NCT04073368|448906129|FG000|Overall Study|Protocol Violation|0|||
124801794|NCT04073368|448906130|FG001|Overall Study|Protocol Violation|1|||
124801795|NCT04073368|448906131|FG002|Overall Study|Protocol Violation|0|||
124801796|NCT04073368|448906132|FG003|Overall Study|Protocol Violation|0|||
124801797|NCT04073368|448906129|FG000|Overall Study|Subject noncompliance|7|||
124801798|NCT04073368|448906130|FG001|Overall Study|Subject noncompliance|4|||
124801799|NCT04073368|448906131|FG002|Overall Study|Subject noncompliance|0|||
124801800|NCT04073368|448906132|FG003|Overall Study|Subject noncompliance|0|||
124801801|NCT00145600|448906133|FG000|Overall Study|Death|1|||
124801802|NCT00145600|448906134|FG001|Overall Study|Death|2|||
124801803|NCT00145600|448906135|FG002|Overall Study|Death|2|||
124801804|NCT00145600|448906136|FG003|Overall Study|Death|6|||
124801805|NCT00145600|448906133|FG000|Overall Study|Ineligible|3|||
124801806|NCT00145600|448906134|FG001|Overall Study|Ineligible|0|||
124801807|NCT00145600|448906135|FG002|Overall Study|Ineligible|1|||
124801808|NCT00145600|448906136|FG003|Overall Study|Ineligible|5|||
124801809|NCT00145600|448906133|FG000|Overall Study|Lost to Follow-up|2|||
124801810|NCT00145600|448906134|FG001|Overall Study|Lost to Follow-up|6|||
124801811|NCT00145600|448906135|FG002|Overall Study|Lost to Follow-up|2|||
124801812|NCT00145600|448906136|FG003|Overall Study|Lost to Follow-up|4|||
124801813|NCT00145600|448906133|FG000|Overall Study|Noncompliance|1|||
124801814|NCT00145600|448906134|FG001|Overall Study|Noncompliance|0|||
124801815|NCT00145600|448906135|FG002|Overall Study|Noncompliance|0|||
124801816|NCT00145600|448906136|FG003|Overall Study|Noncompliance|0|||
124801817|NCT00145600|448906133|FG000|Overall Study|Withdrawal by Subject|1|||
124801818|NCT00145600|448906134|FG001|Overall Study|Withdrawal by Subject|2|||
124801819|NCT00145600|448906135|FG002|Overall Study|Withdrawal by Subject|0|||
124801820|NCT00145600|448906136|FG003|Overall Study|Withdrawal by Subject|1|||
124631677|NCT05271175|448267327|FG000|Six Months Follow up|Lost to Follow-up|8|||
124631678|NCT05271175|448267328|FG001|Six Months Follow up|Lost to Follow-up|2|||
124631679|NCT05271175|448267329|FG002|Six Months Follow up|Lost to Follow-up|2|||
124631680|NCT00991887|448267330|FG000|Overall Study|Lost to Follow-up|2|||
124631681|NCT00991887|448267331|FG001|Overall Study|Lost to Follow-up|1|||
124631682|NCT02723344|448267332|FG000|Overall Study|Lost to Follow-up|0|||
124631683|NCT02723344|448267333|FG001|Overall Study|Lost to Follow-up|4|||
124631684|NCT02964247|448267336|FG000|Overall Study|Lost to Follow-up|2|||
124631685|NCT02964247|448267337|FG001|Overall Study|Lost to Follow-up|0|||
124631686|NCT02964247|448267336|FG000|Overall Study|Withdrawal by Subject|1|||
124801821|NCT01539642|448906142|FG000|Overall Study|Lack of Efficacy|20|||
124801822|NCT01539642|448906143|FG001|Overall Study|Lack of Efficacy|18|||
124801823|NCT01539642|448906142|FG000|Overall Study|Patient ready for early discharge|8|||
124801824|NCT01539642|448906143|FG001|Overall Study|Patient ready for early discharge|7|||
124801825|NCT01539642|448906142|FG000|Overall Study|Adverse Event|6|||
124801826|NCT01539642|448906143|FG001|Overall Study|Adverse Event|4|||
124801827|NCT01539642|448906142|FG000|Overall Study|Withdrawal by Subject|2|||
124801828|NCT01539642|448906143|FG001|Overall Study|Withdrawal by Subject|2|||
124801829|NCT00761579|448906144|FG000|Overall Study|Adverse Event|10|||
124801830|NCT00761579|448906144|FG000|Overall Study|Death|2|||
124801831|NCT00761579|448906144|FG000|Overall Study|Lack of Efficacy|21|||
124801832|NCT00761579|448906144|FG000|Overall Study|Lost to Follow-up|16|||
124631687|NCT02964247|448267337|FG001|Overall Study|Withdrawal by Subject|2|||
124631688|NCT00740636|448267340|FG000|Overall Study|Adverse Event|0|||
124631689|NCT00740636|448267341|FG001|Overall Study|Adverse Event|2|||
124631690|NCT00740636|448267340|FG000|Overall Study|Patient Ineligible|0|||
124631691|NCT00740636|448267341|FG001|Overall Study|Patient Ineligible|1|||
124631692|NCT00740636|448267340|FG000|Overall Study|Patient Not Treated|0|||
124631693|NCT00740636|448267341|FG001|Overall Study|Patient Not Treated|1|||
124631694|NCT00740636|448267340|FG000|Overall Study|Progressive Disease|1|||
124631695|NCT00740636|448267341|FG001|Overall Study|Progressive Disease|0|||
124631696|NCT00740636|448267340|FG000|Overall Study|Death|1|||
124631697|NCT00740636|448267341|FG001|Overall Study|Death|0|||
124631698|NCT03832686|448267342|FG000|Overall Study|Lost to Follow-up|6|||
124631699|NCT03832686|448267343|FG001|Overall Study|Lost to Follow-up|9|||
124631700|NCT03832686|448267342|FG000|Overall Study|Discontinued Intervention|5|||
124631701|NCT03832686|448267343|FG001|Overall Study|Discontinued Intervention|4|||
124631702|NCT01609790|448267344|FG000|Overall Study|Protocol Violation|1|||
124631703|NCT01609790|448267345|FG001|Overall Study|Protocol Violation|7|||
124631704|NCT01609790|448267346|FG002|Overall Study|Protocol Violation|8|||
124631705|NCT00739882|448268916|FG000|Double-blind Period|Adverse Event|1|||
124631706|NCT00739882|448268917|FG001|Double-blind Period|Adverse Event|2|||
124631707|NCT00739882|448268916|FG000|Double-blind Period|Protocol Violation|1|||
124631708|NCT00739882|448268917|FG001|Double-blind Period|Protocol Violation|0|||
124631709|NCT00739882|448268916|FG000|Double-blind Period|Lack of Efficacy|1|||
124631710|NCT00739882|448268917|FG001|Double-blind Period|Lack of Efficacy|1|||
124631711|NCT00739882|448268916|FG000|Double-blind Period|Other|16|||
124801833|NCT00761579|448906144|FG000|Overall Study|Pregnancy|1|||
124801834|NCT00761579|448906144|FG000|Overall Study|Withdrawal by Subject|34|||
124801835|NCT00761579|448906144|FG000|Overall Study|Lack of compliance|2|||
124801836|NCT00761579|448906144|FG000|Overall Study|Protocol deviation|1|||
124801837|NCT00761579|448906144|FG000|Overall Study|Drug overdose|1|||
124801838|NCT00761579|448906144|FG000|Overall Study|Aggravation of depression|1|||
124631712|NCT00739882|448268917|FG001|Double-blind Period|Other|8|||
124631713|NCT00739882|448268916|FG000|Open-label Period|Adverse Event|1|||
124631714|NCT00739882|448268917|FG001|Open-label Period|Adverse Event|0|||
124631715|NCT00739882|448268916|FG000|Open-label Period|Other|9|||
124631716|NCT00739882|448268917|FG001|Open-label Period|Other|5|||
124631717|NCT03593525|448268933|FG000|Overall Study|Withdrawal by Subject|1|||
124631718|NCT03593525|448268934|FG001|Overall Study|Withdrawal by Subject|0|||
124631719|NCT03593525|448268933|FG000|Overall Study|Lost to Follow-up|7|||
124631720|NCT03593525|448268934|FG001|Overall Study|Lost to Follow-up|5|||
124631721|NCT03103087|448268935|FG000|Overall Study|Did not receive any study drug|1|||
124631722|NCT03103087|448268936|FG001|Overall Study|Did not receive any study drug|0|||
124631723|NCT03103087|448268937|FG002|Overall Study|Did not receive any study drug|0|||
124631724|NCT03103087|448268935|FG000|Overall Study|Protocol Violation|1|||
124631725|NCT03103087|448268936|FG001|Overall Study|Protocol Violation|2|||
124631726|NCT03103087|448268937|FG002|Overall Study|Protocol Violation|1|||
124631727|NCT03103087|448268935|FG000|Overall Study|Lack of Efficacy|2|||
124631728|NCT03103087|448268936|FG001|Overall Study|Lack of Efficacy|1|||
124631729|NCT03103087|448268937|FG002|Overall Study|Lack of Efficacy|1|||
124631730|NCT03103087|448268935|FG000|Overall Study|Pregnancy|0|||
124631731|NCT03103087|448268936|FG001|Overall Study|Pregnancy|0|||
124631732|NCT03103087|448268937|FG002|Overall Study|Pregnancy|1|||
124631733|NCT03103087|448268935|FG000|Overall Study|Adverse Event|2|||
124631734|NCT03103087|448268936|FG001|Overall Study|Adverse Event|15|||
124631735|NCT03103087|448268937|FG002|Overall Study|Adverse Event|6|||
124631736|NCT03103087|448268935|FG000|Overall Study|Withdrawal by Subject|13|||
124631737|NCT03103087|448268936|FG001|Overall Study|Withdrawal by Subject|6|||
124631738|NCT03103087|448268937|FG002|Overall Study|Withdrawal by Subject|6|||
124631739|NCT03103087|448268935|FG000|Overall Study|Lost to Follow-up|4|||
124631740|NCT03103087|448268936|FG001|Overall Study|Lost to Follow-up|2|||
124631741|NCT03103087|448268937|FG002|Overall Study|Lost to Follow-up|7|||
124631742|NCT03103087|448268935|FG000|Overall Study|Other reason not reported|1|||
124631743|NCT03103087|448268936|FG001|Overall Study|Other reason not reported|3|||
124631744|NCT03103087|448268937|FG002|Overall Study|Other reason not reported|5|||
124631745|NCT00075816|448268938|FG000|Overall Study|Did not undergo transplantation|14|||
124631746|NCT00075816|448268939|FG001|Overall Study|Did not undergo transplantation|11|||
124631747|NCT01662635|448268940|FG000|Overall Study|scarce samples for evaluation|30|||
124631748|NCT02445248|448268941|FG000|Overall Study|Death|45|||
124631749|NCT02445248|448268942|FG001|Overall Study|Death|12|||
124631750|NCT02445248|448268941|FG000|Overall Study|Progressive disease|13|||
124631751|NCT02445248|448268942|FG001|Overall Study|Progressive disease|1|||
124631752|NCT02445248|448268941|FG000|Overall Study|Subject decision|8|||
124631753|NCT02445248|448268942|FG001|Overall Study|Subject decision|0|||
124631754|NCT02445248|448268941|FG000|Overall Study|Physician Decision|5|||
124631755|NCT02445248|448268942|FG001|Overall Study|Physician Decision|0|||
124631756|NCT02445248|448268941|FG000|Overall Study|Adverse Event|1|||
124801839|NCT00761579|448906144|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
124801840|NCT00761579|448906144|FG000|Overall Study|Lost survey form|1|||
124801841|NCT00761579|448906144|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
124631757|NCT02445248|448268942|FG001|Overall Study|Adverse Event|0|||
124631758|NCT02445248|448268941|FG000|Overall Study|Lost to Follow-up|1|||
124631759|NCT02445248|448268942|FG001|Overall Study|Lost to Follow-up|0|||
124631760|NCT00351468|448268943|FG000|Overall Study|Adverse Event|42|||
124631761|NCT00351468|448268943|FG000|Overall Study|Withdrawal by Subject|39|||
124631762|NCT00351468|448268943|FG000|Overall Study|Various -follow up w clinical team|39|||
124631763|NCT00351468|448268943|FG000|Overall Study|Lack of Efficacy|32|||
124631764|NCT00351468|448268943|FG000|Overall Study|Non-compliance|8|||
124631765|NCT00351468|448268943|FG000|Overall Study|Lost to Follow-up|4|||
124631766|NCT00351468|448268943|FG000|Overall Study|Protocol Violation|3|||
124631767|NCT00683618|448268944|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
124631768|NCT00683618|448268945|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
124631769|NCT00683618|448268946|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
124631770|NCT00683618|448268944|FG000|Randomised Treatment Period|Protocol Violation|0|||
124631771|NCT00683618|448268945|FG001|Randomised Treatment Period|Protocol Violation|1|||
124631772|NCT00683618|448268946|FG002|Randomised Treatment Period|Protocol Violation|0|||
124631773|NCT00683618|448268944|FG000|Randomised Treatment Period|Adverse Event|2|||
124631774|NCT00683618|448268945|FG001|Randomised Treatment Period|Adverse Event|0|||
124631775|NCT00683618|448268946|FG002|Randomised Treatment Period|Adverse Event|2|||
124631776|NCT00683618|448268944|FG000|Randomised Treatment Period|Reason not provided|0|||
124631777|NCT00683618|448268945|FG001|Randomised Treatment Period|Reason not provided|0|||
124752575|NCT02737475|448716769|FG012|Overall Study|Disease Progression|0|||
124752576|NCT02737475|448716770|FG013|Overall Study|Disease Progression|0|||
124752577|NCT02737475|448716771|FG014|Overall Study|Disease Progression|0|||
124752578|NCT02737475|448716772|FG015|Overall Study|Disease Progression|0|||
124752579|NCT02737475|448716773|FG016|Overall Study|Disease Progression|0|||
124752580|NCT02737475|448716774|FG017|Overall Study|Disease Progression|0|||
124752581|NCT02737475|448716775|FG018|Overall Study|Disease Progression|0|||
124752582|NCT02737475|448716776|FG019|Overall Study|Disease Progression|0|||
124752583|NCT02737475|448716777|FG020|Overall Study|Disease Progression|0|||
124631778|NCT00683618|448268946|FG002|Randomised Treatment Period|Reason not provided|2|||
124631779|NCT00683618|448268944|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
124631780|NCT00683618|448268945|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
124801842|NCT03611010|448906145|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
124801843|NCT03611010|448906146|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
124801844|NCT03611010|448906147|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
124801845|NCT03611010|448906148|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
124801846|NCT00598702|448906149|FG000|Overall Study|Other|0|||
124801847|NCT00598702|448906150|FG001|Overall Study|Other|2|||
124801848|NCT00598702|448906151|FG002|Overall Study|Other|0|||
124801849|NCT00598702|448906152|FG003|Overall Study|Other|0|||
124801850|NCT00598702|448906153|FG004|Overall Study|Other|0|||
124801851|NCT00598702|448906154|FG005|Overall Study|Other|1|||
124801852|NCT00598702|448906155|FG006|Overall Study|Other|0|||
124801853|NCT00598702|448906156|FG007|Overall Study|Other|0|||
124801854|NCT00598702|448906149|FG000|Overall Study|Early discharge from hospital|0|||
124801855|NCT00598702|448906150|FG001|Overall Study|Early discharge from hospital|0|||
124801856|NCT00598702|448906151|FG002|Overall Study|Early discharge from hospital|2|||
124801857|NCT00598702|448906152|FG003|Overall Study|Early discharge from hospital|5|||
124801858|NCT00598702|448906153|FG004|Overall Study|Early discharge from hospital|0|||
124801859|NCT00598702|448906154|FG005|Overall Study|Early discharge from hospital|10|||
124801860|NCT00598702|448906155|FG006|Overall Study|Early discharge from hospital|1|||
124801861|NCT00598702|448906156|FG007|Overall Study|Early discharge from hospital|0|||
124801862|NCT00598702|448906149|FG000|Overall Study|Adverse Event|0|||
124801863|NCT00598702|448906150|FG001|Overall Study|Adverse Event|0|||
124801864|NCT00598702|448906151|FG002|Overall Study|Adverse Event|0|||
124801865|NCT00598702|448906152|FG003|Overall Study|Adverse Event|1|||
124801866|NCT00598702|448906153|FG004|Overall Study|Adverse Event|0|||
124801867|NCT00598702|448906154|FG005|Overall Study|Adverse Event|0|||
124801868|NCT00598702|448906155|FG006|Overall Study|Adverse Event|0|||
124801869|NCT00598702|448906156|FG007|Overall Study|Adverse Event|0|||
124801870|NCT00598702|448906149|FG000|Overall Study|Withdrawal by Subject|0|||
124801871|NCT00598702|448906150|FG001|Overall Study|Withdrawal by Subject|0|||
124801872|NCT00598702|448906151|FG002|Overall Study|Withdrawal by Subject|0|||
124801873|NCT00598702|448906152|FG003|Overall Study|Withdrawal by Subject|1|||
124801874|NCT00598702|448906153|FG004|Overall Study|Withdrawal by Subject|1|||
124801875|NCT00598702|448906154|FG005|Overall Study|Withdrawal by Subject|0|||
124801876|NCT00598702|448906155|FG006|Overall Study|Withdrawal by Subject|0|||
124801877|NCT00598702|448906156|FG007|Overall Study|Withdrawal by Subject|0|||
124801878|NCT00598702|448906149|FG000|Overall Study|Physician Decision|0|||
124801879|NCT00598702|448906150|FG001|Overall Study|Physician Decision|0|||
124801880|NCT00598702|448906151|FG002|Overall Study|Physician Decision|0|||
124801881|NCT00598702|448906152|FG003|Overall Study|Physician Decision|0|||
124801882|NCT00598702|448906153|FG004|Overall Study|Physician Decision|1|||
124801883|NCT00598702|448906154|FG005|Overall Study|Physician Decision|0|||
124801884|NCT00598702|448906155|FG006|Overall Study|Physician Decision|0|||
124801885|NCT00598702|448906156|FG007|Overall Study|Physician Decision|0|||
124801886|NCT00598702|448906149|FG000|Overall Study|Dose limiting toxicity|0|||
124801887|NCT00598702|448906150|FG001|Overall Study|Dose limiting toxicity|0|||
124801888|NCT00598702|448906151|FG002|Overall Study|Dose limiting toxicity|0|||
124801889|NCT00598702|448906152|FG003|Overall Study|Dose limiting toxicity|1|||
124801890|NCT00598702|448906153|FG004|Overall Study|Dose limiting toxicity|1|||
124801891|NCT00598702|448906154|FG005|Overall Study|Dose limiting toxicity|1|||
124801892|NCT00598702|448906155|FG006|Overall Study|Dose limiting toxicity|0|||
124801893|NCT00598702|448906156|FG007|Overall Study|Dose limiting toxicity|0|||
124801894|NCT02600351|448906157|FG000|Overall Study|Lack of Efficacy|3|||
124801895|NCT02600351|448906158|FG001|Overall Study|Lack of Efficacy|0|||
124801896|NCT02600351|448906159|FG002|Overall Study|Lack of Efficacy|5|||
124801897|NCT02600351|448906160|FG003|Overall Study|Lack of Efficacy|2|||
124801898|NCT02600351|448906157|FG000|Overall Study|Lost to Follow-up|1|||
124801899|NCT02600351|448906158|FG001|Overall Study|Lost to Follow-up|0|||
124801900|NCT02600351|448906159|FG002|Overall Study|Lost to Follow-up|0|||
124801901|NCT02600351|448906160|FG003|Overall Study|Lost to Follow-up|0|||
124801902|NCT02600351|448906157|FG000|Overall Study|Randomized but Not Treated|1|||
124801903|NCT02600351|448906158|FG001|Overall Study|Randomized but Not Treated|0|||
124801904|NCT02600351|448906159|FG002|Overall Study|Randomized but Not Treated|1|||
124801905|NCT02600351|448906160|FG003|Overall Study|Randomized but Not Treated|3|||
124631781|NCT00683618|448268946|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
124801906|NCT04087213|448906163|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
124801907|NCT04087213|448906163|FG000|In-Facility Introduction|Adverse Event|1|||
124801908|NCT04087213|448906163|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
124801909|NCT04087213|448906163|FG000|Assisted Evaluable Period|Personal reasons|3|||
124801910|NCT04087213|448906163|FG000|Transition Period B|Renal Transplantation|1|||
124801911|NCT01859143|448906164|FG000|Overall Study|Lost to Follow-up|2|||
124801912|NCT01859143|448906165|FG001|Overall Study|Lost to Follow-up|0|||
124801913|NCT02413372|448906169|FG000|Treatment|Lost to Follow-up|0|||
124801914|NCT02413372|448906170|FG001|Treatment|Lost to Follow-up|2|||
124801915|NCT02413372|448906171|FG002|Treatment|Lost to Follow-up|1|||
124801916|NCT02413372|448906169|FG000|Treatment|Withdrawal by Subject|1|||
124801917|NCT02413372|448906170|FG001|Treatment|Withdrawal by Subject|0|||
124801918|NCT02413372|448906171|FG002|Treatment|Withdrawal by Subject|0|||
124631782|NCT00683618|448268944|FG000|Extension Treatment Period|Adverse Event|1|||
124631783|NCT00683618|448268945|FG001|Extension Treatment Period|Adverse Event|0|||
124631784|NCT00683618|448268946|FG002|Extension Treatment Period|Adverse Event|0|||
124631785|NCT00683618|448268944|FG000|Extension Treatment Period|Protocol Violation|1|||
124631786|NCT00683618|448268945|FG001|Extension Treatment Period|Protocol Violation|0|||
124631787|NCT00683618|448268946|FG002|Extension Treatment Period|Protocol Violation|0|||
124631788|NCT04570670|448268947|FG000|Overall Study|Withdrawal by Subject|1|||
124631789|NCT04570670|448268948|FG001|Overall Study|Withdrawal by Subject|0|||
124631790|NCT01892501|448268949|FG000|Overall Study|Protocol Violation|2|||
124631791|NCT01892501|448268949|FG000|Overall Study|Puncture not carried out|9|||
124801919|NCT02413372|448906169|FG000|Follow-up|Lost to Follow-up|1|||
124801920|NCT02413372|448906170|FG001|Follow-up|Lost to Follow-up|1|||
124801921|NCT02413372|448906171|FG002|Follow-up|Lost to Follow-up|0|||
124801922|NCT02413372|448906169|FG000|Follow-up|Subject Withdrew Consent|1|||
124801923|NCT02413372|448906170|FG001|Follow-up|Subject Withdrew Consent|0|||
124801924|NCT02413372|448906171|FG002|Follow-up|Subject Withdrew Consent|1|||
124801925|NCT02413372|448906169|FG000|Follow-up|Subject unable to return for visit|0|||
124801926|NCT02413372|448906170|FG001|Follow-up|Subject unable to return for visit|0|||
124801927|NCT02413372|448906171|FG002|Follow-up|Subject unable to return for visit|1|||
124801928|NCT02556203|448906178|FG000|Overall Study|Withdrawal by Subject|21|||
124801929|NCT02556203|448906179|FG001|Overall Study|Withdrawal by Subject|21|||
124801930|NCT02556203|448906178|FG000|Overall Study|Lost to Follow-up|5|||
124801931|NCT02556203|448906179|FG001|Overall Study|Lost to Follow-up|5|||
124801932|NCT02556203|448906178|FG000|Overall Study|Adverse Event|1|||
124801933|NCT02556203|448906179|FG001|Overall Study|Adverse Event|0|||
124801934|NCT04587271|448906180|FG000|Overall Study|Lost to Follow-up|2|||
124801935|NCT04587271|448906181|FG001|Overall Study|Lost to Follow-up|2|||
124801936|NCT04587271|448906182|FG002|Overall Study|Lost to Follow-up|0|||
124801937|NCT04587271|448906183|FG003|Overall Study|Lost to Follow-up|2|||
124801938|NCT04587271|448906184|FG004|Overall Study|Lost to Follow-up|2|||
124801939|NCT04587271|448906185|FG005|Overall Study|Lost to Follow-up|0|||
124801940|NCT04587271|448906180|FG000|Overall Study|Caregiver brought child to visits|0|||
124801941|NCT04587271|448906181|FG001|Overall Study|Caregiver brought child to visits|0|||
124801942|NCT04587271|448906182|FG002|Overall Study|Caregiver brought child to visits|0|||
124801943|NCT04587271|448906183|FG003|Overall Study|Caregiver brought child to visits|1|||
124801944|NCT04587271|448906184|FG004|Overall Study|Caregiver brought child to visits|0|||
124801945|NCT04587271|448906185|FG005|Overall Study|Caregiver brought child to visits|0|||
124801946|NCT02943460|448906189|FG000|Blinded Study Phase|Adverse Event|3|||
124801947|NCT02943460|448906190|FG001|Blinded Study Phase|Adverse Event|0|||
124801948|NCT02943460|448906191|FG002|Blinded Study Phase|Adverse Event|0|||
124801949|NCT02943460|448906189|FG000|Blinded Study Phase|Withdrew Consent|0|||
124801950|NCT02943460|448906190|FG001|Blinded Study Phase|Withdrew Consent|1|||
124801951|NCT02943460|448906191|FG002|Blinded Study Phase|Withdrew Consent|0|||
124801952|NCT02943460|448906189|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
124801953|NCT02943460|448906190|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
124801954|NCT02943460|448906191|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
124801955|NCT02943460|448906189|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
124801956|NCT02943460|448906190|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
124801957|NCT02943460|448906191|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
124801958|NCT02943460|448906189|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
124801959|NCT02943460|448906190|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
124801960|NCT02943460|448906191|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
124801961|NCT01925274|448906192|FG000|Overall Study|Death|1|||
124801962|NCT01925274|448906193|FG001|Overall Study|Death|0|||
124801963|NCT01925274|448906194|FG002|Overall Study|Death|0|||
124801964|NCT01925274|448906192|FG000|Overall Study|Lost to Follow-up|0|||
124801965|NCT01925274|448906193|FG001|Overall Study|Lost to Follow-up|1|||
124801966|NCT01925274|448906194|FG002|Overall Study|Lost to Follow-up|0|||
124801967|NCT01925274|448906192|FG000|Overall Study|Withdrawal by Subject|1|||
124631792|NCT01892501|448268949|FG000|Overall Study|Radiological monitoring not carried out|5|||
124631793|NCT01892501|448268949|FG000|Overall Study|Non-contributory histological result|12|||
124631794|NCT02549859|448268950|FG000|Long-term 60 Hz DBS|Study Closed|1|||
124801968|NCT01925274|448906193|FG001|Overall Study|Withdrawal by Subject|2|||
124801969|NCT01925274|448906194|FG002|Overall Study|Withdrawal by Subject|0|||
124801970|NCT01925274|448906192|FG000|Overall Study|Study terminated by sponsor|4|||
124801971|NCT01925274|448906193|FG001|Overall Study|Study terminated by sponsor|0|||
124801972|NCT01925274|448906194|FG002|Overall Study|Study terminated by sponsor|0|||
124801973|NCT01925274|448906192|FG000|Overall Study|Protocol amendment|1|||
124801974|NCT01925274|448906193|FG001|Overall Study|Protocol amendment|3|||
124801975|NCT01925274|448906194|FG002|Overall Study|Protocol amendment|6|||
124801976|NCT01031381|448906197|FG000|Overall Study|Physician Decision|3|||
124801977|NCT01031381|448906197|FG000|Overall Study|Withdrawal by Subject|6|||
124801978|NCT00723398|448906198|FG000|Overall Study|Withdrawal by Subject|2|||
124801979|NCT00723398|448906199|FG001|Overall Study|Withdrawal by Subject|6|||
124801980|NCT00723398|448906200|FG002|Overall Study|Withdrawal by Subject|4|||
124801981|NCT00723398|448906201|FG003|Overall Study|Withdrawal by Subject|4|||
124801982|NCT00723398|448906202|FG004|Overall Study|Withdrawal by Subject|4|||
124801983|NCT00723398|448906198|FG000|Overall Study|Protocol Violation|2|||
124801984|NCT00723398|448906199|FG001|Overall Study|Protocol Violation|1|||
124801985|NCT00723398|448906200|FG002|Overall Study|Protocol Violation|5|||
124801986|NCT00723398|448906201|FG003|Overall Study|Protocol Violation|0|||
124801987|NCT00723398|448906202|FG004|Overall Study|Protocol Violation|0|||
124801988|NCT00723398|448906198|FG000|Overall Study|Physician Decision|2|||
124801989|NCT00723398|448906199|FG001|Overall Study|Physician Decision|2|||
124801990|NCT00723398|448906200|FG002|Overall Study|Physician Decision|5|||
124801991|NCT00723398|448906201|FG003|Overall Study|Physician Decision|0|||
124801992|NCT00723398|448906202|FG004|Overall Study|Physician Decision|1|||
124801993|NCT00723398|448906198|FG000|Overall Study|Adverse Event|0|||
124801994|NCT00723398|448906199|FG001|Overall Study|Adverse Event|5|||
124801995|NCT00723398|448906200|FG002|Overall Study|Adverse Event|3|||
124801996|NCT00723398|448906201|FG003|Overall Study|Adverse Event|1|||
124801997|NCT00723398|448906202|FG004|Overall Study|Adverse Event|4|||
124801998|NCT00723398|448906198|FG000|Overall Study|Lost to Follow-up|0|||
124801999|NCT00723398|448906199|FG001|Overall Study|Lost to Follow-up|1|||
124802000|NCT00723398|448906200|FG002|Overall Study|Lost to Follow-up|0|||
124802001|NCT00723398|448906201|FG003|Overall Study|Lost to Follow-up|0|||
124802002|NCT00723398|448906202|FG004|Overall Study|Lost to Follow-up|0|||
124802003|NCT00580970|448906205|FG000|Pre-treatment|Non-compliance|1|||
124802004|NCT00580970|448906205|FG000|Treatment (Lovastatin)|Non-compliance|6|||
124802005|NCT00580970|448906205|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
124802006|NCT00580970|448906205|FG000|Treatment (Lovastatin)|Physician Decision|4|||
124802007|NCT00580970|448906205|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
124802008|NCT00580970|448906205|FG000|Treatment (Lovastatin)|Death|1|||
124802009|NCT01008150|448906206|FG000|Overall Study|did not receive study drug|1|||
124802010|NCT01008150|448906207|FG001|Overall Study|did not receive study drug|1|||
124802011|NCT01008150|448906208|FG002|Overall Study|did not receive study drug|1|||
124802012|NCT01008150|448906209|FG003|Overall Study|did not receive study drug|0|||
124802013|NCT01400815|448906210|FG000|Overall Study|Adverse Event|3|||
124802014|NCT01400815|448906211|FG001|Overall Study|Adverse Event|0|||
124802015|NCT01400815|448906210|FG000|Overall Study|Death|0|||
124802016|NCT01400815|448906211|FG001|Overall Study|Death|1|||
124802017|NCT01400815|448906210|FG000|Overall Study|Lost to Follow-up|18|||
124802018|NCT01400815|448906211|FG001|Overall Study|Lost to Follow-up|11|||
124802019|NCT01400815|448906210|FG000|Overall Study|Protocol Violation|0|||
124802020|NCT01400815|448906211|FG001|Overall Study|Protocol Violation|1|||
124802021|NCT01400815|448906210|FG000|Overall Study|Physician Decision|1|||
124802022|NCT01400815|448906211|FG001|Overall Study|Physician Decision|0|||
124802023|NCT01400815|448906210|FG000|Overall Study|Withdrawal by Subject|15|||
124802024|NCT01400815|448906211|FG001|Overall Study|Withdrawal by Subject|8|||
124802025|NCT01400815|448906210|FG000|Overall Study|Subject in jail|1|||
124802026|NCT01400815|448906211|FG001|Overall Study|Subject in jail|0|||
124802027|NCT00568685|448906222|FG000|Overall Study|Adverse Event|2|||
124802028|NCT00568685|448906223|FG001|Overall Study|Adverse Event|3|||
124802029|NCT00568685|448906224|FG002|Overall Study|Adverse Event|3|||
124802030|NCT00568685|448906222|FG000|Overall Study|Withdrawal by Subject|7|||
124802031|NCT00568685|448906223|FG001|Overall Study|Withdrawal by Subject|2|||
124802032|NCT00568685|448906224|FG002|Overall Study|Withdrawal by Subject|2|||
124802033|NCT00568685|448906222|FG000|Overall Study|Protocol Violation|1|||
124802034|NCT00568685|448906223|FG001|Overall Study|Protocol Violation|0|||
124802035|NCT00568685|448906224|FG002|Overall Study|Protocol Violation|0|||
124802036|NCT01147172|448906225|FG000|Overall Study|Withdrawal by Subject|2|||
124802037|NCT01147172|448906225|FG000|Overall Study|Lost to Follow-up|2|||
124802038|NCT02787551|448906226|FG000|Core Period: 26 Weeks|Adverse Event|10|||
124802039|NCT02787551|448906227|FG001|Core Period: 26 Weeks|Adverse Event|0|||
124802040|NCT02787551|448906226|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
124802041|NCT02787551|448906227|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
124802042|NCT02787551|448906226|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
124802043|NCT02787551|448906227|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
124802044|NCT02787551|448906226|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
124802045|NCT02787551|448906227|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
124802046|NCT02787551|448906226|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
124802047|NCT02787551|448906227|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
124802048|NCT02787551|448906226|FG000|Core Period: 26 Weeks|Other than specified|3|||
124802049|NCT02787551|448906227|FG001|Core Period: 26 Weeks|Other than specified|1|||
124802050|NCT02787551|448906226|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
124802051|NCT02787551|448906227|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
124802052|NCT02787551|448906226|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
124802053|NCT02787551|448906227|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
124802054|NCT02787551|448906226|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
124802055|NCT02787551|448906227|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
124802056|NCT01638819|448906228|FG000|Overall Study|Lost to Follow-up|1|||
124802057|NCT01638819|448906229|FG001|Overall Study|Lost to Follow-up|0|||
124802058|NCT00237185|448906230|FG000|Core|Adverse Event|3|||
124802059|NCT00237185|448906231|FG001|Core|Adverse Event|4|||
124802060|NCT00237185|448906230|FG000|Core|Abnormal laboratory value|0|||
124802061|NCT00237185|448906231|FG001|Core|Abnormal laboratory value|4|||
124802062|NCT00237185|448906230|FG000|Core|Abnormal test procedure results|1|||
124802063|NCT00237185|448906231|FG001|Core|Abnormal test procedure results|0|||
124802064|NCT00237185|448906230|FG000|Core|Lack of Efficacy|30|||
124802065|NCT00237185|448906231|FG001|Core|Lack of Efficacy|23|||
124802066|NCT00237185|448906230|FG000|Core|Protocol Violation|1|||
124802067|NCT00237185|448906231|FG001|Core|Protocol Violation|1|||
124802068|NCT00237185|448906230|FG000|Core|Withdrawal by Subject|4|||
124802069|NCT00237185|448906231|FG001|Core|Withdrawal by Subject|4|||
124802070|NCT00237185|448906230|FG000|Core|Administrative problems|0|||
124802071|NCT00237185|448906231|FG001|Core|Administrative problems|1|||
124802072|NCT00237185|448906230|FG000|Core|Death|4|||
124802073|NCT00237185|448906231|FG001|Core|Death|0|||
124802074|NCT00237185|448906230|FG000|Core|Determined ineligible post randomization|1|||
124802075|NCT00237185|448906231|FG001|Core|Determined ineligible post randomization|0|||
124802076|NCT00237185|448906230|FG000|Extension|Adverse Event|1|||
124802077|NCT00237185|448906231|FG001|Extension|Adverse Event|0|||
124802078|NCT00237185|448906230|FG000|Extension|Abnormal laboratory value|0|||
124802079|NCT00237185|448906231|FG001|Extension|Abnormal laboratory value|1|||
124802080|NCT00237185|448906230|FG000|Extension|Lack of Efficacy|9|||
124802081|NCT00237185|448906231|FG001|Extension|Lack of Efficacy|14|||
124802082|NCT00237185|448906230|FG000|Extension|Condition no longer required study drug|0|||
124802083|NCT00237185|448906231|FG001|Extension|Condition no longer required study drug|1|||
124802084|NCT00237185|448906230|FG000|Extension|Withdrawal by Subject|3|||
124802085|NCT00237185|448906231|FG001|Extension|Withdrawal by Subject|2|||
124802086|NCT00237185|448906230|FG000|Extension|Lost to Follow-up|1|||
124802087|NCT00237185|448906231|FG001|Extension|Lost to Follow-up|0|||
124802088|NCT00237185|448906230|FG000|Extension|Administrative problems|1|||
124802089|NCT00237185|448906231|FG001|Extension|Administrative problems|0|||
124802090|NCT00237185|448906230|FG000|Extension|Death|1|||
124802091|NCT00237185|448906231|FG001|Extension|Death|1|||
124802092|NCT05069259|448906232|FG000|Overall Study|Withdrawal by Subject|1|||
124802093|NCT05069259|448906232|FG000|Overall Study|Sponsor decision|1|||
124802094|NCT03148275|448906233|FG000|Overall Study|Death|6|||
124802095|NCT03148275|448906233|FG000|Overall Study|Adverse Event|3|||
124802096|NCT03148275|448906233|FG000|Overall Study|Liver transplant|2|||
124802097|NCT03148275|448906233|FG000|Overall Study|Patient decision|5|||
124802098|NCT03148275|448906233|FG000|Overall Study|transition to commercial drug|1|||
124802099|NCT03148275|448906233|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
124802100|NCT03803683|448906234|FG000|Overall Study|Lost to Follow-up|41|||
124802101|NCT03803683|448906235|FG001|Overall Study|Lost to Follow-up|18|||
124802102|NCT03803683|448906236|FG002|Overall Study|Lost to Follow-up|12|||
124802103|NCT03803683|448906234|FG000|Overall Study|Withdrawal by Subject|9|||
124802104|NCT03803683|448906235|FG001|Overall Study|Withdrawal by Subject|1|||
124802105|NCT03803683|448906236|FG002|Overall Study|Withdrawal by Subject|4|||
124802106|NCT01897714|448907582|FG000|Phase I (Dose Escalation)|Disease progression|3|||
124802107|NCT01897714|448907583|FG001|Phase I (Dose Escalation)|Disease progression|5|||
124802108|NCT01897714|448907584|FG002|Phase I (Dose Escalation)|Disease progression|1|||
124802109|NCT01897714|448907585|FG003|Phase I (Dose Escalation)|Disease progression|3|||
124802110|NCT01897714|448907586|FG004|Phase I (Dose Escalation)|Disease progression|0|||
124802111|NCT01897714|448907587|FG005|Phase I (Dose Escalation)|Disease progression|0|||
124802112|NCT01897714|448907582|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
124802113|NCT01897714|448907583|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
124802114|NCT01897714|448907584|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
124802115|NCT01897714|448907585|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
124802116|NCT01897714|448907586|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
124802117|NCT01897714|448907587|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
124802118|NCT01897714|448907582|FG000|Phase I (Dose Escalation)|Other|0|||
124802119|NCT01897714|448907583|FG001|Phase I (Dose Escalation)|Other|1|||
124802120|NCT01897714|448907584|FG002|Phase I (Dose Escalation)|Other|0|||
124631795|NCT03922321|448268952|FG000|Overall Study|Participant Moved|1|||
124631796|NCT03922321|448268952|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
124802121|NCT01897714|448907585|FG003|Phase I (Dose Escalation)|Other|0|||
124802122|NCT01897714|448907586|FG004|Phase I (Dose Escalation)|Other|0|||
124631797|NCT02383017|448268953|FG000|Overall Study|Injury Sustained Outside Study|1|||
124802123|NCT01897714|448907587|FG005|Phase I (Dose Escalation)|Other|0|||
124802124|NCT01897714|448907582|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
124802125|NCT01897714|448907583|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
124802126|NCT01897714|448907584|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
124802127|NCT01897714|448907585|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
124802128|NCT01897714|448907586|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
124631798|NCT02383017|448268954|FG001|Overall Study|Injury Sustained Outside Study|0|||
124631799|NCT02383017|448268953|FG000|Overall Study|Compliance|3|||
124631800|NCT02383017|448268954|FG001|Overall Study|Compliance|2|||
124631801|NCT02383017|448268953|FG000|Overall Study|Found to be Hypogonadal|1|||
124631802|NCT02383017|448268954|FG001|Overall Study|Found to be Hypogonadal|0|||
124631803|NCT01068860|448268955|FG000|Overall Study|Withdrawal by Subject|0|||
124631804|NCT01068860|448268956|FG001|Overall Study|Withdrawal by Subject|0|||
124631805|NCT01068860|448268957|FG002|Overall Study|Withdrawal by Subject|0|||
124631806|NCT01068860|448268958|FG003|Overall Study|Withdrawal by Subject|0|||
124631807|NCT01068860|448268959|FG004|Overall Study|Withdrawal by Subject|0|||
124631808|NCT01068860|448268960|FG005|Overall Study|Withdrawal by Subject|2|||
124631809|NCT01068860|448268961|FG006|Overall Study|Withdrawal by Subject|0|||
124631810|NCT01068860|448268962|FG007|Overall Study|Withdrawal by Subject|0|||
124631811|NCT01068860|448268963|FG008|Overall Study|Withdrawal by Subject|0|||
124631812|NCT01068860|448268964|FG009|Overall Study|Withdrawal by Subject|3|||
124631813|NCT01068860|448268955|FG000|Overall Study|Administrative problems; misrandomized|0|||
124631814|NCT01068860|448268956|FG001|Overall Study|Administrative problems; misrandomized|0|||
124631815|NCT01068860|448268957|FG002|Overall Study|Administrative problems; misrandomized|0|||
124631816|NCT01068860|448268958|FG003|Overall Study|Administrative problems; misrandomized|1|||
124631817|NCT01068860|448268959|FG004|Overall Study|Administrative problems; misrandomized|0|||
124631818|NCT01068860|448268960|FG005|Overall Study|Administrative problems; misrandomized|0|||
124631819|NCT01068860|448268961|FG006|Overall Study|Administrative problems; misrandomized|0|||
124631820|NCT01068860|448268962|FG007|Overall Study|Administrative problems; misrandomized|0|||
124631821|NCT01068860|448268963|FG008|Overall Study|Administrative problems; misrandomized|0|||
124631822|NCT01068860|448268964|FG009|Overall Study|Administrative problems; misrandomized|1|||
124631823|NCT01068860|448268955|FG000|Overall Study|Lost to Follow-up|0|||
124631824|NCT01068860|448268956|FG001|Overall Study|Lost to Follow-up|1|||
124631825|NCT01068860|448268957|FG002|Overall Study|Lost to Follow-up|0|||
124631826|NCT01068860|448268958|FG003|Overall Study|Lost to Follow-up|0|||
124631827|NCT01068860|448268959|FG004|Overall Study|Lost to Follow-up|0|||
124631828|NCT01068860|448268960|FG005|Overall Study|Lost to Follow-up|0|||
124631829|NCT01068860|448268961|FG006|Overall Study|Lost to Follow-up|0|||
124631830|NCT01068860|448268962|FG007|Overall Study|Lost to Follow-up|0|||
124631831|NCT01068860|448268963|FG008|Overall Study|Lost to Follow-up|0|||
124631832|NCT01068860|448268964|FG009|Overall Study|Lost to Follow-up|0|||
124631833|NCT00460603|448268965|FG000|Phase 1|Death|1|||
124631834|NCT00460603|448268966|FG001|Phase 1|Death|0|||
124631835|NCT00460603|448268967|FG002|Phase 1|Death|0|||
124631836|NCT00460603|448268968|FG003|Phase 1|Death|2|||
124631837|NCT00460603|448268969|FG004|Phase 1|Death|0|||
124631838|NCT00460603|448268970|FG005|Phase 1|Death|0|||
124631839|NCT00460603|448268971|FG006|Phase 1|Death|0|||
124631840|NCT00460603|448268972|FG007|Phase 1|Death|0|||
124631841|NCT00460603|448268973|FG008|Phase 1|Death|1|||
124631842|NCT00460603|448268974|FG009|Phase 1|Death|0|||
124631843|NCT00460603|448268975|FG010|Phase 1|Death|0|||
124631844|NCT00460603|448268976|FG011|Phase 1|Death|0|||
124631845|NCT00460603|448268965|FG000|Phase 1|Adverse Event|3|||
124631846|NCT00460603|448268966|FG001|Phase 1|Adverse Event|1|||
124631847|NCT00460603|448268967|FG002|Phase 1|Adverse Event|1|||
124631848|NCT00460603|448268968|FG003|Phase 1|Adverse Event|2|||
124631849|NCT00460603|448268969|FG004|Phase 1|Adverse Event|0|||
124631850|NCT00460603|448268970|FG005|Phase 1|Adverse Event|0|||
124631851|NCT00460603|448268971|FG006|Phase 1|Adverse Event|3|||
124631852|NCT00460603|448268972|FG007|Phase 1|Adverse Event|0|||
124631853|NCT00460603|448268973|FG008|Phase 1|Adverse Event|4|||
124631854|NCT00460603|448268974|FG009|Phase 1|Adverse Event|0|||
124631855|NCT00460603|448268975|FG010|Phase 1|Adverse Event|0|||
124631856|NCT00460603|448268976|FG011|Phase 1|Adverse Event|0|||
124631857|NCT00460603|448268965|FG000|Phase 1|Lack of Efficacy|1|||
124631858|NCT00460603|448268966|FG001|Phase 1|Lack of Efficacy|0|||
124631859|NCT00460603|448268967|FG002|Phase 1|Lack of Efficacy|1|||
124631860|NCT00460603|448268968|FG003|Phase 1|Lack of Efficacy|2|||
124802129|NCT01897714|448907587|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
124802130|NCT01897714|448907582|FG000|Phase II (MTD)|Lost to Follow-up|0|||
124802131|NCT01897714|448907583|FG001|Phase II (MTD)|Lost to Follow-up|0|||
124802132|NCT01897714|448907584|FG002|Phase II (MTD)|Lost to Follow-up|0|||
124802133|NCT01897714|448907585|FG003|Phase II (MTD)|Lost to Follow-up|0|||
124802134|NCT01897714|448907586|FG004|Phase II (MTD)|Lost to Follow-up|1|||
124802135|NCT01897714|448907587|FG005|Phase II (MTD)|Lost to Follow-up|0|||
124802136|NCT01897714|448907582|FG000|Phase II (MTD)|Death|0|||
124802137|NCT01897714|448907583|FG001|Phase II (MTD)|Death|0|||
124631861|NCT00460603|448268969|FG004|Phase 1|Lack of Efficacy|2|||
124631862|NCT00460603|448268970|FG005|Phase 1|Lack of Efficacy|2|||
124631863|NCT00460603|448268971|FG006|Phase 1|Lack of Efficacy|2|||
124631864|NCT00460603|448268972|FG007|Phase 1|Lack of Efficacy|2|||
124631865|NCT00460603|448268973|FG008|Phase 1|Lack of Efficacy|11|||
124631866|NCT00460603|448268974|FG009|Phase 1|Lack of Efficacy|0|||
124802138|NCT01897714|448907584|FG002|Phase II (MTD)|Death|0|||
124802139|NCT01897714|448907585|FG003|Phase II (MTD)|Death|0|||
124631867|NCT00460603|448268975|FG010|Phase 1|Lack of Efficacy|0|||
124631868|NCT00460603|448268976|FG011|Phase 1|Lack of Efficacy|0|||
124802140|NCT01897714|448907586|FG004|Phase II (MTD)|Death|25|||
124802141|NCT01897714|448907587|FG005|Phase II (MTD)|Death|10|||
124802142|NCT01897714|448907582|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
124802143|NCT01897714|448907583|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
124802144|NCT01897714|448907584|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
124802145|NCT01897714|448907585|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
124631869|NCT00460603|448268965|FG000|Phase 1|Withdrawal by Subject|1|||
124631870|NCT00460603|448268966|FG001|Phase 1|Withdrawal by Subject|2|||
124631871|NCT00460603|448268967|FG002|Phase 1|Withdrawal by Subject|1|||
124631872|NCT00460603|448268968|FG003|Phase 1|Withdrawal by Subject|1|||
124631873|NCT00460603|448268969|FG004|Phase 1|Withdrawal by Subject|3|||
124631874|NCT00460603|448268970|FG005|Phase 1|Withdrawal by Subject|0|||
124631875|NCT00460603|448268971|FG006|Phase 1|Withdrawal by Subject|1|||
124631876|NCT00460603|448268972|FG007|Phase 1|Withdrawal by Subject|0|||
124631877|NCT00460603|448268973|FG008|Phase 1|Withdrawal by Subject|2|||
124631878|NCT00460603|448268974|FG009|Phase 1|Withdrawal by Subject|0|||
124631879|NCT00460603|448268975|FG010|Phase 1|Withdrawal by Subject|0|||
124631880|NCT00460603|448268976|FG011|Phase 1|Withdrawal by Subject|0|||
124631881|NCT00460603|448268965|FG000|Phase 1|Other|0|||
124631882|NCT00460603|448268966|FG001|Phase 1|Other|3|||
124631883|NCT00460603|448268967|FG002|Phase 1|Other|1|||
124631884|NCT00460603|448268968|FG003|Phase 1|Other|1|||
124631885|NCT00460603|448268969|FG004|Phase 1|Other|1|||
124631886|NCT00460603|448268970|FG005|Phase 1|Other|2|||
124631887|NCT00460603|448268971|FG006|Phase 1|Other|0|||
124631888|NCT00460603|448268972|FG007|Phase 1|Other|1|||
124631889|NCT00460603|448268973|FG008|Phase 1|Other|0|||
124631890|NCT00460603|448268974|FG009|Phase 1|Other|0|||
124631891|NCT00460603|448268975|FG010|Phase 1|Other|0|||
124631892|NCT00460603|448268976|FG011|Phase 1|Other|0|||
124631893|NCT00460603|448268965|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
124631894|NCT00460603|448268966|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
124631895|NCT00460603|448268967|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
124631896|NCT00460603|448268968|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
124631897|NCT00460603|448268969|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
124631898|NCT00460603|448268970|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
124631899|NCT00460603|448268971|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
124631900|NCT00460603|448268972|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
124631901|NCT00460603|448268973|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
124631902|NCT00460603|448268974|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
124631903|NCT00460603|448268975|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
124631904|NCT00460603|448268976|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
124631905|NCT00460603|448268965|FG000|Phase 2|Adverse Event|0|||
124631906|NCT00460603|448268966|FG001|Phase 2|Adverse Event|0|||
124631907|NCT00460603|448268967|FG002|Phase 2|Adverse Event|0|||
124631908|NCT00460603|448268968|FG003|Phase 2|Adverse Event|0|||
124631909|NCT00460603|448268969|FG004|Phase 2|Adverse Event|0|||
124631910|NCT00460603|448268970|FG005|Phase 2|Adverse Event|0|||
124631911|NCT00460603|448268971|FG006|Phase 2|Adverse Event|0|||
124631912|NCT00460603|448268972|FG007|Phase 2|Adverse Event|0|||
124631913|NCT00460603|448268973|FG008|Phase 2|Adverse Event|0|||
124631914|NCT00460603|448268974|FG009|Phase 2|Adverse Event|12|||
124631915|NCT00460603|448268975|FG010|Phase 2|Adverse Event|9|||
124631916|NCT00460603|448268976|FG011|Phase 2|Adverse Event|10|||
124631917|NCT00460603|448268965|FG000|Phase 2|Death|0|||
124631918|NCT00460603|448268966|FG001|Phase 2|Death|0|||
124631919|NCT00460603|448268967|FG002|Phase 2|Death|0|||
124631920|NCT00460603|448268968|FG003|Phase 2|Death|0|||
124802146|NCT01897714|448907586|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
124802147|NCT01897714|448907587|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
124802148|NCT01897714|448907582|FG000|Phase II (MTD)|Other|0|||
124802149|NCT01897714|448907583|FG001|Phase II (MTD)|Other|0|||
124802150|NCT01897714|448907584|FG002|Phase II (MTD)|Other|0|||
124802151|NCT01897714|448907585|FG003|Phase II (MTD)|Other|0|||
124802152|NCT01897714|448907586|FG004|Phase II (MTD)|Other|3|||
124802153|NCT01897714|448907587|FG005|Phase II (MTD)|Other|0|||
124802154|NCT00851630|448907595|FG000|Overall Study|Death|2|||
124802155|NCT00851630|448907596|FG001|Overall Study|Death|1|||
124802156|NCT00851630|448907595|FG000|Overall Study|Clinical failure|0|||
124631921|NCT00460603|448268969|FG004|Phase 2|Death|0|||
124631922|NCT00460603|448268970|FG005|Phase 2|Death|0|||
124631923|NCT00460603|448268971|FG006|Phase 2|Death|0|||
124631924|NCT00460603|448268972|FG007|Phase 2|Death|0|||
124631925|NCT00460603|448268973|FG008|Phase 2|Death|0|||
124631926|NCT00460603|448268974|FG009|Phase 2|Death|4|||
124631927|NCT00460603|448268975|FG010|Phase 2|Death|2|||
124631928|NCT00460603|448268976|FG011|Phase 2|Death|2|||
124631929|NCT00460603|448268965|FG000|Phase 2|Protocol Violation|0|||
124631930|NCT00460603|448268966|FG001|Phase 2|Protocol Violation|0|||
124631931|NCT00460603|448268967|FG002|Phase 2|Protocol Violation|0|||
124631932|NCT00460603|448268968|FG003|Phase 2|Protocol Violation|0|||
124631933|NCT00460603|448268969|FG004|Phase 2|Protocol Violation|0|||
124631934|NCT00460603|448268970|FG005|Phase 2|Protocol Violation|0|||
124802157|NCT00851630|448907596|FG001|Overall Study|Clinical failure|1|||
124802158|NCT02349061|448907597|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
124802159|NCT02349061|448907598|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
124802160|NCT02349061|448907599|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
124802161|NCT02349061|448907597|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
124802162|NCT02349061|448907598|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
124802163|NCT02349061|448907599|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
124631935|NCT00460603|448268971|FG006|Phase 2|Protocol Violation|0|||
124631936|NCT00460603|448268972|FG007|Phase 2|Protocol Violation|0|||
124631937|NCT00460603|448268973|FG008|Phase 2|Protocol Violation|0|||
124631938|NCT00460603|448268974|FG009|Phase 2|Protocol Violation|1|||
124631939|NCT00460603|448268975|FG010|Phase 2|Protocol Violation|1|||
124631940|NCT00460603|448268976|FG011|Phase 2|Protocol Violation|0|||
124631941|NCT00460603|448268965|FG000|Phase 2|Lost to Follow-up|0|||
124631942|NCT00460603|448268966|FG001|Phase 2|Lost to Follow-up|0|||
124631943|NCT00460603|448268967|FG002|Phase 2|Lost to Follow-up|0|||
124631944|NCT00460603|448268968|FG003|Phase 2|Lost to Follow-up|0|||
124631945|NCT00460603|448268969|FG004|Phase 2|Lost to Follow-up|0|||
124631946|NCT00460603|448268970|FG005|Phase 2|Lost to Follow-up|0|||
124631947|NCT00460603|448268971|FG006|Phase 2|Lost to Follow-up|0|||
124631948|NCT00460603|448268972|FG007|Phase 2|Lost to Follow-up|0|||
124631949|NCT00460603|448268973|FG008|Phase 2|Lost to Follow-up|0|||
124631950|NCT00460603|448268974|FG009|Phase 2|Lost to Follow-up|1|||
124631951|NCT00460603|448268975|FG010|Phase 2|Lost to Follow-up|0|||
124631952|NCT00460603|448268976|FG011|Phase 2|Lost to Follow-up|0|||
124631953|NCT00460603|448268965|FG000|Phase 2|Other|0|||
124631954|NCT00460603|448268966|FG001|Phase 2|Other|0|||
124631955|NCT00460603|448268967|FG002|Phase 2|Other|0|||
124631956|NCT00460603|448268968|FG003|Phase 2|Other|0|||
124802164|NCT02349061|448907597|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
124802165|NCT02349061|448907598|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
124802166|NCT02349061|448907599|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
124802167|NCT02349061|448907597|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
124802168|NCT02349061|448907598|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
124631957|NCT00460603|448268969|FG004|Phase 2|Other|0|||
124631958|NCT00460603|448268970|FG005|Phase 2|Other|0|||
124631959|NCT00460603|448268971|FG006|Phase 2|Other|0|||
124631960|NCT00460603|448268972|FG007|Phase 2|Other|0|||
124631961|NCT00460603|448268973|FG008|Phase 2|Other|0|||
124631962|NCT00460603|448268974|FG009|Phase 2|Other|6|||
124802169|NCT02349061|448907599|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
124802170|NCT02349061|448907597|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
124802171|NCT02349061|448907598|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
124802172|NCT02349061|448907599|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
124802173|NCT02349061|448907597|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
124802174|NCT02349061|448907598|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
124802175|NCT02349061|448907599|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
124802176|NCT02349061|448907597|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
124802177|NCT02349061|448907598|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
124802178|NCT02349061|448907599|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
124802179|NCT02349061|448907597|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
124802180|NCT02349061|448907598|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
124802181|NCT02349061|448907599|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
124802182|NCT02349061|448907597|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
124631963|NCT00460603|448268975|FG010|Phase 2|Other|16|||
124631964|NCT00460603|448268976|FG011|Phase 2|Other|7|||
124631965|NCT00460603|448268965|FG000|Phase 2|Objective Progression or Relapse|0|||
124631966|NCT00460603|448268966|FG001|Phase 2|Objective Progression or Relapse|0|||
124631967|NCT00460603|448268967|FG002|Phase 2|Objective Progression or Relapse|0|||
124631968|NCT00460603|448268968|FG003|Phase 2|Objective Progression or Relapse|0|||
124631969|NCT00460603|448268969|FG004|Phase 2|Objective Progression or Relapse|0|||
124631970|NCT00460603|448268970|FG005|Phase 2|Objective Progression or Relapse|0|||
124631971|NCT00460603|448268971|FG006|Phase 2|Objective Progression or Relapse|0|||
124631972|NCT00460603|448268972|FG007|Phase 2|Objective Progression or Relapse|0|||
124631973|NCT00460603|448268973|FG008|Phase 2|Objective Progression or Relapse|0|||
124631974|NCT00460603|448268974|FG009|Phase 2|Objective Progression or Relapse|9|||
124802183|NCT02349061|448907598|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
124802184|NCT02349061|448907599|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
124631975|NCT00460603|448268975|FG010|Phase 2|Objective Progression or Relapse|10|||
124631976|NCT00460603|448268976|FG011|Phase 2|Objective Progression or Relapse|17|||
124631977|NCT00460603|448268965|FG000|Phase 2|Global Deterioration of Health Status|0|||
124631978|NCT00460603|448268966|FG001|Phase 2|Global Deterioration of Health Status|0|||
124631979|NCT00460603|448268967|FG002|Phase 2|Global Deterioration of Health Status|0|||
124631980|NCT00460603|448268968|FG003|Phase 2|Global Deterioration of Health Status|0|||
124631981|NCT00460603|448268969|FG004|Phase 2|Global Deterioration of Health Status|0|||
124631982|NCT00460603|448268970|FG005|Phase 2|Global Deterioration of Health Status|0|||
124631983|NCT00460603|448268971|FG006|Phase 2|Global Deterioration of Health Status|0|||
124631984|NCT00460603|448268972|FG007|Phase 2|Global Deterioration of Health Status|0|||
124631985|NCT00460603|448268973|FG008|Phase 2|Global Deterioration of Health Status|0|||
124631986|NCT00460603|448268974|FG009|Phase 2|Global Deterioration of Health Status|0|||
124631987|NCT00460603|448268975|FG010|Phase 2|Global Deterioration of Health Status|1|||
124631988|NCT00460603|448268976|FG011|Phase 2|Global Deterioration of Health Status|0|||
124631989|NCT00460603|448268965|FG000|Phase 2|Withdrawal by Subject|0|||
124631990|NCT00460603|448268966|FG001|Phase 2|Withdrawal by Subject|0|||
124631991|NCT00460603|448268967|FG002|Phase 2|Withdrawal by Subject|0|||
124631992|NCT00460603|448268968|FG003|Phase 2|Withdrawal by Subject|0|||
124631993|NCT00460603|448268969|FG004|Phase 2|Withdrawal by Subject|0|||
124631994|NCT00460603|448268970|FG005|Phase 2|Withdrawal by Subject|0|||
124631995|NCT00460603|448268971|FG006|Phase 2|Withdrawal by Subject|0|||
124631996|NCT00460603|448268972|FG007|Phase 2|Withdrawal by Subject|0|||
124631997|NCT00460603|448268973|FG008|Phase 2|Withdrawal by Subject|0|||
124631998|NCT00460603|448268974|FG009|Phase 2|Withdrawal by Subject|5|||
124631999|NCT00460603|448268975|FG010|Phase 2|Withdrawal by Subject|4|||
124632000|NCT00460603|448268976|FG011|Phase 2|Withdrawal by Subject|5|||
124632001|NCT00460603|448268965|FG000|Phase 2|Randomized, but not treated|0|||
124632002|NCT00460603|448268966|FG001|Phase 2|Randomized, but not treated|0|||
124632003|NCT00460603|448268967|FG002|Phase 2|Randomized, but not treated|0|||
124632004|NCT00460603|448268968|FG003|Phase 2|Randomized, but not treated|0|||
124632005|NCT00460603|448268969|FG004|Phase 2|Randomized, but not treated|0|||
124632006|NCT00460603|448268970|FG005|Phase 2|Randomized, but not treated|0|||
124632007|NCT00460603|448268971|FG006|Phase 2|Randomized, but not treated|0|||
124632008|NCT00460603|448268972|FG007|Phase 2|Randomized, but not treated|0|||
124632009|NCT00460603|448268973|FG008|Phase 2|Randomized, but not treated|0|||
124632010|NCT00460603|448268974|FG009|Phase 2|Randomized, but not treated|3|||
124632011|NCT00460603|448268975|FG010|Phase 2|Randomized, but not treated|0|||
124632012|NCT00460603|448268976|FG011|Phase 2|Randomized, but not treated|0|||
124632013|NCT00513240|448268977|FG000|Overall Study|Did not have intended surgery|3|||
124632014|NCT00513240|448268978|FG001|Overall Study|Did not have intended surgery|0|||
124632015|NCT00513240|448268977|FG000|Overall Study|Death|3|||
124632016|NCT00513240|448268978|FG001|Overall Study|Death|3|||
124632017|NCT00513240|448268977|FG000|Overall Study|Withdrawal by Subject|7|||
124632018|NCT00513240|448268978|FG001|Overall Study|Withdrawal by Subject|4|||
124632019|NCT05263908|448268979|FG000|Overall Study|No informed consent for publication of study results|397|||
124632020|NCT05263908|448268979|FG000|Overall Study|CRF not collected|1|||
124632021|NCT00289848|448268980|FG000|Overall Study|Adverse Event|6|||
124632022|NCT00289848|448268981|FG001|Overall Study|Adverse Event|4|||
124632023|NCT00289848|448268980|FG000|Overall Study|Death|1|||
124632024|NCT00289848|448268981|FG001|Overall Study|Death|0|||
124632025|NCT00289848|448268980|FG000|Overall Study|Lack of Efficacy|20|||
124632026|NCT00289848|448268981|FG001|Overall Study|Lack of Efficacy|24|||
124632027|NCT00289848|448268980|FG000|Overall Study|Lost to Follow-up|3|||
124632028|NCT00289848|448268981|FG001|Overall Study|Lost to Follow-up|1|||
124632029|NCT00289848|448268980|FG000|Overall Study|Protocol Violation|5|||
124632030|NCT00289848|448268981|FG001|Overall Study|Protocol Violation|2|||
124632031|NCT00289848|448268980|FG000|Overall Study|Withdrawal by Subject|5|||
124632032|NCT00289848|448268981|FG001|Overall Study|Withdrawal by Subject|11|||
124632033|NCT00289848|448268980|FG000|Overall Study|Patient Moved|6|||
124632034|NCT00289848|448268981|FG001|Overall Study|Patient Moved|2|||
124632035|NCT00289848|448268980|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
124632036|NCT00289848|448268981|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
124632037|NCT03871543|448268984|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
124632038|NCT03871543|448268984|FG000|Period 1|Investigator Error|1|||
124632039|NCT03871543|448268984|FG000|Period 1|Protocol Violation|2|||
124632040|NCT03871543|448268984|FG000|Period 1|COVID-19 Related|1|||
124632041|NCT03871543|448268984|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
124632042|NCT03871543|448268984|FG000|Period 1|Withdrawal by Subject|10|||
124632043|NCT03871543|448268984|FG000|Period 2|Adverse Event|1|||
124632044|NCT03871543|448268984|FG000|Period 2|Withdrawal by Subject|1|||
124632045|NCT00923013|448268991|FG000|Overall Study|Refused further treatment|0|||
124632046|NCT00923013|448268992|FG001|Overall Study|Refused further treatment|1|||
124632047|NCT00923013|448268993|FG002|Overall Study|Refused further treatment|2|||
124632048|NCT00923013|448268994|FG003|Overall Study|Refused further treatment|0|||
124632049|NCT00923013|448268995|FG004|Overall Study|Refused further treatment|0|||
124632050|NCT00923013|448268996|FG005|Overall Study|Refused further treatment|0|||
124632051|NCT00923013|448268991|FG000|Overall Study|Switched to alternative treatment|0|||
124632052|NCT00923013|448268992|FG001|Overall Study|Switched to alternative treatment|1|||
124632053|NCT00923013|448268993|FG002|Overall Study|Switched to alternative treatment|0|||
124632054|NCT00923013|448268994|FG003|Overall Study|Switched to alternative treatment|0|||
124632055|NCT00923013|448268995|FG004|Overall Study|Switched to alternative treatment|0|||
124632056|NCT00923013|448268996|FG005|Overall Study|Switched to alternative treatment|0|||
124632057|NCT00923013|448268991|FG000|Overall Study|Death on study|2|||
124632058|NCT00923013|448268992|FG001|Overall Study|Death on study|2|||
124632059|NCT00923013|448268993|FG002|Overall Study|Death on study|0|||
124632060|NCT00923013|448268994|FG003|Overall Study|Death on study|1|||
124632061|NCT00923013|448268995|FG004|Overall Study|Death on study|0|||
124632062|NCT00923013|448268996|FG005|Overall Study|Death on study|0|||
124632063|NCT01108718|448268997|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
124632064|NCT01108718|448268998|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
124632065|NCT02301169|448269001|FG000|Overall Study|Adverse Event|1|||
124632066|NCT02301169|448269002|FG001|Overall Study|Adverse Event|0|||
124632067|NCT02857816|448269009|FG000|Overall Study|Screen Failure|33|||
124632068|NCT02857816|448269009|FG000|Overall Study|Withdrawal by Subject|4|||
124632069|NCT02857816|448269009|FG000|Overall Study|Lost to Follow-up|1|||
124632070|NCT04383327|448269010|FG000|Overall Study|Lost to Follow-up|112|||
124632071|NCT04383327|448269011|FG001|Overall Study|Lost to Follow-up|14|||
124632072|NCT04383327|448269012|FG002|Overall Study|Lost to Follow-up|78|||
124632073|NCT04383327|448269013|FG003|Overall Study|Lost to Follow-up|13|||
124632074|NCT04383327|448269014|FG004|Overall Study|Lost to Follow-up|110|||
124632075|NCT04383327|448269015|FG005|Overall Study|Lost to Follow-up|13|||
124632076|NCT04383327|448269016|FG006|Overall Study|Lost to Follow-up|74|||
124632077|NCT04383327|448269017|FG007|Overall Study|Lost to Follow-up|13|||
124632078|NCT04383327|448269018|FG008|Overall Study|Lost to Follow-up|78|||
124632079|NCT04383327|448269019|FG009|Overall Study|Lost to Follow-up|10|||
124632080|NCT04383327|448269020|FG010|Overall Study|Lost to Follow-up|160|||
124632081|NCT04383327|448269021|FG011|Overall Study|Lost to Follow-up|13|||
124632082|NCT01289678|448269022|FG000|Overall Study|Physician Decision|6|||
124632083|NCT04740918|448269023|FG000|Overall Study|Study Terminated by Sponsor|41|||
124632084|NCT04740918|448269024|FG001|Overall Study|Study Terminated by Sponsor|32|||
124632085|NCT04740918|448269023|FG000|Overall Study|Death|3|||
124632086|NCT04740918|448269024|FG001|Overall Study|Death|6|||
124632087|NCT04740918|448269023|FG000|Overall Study|Withdrawal by Subject|5|||
124632088|NCT04740918|448269024|FG001|Overall Study|Withdrawal by Subject|4|||
124632089|NCT04740918|448269023|FG000|Overall Study|Lost to Follow-up|1|||
124632090|NCT04740918|448269024|FG001|Overall Study|Lost to Follow-up|3|||
124632091|NCT04740918|448269023|FG000|Overall Study|Progressive disease|0|||
124632092|NCT04740918|448269024|FG001|Overall Study|Progressive disease|1|||
124632093|NCT02524847|448269025|FG000|Overall Study|Adverse Event|4|||
124632094|NCT02524847|448269025|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
124632095|NCT02524847|448269025|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
124632096|NCT02524847|448269025|FG000|Overall Study|Death|1|||
124632097|NCT02524847|448269025|FG000|Overall Study|Reason not Specified|1|||
124632098|NCT04352101|448269026|FG000|Overall Study|Physician Decision|2|||
124632099|NCT04352101|448269027|FG001|Overall Study|Physician Decision|1|||
124632100|NCT01709500|448269028|FG000|Overall Study|Randomized but not treated|0|||
124632101|NCT01709500|448269029|FG001|Overall Study|Randomized but not treated|1|||
124632102|NCT01709500|448269028|FG000|Overall Study|Adverse Event|5|||
124632103|NCT01709500|448269029|FG001|Overall Study|Adverse Event|1|||
124632104|NCT01709500|448269028|FG000|Overall Study|Poor compliance to protocol|2|||
124632105|NCT01709500|448269029|FG001|Overall Study|Poor compliance to protocol|1|||
124632106|NCT01709500|448269028|FG000|Overall Study|Other|3|||
124632107|NCT01709500|448269029|FG001|Overall Study|Other|1|||
124632108|NCT01709500|448269028|FG000|Overall Study|Related to IMP administration|1|||
124632109|NCT01709500|448269029|FG001|Overall Study|Related to IMP administration|0|||
124632110|NCT01709500|448269028|FG000|Overall Study|Treatment ongoing|156|||
124632111|NCT01709500|448269029|FG001|Overall Study|Treatment ongoing|78|||
124632112|NCT00908544|448269030|FG000|Overall Study|Withdrawal by Subject|2|||
124632113|NCT00908544|448269031|FG001|Overall Study|Withdrawal by Subject|4|||
124632114|NCT00908544|448269030|FG000|Overall Study|Lack of Efficacy|0|||
124632115|NCT00908544|448269031|FG001|Overall Study|Lack of Efficacy|1|||
124632116|NCT00908544|448269030|FG000|Overall Study|Pregnancy|1|||
124632117|NCT00908544|448269031|FG001|Overall Study|Pregnancy|0|||
124632118|NCT00908544|448269030|FG000|Overall Study|Relocation abroad|1|||
124802185|NCT02349061|448907597|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
124802186|NCT02349061|448907598|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
124802187|NCT02349061|448907599|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
124802188|NCT02349061|448907597|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
124802189|NCT02349061|448907598|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
124632119|NCT00908544|448269031|FG001|Overall Study|Relocation abroad|1|||
124632120|NCT00908544|448269030|FG000|Overall Study|Unable to visit sutdy center|1|||
124802190|NCT02349061|448907599|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
124632121|NCT00908544|448269031|FG001|Overall Study|Unable to visit sutdy center|0|||
124632122|NCT03170544|448269032|FG000|Part 1|Lost to Follow-up|1|||
124632123|NCT03170544|448269033|FG001|Part 1|Lost to Follow-up|0|||
124632124|NCT03170544|448269034|FG002|Part 1|Lost to Follow-up|0|||
124632125|NCT03170544|448269035|FG003|Part 1|Lost to Follow-up|0|||
124632126|NCT03170544|448269036|FG004|Part 1|Lost to Follow-up|0|||
124632127|NCT03170544|448269037|FG005|Part 1|Lost to Follow-up|0|||
124632128|NCT03170544|448269038|FG006|Part 1|Lost to Follow-up|0|||
124632129|NCT03170544|448269039|FG007|Part 1|Lost to Follow-up|0|||
124632130|NCT03170544|448269040|FG008|Part 1|Lost to Follow-up|0|||
124632131|NCT03170544|448269041|FG009|Part 1|Lost to Follow-up|0|||
124632132|NCT03170544|448269042|FG010|Part 1|Lost to Follow-up|0|||
124632133|NCT03170544|448269043|FG011|Part 1|Lost to Follow-up|0|||
124632134|NCT03170544|448269032|FG000|Part 1|Not treated|0|||
124632135|NCT03170544|448269033|FG001|Part 1|Not treated|0|||
124802191|NCT02349061|448907597|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
124802192|NCT02349061|448907598|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
124802193|NCT02349061|448907599|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
124802194|NCT02349061|448907597|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
124802195|NCT02349061|448907598|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
124802196|NCT02349061|448907599|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
124802197|NCT00398411|448907600|FG000|Overall Study|Death|0|||
124802198|NCT00398411|448907601|FG001|Overall Study|Death|1|||
124802199|NCT00537238|448907602|FG000|Overall Study|Death|1|||
124802200|NCT00537238|448907603|FG001|Overall Study|Death|2|||
124802201|NCT00537238|448907602|FG000|Overall Study|Adverse Event|31|||
124802202|NCT00537238|448907603|FG001|Overall Study|Adverse Event|22|||
124802203|NCT00537238|448907602|FG000|Overall Study|Lack of Efficacy|20|||
124802204|NCT00537238|448907603|FG001|Overall Study|Lack of Efficacy|21|||
124802205|NCT00537238|448907602|FG000|Overall Study|Lost to Follow-up|12|||
124802206|NCT00537238|448907603|FG001|Overall Study|Lost to Follow-up|8|||
124802207|NCT00537238|448907602|FG000|Overall Study|Withdrawal by Subject|51|||
124802208|NCT00537238|448907603|FG001|Overall Study|Withdrawal by Subject|47|||
124802209|NCT00537238|448907602|FG000|Overall Study|Protocol Violation|15|||
124802210|NCT00537238|448907603|FG001|Overall Study|Protocol Violation|19|||
124802211|NCT00537238|448907602|FG000|Overall Study|Does not meet entrance criteria|0|||
124802212|NCT00537238|448907603|FG001|Overall Study|Does not meet entrance criteria|2|||
124802213|NCT00537238|448907602|FG000|Overall Study|Other|44|||
124802214|NCT00537238|448907603|FG001|Overall Study|Other|52|||
124802215|NCT03347188|448907604|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
124802216|NCT03347188|448907605|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
124802217|NCT03347188|448907604|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
124802218|NCT03347188|448907605|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
124802219|NCT03347188|448907604|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
124802220|NCT03347188|448907605|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
124802221|NCT03347188|448907604|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
124802222|NCT03347188|448907605|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
124802223|NCT03347188|448907604|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
124802224|NCT03347188|448907605|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
124802225|NCT03347188|448907604|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
124802226|NCT03347188|448907605|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
124802227|NCT03347188|448907604|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
124802228|NCT03347188|448907605|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
124802229|NCT03347188|448907604|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
124802230|NCT03347188|448907605|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
124802231|NCT01193660|448907606|FG000|Overall Study|Withdrawal by Subject|2|||
124802232|NCT01193660|448907607|FG001|Overall Study|Withdrawal by Subject|3|||
124802233|NCT01193660|448907608|FG002|Overall Study|Withdrawal by Subject|1|||
124802234|NCT01193660|448907606|FG000|Overall Study|Death|1|||
124802235|NCT01193660|448907607|FG001|Overall Study|Death|0|||
124802236|NCT01193660|448907608|FG002|Overall Study|Death|0|||
124802237|NCT01193660|448907606|FG000|Overall Study|Physician Decision|1|||
124802238|NCT01193660|448907607|FG001|Overall Study|Physician Decision|0|||
124802239|NCT01193660|448907608|FG002|Overall Study|Physician Decision|1|||
124802240|NCT02572388|448907609|FG000|Overall Study|Withdrawal by Subject|1|||
124802241|NCT02572388|448907610|FG001|Overall Study|Withdrawal by Subject|1|||
124802242|NCT02572388|448907611|FG002|Overall Study|Withdrawal by Subject|2|||
124802243|NCT02572388|448907612|FG003|Overall Study|Withdrawal by Subject|2|||
124802244|NCT00810108|448907615|FG000|Overall Study|Withdrawal by Subject|1|||
124802245|NCT00810108|448907616|FG001|Overall Study|Withdrawal by Subject|0|||
124802246|NCT01051466|448907617|FG000|Overall Study|Adverse Event|1|||
124802247|NCT01051466|448907618|FG001|Overall Study|Adverse Event|0|||
124802248|NCT01051466|448907617|FG000|Overall Study|Lost to Follow-up|1|||
124802249|NCT01051466|448907618|FG001|Overall Study|Lost to Follow-up|1|||
124802250|NCT01051466|448907617|FG000|Overall Study|Withdrawal by Subject|5|||
124802251|NCT01051466|448907618|FG001|Overall Study|Withdrawal by Subject|1|||
124802252|NCT01051466|448907617|FG000|Overall Study|Entry Criteria Not Met|0|||
124802253|NCT01051466|448907618|FG001|Overall Study|Entry Criteria Not Met|3|||
124802254|NCT01051466|448907617|FG000|Overall Study|Physician Decision|1|||
124802255|NCT01051466|448907618|FG001|Overall Study|Physician Decision|0|||
124802256|NCT01676727|448907625|FG000|Overall Study|Death|18|||
124802257|NCT01676727|448907625|FG000|Overall Study|Withdrawal by Subject|6|||
124802258|NCT01676727|448907625|FG000|Overall Study|Screening failure|5|||
124802259|NCT01676727|448907625|FG000|Overall Study|Not willing to attend 1-year visit|2|||
124802260|NCT01676727|448907625|FG000|Overall Study|Valve explanted|1|||
124802261|NCT01578330|448907626|FG000|Overall Study|Adverse Event|2|||
124632136|NCT03170544|448269034|FG002|Part 1|Not treated|0|||
124802262|NCT01578330|448907626|FG000|Overall Study|Protocol Violation|5|||
124802263|NCT01086423|448907627|FG000|Overall Study|Protocol Violation|0|||
124802264|NCT01086423|448907628|FG001|Overall Study|Protocol Violation|0|||
124802265|NCT01086423|448907629|FG002|Overall Study|Protocol Violation|1|||
124802266|NCT01086423|448907627|FG000|Overall Study|Migrated/moved from study area|2|||
124802267|NCT01086423|448907628|FG001|Overall Study|Migrated/moved from study area|0|||
124802268|NCT01086423|448907629|FG002|Overall Study|Migrated/moved from study area|4|||
124802269|NCT01086423|448907627|FG000|Overall Study|Adverse event, fatal|1|||
124802270|NCT01086423|448907628|FG001|Overall Study|Adverse event, fatal|1|||
124802271|NCT01086423|448907629|FG002|Overall Study|Adverse event, fatal|0|||
124802272|NCT01086423|448907627|FG000|Overall Study|Adverse event, non-fatal|2|||
124802273|NCT01086423|448907628|FG001|Overall Study|Adverse event, non-fatal|1|||
124802274|NCT01086423|448907629|FG002|Overall Study|Adverse event, non-fatal|0|||
124802275|NCT01086423|448907627|FG000|Overall Study|Withdrawal by Subject|5|||
124802276|NCT01086423|448907628|FG001|Overall Study|Withdrawal by Subject|1|||
124802277|NCT01086423|448907629|FG002|Overall Study|Withdrawal by Subject|3|||
124802278|NCT01086423|448907627|FG000|Overall Study|Lost to Follow-up|0|||
124802279|NCT01086423|448907628|FG001|Overall Study|Lost to Follow-up|0|||
124802280|NCT01086423|448907629|FG002|Overall Study|Lost to Follow-up|1|||
124802281|NCT03114488|448907630|FG000|Time Period 2|Withdrawal by Subject|1|||
124802282|NCT03114488|448907631|FG001|Time Period 2|Withdrawal by Subject|3|||
124802283|NCT00566501|448907632|FG000|Overall Study|Adverse Event|68|||
124802284|NCT00566501|448907633|FG001|Overall Study|Adverse Event|59|||
124802285|NCT00566501|448907632|FG000|Overall Study|Medication Non-compliance|5|||
124802286|NCT00566501|448907633|FG001|Overall Study|Medication Non-compliance|0|||
124802287|NCT00566501|448907632|FG000|Overall Study|Protocol Violation|2|||
124802288|NCT00566501|448907633|FG001|Overall Study|Protocol Violation|2|||
124802289|NCT00566501|448907632|FG000|Overall Study|Request of Investigator or Sponsor|6|||
124802290|NCT00566501|448907633|FG001|Overall Study|Request of Investigator or Sponsor|7|||
124802291|NCT00566501|448907632|FG000|Overall Study|Withdrawal by Subject|33|||
124802292|NCT00566501|448907633|FG001|Overall Study|Withdrawal by Subject|30|||
124802293|NCT00566501|448907632|FG000|Overall Study|Lack of Efficacy|8|||
124802294|NCT00566501|448907633|FG001|Overall Study|Lack of Efficacy|3|||
124802295|NCT00566501|448907632|FG000|Overall Study|Other|25|||
124802296|NCT00566501|448907633|FG001|Overall Study|Other|21|||
124802297|NCT01368432|448907638|FG000|Overall Study|Lost to Follow-up|0|||
124802298|NCT01368432|448907639|FG001|Overall Study|Lost to Follow-up|1|||
124802299|NCT00437320|448907641|FG000|Overall Study|Participant request|2|||
124802300|NCT00437320|448907642|FG001|Overall Study|Participant request|1|||
124802301|NCT00437320|448907643|FG002|Overall Study|Participant request|4|||
124802302|NCT01938573|448907644|FG000|Overall Study|Lack of Efficacy|1|||
124802303|NCT01938573|448907645|FG001|Overall Study|Lack of Efficacy|0|||
124802304|NCT01938573|448907644|FG000|Overall Study|Operation at other hospital|1|||
124802305|NCT01938573|448907645|FG001|Overall Study|Operation at other hospital|0|||
124802306|NCT03845543|448907653|FG000|Overall Study|Death|25|||
124802307|NCT03845543|448907653|FG000|Overall Study|Withdrawal by Subject|2|||
124802308|NCT03845543|448907653|FG000|Overall Study|Lost to Follow-up|12|||
124802309|NCT03845543|448907653|FG000|Overall Study|Adverse Event|17|||
124802310|NCT02456103|448907654|FG000|Overall Study|Study Closure|207|||
124802311|NCT02456103|448907654|FG000|Overall Study|Physician Decision|1|||
124802312|NCT02456103|448907654|FG000|Overall Study|Required prohibited medications|5|||
124802313|NCT02456103|448907654|FG000|Overall Study|Protocol Violation|1|||
124802314|NCT02456103|448907654|FG000|Overall Study|Adverse Event|5|||
124802315|NCT02456103|448907654|FG000|Overall Study|Abnormal Laboratory Value|2|||
124802316|NCT02456103|448907654|FG000|Overall Study|Lost to Follow-up|1|||
124802317|NCT02456103|448907654|FG000|Overall Study|Withdrawal by Subject|24|||
124802318|NCT02448810|448907656|FG000|Overall Study|Adverse Event|0|||
124802319|NCT02448810|448907657|FG001|Overall Study|Adverse Event|0|||
124802320|NCT02448810|448907658|FG002|Overall Study|Adverse Event|1|||
124802321|NCT02448810|448907659|FG003|Overall Study|Adverse Event|0|||
124802322|NCT02448810|448907660|FG004|Overall Study|Adverse Event|0|||
124802323|NCT02448810|448907661|FG005|Overall Study|Adverse Event|0|||
124802324|NCT02448810|448907662|FG006|Overall Study|Adverse Event|0|||
124802325|NCT02448810|448907663|FG007|Overall Study|Adverse Event|0|||
124632137|NCT03170544|448269035|FG003|Part 1|Not treated|1|||
124632138|NCT03170544|448269036|FG004|Part 1|Not treated|0|||
124802326|NCT02448810|448907656|FG000|Overall Study|Withdrawal by Subject|0|||
124802327|NCT02448810|448907657|FG001|Overall Study|Withdrawal by Subject|0|||
124802328|NCT02448810|448907658|FG002|Overall Study|Withdrawal by Subject|1|||
124802329|NCT02448810|448907659|FG003|Overall Study|Withdrawal by Subject|0|||
124802330|NCT02448810|448907660|FG004|Overall Study|Withdrawal by Subject|3|||
124802331|NCT02448810|448907661|FG005|Overall Study|Withdrawal by Subject|5|||
124802332|NCT02448810|448907662|FG006|Overall Study|Withdrawal by Subject|0|||
124802333|NCT02448810|448907663|FG007|Overall Study|Withdrawal by Subject|2|||
124802334|NCT02448810|448907656|FG000|Overall Study|Other (study terminated by sponsor)|0|||
124802335|NCT02448810|448907657|FG001|Overall Study|Other (study terminated by sponsor)|0|||
124802336|NCT02448810|448907658|FG002|Overall Study|Other (study terminated by sponsor)|0|||
124802337|NCT02448810|448907659|FG003|Overall Study|Other (study terminated by sponsor)|0|||
124802338|NCT02448810|448907660|FG004|Overall Study|Other (study terminated by sponsor)|4|||
124802339|NCT02448810|448907661|FG005|Overall Study|Other (study terminated by sponsor)|2|||
124802340|NCT02448810|448907662|FG006|Overall Study|Other (study terminated by sponsor)|2|||
124802341|NCT02448810|448907663|FG007|Overall Study|Other (study terminated by sponsor)|1|||
124802342|NCT02448810|448907656|FG000|Overall Study|Death|1|||
124802343|NCT02448810|448907657|FG001|Overall Study|Death|0|||
124802344|NCT02448810|448907658|FG002|Overall Study|Death|1|||
124802345|NCT02448810|448907659|FG003|Overall Study|Death|0|||
124802346|NCT02448810|448907660|FG004|Overall Study|Death|1|||
124802347|NCT02448810|448907661|FG005|Overall Study|Death|0|||
124802348|NCT02448810|448907662|FG006|Overall Study|Death|0|||
124802349|NCT02448810|448907663|FG007|Overall Study|Death|0|||
124802350|NCT02448810|448907656|FG000|Overall Study|Other (Progressive disease)|2|||
124632139|NCT03170544|448269037|FG005|Part 1|Not treated|0|||
124632140|NCT03170544|448269038|FG006|Part 1|Not treated|0|||
124632141|NCT03170544|448269039|FG007|Part 1|Not treated|0|||
124632142|NCT03170544|448269040|FG008|Part 1|Not treated|0|||
124632143|NCT03170544|448269041|FG009|Part 1|Not treated|0|||
124632144|NCT03170544|448269042|FG010|Part 1|Not treated|0|||
124632145|NCT03170544|448269043|FG011|Part 1|Not treated|0|||
124632146|NCT02387840|448269044|FG000|Overall Study|Death|0|||
124632147|NCT02387840|448269045|FG001|Overall Study|Death|0|||
124632148|NCT02387840|448269046|FG002|Overall Study|Death|0|||
124632149|NCT02387840|448269047|FG003|Overall Study|Death|0|||
124632150|NCT02387840|448269048|FG004|Overall Study|Death|0|||
124802351|NCT02448810|448907657|FG001|Overall Study|Other (Progressive disease)|2|||
124802352|NCT02448810|448907658|FG002|Overall Study|Other (Progressive disease)|0|||
124802353|NCT02448810|448907659|FG003|Overall Study|Other (Progressive disease)|3|||
124802354|NCT02448810|448907660|FG004|Overall Study|Other (Progressive disease)|23|||
124802355|NCT02448810|448907661|FG005|Overall Study|Other (Progressive disease)|9|||
124802356|NCT02448810|448907662|FG006|Overall Study|Other (Progressive disease)|14|||
124802357|NCT02448810|448907663|FG007|Overall Study|Other (Progressive disease)|5|||
124802358|NCT02448810|448907656|FG000|Overall Study|Lost to Follow-up|0|||
124802359|NCT02448810|448907657|FG001|Overall Study|Lost to Follow-up|1|||
124802360|NCT02448810|448907658|FG002|Overall Study|Lost to Follow-up|0|||
124802361|NCT02448810|448907659|FG003|Overall Study|Lost to Follow-up|0|||
124802362|NCT02448810|448907660|FG004|Overall Study|Lost to Follow-up|0|||
124802363|NCT02448810|448907661|FG005|Overall Study|Lost to Follow-up|0|||
124802364|NCT02448810|448907662|FG006|Overall Study|Lost to Follow-up|0|||
124802365|NCT02448810|448907663|FG007|Overall Study|Lost to Follow-up|0|||
124802366|NCT02448810|448907656|FG000|Overall Study|Other (unspecified)|0|||
124802367|NCT02448810|448907657|FG001|Overall Study|Other (unspecified)|0|||
124802368|NCT02448810|448907658|FG002|Overall Study|Other (unspecified)|0|||
124802369|NCT02448810|448907659|FG003|Overall Study|Other (unspecified)|0|||
124802370|NCT02448810|448907660|FG004|Overall Study|Other (unspecified)|0|||
124802371|NCT02448810|448907661|FG005|Overall Study|Other (unspecified)|0|||
124802372|NCT02448810|448907662|FG006|Overall Study|Other (unspecified)|2|||
124802373|NCT02448810|448907663|FG007|Overall Study|Other (unspecified)|0|||
124802374|NCT00470847|448907668|FG000|Overall Study|Pt still receiving treatment|1|||
124802375|NCT03139279|448907676|FG000|Overall Study|Physician Decision|2|||
124802376|NCT03139279|448907677|FG001|Overall Study|Physician Decision|0|||
124802377|NCT03139279|448907676|FG000|Overall Study|Protocol Violation|5|||
124802378|NCT03139279|448907677|FG001|Overall Study|Protocol Violation|4|||
124802379|NCT03139279|448907676|FG000|Overall Study|Withdrawal by Subject|0|||
124802380|NCT03139279|448907677|FG001|Overall Study|Withdrawal by Subject|2|||
124802381|NCT01090973|448907678|FG000|Overall Study|Disease progression|1|||
124802382|NCT01626495|448907681|FG000|Overall Study|Adverse Event|3|||
124802383|NCT01626495|448907681|FG000|Overall Study|Disease progression|27|||
124802384|NCT01626495|448907681|FG000|Overall Study|Withdrawal by Subject|1|||
124802385|NCT01626495|448907681|FG000|Overall Study|Administrative problem|1|||
124632151|NCT02387840|448269049|FG005|Overall Study|Death|1|||
124632152|NCT03539302|448269055|FG000|Overall Study|Spontaneous cardio version|0|||
124632153|NCT03539302|448269056|FG001|Overall Study|Spontaneous cardio version|0|||
124632154|NCT03539302|448269057|FG002|Overall Study|Spontaneous cardio version|0|||
124802386|NCT01626495|448907681|FG000|Overall Study|Death|2|||
124802387|NCT01626495|448907681|FG000|Overall Study|Physician Decision|1|||
124802388|NCT01626495|448907681|FG000|Overall Study|New cancer therapy|16|||
124632155|NCT03539302|448269058|FG003|Overall Study|Spontaneous cardio version|0|||
124632156|NCT03539302|448269059|FG004|Overall Study|Spontaneous cardio version|0|||
124632157|NCT03539302|448269060|FG005|Overall Study|Spontaneous cardio version|1|||
124802389|NCT01626495|448907681|FG000|Overall Study|Manufacturing failure|1|||
124802390|NCT01934972|448907682|FG000|Overall Study|Withdrawal by Subject|9|||
124802391|NCT01934972|448907683|FG001|Overall Study|Withdrawal by Subject|6|||
124802392|NCT03131453|448907684|FG000|Overall Study|Study terminated by Sponsor|424|||
124802393|NCT03131453|448907685|FG001|Overall Study|Study terminated by Sponsor|222|||
124802394|NCT03131453|448907686|FG002|Overall Study|Study terminated by Sponsor|438|||
124802395|NCT03131453|448907684|FG000|Overall Study|Withdrawal by Subject|18|||
124632158|NCT03539302|448269061|FG006|Overall Study|Spontaneous cardio version|1|||
124632159|NCT00071110|448269064|FG000|Overall Study|Protocol Violation|0|||
124802396|NCT03131453|448907685|FG001|Overall Study|Withdrawal by Subject|7|||
124632160|NCT00071110|448269065|FG001|Overall Study|Protocol Violation|4|||
124632161|NCT02389829|448269068|FG000|Overall Study|Lost to Follow-up|0|||
124802397|NCT03131453|448907686|FG002|Overall Study|Withdrawal by Subject|13|||
124802398|NCT03131453|448907684|FG000|Overall Study|Adverse Event|10|||
124802399|NCT03131453|448907685|FG001|Overall Study|Adverse Event|3|||
124802400|NCT03131453|448907686|FG002|Overall Study|Adverse Event|3|||
124802401|NCT03131453|448907684|FG000|Overall Study|Lost to Follow-up|1|||
124802402|NCT03131453|448907685|FG001|Overall Study|Lost to Follow-up|0|||
124802403|NCT03131453|448907686|FG002|Overall Study|Lost to Follow-up|1|||
124802404|NCT03131453|448907684|FG000|Overall Study|Physician Decision|1|||
124802405|NCT03131453|448907685|FG001|Overall Study|Physician Decision|0|||
124802406|NCT03131453|448907686|FG002|Overall Study|Physician Decision|1|||
124802407|NCT03131453|448907684|FG000|Overall Study|Non-compliance with study treatment|1|||
124802408|NCT03131453|448907685|FG001|Overall Study|Non-compliance with study treatment|0|||
124802409|NCT03131453|448907686|FG002|Overall Study|Non-compliance with study treatment|0|||
124802410|NCT03131453|448907684|FG000|Overall Study|Technical problems|1|||
124802411|NCT03131453|448907685|FG001|Overall Study|Technical problems|0|||
124802412|NCT03131453|448907686|FG002|Overall Study|Technical problems|0|||
124802413|NCT03131453|448907684|FG000|Overall Study|Protocol deviation|0|||
124802414|NCT03131453|448907685|FG001|Overall Study|Protocol deviation|1|||
124802415|NCT03131453|448907686|FG002|Overall Study|Protocol deviation|0|||
124802416|NCT03438383|448907689|FG000|Overall Study|Protocol Violation|9|||
124802417|NCT03438383|448907690|FG001|Overall Study|Protocol Violation|3|||
124802418|NCT02766465|448907691|FG000|Overall Study|Withdrawal by Subject|0|||
124802419|NCT02766465|448907692|FG001|Overall Study|Withdrawal by Subject|10|||
124802420|NCT02435069|448907693|FG000|Dose Response - First Intervention|Adverse Event|0|||
124802421|NCT02435069|448907694|FG001|Dose Response - First Intervention|Adverse Event|1|||
124802422|NCT02435069|448907695|FG002|Dose Response - First Intervention|Adverse Event|1|||
124802423|NCT02435069|448907696|FG003|Dose Response - First Intervention|Adverse Event|0|||
124802424|NCT02435069|448907697|FG004|Dose Response - First Intervention|Adverse Event|0|||
124802425|NCT02435069|448907693|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
124802426|NCT02435069|448907694|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
124802427|NCT02435069|448907695|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
124802428|NCT02435069|448907696|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
124802429|NCT02435069|448907697|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
124802430|NCT01528033|448907698|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
124802431|NCT01528033|448907699|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
124802432|NCT01528033|448907698|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
124802433|NCT01528033|448907699|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
124802434|NCT01528033|448907698|FG000|Primary Endpoint Assessment ITT|Death|2|||
124802435|NCT01528033|448907699|FG001|Primary Endpoint Assessment ITT|Death|2|||
124802436|NCT01528033|448907698|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
124802437|NCT01528033|448907699|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
124802438|NCT01528033|448907698|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
124802439|NCT01528033|448907699|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
124802440|NCT01528033|448907698|FG000|Follow Up|No data available|46|||
124802441|NCT01528033|448907699|FG001|Follow Up|No data available|44|||
124802442|NCT02520661|448907700|FG000|Overall Study|Lost to Follow-up|7|||
124802443|NCT02520661|448907701|FG001|Overall Study|Lost to Follow-up|3|||
124802444|NCT02520661|448907700|FG000|Overall Study|Admitted from ED|49|||
124802445|NCT02520661|448907701|FG001|Overall Study|Admitted from ED|48|||
124802446|NCT02520661|448907700|FG000|Overall Study|ED greater than 24 hours|29|||
124802447|NCT02520661|448907701|FG001|Overall Study|ED greater than 24 hours|38|||
124802448|NCT02520661|448907700|FG000|Overall Study|other ineligibility|14|||
124802449|NCT02520661|448907701|FG001|Overall Study|other ineligibility|22|||
124802450|NCT02520661|448907700|FG000|Overall Study|Withdrawal by Subject|7|||
124802451|NCT02520661|448907701|FG001|Overall Study|Withdrawal by Subject|16|||
124802452|NCT05156073|448907704|FG000|Overall Study|Patient canceled appointment with PCP|1|||
124802453|NCT02891161|448907715|FG000|Study Treatment|Disease Progression|2|||
124802454|NCT02891161|448907716|FG001|Study Treatment|Disease Progression|4|||
124802455|NCT02891161|448907715|FG000|Study Treatment|AE/Side Effects/Complications|1|||
124802456|NCT02891161|448907716|FG001|Study Treatment|AE/Side Effects/Complications|5|||
124802457|NCT02891161|448907715|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
124802458|NCT02891161|448907716|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
124802459|NCT02891161|448907715|FG000|Follow up|Death|4|||
124802460|NCT02891161|448907716|FG001|Follow up|Death|8|||
124802461|NCT02891161|448907715|FG000|Follow up|Refused to Follow up|0|||
124802462|NCT02891161|448907716|FG001|Follow up|Refused to Follow up|2|||
124802463|NCT02891161|448907715|FG000|Follow up|Symptomatic deterioration|0|||
124802464|NCT02891161|448907716|FG001|Follow up|Symptomatic deterioration|1|||
124802465|NCT02891161|448907715|FG000|Follow up|Study terminated|0|||
124802466|NCT02891161|448907716|FG001|Follow up|Study terminated|6|||
124802467|NCT02734433|448907719|FG000|Overall Study|Disease progression|1|||
124802468|NCT02734433|448907720|FG001|Overall Study|Disease progression|5|||
124802469|NCT02734433|448907719|FG000|Overall Study|Clinical progression|0|||
124632162|NCT02389829|448269069|FG001|Overall Study|Lost to Follow-up|1|||
124752584|NCT02737475|448716778|FG021|Overall Study|Disease Progression|0|||
124752585|NCT02737475|448716779|FG022|Overall Study|Disease Progression|0|||
124752586|NCT02737475|448716780|FG023|Overall Study|Disease Progression|0|||
124752587|NCT02737475|448716781|FG024|Overall Study|Disease Progression|0|||
124752588|NCT02737475|448716782|FG025|Overall Study|Disease Progression|0|||
124752589|NCT02737475|448716783|FG026|Overall Study|Disease Progression|1|||
124752590|NCT00546000|448716784|FG000|Overall Study|Adverse Event|1|||
124752591|NCT00546000|448716784|FG000|Overall Study|Lost to Follow-up|1|||
124752592|NCT00546000|448716784|FG000|Overall Study|Baseline HPA Axis Supression|2|||
124752593|NCT00660179|448716786|FG000|Overall Study|Death|44|||
124752594|NCT00660179|448716787|FG001|Overall Study|Death|47|||
124752595|NCT00660179|448716788|FG002|Overall Study|Death|34|||
124752596|NCT00660179|448716786|FG000|Overall Study|Withdrawal of consent|4|||
124752597|NCT00660179|448716787|FG001|Overall Study|Withdrawal of consent|6|||
124752598|NCT00660179|448716788|FG002|Overall Study|Withdrawal of consent|4|||
124752599|NCT00660179|448716786|FG000|Overall Study|Lost to Follow-up|7|||
124752600|NCT00660179|448716787|FG001|Overall Study|Lost to Follow-up|5|||
124752601|NCT00660179|448716788|FG002|Overall Study|Lost to Follow-up|2|||
124752602|NCT00660179|448716786|FG000|Overall Study|Administrative reason|0|||
124752603|NCT00660179|448716787|FG001|Overall Study|Administrative reason|0|||
124752604|NCT00660179|448716788|FG002|Overall Study|Administrative reason|1|||
124752605|NCT00660179|448716786|FG000|Overall Study|Incorrect randomization|1|||
124752606|NCT00660179|448716787|FG001|Overall Study|Incorrect randomization|0|||
124752607|NCT00660179|448716788|FG002|Overall Study|Incorrect randomization|0|||
124752608|NCT01504412|448716789|FG000|Overall Study|Adverse Event|1|||
124752609|NCT01504412|448716790|FG001|Overall Study|Adverse Event|8|||
124752610|NCT01504412|448716791|FG002|Overall Study|Adverse Event|1|||
124752611|NCT01504412|448716792|FG003|Overall Study|Adverse Event|7|||
124752612|NCT01504412|448716793|FG004|Overall Study|Adverse Event|10|||
124752613|NCT01504412|448716789|FG000|Overall Study|Withdrawal by Subject|2|||
124752614|NCT01504412|448716790|FG001|Overall Study|Withdrawal by Subject|1|||
124752615|NCT01504412|448716791|FG002|Overall Study|Withdrawal by Subject|1|||
124752616|NCT01504412|448716792|FG003|Overall Study|Withdrawal by Subject|5|||
124752617|NCT01504412|448716793|FG004|Overall Study|Withdrawal by Subject|1|||
124752618|NCT01504412|448716789|FG000|Overall Study|Other|2|||
124752619|NCT01504412|448716790|FG001|Overall Study|Other|1|||
124752620|NCT01504412|448716791|FG002|Overall Study|Other|1|||
124752621|NCT01504412|448716792|FG003|Overall Study|Other|6|||
124752622|NCT01504412|448716793|FG004|Overall Study|Other|1|||
124752623|NCT01504412|448716789|FG000|Overall Study|Lost to Follow-up|0|||
124752624|NCT01504412|448716790|FG001|Overall Study|Lost to Follow-up|2|||
124752625|NCT01504412|448716791|FG002|Overall Study|Lost to Follow-up|0|||
124752626|NCT01504412|448716792|FG003|Overall Study|Lost to Follow-up|0|||
124752627|NCT01504412|448716793|FG004|Overall Study|Lost to Follow-up|0|||
124752628|NCT01504412|448716789|FG000|Overall Study|Lack of Efficacy|0|||
124752629|NCT01504412|448716790|FG001|Overall Study|Lack of Efficacy|0|||
124752630|NCT01504412|448716791|FG002|Overall Study|Lack of Efficacy|1|||
124752631|NCT01504412|448716792|FG003|Overall Study|Lack of Efficacy|0|||
124752632|NCT01504412|448716793|FG004|Overall Study|Lack of Efficacy|1|||
124752633|NCT01504412|448716789|FG000|Overall Study|Death|0|||
124752634|NCT01504412|448716790|FG001|Overall Study|Death|0|||
124752635|NCT01504412|448716791|FG002|Overall Study|Death|0|||
124752636|NCT01504412|448716792|FG003|Overall Study|Death|1|||
124752637|NCT01504412|448716793|FG004|Overall Study|Death|0|||
124752638|NCT01449006|448716794|FG000|Overall Study|Lost to Follow-up|1|||
124752639|NCT01449006|448716795|FG001|Overall Study|Lost to Follow-up|0|||
124752640|NCT01449006|448716794|FG000|Overall Study|Withdrawal by Subject|1|||
124752641|NCT01449006|448716795|FG001|Overall Study|Withdrawal by Subject|0|||
124752642|NCT01449006|448716794|FG000|Overall Study|Protocol Violation|1|||
124752643|NCT01449006|448716795|FG001|Overall Study|Protocol Violation|0|||
124752644|NCT02221674|448716799|FG000|Overall Study|Lost to Follow-up|1|||
124752645|NCT02221674|448716800|FG001|Overall Study|Lost to Follow-up|0|||
124752646|NCT02221674|448716801|FG002|Overall Study|Lost to Follow-up|0|||
124752647|NCT05292131|448716802|FG000|Overall Study|Lost to Follow-up|1|||
124752648|NCT05292131|448716803|FG001|Overall Study|Lost to Follow-up|1|||
124752649|NCT05292131|448716802|FG000|Overall Study|Withdrawal by Subject|0|||
124752650|NCT05292131|448716803|FG001|Overall Study|Withdrawal by Subject|1|||
124752651|NCT04390880|448716805|FG000|Overall Study|Withdrawal by Subject|1|||
124752652|NCT02557542|448716806|FG000|Overall Study|Poor recruitment|3|||
124752653|NCT02557542|448716807|FG001|Overall Study|Poor recruitment|0|||
124752654|NCT06136897|448716808|FG000|Overall Study|Ineligible|3|||
124752655|NCT06136897|448716808|FG000|Overall Study|Mutation status not confirmed|7|||
124752656|NCT06136897|448716808|FG000|Overall Study|Adverse Event|2|||
124752657|NCT06136897|448716808|FG000|Overall Study|Death|1|||
124752658|NCT06136897|448716808|FG000|Overall Study|Disease progression|18|||
124752659|NCT06136897|448716808|FG000|Overall Study|Other complicating disease|1|||
124752660|NCT06136897|448716808|FG000|Overall Study|Withdrawal by Subject|1|||
124802470|NCT02734433|448907720|FG001|Overall Study|Clinical progression|1|||
124802471|NCT02734433|448907719|FG000|Overall Study|Withdrawal by Subject|1|||
124802472|NCT02734433|448907720|FG001|Overall Study|Withdrawal by Subject|2|||
124802473|NCT02628769|448907721|FG000|First Intervention|Adverse Event|1|||
124802474|NCT02628769|448907722|FG001|First Intervention|Adverse Event|0|||
124802475|NCT02628769|448907721|FG000|First Intervention|Withdrawal by Subject|0|||
124802476|NCT02628769|448907722|FG001|First Intervention|Withdrawal by Subject|1|||
124802477|NCT02628769|448907721|FG000|Second Intervention|Adverse Event|2|||
124802478|NCT02628769|448907722|FG001|Second Intervention|Adverse Event|0|||
124802479|NCT02628769|448907721|FG000|Second Intervention|Physician Decision|0|||
124802480|NCT02628769|448907722|FG001|Second Intervention|Physician Decision|1|||
124802481|NCT05521906|448907729|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
124802482|NCT05521906|448907730|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
124802483|NCT00560885|448907731|FG000|Overall Study|Death|7|||
124802484|NCT00560885|448907731|FG000|Overall Study|Withdrawal by Subject|1|||
124802485|NCT02887859|448907732|FG000|Overall Study|Ongoing|6|||
124802486|NCT02887859|448907732|FG000|Overall Study|Adverse Event|7|||
124802487|NCT02887859|448907732|FG000|Overall Study|Death|1|||
124802488|NCT02887859|448907732|FG000|Overall Study|Physician Decision|1|||
124802489|NCT01507298|448910057|FG000|Overall Study|Protocol Violation|0|||
124802490|NCT01507298|448910058|FG001|Overall Study|Protocol Violation|6|||
124802491|NCT01920555|448910059|FG000|Overall Study|Physician Decision|1|||
124802492|NCT01920555|448910060|FG001|Overall Study|Physician Decision|2|||
124802493|NCT01920555|448910061|FG002|Overall Study|Physician Decision|1|||
124802494|NCT01920555|448910062|FG003|Overall Study|Physician Decision|2|||
124802495|NCT01920555|448910063|FG004|Overall Study|Physician Decision|0|||
124802496|NCT01920555|448910059|FG000|Overall Study|Lack of Efficacy|2|||
124802497|NCT01920555|448910060|FG001|Overall Study|Lack of Efficacy|0|||
124802498|NCT01920555|448910061|FG002|Overall Study|Lack of Efficacy|0|||
124802499|NCT01920555|448910062|FG003|Overall Study|Lack of Efficacy|0|||
124802500|NCT01920555|448910063|FG004|Overall Study|Lack of Efficacy|0|||
124802501|NCT01920555|448910059|FG000|Overall Study|Travel Difficulties|1|||
124802502|NCT01920555|448910060|FG001|Overall Study|Travel Difficulties|1|||
124802503|NCT01920555|448910061|FG002|Overall Study|Travel Difficulties|0|||
124802504|NCT01920555|448910062|FG003|Overall Study|Travel Difficulties|0|||
124802505|NCT01920555|448910063|FG004|Overall Study|Travel Difficulties|1|||
124802506|NCT01920555|448910059|FG000|Overall Study|Lost to Follow-up|0|||
124802507|NCT01920555|448910060|FG001|Overall Study|Lost to Follow-up|1|||
124802508|NCT01920555|448910061|FG002|Overall Study|Lost to Follow-up|0|||
124802509|NCT01920555|448910062|FG003|Overall Study|Lost to Follow-up|1|||
124802510|NCT01920555|448910063|FG004|Overall Study|Lost to Follow-up|0|||
124802511|NCT03265665|448910064|FG000|24-week Data Collection|Withdrawal by Subject|2|||
124802512|NCT03265665|448910065|FG001|24-week Data Collection|Withdrawal by Subject|2|||
124802513|NCT03265665|448910064|FG000|24-week Data Collection|Lost to Follow-up|4|||
124802514|NCT03265665|448910065|FG001|24-week Data Collection|Lost to Follow-up|5|||
124802515|NCT03265665|448910064|FG000|36-week Data Collection|Lost to Follow-up|6|||
124802516|NCT03265665|448910065|FG001|36-week Data Collection|Lost to Follow-up|8|||
124802517|NCT01614600|448910066|FG000|Overall Study|Unacceptable fit|1|||
124802518|NCT01614600|448910066|FG000|Overall Study|Discomfort|1|||
124802519|NCT01614600|448910066|FG000|Overall Study|Unable to remove lens at the end of day|1|||
124802520|NCT01614600|448910066|FG000|Overall Study|Protocol deviation|1|||
124802521|NCT01680965|448910067|FG000|Overall Study|Death|0|||
124802522|NCT01680965|448910068|FG001|Overall Study|Death|0|||
124802523|NCT01680965|448910069|FG002|Overall Study|Death|0|||
124802524|NCT01680965|448910070|FG003|Overall Study|Death|6|||
124802525|NCT00195273|448910071|FG000|Overall Study|Adverse Event|9|||
124802526|NCT00195273|448910072|FG001|Overall Study|Adverse Event|9|||
124802527|NCT00195273|448910071|FG000|Overall Study|Protocol deviation|0|||
124802528|NCT00195273|448910072|FG001|Overall Study|Protocol deviation|1|||
124802529|NCT00195273|448910071|FG000|Overall Study|Lack of Efficacy|3|||
124802530|NCT00195273|448910072|FG001|Overall Study|Lack of Efficacy|1|||
124802531|NCT00195273|448910071|FG000|Overall Study|Procedural complications|9|||
124802532|NCT00195273|448910072|FG001|Overall Study|Procedural complications|3|||
124802533|NCT02186873|448910073|FG000|Overall Study|Adverse Event|1|||
124802534|NCT02186873|448910074|FG001|Overall Study|Adverse Event|3|||
124802535|NCT02186873|448910073|FG000|Overall Study|Lack of Efficacy|0|||
124802536|NCT02186873|448910074|FG001|Overall Study|Lack of Efficacy|1|||
124802537|NCT02186873|448910073|FG000|Overall Study|Lost to Follow-up|1|||
124802538|NCT02186873|448910074|FG001|Overall Study|Lost to Follow-up|2|||
124802539|NCT02186873|448910073|FG000|Overall Study|Withdrawal by Subject|7|||
124802540|NCT02186873|448910074|FG001|Overall Study|Withdrawal by Subject|2|||
124802541|NCT00595465|448910075|FG000|Overall Study|Adverse Event|4|||
124802542|NCT00595465|448910076|FG001|Overall Study|Adverse Event|3|||
124802543|NCT00595465|448910077|FG002|Overall Study|Adverse Event|3|||
124802544|NCT00595465|448910075|FG000|Overall Study|Pregnancy|0|||
124802545|NCT00595465|448910076|FG001|Overall Study|Pregnancy|0|||
124802546|NCT00595465|448910077|FG002|Overall Study|Pregnancy|1|||
124802547|NCT00595465|448910075|FG000|Overall Study|Protocol Violation|2|||
124802548|NCT00595465|448910076|FG001|Overall Study|Protocol Violation|1|||
124802549|NCT00595465|448910077|FG002|Overall Study|Protocol Violation|0|||
124802550|NCT00595465|448910075|FG000|Overall Study|Lost to Follow-up|0|||
124802551|NCT00595465|448910076|FG001|Overall Study|Lost to Follow-up|0|||
124802552|NCT00595465|448910077|FG002|Overall Study|Lost to Follow-up|2|||
124802553|NCT00595465|448910075|FG000|Overall Study|administrative reason|0|||
124802554|NCT00595465|448910076|FG001|Overall Study|administrative reason|0|||
124802555|NCT00595465|448910077|FG002|Overall Study|administrative reason|1|||
124802556|NCT02595970|448910078|FG000|Overall Study|Withdrawal by Subject|2|||
124802557|NCT02595970|448910078|FG000|Overall Study|Physician Decision|2|||
124802558|NCT02595970|448910078|FG000|Overall Study|Protocol Violation|4|||
124802559|NCT02595970|448910078|FG000|Overall Study|Adverse Event|5|||
124802560|NCT02595970|448910078|FG000|Overall Study|Lack of Efficacy|7|||
124802561|NCT00107783|448910079|FG000|Overall Study|Adverse Event|0|||
124802562|NCT00107783|448910080|FG001|Overall Study|Adverse Event|2|||
124802563|NCT00107783|448910079|FG000|Overall Study|Death|0|||
124802564|NCT00107783|448910080|FG001|Overall Study|Death|1|||
124802565|NCT00107783|448910079|FG000|Overall Study|Withdrawal by Subject|2|||
124802566|NCT00107783|448910080|FG001|Overall Study|Withdrawal by Subject|0|||
124802567|NCT00107783|448910079|FG000|Overall Study|Second hip replacement|1|||
124802568|NCT00107783|448910080|FG001|Overall Study|Second hip replacement|1|||
124802569|NCT01886716|448910081|FG000|Week 1|Lost to Follow-up|0|||
124802570|NCT01886716|448910082|FG001|Week 1|Lost to Follow-up|0|||
124802571|NCT01886716|448910083|FG002|Week 1|Lost to Follow-up|2|||
124802572|NCT01886716|448910084|FG003|Week 1|Lost to Follow-up|2|||
124802573|NCT01886716|448910081|FG000|Week 2|Lost to Follow-up|3|||
124802574|NCT01886716|448910082|FG001|Week 2|Lost to Follow-up|2|||
124802575|NCT01886716|448910083|FG002|Week 2|Lost to Follow-up|1|||
124802576|NCT01886716|448910084|FG003|Week 2|Lost to Follow-up|3|||
124802577|NCT01886716|448910081|FG000|Week 3|Lost to Follow-up|1|||
124802578|NCT01886716|448910082|FG001|Week 3|Lost to Follow-up|1|||
124802579|NCT01886716|448910083|FG002|Week 3|Lost to Follow-up|0|||
124802580|NCT01886716|448910084|FG003|Week 3|Lost to Follow-up|1|||
124802581|NCT04879225|448910087|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
124802582|NCT04879225|448910087|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
124802583|NCT03894046|448910090|FG000|Overall Study|Protocol Violation|1|||
124802584|NCT03894046|448910091|FG001|Overall Study|Protocol Violation|0|||
124802585|NCT03894046|448910092|FG002|Overall Study|Protocol Violation|0|||
124802586|NCT03894046|448910090|FG000|Overall Study|Adverse Event|0|||
124802587|NCT03894046|448910091|FG001|Overall Study|Adverse Event|1|||
124802588|NCT03894046|448910092|FG002|Overall Study|Adverse Event|0|||
124802589|NCT03894046|448910090|FG000|Overall Study|Withdrawal by Subject|2|||
124802590|NCT03894046|448910091|FG001|Overall Study|Withdrawal by Subject|3|||
124802591|NCT03894046|448910092|FG002|Overall Study|Withdrawal by Subject|1|||
124802592|NCT03894046|448910090|FG000|Overall Study|Death|15|||
124802593|NCT03894046|448910091|FG001|Overall Study|Death|21|||
124802594|NCT03894046|448910092|FG002|Overall Study|Death|4|||
124802595|NCT03894046|448910090|FG000|Overall Study|No growth of ABC|2|||
124802596|NCT03894046|448910091|FG001|Overall Study|No growth of ABC|1|||
124802597|NCT03894046|448910092|FG002|Overall Study|No growth of ABC|0|||
124802598|NCT03894046|448910090|FG000|Overall Study|Physician Decision|1|||
124802599|NCT03894046|448910091|FG001|Overall Study|Physician Decision|1|||
124802600|NCT03894046|448910092|FG002|Overall Study|Physician Decision|1|||
124802601|NCT03894046|448910090|FG000|Overall Study|Prohibited concomitant medication|1|||
124802602|NCT03894046|448910091|FG001|Overall Study|Prohibited concomitant medication|0|||
124802603|NCT03894046|448910092|FG002|Overall Study|Prohibited concomitant medication|0|||
124802604|NCT03894046|448910090|FG000|Overall Study|Transferred to other arm/group|1|||
124802605|NCT03894046|448910091|FG001|Overall Study|Transferred to other arm/group|1|||
124802606|NCT03894046|448910092|FG002|Overall Study|Transferred to other arm/group|0|||
124802607|NCT02367131|448910093|FG000|Overall Study|Adverse Event|64|||
124802608|NCT02367131|448910093|FG000|Overall Study|No visit since the first visit|3|||
124802609|NCT02367131|448910093|FG000|Overall Study|Request by patient|53|||
124802610|NCT02367131|448910093|FG000|Overall Study|Improvement/remission|2|||
124802611|NCT02367131|448910093|FG000|Overall Study|No change/progressive disease|78|||
124802612|NCT02367131|448910093|FG000|Overall Study|Other than stated above|20|||
124802613|NCT02367131|448910093|FG000|Overall Study|Not treated|2|||
124802614|NCT01973569|448910094|FG000|Overall Study|Adverse Event|9|||
124802615|NCT01973569|448910095|FG001|Overall Study|Adverse Event|2|||
124802616|NCT01973569|448910096|FG002|Overall Study|Adverse Event|4|||
124802617|NCT01973569|448910094|FG000|Overall Study|Protocol Violation|2|||
124802618|NCT01973569|448910095|FG001|Overall Study|Protocol Violation|1|||
124802619|NCT01973569|448910096|FG002|Overall Study|Protocol Violation|3|||
124802620|NCT01973569|448910094|FG000|Overall Study|Withdrawal by Subject|7|||
124802621|NCT01973569|448910095|FG001|Overall Study|Withdrawal by Subject|5|||
124802622|NCT01973569|448910096|FG002|Overall Study|Withdrawal by Subject|2|||
124802623|NCT01973569|448910094|FG000|Overall Study|Invasive dental treatment|3|||
124802624|NCT01973569|448910095|FG001|Overall Study|Invasive dental treatment|5|||
124802625|NCT01973569|448910096|FG002|Overall Study|Invasive dental treatment|6|||
124802626|NCT01973569|448910094|FG000|Overall Study|Prohibited concomitant d|1|||
124802627|NCT01973569|448910095|FG001|Overall Study|Prohibited concomitant d|5|||
124802628|NCT01973569|448910096|FG002|Overall Study|Prohibited concomitant d|0|||
124802629|NCT01973569|448910094|FG000|Overall Study|Disease progression|0|||
124802630|NCT01973569|448910095|FG001|Overall Study|Disease progression|3|||
124802631|NCT01973569|448910096|FG002|Overall Study|Disease progression|0|||
124802632|NCT01973569|448910094|FG000|Overall Study|Other|1|||
124802633|NCT01973569|448910095|FG001|Overall Study|Other|1|||
124802634|NCT01973569|448910096|FG002|Overall Study|Other|0|||
124802635|NCT01973569|448910094|FG000|Overall Study|Did not receive study drug|6|||
124802636|NCT01973569|448910095|FG001|Overall Study|Did not receive study drug|3|||
124802637|NCT01973569|448910096|FG002|Overall Study|Did not receive study drug|3|||
124802638|NCT00137631|448910099|FG000|Overall Study|Lost to Follow-up|37|||
124802639|NCT00137631|448910100|FG001|Overall Study|Lost to Follow-up|41|||
124802640|NCT02486302|448910102|FG000|Overall Study|Discontinued prematurely|410|||
124802641|NCT02486302|448910102|FG000|Overall Study|Documentation not completed|255|||
124802642|NCT02486302|448910102|FG000|Overall Study|Excluded due to legal reasons|8|||
124802643|NCT02486302|448910102|FG000|Overall Study|Not treated|3|||
124802644|NCT01871142|448910103|FG000|Overall Study|Adverse Event|1|||
124802645|NCT02063880|448910109|FG000|Overall Study|Death|21|||
124802646|NCT02063880|448910110|FG001|Overall Study|Death|18|||
124802647|NCT02063880|448910109|FG000|Overall Study|Lost to Follow-up|7|||
124802648|NCT02063880|448910110|FG001|Overall Study|Lost to Follow-up|7|||
124802649|NCT02063880|448910109|FG000|Overall Study|Ineligible|0|||
124802650|NCT02063880|448910110|FG001|Overall Study|Ineligible|2|||
124802651|NCT00567593|448910111|FG000|Overall Study|Adverse Event|1|||
124802652|NCT00567593|448910111|FG000|Overall Study|Physician Decision|1|||
124802653|NCT02106910|448910112|FG000|Overall Study|Lost to Follow-up|1|||
124802654|NCT02106910|448910113|FG001|Overall Study|Lost to Follow-up|1|||
124802655|NCT01675427|448910116|FG000|Overall Study|Withdrawal by Subject|7|||
124802656|NCT01675427|448910116|FG000|Overall Study|Participant Refused Sample Collection|18|||
124802657|NCT01675427|448910116|FG000|Overall Study|Sample not Collected by Mistake|2|||
124802658|NCT01675427|448910116|FG000|Overall Study|Lost to Follow-up|5|||
124802659|NCT01675427|448910116|FG000|Overall Study|Other|2|||
124802660|NCT00700570|448910117|FG000|Overall Study|Adverse Event|2|||
124802661|NCT00700570|448910118|FG001|Overall Study|Adverse Event|6|||
124802662|NCT00700570|448910117|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
124802663|NCT00700570|448910118|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
124802664|NCT00700570|448910117|FG000|Overall Study|Disease Progression|8|||
124802665|NCT00700570|448910118|FG001|Overall Study|Disease Progression|11|||
124802666|NCT00700570|448910117|FG000|Overall Study|Withdrawal by Subject|1|||
124802667|NCT00700570|448910118|FG001|Overall Study|Withdrawal by Subject|6|||
124802668|NCT00611533|448910119|FG000|First Intervention (6 Weeks)|Never started study|0|||
124802669|NCT00611533|448910120|FG001|First Intervention (6 Weeks)|Never started study|1|||
124802670|NCT00611533|448910119|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
124802671|NCT00611533|448910120|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
124802672|NCT00611533|448910119|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
124802673|NCT00611533|448910120|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
124802674|NCT05246397|448910123|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
124802675|NCT04327674|448910129|FG000|Overall Study|Protocol Violation|19|||
124802676|NCT01461980|448910130|FG000|Overall Study|Other|9|||
124802677|NCT01461980|448910131|FG001|Overall Study|Other|8|||
124802678|NCT01461980|448910132|FG002|Overall Study|Other|6|||
124802679|NCT01461980|448910130|FG000|Overall Study|Medication error|7|||
124802680|NCT01461980|448910131|FG001|Overall Study|Medication error|5|||
124802681|NCT01461980|448910132|FG002|Overall Study|Medication error|6|||
124802682|NCT01461980|448910130|FG000|Overall Study|Adverse Event|12|||
124802683|NCT01461980|448910131|FG001|Overall Study|Adverse Event|5|||
124802684|NCT01461980|448910132|FG002|Overall Study|Adverse Event|6|||
124802685|NCT01461980|448910130|FG000|Overall Study|Protocol Violation|12|||
124802686|NCT01461980|448910131|FG001|Overall Study|Protocol Violation|19|||
124802687|NCT01461980|448910132|FG002|Overall Study|Protocol Violation|16|||
124802688|NCT01461980|448910130|FG000|Overall Study|No longer meets eligibility criteria|18|||
124802689|NCT01461980|448910131|FG001|Overall Study|No longer meets eligibility criteria|9|||
124802690|NCT01461980|448910132|FG002|Overall Study|No longer meets eligibility criteria|19|||
124802691|NCT01461980|448910130|FG000|Overall Study|Lost to Follow-up|52|||
124802692|NCT01461980|448910131|FG001|Overall Study|Lost to Follow-up|53|||
124802693|NCT01461980|448910132|FG002|Overall Study|Lost to Follow-up|51|||
124802694|NCT01461980|448910130|FG000|Overall Study|No longer willing to participate|52|||
124802695|NCT01461980|448910131|FG001|Overall Study|No longer willing to participate|38|||
124802696|NCT01461980|448910132|FG002|Overall Study|No longer willing to participate|54|||
124802697|NCT01461980|448910130|FG000|Overall Study|Randomized but not vaccinated|4|||
124802698|NCT01461980|448910131|FG001|Overall Study|Randomized but not vaccinated|8|||
124802699|NCT01461980|448910132|FG002|Overall Study|Randomized but not vaccinated|7|||
124802700|NCT00122109|448910133|FG000|Overall Study|Did not meet criteria|6|||
124802701|NCT00122109|448910134|FG001|Overall Study|Did not meet criteria|7|||
124802702|NCT00809354|448910140|FG000|Overall Study|Adverse Event|32|||
124802703|NCT00809354|448910141|FG001|Overall Study|Adverse Event|45|||
124802704|NCT00809354|448910142|FG002|Overall Study|Adverse Event|37|||
124802705|NCT00809354|448910143|FG003|Overall Study|Adverse Event|53|||
124802706|NCT00809354|448910144|FG004|Overall Study|Adverse Event|26|||
124802707|NCT00809354|448910145|FG005|Overall Study|Adverse Event|33|||
124802708|NCT00809354|448910146|FG006|Overall Study|Adverse Event|44|||
124802709|NCT00809354|448910147|FG007|Overall Study|Adverse Event|40|||
124802710|NCT00809354|448910148|FG008|Overall Study|Adverse Event|46|||
124802711|NCT00809354|448910149|FG009|Overall Study|Adverse Event|26|||
124802712|NCT00809354|448910140|FG000|Overall Study|Lack of Efficacy|23|||
124802713|NCT00809354|448910141|FG001|Overall Study|Lack of Efficacy|23|||
124802714|NCT00809354|448910142|FG002|Overall Study|Lack of Efficacy|22|||
124802715|NCT00809354|448910143|FG003|Overall Study|Lack of Efficacy|15|||
124802716|NCT00809354|448910144|FG004|Overall Study|Lack of Efficacy|40|||
124802717|NCT00809354|448910145|FG005|Overall Study|Lack of Efficacy|19|||
124802718|NCT00809354|448910146|FG006|Overall Study|Lack of Efficacy|21|||
124802719|NCT00809354|448910147|FG007|Overall Study|Lack of Efficacy|15|||
124802720|NCT00809354|448910148|FG008|Overall Study|Lack of Efficacy|18|||
124802721|NCT00809354|448910149|FG009|Overall Study|Lack of Efficacy|38|||
124802722|NCT00809354|448910140|FG000|Overall Study|Lost to Follow-up|10|||
124802723|NCT00809354|448910141|FG001|Overall Study|Lost to Follow-up|11|||
124802724|NCT00809354|448910142|FG002|Overall Study|Lost to Follow-up|8|||
124802725|NCT00809354|448910143|FG003|Overall Study|Lost to Follow-up|13|||
124802726|NCT00809354|448910144|FG004|Overall Study|Lost to Follow-up|6|||
124802727|NCT00809354|448910145|FG005|Overall Study|Lost to Follow-up|2|||
124802728|NCT00809354|448910146|FG006|Overall Study|Lost to Follow-up|0|||
124802729|NCT00809354|448910147|FG007|Overall Study|Lost to Follow-up|5|||
124802730|NCT00809354|448910148|FG008|Overall Study|Lost to Follow-up|4|||
124802731|NCT00809354|448910149|FG009|Overall Study|Lost to Follow-up|0|||
124802732|NCT00809354|448910140|FG000|Overall Study|Protocol Violation|7|||
124802733|NCT00809354|448910141|FG001|Overall Study|Protocol Violation|14|||
124802734|NCT00809354|448910142|FG002|Overall Study|Protocol Violation|14|||
124802735|NCT00809354|448910143|FG003|Overall Study|Protocol Violation|12|||
124802736|NCT00809354|448910144|FG004|Overall Study|Protocol Violation|14|||
124802737|NCT00809354|448910145|FG005|Overall Study|Protocol Violation|6|||
124802738|NCT00809354|448910146|FG006|Overall Study|Protocol Violation|4|||
124802739|NCT00809354|448910147|FG007|Overall Study|Protocol Violation|6|||
124802740|NCT00809354|448910148|FG008|Overall Study|Protocol Violation|9|||
124802741|NCT00809354|448910149|FG009|Overall Study|Protocol Violation|3|||
124802742|NCT00809354|448910140|FG000|Overall Study|Withdrawal by Subject|32|||
124802743|NCT00809354|448910141|FG001|Overall Study|Withdrawal by Subject|27|||
124802744|NCT00809354|448910142|FG002|Overall Study|Withdrawal by Subject|31|||
124802745|NCT00809354|448910143|FG003|Overall Study|Withdrawal by Subject|33|||
124802746|NCT00809354|448910144|FG004|Overall Study|Withdrawal by Subject|34|||
124802747|NCT00809354|448910145|FG005|Overall Study|Withdrawal by Subject|29|||
124802748|NCT00809354|448910146|FG006|Overall Study|Withdrawal by Subject|27|||
124802749|NCT00809354|448910147|FG007|Overall Study|Withdrawal by Subject|19|||
124802750|NCT00809354|448910148|FG008|Overall Study|Withdrawal by Subject|18|||
124802751|NCT00809354|448910149|FG009|Overall Study|Withdrawal by Subject|20|||
124802752|NCT00809354|448910140|FG000|Overall Study|Other|10|||
124802753|NCT00809354|448910141|FG001|Overall Study|Other|2|||
124802754|NCT00809354|448910142|FG002|Overall Study|Other|7|||
124802755|NCT00809354|448910143|FG003|Overall Study|Other|10|||
124802756|NCT00809354|448910144|FG004|Overall Study|Other|5|||
124802757|NCT00809354|448910145|FG005|Overall Study|Other|3|||
124802758|NCT00809354|448910146|FG006|Overall Study|Other|2|||
124802759|NCT00809354|448910147|FG007|Overall Study|Other|3|||
124802760|NCT00809354|448910148|FG008|Overall Study|Other|4|||
124802761|NCT00809354|448910149|FG009|Overall Study|Other|3|||
124802762|NCT00809354|448910140|FG000|Overall Study|Study terminated by sponsor|138|||
124802763|NCT00809354|448910141|FG001|Overall Study|Study terminated by sponsor|134|||
124632163|NCT05207865|448270327|FG000|Open-Label Treatment Phase|Adverse Event|7|||
124632164|NCT05207865|448270327|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
124802764|NCT00809354|448910142|FG002|Overall Study|Study terminated by sponsor|129|||
124802765|NCT00809354|448910143|FG003|Overall Study|Study terminated by sponsor|120|||
124802766|NCT00809354|448910144|FG004|Overall Study|Study terminated by sponsor|126|||
124632165|NCT05207865|448270327|FG000|Open-Label Treatment Phase|Non-compliance|3|||
124802767|NCT00809354|448910145|FG005|Overall Study|Study terminated by sponsor|133|||
124802768|NCT00809354|448910146|FG006|Overall Study|Study terminated by sponsor|124|||
124802769|NCT00809354|448910147|FG007|Overall Study|Study terminated by sponsor|148|||
124802770|NCT00809354|448910148|FG008|Overall Study|Study terminated by sponsor|127|||
124802771|NCT00809354|448910149|FG009|Overall Study|Study terminated by sponsor|135|||
124802772|NCT00809354|448910140|FG000|Overall Study|Withdrawn due to pregnancy|0|||
124802773|NCT00809354|448910141|FG001|Overall Study|Withdrawn due to pregnancy|1|||
124802774|NCT00809354|448910142|FG002|Overall Study|Withdrawn due to pregnancy|0|||
124802775|NCT00809354|448910143|FG003|Overall Study|Withdrawn due to pregnancy|0|||
124802776|NCT00809354|448910144|FG004|Overall Study|Withdrawn due to pregnancy|0|||
124802777|NCT00809354|448910145|FG005|Overall Study|Withdrawn due to pregnancy|0|||
124802778|NCT00809354|448910146|FG006|Overall Study|Withdrawn due to pregnancy|0|||
124802779|NCT00809354|448910147|FG007|Overall Study|Withdrawn due to pregnancy|0|||
124802780|NCT00809354|448910148|FG008|Overall Study|Withdrawn due to pregnancy|0|||
124802781|NCT00809354|448910149|FG009|Overall Study|Withdrawn due to pregnancy|0|||
124802782|NCT00809354|448910140|FG000|Overall Study|Randomized but not Treated|3|||
124802783|NCT00809354|448910141|FG001|Overall Study|Randomized but not Treated|1|||
124802784|NCT00809354|448910142|FG002|Overall Study|Randomized but not Treated|6|||
124802785|NCT00809354|448910143|FG003|Overall Study|Randomized but not Treated|0|||
124802786|NCT00809354|448910144|FG004|Overall Study|Randomized but not Treated|5|||
124802787|NCT00809354|448910145|FG005|Overall Study|Randomized but not Treated|0|||
124802788|NCT00809354|448910146|FG006|Overall Study|Randomized but not Treated|1|||
124802789|NCT00809354|448910147|FG007|Overall Study|Randomized but not Treated|1|||
124802790|NCT00809354|448910148|FG008|Overall Study|Randomized but not Treated|2|||
124802791|NCT00809354|448910149|FG009|Overall Study|Randomized but not Treated|1|||
124802792|NCT00809354|448910140|FG000|Overall Study|Death|0|||
124802793|NCT00809354|448910141|FG001|Overall Study|Death|0|||
124802794|NCT00809354|448910142|FG002|Overall Study|Death|0|||
124632166|NCT05207865|448270327|FG000|Open-Label Treatment Phase|Other|17|||
124632167|NCT05207865|448270327|FG000|Open-Label Treatment Phase|Physician Decision|2|||
124632168|NCT05207865|448270327|FG000|Open-Label Treatment Phase|Pregnancy|1|||
124632169|NCT05207865|448270327|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
124632170|NCT05207865|448270327|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
124632171|NCT05207865|448270327|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
124632172|NCT05207865|448270327|FG000|Follow-up Phase|Lost to Follow-up|1|||
124632173|NCT05207865|448270327|FG000|Follow-up Phase|Non-compliance|1|||
124632174|NCT05207865|448270327|FG000|Follow-up Phase|Not reported|2|||
124632175|NCT05207865|448270327|FG000|Follow-up Phase|Not collected|11|||
124632176|NCT05423093|448270330|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
124632177|NCT05423093|448270330|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
124632178|NCT05423093|448270330|FG000|Attended Intervention Session|Lost to Follow-up|3|||
124632179|NCT05423093|448270330|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
124632180|NCT05423093|448270330|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
124632181|NCT05364931|448270331|FG000|Overall Study|Adverse Event|0|||
124632182|NCT05364931|448270332|FG001|Overall Study|Adverse Event|2|||
124632183|NCT05364931|448270333|FG002|Overall Study|Adverse Event|1|||
124632184|NCT05364931|448270334|FG003|Overall Study|Adverse Event|0|||
124632185|NCT05364931|448270331|FG000|Overall Study|Lost to Follow-up|1|||
124632186|NCT05364931|448270332|FG001|Overall Study|Lost to Follow-up|0|||
124632187|NCT05364931|448270333|FG002|Overall Study|Lost to Follow-up|0|||
124632188|NCT05364931|448270334|FG003|Overall Study|Lost to Follow-up|0|||
124632189|NCT05364931|448270331|FG000|Overall Study|Withdrawal by Subject|1|||
124632190|NCT05364931|448270332|FG001|Overall Study|Withdrawal by Subject|1|||
124632191|NCT05364931|448270333|FG002|Overall Study|Withdrawal by Subject|3|||
124632192|NCT05364931|448270334|FG003|Overall Study|Withdrawal by Subject|2|||
124632193|NCT05364931|448270331|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
124632194|NCT05364931|448270332|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
124632195|NCT05364931|448270333|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
124632196|NCT05364931|448270334|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
124632197|NCT05364931|448270331|FG000|Overall Study|Discontinued|1|||
124632198|NCT05364931|448270332|FG001|Overall Study|Discontinued|0|||
124632199|NCT05364931|448270333|FG002|Overall Study|Discontinued|0|||
124632200|NCT05364931|448270334|FG003|Overall Study|Discontinued|0|||
124632201|NCT03504397|448270335|FG000|Overall Study|Progressive Disease|151|||
124632202|NCT03504397|448270336|FG001|Overall Study|Progressive Disease|199|||
124632203|NCT03504397|448270335|FG000|Overall Study|Withdrawal by Subject|29|||
124632204|NCT03504397|448270336|FG001|Overall Study|Withdrawal by Subject|17|||
124632205|NCT03504397|448270335|FG000|Overall Study|Lost to Follow-up|1|||
124632206|NCT03504397|448270336|FG001|Overall Study|Lost to Follow-up|0|||
124632207|NCT03504397|448270335|FG000|Overall Study|Death|14|||
124802795|NCT00809354|448910143|FG003|Overall Study|Death|0|||
124802796|NCT00809354|448910144|FG004|Overall Study|Death|0|||
124802797|NCT00809354|448910145|FG005|Overall Study|Death|0|||
124802798|NCT00809354|448910146|FG006|Overall Study|Death|0|||
124802799|NCT00809354|448910147|FG007|Overall Study|Death|1|||
124802800|NCT00809354|448910148|FG008|Overall Study|Death|0|||
124802801|NCT00809354|448910149|FG009|Overall Study|Death|0|||
124802802|NCT00267189|448910150|FG000|Overall Study|Patient withdrew consent|1|||
124802803|NCT00267189|448910151|FG001|Overall Study|Patient withdrew consent|1|||
124632208|NCT03504397|448270336|FG001|Overall Study|Death|16|||
124632209|NCT03504397|448270335|FG000|Overall Study|Adverse Event|40|||
124632210|NCT03504397|448270336|FG001|Overall Study|Adverse Event|14|||
124632211|NCT03504397|448270335|FG000|Overall Study|miscellaneous|17|||
124802804|NCT00267189|448910150|FG000|Overall Study|Death|1|||
124802805|NCT00267189|448910151|FG001|Overall Study|Death|0|||
124802806|NCT00267189|448910150|FG000|Overall Study|Missing|3|||
124802807|NCT00267189|448910151|FG001|Overall Study|Missing|0|||
124802808|NCT00100178|448910152|FG000|Overall Study|Lost to Follow-up|0|||
124802809|NCT00100178|448910153|FG001|Overall Study|Lost to Follow-up|6|||
124802810|NCT00100178|448910154|FG002|Overall Study|Lost to Follow-up|5|||
124802811|NCT00100178|448910152|FG000|Overall Study|Adverse Event|2|||
124802812|NCT00100178|448910153|FG001|Overall Study|Adverse Event|2|||
124802813|NCT00100178|448910154|FG002|Overall Study|Adverse Event|1|||
124802814|NCT00100178|448910152|FG000|Overall Study|Withdrawal by Subject|1|||
124802815|NCT00100178|448910153|FG001|Overall Study|Withdrawal by Subject|1|||
124802816|NCT00100178|448910154|FG002|Overall Study|Withdrawal by Subject|1|||
124802817|NCT00100178|448910152|FG000|Overall Study|Physician Decision|6|||
124802818|NCT00100178|448910153|FG001|Overall Study|Physician Decision|1|||
124802819|NCT00100178|448910154|FG002|Overall Study|Physician Decision|3|||
124802820|NCT03257371|448910155|FG000|Overall Study|Lost to Follow-up|1|||
124802821|NCT02477839|448910158|FG000|Overall Study|Adverse Event|0|||
124802822|NCT02477839|448910159|FG001|Overall Study|Adverse Event|1|||
124802823|NCT02477839|448910158|FG000|Overall Study|Protocol Violation|0|||
124802824|NCT02477839|448910159|FG001|Overall Study|Protocol Violation|2|||
124802825|NCT02477839|448910158|FG000|Overall Study|Withdrawal by Subject|3|||
124802826|NCT02477839|448910159|FG001|Overall Study|Withdrawal by Subject|3|||
124802827|NCT02477839|448910158|FG000|Overall Study|Participant had PGS during V6|0|||
124802828|NCT02477839|448910159|FG001|Overall Study|Participant had PGS during V6|1|||
124802829|NCT02477839|448910158|FG000|Overall Study|Parents decided to stop medication|0|||
124802830|NCT02477839|448910159|FG001|Overall Study|Parents decided to stop medication|1|||
124802831|NCT02477839|448910158|FG000|Overall Study|Lack of tolerability|0|||
124802832|NCT02477839|448910159|FG001|Overall Study|Lack of tolerability|1|||
124802833|NCT02477839|448910158|FG000|Overall Study|Exclusion criterion|0|||
124802834|NCT02477839|448910159|FG001|Overall Study|Exclusion criterion|1|||
124802835|NCT01439568|448910166|FG000|Overall Study|Lost to Follow-up|1|||
124802836|NCT01439568|448910167|FG001|Overall Study|Lost to Follow-up|0|||
124802837|NCT01439568|448910166|FG000|Overall Study|Withdrawal by Subject|2|||
124802838|NCT01439568|448910167|FG001|Overall Study|Withdrawal by Subject|2|||
124632212|NCT03504397|448270336|FG001|Overall Study|miscellaneous|15|||
124632213|NCT03504397|448270335|FG000|Overall Study|Protocol deviation|1|||
124632214|NCT03504397|448270336|FG001|Overall Study|Protocol deviation|0|||
124632215|NCT03504397|448270335|FG000|Overall Study|Participants who did not take the study drug|4|||
124632216|NCT03504397|448270336|FG001|Overall Study|Participants who did not take the study drug|4|||
124632217|NCT02596971|448270337|FG000|Overall Study|Death|5|||
124632218|NCT02596971|448270338|FG001|Overall Study|Death|1|||
124632219|NCT02596971|448270339|FG002|Overall Study|Death|5|||
124632220|NCT02596971|448270337|FG000|Overall Study|Withdrawal by Subject|5|||
124632221|NCT02596971|448270338|FG001|Overall Study|Withdrawal by Subject|1|||
124632222|NCT02596971|448270339|FG002|Overall Study|Withdrawal by Subject|4|||
124632223|NCT00595920|448270342|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
124632224|NCT00611923|448270343|FG000|Overall Study|Withdrawal by Subject|2|||
124632225|NCT00611923|448270344|FG001|Overall Study|Withdrawal by Subject|2|||
124632226|NCT03588910|448270345|FG000|Overall Study|Withdrawal by Subject|1|||
124632227|NCT03588910|448270346|FG001|Overall Study|Withdrawal by Subject|0|||
124632228|NCT03588910|448270345|FG000|Overall Study|Allergy|2|||
124632229|NCT03588910|448270346|FG001|Overall Study|Allergy|0|||
124632230|NCT03588910|448270345|FG000|Overall Study|Protocol Violation|0|||
124632231|NCT03588910|448270346|FG001|Overall Study|Protocol Violation|3|||
124632232|NCT03588910|448270345|FG000|Overall Study|Did not complete Day 1 Survey|5|||
124632233|NCT03588910|448270346|FG001|Overall Study|Did not complete Day 1 Survey|10|||
124632234|NCT03588910|448270345|FG000|Overall Study|Did not complete Day 7 Survey|5|||
124632235|NCT03588910|448270346|FG001|Overall Study|Did not complete Day 7 Survey|2|||
124632236|NCT00838903|448270347|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
124632237|NCT00838903|448270348|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
124632238|NCT00838903|448270349|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
124632239|NCT00838903|448270350|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
124632240|NCT00838903|448270347|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
124632241|NCT00838903|448270348|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
124632242|NCT00838903|448270349|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
124632243|NCT00838903|448270350|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
124632244|NCT00838903|448270347|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
124632245|NCT00838903|448270348|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
124632246|NCT00838903|448270349|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
124632247|NCT00838903|448270350|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
124632248|NCT00838903|448270347|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
124632249|NCT00838903|448270348|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
124802839|NCT02607930|448910170|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
124802840|NCT02607930|448910171|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
124802841|NCT02607930|448910172|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
124802842|NCT02607930|448910173|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
124802843|NCT02607930|448910170|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
124802844|NCT02607930|448910171|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
124802845|NCT02607930|448910172|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
124802846|NCT02607930|448910173|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
124632250|NCT00838903|448270349|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
124632251|NCT00838903|448270350|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
124632252|NCT00838903|448270347|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
124632253|NCT00838903|448270348|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
124632254|NCT00838903|448270349|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
124632255|NCT00838903|448270350|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
124632256|NCT00838903|448270347|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
124632257|NCT00838903|448270348|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
124632258|NCT00838903|448270349|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
124632259|NCT00838903|448270350|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
124632260|NCT00838903|448270347|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
124632261|NCT00838903|448270348|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
124632262|NCT00838903|448270349|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
124632263|NCT00838903|448270350|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
124632264|NCT00838903|448270347|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
124632265|NCT00838903|448270348|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
124632266|NCT00838903|448270349|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
124632267|NCT00838903|448270350|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
124632268|NCT00838903|448270347|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
124632269|NCT00838903|448270348|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
124632270|NCT00838903|448270349|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
124632271|NCT00838903|448270350|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
124632272|NCT00838903|448270347|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
124632273|NCT00838903|448270348|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
124632274|NCT00838903|448270349|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
124632275|NCT00838903|448270350|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
124632276|NCT00838903|448270347|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
124632277|NCT00838903|448270348|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
124632278|NCT00838903|448270349|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
124632279|NCT00838903|448270350|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
124632280|NCT00838903|448270347|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
124632281|NCT00838903|448270348|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
124632282|NCT00838903|448270349|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
124632283|NCT00838903|448270350|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
124632284|NCT00838903|448270347|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
124632285|NCT00838903|448270348|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
124632286|NCT00838903|448270349|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
124632287|NCT00838903|448270350|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
124632288|NCT00838903|448270347|FG000|Treatment Period (156 Weeks)|Site closed|0|||
124632289|NCT00838903|448270348|FG001|Treatment Period (156 Weeks)|Site closed|0|||
124632290|NCT00838903|448270349|FG002|Treatment Period (156 Weeks)|Site closed|1|||
124632291|NCT00838903|448270350|FG003|Treatment Period (156 Weeks)|Site closed|0|||
124632292|NCT00838903|448270347|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
124632293|NCT00838903|448270348|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
124632294|NCT00838903|448270349|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
124632295|NCT00838903|448270350|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
124632296|NCT00838903|448270347|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
124632297|NCT00838903|448270348|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
124632298|NCT00838903|448270349|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
124632299|NCT00838903|448270350|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
124632300|NCT00838903|448270347|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
124632301|NCT00838903|448270348|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
124632302|NCT00838903|448270349|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
124632303|NCT00838903|448270350|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
124632304|NCT00838903|448270347|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
124632305|NCT00838903|448270348|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
124632306|NCT00838903|448270349|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
124632307|NCT00838903|448270350|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
124632308|NCT00838903|448270347|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
124632309|NCT00838903|448270348|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
124632310|NCT00838903|448270349|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
124632311|NCT00838903|448270350|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
124632312|NCT00838903|448270347|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
124632313|NCT00838903|448270348|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
124802847|NCT02607930|448910170|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
124632314|NCT00838903|448270349|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
124632315|NCT00838903|448270350|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
124632316|NCT00838903|448270347|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
124632317|NCT00838903|448270348|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
124632318|NCT00838903|448270349|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
124632319|NCT00838903|448270350|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
124632320|NCT00838903|448270347|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
124632321|NCT00838903|448270348|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
124632322|NCT00838903|448270349|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
124632323|NCT00838903|448270350|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
124632324|NCT00838903|448270347|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
124632325|NCT00838903|448270348|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
124632326|NCT00838903|448270349|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
124632327|NCT00838903|448270350|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
124632328|NCT00838903|448270347|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
124632329|NCT00838903|448270348|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
124632330|NCT00838903|448270349|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
124632331|NCT00838903|448270350|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
124632332|NCT00838903|448270347|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
124632333|NCT00838903|448270348|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
124632334|NCT00838903|448270349|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
124632335|NCT00838903|448270350|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
124632336|NCT00838903|448270347|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
124632337|NCT00838903|448270348|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
124632338|NCT00838903|448270349|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
124632339|NCT00838903|448270350|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
124632340|NCT00838903|448270347|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
124632341|NCT00838903|448270348|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
124632342|NCT00838903|448270349|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
124632343|NCT00838903|448270350|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
124632344|NCT00838903|448270347|FG000|Follow-up Period (8 Weeks)|Missing|1|||
124632345|NCT00838903|448270348|FG001|Follow-up Period (8 Weeks)|Missing|2|||
124632346|NCT00838903|448270349|FG002|Follow-up Period (8 Weeks)|Missing|1|||
124632347|NCT00838903|448270350|FG003|Follow-up Period (8 Weeks)|Missing|1|||
124632348|NCT04565145|448270351|FG000|Overall Study|Withdrawal by Subject|1|||
124632349|NCT04565145|448270352|FG001|Overall Study|Withdrawal by Subject|1|||
124632350|NCT03096314|448270353|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
124632351|NCT03096314|448270354|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
124632352|NCT00471822|448270355|FG000|Overall Study|Protocol Violation|2|||
124632353|NCT01062425|448270356|FG000|Overall Study|Protocol Violation|3|||
124632354|NCT01062425|448270357|FG001|Overall Study|Protocol Violation|6|||
124802848|NCT02607930|448910171|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
124802849|NCT02607930|448910172|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
124802850|NCT02607930|448910173|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
124802851|NCT02607930|448910170|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
124802852|NCT02607930|448910171|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
124802853|NCT02607930|448910172|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
124802854|NCT02607930|448910173|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
124802855|NCT02607930|448910170|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
124802856|NCT02607930|448910171|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
124802857|NCT02607930|448910172|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
124802858|NCT02607930|448910173|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
124802859|NCT02607930|448910170|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
124802860|NCT02607930|448910171|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
124802861|NCT02607930|448910172|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
124802862|NCT02607930|448910173|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
124802863|NCT02607930|448910170|FG000|Double-Blinded Treatment Phase|Death|2|||
124802864|NCT02607930|448910171|FG001|Double-Blinded Treatment Phase|Death|1|||
124802865|NCT02607930|448910172|FG002|Double-Blinded Treatment Phase|Death|0|||
124802866|NCT02607930|448910173|FG003|Double-Blinded Treatment Phase|Death|0|||
124802867|NCT02607930|448910170|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
124802868|NCT02607930|448910171|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
124802869|NCT02607930|448910172|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
124802870|NCT02607930|448910173|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
124802871|NCT02607930|448910170|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
124802872|NCT02607930|448910171|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
124802873|NCT02607930|448910172|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
124632355|NCT03003962|448270358|FG000|Overall Study|Withdrawal by Subject|5|||
124802874|NCT02607930|448910173|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
124802875|NCT02607930|448910170|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
124802876|NCT02607930|448910171|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
124802877|NCT02607930|448910172|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
124802878|NCT02607930|448910173|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
124802879|NCT02607930|448910170|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
124802880|NCT02607930|448910171|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
124802881|NCT02607930|448910172|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
124802882|NCT02607930|448910173|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
124802883|NCT02607930|448910170|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
124802884|NCT02607930|448910171|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
124802885|NCT02607930|448910172|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
124802886|NCT02607930|448910173|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
124632356|NCT03003962|448270359|FG001|Overall Study|Withdrawal by Subject|17|||
124632357|NCT03003962|448270358|FG000|Overall Study|Death|274|||
124632358|NCT03003962|448270359|FG001|Overall Study|Death|277|||
124632359|NCT03003962|448270358|FG000|Overall Study|Participants ongoing at DCO|55|||
124632360|NCT03003962|448270359|FG001|Overall Study|Participants ongoing at DCO|40|||
124632361|NCT02069015|448270369|FG000|Overall Study|Lost to Follow-up|39|||
124632362|NCT02069015|448270370|FG001|Overall Study|Lost to Follow-up|32|||
124632363|NCT02069015|448270369|FG000|Overall Study|Withdrawal by Subject|1|||
124632364|NCT02069015|448270370|FG001|Overall Study|Withdrawal by Subject|1|||
124632365|NCT00586703|448270375|FG000|Overall Study|Death|12|||
124632366|NCT03762265|448270376|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
124632367|NCT03762265|448270377|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
124632368|NCT03762265|448270376|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
124632369|NCT03762265|448270377|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
124632370|NCT03762265|448270376|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
124632371|NCT03762265|448270377|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
124632372|NCT03762265|448270376|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
124632373|NCT03762265|448270377|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
124632374|NCT03762265|448270376|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
124632375|NCT03762265|448270377|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
124632376|NCT03762265|448270376|FG000|BT Period: Weeks 1 to 37|Other|0|||
124632377|NCT03762265|448270377|FG001|BT Period: Weeks 1 to 37|Other|1|||
124632378|NCT03762265|448270376|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
124632379|NCT03762265|448270377|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
124632380|NCT03762265|448270376|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
124632381|NCT03762265|448270377|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
124632382|NCT03762265|448270376|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
124632383|NCT03762265|448270377|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
124632384|NCT03762265|448270376|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
124632385|NCT03762265|448270377|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
124632386|NCT03762265|448270376|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
124632387|NCT03762265|448270377|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
124632388|NCT03762265|448270376|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
124632389|NCT03762265|448270377|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
124632390|NCT03762265|448270376|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
124632391|NCT03762265|448270377|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
124632392|NCT03762265|448270376|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
124632393|NCT03762265|448270377|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
124632394|NCT03762265|448270376|FG000|LTE Period: Weeks 61 to 109|Other|1|||
124632395|NCT03762265|448270377|FG001|LTE Period: Weeks 61 to 109|Other|0|||
124632396|NCT00806403|448270380|FG000|Overall Study|Death|4|||
124632397|NCT00806403|448270381|FG001|Overall Study|Death|3|||
124632398|NCT01882985|448270382|FG000|Overall Study|Lost to Follow-up|1|||
124632399|NCT01882985|448270382|FG000|Overall Study|Withdrawal by Subject|1|||
124632400|NCT00765102|448270383|FG000|Overall Study|Progressive disease|18|||
124632401|NCT00765102|448270383|FG000|Overall Study|Adverse Event|6|||
124632402|NCT00765102|448270383|FG000|Overall Study|Physician Decision|4|||
124632403|NCT00765102|448270383|FG000|Overall Study|Withdrawal by Subject|2|||
124632404|NCT00765102|448270383|FG000|Overall Study|Protocol Violation|1|||
124802887|NCT02607930|448910170|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
124632405|NCT01787292|448270386|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
124632406|NCT01787292|448270387|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
124632407|NCT01787292|448270386|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
124632408|NCT01787292|448270387|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
124632409|NCT01827111|448270388|FG000|Overall Study|Disease Progression|1|||
124632410|NCT02962648|448270390|FG000|Overall Study|Withdrawal by Subject|3|||
124632411|NCT02962648|448270390|FG000|Overall Study|Lost to Follow-up|3|||
124632412|NCT02962648|448270390|FG000|Overall Study|Physician Decision|1|||
124802888|NCT02607930|448910171|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
124632413|NCT02962648|448270390|FG000|Overall Study|Subject had problems with transportation|2|||
124632414|NCT01924689|448270391|FG000|Overall Study|Death|0|||
124632415|NCT01924689|448270392|FG001|Overall Study|Death|1|||
124632416|NCT01924689|448270393|FG002|Overall Study|Death|0|||
124632417|NCT01924689|448270394|FG003|Overall Study|Death|1|||
124632418|NCT01924689|448270395|FG004|Overall Study|Death|0|||
124632419|NCT01924689|448270396|FG005|Overall Study|Death|0|||
124632420|NCT01924689|448270391|FG000|Overall Study|Disease progression|0|||
124632421|NCT01924689|448270392|FG001|Overall Study|Disease progression|0|||
124632422|NCT01924689|448270393|FG002|Overall Study|Disease progression|2|||
124632423|NCT01924689|448270394|FG003|Overall Study|Disease progression|0|||
124632424|NCT01924689|448270395|FG004|Overall Study|Disease progression|3|||
124632425|NCT01924689|448270396|FG005|Overall Study|Disease progression|2|||
124632426|NCT01924689|448270391|FG000|Overall Study|New therapy or study|3|||
124632427|NCT01924689|448270392|FG001|Overall Study|New therapy or study|2|||
124632428|NCT01924689|448270393|FG002|Overall Study|New therapy or study|1|||
124632429|NCT01924689|448270394|FG003|Overall Study|New therapy or study|4|||
124632430|NCT01924689|448270395|FG004|Overall Study|New therapy or study|2|||
124632431|NCT01924689|448270396|FG005|Overall Study|New therapy or study|0|||
124632432|NCT01924689|448270391|FG000|Overall Study|Withdrawal of consent|0|||
124632433|NCT01924689|448270392|FG001|Overall Study|Withdrawal of consent|0|||
124632434|NCT01924689|448270393|FG002|Overall Study|Withdrawal of consent|1|||
124632435|NCT01924689|448270394|FG003|Overall Study|Withdrawal of consent|1|||
124632436|NCT01924689|448270395|FG004|Overall Study|Withdrawal of consent|0|||
124632437|NCT01924689|448270396|FG005|Overall Study|Withdrawal of consent|0|||
124632438|NCT01924689|448270391|FG000|Overall Study|Other|0|||
124632439|NCT01924689|448270392|FG001|Overall Study|Other|0|||
124632440|NCT01924689|448270393|FG002|Overall Study|Other|0|||
124632441|NCT01924689|448270394|FG003|Overall Study|Other|0|||
124632442|NCT01924689|448270395|FG004|Overall Study|Other|1|||
124632443|NCT01924689|448270396|FG005|Overall Study|Other|0|||
124632444|NCT01597778|448270398|FG000|Overall Study|Death|7|||
124632445|NCT01597778|448270399|FG001|Overall Study|Death|10|||
124632446|NCT01597778|448270398|FG000|Overall Study|Withdrawal by Subject|3|||
124632447|NCT01597778|448270399|FG001|Overall Study|Withdrawal by Subject|4|||
124632448|NCT01597778|448270398|FG000|Overall Study|Adverse Event|1|||
124632449|NCT01597778|448270399|FG001|Overall Study|Adverse Event|1|||
124632450|NCT01597778|448270398|FG000|Overall Study|Protocol Violation|1|||
124632451|NCT01597778|448270399|FG001|Overall Study|Protocol Violation|11|||
124632452|NCT01597778|448270398|FG000|Overall Study|Transplanted off protocol|2|||
124632453|NCT01597778|448270399|FG001|Overall Study|Transplanted off protocol|3|||
124632454|NCT03267212|448270400|FG000|First Intervention|Lost to Follow-up|0|||
124632455|NCT03267212|448270401|FG001|First Intervention|Lost to Follow-up|2|||
124632456|NCT03267212|448270400|FG000|First Intervention|Withdrawal by Subject|1|||
124632457|NCT03267212|448270401|FG001|First Intervention|Withdrawal by Subject|1|||
124632458|NCT03267212|448270400|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
124632459|NCT03267212|448270401|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
124632460|NCT05691712|448270404|FG000|Overall Study|Adverse Event|0|||
124632461|NCT05691712|448270405|FG001|Overall Study|Adverse Event|1|||
124632462|NCT05691712|448270406|FG002|Overall Study|Adverse Event|2|||
124632463|NCT05691712|448270407|FG003|Overall Study|Adverse Event|1|||
124632464|NCT05691712|448270404|FG000|Overall Study|Withdrawal by Subject|2|||
124632465|NCT05691712|448270405|FG001|Overall Study|Withdrawal by Subject|3|||
124632466|NCT05691712|448270406|FG002|Overall Study|Withdrawal by Subject|3|||
124632467|NCT05691712|448270407|FG003|Overall Study|Withdrawal by Subject|1|||
124632468|NCT05691712|448270404|FG000|Overall Study|Death|1|||
124632469|NCT05691712|448270405|FG001|Overall Study|Death|0|||
124632470|NCT05691712|448270406|FG002|Overall Study|Death|0|||
124632471|NCT05691712|448270407|FG003|Overall Study|Death|0|||
124632472|NCT05691712|448270404|FG000|Overall Study|Pregnancy|0|||
124632473|NCT05691712|448270405|FG001|Overall Study|Pregnancy|1|||
124632474|NCT05691712|448270406|FG002|Overall Study|Pregnancy|0|||
124632475|NCT05691712|448270407|FG003|Overall Study|Pregnancy|0|||
124632476|NCT05691712|448270404|FG000|Overall Study|Assigned Treatment by Mistake|1|||
124632477|NCT05691712|448270405|FG001|Overall Study|Assigned Treatment by Mistake|0|||
124632478|NCT05691712|448270406|FG002|Overall Study|Assigned Treatment by Mistake|0|||
124632479|NCT05691712|448270407|FG003|Overall Study|Assigned Treatment by Mistake|1|||
124632480|NCT00468819|448270408|FG000|Overall Study|Withdrawal by Subject|4|||
124632481|NCT00468819|448270409|FG001|Overall Study|Withdrawal by Subject|0|||
124632482|NCT00468819|448270410|FG002|Overall Study|Withdrawal by Subject|1|||
124632483|NCT00468819|448270408|FG000|Overall Study|Lost to Follow-up|0|||
124632484|NCT00468819|448270409|FG001|Overall Study|Lost to Follow-up|0|||
124632485|NCT00468819|448270410|FG002|Overall Study|Lost to Follow-up|1|||
124632486|NCT00468819|448270408|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
124632487|NCT00468819|448270409|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
124632488|NCT00468819|448270410|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
124752661|NCT06136897|448716808|FG000|Overall Study|Still on treatment|1|||
124752662|NCT06136897|448716808|FG000|Overall Study|Lost to Follow-up|1|||
124752663|NCT03705559|448716809|FG000|Overall Study|COVID Shut down|1|||
124632489|NCT04030299|448270411|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
124632490|NCT04030299|448270411|FG000|Overall Study|Withdrawal by Subject|3|||
124632491|NCT02174627|448270412|FG000|Overall Study|Missing|0|||
124632492|NCT02174627|448270413|FG001|Overall Study|Missing|1|||
124632493|NCT02174627|448270412|FG000|Overall Study|Incorrect enrolment before randomization|0|||
124632494|NCT02174627|448270413|FG001|Overall Study|Incorrect enrolment before randomization|1|||
124632495|NCT02174627|448270412|FG000|Overall Study|Participant decision|84|||
124632496|NCT02174627|448270413|FG001|Overall Study|Participant decision|128|||
124632497|NCT04564092|448270414|FG000|Overall Study|Withdrawal by Subject|1|||
124632498|NCT03830333|448270415|FG000|Overall Study|Death|0|||
124632499|NCT03830333|448270416|FG001|Overall Study|Death|1|||
124632500|NCT03830333|448270415|FG000|Overall Study|Withdrawal by Subject|5|||
124632501|NCT03830333|448270416|FG001|Overall Study|Withdrawal by Subject|1|||
124632502|NCT03830333|448270415|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
124632503|NCT03830333|448270416|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
124632504|NCT02362360|448270422|FG000|Period 1|Lack of Efficacy|1|||
124632505|NCT02362360|448270423|FG001|Period 1|Lack of Efficacy|0|||
124632506|NCT02362360|448270422|FG000|Period 1|Withdrawal by Subject|2|||
124632507|NCT02362360|448270423|FG001|Period 1|Withdrawal by Subject|1|||
124632508|NCT03578367|448270428|FG000|Overall Study|Adverse Event|0|||
124632509|NCT03578367|448270429|FG001|Overall Study|Adverse Event|3|||
124632510|NCT03578367|448270430|FG002|Overall Study|Adverse Event|0|||
124632511|NCT03578367|448270431|FG003|Overall Study|Adverse Event|5|||
124632512|NCT03578367|448270428|FG000|Overall Study|Withdrawal by Subject|2|||
124632513|NCT03578367|448270429|FG001|Overall Study|Withdrawal by Subject|2|||
124632514|NCT03578367|448270430|FG002|Overall Study|Withdrawal by Subject|1|||
124632515|NCT03578367|448270431|FG003|Overall Study|Withdrawal by Subject|3|||
124632516|NCT03578367|448270428|FG000|Overall Study|Physician Decision|0|||
124632517|NCT03578367|448270429|FG001|Overall Study|Physician Decision|0|||
124632518|NCT03578367|448270430|FG002|Overall Study|Physician Decision|14|||
124632519|NCT03578367|448270431|FG003|Overall Study|Physician Decision|0|||
124632520|NCT03578367|448270428|FG000|Overall Study|Death|1|||
124632521|NCT03578367|448270429|FG001|Overall Study|Death|0|||
124632522|NCT03578367|448270430|FG002|Overall Study|Death|0|||
124632523|NCT03578367|448270431|FG003|Overall Study|Death|0|||
124632524|NCT03578367|448270428|FG000|Overall Study|Not treated|0|||
124632525|NCT03578367|448270429|FG001|Overall Study|Not treated|0|||
124632526|NCT03578367|448270430|FG002|Overall Study|Not treated|1|||
124632527|NCT03578367|448270431|FG003|Overall Study|Not treated|0|||
124632528|NCT02729025|448270435|FG000|Overall Study|Sponsor Decision|0|||
124632529|NCT02729025|448270436|FG001|Overall Study|Sponsor Decision|1|||
124632530|NCT05966584|448270438|FG000|Overall Study|Lost to Follow-up|1|||
124632531|NCT04563754|448271767|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
124632532|NCT04563754|448271768|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
124632533|NCT04563754|448271769|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
124632534|NCT04563754|448271767|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
124632535|NCT04563754|448271768|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
124632536|NCT04563754|448271769|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
124632537|NCT04563754|448271767|FG000|Follow up|Lost to Follow-up|61|||
124632538|NCT04563754|448271768|FG001|Follow up|Lost to Follow-up|23|||
124632539|NCT04563754|448271769|FG002|Follow up|Lost to Follow-up|5|||
124632540|NCT04563754|448271767|FG000|Follow up|Death|0|||
124632541|NCT04563754|448271768|FG001|Follow up|Death|2|||
124632542|NCT04563754|448271769|FG002|Follow up|Death|0|||
124632543|NCT04563754|448271767|FG000|Follow up|Ongoing|0|||
124632544|NCT04563754|448271768|FG001|Follow up|Ongoing|28|||
124632545|NCT04563754|448271769|FG002|Follow up|Ongoing|0|||
124632546|NCT04023396|448271770|FG000|Overall Study|Adverse Event|16|||
124632547|NCT04023396|448271770|FG000|Overall Study|Death|1|||
124632548|NCT04023396|448271770|FG000|Overall Study|Lost to Follow-up|1|||
124632549|NCT04023396|448271770|FG000|Overall Study|Withdrawal by Subject|14|||
124632550|NCT04023396|448271770|FG000|Overall Study|Pregnancy|4|||
124632551|NCT04023396|448271770|FG000|Overall Study|Lack of Efficacy|3|||
124632552|NCT04023396|448271770|FG000|Overall Study|Physician Decision|4|||
124632553|NCT04023396|448271770|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
124632554|NCT04021914|448271771|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
124632555|NCT03349060|448271772|FG000|Overall Study|Adverse Event|9|||
124632556|NCT03349060|448271773|FG001|Overall Study|Adverse Event|9|||
124632557|NCT03349060|448271774|FG002|Overall Study|Adverse Event|7|||
124632558|NCT03349060|448271772|FG000|Overall Study|Lack of Efficacy|1|||
124632559|NCT03349060|448271773|FG001|Overall Study|Lack of Efficacy|0|||
124632560|NCT03349060|448271774|FG002|Overall Study|Lack of Efficacy|2|||
124632561|NCT03349060|448271772|FG000|Overall Study|Lost to Follow-up|2|||
124632562|NCT03349060|448271773|FG001|Overall Study|Lost to Follow-up|1|||
124632563|NCT03349060|448271774|FG002|Overall Study|Lost to Follow-up|1|||
124632564|NCT03349060|448271772|FG000|Overall Study|Protocol Violation|2|||
124632565|NCT03349060|448271773|FG001|Overall Study|Protocol Violation|2|||
124632566|NCT03349060|448271774|FG002|Overall Study|Protocol Violation|1|||
124632567|NCT03349060|448271772|FG000|Overall Study|Withdrawal by Subject|5|||
124632568|NCT03349060|448271773|FG001|Overall Study|Withdrawal by Subject|3|||
124632569|NCT03349060|448271774|FG002|Overall Study|Withdrawal by Subject|4|||
124632570|NCT03349060|448271772|FG000|Overall Study|Medication error,no linked adverse event|0|||
124632571|NCT03349060|448271773|FG001|Overall Study|Medication error,no linked adverse event|0|||
124632572|NCT03349060|448271774|FG002|Overall Study|Medication error,no linked adverse event|1|||
124632573|NCT03349060|448271772|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
124632574|NCT03349060|448271773|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
124632575|NCT03349060|448271774|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
124632576|NCT03349060|448271772|FG000|Overall Study|Other|2|||
124632577|NCT03349060|448271773|FG001|Overall Study|Other|1|||
124632578|NCT03349060|448271774|FG002|Overall Study|Other|0|||
124632579|NCT00955409|448271775|FG000|Overall Study|Lack of Efficacy|1|||
124632580|NCT00955409|448271776|FG001|Overall Study|Lack of Efficacy|0|||
124632581|NCT00955409|448271777|FG002|Overall Study|Lack of Efficacy|0|||
124632582|NCT00955409|448271778|FG003|Overall Study|Lack of Efficacy|0|||
124632583|NCT00955409|448271779|FG004|Overall Study|Lack of Efficacy|0|||
124632584|NCT00955409|448271780|FG005|Overall Study|Lack of Efficacy|0|||
124632585|NCT00955409|448271781|FG006|Overall Study|Lack of Efficacy|0|||
124632586|NCT00955409|448271782|FG007|Overall Study|Lack of Efficacy|0|||
124632587|NCT00955409|448271783|FG008|Overall Study|Lack of Efficacy|0|||
124632588|NCT00955409|448271784|FG009|Overall Study|Lack of Efficacy|0|||
124632589|NCT00955409|448271775|FG000|Overall Study|Withdrawal by Subject|1|||
124632590|NCT00955409|448271776|FG001|Overall Study|Withdrawal by Subject|0|||
124632591|NCT00955409|448271777|FG002|Overall Study|Withdrawal by Subject|5|||
124632592|NCT00955409|448271778|FG003|Overall Study|Withdrawal by Subject|2|||
124632593|NCT00955409|448271779|FG004|Overall Study|Withdrawal by Subject|0|||
124632594|NCT00955409|448271780|FG005|Overall Study|Withdrawal by Subject|0|||
124632595|NCT00955409|448271781|FG006|Overall Study|Withdrawal by Subject|2|||
124632596|NCT00955409|448271782|FG007|Overall Study|Withdrawal by Subject|0|||
124632597|NCT00955409|448271783|FG008|Overall Study|Withdrawal by Subject|1|||
124632598|NCT00955409|448271784|FG009|Overall Study|Withdrawal by Subject|0|||
124632599|NCT00955409|448271775|FG000|Overall Study|Caregiver Request|2|||
124632600|NCT00955409|448271776|FG001|Overall Study|Caregiver Request|0|||
124632601|NCT00955409|448271777|FG002|Overall Study|Caregiver Request|6|||
124632602|NCT00955409|448271778|FG003|Overall Study|Caregiver Request|5|||
124632603|NCT00955409|448271779|FG004|Overall Study|Caregiver Request|0|||
124632604|NCT00955409|448271780|FG005|Overall Study|Caregiver Request|2|||
124632605|NCT00955409|448271781|FG006|Overall Study|Caregiver Request|3|||
124632606|NCT00955409|448271782|FG007|Overall Study|Caregiver Request|1|||
124632607|NCT00955409|448271783|FG008|Overall Study|Caregiver Request|3|||
124632608|NCT00955409|448271784|FG009|Overall Study|Caregiver Request|0|||
124632609|NCT00955409|448271775|FG000|Overall Study|Investigator Request|0|||
124632610|NCT00955409|448271776|FG001|Overall Study|Investigator Request|0|||
124632611|NCT00955409|448271777|FG002|Overall Study|Investigator Request|1|||
124632612|NCT00955409|448271778|FG003|Overall Study|Investigator Request|0|||
124632613|NCT00955409|448271779|FG004|Overall Study|Investigator Request|0|||
124632614|NCT00955409|448271780|FG005|Overall Study|Investigator Request|0|||
124632615|NCT00955409|448271781|FG006|Overall Study|Investigator Request|0|||
124632616|NCT00955409|448271782|FG007|Overall Study|Investigator Request|0|||
124632617|NCT00955409|448271783|FG008|Overall Study|Investigator Request|0|||
124802889|NCT02607930|448910172|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
124802890|NCT02607930|448910173|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
124802891|NCT02607930|448910170|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
124802892|NCT02607930|448910171|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
124802893|NCT02607930|448910172|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
124802894|NCT02607930|448910173|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
124802895|NCT02607930|448910170|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
124802896|NCT02607930|448910171|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
124802897|NCT02607930|448910172|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
124632618|NCT00955409|448271784|FG009|Overall Study|Investigator Request|0|||
124632619|NCT00955409|448271775|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
124632620|NCT00955409|448271776|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
124632621|NCT00955409|448271777|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
124632622|NCT00955409|448271778|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
124632623|NCT00955409|448271779|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
124802898|NCT02607930|448910173|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
124802899|NCT02607930|448910170|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
124632624|NCT00955409|448271780|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
124632625|NCT00955409|448271781|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
124632626|NCT00955409|448271782|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
124632627|NCT00955409|448271783|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
124632628|NCT00955409|448271784|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
124802900|NCT02607930|448910171|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
124802901|NCT02607930|448910172|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
124802902|NCT02607930|448910173|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
124802903|NCT03198078|448910174|FG000|Overall Study|Adverse Event|0|||
124802904|NCT03198078|448910175|FG001|Overall Study|Adverse Event|1|||
124802905|NCT03198078|448910176|FG002|Overall Study|Adverse Event|2|||
124802906|NCT03198078|448910174|FG000|Overall Study|Lack of Efficacy|0|||
124802907|NCT03198078|448910175|FG001|Overall Study|Lack of Efficacy|0|||
124802908|NCT03198078|448910176|FG002|Overall Study|Lack of Efficacy|3|||
124802909|NCT03198078|448910174|FG000|Overall Study|Lost to Follow-up|1|||
124802910|NCT03198078|448910175|FG001|Overall Study|Lost to Follow-up|0|||
124802911|NCT03198078|448910176|FG002|Overall Study|Lost to Follow-up|0|||
124802912|NCT03198078|448910174|FG000|Overall Study|Pregnancy|0|||
124802913|NCT03198078|448910175|FG001|Overall Study|Pregnancy|1|||
124802914|NCT03198078|448910176|FG002|Overall Study|Pregnancy|0|||
124802915|NCT03198078|448910174|FG000|Overall Study|Withdrawal by Subject|1|||
124802916|NCT03198078|448910175|FG001|Overall Study|Withdrawal by Subject|0|||
124802917|NCT03198078|448910176|FG002|Overall Study|Withdrawal by Subject|2|||
124802918|NCT03198078|448910174|FG000|Overall Study|Withdrawal by Caregiver|1|||
124802919|NCT03198078|448910175|FG001|Overall Study|Withdrawal by Caregiver|3|||
124802920|NCT03198078|448910176|FG002|Overall Study|Withdrawal by Caregiver|5|||
124802921|NCT03711266|448910177|FG000|Overall Study|Lost to Follow-up|10|||
124802922|NCT01646073|448910178|FG000|Period A (12 Weeks)|Adverse Event|0|||
124802923|NCT01646073|448910179|FG001|Period A (12 Weeks)|Adverse Event|2|||
124802924|NCT01646073|448910178|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
124802925|NCT01646073|448910179|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
124802926|NCT01646073|448910178|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
124802927|NCT01646073|448910179|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
124802928|NCT01646073|448910178|FG000|Period A (12 Weeks)|Protocol Violation|0|||
124802929|NCT01646073|448910179|FG001|Period A (12 Weeks)|Protocol Violation|1|||
124802930|NCT01646073|448910178|FG000|Period A (12 Weeks)|Other|0|||
124802931|NCT01646073|448910179|FG001|Period A (12 Weeks)|Other|1|||
124802932|NCT01646073|448910178|FG000|Period B (12 Weeks)|Adverse Event|0|||
124802933|NCT01646073|448910179|FG001|Period B (12 Weeks)|Adverse Event|7|||
124802934|NCT01646073|448910178|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
124802935|NCT01646073|448910179|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
124802936|NCT01646073|448910178|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
124632629|NCT00955409|448271775|FG000|Overall Study|Lost to Follow-up|0|||
124632630|NCT00955409|448271776|FG001|Overall Study|Lost to Follow-up|0|||
124632631|NCT00955409|448271777|FG002|Overall Study|Lost to Follow-up|1|||
124632632|NCT00955409|448271778|FG003|Overall Study|Lost to Follow-up|0|||
124632633|NCT00955409|448271779|FG004|Overall Study|Lost to Follow-up|0|||
124632634|NCT00955409|448271780|FG005|Overall Study|Lost to Follow-up|0|||
124632635|NCT00955409|448271781|FG006|Overall Study|Lost to Follow-up|1|||
124632636|NCT00955409|448271782|FG007|Overall Study|Lost to Follow-up|0|||
124632637|NCT00955409|448271783|FG008|Overall Study|Lost to Follow-up|0|||
124632638|NCT00955409|448271784|FG009|Overall Study|Lost to Follow-up|0|||
124632639|NCT00955409|448271775|FG000|Overall Study|Failed to Return|2|||
124632640|NCT00955409|448271776|FG001|Overall Study|Failed to Return|0|||
124632641|NCT00955409|448271777|FG002|Overall Study|Failed to Return|0|||
124632642|NCT00955409|448271778|FG003|Overall Study|Failed to Return|0|||
124632643|NCT00955409|448271779|FG004|Overall Study|Failed to Return|0|||
124632644|NCT00955409|448271780|FG005|Overall Study|Failed to Return|0|||
124802937|NCT01646073|448910179|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
124802938|NCT00057876|448910180|FG000|Overall Study|Adverse Event|8|||
124802939|NCT00057876|448910181|FG001|Overall Study|Adverse Event|8|||
124632645|NCT00955409|448271781|FG006|Overall Study|Failed to Return|0|||
124632646|NCT00955409|448271782|FG007|Overall Study|Failed to Return|2|||
124802940|NCT00057876|448910180|FG000|Overall Study|Death|2|||
124802941|NCT00057876|448910181|FG001|Overall Study|Death|1|||
124802942|NCT00057876|448910180|FG000|Overall Study|Withdrawal by Subject|5|||
124802943|NCT00057876|448910181|FG001|Overall Study|Withdrawal by Subject|6|||
124802944|NCT00057876|448910180|FG000|Overall Study|Lack of Efficacy|10|||
124802945|NCT00057876|448910181|FG001|Overall Study|Lack of Efficacy|8|||
124632647|NCT00955409|448271783|FG008|Overall Study|Failed to Return|0|||
124632648|NCT00955409|448271784|FG009|Overall Study|Failed to Return|0|||
124632649|NCT00955409|448271775|FG000|Overall Study|Adverse Event (AE)|2|||
124632650|NCT00955409|448271776|FG001|Overall Study|Adverse Event (AE)|0|||
124632651|NCT00955409|448271777|FG002|Overall Study|Adverse Event (AE)|0|||
124802946|NCT00057876|448910180|FG000|Overall Study|Ineligible|1|||
124802947|NCT00057876|448910181|FG001|Overall Study|Ineligible|2|||
124802948|NCT00057876|448910180|FG000|Overall Study|other reason|2|||
124802949|NCT00057876|448910181|FG001|Overall Study|other reason|2|||
124802950|NCT00057876|448910180|FG000|Overall Study|other complicating disease|1|||
124802951|NCT00057876|448910181|FG001|Overall Study|other complicating disease|0|||
124802952|NCT03799211|448910188|FG000|Overall Study|Lost to Follow-up|2|||
124802953|NCT03799211|448910189|FG001|Overall Study|Lost to Follow-up|13|||
124802954|NCT03799211|448910188|FG000|Overall Study|Withdrawal by Subject|2|||
124802955|NCT03799211|448910189|FG001|Overall Study|Withdrawal by Subject|0|||
124802956|NCT00764491|448910190|FG000|Overall Study|Lost to Follow-up|35|||
124802957|NCT00764491|448910191|FG001|Overall Study|Lost to Follow-up|17|||
124802958|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
124802959|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
124802960|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Death|1|||
124802961|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Death|0|||
124802962|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
124802963|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
124802964|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
124802965|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
124802966|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
124802967|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
124802968|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
124802969|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
124802970|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
124802971|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
124802972|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
124802973|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
124802974|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
124802975|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
124802976|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
124802977|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
124802978|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
124802979|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
124802980|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
124802981|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
124802982|NCT02927262|448910198|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
124802983|NCT02927262|448910199|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
124802984|NCT02927262|448910198|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
124802985|NCT02927262|448910199|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
124802986|NCT02927262|448910198|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
124802987|NCT02927262|448910199|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
124802988|NCT02927262|448910198|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
124802989|NCT02927262|448910199|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
124802990|NCT00923936|448910200|FG000|Overall Study|progressive disease on study|2|||
124802991|NCT00923936|448910201|FG001|Overall Study|progressive disease on study|1|||
124802992|NCT00923936|448910200|FG000|Overall Study|Adverse Event|2|||
124802993|NCT00923936|448910201|FG001|Overall Study|Adverse Event|1|||
124802994|NCT00923936|448910200|FG000|Overall Study|Lost to follow up|2|||
124802995|NCT00923936|448910201|FG001|Overall Study|Lost to follow up|0|||
124802996|NCT00923936|448910200|FG000|Overall Study|Continuing in follow up period|2|||
124802997|NCT00923936|448910201|FG001|Overall Study|Continuing in follow up period|1|||
124802998|NCT01697358|448910202|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
124802999|NCT01697358|448910203|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
124803000|NCT01697358|448910202|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
124803001|NCT01697358|448910203|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
124803002|NCT01697358|448910202|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
124803003|NCT01697358|448910203|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
124803004|NCT01697358|448910202|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
124803005|NCT01697358|448910203|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
124803006|NCT01697358|448910202|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
124803007|NCT01697358|448910203|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
124803008|NCT01697358|448910202|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
124803009|NCT01697358|448910203|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
124803010|NCT01697358|448910202|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
124803011|NCT01697358|448910203|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
124803012|NCT01697358|448910202|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
124803013|NCT01697358|448910203|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
124803014|NCT01697358|448910202|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
124803015|NCT01697358|448910203|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
124803016|NCT01697358|448910202|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
124632652|NCT00955409|448271778|FG003|Overall Study|Adverse Event (AE)|0|||
124632653|NCT00955409|448271779|FG004|Overall Study|Adverse Event (AE)|0|||
124632654|NCT00955409|448271780|FG005|Overall Study|Adverse Event (AE)|1|||
124819540|NCT05147350|448965753|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
124803017|NCT01697358|448910203|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
124803018|NCT02038452|448910204|FG000|Overall Study|Withdrawal by Subject|7|||
124803019|NCT02038452|448910205|FG001|Overall Study|Withdrawal by Subject|9|||
124803020|NCT02038452|448910204|FG000|Overall Study|Lost to Follow-up|31|||
124803021|NCT02038452|448910205|FG001|Overall Study|Lost to Follow-up|28|||
124803022|NCT01460368|448910208|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
124803023|NCT01460368|448910209|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
124803024|NCT01460368|448910210|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
124803025|NCT01460368|448910211|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
124803026|NCT01460368|448910212|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
124803027|NCT01460368|448910213|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
124803028|NCT01460368|448910214|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
124803029|NCT01460368|448910208|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
124803030|NCT01460368|448910209|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
124803031|NCT01460368|448910210|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
124803032|NCT01460368|448910211|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
124803033|NCT01460368|448910212|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
124803034|NCT01460368|448910213|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
124803035|NCT01460368|448910214|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
124803036|NCT01460368|448910208|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
124803037|NCT01460368|448910209|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
124803038|NCT01460368|448910210|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
124803039|NCT01460368|448910211|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
124803040|NCT01460368|448910212|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
124803041|NCT01460368|448910213|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
124803042|NCT01460368|448910214|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
124803043|NCT01460368|448910208|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
124803044|NCT01460368|448910209|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
124803045|NCT01460368|448910210|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
124632655|NCT00955409|448271781|FG006|Overall Study|Adverse Event (AE)|2|||
124632656|NCT00955409|448271782|FG007|Overall Study|Adverse Event (AE)|0|||
124803046|NCT01460368|448910211|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
124803047|NCT01460368|448910212|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
124803048|NCT01460368|448910213|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
124803049|NCT01460368|448910214|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
124803050|NCT01460368|448910208|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
124803051|NCT01460368|448910209|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
124803052|NCT01460368|448910210|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
124803053|NCT01460368|448910211|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
124803054|NCT01460368|448910212|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
124803055|NCT01460368|448910213|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
124632657|NCT00955409|448271783|FG008|Overall Study|Adverse Event (AE)|2|||
124632658|NCT00955409|448271784|FG009|Overall Study|Adverse Event (AE)|0|||
124632659|NCT00955409|448271775|FG000|Overall Study|Reason not Specified|2|||
124632660|NCT00955409|448271776|FG001|Overall Study|Reason not Specified|1|||
124632661|NCT00955409|448271777|FG002|Overall Study|Reason not Specified|13|||
124632662|NCT00955409|448271778|FG003|Overall Study|Reason not Specified|1|||
124632663|NCT00955409|448271779|FG004|Overall Study|Reason not Specified|2|||
124632664|NCT00955409|448271780|FG005|Overall Study|Reason not Specified|0|||
124632665|NCT00955409|448271781|FG006|Overall Study|Reason not Specified|16|||
124632666|NCT00955409|448271782|FG007|Overall Study|Reason not Specified|0|||
124632667|NCT00955409|448271783|FG008|Overall Study|Reason not Specified|8|||
124632668|NCT00955409|448271784|FG009|Overall Study|Reason not Specified|1|||
124632669|NCT00485732|448271785|FG000|Overall Study|Protocol Violation|1|||
124632670|NCT00485732|448271786|FG001|Overall Study|Protocol Violation|3|||
124632671|NCT00485732|448271785|FG000|Overall Study|Withdrawal by Subject|5|||
124632672|NCT00485732|448271786|FG001|Overall Study|Withdrawal by Subject|4|||
124632673|NCT00485732|448271785|FG000|Overall Study|Lost to Follow-up|2|||
124632674|NCT00485732|448271786|FG001|Overall Study|Lost to Follow-up|2|||
124632675|NCT00803790|448271787|FG000|Period 1|Adverse Event|0|||
124632676|NCT00803790|448271788|FG001|Period 1|Adverse Event|1|||
124632677|NCT00803790|448271789|FG002|Period 1|Adverse Event|0|||
124632678|NCT00803790|448271790|FG003|Period 1|Adverse Event|0|||
124632679|NCT00803790|448271787|FG000|Period 1|Lost to Follow-up|1|||
124803056|NCT01460368|448910214|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
124632680|NCT00803790|448271788|FG001|Period 1|Lost to Follow-up|2|||
124632681|NCT00803790|448271789|FG002|Period 1|Lost to Follow-up|0|||
124632682|NCT00803790|448271790|FG003|Period 1|Lost to Follow-up|0|||
124803057|NCT00299182|448910224|FG000|Overall Study|Withdrawal by Subject|0|||
124632683|NCT00803790|448271787|FG000|Period 1|Withdrawal by Subject|8|||
124632684|NCT00803790|448271788|FG001|Period 1|Withdrawal by Subject|6|||
124632685|NCT00803790|448271789|FG002|Period 1|Withdrawal by Subject|0|||
124632686|NCT00803790|448271790|FG003|Period 1|Withdrawal by Subject|0|||
124632687|NCT00803790|448271787|FG000|Period 1|positive drug screen or personal reasons|0|||
124632688|NCT00803790|448271788|FG001|Period 1|positive drug screen or personal reasons|3|||
124632689|NCT00803790|448271789|FG002|Period 1|positive drug screen or personal reasons|0|||
124632690|NCT00803790|448271790|FG003|Period 1|positive drug screen or personal reasons|4|||
124632691|NCT00803790|448271787|FG000|Period 1|Protocol Violation|0|||
124632692|NCT00803790|448271788|FG001|Period 1|Protocol Violation|0|||
124632693|NCT00803790|448271789|FG002|Period 1|Protocol Violation|1|||
124632694|NCT00803790|448271790|FG003|Period 1|Protocol Violation|0|||
124632695|NCT00803790|448271787|FG000|Period 2|Adverse Event|0|||
124632696|NCT00803790|448271788|FG001|Period 2|Adverse Event|0|||
124632697|NCT00803790|448271789|FG002|Period 2|Adverse Event|1|||
124632698|NCT00803790|448271790|FG003|Period 2|Adverse Event|1|||
124632699|NCT00803790|448271787|FG000|Period 2|Withdrawal by Subject|1|||
124632700|NCT00803790|448271788|FG001|Period 2|Withdrawal by Subject|0|||
124632701|NCT00803790|448271789|FG002|Period 2|Withdrawal by Subject|0|||
124632702|NCT00803790|448271790|FG003|Period 2|Withdrawal by Subject|0|||
124632703|NCT00803790|448271787|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
124632704|NCT00803790|448271788|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
124632705|NCT00803790|448271789|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
124632706|NCT00803790|448271790|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
124632707|NCT01880554|448271791|FG000|Overall Study|Protocol Violation|14|||
124632708|NCT01880554|448271791|FG000|Overall Study|Simon's design requirements|2|||
124632709|NCT05161481|448271792|FG000|Overall Study|Withdrawal of consent|0|||
124632710|NCT05161481|448271793|FG001|Overall Study|Withdrawal of consent|1|||
124632711|NCT05161481|448271794|FG002|Overall Study|Withdrawal of consent|1|||
124632712|NCT05161481|448271792|FG000|Overall Study|Study terminated by sponsor|3|||
124632713|NCT05161481|448271793|FG001|Overall Study|Study terminated by sponsor|3|||
124632714|NCT05161481|448271794|FG002|Overall Study|Study terminated by sponsor|2|||
124632715|NCT05161481|448271792|FG000|Overall Study|Adverse Event|3|||
124632716|NCT05161481|448271793|FG001|Overall Study|Adverse Event|0|||
124632717|NCT05161481|448271794|FG002|Overall Study|Adverse Event|6|||
124632718|NCT05161481|448271792|FG000|Overall Study|Randomised in error and was not treated|1|||
124632719|NCT05161481|448271793|FG001|Overall Study|Randomised in error and was not treated|0|||
124632720|NCT05161481|448271794|FG002|Overall Study|Randomised in error and was not treated|0|||
124632721|NCT05161481|448271792|FG000|Overall Study|Subject decision|0|||
124632722|NCT05161481|448271793|FG001|Overall Study|Subject decision|0|||
124632723|NCT05161481|448271794|FG002|Overall Study|Subject decision|1|||
124632724|NCT03802825|448271797|FG000|Overall Study|Lost to follow-up for intervention|12|||
124632725|NCT03802825|448271798|FG001|Overall Study|Lost to follow-up for intervention|3|||
124632726|NCT03802825|448271797|FG000|Overall Study|Received only 1 component of intervention|0|||
124632727|NCT03802825|448271798|FG001|Overall Study|Received only 1 component of intervention|13|||
124632728|NCT03428152|448271799|FG000|Overall Study|Physician Decision|4|||
124632729|NCT03428152|448271800|FG001|Overall Study|Physician Decision|2|||
124632730|NCT03428152|448271799|FG000|Overall Study|Protocol Violation|3|||
124632731|NCT03428152|448271800|FG001|Overall Study|Protocol Violation|5|||
124632732|NCT03428152|448271799|FG000|Overall Study|Lack of Efficacy|0|||
124632733|NCT03428152|448271800|FG001|Overall Study|Lack of Efficacy|4|||
124632734|NCT02570308|448271807|FG000|Overall Study|Death|1|||
124632735|NCT02570308|448271808|FG001|Overall Study|Death|5|||
124632736|NCT02570308|448271809|FG002|Overall Study|Death|4|||
124632737|NCT02570308|448271810|FG003|Overall Study|Death|4|||
124632738|NCT02570308|448271811|FG004|Overall Study|Death|69|||
124632739|NCT02570308|448271807|FG000|Overall Study|Lost to Follow-up|0|||
124632740|NCT02570308|448271808|FG001|Overall Study|Lost to Follow-up|0|||
124632741|NCT02570308|448271809|FG002|Overall Study|Lost to Follow-up|0|||
124632742|NCT02570308|448271810|FG003|Overall Study|Lost to Follow-up|0|||
124632743|NCT02570308|448271811|FG004|Overall Study|Lost to Follow-up|2|||
124632744|NCT02570308|448271807|FG000|Overall Study|Withdrawal by Subject|0|||
124632745|NCT02570308|448271808|FG001|Overall Study|Withdrawal by Subject|0|||
124632746|NCT02570308|448271809|FG002|Overall Study|Withdrawal by Subject|0|||
124632747|NCT02570308|448271810|FG003|Overall Study|Withdrawal by Subject|0|||
124632748|NCT02570308|448271811|FG004|Overall Study|Withdrawal by Subject|1|||
124632749|NCT02570308|448271807|FG000|Overall Study|Other|0|||
124632750|NCT02570308|448271808|FG001|Overall Study|Other|0|||
124632751|NCT02570308|448271809|FG002|Overall Study|Other|0|||
124632752|NCT02570308|448271810|FG003|Overall Study|Other|0|||
124632753|NCT02570308|448271811|FG004|Overall Study|Other|2|||
124632754|NCT01283464|448271812|FG000|Overall Study|Lost to Follow-up|0|||
124632755|NCT01283464|448271813|FG001|Overall Study|Lost to Follow-up|1|||
124632756|NCT01283464|448271812|FG000|Overall Study|Withdrawal by Subject|1|||
124632757|NCT01283464|448271813|FG001|Overall Study|Withdrawal by Subject|0|||
124632758|NCT01283464|448271812|FG000|Overall Study|Physician Decision|1|||
124632759|NCT01283464|448271813|FG001|Overall Study|Physician Decision|0|||
124632760|NCT01286467|448271814|FG000|Overall Study|Death|1|||
124632761|NCT01286467|448271815|FG001|Overall Study|Death|1|||
124632762|NCT01286467|448271816|FG002|Overall Study|Death|1|||
124632763|NCT01286467|448271817|FG003|Overall Study|Death|0|||
124632764|NCT01286467|448271814|FG000|Overall Study|Lost to Follow-up|0|||
124632765|NCT01286467|448271815|FG001|Overall Study|Lost to Follow-up|0|||
124632766|NCT01286467|448271816|FG002|Overall Study|Lost to Follow-up|0|||
124632767|NCT01286467|448271817|FG003|Overall Study|Lost to Follow-up|1|||
124632768|NCT01286467|448271814|FG000|Overall Study|Withdrawal by Subject|0|||
124632769|NCT01286467|448271815|FG001|Overall Study|Withdrawal by Subject|0|||
124632770|NCT01286467|448271816|FG002|Overall Study|Withdrawal by Subject|1|||
124632771|NCT01286467|448271817|FG003|Overall Study|Withdrawal by Subject|0|||
124632772|NCT01286467|448271814|FG000|Overall Study|Physician Decision|0|||
124632773|NCT01286467|448271815|FG001|Overall Study|Physician Decision|0|||
124632774|NCT01286467|448271816|FG002|Overall Study|Physician Decision|0|||
124632775|NCT01286467|448271817|FG003|Overall Study|Physician Decision|1|||
124632776|NCT01286467|448271814|FG000|Overall Study|Disease progression|3|||
124632777|NCT01286467|448271815|FG001|Overall Study|Disease progression|2|||
124632778|NCT01286467|448271816|FG002|Overall Study|Disease progression|2|||
124632779|NCT01286467|448271817|FG003|Overall Study|Disease progression|3|||
124632780|NCT01286467|448271814|FG000|Overall Study|Adverse Event|0|||
124632781|NCT01286467|448271815|FG001|Overall Study|Adverse Event|1|||
124632782|NCT01286467|448271816|FG002|Overall Study|Adverse Event|2|||
124632783|NCT01286467|448271817|FG003|Overall Study|Adverse Event|3|||
124632784|NCT01286467|448271814|FG000|Overall Study|Study drug stop longer than 14 days|0|||
124632785|NCT01286467|448271815|FG001|Overall Study|Study drug stop longer than 14 days|0|||
124632786|NCT01286467|448271816|FG002|Overall Study|Study drug stop longer than 14 days|1|||
124632787|NCT01286467|448271817|FG003|Overall Study|Study drug stop longer than 14 days|0|||
124632788|NCT01058642|448271818|FG000|Treatment Period 1|Adverse Event|0|||
124632789|NCT01058642|448271819|FG001|Treatment Period 1|Adverse Event|1|||
124632790|NCT01058642|448271820|FG002|Treatment Period 1|Adverse Event|1|||
124632791|NCT01058642|448271821|FG003|Treatment Period 1|Adverse Event|0|||
124632792|NCT01058642|448271818|FG000|Treatment Period 1|Physician Decision|0|||
124632793|NCT01058642|448271819|FG001|Treatment Period 1|Physician Decision|0|||
124632794|NCT01058642|448271820|FG002|Treatment Period 1|Physician Decision|1|||
124632795|NCT01058642|448271821|FG003|Treatment Period 1|Physician Decision|0|||
124632796|NCT01058642|448271818|FG000|Treatment Period 1|Withdrawal by Subject|1|||
124632797|NCT01058642|448271819|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124632798|NCT01058642|448271820|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124632799|NCT01058642|448271821|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124752664|NCT01979952|448716812|FG000|Overall Study|Adverse Event|4|||
124752665|NCT01979952|448716813|FG001|Overall Study|Adverse Event|5|||
124752666|NCT01979952|448716812|FG000|Overall Study|Protocol Violation|1|||
124752667|NCT01979952|448716813|FG001|Overall Study|Protocol Violation|0|||
124752668|NCT01979952|448716812|FG000|Overall Study|Withdrawal by Subject|2|||
124752669|NCT01979952|448716813|FG001|Overall Study|Withdrawal by Subject|1|||
124752670|NCT01979952|448716812|FG000|Overall Study|Other than specified above|1|||
124752671|NCT01979952|448716813|FG001|Overall Study|Other than specified above|0|||
124752672|NCT05438576|448716814|FG000|Overall Study|Death|1|||
124752673|NCT05438576|448716815|FG001|Overall Study|Death|1|||
124752674|NCT05438576|448716814|FG000|Overall Study|Withdrawal by Subject|4|||
124752675|NCT05438576|448716815|FG001|Overall Study|Withdrawal by Subject|2|||
124752676|NCT05438576|448716814|FG000|Overall Study|Not Eligible|2|||
124752677|NCT05438576|448716815|FG001|Overall Study|Not Eligible|1|||
124752678|NCT05438576|448716814|FG000|Overall Study|Did not complete baseline testing|22|||
124752679|NCT05438576|448716815|FG001|Overall Study|Did not complete baseline testing|4|||
124752680|NCT01067144|448716821|FG000|Treatment|Did not receive allocated intervention|4|||
124752681|NCT01067144|448716822|FG001|Treatment|Did not receive allocated intervention|7|||
124752682|NCT01067144|448716821|FG000|Follow-up|Lost to Follow-up|22|||
124752683|NCT01067144|448716822|FG001|Follow-up|Lost to Follow-up|12|||
124752684|NCT01067144|448716821|FG000|Follow-up|Censored owing to second surgery|19|||
124752685|NCT01067144|448716822|FG001|Follow-up|Censored owing to second surgery|28|||
124752686|NCT01067144|448716821|FG000|Follow-up|Withdrawal by Subject|18|||
124752687|NCT01067144|448716822|FG001|Follow-up|Withdrawal by Subject|14|||
124752688|NCT01067144|448716821|FG000|Follow-up|Surgery cancelled|0|||
124752689|NCT01067144|448716822|FG001|Follow-up|Surgery cancelled|1|||
124752690|NCT01067144|448716821|FG000|Follow-up|Death|0|||
124752691|NCT01067144|448716822|FG001|Follow-up|Death|1|||
124752692|NCT00203424|448716824|FG000|Treatment Period|Withdrawal by Subject|4|||
124752693|NCT00203424|448716824|FG000|Treatment Period|Adverse Event|5|||
124752694|NCT00203424|448716824|FG000|Treatment Period|progressive disease|2|||
124752695|NCT00203424|448716824|FG000|Follow-up Period|Withdrawal by Subject|1|||
124752696|NCT00203424|448716824|FG000|Follow-up Period|progressive disease|4|||
124752697|NCT00203424|448716824|FG000|Follow-up Period|Lost to Follow-up|1|||
124752698|NCT00555672|448716825|FG000|Overall Study|Death|0|||
124752699|NCT00555672|448716826|FG001|Overall Study|Death|2|||
124752700|NCT00555672|448716825|FG000|Overall Study|Adverse Event|8|||
124752701|NCT00555672|448716826|FG001|Overall Study|Adverse Event|2|||
124752702|NCT00555672|448716825|FG000|Overall Study|Objective progression or relapse|11|||
124632800|NCT01058642|448271818|FG000|Treatment Period 1|Lack of Efficacy|0|||
124632801|NCT01058642|448271819|FG001|Treatment Period 1|Lack of Efficacy|0|||
124632802|NCT01058642|448271820|FG002|Treatment Period 1|Lack of Efficacy|0|||
124632803|NCT01058642|448271821|FG003|Treatment Period 1|Lack of Efficacy|1|||
124632804|NCT01058642|448271818|FG000|Treatment Period 1|Protocol Violation|0|||
124632805|NCT01058642|448271819|FG001|Treatment Period 1|Protocol Violation|0|||
124632806|NCT01058642|448271820|FG002|Treatment Period 1|Protocol Violation|0|||
124632807|NCT01058642|448271821|FG003|Treatment Period 1|Protocol Violation|1|||
124632808|NCT01058642|448271818|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
124632809|NCT01058642|448271819|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
124632810|NCT01058642|448271820|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
124632811|NCT01058642|448271821|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
124632812|NCT01256450|448271822|FG000|Open-label Titration|Adverse Event|39|||
124632813|NCT01256450|448271823|FG001|Open-label Titration|Adverse Event|0|||
124632814|NCT01256450|448271824|FG002|Open-label Titration|Adverse Event|0|||
124632815|NCT01256450|448271822|FG000|Open-label Titration|Lost to Follow-up|7|||
124632816|NCT01256450|448271823|FG001|Open-label Titration|Lost to Follow-up|0|||
124632817|NCT01256450|448271824|FG002|Open-label Titration|Lost to Follow-up|0|||
124632818|NCT01256450|448271822|FG000|Open-label Titration|Lack of analgesic effect|30|||
124632819|NCT01256450|448271823|FG001|Open-label Titration|Lack of analgesic effect|0|||
124632820|NCT01256450|448271824|FG002|Open-label Titration|Lack of analgesic effect|0|||
124632821|NCT01256450|448271822|FG000|Open-label Titration|Non-compliance|9|||
124632822|NCT01256450|448271823|FG001|Open-label Titration|Non-compliance|0|||
124632823|NCT01256450|448271824|FG002|Open-label Titration|Non-compliance|0|||
124632824|NCT01256450|448271822|FG000|Open-label Titration|Screen failure|1|||
124632825|NCT01256450|448271823|FG001|Open-label Titration|Screen failure|0|||
124632826|NCT01256450|448271824|FG002|Open-label Titration|Screen failure|0|||
124632827|NCT01256450|448271822|FG000|Open-label Titration|Other|13|||
124632828|NCT01256450|448271823|FG001|Open-label Titration|Other|0|||
124632829|NCT01256450|448271824|FG002|Open-label Titration|Other|0|||
124632830|NCT01256450|448271822|FG000|Double-blind Treatment|Adverse Event|0|||
124632831|NCT01256450|448271823|FG001|Double-blind Treatment|Adverse Event|8|||
124632832|NCT01256450|448271824|FG002|Double-blind Treatment|Adverse Event|6|||
124632833|NCT01256450|448271822|FG000|Double-blind Treatment|Lost to Follow-up|0|||
124632834|NCT01256450|448271823|FG001|Double-blind Treatment|Lost to Follow-up|1|||
124632835|NCT01256450|448271824|FG002|Double-blind Treatment|Lost to Follow-up|7|||
124632836|NCT01256450|448271822|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
124632837|NCT01256450|448271823|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
124632838|NCT01256450|448271824|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
124632839|NCT01256450|448271822|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
124632840|NCT01256450|448271823|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
124632841|NCT01256450|448271824|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
124632842|NCT01256450|448271822|FG000|Double-blind Treatment|Non-compliance|0|||
124632843|NCT01256450|448271823|FG001|Double-blind Treatment|Non-compliance|5|||
124632844|NCT01256450|448271824|FG002|Double-blind Treatment|Non-compliance|4|||
124632845|NCT01256450|448271822|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
124632846|NCT01256450|448271823|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
124632847|NCT01256450|448271824|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
124632848|NCT01256450|448271822|FG000|Double-blind Treatment|Other|0|||
124632849|NCT01256450|448271823|FG001|Double-blind Treatment|Other|9|||
124632850|NCT01256450|448271824|FG002|Double-blind Treatment|Other|12|||
124632851|NCT03866512|448271825|FG000|Overall Study|Lost to Follow-up|1|||
124632852|NCT03866512|448271826|FG001|Overall Study|Lost to Follow-up|2|||
124632853|NCT03866512|448271827|FG002|Overall Study|Lost to Follow-up|1|||
124632854|NCT03866512|448271825|FG000|Overall Study|Cannulation issues|0|||
124632855|NCT03866512|448271826|FG001|Overall Study|Cannulation issues|1|||
124632856|NCT03866512|448271827|FG002|Overall Study|Cannulation issues|2|||
124632857|NCT04242498|448271838|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
124632858|NCT04242498|448271839|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
124632859|NCT04242498|448271840|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
124632860|NCT04242498|448271841|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
124632861|NCT04242498|448271842|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
124632862|NCT04242498|448271843|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
124632863|NCT04242498|448271844|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
124632864|NCT04242498|448271838|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
124632865|NCT04242498|448271839|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
124632866|NCT04242498|448271840|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
124632867|NCT04242498|448271841|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
124632868|NCT04242498|448271842|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
124632869|NCT04242498|448271843|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
124632870|NCT04242498|448271844|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
124632871|NCT04242498|448271838|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
124632872|NCT04242498|448271839|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
124632873|NCT04242498|448271840|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
124632874|NCT04242498|448271841|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
124632875|NCT04242498|448271842|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
124632876|NCT04242498|448271843|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
124632877|NCT04242498|448271844|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
124632878|NCT04242498|448271838|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
124632879|NCT04242498|448271839|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
124632880|NCT04242498|448271840|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
124632881|NCT04242498|448271841|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
124632882|NCT04242498|448271842|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
124632883|NCT04242498|448271843|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
124632884|NCT04242498|448271844|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
124632885|NCT04242498|448271838|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
124632886|NCT04242498|448271839|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
124632887|NCT04242498|448271840|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
124632888|NCT04242498|448271841|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
124632889|NCT04242498|448271842|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
124632890|NCT04242498|448271843|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
124632891|NCT04242498|448271844|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
124803058|NCT00299182|448910225|FG001|Overall Study|Withdrawal by Subject|0|||
124803059|NCT00299182|448910226|FG002|Overall Study|Withdrawal by Subject|1|||
124803060|NCT00299182|448910227|FG003|Overall Study|Withdrawal by Subject|0|||
124803061|NCT00299182|448910228|FG004|Overall Study|Withdrawal by Subject|1|||
124632892|NCT04242498|448271838|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
124632893|NCT04242498|448271839|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
124632894|NCT04242498|448271840|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
124632895|NCT04242498|448271841|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
124632896|NCT04242498|448271842|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
124632897|NCT04242498|448271843|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
124632898|NCT04242498|448271844|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
124632899|NCT04242498|448271838|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
124632900|NCT04242498|448271839|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
124632901|NCT04242498|448271840|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
124632902|NCT04242498|448271841|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
124632903|NCT04242498|448271842|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
124632904|NCT04242498|448271843|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
124632905|NCT04242498|448271844|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
124632906|NCT04242498|448271838|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
124632907|NCT04242498|448271839|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
124632908|NCT04242498|448271840|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
124632909|NCT04242498|448271841|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
124632910|NCT04242498|448271842|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
124632911|NCT04242498|448271843|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
124632912|NCT04242498|448271844|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
124632913|NCT04242498|448271838|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
124632914|NCT04242498|448271839|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
124632915|NCT04242498|448271840|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
124632916|NCT04242498|448271841|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
124632917|NCT04242498|448271842|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
124632918|NCT04242498|448271843|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
124632919|NCT04242498|448271844|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
124632920|NCT04242498|448271838|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
124632921|NCT04242498|448271839|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
124632922|NCT04242498|448271840|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
124632923|NCT04242498|448271841|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
124632924|NCT04242498|448271842|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
124632925|NCT04242498|448271843|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
124632926|NCT04242498|448271844|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
124632927|NCT04242498|448271838|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
124632928|NCT04242498|448271839|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
124803062|NCT00299182|448910229|FG005|Overall Study|Withdrawal by Subject|2|||
124803063|NCT00299182|448910230|FG006|Overall Study|Withdrawal by Subject|0|||
124632929|NCT04242498|448271840|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
124632930|NCT04242498|448271841|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
124632931|NCT04242498|448271842|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
124632932|NCT04242498|448271843|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
124632933|NCT04242498|448271844|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
124632934|NCT04242498|448271838|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
124632935|NCT04242498|448271839|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
124632936|NCT04242498|448271840|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
124632937|NCT04242498|448271841|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
124632938|NCT04242498|448271842|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
124632939|NCT04242498|448271843|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
124632940|NCT04242498|448271844|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
124632941|NCT04242498|448271838|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
124632942|NCT04242498|448271839|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
124632943|NCT04242498|448271840|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
124632944|NCT04242498|448271841|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
124632945|NCT04242498|448271842|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
124632946|NCT04242498|448271843|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
124632947|NCT04242498|448271844|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
124632948|NCT04242498|448271838|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
124632949|NCT04242498|448271839|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
124632950|NCT04242498|448271840|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
124632951|NCT04242498|448271841|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
124632952|NCT04242498|448271842|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
124632953|NCT04242498|448271843|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
124632954|NCT04242498|448271844|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
124632955|NCT04242498|448271838|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
124632956|NCT04242498|448271839|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
124632957|NCT04242498|448271840|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
124632958|NCT04242498|448271841|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
124632959|NCT04242498|448271842|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
124632960|NCT04242498|448271843|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
124632961|NCT04242498|448271844|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
124632962|NCT04242498|448271838|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
124632963|NCT04242498|448271839|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
124632964|NCT04242498|448271840|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
124632965|NCT04242498|448271841|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
124632966|NCT04242498|448271842|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
124632967|NCT04242498|448271843|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
124632968|NCT04242498|448271844|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
124632969|NCT04426006|448271845|FG000|Inclusion|Protocol Violation|1|||
124632970|NCT04426006|448271845|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
124632971|NCT04426006|448271845|FG000|Inclusion|Blood sample at inclusion not done|1|||
124632972|NCT04426006|448271845|FG000|3 Months|Lost to Follow-up|17|||
124632973|NCT04426006|448271845|FG000|12 Months|Lost to Follow-up|38|||
124632974|NCT03380429|448271848|FG000|Overall Study|Physician Decision|0|||
124632975|NCT03380429|448271849|FG001|Overall Study|Physician Decision|1|||
124632976|NCT03380429|448271850|FG002|Overall Study|Physician Decision|0|||
124632977|NCT03380429|448271851|FG003|Overall Study|Physician Decision|1|||
124632978|NCT03380429|448271852|FG004|Overall Study|Physician Decision|1|||
124632979|NCT03380429|448271848|FG000|Overall Study|Withdrawal by Subject|3|||
124632980|NCT03380429|448271849|FG001|Overall Study|Withdrawal by Subject|3|||
124632981|NCT03380429|448271850|FG002|Overall Study|Withdrawal by Subject|5|||
124632982|NCT03380429|448271851|FG003|Overall Study|Withdrawal by Subject|2|||
124632983|NCT03380429|448271852|FG004|Overall Study|Withdrawal by Subject|1|||
124632984|NCT03380429|448271848|FG000|Overall Study|Lost to Follow-up|0|||
124632985|NCT03380429|448271849|FG001|Overall Study|Lost to Follow-up|2|||
124632986|NCT03380429|448271850|FG002|Overall Study|Lost to Follow-up|4|||
124632987|NCT03380429|448271851|FG003|Overall Study|Lost to Follow-up|3|||
124632988|NCT03380429|448271852|FG004|Overall Study|Lost to Follow-up|1|||
124632989|NCT03380429|448271848|FG000|Overall Study|Protocol Violation|1|||
124632990|NCT03380429|448271849|FG001|Overall Study|Protocol Violation|0|||
124632991|NCT03380429|448271850|FG002|Overall Study|Protocol Violation|1|||
124632992|NCT03380429|448271851|FG003|Overall Study|Protocol Violation|0|||
124632993|NCT03380429|448271852|FG004|Overall Study|Protocol Violation|1|||
124632994|NCT03380429|448271848|FG000|Overall Study|Lack of Efficacy|0|||
124632995|NCT03380429|448271849|FG001|Overall Study|Lack of Efficacy|0|||
124632996|NCT03380429|448271850|FG002|Overall Study|Lack of Efficacy|0|||
124632997|NCT03380429|448271851|FG003|Overall Study|Lack of Efficacy|2|||
124632998|NCT03380429|448271852|FG004|Overall Study|Lack of Efficacy|1|||
124632999|NCT03380429|448271848|FG000|Overall Study|Adverse Event|1|||
124633000|NCT03380429|448271849|FG001|Overall Study|Adverse Event|1|||
124633001|NCT03380429|448271850|FG002|Overall Study|Adverse Event|1|||
124633002|NCT03380429|448271851|FG003|Overall Study|Adverse Event|2|||
124633003|NCT03380429|448271852|FG004|Overall Study|Adverse Event|0|||
124633004|NCT04760626|448271853|FG000|Overall Study|Withdrawal by Subject|24|||
124803064|NCT00299182|448910224|FG000|Overall Study|Chemotherapy Changed|0|||
124803065|NCT00299182|448910225|FG001|Overall Study|Chemotherapy Changed|0|||
124803066|NCT00299182|448910226|FG002|Overall Study|Chemotherapy Changed|1|||
124803067|NCT00299182|448910227|FG003|Overall Study|Chemotherapy Changed|0|||
124633005|NCT04760626|448271854|FG001|Overall Study|Withdrawal by Subject|20|||
124633006|NCT04760626|448271853|FG000|Overall Study|Lost to Follow-up|14|||
124633007|NCT04760626|448271854|FG001|Overall Study|Lost to Follow-up|19|||
124633008|NCT04760626|448271853|FG000|Overall Study|Physician Decision|3|||
124633009|NCT04760626|448271854|FG001|Overall Study|Physician Decision|5|||
124633010|NCT04760626|448271853|FG000|Overall Study|Death|3|||
124633011|NCT04760626|448271854|FG001|Overall Study|Death|6|||
124633012|NCT04760626|448271853|FG000|Overall Study|Site closure|1|||
124633013|NCT04760626|448271854|FG001|Overall Study|Site closure|0|||
124633014|NCT02946463|448271855|FG000|Primary Evaluation Period|Physician Decision|0|||
124633015|NCT02946463|448271856|FG001|Primary Evaluation Period|Physician Decision|1|||
124633016|NCT02946463|448271857|FG002|Primary Evaluation Period|Physician Decision|0|||
124803068|NCT00299182|448910228|FG004|Overall Study|Chemotherapy Changed|1|||
124803069|NCT00299182|448910229|FG005|Overall Study|Chemotherapy Changed|0|||
124803070|NCT00299182|448910230|FG006|Overall Study|Chemotherapy Changed|1|||
124803071|NCT00299182|448910224|FG000|Overall Study|Adverse Event|0|||
124803072|NCT00299182|448910225|FG001|Overall Study|Adverse Event|0|||
124803073|NCT00299182|448910226|FG002|Overall Study|Adverse Event|0|||
124633017|NCT02946463|448271858|FG003|Primary Evaluation Period|Physician Decision|0|||
124633018|NCT02946463|448271855|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
124633019|NCT02946463|448271856|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
124633020|NCT02946463|448271857|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
124633021|NCT02946463|448271858|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
124633022|NCT02946463|448271855|FG000|Extension Period|Death|4|||
124633023|NCT02946463|448271856|FG001|Extension Period|Death|4|||
124633024|NCT02946463|448271857|FG002|Extension Period|Death|0|||
124633025|NCT02946463|448271858|FG003|Extension Period|Death|0|||
124633026|NCT02946463|448271855|FG000|Extension Period|Withdrawal by Subject|4|||
124633027|NCT02946463|448271856|FG001|Extension Period|Withdrawal by Subject|3|||
124633028|NCT02946463|448271857|FG002|Extension Period|Withdrawal by Subject|0|||
124633029|NCT02946463|448271858|FG003|Extension Period|Withdrawal by Subject|0|||
124633030|NCT02946463|448271855|FG000|Extension Period|Other than specified|2|||
124633031|NCT02946463|448271856|FG001|Extension Period|Other than specified|3|||
124633032|NCT02946463|448271857|FG002|Extension Period|Other than specified|2|||
124633033|NCT02946463|448271858|FG003|Extension Period|Other than specified|0|||
124633034|NCT02946463|448271855|FG000|Extension Period|Physician Decision|1|||
124633035|NCT02946463|448271856|FG001|Extension Period|Physician Decision|4|||
124633036|NCT02946463|448271857|FG002|Extension Period|Physician Decision|0|||
124633037|NCT02946463|448271858|FG003|Extension Period|Physician Decision|0|||
124633038|NCT02946463|448271855|FG000|Extension Period|Pregnancy|3|||
124633039|NCT02946463|448271856|FG001|Extension Period|Pregnancy|1|||
124633040|NCT02946463|448271857|FG002|Extension Period|Pregnancy|0|||
124633041|NCT02946463|448271858|FG003|Extension Period|Pregnancy|0|||
124633042|NCT02946463|448271855|FG000|Extension Period|Adverse Event|1|||
124633043|NCT02946463|448271856|FG001|Extension Period|Adverse Event|2|||
124633044|NCT02946463|448271857|FG002|Extension Period|Adverse Event|0|||
124633045|NCT02946463|448271858|FG003|Extension Period|Adverse Event|0|||
124633046|NCT02946463|448271855|FG000|Extension Period|Lost to Follow-up|1|||
124633047|NCT02946463|448271856|FG001|Extension Period|Lost to Follow-up|0|||
124633048|NCT02946463|448271857|FG002|Extension Period|Lost to Follow-up|0|||
124633049|NCT02946463|448271858|FG003|Extension Period|Lost to Follow-up|0|||
124803074|NCT00299182|448910227|FG003|Overall Study|Adverse Event|0|||
124803075|NCT00299182|448910228|FG004|Overall Study|Adverse Event|0|||
124803076|NCT00299182|448910229|FG005|Overall Study|Adverse Event|1|||
124633050|NCT01753310|448271859|FG000|Overall Study|Entered into open label extension study|25|||
124633051|NCT01753310|448271860|FG001|Overall Study|Entered into open label extension study|22|||
124633052|NCT01753310|448271859|FG000|Overall Study|Adverse Event|1|||
124633053|NCT01753310|448271860|FG001|Overall Study|Adverse Event|0|||
124633054|NCT01753310|448271859|FG000|Overall Study|Lost to Follow-up|2|||
124633055|NCT01753310|448271860|FG001|Overall Study|Lost to Follow-up|0|||
124633056|NCT01753310|448271859|FG000|Overall Study|Subject decision|2|||
124633057|NCT01753310|448271860|FG001|Overall Study|Subject decision|2|||
124633058|NCT01753310|448271859|FG000|Overall Study|Sponsor decision|1|||
124633059|NCT01753310|448271860|FG001|Overall Study|Sponsor decision|0|||
124633060|NCT01753310|448271859|FG000|Overall Study|Withdrawal by Subject|1|||
124633061|NCT01753310|448271860|FG001|Overall Study|Withdrawal by Subject|0|||
124633062|NCT02169271|448271861|FG000|Overall Study|Protocol Violation|1|||
124633063|NCT02169271|448271862|FG001|Overall Study|Protocol Violation|2|||
124633064|NCT00226499|448271864|FG000|Overall Study|Adverse Event|10|||
124633065|NCT00226499|448271865|FG001|Overall Study|Adverse Event|6|||
124633066|NCT00226499|448271866|FG002|Overall Study|Adverse Event|3|||
124633067|NCT00226499|448271864|FG000|Overall Study|Others|1064|||
124633068|NCT00226499|448271865|FG001|Overall Study|Others|1066|||
124633069|NCT00226499|448271866|FG002|Overall Study|Others|356|||
124633070|NCT00946920|448271869|FG000|Overall Study|Withdrawal by Subject|28|||
124633071|NCT00946920|448271870|FG001|Overall Study|Withdrawal by Subject|15|||
124633072|NCT00946920|448271869|FG000|Overall Study|Lost to Follow-up|2|||
124633073|NCT00946920|448271870|FG001|Overall Study|Lost to Follow-up|2|||
124633074|NCT00946920|448271869|FG000|Overall Study|Physician Decision|5|||
124633075|NCT00946920|448271870|FG001|Overall Study|Physician Decision|2|||
124633076|NCT00946920|448271869|FG000|Overall Study|Adverse Event|41|||
124633077|NCT00946920|448271870|FG001|Overall Study|Adverse Event|14|||
124633078|NCT00946920|448271869|FG000|Overall Study|Protocol Violation|16|||
124633079|NCT00946920|448271870|FG001|Overall Study|Protocol Violation|8|||
124633080|NCT00946920|448271869|FG000|Overall Study|Miscellaneous reasons|18|||
124633081|NCT00946920|448271870|FG001|Overall Study|Miscellaneous reasons|3|||
124633082|NCT04616612|448271871|FG000|Overall Study|Lost to Follow-up|6|||
124633083|NCT04616612|448271872|FG001|Overall Study|Lost to Follow-up|3|||
124633084|NCT01597973|448271873|FG000|Overall Study|Found ineligible before study medication started|4|||
124633085|NCT01597973|448271874|FG001|Overall Study|Found ineligible before study medication started|2|||
124633086|NCT01597973|448271873|FG000|Overall Study|Eligible pathogen not confirmed|14|||
124633087|NCT01597973|448271874|FG001|Overall Study|Eligible pathogen not confirmed|15|||
124633088|NCT01597973|448271873|FG000|Overall Study|LAR not authorized to consent|0|||
124633089|NCT01597973|448271874|FG001|Overall Study|LAR not authorized to consent|1|||
124633090|NCT01597973|448271873|FG000|Overall Study|Ineligible due to early seizures|1|||
124633091|NCT01597973|448271874|FG001|Overall Study|Ineligible due to early seizures|0|||
124633092|NCT01597973|448271873|FG000|Overall Study|Ineligible due to non-target infection|1|||
124633093|NCT01597973|448271874|FG001|Overall Study|Ineligible due to non-target infection|1|||
124633094|NCT01288079|448271882|FG000|Overall Study|Withdrawal by Subject|2|||
124633095|NCT01288079|448271883|FG001|Overall Study|Withdrawal by Subject|4|||
124633096|NCT01288079|448271884|FG002|Overall Study|Withdrawal by Subject|1|||
124633097|NCT01288079|448271885|FG003|Overall Study|Withdrawal by Subject|0|||
124633098|NCT01288079|448271882|FG000|Overall Study|Adverse Event|2|||
124633099|NCT01288079|448271883|FG001|Overall Study|Adverse Event|1|||
124803077|NCT00299182|448910230|FG006|Overall Study|Adverse Event|0|||
124803078|NCT00299182|448910224|FG000|Overall Study|Not Eligible|0|||
124803079|NCT00299182|448910225|FG001|Overall Study|Not Eligible|0|||
124803080|NCT00299182|448910226|FG002|Overall Study|Not Eligible|0|||
124803081|NCT00299182|448910227|FG003|Overall Study|Not Eligible|0|||
124803082|NCT00299182|448910228|FG004|Overall Study|Not Eligible|1|||
124633100|NCT01288079|448271884|FG002|Overall Study|Adverse Event|2|||
124633101|NCT01288079|448271885|FG003|Overall Study|Adverse Event|3|||
124633102|NCT01288079|448271882|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
124633103|NCT01288079|448271883|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
124633104|NCT01288079|448271884|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
124633105|NCT01288079|448271885|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
124633106|NCT01288079|448271882|FG000|Overall Study|Condition under Investigation Worsened|0|||
124633107|NCT01288079|448271883|FG001|Overall Study|Condition under Investigation Worsened|0|||
124633108|NCT01288079|448271884|FG002|Overall Study|Condition under Investigation Worsened|0|||
124633109|NCT01288079|448271885|FG003|Overall Study|Condition under Investigation Worsened|1|||
124633110|NCT01288079|448271882|FG000|Overall Study|Lack of Efficacy|2|||
124633111|NCT01288079|448271883|FG001|Overall Study|Lack of Efficacy|2|||
124633112|NCT01288079|448271884|FG002|Overall Study|Lack of Efficacy|0|||
124633113|NCT01288079|448271885|FG003|Overall Study|Lack of Efficacy|2|||
124633114|NCT01288079|448271882|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
124633115|NCT01288079|448271883|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
124633116|NCT01288079|448271884|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
124633117|NCT01288079|448271885|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
124803083|NCT00299182|448910229|FG005|Overall Study|Not Eligible|0|||
124803084|NCT00299182|448910230|FG006|Overall Study|Not Eligible|0|||
124803085|NCT01631812|448910231|FG000|Overall Study|Adverse Event|25|||
124633118|NCT01288079|448271882|FG000|Overall Study|Lost to Follow-up|1|||
124633119|NCT01288079|448271883|FG001|Overall Study|Lost to Follow-up|1|||
124633120|NCT01288079|448271884|FG002|Overall Study|Lost to Follow-up|1|||
124633121|NCT01288079|448271885|FG003|Overall Study|Lost to Follow-up|0|||
124633122|NCT01288079|448271882|FG000|Overall Study|Other or Study Termination|11|||
124633123|NCT01288079|448271883|FG001|Overall Study|Other or Study Termination|15|||
124633124|NCT01288079|448271884|FG002|Overall Study|Other or Study Termination|14|||
124633125|NCT01288079|448271885|FG003|Overall Study|Other or Study Termination|8|||
124633126|NCT01530464|448271886|FG000|Washout (24h)|Withdrawal by Subject|1|||
124633127|NCT01530464|448271887|FG001|Washout (24h)|Withdrawal by Subject|0|||
124633128|NCT01530464|448271886|FG000|Washout (24h)|Withdrawal by Subject|0|||
124633129|NCT01530464|448271887|FG001|Washout (24h)|Withdrawal by Subject|1|||
124633130|NCT00503698|448271896|FG000|Overall Study|Protocol Violation|5|||
124633131|NCT00503698|448271897|FG001|Overall Study|Protocol Violation|6|||
124633132|NCT00503698|448271896|FG000|Overall Study|Adverse Event|52|||
124633133|NCT00503698|448271897|FG001|Overall Study|Adverse Event|41|||
124633134|NCT00503698|448271896|FG000|Overall Study|Death|1|||
124633135|NCT00503698|448271897|FG001|Overall Study|Death|0|||
124633136|NCT00503698|448271896|FG000|Overall Study|Lack of Efficacy|3|||
124633137|NCT00503698|448271897|FG001|Overall Study|Lack of Efficacy|4|||
124633138|NCT00503698|448271896|FG000|Overall Study|Trial terminated|216|||
124633139|NCT00503698|448271897|FG001|Overall Study|Trial terminated|253|||
124633140|NCT00503698|448271896|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
124633141|NCT00503698|448271897|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
124633142|NCT00503698|448271896|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
124633143|NCT00503698|448271897|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
124633144|NCT00503698|448271896|FG000|Overall Study|Any condition in exclusion criteria|4|||
124633145|NCT00503698|448271897|FG001|Overall Study|Any condition in exclusion criteria|6|||
124633146|NCT00503698|448271896|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
124633147|NCT00503698|448271897|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
124633148|NCT00503698|448271896|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
124633149|NCT00503698|448271897|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
124633150|NCT00503698|448271896|FG000|Overall Study|Critically ill|2|||
124633151|NCT00503698|448271897|FG001|Overall Study|Critically ill|0|||
124633152|NCT00503698|448271896|FG000|Overall Study|Unclassified|48|||
124633153|NCT00503698|448271897|FG001|Overall Study|Unclassified|32|||
124633154|NCT00503698|448271896|FG000|Overall Study|Not exposed to trial drug|11|||
124633155|NCT00503698|448271897|FG001|Overall Study|Not exposed to trial drug|6|||
124633156|NCT02107131|448271900|FG000|Overall Study|Lost to Follow-up|4|||
124633157|NCT02107131|448271901|FG001|Overall Study|Lost to Follow-up|4|||
124633158|NCT02107131|448271900|FG000|Overall Study|Physician Decision|1|||
124633159|NCT02107131|448271901|FG001|Overall Study|Physician Decision|0|||
124633160|NCT02107131|448271900|FG000|Overall Study|Withdrawal by Subject|2|||
124633161|NCT02107131|448271901|FG001|Overall Study|Withdrawal by Subject|0|||
124633162|NCT02107131|448271900|FG000|Overall Study|mental instability|1|||
124633163|NCT02107131|448271901|FG001|Overall Study|mental instability|0|||
124633164|NCT02107131|448271900|FG000|Overall Study|Death|0|||
124633165|NCT02107131|448271901|FG001|Overall Study|Death|1|||
124633166|NCT02107131|448271900|FG000|Overall Study|Protocol Violation|0|||
124633167|NCT02107131|448271901|FG001|Overall Study|Protocol Violation|4|||
124633168|NCT02259010|448271902|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
124633169|NCT01546025|448271905|FG000|Overall Study|Lost to Follow-up|0|||
124633170|NCT01546025|448271906|FG001|Overall Study|Lost to Follow-up|1|||
124633171|NCT04242446|448273223|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
124633172|NCT04242446|448273224|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
124633173|NCT04242446|448273225|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
124633174|NCT04242446|448273226|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
124633175|NCT04242446|448273227|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
124633176|NCT04242446|448273228|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
124633177|NCT04242446|448273229|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
124633178|NCT04242446|448273223|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
124633179|NCT04242446|448273224|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
124633180|NCT04242446|448273225|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
124633181|NCT04242446|448273226|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
124633182|NCT04242446|448273227|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
124633183|NCT04242446|448273228|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
124633184|NCT04242446|448273229|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
124633185|NCT04242446|448273223|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
124633186|NCT04242446|448273224|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
124633187|NCT04242446|448273225|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
124633188|NCT04242446|448273226|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
124633189|NCT04242446|448273227|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
124633190|NCT04242446|448273228|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
124633191|NCT04242446|448273229|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
124633192|NCT04242446|448273223|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
124633193|NCT04242446|448273224|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
124633194|NCT04242446|448273225|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
124633195|NCT04242446|448273226|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
124633196|NCT04242446|448273227|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
124633197|NCT04242446|448273228|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
124633198|NCT04242446|448273229|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
124633199|NCT04242446|448273223|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
124633200|NCT04242446|448273224|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
124633201|NCT04242446|448273225|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
124633202|NCT04242446|448273226|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
124633203|NCT04242446|448273227|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
124633204|NCT04242446|448273228|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
124633205|NCT04242446|448273229|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
124633206|NCT04242446|448273223|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
124633207|NCT04242446|448273224|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
124633208|NCT04242446|448273225|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
124633209|NCT04242446|448273226|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
124633210|NCT04242446|448273227|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
124633211|NCT04242446|448273228|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
124803086|NCT01631812|448910231|FG000|Overall Study|Lack of Efficacy|5|||
124803087|NCT01631812|448910231|FG000|Overall Study|Withdrawal by Subject|4|||
124803088|NCT01631812|448910231|FG000|Overall Study|Physician Decision|3|||
124803089|NCT00072176|448910234|FG000|Overall Study|Withdrawal by Subject|1|||
124803090|NCT00072176|448910235|FG001|Overall Study|Withdrawal by Subject|0|||
124803091|NCT00072176|448910234|FG000|Overall Study|Protocol Violation|0|||
124633212|NCT04242446|448273229|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
124633213|NCT04242446|448273223|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
124633214|NCT04242446|448273224|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
124633215|NCT04242446|448273225|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
124633216|NCT04242446|448273226|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
124633217|NCT04242446|448273227|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
124633218|NCT04242446|448273228|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
124633219|NCT04242446|448273229|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
124633220|NCT04242446|448273223|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
124633221|NCT04242446|448273224|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
124633222|NCT04242446|448273225|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
124633223|NCT04242446|448273226|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
124633224|NCT04242446|448273227|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
124633225|NCT04242446|448273228|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
124633226|NCT04242446|448273229|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
124633227|NCT04242446|448273223|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
124633228|NCT04242446|448273224|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
124633229|NCT04242446|448273225|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
124633230|NCT04242446|448273226|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
124633231|NCT04242446|448273227|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
124633232|NCT04242446|448273228|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
124633233|NCT04242446|448273229|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
124633234|NCT04242446|448273223|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
124803092|NCT00072176|448910235|FG001|Overall Study|Protocol Violation|1|||
124803093|NCT02024555|448910239|FG000|Overall Study|Lost to Follow-up|1|||
124803094|NCT02024555|448910240|FG001|Overall Study|Lost to Follow-up|1|||
124803095|NCT02024555|448910239|FG000|Overall Study|Withdrawal by Subject|5|||
124803096|NCT02024555|448910240|FG001|Overall Study|Withdrawal by Subject|1|||
124803097|NCT03805646|448910242|FG000|Overall Study|Death|40|||
124803098|NCT03805646|448910243|FG001|Overall Study|Death|49|||
124803099|NCT03805646|448910242|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
124803100|NCT03805646|448910243|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
124803101|NCT03350620|448910246|FG000|Stage 2|Adverse Event|0|||
124803102|NCT03350620|448910247|FG001|Stage 2|Adverse Event|1|||
124803103|NCT03350620|448910248|FG002|Stage 2|Adverse Event|1|||
124803104|NCT03350620|448910246|FG000|Stage 2|Lack of Efficacy|0|||
124803105|NCT03350620|448910247|FG001|Stage 2|Lack of Efficacy|2|||
124803106|NCT03350620|448910248|FG002|Stage 2|Lack of Efficacy|0|||
124803107|NCT03350620|448910246|FG000|Stage 2|Lost to Follow-up|1|||
124803108|NCT03350620|448910247|FG001|Stage 2|Lost to Follow-up|2|||
124803109|NCT03350620|448910248|FG002|Stage 2|Lost to Follow-up|2|||
124803110|NCT03350620|448910246|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
124819541|NCT05147350|448965754|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
124803111|NCT03350620|448910247|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
124803112|NCT03350620|448910248|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
124803113|NCT00257608|448911988|FG000|Chemotherapy Phase|Adverse Event|138|||
124803114|NCT00257608|448911989|FG001|Chemotherapy Phase|Adverse Event|0|||
124633235|NCT04242446|448273224|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
124633236|NCT04242446|448273225|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
124633237|NCT04242446|448273226|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
124633238|NCT04242446|448273227|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
124633239|NCT04242446|448273228|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
124633240|NCT04242446|448273229|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
124633241|NCT04242446|448273223|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
124633242|NCT04242446|448273224|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
124633243|NCT04242446|448273225|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
124633244|NCT04242446|448273226|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
124633245|NCT04242446|448273227|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
124633246|NCT04242446|448273228|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
124633247|NCT04242446|448273229|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
124633248|NCT04242446|448273223|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
124633249|NCT04242446|448273224|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
124633250|NCT04242446|448273225|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
124633251|NCT04242446|448273226|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
124633252|NCT04242446|448273227|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
124633253|NCT04242446|448273228|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
124633254|NCT04242446|448273229|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
124633255|NCT04242446|448273223|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
124633256|NCT04242446|448273224|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
124633257|NCT04242446|448273225|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
124633258|NCT04242446|448273226|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
124633259|NCT04242446|448273227|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
124633260|NCT04242446|448273228|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
124633261|NCT04242446|448273229|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
124633262|NCT04242446|448273223|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
124633263|NCT04242446|448273224|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
124633264|NCT04242446|448273225|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
124633265|NCT04242446|448273226|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
124633266|NCT04242446|448273227|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
124633267|NCT04242446|448273228|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
124633268|NCT04242446|448273229|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
124633269|NCT04242446|448273223|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
124633270|NCT04242446|448273224|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
124633271|NCT04242446|448273225|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
124633272|NCT04242446|448273226|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
124633273|NCT04242446|448273227|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
124633274|NCT04242446|448273228|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
124633275|NCT04242446|448273229|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
124633276|NCT04242446|448273223|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
124633277|NCT04242446|448273224|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
124633278|NCT04242446|448273225|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
124633279|NCT04242446|448273226|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
124633280|NCT04242446|448273227|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
124633281|NCT04242446|448273228|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
124633282|NCT04242446|448273229|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
124633283|NCT04242446|448273223|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
124633284|NCT04242446|448273224|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
124803115|NCT00257608|448911990|FG002|Chemotherapy Phase|Adverse Event|0|||
124803116|NCT00257608|448911988|FG000|Chemotherapy Phase|Disease progression|139|||
124803117|NCT00257608|448911989|FG001|Chemotherapy Phase|Disease progression|0|||
124633285|NCT04242446|448273225|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
124633286|NCT04242446|448273226|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
124633287|NCT04242446|448273227|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
124633288|NCT04242446|448273228|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
124633289|NCT04242446|448273229|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
124633290|NCT04242446|448273223|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
124633291|NCT04242446|448273224|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
124633292|NCT04242446|448273225|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
124633293|NCT04242446|448273226|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
124633294|NCT04242446|448273227|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
124633295|NCT04242446|448273228|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
124633296|NCT04242446|448273229|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
124633297|NCT04242446|448273223|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
124633298|NCT04242446|448273224|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
124633299|NCT04242446|448273225|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
124633300|NCT04242446|448273226|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
124633301|NCT04242446|448273227|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
124633302|NCT04242446|448273228|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
124633303|NCT04242446|448273229|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
124633304|NCT04242446|448273223|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
124633305|NCT04242446|448273224|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
124633306|NCT04242446|448273225|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
124633307|NCT04242446|448273226|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
124633308|NCT04242446|448273227|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
124633309|NCT04242446|448273228|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
124633310|NCT04242446|448273229|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
124633311|NCT04242446|448273223|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
124633312|NCT04242446|448273224|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
124633313|NCT04242446|448273225|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
124633314|NCT04242446|448273226|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
124633315|NCT04242446|448273227|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
124633316|NCT04242446|448273228|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
124633317|NCT04242446|448273229|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
124633318|NCT04242446|448273223|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
124633319|NCT04242446|448273224|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
124633320|NCT04242446|448273225|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
124633321|NCT04242446|448273226|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
124633322|NCT04242446|448273227|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
124633323|NCT04242446|448273228|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
124633324|NCT04242446|448273229|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
124633325|NCT04242446|448273223|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
124633326|NCT04242446|448273224|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
124633327|NCT04242446|448273225|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
124633328|NCT04242446|448273226|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
124633329|NCT04242446|448273227|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
124633330|NCT04242446|448273228|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
124633331|NCT04242446|448273229|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
124633332|NCT04242446|448273223|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
124633333|NCT04242446|448273224|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
124633334|NCT04242446|448273225|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
124633335|NCT04242446|448273226|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
124633336|NCT04242446|448273227|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
124633337|NCT04242446|448273228|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
124633338|NCT04242446|448273229|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
124803118|NCT00257608|448911990|FG002|Chemotherapy Phase|Disease progression|0|||
124803119|NCT00257608|448911988|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
124803120|NCT00257608|448911989|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
124803121|NCT00257608|448911990|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
124803122|NCT00257608|448911988|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
124803123|NCT00257608|448911989|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
124633339|NCT04075825|448273230|FG000|Overall Study|Withdrawal by Subject|6|||
124633340|NCT04075825|448273231|FG001|Overall Study|Withdrawal by Subject|8|||
124633341|NCT04075825|448273230|FG000|Overall Study|Physician Decision|3|||
124633342|NCT04075825|448273231|FG001|Overall Study|Physician Decision|1|||
124633343|NCT04075825|448273230|FG000|Overall Study|Lost to Follow-up|5|||
124633344|NCT04075825|448273231|FG001|Overall Study|Lost to Follow-up|1|||
124633345|NCT04075825|448273230|FG000|Overall Study|Participation in New Clinical Trial|1|||
124633346|NCT04075825|448273231|FG001|Overall Study|Participation in New Clinical Trial|1|||
124633347|NCT04075825|448273230|FG000|Overall Study|Reason Not Specified|2|||
124633348|NCT04075825|448273231|FG001|Overall Study|Reason Not Specified|2|||
124633349|NCT02861586|448273232|FG000|Overall Study|Withdrawal by Subject|1|||
124633350|NCT02861586|448273233|FG001|Overall Study|Withdrawal by Subject|2|||
124633351|NCT02861586|448273234|FG002|Overall Study|Withdrawal by Subject|0|||
124633352|NCT02861586|448273235|FG003|Overall Study|Withdrawal by Subject|0|||
124633353|NCT02861586|448273236|FG004|Overall Study|Withdrawal by Subject|0|||
124633354|NCT02861586|448273237|FG005|Overall Study|Withdrawal by Subject|1|||
124633355|NCT02861586|448273238|FG006|Overall Study|Withdrawal by Subject|1|||
124633356|NCT02861586|448273239|FG007|Overall Study|Withdrawal by Subject|0|||
124633357|NCT02861586|448273232|FG000|Overall Study|Lost to Follow-up|3|||
124633358|NCT02861586|448273233|FG001|Overall Study|Lost to Follow-up|1|||
124633359|NCT02861586|448273234|FG002|Overall Study|Lost to Follow-up|1|||
124633360|NCT02861586|448273235|FG003|Overall Study|Lost to Follow-up|0|||
124633361|NCT02861586|448273236|FG004|Overall Study|Lost to Follow-up|0|||
124633362|NCT02861586|448273237|FG005|Overall Study|Lost to Follow-up|3|||
124633363|NCT02861586|448273238|FG006|Overall Study|Lost to Follow-up|0|||
124633364|NCT02861586|448273239|FG007|Overall Study|Lost to Follow-up|0|||
124633365|NCT02861586|448273232|FG000|Overall Study|Adverse Event|0|||
124633366|NCT02861586|448273233|FG001|Overall Study|Adverse Event|0|||
124633367|NCT02861586|448273234|FG002|Overall Study|Adverse Event|0|||
124633368|NCT02861586|448273235|FG003|Overall Study|Adverse Event|0|||
124633369|NCT02861586|448273236|FG004|Overall Study|Adverse Event|0|||
124633370|NCT02861586|448273237|FG005|Overall Study|Adverse Event|1|||
124633371|NCT02861586|448273238|FG006|Overall Study|Adverse Event|0|||
124633372|NCT02861586|448273239|FG007|Overall Study|Adverse Event|0|||
124633373|NCT03985800|448273240|FG000|Overall Study|Death|1|||
124633374|NCT03985800|448273241|FG001|Overall Study|Death|2|||
124633375|NCT03985800|448273240|FG000|Overall Study|Withdrawal by Subject|3|||
124633376|NCT03985800|448273241|FG001|Overall Study|Withdrawal by Subject|6|||
124633377|NCT03985800|448273240|FG000|Overall Study|Protocol Violation|2|||
124633378|NCT03985800|448273241|FG001|Overall Study|Protocol Violation|0|||
124633379|NCT04815083|448273242|FG000|Overall Study|Physician Decision|1|||
124633380|NCT04815083|448273242|FG000|Overall Study|Study pause|2|||
124633381|NCT04815083|448273242|FG000|Overall Study|Screening failure|4|||
124633382|NCT04281485|448273245|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
124633383|NCT04281485|448273246|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
124633384|NCT04281485|448273245|FG000|Overall Study|Ongoing (Safety data collection)|10|||
124803124|NCT00257608|448911990|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
124803125|NCT00257608|448911988|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
124803126|NCT00257608|448911989|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
124803127|NCT00257608|448911990|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
124803128|NCT00257608|448911988|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
124803129|NCT00257608|448911989|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
124803130|NCT00257608|448911990|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
124803131|NCT00257608|448911988|FG000|Chemotherapy Phase|Physician Decision|28|||
124633385|NCT04281485|448273246|FG001|Overall Study|Ongoing (Safety data collection)|5|||
124633386|NCT00957801|448273254|FG000|Overall Study|Withdrawal by Subject|0|||
124633387|NCT00957801|448273255|FG001|Overall Study|Withdrawal by Subject|0|||
124633388|NCT00957801|448273256|FG002|Overall Study|Withdrawal by Subject|0|||
124633389|NCT00957801|448273257|FG003|Overall Study|Withdrawal by Subject|1|||
124633390|NCT01778855|448273258|FG000|Overall Study|Death|0|||
124633391|NCT01778855|448273259|FG001|Overall Study|Death|1|||
124633392|NCT03922308|448273262|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
124633393|NCT03922308|448273263|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
124633394|NCT03922308|448273264|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
124633395|NCT03922308|448273262|FG000|Overall Study|Lost to Follow-up|1|||
124633396|NCT03922308|448273263|FG001|Overall Study|Lost to Follow-up|0|||
124633397|NCT03922308|448273264|FG002|Overall Study|Lost to Follow-up|0|||
124633398|NCT03922308|448273262|FG000|Overall Study|Reason not Specified|0|||
124633399|NCT03922308|448273263|FG001|Overall Study|Reason not Specified|2|||
124803132|NCT00257608|448911989|FG001|Chemotherapy Phase|Physician Decision|0|||
124633400|NCT03922308|448273264|FG002|Overall Study|Reason not Specified|1|||
124633401|NCT00777296|448273267|FG000|Overall Study|Adverse Event|0|||
124633402|NCT00777296|448273268|FG001|Overall Study|Adverse Event|1|||
124633403|NCT00777296|448273269|FG002|Overall Study|Adverse Event|0|||
124633404|NCT00777296|448273270|FG003|Overall Study|Adverse Event|1|||
124633405|NCT00777296|448273267|FG000|Overall Study|Withdrawal by Subject|1|||
124633406|NCT00777296|448273268|FG001|Overall Study|Withdrawal by Subject|0|||
124633407|NCT00777296|448273269|FG002|Overall Study|Withdrawal by Subject|0|||
124633408|NCT00777296|448273270|FG003|Overall Study|Withdrawal by Subject|0|||
124633409|NCT00777296|448273267|FG000|Overall Study|CRF form not completed|0|||
124633410|NCT00777296|448273268|FG001|Overall Study|CRF form not completed|0|||
124633411|NCT00777296|448273269|FG002|Overall Study|CRF form not completed|2|||
124633412|NCT00777296|448273270|FG003|Overall Study|CRF form not completed|0|||
124633413|NCT01139125|448273272|FG000|Overall Study|Withdrawal by Subject|1|||
124633414|NCT02022202|448273274|FG000|Overall Study|Withdrawal by Subject|2|||
124633415|NCT02022202|448273274|FG000|Overall Study|Disease Progression|3|||
124633416|NCT02022202|448273274|FG000|Overall Study|Desire go to immediately to surgery|3|||
124633417|NCT05581641|448273275|FG000|Overall Study|Withdrawal by Subject|0|||
124633418|NCT05581641|448273276|FG001|Overall Study|Withdrawal by Subject|1|||
124633419|NCT05581641|448273277|FG002|Overall Study|Withdrawal by Subject|3|||
124633420|NCT05581641|448273278|FG003|Overall Study|Withdrawal by Subject|1|||
124633421|NCT05581641|448273275|FG000|Overall Study|Lost to Follow-up|0|||
124633422|NCT05581641|448273276|FG001|Overall Study|Lost to Follow-up|1|||
124633423|NCT05581641|448273277|FG002|Overall Study|Lost to Follow-up|0|||
124633424|NCT05581641|448273278|FG003|Overall Study|Lost to Follow-up|1|||
124633425|NCT05581641|448273275|FG000|Overall Study|Protocol Violation|1|||
124633426|NCT05581641|448273276|FG001|Overall Study|Protocol Violation|0|||
124633427|NCT05581641|448273277|FG002|Overall Study|Protocol Violation|0|||
124633428|NCT05581641|448273278|FG003|Overall Study|Protocol Violation|0|||
124633429|NCT05581641|448273275|FG000|Overall Study|Other|1|||
124633430|NCT05581641|448273276|FG001|Overall Study|Other|0|||
124633431|NCT05581641|448273277|FG002|Overall Study|Other|2|||
124633432|NCT05581641|448273278|FG003|Overall Study|Other|1|||
124633433|NCT01383174|448273279|FG000|3 Month Assessment|Death|0|||
124633434|NCT01383174|448273280|FG001|3 Month Assessment|Death|1|||
124633435|NCT01383174|448273279|FG000|3 Month Assessment|Lost to Follow-up|2|||
124803133|NCT00257608|448911990|FG002|Chemotherapy Phase|Physician Decision|0|||
124803134|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Adverse Event|0|||
124803135|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Adverse Event|34|||
124803136|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Adverse Event|38|||
124803137|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Disease progression|0|||
124803138|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Disease progression|204|||
124803139|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Disease progression|168|||
124803140|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
124633436|NCT01383174|448273280|FG001|3 Month Assessment|Lost to Follow-up|0|||
124633437|NCT01383174|448273279|FG000|3 Month Assessment|Refused to complete|4|||
124633438|NCT01383174|448273280|FG001|3 Month Assessment|Refused to complete|0|||
124633439|NCT01383174|448273279|FG000|6 Month Assessment|Lost to Follow-up|1|||
124803141|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
124803142|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
124803143|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
124803144|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
124803145|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
124803146|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
124803147|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
124803148|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
124803149|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
124803150|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
124803151|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
124803152|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
124633440|NCT01383174|448273280|FG001|6 Month Assessment|Lost to Follow-up|1|||
124633441|NCT01383174|448273279|FG000|6 Month Assessment|Refused to complete|4|||
124633442|NCT01383174|448273280|FG001|6 Month Assessment|Refused to complete|0|||
124803153|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
124803154|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
124633443|NCT02166333|448273283|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
124633444|NCT02166333|448273284|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
124633445|NCT02166333|448273285|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
124633446|NCT02166333|448273286|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
124633447|NCT02166333|448273287|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
124633448|NCT02166333|448273288|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
124633449|NCT02166333|448273283|FG000|Stage 1|Death|4|||
124633450|NCT02166333|448273284|FG001|Stage 1|Death|0|||
124633451|NCT02166333|448273285|FG002|Stage 1|Death|2|||
124633452|NCT02166333|448273286|FG003|Stage 1|Death|0|||
124633453|NCT02166333|448273287|FG004|Stage 1|Death|3|||
124633454|NCT02166333|448273288|FG005|Stage 1|Death|2|||
124633455|NCT02166333|448273283|FG000|Stage 1|Lost to Follow-up|12|||
124633456|NCT02166333|448273284|FG001|Stage 1|Lost to Follow-up|0|||
124633457|NCT02166333|448273285|FG002|Stage 1|Lost to Follow-up|6|||
124633458|NCT02166333|448273286|FG003|Stage 1|Lost to Follow-up|0|||
124633459|NCT02166333|448273287|FG004|Stage 1|Lost to Follow-up|3|||
124633460|NCT02166333|448273288|FG005|Stage 1|Lost to Follow-up|3|||
124633461|NCT02166333|448273283|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
124633462|NCT02166333|448273284|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
124633463|NCT02166333|448273285|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
124633464|NCT02166333|448273286|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
124633465|NCT02166333|448273287|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
124633466|NCT02166333|448273288|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
124633467|NCT02166333|448273283|FG000|Stage 2|Death|4|||
124633468|NCT02166333|448273284|FG001|Stage 2|Death|2|||
124633469|NCT02166333|448273285|FG002|Stage 2|Death|1|||
124633470|NCT02166333|448273286|FG003|Stage 2|Death|0|||
124633471|NCT02166333|448273287|FG004|Stage 2|Death|0|||
124633472|NCT02166333|448273288|FG005|Stage 2|Death|1|||
124633473|NCT02166333|448273283|FG000|Stage 2|Lost to Follow-up|23|||
124633474|NCT02166333|448273284|FG001|Stage 2|Lost to Follow-up|4|||
124633475|NCT02166333|448273285|FG002|Stage 2|Lost to Follow-up|11|||
124633476|NCT02166333|448273286|FG003|Stage 2|Lost to Follow-up|9|||
124633477|NCT02166333|448273287|FG004|Stage 2|Lost to Follow-up|3|||
124633478|NCT02166333|448273288|FG005|Stage 2|Lost to Follow-up|6|||
124633479|NCT00682786|448273293|FG000|Overall Study|Withdrawal by Subject|2|||
124633480|NCT00682786|448273294|FG001|Overall Study|Withdrawal by Subject|2|||
124633481|NCT00682786|448273293|FG000|Overall Study|Did not receive irinotecan|0|||
124633482|NCT00682786|448273294|FG001|Overall Study|Did not receive irinotecan|1|||
124633483|NCT00359424|448273295|FG000|Overall Study|Death|99|||
124633484|NCT00359424|448273296|FG001|Overall Study|Death|58|||
124633485|NCT00359424|448273295|FG000|Overall Study|Lost to Follow-up|19|||
124633486|NCT00359424|448273296|FG001|Overall Study|Lost to Follow-up|7|||
124633487|NCT00359424|448273295|FG000|Overall Study|Withdrawal by Subject|10|||
124633488|NCT00359424|448273296|FG001|Overall Study|Withdrawal by Subject|2|||
124633489|NCT00359424|448273295|FG000|Overall Study|follow up not conducted|2|||
124633490|NCT00359424|448273296|FG001|Overall Study|follow up not conducted|0|||
124633491|NCT02462603|448273299|FG000|Overall Study|Investigator Decision|1|||
124633492|NCT02462603|448273299|FG000|Overall Study|Non-Compliance|1|||
124633493|NCT02462603|448273299|FG000|Overall Study|Withdrawal by Subject|2|||
124633494|NCT01991743|448273303|FG000|Overall Study|external cephalic version not performed|0|||
124633495|NCT01991743|448273304|FG001|Overall Study|external cephalic version not performed|0|||
124633496|NCT01991743|448273305|FG002|Overall Study|external cephalic version not performed|1|||
124633497|NCT01991743|448273306|FG003|Overall Study|external cephalic version not performed|0|||
124633498|NCT01167140|448273307|FG000|Overall Study|Withdrawal by Subject|1|||
124633499|NCT03805412|448273308|FG000|Overall Study|Lost to Follow-up|0|||
124633500|NCT03805412|448273309|FG001|Overall Study|Lost to Follow-up|1|||
124633501|NCT04390113|448273310|FG000|Overall Study|Not Treated|0|||
124633502|NCT04390113|448273311|FG001|Overall Study|Not Treated|1|||
124633503|NCT04390113|448273310|FG000|Overall Study|Adverse Event|1|||
124633504|NCT04390113|448273311|FG001|Overall Study|Adverse Event|0|||
124633505|NCT04390113|448273310|FG000|Overall Study|Death|2|||
124633506|NCT04390113|448273311|FG001|Overall Study|Death|1|||
124633507|NCT04390113|448273310|FG000|Overall Study|Physician Decision|1|||
124633508|NCT04390113|448273311|FG001|Overall Study|Physician Decision|3|||
124633509|NCT04390113|448273310|FG000|Overall Study|Study Terminated by Sponsor|5|||
124633510|NCT04390113|448273311|FG001|Overall Study|Study Terminated by Sponsor|3|||
124803155|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Physician Decision|0|||
124803156|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Physician Decision|8|||
124803157|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Physician Decision|11|||
124803158|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
124803159|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
124803160|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
124803161|NCT00257608|448911988|FG000|Post Chemotherapy Phase|Not treated|0|||
124633511|NCT04390113|448273310|FG000|Overall Study|Withdrawal by Subject|10|||
124633512|NCT04390113|448273311|FG001|Overall Study|Withdrawal by Subject|5|||
124633513|NCT04390113|448273310|FG000|Overall Study|Other|1|||
124633514|NCT04390113|448273311|FG001|Overall Study|Other|0|||
124633515|NCT04390113|448273310|FG000|Overall Study|Missing|0|||
124633516|NCT04390113|448273311|FG001|Overall Study|Missing|1|||
124633517|NCT01806051|448273317|FG000|Overall Study|Withdrawal by Subject|6|||
124633518|NCT02208362|448273318|FG000|Overall Study|Participant did not complete treatment|0|||
124633519|NCT02208362|448273319|FG001|Overall Study|Participant did not complete treatment|1|||
124633520|NCT02208362|448273320|FG002|Overall Study|Participant did not complete treatment|0|||
124633521|NCT02208362|448273321|FG003|Overall Study|Participant did not complete treatment|0|||
124633522|NCT02208362|448273322|FG004|Overall Study|Participant did not complete treatment|0|||
124633523|NCT02208362|448273323|FG005|Overall Study|Participant did not complete treatment|0|||
124633524|NCT02208362|448273324|FG006|Overall Study|Participant did not complete treatment|1|||
124633525|NCT02208362|448273325|FG007|Overall Study|Participant did not complete treatment|1|||
124633526|NCT02208362|448273326|FG008|Overall Study|Participant did not complete treatment|2|||
124633527|NCT02208362|448273327|FG009|Overall Study|Participant did not complete treatment|0|||
124633528|NCT02208362|448273328|FG010|Overall Study|Participant did not complete treatment|1|||
124633529|NCT02208362|448273329|FG011|Overall Study|Participant did not complete treatment|0|||
124633530|NCT02208362|448273318|FG000|Overall Study|Participant received disallowed treatment|0|||
124633531|NCT02208362|448273319|FG001|Overall Study|Participant received disallowed treatment|0|||
124633532|NCT02208362|448273320|FG002|Overall Study|Participant received disallowed treatment|0|||
124633533|NCT02208362|448273321|FG003|Overall Study|Participant received disallowed treatment|0|||
124633534|NCT02208362|448273322|FG004|Overall Study|Participant received disallowed treatment|0|||
124633535|NCT02208362|448273323|FG005|Overall Study|Participant received disallowed treatment|0|||
124633536|NCT02208362|448273324|FG006|Overall Study|Participant received disallowed treatment|0|||
124633537|NCT02208362|448273325|FG007|Overall Study|Participant received disallowed treatment|0|||
124633538|NCT02208362|448273326|FG008|Overall Study|Participant received disallowed treatment|1|||
124633539|NCT02208362|448273327|FG009|Overall Study|Participant received disallowed treatment|0|||
124633540|NCT02208362|448273328|FG010|Overall Study|Participant received disallowed treatment|0|||
124633541|NCT02208362|448273329|FG011|Overall Study|Participant received disallowed treatment|0|||
124633542|NCT03817190|448273330|FG000|Overall Study|Early Termination|13|||
124633543|NCT03817190|448273331|FG001|Overall Study|Early Termination|20|||
124633544|NCT03817190|448273330|FG000|Overall Study|Adverse Event|10|||
124633545|NCT03817190|448273331|FG001|Overall Study|Adverse Event|17|||
124633546|NCT03817190|448273330|FG000|Overall Study|Withdrawal by Subject|12|||
124633547|NCT03817190|448273331|FG001|Overall Study|Withdrawal by Subject|8|||
124803162|NCT00257608|448911989|FG001|Post Chemotherapy Phase|Not treated|4|||
124803163|NCT00257608|448911990|FG002|Post Chemotherapy Phase|Not treated|7|||
124803164|NCT02171065|448911991|FG000|Overall Study|Withdrawal by Subject|1|||
124633548|NCT03817190|448273330|FG000|Overall Study|Lost to Follow-up|11|||
124633549|NCT03817190|448273331|FG001|Overall Study|Lost to Follow-up|7|||
124633550|NCT03817190|448273330|FG000|Overall Study|Lack of Efficacy|7|||
124633551|NCT03817190|448273331|FG001|Overall Study|Lack of Efficacy|5|||
124633552|NCT03817190|448273330|FG000|Overall Study|Investigator Decision|5|||
124633553|NCT03817190|448273331|FG001|Overall Study|Investigator Decision|1|||
124633554|NCT03817190|448273330|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
124633555|NCT03817190|448273331|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
124633556|NCT03817190|448273330|FG000|Overall Study|Lack of Contact|1|||
124633557|NCT03817190|448273331|FG001|Overall Study|Lack of Contact|0|||
124803165|NCT02171065|448911992|FG001|Overall Study|Withdrawal by Subject|0|||
124803166|NCT02171065|448911993|FG002|Overall Study|Withdrawal by Subject|0|||
124803167|NCT02171065|448911991|FG000|Overall Study|Lost to Follow-up|0|||
124803168|NCT02171065|448911992|FG001|Overall Study|Lost to Follow-up|0|||
124803169|NCT02171065|448911993|FG002|Overall Study|Lost to Follow-up|1|||
124803170|NCT01854658|448911996|FG000|Overall Study|Protocol Violation|6|||
124633558|NCT03817190|448273330|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
124633559|NCT03817190|448273331|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
124633560|NCT03525678|448273332|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
124633561|NCT03525678|448273333|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
124633562|NCT03525678|448273334|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
124633563|NCT03525678|448273335|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
124633564|NCT03525678|448273336|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
124633565|NCT03525678|448273332|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
124633566|NCT03525678|448273333|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
124633567|NCT03525678|448273334|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
124633568|NCT03525678|448273335|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
124633569|NCT03525678|448273336|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
124633570|NCT03525678|448273332|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
124633571|NCT03525678|448273333|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
124633572|NCT03525678|448273334|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
124633573|NCT03525678|448273335|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
124633574|NCT03525678|448273336|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
124633575|NCT03525678|448273332|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
124633576|NCT03525678|448273333|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
124633577|NCT03525678|448273334|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
124633578|NCT03525678|448273335|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
124803171|NCT01854658|448911997|FG001|Overall Study|Protocol Violation|2|||
124803172|NCT01854658|448911998|FG002|Overall Study|Protocol Violation|2|||
124803173|NCT01854658|448911999|FG003|Overall Study|Protocol Violation|1|||
124633579|NCT03525678|448273336|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
124633580|NCT03525678|448273332|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
124633581|NCT03525678|448273333|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
124633582|NCT03525678|448273334|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
124633583|NCT03525678|448273335|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
124633584|NCT03525678|448273336|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
124633585|NCT03525678|448273332|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
124633586|NCT03525678|448273333|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
124633587|NCT03525678|448273334|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
124633588|NCT03525678|448273335|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
124633589|NCT03525678|448273336|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
124633590|NCT00917852|448274686|FG000|Overall Study|Death|6|||
124633591|NCT00471081|448274687|FG000|Active Phase|Protocol Violation|1|||
124633592|NCT00471081|448274688|FG001|Active Phase|Protocol Violation|1|||
124633593|NCT00471081|448274687|FG000|Active Phase|Withdrawal by Subject|0|||
124633594|NCT00471081|448274688|FG001|Active Phase|Withdrawal by Subject|3|||
124633595|NCT00471081|448274687|FG000|Active Phase|Lost to Follow-up|0|||
124633596|NCT00471081|448274688|FG001|Active Phase|Lost to Follow-up|1|||
124633597|NCT00471081|448274687|FG000|Active Phase|Lost health plan/insurance|1|||
124633598|NCT00471081|448274688|FG001|Active Phase|Lost health plan/insurance|8|||
124633599|NCT00471081|448274687|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
124633600|NCT00471081|448274688|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
124633601|NCT00471081|448274687|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
124633602|NCT00471081|448274688|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
124633603|NCT00471081|448274687|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
124633604|NCT00471081|448274688|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
124633605|NCT02844933|448274689|FG000|Overall Study|Discontinued due to premature termination of study|3|||
124633606|NCT02844933|448274690|FG001|Overall Study|Discontinued due to premature termination of study|2|||
124633607|NCT02393950|448274692|FG000|Overall Study|Adverse Event|1|||
124633608|NCT02393950|448274693|FG001|Overall Study|Adverse Event|0|||
124633609|NCT02393950|448274692|FG000|Overall Study|Withdrawal by Subject|0|||
124633610|NCT02393950|448274693|FG001|Overall Study|Withdrawal by Subject|1|||
124633611|NCT04335123|448274694|FG000|Overall Study|Withdrawal by Subject|2|||
124633612|NCT04335123|448274695|FG001|Overall Study|Withdrawal by Subject|0|||
124633613|NCT04335123|448274694|FG000|Overall Study|Physician Decision|2|||
124633614|NCT04335123|448274695|FG001|Overall Study|Physician Decision|0|||
124633615|NCT04537078|448274698|FG000|Overall Study|Protocol Violation|3|||
124633616|NCT04537078|448274699|FG001|Overall Study|Protocol Violation|2|||
124633617|NCT04537078|448274698|FG000|Overall Study|Lost to Follow-up|1|||
124633618|NCT04537078|448274699|FG001|Overall Study|Lost to Follow-up|0|||
124633619|NCT04537078|448274698|FG000|Overall Study|Withdrawal by Subject|0|||
124633620|NCT04537078|448274699|FG001|Overall Study|Withdrawal by Subject|1|||
124633621|NCT01293695|448274700|FG000|Overall Study|Withdrawal by Subject|7|||
124633622|NCT01293695|448274701|FG001|Overall Study|Withdrawal by Subject|1|||
124633623|NCT01293695|448274700|FG000|Overall Study|Lost to Follow-up|8|||
124633624|NCT01293695|448274701|FG001|Overall Study|Lost to Follow-up|6|||
124633625|NCT02626026|448274702|FG000|Overall Study|Randomized but Never Treated|0|||
124633626|NCT02626026|448274703|FG001|Overall Study|Randomized but Never Treated|0|||
124633627|NCT02626026|448274704|FG002|Overall Study|Randomized but Never Treated|0|||
124633628|NCT02626026|448274705|FG003|Overall Study|Randomized but Never Treated|0|||
124633629|NCT02626026|448274706|FG004|Overall Study|Randomized but Never Treated|1|||
124633630|NCT02626026|448274707|FG005|Overall Study|Randomized but Never Treated|0|||
124633631|NCT00191477|448274709|FG000|Overall Study|Tumor Recurrence|49|||
124633632|NCT00191477|448274710|FG001|Overall Study|Tumor Recurrence|48|||
124633633|NCT00191477|448274709|FG000|Overall Study|Death, Study Disease|1|||
124633634|NCT00191477|448274710|FG001|Overall Study|Death, Study Disease|1|||
124633635|NCT00191477|448274709|FG000|Overall Study|Death, Other Cause|3|||
124633636|NCT00191477|448274710|FG001|Overall Study|Death, Other Cause|6|||
124633637|NCT00191477|448274709|FG000|Overall Study|Lost to Follow-up|23|||
124803174|NCT01854658|448911996|FG000|Overall Study|Physician Decision|7|||
124803175|NCT01854658|448911997|FG001|Overall Study|Physician Decision|5|||
124803176|NCT01854658|448911998|FG002|Overall Study|Physician Decision|2|||
124633638|NCT00191477|448274710|FG001|Overall Study|Lost to Follow-up|21|||
124633639|NCT00191477|448274709|FG000|Overall Study|Protocol Violation|1|||
124633640|NCT00191477|448274710|FG001|Overall Study|Protocol Violation|1|||
124633641|NCT00191477|448274709|FG000|Overall Study|Treatment Change|2|||
124633642|NCT00191477|448274710|FG001|Overall Study|Treatment Change|0|||
124633643|NCT00191477|448274709|FG000|Overall Study|Withdrawal by Subject|2|||
124633644|NCT00191477|448274710|FG001|Overall Study|Withdrawal by Subject|0|||
124633645|NCT00191477|448274709|FG000|Overall Study|Other|2|||
124633646|NCT00191477|448274710|FG001|Overall Study|Other|0|||
124633647|NCT00191477|448274709|FG000|Overall Study|Not Eligible|41|||
124803177|NCT01854658|448911999|FG003|Overall Study|Physician Decision|4|||
124633648|NCT00191477|448274710|FG001|Overall Study|Not Eligible|38|||
124633649|NCT00191477|448274709|FG000|Overall Study|Pathological Specimen Lost|1|||
124633650|NCT00191477|448274710|FG001|Overall Study|Pathological Specimen Lost|0|||
124633651|NCT00191477|448274709|FG000|Overall Study|Discontinued Prior to Instillation|13|||
124633652|NCT00191477|448274710|FG001|Overall Study|Discontinued Prior to Instillation|14|||
124633653|NCT01697748|448274715|FG000|Overall Study|ineligible skin incision|1|||
124633654|NCT01697748|448274716|FG001|Overall Study|ineligible skin incision|2|||
124633655|NCT01697748|448274715|FG000|Overall Study|ineligible uterine incision|4|||
124633656|NCT01697748|448274716|FG001|Overall Study|ineligible uterine incision|1|||
124633657|NCT01697748|448274715|FG000|Overall Study|Lost to Follow-up|53|||
124633658|NCT01697748|448274716|FG001|Overall Study|Lost to Follow-up|65|||
124633659|NCT01704495|448274717|FG000|Subjects Randomized|Other Reason|3|||
124633660|NCT01704495|448274718|FG001|Subjects Randomized|Other Reason|2|||
124633661|NCT01704495|448274719|FG002|Subjects Randomized|Other Reason|3|||
124633662|NCT01704495|448274720|FG003|Subjects Randomized|Other Reason|2|||
124633663|NCT01704495|448274717|FG000|Subjects Randomized|Discontinuation criteria met|4|||
124633664|NCT01704495|448274718|FG001|Subjects Randomized|Discontinuation criteria met|2|||
124633665|NCT01704495|448274719|FG002|Subjects Randomized|Discontinuation criteria met|2|||
124633666|NCT01704495|448274720|FG003|Subjects Randomized|Discontinuation criteria met|0|||
124633667|NCT01704495|448274717|FG000|Subjects Randomized|Adverse Event|8|||
124633668|NCT01704495|448274718|FG001|Subjects Randomized|Adverse Event|2|||
124633669|NCT01704495|448274719|FG002|Subjects Randomized|Adverse Event|0|||
124633670|NCT01704495|448274720|FG003|Subjects Randomized|Adverse Event|7|||
124633671|NCT01704495|448274717|FG000|Subjects Randomized|Withdrawal by Subject|5|||
124633672|NCT01704495|448274718|FG001|Subjects Randomized|Withdrawal by Subject|5|||
124633673|NCT01704495|448274719|FG002|Subjects Randomized|Withdrawal by Subject|5|||
124633674|NCT01704495|448274720|FG003|Subjects Randomized|Withdrawal by Subject|5|||
124633675|NCT01704495|448274717|FG000|Subjects Randomized|Protocol Violation|1|||
124633676|NCT01704495|448274718|FG001|Subjects Randomized|Protocol Violation|1|||
124633677|NCT01704495|448274719|FG002|Subjects Randomized|Protocol Violation|2|||
124633678|NCT01704495|448274720|FG003|Subjects Randomized|Protocol Violation|0|||
124633679|NCT01704495|448274717|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
124633680|NCT01704495|448274718|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
124633681|NCT01704495|448274719|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
124633682|NCT01704495|448274720|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
124633683|NCT01704495|448274717|FG000|Optional Safety Extension|Adverse Event|0|||
124633684|NCT01704495|448274718|FG001|Optional Safety Extension|Adverse Event|4|||
124633685|NCT01704495|448274719|FG002|Optional Safety Extension|Adverse Event|0|||
124633686|NCT01704495|448274720|FG003|Optional Safety Extension|Adverse Event|1|||
124633687|NCT01704495|448274717|FG000|Optional Safety Extension|Other reason|27|||
124633688|NCT01704495|448274718|FG001|Optional Safety Extension|Other reason|29|||
124633689|NCT01704495|448274719|FG002|Optional Safety Extension|Other reason|30|||
124633690|NCT01704495|448274720|FG003|Optional Safety Extension|Other reason|28|||
124633691|NCT01704495|448274717|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
124633692|NCT01704495|448274718|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
124633693|NCT01704495|448274719|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
124633694|NCT01704495|448274720|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
124633695|NCT00997373|448274725|FG000|Overall Study|Withdrawal by Subject|5|||
124633696|NCT00997373|448274726|FG001|Overall Study|Withdrawal by Subject|0|||
124633697|NCT00997373|448274725|FG000|Overall Study|wrong tumor type|4|||
124633698|NCT00997373|448274726|FG001|Overall Study|wrong tumor type|0|||
124633699|NCT00997373|448274725|FG000|Overall Study|could not have hysterectomy|6|||
124633700|NCT00997373|448274726|FG001|Overall Study|could not have hysterectomy|0|||
124633701|NCT03376789|448274730|FG000|Overall Study|Withdrawal by Subject|3|||
124633702|NCT03376789|448274731|FG001|Overall Study|Withdrawal by Subject|5|||
124633703|NCT03376789|448274730|FG000|Overall Study|Protocol Violation|0|||
124633704|NCT03376789|448274731|FG001|Overall Study|Protocol Violation|1|||
124633705|NCT03376789|448274730|FG000|Overall Study|Adverse Event|0|||
124633706|NCT03376789|448274731|FG001|Overall Study|Adverse Event|1|||
124633707|NCT03376789|448274730|FG000|Overall Study|Lost to Follow-up|1|||
124633708|NCT03376789|448274731|FG001|Overall Study|Lost to Follow-up|1|||
124633709|NCT03376789|448274730|FG000|Overall Study|Per sponsor due to noncompliance|1|||
124633710|NCT03376789|448274731|FG001|Overall Study|Per sponsor due to noncompliance|0|||
124633711|NCT03376789|448274730|FG000|Overall Study|Subject off study medication|0|||
124633712|NCT03376789|448274731|FG001|Overall Study|Subject off study medication|1|||
124633713|NCT04177095|448274732|FG000|Overall Study|Withdrawal by Subject|3|||
124633714|NCT04177095|448274732|FG000|Overall Study|Screen Failure|3|||
124633715|NCT04177095|448274732|FG000|Overall Study|Problems with the Trugraf assay|1|||
124633716|NCT03876743|448274735|FG000|Overall Study|Lost to Follow-up|6|||
124633717|NCT03876743|448274736|FG001|Overall Study|Lost to Follow-up|4|||
124633718|NCT03876743|448274737|FG002|Overall Study|Lost to Follow-up|4|||
124633719|NCT03876743|448274738|FG003|Overall Study|Lost to Follow-up|7|||
124633720|NCT03889418|448274739|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
124633721|NCT03889418|448274740|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
124633722|NCT03889418|448274741|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
124633723|NCT03889418|448274742|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
124633724|NCT03889418|448274743|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
124633725|NCT03889418|448274744|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
124633726|NCT03889418|448274745|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
124633727|NCT03889418|448274746|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
124633728|NCT03889418|448274747|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
124633729|NCT03889418|448274748|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
124633730|NCT03889418|448274739|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
124633731|NCT03889418|448274740|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
124633732|NCT03889418|448274741|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
124633733|NCT03889418|448274742|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
124633734|NCT03889418|448274743|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
124633735|NCT03889418|448274744|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
124633736|NCT03889418|448274745|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
124633737|NCT03889418|448274746|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
124633738|NCT03889418|448274747|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
124633739|NCT03889418|448274748|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
124633740|NCT03889418|448274739|FG000|October-December 2019 (Month 7-9)|Death|0|||
124633741|NCT03889418|448274740|FG001|October-December 2019 (Month 7-9)|Death|0|||
124633742|NCT03889418|448274741|FG002|October-December 2019 (Month 7-9)|Death|0|||
124633743|NCT03889418|448274742|FG003|October-December 2019 (Month 7-9)|Death|0|||
124633744|NCT03889418|448274743|FG004|October-December 2019 (Month 7-9)|Death|0|||
124633745|NCT03889418|448274744|FG005|October-December 2019 (Month 7-9)|Death|0|||
124633746|NCT03889418|448274745|FG006|October-December 2019 (Month 7-9)|Death|0|||
124633747|NCT03889418|448274746|FG007|October-December 2019 (Month 7-9)|Death|0|||
124633748|NCT03889418|448274747|FG008|October-December 2019 (Month 7-9)|Death|1|||
124633749|NCT03889418|448274748|FG009|October-December 2019 (Month 7-9)|Death|0|||
124633750|NCT03889418|448274739|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
124633751|NCT03889418|448274740|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
124633752|NCT03889418|448274741|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
124633753|NCT03889418|448274742|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
124633754|NCT03889418|448274743|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
124633755|NCT03889418|448274744|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
124633756|NCT03889418|448274745|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
124633757|NCT03889418|448274746|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
124633758|NCT03889418|448274747|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
124633759|NCT03889418|448274748|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
124633760|NCT03889418|448274739|FG000|April - June 2020 (Month 13-15)|Death|0|||
124633761|NCT03889418|448274740|FG001|April - June 2020 (Month 13-15)|Death|1|||
124633762|NCT03889418|448274741|FG002|April - June 2020 (Month 13-15)|Death|0|||
124633763|NCT03889418|448274742|FG003|April - June 2020 (Month 13-15)|Death|0|||
124633764|NCT03889418|448274743|FG004|April - June 2020 (Month 13-15)|Death|0|||
124633765|NCT03889418|448274744|FG005|April - June 2020 (Month 13-15)|Death|0|||
124633766|NCT03889418|448274745|FG006|April - June 2020 (Month 13-15)|Death|0|||
124633767|NCT03889418|448274746|FG007|April - June 2020 (Month 13-15)|Death|0|||
124633768|NCT03889418|448274747|FG008|April - June 2020 (Month 13-15)|Death|0|||
124633769|NCT03889418|448274748|FG009|April - June 2020 (Month 13-15)|Death|0|||
124633770|NCT03889418|448274739|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
124633771|NCT03889418|448274740|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
124633772|NCT03889418|448274741|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
124633773|NCT03889418|448274742|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
124633774|NCT03889418|448274743|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
124633775|NCT03889418|448274744|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
124633776|NCT03889418|448274745|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
124633777|NCT03889418|448274746|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
124633778|NCT03889418|448274747|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
124633779|NCT03889418|448274748|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
124633780|NCT03889418|448274739|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
124633781|NCT03889418|448274740|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
124633782|NCT03889418|448274741|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
124633783|NCT03889418|448274742|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
124633784|NCT03889418|448274743|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
124633785|NCT03889418|448274744|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
124633786|NCT03889418|448274745|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
124633787|NCT03889418|448274746|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
124633788|NCT03889418|448274747|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
124633789|NCT03889418|448274748|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
124633790|NCT03889418|448274739|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
124633791|NCT03889418|448274740|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
124633792|NCT03889418|448274741|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
124803178|NCT01854658|448911996|FG000|Overall Study|Lost to Follow-up|8|||
124633793|NCT03889418|448274742|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
124633794|NCT03889418|448274743|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
124633795|NCT03889418|448274744|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
124633796|NCT03889418|448274745|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
124633797|NCT03889418|448274746|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
124633798|NCT03889418|448274747|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
124633799|NCT03889418|448274748|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
124633800|NCT00092118|448274749|FG000|Overall Study|Adverse Event|35|||
124633801|NCT00092118|448274750|FG001|Overall Study|Adverse Event|32|||
124633802|NCT00092118|448274749|FG000|Overall Study|Lack of Efficacy|12|||
124633803|NCT00092118|448274750|FG001|Overall Study|Lack of Efficacy|14|||
124633804|NCT00092118|448274749|FG000|Overall Study|Lost to Follow-up|4|||
124633805|NCT00092118|448274750|FG001|Overall Study|Lost to Follow-up|3|||
124633806|NCT00092118|448274749|FG000|Overall Study|Protocol Violation|23|||
124633807|NCT00092118|448274750|FG001|Overall Study|Protocol Violation|25|||
124633808|NCT00092118|448274749|FG000|Overall Study|Withdrawal by Subject|4|||
124633809|NCT00092118|448274750|FG001|Overall Study|Withdrawal by Subject|10|||
124633810|NCT00092118|448274749|FG000|Overall Study|Other|6|||
124633811|NCT00092118|448274750|FG001|Overall Study|Other|5|||
124633812|NCT03751098|448274751|FG000|Overall Study|Withdrawal by Subject|0|||
124633813|NCT03751098|448274752|FG001|Overall Study|Withdrawal by Subject|1|||
124633814|NCT01213966|448274755|FG000|Overall Study|Protocol Violation|1|||
124633815|NCT01213966|448274756|FG001|Overall Study|Protocol Violation|0|||
124633816|NCT01213966|448274757|FG002|Overall Study|Protocol Violation|3|||
124633817|NCT01213966|448274758|FG003|Overall Study|Protocol Violation|1|||
124633818|NCT03644342|448274759|FG000|Overall Study|Adverse Event|2|||
124633819|NCT03644342|448274760|FG001|Overall Study|Adverse Event|0|||
124633820|NCT03644342|448274759|FG000|Overall Study|Protocol Violation|0|||
124633821|NCT03644342|448274760|FG001|Overall Study|Protocol Violation|1|||
124633822|NCT01591096|448274765|FG000|Overall Study|Adverse Event|1|||
124633823|NCT01831635|448274766|FG000|Overall Study|Withdrawal by Subject|0|||
124633824|NCT01831635|448274767|FG001|Overall Study|Withdrawal by Subject|2|||
124633825|NCT01831635|448274768|FG002|Overall Study|Withdrawal by Subject|0|||
124633826|NCT03655405|448274769|FG000|Overall Study|Death after initial data collection|4|||
124633827|NCT03655405|448274770|FG001|Overall Study|Death after initial data collection|2|||
124633828|NCT03655405|448274769|FG000|Overall Study|Died before initial data collection|1|||
124633829|NCT03655405|448274770|FG001|Overall Study|Died before initial data collection|2|||
124633830|NCT03655405|448274769|FG000|Overall Study|Protocol Violation|0|||
124633831|NCT03655405|448274770|FG001|Overall Study|Protocol Violation|1|||
124633832|NCT02859337|448274773|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
124633833|NCT02859337|448274774|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
124633834|NCT02859337|448274775|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
124633835|NCT02859337|448274773|FG000|Overall Study|Withdrawal by Subject|3|||
124633836|NCT02859337|448274774|FG001|Overall Study|Withdrawal by Subject|1|||
124633837|NCT02859337|448274775|FG002|Overall Study|Withdrawal by Subject|0|||
124633838|NCT02859337|448274773|FG000|Overall Study|Lost to Follow-up|1|||
124633839|NCT02859337|448274774|FG001|Overall Study|Lost to Follow-up|0|||
124633840|NCT02859337|448274775|FG002|Overall Study|Lost to Follow-up|0|||
124633841|NCT01445730|448274776|FG000|Overall Study|Adverse Event|1|||
124633842|NCT01445730|448274776|FG000|Overall Study|For the advice of a dentist|1|||
124633843|NCT01445730|448274776|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
124633844|NCT00030901|448274781|FG000|Initial Registration|Ineligible|167|||
124633845|NCT00030901|448274782|FG001|Initial Registration|Ineligible|0|||
124633846|NCT00030901|448274783|FG002|Initial Registration|Ineligible|0|||
124633847|NCT00030901|448274781|FG000|Randomization|Adverse Event|0|||
124633848|NCT00030901|448274782|FG001|Randomization|Adverse Event|11|||
124633849|NCT00030901|448274783|FG002|Randomization|Adverse Event|7|||
124633850|NCT00030901|448274781|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
124803179|NCT01854658|448911997|FG001|Overall Study|Lost to Follow-up|9|||
124803180|NCT01854658|448911998|FG002|Overall Study|Lost to Follow-up|8|||
124803181|NCT01854658|448911999|FG003|Overall Study|Lost to Follow-up|4|||
124633851|NCT00030901|448274782|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
124633852|NCT00030901|448274783|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
124633853|NCT00030901|448274781|FG000|Randomization|Progression/Relapse|0|||
124633854|NCT00030901|448274782|FG001|Randomization|Progression/Relapse|22|||
124633855|NCT00030901|448274783|FG002|Randomization|Progression/Relapse|21|||
124633856|NCT00030901|448274781|FG000|Randomization|Death|0|||
124633857|NCT00030901|448274782|FG001|Randomization|Death|1|||
124633858|NCT00030901|448274783|FG002|Randomization|Death|3|||
124633859|NCT00030901|448274781|FG000|Randomization|Other|0|||
124633860|NCT00030901|448274782|FG001|Randomization|Other|36|||
124633861|NCT00030901|448274783|FG002|Randomization|Other|33|||
124633862|NCT00030901|448274781|FG000|Randomization|Ineligible|0|||
124803182|NCT01854658|448911996|FG000|Overall Study|Withdrawal by Subject|28|||
124633863|NCT00030901|448274782|FG001|Randomization|Ineligible|15|||
124633864|NCT00030901|448274783|FG002|Randomization|Ineligible|14|||
124633865|NCT02576847|448274786|FG000|Overall Study|Adverse Event|27|||
124803183|NCT01854658|448911997|FG001|Overall Study|Withdrawal by Subject|21|||
124803184|NCT01854658|448911998|FG002|Overall Study|Withdrawal by Subject|29|||
124803185|NCT01854658|448911999|FG003|Overall Study|Withdrawal by Subject|15|||
124803186|NCT01854658|448911996|FG000|Overall Study|Protocol-specified criteria|15|||
124803187|NCT01854658|448911997|FG001|Overall Study|Protocol-specified criteria|15|||
124803188|NCT01854658|448911998|FG002|Overall Study|Protocol-specified criteria|10|||
124803189|NCT01854658|448911999|FG003|Overall Study|Protocol-specified criteria|7|||
124803190|NCT01854658|448911996|FG000|Overall Study|Lack of Efficacy|3|||
124803191|NCT01854658|448911997|FG001|Overall Study|Lack of Efficacy|8|||
124803192|NCT01854658|448911998|FG002|Overall Study|Lack of Efficacy|4|||
124803193|NCT01854658|448911999|FG003|Overall Study|Lack of Efficacy|7|||
124803194|NCT01854658|448911996|FG000|Overall Study|Adverse Event|21|||
124803195|NCT01854658|448911997|FG001|Overall Study|Adverse Event|14|||
124803196|NCT01854658|448911998|FG002|Overall Study|Adverse Event|23|||
124803197|NCT01854658|448911999|FG003|Overall Study|Adverse Event|19|||
124803198|NCT01854658|448911996|FG000|Overall Study|Administrative reasons|5|||
124803199|NCT01854658|448911997|FG001|Overall Study|Administrative reasons|1|||
124803200|NCT01854658|448911998|FG002|Overall Study|Administrative reasons|2|||
124803201|NCT01854658|448911999|FG003|Overall Study|Administrative reasons|2|||
124803202|NCT01858376|448912000|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
124803203|NCT02203071|448912003|FG000|Overall Study|Lost to Follow-up|3|||
124803204|NCT02203071|448912004|FG001|Overall Study|Lost to Follow-up|1|||
124803205|NCT02436304|448912010|FG000|Overall Study|Lost to Follow-up|0|||
124803206|NCT02436304|448912011|FG001|Overall Study|Lost to Follow-up|1|||
124803207|NCT02436304|448912012|FG002|Overall Study|Lost to Follow-up|0|||
124803208|NCT02436304|448912010|FG000|Overall Study|Withdrawal by Subject|0|||
124803209|NCT02436304|448912011|FG001|Overall Study|Withdrawal by Subject|1|||
124803210|NCT02436304|448912012|FG002|Overall Study|Withdrawal by Subject|0|||
124803211|NCT02436304|448912010|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
124803212|NCT02436304|448912011|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
124633866|NCT02576847|448274786|FG000|Overall Study|Lost to Follow-up|22|||
124633867|NCT02576847|448274786|FG000|Overall Study|Physician Decision|1|||
124633868|NCT02576847|448274786|FG000|Overall Study|Pregnancy|1|||
124633869|NCT02576847|448274786|FG000|Overall Study|Protocol Violation|3|||
124803213|NCT02436304|448912012|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
124803214|NCT03793556|448912013|FG000|Overall Study|Withdrawal by Subject|12|||
124803215|NCT03793556|448912014|FG001|Overall Study|Withdrawal by Subject|1|||
124803216|NCT03793556|448912013|FG000|Overall Study|Lost to Follow-up|1|||
124803217|NCT03793556|448912014|FG001|Overall Study|Lost to Follow-up|1|||
124803218|NCT04416633|448912015|FG000|Overall Study|Death|1|||
124803219|NCT04416633|448912015|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
124803220|NCT04416633|448912015|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
124803221|NCT04416633|448912015|FG000|Overall Study|Adverse Event|6|||
124803222|NCT04416633|448912015|FG000|Overall Study|Withdrawal by Subject|6|||
124803223|NCT04612790|448912016|FG000|DB Period (Up to 36 Weeks)|Death|1|||
124803224|NCT04612790|448912017|FG001|DB Period (Up to 36 Weeks)|Death|1|||
124803225|NCT04612790|448912018|FG002|DB Period (Up to 36 Weeks)|Death|0|||
124803226|NCT04612790|448912019|FG003|DB Period (Up to 36 Weeks)|Death|0|||
124803227|NCT04612790|448912016|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
124803228|NCT04612790|448912017|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
124803229|NCT04612790|448912018|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
124803230|NCT04612790|448912019|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
124803231|NCT04612790|448912016|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
124803232|NCT04612790|448912017|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
124803233|NCT04612790|448912018|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
124803234|NCT04612790|448912019|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
124803235|NCT04612790|448912016|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
124803236|NCT04612790|448912017|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
124803237|NCT04612790|448912018|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
124803238|NCT04612790|448912019|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
124803239|NCT04612790|448912016|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
124803240|NCT04612790|448912017|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
124803241|NCT04612790|448912018|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
124803242|NCT04612790|448912019|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
124803243|NCT04612790|448912016|FG000|DB Period (Up to 36 Weeks)|Other|1|||
124803244|NCT04612790|448912017|FG001|DB Period (Up to 36 Weeks)|Other|0|||
124803245|NCT04612790|448912018|FG002|DB Period (Up to 36 Weeks)|Other|0|||
124803246|NCT04612790|448912019|FG003|DB Period (Up to 36 Weeks)|Other|0|||
124803247|NCT04612790|448912016|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
124803248|NCT04612790|448912017|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
124633870|NCT02576847|448274786|FG000|Overall Study|Withdrawal by Subject|78|||
124803249|NCT04612790|448912018|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
124803250|NCT04612790|448912019|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
124803251|NCT04612790|448912016|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
124633871|NCT02576847|448274786|FG000|Overall Study|Other|5|||
124803252|NCT04612790|448912017|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
124803253|NCT04612790|448912018|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
124803254|NCT04612790|448912019|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
124803255|NCT04612790|448912016|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
124803256|NCT04612790|448912017|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
124803257|NCT04612790|448912018|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
124803258|NCT04612790|448912019|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
124803259|NCT04612790|448912016|FG000|OLE Period (Up to 1 Year)|Other|0|||
124803260|NCT04612790|448912017|FG001|OLE Period (Up to 1 Year)|Other|0|||
124803261|NCT04612790|448912018|FG002|OLE Period (Up to 1 Year)|Other|0|||
124803262|NCT04612790|448912019|FG003|OLE Period (Up to 1 Year)|Other|1|||
124803263|NCT00785928|448912020|FG000|Treatment Phase|Adverse Event|1|||
124803264|NCT00785928|448912021|FG001|Treatment Phase|Adverse Event|1|||
124803265|NCT00785928|448912022|FG002|Treatment Phase|Adverse Event|2|||
124803266|NCT00785928|448912023|FG003|Treatment Phase|Adverse Event|0|||
124803267|NCT00785928|448912024|FG004|Treatment Phase|Adverse Event|0|||
124803268|NCT00785928|448912025|FG005|Treatment Phase|Adverse Event|0|||
124803269|NCT00785928|448912026|FG006|Treatment Phase|Adverse Event|2|||
124803270|NCT00785928|448912020|FG000|Treatment Phase|Inadequate Response|0|||
124803271|NCT00785928|448912021|FG001|Treatment Phase|Inadequate Response|1|||
124803272|NCT00785928|448912022|FG002|Treatment Phase|Inadequate Response|0|||
124803273|NCT00785928|448912023|FG003|Treatment Phase|Inadequate Response|0|||
124803274|NCT00785928|448912024|FG004|Treatment Phase|Inadequate Response|0|||
124803275|NCT00785928|448912025|FG005|Treatment Phase|Inadequate Response|0|||
124803276|NCT00785928|448912026|FG006|Treatment Phase|Inadequate Response|0|||
124803277|NCT00785928|448912020|FG000|Treatment Phase|Lack of Efficacy|0|||
124803278|NCT00785928|448912021|FG001|Treatment Phase|Lack of Efficacy|1|||
124803279|NCT00785928|448912022|FG002|Treatment Phase|Lack of Efficacy|1|||
124803280|NCT00785928|448912023|FG003|Treatment Phase|Lack of Efficacy|0|||
124803281|NCT00785928|448912024|FG004|Treatment Phase|Lack of Efficacy|0|||
124803282|NCT00785928|448912025|FG005|Treatment Phase|Lack of Efficacy|0|||
124803283|NCT00785928|448912026|FG006|Treatment Phase|Lack of Efficacy|0|||
124803284|NCT00785928|448912020|FG000|Treatment Phase|Physician Decision|0|||
124633872|NCT01205776|448274787|FG000|Overall Study|Lost to Follow-up|53|||
124633873|NCT01205776|448274788|FG001|Overall Study|Lost to Follow-up|61|||
124633874|NCT01205776|448274787|FG000|Overall Study|Withdrawal by Subject|11|||
124633875|NCT01205776|448274788|FG001|Overall Study|Withdrawal by Subject|34|||
124633876|NCT00734994|448274789|FG000|Overall Study|Withdrawal by Subject|1|||
124633877|NCT04146012|448274792|FG000|Overall Study|Study Terminated|30|||
124633878|NCT04146012|448274793|FG001|Overall Study|Study Terminated|15|||
124633879|NCT01622673|448274794|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124633880|NCT01622673|448274795|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124633881|NCT01622673|448274796|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124633882|NCT01622673|448274797|FG003|Treatment Period 1|Withdrawal by Subject|1|||
124633883|NCT01622673|448274798|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124633884|NCT01622673|448274799|FG005|Treatment Period 1|Withdrawal by Subject|0|||
124633885|NCT01622673|448274794|FG000|Treatment Period 1|Protocol Violation|0|||
124633886|NCT01622673|448274795|FG001|Treatment Period 1|Protocol Violation|1|||
124633887|NCT01622673|448274796|FG002|Treatment Period 1|Protocol Violation|0|||
124633888|NCT01622673|448274797|FG003|Treatment Period 1|Protocol Violation|0|||
124633889|NCT01622673|448274798|FG004|Treatment Period 1|Protocol Violation|0|||
124633890|NCT01622673|448274799|FG005|Treatment Period 1|Protocol Violation|0|||
124633891|NCT01622673|448274794|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124633892|NCT01622673|448274795|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124633893|NCT01622673|448274796|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124633894|NCT01622673|448274797|FG003|Treatment Period 2|Withdrawal by Subject|1|||
124633895|NCT01622673|448274798|FG004|Treatment Period 2|Withdrawal by Subject|0|||
124633896|NCT01622673|448274799|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124633897|NCT01622673|448274794|FG000|Treatment Period 3|Protocol Violation|0|||
124633898|NCT01622673|448274795|FG001|Treatment Period 3|Protocol Violation|1|||
124633899|NCT01622673|448274796|FG002|Treatment Period 3|Protocol Violation|0|||
124633900|NCT01622673|448274797|FG003|Treatment Period 3|Protocol Violation|0|||
124633901|NCT01622673|448274798|FG004|Treatment Period 3|Protocol Violation|0|||
124633902|NCT01622673|448274799|FG005|Treatment Period 3|Protocol Violation|0|||
124633903|NCT05514873|448274800|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
124633904|NCT05514873|448274800|FG000|Main Treatment Period|Adverse Event|2|||
124633905|NCT05514873|448274800|FG000|Extension Treatment Period|Lost to Follow-up|3|||
124803285|NCT00785928|448912021|FG001|Treatment Phase|Physician Decision|0|||
124803286|NCT00785928|448912022|FG002|Treatment Phase|Physician Decision|0|||
124803287|NCT00785928|448912023|FG003|Treatment Phase|Physician Decision|0|||
124803288|NCT00785928|448912024|FG004|Treatment Phase|Physician Decision|1|||
124803289|NCT00785928|448912025|FG005|Treatment Phase|Physician Decision|0|||
124633906|NCT02747108|448274802|FG000|Overall Study|Death|2|||
124633907|NCT02747108|448274803|FG001|Overall Study|Death|2|||
124633908|NCT02747108|448274802|FG000|Overall Study|Withdrawal by Subject|1|||
124633909|NCT02747108|448274803|FG001|Overall Study|Withdrawal by Subject|0|||
124633910|NCT02747108|448274802|FG000|Overall Study|Protocol Violation|2|||
124633911|NCT02747108|448274803|FG001|Overall Study|Protocol Violation|0|||
124633912|NCT03896503|448276164|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
124633913|NCT03896503|448276165|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
124633914|NCT03896503|448276166|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
124633915|NCT03896503|448276167|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
124633916|NCT03896503|448276168|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
124633917|NCT03896503|448276169|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
124633918|NCT03896503|448276170|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
124633919|NCT03896503|448276171|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
124633920|NCT03896503|448276164|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
124633921|NCT03896503|448276165|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
124633922|NCT03896503|448276166|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
124633923|NCT03896503|448276167|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
124633924|NCT03896503|448276168|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
124633925|NCT03896503|448276169|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
124633926|NCT03896503|448276170|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
124633927|NCT03896503|448276171|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
124633928|NCT03896503|448276164|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
124633929|NCT03896503|448276165|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
124633930|NCT03896503|448276166|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
124633931|NCT03896503|448276167|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
124633932|NCT03896503|448276168|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
124633933|NCT03896503|448276169|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
124633934|NCT03896503|448276170|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
124633935|NCT03896503|448276171|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
124633936|NCT03896503|448276164|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
124633937|NCT03896503|448276165|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
124633938|NCT03896503|448276166|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
124633939|NCT03896503|448276167|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
124633940|NCT03896503|448276168|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
124633941|NCT03896503|448276169|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
124633942|NCT03896503|448276170|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
124633943|NCT03896503|448276171|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
124633944|NCT03896503|448276164|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
124633945|NCT03896503|448276165|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
124633946|NCT03896503|448276166|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
124633947|NCT03896503|448276167|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
124633948|NCT03896503|448276168|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
124633949|NCT03896503|448276169|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
124633950|NCT03896503|448276170|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
124633951|NCT03896503|448276171|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
124633952|NCT03896503|448276164|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
124633953|NCT03896503|448276165|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
124633954|NCT03896503|448276166|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
124633955|NCT03896503|448276167|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
124633956|NCT03896503|448276168|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
124633957|NCT03896503|448276169|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
124633958|NCT03896503|448276170|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
124633959|NCT03896503|448276171|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
124633960|NCT03896503|448276164|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
124633961|NCT03896503|448276165|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
124633962|NCT03896503|448276166|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
124633963|NCT03896503|448276167|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
124633964|NCT03896503|448276168|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
124633965|NCT03896503|448276169|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
124633966|NCT03896503|448276170|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
124633967|NCT03896503|448276171|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
124803290|NCT00785928|448912026|FG006|Treatment Phase|Physician Decision|0|||
124803291|NCT00785928|448912020|FG000|Treatment Phase|Sponsor Decision|1|||
124803292|NCT00785928|448912021|FG001|Treatment Phase|Sponsor Decision|0|||
124633968|NCT03896503|448276164|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
124633969|NCT03896503|448276165|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
124633970|NCT03896503|448276166|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
124633971|NCT03896503|448276167|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
124633972|NCT03896503|448276168|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
124633973|NCT03896503|448276169|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
124633974|NCT03896503|448276170|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
124633975|NCT03896503|448276171|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
124633976|NCT03896503|448276164|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
124633977|NCT03896503|448276165|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
124633978|NCT03896503|448276166|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
124633979|NCT03896503|448276167|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
124633980|NCT03896503|448276168|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
124633981|NCT03896503|448276169|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
124633982|NCT03896503|448276170|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
124633983|NCT03896503|448276171|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
124633984|NCT03896503|448276164|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
124803293|NCT00785928|448912022|FG002|Treatment Phase|Sponsor Decision|0|||
124803294|NCT00785928|448912023|FG003|Treatment Phase|Sponsor Decision|0|||
124803295|NCT00785928|448912024|FG004|Treatment Phase|Sponsor Decision|0|||
124803296|NCT00785928|448912025|FG005|Treatment Phase|Sponsor Decision|0|||
124803297|NCT00785928|448912026|FG006|Treatment Phase|Sponsor Decision|1|||
124803298|NCT00785928|448912020|FG000|Treatment Phase|Withdrawal by Subject|1|||
124803299|NCT00785928|448912021|FG001|Treatment Phase|Withdrawal by Subject|2|||
124803300|NCT00785928|448912022|FG002|Treatment Phase|Withdrawal by Subject|0|||
124803301|NCT00785928|448912023|FG003|Treatment Phase|Withdrawal by Subject|0|||
124803302|NCT00785928|448912024|FG004|Treatment Phase|Withdrawal by Subject|1|||
124803303|NCT00785928|448912025|FG005|Treatment Phase|Withdrawal by Subject|0|||
124803304|NCT00785928|448912026|FG006|Treatment Phase|Withdrawal by Subject|0|||
124803305|NCT00570765|448912031|FG000|DB Phase|Withdrawal by Subject|1|||
124803306|NCT00570765|448912032|FG001|DB Phase|Withdrawal by Subject|0|||
124803307|NCT00570765|448912033|FG002|DB Phase|Withdrawal by Subject|0|||
124803308|NCT00570765|448912034|FG003|DB Phase|Withdrawal by Subject|0|||
124803309|NCT00570765|448912031|FG000|DB Phase|Protocol Violation|0|||
124803310|NCT00570765|448912032|FG001|DB Phase|Protocol Violation|1|||
124803311|NCT00570765|448912033|FG002|DB Phase|Protocol Violation|0|||
124803312|NCT00570765|448912034|FG003|DB Phase|Protocol Violation|0|||
124803313|NCT00570765|448912031|FG000|DB Phase|Adverse Event|3|||
124803314|NCT00570765|448912032|FG001|DB Phase|Adverse Event|6|||
124803315|NCT00570765|448912033|FG002|DB Phase|Adverse Event|0|||
124803316|NCT00570765|448912034|FG003|DB Phase|Adverse Event|0|||
124803317|NCT00570765|448912031|FG000|DB Phase|Did Not Receive Study Drug|0|||
124803318|NCT00570765|448912032|FG001|DB Phase|Did Not Receive Study Drug|0|||
124803319|NCT00570765|448912033|FG002|DB Phase|Did Not Receive Study Drug|1|||
124803320|NCT00570765|448912034|FG003|DB Phase|Did Not Receive Study Drug|0|||
124803321|NCT00570765|448912031|FG000|LTSE Phase|Withdrawal by Subject|0|||
124803322|NCT00570765|448912032|FG001|LTSE Phase|Withdrawal by Subject|0|||
124803323|NCT00570765|448912033|FG002|LTSE Phase|Withdrawal by Subject|0|||
124803324|NCT00570765|448912034|FG003|LTSE Phase|Withdrawal by Subject|1|||
124803325|NCT00570765|448912031|FG000|LTSE Phase|Adverse Event|0|||
124803326|NCT00570765|448912032|FG001|LTSE Phase|Adverse Event|0|||
124803327|NCT00570765|448912033|FG002|LTSE Phase|Adverse Event|0|||
124803328|NCT00570765|448912034|FG003|LTSE Phase|Adverse Event|7|||
124803329|NCT00570765|448912031|FG000|LTSE Phase|Physician Decision|0|||
124803330|NCT00570765|448912032|FG001|LTSE Phase|Physician Decision|0|||
124803331|NCT00570765|448912033|FG002|LTSE Phase|Physician Decision|0|||
124803332|NCT00570765|448912034|FG003|LTSE Phase|Physician Decision|4|||
124803333|NCT03387683|448912035|FG000|Overall Study|In receipt of disallowed medication|1|||
124803334|NCT03387683|448912036|FG001|Overall Study|In receipt of disallowed medication|0|||
124803335|NCT03387683|448912035|FG000|Overall Study|Did not receive treatment|1|||
124803336|NCT03387683|448912036|FG001|Overall Study|Did not receive treatment|0|||
124803337|NCT00875979|448912040|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
124803338|NCT00875979|448912041|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
124803339|NCT00875979|448912040|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
124803340|NCT00875979|448912041|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
124803341|NCT00875979|448912040|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
124803342|NCT00875979|448912041|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
124803343|NCT00875979|448912040|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
124803344|NCT00875979|448912041|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
124803345|NCT00875979|448912040|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
124803346|NCT00875979|448912041|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
124803347|NCT00875979|448912040|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
124803348|NCT00875979|448912041|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
124803349|NCT00875979|448912040|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
124803350|NCT00875979|448912041|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
124803351|NCT00875979|448912040|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
124803352|NCT00875979|448912041|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
124803353|NCT00875979|448912040|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
124803354|NCT00875979|448912041|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
124803355|NCT01649804|448912042|FG000|Overall Study|Administrative/Other|8|||
124803356|NCT01123850|448912049|FG000|Overall Study|Slow enrollment|45|||
124803357|NCT02083081|448912050|FG000|Overall Study|Lost to Follow-up|31|||
124803358|NCT02083081|448912051|FG001|Overall Study|Lost to Follow-up|9|||
124803359|NCT02028871|448912054|FG000|Overall Study|Positive urine drug screen|1|||
124803360|NCT02028871|448912055|FG001|Overall Study|Positive urine drug screen|1|||
124803361|NCT02028871|448912054|FG000|Overall Study|Withdrawal by Subject|1|||
124803362|NCT02028871|448912055|FG001|Overall Study|Withdrawal by Subject|2|||
124803363|NCT02028871|448912054|FG000|Overall Study|IV placement difficulty|1|||
124803364|NCT02028871|448912055|FG001|Overall Study|IV placement difficulty|0|||
124803365|NCT02028871|448912054|FG000|Overall Study|Current Illness|1|||
124803366|NCT02028871|448912055|FG001|Overall Study|Current Illness|0|||
124803367|NCT01691898|448912056|FG000|Overall Study|Death|34|||
124803368|NCT01691898|448912057|FG001|Overall Study|Death|32|||
124803369|NCT01691898|448912058|FG002|Overall Study|Death|6|||
124803370|NCT01691898|448912059|FG003|Overall Study|Death|3|||
124803371|NCT01691898|448912060|FG004|Overall Study|Death|8|||
124803372|NCT01691898|448912061|FG005|Overall Study|Death|31|||
124803373|NCT01691898|448912056|FG000|Overall Study|Adverse Event|0|||
124803374|NCT01691898|448912057|FG001|Overall Study|Adverse Event|1|||
124803375|NCT01691898|448912058|FG002|Overall Study|Adverse Event|0|||
124803376|NCT01691898|448912059|FG003|Overall Study|Adverse Event|1|||
124803377|NCT01691898|448912060|FG004|Overall Study|Adverse Event|1|||
124803378|NCT01691898|448912061|FG005|Overall Study|Adverse Event|0|||
124803379|NCT01691898|448912056|FG000|Overall Study|Progression of Disease|1|||
124803380|NCT01691898|448912057|FG001|Overall Study|Progression of Disease|2|||
124803381|NCT01691898|448912058|FG002|Overall Study|Progression of Disease|1|||
124803382|NCT01691898|448912059|FG003|Overall Study|Progression of Disease|0|||
124803383|NCT01691898|448912060|FG004|Overall Study|Progression of Disease|0|||
124803384|NCT01691898|448912061|FG005|Overall Study|Progression of Disease|1|||
124803385|NCT01691898|448912056|FG000|Overall Study|Lost to Follow-up|3|||
124803386|NCT01691898|448912057|FG001|Overall Study|Lost to Follow-up|1|||
124803387|NCT01691898|448912058|FG002|Overall Study|Lost to Follow-up|0|||
124803388|NCT01691898|448912059|FG003|Overall Study|Lost to Follow-up|0|||
124803389|NCT01691898|448912060|FG004|Overall Study|Lost to Follow-up|1|||
124803390|NCT01691898|448912061|FG005|Overall Study|Lost to Follow-up|0|||
124803391|NCT01691898|448912056|FG000|Overall Study|Withdrawal by Subject|9|||
124803392|NCT01691898|448912057|FG001|Overall Study|Withdrawal by Subject|8|||
124803393|NCT01691898|448912058|FG002|Overall Study|Withdrawal by Subject|2|||
124803394|NCT01691898|448912059|FG003|Overall Study|Withdrawal by Subject|1|||
124803395|NCT01691898|448912060|FG004|Overall Study|Withdrawal by Subject|3|||
124803396|NCT01691898|448912061|FG005|Overall Study|Withdrawal by Subject|3|||
124803397|NCT01691898|448912056|FG000|Overall Study|Non-Compliance|0|||
124803398|NCT01691898|448912057|FG001|Overall Study|Non-Compliance|0|||
124803399|NCT01691898|448912058|FG002|Overall Study|Non-Compliance|0|||
124803400|NCT01691898|448912059|FG003|Overall Study|Non-Compliance|0|||
124803401|NCT01691898|448912060|FG004|Overall Study|Non-Compliance|1|||
124633985|NCT03896503|448276165|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
124633986|NCT03896503|448276166|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
124633987|NCT03896503|448276167|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
124633988|NCT03896503|448276168|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
124633989|NCT03896503|448276169|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
124633990|NCT03896503|448276170|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
124633991|NCT03896503|448276171|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
124803402|NCT01691898|448912061|FG005|Overall Study|Non-Compliance|0|||
124803403|NCT01104155|448912062|FG000|Overall Study|Adverse Event|15|||
124803404|NCT01104155|448912063|FG001|Overall Study|Adverse Event|8|||
124803405|NCT01104155|448912062|FG000|Overall Study|Participant choice|6|||
124803406|NCT01104155|448912063|FG001|Overall Study|Participant choice|5|||
124803407|NCT01104155|448912062|FG000|Overall Study|Withdrawal of consent|1|||
124803408|NCT01104155|448912063|FG001|Overall Study|Withdrawal of consent|1|||
124803409|NCT01104155|448912062|FG000|Overall Study|Other|3|||
124803410|NCT01104155|448912063|FG001|Overall Study|Other|4|||
124803411|NCT01484132|448912064|FG000|Overall Study|Lost to Follow-up|8|||
124803412|NCT01484132|448912064|FG000|Overall Study|Difficulty with time commitment|2|||
124803413|NCT01484132|448912064|FG000|Overall Study|Ineligible|1|||
124803414|NCT01484132|448912064|FG000|Overall Study|No pre-treatment urine sample collected|1|||
124803415|NCT01484132|448912064|FG000|Overall Study|No post-treatment urine sample collected|10|||
124803416|NCT02808650|448912066|FG000|Overall Study|Death|0|||
124803417|NCT02808650|448912067|FG001|Overall Study|Death|0|||
124803418|NCT02808650|448912068|FG002|Overall Study|Death|0|||
124803419|NCT02808650|448912069|FG003|Overall Study|Death|0|||
124803420|NCT02808650|448912070|FG004|Overall Study|Death|1|||
124803421|NCT02808650|448912066|FG000|Overall Study|Lack of Efficacy|5|||
124803422|NCT02808650|448912067|FG001|Overall Study|Lack of Efficacy|5|||
124803423|NCT02808650|448912068|FG002|Overall Study|Lack of Efficacy|6|||
124803424|NCT02808650|448912069|FG003|Overall Study|Lack of Efficacy|5|||
124803425|NCT02808650|448912070|FG004|Overall Study|Lack of Efficacy|4|||
124803426|NCT02808650|448912066|FG000|Overall Study|Physician Decision|1|||
124803427|NCT02808650|448912067|FG001|Overall Study|Physician Decision|1|||
124803428|NCT02808650|448912068|FG002|Overall Study|Physician Decision|0|||
124803429|NCT02808650|448912069|FG003|Overall Study|Physician Decision|0|||
124803430|NCT02808650|448912070|FG004|Overall Study|Physician Decision|0|||
124803431|NCT02808650|448912066|FG000|Overall Study|Withdrawal by Subject|0|||
124803432|NCT02808650|448912067|FG001|Overall Study|Withdrawal by Subject|0|||
124803433|NCT02808650|448912068|FG002|Overall Study|Withdrawal by Subject|0|||
124803434|NCT02808650|448912069|FG003|Overall Study|Withdrawal by Subject|1|||
124803435|NCT02808650|448912070|FG004|Overall Study|Withdrawal by Subject|1|||
124803436|NCT02939079|448912071|FG000|Overall Study|Adverse Event|2|||
124803437|NCT02939079|448912072|FG001|Overall Study|Adverse Event|1|||
124803438|NCT02939079|448912071|FG000|Overall Study|Lost to Follow-up|0|||
124803439|NCT02939079|448912072|FG001|Overall Study|Lost to Follow-up|2|||
124803440|NCT02939079|448912071|FG000|Overall Study|Protocol Violation|1|||
124803441|NCT02939079|448912072|FG001|Overall Study|Protocol Violation|0|||
124803442|NCT02939079|448912071|FG000|Overall Study|Withdrawal by Subject|0|||
124803443|NCT02939079|448912072|FG001|Overall Study|Withdrawal by Subject|1|||
124803444|NCT02939079|448912071|FG000|Overall Study|relapse during the study|1|||
124803445|NCT02939079|448912072|FG001|Overall Study|relapse during the study|1|||
124803446|NCT04093414|448912073|FG000|3 Month Follow up|Physician Decision|0|||
124803447|NCT04093414|448912074|FG001|3 Month Follow up|Physician Decision|1|||
124803448|NCT04093414|448912073|FG000|6month Follow up|Physician Decision|1|||
124803449|NCT04093414|448912074|FG001|6month Follow up|Physician Decision|3|||
124803450|NCT04209348|448912075|FG000|Overall Study|Lost to Follow-up|1|||
124803451|NCT04209348|448912076|FG001|Overall Study|Lost to Follow-up|0|||
124803452|NCT02770170|448912084|FG000|Overall Study|Withdrawal by Subject|0|||
124803453|NCT02770170|448912085|FG001|Overall Study|Withdrawal by Subject|0|||
124803454|NCT02770170|448912086|FG002|Overall Study|Withdrawal by Subject|0|||
124803455|NCT02770170|448912087|FG003|Overall Study|Withdrawal by Subject|2|||
124803456|NCT02770170|448912084|FG000|Overall Study|due to pregnancy|1|||
124803457|NCT02770170|448912085|FG001|Overall Study|due to pregnancy|0|||
124803458|NCT02770170|448912086|FG002|Overall Study|due to pregnancy|0|||
124803459|NCT02770170|448912087|FG003|Overall Study|due to pregnancy|0|||
124803460|NCT02770170|448912084|FG000|Overall Study|Lack of Efficacy|2|||
124803461|NCT02770170|448912085|FG001|Overall Study|Lack of Efficacy|0|||
124803462|NCT02770170|448912086|FG002|Overall Study|Lack of Efficacy|0|||
124803463|NCT02770170|448912087|FG003|Overall Study|Lack of Efficacy|1|||
124803464|NCT02770170|448912084|FG000|Overall Study|Adverse Event|4|||
124803465|NCT02770170|448912085|FG001|Overall Study|Adverse Event|3|||
124803466|NCT02770170|448912086|FG002|Overall Study|Adverse Event|5|||
124803467|NCT02770170|448912087|FG003|Overall Study|Adverse Event|3|||
124803468|NCT02770170|448912084|FG000|Overall Study|due to disease worsening|0|||
124803469|NCT02770170|448912085|FG001|Overall Study|due to disease worsening|0|||
124803470|NCT02770170|448912086|FG002|Overall Study|due to disease worsening|0|||
124803471|NCT02770170|448912087|FG003|Overall Study|due to disease worsening|1|||
124803472|NCT00445978|448912088|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
124803473|NCT00445978|448912088|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
124803474|NCT00445978|448912088|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
124803475|NCT00445978|448912088|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
124803476|NCT00445978|448912088|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
124803477|NCT00445978|448912088|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
124803478|NCT00445978|448912088|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
124803479|NCT00445978|448912088|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
124803480|NCT00445978|448912088|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
124803481|NCT01822496|448912091|FG000|Overall Study|Protocol Violation|2|||
124803482|NCT01822496|448912092|FG001|Overall Study|Protocol Violation|2|||
124803483|NCT01822496|448912093|FG002|Overall Study|Protocol Violation|0|||
124803484|NCT01822496|448912094|FG003|Overall Study|Protocol Violation|1|||
124803485|NCT01822496|448912091|FG000|Overall Study|Withdrawal by Subject|0|||
124803486|NCT01822496|448912092|FG001|Overall Study|Withdrawal by Subject|0|||
124803487|NCT01822496|448912093|FG002|Overall Study|Withdrawal by Subject|0|||
124803488|NCT01822496|448912094|FG003|Overall Study|Withdrawal by Subject|3|||
124803489|NCT00304239|448912095|FG000|Overall Study|Protocol Deviations/Violations|15|||
124803490|NCT00304239|448912096|FG001|Overall Study|Protocol Deviations/Violations|0|||
124803491|NCT00304239|448912095|FG000|Overall Study|Adverse Event|2|||
124803492|NCT00304239|448912096|FG001|Overall Study|Adverse Event|0|||
124803493|NCT02979197|448912097|FG000|Overall Study|Adverse Event|4|||
124803494|NCT02979197|448912098|FG001|Overall Study|Adverse Event|2|||
124803495|NCT02979197|448912099|FG002|Overall Study|Adverse Event|0|||
124803496|NCT02979197|448912097|FG000|Overall Study|Protocol Violation|0|||
124803497|NCT02979197|448912098|FG001|Overall Study|Protocol Violation|1|||
124803498|NCT02979197|448912099|FG002|Overall Study|Protocol Violation|0|||
124803499|NCT02979197|448912097|FG000|Overall Study|Subject unable to commit to study dates|0|||
124803500|NCT02979197|448912098|FG001|Overall Study|Subject unable to commit to study dates|1|||
124803501|NCT02979197|448912099|FG002|Overall Study|Subject unable to commit to study dates|0|||
124803502|NCT03643159|448912100|FG000|Overall Study|Adverse Event|1|||
124803503|NCT03643159|448912100|FG000|Overall Study|Withdrawal by Subject|1|||
124803504|NCT01898208|448912103|FG000|Overall Study|Positive blood culture|17|||
124803505|NCT01898208|448912104|FG001|Overall Study|Positive blood culture|23|||
124803506|NCT01898208|448912105|FG002|Overall Study|Positive blood culture|15|||
124803507|NCT01898208|448912103|FG000|Overall Study|Death/comfort care within 24 hours|10|||
124803508|NCT01898208|448912104|FG001|Overall Study|Death/comfort care within 24 hours|9|||
124803509|NCT01898208|448912105|FG002|Overall Study|Death/comfort care within 24 hours|8|||
124803510|NCT01898208|448912103|FG000|Overall Study|Negative Gram Stain|6|||
124803511|NCT01898208|448912104|FG001|Overall Study|Negative Gram Stain|9|||
124803512|NCT01898208|448912105|FG002|Overall Study|Negative Gram Stain|6|||
124803513|NCT01898208|448912103|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
124803514|NCT01898208|448912104|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
124803515|NCT01898208|448912105|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
124803516|NCT01898208|448912103|FG000|Overall Study|System/Technical Error|1|||
124803517|NCT01898208|448912104|FG001|Overall Study|System/Technical Error|2|||
124803518|NCT01898208|448912105|FG002|Overall Study|System/Technical Error|3|||
124803519|NCT01898208|448912103|FG000|Overall Study|Lost to Follow-up|3|||
124803520|NCT01898208|448912104|FG001|Overall Study|Lost to Follow-up|1|||
124803521|NCT01898208|448912105|FG002|Overall Study|Lost to Follow-up|1|||
124803522|NCT02436681|448912106|FG000|Overall Study|Lost to Follow-up|10|||
124803523|NCT02436681|448912106|FG000|Overall Study|Withdrawal by Subject|2|||
124803524|NCT02436681|448912106|FG000|Overall Study|Death|2|||
124803525|NCT02030938|448912109|FG000|Overall Study|Lost to Follow-up|4|||
124803526|NCT02030938|448912109|FG000|Overall Study|Withdrawal by Subject|1|||
124803527|NCT03954132|448912111|FG000|Overall Study|Adverse Event|2|||
124803528|NCT03954132|448912112|FG001|Overall Study|Adverse Event|0|||
124803529|NCT03954132|448912111|FG000|Overall Study|Patient's wish|5|||
124803530|NCT03954132|448912112|FG001|Overall Study|Patient's wish|0|||
124803531|NCT03954132|448912111|FG000|Overall Study|Lost to Follow-up|10|||
124803532|NCT03954132|448912112|FG001|Overall Study|Lost to Follow-up|0|||
124803533|NCT03954132|448912111|FG000|Overall Study|Screening failure|0|||
124803534|NCT03954132|448912112|FG001|Overall Study|Screening failure|1|||
124803535|NCT03954132|448912111|FG000|Overall Study|No registration after Visit 1|5|||
124803536|NCT03954132|448912112|FG001|Overall Study|No registration after Visit 1|2|||
124803537|NCT03954132|448912111|FG000|Overall Study|Other reason than listed|2|||
124803538|NCT03954132|448912112|FG001|Overall Study|Other reason than listed|2|||
124803539|NCT03954132|448912111|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
124803540|NCT03954132|448912112|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
124803541|NCT03954132|448912111|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
124803542|NCT03954132|448912112|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
124803543|NCT00932737|448912118|FG000|Overall Study|Not treated in second episode|1|||
124803544|NCT00932737|448912119|FG001|Overall Study|Not treated in second episode|0|||
124803545|NCT00932737|448912118|FG000|Overall Study|Adverse Event|0|||
124803546|NCT00932737|448912119|FG001|Overall Study|Adverse Event|1|||
124803547|NCT04399837|448912120|FG000|Overall Study|Other than listed|0|||
124803548|NCT04399837|448912121|FG001|Overall Study|Other than listed|2|||
124803549|NCT04399837|448912122|FG002|Overall Study|Other than listed|2|||
124803550|NCT04399837|448912123|FG003|Overall Study|Other than listed|3|||
124803551|NCT04399837|448912120|FG000|Overall Study|Withdrawal by Subject|1|||
124803552|NCT04399837|448912121|FG001|Overall Study|Withdrawal by Subject|2|||
124803553|NCT04399837|448912122|FG002|Overall Study|Withdrawal by Subject|1|||
124803554|NCT04399837|448912123|FG003|Overall Study|Withdrawal by Subject|1|||
124803555|NCT01554397|448912125|FG000|Overall Study|Withdrawal by Subject|1|||
124803556|NCT01554397|448912126|FG001|Overall Study|Withdrawal by Subject|0|||
124803557|NCT01554397|448912125|FG000|Overall Study|Ineligible|7|||
124803558|NCT01554397|448912126|FG001|Overall Study|Ineligible|0|||
124803559|NCT00369122|448914207|FG000|Overall Study|Ineligible|10|||
124803560|NCT00369122|448914207|FG000|Overall Study|No protocol treatment|1|||
124803561|NCT00004635|448914208|FG000|Period One|refused|2|||
124803562|NCT00004635|448914209|FG001|Period One|refused|1|||
124803563|NCT00004635|448914208|FG000|Period One|Withdrawal by Subject|1|||
124803564|NCT00004635|448914209|FG001|Period One|Withdrawal by Subject|1|||
124803565|NCT00004635|448914208|FG000|Period One|Protocol Violation|1|||
124803566|NCT00004635|448914209|FG001|Period One|Protocol Violation|0|||
124803567|NCT00004635|448914208|FG000|Period One|PSA did not go <5 ng/mL|1|||
124803568|NCT00004635|448914209|FG001|Period One|PSA did not go <5 ng/mL|0|||
124803569|NCT00004635|448914208|FG000|Period One|second malignancy|1|||
124803570|NCT00004635|448914209|FG001|Period One|second malignancy|0|||
124803571|NCT00004635|448914208|FG000|Period One|progressed|0|||
124803572|NCT00004635|448914209|FG001|Period One|progressed|2|||
124803573|NCT00004635|448914208|FG000|Period One|health problem|0|||
124803574|NCT00004635|448914209|FG001|Period One|health problem|1|||
124803575|NCT00004635|448914208|FG000|Period One|discrepancy in data entry|0|||
124803576|NCT00004635|448914209|FG001|Period One|discrepancy in data entry|1|||
124803577|NCT00004635|448914208|FG000|Period Two|progression|2|||
124803578|NCT00004635|448914209|FG001|Period Two|progression|3|||
124803579|NCT00004635|448914208|FG000|Period Two|Adverse Event|1|||
124803580|NCT00004635|448914209|FG001|Period Two|Adverse Event|0|||
124803581|NCT00004635|448914208|FG000|Period Two|refused|0|||
124803582|NCT00004635|448914209|FG001|Period Two|refused|2|||
124803583|NCT00004635|448914208|FG000|Period Two|health problem|1|||
124803584|NCT00004635|448914209|FG001|Period Two|health problem|1|||
124803585|NCT00004635|448914208|FG000|Period Two|travel issues|0|||
124803586|NCT00004635|448914209|FG001|Period Two|travel issues|1|||
124803587|NCT00004635|448914208|FG000|Period Two|secondary malignancy|1|||
124803588|NCT00004635|448914209|FG001|Period Two|secondary malignancy|1|||
124803589|NCT00004635|448914208|FG000|Period Two|Lost to Follow-up|1|||
124803590|NCT00004635|448914209|FG001|Period Two|Lost to Follow-up|0|||
124803591|NCT00004635|448914208|FG000|Period Two|discrepancy in data entry|0|||
124803592|NCT00004635|448914209|FG001|Period Two|discrepancy in data entry|1|||
124803593|NCT00408629|448914210|FG000|Overall Study|Adverse Event|13|||
124803594|NCT00408629|448914211|FG001|Overall Study|Adverse Event|27|||
124803595|NCT00408629|448914210|FG000|Overall Study|Withdrawal by Subject|8|||
124803596|NCT00408629|448914211|FG001|Overall Study|Withdrawal by Subject|4|||
124803597|NCT00408629|448914210|FG000|Overall Study|Lost to Follow-up|1|||
124803598|NCT00408629|448914211|FG001|Overall Study|Lost to Follow-up|1|||
124803599|NCT00408629|448914210|FG000|Overall Study|Lack of Efficacy|63|||
124803600|NCT00408629|448914211|FG001|Overall Study|Lack of Efficacy|73|||
124803601|NCT00408629|448914210|FG000|Overall Study|Protocol Violation|1|||
124803602|NCT00408629|448914211|FG001|Overall Study|Protocol Violation|5|||
124803603|NCT00408629|448914210|FG000|Overall Study|Miscellaneous|11|||
124803604|NCT00408629|448914211|FG001|Overall Study|Miscellaneous|15|||
124803605|NCT00191906|448914212|FG000|Study Period II|Adverse Event|0|||
124803606|NCT00191906|448914213|FG001|Study Period II|Adverse Event|1|||
124803607|NCT00191906|448914214|FG002|Study Period II|Adverse Event|0|||
124803608|NCT00191906|448914215|FG003|Study Period II|Adverse Event|0|||
124803609|NCT00191906|448914212|FG000|Study Period II|Withdrawal by Subject|0|||
124803610|NCT00191906|448914213|FG001|Study Period II|Withdrawal by Subject|3|||
124803611|NCT00191906|448914214|FG002|Study Period II|Withdrawal by Subject|0|||
124803612|NCT00191906|448914215|FG003|Study Period II|Withdrawal by Subject|0|||
124803613|NCT00191906|448914212|FG000|Study Period II|Parent/Caregiver Decision|0|||
124803614|NCT00191906|448914213|FG001|Study Period II|Parent/Caregiver Decision|1|||
124803615|NCT00191906|448914214|FG002|Study Period II|Parent/Caregiver Decision|0|||
124803616|NCT00191906|448914215|FG003|Study Period II|Parent/Caregiver Decision|0|||
124803617|NCT00191906|448914212|FG000|Study Period II|Entry Criteria Exclusion|0|||
124803618|NCT00191906|448914213|FG001|Study Period II|Entry Criteria Exclusion|0|||
124803619|NCT00191906|448914214|FG002|Study Period II|Entry Criteria Exclusion|1|||
124803620|NCT00191906|448914215|FG003|Study Period II|Entry Criteria Exclusion|0|||
124803621|NCT00191906|448914212|FG000|Study Period III|Adverse Event|1|||
124803622|NCT00191906|448914213|FG001|Study Period III|Adverse Event|0|||
124803623|NCT00191906|448914214|FG002|Study Period III|Adverse Event|0|||
124803624|NCT00191906|448914215|FG003|Study Period III|Adverse Event|0|||
124803625|NCT00191906|448914212|FG000|Study Period III|Lost to Follow-up|0|||
124633992|NCT03896503|448276164|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
124803626|NCT00191906|448914213|FG001|Study Period III|Lost to Follow-up|1|||
124633993|NCT03896503|448276165|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
124633994|NCT03896503|448276166|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
124803627|NCT00191906|448914214|FG002|Study Period III|Lost to Follow-up|0|||
124803628|NCT00191906|448914215|FG003|Study Period III|Lost to Follow-up|0|||
124803629|NCT00191906|448914212|FG000|Study Period III|Parent/Caregiver Decision|1|||
124803630|NCT00191906|448914213|FG001|Study Period III|Parent/Caregiver Decision|0|||
124803631|NCT00191906|448914214|FG002|Study Period III|Parent/Caregiver Decision|0|||
124803632|NCT00191906|448914215|FG003|Study Period III|Parent/Caregiver Decision|0|||
124803633|NCT00191906|448914212|FG000|Study Period III|Lack of Efficacy|3|||
124803634|NCT00191906|448914213|FG001|Study Period III|Lack of Efficacy|3|||
124803635|NCT00191906|448914214|FG002|Study Period III|Lack of Efficacy|0|||
124803636|NCT00191906|448914215|FG003|Study Period III|Lack of Efficacy|0|||
124803637|NCT00333801|448914216|FG000|Overall Study|Moved to another state|5|||
124803638|NCT00333801|448914217|FG001|Overall Study|Moved to another state|3|||
124803639|NCT00333801|448914216|FG000|Overall Study|Lost to Follow-up|2|||
124803640|NCT00333801|448914217|FG001|Overall Study|Lost to Follow-up|0|||
124803641|NCT00333801|448914216|FG000|Overall Study|Incarcerated|1|||
124803642|NCT00333801|448914217|FG001|Overall Study|Incarcerated|2|||
124803643|NCT00333801|448914216|FG000|Overall Study|Withdrawal by Subject|0|||
124803644|NCT00333801|448914217|FG001|Overall Study|Withdrawal by Subject|1|||
124803645|NCT03633617|448914218|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
124803646|NCT03633617|448914219|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
124803647|NCT03633617|448914220|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803648|NCT03633617|448914221|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803649|NCT03633617|448914222|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803650|NCT03633617|448914223|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803651|NCT03633617|448914224|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803652|NCT03633617|448914225|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803653|NCT03633617|448914226|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803654|NCT03633617|448914227|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803655|NCT03633617|448914228|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
124803656|NCT03633617|448914218|FG000|Part A|Unconfirmed early termination visit|1|||
124803657|NCT03633617|448914219|FG001|Part A|Unconfirmed early termination visit|0|||
124803658|NCT03633617|448914220|FG002|Part A|Unconfirmed early termination visit|0|||
124803659|NCT03633617|448914221|FG003|Part A|Unconfirmed early termination visit|0|||
124803660|NCT03633617|448914222|FG004|Part A|Unconfirmed early termination visit|0|||
124803661|NCT03633617|448914223|FG005|Part A|Unconfirmed early termination visit|0|||
124803662|NCT03633617|448914224|FG006|Part A|Unconfirmed early termination visit|0|||
124803663|NCT03633617|448914225|FG007|Part A|Unconfirmed early termination visit|0|||
124803664|NCT03633617|448914226|FG008|Part A|Unconfirmed early termination visit|0|||
124803665|NCT03633617|448914227|FG009|Part A|Unconfirmed early termination visit|0|||
124803666|NCT03633617|448914228|FG010|Part A|Unconfirmed early termination visit|0|||
124803667|NCT03633617|448914218|FG000|Part A|Adverse Event|0|||
124803668|NCT03633617|448914219|FG001|Part A|Adverse Event|1|||
124803669|NCT03633617|448914220|FG002|Part A|Adverse Event|0|||
124803670|NCT03633617|448914221|FG003|Part A|Adverse Event|0|||
124803671|NCT03633617|448914222|FG004|Part A|Adverse Event|0|||
124803672|NCT03633617|448914223|FG005|Part A|Adverse Event|0|||
124803673|NCT03633617|448914224|FG006|Part A|Adverse Event|0|||
124803674|NCT03633617|448914225|FG007|Part A|Adverse Event|0|||
124803675|NCT03633617|448914226|FG008|Part A|Adverse Event|0|||
124803676|NCT03633617|448914227|FG009|Part A|Adverse Event|0|||
124803677|NCT03633617|448914228|FG010|Part A|Adverse Event|0|||
124803678|NCT03633617|448914218|FG000|Part A|Pregnancy|1|||
124803679|NCT03633617|448914219|FG001|Part A|Pregnancy|0|||
124803680|NCT03633617|448914220|FG002|Part A|Pregnancy|0|||
124803681|NCT03633617|448914221|FG003|Part A|Pregnancy|0|||
124803682|NCT03633617|448914222|FG004|Part A|Pregnancy|0|||
124803683|NCT03633617|448914223|FG005|Part A|Pregnancy|0|||
124803684|NCT03633617|448914224|FG006|Part A|Pregnancy|0|||
124803685|NCT03633617|448914225|FG007|Part A|Pregnancy|0|||
124803686|NCT03633617|448914226|FG008|Part A|Pregnancy|0|||
124803687|NCT03633617|448914227|FG009|Part A|Pregnancy|0|||
124803688|NCT03633617|448914228|FG010|Part A|Pregnancy|0|||
124803689|NCT03633617|448914218|FG000|Part A|Withdrawal by Subject|0|||
124803690|NCT03633617|448914219|FG001|Part A|Withdrawal by Subject|1|||
124803691|NCT03633617|448914220|FG002|Part A|Withdrawal by Subject|0|||
124803692|NCT03633617|448914221|FG003|Part A|Withdrawal by Subject|0|||
124803693|NCT03633617|448914222|FG004|Part A|Withdrawal by Subject|0|||
124803694|NCT03633617|448914223|FG005|Part A|Withdrawal by Subject|0|||
124803695|NCT03633617|448914224|FG006|Part A|Withdrawal by Subject|0|||
124803696|NCT03633617|448914225|FG007|Part A|Withdrawal by Subject|0|||
124803697|NCT03633617|448914226|FG008|Part A|Withdrawal by Subject|0|||
124803698|NCT03633617|448914227|FG009|Part A|Withdrawal by Subject|0|||
124803699|NCT03633617|448914228|FG010|Part A|Withdrawal by Subject|0|||
124803700|NCT03633617|448914218|FG000|Part B|Adverse Event|0|||
124803701|NCT03633617|448914219|FG001|Part B|Adverse Event|0|||
124803702|NCT03633617|448914220|FG002|Part B|Adverse Event|2|||
124803703|NCT03633617|448914221|FG003|Part B|Adverse Event|2|||
124803704|NCT03633617|448914222|FG004|Part B|Adverse Event|1|||
124803705|NCT03633617|448914223|FG005|Part B|Adverse Event|0|||
124803706|NCT03633617|448914224|FG006|Part B|Adverse Event|0|||
124803707|NCT03633617|448914225|FG007|Part B|Adverse Event|0|||
124803708|NCT03633617|448914226|FG008|Part B|Adverse Event|0|||
124803709|NCT03633617|448914227|FG009|Part B|Adverse Event|0|||
124803710|NCT03633617|448914228|FG010|Part B|Adverse Event|0|||
124803711|NCT03633617|448914218|FG000|Part B|Withdrawal by Subject|0|||
124803712|NCT03633617|448914219|FG001|Part B|Withdrawal by Subject|0|||
124803713|NCT03633617|448914220|FG002|Part B|Withdrawal by Subject|1|||
124803714|NCT03633617|448914221|FG003|Part B|Withdrawal by Subject|0|||
124803715|NCT03633617|448914222|FG004|Part B|Withdrawal by Subject|2|||
124803716|NCT03633617|448914223|FG005|Part B|Withdrawal by Subject|0|||
124803717|NCT03633617|448914224|FG006|Part B|Withdrawal by Subject|0|||
124803718|NCT03633617|448914225|FG007|Part B|Withdrawal by Subject|0|||
124803719|NCT03633617|448914226|FG008|Part B|Withdrawal by Subject|0|||
124803720|NCT03633617|448914227|FG009|Part B|Withdrawal by Subject|0|||
124803721|NCT03633617|448914228|FG010|Part B|Withdrawal by Subject|0|||
124803722|NCT03633617|448914218|FG000|Part B|Lost to Follow-up|0|||
124803723|NCT03633617|448914219|FG001|Part B|Lost to Follow-up|0|||
124803724|NCT03633617|448914220|FG002|Part B|Lost to Follow-up|0|||
124803725|NCT03633617|448914221|FG003|Part B|Lost to Follow-up|0|||
124803726|NCT03633617|448914222|FG004|Part B|Lost to Follow-up|1|||
124803727|NCT03633617|448914223|FG005|Part B|Lost to Follow-up|0|||
124803728|NCT03633617|448914224|FG006|Part B|Lost to Follow-up|0|||
124803729|NCT03633617|448914225|FG007|Part B|Lost to Follow-up|0|||
124803730|NCT03633617|448914226|FG008|Part B|Lost to Follow-up|0|||
124803731|NCT03633617|448914227|FG009|Part B|Lost to Follow-up|0|||
124803732|NCT03633617|448914228|FG010|Part B|Lost to Follow-up|0|||
124803733|NCT03633617|448914218|FG000|Part B|Physician Decision|0|||
124803734|NCT03633617|448914219|FG001|Part B|Physician Decision|0|||
124803735|NCT03633617|448914220|FG002|Part B|Physician Decision|0|||
124803736|NCT03633617|448914221|FG003|Part B|Physician Decision|0|||
124803737|NCT03633617|448914222|FG004|Part B|Physician Decision|1|||
124803738|NCT03633617|448914223|FG005|Part B|Physician Decision|0|||
124803739|NCT03633617|448914224|FG006|Part B|Physician Decision|0|||
124803740|NCT03633617|448914225|FG007|Part B|Physician Decision|0|||
124803741|NCT03633617|448914226|FG008|Part B|Physician Decision|0|||
124803742|NCT03633617|448914227|FG009|Part B|Physician Decision|0|||
124803743|NCT03633617|448914228|FG010|Part B|Physician Decision|0|||
124803744|NCT03633617|448914218|FG000|Part B|COVID-19 Restrictions|0|||
124803745|NCT03633617|448914219|FG001|Part B|COVID-19 Restrictions|0|||
124803746|NCT03633617|448914220|FG002|Part B|COVID-19 Restrictions|1|||
124803747|NCT03633617|448914221|FG003|Part B|COVID-19 Restrictions|0|||
124803748|NCT03633617|448914222|FG004|Part B|COVID-19 Restrictions|0|||
124803749|NCT03633617|448914223|FG005|Part B|COVID-19 Restrictions|0|||
124803750|NCT03633617|448914224|FG006|Part B|COVID-19 Restrictions|0|||
124803751|NCT03633617|448914225|FG007|Part B|COVID-19 Restrictions|0|||
124803752|NCT03633617|448914226|FG008|Part B|COVID-19 Restrictions|0|||
124803753|NCT03633617|448914227|FG009|Part B|COVID-19 Restrictions|0|||
124803754|NCT03633617|448914228|FG010|Part B|COVID-19 Restrictions|0|||
124803755|NCT03633617|448914218|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803756|NCT03633617|448914219|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803757|NCT03633617|448914220|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
124803758|NCT03633617|448914221|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803759|NCT03633617|448914222|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803760|NCT03633617|448914223|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803761|NCT03633617|448914224|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803762|NCT03633617|448914225|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803763|NCT03633617|448914226|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803764|NCT03633617|448914227|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803765|NCT03633617|448914228|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
124803766|NCT03633617|448914218|FG000|Part C (& Follow-up)|Adverse Event|0|||
124803767|NCT03633617|448914219|FG001|Part C (& Follow-up)|Adverse Event|0|||
124803768|NCT03633617|448914220|FG002|Part C (& Follow-up)|Adverse Event|0|||
124803769|NCT03633617|448914221|FG003|Part C (& Follow-up)|Adverse Event|0|||
124803770|NCT03633617|448914222|FG004|Part C (& Follow-up)|Adverse Event|0|||
124803771|NCT03633617|448914223|FG005|Part C (& Follow-up)|Adverse Event|1|||
124803772|NCT03633617|448914224|FG006|Part C (& Follow-up)|Adverse Event|0|||
124803773|NCT03633617|448914225|FG007|Part C (& Follow-up)|Adverse Event|1|||
124803774|NCT03633617|448914226|FG008|Part C (& Follow-up)|Adverse Event|0|||
124803775|NCT03633617|448914227|FG009|Part C (& Follow-up)|Adverse Event|0|||
124803776|NCT03633617|448914228|FG010|Part C (& Follow-up)|Adverse Event|0|||
124803777|NCT03633617|448914218|FG000|Part C (& Follow-up)|Pregnancy|0|||
124803778|NCT03633617|448914219|FG001|Part C (& Follow-up)|Pregnancy|0|||
124803779|NCT03633617|448914220|FG002|Part C (& Follow-up)|Pregnancy|0|||
124803780|NCT03633617|448914221|FG003|Part C (& Follow-up)|Pregnancy|0|||
124803781|NCT03633617|448914222|FG004|Part C (& Follow-up)|Pregnancy|0|||
124803782|NCT03633617|448914223|FG005|Part C (& Follow-up)|Pregnancy|0|||
124803783|NCT03633617|448914224|FG006|Part C (& Follow-up)|Pregnancy|0|||
124633995|NCT03896503|448276167|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
124803784|NCT03633617|448914225|FG007|Part C (& Follow-up)|Pregnancy|0|||
124803785|NCT03633617|448914226|FG008|Part C (& Follow-up)|Pregnancy|0|||
124803786|NCT03633617|448914227|FG009|Part C (& Follow-up)|Pregnancy|1|||
124803787|NCT03633617|448914228|FG010|Part C (& Follow-up)|Pregnancy|0|||
124803788|NCT03633617|448914218|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
124803789|NCT03633617|448914219|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
124803790|NCT03633617|448914220|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
124803791|NCT03633617|448914221|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
124803792|NCT03633617|448914222|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
124803793|NCT03633617|448914223|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
124803794|NCT03633617|448914224|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
124803795|NCT03633617|448914225|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
124803796|NCT03633617|448914226|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
124803797|NCT03633617|448914227|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
124803798|NCT03633617|448914228|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
124803799|NCT03633617|448914218|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
124803800|NCT03633617|448914219|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
124803801|NCT03633617|448914220|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
124803802|NCT03633617|448914221|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
124803803|NCT03633617|448914222|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
124803804|NCT03633617|448914223|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
124803805|NCT03633617|448914224|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
124803806|NCT03633617|448914225|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
124803807|NCT03633617|448914226|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
124803808|NCT03633617|448914227|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
124803809|NCT03633617|448914228|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
124803810|NCT03633617|448914218|FG000|Part C (& Follow-up)|Physician Decision|0|||
124803811|NCT03633617|448914219|FG001|Part C (& Follow-up)|Physician Decision|0|||
124803812|NCT03633617|448914220|FG002|Part C (& Follow-up)|Physician Decision|0|||
124803813|NCT03633617|448914221|FG003|Part C (& Follow-up)|Physician Decision|0|||
124803814|NCT03633617|448914222|FG004|Part C (& Follow-up)|Physician Decision|0|||
124803815|NCT03633617|448914223|FG005|Part C (& Follow-up)|Physician Decision|0|||
124803816|NCT03633617|448914224|FG006|Part C (& Follow-up)|Physician Decision|0|||
124803817|NCT03633617|448914225|FG007|Part C (& Follow-up)|Physician Decision|1|||
124803818|NCT03633617|448914226|FG008|Part C (& Follow-up)|Physician Decision|0|||
124803819|NCT03633617|448914227|FG009|Part C (& Follow-up)|Physician Decision|0|||
124803820|NCT03633617|448914228|FG010|Part C (& Follow-up)|Physician Decision|1|||
124803821|NCT03633617|448914218|FG000|Part C (& Follow-up)|COVID-19 related|0|||
124803822|NCT03633617|448914219|FG001|Part C (& Follow-up)|COVID-19 related|0|||
124803823|NCT03633617|448914220|FG002|Part C (& Follow-up)|COVID-19 related|0|||
124803824|NCT03633617|448914221|FG003|Part C (& Follow-up)|COVID-19 related|0|||
124803825|NCT03633617|448914222|FG004|Part C (& Follow-up)|COVID-19 related|0|||
124803826|NCT03633617|448914223|FG005|Part C (& Follow-up)|COVID-19 related|1|||
124803827|NCT03633617|448914224|FG006|Part C (& Follow-up)|COVID-19 related|0|||
124803828|NCT03633617|448914225|FG007|Part C (& Follow-up)|COVID-19 related|0|||
124803829|NCT03633617|448914226|FG008|Part C (& Follow-up)|COVID-19 related|0|||
124803830|NCT03633617|448914227|FG009|Part C (& Follow-up)|COVID-19 related|0|||
124803831|NCT03633617|448914228|FG010|Part C (& Follow-up)|COVID-19 related|0|||
124803832|NCT03633617|448914218|FG000|Part C (& Follow-up)|Protocol Violation|0|||
124803833|NCT03633617|448914219|FG001|Part C (& Follow-up)|Protocol Violation|0|||
124803834|NCT03633617|448914220|FG002|Part C (& Follow-up)|Protocol Violation|0|||
124803835|NCT03633617|448914221|FG003|Part C (& Follow-up)|Protocol Violation|0|||
124803836|NCT03633617|448914222|FG004|Part C (& Follow-up)|Protocol Violation|0|||
124803837|NCT03633617|448914223|FG005|Part C (& Follow-up)|Protocol Violation|0|||
124803838|NCT03633617|448914224|FG006|Part C (& Follow-up)|Protocol Violation|0|||
124803839|NCT03633617|448914225|FG007|Part C (& Follow-up)|Protocol Violation|0|||
124803840|NCT03633617|448914226|FG008|Part C (& Follow-up)|Protocol Violation|0|||
124803841|NCT03633617|448914227|FG009|Part C (& Follow-up)|Protocol Violation|3|||
124803842|NCT03633617|448914228|FG010|Part C (& Follow-up)|Protocol Violation|1|||
124803843|NCT03633617|448914218|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
124803844|NCT03633617|448914219|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
124803845|NCT03633617|448914220|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
124803846|NCT03633617|448914221|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
124803847|NCT03633617|448914222|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
124803848|NCT03633617|448914223|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
124803849|NCT03633617|448914224|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
124803850|NCT03633617|448914225|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
124803851|NCT03633617|448914226|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
124803852|NCT03633617|448914227|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
124803853|NCT03633617|448914228|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
124803854|NCT01890746|448914229|FG000|Overall Study|Death|39|||
124803855|NCT01890746|448914230|FG001|Overall Study|Death|30|||
124803856|NCT01890746|448914229|FG000|Overall Study|Adverse Event|1|||
124803857|NCT01890746|448914230|FG001|Overall Study|Adverse Event|0|||
124803858|NCT01890746|448914229|FG000|Overall Study|Lost to Follow-up|4|||
124803859|NCT01890746|448914230|FG001|Overall Study|Lost to Follow-up|1|||
124803860|NCT01890746|448914229|FG000|Overall Study|Physician Decision|3|||
124803861|NCT01890746|448914230|FG001|Overall Study|Physician Decision|2|||
124803862|NCT01890746|448914229|FG000|Overall Study|Withdrawal by Subject|5|||
124803863|NCT01890746|448914230|FG001|Overall Study|Withdrawal by Subject|8|||
124803864|NCT02642029|448914231|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
124803865|NCT02642029|448914232|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
124803866|NCT02642029|448914233|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
124803867|NCT02642029|448914234|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
124803868|NCT02642029|448914235|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
124803869|NCT02642029|448914236|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
124803870|NCT02642029|448914231|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
124803871|NCT02642029|448914232|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
124803872|NCT02642029|448914233|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
124803873|NCT02642029|448914234|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
124803874|NCT02642029|448914235|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
124803875|NCT02642029|448914236|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
124803876|NCT02642029|448914231|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
124803877|NCT02642029|448914232|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
124803878|NCT02642029|448914233|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
124803879|NCT02642029|448914234|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
124803880|NCT02642029|448914235|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
124803881|NCT02642029|448914236|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
124803882|NCT02642029|448914231|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
124803883|NCT02642029|448914232|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
124803884|NCT02642029|448914233|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
124803885|NCT02642029|448914234|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
124803886|NCT02642029|448914235|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
124803887|NCT02642029|448914236|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
124803888|NCT02642029|448914231|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
124803889|NCT02642029|448914232|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
124803890|NCT02642029|448914233|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
124803891|NCT02642029|448914234|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
124803892|NCT02642029|448914235|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
124803893|NCT02642029|448914236|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
124803894|NCT02642029|448914231|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
124803895|NCT02642029|448914232|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
124803896|NCT02642029|448914233|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
124803897|NCT02642029|448914234|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
124803898|NCT02642029|448914235|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
124803899|NCT02642029|448914236|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
124803900|NCT01050543|448914241|FG000|Overall Study|Withdrawal by Subject|0|||
124803901|NCT01050543|448914242|FG001|Overall Study|Withdrawal by Subject|2|||
124803902|NCT01050543|448914241|FG000|Overall Study|Protocol Violation|0|||
124803903|NCT01050543|448914242|FG001|Overall Study|Protocol Violation|1|||
124803904|NCT01050543|448914241|FG000|Overall Study|Administrative|4|||
124803905|NCT01050543|448914242|FG001|Overall Study|Administrative|1|||
124803906|NCT00676338|448914243|FG000|Overall Study|Adverse Event|6|||
124803907|NCT00676338|448914244|FG001|Overall Study|Adverse Event|6|||
124803908|NCT00676338|448914245|FG002|Overall Study|Adverse Event|5|||
124803909|NCT00676338|448914246|FG003|Overall Study|Adverse Event|1|||
124803910|NCT00676338|448914243|FG000|Overall Study|Lost to Follow-up|4|||
124803911|NCT00676338|448914244|FG001|Overall Study|Lost to Follow-up|1|||
124803912|NCT00676338|448914245|FG002|Overall Study|Lost to Follow-up|3|||
124803913|NCT00676338|448914246|FG003|Overall Study|Lost to Follow-up|4|||
124803914|NCT00676338|448914243|FG000|Overall Study|Physician Decision|3|||
124803915|NCT00676338|448914244|FG001|Overall Study|Physician Decision|3|||
124803916|NCT00676338|448914245|FG002|Overall Study|Physician Decision|2|||
124803917|NCT00676338|448914246|FG003|Overall Study|Physician Decision|3|||
124803918|NCT00676338|448914243|FG000|Overall Study|Protocol Violation|5|||
124803919|NCT00676338|448914244|FG001|Overall Study|Protocol Violation|9|||
124803920|NCT00676338|448914245|FG002|Overall Study|Protocol Violation|2|||
124803921|NCT00676338|448914246|FG003|Overall Study|Protocol Violation|5|||
124803922|NCT00676338|448914243|FG000|Overall Study|Withdrawal by Subject|17|||
124803923|NCT00676338|448914244|FG001|Overall Study|Withdrawal by Subject|9|||
124803924|NCT00676338|448914245|FG002|Overall Study|Withdrawal by Subject|12|||
124803925|NCT00676338|448914246|FG003|Overall Study|Withdrawal by Subject|6|||
124803926|NCT00676338|448914243|FG000|Overall Study|Entry Criteria Not Met|0|||
124803927|NCT00676338|448914244|FG001|Overall Study|Entry Criteria Not Met|2|||
124803928|NCT00676338|448914245|FG002|Overall Study|Entry Criteria Not Met|1|||
124633996|NCT03896503|448276168|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
124633997|NCT03896503|448276169|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
124633998|NCT03896503|448276170|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
124633999|NCT03896503|448276171|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
124634000|NCT00437021|448276172|FG000|Overall Study|Adverse Event|0|||
124634001|NCT00437021|448276173|FG001|Overall Study|Adverse Event|0|||
124634002|NCT00437021|448276174|FG002|Overall Study|Adverse Event|0|||
124803929|NCT00676338|448914246|FG003|Overall Study|Entry Criteria Not Met|1|||
124803930|NCT00676338|448914243|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
124803931|NCT00676338|448914244|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
124803932|NCT00676338|448914245|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
124803933|NCT00676338|448914246|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
124803934|NCT00412542|448914249|FG000|Overall Study|Withdrawal by Subject|0|||
124803935|NCT00412542|448914250|FG001|Overall Study|Withdrawal by Subject|2|||
124803936|NCT00412542|448914249|FG000|Overall Study|Not Eligible|0|||
124803937|NCT00412542|448914250|FG001|Overall Study|Not Eligible|1|||
124803938|NCT02124161|448914253|FG000|Overall Study|Other unspecified|0|||
124803939|NCT02124161|448914254|FG001|Overall Study|Other unspecified|1|||
124803940|NCT02124161|448914253|FG000|Overall Study|Death|1|||
124803941|NCT02124161|448914254|FG001|Overall Study|Death|0|||
124803942|NCT02124161|448914253|FG000|Overall Study|Protocol Violation|2|||
124803943|NCT02124161|448914254|FG001|Overall Study|Protocol Violation|1|||
124803944|NCT02124161|448914253|FG000|Overall Study|Withdrawal by Subject|1|||
124803945|NCT02124161|448914254|FG001|Overall Study|Withdrawal by Subject|2|||
124803946|NCT02124161|448914253|FG000|Overall Study|Adverse Event|2|||
124803947|NCT02124161|448914254|FG001|Overall Study|Adverse Event|0|||
124803948|NCT02124161|448914253|FG000|Overall Study|Does not meet entrance criteria|2|||
124803949|NCT02124161|448914254|FG001|Overall Study|Does not meet entrance criteria|3|||
124803950|NCT02124161|448914253|FG000|Overall Study|No longer meets eligibility criteria|5|||
124803951|NCT02124161|448914254|FG001|Overall Study|No longer meets eligibility criteria|4|||
124803952|NCT02124161|448914253|FG000|Overall Study|Lost to Follow-up|3|||
124803953|NCT02124161|448914254|FG001|Overall Study|Lost to Follow-up|4|||
124803954|NCT02517866|448914255|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
124803955|NCT02517866|448914256|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
124803956|NCT02517866|448914257|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
124803957|NCT02517866|448914255|FG000|Overall Study|Significant Protocol Deviation|4|||
124803958|NCT02517866|448914256|FG001|Overall Study|Significant Protocol Deviation|1|||
124803959|NCT02517866|448914257|FG002|Overall Study|Significant Protocol Deviation|0|||
124803960|NCT02517866|448914255|FG000|Overall Study|Lost to Follow-up|1|||
124803961|NCT02517866|448914256|FG001|Overall Study|Lost to Follow-up|0|||
124803962|NCT02517866|448914257|FG002|Overall Study|Lost to Follow-up|0|||
124803963|NCT02517866|448914255|FG000|Overall Study|Voluntary Withdrawal|2|||
124803964|NCT02517866|448914256|FG001|Overall Study|Voluntary Withdrawal|2|||
124803965|NCT02517866|448914257|FG002|Overall Study|Voluntary Withdrawal|0|||
124803966|NCT02517866|448914255|FG000|Overall Study|Investigator Decision|2|||
124634003|NCT00437021|448276175|FG003|Overall Study|Adverse Event|0|||
124634004|NCT00437021|448276176|FG004|Overall Study|Adverse Event|0|||
124634005|NCT00437021|448276177|FG005|Overall Study|Adverse Event|0|||
124634006|NCT00437021|448276178|FG006|Overall Study|Adverse Event|1|||
124634007|NCT00437021|448276179|FG007|Overall Study|Adverse Event|0|||
124634008|NCT00437021|448276180|FG008|Overall Study|Adverse Event|0|||
124634009|NCT00437021|448276181|FG009|Overall Study|Adverse Event|0|||
124634010|NCT00437021|448276182|FG010|Overall Study|Adverse Event|0|||
124634011|NCT00437021|448276183|FG011|Overall Study|Adverse Event|0|||
124803967|NCT02517866|448914256|FG001|Overall Study|Investigator Decision|1|||
124803968|NCT02517866|448914257|FG002|Overall Study|Investigator Decision|0|||
124803969|NCT02517866|448914255|FG000|Overall Study|Reason not specified|2|||
124803970|NCT02517866|448914256|FG001|Overall Study|Reason not specified|0|||
124803971|NCT02517866|448914257|FG002|Overall Study|Reason not specified|0|||
124803972|NCT01147640|448914258|FG000|Overall Study|Adverse Event|2|||
124803973|NCT01147640|448914259|FG001|Overall Study|Adverse Event|0|||
124803974|NCT01147640|448914258|FG000|Overall Study|Physician Decision|1|||
124803975|NCT01147640|448914259|FG001|Overall Study|Physician Decision|0|||
124803976|NCT01147640|448914258|FG000|Overall Study|Withdrawal by Subject|1|||
124803977|NCT01147640|448914259|FG001|Overall Study|Withdrawal by Subject|0|||
124803978|NCT01147640|448914258|FG000|Overall Study|Lost to Follow-up|0|||
124634012|NCT00437021|448276172|FG000|Overall Study|Lost to Follow-up|0|||
124634013|NCT00437021|448276173|FG001|Overall Study|Lost to Follow-up|3|||
124634014|NCT00437021|448276174|FG002|Overall Study|Lost to Follow-up|0|||
124634015|NCT00437021|448276175|FG003|Overall Study|Lost to Follow-up|0|||
124803979|NCT01147640|448914259|FG001|Overall Study|Lost to Follow-up|1|||
124803980|NCT01147640|448914258|FG000|Overall Study|Didn't meet eligibility criteria|1|||
124803981|NCT01147640|448914259|FG001|Overall Study|Didn't meet eligibility criteria|0|||
124803982|NCT01797731|448914261|FG000|Overall Study|Didn't have proper radiographs required|3|||
124803983|NCT01797731|448914262|FG001|Overall Study|Didn't have proper radiographs required|3|||
124803984|NCT01954342|448914263|FG000|Overall Study|Missing data from 13-16week study visit|0|||
124803985|NCT01954342|448914264|FG001|Overall Study|Missing data from 13-16week study visit|0|||
124803986|NCT01954342|448914265|FG002|Overall Study|Missing data from 13-16week study visit|0|||
124803987|NCT01954342|448914266|FG003|Overall Study|Missing data from 13-16week study visit|1|||
124803988|NCT01954342|448914263|FG000|Overall Study|Miscarriage|0|||
124803989|NCT01954342|448914264|FG001|Overall Study|Miscarriage|0|||
124803990|NCT01954342|448914265|FG002|Overall Study|Miscarriage|0|||
124803991|NCT01954342|448914266|FG003|Overall Study|Miscarriage|3|||
124803992|NCT01954342|448914263|FG000|Overall Study|Lost to Follow-up|0|||
124803993|NCT01954342|448914264|FG001|Overall Study|Lost to Follow-up|0|||
124634016|NCT00437021|448276176|FG004|Overall Study|Lost to Follow-up|0|||
124634017|NCT00437021|448276177|FG005|Overall Study|Lost to Follow-up|2|||
124634018|NCT00437021|448276178|FG006|Overall Study|Lost to Follow-up|0|||
124803994|NCT01954342|448914265|FG002|Overall Study|Lost to Follow-up|0|||
124803995|NCT01954342|448914266|FG003|Overall Study|Lost to Follow-up|5|||
124803996|NCT01954342|448914263|FG000|Overall Study|Preterm delivery|0|||
124803997|NCT01954342|448914264|FG001|Overall Study|Preterm delivery|0|||
124803998|NCT01954342|448914265|FG002|Overall Study|Preterm delivery|0|||
124803999|NCT01954342|448914266|FG003|Overall Study|Preterm delivery|3|||
124804000|NCT01954342|448914263|FG000|Overall Study|Pre-eclampsia|0|||
124804001|NCT01954342|448914264|FG001|Overall Study|Pre-eclampsia|0|||
124804002|NCT01954342|448914265|FG002|Overall Study|Pre-eclampsia|0|||
124804003|NCT01954342|448914266|FG003|Overall Study|Pre-eclampsia|4|||
124804004|NCT01954342|448914263|FG000|Overall Study|Unreliable Data|0|||
124804005|NCT01954342|448914264|FG001|Overall Study|Unreliable Data|0|||
124804006|NCT01954342|448914265|FG002|Overall Study|Unreliable Data|0|||
124804007|NCT01954342|448914266|FG003|Overall Study|Unreliable Data|2|||
124804008|NCT00629772|448914271|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
124804009|NCT00629772|448914272|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
124804010|NCT00629772|448914271|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
124804011|NCT00629772|448914272|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
124804012|NCT01497275|448914273|FG000|Overall Study|Death|1|||
124804013|NCT01497275|448914273|FG000|Overall Study|Adverse Event|1|||
124804014|NCT01950169|448914274|FG000|Overall Study|Withdrawal by Subject|2|||
124804015|NCT01950169|448914275|FG001|Overall Study|Withdrawal by Subject|8|||
124804016|NCT01950169|448914276|FG002|Overall Study|Withdrawal by Subject|1|||
124804017|NCT01950169|448914274|FG000|Overall Study|Death|1|||
124804018|NCT01950169|448914275|FG001|Overall Study|Death|0|||
124804019|NCT01950169|448914276|FG002|Overall Study|Death|0|||
124804020|NCT00285818|448914287|FG000|Overall Study|Withdrawal by Subject|3|||
124804021|NCT00285818|448914288|FG001|Overall Study|Withdrawal by Subject|2|||
124804022|NCT00285818|448914287|FG000|Overall Study|Lost to Follow-up|1|||
124804023|NCT00285818|448914288|FG001|Overall Study|Lost to Follow-up|0|||
124804024|NCT01230710|448914293|FG000|Overall Study|Disease Progression|41|||
124804025|NCT01230710|448914293|FG000|Overall Study|Lost to Follow-up|3|||
124804026|NCT01230710|448914293|FG000|Overall Study|Death|4|||
124804027|NCT01230710|448914293|FG000|Overall Study|Withdrawal of Consent|1|||
124804028|NCT05394350|448914294|FG000|Overall Study|Death|2|||
124804029|NCT05394350|448914295|FG001|Overall Study|Death|2|||
124804030|NCT05394350|448914296|FG002|Overall Study|Death|4|||
124804031|NCT05394350|448914297|FG003|Overall Study|Death|0|||
124804032|NCT05394350|448914298|FG004|Overall Study|Death|1|||
124804033|NCT05394350|448914299|FG005|Overall Study|Death|0|||
124804034|NCT05394350|448914294|FG000|Overall Study|Study terminated by sponsor|1|||
124804035|NCT05394350|448914295|FG001|Overall Study|Study terminated by sponsor|1|||
124804036|NCT05394350|448914296|FG002|Overall Study|Study terminated by sponsor|7|||
124804037|NCT05394350|448914297|FG003|Overall Study|Study terminated by sponsor|3|||
124804038|NCT05394350|448914298|FG004|Overall Study|Study terminated by sponsor|2|||
124804039|NCT05394350|448914299|FG005|Overall Study|Study terminated by sponsor|4|||
124804040|NCT01336569|448914300|FG000|Overall Study|Lost to Follow-up|4|||
124804041|NCT02963935|448914303|FG000|Overall Study|Adverse Event|12|||
124804042|NCT02963935|448914304|FG001|Overall Study|Adverse Event|6|||
124804043|NCT02963935|448914303|FG000|Overall Study|Protocol Violation|2|||
124804044|NCT02963935|448914304|FG001|Overall Study|Protocol Violation|1|||
124804045|NCT02963935|448914303|FG000|Overall Study|Lack of Efficacy|0|||
124804046|NCT02963935|448914304|FG001|Overall Study|Lack of Efficacy|2|||
124804047|NCT02963935|448914303|FG000|Overall Study|Lost to Follow-up|1|||
124804048|NCT02963935|448914304|FG001|Overall Study|Lost to Follow-up|6|||
124804049|NCT02963935|448914303|FG000|Overall Study|Unclassified|13|||
124804050|NCT02963935|448914304|FG001|Overall Study|Unclassified|22|||
124804051|NCT00464269|448914305|FG000|Overall Study|Lack of Efficacy|1|||
124804052|NCT00464269|448914306|FG001|Overall Study|Lack of Efficacy|0|||
124804053|NCT00464269|448914307|FG002|Overall Study|Lack of Efficacy|0|||
124634019|NCT00437021|448276179|FG007|Overall Study|Lost to Follow-up|1|||
124634020|NCT00437021|448276180|FG008|Overall Study|Lost to Follow-up|0|||
124634021|NCT00437021|448276181|FG009|Overall Study|Lost to Follow-up|0|||
124804054|NCT00464269|448914308|FG003|Overall Study|Lack of Efficacy|0|||
124804055|NCT00464269|448914305|FG000|Overall Study|Lost to Follow-up|0|||
124804056|NCT00464269|448914306|FG001|Overall Study|Lost to Follow-up|4|||
124804057|NCT00464269|448914307|FG002|Overall Study|Lost to Follow-up|0|||
124804058|NCT00464269|448914308|FG003|Overall Study|Lost to Follow-up|1|||
124804059|NCT00464269|448914305|FG000|Overall Study|Withdrawal by Subject|0|||
124804060|NCT00464269|448914306|FG001|Overall Study|Withdrawal by Subject|2|||
124804061|NCT00464269|448914307|FG002|Overall Study|Withdrawal by Subject|1|||
124804062|NCT00464269|448914308|FG003|Overall Study|Withdrawal by Subject|1|||
124804063|NCT00464269|448914305|FG000|Overall Study|Other reason|3|||
124804064|NCT00464269|448914306|FG001|Overall Study|Other reason|3|||
124804065|NCT00464269|448914307|FG002|Overall Study|Other reason|1|||
124804066|NCT00464269|448914308|FG003|Overall Study|Other reason|1|||
124804067|NCT00464269|448914305|FG000|Overall Study|AE, serious fatal|0|||
124804068|NCT00464269|448914306|FG001|Overall Study|AE, serious fatal|0|||
124804069|NCT00464269|448914307|FG002|Overall Study|AE, serious fatal|1|||
124804070|NCT00464269|448914308|FG003|Overall Study|AE, serious fatal|1|||
124804071|NCT00464269|448914305|FG000|Overall Study|SAE, non-fatal|0|||
124804072|NCT00464269|448914306|FG001|Overall Study|SAE, non-fatal|0|||
124804073|NCT00464269|448914307|FG002|Overall Study|SAE, non-fatal|0|||
124804074|NCT00464269|448914308|FG003|Overall Study|SAE, non-fatal|1|||
124804075|NCT00464269|448914305|FG000|Overall Study|AE, non-serious non-fatal|2|||
124804076|NCT00464269|448914306|FG001|Overall Study|AE, non-serious non-fatal|8|||
124804077|NCT00464269|448914307|FG002|Overall Study|AE, non-serious non-fatal|3|||
124804078|NCT00464269|448914308|FG003|Overall Study|AE, non-serious non-fatal|4|||
124804079|NCT00464269|448914305|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
124804080|NCT00464269|448914306|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
124804081|NCT00464269|448914307|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
124804082|NCT00464269|448914308|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
124804083|NCT02337738|448914309|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
124804084|NCT02337738|448914310|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
124804085|NCT02337738|448914311|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
124804086|NCT02337738|448914309|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
124804087|NCT02337738|448914310|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
124804088|NCT02337738|448914311|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
124804089|NCT02337738|448914309|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
124804090|NCT02337738|448914310|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
124804091|NCT02337738|448914311|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
124804092|NCT02337738|448914309|FG000|Overall Study|Voluntary Withdrawal|10|||
124804093|NCT02337738|448914310|FG001|Overall Study|Voluntary Withdrawal|5|||
124804094|NCT02337738|448914311|FG002|Overall Study|Voluntary Withdrawal|2|||
124804095|NCT02337738|448914309|FG000|Overall Study|Lack of Efficacy|2|||
124804096|NCT02337738|448914310|FG001|Overall Study|Lack of Efficacy|4|||
124804097|NCT02337738|448914311|FG002|Overall Study|Lack of Efficacy|0|||
124804098|NCT02337738|448914309|FG000|Overall Study|Investigator's Judgment|1|||
124804099|NCT02337738|448914310|FG001|Overall Study|Investigator's Judgment|1|||
124804100|NCT02337738|448914311|FG002|Overall Study|Investigator's Judgment|3|||
124804101|NCT00406354|448914312|FG000|All Randomized Patients|Protocol Violation|0|||
124804102|NCT00406354|448914313|FG001|All Randomized Patients|Protocol Violation|0|||
124804103|NCT00406354|448914314|FG002|All Randomized Patients|Protocol Violation|1|||
124804104|NCT00406354|448914312|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
124804105|NCT00406354|448914313|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
124804106|NCT00406354|448914314|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
124804107|NCT00406354|448914312|FG000|All Randomized and Treated Patients|Adverse Event|6|||
124804108|NCT00406354|448914313|FG001|All Randomized and Treated Patients|Adverse Event|2|||
124804109|NCT00406354|448914314|FG002|All Randomized and Treated Patients|Adverse Event|1|||
124804110|NCT00406354|448914312|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
124804111|NCT00406354|448914313|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
124804112|NCT00406354|448914314|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
124804113|NCT00406354|448914312|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
124804114|NCT00406354|448914313|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
124804115|NCT00406354|448914314|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
124804116|NCT00406354|448914312|FG000|All Randomized and Treated Patients|Physician Decision|0|||
124804117|NCT00406354|448914313|FG001|All Randomized and Treated Patients|Physician Decision|0|||
124804118|NCT00406354|448914314|FG002|All Randomized and Treated Patients|Physician Decision|1|||
124804119|NCT00747461|448914315|FG000|Overall Study|study terminated by sponsor|5|||
124804120|NCT01565642|448914330|FG000|Overall Study|Withdrawal by Subject|2|||
124804121|NCT01565642|448914331|FG001|Overall Study|Withdrawal by Subject|1|||
124804122|NCT00961649|448914333|FG000|Overall Study|Adverse Event|4|||
124804123|NCT00961649|448914334|FG001|Overall Study|Adverse Event|0|||
124804124|NCT00961649|448914335|FG002|Overall Study|Adverse Event|0|||
124804125|NCT00961649|448914336|FG003|Overall Study|Adverse Event|2|||
124804126|NCT00961649|448914333|FG000|Overall Study|Inadequate control of IOP|0|||
124804127|NCT00961649|448914334|FG001|Overall Study|Inadequate control of IOP|0|||
124804128|NCT00961649|448914335|FG002|Overall Study|Inadequate control of IOP|0|||
124804129|NCT00961649|448914336|FG003|Overall Study|Inadequate control of IOP|1|||
124804130|NCT00961649|448914333|FG000|Overall Study|Patient has travel plans during holidays|0|||
124804131|NCT00961649|448914334|FG001|Overall Study|Patient has travel plans during holidays|0|||
124804132|NCT00961649|448914335|FG002|Overall Study|Patient has travel plans during holidays|1|||
124804133|NCT00961649|448914336|FG003|Overall Study|Patient has travel plans during holidays|0|||
124804134|NCT00961649|448914333|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
124804135|NCT00961649|448914334|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
124804136|NCT00961649|448914335|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
124804137|NCT00961649|448914336|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
124804138|NCT00961649|448914333|FG000|Overall Study|Study terminated by sponsor|4|||
124804139|NCT00961649|448914334|FG001|Overall Study|Study terminated by sponsor|4|||
124804140|NCT00961649|448914335|FG002|Overall Study|Study terminated by sponsor|4|||
124804141|NCT00961649|448914336|FG003|Overall Study|Study terminated by sponsor|1|||
124804142|NCT02711345|448914337|FG000|Overall Study|Adverse Event|0|||
124804143|NCT02711345|448914338|FG001|Overall Study|Adverse Event|0|||
124804144|NCT02711345|448914339|FG002|Overall Study|Adverse Event|0|||
124804145|NCT02711345|448914340|FG003|Overall Study|Adverse Event|1|||
124804146|NCT02711345|448914341|FG004|Overall Study|Adverse Event|1|||
124804147|NCT02711345|448914342|FG005|Overall Study|Adverse Event|2|||
124804148|NCT02711345|448914343|FG006|Overall Study|Adverse Event|1|||
124804149|NCT02711345|448914344|FG007|Overall Study|Adverse Event|0|||
124804150|NCT02711345|448914345|FG008|Overall Study|Adverse Event|0|||
124804151|NCT02711345|448914346|FG009|Overall Study|Adverse Event|2|||
124804152|NCT02711345|448914337|FG000|Overall Study|Physician Decision|0|||
124804153|NCT02711345|448914338|FG001|Overall Study|Physician Decision|0|||
124804154|NCT02711345|448914339|FG002|Overall Study|Physician Decision|1|||
124804155|NCT02711345|448914340|FG003|Overall Study|Physician Decision|0|||
124804156|NCT02711345|448914341|FG004|Overall Study|Physician Decision|0|||
124804157|NCT02711345|448914342|FG005|Overall Study|Physician Decision|0|||
124804158|NCT02711345|448914343|FG006|Overall Study|Physician Decision|0|||
124804159|NCT02711345|448914344|FG007|Overall Study|Physician Decision|0|||
124804160|NCT02711345|448914345|FG008|Overall Study|Physician Decision|1|||
124804161|NCT02711345|448914346|FG009|Overall Study|Physician Decision|0|||
124804162|NCT02711345|448914337|FG000|Overall Study|Progressive disease|1|||
124804163|NCT02711345|448914338|FG001|Overall Study|Progressive disease|3|||
124804164|NCT02711345|448914339|FG002|Overall Study|Progressive disease|5|||
124804165|NCT02711345|448914340|FG003|Overall Study|Progressive disease|3|||
124804166|NCT02711345|448914341|FG004|Overall Study|Progressive disease|7|||
124804167|NCT02711345|448914342|FG005|Overall Study|Progressive disease|2|||
124804168|NCT02711345|448914343|FG006|Overall Study|Progressive disease|8|||
124804169|NCT02711345|448914344|FG007|Overall Study|Progressive disease|4|||
124804170|NCT02711345|448914345|FG008|Overall Study|Progressive disease|5|||
124804171|NCT02711345|448914346|FG009|Overall Study|Progressive disease|6|||
124804172|NCT02711345|448914337|FG000|Overall Study|Subject/guardian decision|0|||
124804173|NCT02711345|448914338|FG001|Overall Study|Subject/guardian decision|0|||
124804174|NCT02711345|448914339|FG002|Overall Study|Subject/guardian decision|0|||
124804175|NCT02711345|448914340|FG003|Overall Study|Subject/guardian decision|0|||
124804176|NCT02711345|448914341|FG004|Overall Study|Subject/guardian decision|0|||
124804177|NCT02711345|448914342|FG005|Overall Study|Subject/guardian decision|2|||
124804178|NCT02711345|448914343|FG006|Overall Study|Subject/guardian decision|3|||
124804179|NCT02711345|448914344|FG007|Overall Study|Subject/guardian decision|1|||
124804180|NCT02711345|448914345|FG008|Overall Study|Subject/guardian decision|0|||
124804181|NCT02711345|448914346|FG009|Overall Study|Subject/guardian decision|4|||
124804182|NCT02711345|448914337|FG000|Overall Study|Death|1|||
124804183|NCT02711345|448914338|FG001|Overall Study|Death|0|||
124804184|NCT02711345|448914339|FG002|Overall Study|Death|0|||
124804185|NCT02711345|448914340|FG003|Overall Study|Death|0|||
124804186|NCT02711345|448914341|FG004|Overall Study|Death|0|||
124804187|NCT02711345|448914342|FG005|Overall Study|Death|0|||
124804188|NCT02711345|448914343|FG006|Overall Study|Death|0|||
124804189|NCT02711345|448914344|FG007|Overall Study|Death|1|||
124804190|NCT02711345|448914345|FG008|Overall Study|Death|0|||
124804191|NCT02711345|448914346|FG009|Overall Study|Death|0|||
124804192|NCT04043728|448914347|FG000|Overall Study|Lost to Follow-up|1|||
124804193|NCT04043728|448914348|FG001|Overall Study|Lost to Follow-up|2|||
124804194|NCT04043728|448914349|FG002|Overall Study|Lost to Follow-up|0|||
124804195|NCT01033851|448914350|FG000|Overall Study|Withdrawal by Subject|3|||
124804196|NCT01033851|448914351|FG001|Overall Study|Withdrawal by Subject|7|||
124804197|NCT02349542|448914352|FG000|Overall Study|Withdrawal by Subject|5|||
124804198|NCT01011738|448914353|FG000|Overall Study|Death|12|||
124804199|NCT01011738|448914354|FG001|Overall Study|Death|3|||
124804200|NCT01011738|448914355|FG002|Overall Study|Death|0|||
124804201|NCT01011738|448914353|FG000|Overall Study|Unknown reasons|312|||
124804202|NCT01011738|448914354|FG001|Overall Study|Unknown reasons|291|||
124804203|NCT01011738|448914355|FG002|Overall Study|Unknown reasons|17|||
124634022|NCT00437021|448276182|FG010|Overall Study|Lost to Follow-up|0|||
124804204|NCT01163266|448914358|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
124804205|NCT01163266|448914359|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
124804206|NCT01163266|448914360|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
124804207|NCT01163266|448914358|FG000|Overall Study|Lack of Efficacy|1|||
124804208|NCT01163266|448914359|FG001|Overall Study|Lack of Efficacy|3|||
124804209|NCT01163266|448914360|FG002|Overall Study|Lack of Efficacy|1|||
124804210|NCT01163266|448914358|FG000|Overall Study|Noncompliance with Study Drug|0|||
124804211|NCT01163266|448914359|FG001|Overall Study|Noncompliance with Study Drug|2|||
124804212|NCT01163266|448914360|FG002|Overall Study|Noncompliance with Study Drug|0|||
124804213|NCT01163266|448914358|FG000|Overall Study|Protocol Deviations|2|||
124804214|NCT01163266|448914359|FG001|Overall Study|Protocol Deviations|2|||
124804215|NCT01163266|448914360|FG002|Overall Study|Protocol Deviations|5|||
124804216|NCT01163266|448914358|FG000|Overall Study|Withdrawal of Consent|5|||
124804217|NCT01163266|448914359|FG001|Overall Study|Withdrawal of Consent|7|||
124804218|NCT01163266|448914360|FG002|Overall Study|Withdrawal of Consent|3|||
124804219|NCT01163266|448914358|FG000|Overall Study|Lost to Follow-up|7|||
124804220|NCT01163266|448914359|FG001|Overall Study|Lost to Follow-up|7|||
124804221|NCT01163266|448914360|FG002|Overall Study|Lost to Follow-up|10|||
124804222|NCT01163266|448914358|FG000|Overall Study|Other|1|||
124804223|NCT01163266|448914359|FG001|Overall Study|Other|1|||
124804224|NCT01163266|448914360|FG002|Overall Study|Other|2|||
124804225|NCT02586064|448914361|FG000|Overall Study|Other Obligations|6|||
124804226|NCT02586064|448914362|FG001|Overall Study|Other Obligations|6|||
124804227|NCT02586064|448914361|FG000|Overall Study|Other|3|||
124804228|NCT02586064|448914362|FG001|Overall Study|Other|7|||
124804229|NCT02586064|448914361|FG000|Overall Study|Never Started|3|||
124804230|NCT02586064|448914362|FG001|Overall Study|Never Started|3|||
124804231|NCT02586064|448914361|FG000|Overall Study|Lost Interest|1|||
124804232|NCT02586064|448914362|FG001|Overall Study|Lost Interest|4|||
124804233|NCT02586064|448914361|FG000|Overall Study|Miscellaneous Life Issues|0|||
124804234|NCT02586064|448914362|FG001|Overall Study|Miscellaneous Life Issues|5|||
124804235|NCT02586064|448914361|FG000|Overall Study|Infrequent Attendance|2|||
124804236|NCT02586064|448914362|FG001|Overall Study|Infrequent Attendance|1|||
124804237|NCT02586064|448914361|FG000|Overall Study|Timed Out|2|||
124804238|NCT02586064|448914362|FG001|Overall Study|Timed Out|0|||
124804239|NCT02586064|448914361|FG000|Overall Study|AUD relapse|0|||
124804240|NCT02586064|448914362|FG001|Overall Study|AUD relapse|2|||
124804241|NCT02586064|448914361|FG000|Overall Study|Legal Issue|1|||
124804242|NCT02586064|448914362|FG001|Overall Study|Legal Issue|0|||
124804243|NCT02919696|448914363|FG000|Overall Study|Adverse Event|1|||
124804244|NCT02919696|448914364|FG001|Overall Study|Adverse Event|2|||
124804245|NCT02919696|448914363|FG000|Overall Study|Withdrawal by Subject|2|||
124804246|NCT02919696|448914364|FG001|Overall Study|Withdrawal by Subject|1|||
124804247|NCT02919696|448914363|FG000|Overall Study|Sponsor Decision|1|||
124804248|NCT02919696|448914364|FG001|Overall Study|Sponsor Decision|1|||
124804249|NCT02919696|448914363|FG000|Overall Study|Never Treated|0|||
124804250|NCT02919696|448914364|FG001|Overall Study|Never Treated|1|||
124804251|NCT04308304|448914365|FG000|Overall Study|Withdrawal by Subject|4|||
124804252|NCT04308304|448914366|FG001|Overall Study|Withdrawal by Subject|0|||
124804253|NCT04308304|448914365|FG000|Overall Study|Protocol Violation|1|||
124804254|NCT04308304|448914366|FG001|Overall Study|Protocol Violation|0|||
124804255|NCT00945555|448914367|FG000|Overall Study|Referred to another hospital|5|||
124804256|NCT00945555|448914367|FG000|Overall Study|Worsening condition, intensive care unit|1|||
124804257|NCT00945555|448914367|FG000|Overall Study|Withdrawal by Subject|2|||
124804258|NCT00945555|448914367|FG000|Overall Study|Participant continued treatment at home|1|||
124804259|NCT00945555|448914367|FG000|Overall Study|Death|18|||
124804260|NCT00945555|448914367|FG000|Overall Study|Other|1|||
124804261|NCT04502979|448914371|FG000|Overall Study|Lost to Follow-up|1|||
124804262|NCT04502979|448914372|FG001|Overall Study|Lost to Follow-up|3|||
124804263|NCT04502979|448914371|FG000|Overall Study|Withdrawal by Subject|2|||
124804264|NCT04502979|448914372|FG001|Overall Study|Withdrawal by Subject|1|||
124804265|NCT01558739|448914381|FG000|Overall Study|Adverse Event|7|||
124804266|NCT01558739|448914381|FG000|Overall Study|Withdrawal by Subject|2|||
124804267|NCT01558739|448914381|FG000|Overall Study|Death|3|||
124804268|NCT01558739|448914381|FG000|Overall Study|Disease Progression|4|||
124804269|NCT01558739|448914381|FG000|Overall Study|Protocol Violation|1|||
124804270|NCT02719327|448914385|FG000|Overall Study|Withdrawal by Subject|11|||
124804271|NCT02719327|448914386|FG001|Overall Study|Withdrawal by Subject|8|||
124804272|NCT01066000|448914389|FG000|Overall Study|Protocol Violation|4|||
124804273|NCT01066000|448914389|FG000|Overall Study|Death|3|||
124804274|NCT01066000|448914389|FG000|Overall Study|Withdrawal by Subject|1|||
124804275|NCT01066000|448914389|FG000|Overall Study|Adverse Event|1|||
124804276|NCT00566111|448914390|FG000|Overall Study|Adverse Event|0|||
124804277|NCT00566111|448914391|FG001|Overall Study|Adverse Event|2|||
124804278|NCT02497612|448916056|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
124804279|NCT02497612|448916057|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
124634023|NCT00437021|448276183|FG011|Overall Study|Lost to Follow-up|0|||
124634024|NCT00437021|448276172|FG000|Overall Study|Withdrawal by Subject|2|||
124804280|NCT02497612|448916058|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
124804281|NCT02497612|448916059|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
124804282|NCT02497612|448916056|FG000|Overall Study|Participant's request|2|||
124804283|NCT02497612|448916057|FG001|Overall Study|Participant's request|3|||
124804284|NCT02497612|448916058|FG002|Overall Study|Participant's request|4|||
124804285|NCT02497612|448916059|FG003|Overall Study|Participant's request|1|||
124804286|NCT02497612|448916056|FG000|Overall Study|Investigator's judgement|1|||
124804287|NCT02497612|448916057|FG001|Overall Study|Investigator's judgement|0|||
124804288|NCT02497612|448916058|FG002|Overall Study|Investigator's judgement|0|||
124804289|NCT02497612|448916059|FG003|Overall Study|Investigator's judgement|2|||
124804290|NCT02497612|448916056|FG000|Overall Study|Adverse Event|3|||
124804291|NCT02497612|448916057|FG001|Overall Study|Adverse Event|1|||
124804292|NCT02497612|448916058|FG002|Overall Study|Adverse Event|4|||
124804293|NCT02497612|448916059|FG003|Overall Study|Adverse Event|1|||
124804294|NCT02497612|448916056|FG000|Overall Study|Lost to Follow-up|1|||
124804295|NCT02497612|448916057|FG001|Overall Study|Lost to Follow-up|1|||
124804296|NCT02497612|448916058|FG002|Overall Study|Lost to Follow-up|0|||
124804297|NCT02497612|448916059|FG003|Overall Study|Lost to Follow-up|1|||
124804298|NCT02497612|448916056|FG000|Overall Study|Other unspecified|1|||
124804299|NCT02497612|448916057|FG001|Overall Study|Other unspecified|1|||
124804300|NCT02497612|448916058|FG002|Overall Study|Other unspecified|2|||
124804301|NCT02497612|448916059|FG003|Overall Study|Other unspecified|0|||
124804302|NCT02497612|448916056|FG000|Overall Study|Not eligible|1|||
124804303|NCT02497612|448916057|FG001|Overall Study|Not eligible|0|||
124804304|NCT02497612|448916058|FG002|Overall Study|Not eligible|0|||
124804305|NCT02497612|448916059|FG003|Overall Study|Not eligible|1|||
124804306|NCT05021081|448916062|FG000|Phase 2|Subject enrolled in error|1|||
124804307|NCT05021081|448916063|FG001|Phase 2|Subject enrolled in error|1|||
124804308|NCT05021081|448916064|FG002|Phase 2|Subject enrolled in error|0|||
124804309|NCT02651467|448916065|FG000|Overall Study|Withdrawal by Subject|0|||
124804310|NCT02651467|448916066|FG001|Overall Study|Withdrawal by Subject|0|||
124804311|NCT02651467|448916067|FG002|Overall Study|Withdrawal by Subject|2|||
124804312|NCT02651467|448916065|FG000|Overall Study|Other (Not specified)|1|||
124804313|NCT02651467|448916066|FG001|Overall Study|Other (Not specified)|0|||
124804314|NCT02651467|448916067|FG002|Overall Study|Other (Not specified)|2|||
124804315|NCT02024529|448916070|FG000|Overall Study|Withdrawal by Subject|11|||
124804316|NCT02024529|448916071|FG001|Overall Study|Withdrawal by Subject|21|||
124804317|NCT02024529|448916070|FG000|Overall Study|Lost to Follow-up|2|||
124804318|NCT02024529|448916071|FG001|Overall Study|Lost to Follow-up|4|||
124804319|NCT00573937|448916072|FG000|Overall Study|Study Terminated|0|||
124804320|NCT00573937|448916073|FG001|Overall Study|Study Terminated|1|||
124804321|NCT04171765|448916074|FG000|Overall Study|Adverse Event|2|||
124804322|NCT04171765|448916075|FG001|Overall Study|Adverse Event|0|||
124804323|NCT04171765|448916076|FG002|Overall Study|Adverse Event|1|||
124804324|NCT04171765|448916077|FG003|Overall Study|Adverse Event|0|||
124804325|NCT04171765|448916074|FG000|Overall Study|Lost to Follow-up|0|||
124804326|NCT04171765|448916075|FG001|Overall Study|Lost to Follow-up|2|||
124804327|NCT04171765|448916076|FG002|Overall Study|Lost to Follow-up|2|||
124804328|NCT04171765|448916077|FG003|Overall Study|Lost to Follow-up|2|||
124804329|NCT04171765|448916074|FG000|Overall Study|Week 58 visit missed|0|||
124804330|NCT04171765|448916075|FG001|Overall Study|Week 58 visit missed|0|||
124804331|NCT04171765|448916076|FG002|Overall Study|Week 58 visit missed|1|||
124804332|NCT04171765|448916077|FG003|Overall Study|Week 58 visit missed|0|||
124804333|NCT04171765|448916074|FG000|Overall Study|Study terminated by sponsor|2|||
124804334|NCT04171765|448916075|FG001|Overall Study|Study terminated by sponsor|0|||
124804335|NCT04171765|448916076|FG002|Overall Study|Study terminated by sponsor|0|||
124804336|NCT04171765|448916077|FG003|Overall Study|Study terminated by sponsor|0|||
124804337|NCT04171765|448916074|FG000|Overall Study|Withdrawal by Subject|1|||
124804338|NCT04171765|448916075|FG001|Overall Study|Withdrawal by Subject|0|||
124804339|NCT04171765|448916076|FG002|Overall Study|Withdrawal by Subject|0|||
124804340|NCT04171765|448916077|FG003|Overall Study|Withdrawal by Subject|3|||
124804341|NCT00631696|448916080|FG000|Overall Study|Entered, not randomized to treatment|1|||
124804342|NCT00631696|448916081|FG001|Overall Study|Entered, not randomized to treatment|1|||
124804343|NCT00631696|448916080|FG000|Overall Study|Discontinued after database release date|1|||
124804344|NCT00631696|448916081|FG001|Overall Study|Discontinued after database release date|0|||
124804345|NCT00631696|448916080|FG000|Overall Study|Follow up after database release date|1|||
124804346|NCT00631696|448916081|FG001|Overall Study|Follow up after database release date|0|||
124804347|NCT00631696|448916080|FG000|Overall Study|Lost to Follow-up|7|||
124804348|NCT00631696|448916081|FG001|Overall Study|Lost to Follow-up|10|||
124804349|NCT00631696|448916080|FG000|Overall Study|Withdrawal by Subject|2|||
124804350|NCT00631696|448916081|FG001|Overall Study|Withdrawal by Subject|9|||
124804351|NCT00631696|448916080|FG000|Overall Study|Other|8|||
124804352|NCT00631696|448916081|FG001|Overall Study|Other|8|||
124804353|NCT00631696|448916080|FG000|Overall Study|Protocol Violation|9|||
124804354|NCT00631696|448916081|FG001|Overall Study|Protocol Violation|9|||
124804355|NCT00631696|448916080|FG000|Overall Study|Study terminated by sponsor|3|||
124804356|NCT00631696|448916081|FG001|Overall Study|Study terminated by sponsor|3|||
124804357|NCT00631696|448916080|FG000|Overall Study|Adverse Event|5|||
124804358|NCT00631696|448916081|FG001|Overall Study|Adverse Event|0|||
124804359|NCT01426438|448916083|FG000|Overall Study|Lost to Follow-up|1|||
124804360|NCT01426438|448916084|FG001|Overall Study|Lost to Follow-up|3|||
124804361|NCT01426438|448916083|FG000|Overall Study|Off study Treatment|9|||
124804362|NCT01426438|448916084|FG001|Overall Study|Off study Treatment|3|||
124804363|NCT01426438|448916083|FG000|Overall Study|Poor scan quality|3|||
124804364|NCT01426438|448916084|FG001|Overall Study|Poor scan quality|2|||
124804365|NCT01426438|448916083|FG000|Overall Study|Missed Scan|2|||
124804366|NCT01426438|448916084|FG001|Overall Study|Missed Scan|2|||
124804367|NCT01134731|448916085|FG000|Overall Study|Adverse Event|3|||
124804368|NCT01134731|448916086|FG001|Overall Study|Adverse Event|2|||
124804369|NCT01134731|448916087|FG002|Overall Study|Adverse Event|1|||
124804370|NCT01134731|448916085|FG000|Overall Study|Physician Decision|2|||
124804371|NCT01134731|448916086|FG001|Overall Study|Physician Decision|2|||
124804372|NCT01134731|448916087|FG002|Overall Study|Physician Decision|2|||
124804373|NCT01134731|448916085|FG000|Overall Study|Lack of Efficacy|0|||
124804374|NCT01134731|448916086|FG001|Overall Study|Lack of Efficacy|0|||
124804375|NCT01134731|448916087|FG002|Overall Study|Lack of Efficacy|1|||
124804376|NCT01134731|448916085|FG000|Overall Study|Withdrawal by Subject|3|||
124804377|NCT01134731|448916086|FG001|Overall Study|Withdrawal by Subject|3|||
124804378|NCT01134731|448916087|FG002|Overall Study|Withdrawal by Subject|1|||
124804379|NCT01134731|448916085|FG000|Overall Study|Lost to Follow-up|5|||
124804380|NCT01134731|448916086|FG001|Overall Study|Lost to Follow-up|4|||
124804381|NCT01134731|448916087|FG002|Overall Study|Lost to Follow-up|3|||
124804382|NCT02122458|448916088|FG000|Overall Study|Withdrawal by Subject|0|||
124804383|NCT02122458|448916089|FG001|Overall Study|Withdrawal by Subject|0|||
124804384|NCT02122458|448916090|FG002|Overall Study|Withdrawal by Subject|0|||
124804385|NCT02122458|448916091|FG003|Overall Study|Withdrawal by Subject|4|||
124804386|NCT02122458|448916092|FG004|Overall Study|Withdrawal by Subject|4|||
124804387|NCT02122458|448916093|FG005|Overall Study|Withdrawal by Subject|4|||
124804388|NCT02122458|448916094|FG006|Overall Study|Withdrawal by Subject|0|||
124804389|NCT02122458|448916088|FG000|Overall Study|Lost to Follow-up|1|||
124804390|NCT02122458|448916089|FG001|Overall Study|Lost to Follow-up|3|||
124804391|NCT02122458|448916090|FG002|Overall Study|Lost to Follow-up|0|||
124804392|NCT02122458|448916091|FG003|Overall Study|Lost to Follow-up|7|||
124804393|NCT02122458|448916092|FG004|Overall Study|Lost to Follow-up|5|||
124804394|NCT02122458|448916093|FG005|Overall Study|Lost to Follow-up|15|||
124804395|NCT02122458|448916094|FG006|Overall Study|Lost to Follow-up|1|||
124804396|NCT02122458|448916088|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
124804397|NCT02122458|448916089|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
124804398|NCT02122458|448916090|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
124804399|NCT02122458|448916091|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
124804400|NCT02122458|448916092|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
124804401|NCT02122458|448916093|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
124804402|NCT02122458|448916094|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
124804403|NCT02122458|448916088|FG000|Overall Study|Adverse Event|1|||
124804404|NCT02122458|448916089|FG001|Overall Study|Adverse Event|0|||
124804405|NCT02122458|448916090|FG002|Overall Study|Adverse Event|0|||
124804406|NCT02122458|448916091|FG003|Overall Study|Adverse Event|0|||
124804407|NCT02122458|448916092|FG004|Overall Study|Adverse Event|0|||
124804408|NCT02122458|448916093|FG005|Overall Study|Adverse Event|0|||
124804409|NCT02122458|448916094|FG006|Overall Study|Adverse Event|0|||
124804410|NCT02122458|448916088|FG000|Overall Study|Experimental Error|0|||
124804411|NCT02122458|448916089|FG001|Overall Study|Experimental Error|0|||
124804412|NCT02122458|448916090|FG002|Overall Study|Experimental Error|0|||
124804413|NCT02122458|448916091|FG003|Overall Study|Experimental Error|0|||
124804414|NCT02122458|448916092|FG004|Overall Study|Experimental Error|3|||
124804415|NCT02122458|448916093|FG005|Overall Study|Experimental Error|0|||
124804416|NCT02122458|448916094|FG006|Overall Study|Experimental Error|0|||
124804417|NCT02122458|448916088|FG000|Overall Study|Deployed or Moved|0|||
124804418|NCT02122458|448916089|FG001|Overall Study|Deployed or Moved|0|||
124804419|NCT02122458|448916090|FG002|Overall Study|Deployed or Moved|0|||
124804420|NCT02122458|448916091|FG003|Overall Study|Deployed or Moved|0|||
124804421|NCT02122458|448916092|FG004|Overall Study|Deployed or Moved|1|||
124804422|NCT02122458|448916093|FG005|Overall Study|Deployed or Moved|0|||
124804423|NCT02122458|448916094|FG006|Overall Study|Deployed or Moved|0|||
124804424|NCT02122458|448916088|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
124804425|NCT02122458|448916089|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
124804426|NCT02122458|448916090|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
124804427|NCT02122458|448916091|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
124804428|NCT02122458|448916092|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
124804429|NCT02122458|448916093|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
124804430|NCT02122458|448916094|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
124804431|NCT02122458|448916088|FG000|Overall Study|Noncompliance|0|||
124804432|NCT02122458|448916089|FG001|Overall Study|Noncompliance|1|||
124804433|NCT02122458|448916090|FG002|Overall Study|Noncompliance|0|||
124804434|NCT02122458|448916091|FG003|Overall Study|Noncompliance|0|||
124804435|NCT02122458|448916092|FG004|Overall Study|Noncompliance|0|||
124804436|NCT02122458|448916093|FG005|Overall Study|Noncompliance|0|||
124804437|NCT02122458|448916094|FG006|Overall Study|Noncompliance|0|||
124804438|NCT03161093|448916095|FG000|Overall Study|Protocol Violation|11|||
124804439|NCT03161093|448916096|FG001|Overall Study|Protocol Violation|14|||
124804440|NCT03161093|448916097|FG002|Overall Study|Protocol Violation|6|||
124804441|NCT03161093|448916098|FG003|Overall Study|Protocol Violation|13|||
124804442|NCT03161093|448916099|FG004|Overall Study|Protocol Violation|1|||
124804443|NCT03161093|448916100|FG005|Overall Study|Protocol Violation|0|||
124804444|NCT03161093|448916095|FG000|Overall Study|Adverse Event|5|||
124804445|NCT03161093|448916096|FG001|Overall Study|Adverse Event|21|||
124804446|NCT03161093|448916097|FG002|Overall Study|Adverse Event|16|||
124804447|NCT03161093|448916098|FG003|Overall Study|Adverse Event|35|||
124804448|NCT03161093|448916099|FG004|Overall Study|Adverse Event|2|||
124804449|NCT03161093|448916100|FG005|Overall Study|Adverse Event|1|||
124804450|NCT03161093|448916095|FG000|Overall Study|Lack of Efficacy|9|||
124804451|NCT03161093|448916096|FG001|Overall Study|Lack of Efficacy|13|||
124804452|NCT03161093|448916097|FG002|Overall Study|Lack of Efficacy|9|||
124804453|NCT03161093|448916098|FG003|Overall Study|Lack of Efficacy|24|||
124804454|NCT03161093|448916099|FG004|Overall Study|Lack of Efficacy|4|||
124804455|NCT03161093|448916100|FG005|Overall Study|Lack of Efficacy|1|||
124804456|NCT03161093|448916095|FG000|Overall Study|Physician Decision|0|||
124804457|NCT03161093|448916096|FG001|Overall Study|Physician Decision|1|||
124804458|NCT03161093|448916097|FG002|Overall Study|Physician Decision|0|||
124804459|NCT03161093|448916098|FG003|Overall Study|Physician Decision|2|||
124804460|NCT03161093|448916099|FG004|Overall Study|Physician Decision|17|||
124804461|NCT03161093|448916100|FG005|Overall Study|Physician Decision|15|||
124804462|NCT03161093|448916095|FG000|Overall Study|Withdrawal by Subject|24|||
124804463|NCT03161093|448916096|FG001|Overall Study|Withdrawal by Subject|73|||
124804464|NCT03161093|448916097|FG002|Overall Study|Withdrawal by Subject|44|||
124804465|NCT03161093|448916098|FG003|Overall Study|Withdrawal by Subject|97|||
124804466|NCT03161093|448916099|FG004|Overall Study|Withdrawal by Subject|11|||
124804467|NCT03161093|448916100|FG005|Overall Study|Withdrawal by Subject|10|||
124804468|NCT03161093|448916095|FG000|Overall Study|Lost to Follow-up|3|||
124804469|NCT03161093|448916096|FG001|Overall Study|Lost to Follow-up|12|||
124804470|NCT03161093|448916097|FG002|Overall Study|Lost to Follow-up|4|||
124804471|NCT03161093|448916098|FG003|Overall Study|Lost to Follow-up|7|||
124804472|NCT03161093|448916099|FG004|Overall Study|Lost to Follow-up|8|||
124804473|NCT03161093|448916100|FG005|Overall Study|Lost to Follow-up|13|||
124804474|NCT03161093|448916095|FG000|Overall Study|Death|3|||
124804475|NCT03161093|448916096|FG001|Overall Study|Death|9|||
124804476|NCT03161093|448916097|FG002|Overall Study|Death|7|||
124804477|NCT03161093|448916098|FG003|Overall Study|Death|9|||
124804478|NCT03161093|448916099|FG004|Overall Study|Death|0|||
124804479|NCT03161093|448916100|FG005|Overall Study|Death|0|||
124804480|NCT03161093|448916095|FG000|Overall Study|Unknown - Not reported|0|||
124804481|NCT03161093|448916096|FG001|Overall Study|Unknown - Not reported|1|||
124804482|NCT03161093|448916097|FG002|Overall Study|Unknown - Not reported|0|||
124804483|NCT03161093|448916098|FG003|Overall Study|Unknown - Not reported|0|||
124804484|NCT03161093|448916099|FG004|Overall Study|Unknown - Not reported|0|||
124804485|NCT03161093|448916100|FG005|Overall Study|Unknown - Not reported|1|||
124804486|NCT00091442|448916101|FG000|Overall Study|Progressive Disease|220|||
124804487|NCT00091442|448916102|FG001|Overall Study|Progressive Disease|189|||
124804488|NCT00091442|448916101|FG000|Overall Study|Physician Decision|61|||
124804489|NCT00091442|448916102|FG001|Overall Study|Physician Decision|58|||
124804490|NCT00091442|448916101|FG000|Overall Study|Withdrawal by Subject|38|||
124804491|NCT00091442|448916102|FG001|Overall Study|Withdrawal by Subject|46|||
124804492|NCT00091442|448916101|FG000|Overall Study|Adverse Event|29|||
124804493|NCT00091442|448916102|FG001|Overall Study|Adverse Event|48|||
124804494|NCT00091442|448916101|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
124804495|NCT00091442|448916102|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
124804496|NCT00091442|448916101|FG000|Overall Study|Death|9|||
124804497|NCT00091442|448916102|FG001|Overall Study|Death|7|||
124804498|NCT00091442|448916101|FG000|Overall Study|Lost to Follow-up|1|||
124804499|NCT00091442|448916102|FG001|Overall Study|Lost to Follow-up|3|||
124804500|NCT00091442|448916101|FG000|Overall Study|Other|2|||
124804501|NCT00091442|448916102|FG001|Overall Study|Other|6|||
124804502|NCT01332331|448916104|FG000|Overall Study|Lost to Follow-up|0|||
124804503|NCT01332331|448916105|FG001|Overall Study|Lost to Follow-up|1|||
124804504|NCT01332331|448916104|FG000|Overall Study|Adverse Event|1|||
124804505|NCT01332331|448916105|FG001|Overall Study|Adverse Event|1|||
124804506|NCT01332331|448916104|FG000|Overall Study|Physician Decision|1|||
124804507|NCT01332331|448916105|FG001|Overall Study|Physician Decision|0|||
124804508|NCT04810481|448916107|FG000|Overall Study|Disqualified data sets|10|||
124804509|NCT04810481|448916108|FG001|Overall Study|Disqualified data sets|28|||
124804510|NCT05055128|448916119|FG000|Overall Study|Adverse Event|0|||
124804511|NCT05055128|448916120|FG001|Overall Study|Adverse Event|0|||
124804512|NCT05055128|448916121|FG002|Overall Study|Adverse Event|0|||
124804513|NCT05055128|448916122|FG003|Overall Study|Adverse Event|1|||
124804514|NCT05055128|448916123|FG004|Overall Study|Adverse Event|1|||
124804515|NCT05055128|448916119|FG000|Overall Study|Protocol Violation|0|||
124804516|NCT05055128|448916120|FG001|Overall Study|Protocol Violation|0|||
124804517|NCT05055128|448916121|FG002|Overall Study|Protocol Violation|0|||
124804518|NCT05055128|448916122|FG003|Overall Study|Protocol Violation|1|||
124804519|NCT05055128|448916123|FG004|Overall Study|Protocol Violation|0|||
124804520|NCT05055128|448916119|FG000|Overall Study|Withdrawal by Subject|5|||
124804521|NCT05055128|448916120|FG001|Overall Study|Withdrawal by Subject|2|||
124804522|NCT05055128|448916121|FG002|Overall Study|Withdrawal by Subject|2|||
124804523|NCT05055128|448916122|FG003|Overall Study|Withdrawal by Subject|4|||
124804524|NCT05055128|448916123|FG004|Overall Study|Withdrawal by Subject|2|||
124804525|NCT05055128|448916119|FG000|Overall Study|Randomized By Mistake|0|||
124804526|NCT05055128|448916120|FG001|Overall Study|Randomized By Mistake|1|||
124804527|NCT05055128|448916121|FG002|Overall Study|Randomized By Mistake|0|||
124804528|NCT05055128|448916122|FG003|Overall Study|Randomized By Mistake|0|||
124804529|NCT05055128|448916123|FG004|Overall Study|Randomized By Mistake|0|||
124804530|NCT05055128|448916119|FG000|Overall Study|Other|1|||
124804531|NCT05055128|448916120|FG001|Overall Study|Other|0|||
124804532|NCT05055128|448916121|FG002|Overall Study|Other|0|||
124804533|NCT05055128|448916122|FG003|Overall Study|Other|0|||
124804534|NCT05055128|448916123|FG004|Overall Study|Other|0|||
124804535|NCT01385371|448916124|FG000|Overall Study|Adverse Event|54|||
124804536|NCT01385371|448916125|FG001|Overall Study|Adverse Event|19|||
124804537|NCT01385371|448916124|FG000|Overall Study|Lost to Follow-up|16|||
124804538|NCT01385371|448916125|FG001|Overall Study|Lost to Follow-up|16|||
124804539|NCT01385371|448916124|FG000|Overall Study|Withdrawal by Subject|52|||
124804540|NCT01385371|448916125|FG001|Overall Study|Withdrawal by Subject|39|||
124804541|NCT01385371|448916124|FG000|Overall Study|Protocol Violation|25|||
124804542|NCT01385371|448916125|FG001|Overall Study|Protocol Violation|21|||
124804543|NCT01385371|448916124|FG000|Overall Study|Administrative|2|||
124804544|NCT01385371|448916125|FG001|Overall Study|Administrative|2|||
124804545|NCT00936611|448916126|FG000|Overall Study|Progressive Disease|3|||
124804546|NCT00936611|448916126|FG000|Overall Study|New Systemic Therapy|22|||
124804547|NCT00936611|448916126|FG000|Overall Study|Lost to Follow-up|1|||
124804548|NCT00936611|448916126|FG000|Overall Study|Withdrawal by Subject|2|||
124804549|NCT00936611|448916126|FG000|Overall Study|Still on Follow-up|1|||
124804550|NCT00936611|448916126|FG000|Overall Study|Still on Active Therapy|7|||
124804551|NCT00936611|448916126|FG000|Overall Study|Ineligible for Study Drug|3|||
124804552|NCT01346969|448916127|FG000|Overall Study|Withdrawal by Subject|0|||
124804553|NCT01346969|448916128|FG001|Overall Study|Withdrawal by Subject|0|||
124804554|NCT01346969|448916129|FG002|Overall Study|Withdrawal by Subject|1|||
124804555|NCT01346969|448916130|FG003|Overall Study|Withdrawal by Subject|0|||
124804556|NCT01346969|448916127|FG000|Overall Study|Lost to Follow-up|1|||
124804557|NCT01346969|448916128|FG001|Overall Study|Lost to Follow-up|0|||
124804558|NCT01346969|448916129|FG002|Overall Study|Lost to Follow-up|2|||
124804559|NCT01346969|448916130|FG003|Overall Study|Lost to Follow-up|0|||
124804560|NCT01346969|448916127|FG000|Overall Study|Physician Decision|0|||
124804561|NCT01346969|448916128|FG001|Overall Study|Physician Decision|0|||
124804562|NCT01346969|448916129|FG002|Overall Study|Physician Decision|0|||
124804563|NCT01346969|448916130|FG003|Overall Study|Physician Decision|1|||
124804564|NCT01346969|448916127|FG000|Overall Study|Randomized but not treated|1|||
124804565|NCT01346969|448916128|FG001|Overall Study|Randomized but not treated|0|||
124804566|NCT01346969|448916129|FG002|Overall Study|Randomized but not treated|0|||
124804567|NCT01346969|448916130|FG003|Overall Study|Randomized but not treated|0|||
124804568|NCT02906332|448916134|FG000|Overall Study|Withdrawal by Subject|1|||
124804569|NCT02949700|448916135|FG000|Phase I|Withdrawal by Subject|1|||
124804570|NCT02949700|448916136|FG001|Phase I|Withdrawal by Subject|1|||
124804571|NCT02949700|448916137|FG002|Phase I|Withdrawal by Subject|0|||
124804572|NCT02949700|448916138|FG003|Phase I|Withdrawal by Subject|0|||
124804573|NCT02949700|448916135|FG000|Phase I|Protocol Violation|1|||
124804574|NCT02949700|448916136|FG001|Phase I|Protocol Violation|0|||
124804575|NCT02949700|448916137|FG002|Phase I|Protocol Violation|0|||
124804576|NCT02949700|448916138|FG003|Phase I|Protocol Violation|0|||
124804577|NCT02949700|448916135|FG000|Phase II|Withdrawal by Subject|0|||
124804578|NCT02949700|448916136|FG001|Phase II|Withdrawal by Subject|0|||
124804579|NCT02949700|448916137|FG002|Phase II|Withdrawal by Subject|0|||
124804580|NCT02949700|448916138|FG003|Phase II|Withdrawal by Subject|2|||
124804581|NCT02949700|448916135|FG000|Phase II|Protocol Violation|0|||
124804582|NCT02949700|448916136|FG001|Phase II|Protocol Violation|0|||
124804583|NCT02949700|448916137|FG002|Phase II|Protocol Violation|1|||
124804584|NCT02949700|448916138|FG003|Phase II|Protocol Violation|3|||
124804585|NCT03945266|448916139|FG000|Overall Study|Withdrawal by Subject|1|||
124804586|NCT03945266|448916140|FG001|Overall Study|Withdrawal by Subject|0|||
124804587|NCT03945266|448916139|FG000|Overall Study|Miscarriage|0|||
124804588|NCT03945266|448916140|FG001|Overall Study|Miscarriage|2|||
124804589|NCT03945266|448916139|FG000|Overall Study|Lost to Follow-up|1|||
124804590|NCT03945266|448916140|FG001|Overall Study|Lost to Follow-up|0|||
124804591|NCT01686828|448916141|FG000|Overall Study|Physician Decision|1|||
124804592|NCT01686828|448916142|FG001|Overall Study|Physician Decision|0|||
124804593|NCT01686828|448916143|FG002|Overall Study|Physician Decision|0|||
124804594|NCT01686828|448916144|FG003|Overall Study|Physician Decision|0|||
124804595|NCT01686828|448916141|FG000|Overall Study|New Job|0|||
124804596|NCT01686828|448916142|FG001|Overall Study|New Job|1|||
124804597|NCT01686828|448916143|FG002|Overall Study|New Job|0|||
124804598|NCT01686828|448916144|FG003|Overall Study|New Job|0|||
124804599|NCT01686828|448916141|FG000|Overall Study|Weight Loss|0|||
124804600|NCT01686828|448916142|FG001|Overall Study|Weight Loss|0|||
124804601|NCT01686828|448916143|FG002|Overall Study|Weight Loss|1|||
124804602|NCT01686828|448916144|FG003|Overall Study|Weight Loss|0|||
124804603|NCT04176705|448916147|FG000|Overall Study|Withdrawal by Subject|4|||
124804604|NCT04176705|448916148|FG001|Overall Study|Withdrawal by Subject|4|||
124804605|NCT04176705|448916147|FG000|Overall Study|Death|1|||
124804606|NCT04176705|448916148|FG001|Overall Study|Death|1|||
124804607|NCT04176705|448916147|FG000|Overall Study|Lost to Follow-up|3|||
124804608|NCT04176705|448916148|FG001|Overall Study|Lost to Follow-up|3|||
124804609|NCT02423772|448916149|FG000|Overall Study|Lost to Follow-up|3|||
124804610|NCT02423772|448916150|FG001|Overall Study|Lost to Follow-up|3|||
124804611|NCT02423772|448916149|FG000|Overall Study|Did not begin intervention|2|||
124804612|NCT02423772|448916150|FG001|Overall Study|Did not begin intervention|5|||
124804613|NCT02484690|448916154|FG000|Overall Study|Adverse Event|1|||
124804614|NCT02484690|448916155|FG001|Overall Study|Adverse Event|3|||
124804615|NCT02484690|448916156|FG002|Overall Study|Adverse Event|0|||
124804616|NCT02484690|448916157|FG003|Overall Study|Adverse Event|0|||
124804617|NCT02484690|448916158|FG004|Overall Study|Adverse Event|5|||
124804618|NCT02484690|448916154|FG000|Overall Study|Death|0|||
124804619|NCT02484690|448916155|FG001|Overall Study|Death|0|||
124804620|NCT02484690|448916156|FG002|Overall Study|Death|0|||
124804621|NCT02484690|448916157|FG003|Overall Study|Death|0|||
124804622|NCT02484690|448916158|FG004|Overall Study|Death|1|||
124804623|NCT02484690|448916154|FG000|Overall Study|Withdrawal by Subject|1|||
124804624|NCT02484690|448916155|FG001|Overall Study|Withdrawal by Subject|3|||
124804625|NCT02484690|448916156|FG002|Overall Study|Withdrawal by Subject|1|||
124804626|NCT02484690|448916157|FG003|Overall Study|Withdrawal by Subject|2|||
124804627|NCT02484690|448916158|FG004|Overall Study|Withdrawal by Subject|0|||
124804628|NCT02484690|448916154|FG000|Overall Study|Physician Decision|2|||
124804629|NCT02484690|448916155|FG001|Overall Study|Physician Decision|0|||
124804630|NCT02484690|448916156|FG002|Overall Study|Physician Decision|1|||
124804631|NCT02484690|448916157|FG003|Overall Study|Physician Decision|0|||
124804632|NCT02484690|448916158|FG004|Overall Study|Physician Decision|0|||
124804633|NCT02484690|448916154|FG000|Overall Study|Lost to Follow-up|0|||
124804634|NCT02484690|448916155|FG001|Overall Study|Lost to Follow-up|0|||
124804635|NCT02484690|448916156|FG002|Overall Study|Lost to Follow-up|1|||
124804636|NCT02484690|448916157|FG003|Overall Study|Lost to Follow-up|0|||
124804637|NCT02484690|448916158|FG004|Overall Study|Lost to Follow-up|0|||
124804638|NCT03360747|448916159|FG000|Overall Study|Voluntary Withdrawal|1|||
124804639|NCT01759511|448916162|FG000|Overall Study|Adverse Event|4|||
124804640|NCT01759511|448916162|FG000|Overall Study|Death|2|||
124804641|NCT01759511|448916162|FG000|Overall Study|Lack of Efficacy|2|||
124804642|NCT01759511|448916162|FG000|Overall Study|Physician Decision|1|||
124804643|NCT01759511|448916162|FG000|Overall Study|Progressive Disease|5|||
124804644|NCT01759511|448916162|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
124804645|NCT01759511|448916162|FG000|Overall Study|Study Terminated by Sponsor|13|||
124804646|NCT01759511|448916162|FG000|Overall Study|Withdrawal by Subject|3|||
124804647|NCT04916769|448916164|FG000|Period 1|Physician Decision|0|||
124804648|NCT04916769|448916165|FG001|Period 1|Physician Decision|0|||
124804649|NCT04916769|448916166|FG002|Period 1|Physician Decision|0|||
124804650|NCT04916769|448916167|FG003|Period 1|Physician Decision|0|||
124804651|NCT04916769|448916168|FG004|Period 1|Physician Decision|0|||
124804652|NCT04916769|448916169|FG005|Period 1|Physician Decision|1|||
124804653|NCT04916769|448916164|FG000|Period 2|Physician Decision|0|||
124804654|NCT04916769|448916165|FG001|Period 2|Physician Decision|1|||
124804655|NCT04916769|448916166|FG002|Period 2|Physician Decision|0|||
124804656|NCT04916769|448916167|FG003|Period 2|Physician Decision|0|||
124804657|NCT04916769|448916168|FG004|Period 2|Physician Decision|0|||
124804658|NCT04916769|448916169|FG005|Period 2|Physician Decision|0|||
124804659|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
124804660|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
124804661|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
124804662|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
124804663|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
124804664|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
124804665|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
124804666|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
124804667|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
124804668|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
124804669|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
124804670|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
124804671|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
124804672|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
124804673|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
124804674|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
124804675|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
124804676|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
124804677|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
124819542|NCT05147350|448965747|FG000|Overall Study|Withdrawal by Subject|0|||
124804678|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
124804679|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
124804680|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
124804681|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
124804682|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
124804683|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
124804684|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
124804685|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
124804686|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
124804687|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
124804688|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
124804689|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
124804690|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
124804691|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
124804692|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
124804693|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
124804694|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
124804695|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
124804696|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
124804697|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
124804698|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
124804699|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
124804700|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
124804701|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
124804702|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
124804703|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
124804704|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
124804705|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
124804706|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
124804707|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
124804708|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
124804709|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
124804710|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
124804711|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
124804712|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
124804713|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
124804714|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
124804715|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
124804716|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
124804717|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
124804718|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
124804719|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
124804720|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
124804721|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
124819543|NCT05147350|448965748|FG001|Overall Study|Withdrawal by Subject|0|||
124634025|NCT00437021|448276173|FG001|Overall Study|Withdrawal by Subject|1|||
124804722|NCT04526509|448916182|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
124804723|NCT04526509|448916183|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
124804724|NCT04526509|448916184|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
124804725|NCT04526509|448916185|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
124804726|NCT04526509|448916186|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
124804727|NCT04526509|448916187|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
124804728|NCT04526509|448916188|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
124804729|NCT04526509|448916182|FG000|Enrolled|Study Terminated by Sponsor|0|||
124804730|NCT04526509|448916183|FG001|Enrolled|Study Terminated by Sponsor|0|||
124804731|NCT04526509|448916184|FG002|Enrolled|Study Terminated by Sponsor|0|||
124804732|NCT04526509|448916185|FG003|Enrolled|Study Terminated by Sponsor|0|||
124804733|NCT04526509|448916186|FG004|Enrolled|Study Terminated by Sponsor|0|||
124804734|NCT04526509|448916187|FG005|Enrolled|Study Terminated by Sponsor|0|||
124804735|NCT04526509|448916188|FG006|Enrolled|Study Terminated by Sponsor|1|||
124804736|NCT04526509|448916182|FG000|Enrolled|Death prior to lymphodepletion|0|||
124804737|NCT04526509|448916183|FG001|Enrolled|Death prior to lymphodepletion|0|||
124804738|NCT04526509|448916184|FG002|Enrolled|Death prior to lymphodepletion|0|||
124804739|NCT04526509|448916185|FG003|Enrolled|Death prior to lymphodepletion|1|||
124804740|NCT04526509|448916186|FG004|Enrolled|Death prior to lymphodepletion|0|||
124804741|NCT04526509|448916187|FG005|Enrolled|Death prior to lymphodepletion|0|||
124804742|NCT04526509|448916188|FG006|Enrolled|Death prior to lymphodepletion|0|||
124804743|NCT04526509|448916182|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
124804744|NCT04526509|448916183|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
124804745|NCT04526509|448916184|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
124804746|NCT04526509|448916185|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
124804747|NCT04526509|448916186|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
124804748|NCT04526509|448916187|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
124804749|NCT04526509|448916188|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
124804750|NCT04526509|448916182|FG000|Enrolled|Physician Decision|0|||
124804751|NCT04526509|448916183|FG001|Enrolled|Physician Decision|1|||
124804752|NCT04526509|448916184|FG002|Enrolled|Physician Decision|0|||
124804753|NCT04526509|448916185|FG003|Enrolled|Physician Decision|0|||
124804754|NCT04526509|448916186|FG004|Enrolled|Physician Decision|0|||
124804755|NCT04526509|448916187|FG005|Enrolled|Physician Decision|0|||
124804756|NCT04526509|448916188|FG006|Enrolled|Physician Decision|0|||
124804757|NCT04340193|448916190|FG000|Overall Study|Other reason|0|||
124804758|NCT04340193|448916191|FG001|Overall Study|Other reason|0|||
124804759|NCT04340193|448916192|FG002|Overall Study|Other reason|1|||
124804760|NCT04340193|448916190|FG000|Overall Study|Disease recurrence|0|||
124804761|NCT04340193|448916191|FG001|Overall Study|Disease recurrence|1|||
124804762|NCT04340193|448916192|FG002|Overall Study|Disease recurrence|0|||
124804763|NCT04340193|448916190|FG000|Overall Study|Study drug toxicity|1|||
124804764|NCT04340193|448916191|FG001|Overall Study|Study drug toxicity|0|||
124804765|NCT04340193|448916192|FG002|Overall Study|Study drug toxicity|0|||
124804766|NCT04340193|448916190|FG000|Overall Study|Disease progression|1|||
124804767|NCT04340193|448916191|FG001|Overall Study|Disease progression|2|||
124804768|NCT04340193|448916192|FG002|Overall Study|Disease progression|3|||
124804769|NCT04340193|448916190|FG000|Overall Study|Administrative reasons by sponsor|0|||
124804770|NCT04340193|448916191|FG001|Overall Study|Administrative reasons by sponsor|1|||
124804771|NCT04340193|448916192|FG002|Overall Study|Administrative reasons by sponsor|0|||
124804772|NCT04340193|448916190|FG000|Overall Study|Adverse Event|1|||
124804773|NCT04340193|448916191|FG001|Overall Study|Adverse Event|1|||
124804774|NCT04340193|448916192|FG002|Overall Study|Adverse Event|0|||
124804775|NCT00589290|448916193|FG000|Overall Study|Withdrawal by Subject|1|||
124804776|NCT01067976|448916194|FG000|Overall Study|Study drug never administered|20|||
124804777|NCT01067976|448916194|FG000|Overall Study|Study prematurely discontinued|2|||
124804778|NCT04449861|448916195|FG000|Overall Study|Withdrawal by Subject|4|||
124804779|NCT04449861|448916195|FG000|Overall Study|Lost to Follow-up|5|||
124804780|NCT04449861|448916195|FG000|Overall Study|Death|112|||
124804781|NCT05268055|448916196|FG000|Overall Study|Lost to Follow-up|68|||
124804782|NCT05268055|448916197|FG001|Overall Study|Lost to Follow-up|68|||
124804783|NCT05268055|448916196|FG000|Overall Study|Withdrawal by Subject|12|||
124804784|NCT05268055|448916197|FG001|Overall Study|Withdrawal by Subject|8|||
124804785|NCT03507400|448916198|FG000|Overall Study|discontinued|5|||
124804786|NCT03507400|448916199|FG001|Overall Study|discontinued|1|||
124804787|NCT03507400|448916198|FG000|Overall Study|Lost to Follow-up|8|||
124804788|NCT03507400|448916199|FG001|Overall Study|Lost to Follow-up|6|||
124804789|NCT03507400|448916198|FG000|Overall Study|Protocol Violation|0|||
124804790|NCT03507400|448916199|FG001|Overall Study|Protocol Violation|1|||
124804791|NCT01555983|448916200|FG000|Overall Study|Withdrawal by Subject|1|||
124804792|NCT01555983|448916201|FG001|Overall Study|Withdrawal by Subject|0|||
124804793|NCT01555983|448916202|FG002|Overall Study|Withdrawal by Subject|0|||
124804794|NCT01555983|448916203|FG003|Overall Study|Withdrawal by Subject|0|||
124804795|NCT01555983|448916204|FG004|Overall Study|Withdrawal by Subject|1|||
124804796|NCT01555983|448916205|FG005|Overall Study|Withdrawal by Subject|1|||
124804797|NCT02598960|448918084|FG000|Treatment Period|Disease Progression|4|||
124804798|NCT02598960|448918085|FG001|Treatment Period|Disease Progression|4|||
124804799|NCT02598960|448918086|FG002|Treatment Period|Disease Progression|4|||
124804800|NCT02598960|448918087|FG003|Treatment Period|Disease Progression|6|||
124804801|NCT02598960|448918088|FG004|Treatment Period|Disease Progression|8|||
124804802|NCT02598960|448918089|FG005|Treatment Period|Disease Progression|2|||
124804803|NCT02598960|448918090|FG006|Treatment Period|Disease Progression|2|||
124804804|NCT02598960|448918091|FG007|Treatment Period|Disease Progression|3|||
124804805|NCT02598960|448918092|FG008|Treatment Period|Disease Progression|7|||
124804806|NCT02598960|448918093|FG009|Treatment Period|Disease Progression|9|||
124804807|NCT02598960|448918094|FG010|Treatment Period|Disease Progression|7|||
124804808|NCT02598960|448918095|FG011|Treatment Period|Disease Progression|143|||
124804809|NCT02598960|448918096|FG012|Treatment Period|Disease Progression|23|||
124804810|NCT02598960|448918084|FG000|Treatment Period|Study drug toxicity|0|||
124804811|NCT02598960|448918085|FG001|Treatment Period|Study drug toxicity|0|||
124804812|NCT02598960|448918086|FG002|Treatment Period|Study drug toxicity|0|||
124804813|NCT02598960|448918087|FG003|Treatment Period|Study drug toxicity|0|||
124804814|NCT02598960|448918088|FG004|Treatment Period|Study drug toxicity|0|||
124804815|NCT02598960|448918089|FG005|Treatment Period|Study drug toxicity|0|||
124804816|NCT02598960|448918090|FG006|Treatment Period|Study drug toxicity|0|||
124804817|NCT02598960|448918091|FG007|Treatment Period|Study drug toxicity|0|||
124804818|NCT02598960|448918092|FG008|Treatment Period|Study drug toxicity|0|||
124804819|NCT02598960|448918093|FG009|Treatment Period|Study drug toxicity|1|||
124804820|NCT02598960|448918094|FG010|Treatment Period|Study drug toxicity|0|||
124804821|NCT02598960|448918095|FG011|Treatment Period|Study drug toxicity|3|||
124804822|NCT02598960|448918096|FG012|Treatment Period|Study drug toxicity|0|||
124804823|NCT02598960|448918084|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
124804824|NCT02598960|448918085|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
124804825|NCT02598960|448918086|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
124804826|NCT02598960|448918087|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
124804827|NCT02598960|448918088|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
124804828|NCT02598960|448918089|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
124804829|NCT02598960|448918090|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
124804830|NCT02598960|448918091|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
124804831|NCT02598960|448918092|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
124804832|NCT02598960|448918093|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
124804833|NCT02598960|448918094|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
124804834|NCT02598960|448918095|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
124804835|NCT02598960|448918096|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
124804836|NCT02598960|448918084|FG000|Treatment Period|participant request to discontinue|0|||
124804837|NCT02598960|448918085|FG001|Treatment Period|participant request to discontinue|1|||
124804838|NCT02598960|448918086|FG002|Treatment Period|participant request to discontinue|0|||
124804839|NCT02598960|448918087|FG003|Treatment Period|participant request to discontinue|0|||
124804840|NCT02598960|448918088|FG004|Treatment Period|participant request to discontinue|1|||
124804841|NCT02598960|448918089|FG005|Treatment Period|participant request to discontinue|0|||
124804842|NCT02598960|448918090|FG006|Treatment Period|participant request to discontinue|0|||
124804843|NCT02598960|448918091|FG007|Treatment Period|participant request to discontinue|0|||
124804844|NCT02598960|448918092|FG008|Treatment Period|participant request to discontinue|0|||
124804845|NCT02598960|448918093|FG009|Treatment Period|participant request to discontinue|0|||
124804846|NCT02598960|448918094|FG010|Treatment Period|participant request to discontinue|1|||
124804847|NCT02598960|448918095|FG011|Treatment Period|participant request to discontinue|4|||
124804848|NCT02598960|448918096|FG012|Treatment Period|participant request to discontinue|0|||
124804849|NCT02598960|448918084|FG000|Treatment Period|participant withdrew consent|0|||
124804850|NCT02598960|448918085|FG001|Treatment Period|participant withdrew consent|0|||
124804851|NCT02598960|448918086|FG002|Treatment Period|participant withdrew consent|0|||
124804852|NCT02598960|448918087|FG003|Treatment Period|participant withdrew consent|0|||
124804853|NCT02598960|448918088|FG004|Treatment Period|participant withdrew consent|0|||
124804854|NCT02598960|448918089|FG005|Treatment Period|participant withdrew consent|0|||
124804855|NCT02598960|448918090|FG006|Treatment Period|participant withdrew consent|0|||
124804856|NCT02598960|448918091|FG007|Treatment Period|participant withdrew consent|0|||
124804857|NCT02598960|448918092|FG008|Treatment Period|participant withdrew consent|0|||
124804858|NCT02598960|448918093|FG009|Treatment Period|participant withdrew consent|0|||
124804859|NCT02598960|448918094|FG010|Treatment Period|participant withdrew consent|0|||
124804860|NCT02598960|448918095|FG011|Treatment Period|participant withdrew consent|3|||
124804861|NCT02598960|448918096|FG012|Treatment Period|participant withdrew consent|0|||
124804862|NCT02598960|448918084|FG000|Treatment Period|No longer meets study criteria|0|||
124804863|NCT02598960|448918085|FG001|Treatment Period|No longer meets study criteria|0|||
124804864|NCT02598960|448918086|FG002|Treatment Period|No longer meets study criteria|0|||
124804865|NCT02598960|448918087|FG003|Treatment Period|No longer meets study criteria|0|||
124804866|NCT02598960|448918088|FG004|Treatment Period|No longer meets study criteria|0|||
124804867|NCT02598960|448918089|FG005|Treatment Period|No longer meets study criteria|0|||
124804868|NCT02598960|448918090|FG006|Treatment Period|No longer meets study criteria|0|||
124804869|NCT02598960|448918091|FG007|Treatment Period|No longer meets study criteria|0|||
124804870|NCT02598960|448918092|FG008|Treatment Period|No longer meets study criteria|0|||
124804871|NCT02598960|448918093|FG009|Treatment Period|No longer meets study criteria|0|||
124804872|NCT02598960|448918094|FG010|Treatment Period|No longer meets study criteria|0|||
124804873|NCT02598960|448918095|FG011|Treatment Period|No longer meets study criteria|1|||
124804874|NCT02598960|448918096|FG012|Treatment Period|No longer meets study criteria|0|||
124804875|NCT02598960|448918084|FG000|Treatment Period|Other Reasons|0|||
124804876|NCT02598960|448918085|FG001|Treatment Period|Other Reasons|0|||
124804877|NCT02598960|448918086|FG002|Treatment Period|Other Reasons|0|||
124804878|NCT02598960|448918087|FG003|Treatment Period|Other Reasons|0|||
124804879|NCT02598960|448918088|FG004|Treatment Period|Other Reasons|0|||
124804880|NCT02598960|448918089|FG005|Treatment Period|Other Reasons|0|||
124804881|NCT02598960|448918090|FG006|Treatment Period|Other Reasons|0|||
124804882|NCT02598960|448918091|FG007|Treatment Period|Other Reasons|0|||
124804883|NCT02598960|448918092|FG008|Treatment Period|Other Reasons|0|||
124804884|NCT02598960|448918093|FG009|Treatment Period|Other Reasons|0|||
124804885|NCT02598960|448918094|FG010|Treatment Period|Other Reasons|0|||
124804886|NCT02598960|448918095|FG011|Treatment Period|Other Reasons|0|||
124804887|NCT02598960|448918096|FG012|Treatment Period|Other Reasons|1|||
124804888|NCT02598960|448918084|FG000|Participants Entering Follow Up Period|Death|1|||
124804889|NCT02598960|448918085|FG001|Participants Entering Follow Up Period|Death|0|||
124804890|NCT02598960|448918086|FG002|Participants Entering Follow Up Period|Death|0|||
124804891|NCT02598960|448918087|FG003|Participants Entering Follow Up Period|Death|0|||
124804892|NCT02598960|448918088|FG004|Participants Entering Follow Up Period|Death|0|||
124804893|NCT02598960|448918089|FG005|Participants Entering Follow Up Period|Death|0|||
124804894|NCT02598960|448918090|FG006|Participants Entering Follow Up Period|Death|0|||
124804895|NCT02598960|448918091|FG007|Participants Entering Follow Up Period|Death|0|||
124804896|NCT02598960|448918092|FG008|Participants Entering Follow Up Period|Death|0|||
124804897|NCT02598960|448918093|FG009|Participants Entering Follow Up Period|Death|1|||
124804898|NCT02598960|448918094|FG010|Participants Entering Follow Up Period|Death|0|||
124804899|NCT02598960|448918095|FG011|Participants Entering Follow Up Period|Death|11|||
124804900|NCT02598960|448918096|FG012|Participants Entering Follow Up Period|Death|2|||
124804901|NCT02598960|448918084|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804902|NCT02598960|448918085|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804903|NCT02598960|448918086|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804904|NCT02598960|448918087|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804905|NCT02598960|448918088|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804906|NCT02598960|448918089|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804907|NCT02598960|448918090|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804908|NCT02598960|448918091|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804909|NCT02598960|448918092|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804910|NCT02598960|448918093|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804911|NCT02598960|448918094|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804912|NCT02598960|448918095|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
124804913|NCT02598960|448918096|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
124804914|NCT02598960|448918084|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
124804915|NCT02598960|448918085|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
124804916|NCT02598960|448918086|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
124804917|NCT02598960|448918087|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
124804918|NCT02598960|448918088|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
124804919|NCT02598960|448918089|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
124804920|NCT02598960|448918090|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
124804921|NCT02598960|448918091|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
124804922|NCT02598960|448918092|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
124804923|NCT02598960|448918093|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
124804924|NCT02598960|448918094|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
124804925|NCT02598960|448918095|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
124804926|NCT02598960|448918096|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
124804927|NCT02598960|448918084|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804928|NCT02598960|448918085|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804929|NCT02598960|448918086|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804930|NCT02598960|448918087|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804931|NCT02598960|448918088|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804932|NCT02598960|448918089|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804933|NCT02598960|448918090|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804934|NCT02598960|448918091|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804935|NCT02598960|448918092|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804936|NCT02598960|448918093|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804937|NCT02598960|448918094|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804938|NCT02598960|448918095|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
124804939|NCT02598960|448918096|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
124804940|NCT02598960|448918084|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
124804941|NCT02598960|448918085|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
124804942|NCT02598960|448918086|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
124804943|NCT02598960|448918087|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
124804944|NCT02598960|448918088|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
124804945|NCT02598960|448918089|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
124804946|NCT02598960|448918090|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
124804947|NCT02598960|448918091|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
124804948|NCT02598960|448918092|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
124804949|NCT02598960|448918093|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
124804950|NCT02598960|448918094|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
124804951|NCT02598960|448918095|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
124804952|NCT02598960|448918096|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
124804953|NCT00108433|448918097|FG000|Overall Study|Lack of Efficacy|1|||
124804954|NCT00108433|448918098|FG001|Overall Study|Lack of Efficacy|2|||
124804955|NCT00108433|448918097|FG000|Overall Study|Death|3|||
124804956|NCT00108433|448918098|FG001|Overall Study|Death|0|||
124804957|NCT00108433|448918097|FG000|Overall Study|Adverse Event|3|||
124804958|NCT00108433|448918098|FG001|Overall Study|Adverse Event|1|||
124804959|NCT00108433|448918097|FG000|Overall Study|Other|14|||
124804960|NCT00108433|448918098|FG001|Overall Study|Other|14|||
124804961|NCT04195906|448918099|FG000|Part 1|Adverse Event|3|||
124804962|NCT04195906|448918100|FG001|Part 1|Adverse Event|7|||
124804963|NCT04195906|448918099|FG000|Part 1|Withdrawal by Subject|0|||
124804964|NCT04195906|448918100|FG001|Part 1|Withdrawal by Subject|1|||
124804965|NCT04195906|448918099|FG000|Part 2|Adverse Event|1|||
124804966|NCT04195906|448918100|FG001|Part 2|Adverse Event|1|||
124804967|NCT04195906|448918099|FG000|Part 2|Withdrawal by Subject|0|||
124804968|NCT04195906|448918100|FG001|Part 2|Withdrawal by Subject|3|||
124804969|NCT04195906|448918099|FG000|Part 2|Other|1|||
124804970|NCT04195906|448918100|FG001|Part 2|Other|3|||
124804971|NCT00371826|448918106|FG000|Core Phase (12 Months)|Adverse Event|15|||
124804972|NCT00371826|448918107|FG001|Core Phase (12 Months)|Adverse Event|4|||
124804973|NCT00371826|448918108|FG002|Core Phase (12 Months)|Adverse Event|9|||
124804974|NCT00371826|448918106|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
124804975|NCT00371826|448918107|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
124804976|NCT00371826|448918108|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
124804977|NCT00371826|448918106|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
124804978|NCT00371826|448918107|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
124804979|NCT00371826|448918108|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
124804980|NCT00371826|448918106|FG000|Core Phase (12 Months)|Protocol Violation|1|||
124804981|NCT00371826|448918107|FG001|Core Phase (12 Months)|Protocol Violation|0|||
124804982|NCT00371826|448918108|FG002|Core Phase (12 Months)|Protocol Violation|1|||
124804983|NCT00371826|448918106|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
124804984|NCT00371826|448918107|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
124804985|NCT00371826|448918108|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
124804986|NCT00371826|448918106|FG000|Core Phase (12 Months)|Administrative problems|1|||
124804987|NCT00371826|448918107|FG001|Core Phase (12 Months)|Administrative problems|0|||
124804988|NCT00371826|448918108|FG002|Core Phase (12 Months)|Administrative problems|8|||
124804989|NCT00371826|448918106|FG000|Core Phase (12 Months)|Graft Loss|0|||
124804990|NCT00371826|448918107|FG001|Core Phase (12 Months)|Graft Loss|1|||
124804991|NCT00371826|448918108|FG002|Core Phase (12 Months)|Graft Loss|0|||
124804992|NCT00371826|448918106|FG000|Extension Phase (24 Months)|Adverse Event|4|||
124804993|NCT00371826|448918107|FG001|Extension Phase (24 Months)|Adverse Event|5|||
124804994|NCT00371826|448918108|FG002|Extension Phase (24 Months)|Adverse Event|0|||
124804995|NCT00371826|448918106|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
124804996|NCT00371826|448918107|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
124804997|NCT00371826|448918108|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
124804998|NCT00371826|448918106|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
124804999|NCT00371826|448918107|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
124805000|NCT00371826|448918108|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
124805001|NCT00371826|448918106|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
124805002|NCT00371826|448918107|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
124805003|NCT00371826|448918108|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
124805004|NCT00371826|448918106|FG000|Extension Phase (24 Months)|Administrative problems|0|||
124805005|NCT00371826|448918107|FG001|Extension Phase (24 Months)|Administrative problems|0|||
124805006|NCT00371826|448918108|FG002|Extension Phase (24 Months)|Administrative problems|2|||
124805007|NCT00734474|448918111|FG000|Overall Study|Entry Criteria Not Met|0|||
124805008|NCT00734474|448918112|FG001|Overall Study|Entry Criteria Not Met|0|||
124805009|NCT00734474|448918113|FG002|Overall Study|Entry Criteria Not Met|5|||
124805010|NCT00734474|448918114|FG003|Overall Study|Entry Criteria Not Met|0|||
124805011|NCT00734474|448918115|FG004|Overall Study|Entry Criteria Not Met|3|||
124805012|NCT00734474|448918116|FG005|Overall Study|Entry Criteria Not Met|1|||
124805013|NCT00734474|448918117|FG006|Overall Study|Entry Criteria Not Met|0|||
124805014|NCT00734474|448918118|FG007|Overall Study|Entry Criteria Not Met|1|||
124805015|NCT00734474|448918119|FG008|Overall Study|Entry Criteria Not Met|1|||
124805016|NCT00734474|448918111|FG000|Overall Study|Lost to Follow-up|1|||
124805017|NCT00734474|448918112|FG001|Overall Study|Lost to Follow-up|0|||
124805018|NCT00734474|448918113|FG002|Overall Study|Lost to Follow-up|13|||
124805019|NCT00734474|448918114|FG003|Overall Study|Lost to Follow-up|0|||
124805020|NCT00734474|448918115|FG004|Overall Study|Lost to Follow-up|11|||
124805021|NCT00734474|448918116|FG005|Overall Study|Lost to Follow-up|1|||
124805022|NCT00734474|448918117|FG006|Overall Study|Lost to Follow-up|0|||
124805023|NCT00734474|448918118|FG007|Overall Study|Lost to Follow-up|9|||
124805024|NCT00734474|448918119|FG008|Overall Study|Lost to Follow-up|4|||
124805025|NCT00734474|448918111|FG000|Overall Study|Withdrawal by Subject|2|||
124805026|NCT00734474|448918112|FG001|Overall Study|Withdrawal by Subject|1|||
124805027|NCT00734474|448918113|FG002|Overall Study|Withdrawal by Subject|18|||
124805028|NCT00734474|448918114|FG003|Overall Study|Withdrawal by Subject|0|||
124805029|NCT00734474|448918115|FG004|Overall Study|Withdrawal by Subject|24|||
124805030|NCT00734474|448918116|FG005|Overall Study|Withdrawal by Subject|2|||
124805031|NCT00734474|448918117|FG006|Overall Study|Withdrawal by Subject|0|||
124805032|NCT00734474|448918118|FG007|Overall Study|Withdrawal by Subject|36|||
124805033|NCT00734474|448918119|FG008|Overall Study|Withdrawal by Subject|21|||
124805034|NCT00734474|448918111|FG000|Overall Study|Physician Decision|0|||
124805035|NCT00734474|448918112|FG001|Overall Study|Physician Decision|0|||
124805036|NCT00734474|448918113|FG002|Overall Study|Physician Decision|4|||
124805037|NCT00734474|448918114|FG003|Overall Study|Physician Decision|1|||
124805038|NCT00734474|448918115|FG004|Overall Study|Physician Decision|11|||
124805039|NCT00734474|448918116|FG005|Overall Study|Physician Decision|0|||
124805040|NCT00734474|448918117|FG006|Overall Study|Physician Decision|0|||
124805041|NCT00734474|448918118|FG007|Overall Study|Physician Decision|9|||
124805042|NCT00734474|448918119|FG008|Overall Study|Physician Decision|9|||
124805043|NCT00734474|448918111|FG000|Overall Study|Adverse Event|4|||
124805044|NCT00734474|448918112|FG001|Overall Study|Adverse Event|4|||
124805045|NCT00734474|448918113|FG002|Overall Study|Adverse Event|63|||
124805046|NCT00734474|448918114|FG003|Overall Study|Adverse Event|1|||
124805047|NCT00734474|448918115|FG004|Overall Study|Adverse Event|64|||
124805048|NCT00734474|448918116|FG005|Overall Study|Adverse Event|0|||
124805049|NCT00734474|448918117|FG006|Overall Study|Adverse Event|1|||
124805050|NCT00734474|448918118|FG007|Overall Study|Adverse Event|65|||
124805051|NCT00734474|448918119|FG008|Overall Study|Adverse Event|39|||
124805052|NCT00734474|448918111|FG000|Overall Study|Protocol Violation|0|||
124805053|NCT00734474|448918112|FG001|Overall Study|Protocol Violation|0|||
124805054|NCT00734474|448918113|FG002|Overall Study|Protocol Violation|4|||
124805055|NCT00734474|448918114|FG003|Overall Study|Protocol Violation|0|||
124805056|NCT00734474|448918115|FG004|Overall Study|Protocol Violation|3|||
124805057|NCT00734474|448918116|FG005|Overall Study|Protocol Violation|0|||
124805058|NCT00734474|448918117|FG006|Overall Study|Protocol Violation|0|||
124805059|NCT00734474|448918118|FG007|Overall Study|Protocol Violation|3|||
124805060|NCT00734474|448918119|FG008|Overall Study|Protocol Violation|1|||
124805061|NCT00734474|448918111|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
124805062|NCT00734474|448918112|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
124805063|NCT00734474|448918113|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
124634026|NCT00437021|448276174|FG002|Overall Study|Withdrawal by Subject|0|||
124805064|NCT00734474|448918114|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
124805065|NCT00734474|448918115|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
124805066|NCT00734474|448918116|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
124805067|NCT00734474|448918117|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
124805068|NCT00734474|448918118|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
124805069|NCT00734474|448918119|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
124805070|NCT00734474|448918111|FG000|Overall Study|Sponsor Decision|0|||
124805071|NCT00734474|448918112|FG001|Overall Study|Sponsor Decision|0|||
124805072|NCT00734474|448918113|FG002|Overall Study|Sponsor Decision|0|||
124805073|NCT00734474|448918114|FG003|Overall Study|Sponsor Decision|0|||
124805074|NCT00734474|448918115|FG004|Overall Study|Sponsor Decision|2|||
124805075|NCT00734474|448918116|FG005|Overall Study|Sponsor Decision|0|||
124805076|NCT00734474|448918117|FG006|Overall Study|Sponsor Decision|0|||
124805077|NCT00734474|448918118|FG007|Overall Study|Sponsor Decision|0|||
124805078|NCT00734474|448918119|FG008|Overall Study|Sponsor Decision|0|||
124805079|NCT00734474|448918111|FG000|Overall Study|Death|0|||
124805080|NCT00734474|448918112|FG001|Overall Study|Death|0|||
124805081|NCT00734474|448918113|FG002|Overall Study|Death|1|||
124805082|NCT00734474|448918114|FG003|Overall Study|Death|0|||
124805083|NCT00734474|448918115|FG004|Overall Study|Death|0|||
124805084|NCT00734474|448918116|FG005|Overall Study|Death|0|||
124805085|NCT00734474|448918117|FG006|Overall Study|Death|0|||
124805086|NCT00734474|448918118|FG007|Overall Study|Death|2|||
124805087|NCT00734474|448918119|FG008|Overall Study|Death|1|||
124805088|NCT00734474|448918111|FG000|Overall Study|Lack of Efficacy|0|||
124805089|NCT00734474|448918112|FG001|Overall Study|Lack of Efficacy|0|||
124805090|NCT00734474|448918113|FG002|Overall Study|Lack of Efficacy|4|||
124805091|NCT00734474|448918114|FG003|Overall Study|Lack of Efficacy|0|||
124805092|NCT00734474|448918115|FG004|Overall Study|Lack of Efficacy|0|||
124805093|NCT00734474|448918116|FG005|Overall Study|Lack of Efficacy|0|||
124805094|NCT00734474|448918117|FG006|Overall Study|Lack of Efficacy|0|||
124805095|NCT00734474|448918118|FG007|Overall Study|Lack of Efficacy|4|||
124805096|NCT00734474|448918119|FG008|Overall Study|Lack of Efficacy|6|||
124805097|NCT00385762|448918128|FG000|Overall Study|Adverse Event|1|||
124805098|NCT00385762|448918128|FG000|Overall Study|Lost to Follow-up|1|||
124805099|NCT00573183|448918129|FG000|Overall Study|Lost to Follow-up|52|||
124805100|NCT00573183|448918130|FG001|Overall Study|Lost to Follow-up|50|||
124805101|NCT00573183|448918129|FG000|Overall Study|Withdrawal by Subject|8|||
124805102|NCT00573183|448918130|FG001|Overall Study|Withdrawal by Subject|2|||
124805103|NCT00573183|448918129|FG000|Overall Study|Death|0|||
124805104|NCT00573183|448918130|FG001|Overall Study|Death|1|||
124805105|NCT00573183|448918129|FG000|Overall Study|Adverse Event|2|||
124805106|NCT00573183|448918130|FG001|Overall Study|Adverse Event|0|||
124805107|NCT00573183|448918129|FG000|Overall Study|Incarceration|5|||
124805108|NCT00573183|448918130|FG001|Overall Study|Incarceration|8|||
124805109|NCT00573183|448918129|FG000|Overall Study|Other|5|||
124805110|NCT00573183|448918130|FG001|Overall Study|Other|2|||
124805111|NCT00428792|448918133|FG000|Overall Study|Lack of Efficacy|1|||
124805112|NCT00428792|448918134|FG001|Overall Study|Lack of Efficacy|3|||
124805113|NCT00428792|448918133|FG000|Overall Study|Lost to Follow-up|0|||
124805114|NCT00428792|448918134|FG001|Overall Study|Lost to Follow-up|1|||
124805115|NCT02570074|448918135|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
124805116|NCT02570074|448918136|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
124805117|NCT03270644|448918141|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
124805118|NCT03270644|448918141|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
124805119|NCT00354614|448918143|FG000|Overall Study|Lack of Efficacy|28|||
124805120|NCT01500031|448918144|FG000|Overall Study|Death|1|||
124805121|NCT01500031|448918144|FG000|Overall Study|Withdrawal by Subject|4|||
124805122|NCT01856907|448918146|FG000|Overall Study|Pregnancy|0|||
124805123|NCT01856907|448918147|FG001|Overall Study|Pregnancy|1|||
124805124|NCT01856907|448918148|FG002|Overall Study|Pregnancy|0|||
124805125|NCT01856907|448918146|FG000|Overall Study|Pregnancy|0|||
124805126|NCT01856907|448918147|FG001|Overall Study|Pregnancy|1|||
124805127|NCT01856907|448918148|FG002|Overall Study|Pregnancy|0|||
124805128|NCT01856907|448918146|FG000|Overall Study|Withdrawal by Subject|0|||
124805129|NCT01856907|448918147|FG001|Overall Study|Withdrawal by Subject|1|||
124805130|NCT01856907|448918148|FG002|Overall Study|Withdrawal by Subject|0|||
124805131|NCT01604408|448918151|FG000|Treatment Period 1|Protocol Violation|0|||
124805132|NCT01604408|448918152|FG001|Treatment Period 1|Protocol Violation|1|||
124805133|NCT01604408|448918151|FG000|Treatment Period 2|Withdrawal by Subject|1|||
124805134|NCT01604408|448918152|FG001|Treatment Period 2|Withdrawal by Subject|1|||
124805135|NCT01604408|448918151|FG000|Treatment Period 2|Protocol Violation|1|||
124805136|NCT01604408|448918152|FG001|Treatment Period 2|Protocol Violation|0|||
124805137|NCT01604408|448918151|FG000|Treatment Period 2|Adverse Event|0|||
124805138|NCT01604408|448918152|FG001|Treatment Period 2|Adverse Event|1|||
124634027|NCT00437021|448276175|FG003|Overall Study|Withdrawal by Subject|0|||
124805139|NCT01604408|448918151|FG000|Treatment Period 3|Protocol Violation|1|||
124805140|NCT01604408|448918152|FG001|Treatment Period 3|Protocol Violation|1|||
124805141|NCT01604408|448918151|FG000|Treatment Period 3|Adverse Event|0|||
124805142|NCT01604408|448918152|FG001|Treatment Period 3|Adverse Event|3|||
124805143|NCT01604408|448918151|FG000|Treatment Period 3|Withdrawal by Subject|3|||
124805144|NCT01604408|448918152|FG001|Treatment Period 3|Withdrawal by Subject|1|||
124805145|NCT01604408|448918151|FG000|Treatment Period 3|Sponsor Decision|1|||
124805146|NCT01604408|448918152|FG001|Treatment Period 3|Sponsor Decision|0|||
124805147|NCT01604408|448918151|FG000|Treatment Period 4|Death|1|||
124805148|NCT01604408|448918152|FG001|Treatment Period 4|Death|0|||
124805149|NCT01604408|448918151|FG000|Treatment Period 4|Withdrawal by Subject|2|||
124805150|NCT01604408|448918152|FG001|Treatment Period 4|Withdrawal by Subject|1|||
124805151|NCT01604408|448918151|FG000|Treatment Period 4|Adverse Event|0|||
124805152|NCT01604408|448918152|FG001|Treatment Period 4|Adverse Event|1|||
124805153|NCT01604408|448918151|FG000|Treatment Period 5|Adverse Event|4|||
124805154|NCT01604408|448918152|FG001|Treatment Period 5|Adverse Event|0|||
124805155|NCT01604408|448918151|FG000|Treatment Period 6|Lost to Follow-up|0|||
124805156|NCT01604408|448918152|FG001|Treatment Period 6|Lost to Follow-up|1|||
124805157|NCT01604408|448918151|FG000|Treatment Period 6|Adverse Event|2|||
124805158|NCT01604408|448918152|FG001|Treatment Period 6|Adverse Event|0|||
124805159|NCT01604408|448918151|FG000|Treatment Period 6|Sponsor decision|0|||
124805160|NCT01604408|448918152|FG001|Treatment Period 6|Sponsor decision|1|||
124805161|NCT01604408|448918151|FG000|Observation Period|Adverse Event|1|||
124805162|NCT01604408|448918152|FG001|Observation Period|Adverse Event|1|||
124805163|NCT01604408|448918151|FG000|Observation Period|Withdrawal by Subject|0|||
124805164|NCT01604408|448918152|FG001|Observation Period|Withdrawal by Subject|2|||
124805165|NCT00917501|448918154|FG000|Overall Study|Lost to Follow-up|4|||
124805166|NCT00917501|448918155|FG001|Overall Study|Lost to Follow-up|1|||
124805167|NCT00917501|448918154|FG000|Overall Study|Withdrawal by Subject|3|||
124805168|NCT00917501|448918155|FG001|Overall Study|Withdrawal by Subject|1|||
124805169|NCT00917501|448918154|FG000|Overall Study|Lack of Efficacy|1|||
124805170|NCT00917501|448918155|FG001|Overall Study|Lack of Efficacy|2|||
124805171|NCT00917501|448918154|FG000|Overall Study|trouble swollowing capsules|0|||
124805172|NCT00917501|448918155|FG001|Overall Study|trouble swollowing capsules|1|||
124805173|NCT05095454|448918156|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
124805174|NCT05095454|448918157|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
124805175|NCT01999114|448918158|FG000|Overall Study|Adverse Event|8|||
124805176|NCT01999114|448918159|FG001|Overall Study|Adverse Event|7|||
124805177|NCT01999114|448918160|FG002|Overall Study|Adverse Event|2|||
124805178|NCT01999114|448918161|FG003|Overall Study|Adverse Event|2|||
124805179|NCT01999114|448918162|FG004|Overall Study|Adverse Event|1|||
124805180|NCT01999114|448918158|FG000|Overall Study|Withdrawal by Subject|0|||
124805181|NCT01999114|448918159|FG001|Overall Study|Withdrawal by Subject|0|||
124805182|NCT01999114|448918160|FG002|Overall Study|Withdrawal by Subject|1|||
124805183|NCT01999114|448918161|FG003|Overall Study|Withdrawal by Subject|0|||
124805184|NCT01999114|448918162|FG004|Overall Study|Withdrawal by Subject|1|||
124805185|NCT01999114|448918158|FG000|Overall Study|Lost to Follow-up|0|||
124805186|NCT01999114|448918159|FG001|Overall Study|Lost to Follow-up|0|||
124805187|NCT01999114|448918160|FG002|Overall Study|Lost to Follow-up|1|||
124805188|NCT01999114|448918161|FG003|Overall Study|Lost to Follow-up|0|||
124805189|NCT01999114|448918162|FG004|Overall Study|Lost to Follow-up|0|||
124805190|NCT01999114|448918158|FG000|Overall Study|Administrative|0|||
124805191|NCT01999114|448918159|FG001|Overall Study|Administrative|0|||
124805192|NCT01999114|448918160|FG002|Overall Study|Administrative|1|||
124805193|NCT01999114|448918161|FG003|Overall Study|Administrative|1|||
124805194|NCT01999114|448918162|FG004|Overall Study|Administrative|2|||
124805195|NCT00722423|448918165|FG000|Overall Study|Protocol Violation|0|||
124805196|NCT00722423|448918166|FG001|Overall Study|Protocol Violation|1|||
124805197|NCT05085730|448918169|FG000|Overall Study|Withdrawal by Subject|4|||
124805198|NCT05085730|448918169|FG000|Overall Study|Physician Decision|1|||
124805199|NCT01453725|448918170|FG000|Overall Study|Adverse Event|3|||
124805200|NCT01453725|448918171|FG001|Overall Study|Adverse Event|3|||
124805201|NCT01453725|448918170|FG000|Overall Study|Lost to Follow-up|4|||
124805202|NCT01453725|448918171|FG001|Overall Study|Lost to Follow-up|0|||
124805203|NCT01453725|448918170|FG000|Overall Study|Non-compliance With Protocol|1|||
124805204|NCT01453725|448918171|FG001|Overall Study|Non-compliance With Protocol|2|||
124805205|NCT01453725|448918170|FG000|Overall Study|Protocol Violation|1|||
124805206|NCT01453725|448918171|FG001|Overall Study|Protocol Violation|0|||
124805207|NCT01453725|448918170|FG000|Overall Study|Withdrawal by Subject|2|||
124805208|NCT01453725|448918171|FG001|Overall Study|Withdrawal by Subject|3|||
124805209|NCT01453725|448918170|FG000|Overall Study|Pregnancy Wish|0|||
124805210|NCT01453725|448918171|FG001|Overall Study|Pregnancy Wish|2|||
124805211|NCT01453725|448918170|FG000|Overall Study|Pregnancy|1|||
124805212|NCT01453725|448918171|FG001|Overall Study|Pregnancy|0|||
124805213|NCT01453725|448918170|FG000|Overall Study|Physician Decision|1|||
124805214|NCT01453725|448918171|FG001|Overall Study|Physician Decision|1|||
124805215|NCT03605212|448918172|FG000|Treatment Period|Adverse Event|1|||
124805216|NCT03605212|448918173|FG001|Treatment Period|Adverse Event|0|||
124805217|NCT03605212|448918174|FG002|Treatment Period|Adverse Event|0|||
124805218|NCT03605212|448918175|FG003|Treatment Period|Adverse Event|0|||
124805219|NCT03605212|448918176|FG004|Treatment Period|Adverse Event|0|||
124634028|NCT00437021|448276176|FG004|Overall Study|Withdrawal by Subject|0|||
124805220|NCT03605212|448918172|FG000|Treatment Period|Physician Decision|0|||
124805221|NCT03605212|448918173|FG001|Treatment Period|Physician Decision|0|||
124805222|NCT03605212|448918174|FG002|Treatment Period|Physician Decision|0|||
124805223|NCT03605212|448918175|FG003|Treatment Period|Physician Decision|0|||
124805224|NCT03605212|448918176|FG004|Treatment Period|Physician Decision|1|||
124805225|NCT01756053|448918177|FG000|Period 1 (10 Days)|Protocol Violation|1|||
124805226|NCT01756053|448918178|FG001|Period 1 (10 Days)|Protocol Violation|1|||
124805227|NCT01756053|448918177|FG000|Period 2 (10 Days)|Protocol Violation|0|||
124805228|NCT01756053|448918178|FG001|Period 2 (10 Days)|Protocol Violation|2|||
124805229|NCT01986140|448918179|FG000|Overall Study|Withdrawal by Subject|31|||
124805230|NCT01986140|448918180|FG001|Overall Study|Withdrawal by Subject|25|||
124805231|NCT01986140|448918179|FG000|Overall Study|alternative treatment|1|||
124805232|NCT01986140|448918180|FG001|Overall Study|alternative treatment|1|||
124805233|NCT01986140|448918179|FG000|Overall Study|found not eligible|3|||
124805234|NCT01986140|448918180|FG001|Overall Study|found not eligible|0|||
124805235|NCT01986140|448918179|FG000|Overall Study|Adverse Event|0|||
124805236|NCT01986140|448918180|FG001|Overall Study|Adverse Event|1|||
124805237|NCT01986140|448918179|FG000|Overall Study|progression disease|0|||
124805238|NCT01986140|448918180|FG001|Overall Study|progression disease|1|||
124805239|NCT01069627|448918183|FG000|Overall Study|Disease progression|7|||
124805240|NCT01069627|448918183|FG000|Overall Study|Adverse Event|12|||
124805241|NCT01069627|448918183|FG000|Overall Study|Protocol Violation|1|||
124805242|NCT00471146|448918184|FG000|Overall Study|Adverse Event|32|||
124805243|NCT00471146|448918185|FG001|Overall Study|Adverse Event|33|||
124805244|NCT00471146|448918184|FG000|Overall Study|Withdrawal by Subject|14|||
124805245|NCT00471146|448918185|FG001|Overall Study|Withdrawal by Subject|11|||
124805246|NCT00471146|448918184|FG000|Overall Study|Death|11|||
124805247|NCT00471146|448918185|FG001|Overall Study|Death|12|||
124805248|NCT00471146|448918184|FG000|Overall Study|Lost to Follow-up|4|||
124805249|NCT00471146|448918185|FG001|Overall Study|Lost to Follow-up|2|||
124805250|NCT00471146|448918184|FG000|Overall Study|Protocol Violation|2|||
124805251|NCT00471146|448918185|FG001|Overall Study|Protocol Violation|2|||
124805252|NCT00471146|448918184|FG000|Overall Study|Objective progression or relapse|84|||
124805253|NCT00471146|448918185|FG001|Overall Study|Objective progression or relapse|87|||
124805254|NCT00471146|448918184|FG000|Overall Study|Global deterioration of health status|12|||
124805255|NCT00471146|448918185|FG001|Overall Study|Global deterioration of health status|14|||
124805256|NCT00471146|448918184|FG000|Overall Study|Randomized but not treated|9|||
124805257|NCT00471146|448918185|FG001|Overall Study|Randomized but not treated|8|||
124805258|NCT00471146|448918184|FG000|Overall Study|Other|4|||
124805259|NCT00471146|448918185|FG001|Overall Study|Other|5|||
124805260|NCT02149875|448918186|FG000|Overall Study|Lost to Follow-up|3|||
124805261|NCT02149875|448918187|FG001|Overall Study|Lost to Follow-up|4|||
124805262|NCT02149875|448918188|FG002|Overall Study|Lost to Follow-up|5|||
124805263|NCT02149875|448918186|FG000|Overall Study|Withdrawal by Subject|3|||
124805264|NCT02149875|448918187|FG001|Overall Study|Withdrawal by Subject|2|||
124805265|NCT02149875|448918188|FG002|Overall Study|Withdrawal by Subject|2|||
124805266|NCT02149875|448918186|FG000|Overall Study|Physician Decision|1|||
124805267|NCT02149875|448918187|FG001|Overall Study|Physician Decision|2|||
124805268|NCT02149875|448918188|FG002|Overall Study|Physician Decision|2|||
124805269|NCT02478372|448918189|FG000|Overall Study|Protocol Violation|12|||
124805270|NCT02478372|448918190|FG001|Overall Study|Protocol Violation|8|||
124805271|NCT02478372|448918189|FG000|Overall Study|Lost to Follow-up|1|||
124805272|NCT02478372|448918190|FG001|Overall Study|Lost to Follow-up|4|||
124805273|NCT02478372|448918189|FG000|Overall Study|Death|0|||
124805274|NCT02478372|448918190|FG001|Overall Study|Death|2|||
124805275|NCT03800173|448918197|FG000|Overall Study|Lost to Follow-up|0|||
124805276|NCT03800173|448918198|FG001|Overall Study|Lost to Follow-up|0|||
124805277|NCT03800173|448918199|FG002|Overall Study|Lost to Follow-up|0|||
124805278|NCT03800173|448918200|FG003|Overall Study|Lost to Follow-up|0|||
124805279|NCT03800173|448918201|FG004|Overall Study|Lost to Follow-up|1|||
124805280|NCT02507973|448918202|FG000|Overall Study|Adverse Event|1|||
124805281|NCT00910273|448918203|FG000|Overall Study|Lack of Efficacy|6|||
124805282|NCT00910273|448918204|FG001|Overall Study|Lack of Efficacy|9|||
124805283|NCT00910273|448918203|FG000|Overall Study|Adverse Event|1|||
124805284|NCT00910273|448918204|FG001|Overall Study|Adverse Event|1|||
124805285|NCT00910273|448918203|FG000|Overall Study|Withdrawal by Subject|1|||
124805286|NCT00910273|448918204|FG001|Overall Study|Withdrawal by Subject|0|||
124805287|NCT00910273|448918203|FG000|Overall Study|Discontinuation of study by sponsor|8|||
124805288|NCT00910273|448918204|FG001|Overall Study|Discontinuation of study by sponsor|2|||
124805289|NCT00910273|448918203|FG000|Overall Study|Protocol Violation|1|||
124805290|NCT00910273|448918204|FG001|Overall Study|Protocol Violation|0|||
124805291|NCT00910273|448918203|FG000|Overall Study|Lost to Follow-up|1|||
124805292|NCT00910273|448918204|FG001|Overall Study|Lost to Follow-up|1|||
124805293|NCT03841448|448918205|FG000|Double-blind Treatment (DBT) Period|Death|1|||
124805294|NCT03841448|448918206|FG001|Double-blind Treatment (DBT) Period|Death|1|||
124805295|NCT03841448|448918207|FG002|Double-blind Treatment (DBT) Period|Death|0|||
124805296|NCT03841448|448918208|FG003|Double-blind Treatment (DBT) Period|Death|0|||
124805297|NCT03841448|448918205|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
124805298|NCT03841448|448918206|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
124805299|NCT03841448|448918207|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
124805300|NCT03841448|448918208|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
124805301|NCT03841448|448918205|FG000|Open-Label Extension (OLE) Period|Death|0|||
124805302|NCT03841448|448918206|FG001|Open-Label Extension (OLE) Period|Death|0|||
124805303|NCT03841448|448918207|FG002|Open-Label Extension (OLE) Period|Death|0|||
124805304|NCT03841448|448918208|FG003|Open-Label Extension (OLE) Period|Death|1|||
124805305|NCT03841448|448918205|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
124805306|NCT03841448|448918206|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
124805307|NCT03841448|448918207|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
124805308|NCT03841448|448918208|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
124805309|NCT03841448|448918205|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
124805310|NCT03841448|448918206|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
124805311|NCT03841448|448918207|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
124805312|NCT03841448|448918208|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
124805313|NCT03841448|448918205|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
124805314|NCT03841448|448918206|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
124805315|NCT03841448|448918207|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
124805316|NCT03841448|448918208|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
124805317|NCT00543543|448918209|FG000|Base Study|Adverse Event|1|||
124805318|NCT00543543|448918210|FG001|Base Study|Adverse Event|11|||
124805319|NCT00543543|448918211|FG002|Base Study|Adverse Event|0|||
124805320|NCT00543543|448918212|FG003|Base Study|Adverse Event|5|||
124805321|NCT00543543|448918209|FG000|Base Study|Lost to Follow-up|12|||
124805322|NCT00543543|448918210|FG001|Base Study|Lost to Follow-up|749|||
124805323|NCT00543543|448918211|FG002|Base Study|Lost to Follow-up|9|||
124805324|NCT00543543|448918212|FG003|Base Study|Lost to Follow-up|701|||
124805325|NCT00543543|448918209|FG000|Base Study|Physician Decision|0|||
124805326|NCT00543543|448918210|FG001|Base Study|Physician Decision|4|||
124805327|NCT00543543|448918211|FG002|Base Study|Physician Decision|0|||
124805328|NCT00543543|448918212|FG003|Base Study|Physician Decision|7|||
124805329|NCT00543543|448918209|FG000|Base Study|Protocol Violation|0|||
124805330|NCT00543543|448918210|FG001|Base Study|Protocol Violation|6|||
124805331|NCT00543543|448918211|FG002|Base Study|Protocol Violation|0|||
124805332|NCT00543543|448918212|FG003|Base Study|Protocol Violation|6|||
124805333|NCT00543543|448918209|FG000|Base Study|Withdrawal by Subject|7|||
124805334|NCT00543543|448918210|FG001|Base Study|Withdrawal by Subject|482|||
124805335|NCT00543543|448918211|FG002|Base Study|Withdrawal by Subject|5|||
124805336|NCT00543543|448918212|FG003|Base Study|Withdrawal by Subject|503|||
124805337|NCT00543543|448918209|FG000|Extension Study|Adverse Event|0|||
124805338|NCT00543543|448918210|FG001|Extension Study|Adverse Event|0|||
124805339|NCT00543543|448918211|FG002|Extension Study|Adverse Event|0|||
124805340|NCT00543543|448918212|FG003|Extension Study|Adverse Event|5|||
124805341|NCT00543543|448918209|FG000|Extension Study|Lost to Follow-up|0|||
124805342|NCT00543543|448918210|FG001|Extension Study|Lost to Follow-up|0|||
124805343|NCT00543543|448918211|FG002|Extension Study|Lost to Follow-up|0|||
124805344|NCT00543543|448918212|FG003|Extension Study|Lost to Follow-up|77|||
124805345|NCT00543543|448918209|FG000|Extension Study|Physician Decision|0|||
124805346|NCT00543543|448918210|FG001|Extension Study|Physician Decision|0|||
124805347|NCT00543543|448918211|FG002|Extension Study|Physician Decision|0|||
124805348|NCT00543543|448918212|FG003|Extension Study|Physician Decision|7|||
124805349|NCT00543543|448918209|FG000|Extension Study|Pregnancy|0|||
124805350|NCT00543543|448918210|FG001|Extension Study|Pregnancy|0|||
124805351|NCT00543543|448918211|FG002|Extension Study|Pregnancy|0|||
124805352|NCT00543543|448918212|FG003|Extension Study|Pregnancy|6|||
124805353|NCT00543543|448918209|FG000|Extension Study|Protocol Violation|0|||
124805354|NCT00543543|448918210|FG001|Extension Study|Protocol Violation|0|||
124805355|NCT00543543|448918211|FG002|Extension Study|Protocol Violation|0|||
124805356|NCT00543543|448918212|FG003|Extension Study|Protocol Violation|11|||
124805357|NCT00543543|448918209|FG000|Extension Study|Withdrawal by Subject|0|||
124805358|NCT00543543|448918210|FG001|Extension Study|Withdrawal by Subject|0|||
124805359|NCT00543543|448918211|FG002|Extension Study|Withdrawal by Subject|0|||
124805360|NCT00543543|448918212|FG003|Extension Study|Withdrawal by Subject|120|||
124805361|NCT01361568|448918213|FG000|Overall Study|Adverse Event|0|||
124805362|NCT01361568|448918214|FG001|Overall Study|Adverse Event|0|||
124805363|NCT01361568|448918215|FG002|Overall Study|Adverse Event|0|||
124805364|NCT01361568|448918216|FG003|Overall Study|Adverse Event|0|||
124805365|NCT01361568|448918217|FG004|Overall Study|Adverse Event|1|||
124805366|NCT01361568|448918218|FG005|Overall Study|Adverse Event|0|||
124805367|NCT01361568|448918213|FG000|Overall Study|Physician Decision|0|||
124805368|NCT01361568|448918214|FG001|Overall Study|Physician Decision|0|||
124805369|NCT01361568|448918215|FG002|Overall Study|Physician Decision|0|||
124805370|NCT01361568|448918216|FG003|Overall Study|Physician Decision|0|||
124805371|NCT01361568|448918217|FG004|Overall Study|Physician Decision|0|||
124805372|NCT01361568|448918218|FG005|Overall Study|Physician Decision|1|||
124805373|NCT01361568|448918213|FG000|Overall Study|Withdrawal by Subject|2|||
124805374|NCT01361568|448918214|FG001|Overall Study|Withdrawal by Subject|1|||
124805375|NCT01361568|448918215|FG002|Overall Study|Withdrawal by Subject|0|||
124805376|NCT01361568|448918216|FG003|Overall Study|Withdrawal by Subject|0|||
124805377|NCT01361568|448918217|FG004|Overall Study|Withdrawal by Subject|0|||
124805378|NCT01361568|448918218|FG005|Overall Study|Withdrawal by Subject|1|||
124805379|NCT02959983|448918219|FG000|Overall Study|Protocol Violation|0|||
124805380|NCT02959983|448918220|FG001|Overall Study|Protocol Violation|1|||
124805381|NCT02959983|448918219|FG000|Overall Study|Lack of Efficacy|0|||
124805382|NCT02959983|448918220|FG001|Overall Study|Lack of Efficacy|1|||
124805383|NCT02959983|448918219|FG000|Overall Study|Lost to Follow-up|12|||
124805384|NCT02959983|448918220|FG001|Overall Study|Lost to Follow-up|9|||
124805385|NCT02959983|448918219|FG000|Overall Study|Other|1|||
124805386|NCT02959983|448918220|FG001|Overall Study|Other|1|||
124805387|NCT02959983|448918219|FG000|Overall Study|Physician Decision|1|||
124805388|NCT02959983|448918220|FG001|Overall Study|Physician Decision|0|||
124805389|NCT02959983|448918219|FG000|Overall Study|Adverse Event|5|||
124805390|NCT02959983|448918220|FG001|Overall Study|Adverse Event|1|||
124805391|NCT02959983|448918219|FG000|Overall Study|Withdrawal by Subject|7|||
124805392|NCT02959983|448918220|FG001|Overall Study|Withdrawal by Subject|12|||
124805393|NCT00484094|448918221|FG000|Overall Study|Discontinued|39|||
124805394|NCT00484094|448918221|FG000|Overall Study|Other|3|||
124805395|NCT00586625|448918222|FG000|Overall Study|Adverse Event|6|||
124805396|NCT00586625|448918223|FG001|Overall Study|Adverse Event|6|||
124805397|NCT00586625|448918222|FG000|Overall Study|Protocol Violation|3|||
124805398|NCT00586625|448918223|FG001|Overall Study|Protocol Violation|0|||
124805399|NCT00586625|448918222|FG000|Overall Study|Withdrawal by Subject|32|||
124805400|NCT00586625|448918223|FG001|Overall Study|Withdrawal by Subject|10|||
124805401|NCT00586625|448918222|FG000|Overall Study|Subject non-compliance|0|||
124805402|NCT00586625|448918223|FG001|Overall Study|Subject non-compliance|1|||
124805403|NCT00586625|448918222|FG000|Overall Study|Subject unable to return for visit|2|||
124805404|NCT00586625|448918223|FG001|Overall Study|Subject unable to return for visit|0|||
124805405|NCT00165984|448918224|FG000|Overall Study|Death|15|||
124805406|NCT01736124|448918225|FG000|Post-intervention Assessment|Death|2|||
124805407|NCT01736124|448918226|FG001|Post-intervention Assessment|Death|2|||
124805408|NCT01736124|448918225|FG000|Post-intervention Assessment|lost computer access|1|||
124805409|NCT01736124|448918226|FG001|Post-intervention Assessment|lost computer access|1|||
124805410|NCT01736124|448918225|FG000|Post-intervention Assessment|Moved away|3|||
124805411|NCT01736124|448918226|FG001|Post-intervention Assessment|Moved away|1|||
124805412|NCT01736124|448918225|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
124805413|NCT01736124|448918226|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
124805414|NCT01736124|448918225|FG000|Post-intervention Assessment|Illness|3|||
124805415|NCT01736124|448918226|FG001|Post-intervention Assessment|Illness|2|||
124805416|NCT01736124|448918225|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
124805417|NCT01736124|448918226|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
124805418|NCT01736124|448918225|FG000|Post-intervention Assessment|Temporarily away|3|||
124805419|NCT01736124|448918226|FG001|Post-intervention Assessment|Temporarily away|1|||
124805420|NCT01736124|448918225|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
124805421|NCT01736124|448918226|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
124805422|NCT01736124|448918225|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
124805423|NCT01736124|448918226|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
124805424|NCT01736124|448918225|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
124805425|NCT01736124|448918226|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
124805426|NCT01736124|448918225|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
124805427|NCT01736124|448918226|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
124805428|NCT01736124|448918225|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
124805429|NCT01736124|448918226|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
124805430|NCT01736124|448918225|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
124805431|NCT01736124|448918226|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
124805432|NCT01736124|448918225|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
124805433|NCT01736124|448918226|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
124805434|NCT01736124|448918225|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
124805435|NCT01736124|448918226|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
124805436|NCT01736124|448918225|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
124805437|NCT01736124|448918226|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
124805438|NCT03553927|448918227|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
124805439|NCT03553927|448918228|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
124805440|NCT03553927|448918227|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
124805441|NCT03553927|448918228|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
124805442|NCT01193842|448918230|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
124805443|NCT01193842|448918231|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
124805444|NCT01193842|448918232|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
124805445|NCT01193842|448918233|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
124805446|NCT01193842|448918234|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
124805447|NCT01193842|448918230|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
124805448|NCT01193842|448918231|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
124805449|NCT01193842|448918232|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
124805450|NCT01193842|448918233|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
124805451|NCT01193842|448918234|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
124805452|NCT01193842|448918230|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
124805453|NCT01193842|448918231|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
124805454|NCT01193842|448918232|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
124805455|NCT01193842|448918233|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
124805456|NCT01193842|448918234|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
124805457|NCT01193842|448918230|FG000|Phase II: Randomized Groups|Death|0|||
124805458|NCT01193842|448918231|FG001|Phase II: Randomized Groups|Death|0|||
124805459|NCT01193842|448918232|FG002|Phase II: Randomized Groups|Death|0|||
124805460|NCT01193842|448918233|FG003|Phase II: Randomized Groups|Death|1|||
124805461|NCT01193842|448918234|FG004|Phase II: Randomized Groups|Death|1|||
124805462|NCT01193842|448918230|FG000|Phase II: Randomized Groups|Adverse Event|0|||
124805463|NCT01193842|448918231|FG001|Phase II: Randomized Groups|Adverse Event|0|||
124805464|NCT01193842|448918232|FG002|Phase II: Randomized Groups|Adverse Event|0|||
124805465|NCT01193842|448918233|FG003|Phase II: Randomized Groups|Adverse Event|5|||
124805466|NCT01193842|448918234|FG004|Phase II: Randomized Groups|Adverse Event|3|||
124634029|NCT00437021|448276177|FG005|Overall Study|Withdrawal by Subject|0|||
124634030|NCT00437021|448276178|FG006|Overall Study|Withdrawal by Subject|0|||
124634031|NCT00437021|448276179|FG007|Overall Study|Withdrawal by Subject|0|||
124634032|NCT00437021|448276180|FG008|Overall Study|Withdrawal by Subject|0|||
124634033|NCT00437021|448276181|FG009|Overall Study|Withdrawal by Subject|0|||
124634034|NCT00437021|448276182|FG010|Overall Study|Withdrawal by Subject|0|||
124634035|NCT00437021|448276183|FG011|Overall Study|Withdrawal by Subject|0|||
124634036|NCT05573464|448276184|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
124805467|NCT01193842|448918230|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
124805468|NCT01193842|448918231|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
124805469|NCT01193842|448918232|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
124805470|NCT01193842|448918233|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
124805471|NCT01193842|448918234|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
124805472|NCT01193842|448918230|FG000|Phase II: Randomized Groups|Ineligible|0|||
124805473|NCT01193842|448918231|FG001|Phase II: Randomized Groups|Ineligible|0|||
124805474|NCT01193842|448918232|FG002|Phase II: Randomized Groups|Ineligible|0|||
124805475|NCT01193842|448918233|FG003|Phase II: Randomized Groups|Ineligible|0|||
124805476|NCT01193842|448918234|FG004|Phase II: Randomized Groups|Ineligible|1|||
124805477|NCT01193842|448918230|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
124805478|NCT01193842|448918231|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
124805479|NCT01193842|448918232|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
124805480|NCT01193842|448918233|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
124805481|NCT01193842|448918234|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
124805482|NCT03698331|448918235|FG000|Overall Study|Adverse Event|2|||
124805483|NCT03698331|448918236|FG001|Overall Study|Adverse Event|3|||
124805484|NCT03698331|448918235|FG000|Overall Study|Withdrawal by Subject|1|||
124805485|NCT03698331|448918236|FG001|Overall Study|Withdrawal by Subject|1|||
124805486|NCT03698331|448918235|FG000|Overall Study|Lost to Follow-up|0|||
124805487|NCT03698331|448918236|FG001|Overall Study|Lost to Follow-up|2|||
124805488|NCT03698331|448918235|FG000|Overall Study|Non-compliance with study drug|1|||
124805489|NCT03698331|448918236|FG001|Overall Study|Non-compliance with study drug|0|||
124805490|NCT02130024|448918238|FG000|Overall Study|Adverse Event|10|||
124805491|NCT02130024|448918239|FG001|Overall Study|Adverse Event|11|||
124805492|NCT02130024|448918238|FG000|Overall Study|Death|2|||
124805493|NCT02130024|448918239|FG001|Overall Study|Death|2|||
124805494|NCT02130024|448918238|FG000|Overall Study|Lost to Follow-up|1|||
124805495|NCT02130024|448918239|FG001|Overall Study|Lost to Follow-up|1|||
124805496|NCT02130024|448918238|FG000|Overall Study|Physician Decision|1|||
124805497|NCT02130024|448918239|FG001|Overall Study|Physician Decision|3|||
124805498|NCT02130024|448918238|FG000|Overall Study|Protocol Deviation|4|||
124805499|NCT02130024|448918239|FG001|Overall Study|Protocol Deviation|0|||
124805500|NCT02130024|448918238|FG000|Overall Study|Site Administration Problems|1|||
124805501|NCT02130024|448918239|FG001|Overall Study|Site Administration Problems|0|||
124634037|NCT05573464|448276185|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
124634038|NCT05573464|448276184|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
124805502|NCT02130024|448918238|FG000|Overall Study|Subject Withdrew Consent|6|||
124805503|NCT02130024|448918239|FG001|Overall Study|Subject Withdrew Consent|14|||
124805504|NCT01467583|448918240|FG000|Overall Study|Death|1|||
124805505|NCT01467583|448918241|FG001|Overall Study|Death|1|||
124805506|NCT01467583|448918242|FG002|Overall Study|Death|0|||
124805507|NCT01467583|448918240|FG000|Overall Study|Withdrawal by Subject|1|||
124805508|NCT01467583|448918241|FG001|Overall Study|Withdrawal by Subject|0|||
124805509|NCT01467583|448918242|FG002|Overall Study|Withdrawal by Subject|0|||
124805510|NCT01467583|448918240|FG000|Overall Study|Protocol Violation|0|||
124805511|NCT01467583|448918241|FG001|Overall Study|Protocol Violation|0|||
124634039|NCT05573464|448276185|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
124805512|NCT01467583|448918242|FG002|Overall Study|Protocol Violation|2|||
124805513|NCT05274165|448918245|FG000|Overall Study|Withdrawal by Subject|3|||
124805514|NCT05274165|448918246|FG001|Overall Study|Withdrawal by Subject|3|||
124805515|NCT01386008|448918247|FG000|Overall Study|exited w/o incident /study discontinued|17|||
124805516|NCT01386008|448918247|FG000|Overall Study|Adverse Event|3|||
124805517|NCT03001882|448918248|FG000|Overall Study|Death|1|||
124805518|NCT03001882|448918249|FG001|Overall Study|Death|0|||
124805519|NCT03001882|448918250|FG002|Overall Study|Death|0|||
124805520|NCT03001882|448918251|FG003|Overall Study|Death|3|||
124805521|NCT03001882|448918248|FG000|Overall Study|Participant withdrew consent|0|||
124805522|NCT03001882|448918249|FG001|Overall Study|Participant withdrew consent|1|||
124805523|NCT03001882|448918250|FG002|Overall Study|Participant withdrew consent|0|||
124805524|NCT03001882|448918251|FG003|Overall Study|Participant withdrew consent|5|||
124805525|NCT03001882|448918248|FG000|Overall Study|Other reasons|1|||
124805526|NCT03001882|448918249|FG001|Overall Study|Other reasons|2|||
124805527|NCT03001882|448918250|FG002|Overall Study|Other reasons|0|||
124805528|NCT03001882|448918251|FG003|Overall Study|Other reasons|5|||
124805529|NCT03001882|448918248|FG000|Overall Study|Administrative reason by sponsor|0|||
124805530|NCT03001882|448918249|FG001|Overall Study|Administrative reason by sponsor|0|||
124805531|NCT03001882|448918250|FG002|Overall Study|Administrative reason by sponsor|0|||
124805532|NCT03001882|448918251|FG003|Overall Study|Administrative reason by sponsor|1|||
124805533|NCT03001882|448918248|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
124805534|NCT03001882|448918249|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
124805535|NCT03001882|448918250|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
124805536|NCT03001882|448918251|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
124805537|NCT03001882|448918248|FG000|Overall Study|Not reported|0|||
124805538|NCT03001882|448918249|FG001|Overall Study|Not reported|0|||
124805539|NCT03001882|448918250|FG002|Overall Study|Not reported|0|||
124805540|NCT03001882|448918251|FG003|Overall Study|Not reported|6|||
124805541|NCT03001882|448918248|FG000|Overall Study|Maximum clinical benefit|2|||
124805542|NCT03001882|448918249|FG001|Overall Study|Maximum clinical benefit|3|||
124805543|NCT03001882|448918250|FG002|Overall Study|Maximum clinical benefit|0|||
124805544|NCT03001882|448918251|FG003|Overall Study|Maximum clinical benefit|10|||
124805545|NCT03001882|448918248|FG000|Overall Study|AE unrelated to study drug|3|||
124805546|NCT03001882|448918249|FG001|Overall Study|AE unrelated to study drug|3|||
124805547|NCT03001882|448918250|FG002|Overall Study|AE unrelated to study drug|0|||
124805548|NCT03001882|448918251|FG003|Overall Study|AE unrelated to study drug|11|||
124805549|NCT03001882|448918248|FG000|Overall Study|Study Drug Toxicity|8|||
124805550|NCT03001882|448918249|FG001|Overall Study|Study Drug Toxicity|5|||
124805551|NCT03001882|448918250|FG002|Overall Study|Study Drug Toxicity|0|||
124805552|NCT03001882|448918251|FG003|Overall Study|Study Drug Toxicity|37|||
124805553|NCT03001882|448918248|FG000|Overall Study|Disease progression|16|||
124805554|NCT03001882|448918249|FG001|Overall Study|Disease progression|14|||
124805555|NCT03001882|448918250|FG002|Overall Study|Disease progression|1|||
124805556|NCT03001882|448918251|FG003|Overall Study|Disease progression|90|||
124805557|NCT00976677|448918252|FG000|Overall Study|Adverse Event|1|||
124805558|NCT00976677|448918253|FG001|Overall Study|Adverse Event|0|||
124805559|NCT00976677|448918252|FG000|Overall Study|Withdrawal by Subject|0|||
124805560|NCT00976677|448918253|FG001|Overall Study|Withdrawal by Subject|2|||
124805561|NCT00976677|448918252|FG000|Overall Study|Disease progression|1|||
124805562|NCT00976677|448918253|FG001|Overall Study|Disease progression|1|||
124805563|NCT00976677|448918252|FG000|Overall Study|Trial unblinded|2|||
124805564|NCT00976677|448918253|FG001|Overall Study|Trial unblinded|2|||
124805565|NCT00976677|448918252|FG000|Overall Study|Unknown/Missing|1|||
124805566|NCT00976677|448918253|FG001|Overall Study|Unknown/Missing|0|||
124805567|NCT00615108|448919568|FG000|Overall Study|Adverse Event|122|||
124805568|NCT00615108|448919568|FG000|Overall Study|Other|370|||
124805569|NCT00615108|448919568|FG000|Overall Study|Lost to Follow-up|15|||
124805570|NCT01393301|448919569|FG000|Overall Study|Lost to Follow-up|5|||
124805571|NCT01393301|448919570|FG001|Overall Study|Lost to Follow-up|3|||
124805572|NCT01393301|448919569|FG000|Overall Study|Withdrawal by Subject|2|||
124805573|NCT01393301|448919570|FG001|Overall Study|Withdrawal by Subject|0|||
124805574|NCT01393301|448919569|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
124805575|NCT01393301|448919570|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
124805576|NCT02758171|448919571|FG000|Wash-out|Withdrawal by Subject|1|||
124805577|NCT02758171|448919572|FG001|Wash-out|Withdrawal by Subject|0|||
124805578|NCT02758171|448919571|FG000|Wash-out|Other reason|1|||
124805579|NCT02758171|448919572|FG001|Wash-out|Other reason|0|||
124805580|NCT00853073|448919573|FG000|Overall Study|Withdrawal by Subject|3|||
124805581|NCT00853073|448919574|FG001|Overall Study|Withdrawal by Subject|2|||
124634040|NCT05573464|448276184|FG000|12-week Treatment Period|Protocol Violation|3|||
124805582|NCT03643575|448919575|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
124805583|NCT03643575|448919576|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
124805584|NCT03643575|448919577|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
124805585|NCT03643575|448919578|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
124805586|NCT03643575|448919579|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
124805587|NCT03643575|448919580|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
124805588|NCT03643575|448919575|FG000|Washout: 7 Days|Adverse Event|1|||
124805589|NCT03643575|448919576|FG001|Washout: 7 Days|Adverse Event|0|||
124805590|NCT03643575|448919577|FG002|Washout: 7 Days|Adverse Event|0|||
124805591|NCT03643575|448919578|FG003|Washout: 7 Days|Adverse Event|0|||
124805592|NCT03643575|448919579|FG004|Washout: 7 Days|Adverse Event|0|||
124805593|NCT03643575|448919580|FG005|Washout: 7 Days|Adverse Event|0|||
124805594|NCT03643575|448919575|FG000|Washout: 7 Days|Non compliance check in|0|||
124805595|NCT03643575|448919576|FG001|Washout: 7 Days|Non compliance check in|1|||
124805596|NCT03643575|448919577|FG002|Washout: 7 Days|Non compliance check in|0|||
124805597|NCT03643575|448919578|FG003|Washout: 7 Days|Non compliance check in|0|||
124805598|NCT03643575|448919579|FG004|Washout: 7 Days|Non compliance check in|0|||
124805599|NCT03643575|448919580|FG005|Washout: 7 Days|Non compliance check in|0|||
124805600|NCT01309165|448919581|FG000|Overall Study|Lost to Follow-up|4|||
124805601|NCT01309165|448919582|FG001|Overall Study|Lost to Follow-up|3|||
124805602|NCT01309165|448919581|FG000|Overall Study|Return to work|1|||
124805603|NCT01309165|448919582|FG001|Overall Study|Return to work|2|||
124805604|NCT01309165|448919581|FG000|Overall Study|Left country|0|||
124805605|NCT01309165|448919582|FG001|Overall Study|Left country|1|||
124805606|NCT01309165|448919581|FG000|Overall Study|No transportation|0|||
124805607|NCT01309165|448919582|FG001|Overall Study|No transportation|1|||
124805608|NCT01309165|448919581|FG000|Overall Study|Admitted to hospital for second stroke|1|||
124805609|NCT01309165|448919582|FG001|Overall Study|Admitted to hospital for second stroke|0|||
124805610|NCT02410551|448919584|FG000|Overall Study|Adverse Event|1|||
124805611|NCT02410551|448919584|FG000|Overall Study|Withdrawal by Subject|1|||
124805612|NCT02410551|448919584|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
124805613|NCT01739309|448919586|FG000|Overall Study|Adverse Event|1|||
124805614|NCT01739309|448919586|FG000|Overall Study|Withdrawal by Subject|1|||
124805615|NCT00986830|448919589|FG000|Overall Study|Death|1|||
124805616|NCT00986830|448919589|FG000|Overall Study|Lost to Follow-up|1|||
124805617|NCT00986830|448919589|FG000|Overall Study|Lack of Efficacy|1|||
124805618|NCT00986830|448919589|FG000|Overall Study|Unable to access sinus with device|5|||
124805619|NCT01495975|448919590|FG000|Overall Study|Lost to Follow-up|1|||
124805620|NCT01495975|448919591|FG001|Overall Study|Lost to Follow-up|0|||
124805621|NCT05447897|448919592|FG000|Overall Study|Did not participate in survey|2|||
124805622|NCT04553679|448919593|FG000|Overall Study|Withdrawal by Subject|2|||
124805623|NCT04553679|448919594|FG001|Overall Study|Withdrawal by Subject|0|||
124805624|NCT04553679|448919593|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
124805625|NCT04553679|448919594|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
124805626|NCT00333840|448919595|FG000|First-line Treatment Period|Adverse Event|38|||
124805627|NCT00333840|448919596|FG001|First-line Treatment Period|Adverse Event|37|||
124805628|NCT00333840|448919597|FG002|First-line Treatment Period|Adverse Event|0|||
124805629|NCT00333840|448919598|FG003|First-line Treatment Period|Adverse Event|0|||
124805630|NCT00333840|448919595|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
124805631|NCT00333840|448919596|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
124805632|NCT00333840|448919597|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
124805633|NCT00333840|448919598|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
124805634|NCT00333840|448919595|FG000|First-line Treatment Period|Abnormal procedure|2|||
124805635|NCT00333840|448919596|FG001|First-line Treatment Period|Abnormal procedure|0|||
124805636|NCT00333840|448919597|FG002|First-line Treatment Period|Abnormal procedure|0|||
124805637|NCT00333840|448919598|FG003|First-line Treatment Period|Abnormal procedure|0|||
124805638|NCT00333840|448919595|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
124805639|NCT00333840|448919596|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
124805640|NCT00333840|448919597|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
124805641|NCT00333840|448919598|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
124805642|NCT00333840|448919595|FG000|First-line Treatment Period|No longer required study drug|21|||
124805643|NCT00333840|448919596|FG001|First-line Treatment Period|No longer required study drug|8|||
124805644|NCT00333840|448919597|FG002|First-line Treatment Period|No longer required study drug|0|||
124805645|NCT00333840|448919598|FG003|First-line Treatment Period|No longer required study drug|0|||
124805646|NCT00333840|448919595|FG000|First-line Treatment Period|Protocol Violation|17|||
124805647|NCT00333840|448919596|FG001|First-line Treatment Period|Protocol Violation|17|||
124805648|NCT00333840|448919597|FG002|First-line Treatment Period|Protocol Violation|0|||
124805649|NCT00333840|448919598|FG003|First-line Treatment Period|Protocol Violation|0|||
124805650|NCT00333840|448919595|FG000|First-line Treatment Period|Subject withdrew consent|57|||
124805651|NCT00333840|448919596|FG001|First-line Treatment Period|Subject withdrew consent|77|||
124805652|NCT00333840|448919597|FG002|First-line Treatment Period|Subject withdrew consent|0|||
124805653|NCT00333840|448919598|FG003|First-line Treatment Period|Subject withdrew consent|0|||
124805654|NCT00333840|448919595|FG000|First-line Treatment Period|Lost to Follow-up|15|||
124805655|NCT00333840|448919596|FG001|First-line Treatment Period|Lost to Follow-up|6|||
124805656|NCT00333840|448919597|FG002|First-line Treatment Period|Lost to Follow-up|0|||
124805657|NCT00333840|448919598|FG003|First-line Treatment Period|Lost to Follow-up|0|||
124805658|NCT00333840|448919595|FG000|First-line Treatment Period|Administrative problems|12|||
124805659|NCT00333840|448919596|FG001|First-line Treatment Period|Administrative problems|6|||
124805660|NCT00333840|448919597|FG002|First-line Treatment Period|Administrative problems|0|||
124805661|NCT00333840|448919598|FG003|First-line Treatment Period|Administrative problems|0|||
124805662|NCT00333840|448919595|FG000|First-line Treatment Period|Death|19|||
124805663|NCT00333840|448919596|FG001|First-line Treatment Period|Death|2|||
124805664|NCT00333840|448919597|FG002|First-line Treatment Period|Death|0|||
124805665|NCT00333840|448919598|FG003|First-line Treatment Period|Death|0|||
124805666|NCT00333840|448919595|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
124805667|NCT00333840|448919596|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
124805668|NCT00333840|448919597|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
124805669|NCT00333840|448919598|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
124805670|NCT00333840|448919595|FG000|Second-line Treatment Period|Adverse Event|0|||
124805671|NCT00333840|448919596|FG001|Second-line Treatment Period|Adverse Event|0|||
124805672|NCT00333840|448919597|FG002|Second-line Treatment Period|Adverse Event|3|||
124805673|NCT00333840|448919598|FG003|Second-line Treatment Period|Adverse Event|34|||
124805674|NCT00333840|448919595|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
124805675|NCT00333840|448919596|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
124805676|NCT00333840|448919597|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
124805677|NCT00333840|448919598|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
124805678|NCT00333840|448919595|FG000|Second-line Treatment Period|Abnormal procedure|0|||
124805679|NCT00333840|448919596|FG001|Second-line Treatment Period|Abnormal procedure|0|||
124805680|NCT00333840|448919597|FG002|Second-line Treatment Period|Abnormal procedure|0|||
124805681|NCT00333840|448919598|FG003|Second-line Treatment Period|Abnormal procedure|1|||
124805682|NCT00333840|448919595|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
124805683|NCT00333840|448919596|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
124805684|NCT00333840|448919597|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
124805685|NCT00333840|448919598|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
124805686|NCT00333840|448919595|FG000|Second-line Treatment Period|No longer required study drug|0|||
124805687|NCT00333840|448919596|FG001|Second-line Treatment Period|No longer required study drug|0|||
124805688|NCT00333840|448919597|FG002|Second-line Treatment Period|No longer required study drug|1|||
124805689|NCT00333840|448919598|FG003|Second-line Treatment Period|No longer required study drug|14|||
124805690|NCT00333840|448919595|FG000|Second-line Treatment Period|Protocol Violation|0|||
124805691|NCT00333840|448919596|FG001|Second-line Treatment Period|Protocol Violation|0|||
124805692|NCT00333840|448919597|FG002|Second-line Treatment Period|Protocol Violation|1|||
124805693|NCT00333840|448919598|FG003|Second-line Treatment Period|Protocol Violation|10|||
124805694|NCT00333840|448919595|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
124805695|NCT00333840|448919596|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
124805696|NCT00333840|448919597|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
124805697|NCT00333840|448919598|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
124805698|NCT00333840|448919595|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
124805699|NCT00333840|448919596|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
124805700|NCT00333840|448919597|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
124805701|NCT00333840|448919598|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
124805702|NCT00333840|448919595|FG000|Second-line Treatment Period|Administrative problems|0|||
124805703|NCT00333840|448919596|FG001|Second-line Treatment Period|Administrative problems|0|||
124805704|NCT00333840|448919597|FG002|Second-line Treatment Period|Administrative problems|0|||
124805705|NCT00333840|448919598|FG003|Second-line Treatment Period|Administrative problems|7|||
124805706|NCT00333840|448919595|FG000|Second-line Treatment Period|Death|0|||
124805707|NCT00333840|448919596|FG001|Second-line Treatment Period|Death|0|||
124805708|NCT00333840|448919597|FG002|Second-line Treatment Period|Death|0|||
124805709|NCT00333840|448919598|FG003|Second-line Treatment Period|Death|9|||
124805710|NCT00074984|448919602|FG000|Overall Study|Death|1|||
124805711|NCT00074984|448919603|FG001|Overall Study|Death|2|||
124805712|NCT00074984|448919602|FG000|Overall Study|Withdrawal by Subject|2|||
124805713|NCT00074984|448919603|FG001|Overall Study|Withdrawal by Subject|3|||
124805714|NCT00074984|448919602|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
124805715|NCT00074984|448919603|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
124805716|NCT03719586|448919605|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
124805717|NCT03719586|448919606|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
124805718|NCT03719586|448919607|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
124805719|NCT03719586|448919608|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
124805720|NCT00369707|448919612|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
124805721|NCT00369707|448919612|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
124805722|NCT00369707|448919612|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
124805723|NCT00369707|448919612|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
124805724|NCT00369707|448919612|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
124805725|NCT00369707|448919612|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
124805726|NCT00369707|448919612|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
124805727|NCT00369707|448919612|FG000|Follow up for 2 Years After Treatment|Death|1|||
124805728|NCT00369707|448919612|FG000|Follow up for 2 Years After Treatment|Other|2|||
124805729|NCT02046733|448919613|FG000|Overall Study|never initiated 'treatment visits'|6|||
124805730|NCT02046733|448919614|FG001|Overall Study|never initiated 'treatment visits'|0|||
124805731|NCT01254292|448919619|FG000|Comparative Phase|Adverse Event|25|||
124805732|NCT01254292|448919620|FG001|Comparative Phase|Adverse Event|25|||
124805733|NCT01254292|448919619|FG000|Comparative Phase|Lost to Follow-up|3|||
124805734|NCT01254292|448919620|FG001|Comparative Phase|Lost to Follow-up|21|||
124805735|NCT01254292|448919619|FG000|Comparative Phase|Pregnancy|2|||
124805736|NCT01254292|448919620|FG001|Comparative Phase|Pregnancy|6|||
124805737|NCT01254292|448919619|FG000|Comparative Phase|Withdrawal by Subject|20|||
124805738|NCT01254292|448919620|FG001|Comparative Phase|Withdrawal by Subject|21|||
124805739|NCT01254292|448919619|FG000|Comparative Phase|Protocol Violation|1|||
124805740|NCT01254292|448919620|FG001|Comparative Phase|Protocol Violation|2|||
124805741|NCT01254292|448919619|FG000|Comparative Phase|Wish for pregnancy|4|||
124805742|NCT01254292|448919620|FG001|Comparative Phase|Wish for pregnancy|6|||
124805743|NCT01254292|448919619|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
124805744|NCT01254292|448919620|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
124805745|NCT01254292|448919619|FG000|LCS12 Extension Phase|Adverse Event|9|||
124805746|NCT01254292|448919620|FG001|LCS12 Extension Phase|Adverse Event|0|||
124805747|NCT01254292|448919619|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
124805748|NCT01254292|448919620|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
124805749|NCT01254292|448919619|FG000|LCS12 Extension Phase|Other unknown|4|||
124805750|NCT01254292|448919620|FG001|LCS12 Extension Phase|Other unknown|0|||
124805751|NCT01254292|448919619|FG000|LCS12 Extension Phase|Pregnancy|2|||
124805752|NCT01254292|448919620|FG001|LCS12 Extension Phase|Pregnancy|0|||
124805753|NCT01254292|448919619|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
124805754|NCT01254292|448919620|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
124805755|NCT04041375|448919621|FG000|Intervention Phase|Withdrawal by Subject|2|||
124805756|NCT04041375|448919622|FG001|Intervention Phase|Withdrawal by Subject|2|||
124805757|NCT04041375|448919621|FG000|Follow-up Phase|Death|2|||
124805758|NCT04041375|448919622|FG001|Follow-up Phase|Death|0|||
124805759|NCT04041375|448919621|FG000|Follow-up Phase|Lost to Follow-up|2|||
124805760|NCT04041375|448919622|FG001|Follow-up Phase|Lost to Follow-up|1|||
124805761|NCT04041375|448919621|FG000|Follow-up Phase|Too ill|3|||
124805762|NCT04041375|448919622|FG001|Follow-up Phase|Too ill|0|||
124805763|NCT04674644|448919628|FG000|Overall Study|with missing data|37|||
124805764|NCT00199875|448919629|FG000|Overall Study|Withdrawal by Subject|0|||
124805765|NCT00199875|448919630|FG001|Overall Study|Withdrawal by Subject|0|||
124805766|NCT00199875|448919631|FG002|Overall Study|Withdrawal by Subject|0|||
124805767|NCT00199875|448919632|FG003|Overall Study|Withdrawal by Subject|0|||
124805768|NCT00199875|448919633|FG004|Overall Study|Withdrawal by Subject|1|||
124805769|NCT03277690|448919637|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
124805770|NCT03277690|448919638|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
124805771|NCT03277690|448919637|FG000|Dose Titration and Maintenance|Physician Decision|1|||
124805772|NCT03277690|448919638|FG001|Dose Titration and Maintenance|Physician Decision|0|||
124805773|NCT03277690|448919637|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
124805774|NCT03277690|448919638|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
124805775|NCT03277690|448919637|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
124805776|NCT03277690|448919638|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
124805777|NCT03277690|448919637|FG000|Dose Titration and Maintenance|Adverse Event|15|||
124805778|NCT03277690|448919638|FG001|Dose Titration and Maintenance|Adverse Event|0|||
124805779|NCT03277690|448919637|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
124805780|NCT03277690|448919638|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
124805781|NCT03277690|448919637|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
124805782|NCT03277690|448919638|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
124805783|NCT00747812|448919639|FG000|Overall Study|Research Site Staff Relocation|5|||
124805784|NCT00747812|448919640|FG001|Overall Study|Research Site Staff Relocation|3|||
124805785|NCT01013350|448919641|FG000|Overall Study|Lost to Follow-up|15|||
124805786|NCT01013350|448919642|FG001|Overall Study|Lost to Follow-up|95|||
124805787|NCT01013350|448919641|FG000|Overall Study|Adverse Event|0|||
124805788|NCT01013350|448919642|FG001|Overall Study|Adverse Event|1|||
124805789|NCT01013350|448919641|FG000|Overall Study|Physician Decision|4|||
124805790|NCT01013350|448919642|FG001|Overall Study|Physician Decision|20|||
124805791|NCT01013350|448919641|FG000|Overall Study|Withdrawal by Subject|15|||
124805792|NCT01013350|448919642|FG001|Overall Study|Withdrawal by Subject|38|||
124805793|NCT01013350|448919641|FG000|Overall Study|Death|3|||
124805794|NCT01013350|448919642|FG001|Overall Study|Death|5|||
124805795|NCT01013350|448919641|FG000|Overall Study|Participant entered interventional study|0|||
124805796|NCT01013350|448919642|FG001|Overall Study|Participant entered interventional study|8|||
124805797|NCT01013350|448919641|FG000|Overall Study|Other|1|||
124805798|NCT01013350|448919642|FG001|Overall Study|Other|25|||
124805799|NCT01708161|448919643|FG000|Overall Study|Adverse Event|1|||
124805800|NCT01708161|448919644|FG001|Overall Study|Adverse Event|3|||
124805801|NCT01708161|448919645|FG002|Overall Study|Adverse Event|4|||
124805802|NCT01708161|448919646|FG003|Overall Study|Adverse Event|2|||
124805803|NCT01708161|448919647|FG004|Overall Study|Adverse Event|3|||
124805804|NCT01708161|448919648|FG005|Overall Study|Adverse Event|0|||
124805805|NCT01708161|448919643|FG000|Overall Study|Death|0|||
124805806|NCT01708161|448919644|FG001|Overall Study|Death|0|||
124805807|NCT01708161|448919645|FG002|Overall Study|Death|0|||
124805808|NCT01708161|448919646|FG003|Overall Study|Death|1|||
124805809|NCT01708161|448919647|FG004|Overall Study|Death|0|||
124805810|NCT01708161|448919648|FG005|Overall Study|Death|1|||
124805811|NCT01708161|448919643|FG000|Overall Study|Withdrawal by Subject|0|||
124805812|NCT01708161|448919644|FG001|Overall Study|Withdrawal by Subject|1|||
124805813|NCT01708161|448919645|FG002|Overall Study|Withdrawal by Subject|1|||
124805814|NCT01708161|448919646|FG003|Overall Study|Withdrawal by Subject|0|||
124805815|NCT01708161|448919647|FG004|Overall Study|Withdrawal by Subject|0|||
124805816|NCT01708161|448919648|FG005|Overall Study|Withdrawal by Subject|0|||
124805817|NCT01708161|448919643|FG000|Overall Study|Administrative problems|0|||
124805818|NCT01708161|448919644|FG001|Overall Study|Administrative problems|1|||
124805819|NCT01708161|448919645|FG002|Overall Study|Administrative problems|0|||
124805820|NCT01708161|448919646|FG003|Overall Study|Administrative problems|0|||
124805821|NCT01708161|448919647|FG004|Overall Study|Administrative problems|0|||
124805822|NCT01708161|448919648|FG005|Overall Study|Administrative problems|0|||
124805823|NCT01708161|448919643|FG000|Overall Study|Disease progression|3|||
124805824|NCT01708161|448919644|FG001|Overall Study|Disease progression|5|||
124805825|NCT01708161|448919645|FG002|Overall Study|Disease progression|5|||
124805826|NCT01708161|448919646|FG003|Overall Study|Disease progression|13|||
124805827|NCT01708161|448919647|FG004|Overall Study|Disease progression|3|||
124805828|NCT01708161|448919648|FG005|Overall Study|Disease progression|0|||
124805829|NCT02019277|448919649|FG000|Overall Study|Withdrawal by Subject|3|||
124805830|NCT02019277|448919649|FG000|Overall Study|Death|7|||
124805831|NCT02019277|448919649|FG000|Overall Study|Did no Cooperate|1|||
124805832|NCT02019277|448919649|FG000|Overall Study|Adverse Event|1|||
124805833|NCT02633501|448919651|FG000|Overall Study|Adverse Event|0|||
124805834|NCT02633501|448919652|FG001|Overall Study|Adverse Event|0|||
124805835|NCT02633501|448919653|FG002|Overall Study|Adverse Event|1|||
124805836|NCT02633501|448919654|FG003|Overall Study|Adverse Event|0|||
124805837|NCT02633501|448919655|FG004|Overall Study|Adverse Event|1|||
124805838|NCT02633501|448919656|FG005|Overall Study|Adverse Event|1|||
124805839|NCT02633501|448919651|FG000|Overall Study|Withdrawal by Subject|2|||
124805840|NCT02633501|448919652|FG001|Overall Study|Withdrawal by Subject|1|||
124805841|NCT02633501|448919653|FG002|Overall Study|Withdrawal by Subject|2|||
124805842|NCT02633501|448919654|FG003|Overall Study|Withdrawal by Subject|2|||
124805843|NCT02633501|448919655|FG004|Overall Study|Withdrawal by Subject|1|||
124805844|NCT02633501|448919656|FG005|Overall Study|Withdrawal by Subject|3|||
124805845|NCT02633501|448919651|FG000|Overall Study|Various other reasons|0|||
124805846|NCT02633501|448919652|FG001|Overall Study|Various other reasons|2|||
124805847|NCT02633501|448919653|FG002|Overall Study|Various other reasons|4|||
124805848|NCT02633501|448919654|FG003|Overall Study|Various other reasons|1|||
124805849|NCT02633501|448919655|FG004|Overall Study|Various other reasons|7|||
124805850|NCT02633501|448919656|FG005|Overall Study|Various other reasons|11|||
124805851|NCT02633501|448919651|FG000|Overall Study|Lost to Follow-up|0|||
124805852|NCT02633501|448919652|FG001|Overall Study|Lost to Follow-up|0|||
124805853|NCT02633501|448919653|FG002|Overall Study|Lost to Follow-up|0|||
124805854|NCT02633501|448919654|FG003|Overall Study|Lost to Follow-up|1|||
124805855|NCT02633501|448919655|FG004|Overall Study|Lost to Follow-up|2|||
124805856|NCT02633501|448919656|FG005|Overall Study|Lost to Follow-up|0|||
124805857|NCT00395733|448919657|FG000|Period 2|Withdrawal by Subject|1|||
124805858|NCT00395733|448919658|FG001|Period 2|Withdrawal by Subject|2|||
124805859|NCT00395733|448919657|FG000|Period 2|Protocol Violation|0|||
124805860|NCT00395733|448919658|FG001|Period 2|Protocol Violation|1|||
124805861|NCT00395733|448919657|FG000|Period 2|Adverse Event|0|||
124805862|NCT00395733|448919658|FG001|Period 2|Adverse Event|2|||
124805863|NCT00395733|448919657|FG000|Period 2|Technical problems|1|||
124805864|NCT00395733|448919658|FG001|Period 2|Technical problems|0|||
124805865|NCT01672736|448919660|FG000|Overall Study|Available drug expired on 31 May 16|3|||
124805866|NCT02853344|448919665|FG000|Overall Study|Lost to Follow-up|1|||
124805867|NCT02853344|448919666|FG001|Overall Study|Lost to Follow-up|1|||
124805868|NCT02853344|448919665|FG000|Overall Study|Withdrawal by Subject|2|||
124805869|NCT02853344|448919666|FG001|Overall Study|Withdrawal by Subject|4|||
124805870|NCT02853344|448919665|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
124805871|NCT02853344|448919666|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
124805872|NCT02853344|448919665|FG000|Overall Study|Death|70|||
124805873|NCT02853344|448919666|FG001|Overall Study|Death|112|||
124805874|NCT02913612|448919667|FG000|Overall Study|Lost to Follow-up|6|||
124805875|NCT02913612|448919668|FG001|Overall Study|Lost to Follow-up|5|||
124805876|NCT02913612|448919669|FG002|Overall Study|Lost to Follow-up|2|||
124805877|NCT02913612|448919670|FG003|Overall Study|Lost to Follow-up|0|||
124805878|NCT02913612|448919667|FG000|Overall Study|Physician Decision|1|||
124805879|NCT02913612|448919668|FG001|Overall Study|Physician Decision|4|||
124805880|NCT02913612|448919669|FG002|Overall Study|Physician Decision|1|||
124805881|NCT02913612|448919670|FG003|Overall Study|Physician Decision|0|||
124805882|NCT02913612|448919667|FG000|Overall Study|Withdrawal by Subject|2|||
124805883|NCT02913612|448919668|FG001|Overall Study|Withdrawal by Subject|4|||
124805884|NCT02913612|448919669|FG002|Overall Study|Withdrawal by Subject|0|||
124805885|NCT02913612|448919670|FG003|Overall Study|Withdrawal by Subject|0|||
124805886|NCT02913612|448919667|FG000|Overall Study|Hemangioma resolved|1|||
124805887|NCT02913612|448919668|FG001|Overall Study|Hemangioma resolved|0|||
124805888|NCT02913612|448919669|FG002|Overall Study|Hemangioma resolved|0|||
124805889|NCT02913612|448919670|FG003|Overall Study|Hemangioma resolved|0|||
124805890|NCT02913612|448919667|FG000|Overall Study|Local IRB decision|1|||
124805891|NCT02913612|448919668|FG001|Overall Study|Local IRB decision|0|||
124805892|NCT02913612|448919669|FG002|Overall Study|Local IRB decision|0|||
124805893|NCT02913612|448919670|FG003|Overall Study|Local IRB decision|0|||
124805894|NCT02913612|448919667|FG000|Overall Study|Study drug non-compliance|1|||
124805895|NCT02913612|448919668|FG001|Overall Study|Study drug non-compliance|1|||
124805896|NCT02913612|448919669|FG002|Overall Study|Study drug non-compliance|0|||
124805897|NCT02913612|448919670|FG003|Overall Study|Study drug non-compliance|0|||
124805898|NCT02913612|448919667|FG000|Overall Study|Insurance issues|0|||
124805899|NCT02913612|448919668|FG001|Overall Study|Insurance issues|1|||
124805900|NCT02913612|448919669|FG002|Overall Study|Insurance issues|0|||
124805901|NCT02913612|448919670|FG003|Overall Study|Insurance issues|0|||
124805902|NCT02913612|448919667|FG000|Overall Study|Needed to treat second hemangioma|0|||
124805903|NCT02913612|448919668|FG001|Overall Study|Needed to treat second hemangioma|1|||
124805904|NCT02913612|448919669|FG002|Overall Study|Needed to treat second hemangioma|0|||
124805905|NCT02913612|448919670|FG003|Overall Study|Needed to treat second hemangioma|0|||
124805906|NCT02913612|448919667|FG000|Overall Study|Study completion criteria not met|0|||
124805907|NCT02913612|448919668|FG001|Overall Study|Study completion criteria not met|1|||
124805908|NCT02913612|448919669|FG002|Overall Study|Study completion criteria not met|0|||
124805909|NCT02913612|448919670|FG003|Overall Study|Study completion criteria not met|0|||
124805910|NCT02913612|448919667|FG000|Overall Study|Ineligible|0|||
124805911|NCT02913612|448919668|FG001|Overall Study|Ineligible|1|||
124805912|NCT02913612|448919669|FG002|Overall Study|Ineligible|0|||
124805913|NCT02913612|448919670|FG003|Overall Study|Ineligible|0|||
124805914|NCT03452228|448919671|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
124805915|NCT03452228|448919672|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
124805916|NCT03452228|448919673|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
124805917|NCT03452228|448919671|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
124805918|NCT03452228|448919672|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
124805919|NCT03452228|448919673|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
124805920|NCT03452228|448919671|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
124805921|NCT03452228|448919672|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
124805922|NCT03452228|448919673|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
124805923|NCT03452228|448919671|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
124805924|NCT03452228|448919672|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
124805925|NCT03452228|448919673|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
124805926|NCT01262573|448919674|FG000|Overall Study|Withdrawal by Subject|0|||
124805927|NCT01262573|448919675|FG001|Overall Study|Withdrawal by Subject|1|||
124805928|NCT02955797|448919676|FG000|Overall Study|Protocol Violation|1|||
124805929|NCT02955797|448919677|FG001|Overall Study|Protocol Violation|0|||
124805930|NCT02955797|448919678|FG002|Overall Study|Protocol Violation|0|||
124805931|NCT02955797|448919679|FG003|Overall Study|Protocol Violation|1|||
124805932|NCT02955797|448919676|FG000|Overall Study|Withdrawal by Subject|2|||
124805933|NCT02955797|448919677|FG001|Overall Study|Withdrawal by Subject|2|||
124805934|NCT02955797|448919678|FG002|Overall Study|Withdrawal by Subject|0|||
124805935|NCT02955797|448919679|FG003|Overall Study|Withdrawal by Subject|1|||
124805936|NCT02955797|448919676|FG000|Overall Study|Lost to Follow-up|0|||
124805937|NCT02955797|448919677|FG001|Overall Study|Lost to Follow-up|1|||
124805938|NCT02955797|448919678|FG002|Overall Study|Lost to Follow-up|0|||
124805939|NCT02955797|448919679|FG003|Overall Study|Lost to Follow-up|0|||
124805940|NCT02081183|448919681|FG000|Overall Study|Lost to Follow-up|0|||
124805941|NCT02081183|448919682|FG001|Overall Study|Lost to Follow-up|1|||
124805942|NCT02081183|448919681|FG000|Overall Study|Protocol Violation|1|||
124805943|NCT02081183|448919682|FG001|Overall Study|Protocol Violation|0|||
124805944|NCT02081183|448919681|FG000|Overall Study|Other|3|||
124805945|NCT02081183|448919682|FG001|Overall Study|Other|3|||
124805946|NCT04128371|448919687|FG000|Overall Study|Lack of Efficacy|1|||
124805947|NCT00968864|448919688|FG000|Overall Study|Protocol exception/ not evaluable|1|||
124634041|NCT05573464|448276185|FG001|12-week Treatment Period|Protocol Violation|1|||
124634042|NCT05573464|448276184|FG000|12-week Treatment Period|Physician Decision|1|||
124805948|NCT00397215|448919700|FG000|Month 0 (Day 0)|Adverse Event|0|||
124805949|NCT00397215|448919701|FG001|Month 0 (Day 0)|Adverse Event|1|||
124805950|NCT00397215|448919702|FG002|Month 0 (Day 0)|Adverse Event|0|||
124805951|NCT00397215|448919703|FG003|Month 0 (Day 0)|Adverse Event|0|||
124805952|NCT00397215|448919700|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
124805953|NCT00397215|448919701|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
124805954|NCT00397215|448919702|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
124805955|NCT00397215|448919703|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
124805956|NCT00397215|448919700|FG000|Month 0 (Day 0)|Other|4|||
124805957|NCT00397215|448919701|FG001|Month 0 (Day 0)|Other|1|||
124805958|NCT00397215|448919702|FG002|Month 0 (Day 0)|Other|3|||
124805959|NCT00397215|448919703|FG003|Month 0 (Day 0)|Other|3|||
124805960|NCT00397215|448919700|FG000|Month 6 (Day 180)|Adverse Event|0|||
124805961|NCT00397215|448919701|FG001|Month 6 (Day 180)|Adverse Event|3|||
124805962|NCT00397215|448919702|FG002|Month 6 (Day 180)|Adverse Event|2|||
124805963|NCT00397215|448919703|FG003|Month 6 (Day 180)|Adverse Event|0|||
124805964|NCT00397215|448919700|FG000|Month 6 (Day 180)|Other|2|||
124805965|NCT00397215|448919701|FG001|Month 6 (Day 180)|Other|0|||
124805966|NCT00397215|448919702|FG002|Month 6 (Day 180)|Other|3|||
124805967|NCT00397215|448919703|FG003|Month 6 (Day 180)|Other|0|||
124805968|NCT02128932|448919704|FG000|Overall Study|Withdrawal by Subject|11|||
124805969|NCT02128932|448919705|FG001|Overall Study|Withdrawal by Subject|7|||
124805970|NCT02128932|448919706|FG002|Overall Study|Withdrawal by Subject|8|||
124805971|NCT02128932|448919704|FG000|Overall Study|Death|2|||
124805972|NCT02128932|448919705|FG001|Overall Study|Death|0|||
124805973|NCT02128932|448919706|FG002|Overall Study|Death|2|||
124805974|NCT02128932|448919704|FG000|Overall Study|Lost to Follow-up|2|||
124805975|NCT02128932|448919705|FG001|Overall Study|Lost to Follow-up|1|||
124805976|NCT02128932|448919706|FG002|Overall Study|Lost to Follow-up|1|||
124805977|NCT02128932|448919704|FG000|Overall Study|No reason for withdrawal|12|||
124805978|NCT02128932|448919705|FG001|Overall Study|No reason for withdrawal|11|||
124805979|NCT02128932|448919706|FG002|Overall Study|No reason for withdrawal|7|||
124805980|NCT00657358|448919711|FG000|Overall Study|Lack of Efficacy|6|||
124805981|NCT02728596|448919712|FG000|Overall Study|Refusal unrelated to adverse event|3|||
124805982|NCT02728596|448919713|FG001|Overall Study|Refusal unrelated to adverse event|6|||
124805983|NCT02728596|448919714|FG002|Overall Study|Refusal unrelated to adverse event|7|||
124805984|NCT02728596|448919715|FG003|Overall Study|Refusal unrelated to adverse event|7|||
124805985|NCT02728596|448919712|FG000|Overall Study|Death|44|||
124805986|NCT02728596|448919713|FG001|Overall Study|Death|42|||
124805987|NCT02728596|448919714|FG002|Overall Study|Death|123|||
124805988|NCT02728596|448919715|FG003|Overall Study|Death|68|||
124805989|NCT01414608|448919721|FG000|Overall Study|Ineligible|5|||
124805990|NCT01414608|448919722|FG001|Overall Study|Ineligible|2|||
124805991|NCT03672643|448919723|FG000|Overall Study|Adverse Event|3|||
124805992|NCT03672643|448919723|FG000|Overall Study|Death|2|||
124805993|NCT03672643|448919723|FG000|Overall Study|Withdrawal by Subject|1|||
124805994|NCT03672643|448919723|FG000|Overall Study|Progressive disease|11|||
124805995|NCT03672643|448919723|FG000|Overall Study|Global deterioration of health status|1|||
124805996|NCT03672643|448919723|FG000|Overall Study|Refused further treatment|7|||
124805997|NCT03672643|448919723|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
124805998|NCT05736224|448919724|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
124805999|NCT02557295|448919725|FG000|Overall Study|Withdrawal by Subject|9|||
124806000|NCT02557295|448919726|FG001|Overall Study|Withdrawal by Subject|2|||
124806001|NCT02557295|448919727|FG002|Overall Study|Withdrawal by Subject|4|||
124806002|NCT02557295|448919728|FG003|Overall Study|Withdrawal by Subject|0|||
124806003|NCT02557295|448919729|FG004|Overall Study|Withdrawal by Subject|0|||
124806004|NCT02557295|448919730|FG005|Overall Study|Withdrawal by Subject|0|||
124806005|NCT02557295|448919731|FG006|Overall Study|Withdrawal by Subject|15|||
124806006|NCT02557295|448919732|FG007|Overall Study|Withdrawal by Subject|1|||
124806007|NCT02557295|448919733|FG008|Overall Study|Withdrawal by Subject|3|||
124806008|NCT02557295|448919725|FG000|Overall Study|Disease Progression|0|||
124806009|NCT02557295|448919726|FG001|Overall Study|Disease Progression|0|||
124806010|NCT02557295|448919727|FG002|Overall Study|Disease Progression|0|||
124806011|NCT02557295|448919728|FG003|Overall Study|Disease Progression|0|||
124806012|NCT02557295|448919729|FG004|Overall Study|Disease Progression|0|||
124806013|NCT02557295|448919730|FG005|Overall Study|Disease Progression|0|||
124806014|NCT02557295|448919731|FG006|Overall Study|Disease Progression|1|||
124806015|NCT02557295|448919732|FG007|Overall Study|Disease Progression|0|||
124806016|NCT02557295|448919733|FG008|Overall Study|Disease Progression|0|||
124806017|NCT02557295|448919725|FG000|Overall Study|Lack of Efficacy|24|||
124634043|NCT05573464|448276185|FG001|12-week Treatment Period|Physician Decision|2|||
124634044|NCT05573464|448276184|FG000|12-week Treatment Period|Lost to Follow-up|2|||
124634045|NCT05573464|448276185|FG001|12-week Treatment Period|Lost to Follow-up|0|||
124634046|NCT05573464|448276184|FG000|12-week Treatment Period|Adverse Event|20|||
124806018|NCT02557295|448919726|FG001|Overall Study|Lack of Efficacy|1|||
124806019|NCT02557295|448919727|FG002|Overall Study|Lack of Efficacy|3|||
124806020|NCT02557295|448919728|FG003|Overall Study|Lack of Efficacy|0|||
124806021|NCT02557295|448919729|FG004|Overall Study|Lack of Efficacy|0|||
124806022|NCT02557295|448919730|FG005|Overall Study|Lack of Efficacy|0|||
124634047|NCT05573464|448276185|FG001|12-week Treatment Period|Adverse Event|9|||
124806023|NCT02557295|448919731|FG006|Overall Study|Lack of Efficacy|12|||
124806024|NCT02557295|448919732|FG007|Overall Study|Lack of Efficacy|1|||
124806025|NCT02557295|448919733|FG008|Overall Study|Lack of Efficacy|0|||
124806026|NCT02557295|448919725|FG000|Overall Study|Adverse Event|16|||
124806027|NCT02557295|448919726|FG001|Overall Study|Adverse Event|2|||
124806028|NCT02557295|448919727|FG002|Overall Study|Adverse Event|3|||
124806029|NCT02557295|448919728|FG003|Overall Study|Adverse Event|0|||
124806030|NCT02557295|448919729|FG004|Overall Study|Adverse Event|0|||
124806031|NCT02557295|448919730|FG005|Overall Study|Adverse Event|0|||
124806032|NCT02557295|448919731|FG006|Overall Study|Adverse Event|2|||
124806033|NCT02557295|448919732|FG007|Overall Study|Adverse Event|1|||
124806034|NCT02557295|448919733|FG008|Overall Study|Adverse Event|1|||
124806035|NCT02557295|448919725|FG000|Overall Study|Lost to Follow-up|4|||
124806036|NCT02557295|448919726|FG001|Overall Study|Lost to Follow-up|0|||
124806037|NCT02557295|448919727|FG002|Overall Study|Lost to Follow-up|0|||
124806038|NCT02557295|448919728|FG003|Overall Study|Lost to Follow-up|0|||
124806039|NCT02557295|448919729|FG004|Overall Study|Lost to Follow-up|0|||
124806040|NCT02557295|448919730|FG005|Overall Study|Lost to Follow-up|0|||
124806041|NCT02557295|448919731|FG006|Overall Study|Lost to Follow-up|9|||
124806042|NCT02557295|448919732|FG007|Overall Study|Lost to Follow-up|0|||
124806043|NCT02557295|448919733|FG008|Overall Study|Lost to Follow-up|0|||
124806044|NCT02557295|448919725|FG000|Overall Study|Study Close|54|||
124806045|NCT02557295|448919726|FG001|Overall Study|Study Close|3|||
124806046|NCT02557295|448919727|FG002|Overall Study|Study Close|5|||
124806047|NCT02557295|448919728|FG003|Overall Study|Study Close|3|||
124806048|NCT02557295|448919729|FG004|Overall Study|Study Close|0|||
124806049|NCT02557295|448919730|FG005|Overall Study|Study Close|0|||
124806050|NCT02557295|448919731|FG006|Overall Study|Study Close|37|||
124806051|NCT02557295|448919732|FG007|Overall Study|Study Close|3|||
124806052|NCT02557295|448919733|FG008|Overall Study|Study Close|19|||
124806053|NCT02557295|448919725|FG000|Overall Study|except for study close|4|||
124806054|NCT02557295|448919726|FG001|Overall Study|except for study close|0|||
124806055|NCT02557295|448919727|FG002|Overall Study|except for study close|0|||
124806056|NCT02557295|448919728|FG003|Overall Study|except for study close|0|||
124806057|NCT02557295|448919729|FG004|Overall Study|except for study close|0|||
124806058|NCT02557295|448919730|FG005|Overall Study|except for study close|0|||
124806059|NCT02557295|448919731|FG006|Overall Study|except for study close|5|||
124806060|NCT02557295|448919732|FG007|Overall Study|except for study close|1|||
124806061|NCT02557295|448919733|FG008|Overall Study|except for study close|0|||
124806062|NCT04806503|448921632|FG000|Overall Study|Lost to Follow-up|0|||
124806063|NCT04806503|448921633|FG001|Overall Study|Lost to Follow-up|0|||
124806064|NCT04806503|448921634|FG002|Overall Study|Lost to Follow-up|1|||
124806065|NCT04806503|448921635|FG003|Overall Study|Lost to Follow-up|0|||
124806066|NCT04806503|448921636|FG004|Overall Study|Lost to Follow-up|0|||
124806067|NCT04806503|448921632|FG000|Overall Study|Withdrawal by Subject|1|||
124806068|NCT04806503|448921633|FG001|Overall Study|Withdrawal by Subject|0|||
124806069|NCT04806503|448921634|FG002|Overall Study|Withdrawal by Subject|1|||
124806070|NCT04806503|448921635|FG003|Overall Study|Withdrawal by Subject|1|||
124806071|NCT04806503|448921636|FG004|Overall Study|Withdrawal by Subject|1|||
124806072|NCT04806503|448921632|FG000|Overall Study|Adverse Event|1|||
124806073|NCT04806503|448921633|FG001|Overall Study|Adverse Event|1|||
124806074|NCT04806503|448921634|FG002|Overall Study|Adverse Event|0|||
124806075|NCT04806503|448921635|FG003|Overall Study|Adverse Event|1|||
124806076|NCT04806503|448921636|FG004|Overall Study|Adverse Event|0|||
124806077|NCT03589469|448921637|FG000|Overall Study|Withdrawal by Subject|8|||
124806078|NCT03589469|448921637|FG000|Overall Study|Physician Decision|20|||
124806079|NCT03589469|448921637|FG000|Overall Study|Death|97|||
124806080|NCT03589469|448921637|FG000|Overall Study|Lost to Follow-up|8|||
124806081|NCT03589469|448921637|FG000|Overall Study|Miscellaneous|1|||
124806082|NCT00617851|448921638|FG000|Overall Study|Death|0|||
124806083|NCT00617851|448921639|FG001|Overall Study|Death|0|||
124806084|NCT00617851|448921640|FG002|Overall Study|Death|0|||
124806085|NCT00617851|448921641|FG003|Overall Study|Death|1|||
124806086|NCT00617851|448921638|FG000|Overall Study|Withdrawal by Subject|14|||
124806087|NCT00617851|448921639|FG001|Overall Study|Withdrawal by Subject|7|||
124806088|NCT00617851|448921640|FG002|Overall Study|Withdrawal by Subject|12|||
124806089|NCT00617851|448921641|FG003|Overall Study|Withdrawal by Subject|4|||
124806090|NCT00617851|448921638|FG000|Overall Study|Lost to Follow-up|27|||
124806091|NCT00617851|448921639|FG001|Overall Study|Lost to Follow-up|29|||
124806092|NCT00617851|448921640|FG002|Overall Study|Lost to Follow-up|31|||
124806093|NCT00617851|448921641|FG003|Overall Study|Lost to Follow-up|19|||
124806094|NCT00617851|448921638|FG000|Overall Study|Inappropriate Enrollment|5|||
124806095|NCT00617851|448921639|FG001|Overall Study|Inappropriate Enrollment|4|||
124806096|NCT00617851|448921640|FG002|Overall Study|Inappropriate Enrollment|1|||
124806097|NCT00617851|448921641|FG003|Overall Study|Inappropriate Enrollment|1|||
124806098|NCT00617851|448921638|FG000|Overall Study|Unable to classify|1|||
124806099|NCT00617851|448921639|FG001|Overall Study|Unable to classify|0|||
124806100|NCT00617851|448921640|FG002|Overall Study|Unable to classify|1|||
124634048|NCT05573464|448276184|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
124806101|NCT00617851|448921641|FG003|Overall Study|Unable to classify|0|||
124806102|NCT00902668|448921648|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
124806103|NCT01914757|448921649|FG000|Overall Study|Severe non-compliance to protocol|3|||
124806104|NCT01914757|448921650|FG001|Overall Study|Severe non-compliance to protocol|1|||
124806105|NCT01914757|448921651|FG002|Overall Study|Severe non-compliance to protocol|2|||
124806106|NCT01914757|448921649|FG000|Overall Study|Lost to Follow-up|5|||
124806107|NCT01914757|448921650|FG001|Overall Study|Lost to Follow-up|8|||
124806108|NCT01914757|448921651|FG002|Overall Study|Lost to Follow-up|6|||
124806109|NCT01914757|448921649|FG000|Overall Study|Withdrawal by Subject|15|||
124806110|NCT01914757|448921650|FG001|Overall Study|Withdrawal by Subject|27|||
124806111|NCT01914757|448921651|FG002|Overall Study|Withdrawal by Subject|19|||
124806112|NCT01914757|448921649|FG000|Overall Study|Death|2|||
124806113|NCT01914757|448921650|FG001|Overall Study|Death|2|||
124806114|NCT01914757|448921651|FG002|Overall Study|Death|1|||
124806115|NCT01914757|448921649|FG000|Overall Study|Adverse Event|4|||
124806116|NCT01914757|448921650|FG001|Overall Study|Adverse Event|3|||
124806117|NCT01914757|448921651|FG002|Overall Study|Adverse Event|4|||
124806118|NCT01914757|448921649|FG000|Overall Study|Study specific withdrawal criteria|0|||
124806119|NCT01914757|448921650|FG001|Overall Study|Study specific withdrawal criteria|1|||
124806120|NCT01914757|448921651|FG002|Overall Study|Study specific withdrawal criteria|0|||
124806121|NCT01914757|448921649|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
124806122|NCT01914757|448921650|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124806123|NCT01914757|448921651|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
124806124|NCT01914757|448921649|FG000|Overall Study|Other reasons|5|||
124806125|NCT01914757|448921650|FG001|Overall Study|Other reasons|9|||
124806126|NCT01914757|448921651|FG002|Overall Study|Other reasons|4|||
124806127|NCT02833350|448921658|FG000|Overall Study|Adverse Event|0|||
124806128|NCT02833350|448921659|FG001|Overall Study|Adverse Event|3|||
124806129|NCT02833350|448921660|FG002|Overall Study|Adverse Event|4|||
124806130|NCT02833350|448921661|FG003|Overall Study|Adverse Event|4|||
124806131|NCT02833350|448921662|FG004|Overall Study|Adverse Event|1|||
124806132|NCT02833350|448921663|FG005|Overall Study|Adverse Event|0|||
124806133|NCT02833350|448921664|FG006|Overall Study|Adverse Event|1|||
124806134|NCT02833350|448921658|FG000|Overall Study|Death|0|||
124806135|NCT02833350|448921659|FG001|Overall Study|Death|0|||
124806136|NCT02833350|448921660|FG002|Overall Study|Death|1|||
124806137|NCT02833350|448921661|FG003|Overall Study|Death|0|||
124806138|NCT02833350|448921662|FG004|Overall Study|Death|0|||
124806139|NCT02833350|448921663|FG005|Overall Study|Death|0|||
124806140|NCT02833350|448921664|FG006|Overall Study|Death|0|||
124806141|NCT02833350|448921658|FG000|Overall Study|Lack of Efficacy|0|||
124806142|NCT02833350|448921659|FG001|Overall Study|Lack of Efficacy|2|||
124806143|NCT02833350|448921660|FG002|Overall Study|Lack of Efficacy|1|||
124806144|NCT02833350|448921661|FG003|Overall Study|Lack of Efficacy|4|||
124806145|NCT02833350|448921662|FG004|Overall Study|Lack of Efficacy|0|||
124806146|NCT02833350|448921663|FG005|Overall Study|Lack of Efficacy|1|||
124806147|NCT02833350|448921664|FG006|Overall Study|Lack of Efficacy|1|||
124806148|NCT02833350|448921658|FG000|Overall Study|Lost to Follow-up|0|||
124806149|NCT02833350|448921659|FG001|Overall Study|Lost to Follow-up|1|||
124806150|NCT02833350|448921660|FG002|Overall Study|Lost to Follow-up|0|||
124806151|NCT02833350|448921661|FG003|Overall Study|Lost to Follow-up|0|||
124634049|NCT05573464|448276185|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
124634050|NCT05573464|448276184|FG000|12-week Treatment Period|Randomised, not treated|0|||
124634051|NCT05573464|448276185|FG001|12-week Treatment Period|Randomised, not treated|1|||
124634052|NCT05573464|448276184|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
124634053|NCT05573464|448276185|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
124634054|NCT05573464|448276184|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
124634055|NCT05573464|448276185|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
124634056|NCT05573464|448276184|FG000|52-week Treatment Period|Protocol Violation|1|||
124634057|NCT05573464|448276185|FG001|52-week Treatment Period|Protocol Violation|1|||
124634058|NCT05573464|448276184|FG000|52-week Treatment Period|Physician Decision|2|||
124634059|NCT05573464|448276185|FG001|52-week Treatment Period|Physician Decision|2|||
124634060|NCT05573464|448276184|FG000|52-week Treatment Period|Lost to Follow-up|1|||
124634061|NCT05573464|448276185|FG001|52-week Treatment Period|Lost to Follow-up|1|||
124634062|NCT05573464|448276184|FG000|52-week Treatment Period|Adverse Event|11|||
124806152|NCT02833350|448921662|FG004|Overall Study|Lost to Follow-up|0|||
124806153|NCT02833350|448921663|FG005|Overall Study|Lost to Follow-up|0|||
124806154|NCT02833350|448921664|FG006|Overall Study|Lost to Follow-up|1|||
124806155|NCT02833350|448921658|FG000|Overall Study|Withdrawal by Subject|3|||
124806156|NCT02833350|448921659|FG001|Overall Study|Withdrawal by Subject|3|||
124806157|NCT02833350|448921660|FG002|Overall Study|Withdrawal by Subject|2|||
124806158|NCT02833350|448921661|FG003|Overall Study|Withdrawal by Subject|0|||
124806159|NCT02833350|448921662|FG004|Overall Study|Withdrawal by Subject|2|||
124806160|NCT02833350|448921663|FG005|Overall Study|Withdrawal by Subject|0|||
124806161|NCT02833350|448921664|FG006|Overall Study|Withdrawal by Subject|2|||
124806162|NCT03342963|448921665|FG000|Overall Study|Adverse Event|1|||
124806163|NCT03342963|448921666|FG001|Overall Study|Adverse Event|2|||
124806164|NCT03342963|448921667|FG002|Overall Study|Adverse Event|0|||
124806165|NCT03342963|448921668|FG003|Overall Study|Adverse Event|0|||
124806166|NCT03342963|448921665|FG000|Overall Study|Withdrawal by Subject|1|||
124806167|NCT03342963|448921666|FG001|Overall Study|Withdrawal by Subject|0|||
124806168|NCT03342963|448921667|FG002|Overall Study|Withdrawal by Subject|0|||
124806169|NCT03342963|448921668|FG003|Overall Study|Withdrawal by Subject|0|||
124806170|NCT01189604|448921672|FG000|Overall Study|Impossible to visit|0|||
124806171|NCT01189604|448921673|FG001|Overall Study|Impossible to visit|0|||
124806172|NCT01189604|448921674|FG002|Overall Study|Impossible to visit|0|||
124806173|NCT01189604|448921675|FG003|Overall Study|Impossible to visit|0|||
124806174|NCT01189604|448921676|FG004|Overall Study|Impossible to visit|0|||
124806175|NCT01189604|448921677|FG005|Overall Study|Impossible to visit|1|||
124806176|NCT01189604|448921678|FG006|Overall Study|Impossible to visit|0|||
124806177|NCT01189604|448921672|FG000|Overall Study|Adverse Event|0|||
124806178|NCT01189604|448921673|FG001|Overall Study|Adverse Event|1|||
124806179|NCT01189604|448921674|FG002|Overall Study|Adverse Event|0|||
124806180|NCT01189604|448921675|FG003|Overall Study|Adverse Event|0|||
124806181|NCT01189604|448921676|FG004|Overall Study|Adverse Event|2|||
124806182|NCT01189604|448921677|FG005|Overall Study|Adverse Event|0|||
124806183|NCT01189604|448921678|FG006|Overall Study|Adverse Event|1|||
124806184|NCT01189604|448921672|FG000|Overall Study|Withdrawal by Subject|1|||
124806185|NCT01189604|448921673|FG001|Overall Study|Withdrawal by Subject|0|||
124806186|NCT01189604|448921674|FG002|Overall Study|Withdrawal by Subject|0|||
124806187|NCT01189604|448921675|FG003|Overall Study|Withdrawal by Subject|0|||
124806188|NCT01189604|448921676|FG004|Overall Study|Withdrawal by Subject|0|||
124806189|NCT01189604|448921677|FG005|Overall Study|Withdrawal by Subject|0|||
124806190|NCT01189604|448921678|FG006|Overall Study|Withdrawal by Subject|0|||
124806191|NCT03626168|448921679|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
124806192|NCT03626168|448921680|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
124806193|NCT03626168|448921679|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
124806194|NCT03626168|448921680|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
124806195|NCT03626168|448921679|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
124806196|NCT03626168|448921680|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
124806197|NCT02248701|448921681|FG000|Overall Study|Withdrawal by Subject|2|||
124806198|NCT02248701|448921682|FG001|Overall Study|Withdrawal by Subject|1|||
124806199|NCT02248701|448921681|FG000|Overall Study|Physician Decision|0|||
124806200|NCT02248701|448921682|FG001|Overall Study|Physician Decision|1|||
124806201|NCT02248701|448921681|FG000|Overall Study|Adverse Event|1|||
124806202|NCT02248701|448921682|FG001|Overall Study|Adverse Event|0|||
124806203|NCT02248701|448921681|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
124806204|NCT02248701|448921682|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
124806205|NCT00808483|448921683|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
124806206|NCT00808483|448921684|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
124806207|NCT00808483|448921683|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
124806208|NCT00808483|448921684|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
124806209|NCT00808483|448921683|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
124806210|NCT00808483|448921684|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
124806211|NCT02038881|448921685|FG000|Overall Study|Withdrawal by Subject|0|||
124806212|NCT02038881|448921686|FG001|Overall Study|Withdrawal by Subject|0|||
124806213|NCT02038881|448921687|FG002|Overall Study|Withdrawal by Subject|1|||
124806214|NCT02038881|448921685|FG000|Overall Study|Lost to Follow-up|2|||
124806215|NCT02038881|448921686|FG001|Overall Study|Lost to Follow-up|0|||
124806216|NCT02038881|448921687|FG002|Overall Study|Lost to Follow-up|0|||
124806217|NCT02038881|448921685|FG000|Overall Study|incarcerated|1|||
124806218|NCT02038881|448921686|FG001|Overall Study|incarcerated|0|||
124806219|NCT02038881|448921687|FG002|Overall Study|incarcerated|0|||
124806220|NCT02357979|448921688|FG000|Overall Study|Lost to Follow-up|5|||
124806221|NCT02357979|448921689|FG001|Overall Study|Lost to Follow-up|5|||
124806222|NCT03945214|448921690|FG000|Overall Study|Lost to Follow-up|3|||
124806223|NCT03945214|448921691|FG001|Overall Study|Lost to Follow-up|4|||
124806224|NCT03945214|448921692|FG002|Overall Study|Lost to Follow-up|7|||
124806225|NCT03945214|448921693|FG003|Overall Study|Lost to Follow-up|4|||
124806226|NCT00880542|448921694|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
124806227|NCT00880542|448921694|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
124806228|NCT00880542|448921694|FG000|REP: Surgical Resection|progressive disease|1|||
124806229|NCT00850070|448921695|FG000|Overall Study|Lack of Efficacy|1|||
124806230|NCT00850070|448921696|FG001|Overall Study|Lack of Efficacy|1|||
124806231|NCT00850070|448921695|FG000|Overall Study|Adverse Event|2|||
124806232|NCT00850070|448921696|FG001|Overall Study|Adverse Event|0|||
124806233|NCT05047770|448921697|FG000|Overall Study|Withdrawal by Subject|15|||
124806234|NCT05047770|448921698|FG001|Overall Study|Withdrawal by Subject|10|||
124806235|NCT05047770|448921699|FG002|Overall Study|Withdrawal by Subject|6|||
124806236|NCT05047770|448921700|FG003|Overall Study|Withdrawal by Subject|12|||
124806237|NCT05047770|448921697|FG000|Overall Study|Lost to Follow-up|7|||
124806238|NCT05047770|448921698|FG001|Overall Study|Lost to Follow-up|5|||
124806239|NCT05047770|448921699|FG002|Overall Study|Lost to Follow-up|12|||
124806240|NCT05047770|448921700|FG003|Overall Study|Lost to Follow-up|13|||
124806241|NCT05047770|448921697|FG000|Overall Study|Other|1|||
124806242|NCT05047770|448921698|FG001|Overall Study|Other|0|||
124806243|NCT05047770|448921699|FG002|Overall Study|Other|1|||
124806244|NCT05047770|448921700|FG003|Overall Study|Other|0|||
124806245|NCT04289623|448921703|FG000|Wave 1 Emails|Email was not delivered|268|||
124806246|NCT04289623|448921704|FG001|Wave 1 Emails|Email was not delivered|257|||
124806247|NCT04289623|448921705|FG002|Wave 1 Emails|Email was not delivered|0|||
124806248|NCT04289623|448921706|FG003|Wave 1 Emails|Email was not delivered|0|||
124806249|NCT04289623|448921707|FG004|Wave 1 Emails|Email was not delivered|0|||
124806250|NCT04289623|448921708|FG005|Wave 1 Emails|Email was not delivered|0|||
124806251|NCT03758443|448921709|FG000|Induction Period|Adverse Event|2|||
124806252|NCT03758443|448921710|FG001|Induction Period|Adverse Event|4|||
124806253|NCT03758443|448921711|FG002|Induction Period|Adverse Event|2|||
124806254|NCT03758443|448921712|FG003|Induction Period|Adverse Event|3|||
124806255|NCT03758443|448921709|FG000|Induction Period|Physician Decision|1|||
124806256|NCT03758443|448921710|FG001|Induction Period|Physician Decision|1|||
124806257|NCT03758443|448921711|FG002|Induction Period|Physician Decision|3|||
124806258|NCT03758443|448921712|FG003|Induction Period|Physician Decision|0|||
124806259|NCT03758443|448921709|FG000|Induction Period|Protocol Violation|0|||
124806260|NCT03758443|448921710|FG001|Induction Period|Protocol Violation|0|||
124806261|NCT03758443|448921711|FG002|Induction Period|Protocol Violation|0|||
124806262|NCT03758443|448921712|FG003|Induction Period|Protocol Violation|1|||
124806263|NCT03758443|448921709|FG000|Induction Period|Withdrawal by Subject|3|||
124806264|NCT03758443|448921710|FG001|Induction Period|Withdrawal by Subject|2|||
124806265|NCT03758443|448921711|FG002|Induction Period|Withdrawal by Subject|2|||
124806266|NCT03758443|448921712|FG003|Induction Period|Withdrawal by Subject|4|||
124806267|NCT03758443|448921709|FG000|Extended Induction Period|Adverse Event|1|||
124806268|NCT03758443|448921710|FG001|Extended Induction Period|Adverse Event|1|||
124806269|NCT03758443|448921711|FG002|Extended Induction Period|Adverse Event|0|||
124806270|NCT03758443|448921712|FG003|Extended Induction Period|Adverse Event|1|||
124806271|NCT03758443|448921709|FG000|Extended Induction Period|Lost to Follow-up|1|||
124806272|NCT03758443|448921710|FG001|Extended Induction Period|Lost to Follow-up|0|||
124806273|NCT03758443|448921711|FG002|Extended Induction Period|Lost to Follow-up|0|||
124806274|NCT03758443|448921712|FG003|Extended Induction Period|Lost to Follow-up|0|||
124806275|NCT03758443|448921709|FG000|Extended Induction Period|Physician Decision|2|||
124806276|NCT03758443|448921710|FG001|Extended Induction Period|Physician Decision|1|||
124806277|NCT03758443|448921711|FG002|Extended Induction Period|Physician Decision|2|||
124806278|NCT03758443|448921712|FG003|Extended Induction Period|Physician Decision|2|||
124806279|NCT03758443|448921709|FG000|Extended Induction Period|Protocol Violation|0|||
124806280|NCT03758443|448921710|FG001|Extended Induction Period|Protocol Violation|0|||
124806281|NCT03758443|448921711|FG002|Extended Induction Period|Protocol Violation|0|||
124806282|NCT03758443|448921712|FG003|Extended Induction Period|Protocol Violation|1|||
124806283|NCT03758443|448921709|FG000|Extended Induction Period|Withdrawal by Subject|8|||
124806284|NCT03758443|448921710|FG001|Extended Induction Period|Withdrawal by Subject|1|||
124806285|NCT03758443|448921711|FG002|Extended Induction Period|Withdrawal by Subject|7|||
124806286|NCT03758443|448921712|FG003|Extended Induction Period|Withdrawal by Subject|3|||
124806287|NCT03758443|448921709|FG000|Extended Induction Period|Miscellaneous|1|||
124806288|NCT03758443|448921710|FG001|Extended Induction Period|Miscellaneous|0|||
124806289|NCT03758443|448921711|FG002|Extended Induction Period|Miscellaneous|0|||
124806290|NCT03758443|448921712|FG003|Extended Induction Period|Miscellaneous|0|||
124806291|NCT03758443|448921709|FG000|Maintenance Period|Adverse Event|1|||
124806292|NCT03758443|448921710|FG001|Maintenance Period|Adverse Event|2|||
124806293|NCT03758443|448921711|FG002|Maintenance Period|Adverse Event|0|||
124806294|NCT03758443|448921712|FG003|Maintenance Period|Adverse Event|0|||
124806295|NCT03758443|448921709|FG000|Maintenance Period|Lost to Follow-up|0|||
124806296|NCT03758443|448921710|FG001|Maintenance Period|Lost to Follow-up|0|||
124806297|NCT03758443|448921711|FG002|Maintenance Period|Lost to Follow-up|0|||
124806298|NCT03758443|448921712|FG003|Maintenance Period|Lost to Follow-up|1|||
124806299|NCT03758443|448921709|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
124806300|NCT03758443|448921710|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
124806301|NCT03758443|448921711|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
124806302|NCT03758443|448921712|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
124806303|NCT03758443|448921709|FG000|Maintenance Period|Protocol Violation|0|||
124806304|NCT03758443|448921710|FG001|Maintenance Period|Protocol Violation|1|||
124806305|NCT03758443|448921711|FG002|Maintenance Period|Protocol Violation|0|||
124806306|NCT03758443|448921712|FG003|Maintenance Period|Protocol Violation|0|||
124806307|NCT03758443|448921709|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
124806308|NCT03758443|448921710|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
124806309|NCT03758443|448921711|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
124806310|NCT03758443|448921712|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
124806311|NCT03758443|448921709|FG000|Maintenance Period|Withdrawal by Subject|1|||
124806312|NCT03758443|448921710|FG001|Maintenance Period|Withdrawal by Subject|0|||
124806313|NCT03758443|448921711|FG002|Maintenance Period|Withdrawal by Subject|1|||
124806314|NCT03758443|448921712|FG003|Maintenance Period|Withdrawal by Subject|1|||
124806315|NCT03758443|448921709|FG000|Maintenance Period|Miscellaneous|0|||
124806316|NCT03758443|448921710|FG001|Maintenance Period|Miscellaneous|0|||
124806317|NCT03758443|448921711|FG002|Maintenance Period|Miscellaneous|1|||
124806318|NCT03758443|448921712|FG003|Maintenance Period|Miscellaneous|0|||
124806319|NCT01436396|448921713|FG000|Overall Study|Protocol Violation|7|||
124806320|NCT01436396|448921714|FG001|Overall Study|Protocol Violation|5|||
124806321|NCT01436396|448921713|FG000|Overall Study|Adverse Event|1|||
124806322|NCT01436396|448921714|FG001|Overall Study|Adverse Event|2|||
124806323|NCT01436396|448921713|FG000|Overall Study|Withdrawal by Subject|19|||
124806324|NCT01436396|448921714|FG001|Overall Study|Withdrawal by Subject|29|||
124806325|NCT01436396|448921713|FG000|Overall Study|Serious adverse event|2|||
124806326|NCT01436396|448921714|FG001|Overall Study|Serious adverse event|3|||
124806327|NCT01436396|448921713|FG000|Overall Study|Lost to Follow-up|3|||
124806328|NCT01436396|448921714|FG001|Overall Study|Lost to Follow-up|3|||
124806329|NCT01772160|448921718|FG000|Overall Study|Death|3|||
124806330|NCT01772160|448921718|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
124806331|NCT01772160|448921718|FG000|Overall Study|Consent withdrawal|3|||
124806332|NCT01772160|448921718|FG000|Overall Study|Migrated / moved from the study area|4|||
124806333|NCT01772160|448921718|FG000|Overall Study|Lost to Follow-up|30|||
124806334|NCT01772160|448921718|FG000|Overall Study|Other|5|||
124806335|NCT01522248|448921719|FG000|Overall Study|Lost to Follow-up|1|||
124806336|NCT01522248|448921720|FG001|Overall Study|Lost to Follow-up|0|||
124806337|NCT00178633|448921722|FG000|Overall Study|Lost to Follow-up|6|||
124806338|NCT00538291|448921723|FG000|Overall Study|Adverse Event|2|||
124806339|NCT00538291|448921723|FG000|Overall Study|Withdrawal by Subject|1|||
124806340|NCT00591344|448921724|FG000|Overall Study|Transportation issues|1|||
124806341|NCT00591344|448921725|FG001|Overall Study|Transportation issues|0|||
124806342|NCT00591344|448921724|FG000|Overall Study|Moved out of state|1|||
124806343|NCT00591344|448921725|FG001|Overall Study|Moved out of state|0|||
124806344|NCT00591344|448921724|FG000|Overall Study|Medical complications|1|||
124806345|NCT00591344|448921725|FG001|Overall Study|Medical complications|3|||
124806346|NCT00591344|448921724|FG000|Overall Study|Underwent DBS|2|||
124806347|NCT00591344|448921725|FG001|Overall Study|Underwent DBS|2|||
124806348|NCT00591344|448921724|FG000|Overall Study|Death|0|||
124806349|NCT00591344|448921725|FG001|Overall Study|Death|1|||
124806350|NCT00591344|448921724|FG000|Overall Study|Lost to Follow-up|0|||
124806351|NCT00591344|448921725|FG001|Overall Study|Lost to Follow-up|1|||
124806352|NCT00591344|448921724|FG000|Overall Study|Did not want to come off medication|0|||
124806353|NCT00591344|448921725|FG001|Overall Study|Did not want to come off medication|1|||
124806354|NCT00694707|448921726|FG000|Overall Study|Did Not Receive Treatment|0|||
124806355|NCT00694707|448921727|FG001|Overall Study|Did Not Receive Treatment|0|||
124806356|NCT00694707|448921728|FG002|Overall Study|Did Not Receive Treatment|1|||
124806357|NCT00694707|448921729|FG003|Overall Study|Did Not Receive Treatment|1|||
124806358|NCT00694707|448921730|FG004|Overall Study|Did Not Receive Treatment|1|||
124806359|NCT00694707|448921726|FG000|Overall Study|Adverse Event|22|||
124806360|NCT00694707|448921727|FG001|Overall Study|Adverse Event|14|||
124806361|NCT00694707|448921728|FG002|Overall Study|Adverse Event|8|||
124806362|NCT00694707|448921729|FG003|Overall Study|Adverse Event|12|||
124806363|NCT00694707|448921730|FG004|Overall Study|Adverse Event|13|||
124806364|NCT00694707|448921726|FG000|Overall Study|Insufficient Therapeutic Response|33|||
124806365|NCT00694707|448921727|FG001|Overall Study|Insufficient Therapeutic Response|18|||
124806366|NCT00694707|448921728|FG002|Overall Study|Insufficient Therapeutic Response|17|||
124806367|NCT00694707|448921729|FG003|Overall Study|Insufficient Therapeutic Response|15|||
124806368|NCT00694707|448921730|FG004|Overall Study|Insufficient Therapeutic Response|10|||
124806369|NCT00694707|448921726|FG000|Overall Study|Protocol Violation|1|||
124806370|NCT00694707|448921727|FG001|Overall Study|Protocol Violation|2|||
124806371|NCT00694707|448921728|FG002|Overall Study|Protocol Violation|1|||
124806372|NCT00694707|448921729|FG003|Overall Study|Protocol Violation|3|||
124806373|NCT00694707|448921730|FG004|Overall Study|Protocol Violation|1|||
124806374|NCT00694707|448921726|FG000|Overall Study|Withdrawal of Consent|14|||
124806375|NCT00694707|448921727|FG001|Overall Study|Withdrawal of Consent|18|||
124806376|NCT00694707|448921728|FG002|Overall Study|Withdrawal of Consent|22|||
124806377|NCT00694707|448921729|FG003|Overall Study|Withdrawal of Consent|16|||
124806378|NCT00694707|448921730|FG004|Overall Study|Withdrawal of Consent|15|||
124806379|NCT00694707|448921726|FG000|Overall Study|Lost to Follow-up|0|||
124806380|NCT00694707|448921727|FG001|Overall Study|Lost to Follow-up|1|||
124806381|NCT00694707|448921728|FG002|Overall Study|Lost to Follow-up|2|||
124806382|NCT00694707|448921729|FG003|Overall Study|Lost to Follow-up|0|||
124806383|NCT00694707|448921730|FG004|Overall Study|Lost to Follow-up|0|||
124806384|NCT00694707|448921726|FG000|Overall Study|Jeopardizing Parole Status|1|||
124806385|NCT00694707|448921727|FG001|Overall Study|Jeopardizing Parole Status|0|||
124634063|NCT05573464|448276185|FG001|52-week Treatment Period|Adverse Event|8|||
124634064|NCT05573464|448276184|FG000|52-week Treatment Period|Death|1|||
124634065|NCT05573464|448276185|FG001|52-week Treatment Period|Death|1|||
124806386|NCT00694707|448921728|FG002|Overall Study|Jeopardizing Parole Status|0|||
124806387|NCT00694707|448921729|FG003|Overall Study|Jeopardizing Parole Status|0|||
124806388|NCT00694707|448921730|FG004|Overall Study|Jeopardizing Parole Status|0|||
124806389|NCT00694707|448921726|FG000|Overall Study|Death in the Family|1|||
124806390|NCT00694707|448921727|FG001|Overall Study|Death in the Family|0|||
124806391|NCT00694707|448921728|FG002|Overall Study|Death in the Family|0|||
124806392|NCT00694707|448921729|FG003|Overall Study|Death in the Family|0|||
124806393|NCT00694707|448921730|FG004|Overall Study|Death in the Family|0|||
124806394|NCT00694707|448921726|FG000|Overall Study|Arrest by Police|0|||
124806395|NCT00694707|448921727|FG001|Overall Study|Arrest by Police|1|||
124806396|NCT00694707|448921728|FG002|Overall Study|Arrest by Police|0|||
124634066|NCT05734157|448276186|FG000|Overall Study|Death|3|||
124806397|NCT00694707|448921729|FG003|Overall Study|Arrest by Police|0|||
124806398|NCT00694707|448921730|FG004|Overall Study|Arrest by Police|0|||
124806399|NCT00694707|448921726|FG000|Overall Study|Administrative Reasons|0|||
124806400|NCT00694707|448921727|FG001|Overall Study|Administrative Reasons|1|||
124806401|NCT00694707|448921728|FG002|Overall Study|Administrative Reasons|0|||
124806402|NCT00694707|448921729|FG003|Overall Study|Administrative Reasons|2|||
124806403|NCT00694707|448921730|FG004|Overall Study|Administrative Reasons|0|||
124806404|NCT00694707|448921726|FG000|Overall Study|Notification of Past Head Injury|0|||
124806405|NCT00694707|448921727|FG001|Overall Study|Notification of Past Head Injury|0|||
124806406|NCT00694707|448921728|FG002|Overall Study|Notification of Past Head Injury|0|||
124806407|NCT00694707|448921729|FG003|Overall Study|Notification of Past Head Injury|1|||
124806408|NCT00694707|448921730|FG004|Overall Study|Notification of Past Head Injury|0|||
124806409|NCT01904058|448921738|FG000|Overall Study|Adverse Event|2|||
124806410|NCT01904058|448921739|FG001|Overall Study|Adverse Event|0|||
124806411|NCT01904058|448921740|FG002|Overall Study|Adverse Event|0|||
124806412|NCT01904058|448921741|FG003|Overall Study|Adverse Event|0|||
124806413|NCT01904058|448921738|FG000|Overall Study|Withdrawal by Subject|1|||
124806414|NCT01904058|448921739|FG001|Overall Study|Withdrawal by Subject|0|||
124806415|NCT01904058|448921740|FG002|Overall Study|Withdrawal by Subject|1|||
124806416|NCT01904058|448921741|FG003|Overall Study|Withdrawal by Subject|0|||
124806417|NCT01904058|448921738|FG000|Overall Study|Pregnancy|0|||
124806418|NCT01904058|448921739|FG001|Overall Study|Pregnancy|0|||
124806419|NCT01904058|448921740|FG002|Overall Study|Pregnancy|0|||
124806420|NCT01904058|448921741|FG003|Overall Study|Pregnancy|1|||
124806421|NCT03096483|448921743|FG000|Overall Study|Withdrawal by site|1|||
124806422|NCT01024231|448921749|FG000|Overall Study|Other Reasons|1|||
124806423|NCT01024231|448921750|FG001|Overall Study|Other Reasons|2|||
124806424|NCT01024231|448921751|FG002|Overall Study|Other Reasons|0|||
124806425|NCT01024231|448921752|FG003|Overall Study|Other Reasons|0|||
124806426|NCT01024231|448921753|FG004|Overall Study|Other Reasons|2|||
124806427|NCT01024231|448921754|FG005|Overall Study|Other Reasons|0|||
124806428|NCT01024231|448921755|FG006|Overall Study|Other Reasons|1|||
124806429|NCT01024231|448921749|FG000|Overall Study|Maximum Clinical Benefit|1|||
124806430|NCT01024231|448921750|FG001|Overall Study|Maximum Clinical Benefit|2|||
124806431|NCT01024231|448921751|FG002|Overall Study|Maximum Clinical Benefit|0|||
124806432|NCT01024231|448921752|FG003|Overall Study|Maximum Clinical Benefit|1|||
124806433|NCT01024231|448921753|FG004|Overall Study|Maximum Clinical Benefit|1|||
124806434|NCT01024231|448921754|FG005|Overall Study|Maximum Clinical Benefit|0|||
124806435|NCT01024231|448921755|FG006|Overall Study|Maximum Clinical Benefit|0|||
124806436|NCT01024231|448921749|FG000|Overall Study|Disease Progression|3|||
124806437|NCT01024231|448921750|FG001|Overall Study|Disease Progression|1|||
124806438|NCT01024231|448921751|FG002|Overall Study|Disease Progression|3|||
124806439|NCT01024231|448921752|FG003|Overall Study|Disease Progression|0|||
124806440|NCT01024231|448921753|FG004|Overall Study|Disease Progression|4|||
124806441|NCT01024231|448921754|FG005|Overall Study|Disease Progression|11|||
124806442|NCT01024231|448921755|FG006|Overall Study|Disease Progression|6|||
124806443|NCT01024231|448921749|FG000|Overall Study|AE unrelated to Study Drug|0|||
124806444|NCT01024231|448921750|FG001|Overall Study|AE unrelated to Study Drug|1|||
124806445|NCT01024231|448921751|FG002|Overall Study|AE unrelated to Study Drug|0|||
124806446|NCT01024231|448921752|FG003|Overall Study|AE unrelated to Study Drug|0|||
124806447|NCT01024231|448921753|FG004|Overall Study|AE unrelated to Study Drug|0|||
124806448|NCT01024231|448921754|FG005|Overall Study|AE unrelated to Study Drug|0|||
124806449|NCT01024231|448921755|FG006|Overall Study|AE unrelated to Study Drug|0|||
124806450|NCT01024231|448921749|FG000|Overall Study|No longer meets criteria|0|||
124806451|NCT01024231|448921750|FG001|Overall Study|No longer meets criteria|0|||
124806452|NCT01024231|448921751|FG002|Overall Study|No longer meets criteria|0|||
124806453|NCT01024231|448921752|FG003|Overall Study|No longer meets criteria|0|||
124806454|NCT01024231|448921753|FG004|Overall Study|No longer meets criteria|1|||
124806455|NCT01024231|448921754|FG005|Overall Study|No longer meets criteria|0|||
124806456|NCT01024231|448921755|FG006|Overall Study|No longer meets criteria|1|||
124806457|NCT01024231|448921749|FG000|Overall Study|Study Drug Toxicity|1|||
124806458|NCT01024231|448921750|FG001|Overall Study|Study Drug Toxicity|6|||
124806459|NCT01024231|448921751|FG002|Overall Study|Study Drug Toxicity|6|||
124806460|NCT01024231|448921752|FG003|Overall Study|Study Drug Toxicity|4|||
124806461|NCT01024231|448921753|FG004|Overall Study|Study Drug Toxicity|2|||
124806462|NCT01024231|448921754|FG005|Overall Study|Study Drug Toxicity|0|||
124806463|NCT01024231|448921755|FG006|Overall Study|Study Drug Toxicity|7|||
124806464|NCT01024231|448921749|FG000|Overall Study|Death|6|||
124806465|NCT01024231|448921750|FG001|Overall Study|Death|2|||
124806466|NCT01024231|448921751|FG002|Overall Study|Death|1|||
124806467|NCT01024231|448921752|FG003|Overall Study|Death|0|||
124806468|NCT01024231|448921753|FG004|Overall Study|Death|4|||
124806469|NCT01024231|448921754|FG005|Overall Study|Death|3|||
124806470|NCT01024231|448921755|FG006|Overall Study|Death|5|||
124806471|NCT01024231|448921749|FG000|Overall Study|Lost to Follow-up|0|||
124806472|NCT01024231|448921750|FG001|Overall Study|Lost to Follow-up|0|||
124806473|NCT01024231|448921751|FG002|Overall Study|Lost to Follow-up|0|||
124806474|NCT01024231|448921752|FG003|Overall Study|Lost to Follow-up|0|||
124806475|NCT01024231|448921753|FG004|Overall Study|Lost to Follow-up|0|||
124806476|NCT01024231|448921754|FG005|Overall Study|Lost to Follow-up|0|||
124806477|NCT01024231|448921755|FG006|Overall Study|Lost to Follow-up|1|||
124806478|NCT01024231|448921749|FG000|Overall Study|Withdrew Consent|0|||
124806479|NCT01024231|448921750|FG001|Overall Study|Withdrew Consent|1|||
124806480|NCT01024231|448921751|FG002|Overall Study|Withdrew Consent|0|||
124806481|NCT01024231|448921752|FG003|Overall Study|Withdrew Consent|0|||
124806482|NCT01024231|448921753|FG004|Overall Study|Withdrew Consent|0|||
124806483|NCT01024231|448921754|FG005|Overall Study|Withdrew Consent|0|||
124806484|NCT01024231|448921755|FG006|Overall Study|Withdrew Consent|0|||
124806485|NCT01024231|448921749|FG000|Overall Study|Continuing on Treatment|0|||
124806486|NCT01024231|448921750|FG001|Overall Study|Continuing on Treatment|0|||
124806487|NCT01024231|448921751|FG002|Overall Study|Continuing on Treatment|0|||
124806488|NCT01024231|448921752|FG003|Overall Study|Continuing on Treatment|0|||
124806489|NCT01024231|448921753|FG004|Overall Study|Continuing on Treatment|3|||
124806490|NCT01024231|448921754|FG005|Overall Study|Continuing on Treatment|2|||
124806491|NCT01024231|448921755|FG006|Overall Study|Continuing on Treatment|0|||
124806492|NCT00973674|448921759|FG000|Overall Study|Protocol Violation|2|||
124806493|NCT00973674|448921760|FG001|Overall Study|Protocol Violation|0|||
124806494|NCT02713204|448921761|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
124806495|NCT02713204|448921762|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
124806496|NCT02713204|448921763|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
124806497|NCT02713204|448921764|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
124806498|NCT02713204|448921765|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
124806499|NCT02713204|448921766|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
124806500|NCT02713204|448921767|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
124806501|NCT02713204|448921768|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
124806502|NCT02713204|448921761|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124806503|NCT02713204|448921762|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124806504|NCT02713204|448921763|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
124806505|NCT02713204|448921764|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124806506|NCT02713204|448921765|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124806507|NCT02713204|448921766|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124806508|NCT02713204|448921767|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124806509|NCT02713204|448921768|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
124806510|NCT02713204|448921761|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124806511|NCT02713204|448921762|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
124806512|NCT02713204|448921763|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124806513|NCT02713204|448921764|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124806514|NCT02713204|448921765|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124806515|NCT02713204|448921766|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124806516|NCT02713204|448921767|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124806517|NCT02713204|448921768|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
124806518|NCT02713204|448921761|FG000|From Week 12 up to Week 36|Adverse Event|1|||
124806519|NCT02713204|448921762|FG001|From Week 12 up to Week 36|Adverse Event|0|||
124806520|NCT02713204|448921763|FG002|From Week 12 up to Week 36|Adverse Event|0|||
124806521|NCT02713204|448921764|FG003|From Week 12 up to Week 36|Adverse Event|1|||
124806522|NCT02713204|448921765|FG004|From Week 12 up to Week 36|Adverse Event|1|||
124806523|NCT02713204|448921766|FG005|From Week 12 up to Week 36|Adverse Event|0|||
124806524|NCT02713204|448921767|FG006|From Week 12 up to Week 36|Adverse Event|2|||
124806525|NCT02713204|448921768|FG007|From Week 12 up to Week 36|Adverse Event|1|||
124806526|NCT02713204|448921761|FG000|From Week 12 up to Week 36|Death|0|||
124806527|NCT02713204|448921762|FG001|From Week 12 up to Week 36|Death|0|||
124806528|NCT02713204|448921763|FG002|From Week 12 up to Week 36|Death|0|||
124806529|NCT02713204|448921764|FG003|From Week 12 up to Week 36|Death|1|||
124806530|NCT02713204|448921765|FG004|From Week 12 up to Week 36|Death|0|||
124806531|NCT02713204|448921766|FG005|From Week 12 up to Week 36|Death|1|||
124806532|NCT02713204|448921767|FG006|From Week 12 up to Week 36|Death|0|||
124806533|NCT02713204|448921768|FG007|From Week 12 up to Week 36|Death|3|||
124806534|NCT02713204|448921761|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
124634067|NCT05734157|448276186|FG000|Overall Study|Withdrawal by Subject|2|||
124634068|NCT05734157|448276186|FG000|Overall Study|Lost to Follow-up|1|||
124634069|NCT05734157|448276186|FG000|Overall Study|Telephone call|3|||
124634070|NCT00210210|448276190|FG000|Overall Study|Withdrawal by Subject|3|||
124634071|NCT00210210|448276191|FG001|Overall Study|Withdrawal by Subject|2|||
124634072|NCT00210210|448276190|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
124806535|NCT02713204|448921762|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
124806536|NCT02713204|448921763|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
124806537|NCT02713204|448921764|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
124806538|NCT02713204|448921765|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
124806539|NCT02713204|448921766|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
124806540|NCT02713204|448921767|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
124806541|NCT02713204|448921768|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
124806542|NCT02713204|448921761|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
124806543|NCT02713204|448921762|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
124806544|NCT02713204|448921763|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
124806545|NCT02713204|448921764|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
124806546|NCT02713204|448921765|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
124806547|NCT02713204|448921766|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
124806548|NCT02713204|448921767|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
124806549|NCT02713204|448921768|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
124806550|NCT01710046|448921770|FG000|Overall Study|Lost to Follow-up|1|||
124806551|NCT01710046|448921771|FG001|Overall Study|Lost to Follow-up|0|||
124634073|NCT00210210|448276191|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
124634074|NCT04225715|448276193|FG000|Overall Study|Reason not Specified|1|||
124634075|NCT04225715|448276194|FG001|Overall Study|Reason not Specified|0|||
124806552|NCT03896165|448921772|FG000|Overall Study|Withdrawal by Subject|2|||
124806553|NCT03181893|448921773|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806554|NCT03181893|448921774|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
124806555|NCT03181893|448921775|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806556|NCT03181893|448921776|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806557|NCT03181893|448921777|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806558|NCT03181893|448921778|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806559|NCT03181893|448921779|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806560|NCT03181893|448921780|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806561|NCT03181893|448921781|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806562|NCT03181893|448921782|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806563|NCT03181893|448921783|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
124806564|NCT03181893|448921773|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
124806565|NCT03181893|448921774|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
124806566|NCT03181893|448921775|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806567|NCT03181893|448921776|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806568|NCT03181893|448921777|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806569|NCT03181893|448921778|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806570|NCT03181893|448921779|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806571|NCT03181893|448921780|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806572|NCT03181893|448921781|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806573|NCT03181893|448921782|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806574|NCT03181893|448921783|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
124806575|NCT03181893|448921773|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806576|NCT03181893|448921774|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806577|NCT03181893|448921775|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806578|NCT03181893|448921776|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806579|NCT03181893|448921777|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806580|NCT03181893|448921778|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806581|NCT03181893|448921779|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806582|NCT03181893|448921780|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
124806583|NCT03181893|448921781|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
124806584|NCT03181893|448921782|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806585|NCT03181893|448921783|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
124806586|NCT03181893|448921773|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806587|NCT03181893|448921774|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806588|NCT03181893|448921775|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806589|NCT03181893|448921776|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806590|NCT03181893|448921777|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806591|NCT03181893|448921778|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806592|NCT03181893|448921779|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806593|NCT03181893|448921780|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806594|NCT03181893|448921781|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806595|NCT03181893|448921782|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
124806596|NCT03181893|448921783|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
124806597|NCT03181893|448921773|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806598|NCT03181893|448921774|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806599|NCT03181893|448921775|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806600|NCT03181893|448921776|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806601|NCT03181893|448921777|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806602|NCT03181893|448921778|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806603|NCT03181893|448921779|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806604|NCT03181893|448921780|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806605|NCT03181893|448921781|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806606|NCT03181893|448921782|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
124806607|NCT03181893|448921783|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
124806608|NCT03000569|448921784|FG000|Overall Study|Withdrawal by Subject|1|||
124806609|NCT03000569|448921785|FG001|Overall Study|Withdrawal by Subject|0|||
124806610|NCT04815031|448921786|FG000|Overall Study|No adverse event information (missing information)|33|||
124806611|NCT04122534|448921787|FG000|Overall Study|Lost to Follow-up|4|||
124806612|NCT01254630|448921791|FG000|Overall Study|Adverse Event|36|||
124806613|NCT01254630|448921792|FG001|Overall Study|Adverse Event|15|||
124806614|NCT01254630|448921793|FG002|Overall Study|Adverse Event|40|||
124806615|NCT01254630|448921794|FG003|Overall Study|Adverse Event|8|||
124806616|NCT01254630|448921791|FG000|Overall Study|Death|461|||
124806617|NCT01254630|448921792|FG001|Overall Study|Death|151|||
124806618|NCT01254630|448921793|FG002|Overall Study|Death|478|||
124806619|NCT01254630|448921794|FG003|Overall Study|Death|139|||
124806620|NCT01254630|448921791|FG000|Overall Study|Lost to Follow-up|80|||
124806621|NCT01254630|448921792|FG001|Overall Study|Lost to Follow-up|26|||
124806622|NCT01254630|448921793|FG002|Overall Study|Lost to Follow-up|89|||
124806623|NCT01254630|448921794|FG003|Overall Study|Lost to Follow-up|32|||
124806624|NCT01254630|448921791|FG000|Overall Study|Physician Decision|24|||
124806625|NCT01254630|448921792|FG001|Overall Study|Physician Decision|8|||
124806626|NCT01254630|448921793|FG002|Overall Study|Physician Decision|16|||
124806627|NCT01254630|448921794|FG003|Overall Study|Physician Decision|7|||
124806628|NCT01254630|448921791|FG000|Overall Study|Withdrawal by Subject|201|||
124806629|NCT01254630|448921792|FG001|Overall Study|Withdrawal by Subject|94|||
124806630|NCT01254630|448921793|FG002|Overall Study|Withdrawal by Subject|188|||
124806631|NCT01254630|448921794|FG003|Overall Study|Withdrawal by Subject|89|||
124806632|NCT01254630|448921791|FG000|Overall Study|Study terminated by sponsor|0|||
124806633|NCT01254630|448921792|FG001|Overall Study|Study terminated by sponsor|994|||
124806634|NCT01254630|448921793|FG002|Overall Study|Study terminated by sponsor|0|||
124806635|NCT01254630|448921794|FG003|Overall Study|Study terminated by sponsor|1010|||
124806636|NCT01254630|448921791|FG000|Overall Study|Status not recorded|0|||
124806637|NCT01254630|448921792|FG001|Overall Study|Status not recorded|0|||
124806638|NCT01254630|448921793|FG002|Overall Study|Status not recorded|1|||
124806639|NCT01254630|448921794|FG003|Overall Study|Status not recorded|0|||
124806640|NCT02020577|448921795|FG000|Overall Study|Progressive disease|3|||
124806641|NCT02020577|448921796|FG001|Overall Study|Progressive disease|38|||
124806642|NCT02020577|448921795|FG000|Overall Study|Other AE or clinical progression|0|||
124806643|NCT02020577|448921796|FG001|Overall Study|Other AE or clinical progression|15|||
124806644|NCT02020577|448921795|FG000|Overall Study|Withdrawal by Subject|0|||
124806645|NCT02020577|448921796|FG001|Overall Study|Withdrawal by Subject|1|||
124806646|NCT02020577|448921795|FG000|Overall Study|Other than stated above|0|||
124806647|NCT02020577|448921796|FG001|Overall Study|Other than stated above|1|||
124806648|NCT00761631|448921797|FG000|Overall Study|Parent/legal guardian request|8|||
124806649|NCT00761631|448921798|FG001|Overall Study|Parent/legal guardian request|3|||
124806650|NCT00761631|448921799|FG002|Overall Study|Parent/legal guardian request|8|||
124806651|NCT00761631|448921800|FG003|Overall Study|Parent/legal guardian request|0|||
124806652|NCT00761631|448921801|FG004|Overall Study|Parent/legal guardian request|5|||
124806653|NCT00761631|448921802|FG005|Overall Study|Parent/legal guardian request|0|||
124806654|NCT00761631|448921797|FG000|Overall Study|Lost to Follow-up|2|||
124806655|NCT00761631|448921798|FG001|Overall Study|Lost to Follow-up|4|||
124806656|NCT00761631|448921799|FG002|Overall Study|Lost to Follow-up|7|||
124806657|NCT00761631|448921800|FG003|Overall Study|Lost to Follow-up|1|||
124806658|NCT00761631|448921801|FG004|Overall Study|Lost to Follow-up|6|||
124806659|NCT00761631|448921802|FG005|Overall Study|Lost to Follow-up|1|||
124806660|NCT00761631|448921797|FG000|Overall Study|Protocol Violation|2|||
124806661|NCT00761631|448921798|FG001|Overall Study|Protocol Violation|0|||
124806662|NCT00761631|448921799|FG002|Overall Study|Protocol Violation|0|||
124806663|NCT00761631|448921800|FG003|Overall Study|Protocol Violation|1|||
124806664|NCT00761631|448921801|FG004|Overall Study|Protocol Violation|5|||
124634076|NCT04225715|448276195|FG002|Overall Study|Reason not Specified|0|||
124806665|NCT00761631|448921802|FG005|Overall Study|Protocol Violation|1|||
124806666|NCT00761631|448921797|FG000|Overall Study|Randomized, not treated|1|||
124806667|NCT00761631|448921798|FG001|Overall Study|Randomized, not treated|0|||
124806668|NCT00761631|448921799|FG002|Overall Study|Randomized, not treated|0|||
124806669|NCT00761631|448921800|FG003|Overall Study|Randomized, not treated|0|||
124806670|NCT00761631|448921801|FG004|Overall Study|Randomized, not treated|0|||
124806671|NCT00761631|448921802|FG005|Overall Study|Randomized, not treated|0|||
124806672|NCT00761631|448921797|FG000|Overall Study|Failed to return|1|||
124806673|NCT00761631|448921798|FG001|Overall Study|Failed to return|0|||
124806674|NCT00761631|448921799|FG002|Overall Study|Failed to return|1|||
124806675|NCT00761631|448921800|FG003|Overall Study|Failed to return|1|||
124806676|NCT00761631|448921801|FG004|Overall Study|Failed to return|5|||
124806677|NCT00761631|448921802|FG005|Overall Study|Failed to return|2|||
124806678|NCT00761631|448921797|FG000|Overall Study|Physician Decision|1|||
124806679|NCT00761631|448921798|FG001|Overall Study|Physician Decision|0|||
124806680|NCT00761631|448921799|FG002|Overall Study|Physician Decision|0|||
124806681|NCT00761631|448921800|FG003|Overall Study|Physician Decision|0|||
124806682|NCT00761631|448921801|FG004|Overall Study|Physician Decision|0|||
124806683|NCT00761631|448921802|FG005|Overall Study|Physician Decision|0|||
124806684|NCT00761631|448921797|FG000|Overall Study|Other|0|||
124806685|NCT00761631|448921798|FG001|Overall Study|Other|0|||
124806686|NCT00761631|448921799|FG002|Overall Study|Other|0|||
124806687|NCT00761631|448921800|FG003|Overall Study|Other|0|||
124806688|NCT00761631|448921801|FG004|Overall Study|Other|1|||
124806689|NCT00761631|448921802|FG005|Overall Study|Other|1|||
124806690|NCT03673046|448923394|FG000|Overall Study|Adverse Event|1|||
124806691|NCT03673046|448923395|FG001|Overall Study|Adverse Event|1|||
124806692|NCT03673046|448923394|FG000|Overall Study|Withdrawal by Subject|8|||
124806693|NCT03673046|448923395|FG001|Overall Study|Withdrawal by Subject|2|||
124806694|NCT03817879|448923396|FG000|Overall Study|Drop out|5|||
124806695|NCT03817879|448923397|FG001|Overall Study|Drop out|12|||
124806696|NCT03817879|448923396|FG000|Overall Study|Withdrawal by Subject|0|||
124806697|NCT03817879|448923397|FG001|Overall Study|Withdrawal by Subject|1|||
124806698|NCT01896050|448923400|FG000|Overall Study|Adverse Event|37|||
124806699|NCT01896050|448923401|FG001|Overall Study|Adverse Event|2|||
124806700|NCT01896050|448923400|FG000|Overall Study|Death|1|||
124806701|NCT01896050|448923401|FG001|Overall Study|Death|0|||
124806702|NCT00392015|448923402|FG000|Overall Study|Lost to Follow-up|2|||
124806703|NCT00392015|448923403|FG001|Overall Study|Lost to Follow-up|0|||
124806704|NCT00392015|448923404|FG002|Overall Study|Lost to Follow-up|2|||
124806705|NCT00392015|448923405|FG003|Overall Study|Lost to Follow-up|1|||
124806706|NCT00392015|448923406|FG004|Overall Study|Lost to Follow-up|1|||
124806707|NCT00392015|448923407|FG005|Overall Study|Lost to Follow-up|0|||
124806708|NCT00392015|448923402|FG000|Overall Study|Withdrawal by Subject|0|||
124806709|NCT00392015|448923403|FG001|Overall Study|Withdrawal by Subject|0|||
124806710|NCT00392015|448923404|FG002|Overall Study|Withdrawal by Subject|2|||
124806711|NCT00392015|448923405|FG003|Overall Study|Withdrawal by Subject|0|||
124806712|NCT00392015|448923406|FG004|Overall Study|Withdrawal by Subject|0|||
124806713|NCT00392015|448923407|FG005|Overall Study|Withdrawal by Subject|0|||
124806714|NCT00392015|448923402|FG000|Overall Study|Adverse Event|0|||
124806715|NCT00392015|448923403|FG001|Overall Study|Adverse Event|0|||
124806716|NCT00392015|448923404|FG002|Overall Study|Adverse Event|0|||
124806717|NCT00392015|448923405|FG003|Overall Study|Adverse Event|0|||
124806718|NCT00392015|448923406|FG004|Overall Study|Adverse Event|1|||
124806719|NCT00392015|448923407|FG005|Overall Study|Adverse Event|0|||
124806720|NCT00392015|448923402|FG000|Overall Study|Previous trial recipient|0|||
124806721|NCT00392015|448923403|FG001|Overall Study|Previous trial recipient|0|||
124806722|NCT00392015|448923404|FG002|Overall Study|Previous trial recipient|0|||
124806723|NCT00392015|448923405|FG003|Overall Study|Previous trial recipient|0|||
124806724|NCT00392015|448923406|FG004|Overall Study|Previous trial recipient|1|||
124806725|NCT00392015|448923407|FG005|Overall Study|Previous trial recipient|0|||
124806726|NCT02180724|448923408|FG000|Overall Study|Death|26|||
124806727|NCT02180724|448923409|FG001|Overall Study|Death|1|||
124806728|NCT02180724|448923408|FG000|Overall Study|Lost to Follow-up|3|||
124806729|NCT02180724|448923409|FG001|Overall Study|Lost to Follow-up|1|||
124806730|NCT02180724|448923408|FG000|Overall Study|Withdrawal by Subject|4|||
124806731|NCT02180724|448923409|FG001|Overall Study|Withdrawal by Subject|2|||
124806732|NCT02180724|448923408|FG000|Overall Study|PI Decision|5|||
124806733|NCT02180724|448923409|FG001|Overall Study|PI Decision|2|||
124806734|NCT02180724|448923408|FG000|Overall Study|Study terminated by sponsor|54|||
124806735|NCT02180724|448923409|FG001|Overall Study|Study terminated by sponsor|8|||
124806736|NCT03693300|448923410|FG000|Overall Study|Withdrawal by Subject|6|||
124806737|NCT03693300|448923411|FG001|Overall Study|Withdrawal by Subject|0|||
124806738|NCT03693300|448923410|FG000|Overall Study|Death|50|||
124806739|NCT03693300|448923411|FG001|Overall Study|Death|2|||
124806740|NCT03693300|448923410|FG000|Overall Study|Lost to Follow-up|2|||
124806741|NCT03693300|448923411|FG001|Overall Study|Lost to Follow-up|0|||
124806742|NCT02206048|448923412|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
124806743|NCT02925923|448923416|FG000|Overall Study|blood samples hemolyzed|0|||
124806744|NCT02925923|448923417|FG001|Overall Study|blood samples hemolyzed|2|||
124806745|NCT00866788|448923418|FG000|Overall Study|Adverse Event|0|||
124806746|NCT00866788|448923419|FG001|Overall Study|Adverse Event|2|||
124806747|NCT00866788|448923420|FG002|Overall Study|Adverse Event|0|||
124806748|NCT00866788|448923421|FG003|Overall Study|Adverse Event|1|||
124806749|NCT00866788|448923418|FG000|Overall Study|Lost to Follow-up|1|||
124806750|NCT00866788|448923419|FG001|Overall Study|Lost to Follow-up|1|||
124806751|NCT00866788|448923420|FG002|Overall Study|Lost to Follow-up|0|||
124806752|NCT00866788|448923421|FG003|Overall Study|Lost to Follow-up|2|||
124806753|NCT00866788|448923418|FG000|Overall Study|Withdrawal by Subject|2|||
124806754|NCT00866788|448923419|FG001|Overall Study|Withdrawal by Subject|1|||
124806755|NCT00866788|448923420|FG002|Overall Study|Withdrawal by Subject|0|||
124806756|NCT00866788|448923421|FG003|Overall Study|Withdrawal by Subject|1|||
124806757|NCT00866788|448923418|FG000|Overall Study|Pregnancy|0|||
124806758|NCT00866788|448923419|FG001|Overall Study|Pregnancy|1|||
124806759|NCT00866788|448923420|FG002|Overall Study|Pregnancy|0|||
124806760|NCT00866788|448923421|FG003|Overall Study|Pregnancy|0|||
124806761|NCT00866788|448923418|FG000|Overall Study|Disease progression|3|||
124806762|NCT00866788|448923419|FG001|Overall Study|Disease progression|1|||
124806763|NCT00866788|448923420|FG002|Overall Study|Disease progression|1|||
124806764|NCT00866788|448923421|FG003|Overall Study|Disease progression|0|||
124806765|NCT00866788|448923418|FG000|Overall Study|Physician Decision|0|||
124806766|NCT00866788|448923419|FG001|Overall Study|Physician Decision|0|||
124806767|NCT00866788|448923420|FG002|Overall Study|Physician Decision|1|||
124806768|NCT00866788|448923421|FG003|Overall Study|Physician Decision|1|||
124806769|NCT02742441|448923422|FG000|Overall Study|Lost to Follow-up|4|||
124806770|NCT02742441|448923423|FG001|Overall Study|Lost to Follow-up|4|||
124806771|NCT02742441|448923422|FG000|Overall Study|Withdrawal by Subject|2|||
124806772|NCT02742441|448923423|FG001|Overall Study|Withdrawal by Subject|2|||
124806773|NCT02742441|448923422|FG000|Overall Study|Adverse Event|0|||
124806774|NCT02742441|448923423|FG001|Overall Study|Adverse Event|2|||
124806775|NCT01824342|448923431|FG000|Overall Study|Withdrawal by Subject|0|||
124806776|NCT01824342|448923432|FG001|Overall Study|Withdrawal by Subject|3|||
124806777|NCT01824342|448923431|FG000|Overall Study|Adverse Event|1|||
124806778|NCT01824342|448923432|FG001|Overall Study|Adverse Event|1|||
124806779|NCT01824342|448923431|FG000|Overall Study|Disease Progression|1|||
124806780|NCT01824342|448923432|FG001|Overall Study|Disease Progression|1|||
124806781|NCT01824342|448923431|FG000|Overall Study|Physician Decision|5|||
124806782|NCT01824342|448923432|FG001|Overall Study|Physician Decision|0|||
124806783|NCT01824342|448923431|FG000|Overall Study|Death|2|||
124806784|NCT01824342|448923432|FG001|Overall Study|Death|0|||
124806785|NCT02008318|448923438|FG000|Overall Study|Adverse Event|4|||
124806786|NCT02008318|448923439|FG001|Overall Study|Adverse Event|0|||
124806787|NCT02008318|448923438|FG000|Overall Study|Physician Decision|2|||
124806788|NCT02008318|448923439|FG001|Overall Study|Physician Decision|0|||
124806789|NCT02008318|448923438|FG000|Overall Study|Progressive Disease|2|||
124806790|NCT02008318|448923439|FG001|Overall Study|Progressive Disease|0|||
124806791|NCT02008318|448923438|FG000|Overall Study|Protocol Violation|1|||
124806792|NCT02008318|448923439|FG001|Overall Study|Protocol Violation|1|||
124806793|NCT02008318|448923438|FG000|Overall Study|Withdrawal by Subject|3|||
124806794|NCT02008318|448923439|FG001|Overall Study|Withdrawal by Subject|0|||
124806795|NCT02281773|448923440|FG000|Overall Study|Adverse Event|6|||
124806796|NCT02281773|448923441|FG001|Overall Study|Adverse Event|1|||
124806797|NCT02281773|448923442|FG002|Overall Study|Adverse Event|4|||
124806798|NCT02281773|448923443|FG003|Overall Study|Adverse Event|8|||
124806799|NCT02281773|448923444|FG004|Overall Study|Adverse Event|9|||
124806800|NCT02281773|448923440|FG000|Overall Study|Protocol Violation|1|||
124806801|NCT02281773|448923441|FG001|Overall Study|Protocol Violation|0|||
124806802|NCT02281773|448923442|FG002|Overall Study|Protocol Violation|0|||
124806803|NCT02281773|448923443|FG003|Overall Study|Protocol Violation|2|||
124806804|NCT02281773|448923444|FG004|Overall Study|Protocol Violation|2|||
124806805|NCT02281773|448923440|FG000|Overall Study|Lost to Follow-up|2|||
124806806|NCT02281773|448923441|FG001|Overall Study|Lost to Follow-up|2|||
124806807|NCT02281773|448923442|FG002|Overall Study|Lost to Follow-up|6|||
124806808|NCT02281773|448923443|FG003|Overall Study|Lost to Follow-up|2|||
124806809|NCT02281773|448923444|FG004|Overall Study|Lost to Follow-up|10|||
124806810|NCT02281773|448923440|FG000|Overall Study|Withdrawal by Subject|2|||
124806811|NCT02281773|448923441|FG001|Overall Study|Withdrawal by Subject|8|||
124806812|NCT02281773|448923442|FG002|Overall Study|Withdrawal by Subject|6|||
124806813|NCT02281773|448923443|FG003|Overall Study|Withdrawal by Subject|6|||
124806814|NCT02281773|448923444|FG004|Overall Study|Withdrawal by Subject|8|||
124806815|NCT02281773|448923440|FG000|Overall Study|Other Reason|0|||
124806816|NCT02281773|448923441|FG001|Overall Study|Other Reason|4|||
124806817|NCT02281773|448923442|FG002|Overall Study|Other Reason|2|||
124806818|NCT02281773|448923443|FG003|Overall Study|Other Reason|3|||
124806819|NCT02281773|448923444|FG004|Overall Study|Other Reason|1|||
124806820|NCT02104752|448923445|FG000|Overall Study|Withdrawal by Subject|1|||
124806821|NCT02104752|448923446|FG001|Overall Study|Withdrawal by Subject|0|||
124806822|NCT02104752|448923445|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
124806823|NCT02104752|448923446|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
124806824|NCT05439941|448923447|FG000|Overall Study|Lack of Efficacy|8|||
124634077|NCT04225715|448276196|FG003|Overall Study|Reason not Specified|0|||
124634078|NCT04225715|448276197|FG004|Overall Study|Reason not Specified|0|||
124806825|NCT05439941|448923448|FG001|Overall Study|Lack of Efficacy|5|||
124806826|NCT05439941|448923449|FG002|Overall Study|Lack of Efficacy|3|||
124806827|NCT05439941|448923447|FG000|Overall Study|Treatment Failure|0|||
124806828|NCT05439941|448923448|FG001|Overall Study|Treatment Failure|1|||
124806829|NCT05439941|448923449|FG002|Overall Study|Treatment Failure|0|||
124806830|NCT05439941|448923447|FG000|Overall Study|Adverse Event|1|||
124806831|NCT05439941|448923448|FG001|Overall Study|Adverse Event|3|||
124806832|NCT05439941|448923449|FG002|Overall Study|Adverse Event|0|||
124634079|NCT04225715|448276198|FG005|Overall Study|Reason not Specified|0|||
124806833|NCT05439941|448923447|FG000|Overall Study|Adverse Event - Parent Study|1|||
124806834|NCT05439941|448923448|FG001|Overall Study|Adverse Event - Parent Study|0|||
124806835|NCT05439941|448923449|FG002|Overall Study|Adverse Event - Parent Study|0|||
124806836|NCT05439941|448923447|FG000|Overall Study|Pregnancy|1|||
124806837|NCT05439941|448923448|FG001|Overall Study|Pregnancy|0|||
124806838|NCT05439941|448923449|FG002|Overall Study|Pregnancy|0|||
124806839|NCT05439941|448923447|FG000|Overall Study|Withdrawal by Subject|9|||
124806840|NCT05439941|448923448|FG001|Overall Study|Withdrawal by Subject|6|||
124806841|NCT05439941|448923449|FG002|Overall Study|Withdrawal by Subject|10|||
124806842|NCT05439941|448923447|FG000|Overall Study|Non-Compliance|1|||
124806843|NCT05439941|448923448|FG001|Overall Study|Non-Compliance|1|||
124806844|NCT05439941|448923449|FG002|Overall Study|Non-Compliance|1|||
124806845|NCT05439941|448923447|FG000|Overall Study|Lost to Follow-up|2|||
124806846|NCT05439941|448923448|FG001|Overall Study|Lost to Follow-up|2|||
124806847|NCT05439941|448923449|FG002|Overall Study|Lost to Follow-up|0|||
124806848|NCT05439941|448923447|FG000|Overall Study|Physician Decision|1|||
124806849|NCT05439941|448923448|FG001|Overall Study|Physician Decision|0|||
124806850|NCT05439941|448923449|FG002|Overall Study|Physician Decision|0|||
124806851|NCT05439941|448923447|FG000|Overall Study|Trial Termination by Sponsor|78|||
124806852|NCT05439941|448923448|FG001|Overall Study|Trial Termination by Sponsor|83|||
124806853|NCT05439941|448923449|FG002|Overall Study|Trial Termination by Sponsor|65|||
124806854|NCT05439941|448923447|FG000|Overall Study|Other than Reasons Listed|2|||
124806855|NCT05439941|448923448|FG001|Overall Study|Other than Reasons Listed|1|||
124806856|NCT05439941|448923449|FG002|Overall Study|Other than Reasons Listed|0|||
124806857|NCT00231842|448923450|FG000|Overall Study|Withdrawal by Subject|3|||
124806858|NCT00231842|448923450|FG000|Overall Study|Did not complete the last 3 cycle|8|||
124806859|NCT02422303|448923451|FG000|Overall Study|Lost to Follow-up|1|||
124806860|NCT02422303|448923452|FG001|Overall Study|Lost to Follow-up|1|||
124806861|NCT02899299|448923454|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
124806862|NCT02899299|448923455|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
124806863|NCT02899299|448923454|FG000|Pre-treatment|Participant withdrew consent|1|||
124806864|NCT02899299|448923455|FG001|Pre-treatment|Participant withdrew consent|11|||
124806865|NCT02899299|448923454|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
124806866|NCT02899299|448923455|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
124806867|NCT02899299|448923454|FG000|Pre-treatment|Not reported|0|||
124806868|NCT02899299|448923455|FG001|Pre-treatment|Not reported|1|||
124806869|NCT02899299|448923454|FG000|Treatment|Disease Progression|182|||
124806870|NCT02899299|448923455|FG001|Treatment|Disease Progression|43|||
124806871|NCT02899299|448923454|FG000|Treatment|Study Drug Toxicity|60|||
124806872|NCT02899299|448923455|FG001|Treatment|Study Drug Toxicity|24|||
124806873|NCT02899299|448923454|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
124806874|NCT02899299|448923455|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
124806875|NCT02899299|448923454|FG000|Treatment|Participant request to discontinue Study treatment|4|||
124806876|NCT02899299|448923455|FG001|Treatment|Participant request to discontinue Study treatment|10|||
124806877|NCT02899299|448923454|FG000|Treatment|Participant withdrew consent|6|||
124806878|NCT02899299|448923455|FG001|Treatment|Participant withdrew consent|3|||
124806879|NCT02899299|448923454|FG000|Treatment|Lost to Follow-up|0|||
124806880|NCT02899299|448923455|FG001|Treatment|Lost to Follow-up|2|||
124806881|NCT02899299|448923454|FG000|Treatment|Maximum Clinical Benefit|11|||
124806882|NCT02899299|448923455|FG001|Treatment|Maximum Clinical Benefit|2|||
124806883|NCT02899299|448923454|FG000|Treatment|Poor/Non-compliance|1|||
124806884|NCT02899299|448923455|FG001|Treatment|Poor/Non-compliance|0|||
124806885|NCT02899299|448923454|FG000|Treatment|Participant no longer meets Study criteria|4|||
124806886|NCT02899299|448923455|FG001|Treatment|Participant no longer meets Study criteria|0|||
124806887|NCT02899299|448923454|FG000|Treatment|Administrative reason by Sponsor|2|||
124806888|NCT02899299|448923455|FG001|Treatment|Administrative reason by Sponsor|0|||
124806889|NCT02899299|448923454|FG000|Treatment|Other reasons|12|||
124806890|NCT02899299|448923455|FG001|Treatment|Other reasons|2|||
124806891|NCT02899299|448923454|FG000|Treatment|Not reported|7|||
124806892|NCT02899299|448923455|FG001|Treatment|Not reported|0|||
124806893|NCT00313300|448923456|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
124806894|NCT00313300|448923457|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
124806895|NCT00313300|448923458|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
124806896|NCT00313300|448923459|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
124806897|NCT00313300|448923460|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
124806898|NCT00313300|448923456|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
124806899|NCT00313300|448923457|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
124806900|NCT00313300|448923458|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
124806901|NCT00313300|448923459|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
124806902|NCT00313300|448923460|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
124806903|NCT00313300|448923456|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
124806904|NCT00313300|448923457|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
124806905|NCT00313300|448923458|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
124806906|NCT00313300|448923459|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
124806907|NCT00313300|448923460|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
124806908|NCT00313300|448923456|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
124806909|NCT00313300|448923457|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
124806910|NCT00313300|448923458|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
124806911|NCT00313300|448923459|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
124806912|NCT00313300|448923460|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
124806913|NCT00313300|448923456|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
124806914|NCT00313300|448923457|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
124806915|NCT00313300|448923458|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
124806916|NCT00313300|448923459|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
124806917|NCT00313300|448923460|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
124806918|NCT00313300|448923456|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
124806919|NCT00313300|448923457|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
124806920|NCT00313300|448923458|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
124806921|NCT00313300|448923459|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
124806922|NCT00313300|448923460|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
124806923|NCT00313300|448923456|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
124806924|NCT00313300|448923457|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
124806925|NCT00313300|448923458|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
124806926|NCT00313300|448923459|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
124806927|NCT00313300|448923460|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
124806928|NCT00313300|448923456|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
124806929|NCT00313300|448923457|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
124806930|NCT00313300|448923458|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
124806931|NCT00313300|448923459|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
124806932|NCT00313300|448923460|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
124806933|NCT00313300|448923456|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
124806934|NCT00313300|448923457|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
124806935|NCT00313300|448923458|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
124806936|NCT00313300|448923459|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
124806937|NCT00313300|448923460|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
124806938|NCT00313300|448923456|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
124806939|NCT00313300|448923457|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
124806940|NCT00313300|448923458|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
124806941|NCT00313300|448923459|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
124806942|NCT00313300|448923460|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
124806943|NCT00313300|448923456|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
124806944|NCT00313300|448923457|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
124806945|NCT00313300|448923458|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
124806946|NCT00313300|448923459|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
124806947|NCT00313300|448923460|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
124806948|NCT00313300|448923456|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
124806949|NCT00313300|448923457|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
124806950|NCT00313300|448923458|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
124806951|NCT00313300|448923459|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
124806952|NCT00313300|448923460|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
124806953|NCT00313300|448923456|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
124806954|NCT00313300|448923457|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
124806955|NCT00313300|448923458|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
124806956|NCT00313300|448923459|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
124806957|NCT00313300|448923460|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
124806958|NCT00313300|448923456|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
124806959|NCT00313300|448923457|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
124806960|NCT00313300|448923458|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
124806961|NCT00313300|448923459|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
124806962|NCT00313300|448923460|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
124806963|NCT00313300|448923456|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
124806964|NCT00313300|448923457|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
124806965|NCT00313300|448923458|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
124806966|NCT00313300|448923459|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
124806967|NCT00313300|448923460|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
124806968|NCT00313300|448923456|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
124806969|NCT00313300|448923457|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
124806970|NCT00313300|448923458|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
124806971|NCT00313300|448923459|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
124806972|NCT00313300|448923460|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
124806973|NCT00313300|448923456|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
124806974|NCT00313300|448923457|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
124806975|NCT00313300|448923458|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
124806976|NCT00313300|448923459|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
124806977|NCT00313300|448923460|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
124634080|NCT04225715|448276199|FG006|Overall Study|Reason not Specified|0|||
124806978|NCT00313300|448923456|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
124806979|NCT00313300|448923457|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
124806980|NCT00313300|448923458|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
124806981|NCT00313300|448923459|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
124806982|NCT00313300|448923460|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
124806983|NCT00313300|448923456|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
124806984|NCT00313300|448923457|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
124806985|NCT00313300|448923458|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
124806986|NCT00313300|448923459|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
124806987|NCT00313300|448923460|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
124806988|NCT00313300|448923456|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
124806989|NCT00313300|448923457|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
124806990|NCT00313300|448923458|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
124806991|NCT00313300|448923459|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
124806992|NCT00313300|448923460|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
124806993|NCT00313300|448923456|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
124806994|NCT00313300|448923457|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
124806995|NCT00313300|448923458|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
124806996|NCT00313300|448923459|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
124806997|NCT00313300|448923460|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
124806998|NCT02336373|448923461|FG000|Overall Study|Protocol closed early|4|||
124806999|NCT02336373|448923461|FG000|Overall Study|Physician Decision|14|||
124807000|NCT00850343|448923463|FG000|Overall Study|Withdrawal by Subject|11|||
124807001|NCT00850343|448923464|FG001|Overall Study|Withdrawal by Subject|0|||
124807002|NCT00850343|448923465|FG002|Overall Study|Withdrawal by Subject|3|||
124807003|NCT00850343|448923466|FG003|Overall Study|Withdrawal by Subject|2|||
124807004|NCT00850343|448923463|FG000|Overall Study|Adverse Event|15|||
124807005|NCT00850343|448923464|FG001|Overall Study|Adverse Event|2|||
124807006|NCT00850343|448923465|FG002|Overall Study|Adverse Event|6|||
124807007|NCT00850343|448923466|FG003|Overall Study|Adverse Event|6|||
124807008|NCT00850343|448923463|FG000|Overall Study|Pregnancy|0|||
124807009|NCT00850343|448923464|FG001|Overall Study|Pregnancy|0|||
124807010|NCT00850343|448923465|FG002|Overall Study|Pregnancy|0|||
124807011|NCT00850343|448923466|FG003|Overall Study|Pregnancy|1|||
124807012|NCT00850343|448923463|FG000|Overall Study|Lack of Efficacy|17|||
124807013|NCT00850343|448923464|FG001|Overall Study|Lack of Efficacy|0|||
124807014|NCT00850343|448923465|FG002|Overall Study|Lack of Efficacy|3|||
124807015|NCT00850343|448923466|FG003|Overall Study|Lack of Efficacy|2|||
124807016|NCT00850343|448923463|FG000|Overall Study|Non-compliance with Study Procedures|1|||
124807017|NCT00850343|448923464|FG001|Overall Study|Non-compliance with Study Procedures|0|||
124807018|NCT00850343|448923465|FG002|Overall Study|Non-compliance with Study Procedures|1|||
124807019|NCT00850343|448923466|FG003|Overall Study|Non-compliance with Study Procedures|1|||
124807020|NCT00850343|448923463|FG000|Overall Study|Physician Decision|2|||
124807021|NCT00850343|448923464|FG001|Overall Study|Physician Decision|1|||
124807022|NCT00850343|448923465|FG002|Overall Study|Physician Decision|1|||
124807023|NCT00850343|448923466|FG003|Overall Study|Physician Decision|1|||
124807024|NCT01926015|448923468|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124807025|NCT01926015|448923469|FG001|Overall Study|Withdrawal by parent/guardian|1|||
124807026|NCT01926015|448923468|FG000|Overall Study|Randomized not treated|2|||
124807027|NCT01926015|448923469|FG001|Overall Study|Randomized not treated|0|||
124807028|NCT00639678|448923470|FG000|Overall Study|Withdrawal by Subject|3|||
124807029|NCT00639678|448923471|FG001|Overall Study|Withdrawal by Subject|0|||
124807030|NCT00639678|448923472|FG002|Overall Study|Withdrawal by Subject|4|||
124807031|NCT00639678|448923473|FG003|Overall Study|Withdrawal by Subject|0|||
124807032|NCT00639678|448923470|FG000|Overall Study|Lost to Follow-up|1|||
124807033|NCT00639678|448923471|FG001|Overall Study|Lost to Follow-up|0|||
124807034|NCT00639678|448923472|FG002|Overall Study|Lost to Follow-up|6|||
124634081|NCT04225715|448276200|FG007|Overall Study|Reason not Specified|0|||
124634082|NCT04225715|448276201|FG008|Overall Study|Reason not Specified|0|||
124634083|NCT04225715|448276193|FG000|Overall Study|Protocol Violation|1|||
124634084|NCT04225715|448276194|FG001|Overall Study|Protocol Violation|0|||
124807035|NCT00639678|448923473|FG003|Overall Study|Lost to Follow-up|0|||
124807036|NCT00639678|448923470|FG000|Overall Study|Adverse Event|0|||
124807037|NCT00639678|448923471|FG001|Overall Study|Adverse Event|1|||
124807038|NCT00639678|448923472|FG002|Overall Study|Adverse Event|0|||
124807039|NCT00639678|448923473|FG003|Overall Study|Adverse Event|0|||
124807040|NCT00639678|448923470|FG000|Overall Study|Lack of Compliance|0|||
124807041|NCT00639678|448923471|FG001|Overall Study|Lack of Compliance|0|||
124807042|NCT00639678|448923472|FG002|Overall Study|Lack of Compliance|1|||
124807043|NCT00639678|448923473|FG003|Overall Study|Lack of Compliance|0|||
124807044|NCT01364649|448923474|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
124807045|NCT01364649|448923475|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
124807046|NCT01364649|448923474|FG000|Overall Study|Lack of Efficacy|6|||
124807047|NCT01364649|448923475|FG001|Overall Study|Lack of Efficacy|0|||
124807048|NCT01364649|448923474|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
124807049|NCT01364649|448923475|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
124807050|NCT01364649|448923474|FG000|Overall Study|Protocol Deviations|4|||
124807051|NCT01364649|448923475|FG001|Overall Study|Protocol Deviations|8|||
124807052|NCT01364649|448923474|FG000|Overall Study|Withdrawal of Consent|9|||
124807053|NCT01364649|448923475|FG001|Overall Study|Withdrawal of Consent|7|||
124807054|NCT01364649|448923474|FG000|Overall Study|Lost to Follow-up|12|||
124807055|NCT01364649|448923475|FG001|Overall Study|Lost to Follow-up|13|||
124807056|NCT01364649|448923474|FG000|Overall Study|Other|4|||
124807057|NCT01364649|448923475|FG001|Overall Study|Other|1|||
124807058|NCT02468232|448923478|FG000|Core Part of Study|Adverse Event|0|||
124807059|NCT02468232|448923479|FG001|Core Part of Study|Adverse Event|1|||
124807060|NCT02468232|448923480|FG002|Core Part of Study|Adverse Event|0|||
124807061|NCT02468232|448923481|FG003|Core Part of Study|Adverse Event|0|||
124807062|NCT02468232|448923478|FG000|Core Part of Study|Death|20|||
124807063|NCT02468232|448923479|FG001|Core Part of Study|Death|17|||
124807064|NCT02468232|448923480|FG002|Core Part of Study|Death|0|||
124634085|NCT04225715|448276195|FG002|Overall Study|Protocol Violation|0|||
124634086|NCT04225715|448276196|FG003|Overall Study|Protocol Violation|0|||
124634087|NCT04225715|448276197|FG004|Overall Study|Protocol Violation|0|||
124634088|NCT04225715|448276198|FG005|Overall Study|Protocol Violation|9|||
124634089|NCT04225715|448276199|FG006|Overall Study|Protocol Violation|0|||
124634090|NCT04225715|448276200|FG007|Overall Study|Protocol Violation|0|||
124634091|NCT04225715|448276201|FG008|Overall Study|Protocol Violation|0|||
124634092|NCT04225715|448276193|FG000|Overall Study|Withdrawal by Subject|4|||
124634093|NCT04225715|448276194|FG001|Overall Study|Withdrawal by Subject|1|||
124634094|NCT04225715|448276195|FG002|Overall Study|Withdrawal by Subject|1|||
124634095|NCT04225715|448276196|FG003|Overall Study|Withdrawal by Subject|0|||
124634096|NCT04225715|448276197|FG004|Overall Study|Withdrawal by Subject|3|||
124634097|NCT04225715|448276198|FG005|Overall Study|Withdrawal by Subject|1|||
124634098|NCT04225715|448276199|FG006|Overall Study|Withdrawal by Subject|1|||
124634099|NCT04225715|448276200|FG007|Overall Study|Withdrawal by Subject|1|||
124634100|NCT04225715|448276201|FG008|Overall Study|Withdrawal by Subject|0|||
124634101|NCT04225715|448276193|FG000|Overall Study|Adverse Event|0|||
124634102|NCT04225715|448276194|FG001|Overall Study|Adverse Event|0|||
124634103|NCT04225715|448276195|FG002|Overall Study|Adverse Event|0|||
124634104|NCT04225715|448276196|FG003|Overall Study|Adverse Event|0|||
124634105|NCT04225715|448276197|FG004|Overall Study|Adverse Event|0|||
124634106|NCT04225715|448276198|FG005|Overall Study|Adverse Event|0|||
124634107|NCT04225715|448276199|FG006|Overall Study|Adverse Event|0|||
124634108|NCT04225715|448276200|FG007|Overall Study|Adverse Event|0|||
124634109|NCT04225715|448276201|FG008|Overall Study|Adverse Event|1|||
124634110|NCT04225715|448276193|FG000|Overall Study|Arm Terminated By Sponsor|0|||
124634111|NCT04225715|448276194|FG001|Overall Study|Arm Terminated By Sponsor|0|||
124634112|NCT04225715|448276195|FG002|Overall Study|Arm Terminated By Sponsor|0|||
124634113|NCT04225715|448276196|FG003|Overall Study|Arm Terminated By Sponsor|0|||
124634114|NCT04225715|448276197|FG004|Overall Study|Arm Terminated By Sponsor|0|||
124634115|NCT04225715|448276198|FG005|Overall Study|Arm Terminated By Sponsor|0|||
124634116|NCT04225715|448276199|FG006|Overall Study|Arm Terminated By Sponsor|0|||
124634117|NCT04225715|448276200|FG007|Overall Study|Arm Terminated By Sponsor|17|||
124634118|NCT04225715|448276201|FG008|Overall Study|Arm Terminated By Sponsor|18|||
124634119|NCT03318861|448276202|FG000|Overall Study|Death|2|||
124634120|NCT03318861|448276203|FG001|Overall Study|Death|3|||
124634121|NCT03318861|448276204|FG002|Overall Study|Death|3|||
124634122|NCT03318861|448276205|FG003|Overall Study|Death|2|||
124634123|NCT03318861|448276206|FG004|Overall Study|Death|2|||
124634124|NCT03318861|448276202|FG000|Overall Study|Enrolled But Never Treated|0|||
124807065|NCT02468232|448923481|FG003|Core Part of Study|Death|0|||
124807066|NCT02468232|448923478|FG000|Core Part of Study|Technical Problems|1|||
124807067|NCT02468232|448923479|FG001|Core Part of Study|Technical Problems|1|||
124807068|NCT02468232|448923480|FG002|Core Part of Study|Technical Problems|0|||
124807069|NCT02468232|448923481|FG003|Core Part of Study|Technical Problems|0|||
124807070|NCT02468232|448923478|FG000|OLE Part of Study|Adverse Event|0|||
124807071|NCT02468232|448923479|FG001|OLE Part of Study|Adverse Event|0|||
124807072|NCT02468232|448923480|FG002|OLE Part of Study|Adverse Event|4|||
124807073|NCT02468232|448923481|FG003|OLE Part of Study|Adverse Event|5|||
124807074|NCT02468232|448923478|FG000|OLE Part of Study|Death|0|||
124807075|NCT02468232|448923479|FG001|OLE Part of Study|Death|0|||
124807076|NCT02468232|448923480|FG002|OLE Part of Study|Death|4|||
124807077|NCT02468232|448923481|FG003|OLE Part of Study|Death|2|||
124634125|NCT03318861|448276203|FG001|Overall Study|Enrolled But Never Treated|1|||
124807078|NCT02468232|448923478|FG000|OLE Part of Study|Physician Decision|0|||
124807079|NCT02468232|448923479|FG001|OLE Part of Study|Physician Decision|0|||
124807080|NCT02468232|448923480|FG002|OLE Part of Study|Physician Decision|4|||
124634126|NCT03318861|448276204|FG002|Overall Study|Enrolled But Never Treated|0|||
124634127|NCT03318861|448276205|FG003|Overall Study|Enrolled But Never Treated|1|||
124634128|NCT03318861|448276206|FG004|Overall Study|Enrolled But Never Treated|1|||
124634129|NCT03318861|448276202|FG000|Overall Study|Informed Consent Withdraw|0|||
124807081|NCT02468232|448923481|FG003|OLE Part of Study|Physician Decision|0|||
124807082|NCT02468232|448923478|FG000|OLE Part of Study|Subject/Guardian decision|0|||
124807083|NCT02468232|448923479|FG001|OLE Part of Study|Subject/Guardian decision|0|||
124807084|NCT02468232|448923480|FG002|OLE Part of Study|Subject/Guardian decision|2|||
124807085|NCT02468232|448923481|FG003|OLE Part of Study|Subject/Guardian decision|5|||
124807086|NCT00246753|448923482|FG000|Overall Study|Withdrawal by Subject|2|||
124807087|NCT00246753|448923482|FG000|Overall Study|Physician Decision|2|||
124807088|NCT00246753|448923482|FG000|Overall Study|Adverse Event|2|||
124807089|NCT00246753|448923482|FG000|Overall Study|Unacceptable toxicity|2|||
124807090|NCT02764333|448923491|FG000|Overall Study|Ineligible|1|||
124807091|NCT01303861|448923505|FG000|Overall Study|Lost to Follow-up|34|||
124807092|NCT01303861|448923506|FG001|Overall Study|Lost to Follow-up|14|||
124807093|NCT01303861|448923507|FG002|Overall Study|Lost to Follow-up|27|||
124807094|NCT01303861|448923508|FG003|Overall Study|Lost to Follow-up|31|||
124807095|NCT01303861|448923505|FG000|Overall Study|Lack of Efficacy|3|||
124807096|NCT01303861|448923506|FG001|Overall Study|Lack of Efficacy|2|||
124807097|NCT01303861|448923507|FG002|Overall Study|Lack of Efficacy|1|||
124807098|NCT01303861|448923508|FG003|Overall Study|Lack of Efficacy|0|||
124807099|NCT01303861|448923505|FG000|Overall Study|Withdrawal by Subject|16|||
124807100|NCT01303861|448923506|FG001|Overall Study|Withdrawal by Subject|8|||
124807101|NCT01303861|448923507|FG002|Overall Study|Withdrawal by Subject|8|||
124807102|NCT01303861|448923508|FG003|Overall Study|Withdrawal by Subject|23|||
124807103|NCT01303861|448923505|FG000|Overall Study|Adverse Event|4|||
124807104|NCT01303861|448923506|FG001|Overall Study|Adverse Event|1|||
124807105|NCT01303861|448923507|FG002|Overall Study|Adverse Event|0|||
124807106|NCT01303861|448923508|FG003|Overall Study|Adverse Event|5|||
124807107|NCT01303861|448923505|FG000|Overall Study|Pregnancy|1|||
124807108|NCT01303861|448923506|FG001|Overall Study|Pregnancy|0|||
124807109|NCT01303861|448923507|FG002|Overall Study|Pregnancy|0|||
124807110|NCT01303861|448923508|FG003|Overall Study|Pregnancy|0|||
124807111|NCT01788046|448923510|FG000|Overall Study|Withdrawal by Subject|12|||
124807112|NCT01788046|448923511|FG001|Overall Study|Withdrawal by Subject|12|||
124807113|NCT01788046|448923510|FG000|Overall Study|Lost to Follow-up|12|||
124807114|NCT01788046|448923511|FG001|Overall Study|Lost to Follow-up|19|||
124807115|NCT01788046|448923510|FG000|Overall Study|Death|7|||
124807116|NCT01788046|448923511|FG001|Overall Study|Death|5|||
124807117|NCT01788046|448923510|FG000|Overall Study|Protocol Specified Criteria|25|||
124807118|NCT01788046|448923511|FG001|Overall Study|Protocol Specified Criteria|1|||
124807119|NCT01031706|448923514|FG000|Overall Study|Adverse Event|1|||
124807120|NCT01031706|448923515|FG001|Overall Study|Adverse Event|0|||
124807121|NCT01031706|448923514|FG000|Overall Study|Withdrawal by Subject|1|||
124807122|NCT01031706|448923515|FG001|Overall Study|Withdrawal by Subject|1|||
124807123|NCT03840174|448923516|FG000|Overall Study|Withdrawal by Subject|1|||
124807124|NCT03840174|448923517|FG001|Overall Study|Withdrawal by Subject|0|||
124807125|NCT03840174|448923518|FG002|Overall Study|Withdrawal by Subject|0|||
124807126|NCT03840174|448923519|FG003|Overall Study|Withdrawal by Subject|0|||
124807127|NCT00131508|448923522|FG000|Overall Study|Disease progression|0|||
124807128|NCT00131508|448923523|FG001|Overall Study|Disease progression|2|||
124807129|NCT00131508|448923522|FG000|Overall Study|Non-Compliance|2|||
124807130|NCT00131508|448923523|FG001|Overall Study|Non-Compliance|4|||
124807131|NCT00131508|448923522|FG000|Overall Study|Withdrawal by Subject|1|||
124807132|NCT00131508|448923523|FG001|Overall Study|Withdrawal by Subject|2|||
124807133|NCT01268150|448923527|FG000|Treatment Phase|Progression of disease|18|||
124807134|NCT01268150|448923527|FG000|Treatment Phase|Adverse Event|3|||
124807135|NCT01268150|448923527|FG000|Treatment Phase|Withdrawal by Subject|3|||
124807136|NCT01268150|448923527|FG000|Treatment Phase|Other|4|||
124807137|NCT01268150|448923527|FG000|Extension Phase|Adverse Event|3|||
124807138|NCT01268150|448923527|FG000|Extension Phase|Disease progression|18|||
124634130|NCT03318861|448276203|FG001|Overall Study|Informed Consent Withdraw|0|||
124634131|NCT03318861|448276204|FG002|Overall Study|Informed Consent Withdraw|0|||
124634132|NCT03318861|448276205|FG003|Overall Study|Informed Consent Withdraw|1|||
124807139|NCT01268150|448923527|FG000|Extension Phase|Other|6|||
124807140|NCT04738734|448923529|FG000|Overall Study|Withdrawal by Subject|2|||
124807141|NCT04738734|448923530|FG001|Overall Study|Withdrawal by Subject|4|||
124807142|NCT04738734|448923529|FG000|Overall Study|Lost to Follow-up|5|||
124807143|NCT04738734|448923530|FG001|Overall Study|Lost to Follow-up|2|||
124807144|NCT04738734|448923529|FG000|Overall Study|Physician Decision|0|||
124807145|NCT04738734|448923530|FG001|Overall Study|Physician Decision|1|||
124807146|NCT04738734|448923529|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
124807147|NCT04738734|448923530|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
124807148|NCT02435147|448923533|FG000|Overall Study|non-evaluable DXA scan|11|||
124807149|NCT04402060|448923534|FG000|Overall Study|Death|1|||
124807150|NCT04402060|448923535|FG001|Overall Study|Death|12|||
124807151|NCT04402060|448923536|FG002|Overall Study|Death|7|||
124807152|NCT04402060|448923534|FG000|Overall Study|Adverse Event|0|||
124807153|NCT04402060|448923535|FG001|Overall Study|Adverse Event|0|||
124807154|NCT04402060|448923536|FG002|Overall Study|Adverse Event|1|||
124807155|NCT04402060|448923534|FG000|Overall Study|Withdrawal by Subject|0|||
124807156|NCT04402060|448923535|FG001|Overall Study|Withdrawal by Subject|1|||
124807157|NCT04402060|448923536|FG002|Overall Study|Withdrawal by Subject|2|||
124807158|NCT04402060|448923534|FG000|Overall Study|Sponsor Request|0|||
124807159|NCT04402060|448923535|FG001|Overall Study|Sponsor Request|2|||
124807160|NCT04402060|448923536|FG002|Overall Study|Sponsor Request|0|||
124807161|NCT04402060|448923534|FG000|Overall Study|Physician Decision|0|||
124807162|NCT04402060|448923535|FG001|Overall Study|Physician Decision|0|||
124807163|NCT04402060|448923536|FG002|Overall Study|Physician Decision|1|||
124807164|NCT04402060|448923534|FG000|Overall Study|Other|0|||
124807165|NCT04402060|448923535|FG001|Overall Study|Other|1|||
124807166|NCT04402060|448923536|FG002|Overall Study|Other|0|||
124807167|NCT06238362|448923540|FG000|Overall Study|Insufficient total sleep time|1|||
124807168|NCT06238362|448923541|FG001|Overall Study|Insufficient total sleep time|0|||
124807169|NCT06238362|448923540|FG000|Overall Study|Inadequate signal quality|1|||
124807170|NCT06238362|448923541|FG001|Overall Study|Inadequate signal quality|0|||
124807171|NCT05136690|448923542|FG000|Period 1|Withdrawal by Subject|0|||
124807172|NCT05136690|448923543|FG001|Period 1|Withdrawal by Subject|1|||
124807173|NCT05136690|448923542|FG000|Period 2|Lost to Follow-up|0|||
124807174|NCT05136690|448923543|FG001|Period 2|Lost to Follow-up|3|||
124807175|NCT05136690|448923542|FG000|Period 2|Withdrawal by Subject|0|||
124807176|NCT05136690|448923543|FG001|Period 2|Withdrawal by Subject|1|||
124807177|NCT01863953|448924762|FG000|Overall Study|Adverse Event|0|||
124807178|NCT01863953|448924763|FG001|Overall Study|Adverse Event|0|||
124807179|NCT01863953|448924764|FG002|Overall Study|Adverse Event|1|||
124807180|NCT02202837|448924765|FG000|Overall Study|Enbrel treatment discontinued|36|||
124807181|NCT02202837|448924766|FG001|Overall Study|Enbrel treatment discontinued|4|||
124807182|NCT02202837|448924765|FG000|Overall Study|Other|10|||
124807183|NCT02202837|448924766|FG001|Overall Study|Other|0|||
124807184|NCT02202837|448924765|FG000|Overall Study|Lost to Follow-up|7|||
124807185|NCT02202837|448924766|FG001|Overall Study|Lost to Follow-up|1|||
124807186|NCT01313858|448924767|FG000|Overall Study|Premature Treatment Termination|251|||
124807187|NCT01313858|448924768|FG001|Overall Study|Premature Treatment Termination|219|||
124807188|NCT01313858|448924769|FG002|Overall Study|Premature Treatment Termination|191|||
124807189|NCT01313858|448924767|FG000|Overall Study|Lost to Follow-up|35|||
124807190|NCT01313858|448924768|FG001|Overall Study|Lost to Follow-up|51|||
124807191|NCT01313858|448924769|FG002|Overall Study|Lost to Follow-up|47|||
124807192|NCT01626456|448924781|FG000|Overall Study|Withdrawal by Subject|21|||
124807193|NCT01626456|448924782|FG001|Overall Study|Withdrawal by Subject|46|||
124807194|NCT01626456|448924781|FG000|Overall Study|Adverse Event|2|||
124807195|NCT01626456|448924782|FG001|Overall Study|Adverse Event|27|||
124807196|NCT01626456|448924781|FG000|Overall Study|Lost to Follow-up|2|||
124807197|NCT01626456|448924782|FG001|Overall Study|Lost to Follow-up|27|||
124807198|NCT01626456|448924781|FG000|Overall Study|Lack of Efficacy|6|||
124807199|NCT01626456|448924782|FG001|Overall Study|Lack of Efficacy|7|||
124807200|NCT01626456|448924781|FG000|Overall Study|Physician Decision|1|||
124807201|NCT01626456|448924782|FG001|Overall Study|Physician Decision|4|||
124807202|NCT01626456|448924781|FG000|Overall Study|Protocol Violation|1|||
124807203|NCT01626456|448924782|FG001|Overall Study|Protocol Violation|1|||
124807204|NCT01626456|448924781|FG000|Overall Study|Site Closure|2|||
124807205|NCT01626456|448924782|FG001|Overall Study|Site Closure|3|||
124807206|NCT01626456|448924781|FG000|Overall Study|Incarceration|0|||
124807207|NCT01626456|448924782|FG001|Overall Study|Incarceration|2|||
124807208|NCT00506662|448924783|FG000|Overall Study|Adverse Event|0|||
124807209|NCT00506662|448924784|FG001|Overall Study|Adverse Event|2|||
124807210|NCT00506662|448924783|FG000|Overall Study|Lack of Efficacy|1|||
124807211|NCT00506662|448924784|FG001|Overall Study|Lack of Efficacy|0|||
124807212|NCT00506662|448924783|FG000|Overall Study|Protocol Violation|2|||
124807213|NCT00506662|448924784|FG001|Overall Study|Protocol Violation|4|||
124807214|NCT00506662|448924783|FG000|Overall Study|Trial terminated|10|||
124807215|NCT00506662|448924784|FG001|Overall Study|Trial terminated|16|||
124634133|NCT03318861|448276206|FG004|Overall Study|Informed Consent Withdraw|0|||
124634134|NCT03318861|448276202|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
124634135|NCT03318861|448276203|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
124807216|NCT00506662|448924783|FG000|Overall Study|Not recorded|4|||
124807217|NCT00506662|448924784|FG001|Overall Study|Not recorded|6|||
124807218|NCT04015336|448924785|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
124807219|NCT01816074|448924790|FG000|Phase 1|Time commitment issues|0|||
124807220|NCT01816074|448924791|FG001|Phase 1|Time commitment issues|0|||
124807221|NCT01816074|448924792|FG002|Phase 1|Time commitment issues|1|||
124807222|NCT01816074|448924793|FG003|Phase 1|Time commitment issues|0|||
124807223|NCT01816074|448924790|FG000|Phase 2|Time commitment Issues|0|||
124634136|NCT03318861|448276204|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
124807224|NCT01816074|448924791|FG001|Phase 2|Time commitment Issues|2|||
124807225|NCT01816074|448924792|FG002|Phase 2|Time commitment Issues|0|||
124807226|NCT01816074|448924793|FG003|Phase 2|Time commitment Issues|0|||
124807227|NCT01816074|448924790|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
124807228|NCT01816074|448924791|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
124807229|NCT01816074|448924792|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
124807230|NCT01816074|448924793|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
124807231|NCT01816074|448924790|FG000|Phase 2|Physician Decision|0|||
124807232|NCT01816074|448924791|FG001|Phase 2|Physician Decision|0|||
124807233|NCT01816074|448924792|FG002|Phase 2|Physician Decision|0|||
124807234|NCT01816074|448924793|FG003|Phase 2|Physician Decision|1|||
124807235|NCT01816074|448924790|FG000|Phase 2|Withdrawal by Subject|1|||
124807236|NCT01816074|448924791|FG001|Phase 2|Withdrawal by Subject|0|||
124807237|NCT01816074|448924792|FG002|Phase 2|Withdrawal by Subject|0|||
124807238|NCT01816074|448924793|FG003|Phase 2|Withdrawal by Subject|0|||
124807239|NCT01200524|448924795|FG000|Overall Study|Withdrawal by Subject|1|||
124807240|NCT01200524|448924796|FG001|Overall Study|Withdrawal by Subject|1|||
124807241|NCT01200524|448924797|FG002|Overall Study|Withdrawal by Subject|3|||
124807242|NCT01200524|448924795|FG000|Overall Study|Adverse Event|1|||
124807243|NCT01200524|448924796|FG001|Overall Study|Adverse Event|0|||
124807244|NCT01200524|448924797|FG002|Overall Study|Adverse Event|0|||
124807245|NCT01200524|448924795|FG000|Overall Study|Non availability of study nurse|0|||
124807246|NCT01200524|448924796|FG001|Overall Study|Non availability of study nurse|0|||
124807247|NCT01200524|448924797|FG002|Overall Study|Non availability of study nurse|1|||
124807248|NCT02476201|448924800|FG000|Overall Study|Unable to program MPP|9|||
124807249|NCT02476201|448924800|FG000|Overall Study|Study echo not performed|5|||
124807250|NCT02476201|448924800|FG000|Overall Study|Adverse Event|4|||
124807251|NCT02476201|448924800|FG000|Overall Study|Death|2|||
124807252|NCT02476201|448924800|FG000|Overall Study|Lost to Follow-up|2|||
124807253|NCT02476201|448924800|FG000|Overall Study|MPP programmed to OFF|2|||
124807254|NCT02476201|448924800|FG000|Overall Study|Withdrawal by Subject|1|||
124807255|NCT02476201|448924800|FG000|Overall Study|Unsuccessful implant|1|||
124807256|NCT00491764|448924805|FG000|Overall Study|Adverse Event|1|||
124807257|NCT00491764|448924806|FG001|Overall Study|Adverse Event|2|||
124807258|NCT00491764|448924807|FG002|Overall Study|Adverse Event|4|||
124807259|NCT00491764|448924808|FG003|Overall Study|Adverse Event|4|||
124807260|NCT00491764|448924809|FG004|Overall Study|Adverse Event|0|||
124807261|NCT00491764|448924810|FG005|Overall Study|Adverse Event|1|||
124807262|NCT00491764|448924805|FG000|Overall Study|Lost to Follow-up|0|||
124807263|NCT00491764|448924806|FG001|Overall Study|Lost to Follow-up|1|||
124807264|NCT00491764|448924807|FG002|Overall Study|Lost to Follow-up|0|||
124807265|NCT00491764|448924808|FG003|Overall Study|Lost to Follow-up|1|||
124807266|NCT00491764|448924809|FG004|Overall Study|Lost to Follow-up|0|||
124807267|NCT00491764|448924810|FG005|Overall Study|Lost to Follow-up|3|||
124807268|NCT00491764|448924805|FG000|Overall Study|Withdrawal by Subject|2|||
124807269|NCT00491764|448924806|FG001|Overall Study|Withdrawal by Subject|3|||
124807270|NCT00491764|448924807|FG002|Overall Study|Withdrawal by Subject|1|||
124807271|NCT00491764|448924808|FG003|Overall Study|Withdrawal by Subject|2|||
124807272|NCT00491764|448924809|FG004|Overall Study|Withdrawal by Subject|2|||
124807273|NCT00491764|448924810|FG005|Overall Study|Withdrawal by Subject|4|||
124807274|NCT00491764|448924805|FG000|Overall Study|Non Compliance with the Protocol|1|||
124807275|NCT00491764|448924806|FG001|Overall Study|Non Compliance with the Protocol|0|||
124807276|NCT00491764|448924807|FG002|Overall Study|Non Compliance with the Protocol|0|||
124807277|NCT00491764|448924808|FG003|Overall Study|Non Compliance with the Protocol|0|||
124807278|NCT00491764|448924809|FG004|Overall Study|Non Compliance with the Protocol|0|||
124807279|NCT00491764|448924810|FG005|Overall Study|Non Compliance with the Protocol|0|||
124807280|NCT00491764|448924805|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
124807281|NCT00491764|448924806|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
124807282|NCT00491764|448924807|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
124807283|NCT00491764|448924808|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
124807284|NCT00491764|448924809|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
124807285|NCT00491764|448924810|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
124807286|NCT00491764|448924805|FG000|Overall Study|Administrative|1|||
124807287|NCT00491764|448924806|FG001|Overall Study|Administrative|0|||
124807288|NCT00491764|448924807|FG002|Overall Study|Administrative|2|||
124807289|NCT00491764|448924808|FG003|Overall Study|Administrative|1|||
124807290|NCT00491764|448924809|FG004|Overall Study|Administrative|0|||
124807291|NCT00491764|448924810|FG005|Overall Study|Administrative|0|||
124807292|NCT03725852|448924821|FG000|Overall Study|Death|1|||
124807293|NCT03725852|448924822|FG001|Overall Study|Death|0|||
124807294|NCT03725852|448924821|FG000|Overall Study|Withdrawal by Subject|1|||
124807295|NCT03725852|448924822|FG001|Overall Study|Withdrawal by Subject|0|||
124807296|NCT03725852|448924821|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
124807297|NCT03725852|448924822|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
124807298|NCT00116428|448924823|FG000|Overall Study|Withdrawal by Subject|2|||
124807299|NCT00116428|448924824|FG001|Overall Study|Withdrawal by Subject|5|||
124807300|NCT00116428|448924823|FG000|Overall Study|Did not meet inclusion criteria|1|||
124807301|NCT00116428|448924824|FG001|Overall Study|Did not meet inclusion criteria|0|||
124807302|NCT00669396|448924825|FG000|Overall Study|Lost to Follow-up|10|||
124807303|NCT00669396|448924826|FG001|Overall Study|Lost to Follow-up|12|||
124807304|NCT01297920|448924827|FG000|Overall Study|Adverse Event|42|||
124807305|NCT01297920|448924828|FG001|Overall Study|Adverse Event|10|||
124807306|NCT01297920|448924829|FG002|Overall Study|Adverse Event|38|||
124807307|NCT01297920|448924827|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
124807308|NCT01297920|448924828|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
124807309|NCT01297920|448924829|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
124807310|NCT01297920|448924827|FG000|Overall Study|Noncompliance|1|||
124807311|NCT01297920|448924828|FG001|Overall Study|Noncompliance|0|||
124807312|NCT01297920|448924829|FG002|Overall Study|Noncompliance|0|||
124807313|NCT01297920|448924827|FG000|Overall Study|Protocol Violation|1|||
124807314|NCT01297920|448924828|FG001|Overall Study|Protocol Violation|3|||
124807315|NCT01297920|448924829|FG002|Overall Study|Protocol Violation|0|||
124807316|NCT01297920|448924827|FG000|Overall Study|Inadequate Control of IOP|7|||
124807317|NCT01297920|448924828|FG001|Overall Study|Inadequate Control of IOP|9|||
124807318|NCT01297920|448924829|FG002|Overall Study|Inadequate Control of IOP|17|||
124807319|NCT01297920|448924827|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
124807320|NCT01297920|448924828|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
124807321|NCT01297920|448924829|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
124807322|NCT00474760|448924830|FG000|Overall Study|Death|0|||
124807323|NCT00474760|448924831|FG001|Overall Study|Death|0|||
124807324|NCT00474760|448924832|FG002|Overall Study|Death|0|||
124807325|NCT00474760|448924833|FG003|Overall Study|Death|0|||
124807326|NCT00474760|448924834|FG004|Overall Study|Death|2|||
124807327|NCT00474760|448924835|FG005|Overall Study|Death|0|||
124807328|NCT00474760|448924836|FG006|Overall Study|Death|0|||
124807329|NCT00474760|448924830|FG000|Overall Study|Adverse Event|0|||
124807330|NCT00474760|448924831|FG001|Overall Study|Adverse Event|0|||
124807331|NCT00474760|448924832|FG002|Overall Study|Adverse Event|0|||
124807332|NCT00474760|448924833|FG003|Overall Study|Adverse Event|0|||
124807333|NCT00474760|448924834|FG004|Overall Study|Adverse Event|1|||
124807334|NCT00474760|448924835|FG005|Overall Study|Adverse Event|7|||
124807335|NCT00474760|448924836|FG006|Overall Study|Adverse Event|0|||
124807336|NCT00474760|448924830|FG000|Overall Study|Laboratory abnormality|0|||
124807337|NCT00474760|448924831|FG001|Overall Study|Laboratory abnormality|0|||
124807338|NCT00474760|448924832|FG002|Overall Study|Laboratory abnormality|0|||
124807339|NCT00474760|448924833|FG003|Overall Study|Laboratory abnormality|0|||
124807340|NCT00474760|448924834|FG004|Overall Study|Laboratory abnormality|0|||
124807341|NCT00474760|448924835|FG005|Overall Study|Laboratory abnormality|1|||
124807342|NCT00474760|448924836|FG006|Overall Study|Laboratory abnormality|0|||
124807343|NCT00474760|448924830|FG000|Overall Study|Withdrawal by Subject|0|||
124807344|NCT00474760|448924831|FG001|Overall Study|Withdrawal by Subject|0|||
124807345|NCT00474760|448924832|FG002|Overall Study|Withdrawal by Subject|0|||
124807346|NCT00474760|448924833|FG003|Overall Study|Withdrawal by Subject|1|||
124807347|NCT00474760|448924834|FG004|Overall Study|Withdrawal by Subject|0|||
124807348|NCT00474760|448924835|FG005|Overall Study|Withdrawal by Subject|1|||
124807349|NCT00474760|448924836|FG006|Overall Study|Withdrawal by Subject|1|||
124807350|NCT00474760|448924830|FG000|Overall Study|Other|0|||
124807351|NCT00474760|448924831|FG001|Overall Study|Other|1|||
124807352|NCT00474760|448924832|FG002|Overall Study|Other|0|||
124807353|NCT00474760|448924833|FG003|Overall Study|Other|0|||
124807354|NCT00474760|448924834|FG004|Overall Study|Other|1|||
124807355|NCT00474760|448924835|FG005|Overall Study|Other|0|||
124807356|NCT00474760|448924836|FG006|Overall Study|Other|0|||
124807357|NCT00474760|448924830|FG000|Overall Study|Progressive disease|3|||
124807358|NCT00474760|448924831|FG001|Overall Study|Progressive disease|2|||
124807359|NCT00474760|448924832|FG002|Overall Study|Progressive disease|3|||
124807360|NCT00474760|448924833|FG003|Overall Study|Progressive disease|2|||
124807361|NCT00474760|448924834|FG004|Overall Study|Progressive disease|8|||
124807362|NCT00474760|448924835|FG005|Overall Study|Progressive disease|20|||
124807363|NCT00474760|448924836|FG006|Overall Study|Progressive disease|7|||
124807364|NCT00474760|448924830|FG000|Overall Study|Terminated by sponsor|0|||
124807365|NCT00474760|448924831|FG001|Overall Study|Terminated by sponsor|0|||
124807366|NCT00474760|448924832|FG002|Overall Study|Terminated by sponsor|0|||
124807367|NCT00474760|448924833|FG003|Overall Study|Terminated by sponsor|0|||
124807368|NCT00474760|448924834|FG004|Overall Study|Terminated by sponsor|0|||
124807369|NCT00474760|448924835|FG005|Overall Study|Terminated by sponsor|0|||
124807370|NCT00474760|448924836|FG006|Overall Study|Terminated by sponsor|2|||
124807371|NCT02155881|448924845|FG000|Overall Study|Withdrawal by Subject|0|||
124807372|NCT02155881|448924846|FG001|Overall Study|Withdrawal by Subject|2|||
124807373|NCT02155881|448924845|FG000|Overall Study|Inappropriately randomized|2|||
124807374|NCT02155881|448924846|FG001|Overall Study|Inappropriately randomized|2|||
124807375|NCT00066729|448924847|FG000|Overall Study|Lost to Follow-up|1|||
124807376|NCT00066729|448924847|FG000|Overall Study|Disease progression|1|||
124807377|NCT01811225|448924848|FG000|Treatment Period 1|Adverse Event|2|||
124807378|NCT01811225|448924849|FG001|Treatment Period 1|Adverse Event|3|||
124807379|NCT01811225|448924848|FG000|Treatment Period 1|Lost to Follow-up|12|||
124807380|NCT01811225|448924849|FG001|Treatment Period 1|Lost to Follow-up|8|||
124807381|NCT01811225|448924848|FG000|Treatment Period 1|transporation|1|||
124807382|NCT01811225|448924849|FG001|Treatment Period 1|transporation|0|||
124807383|NCT01811225|448924848|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
124807384|NCT01811225|448924849|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
124807385|NCT01811225|448924848|FG000|Treatment Period 2|Lost to Follow-up|1|||
124807386|NCT01811225|448924849|FG001|Treatment Period 2|Lost to Follow-up|2|||
124807387|NCT01811225|448924848|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
124807388|NCT01811225|448924849|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
124807389|NCT02158975|448924850|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
124807390|NCT02840721|448924853|FG000|Treatment Period|Adverse Event|1|||
124807391|NCT02840721|448924853|FG000|Follow-Up|Lack of Efficacy|1|||
124807392|NCT02840721|448924853|FG000|Follow-Up|Withdrawal by Subject|4|||
124807393|NCT02840721|448924853|FG000|Follow-Up|Withdrawal of Consent|2|||
124807394|NCT01967173|448924854|FG000|Overall Study|Lost to Follow-up|5|||
124807395|NCT01967173|448924855|FG001|Overall Study|Lost to Follow-up|3|||
124807396|NCT01967173|448924856|FG002|Overall Study|Lost to Follow-up|2|||
124807397|NCT01967173|448924857|FG003|Overall Study|Lost to Follow-up|4|||
124807398|NCT01967173|448924858|FG004|Overall Study|Lost to Follow-up|8|||
124807399|NCT01967173|448924859|FG005|Overall Study|Lost to Follow-up|12|||
124807400|NCT01967173|448924860|FG006|Overall Study|Lost to Follow-up|6|||
124807401|NCT01967173|448924861|FG007|Overall Study|Lost to Follow-up|8|||
124807402|NCT01967173|448924854|FG000|Overall Study|Physician Decision|2|||
124807403|NCT01967173|448924855|FG001|Overall Study|Physician Decision|0|||
124807404|NCT01967173|448924856|FG002|Overall Study|Physician Decision|2|||
124807405|NCT01967173|448924857|FG003|Overall Study|Physician Decision|1|||
124807406|NCT01967173|448924858|FG004|Overall Study|Physician Decision|1|||
124807407|NCT01967173|448924859|FG005|Overall Study|Physician Decision|1|||
124807408|NCT01967173|448924860|FG006|Overall Study|Physician Decision|1|||
124807409|NCT01967173|448924861|FG007|Overall Study|Physician Decision|0|||
124807410|NCT01967173|448924854|FG000|Overall Study|Lack of Efficacy|2|||
124807411|NCT01967173|448924855|FG001|Overall Study|Lack of Efficacy|0|||
124807412|NCT01967173|448924856|FG002|Overall Study|Lack of Efficacy|2|||
124807413|NCT01967173|448924857|FG003|Overall Study|Lack of Efficacy|2|||
124807414|NCT01967173|448924858|FG004|Overall Study|Lack of Efficacy|0|||
124807415|NCT01967173|448924859|FG005|Overall Study|Lack of Efficacy|1|||
124807416|NCT01967173|448924860|FG006|Overall Study|Lack of Efficacy|0|||
124807417|NCT01967173|448924861|FG007|Overall Study|Lack of Efficacy|2|||
124807418|NCT01967173|448924854|FG000|Overall Study|Pregnancy|0|||
124807419|NCT01967173|448924855|FG001|Overall Study|Pregnancy|0|||
124807420|NCT01967173|448924856|FG002|Overall Study|Pregnancy|0|||
124807421|NCT01967173|448924857|FG003|Overall Study|Pregnancy|0|||
124807422|NCT01967173|448924858|FG004|Overall Study|Pregnancy|0|||
124807423|NCT01967173|448924859|FG005|Overall Study|Pregnancy|0|||
124807424|NCT01967173|448924860|FG006|Overall Study|Pregnancy|1|||
124807425|NCT01967173|448924861|FG007|Overall Study|Pregnancy|1|||
124807426|NCT01967173|448924854|FG000|Overall Study|Adverse Event|0|||
124807427|NCT01967173|448924855|FG001|Overall Study|Adverse Event|0|||
124807428|NCT01967173|448924856|FG002|Overall Study|Adverse Event|0|||
124807429|NCT01967173|448924857|FG003|Overall Study|Adverse Event|0|||
124807430|NCT01967173|448924858|FG004|Overall Study|Adverse Event|0|||
124807431|NCT01967173|448924859|FG005|Overall Study|Adverse Event|0|||
124807432|NCT01967173|448924860|FG006|Overall Study|Adverse Event|0|||
124807433|NCT01967173|448924861|FG007|Overall Study|Adverse Event|1|||
124807434|NCT01967173|448924854|FG000|Overall Study|Withdrawal by Subject|15|||
124807435|NCT01967173|448924855|FG001|Overall Study|Withdrawal by Subject|14|||
124807436|NCT01967173|448924856|FG002|Overall Study|Withdrawal by Subject|10|||
124807437|NCT01967173|448924857|FG003|Overall Study|Withdrawal by Subject|7|||
124807438|NCT01967173|448924858|FG004|Overall Study|Withdrawal by Subject|8|||
124807439|NCT01967173|448924859|FG005|Overall Study|Withdrawal by Subject|9|||
124807440|NCT01967173|448924860|FG006|Overall Study|Withdrawal by Subject|10|||
124807441|NCT01967173|448924861|FG007|Overall Study|Withdrawal by Subject|12|||
124807442|NCT00423514|448924862|FG000|Overall Study|Ineligible|1|||
124807443|NCT00423514|448924863|FG001|Overall Study|Ineligible|0|||
124807444|NCT03685123|448924864|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
124807445|NCT03685123|448924865|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
124807446|NCT03685123|448924866|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
124807447|NCT03685123|448924864|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
124807448|NCT03685123|448924865|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
124807449|NCT03685123|448924866|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
124807450|NCT03685123|448924864|FG000|Weight Loss Phase|Lost to Follow-up|1|||
124807451|NCT03685123|448924865|FG001|Weight Loss Phase|Lost to Follow-up|0|||
124807452|NCT03685123|448924866|FG002|Weight Loss Phase|Lost to Follow-up|0|||
124807453|NCT03685123|448924864|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
124807454|NCT03685123|448924865|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
124807455|NCT03685123|448924866|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
124807456|NCT03685123|448924864|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
124807457|NCT03685123|448924865|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
124807458|NCT03685123|448924866|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
124807459|NCT03685123|448924864|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
124807460|NCT03685123|448924865|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
124807461|NCT03685123|448924866|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
124807462|NCT00400764|448924867|FG000|Phase Ib|Adverse Event|1|||
124807463|NCT00400764|448924868|FG001|Phase Ib|Adverse Event|0|||
124807464|NCT00400764|448924869|FG002|Phase Ib|Adverse Event|0|||
124807465|NCT00400764|448924870|FG003|Phase Ib|Adverse Event|0|||
124807466|NCT00400764|448924871|FG004|Phase Ib|Adverse Event|0|||
124807467|NCT00400764|448924867|FG000|Phase Ib|Death|1|||
124807468|NCT00400764|448924868|FG001|Phase Ib|Death|0|||
124807469|NCT00400764|448924869|FG002|Phase Ib|Death|0|||
124807470|NCT00400764|448924870|FG003|Phase Ib|Death|0|||
124807471|NCT00400764|448924871|FG004|Phase Ib|Death|0|||
124807472|NCT00400764|448924867|FG000|Phase Ib|Disease Progression|4|||
124807473|NCT00400764|448924868|FG001|Phase Ib|Disease Progression|4|||
124807474|NCT00400764|448924869|FG002|Phase Ib|Disease Progression|0|||
124807475|NCT00400764|448924870|FG003|Phase Ib|Disease Progression|0|||
124807476|NCT00400764|448924871|FG004|Phase Ib|Disease Progression|0|||
124807477|NCT00400764|448924867|FG000|Phase II|Death|0|||
124807478|NCT00400764|448924868|FG001|Phase II|Death|0|||
124807479|NCT00400764|448924869|FG002|Phase II|Death|1|||
124807480|NCT00400764|448924870|FG003|Phase II|Death|2|||
124807481|NCT00400764|448924871|FG004|Phase II|Death|0|||
124807482|NCT00400764|448924867|FG000|Phase II|Lost to Follow-up|0|||
124807483|NCT00400764|448924868|FG001|Phase II|Lost to Follow-up|0|||
124807484|NCT00400764|448924869|FG002|Phase II|Lost to Follow-up|1|||
124807485|NCT00400764|448924870|FG003|Phase II|Lost to Follow-up|0|||
124807486|NCT00400764|448924871|FG004|Phase II|Lost to Follow-up|0|||
124807487|NCT00400764|448924867|FG000|Phase II|Physician Decision|0|||
124807488|NCT00400764|448924868|FG001|Phase II|Physician Decision|0|||
124807489|NCT00400764|448924869|FG002|Phase II|Physician Decision|1|||
124807490|NCT00400764|448924870|FG003|Phase II|Physician Decision|1|||
124807491|NCT00400764|448924871|FG004|Phase II|Physician Decision|0|||
124807492|NCT00400764|448924867|FG000|Phase II|Sponsor's decision to terminate|0|||
124807493|NCT00400764|448924868|FG001|Phase II|Sponsor's decision to terminate|0|||
124807494|NCT00400764|448924869|FG002|Phase II|Sponsor's decision to terminate|18|||
124807495|NCT00400764|448924870|FG003|Phase II|Sponsor's decision to terminate|22|||
124807496|NCT00400764|448924871|FG004|Phase II|Sponsor's decision to terminate|11|||
124807497|NCT00400764|448924867|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
124807498|NCT00400764|448924868|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
124807499|NCT00400764|448924869|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
124807500|NCT00400764|448924870|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
124807501|NCT00400764|448924871|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
124807502|NCT00400764|448924867|FG000|Phase II|Withdrawal by Subject|0|||
124807503|NCT00400764|448924868|FG001|Phase II|Withdrawal by Subject|0|||
124807504|NCT00400764|448924869|FG002|Phase II|Withdrawal by Subject|1|||
124807505|NCT00400764|448924870|FG003|Phase II|Withdrawal by Subject|1|||
124807506|NCT00400764|448924871|FG004|Phase II|Withdrawal by Subject|0|||
124807507|NCT02628938|448924872|FG000|Overall Study|Did not attend the follow up recall|2|||
124807508|NCT02628938|448924873|FG001|Overall Study|Did not attend the follow up recall|2|||
124807509|NCT02628938|448924874|FG002|Overall Study|Did not attend the follow up recall|1|||
124807510|NCT02628938|448924872|FG000|Overall Study|Failure to comply with the instructions|3|||
124807511|NCT02628938|448924873|FG001|Overall Study|Failure to comply with the instructions|0|||
124807512|NCT02628938|448924874|FG002|Overall Study|Failure to comply with the instructions|3|||
124807513|NCT03113916|448924875|FG000|Overall Study|Withdrawal by Subject|9|||
124807514|NCT03113916|448924876|FG001|Overall Study|Withdrawal by Subject|7|||
124807515|NCT03113916|448924875|FG000|Overall Study|Pregnancy|1|||
124807516|NCT03113916|448924876|FG001|Overall Study|Pregnancy|3|||
124807517|NCT03113916|448924875|FG000|Overall Study|Lost to Follow-up|1|||
124807518|NCT03113916|448924876|FG001|Overall Study|Lost to Follow-up|2|||
124807519|NCT00241358|448924877|FG000|Overall Study|Determined to be not ineligible|0|||
124807520|NCT00241358|448924878|FG001|Overall Study|Determined to be not ineligible|1|||
124807521|NCT00241358|448924879|FG002|Overall Study|Determined to be not ineligible|1|||
124807522|NCT01758523|448924880|FG000|Overall Study|Adverse Event|2|||
124807523|NCT01758523|448924881|FG001|Overall Study|Adverse Event|1|||
124807524|NCT01758523|448924880|FG000|Overall Study|Lack of Efficacy|4|||
124807525|NCT01758523|448924881|FG001|Overall Study|Lack of Efficacy|2|||
124807526|NCT01758523|448924880|FG000|Overall Study|Lost to Follow-up|3|||
124807527|NCT01758523|448924881|FG001|Overall Study|Lost to Follow-up|4|||
124807528|NCT01758523|448924880|FG000|Overall Study|Withdrawal by Subject|12|||
124807529|NCT01758523|448924881|FG001|Overall Study|Withdrawal by Subject|7|||
124807530|NCT00621959|448924882|FG000|Overall Study|Adverse Event|4|||
124807531|NCT00621959|448924883|FG001|Overall Study|Adverse Event|2|||
124807532|NCT00621959|448924882|FG000|Overall Study|Lack of Efficacy|1|||
124807533|NCT00621959|448924883|FG001|Overall Study|Lack of Efficacy|1|||
124807534|NCT00621959|448924882|FG000|Overall Study|Lost to Follow-up|0|||
124807535|NCT00621959|448924883|FG001|Overall Study|Lost to Follow-up|2|||
124807536|NCT00621959|448924882|FG000|Overall Study|Withdrawal by Subject|1|||
124807537|NCT00621959|448924883|FG001|Overall Study|Withdrawal by Subject|1|||
124807538|NCT00621959|448924882|FG000|Overall Study|Other|1|||
124807539|NCT00621959|448924883|FG001|Overall Study|Other|3|||
124807540|NCT00590135|448924884|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
124807541|NCT03439657|448924885|FG000|Overall Study|Adverse Event|2|||
124807542|NCT03439657|448924886|FG001|Overall Study|Adverse Event|3|||
124807543|NCT03439657|448924885|FG000|Overall Study|Lost to Follow-up|1|||
124807544|NCT03439657|448924886|FG001|Overall Study|Lost to Follow-up|0|||
124807545|NCT03439657|448924885|FG000|Overall Study|Protocol Violation|1|||
124807546|NCT03439657|448924886|FG001|Overall Study|Protocol Violation|1|||
124807547|NCT03439657|448924885|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
124807548|NCT03439657|448924886|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
124807549|NCT04032652|448924889|FG000|Overall Study|The study was terminated and the PI has|1|||
124807550|NCT04032652|448924890|FG001|Overall Study|The study was terminated and the PI has|1|||
124807551|NCT00289016|448924893|FG000|Overall Study|Disease Progression|29|||
124807552|NCT00289016|448924893|FG000|Overall Study|Death|2|||
124807553|NCT00289016|448924893|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
124807554|NCT00289016|448924893|FG000|Overall Study|Withdrawal by Subject|2|||
124807555|NCT00289016|448924893|FG000|Overall Study|Adverse Event|1|||
124634137|NCT03318861|448276205|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
124634138|NCT03318861|448276206|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
124634139|NCT02275546|448276217|FG000|Treatment Period 2|Withdrawal by Subject|2|||
124634140|NCT02275546|448276218|FG001|Treatment Period 2|Withdrawal by Subject|1|||
124634141|NCT02275546|448276217|FG000|Treatment Period 2|Protocol Violation|0|||
124634142|NCT02275546|448276218|FG001|Treatment Period 2|Protocol Violation|1|||
124634143|NCT02955355|448276219|FG000|Overall Study|Adverse Event|4|||
124634144|NCT02955355|448276219|FG000|Overall Study|Death|1|||
124634145|NCT02955355|448276219|FG000|Overall Study|Physician Decision|21|||
124634146|NCT02955355|448276219|FG000|Overall Study|Site Terminated by Sponsor|35|||
124634147|NCT02955355|448276219|FG000|Overall Study|Withdrawal by Subject|19|||
124634148|NCT02955355|448276219|FG000|Overall Study|Reason Not Specified|5|||
124634149|NCT02612623|448276220|FG000|Overall Study|Withdrawal by Subject|0|||
124634150|NCT02612623|448276221|FG001|Overall Study|Withdrawal by Subject|1|||
124634151|NCT02612623|448276222|FG002|Overall Study|Withdrawal by Subject|0|||
124634152|NCT02612623|448276223|FG003|Overall Study|Withdrawal by Subject|0|||
124634153|NCT02612623|448276220|FG000|Overall Study|Adverse Event|1|||
124634154|NCT02612623|448276221|FG001|Overall Study|Adverse Event|0|||
124634155|NCT02612623|448276222|FG002|Overall Study|Adverse Event|1|||
124634156|NCT02612623|448276223|FG003|Overall Study|Adverse Event|0|||
124634157|NCT05177484|448276224|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
124634158|NCT05177484|448276225|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
124634159|NCT05177484|448276224|FG000|Overall Study|Inadvertently withdrawn|3|||
124634160|NCT05177484|448276225|FG001|Overall Study|Inadvertently withdrawn|1|||
124634161|NCT05177484|448276224|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
124634162|NCT05177484|448276225|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
124634163|NCT05486091|448276230|FG000|Overall Study|Withdrawal by Subject|1|||
124634164|NCT05486091|448276230|FG000|Overall Study|Lost to Follow-up|2|||
124634165|NCT01568892|448276231|FG000|Open-label Phase|Adverse Event|2|||
124634166|NCT01568892|448276232|FG001|Open-label Phase|Adverse Event|0|||
124634167|NCT01568892|448276231|FG000|Open-label Phase|Lack of Efficacy|4|||
124634168|NCT01568892|448276232|FG001|Open-label Phase|Lack of Efficacy|2|||
124634169|NCT01568892|448276231|FG000|Open-label Phase|Lost to Follow-up|0|||
124634170|NCT01568892|448276232|FG001|Open-label Phase|Lost to Follow-up|1|||
124634171|NCT01592786|448276240|FG000|Overall Study|Adverse Event|60|||
124634172|NCT01592786|448276240|FG000|Overall Study|Lack of Efficacy|19|||
124634173|NCT01592786|448276240|FG000|Overall Study|Protocol Violation|14|||
124634174|NCT01592786|448276240|FG000|Overall Study|Withdrawal by Subject|23|||
124634175|NCT01592786|448276240|FG000|Overall Study|Lost to Follow-up|19|||
124634176|NCT01592786|448276240|FG000|Overall Study|Other|3|||
124634177|NCT02172664|448276243|FG000|Overall Study|Lost to Follow-up|4|||
124634178|NCT02172664|448276244|FG001|Overall Study|Lost to Follow-up|4|||
124634179|NCT02172664|448276243|FG000|Overall Study|Death|1|||
124634180|NCT02172664|448276244|FG001|Overall Study|Death|1|||
124634181|NCT02172664|448276243|FG000|Overall Study|Moved out of area|1|||
124634182|NCT02172664|448276244|FG001|Overall Study|Moved out of area|1|||
124634183|NCT03810092|448276245|FG000|Overall Study|no ground support|17|||
124634184|NCT03810092|448276245|FG000|Overall Study|ADL not done at J0|16|||
124634185|NCT03810092|448276245|FG000|Overall Study|No hemoglobin measure at J5|27|||
124634186|NCT01139775|448276248|FG000|Overall Study|Adverse Event|0|||
124634187|NCT01139775|448276249|FG001|Overall Study|Adverse Event|6|||
124634188|NCT01139775|448276250|FG002|Overall Study|Adverse Event|2|||
124634189|NCT01139775|448276248|FG000|Overall Study|Protocol Violation|0|||
124634190|NCT01139775|448276249|FG001|Overall Study|Protocol Violation|5|||
124807556|NCT00289016|448924893|FG000|Overall Study|Other|1|||
124634191|NCT01139775|448276250|FG002|Overall Study|Protocol Violation|0|||
124634192|NCT01139775|448276248|FG000|Overall Study|Withdrawal by Subject|1|||
124634193|NCT01139775|448276249|FG001|Overall Study|Withdrawal by Subject|0|||
124634194|NCT01139775|448276250|FG002|Overall Study|Withdrawal by Subject|2|||
124634195|NCT01139775|448276248|FG000|Overall Study|Physician Decision|0|||
124634196|NCT01139775|448276249|FG001|Overall Study|Physician Decision|2|||
124634197|NCT01139775|448276250|FG002|Overall Study|Physician Decision|2|||
124807557|NCT02764697|448924894|FG000|Overall Study|Lack of Efficacy|3|||
124807558|NCT00302107|448924895|FG000|Overall Study|Lost to Follow-up|6|||
124807559|NCT00302107|448924896|FG001|Overall Study|Lost to Follow-up|5|||
124634198|NCT03193853|448276253|FG000|Overall Study|Death|6|||
124634199|NCT01956773|448276254|FG000|Overall Study|Lost to Follow-up|628|||
124634200|NCT01956773|448276255|FG001|Overall Study|Lost to Follow-up|1|||
124634201|NCT00450437|448276258|FG000|Overall Study|Withdrawal by Subject|10|||
124634202|NCT00450437|448276259|FG001|Overall Study|Withdrawal by Subject|2|||
124634203|NCT00450437|448276260|FG002|Overall Study|Withdrawal by Subject|0|||
124634204|NCT00450437|448276261|FG003|Overall Study|Withdrawal by Subject|1|||
124634205|NCT00450437|448276258|FG000|Overall Study|Lost to Follow-up|31|||
124634206|NCT00450437|448276259|FG001|Overall Study|Lost to Follow-up|12|||
124634207|NCT00450437|448276260|FG002|Overall Study|Lost to Follow-up|19|||
124634208|NCT00450437|448276261|FG003|Overall Study|Lost to Follow-up|9|||
124634209|NCT00450437|448276258|FG000|Overall Study|Protocol Violation|0|||
124634210|NCT00450437|448276259|FG001|Overall Study|Protocol Violation|1|||
124634211|NCT00450437|448276260|FG002|Overall Study|Protocol Violation|0|||
124634212|NCT00450437|448276261|FG003|Overall Study|Protocol Violation|1|||
124807560|NCT00302107|448924895|FG000|Overall Study|Protocol Violation|1|||
124807561|NCT00302107|448924896|FG001|Overall Study|Protocol Violation|0|||
124807562|NCT00302107|448924895|FG000|Overall Study|Relocation|0|||
124807563|NCT00302107|448924896|FG001|Overall Study|Relocation|1|||
124807564|NCT00302107|448924895|FG000|Overall Study|Withdrawal by Subject|0|||
124807565|NCT00302107|448924896|FG001|Overall Study|Withdrawal by Subject|3|||
124807566|NCT00302107|448924895|FG000|Overall Study|Adverse Event|1|||
124807567|NCT00302107|448924896|FG001|Overall Study|Adverse Event|0|||
124807568|NCT01790932|448924897|FG000|Overall Study|Disease Progression|41|||
124807569|NCT01790932|448924897|FG000|Overall Study|Adverse Event|7|||
124807570|NCT01790932|448924897|FG000|Overall Study|Physician Decision|1|||
124807571|NCT01790932|448924897|FG000|Overall Study|Withdrawal by Subject|1|||
124807572|NCT04223973|448924898|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
124807573|NCT04223973|448924899|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
124807574|NCT04223973|448924898|FG000|Overall Study|Adverse Event|4|||
124807575|NCT04223973|448924899|FG001|Overall Study|Adverse Event|0|||
124807576|NCT04223973|448924898|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
124807577|NCT04223973|448924899|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
124807578|NCT04223973|448924898|FG000|Overall Study|Physician Decision|1|||
124807579|NCT04223973|448924899|FG001|Overall Study|Physician Decision|1|||
124807580|NCT04223973|448924898|FG000|Overall Study|Withdrawal by Subject|0|||
124807581|NCT04223973|448924899|FG001|Overall Study|Withdrawal by Subject|1|||
124807582|NCT02612129|448924901|FG000|Single Dose Treatment Period|Screening Failure|1|||
124807583|NCT02612129|448924902|FG001|Single Dose Treatment Period|Screening Failure|0|||
124807584|NCT02612129|448924903|FG002|Single Dose Treatment Period|Screening Failure|0|||
124807585|NCT02612129|448924901|FG000|Continuous Treatment Period|Early Escape|0|||
124807586|NCT02612129|448924902|FG001|Continuous Treatment Period|Early Escape|2|||
124807587|NCT02612129|448924903|FG002|Continuous Treatment Period|Early Escape|0|||
124807588|NCT02612129|448924901|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
124807589|NCT02612129|448924902|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
124807590|NCT02612129|448924903|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
124807591|NCT02612129|448924901|FG000|Continuous Treatment Period|Safety Reasons|0|||
124807592|NCT02612129|448924902|FG001|Continuous Treatment Period|Safety Reasons|3|||
124807593|NCT02612129|448924903|FG002|Continuous Treatment Period|Safety Reasons|0|||
124807594|NCT02612129|448924901|FG000|Continuous Treatment Period|Death|0|||
124807595|NCT02612129|448924902|FG001|Continuous Treatment Period|Death|1|||
124807596|NCT02612129|448924903|FG002|Continuous Treatment Period|Death|0|||
124807597|NCT02612129|448924901|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
124807598|NCT02612129|448924902|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
124807599|NCT02612129|448924903|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
124807600|NCT00531934|448927203|FG000|Overall Study|Adverse Event|4|||
124807601|NCT00531934|448927204|FG001|Overall Study|Adverse Event|8|||
124807602|NCT00531934|448927203|FG000|Overall Study|Progression|52|||
124807603|NCT00531934|448927204|FG001|Overall Study|Progression|42|||
124634213|NCT00450437|448276258|FG000|Overall Study|Inappropriate enrollment|4|||
124634214|NCT00450437|448276259|FG001|Overall Study|Inappropriate enrollment|1|||
124634215|NCT00450437|448276260|FG002|Overall Study|Inappropriate enrollment|3|||
124807604|NCT00531934|448927203|FG000|Overall Study|Death|7|||
124634216|NCT00450437|448276261|FG003|Overall Study|Inappropriate enrollment|0|||
124634217|NCT00450437|448276258|FG000|Overall Study|Administrative reason|0|||
124634218|NCT00450437|448276259|FG001|Overall Study|Administrative reason|0|||
124634219|NCT00450437|448276260|FG002|Overall Study|Administrative reason|1|||
124634220|NCT00450437|448276261|FG003|Overall Study|Administrative reason|0|||
124634221|NCT00450437|448276258|FG000|Overall Study|Unable to Classify|1|||
124634222|NCT00450437|448276259|FG001|Overall Study|Unable to Classify|0|||
124634223|NCT00450437|448276260|FG002|Overall Study|Unable to Classify|1|||
124634224|NCT00450437|448276261|FG003|Overall Study|Unable to Classify|0|||
124807605|NCT00531934|448927204|FG001|Overall Study|Death|10|||
124807606|NCT00531934|448927203|FG000|Overall Study|Withdrawal by Subject|1|||
124807607|NCT00531934|448927204|FG001|Overall Study|Withdrawal by Subject|1|||
124807608|NCT00531934|448927203|FG000|Overall Study|Other|2|||
124807609|NCT00531934|448927204|FG001|Overall Study|Other|2|||
124807610|NCT01543698|448927209|FG000|Phase 1b|Disease progression|2|||
124807611|NCT01543698|448927210|FG001|Phase 1b|Disease progression|4|||
124807612|NCT01543698|448927211|FG002|Phase 1b|Disease progression|3|||
124807613|NCT01543698|448927212|FG003|Phase 1b|Disease progression|2|||
124807614|NCT01543698|448927213|FG004|Phase 1b|Disease progression|10|||
124807615|NCT01543698|448927214|FG005|Phase 1b|Disease progression|6|||
124807616|NCT01543698|448927215|FG006|Phase 1b|Disease progression|5|||
124807617|NCT01543698|448927216|FG007|Phase 1b|Disease progression|3|||
124807618|NCT01543698|448927217|FG008|Phase 1b|Disease progression|4|||
124807619|NCT01543698|448927218|FG009|Phase 1b|Disease progression|5|||
124807620|NCT01543698|448927219|FG010|Phase 1b|Disease progression|1|||
124807621|NCT01543698|448927220|FG011|Phase 1b|Disease progression|0|||
124807622|NCT01543698|448927221|FG012|Phase 1b|Disease progression|0|||
124807623|NCT01543698|448927222|FG013|Phase 1b|Disease progression|0|||
124807624|NCT01543698|448927223|FG014|Phase 1b|Disease progression|0|||
124807625|NCT01543698|448927209|FG000|Phase 1b|Death|0|||
124807626|NCT01543698|448927210|FG001|Phase 1b|Death|0|||
124807627|NCT01543698|448927211|FG002|Phase 1b|Death|1|||
124807628|NCT01543698|448927212|FG003|Phase 1b|Death|1|||
124807629|NCT01543698|448927213|FG004|Phase 1b|Death|0|||
124807630|NCT01543698|448927214|FG005|Phase 1b|Death|0|||
124807631|NCT01543698|448927215|FG006|Phase 1b|Death|0|||
124807632|NCT01543698|448927216|FG007|Phase 1b|Death|0|||
124807633|NCT01543698|448927217|FG008|Phase 1b|Death|0|||
124807634|NCT01543698|448927218|FG009|Phase 1b|Death|0|||
124807635|NCT01543698|448927219|FG010|Phase 1b|Death|1|||
124807636|NCT01543698|448927220|FG011|Phase 1b|Death|0|||
124807637|NCT01543698|448927221|FG012|Phase 1b|Death|0|||
124807638|NCT01543698|448927222|FG013|Phase 1b|Death|0|||
124807639|NCT01543698|448927223|FG014|Phase 1b|Death|0|||
124807640|NCT01543698|448927209|FG000|Phase 1b|Withdrawal by Subject|0|||
124807641|NCT01543698|448927210|FG001|Phase 1b|Withdrawal by Subject|1|||
124807642|NCT01543698|448927211|FG002|Phase 1b|Withdrawal by Subject|0|||
124807643|NCT01543698|448927212|FG003|Phase 1b|Withdrawal by Subject|1|||
124807644|NCT01543698|448927213|FG004|Phase 1b|Withdrawal by Subject|0|||
124807645|NCT01543698|448927214|FG005|Phase 1b|Withdrawal by Subject|0|||
124807646|NCT01543698|448927215|FG006|Phase 1b|Withdrawal by Subject|1|||
124807647|NCT01543698|448927216|FG007|Phase 1b|Withdrawal by Subject|0|||
124807648|NCT01543698|448927217|FG008|Phase 1b|Withdrawal by Subject|0|||
124807649|NCT01543698|448927218|FG009|Phase 1b|Withdrawal by Subject|0|||
124807650|NCT01543698|448927219|FG010|Phase 1b|Withdrawal by Subject|0|||
124807651|NCT01543698|448927220|FG011|Phase 1b|Withdrawal by Subject|0|||
124807652|NCT01543698|448927221|FG012|Phase 1b|Withdrawal by Subject|0|||
124807653|NCT01543698|448927222|FG013|Phase 1b|Withdrawal by Subject|0|||
124807654|NCT01543698|448927223|FG014|Phase 1b|Withdrawal by Subject|0|||
124807655|NCT01543698|448927209|FG000|Phase 1b|Adverse Event|1|||
124807656|NCT01543698|448927210|FG001|Phase 1b|Adverse Event|0|||
124807657|NCT01543698|448927211|FG002|Phase 1b|Adverse Event|0|||
124807658|NCT01543698|448927212|FG003|Phase 1b|Adverse Event|1|||
124807659|NCT01543698|448927213|FG004|Phase 1b|Adverse Event|2|||
124807660|NCT01543698|448927214|FG005|Phase 1b|Adverse Event|2|||
124807661|NCT01543698|448927215|FG006|Phase 1b|Adverse Event|0|||
124807662|NCT01543698|448927216|FG007|Phase 1b|Adverse Event|0|||
124807663|NCT01543698|448927217|FG008|Phase 1b|Adverse Event|1|||
124807664|NCT01543698|448927218|FG009|Phase 1b|Adverse Event|1|||
124807665|NCT01543698|448927219|FG010|Phase 1b|Adverse Event|2|||
124807666|NCT01543698|448927220|FG011|Phase 1b|Adverse Event|0|||
124807667|NCT01543698|448927221|FG012|Phase 1b|Adverse Event|0|||
124807668|NCT01543698|448927222|FG013|Phase 1b|Adverse Event|0|||
124807669|NCT01543698|448927223|FG014|Phase 1b|Adverse Event|0|||
124807670|NCT01543698|448927209|FG000|Phase 1b|Administrative problems|1|||
124807671|NCT01543698|448927210|FG001|Phase 1b|Administrative problems|0|||
124807672|NCT01543698|448927211|FG002|Phase 1b|Administrative problems|0|||
124807673|NCT01543698|448927212|FG003|Phase 1b|Administrative problems|0|||
124807674|NCT01543698|448927213|FG004|Phase 1b|Administrative problems|1|||
124807675|NCT01543698|448927214|FG005|Phase 1b|Administrative problems|0|||
124807676|NCT01543698|448927215|FG006|Phase 1b|Administrative problems|0|||
124807677|NCT01543698|448927216|FG007|Phase 1b|Administrative problems|1|||
124807678|NCT01543698|448927217|FG008|Phase 1b|Administrative problems|0|||
124807679|NCT01543698|448927218|FG009|Phase 1b|Administrative problems|0|||
124807680|NCT01543698|448927219|FG010|Phase 1b|Administrative problems|2|||
124807681|NCT01543698|448927220|FG011|Phase 1b|Administrative problems|0|||
124807682|NCT01543698|448927221|FG012|Phase 1b|Administrative problems|0|||
124807683|NCT01543698|448927222|FG013|Phase 1b|Administrative problems|0|||
124807684|NCT01543698|448927223|FG014|Phase 1b|Administrative problems|0|||
124807685|NCT01543698|448927209|FG000|Phase 1b|Protocol Violation|2|||
124807686|NCT01543698|448927210|FG001|Phase 1b|Protocol Violation|0|||
124807687|NCT01543698|448927211|FG002|Phase 1b|Protocol Violation|0|||
124807688|NCT01543698|448927212|FG003|Phase 1b|Protocol Violation|0|||
124807689|NCT01543698|448927213|FG004|Phase 1b|Protocol Violation|0|||
124807690|NCT01543698|448927214|FG005|Phase 1b|Protocol Violation|0|||
124807691|NCT01543698|448927215|FG006|Phase 1b|Protocol Violation|0|||
124807692|NCT01543698|448927216|FG007|Phase 1b|Protocol Violation|0|||
124807693|NCT01543698|448927217|FG008|Phase 1b|Protocol Violation|0|||
124807694|NCT01543698|448927218|FG009|Phase 1b|Protocol Violation|0|||
124807695|NCT01543698|448927219|FG010|Phase 1b|Protocol Violation|0|||
124807696|NCT01543698|448927220|FG011|Phase 1b|Protocol Violation|0|||
124807697|NCT01543698|448927221|FG012|Phase 1b|Protocol Violation|0|||
124807698|NCT01543698|448927222|FG013|Phase 1b|Protocol Violation|0|||
124807699|NCT01543698|448927223|FG014|Phase 1b|Protocol Violation|0|||
124807700|NCT01543698|448927209|FG000|Phase 2|Protocol Violation|0|||
124807701|NCT01543698|448927210|FG001|Phase 2|Protocol Violation|0|||
124807702|NCT01543698|448927211|FG002|Phase 2|Protocol Violation|0|||
124807703|NCT01543698|448927212|FG003|Phase 2|Protocol Violation|0|||
124807704|NCT01543698|448927213|FG004|Phase 2|Protocol Violation|0|||
124807705|NCT01543698|448927214|FG005|Phase 2|Protocol Violation|0|||
124807706|NCT01543698|448927215|FG006|Phase 2|Protocol Violation|0|||
124807707|NCT01543698|448927216|FG007|Phase 2|Protocol Violation|0|||
124807708|NCT01543698|448927217|FG008|Phase 2|Protocol Violation|0|||
124807709|NCT01543698|448927218|FG009|Phase 2|Protocol Violation|0|||
124807710|NCT01543698|448927219|FG010|Phase 2|Protocol Violation|0|||
124807711|NCT01543698|448927220|FG011|Phase 2|Protocol Violation|0|||
124807712|NCT01543698|448927221|FG012|Phase 2|Protocol Violation|1|||
124807713|NCT01543698|448927222|FG013|Phase 2|Protocol Violation|0|||
124807714|NCT01543698|448927223|FG014|Phase 2|Protocol Violation|0|||
124807715|NCT01543698|448927209|FG000|Phase 2|Disease progression|0|||
124807716|NCT01543698|448927210|FG001|Phase 2|Disease progression|0|||
124807717|NCT01543698|448927211|FG002|Phase 2|Disease progression|0|||
124807718|NCT01543698|448927212|FG003|Phase 2|Disease progression|0|||
124807719|NCT01543698|448927213|FG004|Phase 2|Disease progression|0|||
124807720|NCT01543698|448927214|FG005|Phase 2|Disease progression|0|||
124807721|NCT01543698|448927215|FG006|Phase 2|Disease progression|0|||
124807722|NCT01543698|448927216|FG007|Phase 2|Disease progression|0|||
124807723|NCT01543698|448927217|FG008|Phase 2|Disease progression|0|||
124807724|NCT01543698|448927218|FG009|Phase 2|Disease progression|0|||
124807725|NCT01543698|448927219|FG010|Phase 2|Disease progression|0|||
124807726|NCT01543698|448927220|FG011|Phase 2|Disease progression|10|||
124807727|NCT01543698|448927221|FG012|Phase 2|Disease progression|21|||
124807728|NCT01543698|448927222|FG013|Phase 2|Disease progression|30|||
124807729|NCT01543698|448927223|FG014|Phase 2|Disease progression|25|||
124807730|NCT01543698|448927209|FG000|Phase 2|Death|0|||
124807731|NCT01543698|448927210|FG001|Phase 2|Death|0|||
124807732|NCT01543698|448927211|FG002|Phase 2|Death|0|||
124807733|NCT01543698|448927212|FG003|Phase 2|Death|0|||
124807734|NCT01543698|448927213|FG004|Phase 2|Death|0|||
124807735|NCT01543698|448927214|FG005|Phase 2|Death|0|||
124807736|NCT01543698|448927215|FG006|Phase 2|Death|0|||
124807737|NCT01543698|448927216|FG007|Phase 2|Death|0|||
124807738|NCT01543698|448927217|FG008|Phase 2|Death|0|||
124807739|NCT01543698|448927218|FG009|Phase 2|Death|0|||
124807740|NCT01543698|448927219|FG010|Phase 2|Death|0|||
124807741|NCT01543698|448927220|FG011|Phase 2|Death|0|||
124807742|NCT01543698|448927221|FG012|Phase 2|Death|1|||
124807743|NCT01543698|448927222|FG013|Phase 2|Death|1|||
124807744|NCT01543698|448927223|FG014|Phase 2|Death|1|||
124807745|NCT01543698|448927209|FG000|Phase 2|Administrative problems|0|||
124807746|NCT01543698|448927210|FG001|Phase 2|Administrative problems|0|||
124807747|NCT01543698|448927211|FG002|Phase 2|Administrative problems|0|||
124807748|NCT01543698|448927212|FG003|Phase 2|Administrative problems|0|||
124807749|NCT01543698|448927213|FG004|Phase 2|Administrative problems|0|||
124807750|NCT01543698|448927214|FG005|Phase 2|Administrative problems|0|||
124807751|NCT01543698|448927215|FG006|Phase 2|Administrative problems|0|||
124807752|NCT01543698|448927216|FG007|Phase 2|Administrative problems|0|||
124807753|NCT01543698|448927217|FG008|Phase 2|Administrative problems|0|||
124807754|NCT01543698|448927218|FG009|Phase 2|Administrative problems|0|||
124634225|NCT02492867|448276262|FG000|Overall Study|Alternate therapy|1|||
124807755|NCT01543698|448927219|FG010|Phase 2|Administrative problems|0|||
124807756|NCT01543698|448927220|FG011|Phase 2|Administrative problems|0|||
124807757|NCT01543698|448927221|FG012|Phase 2|Administrative problems|0|||
124807758|NCT01543698|448927222|FG013|Phase 2|Administrative problems|3|||
124807759|NCT01543698|448927223|FG014|Phase 2|Administrative problems|1|||
124807760|NCT01543698|448927209|FG000|Phase 2|Withdrawal by Subject|0|||
124807761|NCT01543698|448927210|FG001|Phase 2|Withdrawal by Subject|0|||
124807762|NCT01543698|448927211|FG002|Phase 2|Withdrawal by Subject|0|||
124807763|NCT01543698|448927212|FG003|Phase 2|Withdrawal by Subject|0|||
124807764|NCT01543698|448927213|FG004|Phase 2|Withdrawal by Subject|0|||
124807765|NCT01543698|448927214|FG005|Phase 2|Withdrawal by Subject|0|||
124807766|NCT01543698|448927215|FG006|Phase 2|Withdrawal by Subject|0|||
124807767|NCT01543698|448927216|FG007|Phase 2|Withdrawal by Subject|0|||
124807768|NCT01543698|448927217|FG008|Phase 2|Withdrawal by Subject|0|||
124807769|NCT01543698|448927218|FG009|Phase 2|Withdrawal by Subject|0|||
124807770|NCT01543698|448927219|FG010|Phase 2|Withdrawal by Subject|0|||
124807771|NCT01543698|448927220|FG011|Phase 2|Withdrawal by Subject|0|||
124807772|NCT01543698|448927221|FG012|Phase 2|Withdrawal by Subject|0|||
124807773|NCT01543698|448927222|FG013|Phase 2|Withdrawal by Subject|3|||
124807774|NCT01543698|448927223|FG014|Phase 2|Withdrawal by Subject|1|||
124807775|NCT01543698|448927209|FG000|Phase 2|Adverse Event|0|||
124807776|NCT01543698|448927210|FG001|Phase 2|Adverse Event|0|||
124807777|NCT01543698|448927211|FG002|Phase 2|Adverse Event|0|||
124807778|NCT01543698|448927212|FG003|Phase 2|Adverse Event|0|||
124807779|NCT01543698|448927213|FG004|Phase 2|Adverse Event|0|||
124807780|NCT01543698|448927214|FG005|Phase 2|Adverse Event|0|||
124807781|NCT01543698|448927215|FG006|Phase 2|Adverse Event|0|||
124807782|NCT01543698|448927216|FG007|Phase 2|Adverse Event|0|||
124807783|NCT01543698|448927217|FG008|Phase 2|Adverse Event|0|||
124807784|NCT01543698|448927218|FG009|Phase 2|Adverse Event|0|||
124807785|NCT01543698|448927219|FG010|Phase 2|Adverse Event|0|||
124807786|NCT01543698|448927220|FG011|Phase 2|Adverse Event|1|||
124807787|NCT01543698|448927221|FG012|Phase 2|Adverse Event|3|||
124807788|NCT01543698|448927222|FG013|Phase 2|Adverse Event|5|||
124807789|NCT01543698|448927223|FG014|Phase 2|Adverse Event|14|||
124807790|NCT00150709|448927224|FG000|Overall Study|Protocol Violation|7|||
124807791|NCT00150709|448927225|FG001|Overall Study|Protocol Violation|8|||
124807792|NCT00150709|448927226|FG002|Overall Study|Protocol Violation|3|||
124807793|NCT00150709|448927227|FG003|Overall Study|Protocol Violation|1|||
124807794|NCT00150709|448927224|FG000|Overall Study|Adverse Event|8|||
124807795|NCT00150709|448927225|FG001|Overall Study|Adverse Event|2|||
124807796|NCT00150709|448927226|FG002|Overall Study|Adverse Event|2|||
124807797|NCT00150709|448927227|FG003|Overall Study|Adverse Event|3|||
124807798|NCT00150709|448927224|FG000|Overall Study|Lack of Efficacy|6|||
124807799|NCT00150709|448927225|FG001|Overall Study|Lack of Efficacy|11|||
124807800|NCT00150709|448927226|FG002|Overall Study|Lack of Efficacy|9|||
124807801|NCT00150709|448927227|FG003|Overall Study|Lack of Efficacy|0|||
124807802|NCT00150709|448927224|FG000|Overall Study|Withdrawal by Subject|7|||
124807803|NCT00150709|448927225|FG001|Overall Study|Withdrawal by Subject|10|||
124807804|NCT00150709|448927226|FG002|Overall Study|Withdrawal by Subject|5|||
124807805|NCT00150709|448927227|FG003|Overall Study|Withdrawal by Subject|0|||
124807806|NCT00150709|448927224|FG000|Overall Study|Lost to Follow-up|3|||
124807807|NCT00150709|448927225|FG001|Overall Study|Lost to Follow-up|2|||
124807808|NCT00150709|448927226|FG002|Overall Study|Lost to Follow-up|0|||
124807809|NCT00150709|448927227|FG003|Overall Study|Lost to Follow-up|0|||
124807810|NCT00150709|448927224|FG000|Overall Study|Sponsor decision|0|||
124807811|NCT00150709|448927225|FG001|Overall Study|Sponsor decision|0|||
124807812|NCT00150709|448927226|FG002|Overall Study|Sponsor decision|0|||
124807813|NCT00150709|448927227|FG003|Overall Study|Sponsor decision|1|||
124807814|NCT00150709|448927224|FG000|Overall Study|Site/Investigator discontinued the study|5|||
124807815|NCT00150709|448927225|FG001|Overall Study|Site/Investigator discontinued the study|5|||
124807816|NCT00150709|448927226|FG002|Overall Study|Site/Investigator discontinued the study|2|||
124807817|NCT00150709|448927227|FG003|Overall Study|Site/Investigator discontinued the study|0|||
124807818|NCT00150709|448927224|FG000|Overall Study|Decision of parent(s)|1|||
124807819|NCT00150709|448927225|FG001|Overall Study|Decision of parent(s)|2|||
124807820|NCT00150709|448927226|FG002|Overall Study|Decision of parent(s)|0|||
124807821|NCT00150709|448927227|FG003|Overall Study|Decision of parent(s)|0|||
124807822|NCT00150709|448927224|FG000|Overall Study|Decision of parent(s) and investigator|3|||
124807823|NCT00150709|448927225|FG001|Overall Study|Decision of parent(s) and investigator|0|||
124807824|NCT00150709|448927226|FG002|Overall Study|Decision of parent(s) and investigator|0|||
124807825|NCT00150709|448927227|FG003|Overall Study|Decision of parent(s) and investigator|0|||
124807826|NCT00150709|448927224|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
124807827|NCT00150709|448927225|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
124807828|NCT00150709|448927226|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
124807829|NCT00150709|448927227|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
124807830|NCT00150709|448927224|FG000|Overall Study|Investigator decision|1|||
124807831|NCT00150709|448927225|FG001|Overall Study|Investigator decision|0|||
124807832|NCT00150709|448927226|FG002|Overall Study|Investigator decision|0|||
124807833|NCT00150709|448927227|FG003|Overall Study|Investigator decision|1|||
124807834|NCT00150709|448927224|FG000|Overall Study|Subject relocated|2|||
124807835|NCT00150709|448927225|FG001|Overall Study|Subject relocated|2|||
124807836|NCT00150709|448927226|FG002|Overall Study|Subject relocated|1|||
124807837|NCT00150709|448927227|FG003|Overall Study|Subject relocated|0|||
124807838|NCT00150709|448927224|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
124807839|NCT00150709|448927225|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
124807840|NCT00150709|448927226|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
124807841|NCT00150709|448927227|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
124634226|NCT02492867|448276262|FG000|Overall Study|Withdrawal by Subject|2|||
124807842|NCT00150709|448927224|FG000|Overall Study|Convenience|0|||
124807843|NCT00150709|448927225|FG001|Overall Study|Convenience|1|||
124807844|NCT00150709|448927226|FG002|Overall Study|Convenience|0|||
124634227|NCT02492867|448276262|FG000|Overall Study|Disease progression after treatment started|1|||
124807845|NCT00150709|448927227|FG003|Overall Study|Convenience|0|||
124807846|NCT00150709|448927224|FG000|Overall Study|Subject entered new drug study|0|||
124807847|NCT00150709|448927225|FG001|Overall Study|Subject entered new drug study|1|||
124807848|NCT00150709|448927226|FG002|Overall Study|Subject entered new drug study|0|||
124807849|NCT00150709|448927227|FG003|Overall Study|Subject entered new drug study|0|||
124807850|NCT00150709|448927224|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
124807851|NCT00150709|448927225|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
124807852|NCT00150709|448927226|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
124807853|NCT00150709|448927227|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
124807854|NCT00150709|448927224|FG000|Overall Study|Lack of ease of swallowing|0|||
124807855|NCT00150709|448927225|FG001|Overall Study|Lack of ease of swallowing|1|||
124807856|NCT00150709|448927226|FG002|Overall Study|Lack of ease of swallowing|0|||
124807857|NCT00150709|448927227|FG003|Overall Study|Lack of ease of swallowing|0|||
124807858|NCT02975336|448927228|FG000|DBPC (52 Weeks)|Adverse Event|16|||
124807859|NCT02975336|448927229|FG001|DBPC (52 Weeks)|Adverse Event|17|||
124807860|NCT02975336|448927230|FG002|DBPC (52 Weeks)|Adverse Event|13|||
124807861|NCT02975336|448927231|FG003|DBPC (52 Weeks)|Adverse Event|18|||
124807862|NCT02975336|448927232|FG004|DBPC (52 Weeks)|Adverse Event|0|||
124807863|NCT02975336|448927233|FG005|DBPC (52 Weeks)|Adverse Event|0|||
124807864|NCT02975336|448927234|FG006|DBPC (52 Weeks)|Adverse Event|0|||
124807865|NCT02975336|448927235|FG007|DBPC (52 Weeks)|Adverse Event|0|||
124807866|NCT02975336|448927228|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
124807867|NCT02975336|448927229|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
124807868|NCT02975336|448927230|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
124807869|NCT02975336|448927231|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
124807870|NCT02975336|448927232|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
124807871|NCT02975336|448927233|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
124807872|NCT02975336|448927234|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
124807873|NCT02975336|448927235|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
124807874|NCT02975336|448927228|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
124807875|NCT02975336|448927229|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
124807876|NCT02975336|448927230|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
124807877|NCT02975336|448927231|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
124807878|NCT02975336|448927232|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
124807879|NCT02975336|448927233|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
124807880|NCT02975336|448927234|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
124807881|NCT02975336|448927235|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
124807882|NCT02975336|448927228|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
124807883|NCT02975336|448927229|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
124807884|NCT02975336|448927230|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
124807885|NCT02975336|448927231|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
124807886|NCT02975336|448927232|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
124807887|NCT02975336|448927233|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
124807888|NCT02975336|448927234|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
124807889|NCT02975336|448927235|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
124807890|NCT02975336|448927228|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
124807891|NCT02975336|448927229|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
124807892|NCT02975336|448927230|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
124807893|NCT02975336|448927231|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
124807894|NCT02975336|448927232|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
124807895|NCT02975336|448927233|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
124807896|NCT02975336|448927234|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
124807897|NCT02975336|448927235|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
124807898|NCT02975336|448927228|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
124807899|NCT02975336|448927229|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
124807900|NCT02975336|448927230|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
124807901|NCT02975336|448927231|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
124807902|NCT02975336|448927232|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
124807903|NCT02975336|448927233|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
124807904|NCT02975336|448927234|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
124807905|NCT02975336|448927235|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
124807906|NCT02975336|448927228|FG000|LTE (104 Weeks)|Adverse Event|0|||
124807907|NCT02975336|448927229|FG001|LTE (104 Weeks)|Adverse Event|0|||
124807908|NCT02975336|448927230|FG002|LTE (104 Weeks)|Adverse Event|0|||
124807909|NCT02975336|448927231|FG003|LTE (104 Weeks)|Adverse Event|0|||
124807910|NCT02975336|448927232|FG004|LTE (104 Weeks)|Adverse Event|7|||
124807911|NCT02975336|448927233|FG005|LTE (104 Weeks)|Adverse Event|4|||
124807912|NCT02975336|448927234|FG006|LTE (104 Weeks)|Adverse Event|2|||
124807913|NCT02975336|448927235|FG007|LTE (104 Weeks)|Adverse Event|0|||
124807914|NCT02975336|448927228|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
124807915|NCT02975336|448927229|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
124807916|NCT02975336|448927230|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
124807917|NCT02975336|448927231|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
124807918|NCT02975336|448927232|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
124807919|NCT02975336|448927233|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
124807920|NCT02975336|448927234|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
124807921|NCT02975336|448927235|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
124807922|NCT02975336|448927228|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
124807923|NCT02975336|448927229|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
124807924|NCT02975336|448927230|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
124807925|NCT02975336|448927231|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
124807926|NCT02975336|448927232|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
124807927|NCT02975336|448927233|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
124807928|NCT02975336|448927234|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
124807929|NCT02975336|448927235|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
124807930|NCT02975336|448927228|FG000|LTE (104 Weeks)|Other|0|||
124807931|NCT02975336|448927229|FG001|LTE (104 Weeks)|Other|0|||
124807932|NCT02975336|448927230|FG002|LTE (104 Weeks)|Other|0|||
124807933|NCT02975336|448927231|FG003|LTE (104 Weeks)|Other|0|||
124807934|NCT02975336|448927232|FG004|LTE (104 Weeks)|Other|55|||
124807935|NCT02975336|448927233|FG005|LTE (104 Weeks)|Other|63|||
124807936|NCT02975336|448927234|FG006|LTE (104 Weeks)|Other|76|||
124807937|NCT02975336|448927235|FG007|LTE (104 Weeks)|Other|72|||
124807938|NCT03650556|448927236|FG000|Overall Study|Death|2|||
124807939|NCT03650556|448927236|FG000|Overall Study|Withdrawal by Subject|20|||
124807940|NCT03650556|448927236|FG000|Overall Study|Physician Decision|2|||
124807941|NCT03650556|448927236|FG000|Overall Study|Lost to Follow-up|8|||
124807942|NCT03650556|448927236|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
124807943|NCT03650556|448927236|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
124807944|NCT00691301|448927237|FG000|Overall Study|Adverse Event|10|||
124807945|NCT00691301|448927237|FG000|Overall Study|Death|2|||
124807946|NCT00691301|448927237|FG000|Overall Study|Lack of Efficacy|32|||
124807947|NCT00691301|448927237|FG000|Overall Study|Withdrawal by Subject|4|||
124807948|NCT00691301|448927237|FG000|Overall Study|Concurrent illness|2|||
124807949|NCT00691301|448927237|FG000|Overall Study|other reason|3|||
124807950|NCT00691301|448927237|FG000|Overall Study|Did not initiate study treatment|1|||
124807951|NCT01823146|448927238|FG000|Overall Study|Withdrawal by Subject|0|||
124807952|NCT01823146|448927239|FG001|Overall Study|Withdrawal by Subject|1|||
124807953|NCT01823146|448927238|FG000|Overall Study|Lost to Follow-up|2|||
124807954|NCT01823146|448927239|FG001|Overall Study|Lost to Follow-up|1|||
124807955|NCT00463580|448927240|FG000|Overall Study|Lost to Follow-up|1|||
124807956|NCT00463580|448927241|FG001|Overall Study|Lost to Follow-up|0|||
124807957|NCT00463580|448927240|FG000|Overall Study|Schedule conflict|2|||
124807958|NCT00463580|448927241|FG001|Overall Study|Schedule conflict|0|||
124807959|NCT00463580|448927240|FG000|Overall Study|Medical/psychiatric complications|0|||
124807960|NCT00463580|448927241|FG001|Overall Study|Medical/psychiatric complications|2|||
124807961|NCT03917459|448927242|FG000|Overall Study|Adverse Event|1|||
124807962|NCT03917459|448927243|FG001|Overall Study|Adverse Event|0|||
124807963|NCT03917459|448927242|FG000|Overall Study|Withdrawal by Subject|0|||
124807964|NCT03917459|448927243|FG001|Overall Study|Withdrawal by Subject|1|||
124807965|NCT00075218|448927244|FG000|Double-Blind Treatment|Adverse Event|23|||
124807966|NCT00075218|448927245|FG001|Double-Blind Treatment|Adverse Event|4|||
124807967|NCT00075218|448927246|FG002|Double-Blind Treatment|Adverse Event|0|||
124807968|NCT00075218|448927244|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
124807969|NCT00075218|448927245|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
124807970|NCT00075218|448927246|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
124807971|NCT00075218|448927244|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
124807972|NCT00075218|448927245|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
124807973|NCT00075218|448927246|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
124807974|NCT00075218|448927244|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
124807975|NCT00075218|448927245|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
124807976|NCT00075218|448927246|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
124807977|NCT00075218|448927244|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
124807978|NCT00075218|448927245|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
124807979|NCT00075218|448927246|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
124807980|NCT00075218|448927244|FG000|Double-Blind Treatment|No study medication taken|2|||
124807981|NCT00075218|448927245|FG001|Double-Blind Treatment|No study medication taken|0|||
124807982|NCT00075218|448927246|FG002|Double-Blind Treatment|No study medication taken|0|||
124807983|NCT00075218|448927244|FG000|Open-Label Treatment|Lack of Efficacy|0|||
124807984|NCT00075218|448927245|FG001|Open-Label Treatment|Lack of Efficacy|0|||
124807985|NCT00075218|448927246|FG002|Open-Label Treatment|Lack of Efficacy|174|||
124807986|NCT00075218|448927244|FG000|Open-Label Treatment|Adverse Event|0|||
124807987|NCT00075218|448927245|FG001|Open-Label Treatment|Adverse Event|0|||
124807988|NCT00075218|448927246|FG002|Open-Label Treatment|Adverse Event|51|||
124807989|NCT00075218|448927244|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
124807990|NCT00075218|448927245|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
124807991|NCT00075218|448927246|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
124807992|NCT00075218|448927244|FG000|Open-Label Treatment|Decision of Sponsor|0|||
124807993|NCT00075218|448927245|FG001|Open-Label Treatment|Decision of Sponsor|0|||
124807994|NCT00075218|448927246|FG002|Open-Label Treatment|Decision of Sponsor|8|||
124807995|NCT00075218|448927244|FG000|Open-Label Treatment|Protocol Violation|0|||
124807996|NCT00075218|448927245|FG001|Open-Label Treatment|Protocol Violation|0|||
124807997|NCT00075218|448927246|FG002|Open-Label Treatment|Protocol Violation|1|||
124807998|NCT00075218|448927244|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
124634228|NCT02492867|448276262|FG000|Overall Study|Death|1|||
124807999|NCT00075218|448927245|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
124808000|NCT00075218|448927246|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
124808001|NCT00845858|448927249|FG000|Overall Study|Withdrawal by Subject|5|||
124808002|NCT00845858|448927250|FG001|Overall Study|Withdrawal by Subject|1|||
124808003|NCT00845858|448927251|FG002|Overall Study|Withdrawal by Subject|1|||
124808004|NCT00845858|448927249|FG000|Overall Study|Adverse Event|3|||
124808005|NCT00845858|448927250|FG001|Overall Study|Adverse Event|8|||
124808006|NCT00845858|448927251|FG002|Overall Study|Adverse Event|4|||
124808007|NCT00845858|448927249|FG000|Overall Study|Protocol Violation|0|||
124808008|NCT00845858|448927250|FG001|Overall Study|Protocol Violation|0|||
124808009|NCT00845858|448927251|FG002|Overall Study|Protocol Violation|1|||
124808010|NCT00845858|448927249|FG000|Overall Study|not eligible|0|||
124808011|NCT00845858|448927250|FG001|Overall Study|not eligible|3|||
124808012|NCT00845858|448927251|FG002|Overall Study|not eligible|2|||
124808013|NCT02191137|448927252|FG000|Treatment|Death|4|||
124808014|NCT02191137|448927252|FG000|Treatment|Withdrawal by Subject|3|||
124808015|NCT02191137|448927252|FG000|Treatment|Adverse Event|2|||
124808016|NCT02191137|448927252|FG000|Treatment|Other|1|||
124808017|NCT02191137|448927252|FG000|Follow-up|Lost to Follow-up|2|||
124808018|NCT02191137|448927252|FG000|Follow-up|Ongoing/unknown|2|||
124808019|NCT02191137|448927252|FG000|Follow-up|Adverse Event|1|||
124808020|NCT02404220|448927259|FG000|Overall Study|Adverse Event|0|||
124808021|NCT02404220|448927260|FG001|Overall Study|Adverse Event|0|||
124808022|NCT02404220|448927261|FG002|Overall Study|Adverse Event|1|||
124808023|NCT02404220|448927262|FG003|Overall Study|Adverse Event|0|||
124808024|NCT02404220|448927259|FG000|Overall Study|Death|5|||
124808025|NCT02404220|448927260|FG001|Overall Study|Death|5|||
124808026|NCT02404220|448927261|FG002|Overall Study|Death|3|||
124808027|NCT02404220|448927262|FG003|Overall Study|Death|8|||
124808028|NCT02404220|448927259|FG000|Overall Study|Progressive Disease|0|||
124808029|NCT02404220|448927260|FG001|Overall Study|Progressive Disease|0|||
124808030|NCT02404220|448927261|FG002|Overall Study|Progressive Disease|1|||
124808031|NCT02404220|448927262|FG003|Overall Study|Progressive Disease|1|||
124808032|NCT02404220|448927259|FG000|Overall Study|Study Terminated by Sponsor|0|||
124808033|NCT02404220|448927260|FG001|Overall Study|Study Terminated by Sponsor|0|||
124808034|NCT02404220|448927261|FG002|Overall Study|Study Terminated by Sponsor|2|||
124808035|NCT02404220|448927262|FG003|Overall Study|Study Terminated by Sponsor|1|||
124808036|NCT02404220|448927259|FG000|Overall Study|Withdrawal by Subject|0|||
124808037|NCT02404220|448927260|FG001|Overall Study|Withdrawal by Subject|1|||
124808038|NCT02404220|448927261|FG002|Overall Study|Withdrawal by Subject|0|||
124808039|NCT02404220|448927262|FG003|Overall Study|Withdrawal by Subject|0|||
124808040|NCT02404220|448927259|FG000|Overall Study|Enrolled but Never Treated|0|||
124808041|NCT02404220|448927260|FG001|Overall Study|Enrolled but Never Treated|2|||
124808042|NCT02404220|448927261|FG002|Overall Study|Enrolled but Never Treated|0|||
124808043|NCT02404220|448927262|FG003|Overall Study|Enrolled but Never Treated|0|||
124808044|NCT03469934|448927265|FG000|Overall Study|Withdrawal by Subject|0|||
124808045|NCT03469934|448927266|FG001|Overall Study|Withdrawal by Subject|1|||
124808046|NCT02329080|448927267|FG000|Overall Study|Adverse Event|1|||
124808047|NCT02329080|448927267|FG000|Overall Study|Death|4|||
124808048|NCT02329080|448927267|FG000|Overall Study|Lack of Efficacy|22|||
124808049|NCT02329080|448927267|FG000|Overall Study|Lost to Follow-up|1|||
124808050|NCT02329080|448927267|FG000|Overall Study|Physician Decision|2|||
124808051|NCT02329080|448927267|FG000|Overall Study|Partial response|4|||
124808052|NCT02329080|448927267|FG000|Overall Study|Complete response|4|||
124808053|NCT00071396|448927274|FG000|Overall Study|Withdrawal by Subject|1|||
124808054|NCT00071396|448927274|FG000|Overall Study|Physician Decision|2|||
124808055|NCT03082261|448927275|FG000|Overall Study|Death|4|||
124808056|NCT03082261|448927275|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
124808057|NCT03082261|448927275|FG000|Overall Study|Insurance denial|1|||
124808058|NCT03082261|448927275|FG000|Overall Study|Peripheral lead added|1|||
124634229|NCT03296527|448276263|FG000|Overall Study|Adverse Event|15|||
124808059|NCT03082261|448927275|FG000|Overall Study|Withdrawal by Subject|40|||
124808060|NCT03082261|448927275|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
124808061|NCT03082261|448927275|FG000|Overall Study|Subject implanted with device other than study device|1|||
124808062|NCT03082261|448927275|FG000|Overall Study|Lost to Follow-up|14|||
124808063|NCT03082261|448927275|FG000|Overall Study|Subject moved to a different state|1|||
124808064|NCT03082261|448927275|FG000|Overall Study|Subject non-compliance|2|||
124808065|NCT03082261|448927275|FG000|Overall Study|Subject participation terminated by investigator|9|||
124808066|NCT03082261|448927275|FG000|Overall Study|Subject participation terminated by sponsor|4|||
124808067|NCT03082261|448927275|FG000|Overall Study|System explant|19|||
124808068|NCT03082261|448927275|FG000|Overall Study|Unable to place lead(s)|2|||
124808069|NCT03082261|448927275|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
124808070|NCT02639546|448927276|FG000|Overall Study|Death|2|||
124808071|NCT02639546|448927277|FG001|Overall Study|Death|2|||
124808072|NCT02639546|448927278|FG002|Overall Study|Death|1|||
124634230|NCT03296527|448276264|FG001|Overall Study|Adverse Event|33|||
124808073|NCT02639546|448927279|FG003|Overall Study|Death|2|||
124808074|NCT02639546|448927280|FG004|Overall Study|Death|2|||
124808075|NCT02639546|448927281|FG005|Overall Study|Death|2|||
124808076|NCT02639546|448927282|FG006|Overall Study|Death|0|||
124808077|NCT02639546|448927283|FG007|Overall Study|Death|0|||
124808078|NCT02639546|448927276|FG000|Overall Study|Lost to Follow-up|0|||
124808079|NCT02639546|448927277|FG001|Overall Study|Lost to Follow-up|0|||
124808080|NCT02639546|448927278|FG002|Overall Study|Lost to Follow-up|1|||
124808081|NCT02639546|448927279|FG003|Overall Study|Lost to Follow-up|0|||
124808082|NCT02639546|448927280|FG004|Overall Study|Lost to Follow-up|1|||
124808083|NCT02639546|448927281|FG005|Overall Study|Lost to Follow-up|1|||
124808084|NCT02639546|448927282|FG006|Overall Study|Lost to Follow-up|0|||
124808085|NCT02639546|448927283|FG007|Overall Study|Lost to Follow-up|1|||
124808086|NCT02639546|448927276|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
124808087|NCT02639546|448927277|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
124808088|NCT02639546|448927278|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
124808089|NCT02639546|448927279|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
124808090|NCT02639546|448927280|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
124808091|NCT02639546|448927281|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
124808092|NCT02639546|448927282|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
124808093|NCT02639546|448927283|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
124808094|NCT02639546|448927276|FG000|Overall Study|Study Terminated By Sponsor|0|||
124808095|NCT02639546|448927277|FG001|Overall Study|Study Terminated By Sponsor|2|||
124808096|NCT02639546|448927278|FG002|Overall Study|Study Terminated By Sponsor|3|||
124808097|NCT02639546|448927279|FG003|Overall Study|Study Terminated By Sponsor|4|||
124808098|NCT02639546|448927280|FG004|Overall Study|Study Terminated By Sponsor|4|||
124808099|NCT02639546|448927281|FG005|Overall Study|Study Terminated By Sponsor|3|||
124808100|NCT02639546|448927282|FG006|Overall Study|Study Terminated By Sponsor|3|||
124808101|NCT02639546|448927283|FG007|Overall Study|Study Terminated By Sponsor|9|||
124808102|NCT02639546|448927276|FG000|Overall Study|Withdrawal by Subject|2|||
124808103|NCT02639546|448927277|FG001|Overall Study|Withdrawal by Subject|2|||
124808104|NCT02639546|448927278|FG002|Overall Study|Withdrawal by Subject|1|||
124808105|NCT02639546|448927279|FG003|Overall Study|Withdrawal by Subject|0|||
124808106|NCT02639546|448927280|FG004|Overall Study|Withdrawal by Subject|0|||
124808107|NCT02639546|448927281|FG005|Overall Study|Withdrawal by Subject|1|||
124808108|NCT02639546|448927282|FG006|Overall Study|Withdrawal by Subject|2|||
124808109|NCT02639546|448927283|FG007|Overall Study|Withdrawal by Subject|1|||
124808110|NCT01032174|448927286|FG000|Overall Study|Adverse Event|0|||
124808111|NCT01032174|448927287|FG001|Overall Study|Adverse Event|1|||
124808112|NCT00113087|448927289|FG000|Overall Study|Death or Transplant|14|||
124808113|NCT00113087|448927290|FG001|Overall Study|Death or Transplant|16|||
124808114|NCT00113087|448927289|FG000|Overall Study|Family or MD withdrew subject|10|||
124808115|NCT00113087|448927290|FG001|Overall Study|Family or MD withdrew subject|5|||
124808116|NCT01281137|448927291|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
124634231|NCT03296527|448276263|FG000|Overall Study|Protocol Deviation|4|||
124634232|NCT03296527|448276264|FG001|Overall Study|Protocol Deviation|0|||
124634233|NCT03296527|448276263|FG000|Overall Study|Participant withdrew consent|3|||
124808117|NCT01281137|448927292|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
124808118|NCT01281137|448927291|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
124808119|NCT01281137|448927292|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
124808120|NCT01281137|448927291|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
124808121|NCT01281137|448927292|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
124808122|NCT01281137|448927291|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
124808123|NCT01281137|448927292|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
124808124|NCT01281137|448927291|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
124808125|NCT01281137|448927292|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
124808126|NCT00386607|448927295|FG000|Core|Adverse Event|40|||
124808127|NCT00386607|448927296|FG001|Core|Adverse Event|0|||
124808128|NCT00386607|448927295|FG000|Core|Abnormal laboratory value(s)|3|||
124808129|NCT00386607|448927296|FG001|Core|Abnormal laboratory value(s)|0|||
124808130|NCT00386607|448927295|FG000|Core|Unsatisfactory therapeutic effect|23|||
124808131|NCT00386607|448927296|FG001|Core|Unsatisfactory therapeutic effect|0|||
124808132|NCT00386607|448927295|FG000|Core|Condition no longer requires study drug|4|||
124808133|NCT00386607|448927296|FG001|Core|Condition no longer requires study drug|0|||
124808134|NCT00386607|448927295|FG000|Core|Patient withdrew consent|15|||
124808135|NCT00386607|448927296|FG001|Core|Patient withdrew consent|0|||
124808136|NCT00386607|448927295|FG000|Core|Lost to Follow-up|23|||
124808137|NCT00386607|448927296|FG001|Core|Lost to Follow-up|0|||
124808138|NCT00386607|448927295|FG000|Core|Administrative problems|1|||
124808139|NCT00386607|448927296|FG001|Core|Administrative problems|0|||
124634234|NCT03296527|448276264|FG001|Overall Study|Participant withdrew consent|1|||
124808140|NCT00386607|448927295|FG000|Core|Protocol Deviation|6|||
124808141|NCT00386607|448927296|FG001|Core|Protocol Deviation|0|||
124808142|NCT00386607|448927295|FG000|Extension|Adverse Event|0|||
124808143|NCT00386607|448927296|FG001|Extension|Adverse Event|6|||
124808144|NCT00386607|448927295|FG000|Extension|Abnormal laboratory value(s)|0|||
124808145|NCT00386607|448927296|FG001|Extension|Abnormal laboratory value(s)|1|||
124808146|NCT00386607|448927295|FG000|Extension|Administrative problems|0|||
124808147|NCT00386607|448927296|FG001|Extension|Administrative problems|1|||
124808148|NCT00386607|448927295|FG000|Extension|Lost to Follow-up|0|||
124808149|NCT00386607|448927296|FG001|Extension|Lost to Follow-up|3|||
124808150|NCT00386607|448927295|FG000|Extension|Patient withdrew consent|0|||
124808151|NCT00386607|448927296|FG001|Extension|Patient withdrew consent|5|||
124808152|NCT00386607|448927295|FG000|Extension|Unsatisfactory therapeutic effect|0|||
124808153|NCT00386607|448927296|FG001|Extension|Unsatisfactory therapeutic effect|1|||
124808154|NCT04251273|448927299|FG000|Overall Study|Lost to Follow-up|331|||
124808155|NCT04251273|448927300|FG001|Overall Study|Lost to Follow-up|290|||
124808156|NCT01986907|448927301|FG000|Overall Study|Adverse Event|11|||
124808157|NCT01986907|448927301|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
124808158|NCT01986907|448927301|FG000|Overall Study|Protocol Violation|4|||
124808159|NCT01986907|448927301|FG000|Overall Study|Withdrawal by Subject|76|||
124808160|NCT01986907|448927301|FG000|Overall Study|Lost to Follow-up|38|||
124808161|NCT01986907|448927301|FG000|Overall Study|Death|9|||
124808162|NCT00810693|448927302|FG000|Treatment Period|Adverse Event|8|||
124808163|NCT00810693|448927303|FG001|Treatment Period|Adverse Event|1|||
124808164|NCT00810693|448927304|FG002|Treatment Period|Adverse Event|7|||
124808165|NCT00810693|448927302|FG000|Treatment Period|Death|0|||
124808166|NCT00810693|448927303|FG001|Treatment Period|Death|1|||
124808167|NCT00810693|448927304|FG002|Treatment Period|Death|2|||
124808168|NCT00810693|448927302|FG000|Treatment Period|Lack of Efficacy|0|||
124808169|NCT00810693|448927303|FG001|Treatment Period|Lack of Efficacy|0|||
124808170|NCT00810693|448927304|FG002|Treatment Period|Lack of Efficacy|1|||
124808171|NCT00810693|448927302|FG000|Treatment Period|Lost to Follow-up|1|||
124808172|NCT00810693|448927303|FG001|Treatment Period|Lost to Follow-up|0|||
124808173|NCT00810693|448927304|FG002|Treatment Period|Lost to Follow-up|0|||
124808174|NCT00810693|448927302|FG000|Treatment Period|Non-compliance|1|||
124808175|NCT00810693|448927303|FG001|Treatment Period|Non-compliance|0|||
124808176|NCT00810693|448927304|FG002|Treatment Period|Non-compliance|0|||
124808177|NCT00810693|448927302|FG000|Treatment Period|Protocol Violation|1|||
124808178|NCT00810693|448927303|FG001|Treatment Period|Protocol Violation|2|||
124808179|NCT00810693|448927304|FG002|Treatment Period|Protocol Violation|2|||
124808180|NCT00810693|448927302|FG000|Treatment Period|Withdrawal by Subject|6|||
124808181|NCT00810693|448927303|FG001|Treatment Period|Withdrawal by Subject|2|||
124808182|NCT00810693|448927304|FG002|Treatment Period|Withdrawal by Subject|3|||
124808183|NCT00810693|448927302|FG000|Treatment Period|Not treated|0|||
124808184|NCT00810693|448927303|FG001|Treatment Period|Not treated|1|||
124808185|NCT00810693|448927304|FG002|Treatment Period|Not treated|1|||
124808186|NCT00810693|448927302|FG000|Follow-up Period (FUP)|Adverse Event|3|||
124808187|NCT00810693|448927303|FG001|Follow-up Period (FUP)|Adverse Event|1|||
124808188|NCT00810693|448927304|FG002|Follow-up Period (FUP)|Adverse Event|1|||
124808189|NCT00810693|448927302|FG000|Follow-up Period (FUP)|Death|2|||
124808190|NCT00810693|448927303|FG001|Follow-up Period (FUP)|Death|0|||
124808191|NCT00810693|448927304|FG002|Follow-up Period (FUP)|Death|1|||
124808192|NCT00810693|448927302|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
124808193|NCT00810693|448927303|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
124808194|NCT00810693|448927304|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
124808195|NCT00810693|448927302|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
124808196|NCT00810693|448927303|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
124808197|NCT00810693|448927304|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
124808198|NCT00810693|448927302|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
124808199|NCT00810693|448927303|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
124808200|NCT00810693|448927304|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
124808201|NCT03212690|448927305|FG000|Overall Study|Protocol Violation|1|||
124808202|NCT00331422|448927308|FG000|Overall Study|Did not receive entire study regimen|5|||
124808203|NCT02345226|448927309|FG000|Double-Blind Phase|Adverse Event|5|||
124808204|NCT02345226|448927310|FG001|Double-Blind Phase|Adverse Event|6|||
124808205|NCT02345226|448927309|FG000|Double-Blind Phase|Death|3|||
124808206|NCT02345226|448927310|FG001|Double-Blind Phase|Death|0|||
124808207|NCT02345226|448927309|FG000|Double-Blind Phase|Pregnancy|0|||
124808208|NCT02345226|448927310|FG001|Double-Blind Phase|Pregnancy|1|||
124808209|NCT02345226|448927309|FG000|Double-Blind Phase|Lack of Efficacy|1|||
124808210|NCT02345226|448927310|FG001|Double-Blind Phase|Lack of Efficacy|0|||
124808211|NCT02345226|448927309|FG000|Double-Blind Phase|Investigator's Discretion|4|||
124808212|NCT02345226|448927310|FG001|Double-Blind Phase|Investigator's Discretion|3|||
124808213|NCT02345226|448927309|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
124808214|NCT02345226|448927310|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
124808215|NCT02345226|448927309|FG000|Double-Blind Phase|Withdrew Consent|41|||
124808216|NCT02345226|448927310|FG001|Double-Blind Phase|Withdrew Consent|39|||
124808217|NCT02345226|448927309|FG000|Double-Blind Phase|Lost to Follow-up|12|||
124808218|NCT02345226|448927310|FG001|Double-Blind Phase|Lost to Follow-up|16|||
124808219|NCT02345226|448927309|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
124808220|NCT02345226|448927310|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
124808221|NCT02345226|448927309|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
124808222|NCT02345226|448927310|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
124808223|NCT03386474|448927319|FG000|Overall Study|Death|1|||
124808224|NCT03386474|448927320|FG001|Overall Study|Death|0|||
124808225|NCT03386474|448927319|FG000|Overall Study|Adverse Event|0|||
124808226|NCT03386474|448927320|FG001|Overall Study|Adverse Event|1|||
124808243|NCT02282358|448927325|FG000|Overall Study|Nonevaluable|1|||
124808244|NCT04203797|448927326|FG000|Overall Study|Adverse Event|1|||
124808245|NCT04203797|448927327|FG001|Overall Study|Adverse Event|0|||
124808246|NCT04203797|448927326|FG000|Overall Study|Did not complete End of Study follow-up|1|||
124808247|NCT04203797|448927327|FG001|Overall Study|Did not complete End of Study follow-up|0|||
124808248|NCT04357782|448927328|FG000|Overall Study|Discharged from hospital|1|||
124808249|NCT04357782|448927329|FG001|Overall Study|Discharged from hospital|0|||
124808250|NCT04357782|448927328|FG000|Overall Study|Death|0|||
124808251|NCT04357782|448927329|FG001|Overall Study|Death|2|||
124808252|NCT01786148|448927330|FG000|Overall Study|Lost to Follow-up|21|||
124808253|NCT01786148|448927331|FG001|Overall Study|Lost to Follow-up|13|||
124808254|NCT01786148|448927330|FG000|Overall Study|Death|0|||
124808255|NCT01786148|448927331|FG001|Overall Study|Death|1|||
124808256|NCT01786148|448927330|FG000|Overall Study|Withdrawal by Subject|0|||
124808257|NCT01786148|448927331|FG001|Overall Study|Withdrawal by Subject|7|||
124808258|NCT01786148|448927330|FG000|Overall Study|Incarceration|1|||
124808259|NCT01786148|448927331|FG001|Overall Study|Incarceration|1|||
124808260|NCT03780543|448927333|FG000|Overall Study|Adverse Event|1|||
124808261|NCT03780543|448927334|FG001|Overall Study|Adverse Event|0|||
124808262|NCT03780543|448927335|FG002|Overall Study|Adverse Event|2|||
124808263|NCT03780543|448927333|FG000|Overall Study|Lost to Follow-up|2|||
124808264|NCT03780543|448927334|FG001|Overall Study|Lost to Follow-up|0|||
124808265|NCT03780543|448927335|FG002|Overall Study|Lost to Follow-up|1|||
124808266|NCT03780543|448927333|FG000|Overall Study|Study terminated by Sponsor|8|||
124808267|NCT03780543|448927334|FG001|Overall Study|Study terminated by Sponsor|7|||
124808268|NCT03780543|448927335|FG002|Overall Study|Study terminated by Sponsor|13|||
124808269|NCT03780543|448927333|FG000|Overall Study|Withdrawal by Subject|1|||
124808270|NCT03780543|448927334|FG001|Overall Study|Withdrawal by Subject|8|||
124808271|NCT03780543|448927335|FG002|Overall Study|Withdrawal by Subject|1|||
124808272|NCT03780543|448927333|FG000|Overall Study|Noncompliance with study drug|1|||
124808273|NCT03780543|448927334|FG001|Overall Study|Noncompliance with study drug|0|||
124808274|NCT03780543|448927335|FG002|Overall Study|Noncompliance with study drug|0|||
124808275|NCT00516074|448927344|FG000|Overall Study|Adverse Event|0|||
124808276|NCT00516074|448927345|FG001|Overall Study|Adverse Event|1|||
124808277|NCT00516074|448927344|FG000|Overall Study|Subject Decision|4|||
124808278|NCT00516074|448927345|FG001|Overall Study|Subject Decision|2|||
124808279|NCT00516074|448927344|FG000|Overall Study|Loss of Glucose Control|2|||
124808280|NCT00516074|448927345|FG001|Overall Study|Loss of Glucose Control|0|||
124808281|NCT02215096|448927346|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
124808282|NCT02215096|448927347|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
124808283|NCT02215096|448927348|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
124808284|NCT02215096|448927349|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
124808285|NCT02215096|448927350|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
124808286|NCT02215096|448927346|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
124808287|NCT02215096|448927347|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
124808288|NCT02215096|448927348|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
124808289|NCT02215096|448927349|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
124808290|NCT02215096|448927350|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
124808291|NCT02215096|448927346|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
124808292|NCT02215096|448927347|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
124808293|NCT02215096|448927348|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
124808294|NCT02215096|448927349|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
124808295|NCT02215096|448927350|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
124808296|NCT02215096|448927346|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
124808297|NCT02215096|448927347|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
124808298|NCT02215096|448927348|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
124808299|NCT02215096|448927349|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
124808300|NCT02215096|448927350|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
124808301|NCT00287365|448927351|FG000|Overall Study|sample not acquired|13|||
124808302|NCT03021304|448927352|FG000|Overall Study|Lack of Efficacy|1|||
124808303|NCT02663908|448927353|FG000|Overall Study|Withdrawal by Subject|8|||
124808304|NCT02663908|448927354|FG001|Overall Study|Withdrawal by Subject|5|||
124808305|NCT02663908|448927353|FG000|Overall Study|Lost to Follow-up|1|||
124808306|NCT02663908|448927354|FG001|Overall Study|Lost to Follow-up|5|||
124808307|NCT02663908|448927353|FG000|Overall Study|Adverse Event|13|||
124808308|NCT02663908|448927354|FG001|Overall Study|Adverse Event|11|||
124808309|NCT02663908|448927353|FG000|Overall Study|Protocol Violation|1|||
124808310|NCT02663908|448927354|FG001|Overall Study|Protocol Violation|2|||
124808311|NCT02663908|448927353|FG000|Overall Study|Lack of therapeutic response|2|||
124808312|NCT02663908|448927354|FG001|Overall Study|Lack of therapeutic response|0|||
124808313|NCT02663908|448927353|FG000|Overall Study|COVID-19|1|||
124808314|NCT02663908|448927354|FG001|Overall Study|COVID-19|0|||
124808315|NCT02663908|448927353|FG000|Overall Study|Site closed|1|||
124808316|NCT02663908|448927354|FG001|Overall Study|Site closed|0|||
124808317|NCT02663908|448927353|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
124808318|NCT02663908|448927354|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
124808319|NCT02663908|448927353|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
124808320|NCT02663908|448927354|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
124808321|NCT02663908|448927353|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
124808322|NCT02663908|448927354|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
124808323|NCT02663908|448927353|FG000|Overall Study|Death|1|||
124808324|NCT02663908|448927354|FG001|Overall Study|Death|0|||
124808325|NCT02663908|448927353|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
124808326|NCT02663908|448927354|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
124808327|NCT02663908|448927353|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
124808328|NCT02663908|448927354|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
124808329|NCT03308786|448927356|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
124808330|NCT00370071|448927359|FG000|Overall Study|Withdrawal by Subject|2|||
124808331|NCT01441180|448927360|FG000|Overall Study|Lost to Follow-up|1|||
124808332|NCT01441180|448927361|FG001|Overall Study|Lost to Follow-up|1|||
124808333|NCT01441180|448927362|FG002|Overall Study|Lost to Follow-up|1|||
124808334|NCT01441180|448927360|FG000|Overall Study|Discontinued|0|||
124808335|NCT01441180|448927361|FG001|Overall Study|Discontinued|0|||
124808336|NCT01441180|448927362|FG002|Overall Study|Discontinued|2|||
124634235|NCT03296527|448276263|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
124634236|NCT03296527|448276264|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
124634237|NCT03296527|448276263|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
124634238|NCT03296527|448276264|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
124634239|NCT03296527|448276263|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
124634240|NCT03296527|448276264|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
124634241|NCT03296527|448276263|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
124634242|NCT03296527|448276264|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
124634243|NCT03296527|448276263|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
124634244|NCT03296527|448276264|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
124634245|NCT00122382|448276265|FG000|Double-Blind Study|Adverse Event|9|||
124634246|NCT00122382|448276266|FG001|Double-Blind Study|Adverse Event|11|||
124634247|NCT00122382|448276267|FG002|Double-Blind Study|Adverse Event|0|||
124634248|NCT00122382|448276265|FG000|Double-Blind Study|Death|2|||
124634249|NCT00122382|448276266|FG001|Double-Blind Study|Death|2|||
124808337|NCT01402011|448927367|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
124634250|NCT00122382|448276267|FG002|Double-Blind Study|Death|0|||
124634251|NCT00122382|448276265|FG000|Double-Blind Study|Lack of Efficacy|0|||
124634252|NCT00122382|448276266|FG001|Double-Blind Study|Lack of Efficacy|8|||
124808338|NCT01402011|448927368|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
124808339|NCT01402011|448927369|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
124808340|NCT01402011|448927367|FG000|Active Treatment Period|Withdrawal by Subject|1|||
124808341|NCT01402011|448927368|FG001|Active Treatment Period|Withdrawal by Subject|3|||
124808342|NCT01402011|448927369|FG002|Active Treatment Period|Withdrawal by Subject|0|||
124808343|NCT01402011|448927367|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
124808344|NCT01402011|448927368|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
124808345|NCT01402011|448927369|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
124808346|NCT00825682|448929054|FG000|Overall Study|personal reasons/ inconvenience|13|||
124808347|NCT00825682|448929055|FG001|Overall Study|personal reasons/ inconvenience|5|||
124808348|NCT00316719|448929056|FG000|Overall Study|Adverse Event|0|||
124808349|NCT00316719|448929057|FG001|Overall Study|Adverse Event|6|||
124808350|NCT00316719|448929056|FG000|Overall Study|Consent withdrawn|2|||
124808351|NCT00316719|448929057|FG001|Overall Study|Consent withdrawn|0|||
124808352|NCT01644565|448929060|FG000|Overall Study|Undisclosed Medical History|1|||
124808353|NCT01644565|448929061|FG001|Overall Study|Undisclosed Medical History|0|||
124808354|NCT01644565|448929062|FG002|Overall Study|Undisclosed Medical History|0|||
124808355|NCT01644565|448929063|FG003|Overall Study|Undisclosed Medical History|0|||
124808356|NCT01644565|448929064|FG004|Overall Study|Undisclosed Medical History|0|||
124808357|NCT01644565|448929065|FG005|Overall Study|Undisclosed Medical History|0|||
124808358|NCT01644565|448929066|FG006|Overall Study|Undisclosed Medical History|0|||
124808359|NCT01644565|448929067|FG007|Overall Study|Undisclosed Medical History|0|||
124808360|NCT01644565|448929068|FG008|Overall Study|Undisclosed Medical History|0|||
124808361|NCT01644565|448929060|FG000|Overall Study|Lost to Follow-up|0|||
124808362|NCT01644565|448929061|FG001|Overall Study|Lost to Follow-up|0|||
124808363|NCT01644565|448929062|FG002|Overall Study|Lost to Follow-up|0|||
124808364|NCT01644565|448929063|FG003|Overall Study|Lost to Follow-up|1|||
124808365|NCT01644565|448929064|FG004|Overall Study|Lost to Follow-up|0|||
124808366|NCT01644565|448929065|FG005|Overall Study|Lost to Follow-up|0|||
124808367|NCT01644565|448929066|FG006|Overall Study|Lost to Follow-up|0|||
124808368|NCT01644565|448929067|FG007|Overall Study|Lost to Follow-up|2|||
124808369|NCT01644565|448929068|FG008|Overall Study|Lost to Follow-up|0|||
124808370|NCT01644565|448929060|FG000|Overall Study|Family emergency|0|||
124808371|NCT01644565|448929061|FG001|Overall Study|Family emergency|0|||
124808372|NCT01644565|448929062|FG002|Overall Study|Family emergency|0|||
124808373|NCT01644565|448929063|FG003|Overall Study|Family emergency|0|||
124808374|NCT01644565|448929064|FG004|Overall Study|Family emergency|1|||
124808375|NCT01644565|448929065|FG005|Overall Study|Family emergency|0|||
124808376|NCT01644565|448929066|FG006|Overall Study|Family emergency|0|||
124808377|NCT01644565|448929067|FG007|Overall Study|Family emergency|0|||
124808378|NCT01644565|448929068|FG008|Overall Study|Family emergency|0|||
124808379|NCT01644565|448929060|FG000|Overall Study|Relocation|0|||
124808380|NCT01644565|448929061|FG001|Overall Study|Relocation|0|||
124808381|NCT01644565|448929062|FG002|Overall Study|Relocation|0|||
124808382|NCT01644565|448929063|FG003|Overall Study|Relocation|0|||
124808383|NCT01644565|448929064|FG004|Overall Study|Relocation|0|||
124808384|NCT01644565|448929065|FG005|Overall Study|Relocation|0|||
124808385|NCT01644565|448929066|FG006|Overall Study|Relocation|0|||
124808386|NCT01644565|448929067|FG007|Overall Study|Relocation|0|||
124808387|NCT01644565|448929068|FG008|Overall Study|Relocation|1|||
124808388|NCT01550289|448929069|FG000|Overall Study|Protocol Violation|1|||
124808389|NCT01550289|448929070|FG001|Overall Study|Protocol Violation|0|||
124808390|NCT01550289|448929069|FG000|Overall Study|Lost to Follow-up|1|||
124808391|NCT01550289|448929070|FG001|Overall Study|Lost to Follow-up|1|||
124808392|NCT01550289|448929069|FG000|Overall Study|Withdrawal by Subject|11|||
124808393|NCT01550289|448929070|FG001|Overall Study|Withdrawal by Subject|3|||
124634253|NCT00122382|448276267|FG002|Double-Blind Study|Lack of Efficacy|0|||
124634254|NCT00122382|448276265|FG000|Double-Blind Study|Lost to Follow-up|2|||
124634255|NCT00122382|448276266|FG001|Double-Blind Study|Lost to Follow-up|1|||
124634256|NCT00122382|448276267|FG002|Double-Blind Study|Lost to Follow-up|0|||
124634257|NCT00122382|448276265|FG000|Double-Blind Study|Pregnancy|2|||
124634258|NCT00122382|448276266|FG001|Double-Blind Study|Pregnancy|0|||
124634259|NCT00122382|448276267|FG002|Double-Blind Study|Pregnancy|0|||
124634260|NCT00122382|448276265|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
124634261|NCT00122382|448276266|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
124634262|NCT00122382|448276267|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
124634263|NCT00122382|448276265|FG000|Double-Blind Study|Withdrawal of Consent|7|||
124634264|NCT00122382|448276266|FG001|Double-Blind Study|Withdrawal of Consent|3|||
124808394|NCT00094172|448929076|FG000|Overall Study|Adverse Event|0|||
124808395|NCT00094172|448929077|FG001|Overall Study|Adverse Event|1|||
124808396|NCT00094172|448929076|FG000|Overall Study|Lost to Follow-up|2|||
124634265|NCT00122382|448276267|FG002|Double-Blind Study|Withdrawal of Consent|0|||
124808397|NCT00094172|448929077|FG001|Overall Study|Lost to Follow-up|0|||
124808398|NCT00094172|448929076|FG000|Overall Study|Protocol Violation|0|||
124808399|NCT00094172|448929077|FG001|Overall Study|Protocol Violation|1|||
124808400|NCT00094172|448929076|FG000|Overall Study|Withdrawal by Subject|10|||
124808401|NCT00094172|448929077|FG001|Overall Study|Withdrawal by Subject|5|||
124808402|NCT00094172|448929076|FG000|Overall Study|Primary endpoint met.|1|||
124808403|NCT00094172|448929077|FG001|Overall Study|Primary endpoint met.|0|||
124634266|NCT00122382|448276265|FG000|Double-Blind Study|Protocol Violation|1|||
124634267|NCT00122382|448276266|FG001|Double-Blind Study|Protocol Violation|0|||
124634268|NCT00122382|448276267|FG002|Double-Blind Study|Protocol Violation|0|||
124634269|NCT00122382|448276265|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
124634270|NCT00122382|448276266|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
124634271|NCT00122382|448276267|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
124634272|NCT00122382|448276265|FG000|Double-Blind Study|Randomized but not treated|0|||
124634273|NCT00122382|448276266|FG001|Double-Blind Study|Randomized but not treated|2|||
124634274|NCT00122382|448276267|FG002|Double-Blind Study|Randomized but not treated|0|||
124634275|NCT00122382|448276265|FG000|Open-Label Study|Adverse Event|0|||
124634276|NCT00122382|448276266|FG001|Open-Label Study|Adverse Event|0|||
124634277|NCT00122382|448276267|FG002|Open-Label Study|Adverse Event|11|||
124808404|NCT00094172|448929076|FG000|Overall Study|Started other MS therapy due to disease|1|||
124808405|NCT00094172|448929077|FG001|Overall Study|Started other MS therapy due to disease|0|||
124808406|NCT00713323|448929078|FG000|Overall Study|Adverse Event|75|||
124808407|NCT00713323|448929078|FG000|Overall Study|Withdrawal by Subject|15|||
124808408|NCT00713323|448929078|FG000|Overall Study|Lost to Follow-up|11|||
124808409|NCT00713323|448929078|FG000|Overall Study|Lack of Efficacy|36|||
124808410|NCT00713323|448929078|FG000|Overall Study|Low creatine clearance at screening|1|||
124808411|NCT00713323|448929078|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
124808412|NCT00713323|448929078|FG000|Overall Study|Surgery cured allodynic pain|1|||
124808413|NCT00713323|448929078|FG000|Overall Study|Pain free|1|||
124808414|NCT00713323|448929078|FG000|Overall Study|Non-compliance|1|||
124808415|NCT00713323|448929078|FG000|Overall Study|Pain resolved|1|||
124808416|NCT00713323|448929078|FG000|Overall Study|Subject travelling to USA|1|||
124808417|NCT00713323|448929078|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
124808418|NCT00713323|448929078|FG000|Overall Study|Treatment that may interact with Sativex|1|||
124808419|NCT02478632|448929079|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
124808420|NCT02478632|448929080|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
124808421|NCT02478632|448929079|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
124808422|NCT02478632|448929080|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
124808423|NCT02478632|448929079|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
124808424|NCT02478632|448929080|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
124808425|NCT04622306|448929081|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
124808426|NCT04622306|448929082|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
124808427|NCT04622306|448929083|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
124808428|NCT04622306|448929084|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
124808429|NCT04622306|448929085|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
124808430|NCT04622306|448929086|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
124808431|NCT04622306|448929081|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
124808432|NCT04622306|448929082|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
124808433|NCT04622306|448929083|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
124808434|NCT04622306|448929084|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
124808435|NCT04622306|448929085|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
124808436|NCT04622306|448929086|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
124808437|NCT00864721|448929087|FG000|Overall Study|Patient request|11|||
124808438|NCT00864721|448929087|FG000|Overall Study|Hospitalized|1|||
124808439|NCT00864721|448929087|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
124808440|NCT00864721|448929087|FG000|Overall Study|Adverse Event|21|||
124808441|NCT01868503|448929088|FG000|Overall Study|Withdrawal by Subject|1|||
124808442|NCT01868503|448929088|FG000|Overall Study|Protocol Violation|1|||
124808443|NCT00736944|448929089|FG000|Induction|Death|1|||
124808444|NCT00736944|448929089|FG000|Definitive Treatment|Physician Decision|1|||
124808445|NCT05350410|448929090|FG000|Overall Study|Withdrawal by Subject|1|||
124808446|NCT01601132|448929091|FG000|Overall Study|Patient withdrew consent|1|||
124808447|NCT01601132|448929091|FG000|Overall Study|Protocol deviation|1|||
124808448|NCT02110238|448929092|FG000|12 Week Pivotal Phase|Adverse Event|3|||
124808449|NCT02110238|448929093|FG001|12 Week Pivotal Phase|Adverse Event|0|||
124808450|NCT02110238|448929092|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
124808451|NCT02110238|448929093|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
124808452|NCT02110238|448929092|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
124808453|NCT02110238|448929093|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
124808454|NCT02110238|448929092|FG000|12 Week Pivotal Phase|Physician Decision|0|||
124808455|NCT02110238|448929093|FG001|12 Week Pivotal Phase|Physician Decision|2|||
124808456|NCT02110238|448929092|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
124808457|NCT02110238|448929093|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
124808458|NCT02110238|448929092|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
124808459|NCT02110238|448929093|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
124634278|NCT00122382|448276265|FG000|Open-Label Study|Death|0|||
124634279|NCT00122382|448276266|FG001|Open-Label Study|Death|0|||
124634280|NCT00122382|448276267|FG002|Open-Label Study|Death|2|||
124808460|NCT02110238|448929092|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
124808461|NCT02110238|448929093|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
124808462|NCT02110238|448929092|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
124808463|NCT02110238|448929093|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
124808464|NCT02110238|448929092|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
124808465|NCT02110238|448929093|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
124808466|NCT02110238|448929092|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
124808467|NCT02110238|448929093|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
124808468|NCT02110238|448929092|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
124808469|NCT02110238|448929093|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
124808470|NCT00697788|448929094|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
124808471|NCT00697788|448929095|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
124808472|NCT00697788|448929096|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
124808473|NCT00697788|448929097|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
124808474|NCT00697788|448929098|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
124808475|NCT00697788|448929099|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
124808476|NCT00697788|448929100|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
124808477|NCT00697788|448929101|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
124808478|NCT00697788|448929094|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
124808479|NCT00697788|448929095|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
124808480|NCT00697788|448929096|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
124808481|NCT00697788|448929097|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
124808482|NCT00697788|448929098|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
124808483|NCT00697788|448929099|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
124808484|NCT00697788|448929100|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
124808485|NCT00697788|448929101|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
124808486|NCT01419626|448929105|FG000|Overall Study|Protocol Violation|3|||
124808487|NCT01419626|448929106|FG001|Overall Study|Protocol Violation|2|||
124808488|NCT01419626|448929107|FG002|Overall Study|Protocol Violation|2|||
124808489|NCT01419626|448929105|FG000|Overall Study|Withdrawal by Subject|1|||
124808490|NCT01419626|448929106|FG001|Overall Study|Withdrawal by Subject|0|||
124808491|NCT01419626|448929107|FG002|Overall Study|Withdrawal by Subject|0|||
124808492|NCT01419626|448929105|FG000|Overall Study|Lost to Follow-up|0|||
124808493|NCT01419626|448929106|FG001|Overall Study|Lost to Follow-up|1|||
124808494|NCT01419626|448929107|FG002|Overall Study|Lost to Follow-up|1|||
124808495|NCT01365052|448929108|FG000|Overall Study|Adverse Event|4|||
124808496|NCT01365052|448929109|FG001|Overall Study|Adverse Event|4|||
124808497|NCT01145625|448929110|FG000|Overall Study|Lost to Follow-up|8|||
124808498|NCT01145625|448929111|FG001|Overall Study|Lost to Follow-up|9|||
124808499|NCT01145625|448929110|FG000|Overall Study|Adverse Event|6|||
124808500|NCT01145625|448929111|FG001|Overall Study|Adverse Event|4|||
124808501|NCT01145625|448929110|FG000|Overall Study|Protocol Violation|3|||
124808502|NCT01145625|448929111|FG001|Overall Study|Protocol Violation|1|||
124808503|NCT01145625|448929110|FG000|Overall Study|Withdrawal by Subject|7|||
124808504|NCT01145625|448929111|FG001|Overall Study|Withdrawal by Subject|16|||
124808505|NCT01145625|448929110|FG000|Overall Study|Pregnancy|0|||
124808506|NCT01145625|448929111|FG001|Overall Study|Pregnancy|1|||
124808507|NCT03080454|448929112|FG000|Baseline|Adverse Event|2|||
124808508|NCT03080454|448929112|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
124808509|NCT03080454|448929112|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
124808510|NCT00216476|448929113|FG000|Overall Study|Withdrawal by Subject|59|||
124808511|NCT00216476|448929114|FG001|Overall Study|Withdrawal by Subject|72|||
124808512|NCT00216476|448929115|FG002|Overall Study|Withdrawal by Subject|9|||
124808513|NCT00216476|448929113|FG000|Overall Study|Lost to Follow-up|10|||
124808514|NCT00216476|448929114|FG001|Overall Study|Lost to Follow-up|9|||
124808515|NCT00216476|448929115|FG002|Overall Study|Lost to Follow-up|1|||
124808516|NCT00216476|448929113|FG000|Overall Study|Adverse Event|6|||
124808517|NCT00216476|448929114|FG001|Overall Study|Adverse Event|10|||
124808518|NCT00216476|448929115|FG002|Overall Study|Adverse Event|1|||
124808519|NCT00216476|448929113|FG000|Overall Study|Lack of Efficacy|4|||
124808520|NCT00216476|448929114|FG001|Overall Study|Lack of Efficacy|3|||
124808521|NCT00216476|448929115|FG002|Overall Study|Lack of Efficacy|0|||
124808522|NCT00216476|448929113|FG000|Overall Study|Death|2|||
124808523|NCT00216476|448929114|FG001|Overall Study|Death|0|||
124808524|NCT00216476|448929115|FG002|Overall Study|Death|0|||
124808525|NCT00216476|448929113|FG000|Overall Study|Pregnancy|0|||
124634281|NCT00122382|448276265|FG000|Open-Label Study|Lack of Efficacy|0|||
124634282|NCT00122382|448276266|FG001|Open-Label Study|Lack of Efficacy|0|||
124634283|NCT00122382|448276267|FG002|Open-Label Study|Lack of Efficacy|3|||
124808526|NCT00216476|448929114|FG001|Overall Study|Pregnancy|1|||
124808527|NCT00216476|448929115|FG002|Overall Study|Pregnancy|1|||
124808528|NCT00216476|448929113|FG000|Overall Study|Other|0|||
124808529|NCT00216476|448929114|FG001|Overall Study|Other|0|||
124808530|NCT00216476|448929115|FG002|Overall Study|Other|1|||
124808531|NCT00216476|448929113|FG000|Overall Study|Refuses Injection|11|||
124808532|NCT00216476|448929114|FG001|Overall Study|Refuses Injection|0|||
124808533|NCT00216476|448929115|FG002|Overall Study|Refuses Injection|0|||
124808534|NCT00216476|448929113|FG000|Overall Study|No Further Need for Treatment|3|||
124808535|NCT00216476|448929114|FG001|Overall Study|No Further Need for Treatment|4|||
124808536|NCT00216476|448929115|FG002|Overall Study|No Further Need for Treatment|1|||
124808537|NCT00216476|448929113|FG000|Overall Study|Non-compliance|0|||
124808538|NCT00216476|448929114|FG001|Overall Study|Non-compliance|4|||
124808539|NCT00216476|448929115|FG002|Overall Study|Non-compliance|1|||
124808540|NCT00216476|448929113|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
124808541|NCT00216476|448929114|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
124808542|NCT00216476|448929115|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
124808543|NCT00216476|448929113|FG000|Overall Study|Administrative Reasons|1|||
124808544|NCT00216476|448929114|FG001|Overall Study|Administrative Reasons|1|||
124808545|NCT00216476|448929115|FG002|Overall Study|Administrative Reasons|0|||
124808546|NCT00216476|448929113|FG000|Overall Study|Protocol Deviation|5|||
124808547|NCT00216476|448929114|FG001|Overall Study|Protocol Deviation|1|||
124808548|NCT00216476|448929115|FG002|Overall Study|Protocol Deviation|0|||
124808549|NCT00216476|448929113|FG000|Overall Study|Patient Moved|2|||
124808550|NCT00216476|448929114|FG001|Overall Study|Patient Moved|2|||
124808551|NCT00216476|448929115|FG002|Overall Study|Patient Moved|0|||
124808552|NCT02202980|448929116|FG000|Overall Study|Lack of Efficacy|1|||
124808553|NCT02202980|448929117|FG001|Overall Study|Lack of Efficacy|0|||
124808554|NCT02202980|448929118|FG002|Overall Study|Lack of Efficacy|7|||
124808555|NCT02202980|448929119|FG003|Overall Study|Lack of Efficacy|0|||
124808556|NCT02202980|448929120|FG004|Overall Study|Lack of Efficacy|3|||
124808557|NCT02202980|448929121|FG005|Overall Study|Lack of Efficacy|1|||
124808558|NCT02202980|448929122|FG006|Overall Study|Lack of Efficacy|11|||
124808559|NCT02202980|448929123|FG007|Overall Study|Lack of Efficacy|2|||
124808560|NCT02202980|448929124|FG008|Overall Study|Lack of Efficacy|2|||
124808561|NCT02202980|448929125|FG009|Overall Study|Lack of Efficacy|0|||
124808562|NCT02202980|448929126|FG010|Overall Study|Lack of Efficacy|0|||
124808563|NCT02202980|448929127|FG011|Overall Study|Lack of Efficacy|3|||
124808564|NCT02202980|448929128|FG012|Overall Study|Lack of Efficacy|10|||
124808565|NCT02202980|448929129|FG013|Overall Study|Lack of Efficacy|0|||
124808566|NCT02202980|448929116|FG000|Overall Study|Protocol Violation|0|||
124808567|NCT02202980|448929117|FG001|Overall Study|Protocol Violation|0|||
124808568|NCT02202980|448929118|FG002|Overall Study|Protocol Violation|0|||
124808569|NCT02202980|448929119|FG003|Overall Study|Protocol Violation|3|||
124808570|NCT02202980|448929120|FG004|Overall Study|Protocol Violation|3|||
124808571|NCT02202980|448929121|FG005|Overall Study|Protocol Violation|0|||
124808572|NCT02202980|448929122|FG006|Overall Study|Protocol Violation|0|||
124808573|NCT02202980|448929123|FG007|Overall Study|Protocol Violation|0|||
124808574|NCT02202980|448929124|FG008|Overall Study|Protocol Violation|0|||
124808575|NCT02202980|448929125|FG009|Overall Study|Protocol Violation|0|||
124808576|NCT02202980|448929126|FG010|Overall Study|Protocol Violation|0|||
124808577|NCT02202980|448929127|FG011|Overall Study|Protocol Violation|0|||
124808578|NCT02202980|448929128|FG012|Overall Study|Protocol Violation|0|||
124808579|NCT02202980|448929129|FG013|Overall Study|Protocol Violation|0|||
124808580|NCT02202980|448929116|FG000|Overall Study|Lost to Follow-up|0|||
124808581|NCT02202980|448929117|FG001|Overall Study|Lost to Follow-up|1|||
124808582|NCT02202980|448929118|FG002|Overall Study|Lost to Follow-up|1|||
124808583|NCT02202980|448929119|FG003|Overall Study|Lost to Follow-up|1|||
124808584|NCT02202980|448929120|FG004|Overall Study|Lost to Follow-up|0|||
124808585|NCT02202980|448929121|FG005|Overall Study|Lost to Follow-up|0|||
124808586|NCT02202980|448929122|FG006|Overall Study|Lost to Follow-up|0|||
124808587|NCT02202980|448929123|FG007|Overall Study|Lost to Follow-up|1|||
124808588|NCT02202980|448929124|FG008|Overall Study|Lost to Follow-up|1|||
124808589|NCT02202980|448929125|FG009|Overall Study|Lost to Follow-up|0|||
124808590|NCT02202980|448929126|FG010|Overall Study|Lost to Follow-up|0|||
124808591|NCT02202980|448929127|FG011|Overall Study|Lost to Follow-up|0|||
124808592|NCT02202980|448929128|FG012|Overall Study|Lost to Follow-up|1|||
124808593|NCT02202980|448929129|FG013|Overall Study|Lost to Follow-up|0|||
124808594|NCT02202980|448929116|FG000|Overall Study|Withdrew Consent|0|||
124808595|NCT02202980|448929117|FG001|Overall Study|Withdrew Consent|1|||
124808596|NCT02202980|448929118|FG002|Overall Study|Withdrew Consent|2|||
124808597|NCT02202980|448929119|FG003|Overall Study|Withdrew Consent|0|||
124808598|NCT02202980|448929120|FG004|Overall Study|Withdrew Consent|0|||
124808599|NCT02202980|448929121|FG005|Overall Study|Withdrew Consent|0|||
124808600|NCT02202980|448929122|FG006|Overall Study|Withdrew Consent|0|||
124808601|NCT02202980|448929123|FG007|Overall Study|Withdrew Consent|0|||
124808602|NCT02202980|448929124|FG008|Overall Study|Withdrew Consent|1|||
124808603|NCT02202980|448929125|FG009|Overall Study|Withdrew Consent|0|||
124808604|NCT02202980|448929126|FG010|Overall Study|Withdrew Consent|0|||
124808605|NCT02202980|448929127|FG011|Overall Study|Withdrew Consent|0|||
124808606|NCT02202980|448929128|FG012|Overall Study|Withdrew Consent|0|||
124808607|NCT02202980|448929129|FG013|Overall Study|Withdrew Consent|0|||
124808608|NCT00696800|448929132|FG000|Overall Study|Adverse Event|16|||
124808609|NCT00696800|448929133|FG001|Overall Study|Adverse Event|3|||
124808610|NCT00696800|448929132|FG000|Overall Study|Insufficient compliance with medication|2|||
124808611|NCT00696800|448929133|FG001|Overall Study|Insufficient compliance with medication|1|||
124808612|NCT00696800|448929132|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
124808613|NCT00696800|448929133|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
124808614|NCT00696800|448929132|FG000|Overall Study|Insufficient ovarian response|4|||
124808615|NCT00696800|448929133|FG001|Overall Study|Insufficient ovarian response|1|||
124808616|NCT00696800|448929132|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
124808617|NCT00696800|448929133|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
124808618|NCT00696800|448929132|FG000|Overall Study|Too high ovarian response|6|||
124808619|NCT00696800|448929133|FG001|Overall Study|Too high ovarian response|1|||
124808620|NCT00696800|448929132|FG000|Overall Study|No/too few/bad quality oocytes|4|||
124808621|NCT00696800|448929133|FG001|Overall Study|No/too few/bad quality oocytes|3|||
124634284|NCT00122382|448276265|FG000|Open-Label Study|Lost to Follow-up|0|||
124634285|NCT00122382|448276266|FG001|Open-Label Study|Lost to Follow-up|0|||
124634286|NCT00122382|448276267|FG002|Open-Label Study|Lost to Follow-up|3|||
124634287|NCT00122382|448276265|FG000|Open-Label Study|Pregnancy|0|||
124634288|NCT00122382|448276266|FG001|Open-Label Study|Pregnancy|0|||
124634289|NCT00122382|448276267|FG002|Open-Label Study|Pregnancy|2|||
124634290|NCT00122382|448276265|FG000|Open-Label Study|Poor/Non-Compliance|0|||
124808622|NCT00696800|448929132|FG000|Overall Study|No/abnormal fertilization|11|||
124808623|NCT00696800|448929133|FG001|Overall Study|No/abnormal fertilization|13|||
124808624|NCT00696800|448929132|FG000|Overall Study|No/too few/bad quality embryos|24|||
124808625|NCT00696800|448929133|FG001|Overall Study|No/too few/bad quality embryos|18|||
124808626|NCT00696800|448929132|FG000|Overall Study|Other Reasons|5|||
124808627|NCT00696800|448929133|FG001|Overall Study|Other Reasons|3|||
124808628|NCT00696800|448929132|FG000|Overall Study|Not treated|1|||
124808629|NCT00696800|448929133|FG001|Overall Study|Not treated|2|||
124808630|NCT05224141|448929138|FG000|Overall Study|Ongoing|75|||
124808631|NCT05224141|448929139|FG001|Overall Study|Ongoing|88|||
124808632|NCT05224141|448929138|FG000|Overall Study|Withdrawal by Subject|2|||
124808633|NCT05224141|448929139|FG001|Overall Study|Withdrawal by Subject|4|||
124808634|NCT05224141|448929138|FG000|Overall Study|Death|153|||
124808635|NCT05224141|448929139|FG001|Overall Study|Death|138|||
124808636|NCT01609231|448929148|FG000|Overall Study|Adverse Event|1|||
124808637|NCT01609231|448929149|FG001|Overall Study|Adverse Event|3|||
124808638|NCT01609231|448929148|FG000|Overall Study|Physician Decision|1|||
124808639|NCT01609231|448929149|FG001|Overall Study|Physician Decision|0|||
124808640|NCT01609231|448929148|FG000|Overall Study|Withdrawal by Subject|1|||
124808641|NCT01609231|448929149|FG001|Overall Study|Withdrawal by Subject|0|||
124808642|NCT01927627|448929156|FG000|Overall Study|Adverse Event|3|||
124808643|NCT01927627|448929156|FG000|Overall Study|Lack of Efficacy|1|||
124808644|NCT01927627|448929156|FG000|Overall Study|Financial Concerns|1|||
124808645|NCT00467857|448929157|FG000|Overall Study|Adverse Event|1|||
124808646|NCT00467857|448929158|FG001|Overall Study|Adverse Event|0|||
124808647|NCT00467857|448929157|FG000|Overall Study|Withdrew consent|2|||
124808648|NCT00467857|448929158|FG001|Overall Study|Withdrew consent|0|||
124808649|NCT00467857|448929157|FG000|Overall Study|Death|0|||
124808650|NCT00467857|448929158|FG001|Overall Study|Death|1|||
124808651|NCT00467857|448929157|FG000|Overall Study|Discharged from court service|0|||
124808652|NCT00467857|448929158|FG001|Overall Study|Discharged from court service|1|||
124808653|NCT00467857|448929157|FG000|Overall Study|Emergency care required|0|||
124808654|NCT00467857|448929158|FG001|Overall Study|Emergency care required|1|||
124808655|NCT00467857|448929157|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
124808656|NCT00467857|448929158|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
124808657|NCT00467857|448929157|FG000|Overall Study|Discontinuation reason missing|0|||
124808658|NCT00467857|448929158|FG001|Overall Study|Discontinuation reason missing|3|||
124808659|NCT00338104|448929159|FG000|Overall Study|Protocol Violation|2|||
124808660|NCT00338104|448929160|FG001|Overall Study|Protocol Violation|1|||
124808661|NCT00338104|448929161|FG002|Overall Study|Protocol Violation|3|||
124808662|NCT02298023|448929164|FG000|Overall Study|Withdrawal by Subject|1|||
124808663|NCT02298023|448929165|FG001|Overall Study|Withdrawal by Subject|0|||
124808664|NCT02298023|448929166|FG002|Overall Study|Withdrawal by Subject|0|||
124808665|NCT03307785|448929170|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
124808666|NCT03307785|448929171|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
124808667|NCT03307785|448929172|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
124808668|NCT03307785|448929173|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
124808669|NCT03307785|448929174|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
124808670|NCT03307785|448929175|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
124808671|NCT03307785|448929176|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
124808672|NCT03307785|448929177|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
124634291|NCT00122382|448276266|FG001|Open-Label Study|Poor/Non-Compliance|0|||
124634292|NCT00122382|448276267|FG002|Open-Label Study|Poor/Non-Compliance|1|||
124634293|NCT00122382|448276265|FG000|Open-Label Study|Withdrawal of Consent|0|||
124808673|NCT03307785|448929178|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
124808674|NCT03307785|448929179|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
124808675|NCT03307785|448929180|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
124808676|NCT03307785|448929170|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
124808677|NCT03307785|448929171|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
124808678|NCT03307785|448929172|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808679|NCT03307785|448929173|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808680|NCT03307785|448929174|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808681|NCT03307785|448929175|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808682|NCT03307785|448929176|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808683|NCT03307785|448929177|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808684|NCT03307785|448929178|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808685|NCT03307785|448929179|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808686|NCT03307785|448929180|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
124808687|NCT03307785|448929170|FG000|Part A: Up to 28.5 Months|Death|4|||
124808688|NCT03307785|448929171|FG001|Part A: Up to 28.5 Months|Death|4|||
124808689|NCT03307785|448929172|FG002|Part A: Up to 28.5 Months|Death|0|||
124808690|NCT03307785|448929173|FG003|Part A: Up to 28.5 Months|Death|0|||
124808691|NCT03307785|448929174|FG004|Part A: Up to 28.5 Months|Death|0|||
124808692|NCT03307785|448929175|FG005|Part A: Up to 28.5 Months|Death|0|||
124808693|NCT03307785|448929176|FG006|Part A: Up to 28.5 Months|Death|0|||
124808694|NCT03307785|448929177|FG007|Part A: Up to 28.5 Months|Death|0|||
124808695|NCT03307785|448929178|FG008|Part A: Up to 28.5 Months|Death|0|||
124808696|NCT03307785|448929179|FG009|Part A: Up to 28.5 Months|Death|0|||
124808697|NCT03307785|448929180|FG010|Part A: Up to 28.5 Months|Death|0|||
124808698|NCT03307785|448929170|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
124808699|NCT03307785|448929171|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
124808700|NCT03307785|448929172|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
124808701|NCT03307785|448929173|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
124808702|NCT03307785|448929174|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
124808703|NCT03307785|448929175|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
124808704|NCT03307785|448929176|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
124808705|NCT03307785|448929177|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
124808706|NCT03307785|448929178|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
124808707|NCT03307785|448929179|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
124808708|NCT03307785|448929180|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
124808709|NCT03307785|448929170|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808710|NCT03307785|448929171|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808711|NCT03307785|448929172|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
124808712|NCT03307785|448929173|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808713|NCT03307785|448929174|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808714|NCT03307785|448929175|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808715|NCT03307785|448929176|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808716|NCT03307785|448929177|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808717|NCT03307785|448929178|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808718|NCT03307785|448929179|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808719|NCT03307785|448929180|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
124808720|NCT03307785|448929170|FG000|Part B: Up to Approx. 66 Months|Death|0|||
124808721|NCT03307785|448929171|FG001|Part B: Up to Approx. 66 Months|Death|0|||
124808722|NCT03307785|448929172|FG002|Part B: Up to Approx. 66 Months|Death|7|||
124808723|NCT03307785|448929173|FG003|Part B: Up to Approx. 66 Months|Death|0|||
124808724|NCT03307785|448929174|FG004|Part B: Up to Approx. 66 Months|Death|0|||
124808725|NCT03307785|448929175|FG005|Part B: Up to Approx. 66 Months|Death|0|||
124808726|NCT03307785|448929176|FG006|Part B: Up to Approx. 66 Months|Death|0|||
124808727|NCT03307785|448929177|FG007|Part B: Up to Approx. 66 Months|Death|0|||
124808728|NCT03307785|448929178|FG008|Part B: Up to Approx. 66 Months|Death|0|||
124808729|NCT03307785|448929179|FG009|Part B: Up to Approx. 66 Months|Death|0|||
124808730|NCT03307785|448929180|FG010|Part B: Up to Approx. 66 Months|Death|0|||
124808731|NCT03307785|448929170|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808732|NCT03307785|448929171|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808733|NCT03307785|448929172|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
124808734|NCT03307785|448929173|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808735|NCT03307785|448929174|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808736|NCT03307785|448929175|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808737|NCT03307785|448929176|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808738|NCT03307785|448929177|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808739|NCT03307785|448929178|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808740|NCT03307785|448929179|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808741|NCT03307785|448929180|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
124808742|NCT03307785|448929170|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808743|NCT03307785|448929171|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808744|NCT03307785|448929172|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
124808745|NCT03307785|448929173|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808746|NCT03307785|448929174|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808747|NCT03307785|448929175|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808748|NCT03307785|448929176|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808749|NCT03307785|448929177|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808750|NCT03307785|448929178|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808751|NCT03307785|448929179|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808752|NCT03307785|448929180|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
124808753|NCT03307785|448929170|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808754|NCT03307785|448929171|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808755|NCT03307785|448929172|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
124808756|NCT03307785|448929173|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808757|NCT03307785|448929174|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808758|NCT03307785|448929175|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808759|NCT03307785|448929176|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808760|NCT03307785|448929177|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808761|NCT03307785|448929178|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808762|NCT03307785|448929179|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808763|NCT03307785|448929180|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
124808764|NCT03307785|448929170|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808765|NCT03307785|448929171|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808766|NCT03307785|448929172|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808767|NCT03307785|448929173|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
124808768|NCT03307785|448929174|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
124808769|NCT03307785|448929175|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808770|NCT03307785|448929176|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808771|NCT03307785|448929177|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808772|NCT03307785|448929178|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808773|NCT03307785|448929179|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808774|NCT03307785|448929180|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
124808775|NCT03307785|448929170|FG000|Part C: Up to Approx. 60 Months|Death|0|||
124808776|NCT03307785|448929171|FG001|Part C: Up to Approx. 60 Months|Death|0|||
124808777|NCT03307785|448929172|FG002|Part C: Up to Approx. 60 Months|Death|0|||
124808778|NCT03307785|448929173|FG003|Part C: Up to Approx. 60 Months|Death|2|||
124808779|NCT03307785|448929174|FG004|Part C: Up to Approx. 60 Months|Death|5|||
124808780|NCT03307785|448929175|FG005|Part C: Up to Approx. 60 Months|Death|0|||
124808781|NCT03307785|448929176|FG006|Part C: Up to Approx. 60 Months|Death|0|||
124808782|NCT03307785|448929177|FG007|Part C: Up to Approx. 60 Months|Death|0|||
124808783|NCT03307785|448929178|FG008|Part C: Up to Approx. 60 Months|Death|0|||
124808784|NCT03307785|448929179|FG009|Part C: Up to Approx. 60 Months|Death|0|||
124808785|NCT03307785|448929180|FG010|Part C: Up to Approx. 60 Months|Death|0|||
124808786|NCT03307785|448929170|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808787|NCT03307785|448929171|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808788|NCT03307785|448929172|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808789|NCT03307785|448929173|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
124808790|NCT03307785|448929174|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808791|NCT03307785|448929175|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808792|NCT03307785|448929176|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808793|NCT03307785|448929177|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808794|NCT03307785|448929178|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808795|NCT03307785|448929179|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808796|NCT03307785|448929180|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
124808797|NCT03307785|448929170|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808798|NCT03307785|448929171|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808799|NCT03307785|448929172|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808800|NCT03307785|448929173|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808801|NCT03307785|448929174|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
124808802|NCT03307785|448929175|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808803|NCT03307785|448929176|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808804|NCT03307785|448929177|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808805|NCT03307785|448929178|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808806|NCT03307785|448929179|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124808807|NCT03307785|448929180|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
124634294|NCT00122382|448276266|FG001|Open-Label Study|Withdrawal of Consent|0|||
124634295|NCT00122382|448276267|FG002|Open-Label Study|Withdrawal of Consent|4|||
124634296|NCT02040805|448276269|FG000|Overall Study|Lost to Follow-up|14|||
124634297|NCT02040805|448276270|FG001|Overall Study|Lost to Follow-up|9|||
124634298|NCT02040805|448276269|FG000|Overall Study|Withdrawal by Subject|28|||
124808808|NCT03307785|448929170|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808809|NCT03307785|448929171|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808810|NCT03307785|448929172|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808811|NCT03307785|448929173|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808812|NCT03307785|448929174|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808813|NCT03307785|448929175|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
124808814|NCT03307785|448929176|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808815|NCT03307785|448929177|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808816|NCT03307785|448929178|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808817|NCT03307785|448929179|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808818|NCT03307785|448929180|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
124808819|NCT03307785|448929170|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
124808820|NCT03307785|448929171|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
124808821|NCT03307785|448929172|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
124808822|NCT03307785|448929173|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
124808823|NCT03307785|448929174|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
124808824|NCT03307785|448929175|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
124808825|NCT03307785|448929176|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
124808826|NCT03307785|448929177|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
124808827|NCT03307785|448929178|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
124808828|NCT03307785|448929179|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
124808829|NCT03307785|448929180|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
124808830|NCT03307785|448929170|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808831|NCT03307785|448929171|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808832|NCT03307785|448929172|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808833|NCT03307785|448929173|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808834|NCT03307785|448929174|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808835|NCT03307785|448929175|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
124808836|NCT03307785|448929176|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808837|NCT03307785|448929177|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808838|NCT03307785|448929178|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808839|NCT03307785|448929179|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808840|NCT03307785|448929180|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
124808841|NCT03307785|448929170|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808842|NCT03307785|448929171|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808843|NCT03307785|448929172|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808844|NCT03307785|448929173|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808845|NCT03307785|448929174|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808846|NCT03307785|448929175|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
124808847|NCT03307785|448929176|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808848|NCT03307785|448929177|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808849|NCT03307785|448929178|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808850|NCT03307785|448929179|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808851|NCT03307785|448929180|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
124808852|NCT03307785|448929170|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808853|NCT03307785|448929171|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808854|NCT03307785|448929172|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808855|NCT03307785|448929173|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808856|NCT03307785|448929174|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808857|NCT03307785|448929175|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
124808858|NCT03307785|448929176|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808859|NCT03307785|448929177|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808860|NCT03307785|448929178|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808861|NCT03307785|448929179|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808862|NCT03307785|448929180|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
124808863|NCT03307785|448929170|FG000|Part E: Up to 4.4 Months|Death|0|||
124808864|NCT03307785|448929171|FG001|Part E: Up to 4.4 Months|Death|0|||
124808865|NCT03307785|448929172|FG002|Part E: Up to 4.4 Months|Death|0|||
124808866|NCT03307785|448929173|FG003|Part E: Up to 4.4 Months|Death|0|||
124808867|NCT03307785|448929174|FG004|Part E: Up to 4.4 Months|Death|0|||
124808868|NCT03307785|448929175|FG005|Part E: Up to 4.4 Months|Death|0|||
124808869|NCT03307785|448929176|FG006|Part E: Up to 4.4 Months|Death|1|||
124808870|NCT03307785|448929177|FG007|Part E: Up to 4.4 Months|Death|0|||
124808871|NCT03307785|448929178|FG008|Part E: Up to 4.4 Months|Death|0|||
124634299|NCT02040805|448276270|FG001|Overall Study|Withdrawal by Subject|41|||
124634300|NCT03591874|448276271|FG000|Overall Study|Adverse Event|4|||
124808872|NCT03307785|448929179|FG009|Part E: Up to 4.4 Months|Death|0|||
124808873|NCT03307785|448929180|FG010|Part E: Up to 4.4 Months|Death|0|||
124808874|NCT03307785|448929170|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
124808875|NCT03307785|448929171|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
124808876|NCT03307785|448929172|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
124808877|NCT03307785|448929173|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
124808878|NCT03307785|448929174|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
124808879|NCT03307785|448929175|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
124808880|NCT03307785|448929176|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
124808881|NCT03307785|448929177|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
124808882|NCT03307785|448929178|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
124808883|NCT03307785|448929179|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
124808884|NCT03307785|448929180|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
124808885|NCT03307785|448929170|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
124808886|NCT03307785|448929171|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
124808887|NCT03307785|448929172|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
124808888|NCT03307785|448929173|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
124808889|NCT03307785|448929174|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
124808890|NCT03307785|448929175|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
124808891|NCT03307785|448929176|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
124808892|NCT03307785|448929177|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
124808893|NCT03307785|448929178|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
124808894|NCT03307785|448929179|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
124808895|NCT03307785|448929180|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
124808896|NCT00492531|448929182|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
124808897|NCT00492531|448929183|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
124808898|NCT00843856|448929185|FG000|Overall Study|Lost to Follow-up|1|||
124808899|NCT00843856|448929186|FG001|Overall Study|Lost to Follow-up|2|||
124808900|NCT04729621|448929187|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
124808901|NCT04729621|448929188|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
124808902|NCT04729621|448929189|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
124808903|NCT04729621|448929190|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
124808904|NCT04729621|448929191|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
124808905|NCT04729621|448929187|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
124808906|NCT04729621|448929188|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
124808907|NCT04729621|448929189|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
124808908|NCT04729621|448929190|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
124808909|NCT04729621|448929191|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
124808910|NCT04729621|448929187|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
124808911|NCT04729621|448929188|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
124808912|NCT04729621|448929189|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
124808913|NCT04729621|448929190|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
124808914|NCT04729621|448929191|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
124808915|NCT04729621|448929187|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
124808916|NCT04729621|448929188|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
124808917|NCT04729621|448929189|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
124808918|NCT04729621|448929190|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
124808919|NCT04729621|448929191|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
124808920|NCT04729621|448929187|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
124808921|NCT04729621|448929188|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
124808922|NCT04729621|448929189|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
124808923|NCT04729621|448929190|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
124808924|NCT04729621|448929191|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
124808925|NCT04729621|448929187|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
124808926|NCT04729621|448929188|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
124808927|NCT04729621|448929189|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
124808928|NCT04729621|448929190|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
124808929|NCT04729621|448929191|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
124808930|NCT00319501|448929196|FG000|Double-blind Period|Withdrawal by Subject|0|||
124808931|NCT00319501|448929197|FG001|Double-blind Period|Withdrawal by Subject|3|||
124808932|NCT00319501|448929196|FG000|Double-blind Period|Sponsor Request|1|||
124808933|NCT00319501|448929197|FG001|Double-blind Period|Sponsor Request|0|||
124808934|NCT00319501|448929196|FG000|Double-blind Period|Did not receive treatment|42|||
124808935|NCT00319501|448929197|FG001|Double-blind Period|Did not receive treatment|29|||
124808936|NCT00319501|448929196|FG000|Open-label Period|Adverse Event|5|||
124808937|NCT00319501|448929197|FG001|Open-label Period|Adverse Event|0|||
124808938|NCT00319501|448929196|FG000|Open-label Period|Protocol Violation|6|||
124808939|NCT00319501|448929197|FG001|Open-label Period|Protocol Violation|0|||
124808940|NCT00319501|448929196|FG000|Open-label Period|Withdrawal by Subject|38|||
124808941|NCT00319501|448929197|FG001|Open-label Period|Withdrawal by Subject|0|||
124808942|NCT00319501|448929196|FG000|Open-label Period|Principal Investigator decision|6|||
124808943|NCT00319501|448929197|FG001|Open-label Period|Principal Investigator decision|0|||
124808944|NCT00319501|448929196|FG000|Open-label Period|Sponsor request|12|||
124808945|NCT00319501|448929197|FG001|Open-label Period|Sponsor request|0|||
124808946|NCT00319501|448929196|FG000|Open-label Period|Lost to Follow-up|5|||
124808947|NCT00319501|448929197|FG001|Open-label Period|Lost to Follow-up|0|||
124808948|NCT00319501|448929196|FG000|Open-label Period|Did not receive treatment|33|||
124808949|NCT00319501|448929197|FG001|Open-label Period|Did not receive treatment|0|||
124808950|NCT00319501|448929196|FG000|Open-label Period|Other|11|||
124808951|NCT00319501|448929197|FG001|Open-label Period|Other|0|||
124808952|NCT00319501|448929196|FG000|Open-label Extension Period|Adverse Event|2|||
124808953|NCT00319501|448929197|FG001|Open-label Extension Period|Adverse Event|0|||
124808954|NCT00319501|448929196|FG000|Open-label Extension Period|Did not receive treatment|18|||
124808955|NCT00319501|448929197|FG001|Open-label Extension Period|Did not receive treatment|0|||
124808956|NCT00319501|448929196|FG000|Open-label Extension Period|Other|1|||
124808957|NCT00319501|448929197|FG001|Open-label Extension Period|Other|0|||
124808958|NCT00319501|448929196|FG000|Open-label Extension Period|Principal investigator decision|2|||
124808959|NCT00319501|448929197|FG001|Open-label Extension Period|Principal investigator decision|0|||
124808960|NCT00319501|448929196|FG000|Open-label Extension Period|Sponsor request|26|||
124808961|NCT00319501|448929197|FG001|Open-label Extension Period|Sponsor request|0|||
124808962|NCT00319501|448929196|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
124808963|NCT00319501|448929197|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
124808964|NCT01696071|448929203|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
124808965|NCT01696071|448929204|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
124808966|NCT02569671|448929210|FG000|Overall Study|Lost to Follow-up|2|||
124808967|NCT02569671|448929211|FG001|Overall Study|Lost to Follow-up|1|||
124808968|NCT02569671|448929210|FG000|Overall Study|Withdrawal by Subject|1|||
124808969|NCT02569671|448929211|FG001|Overall Study|Withdrawal by Subject|3|||
124808970|NCT03487549|448929212|FG000|Overall Study|Protocol Violation|0|||
124808971|NCT03487549|448929213|FG001|Overall Study|Protocol Violation|1|||
124808972|NCT03487549|448929212|FG000|Overall Study|Lost to Follow-up|2|||
124808973|NCT03487549|448929213|FG001|Overall Study|Lost to Follow-up|1|||
124808974|NCT03487549|448929212|FG000|Overall Study|Withdrawal by Subject|2|||
124808975|NCT03487549|448929213|FG001|Overall Study|Withdrawal by Subject|0|||
124808976|NCT01977794|448930784|FG000|Overall Study|Adverse Event|2|||
124808977|NCT01977794|448930785|FG001|Overall Study|Adverse Event|2|||
124808978|NCT01977794|448930784|FG000|Overall Study|Lost to Follow-up|2|||
124808979|NCT01977794|448930785|FG001|Overall Study|Lost to Follow-up|1|||
124808980|NCT01977794|448930784|FG000|Overall Study|Protocol Violation|1|||
124808981|NCT01977794|448930785|FG001|Overall Study|Protocol Violation|0|||
124808982|NCT01977794|448930784|FG000|Overall Study|Death|1|||
124808983|NCT01977794|448930785|FG001|Overall Study|Death|1|||
124808984|NCT01977794|448930784|FG000|Overall Study|Withdrew consent|2|||
124808985|NCT01977794|448930785|FG001|Overall Study|Withdrew consent|1|||
124808986|NCT01977794|448930784|FG000|Overall Study|Other|0|||
124808987|NCT01977794|448930785|FG001|Overall Study|Other|1|||
124808988|NCT00827502|448930788|FG000|Overall Study|randomized but not treated|11|||
124808989|NCT00827502|448930788|FG000|Overall Study|Adverse Event|1|||
124808990|NCT00827502|448930788|FG000|Overall Study|Lost to Follow-up|4|||
124808991|NCT00827502|448930788|FG000|Overall Study|Withdrawal by Subject|5|||
124808992|NCT01705730|448930793|FG000|Overall Study|Lack of Efficacy|1|||
124808993|NCT01705730|448930793|FG000|Overall Study|Adverse Event|3|||
124808994|NCT01705730|448930793|FG000|Overall Study|Lost to Follow-up|1|||
124634301|NCT03591874|448276272|FG001|Overall Study|Adverse Event|0|||
124634302|NCT03591874|448276271|FG000|Overall Study|Withdrawal by Subject|2|||
124634303|NCT03591874|448276272|FG001|Overall Study|Withdrawal by Subject|1|||
124634304|NCT03591874|448276271|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
124634305|NCT03591874|448276272|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
124634306|NCT03591874|448276271|FG000|Overall Study|On Study at Time of Study Termination|12|||
124634307|NCT03591874|448276272|FG001|Overall Study|On Study at Time of Study Termination|6|||
124634308|NCT02269098|448276273|FG000|Overall Study|Lost to Follow-up|14|||
124634309|NCT02269098|448276274|FG001|Overall Study|Lost to Follow-up|9|||
124634310|NCT03194542|448276279|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
124634311|NCT03194542|448276280|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
124634312|NCT03194542|448276281|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
124634313|NCT03194542|448276282|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
124808995|NCT01705730|448930793|FG000|Overall Study|Reason not Specified|4|||
124808996|NCT03228433|448930794|FG000|Overall Study|Lost to Follow-up|1|||
124808997|NCT03228433|448930795|FG001|Overall Study|Lost to Follow-up|0|||
124808998|NCT03228433|448930796|FG002|Overall Study|Lost to Follow-up|0|||
124808999|NCT03228433|448930797|FG003|Overall Study|Lost to Follow-up|0|||
124809000|NCT03228433|448930798|FG004|Overall Study|Lost to Follow-up|0|||
124809001|NCT03228433|448930799|FG005|Overall Study|Lost to Follow-up|0|||
124809002|NCT03228433|448930794|FG000|Overall Study|Positive alcohol test|0|||
124809003|NCT03228433|448930795|FG001|Overall Study|Positive alcohol test|0|||
124809004|NCT03228433|448930796|FG002|Overall Study|Positive alcohol test|0|||
124809005|NCT03228433|448930797|FG003|Overall Study|Positive alcohol test|1|||
124809006|NCT03228433|448930798|FG004|Overall Study|Positive alcohol test|0|||
124809007|NCT03228433|448930799|FG005|Overall Study|Positive alcohol test|0|||
124809008|NCT01773733|448930800|FG000|Overall Study|Adverse Event|3286|||
124809009|NCT01773733|448930801|FG001|Overall Study|Adverse Event|540|||
124809010|NCT01773733|448930800|FG000|Overall Study|Pregnancy|28|||
124809011|NCT01773733|448930801|FG001|Overall Study|Pregnancy|0|||
124809012|NCT01773733|448930800|FG000|Overall Study|Other different categories of not compl|55415|||
124809013|NCT01773733|448930801|FG001|Overall Study|Other different categories of not compl|7781|||
124809014|NCT01030536|448930802|FG000|Overall Study|Withdrawal by Subject|0|||
124809015|NCT01030536|448930803|FG001|Overall Study|Withdrawal by Subject|0|||
124809016|NCT01030536|448930804|FG002|Overall Study|Withdrawal by Subject|1|||
124809017|NCT01030536|448930805|FG003|Overall Study|Withdrawal by Subject|0|||
124809018|NCT01030536|448930806|FG004|Overall Study|Withdrawal by Subject|0|||
124809019|NCT01030536|448930802|FG000|Overall Study|undefined|1|||
124809020|NCT01030536|448930803|FG001|Overall Study|undefined|0|||
124809021|NCT01030536|448930804|FG002|Overall Study|undefined|1|||
124809022|NCT01030536|448930805|FG003|Overall Study|undefined|1|||
124809023|NCT01030536|448930806|FG004|Overall Study|undefined|0|||
124809024|NCT01030536|448930802|FG000|Overall Study|Adverse Event|0|||
124809025|NCT01030536|448930803|FG001|Overall Study|Adverse Event|3|||
124809026|NCT01030536|448930804|FG002|Overall Study|Adverse Event|1|||
124809027|NCT01030536|448930805|FG003|Overall Study|Adverse Event|0|||
124809028|NCT01030536|448930806|FG004|Overall Study|Adverse Event|1|||
124809029|NCT01030536|448930802|FG000|Overall Study|Progressive disease|6|||
124809030|NCT01030536|448930803|FG001|Overall Study|Progressive disease|2|||
124809031|NCT01030536|448930804|FG002|Overall Study|Progressive disease|3|||
124809032|NCT01030536|448930805|FG003|Overall Study|Progressive disease|2|||
124809033|NCT01030536|448930806|FG004|Overall Study|Progressive disease|0|||
124809034|NCT01030536|448930802|FG000|Overall Study|Death|0|||
124809035|NCT01030536|448930803|FG001|Overall Study|Death|1|||
124809036|NCT01030536|448930804|FG002|Overall Study|Death|0|||
124809037|NCT01030536|448930805|FG003|Overall Study|Death|0|||
124809038|NCT01030536|448930806|FG004|Overall Study|Death|0|||
124809039|NCT01330030|448930811|FG000|Overall Study|Lost to Follow-up|16|||
124809040|NCT01330030|448930812|FG001|Overall Study|Lost to Follow-up|17|||
124809041|NCT04891978|448930816|FG000|Baseline|Protocol Violation|2|||
124809042|NCT04891978|448930817|FG001|Baseline|Protocol Violation|1|||
124809043|NCT04891978|448930818|FG002|Baseline|Protocol Violation|0|||
124809044|NCT04891978|448930816|FG000|Baseline|Missing AIRQ|1|||
124809045|NCT04891978|448930817|FG001|Baseline|Missing AIRQ|0|||
124809046|NCT04891978|448930818|FG002|Baseline|Missing AIRQ|0|||
124809047|NCT04891978|448930816|FG000|Baseline|Did not attend a baseline visit|0|||
124809048|NCT04891978|448930817|FG001|Baseline|Did not attend a baseline visit|0|||
124809049|NCT04891978|448930818|FG002|Baseline|Did not attend a baseline visit|9|||
124809050|NCT01781975|448930824|FG000|Overall Study|Death|1|||
124809051|NCT01781975|448930825|FG001|Overall Study|Death|0|||
124809052|NCT01781975|448930824|FG000|Overall Study|Withdrawal by Subject|1|||
124809053|NCT01781975|448930825|FG001|Overall Study|Withdrawal by Subject|1|||
124809054|NCT01622231|448930826|FG000|Overall Study|Physician Decision|1|||
124809055|NCT01622231|448930826|FG000|Overall Study|Withdrawal by Subject|1|||
124809056|NCT02264639|448930827|FG000|Overall Study|Death (after completing single-dose phase)|1|||
124809057|NCT02264639|448930828|FG001|Overall Study|Death (after completing single-dose phase)|0|||
124809058|NCT02264639|448930829|FG002|Overall Study|Death (after completing single-dose phase)|0|||
124809059|NCT02264639|448930830|FG003|Overall Study|Death (after completing single-dose phase)|0|||
124809060|NCT02264639|448930831|FG004|Overall Study|Death (after completing single-dose phase)|0|||
124809061|NCT02264639|448930827|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
124809062|NCT02264639|448930828|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
124809063|NCT02264639|448930829|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
124809064|NCT02264639|448930830|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
124809065|NCT02264639|448930831|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
124809066|NCT02264639|448930827|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
124809067|NCT02264639|448930828|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
124809068|NCT02264639|448930829|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
124809069|NCT02264639|448930830|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
124809070|NCT02264639|448930831|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
124809071|NCT02264639|448930827|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
124809072|NCT02264639|448930828|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
124809073|NCT02264639|448930829|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
124809074|NCT02264639|448930830|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
124809075|NCT02264639|448930831|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
124809076|NCT04889222|448930835|FG000|Overall Study|Did not meet eligibility criteria|8|||
124809077|NCT04889222|448930835|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
124809078|NCT04889222|448930835|FG000|Overall Study|Did not proceed due to time constraints|5|||
124809079|NCT01180647|448930836|FG000|Overall Study|Lost to Follow-up|5|||
124809080|NCT01180647|448930837|FG001|Overall Study|Lost to Follow-up|6|||
124809081|NCT00702689|448930840|FG000|Overall Study|Withdrawal by Subject|4|||
124809082|NCT00702689|448930840|FG000|Overall Study|Recurrent malignancy|1|||
124809083|NCT00702689|448930840|FG000|Overall Study|Adverse Event|1|||
124809084|NCT02716805|448930848|FG000|Overall Study|Progressive disease|2|||
124809085|NCT02716805|448930849|FG001|Overall Study|Progressive disease|0|||
124809086|NCT02716805|448930850|FG002|Overall Study|Progressive disease|0|||
124809087|NCT02716805|448930851|FG003|Overall Study|Progressive disease|0|||
124809088|NCT02121522|448930858|FG000|Overall Study|Adverse Event|1|||
124809089|NCT00633750|448930860|FG000|Overall Study|Adverse Event|2|||
124809090|NCT00633750|448930860|FG000|Overall Study|Withdrawal by Subject|3|||
124809091|NCT01903031|448930861|FG000|Overall Study|Not Able to Attend Clinic|1|||
124809092|NCT01903031|448930862|FG001|Overall Study|Not Able to Attend Clinic|1|||
124809093|NCT01903031|448930863|FG002|Overall Study|Not Able to Attend Clinic|0|||
124809094|NCT01903031|448930861|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
124809095|NCT01903031|448930862|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
124809096|NCT01903031|448930863|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
124809097|NCT01903031|448930861|FG000|Overall Study|Adverse Event|0|||
124809098|NCT01903031|448930862|FG001|Overall Study|Adverse Event|1|||
124809099|NCT01903031|448930863|FG002|Overall Study|Adverse Event|0|||
124809100|NCT01903031|448930861|FG000|Overall Study|Withdrawal by Subject|0|||
124809101|NCT01903031|448930862|FG001|Overall Study|Withdrawal by Subject|1|||
124809102|NCT01903031|448930863|FG002|Overall Study|Withdrawal by Subject|1|||
124809103|NCT01903031|448930861|FG000|Overall Study|Protocol Violation|0|||
124809104|NCT01903031|448930862|FG001|Overall Study|Protocol Violation|0|||
124809105|NCT01903031|448930863|FG002|Overall Study|Protocol Violation|2|||
124809106|NCT01903031|448930861|FG000|Overall Study|Lost to Follow-up|0|||
124809107|NCT01903031|448930862|FG001|Overall Study|Lost to Follow-up|0|||
124809108|NCT01903031|448930863|FG002|Overall Study|Lost to Follow-up|1|||
124809109|NCT01903031|448930861|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
124809110|NCT01903031|448930862|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
124809111|NCT01903031|448930863|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
124809112|NCT03540030|448930864|FG000|Overall Study|Withdrawal by Subject|2|||
124809113|NCT03540030|448930865|FG001|Overall Study|Withdrawal by Subject|1|||
124809114|NCT03540030|448930864|FG000|Overall Study|screen fail|7|||
124809115|NCT03540030|448930865|FG001|Overall Study|screen fail|1|||
124809116|NCT03540030|448930864|FG000|Overall Study|never had surgery after signing consent|9|||
124809117|NCT03540030|448930865|FG001|Overall Study|never had surgery after signing consent|1|||
124809118|NCT03666624|448930870|FG000|Overall Study|participant grieving over recent death of parent|1|||
124809119|NCT03666624|448930871|FG001|Overall Study|participant grieving over recent death of parent|0|||
124809120|NCT00569270|448930873|FG000|Period: First Intervention|Protocol Violation|0|||
124809121|NCT00569270|448930874|FG001|Period: First Intervention|Protocol Violation|1|||
124809122|NCT00447005|448930875|FG000|Overall Study|Adverse Event|1|||
124809123|NCT00447005|448930875|FG000|Overall Study|Lack of Efficacy|11|||
124809124|NCT03822182|448930876|FG000|Overall Study|Protocol Violation|0|||
124809125|NCT03822182|448930877|FG001|Overall Study|Protocol Violation|1|||
124809126|NCT03822182|448930878|FG002|Overall Study|Protocol Violation|1|||
124809127|NCT00810355|448930882|FG000|Overall Study|Lost to Follow-up|13|||
124809128|NCT00810355|448930883|FG001|Overall Study|Lost to Follow-up|17|||
124809129|NCT00810355|448930884|FG002|Overall Study|Lost to Follow-up|11|||
124809130|NCT00810355|448930882|FG000|Overall Study|Withdrawal by Subject|1|||
124809131|NCT00810355|448930883|FG001|Overall Study|Withdrawal by Subject|0|||
124809132|NCT00810355|448930884|FG002|Overall Study|Withdrawal by Subject|0|||
124809133|NCT01484275|448930885|FG000|Overall Study|Study terminated by sponsor|28|||
124809134|NCT01484275|448930886|FG001|Overall Study|Study terminated by sponsor|32|||
124809135|NCT01484275|448930885|FG000|Overall Study|Other|10|||
124809136|NCT01484275|448930886|FG001|Overall Study|Other|0|||
124809137|NCT01484275|448930885|FG000|Overall Study|Death|3|||
124809138|NCT01484275|448930886|FG001|Overall Study|Death|4|||
124809139|NCT01484275|448930885|FG000|Overall Study|Withdrawal by Subject|1|||
124809140|NCT01484275|448930886|FG001|Overall Study|Withdrawal by Subject|5|||
124809141|NCT01484275|448930885|FG000|Overall Study|Lost to Follow-up|1|||
124809142|NCT01484275|448930886|FG001|Overall Study|Lost to Follow-up|1|||
124809143|NCT04154930|448930889|FG000|Overall Study|Withdrawal by Subject|15|||
124809144|NCT04154930|448930890|FG001|Overall Study|Withdrawal by Subject|6|||
124809145|NCT04154930|448930889|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
124809146|NCT04154930|448930890|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
124809147|NCT04154930|448930889|FG000|Overall Study|Lost to Follow-up|14|||
124809148|NCT04154930|448930890|FG001|Overall Study|Lost to Follow-up|6|||
124809149|NCT04154930|448930889|FG000|Overall Study|Other|6|||
124809150|NCT04154930|448930890|FG001|Overall Study|Other|0|||
124809151|NCT02130297|448930891|FG000|Overall Study|Lost to Follow-up|4|||
124809152|NCT00347360|448930892|FG000|Overall Study|Adverse Event|1|||
124809153|NCT00347360|448930893|FG001|Overall Study|Adverse Event|2|||
124809154|NCT00347360|448930894|FG002|Overall Study|Adverse Event|0|||
124809155|NCT00347360|448930895|FG003|Overall Study|Adverse Event|4|||
124809156|NCT00347360|448930896|FG004|Overall Study|Adverse Event|1|||
124809157|NCT00347360|448930897|FG005|Overall Study|Adverse Event|2|||
124809158|NCT00347360|448930898|FG006|Overall Study|Adverse Event|2|||
124809159|NCT00347360|448930899|FG007|Overall Study|Adverse Event|0|||
124809160|NCT00347360|448930900|FG008|Overall Study|Adverse Event|2|||
124809161|NCT00347360|448930901|FG009|Overall Study|Adverse Event|3|||
124809162|NCT00347360|448930902|FG010|Overall Study|Adverse Event|3|||
124809163|NCT00347360|448930903|FG011|Overall Study|Adverse Event|1|||
124809164|NCT00347360|448930904|FG012|Overall Study|Adverse Event|3|||
124809165|NCT00347360|448930905|FG013|Overall Study|Adverse Event|2|||
124809166|NCT00347360|448930906|FG014|Overall Study|Adverse Event|2|||
124809167|NCT00347360|448930892|FG000|Overall Study|Lost to Follow-up|0|||
124809168|NCT00347360|448930893|FG001|Overall Study|Lost to Follow-up|0|||
124809169|NCT00347360|448930894|FG002|Overall Study|Lost to Follow-up|0|||
124809170|NCT00347360|448930895|FG003|Overall Study|Lost to Follow-up|2|||
124809171|NCT00347360|448930896|FG004|Overall Study|Lost to Follow-up|1|||
124809172|NCT00347360|448930897|FG005|Overall Study|Lost to Follow-up|1|||
124809173|NCT00347360|448930898|FG006|Overall Study|Lost to Follow-up|0|||
124809174|NCT00347360|448930899|FG007|Overall Study|Lost to Follow-up|1|||
124809175|NCT00347360|448930900|FG008|Overall Study|Lost to Follow-up|1|||
124809176|NCT00347360|448930901|FG009|Overall Study|Lost to Follow-up|2|||
124809177|NCT00347360|448930902|FG010|Overall Study|Lost to Follow-up|0|||
124809178|NCT00347360|448930903|FG011|Overall Study|Lost to Follow-up|0|||
124809179|NCT00347360|448930904|FG012|Overall Study|Lost to Follow-up|1|||
124809180|NCT00347360|448930905|FG013|Overall Study|Lost to Follow-up|0|||
124809181|NCT00347360|448930906|FG014|Overall Study|Lost to Follow-up|0|||
124809182|NCT00347360|448930892|FG000|Overall Study|Protocol Violation|2|||
124809183|NCT00347360|448930893|FG001|Overall Study|Protocol Violation|3|||
124809184|NCT00347360|448930894|FG002|Overall Study|Protocol Violation|1|||
124809185|NCT00347360|448930895|FG003|Overall Study|Protocol Violation|2|||
124809186|NCT00347360|448930896|FG004|Overall Study|Protocol Violation|1|||
124809187|NCT00347360|448930897|FG005|Overall Study|Protocol Violation|2|||
124809188|NCT00347360|448930898|FG006|Overall Study|Protocol Violation|0|||
124809189|NCT00347360|448930899|FG007|Overall Study|Protocol Violation|0|||
124809190|NCT00347360|448930900|FG008|Overall Study|Protocol Violation|1|||
124809191|NCT00347360|448930901|FG009|Overall Study|Protocol Violation|2|||
124809192|NCT00347360|448930902|FG010|Overall Study|Protocol Violation|0|||
124809193|NCT00347360|448930903|FG011|Overall Study|Protocol Violation|0|||
124809194|NCT00347360|448930904|FG012|Overall Study|Protocol Violation|0|||
124809195|NCT00347360|448930905|FG013|Overall Study|Protocol Violation|1|||
124809196|NCT00347360|448930906|FG014|Overall Study|Protocol Violation|0|||
124809197|NCT00347360|448930892|FG000|Overall Study|Withdrawal by Subject|0|||
124809198|NCT00347360|448930893|FG001|Overall Study|Withdrawal by Subject|1|||
124809199|NCT00347360|448930894|FG002|Overall Study|Withdrawal by Subject|2|||
124809200|NCT00347360|448930895|FG003|Overall Study|Withdrawal by Subject|4|||
124809201|NCT00347360|448930896|FG004|Overall Study|Withdrawal by Subject|1|||
124809202|NCT00347360|448930897|FG005|Overall Study|Withdrawal by Subject|2|||
124809203|NCT00347360|448930898|FG006|Overall Study|Withdrawal by Subject|1|||
124634314|NCT03194542|448276279|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
124634315|NCT03194542|448276280|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
124809204|NCT00347360|448930899|FG007|Overall Study|Withdrawal by Subject|1|||
124809205|NCT00347360|448930900|FG008|Overall Study|Withdrawal by Subject|1|||
124809206|NCT00347360|448930901|FG009|Overall Study|Withdrawal by Subject|1|||
124809207|NCT00347360|448930902|FG010|Overall Study|Withdrawal by Subject|0|||
124809208|NCT00347360|448930903|FG011|Overall Study|Withdrawal by Subject|3|||
124809209|NCT00347360|448930904|FG012|Overall Study|Withdrawal by Subject|4|||
124809210|NCT00347360|448930905|FG013|Overall Study|Withdrawal by Subject|2|||
124809211|NCT00347360|448930906|FG014|Overall Study|Withdrawal by Subject|1|||
124809212|NCT00347360|448930892|FG000|Overall Study|Lack of Efficacy|1|||
124809213|NCT00347360|448930893|FG001|Overall Study|Lack of Efficacy|1|||
124809214|NCT00347360|448930894|FG002|Overall Study|Lack of Efficacy|3|||
124809215|NCT00347360|448930895|FG003|Overall Study|Lack of Efficacy|1|||
124809216|NCT00347360|448930896|FG004|Overall Study|Lack of Efficacy|0|||
124809217|NCT00347360|448930897|FG005|Overall Study|Lack of Efficacy|1|||
124809218|NCT00347360|448930898|FG006|Overall Study|Lack of Efficacy|0|||
124809219|NCT00347360|448930899|FG007|Overall Study|Lack of Efficacy|1|||
124809220|NCT00347360|448930900|FG008|Overall Study|Lack of Efficacy|1|||
124809221|NCT00347360|448930901|FG009|Overall Study|Lack of Efficacy|0|||
124809222|NCT00347360|448930902|FG010|Overall Study|Lack of Efficacy|0|||
124809223|NCT00347360|448930903|FG011|Overall Study|Lack of Efficacy|0|||
124809224|NCT00347360|448930904|FG012|Overall Study|Lack of Efficacy|0|||
124809225|NCT00347360|448930905|FG013|Overall Study|Lack of Efficacy|0|||
124809226|NCT00347360|448930906|FG014|Overall Study|Lack of Efficacy|0|||
124809227|NCT00347360|448930892|FG000|Overall Study|Reason not listed/blank|1|||
124809228|NCT00347360|448930893|FG001|Overall Study|Reason not listed/blank|0|||
124809229|NCT00347360|448930894|FG002|Overall Study|Reason not listed/blank|0|||
124809230|NCT00347360|448930895|FG003|Overall Study|Reason not listed/blank|0|||
124809231|NCT00347360|448930896|FG004|Overall Study|Reason not listed/blank|0|||
124809232|NCT00347360|448930897|FG005|Overall Study|Reason not listed/blank|0|||
124809233|NCT00347360|448930898|FG006|Overall Study|Reason not listed/blank|1|||
124809234|NCT00347360|448930899|FG007|Overall Study|Reason not listed/blank|0|||
124809235|NCT00347360|448930900|FG008|Overall Study|Reason not listed/blank|0|||
124809236|NCT00347360|448930901|FG009|Overall Study|Reason not listed/blank|0|||
124809237|NCT00347360|448930902|FG010|Overall Study|Reason not listed/blank|0|||
124809238|NCT00347360|448930903|FG011|Overall Study|Reason not listed/blank|0|||
124809239|NCT00347360|448930904|FG012|Overall Study|Reason not listed/blank|0|||
124809240|NCT00347360|448930905|FG013|Overall Study|Reason not listed/blank|1|||
124809241|NCT00347360|448930906|FG014|Overall Study|Reason not listed/blank|0|||
124809242|NCT00347360|448930892|FG000|Overall Study|Per sponsors instruction|0|||
124809243|NCT00347360|448930893|FG001|Overall Study|Per sponsors instruction|1|||
124809244|NCT00347360|448930894|FG002|Overall Study|Per sponsors instruction|0|||
124809245|NCT00347360|448930895|FG003|Overall Study|Per sponsors instruction|0|||
124809246|NCT00347360|448930896|FG004|Overall Study|Per sponsors instruction|0|||
124809247|NCT00347360|448930897|FG005|Overall Study|Per sponsors instruction|0|||
124809248|NCT00347360|448930898|FG006|Overall Study|Per sponsors instruction|0|||
124809249|NCT00347360|448930899|FG007|Overall Study|Per sponsors instruction|0|||
124809250|NCT00347360|448930900|FG008|Overall Study|Per sponsors instruction|0|||
124809251|NCT00347360|448930901|FG009|Overall Study|Per sponsors instruction|0|||
124809252|NCT00347360|448930902|FG010|Overall Study|Per sponsors instruction|0|||
124809253|NCT00347360|448930903|FG011|Overall Study|Per sponsors instruction|0|||
124809254|NCT00347360|448930904|FG012|Overall Study|Per sponsors instruction|0|||
124809255|NCT00347360|448930905|FG013|Overall Study|Per sponsors instruction|0|||
124809256|NCT00347360|448930906|FG014|Overall Study|Per sponsors instruction|0|||
124809257|NCT00347360|448930892|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
124809258|NCT00347360|448930893|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
124809259|NCT00347360|448930894|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
124809260|NCT00347360|448930895|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
124809261|NCT00347360|448930896|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
124809262|NCT00347360|448930897|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
124809263|NCT00347360|448930898|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
124809264|NCT00347360|448930899|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
124809265|NCT00347360|448930900|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
124809266|NCT00347360|448930901|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
124809267|NCT00347360|448930902|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
124809268|NCT00347360|448930903|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
124809269|NCT00347360|448930904|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
124809270|NCT00347360|448930905|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
124809271|NCT00347360|448930906|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
124809272|NCT00347360|448930892|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
124809273|NCT00347360|448930893|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
124809274|NCT00347360|448930894|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
124809275|NCT00347360|448930895|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
124809276|NCT00347360|448930896|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
124809277|NCT00347360|448930897|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
124809278|NCT00347360|448930898|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
124809279|NCT00347360|448930899|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
124809280|NCT00347360|448930900|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
124809281|NCT00347360|448930901|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
124809282|NCT00347360|448930902|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
124809283|NCT00347360|448930903|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
124809284|NCT00347360|448930904|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
124809285|NCT00347360|448930905|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
124809286|NCT00347360|448930906|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
124809287|NCT00347360|448930892|FG000|Overall Study|Abnormal lab values|0|||
124809288|NCT00347360|448930893|FG001|Overall Study|Abnormal lab values|0|||
124634316|NCT03194542|448276281|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
124809289|NCT00347360|448930894|FG002|Overall Study|Abnormal lab values|0|||
124634317|NCT03194542|448276282|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
124809290|NCT00347360|448930895|FG003|Overall Study|Abnormal lab values|0|||
124809291|NCT00347360|448930896|FG004|Overall Study|Abnormal lab values|0|||
124809292|NCT00347360|448930897|FG005|Overall Study|Abnormal lab values|0|||
124809293|NCT00347360|448930898|FG006|Overall Study|Abnormal lab values|1|||
124809294|NCT00347360|448930899|FG007|Overall Study|Abnormal lab values|0|||
124809295|NCT00347360|448930900|FG008|Overall Study|Abnormal lab values|0|||
124809296|NCT00347360|448930901|FG009|Overall Study|Abnormal lab values|0|||
124809297|NCT00347360|448930902|FG010|Overall Study|Abnormal lab values|0|||
124809298|NCT00347360|448930903|FG011|Overall Study|Abnormal lab values|0|||
124809299|NCT00347360|448930904|FG012|Overall Study|Abnormal lab values|0|||
124809300|NCT00347360|448930905|FG013|Overall Study|Abnormal lab values|0|||
124809301|NCT00347360|448930906|FG014|Overall Study|Abnormal lab values|0|||
124809302|NCT00347360|448930892|FG000|Overall Study|PI recommended early withdrawal|0|||
124809303|NCT00347360|448930893|FG001|Overall Study|PI recommended early withdrawal|0|||
124809304|NCT00347360|448930894|FG002|Overall Study|PI recommended early withdrawal|0|||
124809305|NCT00347360|448930895|FG003|Overall Study|PI recommended early withdrawal|0|||
124809306|NCT00347360|448930896|FG004|Overall Study|PI recommended early withdrawal|0|||
124809307|NCT00347360|448930897|FG005|Overall Study|PI recommended early withdrawal|0|||
124809308|NCT00347360|448930898|FG006|Overall Study|PI recommended early withdrawal|0|||
124809309|NCT00347360|448930899|FG007|Overall Study|PI recommended early withdrawal|0|||
124809310|NCT00347360|448930900|FG008|Overall Study|PI recommended early withdrawal|0|||
124809311|NCT00347360|448930901|FG009|Overall Study|PI recommended early withdrawal|1|||
124809312|NCT00347360|448930902|FG010|Overall Study|PI recommended early withdrawal|0|||
124809313|NCT00347360|448930903|FG011|Overall Study|PI recommended early withdrawal|0|||
124809314|NCT00347360|448930904|FG012|Overall Study|PI recommended early withdrawal|0|||
124809315|NCT00347360|448930905|FG013|Overall Study|PI recommended early withdrawal|0|||
124809316|NCT00347360|448930906|FG014|Overall Study|PI recommended early withdrawal|0|||
124809317|NCT00347360|448930892|FG000|Overall Study|Did not meet criteria before ABPM|0|||
124809318|NCT00347360|448930893|FG001|Overall Study|Did not meet criteria before ABPM|0|||
124809319|NCT00347360|448930894|FG002|Overall Study|Did not meet criteria before ABPM|0|||
124809320|NCT00347360|448930895|FG003|Overall Study|Did not meet criteria before ABPM|0|||
124809321|NCT00347360|448930896|FG004|Overall Study|Did not meet criteria before ABPM|0|||
124809322|NCT00347360|448930897|FG005|Overall Study|Did not meet criteria before ABPM|0|||
124809323|NCT00347360|448930898|FG006|Overall Study|Did not meet criteria before ABPM|0|||
124809324|NCT00347360|448930899|FG007|Overall Study|Did not meet criteria before ABPM|0|||
124809325|NCT00347360|448930900|FG008|Overall Study|Did not meet criteria before ABPM|0|||
124809326|NCT00347360|448930901|FG009|Overall Study|Did not meet criteria before ABPM|0|||
124809327|NCT00347360|448930902|FG010|Overall Study|Did not meet criteria before ABPM|1|||
124809328|NCT00347360|448930903|FG011|Overall Study|Did not meet criteria before ABPM|0|||
124809329|NCT00347360|448930904|FG012|Overall Study|Did not meet criteria before ABPM|0|||
124809330|NCT00347360|448930905|FG013|Overall Study|Did not meet criteria before ABPM|0|||
124809331|NCT00347360|448930906|FG014|Overall Study|Did not meet criteria before ABPM|0|||
124809332|NCT00347360|448930892|FG000|Overall Study|Randomized in error|0|||
124809333|NCT00347360|448930893|FG001|Overall Study|Randomized in error|0|||
124809334|NCT00347360|448930894|FG002|Overall Study|Randomized in error|0|||
124809335|NCT00347360|448930895|FG003|Overall Study|Randomized in error|0|||
124809336|NCT00347360|448930896|FG004|Overall Study|Randomized in error|0|||
124809337|NCT00347360|448930897|FG005|Overall Study|Randomized in error|0|||
124809338|NCT00347360|448930898|FG006|Overall Study|Randomized in error|0|||
124809339|NCT00347360|448930899|FG007|Overall Study|Randomized in error|0|||
124809340|NCT00347360|448930900|FG008|Overall Study|Randomized in error|0|||
124809341|NCT00347360|448930901|FG009|Overall Study|Randomized in error|0|||
124809342|NCT00347360|448930902|FG010|Overall Study|Randomized in error|0|||
124809343|NCT00347360|448930903|FG011|Overall Study|Randomized in error|1|||
124809344|NCT00347360|448930904|FG012|Overall Study|Randomized in error|0|||
124809345|NCT00347360|448930905|FG013|Overall Study|Randomized in error|0|||
124809346|NCT00347360|448930906|FG014|Overall Study|Randomized in error|0|||
124809347|NCT00347360|448930892|FG000|Overall Study|Failed inclusion criteria #4|0|||
124809348|NCT00347360|448930893|FG001|Overall Study|Failed inclusion criteria #4|0|||
124809349|NCT00347360|448930894|FG002|Overall Study|Failed inclusion criteria #4|0|||
124809350|NCT00347360|448930895|FG003|Overall Study|Failed inclusion criteria #4|0|||
124809351|NCT00347360|448930896|FG004|Overall Study|Failed inclusion criteria #4|0|||
124809352|NCT00347360|448930897|FG005|Overall Study|Failed inclusion criteria #4|0|||
124809353|NCT00347360|448930898|FG006|Overall Study|Failed inclusion criteria #4|0|||
124809354|NCT00347360|448930899|FG007|Overall Study|Failed inclusion criteria #4|0|||
124809355|NCT00347360|448930900|FG008|Overall Study|Failed inclusion criteria #4|0|||
124809356|NCT00347360|448930901|FG009|Overall Study|Failed inclusion criteria #4|0|||
124809357|NCT00347360|448930902|FG010|Overall Study|Failed inclusion criteria #4|0|||
124809358|NCT00347360|448930903|FG011|Overall Study|Failed inclusion criteria #4|1|||
124809359|NCT00347360|448930904|FG012|Overall Study|Failed inclusion criteria #4|0|||
124809360|NCT00347360|448930905|FG013|Overall Study|Failed inclusion criteria #4|0|||
124809361|NCT00347360|448930906|FG014|Overall Study|Failed inclusion criteria #4|0|||
124809362|NCT00347360|448930892|FG000|Overall Study|Prolonged duration between visits|0|||
124809363|NCT00347360|448930893|FG001|Overall Study|Prolonged duration between visits|0|||
124809364|NCT00347360|448930894|FG002|Overall Study|Prolonged duration between visits|0|||
124809365|NCT00347360|448930895|FG003|Overall Study|Prolonged duration between visits|0|||
124809366|NCT00347360|448930896|FG004|Overall Study|Prolonged duration between visits|0|||
124809367|NCT00347360|448930897|FG005|Overall Study|Prolonged duration between visits|0|||
124809368|NCT00347360|448930898|FG006|Overall Study|Prolonged duration between visits|0|||
124809369|NCT00347360|448930899|FG007|Overall Study|Prolonged duration between visits|0|||
124809370|NCT00347360|448930900|FG008|Overall Study|Prolonged duration between visits|0|||
124809371|NCT00347360|448930901|FG009|Overall Study|Prolonged duration between visits|0|||
124809372|NCT00347360|448930902|FG010|Overall Study|Prolonged duration between visits|0|||
124809373|NCT00347360|448930903|FG011|Overall Study|Prolonged duration between visits|0|||
124809374|NCT00347360|448930904|FG012|Overall Study|Prolonged duration between visits|1|||
124809375|NCT00347360|448930905|FG013|Overall Study|Prolonged duration between visits|0|||
124809376|NCT00347360|448930906|FG014|Overall Study|Prolonged duration between visits|0|||
124809377|NCT00347360|448930892|FG000|Overall Study|Subject left town, ran out of study drug|0|||
124809378|NCT00347360|448930893|FG001|Overall Study|Subject left town, ran out of study drug|0|||
124809379|NCT00347360|448930894|FG002|Overall Study|Subject left town, ran out of study drug|0|||
124809380|NCT00347360|448930895|FG003|Overall Study|Subject left town, ran out of study drug|0|||
124809381|NCT00347360|448930896|FG004|Overall Study|Subject left town, ran out of study drug|0|||
124809382|NCT00347360|448930897|FG005|Overall Study|Subject left town, ran out of study drug|0|||
124809383|NCT00347360|448930898|FG006|Overall Study|Subject left town, ran out of study drug|0|||
124809384|NCT00347360|448930899|FG007|Overall Study|Subject left town, ran out of study drug|0|||
124809385|NCT00347360|448930900|FG008|Overall Study|Subject left town, ran out of study drug|0|||
124809386|NCT00347360|448930901|FG009|Overall Study|Subject left town, ran out of study drug|0|||
124809387|NCT00347360|448930902|FG010|Overall Study|Subject left town, ran out of study drug|0|||
124809388|NCT00347360|448930903|FG011|Overall Study|Subject left town, ran out of study drug|0|||
124809389|NCT00347360|448930904|FG012|Overall Study|Subject left town, ran out of study drug|0|||
124809390|NCT00347360|448930905|FG013|Overall Study|Subject left town, ran out of study drug|1|||
124809391|NCT00347360|448930906|FG014|Overall Study|Subject left town, ran out of study drug|0|||
124809392|NCT00347360|448930892|FG000|Overall Study|Subject refuse to sign updated consent|0|||
124809393|NCT00347360|448930893|FG001|Overall Study|Subject refuse to sign updated consent|0|||
124809394|NCT00347360|448930894|FG002|Overall Study|Subject refuse to sign updated consent|0|||
124809395|NCT00347360|448930895|FG003|Overall Study|Subject refuse to sign updated consent|0|||
124809396|NCT00347360|448930896|FG004|Overall Study|Subject refuse to sign updated consent|0|||
124809397|NCT00347360|448930897|FG005|Overall Study|Subject refuse to sign updated consent|0|||
124809398|NCT00347360|448930898|FG006|Overall Study|Subject refuse to sign updated consent|0|||
124809399|NCT00347360|448930899|FG007|Overall Study|Subject refuse to sign updated consent|0|||
124809400|NCT00347360|448930900|FG008|Overall Study|Subject refuse to sign updated consent|0|||
124809401|NCT00347360|448930901|FG009|Overall Study|Subject refuse to sign updated consent|0|||
124809402|NCT00347360|448930902|FG010|Overall Study|Subject refuse to sign updated consent|0|||
124809403|NCT00347360|448930903|FG011|Overall Study|Subject refuse to sign updated consent|0|||
124809404|NCT00347360|448930904|FG012|Overall Study|Subject refuse to sign updated consent|0|||
124809405|NCT00347360|448930905|FG013|Overall Study|Subject refuse to sign updated consent|0|||
124809406|NCT00347360|448930906|FG014|Overall Study|Subject refuse to sign updated consent|1|||
124809407|NCT00347360|448930892|FG000|Overall Study|Visits conflicted with new job|0|||
124809408|NCT00347360|448930893|FG001|Overall Study|Visits conflicted with new job|0|||
124809409|NCT00347360|448930894|FG002|Overall Study|Visits conflicted with new job|0|||
124809410|NCT00347360|448930895|FG003|Overall Study|Visits conflicted with new job|0|||
124809411|NCT00347360|448930896|FG004|Overall Study|Visits conflicted with new job|0|||
124809412|NCT00347360|448930897|FG005|Overall Study|Visits conflicted with new job|0|||
124809413|NCT00347360|448930898|FG006|Overall Study|Visits conflicted with new job|1|||
124809414|NCT00347360|448930899|FG007|Overall Study|Visits conflicted with new job|0|||
124809415|NCT00347360|448930900|FG008|Overall Study|Visits conflicted with new job|0|||
124809416|NCT00347360|448930901|FG009|Overall Study|Visits conflicted with new job|0|||
124809417|NCT00347360|448930902|FG010|Overall Study|Visits conflicted with new job|0|||
124809418|NCT00347360|448930903|FG011|Overall Study|Visits conflicted with new job|0|||
124809419|NCT00347360|448930904|FG012|Overall Study|Visits conflicted with new job|0|||
124809420|NCT00347360|448930905|FG013|Overall Study|Visits conflicted with new job|0|||
124809421|NCT00347360|448930906|FG014|Overall Study|Visits conflicted with new job|0|||
124809422|NCT00913380|448930912|FG000|Clinical Outcomes|Lost to Follow-up|6|||
124809423|NCT00913380|448930913|FG001|Clinical Outcomes|Lost to Follow-up|6|||
124809424|NCT00806351|448930914|FG000|Overall Study|Death|5|||
124809425|NCT00806351|448930915|FG001|Overall Study|Death|4|||
124809426|NCT02187744|448930916|FG000|Study|Participant refused further follow-up|1|||
124809427|NCT02187744|448930917|FG001|Study|Participant refused further follow-up|0|||
124809428|NCT02187744|448930916|FG000|Study|Other|2|||
124809429|NCT02187744|448930917|FG001|Study|Other|1|||
124809430|NCT02187744|448930916|FG000|Study|Lost to Follow-up|0|||
124809431|NCT02187744|448930917|FG001|Study|Lost to Follow-up|2|||
124809432|NCT02187744|448930916|FG000|Study|Related adverse event, not serious|0|||
124809433|NCT02187744|448930917|FG001|Study|Related adverse event, not serious|2|||
124809434|NCT02187744|448930916|FG000|Study|Death|1|||
124809435|NCT02187744|448930917|FG001|Study|Death|0|||
124809436|NCT02187744|448930916|FG000|Study|Related adverse event, serious non-fatal|0|||
124809437|NCT02187744|448930917|FG001|Study|Related adverse event, serious non-fatal|1|||
124809438|NCT02187744|448930916|FG000|Treatment|Death|1|||
124809439|NCT02187744|448930917|FG001|Treatment|Death|0|||
124809440|NCT02187744|448930916|FG000|Treatment|Related adverse event, serious non-fatal|0|||
124809441|NCT02187744|448930917|FG001|Treatment|Related adverse event, serious non-fatal|1|||
124809442|NCT02187744|448930916|FG000|Treatment|Related adverse event, not serious|0|||
124809443|NCT02187744|448930917|FG001|Treatment|Related adverse event, not serious|2|||
124809444|NCT02187744|448930916|FG000|Treatment|Lost to Follow-up|0|||
124809445|NCT02187744|448930917|FG001|Treatment|Lost to Follow-up|1|||
124809446|NCT02187744|448930916|FG000|Treatment|Other|2|||
124809447|NCT02187744|448930917|FG001|Treatment|Other|0|||
124809448|NCT02187744|448930916|FG000|Treatment|Participant refused continued treatment|1|||
124809449|NCT02187744|448930917|FG001|Treatment|Participant refused continued treatment|1|||
124809450|NCT00508755|448930923|FG000|Overall Study|Withdrawal by Subject|1|||
124809451|NCT02004522|448930929|FG000|Overall Study|Adverse Event|55|||
124809452|NCT02004522|448930930|FG001|Overall Study|Adverse Event|6|||
124809453|NCT02004522|448930929|FG000|Overall Study|Withdrawal by Subject|13|||
124809454|NCT02004522|448930930|FG001|Overall Study|Withdrawal by Subject|7|||
124809455|NCT02004522|448930929|FG000|Overall Study|Death|12|||
124809456|NCT02004522|448930930|FG001|Overall Study|Death|3|||
124809457|NCT02004522|448930929|FG000|Overall Study|Physician Decision|3|||
124809458|NCT02004522|448930930|FG001|Overall Study|Physician Decision|4|||
124809459|NCT02004522|448930929|FG000|Overall Study|Protocol Violation|1|||
124809460|NCT02004522|448930930|FG001|Overall Study|Protocol Violation|0|||
124809461|NCT02004522|448930929|FG000|Overall Study|Other is reason listed by PI|4|||
124809462|NCT02004522|448930930|FG001|Overall Study|Other is reason listed by PI|1|||
124809463|NCT02004522|448930929|FG000|Overall Study|Never Dosed|2|||
124809464|NCT02004522|448930930|FG001|Overall Study|Never Dosed|4|||
124809465|NCT02004522|448930929|FG000|Overall Study|Disease Progression|35|||
124809466|NCT02004522|448930930|FG001|Overall Study|Disease Progression|31|||
124809467|NCT02004522|448930929|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
124809468|NCT02004522|448930930|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
124809469|NCT01787331|448930931|FG000|Overall Study|Physician Decision|1|||
124809470|NCT01787331|448930931|FG000|Overall Study|Withdrawal by Subject|1|||
124809471|NCT01999868|448930932|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
124809472|NCT01999868|448930933|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
124809473|NCT01999868|448930934|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
124809474|NCT01999868|448930932|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
124809475|NCT01999868|448930933|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
124809476|NCT01999868|448930934|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
124809477|NCT01999868|448930932|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
124809478|NCT01999868|448930933|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
124809479|NCT01999868|448930934|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
124809480|NCT01999868|448930932|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
124809481|NCT01999868|448930933|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
124809482|NCT01999868|448930934|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
124809483|NCT01999868|448930932|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
124809484|NCT01999868|448930933|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
124809485|NCT01999868|448930934|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
124809486|NCT01999868|448930932|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
124809487|NCT01999868|448930933|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
124809488|NCT01999868|448930934|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
124809489|NCT01999868|448930932|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
124809490|NCT01999868|448930933|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
124809491|NCT01999868|448930934|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
124809492|NCT01999868|448930932|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
124809493|NCT01999868|448930933|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
124809494|NCT01999868|448930934|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
124809495|NCT01999868|448930932|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
124809496|NCT01999868|448930933|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
124809497|NCT01999868|448930934|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
124809498|NCT01999868|448930932|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
124809499|NCT01999868|448930933|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
124809500|NCT01999868|448930934|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
124809501|NCT01999868|448930932|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
124809502|NCT01999868|448930933|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
124809503|NCT01999868|448930934|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
124809504|NCT01999868|448930932|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
124809505|NCT01999868|448930933|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
124809506|NCT01999868|448930934|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
124809507|NCT01999868|448930932|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
124809508|NCT01999868|448930933|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
124809509|NCT01999868|448930934|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
124809510|NCT01999868|448930932|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
124809511|NCT01999868|448930933|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
124809512|NCT01999868|448930934|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
124809513|NCT01999868|448930932|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
124809514|NCT01999868|448930933|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
124809515|NCT01999868|448930934|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
124809516|NCT00450255|448930940|FG000|Overall Study|Prior RFA ablation of liver|1|||
124809517|NCT01757535|448930941|FG000|Overall Study|Disease Relapse|151|||
124809518|NCT01757535|448930942|FG001|Overall Study|Disease Relapse|181|||
124809519|NCT01757535|448930941|FG000|Overall Study|Other Reasons|28|||
124809520|NCT01757535|448930942|FG001|Overall Study|Other Reasons|27|||
124809521|NCT01757535|448930941|FG000|Overall Study|Adverse Event|31|||
124809522|NCT01757535|448930942|FG001|Overall Study|Adverse Event|11|||
124809523|NCT01757535|448930941|FG000|Overall Study|Withdrew Consent|19|||
124809524|NCT01757535|448930942|FG001|Overall Study|Withdrew Consent|13|||
124809525|NCT01757535|448930941|FG000|Overall Study|Physician Decision|7|||
124809526|NCT01757535|448930942|FG001|Overall Study|Physician Decision|0|||
124809527|NCT01757535|448930941|FG000|Overall Study|Death|2|||
124809528|NCT01757535|448930942|FG001|Overall Study|Death|2|||
124809529|NCT03730012|448930943|FG000|Overall Study|Adverse Event|0|||
124809530|NCT03730012|448930944|FG001|Overall Study|Adverse Event|1|||
124809531|NCT03730012|448930943|FG000|Overall Study|Lack of Efficacy|1|||
124809532|NCT03730012|448930944|FG001|Overall Study|Lack of Efficacy|5|||
124809533|NCT03730012|448930943|FG000|Overall Study|Withdrawal by Subject|0|||
124809534|NCT03730012|448930944|FG001|Overall Study|Withdrawal by Subject|1|||
124809535|NCT03730012|448930943|FG000|Overall Study|Miscellaneous|2|||
124809536|NCT03730012|448930944|FG001|Overall Study|Miscellaneous|1|||
124809537|NCT05147428|448930945|FG000|Overall Study|Removed prior to mailing|289|||
124809538|NCT05147428|448930946|FG001|Overall Study|Removed prior to mailing|306|||
124809539|NCT05147428|448930947|FG002|Overall Study|Removed prior to mailing|270|||
124809540|NCT05147428|448930945|FG000|Overall Study|Died or disenrolled during blackout period|239|||
124809541|NCT05147428|448930946|FG001|Overall Study|Died or disenrolled during blackout period|278|||
124809542|NCT05147428|448930947|FG002|Overall Study|Died or disenrolled during blackout period|273|||
124809543|NCT04680052|448932666|FG000|Overall Study|Ongoing|244|||
124809544|NCT04680052|448932667|FG001|Overall Study|Ongoing|229|||
124809545|NCT04680052|448932668|FG002|Overall Study|Ongoing|39|||
124809546|NCT04680052|448932669|FG003|Overall Study|Ongoing|46|||
124809547|NCT04680052|448932666|FG000|Overall Study|Death|15|||
124809548|NCT04680052|448932667|FG001|Overall Study|Death|22|||
124809549|NCT04680052|448932668|FG002|Overall Study|Death|7|||
124809550|NCT04680052|448932669|FG003|Overall Study|Death|1|||
124809551|NCT04680052|448932666|FG000|Overall Study|Lost to Follow-up|3|||
124809552|NCT04680052|448932667|FG001|Overall Study|Lost to Follow-up|2|||
124809553|NCT04680052|448932668|FG002|Overall Study|Lost to Follow-up|0|||
124809554|NCT04680052|448932669|FG003|Overall Study|Lost to Follow-up|1|||
124809555|NCT04680052|448932666|FG000|Overall Study|Withdrawal by Subject|11|||
124809556|NCT04680052|448932667|FG001|Overall Study|Withdrawal by Subject|19|||
124809557|NCT04680052|448932668|FG002|Overall Study|Withdrawal by Subject|7|||
124809558|NCT04680052|448932669|FG003|Overall Study|Withdrawal by Subject|5|||
124809559|NCT04680052|448932666|FG000|Overall Study|Missing|0|||
124809560|NCT04680052|448932667|FG001|Overall Study|Missing|1|||
124809561|NCT04680052|448932668|FG002|Overall Study|Missing|0|||
124809562|NCT04680052|448932669|FG003|Overall Study|Missing|0|||
124809563|NCT04680052|448932666|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
124809564|NCT04680052|448932667|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
124809565|NCT04680052|448932668|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
124809566|NCT04680052|448932669|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
124809567|NCT04680052|448932666|FG000|Overall Study|Physician Decision|0|||
124809568|NCT04680052|448932667|FG001|Overall Study|Physician Decision|1|||
124809569|NCT04680052|448932668|FG002|Overall Study|Physician Decision|0|||
124809570|NCT04680052|448932669|FG003|Overall Study|Physician Decision|0|||
124809571|NCT03320057|448932670|FG000|Overall Study|Lost to Follow-up|4|||
124809572|NCT03320057|448932671|FG001|Overall Study|Lost to Follow-up|17|||
124809573|NCT03320057|448932670|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
124809574|NCT03320057|448932671|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
124809575|NCT01367002|448932674|FG000|Overall Study|Withdrawal by Subject|1|||
124809576|NCT01367002|448932675|FG001|Overall Study|Withdrawal by Subject|0|||
124809577|NCT01367002|448932674|FG000|Overall Study|Physician Decision|0|||
124809578|NCT01367002|448932675|FG001|Overall Study|Physician Decision|2|||
124809579|NCT00717093|448932677|FG000|Overall Study|Adverse Event|19|||
124809580|NCT00717093|448932678|FG001|Overall Study|Adverse Event|9|||
124809581|NCT00717093|448932677|FG000|Overall Study|Lack of Efficacy|3|||
124809582|NCT00717093|448932678|FG001|Overall Study|Lack of Efficacy|13|||
124809583|NCT00717093|448932677|FG000|Overall Study|Lost to Follow-up|9|||
124809584|NCT00717093|448932678|FG001|Overall Study|Lost to Follow-up|6|||
124809585|NCT00717093|448932677|FG000|Overall Study|Withdrawal by Subject|12|||
124809586|NCT00717093|448932678|FG001|Overall Study|Withdrawal by Subject|19|||
124809587|NCT00717093|448932677|FG000|Overall Study|Other|0|||
124809588|NCT00717093|448932678|FG001|Overall Study|Other|1|||
124809589|NCT00717093|448932677|FG000|Overall Study|Randomized but not treated|1|||
124809590|NCT00717093|448932678|FG001|Overall Study|Randomized but not treated|0|||
124809591|NCT01516437|448932679|FG000|Overall Study|Reason not specified|0|||
124809592|NCT01516437|448932680|FG001|Overall Study|Reason not specified|0|||
124809593|NCT01516437|448932681|FG002|Overall Study|Reason not specified|1|||
124809594|NCT01516437|448932682|FG003|Overall Study|Reason not specified|1|||
124809595|NCT00217620|448932683|FG000|Overall Study|Adverse Event|2|||
124809596|NCT00217620|448932683|FG000|Overall Study|Progression|31|||
124809597|NCT00217620|448932683|FG000|Overall Study|Not Protocol Specified|4|||
124809598|NCT00217620|448932683|FG000|Overall Study|Ineligible|13|||
124809599|NCT00217620|448932683|FG000|Overall Study|Never received treatment|1|||
124634318|NCT03194542|448276279|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
124634319|NCT03194542|448276280|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
124634320|NCT03194542|448276281|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
124634321|NCT03194542|448276282|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
124634322|NCT03194542|448276279|FG000|Overall Study|Loss of Response|4|||
124634323|NCT03194542|448276280|FG001|Overall Study|Loss of Response|2|||
124634324|NCT03194542|448276281|FG002|Overall Study|Loss of Response|3|||
124634325|NCT03194542|448276282|FG003|Overall Study|Loss of Response|4|||
124634326|NCT03194542|448276279|FG000|Overall Study|Physician Decision|0|||
124634327|NCT03194542|448276280|FG001|Overall Study|Physician Decision|1|||
124634328|NCT03194542|448276281|FG002|Overall Study|Physician Decision|0|||
124634329|NCT03194542|448276282|FG003|Overall Study|Physician Decision|0|||
124634330|NCT03194542|448276279|FG000|Overall Study|Lack of Efficacy|2|||
124634331|NCT03194542|448276280|FG001|Overall Study|Lack of Efficacy|2|||
124634332|NCT03194542|448276281|FG002|Overall Study|Lack of Efficacy|2|||
124634333|NCT03194542|448276282|FG003|Overall Study|Lack of Efficacy|6|||
124809600|NCT02468674|448932688|FG000|Overall Study|Adverse Event|0|||
124809601|NCT02468674|448932689|FG001|Overall Study|Adverse Event|0|||
124809602|NCT02468674|448932690|FG002|Overall Study|Adverse Event|0|||
124809603|NCT02468674|448932691|FG003|Overall Study|Adverse Event|1|||
124809604|NCT02468674|448932692|FG004|Overall Study|Adverse Event|0|||
124809605|NCT02468674|448932693|FG005|Overall Study|Adverse Event|1|||
124809606|NCT02468674|448932694|FG006|Overall Study|Adverse Event|0|||
124809607|NCT02468674|448932695|FG007|Overall Study|Adverse Event|0|||
124809608|NCT02468674|448932696|FG008|Overall Study|Adverse Event|0|||
124809609|NCT02468674|448932688|FG000|Overall Study|Lost to Follow-up|1|||
124809610|NCT02468674|448932689|FG001|Overall Study|Lost to Follow-up|0|||
124809611|NCT02468674|448932690|FG002|Overall Study|Lost to Follow-up|0|||
124809612|NCT02468674|448932691|FG003|Overall Study|Lost to Follow-up|0|||
124809613|NCT02468674|448932692|FG004|Overall Study|Lost to Follow-up|0|||
124809614|NCT02468674|448932693|FG005|Overall Study|Lost to Follow-up|0|||
124809615|NCT02468674|448932694|FG006|Overall Study|Lost to Follow-up|0|||
124809616|NCT02468674|448932695|FG007|Overall Study|Lost to Follow-up|1|||
124809617|NCT02468674|448932696|FG008|Overall Study|Lost to Follow-up|1|||
124809618|NCT02468674|448932688|FG000|Overall Study|Physician Decision|0|||
124809619|NCT02468674|448932689|FG001|Overall Study|Physician Decision|0|||
124809620|NCT02468674|448932690|FG002|Overall Study|Physician Decision|0|||
124809621|NCT02468674|448932691|FG003|Overall Study|Physician Decision|0|||
124809622|NCT02468674|448932692|FG004|Overall Study|Physician Decision|0|||
124809623|NCT02468674|448932693|FG005|Overall Study|Physician Decision|0|||
124809624|NCT02468674|448932694|FG006|Overall Study|Physician Decision|1|||
124809625|NCT02468674|448932695|FG007|Overall Study|Physician Decision|0|||
124809626|NCT02468674|448932696|FG008|Overall Study|Physician Decision|0|||
124809627|NCT02468674|448932688|FG000|Overall Study|Patient/Guardian Decision|0|||
124809628|NCT02468674|448932689|FG001|Overall Study|Patient/Guardian Decision|0|||
124809629|NCT02468674|448932690|FG002|Overall Study|Patient/Guardian Decision|0|||
124809630|NCT02468674|448932691|FG003|Overall Study|Patient/Guardian Decision|0|||
124809631|NCT02468674|448932692|FG004|Overall Study|Patient/Guardian Decision|1|||
124809632|NCT02468674|448932693|FG005|Overall Study|Patient/Guardian Decision|0|||
124809633|NCT02468674|448932694|FG006|Overall Study|Patient/Guardian Decision|0|||
124809634|NCT02468674|448932695|FG007|Overall Study|Patient/Guardian Decision|2|||
124809635|NCT02468674|448932696|FG008|Overall Study|Patient/Guardian Decision|1|||
124634334|NCT03194542|448276279|FG000|Overall Study|Withdrawal by Subject|2|||
124809636|NCT02468674|448932688|FG000|Overall Study|Protocol Deviation|0|||
124809637|NCT02468674|448932689|FG001|Overall Study|Protocol Deviation|0|||
124809638|NCT02468674|448932690|FG002|Overall Study|Protocol Deviation|0|||
124809639|NCT02468674|448932691|FG003|Overall Study|Protocol Deviation|0|||
124809640|NCT02468674|448932692|FG004|Overall Study|Protocol Deviation|0|||
124809641|NCT02468674|448932693|FG005|Overall Study|Protocol Deviation|0|||
124634335|NCT03194542|448276280|FG001|Overall Study|Withdrawal by Subject|1|||
124634336|NCT03194542|448276281|FG002|Overall Study|Withdrawal by Subject|5|||
124809642|NCT02468674|448932694|FG006|Overall Study|Protocol Deviation|0|||
124809643|NCT02468674|448932695|FG007|Overall Study|Protocol Deviation|1|||
124809644|NCT02468674|448932696|FG008|Overall Study|Protocol Deviation|1|||
124809645|NCT01897454|448932697|FG000|Overall Study|Withdrawal by Subject|1|||
124809646|NCT03689530|448932702|FG000|Overall Study|Withdrawal by Subject|53|||
124809647|NCT03689530|448932703|FG001|Overall Study|Withdrawal by Subject|16|||
124809648|NCT01392443|448932704|FG000|Overall Study|Disease progression|30|||
124809649|NCT01392443|448932704|FG000|Overall Study|Adverse Event|24|||
124809650|NCT01392443|448932704|FG000|Overall Study|Death|7|||
124809651|NCT01392443|448932704|FG000|Overall Study|Withdrawal by Subject|5|||
124809652|NCT01392443|448932704|FG000|Overall Study|Lost to Follow-up|1|||
124809653|NCT01392443|448932704|FG000|Overall Study|Protocol Violation|1|||
124809654|NCT00533897|448932707|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
124809655|NCT00533897|448932708|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
124809656|NCT00533897|448932709|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
124809657|NCT00533897|448932710|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
124809658|NCT00533897|448932711|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
124809659|NCT00533897|448932712|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
124809660|NCT00533897|448932713|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
124809661|NCT00533897|448932714|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
124809662|NCT00533897|448932707|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
124809663|NCT00533897|448932708|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
124809664|NCT00533897|448932709|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
124809665|NCT00533897|448932710|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
124809666|NCT00533897|448932711|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
124809667|NCT00533897|448932712|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
124809668|NCT00533897|448932713|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
124809669|NCT00533897|448932714|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
124809670|NCT00533897|448932707|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
124809671|NCT00533897|448932708|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
124809672|NCT00533897|448932709|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
124809673|NCT00533897|448932710|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
124809674|NCT00533897|448932711|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
124809675|NCT00533897|448932712|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
124809676|NCT00533897|448932713|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
124809677|NCT00533897|448932714|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
124809678|NCT00533897|448932707|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
124809679|NCT00533897|448932708|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
124809680|NCT00533897|448932709|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
124809681|NCT00533897|448932710|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
124809682|NCT00533897|448932711|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
124809683|NCT00533897|448932712|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
124809684|NCT00533897|448932713|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
124809685|NCT00533897|448932714|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
124809686|NCT00533897|448932707|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
124809687|NCT00533897|448932708|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
124809688|NCT00533897|448932709|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
124809689|NCT00533897|448932710|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
124809690|NCT00533897|448932711|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
124809691|NCT00533897|448932712|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
124809692|NCT00533897|448932713|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
124809693|NCT00533897|448932714|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
124809694|NCT00533897|448932707|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
124809695|NCT00533897|448932708|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
124809696|NCT00533897|448932709|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
124809697|NCT00533897|448932710|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
124809698|NCT00533897|448932711|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
124809699|NCT00533897|448932712|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
124809700|NCT00533897|448932713|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
124809701|NCT00533897|448932714|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
124809702|NCT00533897|448932707|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
124809703|NCT00533897|448932708|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
124809704|NCT00533897|448932709|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
124809705|NCT00533897|448932710|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
124809706|NCT00533897|448932711|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
124809707|NCT00533897|448932712|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
124809708|NCT00533897|448932713|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
124809709|NCT00533897|448932714|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
124809710|NCT00533897|448932707|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
124809711|NCT00533897|448932708|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
124809712|NCT00533897|448932709|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
124809713|NCT00533897|448932710|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
124809714|NCT00533897|448932711|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
124809715|NCT00533897|448932712|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
124809716|NCT00533897|448932713|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
124809717|NCT00533897|448932714|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
124809718|NCT00533897|448932707|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
124809719|NCT00533897|448932708|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
124809720|NCT00533897|448932709|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
124809721|NCT00533897|448932710|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
124809722|NCT00533897|448932711|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
124809723|NCT00533897|448932712|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
124809724|NCT00533897|448932713|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
124809725|NCT00533897|448932714|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
124809726|NCT00533897|448932707|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
124809727|NCT00533897|448932708|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
124809728|NCT00533897|448932709|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
124809729|NCT00533897|448932710|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
124809730|NCT00533897|448932711|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
124809731|NCT00533897|448932712|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
124809732|NCT00533897|448932713|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
124809733|NCT00533897|448932714|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
124809734|NCT00533897|448932707|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
124809735|NCT00533897|448932708|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
124809736|NCT00533897|448932709|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
124809737|NCT00533897|448932710|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
124809738|NCT00533897|448932711|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
124809739|NCT00533897|448932712|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
124809740|NCT00533897|448932713|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
124809741|NCT00533897|448932714|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
124809742|NCT00533897|448932707|FG000|Long Term Extension (LTE)|Death|0|||
124809743|NCT00533897|448932708|FG001|Long Term Extension (LTE)|Death|0|||
124809744|NCT00533897|448932709|FG002|Long Term Extension (LTE)|Death|0|||
124809745|NCT00533897|448932710|FG003|Long Term Extension (LTE)|Death|0|||
124809746|NCT00533897|448932711|FG004|Long Term Extension (LTE)|Death|0|||
124809747|NCT00533897|448932712|FG005|Long Term Extension (LTE)|Death|0|||
124809748|NCT00533897|448932713|FG006|Long Term Extension (LTE)|Death|1|||
124809749|NCT00533897|448932714|FG007|Long Term Extension (LTE)|Death|3|||
124809750|NCT00533897|448932707|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
124809751|NCT00533897|448932708|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
124809752|NCT00533897|448932709|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
124809753|NCT00533897|448932710|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
124809754|NCT00533897|448932711|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
124809755|NCT00533897|448932712|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
124809756|NCT00533897|448932713|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
124809757|NCT00533897|448932714|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
124809758|NCT00533897|448932707|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
124809759|NCT00533897|448932708|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
124809760|NCT00533897|448932709|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
124809761|NCT00533897|448932710|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
124809762|NCT00533897|448932711|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
124809763|NCT00533897|448932712|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
124809764|NCT00533897|448932713|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
124809765|NCT00533897|448932714|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
124809766|NCT00533897|448932707|FG000|Long Term Extension (LTE)|Adverse Event|0|||
124809767|NCT00533897|448932708|FG001|Long Term Extension (LTE)|Adverse Event|0|||
124809768|NCT00533897|448932709|FG002|Long Term Extension (LTE)|Adverse Event|0|||
124809769|NCT00533897|448932710|FG003|Long Term Extension (LTE)|Adverse Event|0|||
124809770|NCT00533897|448932711|FG004|Long Term Extension (LTE)|Adverse Event|0|||
124809771|NCT00533897|448932712|FG005|Long Term Extension (LTE)|Adverse Event|0|||
124809772|NCT00533897|448932713|FG006|Long Term Extension (LTE)|Adverse Event|2|||
124809773|NCT00533897|448932714|FG007|Long Term Extension (LTE)|Adverse Event|5|||
124809774|NCT00533897|448932707|FG000|Long Term Extension (LTE)|Pregnancy|0|||
124809775|NCT00533897|448932708|FG001|Long Term Extension (LTE)|Pregnancy|0|||
124809776|NCT00533897|448932709|FG002|Long Term Extension (LTE)|Pregnancy|0|||
124809777|NCT00533897|448932710|FG003|Long Term Extension (LTE)|Pregnancy|0|||
124809778|NCT00533897|448932711|FG004|Long Term Extension (LTE)|Pregnancy|0|||
124809779|NCT00533897|448932712|FG005|Long Term Extension (LTE)|Pregnancy|0|||
124809780|NCT00533897|448932713|FG006|Long Term Extension (LTE)|Pregnancy|0|||
124809781|NCT00533897|448932714|FG007|Long Term Extension (LTE)|Pregnancy|2|||
124809782|NCT00533897|448932707|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
124809783|NCT00533897|448932708|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
124809784|NCT00533897|448932709|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
124809785|NCT00533897|448932710|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
124809786|NCT00533897|448932711|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
124809787|NCT00533897|448932712|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
124809788|NCT00533897|448932713|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
124809789|NCT00533897|448932714|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
124809790|NCT00533897|448932707|FG000|Long Term Extension (LTE)|Other|0|||
124809791|NCT00533897|448932708|FG001|Long Term Extension (LTE)|Other|0|||
124809792|NCT00533897|448932709|FG002|Long Term Extension (LTE)|Other|0|||
124809793|NCT00533897|448932710|FG003|Long Term Extension (LTE)|Other|0|||
124809794|NCT00533897|448932711|FG004|Long Term Extension (LTE)|Other|0|||
124809795|NCT00533897|448932712|FG005|Long Term Extension (LTE)|Other|0|||
124809796|NCT00533897|448932713|FG006|Long Term Extension (LTE)|Other|1|||
124809797|NCT00533897|448932714|FG007|Long Term Extension (LTE)|Other|6|||
124809798|NCT02555683|448932715|FG000|Overall Study|Physician Decision|1|||
124809799|NCT02555683|448932716|FG001|Overall Study|Physician Decision|0|||
124809800|NCT02555683|448932717|FG002|Overall Study|Physician Decision|2|||
124809801|NCT02555683|448932715|FG000|Overall Study|Lost to Follow-up|2|||
124809802|NCT02555683|448932716|FG001|Overall Study|Lost to Follow-up|1|||
124809803|NCT02555683|448932717|FG002|Overall Study|Lost to Follow-up|2|||
124809804|NCT02555683|448932715|FG000|Overall Study|Technical Problems|1|||
124809805|NCT02555683|448932716|FG001|Overall Study|Technical Problems|1|||
124809806|NCT02555683|448932717|FG002|Overall Study|Technical Problems|0|||
124809807|NCT02555683|448932715|FG000|Overall Study|Protocol deviation|0|||
124809808|NCT02555683|448932716|FG001|Overall Study|Protocol deviation|1|||
124809809|NCT02555683|448932717|FG002|Overall Study|Protocol deviation|0|||
124809810|NCT02555683|448932715|FG000|Overall Study|Lack of Efficacy|2|||
124809811|NCT02555683|448932716|FG001|Overall Study|Lack of Efficacy|0|||
124809812|NCT02555683|448932717|FG002|Overall Study|Lack of Efficacy|0|||
124809813|NCT02555683|448932715|FG000|Overall Study|Death|0|||
124809814|NCT02555683|448932716|FG001|Overall Study|Death|1|||
124809815|NCT02555683|448932717|FG002|Overall Study|Death|2|||
124809816|NCT02555683|448932715|FG000|Overall Study|Adverse Event|1|||
124809817|NCT02555683|448932716|FG001|Overall Study|Adverse Event|0|||
124809818|NCT02555683|448932717|FG002|Overall Study|Adverse Event|1|||
124809819|NCT02555683|448932715|FG000|Overall Study|Subject/guardian decision|12|||
124809820|NCT02555683|448932716|FG001|Overall Study|Subject/guardian decision|12|||
124809821|NCT02555683|448932717|FG002|Overall Study|Subject/guardian decision|22|||
124809822|NCT02555683|448932715|FG000|Overall Study|Death post Treatment/safety period|0|||
124809823|NCT02555683|448932716|FG001|Overall Study|Death post Treatment/safety period|1|||
124809824|NCT02555683|448932717|FG002|Overall Study|Death post Treatment/safety period|0|||
124809825|NCT05074667|448932718|FG000|Overall Study|Death|1|||
124809826|NCT05074667|448932718|FG000|Overall Study|Withdrawal by Subject|4|||
124809827|NCT05074667|448932718|FG000|Overall Study|Lost to Follow-up|10|||
124809828|NCT01826604|448932720|FG000|Overall Study|Lost to Follow-up|8|||
124809829|NCT01826604|448932721|FG001|Overall Study|Lost to Follow-up|9|||
124809830|NCT00491075|448932722|FG000|Overall Study|Withdrawal by Subject|1|||
124809831|NCT00491075|448932722|FG000|Overall Study|Physician Decision|1|||
124809832|NCT03019185|448932729|FG000|Overall Study|Lost to Follow-up|3|||
124809833|NCT03019185|448932730|FG001|Overall Study|Lost to Follow-up|0|||
124809834|NCT03019185|448932731|FG002|Overall Study|Lost to Follow-up|2|||
124809835|NCT03019185|448932729|FG000|Overall Study|Withdrawal by Subject|1|||
124809836|NCT03019185|448932730|FG001|Overall Study|Withdrawal by Subject|1|||
124809837|NCT03019185|448932731|FG002|Overall Study|Withdrawal by Subject|0|||
124809838|NCT03019185|448932729|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
124809839|NCT03019185|448932730|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
124809840|NCT03019185|448932731|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
124809841|NCT03019185|448932729|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
124809842|NCT03019185|448932730|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
124809843|NCT03019185|448932731|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
124809844|NCT00705289|448932734|FG000|Overall Study|Subject or treating physician's choice|131|||
124809845|NCT02601027|448932735|FG000|Registration to Surgery|Withdrawal by Subject|20|||
124809846|NCT02601027|448932736|FG001|Registration to Surgery|Withdrawal by Subject|10|||
124809847|NCT01146912|448932737|FG000|Overall Study|Already received influenza vaccination|817|||
124809848|NCT01146912|448932738|FG001|Overall Study|Already received influenza vaccination|822|||
124634337|NCT03194542|448276282|FG003|Overall Study|Withdrawal by Subject|4|||
124634338|NCT03194542|448276279|FG000|Overall Study|Progressive Disease|1|||
124809849|NCT01146912|448932739|FG002|Overall Study|Already received influenza vaccination|13|||
124809850|NCT01146912|448932740|FG003|Overall Study|Already received influenza vaccination|15|||
124809851|NCT01146912|448932741|FG004|Overall Study|Already received influenza vaccination|41|||
124809852|NCT01146912|448932742|FG005|Overall Study|Already received influenza vaccination|61|||
124809853|NCT01146912|448932743|FG006|Overall Study|Already received influenza vaccination|56|||
124809854|NCT01146912|448932744|FG007|Overall Study|Already received influenza vaccination|0|||
124809855|NCT01146912|448932737|FG000|Overall Study|< 14 weeks gestational age|0|||
124809856|NCT01146912|448932738|FG001|Overall Study|< 14 weeks gestational age|0|||
124809857|NCT01146912|448932739|FG002|Overall Study|< 14 weeks gestational age|3|||
124809858|NCT01146912|448932740|FG003|Overall Study|< 14 weeks gestational age|2|||
124809859|NCT01146912|448932741|FG004|Overall Study|< 14 weeks gestational age|0|||
124809860|NCT01146912|448932742|FG005|Overall Study|< 14 weeks gestational age|0|||
124809861|NCT01146912|448932743|FG006|Overall Study|< 14 weeks gestational age|0|||
124809862|NCT01146912|448932744|FG007|Overall Study|< 14 weeks gestational age|0|||
124809863|NCT01146912|448932737|FG000|Overall Study|Duplicate patient|0|||
124809864|NCT01146912|448932738|FG001|Overall Study|Duplicate patient|0|||
124809865|NCT01146912|448932739|FG002|Overall Study|Duplicate patient|1|||
124809866|NCT01146912|448932740|FG003|Overall Study|Duplicate patient|0|||
124809867|NCT01146912|448932741|FG004|Overall Study|Duplicate patient|0|||
124809868|NCT01146912|448932742|FG005|Overall Study|Duplicate patient|0|||
124809869|NCT01146912|448932743|FG006|Overall Study|Duplicate patient|0|||
124809870|NCT01146912|448932744|FG007|Overall Study|Duplicate patient|0|||
124809871|NCT02609828|448932747|FG000|Overall Study|Adverse Event|8|||
124809872|NCT02609828|448932748|FG001|Overall Study|Adverse Event|1|||
124809873|NCT02609828|448932749|FG002|Overall Study|Adverse Event|0|||
124809874|NCT02609828|448932750|FG003|Overall Study|Adverse Event|6|||
124809875|NCT02609828|448932747|FG000|Overall Study|Death|15|||
124809876|NCT02609828|448932748|FG001|Overall Study|Death|1|||
124809877|NCT02609828|448932749|FG002|Overall Study|Death|1|||
124809878|NCT02609828|448932750|FG003|Overall Study|Death|19|||
124809879|NCT02609828|448932747|FG000|Overall Study|Insufficient clinical response|2|||
124809880|NCT02609828|448932748|FG001|Overall Study|Insufficient clinical response|1|||
124809881|NCT02609828|448932749|FG002|Overall Study|Insufficient clinical response|0|||
124809882|NCT02609828|448932750|FG003|Overall Study|Insufficient clinical response|0|||
124809883|NCT02609828|448932747|FG000|Overall Study|Lost to Follow-up|0|||
124809884|NCT02609828|448932748|FG001|Overall Study|Lost to Follow-up|0|||
124809885|NCT02609828|448932749|FG002|Overall Study|Lost to Follow-up|0|||
124809886|NCT02609828|448932750|FG003|Overall Study|Lost to Follow-up|1|||
124809887|NCT02609828|448932747|FG000|Overall Study|Protocol Violation|2|||
124809888|NCT02609828|448932748|FG001|Overall Study|Protocol Violation|0|||
124809889|NCT02609828|448932749|FG002|Overall Study|Protocol Violation|0|||
124809890|NCT02609828|448932750|FG003|Overall Study|Protocol Violation|1|||
124809891|NCT02609828|448932747|FG000|Overall Study|Withdrawal by Subject|12|||
124809892|NCT02609828|448932748|FG001|Overall Study|Withdrawal by Subject|1|||
124809893|NCT02609828|448932749|FG002|Overall Study|Withdrawal by Subject|0|||
124809894|NCT02609828|448932750|FG003|Overall Study|Withdrawal by Subject|10|||
124809895|NCT02609828|448932747|FG000|Overall Study|Other|3|||
124809896|NCT02609828|448932748|FG001|Overall Study|Other|0|||
124809897|NCT02609828|448932749|FG002|Overall Study|Other|0|||
124809898|NCT02609828|448932750|FG003|Overall Study|Other|6|||
124809899|NCT02609828|448932747|FG000|Overall Study|Randomized but not treated|1|||
124809900|NCT02609828|448932748|FG001|Overall Study|Randomized but not treated|0|||
124809901|NCT02609828|448932749|FG002|Overall Study|Randomized but not treated|0|||
124809902|NCT02609828|448932750|FG003|Overall Study|Randomized but not treated|0|||
124809903|NCT02980783|448932751|FG000|Overall Study|Lost to Follow-up|1|||
124809904|NCT01696695|448932752|FG000|Overall Study|Disease progression|373|||
124809905|NCT01696695|448932752|FG000|Overall Study|Death|29|||
124809906|NCT01696695|448932752|FG000|Overall Study|Adverse Event|74|||
124809907|NCT01696695|448932752|FG000|Overall Study|Withdrawal by Subject|92|||
124809908|NCT01696695|448932752|FG000|Overall Study|Lost to Follow-up|48|||
124809909|NCT01696695|448932752|FG000|Overall Study|Other|74|||
124809910|NCT01696695|448932752|FG000|Overall Study|Major Protocol Violation|192|||
124809911|NCT03173313|448932755|FG000|Overall Study|Lost to Follow-up|2|||
124809912|NCT03173313|448932756|FG001|Overall Study|Lost to Follow-up|3|||
124809913|NCT03173313|448932755|FG000|Overall Study|Withdrawal by Subject|0|||
124809914|NCT03173313|448932756|FG001|Overall Study|Withdrawal by Subject|1|||
124809915|NCT03173313|448932755|FG000|Overall Study|Death|5|||
124809916|NCT03173313|448932756|FG001|Overall Study|Death|0|||
124809917|NCT03173313|448932755|FG000|Overall Study|Physician Decision|1|||
124809918|NCT03173313|448932756|FG001|Overall Study|Physician Decision|0|||
124809919|NCT03173313|448932755|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
124809920|NCT03173313|448932756|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
124809921|NCT03173313|448932755|FG000|Overall Study|Bone Fracture|1|||
124809922|NCT03173313|448932756|FG001|Overall Study|Bone Fracture|0|||
124809923|NCT03863197|448932757|FG000|Overall Study|Lost to Follow-up|2|||
124809924|NCT03863197|448932758|FG001|Overall Study|Lost to Follow-up|3|||
124809925|NCT03863197|448932757|FG000|Overall Study|Withdrawal by Subject|4|||
124809926|NCT03863197|448932758|FG001|Overall Study|Withdrawal by Subject|0|||
124809927|NCT03863197|448932757|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
124809928|NCT03863197|448932758|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
124809929|NCT01065597|448932766|FG000|Overall Study|Adverse Event|1|||
124809930|NCT02589405|448932769|FG000|Overall Study|Adverse Event|3|||
124809931|NCT02589405|448932769|FG000|Overall Study|Withdrawal by Subject|1|||
124809932|NCT02905149|448932771|FG000|Overall Study|Lost to Follow-up|2|||
124809933|NCT02905149|448932772|FG001|Overall Study|Lost to Follow-up|0|||
124809934|NCT00839852|448932774|FG000|Overall Study|Adverse Event|10|||
124809935|NCT00839852|448932774|FG000|Overall Study|Insufficient Therapeutic Response|3|||
124809936|NCT00839852|448932774|FG000|Overall Study|Protocol Violation|9|||
124809937|NCT00839852|448932774|FG000|Overall Study|Withdrawal of Consent|16|||
124809938|NCT00839852|448932774|FG000|Overall Study|Lost to Follow-up|7|||
124809939|NCT00839852|448932774|FG000|Overall Study|Lack of Compliance While in Jail|1|||
124809940|NCT00839852|448932774|FG000|Overall Study|Pregnancy|1|||
124809941|NCT02761733|448932775|FG000|Overall Study|Death|3|||
124809942|NCT02761733|448932776|FG001|Overall Study|Death|5|||
124809943|NCT02761733|448932777|FG002|Overall Study|Death|1|||
124809944|NCT02761733|448932778|FG003|Overall Study|Death|1|||
124809945|NCT02761733|448932775|FG000|Overall Study|Lost to Follow-up|6|||
124809946|NCT02761733|448932776|FG001|Overall Study|Lost to Follow-up|7|||
124809947|NCT02761733|448932777|FG002|Overall Study|Lost to Follow-up|0|||
124809948|NCT02761733|448932778|FG003|Overall Study|Lost to Follow-up|3|||
124809949|NCT02761733|448932775|FG000|Overall Study|Physician Decision|4|||
124809950|NCT02761733|448932776|FG001|Overall Study|Physician Decision|0|||
124809951|NCT02761733|448932777|FG002|Overall Study|Physician Decision|0|||
124809952|NCT02761733|448932778|FG003|Overall Study|Physician Decision|0|||
124809953|NCT02761733|448932775|FG000|Overall Study|Withdrawal by Subject|2|||
124809954|NCT02761733|448932776|FG001|Overall Study|Withdrawal by Subject|0|||
124809955|NCT02761733|448932777|FG002|Overall Study|Withdrawal by Subject|0|||
124809956|NCT02761733|448932778|FG003|Overall Study|Withdrawal by Subject|0|||
124809957|NCT02761733|448932775|FG000|Overall Study|Discharged from Study Site|10|||
124809958|NCT02761733|448932776|FG001|Overall Study|Discharged from Study Site|9|||
124809959|NCT02761733|448932777|FG002|Overall Study|Discharged from Study Site|25|||
124809960|NCT02761733|448932778|FG003|Overall Study|Discharged from Study Site|11|||
124809961|NCT02761733|448932775|FG000|Overall Study|Cognitive Impairment|5|||
124809962|NCT02761733|448932776|FG001|Overall Study|Cognitive Impairment|0|||
124809963|NCT02761733|448932777|FG002|Overall Study|Cognitive Impairment|1|||
124809964|NCT02761733|448932778|FG003|Overall Study|Cognitive Impairment|0|||
124809965|NCT04295772|448932781|FG000|Overall Study|Protocol Violation|1|||
124809966|NCT04295772|448932782|FG001|Overall Study|Protocol Violation|0|||
124809967|NCT04295772|448932781|FG000|Overall Study|Ongoing for safety monitoring|14|||
124809968|NCT04295772|448932782|FG001|Overall Study|Ongoing for safety monitoring|1|||
124809969|NCT04295772|448932781|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
124809970|NCT04295772|448932782|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
124809971|NCT02846324|448932783|FG000|Overall Study|Other|1|||
124809972|NCT02846324|448932784|FG001|Overall Study|Other|0|||
124809973|NCT02846324|448932785|FG002|Overall Study|Other|0|||
124809974|NCT02846324|448932786|FG003|Overall Study|Other|0|||
124809975|NCT02846324|448932783|FG000|Overall Study|Withdrawal by Subject|1|||
124809976|NCT02846324|448932784|FG001|Overall Study|Withdrawal by Subject|0|||
124809977|NCT02846324|448932785|FG002|Overall Study|Withdrawal by Subject|4|||
124809978|NCT02846324|448932786|FG003|Overall Study|Withdrawal by Subject|0|||
124809979|NCT02805972|448932791|FG000|Washout Period|Lost to Follow-up|3|||
124809980|NCT02805972|448932792|FG001|Washout Period|Lost to Follow-up|0|||
124809981|NCT01206166|448932793|FG000|Overall Study|No evaluable data|2|||
124809982|NCT01206166|448932794|FG001|Overall Study|No evaluable data|3|||
124809983|NCT00932126|448932795|FG000|Overall Study|Adverse Event|0|||
124809984|NCT00932126|448932796|FG001|Overall Study|Adverse Event|0|||
124809985|NCT00932126|448932797|FG002|Overall Study|Adverse Event|0|||
124809986|NCT00932126|448932798|FG003|Overall Study|Adverse Event|0|||
124809987|NCT00932126|448932799|FG004|Overall Study|Adverse Event|0|||
124809988|NCT00932126|448932800|FG005|Overall Study|Adverse Event|0|||
124809989|NCT00932126|448932801|FG006|Overall Study|Adverse Event|1|||
124809990|NCT00932126|448932802|FG007|Overall Study|Adverse Event|2|||
124809991|NCT00932126|448932795|FG000|Overall Study|Protocol Violation|0|||
124809992|NCT00932126|448932796|FG001|Overall Study|Protocol Violation|0|||
124809993|NCT00932126|448932797|FG002|Overall Study|Protocol Violation|0|||
124809994|NCT00932126|448932798|FG003|Overall Study|Protocol Violation|0|||
124809995|NCT00932126|448932799|FG004|Overall Study|Protocol Violation|1|||
124809996|NCT00932126|448932800|FG005|Overall Study|Protocol Violation|0|||
124809997|NCT00932126|448932801|FG006|Overall Study|Protocol Violation|0|||
124809998|NCT00932126|448932802|FG007|Overall Study|Protocol Violation|0|||
124809999|NCT00932126|448932795|FG000|Overall Study|Withdrawal by Subject|0|||
124810000|NCT00932126|448932796|FG001|Overall Study|Withdrawal by Subject|0|||
124810001|NCT00932126|448932797|FG002|Overall Study|Withdrawal by Subject|1|||
124810002|NCT00932126|448932798|FG003|Overall Study|Withdrawal by Subject|0|||
124810003|NCT00932126|448932799|FG004|Overall Study|Withdrawal by Subject|0|||
124810004|NCT00932126|448932800|FG005|Overall Study|Withdrawal by Subject|0|||
124810005|NCT00932126|448932801|FG006|Overall Study|Withdrawal by Subject|0|||
124810006|NCT00932126|448932802|FG007|Overall Study|Withdrawal by Subject|1|||
124810007|NCT00932126|448932795|FG000|Overall Study|Objective progression or relapse|3|||
124810008|NCT00932126|448932796|FG001|Overall Study|Objective progression or relapse|3|||
124810009|NCT00932126|448932797|FG002|Overall Study|Objective progression or relapse|2|||
124810010|NCT00932126|448932798|FG003|Overall Study|Objective progression or relapse|3|||
124810011|NCT00932126|448932799|FG004|Overall Study|Objective progression or relapse|3|||
124810012|NCT00932126|448932800|FG005|Overall Study|Objective progression or relapse|3|||
124810013|NCT00932126|448932801|FG006|Overall Study|Objective progression or relapse|3|||
124810014|NCT00932126|448932802|FG007|Overall Study|Objective progression or relapse|5|||
124810015|NCT00932126|448932795|FG000|Overall Study|Other|0|||
124810016|NCT00932126|448932796|FG001|Overall Study|Other|0|||
124810017|NCT00932126|448932797|FG002|Overall Study|Other|0|||
124810018|NCT00932126|448932798|FG003|Overall Study|Other|0|||
124810019|NCT00932126|448932799|FG004|Overall Study|Other|1|||
124810020|NCT00932126|448932800|FG005|Overall Study|Other|0|||
124810021|NCT00932126|448932801|FG006|Overall Study|Other|1|||
124810022|NCT00932126|448932802|FG007|Overall Study|Other|2|||
124810023|NCT03576495|448932806|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
124810024|NCT03576495|448932807|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
124810025|NCT02635776|448932809|FG000|Overall Study|Physician Decision|1|||
124810026|NCT02635776|448932810|FG001|Overall Study|Physician Decision|0|||
124810027|NCT02635776|448932809|FG000|Overall Study|Adverse Event|51|||
124810028|NCT02635776|448932810|FG001|Overall Study|Adverse Event|3|||
124810029|NCT02635776|448932809|FG000|Overall Study|Withdrawal by Subject|41|||
124810030|NCT02635776|448932810|FG001|Overall Study|Withdrawal by Subject|7|||
124810031|NCT02635776|448932809|FG000|Overall Study|Lost to Follow-up|4|||
124810032|NCT02635776|448932810|FG001|Overall Study|Lost to Follow-up|0|||
124810033|NCT02635776|448932809|FG000|Overall Study|Other reasons|5|||
124810034|NCT02635776|448932810|FG001|Overall Study|Other reasons|1|||
124810035|NCT00788073|448932811|FG000|STX209 Then Placebo|Adverse Event|1|||
124810036|NCT00788073|448932812|FG001|STX209 Then Placebo|Adverse Event|0|||
124810037|NCT00788073|448932811|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
124810038|NCT00788073|448932812|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
124810039|NCT00788073|448932811|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
124810040|NCT00788073|448932812|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
124810041|NCT00788073|448932811|FG000|STX209 Then Placebo|unable to return due to travel|0|||
124810042|NCT00788073|448932812|FG001|STX209 Then Placebo|unable to return due to travel|1|||
124634339|NCT03194542|448276280|FG001|Overall Study|Progressive Disease|0|||
124634340|NCT03194542|448276281|FG002|Overall Study|Progressive Disease|1|||
124634341|NCT03194542|448276282|FG003|Overall Study|Progressive Disease|1|||
124634342|NCT03194542|448276279|FG000|Overall Study|Adverse Event|1|||
124810043|NCT00788073|448932811|FG000|Placebo Then STX209|Adverse Event|2|||
124810044|NCT00788073|448932812|FG001|Placebo Then STX209|Adverse Event|0|||
124810045|NCT00788073|448932811|FG000|Placebo Then STX209|Protocol Violation|0|||
124810046|NCT00788073|448932812|FG001|Placebo Then STX209|Protocol Violation|1|||
124810047|NCT03608254|448932813|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
124810048|NCT03608254|448932813|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
124634343|NCT03194542|448276280|FG001|Overall Study|Adverse Event|2|||
124634344|NCT03194542|448276281|FG002|Overall Study|Adverse Event|0|||
124634345|NCT03194542|448276282|FG003|Overall Study|Adverse Event|5|||
124634346|NCT03194542|448276279|FG000|Overall Study|Death|1|||
124634347|NCT03194542|448276280|FG001|Overall Study|Death|2|||
124634348|NCT03194542|448276281|FG002|Overall Study|Death|0|||
124810049|NCT00660673|448932815|FG000|Overall Study|Adverse Event|84|||
124810050|NCT00660673|448932815|FG000|Overall Study|Lack of Efficacy|7|||
124810051|NCT00660673|448932815|FG000|Overall Study|Withdrawal by Subject|22|||
124810052|NCT00660673|448932815|FG000|Overall Study|Administrative|2|||
124810053|NCT00660673|448932815|FG000|Overall Study|Protocol Violation|2|||
124810054|NCT03208127|448932816|FG000|Overall Study|Death|1|||
124810055|NCT00579098|448932817|FG000|Overall Study|Lost to Follow-up|2|||
124810056|NCT00579098|448932818|FG001|Overall Study|Lost to Follow-up|0|||
124810057|NCT00579098|448932817|FG000|Overall Study|Adverse Event|2|||
124810058|NCT00579098|448932818|FG001|Overall Study|Adverse Event|3|||
124810059|NCT00579098|448932817|FG000|Overall Study|Withdrawal by Subject|2|||
124810060|NCT00579098|448932818|FG001|Overall Study|Withdrawal by Subject|3|||
124810061|NCT00579098|448932817|FG000|Overall Study|AF returned after ablation|3|||
124810062|NCT00579098|448932818|FG001|Overall Study|AF returned after ablation|2|||
124810063|NCT00003487|448932823|FG000|Overall Study|Not evaluable|2|||
124634349|NCT03194542|448276282|FG003|Overall Study|Death|5|||
124634350|NCT03194542|448276279|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
124634351|NCT03194542|448276280|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
124810064|NCT03855228|448932830|FG000|Overall Study|Adverse Event|2|||
124810065|NCT03855228|448932831|FG001|Overall Study|Adverse Event|4|||
124810066|NCT03855228|448932832|FG002|Overall Study|Adverse Event|4|||
124810067|NCT03855228|448932833|FG003|Overall Study|Adverse Event|8|||
124810068|NCT03855228|448932830|FG000|Overall Study|Treatment Failure|1|||
124810069|NCT03855228|448932831|FG001|Overall Study|Treatment Failure|2|||
124810070|NCT03855228|448932832|FG002|Overall Study|Treatment Failure|1|||
124810071|NCT03855228|448932833|FG003|Overall Study|Treatment Failure|8|||
124810072|NCT03855228|448932830|FG000|Overall Study|Lost to Follow-up|0|||
124810073|NCT03855228|448932831|FG001|Overall Study|Lost to Follow-up|0|||
124810074|NCT03855228|448932832|FG002|Overall Study|Lost to Follow-up|0|||
124634352|NCT03194542|448276281|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
124810075|NCT03855228|448932833|FG003|Overall Study|Lost to Follow-up|1|||
124810076|NCT03855228|448932830|FG000|Overall Study|Protocol Violation|0|||
124810077|NCT03855228|448932831|FG001|Overall Study|Protocol Violation|1|||
124810078|NCT03855228|448932832|FG002|Overall Study|Protocol Violation|2|||
124810079|NCT03855228|448932833|FG003|Overall Study|Protocol Violation|1|||
124810080|NCT03855228|448932830|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
124810081|NCT03855228|448932831|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
124810082|NCT03855228|448932832|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
124810083|NCT03855228|448932833|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
124810084|NCT01893203|448932835|FG000|Overall Study|Withdrawal by Subject|1|||
124810085|NCT00678080|448932846|FG000|Overall Study|Physician Decision|2|||
124810086|NCT00678080|448932847|FG001|Overall Study|Physician Decision|0|||
124810087|NCT00678080|448932846|FG000|Overall Study|Lost to Follow-up|1|||
124810088|NCT00678080|448932847|FG001|Overall Study|Lost to Follow-up|0|||
124810089|NCT00678080|448932846|FG000|Overall Study|Withdrawal by Subject|0|||
124810090|NCT00678080|448932847|FG001|Overall Study|Withdrawal by Subject|1|||
124810091|NCT01546207|448934156|FG000|Overall Study|Death|1|||
124810092|NCT03355365|448934159|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
124810093|NCT03355365|448934160|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
124810094|NCT03355365|448934159|FG000|Year 1, First Intervention|Protocol Violation|1|||
124810095|NCT03355365|448934160|FG001|Year 1, First Intervention|Protocol Violation|0|||
124810096|NCT03355365|448934159|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
124810097|NCT03355365|448934160|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
124810098|NCT03355365|448934159|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
124810099|NCT03355365|448934160|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
124810100|NCT03355365|448934159|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
124810101|NCT03355365|448934160|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
124810102|NCT03355365|448934159|FG000|Year 2, Crossover Intervention|severe COVID|0|||
124810103|NCT03355365|448934160|FG001|Year 2, Crossover Intervention|severe COVID|1|||
124810104|NCT03355365|448934159|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
124810105|NCT03355365|448934160|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
124810106|NCT01952145|448934161|FG000|Overall Study|Protocol Violation|2|||
124810107|NCT01952145|448934162|FG001|Overall Study|Protocol Violation|1|||
124810108|NCT01952145|448934161|FG000|Overall Study|Death|0|||
124810109|NCT01952145|448934162|FG001|Overall Study|Death|1|||
124810110|NCT01952145|448934161|FG000|Overall Study|Adverse Event|9|||
124810111|NCT01952145|448934162|FG001|Overall Study|Adverse Event|0|||
124810112|NCT01952145|448934161|FG000|Overall Study|Withdrawal Criteria|16|||
124810113|NCT01952145|448934162|FG001|Overall Study|Withdrawal Criteria|11|||
124810114|NCT01952145|448934161|FG000|Overall Study|Unclassified|1|||
124810115|NCT01952145|448934162|FG001|Overall Study|Unclassified|1|||
124810116|NCT00493025|448934165|FG000|Overall Study|Physician Decision|19|||
124810117|NCT05338216|448934166|FG000|Overall Study|Withdrawal by Subject|1|||
124810118|NCT05338216|448934167|FG001|Overall Study|Withdrawal by Subject|1|||
124810119|NCT00413244|448934168|FG000|Overall Study|Withdrawal by Subject|10|||
124810120|NCT00413244|448934169|FG001|Overall Study|Withdrawal by Subject|1|||
124810121|NCT00446251|448934170|FG000|Overall Study|On-study Transplants|2|||
124810122|NCT00446251|448934170|FG000|Overall Study|Rituximab Infusion Reaction|2|||
124810123|NCT00446251|448934170|FG000|Overall Study|Lost to Follow-up|1|||
124810124|NCT00753766|448934175|FG000|Overall Study|Physician Decision|1|||
124810125|NCT00753766|448934176|FG001|Overall Study|Physician Decision|0|||
124810126|NCT04545554|448934177|FG000|Overall Study|Withdrawal by Subject|0|||
124810127|NCT04545554|448934178|FG001|Overall Study|Withdrawal by Subject|0|||
124810128|NCT04545554|448934179|FG002|Overall Study|Withdrawal by Subject|0|||
124810129|NCT04545554|448934180|FG003|Overall Study|Withdrawal by Subject|1|||
124810130|NCT04545554|448934181|FG004|Overall Study|Withdrawal by Subject|0|||
124810131|NCT04545554|448934182|FG005|Overall Study|Withdrawal by Subject|0|||
124810132|NCT00494299|448934183|FG000|Overall Study|Adverse Event|93|||
124810133|NCT00494299|448934184|FG001|Overall Study|Adverse Event|13|||
124810134|NCT00494299|448934183|FG000|Overall Study|Lost to Follow-up|1|||
124810135|NCT00494299|448934184|FG001|Overall Study|Lost to Follow-up|0|||
124810136|NCT00494299|448934183|FG000|Overall Study|Physician Decision|0|||
124810137|NCT00494299|448934184|FG001|Overall Study|Physician Decision|2|||
124810138|NCT00494299|448934183|FG000|Overall Study|Protocol Violation|1|||
124810139|NCT00494299|448934184|FG001|Overall Study|Protocol Violation|2|||
124810140|NCT00494299|448934183|FG000|Overall Study|Withdrawal by Subject|8|||
124810141|NCT00494299|448934184|FG001|Overall Study|Withdrawal by Subject|3|||
124810142|NCT00494299|448934183|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
124810143|NCT00494299|448934184|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
124810144|NCT00494299|448934183|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
124810145|NCT00494299|448934184|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
124810146|NCT00494299|448934183|FG000|Overall Study|Site Closed by Sponsor|6|||
124810147|NCT00494299|448934184|FG001|Overall Study|Site Closed by Sponsor|0|||
124810148|NCT00494299|448934183|FG000|Overall Study|Protocol Driven Decision Point|11|||
124810149|NCT00494299|448934184|FG001|Overall Study|Protocol Driven Decision Point|22|||
124810150|NCT00066365|448934185|FG000|Overall Study|Adverse Event|1|||
124810151|NCT00066365|448934186|FG001|Overall Study|Adverse Event|0|||
124810152|NCT00066365|448934185|FG000|Overall Study|Lack of Efficacy|15|||
124810153|NCT00066365|448934186|FG001|Overall Study|Lack of Efficacy|12|||
124810154|NCT00066365|448934185|FG000|Overall Study|Physician Decision|1|||
124810155|NCT00066365|448934186|FG001|Overall Study|Physician Decision|0|||
124810156|NCT00066365|448934185|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
124810157|NCT00066365|448934186|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
124810158|NCT00066365|448934185|FG000|Overall Study|Ineligible|4|||
124810159|NCT00066365|448934186|FG001|Overall Study|Ineligible|2|||
124810160|NCT00239590|448934189|FG000|Randomized|Lost to Follow-up|0|||
124810161|NCT00239590|448934190|FG001|Randomized|Lost to Follow-up|1|||
124810162|NCT00239590|448934189|FG000|Randomized|Withdrawal by Subject|0|||
124810163|NCT00239590|448934190|FG001|Randomized|Withdrawal by Subject|1|||
124810164|NCT00239590|448934189|FG000|Completed Study Protocol|Adverse Event|1|||
124810165|NCT00239590|448934190|FG001|Completed Study Protocol|Adverse Event|1|||
124810166|NCT00239590|448934189|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
124810167|NCT00239590|448934190|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
124810168|NCT02362269|448934194|FG000|Overall Study|Moved|1|||
124810169|NCT02362269|448934195|FG001|Overall Study|Moved|0|||
124810170|NCT02362269|448934194|FG000|Overall Study|Lost to Follow-up|0|||
124810171|NCT02362269|448934195|FG001|Overall Study|Lost to Follow-up|6|||
124810172|NCT05213481|448934196|FG000|Overall Study|Adverse Event|3|||
124810173|NCT05213481|448934196|FG000|Overall Study|Lost to Follow-up|1|||
124810174|NCT00415168|448934200|FG000|Overall Study|Death|26|||
124810175|NCT00415168|448934200|FG000|Overall Study|Lost to Follow-up|3|||
124810176|NCT00415168|448934200|FG000|Overall Study|Physician Decision|13|||
124810177|NCT00415168|448934200|FG000|Overall Study|Sponsor Decision|4|||
124810178|NCT00415168|448934200|FG000|Overall Study|Withdrawal by Subject|6|||
124810179|NCT02058693|448934206|FG000|Phase 1|Withdrawal by Subject|3|||
124810180|NCT02058693|448934207|FG001|Phase 1|Withdrawal by Subject|2|||
124810181|NCT02058693|448934206|FG000|Phase 1|Adverse Event|0|||
124810182|NCT02058693|448934207|FG001|Phase 1|Adverse Event|1|||
124810183|NCT02058693|448934206|FG000|Phase 1|Lack of Efficacy|1|||
124810184|NCT02058693|448934207|FG001|Phase 1|Lack of Efficacy|0|||
124810185|NCT02058693|448934206|FG000|Phase 1|Physician Decision|1|||
124810186|NCT02058693|448934207|FG001|Phase 1|Physician Decision|1|||
124810187|NCT02058693|448934206|FG000|Phase 2|Withdrawal by Subject|0|||
124810188|NCT02058693|448934207|FG001|Phase 2|Withdrawal by Subject|2|||
124810189|NCT00722800|448934208|FG000|Overall Study|Withdrawal by Subject|1|||
124810190|NCT00722800|448934209|FG001|Overall Study|Withdrawal by Subject|0|||
124810191|NCT00722800|448934208|FG000|Overall Study|Physician Decision|1|||
124810192|NCT00722800|448934209|FG001|Overall Study|Physician Decision|0|||
124810193|NCT02925117|448934212|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
124810194|NCT02925117|448934213|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
124810195|NCT02925117|448934214|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
124810196|NCT02925117|448934215|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
124810197|NCT02925117|448934216|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
124810198|NCT02925117|448934217|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
124810199|NCT02925117|448934218|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
124810200|NCT02925117|448934219|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
124810201|NCT02925117|448934220|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
124810202|NCT02925117|448934221|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
124810203|NCT02925117|448934222|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
124810204|NCT02925117|448934223|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
124810205|NCT02925117|448934212|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
124810206|NCT02925117|448934213|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
124810207|NCT02925117|448934214|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
124810208|NCT02925117|448934215|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810209|NCT02925117|448934216|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810210|NCT02925117|448934217|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810211|NCT02925117|448934218|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810212|NCT02925117|448934219|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810213|NCT02925117|448934220|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810214|NCT02925117|448934221|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810215|NCT02925117|448934222|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810216|NCT02925117|448934223|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
124810217|NCT02925117|448934212|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
124810218|NCT02925117|448934213|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
124810219|NCT02925117|448934214|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810220|NCT02925117|448934215|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810221|NCT02925117|448934216|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810222|NCT02925117|448934217|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810223|NCT02925117|448934218|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810224|NCT02925117|448934219|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810225|NCT02925117|448934220|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810226|NCT02925117|448934221|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810227|NCT02925117|448934222|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810228|NCT02925117|448934223|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
124810229|NCT02925117|448934212|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
124810230|NCT02925117|448934213|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
124810231|NCT02925117|448934214|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
124810232|NCT02925117|448934215|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
124810233|NCT02925117|448934216|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
124810234|NCT02925117|448934217|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
124810235|NCT02925117|448934218|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
124810236|NCT02925117|448934219|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
124810237|NCT02925117|448934220|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
124810238|NCT02925117|448934221|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
124810239|NCT02925117|448934222|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
124810240|NCT02925117|448934223|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
124810241|NCT02925117|448934212|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810242|NCT02925117|448934213|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810243|NCT02925117|448934214|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810244|NCT02925117|448934215|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810245|NCT02925117|448934216|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810246|NCT02925117|448934217|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
124810247|NCT02925117|448934218|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810248|NCT02925117|448934219|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810249|NCT02925117|448934220|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810250|NCT02925117|448934221|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
124810251|NCT02925117|448934222|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
124810252|NCT02925117|448934223|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
124810253|NCT02925117|448934212|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
124810254|NCT02925117|448934213|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
124810255|NCT02925117|448934214|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
124810256|NCT02925117|448934215|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
124810257|NCT02925117|448934216|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
124810258|NCT02925117|448934217|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
124810259|NCT02925117|448934218|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
124810260|NCT02925117|448934219|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
124810261|NCT02925117|448934220|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
124810262|NCT02925117|448934221|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
124810263|NCT02925117|448934222|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
124810264|NCT02925117|448934223|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
124810265|NCT02925117|448934212|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
124810266|NCT02925117|448934213|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
124810267|NCT02925117|448934214|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
124810268|NCT02925117|448934215|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
124810269|NCT02925117|448934216|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
124810270|NCT02925117|448934217|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
124810271|NCT02925117|448934218|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
124810272|NCT02925117|448934219|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
124810273|NCT02925117|448934220|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
124810274|NCT02925117|448934221|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
124810275|NCT02925117|448934222|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
124810276|NCT02925117|448934223|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
124810277|NCT02925117|448934212|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
124810278|NCT02925117|448934213|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
124810279|NCT02925117|448934214|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
124810280|NCT02925117|448934215|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
124810281|NCT02925117|448934216|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
124810282|NCT02925117|448934217|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
124810283|NCT02925117|448934218|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
124810284|NCT02925117|448934219|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
124810285|NCT02925117|448934220|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
124810286|NCT02925117|448934221|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
124810287|NCT02925117|448934222|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
124810288|NCT02925117|448934223|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
124810289|NCT01449539|448934228|FG000|Overall Study|Withdrawal by Subject|3|||
124810290|NCT01449539|448934228|FG000|Overall Study|Toxicity not study related|1|||
124810291|NCT01972568|448934229|FG000|Overall Study|Other events|3|||
124810292|NCT01972568|448934230|FG001|Overall Study|Other events|0|||
124810293|NCT01972568|448934231|FG002|Overall Study|Other events|0|||
124810294|NCT01972568|448934229|FG000|Overall Study|Lack of Efficacy|0|||
124810295|NCT01972568|448934230|FG001|Overall Study|Lack of Efficacy|1|||
124810296|NCT01972568|448934231|FG002|Overall Study|Lack of Efficacy|2|||
124810297|NCT01972568|448934229|FG000|Overall Study|Protocol Violation|1|||
124810298|NCT01972568|448934230|FG001|Overall Study|Protocol Violation|2|||
124810299|NCT01972568|448934231|FG002|Overall Study|Protocol Violation|2|||
124810300|NCT01972568|448934229|FG000|Overall Study|Withdrawal by Subject|6|||
124810301|NCT01972568|448934230|FG001|Overall Study|Withdrawal by Subject|3|||
124810302|NCT01972568|448934231|FG002|Overall Study|Withdrawal by Subject|7|||
124810303|NCT01972568|448934229|FG000|Overall Study|Lost to Follow-up|1|||
124810304|NCT01972568|448934230|FG001|Overall Study|Lost to Follow-up|0|||
124810305|NCT01972568|448934231|FG002|Overall Study|Lost to Follow-up|0|||
124810306|NCT01972568|448934229|FG000|Overall Study|Adverse Event|5|||
124810307|NCT01972568|448934230|FG001|Overall Study|Adverse Event|6|||
124810308|NCT01972568|448934231|FG002|Overall Study|Adverse Event|5|||
124810309|NCT00306189|448934232|FG000|Overall Study|Physician Decision|0|||
124810310|NCT00306189|448934233|FG001|Overall Study|Physician Decision|0|||
124810311|NCT00306189|448934234|FG002|Overall Study|Physician Decision|0|||
124810312|NCT00306189|448934235|FG003|Overall Study|Physician Decision|1|||
124810313|NCT00306189|448934232|FG000|Overall Study|Adverse Event|3|||
124810314|NCT00306189|448934233|FG001|Overall Study|Adverse Event|3|||
124810315|NCT00306189|448934234|FG002|Overall Study|Adverse Event|2|||
124810316|NCT00306189|448934235|FG003|Overall Study|Adverse Event|2|||
124810317|NCT00306189|448934232|FG000|Overall Study|Withdrawal by Subject|4|||
124810318|NCT00306189|448934233|FG001|Overall Study|Withdrawal by Subject|2|||
124810319|NCT00306189|448934234|FG002|Overall Study|Withdrawal by Subject|8|||
124810320|NCT00306189|448934235|FG003|Overall Study|Withdrawal by Subject|1|||
124810321|NCT00306189|448934232|FG000|Overall Study|Ineligibility determined|1|||
124810322|NCT00306189|448934233|FG001|Overall Study|Ineligibility determined|1|||
124810323|NCT00306189|448934234|FG002|Overall Study|Ineligibility determined|1|||
124810324|NCT00306189|448934235|FG003|Overall Study|Ineligibility determined|1|||
124810325|NCT00306189|448934232|FG000|Overall Study|Other|1|||
124810326|NCT00306189|448934233|FG001|Overall Study|Other|0|||
124810327|NCT00306189|448934234|FG002|Overall Study|Other|0|||
124810328|NCT00306189|448934235|FG003|Overall Study|Other|0|||
124810329|NCT02572401|448934236|FG000|Overall Study|Lost to Follow-up|5|||
124810330|NCT02572401|448934237|FG001|Overall Study|Lost to Follow-up|8|||
124810331|NCT02572401|448934238|FG002|Overall Study|Lost to Follow-up|9|||
124810332|NCT02572401|448934239|FG003|Overall Study|Lost to Follow-up|9|||
124810333|NCT02572401|448934236|FG000|Overall Study|Death|0|||
124810334|NCT02572401|448934237|FG001|Overall Study|Death|0|||
124810335|NCT02572401|448934238|FG002|Overall Study|Death|0|||
124810336|NCT02572401|448934239|FG003|Overall Study|Death|1|||
124810337|NCT02059408|448934240|FG000|Overall Study|Did not get tested|0|||
124810338|NCT02059408|448934241|FG001|Overall Study|Did not get tested|330|||
124810339|NCT02059408|448934242|FG002|Overall Study|Did not get tested|358|||
124810340|NCT00945893|448934243|FG000|Overall Study|Lost to Follow-up|2|||
124810341|NCT00945893|448934244|FG001|Overall Study|Lost to Follow-up|8|||
124810342|NCT00945893|448934243|FG000|Overall Study|Withdrawal of consent|1|||
124810343|NCT00945893|448934244|FG001|Overall Study|Withdrawal of consent|2|||
124810344|NCT01681472|448934246|FG000|Overall Study|Adverse Event|0|||
124810345|NCT01681472|448934247|FG001|Overall Study|Adverse Event|1|||
124810346|NCT01681472|448934248|FG002|Overall Study|Adverse Event|0|||
124810347|NCT01681472|448934249|FG003|Overall Study|Adverse Event|0|||
124810348|NCT00667875|448934250|FG000|Overall Study|Adverse Event|0|||
124810349|NCT00667875|448934251|FG001|Overall Study|Adverse Event|2|||
124810350|NCT00667875|448934252|FG002|Overall Study|Adverse Event|6|||
124810351|NCT00667875|448934250|FG000|Overall Study|Withdrawal by Subject|10|||
124810352|NCT00667875|448934251|FG001|Overall Study|Withdrawal by Subject|9|||
124810353|NCT00667875|448934252|FG002|Overall Study|Withdrawal by Subject|7|||
124810354|NCT01187433|448934260|FG000|Overall Study|Protocol Violation|6|||
124810355|NCT01187433|448934261|FG001|Overall Study|Protocol Violation|2|||
124810356|NCT01187433|448934260|FG000|Overall Study|Withdrawal by Subject|5|||
124810357|NCT01187433|448934261|FG001|Overall Study|Withdrawal by Subject|2|||
124810358|NCT00437983|448934265|FG000|Overall Study|Adverse Event|6|||
124810359|NCT00437983|448934266|FG001|Overall Study|Adverse Event|6|||
124810360|NCT00437983|448934265|FG000|Overall Study|Protocol Violation|2|||
124810361|NCT00437983|448934266|FG001|Overall Study|Protocol Violation|1|||
124810362|NCT00437983|448934265|FG000|Overall Study|Withdrawal by Subject|5|||
124810363|NCT00437983|448934266|FG001|Overall Study|Withdrawal by Subject|6|||
124810364|NCT00672646|448934269|FG000|Overall Study|Lost to Follow-up|0|||
124810365|NCT00672646|448934270|FG001|Overall Study|Lost to Follow-up|1|||
124810366|NCT00672646|448934271|FG002|Overall Study|Lost to Follow-up|2|||
124810367|NCT00672646|448934269|FG000|Overall Study|Withdrawal by Subject|0|||
124810368|NCT00672646|448934270|FG001|Overall Study|Withdrawal by Subject|0|||
124810369|NCT00672646|448934271|FG002|Overall Study|Withdrawal by Subject|1|||
124810370|NCT00142298|448934274|FG000|Overall Study|Adverse Event|10|||
124810371|NCT00142298|448934275|FG001|Overall Study|Adverse Event|10|||
124810372|NCT00142298|448934276|FG002|Overall Study|Adverse Event|1|||
124810373|NCT00142298|448934277|FG003|Overall Study|Adverse Event|5|||
124810374|NCT00142298|448934278|FG004|Overall Study|Adverse Event|2|||
124810375|NCT00142298|448934279|FG005|Overall Study|Adverse Event|2|||
124810376|NCT00142298|448934280|FG006|Overall Study|Adverse Event|0|||
124810377|NCT00142298|448934281|FG007|Overall Study|Adverse Event|0|||
124810378|NCT00142298|448934282|FG008|Overall Study|Adverse Event|0|||
124810379|NCT00142298|448934283|FG009|Overall Study|Adverse Event|0|||
124810380|NCT00142298|448934274|FG000|Overall Study|Clinical disease progression|1|||
124810381|NCT00142298|448934275|FG001|Overall Study|Clinical disease progression|0|||
124810382|NCT00142298|448934276|FG002|Overall Study|Clinical disease progression|0|||
124810383|NCT00142298|448934277|FG003|Overall Study|Clinical disease progression|0|||
124810384|NCT00142298|448934278|FG004|Overall Study|Clinical disease progression|0|||
124810385|NCT00142298|448934279|FG005|Overall Study|Clinical disease progression|0|||
124810386|NCT00142298|448934280|FG006|Overall Study|Clinical disease progression|0|||
124810387|NCT00142298|448934281|FG007|Overall Study|Clinical disease progression|0|||
124810388|NCT00142298|448934282|FG008|Overall Study|Clinical disease progression|0|||
124810389|NCT00142298|448934283|FG009|Overall Study|Clinical disease progression|0|||
124810390|NCT00142298|448934274|FG000|Overall Study|Death|1|||
124810391|NCT00142298|448934275|FG001|Overall Study|Death|1|||
124810392|NCT00142298|448934276|FG002|Overall Study|Death|1|||
124810393|NCT00142298|448934277|FG003|Overall Study|Death|0|||
124810394|NCT00142298|448934278|FG004|Overall Study|Death|0|||
124810395|NCT00142298|448934279|FG005|Overall Study|Death|6|||
124810396|NCT00142298|448934280|FG006|Overall Study|Death|0|||
124810397|NCT00142298|448934281|FG007|Overall Study|Death|0|||
124810398|NCT00142298|448934282|FG008|Overall Study|Death|0|||
124810399|NCT00142298|448934283|FG009|Overall Study|Death|0|||
124810400|NCT00142298|448934274|FG000|Overall Study|Lack of Efficacy|44|||
124810401|NCT00142298|448934275|FG001|Overall Study|Lack of Efficacy|62|||
124810402|NCT00142298|448934276|FG002|Overall Study|Lack of Efficacy|9|||
124810403|NCT00142298|448934277|FG003|Overall Study|Lack of Efficacy|12|||
124810404|NCT00142298|448934278|FG004|Overall Study|Lack of Efficacy|1|||
124810405|NCT00142298|448934279|FG005|Overall Study|Lack of Efficacy|0|||
124810406|NCT00142298|448934280|FG006|Overall Study|Lack of Efficacy|0|||
124810407|NCT00142298|448934281|FG007|Overall Study|Lack of Efficacy|1|||
124810408|NCT00142298|448934282|FG008|Overall Study|Lack of Efficacy|0|||
124810409|NCT00142298|448934283|FG009|Overall Study|Lack of Efficacy|0|||
124810410|NCT00142298|448934274|FG000|Overall Study|Non-compliance|15|||
124810411|NCT00142298|448934275|FG001|Overall Study|Non-compliance|13|||
124810412|NCT00142298|448934276|FG002|Overall Study|Non-compliance|0|||
124810413|NCT00142298|448934277|FG003|Overall Study|Non-compliance|6|||
124810414|NCT00142298|448934278|FG004|Overall Study|Non-compliance|1|||
124810415|NCT00142298|448934279|FG005|Overall Study|Non-compliance|0|||
124810416|NCT00142298|448934280|FG006|Overall Study|Non-compliance|0|||
124810417|NCT00142298|448934281|FG007|Overall Study|Non-compliance|3|||
124810418|NCT00142298|448934282|FG008|Overall Study|Non-compliance|3|||
124810419|NCT00142298|448934283|FG009|Overall Study|Non-compliance|0|||
124810420|NCT00142298|448934274|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
124810421|NCT00142298|448934275|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
124810422|NCT00142298|448934276|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
124810423|NCT00142298|448934277|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
124810424|NCT00142298|448934278|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
124810425|NCT00142298|448934279|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
124810426|NCT00142298|448934280|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
124810427|NCT00142298|448934281|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
124810428|NCT00142298|448934282|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
124810429|NCT00142298|448934283|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
124810430|NCT00142298|448934274|FG000|Overall Study|Pregnancy|4|||
124810431|NCT00142298|448934275|FG001|Overall Study|Pregnancy|4|||
124810432|NCT00142298|448934276|FG002|Overall Study|Pregnancy|2|||
124810433|NCT00142298|448934277|FG003|Overall Study|Pregnancy|3|||
124810434|NCT00142298|448934278|FG004|Overall Study|Pregnancy|0|||
124810435|NCT00142298|448934279|FG005|Overall Study|Pregnancy|0|||
124810436|NCT00142298|448934280|FG006|Overall Study|Pregnancy|0|||
124810437|NCT00142298|448934281|FG007|Overall Study|Pregnancy|0|||
124810438|NCT00142298|448934282|FG008|Overall Study|Pregnancy|1|||
124810439|NCT00142298|448934283|FG009|Overall Study|Pregnancy|0|||
124810440|NCT00142298|448934274|FG000|Overall Study|Virologic breakthrough|19|||
124810441|NCT00142298|448934275|FG001|Overall Study|Virologic breakthrough|23|||
124810442|NCT00142298|448934276|FG002|Overall Study|Virologic breakthrough|9|||
124810443|NCT00142298|448934277|FG003|Overall Study|Virologic breakthrough|7|||
124810444|NCT00142298|448934278|FG004|Overall Study|Virologic breakthrough|2|||
124810445|NCT00142298|448934279|FG005|Overall Study|Virologic breakthrough|3|||
124810446|NCT00142298|448934280|FG006|Overall Study|Virologic breakthrough|3|||
124810447|NCT00142298|448934281|FG007|Overall Study|Virologic breakthrough|0|||
124810448|NCT00142298|448934282|FG008|Overall Study|Virologic breakthrough|0|||
124810449|NCT00142298|448934283|FG009|Overall Study|Virologic breakthrough|0|||
124810450|NCT00142298|448934274|FG000|Overall Study|Other- not specified|0|||
124810451|NCT00142298|448934275|FG001|Overall Study|Other- not specified|3|||
124810452|NCT00142298|448934276|FG002|Overall Study|Other- not specified|0|||
124810453|NCT00142298|448934277|FG003|Overall Study|Other- not specified|1|||
124810454|NCT00142298|448934278|FG004|Overall Study|Other- not specified|0|||
124810455|NCT00142298|448934279|FG005|Overall Study|Other- not specified|0|||
124810456|NCT00142298|448934280|FG006|Overall Study|Other- not specified|0|||
124810457|NCT00142298|448934281|FG007|Overall Study|Other- not specified|0|||
124810458|NCT00142298|448934282|FG008|Overall Study|Other- not specified|0|||
124810459|NCT00142298|448934283|FG009|Overall Study|Other- not specified|0|||
124810460|NCT00142298|448934274|FG000|Overall Study|Lost to Follow-up|0|||
124810461|NCT00142298|448934275|FG001|Overall Study|Lost to Follow-up|0|||
124810462|NCT00142298|448934276|FG002|Overall Study|Lost to Follow-up|0|||
124810463|NCT00142298|448934277|FG003|Overall Study|Lost to Follow-up|0|||
124810464|NCT00142298|448934278|FG004|Overall Study|Lost to Follow-up|0|||
124810465|NCT00142298|448934279|FG005|Overall Study|Lost to Follow-up|0|||
124810466|NCT00142298|448934280|FG006|Overall Study|Lost to Follow-up|2|||
124810467|NCT00142298|448934281|FG007|Overall Study|Lost to Follow-up|0|||
124810468|NCT00142298|448934282|FG008|Overall Study|Lost to Follow-up|0|||
124810469|NCT00142298|448934283|FG009|Overall Study|Lost to Follow-up|0|||
124810470|NCT00142298|448934274|FG000|Overall Study|Treatment Failure|0|||
124810471|NCT00142298|448934275|FG001|Overall Study|Treatment Failure|0|||
124810472|NCT00142298|448934276|FG002|Overall Study|Treatment Failure|0|||
124810473|NCT00142298|448934277|FG003|Overall Study|Treatment Failure|0|||
124810474|NCT00142298|448934278|FG004|Overall Study|Treatment Failure|0|||
124810475|NCT00142298|448934279|FG005|Overall Study|Treatment Failure|2|||
124810476|NCT00142298|448934280|FG006|Overall Study|Treatment Failure|2|||
124810477|NCT00142298|448934281|FG007|Overall Study|Treatment Failure|0|||
124810478|NCT00142298|448934282|FG008|Overall Study|Treatment Failure|0|||
124810479|NCT00142298|448934283|FG009|Overall Study|Treatment Failure|0|||
124810480|NCT00300274|448934284|FG000|Overall Study|Withdrawal by Subject|12|||
124810481|NCT00300274|448934285|FG001|Overall Study|Withdrawal by Subject|3|||
124810482|NCT00300274|448934286|FG002|Overall Study|Withdrawal by Subject|14|||
124810483|NCT00300274|448934284|FG000|Overall Study|Lost to Follow-up|3|||
124810484|NCT00300274|448934285|FG001|Overall Study|Lost to Follow-up|4|||
124810485|NCT00300274|448934286|FG002|Overall Study|Lost to Follow-up|5|||
124810486|NCT00300274|448934284|FG000|Overall Study|Death|31|||
124810487|NCT00300274|448934285|FG001|Overall Study|Death|20|||
124810488|NCT00300274|448934286|FG002|Overall Study|Death|25|||
124810489|NCT00300274|448934284|FG000|Overall Study|Re-transplant|0|||
124810490|NCT00300274|448934285|FG001|Overall Study|Re-transplant|0|||
124810491|NCT00300274|448934286|FG002|Overall Study|Re-transplant|1|||
124810492|NCT00242216|448934287|FG000|Overall Study|Lost to Follow-up|12|||
124810493|NCT00242216|448934288|FG001|Overall Study|Lost to Follow-up|17|||
124810494|NCT00242216|448934287|FG000|Overall Study|Death|4|||
124810495|NCT00242216|448934288|FG001|Overall Study|Death|2|||
124810496|NCT00242216|448934287|FG000|Overall Study|Lack of Efficacy|1|||
124810497|NCT00242216|448934288|FG001|Overall Study|Lack of Efficacy|2|||
124810498|NCT00242216|448934287|FG000|Overall Study|no medicaiton dispensed|1|||
124810499|NCT00242216|448934288|FG001|Overall Study|no medicaiton dispensed|1|||
124810500|NCT04439201|448934289|FG000|Overall Study|Ineligible|2|||
124810501|NCT04439201|448934289|FG000|Overall Study|Never start protocol therapy|1|||
124810502|NCT04439201|448934289|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
124810503|NCT04439201|448934289|FG000|Overall Study|Mutation status not confirmed|4|||
124810504|NCT04439201|448934289|FG000|Overall Study|Adverse Event|1|||
124810505|NCT04439201|448934289|FG000|Overall Study|Death|7|||
124810506|NCT04439201|448934289|FG000|Overall Study|Withdrawal by Subject|2|||
124810507|NCT04439201|448934289|FG000|Overall Study|Disease progression|20|||
124810508|NCT04439201|448934289|FG000|Overall Study|Alternative therapy|1|||
124810509|NCT04439201|448934289|FG000|Overall Study|Physician Decision|1|||
124810510|NCT06956170|448936128|FG000|Overall Study|Death|2|||
124810511|NCT06956170|448936129|FG001|Overall Study|Death|1|||
124810512|NCT06956170|448936128|FG000|Overall Study|Withdrawal by Subject|1|||
124810513|NCT06956170|448936129|FG001|Overall Study|Withdrawal by Subject|0|||
124810514|NCT06956170|448936128|FG000|Overall Study|Ongoing|7|||
124810515|NCT06956170|448936129|FG001|Overall Study|Ongoing|10|||
124810516|NCT01385566|448936130|FG000|Overall Study|Lost to Follow-up|1|||
124810517|NCT01385566|448936131|FG001|Overall Study|Lost to Follow-up|0|||
124810518|NCT01385566|448936132|FG002|Overall Study|Lost to Follow-up|0|||
124810519|NCT01385566|448936133|FG003|Overall Study|Lost to Follow-up|0|||
124810520|NCT01385566|448936134|FG004|Overall Study|Lost to Follow-up|0|||
124810521|NCT01385566|448936135|FG005|Overall Study|Lost to Follow-up|0|||
124810522|NCT01385566|448936130|FG000|Overall Study|Withdrawal by Subject|0|||
124810523|NCT01385566|448936131|FG001|Overall Study|Withdrawal by Subject|0|||
124810524|NCT01385566|448936132|FG002|Overall Study|Withdrawal by Subject|0|||
124810525|NCT01385566|448936133|FG003|Overall Study|Withdrawal by Subject|1|||
124810526|NCT01385566|448936134|FG004|Overall Study|Withdrawal by Subject|0|||
124810527|NCT01385566|448936135|FG005|Overall Study|Withdrawal by Subject|0|||
124810528|NCT00403234|448936138|FG000|Overall Study|Withdrawal by Subject|0|||
124810529|NCT00403234|448936139|FG001|Overall Study|Withdrawal by Subject|1|||
124810530|NCT00403234|448936140|FG002|Overall Study|Withdrawal by Subject|0|||
124810531|NCT00403234|448936141|FG003|Overall Study|Withdrawal by Subject|0|||
124810532|NCT00403234|448936138|FG000|Overall Study|Adverse Event|1|||
124810533|NCT00403234|448936139|FG001|Overall Study|Adverse Event|0|||
124810534|NCT00403234|448936140|FG002|Overall Study|Adverse Event|1|||
124810535|NCT00403234|448936141|FG003|Overall Study|Adverse Event|0|||
124810536|NCT02280304|448936142|FG000|Overall Study|Lost to Follow-up|7|||
124810537|NCT02280304|448936143|FG001|Overall Study|Lost to Follow-up|8|||
124810538|NCT04218695|448936147|FG000|Overall Study|Adverse Event|1|||
124810539|NCT04218695|448936148|FG001|Overall Study|Adverse Event|0|||
124810540|NCT03166735|448936149|FG000|Overall Study|Not Treated|1|||
124810541|NCT03166735|448936150|FG001|Overall Study|Not Treated|0|||
124810542|NCT03166735|448936151|FG002|Overall Study|Not Treated|0|||
124810543|NCT03166735|448936152|FG003|Overall Study|Not Treated|0|||
124810544|NCT03166735|448936153|FG004|Overall Study|Not Treated|0|||
124810545|NCT03166735|448936149|FG000|Overall Study|follow-up not completed as planned|0|||
124810546|NCT03166735|448936150|FG001|Overall Study|follow-up not completed as planned|1|||
124810547|NCT03166735|448936151|FG002|Overall Study|follow-up not completed as planned|1|||
124810548|NCT03166735|448936152|FG003|Overall Study|follow-up not completed as planned|0|||
124810549|NCT03166735|448936153|FG004|Overall Study|follow-up not completed as planned|1|||
124810550|NCT03166735|448936149|FG000|Overall Study|Withdrawal by Subject|0|||
124810551|NCT03166735|448936150|FG001|Overall Study|Withdrawal by Subject|0|||
124810552|NCT03166735|448936151|FG002|Overall Study|Withdrawal by Subject|1|||
124810553|NCT03166735|448936152|FG003|Overall Study|Withdrawal by Subject|1|||
124810554|NCT03166735|448936153|FG004|Overall Study|Withdrawal by Subject|2|||
124810555|NCT03166735|448936149|FG000|Overall Study|Lost to Follow-up|0|||
124810556|NCT03166735|448936150|FG001|Overall Study|Lost to Follow-up|2|||
124810557|NCT03166735|448936151|FG002|Overall Study|Lost to Follow-up|1|||
124810558|NCT03166735|448936152|FG003|Overall Study|Lost to Follow-up|0|||
124810559|NCT03166735|448936153|FG004|Overall Study|Lost to Follow-up|1|||
124810560|NCT00003473|448936154|FG000|Overall Study|Three patients were not evaluable.|3|||
124810561|NCT03372096|448936159|FG000|Overall Study|Study Closed|8|||
124810562|NCT01947582|448936164|FG000|Overall Study|Withdrawal by Subject|1|||
124810563|NCT01603355|448936165|FG000|Overall Study|Lack of Efficacy|2|||
124810564|NCT05154578|448936166|FG000|Overall Study|Withdrawal by Subject|2|||
124810565|NCT05154578|448936167|FG001|Overall Study|Withdrawal by Subject|3|||
124810566|NCT05154578|448936168|FG002|Overall Study|Withdrawal by Subject|2|||
124810567|NCT05154578|448936169|FG003|Overall Study|Withdrawal by Subject|4|||
124810568|NCT05154578|448936170|FG004|Overall Study|Withdrawal by Subject|0|||
124810569|NCT05154578|448936166|FG000|Overall Study|Lost to Follow-up|0|||
124810570|NCT05154578|448936167|FG001|Overall Study|Lost to Follow-up|1|||
124810571|NCT05154578|448936168|FG002|Overall Study|Lost to Follow-up|0|||
124810572|NCT05154578|448936169|FG003|Overall Study|Lost to Follow-up|3|||
124810573|NCT05154578|448936170|FG004|Overall Study|Lost to Follow-up|0|||
124810574|NCT05154578|448936166|FG000|Overall Study|Adverse Event|0|||
124810575|NCT05154578|448936167|FG001|Overall Study|Adverse Event|0|||
124810576|NCT05154578|448936168|FG002|Overall Study|Adverse Event|0|||
124810577|NCT05154578|448936169|FG003|Overall Study|Adverse Event|1|||
124810578|NCT05154578|448936170|FG004|Overall Study|Adverse Event|0|||
124810579|NCT05154578|448936166|FG000|Overall Study|Relocated to another province|0|||
124810580|NCT05154578|448936167|FG001|Overall Study|Relocated to another province|0|||
124810581|NCT05154578|448936168|FG002|Overall Study|Relocated to another province|1|||
124810582|NCT05154578|448936169|FG003|Overall Study|Relocated to another province|0|||
124810583|NCT05154578|448936170|FG004|Overall Study|Relocated to another province|1|||
124810584|NCT05154578|448936166|FG000|Overall Study|Baby loss|0|||
124810585|NCT05154578|448936167|FG001|Overall Study|Baby loss|1|||
124810586|NCT05154578|448936168|FG002|Overall Study|Baby loss|0|||
124810587|NCT05154578|448936169|FG003|Overall Study|Baby loss|0|||
124810588|NCT05154578|448936170|FG004|Overall Study|Baby loss|0|||
124810589|NCT02924571|448936176|FG000|Overall Study|Lost to Follow-up|1|||
124810590|NCT02924571|448936177|FG001|Overall Study|Lost to Follow-up|1|||
124810591|NCT02924571|448936178|FG002|Overall Study|Lost to Follow-up|0|||
124810592|NCT00434954|448936179|FG000|Overall Study|Adverse Event|17|||
124810593|NCT00434954|448936180|FG001|Overall Study|Adverse Event|2|||
124810594|NCT00434954|448936179|FG000|Overall Study|Entry criteria not met|14|||
124810595|NCT00434954|448936180|FG001|Overall Study|Entry criteria not met|16|||
124810596|NCT00434954|448936179|FG000|Overall Study|Lost to Follow-up|0|||
124810597|NCT00434954|448936180|FG001|Overall Study|Lost to Follow-up|1|||
124810598|NCT00434954|448936179|FG000|Overall Study|Physician Decision|6|||
124810599|NCT00434954|448936180|FG001|Overall Study|Physician Decision|3|||
124810600|NCT00434954|448936179|FG000|Overall Study|Protocol Violation|36|||
124810601|NCT00434954|448936180|FG001|Overall Study|Protocol Violation|27|||
124810602|NCT00434954|448936179|FG000|Overall Study|Sponsor decision|1|||
124810603|NCT00434954|448936180|FG001|Overall Study|Sponsor decision|0|||
124810604|NCT00434954|448936179|FG000|Overall Study|Subject decision|8|||
124810605|NCT00434954|448936180|FG001|Overall Study|Subject decision|22|||
124810606|NCT00894166|448936181|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
124810607|NCT00894166|448936182|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
124810608|NCT00894166|448936183|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
124810609|NCT00894166|448936184|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
124810610|NCT00894166|448936185|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
124810611|NCT00894166|448936186|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
124810612|NCT00894166|448936187|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
124810613|NCT00894166|448936188|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
124810614|NCT00894166|448936181|FG000|Overall Study|Death|0|||
124810615|NCT00894166|448936182|FG001|Overall Study|Death|0|||
124810616|NCT00894166|448936183|FG002|Overall Study|Death|0|||
124810617|NCT00894166|448936184|FG003|Overall Study|Death|1|||
124810618|NCT00894166|448936185|FG004|Overall Study|Death|0|||
124810619|NCT00894166|448936186|FG005|Overall Study|Death|0|||
124810620|NCT00894166|448936187|FG006|Overall Study|Death|0|||
124810621|NCT00894166|448936188|FG007|Overall Study|Death|0|||
124810622|NCT03750955|448936196|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
124810623|NCT03750955|448936197|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
124810624|NCT03750955|448936196|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
124810625|NCT03750955|448936197|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
124810626|NCT00142935|448936200|FG000|Overall Study|Other reason|1|||
124810627|NCT00142935|448936201|FG001|Overall Study|Other reason|1|||
124810628|NCT00142935|448936202|FG002|Overall Study|Other reason|1|||
124810629|NCT00142935|448936200|FG000|Overall Study|Lost to Follow-up|2|||
124810630|NCT00142935|448936201|FG001|Overall Study|Lost to Follow-up|5|||
124810631|NCT00142935|448936202|FG002|Overall Study|Lost to Follow-up|5|||
124810632|NCT00142935|448936200|FG000|Overall Study|Death|0|||
124810633|NCT00142935|448936201|FG001|Overall Study|Death|2|||
124810634|NCT00142935|448936202|FG002|Overall Study|Death|1|||
124810635|NCT01180985|448936203|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
124810636|NCT01180985|448936204|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
124810637|NCT00129272|448936212|FG000|Overall Study|Lost to Follow-up|12|||
124810638|NCT00129272|448936213|FG001|Overall Study|Lost to Follow-up|11|||
124810639|NCT00129272|448936212|FG000|Overall Study|Withdrawal by Subject|5|||
124810640|NCT00129272|448936213|FG001|Overall Study|Withdrawal by Subject|11|||
124810641|NCT03345914|448936214|FG000|Overall Study|Transition to another study at week 16|80|||
124810642|NCT03345914|448936215|FG001|Overall Study|Transition to another study at week 16|86|||
124810643|NCT03345914|448936216|FG002|Overall Study|Transition to another study at week 16|78|||
124810644|NCT03345914|448936214|FG000|Overall Study|Transition to OLE during follow-up|37|||
124810645|NCT03345914|448936215|FG001|Overall Study|Transition to OLE during follow-up|33|||
124810646|NCT03345914|448936216|FG002|Overall Study|Transition to OLE during follow-up|39|||
124810647|NCT03345914|448936214|FG000|Overall Study|Physician Decision|0|||
124810648|NCT03345914|448936215|FG001|Overall Study|Physician Decision|1|||
124810649|NCT03345914|448936216|FG002|Overall Study|Physician Decision|1|||
124810650|NCT03345914|448936214|FG000|Overall Study|Withdrawal by Subject|5|||
124810651|NCT03345914|448936215|FG001|Overall Study|Withdrawal by Subject|1|||
124810652|NCT03345914|448936216|FG002|Overall Study|Withdrawal by Subject|2|||
124810653|NCT03345914|448936214|FG000|Overall Study|Other|1|||
124810654|NCT03345914|448936215|FG001|Overall Study|Other|1|||
124810655|NCT03345914|448936216|FG002|Overall Study|Other|1|||
124810656|NCT03345914|448936214|FG000|Overall Study|Ongoing|0|||
124810657|NCT03345914|448936215|FG001|Overall Study|Ongoing|0|||
124810658|NCT03345914|448936216|FG002|Overall Study|Ongoing|1|||
124810659|NCT03758066|448936219|FG000|Overall Study|Lost to Follow-up|14|||
124810660|NCT04138810|448936223|FG000|Overall Study|Withdrawal by Subject|0|||
124810661|NCT04138810|448936224|FG001|Overall Study|Withdrawal by Subject|1|||
124810662|NCT04138810|448936223|FG000|Overall Study|Subject cancelled surgery|1|||
124810663|NCT04138810|448936224|FG001|Overall Study|Subject cancelled surgery|0|||
124810664|NCT01786668|448936225|FG000|Overall Study|Adverse Event|0|||
124810665|NCT01786668|448936226|FG001|Overall Study|Adverse Event|1|||
124810666|NCT01786668|448936227|FG002|Overall Study|Adverse Event|1|||
124810667|NCT01786668|448936228|FG003|Overall Study|Adverse Event|2|||
124810668|NCT01786668|448936225|FG000|Overall Study|Withdrawal by Subject|0|||
124810669|NCT01786668|448936226|FG001|Overall Study|Withdrawal by Subject|0|||
124810670|NCT01786668|448936227|FG002|Overall Study|Withdrawal by Subject|3|||
124810671|NCT01786668|448936228|FG003|Overall Study|Withdrawal by Subject|1|||
124810672|NCT01786668|448936225|FG000|Overall Study|Pregnancy|0|||
124810673|NCT01786668|448936226|FG001|Overall Study|Pregnancy|0|||
124810674|NCT01786668|448936227|FG002|Overall Study|Pregnancy|0|||
124810675|NCT01786668|448936228|FG003|Overall Study|Pregnancy|1|||
124810676|NCT01786668|448936225|FG000|Overall Study|Lost to Follow-up|1|||
124810677|NCT01786668|448936226|FG001|Overall Study|Lost to Follow-up|0|||
124810678|NCT01786668|448936227|FG002|Overall Study|Lost to Follow-up|1|||
124810679|NCT01786668|448936228|FG003|Overall Study|Lost to Follow-up|0|||
124810680|NCT00762385|448936229|FG000|First Intervention|Lens Issue|1|||
124810681|NCT00762385|448936230|FG001|First Intervention|Lens Issue|1|||
124810682|NCT00762385|448936229|FG000|First Intervention|Lost to Follow-up|0|||
124810683|NCT00762385|448936230|FG001|First Intervention|Lost to Follow-up|2|||
124810684|NCT00762385|448936229|FG000|First Intervention|Ineligible|1|||
124810685|NCT00762385|448936230|FG001|First Intervention|Ineligible|0|||
124810686|NCT00762385|448936229|FG000|First Intervention|Protocol Violation|0|||
124810687|NCT00762385|448936230|FG001|First Intervention|Protocol Violation|1|||
124810688|NCT00762385|448936229|FG000|Second Intervention|Protocol Violation|3|||
124810689|NCT00762385|448936230|FG001|Second Intervention|Protocol Violation|3|||
124810690|NCT01540838|448936231|FG000|Overall Study|Open nasogastric tube|9|||
124810691|NCT01540838|448936232|FG001|Overall Study|Open nasogastric tube|7|||
124810692|NCT01540838|448936231|FG000|Overall Study|Treatment doses missing|8|||
124810693|NCT01540838|448936232|FG001|Overall Study|Treatment doses missing|12|||
124810694|NCT01540838|448936231|FG000|Overall Study|Additional antibiotic treatment|1|||
124810695|NCT01540838|448936232|FG001|Overall Study|Additional antibiotic treatment|2|||
124810696|NCT01540838|448936231|FG000|Overall Study|Died before treatment initiation|1|||
124810697|NCT01540838|448936232|FG001|Overall Study|Died before treatment initiation|1|||
124810698|NCT01540838|448936231|FG000|Overall Study|Not BM. Other treatment|3|||
124810699|NCT01540838|448936232|FG001|Overall Study|Not BM. Other treatment|1|||
124810700|NCT02130570|448936233|FG000|Overall Study|Death|3|||
124810701|NCT02130570|448936234|FG001|Overall Study|Death|5|||
124810702|NCT02130570|448936233|FG000|Overall Study|Withdrawal by Subject|6|||
124810703|NCT02130570|448936234|FG001|Overall Study|Withdrawal by Subject|3|||
124810704|NCT02130570|448936233|FG000|Overall Study|Part of practice that discontinued study|0|||
124810705|NCT02130570|448936234|FG001|Overall Study|Part of practice that discontinued study|5|||
124810706|NCT01849783|448936235|FG000|Overall Study|Adverse Event|5|||
124810707|NCT01849783|448936235|FG000|Overall Study|Death|2|||
124810708|NCT01849783|448936235|FG000|Overall Study|Physician Decision|1|||
124810709|NCT01849783|448936235|FG000|Overall Study|Withdrawal by Subject|1|||
124810710|NCT01849783|448936235|FG000|Overall Study|Unable to comply|2|||
124810711|NCT01849783|448936235|FG000|Overall Study|Disease progression|11|||
124810712|NCT01776840|448936236|FG000|Overall Study|Lost to Follow-up|12|||
124810713|NCT01776840|448936237|FG001|Overall Study|Lost to Follow-up|7|||
124810714|NCT01776840|448936236|FG000|Overall Study|Withdrawal by Subject|32|||
124810715|NCT01776840|448936237|FG001|Overall Study|Withdrawal by Subject|48|||
124810716|NCT01776840|448936236|FG000|Overall Study|Sponsor decision|89|||
124810717|NCT01776840|448936237|FG001|Overall Study|Sponsor decision|87|||
124810718|NCT03641339|448936239|FG000|Overall Study|Physician Decision|1|||
124810719|NCT03641339|448936240|FG001|Overall Study|Physician Decision|0|||
124810720|NCT03641339|448936241|FG002|Overall Study|Physician Decision|0|||
124810721|NCT03641339|448936242|FG003|Overall Study|Physician Decision|0|||
124810722|NCT03641339|448936243|FG004|Overall Study|Physician Decision|0|||
124810723|NCT03641339|448936244|FG005|Overall Study|Physician Decision|0|||
124810724|NCT03641339|448936239|FG000|Overall Study|Withdrawal by Subject|0|||
124810725|NCT03641339|448936240|FG001|Overall Study|Withdrawal by Subject|2|||
124810726|NCT03641339|448936241|FG002|Overall Study|Withdrawal by Subject|0|||
124810727|NCT03641339|448936242|FG003|Overall Study|Withdrawal by Subject|2|||
124810728|NCT03641339|448936243|FG004|Overall Study|Withdrawal by Subject|0|||
124810729|NCT03641339|448936244|FG005|Overall Study|Withdrawal by Subject|1|||
124810730|NCT01042678|448936245|FG000|Overall Study|Physician Decision|1|||
124810731|NCT01042678|448936246|FG001|Overall Study|Physician Decision|0|||
124810732|NCT01042678|448936247|FG002|Overall Study|Physician Decision|0|||
124810733|NCT01042678|448936248|FG003|Overall Study|Physician Decision|0|||
124810734|NCT01042678|448936249|FG004|Overall Study|Physician Decision|0|||
124810735|NCT01042678|448936250|FG005|Overall Study|Physician Decision|0|||
124810736|NCT01058655|448936255|FG000|Overall Study|Withdrawal by Subject|1|||
124810737|NCT01058655|448936256|FG001|Overall Study|Withdrawal by Subject|0|||
124810738|NCT01058655|448936257|FG002|Overall Study|Withdrawal by Subject|3|||
124810739|NCT01058655|448936258|FG003|Overall Study|Withdrawal by Subject|4|||
124810740|NCT01058655|448936255|FG000|Overall Study|Prolonged Treatment Delay|0|||
124810741|NCT01058655|448936256|FG001|Overall Study|Prolonged Treatment Delay|0|||
124810742|NCT01058655|448936257|FG002|Overall Study|Prolonged Treatment Delay|0|||
124810743|NCT01058655|448936258|FG003|Overall Study|Prolonged Treatment Delay|2|||
124810744|NCT01058655|448936255|FG000|Overall Study|Symptomatic Deterioration|0|||
124810745|NCT01058655|448936256|FG001|Overall Study|Symptomatic Deterioration|0|||
124810746|NCT01058655|448936257|FG002|Overall Study|Symptomatic Deterioration|0|||
124810747|NCT01058655|448936258|FG003|Overall Study|Symptomatic Deterioration|1|||
124810748|NCT01058655|448936255|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
124810749|NCT01058655|448936256|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
124810750|NCT01058655|448936257|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
124810751|NCT01058655|448936258|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
124810752|NCT01058655|448936255|FG000|Overall Study|Death|0|||
124810753|NCT01058655|448936256|FG001|Overall Study|Death|1|||
124810754|NCT01058655|448936257|FG002|Overall Study|Death|1|||
124810755|NCT01058655|448936258|FG003|Overall Study|Death|0|||
124810756|NCT01058655|448936255|FG000|Overall Study|Disease Progression|1|||
124810757|NCT01058655|448936256|FG001|Overall Study|Disease Progression|2|||
124810758|NCT01058655|448936257|FG002|Overall Study|Disease Progression|4|||
124810759|NCT01058655|448936258|FG003|Overall Study|Disease Progression|24|||
124810760|NCT01058655|448936255|FG000|Overall Study|Other|0|||
124810761|NCT01058655|448936256|FG001|Overall Study|Other|0|||
124810762|NCT01058655|448936257|FG002|Overall Study|Other|0|||
124810763|NCT01058655|448936258|FG003|Overall Study|Other|4|||
124810764|NCT04545060|448936261|FG000|Overall Study|Adverse Event|0|||
124810765|NCT04545060|448936262|FG001|Overall Study|Adverse Event|1|||
124810766|NCT04545060|448936261|FG000|Overall Study|Death|0|||
124810767|NCT04545060|448936262|FG001|Overall Study|Death|5|||
124810768|NCT04545060|448936261|FG000|Overall Study|Lost to Follow-up|10|||
124810769|NCT04545060|448936262|FG001|Overall Study|Lost to Follow-up|13|||
124810770|NCT04545060|448936261|FG000|Overall Study|Physician Decision|3|||
124810771|NCT04545060|448936262|FG001|Overall Study|Physician Decision|0|||
124810772|NCT04545060|448936261|FG000|Overall Study|Withdrawal by Subject|17|||
124810773|NCT04545060|448936262|FG001|Overall Study|Withdrawal by Subject|22|||
124810774|NCT00619177|448936265|FG000|Overall Study|Adverse Event|18|||
124810775|NCT00619177|448936265|FG000|Overall Study|Lost to Follow-up|2|||
124810776|NCT00619177|448936265|FG000|Overall Study|Lack of Efficacy|1|||
124810777|NCT00619177|448936265|FG000|Overall Study|Missing termination information|481|||
124810778|NCT00619177|448936265|FG000|Overall Study|Not specified reasons|6|||
124810779|NCT02319837|448936266|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
124810780|NCT02319837|448936267|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
124810781|NCT02319837|448936268|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
124810782|NCT02319837|448936266|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
124810783|NCT02319837|448936267|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
124810784|NCT02319837|448936268|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
124810785|NCT02319837|448936266|FG000|Study Treatment Phase|Adverse Event|73|||
124810786|NCT02319837|448936267|FG001|Study Treatment Phase|Adverse Event|36|||
124810787|NCT02319837|448936268|FG002|Study Treatment Phase|Adverse Event|63|||
124810788|NCT02319837|448936266|FG000|Study Treatment Phase|Development of castration resistance|0|||
124810789|NCT02319837|448936267|FG001|Study Treatment Phase|Development of castration resistance|2|||
124810790|NCT02319837|448936268|FG002|Study Treatment Phase|Development of castration resistance|0|||
124810791|NCT02319837|448936266|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
124810792|NCT02319837|448936267|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
124810793|NCT02319837|448936268|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
124810794|NCT02319837|448936266|FG000|Study Treatment Phase|Protocol Violation|2|||
124810795|NCT02319837|448936267|FG001|Study Treatment Phase|Protocol Violation|2|||
124810796|NCT02319837|448936268|FG002|Study Treatment Phase|Protocol Violation|1|||
124810797|NCT02319837|448936266|FG000|Study Treatment Phase|Lost to Follow-up|0|||
124810798|NCT02319837|448936267|FG001|Study Treatment Phase|Lost to Follow-up|1|||
124810799|NCT02319837|448936268|FG002|Study Treatment Phase|Lost to Follow-up|0|||
124810800|NCT02319837|448936266|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
124810801|NCT02319837|448936267|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
124810802|NCT02319837|448936268|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
124810803|NCT02319837|448936266|FG000|Study Treatment Phase|Other|0|||
124810804|NCT02319837|448936267|FG001|Study Treatment Phase|Other|1|||
124810805|NCT02319837|448936268|FG002|Study Treatment Phase|Other|0|||
124810806|NCT02319837|448936266|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
124810807|NCT02319837|448936267|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
124810808|NCT02319837|448936268|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
124810809|NCT02319837|448936266|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
124810810|NCT02319837|448936267|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
124810811|NCT02319837|448936268|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
124810812|NCT02319837|448936266|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
124810813|NCT02319837|448936267|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
124810814|NCT02319837|448936268|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
124810815|NCT02319837|448936266|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
124810816|NCT02319837|448936267|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
124810817|NCT02319837|448936268|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
124810818|NCT02319837|448936266|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
124810819|NCT02319837|448936267|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
124634353|NCT03194542|448276282|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
124634354|NCT04762160|448276283|FG000|Overall Study|Study terminated early due to business reasons|5|||
124634355|NCT03971071|448276788|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
124634356|NCT03971071|448276789|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
124634357|NCT03971071|448276790|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
124634358|NCT03971071|448276791|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
124634359|NCT03971071|448276792|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
124634360|NCT03971071|448276788|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
124634361|NCT03971071|448276789|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
124634362|NCT03971071|448276790|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
124634363|NCT03971071|448276791|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
124634364|NCT03971071|448276792|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
124634365|NCT03971071|448276788|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
124634366|NCT03971071|448276789|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
124634367|NCT03971071|448276790|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
124634368|NCT03971071|448276791|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
124634369|NCT03971071|448276792|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
124634370|NCT03971071|448276788|FG000|Open-label Treatment Period|Sponsor decision|0|||
124634371|NCT03971071|448276789|FG001|Open-label Treatment Period|Sponsor decision|0|||
124634372|NCT03971071|448276790|FG002|Open-label Treatment Period|Sponsor decision|0|||
124634373|NCT03971071|448276791|FG003|Open-label Treatment Period|Sponsor decision|0|||
124634374|NCT03971071|448276792|FG004|Open-label Treatment Period|Sponsor decision|1|||
124634375|NCT03971071|448276788|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
124634376|NCT03971071|448276789|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
124634377|NCT03971071|448276790|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
124634378|NCT03971071|448276791|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
124634379|NCT03971071|448276792|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
124634380|NCT03971071|448276788|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
124634381|NCT03971071|448276789|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
124810820|NCT02319837|448936268|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
124810821|NCT02319837|448936266|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
124810822|NCT02319837|448936267|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
124810823|NCT02319837|448936268|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
124810824|NCT02319837|448936266|FG000|Long-Term Follow-Up Phase|Death|33|||
124810825|NCT02319837|448936267|FG001|Long-Term Follow-Up Phase|Death|54|||
124810826|NCT02319837|448936268|FG002|Long-Term Follow-Up Phase|Death|42|||
124810827|NCT00892047|448936269|FG000|Overall Study|Adverse Event|2|||
124810828|NCT00892047|448936270|FG001|Overall Study|Adverse Event|2|||
124810829|NCT00892047|448936269|FG000|Overall Study|subject burden|2|||
124810830|NCT00892047|448936270|FG001|Overall Study|subject burden|3|||
124810831|NCT00892047|448936269|FG000|Overall Study|Lack of Efficacy|0|||
124810832|NCT00892047|448936270|FG001|Overall Study|Lack of Efficacy|2|||
124810833|NCT05306977|448936271|FG000|Overall Study|Withdrawal by Subject|1|||
124810834|NCT01387789|448936277|FG000|Overall Study|Adverse Event|5|||
124810835|NCT01387789|448936277|FG000|Overall Study|Lack of Efficacy|2|||
124810836|NCT01387789|448936277|FG000|Overall Study|Lost to Follow-up|1|||
124810837|NCT00181155|448936278|FG000|Overall Study|Physician Decision|1|||
124810838|NCT00181155|448936279|FG001|Overall Study|Physician Decision|0|||
124810839|NCT00181155|448936278|FG000|Overall Study|Withdrawal by Subject|1|||
124810840|NCT00181155|448936279|FG001|Overall Study|Withdrawal by Subject|0|||
124810841|NCT01788228|448936280|FG000|Overall Study|Migrated/moved from study area|1|||
124810842|NCT01788228|448936281|FG001|Overall Study|Migrated/moved from study area|0|||
124810843|NCT01548287|448936284|FG000|Screening|No reason provided|0|||
124810844|NCT01548287|448936285|FG001|Screening|No reason provided|0|||
124810845|NCT01548287|448936286|FG002|Screening|No reason provided|0|||
124810846|NCT01548287|448936287|FG003|Screening|No reason provided|0|||
124810847|NCT01548287|448936288|FG004|Screening|No reason provided|9|||
124810848|NCT01548287|448936284|FG000|Screening|Did not meet eligibility criteria|0|||
124810849|NCT01548287|448936285|FG001|Screening|Did not meet eligibility criteria|0|||
124810850|NCT01548287|448936286|FG002|Screening|Did not meet eligibility criteria|0|||
124810851|NCT01548287|448936287|FG003|Screening|Did not meet eligibility criteria|0|||
124810852|NCT01548287|448936288|FG004|Screening|Did not meet eligibility criteria|74|||
124810853|NCT01548287|448936284|FG000|Randomized Period|Did not meet inclusion criteria|0|||
124810854|NCT01548287|448936285|FG001|Randomized Period|Did not meet inclusion criteria|0|||
124810855|NCT01548287|448936286|FG002|Randomized Period|Did not meet inclusion criteria|2|||
124810856|NCT01548287|448936287|FG003|Randomized Period|Did not meet inclusion criteria|0|||
124810857|NCT01548287|448936288|FG004|Randomized Period|Did not meet inclusion criteria|0|||
124810858|NCT01548287|448936284|FG000|Randomized Period|Adverse Event|0|||
124810859|NCT01548287|448936285|FG001|Randomized Period|Adverse Event|2|||
124810860|NCT01548287|448936286|FG002|Randomized Period|Adverse Event|5|||
124810861|NCT01548287|448936287|FG003|Randomized Period|Adverse Event|0|||
124810862|NCT01548287|448936288|FG004|Randomized Period|Adverse Event|0|||
124810863|NCT00289783|448936292|FG000|Primary Phase|Adverse Event|10|||
124810864|NCT00289783|448936293|FG001|Primary Phase|Adverse Event|1|||
124810865|NCT00289783|448936292|FG000|Primary Phase|Protocol Violation|27|||
124810866|NCT00289783|448936293|FG001|Primary Phase|Protocol Violation|6|||
124810867|NCT00289783|448936292|FG000|Primary Phase|Withdrawal by Subject|93|||
124810868|NCT00289783|448936293|FG001|Primary Phase|Withdrawal by Subject|40|||
124810869|NCT00289783|448936292|FG000|Primary Phase|Lost to Follow-up|60|||
124634382|NCT03971071|448276790|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
124634383|NCT03971071|448276791|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
124810870|NCT00289783|448936293|FG001|Primary Phase|Lost to Follow-up|14|||
124810871|NCT00289783|448936292|FG000|Primary Phase|Migration from the study area|26|||
124810872|NCT00289783|448936293|FG001|Primary Phase|Migration from the study area|10|||
124810873|NCT00289783|448936292|FG000|Primary Phase|Other|32|||
124810874|NCT00289783|448936293|FG001|Primary Phase|Other|12|||
124810875|NCT00289783|448936292|FG000|Fourth Dose Phase|Adverse Event|1|||
124810876|NCT00289783|448936293|FG001|Fourth Dose Phase|Adverse Event|0|||
124810877|NCT00289783|448936292|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
124810878|NCT00289783|448936293|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
124810879|NCT00289783|448936292|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
124810880|NCT00289783|448936293|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
124810881|NCT00289783|448936292|FG000|Fourth Dose Phase|Migration from the study area|1|||
124810882|NCT00289783|448936293|FG001|Fourth Dose Phase|Migration from the study area|1|||
124810883|NCT00289783|448936292|FG000|Fourth Dose Phase|Other|22|||
124810884|NCT00289783|448936293|FG001|Fourth Dose Phase|Other|10|||
124810885|NCT00566995|448936296|FG000|Overall Study|Toxicity|4|||
124810886|NCT00566995|448936296|FG000|Overall Study|Withdrew consent|3|||
124810887|NCT03128047|448936297|FG000|Overall Study|Withdrawal by Subject|1|||
124810888|NCT01995825|448937606|FG000|Overall Study|Withdrawal by Subject|1|||
124810889|NCT01995825|448937607|FG001|Overall Study|Withdrawal by Subject|0|||
124810890|NCT00560105|448937610|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
124810891|NCT00560105|448937611|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
124810892|NCT02400333|448937614|FG000|Overall Study|Withdrawal by Subject|0|||
124810893|NCT02400333|448937615|FG001|Overall Study|Withdrawal by Subject|1|||
124810894|NCT02400333|448937616|FG002|Overall Study|Withdrawal by Subject|0|||
124810895|NCT02400333|448937617|FG003|Overall Study|Withdrawal by Subject|1|||
124810896|NCT02400333|448937614|FG000|Overall Study|Protocol Violation|1|||
124810897|NCT02400333|448937615|FG001|Overall Study|Protocol Violation|0|||
124810898|NCT02400333|448937616|FG002|Overall Study|Protocol Violation|2|||
124810899|NCT02400333|448937617|FG003|Overall Study|Protocol Violation|1|||
124810900|NCT01034631|448937624|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
124810901|NCT01034631|448937625|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
124810902|NCT01034631|448937626|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
124810903|NCT01034631|448937624|FG000|Phase II|Not Evaluable per protocol|0|||
124810904|NCT01034631|448937625|FG001|Phase II|Not Evaluable per protocol|0|||
124810905|NCT01034631|448937626|FG002|Phase II|Not Evaluable per protocol|2|||
124810906|NCT01034631|448937624|FG000|Phase II|Determined Ineligible per protocol|0|||
124810907|NCT01034631|448937625|FG001|Phase II|Determined Ineligible per protocol|1|||
124810908|NCT01034631|448937626|FG002|Phase II|Determined Ineligible per protocol|0|||
124810909|NCT01560403|448937627|FG000|Overall Study|Lost to Follow-up|0|||
124810910|NCT01560403|448937628|FG001|Overall Study|Lost to Follow-up|1|||
124810911|NCT00983437|448937629|FG000|Overall Study|Adverse Event|9|||
124810912|NCT00983437|448937629|FG000|Overall Study|Lack of Efficacy|1|||
124810913|NCT00983437|448937629|FG000|Overall Study|Withdrawal by Subject|8|||
124810914|NCT00983437|448937629|FG000|Overall Study|Noncompliance to Study Procedures|1|||
124810915|NCT00983437|448937629|FG000|Overall Study|Lost to Follow-up|2|||
124810916|NCT00983437|448937629|FG000|Overall Study|Other Reason|26|||
124810917|NCT01890473|448937630|FG000|Overall Study|Lost to Follow-up|1|||
124810918|NCT01890473|448937631|FG001|Overall Study|Lost to Follow-up|0|||
124810919|NCT01890473|448937630|FG000|Overall Study|Poor/non-compliance|1|||
124810920|NCT01890473|448937631|FG001|Overall Study|Poor/non-compliance|0|||
124810921|NCT04019288|448937632|FG000|Overall Study|Death|1|||
124810922|NCT04019288|448937633|FG001|Overall Study|Death|0|||
124810923|NCT04019288|448937634|FG002|Overall Study|Death|0|||
124810924|NCT00934089|448937635|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
124810925|NCT00934089|448937636|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
124810926|NCT00934089|448937635|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
124810927|NCT00934089|448937636|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
124810928|NCT00541931|448937642|FG000|Overall Study|Adverse Event|1|||
124810929|NCT00541931|448937643|FG001|Overall Study|Adverse Event|0|||
124810930|NCT00541931|448937642|FG000|Overall Study|Lost to Follow-up|3|||
124810931|NCT00541931|448937643|FG001|Overall Study|Lost to Follow-up|3|||
124810932|NCT00541931|448937642|FG000|Overall Study|Withdrawal by Subject|1|||
124810933|NCT00541931|448937643|FG001|Overall Study|Withdrawal by Subject|0|||
124810934|NCT00541931|448937642|FG000|Overall Study|Transportation Issue|0|||
124810935|NCT00541931|448937643|FG001|Overall Study|Transportation Issue|1|||
124810936|NCT00040365|448937644|FG000|Overall Study|Death|1|||
124810937|NCT00040365|448937644|FG000|Overall Study|Progressive disease|7|||
124810938|NCT00040365|448937644|FG000|Overall Study|Lost to Follow-up|3|||
124810939|NCT00680017|448937645|FG000|Overall Study|Adverse Event|13|||
124810940|NCT00680017|448937646|FG001|Overall Study|Adverse Event|7|||
124810941|NCT00680017|448937645|FG000|Overall Study|Withdrawal by Subject|2|||
124810942|NCT00680017|448937646|FG001|Overall Study|Withdrawal by Subject|5|||
124810943|NCT00680017|448937645|FG000|Overall Study|Lost to Follow-up|2|||
124810944|NCT00680017|448937646|FG001|Overall Study|Lost to Follow-up|0|||
124810945|NCT00612040|448937647|FG000|Overall Study|Adverse Event|0|||
124810946|NCT00612040|448937648|FG001|Overall Study|Adverse Event|2|||
124810947|NCT00612040|448937649|FG002|Overall Study|Adverse Event|1|||
124810948|NCT00612040|448937647|FG000|Overall Study|Protocol Violation|1|||
124810949|NCT00612040|448937648|FG001|Overall Study|Protocol Violation|2|||
124810950|NCT00612040|448937649|FG002|Overall Study|Protocol Violation|1|||
124810951|NCT00612040|448937647|FG000|Overall Study|Lack of Efficacy|2|||
124810952|NCT00612040|448937648|FG001|Overall Study|Lack of Efficacy|1|||
124810953|NCT00612040|448937649|FG002|Overall Study|Lack of Efficacy|0|||
124810954|NCT00612040|448937647|FG000|Overall Study|Unclassified|2|||
124810955|NCT00612040|448937648|FG001|Overall Study|Unclassified|2|||
124810956|NCT00612040|448937649|FG002|Overall Study|Unclassified|5|||
124810957|NCT01086033|448937651|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
124810958|NCT01086033|448937651|FG000|Overall Study|Lost to Follow-up|86|||
124810959|NCT01086033|448937651|FG000|Overall Study|Adverse Event|42|||
124810960|NCT01086033|448937651|FG000|Overall Study|Withdrawal by Subject|41|||
124810961|NCT01086033|448937651|FG000|Overall Study|Other|14|||
124810962|NCT01086033|448937651|FG000|Overall Study|Other|13|||
124810963|NCT01086033|448937651|FG000|Overall Study|AE and Withdrew Consent|5|||
124810964|NCT01086033|448937651|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
124810965|NCT01086033|448937651|FG000|Overall Study|Withdrew consent and Other Reason|4|||
124810966|NCT01086033|448937651|FG000|Overall Study|AE and Lack of Efficacy|4|||
124810967|NCT01086033|448937651|FG000|Overall Study|Death|1|||
124810968|NCT01086033|448937651|FG000|Overall Study|AE and Lost to Follow-up|1|||
124810969|NCT01086033|448937651|FG000|Overall Study|AE and Other Reason|1|||
124810970|NCT01086033|448937651|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
124810971|NCT04572633|448937652|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
124810972|NCT03478657|448937658|FG000|Overall Study|Withdrawal by Subject|0|||
124810973|NCT03478657|448937659|FG001|Overall Study|Withdrawal by Subject|1|||
124810974|NCT02590003|448937660|FG000|Overall Study|Death|1|||
124810975|NCT02590003|448937661|FG001|Overall Study|Death|2|||
124810976|NCT03570697|448937662|FG000|Overall Study|Lost to Follow-up|0|||
124810977|NCT03570697|448937663|FG001|Overall Study|Lost to Follow-up|1|||
124810978|NCT03570697|448937662|FG000|Overall Study|Death|2|||
124810979|NCT03570697|448937663|FG001|Overall Study|Death|0|||
124810980|NCT03570697|448937662|FG000|Overall Study|Withdrawal by Subject|4|||
124810981|NCT03570697|448937663|FG001|Overall Study|Withdrawal by Subject|2|||
124810982|NCT03948581|448937664|FG000|Overall Study|Lost to Follow-up|0|||
124810983|NCT03948581|448937665|FG001|Overall Study|Lost to Follow-up|1|||
124810984|NCT03068455|448937666|FG000|Pre-treatment Period|Disease progression|0|||
124810985|NCT03068455|448937667|FG001|Pre-treatment Period|Disease progression|1|||
124810986|NCT03068455|448937666|FG000|Pre-treatment Period|Participant withdrew consent|1|||
124810987|NCT03068455|448937667|FG001|Pre-treatment Period|Participant withdrew consent|1|||
124810988|NCT03068455|448937666|FG000|Pre-treatment Period|Poor/non-compliance|0|||
124810989|NCT03068455|448937667|FG001|Pre-treatment Period|Poor/non-compliance|1|||
124810990|NCT03068455|448937666|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
124810991|NCT03068455|448937667|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
124810992|NCT03068455|448937666|FG000|Pre-treatment Period|Not reported|2|||
124810993|NCT03068455|448937667|FG001|Pre-treatment Period|Not reported|1|||
124810994|NCT03068455|448937666|FG000|Treatment Period|Disease progression|166|||
124810995|NCT03068455|448937667|FG001|Treatment Period|Disease progression|208|||
124810996|NCT03068455|448937666|FG000|Treatment Period|Study drug toxicity|317|||
124810997|NCT03068455|448937667|FG001|Treatment Period|Study drug toxicity|104|||
124810998|NCT03068455|448937666|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
124810999|NCT03068455|448937667|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
124811000|NCT03068455|448937666|FG000|Treatment Period|Participant request to stop therapy|33|||
124811001|NCT03068455|448937667|FG001|Treatment Period|Participant request to stop therapy|20|||
124811002|NCT03068455|448937666|FG000|Treatment Period|Participant withdrew consent|5|||
124811003|NCT03068455|448937667|FG001|Treatment Period|Participant withdrew consent|10|||
124811004|NCT03068455|448937666|FG000|Treatment Period|Poor/non-compliance|3|||
124811005|NCT03068455|448937667|FG001|Treatment Period|Poor/non-compliance|0|||
124811006|NCT03068455|448937666|FG000|Treatment Period|Participant no longer meets study criteria|1|||
124811007|NCT03068455|448937667|FG001|Treatment Period|Participant no longer meets study criteria|3|||
124811008|NCT03068455|448937666|FG000|Treatment Period|Other reasons|12|||
124811009|NCT03068455|448937667|FG001|Treatment Period|Other reasons|4|||
124811010|NCT01876420|448937669|FG000|Overall Study|Missed 30 day visit|1|||
124811011|NCT04472429|448937670|FG000|Randomized Period|Ongoing|90|||
124811012|NCT04472429|448937671|FG001|Randomized Period|Ongoing|40|||
124811013|NCT04472429|448937672|FG002|Randomized Period|Ongoing|0|||
124811014|NCT04472429|448937670|FG000|Randomized Period|Death|52|||
124811015|NCT04472429|448937671|FG001|Randomized Period|Death|37|||
124811016|NCT04472429|448937672|FG002|Randomized Period|Death|0|||
124811017|NCT04472429|448937670|FG000|Randomized Period|Lost to Follow-up|4|||
124811018|NCT04472429|448937671|FG001|Randomized Period|Lost to Follow-up|0|||
124811019|NCT04472429|448937672|FG002|Randomized Period|Lost to Follow-up|0|||
124811020|NCT04472429|448937670|FG000|Randomized Period|Physician Decision|1|||
124811021|NCT04472429|448937671|FG001|Randomized Period|Physician Decision|2|||
124811022|NCT04472429|448937672|FG002|Randomized Period|Physician Decision|0|||
124811023|NCT04472429|448937670|FG000|Randomized Period|Withdrawal by Subject|6|||
124811024|NCT04472429|448937671|FG001|Randomized Period|Withdrawal by Subject|5|||
124811025|NCT04472429|448937672|FG002|Randomized Period|Withdrawal by Subject|0|||
124811026|NCT04472429|448937670|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
124811027|NCT04472429|448937671|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
124811028|NCT04472429|448937672|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
124811029|NCT04472429|448937670|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
124811030|NCT04472429|448937671|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
124811031|NCT04472429|448937672|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
124811032|NCT04472429|448937670|FG000|Open-label Monotherapy Period|Ongoing|0|||
124811033|NCT04472429|448937671|FG001|Open-label Monotherapy Period|Ongoing|0|||
124811034|NCT04472429|448937672|FG002|Open-label Monotherapy Period|Ongoing|32|||
124811035|NCT04472429|448937670|FG000|Open-label Monotherapy Period|Death|0|||
124811036|NCT04472429|448937671|FG001|Open-label Monotherapy Period|Death|0|||
124811037|NCT04472429|448937672|FG002|Open-label Monotherapy Period|Death|35|||
124811038|NCT04472429|448937670|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
124811039|NCT04472429|448937671|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
124811040|NCT04472429|448937672|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
124811041|NCT01416272|448937675|FG000|Overall Study|Unacceptable distance visual acuity|2|||
124811042|NCT01416272|448937675|FG000|Overall Study|Lost to Follow-up|1|||
124811043|NCT01416272|448937675|FG000|Overall Study|Study related complaints|1|||
124811044|NCT01719783|448937676|FG000|Dose 2|Physician Decision|1|||
124811045|NCT01719783|448937677|FG001|Dose 2|Physician Decision|0|||
124811046|NCT01313312|448937678|FG000|Overall Study|Adverse Event|5|||
124811047|NCT01313312|448937678|FG000|Overall Study|Withdrawal by Subject|18|||
124811048|NCT01313312|448937678|FG000|Overall Study|Lack of Efficacy|3|||
124811049|NCT01313312|448937678|FG000|Overall Study|Investigator Decision|1|||
124811050|NCT01313312|448937678|FG000|Overall Study|Observational Phase|1|||
124811051|NCT01313312|448937678|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
124811052|NCT01313312|448937678|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
124811053|NCT01612858|448937680|FG000|Overall Study|Withdrawal by Subject|5|||
124811054|NCT01612858|448937681|FG001|Overall Study|Withdrawal by Subject|1|||
124811055|NCT03988088|448937682|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
124811056|NCT03988088|448937683|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
124811057|NCT03988088|448937684|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
124811058|NCT03988088|448937685|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
124811059|NCT03988088|448937682|FG000|Open-Label Addendum|Lost to Follow-up|0|||
124811060|NCT03988088|448937683|FG001|Open-Label Addendum|Lost to Follow-up|0|||
124811061|NCT03988088|448937684|FG002|Open-Label Addendum|Lost to Follow-up|1|||
124811062|NCT03988088|448937685|FG003|Open-Label Addendum|Lost to Follow-up|0|||
124811063|NCT03113071|448937686|FG000|Overall Study|Withdrawal by Subject|1|||
124811064|NCT03113071|448937687|FG001|Overall Study|Withdrawal by Subject|0|||
124811065|NCT00868608|448937694|FG000|Overall Study|Withdrawal by Subject|3|||
124811066|NCT00868608|448937695|FG001|Overall Study|Withdrawal by Subject|1|||
124811067|NCT00868608|448937696|FG002|Overall Study|Withdrawal by Subject|0|||
124811068|NCT00868608|448937694|FG000|Overall Study|Lost to Follow-up|3|||
124811069|NCT00868608|448937695|FG001|Overall Study|Lost to Follow-up|0|||
124811070|NCT00868608|448937696|FG002|Overall Study|Lost to Follow-up|1|||
124811071|NCT00868608|448937694|FG000|Overall Study|Death|16|||
124811072|NCT00868608|448937695|FG001|Overall Study|Death|2|||
124811073|NCT00868608|448937696|FG002|Overall Study|Death|4|||
124811074|NCT00868608|448937694|FG000|Overall Study|Other - Unspecified|1|||
124811075|NCT00868608|448937695|FG001|Overall Study|Other - Unspecified|0|||
124811076|NCT00868608|448937696|FG002|Overall Study|Other - Unspecified|0|||
124811077|NCT03344796|448937697|FG000|Overall Study|Lost to Follow-up|0|||
124811078|NCT03344796|448937698|FG001|Overall Study|Lost to Follow-up|0|||
124811079|NCT03344796|448937699|FG002|Overall Study|Lost to Follow-up|0|||
124811080|NCT03344796|448937700|FG003|Overall Study|Lost to Follow-up|0|||
124811081|NCT03344796|448937701|FG004|Overall Study|Lost to Follow-up|0|||
124811082|NCT03344796|448937702|FG005|Overall Study|Lost to Follow-up|2|||
124811083|NCT01999179|448937703|FG000|Overall Study|Adverse Event|1|||
124811084|NCT01999179|448937703|FG000|Overall Study|Lost to Follow-up|1|||
124811085|NCT01999179|448937703|FG000|Overall Study|Change in Therapy|3|||
124811086|NCT01999179|448937703|FG000|Overall Study|New catheter|2|||
124811087|NCT02564796|448937707|FG000|Overall Study|Physician Decision|2|||
124811088|NCT02564796|448937708|FG001|Overall Study|Physician Decision|2|||
124811089|NCT00594659|448937716|FG000|Overall Study|Lost to Follow-up|13|||
124811090|NCT00594659|448937717|FG001|Overall Study|Lost to Follow-up|9|||
124811091|NCT00594659|448937718|FG002|Overall Study|Lost to Follow-up|7|||
124811092|NCT00660699|448937719|FG000|Overall Study|Withdrawal by Subject|2|||
124811093|NCT05358444|448937730|FG000|Overall Study|Withdrawal by Subject|0|||
124811094|NCT05358444|448937731|FG001|Overall Study|Withdrawal by Subject|1|||
124811095|NCT05358444|448937730|FG000|Overall Study|Lost to Follow-up|0|||
124811096|NCT05358444|448937731|FG001|Overall Study|Lost to Follow-up|3|||
124811097|NCT02900976|448937734|FG000|Overall Study|Adverse Event|0|||
124811098|NCT02900976|448937735|FG001|Overall Study|Adverse Event|1|||
124811099|NCT02900976|448937734|FG000|Overall Study|Physician Decision|0|||
124811100|NCT02900976|448937735|FG001|Overall Study|Physician Decision|2|||
124811101|NCT02900976|448937734|FG000|Overall Study|Progressive disease|0|||
124811102|NCT02900976|448937735|FG001|Overall Study|Progressive disease|6|||
124811112|NCT04997304|448937739|FG000|Overall Study|Lost to Follow-up|11|||
124811113|NCT04997304|448937739|FG000|Overall Study|Death|1|||
124811114|NCT04997304|448937739|FG000|Overall Study|Withdrawal by Subject|14|||
124811115|NCT01752985|448937740|FG000|Treatment Period|Subject request to discontinue treatment|1|||
124811116|NCT01752985|448937741|FG001|Treatment Period|Subject request to discontinue treatment|0|||
124811117|NCT01752985|448937742|FG002|Treatment Period|Subject request to discontinue treatment|1|||
124811118|NCT01752985|448937740|FG000|Treatment Period|Subject no longer meets study criteria|0|||
124811119|NCT01752985|448937741|FG001|Treatment Period|Subject no longer meets study criteria|1|||
124811120|NCT01752985|448937742|FG002|Treatment Period|Subject no longer meets study criteria|1|||
124811121|NCT01752985|448937740|FG000|Treatment Period|Adverse Event|2|||
124811122|NCT01752985|448937741|FG001|Treatment Period|Adverse Event|1|||
124811123|NCT01752985|448937742|FG002|Treatment Period|Adverse Event|2|||
124811124|NCT01752985|448937740|FG000|Treatment Period|Withdrawal by Subject|1|||
124811125|NCT01752985|448937741|FG001|Treatment Period|Withdrawal by Subject|1|||
124811126|NCT01752985|448937742|FG002|Treatment Period|Withdrawal by Subject|0|||
124811127|NCT01752985|448937740|FG000|Treatment Period|Lost to Follow-up|0|||
124811128|NCT01752985|448937741|FG001|Treatment Period|Lost to Follow-up|0|||
124811129|NCT01752985|448937742|FG002|Treatment Period|Lost to Follow-up|1|||
124811130|NCT06934993|448937743|FG000|Overall Study|Withdrawal by Subject|29|||
124811131|NCT06934993|448937743|FG000|Overall Study|elevated postoperative creatinine level|11|||
124811132|NCT06934993|448937743|FG000|Overall Study|Death|3|||
124811133|NCT04092582|448939237|FG000|Overall Study|Death|1|||
124811134|NCT04092582|448939238|FG001|Overall Study|Death|1|||
124811135|NCT04092582|448939237|FG000|Overall Study|Withdrawal by Subject|4|||
124811136|NCT04092582|448939238|FG001|Overall Study|Withdrawal by Subject|1|||
124811137|NCT04092582|448939237|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
124811138|NCT04092582|448939238|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
124811139|NCT01871532|448939248|FG000|Overall Study|Withdrawal by Subject|1|||
124811140|NCT01871532|448939249|FG001|Overall Study|Withdrawal by Subject|2|||
124811141|NCT00283400|448939250|FG000|Overall Study|Withdrawal by Subject|1|||
124811142|NCT00283400|448939251|FG001|Overall Study|Withdrawal by Subject|1|||
124811143|NCT00283400|448939252|FG002|Overall Study|Withdrawal by Subject|0|||
124811144|NCT00283400|448939253|FG003|Overall Study|Withdrawal by Subject|0|||
124811145|NCT00283400|448939250|FG000|Overall Study|Death|1|||
124811146|NCT00283400|448939251|FG001|Overall Study|Death|0|||
124811147|NCT00283400|448939252|FG002|Overall Study|Death|1|||
124811148|NCT00283400|448939253|FG003|Overall Study|Death|0|||
124811149|NCT04401423|448939254|FG000|Overall Study|Withdrawal by Subject|3|||
124811150|NCT04401423|448939255|FG001|Overall Study|Withdrawal by Subject|1|||
124811151|NCT04401423|448939254|FG000|Overall Study|Physician Decision|2|||
124811152|NCT04401423|448939255|FG001|Overall Study|Physician Decision|1|||
124811153|NCT01020981|448939256|FG000|Overall Study|Did not return mailed survey|74|||
124811154|NCT01020981|448939257|FG001|Overall Study|Did not return mailed survey|58|||
124811155|NCT01020981|448939256|FG000|Overall Study|Survey returned undeliverable|8|||
124811156|NCT01020981|448939257|FG001|Overall Study|Survey returned undeliverable|32|||
124811157|NCT01020981|448939256|FG000|Overall Study|Participant declined to complete survey|2|||
124811158|NCT01020981|448939257|FG001|Overall Study|Participant declined to complete survey|0|||
124811159|NCT00064337|448939260|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
124811160|NCT00064337|448939260|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
124811161|NCT00064337|448939260|FG000|PBSCC or Induction/PBSCC|Progression|3|||
124811162|NCT00064337|448939260|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
124811163|NCT00064337|448939260|FG000|PBSCC or Induction/PBSCC|Death|2|||
124811164|NCT00064337|448939260|FG000|Transplant|Adverse Event|9|||
124811165|NCT00064337|448939260|FG000|Transplant|Not protocol-specified|5|||
124811166|NCT00064337|448939260|FG000|Transplant|Death|3|||
124811167|NCT00064337|448939260|FG000|Transplant|Patient Refusal|2|||
124811168|NCT00064337|448939260|FG000|Transplant|Progression|2|||
124811169|NCT00064337|448939260|FG000|Maintenance|Adverse Event|3|||
124811170|NCT00064337|448939260|FG000|Maintenance|Progression|2|||
124811171|NCT00064337|448939260|FG000|Maintenance|On treatment at time of analysis|2|||
124811172|NCT00064337|448939260|FG000|Maintenance|Not protocol-specified|2|||
124811173|NCT00064337|448939260|FG000|Maintenance|Death|1|||
124811174|NCT02279420|448939261|FG000|Overall Study|Lost to Follow-up|23|||
124811175|NCT05096221|448939264|FG000|Part 2|Physician Decision|0|||
124811176|NCT05096221|448939265|FG001|Part 2|Physician Decision|1|||
124811177|NCT01896102|448939266|FG000|Overall Study|Death|1|||
124811178|NCT01896102|448939266|FG000|Overall Study|Participant to receive allogenic transplant|2|||
124811179|NCT04515394|448939281|FG000|Overall Study|Participant did not receive treatment|1|||
124811180|NCT03330288|448939282|FG000|Overall Study|Other reason|1|||
124811181|NCT03330288|448939283|FG001|Overall Study|Other reason|1|||
124811182|NCT03330288|448939282|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
124811183|NCT03330288|448939283|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
124811184|NCT03330288|448939282|FG000|Overall Study|Adverse Event|1|||
124811185|NCT03330288|448939283|FG001|Overall Study|Adverse Event|0|||
124811186|NCT03330288|448939282|FG000|Overall Study|Withdrawal by Subject|1|||
124811187|NCT03330288|448939283|FG001|Overall Study|Withdrawal by Subject|0|||
124811188|NCT03330288|448939282|FG000|Overall Study|Lost to Follow-up|26|||
124811189|NCT03330288|448939283|FG001|Overall Study|Lost to Follow-up|7|||
124811190|NCT01254331|448939290|FG000|Initial Phase|Adverse Event|3|||
124811191|NCT01254331|448939290|FG000|Initial Phase|Withdrawal by Subject|1|||
124811192|NCT01254331|448939290|FG000|Initial Phase|Pregnancy|1|||
124811193|NCT01254331|448939290|FG000|Extension Phase|Lack of Efficacy|1|||
124811194|NCT01254331|448939290|FG000|Extension Phase|Lost to Follow-up|3|||
124811195|NCT01443078|448939291|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
124811196|NCT01443078|448939291|FG000|Overall Study|Withdrawal by Subject|1|||
124811197|NCT01443078|448939291|FG000|Overall Study|Patient had brain mets|1|||
124811198|NCT02993757|448939303|FG000|Overall Study|Non compliance with the protocol|155|||
124811199|NCT02993757|448939304|FG001|Overall Study|Non compliance with the protocol|170|||
124811200|NCT02993757|448939303|FG000|Overall Study|Lost to Follow-up|1|||
124811201|NCT02993757|448939304|FG001|Overall Study|Lost to Follow-up|0|||
124811202|NCT02993757|448939303|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
124811203|NCT02993757|448939304|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
124811204|NCT02762578|448939305|FG000|Overall Study|Adverse Event|1|||
124811205|NCT02762578|448939306|FG001|Overall Study|Adverse Event|6|||
124811206|NCT02762578|448939305|FG000|Overall Study|Protocol Violation|4|||
124811207|NCT02762578|448939306|FG001|Overall Study|Protocol Violation|2|||
124811208|NCT02762578|448939305|FG000|Overall Study|Withdrawal by Subject|4|||
124811209|NCT02762578|448939306|FG001|Overall Study|Withdrawal by Subject|2|||
124811210|NCT02762578|448939305|FG000|Overall Study|Unclassified|6|||
124811211|NCT02762578|448939306|FG001|Overall Study|Unclassified|0|||
124811212|NCT00259610|448939309|FG000|Overall Study|Withdrawal by Subject|33|||
124811213|NCT00259610|448939310|FG001|Overall Study|Withdrawal by Subject|25|||
124811214|NCT00259610|448939311|FG002|Overall Study|Withdrawal by Subject|29|||
124811215|NCT00259610|448939312|FG003|Overall Study|Withdrawal by Subject|19|||
124811216|NCT00259610|448939309|FG000|Overall Study|Lost to Follow-up|19|||
124811217|NCT00259610|448939310|FG001|Overall Study|Lost to Follow-up|8|||
124811218|NCT00259610|448939311|FG002|Overall Study|Lost to Follow-up|18|||
124811219|NCT00259610|448939312|FG003|Overall Study|Lost to Follow-up|15|||
124811220|NCT00259610|448939309|FG000|Overall Study|Physician Decision|6|||
124811221|NCT00259610|448939310|FG001|Overall Study|Physician Decision|4|||
124811222|NCT00259610|448939311|FG002|Overall Study|Physician Decision|7|||
124811223|NCT00259610|448939312|FG003|Overall Study|Physician Decision|2|||
124811224|NCT00259610|448939309|FG000|Overall Study|Death|1|||
124811225|NCT00259610|448939310|FG001|Overall Study|Death|1|||
124811226|NCT00259610|448939311|FG002|Overall Study|Death|2|||
124811227|NCT00259610|448939312|FG003|Overall Study|Death|0|||
124811228|NCT00259610|448939309|FG000|Overall Study|non medical reason|6|||
124811229|NCT00259610|448939310|FG001|Overall Study|non medical reason|2|||
124811230|NCT00259610|448939311|FG002|Overall Study|non medical reason|10|||
124811231|NCT00259610|448939312|FG003|Overall Study|non medical reason|3|||
124811232|NCT00259610|448939309|FG000|Overall Study|Adverse Event|3|||
124811233|NCT00259610|448939310|FG001|Overall Study|Adverse Event|4|||
124811234|NCT00259610|448939311|FG002|Overall Study|Adverse Event|5|||
124811235|NCT00259610|448939312|FG003|Overall Study|Adverse Event|2|||
124811236|NCT00259610|448939309|FG000|Overall Study|Serious Adverse Event|8|||
124811237|NCT00259610|448939310|FG001|Overall Study|Serious Adverse Event|2|||
124811238|NCT00259610|448939311|FG002|Overall Study|Serious Adverse Event|2|||
124811239|NCT00259610|448939312|FG003|Overall Study|Serious Adverse Event|2|||
124811240|NCT00957580|448939315|FG000|Overall Study|Ongoing at data cut-off|0|||
124811241|NCT00957580|448939316|FG001|Overall Study|Ongoing at data cut-off|1|||
124811242|NCT00957580|448939317|FG002|Overall Study|Ongoing at data cut-off|0|||
124811243|NCT00957580|448939315|FG000|Overall Study|Enrolled but not treated|0|||
124811244|NCT00957580|448939316|FG001|Overall Study|Enrolled but not treated|1|||
124811245|NCT00957580|448939317|FG002|Overall Study|Enrolled but not treated|0|||
124811246|NCT01090492|448939318|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
124811247|NCT01090492|448939319|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
124811248|NCT01090492|448939320|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
124811249|NCT01090492|448939321|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
124811250|NCT01090492|448939322|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
124811251|NCT01090492|448939323|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
124811252|NCT01090492|448939324|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
124811253|NCT01090492|448939325|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
124811254|NCT01090492|448939318|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
124811255|NCT01090492|448939319|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
124811256|NCT01090492|448939320|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
124811257|NCT01090492|448939321|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
124811258|NCT01090492|448939322|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
124811259|NCT01090492|448939323|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
124811260|NCT01090492|448939324|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
124811261|NCT01090492|448939325|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
124811262|NCT01090492|448939318|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811263|NCT01090492|448939319|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811264|NCT01090492|448939320|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
124811265|NCT01090492|448939321|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811266|NCT01090492|448939322|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811267|NCT01090492|448939323|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811268|NCT01090492|448939324|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811269|NCT01090492|448939325|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811270|NCT01090492|448939318|FG000|First Intervention Period (4 Weeks)|Other|0|||
124811271|NCT01090492|448939319|FG001|First Intervention Period (4 Weeks)|Other|0|||
124811272|NCT01090492|448939320|FG002|First Intervention Period (4 Weeks)|Other|1|||
124811273|NCT01090492|448939321|FG003|First Intervention Period (4 Weeks)|Other|1|||
124811274|NCT01090492|448939322|FG004|First Intervention Period (4 Weeks)|Other|2|||
124811275|NCT01090492|448939323|FG005|First Intervention Period (4 Weeks)|Other|0|||
124811276|NCT01090492|448939324|FG006|First Intervention Period (4 Weeks)|Other|0|||
124811277|NCT01090492|448939325|FG007|First Intervention Period (4 Weeks)|Other|0|||
124811278|NCT01090492|448939318|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
124811279|NCT01090492|448939319|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
124811280|NCT01090492|448939320|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
124811281|NCT01090492|448939321|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
124811282|NCT01090492|448939322|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
124811283|NCT01090492|448939323|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
124811284|NCT01090492|448939324|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
124811285|NCT01090492|448939325|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
124811286|NCT01090492|448939318|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
124811287|NCT01090492|448939319|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
124811288|NCT01090492|448939320|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
124811289|NCT01090492|448939321|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
124811290|NCT01090492|448939322|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
124811291|NCT01090492|448939323|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
124811292|NCT01090492|448939324|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
124811293|NCT01090492|448939325|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
124811294|NCT01090492|448939318|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
124811295|NCT01090492|448939319|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
124811296|NCT01090492|448939320|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
124811297|NCT01090492|448939321|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
124811298|NCT01090492|448939322|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
124811299|NCT01090492|448939323|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
124811300|NCT01090492|448939324|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
124811301|NCT01090492|448939325|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
124811302|NCT01090492|448939318|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
124811303|NCT01090492|448939319|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
124811304|NCT01090492|448939320|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
124811305|NCT01090492|448939321|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
124811306|NCT01090492|448939322|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
124811307|NCT01090492|448939323|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
124811308|NCT01090492|448939324|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
124811309|NCT01090492|448939325|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
124811310|NCT01090492|448939318|FG000|Second Intervention Period (4 Weeks)|Other|0|||
124811311|NCT01090492|448939319|FG001|Second Intervention Period (4 Weeks)|Other|1|||
124811312|NCT01090492|448939320|FG002|Second Intervention Period (4 Weeks)|Other|1|||
124811313|NCT01090492|448939321|FG003|Second Intervention Period (4 Weeks)|Other|0|||
124811314|NCT01090492|448939322|FG004|Second Intervention Period (4 Weeks)|Other|0|||
124811315|NCT01090492|448939323|FG005|Second Intervention Period (4 Weeks)|Other|0|||
124811316|NCT01090492|448939324|FG006|Second Intervention Period (4 Weeks)|Other|0|||
124811317|NCT01090492|448939325|FG007|Second Intervention Period (4 Weeks)|Other|0|||
124811318|NCT01090492|448939318|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
124811319|NCT01090492|448939319|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
124811320|NCT01090492|448939320|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
124811321|NCT01090492|448939321|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
124811322|NCT01090492|448939322|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
124811323|NCT01090492|448939323|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
124811324|NCT01090492|448939324|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
124811325|NCT01090492|448939325|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
124811326|NCT01090492|448939318|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811327|NCT01090492|448939319|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811328|NCT01090492|448939320|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811329|NCT01090492|448939321|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811330|NCT01090492|448939322|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811331|NCT01090492|448939323|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811332|NCT01090492|448939324|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
124811333|NCT01090492|448939325|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
124811334|NCT01768286|448939326|FG000|Overall Study|Randomized But Not Treated|0|||
124811335|NCT01768286|448939327|FG001|Overall Study|Randomized But Not Treated|0|||
124811336|NCT01768286|448939328|FG002|Overall Study|Randomized But Not Treated|1|||
124811337|NCT01768286|448939329|FG003|Overall Study|Randomized But Not Treated|0|||
124811338|NCT01768286|448939326|FG000|Overall Study|Lack of Efficacy|7|||
124811339|NCT01768286|448939327|FG001|Overall Study|Lack of Efficacy|4|||
124811340|NCT01768286|448939328|FG002|Overall Study|Lack of Efficacy|0|||
124811341|NCT01768286|448939329|FG003|Overall Study|Lack of Efficacy|1|||
124811342|NCT01768286|448939326|FG000|Overall Study|Withdrew Consent|0|||
124811343|NCT01768286|448939327|FG001|Overall Study|Withdrew Consent|0|||
124811344|NCT01768286|448939328|FG002|Overall Study|Withdrew Consent|1|||
124811345|NCT01768286|448939329|FG003|Overall Study|Withdrew Consent|0|||
124811346|NCT01602120|448939330|FG000|Overall Study|Adverse Event|3|||
124811347|NCT01602120|448939331|FG001|Overall Study|Adverse Event|6|||
124811348|NCT01602120|448939332|FG002|Overall Study|Adverse Event|0|||
124811349|NCT01602120|448939333|FG003|Overall Study|Adverse Event|2|||
124811350|NCT01602120|448939330|FG000|Overall Study|Death|0|||
124811351|NCT01602120|448939331|FG001|Overall Study|Death|4|||
124811352|NCT01602120|448939332|FG002|Overall Study|Death|0|||
124811353|NCT01602120|448939333|FG003|Overall Study|Death|0|||
124811354|NCT01602120|448939330|FG000|Overall Study|Lost to Follow-up|0|||
124811355|NCT01602120|448939331|FG001|Overall Study|Lost to Follow-up|1|||
124811356|NCT01602120|448939332|FG002|Overall Study|Lost to Follow-up|0|||
124811357|NCT01602120|448939333|FG003|Overall Study|Lost to Follow-up|1|||
124811358|NCT01602120|448939330|FG000|Overall Study|Protocol Violation|1|||
124811359|NCT01602120|448939331|FG001|Overall Study|Protocol Violation|1|||
124811360|NCT01602120|448939332|FG002|Overall Study|Protocol Violation|0|||
124811361|NCT01602120|448939333|FG003|Overall Study|Protocol Violation|0|||
124811362|NCT01602120|448939330|FG000|Overall Study|Non-compliance|0|||
124811363|NCT01602120|448939331|FG001|Overall Study|Non-compliance|3|||
124811364|NCT01602120|448939332|FG002|Overall Study|Non-compliance|0|||
124811365|NCT01602120|448939333|FG003|Overall Study|Non-compliance|1|||
124811366|NCT01602120|448939330|FG000|Overall Study|Withdrawal by Subject|8|||
124811367|NCT01602120|448939331|FG001|Overall Study|Withdrawal by Subject|17|||
124811368|NCT01602120|448939332|FG002|Overall Study|Withdrawal by Subject|0|||
124811369|NCT01602120|448939333|FG003|Overall Study|Withdrawal by Subject|3|||
124811370|NCT01602120|448939330|FG000|Overall Study|Study Terminated by Sponsor|12|||
124811371|NCT01602120|448939331|FG001|Overall Study|Study Terminated by Sponsor|24|||
124811372|NCT01602120|448939332|FG002|Overall Study|Study Terminated by Sponsor|17|||
124811373|NCT01602120|448939333|FG003|Overall Study|Study Terminated by Sponsor|44|||
124811374|NCT01602120|448939330|FG000|Overall Study|Physician Decision|2|||
124811375|NCT01602120|448939331|FG001|Overall Study|Physician Decision|3|||
124811376|NCT01602120|448939332|FG002|Overall Study|Physician Decision|0|||
124811377|NCT01602120|448939333|FG003|Overall Study|Physician Decision|0|||
124811378|NCT01602120|448939330|FG000|Overall Study|Unspecified Reason|3|||
124811379|NCT01602120|448939331|FG001|Overall Study|Unspecified Reason|1|||
124811380|NCT01602120|448939332|FG002|Overall Study|Unspecified Reason|0|||
124811381|NCT01602120|448939333|FG003|Overall Study|Unspecified Reason|2|||
124811382|NCT01611155|448939334|FG000|Overall Study|Adverse Event|1|||
124811383|NCT01611155|448939335|FG001|Overall Study|Adverse Event|1|||
124811384|NCT01611155|448939334|FG000|Overall Study|Refused further treatment|6|||
124811385|NCT01611155|448939335|FG001|Overall Study|Refused further treatment|4|||
124811386|NCT01611155|448939334|FG000|Overall Study|Disease progression|1|||
124811387|NCT01611155|448939335|FG001|Overall Study|Disease progression|0|||
124634384|NCT03971071|448276792|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
124811388|NCT01611155|448939334|FG000|Overall Study|Withdrawal by Subject|1|||
124811389|NCT01611155|448939335|FG001|Overall Study|Withdrawal by Subject|0|||
124634385|NCT03210714|448276795|FG000|Overall Study|Adverse Event|6|||
124634386|NCT03210714|448276795|FG000|Overall Study|Physician Decision|1|||
124811390|NCT01611155|448939334|FG000|Overall Study|Alternative treatment|0|||
124811391|NCT01611155|448939335|FG001|Overall Study|Alternative treatment|1|||
124811392|NCT01611155|448939334|FG000|Overall Study|Ineligible patient|0|||
124811393|NCT01611155|448939335|FG001|Overall Study|Ineligible patient|1|||
124811394|NCT02699593|448939337|FG000|Period 1|Unsatisfactory Visual Response|0|||
124811395|NCT02699593|448939338|FG001|Period 1|Unsatisfactory Visual Response|1|||
124811396|NCT02699593|448939337|FG000|Period 1|Torn Contact Len|4|||
124811397|NCT02699593|448939338|FG001|Period 1|Torn Contact Len|3|||
124811398|NCT02699593|448939337|FG000|Period 1|Protocol Violation|0|||
124634387|NCT03210714|448276795|FG000|Overall Study|Progressive disease|11|||
124811399|NCT02699593|448939338|FG001|Period 1|Protocol Violation|1|||
124811400|NCT02699593|448939337|FG000|Period 1|Withdrawal by Subject|0|||
124811401|NCT02699593|448939338|FG001|Period 1|Withdrawal by Subject|1|||
124811402|NCT02699593|448939337|FG000|Period 1|Adverse Event|1|||
124811403|NCT02699593|448939338|FG001|Period 1|Adverse Event|1|||
124811404|NCT02699593|448939337|FG000|Period 2|Adverse Event|1|||
124811405|NCT02699593|448939338|FG001|Period 2|Adverse Event|1|||
124811406|NCT02699593|448939337|FG000|Period 2|Lost Contact Lens|0|||
124811407|NCT02699593|448939338|FG001|Period 2|Lost Contact Lens|1|||
124811408|NCT02699593|448939337|FG000|Period 2|Torn Contact Lens|1|||
124811409|NCT02699593|448939338|FG001|Period 2|Torn Contact Lens|0|||
124811410|NCT00911547|448939339|FG000|Overall Study|Adverse Event|8|||
124811411|NCT00911547|448939340|FG001|Overall Study|Adverse Event|27|||
124811412|NCT00911547|448939341|FG002|Overall Study|Adverse Event|11|||
124811413|NCT00911547|448939342|FG003|Overall Study|Adverse Event|6|||
124811414|NCT00911547|448939339|FG000|Overall Study|Lost to Follow-up|0|||
124811415|NCT00911547|448939340|FG001|Overall Study|Lost to Follow-up|0|||
124811416|NCT00911547|448939341|FG002|Overall Study|Lost to Follow-up|2|||
124811417|NCT00911547|448939342|FG003|Overall Study|Lost to Follow-up|1|||
124811418|NCT00911547|448939339|FG000|Overall Study|Protocol Violation|0|||
124811419|NCT00911547|448939340|FG001|Overall Study|Protocol Violation|5|||
124811420|NCT00911547|448939341|FG002|Overall Study|Protocol Violation|5|||
124811421|NCT00911547|448939342|FG003|Overall Study|Protocol Violation|1|||
124811422|NCT00911547|448939339|FG000|Overall Study|Withdrawal by Subject|3|||
124811423|NCT00911547|448939340|FG001|Overall Study|Withdrawal by Subject|10|||
124811424|NCT00911547|448939341|FG002|Overall Study|Withdrawal by Subject|4|||
124811425|NCT00911547|448939342|FG003|Overall Study|Withdrawal by Subject|8|||
124811426|NCT00915278|448939343|FG000|Overall Study|Death|1|||
124811427|NCT00915278|448939344|FG001|Overall Study|Death|0|||
124811428|NCT00915278|448939345|FG002|Overall Study|Death|0|||
124811429|NCT00915278|448939346|FG003|Overall Study|Death|0|||
124811430|NCT00915278|448939347|FG004|Overall Study|Death|0|||
124811431|NCT00915278|448939348|FG005|Overall Study|Death|0|||
124811432|NCT00915278|448939343|FG000|Overall Study|Lost to Follow-up|0|||
124811433|NCT00915278|448939344|FG001|Overall Study|Lost to Follow-up|1|||
124811434|NCT00915278|448939345|FG002|Overall Study|Lost to Follow-up|0|||
124811435|NCT00915278|448939346|FG003|Overall Study|Lost to Follow-up|0|||
124811436|NCT00915278|448939347|FG004|Overall Study|Lost to Follow-up|0|||
124811437|NCT00915278|448939348|FG005|Overall Study|Lost to Follow-up|0|||
124811438|NCT00915278|448939343|FG000|Overall Study|Withdrawal by Subject|0|||
124811439|NCT00915278|448939344|FG001|Overall Study|Withdrawal by Subject|1|||
124811440|NCT00915278|448939345|FG002|Overall Study|Withdrawal by Subject|0|||
124811441|NCT00915278|448939346|FG003|Overall Study|Withdrawal by Subject|0|||
124811442|NCT00915278|448939347|FG004|Overall Study|Withdrawal by Subject|1|||
124811443|NCT00915278|448939348|FG005|Overall Study|Withdrawal by Subject|4|||
124811444|NCT00915278|448939343|FG000|Overall Study|Adverse Event|4|||
124811445|NCT00915278|448939344|FG001|Overall Study|Adverse Event|1|||
124811446|NCT00915278|448939345|FG002|Overall Study|Adverse Event|0|||
124811447|NCT00915278|448939346|FG003|Overall Study|Adverse Event|0|||
124811448|NCT00915278|448939347|FG004|Overall Study|Adverse Event|0|||
124811449|NCT00915278|448939348|FG005|Overall Study|Adverse Event|0|||
124811450|NCT00915278|448939343|FG000|Overall Study|Progressive disease/clinical progression|0|||
124811451|NCT00915278|448939344|FG001|Overall Study|Progressive disease/clinical progression|0|||
124811452|NCT00915278|448939345|FG002|Overall Study|Progressive disease/clinical progression|0|||
124811453|NCT00915278|448939346|FG003|Overall Study|Progressive disease/clinical progression|3|||
124811454|NCT00915278|448939347|FG004|Overall Study|Progressive disease/clinical progression|1|||
124811455|NCT00915278|448939348|FG005|Overall Study|Progressive disease/clinical progression|2|||
124811456|NCT00915278|448939343|FG000|Overall Study|Infusion related AEs|0|||
124811457|NCT00915278|448939344|FG001|Overall Study|Infusion related AEs|0|||
124634388|NCT03210714|448276795|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
124634389|NCT01909934|448276796|FG000|Overall Study|Withdrawal by Subject|3|||
124811458|NCT00915278|448939345|FG002|Overall Study|Infusion related AEs|0|||
124811459|NCT00915278|448939346|FG003|Overall Study|Infusion related AEs|0|||
124811460|NCT00915278|448939347|FG004|Overall Study|Infusion related AEs|0|||
124811461|NCT00915278|448939348|FG005|Overall Study|Infusion related AEs|2|||
124811462|NCT00915278|448939343|FG000|Overall Study|Admission to hospice|0|||
124811463|NCT00915278|448939344|FG001|Overall Study|Admission to hospice|0|||
124811464|NCT00915278|448939345|FG002|Overall Study|Admission to hospice|1|||
124811465|NCT00915278|448939346|FG003|Overall Study|Admission to hospice|0|||
124811466|NCT00915278|448939347|FG004|Overall Study|Admission to hospice|0|||
124811467|NCT00915278|448939348|FG005|Overall Study|Admission to hospice|0|||
124811468|NCT00453063|448939353|FG000|Overall Study|Adverse Event|1|||
124811469|NCT00453063|448939354|FG001|Overall Study|Adverse Event|2|||
124811470|NCT00453063|448939353|FG000|Overall Study|Withdrawal by Subject|1|||
124811471|NCT00453063|448939354|FG001|Overall Study|Withdrawal by Subject|1|||
124811472|NCT00453063|448939353|FG000|Overall Study|Protocol Violation|1|||
124811473|NCT00453063|448939354|FG001|Overall Study|Protocol Violation|0|||
124811474|NCT00228384|448939355|FG000|Overall Study|Death|9|||
124811475|NCT00228384|448939356|FG001|Overall Study|Death|3|||
124811476|NCT00228384|448939355|FG000|Overall Study|Lost to Follow-up|6|||
124811477|NCT00228384|448939356|FG001|Overall Study|Lost to Follow-up|10|||
124811478|NCT00228384|448939355|FG000|Overall Study|Surgical Intervention (bypass)|5|||
124811479|NCT00228384|448939356|FG001|Overall Study|Surgical Intervention (bypass)|5|||
124811480|NCT00228384|448939355|FG000|Overall Study|Withdrawal by Subject|9|||
124811481|NCT00228384|448939356|FG001|Overall Study|Withdrawal by Subject|10|||
124811482|NCT00228384|448939355|FG000|Overall Study|Physician Decision|0|||
124811483|NCT00228384|448939356|FG001|Overall Study|Physician Decision|1|||
124811484|NCT01785069|448939362|FG000|Overall Study|Implanted with nonstudy device|1|||
124811485|NCT01785069|448939363|FG001|Overall Study|Implanted with nonstudy device|2|||
124811486|NCT01785069|448939364|FG002|Overall Study|Implanted with nonstudy device|1|||
124811487|NCT01785069|448939365|FG003|Overall Study|Implanted with nonstudy device|0|||
124811488|NCT01785069|448939362|FG000|Overall Study|Death|0|||
124811489|NCT01785069|448939363|FG001|Overall Study|Death|0|||
124811490|NCT01785069|448939364|FG002|Overall Study|Death|2|||
124811491|NCT01785069|448939365|FG003|Overall Study|Death|0|||
124811492|NCT01785069|448939362|FG000|Overall Study|Subject choice|2|||
124811493|NCT01785069|448939363|FG001|Overall Study|Subject choice|2|||
124811494|NCT01785069|448939364|FG002|Overall Study|Subject choice|0|||
124811495|NCT01785069|448939365|FG003|Overall Study|Subject choice|1|||
124811496|NCT01785069|448939362|FG000|Overall Study|Lost to Follow-up|1|||
124811497|NCT01785069|448939363|FG001|Overall Study|Lost to Follow-up|2|||
124811498|NCT01785069|448939364|FG002|Overall Study|Lost to Follow-up|4|||
124811499|NCT01785069|448939365|FG003|Overall Study|Lost to Follow-up|1|||
124811500|NCT01785069|448939362|FG000|Overall Study|Reason not Specified|1|||
124811501|NCT01785069|448939363|FG001|Overall Study|Reason not Specified|2|||
124811502|NCT01785069|448939364|FG002|Overall Study|Reason not Specified|1|||
124811503|NCT01785069|448939365|FG003|Overall Study|Reason not Specified|4|||
124811504|NCT01785069|448939362|FG000|Overall Study|Not evaluable|7|||
124811505|NCT01785069|448939363|FG001|Overall Study|Not evaluable|4|||
124811506|NCT01785069|448939364|FG002|Overall Study|Not evaluable|5|||
124811507|NCT01785069|448939365|FG003|Overall Study|Not evaluable|8|||
124811508|NCT01453361|448939368|FG000|Overall Study|Disease Progression|6|||
124811509|NCT01453361|448939368|FG000|Overall Study|Screen-Failures|10|||
124811510|NCT04560998|448939369|FG000|Overall Study|Withdrawal by Subject|18|||
124811511|NCT04560998|448939370|FG001|Overall Study|Withdrawal by Subject|12|||
124811512|NCT04560998|448939369|FG000|Overall Study|Lost to Follow-up|8|||
124811513|NCT04560998|448939370|FG001|Overall Study|Lost to Follow-up|5|||
124811514|NCT04560998|448939369|FG000|Overall Study|Physician Decision|4|||
124811515|NCT04560998|448939370|FG001|Overall Study|Physician Decision|0|||
124811516|NCT02025621|448941011|FG000|Overall Study|Withdrawal by Subject|1|||
124811517|NCT02025621|448941012|FG001|Overall Study|Withdrawal by Subject|0|||
124811518|NCT02025621|448941011|FG000|Overall Study|Death|0|||
124811519|NCT02025621|448941012|FG001|Overall Study|Death|1|||
124811520|NCT02025621|448941011|FG000|Overall Study|No longer eligible|10|||
124811521|NCT02025621|448941012|FG001|Overall Study|No longer eligible|15|||
124811522|NCT02025621|448941011|FG000|Overall Study|Surgery initiated before infusion|3|||
124811523|NCT02025621|448941012|FG001|Overall Study|Surgery initiated before infusion|3|||
124811524|NCT00739674|448941013|FG000|Overall Study|Screening failures|19|||
124811525|NCT00739674|448941014|FG001|Overall Study|Screening failures|17|||
124811526|NCT00739674|448941013|FG000|Overall Study|Site 212 removal|19|||
124811527|NCT00739674|448941014|FG001|Overall Study|Site 212 removal|13|||
124811528|NCT00739674|448941013|FG000|Overall Study|No follow-up data|33|||
124811529|NCT00739674|448941014|FG001|Overall Study|No follow-up data|18|||
124811530|NCT00739674|448941013|FG000|Overall Study|Dietician consultation >30 days|1|||
124811531|NCT00739674|448941014|FG001|Overall Study|Dietician consultation >30 days|9|||
124811532|NCT00739674|448941013|FG000|Overall Study|Adverse Event|22|||
124811533|NCT00739674|448941014|FG001|Overall Study|Adverse Event|13|||
124811534|NCT00739674|448941013|FG000|Overall Study|Death|1|||
124811535|NCT00739674|448941014|FG001|Overall Study|Death|0|||
124634390|NCT01909934|448276796|FG000|Overall Study|Lost to Follow-up|1|||
124811536|NCT00739674|448941013|FG000|Overall Study|Lack of Efficacy|1|||
124811537|NCT00739674|448941014|FG001|Overall Study|Lack of Efficacy|0|||
124811538|NCT00739674|448941013|FG000|Overall Study|Lost to Follow-up|52|||
124811539|NCT00739674|448941014|FG001|Overall Study|Lost to Follow-up|30|||
124811540|NCT00739674|448941013|FG000|Overall Study|Protocol Violation|5|||
124811541|NCT00739674|448941014|FG001|Overall Study|Protocol Violation|5|||
124811542|NCT00739674|448941013|FG000|Overall Study|Withdrawal by Subject|9|||
124811543|NCT00739674|448941014|FG001|Overall Study|Withdrawal by Subject|9|||
124811544|NCT00739674|448941013|FG000|Overall Study|Reason missing|2|||
124811545|NCT00739674|448941014|FG001|Overall Study|Reason missing|0|||
124811546|NCT00739674|448941013|FG000|Overall Study|Clinic closed|6|||
124811547|NCT00739674|448941014|FG001|Overall Study|Clinic closed|4|||
124811548|NCT00739674|448941013|FG000|Overall Study|Patient moved|3|||
124811549|NCT00739674|448941014|FG001|Overall Study|Patient moved|2|||
124811550|NCT00739674|448941013|FG000|Overall Study|Non compliant|4|||
124811551|NCT00739674|448941014|FG001|Overall Study|Non compliant|0|||
124811552|NCT00739674|448941013|FG000|Overall Study|Unable to attend visit|3|||
124811553|NCT00739674|448941014|FG001|Overall Study|Unable to attend visit|1|||
124811554|NCT00739674|448941013|FG000|Overall Study|Home monitoring off meds|1|||
124811555|NCT00739674|448941014|FG001|Overall Study|Home monitoring off meds|0|||
124811556|NCT00739674|448941013|FG000|Overall Study|Erectile dysfunction|0|||
124811557|NCT00739674|448941014|FG001|Overall Study|Erectile dysfunction|1|||
124811558|NCT01594281|448941015|FG000|Interventional Core Phase|Protocol Deviation|1|||
124811559|NCT01594281|448941016|FG001|Interventional Core Phase|Protocol Deviation|0|||
124811560|NCT01594281|448941017|FG002|Interventional Core Phase|Protocol Deviation|0|||
124811561|NCT01594281|448941015|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
124811562|NCT01594281|448941016|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
124811563|NCT01594281|448941017|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
124811564|NCT01594281|448941015|FG000|Interventional Core Phase|Death|1|||
124811565|NCT01594281|448941016|FG001|Interventional Core Phase|Death|1|||
124811566|NCT01594281|448941017|FG002|Interventional Core Phase|Death|2|||
124811567|NCT01594281|448941015|FG000|Interventional Core Phase|Lost to Follow-up|1|||
124811568|NCT01594281|448941016|FG001|Interventional Core Phase|Lost to Follow-up|4|||
124811569|NCT01594281|448941017|FG002|Interventional Core Phase|Lost to Follow-up|1|||
124811570|NCT01594281|448941015|FG000|Interventional Core Phase|Adverse Event|4|||
124811571|NCT01594281|448941016|FG001|Interventional Core Phase|Adverse Event|4|||
124811572|NCT01594281|448941017|FG002|Interventional Core Phase|Adverse Event|4|||
124811573|NCT01594281|448941015|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
124811574|NCT01594281|448941016|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
124811575|NCT01594281|448941017|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
124811576|NCT01594281|448941015|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
124811577|NCT01594281|448941016|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
124811578|NCT01594281|448941017|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
124811579|NCT01594281|448941015|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
124811580|NCT01594281|448941016|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
124811581|NCT01594281|448941017|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
124811582|NCT04805541|448941019|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
124811583|NCT01543958|448941022|FG000|Overall Study|Loss to follow-up|3|||
124811584|NCT01543958|448941022|FG000|Overall Study|ART initiation|1|||
124811585|NCT01945281|448941023|FG000|Overall Study|Adverse Event|1|||
124811586|NCT01945281|448941024|FG001|Overall Study|Adverse Event|0|||
124811587|NCT01945281|448941023|FG000|Overall Study|Death|3|||
124811588|NCT01945281|448941024|FG001|Overall Study|Death|3|||
124811589|NCT01945281|448941023|FG000|Overall Study|Physician Decision|1|||
124811590|NCT01945281|448941024|FG001|Overall Study|Physician Decision|1|||
124811591|NCT01945281|448941023|FG000|Overall Study|Technical Problems|1|||
124811592|NCT01945281|448941024|FG001|Overall Study|Technical Problems|0|||
124811593|NCT00799383|448941030|FG000|Overall Study|Protocol Violation|1|||
124811594|NCT00799383|448941031|FG001|Overall Study|Protocol Violation|1|||
124811595|NCT00799383|448941030|FG000|Overall Study|Adverse Event|0|||
124811596|NCT00799383|448941031|FG001|Overall Study|Adverse Event|1|||
124811597|NCT00799383|448941030|FG000|Overall Study|Lost to Follow-up|1|||
124811598|NCT00799383|448941031|FG001|Overall Study|Lost to Follow-up|2|||
124811599|NCT00799383|448941030|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
124811600|NCT00799383|448941031|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
124811601|NCT00799383|448941030|FG000|Overall Study|Withdrawal by Subject|0|||
124811602|NCT00799383|448941031|FG001|Overall Study|Withdrawal by Subject|1|||
124811603|NCT00726986|448941032|FG000|Induction Phase|Adverse Event|4|||
124811604|NCT00726986|448941032|FG000|Induction Phase|Withdrawal by Subject|2|||
124811605|NCT00726986|448941032|FG000|Induction Phase|Death|2|||
124811606|NCT00726986|448941032|FG000|Induction Phase|Lack of Efficacy|5|||
124811607|NCT00726986|448941032|FG000|Induction Phase|Secondary Disease|2|||
124811608|NCT00726986|448941032|FG000|Maintenance Phase|Adverse Event|1|||
124811609|NCT00726986|448941032|FG000|Maintenance Phase|Lack of Efficacy|2|||
124634391|NCT01909934|448276796|FG000|Overall Study|Death|25|||
124634392|NCT01909934|448276796|FG000|Overall Study|Withdrawal of Informed Consent|1|||
124634393|NCT01909934|448276796|FG000|Overall Study|Reason Not Specified|1|||
124634394|NCT03907488|448276812|FG000|Overall Study|Adverse Event|20|||
124634395|NCT03907488|448276813|FG001|Overall Study|Adverse Event|20|||
124634396|NCT03907488|448276812|FG000|Overall Study|Withdrawal by Subject|9|||
124811610|NCT02165215|448941039|FG000|Induction Phase|Adverse Event|1|||
124811611|NCT02165215|448941040|FG001|Induction Phase|Adverse Event|0|||
124811612|NCT02165215|448941041|FG002|Induction Phase|Adverse Event|0|||
124811613|NCT02165215|448941039|FG000|Induction Phase|Withdrawal by Subject|10|||
124811614|NCT02165215|448941040|FG001|Induction Phase|Withdrawal by Subject|0|||
124811615|NCT02165215|448941041|FG002|Induction Phase|Withdrawal by Subject|0|||
124811616|NCT02165215|448941039|FG000|Induction Phase|Protocol Violation|1|||
124634397|NCT03907488|448276813|FG001|Overall Study|Withdrawal by Subject|13|||
124634398|NCT03907488|448276812|FG000|Overall Study|Lack of Efficacy|0|||
124634399|NCT03907488|448276813|FG001|Overall Study|Lack of Efficacy|9|||
124811617|NCT02165215|448941040|FG001|Induction Phase|Protocol Violation|0|||
124811618|NCT02165215|448941041|FG002|Induction Phase|Protocol Violation|0|||
124811619|NCT02165215|448941039|FG000|Induction Phase|Physician Decision|1|||
124811620|NCT02165215|448941040|FG001|Induction Phase|Physician Decision|0|||
124811621|NCT02165215|448941041|FG002|Induction Phase|Physician Decision|0|||
124811622|NCT02165215|448941039|FG000|Induction Phase|Lack of Efficacy|2|||
124811623|NCT02165215|448941040|FG001|Induction Phase|Lack of Efficacy|0|||
124811624|NCT02165215|448941041|FG002|Induction Phase|Lack of Efficacy|0|||
124811625|NCT02165215|448941039|FG000|Induction Phase|Non-Compliance|2|||
124811626|NCT02165215|448941040|FG001|Induction Phase|Non-Compliance|0|||
124811627|NCT02165215|448941041|FG002|Induction Phase|Non-Compliance|0|||
124811628|NCT02165215|448941039|FG000|Induction Phase|Lost to Follow-up|6|||
124811629|NCT02165215|448941040|FG001|Induction Phase|Lost to Follow-up|0|||
124811630|NCT02165215|448941041|FG002|Induction Phase|Lost to Follow-up|0|||
124811631|NCT02165215|448941039|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124811632|NCT02165215|448941040|FG001|Maintenance Phase|Withdrawal by Subject|7|||
124811633|NCT02165215|448941041|FG002|Maintenance Phase|Withdrawal by Subject|3|||
124811634|NCT02165215|448941039|FG000|Maintenance Phase|Multiple reasons|0|||
124811635|NCT02165215|448941040|FG001|Maintenance Phase|Multiple reasons|2|||
124811636|NCT02165215|448941041|FG002|Maintenance Phase|Multiple reasons|1|||
124811637|NCT02165215|448941039|FG000|Maintenance Phase|Lost to Follow-up|0|||
124811638|NCT02165215|448941040|FG001|Maintenance Phase|Lost to Follow-up|2|||
124811639|NCT02165215|448941041|FG002|Maintenance Phase|Lost to Follow-up|0|||
124811640|NCT02165215|448941039|FG000|Maintenance Phase|Adverse Event|0|||
124811641|NCT02165215|448941040|FG001|Maintenance Phase|Adverse Event|1|||
124811642|NCT02165215|448941041|FG002|Maintenance Phase|Adverse Event|1|||
124811643|NCT04678661|448941042|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
124811644|NCT04678661|448941043|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
124811645|NCT04678661|448941042|FG000|Overall Study|Protocol Violation|2|||
124811646|NCT04678661|448941043|FG001|Overall Study|Protocol Violation|0|||
124811647|NCT04678661|448941042|FG000|Overall Study|Withdrawal by Subject|1|||
124811648|NCT04678661|448941043|FG001|Overall Study|Withdrawal by Subject|0|||
124811649|NCT04678661|448941042|FG000|Overall Study|Lost to Follow-up|2|||
124811650|NCT04678661|448941043|FG001|Overall Study|Lost to Follow-up|0|||
124811651|NCT04678661|448941042|FG000|Overall Study|Death|2|||
124811652|NCT04678661|448941043|FG001|Overall Study|Death|0|||
124811653|NCT01397890|448941044|FG000|Overall Study|Withdrawal by Subject|7|||
124811654|NCT01397890|448941045|FG001|Overall Study|Withdrawal by Subject|11|||
124811655|NCT01397890|448941044|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
124811656|NCT01397890|448941045|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
124811657|NCT01397890|448941044|FG000|Overall Study|Death|2|||
124811658|NCT01397890|448941045|FG001|Overall Study|Death|3|||
124811659|NCT01397890|448941044|FG000|Overall Study|Lost to Follow-up|1|||
124811660|NCT01397890|448941045|FG001|Overall Study|Lost to Follow-up|4|||
124811661|NCT01397890|448941044|FG000|Overall Study|Condition under Investigation Worsened|1|||
124811662|NCT01397890|448941045|FG001|Overall Study|Condition under Investigation Worsened|3|||
124811663|NCT01397890|448941044|FG000|Overall Study|Adverse Event|1|||
124811664|NCT01397890|448941045|FG001|Overall Study|Adverse Event|2|||
124811665|NCT01397890|448941044|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
124811666|NCT01397890|448941045|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
124811667|NCT01397890|448941044|FG000|Overall Study|Others|2|||
124811668|NCT01397890|448941045|FG001|Overall Study|Others|1|||
124811669|NCT03094169|448941046|FG000|Overall Study|Lack of Efficacy|0|||
124811670|NCT03094169|448941047|FG001|Overall Study|Lack of Efficacy|0|||
124811671|NCT03094169|448941048|FG002|Overall Study|Lack of Efficacy|0|||
124811672|NCT03094169|448941049|FG003|Overall Study|Lack of Efficacy|0|||
124811673|NCT03094169|448941050|FG004|Overall Study|Lack of Efficacy|0|||
124811674|NCT03094169|448941051|FG005|Overall Study|Lack of Efficacy|0|||
124811675|NCT03094169|448941052|FG006|Overall Study|Lack of Efficacy|0|||
124811676|NCT03094169|448941053|FG007|Overall Study|Lack of Efficacy|21|||
124811677|NCT03094169|448941046|FG000|Overall Study|Adverse Event|0|||
124811678|NCT03094169|448941047|FG001|Overall Study|Adverse Event|0|||
124811679|NCT03094169|448941048|FG002|Overall Study|Adverse Event|0|||
124634400|NCT03907488|448276812|FG000|Overall Study|Death|3|||
124634401|NCT03907488|448276813|FG001|Overall Study|Death|8|||
124634402|NCT03907488|448276812|FG000|Overall Study|not protocol specified|5|||
124634403|NCT03907488|448276813|FG001|Overall Study|not protocol specified|8|||
124811680|NCT03094169|448941049|FG003|Overall Study|Adverse Event|0|||
124634404|NCT03907488|448276812|FG000|Overall Study|Ineligible|9|||
124811681|NCT03094169|448941050|FG004|Overall Study|Adverse Event|0|||
124811682|NCT03094169|448941051|FG005|Overall Study|Adverse Event|0|||
124811683|NCT03094169|448941052|FG006|Overall Study|Adverse Event|0|||
124811684|NCT03094169|448941053|FG007|Overall Study|Adverse Event|2|||
124811685|NCT03094169|448941046|FG000|Overall Study|Withdrawal by Subject|0|||
124811686|NCT03094169|448941047|FG001|Overall Study|Withdrawal by Subject|0|||
124811687|NCT03094169|448941048|FG002|Overall Study|Withdrawal by Subject|0|||
124811688|NCT03094169|448941049|FG003|Overall Study|Withdrawal by Subject|0|||
124811689|NCT03094169|448941050|FG004|Overall Study|Withdrawal by Subject|0|||
124811690|NCT03094169|448941051|FG005|Overall Study|Withdrawal by Subject|0|||
124634405|NCT03907488|448276813|FG001|Overall Study|Ineligible|15|||
124811691|NCT03094169|448941052|FG006|Overall Study|Withdrawal by Subject|1|||
124811692|NCT03094169|448941053|FG007|Overall Study|Withdrawal by Subject|1|||
124811693|NCT03094169|448941046|FG000|Overall Study|Trial Termination|0|||
124811694|NCT03094169|448941047|FG001|Overall Study|Trial Termination|0|||
124811695|NCT03094169|448941048|FG002|Overall Study|Trial Termination|0|||
124811696|NCT03094169|448941049|FG003|Overall Study|Trial Termination|0|||
124634406|NCT01662492|448276814|FG000|Overall Study|Other miscellaneous reasons.|1|||
124634407|NCT01662492|448276815|FG001|Overall Study|Other miscellaneous reasons.|0|||
124634408|NCT01662492|448276816|FG002|Overall Study|Other miscellaneous reasons.|1|||
124634409|NCT01662492|448276814|FG000|Overall Study|Withdrawal by Subject|0|||
124634410|NCT01662492|448276815|FG001|Overall Study|Withdrawal by Subject|0|||
124634411|NCT01662492|448276816|FG002|Overall Study|Withdrawal by Subject|1|||
124811697|NCT03094169|448941050|FG004|Overall Study|Trial Termination|0|||
124811698|NCT03094169|448941051|FG005|Overall Study|Trial Termination|0|||
124811699|NCT03094169|448941052|FG006|Overall Study|Trial Termination|0|||
124811700|NCT03094169|448941053|FG007|Overall Study|Trial Termination|1|||
124811701|NCT04645953|448941054|FG000|Overall Study|Lost to Follow-up|2|||
124811702|NCT04645953|448941055|FG001|Overall Study|Lost to Follow-up|1|||
124811703|NCT04645953|448941056|FG002|Overall Study|Lost to Follow-up|1|||
124811704|NCT04645953|448941054|FG000|Overall Study|Withdrawal by Subject|0|||
124811705|NCT04645953|448941055|FG001|Overall Study|Withdrawal by Subject|1|||
124811706|NCT04645953|448941056|FG002|Overall Study|Withdrawal by Subject|0|||
124811707|NCT04645953|448941054|FG000|Overall Study|Physician Decision|0|||
124811708|NCT04645953|448941055|FG001|Overall Study|Physician Decision|1|||
124811709|NCT04645953|448941056|FG002|Overall Study|Physician Decision|0|||
124811710|NCT04645953|448941054|FG000|Overall Study|Discontinued Prior to Dosing|0|||
124811711|NCT04645953|448941055|FG001|Overall Study|Discontinued Prior to Dosing|0|||
124811712|NCT04645953|448941056|FG002|Overall Study|Discontinued Prior to Dosing|2|||
124811713|NCT00002651|448941057|FG000|Induction|Adverse Event|44|||
124811714|NCT00002651|448941058|FG001|Induction|Adverse Event|0|||
124811715|NCT00002651|448941059|FG002|Induction|Adverse Event|0|||
124811716|NCT00002651|448941057|FG000|Induction|Refusal unrelated to adverse event|50|||
124811717|NCT00002651|448941058|FG001|Induction|Refusal unrelated to adverse event|0|||
124811718|NCT00002651|448941059|FG002|Induction|Refusal unrelated to adverse event|0|||
124811719|NCT00002651|448941057|FG000|Induction|Progression/relapse|274|||
124811720|NCT00002651|448941058|FG001|Induction|Progression/relapse|0|||
124811721|NCT00002651|448941059|FG002|Induction|Progression/relapse|0|||
124811722|NCT00002651|448941057|FG000|Induction|Death|62|||
124811723|NCT00002651|448941058|FG001|Induction|Death|0|||
124811724|NCT00002651|448941059|FG002|Induction|Death|0|||
124811725|NCT00002651|448941057|FG000|Induction|Other|823|||
124811726|NCT00002651|448941058|FG001|Induction|Other|0|||
124811727|NCT00002651|448941059|FG002|Induction|Other|0|||
124811728|NCT00002651|448941057|FG000|Induction|not eligible|90|||
124811729|NCT00002651|448941058|FG001|Induction|not eligible|0|||
124811730|NCT00002651|448941059|FG002|Induction|not eligible|0|||
124811731|NCT00002651|448941057|FG000|Consolidation and Randomization|Adverse Event|0|||
124811732|NCT00002651|448941058|FG001|Consolidation and Randomization|Adverse Event|36|||
124811733|NCT00002651|448941059|FG002|Consolidation and Randomization|Adverse Event|14|||
124811734|NCT00002651|448941057|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
124811735|NCT00002651|448941058|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
124811736|NCT00002651|448941059|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
124811737|NCT00002651|448941057|FG000|Consolidation and Randomization|Progression/relapse|0|||
124811738|NCT00002651|448941058|FG001|Consolidation and Randomization|Progression/relapse|295|||
124811739|NCT00002651|448941059|FG002|Consolidation and Randomization|Progression/relapse|298|||
124811740|NCT00002651|448941057|FG000|Consolidation and Randomization|Death|0|||
124811741|NCT00002651|448941058|FG001|Consolidation and Randomization|Death|38|||
124811742|NCT00002651|448941059|FG002|Consolidation and Randomization|Death|48|||
124811743|NCT00002651|448941057|FG000|Consolidation and Randomization|Other|0|||
124811744|NCT00002651|448941058|FG001|Consolidation and Randomization|Other|314|||
124811745|NCT00002651|448941059|FG002|Consolidation and Randomization|Other|313|||
124811746|NCT00002651|448941057|FG000|Consolidation and Randomization|not eligible|0|||
124634412|NCT01662492|448276814|FG000|Overall Study|Protocol Violation|1|||
124634413|NCT01662492|448276815|FG001|Overall Study|Protocol Violation|0|||
124811747|NCT00002651|448941058|FG001|Consolidation and Randomization|not eligible|102|||
124811748|NCT00002651|448941059|FG002|Consolidation and Randomization|not eligible|112|||
124811749|NCT03741062|448941060|FG000|Overall Study|Protocol Violation|1|||
124811750|NCT03741062|448941061|FG001|Overall Study|Protocol Violation|0|||
124811751|NCT02763462|448941065|FG000|Overall Study|Protocol Violation|6|||
124811752|NCT03417219|448941066|FG000|Overall Study|Lost to Follow-up|0|||
124811753|NCT03417219|448941067|FG001|Overall Study|Lost to Follow-up|3|||
124811754|NCT00261807|448941068|FG000|Overall Study|Lost to Follow-up|2|||
124811755|NCT00261807|448941068|FG000|Overall Study|Adverse Event|2|||
124811756|NCT00261807|448941068|FG000|Overall Study|Death|1|||
124811757|NCT00261807|448941068|FG000|Overall Study|Protocol Violation|2|||
124811758|NCT00675948|448941071|FG000|Overall Study|Adverse Event|23|||
124811759|NCT00675948|448941072|FG001|Overall Study|Adverse Event|1|||
124811760|NCT00675948|448941071|FG000|Overall Study|Lack of Efficacy|3|||
124811761|NCT00675948|448941072|FG001|Overall Study|Lack of Efficacy|0|||
124811762|NCT00675948|448941071|FG000|Overall Study|Withdrawal by Subject|7|||
124811763|NCT00675948|448941072|FG001|Overall Study|Withdrawal by Subject|0|||
124811764|NCT00675948|448941071|FG000|Overall Study|Lost to Follow-up|2|||
124811765|NCT00675948|448941072|FG001|Overall Study|Lost to Follow-up|0|||
124811766|NCT00675948|448941071|FG000|Overall Study|Protocol Violation|1|||
124811767|NCT00675948|448941072|FG001|Overall Study|Protocol Violation|0|||
124811768|NCT00675948|448941071|FG000|Overall Study|Pain under control|1|||
124811769|NCT00675948|448941072|FG001|Overall Study|Pain under control|0|||
124811770|NCT00675948|448941071|FG000|Overall Study|Sponsor decision|0|||
124811771|NCT00675948|448941072|FG001|Overall Study|Sponsor decision|1|||
124811772|NCT00675948|448941071|FG000|Overall Study|Patient died|1|||
124811773|NCT00675948|448941072|FG001|Overall Study|Patient died|0|||
124811774|NCT00675948|448941071|FG000|Overall Study|Patient unable to comply with diaries|1|||
124811775|NCT00675948|448941072|FG001|Overall Study|Patient unable to comply with diaries|0|||
124811776|NCT00675948|448941071|FG000|Overall Study|Patient feels unable to take medication|0|||
124811777|NCT00675948|448941072|FG001|Overall Study|Patient feels unable to take medication|1|||
124811778|NCT02527161|448941073|FG000|Overall Study|Failed MRI|52|||
124811779|NCT02527161|448941073|FG000|Overall Study|Withdrawal by Subject|19|||
124811780|NCT02527161|448941073|FG000|Overall Study|Delay in or unfit for surgery|16|||
124811781|NCT02527161|448941073|FG000|Overall Study|MRI contraindication|6|||
124811782|NCT02527161|448941073|FG000|Overall Study|Consent violation|4|||
124811783|NCT02527161|448941073|FG000|Overall Study|Only Recruited to Part A|27|||
124811784|NCT02527161|448941073|FG000|Overall Study|Physician Decision|1|||
124811785|NCT02527161|448941073|FG000|Overall Study|Adverse Event|1|||
124811786|NCT02527161|448941073|FG000|Overall Study|Lost to Follow-up|6|||
124811787|NCT05209360|448941074|FG000|Overall Study|Withdrawal by Subject|0|||
124811788|NCT05209360|448941075|FG001|Overall Study|Withdrawal by Subject|0|||
124811789|NCT05209360|448941076|FG002|Overall Study|Withdrawal by Subject|1|||
124811790|NCT05209360|448941077|FG003|Overall Study|Withdrawal by Subject|0|||
124811791|NCT05209360|448941078|FG004|Overall Study|Withdrawal by Subject|0|||
124811792|NCT05209360|448941079|FG005|Overall Study|Withdrawal by Subject|0|||
124811793|NCT02100514|448941080|FG000|Treatment Period|Adverse Event|0|||
124811794|NCT02100514|448941081|FG001|Treatment Period|Adverse Event|5|||
124811795|NCT02100514|448941082|FG002|Treatment Period|Adverse Event|0|||
124811796|NCT02100514|448941083|FG003|Treatment Period|Adverse Event|0|||
124811797|NCT02100514|448941084|FG004|Treatment Period|Adverse Event|0|||
124811798|NCT02100514|448941080|FG000|Treatment Period|Death|2|||
124811799|NCT02100514|448941081|FG001|Treatment Period|Death|2|||
124811800|NCT02100514|448941082|FG002|Treatment Period|Death|0|||
124811801|NCT02100514|448941083|FG003|Treatment Period|Death|0|||
124811802|NCT02100514|448941084|FG004|Treatment Period|Death|0|||
124811803|NCT02100514|448941080|FG000|Treatment Period|Lost to Follow-up|5|||
124811804|NCT02100514|448941081|FG001|Treatment Period|Lost to Follow-up|17|||
124811805|NCT02100514|448941082|FG002|Treatment Period|Lost to Follow-up|0|||
124811806|NCT02100514|448941083|FG003|Treatment Period|Lost to Follow-up|0|||
124811807|NCT02100514|448941084|FG004|Treatment Period|Lost to Follow-up|0|||
124811808|NCT02100514|448941080|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
124811809|NCT02100514|448941081|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
124811810|NCT02100514|448941082|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
124811811|NCT02100514|448941083|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
124811812|NCT02100514|448941084|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
124811813|NCT02100514|448941080|FG000|Treatment Period|Protocol Violation|1|||
124811814|NCT02100514|448941081|FG001|Treatment Period|Protocol Violation|1|||
124811815|NCT02100514|448941082|FG002|Treatment Period|Protocol Violation|0|||
124811816|NCT02100514|448941083|FG003|Treatment Period|Protocol Violation|0|||
124811817|NCT02100514|448941084|FG004|Treatment Period|Protocol Violation|0|||
124811818|NCT02100514|448941080|FG000|Treatment Period|Withdrawal by Subject|12|||
124811819|NCT02100514|448941081|FG001|Treatment Period|Withdrawal by Subject|37|||
124811820|NCT02100514|448941082|FG002|Treatment Period|Withdrawal by Subject|0|||
124811821|NCT02100514|448941083|FG003|Treatment Period|Withdrawal by Subject|0|||
124811822|NCT02100514|448941084|FG004|Treatment Period|Withdrawal by Subject|0|||
124634414|NCT01662492|448276816|FG002|Overall Study|Protocol Violation|0|||
124634415|NCT01662492|448276814|FG000|Overall Study|Lost to Follow-up|0|||
124634416|NCT01662492|448276815|FG001|Overall Study|Lost to Follow-up|0|||
124811823|NCT02100514|448941080|FG000|Treatment Period|Other|9|||
124811824|NCT02100514|448941081|FG001|Treatment Period|Other|11|||
124811825|NCT02100514|448941082|FG002|Treatment Period|Other|0|||
124811826|NCT02100514|448941083|FG003|Treatment Period|Other|0|||
124811827|NCT02100514|448941084|FG004|Treatment Period|Other|0|||
124811828|NCT02100514|448941080|FG000|Extension Period|Withdrew consent|0|||
124811829|NCT02100514|448941081|FG001|Extension Period|Withdrew consent|0|||
124811830|NCT02100514|448941082|FG002|Extension Period|Withdrew consent|2|||
124811831|NCT02100514|448941083|FG003|Extension Period|Withdrew consent|0|||
124811832|NCT02100514|448941084|FG004|Extension Period|Withdrew consent|0|||
124811833|NCT00724932|448941085|FG000|Overall Study|Lost to Follow-up|1|||
124811834|NCT00724932|448941086|FG001|Overall Study|Lost to Follow-up|0|||
124811835|NCT00724932|448941085|FG000|Overall Study|Not treated|4|||
124811836|NCT00724932|448941086|FG001|Overall Study|Not treated|3|||
124811837|NCT02021331|448941087|FG000|Overall Study|Adverse Event|0|||
124811838|NCT02021331|448941088|FG001|Overall Study|Adverse Event|2|||
124811839|NCT00762229|448941089|FG000|Overall Study|Lost to Follow-up|1|||
124811840|NCT00762229|448941090|FG001|Overall Study|Lost to Follow-up|1|||
124811841|NCT00762229|448941089|FG000|Overall Study|did not recveive intervention|0|||
124811842|NCT00762229|448941090|FG001|Overall Study|did not recveive intervention|1|||
124811843|NCT00319553|448941095|FG000|Overall Study|Protocol Violation|1|||
124811844|NCT00319553|448941096|FG001|Overall Study|Protocol Violation|2|||
124811845|NCT00319553|448941095|FG000|Overall Study|Lost to Follow-up|2|||
124811846|NCT00319553|448941096|FG001|Overall Study|Lost to Follow-up|1|||
124811847|NCT00319553|448941095|FG000|Overall Study|Withdrawal by Subject|1|||
124811848|NCT00319553|448941096|FG001|Overall Study|Withdrawal by Subject|1|||
124811849|NCT00885846|448941098|FG000|Overall Study|Withdrawal by Subject|2|||
124811850|NCT00885846|448941099|FG001|Overall Study|Withdrawal by Subject|5|||
124811851|NCT00885846|448941100|FG002|Overall Study|Withdrawal by Subject|2|||
124811852|NCT01081678|448941102|FG000|Overall Study|Ineligibility Determined|0|||
124811853|NCT01081678|448941103|FG001|Overall Study|Ineligibility Determined|0|||
124811854|NCT01081678|448941104|FG002|Overall Study|Ineligibility Determined|1|||
124811855|NCT01081678|448941105|FG003|Overall Study|Ineligibility Determined|1|||
124811856|NCT01081678|448941102|FG000|Overall Study|Noncompliance|3|||
124811857|NCT01081678|448941103|FG001|Overall Study|Noncompliance|4|||
124811858|NCT01081678|448941104|FG002|Overall Study|Noncompliance|5|||
124811859|NCT01081678|448941105|FG003|Overall Study|Noncompliance|2|||
124811860|NCT01081678|448941102|FG000|Overall Study|Adverse Event|2|||
124811861|NCT01081678|448941103|FG001|Overall Study|Adverse Event|1|||
124811862|NCT01081678|448941104|FG002|Overall Study|Adverse Event|2|||
124811863|NCT01081678|448941105|FG003|Overall Study|Adverse Event|2|||
124811864|NCT01081678|448941102|FG000|Overall Study|Withdrawal by Subject|15|||
124811865|NCT01081678|448941103|FG001|Overall Study|Withdrawal by Subject|7|||
124811866|NCT01081678|448941104|FG002|Overall Study|Withdrawal by Subject|17|||
124811867|NCT01081678|448941105|FG003|Overall Study|Withdrawal by Subject|14|||
124811868|NCT01081678|448941102|FG000|Overall Study|Administrative Decision|1|||
124811869|NCT01081678|448941103|FG001|Overall Study|Administrative Decision|0|||
124811870|NCT01081678|448941104|FG002|Overall Study|Administrative Decision|0|||
124811871|NCT01081678|448941105|FG003|Overall Study|Administrative Decision|1|||
124811872|NCT01081678|448941102|FG000|Overall Study|Lost to Follow-up|4|||
124811873|NCT01081678|448941103|FG001|Overall Study|Lost to Follow-up|1|||
124811874|NCT01081678|448941104|FG002|Overall Study|Lost to Follow-up|4|||
124811875|NCT01081678|448941105|FG003|Overall Study|Lost to Follow-up|3|||
124811876|NCT01081678|448941102|FG000|Overall Study|Death|2|||
124811877|NCT01081678|448941103|FG001|Overall Study|Death|2|||
124811878|NCT01081678|448941104|FG002|Overall Study|Death|2|||
124811879|NCT01081678|448941105|FG003|Overall Study|Death|6|||
124811880|NCT01081678|448941102|FG000|Overall Study|Other|0|||
124811881|NCT01081678|448941103|FG001|Overall Study|Other|1|||
124811882|NCT01081678|448941104|FG002|Overall Study|Other|0|||
124811883|NCT01081678|448941105|FG003|Overall Study|Other|0|||
124811884|NCT00444912|448941108|FG000|Overall Study|Death|1|||
124811885|NCT00444912|448941109|FG001|Overall Study|Death|2|||
124811886|NCT00444912|448941108|FG000|Overall Study|Lost to Follow-up|1|||
124811887|NCT00444912|448941109|FG001|Overall Study|Lost to Follow-up|0|||
124811888|NCT00444912|448941108|FG000|Overall Study|Participant Failed Mobilization|1|||
124811889|NCT00444912|448941109|FG001|Overall Study|Participant Failed Mobilization|0|||
124811890|NCT01281865|448941110|FG000|Overall Study|Adverse Event|1|||
124811891|NCT01281865|448941111|FG001|Overall Study|Adverse Event|1|||
124811892|NCT01281865|448941110|FG000|Overall Study|Withdrawal by Subject|1|||
124811893|NCT01281865|448941111|FG001|Overall Study|Withdrawal by Subject|0|||
124811894|NCT01281865|448941110|FG000|Overall Study|Lack of Efficacy|1|||
124811895|NCT01281865|448941111|FG001|Overall Study|Lack of Efficacy|0|||
124811896|NCT02747875|448941112|FG000|Overall Study|Physician Decision|1|||
124811897|NCT02747875|448941113|FG001|Overall Study|Physician Decision|0|||
124811898|NCT02747875|448941112|FG000|Overall Study|Adverse Event|0|||
124811899|NCT02747875|448941113|FG001|Overall Study|Adverse Event|1|||
124811900|NCT01702805|448941115|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
124811901|NCT01702805|448941116|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
124811902|NCT01702805|448941115|FG000|Overall Study|Incomplete Follow-up|18|||
124811903|NCT01702805|448941116|FG001|Overall Study|Incomplete Follow-up|15|||
124811904|NCT01702805|448941115|FG000|Overall Study|Vital Status Assessment Only|40|||
124811905|NCT01702805|448941116|FG001|Overall Study|Vital Status Assessment Only|39|||
124811906|NCT01702805|448941115|FG000|Overall Study|Lost to Follow-up|5|||
124811907|NCT01702805|448941116|FG001|Overall Study|Lost to Follow-up|5|||
124811908|NCT02499783|448941117|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
124811909|NCT02499783|448941118|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
124811910|NCT02499783|448941119|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
124811911|NCT02499783|448941117|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
124811912|NCT02499783|448941118|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
124811913|NCT02499783|448941119|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
124811914|NCT02499783|448941117|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
124811915|NCT02499783|448941118|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
124811916|NCT02499783|448941119|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
124811917|NCT02499783|448941117|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
124811918|NCT02499783|448941118|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
124811919|NCT02499783|448941119|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
124811920|NCT02499783|448941117|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
124811921|NCT02499783|448941118|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
124811922|NCT02499783|448941119|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
124811923|NCT02499783|448941117|FG000|DB Period: Weeks 0-8|Other|1|||
124811924|NCT02499783|448941118|FG001|DB Period: Weeks 0-8|Other|1|||
124811925|NCT02499783|448941119|FG002|DB Period: Weeks 0-8|Other|0|||
124811926|NCT02499783|448941117|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
124811927|NCT02499783|448941118|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
124811928|NCT02499783|448941119|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
124811929|NCT02499783|448941117|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
124811930|NCT02499783|448941118|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
124811931|NCT02499783|448941119|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
124811932|NCT02499783|448941117|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
124811933|NCT02499783|448941118|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
124811934|NCT02499783|448941119|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
124811935|NCT02499783|448941117|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
124811936|NCT02499783|448941118|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
124811937|NCT02499783|448941119|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
124811938|NCT01866293|448941120|FG000|Overall Study|Adverse Event|2|||
124811939|NCT04457336|448941121|FG000|Period 2: Part A|Withdrawal by Subject|0|||
124811940|NCT04457336|448941122|FG001|Period 2: Part A|Withdrawal by Subject|1|||
124811941|NCT04457336|448941123|FG002|Period 2: Part A|Withdrawal by Subject|1|||
124811942|NCT04457336|448941124|FG003|Period 2: Part A|Withdrawal by Subject|1|||
124811943|NCT04457336|448941125|FG004|Period 2: Part A|Withdrawal by Subject|0|||
124811944|NCT04457336|448941126|FG005|Period 2: Part A|Withdrawal by Subject|0|||
124811945|NCT04457336|448941127|FG006|Period 2: Part A|Withdrawal by Subject|0|||
124811946|NCT04457336|448941128|FG007|Period 2: Part A|Withdrawal by Subject|0|||
124811947|NCT04457336|448941121|FG000|Period 2: Part A|Adverse Event|0|||
124811948|NCT04457336|448941122|FG001|Period 2: Part A|Adverse Event|0|||
124811949|NCT04457336|448941123|FG002|Period 2: Part A|Adverse Event|1|||
124811950|NCT04457336|448941124|FG003|Period 2: Part A|Adverse Event|1|||
124811951|NCT04457336|448941125|FG004|Period 2: Part A|Adverse Event|0|||
124811952|NCT04457336|448941126|FG005|Period 2: Part A|Adverse Event|0|||
124811953|NCT04457336|448941127|FG006|Period 2: Part A|Adverse Event|0|||
124811954|NCT04457336|448941128|FG007|Period 2: Part A|Adverse Event|0|||
124811955|NCT04457336|448941121|FG000|Period 2: Part A|Study Terminated|0|||
124811956|NCT04457336|448941122|FG001|Period 2: Part A|Study Terminated|0|||
124811957|NCT04457336|448941123|FG002|Period 2: Part A|Study Terminated|1|||
124811958|NCT04457336|448941124|FG003|Period 2: Part A|Study Terminated|0|||
124811959|NCT04457336|448941125|FG004|Period 2: Part A|Study Terminated|0|||
124811960|NCT04457336|448941126|FG005|Period 2: Part A|Study Terminated|0|||
124811961|NCT04457336|448941127|FG006|Period 2: Part A|Study Terminated|0|||
124811962|NCT04457336|448941128|FG007|Period 2: Part A|Study Terminated|0|||
124811963|NCT04457336|448941121|FG000|Period 2: Part A|Protocol Violation|0|||
124811964|NCT04457336|448941122|FG001|Period 2: Part A|Protocol Violation|1|||
124811965|NCT04457336|448941123|FG002|Period 2: Part A|Protocol Violation|0|||
124811966|NCT04457336|448941124|FG003|Period 2: Part A|Protocol Violation|0|||
124811967|NCT04457336|448941125|FG004|Period 2: Part A|Protocol Violation|0|||
124811968|NCT04457336|448941126|FG005|Period 2: Part A|Protocol Violation|0|||
124811969|NCT04457336|448941127|FG006|Period 2: Part A|Protocol Violation|0|||
124811970|NCT04457336|448941128|FG007|Period 2: Part A|Protocol Violation|0|||
124811971|NCT04457336|448941121|FG000|Period 2: Part A|Lost to Follow-up|0|||
124811972|NCT04457336|448941122|FG001|Period 2: Part A|Lost to Follow-up|1|||
124811973|NCT04457336|448941123|FG002|Period 2: Part A|Lost to Follow-up|0|||
124811974|NCT04457336|448941124|FG003|Period 2: Part A|Lost to Follow-up|0|||
124811975|NCT04457336|448941125|FG004|Period 2: Part A|Lost to Follow-up|0|||
124811976|NCT04457336|448941126|FG005|Period 2: Part A|Lost to Follow-up|0|||
124811977|NCT04457336|448941127|FG006|Period 2: Part A|Lost to Follow-up|0|||
124811978|NCT04457336|448941128|FG007|Period 2: Part A|Lost to Follow-up|0|||
124811979|NCT04457336|448941121|FG000|Period 2: Part A|Other|0|||
124811980|NCT04457336|448941122|FG001|Period 2: Part A|Other|1|||
124811981|NCT04457336|448941123|FG002|Period 2: Part A|Other|0|||
124811982|NCT04457336|448941124|FG003|Period 2: Part A|Other|0|||
124811983|NCT04457336|448941125|FG004|Period 2: Part A|Other|0|||
124811984|NCT04457336|448941126|FG005|Period 2: Part A|Other|0|||
124811985|NCT04457336|448941127|FG006|Period 2: Part A|Other|0|||
124811986|NCT04457336|448941128|FG007|Period 2: Part A|Other|0|||
124811987|NCT04457336|448941121|FG000|Period 2: Part A|Physician Decision|0|||
124811988|NCT04457336|448941122|FG001|Period 2: Part A|Physician Decision|0|||
124811989|NCT04457336|448941123|FG002|Period 2: Part A|Physician Decision|0|||
124811990|NCT04457336|448941124|FG003|Period 2: Part A|Physician Decision|1|||
124811991|NCT04457336|448941125|FG004|Period 2: Part A|Physician Decision|0|||
124811992|NCT04457336|448941126|FG005|Period 2: Part A|Physician Decision|0|||
124811993|NCT04457336|448941127|FG006|Period 2: Part A|Physician Decision|0|||
124811994|NCT04457336|448941128|FG007|Period 2: Part A|Physician Decision|0|||
124811995|NCT04457336|448941121|FG000|Period 3: Part B|Study Terminated|0|||
124811996|NCT04457336|448941122|FG001|Period 3: Part B|Study Terminated|0|||
124811997|NCT04457336|448941123|FG002|Period 3: Part B|Study Terminated|0|||
124811998|NCT04457336|448941124|FG003|Period 3: Part B|Study Terminated|0|||
124811999|NCT04457336|448941125|FG004|Period 3: Part B|Study Terminated|1|||
124812000|NCT04457336|448941126|FG005|Period 3: Part B|Study Terminated|10|||
124812001|NCT04457336|448941127|FG006|Period 3: Part B|Study Terminated|13|||
124812002|NCT04457336|448941128|FG007|Period 3: Part B|Study Terminated|0|||
124812003|NCT04457336|448941121|FG000|Period 3: Part B|Withdrawal by Subject|0|||
124812004|NCT04457336|448941122|FG001|Period 3: Part B|Withdrawal by Subject|0|||
124812005|NCT04457336|448941123|FG002|Period 3: Part B|Withdrawal by Subject|0|||
124812006|NCT04457336|448941124|FG003|Period 3: Part B|Withdrawal by Subject|0|||
124812007|NCT04457336|448941125|FG004|Period 3: Part B|Withdrawal by Subject|0|||
124812008|NCT04457336|448941126|FG005|Period 3: Part B|Withdrawal by Subject|1|||
124812009|NCT04457336|448941127|FG006|Period 3: Part B|Withdrawal by Subject|2|||
124812010|NCT04457336|448941128|FG007|Period 3: Part B|Withdrawal by Subject|0|||
124812011|NCT04457336|448941121|FG000|Period 4: Part C|Study Terminated|0|||
124812012|NCT04457336|448941122|FG001|Period 4: Part C|Study Terminated|0|||
124812013|NCT04457336|448941123|FG002|Period 4: Part C|Study Terminated|0|||
124812014|NCT04457336|448941124|FG003|Period 4: Part C|Study Terminated|0|||
124812015|NCT04457336|448941125|FG004|Period 4: Part C|Study Terminated|0|||
124812016|NCT04457336|448941126|FG005|Period 4: Part C|Study Terminated|0|||
124812017|NCT04457336|448941127|FG006|Period 4: Part C|Study Terminated|0|||
124812018|NCT04457336|448941128|FG007|Period 4: Part C|Study Terminated|30|||
124812019|NCT04457336|448941121|FG000|Period 4: Part C|Adverse Event|0|||
124812020|NCT04457336|448941122|FG001|Period 4: Part C|Adverse Event|0|||
124812021|NCT04457336|448941123|FG002|Period 4: Part C|Adverse Event|0|||
124812022|NCT04457336|448941124|FG003|Period 4: Part C|Adverse Event|0|||
124812023|NCT04457336|448941125|FG004|Period 4: Part C|Adverse Event|0|||
124812024|NCT04457336|448941126|FG005|Period 4: Part C|Adverse Event|0|||
124812025|NCT04457336|448941127|FG006|Period 4: Part C|Adverse Event|0|||
124812026|NCT04457336|448941128|FG007|Period 4: Part C|Adverse Event|2|||
124812027|NCT04457336|448941121|FG000|Period 4: Part C|Site Terminated|0|||
124812028|NCT04457336|448941122|FG001|Period 4: Part C|Site Terminated|0|||
124812029|NCT04457336|448941123|FG002|Period 4: Part C|Site Terminated|0|||
124812030|NCT04457336|448941124|FG003|Period 4: Part C|Site Terminated|0|||
124812031|NCT04457336|448941125|FG004|Period 4: Part C|Site Terminated|0|||
124812032|NCT04457336|448941126|FG005|Period 4: Part C|Site Terminated|0|||
124812033|NCT04457336|448941127|FG006|Period 4: Part C|Site Terminated|0|||
124812034|NCT04457336|448941128|FG007|Period 4: Part C|Site Terminated|1|||
124812035|NCT04457336|448941121|FG000|Period 4: Part C|Other|0|||
124812036|NCT04457336|448941122|FG001|Period 4: Part C|Other|0|||
124812037|NCT04457336|448941123|FG002|Period 4: Part C|Other|0|||
124812038|NCT04457336|448941124|FG003|Period 4: Part C|Other|0|||
124812039|NCT04457336|448941125|FG004|Period 4: Part C|Other|0|||
124812040|NCT04457336|448941126|FG005|Period 4: Part C|Other|0|||
124812041|NCT04457336|448941127|FG006|Period 4: Part C|Other|0|||
124812042|NCT04457336|448941128|FG007|Period 4: Part C|Other|2|||
124812043|NCT04457336|448941121|FG000|Period 4: Part C|Withdrawal by Subject|0|||
124812044|NCT04457336|448941122|FG001|Period 4: Part C|Withdrawal by Subject|0|||
124812045|NCT04457336|448941123|FG002|Period 4: Part C|Withdrawal by Subject|0|||
124812046|NCT04457336|448941124|FG003|Period 4: Part C|Withdrawal by Subject|0|||
124812047|NCT04457336|448941125|FG004|Period 4: Part C|Withdrawal by Subject|0|||
124812048|NCT04457336|448941126|FG005|Period 4: Part C|Withdrawal by Subject|0|||
124812049|NCT04457336|448941127|FG006|Period 4: Part C|Withdrawal by Subject|0|||
124812050|NCT04457336|448941128|FG007|Period 4: Part C|Withdrawal by Subject|3|||
124634417|NCT01662492|448276816|FG002|Overall Study|Lost to Follow-up|2|||
124634418|NCT01662492|448276814|FG000|Overall Study|Lack of Efficacy|1|||
124634419|NCT01662492|448276815|FG001|Overall Study|Lack of Efficacy|1|||
124812051|NCT02571075|448941133|FG000|Overall Study|Lost to Follow-up|20|||
124812052|NCT02571075|448941134|FG001|Overall Study|Lost to Follow-up|24|||
124812053|NCT02693119|448941135|FG000|Open-Label Period|Withdrawal by Subject|0|||
124812054|NCT02693119|448941136|FG001|Open-Label Period|Withdrawal by Subject|1|||
124812055|NCT04203498|448941137|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
124812056|NCT04203498|448941138|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
124812057|NCT04203498|448941137|FG000|Overall Study|Withdrawal of patient consent|7|||
124812058|NCT04203498|448941138|FG001|Overall Study|Withdrawal of patient consent|2|||
124812059|NCT04203498|448941137|FG000|Overall Study|Adverse Event|4|||
124812060|NCT04203498|448941138|FG001|Overall Study|Adverse Event|1|||
124812061|NCT04203498|448941137|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
124634420|NCT01662492|448276816|FG002|Overall Study|Lack of Efficacy|2|||
124812062|NCT04203498|448941138|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
124812063|NCT04203498|448941137|FG000|Overall Study|Did not receive IMP|2|||
124812064|NCT04203498|448941138|FG001|Overall Study|Did not receive IMP|0|||
124812065|NCT02106975|448941139|FG000|Overall Study|Death|25|||
124812066|NCT02106975|448941140|FG001|Overall Study|Death|39|||
124812067|NCT02935842|448941142|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
124812068|NCT02935842|448941143|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
124812069|NCT02935842|448941144|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
124812070|NCT02935842|448941145|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
124812071|NCT02935842|448941142|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
124812072|NCT02935842|448941143|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
124812073|NCT02935842|448941144|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
124812074|NCT02935842|448941145|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
124812075|NCT02935842|448941142|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
124812076|NCT02935842|448941143|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
124812077|NCT02935842|448941144|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
124812078|NCT02935842|448941145|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
124812079|NCT02935842|448941142|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
124812080|NCT02935842|448941143|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
124812081|NCT02935842|448941144|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
124812082|NCT02935842|448941145|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
124812083|NCT02935842|448941142|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
124812084|NCT02935842|448941143|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
124812085|NCT02935842|448941144|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
124812086|NCT02935842|448941145|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
124812087|NCT01201785|448941146|FG000|Overall Study|Lost to Follow-up|16|||
124812088|NCT04545385|448941147|FG000|Overall Study|Withdrawal by Subject|2|||
124812089|NCT04545385|448941148|FG001|Overall Study|Withdrawal by Subject|0|||
124812090|NCT04545385|448941147|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
124812091|NCT04545385|448941148|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
124812092|NCT04545385|448941147|FG000|Overall Study|Study termination|10|||
124812093|NCT04545385|448941148|FG001|Overall Study|Study termination|10|||
124812094|NCT04545385|448941147|FG000|Overall Study|Sponsor decision|2|||
124812095|NCT04545385|448941148|FG001|Overall Study|Sponsor decision|2|||
124812096|NCT04545385|448941147|FG000|Overall Study|Other than specified|1|||
124812097|NCT04545385|448941148|FG001|Overall Study|Other than specified|0|||
124812098|NCT00939770|448941149|FG000|Overall Study|Adverse Event|1|||
124812099|NCT00939770|448941150|FG001|Overall Study|Adverse Event|1|||
124812100|NCT00939770|448941151|FG002|Overall Study|Adverse Event|0|||
124812101|NCT00939770|448941152|FG003|Overall Study|Adverse Event|0|||
124812102|NCT00939770|448941153|FG004|Overall Study|Adverse Event|6|||
124812103|NCT00939770|448941154|FG005|Overall Study|Adverse Event|2|||
124812104|NCT00939770|448941155|FG006|Overall Study|Adverse Event|1|||
124812105|NCT00939770|448941156|FG007|Overall Study|Adverse Event|1|||
124812106|NCT00939770|448941149|FG000|Overall Study|Lack of Efficacy|4|||
124812107|NCT00939770|448941150|FG001|Overall Study|Lack of Efficacy|6|||
124812108|NCT00939770|448941151|FG002|Overall Study|Lack of Efficacy|13|||
124812109|NCT00939770|448941152|FG003|Overall Study|Lack of Efficacy|9|||
124812110|NCT00939770|448941153|FG004|Overall Study|Lack of Efficacy|16|||
124812111|NCT00939770|448941154|FG005|Overall Study|Lack of Efficacy|8|||
124812112|NCT00939770|448941155|FG006|Overall Study|Lack of Efficacy|11|||
124812113|NCT00939770|448941156|FG007|Overall Study|Lack of Efficacy|1|||
124812114|NCT00939770|448941149|FG000|Overall Study|Lost to Follow-up|0|||
124812115|NCT00939770|448941150|FG001|Overall Study|Lost to Follow-up|0|||
124812116|NCT00939770|448941151|FG002|Overall Study|Lost to Follow-up|0|||
124812117|NCT00939770|448941152|FG003|Overall Study|Lost to Follow-up|0|||
124812118|NCT00939770|448941153|FG004|Overall Study|Lost to Follow-up|1|||
124812119|NCT00939770|448941154|FG005|Overall Study|Lost to Follow-up|0|||
124812120|NCT00939770|448941155|FG006|Overall Study|Lost to Follow-up|0|||
124812121|NCT00939770|448941156|FG007|Overall Study|Lost to Follow-up|0|||
124812122|NCT00939770|448941149|FG000|Overall Study|Physician Decision|0|||
124812123|NCT00939770|448941150|FG001|Overall Study|Physician Decision|0|||
124812124|NCT00939770|448941151|FG002|Overall Study|Physician Decision|2|||
124812125|NCT00939770|448941152|FG003|Overall Study|Physician Decision|0|||
124812126|NCT00939770|448941153|FG004|Overall Study|Physician Decision|7|||
124812127|NCT00939770|448941154|FG005|Overall Study|Physician Decision|1|||
124812128|NCT00939770|448941155|FG006|Overall Study|Physician Decision|0|||
124812129|NCT00939770|448941156|FG007|Overall Study|Physician Decision|6|||
124812130|NCT00939770|448941149|FG000|Overall Study|Protocol Violation|0|||
124812131|NCT00939770|448941150|FG001|Overall Study|Protocol Violation|0|||
124812132|NCT00939770|448941151|FG002|Overall Study|Protocol Violation|0|||
124812133|NCT00939770|448941152|FG003|Overall Study|Protocol Violation|0|||
124812134|NCT00939770|448941153|FG004|Overall Study|Protocol Violation|1|||
124812135|NCT00939770|448941154|FG005|Overall Study|Protocol Violation|0|||
124812136|NCT00939770|448941155|FG006|Overall Study|Protocol Violation|0|||
124812137|NCT00939770|448941156|FG007|Overall Study|Protocol Violation|0|||
124812138|NCT00939770|448941149|FG000|Overall Study|Withdrawal by Subject|0|||
124812139|NCT00939770|448941150|FG001|Overall Study|Withdrawal by Subject|1|||
124812140|NCT00939770|448941151|FG002|Overall Study|Withdrawal by Subject|5|||
124812141|NCT00939770|448941152|FG003|Overall Study|Withdrawal by Subject|2|||
124812142|NCT00939770|448941153|FG004|Overall Study|Withdrawal by Subject|6|||
124812143|NCT00939770|448941154|FG005|Overall Study|Withdrawal by Subject|0|||
124812144|NCT00939770|448941155|FG006|Overall Study|Withdrawal by Subject|2|||
124812145|NCT00939770|448941156|FG007|Overall Study|Withdrawal by Subject|2|||
124812146|NCT00191139|448941157|FG000|Overall Study|Adverse Event|2|||
124812147|NCT00191139|448941158|FG001|Overall Study|Adverse Event|6|||
124812148|NCT00191139|448941157|FG000|Overall Study|Death|2|||
124812149|NCT00191139|448941158|FG001|Overall Study|Death|0|||
124812150|NCT00191139|448941157|FG000|Overall Study|Withdrawal by Subject|0|||
124812151|NCT00191139|448941158|FG001|Overall Study|Withdrawal by Subject|3|||
124812152|NCT00191139|448941157|FG000|Overall Study|Disease Progression|0|||
124812153|NCT00191139|448941158|FG001|Overall Study|Disease Progression|1|||
124812154|NCT00191139|448941157|FG000|Overall Study|Other|1|||
124812155|NCT00191139|448941158|FG001|Overall Study|Other|2|||
124812156|NCT03128411|448941165|FG000|Treatment Phase|Adverse Event|21|||
124812157|NCT03128411|448941165|FG000|Treatment Phase|Physician Decision|1|||
124812158|NCT03128411|448941165|FG000|Treatment Phase|Other|2|||
124812159|NCT03128411|448941165|FG000|Long Term Follow-up Phase|Death|2|||
124819544|NCT05147350|448965749|FG002|Overall Study|Withdrawal by Subject|3|||
124819545|NCT05147350|448965750|FG003|Overall Study|Withdrawal by Subject|1|||
124819546|NCT05147350|448965751|FG004|Overall Study|Withdrawal by Subject|1|||
124819547|NCT05147350|448965752|FG005|Overall Study|Withdrawal by Subject|0|||
124819548|NCT05147350|448965753|FG006|Overall Study|Withdrawal by Subject|1|||
124819549|NCT05147350|448965754|FG007|Overall Study|Withdrawal by Subject|0|||
124819550|NCT05147350|448965747|FG000|Overall Study|Other Reasons|0|||
124819551|NCT05147350|448965748|FG001|Overall Study|Other Reasons|0|||
124819552|NCT05147350|448965749|FG002|Overall Study|Other Reasons|2|||
124819553|NCT05147350|448965750|FG003|Overall Study|Other Reasons|0|||
124819554|NCT05147350|448965751|FG004|Overall Study|Other Reasons|0|||
124819555|NCT05147350|448965752|FG005|Overall Study|Other Reasons|2|||
124819556|NCT05147350|448965753|FG006|Overall Study|Other Reasons|1|||
124819557|NCT05147350|448965754|FG007|Overall Study|Other Reasons|1|||
124819558|NCT02627144|448965758|FG000|Overall Study|Serious adverse event|32|||
124819559|NCT02627144|448965758|FG000|Overall Study|Cancer progression|171|||
124819560|NCT02627144|448965758|FG000|Overall Study|Death from cancer|20|||
124819561|NCT02627144|448965758|FG000|Overall Study|Death from other cause|8|||
124819562|NCT02627144|448965758|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
124819563|NCT02627144|448965758|FG000|Overall Study|Administrative reasons|65|||
124819564|NCT02627144|448965758|FG000|Overall Study|Lost to Follow-up|8|||
124819565|NCT02627144|448965758|FG000|Overall Study|Enrolled, not treated|6|||
124819566|NCT02627144|448965758|FG000|Overall Study|Other|17|||
124819567|NCT00420927|448965761|FG000|Period 1|Adverse Event|19|||
124634421|NCT01611883|448276823|FG000|Overall Study|Adverse Event|1|||
124634422|NCT01611883|448276824|FG001|Overall Study|Adverse Event|1|||
124634423|NCT05142722|448277629|FG000|Overall Study|Lost to Follow-up|16|||
124634424|NCT05142722|448277630|FG001|Overall Study|Lost to Follow-up|38|||
124634425|NCT05142722|448277629|FG000|Overall Study|Withdrawal by Subject|20|||
124634426|NCT05142722|448277630|FG001|Overall Study|Withdrawal by Subject|27|||
124634427|NCT05142722|448277629|FG000|Overall Study|Death|11|||
124634428|NCT05142722|448277630|FG001|Overall Study|Death|17|||
124634429|NCT05142722|448277629|FG000|Overall Study|Physician Decision|0|||
124634430|NCT05142722|448277630|FG001|Overall Study|Physician Decision|1|||
124634431|NCT05142722|448277629|FG000|Overall Study|Participant Moved Away|0|||
124634432|NCT05142722|448277630|FG001|Overall Study|Participant Moved Away|2|||
124634433|NCT05142722|448277629|FG000|Overall Study|Adverse Event|2|||
124634434|NCT05142722|448277630|FG001|Overall Study|Adverse Event|1|||
124634435|NCT05731700|448277631|FG000|Overall Study|Death|1|||
124634436|NCT05468164|448277640|FG000|Treatment Period 4|Adverse Event|0|||
124634437|NCT05468164|448277641|FG001|Treatment Period 4|Adverse Event|0|||
124634438|NCT05468164|448277642|FG002|Treatment Period 4|Adverse Event|0|||
124634439|NCT05468164|448277643|FG003|Treatment Period 4|Adverse Event|1|||
124634440|NCT04846569|448277644|FG000|Overall Study|Withdrawal by Subject|3|||
124819568|NCT00420927|448965762|FG001|Period 1|Adverse Event|15|||
124819569|NCT00420927|448965763|FG002|Period 1|Adverse Event|0|||
124819570|NCT00420927|448965764|FG003|Period 1|Adverse Event|0|||
124819571|NCT00420927|448965765|FG004|Period 1|Adverse Event|0|||
124634441|NCT04846569|448277645|FG001|Overall Study|Withdrawal by Subject|1|||
124634442|NCT01467713|448277646|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
124634443|NCT01467713|448277647|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
124819572|NCT00420927|448965766|FG005|Period 1|Adverse Event|0|||
124819573|NCT00420927|448965767|FG006|Period 1|Adverse Event|0|||
124819574|NCT00420927|448965761|FG000|Period 1|Withdrawal by Subject|7|||
124819575|NCT00420927|448965762|FG001|Period 1|Withdrawal by Subject|12|||
124819576|NCT00420927|448965763|FG002|Period 1|Withdrawal by Subject|0|||
124819577|NCT00420927|448965764|FG003|Period 1|Withdrawal by Subject|0|||
124819578|NCT00420927|448965765|FG004|Period 1|Withdrawal by Subject|0|||
124819579|NCT00420927|448965766|FG005|Period 1|Withdrawal by Subject|0|||
124634444|NCT01467713|448277648|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
124634445|NCT01467713|448277649|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
124634446|NCT01467713|448277646|FG000|Overall Study|Major Protocol Deviation|2|||
124634447|NCT01467713|448277647|FG001|Overall Study|Major Protocol Deviation|4|||
124634448|NCT01467713|448277648|FG002|Overall Study|Major Protocol Deviation|4|||
124634449|NCT01467713|448277649|FG003|Overall Study|Major Protocol Deviation|1|||
124634450|NCT01467713|448277646|FG000|Overall Study|Lost to Follow-up|9|||
124634451|NCT01467713|448277647|FG001|Overall Study|Lost to Follow-up|12|||
124634452|NCT01467713|448277648|FG002|Overall Study|Lost to Follow-up|6|||
124634453|NCT01467713|448277649|FG003|Overall Study|Lost to Follow-up|9|||
124634454|NCT01467713|448277646|FG000|Overall Study|Voluntary Withdrawal|18|||
124634455|NCT01467713|448277647|FG001|Overall Study|Voluntary Withdrawal|14|||
124634456|NCT01467713|448277648|FG002|Overall Study|Voluntary Withdrawal|21|||
124634457|NCT01467713|448277649|FG003|Overall Study|Voluntary Withdrawal|20|||
124634458|NCT01467713|448277646|FG000|Overall Study|Study Termination|23|||
124634459|NCT01467713|448277647|FG001|Overall Study|Study Termination|33|||
124634460|NCT01467713|448277648|FG002|Overall Study|Study Termination|28|||
124634461|NCT01467713|448277649|FG003|Overall Study|Study Termination|29|||
124634462|NCT01467713|448277646|FG000|Overall Study|Pregnancy|0|||
124634463|NCT01467713|448277647|FG001|Overall Study|Pregnancy|1|||
124634464|NCT01467713|448277648|FG002|Overall Study|Pregnancy|1|||
124634465|NCT01467713|448277649|FG003|Overall Study|Pregnancy|3|||
124634466|NCT01467713|448277646|FG000|Overall Study|Relapse|35|||
124634467|NCT01467713|448277647|FG001|Overall Study|Relapse|25|||
124634468|NCT01467713|448277648|FG002|Overall Study|Relapse|28|||
124634469|NCT01467713|448277649|FG003|Overall Study|Relapse|35|||
124634470|NCT01467713|448277646|FG000|Overall Study|Reason not Specified|6|||
124634471|NCT01467713|448277647|FG001|Overall Study|Reason not Specified|11|||
124634472|NCT01467713|448277648|FG002|Overall Study|Reason not Specified|8|||
124634473|NCT01467713|448277649|FG003|Overall Study|Reason not Specified|7|||
124634474|NCT00536939|448277654|FG000|Overall Study|Withdrawal by Subject|1|||
124634475|NCT00536939|448277655|FG001|Overall Study|Withdrawal by Subject|0|||
124634476|NCT00536939|448277654|FG000|Overall Study|Other Complicating Disease|1|||
124634477|NCT00536939|448277655|FG001|Overall Study|Other Complicating Disease|0|||
124634478|NCT01100086|448277656|FG000|Period 1|Withdrawal by Subject|1|||
124634479|NCT01100086|448277657|FG001|Period 1|Withdrawal by Subject|0|||
124634480|NCT02954601|448277664|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
124634481|NCT02954601|448277665|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
124634482|NCT02954601|448277666|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
124634483|NCT02954601|448277667|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
124634484|NCT01611935|448277668|FG000|Overall Study|Family Declined Participation|1|||
124634485|NCT01611935|448277669|FG001|Overall Study|Family Declined Participation|0|||
124634486|NCT00333983|448277670|FG000|Overall Study|Lost to Follow-up|2|||
124634487|NCT00333983|448277671|FG001|Overall Study|Lost to Follow-up|1|||
124634488|NCT00333983|448277672|FG002|Overall Study|Lost to Follow-up|0|||
124634489|NCT00333983|448277670|FG000|Overall Study|Adverse Event|1|||
124634490|NCT00333983|448277671|FG001|Overall Study|Adverse Event|1|||
124634491|NCT00333983|448277672|FG002|Overall Study|Adverse Event|1|||
124634492|NCT00333983|448277670|FG000|Overall Study|Withdrawal by Subject|0|||
124634493|NCT00333983|448277671|FG001|Overall Study|Withdrawal by Subject|3|||
124634494|NCT00333983|448277672|FG002|Overall Study|Withdrawal by Subject|1|||
124634495|NCT00833105|448277673|FG000|Overall Study|Withdrawal by Subject|1|||
124634496|NCT00833105|448277673|FG000|Overall Study|Adverse Event|2|||
124634497|NCT03817853|448277684|FG000|Induction Phase|Adverse Event|5|||
124634498|NCT03817853|448277685|FG001|Induction Phase|Adverse Event|0|||
124634499|NCT03817853|448277686|FG002|Induction Phase|Adverse Event|0|||
124634500|NCT03817853|448277684|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
124634501|NCT03817853|448277685|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
124634502|NCT03817853|448277686|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
124812160|NCT01798004|448942575|FG000|Overall Study|Death|2|||
124812161|NCT01798004|448942575|FG000|Overall Study|Lack of Efficacy|8|||
124812162|NCT01798004|448942575|FG000|Overall Study|Physician Decision|25|||
124812163|NCT01798004|448942575|FG000|Overall Study|Withdrawal by Subject|4|||
124812164|NCT01798004|448942575|FG000|Overall Study|Ineligible|4|||
124812165|NCT01798004|448942575|FG000|Overall Study|Patient/parent refusal|7|||
124634503|NCT03817853|448277684|FG000|Induction Phase|Physician Decision|2|||
124634504|NCT03817853|448277685|FG001|Induction Phase|Physician Decision|0|||
124634505|NCT03817853|448277686|FG002|Induction Phase|Physician Decision|0|||
124634506|NCT03817853|448277684|FG000|Induction Phase|Progressive Disease|6|||
124634507|NCT03817853|448277685|FG001|Induction Phase|Progressive Disease|0|||
124634508|NCT03817853|448277686|FG002|Induction Phase|Progressive Disease|0|||
124634509|NCT03817853|448277684|FG000|Induction Phase|Withdrawal by Subject|4|||
124634510|NCT03817853|448277685|FG001|Induction Phase|Withdrawal by Subject|0|||
124634511|NCT03817853|448277686|FG002|Induction Phase|Withdrawal by Subject|0|||
124634512|NCT03817853|448277684|FG000|Maintenance Phase|Adverse Event|0|||
124634513|NCT03817853|448277685|FG001|Maintenance Phase|Adverse Event|8|||
124634514|NCT03817853|448277686|FG002|Maintenance Phase|Adverse Event|0|||
124634515|NCT03817853|448277684|FG000|Maintenance Phase|Death|0|||
124634516|NCT03817853|448277685|FG001|Maintenance Phase|Death|5|||
124634517|NCT03817853|448277686|FG002|Maintenance Phase|Death|0|||
124634518|NCT03817853|448277684|FG000|Maintenance Phase|Progressive Disease|0|||
124634519|NCT03817853|448277685|FG001|Maintenance Phase|Progressive Disease|7|||
124634520|NCT03817853|448277686|FG002|Maintenance Phase|Progressive Disease|0|||
124634521|NCT03817853|448277684|FG000|Maintenance Phase|Withdrawal by Subject|0|||
124634522|NCT03817853|448277685|FG001|Maintenance Phase|Withdrawal by Subject|2|||
124634523|NCT03817853|448277686|FG002|Maintenance Phase|Withdrawal by Subject|0|||
124634524|NCT03817853|448277684|FG000|Maintenance Phase|Physician Decision|0|||
124634525|NCT03817853|448277685|FG001|Maintenance Phase|Physician Decision|1|||
124634526|NCT03817853|448277686|FG002|Maintenance Phase|Physician Decision|0|||
124634527|NCT03817853|448277684|FG000|Maintenance Phase|Various reasons|0|||
124634528|NCT03817853|448277685|FG001|Maintenance Phase|Various reasons|4|||
124634529|NCT03817853|448277686|FG002|Maintenance Phase|Various reasons|0|||
124634530|NCT03817853|448277684|FG000|Maintenance Phase|Protocol Deviation|0|||
124634531|NCT03817853|448277685|FG001|Maintenance Phase|Protocol Deviation|1|||
124634532|NCT03817853|448277686|FG002|Maintenance Phase|Protocol Deviation|0|||
124634533|NCT03817853|448277684|FG000|Follow-up Phase|Adverse Event|0|||
124634534|NCT03817853|448277685|FG001|Follow-up Phase|Adverse Event|0|||
124634535|NCT03817853|448277686|FG002|Follow-up Phase|Adverse Event|2|||
124634536|NCT03817853|448277684|FG000|Follow-up Phase|Death|0|||
124634537|NCT03817853|448277685|FG001|Follow-up Phase|Death|0|||
124634538|NCT03817853|448277686|FG002|Follow-up Phase|Death|1|||
124634539|NCT03817853|448277684|FG000|Follow-up Phase|Progressive Disease|0|||
124634540|NCT03817853|448277685|FG001|Follow-up Phase|Progressive Disease|0|||
124634541|NCT03817853|448277686|FG002|Follow-up Phase|Progressive Disease|3|||
124634542|NCT03817853|448277684|FG000|Follow-up Phase|Withdrawal by Subject|0|||
124634543|NCT03817853|448277685|FG001|Follow-up Phase|Withdrawal by Subject|0|||
124634544|NCT03817853|448277686|FG002|Follow-up Phase|Withdrawal by Subject|1|||
124634545|NCT00314340|448277687|FG000|Overall Study|lost interest|1|||
124634546|NCT01620138|448277690|FG000|Overall Study|Withdrawal by Subject|3|||
124634547|NCT01620138|448277691|FG001|Overall Study|Withdrawal by Subject|0|||
124634548|NCT01620138|448277690|FG000|Overall Study|Lack of Efficacy|1|||
124634549|NCT01620138|448277691|FG001|Overall Study|Lack of Efficacy|0|||
124634550|NCT01620138|448277690|FG000|Overall Study|Adverse Event|2|||
124634551|NCT01620138|448277691|FG001|Overall Study|Adverse Event|0|||
124634552|NCT03252535|448277692|FG000|Overall Study|Withdrawal by Subject|1|||
124634553|NCT03252535|448277693|FG001|Overall Study|Withdrawal by Subject|0|||
124634554|NCT03252535|448277694|FG002|Overall Study|Withdrawal by Subject|0|||
124634555|NCT03252535|448277692|FG000|Overall Study|Physician Decision|0|||
124634556|NCT03252535|448277693|FG001|Overall Study|Physician Decision|1|||
124634557|NCT03252535|448277694|FG002|Overall Study|Physician Decision|0|||
124634558|NCT03252535|448277692|FG000|Overall Study|Met discontinuation criteria|0|||
124634559|NCT03252535|448277693|FG001|Overall Study|Met discontinuation criteria|1|||
124634560|NCT03252535|448277694|FG002|Overall Study|Met discontinuation criteria|0|||
124634561|NCT06509438|448277695|FG000|Overall Study|Adverse Event|1|||
124634562|NCT06509438|448277695|FG000|Overall Study|Lost to Follow-up|3|||
124634563|NCT05600283|448277696|FG000|Overall Study|Withdrawal by Subject|3|||
124634564|NCT05600283|448277697|FG001|Overall Study|Withdrawal by Subject|8|||
124634565|NCT05600283|448277696|FG000|Overall Study|invalid individual swab|1|||
124634566|NCT05600283|448277697|FG001|Overall Study|invalid individual swab|0|||
124634567|NCT05600283|448277696|FG000|Overall Study|missing clinician collection|3|||
124634568|NCT05600283|448277697|FG001|Overall Study|missing clinician collection|0|||
124634569|NCT05600283|448277696|FG000|Overall Study|screening failure|0|||
124634570|NCT05600283|448277697|FG001|Overall Study|screening failure|2|||
124634571|NCT02867592|448277698|FG000|Overall Study|Adverse Event|3|||
124634572|NCT02867592|448277699|FG001|Overall Study|Adverse Event|0|||
124634573|NCT02867592|448277700|FG002|Overall Study|Adverse Event|2|||
124634574|NCT02867592|448277701|FG003|Overall Study|Adverse Event|1|||
124634575|NCT02867592|448277702|FG004|Overall Study|Adverse Event|1|||
124634576|NCT02867592|448277703|FG005|Overall Study|Adverse Event|5|||
124634577|NCT02867592|448277698|FG000|Overall Study|Death|0|||
124634578|NCT02867592|448277699|FG001|Overall Study|Death|0|||
124634579|NCT02867592|448277700|FG002|Overall Study|Death|0|||
124634580|NCT02867592|448277701|FG003|Overall Study|Death|1|||
124634581|NCT02867592|448277702|FG004|Overall Study|Death|0|||
124634582|NCT02867592|448277703|FG005|Overall Study|Death|1|||
124634583|NCT02867592|448277698|FG000|Overall Study|Lack of Efficacy|8|||
124634584|NCT02867592|448277699|FG001|Overall Study|Lack of Efficacy|10|||
124634585|NCT02867592|448277700|FG002|Overall Study|Lack of Efficacy|8|||
124634586|NCT02867592|448277701|FG003|Overall Study|Lack of Efficacy|8|||
124634587|NCT02867592|448277702|FG004|Overall Study|Lack of Efficacy|12|||
124634588|NCT02867592|448277703|FG005|Overall Study|Lack of Efficacy|17|||
124634589|NCT02867592|448277698|FG000|Overall Study|Physician Decision|1|||
124634590|NCT02867592|448277699|FG001|Overall Study|Physician Decision|2|||
124634591|NCT02867592|448277700|FG002|Overall Study|Physician Decision|2|||
124634592|NCT02867592|448277701|FG003|Overall Study|Physician Decision|0|||
124634593|NCT02867592|448277702|FG004|Overall Study|Physician Decision|5|||
124634594|NCT02867592|448277703|FG005|Overall Study|Physician Decision|1|||
124634595|NCT02867592|448277698|FG000|Overall Study|Protocol Violation|0|||
124634596|NCT02867592|448277699|FG001|Overall Study|Protocol Violation|0|||
124634597|NCT02867592|448277700|FG002|Overall Study|Protocol Violation|0|||
124634598|NCT02867592|448277701|FG003|Overall Study|Protocol Violation|0|||
124634599|NCT02867592|448277702|FG004|Overall Study|Protocol Violation|1|||
124634600|NCT02867592|448277703|FG005|Overall Study|Protocol Violation|1|||
124634601|NCT02867592|448277698|FG000|Overall Study|Withdrawal by Subject|0|||
124634602|NCT02867592|448277699|FG001|Overall Study|Withdrawal by Subject|1|||
124634603|NCT02867592|448277700|FG002|Overall Study|Withdrawal by Subject|0|||
124634604|NCT02867592|448277701|FG003|Overall Study|Withdrawal by Subject|1|||
124634605|NCT02867592|448277702|FG004|Overall Study|Withdrawal by Subject|3|||
124634606|NCT02867592|448277703|FG005|Overall Study|Withdrawal by Subject|3|||
124634607|NCT02867592|448277698|FG000|Overall Study|Ineligible|1|||
124634608|NCT02867592|448277699|FG001|Overall Study|Ineligible|1|||
124634609|NCT02867592|448277700|FG002|Overall Study|Ineligible|0|||
124634610|NCT02867592|448277701|FG003|Overall Study|Ineligible|0|||
124634611|NCT02867592|448277702|FG004|Overall Study|Ineligible|2|||
124634612|NCT02867592|448277703|FG005|Overall Study|Ineligible|0|||
124634613|NCT02867592|448277698|FG000|Overall Study|No Treatment|1|||
124634614|NCT02867592|448277699|FG001|Overall Study|No Treatment|0|||
124634615|NCT02867592|448277700|FG002|Overall Study|No Treatment|0|||
124634616|NCT02867592|448277701|FG003|Overall Study|No Treatment|0|||
124634617|NCT02867592|448277702|FG004|Overall Study|No Treatment|0|||
124634618|NCT02867592|448277703|FG005|Overall Study|No Treatment|0|||
124634619|NCT02867592|448277698|FG000|Overall Study|Still on Therapy|0|||
124634620|NCT02867592|448277699|FG001|Overall Study|Still on Therapy|0|||
124634621|NCT02867592|448277700|FG002|Overall Study|Still on Therapy|0|||
124634622|NCT02867592|448277701|FG003|Overall Study|Still on Therapy|0|||
124634623|NCT02867592|448277702|FG004|Overall Study|Still on Therapy|1|||
124634624|NCT02867592|448277703|FG005|Overall Study|Still on Therapy|0|||
124634625|NCT02867592|448277698|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
124634626|NCT02867592|448277699|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
124634627|NCT02867592|448277700|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
124634628|NCT02867592|448277701|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
124634629|NCT02867592|448277702|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
124634630|NCT02867592|448277703|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
124634631|NCT02867592|448277698|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
124634632|NCT02867592|448277699|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
124634633|NCT02867592|448277700|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
124634634|NCT02867592|448277701|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
124634635|NCT02867592|448277702|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
124634636|NCT02867592|448277703|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
124634637|NCT03581292|448277704|FG000|Overall Study|Physician Decision|9|||
124634638|NCT03581292|448277705|FG001|Overall Study|Physician Decision|5|||
124634639|NCT03581292|448277704|FG000|Overall Study|Withdrawal by Subject|3|||
124634640|NCT03581292|448277705|FG001|Overall Study|Withdrawal by Subject|0|||
124634641|NCT03581292|448277704|FG000|Overall Study|Withdrawal before Therapy Start|1|||
124634642|NCT03581292|448277705|FG001|Overall Study|Withdrawal before Therapy Start|0|||
124634643|NCT00570141|448279054|FG000|Overall Study|Adverse Event|1|||
124634644|NCT00570141|448279054|FG000|Overall Study|Missed visits|1|||
124634645|NCT00570141|448279054|FG000|Overall Study|Lost to Follow-up|1|||
124634646|NCT01209949|448279066|FG000|Overall Study|Lost to Follow-up|3|||
124634647|NCT00729612|448279071|FG000|Overall Study|Non evaluable for response|10|||
124634648|NCT02075203|448279077|FG000|Overall Study|Withdrawal by Subject|1|||
124634649|NCT02075203|448279078|FG001|Overall Study|Withdrawal by Subject|0|||
124634650|NCT02075203|448279079|FG002|Overall Study|Withdrawal by Subject|1|||
124634651|NCT02075203|448279077|FG000|Overall Study|Adverse Event|1|||
124634652|NCT02075203|448279078|FG001|Overall Study|Adverse Event|0|||
124634653|NCT02075203|448279079|FG002|Overall Study|Adverse Event|0|||
124634654|NCT02075203|448279077|FG000|Overall Study|participant refused to use contraception|1|||
124634655|NCT02075203|448279078|FG001|Overall Study|participant refused to use contraception|0|||
124634656|NCT02075203|448279079|FG002|Overall Study|participant refused to use contraception|0|||
124634657|NCT03214224|448279080|FG000|Overall Study|Protocol Violation|1|||
124634658|NCT03214224|448279080|FG000|Overall Study|Withdrawal by Subject|2|||
124634659|NCT03214224|448279080|FG000|Overall Study|Practice controls or therapists|6|||
124634660|NCT02712320|448279081|FG000|Overall Study|Lost to Follow-up|1|||
124634661|NCT02712320|448279081|FG000|Overall Study|Withdrawal by Subject|1|||
124634662|NCT02712320|448279081|FG000|Overall Study|Transferred to another facility|1|||
124819580|NCT00420927|448965767|FG006|Period 1|Withdrawal by Subject|0|||
124634663|NCT02712320|448279081|FG000|Overall Study|Treating with the prohibited medications|2|||
124634664|NCT00568451|448279082|FG000|Overall Study|Disease Progression|0|||
124634665|NCT00568451|448279083|FG001|Overall Study|Disease Progression|0|||
124634666|NCT00568451|448279084|FG002|Overall Study|Disease Progression|2|||
124634667|NCT00568451|448279085|FG003|Overall Study|Disease Progression|7|||
124634668|NCT05266053|448279088|FG000|Overall Study|Withdrawal by Subject|8|||
124634669|NCT05266053|448279089|FG001|Overall Study|Withdrawal by Subject|4|||
124634670|NCT05344560|448279090|FG000|Period 1|Subject out of visit window|1|||
124634671|NCT05344560|448279091|FG001|Period 1|Subject out of visit window|1|||
124634672|NCT05344560|448279090|FG000|Period 2|Covid-19 Related|1|||
124634673|NCT05344560|448279091|FG001|Period 2|Covid-19 Related|0|||
124634674|NCT05344560|448279090|FG000|Period 2|Adverse Event|1|||
124634675|NCT05344560|448279091|FG001|Period 2|Adverse Event|0|||
124634676|NCT05344560|448279090|FG000|Period 2|Subject out of visit window|1|||
124634677|NCT05344560|448279091|FG001|Period 2|Subject out of visit window|1|||
124634678|NCT05344560|448279090|FG000|Period 3|Subject out of visit window|1|||
124634679|NCT05344560|448279091|FG001|Period 3|Subject out of visit window|0|||
124634680|NCT01343043|448279094|FG000|Overall Study|Disease progression before treatment|1|||
124634681|NCT01343043|448279095|FG001|Overall Study|Disease progression before treatment|0|||
124634682|NCT01343043|448279096|FG002|Overall Study|Disease progression before treatment|0|||
124634683|NCT01343043|448279097|FG003|Overall Study|Disease progression before treatment|0|||
124634684|NCT01343043|448279094|FG000|Overall Study|Withdrawal by Subject|1|||
124634685|NCT01343043|448279095|FG001|Overall Study|Withdrawal by Subject|0|||
124634686|NCT01343043|448279096|FG002|Overall Study|Withdrawal by Subject|0|||
124634687|NCT01343043|448279097|FG003|Overall Study|Withdrawal by Subject|0|||
124634688|NCT01343043|448279094|FG000|Overall Study|Death|1|||
124634689|NCT01343043|448279095|FG001|Overall Study|Death|1|||
124634690|NCT01343043|448279096|FG002|Overall Study|Death|0|||
124634691|NCT01343043|448279097|FG003|Overall Study|Death|1|||
124634692|NCT00360282|448279098|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
124634693|NCT00360282|448279099|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
124634694|NCT00360282|448279100|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
124634695|NCT00360282|448279101|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
124634696|NCT00360282|448279098|FG000|Second Intervention|Adverse Event|0|||
124634697|NCT00360282|448279099|FG001|Second Intervention|Adverse Event|1|||
124634698|NCT00360282|448279100|FG002|Second Intervention|Adverse Event|0|||
124634699|NCT00360282|448279101|FG003|Second Intervention|Adverse Event|0|||
124634700|NCT00925704|448279102|FG000|First Intervention|Withdrew consent|0|||
124634701|NCT00925704|448279103|FG001|First Intervention|Withdrew consent|0|||
124634702|NCT00925704|448279104|FG002|First Intervention|Withdrew consent|0|||
124634703|NCT00925704|448279105|FG003|First Intervention|Withdrew consent|1|||
124634704|NCT00925704|448279106|FG004|First Intervention|Withdrew consent|1|||
124634705|NCT00925704|448279107|FG005|First Intervention|Withdrew consent|0|||
124634706|NCT00925704|448279102|FG000|Second Intervention|Withdrawal by Subject|1|||
124634707|NCT00925704|448279103|FG001|Second Intervention|Withdrawal by Subject|0|||
124634708|NCT00925704|448279104|FG002|Second Intervention|Withdrawal by Subject|0|||
124634709|NCT00925704|448279105|FG003|Second Intervention|Withdrawal by Subject|0|||
124634710|NCT00925704|448279106|FG004|Second Intervention|Withdrawal by Subject|1|||
124634711|NCT00925704|448279107|FG005|Second Intervention|Withdrawal by Subject|0|||
124634712|NCT00925704|448279102|FG000|Third Intervention|Withdrew consent|0|||
124634713|NCT00925704|448279103|FG001|Third Intervention|Withdrew consent|0|||
124634714|NCT00925704|448279104|FG002|Third Intervention|Withdrew consent|0|||
124634715|NCT00925704|448279105|FG003|Third Intervention|Withdrew consent|0|||
124634716|NCT00925704|448279106|FG004|Third Intervention|Withdrew consent|0|||
124634717|NCT00925704|448279107|FG005|Third Intervention|Withdrew consent|1|||
124634718|NCT02996968|448279108|FG000|Overall Study|Withdrawal by Subject|1|||
124634719|NCT02996968|448279109|FG001|Overall Study|Withdrawal by Subject|0|||
124634720|NCT02044302|448279113|FG000|Overall Study|study terminated|2|||
124634721|NCT02044302|448279114|FG001|Overall Study|study terminated|0|||
124634722|NCT00449865|448279119|FG000|Overall Study|Withdrawal by Subject|110|||
124634723|NCT00449865|448279120|FG001|Overall Study|Withdrawal by Subject|110|||
124634724|NCT00449865|448279119|FG000|Overall Study|Lost to Follow-up|36|||
124634725|NCT00449865|448279120|FG001|Overall Study|Lost to Follow-up|37|||
124634726|NCT00449865|448279119|FG000|Overall Study|Physician Decision|13|||
124634727|NCT00449865|448279120|FG001|Overall Study|Physician Decision|12|||
124634728|NCT00449865|448279119|FG000|Overall Study|Death|31|||
124634729|NCT00449865|448279120|FG001|Overall Study|Death|40|||
124634730|NCT00449865|448279119|FG000|Overall Study|Protocol Violation|8|||
124634731|NCT00449865|448279120|FG001|Overall Study|Protocol Violation|7|||
124634732|NCT00449865|448279119|FG000|Overall Study|Study was stopped|324|||
124634733|NCT00449865|448279120|FG001|Overall Study|Study was stopped|328|||
124634734|NCT00444535|448279121|FG000|Overall Study|Withdrawal by Subject|5|||
124634735|NCT00444535|448279121|FG000|Overall Study|Physician Decision|5|||
124634736|NCT00444535|448279121|FG000|Overall Study|progressive disease|1|||
124634737|NCT00444535|448279121|FG000|Overall Study|Adverse Event|2|||
124634738|NCT00406367|448279122|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
124634739|NCT00406367|448279123|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
124634740|NCT00406367|448279122|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
124634741|NCT00406367|448279123|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
124634742|NCT00406367|448279122|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
124634743|NCT00406367|448279123|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
124634744|NCT00406367|448279122|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
124634745|NCT00406367|448279123|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
124634746|NCT00406367|448279122|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
124634747|NCT00406367|448279123|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
124634748|NCT00406367|448279122|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
124634749|NCT00406367|448279123|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
124634750|NCT00406367|448279122|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
124634751|NCT00406367|448279123|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
124634752|NCT00406367|448279122|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
124634753|NCT00406367|448279123|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
124634754|NCT00406367|448279122|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
124634755|NCT00406367|448279123|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
124634756|NCT00406367|448279122|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
124634757|NCT00406367|448279123|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
124634758|NCT00406367|448279122|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
124634759|NCT00406367|448279123|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
124634760|NCT00406367|448279122|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
124634761|NCT00406367|448279123|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
124634762|NCT00171210|448279124|FG000|Overall Study|Adverse Event|16|||
124634763|NCT00171210|448279125|FG001|Overall Study|Adverse Event|27|||
124634764|NCT00171210|448279124|FG000|Overall Study|Abnormal laboratory value(s)|6|||
124634765|NCT00171210|448279125|FG001|Overall Study|Abnormal laboratory value(s)|3|||
124634766|NCT00171210|448279124|FG000|Overall Study|Abnormal test procedure result(s)|0|||
124634767|NCT00171210|448279125|FG001|Overall Study|Abnormal test procedure result(s)|1|||
124634768|NCT00171210|448279124|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
124634769|NCT00171210|448279125|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
124634770|NCT00171210|448279124|FG000|Overall Study|Protocol Violation|0|||
124634771|NCT00171210|448279125|FG001|Overall Study|Protocol Violation|2|||
124634772|NCT00171210|448279124|FG000|Overall Study|Withdrawal by Subject|32|||
124634773|NCT00171210|448279125|FG001|Overall Study|Withdrawal by Subject|30|||
124634774|NCT00171210|448279124|FG000|Overall Study|Lost to Follow-up|1|||
124634775|NCT00171210|448279125|FG001|Overall Study|Lost to Follow-up|0|||
124634776|NCT00171210|448279124|FG000|Overall Study|Administrative problems|1|||
124634777|NCT00171210|448279125|FG001|Overall Study|Administrative problems|1|||
124634778|NCT00171210|448279124|FG000|Overall Study|Death|2|||
124634779|NCT00171210|448279125|FG001|Overall Study|Death|3|||
124634780|NCT00171210|448279124|FG000|Overall Study|Stopped at end of core|0|||
124634781|NCT00171210|448279125|FG001|Overall Study|Stopped at end of core|32|||
124634782|NCT00171210|448279124|FG000|Overall Study|Stopped at end of extension 1|0|||
124634783|NCT00171210|448279125|FG001|Overall Study|Stopped at end of extension 1|1|||
124634784|NCT03187301|448279128|FG000|Titration Period|Adverse Event|0|||
124634785|NCT03187301|448279129|FG001|Titration Period|Adverse Event|0|||
124634786|NCT03187301|448279130|FG002|Titration Period|Adverse Event|0|||
124634787|NCT03187301|448279131|FG003|Titration Period|Adverse Event|0|||
124634788|NCT03187301|448279132|FG004|Titration Period|Adverse Event|0|||
124634789|NCT03187301|448279133|FG005|Titration Period|Adverse Event|0|||
124634790|NCT03187301|448279134|FG006|Titration Period|Adverse Event|5|||
124634791|NCT03187301|448279128|FG000|Titration Period|Withdrawal by Subject|0|||
124634792|NCT03187301|448279129|FG001|Titration Period|Withdrawal by Subject|0|||
124634793|NCT03187301|448279130|FG002|Titration Period|Withdrawal by Subject|0|||
124634794|NCT03187301|448279131|FG003|Titration Period|Withdrawal by Subject|0|||
124634795|NCT03187301|448279132|FG004|Titration Period|Withdrawal by Subject|0|||
124634796|NCT03187301|448279133|FG005|Titration Period|Withdrawal by Subject|0|||
124634797|NCT03187301|448279134|FG006|Titration Period|Withdrawal by Subject|1|||
124634798|NCT03187301|448279128|FG000|Titration Period|Exclusion Criteria Met|0|||
124634799|NCT03187301|448279129|FG001|Titration Period|Exclusion Criteria Met|0|||
124634800|NCT03187301|448279130|FG002|Titration Period|Exclusion Criteria Met|0|||
124634801|NCT03187301|448279131|FG003|Titration Period|Exclusion Criteria Met|0|||
124634802|NCT03187301|448279132|FG004|Titration Period|Exclusion Criteria Met|0|||
124634803|NCT03187301|448279133|FG005|Titration Period|Exclusion Criteria Met|0|||
124634804|NCT03187301|448279134|FG006|Titration Period|Exclusion Criteria Met|1|||
124634805|NCT03187301|448279128|FG000|Pre-Intervention|Withdrawal by Subject|1|||
124634806|NCT03187301|448279129|FG001|Pre-Intervention|Withdrawal by Subject|0|||
124634807|NCT03187301|448279130|FG002|Pre-Intervention|Withdrawal by Subject|0|||
124634808|NCT03187301|448279131|FG003|Pre-Intervention|Withdrawal by Subject|0|||
124634809|NCT03187301|448279132|FG004|Pre-Intervention|Withdrawal by Subject|0|||
124634810|NCT03187301|448279133|FG005|Pre-Intervention|Withdrawal by Subject|0|||
124634811|NCT03187301|448279134|FG006|Pre-Intervention|Withdrawal by Subject|0|||
124634812|NCT05005507|448279140|FG000|Overall Study|Premature termination of study|1|||
124634813|NCT00442897|448279146|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
124634814|NCT00442897|448279147|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
124634815|NCT00442897|448279146|FG000|Base Study (12 Week Follow-up)|Death|0|||
124634816|NCT00442897|448279147|FG001|Base Study (12 Week Follow-up)|Death|1|||
124634817|NCT00442897|448279146|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
124634818|NCT00442897|448279147|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
124634819|NCT00442897|448279146|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
124634820|NCT00442897|448279147|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
124634821|NCT00442897|448279146|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
124634822|NCT00442897|448279147|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
124634823|NCT00442897|448279146|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
124634824|NCT00442897|448279147|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
124634825|NCT00442897|448279146|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
124634826|NCT00442897|448279147|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
124634827|NCT00442897|448279146|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
124634828|NCT00442897|448279147|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
124634829|NCT04498182|448279148|FG000|Overall Study|Adverse Event|2|||
124634830|NCT04498182|448279149|FG001|Overall Study|Adverse Event|3|||
124634831|NCT04498182|448279150|FG002|Overall Study|Adverse Event|2|||
124634832|NCT04498182|448279148|FG000|Overall Study|Withdrawal of Consent|3|||
124634833|NCT04498182|448279149|FG001|Overall Study|Withdrawal of Consent|4|||
124634834|NCT04498182|448279150|FG002|Overall Study|Withdrawal of Consent|3|||
124634835|NCT04498182|448279148|FG000|Overall Study|Non-Compliant|1|||
124634836|NCT04498182|448279149|FG001|Overall Study|Non-Compliant|0|||
124634837|NCT04498182|448279150|FG002|Overall Study|Non-Compliant|1|||
124634838|NCT04498182|448279148|FG000|Overall Study|Lost to Follow-up|0|||
124634839|NCT04498182|448279149|FG001|Overall Study|Lost to Follow-up|0|||
124634840|NCT04498182|448279150|FG002|Overall Study|Lost to Follow-up|1|||
124634841|NCT04498182|448279148|FG000|Overall Study|Investigator Decision|0|||
124634842|NCT04498182|448279149|FG001|Overall Study|Investigator Decision|0|||
124634843|NCT04498182|448279150|FG002|Overall Study|Investigator Decision|1|||
124634844|NCT04498182|448279148|FG000|Overall Study|Protocol Violation|1|||
124634845|NCT04498182|448279149|FG001|Overall Study|Protocol Violation|0|||
124634846|NCT04498182|448279150|FG002|Overall Study|Protocol Violation|2|||
124634847|NCT02275819|448279152|FG000|Overall Study|Adverse Event|0|||
124634848|NCT02275819|448279153|FG001|Overall Study|Adverse Event|1|||
124634849|NCT01346059|448279154|FG000|Overall Study|Withdrawal by Subject|1|||
124634850|NCT01346059|448279155|FG001|Overall Study|Withdrawal by Subject|0|||
124634851|NCT02556775|448279156|FG000|Overall Study|Withdrawal by Subject|1|||
124634852|NCT02556775|448279157|FG001|Overall Study|Withdrawal by Subject|0|||
124634853|NCT02556775|448279158|FG002|Overall Study|Withdrawal by Subject|1|||
124634854|NCT02556775|448279159|FG003|Overall Study|Withdrawal by Subject|0|||
124634855|NCT02556775|448279156|FG000|Overall Study|Lost to Follow-up|1|||
124634856|NCT02556775|448279157|FG001|Overall Study|Lost to Follow-up|0|||
124634857|NCT02556775|448279158|FG002|Overall Study|Lost to Follow-up|0|||
124634858|NCT02556775|448279159|FG003|Overall Study|Lost to Follow-up|0|||
124634859|NCT00558467|448279165|FG000|Overall Study|Adverse Event|1|||
124634860|NCT00558467|448279166|FG001|Overall Study|Adverse Event|2|||
124634861|NCT00558467|448279165|FG000|Overall Study|Lack of Efficacy|0|||
124634862|NCT00558467|448279166|FG001|Overall Study|Lack of Efficacy|1|||
124812166|NCT01798004|448942575|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
124812167|NCT01798004|448942575|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
124812168|NCT03539081|448942583|FG000|Overall Study|Withdrawal by Subject|2|||
124812169|NCT03539081|448942584|FG001|Overall Study|Withdrawal by Subject|3|||
124634863|NCT00558467|448279165|FG000|Overall Study|Patient moving out of state|0|||
124634864|NCT00558467|448279166|FG001|Overall Study|Patient moving out of state|1|||
124812170|NCT03539081|448942585|FG002|Overall Study|Withdrawal by Subject|0|||
124812171|NCT03539081|448942583|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
124812172|NCT03539081|448942584|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
124634865|NCT02025725|448279175|FG000|Overall Study|Adverse Event|5|||
124634866|NCT02025725|448279176|FG001|Overall Study|Adverse Event|0|||
124634867|NCT02025725|448279175|FG000|Overall Study|Lost to Follow-up|2|||
124634868|NCT02025725|448279176|FG001|Overall Study|Lost to Follow-up|0|||
124812173|NCT03539081|448942585|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
124812174|NCT01673867|448942589|FG000|Randomization|Adverse event unrelated to study drug|1|||
124819581|NCT00420927|448965761|FG000|Period 1|Lost to Follow-up|8|||
124634869|NCT02025725|448279175|FG000|Overall Study|Protocol Violation|1|||
124634870|NCT02025725|448279176|FG001|Overall Study|Protocol Violation|1|||
124634871|NCT02025725|448279175|FG000|Overall Study|Withdrawal by Subject|3|||
124634872|NCT02025725|448279176|FG001|Overall Study|Withdrawal by Subject|2|||
124634873|NCT02025725|448279175|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
124634874|NCT02025725|448279176|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
124634875|NCT03331796|448279177|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
124634876|NCT03331796|448279178|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
124634877|NCT03331796|448279179|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
124634878|NCT03331796|448279177|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
124634879|NCT03331796|448279178|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
124634880|NCT03331796|448279179|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
124634881|NCT03331796|448279177|FG000|Extended Follow-up|Adverse Event|1|||
124634882|NCT03331796|448279178|FG001|Extended Follow-up|Adverse Event|0|||
124634883|NCT03331796|448279179|FG002|Extended Follow-up|Adverse Event|1|||
124634884|NCT03331796|448279177|FG000|Extended Follow-up|Lost to Follow-up|0|||
124634885|NCT03331796|448279178|FG001|Extended Follow-up|Lost to Follow-up|0|||
124634886|NCT03331796|448279179|FG002|Extended Follow-up|Lost to Follow-up|1|||
124634887|NCT03331796|448279177|FG000|Extended Follow-up|Withdrawal by Subject|1|||
124634888|NCT03331796|448279178|FG001|Extended Follow-up|Withdrawal by Subject|0|||
124634889|NCT03331796|448279179|FG002|Extended Follow-up|Withdrawal by Subject|0|||
124634890|NCT03331796|448279177|FG000|Extended Follow-up|Termination of Funding|0|||
124634891|NCT03331796|448279178|FG001|Extended Follow-up|Termination of Funding|1|||
124634892|NCT03331796|448279179|FG002|Extended Follow-up|Termination of Funding|0|||
124634893|NCT00594165|448279180|FG000|Overall Study|Major protocol violation|1|||
124634894|NCT00594165|448279180|FG000|Overall Study|Lack of Efficacy|12|||
124634895|NCT00594165|448279180|FG000|Overall Study|Adverse Event|52|||
124634896|NCT00594165|448279180|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
124634897|NCT00594165|448279180|FG000|Overall Study|Subject withdrew consent|27|||
124634898|NCT00594165|448279180|FG000|Overall Study|Study ended per sponsor|102|||
124634899|NCT00594165|448279180|FG000|Overall Study|Lost to Follow-up|4|||
124634900|NCT00594165|448279180|FG000|Overall Study|Other: PI discretion|5|||
124634901|NCT00594165|448279180|FG000|Overall Study|Other: Subject moving|3|||
124634902|NCT00594165|448279180|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
124634903|NCT00594165|448279180|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
124634904|NCT00594165|448279180|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
124634905|NCT00594165|448279180|FG000|Overall Study|Other: Site terminated participation|2|||
124634906|NCT00571727|448279183|FG000|Overall Study|Did not enter in this study|1|||
124634907|NCT00571727|448279183|FG000|Overall Study|Non-compliance|4|||
124634908|NCT00571727|448279183|FG000|Overall Study|Lost to Follow-up|30|||
124634909|NCT00571727|448279183|FG000|Overall Study|Poor growth|1|||
124634910|NCT00571727|448279183|FG000|Overall Study|Parent/patient decision|2|||
124634911|NCT00571727|448279183|FG000|Overall Study|Participant transferred to commercial drug|14|||
124634912|NCT00571727|448279183|FG000|Overall Study|Unable to provide study drug|6|||
124634913|NCT00571727|448279183|FG000|Overall Study|On-treatment at end of study|8|||
124634914|NCT01735916|448281374|FG000|Overall Study|Subject not eligible to be randomized|11|||
124634915|NCT01735916|448281375|FG001|Overall Study|Subject not eligible to be randomized|0|||
124634916|NCT01735916|448281376|FG002|Overall Study|Subject not eligible to be randomized|0|||
124634917|NCT01735916|448281374|FG000|Overall Study|Early termination of study by sponsor|4|||
124634918|NCT01735916|448281375|FG001|Overall Study|Early termination of study by sponsor|19|||
124634919|NCT01735916|448281376|FG002|Overall Study|Early termination of study by sponsor|7|||
124634920|NCT01735916|448281374|FG000|Overall Study|Withdrawal by Subject|3|||
124634921|NCT01735916|448281375|FG001|Overall Study|Withdrawal by Subject|0|||
124634922|NCT01735916|448281376|FG002|Overall Study|Withdrawal by Subject|0|||
124634923|NCT04227197|448281377|FG000|Randomization|Protocol Violation|1|||
124634924|NCT04227197|448281378|FG001|Randomization|Protocol Violation|0|||
124634925|NCT04227197|448281377|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
124634926|NCT04227197|448281378|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
124634927|NCT04227197|448281377|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
124634928|NCT04227197|448281378|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
124634929|NCT04227197|448281377|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
124634930|NCT04227197|448281378|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
124634931|NCT04227197|448281377|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
124634932|NCT04227197|448281378|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
124634933|NCT04227197|448281377|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
124634934|NCT04227197|448281378|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
124634935|NCT04227197|448281377|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
124634936|NCT04227197|448281378|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
124634937|NCT03656068|448281379|FG000|Overall Study|Withdrawal by Subject|4|||
124634938|NCT03656068|448281379|FG000|Overall Study|Adverse Event|1|||
124634939|NCT00162981|448281380|FG000|Overall Study|Adverse Event|2|||
124634940|NCT00162981|448281381|FG001|Overall Study|Adverse Event|5|||
124634941|NCT00162981|448281380|FG000|Overall Study|Withdrawal by Subject|1|||
124634942|NCT00162981|448281381|FG001|Overall Study|Withdrawal by Subject|1|||
124634943|NCT00162981|448281380|FG000|Overall Study|Physician Decision|1|||
124634944|NCT00162981|448281381|FG001|Overall Study|Physician Decision|0|||
124634945|NCT00455403|448281388|FG000|Overall Study|Lost to Follow-up|2|||
124634946|NCT00455403|448281389|FG001|Overall Study|Lost to Follow-up|1|||
124634947|NCT00455403|448281388|FG000|Overall Study|Withdrawal by Subject|1|||
124634948|NCT00455403|448281389|FG001|Overall Study|Withdrawal by Subject|3|||
124634949|NCT00455403|448281388|FG000|Overall Study|Protocol Violation|0|||
124634950|NCT00455403|448281389|FG001|Overall Study|Protocol Violation|2|||
124634951|NCT00350207|448281390|FG000|Overall Study|Adverse Event|5|||
124634952|NCT00350207|448281391|FG001|Overall Study|Adverse Event|2|||
124634953|NCT00350207|448281392|FG002|Overall Study|Adverse Event|2|||
124634954|NCT00350207|448281390|FG000|Overall Study|Lack of Efficacy|1|||
124634955|NCT00350207|448281391|FG001|Overall Study|Lack of Efficacy|0|||
124634956|NCT00350207|448281392|FG002|Overall Study|Lack of Efficacy|2|||
124634957|NCT00350207|448281390|FG000|Overall Study|Lost to Follow-up|1|||
124634958|NCT00350207|448281391|FG001|Overall Study|Lost to Follow-up|0|||
124634959|NCT00350207|448281392|FG002|Overall Study|Lost to Follow-up|1|||
124634960|NCT00350207|448281390|FG000|Overall Study|Withdrawal by Subject|0|||
124634961|NCT00350207|448281391|FG001|Overall Study|Withdrawal by Subject|1|||
124634962|NCT00350207|448281392|FG002|Overall Study|Withdrawal by Subject|1|||
124812175|NCT01673867|448942590|FG001|Randomization|Adverse event unrelated to study drug|0|||
124812176|NCT01673867|448942589|FG000|Randomization|Participant request to discontinue study treatment|0|||
124812177|NCT01673867|448942590|FG001|Randomization|Participant request to discontinue study treatment|4|||
124812178|NCT01673867|448942589|FG000|Randomization|Withdrawal by participant|0|||
124812179|NCT01673867|448942590|FG001|Randomization|Withdrawal by participant|12|||
124812180|NCT01673867|448942589|FG000|Randomization|Lost to Follow-up|0|||
124812181|NCT01673867|448942590|FG001|Randomization|Lost to Follow-up|1|||
124634963|NCT00350207|448281390|FG000|Overall Study|Other|1|||
124634964|NCT00350207|448281391|FG001|Overall Study|Other|3|||
124634965|NCT00350207|448281392|FG002|Overall Study|Other|1|||
124634966|NCT00495391|448281393|FG000|Overall Study|Lack of Efficacy|34|||
124634967|NCT00495391|448281394|FG001|Overall Study|Lack of Efficacy|18|||
124634968|NCT00495391|448281393|FG000|Overall Study|Withdrawal by Subject|2|||
124634969|NCT00495391|448281394|FG001|Overall Study|Withdrawal by Subject|3|||
124634970|NCT00502242|448281406|FG000|Overall Study|Lack of Efficacy|1|||
124634971|NCT00502242|448281407|FG001|Overall Study|Lack of Efficacy|11|||
124634972|NCT00502242|448281406|FG000|Overall Study|Adverse Event|31|||
124634973|NCT00502242|448281407|FG001|Overall Study|Adverse Event|20|||
124634974|NCT00502242|448281406|FG000|Overall Study|Physician Decision|2|||
124634975|NCT00502242|448281407|FG001|Overall Study|Physician Decision|3|||
124634976|NCT00502242|448281406|FG000|Overall Study|Other - Unspecified|8|||
124634977|NCT00502242|448281407|FG001|Overall Study|Other - Unspecified|14|||
124634978|NCT00502242|448281406|FG000|Overall Study|Protocol Violation|3|||
124634979|NCT00502242|448281407|FG001|Overall Study|Protocol Violation|1|||
124634980|NCT00502242|448281406|FG000|Overall Study|Withdrawal by Subject|6|||
124634981|NCT00502242|448281407|FG001|Overall Study|Withdrawal by Subject|7|||
124634982|NCT03207815|448281408|FG000|Overall Study|Protocol Violation|3|||
124634983|NCT03207815|448281409|FG001|Overall Study|Protocol Violation|1|||
124634984|NCT03207815|448281408|FG000|Overall Study|Adverse Event|1|||
124634985|NCT03207815|448281409|FG001|Overall Study|Adverse Event|2|||
124634986|NCT03207815|448281408|FG000|Overall Study|Lost to Follow-up|1|||
124634987|NCT03207815|448281409|FG001|Overall Study|Lost to Follow-up|2|||
124634988|NCT03207815|448281408|FG000|Overall Study|Investigator's Discretion|1|||
124634989|NCT03207815|448281409|FG001|Overall Study|Investigator's Discretion|1|||
124634990|NCT03207815|448281408|FG000|Overall Study|Lack of Efficacy|0|||
124634991|NCT03207815|448281409|FG001|Overall Study|Lack of Efficacy|1|||
124634992|NCT03207815|448281408|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
124634993|NCT03207815|448281409|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
124634994|NCT03207815|448281408|FG000|Overall Study|Withdrew Consent|1|||
124634995|NCT03207815|448281409|FG001|Overall Study|Withdrew Consent|0|||
124634996|NCT01671007|448281410|FG000|Overall Study|Other reasons than listed|166|||
124634997|NCT01671007|448281411|FG001|Overall Study|Other reasons than listed|373|||
124634998|NCT01671007|448281412|FG002|Overall Study|Other reasons than listed|197|||
124634999|NCT01671007|448281413|FG003|Overall Study|Other reasons than listed|228|||
124812182|NCT01673867|448942589|FG000|Randomization|Participant no longer meets study criteria|4|||
124819582|NCT00420927|448965762|FG001|Period 1|Lost to Follow-up|6|||
124635000|NCT01671007|448281414|FG004|Overall Study|Other reasons than listed|14|||
124635001|NCT01671007|448281415|FG005|Overall Study|Other reasons than listed|71|||
124635002|NCT01671007|448281416|FG006|Overall Study|Other reasons than listed|17|||
124635003|NCT01671007|448281417|FG007|Overall Study|Other reasons than listed|66|||
124635004|NCT01671007|448281418|FG008|Overall Study|Other reasons than listed|0|||
124635005|NCT01671007|448281410|FG000|Overall Study|Withdrawal by Subject|36|||
124635006|NCT01671007|448281411|FG001|Overall Study|Withdrawal by Subject|59|||
124635007|NCT01671007|448281412|FG002|Overall Study|Withdrawal by Subject|53|||
124635008|NCT01671007|448281413|FG003|Overall Study|Withdrawal by Subject|58|||
124635009|NCT01671007|448281414|FG004|Overall Study|Withdrawal by Subject|4|||
124635010|NCT01671007|448281415|FG005|Overall Study|Withdrawal by Subject|15|||
124635011|NCT01671007|448281416|FG006|Overall Study|Withdrawal by Subject|1|||
124635012|NCT01671007|448281417|FG007|Overall Study|Withdrawal by Subject|19|||
124635013|NCT01671007|448281418|FG008|Overall Study|Withdrawal by Subject|0|||
124635014|NCT01671007|448281410|FG000|Overall Study|Lost to Follow-up|93|||
124635015|NCT01671007|448281411|FG001|Overall Study|Lost to Follow-up|142|||
124635016|NCT01671007|448281412|FG002|Overall Study|Lost to Follow-up|91|||
124635017|NCT01671007|448281413|FG003|Overall Study|Lost to Follow-up|63|||
124635018|NCT01671007|448281414|FG004|Overall Study|Lost to Follow-up|7|||
124635019|NCT01671007|448281415|FG005|Overall Study|Lost to Follow-up|20|||
124635020|NCT01671007|448281416|FG006|Overall Study|Lost to Follow-up|2|||
124635021|NCT01671007|448281417|FG007|Overall Study|Lost to Follow-up|28|||
124635022|NCT01671007|448281418|FG008|Overall Study|Lost to Follow-up|0|||
124635023|NCT01671007|448281410|FG000|Overall Study|No end of study case report form|3|||
124635024|NCT01671007|448281411|FG001|Overall Study|No end of study case report form|1|||
124635025|NCT01671007|448281412|FG002|Overall Study|No end of study case report form|0|||
124635026|NCT01671007|448281413|FG003|Overall Study|No end of study case report form|2|||
124635027|NCT01671007|448281414|FG004|Overall Study|No end of study case report form|0|||
124635028|NCT01671007|448281415|FG005|Overall Study|No end of study case report form|0|||
124635029|NCT01671007|448281416|FG006|Overall Study|No end of study case report form|0|||
124635030|NCT01671007|448281417|FG007|Overall Study|No end of study case report form|0|||
124635031|NCT01671007|448281418|FG008|Overall Study|No end of study case report form|0|||
124635032|NCT01671007|448281410|FG000|Overall Study|Not eligible|23|||
124635033|NCT01671007|448281411|FG001|Overall Study|Not eligible|76|||
124635034|NCT01671007|448281412|FG002|Overall Study|Not eligible|25|||
124635035|NCT01671007|448281413|FG003|Overall Study|Not eligible|17|||
124635036|NCT01671007|448281414|FG004|Overall Study|Not eligible|0|||
124635037|NCT01671007|448281415|FG005|Overall Study|Not eligible|6|||
124635038|NCT01671007|448281416|FG006|Overall Study|Not eligible|1|||
124635039|NCT01671007|448281417|FG007|Overall Study|Not eligible|19|||
124635040|NCT01671007|448281418|FG008|Overall Study|Not eligible|0|||
124635041|NCT00391768|448281419|FG000|Overall Study|Withdrawal by Subject|0|||
124635042|NCT00391768|448281420|FG001|Overall Study|Withdrawal by Subject|0|||
124635043|NCT00391768|448281421|FG002|Overall Study|Withdrawal by Subject|1|||
124635044|NCT00391768|448281422|FG003|Overall Study|Withdrawal by Subject|0|||
124635045|NCT00391768|448281423|FG004|Overall Study|Withdrawal by Subject|0|||
124635046|NCT00391768|448281424|FG005|Overall Study|Withdrawal by Subject|1|||
124635047|NCT00391768|448281425|FG006|Overall Study|Withdrawal by Subject|1|||
124635048|NCT00391768|448281419|FG000|Overall Study|Lost to Follow-up|0|||
124635049|NCT00391768|448281420|FG001|Overall Study|Lost to Follow-up|0|||
124635050|NCT00391768|448281421|FG002|Overall Study|Lost to Follow-up|0|||
124635051|NCT00391768|448281422|FG003|Overall Study|Lost to Follow-up|1|||
124635052|NCT00391768|448281423|FG004|Overall Study|Lost to Follow-up|2|||
124635053|NCT00391768|448281424|FG005|Overall Study|Lost to Follow-up|2|||
124635054|NCT00391768|448281425|FG006|Overall Study|Lost to Follow-up|3|||
124635055|NCT04630002|448281426|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
124635056|NCT04630002|448281427|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
124635057|NCT04630002|448281428|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
124635058|NCT04630002|448281426|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
124635059|NCT04630002|448281427|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
124635060|NCT04630002|448281428|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
124635061|NCT04630002|448281426|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
124635062|NCT04630002|448281427|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
124635063|NCT04630002|448281428|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
124635064|NCT04630002|448281426|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
124812183|NCT01673867|448942590|FG001|Randomization|Participant no longer meets study criteria|5|||
124812184|NCT01673867|448942589|FG000|Treatment|Disease Progression|208|||
124812185|NCT01673867|448942590|FG001|Treatment|Disease Progression|178|||
124812186|NCT01673867|448942589|FG000|Treatment|Study Drug Toxicity|23|||
124812187|NCT01673867|448942590|FG001|Treatment|Study Drug Toxicity|43|||
124812188|NCT01673867|448942589|FG000|Treatment|Death|2|||
124812189|NCT01673867|448942590|FG001|Treatment|Death|3|||
124812190|NCT01673867|448942589|FG000|Treatment|Adverse event unrelated to study drug|23|||
124635065|NCT04630002|448281427|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
124635066|NCT04630002|448281428|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
124635067|NCT04630002|448281426|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
124635068|NCT04630002|448281427|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
124635069|NCT04630002|448281428|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
124635070|NCT04630002|448281426|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
124635071|NCT04630002|448281427|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
124635072|NCT04630002|448281428|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
124635073|NCT04630002|448281426|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
124635074|NCT04630002|448281427|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
124635075|NCT04630002|448281428|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
124635076|NCT04630002|448281426|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
124812191|NCT01673867|448942590|FG001|Treatment|Adverse event unrelated to study drug|10|||
124812192|NCT01673867|448942589|FG000|Treatment|Participant request to discontinue study treatment|7|||
124635077|NCT04630002|448281427|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
124635078|NCT04630002|448281428|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
124635079|NCT02182843|448281429|FG000|Overall Study|Withdrawal by Subject|7|||
124635080|NCT02182843|448281429|FG000|Overall Study|Lost to Follow-up|2|||
124635081|NCT02182843|448281429|FG000|Overall Study|Adverse Event|1|||
124635082|NCT02375971|448281431|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
124635083|NCT02375971|448281432|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
124635084|NCT02375971|448281433|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
124635085|NCT02375971|448281431|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
124635086|NCT02375971|448281432|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
124635087|NCT02375971|448281433|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
124635088|NCT02375971|448281431|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
124635089|NCT02375971|448281432|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
124635090|NCT02375971|448281433|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
124635091|NCT02375971|448281431|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
124635092|NCT02375971|448281432|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
124635093|NCT02375971|448281433|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
124635094|NCT02375971|448281431|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
124635095|NCT02375971|448281432|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
124635096|NCT02375971|448281433|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
124635097|NCT02375971|448281431|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
124635098|NCT02375971|448281432|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
124635099|NCT02375971|448281433|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
124635100|NCT02375971|448281431|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
124635101|NCT02375971|448281432|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
124635102|NCT02375971|448281433|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
124635103|NCT02375971|448281431|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
124635104|NCT02375971|448281432|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
124635105|NCT02375971|448281433|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
124635106|NCT00891020|448281434|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
124635107|NCT00891020|448281435|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
124812193|NCT01673867|448942590|FG001|Treatment|Participant request to discontinue study treatment|17|||
124812194|NCT01673867|448942589|FG000|Treatment|Withdrawal by participant|5|||
124812195|NCT01673867|448942590|FG001|Treatment|Withdrawal by participant|5|||
124812196|NCT01673867|448942589|FG000|Treatment|Maximum clinical benefit|1|||
124812197|NCT01673867|448942590|FG001|Treatment|Maximum clinical benefit|10|||
124812198|NCT01673867|448942589|FG000|Treatment|Participant no longer meets study criteria|2|||
124812199|NCT01673867|448942590|FG001|Treatment|Participant no longer meets study criteria|0|||
124812200|NCT01673867|448942589|FG000|Treatment|Administrative reason by sponsor|3|||
124812201|NCT01673867|448942590|FG001|Treatment|Administrative reason by sponsor|0|||
124812202|NCT01673867|448942589|FG000|Treatment|Other reason|11|||
124635108|NCT00891020|448281436|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
124635109|NCT00891020|448281434|FG000|24 Week Treatment Period|Death|0|||
124635110|NCT00891020|448281435|FG001|24 Week Treatment Period|Death|2|||
124635111|NCT00891020|448281436|FG002|24 Week Treatment Period|Death|0|||
124635112|NCT00891020|448281434|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
124635113|NCT00891020|448281435|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
124635114|NCT00891020|448281436|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
124635115|NCT00891020|448281434|FG000|24 Week Treatment Period|Failure to return|4|||
124635116|NCT00891020|448281435|FG001|24 Week Treatment Period|Failure to return|5|||
124635117|NCT00891020|448281436|FG002|24 Week Treatment Period|Failure to return|5|||
124635118|NCT00891020|448281434|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
124635119|NCT00891020|448281435|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
124635120|NCT00891020|448281436|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
124635121|NCT00891020|448281434|FG000|24 Week Treatment Period|Other protocol violation|1|||
124635122|NCT00891020|448281435|FG001|24 Week Treatment Period|Other protocol violation|1|||
124635123|NCT00891020|448281436|FG002|24 Week Treatment Period|Other protocol violation|2|||
124635124|NCT00891020|448281434|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
124635125|NCT00891020|448281435|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
124635126|NCT00891020|448281436|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
124635127|NCT00891020|448281434|FG000|24 Week Treatment Period|Withdrew consent|6|||
124635128|NCT00891020|448281435|FG001|24 Week Treatment Period|Withdrew consent|3|||
124812203|NCT01673867|448942590|FG001|Treatment|Other reason|2|||
124812204|NCT02550106|448942593|FG000|Overall Study|Adverse Event|1|||
124635129|NCT00891020|448281436|FG002|24 Week Treatment Period|Withdrew consent|15|||
124635130|NCT00891020|448281434|FG000|24 Week Treatment Period|Administrative/Other|5|||
124635131|NCT00891020|448281435|FG001|24 Week Treatment Period|Administrative/Other|6|||
124635132|NCT00891020|448281436|FG002|24 Week Treatment Period|Administrative/Other|1|||
124812205|NCT02550106|448942593|FG000|Overall Study|Lack of Efficacy|3|||
124812206|NCT02550106|448942593|FG000|Overall Study|Protocol Violation|6|||
124635133|NCT00891020|448281434|FG000|Long-term Extension Period|Adverse Event|1|||
124635134|NCT00891020|448281435|FG001|Long-term Extension Period|Adverse Event|11|||
124635135|NCT00891020|448281436|FG002|Long-term Extension Period|Adverse Event|10|||
124635136|NCT00891020|448281434|FG000|Long-term Extension Period|Death|0|||
124635137|NCT00891020|448281435|FG001|Long-term Extension Period|Death|0|||
124635138|NCT00891020|448281436|FG002|Long-term Extension Period|Death|1|||
124635139|NCT00891020|448281434|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
124812207|NCT02550106|448942593|FG000|Overall Study|Withdrawal by Subject|2|||
124812208|NCT02195583|448942594|FG000|Overall Study|Lost to Follow-up|1|||
124812209|NCT02195583|448942594|FG000|Overall Study|Withdrawal by Subject|4|||
124812210|NCT02195583|448942594|FG000|Overall Study|Adverse Event|2|||
124812211|NCT02195583|448942594|FG000|Overall Study|Other Reason|2|||
124812212|NCT01709513|448942595|FG000|Overall Study|Randomized but not treated|0|||
124812213|NCT01709513|448942596|FG001|Overall Study|Randomized but not treated|1|||
124812214|NCT01709513|448942597|FG002|Overall Study|Randomized but not treated|0|||
124812215|NCT01709513|448942595|FG000|Overall Study|Adverse Event|16|||
124812216|NCT01709513|448942596|FG001|Overall Study|Adverse Event|31|||
124812217|NCT01709513|448942597|FG002|Overall Study|Adverse Event|23|||
124812218|NCT01709513|448942595|FG000|Overall Study|Poor compliance to protocol|2|||
124812219|NCT01709513|448942596|FG001|Overall Study|Poor compliance to protocol|0|||
124812220|NCT01709513|448942597|FG002|Overall Study|Poor compliance to protocol|0|||
124812221|NCT01709513|448942595|FG000|Overall Study|Other|3|||
124812222|NCT01709513|448942596|FG001|Overall Study|Other|11|||
124812223|NCT01709513|448942597|FG002|Overall Study|Other|7|||
124812224|NCT00926328|448942598|FG000|Overall Study|Lost to Follow-up|12|||
124812225|NCT00926328|448942599|FG001|Overall Study|Lost to Follow-up|14|||
124812226|NCT00289133|448942600|FG000|Overall Study|Non-study device implanted|12|||
124812227|NCT00289133|448942601|FG001|Overall Study|Non-study device implanted|0|||
124812228|NCT00289133|448942600|FG000|Overall Study|Protocol Violation|32|||
124635140|NCT00891020|448281435|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
124635141|NCT00891020|448281436|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
124635142|NCT00891020|448281434|FG000|Long-term Extension Period|Protocol Violation|0|||
124635143|NCT00891020|448281435|FG001|Long-term Extension Period|Protocol Violation|1|||
124635144|NCT00891020|448281436|FG002|Long-term Extension Period|Protocol Violation|1|||
124635145|NCT00891020|448281434|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
124635146|NCT00891020|448281435|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
124635147|NCT00891020|448281436|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
124635148|NCT00891020|448281434|FG000|Long-term Extension Period|Failure to return|0|||
124635149|NCT00891020|448281435|FG001|Long-term Extension Period|Failure to return|2|||
124635150|NCT00891020|448281436|FG002|Long-term Extension Period|Failure to return|3|||
124635151|NCT00891020|448281434|FG000|Long-term Extension Period|Administrative|1|||
124635152|NCT00891020|448281435|FG001|Long-term Extension Period|Administrative|2|||
124635153|NCT00891020|448281436|FG002|Long-term Extension Period|Administrative|2|||
124635154|NCT00320710|448281444|FG000|Overall Study|Disease progression|24|||
124635155|NCT00320710|448281445|FG001|Overall Study|Disease progression|19|||
124635156|NCT00320710|448281446|FG002|Overall Study|Disease progression|2|||
124635157|NCT00320710|448281444|FG000|Overall Study|Death|10|||
124635158|NCT00320710|448281445|FG001|Overall Study|Death|7|||
124635159|NCT00320710|448281446|FG002|Overall Study|Death|1|||
124635160|NCT00320710|448281444|FG000|Overall Study|Administrative problems|1|||
124635161|NCT00320710|448281445|FG001|Overall Study|Administrative problems|2|||
124635162|NCT00320710|448281446|FG002|Overall Study|Administrative problems|0|||
124635163|NCT00320710|448281444|FG000|Overall Study|Withdrawal by Subject|20|||
124635164|NCT00320710|448281445|FG001|Overall Study|Withdrawal by Subject|26|||
124635165|NCT00320710|448281446|FG002|Overall Study|Withdrawal by Subject|1|||
124635166|NCT00320710|448281444|FG000|Overall Study|Protocol Violation|6|||
124635167|NCT00320710|448281445|FG001|Overall Study|Protocol Violation|5|||
124635168|NCT00320710|448281446|FG002|Overall Study|Protocol Violation|0|||
124635169|NCT00320710|448281444|FG000|Overall Study|Abnormal test procedure result(s)|2|||
124635170|NCT00320710|448281445|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124635171|NCT00320710|448281446|FG002|Overall Study|Abnormal test procedure result(s)|0|||
124812229|NCT00289133|448942601|FG001|Overall Study|Protocol Violation|38|||
124812230|NCT00289133|448942600|FG000|Overall Study|Withdrawal by Subject|9|||
124812231|NCT00289133|448942601|FG001|Overall Study|Withdrawal by Subject|10|||
124635172|NCT00320710|448281444|FG000|Overall Study|Abnormal laboratory value(s)|12|||
124635173|NCT00320710|448281445|FG001|Overall Study|Abnormal laboratory value(s)|3|||
124635174|NCT00320710|448281446|FG002|Overall Study|Abnormal laboratory value(s)|0|||
124635175|NCT00320710|448281444|FG000|Overall Study|Adverse Event|18|||
124635176|NCT00320710|448281445|FG001|Overall Study|Adverse Event|14|||
124812232|NCT00289133|448942600|FG000|Overall Study|Death|5|||
124812233|NCT00289133|448942601|FG001|Overall Study|Death|10|||
124812234|NCT00289133|448942600|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
124812235|NCT00289133|448942601|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
124635177|NCT00320710|448281446|FG002|Overall Study|Adverse Event|1|||
124812236|NCT00289133|448942600|FG000|Overall Study|Physician Decision|41|||
124812237|NCT00289133|448942601|FG001|Overall Study|Physician Decision|45|||
124635178|NCT00320710|448281444|FG000|Overall Study|Lost to Follow-up|1|||
124635179|NCT00320710|448281445|FG001|Overall Study|Lost to Follow-up|0|||
124635180|NCT00320710|448281446|FG002|Overall Study|Lost to Follow-up|0|||
124635181|NCT03448419|448281447|FG000|Overall Study|Adverse Event|10|||
124635182|NCT03448419|448281448|FG001|Overall Study|Adverse Event|9|||
124635183|NCT03448419|448281447|FG000|Overall Study|Lost to Follow-up|0|||
124635184|NCT03448419|448281448|FG001|Overall Study|Lost to Follow-up|2|||
124635185|NCT03448419|448281447|FG000|Overall Study|Withdrawal by Subject|3|||
124635186|NCT03448419|448281448|FG001|Overall Study|Withdrawal by Subject|1|||
124635187|NCT03448419|448281447|FG000|Overall Study|Not treated|0|||
124635188|NCT03448419|448281448|FG001|Overall Study|Not treated|1|||
124635189|NCT03448419|448281447|FG000|Overall Study|Patient did not attend all visits|0|||
124635190|NCT03448419|448281448|FG001|Overall Study|Patient did not attend all visits|2|||
124635191|NCT03448419|448281447|FG000|Overall Study|Withdrawn by Sponsor|0|||
124635192|NCT03448419|448281448|FG001|Overall Study|Withdrawn by Sponsor|1|||
124635193|NCT00832455|448281449|FG000|Overall Study|Adverse Event|13|||
124635194|NCT00832455|448281449|FG000|Overall Study|Lost to Follow-up|26|||
124635195|NCT00832455|448281449|FG000|Overall Study|Protocol Violation|4|||
124635196|NCT00832455|448281449|FG000|Overall Study|Withdrawal by Subject|17|||
124635197|NCT00832455|448281449|FG000|Overall Study|Screening Failure|2|||
124635198|NCT00832455|448281449|FG000|Overall Study|Stopped Medication|4|||
124635199|NCT00832455|448281449|FG000|Overall Study|Parent misunderstood study|1|||
124635200|NCT00832455|448281449|FG000|Overall Study|Parent dissatisfied|1|||
124635201|NCT00832455|448281449|FG000|Overall Study|No improvement|3|||
124635202|NCT00832455|448281449|FG000|Overall Study|Patient moved|1|||
124635203|NCT05047211|448281451|FG000|Overall Study|Lost to Follow-up|8|||
124635204|NCT05047211|448281452|FG001|Overall Study|Lost to Follow-up|5|||
124635205|NCT00561392|448281453|FG000|Overall Study|Adverse Event|38|||
124635206|NCT00561392|448281453|FG000|Overall Study|Lack of Efficacy|2|||
124635207|NCT00561392|448281453|FG000|Overall Study|Protocol Violation|1|||
124635208|NCT00561392|448281453|FG000|Overall Study|Withdrawal by Subject|8|||
124635209|NCT00561392|448281453|FG000|Overall Study|Administrative problems|4|||
124635210|NCT01575834|448281454|FG000|Overall Study|Withdrawal by Subject|352|||
124635211|NCT01575834|448281455|FG001|Overall Study|Withdrawal by Subject|390|||
124635212|NCT01575834|448281454|FG000|Overall Study|Death|81|||
124635213|NCT01575834|448281455|FG001|Overall Study|Death|74|||
124635214|NCT01575834|448281454|FG000|Overall Study|Other|70|||
124635215|NCT01575834|448281455|FG001|Overall Study|Other|70|||
124635216|NCT01575834|448281454|FG000|Overall Study|Adverse Event|63|||
124635217|NCT01575834|448281455|FG001|Overall Study|Adverse Event|61|||
124635218|NCT01575834|448281454|FG000|Overall Study|Lost to Follow-up|55|||
124635219|NCT01575834|448281455|FG001|Overall Study|Lost to Follow-up|68|||
124635220|NCT01575834|448281454|FG000|Overall Study|Noncompliance|52|||
124635221|NCT01575834|448281455|FG001|Overall Study|Noncompliance|27|||
124635222|NCT01575834|448281454|FG000|Overall Study|Administrative decision|15|||
124635223|NCT01575834|448281455|FG001|Overall Study|Administrative decision|33|||
124635224|NCT01575834|448281454|FG000|Overall Study|Ineligibility Determined|5|||
124635225|NCT01575834|448281455|FG001|Overall Study|Ineligibility Determined|8|||
124635226|NCT01575834|448281454|FG000|Overall Study|Protocol Deviation|4|||
124635227|NCT01575834|448281455|FG001|Overall Study|Protocol Deviation|3|||
124635228|NCT01575834|448281454|FG000|Overall Study|Requirement for Alternative Therapy|2|||
124635229|NCT01575834|448281455|FG001|Overall Study|Requirement for Alternative Therapy|4|||
124635230|NCT02220764|448281462|FG000|Overall Study|Lost to Follow-up|3|||
124635231|NCT02220764|448281463|FG001|Overall Study|Lost to Follow-up|1|||
124635232|NCT02220764|448281462|FG000|Overall Study|Death|1|||
124635233|NCT02220764|448281463|FG001|Overall Study|Death|0|||
124635234|NCT05000164|448281464|FG000|Overall Study|Adverse Event|1|||
124635235|NCT05000164|448281464|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
124635236|NCT05000164|448281464|FG000|Overall Study|Lens Discomfort|3|||
124635237|NCT05000164|448281464|FG000|Overall Study|Withdrew Consent during Study|2|||
124635238|NCT05000164|448281464|FG000|Overall Study|Subject Withdrawn by PI|2|||
124635239|NCT05000164|448281464|FG000|Overall Study|Other Fractured Test Article|1|||
124635240|NCT03493854|448281465|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
124635241|NCT03493854|448281466|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
124635242|NCT03493854|448281465|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
124635243|NCT03493854|448281466|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
124812238|NCT00289133|448942600|FG000|Overall Study|Revision|8|||
124635244|NCT03493854|448281465|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
124635245|NCT03493854|448281466|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
124635246|NCT03493854|448281465|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
124635247|NCT03493854|448281466|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
124635248|NCT03493854|448281465|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
124635249|NCT03493854|448281466|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
124635250|NCT03493854|448281465|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
124635251|NCT03493854|448281466|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
124812239|NCT00289133|448942601|FG001|Overall Study|Revision|6|||
124812240|NCT00289133|448942600|FG000|Overall Study|Lost to Follow-up|92|||
124635252|NCT03493854|448281465|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
124635253|NCT03493854|448281466|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
124635254|NCT03493854|448281465|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
124635255|NCT03493854|448281466|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
124635256|NCT03493854|448281465|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
124635257|NCT03493854|448281466|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
124635258|NCT03493854|448281465|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
124635259|NCT03493854|448281466|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
124635260|NCT03493854|448281465|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
124635261|NCT03493854|448281466|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
124635262|NCT03493854|448281465|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
124635263|NCT03493854|448281466|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
124635264|NCT03493854|448281465|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
124635265|NCT03493854|448281466|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
124635266|NCT03493854|448281465|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
124635267|NCT03493854|448281466|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
124812241|NCT00289133|448942601|FG001|Overall Study|Lost to Follow-up|115|||
124812242|NCT04613375|448942605|FG000|Overall Study|Death|198|||
124812243|NCT04613375|448942605|FG000|Overall Study|Withdrawal by Subject|3|||
124812244|NCT01921387|448942608|FG000|Overall Study|Adverse Event|1|||
124812245|NCT03095612|448942612|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
124812246|NCT03095612|448942613|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
124635268|NCT03493854|448281465|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
124635269|NCT03493854|448281466|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
124812247|NCT03095612|448942614|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
124812248|NCT03095612|448942615|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
124812249|NCT03095612|448942616|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
124812250|NCT03095612|448942617|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
124812251|NCT03095612|448942618|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
124812252|NCT04447794|448942619|FG000|Overall Study|Lost to Follow-up|2|||
124812253|NCT04447794|448942620|FG001|Overall Study|Lost to Follow-up|3|||
124812254|NCT04447794|448942621|FG002|Overall Study|Lost to Follow-up|8|||
124812255|NCT04447794|448942619|FG000|Overall Study|Withdrawal by Subject|1|||
124812256|NCT04447794|448942620|FG001|Overall Study|Withdrawal by Subject|1|||
124812257|NCT04447794|448942621|FG002|Overall Study|Withdrawal by Subject|0|||
124812258|NCT00621582|448942622|FG000|Overall Study|Adverse Event|7|||
124812259|NCT00621582|448942622|FG000|Overall Study|Protocol Violation|57|||
124812260|NCT00621582|448942622|FG000|Overall Study|Lost to Follow-up|24|||
124812261|NCT00621582|448942622|FG000|Overall Study|issues not identified by investigators|18|||
124812262|NCT01387932|448942623|FG000|Randomized and Treated|Physician Decision|3|||
124812263|NCT01387932|448942624|FG001|Randomized and Treated|Physician Decision|2|||
124812264|NCT01387932|448942623|FG000|Randomized and Treated|Withdrawal by Subject|4|||
124812265|NCT01387932|448942624|FG001|Randomized and Treated|Withdrawal by Subject|2|||
124812266|NCT01387932|448942623|FG000|Survival Follow-up|Liver Transplant|24|||
124812267|NCT01387932|448942624|FG001|Survival Follow-up|Liver Transplant|28|||
124812268|NCT01387932|448942623|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
124812269|NCT01387932|448942624|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
124812270|NCT01387932|448942623|FG000|Survival Follow-up|Withdrawal by Subject|2|||
124812271|NCT01387932|448942624|FG001|Survival Follow-up|Withdrawal by Subject|4|||
124812272|NCT01387932|448942623|FG000|Survival Follow-up|Lost to Follow-up|6|||
124812273|NCT01387932|448942624|FG001|Survival Follow-up|Lost to Follow-up|5|||
124812274|NCT00963937|448942625|FG000|Overall Study|Protocol Violation|1|||
124635270|NCT03493854|448281465|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
124635271|NCT03493854|448281466|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
124635272|NCT03493854|448281465|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
124635273|NCT03493854|448281466|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
124635274|NCT03493854|448281465|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
124635275|NCT03493854|448281466|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
124635276|NCT02198664|448281469|FG000|Overall Study|Adverse Event|2|||
124635277|NCT02198664|448281470|FG001|Overall Study|Adverse Event|0|||
124635278|NCT02198664|448281469|FG000|Overall Study|Withdrawal by Subject|11|||
124635279|NCT02198664|448281470|FG001|Overall Study|Withdrawal by Subject|8|||
124635280|NCT02198664|448281469|FG000|Overall Study|Failure to tolerate|2|||
124635281|NCT02198664|448281470|FG001|Overall Study|Failure to tolerate|0|||
124812275|NCT00963937|448942626|FG001|Overall Study|Protocol Violation|1|||
124812276|NCT00963937|448942627|FG002|Overall Study|Protocol Violation|0|||
124812277|NCT00963937|448942625|FG000|Overall Study|Physician Decision|18|||
124812278|NCT00963937|448942626|FG001|Overall Study|Physician Decision|10|||
124812279|NCT00963937|448942627|FG002|Overall Study|Physician Decision|4|||
124812280|NCT00939640|448942630|FG000|Overall Study|Physician Decision|1|||
124635282|NCT02198664|448281469|FG000|Overall Study|Not stated|1|||
124635283|NCT02198664|448281470|FG001|Overall Study|Not stated|0|||
124635284|NCT05343364|448281473|FG000|Overall Study|Miscellaneous|0|||
124635285|NCT05343364|448281474|FG001|Overall Study|Miscellaneous|1|||
124635286|NCT01262872|448281476|FG000|Step 2|Death|0|||
124635287|NCT01262872|448281477|FG001|Step 2|Death|0|||
124635288|NCT01262872|448281478|FG002|Step 2|Death|0|||
124635289|NCT01262872|448281479|FG003|Step 2|Death|1|||
124635290|NCT01262872|448281480|FG004|Step 2|Death|0|||
124635291|NCT01262872|448281481|FG005|Step 2|Death|2|||
124635292|NCT01262872|448281482|FG006|Step 2|Death|2|||
124635293|NCT01262872|448281483|FG007|Step 2|Death|1|||
124635294|NCT01262872|448281476|FG000|Step 2|Protocol Violation|0|||
124635295|NCT01262872|448281477|FG001|Step 2|Protocol Violation|0|||
124635296|NCT01262872|448281478|FG002|Step 2|Protocol Violation|1|||
124635297|NCT01262872|448281479|FG003|Step 2|Protocol Violation|0|||
124635298|NCT01262872|448281480|FG004|Step 2|Protocol Violation|0|||
124635299|NCT01262872|448281481|FG005|Step 2|Protocol Violation|0|||
124635300|NCT01262872|448281482|FG006|Step 2|Protocol Violation|3|||
124635301|NCT01262872|448281483|FG007|Step 2|Protocol Violation|1|||
124635302|NCT01262872|448281476|FG000|Step 2|Withdrawal by Subject|0|||
124635303|NCT01262872|448281477|FG001|Step 2|Withdrawal by Subject|0|||
124635304|NCT01262872|448281478|FG002|Step 2|Withdrawal by Subject|4|||
124635305|NCT01262872|448281479|FG003|Step 2|Withdrawal by Subject|6|||
124635306|NCT01262872|448281480|FG004|Step 2|Withdrawal by Subject|3|||
124635307|NCT01262872|448281481|FG005|Step 2|Withdrawal by Subject|1|||
124635308|NCT01262872|448281482|FG006|Step 2|Withdrawal by Subject|2|||
124635309|NCT01262872|448281483|FG007|Step 2|Withdrawal by Subject|1|||
124635310|NCT01262872|448281476|FG000|Step 2|Migrated/moved from study area|0|||
124635311|NCT01262872|448281477|FG001|Step 2|Migrated/moved from study area|0|||
124635312|NCT01262872|448281478|FG002|Step 2|Migrated/moved from study area|4|||
124635313|NCT01262872|448281479|FG003|Step 2|Migrated/moved from study area|3|||
124635314|NCT01262872|448281480|FG004|Step 2|Migrated/moved from study area|2|||
124635315|NCT01262872|448281481|FG005|Step 2|Migrated/moved from study area|6|||
124635316|NCT01262872|448281482|FG006|Step 2|Migrated/moved from study area|2|||
124635317|NCT01262872|448281483|FG007|Step 2|Migrated/moved from study area|3|||
124635318|NCT01753570|448281484|FG000|Overall Study|Adverse Event|1|||
124635319|NCT01753570|448281485|FG001|Overall Study|Adverse Event|0|||
124635320|NCT01753570|448281486|FG002|Overall Study|Adverse Event|1|||
124635321|NCT01753570|448281484|FG000|Overall Study|Physician Decision|0|||
124635322|NCT01753570|448281485|FG001|Overall Study|Physician Decision|1|||
124635323|NCT01753570|448281486|FG002|Overall Study|Physician Decision|0|||
124635324|NCT01753570|448281484|FG000|Overall Study|Withdrawal by Subject|1|||
124635325|NCT01753570|448281485|FG001|Overall Study|Withdrawal by Subject|4|||
124635326|NCT01753570|448281486|FG002|Overall Study|Withdrawal by Subject|0|||
124635327|NCT01000155|448281489|FG000|Overall Study|Withdrawal by Subject|1|||
124635328|NCT01000155|448281489|FG000|Overall Study|Adverse Event|1|||
124635329|NCT00720213|448281492|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
124635330|NCT00720213|448281493|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
124635331|NCT00720213|448281494|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
124635332|NCT01808066|448281499|FG000|Overall Study|Withdrawal by Subject|15|||
124635333|NCT01252095|448281500|FG000|Overall Study|Disease progression|1|||
124635334|NCT01252095|448281501|FG001|Overall Study|Disease progression|0|||
124635335|NCT00365794|448281502|FG000|Overall Study|Withdrawal by Subject|2|||
124635336|NCT00745901|448281503|FG000|Overall Study|Adverse Event|3|||
124635337|NCT00745901|448281504|FG001|Overall Study|Adverse Event|4|||
124635338|NCT00745901|448281503|FG000|Overall Study|Protocol Violation|0|||
124812281|NCT01235689|448942636|FG000|Overall Study|Adverse Event|12|||
124812282|NCT01235689|448942637|FG001|Overall Study|Adverse Event|16|||
124812283|NCT01235689|448942636|FG000|Overall Study|Lack of Efficacy|12|||
124812284|NCT01235689|448942637|FG001|Overall Study|Lack of Efficacy|5|||
124812285|NCT01235689|448942636|FG000|Overall Study|Withdrawal by Subject|3|||
124812286|NCT01235689|448942637|FG001|Overall Study|Withdrawal by Subject|4|||
124812287|NCT01235689|448942636|FG000|Overall Study|Lost to Follow-up|1|||
124812288|NCT01235689|448942637|FG001|Overall Study|Lost to Follow-up|2|||
124635339|NCT00745901|448281504|FG001|Overall Study|Protocol Violation|1|||
124635340|NCT00745901|448281503|FG000|Overall Study|Withdrawal by Subject|1|||
124635341|NCT00745901|448281504|FG001|Overall Study|Withdrawal by Subject|0|||
124635342|NCT00745901|448281503|FG000|Overall Study|Lost to Follow-up|7|||
124635343|NCT00745901|448281504|FG001|Overall Study|Lost to Follow-up|4|||
124635344|NCT00745901|448281503|FG000|Overall Study|Pregnancy|2|||
124635345|NCT00745901|448281504|FG001|Overall Study|Pregnancy|4|||
124635346|NCT00745901|448281503|FG000|Overall Study|Lack of compliance|2|||
124635347|NCT00745901|448281504|FG001|Overall Study|Lack of compliance|2|||
124635348|NCT00745901|448281503|FG000|Overall Study|Patient's next menses did not start with|1|||
124635349|NCT00745901|448281504|FG001|Overall Study|Patient's next menses did not start with|0|||
124635350|NCT00745901|448281503|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
124635351|NCT00745901|448281504|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
124812289|NCT01235689|448942636|FG000|Overall Study|Miscellaneous|1|||
124812290|NCT01235689|448942637|FG001|Overall Study|Miscellaneous|5|||
124635352|NCT00745901|448281503|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
124635353|NCT00745901|448281504|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
124635354|NCT00745901|448281503|FG000|Overall Study|Patient didn't take any study medication|7|||
124635355|NCT00745901|448281504|FG001|Overall Study|Patient didn't take any study medication|3|||
124635356|NCT00884117|448281505|FG000|Overall Study|Adverse Event|2|||
124635357|NCT00884117|448281505|FG000|Overall Study|Withdrawal by Subject|89|||
124635358|NCT00884117|448281505|FG000|Overall Study|Death|3|||
124635359|NCT00884117|448281505|FG000|Overall Study|Lost to Follow-up|143|||
124635360|NCT00884117|448281505|FG000|Overall Study|Other|12|||
124635361|NCT01786993|448281506|FG000|Overall Study|Death|6|||
124635362|NCT01786993|448281507|FG001|Overall Study|Death|7|||
124635363|NCT01786993|448281506|FG000|Overall Study|Withdrawal by Subject|3|||
124635364|NCT01786993|448281507|FG001|Overall Study|Withdrawal by Subject|2|||
124635365|NCT01786993|448281506|FG000|Overall Study|Lost to Follow-up|0|||
124635366|NCT01786993|448281507|FG001|Overall Study|Lost to Follow-up|1|||
124635367|NCT01786993|448281506|FG000|Overall Study|Subject Non-Compliance|1|||
124635368|NCT01786993|448281507|FG001|Overall Study|Subject Non-Compliance|0|||
124635369|NCT01786993|448281506|FG000|Overall Study|System Explant|1|||
124635370|NCT01786993|448281507|FG001|Overall Study|System Explant|0|||
124635371|NCT01786993|448281506|FG000|Overall Study|Hospice Admission|1|||
124635372|NCT01786993|448281507|FG001|Overall Study|Hospice Admission|0|||
124635373|NCT02505217|448281510|FG000|Overall Study|Withdrawal by Subject|1|||
124635374|NCT02505217|448281511|FG001|Overall Study|Withdrawal by Subject|2|||
124635375|NCT00153179|448281512|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
124635376|NCT00153179|448281513|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
124635377|NCT00153179|448281514|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
124635378|NCT00153179|448281515|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
124635379|NCT04495829|448281516|FG000|Overall Study|Lost to Follow-up|2|||
124635380|NCT04495829|448281516|FG000|Overall Study|Inclusion criterion not met|3|||
124635381|NCT02712554|448281517|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
124635382|NCT02712554|448281518|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
124812291|NCT00389597|448942638|FG000|Overall Study|Lost to Follow-up|8|||
124812292|NCT00389597|448942639|FG001|Overall Study|Lost to Follow-up|6|||
124812293|NCT00389597|448942640|FG002|Overall Study|Lost to Follow-up|4|||
124812294|NCT00389597|448942641|FG003|Overall Study|Lost to Follow-up|6|||
124812295|NCT00005044|448942642|FG000|Overall Study|Protocol Violation|37|||
124812296|NCT00005044|448942643|FG001|Overall Study|Protocol Violation|46|||
124812297|NCT00005044|448942642|FG000|Overall Study|Withdrawal by Subject|1|||
124812298|NCT00005044|448942643|FG001|Overall Study|Withdrawal by Subject|5|||
124812299|NCT00005044|448942642|FG000|Overall Study|No protocol treatment|0|||
124812300|NCT00005044|448942643|FG001|Overall Study|No protocol treatment|1|||
124635383|NCT02712554|448281517|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
124635384|NCT02712554|448281518|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
124635385|NCT02712554|448281517|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
124635386|NCT02712554|448281518|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
124635387|NCT02712554|448281517|FG000|Part B: Qualification Phase|Adverse Event|0|||
124635388|NCT02712554|448281518|FG001|Part B: Qualification Phase|Adverse Event|1|||
124635389|NCT02712554|448281517|FG000|Part B: Treatment Phase|Adverse Event|0|||
124635390|NCT02712554|448281518|FG001|Part B: Treatment Phase|Adverse Event|1|||
124635391|NCT02712554|448281517|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
124635392|NCT02712554|448281518|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
124635393|NCT02712554|448281517|FG000|Part B: Treatment Phase|Other|0|||
124635394|NCT02712554|448281518|FG001|Part B: Treatment Phase|Other|1|||
124635395|NCT03859427|448281519|FG000|Overall Study|Withdrawal by Subject|4|||
124635396|NCT03859427|448281520|FG001|Overall Study|Withdrawal by Subject|7|||
124635397|NCT03859427|448281519|FG000|Overall Study|Decision by sponsor|0|||
124635398|NCT03859427|448281520|FG001|Overall Study|Decision by sponsor|3|||
124635399|NCT03859427|448281519|FG000|Overall Study|Lost to Follow-up|3|||
124635400|NCT03859427|448281520|FG001|Overall Study|Lost to Follow-up|2|||
124635401|NCT03859427|448281519|FG000|Overall Study|Death|22|||
124635402|NCT03859427|448281520|FG001|Overall Study|Death|25|||
124635403|NCT02503540|448281521|FG000|Overall Study|Death|2|||
124812301|NCT04431453|448942644|FG000|Overall Study|Withdrew Consent|0|||
124812302|NCT04431453|448942645|FG001|Overall Study|Withdrew Consent|1|||
124812303|NCT04431453|448942646|FG002|Overall Study|Withdrew Consent|0|||
124635404|NCT02503540|448281521|FG000|Overall Study|Withdrawal by Subject|1|||
124635405|NCT01804946|448281522|FG000|Overall Study|Protocol Violation|1|||
124635406|NCT01804946|448281523|FG001|Overall Study|Protocol Violation|0|||
124635407|NCT01804946|448281522|FG000|Overall Study|Adverse Event|0|||
124635408|NCT01804946|448281523|FG001|Overall Study|Adverse Event|1|||
124635409|NCT01804946|448281522|FG000|Overall Study|Insufficient data available|0|||
124635410|NCT01804946|448281523|FG001|Overall Study|Insufficient data available|1|||
124635411|NCT01804946|448281522|FG000|Overall Study|Do not meet inclusion criteria|1|||
124635412|NCT01804946|448281523|FG001|Overall Study|Do not meet inclusion criteria|2|||
124812304|NCT04431453|448942647|FG003|Overall Study|Withdrew Consent|2|||
124812305|NCT04431453|448942648|FG004|Overall Study|Withdrew Consent|0|||
124812306|NCT04431453|448942649|FG005|Overall Study|Withdrew Consent|0|||
124635413|NCT00722137|448281524|FG000|Overall Study|Overt Disease Progression|5|||
124635414|NCT00722137|448281525|FG001|Overall Study|Overt Disease Progression|4|||
124635415|NCT00722137|448281524|FG000|Overall Study|Adverse Event|17|||
124635416|NCT00722137|448281525|FG001|Overall Study|Adverse Event|21|||
124635417|NCT00722137|448281524|FG000|Overall Study|Death|12|||
124635418|NCT00722137|448281525|FG001|Overall Study|Death|7|||
124635419|NCT00722137|448281524|FG000|Overall Study|Withdrawal by Subject|6|||
124635420|NCT00722137|448281525|FG001|Overall Study|Withdrawal by Subject|9|||
124635421|NCT00722137|448281524|FG000|Overall Study|Other Reason Unknown|3|||
124635422|NCT00722137|448281525|FG001|Overall Study|Other Reason Unknown|4|||
124635423|NCT00722137|448281524|FG000|Overall Study|Randomized But Not Treated|2|||
124635424|NCT00722137|448281525|FG001|Overall Study|Randomized But Not Treated|3|||
124635425|NCT01129557|448281526|FG000|Overall Study|Adverse Event|1|||
124635426|NCT01129557|448281527|FG001|Overall Study|Adverse Event|2|||
124635427|NCT01129557|448281528|FG002|Overall Study|Adverse Event|2|||
124635428|NCT01129557|448281526|FG000|Overall Study|Novartis terminated study early|3|||
124635429|NCT01129557|448281527|FG001|Overall Study|Novartis terminated study early|3|||
124635430|NCT01129557|448281528|FG002|Overall Study|Novartis terminated study early|2|||
124635431|NCT00669669|448281529|FG000|Overall Study|To late to start treatment|1|||
124635432|NCT00848718|448281530|FG000|Overall Study|Adverse Event|2|||
124635433|NCT00848718|448281531|FG001|Overall Study|Adverse Event|2|||
124635434|NCT00848718|448281532|FG002|Overall Study|Adverse Event|1|||
124635435|NCT00848718|448281533|FG003|Overall Study|Adverse Event|1|||
124635436|NCT00848718|448281534|FG004|Overall Study|Adverse Event|1|||
124635437|NCT00848718|448281535|FG005|Overall Study|Adverse Event|0|||
124635438|NCT00848718|448281536|FG006|Overall Study|Adverse Event|0|||
124635439|NCT00848718|448281537|FG007|Overall Study|Adverse Event|1|||
124635440|NCT00848718|448281538|FG008|Overall Study|Adverse Event|1|||
124635441|NCT00848718|448281539|FG009|Overall Study|Adverse Event|0|||
124635442|NCT00848718|448281540|FG010|Overall Study|Adverse Event|0|||
124635443|NCT00848718|448281541|FG011|Overall Study|Adverse Event|0|||
124635444|NCT00848718|448281542|FG012|Overall Study|Adverse Event|2|||
124635445|NCT00848718|448281530|FG000|Overall Study|Lack of Efficacy|0|||
124635446|NCT00848718|448281531|FG001|Overall Study|Lack of Efficacy|0|||
124635447|NCT00848718|448281532|FG002|Overall Study|Lack of Efficacy|1|||
124635448|NCT00848718|448281533|FG003|Overall Study|Lack of Efficacy|0|||
124635449|NCT00848718|448281534|FG004|Overall Study|Lack of Efficacy|0|||
124635450|NCT00848718|448281535|FG005|Overall Study|Lack of Efficacy|0|||
124635451|NCT00848718|448281536|FG006|Overall Study|Lack of Efficacy|1|||
124635452|NCT00848718|448281537|FG007|Overall Study|Lack of Efficacy|0|||
124635453|NCT00848718|448281538|FG008|Overall Study|Lack of Efficacy|0|||
124635454|NCT00848718|448281539|FG009|Overall Study|Lack of Efficacy|0|||
124635455|NCT00848718|448281540|FG010|Overall Study|Lack of Efficacy|0|||
124635456|NCT00848718|448281541|FG011|Overall Study|Lack of Efficacy|0|||
124635457|NCT00848718|448281542|FG012|Overall Study|Lack of Efficacy|0|||
124635458|NCT00848718|448281530|FG000|Overall Study|Physician Decision|0|||
124635459|NCT00848718|448281531|FG001|Overall Study|Physician Decision|1|||
124635460|NCT00848718|448281532|FG002|Overall Study|Physician Decision|0|||
124635461|NCT00848718|448281533|FG003|Overall Study|Physician Decision|0|||
124635462|NCT00848718|448281534|FG004|Overall Study|Physician Decision|1|||
124635463|NCT00848718|448281535|FG005|Overall Study|Physician Decision|1|||
124635464|NCT00848718|448281536|FG006|Overall Study|Physician Decision|0|||
124635465|NCT00848718|448281537|FG007|Overall Study|Physician Decision|0|||
124635466|NCT00848718|448281538|FG008|Overall Study|Physician Decision|1|||
124635467|NCT00848718|448281539|FG009|Overall Study|Physician Decision|2|||
124635468|NCT00848718|448281540|FG010|Overall Study|Physician Decision|0|||
124635469|NCT00848718|448281541|FG011|Overall Study|Physician Decision|0|||
124635470|NCT00848718|448281542|FG012|Overall Study|Physician Decision|1|||
124635471|NCT00848718|448281530|FG000|Overall Study|Progressive disease before treatment|1|||
124635472|NCT00848718|448281531|FG001|Overall Study|Progressive disease before treatment|5|||
124812307|NCT04431453|448942650|FG006|Overall Study|Withdrew Consent|0|||
124812308|NCT04431453|448942651|FG007|Overall Study|Withdrew Consent|0|||
124812309|NCT04431453|448942644|FG000|Overall Study|Death|1|||
124635473|NCT00848718|448281532|FG002|Overall Study|Progressive disease before treatment|1|||
124635474|NCT00848718|448281533|FG003|Overall Study|Progressive disease before treatment|3|||
124635475|NCT00848718|448281534|FG004|Overall Study|Progressive disease before treatment|4|||
124635476|NCT00848718|448281535|FG005|Overall Study|Progressive disease before treatment|4|||
124635477|NCT00848718|448281536|FG006|Overall Study|Progressive disease before treatment|2|||
124635478|NCT00848718|448281537|FG007|Overall Study|Progressive disease before treatment|1|||
124635479|NCT00848718|448281538|FG008|Overall Study|Progressive disease before treatment|2|||
124635480|NCT00848718|448281539|FG009|Overall Study|Progressive disease before treatment|7|||
124635481|NCT00848718|448281540|FG010|Overall Study|Progressive disease before treatment|3|||
124635482|NCT00848718|448281541|FG011|Overall Study|Progressive disease before treatment|6|||
124812310|NCT04431453|448942645|FG001|Overall Study|Death|0|||
124635483|NCT00848718|448281542|FG012|Overall Study|Progressive disease before treatment|2|||
124635484|NCT00848718|448281530|FG000|Overall Study|Protocol Violation|0|||
124812311|NCT04431453|448942646|FG002|Overall Study|Death|0|||
124635485|NCT00848718|448281531|FG001|Overall Study|Protocol Violation|1|||
124635486|NCT00848718|448281532|FG002|Overall Study|Protocol Violation|0|||
124635487|NCT00848718|448281533|FG003|Overall Study|Protocol Violation|0|||
124635488|NCT00848718|448281534|FG004|Overall Study|Protocol Violation|0|||
124635489|NCT00848718|448281535|FG005|Overall Study|Protocol Violation|0|||
124635490|NCT00848718|448281536|FG006|Overall Study|Protocol Violation|0|||
124635491|NCT00848718|448281537|FG007|Overall Study|Protocol Violation|1|||
124635492|NCT00848718|448281538|FG008|Overall Study|Protocol Violation|0|||
124635493|NCT00848718|448281539|FG009|Overall Study|Protocol Violation|0|||
124635494|NCT00848718|448281540|FG010|Overall Study|Protocol Violation|0|||
124635495|NCT00848718|448281541|FG011|Overall Study|Protocol Violation|0|||
124635496|NCT00848718|448281542|FG012|Overall Study|Protocol Violation|1|||
124635497|NCT00848718|448281530|FG000|Overall Study|Withdrawal by Subject|1|||
124635498|NCT00848718|448281531|FG001|Overall Study|Withdrawal by Subject|0|||
124635499|NCT00848718|448281532|FG002|Overall Study|Withdrawal by Subject|0|||
124635500|NCT00848718|448281533|FG003|Overall Study|Withdrawal by Subject|1|||
124635501|NCT00848718|448281534|FG004|Overall Study|Withdrawal by Subject|0|||
124635502|NCT00848718|448281535|FG005|Overall Study|Withdrawal by Subject|0|||
124635503|NCT00848718|448281536|FG006|Overall Study|Withdrawal by Subject|0|||
124635504|NCT00848718|448281537|FG007|Overall Study|Withdrawal by Subject|0|||
124635505|NCT00848718|448281538|FG008|Overall Study|Withdrawal by Subject|0|||
124635506|NCT00848718|448281539|FG009|Overall Study|Withdrawal by Subject|0|||
124635507|NCT00848718|448281540|FG010|Overall Study|Withdrawal by Subject|1|||
124635508|NCT00848718|448281541|FG011|Overall Study|Withdrawal by Subject|0|||
124635509|NCT00848718|448281542|FG012|Overall Study|Withdrawal by Subject|0|||
124635510|NCT00848718|448281530|FG000|Overall Study|Progressive disease during treatment|3|||
124635511|NCT00848718|448281531|FG001|Overall Study|Progressive disease during treatment|0|||
124635512|NCT00848718|448281532|FG002|Overall Study|Progressive disease during treatment|3|||
124635513|NCT00848718|448281533|FG003|Overall Study|Progressive disease during treatment|0|||
124635514|NCT00848718|448281534|FG004|Overall Study|Progressive disease during treatment|0|||
124635515|NCT00848718|448281535|FG005|Overall Study|Progressive disease during treatment|0|||
124635516|NCT00848718|448281536|FG006|Overall Study|Progressive disease during treatment|0|||
124635517|NCT00848718|448281537|FG007|Overall Study|Progressive disease during treatment|2|||
124635518|NCT00848718|448281538|FG008|Overall Study|Progressive disease during treatment|0|||
124635519|NCT00848718|448281539|FG009|Overall Study|Progressive disease during treatment|0|||
124635520|NCT00848718|448281540|FG010|Overall Study|Progressive disease during treatment|0|||
124635521|NCT00848718|448281541|FG011|Overall Study|Progressive disease during treatment|0|||
124635522|NCT00848718|448281542|FG012|Overall Study|Progressive disease during treatment|2|||
124635523|NCT02418182|448281544|FG000|Overall Study|Unable to re-consent|18|||
124635524|NCT02418182|448281545|FG001|Overall Study|Unable to re-consent|15|||
124635525|NCT02418182|448281544|FG000|Overall Study|Lost to Follow-up|0|||
124635526|NCT02418182|448281545|FG001|Overall Study|Lost to Follow-up|2|||
124812312|NCT04431453|448942647|FG003|Overall Study|Death|0|||
124812313|NCT04431453|448942648|FG004|Overall Study|Death|0|||
124812314|NCT04431453|448942649|FG005|Overall Study|Death|0|||
124812315|NCT04431453|448942650|FG006|Overall Study|Death|0|||
124812316|NCT04431453|448942651|FG007|Overall Study|Death|1|||
124812317|NCT04431453|448942644|FG000|Overall Study|Lost to Follow-up|0|||
124812318|NCT04431453|448942645|FG001|Overall Study|Lost to Follow-up|0|||
124812319|NCT04431453|448942646|FG002|Overall Study|Lost to Follow-up|1|||
124812320|NCT04431453|448942647|FG003|Overall Study|Lost to Follow-up|1|||
124812321|NCT04431453|448942648|FG004|Overall Study|Lost to Follow-up|0|||
124812322|NCT04431453|448942649|FG005|Overall Study|Lost to Follow-up|0|||
124812323|NCT04431453|448942650|FG006|Overall Study|Lost to Follow-up|0|||
124812324|NCT04431453|448942651|FG007|Overall Study|Lost to Follow-up|0|||
124812325|NCT04431453|448942644|FG000|Overall Study|Enrolled but Never Treated|0|||
124812326|NCT04431453|448942645|FG001|Overall Study|Enrolled but Never Treated|0|||
124635527|NCT02431676|448281548|FG000|Overall Study|no lab obtained|0|||
124635528|NCT02431676|448281549|FG001|Overall Study|no lab obtained|1|||
124635529|NCT02431676|448281550|FG002|Overall Study|no lab obtained|2|||
124635530|NCT00570687|448282970|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124812327|NCT04431453|448942646|FG002|Overall Study|Enrolled but Never Treated|0|||
124812328|NCT04431453|448942647|FG003|Overall Study|Enrolled but Never Treated|0|||
124635531|NCT00570687|448282971|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635532|NCT00570687|448282972|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635533|NCT00570687|448282973|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635534|NCT00570687|448282974|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
124635535|NCT00570687|448282975|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
124635536|NCT00570687|448282976|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
124635537|NCT00570687|448282977|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
124635538|NCT00570687|448282978|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
124812329|NCT04431453|448942648|FG004|Overall Study|Enrolled but Never Treated|1|||
124812330|NCT04431453|448942649|FG005|Overall Study|Enrolled but Never Treated|0|||
124812331|NCT04431453|448942650|FG006|Overall Study|Enrolled but Never Treated|0|||
124819583|NCT00420927|448965763|FG002|Period 1|Lost to Follow-up|0|||
124812332|NCT04431453|448942651|FG007|Overall Study|Enrolled but Never Treated|0|||
124812333|NCT03546062|448942652|FG000|Overall Study|Adverse Event|6|||
124812334|NCT03546062|448942653|FG001|Overall Study|Adverse Event|5|||
124812335|NCT03546062|448942654|FG002|Overall Study|Adverse Event|8|||
124812336|NCT02083965|448942656|FG000|Treatment Period|Other|1|||
124812337|NCT02083965|448942657|FG001|Treatment Period|Other|0|||
124812338|NCT04502433|448942658|FG000|Overall Study|Death|2|||
124812339|NCT04502433|448942659|FG001|Overall Study|Death|4|||
124812340|NCT04502433|448942658|FG000|Overall Study|Lost to Follow-up|1|||
124812341|NCT04502433|448942659|FG001|Overall Study|Lost to Follow-up|0|||
124812342|NCT04502433|448942658|FG000|Overall Study|Physician Decision|0|||
124812343|NCT04502433|448942659|FG001|Overall Study|Physician Decision|1|||
124812344|NCT01702961|448942662|FG000|Overall Study|Additional treatment|3|||
124812345|NCT01702961|448942662|FG000|Overall Study|Progressive disease|5|||
124812346|NCT01702961|448942662|FG000|Overall Study|Relapse|20|||
124812347|NCT01702961|448942662|FG000|Overall Study|Death|6|||
124812348|NCT01702961|448942662|FG000|Overall Study|Lost to Follow-up|2|||
124812349|NCT01702961|448942662|FG000|Overall Study|Ongoing|11|||
124812350|NCT02229383|448942663|FG000|Overall Study|Adverse Event|7|||
124812351|NCT02229383|448942664|FG001|Overall Study|Adverse Event|4|||
124812352|NCT02229383|448942663|FG000|Overall Study|Death|0|||
124812353|NCT02229383|448942664|FG001|Overall Study|Death|1|||
124812354|NCT02229383|448942663|FG000|Overall Study|Lost to Follow-up|5|||
124812355|NCT02229383|448942664|FG001|Overall Study|Lost to Follow-up|3|||
124812356|NCT02229383|448942663|FG000|Overall Study|Withdrawal by Subject|4|||
124812357|NCT02229383|448942664|FG001|Overall Study|Withdrawal by Subject|6|||
124812358|NCT02229383|448942663|FG000|Overall Study|Did not receive treatment|1|||
124812359|NCT02229383|448942664|FG001|Overall Study|Did not receive treatment|0|||
124812360|NCT02229383|448942663|FG000|Overall Study|Other|3|||
124812361|NCT02229383|448942664|FG001|Overall Study|Other|8|||
124635539|NCT00570687|448282979|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
124635540|NCT00570687|448282970|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635541|NCT00570687|448282971|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635542|NCT00570687|448282972|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635543|NCT00570687|448282973|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635544|NCT00570687|448282974|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635545|NCT00570687|448282975|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635546|NCT00570687|448282976|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635547|NCT00570687|448282977|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635548|NCT00570687|448282978|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
124635549|NCT00570687|448282979|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635550|NCT00570687|448282970|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635551|NCT00570687|448282971|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635552|NCT00570687|448282972|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635553|NCT00570687|448282973|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635554|NCT00570687|448282974|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635555|NCT00570687|448282975|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635556|NCT00570687|448282976|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
124635557|NCT00570687|448282977|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635558|NCT00570687|448282978|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635559|NCT00570687|448282979|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
124635560|NCT01102257|448282985|FG000|Overall Study|Adverse Event|1|||
124635561|NCT01102257|448282986|FG001|Overall Study|Adverse Event|0|||
124635562|NCT01102257|448282985|FG000|Overall Study|Adverse Event|1|||
124635563|NCT01102257|448282986|FG001|Overall Study|Adverse Event|0|||
124635564|NCT01120184|448282987|FG000|Overall Study|Adverse Event|0|||
124635565|NCT01120184|448282988|FG001|Overall Study|Adverse Event|1|||
124635566|NCT01120184|448282989|FG002|Overall Study|Adverse Event|0|||
124635567|NCT01120184|448282987|FG000|Overall Study|Lost to Follow-up|13|||
124635568|NCT01120184|448282988|FG001|Overall Study|Lost to Follow-up|13|||
124635569|NCT01120184|448282989|FG002|Overall Study|Lost to Follow-up|11|||
124635570|NCT01120184|448282987|FG000|Overall Study|Physician Decision|9|||
124812362|NCT00674362|448942667|FG000|Double Blind|Adverse Event|6|||
124812363|NCT00674362|448942668|FG001|Double Blind|Adverse Event|6|||
124812364|NCT00674362|448942667|FG000|Double Blind|Lack of Efficacy|2|||
124812365|NCT00674362|448942668|FG001|Double Blind|Lack of Efficacy|6|||
124635571|NCT01120184|448282988|FG001|Overall Study|Physician Decision|1|||
124635572|NCT01120184|448282989|FG002|Overall Study|Physician Decision|3|||
124635573|NCT01120184|448282987|FG000|Overall Study|Reason not Specified|8|||
124635574|NCT01120184|448282988|FG001|Overall Study|Reason not Specified|3|||
124812366|NCT00674362|448942667|FG000|Double Blind|Loss of efficacy|0|||
124812367|NCT00674362|448942668|FG001|Double Blind|Loss of efficacy|1|||
124812368|NCT00674362|448942667|FG000|Double Blind|Withdrawal by Subject|4|||
124812369|NCT00674362|448942668|FG001|Double Blind|Withdrawal by Subject|3|||
124812370|NCT00674362|448942667|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
124812371|NCT00674362|448942668|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
124635575|NCT01120184|448282989|FG002|Overall Study|Reason not Specified|12|||
124635576|NCT01120184|448282987|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
124635577|NCT01120184|448282988|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
124635578|NCT01120184|448282989|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
124635579|NCT01120184|448282987|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
124635580|NCT01120184|448282988|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
124635581|NCT01120184|448282989|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
124635582|NCT01120184|448282987|FG000|Overall Study|Death|170|||
124635583|NCT01120184|448282988|FG001|Overall Study|Death|176|||
124635584|NCT01120184|448282989|FG002|Overall Study|Death|169|||
124635585|NCT04003636|448282990|FG000|Overall Study|Death|409|||
124635586|NCT04003636|448282991|FG001|Overall Study|Death|443|||
124635587|NCT04003636|448282990|FG000|Overall Study|Lost to Follow-up|0|||
124635588|NCT04003636|448282991|FG001|Overall Study|Lost to Follow-up|1|||
124635589|NCT04003636|448282990|FG000|Overall Study|Withdrawal by Subject|5|||
124635590|NCT04003636|448282991|FG001|Overall Study|Withdrawal by Subject|2|||
124635591|NCT04003636|448282990|FG000|Overall Study|Participant On-going|119|||
124635592|NCT04003636|448282991|FG001|Overall Study|Participant On-going|90|||
124635593|NCT03270657|448282993|FG000|Overall Study|Withdrawal by Subject|1|||
124635594|NCT04509076|448282994|FG000|Overall Study|Withdrawal by Subject|1|||
124635595|NCT04509076|448282995|FG001|Overall Study|Withdrawal by Subject|2|||
124635596|NCT04509076|448282994|FG000|Overall Study|Lost to Follow-up|1|||
124635597|NCT04509076|448282995|FG001|Overall Study|Lost to Follow-up|2|||
124635598|NCT01812109|448282997|FG000|Overall Study|research personnel delay|16|||
124635599|NCT01812109|448282997|FG000|Overall Study|NIRS Unattainable|17|||
124635600|NCT03313180|448282998|FG000|Overall Study|Adverse Event|120|||
124635601|NCT03313180|448282998|FG000|Overall Study|Lost to Follow-up|3|||
124635602|NCT03313180|448282998|FG000|Overall Study|Withdrawal by Subject|39|||
124635603|NCT03313180|448282998|FG000|Overall Study|Other than listed above|15|||
124635604|NCT03313180|448282998|FG000|Overall Study|Covid-19 related|2|||
124635605|NCT00461630|448282999|FG000|Overall Study|Death|798|||
124635606|NCT00461630|448283000|FG001|Overall Study|Death|732|||
124635607|NCT00461630|448282999|FG000|Overall Study|Lost to Follow-up|108|||
124635608|NCT00461630|448283000|FG001|Overall Study|Lost to Follow-up|95|||
124635609|NCT02588612|448283005|FG000|Overall Study|Physician Decision|1|||
124635610|NCT02588612|448283005|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
124635611|NCT02588612|448283005|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
124635612|NCT02588612|448283005|FG000|Overall Study|Death prior to T-cell infusion|1|||
124635613|NCT02841995|448283012|FG000|Overall Study|Disease progression|5|||
124635614|NCT02841995|448283013|FG001|Overall Study|Disease progression|11|||
124635615|NCT02841995|448283014|FG002|Overall Study|Disease progression|8|||
124635616|NCT02841995|448283012|FG000|Overall Study|Withdrawal by Subject|2|||
124635617|NCT02841995|448283013|FG001|Overall Study|Withdrawal by Subject|4|||
124635618|NCT02841995|448283014|FG002|Overall Study|Withdrawal by Subject|4|||
124635619|NCT02841995|448283012|FG000|Overall Study|Adverse Event|2|||
124635620|NCT02841995|448283013|FG001|Overall Study|Adverse Event|0|||
124635621|NCT02841995|448283014|FG002|Overall Study|Adverse Event|1|||
124635622|NCT02841995|448283012|FG000|Overall Study|Investigator decision|2|||
124635623|NCT02841995|448283013|FG001|Overall Study|Investigator decision|0|||
124635624|NCT02841995|448283014|FG002|Overall Study|Investigator decision|1|||
124635625|NCT02841995|448283012|FG000|Overall Study|Death|0|||
124635626|NCT02841995|448283013|FG001|Overall Study|Death|0|||
124635627|NCT02841995|448283014|FG002|Overall Study|Death|2|||
124635628|NCT02841995|448283012|FG000|Overall Study|Noncompliance to protocol|1|||
124635629|NCT02841995|448283013|FG001|Overall Study|Noncompliance to protocol|0|||
124635630|NCT02841995|448283014|FG002|Overall Study|Noncompliance to protocol|0|||
124635631|NCT02841995|448283012|FG000|Overall Study|Sponsor decision|1|||
124635632|NCT02841995|448283013|FG001|Overall Study|Sponsor decision|0|||
124635633|NCT02841995|448283014|FG002|Overall Study|Sponsor decision|0|||
124635634|NCT02841995|448283012|FG000|Overall Study|Other|4|||
124635635|NCT02841995|448283013|FG001|Overall Study|Other|1|||
124812372|NCT00674362|448942667|FG000|Double Blind|Other: Surgery|0|||
124812373|NCT00674362|448942668|FG001|Double Blind|Other: Surgery|1|||
124635636|NCT02841995|448283014|FG002|Overall Study|Other|5|||
124635637|NCT03809663|448283016|FG000|Overall Study|Decision by sponsor|24|||
124635638|NCT03809663|448283017|FG001|Overall Study|Decision by sponsor|18|||
124635639|NCT03809663|448283018|FG002|Overall Study|Decision by sponsor|20|||
124635640|NCT03809663|448283019|FG003|Overall Study|Decision by sponsor|20|||
124635641|NCT03809663|448283020|FG004|Overall Study|Decision by sponsor|0|||
124635642|NCT03809663|448283021|FG005|Overall Study|Decision by sponsor|0|||
124635643|NCT03809663|448283016|FG000|Overall Study|Withdrawal by Subject|26|||
124635644|NCT03809663|448283017|FG001|Overall Study|Withdrawal by Subject|22|||
124812374|NCT00674362|448942667|FG000|Open Label|Adverse Event|1|||
124635645|NCT03809663|448283018|FG002|Overall Study|Withdrawal by Subject|27|||
124635646|NCT03809663|448283019|FG003|Overall Study|Withdrawal by Subject|26|||
124635647|NCT03809663|448283020|FG004|Overall Study|Withdrawal by Subject|0|||
124635648|NCT03809663|448283021|FG005|Overall Study|Withdrawal by Subject|0|||
124635649|NCT03809663|448283016|FG000|Overall Study|Lost to Follow-up|1|||
124635650|NCT03809663|448283017|FG001|Overall Study|Lost to Follow-up|4|||
124635651|NCT03809663|448283018|FG002|Overall Study|Lost to Follow-up|1|||
124635652|NCT03809663|448283019|FG003|Overall Study|Lost to Follow-up|1|||
124635653|NCT03809663|448283020|FG004|Overall Study|Lost to Follow-up|0|||
124635654|NCT03809663|448283021|FG005|Overall Study|Lost to Follow-up|0|||
124635655|NCT01703260|448283022|FG000|Overall Study|Adverse Event|1|||
124635656|NCT01703260|448283023|FG001|Overall Study|Adverse Event|2|||
124635657|NCT01703260|448283024|FG002|Overall Study|Adverse Event|2|||
124635658|NCT01703260|448283022|FG000|Overall Study|Lost to Follow-up|1|||
124635659|NCT01703260|448283023|FG001|Overall Study|Lost to Follow-up|0|||
124635660|NCT01703260|448283024|FG002|Overall Study|Lost to Follow-up|0|||
124635661|NCT01703260|448283022|FG000|Overall Study|Withdrawal by Subject|0|||
124635662|NCT01703260|448283023|FG001|Overall Study|Withdrawal by Subject|0|||
124635663|NCT01703260|448283024|FG002|Overall Study|Withdrawal by Subject|1|||
124635664|NCT01703260|448283022|FG000|Overall Study|Study Termination|1|||
124635665|NCT01703260|448283023|FG001|Overall Study|Study Termination|2|||
124635666|NCT01703260|448283024|FG002|Overall Study|Study Termination|0|||
124635667|NCT04548193|448283028|FG000|Overall Study|Lost to Follow-up|0|||
124635668|NCT04548193|448283029|FG001|Overall Study|Lost to Follow-up|1|||
124635669|NCT04548193|448283028|FG000|Overall Study|Death|0|||
124635670|NCT04548193|448283029|FG001|Overall Study|Death|1|||
124635671|NCT04548193|448283028|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
124635672|NCT04548193|448283029|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
124635673|NCT04548193|448283028|FG000|Overall Study|Withdrawal by Subject|2|||
124635674|NCT04548193|448283029|FG001|Overall Study|Withdrawal by Subject|2|||
124635675|NCT00630825|448283031|FG000|Overall Study|Adverse Event|4|||
124635676|NCT00630825|448283032|FG001|Overall Study|Adverse Event|4|||
124635677|NCT00630825|448283033|FG002|Overall Study|Adverse Event|3|||
124635678|NCT00630825|448283034|FG003|Overall Study|Adverse Event|1|||
124635679|NCT00630825|448283031|FG000|Overall Study|Entry Criteria Not Met|1|||
124635680|NCT00630825|448283032|FG001|Overall Study|Entry Criteria Not Met|0|||
124635681|NCT00630825|448283033|FG002|Overall Study|Entry Criteria Not Met|2|||
124635682|NCT00630825|448283034|FG003|Overall Study|Entry Criteria Not Met|1|||
124635683|NCT00630825|448283031|FG000|Overall Study|Lost to Follow-up|1|||
124635684|NCT00630825|448283032|FG001|Overall Study|Lost to Follow-up|1|||
124635685|NCT00630825|448283033|FG002|Overall Study|Lost to Follow-up|1|||
124635686|NCT00630825|448283034|FG003|Overall Study|Lost to Follow-up|1|||
124635687|NCT00630825|448283031|FG000|Overall Study|Physician Decision|1|||
124635688|NCT00630825|448283032|FG001|Overall Study|Physician Decision|0|||
124635689|NCT00630825|448283033|FG002|Overall Study|Physician Decision|0|||
124635690|NCT00630825|448283034|FG003|Overall Study|Physician Decision|0|||
124635691|NCT00630825|448283031|FG000|Overall Study|Withdrawal by Subject|2|||
124635692|NCT00630825|448283032|FG001|Overall Study|Withdrawal by Subject|2|||
124635693|NCT00630825|448283033|FG002|Overall Study|Withdrawal by Subject|2|||
124635694|NCT00630825|448283034|FG003|Overall Study|Withdrawal by Subject|3|||
124635695|NCT02042014|448283035|FG000|Overall Study|Adverse Event|1|||
124635696|NCT02042014|448283035|FG000|Overall Study|Physician Decision|7|||
124635697|NCT02211209|448283037|FG000|Overall Study|Investigator judgment|0|||
124635698|NCT02211209|448283038|FG001|Overall Study|Investigator judgment|1|||
124635699|NCT02211209|448283037|FG000|Overall Study|Voluntary withdrawal|1|||
124635700|NCT02211209|448283038|FG001|Overall Study|Voluntary withdrawal|4|||
124635701|NCT02211209|448283037|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
124635702|NCT02211209|448283038|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
124635703|NCT02211209|448283037|FG000|Overall Study|Reason Not Specified|1|||
124635704|NCT02211209|448283038|FG001|Overall Study|Reason Not Specified|0|||
124635705|NCT02792062|448283041|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
124635706|NCT02792062|448283042|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
124635707|NCT02792062|448283043|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
124635708|NCT02792062|448283044|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
124635709|NCT02792062|448283045|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
124635710|NCT02792062|448283046|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
124635711|NCT03309943|448283049|FG000|Overall Study|Withdrawal by Subject|0|||
124635712|NCT03309943|448283050|FG001|Overall Study|Withdrawal by Subject|1|||
124635713|NCT03309943|448283049|FG000|Overall Study|Inappropriate behavior towards staff|0|||
124635714|NCT03309943|448283050|FG001|Overall Study|Inappropriate behavior towards staff|1|||
124635715|NCT00931255|448283051|FG000|Overall Study|Follow up biopsy not done|2|||
124635716|NCT00931255|448283052|FG001|Overall Study|Follow up biopsy not done|3|||
124635717|NCT01372995|448283053|FG000|Overall Study|Spouse withdrew participant from study|0|||
124635718|NCT01372995|448283054|FG001|Overall Study|Spouse withdrew participant from study|1|||
124635719|NCT01372995|448283055|FG002|Overall Study|Spouse withdrew participant from study|0|||
124635720|NCT01372995|448283053|FG000|Overall Study|Physician Decision|0|||
124635721|NCT01372995|448283054|FG001|Overall Study|Physician Decision|0|||
124635722|NCT01372995|448283055|FG002|Overall Study|Physician Decision|1|||
124635723|NCT00558701|448283062|FG000|Overall Study|Protocol Deviations|1|||
124635724|NCT00558701|448283063|FG001|Overall Study|Protocol Deviations|4|||
124635725|NCT00427648|448283064|FG000|Overall Study|Protocol Violation|1|||
124635726|NCT00427648|448283065|FG001|Overall Study|Protocol Violation|2|||
124635727|NCT00427648|448283064|FG000|Overall Study|Adverse Event|0|||
124635728|NCT00427648|448283065|FG001|Overall Study|Adverse Event|1|||
124635729|NCT01297517|448283066|FG000|Overall Study|Adverse Event|21|||
124635730|NCT01297517|448283067|FG001|Overall Study|Adverse Event|7|||
124635731|NCT01297517|448283068|FG002|Overall Study|Adverse Event|16|||
124635732|NCT01297517|448283066|FG000|Overall Study|Lost to Follow-up|1|||
124635733|NCT01297517|448283067|FG001|Overall Study|Lost to Follow-up|0|||
124635734|NCT01297517|448283068|FG002|Overall Study|Lost to Follow-up|1|||
124635735|NCT01297517|448283066|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
124635736|NCT01297517|448283067|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
124635737|NCT01297517|448283068|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
124635738|NCT01297517|448283066|FG000|Overall Study|Noncompliance|1|||
124635739|NCT01297517|448283067|FG001|Overall Study|Noncompliance|0|||
124635740|NCT01297517|448283068|FG002|Overall Study|Noncompliance|0|||
124635741|NCT01297517|448283066|FG000|Overall Study|Protocol Violation|1|||
124635742|NCT01297517|448283067|FG001|Overall Study|Protocol Violation|1|||
124635743|NCT01297517|448283068|FG002|Overall Study|Protocol Violation|1|||
124635744|NCT01297517|448283066|FG000|Overall Study|Inadequate Control of IOP|1|||
124635745|NCT01297517|448283067|FG001|Overall Study|Inadequate Control of IOP|1|||
124635746|NCT01297517|448283068|FG002|Overall Study|Inadequate Control of IOP|2|||
124635747|NCT00628212|448283073|FG000|Overall Study|Adverse Event|2|||
124635748|NCT00628212|448283074|FG001|Overall Study|Adverse Event|0|||
124635749|NCT00628212|448283075|FG002|Overall Study|Adverse Event|1|||
124635750|NCT00628212|448283076|FG003|Overall Study|Adverse Event|2|||
124635751|NCT00628212|448283073|FG000|Overall Study|Physician Decision|1|||
124635752|NCT00628212|448283074|FG001|Overall Study|Physician Decision|1|||
124635753|NCT00628212|448283075|FG002|Overall Study|Physician Decision|2|||
124635754|NCT00628212|448283076|FG003|Overall Study|Physician Decision|3|||
124635755|NCT01681212|448283077|FG000|Overall Study|No longer met study criteria|5|||
124635756|NCT01681212|448283077|FG000|Overall Study|Administrative reason by sponsor|1|||
124635757|NCT01464424|448283078|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
124635758|NCT01464424|448283079|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
124635759|NCT01464333|448283080|FG000|Overall Study|Adverse Event|34|||
124635760|NCT01464333|448283080|FG000|Overall Study|Lack of Efficacy|72|||
124635761|NCT01464333|448283080|FG000|Overall Study|Withdrawal by Subject|11|||
124635762|NCT01464333|448283080|FG000|Overall Study|Other|4|||
124635763|NCT01464333|448283080|FG000|Overall Study|No Hospital Visit|42|||
124635764|NCT00789373|448283081|FG000|Induction|Adverse Event|64|||
124635765|NCT00789373|448283082|FG001|Induction|Adverse Event|0|||
124635766|NCT00789373|448283083|FG002|Induction|Adverse Event|0|||
124635767|NCT00789373|448283081|FG000|Induction|Death Due to study disease|24|||
124635768|NCT00789373|448283082|FG001|Induction|Death Due to study disease|0|||
124635769|NCT00789373|448283083|FG002|Induction|Death Due to study disease|0|||
124635770|NCT00789373|448283081|FG000|Induction|Death due to adverse event|19|||
124635771|NCT00789373|448283082|FG001|Induction|Death due to adverse event|0|||
124635772|NCT00789373|448283083|FG002|Induction|Death due to adverse event|0|||
124635773|NCT00789373|448283081|FG000|Induction|Death due to toxicity|11|||
124635774|NCT00789373|448283082|FG001|Induction|Death due to toxicity|0|||
124635775|NCT00789373|448283083|FG002|Induction|Death due to toxicity|0|||
124635776|NCT00789373|448283081|FG000|Induction|Death due to procedure|1|||
124635777|NCT00789373|448283082|FG001|Induction|Death due to procedure|0|||
124635778|NCT00789373|448283083|FG002|Induction|Death due to procedure|0|||
124635779|NCT00789373|448283081|FG000|Induction|Investigator decision|7|||
124635780|NCT00789373|448283082|FG001|Induction|Investigator decision|0|||
124635781|NCT00789373|448283083|FG002|Induction|Investigator decision|0|||
124635782|NCT00789373|448283081|FG000|Induction|Protocol entry criteria not met|9|||
124635783|NCT00789373|448283082|FG001|Induction|Protocol entry criteria not met|0|||
124635784|NCT00789373|448283083|FG002|Induction|Protocol entry criteria not met|0|||
124635785|NCT00789373|448283081|FG000|Induction|Lost to Follow-up|6|||
124635786|NCT00789373|448283082|FG001|Induction|Lost to Follow-up|0|||
124635787|NCT00789373|448283083|FG002|Induction|Lost to Follow-up|0|||
124635788|NCT00789373|448283081|FG000|Induction|Protocol Violation|1|||
124635789|NCT00789373|448283082|FG001|Induction|Protocol Violation|0|||
124635790|NCT00789373|448283083|FG002|Induction|Protocol Violation|0|||
124635791|NCT00789373|448283081|FG000|Induction|Progressive Disease|220|||
124635792|NCT00789373|448283082|FG001|Induction|Progressive Disease|0|||
124635793|NCT00789373|448283083|FG002|Induction|Progressive Disease|0|||
124635794|NCT00789373|448283081|FG000|Induction|Withdrawal by Subject|37|||
124635795|NCT00789373|448283082|FG001|Induction|Withdrawal by Subject|0|||
124635796|NCT00789373|448283083|FG002|Induction|Withdrawal by Subject|0|||
124635797|NCT00789373|448283081|FG000|Maintenance|Adverse Event|0|||
124635798|NCT00789373|448283082|FG001|Maintenance|Adverse Event|65|||
124635799|NCT00789373|448283083|FG002|Maintenance|Adverse Event|12|||
124635800|NCT00789373|448283081|FG000|Maintenance|Death due to study disease|0|||
124635801|NCT00789373|448283082|FG001|Maintenance|Death due to study disease|3|||
124635802|NCT00789373|448283083|FG002|Maintenance|Death due to study disease|1|||
124635803|NCT00789373|448283081|FG000|Maintenance|Death due to adverse event|0|||
124635804|NCT00789373|448283082|FG001|Maintenance|Death due to adverse event|4|||
124635805|NCT00789373|448283083|FG002|Maintenance|Death due to adverse event|1|||
124635806|NCT00789373|448283081|FG000|Maintenance|Death due to toxicity|0|||
124635807|NCT00789373|448283082|FG001|Maintenance|Death due to toxicity|1|||
124635808|NCT00789373|448283083|FG002|Maintenance|Death due to toxicity|2|||
124635809|NCT00789373|448283081|FG000|Maintenance|Investigator Decision|0|||
124635810|NCT00789373|448283082|FG001|Maintenance|Investigator Decision|4|||
124635811|NCT00789373|448283083|FG002|Maintenance|Investigator Decision|2|||
124635812|NCT00789373|448283081|FG000|Maintenance|Protocol entry criteria not met|0|||
124635813|NCT00789373|448283082|FG001|Maintenance|Protocol entry criteria not met|2|||
124635814|NCT00789373|448283083|FG002|Maintenance|Protocol entry criteria not met|0|||
124635815|NCT00789373|448283081|FG000|Maintenance|Lost to Follow-up|0|||
124635816|NCT00789373|448283082|FG001|Maintenance|Lost to Follow-up|2|||
124635817|NCT00789373|448283083|FG002|Maintenance|Lost to Follow-up|0|||
124635818|NCT00789373|448283081|FG000|Maintenance|Progressive Disease|0|||
124635819|NCT00789373|448283082|FG001|Maintenance|Progressive Disease|253|||
124635820|NCT00789373|448283083|FG002|Maintenance|Progressive Disease|152|||
124635821|NCT00789373|448283081|FG000|Maintenance|Withdrawal by Subject|0|||
124635822|NCT00789373|448283082|FG001|Maintenance|Withdrawal by Subject|21|||
124635823|NCT00789373|448283083|FG002|Maintenance|Withdrawal by Subject|8|||
124635824|NCT00789373|448283081|FG000|Maintenance|Sponsor Decision|0|||
124635825|NCT00789373|448283082|FG001|Maintenance|Sponsor Decision|0|||
124635826|NCT00789373|448283083|FG002|Maintenance|Sponsor Decision|2|||
124635827|NCT00789373|448283081|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
124635828|NCT00789373|448283082|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
124635829|NCT00789373|448283083|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
124635830|NCT01741688|448283085|FG000|Overall Study|Lack of insurance coverage|2|||
124635831|NCT01741688|448283085|FG000|Overall Study|Withdrawal by Subject|1|||
124635832|NCT02282813|448283086|FG000|Overall Study|Withdrawal by Subject|4|||
124635833|NCT02282813|448283087|FG001|Overall Study|Withdrawal by Subject|5|||
124635834|NCT02282813|448283088|FG002|Overall Study|Withdrawal by Subject|0|||
124635835|NCT02282813|448283086|FG000|Overall Study|Adverse Event|3|||
124635836|NCT02282813|448283087|FG001|Overall Study|Adverse Event|10|||
124635837|NCT02282813|448283088|FG002|Overall Study|Adverse Event|1|||
124635838|NCT02282813|448283086|FG000|Overall Study|Subject non-compliance|1|||
124635839|NCT02282813|448283087|FG001|Overall Study|Subject non-compliance|4|||
124635840|NCT02282813|448283088|FG002|Overall Study|Subject non-compliance|0|||
124635841|NCT02282813|448283086|FG000|Overall Study|Physician Decision|0|||
124635842|NCT02282813|448283087|FG001|Overall Study|Physician Decision|3|||
124635843|NCT02282813|448283088|FG002|Overall Study|Physician Decision|1|||
124635844|NCT02282813|448283086|FG000|Overall Study|Lost to Follow-up|2|||
124635845|NCT02282813|448283087|FG001|Overall Study|Lost to Follow-up|0|||
124635846|NCT02282813|448283088|FG002|Overall Study|Lost to Follow-up|1|||
124635847|NCT02282813|448283086|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
124635848|NCT02282813|448283087|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
124635849|NCT02282813|448283088|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
124635850|NCT02282813|448283086|FG000|Overall Study|Lack of Efficacy|1|||
124635851|NCT02282813|448283087|FG001|Overall Study|Lack of Efficacy|0|||
124635852|NCT02282813|448283088|FG002|Overall Study|Lack of Efficacy|0|||
124635853|NCT02282813|448283086|FG000|Overall Study|Administrative reasons|0|||
124635854|NCT02282813|448283087|FG001|Overall Study|Administrative reasons|1|||
124635855|NCT02282813|448283088|FG002|Overall Study|Administrative reasons|0|||
124635856|NCT00739661|448283090|FG000|Overall Study|Adverse Event|2|||
124635857|NCT00739661|448283091|FG001|Overall Study|Adverse Event|0|||
124635858|NCT00739661|448283090|FG000|Overall Study|Physician decision to withdraw patient|1|||
124635859|NCT00739661|448283091|FG001|Overall Study|Physician decision to withdraw patient|0|||
124635860|NCT00739661|448283090|FG000|Overall Study|Patient decision to withdraw|9|||
124635861|NCT00739661|448283091|FG001|Overall Study|Patient decision to withdraw|4|||
124635862|NCT00739661|448283090|FG000|Overall Study|Disease progression, radiographic|33|||
124635863|NCT00739661|448283091|FG001|Overall Study|Disease progression, radiographic|37|||
124635864|NCT00739661|448283090|FG000|Overall Study|Reason for discontinuation not available|1|||
124635865|NCT00739661|448283091|FG001|Overall Study|Reason for discontinuation not available|1|||
124635866|NCT02105987|448283093|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
124635867|NCT02105987|448283094|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
124635868|NCT02105987|448283095|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
124635869|NCT02105987|448283096|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
124635870|NCT02105987|448283097|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
124635871|NCT02105987|448283098|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
124635872|NCT02105987|448283093|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
124635873|NCT02105987|448283094|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
124635874|NCT02105987|448283095|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
124635875|NCT02105987|448283096|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
124635876|NCT02105987|448283097|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
124635877|NCT02105987|448283098|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
124635878|NCT02105987|448283093|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
124635879|NCT02105987|448283094|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
124635880|NCT02105987|448283095|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
124635881|NCT02105987|448283096|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
124635882|NCT02105987|448283097|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
124635883|NCT02105987|448283098|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
124635884|NCT02105987|448283093|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
124635885|NCT02105987|448283094|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
124635886|NCT02105987|448283095|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
124635887|NCT02105987|448283096|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
124635888|NCT02105987|448283097|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
124635889|NCT02105987|448283098|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
124635890|NCT02105987|448283093|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
124635891|NCT02105987|448283094|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
124635892|NCT02105987|448283095|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
124635893|NCT02105987|448283096|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
124635894|NCT02105987|448283097|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
124635895|NCT02105987|448283098|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
124635896|NCT02105987|448283093|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
124635897|NCT02105987|448283094|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
124635898|NCT02105987|448283095|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
124635899|NCT02105987|448283096|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
124635900|NCT02105987|448283097|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
124635901|NCT02105987|448283098|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
124635902|NCT02105987|448283093|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
124635903|NCT02105987|448283094|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
124635904|NCT02105987|448283095|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
124635905|NCT02105987|448283096|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
124635906|NCT02105987|448283097|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
124635907|NCT02105987|448283098|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
124635908|NCT02105987|448283093|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
124635909|NCT02105987|448283094|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
124635910|NCT02105987|448283095|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
124635911|NCT02105987|448283096|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
124635912|NCT02105987|448283097|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
124635913|NCT02105987|448283098|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
124635914|NCT02105987|448283093|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
124635915|NCT02105987|448283094|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
124635916|NCT02105987|448283095|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
124635917|NCT02105987|448283096|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
124635918|NCT02105987|448283097|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
124635919|NCT02105987|448283098|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
124635920|NCT02105987|448283093|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
124635921|NCT02105987|448283094|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
124635922|NCT02105987|448283095|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
124635923|NCT02105987|448283096|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
124635924|NCT02105987|448283097|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
124635925|NCT02105987|448283098|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
124635926|NCT02105987|448283093|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
124635927|NCT02105987|448283094|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
124635928|NCT02105987|448283095|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
124635929|NCT02105987|448283096|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
124635930|NCT02105987|448283097|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
124635931|NCT02105987|448283098|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
124635932|NCT02105987|448283093|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
124635933|NCT02105987|448283094|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
124635934|NCT02105987|448283095|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
124635935|NCT02105987|448283096|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
124635936|NCT02105987|448283097|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
124635937|NCT02105987|448283098|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
124635938|NCT02105987|448283093|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
124635939|NCT02105987|448283094|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
124635940|NCT02105987|448283095|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
124635941|NCT02105987|448283096|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
124635942|NCT02105987|448283097|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
124635943|NCT02105987|448283098|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
124635944|NCT02105987|448283093|FG000|Continuation Phase|Protocol Violation|0|||
124635945|NCT02105987|448283094|FG001|Continuation Phase|Protocol Violation|0|||
124635946|NCT02105987|448283095|FG002|Continuation Phase|Protocol Violation|0|||
124635947|NCT02105987|448283096|FG003|Continuation Phase|Protocol Violation|0|||
124635948|NCT02105987|448283097|FG004|Continuation Phase|Protocol Violation|1|||
124635949|NCT02105987|448283098|FG005|Continuation Phase|Protocol Violation|0|||
124635950|NCT01420068|448283100|FG000|Overall Study|Administrative problems|1|||
124635951|NCT01420068|448283101|FG001|Overall Study|Administrative problems|3|||
124635952|NCT01420068|448283100|FG000|Overall Study|Withdrawal by Subject|1|||
124635953|NCT01420068|448283101|FG001|Overall Study|Withdrawal by Subject|2|||
124635954|NCT01153815|448283108|FG000|Overall Study|Adverse Event|3|||
124635955|NCT01153815|448283109|FG001|Overall Study|Adverse Event|1|||
124635956|NCT01153815|448283108|FG000|Overall Study|Withdrawal by Subject|6|||
124635957|NCT01153815|448283109|FG001|Overall Study|Withdrawal by Subject|4|||
124635958|NCT01890122|448283112|FG000|Overall Study|Adverse Event|1|||
124635959|NCT01890122|448283113|FG001|Overall Study|Adverse Event|1|||
124635960|NCT01890122|448283114|FG002|Overall Study|Adverse Event|1|||
124635961|NCT01890122|448283115|FG003|Overall Study|Adverse Event|2|||
124635962|NCT01890122|448283112|FG000|Overall Study|Major Protocol Deviation|3|||
124635963|NCT01890122|448283113|FG001|Overall Study|Major Protocol Deviation|1|||
124635964|NCT01890122|448283114|FG002|Overall Study|Major Protocol Deviation|0|||
124635965|NCT01890122|448283115|FG003|Overall Study|Major Protocol Deviation|1|||
124635966|NCT01890122|448283112|FG000|Overall Study|Lost to Follow-up|0|||
124635967|NCT01890122|448283113|FG001|Overall Study|Lost to Follow-up|1|||
124635968|NCT01890122|448283114|FG002|Overall Study|Lost to Follow-up|2|||
124635969|NCT01890122|448283115|FG003|Overall Study|Lost to Follow-up|2|||
124635970|NCT01890122|448283112|FG000|Overall Study|Voluntary Withdrawal|8|||
124635971|NCT01890122|448283113|FG001|Overall Study|Voluntary Withdrawal|8|||
124635972|NCT01890122|448283114|FG002|Overall Study|Voluntary Withdrawal|2|||
124635973|NCT01890122|448283115|FG003|Overall Study|Voluntary Withdrawal|11|||
124635974|NCT01890122|448283112|FG000|Overall Study|Lack of Efficacy|14|||
124635975|NCT01890122|448283113|FG001|Overall Study|Lack of Efficacy|24|||
124635976|NCT01890122|448283114|FG002|Overall Study|Lack of Efficacy|7|||
124635977|NCT01890122|448283115|FG003|Overall Study|Lack of Efficacy|41|||
124635978|NCT01890122|448283112|FG000|Overall Study|Reason not Specified|0|||
124635979|NCT01890122|448283113|FG001|Overall Study|Reason not Specified|1|||
124635980|NCT01890122|448283114|FG002|Overall Study|Reason not Specified|1|||
124635981|NCT01890122|448283115|FG003|Overall Study|Reason not Specified|2|||
124635982|NCT01890122|448283112|FG000|Overall Study|Randomized but not Treated|1|||
124635983|NCT01890122|448283113|FG001|Overall Study|Randomized but not Treated|1|||
124635984|NCT01890122|448283114|FG002|Overall Study|Randomized but not Treated|0|||
124635985|NCT01890122|448283115|FG003|Overall Study|Randomized but not Treated|0|||
124635986|NCT02062450|448283116|FG000|Overall Study|No follow-up visit|124|||
124635987|NCT02907177|448283117|FG000|Overall Study|Death|0|||
124635988|NCT02907177|448283118|FG001|Overall Study|Death|1|||
124635989|NCT02907177|448283117|FG000|Overall Study|Physician Decision|3|||
124635990|NCT02907177|448283118|FG001|Overall Study|Physician Decision|3|||
124635991|NCT02907177|448283117|FG000|Overall Study|Withdrawal by Subject|15|||
124635992|NCT02907177|448283118|FG001|Overall Study|Withdrawal by Subject|7|||
124635993|NCT02907177|448283117|FG000|Overall Study|Sponsor's Decision|50|||
124635994|NCT02907177|448283118|FG001|Overall Study|Sponsor's Decision|57|||
124635995|NCT01486446|448283123|FG000|Overall Study|Adverse Event|1|||
124635996|NCT01486446|448283124|FG001|Overall Study|Adverse Event|0|||
124635997|NCT04031846|448283125|FG000|Overall Study|Lost to Follow-up|4|||
124635998|NCT04031846|448283126|FG001|Overall Study|Lost to Follow-up|4|||
124635999|NCT04031846|448283125|FG000|Overall Study|Physician Decision|0|||
124636000|NCT04031846|448283126|FG001|Overall Study|Physician Decision|1|||
124636001|NCT04031846|448283125|FG000|Overall Study|Protocol Violation|1|||
124636002|NCT04031846|448283126|FG001|Overall Study|Protocol Violation|1|||
124636003|NCT04031846|448283125|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
124636004|NCT04031846|448283126|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
124636005|NCT03048747|448285086|FG000|Overall Study|Adverse Event|2|||
124636006|NCT03048747|448285086|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
124636007|NCT03048747|448285086|FG000|Overall Study|Physician Decision|1|||
124636008|NCT00824772|448285087|FG000|Overall Study|Withdrawal by Subject|8|||
124636009|NCT00866281|448285088|FG000|Overall Study|Adverse Event|1|||
124636010|NCT00866281|448285089|FG001|Overall Study|Adverse Event|0|||
124636011|NCT00866281|448285088|FG000|Overall Study|Withdrawal by participants|3|||
124636012|NCT00866281|448285089|FG001|Overall Study|Withdrawal by participants|0|||
124636013|NCT00866281|448285088|FG000|Overall Study|Disease progression|3|||
124636014|NCT00866281|448285089|FG001|Overall Study|Disease progression|11|||
124636015|NCT00866281|448285088|FG000|Overall Study|New cancer therapy|0|||
124636016|NCT00866281|448285089|FG001|Overall Study|New cancer therapy|4|||
124636017|NCT01894841|448285092|FG000|Overall Study|Withdrawal by Subject|9|||
124636018|NCT01894841|448285093|FG001|Overall Study|Withdrawal by Subject|4|||
124636019|NCT01894841|448285092|FG000|Overall Study|Withdrawn by investigator|2|||
124636020|NCT01894841|448285093|FG001|Overall Study|Withdrawn by investigator|2|||
124636021|NCT01894841|448285092|FG000|Overall Study|Lost to Follow-up|7|||
124636022|NCT01894841|448285093|FG001|Overall Study|Lost to Follow-up|3|||
124636023|NCT00529087|448285095|FG000|Overall Study|Adverse Event|10|||
124636024|NCT00529087|448285096|FG001|Overall Study|Adverse Event|13|||
124636025|NCT00529087|448285097|FG002|Overall Study|Adverse Event|4|||
124636026|NCT00529087|448285095|FG000|Overall Study|Lost to Follow-up|6|||
124636027|NCT00529087|448285096|FG001|Overall Study|Lost to Follow-up|4|||
124636028|NCT00529087|448285097|FG002|Overall Study|Lost to Follow-up|1|||
124812375|NCT00674362|448942668|FG001|Open Label|Adverse Event|0|||
124812376|NCT00674362|448942667|FG000|Open Label|Other: Subject moved to extension study|1|||
124812377|NCT00674362|448942668|FG001|Open Label|Other: Subject moved to extension study|0|||
124812378|NCT03137537|448942671|FG000|Overall Study|Adverse Event|0|||
124812379|NCT03137537|448942672|FG001|Overall Study|Adverse Event|1|||
124812380|NCT03386448|448942673|FG000|Overall Study|Adverse Event|0|||
124812381|NCT03386448|448942674|FG001|Overall Study|Adverse Event|2|||
124812382|NCT01146665|448942675|FG000|Overall Study|Withdrawal by Subject|10|||
124812383|NCT01146665|448942676|FG001|Overall Study|Withdrawal by Subject|16|||
124812384|NCT01817530|448942678|FG000|Overall Study|Exclusionary Medication Received|0|||
124812385|NCT01817530|448942679|FG001|Overall Study|Exclusionary Medication Received|0|||
124812386|NCT01817530|448942680|FG002|Overall Study|Exclusionary Medication Received|0|||
124812387|NCT01817530|448942681|FG003|Overall Study|Exclusionary Medication Received|0|||
124812388|NCT01817530|448942682|FG004|Overall Study|Exclusionary Medication Received|1|||
124812389|NCT01817530|448942683|FG005|Overall Study|Exclusionary Medication Received|0|||
124812390|NCT01817530|448942684|FG006|Overall Study|Exclusionary Medication Received|0|||
124812391|NCT01817530|448942685|FG007|Overall Study|Exclusionary Medication Received|0|||
124812392|NCT01817530|448942678|FG000|Overall Study|Adverse Event|6|||
124812393|NCT01817530|448942679|FG001|Overall Study|Adverse Event|3|||
124812394|NCT01817530|448942680|FG002|Overall Study|Adverse Event|2|||
124812395|NCT01817530|448942681|FG003|Overall Study|Adverse Event|5|||
124812396|NCT01817530|448942682|FG004|Overall Study|Adverse Event|0|||
124812397|NCT01817530|448942683|FG005|Overall Study|Adverse Event|10|||
124812398|NCT01817530|448942684|FG006|Overall Study|Adverse Event|5|||
124812399|NCT01817530|448942685|FG007|Overall Study|Adverse Event|8|||
124812400|NCT01817530|448942678|FG000|Overall Study|Subject Noncompliant|3|||
124812401|NCT01817530|448942679|FG001|Overall Study|Subject Noncompliant|1|||
124812402|NCT01817530|448942680|FG002|Overall Study|Subject Noncompliant|0|||
124812403|NCT01817530|448942681|FG003|Overall Study|Subject Noncompliant|4|||
124812404|NCT01817530|448942682|FG004|Overall Study|Subject Noncompliant|0|||
124812405|NCT01817530|448942683|FG005|Overall Study|Subject Noncompliant|1|||
124812406|NCT01817530|448942684|FG006|Overall Study|Subject Noncompliant|1|||
124812407|NCT01817530|448942685|FG007|Overall Study|Subject Noncompliant|1|||
124812408|NCT01817530|448942678|FG000|Overall Study|Lack of Efficacy|1|||
124812409|NCT01817530|448942679|FG001|Overall Study|Lack of Efficacy|0|||
124812410|NCT01817530|448942680|FG002|Overall Study|Lack of Efficacy|0|||
124812411|NCT01817530|448942681|FG003|Overall Study|Lack of Efficacy|0|||
124812412|NCT01817530|448942682|FG004|Overall Study|Lack of Efficacy|0|||
124812413|NCT01817530|448942683|FG005|Overall Study|Lack of Efficacy|1|||
124812414|NCT01817530|448942684|FG006|Overall Study|Lack of Efficacy|0|||
124812415|NCT01817530|448942685|FG007|Overall Study|Lack of Efficacy|1|||
124812416|NCT01817530|448942678|FG000|Overall Study|Pregnancy|0|||
124812417|NCT01817530|448942679|FG001|Overall Study|Pregnancy|0|||
124812418|NCT01817530|448942680|FG002|Overall Study|Pregnancy|0|||
124812419|NCT01817530|448942681|FG003|Overall Study|Pregnancy|0|||
124812420|NCT01817530|448942682|FG004|Overall Study|Pregnancy|0|||
124812421|NCT01817530|448942683|FG005|Overall Study|Pregnancy|1|||
124812422|NCT01817530|448942684|FG006|Overall Study|Pregnancy|0|||
124812423|NCT01817530|448942685|FG007|Overall Study|Pregnancy|0|||
124812424|NCT01817530|448942678|FG000|Overall Study|Other|0|||
124812425|NCT01817530|448942679|FG001|Overall Study|Other|1|||
124812426|NCT01817530|448942680|FG002|Overall Study|Other|0|||
124812427|NCT01817530|448942681|FG003|Overall Study|Other|0|||
124812428|NCT01817530|448942682|FG004|Overall Study|Other|1|||
124812429|NCT01817530|448942683|FG005|Overall Study|Other|0|||
124812430|NCT01817530|448942684|FG006|Overall Study|Other|5|||
124812431|NCT01817530|448942685|FG007|Overall Study|Other|0|||
124812432|NCT01817530|448942678|FG000|Overall Study|Surgery or Invasive Intervention|1|||
124812433|NCT01817530|448942679|FG001|Overall Study|Surgery or Invasive Intervention|0|||
124812434|NCT01817530|448942680|FG002|Overall Study|Surgery or Invasive Intervention|0|||
124812435|NCT01817530|448942681|FG003|Overall Study|Surgery or Invasive Intervention|0|||
124812436|NCT01817530|448942682|FG004|Overall Study|Surgery or Invasive Intervention|1|||
124636029|NCT00529087|448285095|FG000|Overall Study|Protocol Violation|8|||
124812437|NCT01817530|448942683|FG005|Overall Study|Surgery or Invasive Intervention|1|||
124812438|NCT01817530|448942684|FG006|Overall Study|Surgery or Invasive Intervention|1|||
124636030|NCT00529087|448285096|FG001|Overall Study|Protocol Violation|7|||
124636031|NCT00529087|448285097|FG002|Overall Study|Protocol Violation|6|||
124812439|NCT01817530|448942685|FG007|Overall Study|Surgery or Invasive Intervention|0|||
124812440|NCT01817530|448942678|FG000|Overall Study|Consent Withdrawn by Subject|3|||
124812441|NCT01817530|448942679|FG001|Overall Study|Consent Withdrawn by Subject|4|||
124812442|NCT01817530|448942680|FG002|Overall Study|Consent Withdrawn by Subject|7|||
124812443|NCT01817530|448942681|FG003|Overall Study|Consent Withdrawn by Subject|3|||
124812444|NCT01817530|448942682|FG004|Overall Study|Consent Withdrawn by Subject|5|||
124812445|NCT01817530|448942683|FG005|Overall Study|Consent Withdrawn by Subject|3|||
124812446|NCT01817530|448942684|FG006|Overall Study|Consent Withdrawn by Subject|3|||
124812447|NCT01817530|448942685|FG007|Overall Study|Consent Withdrawn by Subject|10|||
124812448|NCT01817530|448942678|FG000|Overall Study|Lost to Follow-up|1|||
124812449|NCT01817530|448942679|FG001|Overall Study|Lost to Follow-up|4|||
124812450|NCT01817530|448942680|FG002|Overall Study|Lost to Follow-up|2|||
124812451|NCT01817530|448942681|FG003|Overall Study|Lost to Follow-up|1|||
124812452|NCT01817530|448942682|FG004|Overall Study|Lost to Follow-up|3|||
124812453|NCT01817530|448942683|FG005|Overall Study|Lost to Follow-up|2|||
124812454|NCT01817530|448942684|FG006|Overall Study|Lost to Follow-up|8|||
124812455|NCT01817530|448942685|FG007|Overall Study|Lost to Follow-up|4|||
124812456|NCT03846804|448942686|FG000|Overall Study|Refused blood draw|1|||
124812457|NCT03846804|448942686|FG000|Overall Study|Protocol Violation|1|||
124812458|NCT00404235|448942687|FG000|Overall Study|Withdrawal by Subject|1|||
124812459|NCT00404235|448942688|FG001|Overall Study|Withdrawal by Subject|2|||
124812460|NCT00345839|448942689|FG000|Overall Study|Withdrawal by Subject|91|||
124812461|NCT00345839|448942690|FG001|Overall Study|Withdrawal by Subject|98|||
124812462|NCT00345839|448942689|FG000|Overall Study|Lost to Follow-up|58|||
124812463|NCT00345839|448942690|FG001|Overall Study|Lost to Follow-up|61|||
124812464|NCT03298867|448942693|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
124812465|NCT03298867|448942694|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
124812466|NCT03298867|448942693|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
124812467|NCT03298867|448942694|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
124812468|NCT03298867|448942693|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
124812469|NCT03298867|448942694|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
124812470|NCT03298867|448942693|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
124812471|NCT03298867|448942694|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
124812472|NCT03298867|448942693|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
124812473|NCT03298867|448942694|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
124812474|NCT03298867|448942693|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
124812475|NCT03298867|448942694|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
124812476|NCT03298867|448942693|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
124812477|NCT03298867|448942694|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
124812478|NCT03298867|448942693|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
124812479|NCT03298867|448942694|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
124812480|NCT03298867|448942693|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
124812481|NCT03298867|448942694|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
124812482|NCT00743483|448942695|FG000|Baseline Period|Physician Decision|1|||
124812483|NCT00743483|448942695|FG000|Treatment Period|Adverse Event|1|||
124812484|NCT01466153|448942696|FG000|Overall Study|Disease Progression|2|||
124812485|NCT01466153|448942697|FG001|Overall Study|Disease Progression|2|||
124812486|NCT01466153|448942698|FG002|Overall Study|Disease Progression|0|||
124812487|NCT01466153|448942696|FG000|Overall Study|Adverse Event|14|||
124812488|NCT01466153|448942697|FG001|Overall Study|Adverse Event|13|||
124812489|NCT01466153|448942698|FG002|Overall Study|Adverse Event|17|||
124812490|NCT01466153|448942696|FG000|Overall Study|Withdrawal of Consent|2|||
124812491|NCT01466153|448942697|FG001|Overall Study|Withdrawal of Consent|0|||
124812492|NCT01466153|448942698|FG002|Overall Study|Withdrawal of Consent|0|||
124812493|NCT01466153|448942696|FG000|Overall Study|Investigator Discretion|3|||
124812494|NCT01466153|448942697|FG001|Overall Study|Investigator Discretion|2|||
124812495|NCT01466153|448942698|FG002|Overall Study|Investigator Discretion|2|||
124812496|NCT01466153|448942696|FG000|Overall Study|Randomized-Not Treated|2|||
124812497|NCT01466153|448942697|FG001|Overall Study|Randomized-Not Treated|3|||
124812498|NCT01466153|448942698|FG002|Overall Study|Randomized-Not Treated|4|||
124812499|NCT01466153|448942696|FG000|Overall Study|Other-Unspecified|6|||
124812500|NCT01466153|448942697|FG001|Overall Study|Other-Unspecified|4|||
124812501|NCT01466153|448942698|FG002|Overall Study|Other-Unspecified|2|||
124812502|NCT03281577|448944575|FG000|Overall Study|Adverse Event|0|||
124812503|NCT03281577|448944576|FG001|Overall Study|Adverse Event|0|||
124812504|NCT03281577|448944577|FG002|Overall Study|Adverse Event|0|||
124812505|NCT03281577|448944578|FG003|Overall Study|Adverse Event|1|||
124812506|NCT03281577|448944575|FG000|Overall Study|Withdrawal by Subject|1|||
124636032|NCT00529087|448285095|FG000|Overall Study|Withdrawal by Subject|3|||
124812507|NCT03281577|448944576|FG001|Overall Study|Withdrawal by Subject|0|||
124812508|NCT03281577|448944577|FG002|Overall Study|Withdrawal by Subject|0|||
124636033|NCT00529087|448285096|FG001|Overall Study|Withdrawal by Subject|3|||
124812509|NCT03281577|448944578|FG003|Overall Study|Withdrawal by Subject|0|||
124812510|NCT02323113|448944579|FG000|Overall Study|Adverse Event|3|||
124812511|NCT02323113|448944580|FG001|Overall Study|Adverse Event|3|||
124812512|NCT02323113|448944581|FG002|Overall Study|Adverse Event|2|||
124812513|NCT02323113|448944582|FG003|Overall Study|Adverse Event|5|||
124812514|NCT02323113|448944583|FG004|Overall Study|Adverse Event|8|||
124812515|NCT02323113|448944584|FG005|Overall Study|Adverse Event|3|||
124812516|NCT02323113|448944585|FG006|Overall Study|Adverse Event|6|||
124812517|NCT02323113|448944586|FG007|Overall Study|Adverse Event|0|||
124812518|NCT02323113|448944579|FG000|Overall Study|Progressive Disease|0|||
124812519|NCT02323113|448944580|FG001|Overall Study|Progressive Disease|1|||
124812520|NCT02323113|448944581|FG002|Overall Study|Progressive Disease|1|||
124812521|NCT02323113|448944582|FG003|Overall Study|Progressive Disease|0|||
124812522|NCT02323113|448944583|FG004|Overall Study|Progressive Disease|0|||
124812523|NCT02323113|448944584|FG005|Overall Study|Progressive Disease|3|||
124812524|NCT02323113|448944585|FG006|Overall Study|Progressive Disease|0|||
124812525|NCT02323113|448944586|FG007|Overall Study|Progressive Disease|0|||
124812526|NCT02323113|448944579|FG000|Overall Study|Symptomatic Deterioration|0|||
124812527|NCT02323113|448944580|FG001|Overall Study|Symptomatic Deterioration|0|||
124812528|NCT02323113|448944581|FG002|Overall Study|Symptomatic Deterioration|1|||
124812529|NCT02323113|448944582|FG003|Overall Study|Symptomatic Deterioration|0|||
124812530|NCT02323113|448944583|FG004|Overall Study|Symptomatic Deterioration|1|||
124812531|NCT02323113|448944584|FG005|Overall Study|Symptomatic Deterioration|0|||
124812532|NCT02323113|448944585|FG006|Overall Study|Symptomatic Deterioration|0|||
124812533|NCT02323113|448944586|FG007|Overall Study|Symptomatic Deterioration|0|||
124812534|NCT02323113|448944579|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
124812535|NCT02323113|448944580|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
124812536|NCT02323113|448944581|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
124812537|NCT02323113|448944582|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
124812538|NCT02323113|448944583|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
124812539|NCT02323113|448944584|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
124812540|NCT02323113|448944585|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
124812541|NCT02323113|448944586|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
124812542|NCT02323113|448944579|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
124812543|NCT02323113|448944580|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
124812544|NCT02323113|448944581|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
124812545|NCT02323113|448944582|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
124812546|NCT02323113|448944583|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
124812547|NCT02323113|448944584|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
124812548|NCT02323113|448944585|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
124812549|NCT02323113|448944586|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
124812550|NCT01663532|448944587|FG000|Overall Study|Lost to Follow-up|9|||
124812551|NCT01663532|448944588|FG001|Overall Study|Lost to Follow-up|10|||
124812552|NCT01663532|448944587|FG000|Overall Study|Adverse Event|7|||
124812553|NCT01663532|448944588|FG001|Overall Study|Adverse Event|13|||
124812554|NCT01663532|448944587|FG000|Overall Study|Met Withdrawal Criteria|7|||
124812555|NCT01663532|448944588|FG001|Overall Study|Met Withdrawal Criteria|6|||
124812556|NCT01663532|448944587|FG000|Overall Study|Physician Decision|1|||
124812557|NCT01663532|448944588|FG001|Overall Study|Physician Decision|1|||
124812558|NCT01663532|448944587|FG000|Overall Study|Withdrawal by Subject|35|||
124812559|NCT01663532|448944588|FG001|Overall Study|Withdrawal by Subject|17|||
124812560|NCT01663532|448944587|FG000|Overall Study|Lack of Efficacy|15|||
124812561|NCT01663532|448944588|FG001|Overall Study|Lack of Efficacy|60|||
124812562|NCT00354744|448944589|FG000|Overall Study|Adverse Event|2|||
124812563|NCT00354744|448944589|FG000|Overall Study|Death|2|||
124812564|NCT00354744|448944589|FG000|Overall Study|Lack of Efficacy|11|||
124812565|NCT00354744|448944589|FG000|Overall Study|Lost to Follow-up|2|||
124812566|NCT00354744|448944589|FG000|Overall Study|Physician Decision|11|||
124812567|NCT00354744|448944589|FG000|Overall Study|Withdrawal by Subject|14|||
124812568|NCT01513343|448944590|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
124812569|NCT01513343|448944591|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
124812570|NCT01513343|448944590|FG000|Post Data Collection|Dropped/withdrew from study|7|||
124812571|NCT01513343|448944591|FG001|Post Data Collection|Dropped/withdrew from study|1|||
124812572|NCT01513343|448944590|FG000|Post Data Collection|Lost to Follow-up|10|||
124812573|NCT01513343|448944591|FG001|Post Data Collection|Lost to Follow-up|23|||
124812574|NCT01513343|448944590|FG000|6-month Follow-up|Lost to Follow-up|28|||
124812575|NCT01513343|448944591|FG001|6-month Follow-up|Lost to Follow-up|17|||
124812576|NCT01513343|448944590|FG000|12-month Follow-up|Lost to Follow-up|10|||
124636034|NCT00529087|448285097|FG002|Overall Study|Withdrawal by Subject|3|||
124636035|NCT00529087|448285095|FG000|Overall Study|Protocol deviation|1|||
124636036|NCT00529087|448285096|FG001|Overall Study|Protocol deviation|1|||
124636037|NCT00529087|448285097|FG002|Overall Study|Protocol deviation|2|||
124812577|NCT01513343|448944591|FG001|12-month Follow-up|Lost to Follow-up|3|||
124812578|NCT01749137|448944592|FG000|Overall Study|Adverse Event|4|||
124636038|NCT00318474|448285098|FG000|Overall Study|Adverse Event|1|||
124812579|NCT01749137|448944593|FG001|Overall Study|Adverse Event|4|||
124812580|NCT01749137|448944592|FG000|Overall Study|Lost to Follow-up|2|||
124812581|NCT01749137|448944593|FG001|Overall Study|Lost to Follow-up|3|||
124636039|NCT00318474|448285099|FG001|Overall Study|Adverse Event|1|||
124812582|NCT01749137|448944592|FG000|Overall Study|Physician Decision|1|||
124812583|NCT01749137|448944593|FG001|Overall Study|Physician Decision|0|||
124812584|NCT01749137|448944592|FG000|Overall Study|Withdrawal by Subject|8|||
124812585|NCT01749137|448944593|FG001|Overall Study|Withdrawal by Subject|4|||
124812586|NCT02587234|448944594|FG000|Overall Study|Withdrawal by Subject|1|||
124812587|NCT02587234|448944595|FG001|Overall Study|Withdrawal by Subject|1|||
124812588|NCT02587234|448944594|FG000|Overall Study|Lost to Follow-up|0|||
124812589|NCT02587234|448944595|FG001|Overall Study|Lost to Follow-up|2|||
124812590|NCT01153347|448944596|FG000|Overall Study|Withdrawal by Subject|7|||
124812591|NCT01153347|448944597|FG001|Overall Study|Withdrawal by Subject|7|||
124812592|NCT01153347|448944598|FG002|Overall Study|Withdrawal by Subject|7|||
124812593|NCT01153347|448944599|FG003|Overall Study|Withdrawal by Subject|7|||
124812594|NCT01153347|448944596|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124812595|NCT01153347|448944597|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
124812596|NCT01153347|448944598|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
124812597|NCT01153347|448944599|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
124812598|NCT01153347|448944596|FG000|Overall Study|Adverse Event|3|||
124812599|NCT01153347|448944597|FG001|Overall Study|Adverse Event|9|||
124812600|NCT01153347|448944598|FG002|Overall Study|Adverse Event|21|||
124812601|NCT01153347|448944599|FG003|Overall Study|Adverse Event|7|||
124812602|NCT01153347|448944596|FG000|Overall Study|Severe non-compliance to protocol|6|||
124812603|NCT01153347|448944597|FG001|Overall Study|Severe non-compliance to protocol|7|||
124812604|NCT01153347|448944598|FG002|Overall Study|Severe non-compliance to protocol|4|||
124812605|NCT01153347|448944599|FG003|Overall Study|Severe non-compliance to protocol|3|||
124812606|NCT01153347|448944596|FG000|Overall Study|Condition under investigation worsened|1|||
124812607|NCT01153347|448944597|FG001|Overall Study|Condition under investigation worsened|1|||
124812608|NCT01153347|448944598|FG002|Overall Study|Condition under investigation worsened|0|||
124812609|NCT01153347|448944599|FG003|Overall Study|Condition under investigation worsened|0|||
124812610|NCT01153347|448944596|FG000|Overall Study|Lack of Efficacy|2|||
124812611|NCT01153347|448944597|FG001|Overall Study|Lack of Efficacy|2|||
124812612|NCT01153347|448944598|FG002|Overall Study|Lack of Efficacy|0|||
124812613|NCT01153347|448944599|FG003|Overall Study|Lack of Efficacy|4|||
124812614|NCT01153347|448944596|FG000|Overall Study|Study-specific withdrawal criteria|4|||
124812615|NCT01153347|448944597|FG001|Overall Study|Study-specific withdrawal criteria|3|||
124812616|NCT01153347|448944598|FG002|Overall Study|Study-specific withdrawal criteria|1|||
124812617|NCT01153347|448944599|FG003|Overall Study|Study-specific withdrawal criteria|2|||
124812618|NCT01153347|448944596|FG000|Overall Study|Lost to Follow-up|4|||
124812619|NCT01153347|448944597|FG001|Overall Study|Lost to Follow-up|9|||
124812620|NCT01153347|448944598|FG002|Overall Study|Lost to Follow-up|11|||
124812621|NCT01153347|448944599|FG003|Overall Study|Lost to Follow-up|8|||
124812622|NCT01153347|448944596|FG000|Overall Study|Other|5|||
124812623|NCT01153347|448944597|FG001|Overall Study|Other|5|||
124812624|NCT01153347|448944598|FG002|Overall Study|Other|4|||
124812625|NCT01153347|448944599|FG003|Overall Study|Other|0|||
124812626|NCT01153347|448944596|FG000|Overall Study|Death|1|||
124812627|NCT01153347|448944597|FG001|Overall Study|Death|0|||
124812628|NCT01153347|448944598|FG002|Overall Study|Death|0|||
124812629|NCT01153347|448944599|FG003|Overall Study|Death|0|||
124812630|NCT01706146|448944600|FG000|Overall Study|Withdrawal by Subject|1|||
124812631|NCT01706146|448944600|FG000|Overall Study|Adverse Event|3|||
124812632|NCT01706146|448944600|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
124812633|NCT02582983|448944601|FG000|Overall Study|Death|3|||
124812634|NCT02582983|448944601|FG000|Overall Study|Withdrawal by Subject|2|||
124812635|NCT02582983|448944601|FG000|Overall Study|Adverse Event|1|||
124812636|NCT01751178|448944602|FG000|Overall Study|Adverse Event|2|||
124812637|NCT01751178|448944603|FG001|Overall Study|Adverse Event|0|||
124812638|NCT01751178|448944604|FG002|Overall Study|Adverse Event|0|||
124812639|NCT01751178|448944602|FG000|Overall Study|Other Reason (unknown)|1|||
124812640|NCT01751178|448944603|FG001|Overall Study|Other Reason (unknown)|0|||
124812641|NCT01751178|448944604|FG002|Overall Study|Other Reason (unknown)|2|||
124812642|NCT00289991|448944605|FG000|Overall Study|Death|35|||
124636040|NCT00318474|448285098|FG000|Overall Study|Lost to Follow-up|0|||
124636041|NCT00318474|448285099|FG001|Overall Study|Lost to Follow-up|1|||
124636042|NCT00318474|448285098|FG000|Overall Study|Pregnancy|0|||
124812643|NCT00289991|448944606|FG001|Overall Study|Death|38|||
124812644|NCT00289991|448944605|FG000|Overall Study|Adverse Event|15|||
124812645|NCT00289991|448944606|FG001|Overall Study|Adverse Event|13|||
124812646|NCT00289991|448944605|FG000|Overall Study|Failure of prophylaxis|1|||
124812647|NCT00289991|448944606|FG001|Overall Study|Failure of prophylaxis|1|||
124812648|NCT00289991|448944605|FG000|Overall Study|Fungal breakthrough infection|0|||
124812649|NCT00289991|448944606|FG001|Overall Study|Fungal breakthrough infection|1|||
124812650|NCT00289991|448944605|FG000|Overall Study|Lost to Follow-up|0|||
124812651|NCT00289991|448944606|FG001|Overall Study|Lost to Follow-up|1|||
124812652|NCT00289991|448944605|FG000|Overall Study|Withdrawal by Subject|2|||
124812653|NCT00289991|448944606|FG001|Overall Study|Withdrawal by Subject|12|||
124812654|NCT00289991|448944605|FG000|Overall Study|Other|5|||
124812655|NCT00289991|448944606|FG001|Overall Study|Other|14|||
124812656|NCT01606007|448944611|FG000|Overall Study|Reason 'Other' in the protocol|0|||
124812657|NCT01606007|448944612|FG001|Overall Study|Reason 'Other' in the protocol|1|||
124812658|NCT01606007|448944613|FG002|Overall Study|Reason 'Other' in the protocol|1|||
124812659|NCT01606007|448944611|FG000|Overall Study|Pregnancy|0|||
124812660|NCT01606007|448944612|FG001|Overall Study|Pregnancy|1|||
124812661|NCT01606007|448944613|FG002|Overall Study|Pregnancy|1|||
124812662|NCT01606007|448944611|FG000|Overall Study|Withdrawal by Subject|8|||
124812663|NCT01606007|448944612|FG001|Overall Study|Withdrawal by Subject|6|||
124812664|NCT01606007|448944613|FG002|Overall Study|Withdrawal by Subject|1|||
124812665|NCT01606007|448944611|FG000|Overall Study|Adverse Event|0|||
124812666|NCT01606007|448944612|FG001|Overall Study|Adverse Event|1|||
124812667|NCT01606007|448944613|FG002|Overall Study|Adverse Event|1|||
124812668|NCT01606007|448944611|FG000|Overall Study|discontinue study treatment|0|||
124812669|NCT01606007|448944612|FG001|Overall Study|discontinue study treatment|2|||
124812670|NCT01606007|448944613|FG002|Overall Study|discontinue study treatment|1|||
124812671|NCT01606007|448944611|FG000|Overall Study|Lost to Follow-up|6|||
124812672|NCT01606007|448944612|FG001|Overall Study|Lost to Follow-up|8|||
124812673|NCT01606007|448944613|FG002|Overall Study|Lost to Follow-up|5|||
124812674|NCT01606007|448944611|FG000|Overall Study|Poor/Non-compliance|1|||
124812675|NCT01606007|448944612|FG001|Overall Study|Poor/Non-compliance|0|||
124812676|NCT01606007|448944613|FG002|Overall Study|Poor/Non-compliance|0|||
124812677|NCT01007812|448944616|FG000|Period 1, One Week|Lost to Follow-up|0|||
124812678|NCT01007812|448944617|FG001|Period 1, One Week|Lost to Follow-up|1|||
124812679|NCT01007812|448944616|FG000|Period 1, One Week|Discomfort|1|||
124812680|NCT01007812|448944617|FG001|Period 1, One Week|Discomfort|0|||
124812681|NCT01091974|448944618|FG000|Overall Study|Did not start intervention|3|||
124812682|NCT01091974|448944619|FG001|Overall Study|Did not start intervention|1|||
124812683|NCT01091974|448944620|FG002|Overall Study|Did not start intervention|3|||
124812684|NCT01091974|448944621|FG003|Overall Study|Did not start intervention|1|||
124812685|NCT01091974|448944618|FG000|Overall Study|resumed sleep medication|0|||
124812686|NCT01091974|448944619|FG001|Overall Study|resumed sleep medication|0|||
124812687|NCT01091974|448944620|FG002|Overall Study|resumed sleep medication|1|||
124812688|NCT01091974|448944621|FG003|Overall Study|resumed sleep medication|2|||
124812689|NCT01091974|448944618|FG000|Overall Study|Withdrawal by Subject|1|||
124812690|NCT01091974|448944619|FG001|Overall Study|Withdrawal by Subject|3|||
124812691|NCT01091974|448944620|FG002|Overall Study|Withdrawal by Subject|2|||
124812692|NCT01091974|448944621|FG003|Overall Study|Withdrawal by Subject|2|||
124812693|NCT01091974|448944618|FG000|Overall Study|side-effects|1|||
124812694|NCT01091974|448944619|FG001|Overall Study|side-effects|1|||
124812695|NCT01091974|448944620|FG002|Overall Study|side-effects|0|||
124812696|NCT01091974|448944621|FG003|Overall Study|side-effects|2|||
124812697|NCT00555971|448944622|FG000|Overall Study|Adverse Event|1|||
124812698|NCT00555971|448944623|FG001|Overall Study|Adverse Event|1|||
124812699|NCT00518284|448944624|FG000|Overall Study|Adverse Event|0|||
124812700|NCT00518284|448944625|FG001|Overall Study|Adverse Event|1|||
124812701|NCT00518284|448944626|FG002|Overall Study|Adverse Event|0|||
124812702|NCT00518284|448944627|FG003|Overall Study|Adverse Event|0|||
124812703|NCT00518284|448944624|FG000|Overall Study|Study Termination|0|||
124812704|NCT00518284|448944625|FG001|Overall Study|Study Termination|2|||
124812705|NCT00518284|448944626|FG002|Overall Study|Study Termination|1|||
124812706|NCT00518284|448944627|FG003|Overall Study|Study Termination|2|||
124812707|NCT02571777|448944628|FG000|Overall Study|Subject/guardian decision|34|||
124812708|NCT02571777|448944629|FG001|Overall Study|Subject/guardian decision|26|||
124812709|NCT02571777|448944630|FG002|Overall Study|Subject/guardian decision|26|||
124812710|NCT02571777|448944631|FG003|Overall Study|Subject/guardian decision|25|||
124812711|NCT02571777|448944632|FG004|Overall Study|Subject/guardian decision|27|||
124812712|NCT02571777|448944628|FG000|Overall Study|Protocol Deviation|2|||
124812713|NCT02571777|448944629|FG001|Overall Study|Protocol Deviation|3|||
124812714|NCT02571777|448944630|FG002|Overall Study|Protocol Deviation|4|||
124812715|NCT02571777|448944631|FG003|Overall Study|Protocol Deviation|8|||
124812716|NCT02571777|448944632|FG004|Overall Study|Protocol Deviation|4|||
124812717|NCT02571777|448944628|FG000|Overall Study|Death|1|||
124812718|NCT02571777|448944629|FG001|Overall Study|Death|1|||
124812719|NCT02571777|448944630|FG002|Overall Study|Death|4|||
124812720|NCT02571777|448944631|FG003|Overall Study|Death|0|||
124812721|NCT02571777|448944632|FG004|Overall Study|Death|0|||
124812722|NCT02571777|448944628|FG000|Overall Study|Lost to Follow-up|1|||
124812723|NCT02571777|448944629|FG001|Overall Study|Lost to Follow-up|1|||
124812724|NCT02571777|448944630|FG002|Overall Study|Lost to Follow-up|2|||
124812725|NCT02571777|448944631|FG003|Overall Study|Lost to Follow-up|0|||
124812726|NCT02571777|448944632|FG004|Overall Study|Lost to Follow-up|1|||
124812727|NCT02571777|448944628|FG000|Overall Study|Physician Decision|1|||
124812728|NCT02571777|448944629|FG001|Overall Study|Physician Decision|7|||
124812729|NCT02571777|448944630|FG002|Overall Study|Physician Decision|5|||
124812730|NCT02571777|448944631|FG003|Overall Study|Physician Decision|2|||
124812731|NCT02571777|448944632|FG004|Overall Study|Physician Decision|4|||
124812732|NCT02571777|448944628|FG000|Overall Study|Pregnancy|0|||
124812733|NCT02571777|448944629|FG001|Overall Study|Pregnancy|0|||
124812734|NCT02571777|448944630|FG002|Overall Study|Pregnancy|0|||
124812735|NCT02571777|448944631|FG003|Overall Study|Pregnancy|2|||
124812736|NCT02571777|448944632|FG004|Overall Study|Pregnancy|0|||
124812737|NCT00801632|448944633|FG000|Overall Study|Re-transplant|1|||
124812738|NCT01350492|448944639|FG000|Intervention|Lost to Follow-up|2|||
124812739|NCT01350492|448944640|FG001|Intervention|Lost to Follow-up|5|||
124812740|NCT01350492|448944639|FG000|Intervention|Withdrawal by Subject|3|||
124812741|NCT01350492|448944640|FG001|Intervention|Withdrawal by Subject|1|||
124812742|NCT01350492|448944639|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
124812743|NCT01350492|448944640|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
124812744|NCT01350492|448944639|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
124812745|NCT01350492|448944640|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
124812746|NCT00205881|448944641|FG000|Overall Study|Withdrawal by Subject|16|||
124812747|NCT00781274|448944650|FG000|Overall Study|Withdrawal by Subject|2|||
124812748|NCT01534962|448944651|FG000|Overall Study|Randomized but did not start treatment|2|||
124812749|NCT01534962|448944652|FG001|Overall Study|Randomized but did not start treatment|0|||
124812750|NCT01534962|448944653|FG002|Overall Study|Randomized but did not start treatment|0|||
124812751|NCT01534962|448944654|FG003|Overall Study|Randomized but did not start treatment|1|||
124812752|NCT01534962|448944651|FG000|Overall Study|Discontinued at AF recurrence|35|||
124812753|NCT01534962|448944652|FG001|Overall Study|Discontinued at AF recurrence|26|||
124812754|NCT01534962|448944653|FG002|Overall Study|Discontinued at AF recurrence|24|||
124812755|NCT01534962|448944654|FG003|Overall Study|Discontinued at AF recurrence|31|||
124812756|NCT00282984|448944655|FG000|Overall Study|Death|2|||
124812757|NCT00282984|448944656|FG001|Overall Study|Death|5|||
124812758|NCT00282984|448944655|FG000|Overall Study|Adverse Event|8|||
124812759|NCT00282984|448944656|FG001|Overall Study|Adverse Event|5|||
124812760|NCT00282984|448944655|FG000|Overall Study|Lack of Efficacy|0|||
124812761|NCT00282984|448944656|FG001|Overall Study|Lack of Efficacy|2|||
124812762|NCT00282984|448944655|FG000|Overall Study|Lost to Follow-up|14|||
124812763|NCT00282984|448944656|FG001|Overall Study|Lost to Follow-up|10|||
124812764|NCT00282984|448944655|FG000|Overall Study|Withdrawal by Participant|22|||
124812765|NCT00282984|448944656|FG001|Overall Study|Withdrawal by Participant|34|||
124812766|NCT00282984|448944655|FG000|Overall Study|Participant stopped study medication|2|||
124812767|NCT00282984|448944656|FG001|Overall Study|Participant stopped study medication|2|||
124812768|NCT00282984|448944655|FG000|Overall Study|Participant only allowed phone follow-up|0|||
124812769|NCT00282984|448944656|FG001|Overall Study|Participant only allowed phone follow-up|1|||
124812770|NCT00282984|448944655|FG000|Overall Study|Participant used antipsychosis meds|0|||
124812771|NCT00282984|448944656|FG001|Overall Study|Participant used antipsychosis meds|1|||
124812772|NCT00282984|448944655|FG000|Overall Study|lack of motivation|1|||
124812773|NCT00282984|448944656|FG001|Overall Study|lack of motivation|0|||
124812774|NCT00282984|448944655|FG000|Overall Study|in prison|0|||
124812775|NCT00282984|448944656|FG001|Overall Study|in prison|1|||
124812776|NCT00282984|448944655|FG000|Overall Study|Protocol Violation|2|||
124812777|NCT00282984|448944656|FG001|Overall Study|Protocol Violation|0|||
124812778|NCT00191269|448944657|FG000|Overall Study|Protocol Violation|0|||
124812779|NCT00191269|448944658|FG001|Overall Study|Protocol Violation|2|||
124812780|NCT00191269|448944657|FG000|Overall Study|Adverse Event|1|||
124812781|NCT00191269|448944658|FG001|Overall Study|Adverse Event|4|||
124812782|NCT00191269|448944657|FG000|Overall Study|Progression of Disease|4|||
124812783|NCT00191269|448944658|FG001|Overall Study|Progression of Disease|42|||
124812784|NCT00191269|448944657|FG000|Overall Study|Lack of Efficacy|1|||
124812785|NCT00191269|448944658|FG001|Overall Study|Lack of Efficacy|5|||
124812786|NCT00191269|448944657|FG000|Overall Study|Withdrawal by Subject|0|||
124812787|NCT00191269|448944658|FG001|Overall Study|Withdrawal by Subject|1|||
124812788|NCT00191269|448944657|FG000|Overall Study|Pathologic Aggrevation|0|||
124812789|NCT00191269|448944658|FG001|Overall Study|Pathologic Aggrevation|1|||
124812790|NCT00191269|448944657|FG000|Overall Study|Physician Decision|0|||
124812791|NCT00191269|448944658|FG001|Overall Study|Physician Decision|3|||
124812792|NCT02151110|448944664|FG000|Overall Study|Withdrawal by Subject|0|||
124812793|NCT02151110|448944665|FG001|Overall Study|Withdrawal by Subject|0|||
124812794|NCT02151110|448944666|FG002|Overall Study|Withdrawal by Subject|0|||
124812795|NCT02151110|448944667|FG003|Overall Study|Withdrawal by Subject|0|||
124812796|NCT02151110|448944668|FG004|Overall Study|Withdrawal by Subject|0|||
124636043|NCT00318474|448285099|FG001|Overall Study|Pregnancy|2|||
124812797|NCT02151110|448944669|FG005|Overall Study|Withdrawal by Subject|0|||
124812798|NCT02151110|448944670|FG006|Overall Study|Withdrawal by Subject|0|||
124812799|NCT02151110|448944671|FG007|Overall Study|Withdrawal by Subject|1|||
124812800|NCT02151110|448944664|FG000|Overall Study|Lost to Follow-up|0|||
124812801|NCT02151110|448944665|FG001|Overall Study|Lost to Follow-up|0|||
124812802|NCT02151110|448944666|FG002|Overall Study|Lost to Follow-up|0|||
124812803|NCT02151110|448944667|FG003|Overall Study|Lost to Follow-up|0|||
124812804|NCT02151110|448944668|FG004|Overall Study|Lost to Follow-up|0|||
124812805|NCT02151110|448944669|FG005|Overall Study|Lost to Follow-up|0|||
124812806|NCT02151110|448944670|FG006|Overall Study|Lost to Follow-up|0|||
124812807|NCT02151110|448944671|FG007|Overall Study|Lost to Follow-up|2|||
124812808|NCT02015754|448944672|FG000|Overall Study|Disease progression|5|||
124812809|NCT02015754|448944672|FG000|Overall Study|Change in treatment modality|5|||
124812810|NCT02015754|448944672|FG000|Overall Study|Lost to Follow-up|1|||
124812811|NCT01128842|448944673|FG000|Overall Study|Adverse Event|1|||
124812812|NCT01128842|448944673|FG000|Overall Study|Disease Progression|6|||
124812813|NCT04528732|448944674|FG000|Overall Study|Death|1|||
124812814|NCT04528732|448944675|FG001|Overall Study|Death|0|||
124812815|NCT04528732|448944676|FG002|Overall Study|Death|1|||
124812816|NCT04528732|448944674|FG000|Overall Study|Lost to Follow-up|0|||
124812817|NCT04528732|448944675|FG001|Overall Study|Lost to Follow-up|1|||
124812818|NCT04528732|448944676|FG002|Overall Study|Lost to Follow-up|2|||
124812819|NCT01300650|448944683|FG000|Overall Study|Adverse Event|1|||
124812820|NCT02369016|448944684|FG000|Overall Study|AE associated with clinical disease progression|2|||
124812821|NCT02369016|448944685|FG001|Overall Study|AE associated with clinical disease progression|1|||
124812822|NCT02369016|448944684|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
124812823|NCT02369016|448944685|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
124812824|NCT02369016|448944684|FG000|Overall Study|Progressive disease - clinical progression|1|||
124812825|NCT02369016|448944685|FG001|Overall Study|Progressive disease - clinical progression|4|||
124812826|NCT02369016|448944684|FG000|Overall Study|withdrawal by patient|4|||
124812827|NCT02369016|448944685|FG001|Overall Study|withdrawal by patient|0|||
124812828|NCT02369016|448944684|FG000|Overall Study|Progressive disease - radiological progression|6|||
124812829|NCT02369016|448944685|FG001|Overall Study|Progressive disease - radiological progression|2|||
124812830|NCT00668707|448944686|FG000|Overall Study|Cancer Recurrence|58|||
124812831|NCT00668707|448944687|FG001|Overall Study|Cancer Recurrence|58|||
124812832|NCT00668707|448944686|FG000|Overall Study|Withdrawal by Subject|117|||
124812833|NCT00668707|448944687|FG001|Overall Study|Withdrawal by Subject|100|||
124812834|NCT00668707|448944686|FG000|Overall Study|Lost to Follow-up|3|||
124812835|NCT00668707|448944687|FG001|Overall Study|Lost to Follow-up|6|||
124812836|NCT00668707|448944686|FG000|Overall Study|Protocol Violation|10|||
124812837|NCT00668707|448944687|FG001|Overall Study|Protocol Violation|12|||
124812838|NCT00668707|448944686|FG000|Overall Study|Death|11|||
124812839|NCT00668707|448944687|FG001|Overall Study|Death|4|||
124812840|NCT00923156|448944688|FG000|Overall Study|Adverse Event|0|||
124812841|NCT00923156|448944689|FG001|Overall Study|Adverse Event|2|||
124812842|NCT00923156|448944690|FG002|Overall Study|Adverse Event|1|||
124812843|NCT00923156|448944688|FG000|Overall Study|Abnormal laboratory values|0|||
124812844|NCT00923156|448944689|FG001|Overall Study|Abnormal laboratory values|0|||
124812845|NCT00923156|448944690|FG002|Overall Study|Abnormal laboratory values|1|||
124812846|NCT00923156|448944688|FG000|Overall Study|Withdrawal by Subject|0|||
124812847|NCT00923156|448944689|FG001|Overall Study|Withdrawal by Subject|1|||
124812848|NCT00923156|448944690|FG002|Overall Study|Withdrawal by Subject|0|||
124812849|NCT00923156|448944688|FG000|Overall Study|Death|0|||
124812850|NCT00923156|448944689|FG001|Overall Study|Death|1|||
124812851|NCT00923156|448944690|FG002|Overall Study|Death|0|||
124812852|NCT00923156|448944688|FG000|Overall Study|Lack of Efficacy|0|||
124812853|NCT00923156|448944689|FG001|Overall Study|Lack of Efficacy|0|||
124812854|NCT00923156|448944690|FG002|Overall Study|Lack of Efficacy|1|||
124812855|NCT01201850|448944691|FG000|Overall Study|Tumor progression|4|||
124812856|NCT03338010|448944692|FG000|Overall Study|Withdrawal by Subject|14|||
124812857|NCT03338010|448944693|FG001|Overall Study|Withdrawal by Subject|8|||
124812858|NCT03338010|448944692|FG000|Overall Study|Lost to Follow-up|4|||
124812859|NCT03338010|448944693|FG001|Overall Study|Lost to Follow-up|2|||
124812860|NCT03338010|448944692|FG000|Overall Study|Adverse Event|3|||
124812861|NCT03338010|448944693|FG001|Overall Study|Adverse Event|2|||
124812862|NCT03338010|448944692|FG000|Overall Study|Physician Decision|2|||
124812863|NCT03338010|448944693|FG001|Overall Study|Physician Decision|2|||
124812864|NCT03338010|448944692|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124812865|NCT03338010|448944693|FG001|Overall Study|Non-Compliance with Study Drug|3|||
124812866|NCT03338010|448944692|FG000|Overall Study|Protocol Violation|0|||
124812867|NCT03338010|448944693|FG001|Overall Study|Protocol Violation|1|||
124812868|NCT02465515|448944696|FG000|Overall Study|Investigator site closed|4|||
124812869|NCT02465515|448944697|FG001|Overall Study|Investigator site closed|5|||
124812870|NCT02465515|448944696|FG000|Overall Study|Withdrawal by Subject|74|||
124812871|NCT02465515|448944697|FG001|Overall Study|Withdrawal by Subject|43|||
124812872|NCT02465515|448944696|FG000|Overall Study|Physician Decision|8|||
124812873|NCT02465515|448944697|FG001|Overall Study|Physician Decision|12|||
124812874|NCT02465515|448944696|FG000|Overall Study|Lost to Follow-up|68|||
124812875|NCT02465515|448944697|FG001|Overall Study|Lost to Follow-up|51|||
124812876|NCT00816595|448944698|FG000|Overall Study|Withdrawal by Subject|2|||
124812877|NCT00816595|448944699|FG001|Overall Study|Withdrawal by Subject|0|||
124812878|NCT00293033|448944700|FG000|Open-label Titration Period|Adverse Event|10|||
124812879|NCT00293033|448944700|FG000|Open-label Titration Period|Death|3|||
124812880|NCT00293033|448944700|FG000|Open-label Titration Period|Lack of Efficacy|5|||
124812881|NCT00293033|448944700|FG000|Open-label Titration Period|Protocol Violation|2|||
124812882|NCT00293033|448944700|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
124812883|NCT00293033|448944700|FG000|Open-label Titration Period|Noncompliance and other|27|||
124812884|NCT00293033|448944700|FG000|Double-blind Treatment Period|Adverse Event|3|||
124812885|NCT00293033|448944700|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
124812886|NCT00293033|448944700|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
124812887|NCT00293033|448944700|FG000|Double-blind Treatment Period|Noncompliance|4|||
124812888|NCT03583697|448944701|FG000|Overall Study|Withdrawal by Subject|0|||
124812889|NCT03583697|448944702|FG001|Overall Study|Withdrawal by Subject|0|||
124812890|NCT03583697|448944703|FG002|Overall Study|Withdrawal by Subject|1|||
124812891|NCT03583697|448944701|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
124812892|NCT03583697|448944702|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
124812893|NCT03583697|448944703|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
124812894|NCT00114530|448944705|FG000|Overall Study|Death|3|||
124812895|NCT00114530|448944706|FG001|Overall Study|Death|11|||
124812896|NCT00114530|448944705|FG000|Overall Study|Lost to Follow-up|1|||
124812897|NCT00114530|448944706|FG001|Overall Study|Lost to Follow-up|1|||
124812898|NCT00114530|448944705|FG000|Overall Study|Physician Decision|1|||
124812899|NCT00114530|448944706|FG001|Overall Study|Physician Decision|1|||
124812900|NCT00114530|448944705|FG000|Overall Study|Withdrawal by Subject|2|||
124812901|NCT00114530|448944706|FG001|Overall Study|Withdrawal by Subject|6|||
124812902|NCT00114530|448944705|FG000|Overall Study|Breast Cancer|1|||
124812903|NCT00114530|448944706|FG001|Overall Study|Breast Cancer|0|||
124812904|NCT00114530|448944705|FG000|Overall Study|Subject decision after endpoint failure|0|||
124812905|NCT00114530|448944706|FG001|Overall Study|Subject decision after endpoint failure|1|||
124812906|NCT00114530|448944705|FG000|Overall Study|Ineligible|1|||
124812907|NCT00114530|448944706|FG001|Overall Study|Ineligible|0|||
124812908|NCT00365508|448944709|FG000|Overall Study|Lost to Follow-up|139|||
124812909|NCT00365508|448944710|FG001|Overall Study|Lost to Follow-up|154|||
124812910|NCT01064310|448944712|FG000|Period 1|Adverse Event|7|||
124812911|NCT01064310|448944713|FG001|Period 1|Adverse Event|10|||
124812912|NCT01064310|448944714|FG002|Period 1|Adverse Event|0|||
124812913|NCT01064310|448944712|FG000|Period 1|Physician Decision|1|||
124812914|NCT01064310|448944713|FG001|Period 1|Physician Decision|0|||
124812915|NCT01064310|448944714|FG002|Period 1|Physician Decision|0|||
124812916|NCT01064310|448944712|FG000|Period 1|Withdrawal by Subject|2|||
124812917|NCT01064310|448944713|FG001|Period 1|Withdrawal by Subject|2|||
124812918|NCT01064310|448944714|FG002|Period 1|Withdrawal by Subject|0|||
124812919|NCT01064310|448944712|FG000|Period 1|Lack of Efficacy|3|||
124812920|NCT01064310|448944713|FG001|Period 1|Lack of Efficacy|5|||
124812921|NCT01064310|448944714|FG002|Period 1|Lack of Efficacy|0|||
124812922|NCT01064310|448944712|FG000|Period 1|Entered Open-label Period|1|||
124812923|NCT01064310|448944713|FG001|Period 1|Entered Open-label Period|1|||
124812924|NCT01064310|448944714|FG002|Period 1|Entered Open-label Period|0|||
124812925|NCT01064310|448944712|FG000|Period 2|Adverse Event|2|||
124812926|NCT01064310|448944713|FG001|Period 2|Adverse Event|1|||
124812927|NCT01064310|448944714|FG002|Period 2|Adverse Event|0|||
124812928|NCT01064310|448944712|FG000|Period 2|Physician Decision|0|||
124812929|NCT01064310|448944713|FG001|Period 2|Physician Decision|1|||
124812930|NCT01064310|448944714|FG002|Period 2|Physician Decision|0|||
124812931|NCT01064310|448944712|FG000|Period 2|Entered Open-label Period|1|||
124812932|NCT01064310|448944713|FG001|Period 2|Entered Open-label Period|0|||
124812933|NCT01064310|448944714|FG002|Period 2|Entered Open-label Period|0|||
124812934|NCT01064310|448944712|FG000|Period 2|Lack of Efficacy|1|||
124812935|NCT01064310|448944713|FG001|Period 2|Lack of Efficacy|4|||
124812936|NCT01064310|448944714|FG002|Period 2|Lack of Efficacy|0|||
124812937|NCT01064310|448944712|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
124812938|NCT01064310|448944713|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
124812939|NCT01064310|448944714|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
124812940|NCT01064310|448944712|FG000|Open Label Pazopinib|Adverse Event|0|||
124812941|NCT01064310|448944713|FG001|Open Label Pazopinib|Adverse Event|0|||
124812942|NCT01064310|448944714|FG002|Open Label Pazopinib|Adverse Event|12|||
124812943|NCT01064310|448944712|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
124812944|NCT01064310|448944713|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
124812945|NCT01064310|448944714|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
124812946|NCT01064310|448944712|FG000|Open Label Pazopinib|Physician Decision|0|||
124812947|NCT01064310|448944713|FG001|Open Label Pazopinib|Physician Decision|0|||
124812948|NCT01064310|448944714|FG002|Open Label Pazopinib|Physician Decision|20|||
124812949|NCT00679432|448944715|FG000|Overall Study|Adverse Event|5|||
124812950|NCT00679432|448944716|FG001|Overall Study|Adverse Event|6|||
124812951|NCT00679432|448944717|FG002|Overall Study|Adverse Event|10|||
124812952|NCT00679432|448944718|FG003|Overall Study|Adverse Event|7|||
124812953|NCT00679432|448944715|FG000|Overall Study|Protocol Violation|1|||
124812954|NCT00679432|448944716|FG001|Overall Study|Protocol Violation|1|||
124812955|NCT00679432|448944717|FG002|Overall Study|Protocol Violation|2|||
124812956|NCT00679432|448944718|FG003|Overall Study|Protocol Violation|1|||
124812957|NCT00679432|448944715|FG000|Overall Study|Withdrawal by Subject|8|||
124812958|NCT00679432|448944716|FG001|Overall Study|Withdrawal by Subject|11|||
124812959|NCT00679432|448944717|FG002|Overall Study|Withdrawal by Subject|10|||
124812960|NCT00679432|448944718|FG003|Overall Study|Withdrawal by Subject|9|||
124812961|NCT00679432|448944715|FG000|Overall Study|Lost to Follow-up|1|||
124812962|NCT00679432|448944716|FG001|Overall Study|Lost to Follow-up|5|||
124812963|NCT00679432|448944717|FG002|Overall Study|Lost to Follow-up|4|||
124812964|NCT00679432|448944718|FG003|Overall Study|Lost to Follow-up|2|||
124812965|NCT00679432|448944715|FG000|Overall Study|Physician Decision|3|||
124812966|NCT00679432|448944716|FG001|Overall Study|Physician Decision|2|||
124812967|NCT00679432|448944717|FG002|Overall Study|Physician Decision|2|||
124812968|NCT00679432|448944718|FG003|Overall Study|Physician Decision|2|||
124812969|NCT00679432|448944715|FG000|Overall Study|Sponsor decision|1|||
124812970|NCT00679432|448944716|FG001|Overall Study|Sponsor decision|0|||
124812971|NCT00679432|448944717|FG002|Overall Study|Sponsor decision|0|||
124812972|NCT00679432|448944718|FG003|Overall Study|Sponsor decision|0|||
124812973|NCT00679432|448944715|FG000|Overall Study|Lack of Efficacy|13|||
124812974|NCT00679432|448944716|FG001|Overall Study|Lack of Efficacy|9|||
124812975|NCT00679432|448944717|FG002|Overall Study|Lack of Efficacy|14|||
124812976|NCT00679432|448944718|FG003|Overall Study|Lack of Efficacy|8|||
124812977|NCT00679432|448944715|FG000|Overall Study|Infectious colitis, normal histology|5|||
124812978|NCT00679432|448944716|FG001|Overall Study|Infectious colitis, normal histology|4|||
124812979|NCT00679432|448944717|FG002|Overall Study|Infectious colitis, normal histology|8|||
124812980|NCT00679432|448944718|FG003|Overall Study|Infectious colitis, normal histology|3|||
124812981|NCT00679432|448944715|FG000|Overall Study|Randomization error, return to prior Rx|0|||
124812982|NCT00679432|448944716|FG001|Overall Study|Randomization error, return to prior Rx|0|||
124812983|NCT00679432|448944717|FG002|Overall Study|Randomization error, return to prior Rx|3|||
124812984|NCT00679432|448944718|FG003|Overall Study|Randomization error, return to prior Rx|0|||
124812985|NCT00873015|448944720|FG000|Overall Study|Withdrawal by Subject|0|||
124812986|NCT00873015|448944721|FG001|Overall Study|Withdrawal by Subject|1|||
124812987|NCT00873015|448944722|FG002|Overall Study|Withdrawal by Subject|0|||
124812988|NCT00873015|448944723|FG003|Overall Study|Withdrawal by Subject|0|||
124812989|NCT02339584|448944724|FG000|Overall Study|Adverse Event|11|||
124812990|NCT02339584|448944725|FG001|Overall Study|Adverse Event|7|||
124812991|NCT02339584|448944724|FG000|Overall Study|Lack of Efficacy|0|||
124812992|NCT02339584|448944725|FG001|Overall Study|Lack of Efficacy|1|||
124812993|NCT02339584|448944724|FG000|Overall Study|Physician Decision|1|||
124812994|NCT02339584|448944725|FG001|Overall Study|Physician Decision|2|||
124812995|NCT02339584|448944724|FG000|Overall Study|Protocol Violation|1|||
124812996|NCT02339584|448944725|FG001|Overall Study|Protocol Violation|1|||
124812997|NCT02339584|448944724|FG000|Overall Study|Withdrawal by Subject|2|||
124812998|NCT02339584|448944725|FG001|Overall Study|Withdrawal by Subject|4|||
124812999|NCT01382212|448944726|FG000|Overall Study|Kidney transplant|1|||
124813000|NCT01382212|448944726|FG000|Overall Study|Withdrew consent|1|||
124813001|NCT00873912|448944728|FG000|Overall Study|Withdrawal by Subject|1|||
124813002|NCT00873912|448944729|FG001|Overall Study|Withdrawal by Subject|0|||
124813003|NCT00873912|448944728|FG000|Overall Study|Lost to Follow-up|2|||
124813004|NCT00873912|448944729|FG001|Overall Study|Lost to Follow-up|0|||
124813005|NCT01980940|448944731|FG000|Overall Study|Protocol Violation|0|||
124813006|NCT01980940|448944732|FG001|Overall Study|Protocol Violation|0|||
124813007|NCT01980940|448944733|FG002|Overall Study|Protocol Violation|0|||
124813008|NCT01980940|448944734|FG003|Overall Study|Protocol Violation|0|||
124813009|NCT01980940|448944735|FG004|Overall Study|Protocol Violation|0|||
124813010|NCT01980940|448944736|FG005|Overall Study|Protocol Violation|2|||
124813011|NCT01980940|448944737|FG006|Overall Study|Protocol Violation|0|||
124813012|NCT01980940|448944738|FG007|Overall Study|Protocol Violation|0|||
124813013|NCT00259649|448946247|FG000|Overall Study|Lost to Follow-up|7|||
124813014|NCT00259649|448946247|FG000|Overall Study|irregular menses|3|||
124813015|NCT00709761|448946248|FG000|Overall Study|Withdrawal by Subject|8|||
124813016|NCT00709761|448946248|FG000|Overall Study|study closed/terminated|17|||
124813017|NCT00709761|448946248|FG000|Overall Study|Lost to Follow-up|2|||
124813018|NCT00443261|448946249|FG000|Overall Study|Death|1|||
124813019|NCT03311724|448946250|FG000|Overall Study|Physician Decision|0|||
124813020|NCT03311724|448946251|FG001|Overall Study|Physician Decision|0|||
124813021|NCT03311724|448946252|FG002|Overall Study|Physician Decision|0|||
124813022|NCT03311724|448946253|FG003|Overall Study|Physician Decision|1|||
124813023|NCT03311724|448946250|FG000|Overall Study|Protocol Violation|1|||
124813024|NCT03311724|448946251|FG001|Overall Study|Protocol Violation|0|||
124813025|NCT03311724|448946252|FG002|Overall Study|Protocol Violation|1|||
124813026|NCT03311724|448946253|FG003|Overall Study|Protocol Violation|0|||
124813027|NCT03311724|448946250|FG000|Overall Study|Withdrawal by Subject|1|||
124813028|NCT03311724|448946251|FG001|Overall Study|Withdrawal by Subject|1|||
124813029|NCT03311724|448946252|FG002|Overall Study|Withdrawal by Subject|0|||
124813030|NCT03311724|448946253|FG003|Overall Study|Withdrawal by Subject|0|||
124813031|NCT03311724|448946250|FG000|Overall Study|Lost to Follow-up|1|||
124813032|NCT03311724|448946251|FG001|Overall Study|Lost to Follow-up|0|||
124813033|NCT03311724|448946252|FG002|Overall Study|Lost to Follow-up|0|||
124813034|NCT03311724|448946253|FG003|Overall Study|Lost to Follow-up|0|||
124813035|NCT03311724|448946250|FG000|Overall Study|Sponsor Decision|0|||
124813036|NCT03311724|448946251|FG001|Overall Study|Sponsor Decision|0|||
124813037|NCT03311724|448946252|FG002|Overall Study|Sponsor Decision|1|||
124813038|NCT03311724|448946253|FG003|Overall Study|Sponsor Decision|0|||
124813039|NCT01433991|448946255|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
124813040|NCT01433991|448946256|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
124813041|NCT01433991|448946257|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
124813042|NCT01433991|448946258|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
124813043|NCT01433991|448946255|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
124636044|NCT00318474|448285098|FG000|Overall Study|Protocol Violation|1|||
124636045|NCT00318474|448285099|FG001|Overall Study|Protocol Violation|0|||
124636046|NCT00318474|448285098|FG000|Overall Study|Withdrawal by Subject|3|||
124636047|NCT00318474|448285099|FG001|Overall Study|Withdrawal by Subject|2|||
124636048|NCT00318474|448285098|FG000|Overall Study|Fall in GFR|3|||
124636049|NCT00318474|448285099|FG001|Overall Study|Fall in GFR|3|||
124636050|NCT00318474|448285098|FG000|Overall Study|Post-therapy hyperflycemia|0|||
124636051|NCT00318474|448285099|FG001|Overall Study|Post-therapy hyperflycemia|1|||
124636052|NCT00318474|448285098|FG000|Overall Study|Trial terminated|10|||
124636053|NCT00318474|448285099|FG001|Overall Study|Trial terminated|7|||
124636054|NCT00457002|448285104|FG000|Overall Study|Death|40|||
124636055|NCT00457002|448285105|FG001|Overall Study|Death|47|||
124636056|NCT00457002|448285104|FG000|Overall Study|Adverse Event|284|||
124636057|NCT00457002|448285105|FG001|Overall Study|Adverse Event|260|||
124636058|NCT00457002|448285104|FG000|Overall Study|Withdrawal by Subject|299|||
124636059|NCT00457002|448285105|FG001|Overall Study|Withdrawal by Subject|271|||
124636060|NCT00457002|448285104|FG000|Overall Study|Lost to Follow-up|72|||
124636061|NCT00457002|448285105|FG001|Overall Study|Lost to Follow-up|71|||
124636062|NCT00457002|448285104|FG000|Overall Study|Poor/Non-compliance|46|||
124636063|NCT00457002|448285105|FG001|Overall Study|Poor/Non-compliance|33|||
124636064|NCT00457002|448285104|FG000|Overall Study|No longer met criteria|41|||
124636065|NCT00457002|448285105|FG001|Overall Study|No longer met criteria|37|||
124636066|NCT00457002|448285104|FG000|Overall Study|Administrative reason by Sponsor|1|||
124636067|NCT00457002|448285105|FG001|Overall Study|Administrative reason by Sponsor|0|||
124636068|NCT00457002|448285104|FG000|Overall Study|non-specified|29|||
124636069|NCT00457002|448285105|FG001|Overall Study|non-specified|38|||
124636070|NCT00457002|448285104|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
124636071|NCT00457002|448285105|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
124636072|NCT02283268|448285111|FG000|Overall Study|Withdrawal by Subject|1|||
124636073|NCT00454246|448285112|FG000|Overall Study|Adverse Event|2|||
124636074|NCT00454246|448285113|FG001|Overall Study|Adverse Event|2|||
124636075|NCT00454246|448285114|FG002|Overall Study|Adverse Event|0|||
124636076|NCT00454246|448285112|FG000|Overall Study|Violation of selection criteria at entry|6|||
124636077|NCT00454246|448285113|FG001|Overall Study|Violation of selection criteria at entry|0|||
124636078|NCT00454246|448285114|FG002|Overall Study|Violation of selection criteria at entry|0|||
124636079|NCT00454246|448285112|FG000|Overall Study|Protocol Violation|1|||
124636080|NCT00454246|448285113|FG001|Overall Study|Protocol Violation|0|||
124636081|NCT00454246|448285114|FG002|Overall Study|Protocol Violation|0|||
124636082|NCT00454246|448285112|FG000|Overall Study|Refused Treatment|1|||
124813044|NCT01433991|448946256|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
124813045|NCT01433991|448946257|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
124813046|NCT01433991|448946258|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
124813047|NCT01433991|448946255|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
124813048|NCT01433991|448946256|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
124813049|NCT01433991|448946257|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
124813050|NCT01433991|448946258|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
124813051|NCT01433991|448946255|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
124813052|NCT01433991|448946256|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
124813053|NCT01433991|448946257|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
124813054|NCT01433991|448946258|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
124813055|NCT01433991|448946255|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
124813056|NCT01433991|448946256|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
124813057|NCT01433991|448946257|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
124813058|NCT01433991|448946258|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
124813059|NCT01433991|448946255|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
124813060|NCT01433991|448946256|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
124813061|NCT01433991|448946257|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
124813062|NCT01433991|448946258|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
124813063|NCT01433991|448946255|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
124813064|NCT01433991|448946256|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
124813065|NCT01433991|448946257|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
124813066|NCT01433991|448946258|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
124813067|NCT00844831|448946259|FG000|Overall Study|Withdrawal by Subject|4|||
124636083|NCT00454246|448285113|FG001|Overall Study|Refused Treatment|1|||
124636084|NCT00454246|448285114|FG002|Overall Study|Refused Treatment|0|||
124636085|NCT00454246|448285112|FG000|Overall Study|Failure to return|1|||
124636086|NCT00454246|448285113|FG001|Overall Study|Failure to return|0|||
124636087|NCT00454246|448285114|FG002|Overall Study|Failure to return|0|||
124813068|NCT00844831|448946259|FG000|Overall Study|Adverse Event|1|||
124636088|NCT00454246|448285112|FG000|Overall Study|Early termination of study|62|||
124636089|NCT00454246|448285113|FG001|Overall Study|Early termination of study|26|||
124636090|NCT00454246|448285114|FG002|Overall Study|Early termination of study|9|||
124813069|NCT00844831|448946259|FG000|Overall Study|Physician Decision|1|||
124813070|NCT01193530|448946262|FG000|Overall Study|Withdrawal by Subject|2|||
124813071|NCT01193530|448946263|FG001|Overall Study|Withdrawal by Subject|2|||
124636091|NCT05326529|448285115|FG000|Overall Study|Lack of Efficacy|0|||
124636092|NCT05326529|448285116|FG001|Overall Study|Lack of Efficacy|1|||
124636093|NCT05326529|448285117|FG002|Overall Study|Lack of Efficacy|0|||
124636094|NCT05326529|448285115|FG000|Overall Study|Physician Decision|0|||
124636095|NCT05326529|448285116|FG001|Overall Study|Physician Decision|0|||
124636096|NCT05326529|448285117|FG002|Overall Study|Physician Decision|2|||
124636097|NCT01379768|448285118|FG000|Overall Study|Adverse Event|1|||
124636098|NCT01379768|448285119|FG001|Overall Study|Adverse Event|1|||
124636099|NCT01379768|448285120|FG002|Overall Study|Adverse Event|0|||
124636100|NCT01379768|448285118|FG000|Overall Study|Lost to Follow-up|2|||
124636101|NCT01379768|448285119|FG001|Overall Study|Lost to Follow-up|0|||
124636102|NCT01379768|448285120|FG002|Overall Study|Lost to Follow-up|0|||
124636103|NCT00708552|448285126|FG000|Overall Study|Adverse Event|10|||
124636104|NCT00708552|448285127|FG001|Overall Study|Adverse Event|3|||
124636105|NCT00708552|448285128|FG002|Overall Study|Adverse Event|4|||
124636106|NCT00708552|448285129|FG003|Overall Study|Adverse Event|6|||
124636107|NCT00708552|448285126|FG000|Overall Study|Lack of Efficacy|0|||
124636108|NCT00708552|448285127|FG001|Overall Study|Lack of Efficacy|4|||
124636109|NCT00708552|448285128|FG002|Overall Study|Lack of Efficacy|1|||
124636110|NCT00708552|448285129|FG003|Overall Study|Lack of Efficacy|0|||
124636111|NCT00708552|448285126|FG000|Overall Study|Protocol Violation|0|||
124636112|NCT00708552|448285127|FG001|Overall Study|Protocol Violation|0|||
124636113|NCT00708552|448285128|FG002|Overall Study|Protocol Violation|2|||
124636114|NCT00708552|448285129|FG003|Overall Study|Protocol Violation|4|||
124636115|NCT00708552|448285126|FG000|Overall Study|Lost to Follow-up|4|||
124636116|NCT00708552|448285127|FG001|Overall Study|Lost to Follow-up|2|||
124636117|NCT00708552|448285128|FG002|Overall Study|Lost to Follow-up|0|||
124636118|NCT00708552|448285129|FG003|Overall Study|Lost to Follow-up|1|||
124636119|NCT00708552|448285126|FG000|Overall Study|Physician Decision|1|||
124636120|NCT00708552|448285127|FG001|Overall Study|Physician Decision|2|||
124636121|NCT00708552|448285128|FG002|Overall Study|Physician Decision|0|||
124636122|NCT00708552|448285129|FG003|Overall Study|Physician Decision|0|||
124636123|NCT00708552|448285126|FG000|Overall Study|Withdrawal by Subject|12|||
124636124|NCT00708552|448285127|FG001|Overall Study|Withdrawal by Subject|7|||
124636125|NCT00708552|448285128|FG002|Overall Study|Withdrawal by Subject|8|||
124636126|NCT00708552|448285129|FG003|Overall Study|Withdrawal by Subject|10|||
124636127|NCT03168711|448285133|FG000|Overall Study|Adverse Event|2|||
124636128|NCT03168711|448285134|FG001|Overall Study|Adverse Event|0|||
124636129|NCT03168711|448285133|FG000|Overall Study|Withdrawal by Subject|0|||
124636130|NCT03168711|448285134|FG001|Overall Study|Withdrawal by Subject|1|||
124636131|NCT03168711|448285133|FG000|Overall Study|Death|0|||
124636132|NCT03168711|448285134|FG001|Overall Study|Death|1|||
124636133|NCT01609010|448285135|FG000|Overall Study|Stable disease (SD)|22|||
124636134|NCT01609010|448285136|FG001|Overall Study|Stable disease (SD)|16|||
124636135|NCT01609010|448285135|FG000|Overall Study|Progressive disease (PD)|8|||
124636136|NCT01609010|448285136|FG001|Overall Study|Progressive disease (PD)|10|||
124636137|NCT01609010|448285135|FG000|Overall Study|Adverse Event|3|||
124636138|NCT01609010|448285136|FG001|Overall Study|Adverse Event|6|||
124636139|NCT01609010|448285135|FG000|Overall Study|Withdrawal by Subject|2|||
124636140|NCT01609010|448285136|FG001|Overall Study|Withdrawal by Subject|2|||
124636141|NCT01609010|448285135|FG000|Overall Study|Other|2|||
124636142|NCT01609010|448285136|FG001|Overall Study|Other|0|||
124636143|NCT01609010|448285135|FG000|Overall Study|Other malignancy|1|||
124636144|NCT01609010|448285136|FG001|Overall Study|Other malignancy|0|||
124636145|NCT01609010|448285135|FG000|Overall Study|Pathology review|2|||
124813072|NCT01193530|448946262|FG000|Overall Study|Began Contraindicated Therapy|1|||
124813073|NCT01193530|448946263|FG001|Overall Study|Began Contraindicated Therapy|0|||
124813074|NCT01193530|448946262|FG000|Overall Study|Lost Light Box|0|||
124813075|NCT01193530|448946263|FG001|Overall Study|Lost Light Box|1|||
124636146|NCT01609010|448285136|FG001|Overall Study|Pathology review|1|||
124636147|NCT01609010|448285135|FG000|Overall Study|Protocol Violation|1|||
124636148|NCT01609010|448285136|FG001|Overall Study|Protocol Violation|1|||
124636149|NCT01609010|448285135|FG000|Overall Study|New cancer|1|||
124636150|NCT01609010|448285136|FG001|Overall Study|New cancer|0|||
124636151|NCT01609010|448285135|FG000|Overall Study|Lost to Follow-up|1|||
124636152|NCT01609010|448285136|FG001|Overall Study|Lost to Follow-up|1|||
124636153|NCT01017874|448285137|FG000|Overall Study|Withdrawal by Subject|23|||
124813076|NCT01193530|448946262|FG000|Overall Study|Returned home - out of state|0|||
124813077|NCT01193530|448946263|FG001|Overall Study|Returned home - out of state|1|||
124636154|NCT01017874|448285138|FG001|Overall Study|Withdrawal by Subject|20|||
124636155|NCT01017874|448285137|FG000|Overall Study|Sponsor decision|3|||
124636156|NCT01017874|448285138|FG001|Overall Study|Sponsor decision|1|||
124636157|NCT01017874|448285137|FG000|Overall Study|Lost to Follow-up|3|||
124636158|NCT01017874|448285138|FG001|Overall Study|Lost to Follow-up|2|||
124636159|NCT01017874|448285137|FG000|Overall Study|Physician Decision|1|||
124636160|NCT01017874|448285138|FG001|Overall Study|Physician Decision|3|||
124636161|NCT01966120|448285139|FG000|Overall Study|Withdrawal by Subject|0|||
124636162|NCT01966120|448285140|FG001|Overall Study|Withdrawal by Subject|5|||
124636163|NCT01966120|448285139|FG000|Overall Study|Lost to Follow-up|1|||
124636164|NCT01966120|448285140|FG001|Overall Study|Lost to Follow-up|1|||
124636165|NCT03123393|448285144|FG000|Overall Study|Study Terminated by Sponsor|6|||
124636166|NCT03123393|448285145|FG001|Overall Study|Study Terminated by Sponsor|9|||
124636167|NCT03123393|448285144|FG000|Overall Study|Withdrawal by Subject|2|||
124636168|NCT03123393|448285145|FG001|Overall Study|Withdrawal by Subject|1|||
124636169|NCT03123393|448285144|FG000|Overall Study|Reason not Specified|13|||
124636170|NCT03123393|448285145|FG001|Overall Study|Reason not Specified|13|||
124636171|NCT03321968|448285149|FG000|Overall Study|Withdrawal by Subject|1|||
124636172|NCT03321968|448285150|FG001|Overall Study|Withdrawal by Subject|2|||
124636173|NCT03321968|448285151|FG002|Overall Study|Withdrawal by Subject|1|||
124636174|NCT03321968|448285149|FG000|Overall Study|Lost to Follow-up|2|||
124813078|NCT01193530|448946262|FG000|Overall Study|Non-Compliance|0|||
124813079|NCT01193530|448946263|FG001|Overall Study|Non-Compliance|1|||
124813080|NCT03305575|448946274|FG000|Overall Study|Physician Decision|1|||
124813081|NCT03305575|448946275|FG001|Overall Study|Physician Decision|0|||
124813082|NCT03486223|448946284|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
124813083|NCT03486223|448946285|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
124813084|NCT01819831|448946286|FG000|Overall Study|Withdrawal by Subject|1|||
124813085|NCT03068130|448946306|FG000|Overall Study|Adverse Event|19|||
124813086|NCT03068130|448946306|FG000|Overall Study|Death|14|||
124813087|NCT03068130|448946306|FG000|Overall Study|Lost to Follow-up|4|||
124813088|NCT03068130|448946306|FG000|Overall Study|Withdrawal by Subject|26|||
124813089|NCT03068130|448946306|FG000|Overall Study|Administrative Reasons|3|||
124813090|NCT03068130|448946306|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
124813091|NCT03068130|448946306|FG000|Overall Study|Study terminated by sponsor|194|||
124813092|NCT03130257|448946307|FG000|Overall Study|Withdrawal by Subject|1|||
124813093|NCT03130257|448946308|FG001|Overall Study|Withdrawal by Subject|0|||
124813094|NCT03130257|448946309|FG002|Overall Study|Withdrawal by Subject|2|||
124813095|NCT00297830|448946310|FG000|6 Month Visit|Death|1|||
124813096|NCT00297830|448946311|FG001|6 Month Visit|Death|0|||
124813097|NCT00297830|448946312|FG002|6 Month Visit|Death|2|||
124813098|NCT00297830|448946310|FG000|6 Month Visit|Withdrawal by Subject|2|||
124813099|NCT00297830|448946311|FG001|6 Month Visit|Withdrawal by Subject|1|||
124813100|NCT00297830|448946312|FG002|6 Month Visit|Withdrawal by Subject|1|||
124813101|NCT00297830|448946310|FG000|6 Month Visit|Adverse Event|0|||
124813102|NCT00297830|448946311|FG001|6 Month Visit|Adverse Event|1|||
124813103|NCT00297830|448946312|FG002|6 Month Visit|Adverse Event|0|||
124813104|NCT00297830|448946310|FG000|12 Month Visit|Lost to Follow-up|1|||
124813105|NCT00297830|448946311|FG001|12 Month Visit|Lost to Follow-up|0|||
124813106|NCT00297830|448946312|FG002|12 Month Visit|Lost to Follow-up|0|||
124813107|NCT00297830|448946310|FG000|12 Month Visit|Adverse Event|0|||
124813108|NCT00297830|448946311|FG001|12 Month Visit|Adverse Event|3|||
124813109|NCT00297830|448946312|FG002|12 Month Visit|Adverse Event|0|||
124813110|NCT00297830|448946310|FG000|12 Month Visit|Withdrawal by Subject|0|||
124813111|NCT00297830|448946311|FG001|12 Month Visit|Withdrawal by Subject|3|||
124813112|NCT00297830|448946312|FG002|12 Month Visit|Withdrawal by Subject|0|||
124813113|NCT04377620|448946315|FG000|Overall Study|Death|42|||
124813114|NCT04377620|448946316|FG001|Overall Study|Death|48|||
124813115|NCT04377620|448946317|FG002|Overall Study|Death|36|||
124813116|NCT04377620|448946315|FG000|Overall Study|Withdrawal by Subject|0|||
124813117|NCT04377620|448946316|FG001|Overall Study|Withdrawal by Subject|2|||
124813118|NCT04377620|448946317|FG002|Overall Study|Withdrawal by Subject|0|||
124813119|NCT00288054|448946318|FG000|Overall Study|Protocol Violation|2|||
124813120|NCT00288054|448946318|FG000|Overall Study|Lack of Efficacy|16|||
124813121|NCT00288054|448946318|FG000|Overall Study|Adverse Event|3|||
124813122|NCT00288054|448946318|FG000|Overall Study|Withdrawal by Subject|1|||
124813123|NCT00288054|448946318|FG000|Overall Study|Not protocol specified|2|||
124813124|NCT03733470|448946329|FG000|Overall Study|PI Decision|1|||
124636175|NCT03321968|448285150|FG001|Overall Study|Lost to Follow-up|0|||
124813125|NCT03733470|448946330|FG001|Overall Study|PI Decision|1|||
124813126|NCT01010061|448946331|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
124813127|NCT01010061|448946332|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
124813128|NCT01010061|448946331|FG000|Overall Study|Disease Progression|2|||
124636176|NCT03321968|448285151|FG002|Overall Study|Lost to Follow-up|1|||
124636177|NCT03321968|448285149|FG000|Overall Study|Other than specified|0|||
124636178|NCT03321968|448285150|FG001|Overall Study|Other than specified|0|||
124813129|NCT01010061|448946332|FG001|Overall Study|Disease Progression|8|||
124813130|NCT01010061|448946331|FG000|Overall Study|Withdrew Consent|5|||
124813131|NCT01010061|448946332|FG001|Overall Study|Withdrew Consent|1|||
124813132|NCT01010061|448946331|FG000|Overall Study|Death|3|||
124636179|NCT03321968|448285151|FG002|Overall Study|Other than specified|1|||
124636180|NCT02155283|448285153|FG000|Overall Study|Lost to Follow-up|3|||
124813133|NCT01010061|448946332|FG001|Overall Study|Death|6|||
124813134|NCT01010061|448946331|FG000|Overall Study|Administrative/Other|0|||
124813135|NCT01010061|448946332|FG001|Overall Study|Administrative/Other|1|||
124813136|NCT01010061|448946331|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
124813137|NCT01010061|448946332|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
124813138|NCT01010061|448946331|FG000|Overall Study|Insufficient Therapeutic Response|1|||
124813139|NCT01010061|448946332|FG001|Overall Study|Insufficient Therapeutic Response|5|||
124813140|NCT01010061|448946331|FG000|Overall Study|Violation of Selection Criteria|0|||
124813141|NCT01010061|448946332|FG001|Overall Study|Violation of Selection Criteria|1|||
124813142|NCT01010061|448946331|FG000|Overall Study|Did Not Receive Treatment|2|||
124813143|NCT01010061|448946332|FG001|Overall Study|Did Not Receive Treatment|2|||
124813144|NCT02197520|448946340|FG000|Period 1|Withdrawal by Subject|1|||
124813145|NCT02197520|448946341|FG001|Period 1|Withdrawal by Subject|0|||
124813146|NCT02197520|448946340|FG000|Period 2|Adverse Event|0|||
124813147|NCT02197520|448946341|FG001|Period 2|Adverse Event|2|||
124813148|NCT02197520|448946340|FG000|Period 2|Withdrawal by Subject|1|||
124813149|NCT02197520|448946341|FG001|Period 2|Withdrawal by Subject|0|||
124813150|NCT01306942|448946342|FG000|Phase I|Adverse Event|2|||
124813151|NCT01306942|448946343|FG001|Phase I|Adverse Event|2|||
124813152|NCT01306942|448946344|FG002|Phase I|Adverse Event|0|||
124813153|NCT01306942|448946345|FG003|Phase I|Adverse Event|0|||
124813154|NCT01306942|448946342|FG000|Phase I|Physician Decision|3|||
124813155|NCT01306942|448946343|FG001|Phase I|Physician Decision|1|||
124813156|NCT01306942|448946344|FG002|Phase I|Physician Decision|0|||
124813157|NCT01306942|448946345|FG003|Phase I|Physician Decision|0|||
124813158|NCT01306942|448946342|FG000|Phase II|Adverse Event|0|||
124813159|NCT01306942|448946343|FG001|Phase II|Adverse Event|0|||
124813160|NCT01306942|448946344|FG002|Phase II|Adverse Event|0|||
124813161|NCT01306942|448946345|FG003|Phase II|Adverse Event|6|||
124813162|NCT01306942|448946342|FG000|Phase II|Physician Decision|2|||
124813163|NCT01306942|448946343|FG001|Phase II|Physician Decision|0|||
124813164|NCT01306942|448946344|FG002|Phase II|Physician Decision|0|||
124813165|NCT01306942|448946345|FG003|Phase II|Physician Decision|5|||
124813166|NCT01306942|448946342|FG000|Phase II|Withdrawal by Subject|0|||
124813167|NCT01306942|448946343|FG001|Phase II|Withdrawal by Subject|0|||
124813168|NCT01306942|448946344|FG002|Phase II|Withdrawal by Subject|0|||
124813169|NCT01306942|448946345|FG003|Phase II|Withdrawal by Subject|2|||
124813170|NCT01306942|448946342|FG000|Phase II|Death|0|||
124813171|NCT01306942|448946343|FG001|Phase II|Death|0|||
124813172|NCT01306942|448946344|FG002|Phase II|Death|0|||
124813173|NCT01306942|448946345|FG003|Phase II|Death|1|||
124813174|NCT01306942|448946342|FG000|Phase II|Not finished treatment|0|||
124813175|NCT01306942|448946343|FG001|Phase II|Not finished treatment|0|||
124813176|NCT01306942|448946344|FG002|Phase II|Not finished treatment|0|||
124813177|NCT01306942|448946345|FG003|Phase II|Not finished treatment|1|||
124813178|NCT01306942|448946342|FG000|Phase II|Protocol Violation|0|||
124813179|NCT01306942|448946343|FG001|Phase II|Protocol Violation|0|||
124813180|NCT01306942|448946344|FG002|Phase II|Protocol Violation|0|||
124813181|NCT01306942|448946345|FG003|Phase II|Protocol Violation|1|||
124813182|NCT02021773|448946349|FG000|Overall Study|Adverse Event|1|||
124813183|NCT02021773|448946350|FG001|Overall Study|Adverse Event|4|||
124813184|NCT02021773|448946351|FG002|Overall Study|Adverse Event|3|||
124813185|NCT02021773|448946349|FG000|Overall Study|Lack of Efficacy|2|||
124813186|NCT02021773|448946350|FG001|Overall Study|Lack of Efficacy|2|||
124813187|NCT02021773|448946351|FG002|Overall Study|Lack of Efficacy|2|||
124813188|NCT02021773|448946349|FG000|Overall Study|Protocol Violation|2|||
124813189|NCT02021773|448946350|FG001|Overall Study|Protocol Violation|3|||
124813190|NCT02021773|448946351|FG002|Overall Study|Protocol Violation|1|||
124813191|NCT02021773|448946349|FG000|Overall Study|Withdrawal by Subject|3|||
124813192|NCT02021773|448946350|FG001|Overall Study|Withdrawal by Subject|4|||
124813193|NCT02021773|448946351|FG002|Overall Study|Withdrawal by Subject|5|||
124813194|NCT02021773|448946349|FG000|Overall Study|Lost to Follow-up|1|||
124813195|NCT02021773|448946350|FG001|Overall Study|Lost to Follow-up|3|||
124813196|NCT02021773|448946351|FG002|Overall Study|Lost to Follow-up|0|||
124813197|NCT02021773|448946349|FG000|Overall Study|Reason not specified|3|||
124813198|NCT02021773|448946350|FG001|Overall Study|Reason not specified|0|||
124813199|NCT02021773|448946351|FG002|Overall Study|Reason not specified|0|||
124813200|NCT02243696|448946352|FG000|Overall Study|Death|282|||
124813201|NCT02243696|448946352|FG000|Overall Study|Withdrawal by Subject|79|||
124813202|NCT02243696|448946352|FG000|Overall Study|Lost to Follow-up|57|||
124813203|NCT02243696|448946352|FG000|Overall Study|Subject No Longer has Study System|42|||
124813204|NCT02243696|448946352|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
124813205|NCT02243696|448946352|FG000|Overall Study|Study Terminated for EP PASSION|961|||
124813206|NCT00087607|448946353|FG000|Overall Study|Adverse Event|14|||
124813207|NCT00087607|448946354|FG001|Overall Study|Adverse Event|24|||
124813208|NCT00087607|448946353|FG000|Overall Study|Death|0|||
124813209|NCT00087607|448946354|FG001|Overall Study|Death|1|||
124813210|NCT00087607|448946353|FG000|Overall Study|Insufficient Therapeutic Response|53|||
124813211|NCT00087607|448946354|FG001|Overall Study|Insufficient Therapeutic Response|42|||
124813212|NCT00087607|448946353|FG000|Overall Study|Failure to return|21|||
124813213|NCT00087607|448946354|FG001|Overall Study|Failure to return|17|||
124813214|NCT00087607|448946353|FG000|Overall Study|Withdrew Consent|12|||
124813215|NCT00087607|448946354|FG001|Overall Study|Withdrew Consent|16|||
124813216|NCT00087607|448946353|FG000|Overall Study|Administrative|12|||
124813217|NCT00087607|448946354|FG001|Overall Study|Administrative|12|||
124813218|NCT00087607|448946353|FG000|Overall Study|Refused Treatment|5|||
124813219|NCT00087607|448946354|FG001|Overall Study|Refused Treatment|7|||
124813220|NCT00087607|448946353|FG000|Overall Study|Other Protocol Violation|5|||
124813221|NCT00087607|448946354|FG001|Overall Study|Other Protocol Violation|2|||
124813222|NCT00087607|448946353|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
124813223|NCT00087607|448946354|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
124813224|NCT00190671|448946355|FG000|Overall Study|Satisfactory Response|4|||
124813225|NCT00190671|448946356|FG001|Overall Study|Satisfactory Response|7|||
124813226|NCT00190671|448946355|FG000|Overall Study|Lack of Efficacy|19|||
124813227|NCT00190671|448946356|FG001|Overall Study|Lack of Efficacy|24|||
124813228|NCT00190671|448946355|FG000|Overall Study|Death from Study Disease|1|||
124813229|NCT00190671|448946356|FG001|Overall Study|Death from Study Disease|1|||
124813230|NCT00190671|448946355|FG000|Overall Study|Adverse Event|3|||
124813231|NCT00190671|448946356|FG001|Overall Study|Adverse Event|2|||
124813232|NCT00190671|448946355|FG000|Overall Study|Clinical Relapse|0|||
124813233|NCT00190671|448946356|FG001|Overall Study|Clinical Relapse|1|||
124813234|NCT00190671|448946355|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
124813235|NCT00190671|448946356|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
124813236|NCT00190671|448946355|FG000|Overall Study|Death from Other Causes|0|||
124813237|NCT00190671|448946356|FG001|Overall Study|Death from Other Causes|2|||
124813238|NCT00190671|448946355|FG000|Overall Study|Protocol Violation|0|||
124813239|NCT00190671|448946356|FG001|Overall Study|Protocol Violation|1|||
124813240|NCT00190671|448946355|FG000|Overall Study|Withdrawal by Subject|0|||
124813241|NCT00190671|448946356|FG001|Overall Study|Withdrawal by Subject|2|||
124813242|NCT02094677|448946357|FG000|Overall Study|Screening|3|||
124813243|NCT02094677|448946358|FG001|Overall Study|Screening|1|||
124813244|NCT03408483|448946359|FG000|Overall Study|Physician Decision|3|||
124813245|NCT03408483|448946360|FG001|Overall Study|Physician Decision|3|||
124813246|NCT03408483|448946359|FG000|Overall Study|Lost to Follow-up|3|||
124813247|NCT03408483|448946360|FG001|Overall Study|Lost to Follow-up|0|||
124813248|NCT05399641|448946361|FG000|Overall Study|Adverse Event|0|||
124813249|NCT05399641|448946362|FG001|Overall Study|Adverse Event|1|||
124813250|NCT05399641|448946363|FG002|Overall Study|Adverse Event|1|||
124813251|NCT05399641|448946361|FG000|Overall Study|Lost to Follow-up|1|||
124813252|NCT05399641|448946362|FG001|Overall Study|Lost to Follow-up|2|||
124813253|NCT05399641|448946363|FG002|Overall Study|Lost to Follow-up|2|||
124813254|NCT05399641|448946361|FG000|Overall Study|Physician Decision|1|||
124813255|NCT05399641|448946362|FG001|Overall Study|Physician Decision|3|||
124813256|NCT05399641|448946363|FG002|Overall Study|Physician Decision|3|||
124813257|NCT05399641|448946361|FG000|Overall Study|Withdrawal by Subject|4|||
124813258|NCT05399641|448946362|FG001|Overall Study|Withdrawal by Subject|11|||
124813259|NCT05399641|448946363|FG002|Overall Study|Withdrawal by Subject|7|||
124813260|NCT05399641|448946361|FG000|Overall Study|Reason not defined|3|||
124813261|NCT05399641|448946362|FG001|Overall Study|Reason not defined|5|||
124813262|NCT05399641|448946363|FG002|Overall Study|Reason not defined|6|||
124813263|NCT00478231|448946364|FG000|Overall Study|Death|7|||
124813264|NCT00478231|448946364|FG000|Overall Study|Lack of Efficacy|47|||
124813265|NCT00478231|448946364|FG000|Overall Study|Lost to Follow-up|7|||
124813266|NCT00478231|448946364|FG000|Overall Study|Withdrawal by Subject|6|||
124813267|NCT00478231|448946364|FG000|Overall Study|Other|9|||
124813268|NCT00478231|448946364|FG000|Overall Study|Adverse Event|5|||
124813269|NCT00478231|448946364|FG000|Overall Study|Randomized, not treated|3|||
124813270|NCT04066023|448946370|FG000|Overall Study|Adverse Event|0|||
124813271|NCT04066023|448946371|FG001|Overall Study|Adverse Event|0|||
124813272|NCT04066023|448946372|FG002|Overall Study|Adverse Event|1|||
124813273|NCT04066023|448946370|FG000|Overall Study|Sponsor decision|3|||
124813274|NCT04066023|448946371|FG001|Overall Study|Sponsor decision|6|||
124813275|NCT04066023|448946372|FG002|Overall Study|Sponsor decision|2|||
124813276|NCT04066023|448946370|FG000|Overall Study|Physician Decision|0|||
124813277|NCT04066023|448946371|FG001|Overall Study|Physician Decision|0|||
124813278|NCT04066023|448946372|FG002|Overall Study|Physician Decision|1|||
124813279|NCT04066023|448946370|FG000|Overall Study|Lost to Follow-up|0|||
124813280|NCT04066023|448946371|FG001|Overall Study|Lost to Follow-up|1|||
124813281|NCT04066023|448946372|FG002|Overall Study|Lost to Follow-up|1|||
124813282|NCT04066023|448946370|FG000|Overall Study|Noncompliance|0|||
124813283|NCT04066023|448946371|FG001|Overall Study|Noncompliance|1|||
124813284|NCT04066023|448946372|FG002|Overall Study|Noncompliance|1|||
124813285|NCT00751933|448946373|FG000|Overall Study|Withdrawal by Subject|0|||
124813286|NCT00751933|448946374|FG001|Overall Study|Withdrawal by Subject|1|||
124813287|NCT00751933|448946375|FG002|Overall Study|Withdrawal by Subject|0|||
124813288|NCT00751933|448946376|FG003|Overall Study|Withdrawal by Subject|0|||
124813289|NCT00751933|448946373|FG000|Overall Study|Physician Decision|0|||
124813290|NCT00751933|448946374|FG001|Overall Study|Physician Decision|0|||
124813291|NCT00751933|448946375|FG002|Overall Study|Physician Decision|1|||
124813292|NCT00751933|448946376|FG003|Overall Study|Physician Decision|1|||
124813293|NCT05248867|448946378|FG000|Double-blind Period|Lost to Follow-up|0|||
124813294|NCT05248867|448946379|FG001|Double-blind Period|Lost to Follow-up|3|||
124813295|NCT05248867|448946380|FG002|Double-blind Period|Lost to Follow-up|0|||
124813296|NCT05248867|448946381|FG003|Double-blind Period|Lost to Follow-up|0|||
124813297|NCT05248867|448946382|FG004|Double-blind Period|Lost to Follow-up|0|||
124813298|NCT05248867|448946383|FG005|Double-blind Period|Lost to Follow-up|0|||
124813299|NCT05248867|448946378|FG000|Double-blind Period|Withdrawal by Subject|5|||
124813300|NCT05248867|448946379|FG001|Double-blind Period|Withdrawal by Subject|14|||
124813301|NCT05248867|448946380|FG002|Double-blind Period|Withdrawal by Subject|0|||
124813302|NCT05248867|448946381|FG003|Double-blind Period|Withdrawal by Subject|0|||
124813303|NCT05248867|448946382|FG004|Double-blind Period|Withdrawal by Subject|0|||
124813304|NCT05248867|448946383|FG005|Double-blind Period|Withdrawal by Subject|0|||
124813305|NCT05248867|448946378|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
124813306|NCT05248867|448946379|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
124813307|NCT05248867|448946380|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
124813308|NCT05248867|448946381|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
124813309|NCT05248867|448946382|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
124813310|NCT05248867|448946383|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
124813311|NCT05248867|448946378|FG000|Double-blind Period|Other, not specified|3|||
124813312|NCT05248867|448946379|FG001|Double-blind Period|Other, not specified|8|||
124813313|NCT05248867|448946380|FG002|Double-blind Period|Other, not specified|0|||
124813314|NCT05248867|448946381|FG003|Double-blind Period|Other, not specified|0|||
124813315|NCT05248867|448946382|FG004|Double-blind Period|Other, not specified|0|||
124813316|NCT05248867|448946383|FG005|Double-blind Period|Other, not specified|0|||
124813317|NCT05248867|448946378|FG000|Open-label Period|Withdrawal by Subject|0|||
124813318|NCT05248867|448946379|FG001|Open-label Period|Withdrawal by Subject|0|||
124813319|NCT05248867|448946380|FG002|Open-label Period|Withdrawal by Subject|3|||
124813320|NCT05248867|448946381|FG003|Open-label Period|Withdrawal by Subject|1|||
124813321|NCT05248867|448946382|FG004|Open-label Period|Withdrawal by Subject|7|||
124813322|NCT05248867|448946383|FG005|Open-label Period|Withdrawal by Subject|9|||
124813323|NCT05248867|448946378|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
124813324|NCT05248867|448946379|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
124813325|NCT05248867|448946380|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
124813326|NCT05248867|448946381|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
124813327|NCT05248867|448946382|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
124813328|NCT05248867|448946383|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
124813329|NCT05248867|448946378|FG000|Open-label Period|Lost to Follow-up|0|||
124813330|NCT05248867|448946379|FG001|Open-label Period|Lost to Follow-up|0|||
124813331|NCT05248867|448946380|FG002|Open-label Period|Lost to Follow-up|0|||
124813332|NCT05248867|448946381|FG003|Open-label Period|Lost to Follow-up|0|||
124813333|NCT05248867|448946382|FG004|Open-label Period|Lost to Follow-up|5|||
124813334|NCT05248867|448946383|FG005|Open-label Period|Lost to Follow-up|2|||
124813335|NCT05248867|448946378|FG000|Open-label Period|COVID-19 Infection|0|||
124813336|NCT05248867|448946379|FG001|Open-label Period|COVID-19 Infection|0|||
124813337|NCT05248867|448946380|FG002|Open-label Period|COVID-19 Infection|0|||
124813338|NCT05248867|448946381|FG003|Open-label Period|COVID-19 Infection|0|||
124813339|NCT05248867|448946382|FG004|Open-label Period|COVID-19 Infection|1|||
124813340|NCT05248867|448946383|FG005|Open-label Period|COVID-19 Infection|0|||
124813341|NCT05248867|448946378|FG000|Open-label Period|Other, not specified|0|||
124813342|NCT05248867|448946379|FG001|Open-label Period|Other, not specified|0|||
124813343|NCT05248867|448946380|FG002|Open-label Period|Other, not specified|0|||
124813344|NCT05248867|448946381|FG003|Open-label Period|Other, not specified|0|||
124813345|NCT05248867|448946382|FG004|Open-label Period|Other, not specified|4|||
124813346|NCT05248867|448946383|FG005|Open-label Period|Other, not specified|0|||
124813347|NCT01084083|448946386|FG000|Overall Study|Adverse Event|5|||
124813348|NCT01084083|448946386|FG000|Overall Study|Death|1|||
124813349|NCT01084083|448946386|FG000|Overall Study|Withdrawal by Subject|2|||
124813350|NCT01084083|448946386|FG000|Overall Study|Complicating disease|1|||
124813351|NCT01084083|448946386|FG000|Overall Study|Other|2|||
124813352|NCT01084083|448946386|FG000|Overall Study|Never started assigned therapy|1|||
124813353|NCT01273597|448946387|FG000|Overall Study|Adverse Event|5|||
124813354|NCT01273597|448946387|FG000|Overall Study|Underwent Kidney Transplantation|2|||
124813355|NCT01273597|448946387|FG000|Overall Study|Reason Not Reported|1|||
124813356|NCT01088997|448946388|FG000|Overall Study|Physician Decision|1|||
124813357|NCT01088997|448946389|FG001|Overall Study|Physician Decision|1|||
124813358|NCT01088997|448946388|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
124813359|NCT01088997|448946389|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
124813360|NCT01088997|448946388|FG000|Overall Study|Excluded prior to receiving drug|1|||
124813361|NCT01088997|448946389|FG001|Overall Study|Excluded prior to receiving drug|1|||
124813362|NCT05695209|448946392|FG000|3-months|Withdrawal by Subject|2|||
124813363|NCT05695209|448946393|FG001|3-months|Withdrawal by Subject|0|||
124813364|NCT05695209|448946392|FG000|3-months|Unable to contact for 3-month data collection|0|||
124813365|NCT05695209|448946393|FG001|3-months|Unable to contact for 3-month data collection|1|||
124813366|NCT05695209|448946392|FG000|6-months|Lost to Follow-up|1|||
124813367|NCT05695209|448946393|FG001|6-months|Lost to Follow-up|1|||
124813368|NCT04731363|448946394|FG000|Overall Study|Could not obtain samples|0|||
124813369|NCT04731363|448946395|FG001|Overall Study|Could not obtain samples|1|||
124813370|NCT04731363|448946396|FG002|Overall Study|Could not obtain samples|0|||
124813371|NCT04731363|448946397|FG003|Overall Study|Could not obtain samples|0|||
124813372|NCT04731363|448946394|FG000|Overall Study|Physician Decision|0|||
124813373|NCT04731363|448946395|FG001|Overall Study|Physician Decision|1|||
124813374|NCT04731363|448946396|FG002|Overall Study|Physician Decision|0|||
124813375|NCT04731363|448946397|FG003|Overall Study|Physician Decision|0|||
124813376|NCT02513394|448946398|FG000|Overall Study|Withdrawal by Subject|11|||
124813377|NCT02513394|448946399|FG001|Overall Study|Withdrawal by Subject|23|||
124813378|NCT02513394|448946398|FG000|Overall Study|Ineligible|1|||
124813379|NCT02513394|448946399|FG001|Overall Study|Ineligible|0|||
124813380|NCT05766423|448946400|FG000|Overall Study|Withdrawal by Subject|1|||
124813381|NCT05766423|448946401|FG001|Overall Study|Withdrawal by Subject|0|||
124813382|NCT05766423|448946400|FG000|Overall Study|Consented, not scheduled|3|||
124813383|NCT05766423|448946401|FG001|Overall Study|Consented, not scheduled|5|||
124813384|NCT00688753|448948446|FG000|Overall Study|Disease progression|55|||
124813385|NCT00688753|448948446|FG000|Overall Study|Missing|1|||
124813386|NCT00688753|448948446|FG000|Overall Study|Death|9|||
124813387|NCT00688753|448948446|FG000|Overall Study|Withdrawal by Subject|3|||
124813388|NCT00688753|448948446|FG000|Overall Study|Adverse Event|20|||
124813389|NCT00688753|448948446|FG000|Overall Study|Protocol Violation|1|||
124813390|NCT00688753|448948446|FG000|Overall Study|Lost to Follow-up|3|||
124813391|NCT03749447|448948447|FG000|Overall Study|Adverse Event|11|||
124813392|NCT03749447|448948448|FG001|Overall Study|Adverse Event|3|||
124813393|NCT03749447|448948447|FG000|Overall Study|Death|1|||
124813394|NCT03749447|448948448|FG001|Overall Study|Death|1|||
124813395|NCT03749447|448948447|FG000|Overall Study|Lost to Follow-up|2|||
124813396|NCT03749447|448948448|FG001|Overall Study|Lost to Follow-up|2|||
124813397|NCT03749447|448948447|FG000|Overall Study|Reason Not Specified|0|||
124813398|NCT03749447|448948448|FG001|Overall Study|Reason Not Specified|3|||
124813399|NCT03749447|448948447|FG000|Overall Study|Physician Decision|4|||
124813400|NCT03749447|448948448|FG001|Overall Study|Physician Decision|3|||
124813401|NCT03749447|448948447|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
124813402|NCT03749447|448948448|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
124813403|NCT03749447|448948447|FG000|Overall Study|Study Terminated By Sponsor|112|||
124813404|NCT03749447|448948448|FG001|Overall Study|Study Terminated By Sponsor|105|||
124813405|NCT03749447|448948447|FG000|Overall Study|Withdrawal by Subject|12|||
124813406|NCT03749447|448948448|FG001|Overall Study|Withdrawal by Subject|6|||
124813407|NCT03749447|448948447|FG000|Overall Study|Non-compliance With Study Drug|0|||
124813408|NCT03749447|448948448|FG001|Overall Study|Non-compliance With Study Drug|1|||
124813409|NCT05996718|448948449|FG000|Overall Study|Lost to Follow-up|3|||
124813410|NCT01218113|448948450|FG000|Overall Study|Withdrawal by Subject|1|||
124813411|NCT01218113|448948451|FG001|Overall Study|Withdrawal by Subject|0|||
124813412|NCT01218113|448948452|FG002|Overall Study|Withdrawal by Subject|1|||
124813413|NCT01218113|448948450|FG000|Overall Study|Lost to Follow-up|4|||
124813414|NCT01218113|448948451|FG001|Overall Study|Lost to Follow-up|1|||
124813415|NCT01218113|448948452|FG002|Overall Study|Lost to Follow-up|4|||
124813416|NCT01218113|448948450|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
124813417|NCT01218113|448948451|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
124813418|NCT01218113|448948452|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
124813419|NCT01713686|448948453|FG000|Overall Study|Lost to Follow-up|9|||
124813420|NCT01713686|448948453|FG000|Overall Study|Withdrawal by Subject|6|||
124813421|NCT04840615|448948454|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
124813422|NCT04840615|448948455|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
124813423|NCT04840615|448948456|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
124813424|NCT00967668|448948457|FG000|Overall Study|Withdrawal by Subject|13|||
124813425|NCT00967668|448948458|FG001|Overall Study|Withdrawal by Subject|8|||
124813426|NCT00967668|448948459|FG002|Overall Study|Withdrawal by Subject|8|||
124813427|NCT00967668|448948457|FG000|Overall Study|Death|0|||
124813428|NCT00967668|448948458|FG001|Overall Study|Death|2|||
124813429|NCT00967668|448948459|FG002|Overall Study|Death|4|||
124813430|NCT00967668|448948457|FG000|Overall Study|Removed due to behavior|1|||
124813431|NCT00967668|448948458|FG001|Overall Study|Removed due to behavior|1|||
124813432|NCT00967668|448948459|FG002|Overall Study|Removed due to behavior|2|||
124813433|NCT00967668|448948457|FG000|Overall Study|Refused Year 2|11|||
124813434|NCT00967668|448948458|FG001|Overall Study|Refused Year 2|6|||
124813435|NCT00967668|448948459|FG002|Overall Study|Refused Year 2|4|||
124813436|NCT00967668|448948457|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
124813437|NCT00967668|448948458|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
124813438|NCT00967668|448948459|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
124813439|NCT00967668|448948457|FG000|Overall Study|Lost to Follow-up|15|||
124813440|NCT00967668|448948458|FG001|Overall Study|Lost to Follow-up|9|||
124813441|NCT00967668|448948459|FG002|Overall Study|Lost to Follow-up|16|||
124813442|NCT00967668|448948457|FG000|Overall Study|Refused 12-mo assessment|3|||
124813443|NCT00967668|448948458|FG001|Overall Study|Refused 12-mo assessment|1|||
124813444|NCT00967668|448948459|FG002|Overall Study|Refused 12-mo assessment|9|||
124813445|NCT00967668|448948457|FG000|Overall Study|Pregnancy|1|||
124813446|NCT00967668|448948458|FG001|Overall Study|Pregnancy|0|||
124813447|NCT00967668|448948459|FG002|Overall Study|Pregnancy|0|||
124813448|NCT00115739|448948460|FG000|Overall Study|Lost to Follow-up|3|||
124813449|NCT02200211|448948463|FG000|Overall Study|Lost to Follow-up|7|||
124813450|NCT02200211|448948464|FG001|Overall Study|Lost to Follow-up|7|||
124813451|NCT02200211|448948465|FG002|Overall Study|Lost to Follow-up|1|||
124813452|NCT02200211|448948466|FG003|Overall Study|Lost to Follow-up|2|||
124813453|NCT02200211|448948463|FG000|Overall Study|Withdrawal by Subject|1|||
124813454|NCT02200211|448948464|FG001|Overall Study|Withdrawal by Subject|0|||
124813455|NCT02200211|448948465|FG002|Overall Study|Withdrawal by Subject|0|||
124813456|NCT02200211|448948466|FG003|Overall Study|Withdrawal by Subject|0|||
124813457|NCT01918774|448948467|FG000|Overall Study|Lost prior to first CBTw session|4|||
124813458|NCT01918774|448948467|FG000|Overall Study|Lost to Follow-up|1|||
124813459|NCT01606800|448948468|FG000|Overall Study|Adverse Event|3|||
124813460|NCT01606800|448948469|FG001|Overall Study|Adverse Event|1|||
124813461|NCT01606800|448948468|FG000|Overall Study|Participant withdrew consent|0|||
124813462|NCT01606800|448948469|FG001|Overall Study|Participant withdrew consent|1|||
124813463|NCT01606800|448948468|FG000|Overall Study|Missing completion status|2|||
124813464|NCT01606800|448948469|FG001|Overall Study|Missing completion status|0|||
124813465|NCT00042289|448948470|FG000|Overall Study|Lost to Follow-up|3|||
124813466|NCT00042289|448948471|FG001|Overall Study|Lost to Follow-up|0|||
124813467|NCT00042289|448948472|FG002|Overall Study|Lost to Follow-up|0|||
124813468|NCT00042289|448948473|FG003|Overall Study|Lost to Follow-up|1|||
124813469|NCT00042289|448948474|FG004|Overall Study|Lost to Follow-up|3|||
124813470|NCT00042289|448948475|FG005|Overall Study|Lost to Follow-up|3|||
124813471|NCT00042289|448948476|FG006|Overall Study|Lost to Follow-up|6|||
124813472|NCT00042289|448948477|FG007|Overall Study|Lost to Follow-up|1|||
124813473|NCT00042289|448948478|FG008|Overall Study|Lost to Follow-up|1|||
124813474|NCT00042289|448948479|FG009|Overall Study|Lost to Follow-up|0|||
124813475|NCT00042289|448948480|FG010|Overall Study|Lost to Follow-up|0|||
124813476|NCT00042289|448948481|FG011|Overall Study|Lost to Follow-up|0|||
124813477|NCT00042289|448948482|FG012|Overall Study|Lost to Follow-up|0|||
124813478|NCT00042289|448948483|FG013|Overall Study|Lost to Follow-up|0|||
124813479|NCT00042289|448948484|FG014|Overall Study|Lost to Follow-up|0|||
124813480|NCT00042289|448948485|FG015|Overall Study|Lost to Follow-up|1|||
124813481|NCT00042289|448948486|FG016|Overall Study|Lost to Follow-up|1|||
124813482|NCT00042289|448948487|FG017|Overall Study|Lost to Follow-up|0|||
124813483|NCT00042289|448948488|FG018|Overall Study|Lost to Follow-up|3|||
124813484|NCT00042289|448948489|FG019|Overall Study|Lost to Follow-up|2|||
124813485|NCT00042289|448948490|FG020|Overall Study|Lost to Follow-up|0|||
124813486|NCT00042289|448948491|FG021|Overall Study|Lost to Follow-up|0|||
124813487|NCT00042289|448948492|FG022|Overall Study|Lost to Follow-up|0|||
124813488|NCT00042289|448948493|FG023|Overall Study|Lost to Follow-up|0|||
124813489|NCT00042289|448948494|FG024|Overall Study|Lost to Follow-up|0|||
124813490|NCT00042289|448948495|FG025|Overall Study|Lost to Follow-up|0|||
124813491|NCT00042289|448948496|FG026|Overall Study|Lost to Follow-up|2|||
124813492|NCT00042289|448948497|FG027|Overall Study|Lost to Follow-up|2|||
124813493|NCT00042289|448948498|FG028|Overall Study|Lost to Follow-up|2|||
124813494|NCT00042289|448948499|FG029|Overall Study|Lost to Follow-up|0|||
124813495|NCT00042289|448948500|FG030|Overall Study|Lost to Follow-up|0|||
124813496|NCT00042289|448948501|FG031|Overall Study|Lost to Follow-up|2|||
124813497|NCT00042289|448948502|FG032|Overall Study|Lost to Follow-up|1|||
124813498|NCT00042289|448948503|FG033|Overall Study|Lost to Follow-up|1|||
124813499|NCT00042289|448948504|FG034|Overall Study|Lost to Follow-up|1|||
124813500|NCT00042289|448948505|FG035|Overall Study|Lost to Follow-up|2|||
124813501|NCT00042289|448948506|FG036|Overall Study|Lost to Follow-up|1|||
124813502|NCT00042289|448948507|FG037|Overall Study|Lost to Follow-up|1|||
124813503|NCT00042289|448948508|FG038|Overall Study|Lost to Follow-up|0|||
124813504|NCT00042289|448948509|FG039|Overall Study|Lost to Follow-up|5|||
124813505|NCT00042289|448948510|FG040|Overall Study|Lost to Follow-up|0|||
124813506|NCT00042289|448948511|FG041|Overall Study|Lost to Follow-up|2|||
124813507|NCT00042289|448948512|FG042|Overall Study|Lost to Follow-up|2|||
124813508|NCT00042289|448948513|FG043|Overall Study|Lost to Follow-up|0|||
124813509|NCT00042289|448948514|FG044|Overall Study|Lost to Follow-up|0|||
124813510|NCT00042289|448948515|FG045|Overall Study|Lost to Follow-up|1|||
124813511|NCT00042289|448948516|FG046|Overall Study|Lost to Follow-up|0|||
124813512|NCT00042289|448948470|FG000|Overall Study|Other reason|0|||
124813513|NCT00042289|448948471|FG001|Overall Study|Other reason|0|||
124813514|NCT00042289|448948472|FG002|Overall Study|Other reason|0|||
124813515|NCT00042289|448948473|FG003|Overall Study|Other reason|2|||
124813516|NCT00042289|448948474|FG004|Overall Study|Other reason|0|||
124813517|NCT00042289|448948475|FG005|Overall Study|Other reason|0|||
124813518|NCT00042289|448948476|FG006|Overall Study|Other reason|0|||
124813519|NCT00042289|448948477|FG007|Overall Study|Other reason|0|||
124813520|NCT00042289|448948478|FG008|Overall Study|Other reason|0|||
124813521|NCT00042289|448948479|FG009|Overall Study|Other reason|0|||
124813522|NCT00042289|448948480|FG010|Overall Study|Other reason|0|||
124813523|NCT00042289|448948481|FG011|Overall Study|Other reason|0|||
124813524|NCT00042289|448948482|FG012|Overall Study|Other reason|0|||
124813525|NCT00042289|448948483|FG013|Overall Study|Other reason|0|||
124813526|NCT00042289|448948484|FG014|Overall Study|Other reason|0|||
124813527|NCT00042289|448948485|FG015|Overall Study|Other reason|0|||
124813528|NCT00042289|448948486|FG016|Overall Study|Other reason|0|||
124813529|NCT00042289|448948487|FG017|Overall Study|Other reason|0|||
124813530|NCT00042289|448948488|FG018|Overall Study|Other reason|1|||
124813531|NCT00042289|448948489|FG019|Overall Study|Other reason|0|||
124813532|NCT00042289|448948490|FG020|Overall Study|Other reason|0|||
124813533|NCT00042289|448948491|FG021|Overall Study|Other reason|0|||
124813534|NCT00042289|448948492|FG022|Overall Study|Other reason|0|||
124813535|NCT00042289|448948493|FG023|Overall Study|Other reason|1|||
124813536|NCT00042289|448948494|FG024|Overall Study|Other reason|0|||
124813537|NCT00042289|448948495|FG025|Overall Study|Other reason|0|||
124813538|NCT00042289|448948496|FG026|Overall Study|Other reason|1|||
124813539|NCT00042289|448948497|FG027|Overall Study|Other reason|0|||
124813540|NCT00042289|448948498|FG028|Overall Study|Other reason|3|||
124813541|NCT00042289|448948499|FG029|Overall Study|Other reason|0|||
124813542|NCT00042289|448948500|FG030|Overall Study|Other reason|0|||
124813543|NCT00042289|448948501|FG031|Overall Study|Other reason|1|||
124813544|NCT00042289|448948502|FG032|Overall Study|Other reason|0|||
124813545|NCT00042289|448948503|FG033|Overall Study|Other reason|1|||
124813546|NCT00042289|448948504|FG034|Overall Study|Other reason|0|||
124813547|NCT00042289|448948505|FG035|Overall Study|Other reason|2|||
124813548|NCT00042289|448948506|FG036|Overall Study|Other reason|0|||
124813549|NCT00042289|448948507|FG037|Overall Study|Other reason|0|||
124813550|NCT00042289|448948508|FG038|Overall Study|Other reason|0|||
124813551|NCT00042289|448948509|FG039|Overall Study|Other reason|0|||
124813552|NCT00042289|448948510|FG040|Overall Study|Other reason|0|||
124813553|NCT00042289|448948511|FG041|Overall Study|Other reason|0|||
124813554|NCT00042289|448948512|FG042|Overall Study|Other reason|0|||
124813555|NCT00042289|448948513|FG043|Overall Study|Other reason|1|||
124813556|NCT00042289|448948514|FG044|Overall Study|Other reason|0|||
124813557|NCT00042289|448948515|FG045|Overall Study|Other reason|0|||
124813558|NCT00042289|448948516|FG046|Overall Study|Other reason|0|||
124813559|NCT00042289|448948470|FG000|Overall Study|Severe debilitation, unable to continue|0|||
124813560|NCT00042289|448948471|FG001|Overall Study|Severe debilitation, unable to continue|0|||
124813561|NCT00042289|448948472|FG002|Overall Study|Severe debilitation, unable to continue|0|||
124813562|NCT00042289|448948473|FG003|Overall Study|Severe debilitation, unable to continue|0|||
124813563|NCT00042289|448948474|FG004|Overall Study|Severe debilitation, unable to continue|0|||
124813564|NCT00042289|448948475|FG005|Overall Study|Severe debilitation, unable to continue|0|||
124813565|NCT00042289|448948476|FG006|Overall Study|Severe debilitation, unable to continue|0|||
124813566|NCT00042289|448948477|FG007|Overall Study|Severe debilitation, unable to continue|0|||
124813567|NCT00042289|448948478|FG008|Overall Study|Severe debilitation, unable to continue|0|||
124813568|NCT00042289|448948479|FG009|Overall Study|Severe debilitation, unable to continue|0|||
124813569|NCT00042289|448948480|FG010|Overall Study|Severe debilitation, unable to continue|0|||
124813570|NCT00042289|448948481|FG011|Overall Study|Severe debilitation, unable to continue|0|||
124813571|NCT00042289|448948482|FG012|Overall Study|Severe debilitation, unable to continue|0|||
124813572|NCT00042289|448948483|FG013|Overall Study|Severe debilitation, unable to continue|0|||
124813573|NCT00042289|448948484|FG014|Overall Study|Severe debilitation, unable to continue|0|||
124813574|NCT00042289|448948485|FG015|Overall Study|Severe debilitation, unable to continue|0|||
124813575|NCT00042289|448948486|FG016|Overall Study|Severe debilitation, unable to continue|0|||
124813576|NCT00042289|448948487|FG017|Overall Study|Severe debilitation, unable to continue|0|||
124813577|NCT00042289|448948488|FG018|Overall Study|Severe debilitation, unable to continue|0|||
124813578|NCT00042289|448948489|FG019|Overall Study|Severe debilitation, unable to continue|0|||
124813579|NCT00042289|448948490|FG020|Overall Study|Severe debilitation, unable to continue|0|||
124813580|NCT00042289|448948491|FG021|Overall Study|Severe debilitation, unable to continue|1|||
124636181|NCT02155283|448285153|FG000|Overall Study|Withdrawal by Subject|1|||
124636182|NCT02155283|448285153|FG000|Overall Study|Protocol Violation|3|||
124636183|NCT00463047|448285157|FG000|Titration Period 1|Adverse Event|10|||
124636184|NCT00463047|448285158|FG001|Titration Period 1|Adverse Event|8|||
124636185|NCT00463047|448285157|FG000|Titration Period 1|Lack of Efficacy|10|||
124636186|NCT00463047|448285158|FG001|Titration Period 1|Lack of Efficacy|4|||
124636187|NCT00463047|448285157|FG000|Titration Period 1|Lost to Follow-up|2|||
124636188|NCT00463047|448285158|FG001|Titration Period 1|Lost to Follow-up|0|||
124636189|NCT00463047|448285157|FG000|Titration Period 1|Non-compliance with study medication|3|||
124636190|NCT00463047|448285158|FG001|Titration Period 1|Non-compliance with study medication|5|||
124813581|NCT00042289|448948492|FG022|Overall Study|Severe debilitation, unable to continue|0|||
124813582|NCT00042289|448948493|FG023|Overall Study|Severe debilitation, unable to continue|1|||
124813583|NCT00042289|448948494|FG024|Overall Study|Severe debilitation, unable to continue|0|||
124813584|NCT00042289|448948495|FG025|Overall Study|Severe debilitation, unable to continue|0|||
124636191|NCT00463047|448285157|FG000|Titration Period 1|Protocol Violation|5|||
124636192|NCT00463047|448285158|FG001|Titration Period 1|Protocol Violation|5|||
124636193|NCT00463047|448285157|FG000|Titration Period 1|Withdrawal by Subject|3|||
124636194|NCT00463047|448285158|FG001|Titration Period 1|Withdrawal by Subject|5|||
124813585|NCT00042289|448948496|FG026|Overall Study|Severe debilitation, unable to continue|0|||
124813586|NCT00042289|448948497|FG027|Overall Study|Severe debilitation, unable to continue|1|||
124813587|NCT00042289|448948498|FG028|Overall Study|Severe debilitation, unable to continue|0|||
124813588|NCT00042289|448948499|FG029|Overall Study|Severe debilitation, unable to continue|0|||
124813589|NCT00042289|448948500|FG030|Overall Study|Severe debilitation, unable to continue|0|||
124813590|NCT00042289|448948501|FG031|Overall Study|Severe debilitation, unable to continue|1|||
124813591|NCT00042289|448948502|FG032|Overall Study|Severe debilitation, unable to continue|1|||
124813592|NCT00042289|448948503|FG033|Overall Study|Severe debilitation, unable to continue|0|||
124813593|NCT00042289|448948504|FG034|Overall Study|Severe debilitation, unable to continue|0|||
124813594|NCT00042289|448948505|FG035|Overall Study|Severe debilitation, unable to continue|0|||
124813595|NCT00042289|448948506|FG036|Overall Study|Severe debilitation, unable to continue|0|||
124813596|NCT00042289|448948507|FG037|Overall Study|Severe debilitation, unable to continue|0|||
124813597|NCT00042289|448948508|FG038|Overall Study|Severe debilitation, unable to continue|0|||
124813598|NCT00042289|448948509|FG039|Overall Study|Severe debilitation, unable to continue|0|||
124813599|NCT00042289|448948510|FG040|Overall Study|Severe debilitation, unable to continue|0|||
124813600|NCT00042289|448948511|FG041|Overall Study|Severe debilitation, unable to continue|0|||
124813601|NCT00042289|448948512|FG042|Overall Study|Severe debilitation, unable to continue|0|||
124813602|NCT00042289|448948513|FG043|Overall Study|Severe debilitation, unable to continue|0|||
124813603|NCT00042289|448948514|FG044|Overall Study|Severe debilitation, unable to continue|0|||
124813604|NCT00042289|448948515|FG045|Overall Study|Severe debilitation, unable to continue|0|||
124813605|NCT00042289|448948516|FG046|Overall Study|Severe debilitation, unable to continue|0|||
124813606|NCT00042289|448948470|FG000|Overall Study|Site closed|0|||
124813607|NCT00042289|448948471|FG001|Overall Study|Site closed|0|||
124813608|NCT00042289|448948472|FG002|Overall Study|Site closed|0|||
124813609|NCT00042289|448948473|FG003|Overall Study|Site closed|0|||
124813610|NCT00042289|448948474|FG004|Overall Study|Site closed|0|||
124813611|NCT00042289|448948475|FG005|Overall Study|Site closed|0|||
124813612|NCT00042289|448948476|FG006|Overall Study|Site closed|0|||
124813613|NCT00042289|448948477|FG007|Overall Study|Site closed|0|||
124813614|NCT00042289|448948478|FG008|Overall Study|Site closed|0|||
124813615|NCT00042289|448948479|FG009|Overall Study|Site closed|0|||
124813616|NCT00042289|448948480|FG010|Overall Study|Site closed|0|||
124813617|NCT00042289|448948481|FG011|Overall Study|Site closed|0|||
124813618|NCT00042289|448948482|FG012|Overall Study|Site closed|0|||
124813619|NCT00042289|448948483|FG013|Overall Study|Site closed|0|||
124813620|NCT00042289|448948484|FG014|Overall Study|Site closed|0|||
124813621|NCT00042289|448948485|FG015|Overall Study|Site closed|0|||
124813622|NCT00042289|448948486|FG016|Overall Study|Site closed|0|||
124813623|NCT00042289|448948487|FG017|Overall Study|Site closed|0|||
124813624|NCT00042289|448948488|FG018|Overall Study|Site closed|0|||
124813625|NCT00042289|448948489|FG019|Overall Study|Site closed|0|||
124813626|NCT00042289|448948490|FG020|Overall Study|Site closed|0|||
124813627|NCT00042289|448948491|FG021|Overall Study|Site closed|0|||
124813628|NCT00042289|448948492|FG022|Overall Study|Site closed|0|||
124813629|NCT00042289|448948493|FG023|Overall Study|Site closed|0|||
124813630|NCT00042289|448948494|FG024|Overall Study|Site closed|0|||
124813631|NCT00042289|448948495|FG025|Overall Study|Site closed|0|||
124813632|NCT00042289|448948496|FG026|Overall Study|Site closed|0|||
124813633|NCT00042289|448948497|FG027|Overall Study|Site closed|0|||
124813634|NCT00042289|448948498|FG028|Overall Study|Site closed|0|||
124813635|NCT00042289|448948499|FG029|Overall Study|Site closed|0|||
124813636|NCT00042289|448948500|FG030|Overall Study|Site closed|0|||
124813637|NCT00042289|448948501|FG031|Overall Study|Site closed|3|||
124813638|NCT00042289|448948502|FG032|Overall Study|Site closed|0|||
124813639|NCT00042289|448948503|FG033|Overall Study|Site closed|0|||
124813640|NCT00042289|448948504|FG034|Overall Study|Site closed|0|||
124813641|NCT00042289|448948505|FG035|Overall Study|Site closed|0|||
124813642|NCT00042289|448948506|FG036|Overall Study|Site closed|1|||
124813643|NCT00042289|448948507|FG037|Overall Study|Site closed|0|||
124813644|NCT00042289|448948508|FG038|Overall Study|Site closed|0|||
124813645|NCT00042289|448948509|FG039|Overall Study|Site closed|0|||
124813646|NCT00042289|448948510|FG040|Overall Study|Site closed|0|||
124813647|NCT00042289|448948511|FG041|Overall Study|Site closed|0|||
124636195|NCT00463047|448285157|FG000|Titration Period 1|Non-compliance procedures|4|||
124636196|NCT00463047|448285158|FG001|Titration Period 1|Non-compliance procedures|10|||
124813648|NCT00042289|448948512|FG042|Overall Study|Site closed|1|||
124636197|NCT00463047|448285157|FG000|Titration Period 1|Other|0|||
124636198|NCT00463047|448285158|FG001|Titration Period 1|Other|2|||
124813649|NCT00042289|448948513|FG043|Overall Study|Site closed|0|||
124813650|NCT00042289|448948514|FG044|Overall Study|Site closed|0|||
124813651|NCT00042289|448948515|FG045|Overall Study|Site closed|0|||
124813652|NCT00042289|448948516|FG046|Overall Study|Site closed|0|||
124813653|NCT00042289|448948470|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
124636199|NCT00463047|448285157|FG000|Titration Period 2|Adverse Event|9|||
124813654|NCT00042289|448948471|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
124813655|NCT00042289|448948472|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
124813656|NCT00042289|448948473|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
124813657|NCT00042289|448948474|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
124813658|NCT00042289|448948475|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
124813659|NCT00042289|448948476|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
124813660|NCT00042289|448948477|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
124813661|NCT00042289|448948478|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
124813662|NCT00042289|448948479|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
124813663|NCT00042289|448948480|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
124813664|NCT00042289|448948481|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
124813665|NCT00042289|448948482|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
124813666|NCT00042289|448948483|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
124813667|NCT00042289|448948484|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
124813668|NCT00042289|448948485|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
124813669|NCT00042289|448948486|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
124813670|NCT00042289|448948487|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
124813671|NCT00042289|448948488|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
124813672|NCT00042289|448948489|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
124813673|NCT00042289|448948490|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
124813674|NCT00042289|448948491|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
124813675|NCT00042289|448948492|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
124813676|NCT00042289|448948493|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
124813677|NCT00042289|448948494|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
124813678|NCT00042289|448948495|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
124813679|NCT00042289|448948496|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
124813680|NCT00042289|448948497|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
124813681|NCT00042289|448948498|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
124813682|NCT00042289|448948499|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
124813683|NCT00042289|448948500|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
124813684|NCT00042289|448948501|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
124813685|NCT00042289|448948502|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
124813686|NCT00042289|448948503|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
124813687|NCT00042289|448948504|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
124813688|NCT00042289|448948505|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
124813689|NCT00042289|448948506|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
124813690|NCT00042289|448948507|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
124813691|NCT00042289|448948508|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
124813692|NCT00042289|448948509|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
124813693|NCT00042289|448948510|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
124813694|NCT00042289|448948511|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
124813695|NCT00042289|448948512|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
124813696|NCT00042289|448948513|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
124813697|NCT00042289|448948514|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
124813698|NCT00042289|448948515|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
124813699|NCT00042289|448948516|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
124813700|NCT00042289|448948470|FG000|Overall Study|Protocol Violation|0|||
124813701|NCT00042289|448948471|FG001|Overall Study|Protocol Violation|0|||
124813702|NCT00042289|448948472|FG002|Overall Study|Protocol Violation|0|||
124813703|NCT00042289|448948473|FG003|Overall Study|Protocol Violation|0|||
124813704|NCT00042289|448948474|FG004|Overall Study|Protocol Violation|0|||
124813705|NCT00042289|448948475|FG005|Overall Study|Protocol Violation|1|||
124813706|NCT00042289|448948476|FG006|Overall Study|Protocol Violation|0|||
124813707|NCT00042289|448948477|FG007|Overall Study|Protocol Violation|1|||
124813708|NCT00042289|448948478|FG008|Overall Study|Protocol Violation|0|||
124813709|NCT00042289|448948479|FG009|Overall Study|Protocol Violation|0|||
124813710|NCT00042289|448948480|FG010|Overall Study|Protocol Violation|0|||
124813711|NCT00042289|448948481|FG011|Overall Study|Protocol Violation|0|||
124813712|NCT00042289|448948482|FG012|Overall Study|Protocol Violation|0|||
124813713|NCT00042289|448948483|FG013|Overall Study|Protocol Violation|0|||
124813714|NCT00042289|448948484|FG014|Overall Study|Protocol Violation|0|||
124813715|NCT00042289|448948485|FG015|Overall Study|Protocol Violation|0|||
124813716|NCT00042289|448948486|FG016|Overall Study|Protocol Violation|0|||
124813717|NCT00042289|448948487|FG017|Overall Study|Protocol Violation|0|||
124813718|NCT00042289|448948488|FG018|Overall Study|Protocol Violation|0|||
124813719|NCT00042289|448948489|FG019|Overall Study|Protocol Violation|0|||
124813720|NCT00042289|448948490|FG020|Overall Study|Protocol Violation|0|||
124813721|NCT00042289|448948491|FG021|Overall Study|Protocol Violation|0|||
124813722|NCT00042289|448948492|FG022|Overall Study|Protocol Violation|0|||
124813723|NCT00042289|448948493|FG023|Overall Study|Protocol Violation|1|||
124813724|NCT00042289|448948494|FG024|Overall Study|Protocol Violation|1|||
124813725|NCT00042289|448948495|FG025|Overall Study|Protocol Violation|0|||
124813726|NCT00042289|448948496|FG026|Overall Study|Protocol Violation|2|||
124813727|NCT00042289|448948497|FG027|Overall Study|Protocol Violation|0|||
124813728|NCT00042289|448948498|FG028|Overall Study|Protocol Violation|0|||
124813729|NCT00042289|448948499|FG029|Overall Study|Protocol Violation|0|||
124813730|NCT00042289|448948500|FG030|Overall Study|Protocol Violation|1|||
124813731|NCT00042289|448948501|FG031|Overall Study|Protocol Violation|0|||
124813732|NCT00042289|448948502|FG032|Overall Study|Protocol Violation|0|||
124813733|NCT00042289|448948503|FG033|Overall Study|Protocol Violation|0|||
124813734|NCT00042289|448948504|FG034|Overall Study|Protocol Violation|0|||
124813735|NCT00042289|448948505|FG035|Overall Study|Protocol Violation|0|||
124813736|NCT00042289|448948506|FG036|Overall Study|Protocol Violation|0|||
124813737|NCT00042289|448948507|FG037|Overall Study|Protocol Violation|0|||
124813738|NCT00042289|448948508|FG038|Overall Study|Protocol Violation|0|||
124813739|NCT00042289|448948509|FG039|Overall Study|Protocol Violation|0|||
124813740|NCT00042289|448948510|FG040|Overall Study|Protocol Violation|0|||
124813741|NCT00042289|448948511|FG041|Overall Study|Protocol Violation|1|||
124813742|NCT00042289|448948512|FG042|Overall Study|Protocol Violation|1|||
124813743|NCT00042289|448948513|FG043|Overall Study|Protocol Violation|1|||
124813744|NCT00042289|448948514|FG044|Overall Study|Protocol Violation|0|||
124813745|NCT00042289|448948515|FG045|Overall Study|Protocol Violation|0|||
124813746|NCT00042289|448948516|FG046|Overall Study|Protocol Violation|0|||
124813747|NCT00042289|448948470|FG000|Overall Study|Withdrawal by Subject|4|||
124813748|NCT00042289|448948471|FG001|Overall Study|Withdrawal by Subject|1|||
124813749|NCT00042289|448948472|FG002|Overall Study|Withdrawal by Subject|0|||
124813750|NCT00042289|448948473|FG003|Overall Study|Withdrawal by Subject|2|||
124813751|NCT00042289|448948474|FG004|Overall Study|Withdrawal by Subject|0|||
124813752|NCT00042289|448948475|FG005|Overall Study|Withdrawal by Subject|2|||
124813753|NCT00042289|448948476|FG006|Overall Study|Withdrawal by Subject|0|||
124813754|NCT00042289|448948477|FG007|Overall Study|Withdrawal by Subject|0|||
124813755|NCT00042289|448948478|FG008|Overall Study|Withdrawal by Subject|0|||
124813756|NCT00042289|448948479|FG009|Overall Study|Withdrawal by Subject|1|||
124813757|NCT00042289|448948480|FG010|Overall Study|Withdrawal by Subject|0|||
124813758|NCT00042289|448948481|FG011|Overall Study|Withdrawal by Subject|0|||
124813759|NCT00042289|448948482|FG012|Overall Study|Withdrawal by Subject|2|||
124813760|NCT00042289|448948483|FG013|Overall Study|Withdrawal by Subject|0|||
124813761|NCT00042289|448948484|FG014|Overall Study|Withdrawal by Subject|0|||
124813762|NCT00042289|448948485|FG015|Overall Study|Withdrawal by Subject|0|||
124813763|NCT00042289|448948486|FG016|Overall Study|Withdrawal by Subject|0|||
124813764|NCT00042289|448948487|FG017|Overall Study|Withdrawal by Subject|0|||
124813765|NCT00042289|448948488|FG018|Overall Study|Withdrawal by Subject|0|||
124813766|NCT00042289|448948489|FG019|Overall Study|Withdrawal by Subject|0|||
124813767|NCT00042289|448948490|FG020|Overall Study|Withdrawal by Subject|0|||
124813768|NCT00042289|448948491|FG021|Overall Study|Withdrawal by Subject|1|||
124813769|NCT00042289|448948492|FG022|Overall Study|Withdrawal by Subject|1|||
124813770|NCT00042289|448948493|FG023|Overall Study|Withdrawal by Subject|1|||
124813771|NCT00042289|448948494|FG024|Overall Study|Withdrawal by Subject|0|||
124813772|NCT00042289|448948495|FG025|Overall Study|Withdrawal by Subject|0|||
124813773|NCT00042289|448948496|FG026|Overall Study|Withdrawal by Subject|1|||
124813774|NCT00042289|448948497|FG027|Overall Study|Withdrawal by Subject|0|||
124813775|NCT00042289|448948498|FG028|Overall Study|Withdrawal by Subject|2|||
124813776|NCT00042289|448948499|FG029|Overall Study|Withdrawal by Subject|0|||
124813777|NCT00042289|448948500|FG030|Overall Study|Withdrawal by Subject|0|||
124813778|NCT00042289|448948501|FG031|Overall Study|Withdrawal by Subject|1|||
124813779|NCT00042289|448948502|FG032|Overall Study|Withdrawal by Subject|2|||
124813780|NCT00042289|448948503|FG033|Overall Study|Withdrawal by Subject|1|||
124636200|NCT00463047|448285158|FG001|Titration Period 2|Adverse Event|9|||
124636201|NCT00463047|448285157|FG000|Titration Period 2|Lack of Efficacy|6|||
124636202|NCT00463047|448285158|FG001|Titration Period 2|Lack of Efficacy|4|||
124636203|NCT00463047|448285157|FG000|Titration Period 2|Withdrawal by Subject|1|||
124636204|NCT00463047|448285158|FG001|Titration Period 2|Withdrawal by Subject|0|||
124636205|NCT00463047|448285157|FG000|Titration Period 2|Protocol Violation|2|||
124636206|NCT00463047|448285158|FG001|Titration Period 2|Protocol Violation|3|||
124636207|NCT00463047|448285157|FG000|Titration Period 2|Lost to Follow-up|1|||
124636208|NCT00463047|448285158|FG001|Titration Period 2|Lost to Follow-up|2|||
124813781|NCT00042289|448948504|FG034|Overall Study|Withdrawal by Subject|0|||
124813782|NCT00042289|448948505|FG035|Overall Study|Withdrawal by Subject|0|||
124813783|NCT00042289|448948506|FG036|Overall Study|Withdrawal by Subject|0|||
124813784|NCT00042289|448948507|FG037|Overall Study|Withdrawal by Subject|1|||
124813785|NCT00042289|448948508|FG038|Overall Study|Withdrawal by Subject|0|||
124813786|NCT00042289|448948509|FG039|Overall Study|Withdrawal by Subject|0|||
124813787|NCT00042289|448948510|FG040|Overall Study|Withdrawal by Subject|0|||
124636209|NCT00463047|448285157|FG000|Titration Period 2|Non-compliance study medication|4|||
124813788|NCT00042289|448948511|FG041|Overall Study|Withdrawal by Subject|0|||
124813789|NCT00042289|448948512|FG042|Overall Study|Withdrawal by Subject|1|||
124813790|NCT00042289|448948513|FG043|Overall Study|Withdrawal by Subject|0|||
124813791|NCT00042289|448948514|FG044|Overall Study|Withdrawal by Subject|0|||
124813792|NCT00042289|448948515|FG045|Overall Study|Withdrawal by Subject|0|||
124636210|NCT00463047|448285158|FG001|Titration Period 2|Non-compliance study medication|2|||
124636211|NCT00463047|448285157|FG000|Titration Period 2|Non-compliance procedures|4|||
124636212|NCT00463047|448285158|FG001|Titration Period 2|Non-compliance procedures|1|||
124813793|NCT00042289|448948516|FG046|Overall Study|Withdrawal by Subject|0|||
124813794|NCT00745823|448948517|FG000|Overall Study|Adverse Event|5|||
124813795|NCT00745823|448948518|FG001|Overall Study|Adverse Event|3|||
124813796|NCT00745823|448948517|FG000|Overall Study|Lack of Efficacy|20|||
124813797|NCT00745823|448948518|FG001|Overall Study|Lack of Efficacy|6|||
124813798|NCT00745823|448948517|FG000|Overall Study|Lost to Follow-up|10|||
124813799|NCT00745823|448948518|FG001|Overall Study|Lost to Follow-up|11|||
124813800|NCT00745823|448948517|FG000|Overall Study|Physician Decision|10|||
124813801|NCT00745823|448948518|FG001|Overall Study|Physician Decision|5|||
124813802|NCT00745823|448948517|FG000|Overall Study|Pregnancy|0|||
124813803|NCT00745823|448948518|FG001|Overall Study|Pregnancy|4|||
124813804|NCT00745823|448948517|FG000|Overall Study|Withdrawal by Subject|14|||
124813805|NCT00745823|448948518|FG001|Overall Study|Withdrawal by Subject|8|||
124813806|NCT00745823|448948517|FG000|Overall Study|Study Terminated by Sponsor|326|||
124813807|NCT00745823|448948518|FG001|Overall Study|Study Terminated by Sponsor|349|||
124813808|NCT01687998|448948519|FG000|Overall Study|Withdrawal by Subject|49|||
124813809|NCT01687998|448948520|FG001|Overall Study|Withdrawal by Subject|51|||
124813810|NCT01687998|448948519|FG000|Overall Study|Known to be Alive at Study End|54|||
124813811|NCT01687998|448948520|FG001|Overall Study|Known to be Alive at Study End|62|||
124813812|NCT01687998|448948519|FG000|Overall Study|Lost to Follow-up|9|||
124813813|NCT01687998|448948520|FG001|Overall Study|Lost to Follow-up|7|||
124813814|NCT00717197|448948527|FG000|Overall Study|Unable to purchase study drug|5|||
124813815|NCT00717197|448948527|FG000|Overall Study|Tumor Progression|1|||
124813816|NCT00717197|448948527|FG000|Overall Study|Physician Decision|1|||
124813817|NCT00982137|448948528|FG000|Overall Study|Lost to Follow-up|0|||
124813818|NCT00982137|448948529|FG001|Overall Study|Lost to Follow-up|0|||
124813819|NCT00982137|448948530|FG002|Overall Study|Lost to Follow-up|0|||
124813820|NCT00982137|448948531|FG003|Overall Study|Lost to Follow-up|1|||
124813821|NCT00982137|448948528|FG000|Overall Study|Withdrawal by Subject|0|||
124813822|NCT00982137|448948529|FG001|Overall Study|Withdrawal by Subject|1|||
124813823|NCT00982137|448948530|FG002|Overall Study|Withdrawal by Subject|0|||
124813824|NCT00982137|448948531|FG003|Overall Study|Withdrawal by Subject|0|||
124813825|NCT00612690|448948540|FG000|Overall Study|Lost to Follow-up|72|||
124813826|NCT00612690|448948541|FG001|Overall Study|Lost to Follow-up|98|||
124813827|NCT00612690|448948540|FG000|Overall Study|Withdrawal by Subject|32|||
124813828|NCT00612690|448948541|FG001|Overall Study|Withdrawal by Subject|20|||
124813829|NCT00612690|448948540|FG000|Overall Study|Withdrawal by Site|11|||
124813830|NCT00612690|448948541|FG001|Overall Study|Withdrawal by Site|0|||
124813831|NCT00787891|448948543|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
124813832|NCT00787891|448948544|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
124813833|NCT00787891|448948543|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
124813834|NCT00787891|448948544|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
124813835|NCT00787891|448948543|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
124813836|NCT00787891|448948544|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
124813837|NCT00787891|448948543|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
124813838|NCT00787891|448948544|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
124813839|NCT00787891|448948543|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
124813840|NCT00787891|448948544|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
124813841|NCT00787891|448948543|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
124813842|NCT00787891|448948544|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
124813843|NCT00787891|448948543|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
124813844|NCT00787891|448948544|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
124813845|NCT00787891|448948543|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
124813846|NCT00787891|448948544|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
124813847|NCT00787891|448948543|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
124813848|NCT00787891|448948544|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
124813849|NCT00787891|448948543|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
124813850|NCT00787891|448948544|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
124636213|NCT00463047|448285157|FG000|Titration Period 2|Other|3|||
124636214|NCT00463047|448285158|FG001|Titration Period 2|Other|2|||
124636215|NCT00463047|448285157|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
124813851|NCT02955602|448948545|FG000|Overall Study|Adverse Event|0|||
124813852|NCT02955602|448948546|FG001|Overall Study|Adverse Event|3|||
124813853|NCT02955602|448948547|FG002|Overall Study|Adverse Event|0|||
124813854|NCT02955602|448948545|FG000|Overall Study|Withdrawal of informed consent|1|||
124636216|NCT00463047|448285158|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
124813855|NCT02955602|448948546|FG001|Overall Study|Withdrawal of informed consent|3|||
124813856|NCT02955602|448948547|FG002|Overall Study|Withdrawal of informed consent|2|||
124813857|NCT02955602|448948545|FG000|Overall Study|Lost to Follow-up|0|||
124813858|NCT02955602|448948546|FG001|Overall Study|Lost to Follow-up|0|||
124813859|NCT02955602|448948547|FG002|Overall Study|Lost to Follow-up|1|||
124813860|NCT02955602|448948545|FG000|Overall Study|Other|0|||
124813861|NCT02955602|448948546|FG001|Overall Study|Other|1|||
124813862|NCT02955602|448948547|FG002|Overall Study|Other|3|||
124813863|NCT02980601|448948550|FG000|Overall Study|Lost to Follow-up|2|||
124813864|NCT02980601|448948551|FG001|Overall Study|Lost to Follow-up|2|||
124813865|NCT02980601|448948550|FG000|Overall Study|Death|0|||
124813866|NCT02980601|448948551|FG001|Overall Study|Death|1|||
124813867|NCT02980601|448948550|FG000|Overall Study|Graft loss|1|||
124813868|NCT02980601|448948551|FG001|Overall Study|Graft loss|0|||
124813869|NCT02980601|448948550|FG000|Overall Study|Failed to sign consent|2|||
124813870|NCT02980601|448948551|FG001|Overall Study|Failed to sign consent|0|||
124813871|NCT01575769|448948552|FG000|Overall Study|Adverse Event|1|||
124813872|NCT01575769|448948552|FG000|Overall Study|Study terminated by sponsor|40|||
124813873|NCT03156543|448948555|FG000|Overall Study|Withdrawal by Subject|1|||
124813874|NCT03156543|448948556|FG001|Overall Study|Withdrawal by Subject|0|||
124813875|NCT00674700|448948557|FG000|Year 1|Adverse Event|17|||
124813876|NCT00674700|448948558|FG001|Year 1|Adverse Event|20|||
124813877|NCT00674700|448948559|FG002|Year 1|Adverse Event|5|||
124813878|NCT00674700|448948557|FG000|Year 1|Withdrawal by Subject|7|||
124813879|NCT00674700|448948558|FG001|Year 1|Withdrawal by Subject|7|||
124813880|NCT00674700|448948559|FG002|Year 1|Withdrawal by Subject|6|||
124813881|NCT00674700|448948557|FG000|Year 1|Any other reason not above-mentioned|7|||
124813882|NCT00674700|448948558|FG001|Year 1|Any other reason not above-mentioned|7|||
124813883|NCT00674700|448948559|FG002|Year 1|Any other reason not above-mentioned|6|||
124813884|NCT00674700|448948557|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
124813885|NCT00674700|448948558|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
124813886|NCT00674700|448948559|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
124813887|NCT00674700|448948557|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
124813888|NCT00674700|448948558|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
124813889|NCT00674700|448948559|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
124813890|NCT00674700|448948557|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
124813891|NCT00674700|448948558|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
124813892|NCT00674700|448948559|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
124813893|NCT00395304|448948560|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124813894|NCT00395304|448948561|FG001|Treatment Period 1|Withdrawal by Subject|3|||
124813895|NCT00395304|448948562|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124813896|NCT00395304|448948563|FG003|Treatment Period 1|Withdrawal by Subject|2|||
124813897|NCT00395304|448948564|FG004|Treatment Period 1|Withdrawal by Subject|1|||
124813898|NCT00395304|448948565|FG005|Treatment Period 1|Withdrawal by Subject|1|||
124813899|NCT00395304|448948560|FG000|Treatment Period 1|Lost to Follow-up|1|||
124813900|NCT00395304|448948561|FG001|Treatment Period 1|Lost to Follow-up|0|||
124813901|NCT00395304|448948562|FG002|Treatment Period 1|Lost to Follow-up|0|||
124813902|NCT00395304|448948563|FG003|Treatment Period 1|Lost to Follow-up|1|||
124813903|NCT00395304|448948564|FG004|Treatment Period 1|Lost to Follow-up|0|||
124813904|NCT00395304|448948565|FG005|Treatment Period 1|Lost to Follow-up|1|||
124813905|NCT00395304|448948560|FG000|Treatment Period 1|Physician Decision|0|||
124813906|NCT00395304|448948561|FG001|Treatment Period 1|Physician Decision|1|||
124636217|NCT00463047|448285157|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
124636218|NCT00463047|448285158|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
124636219|NCT00463047|448285157|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
124636220|NCT00463047|448285158|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
124636221|NCT00463047|448285157|FG000|Double-Blind Treatment Period 1|Other|1|||
124636222|NCT00463047|448285158|FG001|Double-Blind Treatment Period 1|Other|0|||
124636223|NCT00463047|448285157|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
124636224|NCT00463047|448285158|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
124636225|NCT00463047|448285157|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
124636226|NCT00463047|448285158|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
124813907|NCT00395304|448948562|FG002|Treatment Period 1|Physician Decision|0|||
124813908|NCT00395304|448948563|FG003|Treatment Period 1|Physician Decision|0|||
124813909|NCT00395304|448948564|FG004|Treatment Period 1|Physician Decision|0|||
124813910|NCT00395304|448948565|FG005|Treatment Period 1|Physician Decision|0|||
124813911|NCT00395304|448948560|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124813912|NCT00395304|448948561|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124813913|NCT00395304|448948562|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124813914|NCT00395304|448948563|FG003|Treatment Period 2|Withdrawal by Subject|1|||
124813915|NCT00395304|448948564|FG004|Treatment Period 2|Withdrawal by Subject|0|||
124813916|NCT00395304|448948565|FG005|Treatment Period 2|Withdrawal by Subject|2|||
124813917|NCT00395304|448948560|FG000|Treatment Period 2|Lost to Follow-up|0|||
124813918|NCT00395304|448948561|FG001|Treatment Period 2|Lost to Follow-up|3|||
124813919|NCT00395304|448948562|FG002|Treatment Period 2|Lost to Follow-up|0|||
124813920|NCT00395304|448948563|FG003|Treatment Period 2|Lost to Follow-up|0|||
124813921|NCT00395304|448948564|FG004|Treatment Period 2|Lost to Follow-up|0|||
124813922|NCT00395304|448948565|FG005|Treatment Period 2|Lost to Follow-up|0|||
124813923|NCT00395304|448948560|FG000|Treatment Period 2|Physician Decision|0|||
124813924|NCT00395304|448948561|FG001|Treatment Period 2|Physician Decision|0|||
124813925|NCT00395304|448948562|FG002|Treatment Period 2|Physician Decision|1|||
124813926|NCT00395304|448948563|FG003|Treatment Period 2|Physician Decision|0|||
124813927|NCT00395304|448948564|FG004|Treatment Period 2|Physician Decision|0|||
124813928|NCT00395304|448948565|FG005|Treatment Period 2|Physician Decision|0|||
124813929|NCT00395304|448948560|FG000|Treatment Period 2|Other|0|||
124813930|NCT00395304|448948561|FG001|Treatment Period 2|Other|1|||
124813931|NCT00395304|448948562|FG002|Treatment Period 2|Other|0|||
124813932|NCT00395304|448948563|FG003|Treatment Period 2|Other|0|||
124813933|NCT00395304|448948564|FG004|Treatment Period 2|Other|0|||
124813934|NCT00395304|448948565|FG005|Treatment Period 2|Other|0|||
124813935|NCT00395304|448948560|FG000|Treatment Period 3|Withdrawal by Subject|0|||
124813936|NCT00395304|448948561|FG001|Treatment Period 3|Withdrawal by Subject|0|||
124813937|NCT00395304|448948562|FG002|Treatment Period 3|Withdrawal by Subject|0|||
124813938|NCT00395304|448948563|FG003|Treatment Period 3|Withdrawal by Subject|1|||
124813939|NCT00395304|448948564|FG004|Treatment Period 3|Withdrawal by Subject|0|||
124813940|NCT00395304|448948565|FG005|Treatment Period 3|Withdrawal by Subject|1|||
124813941|NCT00395304|448948560|FG000|Treatment Period 3|Lost to Follow-up|1|||
124813942|NCT00395304|448948561|FG001|Treatment Period 3|Lost to Follow-up|1|||
124813943|NCT00395304|448948562|FG002|Treatment Period 3|Lost to Follow-up|0|||
124813944|NCT00395304|448948563|FG003|Treatment Period 3|Lost to Follow-up|0|||
124813945|NCT00395304|448948564|FG004|Treatment Period 3|Lost to Follow-up|0|||
124813946|NCT00395304|448948565|FG005|Treatment Period 3|Lost to Follow-up|0|||
124813947|NCT00395304|448948560|FG000|Treatment Period 3|Physician Decision|0|||
124813948|NCT00395304|448948561|FG001|Treatment Period 3|Physician Decision|1|||
124813949|NCT00395304|448948562|FG002|Treatment Period 3|Physician Decision|0|||
124813950|NCT00395304|448948563|FG003|Treatment Period 3|Physician Decision|0|||
124813951|NCT00395304|448948564|FG004|Treatment Period 3|Physician Decision|0|||
124813952|NCT00395304|448948565|FG005|Treatment Period 3|Physician Decision|0|||
124813953|NCT00395304|448948560|FG000|Treatment Period 3|Other|0|||
124813954|NCT00395304|448948561|FG001|Treatment Period 3|Other|0|||
124813955|NCT00395304|448948562|FG002|Treatment Period 3|Other|0|||
124813956|NCT00395304|448948563|FG003|Treatment Period 3|Other|1|||
124813957|NCT00395304|448948564|FG004|Treatment Period 3|Other|0|||
124813958|NCT00395304|448948565|FG005|Treatment Period 3|Other|0|||
124813959|NCT03797014|448948567|FG000|Overall Study|Withdrawal by Subject|1|||
124813960|NCT03797014|448948567|FG000|Overall Study|Lost to Follow-up|1|||
124813961|NCT03797014|448948567|FG000|Overall Study|Protocol Violation|1|||
124813962|NCT01970397|448948568|FG000|Overall Study|Adverse Event|0|||
124813963|NCT01970397|448948569|FG001|Overall Study|Adverse Event|1|||
124813964|NCT01970397|448948568|FG000|Overall Study|Lost to Follow-up|0|||
124813965|NCT01970397|448948569|FG001|Overall Study|Lost to Follow-up|1|||
124813966|NCT01970397|448948568|FG000|Overall Study|Personal Reasons|1|||
124813967|NCT01970397|448948569|FG001|Overall Study|Personal Reasons|2|||
124813968|NCT01970397|448948568|FG000|Overall Study|Protocol Violation|1|||
124813969|NCT01970397|448948569|FG001|Overall Study|Protocol Violation|1|||
124813970|NCT01389817|448948572|FG000|Overall Study|Physician Decision|1|||
124813971|NCT01389817|448948573|FG001|Overall Study|Physician Decision|0|||
124813972|NCT01389817|448948572|FG000|Overall Study|Lost to Follow-up|1|||
124813973|NCT01389817|448948573|FG001|Overall Study|Lost to Follow-up|0|||
124813974|NCT01389817|448948572|FG000|Overall Study|Withdrawal by Subject|2|||
124813975|NCT01389817|448948573|FG001|Overall Study|Withdrawal by Subject|0|||
124813976|NCT01434667|448948579|FG000|Overall Study|Lost to Follow-up|5|||
124813977|NCT01434667|448948580|FG001|Overall Study|Lost to Follow-up|10|||
124813978|NCT04115839|448948581|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
124813979|NCT04115839|448948582|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
124813980|NCT04115839|448948583|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
124813981|NCT04115839|448948584|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
124813982|NCT04115839|448948585|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
124813983|NCT04115839|448948586|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
124813984|NCT04115839|448948587|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
124813985|NCT04115839|448948581|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
124813986|NCT04115839|448948582|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
124813987|NCT04115839|448948583|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
124813988|NCT04115839|448948584|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
124813989|NCT04115839|448948585|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
124813990|NCT04115839|448948586|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
124813991|NCT04115839|448948587|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
124813992|NCT04115839|448948581|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
124813993|NCT04115839|448948582|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
124813994|NCT04115839|448948583|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
124813995|NCT04115839|448948584|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
124813996|NCT04115839|448948585|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
124813997|NCT04115839|448948586|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
124813998|NCT04115839|448948587|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
124813999|NCT04115839|448948581|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
124814000|NCT04115839|448948582|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
124814001|NCT04115839|448948583|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
124814002|NCT04115839|448948584|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
124814003|NCT04115839|448948585|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
124814004|NCT04115839|448948586|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
124814005|NCT04115839|448948587|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
124814006|NCT04115839|448948581|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
124814007|NCT04115839|448948582|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
124814008|NCT04115839|448948583|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
124814009|NCT04115839|448948584|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
124814010|NCT04115839|448948585|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
124814011|NCT04115839|448948586|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
124814012|NCT04115839|448948587|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
124814013|NCT04115839|448948581|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
124814014|NCT04115839|448948582|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
124814015|NCT04115839|448948583|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
124814016|NCT04115839|448948584|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
124814017|NCT04115839|448948585|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
124814018|NCT04115839|448948586|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
124814019|NCT04115839|448948587|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
124814020|NCT02966028|448948588|FG000|Overall Study|Adverse Event|7|||
124814021|NCT02966028|448948589|FG001|Overall Study|Adverse Event|13|||
124814022|NCT02966028|448948590|FG002|Overall Study|Adverse Event|10|||
124814023|NCT02966028|448948588|FG000|Overall Study|Physician Decision|1|||
124814024|NCT02966028|448948589|FG001|Overall Study|Physician Decision|0|||
124814025|NCT02966028|448948590|FG002|Overall Study|Physician Decision|2|||
124814026|NCT02966028|448948588|FG000|Overall Study|Withdrawal by Subject|7|||
124814027|NCT02966028|448948589|FG001|Overall Study|Withdrawal by Subject|5|||
124814028|NCT02966028|448948590|FG002|Overall Study|Withdrawal by Subject|5|||
124814029|NCT02966028|448948588|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
124814030|NCT02966028|448948589|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
124814031|NCT02966028|448948590|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
124814032|NCT03535844|448948597|FG000|Overall Study|Withdrawal by Subject|0|||
124814033|NCT03535844|448948598|FG001|Overall Study|Withdrawal by Subject|1|||
124814034|NCT02835820|448948601|FG000|Overall Study|Baseline Screen Failure|0|||
124814035|NCT02835820|448948602|FG001|Overall Study|Baseline Screen Failure|3|||
124814036|NCT00160693|448948606|FG000|Overall Study|Adverse Event|97|||
124814037|NCT00160693|448948606|FG000|Overall Study|Lack of Efficacy|30|||
124814038|NCT00160693|448948606|FG000|Overall Study|Protocol Violation|24|||
124814039|NCT00160693|448948606|FG000|Overall Study|Lost to Follow-up|15|||
124814040|NCT00160693|448948606|FG000|Overall Study|Withdrawal by Subject|54|||
124814041|NCT00160693|448948606|FG000|Overall Study|Study terminated by sponsor|15|||
124814042|NCT03039283|448948609|FG000|Overall Study|Protocol Violation|2|||
124814043|NCT01867424|448948610|FG000|Overall Study|Patient noncompliance|2|||
124814044|NCT01867424|448948611|FG001|Overall Study|Patient noncompliance|1|||
124814045|NCT01056653|448948612|FG000|Overall Study|Lost to Follow-up|0|||
124814046|NCT01056653|448948613|FG001|Overall Study|Lost to Follow-up|0|||
124814047|NCT01056653|448948614|FG002|Overall Study|Lost to Follow-up|2|||
124814048|NCT05386680|448948615|FG000|Overall Study|Guardian decision|2|||
124814049|NCT01847274|448948616|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
124814050|NCT01847274|448948617|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
124814051|NCT01847274|448948618|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
124814052|NCT01847274|448948619|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
124814053|NCT01847274|448948620|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
124814054|NCT01847274|448948621|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
124814055|NCT01847274|448948622|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
124814056|NCT01847274|448948623|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
124814057|NCT01847274|448948624|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
124814058|NCT01847274|448948625|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
124814059|NCT01847274|448948626|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
124814060|NCT01847274|448948616|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
124814061|NCT01847274|448948617|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
124814062|NCT01847274|448948618|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
124814063|NCT01847274|448948619|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
124814064|NCT01847274|448948620|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
124814065|NCT01847274|448948621|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
124814066|NCT01847274|448948622|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
124819584|NCT00420927|448965764|FG003|Period 1|Lost to Follow-up|0|||
124814067|NCT01847274|448948623|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
124814068|NCT01847274|448948624|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
124814069|NCT01847274|448948625|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
124814070|NCT01847274|448948626|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
124814071|NCT01847274|448948616|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
124814072|NCT01847274|448948617|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
124814073|NCT01847274|448948618|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
124814074|NCT01847274|448948619|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
124814075|NCT01847274|448948620|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
124814076|NCT01847274|448948621|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
124814077|NCT01847274|448948622|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
124814078|NCT01847274|448948623|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
124814079|NCT01847274|448948624|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
124814080|NCT01847274|448948625|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
124814081|NCT01847274|448948626|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
124814082|NCT01847274|448948616|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814083|NCT01847274|448948617|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814084|NCT01847274|448948618|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814085|NCT01847274|448948619|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
124814086|NCT01847274|448948620|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814087|NCT01847274|448948621|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814088|NCT01847274|448948622|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814089|NCT01847274|448948623|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814090|NCT01847274|448948624|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814091|NCT01847274|448948625|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814092|NCT01847274|448948626|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
124814093|NCT01847274|448948616|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
124814094|NCT01847274|448948617|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
124814095|NCT01847274|448948618|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
124814096|NCT01847274|448948619|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
124814097|NCT01847274|448948620|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
124814098|NCT01847274|448948621|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
124814099|NCT01847274|448948622|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
124814100|NCT01847274|448948623|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
124814101|NCT01847274|448948624|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
124814102|NCT01847274|448948625|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
124814103|NCT01847274|448948626|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
124814104|NCT01847274|448948616|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
124814105|NCT01847274|448948617|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
124814106|NCT01847274|448948618|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
124814107|NCT01847274|448948619|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
124814108|NCT01847274|448948620|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
124814109|NCT01847274|448948621|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
124814110|NCT01847274|448948622|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
124814111|NCT01847274|448948623|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
124814112|NCT01847274|448948624|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
124814113|NCT01847274|448948625|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
124814114|NCT01847274|448948626|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
124814115|NCT01847274|448948616|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
124814116|NCT01847274|448948617|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
124814117|NCT01847274|448948618|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
124814118|NCT01847274|448948619|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
124814119|NCT01847274|448948620|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
124814120|NCT01847274|448948621|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
124814121|NCT01847274|448948622|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
124814122|NCT01847274|448948623|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
124814123|NCT01847274|448948624|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
124814124|NCT01847274|448948625|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
124814125|NCT01847274|448948626|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
124814126|NCT01847274|448948616|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814127|NCT01847274|448948617|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814128|NCT01847274|448948618|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814129|NCT01847274|448948619|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814130|NCT01847274|448948620|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814131|NCT01847274|448948621|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
124814132|NCT01847274|448948622|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814133|NCT01847274|448948623|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814134|NCT01847274|448948624|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814135|NCT01847274|448948625|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814136|NCT01847274|448948626|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
124814137|NCT01847274|448948616|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814138|NCT01847274|448948617|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814139|NCT01847274|448948618|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814140|NCT01847274|448948619|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814141|NCT01847274|448948620|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
124814142|NCT01847274|448948621|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814143|NCT01847274|448948622|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814144|NCT01847274|448948623|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814145|NCT01847274|448948624|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814146|NCT01847274|448948625|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814147|NCT01847274|448948626|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
124814148|NCT01847274|448948616|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814149|NCT01847274|448948617|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814150|NCT01847274|448948618|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814151|NCT01847274|448948619|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814152|NCT01847274|448948620|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814153|NCT01847274|448948621|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814154|NCT01847274|448948622|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
124814155|NCT01847274|448948623|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814156|NCT01847274|448948624|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814157|NCT01847274|448948625|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814158|NCT01847274|448948626|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
124814159|NCT01847274|448948616|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814160|NCT01847274|448948617|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814161|NCT01847274|448948618|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814162|NCT01847274|448948619|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814163|NCT01847274|448948620|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814164|NCT01847274|448948621|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814165|NCT01847274|448948622|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
124814166|NCT01847274|448948623|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814167|NCT01847274|448948624|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814168|NCT01847274|448948625|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814169|NCT01847274|448948626|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
124814170|NCT01847274|448948616|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814171|NCT01847274|448948617|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814172|NCT01847274|448948618|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814173|NCT01847274|448948619|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814174|NCT01847274|448948620|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814175|NCT01847274|448948621|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814176|NCT01847274|448948622|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
124814177|NCT01847274|448948623|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814178|NCT01847274|448948624|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814179|NCT01847274|448948625|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814180|NCT01847274|448948626|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
124814181|NCT01847274|448948616|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
124814182|NCT01847274|448948617|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
124814183|NCT01847274|448948618|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
124814184|NCT01847274|448948619|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
124814185|NCT01847274|448948620|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
124814186|NCT01847274|448948621|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
124814187|NCT01847274|448948622|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
124814188|NCT01847274|448948623|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
124814189|NCT01847274|448948624|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
124814190|NCT01847274|448948625|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
124814191|NCT01847274|448948626|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
124814192|NCT01847274|448948616|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814193|NCT01847274|448948617|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814194|NCT01847274|448948618|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814195|NCT01847274|448948619|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814196|NCT01847274|448948620|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814197|NCT01847274|448948621|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814198|NCT01847274|448948622|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814199|NCT01847274|448948623|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
124814200|NCT01847274|448948624|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814201|NCT01847274|448948625|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
124814202|NCT01847274|448948626|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
124814203|NCT01847274|448948616|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
124814204|NCT01847274|448948617|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
124814205|NCT01847274|448948618|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
124814206|NCT01847274|448948619|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
124814207|NCT01847274|448948620|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
124814208|NCT01847274|448948621|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
124814209|NCT01847274|448948622|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
124814210|NCT01847274|448948623|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
124814211|NCT01847274|448948624|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
124814212|NCT01847274|448948625|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
124814213|NCT01847274|448948626|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
124814214|NCT01847274|448948616|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814215|NCT01847274|448948617|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814216|NCT01847274|448948618|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814217|NCT01847274|448948619|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814218|NCT01847274|448948620|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814219|NCT01847274|448948621|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814220|NCT01847274|448948622|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814221|NCT01847274|448948623|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814222|NCT01847274|448948624|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814223|NCT01847274|448948625|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
124814224|NCT01847274|448948626|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
124814225|NCT03727230|448948627|FG000|Overall Study|Lost to Follow-up|12|||
124814226|NCT03470441|448948632|FG000|Overall Study|Death|0|||
124814227|NCT03470441|448948633|FG001|Overall Study|Death|1|||
124814228|NCT03470441|448948634|FG002|Overall Study|Death|1|||
124814229|NCT03470441|448948635|FG003|Overall Study|Death|0|||
124814230|NCT03470441|448948632|FG000|Overall Study|Adverse Event|0|||
124814231|NCT03470441|448948633|FG001|Overall Study|Adverse Event|0|||
124814232|NCT03470441|448948634|FG002|Overall Study|Adverse Event|0|||
124814233|NCT03470441|448948635|FG003|Overall Study|Adverse Event|1|||
124814234|NCT03470441|448948632|FG000|Overall Study|Withdrawal by Subject|1|||
124814235|NCT03470441|448948633|FG001|Overall Study|Withdrawal by Subject|4|||
124814236|NCT03470441|448948634|FG002|Overall Study|Withdrawal by Subject|1|||
124814237|NCT03470441|448948635|FG003|Overall Study|Withdrawal by Subject|3|||
124814238|NCT03768414|448948636|FG000|Overall Study|Adverse Event or side effects|72|||
124814239|NCT03768414|448948637|FG001|Overall Study|Adverse Event or side effects|28|||
124814240|NCT03768414|448948636|FG000|Overall Study|Refusal unrelated to adverse event|33|||
124814241|NCT03768414|448948637|FG001|Overall Study|Refusal unrelated to adverse event|33|||
124814242|NCT03768414|448948636|FG000|Overall Study|Progression/relapse|132|||
124814243|NCT03768414|448948637|FG001|Overall Study|Progression/relapse|60|||
124814244|NCT03768414|448948636|FG000|Overall Study|Death|9|||
124814245|NCT03768414|448948637|FG001|Overall Study|Death|6|||
124814246|NCT03768414|448948636|FG000|Overall Study|Other - not protocol specified|45|||
124814247|NCT03768414|448948637|FG001|Overall Study|Other - not protocol specified|18|||
124814248|NCT03768414|448948636|FG000|Overall Study|Reason under review|3|||
124814249|NCT03768414|448948637|FG001|Overall Study|Reason under review|2|||
124814250|NCT02538029|448948640|FG000|Overall Study|unable to complete cognitive assessments|1|||
124814251|NCT02538029|448948641|FG001|Overall Study|unable to complete cognitive assessments|0|||
124814252|NCT02538029|448948642|FG002|Overall Study|unable to complete cognitive assessments|1|||
124814253|NCT04292743|448948646|FG000|Overall Study|Physician Decision|1|||
124814254|NCT04292743|448948647|FG001|Overall Study|Physician Decision|3|||
124814255|NCT04292743|448948648|FG002|Overall Study|Physician Decision|0|||
124814256|NCT04292743|448948649|FG003|Overall Study|Physician Decision|0|||
124814257|NCT04292743|448948646|FG000|Overall Study|Withdrawal by Subject|0|||
124814258|NCT04292743|448948647|FG001|Overall Study|Withdrawal by Subject|5|||
124814259|NCT04292743|448948648|FG002|Overall Study|Withdrawal by Subject|0|||
124636227|NCT00463047|448285157|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
124636228|NCT00463047|448285158|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
124636229|NCT03020992|448285164|FG000|Overall Study|Adverse Event|5|||
124814260|NCT04292743|448948649|FG003|Overall Study|Withdrawal by Subject|0|||
124814261|NCT04292743|448948646|FG000|Overall Study|Death|0|||
124814262|NCT04292743|448948647|FG001|Overall Study|Death|1|||
124814263|NCT04292743|448948648|FG002|Overall Study|Death|0|||
124814264|NCT04292743|448948649|FG003|Overall Study|Death|0|||
124814265|NCT04292743|448948646|FG000|Overall Study|Progression of Disease|2|||
124814266|NCT04292743|448948647|FG001|Overall Study|Progression of Disease|5|||
124814267|NCT04292743|448948648|FG002|Overall Study|Progression of Disease|0|||
124814268|NCT04292743|448948649|FG003|Overall Study|Progression of Disease|0|||
124814269|NCT04292743|448948646|FG000|Overall Study|No Treatment per protocol|0|||
124814270|NCT04292743|448948647|FG001|Overall Study|No Treatment per protocol|2|||
124814271|NCT04292743|448948648|FG002|Overall Study|No Treatment per protocol|0|||
124814272|NCT04292743|448948649|FG003|Overall Study|No Treatment per protocol|0|||
124814273|NCT03187197|448950463|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
124814274|NCT03187197|448950464|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
124814275|NCT03187197|448950465|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
124814276|NCT03187197|448950463|FG000|Overall Study|Withdrawal by Subject|8|||
124814277|NCT03187197|448950464|FG001|Overall Study|Withdrawal by Subject|63|||
124814278|NCT03187197|448950465|FG002|Overall Study|Withdrawal by Subject|4|||
124814279|NCT03187197|448950463|FG000|Overall Study|Lost to Follow-up|1|||
124814280|NCT03187197|448950464|FG001|Overall Study|Lost to Follow-up|60|||
124814281|NCT03187197|448950465|FG002|Overall Study|Lost to Follow-up|7|||
124814282|NCT03187197|448950463|FG000|Overall Study|Adverse Event|6|||
124814283|NCT03187197|448950464|FG001|Overall Study|Adverse Event|29|||
124814284|NCT03187197|448950465|FG002|Overall Study|Adverse Event|0|||
124814285|NCT03187197|448950463|FG000|Overall Study|Death|0|||
124814286|NCT03187197|448950464|FG001|Overall Study|Death|11|||
124814287|NCT03187197|448950465|FG002|Overall Study|Death|0|||
124814288|NCT03187197|448950463|FG000|Overall Study|Administrative problem|1|||
124814289|NCT03187197|448950464|FG001|Overall Study|Administrative problem|1|||
124814290|NCT03187197|448950465|FG002|Overall Study|Administrative problem|0|||
124814291|NCT03187197|448950463|FG000|Overall Study|Reason not listed|2|||
124814292|NCT03187197|448950464|FG001|Overall Study|Reason not listed|54|||
124814293|NCT03187197|448950465|FG002|Overall Study|Reason not listed|1|||
124814294|NCT03187197|448950463|FG000|Overall Study|Missing|1|||
124814295|NCT03187197|448950464|FG001|Overall Study|Missing|32|||
124814296|NCT03187197|448950465|FG002|Overall Study|Missing|3|||
124814297|NCT03187197|448950463|FG000|Overall Study|Status missing|2|||
124814298|NCT03187197|448950464|FG001|Overall Study|Status missing|33|||
124814299|NCT03187197|448950465|FG002|Overall Study|Status missing|3|||
124814300|NCT03187197|448950463|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
124814301|NCT03187197|448950464|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
124814302|NCT03187197|448950465|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
124814303|NCT02385045|448950466|FG000|Overall Study|Endoscopy could not be completed|4|||
124814304|NCT02871297|448950467|FG000|Overall Study|Adverse Event|34|||
124814305|NCT02871297|448950467|FG000|Overall Study|Lack of Efficacy|10|||
124814306|NCT02871297|448950467|FG000|Overall Study|Non-compliance with study drug|15|||
124814307|NCT02871297|448950467|FG000|Overall Study|Protocol Violation|3|||
124814308|NCT02871297|448950467|FG000|Overall Study|Withdrawal by Subject|20|||
124814309|NCT02871297|448950467|FG000|Overall Study|Lost to Follow-up|13|||
124814310|NCT02871297|448950467|FG000|Overall Study|Rolled over to 13546A|2|||
124814311|NCT02871297|448950467|FG000|Overall Study|Other than specified|39|||
124814312|NCT02034110|448950468|FG000|Overall Study|Physician Decision|0|||
124814313|NCT02034110|448950469|FG001|Overall Study|Physician Decision|0|||
124814314|NCT02034110|448950470|FG002|Overall Study|Physician Decision|0|||
124814315|NCT02034110|448950471|FG003|Overall Study|Physician Decision|0|||
124814316|NCT02034110|448950472|FG004|Overall Study|Physician Decision|2|||
124814317|NCT02034110|448950473|FG005|Overall Study|Physician Decision|0|||
124814318|NCT02034110|448950474|FG006|Overall Study|Physician Decision|1|||
124814319|NCT02034110|448950475|FG007|Overall Study|Physician Decision|0|||
124814320|NCT02034110|448950468|FG000|Overall Study|Lost to Follow-up|1|||
124814321|NCT02034110|448950469|FG001|Overall Study|Lost to Follow-up|0|||
124814322|NCT02034110|448950470|FG002|Overall Study|Lost to Follow-up|0|||
124814323|NCT02034110|448950471|FG003|Overall Study|Lost to Follow-up|0|||
124814324|NCT02034110|448950472|FG004|Overall Study|Lost to Follow-up|1|||
124814325|NCT02034110|448950473|FG005|Overall Study|Lost to Follow-up|0|||
124814326|NCT02034110|448950474|FG006|Overall Study|Lost to Follow-up|1|||
124814327|NCT02034110|448950475|FG007|Overall Study|Lost to Follow-up|0|||
124814328|NCT02034110|448950468|FG000|Overall Study|Withdrawal by Subject|5|||
124814329|NCT02034110|448950469|FG001|Overall Study|Withdrawal by Subject|7|||
124814330|NCT02034110|448950470|FG002|Overall Study|Withdrawal by Subject|0|||
124814331|NCT02034110|448950471|FG003|Overall Study|Withdrawal by Subject|3|||
124814332|NCT02034110|448950472|FG004|Overall Study|Withdrawal by Subject|7|||
124814333|NCT02034110|448950473|FG005|Overall Study|Withdrawal by Subject|0|||
124814334|NCT02034110|448950474|FG006|Overall Study|Withdrawal by Subject|3|||
124814335|NCT02034110|448950475|FG007|Overall Study|Withdrawal by Subject|1|||
124814336|NCT02034110|448950468|FG000|Overall Study|Study closed by sponsor|6|||
124814337|NCT02034110|448950469|FG001|Overall Study|Study closed by sponsor|2|||
124814338|NCT02034110|448950470|FG002|Overall Study|Study closed by sponsor|0|||
124814339|NCT02034110|448950471|FG003|Overall Study|Study closed by sponsor|6|||
124814340|NCT02034110|448950472|FG004|Overall Study|Study closed by sponsor|7|||
124814341|NCT02034110|448950473|FG005|Overall Study|Study closed by sponsor|0|||
124814342|NCT02034110|448950474|FG006|Overall Study|Study closed by sponsor|42|||
124814343|NCT02034110|448950475|FG007|Overall Study|Study closed by sponsor|0|||
124814344|NCT00621985|448950476|FG000|Dexamethasone Admission|Adverse Event|1|||
124814345|NCT01877265|448950478|FG000|Treatment Period 1|Sponsor Decision|0|||
124814346|NCT01877265|448950479|FG001|Treatment Period 1|Sponsor Decision|0|||
124814347|NCT01877265|448950480|FG002|Treatment Period 1|Sponsor Decision|1|||
124814348|NCT01877265|448950481|FG003|Treatment Period 1|Sponsor Decision|0|||
124814349|NCT01877265|448950482|FG004|Treatment Period 1|Sponsor Decision|0|||
124814350|NCT01877265|448950483|FG005|Treatment Period 1|Sponsor Decision|0|||
124814351|NCT01877265|448950478|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
124814352|NCT01877265|448950479|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
124814353|NCT01877265|448950480|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
124814354|NCT01877265|448950481|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
124814355|NCT01877265|448950482|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
124814356|NCT01877265|448950483|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
124814357|NCT01877265|448950478|FG000|Treatment Period 3|Lost to Follow-up|1|||
124814358|NCT01877265|448950479|FG001|Treatment Period 3|Lost to Follow-up|0|||
124814359|NCT01877265|448950480|FG002|Treatment Period 3|Lost to Follow-up|0|||
124814360|NCT01877265|448950481|FG003|Treatment Period 3|Lost to Follow-up|0|||
124814361|NCT01877265|448950482|FG004|Treatment Period 3|Lost to Follow-up|0|||
124814362|NCT01877265|448950483|FG005|Treatment Period 3|Lost to Follow-up|0|||
124814363|NCT00691015|448950484|FG000|Overall Study|Refused further treatment|1|||
124814364|NCT04160195|448950485|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
124814365|NCT04160195|448950486|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
124814366|NCT00684593|448950490|FG000|Overall Study|Adverse Event|0|||
124814367|NCT00684593|448950491|FG001|Overall Study|Adverse Event|2|||
124814368|NCT00590720|448950494|FG000|Overall Study|Lost to Follow-up|1|||
124814369|NCT00590720|448950495|FG001|Overall Study|Lost to Follow-up|0|||
124814370|NCT00590720|448950494|FG000|Overall Study|Withdrawal by Subject|0|||
124814371|NCT00590720|448950495|FG001|Overall Study|Withdrawal by Subject|1|||
124814372|NCT01001377|448950496|FG000|Overall Study|Ineligibility determined|2|||
124814373|NCT01001377|448950497|FG001|Overall Study|Ineligibility determined|0|||
124814374|NCT01001377|448950496|FG000|Overall Study|Withdrawal by Subject|19|||
124814375|NCT01001377|448950497|FG001|Overall Study|Withdrawal by Subject|20|||
124814376|NCT01001377|448950496|FG000|Overall Study|Lost to Follow-up|14|||
124814377|NCT01001377|448950497|FG001|Overall Study|Lost to Follow-up|17|||
124814378|NCT01001377|448950496|FG000|Overall Study|Death|391|||
124814379|NCT01001377|448950497|FG001|Overall Study|Death|384|||
124814380|NCT02193867|448950500|FG000|Overall Study|Death|2|||
124814381|NCT02193867|448950500|FG000|Overall Study|Sponsor Study Termination|2|||
124814382|NCT03616600|448950501|FG000|Overall Study|Withdrawal by Subject|1|||
124814383|NCT03616600|448950502|FG001|Overall Study|Withdrawal by Subject|0|||
124814384|NCT03600818|448950503|FG000|Overall Study|Adverse Event|4|||
124814385|NCT03600818|448950504|FG001|Overall Study|Adverse Event|7|||
124814386|NCT03600818|448950503|FG000|Overall Study|Lack of Efficacy|9|||
124814387|NCT03600818|448950504|FG001|Overall Study|Lack of Efficacy|4|||
124814388|NCT03600818|448950503|FG000|Overall Study|Withdrawal by Subject|4|||
124814389|NCT03600818|448950504|FG001|Overall Study|Withdrawal by Subject|3|||
124814390|NCT03600818|448950503|FG000|Overall Study|Other-unspecified|5|||
124814391|NCT03600818|448950504|FG001|Overall Study|Other-unspecified|3|||
124814392|NCT03600818|448950503|FG000|Overall Study|Randomized and not treated|0|||
124814393|NCT03600818|448950504|FG001|Overall Study|Randomized and not treated|1|||
124814394|NCT01488370|448950508|FG000|Overall Study|Protocol Violation|0|||
124814395|NCT01488370|448950509|FG001|Overall Study|Protocol Violation|1|||
124814396|NCT01488370|448950510|FG002|Overall Study|Protocol Violation|1|||
124814397|NCT01471171|448950511|FG000|Treatment Period 1|Adverse Event|4|||
124814398|NCT01471171|448950512|FG001|Treatment Period 1|Adverse Event|1|||
124814399|NCT01471171|448950511|FG000|Treatment Period 2|Adverse Event|1|||
124814400|NCT01471171|448950512|FG001|Treatment Period 2|Adverse Event|0|||
124814401|NCT03478930|448950514|FG000|Overall Study|Adverse Event|0|||
124814402|NCT03478930|448950515|FG001|Overall Study|Adverse Event|1|||
124814403|NCT03478930|448950514|FG000|Overall Study|Lack of Efficacy|3|||
124814404|NCT03478930|448950515|FG001|Overall Study|Lack of Efficacy|3|||
124814405|NCT03478930|448950514|FG000|Overall Study|Withdrawal by Subject|6|||
124814406|NCT03478930|448950515|FG001|Overall Study|Withdrawal by Subject|5|||
124814407|NCT04189081|448950516|FG000|Overall Study|Lost to Follow-up|1|||
124636230|NCT03020992|448285164|FG000|Overall Study|Withdrawal by Subject|1|||
124814408|NCT04189081|448950517|FG001|Overall Study|Lost to Follow-up|0|||
124814409|NCT04189081|448950518|FG002|Overall Study|Lost to Follow-up|0|||
124814410|NCT04189081|448950516|FG000|Overall Study|Withdrawal by Subject|0|||
124814411|NCT04189081|448950517|FG001|Overall Study|Withdrawal by Subject|0|||
124819585|NCT00420927|448965765|FG004|Period 1|Lost to Follow-up|0|||
124814412|NCT04189081|448950518|FG002|Overall Study|Withdrawal by Subject|1|||
124814413|NCT00705484|448950521|FG000|Overall Study|Adverse Event|28|||
124814414|NCT00705484|448950522|FG001|Overall Study|Adverse Event|27|||
124814415|NCT00705484|448950521|FG000|Overall Study|Lost to Follow-up|169|||
124814416|NCT00705484|448950522|FG001|Overall Study|Lost to Follow-up|250|||
124814417|NCT00705484|448950521|FG000|Overall Study|Withdrawal by Subject|96|||
124814418|NCT00705484|448950522|FG001|Overall Study|Withdrawal by Subject|72|||
124814419|NCT00705484|448950521|FG000|Overall Study|Administrative|89|||
124814420|NCT00705484|448950522|FG001|Overall Study|Administrative|59|||
124814421|NCT03982368|448950530|FG000|Overall Study|Adverse Event|6|||
124814422|NCT03982368|448950531|FG001|Overall Study|Adverse Event|4|||
124814423|NCT03982368|448950532|FG002|Overall Study|Adverse Event|3|||
124814424|NCT03982368|448950530|FG000|Overall Study|Lost to Follow-up|2|||
124814425|NCT03982368|448950531|FG001|Overall Study|Lost to Follow-up|1|||
124814426|NCT03982368|448950532|FG002|Overall Study|Lost to Follow-up|0|||
124814427|NCT03982368|448950530|FG000|Overall Study|Withdrawal by Subject|1|||
124814428|NCT03982368|448950531|FG001|Overall Study|Withdrawal by Subject|2|||
124814429|NCT03982368|448950532|FG002|Overall Study|Withdrawal by Subject|0|||
124814430|NCT03982368|448950530|FG000|Overall Study|unknow|4|||
124814431|NCT03982368|448950531|FG001|Overall Study|unknow|0|||
124814432|NCT03982368|448950532|FG002|Overall Study|unknow|2|||
124814433|NCT03706079|448950533|FG000|Predecessor Study|Death|0|||
124814434|NCT03706079|448950534|FG001|Predecessor Study|Death|2|||
124814435|NCT03706079|448950535|FG002|Predecessor Study|Death|0|||
124814436|NCT03706079|448950536|FG003|Predecessor Study|Death|1|||
124814437|NCT03706079|448950537|FG004|Predecessor Study|Death|0|||
124814438|NCT03706079|448950538|FG005|Predecessor Study|Death|0|||
124814439|NCT03706079|448950533|FG000|Predecessor Study|Lost to Follow-up|5|||
124814440|NCT03706079|448950534|FG001|Predecessor Study|Lost to Follow-up|2|||
124814441|NCT03706079|448950535|FG002|Predecessor Study|Lost to Follow-up|0|||
124814442|NCT03706079|448950536|FG003|Predecessor Study|Lost to Follow-up|0|||
124814443|NCT03706079|448950537|FG004|Predecessor Study|Lost to Follow-up|1|||
124814444|NCT03706079|448950538|FG005|Predecessor Study|Lost to Follow-up|0|||
124814445|NCT03706079|448950533|FG000|Predecessor Study|Withdrawal by Subject|8|||
124814446|NCT03706079|448950534|FG001|Predecessor Study|Withdrawal by Subject|15|||
124814447|NCT03706079|448950535|FG002|Predecessor Study|Withdrawal by Subject|0|||
124814448|NCT03706079|448950536|FG003|Predecessor Study|Withdrawal by Subject|5|||
124814449|NCT03706079|448950537|FG004|Predecessor Study|Withdrawal by Subject|2|||
124814450|NCT03706079|448950538|FG005|Predecessor Study|Withdrawal by Subject|0|||
124814451|NCT03706079|448950533|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
124814452|NCT03706079|448950534|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
124814453|NCT03706079|448950535|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
124814454|NCT03706079|448950536|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
124814455|NCT03706079|448950537|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
124814456|NCT03706079|448950538|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
124814457|NCT03706079|448950533|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
124814458|NCT03706079|448950534|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
124814459|NCT03706079|448950535|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
124814460|NCT03706079|448950536|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
124814461|NCT03706079|448950537|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
124814462|NCT03706079|448950538|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
124814463|NCT03706079|448950533|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
124814464|NCT03706079|448950534|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
124814465|NCT03706079|448950535|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
124814466|NCT03706079|448950536|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
124814467|NCT03706079|448950537|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
124814468|NCT03706079|448950538|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
124814469|NCT03706079|448950533|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
124814470|NCT03706079|448950534|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
124814471|NCT03706079|448950535|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
124814472|NCT03706079|448950536|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
124814473|NCT03706079|448950537|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
124814474|NCT03706079|448950538|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
124814475|NCT03706079|448950533|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
124814476|NCT03706079|448950534|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
124814477|NCT03706079|448950535|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
124814478|NCT03706079|448950536|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
124814479|NCT03706079|448950537|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
124814480|NCT03706079|448950538|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
124814481|NCT03706079|448950533|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
124814482|NCT03706079|448950534|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
124814483|NCT03706079|448950535|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
124814484|NCT03706079|448950536|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
124814485|NCT03706079|448950537|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
124814486|NCT03706079|448950538|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
124814487|NCT03706079|448950533|FG000|Long Term Extension (DESTINATION)|Death|8|||
124814488|NCT03706079|448950534|FG001|Long Term Extension (DESTINATION)|Death|2|||
124814489|NCT03706079|448950535|FG002|Long Term Extension (DESTINATION)|Death|2|||
124814490|NCT03706079|448950536|FG003|Long Term Extension (DESTINATION)|Death|1|||
124814491|NCT03706079|448950537|FG004|Long Term Extension (DESTINATION)|Death|0|||
124814492|NCT03706079|448950538|FG005|Long Term Extension (DESTINATION)|Death|0|||
124814493|NCT00329238|448950539|FG000|Overall Study|Adverse Event|147|||
124814494|NCT00329238|448950540|FG001|Overall Study|Adverse Event|129|||
124814495|NCT00329238|448950539|FG000|Overall Study|Protocol Violation|23|||
124814496|NCT00329238|448950540|FG001|Overall Study|Protocol Violation|34|||
124814497|NCT00329238|448950539|FG000|Overall Study|Lost to Follow-up|2|||
124814498|NCT00329238|448950540|FG001|Overall Study|Lost to Follow-up|6|||
124814499|NCT00329238|448950539|FG000|Overall Study|Withdrawal by Subject|64|||
124814500|NCT00329238|448950540|FG001|Overall Study|Withdrawal by Subject|58|||
124814501|NCT00329238|448950539|FG000|Overall Study|Other reason (not specified)|40|||
124814502|NCT00329238|448950540|FG001|Overall Study|Other reason (not specified)|54|||
124814503|NCT05393895|448950543|FG000|Overall Study|Adverse Event|2|||
124814504|NCT05393895|448950544|FG001|Overall Study|Adverse Event|3|||
124814505|NCT05393895|448950543|FG000|Overall Study|Lost to Follow-up|4|||
124814506|NCT05393895|448950544|FG001|Overall Study|Lost to Follow-up|3|||
124814507|NCT05393895|448950543|FG000|Overall Study|Protocol Violation|1|||
124814508|NCT05393895|448950544|FG001|Overall Study|Protocol Violation|0|||
124814509|NCT05393895|448950543|FG000|Overall Study|Withdrawal by Subject|1|||
124814510|NCT05393895|448950544|FG001|Overall Study|Withdrawal by Subject|4|||
124814511|NCT00968513|448950547|FG000|Overall Study|Death|4|||
124814512|NCT00968513|448950548|FG001|Overall Study|Death|10|||
124814513|NCT00968513|448950549|FG002|Overall Study|Death|15|||
124814514|NCT05537883|448950550|FG000|Overall Study|revisional surgery|4|||
124814515|NCT05537883|448950551|FG001|Overall Study|revisional surgery|2|||
124814516|NCT05537883|448950550|FG000|Overall Study|surgeries were cancelled|0|||
124814517|NCT05537883|448950551|FG001|Overall Study|surgeries were cancelled|2|||
124814518|NCT05537883|448950550|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
124814519|NCT05537883|448950551|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
124814520|NCT01302834|448950552|FG000|Overall Study|Protocol Violation|17|||
124814521|NCT01302834|448950553|FG001|Overall Study|Protocol Violation|23|||
124814522|NCT01302834|448950552|FG000|Overall Study|HIV positive|1|||
124814523|NCT01302834|448950553|FG001|Overall Study|HIV positive|3|||
124814524|NCT01328431|448950554|FG000|Baseline|Protocol Violation|0|||
124814525|NCT01328431|448950555|FG001|Baseline|Protocol Violation|2|||
124814526|NCT01328431|448950554|FG000|1 Month (1M)|Lost to Follow-up|55|||
124814527|NCT01328431|448950555|FG001|1 Month (1M)|Lost to Follow-up|58|||
124814528|NCT01328431|448950554|FG000|3 Month (3M)|Death|2|||
124814529|NCT01328431|448950555|FG001|3 Month (3M)|Death|2|||
124814530|NCT01328431|448950554|FG000|3 Month (3M)|Lost to Follow-up|75|||
124814531|NCT01328431|448950555|FG001|3 Month (3M)|Lost to Follow-up|70|||
124814532|NCT01328431|448950554|FG000|12 Month (12M)|Death|2|||
124814533|NCT01328431|448950555|FG001|12 Month (12M)|Death|6|||
124814534|NCT01328431|448950554|FG000|12 Month (12M)|Lost to Follow-up|82|||
124814535|NCT01328431|448950555|FG001|12 Month (12M)|Lost to Follow-up|91|||
124814536|NCT05379231|448950556|FG000|Home Visit|Withdrawal by Subject|2|||
124814537|NCT05379231|448950556|FG000|In-lab Visit|Withdrawal by Subject|2|||
124814538|NCT02296320|448950563|FG000|Overall Study|Withdrawal by Subject|4|||
124814539|NCT02296320|448950564|FG001|Overall Study|Withdrawal by Subject|0|||
124814540|NCT02296320|448950565|FG002|Overall Study|Withdrawal by Subject|2|||
124814541|NCT02296320|448950563|FG000|Overall Study|Death|24|||
124814542|NCT02296320|448950564|FG001|Overall Study|Death|3|||
124814543|NCT02296320|448950565|FG002|Overall Study|Death|27|||
124814544|NCT02296320|448950563|FG000|Overall Study|Lost to Follow-up|5|||
124814545|NCT02296320|448950564|FG001|Overall Study|Lost to Follow-up|2|||
124814546|NCT02296320|448950565|FG002|Overall Study|Lost to Follow-up|7|||
124814547|NCT02296320|448950563|FG000|Overall Study|Not treated|2|||
124814548|NCT02296320|448950564|FG001|Overall Study|Not treated|0|||
124814549|NCT02296320|448950565|FG002|Overall Study|Not treated|0|||
124814550|NCT02296320|448950563|FG000|Overall Study|Not - specified|0|||
124814551|NCT02296320|448950564|FG001|Overall Study|Not - specified|0|||
124814552|NCT02296320|448950565|FG002|Overall Study|Not - specified|1|||
124814553|NCT01203098|448950572|FG000|Overall Study|Adverse Event|3|||
124814554|NCT01203098|448950573|FG001|Overall Study|Adverse Event|1|||
124814555|NCT01203098|448950574|FG002|Overall Study|Adverse Event|7|||
124814556|NCT01203098|448950572|FG000|Overall Study|Lost to Follow-up|0|||
124814557|NCT01203098|448950573|FG001|Overall Study|Lost to Follow-up|0|||
124814558|NCT01203098|448950574|FG002|Overall Study|Lost to Follow-up|1|||
124814559|NCT01203098|448950572|FG000|Overall Study|Physician Decision|2|||
124814560|NCT01203098|448950573|FG001|Overall Study|Physician Decision|2|||
124814561|NCT01203098|448950574|FG002|Overall Study|Physician Decision|0|||
124814562|NCT01203098|448950572|FG000|Overall Study|Withdrawal by Subject|1|||
124814563|NCT01203098|448950573|FG001|Overall Study|Withdrawal by Subject|1|||
124814564|NCT01203098|448950574|FG002|Overall Study|Withdrawal by Subject|3|||
124814565|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
124814566|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
124814567|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
124814568|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
124814569|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
124814570|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
124814571|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
124814572|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
124814573|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
124814574|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
124814575|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
124814576|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
124814577|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
124814578|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
124814579|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
124814580|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
124814581|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
124814582|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
124814583|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
124814584|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
124814585|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
124814586|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
124814587|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
124814588|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
124814589|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
124814590|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
124814591|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
124814592|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
124814593|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
124814594|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
124814595|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
124814596|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
124814597|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
124814598|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
124814599|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
124814600|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
124814601|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
124814602|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
124814603|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
124814604|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
124814605|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
124814606|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
124814607|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
124814608|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
124814609|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
124814610|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
124814611|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
124814612|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
124814613|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
124814614|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
124814615|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
124814616|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
124814617|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
124814618|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
124814619|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
124814620|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
124814621|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
124814622|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
124814623|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
124814624|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
124814625|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
124814626|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
124814627|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
124814628|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
124814629|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
124814630|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
124814631|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
124814632|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
124814633|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
124814634|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
124814635|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Change of location|0|||
124814636|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Change of location|0|||
124814637|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Change of location|0|||
124814638|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Change of location|1|||
124814639|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Change of location|0|||
124814640|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
124814641|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
124814642|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
124814643|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
124814644|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
124814645|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
124814646|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
124814647|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
124814648|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
124814649|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
124814650|NCT00730405|448950575|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
124814651|NCT00730405|448950576|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
124814652|NCT00730405|448950577|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
124814653|NCT00730405|448950578|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
124814654|NCT00730405|448950579|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
124814655|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
124814656|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
124814657|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
124814658|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
124814659|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
124814660|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
124814661|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
124814662|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
124814663|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
124814664|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
124814665|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
124814666|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
124814667|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
124814668|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
124814669|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
124814670|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Death|0|||
124814671|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Death|1|||
124814672|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Death|0|||
124814673|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Death|1|||
124814674|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Death|0|||
124814675|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Change of location|1|||
124814676|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Change of location|1|||
124814677|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Change of location|0|||
124814678|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Change of location|1|||
124814679|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Change of location|0|||
124814680|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
124814681|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
124814682|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
124814683|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
124814684|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
124814685|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
124814686|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
124814687|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
124814688|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
124814689|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
124814690|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
124814691|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
124814692|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
124814693|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
124814694|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
124814695|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
124814696|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
124814697|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
124814698|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
124814699|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
124814700|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
124814701|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
124814702|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
124814703|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
124814704|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
124814705|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
124814706|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
124814707|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
124814708|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
124814709|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
124814710|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
124814711|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
124814712|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
124814713|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
124814714|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
124814715|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
124814716|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
124814717|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
124814718|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
124814719|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
124814720|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
124814721|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
124814722|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
124814723|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
124814724|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
124814725|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
124814726|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
124814727|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
124814728|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
124814729|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
124814730|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Missing|0|||
124814731|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Missing|0|||
124814732|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Missing|2|||
124814733|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Missing|0|||
124814734|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Missing|0|||
124814735|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
124814736|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
124814737|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
124814738|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
124814739|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
124814740|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
124814741|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
124814742|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
124814743|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
124814744|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
124814745|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
124814746|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
124814747|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
124814748|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
124814749|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
124814750|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
124814751|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
124814752|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
124814753|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
124814754|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
124814755|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
124814756|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
124814757|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
124814758|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
124814759|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
124814760|NCT00730405|448950575|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
124814761|NCT00730405|448950576|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
124814762|NCT00730405|448950577|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
124814763|NCT00730405|448950578|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
124814764|NCT00730405|448950579|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
124814765|NCT03851705|448950582|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
124814766|NCT03851705|448950583|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
124814767|NCT03851705|448950584|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
124814768|NCT03851705|448950585|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
124814769|NCT03851705|448950582|FG000|Part 1: Double-Blind Period|Other reason|1|||
124814770|NCT03851705|448950583|FG001|Part 1: Double-Blind Period|Other reason|0|||
124814771|NCT03851705|448950584|FG002|Part 1: Double-Blind Period|Other reason|0|||
124814772|NCT03851705|448950585|FG003|Part 1: Double-Blind Period|Other reason|0|||
124814773|NCT03851705|448950582|FG000|Part 2: Open-Label Period|Other reason|0|||
124814774|NCT03851705|448950583|FG001|Part 2: Open-Label Period|Other reason|0|||
124814775|NCT03851705|448950584|FG002|Part 2: Open-Label Period|Other reason|0|||
124814776|NCT03851705|448950585|FG003|Part 2: Open-Label Period|Other reason|1|||
124814777|NCT03851705|448950582|FG000|Part 2: Open-Label Period|Death|0|||
124814778|NCT03851705|448950583|FG001|Part 2: Open-Label Period|Death|0|||
124814779|NCT03851705|448950584|FG002|Part 2: Open-Label Period|Death|3|||
124814780|NCT03851705|448950585|FG003|Part 2: Open-Label Period|Death|0|||
124814781|NCT03851705|448950582|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
124814782|NCT03851705|448950583|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
124814783|NCT03851705|448950584|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
124814784|NCT03851705|448950585|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
124814785|NCT01496807|448950589|FG000|Overall Study|Progressive Disease|21|||
124814786|NCT01496807|448950589|FG000|Overall Study|Participant preference/toxicity|8|||
124814787|NCT01496807|448950589|FG000|Overall Study|Change in diagnosis|1|||
124814788|NCT02591290|448950596|FG000|Overall Study|Withdrawal by Subject|2|||
124814789|NCT00913497|448950597|FG000|Overall Study|Adverse Event|1|||
124814790|NCT00913497|448950597|FG000|Overall Study|Withdrawal by Subject|2|||
124814791|NCT01390649|448950604|FG000|Overall Study|Physician Decision|1|||
124814792|NCT02217878|448950605|FG000|Overall Study|required morphine due to chest pain|1|||
124814793|NCT02217878|448950606|FG001|Overall Study|required morphine due to chest pain|2|||
124814794|NCT02217878|448950605|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
124814795|NCT02217878|448950606|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
124814796|NCT00334958|448950607|FG000|Overall Study|Medication Noncompliance|0|||
124814797|NCT00334958|448950608|FG001|Overall Study|Medication Noncompliance|3|||
124814798|NCT00334958|448950607|FG000|Overall Study|Protocol Violation|2|||
124814799|NCT00334958|448950608|FG001|Overall Study|Protocol Violation|2|||
124814800|NCT00334958|448950607|FG000|Overall Study|Request of the investigator or sponsor|0|||
124814801|NCT00334958|448950608|FG001|Overall Study|Request of the investigator or sponsor|1|||
124814802|NCT00334958|448950607|FG000|Overall Study|Withdrawal by Subject|7|||
124814803|NCT00334958|448950608|FG001|Overall Study|Withdrawal by Subject|4|||
124814804|NCT00334958|448950607|FG000|Overall Study|Adverse Event|27|||
124814805|NCT00334958|448950608|FG001|Overall Study|Adverse Event|12|||
124814806|NCT00334958|448950607|FG000|Overall Study|Other|1|||
124814807|NCT00334958|448950608|FG001|Overall Study|Other|2|||
124814808|NCT03087643|448950616|FG000|Overall Study|Withdrawal by Subject|2|||
124814809|NCT03087643|448950617|FG001|Overall Study|Withdrawal by Subject|4|||
124814810|NCT03087643|448950616|FG000|Overall Study|Death|2|||
124814811|NCT03087643|448950617|FG001|Overall Study|Death|2|||
124814812|NCT02083783|448950620|FG000|Overall Study|Withdrawal by Subject|1|||
124814813|NCT02083783|448950621|FG001|Overall Study|Withdrawal by Subject|0|||
124814814|NCT01546883|448950622|FG000|Overall Study|Withdrawal by Subject|3|||
124814815|NCT01546883|448950622|FG000|Overall Study|Adverse Event|4|||
124814816|NCT01546883|448950622|FG000|Overall Study|Lost to Follow-up|2|||
124814817|NCT01546883|448950622|FG000|Overall Study|early closure of study|2|||
124814818|NCT01546883|448950622|FG000|Overall Study|other unrelated illness|1|||
124814819|NCT02256631|448950623|FG000|Overall Study|Lost to Follow-up|1|||
124814820|NCT02256631|448950624|FG001|Overall Study|Lost to Follow-up|1|||
124814821|NCT02256631|448950625|FG002|Overall Study|Lost to Follow-up|0|||
124814822|NCT02256631|448950626|FG003|Overall Study|Lost to Follow-up|2|||
124814823|NCT02256631|448950627|FG004|Overall Study|Lost to Follow-up|0|||
124814824|NCT02256631|448950628|FG005|Overall Study|Lost to Follow-up|4|||
124814825|NCT02256631|448950629|FG006|Overall Study|Lost to Follow-up|1|||
124814826|NCT02256631|448950623|FG000|Overall Study|Withdrawal by Subject|0|||
124814827|NCT02256631|448950624|FG001|Overall Study|Withdrawal by Subject|0|||
124814828|NCT02256631|448950625|FG002|Overall Study|Withdrawal by Subject|0|||
124814829|NCT02256631|448950626|FG003|Overall Study|Withdrawal by Subject|1|||
124814830|NCT02256631|448950627|FG004|Overall Study|Withdrawal by Subject|1|||
124814831|NCT02256631|448950628|FG005|Overall Study|Withdrawal by Subject|0|||
124814832|NCT02256631|448950629|FG006|Overall Study|Withdrawal by Subject|1|||
124814833|NCT02256631|448950623|FG000|Overall Study|Unable to get to clinic|0|||
124814834|NCT02256631|448950624|FG001|Overall Study|Unable to get to clinic|2|||
124814835|NCT02256631|448950625|FG002|Overall Study|Unable to get to clinic|0|||
124814836|NCT02256631|448950626|FG003|Overall Study|Unable to get to clinic|1|||
124814837|NCT02256631|448950627|FG004|Overall Study|Unable to get to clinic|0|||
124814838|NCT02256631|448950628|FG005|Overall Study|Unable to get to clinic|1|||
124814839|NCT02256631|448950629|FG006|Overall Study|Unable to get to clinic|2|||
124814840|NCT01427972|448950630|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814841|NCT01427972|448950631|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814842|NCT01427972|448950632|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814843|NCT01427972|448950633|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814844|NCT01427972|448950634|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814845|NCT01427972|448950635|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814846|NCT01427972|448950636|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814847|NCT01427972|448950637|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
124814848|NCT01427972|448950638|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814849|NCT01427972|448950639|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814850|NCT01427972|448950640|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814851|NCT01427972|448950641|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
124814852|NCT01427972|448950630|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814853|NCT01427972|448950631|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814854|NCT01427972|448950632|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814855|NCT01427972|448950633|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814856|NCT01427972|448950634|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814857|NCT01427972|448950635|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
124814858|NCT01427972|448950636|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814859|NCT01427972|448950637|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814860|NCT01427972|448950638|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814861|NCT01427972|448950639|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814862|NCT01427972|448950640|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814863|NCT01427972|448950641|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
124814864|NCT01427972|448950630|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814865|NCT01427972|448950631|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
124814866|NCT01427972|448950632|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814867|NCT01427972|448950633|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814868|NCT01427972|448950634|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814869|NCT01427972|448950635|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814870|NCT01427972|448950636|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814871|NCT01427972|448950637|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814872|NCT01427972|448950638|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814873|NCT01427972|448950639|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814874|NCT01427972|448950640|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814875|NCT01427972|448950641|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
124814876|NCT00824720|448950644|FG000|Overall Study|failed plug insertion|3|||
124814877|NCT00824720|448950645|FG001|Overall Study|failed plug insertion|1|||
124814878|NCT00824720|448950646|FG002|Overall Study|failed plug insertion|0|||
124814879|NCT00824720|448950644|FG000|Overall Study|Protocol Violation|0|||
124814880|NCT00824720|448950645|FG001|Overall Study|Protocol Violation|0|||
124814881|NCT00824720|448950646|FG002|Overall Study|Protocol Violation|1|||
124814882|NCT02777333|448950652|FG000|Overall Study|Withdrawal by Subject|0|||
124814883|NCT02777333|448950653|FG001|Overall Study|Withdrawal by Subject|1|||
124814884|NCT02777333|448950652|FG000|Overall Study|Lost to Follow-up|0|||
124814885|NCT02777333|448950653|FG001|Overall Study|Lost to Follow-up|1|||
124814886|NCT00837811|448950654|FG000|Overall Study|Adverse Event|4|||
124814887|NCT00837811|448950655|FG001|Overall Study|Adverse Event|6|||
124814888|NCT00837811|448950656|FG002|Overall Study|Adverse Event|0|||
124814889|NCT00837811|448950654|FG000|Overall Study|Death|1|||
124814890|NCT00837811|448950655|FG001|Overall Study|Death|1|||
124814891|NCT00837811|448950656|FG002|Overall Study|Death|0|||
124814892|NCT00837811|448950654|FG000|Overall Study|Lack of Efficacy|0|||
124814893|NCT00837811|448950655|FG001|Overall Study|Lack of Efficacy|11|||
124814894|NCT00837811|448950656|FG002|Overall Study|Lack of Efficacy|0|||
124814895|NCT00837811|448950654|FG000|Overall Study|Lost to Follow-up|1|||
124814896|NCT00837811|448950655|FG001|Overall Study|Lost to Follow-up|3|||
124814897|NCT00837811|448950656|FG002|Overall Study|Lost to Follow-up|0|||
124814898|NCT00837811|448950654|FG000|Overall Study|Physician Decision|0|||
124814899|NCT00837811|448950655|FG001|Overall Study|Physician Decision|2|||
124814900|NCT00837811|448950656|FG002|Overall Study|Physician Decision|1|||
124814901|NCT00837811|448950654|FG000|Overall Study|Withdrawal by Subject|1|||
124814902|NCT00837811|448950655|FG001|Overall Study|Withdrawal by Subject|9|||
124814903|NCT00837811|448950656|FG002|Overall Study|Withdrawal by Subject|0|||
124814904|NCT00837811|448950654|FG000|Overall Study|Sponsor Decision|0|||
124814905|NCT00837811|448950655|FG001|Overall Study|Sponsor Decision|2|||
124814906|NCT00837811|448950656|FG002|Overall Study|Sponsor Decision|0|||
124814907|NCT02849678|448952812|FG000|Overall Study|Protocol Violation|3|||
124814908|NCT02849678|448952813|FG001|Overall Study|Protocol Violation|6|||
124814909|NCT03310021|448952817|FG000|Overall Study|Withdrawal by Subject|0|||
124814910|NCT03310021|448952818|FG001|Overall Study|Withdrawal by Subject|0|||
124814911|NCT03310021|448952819|FG002|Overall Study|Withdrawal by Subject|0|||
124814912|NCT03310021|448952820|FG003|Overall Study|Withdrawal by Subject|0|||
124814913|NCT03310021|448952821|FG004|Overall Study|Withdrawal by Subject|0|||
124814914|NCT03310021|448952822|FG005|Overall Study|Withdrawal by Subject|0|||
124814915|NCT03310021|448952823|FG006|Overall Study|Withdrawal by Subject|1|||
124814916|NCT03310021|448952824|FG007|Overall Study|Withdrawal by Subject|0|||
124814917|NCT03310021|448952825|FG008|Overall Study|Withdrawal by Subject|0|||
124814918|NCT03310021|448952826|FG009|Overall Study|Withdrawal by Subject|0|||
124814919|NCT03310021|448952827|FG010|Overall Study|Withdrawal by Subject|0|||
124814920|NCT03310021|448952828|FG011|Overall Study|Withdrawal by Subject|0|||
124814921|NCT03310021|448952829|FG012|Overall Study|Withdrawal by Subject|0|||
124814922|NCT03310021|448952830|FG013|Overall Study|Withdrawal by Subject|0|||
124814923|NCT03310021|448952831|FG014|Overall Study|Withdrawal by Subject|0|||
124814924|NCT03310021|448952832|FG015|Overall Study|Withdrawal by Subject|0|||
124814925|NCT03310021|448952833|FG016|Overall Study|Withdrawal by Subject|0|||
124814926|NCT03310021|448952834|FG017|Overall Study|Withdrawal by Subject|0|||
124814927|NCT03310021|448952835|FG018|Overall Study|Withdrawal by Subject|0|||
124814928|NCT03310021|448952836|FG019|Overall Study|Withdrawal by Subject|0|||
124814929|NCT03310021|448952817|FG000|Overall Study|Lost to Follow-up|0|||
124814930|NCT03310021|448952818|FG001|Overall Study|Lost to Follow-up|0|||
124814931|NCT03310021|448952819|FG002|Overall Study|Lost to Follow-up|0|||
124814932|NCT03310021|448952820|FG003|Overall Study|Lost to Follow-up|0|||
124814933|NCT03310021|448952821|FG004|Overall Study|Lost to Follow-up|0|||
124814934|NCT03310021|448952822|FG005|Overall Study|Lost to Follow-up|0|||
124814935|NCT03310021|448952823|FG006|Overall Study|Lost to Follow-up|0|||
124814936|NCT03310021|448952824|FG007|Overall Study|Lost to Follow-up|0|||
124814937|NCT03310021|448952825|FG008|Overall Study|Lost to Follow-up|0|||
124814938|NCT03310021|448952826|FG009|Overall Study|Lost to Follow-up|0|||
124814939|NCT03310021|448952827|FG010|Overall Study|Lost to Follow-up|1|||
124814940|NCT03310021|448952828|FG011|Overall Study|Lost to Follow-up|0|||
124814941|NCT03310021|448952829|FG012|Overall Study|Lost to Follow-up|0|||
124814942|NCT03310021|448952830|FG013|Overall Study|Lost to Follow-up|0|||
124814943|NCT03310021|448952831|FG014|Overall Study|Lost to Follow-up|0|||
124814944|NCT03310021|448952832|FG015|Overall Study|Lost to Follow-up|0|||
124814945|NCT03310021|448952833|FG016|Overall Study|Lost to Follow-up|0|||
124814946|NCT03310021|448952834|FG017|Overall Study|Lost to Follow-up|0|||
124814947|NCT03310021|448952835|FG018|Overall Study|Lost to Follow-up|0|||
124814948|NCT03310021|448952836|FG019|Overall Study|Lost to Follow-up|0|||
124814949|NCT01874054|448952837|FG000|Overall Study|Withdrawal by Subject|3|||
124814950|NCT01874054|448952837|FG000|Overall Study|Study Termination by Sponsor|42|||
124814951|NCT01874054|448952837|FG000|Overall Study|Lost to Follow-up|5|||
124814952|NCT01874054|448952837|FG000|Overall Study|Death|5|||
124814953|NCT00702923|448952838|FG000|Overall Study|Adverse Event|1|||
124814954|NCT02002091|448952844|FG000|Screening|Lost to Follow-up|10|||
124814955|NCT02002091|448952845|FG001|Screening|Lost to Follow-up|12|||
124814956|NCT02002091|448952844|FG000|Screening|Death|3|||
124814957|NCT02002091|448952845|FG001|Screening|Death|2|||
124814958|NCT00369824|448952846|FG000|Overall Study|Adverse Event|0|||
124814959|NCT00369824|448952847|FG001|Overall Study|Adverse Event|2|||
124814960|NCT00369824|448952848|FG002|Overall Study|Adverse Event|0|||
124814961|NCT00369824|448952849|FG003|Overall Study|Adverse Event|0|||
124814962|NCT00369824|448952850|FG004|Overall Study|Adverse Event|1|||
124814963|NCT00369824|448952851|FG005|Overall Study|Adverse Event|0|||
124814964|NCT00369824|448952846|FG000|Overall Study|Protocol Violation|0|||
124814965|NCT00369824|448952847|FG001|Overall Study|Protocol Violation|1|||
124814966|NCT00369824|448952848|FG002|Overall Study|Protocol Violation|0|||
124814967|NCT00369824|448952849|FG003|Overall Study|Protocol Violation|1|||
124814968|NCT00369824|448952850|FG004|Overall Study|Protocol Violation|1|||
124814969|NCT00369824|448952851|FG005|Overall Study|Protocol Violation|0|||
124814970|NCT00369824|448952846|FG000|Overall Study|Withdrawal by Subject|9|||
124814971|NCT00369824|448952847|FG001|Overall Study|Withdrawal by Subject|5|||
124814972|NCT00369824|448952848|FG002|Overall Study|Withdrawal by Subject|5|||
124814973|NCT00369824|448952849|FG003|Overall Study|Withdrawal by Subject|4|||
124814974|NCT00369824|448952850|FG004|Overall Study|Withdrawal by Subject|6|||
124814975|NCT00369824|448952851|FG005|Overall Study|Withdrawal by Subject|2|||
124814976|NCT00369824|448952846|FG000|Overall Study|Lost to Follow-up|6|||
124814977|NCT00369824|448952847|FG001|Overall Study|Lost to Follow-up|11|||
124814978|NCT00369824|448952848|FG002|Overall Study|Lost to Follow-up|7|||
124814979|NCT00369824|448952849|FG003|Overall Study|Lost to Follow-up|8|||
124814980|NCT00369824|448952850|FG004|Overall Study|Lost to Follow-up|9|||
124814981|NCT00369824|448952851|FG005|Overall Study|Lost to Follow-up|6|||
124814982|NCT00369824|448952846|FG000|Overall Study|Other|0|||
124814983|NCT00369824|448952847|FG001|Overall Study|Other|0|||
124814984|NCT00369824|448952848|FG002|Overall Study|Other|0|||
124814985|NCT00369824|448952849|FG003|Overall Study|Other|2|||
124814986|NCT00369824|448952850|FG004|Overall Study|Other|1|||
124814987|NCT00369824|448952851|FG005|Overall Study|Other|3|||
124814988|NCT03953820|448952852|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
124814989|NCT03953820|448952853|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
124814990|NCT03953820|448952854|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
124814991|NCT03953820|448952852|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
124814992|NCT03953820|448952853|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
124814993|NCT03953820|448952854|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
124814994|NCT03385564|448952856|FG000|Overall Study|Adverse Event|0|||
124814995|NCT03385564|448952857|FG001|Overall Study|Adverse Event|0|||
124814996|NCT03385564|448952858|FG002|Overall Study|Adverse Event|3|||
124814997|NCT03385564|448952859|FG003|Overall Study|Adverse Event|3|||
124814998|NCT03385564|448952856|FG000|Overall Study|Other than listed|0|||
124814999|NCT03385564|448952857|FG001|Overall Study|Other than listed|0|||
124815000|NCT03385564|448952858|FG002|Overall Study|Other than listed|0|||
124815001|NCT03385564|448952859|FG003|Overall Study|Other than listed|5|||
124815002|NCT03385564|448952856|FG000|Overall Study|Withdrawal by Subject|0|||
124815003|NCT03385564|448952857|FG001|Overall Study|Withdrawal by Subject|1|||
124815004|NCT03385564|448952858|FG002|Overall Study|Withdrawal by Subject|1|||
124815005|NCT03385564|448952859|FG003|Overall Study|Withdrawal by Subject|0|||
124815006|NCT03385564|448952856|FG000|Overall Study|Lack of Efficacy|0|||
124815007|NCT03385564|448952857|FG001|Overall Study|Lack of Efficacy|0|||
124815008|NCT03385564|448952858|FG002|Overall Study|Lack of Efficacy|0|||
124815009|NCT03385564|448952859|FG003|Overall Study|Lack of Efficacy|1|||
124815010|NCT03385564|448952856|FG000|Overall Study|Death|0|||
124815011|NCT03385564|448952857|FG001|Overall Study|Death|0|||
124815012|NCT03385564|448952858|FG002|Overall Study|Death|1|||
124815013|NCT03385564|448952859|FG003|Overall Study|Death|0|||
124815014|NCT00622401|448952860|FG000|Overall Study|Disease progression prior to treatment|3|||
124815015|NCT00622401|448952861|FG001|Overall Study|Disease progression prior to treatment|2|||
124815016|NCT00622401|448952862|FG002|Overall Study|Disease progression prior to treatment|0|||
124815017|NCT00799422|448952869|FG000|First Week of Wear|Lost to Follow-up|0|||
124815018|NCT00799422|448952870|FG001|First Week of Wear|Lost to Follow-up|0|||
124815019|NCT00799422|448952871|FG002|First Week of Wear|Lost to Follow-up|1|||
124815020|NCT00799422|448952872|FG003|First Week of Wear|Lost to Follow-up|0|||
124815021|NCT00799422|448952873|FG004|First Week of Wear|Lost to Follow-up|0|||
124815022|NCT00799422|448952874|FG005|First Week of Wear|Lost to Follow-up|0|||
124815023|NCT00799422|448952869|FG000|First Week of Wear|Adverse Event|0|||
124815024|NCT00799422|448952870|FG001|First Week of Wear|Adverse Event|0|||
124815025|NCT00799422|448952871|FG002|First Week of Wear|Adverse Event|0|||
124815026|NCT00799422|448952872|FG003|First Week of Wear|Adverse Event|1|||
124815027|NCT00799422|448952873|FG004|First Week of Wear|Adverse Event|0|||
124815028|NCT00799422|448952874|FG005|First Week of Wear|Adverse Event|0|||
124815029|NCT00530946|448952876|FG000|Overall Study|Adverse Event|1|||
124815030|NCT00530946|448952877|FG001|Overall Study|Adverse Event|2|||
124815031|NCT00530946|448952878|FG002|Overall Study|Adverse Event|1|||
124815032|NCT00530946|448952879|FG003|Overall Study|Adverse Event|1|||
124815033|NCT00530946|448952876|FG000|Overall Study|Protocol Violation|0|||
124815034|NCT00530946|448952877|FG001|Overall Study|Protocol Violation|0|||
124815035|NCT00530946|448952878|FG002|Overall Study|Protocol Violation|0|||
124815036|NCT00530946|448952879|FG003|Overall Study|Protocol Violation|1|||
124815037|NCT00530946|448952876|FG000|Overall Study|Noncompliance|1|||
124815038|NCT00530946|448952877|FG001|Overall Study|Noncompliance|0|||
124815039|NCT00530946|448952878|FG002|Overall Study|Noncompliance|0|||
124815040|NCT00530946|448952879|FG003|Overall Study|Noncompliance|0|||
124815041|NCT00622284|448952880|FG000|Overall Study|Lack of Efficacy|45|||
124815042|NCT00622284|448952881|FG001|Overall Study|Lack of Efficacy|15|||
124815043|NCT00622284|448952880|FG000|Overall Study|Adverse Event|61|||
124815044|NCT00622284|448952881|FG001|Overall Study|Adverse Event|90|||
124815045|NCT00622284|448952880|FG000|Overall Study|Protocol Violation|12|||
124815046|NCT00622284|448952881|FG001|Overall Study|Protocol Violation|5|||
124815047|NCT00622284|448952880|FG000|Overall Study|Lost to Follow-up|11|||
124815048|NCT00622284|448952881|FG001|Overall Study|Lost to Follow-up|13|||
124815049|NCT00622284|448952880|FG000|Overall Study|Withdrawal by Subject|27|||
124815050|NCT00622284|448952881|FG001|Overall Study|Withdrawal by Subject|24|||
124815051|NCT00622284|448952880|FG000|Overall Study|Other reason (not specified)|33|||
124815052|NCT00622284|448952881|FG001|Overall Study|Other reason (not specified)|24|||
124815053|NCT00880009|448952886|FG000|Overall Study|Study terminated by sponsor|14|||
124815054|NCT00880009|448952886|FG000|Overall Study|Withdrawal by Subject|1|||
124815055|NCT00880009|448952886|FG000|Overall Study|Protocol Violation|1|||
124815056|NCT00457301|448952887|FG000|Overall Study|Withdrawal by Subject|3|||
124815057|NCT00457301|448952888|FG001|Overall Study|Withdrawal by Subject|3|||
124815058|NCT00457301|448952887|FG000|Overall Study|Censored out of the study|15|||
124815059|NCT00457301|448952888|FG001|Overall Study|Censored out of the study|14|||
124815060|NCT00457301|448952887|FG000|Overall Study|Death|5|||
124815061|NCT00457301|448952888|FG001|Overall Study|Death|7|||
124815062|NCT03322631|448952889|FG000|Overall Study|Withdrawal by Subject|0|||
124815063|NCT03322631|448952890|FG001|Overall Study|Withdrawal by Subject|1|||
124815064|NCT03322631|448952891|FG002|Overall Study|Withdrawal by Subject|0|||
124815065|NCT03322631|448952892|FG003|Overall Study|Withdrawal by Subject|0|||
124815066|NCT03322631|448952889|FG000|Overall Study|Adverse Event|0|||
124815067|NCT03322631|448952890|FG001|Overall Study|Adverse Event|0|||
124815068|NCT03322631|448952891|FG002|Overall Study|Adverse Event|1|||
124815069|NCT03322631|448952892|FG003|Overall Study|Adverse Event|0|||
124815070|NCT02412618|448952893|FG000|Overall Study|Withdrawal by Subject|1|||
124815071|NCT02412618|448952894|FG001|Overall Study|Withdrawal by Subject|1|||
124815072|NCT02412618|448952893|FG000|Overall Study|Expulsion|1|||
124815073|NCT02412618|448952894|FG001|Overall Study|Expulsion|1|||
124815074|NCT02378961|448952896|FG000|Overall Study|Lack of Efficacy|4|||
124815075|NCT02378961|448952897|FG001|Overall Study|Lack of Efficacy|2|||
124815076|NCT02378961|448952898|FG002|Overall Study|Lack of Efficacy|0|||
124815077|NCT02378961|448952899|FG003|Overall Study|Lack of Efficacy|1|||
124815078|NCT02378961|448952896|FG000|Overall Study|Death|0|||
124815079|NCT02378961|448952897|FG001|Overall Study|Death|0|||
124815080|NCT02378961|448952898|FG002|Overall Study|Death|1|||
124815081|NCT02378961|448952899|FG003|Overall Study|Death|0|||
124815082|NCT01253408|448952900|FG000|Overall Study|Adverse Event|0|||
124815083|NCT01253408|448952901|FG001|Overall Study|Adverse Event|1|||
124815084|NCT01253408|448952902|FG002|Overall Study|Adverse Event|0|||
124815085|NCT01217801|448952903|FG000|Period 1|Protocol Violation|1|||
124815086|NCT01217801|448952904|FG001|Period 1|Protocol Violation|1|||
124815087|NCT01217801|448952903|FG000|Period 1|Withdrawal by Subject|0|||
124815088|NCT01217801|448952904|FG001|Period 1|Withdrawal by Subject|1|||
124815089|NCT03035409|448952908|FG000|Overall Study|Adverse Event|5|||
124815090|NCT03035409|448952908|FG000|Overall Study|Death|2|||
124815091|NCT03035409|448952908|FG000|Overall Study|Withdrawal by Subject|2|||
124815092|NCT03035409|448952908|FG000|Overall Study|Non compliance|4|||
124815093|NCT03035409|448952908|FG000|Overall Study|Patient was jittery|1|||
124815094|NCT03035409|448952908|FG000|Overall Study|Did not like Questionnaire|1|||
124815095|NCT03035409|448952908|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
124815096|NCT03035409|448952908|FG000|Overall Study|Did not like taking drugs|1|||
124815097|NCT00291577|448952911|FG000|Overall Study|Adverse Event|1|||
124815098|NCT00291577|448952911|FG000|Overall Study|Other|4|||
124815099|NCT00291577|448952911|FG000|Overall Study|Withdrawal by Subject|2|||
124815100|NCT00291577|448952911|FG000|Overall Study|Lack of Efficacy|14|||
124815101|NCT04967443|448952912|FG000|Open Label Treatment|Death|1|||
124815102|NCT04967443|448952913|FG001|Open Label Treatment|Death|0|||
124815103|NCT04967443|448952914|FG002|Open Label Treatment|Death|0|||
124815104|NCT04967443|448952915|FG003|Open Label Treatment|Death|0|||
124815105|NCT04967443|448952916|FG004|Open Label Treatment|Death|0|||
124815106|NCT04967443|448952917|FG005|Open Label Treatment|Death|0|||
124815107|NCT04967443|448952918|FG006|Open Label Treatment|Death|0|||
124815108|NCT04967443|448952919|FG007|Open Label Treatment|Death|0|||
124815109|NCT04967443|448952912|FG000|Open Label Treatment|Lost to Follow-up|0|||
124815110|NCT04967443|448952913|FG001|Open Label Treatment|Lost to Follow-up|0|||
124815111|NCT04967443|448952914|FG002|Open Label Treatment|Lost to Follow-up|1|||
124815112|NCT04967443|448952915|FG003|Open Label Treatment|Lost to Follow-up|0|||
124815113|NCT04967443|448952916|FG004|Open Label Treatment|Lost to Follow-up|0|||
124815114|NCT04967443|448952917|FG005|Open Label Treatment|Lost to Follow-up|0|||
124815115|NCT04967443|448952918|FG006|Open Label Treatment|Lost to Follow-up|0|||
124815116|NCT04967443|448952919|FG007|Open Label Treatment|Lost to Follow-up|0|||
124815117|NCT04967443|448952912|FG000|Open Label Treatment|Withdrawal by Subject|0|||
124815118|NCT04967443|448952913|FG001|Open Label Treatment|Withdrawal by Subject|1|||
124815119|NCT04967443|448952914|FG002|Open Label Treatment|Withdrawal by Subject|0|||
124815120|NCT04967443|448952915|FG003|Open Label Treatment|Withdrawal by Subject|1|||
124815121|NCT04967443|448952916|FG004|Open Label Treatment|Withdrawal by Subject|0|||
124815122|NCT04967443|448952917|FG005|Open Label Treatment|Withdrawal by Subject|1|||
124815123|NCT04967443|448952918|FG006|Open Label Treatment|Withdrawal by Subject|2|||
124815124|NCT04967443|448952919|FG007|Open Label Treatment|Withdrawal by Subject|3|||
124815125|NCT04967443|448952912|FG000|Follow-Up|Death|1|||
124815126|NCT04967443|448952913|FG001|Follow-Up|Death|0|||
124815127|NCT04967443|448952914|FG002|Follow-Up|Death|0|||
124815128|NCT04967443|448952915|FG003|Follow-Up|Death|0|||
124815129|NCT04967443|448952916|FG004|Follow-Up|Death|0|||
124815130|NCT04967443|448952917|FG005|Follow-Up|Death|0|||
124815131|NCT04967443|448952918|FG006|Follow-Up|Death|0|||
124815132|NCT04967443|448952919|FG007|Follow-Up|Death|0|||
124815133|NCT04967443|448952912|FG000|Follow-Up|Lost to Follow-up|0|||
124815134|NCT04967443|448952913|FG001|Follow-Up|Lost to Follow-up|0|||
124815135|NCT04967443|448952914|FG002|Follow-Up|Lost to Follow-up|1|||
124815136|NCT04967443|448952915|FG003|Follow-Up|Lost to Follow-up|1|||
124815137|NCT04967443|448952916|FG004|Follow-Up|Lost to Follow-up|0|||
124815138|NCT04967443|448952917|FG005|Follow-Up|Lost to Follow-up|0|||
124815139|NCT04967443|448952918|FG006|Follow-Up|Lost to Follow-up|0|||
124815140|NCT04967443|448952919|FG007|Follow-Up|Lost to Follow-up|0|||
124815141|NCT04967443|448952912|FG000|Follow-Up|Withdrawal by Subject|0|||
124815142|NCT04967443|448952913|FG001|Follow-Up|Withdrawal by Subject|1|||
124815143|NCT04967443|448952914|FG002|Follow-Up|Withdrawal by Subject|0|||
124815144|NCT04967443|448952915|FG003|Follow-Up|Withdrawal by Subject|1|||
124815145|NCT04967443|448952916|FG004|Follow-Up|Withdrawal by Subject|0|||
124815146|NCT04967443|448952917|FG005|Follow-Up|Withdrawal by Subject|1|||
124815147|NCT04967443|448952918|FG006|Follow-Up|Withdrawal by Subject|2|||
124815148|NCT04967443|448952919|FG007|Follow-Up|Withdrawal by Subject|3|||
124815149|NCT04502693|448952921|FG000|Overall Study|Adverse Event|7|||
124815150|NCT04502693|448952922|FG001|Overall Study|Adverse Event|6|||
124815151|NCT04502693|448952923|FG002|Overall Study|Adverse Event|11|||
124815152|NCT04502693|448952924|FG003|Overall Study|Adverse Event|1|||
124815153|NCT04502693|448952921|FG000|Overall Study|Lost to Follow-up|32|||
124815154|NCT04502693|448952922|FG001|Overall Study|Lost to Follow-up|36|||
124815155|NCT04502693|448952923|FG002|Overall Study|Lost to Follow-up|69|||
124815156|NCT04502693|448952924|FG003|Overall Study|Lost to Follow-up|4|||
124815157|NCT04502693|448952921|FG000|Overall Study|Protocol Violation|8|||
124815158|NCT04502693|448952922|FG001|Overall Study|Protocol Violation|8|||
124815159|NCT04502693|448952923|FG002|Overall Study|Protocol Violation|16|||
124815160|NCT04502693|448952924|FG003|Overall Study|Protocol Violation|1|||
124815161|NCT04502693|448952921|FG000|Overall Study|Withdrawal by Subject|46|||
124815162|NCT04502693|448952922|FG001|Overall Study|Withdrawal by Subject|38|||
124815163|NCT04502693|448952923|FG002|Overall Study|Withdrawal by Subject|54|||
124815164|NCT04502693|448952924|FG003|Overall Study|Withdrawal by Subject|7|||
124815165|NCT04502693|448952921|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
124815166|NCT04502693|448952922|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
124815167|NCT04502693|448952923|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
124815168|NCT04502693|448952924|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124815169|NCT04502693|448952921|FG000|Overall Study|Other|1|||
124815170|NCT04502693|448952922|FG001|Overall Study|Other|0|||
124815171|NCT04502693|448952923|FG002|Overall Study|Other|1|||
124815172|NCT04502693|448952924|FG003|Overall Study|Other|1|||
124815173|NCT01552694|448952925|FG000|Overall Study|Lost to Follow-up|0|||
124815174|NCT01552694|448952926|FG001|Overall Study|Lost to Follow-up|1|||
124815175|NCT01552694|448952925|FG000|Overall Study|Protocol Violation|0|||
124815176|NCT01552694|448952926|FG001|Overall Study|Protocol Violation|1|||
124815177|NCT03943147|448952928|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
124815178|NCT03943147|448952929|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
124815179|NCT03943147|448952928|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
124815180|NCT03943147|448952929|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
124815181|NCT03943147|448952928|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
124815182|NCT03943147|448952929|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
124815183|NCT03943147|448952928|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
124815184|NCT03943147|448952929|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
124815185|NCT03943147|448952928|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
124815186|NCT03943147|448952929|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
124815187|NCT03943147|448952928|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
124815188|NCT03943147|448952929|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
124815189|NCT02756013|448952930|FG000|Overall Study|Adverse Event|1|||
124815190|NCT02756013|448952930|FG000|Overall Study|Hypersensitivity|1|||
124815191|NCT00629707|448952931|FG000|Overall Study|Withdrawal by Subject|0|||
124815192|NCT00629707|448952932|FG001|Overall Study|Withdrawal by Subject|1|||
124815193|NCT00629707|448952931|FG000|Overall Study|Physician Decision|0|||
124815194|NCT00629707|448952932|FG001|Overall Study|Physician Decision|1|||
124815195|NCT03724032|448952935|FG000|Overall Study|Physician Decision|1|||
124815196|NCT03724032|448952936|FG001|Overall Study|Physician Decision|0|||
124815197|NCT03724032|448952937|FG002|Overall Study|Physician Decision|0|||
124815198|NCT03724032|448952935|FG000|Overall Study|Protocol Violation|2|||
124815199|NCT03724032|448952936|FG001|Overall Study|Protocol Violation|2|||
124815200|NCT03724032|448952937|FG002|Overall Study|Protocol Violation|1|||
124815201|NCT00001880|448952941|FG000|Overall Study|Death|14|||
124815202|NCT02657369|448952942|FG000|Overall Study|Death|27|||
124815203|NCT02657369|448952942|FG000|Overall Study|Study terminated by sponsor|7|||
124815204|NCT02639065|448952943|FG000|Study Treatment|Disease Progression|13|||
124815205|NCT02639065|448952943|FG000|Study Treatment|Adverse Event|9|||
124815206|NCT02639065|448952943|FG000|Study Treatment|Withdrawal by Subject|1|||
124815207|NCT02639065|448952943|FG000|Follow up|Subject refused to follow up|1|||
124815208|NCT02639065|448952943|FG000|Follow up|Symptomatic Deterioration|2|||
124815209|NCT02639065|448952943|FG000|Follow up|Death|2|||
124815210|NCT02639065|448952943|FG000|Follow up|Study Terminated|1|||
124815211|NCT02639065|448952943|FG000|Follow up|Disease Progression|3|||
124815212|NCT00481078|448952944|FG000|Overall Study|Progression of disease|11|||
124819586|NCT00420927|448965766|FG005|Period 1|Lost to Follow-up|0|||
124815213|NCT00481078|448952945|FG001|Overall Study|Progression of disease|11|||
124815214|NCT00481078|448952944|FG000|Overall Study|Adverse Event|15|||
124815215|NCT00481078|448952945|FG001|Overall Study|Adverse Event|3|||
124815216|NCT00481078|448952944|FG000|Overall Study|Death|5|||
124815217|NCT00481078|448952945|FG001|Overall Study|Death|3|||
124815218|NCT00481078|448952944|FG000|Overall Study|Intercurrent illness|1|||
124815219|NCT00481078|448952945|FG001|Overall Study|Intercurrent illness|0|||
124815220|NCT00481078|448952944|FG000|Overall Study|Withdrawal by Subject|7|||
124815221|NCT00481078|448952945|FG001|Overall Study|Withdrawal by Subject|1|||
124815222|NCT00481078|448952944|FG000|Overall Study|Information not available|1|||
124815223|NCT00481078|448952945|FG001|Overall Study|Information not available|0|||
124815224|NCT00481078|448952944|FG000|Overall Study|Received other treatment|2|||
124815225|NCT00481078|448952945|FG001|Overall Study|Received other treatment|1|||
124815226|NCT00481078|448952944|FG000|Overall Study|Brain metastasis|0|||
124815227|NCT00481078|448952945|FG001|Overall Study|Brain metastasis|1|||
124815228|NCT01845831|448952946|FG000|Inpatient Phase|Withdrawal by Subject|1|||
124815229|NCT01845831|448952947|FG001|Inpatient Phase|Withdrawal by Subject|1|||
124815230|NCT01845831|448952948|FG002|Inpatient Phase|Withdrawal by Subject|0|||
124815231|NCT01845831|448952949|FG003|Inpatient Phase|Withdrawal by Subject|0|||
124815232|NCT01845831|448952950|FG004|Inpatient Phase|Withdrawal by Subject|0|||
124815233|NCT02610725|448952951|FG000|Overall Study|Lost to Follow-up|197|||
124815234|NCT02610725|448952951|FG000|Overall Study|self-reported contraindication|9|||
124815235|NCT04094883|448952952|FG000|Overall Study|Withdrawal by Subject|1|||
124815236|NCT00826943|448952953|FG000|Overall Study|Withdrawal by Subject|0|||
124815237|NCT00826943|448952954|FG001|Overall Study|Withdrawal by Subject|0|||
124815238|NCT00826943|448952955|FG002|Overall Study|Withdrawal by Subject|0|||
124815239|NCT00826943|448952956|FG003|Overall Study|Withdrawal by Subject|0|||
124815240|NCT00826943|448952957|FG004|Overall Study|Withdrawal by Subject|1|||
124815241|NCT00826943|448952958|FG005|Overall Study|Withdrawal by Subject|0|||
124815242|NCT01348165|448952959|FG000|Overall Study|Adverse Event|0|||
124815243|NCT01348165|448952960|FG001|Overall Study|Adverse Event|0|||
124815244|NCT01348165|448952961|FG002|Overall Study|Adverse Event|0|||
124815245|NCT01348165|448952962|FG003|Overall Study|Adverse Event|0|||
124815246|NCT01348165|448952963|FG004|Overall Study|Adverse Event|0|||
124815247|NCT01348165|448952964|FG005|Overall Study|Adverse Event|0|||
124815248|NCT01348165|448952965|FG006|Overall Study|Adverse Event|1|||
124815249|NCT00382252|448952966|FG000|Overall Study|Death|4|||
124815250|NCT00382252|448952966|FG000|Overall Study|Protocol Violation|8|||
124815251|NCT00382252|448952966|FG000|Overall Study|Not treated by RFA|1|||
124815252|NCT05570500|448952969|FG000|Overall Study|Lost to Follow-up|7|||
124815253|NCT05570500|448952970|FG001|Overall Study|Lost to Follow-up|5|||
124815254|NCT04706091|448952971|FG000|Treatment 2|Withdrawal by Subject|1|||
124815255|NCT04706091|448952972|FG001|Treatment 2|Withdrawal by Subject|0|||
124815256|NCT02612727|448952973|FG000|Overall Study|Parent request|4|||
124815257|NCT02612727|448952974|FG001|Overall Study|Parent request|1|||
124815258|NCT02612727|448952973|FG000|Overall Study|Needed treatment incompatible with PT|1|||
124815259|NCT02612727|448952974|FG001|Overall Study|Needed treatment incompatible with PT|1|||
124815260|NCT02612727|448952973|FG000|Overall Study|Direct hyperbilirubinemia|0|||
124815261|NCT02612727|448952974|FG001|Overall Study|Direct hyperbilirubinemia|2|||
124815262|NCT01063868|448952975|FG000|Overall Study|Adverse Event|9|||
124815263|NCT01063868|448952976|FG001|Overall Study|Adverse Event|7|||
124815264|NCT01063868|448952975|FG000|Overall Study|Withdrawal by Subject|3|||
124815265|NCT01063868|448952976|FG001|Overall Study|Withdrawal by Subject|1|||
124815266|NCT01063868|448952975|FG000|Overall Study|Study Terminated By Sponsor|23|||
124815267|NCT01063868|448952976|FG001|Overall Study|Study Terminated By Sponsor|4|||
124815268|NCT01446289|448952979|FG000|Overall Study|Withdrawal by Subject|1|||
124815269|NCT01446289|448952980|FG001|Overall Study|Withdrawal by Subject|0|||
124815270|NCT01446289|448952981|FG002|Overall Study|Withdrawal by Subject|1|||
124815271|NCT01446289|448952982|FG003|Overall Study|Withdrawal by Subject|0|||
124815272|NCT02302807|448952983|FG000|Overall Study|Withdrawal by Subject|28|||
124815273|NCT02302807|448952984|FG001|Overall Study|Withdrawal by Subject|11|||
124815274|NCT02302807|448952983|FG000|Overall Study|Lost to Follow-up|4|||
124815275|NCT02302807|448952984|FG001|Overall Study|Lost to Follow-up|6|||
124815276|NCT02302807|448952983|FG000|Overall Study|Death|397|||
124815277|NCT02302807|448952984|FG001|Overall Study|Death|385|||
124815278|NCT02302807|448952983|FG000|Overall Study|Study Terminated By Sponsor|35|||
124815279|NCT02302807|448952984|FG001|Overall Study|Study Terminated By Sponsor|64|||
124815280|NCT02302807|448952983|FG000|Overall Study|Physician Decision|0|||
124815281|NCT02302807|448952984|FG001|Overall Study|Physician Decision|1|||
124815282|NCT03329573|448952985|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
124815283|NCT03329573|448952986|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
124815284|NCT03329573|448952987|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
124815285|NCT03329573|448952988|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
124815286|NCT03329573|448952985|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
124815287|NCT03329573|448952986|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
124815288|NCT03329573|448952987|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124815289|NCT03329573|448952988|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
124815290|NCT03329573|448952985|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
124815291|NCT03329573|448952986|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
124815292|NCT03329573|448952987|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
124815293|NCT03329573|448952988|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
124815294|NCT03329573|448952985|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
124815295|NCT03329573|448952986|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
124815296|NCT03329573|448952987|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
124815297|NCT03329573|448952988|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
124815298|NCT03307967|448952991|FG000|Overall Study|Lost to Follow-up|4|||
124815299|NCT02578316|448952992|FG000|Extension Phase|Progression of disease|6|||
124815300|NCT02166905|448952993|FG000|Overall Study|Withdrawal by Subject|1|||
124815301|NCT02166905|448952994|FG001|Overall Study|Withdrawal by Subject|0|||
124815302|NCT02166905|448952995|FG002|Overall Study|Withdrawal by Subject|0|||
124815303|NCT02166905|448952996|FG003|Overall Study|Withdrawal by Subject|0|||
124815304|NCT02617628|448952997|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
124815305|NCT02617628|448952998|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
124815306|NCT03278873|448953002|FG000|Overall Study|Withdrawal by Subject|0|||
124815307|NCT03278873|448953003|FG001|Overall Study|Withdrawal by Subject|1|||
124815308|NCT03278873|448953004|FG002|Overall Study|Withdrawal by Subject|0|||
124815309|NCT03278873|448953005|FG003|Overall Study|Withdrawal by Subject|0|||
124815310|NCT03278873|448953002|FG000|Overall Study|Sponsor's decision|0|||
124815311|NCT03278873|448953003|FG001|Overall Study|Sponsor's decision|1|||
124815312|NCT03278873|448953004|FG002|Overall Study|Sponsor's decision|0|||
124815313|NCT03278873|448953005|FG003|Overall Study|Sponsor's decision|0|||
124815314|NCT03278873|448953002|FG000|Overall Study|Early Termination|2|||
124815315|NCT03278873|448953003|FG001|Overall Study|Early Termination|6|||
124815316|NCT03278873|448953004|FG002|Overall Study|Early Termination|0|||
124815317|NCT03278873|448953005|FG003|Overall Study|Early Termination|4|||
124815318|NCT03278873|448953002|FG000|Overall Study|Lost to Follow-up|0|||
124815319|NCT03278873|448953003|FG001|Overall Study|Lost to Follow-up|0|||
124815320|NCT03278873|448953004|FG002|Overall Study|Lost to Follow-up|2|||
124815321|NCT03278873|448953005|FG003|Overall Study|Lost to Follow-up|0|||
124815322|NCT03278873|448953002|FG000|Overall Study|The patient decided to withdraw via email|1|||
124815323|NCT03278873|448953003|FG001|Overall Study|The patient decided to withdraw via email|0|||
124815324|NCT03278873|448953004|FG002|Overall Study|The patient decided to withdraw via email|0|||
124815325|NCT03278873|448953005|FG003|Overall Study|The patient decided to withdraw via email|0|||
124815326|NCT03278873|448953002|FG000|Overall Study|The patient was unresponsive to contact|0|||
124815327|NCT03278873|448953003|FG001|Overall Study|The patient was unresponsive to contact|0|||
124815328|NCT03278873|448953004|FG002|Overall Study|The patient was unresponsive to contact|0|||
124815329|NCT03278873|448953005|FG003|Overall Study|The patient was unresponsive to contact|4|||
124815330|NCT03278873|448953002|FG000|Overall Study|The patient wished to participate no longer|0|||
124815331|NCT03278873|448953003|FG001|Overall Study|The patient wished to participate no longer|1|||
124815332|NCT03278873|448953004|FG002|Overall Study|The patient wished to participate no longer|0|||
124815333|NCT03278873|448953005|FG003|Overall Study|The patient wished to participate no longer|0|||
124815334|NCT03278873|448953002|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
124815335|NCT03278873|448953003|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
124815336|NCT03278873|448953004|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
124815337|NCT03278873|448953005|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
124815338|NCT05243641|448953006|FG000|Overall Study|Adverse Event|3|||
124815339|NCT05243641|448953007|FG001|Overall Study|Adverse Event|0|||
124815340|NCT05243641|448953008|FG002|Overall Study|Adverse Event|0|||
124815341|NCT05243641|448953009|FG003|Overall Study|Adverse Event|1|||
124815342|NCT05243641|448953010|FG004|Overall Study|Adverse Event|0|||
124815343|NCT05243641|448953011|FG005|Overall Study|Adverse Event|0|||
124815344|NCT05243641|448953006|FG000|Overall Study|Disease progression|4|||
124815345|NCT05243641|448953007|FG001|Overall Study|Disease progression|0|||
124815346|NCT05243641|448953008|FG002|Overall Study|Disease progression|0|||
124815347|NCT05243641|448953009|FG003|Overall Study|Disease progression|2|||
124815348|NCT05243641|448953010|FG004|Overall Study|Disease progression|0|||
124815349|NCT05243641|448953011|FG005|Overall Study|Disease progression|0|||
124815350|NCT04518306|448953012|FG000|Double-Blind Period|Run in failure|0|||
124815351|NCT04518306|448953013|FG001|Double-Blind Period|Run in failure|0|||
124815352|NCT04518306|448953014|FG002|Double-Blind Period|Run in failure|1|||
124815353|NCT04518306|448953012|FG000|Double-Blind Period|Adverse Event|0|||
124815354|NCT04518306|448953013|FG001|Double-Blind Period|Adverse Event|2|||
124815355|NCT04518306|448953014|FG002|Double-Blind Period|Adverse Event|2|||
124815356|NCT04518306|448953012|FG000|Double-Blind Period|Lost to Follow-up|1|||
124815357|NCT04518306|448953013|FG001|Double-Blind Period|Lost to Follow-up|2|||
124815358|NCT04518306|448953014|FG002|Double-Blind Period|Lost to Follow-up|2|||
124815359|NCT04518306|448953012|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
124815360|NCT04518306|448953013|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
124815361|NCT04518306|448953014|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
124815362|NCT04518306|448953012|FG000|Double-Blind Period|Other|0|||
124815363|NCT04518306|448953013|FG001|Double-Blind Period|Other|2|||
124815364|NCT04518306|448953014|FG002|Double-Blind Period|Other|0|||
124815365|NCT04518306|448953012|FG000|Double-Blind Period|Missing|0|||
124815366|NCT04518306|448953013|FG001|Double-Blind Period|Missing|1|||
124815367|NCT04518306|448953014|FG002|Double-Blind Period|Missing|0|||
124815368|NCT05372419|448953015|FG000|Overall Study|Protocol Deviation|1|||
124815369|NCT05372419|448953015|FG000|Overall Study|Withdrawal by Subject|5|||
124815370|NCT05372419|448953015|FG000|Overall Study|Lost to Follow-up|7|||
124815371|NCT02801331|448953016|FG000|Overall Study|Transferred to another hospital|8|||
124815372|NCT02801331|448953017|FG001|Overall Study|Transferred to another hospital|7|||
124815373|NCT02801331|448953016|FG000|Overall Study|Withdrawal by Subject|0|||
124815374|NCT02801331|448953017|FG001|Overall Study|Withdrawal by Subject|4|||
124815375|NCT02801331|448953016|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
124815376|NCT02801331|448953017|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
124815377|NCT03253744|448953019|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
124815378|NCT03253744|448953020|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
124815379|NCT03253744|448953021|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
124815380|NCT03253744|448953022|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
124815381|NCT04698187|448953031|FG000|Overall Study|Withdrawal by Subject|7|||
124815382|NCT04698187|448953031|FG000|Overall Study|Death|21|||
124815383|NCT04698187|448953031|FG000|Overall Study|Sponsor Decision|15|||
124815384|NCT04698187|448953031|FG000|Overall Study|In-transit Disease|1|||
124815385|NCT03904043|448953032|FG000|Overall Study|Adverse Event|1|||
124815386|NCT03904043|448953033|FG001|Overall Study|Adverse Event|1|||
124815387|NCT03904043|448953032|FG000|Overall Study|Withdrawal by Subject|1|||
124815388|NCT03904043|448953033|FG001|Overall Study|Withdrawal by Subject|0|||
124815389|NCT03904043|448953032|FG000|Overall Study|Non-compliance|1|||
124815390|NCT03904043|448953033|FG001|Overall Study|Non-compliance|0|||
124815391|NCT03904043|448953032|FG000|Overall Study|Did not start treatment|1|||
124815392|NCT03904043|448953033|FG001|Overall Study|Did not start treatment|0|||
124815393|NCT04362072|448953034|FG000|Treatment|Adverse Event|1|||
124815394|NCT04362072|448953034|FG000|Treatment|Death|9|||
124815395|NCT04362072|448953034|FG000|Treatment|Physician Decision|2|||
124815396|NCT04362072|448953034|FG000|Treatment|Progressive disease|27|||
124815397|NCT04362072|448953034|FG000|Treatment|Withdrawal by Subject|4|||
124815398|NCT04362072|448953034|FG000|Treatment|Global deterioration of health status|1|||
124815399|NCT04362072|448953034|FG000|Treatment|Switched to commercial Lorlatinib|13|||
124815400|NCT04362072|448953034|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
124815401|NCT04362072|448953034|FG000|Treatment|Other|3|||
124815402|NCT04362072|448953034|FG000|Follow up|Death|2|||
124815403|NCT04362072|448953034|FG000|Follow up|Other|2|||
124815404|NCT01133522|448953035|FG000|Overall Study|Withdrawal by Subject|0|||
124815405|NCT01133522|448953036|FG001|Overall Study|Withdrawal by Subject|1|||
124815406|NCT01133522|448953037|FG002|Overall Study|Withdrawal by Subject|0|||
124815407|NCT01133522|448953038|FG003|Overall Study|Withdrawal by Subject|1|||
124815408|NCT01133522|448953039|FG004|Overall Study|Withdrawal by Subject|0|||
124815409|NCT01133522|448953040|FG005|Overall Study|Withdrawal by Subject|0|||
124815410|NCT01133522|448953041|FG006|Overall Study|Withdrawal by Subject|0|||
124815411|NCT01133522|448953042|FG007|Overall Study|Withdrawal by Subject|0|||
124815412|NCT01133522|448953043|FG008|Overall Study|Withdrawal by Subject|0|||
124815413|NCT01133522|448953044|FG009|Overall Study|Withdrawal by Subject|0|||
124815414|NCT01133522|448953035|FG000|Overall Study|Physician Decision|0|||
124815415|NCT01133522|448953036|FG001|Overall Study|Physician Decision|0|||
124815416|NCT01133522|448953037|FG002|Overall Study|Physician Decision|0|||
124815417|NCT01133522|448953038|FG003|Overall Study|Physician Decision|0|||
124815418|NCT01133522|448953039|FG004|Overall Study|Physician Decision|1|||
124815419|NCT01133522|448953040|FG005|Overall Study|Physician Decision|0|||
124815420|NCT01133522|448953041|FG006|Overall Study|Physician Decision|0|||
124815421|NCT01133522|448953042|FG007|Overall Study|Physician Decision|0|||
124815422|NCT01133522|448953043|FG008|Overall Study|Physician Decision|0|||
124815423|NCT01133522|448953044|FG009|Overall Study|Physician Decision|0|||
124815424|NCT00381485|448954671|FG000|Open-Label Run-In Period|Adverse Event|9|||
124815425|NCT00381485|448954672|FG001|Open-Label Run-In Period|Adverse Event|0|||
124815426|NCT00381485|448954673|FG002|Open-Label Run-In Period|Adverse Event|0|||
124815427|NCT00381485|448954674|FG003|Open-Label Run-In Period|Adverse Event|0|||
124815428|NCT00381485|448954671|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
124815429|NCT00381485|448954672|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
124815430|NCT00381485|448954673|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
124815431|NCT00381485|448954674|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
124815432|NCT00381485|448954671|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
124815433|NCT00381485|448954672|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
124815434|NCT00381485|448954673|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
124815435|NCT00381485|448954674|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
124815436|NCT00381485|448954671|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
124815437|NCT00381485|448954672|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
124815438|NCT00381485|448954673|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
124815439|NCT00381485|448954674|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
124815440|NCT00381485|448954671|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
124815441|NCT00381485|448954672|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
124815442|NCT00381485|448954673|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
124815443|NCT00381485|448954674|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
124815444|NCT00381485|448954671|FG000|Open-Label Run-In Period|Treatment failure|1|||
124636231|NCT01006122|448285167|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
124636232|NCT01006122|448285168|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
124636233|NCT01006122|448285167|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
124636234|NCT01006122|448285168|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
124636235|NCT01006122|448285167|FG000|First Double-blind Intervention Period|Pregnancy|0|||
124636236|NCT01006122|448285168|FG001|First Double-blind Intervention Period|Pregnancy|1|||
124636237|NCT01006122|448285167|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
124636238|NCT01006122|448285168|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
124636239|NCT01006122|448285167|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
124636240|NCT01006122|448285168|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
124636241|NCT01006122|448285167|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
124636242|NCT01006122|448285168|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
124636243|NCT01006122|448285167|FG000|First Double-blind Intervention Period|Other|3|||
124636244|NCT01006122|448285168|FG001|First Double-blind Intervention Period|Other|0|||
124636245|NCT01006122|448285167|FG000|First Double-blind Intervention Period|Adverse Event|0|||
124636246|NCT01006122|448285168|FG001|First Double-blind Intervention Period|Adverse Event|4|||
124636247|NCT01006122|448285167|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
124636248|NCT01006122|448285168|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
124636249|NCT01006122|448285167|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
124636250|NCT01006122|448285168|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
124636251|NCT01006122|448285167|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
124636252|NCT01006122|448285168|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
124636253|NCT01006122|448285167|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
124636254|NCT01006122|448285168|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
124636255|NCT01006122|448285167|FG000|Second Double-blind Intervention Period|Death|0|||
124636256|NCT01006122|448285168|FG001|Second Double-blind Intervention Period|Death|1|||
124636257|NCT00529308|448285171|FG000|Overall Study|Withdrawal by Subject|1|||
124636258|NCT00529308|448285172|FG001|Overall Study|Withdrawal by Subject|1|||
124636259|NCT02554682|448285177|FG000|Overall Study|Lost to Follow-up|11|||
124636260|NCT02554682|448285178|FG001|Overall Study|Lost to Follow-up|9|||
124636261|NCT02554682|448285179|FG002|Overall Study|Lost to Follow-up|4|||
124636262|NCT02554682|448285180|FG003|Overall Study|Lost to Follow-up|3|||
124636263|NCT02554682|448285181|FG004|Overall Study|Lost to Follow-up|2|||
124636264|NCT02554682|448285182|FG005|Overall Study|Lost to Follow-up|1|||
124636265|NCT02554682|448285183|FG006|Overall Study|Lost to Follow-up|6|||
124636266|NCT02554682|448285184|FG007|Overall Study|Lost to Follow-up|6|||
124636267|NCT02554682|448285185|FG008|Overall Study|Lost to Follow-up|2|||
124636268|NCT02554682|448285186|FG009|Overall Study|Lost to Follow-up|2|||
124636269|NCT02554682|448285177|FG000|Overall Study|Withdrawal by Subject|2|||
124636270|NCT02554682|448285178|FG001|Overall Study|Withdrawal by Subject|1|||
124636271|NCT02554682|448285179|FG002|Overall Study|Withdrawal by Subject|0|||
124636272|NCT02554682|448285180|FG003|Overall Study|Withdrawal by Subject|0|||
124636273|NCT02554682|448285181|FG004|Overall Study|Withdrawal by Subject|0|||
124636274|NCT02554682|448285182|FG005|Overall Study|Withdrawal by Subject|0|||
124636275|NCT02554682|448285183|FG006|Overall Study|Withdrawal by Subject|0|||
124636276|NCT02554682|448285184|FG007|Overall Study|Withdrawal by Subject|0|||
124636277|NCT02554682|448285185|FG008|Overall Study|Withdrawal by Subject|0|||
124636278|NCT02554682|448285186|FG009|Overall Study|Withdrawal by Subject|0|||
124636279|NCT02554682|448285177|FG000|Overall Study|Physician Decision|2|||
124636280|NCT02554682|448285178|FG001|Overall Study|Physician Decision|2|||
124636281|NCT02554682|448285179|FG002|Overall Study|Physician Decision|0|||
124636282|NCT02554682|448285180|FG003|Overall Study|Physician Decision|0|||
124636283|NCT02554682|448285181|FG004|Overall Study|Physician Decision|0|||
124815445|NCT00381485|448954672|FG001|Open-Label Run-In Period|Treatment failure|0|||
124815446|NCT00381485|448954673|FG002|Open-Label Run-In Period|Treatment failure|0|||
124636284|NCT02554682|448285182|FG005|Overall Study|Physician Decision|0|||
124636285|NCT02554682|448285183|FG006|Overall Study|Physician Decision|0|||
124636286|NCT02554682|448285184|FG007|Overall Study|Physician Decision|0|||
124636287|NCT02554682|448285185|FG008|Overall Study|Physician Decision|0|||
124636288|NCT02554682|448285186|FG009|Overall Study|Physician Decision|0|||
124636289|NCT04526288|448285189|FG000|Overall Study|Disease Progression|1|||
124636290|NCT04526288|448285190|FG001|Overall Study|Disease Progression|0|||
124636291|NCT04830969|448285191|FG000|Overall Study|Withdrawal by Subject|6|||
124636292|NCT04830969|448285192|FG001|Overall Study|Withdrawal by Subject|2|||
124636293|NCT04830969|448285191|FG000|Overall Study|Protocol Violation|3|||
124636294|NCT04830969|448285192|FG001|Overall Study|Protocol Violation|9|||
124636295|NCT04830969|448285191|FG000|Overall Study|Lost to Follow-up|4|||
124636296|NCT04830969|448285192|FG001|Overall Study|Lost to Follow-up|4|||
124636297|NCT00952068|448285196|FG000|Overall Study|Adverse Event|3|||
124636298|NCT00952068|448285196|FG000|Overall Study|Withdrawal by Subject|4|||
124636299|NCT00708461|448285199|FG000|Overall Study|Lost to Follow-up|18|||
124636300|NCT00708461|448285200|FG001|Overall Study|Lost to Follow-up|11|||
124636301|NCT00708461|448285199|FG000|Overall Study|Withdrawal by Subject|8|||
124636302|NCT00708461|448285200|FG001|Overall Study|Withdrawal by Subject|9|||
124636303|NCT00708461|448285199|FG000|Overall Study|left workforce|115|||
124636304|NCT00708461|448285200|FG001|Overall Study|left workforce|180|||
124636305|NCT02630251|448285206|FG000|Overall Study|Physician Decision|0|||
124636306|NCT02630251|448285207|FG001|Overall Study|Physician Decision|0|||
124636307|NCT02630251|448285208|FG002|Overall Study|Physician Decision|1|||
124636308|NCT02630251|448285209|FG003|Overall Study|Physician Decision|0|||
124636309|NCT01537042|448285219|FG000|Overall Study|Adverse Event|0|||
124636310|NCT01537042|448285220|FG001|Overall Study|Adverse Event|2|||
124636311|NCT01537042|448285219|FG000|Overall Study|Lack of Efficacy|0|||
124636312|NCT01537042|448285220|FG001|Overall Study|Lack of Efficacy|1|||
124636313|NCT01537042|448285219|FG000|Overall Study|Protocol Violation|0|||
124636314|NCT01537042|448285220|FG001|Overall Study|Protocol Violation|1|||
124636315|NCT01537042|448285219|FG000|Overall Study|Other|0|||
124636316|NCT01537042|448285220|FG001|Overall Study|Other|1|||
124815447|NCT00381485|448954674|FG003|Open-Label Run-In Period|Treatment failure|0|||
124815448|NCT00381485|448954671|FG000|Double-Blind Treatment Period|Adverse Event|0|||
124815449|NCT00381485|448954672|FG001|Double-Blind Treatment Period|Adverse Event|2|||
124815450|NCT00381485|448954673|FG002|Double-Blind Treatment Period|Adverse Event|2|||
124815451|NCT00381485|448954674|FG003|Double-Blind Treatment Period|Adverse Event|5|||
124815452|NCT00381485|448954671|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
124815453|NCT00381485|448954672|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
124815454|NCT00381485|448954673|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
124815455|NCT00381485|448954674|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
124815456|NCT00381485|448954671|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124815457|NCT00381485|448954672|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
124815458|NCT00381485|448954673|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
124815459|NCT00381485|448954674|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
124815460|NCT00381485|448954671|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
124815461|NCT00381485|448954672|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
124815462|NCT00381485|448954673|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
124815463|NCT00381485|448954674|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
124815464|NCT00381485|448954671|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
124815465|NCT00381485|448954672|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
124815466|NCT00381485|448954673|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
124815467|NCT00381485|448954674|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
124815468|NCT00381485|448954671|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
124815469|NCT00381485|448954672|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
124815470|NCT00381485|448954673|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
124815471|NCT00381485|448954674|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
124815472|NCT00381485|448954671|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
124815473|NCT00381485|448954672|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
124815474|NCT00381485|448954673|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
124815475|NCT00381485|448954674|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
124815476|NCT00381485|448954671|FG000|Double-Blind Treatment Period|Administrative|0|||
124815477|NCT00381485|448954672|FG001|Double-Blind Treatment Period|Administrative|1|||
124815478|NCT00381485|448954673|FG002|Double-Blind Treatment Period|Administrative|0|||
124815479|NCT00381485|448954674|FG003|Double-Blind Treatment Period|Administrative|1|||
124815480|NCT00126191|448954677|FG000|Overall Study|Physician Decision|0|||
124815481|NCT00126191|448954678|FG001|Overall Study|Physician Decision|1|||
124815482|NCT00126191|448954677|FG000|Overall Study|Death|0|||
124815483|NCT00126191|448954678|FG001|Overall Study|Death|1|||
124815484|NCT01898806|448954679|FG000|Overall Study|Withdrawal by Subject|2|||
124815485|NCT01898806|448954679|FG000|Overall Study|Physician Decision|1|||
124636317|NCT00979654|448285221|FG000|Overall Study|Lost to Follow-up|1|||
124636318|NCT00979654|448285221|FG000|Overall Study|Withdrawal by Subject|22|||
124636319|NCT00979654|448285221|FG000|Overall Study|Death|1|||
124636320|NCT00979654|448285221|FG000|Overall Study|Lack of Efficacy|6|||
124636321|NCT00979654|448285221|FG000|Overall Study|Adverse Event|1|||
124636322|NCT00979654|448285221|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
124636323|NCT00979654|448285221|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
124636324|NCT00979654|448285221|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
124636325|NCT00979654|448285221|FG000|Overall Study|Serious Adverse Event|1|||
124636326|NCT00979654|448285221|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
124636327|NCT01779440|448285222|FG000|Overall Study|Withdrawal by Subject|3|||
124636328|NCT01779440|448285223|FG001|Overall Study|Withdrawal by Subject|5|||
124636329|NCT01205269|448285224|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
124636330|NCT01205269|448285225|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
124636331|NCT01205269|448285226|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
124636332|NCT01205269|448285227|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
124636333|NCT01205269|448285228|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
124636334|NCT01205269|448285229|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
124636335|NCT01408303|448285230|FG000|Overall Study|Adverse Event|3|||
124636336|NCT01408303|448285231|FG001|Overall Study|Adverse Event|7|||
124636337|NCT01408303|448285232|FG002|Overall Study|Adverse Event|2|||
124636338|NCT01408303|448285230|FG000|Overall Study|Lost to Follow-up|0|||
124636339|NCT01408303|448285231|FG001|Overall Study|Lost to Follow-up|1|||
124636340|NCT01408303|448285232|FG002|Overall Study|Lost to Follow-up|2|||
124636341|NCT01408303|448285230|FG000|Overall Study|Withdrawal by Subject|2|||
124636342|NCT01408303|448285231|FG001|Overall Study|Withdrawal by Subject|3|||
124636343|NCT01408303|448285232|FG002|Overall Study|Withdrawal by Subject|1|||
124636344|NCT01408303|448285230|FG000|Overall Study|Protocol Violation|0|||
124636345|NCT01408303|448285231|FG001|Overall Study|Protocol Violation|1|||
124636346|NCT01408303|448285232|FG002|Overall Study|Protocol Violation|0|||
124636347|NCT01408303|448285230|FG000|Overall Study|Noncompliance|1|||
124636348|NCT01408303|448285231|FG001|Overall Study|Noncompliance|0|||
124636349|NCT01408303|448285232|FG002|Overall Study|Noncompliance|1|||
124636350|NCT01207687|448285233|FG000|Overall Study|Adverse Event|1|||
124636351|NCT01207687|448285233|FG000|Overall Study|Withdrawal by Subject|1|||
124636352|NCT01801865|448285234|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
124636353|NCT01801865|448285234|FG000|Overall Study|Physician Decision|7|||
124636354|NCT00523848|448285235|FG000|Overall Study|Adverse Event|11|||
124636355|NCT00523848|448285235|FG000|Overall Study|Withdrawal by Subject|2|||
124636356|NCT00523848|448285235|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
124636357|NCT00523848|448285235|FG000|Overall Study|Disease Progression|5|||
124636358|NCT00523848|448285235|FG000|Overall Study|Other, unspecified|4|||
124636359|NCT01367886|448285238|FG000|Overall Study|Lost to Follow-up|4|||
124636360|NCT01367886|448285238|FG000|Overall Study|Lack of Efficacy|2|||
124636361|NCT01367886|448285238|FG000|Overall Study|Death|1|||
124636362|NCT00985504|448285239|FG000|Acute Treatment Period|Adverse Event|3|||
124636363|NCT00985504|448285240|FG001|Acute Treatment Period|Adverse Event|4|||
124636364|NCT00985504|448285239|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
124636365|NCT00985504|448285240|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
124636366|NCT00985504|448285239|FG000|Acute Treatment Period|Protocol Violation|2|||
124636367|NCT00985504|448285240|FG001|Acute Treatment Period|Protocol Violation|0|||
124636368|NCT00985504|448285239|FG000|Acute Treatment Period|Sponsor Decision|0|||
124636369|NCT00985504|448285240|FG001|Acute Treatment Period|Sponsor Decision|1|||
124636370|NCT00985504|448285239|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
124636371|NCT00985504|448285240|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
124636372|NCT00985504|448285239|FG000|Optimization Period|Adverse Event|7|||
124636373|NCT00985504|448285240|FG001|Optimization Period|Adverse Event|9|||
124636374|NCT00985504|448285239|FG000|Optimization Period|Death|0|||
124636375|NCT00985504|448285240|FG001|Optimization Period|Death|1|||
124636376|NCT00985504|448285239|FG000|Optimization Period|Lack of Efficacy|5|||
124636377|NCT00985504|448285240|FG001|Optimization Period|Lack of Efficacy|3|||
124636378|NCT00985504|448285239|FG000|Optimization Period|Lost to Follow-up|0|||
124636379|NCT00985504|448285240|FG001|Optimization Period|Lost to Follow-up|1|||
124636380|NCT00985504|448285239|FG000|Optimization Period|Physician Decision|1|||
124636381|NCT00985504|448285240|FG001|Optimization Period|Physician Decision|0|||
124636382|NCT00985504|448285239|FG000|Optimization Period|Protocol Violation|3|||
124636383|NCT00985504|448285240|FG001|Optimization Period|Protocol Violation|1|||
124636384|NCT00985504|448285239|FG000|Optimization Period|Withdrawal by Subject|10|||
124636385|NCT00985504|448285240|FG001|Optimization Period|Withdrawal by Subject|8|||
124636386|NCT03711786|448285245|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
124636387|NCT03711786|448285246|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
124636388|NCT03711786|448285245|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
124636389|NCT03711786|448285246|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
124815486|NCT01648101|448954680|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
124815487|NCT01648101|448954681|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
124636390|NCT03711786|448285245|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
124636391|NCT03711786|448285246|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
124636392|NCT03711786|448285245|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
124636393|NCT03711786|448285246|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
124636394|NCT03711786|448285245|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
124815488|NCT01648101|448954682|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
124636395|NCT03711786|448285246|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
124815489|NCT01648101|448954680|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
124815490|NCT01648101|448954681|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
124815491|NCT01648101|448954682|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
124815492|NCT01648101|448954680|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
124815493|NCT01648101|448954681|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
124815494|NCT01648101|448954682|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
124815495|NCT01648101|448954680|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
124815496|NCT01648101|448954681|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
124815497|NCT01648101|448954682|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
124815498|NCT01648101|448954680|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
124815499|NCT01648101|448954681|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
124815500|NCT01648101|448954682|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
124815501|NCT01648101|448954680|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
124815502|NCT01648101|448954681|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
124815503|NCT01648101|448954682|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
124636396|NCT03711786|448285245|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
124636397|NCT03711786|448285246|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
124636398|NCT03379727|448285250|FG000|Overall Study|Lack of Efficacy|73|||
124636399|NCT03379727|448285250|FG000|Overall Study|Adverse Event|32|||
124636400|NCT03379727|448285250|FG000|Overall Study|Death|18|||
124815504|NCT01648101|448954680|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
124815505|NCT01648101|448954681|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
124815506|NCT01648101|448954682|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
124815507|NCT01648101|448954680|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
124815508|NCT01648101|448954681|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
124815509|NCT01648101|448954682|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
124815510|NCT01648101|448954680|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
124815511|NCT01648101|448954681|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
124636401|NCT03379727|448285250|FG000|Overall Study|Patient/guardian decision|17|||
124636402|NCT03379727|448285250|FG000|Overall Study|Physician Decision|104|||
124815512|NCT01648101|448954682|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
124815513|NCT01648101|448954680|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
124815514|NCT01648101|448954681|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
124815515|NCT01648101|448954682|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
124815516|NCT01648101|448954680|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
124815517|NCT01648101|448954681|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
124815518|NCT01648101|448954682|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
124815519|NCT02469298|448954696|FG000|Overall Study|Protocol Violation|0|||
124815520|NCT02469298|448954697|FG001|Overall Study|Protocol Violation|1|||
124815521|NCT02469298|448954698|FG002|Overall Study|Protocol Violation|1|||
124815522|NCT02469298|448954699|FG003|Overall Study|Protocol Violation|0|||
124815523|NCT02469298|448954696|FG000|Overall Study|Lost to Follow-up|1|||
124815524|NCT02469298|448954697|FG001|Overall Study|Lost to Follow-up|0|||
124815525|NCT02469298|448954698|FG002|Overall Study|Lost to Follow-up|1|||
124815526|NCT02469298|448954699|FG003|Overall Study|Lost to Follow-up|0|||
124815527|NCT02469298|448954696|FG000|Overall Study|Physician Decision|0|||
124815528|NCT02469298|448954697|FG001|Overall Study|Physician Decision|0|||
124815529|NCT02469298|448954698|FG002|Overall Study|Physician Decision|0|||
124815530|NCT02469298|448954699|FG003|Overall Study|Physician Decision|1|||
124815531|NCT02469298|448954696|FG000|Overall Study|Withdrawal by Subject|0|||
124815532|NCT02469298|448954697|FG001|Overall Study|Withdrawal by Subject|0|||
124815533|NCT02469298|448954698|FG002|Overall Study|Withdrawal by Subject|0|||
124815534|NCT02469298|448954699|FG003|Overall Study|Withdrawal by Subject|1|||
124815535|NCT03000439|448954702|FG000|Open Label Part 1|Adverse Event|6|||
124815536|NCT03000439|448954703|FG001|Open Label Part 1|Adverse Event|0|||
124636403|NCT03379727|448285250|FG000|Overall Study|Protocol Violation|4|||
124636404|NCT03379727|448285250|FG000|Overall Study|Lost to Follow-up|1|||
124636405|NCT06868654|448285251|FG000|Overall Study|Death|4|||
124636406|NCT06868654|448285252|FG001|Overall Study|Death|14|||
124636407|NCT06868654|448285251|FG000|Overall Study|Lost to Follow-up|0|||
124636408|NCT06868654|448285252|FG001|Overall Study|Lost to Follow-up|1|||
124636409|NCT06868654|448285251|FG000|Overall Study|Withdrawal by Subject|5|||
124815537|NCT03000439|448954704|FG002|Open Label Part 1|Adverse Event|0|||
124815538|NCT03000439|448954705|FG003|Open Label Part 1|Adverse Event|0|||
124815539|NCT03000439|448954702|FG000|Open Label Part 1|Other|2|||
124815540|NCT03000439|448954703|FG001|Open Label Part 1|Other|0|||
124815541|NCT03000439|448954704|FG002|Open Label Part 1|Other|0|||
124815542|NCT03000439|448954705|FG003|Open Label Part 1|Other|0|||
124815543|NCT03000439|448954702|FG000|Open Label Part 1|Insufficient clinical response|16|||
124815544|NCT03000439|448954703|FG001|Open Label Part 1|Insufficient clinical response|0|||
124815545|NCT03000439|448954704|FG002|Open Label Part 1|Insufficient clinical response|0|||
124636410|NCT06868654|448285252|FG001|Overall Study|Withdrawal by Subject|3|||
124636411|NCT06868654|448285251|FG000|Overall Study|Physician Decision|0|||
124636412|NCT06868654|448285252|FG001|Overall Study|Physician Decision|1|||
124636413|NCT06868654|448285251|FG000|Overall Study|Ongoing|23|||
124636414|NCT06868654|448285252|FG001|Overall Study|Ongoing|21|||
124636415|NCT00764660|448285257|FG000|Overall Study|Adverse Event|6|||
124636416|NCT00764660|448285258|FG001|Overall Study|Adverse Event|3|||
124636417|NCT00764660|448285257|FG000|Overall Study|Lost to Follow-up|3|||
124636418|NCT00764660|448285258|FG001|Overall Study|Lost to Follow-up|4|||
124636419|NCT00764660|448285257|FG000|Overall Study|Withdrawal by Subject|7|||
124636420|NCT00764660|448285258|FG001|Overall Study|Withdrawal by Subject|3|||
124636421|NCT00764660|448285257|FG000|Overall Study|Noncompliance With Protocol|5|||
124636422|NCT00764660|448285258|FG001|Overall Study|Noncompliance With Protocol|1|||
124636423|NCT00764660|448285257|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
124636424|NCT00764660|448285258|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
124636425|NCT01131455|448285259|FG000|Overall Study|Death of PI|6|||
124636426|NCT01131455|448285260|FG001|Overall Study|Death of PI|4|||
124636427|NCT01131455|448285261|FG002|Overall Study|Death of PI|0|||
124636428|NCT03103152|448285262|FG000|Overall Study|Physician Decision|5|||
124636429|NCT03103152|448285263|FG001|Overall Study|Physician Decision|2|||
124636430|NCT03103152|448285264|FG002|Overall Study|Physician Decision|6|||
124636431|NCT03103152|448285265|FG003|Overall Study|Physician Decision|3|||
124636432|NCT03103152|448285266|FG004|Overall Study|Physician Decision|3|||
124636433|NCT03103152|448285267|FG005|Overall Study|Physician Decision|1|||
124636434|NCT03103152|448285262|FG000|Overall Study|Protocol Violation|2|||
124636435|NCT03103152|448285263|FG001|Overall Study|Protocol Violation|2|||
124636436|NCT03103152|448285264|FG002|Overall Study|Protocol Violation|1|||
124636437|NCT03103152|448285265|FG003|Overall Study|Protocol Violation|2|||
124636438|NCT03103152|448285266|FG004|Overall Study|Protocol Violation|1|||
124636439|NCT03103152|448285267|FG005|Overall Study|Protocol Violation|1|||
124636440|NCT03103152|448285262|FG000|Overall Study|Inter-current illness|0|||
124636441|NCT03103152|448285263|FG001|Overall Study|Inter-current illness|0|||
124815546|NCT03000439|448954705|FG003|Open Label Part 1|Insufficient clinical response|0|||
124636442|NCT03103152|448285264|FG002|Overall Study|Inter-current illness|1|||
124636443|NCT03103152|448285265|FG003|Overall Study|Inter-current illness|0|||
124636444|NCT03103152|448285266|FG004|Overall Study|Inter-current illness|0|||
124636445|NCT03103152|448285267|FG005|Overall Study|Inter-current illness|0|||
124636446|NCT03103152|448285262|FG000|Overall Study|Death|0|||
124636447|NCT03103152|448285263|FG001|Overall Study|Death|1|||
124636448|NCT03103152|448285264|FG002|Overall Study|Death|0|||
124636449|NCT03103152|448285265|FG003|Overall Study|Death|0|||
124815547|NCT03000439|448954702|FG000|Open Label Part 2|Other|0|||
124815548|NCT03000439|448954703|FG001|Open Label Part 2|Other|5|||
124815549|NCT03000439|448954704|FG002|Open Label Part 2|Other|0|||
124815550|NCT03000439|448954705|FG003|Open Label Part 2|Other|0|||
124815551|NCT03000439|448954702|FG000|Open Label Part 2|Insufficient clinical response|0|||
124815552|NCT03000439|448954703|FG001|Open Label Part 2|Insufficient clinical response|12|||
124815553|NCT03000439|448954704|FG002|Open Label Part 2|Insufficient clinical response|0|||
124815554|NCT03000439|448954705|FG003|Open Label Part 2|Insufficient clinical response|0|||
124815555|NCT03000439|448954702|FG000|Double Blind Phase|Adverse Event|0|||
124636450|NCT03103152|448285266|FG004|Overall Study|Death|0|||
124636451|NCT03103152|448285267|FG005|Overall Study|Death|0|||
124636452|NCT03103152|448285262|FG000|Overall Study|Adverse Event|0|||
124636453|NCT03103152|448285263|FG001|Overall Study|Adverse Event|0|||
124636454|NCT03103152|448285264|FG002|Overall Study|Adverse Event|1|||
124636455|NCT03103152|448285265|FG003|Overall Study|Adverse Event|0|||
124636456|NCT03103152|448285266|FG004|Overall Study|Adverse Event|0|||
124636457|NCT03103152|448285267|FG005|Overall Study|Adverse Event|1|||
124815556|NCT03000439|448954703|FG001|Double Blind Phase|Adverse Event|0|||
124815557|NCT03000439|448954704|FG002|Double Blind Phase|Adverse Event|2|||
124815558|NCT03000439|448954705|FG003|Double Blind Phase|Adverse Event|1|||
124815559|NCT03000439|448954702|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
124815560|NCT03000439|448954703|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
124636458|NCT03103152|448285262|FG000|Overall Study|Withdrawal by Subject|1|||
124636459|NCT03103152|448285263|FG001|Overall Study|Withdrawal by Subject|0|||
124636460|NCT03103152|448285264|FG002|Overall Study|Withdrawal by Subject|1|||
124636461|NCT03103152|448285265|FG003|Overall Study|Withdrawal by Subject|1|||
124636462|NCT03103152|448285266|FG004|Overall Study|Withdrawal by Subject|1|||
124636463|NCT03103152|448285267|FG005|Overall Study|Withdrawal by Subject|1|||
124636464|NCT03103152|448285262|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
124636465|NCT03103152|448285263|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
124636466|NCT03103152|448285264|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
124636467|NCT03103152|448285265|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
124636468|NCT03103152|448285266|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
124636469|NCT03103152|448285267|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
124636470|NCT03103152|448285262|FG000|Overall Study|Unacceptable side effects|0|||
124636471|NCT03103152|448285263|FG001|Overall Study|Unacceptable side effects|0|||
124636472|NCT03103152|448285264|FG002|Overall Study|Unacceptable side effects|0|||
124636473|NCT03103152|448285265|FG003|Overall Study|Unacceptable side effects|0|||
124636474|NCT03103152|448285266|FG004|Overall Study|Unacceptable side effects|0|||
124636475|NCT03103152|448285267|FG005|Overall Study|Unacceptable side effects|1|||
124636476|NCT03103152|448285262|FG000|Overall Study|Lost to Follow-up|0|||
124636477|NCT03103152|448285263|FG001|Overall Study|Lost to Follow-up|1|||
124636478|NCT03103152|448285264|FG002|Overall Study|Lost to Follow-up|0|||
124636479|NCT03103152|448285265|FG003|Overall Study|Lost to Follow-up|1|||
124636480|NCT03103152|448285266|FG004|Overall Study|Lost to Follow-up|0|||
124636481|NCT03103152|448285267|FG005|Overall Study|Lost to Follow-up|1|||
124636482|NCT03103152|448285262|FG000|Overall Study|Testicular pain|0|||
124636483|NCT03103152|448285263|FG001|Overall Study|Testicular pain|0|||
124636484|NCT03103152|448285264|FG002|Overall Study|Testicular pain|0|||
124636485|NCT03103152|448285265|FG003|Overall Study|Testicular pain|1|||
124815561|NCT03000439|448954704|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
124815562|NCT03000439|448954705|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
124815563|NCT03000439|448954702|FG000|Double Blind Phase|Other|0|||
124815564|NCT03000439|448954703|FG001|Double Blind Phase|Other|0|||
124815565|NCT03000439|448954704|FG002|Double Blind Phase|Other|10|||
124815566|NCT03000439|448954705|FG003|Double Blind Phase|Other|11|||
124815567|NCT03000439|448954702|FG000|Double Blind Phase|Insufficient clinical response|0|||
124815568|NCT03000439|448954703|FG001|Double Blind Phase|Insufficient clinical response|0|||
124815569|NCT03000439|448954704|FG002|Double Blind Phase|Insufficient clinical response|0|||
124815570|NCT03000439|448954705|FG003|Double Blind Phase|Insufficient clinical response|2|||
124815571|NCT02954237|448954708|FG000|Overall Study|Withdrawal by Subject|25|||
124815572|NCT02954237|448954708|FG000|Overall Study|Missed visit|16|||
124815573|NCT02954237|448954708|FG000|Overall Study|Death|2|||
124815574|NCT03292588|448954709|FG000|Overall Study|Death|1|||
124815575|NCT03292588|448954710|FG001|Overall Study|Death|0|||
124815576|NCT03292588|448954709|FG000|Overall Study|Lost to Follow-up|12|||
124815577|NCT03292588|448954710|FG001|Overall Study|Lost to Follow-up|16|||
124815578|NCT03292588|448954709|FG000|Overall Study|Physician Decision|0|||
124815579|NCT03292588|448954710|FG001|Overall Study|Physician Decision|1|||
124815580|NCT03292588|448954709|FG000|Overall Study|Withdrawal by Subject|4|||
124815581|NCT03292588|448954710|FG001|Overall Study|Withdrawal by Subject|4|||
124815582|NCT03292588|448954709|FG000|Overall Study|Move out of town|1|||
124815583|NCT03292588|448954710|FG001|Overall Study|Move out of town|0|||
124815584|NCT03292588|448954709|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
124815585|NCT03292588|448954710|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
124815586|NCT02151591|448954711|FG000|Overall Study|Lost to Follow-up|6|||
124815587|NCT02151591|448954712|FG001|Overall Study|Lost to Follow-up|3|||
124815588|NCT03633695|448954715|FG000|Overall Study|Lost to Follow-up|4|||
124815589|NCT03633695|448954716|FG001|Overall Study|Lost to Follow-up|5|||
124815590|NCT03633695|448954715|FG000|Overall Study|Discontinued|8|||
124815591|NCT03633695|448954716|FG001|Overall Study|Discontinued|4|||
124636486|NCT03103152|448285266|FG004|Overall Study|Testicular pain|0|||
124636487|NCT03103152|448285267|FG005|Overall Study|Testicular pain|0|||
124636488|NCT03668119|448286732|FG000|Pre-treatment|Disease Progression|1|||
124636489|NCT03668119|448286733|FG001|Pre-treatment|Disease Progression|0|||
124636490|NCT03668119|448286732|FG000|Treatment|Disease Progression|76|||
124636491|NCT03668119|448286733|FG001|Treatment|Disease Progression|57|||
124636492|NCT03668119|448286732|FG000|Treatment|Study drug toxicity|19|||
124636493|NCT03668119|448286733|FG001|Treatment|Study drug toxicity|1|||
124636494|NCT03668119|448286732|FG000|Treatment|Death|3|||
124636495|NCT03668119|448286733|FG001|Treatment|Death|0|||
124636496|NCT03668119|448286732|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
124636497|NCT03668119|448286733|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
124636498|NCT03668119|448286732|FG000|Treatment|Withdrawal by Subject|1|||
124636499|NCT03668119|448286733|FG001|Treatment|Withdrawal by Subject|1|||
124636500|NCT03668119|448286732|FG000|Treatment|Participant request to discontinue study treatment|3|||
124815592|NCT02853604|448954725|FG000|Overall Study|Withdrawal by Subject|12|||
124815593|NCT02853604|448954726|FG001|Overall Study|Withdrawal by Subject|35|||
124815594|NCT02853604|448954725|FG000|Overall Study|Lost to Follow-up|4|||
124815595|NCT02853604|448954726|FG001|Overall Study|Lost to Follow-up|8|||
124815596|NCT02853604|448954725|FG000|Overall Study|Death|1|||
124815597|NCT02853604|448954726|FG001|Overall Study|Death|5|||
124815598|NCT02853604|448954725|FG000|Overall Study|Miscellaneous|11|||
124636501|NCT03668119|448286733|FG001|Treatment|Participant request to discontinue study treatment|1|||
124636502|NCT03668119|448286732|FG000|Treatment|Maximum Clinical Benefit|0|||
124636503|NCT03668119|448286733|FG001|Treatment|Maximum Clinical Benefit|1|||
124636504|NCT03668119|448286732|FG000|Treatment|Participants completed treatment|27|||
124636505|NCT03668119|448286733|FG001|Treatment|Participants completed treatment|11|||
124815599|NCT02853604|448954726|FG001|Overall Study|Miscellaneous|2|||
124815600|NCT02853604|448954725|FG000|Overall Study|Progressive Disease|0|||
124636506|NCT03668119|448286732|FG000|Treatment|Other reasons|2|||
124636507|NCT03668119|448286733|FG001|Treatment|Other reasons|1|||
124636508|NCT03055338|448286736|FG000|Overall Study|Lost to Follow-up|9|||
124636509|NCT03055338|448286737|FG001|Overall Study|Lost to Follow-up|2|||
124636510|NCT03055338|448286738|FG002|Overall Study|Lost to Follow-up|3|||
124636511|NCT03055338|448286736|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
124636512|NCT03055338|448286737|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
124636513|NCT03055338|448286738|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
124636514|NCT03055338|448286736|FG000|Overall Study|Physician Decision|0|||
124636515|NCT03055338|448286737|FG001|Overall Study|Physician Decision|0|||
124636516|NCT03055338|448286738|FG002|Overall Study|Physician Decision|2|||
124636517|NCT03055338|448286736|FG000|Overall Study|Withdrawal by Subject|9|||
124636518|NCT03055338|448286737|FG001|Overall Study|Withdrawal by Subject|8|||
124636519|NCT03055338|448286738|FG002|Overall Study|Withdrawal by Subject|7|||
124636520|NCT03058705|448286739|FG000|Overall Study|Withdrawal by Subject|2|||
124636521|NCT03058705|448286739|FG000|Overall Study|Physician Decision|2|||
124636522|NCT02151851|448286740|FG000|Overall Study|Lack of Efficacy|67|||
124636523|NCT02151851|448286741|FG001|Overall Study|Lack of Efficacy|94|||
124636524|NCT02151851|448286740|FG000|Overall Study|Protocol Violation|0|||
124636525|NCT02151851|448286741|FG001|Overall Study|Protocol Violation|1|||
124636526|NCT02151851|448286740|FG000|Overall Study|Withdrawal by Subject|2|||
124636527|NCT02151851|448286741|FG001|Overall Study|Withdrawal by Subject|5|||
124636528|NCT02151851|448286740|FG000|Overall Study|Medical impairment|1|||
124636529|NCT02151851|448286741|FG001|Overall Study|Medical impairment|0|||
124636530|NCT02151851|448286740|FG000|Overall Study|Low compliance to study visits|0|||
124636531|NCT02151851|448286741|FG001|Overall Study|Low compliance to study visits|1|||
124636532|NCT02151851|448286740|FG000|Overall Study|Subject entered into study in error|0|||
124636533|NCT02151851|448286741|FG001|Overall Study|Subject entered into study in error|1|||
124636534|NCT02151851|448286740|FG000|Overall Study|Adverse Event|6|||
124636535|NCT02151851|448286741|FG001|Overall Study|Adverse Event|28|||
124636536|NCT02159053|448286742|FG000|Overall Study|Death|2|||
124636537|NCT02159053|448286743|FG001|Overall Study|Death|0|||
124636538|NCT02159053|448286744|FG002|Overall Study|Death|1|||
124636539|NCT02159053|448286742|FG000|Overall Study|Physician Decision|0|||
124636540|NCT02159053|448286743|FG001|Overall Study|Physician Decision|1|||
124636541|NCT02159053|448286744|FG002|Overall Study|Physician Decision|1|||
124636542|NCT02159053|448286742|FG000|Overall Study|Lack of Efficacy|3|||
124636543|NCT02159053|448286743|FG001|Overall Study|Lack of Efficacy|4|||
124636544|NCT02159053|448286744|FG002|Overall Study|Lack of Efficacy|7|||
124636545|NCT02159053|448286742|FG000|Overall Study|Adverse Event|7|||
124636546|NCT02159053|448286743|FG001|Overall Study|Adverse Event|6|||
124636547|NCT02159053|448286744|FG002|Overall Study|Adverse Event|5|||
124636548|NCT02159053|448286742|FG000|Overall Study|Participants/guardian decision|8|||
124636549|NCT02159053|448286743|FG001|Overall Study|Participants/guardian decision|10|||
124636550|NCT02159053|448286744|FG002|Overall Study|Participants/guardian decision|6|||
124636551|NCT01540487|448286749|FG000|Overall Study|Protocol Violation|1|||
124636552|NCT01540487|448286750|FG001|Overall Study|Protocol Violation|0|||
124636553|NCT02525783|448286759|FG000|Overall Study|Lost to Follow-up|10|||
124815601|NCT02853604|448954726|FG001|Overall Study|Progressive Disease|2|||
124815602|NCT05275400|448954727|FG000|Treatment Period|Adverse Event|7|||
124815603|NCT05275400|448954728|FG001|Treatment Period|Adverse Event|1|||
124815604|NCT05275400|448954727|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
124815605|NCT05275400|448954728|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
124815606|NCT05275400|448954727|FG000|Treatment Period|Death|5|||
124815607|NCT05275400|448954728|FG001|Treatment Period|Death|2|||
124815608|NCT05275400|448954727|FG000|Treatment Period|Protocol Violation|1|||
124815609|NCT05275400|448954728|FG001|Treatment Period|Protocol Violation|0|||
124815610|NCT05275400|448954727|FG000|Treatment Period|Physician Decision|5|||
124815611|NCT05275400|448954728|FG001|Treatment Period|Physician Decision|4|||
124815612|NCT05275400|448954727|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
124815613|NCT05275400|448954728|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
124815614|NCT05275400|448954727|FG000|Treatment Period|Withdrawal by Subject|30|||
124815615|NCT05275400|448954728|FG001|Treatment Period|Withdrawal by Subject|12|||
124815616|NCT05275400|448954727|FG000|Treatment Period|Lost to Follow-up|1|||
124815617|NCT05275400|448954728|FG001|Treatment Period|Lost to Follow-up|5|||
124815618|NCT05275400|448954727|FG000|Treatment Period|Lack of Efficacy|1|||
124636554|NCT01295671|448286760|FG000|Overall Study|Lost to Follow-up|4|||
124636555|NCT01295671|448286761|FG001|Overall Study|Lost to Follow-up|6|||
124636556|NCT01295671|448286762|FG002|Overall Study|Lost to Follow-up|3|||
124636557|NCT01295671|448286760|FG000|Overall Study|Withdrawal by Subject|3|||
124636558|NCT01295671|448286761|FG001|Overall Study|Withdrawal by Subject|1|||
124636559|NCT01295671|448286762|FG002|Overall Study|Withdrawal by Subject|0|||
124636560|NCT00808210|448286764|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
124636561|NCT00808210|448286765|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
124636562|NCT00808210|448286764|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
124636563|NCT00808210|448286765|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
124636564|NCT00808210|448286764|FG000|Double-Blind TX Period|Adverse Event|0|||
124636565|NCT00808210|448286765|FG001|Double-Blind TX Period|Adverse Event|1|||
124636566|NCT00808210|448286764|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
124636567|NCT00808210|448286765|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
124815619|NCT05275400|448954728|FG001|Treatment Period|Lack of Efficacy|0|||
124815620|NCT05275400|448954727|FG000|Treatment Period|Sponsor Decision|1|||
124815621|NCT05275400|448954728|FG001|Treatment Period|Sponsor Decision|0|||
124636568|NCT00808210|448286764|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
124636569|NCT00808210|448286765|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
124636570|NCT00808210|448286764|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
124636571|NCT00808210|448286765|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
124636572|NCT02356588|448286769|FG000|Overall Study|Lack of Efficacy|4|||
124636573|NCT02356588|448286770|FG001|Overall Study|Lack of Efficacy|10|||
124636574|NCT02356588|448286769|FG000|Overall Study|Adverse Event|0|||
124636575|NCT02356588|448286770|FG001|Overall Study|Adverse Event|2|||
124636576|NCT02356588|448286769|FG000|Overall Study|Withdrawal by Subject|1|||
124636577|NCT02356588|448286770|FG001|Overall Study|Withdrawal by Subject|0|||
124636578|NCT02356588|448286769|FG000|Overall Study|Protocol Violation|0|||
124636579|NCT02356588|448286770|FG001|Overall Study|Protocol Violation|1|||
124636580|NCT03150719|448286773|FG000|Overall Study|Adverse Event|0|||
124636581|NCT03150719|448286774|FG001|Overall Study|Adverse Event|1|||
124636582|NCT03150719|448286773|FG000|Overall Study|Death|0|||
124636583|NCT03150719|448286774|FG001|Overall Study|Death|1|||
124636584|NCT03150719|448286773|FG000|Overall Study|Other|1|||
124636585|NCT03150719|448286774|FG001|Overall Study|Other|0|||
124636586|NCT01790984|448286775|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
124636587|NCT01790984|448286776|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
124636588|NCT01790984|448286777|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
124636589|NCT01790984|448286778|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
124636590|NCT01346696|448286780|FG000|Overall Study|Death|1|||
124636591|NCT01051791|448286789|FG000|Overall Study|Failed screening|3|||
124636592|NCT01051791|448286789|FG000|Overall Study|Withdrawal by Subject|1|||
124636593|NCT00506415|448286791|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
124636594|NCT00506415|448286792|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
124636595|NCT00506415|448286793|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
124636596|NCT00506415|448286794|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
124636597|NCT00506415|448286791|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
124636598|NCT00506415|448286792|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
124636599|NCT00506415|448286793|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
124636600|NCT00506415|448286794|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
124636601|NCT00506415|448286791|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
124636602|NCT00506415|448286792|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
124636603|NCT00506415|448286793|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
124636604|NCT00506415|448286794|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
124636605|NCT00506415|448286791|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
124636606|NCT00506415|448286792|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
124636607|NCT00506415|448286793|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
124636608|NCT00506415|448286794|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
124636609|NCT00506415|448286791|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
124636610|NCT00506415|448286792|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
124636611|NCT00506415|448286793|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
124636612|NCT00506415|448286794|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
124636613|NCT00506415|448286791|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
124636614|NCT00506415|448286792|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
124636615|NCT00506415|448286793|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
124636616|NCT00506415|448286794|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
124636617|NCT00506415|448286791|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
124636618|NCT00506415|448286792|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
124636619|NCT00506415|448286793|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
124636620|NCT00506415|448286794|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
124636621|NCT00506415|448286791|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
124636622|NCT00506415|448286792|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
124636623|NCT00506415|448286793|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
124636624|NCT00506415|448286794|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
124636625|NCT00506415|448286791|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
124636626|NCT00506415|448286792|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
124636627|NCT00506415|448286793|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
124636628|NCT00506415|448286794|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
124636629|NCT00506415|448286791|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
124636630|NCT00506415|448286792|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
124636631|NCT00506415|448286793|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
124636632|NCT00506415|448286794|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
124636633|NCT00506415|448286791|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
124636634|NCT00506415|448286792|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
124636635|NCT00506415|448286793|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
124636636|NCT00506415|448286794|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
124636637|NCT00506415|448286791|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
124636638|NCT00506415|448286792|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
124636639|NCT00506415|448286793|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
124636640|NCT00506415|448286794|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
124636641|NCT00506415|448286791|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
124636642|NCT00506415|448286792|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
124636643|NCT00506415|448286793|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
124636644|NCT00506415|448286794|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
124636645|NCT00506415|448286791|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
124636646|NCT00506415|448286792|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
124636647|NCT00506415|448286793|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
124636648|NCT00506415|448286794|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
124636649|NCT00506415|448286791|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
124636650|NCT00506415|448286792|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
124636651|NCT00506415|448286793|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
124636652|NCT00506415|448286794|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
124636653|NCT00506415|448286791|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
124636654|NCT00506415|448286792|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
124636655|NCT00506415|448286793|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
124636656|NCT00506415|448286794|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
124636657|NCT00506415|448286791|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
124636658|NCT00506415|448286792|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
124636659|NCT00506415|448286793|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
124636660|NCT00506415|448286794|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
124636661|NCT00506415|448286791|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
124636662|NCT00506415|448286792|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
124636663|NCT00506415|448286793|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
124636664|NCT00506415|448286794|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
124636665|NCT00506415|448286791|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
124636666|NCT00506415|448286792|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
124636667|NCT00506415|448286793|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
124636668|NCT00506415|448286794|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
124636669|NCT00506415|448286791|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
124636670|NCT00506415|448286792|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
124636671|NCT00506415|448286793|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
124636672|NCT00506415|448286794|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
124636673|NCT00506415|448286791|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
124636674|NCT00506415|448286792|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
124636675|NCT00506415|448286793|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
124636676|NCT00506415|448286794|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
124636677|NCT00506415|448286791|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
124636678|NCT00506415|448286792|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
124636679|NCT00506415|448286793|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
124636680|NCT00506415|448286794|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
124636681|NCT00506415|448286791|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
124636682|NCT00506415|448286792|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
124636683|NCT00506415|448286793|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
124636684|NCT00506415|448286794|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
124636685|NCT00506415|448286791|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
124636686|NCT00506415|448286792|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
124636687|NCT00506415|448286793|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
124636688|NCT00506415|448286794|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
124636689|NCT04578457|448286795|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
124636690|NCT04578457|448286795|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
124636691|NCT04578457|448286795|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
124636692|NCT04578457|448286795|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
124636693|NCT02019264|448286797|FG000|Overall Study|Not treated|6|||
124636694|NCT02019264|448286798|FG001|Overall Study|Not treated|4|||
124636695|NCT02019264|448286797|FG000|Overall Study|Lost to Follow-up|50|||
124636696|NCT02019264|448286798|FG001|Overall Study|Lost to Follow-up|47|||
124636697|NCT02019264|448286797|FG000|Overall Study|Withdrawal by Subject|142|||
124636698|NCT02019264|448286798|FG001|Overall Study|Withdrawal by Subject|117|||
124815622|NCT05275400|448954727|FG000|Follow-Up Period|Death|2|||
124815623|NCT05275400|448954728|FG001|Follow-Up Period|Death|0|||
124636699|NCT02019264|448286797|FG000|Overall Study|Administrative reason|36|||
124815624|NCT05275400|448954727|FG000|Follow-Up Period|Protocol Violation|1|||
124815625|NCT05275400|448954728|FG001|Follow-Up Period|Protocol Violation|0|||
124815626|NCT05275400|448954727|FG000|Follow-Up Period|Withdrawal by Subject|3|||
124815627|NCT05275400|448954728|FG001|Follow-Up Period|Withdrawal by Subject|0|||
124815628|NCT06333613|448954729|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
124815629|NCT03648541|448954735|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
124815630|NCT03648541|448954736|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
124815631|NCT03648541|448954735|FG000|Re-induction Period Only|Lack of Efficacy|7|||
124815632|NCT03648541|448954736|FG001|Re-induction Period Only|Lack of Efficacy|0|||
124815633|NCT03648541|448954735|FG000|Maintenance Period Only|Missing|0|||
124815634|NCT03648541|448954736|FG001|Maintenance Period Only|Missing|1|||
124815635|NCT03648541|448954735|FG000|Maintenance Period Only|Other not listed below|0|||
124815636|NCT03648541|448954736|FG001|Maintenance Period Only|Other not listed below|4|||
124815637|NCT03648541|448954735|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
124815638|NCT03648541|448954736|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
124815639|NCT03648541|448954735|FG000|Maintenance Period Only|Protocol Violation|0|||
124815640|NCT03648541|448954736|FG001|Maintenance Period Only|Protocol Violation|1|||
124815641|NCT03648541|448954735|FG000|Maintenance Period Only|Lack of Efficacy|0|||
124815642|NCT03648541|448954736|FG001|Maintenance Period Only|Lack of Efficacy|18|||
124815643|NCT03648541|448954735|FG000|Maintenance Period Only|Adverse Event|0|||
124815644|NCT03648541|448954736|FG001|Maintenance Period Only|Adverse Event|4|||
124815645|NCT03648541|448954735|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
124815646|NCT03648541|448954736|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
124815647|NCT04623216|448954737|FG000|Overall Study|Death|5|||
124815648|NCT04623216|448954738|FG001|Overall Study|Death|2|||
124815649|NCT04623216|448954739|FG002|Overall Study|Death|0|||
124815650|NCT04623216|448954740|FG003|Overall Study|Death|0|||
124815651|NCT04623216|448954737|FG000|Overall Study|Terminated by Sponsor|3|||
124815652|NCT04623216|448954738|FG001|Overall Study|Terminated by Sponsor|2|||
124815653|NCT04623216|448954739|FG002|Overall Study|Terminated by Sponsor|2|||
124815654|NCT04623216|448954740|FG003|Overall Study|Terminated by Sponsor|0|||
124815655|NCT04623216|448954737|FG000|Overall Study|Physician Decision|1|||
124815656|NCT04623216|448954738|FG001|Overall Study|Physician Decision|0|||
124815657|NCT04623216|448954739|FG002|Overall Study|Physician Decision|0|||
124815658|NCT04623216|448954740|FG003|Overall Study|Physician Decision|0|||
124815659|NCT01651039|448954741|FG000|Overall Study|Non-evaluables|5|||
124815660|NCT01651039|448954741|FG000|Overall Study|Physician Decision|2|||
124815661|NCT01651039|448954741|FG000|Overall Study|Withdrawal by Subject|1|||
124815662|NCT01651039|448954741|FG000|Overall Study|Progressive Disease|22|||
124815663|NCT04930965|448954744|FG000|Overall Study|Lost to Follow-up|7|||
124815664|NCT04930965|448954745|FG001|Overall Study|Lost to Follow-up|5|||
124815665|NCT00134082|448954746|FG000|Overall Study|Adverse Event|2|||
124815666|NCT00134082|448954746|FG000|Overall Study|Death|1|||
124815667|NCT02197247|448954749|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
124815668|NCT02197247|448954749|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
124636700|NCT02019264|448286798|FG001|Overall Study|Administrative reason|28|||
124636701|NCT02019264|448286797|FG000|Overall Study|Missing|14|||
124636702|NCT02019264|448286798|FG001|Overall Study|Missing|11|||
124636703|NCT00105079|448286799|FG000|Overall Study|Adverse Event|5|||
124636704|NCT00105079|448286800|FG001|Overall Study|Adverse Event|12|||
124636705|NCT00105079|448286799|FG000|Overall Study|Death|3|||
124636706|NCT00105079|448286800|FG001|Overall Study|Death|1|||
124636707|NCT00105079|448286799|FG000|Overall Study|Lost to Follow-up|12|||
124636708|NCT00105079|448286800|FG001|Overall Study|Lost to Follow-up|12|||
124636709|NCT00105079|448286799|FG000|Overall Study|Lack of Efficacy|9|||
124636710|NCT00105079|448286800|FG001|Overall Study|Lack of Efficacy|3|||
124636711|NCT00105079|448286799|FG000|Overall Study|Refused treatment|6|||
124636712|NCT00105079|448286800|FG001|Overall Study|Refused treatment|4|||
124636713|NCT00105079|448286799|FG000|Overall Study|Violation of selection criteria at entry|0|||
124636714|NCT00105079|448286800|FG001|Overall Study|Violation of selection criteria at entry|2|||
124636715|NCT00105079|448286799|FG000|Overall Study|Protocol Violation|1|||
124636716|NCT00105079|448286800|FG001|Overall Study|Protocol Violation|0|||
124636717|NCT00105079|448286799|FG000|Overall Study|Other|3|||
124815669|NCT02197247|448954749|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
124815670|NCT02197247|448954749|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
124815671|NCT02197247|448954749|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
124815672|NCT02197247|448954749|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
124815673|NCT02197247|448954749|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
124815674|NCT02197247|448954749|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
124636718|NCT00105079|448286800|FG001|Overall Study|Other|1|||
124636719|NCT01609296|448286806|FG000|Overall Study|Death|253|||
124636720|NCT01609296|448286806|FG000|Overall Study|Withdrawal by Subject|151|||
124636721|NCT01609296|448286806|FG000|Overall Study|Lost to Follow-up|21|||
124636722|NCT01609296|448286806|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
124636723|NCT01609296|448286806|FG000|Overall Study|missed visit but known to be alive|28|||
124636724|NCT00386360|448286807|FG000|Overall Study|Adverse Event|4|||
124636725|NCT00386360|448286808|FG001|Overall Study|Adverse Event|2|||
124636726|NCT00386360|448286807|FG000|Overall Study|Physician Decision|2|||
124636727|NCT00386360|448286808|FG001|Overall Study|Physician Decision|2|||
124636728|NCT00386360|448286807|FG000|Overall Study|Lost to Follow-up|0|||
124815675|NCT02228460|448954762|FG000|Overall Study|Adverse Event|1|||
124815676|NCT02228460|448954762|FG000|Overall Study|Lost to Follow-up|1|||
124636729|NCT00386360|448286808|FG001|Overall Study|Lost to Follow-up|2|||
124636730|NCT00386360|448286807|FG000|Overall Study|Protocol Violation|0|||
124636731|NCT00386360|448286808|FG001|Overall Study|Protocol Violation|3|||
124636732|NCT00386360|448286807|FG000|Overall Study|Withdrawal by Subject|3|||
124636733|NCT00386360|448286808|FG001|Overall Study|Withdrawal by Subject|6|||
124636734|NCT00386360|448286807|FG000|Overall Study|Did not take any study medication|0|||
124636735|NCT00386360|448286808|FG001|Overall Study|Did not take any study medication|2|||
124636736|NCT02230904|448286809|FG000|Overall Study|Safety follow up could not take place|0|||
124636737|NCT02230904|448286810|FG001|Overall Study|Safety follow up could not take place|1|||
124636738|NCT01532518|448286811|FG000|Overall Study|Withdrawal by Subject|0|||
124636739|NCT01532518|448286812|FG001|Overall Study|Withdrawal by Subject|0|||
124636740|NCT01532518|448286813|FG002|Overall Study|Withdrawal by Subject|1|||
124636741|NCT02677922|448286816|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
124636742|NCT02677922|448286817|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
124636743|NCT02677922|448286818|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
124636744|NCT02677922|448286819|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
124636745|NCT02677922|448286820|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
124636746|NCT02677922|448286821|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
124636747|NCT02677922|448286816|FG000|Treatment Period|Adverse Event|0|||
124636748|NCT02677922|448286817|FG001|Treatment Period|Adverse Event|0|||
124636749|NCT02677922|448286818|FG002|Treatment Period|Adverse Event|1|||
124636750|NCT02677922|448286819|FG003|Treatment Period|Adverse Event|3|||
124636751|NCT02677922|448286820|FG004|Treatment Period|Adverse Event|5|||
124636752|NCT02677922|448286821|FG005|Treatment Period|Adverse Event|2|||
124636753|NCT02677922|448286816|FG000|Treatment Period|Progressive Disease|1|||
124636754|NCT02677922|448286817|FG001|Treatment Period|Progressive Disease|1|||
124636755|NCT02677922|448286818|FG002|Treatment Period|Progressive Disease|0|||
124636756|NCT02677922|448286819|FG003|Treatment Period|Progressive Disease|0|||
124636757|NCT02677922|448286820|FG004|Treatment Period|Progressive Disease|8|||
124636758|NCT02677922|448286821|FG005|Treatment Period|Progressive Disease|7|||
124636759|NCT02677922|448286816|FG000|Treatment Period|Lack of Efficacy|0|||
124636760|NCT02677922|448286817|FG001|Treatment Period|Lack of Efficacy|0|||
124636761|NCT02677922|448286818|FG002|Treatment Period|Lack of Efficacy|0|||
124636762|NCT02677922|448286819|FG003|Treatment Period|Lack of Efficacy|1|||
124636763|NCT02677922|448286820|FG004|Treatment Period|Lack of Efficacy|1|||
124636764|NCT02677922|448286821|FG005|Treatment Period|Lack of Efficacy|6|||
124636765|NCT02677922|448286816|FG000|Treatment Period|Withdrawal by Subject|0|||
124636766|NCT02677922|448286817|FG001|Treatment Period|Withdrawal by Subject|0|||
124636767|NCT02677922|448286818|FG002|Treatment Period|Withdrawal by Subject|1|||
124636768|NCT02677922|448286819|FG003|Treatment Period|Withdrawal by Subject|3|||
124636769|NCT02677922|448286820|FG004|Treatment Period|Withdrawal by Subject|5|||
124636770|NCT02677922|448286821|FG005|Treatment Period|Withdrawal by Subject|5|||
124636771|NCT02677922|448286816|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
124636772|NCT02677922|448286817|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
124815677|NCT01243892|448954763|FG000|Overall Study|Did not meet eligibility criteria|2|||
124815678|NCT01243892|448954764|FG001|Overall Study|Did not meet eligibility criteria|0|||
124815679|NCT00119106|448954765|FG000|Overall Study|HIV infected at baseline|179|||
124815680|NCT00119106|448954766|FG001|Overall Study|HIV infected at baseline|178|||
124636773|NCT02677922|448286818|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
124636774|NCT02677922|448286819|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
124636775|NCT02677922|448286820|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
124636776|NCT02677922|448286821|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
124636777|NCT02677922|448286816|FG000|Treatment Period|Disease Relapse|0|||
124636778|NCT02677922|448286817|FG001|Treatment Period|Disease Relapse|0|||
124636779|NCT02677922|448286818|FG002|Treatment Period|Disease Relapse|0|||
124636780|NCT02677922|448286819|FG003|Treatment Period|Disease Relapse|3|||
124636781|NCT02677922|448286820|FG004|Treatment Period|Disease Relapse|6|||
124636782|NCT02677922|448286821|FG005|Treatment Period|Disease Relapse|1|||
124636783|NCT02677922|448286816|FG000|Treatment Period|Allogeneic HSCT|1|||
124636784|NCT02677922|448286817|FG001|Treatment Period|Allogeneic HSCT|0|||
124636785|NCT02677922|448286818|FG002|Treatment Period|Allogeneic HSCT|0|||
124636786|NCT02677922|448286819|FG003|Treatment Period|Allogeneic HSCT|1|||
124636787|NCT02677922|448286820|FG004|Treatment Period|Allogeneic HSCT|4|||
124815681|NCT03066804|448954767|FG000|Overall Study|Physician Decision|0|||
124815682|NCT03066804|448954768|FG001|Overall Study|Physician Decision|4|||
124815683|NCT03066804|448954767|FG000|Overall Study|Death|23|||
124636788|NCT02677922|448286821|FG005|Treatment Period|Allogeneic HSCT|1|||
124636789|NCT02677922|448286816|FG000|Treatment Period|Other Reasons|0|||
124636790|NCT02677922|448286817|FG001|Treatment Period|Other Reasons|0|||
124636791|NCT02677922|448286818|FG002|Treatment Period|Other Reasons|0|||
124636792|NCT02677922|448286819|FG003|Treatment Period|Other Reasons|1|||
124636793|NCT02677922|448286820|FG004|Treatment Period|Other Reasons|3|||
124636794|NCT02677922|448286821|FG005|Treatment Period|Other Reasons|5|||
124636795|NCT02677922|448286816|FG000|Treatment Period|Death|0|||
124636796|NCT02677922|448286817|FG001|Treatment Period|Death|0|||
124636797|NCT02677922|448286818|FG002|Treatment Period|Death|0|||
124636798|NCT02677922|448286819|FG003|Treatment Period|Death|0|||
124636799|NCT02677922|448286820|FG004|Treatment Period|Death|12|||
124636800|NCT02677922|448286821|FG005|Treatment Period|Death|1|||
124636801|NCT02677922|448286816|FG000|Treatment Period|Non-compliance with Study Drug|0|||
124636802|NCT02677922|448286817|FG001|Treatment Period|Non-compliance with Study Drug|0|||
124636803|NCT02677922|448286818|FG002|Treatment Period|Non-compliance with Study Drug|0|||
124636804|NCT02677922|448286819|FG003|Treatment Period|Non-compliance with Study Drug|0|||
124636805|NCT02677922|448286820|FG004|Treatment Period|Non-compliance with Study Drug|1|||
124636806|NCT02677922|448286821|FG005|Treatment Period|Non-compliance with Study Drug|0|||
124815684|NCT03066804|448954768|FG001|Overall Study|Death|17|||
124815685|NCT03066804|448954767|FG000|Overall Study|Withdrawal by Subject|19|||
124815686|NCT03066804|448954768|FG001|Overall Study|Withdrawal by Subject|25|||
124815687|NCT03066804|448954767|FG000|Overall Study|Lost to Follow-up|2|||
124815688|NCT03066804|448954768|FG001|Overall Study|Lost to Follow-up|0|||
124815689|NCT03066804|448954767|FG000|Overall Study|Adverse Event|2|||
124815690|NCT03066804|448954768|FG001|Overall Study|Adverse Event|3|||
124815691|NCT03066804|448954767|FG000|Overall Study|Technical problems|5|||
124815692|NCT03066804|448954768|FG001|Overall Study|Technical problems|1|||
124815693|NCT02099708|448954769|FG000|Overall Study|Data Not Available|30|||
124636807|NCT02677922|448286816|FG000|Treatment Period|Physician Decision|0|||
124636808|NCT02677922|448286817|FG001|Treatment Period|Physician Decision|0|||
124636809|NCT02677922|448286818|FG002|Treatment Period|Physician Decision|0|||
124636810|NCT02677922|448286819|FG003|Treatment Period|Physician Decision|0|||
124636811|NCT02677922|448286820|FG004|Treatment Period|Physician Decision|0|||
124636812|NCT02677922|448286821|FG005|Treatment Period|Physician Decision|1|||
124636813|NCT02677922|448286816|FG000|Treatment Period|Symptomatic Deterioration|0|||
124636814|NCT02677922|448286817|FG001|Treatment Period|Symptomatic Deterioration|0|||
124815694|NCT02099708|448954769|FG000|Overall Study|Lost to Follow-up|141|||
124815695|NCT02099708|448954769|FG000|Overall Study|Other|29|||
124815696|NCT05466682|448954773|FG000|Overall Study|Withdrawal by Subject|0|||
124815697|NCT05466682|448954774|FG001|Overall Study|Withdrawal by Subject|2|||
124815698|NCT05466682|448954773|FG000|Overall Study|Lost to Follow-up|2|||
124815699|NCT05466682|448954774|FG001|Overall Study|Lost to Follow-up|1|||
124815700|NCT01930123|448954775|FG000|Overall Study|Adverse Event|1|||
124815701|NCT01930123|448954776|FG001|Overall Study|Adverse Event|0|||
124815702|NCT01930123|448954775|FG000|Overall Study|Physician Decision|21|||
124815703|NCT01930123|448954776|FG001|Overall Study|Physician Decision|8|||
124815704|NCT01930123|448954775|FG000|Overall Study|Withdrawal by Subject|1|||
124815705|NCT01930123|448954776|FG001|Overall Study|Withdrawal by Subject|0|||
124815706|NCT01447433|448954779|FG000|Overall Study|Lost to Follow-up|0|||
124815707|NCT01447433|448954780|FG001|Overall Study|Lost to Follow-up|2|||
124815708|NCT01447433|448954779|FG000|Overall Study|Withdrawal by Subject|3|||
124815709|NCT01447433|448954780|FG001|Overall Study|Withdrawal by Subject|3|||
124815710|NCT01447433|448954779|FG000|Overall Study|Protocol Violation|1|||
124815711|NCT01447433|448954780|FG001|Overall Study|Protocol Violation|1|||
124815712|NCT00036270|448954781|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
124815713|NCT00036270|448954782|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
124815714|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
124636815|NCT02677922|448286818|FG002|Treatment Period|Symptomatic Deterioration|0|||
124636816|NCT02677922|448286819|FG003|Treatment Period|Symptomatic Deterioration|0|||
124636817|NCT02677922|448286820|FG004|Treatment Period|Symptomatic Deterioration|1|||
124636818|NCT02677922|448286821|FG005|Treatment Period|Symptomatic Deterioration|0|||
124636819|NCT03926117|448286834|FG000|Overall Study|Unclassified|1|||
124636820|NCT03926117|448286835|FG001|Overall Study|Unclassified|4|||
124636821|NCT03926117|448286836|FG002|Overall Study|Unclassified|1|||
124815715|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
124815716|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
124815717|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
124815718|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
124815719|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
124815720|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Other|277|||
124815721|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Other|288|||
124815722|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
124815723|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
124815724|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
124815725|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
124819587|NCT00420927|448965767|FG006|Period 1|Lost to Follow-up|0|||
124636822|NCT03926117|448286837|FG003|Overall Study|Unclassified|4|||
124815726|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
124815727|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
124815728|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
124815729|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
124815730|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
124815731|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
124815732|NCT00036270|448954781|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
124815733|NCT00036270|448954782|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
124815734|NCT01578187|448954783|FG000|Usability Phase|Withdrawal by Subject|1|||
124815735|NCT01964430|448954784|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
124815736|NCT01964430|448954785|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
124815737|NCT01964430|448954784|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
124636823|NCT03926117|448286834|FG000|Overall Study|Withdrawal by Subject|3|||
124636824|NCT03926117|448286835|FG001|Overall Study|Withdrawal by Subject|0|||
124636825|NCT03926117|448286836|FG002|Overall Study|Withdrawal by Subject|1|||
124636826|NCT03926117|448286837|FG003|Overall Study|Withdrawal by Subject|1|||
124636827|NCT03926117|448286834|FG000|Overall Study|Lost to Follow-up|0|||
124636828|NCT03926117|448286835|FG001|Overall Study|Lost to Follow-up|2|||
124636829|NCT03926117|448286836|FG002|Overall Study|Lost to Follow-up|1|||
124636830|NCT03926117|448286837|FG003|Overall Study|Lost to Follow-up|0|||
124636831|NCT03926117|448286834|FG000|Overall Study|Adverse Event|1|||
124815738|NCT01964430|448954785|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
124815739|NCT01964430|448954784|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
124815740|NCT01964430|448954785|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
124815741|NCT01964430|448954784|FG000|Treatment Period|Adverse Event|71|||
124815742|NCT01964430|448954785|FG001|Treatment Period|Adverse Event|37|||
124815743|NCT01964430|448954784|FG000|Treatment Period|Withdrawal by Subject|36|||
124815744|NCT01964430|448954785|FG001|Treatment Period|Withdrawal by Subject|27|||
124815745|NCT01964430|448954784|FG000|Treatment Period|Death|1|||
124815746|NCT01964430|448954785|FG001|Treatment Period|Death|3|||
124815747|NCT01964430|448954784|FG000|Treatment Period|Protocol Deviation|0|||
124815748|NCT01964430|448954785|FG001|Treatment Period|Protocol Deviation|1|||
124815749|NCT01964430|448954784|FG000|Treatment Period|Physician Decision|5|||
124815750|NCT01964430|448954785|FG001|Treatment Period|Physician Decision|4|||
124815751|NCT01964430|448954784|FG000|Treatment Period|Disease Relapse|28|||
124636832|NCT03926117|448286835|FG001|Overall Study|Adverse Event|2|||
124636833|NCT03926117|448286836|FG002|Overall Study|Adverse Event|3|||
124636834|NCT03926117|448286837|FG003|Overall Study|Adverse Event|1|||
124636835|NCT03926117|448286834|FG000|Overall Study|Randomized but not treated|1|||
124636836|NCT03926117|448286835|FG001|Overall Study|Randomized but not treated|1|||
124636837|NCT03926117|448286836|FG002|Overall Study|Randomized but not treated|0|||
124636838|NCT03926117|448286837|FG003|Overall Study|Randomized but not treated|1|||
124636839|NCT02748356|448286838|FG000|Overall Study|Withdrawal by Subject|1|||
124636840|NCT00996125|448286839|FG000|Overall Study|Adverse Event|0|||
124636841|NCT00996125|448286840|FG001|Overall Study|Adverse Event|2|||
124636842|NCT00996125|448286839|FG000|Overall Study|Lost to Follow-up|1|||
124636843|NCT00996125|448286840|FG001|Overall Study|Lost to Follow-up|6|||
124636844|NCT00996125|448286839|FG000|Overall Study|Withdrawal by Subject|4|||
124636845|NCT00996125|448286840|FG001|Overall Study|Withdrawal by Subject|3|||
124636846|NCT03515811|448286841|FG000|Overall Study|Lost to Follow-up|2|||
124636847|NCT03515811|448286842|FG001|Overall Study|Lost to Follow-up|1|||
124636848|NCT03515811|448286841|FG000|Overall Study|Protocol Violation|1|||
124636849|NCT03515811|448286842|FG001|Overall Study|Protocol Violation|1|||
124636850|NCT03515811|448286841|FG000|Overall Study|Death|1|||
124636851|NCT03515811|448286842|FG001|Overall Study|Death|1|||
124636852|NCT03515811|448286841|FG000|Overall Study|Withdrawal by Subject|0|||
124636853|NCT03515811|448286842|FG001|Overall Study|Withdrawal by Subject|2|||
124636854|NCT03515811|448286841|FG000|Overall Study|Technical Problems|1|||
124636855|NCT03515811|448286842|FG001|Overall Study|Technical Problems|0|||
124636856|NCT03515811|448286841|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
124636857|NCT03515811|448286842|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
124636858|NCT03515811|448286841|FG000|Overall Study|COVID-19|0|||
124636859|NCT03515811|448286842|FG001|Overall Study|COVID-19|1|||
124636860|NCT00237458|448286843|FG000|Overall Study|Lack of Efficacy|1|||
124636861|NCT00237458|448286843|FG000|Overall Study|Adverse Event|1|||
124636862|NCT00237458|448286843|FG000|Overall Study|Withdrawal by Subject|1|||
124636863|NCT01796392|448286848|FG000|Overall Study|Withdrawal by Subject|2|||
124636864|NCT01796392|448286849|FG001|Overall Study|Withdrawal by Subject|0|||
124815752|NCT01964430|448954785|FG001|Treatment Period|Disease Relapse|38|||
124815753|NCT01964430|448954784|FG000|Treatment Period|Other reasons|1|||
124815754|NCT01964430|448954785|FG001|Treatment Period|Other reasons|3|||
124636865|NCT01796392|448286848|FG000|Overall Study|Death|5|||
124636866|NCT01796392|448286849|FG001|Overall Study|Death|1|||
124636867|NCT01796392|448286848|FG000|Overall Study|Excluded for medical reasons|1|||
124636868|NCT01796392|448286849|FG001|Overall Study|Excluded for medical reasons|2|||
124636869|NCT01796392|448286848|FG000|Overall Study|Lost to Follow-up|1|||
124636870|NCT01796392|448286849|FG001|Overall Study|Lost to Follow-up|0|||
124636871|NCT03517540|448286854|FG000|Overall Study|Protocol Violation|2|||
124636872|NCT03517540|448286855|FG001|Overall Study|Protocol Violation|0|||
124636873|NCT03517540|448286856|FG002|Overall Study|Protocol Violation|0|||
124636874|NCT03517540|448286857|FG003|Overall Study|Protocol Violation|1|||
124636875|NCT03517540|448286854|FG000|Overall Study|Adverse Event|9|||
124636876|NCT03517540|448286855|FG001|Overall Study|Adverse Event|3|||
124636877|NCT03517540|448286856|FG002|Overall Study|Adverse Event|8|||
124636878|NCT03517540|448286857|FG003|Overall Study|Adverse Event|1|||
124636879|NCT03517540|448286854|FG000|Overall Study|Withdrawal by Subject|3|||
124636880|NCT03517540|448286855|FG001|Overall Study|Withdrawal by Subject|4|||
124636881|NCT03517540|448286856|FG002|Overall Study|Withdrawal by Subject|1|||
124636882|NCT03517540|448286857|FG003|Overall Study|Withdrawal by Subject|3|||
124636883|NCT01777282|448286858|FG000|Overall Study|Persistent Hyperglycemia|0|||
124636884|NCT01777282|448286859|FG001|Overall Study|Persistent Hyperglycemia|0|||
124636885|NCT01777282|448286860|FG002|Overall Study|Persistent Hyperglycemia|1|||
124636886|NCT01777282|448286861|FG003|Overall Study|Persistent Hyperglycemia|0|||
124636887|NCT01777282|448286862|FG004|Overall Study|Persistent Hyperglycemia|0|||
124636888|NCT01777282|448286858|FG000|Overall Study|New Antidiabetic Medication|0|||
124636889|NCT01777282|448286859|FG001|Overall Study|New Antidiabetic Medication|0|||
124636890|NCT01777282|448286860|FG002|Overall Study|New Antidiabetic Medication|1|||
124636891|NCT01777282|448286861|FG003|Overall Study|New Antidiabetic Medication|0|||
124636892|NCT01777282|448286862|FG004|Overall Study|New Antidiabetic Medication|0|||
124636893|NCT01777282|448286858|FG000|Overall Study|Adverse Event|4|||
124636894|NCT01777282|448286859|FG001|Overall Study|Adverse Event|4|||
124636895|NCT01777282|448286860|FG002|Overall Study|Adverse Event|2|||
124636896|NCT01777282|448286861|FG003|Overall Study|Adverse Event|1|||
124636897|NCT01777282|448286862|FG004|Overall Study|Adverse Event|3|||
124636898|NCT01777282|448286858|FG000|Overall Study|Withdrawal by Subject|4|||
124636899|NCT01777282|448286859|FG001|Overall Study|Withdrawal by Subject|0|||
124636900|NCT01777282|448286860|FG002|Overall Study|Withdrawal by Subject|0|||
124636901|NCT01777282|448286861|FG003|Overall Study|Withdrawal by Subject|1|||
124636902|NCT01777282|448286862|FG004|Overall Study|Withdrawal by Subject|2|||
124636903|NCT01777282|448286858|FG000|Overall Study|Protocol Violation|2|||
124815755|NCT02516163|448954786|FG000|Overall Study|Withdrawal by Subject|1|||
124636904|NCT01777282|448286859|FG001|Overall Study|Protocol Violation|0|||
124636905|NCT01777282|448286860|FG002|Overall Study|Protocol Violation|1|||
124636906|NCT01777282|448286861|FG003|Overall Study|Protocol Violation|0|||
124636907|NCT01777282|448286862|FG004|Overall Study|Protocol Violation|2|||
124636908|NCT01777282|448286858|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
124636909|NCT01777282|448286859|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
124636910|NCT01777282|448286860|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
124636911|NCT01777282|448286861|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
124636912|NCT01777282|448286862|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
124636913|NCT05336227|448288578|FG000|Overall Study|Adverse Event|1|||
124636914|NCT05336227|448288579|FG001|Overall Study|Adverse Event|0|||
124636915|NCT05336227|448288578|FG000|Overall Study|Lost to Follow-up|2|||
124636916|NCT05336227|448288579|FG001|Overall Study|Lost to Follow-up|0|||
124636917|NCT05336227|448288578|FG000|Overall Study|Withdrawal by Subject|1|||
124636918|NCT05336227|448288579|FG001|Overall Study|Withdrawal by Subject|0|||
124636919|NCT01068678|448288582|FG000|Overall Study|Lack of Efficacy|3|||
124815756|NCT02516163|448954786|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
124815757|NCT02516163|448954786|FG000|Overall Study|Unfit/delay in surgery|3|||
124815758|NCT02516163|448954786|FG000|Overall Study|Use of incorrect measurement technique|5|||
124636920|NCT01068678|448288583|FG001|Overall Study|Lack of Efficacy|2|||
124636921|NCT01068678|448288582|FG000|Overall Study|Protocol Violation|5|||
124636922|NCT01068678|448288583|FG001|Overall Study|Protocol Violation|1|||
124636923|NCT01068678|448288582|FG000|Overall Study|Withdrawal criteria|12|||
124636924|NCT01068678|448288583|FG001|Overall Study|Withdrawal criteria|6|||
124636925|NCT01068678|448288582|FG000|Overall Study|Unclassified|18|||
124636926|NCT01068678|448288583|FG001|Overall Study|Unclassified|15|||
124636927|NCT00347958|448288584|FG000|Overall Study|Adverse Event|1|||
124636928|NCT00347958|448288584|FG000|Overall Study|Protocol Violation|2|||
124636929|NCT00347958|448288584|FG000|Overall Study|Withdrawal by Subject|1|||
124636930|NCT00754234|448288585|FG000|Overall Study|Withdrawal by Subject|3|||
124636931|NCT00975611|448288586|FG000|Overall Study|Screen Fail|16|||
124815759|NCT02516163|448954786|FG000|Overall Study|Data not recorded|2|||
124636932|NCT00975611|448288586|FG000|Overall Study|Physician Decision|1|||
124636933|NCT01682226|448288587|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
124636934|NCT01682226|448288587|FG000|Overall Study|Participants did not receive treatment|2|||
124636935|NCT01682226|448288587|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
124636936|NCT03503370|448288588|FG000|Overall Study|Death|3|||
124636937|NCT03503370|448288589|FG001|Overall Study|Death|1|||
124636938|NCT00298272|448288590|FG000|Double-blind Phase|Adverse Event|2|||
124636939|NCT00298272|448288591|FG001|Double-blind Phase|Adverse Event|0|||
124636940|NCT00298272|448288590|FG000|Double-blind Phase|Failure to Return|2|||
124636941|NCT00298272|448288591|FG001|Double-blind Phase|Failure to Return|0|||
124636942|NCT00298272|448288590|FG000|Double-blind Phase|Protocol Violation|2|||
124636943|NCT00298272|448288591|FG001|Double-blind Phase|Protocol Violation|0|||
124636944|NCT00298272|448288590|FG000|Double-blind Phase|Withdrawal by Subject|2|||
124636945|NCT00298272|448288591|FG001|Double-blind Phase|Withdrawal by Subject|0|||
124636946|NCT00298272|448288590|FG000|Open Label Retreatment Phase|Adverse Event|1|||
124636947|NCT00298272|448288591|FG001|Open Label Retreatment Phase|Adverse Event|2|||
124636948|NCT00298272|448288590|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
124636949|NCT00298272|448288591|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
124815760|NCT02516163|448954786|FG000|Overall Study|MRI contraindication exclusion|6|||
124815761|NCT02801396|448954787|FG000|Period 1|Withdrawal by Subject|0|||
124815762|NCT02801396|448954788|FG001|Period 1|Withdrawal by Subject|0|||
124815763|NCT02801396|448954789|FG002|Period 1|Withdrawal by Subject|0|||
124815764|NCT02801396|448954790|FG003|Period 1|Withdrawal by Subject|0|||
124815765|NCT02801396|448954791|FG004|Period 1|Withdrawal by Subject|1|||
124636950|NCT00298272|448288590|FG000|Open Label Retreatment Phase|Failure to Return|1|||
124636951|NCT00298272|448288591|FG001|Open Label Retreatment Phase|Failure to Return|0|||
124636952|NCT00298272|448288590|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
124636953|NCT00298272|448288591|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
124636954|NCT00298272|448288590|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
124636955|NCT00298272|448288591|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
124636956|NCT00298272|448288590|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
124636957|NCT00298272|448288591|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
124815766|NCT02801396|448954792|FG005|Period 1|Withdrawal by Subject|0|||
124815767|NCT01658072|448954795|FG000|Overall Study|Protocol Violation|4|||
124815768|NCT01658072|448954796|FG001|Overall Study|Protocol Violation|2|||
124815769|NCT03208244|448954797|FG000|Overall Study|Death|1|||
124815770|NCT00602797|448954805|FG000|Overall Study|Adverse Event|1|||
124815771|NCT01318993|448954813|FG000|Overall Study|Adverse Event|53|||
124636958|NCT00298272|448288590|FG000|Safety Follow-up Phase|Failure to Return|1|||
124636959|NCT00298272|448288591|FG001|Safety Follow-up Phase|Failure to Return|1|||
124636960|NCT00298272|448288590|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
124636961|NCT00298272|448288591|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
124636962|NCT00298272|448288590|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
124636963|NCT00298272|448288591|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
124636964|NCT04168112|448288592|FG000|Overall Study|Lost to Follow-up|1|||
124636965|NCT04168112|448288593|FG001|Overall Study|Lost to Follow-up|0|||
124636966|NCT04168112|448288592|FG000|Overall Study|Withdrawal by Subject|1|||
124636967|NCT04168112|448288593|FG001|Overall Study|Withdrawal by Subject|0|||
124636968|NCT01344824|448288596|FG000|Overall Study|Adverse Event|15|||
124636969|NCT01344824|448288596|FG000|Overall Study|Withdrawal by Subject|6|||
124636970|NCT01344824|448288596|FG000|Overall Study|Other complicating disease|1|||
124636971|NCT01344824|448288596|FG000|Overall Study|Progression|15|||
124636972|NCT01436370|448288605|FG000|Overall Study|Lost to Follow-up|0|||
124636973|NCT01436370|448288606|FG001|Overall Study|Lost to Follow-up|0|||
124636974|NCT01436370|448288607|FG002|Overall Study|Lost to Follow-up|0|||
124815772|NCT01318993|448954813|FG000|Overall Study|Lack of Efficacy|121|||
124815773|NCT01318993|448954813|FG000|Overall Study|Protocol Violation|3|||
124815774|NCT01318993|448954813|FG000|Overall Study|Protocol based stopping criteria|6|||
124815775|NCT01318993|448954813|FG000|Overall Study|Study closed or terminated|174|||
124815776|NCT01318993|448954813|FG000|Overall Study|Lost to Follow-up|4|||
124815777|NCT01318993|448954813|FG000|Overall Study|Physician Decision|13|||
124815778|NCT01318993|448954813|FG000|Overall Study|Withdrawal by Subject|24|||
124815779|NCT00361569|448954814|FG000|Overall Study|Protocol Violation|3|||
124815780|NCT00361569|448954815|FG001|Overall Study|Protocol Violation|2|||
124815781|NCT00361569|448954816|FG002|Overall Study|Protocol Violation|4|||
124815782|NCT00361569|448954817|FG003|Overall Study|Protocol Violation|2|||
124636975|NCT01436370|448288608|FG003|Overall Study|Lost to Follow-up|0|||
124636976|NCT01436370|448288609|FG004|Overall Study|Lost to Follow-up|1|||
124636977|NCT01436370|448288610|FG005|Overall Study|Lost to Follow-up|0|||
124636978|NCT01436370|448288611|FG006|Overall Study|Lost to Follow-up|0|||
124636979|NCT01436370|448288612|FG007|Overall Study|Lost to Follow-up|0|||
124636980|NCT02395848|448288613|FG000|Overall Study|Lost to Follow-up|2|||
124636981|NCT01754129|448288614|FG000|Overall Study|Death|13|||
124636982|NCT01754129|448288614|FG000|Overall Study|Duodopa discontinuation|9|||
124636983|NCT01754129|448288614|FG000|Overall Study|Lost to Follow-up|7|||
124636984|NCT01754129|448288614|FG000|Overall Study|Withdrew consent|1|||
124636985|NCT01754129|448288614|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
124815783|NCT00361569|448954814|FG000|Overall Study|Withdrawal by Subject|2|||
124815784|NCT00361569|448954815|FG001|Overall Study|Withdrawal by Subject|1|||
124815785|NCT00361569|448954816|FG002|Overall Study|Withdrawal by Subject|9|||
124815786|NCT00361569|448954817|FG003|Overall Study|Withdrawal by Subject|14|||
124815787|NCT00361569|448954814|FG000|Overall Study|Adverse Event|3|||
124815788|NCT00361569|448954815|FG001|Overall Study|Adverse Event|5|||
124815789|NCT00361569|448954816|FG002|Overall Study|Adverse Event|2|||
124815790|NCT00361569|448954817|FG003|Overall Study|Adverse Event|2|||
124815791|NCT00361569|448954814|FG000|Overall Study|Lost to Follow-up|2|||
124815792|NCT00361569|448954815|FG001|Overall Study|Lost to Follow-up|3|||
124815793|NCT00361569|448954816|FG002|Overall Study|Lost to Follow-up|3|||
124815794|NCT00361569|448954817|FG003|Overall Study|Lost to Follow-up|2|||
124815795|NCT00361569|448954814|FG000|Overall Study|Not specified by investigator|2|||
124815796|NCT00361569|448954815|FG001|Overall Study|Not specified by investigator|0|||
124815797|NCT00361569|448954816|FG002|Overall Study|Not specified by investigator|0|||
124815798|NCT00361569|448954817|FG003|Overall Study|Not specified by investigator|1|||
124815799|NCT01558271|448954818|FG000|Overall Study|Adverse Event|6|||
124815800|NCT01558271|448954819|FG001|Overall Study|Adverse Event|3|||
124815801|NCT01558271|448954820|FG002|Overall Study|Adverse Event|4|||
124815802|NCT01558271|448954818|FG000|Overall Study|Lost to Follow-up|1|||
124815803|NCT01558271|448954819|FG001|Overall Study|Lost to Follow-up|0|||
124815804|NCT01558271|448954820|FG002|Overall Study|Lost to Follow-up|0|||
124815805|NCT01558271|448954818|FG000|Overall Study|Protocol Violation|1|||
124815806|NCT01558271|448954819|FG001|Overall Study|Protocol Violation|0|||
124815807|NCT01558271|448954820|FG002|Overall Study|Protocol Violation|0|||
124636986|NCT02058537|448288615|FG000|Overall Study|Withdrawal by Subject|1|||
124636987|NCT02126579|448288616|FG000|Overall Study|disease progression|0|||
124636988|NCT02126579|448288617|FG001|Overall Study|disease progression|0|||
124636989|NCT02126579|448288618|FG002|Overall Study|disease progression|0|||
124636990|NCT02126579|448288619|FG003|Overall Study|disease progression|1|||
124636991|NCT02126579|448288620|FG004|Overall Study|disease progression|0|||
124636992|NCT02126579|448288621|FG005|Overall Study|disease progression|0|||
124636993|NCT02126579|448288622|FG006|Overall Study|disease progression|1|||
124636994|NCT01780038|448288626|FG000|Overall Study|Lost to Follow-up|4|||
124636995|NCT01780038|448288627|FG001|Overall Study|Lost to Follow-up|1|||
124636996|NCT01085630|448288628|FG000|Overall Study|Insufficient data|1|||
124636997|NCT01085630|448288629|FG001|Overall Study|Insufficient data|0|||
124636998|NCT01085630|448288628|FG000|Overall Study|Ineligible|3|||
124636999|NCT01085630|448288629|FG001|Overall Study|Ineligible|0|||
124637000|NCT02609607|448288635|FG000|Overall Study|Lost to Follow-up|0|||
124637001|NCT02609607|448288636|FG001|Overall Study|Lost to Follow-up|1|||
124637002|NCT00651261|448288637|FG000|Overall Study|Adverse Event|32|||
124637003|NCT00651261|448288638|FG001|Overall Study|Adverse Event|22|||
124637004|NCT00651261|448288637|FG000|Overall Study|Death|18|||
124637005|NCT00651261|448288638|FG001|Overall Study|Death|18|||
124637006|NCT00651261|448288637|FG000|Overall Study|Withdrawal by Subject|22|||
124637007|NCT00651261|448288638|FG001|Overall Study|Withdrawal by Subject|40|||
124637008|NCT00651261|448288637|FG000|Overall Study|Induction failure|24|||
124637009|NCT00651261|448288638|FG001|Overall Study|Induction failure|35|||
124637010|NCT00651261|448288637|FG000|Overall Study|Disease progression|58|||
124637011|NCT00651261|448288638|FG001|Overall Study|Disease progression|58|||
124637012|NCT00651261|448288637|FG000|Overall Study|Alternative therapy|109|||
124637013|NCT00651261|448288638|FG001|Overall Study|Alternative therapy|107|||
124637014|NCT00651261|448288637|FG000|Overall Study|Other disease or participant decisions|23|||
124637015|NCT00651261|448288638|FG001|Overall Study|Other disease or participant decisions|23|||
124637016|NCT00651261|448288637|FG000|Overall Study|Never treated|5|||
124637017|NCT00651261|448288638|FG001|Overall Study|Never treated|3|||
124637018|NCT00687271|448288639|FG000|Overall Study|Adverse Event|1|||
124637019|NCT00687271|448288640|FG001|Overall Study|Adverse Event|3|||
124637020|NCT00687271|448288641|FG002|Overall Study|Adverse Event|1|||
124637021|NCT00687271|448288642|FG003|Overall Study|Adverse Event|0|||
124637022|NCT00687271|448288639|FG000|Overall Study|Lost to Follow-up|0|||
124637023|NCT00687271|448288640|FG001|Overall Study|Lost to Follow-up|1|||
124637024|NCT00687271|448288641|FG002|Overall Study|Lost to Follow-up|0|||
124637025|NCT00687271|448288642|FG003|Overall Study|Lost to Follow-up|0|||
124637026|NCT00687271|448288639|FG000|Overall Study|Protocol Violation|2|||
124637027|NCT00687271|448288640|FG001|Overall Study|Protocol Violation|1|||
124637028|NCT00687271|448288641|FG002|Overall Study|Protocol Violation|1|||
124637029|NCT00687271|448288642|FG003|Overall Study|Protocol Violation|0|||
124637030|NCT00687271|448288639|FG000|Overall Study|Withdrawal by Subject|0|||
124637031|NCT00687271|448288640|FG001|Overall Study|Withdrawal by Subject|1|||
124637032|NCT00687271|448288641|FG002|Overall Study|Withdrawal by Subject|3|||
124815808|NCT01558271|448954818|FG000|Overall Study|Withdrawal by Subject|10|||
124815809|NCT01558271|448954819|FG001|Overall Study|Withdrawal by Subject|6|||
124815810|NCT01558271|448954820|FG002|Overall Study|Withdrawal by Subject|12|||
124815811|NCT01558271|448954818|FG000|Overall Study|Physician Decision|0|||
124637033|NCT00687271|448288642|FG003|Overall Study|Withdrawal by Subject|0|||
124637034|NCT01134107|448288643|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
124815812|NCT01558271|448954819|FG001|Overall Study|Physician Decision|2|||
124815813|NCT01558271|448954820|FG002|Overall Study|Physician Decision|1|||
124815814|NCT01594762|448954821|FG000|Overall Study|Withdrawal by Subject|1|||
124815815|NCT01594762|448954822|FG001|Overall Study|Withdrawal by Subject|0|||
124637035|NCT01134107|448288644|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
124637036|NCT01134107|448288643|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
124637037|NCT01134107|448288644|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
124637038|NCT01134107|448288643|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
124637039|NCT01134107|448288644|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
124637040|NCT01134107|448288643|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
124637041|NCT01134107|448288644|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
124637042|NCT01134107|448288643|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
124637043|NCT01134107|448288644|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
124637044|NCT01134107|448288643|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
124637045|NCT01134107|448288644|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
124637046|NCT01134107|448288643|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
124637047|NCT01134107|448288644|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
124637048|NCT03656692|448288645|FG000|Overall Study|Worsening of disease activity|2|||
124637049|NCT03656692|448288645|FG000|Overall Study|Physician Decision|1|||
124637050|NCT05483686|448288652|FG000|Overall Study|Lost to Follow-up|5|||
124637051|NCT05483686|448288653|FG001|Overall Study|Lost to Follow-up|7|||
124637052|NCT03351608|448288662|FG000|Overall Study|Lost to Follow-up|0|||
124637053|NCT03351608|448288663|FG001|Overall Study|Lost to Follow-up|1|||
124637054|NCT03351608|448288664|FG002|Overall Study|Lost to Follow-up|1|||
124637055|NCT03351608|448288665|FG003|Overall Study|Lost to Follow-up|1|||
124637056|NCT03351608|448288666|FG004|Overall Study|Lost to Follow-up|1|||
124637057|NCT03351608|448288662|FG000|Overall Study|Physician Decision|1|||
124637058|NCT03351608|448288663|FG001|Overall Study|Physician Decision|0|||
124637059|NCT03351608|448288664|FG002|Overall Study|Physician Decision|0|||
124637060|NCT03351608|448288665|FG003|Overall Study|Physician Decision|2|||
124637061|NCT03351608|448288666|FG004|Overall Study|Physician Decision|1|||
124637062|NCT03351608|448288662|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
124637063|NCT03351608|448288663|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
124637064|NCT03351608|448288664|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
124637065|NCT03351608|448288665|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
124637066|NCT03351608|448288666|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
124637067|NCT03351608|448288662|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124637068|NCT03351608|448288663|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124637069|NCT03351608|448288664|FG002|Overall Study|Withdrawal by parent/guardian|1|||
124637070|NCT03351608|448288665|FG003|Overall Study|Withdrawal by parent/guardian|1|||
124637071|NCT03351608|448288666|FG004|Overall Study|Withdrawal by parent/guardian|0|||
124637072|NCT03351608|448288662|FG000|Overall Study|Other|0|||
124637073|NCT03351608|448288663|FG001|Overall Study|Other|1|||
124637074|NCT03351608|448288664|FG002|Overall Study|Other|1|||
124637075|NCT03351608|448288665|FG003|Overall Study|Other|3|||
124637076|NCT03351608|448288666|FG004|Overall Study|Other|0|||
124637077|NCT02877004|448288667|FG000|Overall Study|Pregnancy|0|||
124637078|NCT02877004|448288668|FG001|Overall Study|Pregnancy|0|||
124637079|NCT02877004|448288669|FG002|Overall Study|Pregnancy|1|||
124637080|NCT02727478|448288670|FG000|Overall Study|Withdrawal by Subject|8|||
124637081|NCT02727478|448288671|FG001|Overall Study|Withdrawal by Subject|10|||
124637082|NCT02633293|448288672|FG000|Overall Study|Death|56|||
124637083|NCT02633293|448288672|FG000|Overall Study|Progressive Disease|12|||
124637084|NCT02633293|448288672|FG000|Overall Study|Adverse Event|29|||
124637085|NCT02633293|448288672|FG000|Overall Study|Withdrawal by Subject|41|||
124637086|NCT02633293|448288672|FG000|Overall Study|Protocol Violation|1|||
124637087|NCT02633293|448288672|FG000|Overall Study|Lost to Follow-up|1|||
124637088|NCT02633293|448288672|FG000|Overall Study|Study Terminated by Sponsor|24|||
124637089|NCT02633293|448288672|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
124637090|NCT02633293|448288672|FG000|Overall Study|Lung Transplant|5|||
124637091|NCT02633293|448288672|FG000|Overall Study|Lack of Efficacy|2|||
124637092|NCT02633293|448288672|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
124637093|NCT03877068|448288673|FG000|Overall Study|Physician Decision|9|||
124637094|NCT03877068|448288674|FG001|Overall Study|Physician Decision|3|||
124637095|NCT00778817|448288675|FG000|Overall Study|Adverse Event|2|||
124637096|NCT00778817|448288675|FG000|Overall Study|Withdrawal by Subject|2|||
124637097|NCT01418378|448288676|FG000|Overall Study|Death|1|||
124637098|NCT01418378|448288677|FG001|Overall Study|Death|2|||
124637099|NCT01418378|448288676|FG000|Overall Study|Physician Decision|0|||
124637100|NCT01418378|448288677|FG001|Overall Study|Physician Decision|1|||
124637101|NCT01418378|448288676|FG000|Overall Study|ligament imbalance|0|||
124637102|NCT01418378|448288677|FG001|Overall Study|ligament imbalance|1|||
124637103|NCT01418378|448288676|FG000|Overall Study|developed chronic myopathy|0|||
124637104|NCT01418378|448288677|FG001|Overall Study|developed chronic myopathy|1|||
124637105|NCT00288626|448288679|FG000|Overall Study|Death|3|||
124637106|NCT00288626|448288679|FG000|Overall Study|Withdrawal by Subject|4|||
124637107|NCT02187198|448288692|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
124637108|NCT02187198|448288693|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
124637109|NCT02187198|448288692|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
124815816|NCT01594762|448954821|FG000|Overall Study|Lost to Follow-up|10|||
124637110|NCT02187198|448288693|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
124637111|NCT00546377|448288694|FG000|Overall Study|Deemed ineligible|1|||
124637112|NCT00546377|448288694|FG000|Overall Study|Adverse Event|6|||
124637113|NCT01964222|448288697|FG000|Overall Study|Lost to Follow-up|7|||
124637114|NCT01964222|448288698|FG001|Overall Study|Lost to Follow-up|5|||
124637115|NCT01964222|448288697|FG000|Overall Study|Withdrawal by Subject|6|||
124637116|NCT01964222|448288698|FG001|Overall Study|Withdrawal by Subject|6|||
124637117|NCT01964222|448288697|FG000|Overall Study|Screening Failure|2|||
124637118|NCT01964222|448288698|FG001|Overall Study|Screening Failure|0|||
124637119|NCT01737710|448288704|FG000|Overall Study|Lost to Follow-up|0|||
124637120|NCT01737710|448288705|FG001|Overall Study|Lost to Follow-up|2|||
124637121|NCT01737710|448288706|FG002|Overall Study|Lost to Follow-up|2|||
124637122|NCT01737710|448288707|FG003|Overall Study|Lost to Follow-up|0|||
124637123|NCT01737710|448288708|FG004|Overall Study|Lost to Follow-up|0|||
124637124|NCT01737710|448288704|FG000|Overall Study|Withdrawal by Subject|1|||
124637125|NCT01737710|448288705|FG001|Overall Study|Withdrawal by Subject|1|||
124637126|NCT01737710|448288706|FG002|Overall Study|Withdrawal by Subject|1|||
124637127|NCT01737710|448288707|FG003|Overall Study|Withdrawal by Subject|0|||
124637128|NCT01737710|448288708|FG004|Overall Study|Withdrawal by Subject|0|||
124637129|NCT01737710|448288704|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
124637130|NCT01737710|448288705|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
124637131|NCT01737710|448288706|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
124637132|NCT01737710|448288707|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
124815817|NCT01594762|448954822|FG001|Overall Study|Lost to Follow-up|10|||
124815818|NCT03547583|448954823|FG000|Overall Study|Adverse Event|16|||
124815819|NCT03547583|448954824|FG001|Overall Study|Adverse Event|11|||
124815820|NCT03547583|448954825|FG002|Overall Study|Adverse Event|10|||
124815821|NCT03547583|448954823|FG000|Overall Study|Death|11|||
124815822|NCT03547583|448954824|FG001|Overall Study|Death|7|||
124815823|NCT03547583|448954825|FG002|Overall Study|Death|4|||
124815824|NCT03547583|448954823|FG000|Overall Study|Lost to Follow-up|1|||
124815825|NCT03547583|448954824|FG001|Overall Study|Lost to Follow-up|0|||
124815826|NCT03547583|448954825|FG002|Overall Study|Lost to Follow-up|0|||
124815827|NCT03547583|448954823|FG000|Overall Study|Non-compliance with study drug|0|||
124815828|NCT03547583|448954824|FG001|Overall Study|Non-compliance with study drug|0|||
124815829|NCT03547583|448954825|FG002|Overall Study|Non-compliance with study drug|1|||
124815830|NCT03547583|448954823|FG000|Overall Study|Physician Decision|1|||
124815831|NCT03547583|448954824|FG001|Overall Study|Physician Decision|0|||
124815832|NCT03547583|448954825|FG002|Overall Study|Physician Decision|3|||
124815833|NCT03547583|448954823|FG000|Overall Study|Protocol Violation|2|||
124815834|NCT03547583|448954824|FG001|Overall Study|Protocol Violation|1|||
124815835|NCT03547583|448954825|FG002|Overall Study|Protocol Violation|1|||
124815836|NCT03547583|448954823|FG000|Overall Study|Withdrawal by Subject|12|||
124815837|NCT03547583|448954824|FG001|Overall Study|Withdrawal by Subject|19|||
124815838|NCT03547583|448954825|FG002|Overall Study|Withdrawal by Subject|10|||
124815839|NCT03547583|448954823|FG000|Overall Study|Other|2|||
124815840|NCT03547583|448954824|FG001|Overall Study|Other|2|||
124815841|NCT03547583|448954825|FG002|Overall Study|Other|3|||
124815842|NCT01235351|448956546|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
124815843|NCT01235351|448956547|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
124815844|NCT03003390|448956551|FG000|Overall Study|Physician Decision|2|||
124815845|NCT03003390|448956552|FG001|Overall Study|Physician Decision|0|||
124815846|NCT03003390|448956551|FG000|Overall Study|Parent refused intervention|2|||
124815847|NCT03003390|448956552|FG001|Overall Study|Parent refused intervention|0|||
124815848|NCT00307294|448956553|FG000|Overall Study|Withdrawal by Subject|1|||
124815849|NCT01664533|448956556|FG000|Overall Study|Death|42|||
124815850|NCT01664533|448956556|FG000|Overall Study|Lost to Follow-up|3|||
124815851|NCT01664533|448956556|FG000|Overall Study|Study termination|9|||
124815852|NCT01664533|448956556|FG000|Overall Study|Protocol Violation|3|||
124815853|NCT00290888|448956558|FG000|Overall Study|Physician Decision|3|||
124815854|NCT00290888|448956559|FG001|Overall Study|Physician Decision|1|||
124815855|NCT02370160|448956562|FG000|Overall Study|Death|3|||
124815856|NCT02370160|448956563|FG001|Overall Study|Death|4|||
124815857|NCT02370160|448956564|FG002|Overall Study|Death|1|||
124815858|NCT04487730|448956565|FG000|Overall Study|Withdrawal by Subject|3|||
124815859|NCT04487730|448956566|FG001|Overall Study|Withdrawal by Subject|1|||
124815860|NCT04487730|448956565|FG000|Overall Study|Lost to Follow-up|0|||
124815861|NCT04487730|448956566|FG001|Overall Study|Lost to Follow-up|1|||
124637133|NCT01737710|448288708|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
124637134|NCT03363776|448288709|FG000|Overall Study|Progressive disease|2|||
124637135|NCT03363776|448288710|FG001|Overall Study|Progressive disease|3|||
124637136|NCT03363776|448288711|FG002|Overall Study|Progressive disease|1|||
124815862|NCT04487730|448956565|FG000|Overall Study|Physician Decision|0|||
124815863|NCT04487730|448956566|FG001|Overall Study|Physician Decision|1|||
124637137|NCT03363776|448288709|FG000|Overall Study|Study drug toxicity|0|||
124815864|NCT01581931|448956567|FG000|Washout|Adverse Event|0|||
124815865|NCT01581931|448956568|FG001|Washout|Adverse Event|1|||
124815866|NCT03291808|448956573|FG000|Overall Study|Lost to Follow-up|6|||
124815867|NCT03291808|448956573|FG000|Overall Study|Research burden|4|||
124815868|NCT01892293|448956584|FG000|Overall Study|Apheresed but not treated|4|||
124815869|NCT03602482|448956589|FG000|Overall Study|Withdrawal by Subject|6|||
124815870|NCT03602482|448956590|FG001|Overall Study|Withdrawal by Subject|7|||
124815871|NCT03602482|448956591|FG002|Overall Study|Withdrawal by Subject|0|||
124815872|NCT03602482|448956592|FG003|Overall Study|Withdrawal by Subject|0|||
124815873|NCT02397278|448956593|FG000|Overall Study|Withdrawal by Subject|0|||
124815874|NCT02397278|448956594|FG001|Overall Study|Withdrawal by Subject|2|||
124815875|NCT02397278|448956593|FG000|Overall Study|Deemed ineligible following surgery|1|||
124815876|NCT02397278|448956594|FG001|Overall Study|Deemed ineligible following surgery|1|||
124815877|NCT02161731|448956595|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
124815878|NCT02161731|448956596|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
124815879|NCT02161731|448956595|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
124815880|NCT02161731|448956596|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
124815881|NCT01397084|448956601|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
124815882|NCT01397084|448956601|FG000|Overall Study|Protocol Violation|2|||
124815883|NCT01397084|448956601|FG000|Overall Study|Adverse Event|2|||
124815884|NCT01397084|448956601|FG000|Overall Study|Withdrawal by Subject|1|||
124815885|NCT01397084|448956601|FG000|Overall Study|Lost to Follow-up|1|||
124815886|NCT01397084|448956601|FG000|Overall Study|Used other proton pump inhibitor|1|||
124815887|NCT00618072|448956604|FG000|Overall Study|Lost to Follow-up|2|||
124815888|NCT00618072|448956605|FG001|Overall Study|Lost to Follow-up|0|||
124815889|NCT00618072|448956606|FG002|Overall Study|Lost to Follow-up|3|||
124815890|NCT00618072|448956604|FG000|Overall Study|Physician Decision|0|||
124815891|NCT00618072|448956605|FG001|Overall Study|Physician Decision|1|||
124815892|NCT00618072|448956606|FG002|Overall Study|Physician Decision|1|||
124815893|NCT00592384|448956607|FG000|Overall Study|Withdrawal by Subject|5|||
124815894|NCT00592384|448956608|FG001|Overall Study|Withdrawal by Subject|6|||
124815895|NCT02380677|448956612|FG000|Overall Study|Adverse Event|0|||
124815896|NCT02380677|448956613|FG001|Overall Study|Adverse Event|0|||
124815897|NCT02380677|448956614|FG002|Overall Study|Adverse Event|0|||
124815898|NCT02380677|448956615|FG003|Overall Study|Adverse Event|1|||
124815899|NCT02380677|448956616|FG004|Overall Study|Adverse Event|1|||
124815900|NCT02380677|448956617|FG005|Overall Study|Adverse Event|4|||
124815901|NCT02380677|448956618|FG006|Overall Study|Adverse Event|2|||
124815902|NCT02380677|448956619|FG007|Overall Study|Adverse Event|2|||
124815903|NCT02380677|448956620|FG008|Overall Study|Adverse Event|2|||
124815904|NCT02380677|448956621|FG009|Overall Study|Adverse Event|1|||
124815905|NCT02380677|448956622|FG010|Overall Study|Adverse Event|2|||
124815906|NCT02380677|448956623|FG011|Overall Study|Adverse Event|1|||
124815907|NCT02380677|448956612|FG000|Overall Study|Physician Decision|1|||
124815908|NCT02380677|448956613|FG001|Overall Study|Physician Decision|0|||
124815909|NCT02380677|448956614|FG002|Overall Study|Physician Decision|1|||
124815910|NCT02380677|448956615|FG003|Overall Study|Physician Decision|1|||
124815911|NCT02380677|448956616|FG004|Overall Study|Physician Decision|0|||
124815912|NCT02380677|448956617|FG005|Overall Study|Physician Decision|0|||
124815913|NCT02380677|448956618|FG006|Overall Study|Physician Decision|0|||
124815914|NCT02380677|448956619|FG007|Overall Study|Physician Decision|0|||
124815915|NCT02380677|448956620|FG008|Overall Study|Physician Decision|0|||
124815916|NCT02380677|448956621|FG009|Overall Study|Physician Decision|0|||
124815917|NCT02380677|448956622|FG010|Overall Study|Physician Decision|0|||
124815918|NCT02380677|448956623|FG011|Overall Study|Physician Decision|0|||
124815919|NCT02380677|448956612|FG000|Overall Study|Lack of Efficacy|0|||
124815920|NCT02380677|448956613|FG001|Overall Study|Lack of Efficacy|1|||
124815921|NCT02380677|448956614|FG002|Overall Study|Lack of Efficacy|2|||
124815922|NCT02380677|448956615|FG003|Overall Study|Lack of Efficacy|0|||
124815923|NCT02380677|448956616|FG004|Overall Study|Lack of Efficacy|4|||
124815924|NCT02380677|448956617|FG005|Overall Study|Lack of Efficacy|1|||
124815925|NCT02380677|448956618|FG006|Overall Study|Lack of Efficacy|1|||
124815926|NCT02380677|448956619|FG007|Overall Study|Lack of Efficacy|2|||
124815927|NCT02380677|448956620|FG008|Overall Study|Lack of Efficacy|2|||
124815928|NCT02380677|448956621|FG009|Overall Study|Lack of Efficacy|0|||
124815929|NCT02380677|448956622|FG010|Overall Study|Lack of Efficacy|2|||
124815930|NCT02380677|448956623|FG011|Overall Study|Lack of Efficacy|1|||
124815931|NCT02380677|448956612|FG000|Overall Study|Withdrawal by Subject|0|||
124815932|NCT02380677|448956613|FG001|Overall Study|Withdrawal by Subject|0|||
124815933|NCT02380677|448956614|FG002|Overall Study|Withdrawal by Subject|0|||
124815934|NCT02380677|448956615|FG003|Overall Study|Withdrawal by Subject|0|||
124815935|NCT02380677|448956616|FG004|Overall Study|Withdrawal by Subject|0|||
124815936|NCT02380677|448956617|FG005|Overall Study|Withdrawal by Subject|0|||
124815937|NCT02380677|448956618|FG006|Overall Study|Withdrawal by Subject|0|||
124815938|NCT02380677|448956619|FG007|Overall Study|Withdrawal by Subject|0|||
124815939|NCT02380677|448956620|FG008|Overall Study|Withdrawal by Subject|0|||
124815940|NCT02380677|448956621|FG009|Overall Study|Withdrawal by Subject|1|||
124815941|NCT02380677|448956622|FG010|Overall Study|Withdrawal by Subject|0|||
124815942|NCT02380677|448956623|FG011|Overall Study|Withdrawal by Subject|3|||
124815943|NCT02380677|448956612|FG000|Overall Study|Other|0|||
124815944|NCT02380677|448956613|FG001|Overall Study|Other|0|||
124815945|NCT02380677|448956614|FG002|Overall Study|Other|0|||
124815946|NCT02380677|448956615|FG003|Overall Study|Other|1|||
124815947|NCT02380677|448956616|FG004|Overall Study|Other|1|||
124815948|NCT02380677|448956617|FG005|Overall Study|Other|1|||
124815949|NCT02380677|448956618|FG006|Overall Study|Other|0|||
124815950|NCT02380677|448956619|FG007|Overall Study|Other|0|||
124815951|NCT02380677|448956620|FG008|Overall Study|Other|0|||
124815952|NCT02380677|448956621|FG009|Overall Study|Other|0|||
124815953|NCT02380677|448956622|FG010|Overall Study|Other|0|||
124815954|NCT02380677|448956623|FG011|Overall Study|Other|0|||
124815955|NCT04932096|448956624|FG000|Overall Study|Withdrawal by Subject|1|||
124815956|NCT04932096|448956625|FG001|Overall Study|Withdrawal by Subject|1|||
124815957|NCT04932096|448956624|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
124815958|NCT04932096|448956625|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
124815959|NCT00133952|448956633|FG000|Overall Study|Adverse Event|1|||
124815960|NCT00133952|448956634|FG001|Overall Study|Adverse Event|2|||
124815961|NCT00133952|448956633|FG000|Overall Study|Death|3|||
124815962|NCT00133952|448956634|FG001|Overall Study|Death|2|||
124815963|NCT00133952|448956633|FG000|Overall Study|Lost to Follow-up|9|||
124815964|NCT00133952|448956634|FG001|Overall Study|Lost to Follow-up|14|||
124815965|NCT00133952|448956633|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
124815966|NCT00133952|448956634|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
124815967|NCT00133952|448956633|FG000|Overall Study|Protocol Violation|1|||
124815968|NCT00133952|448956634|FG001|Overall Study|Protocol Violation|1|||
124815969|NCT00133952|448956633|FG000|Overall Study|Withdrawal by Subject|20|||
124815970|NCT00133952|448956634|FG001|Overall Study|Withdrawal by Subject|4|||
124815971|NCT00133952|448956633|FG000|Overall Study|Physician Decision|4|||
124815972|NCT00133952|448956634|FG001|Overall Study|Physician Decision|3|||
124815973|NCT00133952|448956633|FG000|Overall Study|Sponsor Decision|0|||
124815974|NCT00133952|448956634|FG001|Overall Study|Sponsor Decision|1|||
124815975|NCT01976338|448956636|FG000|Overall Study|Physician Decision|0|||
124815976|NCT01976338|448956637|FG001|Overall Study|Physician Decision|1|||
124815977|NCT01976338|448956636|FG000|Overall Study|Lost to Follow-up|3|||
124815978|NCT01976338|448956637|FG001|Overall Study|Lost to Follow-up|0|||
124815979|NCT01976338|448956636|FG000|Overall Study|Withdrawal by Subject|5|||
124815980|NCT01976338|448956637|FG001|Overall Study|Withdrawal by Subject|2|||
124815981|NCT01976338|448956636|FG000|Overall Study|Adverse Event|5|||
124815982|NCT01976338|448956637|FG001|Overall Study|Adverse Event|1|||
124815983|NCT00777608|448956638|FG000|Overall Study|Lost to Follow-up|1|||
124815984|NCT00777608|448956639|FG001|Overall Study|Lost to Follow-up|1|||
124815985|NCT00777608|448956638|FG000|Overall Study|Withdrawal by Subject|1|||
124815986|NCT00777608|448956639|FG001|Overall Study|Withdrawal by Subject|3|||
124815987|NCT00777608|448956638|FG000|Overall Study|Protocol Violation|1|||
124815988|NCT00777608|448956639|FG001|Overall Study|Protocol Violation|0|||
124815989|NCT00777608|448956638|FG000|Overall Study|Investigator Decision|1|||
124815990|NCT00777608|448956639|FG001|Overall Study|Investigator Decision|2|||
124815991|NCT04213079|448956640|FG000|Overall Study|Lost to Follow-up|0|||
124815992|NCT04213079|448956641|FG001|Overall Study|Lost to Follow-up|2|||
124815993|NCT03766581|448956644|FG000|Randomization|Other reasons|2|||
124815994|NCT03766581|448956645|FG001|Randomization|Other reasons|1|||
124815995|NCT03766581|448956646|FG002|Randomization|Other reasons|0|||
124815996|NCT03766581|448956647|FG003|Randomization|Other reasons|1|||
124815997|NCT03766581|448956648|FG004|Randomization|Other reasons|0|||
124815998|NCT03766581|448956649|FG005|Randomization|Other reasons|0|||
124815999|NCT03766581|448956650|FG006|Randomization|Other reasons|0|||
124816000|NCT03766581|448956651|FG007|Randomization|Other reasons|0|||
124816001|NCT03766581|448956644|FG000|Randomization|Participant no longer meets study criteria|5|||
124816002|NCT03766581|448956645|FG001|Randomization|Participant no longer meets study criteria|3|||
124816003|NCT03766581|448956646|FG002|Randomization|Participant no longer meets study criteria|4|||
124816004|NCT03766581|448956647|FG003|Randomization|Participant no longer meets study criteria|0|||
124816005|NCT03766581|448956648|FG004|Randomization|Participant no longer meets study criteria|2|||
124816006|NCT03766581|448956649|FG005|Randomization|Participant no longer meets study criteria|3|||
124816007|NCT03766581|448956650|FG006|Randomization|Participant no longer meets study criteria|0|||
124816008|NCT03766581|448956651|FG007|Randomization|Participant no longer meets study criteria|1|||
124816009|NCT03766581|448956644|FG000|Randomization|Participant request to discontinue study treatment|1|||
124816010|NCT03766581|448956645|FG001|Randomization|Participant request to discontinue study treatment|0|||
124816011|NCT03766581|448956646|FG002|Randomization|Participant request to discontinue study treatment|0|||
124816012|NCT03766581|448956647|FG003|Randomization|Participant request to discontinue study treatment|0|||
124816013|NCT03766581|448956648|FG004|Randomization|Participant request to discontinue study treatment|1|||
124816014|NCT03766581|448956649|FG005|Randomization|Participant request to discontinue study treatment|2|||
124816015|NCT03766581|448956650|FG006|Randomization|Participant request to discontinue study treatment|0|||
124816016|NCT03766581|448956651|FG007|Randomization|Participant request to discontinue study treatment|0|||
124816017|NCT03766581|448956644|FG000|Randomization|Participant withdrew consent|1|||
124816018|NCT03766581|448956645|FG001|Randomization|Participant withdrew consent|0|||
124816019|NCT03766581|448956646|FG002|Randomization|Participant withdrew consent|1|||
124816020|NCT03766581|448956647|FG003|Randomization|Participant withdrew consent|2|||
124816021|NCT03766581|448956648|FG004|Randomization|Participant withdrew consent|1|||
124816022|NCT03766581|448956649|FG005|Randomization|Participant withdrew consent|1|||
124816023|NCT03766581|448956650|FG006|Randomization|Participant withdrew consent|0|||
124816024|NCT03766581|448956651|FG007|Randomization|Participant withdrew consent|0|||
124816025|NCT03766581|448956644|FG000|Treatment|Adverse Event|82|||
124816026|NCT03766581|448956645|FG001|Treatment|Adverse Event|44|||
124816027|NCT03766581|448956646|FG002|Treatment|Adverse Event|47|||
124816028|NCT03766581|448956647|FG003|Treatment|Adverse Event|46|||
124816029|NCT03766581|448956648|FG004|Treatment|Adverse Event|50|||
124816030|NCT03766581|448956649|FG005|Treatment|Adverse Event|77|||
124816031|NCT03766581|448956650|FG006|Treatment|Adverse Event|5|||
124816032|NCT03766581|448956651|FG007|Treatment|Adverse Event|2|||
124816033|NCT03766581|448956644|FG000|Treatment|Participant request to discontinue treatment|34|||
124816034|NCT03766581|448956645|FG001|Treatment|Participant request to discontinue treatment|6|||
124816035|NCT03766581|448956646|FG002|Treatment|Participant request to discontinue treatment|10|||
124816036|NCT03766581|448956647|FG003|Treatment|Participant request to discontinue treatment|10|||
124816037|NCT03766581|448956648|FG004|Treatment|Participant request to discontinue treatment|14|||
124816038|NCT03766581|448956649|FG005|Treatment|Participant request to discontinue treatment|15|||
124816039|NCT03766581|448956650|FG006|Treatment|Participant request to discontinue treatment|0|||
124816040|NCT03766581|448956651|FG007|Treatment|Participant request to discontinue treatment|1|||
124816041|NCT03766581|448956644|FG000|Treatment|Participant withdrew consent|11|||
124816042|NCT03766581|448956645|FG001|Treatment|Participant withdrew consent|4|||
124816043|NCT03766581|448956646|FG002|Treatment|Participant withdrew consent|5|||
124816044|NCT03766581|448956647|FG003|Treatment|Participant withdrew consent|5|||
124816045|NCT03766581|448956648|FG004|Treatment|Participant withdrew consent|4|||
124816046|NCT03766581|448956649|FG005|Treatment|Participant withdrew consent|4|||
124816047|NCT03766581|448956650|FG006|Treatment|Participant withdrew consent|0|||
124816048|NCT03766581|448956651|FG007|Treatment|Participant withdrew consent|0|||
124816049|NCT03766581|448956644|FG000|Treatment|Death|1|||
124816050|NCT03766581|448956645|FG001|Treatment|Death|0|||
124816051|NCT03766581|448956646|FG002|Treatment|Death|0|||
124816052|NCT03766581|448956647|FG003|Treatment|Death|0|||
124816053|NCT03766581|448956648|FG004|Treatment|Death|0|||
124816054|NCT03766581|448956649|FG005|Treatment|Death|0|||
124816055|NCT03766581|448956650|FG006|Treatment|Death|0|||
124816056|NCT03766581|448956651|FG007|Treatment|Death|0|||
124816057|NCT03766581|448956644|FG000|Treatment|Lost to Follow-up|1|||
124816058|NCT03766581|448956645|FG001|Treatment|Lost to Follow-up|0|||
124816059|NCT03766581|448956646|FG002|Treatment|Lost to Follow-up|0|||
124816060|NCT03766581|448956647|FG003|Treatment|Lost to Follow-up|1|||
124816061|NCT03766581|448956648|FG004|Treatment|Lost to Follow-up|0|||
124816062|NCT03766581|448956649|FG005|Treatment|Lost to Follow-up|0|||
124816063|NCT03766581|448956650|FG006|Treatment|Lost to Follow-up|0|||
124816064|NCT03766581|448956651|FG007|Treatment|Lost to Follow-up|0|||
124816065|NCT03766581|448956644|FG000|Treatment|Poor/Non compliance|2|||
124816066|NCT03766581|448956645|FG001|Treatment|Poor/Non compliance|2|||
124816067|NCT03766581|448956646|FG002|Treatment|Poor/Non compliance|1|||
124816068|NCT03766581|448956647|FG003|Treatment|Poor/Non compliance|1|||
124816069|NCT03766581|448956648|FG004|Treatment|Poor/Non compliance|1|||
124816070|NCT03766581|448956649|FG005|Treatment|Poor/Non compliance|1|||
124816071|NCT03766581|448956650|FG006|Treatment|Poor/Non compliance|0|||
124816072|NCT03766581|448956651|FG007|Treatment|Poor/Non compliance|0|||
124816073|NCT03766581|448956644|FG000|Treatment|Participant no longer meets study criteria|9|||
124816074|NCT03766581|448956645|FG001|Treatment|Participant no longer meets study criteria|1|||
124816075|NCT03766581|448956646|FG002|Treatment|Participant no longer meets study criteria|5|||
124816076|NCT03766581|448956647|FG003|Treatment|Participant no longer meets study criteria|4|||
124816077|NCT03766581|448956648|FG004|Treatment|Participant no longer meets study criteria|4|||
124816078|NCT03766581|448956649|FG005|Treatment|Participant no longer meets study criteria|4|||
124816079|NCT03766581|448956650|FG006|Treatment|Participant no longer meets study criteria|2|||
124816080|NCT03766581|448956651|FG007|Treatment|Participant no longer meets study criteria|0|||
124816081|NCT03766581|448956644|FG000|Treatment|Other reasons|13|||
124816082|NCT03766581|448956645|FG001|Treatment|Other reasons|8|||
124816083|NCT03766581|448956646|FG002|Treatment|Other reasons|3|||
124816084|NCT03766581|448956647|FG003|Treatment|Other reasons|7|||
124816085|NCT03766581|448956648|FG004|Treatment|Other reasons|3|||
124816086|NCT03766581|448956649|FG005|Treatment|Other reasons|3|||
124816087|NCT03766581|448956650|FG006|Treatment|Other reasons|0|||
124816088|NCT03766581|448956651|FG007|Treatment|Other reasons|0|||
124816089|NCT02732119|448956652|FG000|Phase I|Adverse Event|1|||
124816090|NCT02732119|448956653|FG001|Phase I|Adverse Event|3|||
124816091|NCT02732119|448956654|FG002|Phase I|Adverse Event|1|||
124816092|NCT02732119|448956655|FG003|Phase I|Adverse Event|0|||
124816093|NCT02732119|448956656|FG004|Phase I|Adverse Event|0|||
124816094|NCT02732119|448956652|FG000|Phase I|Progressive disease|7|||
124816095|NCT02732119|448956653|FG001|Phase I|Progressive disease|3|||
124816096|NCT02732119|448956654|FG002|Phase I|Progressive disease|2|||
124816097|NCT02732119|448956655|FG003|Phase I|Progressive disease|0|||
124816098|NCT02732119|448956656|FG004|Phase I|Progressive disease|0|||
124816099|NCT02732119|448956652|FG000|Phase I|Protocol deviation|0|||
124816100|NCT02732119|448956653|FG001|Phase I|Protocol deviation|1|||
124816101|NCT02732119|448956654|FG002|Phase I|Protocol deviation|0|||
124816102|NCT02732119|448956655|FG003|Phase I|Protocol deviation|0|||
124816103|NCT02732119|448956656|FG004|Phase I|Protocol deviation|0|||
124816104|NCT02732119|448956652|FG000|Phase I|Physician Decision|0|||
124816105|NCT02732119|448956653|FG001|Phase I|Physician Decision|3|||
124816106|NCT02732119|448956654|FG002|Phase I|Physician Decision|4|||
124816107|NCT02732119|448956655|FG003|Phase I|Physician Decision|0|||
124816108|NCT02732119|448956656|FG004|Phase I|Physician Decision|0|||
124816109|NCT02732119|448956652|FG000|Phase II|Adverse Event|0|||
124816110|NCT02732119|448956653|FG001|Phase II|Adverse Event|0|||
124816111|NCT02732119|448956654|FG002|Phase II|Adverse Event|0|||
124816112|NCT02732119|448956655|FG003|Phase II|Adverse Event|3|||
124816113|NCT02732119|448956656|FG004|Phase II|Adverse Event|3|||
124816114|NCT02732119|448956652|FG000|Phase II|Death|0|||
124816115|NCT02732119|448956653|FG001|Phase II|Death|0|||
124816116|NCT02732119|448956654|FG002|Phase II|Death|0|||
124816117|NCT02732119|448956655|FG003|Phase II|Death|1|||
124816118|NCT02732119|448956656|FG004|Phase II|Death|0|||
124816119|NCT02732119|448956652|FG000|Phase II|Progressive dissease|0|||
124816120|NCT02732119|448956653|FG001|Phase II|Progressive dissease|0|||
124816121|NCT02732119|448956654|FG002|Phase II|Progressive dissease|0|||
124816122|NCT02732119|448956655|FG003|Phase II|Progressive dissease|30|||
124816123|NCT02732119|448956656|FG004|Phase II|Progressive dissease|23|||
124816124|NCT02732119|448956652|FG000|Phase II|Study terminated by sponsor|0|||
124816125|NCT02732119|448956653|FG001|Phase II|Study terminated by sponsor|0|||
124816126|NCT02732119|448956654|FG002|Phase II|Study terminated by sponsor|0|||
124816127|NCT02732119|448956655|FG003|Phase II|Study terminated by sponsor|2|||
124816128|NCT02732119|448956656|FG004|Phase II|Study terminated by sponsor|2|||
124816129|NCT02732119|448956652|FG000|Phase II|Other|0|||
124816130|NCT02732119|448956653|FG001|Phase II|Other|0|||
124816131|NCT02732119|448956654|FG002|Phase II|Other|0|||
124816132|NCT02732119|448956655|FG003|Phase II|Other|2|||
124816133|NCT02732119|448956656|FG004|Phase II|Other|0|||
124816134|NCT02732119|448956652|FG000|Phase II|Physician Decision|0|||
124816135|NCT02732119|448956653|FG001|Phase II|Physician Decision|0|||
124816136|NCT02732119|448956654|FG002|Phase II|Physician Decision|0|||
124816137|NCT02732119|448956655|FG003|Phase II|Physician Decision|8|||
124816138|NCT02732119|448956656|FG004|Phase II|Physician Decision|5|||
124816139|NCT00520936|448956657|FG000|Overall Study|Physician Decision|0|||
124816140|NCT00520936|448956658|FG001|Overall Study|Physician Decision|2|||
124816141|NCT00520936|448956659|FG002|Overall Study|Physician Decision|1|||
124816142|NCT00520936|448956660|FG003|Overall Study|Physician Decision|0|||
124816143|NCT00520936|448956661|FG004|Overall Study|Physician Decision|0|||
124816144|NCT00520936|448956662|FG005|Overall Study|Physician Decision|0|||
124816145|NCT00520936|448956663|FG006|Overall Study|Physician Decision|0|||
124816146|NCT00520936|448956664|FG007|Overall Study|Physician Decision|0|||
124816147|NCT00520936|448956657|FG000|Overall Study|Withdrawal by Subject|0|||
124816148|NCT00520936|448956658|FG001|Overall Study|Withdrawal by Subject|0|||
124816149|NCT00520936|448956659|FG002|Overall Study|Withdrawal by Subject|0|||
124816150|NCT00520936|448956660|FG003|Overall Study|Withdrawal by Subject|0|||
124816151|NCT00520936|448956661|FG004|Overall Study|Withdrawal by Subject|0|||
124816152|NCT00520936|448956662|FG005|Overall Study|Withdrawal by Subject|0|||
124816153|NCT00520936|448956663|FG006|Overall Study|Withdrawal by Subject|0|||
124816154|NCT00520936|448956664|FG007|Overall Study|Withdrawal by Subject|1|||
124816155|NCT00520936|448956657|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
124816156|NCT00520936|448956658|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
124816157|NCT00520936|448956659|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
124816158|NCT00520936|448956660|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
124816159|NCT00520936|448956661|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
124816160|NCT00520936|448956662|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
124816161|NCT00520936|448956663|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
124816162|NCT00520936|448956664|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
124816163|NCT00520936|448956657|FG000|Overall Study|Death|0|||
124816164|NCT00520936|448956658|FG001|Overall Study|Death|0|||
124816165|NCT00520936|448956659|FG002|Overall Study|Death|0|||
124816166|NCT00520936|448956660|FG003|Overall Study|Death|0|||
124816167|NCT00520936|448956661|FG004|Overall Study|Death|0|||
124816168|NCT00520936|448956662|FG005|Overall Study|Death|0|||
124816169|NCT00520936|448956663|FG006|Overall Study|Death|1|||
124816170|NCT00520936|448956664|FG007|Overall Study|Death|0|||
124816171|NCT00520936|448956657|FG000|Overall Study|Protocol Violation|0|||
124637138|NCT03363776|448288710|FG001|Overall Study|Study drug toxicity|0|||
124816172|NCT00520936|448956658|FG001|Overall Study|Protocol Violation|1|||
124816173|NCT00520936|448956659|FG002|Overall Study|Protocol Violation|1|||
124816174|NCT00520936|448956660|FG003|Overall Study|Protocol Violation|0|||
124816175|NCT00520936|448956661|FG004|Overall Study|Protocol Violation|1|||
124816176|NCT00520936|448956662|FG005|Overall Study|Protocol Violation|0|||
124816177|NCT00520936|448956663|FG006|Overall Study|Protocol Violation|1|||
124816178|NCT00520936|448956664|FG007|Overall Study|Protocol Violation|0|||
124816179|NCT00964860|448956665|FG000|Overall Study|Withdrawal by Subject|0|||
124816180|NCT00964860|448956666|FG001|Overall Study|Withdrawal by Subject|1|||
124816181|NCT03716024|448956667|FG000|Overall Study|Randomized, not Treated|7|||
124816182|NCT03716024|448956668|FG001|Overall Study|Randomized, not Treated|8|||
124816183|NCT03716024|448956667|FG000|Overall Study|Adverse Event|1|||
124816184|NCT03716024|448956668|FG001|Overall Study|Adverse Event|2|||
124816185|NCT03716024|448956667|FG000|Overall Study|Treatment Failure|1|||
124816186|NCT03716024|448956668|FG001|Overall Study|Treatment Failure|0|||
124816187|NCT03716024|448956667|FG000|Overall Study|Lost to Follow-up|2|||
124816188|NCT03716024|448956668|FG001|Overall Study|Lost to Follow-up|6|||
124816189|NCT03716024|448956667|FG000|Overall Study|Withdrawal by Subject|0|||
124816190|NCT03716024|448956668|FG001|Overall Study|Withdrawal by Subject|1|||
124816191|NCT03716024|448956667|FG000|Overall Study|Missing Reason|0|||
124816192|NCT03716024|448956668|FG001|Overall Study|Missing Reason|1|||
124816193|NCT00867568|448956669|FG000|Overall Study|Lack of Efficacy|10|||
124816194|NCT00867568|448956669|FG000|Overall Study|Adverse Event|4|||
124816195|NCT00867568|448956669|FG000|Overall Study|Withdrawal by Subject|1|||
124816196|NCT04343261|448956670|FG000|Overall Study|Adverse Event|1|||
124816197|NCT04343261|448956670|FG000|Overall Study|received inadequate amount of antibodies|7|||
124816198|NCT02585960|448956678|FG000|PK/Safety Assessment Period|Physician Decision|0|||
124816199|NCT02585960|448956679|FG001|PK/Safety Assessment Period|Physician Decision|1|||
124816200|NCT02585960|448956680|FG002|PK/Safety Assessment Period|Physician Decision|0|||
124816201|NCT02585960|448956678|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
124816202|NCT02585960|448956679|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
124816203|NCT02585960|448956680|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
124816204|NCT02585960|448956678|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
124816205|NCT02585960|448956679|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
124816206|NCT02585960|448956680|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
124816207|NCT02585960|448956678|FG000|PK/Safety Assessment Period|Other|4|||
124816208|NCT02585960|448956679|FG001|PK/Safety Assessment Period|Other|4|||
124816209|NCT02585960|448956680|FG002|PK/Safety Assessment Period|Other|0|||
124816210|NCT02585960|448956678|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
124816211|NCT02585960|448956679|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
124816212|NCT02585960|448956680|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
124816213|NCT02585960|448956678|FG000|PK/Safety Assessment Period|Screen Failure|0|||
124816214|NCT02585960|448956679|FG001|PK/Safety Assessment Period|Screen Failure|0|||
124816215|NCT02585960|448956680|FG002|PK/Safety Assessment Period|Screen Failure|1|||
124816216|NCT02585960|448956678|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
124816217|NCT02585960|448956679|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
124816218|NCT02585960|448956680|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
124816219|NCT02585960|448956678|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
124816220|NCT02585960|448956679|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
124816221|NCT02585960|448956680|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
124816222|NCT03639935|448956681|FG000|Overall Study|Death|3|||
124816223|NCT03639935|448956681|FG000|Overall Study|Adverse Event|1|||
124816224|NCT00003479|448956683|FG000|Overall Study|Not evaluable|3|||
124816225|NCT01061177|448956684|FG000|Overall Study|Adverse Event|117|||
124816226|NCT01061177|448956684|FG000|Overall Study|Withdrawal by Subject|27|||
124816227|NCT01061177|448956684|FG000|Overall Study|Disease progression|17|||
124816228|NCT01061177|448956684|FG000|Overall Study|Protocol Violation|11|||
124816229|NCT01061177|448956684|FG000|Overall Study|Lost to Follow-up|9|||
124816230|NCT01061177|448956684|FG000|Overall Study|New cancer therapy|9|||
124816231|NCT01061177|448956684|FG000|Overall Study|Abnormal laboratory values|6|||
124816232|NCT01061177|448956684|FG000|Overall Study|Abnormal test procedure results|4|||
124816233|NCT01061177|448956684|FG000|Overall Study|Administratie problems|4|||
124816234|NCT01061177|448956684|FG000|Overall Study|Death|4|||
124816235|NCT00299104|448956685|FG000|Treatment Period|Adverse Event|14|||
124816236|NCT00299104|448956686|FG001|Treatment Period|Adverse Event|9|||
124816237|NCT00299104|448956687|FG002|Treatment Period|Adverse Event|7|||
124816238|NCT00299104|448956685|FG000|Treatment Period|Death|1|||
124816239|NCT00299104|448956686|FG001|Treatment Period|Death|1|||
124816240|NCT00299104|448956687|FG002|Treatment Period|Death|1|||
124816241|NCT00299104|448956685|FG000|Treatment Period|Insufficient therapeutic response|34|||
124816242|NCT00299104|448956686|FG001|Treatment Period|Insufficient therapeutic response|13|||
124816243|NCT00299104|448956687|FG002|Treatment Period|Insufficient therapeutic response|8|||
124816244|NCT00299104|448956685|FG000|Treatment Period|Failure to return|9|||
124816245|NCT00299104|448956686|FG001|Treatment Period|Failure to return|8|||
124816246|NCT00299104|448956687|FG002|Treatment Period|Failure to return|8|||
124816247|NCT00299104|448956685|FG000|Treatment Period|Violation of selection criteria|1|||
124816248|NCT00299104|448956686|FG001|Treatment Period|Violation of selection criteria|2|||
124816249|NCT00299104|448956687|FG002|Treatment Period|Violation of selection criteria|0|||
124816250|NCT00299104|448956685|FG000|Treatment Period|Protocol Violation|1|||
124816251|NCT00299104|448956686|FG001|Treatment Period|Protocol Violation|1|||
124816252|NCT00299104|448956687|FG002|Treatment Period|Protocol Violation|0|||
124816253|NCT00299104|448956685|FG000|Treatment Period|Refused treatment|9|||
124816254|NCT00299104|448956686|FG001|Treatment Period|Refused treatment|2|||
124816255|NCT00299104|448956687|FG002|Treatment Period|Refused treatment|2|||
124816256|NCT00299104|448956685|FG000|Treatment Period|Withdrew consent|14|||
124816257|NCT00299104|448956686|FG001|Treatment Period|Withdrew consent|19|||
124816258|NCT00299104|448956687|FG002|Treatment Period|Withdrew consent|9|||
124816259|NCT00299104|448956685|FG000|Treatment Period|Administrative reasons|106|||
124816260|NCT00299104|448956686|FG001|Treatment Period|Administrative reasons|120|||
124816261|NCT00299104|448956687|FG002|Treatment Period|Administrative reasons|137|||
124816262|NCT00299104|448956685|FG000|Safety Follow-Up (SFU) Period|Death|3|||
124816263|NCT00299104|448956686|FG001|Safety Follow-Up (SFU) Period|Death|2|||
124816264|NCT00299104|448956687|FG002|Safety Follow-Up (SFU) Period|Death|1|||
124816265|NCT00299104|448956685|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
124816266|NCT00299104|448956686|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
124816267|NCT00299104|448956687|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
124816268|NCT00299104|448956685|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
124816269|NCT00299104|448956686|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
124816270|NCT00299104|448956687|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
124816271|NCT00299104|448956685|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
124816272|NCT00299104|448956686|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
124816273|NCT00299104|448956687|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
124816274|NCT00299104|448956685|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
124816275|NCT00299104|448956686|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
124816276|NCT00299104|448956687|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
124816277|NCT00299104|448956685|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
124816278|NCT00299104|448956686|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
124816279|NCT00299104|448956687|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
124816280|NCT00299104|448956685|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
124816281|NCT00299104|448956686|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
124816282|NCT00299104|448956687|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
124816283|NCT00299104|448956685|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
124816284|NCT00299104|448956686|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
124816285|NCT00299104|448956687|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
124816286|NCT00587054|448956688|FG000|Overall Study|Patient not treated|9|||
124816287|NCT02059395|448956699|FG000|Overall Study|Lost to Follow-up|2|||
124816288|NCT02059395|448956700|FG001|Overall Study|Lost to Follow-up|4|||
124816289|NCT00044083|448956701|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
124816290|NCT00044083|448956702|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
124816291|NCT00044083|448956701|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
124816292|NCT00044083|448956702|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
124816293|NCT00044083|448956701|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
124816294|NCT00044083|448956702|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
124816295|NCT00044083|448956701|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
124816296|NCT00044083|448956702|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
124816297|NCT00044083|448956701|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
124816298|NCT00044083|448956702|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
124816299|NCT00044083|448956701|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
124816300|NCT00044083|448956702|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
124816301|NCT00044083|448956701|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
124816302|NCT00044083|448956702|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
124816303|NCT00044083|448956701|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
124816304|NCT00044083|448956702|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
124816305|NCT00044083|448956701|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
124816306|NCT00044083|448956702|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
124816307|NCT00044083|448956701|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
124816308|NCT00044083|448956702|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
124816309|NCT01619423|448956703|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
124816310|NCT01619423|448956704|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
124816311|NCT01619423|448956705|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
124816312|NCT01619423|448956706|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
124816313|NCT02340975|448956707|FG000|Overall Study|Death|6|||
124816314|NCT02340975|448956708|FG001|Overall Study|Death|23|||
124816315|NCT02340975|448956709|FG002|Overall Study|Death|21|||
124816316|NCT02340975|448956710|FG003|Overall Study|Death|7|||
124816317|NCT02340975|448956711|FG004|Overall Study|Death|21|||
124816318|NCT02340975|448956712|FG005|Overall Study|Death|13|||
124816319|NCT02340975|448956707|FG000|Overall Study|Lost to Follow-up|0|||
124816320|NCT02340975|448956708|FG001|Overall Study|Lost to Follow-up|0|||
124816321|NCT02340975|448956709|FG002|Overall Study|Lost to Follow-up|0|||
124816322|NCT02340975|448956710|FG003|Overall Study|Lost to Follow-up|0|||
124816323|NCT02340975|448956711|FG004|Overall Study|Lost to Follow-up|2|||
124816324|NCT02340975|448956712|FG005|Overall Study|Lost to Follow-up|0|||
124816325|NCT02340975|448956707|FG000|Overall Study|Withdrawal by Subject|0|||
124816326|NCT02340975|448956708|FG001|Overall Study|Withdrawal by Subject|0|||
124816327|NCT02340975|448956709|FG002|Overall Study|Withdrawal by Subject|3|||
124816328|NCT02340975|448956710|FG003|Overall Study|Withdrawal by Subject|3|||
124816329|NCT02340975|448956711|FG004|Overall Study|Withdrawal by Subject|2|||
124816330|NCT02340975|448956712|FG005|Overall Study|Withdrawal by Subject|0|||
124816331|NCT02340975|448956707|FG000|Overall Study|Other|0|||
124816332|NCT02340975|448956708|FG001|Overall Study|Other|4|||
124816333|NCT02340975|448956709|FG002|Overall Study|Other|0|||
124816334|NCT02340975|448956710|FG003|Overall Study|Other|2|||
124816335|NCT02340975|448956711|FG004|Overall Study|Other|0|||
124816336|NCT02340975|448956712|FG005|Overall Study|Other|6|||
124816337|NCT00601458|448956721|FG000|Overall Study|Dosing Error|1|||
124816338|NCT00601458|448956722|FG001|Overall Study|Dosing Error|0|||
124816339|NCT00601458|448956723|FG002|Overall Study|Dosing Error|0|||
124816340|NCT00601458|448956721|FG000|Overall Study|Incomplete Data|0|||
124816341|NCT00601458|448956722|FG001|Overall Study|Incomplete Data|2|||
124816342|NCT00601458|448956723|FG002|Overall Study|Incomplete Data|0|||
124816343|NCT00601458|448956721|FG000|Overall Study|Protocol Violation|3|||
124816344|NCT00601458|448956722|FG001|Overall Study|Protocol Violation|2|||
124816345|NCT00601458|448956723|FG002|Overall Study|Protocol Violation|1|||
124816346|NCT00601458|448956721|FG000|Overall Study|Early Termination|0|||
124816347|NCT00601458|448956722|FG001|Overall Study|Early Termination|1|||
124816348|NCT00601458|448956723|FG002|Overall Study|Early Termination|1|||
124816349|NCT01697566|448956725|FG000|Overall Study|Withdrawal by Subject|0|||
124816350|NCT01697566|448956726|FG001|Overall Study|Withdrawal by Subject|0|||
124816351|NCT01697566|448956727|FG002|Overall Study|Withdrawal by Subject|1|||
124816352|NCT01697566|448956728|FG003|Overall Study|Withdrawal by Subject|1|||
124816353|NCT01697566|448956725|FG000|Overall Study|Final biopsy not obtained|0|||
124816354|NCT01697566|448956726|FG001|Overall Study|Final biopsy not obtained|0|||
124816355|NCT01697566|448956727|FG002|Overall Study|Final biopsy not obtained|1|||
124816356|NCT01697566|448956728|FG003|Overall Study|Final biopsy not obtained|0|||
124816357|NCT01709162|448956729|FG000|Overall Study|Disease progression|3|||
124816358|NCT01709162|448956730|FG001|Overall Study|Disease progression|3|||
124816359|NCT01709162|448956729|FG000|Overall Study|Study drug toxicity|2|||
124816360|NCT01709162|448956730|FG001|Overall Study|Study drug toxicity|0|||
124816361|NCT01709162|448956729|FG000|Overall Study|Administrative reason by sponsor|0|||
124816362|NCT01709162|448956730|FG001|Overall Study|Administrative reason by sponsor|1|||
124816363|NCT01709162|448956729|FG000|Overall Study|Other|1|||
124816364|NCT01709162|448956730|FG001|Overall Study|Other|0|||
124816365|NCT01709162|448956729|FG000|Overall Study|Withdrawal by Subject|0|||
124816366|NCT01709162|448956730|FG001|Overall Study|Withdrawal by Subject|1|||
124816367|NCT02405780|448956733|FG000|Period I|Adverse Event|8|||
124816368|NCT02405780|448956734|FG001|Period I|Adverse Event|0|||
124816369|NCT02405780|448956735|FG002|Period I|Adverse Event|3|||
124816370|NCT02405780|448956736|FG003|Period I|Adverse Event|7|||
124816371|NCT02405780|448956733|FG000|Period I|Medical reasons|1|||
124816372|NCT02405780|448956734|FG001|Period I|Medical reasons|1|||
124816373|NCT02405780|448956735|FG002|Period I|Medical reasons|0|||
124816374|NCT02405780|448956736|FG003|Period I|Medical reasons|1|||
124816375|NCT02405780|448956733|FG000|Period I|Screening Failure|1|||
124816376|NCT02405780|448956734|FG001|Period I|Screening Failure|0|||
124816377|NCT02405780|448956735|FG002|Period I|Screening Failure|1|||
124816378|NCT02405780|448956736|FG003|Period I|Screening Failure|0|||
124816379|NCT02405780|448956733|FG000|Period I|Withdrawal by Subject|9|||
124816380|NCT02405780|448956734|FG001|Period I|Withdrawal by Subject|1|||
124816381|NCT02405780|448956735|FG002|Period I|Withdrawal by Subject|3|||
124816382|NCT02405780|448956736|FG003|Period I|Withdrawal by Subject|4|||
124816383|NCT02405780|448956733|FG000|Period I|Non-compliance with study procedures|8|||
124816384|NCT02405780|448956734|FG001|Period I|Non-compliance with study procedures|6|||
124816385|NCT02405780|448956735|FG002|Period I|Non-compliance with study procedures|8|||
124816386|NCT02405780|448956736|FG003|Period I|Non-compliance with study procedures|11|||
124816387|NCT02405780|448956733|FG000|Period II|Adverse Event|3|||
124816388|NCT02405780|448956734|FG001|Period II|Adverse Event|5|||
124816389|NCT02405780|448956735|FG002|Period II|Adverse Event|4|||
124816390|NCT02405780|448956736|FG003|Period II|Adverse Event|11|||
124816391|NCT02405780|448956733|FG000|Period II|Medical reason|0|||
124816392|NCT02405780|448956734|FG001|Period II|Medical reason|1|||
124816393|NCT02405780|448956735|FG002|Period II|Medical reason|0|||
124816394|NCT02405780|448956736|FG003|Period II|Medical reason|0|||
124816395|NCT02405780|448956733|FG000|Period II|Pregnancy|0|||
124816396|NCT02405780|448956734|FG001|Period II|Pregnancy|0|||
124816397|NCT02405780|448956735|FG002|Period II|Pregnancy|1|||
124816398|NCT02405780|448956736|FG003|Period II|Pregnancy|0|||
124816399|NCT02405780|448956733|FG000|Period II|Withdrawal by Subject|7|||
124816400|NCT02405780|448956734|FG001|Period II|Withdrawal by Subject|4|||
124816401|NCT02405780|448956735|FG002|Period II|Withdrawal by Subject|0|||
124816402|NCT02405780|448956736|FG003|Period II|Withdrawal by Subject|3|||
124816403|NCT02405780|448956733|FG000|Period II|Non-compliance with study procedures|5|||
124816404|NCT02405780|448956734|FG001|Period II|Non-compliance with study procedures|2|||
124816405|NCT02405780|448956735|FG002|Period II|Non-compliance with study procedures|7|||
124816406|NCT02405780|448956736|FG003|Period II|Non-compliance with study procedures|4|||
124816407|NCT01654536|448956737|FG000|Overall Study|Lost to Follow-up|5|||
124816408|NCT01654536|448956738|FG001|Overall Study|Lost to Follow-up|5|||
124816409|NCT01654536|448956737|FG000|Overall Study|Physician Decision|12|||
124816410|NCT01654536|448956738|FG001|Overall Study|Physician Decision|8|||
124816411|NCT01654536|448956737|FG000|Overall Study|Withdrawal by Subject|27|||
124816412|NCT01654536|448956738|FG001|Overall Study|Withdrawal by Subject|25|||
124816413|NCT01587001|448956739|FG000|Overall Study|Lost to Follow-up|2|||
124816414|NCT01587001|448956740|FG001|Overall Study|Lost to Follow-up|0|||
124816415|NCT01587001|448956739|FG000|Overall Study|Insufficient samples to complete testing|4|||
124816416|NCT01587001|448956740|FG001|Overall Study|Insufficient samples to complete testing|1|||
124816417|NCT00074152|448956741|FG000|Overall Study|Death|21|||
124816418|NCT00074152|448956742|FG001|Overall Study|Death|9|||
124816419|NCT00074152|448956741|FG000|Overall Study|Lack of Efficacy|34|||
124816420|NCT00074152|448956742|FG001|Overall Study|Lack of Efficacy|24|||
124816421|NCT02197130|448956743|FG000|Overall Study|Adverse Event|13|||
124816422|NCT02197130|448956744|FG001|Overall Study|Adverse Event|4|||
124816423|NCT02197130|448956745|FG002|Overall Study|Adverse Event|23|||
124816424|NCT02197130|448956743|FG000|Overall Study|Death|0|||
124816425|NCT02197130|448956744|FG001|Overall Study|Death|1|||
124816426|NCT02197130|448956745|FG002|Overall Study|Death|0|||
124816427|NCT02197130|448956743|FG000|Overall Study|Lost to Follow-up|2|||
124816428|NCT02197130|448956744|FG001|Overall Study|Lost to Follow-up|0|||
124816429|NCT02197130|448956745|FG002|Overall Study|Lost to Follow-up|1|||
124816430|NCT02197130|448956743|FG000|Overall Study|Does not meet entrance criteria|0|||
124816431|NCT02197130|448956744|FG001|Overall Study|Does not meet entrance criteria|0|||
124816432|NCT02197130|448956745|FG002|Overall Study|Does not meet entrance criteria|1|||
124816433|NCT02197130|448956743|FG000|Overall Study|Withdrawal by Subject|0|||
124816434|NCT02197130|448956744|FG001|Overall Study|Withdrawal by Subject|3|||
124816435|NCT02197130|448956745|FG002|Overall Study|Withdrawal by Subject|4|||
124816436|NCT02197130|448956743|FG000|Overall Study|Other|1|||
124816437|NCT02197130|448956744|FG001|Overall Study|Other|0|||
124816438|NCT02197130|448956745|FG002|Overall Study|Other|3|||
124816439|NCT01473836|448958713|FG000|Overall Study|Adverse Event|4|||
124816440|NCT01473836|448958713|FG000|Overall Study|Lack of Efficacy|1|||
124816441|NCT01473836|448958713|FG000|Overall Study|Does not meet entrance criteria|1|||
124816442|NCT03364023|448958714|FG000|Overall Study|Lost to Follow-up|3|||
124816443|NCT03364023|448958714|FG000|Overall Study|Death|14|||
124816444|NCT00105469|448958717|FG000|Overall Study|Adverse Event|9|||
124816445|NCT00105469|448958718|FG001|Overall Study|Adverse Event|8|||
124816446|NCT00105469|448958717|FG000|Overall Study|Protocol Violation|4|||
124816447|NCT00105469|448958718|FG001|Overall Study|Protocol Violation|0|||
124816448|NCT00105469|448958717|FG000|Overall Study|Withdrawal by Subject|2|||
124816449|NCT00105469|448958718|FG001|Overall Study|Withdrawal by Subject|3|||
124816450|NCT00105469|448958717|FG000|Overall Study|Lost to Follow-up|1|||
124816451|NCT00105469|448958718|FG001|Overall Study|Lost to Follow-up|0|||
124816452|NCT00105469|448958717|FG000|Overall Study|Lack of Efficacy|2|||
124816453|NCT00105469|448958718|FG001|Overall Study|Lack of Efficacy|0|||
124816454|NCT00105469|448958717|FG000|Overall Study|Other Reason|4|||
124816455|NCT00105469|448958718|FG001|Overall Study|Other Reason|0|||
124816456|NCT00599924|448958720|FG000|Overall Study|Lack of Efficacy|3|||
124816457|NCT00599924|448958721|FG001|Overall Study|Lack of Efficacy|5|||
124816458|NCT00599924|448958722|FG002|Overall Study|Lack of Efficacy|1|||
124816459|NCT00599924|448958723|FG003|Overall Study|Lack of Efficacy|2|||
124816460|NCT00599924|448958724|FG004|Overall Study|Lack of Efficacy|3|||
124816461|NCT00599924|448958725|FG005|Overall Study|Lack of Efficacy|2|||
124816462|NCT00599924|448958726|FG006|Overall Study|Lack of Efficacy|0|||
124816463|NCT00599924|448958720|FG000|Overall Study|Adverse Event|0|||
124816464|NCT00599924|448958721|FG001|Overall Study|Adverse Event|0|||
124816465|NCT00599924|448958722|FG002|Overall Study|Adverse Event|0|||
124816466|NCT00599924|448958723|FG003|Overall Study|Adverse Event|2|||
124816467|NCT00599924|448958724|FG004|Overall Study|Adverse Event|0|||
124816468|NCT00599924|448958725|FG005|Overall Study|Adverse Event|0|||
124816469|NCT00599924|448958726|FG006|Overall Study|Adverse Event|2|||
124816470|NCT00599924|448958720|FG000|Overall Study|Death|0|||
124816471|NCT00599924|448958721|FG001|Overall Study|Death|0|||
124816472|NCT00599924|448958722|FG002|Overall Study|Death|0|||
124816473|NCT00599924|448958723|FG003|Overall Study|Death|2|||
124816474|NCT00599924|448958724|FG004|Overall Study|Death|0|||
124816475|NCT00599924|448958725|FG005|Overall Study|Death|2|||
124816476|NCT00599924|448958726|FG006|Overall Study|Death|1|||
124816477|NCT00599924|448958720|FG000|Overall Study|Protocol Violation|0|||
124816478|NCT00599924|448958721|FG001|Overall Study|Protocol Violation|0|||
124816479|NCT00599924|448958722|FG002|Overall Study|Protocol Violation|0|||
124816480|NCT00599924|448958723|FG003|Overall Study|Protocol Violation|1|||
124816481|NCT00599924|448958724|FG004|Overall Study|Protocol Violation|0|||
124816482|NCT00599924|448958725|FG005|Overall Study|Protocol Violation|0|||
124816483|NCT00599924|448958726|FG006|Overall Study|Protocol Violation|0|||
124816484|NCT00599924|448958720|FG000|Overall Study|Withdrawal by Subject|0|||
124816485|NCT00599924|448958721|FG001|Overall Study|Withdrawal by Subject|0|||
124816486|NCT00599924|448958722|FG002|Overall Study|Withdrawal by Subject|1|||
124816487|NCT00599924|448958723|FG003|Overall Study|Withdrawal by Subject|0|||
124816488|NCT00599924|448958724|FG004|Overall Study|Withdrawal by Subject|1|||
124816489|NCT00599924|448958725|FG005|Overall Study|Withdrawal by Subject|0|||
124816490|NCT00599924|448958726|FG006|Overall Study|Withdrawal by Subject|0|||
124816491|NCT00599924|448958720|FG000|Overall Study|Other|0|||
124816492|NCT00599924|448958721|FG001|Overall Study|Other|0|||
124816493|NCT00599924|448958722|FG002|Overall Study|Other|0|||
124816494|NCT00599924|448958723|FG003|Overall Study|Other|1|||
124816495|NCT00599924|448958724|FG004|Overall Study|Other|2|||
124816496|NCT00599924|448958725|FG005|Overall Study|Other|0|||
124816497|NCT00599924|448958726|FG006|Overall Study|Other|2|||
124816498|NCT02601469|448958727|FG000|Overall Study|Enrolled in Error|1|||
124816499|NCT02601469|448958728|FG001|Overall Study|Enrolled in Error|0|||
124816500|NCT01806298|448958729|FG000|Overall Study|Adverse Event|3|||
124816501|NCT01806298|448958729|FG000|Overall Study|Protocol Non-compliance|1|||
124816502|NCT01806298|448958729|FG000|Overall Study|Withdrawal by Subject|1|||
124816503|NCT01806298|448958729|FG000|Overall Study|Other|5|||
124816504|NCT03808545|448958730|FG000|Overall Study|Withdrawal by Subject|1|||
124816505|NCT03808545|448958731|FG001|Overall Study|Withdrawal by Subject|1|||
124816506|NCT00980057|448958736|FG000|Overall Study|Death|13|||
124816507|NCT00980057|448958737|FG001|Overall Study|Death|3|||
124816508|NCT00980057|448958736|FG000|Overall Study|Adverse Event|0|||
124816509|NCT00980057|448958737|FG001|Overall Study|Adverse Event|1|||
124816510|NCT00980057|448958736|FG000|Overall Study|Physician Decision|4|||
124816511|NCT00980057|448958737|FG001|Overall Study|Physician Decision|0|||
124816512|NCT00980057|448958736|FG000|Overall Study|Lost to Follow-up|1|||
124816513|NCT00980057|448958737|FG001|Overall Study|Lost to Follow-up|0|||
124816514|NCT00980057|448958736|FG000|Overall Study|Withdrawal by Subject|1|||
124816515|NCT00980057|448958737|FG001|Overall Study|Withdrawal by Subject|1|||
124816516|NCT04980040|448958738|FG000|Overall Study|Violated the Inclusion Criteria|260|||
124816517|NCT04980040|448958738|FG000|Overall Study|Violated the Administration & Dosage|225|||
124816518|NCT04980040|448958738|FG000|Overall Study|Lost to Safety-Follow-up|4|||
124816519|NCT04980040|448958738|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
124816520|NCT02820753|448958739|FG000|2 Month|Withdrawal by Subject|3|||
124816521|NCT02820753|448958740|FG001|2 Month|Withdrawal by Subject|3|||
124816522|NCT02820753|448958739|FG000|2 Month|Lost to Follow-up|24|||
124816523|NCT02820753|448958740|FG001|2 Month|Lost to Follow-up|26|||
124816524|NCT02820753|448958739|FG000|2 Month|Stopped per NIH Hold|51|||
124816525|NCT02820753|448958740|FG001|2 Month|Stopped per NIH Hold|13|||
124816526|NCT02820753|448958739|FG000|6 Month|Withdrawal by Subject|2|||
124816527|NCT02820753|448958740|FG001|6 Month|Withdrawal by Subject|2|||
124816528|NCT02820753|448958739|FG000|6 Month|Lost to Follow-up|20|||
124816529|NCT02820753|448958740|FG001|6 Month|Lost to Follow-up|27|||
124816530|NCT02820753|448958739|FG000|6 Month|Stopped per NIH Hold|81|||
124816531|NCT02820753|448958740|FG001|6 Month|Stopped per NIH Hold|81|||
124816532|NCT02820753|448958739|FG000|6 Month|Death|0|||
124816533|NCT02820753|448958740|FG001|6 Month|Death|1|||
124816534|NCT00062374|448958744|FG000|Overall Study|Not treated|12|||
124816535|NCT03555591|448958745|FG000|Overall Study|Protocol Violation|77|||
124816536|NCT00840450|448958746|FG000|Overall Study|Adverse Event|1|||
124816537|NCT00840450|448958746|FG000|Overall Study|Lack of Efficacy|2|||
124816538|NCT00617123|448958747|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
124816539|NCT00617123|448958748|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
124816540|NCT00617123|448958747|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
124816541|NCT00617123|448958748|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
124816542|NCT00617123|448958747|FG000|Referral Screening Period|Adverse Event|0|||
124816543|NCT00617123|448958748|FG001|Referral Screening Period|Adverse Event|1|||
124816544|NCT00617123|448958747|FG000|Study Treatment Period|Withdrawal by Subject|8|||
124816545|NCT00617123|448958748|FG001|Study Treatment Period|Withdrawal by Subject|12|||
124816546|NCT00617123|448958747|FG000|Study Treatment Period|Adverse Event|7|||
124816547|NCT00617123|448958748|FG001|Study Treatment Period|Adverse Event|3|||
124816548|NCT00617123|448958747|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
124816549|NCT00617123|448958748|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
124816550|NCT00617123|448958747|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
124816551|NCT00617123|448958748|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
124816552|NCT02170298|448958749|FG000|Overall Study|Withdrawal by Subject|0|||
124816553|NCT02170298|448958750|FG001|Overall Study|Withdrawal by Subject|1|||
124816554|NCT02170298|448958749|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
124816555|NCT02170298|448958750|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
124816556|NCT02128113|448958751|FG000|Overall Study|Withdrawal by Subject|3|||
124816557|NCT02128113|448958752|FG001|Overall Study|Withdrawal by Subject|1|||
124816558|NCT02128113|448958753|FG002|Overall Study|Withdrawal by Subject|0|||
124816559|NCT02128113|448958751|FG000|Overall Study|Protocol Violation|0|||
124816560|NCT02128113|448958752|FG001|Overall Study|Protocol Violation|1|||
124816561|NCT02128113|448958753|FG002|Overall Study|Protocol Violation|0|||
124816562|NCT02128113|448958751|FG000|Overall Study|Surgery cancelled|0|||
124816563|NCT02128113|448958752|FG001|Overall Study|Surgery cancelled|1|||
124816564|NCT02128113|448958753|FG002|Overall Study|Surgery cancelled|0|||
124816565|NCT02128113|448958751|FG000|Overall Study|Adverse Event|0|||
124816566|NCT02128113|448958752|FG001|Overall Study|Adverse Event|0|||
124816567|NCT02128113|448958753|FG002|Overall Study|Adverse Event|1|||
124816568|NCT00003499|448958757|FG000|Overall Study|Not evaluable|8|||
124816569|NCT01854710|448958764|FG000|Overall Study|Withdrawal by Subject|2|||
124816570|NCT01854710|448958765|FG001|Overall Study|Withdrawal by Subject|1|||
124816571|NCT01854710|448958766|FG002|Overall Study|Withdrawal by Subject|0|||
124816572|NCT01854710|448958767|FG003|Overall Study|Withdrawal by Subject|0|||
124816573|NCT01854710|448958768|FG004|Overall Study|Withdrawal by Subject|0|||
124816574|NCT01854710|448958769|FG005|Overall Study|Withdrawal by Subject|0|||
124816575|NCT01854710|448958764|FG000|Overall Study|CRI procedural error|2|||
124816576|NCT01854710|448958765|FG001|Overall Study|CRI procedural error|2|||
124816577|NCT01854710|448958766|FG002|Overall Study|CRI procedural error|2|||
124816578|NCT01854710|448958767|FG003|Overall Study|CRI procedural error|2|||
124816579|NCT01854710|448958768|FG004|Overall Study|CRI procedural error|2|||
124816580|NCT01854710|448958769|FG005|Overall Study|CRI procedural error|2|||
124816581|NCT00370032|448958770|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
124816582|NCT00370032|448958771|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
124816583|NCT00370032|448958770|FG000|Washout Period|Withdrawal by Subject|0|||
124816584|NCT00370032|448958771|FG001|Washout Period|Withdrawal by Subject|1|||
124816585|NCT00370032|448958770|FG000|Washout Period|Lost to Follow-up|0|||
124816586|NCT00370032|448958771|FG001|Washout Period|Lost to Follow-up|1|||
124816587|NCT00370032|448958770|FG000|Washout Period|Adverse Event|1|||
124816588|NCT00370032|448958771|FG001|Washout Period|Adverse Event|0|||
124816589|NCT00370032|448958770|FG000|Follow-up Period|Withdrawal by Subject|1|||
124816590|NCT00370032|448958771|FG001|Follow-up Period|Withdrawal by Subject|0|||
124816591|NCT01844518|448958777|FG000|Overall Study|Adverse Event|7|||
124816592|NCT01844518|448958778|FG001|Overall Study|Adverse Event|1|||
124816593|NCT01844518|448958777|FG000|Overall Study|Lack of Efficacy|17|||
124816594|NCT01844518|448958778|FG001|Overall Study|Lack of Efficacy|5|||
124816595|NCT01844518|448958777|FG000|Overall Study|Participant's request to discontinue|4|||
124816596|NCT01844518|448958778|FG001|Overall Study|Participant's request to discontinue|1|||
124816597|NCT01844518|448958777|FG000|Overall Study|Poor/Non-compliance|1|||
124816598|NCT01844518|448958778|FG001|Overall Study|Poor/Non-compliance|0|||
124816599|NCT01844518|448958777|FG000|Overall Study|No Longer Met Study Criteria|2|||
124816600|NCT01844518|448958778|FG001|Overall Study|No Longer Met Study Criteria|0|||
124816601|NCT01844518|448958777|FG000|Overall Study|Withdrawal by Subject|9|||
124816602|NCT01844518|448958778|FG001|Overall Study|Withdrawal by Subject|0|||
124816603|NCT01844518|448958777|FG000|Overall Study|Pregnancy|1|||
124816604|NCT01844518|448958778|FG001|Overall Study|Pregnancy|0|||
124816605|NCT04584645|448958780|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
124816606|NCT04584645|448958781|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
124816607|NCT00390468|448958782|FG000|Overall Study|Protocol Violation|2|||
124816608|NCT00390468|448958782|FG000|Overall Study|Lack of Efficacy|1|||
124816609|NCT03129100|448958785|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
124816610|NCT03129100|448958786|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
124816611|NCT03129100|448958787|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
124816612|NCT03129100|448958788|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
124816613|NCT03129100|448958789|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
124816614|NCT03129100|448958790|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
124816615|NCT03129100|448958791|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
124816616|NCT03129100|448958792|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
124816617|NCT03129100|448958793|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
124816618|NCT03129100|448958794|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
124816619|NCT03129100|448958795|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
124816620|NCT03129100|448958796|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
124816621|NCT03129100|448958797|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
124816622|NCT03129100|448958798|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
124816623|NCT03129100|448958799|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
124816624|NCT03129100|448958800|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
124816625|NCT03129100|448958801|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
124816626|NCT03129100|448958802|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
124816627|NCT03129100|448958803|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
124816628|NCT03129100|448958804|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
124816629|NCT03129100|448958805|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
124816630|NCT03129100|448958806|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
124816631|NCT03129100|448958807|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
124816632|NCT03129100|448958808|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
124816633|NCT03129100|448958809|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
124816634|NCT03129100|448958810|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
124816635|NCT03129100|448958785|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
124816636|NCT03129100|448958786|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816637|NCT03129100|448958787|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816638|NCT03129100|448958788|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816639|NCT03129100|448958789|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816640|NCT03129100|448958790|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816641|NCT03129100|448958791|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816642|NCT03129100|448958792|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816643|NCT03129100|448958793|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816644|NCT03129100|448958794|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816645|NCT03129100|448958795|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816646|NCT03129100|448958796|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816647|NCT03129100|448958797|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816648|NCT03129100|448958798|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816649|NCT03129100|448958799|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816650|NCT03129100|448958800|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816651|NCT03129100|448958801|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816652|NCT03129100|448958802|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816653|NCT03129100|448958803|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816654|NCT03129100|448958804|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816655|NCT03129100|448958805|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816656|NCT03129100|448958806|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816657|NCT03129100|448958807|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816658|NCT03129100|448958808|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816659|NCT03129100|448958809|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816660|NCT03129100|448958810|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
124816661|NCT03129100|448958785|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
124816662|NCT03129100|448958786|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
124816663|NCT03129100|448958787|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816664|NCT03129100|448958788|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816665|NCT03129100|448958789|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816666|NCT03129100|448958790|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816667|NCT03129100|448958791|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816668|NCT03129100|448958792|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816669|NCT03129100|448958793|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816670|NCT03129100|448958794|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816671|NCT03129100|448958795|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816672|NCT03129100|448958796|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816673|NCT03129100|448958797|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816674|NCT03129100|448958798|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816675|NCT03129100|448958799|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816676|NCT03129100|448958800|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816677|NCT03129100|448958801|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816678|NCT03129100|448958802|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816679|NCT03129100|448958803|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816680|NCT03129100|448958804|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816681|NCT03129100|448958805|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816682|NCT03129100|448958806|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816683|NCT03129100|448958807|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816684|NCT03129100|448958808|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816685|NCT03129100|448958809|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816686|NCT03129100|448958810|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
124816687|NCT03129100|448958785|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
124816688|NCT03129100|448958786|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
124816689|NCT03129100|448958787|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816690|NCT03129100|448958788|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816691|NCT03129100|448958789|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816692|NCT03129100|448958790|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816693|NCT03129100|448958791|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816694|NCT03129100|448958792|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816695|NCT03129100|448958793|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816696|NCT03129100|448958794|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816697|NCT03129100|448958795|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816698|NCT03129100|448958796|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816699|NCT03129100|448958797|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816700|NCT03129100|448958798|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816701|NCT03129100|448958799|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816702|NCT03129100|448958800|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816703|NCT03129100|448958801|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816704|NCT03129100|448958802|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816705|NCT03129100|448958803|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816706|NCT03129100|448958804|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816707|NCT03129100|448958805|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124637139|NCT03363776|448288711|FG002|Overall Study|Study drug toxicity|1|||
124816708|NCT03129100|448958806|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816709|NCT03129100|448958807|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816710|NCT03129100|448958808|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816711|NCT03129100|448958809|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816712|NCT03129100|448958810|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
124816713|NCT03129100|448958785|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816714|NCT03129100|448958786|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
124816715|NCT03129100|448958787|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816716|NCT03129100|448958788|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816717|NCT03129100|448958789|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816718|NCT03129100|448958790|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816719|NCT03129100|448958791|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816720|NCT03129100|448958792|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816721|NCT03129100|448958793|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816722|NCT03129100|448958794|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816723|NCT03129100|448958795|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816724|NCT03129100|448958796|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816725|NCT03129100|448958797|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816726|NCT03129100|448958798|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816727|NCT03129100|448958799|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816728|NCT03129100|448958800|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816729|NCT03129100|448958801|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816730|NCT03129100|448958802|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816731|NCT03129100|448958803|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816732|NCT03129100|448958804|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816733|NCT03129100|448958805|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816734|NCT03129100|448958806|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816735|NCT03129100|448958807|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816736|NCT03129100|448958808|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816737|NCT03129100|448958809|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816738|NCT03129100|448958810|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
124816739|NCT03129100|448958785|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816740|NCT03129100|448958786|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816741|NCT03129100|448958787|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
124816742|NCT03129100|448958788|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
124816743|NCT03129100|448958789|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816744|NCT03129100|448958790|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
124816745|NCT03129100|448958791|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816746|NCT03129100|448958792|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816747|NCT03129100|448958793|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816748|NCT03129100|448958794|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816749|NCT03129100|448958795|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816750|NCT03129100|448958796|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816751|NCT03129100|448958797|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816752|NCT03129100|448958798|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816753|NCT03129100|448958799|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816754|NCT03129100|448958800|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816755|NCT03129100|448958801|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816756|NCT03129100|448958802|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816757|NCT03129100|448958803|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816758|NCT03129100|448958804|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816759|NCT03129100|448958805|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816760|NCT03129100|448958806|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816761|NCT03129100|448958807|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816762|NCT03129100|448958808|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816763|NCT03129100|448958809|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816764|NCT03129100|448958810|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
124816765|NCT03129100|448958785|FG000|Period2 Extension Period (Group A and B)|Death|0|||
124816766|NCT03129100|448958786|FG001|Period2 Extension Period (Group A and B)|Death|0|||
124816767|NCT03129100|448958787|FG002|Period2 Extension Period (Group A and B)|Death|1|||
124816768|NCT03129100|448958788|FG003|Period2 Extension Period (Group A and B)|Death|0|||
124816769|NCT03129100|448958789|FG004|Period2 Extension Period (Group A and B)|Death|0|||
124816770|NCT03129100|448958790|FG005|Period2 Extension Period (Group A and B)|Death|0|||
124816771|NCT03129100|448958791|FG006|Period2 Extension Period (Group A and B)|Death|0|||
124816772|NCT03129100|448958792|FG007|Period2 Extension Period (Group A and B)|Death|0|||
124816773|NCT03129100|448958793|FG008|Period2 Extension Period (Group A and B)|Death|0|||
124816774|NCT03129100|448958794|FG009|Period2 Extension Period (Group A and B)|Death|0|||
124816775|NCT03129100|448958795|FG010|Period2 Extension Period (Group A and B)|Death|0|||
124816776|NCT03129100|448958796|FG011|Period2 Extension Period (Group A and B)|Death|0|||
124816777|NCT03129100|448958797|FG012|Period2 Extension Period (Group A and B)|Death|0|||
124816778|NCT03129100|448958798|FG013|Period2 Extension Period (Group A and B)|Death|0|||
124816779|NCT03129100|448958799|FG014|Period2 Extension Period (Group A and B)|Death|0|||
124816780|NCT03129100|448958800|FG015|Period2 Extension Period (Group A and B)|Death|0|||
124816781|NCT03129100|448958801|FG016|Period2 Extension Period (Group A and B)|Death|0|||
124816782|NCT03129100|448958802|FG017|Period2 Extension Period (Group A and B)|Death|0|||
124816783|NCT03129100|448958803|FG018|Period2 Extension Period (Group A and B)|Death|0|||
124816784|NCT03129100|448958804|FG019|Period2 Extension Period (Group A and B)|Death|0|||
124816785|NCT03129100|448958805|FG020|Period2 Extension Period (Group A and B)|Death|0|||
124816786|NCT03129100|448958806|FG021|Period2 Extension Period (Group A and B)|Death|0|||
124816787|NCT03129100|448958807|FG022|Period2 Extension Period (Group A and B)|Death|0|||
124816788|NCT03129100|448958808|FG023|Period2 Extension Period (Group A and B)|Death|0|||
124816789|NCT03129100|448958809|FG024|Period2 Extension Period (Group A and B)|Death|0|||
124816790|NCT03129100|448958810|FG025|Period2 Extension Period (Group A and B)|Death|0|||
124816791|NCT03129100|448958785|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816792|NCT03129100|448958786|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816793|NCT03129100|448958787|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
124816794|NCT03129100|448958788|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
124816795|NCT03129100|448958789|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
124816796|NCT03129100|448958790|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
124816797|NCT03129100|448958791|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
124816798|NCT03129100|448958792|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816799|NCT03129100|448958793|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816800|NCT03129100|448958794|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816801|NCT03129100|448958795|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816802|NCT03129100|448958796|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816803|NCT03129100|448958797|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816804|NCT03129100|448958798|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816805|NCT03129100|448958799|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816806|NCT03129100|448958800|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816807|NCT03129100|448958801|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816808|NCT03129100|448958802|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816809|NCT03129100|448958803|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816810|NCT03129100|448958804|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816811|NCT03129100|448958805|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816812|NCT03129100|448958806|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816813|NCT03129100|448958807|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816814|NCT03129100|448958808|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816815|NCT03129100|448958809|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816816|NCT03129100|448958810|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
124816817|NCT03129100|448958785|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816818|NCT03129100|448958786|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816819|NCT03129100|448958787|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
124816820|NCT03129100|448958788|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816821|NCT03129100|448958789|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816822|NCT03129100|448958790|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816823|NCT03129100|448958791|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816824|NCT03129100|448958792|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816825|NCT03129100|448958793|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816826|NCT03129100|448958794|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816827|NCT03129100|448958795|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816828|NCT03129100|448958796|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816829|NCT03129100|448958797|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816830|NCT03129100|448958798|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816831|NCT03129100|448958799|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816832|NCT03129100|448958800|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816833|NCT03129100|448958801|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816834|NCT03129100|448958802|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816835|NCT03129100|448958803|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816836|NCT03129100|448958804|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816837|NCT03129100|448958805|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816838|NCT03129100|448958806|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816839|NCT03129100|448958807|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816840|NCT03129100|448958808|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816841|NCT03129100|448958809|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816842|NCT03129100|448958810|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
124816843|NCT03129100|448958785|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816844|NCT03129100|448958786|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816845|NCT03129100|448958787|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
124816846|NCT03129100|448958788|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816847|NCT03129100|448958789|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816848|NCT03129100|448958790|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816849|NCT03129100|448958791|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816850|NCT03129100|448958792|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816851|NCT03129100|448958793|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816852|NCT03129100|448958794|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816853|NCT03129100|448958795|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816854|NCT03129100|448958796|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816855|NCT03129100|448958797|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816856|NCT03129100|448958798|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816857|NCT03129100|448958799|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816858|NCT03129100|448958800|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816859|NCT03129100|448958801|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816860|NCT03129100|448958802|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816861|NCT03129100|448958803|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816862|NCT03129100|448958804|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816863|NCT03129100|448958805|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816864|NCT03129100|448958806|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816865|NCT03129100|448958807|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816866|NCT03129100|448958808|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816867|NCT03129100|448958809|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816868|NCT03129100|448958810|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
124816869|NCT03129100|448958785|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816870|NCT03129100|448958786|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816871|NCT03129100|448958787|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
124816872|NCT03129100|448958788|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816873|NCT03129100|448958789|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816874|NCT03129100|448958790|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816875|NCT03129100|448958791|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816876|NCT03129100|448958792|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816877|NCT03129100|448958793|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816878|NCT03129100|448958794|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816879|NCT03129100|448958795|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816880|NCT03129100|448958796|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816881|NCT03129100|448958797|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816882|NCT03129100|448958798|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816883|NCT03129100|448958799|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816884|NCT03129100|448958800|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816885|NCT03129100|448958801|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816886|NCT03129100|448958802|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816887|NCT03129100|448958803|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816888|NCT03129100|448958804|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816889|NCT03129100|448958805|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816890|NCT03129100|448958806|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816891|NCT03129100|448958807|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816892|NCT03129100|448958808|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816893|NCT03129100|448958809|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816894|NCT03129100|448958810|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
124816895|NCT03129100|448958785|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816896|NCT03129100|448958786|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816897|NCT03129100|448958787|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816898|NCT03129100|448958788|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816899|NCT03129100|448958789|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
124816900|NCT03129100|448958790|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
124816901|NCT03129100|448958791|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
124816902|NCT03129100|448958792|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816903|NCT03129100|448958793|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816904|NCT03129100|448958794|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816905|NCT03129100|448958795|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816906|NCT03129100|448958796|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816907|NCT03129100|448958797|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816908|NCT03129100|448958798|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816909|NCT03129100|448958799|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816910|NCT03129100|448958800|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816911|NCT03129100|448958801|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816912|NCT03129100|448958802|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816913|NCT03129100|448958803|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816914|NCT03129100|448958804|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816915|NCT03129100|448958805|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816916|NCT03129100|448958806|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816917|NCT03129100|448958807|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816918|NCT03129100|448958808|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816919|NCT03129100|448958809|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816920|NCT03129100|448958810|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
124816921|NCT03129100|448958785|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816922|NCT03129100|448958786|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816923|NCT03129100|448958787|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816924|NCT03129100|448958788|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816925|NCT03129100|448958789|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816926|NCT03129100|448958790|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816927|NCT03129100|448958791|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816928|NCT03129100|448958792|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816929|NCT03129100|448958793|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816930|NCT03129100|448958794|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
124816931|NCT03129100|448958795|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816932|NCT03129100|448958796|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816933|NCT03129100|448958797|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816934|NCT03129100|448958798|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816935|NCT03129100|448958799|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816936|NCT03129100|448958800|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816937|NCT03129100|448958801|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816938|NCT03129100|448958802|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816939|NCT03129100|448958803|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816940|NCT03129100|448958804|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816941|NCT03129100|448958805|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816942|NCT03129100|448958806|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816943|NCT03129100|448958807|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816944|NCT03129100|448958808|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816945|NCT03129100|448958809|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816946|NCT03129100|448958810|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
124816947|NCT03129100|448958785|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816948|NCT03129100|448958786|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816949|NCT03129100|448958787|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816950|NCT03129100|448958788|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816951|NCT03129100|448958789|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816952|NCT03129100|448958790|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816953|NCT03129100|448958791|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816954|NCT03129100|448958792|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816955|NCT03129100|448958793|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816956|NCT03129100|448958794|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816957|NCT03129100|448958795|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816958|NCT03129100|448958796|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
124816959|NCT03129100|448958797|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816960|NCT03129100|448958798|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816961|NCT03129100|448958799|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816962|NCT03129100|448958800|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816963|NCT03129100|448958801|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816964|NCT03129100|448958802|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816965|NCT03129100|448958803|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816966|NCT03129100|448958804|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816967|NCT03129100|448958805|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816968|NCT03129100|448958806|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816969|NCT03129100|448958807|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816970|NCT03129100|448958808|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816971|NCT03129100|448958809|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816972|NCT03129100|448958810|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
124816973|NCT03129100|448958785|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816974|NCT03129100|448958786|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816975|NCT03129100|448958787|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816976|NCT03129100|448958788|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816977|NCT03129100|448958789|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816978|NCT03129100|448958790|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816979|NCT03129100|448958791|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816980|NCT03129100|448958792|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816981|NCT03129100|448958793|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816982|NCT03129100|448958794|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816983|NCT03129100|448958795|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816984|NCT03129100|448958796|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
124816985|NCT03129100|448958797|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
124816986|NCT03129100|448958798|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
124816987|NCT03129100|448958799|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
124816988|NCT03129100|448958800|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816989|NCT03129100|448958801|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816990|NCT03129100|448958802|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816991|NCT03129100|448958803|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816992|NCT03129100|448958804|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816993|NCT03129100|448958805|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816994|NCT03129100|448958806|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816995|NCT03129100|448958807|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816996|NCT03129100|448958808|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816997|NCT03129100|448958809|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816998|NCT03129100|448958810|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
124816999|NCT03129100|448958785|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817000|NCT03129100|448958786|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817001|NCT03129100|448958787|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817002|NCT03129100|448958788|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817003|NCT03129100|448958789|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817004|NCT03129100|448958790|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817005|NCT03129100|448958791|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817006|NCT03129100|448958792|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817007|NCT03129100|448958793|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817008|NCT03129100|448958794|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817009|NCT03129100|448958795|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817010|NCT03129100|448958796|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
124817011|NCT03129100|448958797|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817012|NCT03129100|448958798|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
124817013|NCT03129100|448958799|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
124817014|NCT03129100|448958800|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817015|NCT03129100|448958801|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817016|NCT03129100|448958802|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817017|NCT03129100|448958803|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817018|NCT03129100|448958804|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817019|NCT03129100|448958805|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817020|NCT03129100|448958806|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817021|NCT03129100|448958807|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817022|NCT03129100|448958808|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817023|NCT03129100|448958809|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817024|NCT03129100|448958810|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
124817025|NCT03129100|448958785|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817026|NCT03129100|448958786|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817027|NCT03129100|448958787|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817028|NCT03129100|448958788|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817029|NCT03129100|448958789|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817030|NCT03129100|448958790|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817031|NCT03129100|448958791|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817032|NCT03129100|448958792|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817033|NCT03129100|448958793|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817034|NCT03129100|448958794|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817035|NCT03129100|448958795|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817036|NCT03129100|448958796|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817037|NCT03129100|448958797|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817038|NCT03129100|448958798|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817039|NCT03129100|448958799|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817040|NCT03129100|448958800|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
124817041|NCT03129100|448958801|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817042|NCT03129100|448958802|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817043|NCT03129100|448958803|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817044|NCT03129100|448958804|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817045|NCT03129100|448958805|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817046|NCT03129100|448958806|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817047|NCT03129100|448958807|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817048|NCT03129100|448958808|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817049|NCT03129100|448958809|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817050|NCT03129100|448958810|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
124817051|NCT03129100|448958785|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817052|NCT03129100|448958786|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817053|NCT03129100|448958787|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817054|NCT03129100|448958788|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817055|NCT03129100|448958789|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817056|NCT03129100|448958790|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817057|NCT03129100|448958791|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817058|NCT03129100|448958792|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817059|NCT03129100|448958793|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817060|NCT03129100|448958794|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817061|NCT03129100|448958795|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817062|NCT03129100|448958796|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817063|NCT03129100|448958797|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
124817064|NCT03129100|448958798|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817065|NCT03129100|448958799|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
124817066|NCT03129100|448958800|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
124817067|NCT03129100|448958801|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817068|NCT03129100|448958802|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817069|NCT03129100|448958803|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817070|NCT03129100|448958804|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817071|NCT03129100|448958805|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817072|NCT03129100|448958806|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817073|NCT03129100|448958807|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817074|NCT03129100|448958808|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817075|NCT03129100|448958809|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817076|NCT03129100|448958810|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
124817077|NCT03129100|448958785|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817078|NCT03129100|448958786|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817079|NCT03129100|448958787|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817080|NCT03129100|448958788|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817081|NCT03129100|448958789|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817082|NCT03129100|448958790|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817083|NCT03129100|448958791|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817084|NCT03129100|448958792|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817085|NCT03129100|448958793|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817086|NCT03129100|448958794|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817087|NCT03129100|448958795|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817088|NCT03129100|448958796|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817089|NCT03129100|448958797|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817090|NCT03129100|448958798|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817091|NCT03129100|448958799|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817092|NCT03129100|448958800|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817093|NCT03129100|448958801|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817094|NCT03129100|448958802|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
124817095|NCT03129100|448958803|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817096|NCT03129100|448958804|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
124817097|NCT03129100|448958805|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817098|NCT03129100|448958806|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817099|NCT03129100|448958807|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817100|NCT03129100|448958808|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817101|NCT03129100|448958809|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817102|NCT03129100|448958810|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
124817103|NCT03129100|448958785|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817104|NCT03129100|448958786|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817105|NCT03129100|448958787|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817106|NCT03129100|448958788|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817107|NCT03129100|448958789|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817108|NCT03129100|448958790|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817109|NCT03129100|448958791|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817110|NCT03129100|448958792|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817111|NCT03129100|448958793|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817112|NCT03129100|448958794|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817113|NCT03129100|448958795|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817114|NCT03129100|448958796|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817115|NCT03129100|448958797|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817116|NCT03129100|448958798|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817117|NCT03129100|448958799|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817118|NCT03129100|448958800|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817119|NCT03129100|448958801|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817120|NCT03129100|448958802|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817121|NCT03129100|448958803|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817122|NCT03129100|448958804|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817123|NCT03129100|448958805|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
124817124|NCT03129100|448958806|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817125|NCT03129100|448958807|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817126|NCT03129100|448958808|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817127|NCT03129100|448958809|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817128|NCT03129100|448958810|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
124817129|NCT03129100|448958785|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
124817130|NCT03129100|448958786|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
124817131|NCT03129100|448958787|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
124817132|NCT03129100|448958788|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
124817133|NCT03129100|448958789|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
124817134|NCT03129100|448958790|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
124817135|NCT03129100|448958791|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
124817136|NCT03129100|448958792|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
124817137|NCT03129100|448958793|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
124817138|NCT03129100|448958794|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
124817139|NCT03129100|448958795|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
124817140|NCT03129100|448958796|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
124817141|NCT03129100|448958797|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
124817142|NCT03129100|448958798|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
124817143|NCT03129100|448958799|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
124817144|NCT03129100|448958800|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
124817145|NCT03129100|448958801|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
124817146|NCT03129100|448958802|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
124817147|NCT03129100|448958803|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
124817148|NCT03129100|448958804|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
124817149|NCT03129100|448958805|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
124817150|NCT03129100|448958806|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
124817151|NCT03129100|448958807|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
124817152|NCT03129100|448958808|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
124817153|NCT03129100|448958809|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
124817154|NCT03129100|448958810|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
124817155|NCT03129100|448958785|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817156|NCT03129100|448958786|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817157|NCT03129100|448958787|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817158|NCT03129100|448958788|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817159|NCT03129100|448958789|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817160|NCT03129100|448958790|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817161|NCT03129100|448958791|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817162|NCT03129100|448958792|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817163|NCT03129100|448958793|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817164|NCT03129100|448958794|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817165|NCT03129100|448958795|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817166|NCT03129100|448958796|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817167|NCT03129100|448958797|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817168|NCT03129100|448958798|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817169|NCT03129100|448958799|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817170|NCT03129100|448958800|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817171|NCT03129100|448958801|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817172|NCT03129100|448958802|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817173|NCT03129100|448958803|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817174|NCT03129100|448958804|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817175|NCT03129100|448958805|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
124817176|NCT03129100|448958806|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817177|NCT03129100|448958807|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817178|NCT03129100|448958808|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817179|NCT03129100|448958809|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817180|NCT03129100|448958810|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
124817181|NCT03129100|448958785|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
124817182|NCT03129100|448958786|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
124817183|NCT03129100|448958787|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
124817184|NCT03129100|448958788|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
124817185|NCT03129100|448958789|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
124817186|NCT03129100|448958790|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
124817187|NCT03129100|448958791|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
124817188|NCT03129100|448958792|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
124817189|NCT03129100|448958793|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
124817190|NCT03129100|448958794|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
124817191|NCT03129100|448958795|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
124817192|NCT03129100|448958796|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
124817193|NCT03129100|448958797|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
124817194|NCT03129100|448958798|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
124817195|NCT03129100|448958799|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
124817196|NCT03129100|448958800|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
124817197|NCT03129100|448958801|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
124817198|NCT03129100|448958802|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
124817199|NCT03129100|448958803|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
124817200|NCT03129100|448958804|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
124817201|NCT03129100|448958805|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
124817202|NCT03129100|448958806|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
124817203|NCT03129100|448958807|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
124817204|NCT03129100|448958808|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
124817205|NCT03129100|448958809|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
124817206|NCT03129100|448958810|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
124817207|NCT03129100|448958785|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817208|NCT03129100|448958786|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817209|NCT03129100|448958787|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817210|NCT03129100|448958788|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817211|NCT03129100|448958789|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817212|NCT03129100|448958790|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817213|NCT03129100|448958791|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817214|NCT03129100|448958792|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817215|NCT03129100|448958793|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817216|NCT03129100|448958794|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817217|NCT03129100|448958795|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817218|NCT03129100|448958796|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817219|NCT03129100|448958797|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817220|NCT03129100|448958798|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817221|NCT03129100|448958799|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817222|NCT03129100|448958800|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817223|NCT03129100|448958801|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817224|NCT03129100|448958802|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817225|NCT03129100|448958803|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817226|NCT03129100|448958804|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817227|NCT03129100|448958805|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817228|NCT03129100|448958806|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817229|NCT03129100|448958807|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817230|NCT03129100|448958808|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
124817231|NCT03129100|448958809|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
124817232|NCT03129100|448958810|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
124817233|NCT03129100|448958785|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817234|NCT03129100|448958786|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817235|NCT03129100|448958787|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817236|NCT03129100|448958788|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817237|NCT03129100|448958789|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817238|NCT03129100|448958790|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817239|NCT03129100|448958791|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817240|NCT03129100|448958792|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817241|NCT03129100|448958793|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817242|NCT03129100|448958794|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817243|NCT03129100|448958795|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817244|NCT03129100|448958796|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817245|NCT03129100|448958797|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817246|NCT03129100|448958798|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817247|NCT03129100|448958799|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817248|NCT03129100|448958800|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817249|NCT03129100|448958801|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817250|NCT03129100|448958802|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817251|NCT03129100|448958803|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817252|NCT03129100|448958804|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817253|NCT03129100|448958805|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817254|NCT03129100|448958806|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817255|NCT03129100|448958807|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
124817256|NCT03129100|448958808|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
124817257|NCT03129100|448958809|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
124817258|NCT03129100|448958810|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
124817259|NCT03129100|448958785|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817260|NCT03129100|448958786|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817261|NCT03129100|448958787|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817262|NCT03129100|448958788|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817263|NCT03129100|448958789|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817264|NCT03129100|448958790|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817265|NCT03129100|448958791|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817266|NCT03129100|448958792|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817267|NCT03129100|448958793|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817268|NCT03129100|448958794|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817269|NCT03129100|448958795|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817270|NCT03129100|448958796|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817271|NCT03129100|448958797|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817272|NCT03129100|448958798|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817273|NCT03129100|448958799|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817274|NCT03129100|448958800|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817275|NCT03129100|448958801|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817276|NCT03129100|448958802|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817277|NCT03129100|448958803|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817278|NCT03129100|448958804|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817279|NCT03129100|448958805|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817280|NCT03129100|448958806|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817281|NCT03129100|448958807|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817282|NCT03129100|448958808|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817283|NCT03129100|448958809|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
124817284|NCT03129100|448958810|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
124817285|NCT03129100|448958785|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817286|NCT03129100|448958786|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817287|NCT03129100|448958787|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817288|NCT03129100|448958788|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817289|NCT03129100|448958789|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817290|NCT03129100|448958790|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817291|NCT03129100|448958791|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817292|NCT03129100|448958792|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817293|NCT03129100|448958793|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817294|NCT03129100|448958794|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817295|NCT03129100|448958795|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817296|NCT03129100|448958796|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817297|NCT03129100|448958797|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817298|NCT03129100|448958798|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817299|NCT03129100|448958799|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817300|NCT03129100|448958800|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817301|NCT03129100|448958801|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817302|NCT03129100|448958802|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817303|NCT03129100|448958803|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817304|NCT03129100|448958804|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817305|NCT03129100|448958805|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817306|NCT03129100|448958806|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817307|NCT03129100|448958807|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817308|NCT03129100|448958808|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817309|NCT03129100|448958809|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
124817310|NCT03129100|448958810|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
124817311|NCT03129100|448958785|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
124817312|NCT03129100|448958786|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
124817313|NCT03129100|448958787|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
124817314|NCT03129100|448958788|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
124817315|NCT03129100|448958789|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
124817316|NCT03129100|448958790|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
124817317|NCT03129100|448958791|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
124817318|NCT03129100|448958792|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
124817319|NCT03129100|448958793|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
124817320|NCT03129100|448958794|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
124817321|NCT03129100|448958795|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
124817322|NCT03129100|448958796|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
124817323|NCT03129100|448958797|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
124817324|NCT03129100|448958798|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
124817325|NCT03129100|448958799|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
124817326|NCT03129100|448958800|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
124817327|NCT03129100|448958801|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
124817328|NCT03129100|448958802|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
124817329|NCT03129100|448958803|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
124817330|NCT03129100|448958804|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
124817331|NCT03129100|448958805|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
124817332|NCT03129100|448958806|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
124817333|NCT03129100|448958807|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
124817334|NCT03129100|448958808|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
124817335|NCT03129100|448958809|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
124817336|NCT03129100|448958810|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
124817337|NCT03845985|448958811|FG000|Overall Study|Lost to Follow-up|2|||
124817338|NCT03845985|448958812|FG001|Overall Study|Lost to Follow-up|1|||
124817339|NCT03845985|448958811|FG000|Overall Study|Physician Decision|1|||
124817340|NCT03845985|448958812|FG001|Overall Study|Physician Decision|0|||
124817341|NCT03845985|448958811|FG000|Overall Study|Withdrawal by Subject|4|||
124817342|NCT03845985|448958812|FG001|Overall Study|Withdrawal by Subject|1|||
124817343|NCT03334539|448958815|FG000|Overall Study|Adverse Event|3|||
124817344|NCT03334539|448958816|FG001|Overall Study|Adverse Event|5|||
124817345|NCT03334539|448958817|FG002|Overall Study|Adverse Event|0|||
124817346|NCT03334539|448958815|FG000|Overall Study|Withdrawal by Subject|0|||
124817347|NCT03334539|448958816|FG001|Overall Study|Withdrawal by Subject|1|||
124817348|NCT03334539|448958817|FG002|Overall Study|Withdrawal by Subject|1|||
124817349|NCT03334539|448958815|FG000|Overall Study|Administrative Reasons|1|||
124817350|NCT03334539|448958816|FG001|Overall Study|Administrative Reasons|0|||
124817351|NCT03334539|448958817|FG002|Overall Study|Administrative Reasons|0|||
124817352|NCT03334539|448958815|FG000|Overall Study|Hypertension Not Controlled|0|||
124817353|NCT03334539|448958816|FG001|Overall Study|Hypertension Not Controlled|1|||
124817354|NCT03334539|448958817|FG002|Overall Study|Hypertension Not Controlled|0|||
124817355|NCT03736447|448958819|FG000|Overall Study|Adverse Event|5|||
124817356|NCT03736447|448958820|FG001|Overall Study|Adverse Event|1|||
124817357|NCT03736447|448958819|FG000|Overall Study|Withdrawal by Subject|5|||
124817358|NCT03736447|448958820|FG001|Overall Study|Withdrawal by Subject|1|||
124817359|NCT03736447|448958819|FG000|Overall Study|Lost to Follow-up|1|||
124817360|NCT03736447|448958820|FG001|Overall Study|Lost to Follow-up|0|||
124817361|NCT03736447|448958819|FG000|Overall Study|Physician Decision|1|||
124817362|NCT03736447|448958820|FG001|Overall Study|Physician Decision|0|||
124817363|NCT03736447|448958819|FG000|Overall Study|Continued commitment to study treatment|3|||
124817364|NCT03736447|448958820|FG001|Overall Study|Continued commitment to study treatment|0|||
124817365|NCT03736447|448958819|FG000|Overall Study|Taste aversion to study product|0|||
124817366|NCT03736447|448958820|FG001|Overall Study|Taste aversion to study product|1|||
124817367|NCT00968201|448958821|FG000|Base Study - (Period II)|Adverse Event|8|||
124817368|NCT00968201|448958822|FG001|Base Study - (Period II)|Adverse Event|0|||
124817369|NCT00968201|448958823|FG002|Base Study - (Period II)|Adverse Event|16|||
124817370|NCT00968201|448958821|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
124817371|NCT00968201|448958822|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
124817372|NCT00968201|448958823|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
124817373|NCT00968201|448958821|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
124817374|NCT00968201|448958822|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
124817375|NCT00968201|448958823|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
124817376|NCT00968201|448958821|FG000|Base Study - (Period II)|Protocol Violation|12|||
124817377|NCT00968201|448958822|FG001|Base Study - (Period II)|Protocol Violation|0|||
124817378|NCT00968201|448958823|FG002|Base Study - (Period II)|Protocol Violation|12|||
124817379|NCT00968201|448958821|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
124817380|NCT00968201|448958822|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
124817381|NCT00968201|448958823|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
124817382|NCT00968201|448958821|FG000|Base Study - (Period II)|Site Error|0|||
124817383|NCT00968201|448958822|FG001|Base Study - (Period II)|Site Error|0|||
124817384|NCT00968201|448958823|FG002|Base Study - (Period II)|Site Error|1|||
124817385|NCT00968201|448958821|FG000|Extension Study - (Period III)|Adverse Event|0|||
124817386|NCT00968201|448958822|FG001|Extension Study - (Period III)|Adverse Event|5|||
124817387|NCT00968201|448958823|FG002|Extension Study - (Period III)|Adverse Event|22|||
124817388|NCT00968201|448958821|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
124817389|NCT00968201|448958822|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
124817390|NCT00968201|448958823|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
124817391|NCT00968201|448958821|FG000|Extension Study - (Period III)|Protocol Violation|0|||
124817392|NCT00968201|448958822|FG001|Extension Study - (Period III)|Protocol Violation|17|||
124817393|NCT00968201|448958823|FG002|Extension Study - (Period III)|Protocol Violation|14|||
124817394|NCT00968201|448958821|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
124817395|NCT00968201|448958822|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
124817396|NCT00968201|448958823|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
124817397|NCT00968201|448958821|FG000|Extension Study - (Period III)|Patient Relocated|0|||
124817398|NCT00968201|448958822|FG001|Extension Study - (Period III)|Patient Relocated|1|||
124817399|NCT00968201|448958823|FG002|Extension Study - (Period III)|Patient Relocated|1|||
124817400|NCT00968201|448958821|FG000|Extension Study - (Period III)|Noncompliance|0|||
124817401|NCT00968201|448958822|FG001|Extension Study - (Period III)|Noncompliance|0|||
124817402|NCT00968201|448958823|FG002|Extension Study - (Period III)|Noncompliance|3|||
124817403|NCT00968201|448958821|FG000|Extension Study - (Period III)|Other|0|||
124817404|NCT00968201|448958822|FG001|Extension Study - (Period III)|Other|0|||
124817405|NCT00968201|448958823|FG002|Extension Study - (Period III)|Other|2|||
124817406|NCT00968201|448958821|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
124817407|NCT00968201|448958822|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
124817408|NCT00968201|448958823|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
124817409|NCT02619175|448958824|FG000|Overall Study|Withdrawal by Subject|1|||
124817410|NCT02619175|448958825|FG001|Overall Study|Withdrawal by Subject|0|||
124817411|NCT02619175|448958824|FG000|Overall Study|foot pain|1|||
124817412|NCT02619175|448958825|FG001|Overall Study|foot pain|0|||
124817413|NCT04974697|448958826|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
124817414|NCT04974697|448958826|FG000|Overall Study|Lens discomfort|1|||
124817415|NCT03706456|448958828|FG000|Overall Study|Adverse Event|1|||
124817416|NCT03706456|448958828|FG000|Overall Study|Lack of Efficacy|2|||
124817417|NCT02784431|448958829|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
124817418|NCT02784431|448958829|FG000|Overall Study|Early Study Termination|19|||
124817419|NCT03302234|448958832|FG000|Overall Study|Death|191|||
124817420|NCT03302234|448958833|FG001|Overall Study|Death|192|||
124817421|NCT03302234|448958832|FG000|Overall Study|Withdrawal by Subject|2|||
124817422|NCT03302234|448958833|FG001|Overall Study|Withdrawal by Subject|2|||
124817423|NCT03302234|448958832|FG000|Overall Study|Sponsor Decision|90|||
124817424|NCT03302234|448958833|FG001|Overall Study|Sponsor Decision|89|||
124817425|NCT03302234|448958832|FG000|Overall Study|Laryngeal carcinoma|0|||
124817426|NCT03302234|448958833|FG001|Overall Study|Laryngeal carcinoma|1|||
124817427|NCT03302234|448958832|FG000|Overall Study|Not Reported|1|||
124817428|NCT03302234|448958833|FG001|Overall Study|Not Reported|0|||
124817429|NCT02795832|448958834|FG000|Overall Study|Adverse Event|0|||
124817430|NCT02795832|448958835|FG001|Overall Study|Adverse Event|0|||
124817431|NCT02795832|448958836|FG002|Overall Study|Adverse Event|0|||
124817432|NCT02795832|448958837|FG003|Overall Study|Adverse Event|0|||
124817433|NCT02795832|448958838|FG004|Overall Study|Adverse Event|0|||
124817434|NCT02795832|448958839|FG005|Overall Study|Adverse Event|3|||
124817435|NCT04523220|448958840|FG000|Main Treatment Period|Physician Decision|1|||
124817436|NCT04523220|448958841|FG001|Main Treatment Period|Physician Decision|1|||
124817437|NCT04523220|448958842|FG002|Main Treatment Period|Physician Decision|0|||
124817438|NCT04523220|448958840|FG000|Main Treatment Period|Other|5|||
124817439|NCT04523220|448958841|FG001|Main Treatment Period|Other|2|||
124817440|NCT04523220|448958842|FG002|Main Treatment Period|Other|4|||
124817441|NCT04523220|448958840|FG000|Main Treatment Period|Subject Decision|5|||
124817442|NCT04523220|448958841|FG001|Main Treatment Period|Subject Decision|7|||
124817443|NCT04523220|448958842|FG002|Main Treatment Period|Subject Decision|3|||
124817444|NCT04523220|448958840|FG000|Main Treatment Period|Death|5|||
124817445|NCT04523220|448958841|FG001|Main Treatment Period|Death|11|||
124817446|NCT04523220|448958842|FG002|Main Treatment Period|Death|4|||
124817447|NCT04523220|448958840|FG000|Main Treatment Period|Adverse Event|11|||
124817448|NCT04523220|448958841|FG001|Main Treatment Period|Adverse Event|9|||
124817449|NCT04523220|448958842|FG002|Main Treatment Period|Adverse Event|9|||
124817450|NCT04523220|448958840|FG000|Main Treatment Period|Withdrawal by Subject|3|||
124817451|NCT04523220|448958841|FG001|Main Treatment Period|Withdrawal by Subject|3|||
124817452|NCT04523220|448958842|FG002|Main Treatment Period|Withdrawal by Subject|4|||
124817453|NCT04523220|448958840|FG000|Main Treatment Period|Study drug never adminstered|10|||
124817454|NCT04523220|448958841|FG001|Main Treatment Period|Study drug never adminstered|3|||
124817455|NCT04523220|448958842|FG002|Main Treatment Period|Study drug never adminstered|5|||
124817456|NCT04523220|448958840|FG000|Extension Treatment Period|Physician Decision|1|||
124817457|NCT04523220|448958841|FG001|Extension Treatment Period|Physician Decision|0|||
124817458|NCT04523220|448958842|FG002|Extension Treatment Period|Physician Decision|3|||
124817459|NCT04523220|448958840|FG000|Extension Treatment Period|Other|2|||
124817460|NCT04523220|448958841|FG001|Extension Treatment Period|Other|6|||
124817461|NCT04523220|448958842|FG002|Extension Treatment Period|Other|6|||
124817462|NCT04523220|448958840|FG000|Extension Treatment Period|Subject Decision|5|||
124817463|NCT04523220|448958841|FG001|Extension Treatment Period|Subject Decision|2|||
124817464|NCT04523220|448958842|FG002|Extension Treatment Period|Subject Decision|4|||
124817465|NCT04523220|448958840|FG000|Extension Treatment Period|Death|6|||
124817466|NCT04523220|448958841|FG001|Extension Treatment Period|Death|4|||
124817467|NCT04523220|448958842|FG002|Extension Treatment Period|Death|7|||
124817468|NCT04523220|448958840|FG000|Extension Treatment Period|Adverse Event|6|||
124817469|NCT04523220|448958841|FG001|Extension Treatment Period|Adverse Event|7|||
124817470|NCT04523220|448958842|FG002|Extension Treatment Period|Adverse Event|9|||
124817471|NCT04523220|448958840|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
124817472|NCT04523220|448958841|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
124817473|NCT04523220|448958842|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
124817474|NCT04523220|448958840|FG000|Extension Treatment Period|Study drug never administered|0|||
124817475|NCT04523220|448958841|FG001|Extension Treatment Period|Study drug never administered|1|||
124817476|NCT04523220|448958842|FG002|Extension Treatment Period|Study drug never administered|0|||
124817477|NCT00571948|448958843|FG000|Overall Study|Lost to Follow-up|2|||
124817478|NCT00571948|448958844|FG001|Overall Study|Lost to Follow-up|0|||
124817479|NCT00571948|448958843|FG000|Overall Study|Withdrawal by Subject|1|||
124817480|NCT00571948|448958844|FG001|Overall Study|Withdrawal by Subject|2|||
124817481|NCT00571948|448958843|FG000|Overall Study|Protocol Violation|3|||
124817482|NCT00571948|448958844|FG001|Overall Study|Protocol Violation|3|||
124817483|NCT00571948|448958843|FG000|Overall Study|infant refused study meal|3|||
124817484|NCT00571948|448958844|FG001|Overall Study|infant refused study meal|4|||
124817485|NCT00571948|448958843|FG000|Overall Study|Parent were afraid of blood colection|2|||
124817486|NCT00571948|448958844|FG001|Overall Study|Parent were afraid of blood colection|5|||
124817487|NCT04112784|448958845|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
124817488|NCT04112784|448958845|FG000|Overall Study|Screen Failures|4|||
124817489|NCT00221403|448958846|FG000|Overall Study|Protocol Violation|1|||
124817490|NCT00221403|448958847|FG001|Overall Study|Protocol Violation|0|||
124817491|NCT00221403|448958848|FG002|Overall Study|Protocol Violation|0|||
124817492|NCT00221403|448958846|FG000|Overall Study|Physician Decision|1|||
124817493|NCT00221403|448958847|FG001|Overall Study|Physician Decision|0|||
124817494|NCT00221403|448958848|FG002|Overall Study|Physician Decision|0|||
124817495|NCT00221403|448958846|FG000|Overall Study|Withdrawal by Subject|0|||
124817496|NCT00221403|448958847|FG001|Overall Study|Withdrawal by Subject|3|||
124817497|NCT00221403|448958848|FG002|Overall Study|Withdrawal by Subject|0|||
124817498|NCT00221403|448958846|FG000|Overall Study|Lack of Efficacy|0|||
124817499|NCT00221403|448958847|FG001|Overall Study|Lack of Efficacy|1|||
124817500|NCT00221403|448958848|FG002|Overall Study|Lack of Efficacy|0|||
124817501|NCT00221403|448958846|FG000|Overall Study|Adverse Event|0|||
124817502|NCT00221403|448958847|FG001|Overall Study|Adverse Event|1|||
124817503|NCT00221403|448958848|FG002|Overall Study|Adverse Event|0|||
124817504|NCT02010775|448958849|FG000|Overall Study|Adverse Event|0|||
124817505|NCT02010775|448958850|FG001|Overall Study|Adverse Event|0|||
124817506|NCT02010775|448958851|FG002|Overall Study|Adverse Event|0|||
124817507|NCT02010775|448958852|FG003|Overall Study|Adverse Event|0|||
124817508|NCT02010775|448958853|FG004|Overall Study|Adverse Event|1|||
124637140|NCT03363776|448288709|FG000|Overall Study|Death|1|||
124817509|NCT02010775|448958849|FG000|Overall Study|Pregnancy|0|||
124817510|NCT02010775|448958850|FG001|Overall Study|Pregnancy|0|||
124817511|NCT02010775|448958851|FG002|Overall Study|Pregnancy|2|||
124817512|NCT02010775|448958852|FG003|Overall Study|Pregnancy|0|||
124817513|NCT02010775|448958853|FG004|Overall Study|Pregnancy|0|||
124817514|NCT02010775|448958849|FG000|Overall Study|Lost to Follow-up|2|||
124817515|NCT02010775|448958850|FG001|Overall Study|Lost to Follow-up|0|||
124817516|NCT02010775|448958851|FG002|Overall Study|Lost to Follow-up|0|||
124817517|NCT02010775|448958852|FG003|Overall Study|Lost to Follow-up|1|||
124817518|NCT02010775|448958853|FG004|Overall Study|Lost to Follow-up|1|||
124817519|NCT02010775|448958849|FG000|Overall Study|Personal Reasons|3|||
124817520|NCT02010775|448958850|FG001|Overall Study|Personal Reasons|3|||
124817521|NCT02010775|448958851|FG002|Overall Study|Personal Reasons|1|||
124817522|NCT02010775|448958852|FG003|Overall Study|Personal Reasons|2|||
124817523|NCT02010775|448958853|FG004|Overall Study|Personal Reasons|4|||
124817524|NCT00256750|448958856|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
124817525|NCT00256750|448958857|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
124817526|NCT00256750|448958858|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
124817527|NCT00256750|448958856|FG000|Transplanted Pre-Treatment|Other|2|||
124817528|NCT00256750|448958857|FG001|Transplanted Pre-Treatment|Other|0|||
124817529|NCT00256750|448958858|FG002|Transplanted Pre-Treatment|Other|0|||
124817530|NCT00256750|448958856|FG000|Transplanted Pre-Treatment|Death|1|||
124817531|NCT00256750|448958857|FG001|Transplanted Pre-Treatment|Death|0|||
124817532|NCT00256750|448958858|FG002|Transplanted Pre-Treatment|Death|0|||
124817533|NCT00256750|448958856|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
124817534|NCT00256750|448958857|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
124817535|NCT00256750|448958858|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
124817536|NCT00256750|448958856|FG000|Post-Transplant Treated (12 Months)|Death|3|||
124817537|NCT00256750|448958857|FG001|Post-Transplant Treated (12 Months)|Death|2|||
124817538|NCT00256750|448958858|FG002|Post-Transplant Treated (12 Months)|Death|4|||
124817539|NCT00256750|448958856|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
124817540|NCT00256750|448958857|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
124817541|NCT00256750|448958858|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
124817542|NCT00256750|448958856|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
124817543|NCT00256750|448958857|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
124817544|NCT00256750|448958858|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
124817545|NCT00256750|448958856|FG000|Post-Transplant Treated (12 Months)|Other|5|||
124817546|NCT00256750|448958857|FG001|Post-Transplant Treated (12 Months)|Other|4|||
124817547|NCT00256750|448958858|FG002|Post-Transplant Treated (12 Months)|Other|2|||
124817548|NCT00256750|448958856|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
124817549|NCT00256750|448958857|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
124817550|NCT00256750|448958858|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
124817551|NCT00256750|448958856|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
124817552|NCT00256750|448958857|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
124817553|NCT00256750|448958858|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
124817554|NCT00256750|448958856|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
124817555|NCT00256750|448958857|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
124817556|NCT00256750|448958858|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
124817557|NCT00256750|448958856|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
124817558|NCT00256750|448958857|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
124817559|NCT00256750|448958858|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
124817560|NCT00256750|448958856|FG000|Post-Transplant Treated (24 Months)|Death|3|||
124817561|NCT00256750|448958857|FG001|Post-Transplant Treated (24 Months)|Death|0|||
124817562|NCT00256750|448958858|FG002|Post-Transplant Treated (24 Months)|Death|0|||
124817563|NCT00256750|448958856|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
124817564|NCT00256750|448958857|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
124817565|NCT00256750|448958858|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
124817566|NCT00256750|448958856|FG000|Post-Transplant Treated (24 Months)|Other|2|||
124817567|NCT00256750|448958857|FG001|Post-Transplant Treated (24 Months)|Other|0|||
124817568|NCT00256750|448958858|FG002|Post-Transplant Treated (24 Months)|Other|1|||
124817569|NCT00256750|448958856|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
124817570|NCT00256750|448958857|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
124817571|NCT00256750|448958858|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
124817572|NCT00256750|448958856|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
124817573|NCT00256750|448958857|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
124817574|NCT00256750|448958858|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
124817575|NCT00256750|448958856|FG000|Post-Transplant Treated (36 Months)|Death|0|||
124817576|NCT00256750|448958857|FG001|Post-Transplant Treated (36 Months)|Death|2|||
124817577|NCT00256750|448958858|FG002|Post-Transplant Treated (36 Months)|Death|1|||
124817578|NCT00256750|448958856|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
124817579|NCT00256750|448958857|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
124817580|NCT00256750|448958858|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
124817581|NCT00256750|448958856|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
124817582|NCT00256750|448958857|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
124817583|NCT00256750|448958858|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
124817584|NCT00256750|448958856|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
124637141|NCT03363776|448288710|FG001|Overall Study|Death|0|||
124637142|NCT03363776|448288711|FG002|Overall Study|Death|0|||
124817585|NCT00256750|448958857|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
124817586|NCT00256750|448958858|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
124817587|NCT00256750|448958856|FG000|Post-Transplant Treated (36 Months)|Other|0|||
124817588|NCT00256750|448958857|FG001|Post-Transplant Treated (36 Months)|Other|1|||
124817589|NCT00256750|448958858|FG002|Post-Transplant Treated (36 Months)|Other|1|||
124817590|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
124817591|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
124817592|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
124817593|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
124817594|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
124817595|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
124817596|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
124817597|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
124817598|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
124817599|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
124817600|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
124817601|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
124817602|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
124817603|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
124817604|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
124817605|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
124817606|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
124817607|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
124817608|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
124817609|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
124817610|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
124817611|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
124817612|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
124817613|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
124817614|NCT00256750|448958856|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
124817615|NCT00256750|448958857|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
124817616|NCT00256750|448958858|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
124817617|NCT02030041|448958859|FG000|Overall Study|Withdrawal by Subject|2|||
124817618|NCT02030041|448958860|FG001|Overall Study|Withdrawal by Subject|2|||
124817619|NCT02030041|448958861|FG002|Overall Study|Withdrawal by Subject|1|||
124817620|NCT01197560|448958863|FG000|Overall Study|Adverse Event|6|||
124817621|NCT01197560|448958864|FG001|Overall Study|Adverse Event|8|||
124817622|NCT01197560|448958863|FG000|Overall Study|Death|3|||
124817623|NCT01197560|448958864|FG001|Overall Study|Death|5|||
124817624|NCT01197560|448958863|FG000|Overall Study|Withdrawal by Subject|1|||
124817625|NCT01197560|448958864|FG001|Overall Study|Withdrawal by Subject|1|||
124817626|NCT01197560|448958863|FG000|Overall Study|Disease progression|40|||
124817627|NCT01197560|448958864|FG001|Overall Study|Disease progression|35|||
124817628|NCT01197560|448958863|FG000|Overall Study|Miscellaneous|4|||
124817629|NCT01197560|448958864|FG001|Overall Study|Miscellaneous|3|||
124817630|NCT01197560|448958863|FG000|Overall Study|Missing|0|||
124817631|NCT01197560|448958864|FG001|Overall Study|Missing|1|||
124817632|NCT02006719|448958865|FG000|Overall Study|Withdrawal by Subject|10|||
124817633|NCT02006719|448958866|FG001|Overall Study|Withdrawal by Subject|2|||
124817634|NCT02006719|448958865|FG000|Overall Study|Lost to Follow-up|5|||
124817635|NCT02006719|448958866|FG001|Overall Study|Lost to Follow-up|1|||
124817636|NCT02006719|448958865|FG000|Overall Study|Protocol Violation|2|||
124817637|NCT02006719|448958866|FG001|Overall Study|Protocol Violation|0|||
124817638|NCT02006719|448958865|FG000|Overall Study|Adverse Event|1|||
124817639|NCT02006719|448958866|FG001|Overall Study|Adverse Event|1|||
124817640|NCT02006719|448958865|FG000|Overall Study|Other/Unknown|0|||
124817641|NCT02006719|448958866|FG001|Overall Study|Other/Unknown|1|||
124817642|NCT04659161|448958867|FG000|Overall Study|Adverse Event|10|||
124817643|NCT04659161|448958868|FG001|Overall Study|Adverse Event|6|||
124817644|NCT04659161|448958867|FG000|Overall Study|Withdrawal by Subject|13|||
124817645|NCT04659161|448958868|FG001|Overall Study|Withdrawal by Subject|12|||
124817646|NCT04659161|448958867|FG000|Overall Study|Other|9|||
124817647|NCT04659161|448958868|FG001|Overall Study|Other|8|||
124817648|NCT01929343|448958869|FG000|Overall Study|Physician Decision|0|||
124817649|NCT01929343|448958870|FG001|Overall Study|Physician Decision|2|||
124817650|NCT01929343|448958871|FG002|Overall Study|Physician Decision|0|||
124817651|NCT01929343|448958869|FG000|Overall Study|Withdrawal by Subject|1|||
124817652|NCT01929343|448958870|FG001|Overall Study|Withdrawal by Subject|0|||
124817653|NCT01929343|448958871|FG002|Overall Study|Withdrawal by Subject|0|||
124817654|NCT01737697|448958879|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817655|NCT01737697|448958880|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
124817656|NCT01737697|448958881|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817657|NCT01737697|448958882|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
124817658|NCT01737697|448958883|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
124817659|NCT01737697|448958884|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817660|NCT01737697|448958885|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817661|NCT01737697|448958886|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817662|NCT01737697|448958887|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817663|NCT01737697|448958888|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817664|NCT01737697|448958889|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817665|NCT01737697|448958890|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817666|NCT01737697|448958891|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817667|NCT01737697|448958892|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817668|NCT01737697|448958893|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
124817669|NCT01737697|448958879|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
124817670|NCT01737697|448958880|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
124817671|NCT01737697|448958881|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
124817672|NCT01737697|448958882|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817673|NCT01737697|448958883|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817674|NCT01737697|448958884|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817675|NCT01737697|448958885|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817676|NCT01737697|448958886|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817677|NCT01737697|448958887|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817678|NCT01737697|448958888|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817679|NCT01737697|448958889|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817680|NCT01737697|448958890|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817681|NCT01737697|448958891|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817682|NCT01737697|448958892|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817683|NCT01737697|448958893|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
124817684|NCT01737697|448958879|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817685|NCT01737697|448958880|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817686|NCT01737697|448958881|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817687|NCT01737697|448958882|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
124817688|NCT01737697|448958883|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817689|NCT01737697|448958884|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817690|NCT01737697|448958885|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817691|NCT01737697|448958886|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817692|NCT01737697|448958887|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817693|NCT01737697|448958888|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817694|NCT01737697|448958889|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817695|NCT01737697|448958890|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817696|NCT01737697|448958891|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817697|NCT01737697|448958892|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817698|NCT01737697|448958893|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
124817699|NCT01737697|448958879|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817700|NCT01737697|448958880|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
124817701|NCT01737697|448958881|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817702|NCT01737697|448958882|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817703|NCT01737697|448958883|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817704|NCT01737697|448958884|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817705|NCT01737697|448958885|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817706|NCT01737697|448958886|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817707|NCT01737697|448958887|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817708|NCT01737697|448958888|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817709|NCT01737697|448958889|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817710|NCT01737697|448958890|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817711|NCT01737697|448958891|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817712|NCT01737697|448958892|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817713|NCT01737697|448958893|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
124817714|NCT01737697|448958879|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817715|NCT01737697|448958880|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817716|NCT01737697|448958881|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817717|NCT01737697|448958882|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817718|NCT01737697|448958883|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
124817719|NCT01737697|448958884|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817720|NCT01737697|448958885|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817721|NCT01737697|448958886|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817722|NCT01737697|448958887|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817723|NCT01737697|448958888|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817724|NCT01737697|448958889|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817725|NCT01737697|448958890|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817726|NCT01737697|448958891|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817727|NCT01737697|448958892|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817728|NCT01737697|448958893|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
124817729|NCT01737697|448958879|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817730|NCT01737697|448958880|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
124817731|NCT01737697|448958881|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
124817732|NCT01737697|448958882|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
124817733|NCT01737697|448958883|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
124817734|NCT01737697|448958884|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817735|NCT01737697|448958885|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817736|NCT01737697|448958886|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817737|NCT01737697|448958887|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817738|NCT01737697|448958888|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817739|NCT01737697|448958889|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817740|NCT01737697|448958890|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817741|NCT01737697|448958891|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817742|NCT01737697|448958892|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817743|NCT01737697|448958893|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
124817744|NCT01737697|448958879|FG000|Subacute Phase|Adverse Event|0|||
124817745|NCT01737697|448958880|FG001|Subacute Phase|Adverse Event|0|||
124817746|NCT01737697|448958881|FG002|Subacute Phase|Adverse Event|0|||
124817747|NCT01737697|448958882|FG003|Subacute Phase|Adverse Event|0|||
124817748|NCT01737697|448958883|FG004|Subacute Phase|Adverse Event|0|||
124817749|NCT01737697|448958884|FG005|Subacute Phase|Adverse Event|1|||
124817750|NCT01737697|448958885|FG006|Subacute Phase|Adverse Event|1|||
124817751|NCT01737697|448958886|FG007|Subacute Phase|Adverse Event|1|||
124817752|NCT01737697|448958887|FG008|Subacute Phase|Adverse Event|1|||
124817753|NCT01737697|448958888|FG009|Subacute Phase|Adverse Event|1|||
124817754|NCT01737697|448958889|FG010|Subacute Phase|Adverse Event|4|||
124817755|NCT01737697|448958890|FG011|Subacute Phase|Adverse Event|1|||
124817756|NCT01737697|448958891|FG012|Subacute Phase|Adverse Event|1|||
124817757|NCT01737697|448958892|FG013|Subacute Phase|Adverse Event|0|||
124817758|NCT01737697|448958893|FG014|Subacute Phase|Adverse Event|0|||
124817759|NCT01737697|448958879|FG000|Subacute Phase|Withdrawal by Subject|0|||
124817760|NCT01737697|448958880|FG001|Subacute Phase|Withdrawal by Subject|0|||
124817761|NCT01737697|448958881|FG002|Subacute Phase|Withdrawal by Subject|0|||
124817762|NCT01737697|448958882|FG003|Subacute Phase|Withdrawal by Subject|0|||
124817763|NCT01737697|448958883|FG004|Subacute Phase|Withdrawal by Subject|0|||
124817764|NCT01737697|448958884|FG005|Subacute Phase|Withdrawal by Subject|1|||
124817765|NCT01737697|448958885|FG006|Subacute Phase|Withdrawal by Subject|0|||
124817766|NCT01737697|448958886|FG007|Subacute Phase|Withdrawal by Subject|2|||
124817767|NCT01737697|448958887|FG008|Subacute Phase|Withdrawal by Subject|0|||
124817768|NCT01737697|448958888|FG009|Subacute Phase|Withdrawal by Subject|1|||
124817769|NCT01737697|448958889|FG010|Subacute Phase|Withdrawal by Subject|0|||
124817770|NCT01737697|448958890|FG011|Subacute Phase|Withdrawal by Subject|1|||
124817771|NCT01737697|448958891|FG012|Subacute Phase|Withdrawal by Subject|1|||
124817772|NCT01737697|448958892|FG013|Subacute Phase|Withdrawal by Subject|1|||
124817773|NCT01737697|448958893|FG014|Subacute Phase|Withdrawal by Subject|0|||
124817774|NCT01737697|448958879|FG000|Subacute Phase|Lost to Follow-up|0|||
124817775|NCT01737697|448958880|FG001|Subacute Phase|Lost to Follow-up|0|||
124817776|NCT01737697|448958881|FG002|Subacute Phase|Lost to Follow-up|0|||
124817777|NCT01737697|448958882|FG003|Subacute Phase|Lost to Follow-up|0|||
124817778|NCT01737697|448958883|FG004|Subacute Phase|Lost to Follow-up|0|||
124817779|NCT01737697|448958884|FG005|Subacute Phase|Lost to Follow-up|0|||
124817780|NCT01737697|448958885|FG006|Subacute Phase|Lost to Follow-up|0|||
124817781|NCT01737697|448958886|FG007|Subacute Phase|Lost to Follow-up|0|||
124817782|NCT01737697|448958887|FG008|Subacute Phase|Lost to Follow-up|0|||
124817783|NCT01737697|448958888|FG009|Subacute Phase|Lost to Follow-up|0|||
124817784|NCT01737697|448958889|FG010|Subacute Phase|Lost to Follow-up|0|||
124817785|NCT01737697|448958890|FG011|Subacute Phase|Lost to Follow-up|0|||
124817786|NCT01737697|448958891|FG012|Subacute Phase|Lost to Follow-up|0|||
124817787|NCT01737697|448958892|FG013|Subacute Phase|Lost to Follow-up|0|||
124817788|NCT01737697|448958893|FG014|Subacute Phase|Lost to Follow-up|1|||
124817789|NCT01737697|448958879|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
124817790|NCT01737697|448958880|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
124817791|NCT01737697|448958881|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
124817792|NCT01737697|448958882|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
124817793|NCT01737697|448958883|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
124817794|NCT01737697|448958884|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
124817795|NCT01737697|448958885|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
124817796|NCT01737697|448958886|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
124637143|NCT02097238|448288718|FG000|Overall Study|Death|1|||
124637144|NCT02097238|448288718|FG000|Overall Study|Physician Decision|1|||
124637145|NCT02097238|448288718|FG000|Overall Study|Progressive Disease|17|||
124817797|NCT01737697|448958887|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
124817798|NCT01737697|448958888|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
124817799|NCT01737697|448958889|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
124817800|NCT01737697|448958890|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
124817801|NCT01737697|448958891|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
124817802|NCT01737697|448958892|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
124817803|NCT01737697|448958893|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
124637146|NCT01106911|448288719|FG000|Overall Study|Physician Decision|2|||
124817804|NCT01737697|448958879|FG000|Subacute Phase|Protocol Violation|0|||
124817805|NCT01737697|448958880|FG001|Subacute Phase|Protocol Violation|0|||
124817806|NCT01737697|448958881|FG002|Subacute Phase|Protocol Violation|0|||
124817807|NCT01737697|448958882|FG003|Subacute Phase|Protocol Violation|0|||
124817808|NCT01737697|448958883|FG004|Subacute Phase|Protocol Violation|0|||
124817809|NCT01737697|448958884|FG005|Subacute Phase|Protocol Violation|1|||
124817810|NCT01737697|448958885|FG006|Subacute Phase|Protocol Violation|0|||
124817811|NCT01737697|448958886|FG007|Subacute Phase|Protocol Violation|0|||
124817812|NCT01737697|448958887|FG008|Subacute Phase|Protocol Violation|0|||
124817813|NCT01737697|448958888|FG009|Subacute Phase|Protocol Violation|0|||
124817814|NCT01737697|448958889|FG010|Subacute Phase|Protocol Violation|1|||
124817815|NCT01737697|448958890|FG011|Subacute Phase|Protocol Violation|0|||
124817816|NCT01737697|448958891|FG012|Subacute Phase|Protocol Violation|0|||
124817817|NCT01737697|448958892|FG013|Subacute Phase|Protocol Violation|0|||
124817818|NCT01737697|448958893|FG014|Subacute Phase|Protocol Violation|0|||
124817819|NCT01737697|448958879|FG000|Subacute Phase|Physician Decision|0|||
124817820|NCT01737697|448958880|FG001|Subacute Phase|Physician Decision|0|||
124817821|NCT01737697|448958881|FG002|Subacute Phase|Physician Decision|0|||
124817822|NCT01737697|448958882|FG003|Subacute Phase|Physician Decision|0|||
124817823|NCT01737697|448958883|FG004|Subacute Phase|Physician Decision|0|||
124817824|NCT01737697|448958884|FG005|Subacute Phase|Physician Decision|0|||
124817825|NCT01737697|448958885|FG006|Subacute Phase|Physician Decision|0|||
124817826|NCT01737697|448958886|FG007|Subacute Phase|Physician Decision|0|||
124817827|NCT01737697|448958887|FG008|Subacute Phase|Physician Decision|1|||
124817828|NCT01737697|448958888|FG009|Subacute Phase|Physician Decision|0|||
124817829|NCT01737697|448958889|FG010|Subacute Phase|Physician Decision|0|||
124817830|NCT01737697|448958890|FG011|Subacute Phase|Physician Decision|0|||
124817831|NCT01737697|448958891|FG012|Subacute Phase|Physician Decision|0|||
124817832|NCT01737697|448958892|FG013|Subacute Phase|Physician Decision|0|||
124817833|NCT01737697|448958893|FG014|Subacute Phase|Physician Decision|0|||
124817834|NCT01737697|448958879|FG000|Subacute Phase|Death|0|||
124817835|NCT01737697|448958880|FG001|Subacute Phase|Death|0|||
124817836|NCT01737697|448958881|FG002|Subacute Phase|Death|0|||
124817837|NCT01737697|448958882|FG003|Subacute Phase|Death|0|||
124817838|NCT01737697|448958883|FG004|Subacute Phase|Death|0|||
124817839|NCT01737697|448958884|FG005|Subacute Phase|Death|0|||
124817840|NCT01737697|448958885|FG006|Subacute Phase|Death|0|||
124817841|NCT01737697|448958886|FG007|Subacute Phase|Death|0|||
124817842|NCT01737697|448958887|FG008|Subacute Phase|Death|0|||
124817843|NCT01737697|448958888|FG009|Subacute Phase|Death|0|||
124817844|NCT01737697|448958889|FG010|Subacute Phase|Death|1|||
124817845|NCT01737697|448958890|FG011|Subacute Phase|Death|0|||
124817846|NCT01737697|448958891|FG012|Subacute Phase|Death|0|||
124817847|NCT01737697|448958892|FG013|Subacute Phase|Death|0|||
124817848|NCT01737697|448958893|FG014|Subacute Phase|Death|0|||
124817849|NCT03338998|448958895|FG000|Treatment Period|Withdrawal by Subject|1|||
124817850|NCT03338998|448958896|FG001|Treatment Period|Withdrawal by Subject|1|||
124817851|NCT03338998|448958895|FG000|Treatment Period|Adverse Event|0|||
124817852|NCT03338998|448958896|FG001|Treatment Period|Adverse Event|2|||
124817853|NCT03338998|448958895|FG000|Treatment Period|Protocol deviation|1|||
124817854|NCT03338998|448958896|FG001|Treatment Period|Protocol deviation|0|||
124817855|NCT03338998|448958895|FG000|Treatment Period|Physician Decision|2|||
124817856|NCT03338998|448958896|FG001|Treatment Period|Physician Decision|0|||
124817857|NCT03338998|448958895|FG000|Treatment Period|Subject failed swallow test|4|||
124817858|NCT03338998|448958896|FG001|Treatment Period|Subject failed swallow test|0|||
124817859|NCT03338998|448958895|FG000|Safety Follow-Up Period|Adverse Event|0|||
124817860|NCT03338998|448958896|FG001|Safety Follow-Up Period|Adverse Event|1|||
124817861|NCT03338998|448958895|FG000|Safety Follow-Up Period|Protocol deviation|1|||
124817862|NCT03338998|448958896|FG001|Safety Follow-Up Period|Protocol deviation|0|||
124817863|NCT03338998|448958895|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
124817864|NCT03338998|448958896|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
124817865|NCT03288129|448958897|FG000|Overall Study|Adverse Event|10|||
124817866|NCT03288129|448958897|FG000|Overall Study|Lost to Follow-up|3|||
124817867|NCT03288129|448958897|FG000|Overall Study|Withdrawal by Subject|3|||
124817868|NCT03288129|448958897|FG000|Overall Study|Withdrawal of consent/assent|1|||
124817869|NCT03288129|448958897|FG000|Overall Study|Other|5|||
124817870|NCT04404361|448958902|FG000|Overall Study|Death|12|||
124817871|NCT04404361|448958903|FG001|Overall Study|Death|12|||
124817872|NCT04404361|448958902|FG000|Overall Study|Withdrawal by Subject|13|||
124817873|NCT04404361|448958903|FG001|Overall Study|Withdrawal by Subject|5|||
124817874|NCT04404361|448958902|FG000|Overall Study|Lost to Follow-up|6|||
124817875|NCT04404361|448958903|FG001|Overall Study|Lost to Follow-up|3|||
124817876|NCT04404361|448958902|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
124817877|NCT04404361|448958903|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
124817878|NCT00558558|448958904|FG000|Overall Study|Unable to swallow|1|||
124817879|NCT00558558|448958904|FG000|Overall Study|Withdrawal by Subject|1|||
124817880|NCT00558558|448958904|FG000|Overall Study|Lack of Efficacy|4|||
124817881|NCT02144012|448958905|FG000|Overall Study|Adverse Event|1|||
124817882|NCT02144012|448958906|FG001|Overall Study|Adverse Event|0|||
124817883|NCT02144012|448958905|FG000|Overall Study|Death|1|||
124817884|NCT02144012|448958906|FG001|Overall Study|Death|0|||
124817885|NCT02144012|448958905|FG000|Overall Study|Withdrawal by Subject|11|||
124817886|NCT02144012|448958906|FG001|Overall Study|Withdrawal by Subject|3|||
124817887|NCT02144012|448958905|FG000|Overall Study|Study Terminated by Sponsor|18|||
124817888|NCT02144012|448958906|FG001|Overall Study|Study Terminated by Sponsor|12|||
124817889|NCT02144012|448958905|FG000|Overall Study|Other|3|||
124817890|NCT02144012|448958906|FG001|Overall Study|Other|0|||
124817891|NCT02915016|448958907|FG000|Overall Study|Lost to Follow-up|4|||
124817892|NCT02915016|448958908|FG001|Overall Study|Lost to Follow-up|2|||
124817893|NCT02915016|448958909|FG002|Overall Study|Lost to Follow-up|5|||
124817894|NCT02915016|448958910|FG003|Overall Study|Lost to Follow-up|3|||
124817895|NCT02915016|448958911|FG004|Overall Study|Lost to Follow-up|5|||
124817896|NCT02915016|448958912|FG005|Overall Study|Lost to Follow-up|2|||
124817897|NCT02915016|448958913|FG006|Overall Study|Lost to Follow-up|8|||
124817898|NCT02915016|448958914|FG007|Overall Study|Lost to Follow-up|2|||
124817899|NCT02915016|448958907|FG000|Overall Study|Physician Decision|0|||
124817900|NCT02915016|448958908|FG001|Overall Study|Physician Decision|0|||
124817901|NCT02915016|448958909|FG002|Overall Study|Physician Decision|1|||
124817902|NCT02915016|448958910|FG003|Overall Study|Physician Decision|0|||
124817903|NCT02915016|448958911|FG004|Overall Study|Physician Decision|0|||
124817904|NCT02915016|448958912|FG005|Overall Study|Physician Decision|1|||
124817905|NCT02915016|448958913|FG006|Overall Study|Physician Decision|2|||
124817906|NCT02915016|448958914|FG007|Overall Study|Physician Decision|0|||
124817907|NCT02915016|448958907|FG000|Overall Study|Withdrawal by Subject|2|||
124817908|NCT02915016|448958908|FG001|Overall Study|Withdrawal by Subject|0|||
124817909|NCT02915016|448958909|FG002|Overall Study|Withdrawal by Subject|1|||
124817910|NCT02915016|448958910|FG003|Overall Study|Withdrawal by Subject|0|||
124817911|NCT02915016|448958911|FG004|Overall Study|Withdrawal by Subject|1|||
124817912|NCT02915016|448958912|FG005|Overall Study|Withdrawal by Subject|3|||
124817913|NCT02915016|448958913|FG006|Overall Study|Withdrawal by Subject|1|||
124817914|NCT02915016|448958914|FG007|Overall Study|Withdrawal by Subject|1|||
124817915|NCT02915016|448958907|FG000|Overall Study|Elected not to continue|0|||
124817916|NCT02915016|448958908|FG001|Overall Study|Elected not to continue|0|||
124817917|NCT02915016|448958909|FG002|Overall Study|Elected not to continue|0|||
124817918|NCT02915016|448958910|FG003|Overall Study|Elected not to continue|1|||
124817919|NCT02915016|448958911|FG004|Overall Study|Elected not to continue|0|||
124817920|NCT02915016|448958912|FG005|Overall Study|Elected not to continue|0|||
124752703|NCT00555672|448716826|FG001|Overall Study|Objective progression or relapse|5|||
124752704|NCT00555672|448716825|FG000|Overall Study|Other|3|||
124752705|NCT00555672|448716826|FG001|Overall Study|Other|1|||
124752706|NCT00555672|448716825|FG000|Overall Study|Participant refused|2|||
124752707|NCT00555672|448716826|FG001|Overall Study|Participant refused|0|||
124752708|NCT01053988|448716827|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
124752709|NCT01053988|448716828|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
124752710|NCT01053988|448716829|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
124752711|NCT01053988|448716830|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
124752712|NCT01053988|448716831|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
124752713|NCT01053988|448716832|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
124752714|NCT01053988|448716827|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
124752715|NCT01053988|448716828|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
124752716|NCT01053988|448716829|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
124752717|NCT01053988|448716830|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
124752718|NCT01053988|448716831|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
124752719|NCT01053988|448716832|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
124752720|NCT01053988|448716827|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
124752721|NCT01053988|448716828|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
124752722|NCT01053988|448716829|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
124752723|NCT01053988|448716830|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
124752724|NCT01053988|448716831|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
124752725|NCT01053988|448716832|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
124752726|NCT01053988|448716827|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
124752727|NCT01053988|448716828|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
124752728|NCT01053988|448716829|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
124752729|NCT01053988|448716830|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
124752730|NCT01053988|448716831|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
124752731|NCT01053988|448716832|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
124752732|NCT01053988|448716827|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
124752733|NCT01053988|448716828|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
124752734|NCT01053988|448716829|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
124752735|NCT01053988|448716830|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
124817921|NCT02915016|448958913|FG006|Overall Study|Elected not to continue|1|||
124817922|NCT02915016|448958914|FG007|Overall Study|Elected not to continue|0|||
124817923|NCT02915016|448958907|FG000|Overall Study|HIV infection|1|||
124817924|NCT02915016|448958908|FG001|Overall Study|HIV infection|1|||
124817925|NCT02915016|448958909|FG002|Overall Study|HIV infection|1|||
124817926|NCT02915016|448958910|FG003|Overall Study|HIV infection|0|||
124817927|NCT02915016|448958911|FG004|Overall Study|HIV infection|1|||
124817928|NCT02915016|448958912|FG005|Overall Study|HIV infection|0|||
124817929|NCT02915016|448958913|FG006|Overall Study|HIV infection|0|||
124817930|NCT02915016|448958914|FG007|Overall Study|HIV infection|0|||
124817931|NCT02915016|448958907|FG000|Overall Study|Participant unable to adhere|0|||
124817932|NCT02915016|448958908|FG001|Overall Study|Participant unable to adhere|0|||
124817933|NCT02915016|448958909|FG002|Overall Study|Participant unable to adhere|0|||
124817934|NCT02915016|448958910|FG003|Overall Study|Participant unable to adhere|0|||
124817935|NCT02915016|448958911|FG004|Overall Study|Participant unable to adhere|0|||
124817936|NCT02915016|448958912|FG005|Overall Study|Participant unable to adhere|0|||
124817937|NCT02915016|448958913|FG006|Overall Study|Participant unable to adhere|0|||
124817938|NCT02915016|448958914|FG007|Overall Study|Participant unable to adhere|1|||
124817939|NCT01408485|448960046|FG000|Overall Study|Withdrawal by Subject|21|||
124817940|NCT01315678|448960047|FG000|Overall Study|Withdrawal by Subject|7|||
124817941|NCT01315678|448960048|FG001|Overall Study|Withdrawal by Subject|3|||
124817942|NCT01315678|448960047|FG000|Overall Study|Adverse Event|3|||
124817943|NCT01315678|448960048|FG001|Overall Study|Adverse Event|1|||
124817944|NCT01315678|448960047|FG000|Overall Study|Lost to Follow-up|1|||
124817945|NCT01315678|448960048|FG001|Overall Study|Lost to Follow-up|0|||
124817946|NCT01315678|448960047|FG000|Overall Study|similar reason to those listed above|3|||
124817947|NCT01315678|448960048|FG001|Overall Study|similar reason to those listed above|2|||
124817948|NCT01532414|448960049|FG000|Overall Study|Lost to Follow-up|3|||
124817949|NCT01532414|448960050|FG001|Overall Study|Lost to Follow-up|0|||
124817950|NCT01532414|448960051|FG002|Overall Study|Lost to Follow-up|1|||
124817951|NCT01532414|448960049|FG000|Overall Study|Withdrawal by Subject|3|||
124817952|NCT01532414|448960050|FG001|Overall Study|Withdrawal by Subject|0|||
124817953|NCT01532414|448960051|FG002|Overall Study|Withdrawal by Subject|0|||
124817954|NCT01532414|448960049|FG000|Overall Study|No V6 semen sample|0|||
124817955|NCT01532414|448960050|FG001|Overall Study|No V6 semen sample|1|||
124817956|NCT01532414|448960051|FG002|Overall Study|No V6 semen sample|0|||
124817957|NCT01532414|448960049|FG000|Overall Study|Adverse Event|0|||
124817958|NCT01532414|448960050|FG001|Overall Study|Adverse Event|1|||
124817959|NCT01532414|448960051|FG002|Overall Study|Adverse Event|1|||
124817960|NCT01532414|448960049|FG000|Overall Study|Unable to complete 24 hour PK|0|||
124817961|NCT01532414|448960050|FG001|Overall Study|Unable to complete 24 hour PK|0|||
124817962|NCT01532414|448960051|FG002|Overall Study|Unable to complete 24 hour PK|1|||
124817963|NCT01532414|448960049|FG000|Overall Study|Withdrawn by sponsor|1|||
124817964|NCT01532414|448960050|FG001|Overall Study|Withdrawn by sponsor|0|||
124817965|NCT01532414|448960051|FG002|Overall Study|Withdrawn by sponsor|0|||
124817966|NCT00187486|448960052|FG000|Overall Study|Protocol Violation|1|||
124817967|NCT00578812|448960056|FG000|Overall Study|Not treated|6|||
124817968|NCT00578812|448960057|FG001|Overall Study|Not treated|7|||
124817969|NCT00617773|448960058|FG000|Overall Study|Physician Decision|1|||
124817970|NCT00617773|448960058|FG000|Overall Study|Lack of compliance with the protocol|1|||
124817971|NCT00617773|448960058|FG000|Overall Study|Withdrawal by Subject|1|||
124817972|NCT00617773|448960058|FG000|Overall Study|Death|1|||
124817973|NCT00617773|448960058|FG000|Overall Study|Progressive disease|19|||
124817974|NCT00617773|448960058|FG000|Overall Study|Protocol Violation|1|||
124817975|NCT03217175|448960061|FG000|Overall Study|Physician Decision|4|||
124817976|NCT03217175|448960062|FG001|Overall Study|Physician Decision|1|||
124817977|NCT05035550|448960074|FG000|Overall Study|Withdrawal by Subject|3|||
124817978|NCT05035550|448960075|FG001|Overall Study|Withdrawal by Subject|0|||
124817979|NCT01751867|448960076|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
124817980|NCT01751867|448960077|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
124817981|NCT01751867|448960076|FG000|Overall Study|Diease Progression|4|||
124817982|NCT01751867|448960077|FG001|Overall Study|Diease Progression|18|||
124817983|NCT01751867|448960076|FG000|Overall Study|Adverse Event|8|||
124817984|NCT01751867|448960077|FG001|Overall Study|Adverse Event|15|||
124817985|NCT01751867|448960076|FG000|Overall Study|Poor Compliance|0|||
124817986|NCT01751867|448960077|FG001|Overall Study|Poor Compliance|5|||
124817987|NCT01751867|448960076|FG000|Overall Study|Withdrawal by Subject|3|||
124817988|NCT01751867|448960077|FG001|Overall Study|Withdrawal by Subject|1|||
124817989|NCT01751867|448960076|FG000|Overall Study|Physician Decision|4|||
124817990|NCT01751867|448960077|FG001|Overall Study|Physician Decision|7|||
124817991|NCT01751867|448960076|FG000|Overall Study|Protocol Violation|0|||
124817992|NCT01751867|448960077|FG001|Overall Study|Protocol Violation|2|||
124817993|NCT01751867|448960076|FG000|Overall Study|Death|0|||
124817994|NCT01751867|448960077|FG001|Overall Study|Death|5|||
124817995|NCT01751867|448960076|FG000|Overall Study|Other|11|||
124817996|NCT01751867|448960077|FG001|Overall Study|Other|37|||
124817997|NCT01751867|448960076|FG000|Overall Study|Randomized but not treated.|2|||
124817998|NCT01751867|448960077|FG001|Overall Study|Randomized but not treated.|1|||
124817999|NCT01806545|448960078|FG000|Overall Study|Adverse Event|2|||
124818000|NCT01806545|448960079|FG001|Overall Study|Adverse Event|3|||
124818001|NCT01806545|448960078|FG000|Overall Study|Lost to Follow-up|1|||
124818002|NCT01806545|448960079|FG001|Overall Study|Lost to Follow-up|0|||
124818003|NCT01806545|448960078|FG000|Overall Study|Withdrawal by Subject|3|||
124818004|NCT01806545|448960079|FG001|Overall Study|Withdrawal by Subject|2|||
124818005|NCT01396148|448960080|FG000|Overall Study|Patient Decision|1|||
124818006|NCT00884312|448960083|FG000|Overall Study|Non-fatal Progressive Disease|0|||
124818007|NCT00884312|448960084|FG001|Overall Study|Non-fatal Progressive Disease|8|||
124818008|NCT00884312|448960083|FG000|Overall Study|Fatal Progressive Disease|0|||
124818009|NCT00884312|448960084|FG001|Overall Study|Fatal Progressive Disease|1|||
124818010|NCT00884312|448960083|FG000|Overall Study|Non-fatal Adverse Event|1|||
124818011|NCT00884312|448960084|FG001|Overall Study|Non-fatal Adverse Event|0|||
124818012|NCT00884312|448960083|FG000|Overall Study|Fatal Adverse Event|1|||
124818013|NCT00884312|448960084|FG001|Overall Study|Fatal Adverse Event|4|||
124818014|NCT00884312|448960083|FG000|Overall Study|Withdrawal by Subject|0|||
124818015|NCT00884312|448960084|FG001|Overall Study|Withdrawal by Subject|6|||
124818016|NCT00884312|448960083|FG000|Overall Study|Physician Decision|0|||
124818017|NCT00884312|448960084|FG001|Overall Study|Physician Decision|1|||
124818018|NCT00884312|448960083|FG000|Overall Study|Other|0|||
124818019|NCT00884312|448960084|FG001|Overall Study|Other|4|||
124818020|NCT00884312|448960083|FG000|Overall Study|Did Not Receive Study Drug|0|||
124818021|NCT00884312|448960084|FG001|Overall Study|Did Not Receive Study Drug|1|||
124818022|NCT00224042|448960085|FG000|Overall Study|Adverse Event|2|||
124818023|NCT00224042|448960086|FG001|Overall Study|Adverse Event|1|||
124818024|NCT00224042|448960085|FG000|Overall Study|Protocol Violation|0|||
124818025|NCT00224042|448960086|FG001|Overall Study|Protocol Violation|1|||
124818026|NCT00224042|448960085|FG000|Overall Study|Physician Decision|0|||
124818027|NCT00224042|448960086|FG001|Overall Study|Physician Decision|1|||
124818028|NCT00224042|448960085|FG000|Overall Study|Did not meet lab incusion criteria|2|||
124818029|NCT00224042|448960086|FG001|Overall Study|Did not meet lab incusion criteria|3|||
124818030|NCT00224042|448960085|FG000|Overall Study|Other|2|||
124818031|NCT00224042|448960086|FG001|Overall Study|Other|0|||
124818032|NCT03052725|448960087|FG000|Overall Study|Adverse Event|2|||
124818033|NCT03052725|448960088|FG001|Overall Study|Adverse Event|0|||
124818034|NCT03052725|448960087|FG000|Overall Study|Withdrawal by Subject|3|||
124818035|NCT03052725|448960088|FG001|Overall Study|Withdrawal by Subject|4|||
124818036|NCT03052725|448960087|FG000|Overall Study|Pregnancy|0|||
124818037|NCT03052725|448960088|FG001|Overall Study|Pregnancy|1|||
124818038|NCT03052725|448960087|FG000|Overall Study|Site closure|0|||
124818039|NCT03052725|448960088|FG001|Overall Study|Site closure|1|||
124818040|NCT03052725|448960087|FG000|Overall Study|Study terminated by sponsor|143|||
124818041|NCT03052725|448960088|FG001|Overall Study|Study terminated by sponsor|144|||
124818042|NCT02548650|448960095|FG000|Triple Therapy|Adverse Event|1|||
124818043|NCT02548650|448960096|FG001|Triple Therapy|Adverse Event|0|||
124818044|NCT02548650|448960095|FG000|Triple Therapy|Withdrawal by Subject|0|||
124818045|NCT02548650|448960096|FG001|Triple Therapy|Withdrawal by Subject|4|||
124818046|NCT02548650|448960095|FG000|Double Therapy|Adverse Event|1|||
124818047|NCT02548650|448960096|FG001|Double Therapy|Adverse Event|1|||
124818048|NCT02548650|448960095|FG000|Double Therapy|Withdrawal by Subject|0|||
124818049|NCT02548650|448960096|FG001|Double Therapy|Withdrawal by Subject|1|||
124818050|NCT01539538|448960097|FG000|Overall Study|Adverse Event|13|||
124818051|NCT01539538|448960098|FG001|Overall Study|Adverse Event|18|||
124818052|NCT01539538|448960097|FG000|Overall Study|Lack of Efficacy|13|||
124818053|NCT01539538|448960098|FG001|Overall Study|Lack of Efficacy|16|||
124818054|NCT01539538|448960097|FG000|Overall Study|Withdrawal by Subject|2|||
124818055|NCT01539538|448960098|FG001|Overall Study|Withdrawal by Subject|3|||
124818056|NCT01539538|448960097|FG000|Overall Study|PCA no longer required or PCA problem|3|||
124818057|NCT01539538|448960098|FG001|Overall Study|PCA no longer required or PCA problem|7|||
124818058|NCT01909674|448960099|FG000|Overall Study|Withdrawal by Subject|5|||
124637147|NCT01106911|448288719|FG000|Overall Study|deemed ineligible after screening|3|||
124637148|NCT01814696|448288720|FG000|Overall Study|Withdrawal by Subject|1|||
124818059|NCT01909674|448960100|FG001|Overall Study|Withdrawal by Subject|2|||
124637149|NCT01814696|448288721|FG001|Overall Study|Withdrawal by Subject|0|||
124637150|NCT01814696|448288720|FG000|Overall Study|Randomized to wrong group|1|||
124637151|NCT01814696|448288721|FG001|Overall Study|Randomized to wrong group|0|||
124637152|NCT00410813|448288722|FG000|Overall Study|Adverse Event|6|||
124637153|NCT00410813|448288723|FG001|Overall Study|Adverse Event|11|||
124818060|NCT00847379|448960101|FG000|Overall Study|Study terminated by Sponsor|59|||
124818061|NCT00847379|448960102|FG001|Overall Study|Study terminated by Sponsor|57|||
124818062|NCT00847379|448960103|FG002|Overall Study|Study terminated by Sponsor|57|||
124818063|NCT02969369|448960104|FG000|Study|Adverse Event|1|||
124818064|NCT02969369|448960105|FG001|Study|Adverse Event|6|||
124818065|NCT02969369|448960104|FG000|Study|Lack of Efficacy|0|||
124818066|NCT02969369|448960105|FG001|Study|Lack of Efficacy|1|||
124818067|NCT02969369|448960104|FG000|Study|Lost to Follow-up|0|||
124637154|NCT00410813|448288722|FG000|Overall Study|Progression|32|||
124637155|NCT00410813|448288723|FG001|Overall Study|Progression|21|||
124637156|NCT00410813|448288722|FG000|Overall Study|Not protocol specified|3|||
124818068|NCT02969369|448960105|FG001|Study|Lost to Follow-up|1|||
124818069|NCT02969369|448960104|FG000|Study|Withdrawal by Subject|3|||
124818070|NCT02969369|448960105|FG001|Study|Withdrawal by Subject|5|||
124818071|NCT02969369|448960104|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
124818072|NCT02969369|448960105|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
124818073|NCT02969369|448960104|FG000|Double-blind Period|Adverse Event|1|||
124818074|NCT02969369|448960105|FG001|Double-blind Period|Adverse Event|5|||
124818075|NCT02969369|448960104|FG000|Double-blind Period|Lost to Follow-up|0|||
124818076|NCT02969369|448960105|FG001|Double-blind Period|Lost to Follow-up|1|||
124818077|NCT02969369|448960104|FG000|Double-blind Period|Withdrawal by Subject|2|||
124818078|NCT02969369|448960105|FG001|Double-blind Period|Withdrawal by Subject|3|||
124818079|NCT02969369|448960104|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
124818080|NCT02969369|448960105|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
124818081|NCT02969369|448960104|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
124818082|NCT02969369|448960105|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
124818083|NCT02969369|448960104|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
124818084|NCT02969369|448960105|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
124818085|NCT02969369|448960104|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
124818086|NCT02969369|448960105|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
124818087|NCT00521014|448960106|FG000|Overall Study|Inevaluable, not treated|1|||
124818088|NCT02794883|448960107|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
124818089|NCT02794883|448960108|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
124818090|NCT02794883|448960109|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
124818091|NCT02794883|448960107|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
124818092|NCT02794883|448960108|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
124818093|NCT02794883|448960109|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
124818094|NCT02794883|448960107|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
124818095|NCT02794883|448960108|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
124818096|NCT02794883|448960109|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
124818097|NCT02794883|448960107|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
124818098|NCT02794883|448960108|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
124818099|NCT02794883|448960109|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
124818100|NCT02794883|448960107|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
124818101|NCT02794883|448960108|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
124818102|NCT02794883|448960109|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
124818103|NCT02794883|448960107|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
124818104|NCT02794883|448960108|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
124818105|NCT02794883|448960109|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
124818106|NCT02794883|448960107|FG000|Follow-up Period (up to 2 Years)|Death|12|||
124818107|NCT02794883|448960108|FG001|Follow-up Period (up to 2 Years)|Death|10|||
124818108|NCT02794883|448960109|FG002|Follow-up Period (up to 2 Years)|Death|10|||
124818109|NCT05201703|448960114|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
124818110|NCT05201703|448960115|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
124818111|NCT05201703|448960114|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
124818112|NCT05201703|448960115|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
124818113|NCT00393029|448960116|FG000|Overall Study|Not treated|0|||
124818114|NCT00393029|448960117|FG001|Overall Study|Not treated|1|||
124818115|NCT03715530|448960118|FG000|Overall Study|Lost to Follow-up|3|||
124818116|NCT03715530|448960119|FG001|Overall Study|Lost to Follow-up|1|||
124818117|NCT03715530|448960120|FG002|Overall Study|Lost to Follow-up|2|||
124818118|NCT00211510|448960124|FG000|Overall Study|Physician Decision|3|||
124818119|NCT00211510|448960125|FG001|Overall Study|Physician Decision|1|||
124818120|NCT00211510|448960124|FG000|Overall Study|Withdrawal by Subject|3|||
124818121|NCT00211510|448960125|FG001|Overall Study|Withdrawal by Subject|1|||
124818122|NCT03648983|448960129|FG000|Overall Study|Study was terminated due to PI departure|95|||
124818123|NCT01269463|448960130|FG000|First Intervention|Withdrawal by Subject|1|||
124818124|NCT01269463|448960131|FG001|First Intervention|Withdrawal by Subject|0|||
124818125|NCT01269463|448960130|FG000|First Intervention|Adverse Event|1|||
124818126|NCT01269463|448960131|FG001|First Intervention|Adverse Event|0|||
124818127|NCT01269463|448960130|FG000|First Intervention|Lack of Efficacy|0|||
124818128|NCT01269463|448960131|FG001|First Intervention|Lack of Efficacy|1|||
124818129|NCT01269463|448960130|FG000|First Intervention|Physician Decision|0|||
124818130|NCT01269463|448960131|FG001|First Intervention|Physician Decision|1|||
124818131|NCT02862171|448960134|FG000|Overall Study|Death|1|||
124818132|NCT02862171|448960134|FG000|Overall Study|Lost to Follow-up|13|||
124818133|NCT02862171|448960134|FG000|Overall Study|Withdrawal by Subject|57|||
124818134|NCT02862171|448960134|FG000|Overall Study|Non-compliance|4|||
124818135|NCT02862171|448960134|FG000|Overall Study|HIV-1 seroconversion|18|||
124818136|NCT02549937|448960136|FG000|Overall Study|Death|0|||
124818137|NCT02549937|448960137|FG001|Overall Study|Death|1|||
124818138|NCT02549937|448960138|FG002|Overall Study|Death|0|||
124818139|NCT02549937|448960139|FG003|Overall Study|Death|1|||
124818140|NCT02549937|448960140|FG004|Overall Study|Death|0|||
124818141|NCT02549937|448960141|FG005|Overall Study|Death|8|||
124818142|NCT02549937|448960142|FG006|Overall Study|Death|0|||
124818143|NCT02549937|448960143|FG007|Overall Study|Death|0|||
124818144|NCT02549937|448960144|FG008|Overall Study|Death|19|||
124818145|NCT02549937|448960136|FG000|Overall Study|No follow up required|3|||
124818146|NCT02549937|448960137|FG001|Overall Study|No follow up required|6|||
124818147|NCT02549937|448960138|FG002|Overall Study|No follow up required|3|||
124818148|NCT02549937|448960139|FG003|Overall Study|No follow up required|8|||
124818149|NCT02549937|448960140|FG004|Overall Study|No follow up required|12|||
124818150|NCT02549937|448960141|FG005|Overall Study|No follow up required|21|||
124818151|NCT02549937|448960142|FG006|Overall Study|No follow up required|9|||
124818152|NCT02549937|448960143|FG007|Overall Study|No follow up required|11|||
124818153|NCT02549937|448960144|FG008|Overall Study|No follow up required|0|||
124818154|NCT02549937|448960136|FG000|Overall Study|Other|0|||
124818155|NCT02549937|448960137|FG001|Overall Study|Other|0|||
124818156|NCT02549937|448960138|FG002|Overall Study|Other|0|||
124818157|NCT02549937|448960139|FG003|Overall Study|Other|0|||
124818158|NCT02549937|448960140|FG004|Overall Study|Other|1|||
124818159|NCT02549937|448960141|FG005|Overall Study|Other|0|||
124818160|NCT02549937|448960142|FG006|Overall Study|Other|3|||
124818161|NCT02549937|448960143|FG007|Overall Study|Other|2|||
124818162|NCT02549937|448960144|FG008|Overall Study|Other|3|||
124818163|NCT02549937|448960136|FG000|Overall Study|Lost to Follow-up|0|||
124818164|NCT02549937|448960137|FG001|Overall Study|Lost to Follow-up|0|||
124818165|NCT02549937|448960138|FG002|Overall Study|Lost to Follow-up|0|||
124818166|NCT02549937|448960139|FG003|Overall Study|Lost to Follow-up|0|||
124818167|NCT02549937|448960140|FG004|Overall Study|Lost to Follow-up|0|||
124818168|NCT02549937|448960141|FG005|Overall Study|Lost to Follow-up|0|||
124818169|NCT02549937|448960142|FG006|Overall Study|Lost to Follow-up|0|||
124818170|NCT02549937|448960143|FG007|Overall Study|Lost to Follow-up|0|||
124818171|NCT02549937|448960144|FG008|Overall Study|Lost to Follow-up|3|||
124818172|NCT02549937|448960136|FG000|Overall Study|Withdrawal by Subject|0|||
124818173|NCT02549937|448960137|FG001|Overall Study|Withdrawal by Subject|0|||
124818174|NCT02549937|448960138|FG002|Overall Study|Withdrawal by Subject|0|||
124818175|NCT02549937|448960139|FG003|Overall Study|Withdrawal by Subject|0|||
124818176|NCT02549937|448960140|FG004|Overall Study|Withdrawal by Subject|0|||
124818177|NCT02549937|448960141|FG005|Overall Study|Withdrawal by Subject|1|||
124818178|NCT02549937|448960142|FG006|Overall Study|Withdrawal by Subject|4|||
124818179|NCT02549937|448960143|FG007|Overall Study|Withdrawal by Subject|3|||
124818180|NCT02549937|448960144|FG008|Overall Study|Withdrawal by Subject|2|||
124818181|NCT02549937|448960136|FG000|Overall Study|Sponsor Decision|0|||
124818182|NCT02549937|448960137|FG001|Overall Study|Sponsor Decision|0|||
124818183|NCT02549937|448960138|FG002|Overall Study|Sponsor Decision|0|||
124818184|NCT02549937|448960139|FG003|Overall Study|Sponsor Decision|0|||
124818185|NCT02549937|448960140|FG004|Overall Study|Sponsor Decision|0|||
124818186|NCT02549937|448960141|FG005|Overall Study|Sponsor Decision|0|||
124818187|NCT02549937|448960142|FG006|Overall Study|Sponsor Decision|0|||
124818188|NCT02549937|448960143|FG007|Overall Study|Sponsor Decision|0|||
124818189|NCT02549937|448960144|FG008|Overall Study|Sponsor Decision|6|||
124818190|NCT00662012|448960145|FG000|Overall Study|Lost to Follow-up|85|||
124818191|NCT00662012|448960145|FG000|Overall Study|Death|1|||
124818192|NCT00662012|448960145|FG000|Overall Study|Withdrawal by Subject|1|||
124818193|NCT01949506|448960150|FG000|Overall Study|Physician Decision|1|||
124818194|NCT05475236|448960152|FG000|Overall Study|Withdrawal by Subject|0|||
124818195|NCT05475236|448960153|FG001|Overall Study|Withdrawal by Subject|1|||
124818196|NCT05425745|448960155|FG000|Overall Study|Withdrawal of Consent|3|||
124818197|NCT05425745|448960156|FG001|Overall Study|Withdrawal of Consent|3|||
124818198|NCT05425745|448960155|FG000|Overall Study|Death|2|||
124818199|NCT05425745|448960156|FG001|Overall Study|Death|3|||
124818200|NCT05425745|448960155|FG000|Overall Study|Lost to Follow-up|1|||
124818201|NCT05425745|448960156|FG001|Overall Study|Lost to Follow-up|2|||
124818202|NCT05425745|448960155|FG000|Overall Study|Adverse Event|0|||
124818203|NCT05425745|448960156|FG001|Overall Study|Adverse Event|1|||
124818204|NCT05425745|448960155|FG000|Overall Study|Did not return for end of study visit|0|||
124818205|NCT05425745|448960156|FG001|Overall Study|Did not return for end of study visit|1|||
124818206|NCT05425745|448960155|FG000|Overall Study|End of study visit completed by phone|1|||
124818207|NCT05425745|448960156|FG001|Overall Study|End of study visit completed by phone|0|||
124818208|NCT05425745|448960155|FG000|Overall Study|Subject decision|1|||
124818209|NCT05425745|448960156|FG001|Overall Study|Subject decision|0|||
124818210|NCT05255068|448961908|FG000|Overall Study|Lost to Follow-up|0|||
124818211|NCT05255068|448961909|FG001|Overall Study|Lost to Follow-up|1|||
124818212|NCT00907777|448961912|FG000|Overall Study|Withdrawal by Subject|0|||
124818213|NCT00907777|448961913|FG001|Overall Study|Withdrawal by Subject|1|||
124818214|NCT02674529|448961914|FG000|Overall Study|Lost to Follow-up|1|||
124818215|NCT02674529|448961915|FG001|Overall Study|Lost to Follow-up|2|||
124818216|NCT02674529|448961914|FG000|Overall Study|Withdrawal by Subject|2|||
124818217|NCT02674529|448961915|FG001|Overall Study|Withdrawal by Subject|1|||
124818218|NCT02674529|448961914|FG000|Overall Study|Physician Decision|0|||
124818219|NCT02674529|448961915|FG001|Overall Study|Physician Decision|1|||
124818220|NCT02674529|448961914|FG000|Overall Study|Protocol Violation|0|||
124818221|NCT02674529|448961915|FG001|Overall Study|Protocol Violation|1|||
124818222|NCT02891850|448961916|FG000|Overall Study|Adverse Event|3|||
124818223|NCT02891850|448961917|FG001|Overall Study|Adverse Event|0|||
124818224|NCT02891850|448961916|FG000|Overall Study|Death|0|||
124818225|NCT02891850|448961917|FG001|Overall Study|Death|4|||
124818226|NCT02891850|448961916|FG000|Overall Study|Physician Decision|1|||
124818227|NCT02891850|448961917|FG001|Overall Study|Physician Decision|0|||
124818228|NCT02891850|448961916|FG000|Overall Study|Pregnancy|1|||
124818229|NCT02891850|448961917|FG001|Overall Study|Pregnancy|0|||
124818230|NCT02891850|448961916|FG000|Overall Study|Withdrawal by Subject|2|||
124818231|NCT02891850|448961917|FG001|Overall Study|Withdrawal by Subject|3|||
124818232|NCT00331682|448961920|FG000|Overall Study|Adverse Event|1|||
124818233|NCT00573469|448961921|FG000|Overall Study|Adverse Event|1|||
124818234|NCT00573469|448961922|FG001|Overall Study|Adverse Event|1|||
124818235|NCT00573469|448961923|FG002|Overall Study|Adverse Event|1|||
124818236|NCT00573469|448961921|FG000|Overall Study|Withdrawal by Subject|0|||
124818237|NCT00573469|448961922|FG001|Overall Study|Withdrawal by Subject|2|||
124818238|NCT00573469|448961923|FG002|Overall Study|Withdrawal by Subject|0|||
124818239|NCT00573469|448961921|FG000|Overall Study|Other|5|||
124818240|NCT00573469|448961922|FG001|Overall Study|Other|1|||
124818241|NCT00573469|448961923|FG002|Overall Study|Other|3|||
124818242|NCT03761277|448961924|FG000|Enrollment to Implant|Screen Failure|17|||
124818243|NCT03761277|448961924|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
124818244|NCT03761277|448961924|FG000|Enrollment to Implant|Physician Decision|2|||
124818245|NCT03761277|448961924|FG000|Enrollment to Implant|Site Closure|3|||
124818246|NCT03761277|448961924|FG000|Enrollment to Implant|Sponsor Request|2|||
124818247|NCT03761277|448961924|FG000|Post-Implant to 6 Months|Adverse Event|2|||
124818248|NCT03761277|448961924|FG000|Post-Implant to 6 Months|Death|1|||
124818249|NCT03761277|448961924|FG000|Post-Implant to 6 Months|Site Closure|2|||
124818250|NCT03761277|448961924|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
124818251|NCT03761277|448961924|FG000|6 Months to 12 Months|Physician Decision|2|||
124818252|NCT03761277|448961924|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
124818253|NCT00004978|448961925|FG000|Overall Study|Death|107|||
124818254|NCT00004978|448961926|FG001|Overall Study|Death|116|||
124818255|NCT00004978|448961925|FG000|Overall Study|Lost to Follow-up|101|||
124818256|NCT00004978|448961926|FG001|Overall Study|Lost to Follow-up|108|||
124818257|NCT00004978|448961925|FG000|Overall Study|Withdrawal by Subject|17|||
124818258|NCT00004978|448961926|FG001|Overall Study|Withdrawal by Subject|26|||
124818259|NCT00004978|448961925|FG000|Overall Study|site closure - not in analysis cohort|19|||
124818260|NCT00004978|448961926|FG001|Overall Study|site closure - not in analysis cohort|20|||
124818261|NCT01508650|448961927|FG000|Overall Study|Lost to Follow-up|0|||
124818262|NCT01508650|448961928|FG001|Overall Study|Lost to Follow-up|3|||
124818263|NCT02064894|448961929|FG000|Overall Study|Withdrawal by Subject|43|||
124818264|NCT02064894|448961930|FG001|Overall Study|Withdrawal by Subject|102|||
124818265|NCT02064894|448961931|FG002|Overall Study|Withdrawal by Subject|115|||
124818266|NCT02864498|448961932|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
124818267|NCT02864498|448961933|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
124818268|NCT02864498|448961934|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
124818269|NCT02864498|448961932|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
124818270|NCT02864498|448961933|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
124818271|NCT02864498|448961934|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
124818272|NCT02864498|448961932|FG000|Overall Study|Investigator Discretion|0|||
124818273|NCT02864498|448961933|FG001|Overall Study|Investigator Discretion|2|||
124818274|NCT02864498|448961934|FG002|Overall Study|Investigator Discretion|1|||
124818275|NCT02864498|448961932|FG000|Overall Study|Lost to Follow-up|8|||
124818276|NCT02864498|448961933|FG001|Overall Study|Lost to Follow-up|6|||
124818277|NCT02864498|448961934|FG002|Overall Study|Lost to Follow-up|3|||
124818278|NCT02864498|448961932|FG000|Overall Study|Lack of Efficacy|5|||
124818279|NCT02864498|448961933|FG001|Overall Study|Lack of Efficacy|3|||
124818280|NCT02864498|448961934|FG002|Overall Study|Lack of Efficacy|3|||
124818281|NCT02864498|448961932|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
124818282|NCT02864498|448961933|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
124818283|NCT02864498|448961934|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
124818284|NCT02864498|448961932|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
124818285|NCT02864498|448961933|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
124818286|NCT02864498|448961934|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
124818287|NCT02864498|448961932|FG000|Overall Study|Subject moved out of the country.|0|||
124818288|NCT02864498|448961933|FG001|Overall Study|Subject moved out of the country.|0|||
124818289|NCT02864498|448961934|FG002|Overall Study|Subject moved out of the country.|1|||
124818290|NCT01812174|448961935|FG000|Overall Study|Death|1|||
124818291|NCT01812174|448961936|FG001|Overall Study|Death|0|||
124818292|NCT01812174|448961935|FG000|Overall Study|Protocol Violation|2|||
124818293|NCT01812174|448961936|FG001|Overall Study|Protocol Violation|0|||
124818294|NCT00851747|448961940|FG000|Overall Study|Physician Decision|6|||
124818295|NCT00851747|448961941|FG001|Overall Study|Physician Decision|6|||
124818296|NCT00851747|448961942|FG002|Overall Study|Physician Decision|6|||
124818297|NCT01051323|448961943|FG000|Overall Study|Discontinuation of treatment|103|||
124818298|NCT01051323|448961943|FG000|Overall Study|Transplantation|28|||
124818299|NCT01051323|448961943|FG000|Overall Study|Dialysis dependency|22|||
124818300|NCT01051323|448961943|FG000|Overall Study|Withdrawal by Subject|13|||
124818301|NCT01051323|448961943|FG000|Overall Study|Lost to Follow-up|31|||
124818302|NCT01051323|448961943|FG000|Overall Study|Death|129|||
124818303|NCT01051323|448961943|FG000|Overall Study|Hospitalization|28|||
124818304|NCT01051323|448961943|FG000|Overall Study|Other|148|||
124818305|NCT01051323|448961943|FG000|Overall Study|Missing|37|||
124818306|NCT01537393|448961944|FG000|Overall Study|Exclude prior to study|32|||
124818307|NCT01537393|448961945|FG001|Overall Study|Exclude prior to study|44|||
124818308|NCT01537393|448961944|FG000|Overall Study|Death|20|||
124818309|NCT01537393|448961945|FG001|Overall Study|Death|32|||
124818310|NCT01537393|448961944|FG000|Overall Study|Withdrawal by Subject|18|||
124818311|NCT01537393|448961945|FG001|Overall Study|Withdrawal by Subject|17|||
124818312|NCT01537393|448961944|FG000|Overall Study|Lost to Follow-up|53|||
124818313|NCT01537393|448961945|FG001|Overall Study|Lost to Follow-up|48|||
124818314|NCT01537393|448961944|FG000|Overall Study|Failure - Regrafted|28|||
124818315|NCT01537393|448961945|FG001|Overall Study|Failure - Regrafted|43|||
124818316|NCT01537393|448961944|FG000|Overall Study|Failure - Not regrafted|2|||
124818317|NCT01537393|448961945|FG001|Overall Study|Failure - Not regrafted|6|||
124818318|NCT01537393|448961944|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
124818319|NCT01537393|448961945|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
124818320|NCT01233258|448961952|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
124818321|NCT01233258|448961953|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
124818322|NCT01233258|448961954|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
124818323|NCT01233258|448961955|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
124818324|NCT01233258|448961956|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
124818325|NCT01233258|448961957|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
124818326|NCT01233258|448961952|FG000|First Intervention (6 Months)|Protocol Violation|0|||
124818327|NCT01233258|448961953|FG001|First Intervention (6 Months)|Protocol Violation|0|||
124818328|NCT01233258|448961954|FG002|First Intervention (6 Months)|Protocol Violation|1|||
124818329|NCT01233258|448961955|FG003|First Intervention (6 Months)|Protocol Violation|0|||
124818330|NCT01233258|448961956|FG004|First Intervention (6 Months)|Protocol Violation|0|||
124818331|NCT01233258|448961957|FG005|First Intervention (6 Months)|Protocol Violation|0|||
124818332|NCT01233258|448961952|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
124818333|NCT01233258|448961953|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
124818334|NCT01233258|448961954|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
124818335|NCT01233258|448961955|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
124818336|NCT01233258|448961956|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
124818337|NCT01233258|448961957|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
124818338|NCT01637272|448961958|FG000|Overall Study|Adverse Event|6|||
124818339|NCT01637272|448961958|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124818340|NCT01637272|448961958|FG000|Overall Study|Withdrawal by Subject|3|||
124818341|NCT01637272|448961958|FG000|Overall Study|Lost to Follow-up|2|||
124818342|NCT01637272|448961958|FG000|Overall Study|completed core, did not enter ext. phase|4|||
124818343|NCT01637272|448961958|FG000|Overall Study|Administrative problems|1|||
124818344|NCT01637272|448961958|FG000|Overall Study|Protocol Violation|2|||
124818345|NCT01496612|448961959|FG000|1st Intervention|Adverse Event|1|||
124818346|NCT01496612|448961960|FG001|1st Intervention|Adverse Event|0|||
124818347|NCT01496612|448961959|FG000|1st Intervention|Withdrawal by Subject|1|||
124818348|NCT01496612|448961960|FG001|1st Intervention|Withdrawal by Subject|0|||
124818349|NCT03708328|448961971|FG000|Overall Study|Death|3|||
124818350|NCT03708328|448961972|FG001|Overall Study|Death|3|||
124818351|NCT03708328|448961973|FG002|Overall Study|Death|4|||
124818352|NCT03708328|448961974|FG003|Overall Study|Death|2|||
124818353|NCT03708328|448961975|FG004|Overall Study|Death|2|||
124818354|NCT03708328|448961976|FG005|Overall Study|Death|13|||
124818355|NCT03708328|448961977|FG006|Overall Study|Death|26|||
124818356|NCT03708328|448961978|FG007|Overall Study|Death|18|||
124818357|NCT03708328|448961979|FG008|Overall Study|Death|13|||
124818358|NCT03708328|448961980|FG009|Overall Study|Death|8|||
124818359|NCT03708328|448961971|FG000|Overall Study|Lost to Follow-up|0|||
124818360|NCT03708328|448961972|FG001|Overall Study|Lost to Follow-up|1|||
124818361|NCT03708328|448961973|FG002|Overall Study|Lost to Follow-up|0|||
124818362|NCT03708328|448961974|FG003|Overall Study|Lost to Follow-up|1|||
124818363|NCT03708328|448961975|FG004|Overall Study|Lost to Follow-up|0|||
124818364|NCT03708328|448961976|FG005|Overall Study|Lost to Follow-up|3|||
124818365|NCT03708328|448961977|FG006|Overall Study|Lost to Follow-up|3|||
124818366|NCT03708328|448961978|FG007|Overall Study|Lost to Follow-up|0|||
124818367|NCT03708328|448961979|FG008|Overall Study|Lost to Follow-up|0|||
124818368|NCT03708328|448961980|FG009|Overall Study|Lost to Follow-up|1|||
124818369|NCT03708328|448961971|FG000|Overall Study|Physician Decision|0|||
124818370|NCT03708328|448961972|FG001|Overall Study|Physician Decision|0|||
124818371|NCT03708328|448961973|FG002|Overall Study|Physician Decision|0|||
124818372|NCT03708328|448961974|FG003|Overall Study|Physician Decision|0|||
124818373|NCT03708328|448961975|FG004|Overall Study|Physician Decision|0|||
124818374|NCT03708328|448961976|FG005|Overall Study|Physician Decision|1|||
124818375|NCT03708328|448961977|FG006|Overall Study|Physician Decision|0|||
124818376|NCT03708328|448961978|FG007|Overall Study|Physician Decision|0|||
124818377|NCT03708328|448961979|FG008|Overall Study|Physician Decision|0|||
124818378|NCT03708328|448961980|FG009|Overall Study|Physician Decision|0|||
124818379|NCT03708328|448961971|FG000|Overall Study|Withdrawal by Subject|0|||
124818380|NCT03708328|448961972|FG001|Overall Study|Withdrawal by Subject|0|||
124818381|NCT03708328|448961973|FG002|Overall Study|Withdrawal by Subject|0|||
124818382|NCT03708328|448961974|FG003|Overall Study|Withdrawal by Subject|0|||
124818383|NCT03708328|448961975|FG004|Overall Study|Withdrawal by Subject|1|||
124818384|NCT03708328|448961976|FG005|Overall Study|Withdrawal by Subject|0|||
124818385|NCT03708328|448961977|FG006|Overall Study|Withdrawal by Subject|2|||
124818386|NCT03708328|448961978|FG007|Overall Study|Withdrawal by Subject|4|||
124818387|NCT03708328|448961979|FG008|Overall Study|Withdrawal by Subject|1|||
124818388|NCT03708328|448961980|FG009|Overall Study|Withdrawal by Subject|5|||
124818389|NCT03708328|448961971|FG000|Overall Study|Study Closed Locally|0|||
124818390|NCT03708328|448961972|FG001|Overall Study|Study Closed Locally|0|||
124818391|NCT03708328|448961973|FG002|Overall Study|Study Closed Locally|0|||
124818392|NCT03708328|448961974|FG003|Overall Study|Study Closed Locally|0|||
124818393|NCT03708328|448961975|FG004|Overall Study|Study Closed Locally|0|||
124818394|NCT03708328|448961976|FG005|Overall Study|Study Closed Locally|0|||
124818395|NCT03708328|448961977|FG006|Overall Study|Study Closed Locally|0|||
124818396|NCT03708328|448961978|FG007|Overall Study|Study Closed Locally|1|||
124818397|NCT03708328|448961979|FG008|Overall Study|Study Closed Locally|0|||
124818398|NCT03708328|448961980|FG009|Overall Study|Study Closed Locally|0|||
124818399|NCT03708328|448961971|FG000|Overall Study|Study Ended By Sponsor|0|||
124818400|NCT03708328|448961972|FG001|Overall Study|Study Ended By Sponsor|0|||
124818401|NCT03708328|448961973|FG002|Overall Study|Study Ended By Sponsor|0|||
124818402|NCT03708328|448961974|FG003|Overall Study|Study Ended By Sponsor|0|||
124818403|NCT03708328|448961975|FG004|Overall Study|Study Ended By Sponsor|0|||
124818404|NCT03708328|448961976|FG005|Overall Study|Study Ended By Sponsor|1|||
124818405|NCT03708328|448961977|FG006|Overall Study|Study Ended By Sponsor|0|||
124818406|NCT03708328|448961978|FG007|Overall Study|Study Ended By Sponsor|1|||
124818407|NCT03708328|448961979|FG008|Overall Study|Study Ended By Sponsor|0|||
124818408|NCT03708328|448961980|FG009|Overall Study|Study Ended By Sponsor|0|||
124818409|NCT03708328|448961971|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818410|NCT03708328|448961972|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818411|NCT03708328|448961973|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818412|NCT03708328|448961974|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818413|NCT03708328|448961975|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818414|NCT03708328|448961976|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818415|NCT03708328|448961977|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818416|NCT03708328|448961978|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818417|NCT03708328|448961979|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
124818418|NCT03708328|448961980|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
124818419|NCT02605824|448961981|FG000|Overall Study|Physician Decision|1|||
124818420|NCT02605824|448961982|FG001|Overall Study|Physician Decision|0|||
124818421|NCT02695329|448961985|FG000|Overall Study|Adverse Event|1|||
124818422|NCT02695329|448961986|FG001|Overall Study|Adverse Event|0|||
124818423|NCT02695329|448961985|FG000|Overall Study|Poor X-ray quality for measurement|4|||
124818424|NCT02695329|448961986|FG001|Overall Study|Poor X-ray quality for measurement|5|||
124818425|NCT01032837|448961988|FG000|Overall Study|Adverse event/internal illness|0|||
124818426|NCT01032837|448961989|FG001|Overall Study|Adverse event/internal illness|1|||
124818427|NCT01032837|448961990|FG002|Overall Study|Adverse event/internal illness|0|||
124818428|NCT01032837|448961991|FG003|Overall Study|Adverse event/internal illness|1|||
124818429|NCT01032837|448961988|FG000|Overall Study|Withdrew consent|0|||
124818430|NCT01032837|448961989|FG001|Overall Study|Withdrew consent|2|||
124818431|NCT01032837|448961990|FG002|Overall Study|Withdrew consent|0|||
124818432|NCT01032837|448961991|FG003|Overall Study|Withdrew consent|1|||
124818433|NCT01032837|448961988|FG000|Overall Study|Failed to return|0|||
124818434|NCT01032837|448961989|FG001|Overall Study|Failed to return|0|||
124818435|NCT01032837|448961990|FG002|Overall Study|Failed to return|1|||
124637157|NCT00410813|448288723|FG001|Overall Study|Not protocol specified|4|||
124818436|NCT01032837|448961991|FG003|Overall Study|Failed to return|0|||
124818437|NCT01032837|448961988|FG000|Overall Study|Refused treatment|0|||
124818438|NCT01032837|448961989|FG001|Overall Study|Refused treatment|0|||
124818439|NCT01032837|448961990|FG002|Overall Study|Refused treatment|0|||
124818440|NCT01032837|448961991|FG003|Overall Study|Refused treatment|1|||
124818441|NCT00843024|448961992|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
124818442|NCT00843024|448961993|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
124818443|NCT00843024|448961994|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
124818444|NCT00843024|448961995|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
124818445|NCT00843024|448961996|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
124818446|NCT00843024|448961997|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
124818447|NCT00843024|448961992|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
124818448|NCT00843024|448961993|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
124818449|NCT00843024|448961994|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
124818450|NCT00843024|448961995|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
124818451|NCT00843024|448961996|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
124818452|NCT00843024|448961997|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
124818453|NCT00843024|448961992|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
124818454|NCT00843024|448961993|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
124818455|NCT00843024|448961994|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
124818456|NCT00843024|448961995|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
124818457|NCT00843024|448961996|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
124818458|NCT00843024|448961997|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
124818459|NCT00843024|448961992|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
124818460|NCT00843024|448961993|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
124818461|NCT00843024|448961994|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
124818462|NCT00843024|448961995|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
124818463|NCT00843024|448961996|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
124818464|NCT00843024|448961997|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
124818465|NCT00843024|448961992|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
124818466|NCT00843024|448961993|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
124818467|NCT00843024|448961994|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
124818468|NCT00843024|448961995|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
124818469|NCT00843024|448961996|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
124818470|NCT00843024|448961997|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
124818471|NCT00843024|448961992|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
124818472|NCT00843024|448961993|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
124818473|NCT00843024|448961994|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
124818474|NCT00843024|448961995|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
124818475|NCT00843024|448961996|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
124818476|NCT00843024|448961997|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
124818477|NCT00843024|448961992|FG000|Single-blind Placebo Run-In Phase|Other|0|||
124818478|NCT00843024|448961993|FG001|Single-blind Placebo Run-In Phase|Other|1|||
124818479|NCT00843024|448961994|FG002|Single-blind Placebo Run-In Phase|Other|0|||
124818480|NCT00843024|448961995|FG003|Single-blind Placebo Run-In Phase|Other|0|||
124818481|NCT00843024|448961996|FG004|Single-blind Placebo Run-In Phase|Other|0|||
124818482|NCT00843024|448961997|FG005|Single-blind Placebo Run-In Phase|Other|0|||
124818483|NCT00843024|448961992|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
124818484|NCT00843024|448961993|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
124818485|NCT00843024|448961994|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
124818486|NCT00843024|448961995|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
124818487|NCT00843024|448961996|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
124818488|NCT00843024|448961997|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
124818489|NCT00843024|448961992|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
124818490|NCT00843024|448961993|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
124818491|NCT00843024|448961994|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
124818492|NCT00843024|448961995|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
124818493|NCT00843024|448961996|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
124818494|NCT00843024|448961997|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
124818495|NCT00843024|448961992|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124818496|NCT00843024|448961993|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124818497|NCT00843024|448961994|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124818498|NCT00843024|448961995|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
124818499|NCT00843024|448961996|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124818500|NCT00843024|448961997|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
124818501|NCT00843024|448961992|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
124818502|NCT00843024|448961993|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
124818503|NCT00843024|448961994|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
124818504|NCT00843024|448961995|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
124637158|NCT00410813|448288722|FG000|Overall Study|Ineligible|2|||
124637159|NCT00410813|448288723|FG001|Overall Study|Ineligible|4|||
124637160|NCT00410813|448288722|FG000|Overall Study|Death|0|||
124818505|NCT00843024|448961996|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
124818506|NCT00843024|448961997|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
124818507|NCT00843024|448961992|FG000|Double-blind Treatment Phase|Physician Decision|0|||
124818508|NCT00843024|448961993|FG001|Double-blind Treatment Phase|Physician Decision|0|||
124818509|NCT00843024|448961994|FG002|Double-blind Treatment Phase|Physician Decision|0|||
124818510|NCT00843024|448961995|FG003|Double-blind Treatment Phase|Physician Decision|3|||
124818511|NCT00843024|448961996|FG004|Double-blind Treatment Phase|Physician Decision|1|||
124818512|NCT00843024|448961997|FG005|Double-blind Treatment Phase|Physician Decision|1|||
124818513|NCT00843024|448961992|FG000|Double-blind Treatment Phase|Adverse Event|0|||
124818514|NCT00843024|448961993|FG001|Double-blind Treatment Phase|Adverse Event|0|||
124818515|NCT00843024|448961994|FG002|Double-blind Treatment Phase|Adverse Event|0|||
124818516|NCT00843024|448961995|FG003|Double-blind Treatment Phase|Adverse Event|0|||
124818517|NCT00843024|448961996|FG004|Double-blind Treatment Phase|Adverse Event|1|||
124818518|NCT00843024|448961997|FG005|Double-blind Treatment Phase|Adverse Event|1|||
124818519|NCT00843024|448961992|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
124818520|NCT00843024|448961993|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
124818521|NCT00843024|448961994|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
124818522|NCT00843024|448961995|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
124818523|NCT00843024|448961996|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
124818524|NCT00843024|448961997|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
124818525|NCT02439138|448961999|FG000|Overall Study|Adverse Event|1|||
124818526|NCT02439138|448961999|FG000|Overall Study|PI decision to terminate the study|2|||
124818527|NCT00006237|448962004|FG000|Overall Study|Adverse Event|39|||
124818528|NCT00006237|448962005|FG001|Overall Study|Adverse Event|29|||
124818529|NCT00006237|448962004|FG000|Overall Study|Death|1|||
124818530|NCT00006237|448962005|FG001|Overall Study|Death|0|||
124818531|NCT00006237|448962004|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
124818532|NCT00006237|448962005|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
124818533|NCT00006237|448962004|FG000|Overall Study|Progression/relapse|54|||
124818534|NCT00006237|448962005|FG001|Overall Study|Progression/relapse|2|||
124818535|NCT00006237|448962004|FG000|Overall Study|Not eligible|9|||
124818536|NCT00006237|448962005|FG001|Overall Study|Not eligible|20|||
124818537|NCT00006237|448962004|FG000|Overall Study|Withdrawal by Subject|0|||
124818538|NCT00006237|448962005|FG001|Overall Study|Withdrawal by Subject|1|||
124818539|NCT00006237|448962004|FG000|Overall Study|Not protocol specified|14|||
124818540|NCT00006237|448962005|FG001|Overall Study|Not protocol specified|5|||
124818541|NCT01846416|448962008|FG000|Treatment Phase|Death|2|||
124818542|NCT01846416|448962009|FG001|Treatment Phase|Death|9|||
124818543|NCT01846416|448962010|FG002|Treatment Phase|Death|1|||
124818544|NCT01846416|448962008|FG000|Treatment Phase|Withdrawal by Subject|2|||
124818545|NCT01846416|448962009|FG001|Treatment Phase|Withdrawal by Subject|4|||
124818546|NCT01846416|448962010|FG002|Treatment Phase|Withdrawal by Subject|2|||
124818547|NCT01846416|448962008|FG000|Treatment Phase|Other|1|||
124818548|NCT01846416|448962009|FG001|Treatment Phase|Other|5|||
124818549|NCT01846416|448962010|FG002|Treatment Phase|Other|1|||
124818550|NCT01846416|448962008|FG000|Treatment Phase|Physician Decision|1|||
124818551|NCT01846416|448962009|FG001|Treatment Phase|Physician Decision|2|||
124818552|NCT01846416|448962010|FG002|Treatment Phase|Physician Decision|0|||
124818553|NCT01846416|448962008|FG000|Treatment Phase|Adverse Event|3|||
124818554|NCT01846416|448962009|FG001|Treatment Phase|Adverse Event|4|||
124818555|NCT01846416|448962010|FG002|Treatment Phase|Adverse Event|0|||
124818556|NCT01846416|448962008|FG000|Treatment Phase|Non-compliance|0|||
124818557|NCT01846416|448962009|FG001|Treatment Phase|Non-compliance|2|||
124818558|NCT01846416|448962010|FG002|Treatment Phase|Non-compliance|0|||
124818559|NCT01846416|448962008|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
124818560|NCT01846416|448962009|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
124818561|NCT01846416|448962010|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
124818562|NCT01846416|448962008|FG000|Treatment Phase|Progressive Disease|21|||
124818563|NCT01846416|448962009|FG001|Treatment Phase|Progressive Disease|63|||
124818564|NCT01846416|448962010|FG002|Treatment Phase|Progressive Disease|9|||
124818565|NCT01846416|448962008|FG000|Survival Follow-up|Death|21|||
124818566|NCT01846416|448962009|FG001|Survival Follow-up|Death|62|||
124818567|NCT01846416|448962010|FG002|Survival Follow-up|Death|9|||
124818568|NCT01846416|448962008|FG000|Survival Follow-up|Lost to Follow-up|0|||
124818569|NCT01846416|448962009|FG001|Survival Follow-up|Lost to Follow-up|2|||
124818570|NCT01846416|448962010|FG002|Survival Follow-up|Lost to Follow-up|2|||
124818571|NCT01846416|448962008|FG000|Survival Follow-up|Withdrawal by Subject|2|||
124818572|NCT01846416|448962009|FG001|Survival Follow-up|Withdrawal by Subject|7|||
124818573|NCT01846416|448962010|FG002|Survival Follow-up|Withdrawal by Subject|0|||
124818574|NCT01846416|448962008|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
124818575|NCT01846416|448962009|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
124818576|NCT01846416|448962010|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
124818577|NCT01846416|448962008|FG000|Survival Follow-up|Other|3|||
124818578|NCT01846416|448962009|FG001|Survival Follow-up|Other|1|||
124818579|NCT01846416|448962010|FG002|Survival Follow-up|Other|1|||
124818580|NCT01487200|448962011|FG000|Overall Study|Withdrawal by Subject|0|||
124818581|NCT01487200|448962012|FG001|Overall Study|Withdrawal by Subject|1|||
124818582|NCT01487200|448962013|FG002|Overall Study|Withdrawal by Subject|0|||
124818583|NCT01487200|448962014|FG003|Overall Study|Withdrawal by Subject|0|||
124818584|NCT02837783|448962015|FG000|Overall Study|Adverse Event|1|||
124818585|NCT02837783|448962016|FG001|Overall Study|Adverse Event|0|||
124818586|NCT02837783|448962015|FG000|Overall Study|Other, Not Specified|1|||
124818587|NCT02837783|448962016|FG001|Overall Study|Other, Not Specified|2|||
124818588|NCT01962896|448962017|FG000|Overall Study|Lack of Efficacy|4|||
124818589|NCT02216591|448962018|FG000|Overall Study|Lost to Follow-up|0|||
124818590|NCT02216591|448962019|FG001|Overall Study|Lost to Follow-up|1|||
124818591|NCT02207244|448962020|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
124818592|NCT02207244|448962021|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
124818593|NCT02207244|448962022|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
124818594|NCT02207244|448962023|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
124818595|NCT02207244|448962024|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
124818596|NCT02207244|448962025|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
124818597|NCT02207244|448962026|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
124818598|NCT02207244|448962027|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
124818599|NCT02207244|448962028|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
124818600|NCT02207244|448962029|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
124818601|NCT02207244|448962030|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
124818602|NCT02207244|448962020|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
124818603|NCT02207244|448962021|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818604|NCT02207244|448962022|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
124818605|NCT02207244|448962023|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818606|NCT02207244|448962024|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818607|NCT02207244|448962025|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818608|NCT02207244|448962026|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818609|NCT02207244|448962027|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818610|NCT02207244|448962028|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818611|NCT02207244|448962029|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818612|NCT02207244|448962030|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
124818613|NCT02207244|448962020|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
124818614|NCT02207244|448962021|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
124818615|NCT02207244|448962022|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
124818616|NCT02207244|448962023|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
124818617|NCT02207244|448962024|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
124818618|NCT02207244|448962025|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
124818619|NCT02207244|448962026|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
124818620|NCT02207244|448962027|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
124818621|NCT02207244|448962028|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
124818622|NCT02207244|448962029|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
124818623|NCT02207244|448962030|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
124818624|NCT02207244|448962020|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
124818625|NCT02207244|448962021|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
124818626|NCT02207244|448962022|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818627|NCT02207244|448962023|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818628|NCT02207244|448962024|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818629|NCT02207244|448962025|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818630|NCT02207244|448962026|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818631|NCT02207244|448962027|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818632|NCT02207244|448962028|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818633|NCT02207244|448962029|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818634|NCT02207244|448962030|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
124818635|NCT02207244|448962020|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
124818636|NCT02207244|448962021|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
124818637|NCT02207244|448962022|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
124818638|NCT02207244|448962023|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
124818639|NCT02207244|448962024|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
124818640|NCT02207244|448962025|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
124818641|NCT02207244|448962026|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
124818642|NCT02207244|448962027|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
124818643|NCT02207244|448962028|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
124818644|NCT02207244|448962029|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
124818645|NCT02207244|448962030|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
124818646|NCT02207244|448962020|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818647|NCT02207244|448962021|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
124818648|NCT02207244|448962022|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
124818649|NCT02207244|448962023|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818650|NCT02207244|448962024|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818651|NCT02207244|448962025|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818652|NCT02207244|448962026|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818653|NCT02207244|448962027|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818654|NCT02207244|448962028|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818655|NCT02207244|448962029|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818656|NCT02207244|448962030|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
124818657|NCT02207244|448962020|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818658|NCT02207244|448962021|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
124818659|NCT02207244|448962022|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818660|NCT02207244|448962023|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818661|NCT02207244|448962024|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818662|NCT02207244|448962025|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818663|NCT02207244|448962026|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818664|NCT02207244|448962027|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818665|NCT02207244|448962028|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818666|NCT02207244|448962029|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818667|NCT02207244|448962030|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
124818668|NCT02207244|448962020|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818669|NCT02207244|448962021|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818670|NCT02207244|448962022|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818671|NCT02207244|448962023|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818672|NCT02207244|448962024|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
124818673|NCT02207244|448962025|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
124818674|NCT02207244|448962026|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818675|NCT02207244|448962027|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818676|NCT02207244|448962028|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818677|NCT02207244|448962029|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818678|NCT02207244|448962030|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
124818679|NCT02207244|448962020|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818680|NCT02207244|448962021|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818681|NCT02207244|448962022|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818682|NCT02207244|448962023|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818683|NCT02207244|448962024|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818684|NCT02207244|448962025|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
124818685|NCT02207244|448962026|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818686|NCT02207244|448962027|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818687|NCT02207244|448962028|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818688|NCT02207244|448962029|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818689|NCT02207244|448962030|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
124818690|NCT02207244|448962020|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
124818691|NCT02207244|448962021|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
124818692|NCT02207244|448962022|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
124818693|NCT02207244|448962023|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
124818694|NCT02207244|448962024|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
124818695|NCT02207244|448962025|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
124818696|NCT02207244|448962026|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
124818697|NCT02207244|448962027|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
124818698|NCT02207244|448962028|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
124818699|NCT02207244|448962029|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
124818700|NCT02207244|448962030|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
124818701|NCT02207244|448962020|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
124818702|NCT02207244|448962021|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
124818703|NCT02207244|448962022|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
124818704|NCT02207244|448962023|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
124818705|NCT02207244|448962024|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
124818706|NCT02207244|448962025|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
124818707|NCT02207244|448962026|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
124818708|NCT02207244|448962027|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
124818709|NCT02207244|448962028|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
124818710|NCT02207244|448962029|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
124818711|NCT02207244|448962030|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
124818712|NCT02207244|448962020|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818713|NCT02207244|448962021|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818714|NCT02207244|448962022|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818715|NCT02207244|448962023|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
124818716|NCT02207244|448962024|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818717|NCT02207244|448962025|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
124818718|NCT02207244|448962026|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818719|NCT02207244|448962027|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818720|NCT02207244|448962028|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818721|NCT02207244|448962029|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818722|NCT02207244|448962030|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
124818723|NCT02207244|448962020|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818724|NCT02207244|448962021|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818725|NCT02207244|448962022|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818726|NCT02207244|448962023|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
124818727|NCT02207244|448962024|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818728|NCT02207244|448962025|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818729|NCT02207244|448962026|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818730|NCT02207244|448962027|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818731|NCT02207244|448962028|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818732|NCT02207244|448962029|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818733|NCT02207244|448962030|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
124818734|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
124818735|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
124818736|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
124818737|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
124818738|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
124818739|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
124818740|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
124818741|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
124818742|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
124818743|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
124818744|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
124818745|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818746|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818747|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818748|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818749|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124637161|NCT00410813|448288723|FG001|Overall Study|Death|2|||
124637162|NCT05027451|448288724|FG000|Overall Study|Lost to Follow-up|1|||
124818750|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818751|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818752|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
124818753|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818754|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818755|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
124818756|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
124818757|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
124818758|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
124818759|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
124818760|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
124818761|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
124818762|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
124818763|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
124818764|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
124818765|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
124818766|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
124818767|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
124818768|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
124818769|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
124818770|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
124818771|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
124818772|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
124818773|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
124818774|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
124818775|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
124818776|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
124818777|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
124637163|NCT05027451|448288725|FG001|Overall Study|Lost to Follow-up|1|||
124818778|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
124818779|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
124818780|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
124818781|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
124818782|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
124818783|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
124818784|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
124818785|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
124818786|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
124818787|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
124818788|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
124818789|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818790|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818791|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818792|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818793|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818794|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818795|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818796|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
124818797|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
124818798|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818799|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
124818800|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818801|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818802|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818803|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818804|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818805|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818806|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818807|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818808|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
124818809|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818810|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
124818811|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818812|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818813|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818814|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818815|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818816|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818817|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818818|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
124818819|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818820|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124637164|NCT00954941|448288726|FG000|Overall Study|Received treatment at home|1|||
124637165|NCT00954941|448288727|FG001|Overall Study|Received treatment at home|0|||
124818821|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
124818822|NCT02207244|448962020|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818823|NCT02207244|448962021|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818824|NCT02207244|448962022|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818825|NCT02207244|448962023|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818826|NCT02207244|448962024|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818827|NCT02207244|448962025|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818828|NCT02207244|448962026|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
124818829|NCT02207244|448962027|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818830|NCT02207244|448962028|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818831|NCT02207244|448962029|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818832|NCT02207244|448962030|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
124818833|NCT02207244|448962020|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
124818834|NCT02207244|448962021|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
124818835|NCT02207244|448962022|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
124637166|NCT00954941|448288726|FG000|Overall Study|Withdrawal by Subject|1|||
124637167|NCT00954941|448288727|FG001|Overall Study|Withdrawal by Subject|0|||
124818836|NCT02207244|448962023|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
124818837|NCT02207244|448962024|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
124818838|NCT02207244|448962025|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
124818839|NCT02207244|448962026|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
124818840|NCT02207244|448962027|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
124818841|NCT02207244|448962028|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
124818842|NCT02207244|448962029|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
124818843|NCT02207244|448962030|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
124818844|NCT02207244|448962020|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818845|NCT02207244|448962021|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818846|NCT02207244|448962022|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818847|NCT02207244|448962023|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818848|NCT02207244|448962024|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818849|NCT02207244|448962025|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818850|NCT02207244|448962026|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818851|NCT02207244|448962027|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818852|NCT02207244|448962028|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
124818853|NCT02207244|448962029|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
124818854|NCT02207244|448962030|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
124818855|NCT02207244|448962020|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818856|NCT02207244|448962021|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818857|NCT02207244|448962022|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818858|NCT02207244|448962023|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818859|NCT02207244|448962024|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818860|NCT02207244|448962025|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818861|NCT02207244|448962026|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818862|NCT02207244|448962027|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818863|NCT02207244|448962028|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
124818864|NCT02207244|448962029|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
124818865|NCT02207244|448962030|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
124818866|NCT02207244|448962020|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818867|NCT02207244|448962021|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818868|NCT02207244|448962022|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818869|NCT02207244|448962023|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818870|NCT02207244|448962024|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818871|NCT02207244|448962025|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818872|NCT02207244|448962026|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818873|NCT02207244|448962027|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818874|NCT02207244|448962028|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
124818875|NCT02207244|448962029|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
124818876|NCT02207244|448962030|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
124818877|NCT02207244|448962020|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
124818878|NCT02207244|448962021|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
124818879|NCT02207244|448962022|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
124818880|NCT02207244|448962023|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
124818881|NCT02207244|448962024|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
124818882|NCT02207244|448962025|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
124818883|NCT02207244|448962026|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
124818884|NCT02207244|448962027|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
124818885|NCT02207244|448962028|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
124818886|NCT02207244|448962029|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
124818887|NCT02207244|448962030|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
124818888|NCT02207244|448962020|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
124818889|NCT02207244|448962021|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
124818890|NCT02207244|448962022|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
124818891|NCT02207244|448962023|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
124818892|NCT02207244|448962024|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
124818893|NCT02207244|448962025|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
124818894|NCT02207244|448962026|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
124818895|NCT02207244|448962027|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
124818896|NCT02207244|448962028|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
124818897|NCT02207244|448962029|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
124818898|NCT02207244|448962030|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
124818899|NCT02207244|448962020|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818900|NCT02207244|448962021|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818901|NCT02207244|448962022|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818902|NCT02207244|448962023|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818903|NCT02207244|448962024|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818904|NCT02207244|448962025|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818905|NCT02207244|448962026|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818906|NCT02207244|448962027|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818907|NCT02207244|448962028|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818908|NCT02207244|448962029|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
124818909|NCT02207244|448962030|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
124818910|NCT00039130|448962031|FG000|Overall Study|Adverse Event|11|||
124818911|NCT00039130|448962031|FG000|Overall Study|Death|9|||
124818912|NCT00039130|448962031|FG000|Overall Study|Withdrawal by Subject|3|||
124818913|NCT00039130|448962031|FG000|Overall Study|Progression|2|||
124818914|NCT00039130|448962031|FG000|Overall Study|Subsequent treatment|2|||
124818915|NCT00039130|448962031|FG000|Overall Study|Physician Decision|3|||
124818916|NCT01866930|448962032|FG000|Treatment Period|Other|1|||
124818917|NCT01866930|448962033|FG001|Treatment Period|Other|0|||
124818918|NCT01866930|448962032|FG000|Treatment Period|Death|0|||
124818919|NCT01866930|448962033|FG001|Treatment Period|Death|2|||
124818920|NCT01866930|448962032|FG000|Treatment Period|Poor/non compliance|0|||
124818921|NCT01866930|448962033|FG001|Treatment Period|Poor/non compliance|2|||
124818922|NCT01866930|448962032|FG000|Treatment Period|No longer meets study criteria|0|||
124818923|NCT01866930|448962033|FG001|Treatment Period|No longer meets study criteria|1|||
124818924|NCT01866930|448962032|FG000|Treatment Period|Withdrawal by Subject|2|||
124818925|NCT01866930|448962033|FG001|Treatment Period|Withdrawal by Subject|8|||
124818926|NCT01866930|448962032|FG000|Treatment Period|Lack of Efficacy|1|||
124818927|NCT01866930|448962033|FG001|Treatment Period|Lack of Efficacy|9|||
124818928|NCT01866930|448962032|FG000|Treatment Period|Adverse Event|4|||
124818929|NCT01866930|448962033|FG001|Treatment Period|Adverse Event|12|||
124818930|NCT01866930|448962032|FG000|Treatment Period|Lost to Follow-up|1|||
124818931|NCT01866930|448962033|FG001|Treatment Period|Lost to Follow-up|1|||
124818932|NCT01866930|448962032|FG000|Follow-up Period|Lost to Follow-up|1|||
124818933|NCT01866930|448962033|FG001|Follow-up Period|Lost to Follow-up|1|||
124818934|NCT01866930|448962032|FG000|Follow-up Period|Other|1|||
124818935|NCT01866930|448962033|FG001|Follow-up Period|Other|5|||
124818936|NCT01866930|448962032|FG000|Follow-up Period|No longer required per protocol|1|||
124818937|NCT01866930|448962033|FG001|Follow-up Period|No longer required per protocol|0|||
124818938|NCT01866930|448962032|FG000|Follow-up Period|Withdrawal by Subject|3|||
124818939|NCT01866930|448962033|FG001|Follow-up Period|Withdrawal by Subject|3|||
124818940|NCT00279305|448962036|FG000|Overall Study|Pregnancy|1|||
124818941|NCT00279305|448962037|FG001|Overall Study|Pregnancy|0|||
124818942|NCT00279305|448962036|FG000|Overall Study|Withdrawal by Subject|2|||
124818943|NCT00279305|448962037|FG001|Overall Study|Withdrawal by Subject|0|||
124818944|NCT00279305|448962036|FG000|Overall Study|Dificulting establishing IV|1|||
124818945|NCT00279305|448962037|FG001|Overall Study|Dificulting establishing IV|0|||
124818946|NCT00279305|448962036|FG000|Overall Study|FDA Safety Alert|4|||
124818947|NCT00279305|448962037|FG001|Overall Study|FDA Safety Alert|1|||
124818948|NCT03930797|448962039|FG000|Overall Study|Lost to Follow-up|3|||
124818949|NCT03930797|448962040|FG001|Overall Study|Lost to Follow-up|10|||
124818950|NCT00317356|448962044|FG000|Overall Study|Adverse Event|0|||
124818951|NCT00317356|448962045|FG001|Overall Study|Adverse Event|0|||
124818952|NCT00317356|448962046|FG002|Overall Study|Adverse Event|1|||
124818953|NCT00317356|448962047|FG003|Overall Study|Adverse Event|0|||
124818954|NCT00317356|448962044|FG000|Overall Study|Lack of Efficacy|1|||
124818955|NCT00317356|448962045|FG001|Overall Study|Lack of Efficacy|1|||
124818956|NCT00317356|448962046|FG002|Overall Study|Lack of Efficacy|0|||
124818957|NCT00317356|448962047|FG003|Overall Study|Lack of Efficacy|3|||
124818958|NCT00317356|448962044|FG000|Overall Study|Physician Decision|0|||
124818959|NCT00317356|448962045|FG001|Overall Study|Physician Decision|1|||
124818960|NCT00317356|448962046|FG002|Overall Study|Physician Decision|0|||
124818961|NCT00317356|448962047|FG003|Overall Study|Physician Decision|0|||
124818962|NCT04212650|448962052|FG000|Overall Study|Withdrawal by Subject|1|||
124818963|NCT04212650|448962053|FG001|Overall Study|Withdrawal by Subject|0|||
124818964|NCT03919799|448962054|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
124818965|NCT03919799|448962055|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
124818966|NCT03919799|448962056|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
124818967|NCT03919799|448962057|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
124818968|NCT03919799|448962058|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
124818969|NCT03919799|448962054|FG000|DB Period (28 Weeks)|Adverse Event|1|||
124818970|NCT03919799|448962055|FG001|DB Period (28 Weeks)|Adverse Event|1|||
124818971|NCT03919799|448962056|FG002|DB Period (28 Weeks)|Adverse Event|1|||
124818972|NCT03919799|448962057|FG003|DB Period (28 Weeks)|Adverse Event|0|||
124818973|NCT03919799|448962058|FG004|DB Period (28 Weeks)|Adverse Event|0|||
124818974|NCT03919799|448962054|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
124818975|NCT03919799|448962055|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
124818976|NCT03919799|448962056|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
124818977|NCT03919799|448962057|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
124818978|NCT03919799|448962058|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
124818979|NCT03919799|448962054|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
124818980|NCT03919799|448962055|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
124818981|NCT03919799|448962056|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
124818982|NCT03919799|448962057|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
124818983|NCT03919799|448962058|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
124818984|NCT03919799|448962054|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
124818985|NCT03919799|448962055|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
124818986|NCT03919799|448962056|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
124818987|NCT03919799|448962057|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
124818988|NCT03919799|448962058|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
124818989|NCT00630396|448963952|FG000|Overall Study|Death|4|||
124818990|NCT00630396|448963952|FG000|Overall Study|Lost to Follow-up|3|||
124818991|NCT00790023|448963958|FG000|Overall Study|Adverse Event|2|||
124818992|NCT00790023|448963959|FG001|Overall Study|Adverse Event|1|||
124818993|NCT00790023|448963960|FG002|Overall Study|Adverse Event|4|||
124818994|NCT00790023|448963958|FG000|Overall Study|Protocol Violation|2|||
124818995|NCT00790023|448963959|FG001|Overall Study|Protocol Violation|4|||
124818996|NCT00790023|448963960|FG002|Overall Study|Protocol Violation|2|||
124818997|NCT00790023|448963958|FG000|Overall Study|Withdrawal by Subject|2|||
124818998|NCT00790023|448963959|FG001|Overall Study|Withdrawal by Subject|0|||
124818999|NCT00790023|448963960|FG002|Overall Study|Withdrawal by Subject|6|||
124819000|NCT00790023|448963958|FG000|Overall Study|Lost to Follow-up|0|||
124819001|NCT00790023|448963959|FG001|Overall Study|Lost to Follow-up|0|||
124819002|NCT00790023|448963960|FG002|Overall Study|Lost to Follow-up|1|||
124819003|NCT00790023|448963958|FG000|Overall Study|Other|5|||
124819004|NCT00790023|448963959|FG001|Overall Study|Other|5|||
124819005|NCT00790023|448963960|FG002|Overall Study|Other|8|||
124819006|NCT01338792|448963961|FG000|Overall Study|Adverse Event|2|||
124819007|NCT01338792|448963961|FG000|Overall Study|Death|1|||
124819008|NCT01338792|448963961|FG000|Overall Study|Withdrawal by Subject|1|||
124819009|NCT01652703|448963965|FG000|Overall Study|Withdrawal by Subject|0|||
124819010|NCT01652703|448963966|FG001|Overall Study|Withdrawal by Subject|1|||
124819011|NCT01652703|448963967|FG002|Overall Study|Withdrawal by Subject|3|||
124819012|NCT01652703|448963968|FG003|Overall Study|Withdrawal by Subject|1|||
124819013|NCT01652703|448963969|FG004|Overall Study|Withdrawal by Subject|0|||
124819014|NCT01652703|448963970|FG005|Overall Study|Withdrawal by Subject|1|||
124819015|NCT01652703|448963965|FG000|Overall Study|Other|0|||
124819016|NCT01652703|448963966|FG001|Overall Study|Other|0|||
124819017|NCT01652703|448963967|FG002|Overall Study|Other|0|||
124819018|NCT01652703|448963968|FG003|Overall Study|Other|1|||
124819019|NCT01652703|448963969|FG004|Overall Study|Other|1|||
124819020|NCT01652703|448963970|FG005|Overall Study|Other|1|||
124819021|NCT02155608|448963971|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
124819022|NCT02155608|448963972|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
124819023|NCT02155608|448963971|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
124819024|NCT02155608|448963972|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
124819025|NCT04532164|448963973|FG000|Overall Study|Adverse Event|1|||
124819026|NCT04532164|448963973|FG000|Overall Study|Protocol Violation|5|||
124819027|NCT04532164|448963973|FG000|Overall Study|Lost to Follow-up|1|||
124819028|NCT04532164|448963973|FG000|Overall Study|Found to be Ineligible|3|||
124819029|NCT04532164|448963973|FG000|Overall Study|Withdrawal by Subject|14|||
124819030|NCT02599129|448963974|FG000|Overall Study|Lack of Efficacy|2|||
124819031|NCT02599129|448963975|FG001|Overall Study|Lack of Efficacy|2|||
124819032|NCT02599129|448963974|FG000|Overall Study|Lost to Follow-up|1|||
124819033|NCT02599129|448963975|FG001|Overall Study|Lost to Follow-up|0|||
124819034|NCT02599129|448963974|FG000|Overall Study|Withdrawal by Subject|2|||
124819035|NCT02599129|448963975|FG001|Overall Study|Withdrawal by Subject|1|||
124819036|NCT01029795|448963983|FG000|Overall Study|Entry Criteria Not Met|2|||
124819037|NCT01029795|448963984|FG001|Overall Study|Entry Criteria Not Met|1|||
124819038|NCT01029795|448963983|FG000|Overall Study|Physician Decision|2|||
124819039|NCT01029795|448963984|FG001|Overall Study|Physician Decision|1|||
124819040|NCT01029795|448963983|FG000|Overall Study|Sponsor Decision|11|||
124819041|NCT01029795|448963984|FG001|Overall Study|Sponsor Decision|17|||
124819042|NCT01029795|448963983|FG000|Overall Study|Withdrawal by Subject|1|||
124819043|NCT01029795|448963984|FG001|Overall Study|Withdrawal by Subject|3|||
124819044|NCT00429273|448963994|FG000|Overall Study|Lost to Follow-up|1|||
124819045|NCT00429273|448963995|FG001|Overall Study|Lost to Follow-up|2|||
124819046|NCT00429273|448963996|FG002|Overall Study|Lost to Follow-up|2|||
124819047|NCT00429273|448963994|FG000|Overall Study|Physician Decision|6|||
124819048|NCT00429273|448963995|FG001|Overall Study|Physician Decision|5|||
124819049|NCT00429273|448963996|FG002|Overall Study|Physician Decision|5|||
124819050|NCT00429273|448963994|FG000|Overall Study|Adverse Event|1|||
124819051|NCT00429273|448963995|FG001|Overall Study|Adverse Event|1|||
124819052|NCT00429273|448963996|FG002|Overall Study|Adverse Event|2|||
124819053|NCT01438957|448963997|FG000|Overall Study|Physician Decision|1|||
124819054|NCT01438957|448963998|FG001|Overall Study|Physician Decision|1|||
124819055|NCT01438957|448963999|FG002|Overall Study|Physician Decision|0|||
124819056|NCT01438957|448964000|FG003|Overall Study|Physician Decision|1|||
124819057|NCT01438957|448964001|FG004|Overall Study|Physician Decision|0|||
124819058|NCT02495168|448964003|FG000|Overall Study|Other than Specified|18|||
124819059|NCT02495168|448964004|FG001|Overall Study|Other than Specified|22|||
124819060|NCT02495168|448964005|FG002|Overall Study|Other than Specified|5|||
124819061|NCT02495168|448964003|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
124819062|NCT02495168|448964004|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
124819063|NCT02495168|448964005|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
124819064|NCT02495168|448964003|FG000|Overall Study|Physician Decision|1|||
124752736|NCT01053988|448716831|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
124752737|NCT01053988|448716832|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
124752738|NCT01053988|448716827|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
124752739|NCT01053988|448716828|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
124752740|NCT01053988|448716829|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
124752741|NCT01053988|448716830|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
124752742|NCT01053988|448716831|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
124752743|NCT01053988|448716832|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
124752744|NCT01053988|448716827|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
124752745|NCT01053988|448716828|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
124752746|NCT01053988|448716829|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
124752747|NCT01053988|448716830|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
124752748|NCT01053988|448716831|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
124752749|NCT01053988|448716832|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
124752750|NCT01053988|448716827|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
124752751|NCT01053988|448716828|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
124752752|NCT01053988|448716829|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
124752753|NCT01053988|448716830|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
124752754|NCT01053988|448716831|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
124752755|NCT01053988|448716832|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
124752756|NCT01053988|448716827|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
124752757|NCT01053988|448716828|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
124752758|NCT01053988|448716829|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
124752759|NCT01053988|448716830|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
124752760|NCT01053988|448716831|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
124752761|NCT01053988|448716832|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
124752762|NCT01053988|448716827|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
124752763|NCT01053988|448716828|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
124752764|NCT01053988|448716829|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
124752765|NCT01053988|448716830|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
124752766|NCT01053988|448716831|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
124752767|NCT01053988|448716832|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
124752768|NCT01053988|448716827|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
124752769|NCT01053988|448716828|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
124752770|NCT01053988|448716829|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
124752771|NCT01053988|448716830|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
124752772|NCT01053988|448716831|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
124752773|NCT01053988|448716832|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
124752774|NCT01053988|448716827|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
124752775|NCT01053988|448716828|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
124752776|NCT01053988|448716829|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
124752777|NCT01053988|448716830|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
124752778|NCT01053988|448716831|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
124752779|NCT01053988|448716832|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
124752780|NCT01053988|448716827|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
124752781|NCT01053988|448716828|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
124752782|NCT01053988|448716829|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
124752783|NCT01053988|448716830|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
124752784|NCT01053988|448716831|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
124752785|NCT01053988|448716832|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
124752786|NCT01053988|448716827|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
124752787|NCT01053988|448716828|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
124752788|NCT01053988|448716829|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
124752789|NCT01053988|448716830|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
124752790|NCT01053988|448716831|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
124752791|NCT01053988|448716832|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
124752792|NCT01824355|448716837|FG000|Overall Study|Adverse Event|2|||
124752793|NCT01824355|448716837|FG000|Overall Study|unevaluable reference method results per|1|||
124819065|NCT02495168|448964004|FG001|Overall Study|Physician Decision|1|||
124819066|NCT02495168|448964005|FG002|Overall Study|Physician Decision|0|||
124819067|NCT02495168|448964003|FG000|Overall Study|Lost to Follow-up|10|||
124819068|NCT02495168|448964004|FG001|Overall Study|Lost to Follow-up|6|||
124819069|NCT02495168|448964005|FG002|Overall Study|Lost to Follow-up|1|||
124819070|NCT02495168|448964003|FG000|Overall Study|Withdrawal by Subject|1|||
124819071|NCT02495168|448964004|FG001|Overall Study|Withdrawal by Subject|4|||
124819072|NCT02495168|448964005|FG002|Overall Study|Withdrawal by Subject|2|||
124819073|NCT02495168|448964003|FG000|Overall Study|Protocol Violation|0|||
124819074|NCT02495168|448964004|FG001|Overall Study|Protocol Violation|10|||
124819075|NCT02495168|448964005|FG002|Overall Study|Protocol Violation|1|||
124819076|NCT02495168|448964003|FG000|Overall Study|Adverse Event|4|||
124819077|NCT02495168|448964004|FG001|Overall Study|Adverse Event|8|||
124819078|NCT02495168|448964005|FG002|Overall Study|Adverse Event|3|||
124819079|NCT02495168|448964003|FG000|Overall Study|Lack of Efficacy|0|||
124819080|NCT02495168|448964004|FG001|Overall Study|Lack of Efficacy|0|||
124819081|NCT02495168|448964005|FG002|Overall Study|Lack of Efficacy|3|||
124819082|NCT00727025|448964006|FG000|Overall Study|Physician Decision|23|||
124819083|NCT02269241|448964007|FG000|Overall Study|Lost to Follow-up|269|||
124819084|NCT02269241|448964007|FG000|Overall Study|Withdrawal by Subject|155|||
124819085|NCT02269241|448964007|FG000|Overall Study|Protocol Violation|1|||
124819086|NCT02269241|448964007|FG000|Overall Study|Physician Decision|7|||
124819087|NCT02269241|448964007|FG000|Overall Study|Pregnancy|15|||
124819088|NCT02269241|448964007|FG000|Overall Study|Wish for pregnancy|5|||
124819089|NCT02269241|448964007|FG000|Overall Study|Development of an exclusion criteria|16|||
124819090|NCT02269241|448964007|FG000|Overall Study|Adverse Event|113|||
124819091|NCT02269241|448964007|FG000|Overall Study|At the specific request of the sponsor|20|||
124819092|NCT02269241|448964007|FG000|Overall Study|Several reasons not classified|53|||
124819093|NCT02269241|448964007|FG000|Overall Study|Screening failures|546|||
124819094|NCT02270957|448964008|FG000|Overall Study|Lack of Efficacy|2|||
124819095|NCT02270957|448964009|FG001|Overall Study|Lack of Efficacy|4|||
124819096|NCT02270957|448964008|FG000|Overall Study|Adverse Event|2|||
124819097|NCT02270957|448964009|FG001|Overall Study|Adverse Event|0|||
124819098|NCT00489541|448964014|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
124819099|NCT00489541|448964015|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
124819100|NCT00489541|448964014|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
124819101|NCT00489541|448964015|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
124819102|NCT00489541|448964014|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
124819103|NCT00489541|448964015|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
124819104|NCT00489541|448964014|FG000|12-Month Clinical Follow-up|Death|3|||
124819105|NCT00489541|448964015|FG001|12-Month Clinical Follow-up|Death|2|||
124819106|NCT00489541|448964014|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
124819107|NCT00489541|448964015|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
124819108|NCT00489541|448964014|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
124819109|NCT00489541|448964015|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
124819110|NCT04390191|448964020|FG000|Overall Study|Withdrawal by Subject|1|||
124819111|NCT04390191|448964021|FG001|Overall Study|Withdrawal by Subject|0|||
124819112|NCT03978832|448964026|FG000|Overall Study|Adverse Event|1|||
124819113|NCT03978832|448964026|FG000|Overall Study|Lost to Follow-up|1|||
124819114|NCT03978832|448964026|FG000|Overall Study|Withdrawal by Subject|6|||
124819115|NCT03978832|448964026|FG000|Overall Study|Physician Decision|2|||
124819116|NCT03978832|448964026|FG000|Overall Study|did not pass screening criteria|44|||
124819117|NCT01727297|448964027|FG000|Overall Study|Death|13|||
124819118|NCT01727297|448964028|FG001|Overall Study|Death|0|||
124819119|NCT01727297|448964027|FG000|Overall Study|Protocol Violation|1|||
124819120|NCT01727297|448964028|FG001|Overall Study|Protocol Violation|10|||
124819121|NCT01727297|448964027|FG000|Overall Study|Adverse Event|3|||
124819122|NCT01727297|448964028|FG001|Overall Study|Adverse Event|1|||
124819123|NCT01727297|448964027|FG000|Overall Study|Lost to Follow-up|11|||
124819124|NCT01727297|448964028|FG001|Overall Study|Lost to Follow-up|0|||
124819125|NCT01727297|448964027|FG000|Overall Study|Withdrawal by Subject|26|||
124819126|NCT01727297|448964028|FG001|Overall Study|Withdrawal by Subject|27|||
124819127|NCT01727297|448964027|FG000|Overall Study|Physician Decision|19|||
124819128|NCT01727297|448964028|FG001|Overall Study|Physician Decision|5|||
124637168|NCT00954941|448288726|FG000|Overall Study|Insurance Denial|2|||
124637169|NCT00954941|448288727|FG001|Overall Study|Insurance Denial|2|||
124819129|NCT01727297|448964027|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
124819130|NCT01727297|448964028|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
124819131|NCT02042183|448964029|FG000|Overall Study|Physician Decision|7|||
124819132|NCT02042183|448964030|FG001|Overall Study|Physician Decision|2|||
124637170|NCT00954941|448288726|FG000|Overall Study|Physician Decision|2|||
124819133|NCT02042183|448964029|FG000|Overall Study|Lack of Efficacy|4|||
124819134|NCT02042183|448964030|FG001|Overall Study|Lack of Efficacy|3|||
124819135|NCT02042183|448964029|FG000|Overall Study|Non-compliance with Study Drug|2|||
124819136|NCT02042183|448964030|FG001|Overall Study|Non-compliance with Study Drug|3|||
124819137|NCT02042183|448964029|FG000|Overall Study|Adverse Event|17|||
124819138|NCT02042183|448964030|FG001|Overall Study|Adverse Event|6|||
124819139|NCT02042183|448964029|FG000|Overall Study|Other|3|||
124819140|NCT02042183|448964030|FG001|Overall Study|Other|3|||
124819141|NCT02042183|448964029|FG000|Overall Study|Withdrawal by Subject|21|||
124819142|NCT02042183|448964030|FG001|Overall Study|Withdrawal by Subject|16|||
124819143|NCT02042183|448964029|FG000|Overall Study|Site Terminated by Sponsor|2|||
124819144|NCT02042183|448964030|FG001|Overall Study|Site Terminated by Sponsor|1|||
124819145|NCT02042183|448964029|FG000|Overall Study|Lost to Follow-up|9|||
124819146|NCT02042183|448964030|FG001|Overall Study|Lost to Follow-up|2|||
124819147|NCT01192516|448964031|FG000|Overall Study|Lost to Follow-up|7|||
124819148|NCT01192516|448964032|FG001|Overall Study|Lost to Follow-up|10|||
124819149|NCT01192516|448964033|FG002|Overall Study|Lost to Follow-up|7|||
124819150|NCT01192516|448964031|FG000|Overall Study|Withdrawal by Subject|4|||
124819151|NCT01192516|448964032|FG001|Overall Study|Withdrawal by Subject|4|||
124819152|NCT01192516|448964033|FG002|Overall Study|Withdrawal by Subject|1|||
124819153|NCT01192516|448964031|FG000|Overall Study|started new treatment|5|||
124819154|NCT01192516|448964032|FG001|Overall Study|started new treatment|1|||
124819155|NCT01192516|448964033|FG002|Overall Study|started new treatment|0|||
124819156|NCT01192516|448964031|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
124819157|NCT01192516|448964032|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
124819158|NCT01192516|448964033|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
124819159|NCT01256008|448964034|FG000|Overall Study|Lost to Follow-up|6|||
124819160|NCT01256008|448964035|FG001|Overall Study|Lost to Follow-up|4|||
124819161|NCT01256008|448964036|FG002|Overall Study|Lost to Follow-up|11|||
124819162|NCT01256008|448964034|FG000|Overall Study|Withdrawal by Subject|2|||
124819163|NCT01256008|448964035|FG001|Overall Study|Withdrawal by Subject|3|||
124819164|NCT01256008|448964036|FG002|Overall Study|Withdrawal by Subject|10|||
124819165|NCT02244606|448964037|FG000|Overall Study|Adverse Event|0|||
124819166|NCT02244606|448964038|FG001|Overall Study|Adverse Event|1|||
124819167|NCT02244606|448964039|FG002|Overall Study|Adverse Event|1|||
124819168|NCT02244606|448964040|FG003|Overall Study|Adverse Event|0|||
124819169|NCT02244606|448964037|FG000|Overall Study|Lost to Follow-up|2|||
124819170|NCT02244606|448964038|FG001|Overall Study|Lost to Follow-up|2|||
124819171|NCT02244606|448964039|FG002|Overall Study|Lost to Follow-up|1|||
124819172|NCT02244606|448964040|FG003|Overall Study|Lost to Follow-up|0|||
124819173|NCT02244606|448964037|FG000|Overall Study|Protocol Violation|0|||
124819174|NCT02244606|448964038|FG001|Overall Study|Protocol Violation|0|||
124819175|NCT02244606|448964039|FG002|Overall Study|Protocol Violation|0|||
124819176|NCT02244606|448964040|FG003|Overall Study|Protocol Violation|1|||
124819177|NCT02244606|448964037|FG000|Overall Study|Withdrawal by Subject|1|||
124819178|NCT02244606|448964038|FG001|Overall Study|Withdrawal by Subject|1|||
124819179|NCT02244606|448964039|FG002|Overall Study|Withdrawal by Subject|0|||
124819180|NCT02244606|448964040|FG003|Overall Study|Withdrawal by Subject|0|||
124819181|NCT02244606|448964037|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
124819182|NCT02244606|448964038|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
124819183|NCT02244606|448964039|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
124819184|NCT02244606|448964040|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
124819185|NCT00378378|448964045|FG000|Overall Study|Withdrawal by Subject|0|||
124819186|NCT00378378|448964046|FG001|Overall Study|Withdrawal by Subject|1|||
124819187|NCT00378378|448964047|FG002|Overall Study|Withdrawal by Subject|0|||
124819188|NCT00378378|448964045|FG000|Overall Study|Treatment Failure|0|||
124819189|NCT00378378|448964046|FG001|Overall Study|Treatment Failure|0|||
124819190|NCT00378378|448964047|FG002|Overall Study|Treatment Failure|1|||
124819191|NCT00378378|448964045|FG000|Overall Study|Non-compliance with protocol|0|||
124819192|NCT00378378|448964046|FG001|Overall Study|Non-compliance with protocol|0|||
124819193|NCT00378378|448964047|FG002|Overall Study|Non-compliance with protocol|1|||
124819194|NCT00407797|448964048|FG000|Overall Study|Lost to Follow-up|2|||
124819195|NCT00407797|448964048|FG000|Overall Study|Adverse Event|6|||
124819196|NCT00407797|448964048|FG000|Overall Study|Other|7|||
124819197|NCT00407797|448964048|FG000|Overall Study|Withdrawal by Subject|3|||
124819198|NCT00553644|448964049|FG000|Overall Study|Adverse Event|17|||
124819199|NCT00553644|448964049|FG000|Overall Study|Withdrawal by Subject|4|||
124819200|NCT00553644|448964049|FG000|Overall Study|Physician Decision|1|||
124819201|NCT00553644|448964049|FG000|Overall Study|Alternative therapy|6|||
124819202|NCT03782792|448964050|FG000|Overall Study|Patient left the country|0|||
124819203|NCT03782792|448964051|FG001|Overall Study|Patient left the country|1|||
124819204|NCT03782792|448964050|FG000|Overall Study|Withdrawal by Subject|1|||
124819205|NCT03782792|448964051|FG001|Overall Study|Withdrawal by Subject|2|||
124819206|NCT00814164|448964053|FG000|Overall Study|Progression|7|||
124819207|NCT00814164|448964053|FG000|Overall Study|not stated|7|||
124819208|NCT00814164|448964053|FG000|Overall Study|Death|5|||
124819209|NCT02321800|448964054|FG000|Overall Study|Withdrawal by Subject|3|||
124819210|NCT02321800|448964055|FG001|Overall Study|Withdrawal by Subject|3|||
124819211|NCT02321800|448964054|FG000|Overall Study|Death|1|||
124819212|NCT02321800|448964055|FG001|Overall Study|Death|0|||
124819213|NCT02321800|448964054|FG000|Overall Study|Protocol Violation|1|||
124819214|NCT02321800|448964055|FG001|Overall Study|Protocol Violation|0|||
124819215|NCT02321800|448964054|FG000|Overall Study|Lost to Follow-up|10|||
124819216|NCT02321800|448964055|FG001|Overall Study|Lost to Follow-up|4|||
124819217|NCT02321800|448964054|FG000|Overall Study|Adverse Event|2|||
124819218|NCT02321800|448964055|FG001|Overall Study|Adverse Event|3|||
124819219|NCT02321800|448964054|FG000|Overall Study|Other, Miscellaneous|3|||
124819220|NCT02321800|448964055|FG001|Overall Study|Other, Miscellaneous|1|||
124819221|NCT00982878|448964056|FG000|Overall Study|Physician Decision|1|||
124819222|NCT03132220|448964062|FG000|Overall Study|Lost to Follow-up|17|||
124819223|NCT03132220|448964063|FG001|Overall Study|Lost to Follow-up|8|||
124819224|NCT03132220|448964062|FG000|Overall Study|Withdrawal by Subject|1|||
124819225|NCT03132220|448964063|FG001|Overall Study|Withdrawal by Subject|4|||
124819226|NCT01169493|448964064|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
124819227|NCT01169493|448964065|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
124819228|NCT01169493|448964066|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
124819229|NCT01169493|448964067|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
124819230|NCT01169493|448964068|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
124819231|NCT01169493|448964069|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
124819232|NCT01169493|448964064|FG000|Period 3 (6 Months)|Adverse Event|0|||
124819233|NCT01169493|448964065|FG001|Period 3 (6 Months)|Adverse Event|1|||
124819234|NCT01169493|448964066|FG002|Period 3 (6 Months)|Adverse Event|0|||
124819235|NCT01169493|448964067|FG003|Period 3 (6 Months)|Adverse Event|0|||
124819236|NCT01169493|448964068|FG004|Period 3 (6 Months)|Adverse Event|0|||
124819237|NCT01169493|448964069|FG005|Period 3 (6 Months)|Adverse Event|0|||
124819238|NCT01169493|448964064|FG000|Period 3 (6 Months)|Physician Decision|0|||
124819239|NCT01169493|448964065|FG001|Period 3 (6 Months)|Physician Decision|1|||
124819240|NCT01169493|448964066|FG002|Period 3 (6 Months)|Physician Decision|1|||
124819241|NCT01169493|448964067|FG003|Period 3 (6 Months)|Physician Decision|0|||
124819242|NCT01169493|448964068|FG004|Period 3 (6 Months)|Physician Decision|0|||
124819243|NCT01169493|448964069|FG005|Period 3 (6 Months)|Physician Decision|0|||
124819244|NCT05228132|448964070|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
124819245|NCT05228132|448964070|FG000|Overall Study|Adverse Event|3|||
124819246|NCT05228132|448964070|FG000|Overall Study|Lost to Follow-up|1|||
124819247|NCT05228132|448964070|FG000|Overall Study|Arteriovenous-fistula mature|1|||
124819248|NCT01336764|448964071|FG000|Overall Study|Withdrawal by Subject|5|||
124819249|NCT01336764|448964072|FG001|Overall Study|Withdrawal by Subject|5|||
124819250|NCT01906008|448964082|FG000|Overall Study|Lost to Follow-up|2|||
124819251|NCT01906008|448964083|FG001|Overall Study|Lost to Follow-up|0|||
124819252|NCT01906008|448964082|FG000|Overall Study|Oxaliplatin toxicity|2|||
124819253|NCT01906008|448964083|FG001|Overall Study|Oxaliplatin toxicity|0|||
124819254|NCT01906008|448964082|FG000|Overall Study|Protocol Violation|0|||
124819255|NCT01906008|448964083|FG001|Overall Study|Protocol Violation|1|||
124819256|NCT01906008|448964082|FG000|Overall Study|Withdrawal by Subject|1|||
124819257|NCT01906008|448964083|FG001|Overall Study|Withdrawal by Subject|5|||
124819258|NCT01906008|448964082|FG000|Overall Study|Did not start study med|3|||
124819259|NCT01906008|448964083|FG001|Overall Study|Did not start study med|4|||
124819260|NCT01906008|448964082|FG000|Overall Study|Oxaliplatin stops|10|||
124819261|NCT01906008|448964083|FG001|Overall Study|Oxaliplatin stops|8|||
124819262|NCT01906008|448964082|FG000|Overall Study|Hospice|1|||
124819263|NCT01906008|448964083|FG001|Overall Study|Hospice|0|||
124819264|NCT01906008|448964082|FG000|Overall Study|Physician Decision|3|||
124819265|NCT01906008|448964083|FG001|Overall Study|Physician Decision|3|||
124819266|NCT01906008|448964082|FG000|Overall Study|Lack of compliance of study med|5|||
124819267|NCT01906008|448964083|FG001|Overall Study|Lack of compliance of study med|3|||
124819268|NCT01906008|448964082|FG000|Overall Study|Adverse Event|0|||
124819269|NCT01906008|448964083|FG001|Overall Study|Adverse Event|3|||
124819270|NCT00730132|448964084|FG000|Overall Study|Protocol Violation|154|||
124819271|NCT00730132|448964084|FG000|Overall Study|Death|1|||
124819272|NCT01626391|448964085|FG000|Overall Study|Physician Decision|1|||
124819273|NCT01626391|448964086|FG001|Overall Study|Physician Decision|0|||
124819274|NCT01626391|448964085|FG000|Overall Study|Withdrawal by Subject|1|||
124819275|NCT01626391|448964086|FG001|Overall Study|Withdrawal by Subject|0|||
124819276|NCT02220205|448964087|FG000|Overall Study|Withdrawal by Subject|1|||
124819277|NCT02220205|448964088|FG001|Overall Study|Withdrawal by Subject|0|||
124819278|NCT00518986|448964090|FG000|Overall Study|Adverse Event|12|||
124819279|NCT00518986|448964091|FG001|Overall Study|Adverse Event|7|||
124819280|NCT00518986|448964090|FG000|Overall Study|Lack of Efficacy|0|||
124819281|NCT00518986|448964091|FG001|Overall Study|Lack of Efficacy|2|||
124819282|NCT00518986|448964090|FG000|Overall Study|Lost to Follow-up|3|||
124819283|NCT00518986|448964091|FG001|Overall Study|Lost to Follow-up|2|||
124819284|NCT00518986|448964090|FG000|Overall Study|Physician Decision|0|||
124819285|NCT00518986|448964091|FG001|Overall Study|Physician Decision|3|||
124819286|NCT00518986|448964090|FG000|Overall Study|Protocol Violation|5|||
124819287|NCT00518986|448964091|FG001|Overall Study|Protocol Violation|7|||
124819288|NCT00518986|448964090|FG000|Overall Study|Withdrawal by Subject|4|||
124819289|NCT00518986|448964091|FG001|Overall Study|Withdrawal by Subject|4|||
124819290|NCT00518986|448964090|FG000|Overall Study|Non-Specific|2|||
124819291|NCT00518986|448964091|FG001|Overall Study|Non-Specific|1|||
124819292|NCT02088047|448964092|FG000|Overall Study|Withdrawal by Subject|1|||
124819293|NCT02088047|448964093|FG001|Overall Study|Withdrawal by Subject|0|||
124819294|NCT04171531|448964096|FG000|Overall Study|Lost to Follow-up|4|||
124819295|NCT04171531|448964097|FG001|Overall Study|Lost to Follow-up|5|||
124819296|NCT04171531|448964096|FG000|Overall Study|Consent only through 6 months|1|||
124819297|NCT04171531|448964097|FG001|Overall Study|Consent only through 6 months|1|||
124819298|NCT04171531|448964096|FG000|Overall Study|Insurance did not cover procedure|0|||
124819299|NCT04171531|448964097|FG001|Overall Study|Insurance did not cover procedure|1|||
124819300|NCT04171531|448964096|FG000|Overall Study|Physician Decision|0|||
124819301|NCT04171531|448964097|FG001|Overall Study|Physician Decision|3|||
124819302|NCT04171531|448964096|FG000|Overall Study|Withdrawal by Subject|1|||
124819303|NCT04171531|448964097|FG001|Overall Study|Withdrawal by Subject|5|||
124819304|NCT04862585|448964098|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
124819305|NCT04862585|448964099|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
124819306|NCT04862585|448964098|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
124819307|NCT04862585|448964099|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
124819308|NCT04862585|448964098|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
124819309|NCT04862585|448964099|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
124819310|NCT04862585|448964098|FG000|Overall Study|one withdrew without providing a reason|0|||
124819311|NCT04862585|448964099|FG001|Overall Study|one withdrew without providing a reason|1|||
124819312|NCT03366337|448964100|FG000|Overall Study|Lost to Follow-up|1|||
124819313|NCT03366337|448964101|FG001|Overall Study|Lost to Follow-up|0|||
124819314|NCT03366337|448964102|FG002|Overall Study|Lost to Follow-up|1|||
124819315|NCT03366337|448964103|FG003|Overall Study|Lost to Follow-up|0|||
124819316|NCT03366337|448964100|FG000|Overall Study|Withdrawal by Subject|2|||
124819317|NCT03366337|448964101|FG001|Overall Study|Withdrawal by Subject|0|||
124819318|NCT03366337|448964102|FG002|Overall Study|Withdrawal by Subject|1|||
124819319|NCT03366337|448964103|FG003|Overall Study|Withdrawal by Subject|1|||
124819320|NCT05229406|448964104|FG000|Overall Study|Withdrawal by Subject|1|||
124819321|NCT05229406|448964105|FG001|Overall Study|Withdrawal by Subject|2|||
124819322|NCT00459953|448964106|FG000|Overall Study|not analyzed-household member in study|1|||
124819323|NCT00459953|448964107|FG001|Overall Study|not analyzed-household member in study|1|||
124819324|NCT00496470|448964108|FG000|Overall Study|Adverse Event|8|||
124819325|NCT00496470|448964109|FG001|Overall Study|Adverse Event|10|||
124819326|NCT00496470|448964108|FG000|Overall Study|Withdrawal by Subject|5|||
124819327|NCT00496470|448964109|FG001|Overall Study|Withdrawal by Subject|12|||
124819328|NCT00496470|448964108|FG000|Overall Study|Incorrectly enrolled|13|||
124819329|NCT00496470|448964109|FG001|Overall Study|Incorrectly enrolled|5|||
124819330|NCT00496470|448964108|FG000|Overall Study|Other reason|0|||
124819331|NCT00496470|448964109|FG001|Overall Study|Other reason|2|||
124819332|NCT00621153|448964114|FG000|Overall Study|Safety Reason|8|||
124819333|NCT00621153|448964115|FG001|Overall Study|Safety Reason|7|||
124819334|NCT00621153|448964114|FG000|Overall Study|Adverse Event|3|||
124819335|NCT00621153|448964115|FG001|Overall Study|Adverse Event|2|||
124819336|NCT00621153|448964114|FG000|Overall Study|Lost to Follow-up|5|||
124819337|NCT00621153|448964115|FG001|Overall Study|Lost to Follow-up|1|||
124819338|NCT00621153|448964114|FG000|Overall Study|Withdrawal by Subject|4|||
124819339|NCT00621153|448964115|FG001|Overall Study|Withdrawal by Subject|5|||
124819340|NCT00753415|448964116|FG000|Part A|Disease progression|1|||
124819341|NCT00753415|448964117|FG001|Part A|Disease progression|0|||
124819342|NCT00753415|448964118|FG002|Part A|Disease progression|1|||
124819343|NCT00753415|448964119|FG003|Part A|Disease progression|2|||
124819344|NCT00753415|448964120|FG004|Part A|Disease progression|0|||
124819345|NCT00753415|448964121|FG005|Part A|Disease progression|0|||
124819346|NCT00753415|448964122|FG006|Part A|Disease progression|0|||
124819347|NCT00753415|448964123|FG007|Part A|Disease progression|0|||
124819348|NCT00753415|448964124|FG008|Part A|Disease progression|0|||
124819349|NCT00753415|448964125|FG009|Part A|Disease progression|0|||
124819350|NCT00753415|448964116|FG000|Part A|Withdrawal by Subject|0|||
124819351|NCT00753415|448964117|FG001|Part A|Withdrawal by Subject|0|||
124819352|NCT00753415|448964118|FG002|Part A|Withdrawal by Subject|1|||
124819353|NCT00753415|448964119|FG003|Part A|Withdrawal by Subject|0|||
124819354|NCT00753415|448964120|FG004|Part A|Withdrawal by Subject|0|||
124819355|NCT00753415|448964121|FG005|Part A|Withdrawal by Subject|0|||
124819356|NCT00753415|448964122|FG006|Part A|Withdrawal by Subject|0|||
124637171|NCT00954941|448288727|FG001|Overall Study|Physician Decision|2|||
124819357|NCT00753415|448964123|FG007|Part A|Withdrawal by Subject|0|||
124819358|NCT00753415|448964124|FG008|Part A|Withdrawal by Subject|0|||
124819359|NCT00753415|448964125|FG009|Part A|Withdrawal by Subject|0|||
124819360|NCT00753415|448964116|FG000|Part B|Lost to Follow-up|0|||
124819361|NCT00753415|448964117|FG001|Part B|Lost to Follow-up|0|||
124637172|NCT00954941|448288726|FG000|Overall Study|Ineligible|2|||
124819362|NCT00753415|448964118|FG002|Part B|Lost to Follow-up|0|||
124819363|NCT00753415|448964119|FG003|Part B|Lost to Follow-up|0|||
124819364|NCT00753415|448964120|FG004|Part B|Lost to Follow-up|0|||
124819365|NCT00753415|448964121|FG005|Part B|Lost to Follow-up|0|||
124819366|NCT00753415|448964122|FG006|Part B|Lost to Follow-up|0|||
124637173|NCT00954941|448288727|FG001|Overall Study|Ineligible|2|||
124819367|NCT00753415|448964123|FG007|Part B|Lost to Follow-up|1|||
124819368|NCT00753415|448964124|FG008|Part B|Lost to Follow-up|1|||
124819369|NCT00753415|448964125|FG009|Part B|Lost to Follow-up|0|||
124819370|NCT00753415|448964116|FG000|Part B|Disease progression|0|||
124819371|NCT00753415|448964117|FG001|Part B|Disease progression|0|||
124819372|NCT00753415|448964118|FG002|Part B|Disease progression|0|||
124819373|NCT00753415|448964119|FG003|Part B|Disease progression|0|||
124819374|NCT00753415|448964120|FG004|Part B|Disease progression|0|||
124819375|NCT00753415|448964121|FG005|Part B|Disease progression|0|||
124819376|NCT00753415|448964122|FG006|Part B|Disease progression|0|||
124819377|NCT00753415|448964123|FG007|Part B|Disease progression|0|||
124819378|NCT00753415|448964124|FG008|Part B|Disease progression|2|||
124819379|NCT00753415|448964125|FG009|Part B|Disease progression|1|||
124819380|NCT04419714|448964126|FG000|Overall Study|Technical Fault|5|||
124819381|NCT04419714|448964126|FG000|Overall Study|Protocol Deviation|2|||
124819382|NCT04419714|448964126|FG000|Overall Study|Withdrawal by Subject|1|||
124819383|NCT04023526|448965680|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
124819384|NCT04023526|448965681|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
124819385|NCT04023526|448965680|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
124819386|NCT04023526|448965681|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
124819387|NCT00540514|448965686|FG000|Overall Study|Still on treatment|3|||
124819388|NCT00540514|448965687|FG001|Overall Study|Still on treatment|0|||
124819389|NCT00540514|448965686|FG000|Overall Study|Unacceptable Toxicity|61|||
124819390|NCT00540514|448965687|FG001|Overall Study|Unacceptable Toxicity|62|||
124819391|NCT00540514|448965686|FG000|Overall Study|Adverse Event|20|||
124819392|NCT00540514|448965687|FG001|Overall Study|Adverse Event|24|||
124819393|NCT00540514|448965686|FG000|Overall Study|Physician Decision|86|||
124819394|NCT00540514|448965687|FG001|Overall Study|Physician Decision|99|||
124819395|NCT00540514|448965686|FG000|Overall Study|Protocol Deviation|3|||
124819396|NCT00540514|448965687|FG001|Overall Study|Protocol Deviation|4|||
124819397|NCT00540514|448965686|FG000|Overall Study|Lost to Follow-up|1|||
124819398|NCT00540514|448965687|FG001|Overall Study|Lost to Follow-up|1|||
124819399|NCT00540514|448965686|FG000|Overall Study|Withdrawal by Subject|65|||
124819400|NCT00540514|448965687|FG001|Overall Study|Withdrawal by Subject|67|||
124819401|NCT00540514|448965686|FG000|Overall Study|Excluded prior to treatment|7|||
124819402|NCT00540514|448965687|FG001|Overall Study|Excluded prior to treatment|7|||
124819403|NCT00540514|448965686|FG000|Overall Study|Paclitaxel not available|0|||
124819404|NCT00540514|448965687|FG001|Overall Study|Paclitaxel not available|2|||
124819405|NCT02501473|448965688|FG000|Overall Study|Study Terminated|2|||
124819406|NCT02501473|448965689|FG001|Overall Study|Study Terminated|3|||
124819407|NCT02501473|448965690|FG002|Overall Study|Study Terminated|7|||
124819408|NCT02501473|448965691|FG003|Overall Study|Study Terminated|9|||
124819409|NCT02501473|448965692|FG004|Overall Study|Study Terminated|2|||
124819410|NCT02501473|448965693|FG005|Overall Study|Study Terminated|10|||
124819411|NCT02501473|448965694|FG006|Overall Study|Study Terminated|1|||
124819412|NCT02501473|448965695|FG007|Overall Study|Study Terminated|0|||
124819413|NCT02501473|448965688|FG000|Overall Study|Withdrawal by Subject|0|||
124819414|NCT02501473|448965689|FG001|Overall Study|Withdrawal by Subject|0|||
124819415|NCT02501473|448965690|FG002|Overall Study|Withdrawal by Subject|3|||
124819416|NCT02501473|448965691|FG003|Overall Study|Withdrawal by Subject|3|||
124819417|NCT02501473|448965692|FG004|Overall Study|Withdrawal by Subject|2|||
124819418|NCT02501473|448965693|FG005|Overall Study|Withdrawal by Subject|2|||
124819419|NCT02501473|448965694|FG006|Overall Study|Withdrawal by Subject|0|||
124819420|NCT02501473|448965695|FG007|Overall Study|Withdrawal by Subject|0|||
124819421|NCT02501473|448965688|FG000|Overall Study|Death|0|||
124819422|NCT02501473|448965689|FG001|Overall Study|Death|0|||
124819423|NCT02501473|448965690|FG002|Overall Study|Death|1|||
124819424|NCT02501473|448965691|FG003|Overall Study|Death|1|||
124819425|NCT02501473|448965692|FG004|Overall Study|Death|0|||
124819426|NCT02501473|448965693|FG005|Overall Study|Death|1|||
124819427|NCT02501473|448965694|FG006|Overall Study|Death|0|||
124819428|NCT02501473|448965695|FG007|Overall Study|Death|0|||
124819429|NCT02501473|448965688|FG000|Overall Study|Lost to Follow-up|1|||
124819430|NCT02501473|448965689|FG001|Overall Study|Lost to Follow-up|0|||
124819431|NCT02501473|448965690|FG002|Overall Study|Lost to Follow-up|1|||
124819432|NCT02501473|448965691|FG003|Overall Study|Lost to Follow-up|0|||
124819433|NCT02501473|448965692|FG004|Overall Study|Lost to Follow-up|0|||
124819434|NCT02501473|448965693|FG005|Overall Study|Lost to Follow-up|1|||
124637174|NCT00954941|448288726|FG000|Overall Study|Adverse Event|0|||
124819435|NCT02501473|448965694|FG006|Overall Study|Lost to Follow-up|0|||
124819436|NCT02501473|448965695|FG007|Overall Study|Lost to Follow-up|0|||
124819437|NCT02501473|448965688|FG000|Overall Study|Reason not specified|0|||
124819438|NCT02501473|448965689|FG001|Overall Study|Reason not specified|0|||
124819439|NCT02501473|448965690|FG002|Overall Study|Reason not specified|1|||
124819440|NCT02501473|448965691|FG003|Overall Study|Reason not specified|1|||
124819441|NCT02501473|448965692|FG004|Overall Study|Reason not specified|0|||
124819442|NCT02501473|448965693|FG005|Overall Study|Reason not specified|0|||
124819443|NCT02501473|448965694|FG006|Overall Study|Reason not specified|0|||
124819444|NCT02501473|448965695|FG007|Overall Study|Reason not specified|0|||
124819445|NCT02324569|448965696|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
124819446|NCT02324569|448965697|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
124819447|NCT02324569|448965696|FG000|Overall Study|Voluntary Withdrawal|3|||
124819448|NCT02324569|448965697|FG001|Overall Study|Voluntary Withdrawal|6|||
124819449|NCT02324569|448965696|FG000|Overall Study|Lack of Efficacy|2|||
124819450|NCT02324569|448965697|FG001|Overall Study|Lack of Efficacy|3|||
124819451|NCT02324569|448965696|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
124819452|NCT02324569|448965697|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
124819453|NCT02324569|448965696|FG000|Overall Study|Inconvenient Schedule|2|||
124819454|NCT02324569|448965697|FG001|Overall Study|Inconvenient Schedule|0|||
124819455|NCT00911820|448965698|FG000|Overall Study|RECIST progression|12|||
124819456|NCT00911820|448965699|FG001|Overall Study|RECIST progression|8|||
124819457|NCT00911820|448965698|FG000|Overall Study|Adverse Event|8|||
124819458|NCT00911820|448965699|FG001|Overall Study|Adverse Event|8|||
124819459|NCT00911820|448965698|FG000|Overall Study|Clinical Progression|7|||
124819460|NCT00911820|448965699|FG001|Overall Study|Clinical Progression|5|||
124819461|NCT00911820|448965698|FG000|Overall Study|Physician Decision|5|||
124819462|NCT00911820|448965699|FG001|Overall Study|Physician Decision|9|||
124819463|NCT00911820|448965698|FG000|Overall Study|Decline in Performance Status|4|||
124819464|NCT00911820|448965699|FG001|Overall Study|Decline in Performance Status|2|||
124819465|NCT00911820|448965698|FG000|Overall Study|Withdrawal by Subject|3|||
124819466|NCT00911820|448965699|FG001|Overall Study|Withdrawal by Subject|4|||
124819467|NCT00911820|448965698|FG000|Overall Study|Death|1|||
124819468|NCT00911820|448965699|FG001|Overall Study|Death|2|||
124819469|NCT00911820|448965698|FG000|Overall Study|Pursue surgery|1|||
124819470|NCT00911820|448965699|FG001|Overall Study|Pursue surgery|1|||
124819471|NCT00911820|448965698|FG000|Overall Study|Pursue Radiation|1|||
124819472|NCT00911820|448965699|FG001|Overall Study|Pursue Radiation|0|||
124819473|NCT00911820|448965698|FG000|Overall Study|Still on Therapy|2|||
124819474|NCT00911820|448965699|FG001|Overall Study|Still on Therapy|2|||
124819475|NCT00911820|448965698|FG000|Overall Study|Pathology Not Confirmed|1|||
124819476|NCT00911820|448965699|FG001|Overall Study|Pathology Not Confirmed|0|||
124819477|NCT00911820|448965698|FG000|Overall Study|Withdraw before Receive Treatment|0|||
124819478|NCT00911820|448965699|FG001|Overall Study|Withdraw before Receive Treatment|2|||
124819479|NCT03098550|448965706|FG000|Overall Study|Disease Progression|30|||
124819480|NCT03098550|448965707|FG001|Overall Study|Disease Progression|19|||
124819481|NCT03098550|448965708|FG002|Overall Study|Disease Progression|41|||
124819482|NCT03098550|448965706|FG000|Overall Study|Study Drug Toxicity|2|||
124819483|NCT03098550|448965707|FG001|Overall Study|Study Drug Toxicity|1|||
124819484|NCT03098550|448965708|FG002|Overall Study|Study Drug Toxicity|0|||
124819485|NCT03098550|448965706|FG000|Overall Study|Death|1|||
124819486|NCT03098550|448965707|FG001|Overall Study|Death|0|||
124819487|NCT03098550|448965708|FG002|Overall Study|Death|0|||
124819488|NCT03098550|448965706|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
124819489|NCT03098550|448965707|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
124819490|NCT03098550|448965708|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
124819491|NCT03098550|448965706|FG000|Overall Study|Administrative reason by sponsor|0|||
124819492|NCT03098550|448965707|FG001|Overall Study|Administrative reason by sponsor|0|||
124819493|NCT03098550|448965708|FG002|Overall Study|Administrative reason by sponsor|1|||
124819494|NCT03098550|448965706|FG000|Overall Study|Other reasons|2|||
124819495|NCT03098550|448965707|FG001|Overall Study|Other reasons|0|||
124819496|NCT03098550|448965708|FG002|Overall Study|Other reasons|0|||
124819497|NCT01411774|448965723|FG000|Overall Study|Withdrawal by Subject|0|||
124819498|NCT01411774|448965724|FG001|Overall Study|Withdrawal by Subject|3|||
124819499|NCT00056316|448965725|FG000|Overall Study|Withdrawal by Subject|2|||
124819500|NCT00056316|448965726|FG001|Overall Study|Withdrawal by Subject|2|||
124819501|NCT00056316|448965725|FG000|Overall Study|Death/NH placement of pt|1|||
124819502|NCT00056316|448965726|FG001|Overall Study|Death/NH placement of pt|1|||
124819503|NCT02990910|448965728|FG000|Overall Study|Lack of Efficacy|6|||
124819504|NCT02990910|448965729|FG001|Overall Study|Lack of Efficacy|10|||
124819505|NCT02468414|448965734|FG000|Overall Study|Early Study Termination by Sponsor|1|||
124819506|NCT02468414|448965735|FG001|Overall Study|Early Study Termination by Sponsor|0|||
124819507|NCT02468414|448965734|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
124819508|NCT02468414|448965735|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
124819509|NCT02468414|448965734|FG000|Overall Study|Screen Failure|1|||
124819510|NCT02468414|448965735|FG001|Overall Study|Screen Failure|0|||
124819511|NCT00903695|448965736|FG000|Overall Study|medical exclusion after 1st testing|1|||
124819512|NCT00903695|448965737|FG001|Overall Study|medical exclusion after 1st testing|0|||
124819513|NCT00903695|448965736|FG000|Overall Study|lung cancer|1|||
124819514|NCT00903695|448965737|FG001|Overall Study|lung cancer|0|||
124819515|NCT00543140|448965739|FG000|Overall Study|Lost to Follow-up|33|||
124819516|NCT00543140|448965739|FG000|Overall Study|Withdrawal by Subject|13|||
124819517|NCT00543140|448965739|FG000|Overall Study|Protocol Violation|10|||
124819518|NCT00543140|448965739|FG000|Overall Study|Insufficient weight loss|10|||
124819519|NCT00543140|448965739|FG000|Overall Study|SAE leading to explant of SAGB|3|||
124819520|NCT00543140|448965739|FG000|Overall Study|Death|1|||
124819521|NCT00543140|448965739|FG000|Overall Study|Subject moved|1|||
124819588|NCT00420927|448965761|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
124819589|NCT00420927|448965762|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
124819590|NCT00420927|448965763|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
124819591|NCT00420927|448965764|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
124819592|NCT00420927|448965765|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
124819593|NCT00420927|448965766|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
124819594|NCT00420927|448965767|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
124819595|NCT00420927|448965761|FG000|Period 1|Death|2|||
124819596|NCT00420927|448965762|FG001|Period 1|Death|0|||
124819597|NCT00420927|448965763|FG002|Period 1|Death|0|||
124819598|NCT00420927|448965764|FG003|Period 1|Death|0|||
124819599|NCT00420927|448965765|FG004|Period 1|Death|0|||
124819600|NCT00420927|448965766|FG005|Period 1|Death|0|||
124819601|NCT00420927|448965767|FG006|Period 1|Death|0|||
124819602|NCT00420927|448965761|FG000|Period 1|Subject moved/relocated|0|||
124819603|NCT00420927|448965762|FG001|Period 1|Subject moved/relocated|2|||
124819604|NCT00420927|448965763|FG002|Period 1|Subject moved/relocated|0|||
124819605|NCT00420927|448965764|FG003|Period 1|Subject moved/relocated|0|||
124819606|NCT00420927|448965765|FG004|Period 1|Subject moved/relocated|0|||
124819607|NCT00420927|448965766|FG005|Period 1|Subject moved/relocated|0|||
124819608|NCT00420927|448965767|FG006|Period 1|Subject moved/relocated|0|||
124819609|NCT00420927|448965761|FG000|Period 1|Noncompliant with study drug|1|||
124819610|NCT00420927|448965762|FG001|Period 1|Noncompliant with study drug|1|||
124819611|NCT00420927|448965763|FG002|Period 1|Noncompliant with study drug|0|||
124819612|NCT00420927|448965764|FG003|Period 1|Noncompliant with study drug|0|||
124819613|NCT00420927|448965765|FG004|Period 1|Noncompliant with study drug|0|||
124819614|NCT00420927|448965766|FG005|Period 1|Noncompliant with study drug|0|||
124819615|NCT00420927|448965767|FG006|Period 1|Noncompliant with study drug|0|||
124819616|NCT00420927|448965761|FG000|Period 1|Randomization error|1|||
124819617|NCT00420927|448965762|FG001|Period 1|Randomization error|0|||
124819618|NCT00420927|448965763|FG002|Period 1|Randomization error|0|||
124819619|NCT00420927|448965764|FG003|Period 1|Randomization error|0|||
124819620|NCT00420927|448965765|FG004|Period 1|Randomization error|0|||
124819621|NCT00420927|448965766|FG005|Period 1|Randomization error|0|||
124819622|NCT00420927|448965767|FG006|Period 1|Randomization error|0|||
124819623|NCT00420927|448965761|FG000|Period 1|Suspected tuberculosis/positive test|1|||
124819624|NCT00420927|448965762|FG001|Period 1|Suspected tuberculosis/positive test|1|||
124819625|NCT00420927|448965763|FG002|Period 1|Suspected tuberculosis/positive test|0|||
124819626|NCT00420927|448965764|FG003|Period 1|Suspected tuberculosis/positive test|0|||
124819627|NCT00420927|448965765|FG004|Period 1|Suspected tuberculosis/positive test|0|||
124819628|NCT00420927|448965766|FG005|Period 1|Suspected tuberculosis/positive test|0|||
124819629|NCT00420927|448965767|FG006|Period 1|Suspected tuberculosis/positive test|0|||
124819630|NCT00420927|448965761|FG000|Period 1|Study site closure|0|||
124819631|NCT00420927|448965762|FG001|Period 1|Study site closure|1|||
124819632|NCT00420927|448965763|FG002|Period 1|Study site closure|0|||
124819633|NCT00420927|448965764|FG003|Period 1|Study site closure|0|||
124819634|NCT00420927|448965765|FG004|Period 1|Study site closure|0|||
124819635|NCT00420927|448965766|FG005|Period 1|Study site closure|0|||
124819636|NCT00420927|448965767|FG006|Period 1|Study site closure|0|||
124819637|NCT00420927|448965761|FG000|Period 1|Subject received new diagnosis|0|||
124819638|NCT00420927|448965762|FG001|Period 1|Subject received new diagnosis|2|||
124819639|NCT00420927|448965763|FG002|Period 1|Subject received new diagnosis|0|||
124819640|NCT00420927|448965764|FG003|Period 1|Subject received new diagnosis|0|||
124819641|NCT00420927|448965765|FG004|Period 1|Subject received new diagnosis|0|||
124819642|NCT00420927|448965766|FG005|Period 1|Subject received new diagnosis|0|||
124819643|NCT00420927|448965767|FG006|Period 1|Subject received new diagnosis|0|||
124819644|NCT00420927|448965761|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
124819645|NCT00420927|448965762|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
124819646|NCT00420927|448965763|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
124819647|NCT00420927|448965764|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
124819648|NCT00420927|448965765|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
124819649|NCT00420927|448965766|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
124819650|NCT00420927|448965767|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
124819651|NCT00420927|448965761|FG000|Period 1|Failed to meet entry criteria|8|||
124819652|NCT00420927|448965762|FG001|Period 1|Failed to meet entry criteria|7|||
124819653|NCT00420927|448965763|FG002|Period 1|Failed to meet entry criteria|0|||
124819654|NCT00420927|448965764|FG003|Period 1|Failed to meet entry criteria|0|||
124819655|NCT00420927|448965765|FG004|Period 1|Failed to meet entry criteria|0|||
124819656|NCT00420927|448965766|FG005|Period 1|Failed to meet entry criteria|0|||
124819657|NCT00420927|448965767|FG006|Period 1|Failed to meet entry criteria|0|||
124819658|NCT00420927|448965761|FG000|Period 1|Took prohibited medication|1|||
124819659|NCT00420927|448965762|FG001|Period 1|Took prohibited medication|3|||
124819660|NCT00420927|448965763|FG002|Period 1|Took prohibited medication|0|||
124819661|NCT00420927|448965764|FG003|Period 1|Took prohibited medication|0|||
124819662|NCT00420927|448965765|FG004|Period 1|Took prohibited medication|0|||
124819663|NCT00420927|448965766|FG005|Period 1|Took prohibited medication|0|||
124819664|NCT00420927|448965767|FG006|Period 1|Took prohibited medication|0|||
124819665|NCT00420927|448965761|FG000|Period 2|Adverse Event|0|||
124819666|NCT00420927|448965762|FG001|Period 2|Adverse Event|0|||
124819667|NCT00420927|448965763|FG002|Period 2|Adverse Event|7|||
124819668|NCT00420927|448965764|FG003|Period 2|Adverse Event|3|||
124819669|NCT00420927|448965765|FG004|Period 2|Adverse Event|17|||
124819670|NCT00420927|448965766|FG005|Period 2|Adverse Event|6|||
124819671|NCT00420927|448965767|FG006|Period 2|Adverse Event|20|||
124819672|NCT00420927|448965761|FG000|Period 2|Withdrawal by Subject|0|||
124819673|NCT00420927|448965762|FG001|Period 2|Withdrawal by Subject|0|||
124819674|NCT00420927|448965763|FG002|Period 2|Withdrawal by Subject|1|||
124819675|NCT00420927|448965764|FG003|Period 2|Withdrawal by Subject|3|||
124819676|NCT00420927|448965765|FG004|Period 2|Withdrawal by Subject|11|||
124819677|NCT00420927|448965766|FG005|Period 2|Withdrawal by Subject|2|||
124819678|NCT00420927|448965767|FG006|Period 2|Withdrawal by Subject|12|||
124819679|NCT00420927|448965761|FG000|Period 2|Lost to Follow-up|0|||
124819680|NCT00420927|448965762|FG001|Period 2|Lost to Follow-up|0|||
124819681|NCT00420927|448965763|FG002|Period 2|Lost to Follow-up|2|||
124819682|NCT00420927|448965764|FG003|Period 2|Lost to Follow-up|2|||
124819683|NCT00420927|448965765|FG004|Period 2|Lost to Follow-up|6|||
124819684|NCT00420927|448965766|FG005|Period 2|Lost to Follow-up|3|||
124819685|NCT00420927|448965767|FG006|Period 2|Lost to Follow-up|9|||
124819686|NCT00420927|448965761|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
124819687|NCT00420927|448965762|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
124819688|NCT00420927|448965763|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
124819689|NCT00420927|448965764|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
124819690|NCT00420927|448965765|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
124819691|NCT00420927|448965766|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
124819692|NCT00420927|448965767|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
124819693|NCT00420927|448965761|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
124819694|NCT00420927|448965762|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
124819695|NCT00420927|448965763|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
124819696|NCT00420927|448965764|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
124819697|NCT00420927|448965765|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
124819698|NCT00420927|448965766|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
124819699|NCT00420927|448965767|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
124819700|NCT00420927|448965761|FG000|Period 2|Subject unable to find transportation|0|||
124819701|NCT00420927|448965762|FG001|Period 2|Subject unable to find transportation|0|||
124819702|NCT00420927|448965763|FG002|Period 2|Subject unable to find transportation|0|||
124819703|NCT00420927|448965764|FG003|Period 2|Subject unable to find transportation|0|||
124819704|NCT00420927|448965765|FG004|Period 2|Subject unable to find transportation|0|||
124637873|NCT03777436|448292479|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
124637874|NCT03777436|448292480|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
124637875|NCT03777436|448292478|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
124637876|NCT03777436|448292479|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
124637877|NCT03777436|448292480|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
124637878|NCT03777436|448292478|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
124637879|NCT03777436|448292479|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
124637880|NCT03777436|448292480|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
124819705|NCT00420927|448965766|FG005|Period 2|Subject unable to find transportation|0|||
124819706|NCT00420927|448965767|FG006|Period 2|Subject unable to find transportation|1|||
124819707|NCT00420927|448965761|FG000|Period 2|Physician Decision|0|||
124819708|NCT00420927|448965762|FG001|Period 2|Physician Decision|0|||
124819709|NCT00420927|448965763|FG002|Period 2|Physician Decision|0|||
124819710|NCT00420927|448965764|FG003|Period 2|Physician Decision|0|||
124819711|NCT00420927|448965765|FG004|Period 2|Physician Decision|1|||
124819712|NCT00420927|448965766|FG005|Period 2|Physician Decision|1|||
124819713|NCT00420927|448965767|FG006|Period 2|Physician Decision|0|||
124819714|NCT00420927|448965761|FG000|Period 2|Sponsor decision|0|||
124819715|NCT00420927|448965762|FG001|Period 2|Sponsor decision|0|||
124819716|NCT00420927|448965763|FG002|Period 2|Sponsor decision|1|||
124819717|NCT00420927|448965764|FG003|Period 2|Sponsor decision|0|||
124637881|NCT03777436|448292478|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
124819718|NCT00420927|448965765|FG004|Period 2|Sponsor decision|0|||
124819719|NCT00420927|448965766|FG005|Period 2|Sponsor decision|0|||
124819720|NCT00420927|448965767|FG006|Period 2|Sponsor decision|1|||
124819721|NCT00420927|448965761|FG000|Period 2|Randomization error|0|||
124819722|NCT00420927|448965762|FG001|Period 2|Randomization error|0|||
124819723|NCT00420927|448965763|FG002|Period 2|Randomization error|0|||
124819724|NCT00420927|448965764|FG003|Period 2|Randomization error|0|||
124637882|NCT03777436|448292479|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
124819725|NCT00420927|448965765|FG004|Period 2|Randomization error|1|||
124819726|NCT00420927|448965766|FG005|Period 2|Randomization error|1|||
124819727|NCT00420927|448965767|FG006|Period 2|Randomization error|0|||
124637883|NCT03777436|448292480|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
124819728|NCT00420927|448965761|FG000|Period 2|Noncompliant with study drug|0|||
124819729|NCT00420927|448965762|FG001|Period 2|Noncompliant with study drug|0|||
124819730|NCT00420927|448965763|FG002|Period 2|Noncompliant with study drug|0|||
124819731|NCT00420927|448965764|FG003|Period 2|Noncompliant with study drug|1|||
124819732|NCT00420927|448965765|FG004|Period 2|Noncompliant with study drug|0|||
124819733|NCT00420927|448965766|FG005|Period 2|Noncompliant with study drug|0|||
124819734|NCT00420927|448965767|FG006|Period 2|Noncompliant with study drug|2|||
124819735|NCT00420927|448965761|FG000|Period 2|Methotrexate intolerance|0|||
124819736|NCT00420927|448965762|FG001|Period 2|Methotrexate intolerance|0|||
124819737|NCT00420927|448965763|FG002|Period 2|Methotrexate intolerance|0|||
124819738|NCT00420927|448965764|FG003|Period 2|Methotrexate intolerance|0|||
124819739|NCT00420927|448965765|FG004|Period 2|Methotrexate intolerance|0|||
124819740|NCT00420927|448965766|FG005|Period 2|Methotrexate intolerance|0|||
124819741|NCT00420927|448965767|FG006|Period 2|Methotrexate intolerance|1|||
124819742|NCT00420927|448965761|FG000|Period 2|Took prohibited medication|0|||
124819743|NCT00420927|448965762|FG001|Period 2|Took prohibited medication|0|||
124819744|NCT00420927|448965763|FG002|Period 2|Took prohibited medication|0|||
124819745|NCT00420927|448965764|FG003|Period 2|Took prohibited medication|0|||
124819746|NCT00420927|448965765|FG004|Period 2|Took prohibited medication|1|||
124819747|NCT00420927|448965766|FG005|Period 2|Took prohibited medication|0|||
124819748|NCT00420927|448965767|FG006|Period 2|Took prohibited medication|0|||
124819749|NCT04605484|448965770|FG000|Overall Study|Lost to Follow-up|0|||
124819750|NCT04605484|448965771|FG001|Overall Study|Lost to Follow-up|1|||
124819751|NCT04605484|448965772|FG002|Overall Study|Lost to Follow-up|1|||
124819752|NCT04605484|448965770|FG000|Overall Study|Other|0|||
124819753|NCT04605484|448965771|FG001|Overall Study|Other|1|||
124819754|NCT04605484|448965772|FG002|Overall Study|Other|0|||
124819755|NCT01370356|448965775|FG000|Overall Study|Death|1|||
124819756|NCT01370356|448965776|FG001|Overall Study|Death|0|||
124819757|NCT01370356|448965775|FG000|Overall Study|Lack of Efficacy|6|||
124819758|NCT01370356|448965776|FG001|Overall Study|Lack of Efficacy|28|||
124819759|NCT01370356|448965775|FG000|Overall Study|Lost to Follow-up|76|||
124819760|NCT01370356|448965776|FG001|Overall Study|Lost to Follow-up|81|||
124819761|NCT01370356|448965775|FG000|Overall Study|Withdrawal by Subject|54|||
124819762|NCT01370356|448965776|FG001|Overall Study|Withdrawal by Subject|59|||
124819763|NCT01370356|448965775|FG000|Overall Study|Reason not specified|39|||
124819764|NCT01370356|448965776|FG001|Overall Study|Reason not specified|43|||
124819765|NCT01370356|448965775|FG000|Overall Study|Protocol Violation|3|||
124819766|NCT01370356|448965776|FG001|Overall Study|Protocol Violation|3|||
124819767|NCT01370356|448965775|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
124819768|NCT01370356|448965776|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
124819769|NCT01370356|448965775|FG000|Overall Study|AE Not Related to Study Drug|1|||
124819770|NCT01370356|448965776|FG001|Overall Study|AE Not Related to Study Drug|4|||
124819771|NCT00040664|448965777|FG000|Overall Study|Adverse Event|12|||
124819772|NCT00040664|448965778|FG001|Overall Study|Adverse Event|3|||
124819773|NCT00040664|448965779|FG002|Overall Study|Adverse Event|2|||
124819774|NCT00040664|448965780|FG003|Overall Study|Adverse Event|7|||
124819775|NCT00040664|448965777|FG000|Overall Study|Lack of Efficacy|9|||
124819776|NCT00040664|448965778|FG001|Overall Study|Lack of Efficacy|2|||
124819777|NCT00040664|448965779|FG002|Overall Study|Lack of Efficacy|3|||
124819778|NCT00040664|448965780|FG003|Overall Study|Lack of Efficacy|4|||
124819779|NCT00040664|448965777|FG000|Overall Study|Insufficient CD4 response|1|||
124819780|NCT00040664|448965778|FG001|Overall Study|Insufficient CD4 response|0|||
124819781|NCT00040664|448965779|FG002|Overall Study|Insufficient CD4 response|1|||
124819782|NCT00040664|448965780|FG003|Overall Study|Insufficient CD4 response|0|||
124819783|NCT00040664|448965777|FG000|Overall Study|Lost to Follow-up|4|||
124819784|NCT00040664|448965778|FG001|Overall Study|Lost to Follow-up|2|||
124819785|NCT00040664|448965779|FG002|Overall Study|Lost to Follow-up|0|||
124819786|NCT00040664|448965780|FG003|Overall Study|Lost to Follow-up|2|||
124819787|NCT00040664|448965777|FG000|Overall Study|Protocol Violation|2|||
124819788|NCT00040664|448965778|FG001|Overall Study|Protocol Violation|1|||
124819789|NCT00040664|448965779|FG002|Overall Study|Protocol Violation|0|||
124819790|NCT00040664|448965780|FG003|Overall Study|Protocol Violation|1|||
124819791|NCT00040664|448965777|FG000|Overall Study|Withdrawal by Subject|7|||
124819792|NCT00040664|448965778|FG001|Overall Study|Withdrawal by Subject|0|||
124819793|NCT00040664|448965779|FG002|Overall Study|Withdrawal by Subject|3|||
124819794|NCT00040664|448965780|FG003|Overall Study|Withdrawal by Subject|4|||
124819795|NCT00040664|448965777|FG000|Overall Study|Pregnancy|3|||
124819796|NCT00040664|448965778|FG001|Overall Study|Pregnancy|0|||
124819797|NCT00040664|448965779|FG002|Overall Study|Pregnancy|0|||
124819798|NCT00040664|448965780|FG003|Overall Study|Pregnancy|3|||
124819799|NCT00040664|448965777|FG000|Overall Study|Medication adherence/compliance problems|8|||
124819800|NCT00040664|448965778|FG001|Overall Study|Medication adherence/compliance problems|2|||
124819801|NCT00040664|448965779|FG002|Overall Study|Medication adherence/compliance problems|1|||
124819802|NCT00040664|448965780|FG003|Overall Study|Medication adherence/compliance problems|5|||
124819803|NCT00040664|448965777|FG000|Overall Study|Poor taste|2|||
124819804|NCT00040664|448965778|FG001|Overall Study|Poor taste|0|||
124819805|NCT00040664|448965779|FG002|Overall Study|Poor taste|2|||
124819806|NCT00040664|448965780|FG003|Overall Study|Poor taste|0|||
124819807|NCT00040664|448965777|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
124819808|NCT00040664|448965778|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
124819809|NCT00040664|448965779|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
124819810|NCT00040664|448965780|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
124819811|NCT00040664|448965777|FG000|Overall Study|Change of formulation|2|||
124819812|NCT00040664|448965778|FG001|Overall Study|Change of formulation|2|||
124819813|NCT00040664|448965779|FG002|Overall Study|Change of formulation|0|||
124819814|NCT00040664|448965780|FG003|Overall Study|Change of formulation|0|||
124819815|NCT00040664|448965777|FG000|Overall Study|Non-viability of oral suspension|1|||
124819816|NCT00040664|448965778|FG001|Overall Study|Non-viability of oral suspension|0|||
124819817|NCT00040664|448965779|FG002|Overall Study|Non-viability of oral suspension|1|||
124819818|NCT00040664|448965780|FG003|Overall Study|Non-viability of oral suspension|0|||
124819819|NCT02925494|448965781|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
124819820|NCT02925494|448965782|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
124819821|NCT02925494|448965783|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
124819822|NCT02925494|448965784|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
124819823|NCT02925494|448965781|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
124819824|NCT02925494|448965782|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
124819825|NCT02925494|448965783|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
124819826|NCT02925494|448965784|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
124819827|NCT02925494|448965781|FG000|Post-Treatment Follow-Up Period|Other|1|||
124819828|NCT02925494|448965782|FG001|Post-Treatment Follow-Up Period|Other|4|||
124819829|NCT02925494|448965783|FG002|Post-Treatment Follow-Up Period|Other|3|||
124819830|NCT02925494|448965784|FG003|Post-Treatment Follow-Up Period|Other|6|||
124819831|NCT02925494|448965781|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
124819832|NCT02925494|448965782|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
124819833|NCT02925494|448965783|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
124819834|NCT02925494|448965784|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
124819835|NCT02925494|448965781|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
124819836|NCT02925494|448965782|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
124819837|NCT02925494|448965783|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
124819838|NCT02925494|448965784|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
124819839|NCT02925494|448965781|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
124819840|NCT02925494|448965782|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
124819841|NCT02925494|448965783|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
124819842|NCT02925494|448965784|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
124819843|NCT02925494|448965781|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
124819844|NCT02925494|448965782|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
124819845|NCT02925494|448965783|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
124819846|NCT02925494|448965784|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
124819847|NCT06149247|448965789|FG000|Overall Study|Adverse Event|0|||
124819848|NCT06149247|448965790|FG001|Overall Study|Adverse Event|1|||
124819849|NCT05182125|448965791|FG000|Overall Study|Withdrawal by Subject|0|||
124819850|NCT05182125|448965792|FG001|Overall Study|Withdrawal by Subject|0|||
124819851|NCT05182125|448965793|FG002|Overall Study|Withdrawal by Subject|0|||
124819852|NCT05182125|448965794|FG003|Overall Study|Withdrawal by Subject|0|||
124819853|NCT05182125|448965795|FG004|Overall Study|Withdrawal by Subject|2|||
124819854|NCT05182125|448965796|FG005|Overall Study|Withdrawal by Subject|0|||
124819855|NCT05182125|448965791|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
124819856|NCT05182125|448965792|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
124819857|NCT05182125|448965793|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
124819858|NCT05182125|448965794|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
124819859|NCT05182125|448965795|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
124819860|NCT05182125|448965796|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
124819861|NCT05182125|448965791|FG000|Overall Study|Death|0|||
124819862|NCT05182125|448965792|FG001|Overall Study|Death|0|||
124819863|NCT05182125|448965793|FG002|Overall Study|Death|0|||
124819864|NCT05182125|448965794|FG003|Overall Study|Death|0|||
124819865|NCT05182125|448965795|FG004|Overall Study|Death|1|||
124819866|NCT05182125|448965796|FG005|Overall Study|Death|0|||
124819867|NCT05182125|448965791|FG000|Overall Study|Health Contact Follow-up|5|||
124819868|NCT05182125|448965792|FG001|Overall Study|Health Contact Follow-up|5|||
124819869|NCT05182125|448965793|FG002|Overall Study|Health Contact Follow-up|2|||
124637884|NCT03777436|448292478|FG000|Placebo-controlled Phase|Physician Decision|0|||
124819870|NCT05182125|448965794|FG003|Overall Study|Health Contact Follow-up|9|||
124819871|NCT05182125|448965795|FG004|Overall Study|Health Contact Follow-up|7|||
124819872|NCT05182125|448965796|FG005|Overall Study|Health Contact Follow-up|2|||
124819873|NCT01218243|448965797|FG000|Overall Study|Lack of Efficacy|1|||
124819874|NCT01218243|448965798|FG001|Overall Study|Lack of Efficacy|1|||
124637885|NCT03777436|448292479|FG001|Placebo-controlled Phase|Physician Decision|1|||
124819875|NCT01218243|448965797|FG000|Overall Study|Lost to Follow-up|3|||
124819876|NCT01218243|448965798|FG001|Overall Study|Lost to Follow-up|3|||
124819877|NCT01218243|448965797|FG000|Overall Study|Protocol Violation|5|||
124637886|NCT03777436|448292480|FG002|Placebo-controlled Phase|Physician Decision|0|||
124819878|NCT01218243|448965798|FG001|Overall Study|Protocol Violation|10|||
124819879|NCT02615145|448965800|FG000|Overall Study|Did Not Start Treatment|0|||
124819880|NCT02615145|448965801|FG001|Overall Study|Did Not Start Treatment|0|||
124819881|NCT02615145|448965802|FG002|Overall Study|Did Not Start Treatment|1|||
124819882|NCT02615145|448965803|FG003|Overall Study|Did Not Start Treatment|1|||
124819883|NCT02615145|448965800|FG000|Overall Study|Failure to Return|20|||
124819884|NCT02615145|448965801|FG001|Overall Study|Failure to Return|10|||
124819885|NCT02615145|448965802|FG002|Overall Study|Failure to Return|7|||
124819886|NCT02615145|448965803|FG003|Overall Study|Failure to Return|0|||
124819887|NCT02615145|448965800|FG000|Overall Study|Death|2|||
124819888|NCT02615145|448965801|FG001|Overall Study|Death|3|||
124819889|NCT02615145|448965802|FG002|Overall Study|Death|0|||
124819890|NCT02615145|448965803|FG003|Overall Study|Death|0|||
124819891|NCT02615145|448965800|FG000|Overall Study|Other, Not Specified|5|||
124819892|NCT02615145|448965801|FG001|Overall Study|Other, Not Specified|2|||
124819893|NCT02615145|448965802|FG002|Overall Study|Other, Not Specified|0|||
124819894|NCT02615145|448965803|FG003|Overall Study|Other, Not Specified|0|||
124819895|NCT03727347|448965804|FG000|Overall Study|Withdrawal by Subject|2|||
124819896|NCT03727347|448965804|FG000|Overall Study|Lost to Follow-up|1|||
124819897|NCT03200860|448965805|FG000|Overall Study|Withdrawal by Subject|1|||
124819898|NCT03200860|448965806|FG001|Overall Study|Withdrawal by Subject|0|||
124819899|NCT01744197|448965808|FG000|Overall Study|Received 1 patch|2|||
124819900|NCT01744197|448965809|FG001|Overall Study|Received 1 patch|1|||
124819901|NCT01744197|448965808|FG000|Overall Study|No patch received|2|||
124819902|NCT01744197|448965809|FG001|Overall Study|No patch received|2|||
124819903|NCT04342897|448965810|FG000|Overall Study|Death|7|||
124819904|NCT04342897|448965811|FG001|Overall Study|Death|4|||
124819905|NCT04342897|448965810|FG000|Overall Study|Lost to Follow-up|6|||
124819906|NCT04342897|448965811|FG001|Overall Study|Lost to Follow-up|6|||
124819907|NCT04342897|448965810|FG000|Overall Study|Withdrawal by Subject|1|||
124819908|NCT04342897|448965811|FG001|Overall Study|Withdrawal by Subject|2|||
124819909|NCT01325584|448965819|FG000|Overall Study|Death|1|||
124819910|NCT00887978|448965820|FG000|Overall Study|Adverse Event|18|||
124819911|NCT00887978|448965821|FG001|Overall Study|Adverse Event|5|||
124819912|NCT00887978|448965820|FG000|Overall Study|Clinical Worsening|4|||
124819913|NCT00887978|448965821|FG001|Overall Study|Clinical Worsening|4|||
124819914|NCT00887978|448965820|FG000|Overall Study|Death|2|||
124819915|NCT00887978|448965821|FG001|Overall Study|Death|3|||
124819916|NCT00887978|448965820|FG000|Overall Study|Withdrawal by Subject|1|||
124819917|NCT00887978|448965821|FG001|Overall Study|Withdrawal by Subject|2|||
124819918|NCT00887978|448965820|FG000|Overall Study|Lost to Follow-up|0|||
124819919|NCT00887978|448965821|FG001|Overall Study|Lost to Follow-up|1|||
124819920|NCT00309387|448967512|FG000|Overall Study|Death|72|||
124819921|NCT00309387|448967513|FG001|Overall Study|Death|73|||
124819922|NCT00309387|448967512|FG000|Overall Study|Lost to Follow-up|70|||
124819923|NCT00309387|448967513|FG001|Overall Study|Lost to Follow-up|86|||
124819924|NCT02483520|448967515|FG000|Overall Study|Lost to Follow-up|3|||
124819925|NCT02483520|448967516|FG001|Overall Study|Lost to Follow-up|4|||
124819926|NCT02483520|448967515|FG000|Overall Study|Withdrawal by Subject|4|||
124819927|NCT02483520|448967516|FG001|Overall Study|Withdrawal by Subject|14|||
124819928|NCT02483520|448967515|FG000|Overall Study|Hospitalized|2|||
124819929|NCT02483520|448967516|FG001|Overall Study|Hospitalized|3|||
124819930|NCT02483520|448967515|FG000|Overall Study|Moved to LTC|2|||
124819931|NCT02483520|448967516|FG001|Overall Study|Moved to LTC|3|||
124819932|NCT04492618|448967518|FG000|Overall Study|Withdrawal by Subject|1|||
124819933|NCT01401283|448967519|FG000|Overall Study|surgery cancelled|5|||
124819934|NCT01401283|448967520|FG001|Overall Study|surgery cancelled|8|||
124819935|NCT01401283|448967519|FG000|Overall Study|preoperative arrhythmia|5|||
124819936|NCT01401283|448967520|FG001|Overall Study|preoperative arrhythmia|0|||
124819937|NCT01401283|448967519|FG000|Overall Study|no central venous access|0|||
124819938|NCT01401283|448967520|FG001|Overall Study|no central venous access|1|||
124819939|NCT01401283|448967519|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
124819940|NCT01401283|448967520|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
124819941|NCT02101060|448967526|FG000|Overall Study|Adverse Event|1|||
124819942|NCT02101060|448967527|FG001|Overall Study|Adverse Event|0|||
124819943|NCT02101060|448967526|FG000|Overall Study|Withdrawal by Subject|1|||
124819944|NCT02101060|448967527|FG001|Overall Study|Withdrawal by Subject|1|||
124819945|NCT02101060|448967526|FG000|Overall Study|Lost to Follow-up|3|||
124819946|NCT02101060|448967527|FG001|Overall Study|Lost to Follow-up|3|||
124819947|NCT03462082|448967531|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
124819948|NCT03462082|448967532|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
124819949|NCT03462082|448967533|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
124819950|NCT03462082|448967534|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
124819951|NCT03462082|448967535|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
124819952|NCT03462082|448967536|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
124819953|NCT03462082|448967537|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
124819954|NCT03462082|448967538|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
124819955|NCT00166114|448967541|FG000|Overall Study|Protocol Violation|2|||
124819956|NCT00166114|448967542|FG001|Overall Study|Protocol Violation|1|||
124819957|NCT00166114|448967541|FG000|Overall Study|Withdrawal by Subject|10|||
124819958|NCT00166114|448967542|FG001|Overall Study|Withdrawal by Subject|4|||
124819959|NCT00166114|448967541|FG000|Overall Study|Adverse Event|2|||
124819960|NCT00166114|448967542|FG001|Overall Study|Adverse Event|1|||
124819961|NCT00545168|448967549|FG000|Overall Study|Lost to Follow-up|5|||
124819962|NCT00545168|448967550|FG001|Overall Study|Lost to Follow-up|5|||
124819963|NCT00545168|448967551|FG002|Overall Study|Lost to Follow-up|5|||
124819964|NCT00545168|448967549|FG000|Overall Study|Withdrawal by Subject|9|||
124819965|NCT00545168|448967550|FG001|Overall Study|Withdrawal by Subject|0|||
124819966|NCT00545168|448967551|FG002|Overall Study|Withdrawal by Subject|13|||
124819967|NCT00545168|448967549|FG000|Overall Study|Protocol Violation|1|||
124819968|NCT00545168|448967550|FG001|Overall Study|Protocol Violation|0|||
124819969|NCT00545168|448967551|FG002|Overall Study|Protocol Violation|1|||
124819970|NCT00545168|448967549|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
124819971|NCT00545168|448967550|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
124819972|NCT00545168|448967551|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
124819973|NCT01218204|448967552|FG000|Part B Washout|Adverse Event|0|||
124819974|NCT01218204|448967553|FG001|Part B Washout|Adverse Event|1|||
124819975|NCT01218204|448967554|FG002|Part B Washout|Adverse Event|0|||
124819976|NCT01218204|448967555|FG003|Part B Washout|Adverse Event|0|||
124819977|NCT01218204|448967552|FG000|Part B Washout|Lost to Follow-up|0|||
124819978|NCT01218204|448967553|FG001|Part B Washout|Lost to Follow-up|2|||
124819979|NCT01218204|448967554|FG002|Part B Washout|Lost to Follow-up|0|||
124819980|NCT01218204|448967555|FG003|Part B Washout|Lost to Follow-up|0|||
124819981|NCT01218204|448967552|FG000|Part B Washout|Physician Decision|0|||
124819982|NCT01218204|448967553|FG001|Part B Washout|Physician Decision|14|||
124819983|NCT01218204|448967554|FG002|Part B Washout|Physician Decision|0|||
124819984|NCT01218204|448967555|FG003|Part B Washout|Physician Decision|0|||
124819985|NCT01218204|448967552|FG000|Part B Washout|Withdrawal by Subject|0|||
124819986|NCT01218204|448967553|FG001|Part B Washout|Withdrawal by Subject|14|||
124819987|NCT01218204|448967554|FG002|Part B Washout|Withdrawal by Subject|0|||
124819988|NCT01218204|448967555|FG003|Part B Washout|Withdrawal by Subject|0|||
124819989|NCT01218204|448967552|FG000|Part B Washout|Reached defined stopping criteria|0|||
124819990|NCT01218204|448967553|FG001|Part B Washout|Reached defined stopping criteria|2|||
124819991|NCT01218204|448967554|FG002|Part B Washout|Reached defined stopping criteria|0|||
124819992|NCT01218204|448967555|FG003|Part B Washout|Reached defined stopping criteria|0|||
124819993|NCT01218204|448967552|FG000|Part B Washout|Did not meet continuation criteria|0|||
124819994|NCT01218204|448967553|FG001|Part B Washout|Did not meet continuation criteria|112|||
124819995|NCT01218204|448967554|FG002|Part B Washout|Did not meet continuation criteria|0|||
124819996|NCT01218204|448967555|FG003|Part B Washout|Did not meet continuation criteria|0|||
124819997|NCT01218204|448967552|FG000|Part B Run-in|Adverse Event|0|||
124819998|NCT01218204|448967553|FG001|Part B Run-in|Adverse Event|0|||
124819999|NCT01218204|448967554|FG002|Part B Run-in|Adverse Event|1|||
124820000|NCT01218204|448967555|FG003|Part B Run-in|Adverse Event|0|||
124820001|NCT01218204|448967552|FG000|Part B Run-in|Protocol Violation|0|||
124820002|NCT01218204|448967553|FG001|Part B Run-in|Protocol Violation|0|||
124820003|NCT01218204|448967554|FG002|Part B Run-in|Protocol Violation|2|||
124820004|NCT01218204|448967555|FG003|Part B Run-in|Protocol Violation|0|||
124820005|NCT01218204|448967552|FG000|Part B Run-in|Withdrawal by Subject|0|||
124820006|NCT01218204|448967553|FG001|Part B Run-in|Withdrawal by Subject|0|||
124820007|NCT01218204|448967554|FG002|Part B Run-in|Withdrawal by Subject|3|||
124820008|NCT01218204|448967555|FG003|Part B Run-in|Withdrawal by Subject|0|||
124820009|NCT01218204|448967552|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
124820010|NCT01218204|448967553|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
124820011|NCT01218204|448967554|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
124820012|NCT01218204|448967555|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
124820013|NCT01218204|448967552|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
124820014|NCT01218204|448967553|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
124820015|NCT01218204|448967554|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
124820016|NCT01218204|448967555|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
124820017|NCT00127660|448967561|FG000|Overall Study|Protocol Violation|3|||
124820018|NCT00127660|448967562|FG001|Overall Study|Protocol Violation|3|||
124820019|NCT00127660|448967563|FG002|Overall Study|Protocol Violation|5|||
124820020|NCT00127660|448967564|FG003|Overall Study|Protocol Violation|0|||
124820021|NCT01987505|448967565|FG000|Overall Study|Other|9|||
124820022|NCT01987505|448967565|FG000|Overall Study|Withdrawal by Subject|2|||
124820023|NCT01987505|448967565|FG000|Overall Study|Other Reason|2|||
124820024|NCT01987505|448967565|FG000|Overall Study|Lost to Follow-up|15|||
124820025|NCT01987505|448967565|FG000|Overall Study|Investigator Decision|2|||
124820026|NCT01987505|448967565|FG000|Overall Study|Death|4|||
124820027|NCT05131646|448967566|FG000|Overall Study|Withdrawal by Subject|1|||
124820028|NCT05131646|448967567|FG001|Overall Study|Withdrawal by Subject|0|||
124820029|NCT05131646|448967568|FG002|Overall Study|Withdrawal by Subject|0|||
124820030|NCT03266107|448967569|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
124820031|NCT03266107|448967569|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
124820032|NCT03266107|448967569|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
124820033|NCT03266107|448967569|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
124637887|NCT03777436|448292478|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
124637888|NCT03777436|448292479|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
124637889|NCT03777436|448292480|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
124637890|NCT03777436|448292478|FG000|Apremilast Extension Phase|Adverse Event|0|||
124637891|NCT03777436|448292479|FG001|Apremilast Extension Phase|Adverse Event|0|||
124637892|NCT03777436|448292480|FG002|Apremilast Extension Phase|Adverse Event|6|||
124637893|NCT03777436|448292478|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
124637894|NCT03777436|448292479|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
124637895|NCT03777436|448292480|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
124637896|NCT03777436|448292478|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
124637897|NCT03777436|448292479|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
124637898|NCT03777436|448292480|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
124637899|NCT03777436|448292478|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
124637900|NCT03777436|448292479|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
124637901|NCT03777436|448292480|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
124637902|NCT03777436|448292478|FG000|Apremilast Extension Phase|Miscellaneous|0|||
124637903|NCT03777436|448292479|FG001|Apremilast Extension Phase|Miscellaneous|0|||
124637904|NCT03777436|448292480|FG002|Apremilast Extension Phase|Miscellaneous|1|||
124820034|NCT03454997|448967570|FG000|Overall Study|Staff Coach - Left Oranization|1|||
124820035|NCT03454997|448967571|FG001|Overall Study|Staff Coach - Left Oranization|1|||
124820036|NCT03454997|448967570|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
124820037|NCT03454997|448967571|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
124820038|NCT03454997|448967570|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
124820039|NCT03454997|448967571|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
124820040|NCT03454997|448967570|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
124820041|NCT03454997|448967571|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
124820042|NCT03454997|448967570|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
124820043|NCT03454997|448967571|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
124820044|NCT03454997|448967570|FG000|Overall Study|Client with SMI - Left organization|0|||
124820045|NCT03454997|448967571|FG001|Overall Study|Client with SMI - Left organization|1|||
124820046|NCT03454997|448967570|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
124820047|NCT03454997|448967571|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
124820048|NCT01191801|448967574|FG000|Overall Study|Death|36|||
124820049|NCT01191801|448967575|FG001|Overall Study|Death|12|||
124820050|NCT01191801|448967574|FG000|Overall Study|Lack of Efficacy|176|||
124820051|NCT01191801|448967575|FG001|Overall Study|Lack of Efficacy|258|||
124820052|NCT01191801|448967574|FG000|Overall Study|Adverse Event|9|||
124820053|NCT01191801|448967575|FG001|Overall Study|Adverse Event|8|||
124820054|NCT01191801|448967574|FG000|Overall Study|Protocol Violation|2|||
124820055|NCT01191801|448967575|FG001|Overall Study|Protocol Violation|4|||
124820056|NCT01191801|448967574|FG000|Overall Study|Physician Decision|47|||
124820057|NCT01191801|448967575|FG001|Overall Study|Physician Decision|24|||
124820058|NCT01191801|448967574|FG000|Overall Study|Withdrawal by Subject|1|||
124820059|NCT01191801|448967575|FG001|Overall Study|Withdrawal by Subject|4|||
124820060|NCT01191801|448967574|FG000|Overall Study|Not Provided|45|||
124820061|NCT01191801|448967575|FG001|Overall Study|Not Provided|27|||
124820062|NCT00299975|448967586|FG000|Overall Study|Adverse Event|1|||
124820063|NCT00299975|448967587|FG001|Overall Study|Adverse Event|0|||
124820064|NCT00299975|448967588|FG002|Overall Study|Adverse Event|2|||
124820065|NCT00299975|448967586|FG000|Overall Study|Pregnancy|0|||
124820066|NCT00299975|448967587|FG001|Overall Study|Pregnancy|0|||
124820067|NCT00299975|448967588|FG002|Overall Study|Pregnancy|1|||
124820068|NCT00299975|448967586|FG000|Overall Study|Lack of Efficacy|1|||
124820069|NCT00299975|448967587|FG001|Overall Study|Lack of Efficacy|0|||
124820070|NCT00299975|448967588|FG002|Overall Study|Lack of Efficacy|1|||
124820071|NCT00299975|448967586|FG000|Overall Study|Lost to Follow-up|1|||
124820072|NCT00299975|448967587|FG001|Overall Study|Lost to Follow-up|0|||
124820073|NCT00299975|448967588|FG002|Overall Study|Lost to Follow-up|0|||
124637905|NCT00869999|448292483|FG000|Overall Study|Withdrawal by Subject|1|||
124820074|NCT00299975|448967586|FG000|Overall Study|Withdrawal by Subject|0|||
124820075|NCT00299975|448967587|FG001|Overall Study|Withdrawal by Subject|1|||
124820076|NCT00299975|448967588|FG002|Overall Study|Withdrawal by Subject|3|||
124820077|NCT00299975|448967586|FG000|Overall Study|Physician Decision|0|||
124820078|NCT00299975|448967587|FG001|Overall Study|Physician Decision|0|||
124820079|NCT00299975|448967588|FG002|Overall Study|Physician Decision|1|||
124820080|NCT00171730|448967591|FG000|Overall Study|Adverse Event|3|||
124820081|NCT00171730|448967591|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
124820082|NCT00171730|448967591|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
124820083|NCT00171730|448967591|FG000|Overall Study|Withdrawal by Subject|3|||
124820084|NCT05025241|448967592|FG000|Screening|Failed Screening|5|||
124820085|NCT05025241|448967592|FG000|Treatment and Follow Up|Adverse Event|3|||
124820086|NCT01053221|448967593|FG000|Overall Study|The study was closed prematurely|5|||
124820087|NCT01053221|448967594|FG001|Overall Study|The study was closed prematurely|9|||
124820088|NCT02266225|448967595|FG000|Overall Study|Lost to Follow-up|2|||
124820089|NCT02266225|448967595|FG000|Overall Study|Death|1|||
124820090|NCT02266225|448967595|FG000|Overall Study|Withdrawal by Subject|13|||
124820091|NCT01465997|448967596|FG000|Overall Study|Adverse Event|12|||
124820092|NCT01465997|448967597|FG001|Overall Study|Adverse Event|22|||
124820093|NCT01465997|448967596|FG000|Overall Study|Lack of Efficacy|13|||
124820094|NCT01465997|448967597|FG001|Overall Study|Lack of Efficacy|1|||
124820095|NCT01465997|448967596|FG000|Overall Study|Protocol Violation|1|||
124820096|NCT01465997|448967597|FG001|Overall Study|Protocol Violation|4|||
124820097|NCT01465997|448967596|FG000|Overall Study|Lost to Follow-up|6|||
124820098|NCT01465997|448967597|FG001|Overall Study|Lost to Follow-up|9|||
124820099|NCT01465997|448967596|FG000|Overall Study|Withdrawal by Subject|32|||
124820100|NCT01465997|448967597|FG001|Overall Study|Withdrawal by Subject|35|||
124820101|NCT01465997|448967596|FG000|Overall Study|investigator's decision|1|||
124820102|NCT01465997|448967597|FG001|Overall Study|investigator's decision|1|||
124820103|NCT01465997|448967596|FG000|Overall Study|Death|0|||
124820104|NCT01465997|448967597|FG001|Overall Study|Death|1|||
124820105|NCT01465997|448967596|FG000|Overall Study|sponsor's decision|1|||
124820106|NCT01465997|448967597|FG001|Overall Study|sponsor's decision|1|||
124820107|NCT01465997|448967596|FG000|Overall Study|subject withdrew consent|1|||
124820108|NCT01465997|448967597|FG001|Overall Study|subject withdrew consent|0|||
124820109|NCT01465997|448967596|FG000|Overall Study|local lab unblinded site|1|||
124820110|NCT01465997|448967597|FG001|Overall Study|local lab unblinded site|0|||
124820111|NCT01465997|448967596|FG000|Overall Study|withdrew before follow-up|0|||
124820112|NCT01465997|448967597|FG001|Overall Study|withdrew before follow-up|13|||
124820113|NCT01465997|448967596|FG000|Overall Study|decision by site staff|0|||
124820114|NCT01465997|448967597|FG001|Overall Study|decision by site staff|1|||
124820115|NCT01465997|448967596|FG000|Overall Study|subject left participation SP0993|0|||
124820116|NCT01465997|448967597|FG001|Overall Study|subject left participation SP0993|1|||
124820117|NCT02246660|448967598|FG000|Overall Study|Withdrawal by Subject|0|||
124820118|NCT02246660|448967599|FG001|Overall Study|Withdrawal by Subject|1|||
124820119|NCT02246660|448967600|FG002|Overall Study|Withdrawal by Subject|0|||
124820120|NCT02246660|448967598|FG000|Overall Study|Death|0|||
124820121|NCT02246660|448967599|FG001|Overall Study|Death|0|||
124820122|NCT02246660|448967600|FG002|Overall Study|Death|1|||
124820123|NCT03018704|448967601|FG000|Overall Study|Lost to Follow-up|1|||
124820124|NCT03018704|448967602|FG001|Overall Study|Lost to Follow-up|1|||
124820125|NCT00642460|448967605|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
124820126|NCT00642460|448967606|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
124820127|NCT00642460|448967607|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
124820128|NCT00642460|448967608|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
124820129|NCT00642460|448967609|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
124820130|NCT00642460|448967610|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
124820131|NCT00642460|448967605|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
124820132|NCT00642460|448967606|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
124820133|NCT00642460|448967607|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
124820134|NCT00642460|448967608|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
124820135|NCT00642460|448967609|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
124820136|NCT00642460|448967610|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
124820137|NCT00642460|448967605|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
124820138|NCT00642460|448967606|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
124820139|NCT00642460|448967607|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
124820140|NCT00642460|448967608|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
124820141|NCT00642460|448967609|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
124820142|NCT00642460|448967610|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
124820143|NCT00642460|448967605|FG000|Part II: Open-Label Up to Week 92|Death|0|||
124820144|NCT00642460|448967606|FG001|Part II: Open-Label Up to Week 92|Death|1|||
124820145|NCT00642460|448967607|FG002|Part II: Open-Label Up to Week 92|Death|0|||
124820146|NCT00642460|448967608|FG003|Part II: Open-Label Up to Week 92|Death|2|||
124820147|NCT00642460|448967609|FG004|Part II: Open-Label Up to Week 92|Death|0|||
124820148|NCT00642460|448967610|FG005|Part II: Open-Label Up to Week 92|Death|0|||
124820149|NCT00642460|448967605|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
124637906|NCT00869999|448292483|FG000|Overall Study|removed prior to starting therapy|1|||
124637907|NCT04478695|448292484|FG000|Overall Study|Death|1|||
124820150|NCT00642460|448967606|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
124820151|NCT00642460|448967607|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
124820152|NCT00642460|448967608|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
124820153|NCT00642460|448967609|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
124820154|NCT00642460|448967610|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
124820155|NCT00642460|448967605|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
124820156|NCT00642460|448967606|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
124820157|NCT00642460|448967607|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
124637908|NCT04478695|448292485|FG001|Overall Study|Death|0|||
124820158|NCT00642460|448967608|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
124820159|NCT00642460|448967609|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
124820160|NCT00642460|448967610|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
124820161|NCT00642460|448967605|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
124820162|NCT00642460|448967606|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
124820163|NCT00642460|448967607|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
124820164|NCT00642460|448967608|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
124820165|NCT00642460|448967609|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
124820166|NCT00642460|448967610|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
124820167|NCT00642460|448967605|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
124820168|NCT00642460|448967606|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
124820169|NCT00642460|448967607|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
124820170|NCT00642460|448967608|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
124820171|NCT00642460|448967609|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
124820172|NCT00642460|448967610|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
124820173|NCT00642460|448967605|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
124820174|NCT00642460|448967606|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
124820175|NCT00642460|448967607|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
124820176|NCT00642460|448967608|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
124820177|NCT00642460|448967609|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
124820178|NCT00642460|448967610|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
124820179|NCT00642460|448967605|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
124820180|NCT00642460|448967606|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
124820181|NCT00642460|448967607|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
124820182|NCT00642460|448967608|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
124820183|NCT00642460|448967609|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
124820184|NCT00642460|448967610|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
124820185|NCT00642460|448967605|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
124820186|NCT00642460|448967606|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
124820187|NCT00642460|448967607|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
124820188|NCT00642460|448967608|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
124820189|NCT00642460|448967609|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
124820190|NCT00642460|448967610|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
124820191|NCT00642460|448967605|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
124820192|NCT00642460|448967606|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
124820193|NCT00642460|448967607|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
124820194|NCT00642460|448967608|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
124820195|NCT00642460|448967609|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
124820196|NCT00642460|448967610|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
124820197|NCT00642460|448967605|FG000|Part III: Open-Label Up to Week 260|Other|0|||
124820198|NCT00642460|448967606|FG001|Part III: Open-Label Up to Week 260|Other|0|||
124820199|NCT00642460|448967607|FG002|Part III: Open-Label Up to Week 260|Other|0|||
124820200|NCT00642460|448967608|FG003|Part III: Open-Label Up to Week 260|Other|0|||
124820201|NCT00642460|448967609|FG004|Part III: Open-Label Up to Week 260|Other|2|||
124820202|NCT00642460|448967610|FG005|Part III: Open-Label Up to Week 260|Other|2|||
124820203|NCT00642460|448967605|FG000|Part III: Open-Label Up to Week 260|Death|0|||
124820204|NCT00642460|448967606|FG001|Part III: Open-Label Up to Week 260|Death|0|||
124820205|NCT00642460|448967607|FG002|Part III: Open-Label Up to Week 260|Death|0|||
124820206|NCT00642460|448967608|FG003|Part III: Open-Label Up to Week 260|Death|0|||
124820207|NCT00642460|448967609|FG004|Part III: Open-Label Up to Week 260|Death|0|||
124820208|NCT00642460|448967610|FG005|Part III: Open-Label Up to Week 260|Death|3|||
124820209|NCT00642460|448967605|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
124820210|NCT00642460|448967606|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
124820211|NCT00642460|448967607|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
124820212|NCT00642460|448967608|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
124820213|NCT00642460|448967609|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
124820214|NCT00642460|448967610|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
124820215|NCT00642460|448967605|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
124820216|NCT00642460|448967606|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
124820217|NCT00642460|448967607|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
124637909|NCT00644917|448292486|FG000|Overall Study|Withdrawal by Subject|2|||
124637910|NCT00758485|448292487|FG000|Overall Study|Lost to Follow-up|0|||
124637911|NCT00758485|448292488|FG001|Overall Study|Lost to Follow-up|1|||
124820218|NCT00642460|448967608|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
124820219|NCT00642460|448967609|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
124820220|NCT00642460|448967610|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
124637912|NCT00758485|448292487|FG000|Overall Study|Not Treated|1|||
124820221|NCT00320411|448967611|FG000|Overall Study|No investigational product admin.|4|||
124820222|NCT02557646|448967614|FG000|Overall Study|Adverse Event|40|||
124820223|NCT02557646|448967614|FG000|Overall Study|Death|1|||
124820224|NCT02557646|448967614|FG000|Overall Study|Lack of Efficacy|186|||
124820225|NCT02557646|448967614|FG000|Overall Study|Withdrawal by Subject|18|||
124820226|NCT02557646|448967614|FG000|Overall Study|Lost to Follow-up|17|||
124820227|NCT02557646|448967614|FG000|Overall Study|Other|14|||
124820228|NCT04448171|448967615|FG000|Overall Study|Procedure Cancelled|1|||
124820229|NCT04448171|448967616|FG001|Overall Study|Procedure Cancelled|0|||
124820230|NCT04448171|448967615|FG000|Overall Study|Protocol Violation|1|||
124820231|NCT04448171|448967616|FG001|Overall Study|Protocol Violation|0|||
124820232|NCT00660309|448967617|FG000|Overall Study|Adverse Event|2|||
124820233|NCT00660309|448967618|FG001|Overall Study|Adverse Event|0|||
124820234|NCT00660309|448967617|FG000|Overall Study|Withdrawal by Subject|0|||
124820235|NCT00660309|448967618|FG001|Overall Study|Withdrawal by Subject|3|||
124820236|NCT02573311|448967619|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
124820237|NCT02573311|448967620|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
124820238|NCT02573311|448967619|FG000|Disposition for Part 2|Physician Decision|25|||
124820239|NCT02573311|448967620|FG001|Disposition for Part 2|Physician Decision|7|||
124820240|NCT02573311|448967619|FG000|Disposition for Part 2|Adverse Event|36|||
124820241|NCT02573311|448967620|FG001|Disposition for Part 2|Adverse Event|5|||
124820242|NCT02573311|448967619|FG000|Disposition for Part 2|Lost to Follow-up|76|||
124820243|NCT02573311|448967620|FG001|Disposition for Part 2|Lost to Follow-up|7|||
124820244|NCT02573311|448967619|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
124820245|NCT02573311|448967620|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
124820246|NCT02573311|448967619|FG000|Disposition for Part 2|Investigator decision|0|||
124820247|NCT02573311|448967620|FG001|Disposition for Part 2|Investigator decision|1|||
124820248|NCT02573311|448967619|FG000|Disposition for Part 2|Other than specified above|13|||
124820249|NCT02573311|448967620|FG001|Disposition for Part 2|Other than specified above|3|||
124820250|NCT05683249|448967622|FG000|Overall Study|Adverse Event|3|||
124820251|NCT05683249|448967623|FG001|Overall Study|Adverse Event|1|||
124820252|NCT05683249|448967622|FG000|Overall Study|Lack of Efficacy|0|||
124820253|NCT05683249|448967623|FG001|Overall Study|Lack of Efficacy|2|||
124820254|NCT05683249|448967622|FG000|Overall Study|Lost to Follow-up|6|||
124820255|NCT05683249|448967623|FG001|Overall Study|Lost to Follow-up|5|||
124820256|NCT05683249|448967622|FG000|Overall Study|Non-compliance with Study Drug|2|||
124820257|NCT05683249|448967623|FG001|Overall Study|Non-compliance with Study Drug|0|||
124820258|NCT05683249|448967622|FG000|Overall Study|Protocol Violation|6|||
124820259|NCT05683249|448967623|FG001|Overall Study|Protocol Violation|3|||
124820260|NCT05683249|448967622|FG000|Overall Study|Withdrawal by Subject|9|||
124820261|NCT05683249|448967623|FG001|Overall Study|Withdrawal by Subject|8|||
124820262|NCT05683249|448967622|FG000|Overall Study|Other|0|||
124820263|NCT05683249|448967623|FG001|Overall Study|Other|2|||
124820264|NCT05288062|448967628|FG000|Overall Study|Ineligible|0|||
124820265|NCT05288062|448967629|FG001|Overall Study|Ineligible|0|||
124820266|NCT05288062|448967630|FG002|Overall Study|Ineligible|1|||
124820267|NCT05288062|448967631|FG003|Overall Study|Ineligible|0|||
124820268|NCT05288062|448967628|FG000|Overall Study|Withdrawal by Subject|0|||
124820269|NCT05288062|448967629|FG001|Overall Study|Withdrawal by Subject|0|||
124820270|NCT05288062|448967630|FG002|Overall Study|Withdrawal by Subject|1|||
124820271|NCT05288062|448967631|FG003|Overall Study|Withdrawal by Subject|0|||
124820272|NCT01217814|448967632|FG000|Overall Study|Adverse Event|1|||
124820273|NCT01217814|448967633|FG001|Overall Study|Adverse Event|1|||
124820274|NCT01217814|448967634|FG002|Overall Study|Adverse Event|0|||
124820275|NCT01217814|448967632|FG000|Overall Study|Lack of Efficacy|0|||
124637913|NCT00758485|448292488|FG001|Overall Study|Not Treated|2|||
124637914|NCT02347774|448292489|FG000|Study Participation|Lost to Follow-up|3|||
124637915|NCT02347774|448292490|FG001|Study Participation|Lost to Follow-up|6|||
124637916|NCT02347774|448292491|FG002|Study Participation|Lost to Follow-up|2|||
124637917|NCT02347774|448292489|FG000|Study Participation|Withdrawal by Subject|8|||
124820276|NCT01217814|448967633|FG001|Overall Study|Lack of Efficacy|0|||
124820277|NCT01217814|448967634|FG002|Overall Study|Lack of Efficacy|1|||
124820278|NCT03926169|448967638|FG000|Period A|Adverse Event|2|||
124820279|NCT03926169|448967639|FG001|Period A|Adverse Event|2|||
124820280|NCT03926169|448967640|FG002|Period A|Adverse Event|1|||
124820281|NCT03926169|448967638|FG000|Period A|Withdrawal by Subject|2|||
124820282|NCT03926169|448967639|FG001|Period A|Withdrawal by Subject|2|||
124820283|NCT03926169|448967640|FG002|Period A|Withdrawal by Subject|2|||
124820284|NCT03926169|448967638|FG000|Period A|Lost to Follow-up|3|||
124820285|NCT03926169|448967639|FG001|Period A|Lost to Follow-up|1|||
124820286|NCT03926169|448967640|FG002|Period A|Lost to Follow-up|0|||
124820287|NCT03926169|448967638|FG000|Period A|Lack of Efficacy|0|||
124820288|NCT03926169|448967639|FG001|Period A|Lack of Efficacy|2|||
124820289|NCT03926169|448967640|FG002|Period A|Lack of Efficacy|2|||
124820290|NCT03926169|448967638|FG000|Period A|COVID-19 Infection|0|||
124820291|NCT03926169|448967639|FG001|Period A|COVID-19 Infection|1|||
124820292|NCT03926169|448967640|FG002|Period A|COVID-19 Infection|0|||
124820293|NCT03926169|448967638|FG000|Period A|COVID-19 Logistical Restrictions|0|||
124820294|NCT03926169|448967639|FG001|Period A|COVID-19 Logistical Restrictions|2|||
124820295|NCT03926169|448967640|FG002|Period A|COVID-19 Logistical Restrictions|1|||
124820296|NCT03926169|448967638|FG000|Period A|Other, Not Specified|1|||
124820297|NCT03926169|448967639|FG001|Period A|Other, Not Specified|0|||
124820298|NCT03926169|448967640|FG002|Period A|Other, Not Specified|0|||
124820299|NCT03926169|448967638|FG000|Period B|Adverse Event|3|||
124820300|NCT03926169|448967639|FG001|Period B|Adverse Event|1|||
124820301|NCT03926169|448967640|FG002|Period B|Adverse Event|1|||
124820302|NCT03926169|448967638|FG000|Period B|Withdrawal by Subject|1|||
124820303|NCT03926169|448967639|FG001|Period B|Withdrawal by Subject|3|||
124820304|NCT03926169|448967640|FG002|Period B|Withdrawal by Subject|0|||
124820305|NCT03926169|448967638|FG000|Period B|Lack of Efficacy|3|||
124820306|NCT03926169|448967639|FG001|Period B|Lack of Efficacy|1|||
124820307|NCT03926169|448967640|FG002|Period B|Lack of Efficacy|1|||
124820308|NCT03926169|448967638|FG000|Period B|Lost to Follow-up|1|||
124820309|NCT03926169|448967639|FG001|Period B|Lost to Follow-up|1|||
124820310|NCT03926169|448967640|FG002|Period B|Lost to Follow-up|4|||
124820311|NCT03926169|448967638|FG000|Period B|Other, Not Specified|62|||
124820312|NCT03926169|448967639|FG001|Period B|Other, Not Specified|57|||
124820313|NCT03926169|448967640|FG002|Period B|Other, Not Specified|65|||
124820314|NCT00844896|448967641|FG000|Overall Study|Lost to Follow-up|12|||
124820315|NCT00844896|448967642|FG001|Overall Study|Lost to Follow-up|16|||
124820316|NCT00844896|448967641|FG000|Overall Study|Parents did not have time to complete|0|||
124820317|NCT00844896|448967642|FG001|Overall Study|Parents did not have time to complete|1|||
124820318|NCT02233647|448967643|FG000|Overall Study|Adverse Event|1|||
124820319|NCT01835587|448967647|FG000|Overall Study|Disease Recurrence or Relapse|0|||
124820320|NCT01835587|448967648|FG001|Overall Study|Disease Recurrence or Relapse|3|||
124820321|NCT01835587|448967649|FG002|Overall Study|Disease Recurrence or Relapse|0|||
124820322|NCT01835587|448967650|FG003|Overall Study|Disease Recurrence or Relapse|3|||
124820323|NCT01835587|448967647|FG000|Overall Study|Withdrawal by Subject|2|||
124820324|NCT01835587|448967648|FG001|Overall Study|Withdrawal by Subject|0|||
124820325|NCT01835587|448967649|FG002|Overall Study|Withdrawal by Subject|0|||
124820326|NCT01835587|448967650|FG003|Overall Study|Withdrawal by Subject|3|||
124820327|NCT01835587|448967647|FG000|Overall Study|Adverse Event|0|||
124820328|NCT01835587|448967648|FG001|Overall Study|Adverse Event|0|||
124820329|NCT01835587|448967649|FG002|Overall Study|Adverse Event|2|||
124820330|NCT01835587|448967650|FG003|Overall Study|Adverse Event|2|||
124820331|NCT01835587|448967647|FG000|Overall Study|Death|0|||
124820332|NCT01835587|448967648|FG001|Overall Study|Death|0|||
124820333|NCT01835587|448967649|FG002|Overall Study|Death|0|||
124820334|NCT01835587|448967650|FG003|Overall Study|Death|1|||
124820335|NCT01835587|448967647|FG000|Overall Study|Miscellaneous|0|||
124820336|NCT01835587|448967648|FG001|Overall Study|Miscellaneous|1|||
124820337|NCT01835587|448967649|FG002|Overall Study|Miscellaneous|0|||
124820338|NCT01835587|448967650|FG003|Overall Study|Miscellaneous|0|||
124820339|NCT03199274|448967660|FG000|Overall Study|Withdrawal by Subject|4|||
124820340|NCT03199274|448967661|FG001|Overall Study|Withdrawal by Subject|0|||
124820341|NCT03199274|448967660|FG000|Overall Study|Lost to Follow-up|0|||
124820342|NCT03199274|448967661|FG001|Overall Study|Lost to Follow-up|1|||
124820343|NCT03199274|448967660|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
124820344|NCT03199274|448967661|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
124637918|NCT02347774|448292490|FG001|Study Participation|Withdrawal by Subject|9|||
124637919|NCT02347774|448292491|FG002|Study Participation|Withdrawal by Subject|15|||
124637920|NCT02347774|448292489|FG000|Study Participation|Adverse Event|1|||
124820347|NCT02846779|448967664|FG000|Overall Study|Lost Enrollment|83|||
124820348|NCT02846779|448967665|FG001|Overall Study|Lost Enrollment|82|||
124820349|NCT02846779|448967666|FG002|Overall Study|Lost Enrollment|86|||
124820350|NCT02846779|448967664|FG000|Overall Study|Less than 31 days of follow-up|56|||
124820351|NCT02846779|448967665|FG001|Overall Study|Less than 31 days of follow-up|45|||
124820352|NCT02846779|448967666|FG002|Overall Study|Less than 31 days of follow-up|52|||
124820353|NCT02239978|448968798|FG000|Overall Study|Withdrawal by Subject|2|||
124820354|NCT02239978|448968799|FG001|Overall Study|Withdrawal by Subject|0|||
124820355|NCT01943292|448968814|FG000|Overall Study|Withdrawal by Subject|1|||
124820356|NCT01943292|448968815|FG001|Overall Study|Withdrawal by Subject|0|||
124637921|NCT02347774|448292490|FG001|Study Participation|Adverse Event|4|||
124820357|NCT01943292|448968816|FG002|Overall Study|Withdrawal by Subject|0|||
124820358|NCT00638378|448968817|FG000|Overall Study|Death|2|||
124820359|NCT00638378|448968817|FG000|Overall Study|Adverse Event|1|||
124820360|NCT00638378|448968817|FG000|Overall Study|Disease progression|15|||
124820361|NCT00638378|448968817|FG000|Overall Study|Physician Decision|4|||
124820362|NCT01852110|448968818|FG000|Overall Study|Adverse Event|12|||
124820363|NCT01852110|448968819|FG001|Overall Study|Adverse Event|5|||
124820364|NCT01852110|448968820|FG002|Overall Study|Adverse Event|0|||
124820365|NCT01852110|448968821|FG003|Overall Study|Adverse Event|0|||
124820366|NCT01852110|448968822|FG004|Overall Study|Adverse Event|0|||
124820367|NCT01852110|448968823|FG005|Overall Study|Adverse Event|0|||
124820368|NCT01852110|448968818|FG000|Overall Study|Lost to Follow-up|1|||
124820369|NCT01852110|448968819|FG001|Overall Study|Lost to Follow-up|3|||
124820370|NCT01852110|448968820|FG002|Overall Study|Lost to Follow-up|0|||
124820371|NCT01852110|448968821|FG003|Overall Study|Lost to Follow-up|0|||
124820372|NCT01852110|448968822|FG004|Overall Study|Lost to Follow-up|0|||
124820373|NCT01852110|448968823|FG005|Overall Study|Lost to Follow-up|0|||
124820374|NCT01852110|448968818|FG000|Overall Study|Non-compliance with Study Drug|2|||
124820375|NCT01852110|448968819|FG001|Overall Study|Non-compliance with Study Drug|1|||
124820376|NCT01852110|448968820|FG002|Overall Study|Non-compliance with Study Drug|0|||
124820377|NCT01852110|448968821|FG003|Overall Study|Non-compliance with Study Drug|0|||
124820378|NCT01852110|448968822|FG004|Overall Study|Non-compliance with Study Drug|0|||
124820379|NCT01852110|448968823|FG005|Overall Study|Non-compliance with Study Drug|0|||
124820380|NCT01852110|448968818|FG000|Overall Study|Physician Decision|1|||
124820381|NCT01852110|448968819|FG001|Overall Study|Physician Decision|0|||
124820382|NCT01852110|448968820|FG002|Overall Study|Physician Decision|0|||
124820383|NCT01852110|448968821|FG003|Overall Study|Physician Decision|0|||
124820384|NCT01852110|448968822|FG004|Overall Study|Physician Decision|0|||
124820385|NCT01852110|448968823|FG005|Overall Study|Physician Decision|0|||
124820386|NCT01852110|448968818|FG000|Overall Study|Protocol Violation|0|||
124820387|NCT01852110|448968819|FG001|Overall Study|Protocol Violation|1|||
124820388|NCT01852110|448968820|FG002|Overall Study|Protocol Violation|0|||
124820389|NCT01852110|448968821|FG003|Overall Study|Protocol Violation|0|||
124820390|NCT01852110|448968822|FG004|Overall Study|Protocol Violation|0|||
124820391|NCT01852110|448968823|FG005|Overall Study|Protocol Violation|0|||
124820392|NCT01852110|448968818|FG000|Overall Study|Study Terminated by Sponsor|30|||
124820393|NCT01852110|448968819|FG001|Overall Study|Study Terminated by Sponsor|32|||
124820394|NCT01852110|448968820|FG002|Overall Study|Study Terminated by Sponsor|0|||
124820395|NCT01852110|448968821|FG003|Overall Study|Study Terminated by Sponsor|0|||
124820396|NCT01852110|448968822|FG004|Overall Study|Study Terminated by Sponsor|0|||
124820397|NCT01852110|448968823|FG005|Overall Study|Study Terminated by Sponsor|0|||
124820398|NCT01852110|448968818|FG000|Overall Study|Withdrawal by Subject|4|||
124820399|NCT01852110|448968819|FG001|Overall Study|Withdrawal by Subject|4|||
124820400|NCT01852110|448968820|FG002|Overall Study|Withdrawal by Subject|0|||
124820401|NCT01852110|448968821|FG003|Overall Study|Withdrawal by Subject|0|||
124820402|NCT01852110|448968822|FG004|Overall Study|Withdrawal by Subject|0|||
124820403|NCT01852110|448968823|FG005|Overall Study|Withdrawal by Subject|0|||
124820404|NCT00759031|448968824|FG000|First Intervention (1 Day)|Physician Decision|1|||
124820405|NCT00759031|448968825|FG001|First Intervention (1 Day)|Physician Decision|0|||
124820406|NCT00759031|448968824|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
124820407|NCT00759031|448968825|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
124820408|NCT00759031|448968824|FG000|First Intervention (1 Day)|Screening failure|1|||
124820409|NCT00759031|448968825|FG001|First Intervention (1 Day)|Screening failure|0|||
124820410|NCT02430311|448968826|FG000|Part A|Adverse Event|0|||
124820411|NCT02430311|448968827|FG001|Part A|Adverse Event|1|||
124820412|NCT02430311|448968826|FG000|Part A|Withdrawal by Subject|1|||
124820413|NCT02430311|448968827|FG001|Part A|Withdrawal by Subject|0|||
124820414|NCT02430311|448968826|FG000|Part B|Meet study-specific withdrawal criteria|6|||
124820415|NCT02430311|448968827|FG001|Part B|Meet study-specific withdrawal criteria|6|||
124820416|NCT02430311|448968826|FG000|Part B|Withdrawal by Subject|2|||
124820417|NCT02430311|448968827|FG001|Part B|Withdrawal by Subject|2|||
124820418|NCT02430311|448968826|FG000|Part B|Adverse Event|1|||
124820419|NCT02430311|448968827|FG001|Part B|Adverse Event|0|||
124820420|NCT02430311|448968826|FG000|Part B|Death|1|||
124637922|NCT02347774|448292491|FG002|Study Participation|Adverse Event|6|||
124637923|NCT02347774|448292489|FG000|Study Participation|withdrew consent|1|||
124637924|NCT02347774|448292490|FG001|Study Participation|withdrew consent|1|||
124637925|NCT02347774|448292491|FG002|Study Participation|withdrew consent|1|||
124820421|NCT02430311|448968827|FG001|Part B|Death|0|||
124820422|NCT04180488|448968828|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
124820423|NCT04180488|448968829|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
124820424|NCT04180488|448968830|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
124820425|NCT04180488|448968831|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
124820426|NCT04180488|448968832|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
124820427|NCT04180488|448968833|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
124820428|NCT04180488|448968828|FG000|Overall Study|Withdrawal by Subject|8|||
124637926|NCT02347774|448292489|FG000|Study Participation|Met Prolonged QT criteria|1|||
124637927|NCT02347774|448292490|FG001|Study Participation|Met Prolonged QT criteria|0|||
124637928|NCT02347774|448292491|FG002|Study Participation|Met Prolonged QT criteria|0|||
124637929|NCT02347774|448292489|FG000|Study Participation|non-compliance with study drug|0|||
124637930|NCT02347774|448292490|FG001|Study Participation|non-compliance with study drug|1|||
124820429|NCT04180488|448968829|FG001|Overall Study|Withdrawal by Subject|4|||
124820430|NCT04180488|448968830|FG002|Overall Study|Withdrawal by Subject|5|||
124820431|NCT04180488|448968831|FG003|Overall Study|Withdrawal by Subject|2|||
124820432|NCT04180488|448968832|FG004|Overall Study|Withdrawal by Subject|8|||
124820433|NCT04180488|448968833|FG005|Overall Study|Withdrawal by Subject|6|||
124820434|NCT04180488|448968828|FG000|Overall Study|Adverse Event|3|||
124820435|NCT04180488|448968829|FG001|Overall Study|Adverse Event|2|||
124820436|NCT04180488|448968830|FG002|Overall Study|Adverse Event|0|||
124820437|NCT04180488|448968831|FG003|Overall Study|Adverse Event|0|||
124637931|NCT02347774|448292491|FG002|Study Participation|non-compliance with study drug|0|||
124637932|NCT02347774|448292489|FG000|Study Participation|incarceration|1|||
124820438|NCT04180488|448968832|FG004|Overall Study|Adverse Event|0|||
124820439|NCT04180488|448968833|FG005|Overall Study|Adverse Event|0|||
124820440|NCT04180488|448968828|FG000|Overall Study|Poor compliance to protocol|0|||
124820441|NCT04180488|448968829|FG001|Overall Study|Poor compliance to protocol|0|||
124820442|NCT04180488|448968830|FG002|Overall Study|Poor compliance to protocol|1|||
124820443|NCT04180488|448968831|FG003|Overall Study|Poor compliance to protocol|0|||
124820444|NCT04180488|448968832|FG004|Overall Study|Poor compliance to protocol|0|||
124820445|NCT04180488|448968833|FG005|Overall Study|Poor compliance to protocol|0|||
124820446|NCT00381095|448968841|FG000|Overall Study|Death|3|||
124820447|NCT00381095|448968842|FG001|Overall Study|Death|4|||
124820448|NCT00381095|448968841|FG000|Overall Study|Lack of Efficacy|2|||
124820449|NCT00381095|448968842|FG001|Overall Study|Lack of Efficacy|4|||
124820450|NCT00381095|448968841|FG000|Overall Study|Other|2|||
124820451|NCT00381095|448968842|FG001|Overall Study|Other|2|||
124820452|NCT00381095|448968841|FG000|Overall Study|Protocol Violation|1|||
124820453|NCT00381095|448968842|FG001|Overall Study|Protocol Violation|1|||
124820454|NCT00381095|448968841|FG000|Overall Study|Withdrawal by Subject|3|||
124820455|NCT00381095|448968842|FG001|Overall Study|Withdrawal by Subject|3|||
124820456|NCT00381095|448968841|FG000|Overall Study|Adverse Event|2|||
124820457|NCT00381095|448968842|FG001|Overall Study|Adverse Event|7|||
124820458|NCT01104493|448968843|FG000|Overall Study|Lost to Follow-up|0|||
124820459|NCT01104493|448968844|FG001|Overall Study|Lost to Follow-up|2|||
124820460|NCT01342796|448968846|FG000|Overall Study|Withdrawal by Subject|2|||
124820461|NCT01342796|448968847|FG001|Overall Study|Withdrawal by Subject|0|||
124820462|NCT01342796|448968846|FG000|Overall Study|Lost to Follow-up|0|||
124820463|NCT01342796|448968847|FG001|Overall Study|Lost to Follow-up|3|||
124820464|NCT01342796|448968846|FG000|Overall Study|Inappropriate enrollment|1|||
124820465|NCT01342796|448968847|FG001|Overall Study|Inappropriate enrollment|0|||
124820466|NCT01599234|448968848|FG000|Overall Study|Adverse Event|9|||
124820467|NCT01599234|448968849|FG001|Overall Study|Adverse Event|5|||
124820468|NCT01599234|448968848|FG000|Overall Study|Withdrawal by Subject|2|||
124820469|NCT01599234|448968849|FG001|Overall Study|Withdrawal by Subject|1|||
124820470|NCT01599234|448968848|FG000|Overall Study|Lost to Follow-up|1|||
124820471|NCT01599234|448968849|FG001|Overall Study|Lost to Follow-up|2|||
124820472|NCT01599234|448968848|FG000|Overall Study|Lack of Efficacy|2|||
124820473|NCT01599234|448968849|FG001|Overall Study|Lack of Efficacy|4|||
124820474|NCT01599234|448968848|FG000|Overall Study|Unable to operate spray|1|||
124820475|NCT01599234|448968849|FG001|Overall Study|Unable to operate spray|0|||
124820476|NCT01599234|448968848|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
124820477|NCT01599234|448968849|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
124820478|NCT01599234|448968848|FG000|Overall Study|Death|1|||
124820479|NCT01599234|448968849|FG001|Overall Study|Death|0|||
124820480|NCT01599234|448968848|FG000|Overall Study|Patient would not stop driving|1|||
124820481|NCT01599234|448968849|FG001|Overall Study|Patient would not stop driving|0|||
124820482|NCT01599234|448968848|FG000|Overall Study|Contra-indication discovered|0|||
124820483|NCT01599234|448968849|FG001|Overall Study|Contra-indication discovered|1|||
124820484|NCT01599234|448968848|FG000|Overall Study|Pregnancy|0|||
124820485|NCT01599234|448968849|FG001|Overall Study|Pregnancy|1|||
124820486|NCT02433483|448968850|FG000|Overall Study|Unacceptable toxicity|1|||
124820487|NCT02433483|448968850|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
124820488|NCT03489720|448968851|FG000|Overall Study|Withdrawal by Subject|2|||
124820489|NCT03489720|448968852|FG001|Overall Study|Withdrawal by Subject|0|||
124820490|NCT03342690|448968853|FG000|Overall Study|Missing Information|9|||
124820491|NCT03342690|448968853|FG000|Overall Study|Protocol Violation|16|||
124820492|NCT04626297|448968856|FG000|Overall Study|Adverse Event|5|||
124820493|NCT04626297|448968857|FG001|Overall Study|Adverse Event|3|||
124820494|NCT04626297|448968856|FG000|Overall Study|Lost to Follow-up|7|||
124820495|NCT04626297|448968857|FG001|Overall Study|Lost to Follow-up|3|||
124820496|NCT04626297|448968856|FG000|Overall Study|Protocol Violation|5|||
124637933|NCT02347774|448292490|FG001|Study Participation|incarceration|0|||
124637934|NCT02347774|448292491|FG002|Study Participation|incarceration|0|||
124820497|NCT04626297|448968857|FG001|Overall Study|Protocol Violation|1|||
124820498|NCT04626297|448968856|FG000|Overall Study|Withdrawal by Subject|20|||
124820499|NCT04626297|448968857|FG001|Overall Study|Withdrawal by Subject|6|||
124820500|NCT04626297|448968856|FG000|Overall Study|Sponsor decision|2|||
124820501|NCT04626297|448968857|FG001|Overall Study|Sponsor decision|1|||
124820502|NCT03167411|448968858|FG000|Overall Study|Adverse Event|0|||
124820503|NCT03167411|448968859|FG001|Overall Study|Adverse Event|1|||
124820504|NCT02651922|448968863|FG000|Overall Study|due to exclusion criteria|2|||
124820505|NCT00729651|448968864|FG000|Overall Study|Withdrawal by Subject|5|||
124820506|NCT00729651|448968865|FG001|Overall Study|Withdrawal by Subject|6|||
124820507|NCT00729651|448968864|FG000|Overall Study|Lost to Follow-up|5|||
124637935|NCT02347774|448292489|FG000|Study Participation|randomized in error|0|||
124820508|NCT00729651|448968865|FG001|Overall Study|Lost to Follow-up|4|||
124820509|NCT00729651|448968864|FG000|Overall Study|Protocol Violation|0|||
124820510|NCT00729651|448968865|FG001|Overall Study|Protocol Violation|1|||
124820511|NCT00729651|448968864|FG000|Overall Study|Adverse Event|7|||
124820512|NCT00729651|448968865|FG001|Overall Study|Adverse Event|3|||
124820513|NCT00729651|448968864|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
124820514|NCT00729651|448968865|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
124820515|NCT00729651|448968864|FG000|Overall Study|Subject's private reason|2|||
124820516|NCT00729651|448968865|FG001|Overall Study|Subject's private reason|0|||
124820517|NCT01950741|448968876|FG000|Overall Study|Lost to Follow-up|1|||
124820518|NCT01950741|448968876|FG000|Overall Study|Death|1|||
124820519|NCT01950741|448968876|FG000|Overall Study|Withdrawal by Subject|1|||
124820520|NCT02521870|448968877|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820521|NCT02521870|448968878|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
124820522|NCT02521870|448968879|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820523|NCT02521870|448968880|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820524|NCT02521870|448968881|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820525|NCT02521870|448968882|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820526|NCT02521870|448968883|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820527|NCT02521870|448968884|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820528|NCT02521870|448968885|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820529|NCT02521870|448968886|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820530|NCT02521870|448968887|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820531|NCT02521870|448968888|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
124820532|NCT02521870|448968877|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
124820533|NCT02521870|448968878|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
124820534|NCT02521870|448968879|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
124820535|NCT02521870|448968880|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
124820536|NCT02521870|448968881|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
124820537|NCT02521870|448968882|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
124820538|NCT02521870|448968883|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
124820539|NCT02521870|448968884|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
124820540|NCT02521870|448968885|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
124820541|NCT02521870|448968886|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
124820542|NCT02521870|448968887|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
124820543|NCT02521870|448968888|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
124820544|NCT02521870|448968877|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
124820545|NCT02521870|448968878|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
124820546|NCT02521870|448968879|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
124820547|NCT02521870|448968880|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
124820548|NCT02521870|448968881|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
124820549|NCT02521870|448968882|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
124820550|NCT02521870|448968883|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
124820551|NCT02521870|448968884|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
124820552|NCT02521870|448968885|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
124820553|NCT02521870|448968886|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
124820554|NCT02521870|448968887|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
124820555|NCT02521870|448968888|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
124820556|NCT02521870|448968877|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124820557|NCT02521870|448968878|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124820558|NCT02521870|448968879|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124820559|NCT02521870|448968880|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124820560|NCT02521870|448968881|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
124820561|NCT02521870|448968882|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
124820562|NCT02521870|448968883|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
124820563|NCT02521870|448968884|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124820564|NCT02521870|448968885|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
124820565|NCT02521870|448968886|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
124820566|NCT02521870|448968887|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
124820567|NCT02521870|448968888|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
124637936|NCT02347774|448292490|FG001|Study Participation|randomized in error|0|||
124637937|NCT02347774|448292491|FG002|Study Participation|randomized in error|1|||
124637938|NCT02347774|448292489|FG000|On Study Treatment|Adverse Event|9|||
124637939|NCT02347774|448292490|FG001|On Study Treatment|Adverse Event|15|||
124637940|NCT02347774|448292491|FG002|On Study Treatment|Adverse Event|19|||
124637941|NCT02347774|448292489|FG000|On Study Treatment|Lack of Efficacy|3|||
124820568|NCT02521870|448968877|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
124820569|NCT02521870|448968878|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
124820570|NCT02521870|448968879|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
124820571|NCT02521870|448968880|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
124820572|NCT02521870|448968881|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
124820573|NCT02521870|448968882|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
124820574|NCT02521870|448968883|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
124820575|NCT02521870|448968884|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
124820576|NCT02521870|448968885|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
124820577|NCT02521870|448968886|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
124820578|NCT02521870|448968887|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
124820579|NCT02521870|448968888|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
124820580|NCT02521870|448968877|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
124820581|NCT02521870|448968878|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
124820582|NCT02521870|448968879|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
124820583|NCT02521870|448968880|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
124820584|NCT02521870|448968881|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
124820585|NCT02521870|448968882|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
124820586|NCT02521870|448968883|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
124820587|NCT02521870|448968884|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
124820588|NCT02521870|448968885|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
124820589|NCT02521870|448968886|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
124820590|NCT02521870|448968887|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
124820591|NCT02521870|448968888|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
124820592|NCT02521870|448968877|FG000|Phase 2: Dose Expansion|Death|0|||
124820593|NCT02521870|448968878|FG001|Phase 2: Dose Expansion|Death|0|||
124820594|NCT02521870|448968879|FG002|Phase 2: Dose Expansion|Death|0|||
124820595|NCT02521870|448968880|FG003|Phase 2: Dose Expansion|Death|0|||
124820596|NCT02521870|448968881|FG004|Phase 2: Dose Expansion|Death|1|||
124820597|NCT02521870|448968882|FG005|Phase 2: Dose Expansion|Death|1|||
124820598|NCT02521870|448968883|FG006|Phase 2: Dose Expansion|Death|3|||
124820599|NCT02521870|448968884|FG007|Phase 2: Dose Expansion|Death|1|||
124820600|NCT02521870|448968885|FG008|Phase 2: Dose Expansion|Death|1|||
124820601|NCT02521870|448968886|FG009|Phase 2: Dose Expansion|Death|5|||
124820602|NCT02521870|448968887|FG010|Phase 2: Dose Expansion|Death|2|||
124820603|NCT02521870|448968888|FG011|Phase 2: Dose Expansion|Death|2|||
124820604|NCT02521870|448968877|FG000|Phase 2: Dose Expansion|Other|0|||
124820605|NCT02521870|448968878|FG001|Phase 2: Dose Expansion|Other|0|||
124820606|NCT02521870|448968879|FG002|Phase 2: Dose Expansion|Other|0|||
124820607|NCT02521870|448968880|FG003|Phase 2: Dose Expansion|Other|0|||
124820608|NCT02521870|448968881|FG004|Phase 2: Dose Expansion|Other|10|||
124820609|NCT02521870|448968882|FG005|Phase 2: Dose Expansion|Other|3|||
124820610|NCT02521870|448968883|FG006|Phase 2: Dose Expansion|Other|2|||
124820611|NCT02521870|448968884|FG007|Phase 2: Dose Expansion|Other|0|||
124820612|NCT02521870|448968885|FG008|Phase 2: Dose Expansion|Other|10|||
124820613|NCT02521870|448968886|FG009|Phase 2: Dose Expansion|Other|5|||
124820614|NCT02521870|448968887|FG010|Phase 2: Dose Expansion|Other|1|||
124820615|NCT02521870|448968888|FG011|Phase 2: Dose Expansion|Other|7|||
124820616|NCT02521870|448968877|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820617|NCT02521870|448968878|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820618|NCT02521870|448968879|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820619|NCT02521870|448968880|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820620|NCT02521870|448968881|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
124820621|NCT02521870|448968882|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820622|NCT02521870|448968883|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820623|NCT02521870|448968884|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820624|NCT02521870|448968885|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820625|NCT02521870|448968886|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820626|NCT02521870|448968887|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820627|NCT02521870|448968888|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
124820628|NCT02521870|448968877|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820629|NCT02521870|448968878|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820630|NCT02521870|448968879|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820631|NCT02521870|448968880|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820632|NCT02521870|448968881|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
124820633|NCT02521870|448968882|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820634|NCT02521870|448968883|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820635|NCT02521870|448968884|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820636|NCT02521870|448968885|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820637|NCT02521870|448968886|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820638|NCT02521870|448968887|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820639|NCT02521870|448968888|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
124820640|NCT00519831|448968889|FG000|Overall Study|Adverse Event|3|||
124820641|NCT02854631|448968890|FG000|Overall Study|Adverse Event|1|||
124820642|NCT02854631|448968891|FG001|Overall Study|Adverse Event|2|||
124820643|NCT02854631|448968890|FG000|Overall Study|Withdrew Consent|3|||
124820644|NCT02854631|448968891|FG001|Overall Study|Withdrew Consent|2|||
124820645|NCT02854631|448968890|FG000|Overall Study|Investigator's Discretion|2|||
124820646|NCT02854631|448968891|FG001|Overall Study|Investigator's Discretion|0|||
124820647|NCT02854631|448968890|FG000|Overall Study|Death|12|||
124820648|NCT02854631|448968891|FG001|Overall Study|Death|8|||
124820649|NCT02854631|448968890|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
124820650|NCT02854631|448968891|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
124820651|NCT02854631|448968890|FG000|Overall Study|Protocol Violation|0|||
124820652|NCT02854631|448968891|FG001|Overall Study|Protocol Violation|1|||
124820653|NCT02854631|448968890|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
124820654|NCT02854631|448968891|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
124820655|NCT02854631|448968890|FG000|Overall Study|Lost to Follow-up|4|||
124820656|NCT02854631|448968891|FG001|Overall Study|Lost to Follow-up|2|||
124820657|NCT04656691|448968897|FG000|Overall Study|Adverse Event|1|||
124820658|NCT00600483|448968898|FG000|Overall Study|Lost to Follow-up|26|||
124820659|NCT00600483|448968899|FG001|Overall Study|Lost to Follow-up|47|||
124820660|NCT00600483|448968898|FG000|Overall Study|Randomized but not treated|10|||
124820661|NCT00600483|448968899|FG001|Overall Study|Randomized but not treated|0|||
124820662|NCT01482884|448968905|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
124820663|NCT01482884|448968906|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
124820664|NCT01482884|448968905|FG000|Overall Study|Protocol Violation|1|||
124820665|NCT01482884|448968906|FG001|Overall Study|Protocol Violation|0|||
124820666|NCT01482884|448968905|FG000|Overall Study|Lost to Follow-up|2|||
124820667|NCT01482884|448968906|FG001|Overall Study|Lost to Follow-up|2|||
124820668|NCT01482884|448968905|FG000|Overall Study|Lack of Efficacy|0|||
124820669|NCT01482884|448968906|FG001|Overall Study|Lack of Efficacy|1|||
124820670|NCT01482884|448968905|FG000|Overall Study|Adverse Event|2|||
124820671|NCT01482884|448968906|FG001|Overall Study|Adverse Event|1|||
124820672|NCT01482884|448968905|FG000|Overall Study|Withdrawal by Subject|8|||
124820673|NCT01482884|448968906|FG001|Overall Study|Withdrawal by Subject|13|||
124820674|NCT04102020|448968907|FG000|Overall Study|Adverse Event|1|||
124820675|NCT04102020|448968908|FG001|Overall Study|Adverse Event|0|||
124820676|NCT04102020|448968909|FG002|Overall Study|Adverse Event|0|||
124820677|NCT04102020|448968910|FG003|Overall Study|Adverse Event|1|||
124820678|NCT04102020|448968911|FG004|Overall Study|Adverse Event|0|||
124820679|NCT04102020|448968907|FG000|Overall Study|Withdrawal by Subject|0|||
124820680|NCT04102020|448968908|FG001|Overall Study|Withdrawal by Subject|1|||
124820681|NCT04102020|448968909|FG002|Overall Study|Withdrawal by Subject|1|||
124820682|NCT04102020|448968910|FG003|Overall Study|Withdrawal by Subject|1|||
124820683|NCT04102020|448968911|FG004|Overall Study|Withdrawal by Subject|1|||
124820684|NCT04102020|448968907|FG000|Overall Study|Death|1|||
124820685|NCT04102020|448968908|FG001|Overall Study|Death|4|||
124820686|NCT04102020|448968909|FG002|Overall Study|Death|1|||
124820687|NCT04102020|448968910|FG003|Overall Study|Death|1|||
124820688|NCT04102020|448968911|FG004|Overall Study|Death|0|||
124820689|NCT04102020|448968907|FG000|Overall Study|Physician Decision|1|||
124820690|NCT04102020|448968908|FG001|Overall Study|Physician Decision|2|||
124820691|NCT04102020|448968909|FG002|Overall Study|Physician Decision|2|||
124820692|NCT04102020|448968910|FG003|Overall Study|Physician Decision|0|||
124820693|NCT04102020|448968911|FG004|Overall Study|Physician Decision|1|||
124820694|NCT04102020|448968907|FG000|Overall Study|COVID-19 Infection|1|||
124820695|NCT04102020|448968908|FG001|Overall Study|COVID-19 Infection|0|||
124820696|NCT04102020|448968909|FG002|Overall Study|COVID-19 Infection|0|||
124820697|NCT04102020|448968910|FG003|Overall Study|COVID-19 Infection|0|||
124820698|NCT04102020|448968911|FG004|Overall Study|COVID-19 Infection|0|||
124820699|NCT04102020|448968907|FG000|Overall Study|Not disclosed|5|||
124820700|NCT04102020|448968908|FG001|Overall Study|Not disclosed|3|||
124820701|NCT04102020|448968909|FG002|Overall Study|Not disclosed|8|||
124820702|NCT04102020|448968910|FG003|Overall Study|Not disclosed|0|||
124820703|NCT04102020|448968911|FG004|Overall Study|Not disclosed|1|||
124820704|NCT04102020|448968907|FG000|Overall Study|MIssing|1|||
124820705|NCT04102020|448968908|FG001|Overall Study|MIssing|0|||
124820706|NCT04102020|448968909|FG002|Overall Study|MIssing|1|||
124820707|NCT04102020|448968910|FG003|Overall Study|MIssing|1|||
124820708|NCT04102020|448968911|FG004|Overall Study|MIssing|1|||
124820709|NCT04102020|448968907|FG000|Overall Study|Continuing in ongoing study|13|||
124820710|NCT04102020|448968908|FG001|Overall Study|Continuing in ongoing study|13|||
124820711|NCT04102020|448968909|FG002|Overall Study|Continuing in ongoing study|7|||
124820712|NCT04102020|448968910|FG003|Overall Study|Continuing in ongoing study|26|||
124820713|NCT04102020|448968911|FG004|Overall Study|Continuing in ongoing study|12|||
124820714|NCT05980182|448968923|FG000|Overall Study|Lost to Follow-up|10|||
124820715|NCT04600921|448968924|FG000|Overall Study|Withdrawal by Subject|3|||
124820716|NCT04600921|448968925|FG001|Overall Study|Withdrawal by Subject|5|||
124637942|NCT02347774|448292490|FG001|On Study Treatment|Lack of Efficacy|0|||
124637943|NCT02347774|448292491|FG002|On Study Treatment|Lack of Efficacy|2|||
124820717|NCT04600921|448968924|FG000|Overall Study|Death|0|||
124820718|NCT04600921|448968925|FG001|Overall Study|Death|1|||
124820719|NCT00410046|448970835|FG000|Overall Study|Adverse Event|3|||
124820720|NCT00410046|448970835|FG000|Overall Study|Withdrawal by Subject|1|||
124820721|NCT00410046|448970835|FG000|Overall Study|Lost to Follow-up|1|||
124820722|NCT01384760|448970836|FG000|Overall Study|Lost to Follow-up|0|||
124820723|NCT01384760|448970837|FG001|Overall Study|Lost to Follow-up|6|||
124820724|NCT01384760|448970836|FG000|Overall Study|Protocol Violation|16|||
124820725|NCT01384760|448970837|FG001|Overall Study|Protocol Violation|0|||
124820726|NCT00963547|448970838|FG000|Overall Study|Adverse Event|0|||
124820727|NCT00963547|448970839|FG001|Overall Study|Adverse Event|1|||
124820728|NCT00963547|448970840|FG002|Overall Study|Adverse Event|0|||
124820729|NCT00963547|448970841|FG003|Overall Study|Adverse Event|1|||
124820730|NCT00963547|448970842|FG004|Overall Study|Adverse Event|0|||
124820731|NCT00963547|448970843|FG005|Overall Study|Adverse Event|0|||
124820732|NCT00963547|448970844|FG006|Overall Study|Adverse Event|0|||
124820733|NCT00963547|448970838|FG000|Overall Study|Physician Decision|1|||
124820734|NCT00963547|448970839|FG001|Overall Study|Physician Decision|1|||
124820735|NCT00963547|448970840|FG002|Overall Study|Physician Decision|0|||
124820736|NCT00963547|448970841|FG003|Overall Study|Physician Decision|0|||
124820737|NCT00963547|448970842|FG004|Overall Study|Physician Decision|0|||
124820738|NCT00963547|448970843|FG005|Overall Study|Physician Decision|0|||
124820739|NCT00963547|448970844|FG006|Overall Study|Physician Decision|0|||
124820740|NCT00963547|448970838|FG000|Overall Study|Progressive Disease|3|||
124820741|NCT00963547|448970839|FG001|Overall Study|Progressive Disease|8|||
124820742|NCT00963547|448970840|FG002|Overall Study|Progressive Disease|9|||
124820743|NCT00963547|448970841|FG003|Overall Study|Progressive Disease|5|||
124820744|NCT00963547|448970842|FG004|Overall Study|Progressive Disease|0|||
124820745|NCT00963547|448970843|FG005|Overall Study|Progressive Disease|0|||
124820746|NCT00963547|448970844|FG006|Overall Study|Progressive Disease|0|||
124820747|NCT00963547|448970838|FG000|Overall Study|Withdrawal by Subject|0|||
124820748|NCT00963547|448970839|FG001|Overall Study|Withdrawal by Subject|0|||
124820749|NCT00963547|448970840|FG002|Overall Study|Withdrawal by Subject|3|||
124820750|NCT00963547|448970841|FG003|Overall Study|Withdrawal by Subject|0|||
124820751|NCT00963547|448970842|FG004|Overall Study|Withdrawal by Subject|0|||
124820752|NCT00963547|448970843|FG005|Overall Study|Withdrawal by Subject|0|||
124820753|NCT00963547|448970844|FG006|Overall Study|Withdrawal by Subject|0|||
124820754|NCT00963547|448970838|FG000|Overall Study|Reason Unknown|0|||
124820755|NCT00963547|448970839|FG001|Overall Study|Reason Unknown|1|||
124820756|NCT00963547|448970840|FG002|Overall Study|Reason Unknown|0|||
124820757|NCT00963547|448970841|FG003|Overall Study|Reason Unknown|0|||
124820758|NCT00963547|448970842|FG004|Overall Study|Reason Unknown|0|||
124820759|NCT00963547|448970843|FG005|Overall Study|Reason Unknown|0|||
124820760|NCT00963547|448970844|FG006|Overall Study|Reason Unknown|0|||
124820761|NCT00482612|448970851|FG000|In-treatment Period|No study medication administered|0|||
124820762|NCT00482612|448970852|FG001|In-treatment Period|No study medication administered|0|||
124820763|NCT00482612|448970853|FG002|In-treatment Period|No study medication administered|1|||
124820764|NCT00482612|448970854|FG003|In-treatment Period|No study medication administered|0|||
124820765|NCT00482612|448970851|FG000|Follow-up Period|Other|4|||
124820766|NCT00482612|448970852|FG001|Follow-up Period|Other|2|||
124820767|NCT00482612|448970853|FG002|Follow-up Period|Other|1|||
124820768|NCT00482612|448970854|FG003|Follow-up Period|Other|2|||
124820769|NCT00482612|448970851|FG000|Follow-up Period|Lack of compliance|0|||
124820770|NCT00482612|448970852|FG001|Follow-up Period|Lack of compliance|0|||
124820771|NCT00482612|448970853|FG002|Follow-up Period|Lack of compliance|1|||
124820772|NCT00482612|448970854|FG003|Follow-up Period|Lack of compliance|0|||
124820773|NCT00482612|448970851|FG000|Follow-up Period|Lost to Follow-up|0|||
124820774|NCT00482612|448970852|FG001|Follow-up Period|Lost to Follow-up|4|||
124820775|NCT00482612|448970853|FG002|Follow-up Period|Lost to Follow-up|2|||
124820776|NCT00482612|448970854|FG003|Follow-up Period|Lost to Follow-up|1|||
124820777|NCT00482612|448970851|FG000|Follow-up Period|Adverse Event|4|||
124820778|NCT00482612|448970852|FG001|Follow-up Period|Adverse Event|7|||
124820779|NCT00482612|448970853|FG002|Follow-up Period|Adverse Event|9|||
124820780|NCT00482612|448970854|FG003|Follow-up Period|Adverse Event|0|||
124820781|NCT00482612|448970851|FG000|Follow-up Period|Lack of Efficacy|2|||
124820782|NCT00482612|448970852|FG001|Follow-up Period|Lack of Efficacy|0|||
124820783|NCT00482612|448970853|FG002|Follow-up Period|Lack of Efficacy|1|||
124820784|NCT00482612|448970854|FG003|Follow-up Period|Lack of Efficacy|0|||
124820785|NCT00482612|448970851|FG000|Follow-up Period|Withdrawal by Subject|3|||
124820786|NCT00482612|448970852|FG001|Follow-up Period|Withdrawal by Subject|5|||
124820787|NCT00482612|448970853|FG002|Follow-up Period|Withdrawal by Subject|7|||
124820788|NCT00482612|448970854|FG003|Follow-up Period|Withdrawal by Subject|2|||
124820789|NCT00482612|448970851|FG000|Follow-up Period|Reasons not related to trial|1|||
124820790|NCT00482612|448970852|FG001|Follow-up Period|Reasons not related to trial|0|||
124820791|NCT00482612|448970853|FG002|Follow-up Period|Reasons not related to trial|1|||
124820792|NCT00482612|448970854|FG003|Follow-up Period|Reasons not related to trial|3|||
124820793|NCT01366521|448970855|FG000|Overall Study|Adverse Event|1|||
124820794|NCT01366521|448970856|FG001|Overall Study|Adverse Event|0|||
124820795|NCT01366521|448970857|FG002|Overall Study|Adverse Event|0|||
124820796|NCT01366521|448970858|FG003|Overall Study|Adverse Event|0|||
124820797|NCT01366521|448970855|FG000|Overall Study|Protocol Violation|0|||
124820798|NCT01366521|448970856|FG001|Overall Study|Protocol Violation|0|||
124820799|NCT01366521|448970857|FG002|Overall Study|Protocol Violation|1|||
124820800|NCT01366521|448970858|FG003|Overall Study|Protocol Violation|0|||
124820801|NCT01366521|448970855|FG000|Overall Study|Physician Decision|0|||
124820802|NCT01366521|448970856|FG001|Overall Study|Physician Decision|0|||
124820803|NCT01366521|448970857|FG002|Overall Study|Physician Decision|1|||
124820804|NCT01366521|448970858|FG003|Overall Study|Physician Decision|0|||
124820805|NCT01366521|448970855|FG000|Overall Study|Withdrawal by Subject|0|||
124820806|NCT01366521|448970856|FG001|Overall Study|Withdrawal by Subject|1|||
124820807|NCT01366521|448970857|FG002|Overall Study|Withdrawal by Subject|0|||
124820808|NCT01366521|448970858|FG003|Overall Study|Withdrawal by Subject|0|||
124820809|NCT00660023|448970859|FG000|Overall Study|Adverse Event|2|||
124820810|NCT00660023|448970859|FG000|Overall Study|Death|8|||
124820811|NCT00660023|448970859|FG000|Overall Study|Blood Transfusion|5|||
124820812|NCT00660023|448970859|FG000|Overall Study|Renal Transplantation|3|||
124820813|NCT00660023|448970859|FG000|Overall Study|Withdrawal by Subject|1|||
124820814|NCT00660023|448970859|FG000|Overall Study|Missed Pregnancy Test|1|||
124820815|NCT00660023|448970859|FG000|Overall Study|Other Screening Failure|9|||
124820816|NCT00684307|448970860|FG000|Overall Study|Adverse Event|11|||
124820817|NCT00684307|448970861|FG001|Overall Study|Adverse Event|6|||
124820818|NCT00684307|448970862|FG002|Overall Study|Adverse Event|15|||
124820819|NCT00684307|448970863|FG003|Overall Study|Adverse Event|16|||
124820820|NCT00684307|448970864|FG004|Overall Study|Adverse Event|8|||
124820821|NCT00684307|448970860|FG000|Overall Study|Development of increasing Liver Function|0|||
124820822|NCT00684307|448970861|FG001|Overall Study|Development of increasing Liver Function|2|||
124820823|NCT00684307|448970862|FG002|Overall Study|Development of increasing Liver Function|0|||
124820824|NCT00684307|448970863|FG003|Overall Study|Development of increasing Liver Function|1|||
124820825|NCT00684307|448970864|FG004|Overall Study|Development of increasing Liver Function|0|||
124820826|NCT00684307|448970860|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
124820827|NCT00684307|448970861|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
124820828|NCT00684307|448970862|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
124820829|NCT00684307|448970863|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
124820830|NCT00684307|448970864|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
124820831|NCT00684307|448970860|FG000|Overall Study|Incorrect enrolment or randomization|4|||
124820832|NCT00684307|448970861|FG001|Overall Study|Incorrect enrolment or randomization|0|||
124820833|NCT00684307|448970862|FG002|Overall Study|Incorrect enrolment or randomization|0|||
124820834|NCT00684307|448970863|FG003|Overall Study|Incorrect enrolment or randomization|0|||
124820835|NCT00684307|448970864|FG004|Overall Study|Incorrect enrolment or randomization|0|||
124820836|NCT00684307|448970860|FG000|Overall Study|Interupted IP for more than 7 days|0|||
124820837|NCT00684307|448970861|FG001|Overall Study|Interupted IP for more than 7 days|4|||
124820838|NCT00684307|448970862|FG002|Overall Study|Interupted IP for more than 7 days|1|||
124820839|NCT00684307|448970863|FG003|Overall Study|Interupted IP for more than 7 days|3|||
124820840|NCT00684307|448970864|FG004|Overall Study|Interupted IP for more than 7 days|3|||
124820841|NCT00684307|448970860|FG000|Overall Study|Severe non compliance to protocol|1|||
124820842|NCT00684307|448970861|FG001|Overall Study|Severe non compliance to protocol|0|||
124820843|NCT00684307|448970862|FG002|Overall Study|Severe non compliance to protocol|0|||
124820844|NCT00684307|448970863|FG003|Overall Study|Severe non compliance to protocol|1|||
124820845|NCT00684307|448970864|FG004|Overall Study|Severe non compliance to protocol|2|||
124820846|NCT00684307|448970860|FG000|Overall Study|Participant not willing to continue|7|||
124820847|NCT00684307|448970861|FG001|Overall Study|Participant not willing to continue|10|||
124820848|NCT00684307|448970862|FG002|Overall Study|Participant not willing to continue|11|||
124820849|NCT00684307|448970863|FG003|Overall Study|Participant not willing to continue|5|||
124820850|NCT00684307|448970864|FG004|Overall Study|Participant not willing to continue|8|||
124820851|NCT00684307|448970860|FG000|Overall Study|Criteria from the CSR|0|||
124820852|NCT00684307|448970861|FG001|Overall Study|Criteria from the CSR|0|||
124820853|NCT00684307|448970862|FG002|Overall Study|Criteria from the CSR|1|||
124820854|NCT00684307|448970863|FG003|Overall Study|Criteria from the CSR|3|||
124820855|NCT00684307|448970864|FG004|Overall Study|Criteria from the CSR|3|||
124820856|NCT03506815|448970865|FG000|Overall Study|Adverse Event|8|||
124820857|NCT03506815|448970866|FG001|Overall Study|Adverse Event|0|||
124820858|NCT03506815|448970865|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
124820859|NCT03506815|448970866|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
124820860|NCT03506815|448970865|FG000|Overall Study|Protocol Violation|1|||
124820861|NCT03506815|448970866|FG001|Overall Study|Protocol Violation|0|||
124820862|NCT03506815|448970865|FG000|Overall Study|Elective Surgery|1|||
124820863|NCT03506815|448970866|FG001|Overall Study|Elective Surgery|0|||
124820864|NCT04160091|448970867|FG000|Overall Study|Terminated by Sponsor|7|||
124820865|NCT04160091|448970868|FG001|Overall Study|Terminated by Sponsor|3|||
124820866|NCT04160091|448970869|FG002|Overall Study|Terminated by Sponsor|5|||
124820867|NCT04160091|448970870|FG003|Overall Study|Terminated by Sponsor|2|||
124820868|NCT04160091|448970867|FG000|Overall Study|Noncompliance|0|||
124820869|NCT04160091|448970868|FG001|Overall Study|Noncompliance|0|||
124820870|NCT04160091|448970869|FG002|Overall Study|Noncompliance|0|||
124820871|NCT04160091|448970870|FG003|Overall Study|Noncompliance|1|||
124820872|NCT04160091|448970867|FG000|Overall Study|Withdrawal by Subject|0|||
124820873|NCT04160091|448970868|FG001|Overall Study|Withdrawal by Subject|0|||
124820874|NCT04160091|448970869|FG002|Overall Study|Withdrawal by Subject|0|||
124637944|NCT02347774|448292489|FG000|On Study Treatment|non-complicance with study medication|0|||
124820875|NCT04160091|448970870|FG003|Overall Study|Withdrawal by Subject|1|||
124820876|NCT02899988|448970872|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
124820877|NCT02899988|448970873|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
124820878|NCT02899988|448970874|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820879|NCT02899988|448970875|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820880|NCT02899988|448970876|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820881|NCT02899988|448970877|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820882|NCT02899988|448970878|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820883|NCT02899988|448970879|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820884|NCT02899988|448970880|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820885|NCT02899988|448970881|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820886|NCT02899988|448970882|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
124820887|NCT02899988|448970872|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
124820888|NCT02899988|448970873|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
124820889|NCT02899988|448970874|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
124820890|NCT02899988|448970875|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
124820891|NCT02899988|448970876|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
124820892|NCT02899988|448970877|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
124820893|NCT02899988|448970878|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
124820894|NCT02899988|448970879|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
124820895|NCT02899988|448970880|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
124820896|NCT02899988|448970881|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
124820897|NCT02899988|448970882|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
124820898|NCT02899988|448970872|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
124820899|NCT02899988|448970873|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
124820900|NCT02899988|448970874|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
124820901|NCT02899988|448970875|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
124820902|NCT02899988|448970876|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
124820903|NCT02899988|448970877|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
124820904|NCT02899988|448970878|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
124820905|NCT02899988|448970879|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
124820906|NCT02899988|448970880|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
124820907|NCT02899988|448970881|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
124820908|NCT02899988|448970882|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
124820909|NCT02899988|448970872|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
124820910|NCT02899988|448970873|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
124820911|NCT02899988|448970874|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
124820912|NCT02899988|448970875|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
124820913|NCT02899988|448970876|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
124820914|NCT02899988|448970877|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
124820915|NCT02899988|448970878|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
124820916|NCT02899988|448970879|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
124820917|NCT02899988|448970880|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
124820918|NCT02899988|448970881|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
124820919|NCT02899988|448970882|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
124820920|NCT02899988|448970872|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820921|NCT02899988|448970873|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820922|NCT02899988|448970874|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820923|NCT02899988|448970875|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820924|NCT02899988|448970876|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820925|NCT02899988|448970877|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
124820926|NCT02899988|448970878|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820927|NCT02899988|448970879|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
124820928|NCT02899988|448970880|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820929|NCT02899988|448970881|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820930|NCT02899988|448970882|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
124820931|NCT02899988|448970872|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
124820932|NCT02899988|448970873|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
124637945|NCT02347774|448292490|FG001|On Study Treatment|non-complicance with study medication|2|||
124637946|NCT02347774|448292491|FG002|On Study Treatment|non-complicance with study medication|0|||
124820933|NCT02899988|448970874|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
124820934|NCT02899988|448970875|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
124820935|NCT02899988|448970876|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
124820936|NCT02899988|448970877|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
124820937|NCT02899988|448970878|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
124820938|NCT02899988|448970879|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
124820939|NCT02899988|448970880|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
124820940|NCT02899988|448970881|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
124637947|NCT02347774|448292489|FG000|On Study Treatment|Protocol Violation|0|||
124820941|NCT02899988|448970882|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
124637948|NCT02347774|448292490|FG001|On Study Treatment|Protocol Violation|0|||
124820942|NCT01059825|448970884|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
124820943|NCT01059825|448970885|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
124820944|NCT01059825|448970886|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
124820945|NCT01059825|448970887|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
124820946|NCT01059825|448970888|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
124820947|NCT01059825|448970889|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
124820948|NCT01059825|448970890|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
124820949|NCT01059825|448970884|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
124820950|NCT01059825|448970885|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
124820951|NCT01059825|448970886|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
124820952|NCT01059825|448970887|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
124820953|NCT01059825|448970888|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
124820954|NCT01059825|448970889|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
124820955|NCT01059825|448970890|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
124820956|NCT01059825|448970884|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
124820957|NCT01059825|448970885|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
124820958|NCT01059825|448970886|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
124820959|NCT01059825|448970887|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
124820960|NCT01059825|448970888|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
124820961|NCT01059825|448970889|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
124820962|NCT01059825|448970890|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
124820963|NCT01059825|448970884|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
124820964|NCT01059825|448970885|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
124820965|NCT01059825|448970886|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
124820966|NCT01059825|448970887|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
124820967|NCT01059825|448970888|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
124820968|NCT01059825|448970889|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
124820969|NCT01059825|448970890|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
124820970|NCT01059825|448970884|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
124820971|NCT01059825|448970885|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
124820972|NCT01059825|448970886|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
124820973|NCT01059825|448970887|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
124820974|NCT01059825|448970888|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
124820975|NCT01059825|448970889|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
124820976|NCT01059825|448970890|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
124820977|NCT01059825|448970884|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
124820978|NCT01059825|448970885|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
124820979|NCT01059825|448970886|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
124820980|NCT01059825|448970887|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
124820981|NCT01059825|448970888|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
124820982|NCT01059825|448970889|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
124820983|NCT01059825|448970890|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
124820984|NCT01059825|448970884|FG000|Treatment Period|Lost to Follow-up|2|||
124820985|NCT01059825|448970885|FG001|Treatment Period|Lost to Follow-up|1|||
124820986|NCT01059825|448970886|FG002|Treatment Period|Lost to Follow-up|0|||
124820987|NCT01059825|448970887|FG003|Treatment Period|Lost to Follow-up|1|||
124820988|NCT01059825|448970888|FG004|Treatment Period|Lost to Follow-up|2|||
124820989|NCT01059825|448970889|FG005|Treatment Period|Lost to Follow-up|0|||
124820990|NCT01059825|448970890|FG006|Treatment Period|Lost to Follow-up|0|||
124820991|NCT01059825|448970884|FG000|Treatment Period|Withdrawal by Subject|3|||
124820992|NCT01059825|448970885|FG001|Treatment Period|Withdrawal by Subject|0|||
124820993|NCT01059825|448970886|FG002|Treatment Period|Withdrawal by Subject|1|||
124820994|NCT01059825|448970887|FG003|Treatment Period|Withdrawal by Subject|5|||
124820995|NCT01059825|448970888|FG004|Treatment Period|Withdrawal by Subject|4|||
124820996|NCT01059825|448970889|FG005|Treatment Period|Withdrawal by Subject|1|||
124820997|NCT01059825|448970890|FG006|Treatment Period|Withdrawal by Subject|0|||
124820998|NCT01059825|448970884|FG000|Treatment Period|Other reason not specified|1|||
124820999|NCT01059825|448970885|FG001|Treatment Period|Other reason not specified|2|||
124821000|NCT01059825|448970886|FG002|Treatment Period|Other reason not specified|1|||
124821001|NCT01059825|448970887|FG003|Treatment Period|Other reason not specified|2|||
124821002|NCT01059825|448970888|FG004|Treatment Period|Other reason not specified|0|||
124821003|NCT01059825|448970889|FG005|Treatment Period|Other reason not specified|0|||
124821004|NCT01059825|448970890|FG006|Treatment Period|Other reason not specified|0|||
124821005|NCT01059825|448970884|FG000|Treatment Period|Protocol Violation|0|||
124821006|NCT01059825|448970885|FG001|Treatment Period|Protocol Violation|0|||
124821007|NCT01059825|448970886|FG002|Treatment Period|Protocol Violation|1|||
124821008|NCT01059825|448970887|FG003|Treatment Period|Protocol Violation|1|||
124821009|NCT01059825|448970888|FG004|Treatment Period|Protocol Violation|1|||
124821010|NCT01059825|448970889|FG005|Treatment Period|Protocol Violation|1|||
124821011|NCT01059825|448970890|FG006|Treatment Period|Protocol Violation|0|||
124821012|NCT01059825|448970884|FG000|Treatment Period|Adverse event related to study drug|1|||
124821013|NCT01059825|448970885|FG001|Treatment Period|Adverse event related to study drug|0|||
124821014|NCT01059825|448970886|FG002|Treatment Period|Adverse event related to study drug|1|||
124821015|NCT01059825|448970887|FG003|Treatment Period|Adverse event related to study drug|1|||
124821016|NCT01059825|448970888|FG004|Treatment Period|Adverse event related to study drug|0|||
124821017|NCT01059825|448970889|FG005|Treatment Period|Adverse event related to study drug|0|||
124821018|NCT01059825|448970890|FG006|Treatment Period|Adverse event related to study drug|0|||
124821019|NCT01059825|448970884|FG000|Treatment Period|Insufficient clinical response|3|||
124821020|NCT01059825|448970885|FG001|Treatment Period|Insufficient clinical response|0|||
124821021|NCT01059825|448970886|FG002|Treatment Period|Insufficient clinical response|0|||
124821022|NCT01059825|448970887|FG003|Treatment Period|Insufficient clinical response|0|||
124821023|NCT01059825|448970888|FG004|Treatment Period|Insufficient clinical response|0|||
124821024|NCT01059825|448970889|FG005|Treatment Period|Insufficient clinical response|0|||
124821025|NCT01059825|448970890|FG006|Treatment Period|Insufficient clinical response|0|||
124821026|NCT01059825|448970884|FG000|Treatment Period|Adverse event not related to study drug|0|||
124821027|NCT01059825|448970885|FG001|Treatment Period|Adverse event not related to study drug|1|||
124821028|NCT01059825|448970886|FG002|Treatment Period|Adverse event not related to study drug|2|||
124821029|NCT01059825|448970887|FG003|Treatment Period|Adverse event not related to study drug|1|||
124821030|NCT01059825|448970888|FG004|Treatment Period|Adverse event not related to study drug|1|||
124821031|NCT01059825|448970889|FG005|Treatment Period|Adverse event not related to study drug|1|||
124821032|NCT01059825|448970890|FG006|Treatment Period|Adverse event not related to study drug|0|||
124821033|NCT00549302|448970891|FG000|Double-Blind|Death|2|||
124821034|NCT00549302|448970892|FG001|Double-Blind|Death|9|||
124821035|NCT00549302|448970893|FG002|Double-Blind|Death|0|||
124821036|NCT00549302|448970891|FG000|Double-Blind|Adverse Event|3|||
124821037|NCT00549302|448970892|FG001|Double-Blind|Adverse Event|16|||
124821038|NCT00549302|448970893|FG002|Double-Blind|Adverse Event|0|||
124821039|NCT00549302|448970891|FG000|Double-Blind|Withdrawal by Subject|3|||
124821040|NCT00549302|448970892|FG001|Double-Blind|Withdrawal by Subject|8|||
124821041|NCT00549302|448970893|FG002|Double-Blind|Withdrawal by Subject|0|||
124821042|NCT00549302|448970891|FG000|Double-Blind|Investigator Decision|1|||
124821043|NCT00549302|448970892|FG001|Double-Blind|Investigator Decision|5|||
124821044|NCT00549302|448970893|FG002|Double-Blind|Investigator Decision|0|||
124821045|NCT00549302|448970891|FG000|Double-Blind|Sponsor Decision|0|||
124821046|NCT00549302|448970892|FG001|Double-Blind|Sponsor Decision|1|||
124821047|NCT00549302|448970893|FG002|Double-Blind|Sponsor Decision|0|||
124821048|NCT00549302|448970891|FG000|Double-Blind|Lost to Follow-up|1|||
124821049|NCT00549302|448970892|FG001|Double-Blind|Lost to Follow-up|2|||
124821050|NCT00549302|448970893|FG002|Double-Blind|Lost to Follow-up|0|||
124821051|NCT00549302|448970891|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
124821052|NCT00549302|448970892|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
124821053|NCT00549302|448970893|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
124821054|NCT00549302|448970891|FG000|Double-Blind|New condition or starts new therapy|0|||
124821055|NCT00549302|448970892|FG001|Double-Blind|New condition or starts new therapy|2|||
124821056|NCT00549302|448970893|FG002|Double-Blind|New condition or starts new therapy|0|||
124821057|NCT00549302|448970891|FG000|Open-Label|Adverse Event|0|||
124821058|NCT00549302|448970892|FG001|Open-Label|Adverse Event|0|||
124821059|NCT00549302|448970893|FG002|Open-Label|Adverse Event|11|||
124821060|NCT00549302|448970891|FG000|Open-Label|Death|0|||
124821061|NCT00549302|448970892|FG001|Open-Label|Death|0|||
124821062|NCT00549302|448970893|FG002|Open-Label|Death|40|||
124821063|NCT00549302|448970891|FG000|Open-Label|Investigator Decision|0|||
124821064|NCT00549302|448970892|FG001|Open-Label|Investigator Decision|0|||
124821065|NCT00549302|448970893|FG002|Open-Label|Investigator Decision|5|||
124821066|NCT00549302|448970891|FG000|Open-Label|Lost to Follow-up|0|||
124821067|NCT00549302|448970892|FG001|Open-Label|Lost to Follow-up|0|||
124821068|NCT00549302|448970893|FG002|Open-Label|Lost to Follow-up|2|||
124821069|NCT00549302|448970891|FG000|Open-Label|Other|0|||
124821070|NCT00549302|448970892|FG001|Open-Label|Other|0|||
124821071|NCT00549302|448970893|FG002|Open-Label|Other|3|||
124821072|NCT00549302|448970891|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
124821073|NCT00549302|448970892|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
124821074|NCT00549302|448970893|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
124637949|NCT02347774|448292491|FG002|On Study Treatment|Protocol Violation|1|||
124637950|NCT02347774|448292489|FG000|On Study Treatment|withdrew consent|9|||
124821075|NCT00549302|448970891|FG000|Open-Label|Withdrawal by Subject|0|||
124821076|NCT00549302|448970892|FG001|Open-Label|Withdrawal by Subject|0|||
124821077|NCT00549302|448970893|FG002|Open-Label|Withdrawal by Subject|6|||
124821078|NCT03585504|448970894|FG000|Overall Study|Lost to Follow-up|26|||
124637951|NCT02347774|448292490|FG001|On Study Treatment|withdrew consent|8|||
124821079|NCT03585504|448970895|FG001|Overall Study|Lost to Follow-up|29|||
124821080|NCT01414114|448970896|FG000|Overall Study|Adverse Event|2|||
124637952|NCT02347774|448292491|FG002|On Study Treatment|withdrew consent|12|||
124821081|NCT01414114|448970896|FG000|Overall Study|Withdrawal by Subject|1|||
124821082|NCT01414114|448970896|FG000|Overall Study|Other|2|||
124821083|NCT00105482|448970897|FG000|Overall Study|Adverse Event|1|||
124821084|NCT00105482|448970898|FG001|Overall Study|Adverse Event|1|||
124821085|NCT00105482|448970897|FG000|Overall Study|Lost to Follow-up|26|||
124821086|NCT00105482|448970898|FG001|Overall Study|Lost to Follow-up|17|||
124821087|NCT00105482|448970897|FG000|Overall Study|Withdrawal by Subject|0|||
124821088|NCT00105482|448970898|FG001|Overall Study|Withdrawal by Subject|1|||
124821089|NCT00105482|448970897|FG000|Overall Study|Lost Interest|29|||
124821090|NCT00105482|448970898|FG001|Overall Study|Lost Interest|32|||
124821091|NCT00105482|448970897|FG000|Overall Study|Scheduling Conflict|2|||
124821092|NCT00105482|448970898|FG001|Overall Study|Scheduling Conflict|3|||
124821093|NCT00105482|448970897|FG000|Overall Study|Withdrawn by PI|1|||
124821094|NCT00105482|448970898|FG001|Overall Study|Withdrawn by PI|1|||
124821095|NCT05620563|448970899|FG000|Overall Study|Adverse Event|3|||
124821096|NCT05620563|448970900|FG001|Overall Study|Adverse Event|1|||
124821097|NCT05620563|448970899|FG000|Overall Study|Lost to Follow-up|0|||
124821098|NCT05620563|448970900|FG001|Overall Study|Lost to Follow-up|2|||
124821099|NCT05620563|448970899|FG000|Overall Study|Protocol Deviation|1|||
124821100|NCT05620563|448970900|FG001|Overall Study|Protocol Deviation|2|||
124821101|NCT05620563|448970899|FG000|Overall Study|Withdrawal by Subject|3|||
124821102|NCT05620563|448970900|FG001|Overall Study|Withdrawal by Subject|3|||
124821103|NCT05620563|448970899|FG000|Overall Study|Physician Decision|0|||
124821104|NCT05620563|448970900|FG001|Overall Study|Physician Decision|1|||
124821105|NCT00411645|448970903|FG000|Overall Study|Consent Withdrawn|13|||
124821106|NCT00411645|448970904|FG001|Overall Study|Consent Withdrawn|22|||
124821107|NCT00411645|448970903|FG000|Overall Study|Death|56|||
124821108|NCT00411645|448970904|FG001|Overall Study|Death|135|||
124821109|NCT00411645|448970903|FG000|Overall Study|Investigator/Sponsor Decision|10|||
124821110|NCT00411645|448970904|FG001|Overall Study|Investigator/Sponsor Decision|7|||
124821111|NCT00411645|448970903|FG000|Overall Study|Lost to Follow-up|2|||
124821112|NCT00411645|448970904|FG001|Overall Study|Lost to Follow-up|0|||
124821113|NCT04118166|448970907|FG000|Overall Study|Adverse Event|1|||
124821114|NCT03521934|448970908|FG000|Overall Study|Death|65|||
124821115|NCT03521934|448970909|FG001|Overall Study|Death|73|||
124821116|NCT03521934|448970908|FG000|Overall Study|Withdrawal by Subject|18|||
124821117|NCT03521934|448970909|FG001|Overall Study|Withdrawal by Subject|23|||
124821118|NCT03521934|448970908|FG000|Overall Study|Site Terminated by Sponsor|39|||
124821119|NCT03521934|448970909|FG001|Overall Study|Site Terminated by Sponsor|35|||
124821120|NCT03521934|448970908|FG000|Overall Study|Study Terminated by Sponsor|483|||
124821121|NCT03521934|448970909|FG001|Overall Study|Study Terminated by Sponsor|477|||
124821122|NCT03521934|448970908|FG000|Overall Study|Reason not Specified|3|||
124821123|NCT03521934|448970909|FG001|Overall Study|Reason not Specified|6|||
124821124|NCT03020160|448970912|FG000|Overall Study|Withdrawal by Subject|1|||
124821125|NCT03020160|448970913|FG001|Overall Study|Withdrawal by Subject|0|||
124821126|NCT01513473|448970914|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
124821127|NCT01513473|448970915|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
124821128|NCT01513473|448970914|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
124821129|NCT01513473|448970915|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
124821130|NCT01513473|448970914|FG000|Main Trial (26 Weeks)|Unclassified|0|||
124821131|NCT01513473|448970915|FG001|Main Trial (26 Weeks)|Unclassified|2|||
124821132|NCT01513473|448970914|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
124821133|NCT01513473|448970915|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
124821134|NCT01513473|448970914|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
124821135|NCT01513473|448970915|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
124821136|NCT00211809|448970918|FG000|Overall Study|Lack of Efficacy|1|||
124821137|NCT00211809|448970918|FG000|Overall Study|Lost to Follow-up|2|||
124821138|NCT00211809|448970918|FG000|Overall Study|Pregnancy|1|||
124821139|NCT00211809|448970918|FG000|Overall Study|side effects|2|||
124821140|NCT04294472|448970919|FG000|Overall Study|Adverse Event|0|||
124821141|NCT04294472|448970920|FG001|Overall Study|Adverse Event|1|||
124821142|NCT04294472|448970921|FG002|Overall Study|Adverse Event|1|||
124821143|NCT04294472|448970919|FG000|Overall Study|Randomized but not treated|0|||
124821144|NCT04294472|448970920|FG001|Overall Study|Randomized but not treated|1|||
124821145|NCT04294472|448970921|FG002|Overall Study|Randomized but not treated|1|||
124821146|NCT02603419|448970927|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
124821147|NCT02603419|448970928|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
124821148|NCT02603419|448970929|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
124821149|NCT02603419|448970930|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
124637953|NCT02347774|448292489|FG000|On Study Treatment|Lost to Follow-up|2|||
124637954|NCT02347774|448292490|FG001|On Study Treatment|Lost to Follow-up|6|||
124821150|NCT02603419|448970931|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
124821151|NCT02603419|448970932|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
124637955|NCT02347774|448292491|FG002|On Study Treatment|Lost to Follow-up|1|||
124821152|NCT02603419|448970927|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
124821153|NCT02603419|448970928|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
124821154|NCT02603419|448970929|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
124821155|NCT02603419|448970930|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
124821156|NCT02603419|448970931|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
124821157|NCT02603419|448970932|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
124821158|NCT02603419|448970927|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
124821159|NCT02603419|448970928|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
124821160|NCT02603419|448970929|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
124821161|NCT02603419|448970930|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
124821162|NCT02603419|448970931|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
124821163|NCT02603419|448970932|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
124821164|NCT02603419|448970927|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
124821165|NCT02603419|448970928|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
124821166|NCT02603419|448970929|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
124821167|NCT02603419|448970930|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
124821168|NCT02603419|448970931|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
124821169|NCT02603419|448970932|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
124821170|NCT02603419|448970927|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
124821171|NCT02603419|448970928|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
124821172|NCT02603419|448970929|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
124821173|NCT02603419|448970930|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
124821174|NCT02603419|448970931|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
124821175|NCT02603419|448970932|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
124821176|NCT02603419|448970927|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
124821177|NCT02603419|448970928|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
124821178|NCT02603419|448970929|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
124821179|NCT02603419|448970930|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
124821180|NCT02603419|448970931|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
124821181|NCT02603419|448970932|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
124821182|NCT02603419|448970927|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
124821183|NCT02603419|448970928|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
124821184|NCT02603419|448970929|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
124821185|NCT02603419|448970930|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
124637956|NCT02347774|448292489|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
124637957|NCT02347774|448292490|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
124821186|NCT02603419|448970931|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
124821187|NCT02603419|448970932|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
124821188|NCT02603419|448970927|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
124821189|NCT02603419|448970928|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
124821190|NCT02603419|448970929|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
124821191|NCT02603419|448970930|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
124821192|NCT02603419|448970931|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
124821193|NCT02603419|448970932|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
124637958|NCT02347774|448292491|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
124637959|NCT02347774|448292489|FG000|On Study Treatment|ranomized in error|0|||
124637960|NCT02347774|448292490|FG001|On Study Treatment|ranomized in error|0|||
124637961|NCT02347774|448292491|FG002|On Study Treatment|ranomized in error|1|||
124637962|NCT00921557|448292492|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
124637963|NCT00921557|448292493|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
124637964|NCT00921557|448292494|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
124637965|NCT00921557|448292492|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
124637966|NCT00921557|448292493|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
124637967|NCT00921557|448292494|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
124637968|NCT00921557|448292492|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
124637969|NCT00921557|448292493|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
124637970|NCT00921557|448292494|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
124637971|NCT00921557|448292492|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
124637972|NCT00921557|448292493|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
124637973|NCT00921557|448292494|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
124637974|NCT00921557|448292492|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
124637975|NCT00921557|448292493|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
124637976|NCT00921557|448292494|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
124821194|NCT02603419|448970927|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
124821195|NCT02603419|448970928|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
124821196|NCT02603419|448970929|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
124821197|NCT02603419|448970930|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
124821198|NCT02603419|448970931|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
124821199|NCT02603419|448970932|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
124821200|NCT02603419|448970927|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
124821201|NCT02603419|448970928|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
124821202|NCT02603419|448970929|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
124821203|NCT02603419|448970930|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
124821204|NCT02603419|448970931|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
124821205|NCT02603419|448970932|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
124821206|NCT01049308|448970934|FG000|Pill Counts|Withdrawal by Subject|83|||
124821207|NCT02289417|448970935|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
124821208|NCT02289417|448970936|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
124821209|NCT02289417|448970937|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
124821210|NCT02289417|448970938|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
124821211|NCT02289417|448970939|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
124821212|NCT02289417|448970940|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
124821213|NCT02289417|448970941|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
124821214|NCT02289417|448970942|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
124821215|NCT02289417|448970943|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
124821216|NCT02289417|448970935|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
124821217|NCT02289417|448970936|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
124821218|NCT02289417|448970937|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
124821219|NCT02289417|448970938|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
124821220|NCT02289417|448970939|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
124821221|NCT02289417|448970940|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
124821222|NCT02289417|448970941|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
124821223|NCT02289417|448970942|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
124821224|NCT02289417|448970943|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
124821225|NCT02289417|448970935|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
124821226|NCT02289417|448970936|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
124821227|NCT02289417|448970937|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
124821228|NCT02289417|448970938|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
124821229|NCT02289417|448970939|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
124821230|NCT02289417|448970940|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
124821231|NCT02289417|448970941|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
124821232|NCT02289417|448970942|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
124821233|NCT02289417|448970943|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
124821234|NCT02289417|448970935|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
124821235|NCT02289417|448970936|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
124821236|NCT02289417|448970937|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
124821237|NCT02289417|448970938|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
124821238|NCT02289417|448970939|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
124821239|NCT02289417|448970940|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
124821240|NCT02289417|448970941|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
124821241|NCT02289417|448970942|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
124821242|NCT02289417|448970943|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
124821243|NCT02289417|448970935|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
124821244|NCT02289417|448970936|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
124821245|NCT02289417|448970937|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
124821246|NCT02289417|448970938|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
124821247|NCT02289417|448970939|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
124821248|NCT02289417|448970940|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
124821249|NCT02289417|448970941|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
124821250|NCT02289417|448970942|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
124821251|NCT02289417|448970943|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
124821252|NCT02289417|448970935|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
124821253|NCT02289417|448970936|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
124821254|NCT02289417|448970937|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
124821255|NCT02289417|448970938|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
124821256|NCT02289417|448970939|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
124821257|NCT02289417|448970940|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
124821258|NCT02289417|448970941|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
124821259|NCT02289417|448970942|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
124821260|NCT02289417|448970943|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
124821261|NCT02289417|448970935|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
124821262|NCT02289417|448970936|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
124821263|NCT02289417|448970937|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
124821264|NCT02289417|448970938|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
124821265|NCT02289417|448970939|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
124821266|NCT02289417|448970940|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
124821267|NCT02289417|448970941|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
124821268|NCT02289417|448970942|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
124821269|NCT02289417|448970943|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
124821270|NCT02289417|448970935|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
124821271|NCT02289417|448970936|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
124821272|NCT02289417|448970937|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
124821273|NCT02289417|448970938|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
124821274|NCT02289417|448970939|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
124821275|NCT02289417|448970940|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
124821276|NCT02289417|448970941|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
124821277|NCT02289417|448970942|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
124821278|NCT02289417|448970943|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
124821279|NCT02289417|448970935|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
124821280|NCT02289417|448970936|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
124821281|NCT02289417|448970937|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
124821282|NCT02289417|448970938|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
124821283|NCT02289417|448970939|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
124821284|NCT02289417|448970940|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
124821285|NCT02289417|448970941|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
124821286|NCT02289417|448970942|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
124821287|NCT02289417|448970943|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
124821288|NCT02289417|448970935|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
124821289|NCT02289417|448970936|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
124821290|NCT02289417|448970937|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
124821291|NCT02289417|448970938|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
124821292|NCT02289417|448970939|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
124821293|NCT02289417|448970940|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
124821294|NCT02289417|448970941|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
124821295|NCT02289417|448970942|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
124821296|NCT02289417|448970943|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
124821297|NCT02289417|448970935|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
124821298|NCT02289417|448970936|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
124821299|NCT02289417|448970937|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
124821300|NCT02289417|448970938|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
124821301|NCT02289417|448970939|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
124821302|NCT02289417|448970940|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
124821303|NCT02289417|448970941|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
124821304|NCT02289417|448970942|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
124821305|NCT02289417|448970943|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
124821306|NCT02289417|448970935|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
124821307|NCT02289417|448970936|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
124821308|NCT02289417|448970937|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
124821309|NCT02289417|448970938|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
124821310|NCT02289417|448970939|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
124821311|NCT02289417|448970940|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
124821312|NCT02289417|448970941|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
124821313|NCT02289417|448970942|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
124821314|NCT02289417|448970943|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
124821315|NCT02289417|448970935|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
124821316|NCT02289417|448970936|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
124821317|NCT02289417|448970937|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
124821318|NCT02289417|448970938|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
124821319|NCT02289417|448970939|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
124821320|NCT02289417|448970940|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
124821321|NCT02289417|448970941|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
124821322|NCT02289417|448970942|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
124821323|NCT02289417|448970943|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
124821324|NCT02289417|448970935|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
124637977|NCT00656292|448292495|FG000|Overall Study|Withdrawal by Subject|2|||
124637978|NCT00656292|448292496|FG001|Overall Study|Withdrawal by Subject|3|||
124637979|NCT00656292|448292495|FG000|Overall Study|Screen failure|1|||
124637980|NCT00656292|448292496|FG001|Overall Study|Screen failure|2|||
124821325|NCT02289417|448970936|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
124821326|NCT02289417|448970937|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
124821327|NCT02289417|448970938|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
124821328|NCT02289417|448970939|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
124821329|NCT02289417|448970940|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
124821330|NCT02289417|448970941|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
124821331|NCT02289417|448970942|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
124821332|NCT02289417|448970943|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
124821333|NCT04786990|448970944|FG000|Overall Study|Withdrawal by Subject|1|||
124821334|NCT04786990|448970944|FG000|Overall Study|Adverse Event|1|||
124821335|NCT04786990|448970944|FG000|Overall Study|Lost to Follow-up|1|||
124821336|NCT04786990|448970944|FG000|Overall Study|Noncompliance|1|||
124821337|NCT04786990|448970944|FG000|Overall Study|Unable to complete site visits|1|||
124821338|NCT04786990|448970944|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
124821339|NCT01782222|448970947|FG000|Overall Study|Adverse Event|4|||
124821340|NCT01782222|448970948|FG001|Overall Study|Adverse Event|5|||
124821341|NCT01782222|448970949|FG002|Overall Study|Adverse Event|3|||
124821342|NCT01782222|448970947|FG000|Overall Study|Lack of Efficacy|2|||
124821343|NCT01782222|448970948|FG001|Overall Study|Lack of Efficacy|1|||
124821344|NCT01782222|448970949|FG002|Overall Study|Lack of Efficacy|0|||
124821345|NCT01782222|448970947|FG000|Overall Study|Protocol Violation|1|||
124821346|NCT01782222|448970948|FG001|Overall Study|Protocol Violation|0|||
124821347|NCT01782222|448970949|FG002|Overall Study|Protocol Violation|0|||
124821348|NCT01782222|448970947|FG000|Overall Study|Withdrawal by Subject|1|||
124821349|NCT01782222|448970948|FG001|Overall Study|Withdrawal by Subject|4|||
124821350|NCT01782222|448970949|FG002|Overall Study|Withdrawal by Subject|1|||
124821351|NCT01782222|448970947|FG000|Overall Study|Moved to other state|0|||
124821352|NCT01782222|448970948|FG001|Overall Study|Moved to other state|1|||
124821353|NCT01782222|448970949|FG002|Overall Study|Moved to other state|0|||
124821354|NCT01756898|448970953|FG000|Overall Study|Adverse Event|7|||
124821355|NCT01756898|448970954|FG001|Overall Study|Adverse Event|1|||
124821356|NCT01756898|448970955|FG002|Overall Study|Adverse Event|0|||
124821357|NCT01756898|448970956|FG003|Overall Study|Adverse Event|0|||
124821358|NCT01756898|448970953|FG000|Overall Study|Lack of Efficacy|4|||
124821359|NCT01756898|448970954|FG001|Overall Study|Lack of Efficacy|7|||
124821360|NCT01756898|448970955|FG002|Overall Study|Lack of Efficacy|6|||
124821361|NCT01756898|448970956|FG003|Overall Study|Lack of Efficacy|6|||
124821362|NCT01756898|448970953|FG000|Overall Study|Lost to Follow-up|2|||
124821363|NCT01756898|448970954|FG001|Overall Study|Lost to Follow-up|4|||
124821364|NCT01756898|448970955|FG002|Overall Study|Lost to Follow-up|2|||
124821365|NCT01756898|448970956|FG003|Overall Study|Lost to Follow-up|3|||
124821366|NCT01756898|448970953|FG000|Overall Study|Protocol Violation|1|||
124821367|NCT01756898|448970954|FG001|Overall Study|Protocol Violation|2|||
124821368|NCT01756898|448970955|FG002|Overall Study|Protocol Violation|2|||
124821369|NCT01756898|448970956|FG003|Overall Study|Protocol Violation|1|||
124821370|NCT01756898|448970953|FG000|Overall Study|Withdrew Consent|5|||
124821371|NCT01756898|448970954|FG001|Overall Study|Withdrew Consent|3|||
124821372|NCT01756898|448970955|FG002|Overall Study|Withdrew Consent|5|||
124821373|NCT01756898|448970956|FG003|Overall Study|Withdrew Consent|6|||
124821374|NCT01756898|448970953|FG000|Overall Study|Other|0|||
124821375|NCT01756898|448970954|FG001|Overall Study|Other|2|||
124821376|NCT01756898|448970955|FG002|Overall Study|Other|2|||
124821377|NCT01756898|448970956|FG003|Overall Study|Other|0|||
124821378|NCT01500694|448970957|FG000|Overall Study|Adverse Event|4|||
124821379|NCT01500694|448970958|FG001|Overall Study|Adverse Event|3|||
124821380|NCT01500694|448970957|FG000|Overall Study|Protocol Violation|0|||
124821381|NCT01500694|448970958|FG001|Overall Study|Protocol Violation|1|||
124821382|NCT01500694|448970957|FG000|Overall Study|Withdrawal by Subject|23|||
124821383|NCT01500694|448970958|FG001|Overall Study|Withdrawal by Subject|14|||
124821384|NCT01500694|448970957|FG000|Overall Study|Lost to Follow-up|2|||
124821385|NCT01500694|448970958|FG001|Overall Study|Lost to Follow-up|3|||
124821386|NCT01500694|448970957|FG000|Overall Study|Lack of Efficacy|14|||
124821387|NCT01500694|448970958|FG001|Overall Study|Lack of Efficacy|5|||
124821388|NCT01500694|448970957|FG000|Overall Study|Other|9|||
124821389|NCT01500694|448970958|FG001|Overall Study|Other|3|||
124821390|NCT00496054|448970963|FG000|Overall Study|Adverse Event|1|||
124821391|NCT00496054|448970963|FG000|Overall Study|Lost to Follow-up|7|||
124821392|NCT01858389|448970966|FG000|Overall Study|Death|1|||
124821393|NCT01858389|448970967|FG001|Overall Study|Death|3|||
124821394|NCT01858389|448970966|FG000|Overall Study|Study terminated by sponsor|0|||
124821395|NCT01858389|448970967|FG001|Overall Study|Study terminated by sponsor|2|||
124821396|NCT01858389|448970966|FG000|Overall Study|Withdrawal by Subject|0|||
124821397|NCT01858389|448970967|FG001|Overall Study|Withdrawal by Subject|1|||
124821398|NCT01858389|448970966|FG000|Overall Study|Progressive disease|10|||
124821399|NCT01858389|448970967|FG001|Overall Study|Progressive disease|11|||
124821400|NCT01858389|448970966|FG000|Overall Study|Other|2|||
124821401|NCT01858389|448970967|FG001|Overall Study|Other|4|||
124821402|NCT01858389|448970966|FG000|Overall Study|Adverse Event|3|||
124821403|NCT01858389|448970967|FG001|Overall Study|Adverse Event|1|||
124821404|NCT01858389|448970966|FG000|Overall Study|Did not receive treatment|0|||
124821405|NCT01858389|448970967|FG001|Overall Study|Did not receive treatment|3|||
124821406|NCT03572062|448970968|FG000|Overall Study|Adverse Event|0|||
124821407|NCT03572062|448970969|FG001|Overall Study|Adverse Event|0|||
124821408|NCT03572062|448970970|FG002|Overall Study|Adverse Event|0|||
124821409|NCT03572062|448970971|FG003|Overall Study|Adverse Event|0|||
124821410|NCT03572062|448970972|FG004|Overall Study|Adverse Event|0|||
124821411|NCT03572062|448970973|FG005|Overall Study|Adverse Event|0|||
124821412|NCT03572062|448970974|FG006|Overall Study|Adverse Event|0|||
124821413|NCT03572062|448970975|FG007|Overall Study|Adverse Event|0|||
124821414|NCT03572062|448970976|FG008|Overall Study|Adverse Event|1|||
124821415|NCT03572062|448970977|FG009|Overall Study|Adverse Event|3|||
124821416|NCT03572062|448970968|FG000|Overall Study|Death|0|||
124821417|NCT03572062|448970969|FG001|Overall Study|Death|0|||
124821418|NCT03572062|448970970|FG002|Overall Study|Death|0|||
124821419|NCT03572062|448970971|FG003|Overall Study|Death|0|||
124821420|NCT03572062|448970972|FG004|Overall Study|Death|0|||
124821421|NCT03572062|448970973|FG005|Overall Study|Death|1|||
124821422|NCT03572062|448970974|FG006|Overall Study|Death|0|||
124821423|NCT03572062|448970975|FG007|Overall Study|Death|0|||
124821424|NCT03572062|448970976|FG008|Overall Study|Death|0|||
124821425|NCT03572062|448970977|FG009|Overall Study|Death|0|||
124821426|NCT03572062|448970968|FG000|Overall Study|Lost to Follow-up|0|||
124821427|NCT03572062|448970969|FG001|Overall Study|Lost to Follow-up|0|||
124821428|NCT03572062|448970970|FG002|Overall Study|Lost to Follow-up|0|||
124821429|NCT03572062|448970971|FG003|Overall Study|Lost to Follow-up|0|||
124821430|NCT03572062|448970972|FG004|Overall Study|Lost to Follow-up|0|||
124821431|NCT03572062|448970973|FG005|Overall Study|Lost to Follow-up|1|||
124821432|NCT03572062|448970974|FG006|Overall Study|Lost to Follow-up|1|||
124821433|NCT03572062|448970975|FG007|Overall Study|Lost to Follow-up|0|||
124821434|NCT03572062|448970976|FG008|Overall Study|Lost to Follow-up|0|||
124821435|NCT03572062|448970977|FG009|Overall Study|Lost to Follow-up|0|||
124821436|NCT03572062|448970968|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821437|NCT03572062|448970969|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821438|NCT03572062|448970970|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821439|NCT03572062|448970971|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821440|NCT03572062|448970972|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821441|NCT03572062|448970973|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821442|NCT03572062|448970974|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821443|NCT03572062|448970975|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821444|NCT03572062|448970976|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
124821445|NCT03572062|448970977|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
124821446|NCT03572062|448970968|FG000|Overall Study|Study Terminated By Sponsor|0|||
124821447|NCT03572062|448970969|FG001|Overall Study|Study Terminated By Sponsor|0|||
124821448|NCT03572062|448970970|FG002|Overall Study|Study Terminated By Sponsor|0|||
124821449|NCT03572062|448970971|FG003|Overall Study|Study Terminated By Sponsor|0|||
124821450|NCT03572062|448970972|FG004|Overall Study|Study Terminated By Sponsor|0|||
124821451|NCT03572062|448970973|FG005|Overall Study|Study Terminated By Sponsor|0|||
124821452|NCT03572062|448970974|FG006|Overall Study|Study Terminated By Sponsor|0|||
124821453|NCT03572062|448970975|FG007|Overall Study|Study Terminated By Sponsor|0|||
124821454|NCT03572062|448970976|FG008|Overall Study|Study Terminated By Sponsor|29|||
124821455|NCT03572062|448970977|FG009|Overall Study|Study Terminated By Sponsor|27|||
124821456|NCT03572062|448970968|FG000|Overall Study|Physician Decision|0|||
124821457|NCT03572062|448970969|FG001|Overall Study|Physician Decision|0|||
124821458|NCT03572062|448970970|FG002|Overall Study|Physician Decision|0|||
124821459|NCT03572062|448970971|FG003|Overall Study|Physician Decision|0|||
124821460|NCT03572062|448970972|FG004|Overall Study|Physician Decision|0|||
124821461|NCT03572062|448970973|FG005|Overall Study|Physician Decision|0|||
124821462|NCT03572062|448970974|FG006|Overall Study|Physician Decision|0|||
124821463|NCT03572062|448970975|FG007|Overall Study|Physician Decision|0|||
124821464|NCT03572062|448970976|FG008|Overall Study|Physician Decision|1|||
124821465|NCT03572062|448970977|FG009|Overall Study|Physician Decision|0|||
124821466|NCT03572062|448970968|FG000|Overall Study|Withdrawal by Subject|0|||
124821467|NCT03572062|448970969|FG001|Overall Study|Withdrawal by Subject|0|||
124821468|NCT03572062|448970970|FG002|Overall Study|Withdrawal by Subject|0|||
124821469|NCT03572062|448970971|FG003|Overall Study|Withdrawal by Subject|0|||
124821470|NCT03572062|448970972|FG004|Overall Study|Withdrawal by Subject|0|||
124821471|NCT03572062|448970973|FG005|Overall Study|Withdrawal by Subject|0|||
124637981|NCT03259425|448292497|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
124637982|NCT04157296|448292498|FG000|Overall Study|Withdrawal by Subject|0|||
124637983|NCT04157296|448292499|FG001|Overall Study|Withdrawal by Subject|1|||
124821472|NCT03572062|448970974|FG006|Overall Study|Withdrawal by Subject|0|||
124821473|NCT03572062|448970975|FG007|Overall Study|Withdrawal by Subject|0|||
124821474|NCT03572062|448970976|FG008|Overall Study|Withdrawal by Subject|0|||
124821475|NCT03572062|448970977|FG009|Overall Study|Withdrawal by Subject|1|||
124821476|NCT03572062|448970968|FG000|Overall Study|Randomized But Not Treated|0|||
124821477|NCT03572062|448970969|FG001|Overall Study|Randomized But Not Treated|0|||
124821478|NCT03572062|448970970|FG002|Overall Study|Randomized But Not Treated|0|||
124821479|NCT03572062|448970971|FG003|Overall Study|Randomized But Not Treated|0|||
124821480|NCT03572062|448970972|FG004|Overall Study|Randomized But Not Treated|1|||
124821481|NCT03572062|448970973|FG005|Overall Study|Randomized But Not Treated|2|||
124821482|NCT03572062|448970974|FG006|Overall Study|Randomized But Not Treated|0|||
124821483|NCT03572062|448970975|FG007|Overall Study|Randomized But Not Treated|1|||
124821484|NCT03572062|448970976|FG008|Overall Study|Randomized But Not Treated|0|||
124821485|NCT03572062|448970977|FG009|Overall Study|Randomized But Not Treated|0|||
124821486|NCT00471328|448970978|FG000|Core Phase|Adverse Event|18|||
124821487|NCT00471328|448970979|FG001|Core Phase|Adverse Event|6|||
124821488|NCT00471328|448970978|FG000|Core Phase|Death|8|||
124821489|NCT00471328|448970979|FG001|Core Phase|Death|4|||
124821490|NCT00471328|448970978|FG000|Core Phase|Withdrawal by Subject|2|||
124821491|NCT00471328|448970979|FG001|Core Phase|Withdrawal by Subject|2|||
124821492|NCT00471328|448970978|FG000|Core Phase|Abnormal laboratory value|1|||
124821493|NCT00471328|448970979|FG001|Core Phase|Abnormal laboratory value|0|||
124821494|NCT00471328|448970978|FG000|Core Phase|Disease Progression|78|||
124821495|NCT00471328|448970979|FG001|Core Phase|Disease Progression|53|||
124821496|NCT00471328|448970978|FG000|Core Phase|Administrative Problem|0|||
124821497|NCT00471328|448970979|FG001|Core Phase|Administrative Problem|1|||
124821498|NCT00471328|448970978|FG000|Core Phase|Protocol Deviation|0|||
124821499|NCT00471328|448970979|FG001|Core Phase|Protocol Deviation|1|||
124821500|NCT00471328|448970978|FG000|Extension Phase|Adverse Event|3|||
124821501|NCT00471328|448970979|FG001|Extension Phase|Adverse Event|12|||
124821502|NCT00471328|448970978|FG000|Extension Phase|Withdrawal by Subject|0|||
124821503|NCT00471328|448970979|FG001|Extension Phase|Withdrawal by Subject|2|||
124821504|NCT00471328|448970978|FG000|Extension Phase|Death|1|||
124821505|NCT00471328|448970979|FG001|Extension Phase|Death|7|||
124821506|NCT00471328|448970978|FG000|Extension Phase|Protocol Deviation|3|||
124821507|NCT00471328|448970979|FG001|Extension Phase|Protocol Deviation|1|||
124821508|NCT00471328|448970978|FG000|Extension Phase|Treatment duration as per protocol|0|||
124821509|NCT00471328|448970979|FG001|Extension Phase|Treatment duration as per protocol|1|||
124821510|NCT00471328|448970978|FG000|Extension Phase|Disease Progression|32|||
124821511|NCT00471328|448970979|FG001|Extension Phase|Disease Progression|44|||
124821512|NCT00471328|448970978|FG000|Extension Phase|New cancer Therapy|1|||
124821513|NCT00471328|448970979|FG001|Extension Phase|New cancer Therapy|0|||
124821514|NCT00471328|448970978|FG000|Extension Phase|Administrative Problem|1|||
124821515|NCT00471328|448970979|FG001|Extension Phase|Administrative Problem|0|||
124821516|NCT04051008|448970980|FG000|Overall Study|Withdrawal by Subject|2|||
124821517|NCT04051008|448970981|FG001|Overall Study|Withdrawal by Subject|0|||
124821518|NCT04051008|448970982|FG002|Overall Study|Withdrawal by Subject|1|||
124821519|NCT01605877|448970983|FG000|Overall Study|Withdrawal by Subject|1|||
124821520|NCT00458211|448970984|FG000|Overall Study|Lack of Efficacy|12|||
124821521|NCT00458211|448970984|FG000|Overall Study|Withdrawal by Subject|2|||
124821522|NCT00458211|448970984|FG000|Overall Study|Protocol Violation|2|||
124821523|NCT02634320|448970992|FG000|Overall Study|Adverse Event|2|||
124821524|NCT02634320|448970992|FG000|Overall Study|Lost to Follow-up|3|||
124821525|NCT02634320|448970992|FG000|Overall Study|Moved out of area|2|||
124821526|NCT02634320|448970992|FG000|Overall Study|Out of window for study visits|1|||
124821527|NCT02634320|448970992|FG000|Overall Study|Protocol Violation|1|||
124821528|NCT02634320|448970992|FG000|Overall Study|Withdrawal by Subject|5|||
124821529|NCT02634320|448970992|FG000|Overall Study|Lack of Efficacy|2|||
124821530|NCT00687323|448970993|FG000|Overall Study|Death|25|||
124821531|NCT00687323|448970993|FG000|Overall Study|Withdrawal by Subject|1|||
124821532|NCT00687323|448970993|FG000|Overall Study|Excluded from efficacy evaluations|6|||
124821533|NCT00687323|448970993|FG000|Overall Study|Screen failure|148|||
124821534|NCT02132130|448970997|FG000|Overall Study|Lost to Follow-up|0|||
124821535|NCT02132130|448970998|FG001|Overall Study|Lost to Follow-up|2|||
124821536|NCT02132130|448970999|FG002|Overall Study|Lost to Follow-up|0|||
124821537|NCT02132130|448971000|FG003|Overall Study|Lost to Follow-up|0|||
124821538|NCT02132130|448970997|FG000|Overall Study|Withdrawal by Subject|0|||
124821539|NCT02132130|448970998|FG001|Overall Study|Withdrawal by Subject|0|||
124821540|NCT02132130|448970999|FG002|Overall Study|Withdrawal by Subject|0|||
124821541|NCT02132130|448971000|FG003|Overall Study|Withdrawal by Subject|1|||
124821542|NCT03310775|448971007|FG000|Overall Study|Lost to Follow-up|2|||
124821543|NCT03310775|448971008|FG001|Overall Study|Lost to Follow-up|3|||
124821544|NCT03310775|448971007|FG000|Overall Study|aggravation of depression|0|||
124821545|NCT03310775|448971008|FG001|Overall Study|aggravation of depression|1|||
124821546|NCT00838578|448971009|FG000|Overall Study|Protocol Violation|2|||
124821547|NCT00357968|448971010|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
124821548|NCT00357968|448971011|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
124821549|NCT00357968|448971010|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
124821550|NCT00357968|448971011|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
124821551|NCT04847557|448971016|FG000|Overall Study|Adverse Event|1|||
124821552|NCT04847557|448971017|FG001|Overall Study|Adverse Event|0|||
124821553|NCT04847557|448971016|FG000|Overall Study|Death|19|||
124821554|NCT04847557|448971017|FG001|Overall Study|Death|15|||
124821555|NCT04847557|448971016|FG000|Overall Study|Lost to Follow-up|3|||
124821556|NCT04847557|448971017|FG001|Overall Study|Lost to Follow-up|6|||
124821557|NCT04847557|448971016|FG000|Overall Study|Physician Decision|1|||
124821558|NCT04847557|448971017|FG001|Overall Study|Physician Decision|0|||
124821559|NCT04847557|448971016|FG000|Overall Study|Protocol Violation|0|||
124821560|NCT04847557|448971017|FG001|Overall Study|Protocol Violation|1|||
124821561|NCT04847557|448971016|FG000|Overall Study|Withdrawal by Subject|8|||
124821562|NCT04847557|448971017|FG001|Overall Study|Withdrawal by Subject|14|||
124821563|NCT00996216|448973941|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
124821564|NCT00996216|448973941|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
124821565|NCT00996216|448973941|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
124821566|NCT00793403|448973944|FG000|Overall Study|Other|73|||
124821567|NCT00842712|448973945|FG000|Safety Run-in Part|Adverse Event|0|||
124821568|NCT00842712|448973946|FG001|Safety Run-in Part|Adverse Event|1|||
124821569|NCT00842712|448973947|FG002|Safety Run-in Part|Adverse Event|0|||
124821570|NCT00842712|448973948|FG003|Safety Run-in Part|Adverse Event|0|||
124821571|NCT00842712|448973949|FG004|Safety Run-in Part|Adverse Event|0|||
124821572|NCT00842712|448973950|FG005|Safety Run-in Part|Adverse Event|0|||
124821573|NCT00842712|448973951|FG006|Safety Run-in Part|Adverse Event|0|||
124821574|NCT00842712|448973945|FG000|Safety Run-in Part|Progressive disease|3|||
124821575|NCT00842712|448973946|FG001|Safety Run-in Part|Progressive disease|1|||
124821576|NCT00842712|448973947|FG002|Safety Run-in Part|Progressive disease|0|||
124821577|NCT00842712|448973948|FG003|Safety Run-in Part|Progressive disease|1|||
124821578|NCT00842712|448973949|FG004|Safety Run-in Part|Progressive disease|0|||
124821579|NCT00842712|448973950|FG005|Safety Run-in Part|Progressive disease|0|||
124821580|NCT00842712|448973951|FG006|Safety Run-in Part|Progressive disease|0|||
124821581|NCT00842712|448973945|FG000|Randomized Part|Randomized but not treated|0|||
124821582|NCT00842712|448973946|FG001|Randomized Part|Randomized but not treated|0|||
124821583|NCT00842712|448973947|FG002|Randomized Part|Randomized but not treated|0|||
124821584|NCT00842712|448973948|FG003|Randomized Part|Randomized but not treated|0|||
124821585|NCT00842712|448973949|FG004|Randomized Part|Randomized but not treated|0|||
124821586|NCT00842712|448973950|FG005|Randomized Part|Randomized but not treated|1|||
124821587|NCT00842712|448973951|FG006|Randomized Part|Randomized but not treated|4|||
124821588|NCT00842712|448973945|FG000|Randomized Part|Ongoing at cut-off date|0|||
124821589|NCT00842712|448973946|FG001|Randomized Part|Ongoing at cut-off date|0|||
124821590|NCT00842712|448973947|FG002|Randomized Part|Ongoing at cut-off date|0|||
124821591|NCT00842712|448973948|FG003|Randomized Part|Ongoing at cut-off date|0|||
124821592|NCT00842712|448973949|FG004|Randomized Part|Ongoing at cut-off date|0|||
124821593|NCT00842712|448973950|FG005|Randomized Part|Ongoing at cut-off date|0|||
124821594|NCT00842712|448973951|FG006|Randomized Part|Ongoing at cut-off date|2|||
124821595|NCT01549860|448973957|FG000|Overall Study|Withdrawal by Subject|1|||
124821596|NCT01549860|448973958|FG001|Overall Study|Withdrawal by Subject|0|||
124821597|NCT01549860|448973957|FG000|Overall Study|Physician Decision|1|||
124821598|NCT01549860|448973958|FG001|Overall Study|Physician Decision|1|||
124821599|NCT04271605|448973970|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
124821600|NCT02485301|448973971|FG000|Overall Study|Serious Adverse Events|2|||
124821601|NCT02485301|448973972|FG001|Overall Study|Serious Adverse Events|1|||
124821602|NCT02485301|448973971|FG000|Overall Study|Protocol Violation|0|||
124821603|NCT02485301|448973972|FG001|Overall Study|Protocol Violation|1|||
124821604|NCT02485301|448973971|FG000|Overall Study|Withdrawal by Subject|6|||
124821605|NCT02485301|448973972|FG001|Overall Study|Withdrawal by Subject|7|||
124821606|NCT02485301|448973971|FG000|Overall Study|Migrated/moved from study area|10|||
124821607|NCT02485301|448973972|FG001|Overall Study|Migrated/moved from study area|19|||
124821608|NCT02485301|448973971|FG000|Overall Study|Lost to Follow-up|17|||
124821609|NCT02485301|448973972|FG001|Overall Study|Lost to Follow-up|17|||
124821610|NCT02485301|448973971|FG000|Overall Study|Other|3|||
124821611|NCT02485301|448973972|FG001|Overall Study|Other|4|||
124821612|NCT00085631|448973978|FG000|Overall Study|Missing Data|4|||
124821613|NCT00085631|448973979|FG001|Overall Study|Missing Data|11|||
124821614|NCT00085631|448973980|FG002|Overall Study|Missing Data|7|||
124821615|NCT01349790|448973981|FG000|Overall Study|Investigator Judgement|3|||
124821616|NCT01349790|448973981|FG000|Overall Study|Death|2|||
124821617|NCT01349790|448973981|FG000|Overall Study|Withdrawal by Patient|2|||
124821618|NCT01349790|448973981|FG000|Overall Study|Adverse Event|1|||
124637984|NCT04157296|448292498|FG000|Overall Study|Did not obtain second fMRI.|0|||
124637985|NCT04157296|448292499|FG001|Overall Study|Did not obtain second fMRI.|1|||
124821619|NCT01349790|448973981|FG000|Overall Study|Lost to Follow-up|1|||
124821620|NCT02085785|448973984|FG000|Overall Study|Withdrawal by Subject|2|||
124821621|NCT02085785|448973985|FG001|Overall Study|Withdrawal by Subject|1|||
124821622|NCT02085785|448973984|FG000|Overall Study|Lost to Follow-up|0|||
124821623|NCT02085785|448973985|FG001|Overall Study|Lost to Follow-up|1|||
124821624|NCT00779467|448973986|FG000|Overall Study|Lack of Efficacy|11|||
124821625|NCT00779467|448973987|FG001|Overall Study|Lack of Efficacy|2|||
124821626|NCT00779467|448973988|FG002|Overall Study|Lack of Efficacy|6|||
124821627|NCT00779467|448973989|FG003|Overall Study|Lack of Efficacy|11|||
124821628|NCT00779467|448973986|FG000|Overall Study|failed inclusion criteria|3|||
124821629|NCT00779467|448973987|FG001|Overall Study|failed inclusion criteria|3|||
124821630|NCT00779467|448973988|FG002|Overall Study|failed inclusion criteria|1|||
124821631|NCT00779467|448973989|FG003|Overall Study|failed inclusion criteria|2|||
124821632|NCT00779467|448973986|FG000|Overall Study|missing data|1|||
124821633|NCT00779467|448973987|FG001|Overall Study|missing data|0|||
124821634|NCT00779467|448973988|FG002|Overall Study|missing data|1|||
124821635|NCT00779467|448973989|FG003|Overall Study|missing data|4|||
124821636|NCT00779467|448973986|FG000|Overall Study|technical issue|0|||
124821637|NCT00779467|448973987|FG001|Overall Study|technical issue|0|||
124821638|NCT00779467|448973988|FG002|Overall Study|technical issue|2|||
124821639|NCT00779467|448973989|FG003|Overall Study|technical issue|1|||
124821640|NCT00779467|448973986|FG000|Overall Study|unavailable research staff|0|||
124821641|NCT00779467|448973987|FG001|Overall Study|unavailable research staff|0|||
124821642|NCT00779467|448973988|FG002|Overall Study|unavailable research staff|0|||
124821643|NCT00779467|448973989|FG003|Overall Study|unavailable research staff|1|||
124821644|NCT02692703|448973990|FG000|Overall Study|Lost to Follow-up|1|||
124821645|NCT02692703|448973990|FG000|Overall Study|Other|1|||
124821646|NCT05048784|448973997|FG000|Period 1|Adverse Event|3|||
124821647|NCT05048784|448973998|FG001|Period 1|Adverse Event|1|||
124821648|NCT05048784|448973999|FG002|Period 1|Adverse Event|0|||
124821649|NCT05048784|448974000|FG003|Period 1|Adverse Event|0|||
124821650|NCT05048784|448973997|FG000|Period 2|Lost to Follow-up|0|||
124821651|NCT05048784|448973998|FG001|Period 2|Lost to Follow-up|1|||
124821652|NCT05048784|448973999|FG002|Period 2|Lost to Follow-up|0|||
124821653|NCT05048784|448974000|FG003|Period 2|Lost to Follow-up|0|||
124821654|NCT00885105|448974001|FG000|Overall Study|Withdrawal by Subject|0|||
124821655|NCT00885105|448974002|FG001|Overall Study|Withdrawal by Subject|8|||
124821656|NCT00885105|448974001|FG000|Overall Study|Adverse Event|1|||
124821657|NCT00885105|448974002|FG001|Overall Study|Adverse Event|0|||
124821658|NCT00885105|448974001|FG000|Overall Study|Protocol Violation|0|||
124821659|NCT00885105|448974002|FG001|Overall Study|Protocol Violation|2|||
124821660|NCT03519932|448974003|FG000|First Intervention|Adverse Event|1|||
124821661|NCT03519932|448974004|FG001|First Intervention|Adverse Event|3|||
124821662|NCT00284050|448974005|FG000|Overall Study|Adverse Event|1|||
124821663|NCT00284050|448974006|FG001|Overall Study|Adverse Event|1|||
124821664|NCT00284050|448974007|FG002|Overall Study|Adverse Event|1|||
124821665|NCT00284050|448974005|FG000|Overall Study|Lack of Efficacy|0|||
124821666|NCT00284050|448974006|FG001|Overall Study|Lack of Efficacy|1|||
124821667|NCT00284050|448974007|FG002|Overall Study|Lack of Efficacy|3|||
124821668|NCT00284050|448974005|FG000|Overall Study|Protocol Violation|0|||
124821669|NCT00284050|448974006|FG001|Overall Study|Protocol Violation|1|||
124821670|NCT00284050|448974007|FG002|Overall Study|Protocol Violation|2|||
124821671|NCT00284050|448974005|FG000|Overall Study|Withdrawal by Subject|2|||
124821672|NCT00284050|448974006|FG001|Overall Study|Withdrawal by Subject|2|||
124821673|NCT00284050|448974007|FG002|Overall Study|Withdrawal by Subject|2|||
124821674|NCT00284050|448974005|FG000|Overall Study|Lost to Follow-up|1|||
124821675|NCT00284050|448974006|FG001|Overall Study|Lost to Follow-up|0|||
124821676|NCT00284050|448974007|FG002|Overall Study|Lost to Follow-up|1|||
124821677|NCT00284050|448974005|FG000|Overall Study|Death|1|||
124821678|NCT00284050|448974006|FG001|Overall Study|Death|0|||
124821679|NCT00284050|448974007|FG002|Overall Study|Death|0|||
124821680|NCT02573350|448974010|FG000|Overall Study|Lost to Follow-up|2|||
124821681|NCT02573350|448974011|FG001|Overall Study|Lost to Follow-up|1|||
124821682|NCT02573350|448974010|FG000|Overall Study|Adverse Event|3|||
124821683|NCT02573350|448974011|FG001|Overall Study|Adverse Event|4|||
124821684|NCT02573350|448974010|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
124821685|NCT02573350|448974011|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
124821686|NCT02573350|448974010|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
124821687|NCT02573350|448974011|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
124821688|NCT02573350|448974010|FG000|Overall Study|Subject withdrew consent to participate|6|||
124821689|NCT02573350|448974011|FG001|Overall Study|Subject withdrew consent to participate|1|||
124821690|NCT02573350|448974010|FG000|Overall Study|Protocol Deviation|1|||
124821691|NCT02573350|448974011|FG001|Overall Study|Protocol Deviation|1|||
124821692|NCT00743340|448974012|FG000|Overall Study|Study medication non-compliance|1|||
124821693|NCT00743340|448974012|FG000|Overall Study|Lost to Follow-up|1|||
124821694|NCT00743340|448974012|FG000|Overall Study|Withdrawal from the Study|5|||
124821695|NCT00743340|448974012|FG000|Overall Study|Protocol Violation|1|||
124821696|NCT00743340|448974012|FG000|Overall Study|Virologic failure|8|||
124821697|NCT00743340|448974012|FG000|Overall Study|Pregnancy|1|||
124821698|NCT00743340|448974012|FG000|Overall Study|Rolled over to other Gilead Study|23|||
124821699|NCT00743340|448974012|FG000|Overall Study|Participant Relocated|1|||
124821700|NCT02708121|448974015|FG000|Overall Study|Withdrawn by Study Team|1|||
124821701|NCT02708121|448974016|FG001|Overall Study|Withdrawn by Study Team|1|||
124821702|NCT02708121|448974015|FG000|Overall Study|Withdrawal by Subject|0|||
124821703|NCT02708121|448974016|FG001|Overall Study|Withdrawal by Subject|4|||
124821704|NCT01425281|448974019|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
124821705|NCT01425281|448974020|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
124821706|NCT01425281|448974019|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
124821707|NCT01425281|448974020|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
124821708|NCT01425281|448974019|FG000|At 180-day Clinical Follow-up|Death|0|||
124821709|NCT01425281|448974020|FG001|At 180-day Clinical Follow-up|Death|1|||
124821710|NCT01425281|448974019|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
124821711|NCT01425281|448974020|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
124821712|NCT01425281|448974019|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
124821713|NCT01425281|448974020|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
124821714|NCT01425281|448974019|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
124821715|NCT01425281|448974020|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
124821716|NCT01425281|448974019|FG000|At 2-year Clinical Follow-up|Death|2|||
124821717|NCT01425281|448974020|FG001|At 2-year Clinical Follow-up|Death|0|||
124821718|NCT01425281|448974019|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
124821719|NCT01425281|448974020|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
124821720|NCT01425281|448974019|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
124821721|NCT01425281|448974020|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
124821722|NCT01425281|448974019|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
124821723|NCT01425281|448974020|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
124821724|NCT01425281|448974019|FG000|At 3-year Clinical Follow-up|Death|2|||
124821725|NCT01425281|448974020|FG001|At 3-year Clinical Follow-up|Death|3|||
124821726|NCT01425281|448974019|FG000|At 4-year Clinical Follow-up|Death|7|||
124821727|NCT01425281|448974020|FG001|At 4-year Clinical Follow-up|Death|3|||
124821728|NCT01425281|448974019|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
124821729|NCT01425281|448974020|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
124821730|NCT01425281|448974019|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
124821731|NCT01425281|448974020|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
124821732|NCT01425281|448974019|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
124821733|NCT01425281|448974020|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
124821734|NCT01425281|448974019|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
124821735|NCT01425281|448974020|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
124821736|NCT01425281|448974019|FG000|At 5-year Clinical Follow-up|Death|2|||
124821737|NCT01425281|448974020|FG001|At 5-year Clinical Follow-up|Death|0|||
124821738|NCT01425281|448974019|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
124821739|NCT01425281|448974020|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
124821740|NCT01425281|448974019|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
124821741|NCT01425281|448974020|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
124821742|NCT01425281|448974019|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
124821743|NCT01425281|448974020|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
124821744|NCT01833520|448974021|FG000|Overall Study|Lack of Efficacy|3|||
124821745|NCT01833520|448974022|FG001|Overall Study|Lack of Efficacy|3|||
124821746|NCT01833520|448974023|FG002|Overall Study|Lack of Efficacy|8|||
124821747|NCT01833520|448974024|FG003|Overall Study|Lack of Efficacy|3|||
124821748|NCT02743520|448974025|FG000|Overall Study|Withdrawal by Subject|1|||
124821749|NCT01749514|448974026|FG000|Overall Study|Lost to Follow-up|0|||
124821750|NCT01749514|448974027|FG001|Overall Study|Lost to Follow-up|0|||
124821751|NCT01749514|448974028|FG002|Overall Study|Lost to Follow-up|0|||
124821752|NCT01749514|448974029|FG003|Overall Study|Lost to Follow-up|0|||
124821753|NCT01749514|448974030|FG004|Overall Study|Lost to Follow-up|0|||
124821754|NCT01749514|448974031|FG005|Overall Study|Lost to Follow-up|0|||
124821755|NCT01749514|448974032|FG006|Overall Study|Lost to Follow-up|0|||
124821756|NCT01749514|448974033|FG007|Overall Study|Lost to Follow-up|1|||
124821757|NCT01749514|448974026|FG000|Overall Study|Withdrawal by Subject|0|||
124821758|NCT01749514|448974027|FG001|Overall Study|Withdrawal by Subject|0|||
124821759|NCT01749514|448974028|FG002|Overall Study|Withdrawal by Subject|0|||
124821760|NCT01749514|448974029|FG003|Overall Study|Withdrawal by Subject|0|||
124821761|NCT01749514|448974030|FG004|Overall Study|Withdrawal by Subject|0|||
124821762|NCT01749514|448974031|FG005|Overall Study|Withdrawal by Subject|1|||
124821763|NCT01749514|448974032|FG006|Overall Study|Withdrawal by Subject|0|||
124821764|NCT01749514|448974033|FG007|Overall Study|Withdrawal by Subject|1|||
124821765|NCT01749514|448974026|FG000|Overall Study|Not Reported|0|||
124821766|NCT01749514|448974027|FG001|Overall Study|Not Reported|0|||
124821767|NCT01749514|448974028|FG002|Overall Study|Not Reported|0|||
124821768|NCT01749514|448974029|FG003|Overall Study|Not Reported|0|||
124821769|NCT01749514|448974030|FG004|Overall Study|Not Reported|0|||
124821770|NCT01749514|448974031|FG005|Overall Study|Not Reported|0|||
124821771|NCT01749514|448974032|FG006|Overall Study|Not Reported|0|||
124821772|NCT01749514|448974033|FG007|Overall Study|Not Reported|5|||
124821773|NCT01979016|448974034|FG000|Overall Study|Withdrawal by Subject|2|||
124821774|NCT01979016|448974035|FG001|Overall Study|Withdrawal by Subject|0|||
124821775|NCT01979016|448974034|FG000|Overall Study|Adverse Event|0|||
124821776|NCT01979016|448974035|FG001|Overall Study|Adverse Event|1|||
124821777|NCT04983264|448974037|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
124637986|NCT04157296|448292498|FG000|Overall Study|MRI failed/no second fMRI|0|||
124821778|NCT04983264|448974038|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
124821779|NCT04983264|448974039|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
124821780|NCT04983264|448974037|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
124821781|NCT04983264|448974038|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
124821782|NCT04983264|448974039|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
124821783|NCT00938639|448974040|FG000|Overall Study|Moved away from study area|0|||
124637987|NCT04157296|448292499|FG001|Overall Study|MRI failed/no second fMRI|1|||
124821784|NCT00938639|448974041|FG001|Overall Study|Moved away from study area|1|||
124821785|NCT00938639|448974040|FG000|Overall Study|Lost to Follow-up|1|||
124821786|NCT00938639|448974041|FG001|Overall Study|Lost to Follow-up|2|||
124821787|NCT00938639|448974040|FG000|Overall Study|Family issues|1|||
124821788|NCT00938639|448974041|FG001|Overall Study|Family issues|1|||
124821789|NCT00938639|448974040|FG000|Overall Study|Participant noncompliance|1|||
124821790|NCT00938639|448974041|FG001|Overall Study|Participant noncompliance|0|||
124821791|NCT02509156|448974044|FG000|Randomized Phase|Death|1|||
124821792|NCT02509156|448974045|FG001|Randomized Phase|Death|0|||
124821793|NCT02509156|448974044|FG000|Randomized Phase|Withdrawal by Subject|1|||
124821794|NCT02509156|448974045|FG001|Randomized Phase|Withdrawal by Subject|1|||
124821795|NCT02547649|448974046|FG000|Overall Study|Lost to Follow-up|3|||
124821796|NCT02547649|448974047|FG001|Overall Study|Lost to Follow-up|1|||
124821797|NCT02547649|448974048|FG002|Overall Study|Lost to Follow-up|1|||
124821798|NCT02547649|448974046|FG000|Overall Study|Not vaccinated|0|||
124821799|NCT02547649|448974047|FG001|Overall Study|Not vaccinated|0|||
124821800|NCT02547649|448974048|FG002|Overall Study|Not vaccinated|1|||
124821801|NCT02547649|448974046|FG000|Overall Study|Withdrawal by Subject|0|||
124821802|NCT02547649|448974047|FG001|Overall Study|Withdrawal by Subject|4|||
124821803|NCT02547649|448974048|FG002|Overall Study|Withdrawal by Subject|2|||
124821804|NCT04326231|448974049|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
124821805|NCT02551731|448974052|FG000|Overall Study|Withdrawal by Subject|2|||
124821806|NCT01750242|448974061|FG000|Overall Study|Unreadable Images|3|||
124821807|NCT03765918|448974064|FG000|Overall Study|Death|109|||
124821808|NCT03765918|448974065|FG001|Overall Study|Death|127|||
124821809|NCT03765918|448974064|FG000|Overall Study|Lost to Follow-up|2|||
124821810|NCT03765918|448974065|FG001|Overall Study|Lost to Follow-up|3|||
124821811|NCT03765918|448974064|FG000|Overall Study|Withdrawal by Subject|12|||
124821812|NCT03765918|448974065|FG001|Overall Study|Withdrawal by Subject|16|||
124821813|NCT03765918|448974064|FG000|Overall Study|Participants Ongoing|240|||
124821814|NCT03765918|448974065|FG001|Overall Study|Participants Ongoing|205|||
124821815|NCT04202965|448974066|FG000|Overall Study|Adverse Event|3|||
124821816|NCT04202965|448974066|FG000|Overall Study|Did not meet inclusion criteria|1|||
124821817|NCT00006903|448974067|FG000|Overall Study|Still receiving treatment|0|||
124821818|NCT00006903|448974068|FG001|Overall Study|Still receiving treatment|0|||
124821819|NCT00006903|448974069|FG002|Overall Study|Still receiving treatment|1|||
124821820|NCT00006903|448974067|FG000|Overall Study|Refused further treatment|0|||
124821821|NCT00006903|448974068|FG001|Overall Study|Refused further treatment|2|||
124821822|NCT00006903|448974069|FG002|Overall Study|Refused further treatment|1|||
124821823|NCT00006903|448974067|FG000|Overall Study|Adverse Event|0|||
124821824|NCT00006903|448974068|FG001|Overall Study|Adverse Event|0|||
124821825|NCT00006903|448974069|FG002|Overall Study|Adverse Event|1|||
124821826|NCT00006903|448974067|FG000|Overall Study|Death|0|||
124821827|NCT00006903|448974068|FG001|Overall Study|Death|1|||
124821828|NCT00006903|448974069|FG002|Overall Study|Death|0|||
124821829|NCT00006903|448974067|FG000|Overall Study|Patient never treated|0|||
124821830|NCT00006903|448974068|FG001|Overall Study|Patient never treated|0|||
124821831|NCT00006903|448974069|FG002|Overall Study|Patient never treated|1|||
124821832|NCT00006903|448974067|FG000|Overall Study|Ineligible|10|||
124821833|NCT00006903|448974068|FG001|Overall Study|Ineligible|1|||
124821834|NCT00006903|448974069|FG002|Overall Study|Ineligible|2|||
124821835|NCT01678911|448974079|FG000|Second Intervention|Lost to Follow-up|2|||
124821836|NCT01678911|448974080|FG001|Second Intervention|Lost to Follow-up|0|||
124821837|NCT02706691|448974082|FG000|Overall Study|Adverse Event|1|||
124821838|NCT01402492|448974083|FG000|Overall Study|Withdrawal by Subject|17|||
124821839|NCT01402492|448974084|FG001|Overall Study|Withdrawal by Subject|11|||
124821840|NCT01402492|448974085|FG002|Overall Study|Withdrawal by Subject|11|||
124821841|NCT01402492|448974083|FG000|Overall Study|Adverse Event|2|||
124821842|NCT01402492|448974084|FG001|Overall Study|Adverse Event|3|||
124821843|NCT01402492|448974085|FG002|Overall Study|Adverse Event|4|||
124821844|NCT01402492|448974083|FG000|Overall Study|Physician Decision|0|||
124821845|NCT01402492|448974084|FG001|Overall Study|Physician Decision|3|||
124821846|NCT01402492|448974085|FG002|Overall Study|Physician Decision|0|||
124821847|NCT01402492|448974083|FG000|Overall Study|Incarcerated (N=3)|2|||
124821848|NCT01402492|448974084|FG001|Overall Study|Incarcerated (N=3)|0|||
124821849|NCT01402492|448974085|FG002|Overall Study|Incarcerated (N=3)|1|||
124821850|NCT01980992|448974086|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
124821851|NCT01980992|448974087|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
124821852|NCT01980992|448974086|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
124821853|NCT01980992|448974087|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
124637988|NCT01431716|448292511|FG000|Overall Study|Withdrawal of consent|1|||
124821854|NCT01980992|448974086|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
124821855|NCT01980992|448974087|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
124821856|NCT01980992|448974086|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
124821857|NCT01980992|448974087|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
124821858|NCT01980992|448974086|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
124821859|NCT01980992|448974087|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
124821860|NCT01980992|448974086|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
124821861|NCT01980992|448974087|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
124821862|NCT01366209|448974092|FG000|Overall Study|Adverse Event|6|||
124821863|NCT01366209|448974093|FG001|Overall Study|Adverse Event|7|||
124821864|NCT01366209|448974092|FG000|Overall Study|Withdrawal by Subject|4|||
124821865|NCT01366209|448974093|FG001|Overall Study|Withdrawal by Subject|4|||
124821866|NCT01366209|448974092|FG000|Overall Study|Death|12|||
124821867|NCT01366209|448974093|FG001|Overall Study|Death|19|||
124821868|NCT01366209|448974092|FG000|Overall Study|Lung transplantation|6|||
124821869|NCT01366209|448974093|FG001|Overall Study|Lung transplantation|1|||
124821870|NCT01366209|448974092|FG000|Overall Study|Lost to Follow-up|2|||
124821871|NCT01366209|448974093|FG001|Overall Study|Lost to Follow-up|1|||
124821872|NCT01366209|448974092|FG000|Overall Study|Physician Decision|1|||
124821873|NCT01366209|448974093|FG001|Overall Study|Physician Decision|0|||
124821874|NCT01366209|448974092|FG000|Overall Study|Sponsors decision|0|||
124821875|NCT01366209|448974093|FG001|Overall Study|Sponsors decision|1|||
124821876|NCT01366209|448974092|FG000|Overall Study|Withdrew consent|4|||
124821877|NCT01366209|448974093|FG001|Overall Study|Withdrew consent|3|||
124821878|NCT01985867|448974094|FG000|Overall Study|Lost to Follow-up|3|||
124821879|NCT01985867|448974095|FG001|Overall Study|Lost to Follow-up|4|||
124821880|NCT01985867|448974094|FG000|Overall Study|Adverse Event|3|||
124821881|NCT01985867|448974095|FG001|Overall Study|Adverse Event|2|||
124821882|NCT01985867|448974094|FG000|Overall Study|Lack of Efficacy|1|||
124821883|NCT01985867|448974095|FG001|Overall Study|Lack of Efficacy|0|||
124821884|NCT02670837|448974096|FG000|Overall Study|Death|2|||
124821885|NCT02670837|448974097|FG001|Overall Study|Death|0|||
124821886|NCT02670837|448974098|FG002|Overall Study|Death|0|||
124821887|NCT00553514|448974101|FG000|Overall Study|Protocol deviation|0|||
124821888|NCT00553514|448974102|FG001|Overall Study|Protocol deviation|0|||
124821889|NCT00553514|448974103|FG002|Overall Study|Protocol deviation|0|||
124821890|NCT00553514|448974104|FG003|Overall Study|Protocol deviation|1|||
124821891|NCT00553514|448974105|FG004|Overall Study|Protocol deviation|0|||
124821892|NCT00553514|448974101|FG000|Overall Study|Lack of ovarian response|4|||
124821893|NCT00553514|448974102|FG001|Overall Study|Lack of ovarian response|5|||
124821894|NCT00553514|448974103|FG002|Overall Study|Lack of ovarian response|5|||
124821895|NCT00553514|448974104|FG003|Overall Study|Lack of ovarian response|5|||
124821896|NCT00553514|448974105|FG004|Overall Study|Lack of ovarian response|6|||
124821897|NCT00553514|448974101|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
124821898|NCT00553514|448974102|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
124821899|NCT00553514|448974103|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
124821900|NCT00553514|448974104|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
124821901|NCT00553514|448974105|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
124821902|NCT00553514|448974101|FG000|Overall Study|Risk of multiple pregnancy|0|||
124821903|NCT00553514|448974102|FG001|Overall Study|Risk of multiple pregnancy|2|||
124821904|NCT00553514|448974103|FG002|Overall Study|Risk of multiple pregnancy|0|||
124821905|NCT00553514|448974104|FG003|Overall Study|Risk of multiple pregnancy|1|||
124821906|NCT00553514|448974105|FG004|Overall Study|Risk of multiple pregnancy|0|||
124821907|NCT00553514|448974101|FG000|Overall Study|Other|1|||
124821908|NCT00553514|448974102|FG001|Overall Study|Other|1|||
124821909|NCT00553514|448974103|FG002|Overall Study|Other|0|||
124821910|NCT00553514|448974104|FG003|Overall Study|Other|0|||
124821911|NCT00553514|448974105|FG004|Overall Study|Other|1|||
124821912|NCT01442675|448974108|FG000|Overall Study|Protocol Violation|6|||
124821913|NCT01442675|448974108|FG000|Overall Study|Lost to Follow-up|2|||
124821914|NCT01442675|448974108|FG000|Overall Study|Withdrawal by Subject|4|||
124821915|NCT01919723|448974109|FG000|Overall Study|Blood Samples Hemolyzed|2|||
124821916|NCT01919723|448974110|FG001|Overall Study|Blood Samples Hemolyzed|2|||
124821917|NCT00752232|448974111|FG000|Overall Study|Protocol Violation|0|||
124821918|NCT00752232|448974112|FG001|Overall Study|Protocol Violation|0|||
124821919|NCT00752232|448974113|FG002|Overall Study|Protocol Violation|0|||
124821920|NCT00752232|448974114|FG003|Overall Study|Protocol Violation|0|||
124821921|NCT00752232|448974115|FG004|Overall Study|Protocol Violation|0|||
124821922|NCT00752232|448974116|FG005|Overall Study|Protocol Violation|1|||
124821923|NCT00752232|448974117|FG006|Overall Study|Protocol Violation|0|||
124821924|NCT00752232|448974111|FG000|Overall Study|Caregiver request|2|||
124821925|NCT00752232|448974112|FG001|Overall Study|Caregiver request|0|||
124821926|NCT00752232|448974113|FG002|Overall Study|Caregiver request|0|||
124821927|NCT00752232|448974114|FG003|Overall Study|Caregiver request|0|||
124821928|NCT00752232|448974115|FG004|Overall Study|Caregiver request|1|||
124821929|NCT00752232|448974116|FG005|Overall Study|Caregiver request|0|||
124821930|NCT00752232|448974117|FG006|Overall Study|Caregiver request|0|||
124821931|NCT00752232|448974111|FG000|Overall Study|Investigator request|0|||
124821932|NCT00752232|448974112|FG001|Overall Study|Investigator request|0|||
124821933|NCT00752232|448974113|FG002|Overall Study|Investigator request|0|||
124821934|NCT00752232|448974114|FG003|Overall Study|Investigator request|0|||
124821935|NCT00752232|448974115|FG004|Overall Study|Investigator request|1|||
124821936|NCT00752232|448974116|FG005|Overall Study|Investigator request|0|||
124821937|NCT00752232|448974117|FG006|Overall Study|Investigator request|0|||
124821938|NCT00752232|448974111|FG000|Overall Study|Subject request|0|||
124821939|NCT00752232|448974112|FG001|Overall Study|Subject request|0|||
124821940|NCT00752232|448974113|FG002|Overall Study|Subject request|1|||
124821941|NCT00752232|448974114|FG003|Overall Study|Subject request|0|||
124821942|NCT00752232|448974115|FG004|Overall Study|Subject request|0|||
124821943|NCT00752232|448974116|FG005|Overall Study|Subject request|0|||
124821944|NCT00752232|448974117|FG006|Overall Study|Subject request|0|||
124821945|NCT00752232|448974111|FG000|Overall Study|Group home admission|0|||
124821946|NCT00752232|448974112|FG001|Overall Study|Group home admission|0|||
124821947|NCT00752232|448974113|FG002|Overall Study|Group home admission|0|||
124821948|NCT00752232|448974114|FG003|Overall Study|Group home admission|1|||
124821949|NCT00752232|448974115|FG004|Overall Study|Group home admission|0|||
124821950|NCT00752232|448974116|FG005|Overall Study|Group home admission|0|||
124821951|NCT00752232|448974117|FG006|Overall Study|Group home admission|0|||
124821952|NCT00752232|448974111|FG000|Overall Study|Caregiver could not attend the subject|0|||
124821953|NCT00752232|448974112|FG001|Overall Study|Caregiver could not attend the subject|0|||
124821954|NCT00752232|448974113|FG002|Overall Study|Caregiver could not attend the subject|0|||
124821955|NCT00752232|448974114|FG003|Overall Study|Caregiver could not attend the subject|0|||
124821956|NCT00752232|448974115|FG004|Overall Study|Caregiver could not attend the subject|1|||
124821957|NCT00752232|448974116|FG005|Overall Study|Caregiver could not attend the subject|0|||
124821958|NCT00752232|448974117|FG006|Overall Study|Caregiver could not attend the subject|0|||
124821959|NCT04502589|448974118|FG000|Overall Study|Physician Decision|1|||
124821960|NCT04502589|448974119|FG001|Overall Study|Physician Decision|0|||
124821961|NCT00555321|448974120|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
124821962|NCT00555321|448974121|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
124821963|NCT00555321|448974122|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
124821964|NCT00555321|448974123|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
124821965|NCT00555321|448974124|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
124821966|NCT00555321|448974120|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
124821967|NCT00555321|448974121|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
124821968|NCT00555321|448974122|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
124821969|NCT00555321|448974123|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
124821970|NCT00555321|448974124|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
124821971|NCT00555321|448974120|FG000|Treatment Phase up to 12-months|Death|2|||
124821972|NCT00555321|448974121|FG001|Treatment Phase up to 12-months|Death|1|||
124821973|NCT00555321|448974122|FG002|Treatment Phase up to 12-months|Death|4|||
124821974|NCT00555321|448974123|FG003|Treatment Phase up to 12-months|Death|0|||
124821975|NCT00555321|448974124|FG004|Treatment Phase up to 12-months|Death|0|||
124821976|NCT00555321|448974120|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
124821977|NCT00555321|448974121|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
124821978|NCT00555321|448974122|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
124821979|NCT00555321|448974123|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
124821980|NCT00555321|448974124|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
124821981|NCT00555321|448974120|FG000|Treatment Phase up to 12-months|Other Reason|1|||
124821982|NCT00555321|448974121|FG001|Treatment Phase up to 12-months|Other Reason|3|||
124821983|NCT00555321|448974122|FG002|Treatment Phase up to 12-months|Other Reason|2|||
124821984|NCT00555321|448974123|FG003|Treatment Phase up to 12-months|Other Reason|0|||
124821985|NCT00555321|448974124|FG004|Treatment Phase up to 12-months|Other Reason|0|||
124821986|NCT00555321|448974120|FG000|Treatment Phase up to 12-months|Never treated|2|||
124821987|NCT00555321|448974121|FG001|Treatment Phase up to 12-months|Never treated|3|||
124821988|NCT00555321|448974122|FG002|Treatment Phase up to 12-months|Never treated|1|||
124821989|NCT00555321|448974123|FG003|Treatment Phase up to 12-months|Never treated|0|||
124821990|NCT00555321|448974124|FG004|Treatment Phase up to 12-months|Never treated|4|||
124821991|NCT00555321|448974120|FG000|Long-term Extension Phase|Adverse Event|2|||
124821992|NCT00555321|448974121|FG001|Long-term Extension Phase|Adverse Event|5|||
124821993|NCT00555321|448974122|FG002|Long-term Extension Phase|Adverse Event|2|||
124821994|NCT00555321|448974123|FG003|Long-term Extension Phase|Adverse Event|1|||
124821995|NCT00555321|448974124|FG004|Long-term Extension Phase|Adverse Event|0|||
124821996|NCT00555321|448974120|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
124821997|NCT00555321|448974121|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
124821998|NCT00555321|448974122|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
124821999|NCT00555321|448974123|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
124822000|NCT00555321|448974124|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
124822001|NCT00555321|448974120|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
124822002|NCT00555321|448974121|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
124822003|NCT00555321|448974122|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
124822004|NCT00555321|448974123|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
124822005|NCT00555321|448974124|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
124822006|NCT00555321|448974120|FG000|Long-term Extension Phase|Death|2|||
124822007|NCT00555321|448974121|FG001|Long-term Extension Phase|Death|0|||
124822008|NCT00555321|448974122|FG002|Long-term Extension Phase|Death|0|||
124822009|NCT00555321|448974123|FG003|Long-term Extension Phase|Death|3|||
124822010|NCT00555321|448974124|FG004|Long-term Extension Phase|Death|0|||
124822011|NCT00555321|448974120|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
124822012|NCT00555321|448974121|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
124822013|NCT00555321|448974122|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
124822014|NCT00555321|448974123|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
124822015|NCT00555321|448974124|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
124822016|NCT00555321|448974120|FG000|Long-term Extension Phase|Other Reason|1|||
124822017|NCT00555321|448974121|FG001|Long-term Extension Phase|Other Reason|0|||
124822018|NCT00555321|448974122|FG002|Long-term Extension Phase|Other Reason|2|||
124822019|NCT00555321|448974123|FG003|Long-term Extension Phase|Other Reason|0|||
124822020|NCT00555321|448974124|FG004|Long-term Extension Phase|Other Reason|0|||
124822021|NCT00160251|448974125|FG000|Prior to Amendment 2|Adverse Event|2|||
124822022|NCT00160251|448974126|FG001|Prior to Amendment 2|Adverse Event|1|||
124822023|NCT00160251|448974127|FG002|Prior to Amendment 2|Adverse Event|3|||
124822024|NCT00160251|448974128|FG003|Prior to Amendment 2|Adverse Event|1|||
124822025|NCT00160251|448974129|FG004|Prior to Amendment 2|Adverse Event|1|||
124822026|NCT00160251|448974130|FG005|Prior to Amendment 2|Adverse Event|1|||
124822027|NCT00160251|448974131|FG006|Prior to Amendment 2|Adverse Event|1|||
124822028|NCT00160251|448974132|FG007|Prior to Amendment 2|Adverse Event|0|||
124822029|NCT00160251|448974125|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
124822030|NCT00160251|448974126|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
124822031|NCT00160251|448974127|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
124822032|NCT00160251|448974128|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
124822033|NCT00160251|448974129|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
124822034|NCT00160251|448974130|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
124822035|NCT00160251|448974131|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
124822036|NCT00160251|448974132|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
124822037|NCT00160251|448974125|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
124822038|NCT00160251|448974126|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
124822039|NCT00160251|448974127|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
124822040|NCT00160251|448974128|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
124822041|NCT00160251|448974129|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
124822042|NCT00160251|448974130|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
124822043|NCT00160251|448974131|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
124822044|NCT00160251|448974132|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
124822045|NCT00160251|448974125|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
124822046|NCT00160251|448974126|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
124822047|NCT00160251|448974127|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
124822048|NCT00160251|448974128|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
124822049|NCT00160251|448974129|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
124822050|NCT00160251|448974130|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
124822051|NCT00160251|448974131|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
124822052|NCT00160251|448974132|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
124822053|NCT00160251|448974125|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
124822054|NCT00160251|448974126|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
124822055|NCT00160251|448974127|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
124822056|NCT00160251|448974128|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
124822057|NCT00160251|448974129|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
124822058|NCT00160251|448974130|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
124822059|NCT00160251|448974131|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
124822060|NCT00160251|448974132|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
124822061|NCT00160251|448974125|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
124822062|NCT00160251|448974126|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
124822063|NCT00160251|448974127|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
124822064|NCT00160251|448974128|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
124822065|NCT00160251|448974129|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
124637989|NCT00014495|448292516|FG000|Overall Study|Death|0|||
124637990|NCT00014495|448292517|FG001|Overall Study|Death|0|||
124637991|NCT00014495|448292518|FG002|Overall Study|Death|1|||
124637992|NCT00014495|448292519|FG003|Overall Study|Death|0|||
124637993|NCT00014495|448292516|FG000|Overall Study|Clinical deterioration|0|||
124637994|NCT00014495|448292517|FG001|Overall Study|Clinical deterioration|0|||
124637995|NCT00014495|448292518|FG002|Overall Study|Clinical deterioration|0|||
124637996|NCT00014495|448292519|FG003|Overall Study|Clinical deterioration|1|||
124637997|NCT00984542|448292520|FG000|Overall Study|disease progression|19|||
124637998|NCT00984542|448292520|FG000|Overall Study|toxicity|7|||
124822066|NCT00160251|448974130|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
124822067|NCT00160251|448974131|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
124637999|NCT00984542|448292520|FG000|Overall Study|Death|7|||
124638000|NCT00984542|448292520|FG000|Overall Study|complicating disease|3|||
124638001|NCT00984542|448292520|FG000|Overall Study|Withdrawal by Subject|3|||
124822068|NCT00160251|448974132|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
124822069|NCT00160251|448974125|FG000|Post-amendment 2|Adverse Event|0|||
124822070|NCT00160251|448974126|FG001|Post-amendment 2|Adverse Event|0|||
124822071|NCT00160251|448974127|FG002|Post-amendment 2|Adverse Event|0|||
124822072|NCT00160251|448974128|FG003|Post-amendment 2|Adverse Event|0|||
124822073|NCT00160251|448974129|FG004|Post-amendment 2|Adverse Event|0|||
124822074|NCT00160251|448974130|FG005|Post-amendment 2|Adverse Event|0|||
124822075|NCT00160251|448974131|FG006|Post-amendment 2|Adverse Event|0|||
124822076|NCT00160251|448974132|FG007|Post-amendment 2|Adverse Event|20|||
124822077|NCT00160251|448974125|FG000|Post-amendment 2|Lack of Efficacy|0|||
124822078|NCT00160251|448974126|FG001|Post-amendment 2|Lack of Efficacy|0|||
124822079|NCT00160251|448974127|FG002|Post-amendment 2|Lack of Efficacy|0|||
124822080|NCT00160251|448974128|FG003|Post-amendment 2|Lack of Efficacy|0|||
124822081|NCT00160251|448974129|FG004|Post-amendment 2|Lack of Efficacy|0|||
124822082|NCT00160251|448974130|FG005|Post-amendment 2|Lack of Efficacy|0|||
124822083|NCT00160251|448974131|FG006|Post-amendment 2|Lack of Efficacy|0|||
124822084|NCT00160251|448974132|FG007|Post-amendment 2|Lack of Efficacy|24|||
124822085|NCT00160251|448974125|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
124822086|NCT00160251|448974126|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
124822087|NCT00160251|448974127|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
124822088|NCT00160251|448974128|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
124822089|NCT00160251|448974129|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
124822090|NCT00160251|448974130|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
124822091|NCT00160251|448974131|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
124822092|NCT00160251|448974132|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
124822093|NCT00582166|448974135|FG000|Overall Study|Death|1|||
124822094|NCT00582166|448974135|FG000|Overall Study|Ineligible pathology|1|||
124822095|NCT00126568|448974136|FG000|Overall Study|Death|2|||
124822096|NCT00580606|448974140|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
124822097|NCT00580606|448974141|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
124822098|NCT00580606|448974140|FG000|Open Label (OL)|Withdrawal by Subject|4|||
124822099|NCT00580606|448974141|FG001|Open Label (OL)|Withdrawal by Subject|6|||
124822100|NCT00580606|448974140|FG000|Open Label (OL)|Dosing Symptoms|0|||
124822101|NCT00580606|448974141|FG001|Open Label (OL)|Dosing Symptoms|1|||
124822102|NCT00580606|448974140|FG000|Open Label (OL)|Lost to Follow-up|0|||
124822103|NCT00580606|448974141|FG001|Open Label (OL)|Lost to Follow-up|1|||
124822104|NCT00580606|448974140|FG000|Open Label (OL)|Pregnancy|0|||
124822105|NCT00580606|448974141|FG001|Open Label (OL)|Pregnancy|1|||
124822106|NCT00580606|448974140|FG000|Open Label (OL)|Non-compliance|2|||
124822107|NCT00580606|448974141|FG001|Open Label (OL)|Non-compliance|0|||
124822108|NCT00580606|448974140|FG000|Open Label (OL)|Physician Decision|1|||
124822109|NCT00580606|448974141|FG001|Open Label (OL)|Physician Decision|1|||
124822110|NCT00580606|448974140|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
124822111|NCT00580606|448974141|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
124822112|NCT03918447|448974144|FG000|Overall Study|Death|1|||
124822113|NCT03918447|448974145|FG001|Overall Study|Death|0|||
124822114|NCT03918447|448974144|FG000|Overall Study|Lost to Follow-up|13|||
124822115|NCT03918447|448974145|FG001|Overall Study|Lost to Follow-up|6|||
124822116|NCT03918447|448974144|FG000|Overall Study|Withdrawal by Subject|19|||
124822117|NCT03918447|448974145|FG001|Overall Study|Withdrawal by Subject|17|||
124822118|NCT03918447|448974144|FG000|Overall Study|Study Terminated by Sponsor|195|||
124822119|NCT03918447|448974145|FG001|Overall Study|Study Terminated by Sponsor|197|||
124822120|NCT03918447|448974144|FG000|Overall Study|Reason not Specified|0|||
124822121|NCT03918447|448974145|FG001|Overall Study|Reason not Specified|1|||
124822122|NCT03278613|448974146|FG000|Overall Study|Lost to Follow-up|3|||
124822123|NCT03278613|448974147|FG001|Overall Study|Lost to Follow-up|1|||
124822124|NCT01405456|448974148|FG000|Overall Study|Lost to Follow-up|2|||
124822125|NCT01405456|448974149|FG001|Overall Study|Lost to Follow-up|1|||
124822126|NCT01405456|448974148|FG000|Overall Study|Physician Decision|1|||
124822127|NCT01405456|448974149|FG001|Overall Study|Physician Decision|0|||
124638002|NCT00984542|448292520|FG000|Overall Study|clinical deterioration|2|||
124822128|NCT05353985|448974150|FG000|Overall Study|Adverse Event|5|||
124822129|NCT05353985|448974151|FG001|Overall Study|Adverse Event|7|||
124822130|NCT05353985|448974150|FG000|Overall Study|Lost to Follow-up|1|||
124822131|NCT05353985|448974151|FG001|Overall Study|Lost to Follow-up|1|||
124822132|NCT05353985|448974150|FG000|Overall Study|Protocol Violation|1|||
124822133|NCT05353985|448974151|FG001|Overall Study|Protocol Violation|0|||
124822134|NCT05353985|448974150|FG000|Overall Study|Withdrawal by Subject|13|||
124822135|NCT05353985|448974151|FG001|Overall Study|Withdrawal by Subject|17|||
124822136|NCT05353985|448974150|FG000|Overall Study|Reason Not Specified|1|||
124822137|NCT05353985|448974151|FG001|Overall Study|Reason Not Specified|0|||
124822138|NCT05353985|448974150|FG000|Overall Study|Randomized in Error & Not Treated|0|||
124822139|NCT05353985|448974151|FG001|Overall Study|Randomized in Error & Not Treated|1|||
124822140|NCT02989194|448975843|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
124822141|NCT02989194|448975844|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
124822142|NCT02989194|448975845|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
124822143|NCT02989194|448975843|FG000|Overall Study|Lost to Follow-up|0|||
124822144|NCT02989194|448975844|FG001|Overall Study|Lost to Follow-up|1|||
124822145|NCT02989194|448975845|FG002|Overall Study|Lost to Follow-up|0|||
124822146|NCT02989194|448975843|FG000|Overall Study|Withdrawal by Subject|0|||
124822147|NCT02989194|448975844|FG001|Overall Study|Withdrawal by Subject|1|||
124822148|NCT02989194|448975845|FG002|Overall Study|Withdrawal by Subject|0|||
124822149|NCT01327885|448975846|FG000|Overall Study|Disease progression-according to RECIST|173|||
124822150|NCT01327885|448975847|FG001|Overall Study|Disease progression-according to RECIST|165|||
124822151|NCT01327885|448975846|FG000|Overall Study|Clinical progression|24|||
124822152|NCT01327885|448975847|FG001|Overall Study|Clinical progression|27|||
124822153|NCT01327885|448975846|FG000|Overall Study|Adverse Event|14|||
124822154|NCT01327885|448975847|FG001|Overall Study|Adverse Event|10|||
124822155|NCT01327885|448975846|FG000|Overall Study|Subject choice|5|||
124822156|NCT01327885|448975847|FG001|Overall Study|Subject choice|10|||
124822157|NCT01327885|448975846|FG000|Overall Study|Other|8|||
124822158|NCT01327885|448975847|FG001|Overall Study|Other|6|||
124822159|NCT01327885|448975846|FG000|Overall Study|Withdrawal of consent from study|3|||
124822160|NCT01327885|448975847|FG001|Overall Study|Withdrawal of consent from study|4|||
124822161|NCT01327885|448975846|FG000|Overall Study|Not treated|1|||
124822162|NCT01327885|448975847|FG001|Overall Study|Not treated|1|||
124822163|NCT01327885|448975846|FG000|Overall Study|Administrative decision|0|||
124822164|NCT01327885|448975847|FG001|Overall Study|Administrative decision|1|||
124822165|NCT03824912|448975848|FG000|Overall Study|Lost to Follow-up|18|||
124822166|NCT03824912|448975849|FG001|Overall Study|Lost to Follow-up|15|||
124822167|NCT03824912|448975850|FG002|Overall Study|Lost to Follow-up|8|||
124822168|NCT03824912|448975848|FG000|Overall Study|Negative Baseline Culture Result|118|||
124822169|NCT03824912|448975849|FG001|Overall Study|Negative Baseline Culture Result|112|||
124822170|NCT03824912|448975850|FG002|Overall Study|Negative Baseline Culture Result|57|||
124822171|NCT03824912|448975848|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124822172|NCT03824912|448975849|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124822173|NCT03824912|448975850|FG002|Overall Study|Non-Compliance with Study Drug|1|||
124822174|NCT03824912|448975848|FG000|Overall Study|Protocol Violation|1|||
124822175|NCT03824912|448975849|FG001|Overall Study|Protocol Violation|4|||
124822176|NCT03824912|448975850|FG002|Overall Study|Protocol Violation|1|||
124822177|NCT03824912|448975848|FG000|Overall Study|Withdrawal by Subject|3|||
124822178|NCT03824912|448975849|FG001|Overall Study|Withdrawal by Subject|2|||
124822179|NCT03824912|448975850|FG002|Overall Study|Withdrawal by Subject|1|||
124822180|NCT03824912|448975848|FG000|Overall Study|Participation in another study|0|||
124822181|NCT03824912|448975849|FG001|Overall Study|Participation in another study|1|||
124822182|NCT03824912|448975850|FG002|Overall Study|Participation in another study|0|||
124822183|NCT02254486|448975857|FG000|Overall Study|Adverse Event|1|||
124822184|NCT02254486|448975858|FG001|Overall Study|Adverse Event|1|||
124822185|NCT02254486|448975857|FG000|Overall Study|Lack of Efficacy|1|||
124822186|NCT02254486|448975858|FG001|Overall Study|Lack of Efficacy|0|||
124822187|NCT02254486|448975857|FG000|Overall Study|Lost to Follow-up|2|||
124822188|NCT02254486|448975858|FG001|Overall Study|Lost to Follow-up|4|||
124822189|NCT02254486|448975857|FG000|Overall Study|Protocol Violation|1|||
124822190|NCT02254486|448975858|FG001|Overall Study|Protocol Violation|2|||
124822191|NCT02254486|448975857|FG000|Overall Study|Withdrawal by Subject|17|||
124822192|NCT02254486|448975858|FG001|Overall Study|Withdrawal by Subject|15|||
124822193|NCT02254486|448975857|FG000|Overall Study|GFR<60mL/min|16|||
124822194|NCT02254486|448975858|FG001|Overall Study|GFR<60mL/min|21|||
124822195|NCT02254486|448975857|FG000|Overall Study|Various|12|||
124822196|NCT02254486|448975858|FG001|Overall Study|Various|12|||
124822197|NCT01350414|448975865|FG000|Overall Study|Lost to Follow-up|13|||
124822198|NCT01350414|448975865|FG000|Overall Study|Withdrawal by Subject|4|||
124822199|NCT01350414|448975865|FG000|Overall Study|Physician Decision|2|||
124822200|NCT04166435|448975866|FG000|Overall Study|2 patients ineligible for response|2|||
124822201|NCT01484197|448975867|FG000|Treatment Period 1|Adverse Event|1|||
124822202|NCT01484197|448975868|FG001|Treatment Period 1|Adverse Event|0|||
124822203|NCT01484197|448975869|FG002|Treatment Period 1|Adverse Event|0|||
124822204|NCT01484197|448975870|FG003|Treatment Period 1|Adverse Event|0|||
124822205|NCT01484197|448975867|FG000|Treatment Period 2|Subject withdrew consent|0|||
124822206|NCT01484197|448975868|FG001|Treatment Period 2|Subject withdrew consent|0|||
124822207|NCT01484197|448975869|FG002|Treatment Period 2|Subject withdrew consent|0|||
124638003|NCT02091089|448292556|FG000|Overall Study|Lost to Follow-up|2|||
124822208|NCT01484197|448975870|FG003|Treatment Period 2|Subject withdrew consent|1|||
124822209|NCT03033394|448975873|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
124822210|NCT03033394|448975873|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
124822211|NCT03033394|448975873|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
124822212|NCT03033394|448975873|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
124822213|NCT03033394|448975873|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
124822214|NCT02036294|448975874|FG000|Overall Study|Death|7|||
124822215|NCT02036294|448975875|FG001|Overall Study|Death|8|||
124822216|NCT02036294|448975874|FG000|Overall Study|Withdrawal by Subject|2|||
124822217|NCT02036294|448975875|FG001|Overall Study|Withdrawal by Subject|3|||
124822218|NCT00356369|448975876|FG000|Active Phase|Withdrawal by Subject|2|||
124822219|NCT00356369|448975877|FG001|Active Phase|Withdrawal by Subject|1|||
124822220|NCT02117648|448975879|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
124822221|NCT02117648|448975879|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
124822222|NCT02117648|448975879|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
124822223|NCT02117648|448975879|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
124822224|NCT02117648|448975879|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
124822225|NCT02117648|448975879|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
124822226|NCT02117648|448975879|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
124822227|NCT02117648|448975879|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
124822228|NCT02117648|448975879|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
124822229|NCT02117648|448975879|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
124822230|NCT02117648|448975879|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
124822231|NCT02532972|448975884|FG000|Overall Study|Withdrawal by Subject|1|||
124822232|NCT01606436|448975885|FG000|Overall Study|Withdrawal by Subject|0|||
124822233|NCT01606436|448975886|FG001|Overall Study|Withdrawal by Subject|0|||
124822234|NCT01606436|448975887|FG002|Overall Study|Withdrawal by Subject|1|||
124822235|NCT01606436|448975888|FG003|Overall Study|Withdrawal by Subject|1|||
124822236|NCT01606436|448975889|FG004|Overall Study|Withdrawal by Subject|1|||
124822237|NCT01606436|448975890|FG005|Overall Study|Withdrawal by Subject|0|||
124822238|NCT01606436|448975885|FG000|Overall Study|Adverse Event|0|||
124822239|NCT01606436|448975886|FG001|Overall Study|Adverse Event|0|||
124822240|NCT01606436|448975887|FG002|Overall Study|Adverse Event|1|||
124822241|NCT01606436|448975888|FG003|Overall Study|Adverse Event|0|||
124822242|NCT01606436|448975889|FG004|Overall Study|Adverse Event|0|||
124822243|NCT01606436|448975890|FG005|Overall Study|Adverse Event|0|||
124822244|NCT01606436|448975885|FG000|Overall Study|Sponsor Decision|0|||
124822245|NCT01606436|448975886|FG001|Overall Study|Sponsor Decision|0|||
124822246|NCT01606436|448975887|FG002|Overall Study|Sponsor Decision|0|||
124822247|NCT01606436|448975888|FG003|Overall Study|Sponsor Decision|1|||
124822248|NCT01606436|448975889|FG004|Overall Study|Sponsor Decision|0|||
124822249|NCT01606436|448975890|FG005|Overall Study|Sponsor Decision|0|||
124822250|NCT02859454|448975891|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
124822251|NCT01025752|448975892|FG000|Overall Study|Lost to Follow-up|7|||
124822252|NCT01025752|448975893|FG001|Overall Study|Lost to Follow-up|10|||
124822253|NCT01025752|448975892|FG000|Overall Study|Physician Decision|1|||
124822254|NCT01025752|448975893|FG001|Overall Study|Physician Decision|3|||
124822255|NCT01417234|448975896|FG000|Overall Study|Subject non-compliant|3|||
124822256|NCT00023764|448975897|FG000|Overall Study|Other|1|||
124822257|NCT00023764|448975897|FG000|Overall Study|Adverse Event|4|||
124822258|NCT00023764|448975897|FG000|Overall Study|Withdrawal by Subject|1|||
124822259|NCT00023764|448975897|FG000|Overall Study|Progression of disease|6|||
124822260|NCT00023764|448975897|FG000|Overall Study|patient received other treatment|1|||
124822261|NCT00023764|448975897|FG000|Overall Study|delay in obtaining staging images|1|||
124822262|NCT02407704|448975900|FG000|Overall Study|Lost to Follow-up|0|||
124822263|NCT02407704|448975901|FG001|Overall Study|Lost to Follow-up|0|||
124822264|NCT02407704|448975902|FG002|Overall Study|Lost to Follow-up|0|||
124822265|NCT02407704|448975903|FG003|Overall Study|Lost to Follow-up|2|||
124822266|NCT02407704|448975900|FG000|Overall Study|Protocol Violation|0|||
124822267|NCT02407704|448975901|FG001|Overall Study|Protocol Violation|0|||
124822268|NCT02407704|448975902|FG002|Overall Study|Protocol Violation|0|||
124822269|NCT02407704|448975903|FG003|Overall Study|Protocol Violation|1|||
124822270|NCT02407704|448975900|FG000|Overall Study|Withdrawal by Subject|0|||
124822271|NCT02407704|448975901|FG001|Overall Study|Withdrawal by Subject|0|||
124822272|NCT02407704|448975902|FG002|Overall Study|Withdrawal by Subject|1|||
124822273|NCT02407704|448975903|FG003|Overall Study|Withdrawal by Subject|0|||
124822274|NCT03944954|448975904|FG000|Overall Study|Withdrawal by Subject|22|||
124822275|NCT03944954|448975905|FG001|Overall Study|Withdrawal by Subject|4|||
124822276|NCT03944954|448975904|FG000|Overall Study|Lost to Follow-up|18|||
124822277|NCT03944954|448975905|FG001|Overall Study|Lost to Follow-up|0|||
124822278|NCT03944954|448975904|FG000|Overall Study|Failed Medical Screening|7|||
124822279|NCT03944954|448975905|FG001|Overall Study|Failed Medical Screening|0|||
124822280|NCT02268084|448975912|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
124822281|NCT02268084|448975913|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
124822282|NCT02268084|448975912|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
124822283|NCT02268084|448975913|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
124822284|NCT05227027|448975914|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
124822285|NCT05227027|448975915|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
124822286|NCT03334448|448975921|FG000|Washout|Personal Reason|0|||
124822287|NCT03334448|448975922|FG001|Washout|Personal Reason|1|||
124822288|NCT03334448|448975923|FG002|Washout|Personal Reason|0|||
124822289|NCT03334448|448975924|FG003|Washout|Personal Reason|0|||
124822290|NCT03334448|448975921|FG000|Washout|Protocol Violation|0|||
124822291|NCT03334448|448975922|FG001|Washout|Protocol Violation|0|||
124822292|NCT03334448|448975923|FG002|Washout|Protocol Violation|0|||
124822293|NCT03334448|448975924|FG003|Washout|Protocol Violation|1|||
124822294|NCT01683383|448975925|FG000|Overall Study|Infant was not transported|1|||
124822295|NCT01683383|448975926|FG001|Overall Study|Infant was not transported|0|||
124822296|NCT00855920|448975927|FG000|Overall Study|Protocol Violation|0|||
124822297|NCT00855920|448975928|FG001|Overall Study|Protocol Violation|0|||
124822298|NCT00855920|448975929|FG002|Overall Study|Protocol Violation|2|||
124822299|NCT00855920|448975927|FG000|Overall Study|Adverse Event|2|||
124822300|NCT00855920|448975928|FG001|Overall Study|Adverse Event|1|||
124822301|NCT00855920|448975929|FG002|Overall Study|Adverse Event|1|||
124822302|NCT00855920|448975927|FG000|Overall Study|Lack of Efficacy|2|||
124822303|NCT00855920|448975928|FG001|Overall Study|Lack of Efficacy|2|||
124822304|NCT00855920|448975929|FG002|Overall Study|Lack of Efficacy|2|||
124822305|NCT00855920|448975927|FG000|Overall Study|Withdrawal by Subject|2|||
124822306|NCT00855920|448975928|FG001|Overall Study|Withdrawal by Subject|3|||
124822307|NCT00855920|448975929|FG002|Overall Study|Withdrawal by Subject|2|||
124822308|NCT00855920|448975927|FG000|Overall Study|Lost to Follow-up|1|||
124822309|NCT00855920|448975928|FG001|Overall Study|Lost to Follow-up|0|||
124822310|NCT00855920|448975929|FG002|Overall Study|Lost to Follow-up|2|||
124822311|NCT00855920|448975927|FG000|Overall Study|Death|0|||
124822312|NCT00855920|448975928|FG001|Overall Study|Death|1|||
124822313|NCT00855920|448975929|FG002|Overall Study|Death|0|||
124822314|NCT00855920|448975927|FG000|Overall Study|Decision by the sponsor|0|||
124822315|NCT00855920|448975928|FG001|Overall Study|Decision by the sponsor|1|||
124822316|NCT00855920|448975929|FG002|Overall Study|Decision by the sponsor|1|||
124822317|NCT00855920|448975927|FG000|Overall Study|Other than specified above|1|||
124822318|NCT00855920|448975928|FG001|Overall Study|Other than specified above|1|||
124822319|NCT00855920|448975929|FG002|Overall Study|Other than specified above|1|||
124822320|NCT00996307|448975930|FG000|Overall Study|Adverse Event|0|||
124822321|NCT00996307|448975931|FG001|Overall Study|Adverse Event|1|||
124822322|NCT00996307|448975932|FG002|Overall Study|Adverse Event|0|||
124822323|NCT00996307|448975933|FG003|Overall Study|Adverse Event|0|||
124822324|NCT00996307|448975930|FG000|Overall Study|Withdrawal by Subject|3|||
124822325|NCT00996307|448975931|FG001|Overall Study|Withdrawal by Subject|2|||
124822326|NCT00996307|448975932|FG002|Overall Study|Withdrawal by Subject|5|||
124822327|NCT00996307|448975933|FG003|Overall Study|Withdrawal by Subject|5|||
124822328|NCT00996307|448975930|FG000|Overall Study|Lost to Follow-up|13|||
124822329|NCT00996307|448975931|FG001|Overall Study|Lost to Follow-up|13|||
124822330|NCT00996307|448975932|FG002|Overall Study|Lost to Follow-up|7|||
124822331|NCT00996307|448975933|FG003|Overall Study|Lost to Follow-up|15|||
124822332|NCT00996307|448975930|FG000|Overall Study|Administrative reason|0|||
124822333|NCT00996307|448975931|FG001|Overall Study|Administrative reason|1|||
124822334|NCT00996307|448975932|FG002|Overall Study|Administrative reason|0|||
124822335|NCT00996307|448975933|FG003|Overall Study|Administrative reason|0|||
124822336|NCT00996307|448975930|FG000|Overall Study|Unable to classify|4|||
124822337|NCT00996307|448975931|FG001|Overall Study|Unable to classify|0|||
124822338|NCT00996307|448975932|FG002|Overall Study|Unable to classify|2|||
124822339|NCT00996307|448975933|FG003|Overall Study|Unable to classify|1|||
124822340|NCT02496611|448975936|FG000|Overall Study|Lost to Follow-up|2|||
124822341|NCT02496611|448975937|FG001|Overall Study|Lost to Follow-up|1|||
124822342|NCT02496611|448975936|FG000|Overall Study|Withdrawal by Subject|5|||
124822343|NCT02496611|448975937|FG001|Overall Study|Withdrawal by Subject|2|||
124822344|NCT02850965|448975938|FG000|Overall Study|Other than listed|3|||
124822345|NCT02850965|448975939|FG001|Overall Study|Other than listed|4|||
124822346|NCT02850965|448975938|FG000|Overall Study|Protocol Violation|0|||
124822347|NCT02850965|448975939|FG001|Overall Study|Protocol Violation|2|||
124822348|NCT02850965|448975938|FG000|Overall Study|Lost to Follow-up|5|||
124822349|NCT02850965|448975939|FG001|Overall Study|Lost to Follow-up|3|||
124822350|NCT02850965|448975938|FG000|Overall Study|Lack of Efficacy|4|||
124822351|NCT02850965|448975939|FG001|Overall Study|Lack of Efficacy|8|||
124822352|NCT02850965|448975938|FG000|Overall Study|Adverse Event|3|||
124822353|NCT02850965|448975939|FG001|Overall Study|Adverse Event|2|||
124638004|NCT02929589|448292558|FG000|Overall Study|Withdrawal by Subject|1|||
124638005|NCT02929589|448292559|FG001|Overall Study|Withdrawal by Subject|0|||
124638006|NCT02929589|448292560|FG002|Overall Study|Withdrawal by Subject|0|||
124638007|NCT02929589|448292561|FG003|Overall Study|Withdrawal by Subject|0|||
124638008|NCT02929589|448292558|FG000|Overall Study|Physician Decision|2|||
124822354|NCT02850965|448975938|FG000|Overall Study|Withdrawal by Subject|3|||
124822355|NCT02850965|448975939|FG001|Overall Study|Withdrawal by Subject|4|||
124822356|NCT02850965|448975938|FG000|Overall Study|Physician Decision|0|||
124822357|NCT02850965|448975939|FG001|Overall Study|Physician Decision|1|||
124822358|NCT02850965|448975938|FG000|Overall Study|Randomized but not treated|0|||
124822359|NCT02850965|448975939|FG001|Overall Study|Randomized but not treated|1|||
124822360|NCT02788357|448975942|FG000|Overall Study|Lost to Follow-up|3|||
124822361|NCT02788357|448975943|FG001|Overall Study|Lost to Follow-up|0|||
124822362|NCT00371137|448975944|FG000|Overall Study|Adverse Event|20|||
124638009|NCT02929589|448292559|FG001|Overall Study|Physician Decision|0|||
124822363|NCT00371137|448975945|FG001|Overall Study|Adverse Event|35|||
124822364|NCT00371137|448975946|FG002|Overall Study|Adverse Event|42|||
124822365|NCT00371137|448975944|FG000|Overall Study|Withdrawal by Subject|11|||
124822366|NCT00371137|448975945|FG001|Overall Study|Withdrawal by Subject|10|||
124822367|NCT00371137|448975946|FG002|Overall Study|Withdrawal by Subject|15|||
124822368|NCT00371137|448975944|FG000|Overall Study|Lost to Follow-up|6|||
124822369|NCT00371137|448975945|FG001|Overall Study|Lost to Follow-up|3|||
124822370|NCT00371137|448975946|FG002|Overall Study|Lost to Follow-up|5|||
124822371|NCT00371137|448975944|FG000|Overall Study|Lack of Efficacy|30|||
124822372|NCT00371137|448975945|FG001|Overall Study|Lack of Efficacy|12|||
124822373|NCT00371137|448975946|FG002|Overall Study|Lack of Efficacy|13|||
124822374|NCT00371137|448975944|FG000|Overall Study|Sponsor Decision|2|||
124822375|NCT00371137|448975945|FG001|Overall Study|Sponsor Decision|1|||
124822376|NCT00371137|448975946|FG002|Overall Study|Sponsor Decision|2|||
124822377|NCT00371137|448975944|FG000|Overall Study|Physician Decision|1|||
124822378|NCT00371137|448975945|FG001|Overall Study|Physician Decision|1|||
124822379|NCT00371137|448975946|FG002|Overall Study|Physician Decision|1|||
124822380|NCT00371137|448975944|FG000|Overall Study|Protocol Violation|2|||
124822381|NCT00371137|448975945|FG001|Overall Study|Protocol Violation|1|||
124822382|NCT00371137|448975946|FG002|Overall Study|Protocol Violation|1|||
124822383|NCT00536198|448975947|FG000|Overall Study|Lost to Follow-up|15|||
124822384|NCT00536198|448975948|FG001|Overall Study|Lost to Follow-up|14|||
124822385|NCT00536198|448975947|FG000|Overall Study|Withdrawal by Subject|16|||
124822386|NCT00536198|448975948|FG001|Overall Study|Withdrawal by Subject|12|||
124822387|NCT00536198|448975947|FG000|Overall Study|Adverse Event|2|||
124822388|NCT00536198|448975948|FG001|Overall Study|Adverse Event|2|||
124822389|NCT00536198|448975947|FG000|Overall Study|Rescue|3|||
124822390|NCT00536198|448975948|FG001|Overall Study|Rescue|9|||
124822391|NCT00536198|448975947|FG000|Overall Study|Pregnancy|1|||
124822392|NCT00536198|448975948|FG001|Overall Study|Pregnancy|1|||
124822393|NCT00536198|448975947|FG000|Overall Study|Protocol Violation|0|||
124822394|NCT00536198|448975948|FG001|Overall Study|Protocol Violation|1|||
124822395|NCT02013791|448975949|FG000|Period 1|Lost to Follow-up|0|||
124822396|NCT02013791|448975950|FG001|Period 1|Lost to Follow-up|0|||
124822397|NCT02013791|448975951|FG002|Period 1|Lost to Follow-up|0|||
124822398|NCT02013791|448975952|FG003|Period 1|Lost to Follow-up|1|||
124822399|NCT02013791|448975953|FG004|Period 1|Lost to Follow-up|0|||
124822400|NCT02013791|448975954|FG005|Period 1|Lost to Follow-up|0|||
124822401|NCT02013791|448975955|FG006|Period 1|Lost to Follow-up|1|||
124822402|NCT02013791|448975956|FG007|Period 1|Lost to Follow-up|1|||
124822403|NCT02013791|448975957|FG008|Period 1|Lost to Follow-up|0|||
124822404|NCT02013791|448975949|FG000|Period 1|Other Miscellaneous Reasons|0|||
124822405|NCT02013791|448975950|FG001|Period 1|Other Miscellaneous Reasons|2|||
124822406|NCT02013791|448975951|FG002|Period 1|Other Miscellaneous Reasons|0|||
124822407|NCT02013791|448975952|FG003|Period 1|Other Miscellaneous Reasons|0|||
124822408|NCT02013791|448975953|FG004|Period 1|Other Miscellaneous Reasons|0|||
124822409|NCT02013791|448975954|FG005|Period 1|Other Miscellaneous Reasons|0|||
124822410|NCT02013791|448975955|FG006|Period 1|Other Miscellaneous Reasons|0|||
124822411|NCT02013791|448975956|FG007|Period 1|Other Miscellaneous Reasons|0|||
124822412|NCT02013791|448975957|FG008|Period 1|Other Miscellaneous Reasons|0|||
124822413|NCT03798483|448975958|FG000|Overall Study|Lost to Follow-up|2|||
124822414|NCT00640601|448975963|FG000|Overall Study|Adverse Event|43|||
124822415|NCT00640601|448975963|FG000|Overall Study|Withdrawal by Subject|20|||
124822416|NCT00640601|448975963|FG000|Overall Study|Protocol Violation|6|||
124822417|NCT00640601|448975963|FG000|Overall Study|Lack of Efficacy|16|||
124822418|NCT00640601|448975963|FG000|Overall Study|Lost to Follow-up|9|||
124822419|NCT00640601|448975963|FG000|Overall Study|Physician Decision|8|||
124822420|NCT00640601|448975963|FG000|Overall Study|treatment naive, combination therapy|10|||
124822421|NCT02007109|448975964|FG000|Overall Study|Diary not returned or excluded|102|||
124822422|NCT02007109|448975964|FG000|Overall Study|Excluded - Age<7yo|9|||
124822423|NCT01918085|448975965|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
124822424|NCT01918085|448975966|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
124822425|NCT00646776|448975969|FG000|Overall Study|Adverse Event|1|||
124822426|NCT00646776|448975970|FG001|Overall Study|Adverse Event|9|||
124638010|NCT02929589|448292560|FG002|Overall Study|Physician Decision|0|||
124822427|NCT00646776|448975969|FG000|Overall Study|Investigator discretion|0|||
124822428|NCT00646776|448975970|FG001|Overall Study|Investigator discretion|4|||
124822429|NCT00439244|448975971|FG000|Overall Study|Adverse Event|5|||
124822430|NCT00439244|448975972|FG001|Overall Study|Adverse Event|2|||
124822431|NCT00439244|448975973|FG002|Overall Study|Adverse Event|3|||
124822432|NCT00439244|448975971|FG000|Overall Study|Withdrawal by Subject|3|||
124822433|NCT00439244|448975972|FG001|Overall Study|Withdrawal by Subject|1|||
124822434|NCT00439244|448975973|FG002|Overall Study|Withdrawal by Subject|2|||
124822435|NCT00439244|448975971|FG000|Overall Study|Lost to Follow-up|2|||
124822436|NCT00439244|448975972|FG001|Overall Study|Lost to Follow-up|1|||
124822437|NCT00439244|448975973|FG002|Overall Study|Lost to Follow-up|2|||
124822438|NCT00439244|448975971|FG000|Overall Study|Death|0|||
124822439|NCT00439244|448975972|FG001|Overall Study|Death|1|||
124822440|NCT00439244|448975973|FG002|Overall Study|Death|0|||
124822441|NCT00439244|448975971|FG000|Overall Study|Protocol Violation|0|||
124822442|NCT00439244|448975972|FG001|Overall Study|Protocol Violation|1|||
124822443|NCT00439244|448975973|FG002|Overall Study|Protocol Violation|0|||
124822444|NCT00439244|448975971|FG000|Overall Study|Administrative problems|1|||
124822445|NCT00439244|448975972|FG001|Overall Study|Administrative problems|0|||
124822446|NCT00439244|448975973|FG002|Overall Study|Administrative problems|0|||
124822447|NCT03655691|448975974|FG000|Overall Study|Adverse Event|0|||
124822448|NCT03655691|448975975|FG001|Overall Study|Adverse Event|0|||
124822449|NCT03655691|448975976|FG002|Overall Study|Adverse Event|1|||
124822450|NCT03655691|448975974|FG000|Overall Study|Lost to Follow-up|1|||
124822451|NCT03655691|448975975|FG001|Overall Study|Lost to Follow-up|1|||
124822452|NCT03655691|448975976|FG002|Overall Study|Lost to Follow-up|2|||
124822453|NCT03655691|448975974|FG000|Overall Study|Protocol Violation|0|||
124822454|NCT03655691|448975975|FG001|Overall Study|Protocol Violation|1|||
124822455|NCT03655691|448975976|FG002|Overall Study|Protocol Violation|0|||
124822456|NCT03655691|448975974|FG000|Overall Study|Withdrawal by Subject|1|||
124822457|NCT03655691|448975975|FG001|Overall Study|Withdrawal by Subject|1|||
124822458|NCT03655691|448975976|FG002|Overall Study|Withdrawal by Subject|0|||
124822459|NCT01753856|448975977|FG000|Overall Study|Adverse Event|1|||
124822460|NCT01753856|448975978|FG001|Overall Study|Adverse Event|0|||
124822461|NCT01753856|448975977|FG000|Overall Study|Withdrawal by Subject|0|||
124822462|NCT01753856|448975978|FG001|Overall Study|Withdrawal by Subject|2|||
124822463|NCT01753856|448975977|FG000|Overall Study|Sponsor Decision|2|||
124822464|NCT01753856|448975978|FG001|Overall Study|Sponsor Decision|0|||
124822465|NCT05109442|448975979|FG000|Overall Study|Withdrawal by Subject|0|||
124822466|NCT05109442|448975980|FG001|Overall Study|Withdrawal by Subject|0|||
124822467|NCT05109442|448975981|FG002|Overall Study|Withdrawal by Subject|1|||
124822468|NCT05109442|448975982|FG003|Overall Study|Withdrawal by Subject|0|||
124822469|NCT05109442|448975983|FG004|Overall Study|Withdrawal by Subject|0|||
124822470|NCT05109442|448975984|FG005|Overall Study|Withdrawal by Subject|0|||
124822471|NCT05109442|448975979|FG000|Overall Study|Adverse Event|0|||
124822472|NCT05109442|448975980|FG001|Overall Study|Adverse Event|1|||
124822473|NCT05109442|448975981|FG002|Overall Study|Adverse Event|5|||
124822474|NCT05109442|448975982|FG003|Overall Study|Adverse Event|0|||
124822475|NCT05109442|448975983|FG004|Overall Study|Adverse Event|0|||
124822476|NCT05109442|448975984|FG005|Overall Study|Adverse Event|2|||
124822477|NCT05109442|448975979|FG000|Overall Study|Death|0|||
124822478|NCT05109442|448975980|FG001|Overall Study|Death|0|||
124822479|NCT05109442|448975981|FG002|Overall Study|Death|4|||
124822480|NCT05109442|448975982|FG003|Overall Study|Death|0|||
124822481|NCT05109442|448975983|FG004|Overall Study|Death|0|||
124822482|NCT05109442|448975984|FG005|Overall Study|Death|1|||
124822483|NCT05109442|448975979|FG000|Overall Study|Physician Decision|1|||
124822484|NCT05109442|448975980|FG001|Overall Study|Physician Decision|0|||
124822485|NCT05109442|448975981|FG002|Overall Study|Physician Decision|1|||
124822486|NCT05109442|448975982|FG003|Overall Study|Physician Decision|0|||
124822487|NCT05109442|448975983|FG004|Overall Study|Physician Decision|0|||
124822488|NCT05109442|448975984|FG005|Overall Study|Physician Decision|2|||
124822489|NCT05109442|448975979|FG000|Overall Study|Other than listed|0|||
124822490|NCT05109442|448975980|FG001|Overall Study|Other than listed|0|||
124822491|NCT05109442|448975981|FG002|Overall Study|Other than listed|9|||
124822492|NCT05109442|448975982|FG003|Overall Study|Other than listed|2|||
124822493|NCT05109442|448975983|FG004|Overall Study|Other than listed|0|||
124822494|NCT05109442|448975984|FG005|Overall Study|Other than listed|8|||
124822495|NCT05109442|448975979|FG000|Overall Study|Lack of Efficacy|3|||
124822496|NCT05109442|448975980|FG001|Overall Study|Lack of Efficacy|5|||
124822497|NCT05109442|448975981|FG002|Overall Study|Lack of Efficacy|29|||
124822498|NCT05109442|448975982|FG003|Overall Study|Lack of Efficacy|10|||
124822499|NCT05109442|448975983|FG004|Overall Study|Lack of Efficacy|11|||
124822500|NCT05109442|448975984|FG005|Overall Study|Lack of Efficacy|17|||
124822501|NCT04853225|448975985|FG000|Overall Study|Withdrawal by Subject|81|||
124822502|NCT04853225|448975986|FG001|Overall Study|Withdrawal by Subject|4|||
124822503|NCT04853225|448975987|FG002|Overall Study|Withdrawal by Subject|1|||
124822504|NCT04853225|448975985|FG000|Overall Study|Physician Decision|12|||
124822505|NCT04853225|448975986|FG001|Overall Study|Physician Decision|4|||
124822506|NCT04853225|448975987|FG002|Overall Study|Physician Decision|1|||
124822507|NCT04853225|448975985|FG000|Overall Study|Lost to Follow-up|50|||
124822508|NCT04853225|448975986|FG001|Overall Study|Lost to Follow-up|0|||
124822509|NCT04853225|448975987|FG002|Overall Study|Lost to Follow-up|0|||
124822510|NCT04853225|448975985|FG000|Overall Study|Other|102|||
124822511|NCT04853225|448975986|FG001|Overall Study|Other|11|||
124822512|NCT04853225|448975987|FG002|Overall Study|Other|5|||
124822513|NCT04853225|448975985|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
124822514|NCT04853225|448975986|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
124822515|NCT04853225|448975987|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
124822516|NCT04853225|448975985|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
124822517|NCT04853225|448975986|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
124822518|NCT04853225|448975987|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
124822519|NCT00793598|448977250|FG000|Overall Study|Patient Request|0|||
124822520|NCT00793598|448977251|FG001|Overall Study|Patient Request|1|||
124822521|NCT00793598|448977252|FG002|Overall Study|Patient Request|0|||
124822522|NCT00793598|448977253|FG003|Overall Study|Patient Request|0|||
124822523|NCT00793598|448977254|FG004|Overall Study|Patient Request|0|||
124822524|NCT00793598|448977255|FG005|Overall Study|Patient Request|0|||
124822525|NCT00793598|448977256|FG006|Overall Study|Patient Request|0|||
124822526|NCT00793598|448977257|FG007|Overall Study|Patient Request|0|||
124822527|NCT00793598|448977250|FG000|Overall Study|Protocol Violation|0|||
124822528|NCT00793598|448977251|FG001|Overall Study|Protocol Violation|0|||
124822529|NCT00793598|448977252|FG002|Overall Study|Protocol Violation|0|||
124822530|NCT00793598|448977253|FG003|Overall Study|Protocol Violation|0|||
124822531|NCT00793598|448977254|FG004|Overall Study|Protocol Violation|0|||
124822532|NCT00793598|448977255|FG005|Overall Study|Protocol Violation|0|||
124822533|NCT00793598|448977256|FG006|Overall Study|Protocol Violation|0|||
124822534|NCT00793598|448977257|FG007|Overall Study|Protocol Violation|1|||
124822535|NCT00793598|448977250|FG000|Overall Study|Subject not dosed|0|||
124822536|NCT00793598|448977251|FG001|Overall Study|Subject not dosed|0|||
124822537|NCT00793598|448977252|FG002|Overall Study|Subject not dosed|0|||
124822538|NCT00793598|448977253|FG003|Overall Study|Subject not dosed|0|||
124822539|NCT00793598|448977254|FG004|Overall Study|Subject not dosed|0|||
124822540|NCT00793598|448977255|FG005|Overall Study|Subject not dosed|1|||
124822541|NCT00793598|448977256|FG006|Overall Study|Subject not dosed|0|||
124822542|NCT00793598|448977257|FG007|Overall Study|Subject not dosed|0|||
124822543|NCT02154490|448977258|FG000|Overall Study|No tissue submitted|23|||
124822544|NCT02154490|448977258|FG000|Overall Study|No biomarker results|167|||
124822545|NCT02154490|448977258|FG000|Overall Study|Not assigned to a sub-study|270|||
124822546|NCT02154490|448977258|FG000|Overall Study|Did not register to a sub-study|749|||
124822547|NCT02961751|448977259|FG000|Overall Study|Lost to Follow-up|11|||
124822548|NCT02961751|448977259|FG000|Overall Study|Physician Decision|2|||
124822549|NCT02961751|448977259|FG000|Overall Study|Not Eligible at Enrollment|1|||
124822550|NCT02961751|448977259|FG000|Overall Study|Protocol Violation|1|||
124822551|NCT02373202|448977260|FG000|Overall Study|Adverse Event|2|||
124822552|NCT02373202|448977261|FG001|Overall Study|Adverse Event|5|||
124822553|NCT02373202|448977262|FG002|Overall Study|Adverse Event|2|||
124822554|NCT02373202|448977263|FG003|Overall Study|Adverse Event|1|||
124822555|NCT02373202|448977260|FG000|Overall Study|Lack of Efficacy|0|||
124822556|NCT02373202|448977261|FG001|Overall Study|Lack of Efficacy|0|||
124822557|NCT02373202|448977262|FG002|Overall Study|Lack of Efficacy|1|||
124822558|NCT02373202|448977263|FG003|Overall Study|Lack of Efficacy|0|||
124822559|NCT02373202|448977260|FG000|Overall Study|Other|0|||
124822560|NCT02373202|448977261|FG001|Overall Study|Other|1|||
124822561|NCT02373202|448977262|FG002|Overall Study|Other|0|||
124822562|NCT02373202|448977263|FG003|Overall Study|Other|0|||
124822563|NCT02310568|448977270|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
124822564|NCT02310568|448977271|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
124822565|NCT02310568|448977272|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
124822566|NCT02310568|448977273|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
124822567|NCT02310568|448977274|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
124822568|NCT02310568|448977270|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
124822569|NCT02310568|448977271|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
124822570|NCT02310568|448977272|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
124822571|NCT02310568|448977273|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
124822572|NCT02310568|448977274|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
124822573|NCT02310568|448977270|FG000|Stage 1 ( 4 Weeks)|Other|1|||
124822574|NCT02310568|448977271|FG001|Stage 1 ( 4 Weeks)|Other|1|||
124822575|NCT02310568|448977272|FG002|Stage 1 ( 4 Weeks)|Other|0|||
124822576|NCT02310568|448977273|FG003|Stage 1 ( 4 Weeks)|Other|0|||
124822577|NCT02310568|448977274|FG004|Stage 1 ( 4 Weeks)|Other|0|||
124822578|NCT02310568|448977270|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
124822579|NCT02310568|448977271|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
124822580|NCT02310568|448977272|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
124822581|NCT02310568|448977273|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
124822582|NCT02310568|448977274|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
124822583|NCT02310568|448977270|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
124822584|NCT02310568|448977271|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
124822585|NCT02310568|448977272|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
124822586|NCT02310568|448977273|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
124822587|NCT02310568|448977274|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
124822588|NCT02310568|448977270|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
124822589|NCT02310568|448977271|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
124822590|NCT02310568|448977272|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
124822591|NCT02310568|448977273|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
124822592|NCT02310568|448977274|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
124822593|NCT02310568|448977270|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
124822594|NCT02310568|448977271|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
124822595|NCT02310568|448977272|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
124822596|NCT02310568|448977273|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
124822597|NCT02310568|448977274|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
124822598|NCT02310568|448977270|FG000|Stage 2 (4 Weeks)|Other|0|||
124822599|NCT02310568|448977271|FG001|Stage 2 (4 Weeks)|Other|1|||
124822600|NCT02310568|448977272|FG002|Stage 2 (4 Weeks)|Other|1|||
124822601|NCT02310568|448977273|FG003|Stage 2 (4 Weeks)|Other|0|||
124822602|NCT02310568|448977274|FG004|Stage 2 (4 Weeks)|Other|0|||
124822603|NCT02310568|448977270|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
124822604|NCT02310568|448977271|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
124822605|NCT02310568|448977272|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
124822606|NCT02310568|448977273|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
124822607|NCT02310568|448977274|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
124822608|NCT02310568|448977270|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
124822609|NCT02310568|448977271|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
124822610|NCT02310568|448977272|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
124822611|NCT02310568|448977273|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
124822612|NCT02310568|448977274|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
124822613|NCT02310568|448977270|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
124822614|NCT02310568|448977271|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
124822615|NCT02310568|448977272|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
124822616|NCT02310568|448977273|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
124822617|NCT02310568|448977274|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
124822618|NCT01224431|448977282|FG000|Overall Study|not randomized|0|||
124822619|NCT01224431|448977283|FG001|Overall Study|not randomized|4|||
124822620|NCT01224431|448977282|FG000|Overall Study|no video record|0|||
124822621|NCT01224431|448977283|FG001|Overall Study|no video record|1|||
124822622|NCT02511184|448977290|FG000|Overall Study|Death|1|||
124822623|NCT02511184|448977291|FG001|Overall Study|Death|0|||
124822624|NCT02511184|448977290|FG000|Overall Study|Lost to Follow-up|0|||
124822625|NCT02511184|448977291|FG001|Overall Study|Lost to Follow-up|1|||
124822626|NCT02511184|448977290|FG000|Overall Study|Study terminated by sponsor|1|||
124822627|NCT02511184|448977291|FG001|Overall Study|Study terminated by sponsor|5|||
124822628|NCT02511184|448977290|FG000|Overall Study|Withdrawal by Subject|0|||
124822629|NCT02511184|448977291|FG001|Overall Study|Withdrawal by Subject|1|||
124822630|NCT02041286|448977296|FG000|Overall Study|Adverse Event|1|||
124822631|NCT01963403|448977303|FG000|Overall Study|Lost to Follow-up|2|||
124822632|NCT01963403|448977304|FG001|Overall Study|Lost to Follow-up|3|||
124822633|NCT01963403|448977303|FG000|Overall Study|Implant removal|0|||
124822634|NCT01963403|448977304|FG001|Overall Study|Implant removal|1|||
124822635|NCT02289690|448977305|FG000|Overall Study|Adverse Event Related to Progression|0|||
124822636|NCT02289690|448977306|FG001|Overall Study|Adverse Event Related to Progression|1|||
124822637|NCT02289690|448977307|FG002|Overall Study|Adverse Event Related to Progression|1|||
124822638|NCT02289690|448977308|FG003|Overall Study|Adverse Event Related to Progression|0|||
124822639|NCT02289690|448977309|FG004|Overall Study|Adverse Event Related to Progression|1|||
124822640|NCT02289690|448977310|FG005|Overall Study|Adverse Event Related to Progression|0|||
124822641|NCT02289690|448977311|FG006|Overall Study|Adverse Event Related to Progression|1|||
124822642|NCT02289690|448977312|FG007|Overall Study|Adverse Event Related to Progression|0|||
124822643|NCT02289690|448977313|FG008|Overall Study|Adverse Event Related to Progression|0|||
124822644|NCT02289690|448977314|FG009|Overall Study|Adverse Event Related to Progression|0|||
124822645|NCT02289690|448977305|FG000|Overall Study|Withdrawal by Subject|1|||
124638011|NCT02929589|448292561|FG003|Overall Study|Physician Decision|0|||
124638012|NCT01422889|448292562|FG000|Overall Study|No Data Entered for Study Stent|9|||
124638013|NCT02343939|448292563|FG000|Overall Study|Death|0|||
124638014|NCT02343939|448292564|FG001|Overall Study|Death|15|||
124638015|NCT02343939|448292565|FG002|Overall Study|Death|4|||
124638016|NCT02343939|448292566|FG003|Overall Study|Death|2|||
124638017|NCT02343939|448292567|FG004|Overall Study|Death|5|||
124638018|NCT02343939|448292568|FG005|Overall Study|Death|11|||
124638019|NCT02343939|448292569|FG006|Overall Study|Death|8|||
124638020|NCT02343939|448292570|FG007|Overall Study|Death|22|||
124638021|NCT02343939|448292571|FG008|Overall Study|Death|1|||
124638022|NCT02343939|448292563|FG000|Overall Study|Study terminated by sponsor|0|||
124638023|NCT02343939|448292564|FG001|Overall Study|Study terminated by sponsor|27|||
124638024|NCT02343939|448292565|FG002|Overall Study|Study terminated by sponsor|0|||
124638025|NCT02343939|448292566|FG003|Overall Study|Study terminated by sponsor|1|||
124638026|NCT02343939|448292567|FG004|Overall Study|Study terminated by sponsor|1|||
124638027|NCT02343939|448292568|FG005|Overall Study|Study terminated by sponsor|5|||
124638028|NCT02343939|448292569|FG006|Overall Study|Study terminated by sponsor|3|||
124638029|NCT02343939|448292570|FG007|Overall Study|Study terminated by sponsor|4|||
124822646|NCT02289690|448977306|FG001|Overall Study|Withdrawal by Subject|0|||
124822647|NCT02289690|448977307|FG002|Overall Study|Withdrawal by Subject|0|||
124822648|NCT02289690|448977308|FG003|Overall Study|Withdrawal by Subject|0|||
124822649|NCT02289690|448977309|FG004|Overall Study|Withdrawal by Subject|1|||
124638030|NCT02343939|448292571|FG008|Overall Study|Study terminated by sponsor|0|||
124638031|NCT02343939|448292563|FG000|Overall Study|Withdrew consent|3|||
124638032|NCT02343939|448292564|FG001|Overall Study|Withdrew consent|6|||
124638033|NCT02343939|448292565|FG002|Overall Study|Withdrew consent|1|||
124638034|NCT02343939|448292566|FG003|Overall Study|Withdrew consent|2|||
124822650|NCT02289690|448977310|FG005|Overall Study|Withdrawal by Subject|1|||
124822651|NCT02289690|448977311|FG006|Overall Study|Withdrawal by Subject|0|||
124822652|NCT02289690|448977312|FG007|Overall Study|Withdrawal by Subject|0|||
124822653|NCT02289690|448977313|FG008|Overall Study|Withdrawal by Subject|4|||
124822654|NCT02289690|448977314|FG009|Overall Study|Withdrawal by Subject|2|||
124822655|NCT02289690|448977305|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
124822656|NCT02289690|448977306|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
124822657|NCT02289690|448977307|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
124822658|NCT02289690|448977308|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
124822659|NCT02289690|448977309|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
124822660|NCT02289690|448977310|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
124822661|NCT02289690|448977311|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
124822662|NCT02289690|448977312|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
124822663|NCT02289690|448977313|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
124822664|NCT02289690|448977314|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
124822665|NCT02289690|448977305|FG000|Overall Study|Lost to Follow-up|0|||
124822666|NCT02289690|448977306|FG001|Overall Study|Lost to Follow-up|0|||
124822667|NCT02289690|448977307|FG002|Overall Study|Lost to Follow-up|0|||
124822668|NCT02289690|448977308|FG003|Overall Study|Lost to Follow-up|0|||
124822669|NCT02289690|448977309|FG004|Overall Study|Lost to Follow-up|0|||
124822670|NCT02289690|448977310|FG005|Overall Study|Lost to Follow-up|0|||
124822671|NCT02289690|448977311|FG006|Overall Study|Lost to Follow-up|0|||
124822672|NCT02289690|448977312|FG007|Overall Study|Lost to Follow-up|1|||
124822673|NCT02289690|448977313|FG008|Overall Study|Lost to Follow-up|0|||
124822674|NCT02289690|448977314|FG009|Overall Study|Lost to Follow-up|2|||
124822675|NCT02289690|448977305|FG000|Overall Study|Death|0|||
124822676|NCT02289690|448977306|FG001|Overall Study|Death|0|||
124822677|NCT02289690|448977307|FG002|Overall Study|Death|0|||
124822678|NCT02289690|448977308|FG003|Overall Study|Death|0|||
124822679|NCT02289690|448977309|FG004|Overall Study|Death|0|||
124822680|NCT02289690|448977310|FG005|Overall Study|Death|0|||
124822681|NCT02289690|448977311|FG006|Overall Study|Death|0|||
124822682|NCT02289690|448977312|FG007|Overall Study|Death|49|||
124822683|NCT02289690|448977313|FG008|Overall Study|Death|45|||
124822684|NCT02289690|448977314|FG009|Overall Study|Death|41|||
124822685|NCT02289690|448977305|FG000|Overall Study|Sponsor Discontinued Study|0|||
124822686|NCT02289690|448977306|FG001|Overall Study|Sponsor Discontinued Study|0|||
124822687|NCT02289690|448977307|FG002|Overall Study|Sponsor Discontinued Study|0|||
124822688|NCT02289690|448977308|FG003|Overall Study|Sponsor Discontinued Study|0|||
124822689|NCT02289690|448977309|FG004|Overall Study|Sponsor Discontinued Study|0|||
124822690|NCT02289690|448977310|FG005|Overall Study|Sponsor Discontinued Study|0|||
124822691|NCT02289690|448977311|FG006|Overall Study|Sponsor Discontinued Study|0|||
124822692|NCT02289690|448977312|FG007|Overall Study|Sponsor Discontinued Study|9|||
124822693|NCT02289690|448977313|FG008|Overall Study|Sponsor Discontinued Study|7|||
124822694|NCT02289690|448977314|FG009|Overall Study|Sponsor Discontinued Study|15|||
124822695|NCT02289690|448977305|FG000|Overall Study|Other|0|||
124822696|NCT02289690|448977306|FG001|Overall Study|Other|0|||
124822697|NCT02289690|448977307|FG002|Overall Study|Other|0|||
124822698|NCT02289690|448977308|FG003|Overall Study|Other|1|||
124822699|NCT02289690|448977309|FG004|Overall Study|Other|1|||
124822700|NCT02289690|448977310|FG005|Overall Study|Other|0|||
124822701|NCT02289690|448977311|FG006|Overall Study|Other|1|||
124822702|NCT02289690|448977312|FG007|Overall Study|Other|2|||
124822703|NCT02289690|448977313|FG008|Overall Study|Other|3|||
124822704|NCT02289690|448977314|FG009|Overall Study|Other|1|||
124822705|NCT04016285|448977317|FG000|Overall Study|Did not progress to surgery|2|||
124822706|NCT04016285|448977318|FG001|Overall Study|Did not progress to surgery|5|||
124822707|NCT04016285|448977317|FG000|Overall Study|Failed to collect outcome data|5|||
124822708|NCT04016285|448977318|FG001|Overall Study|Failed to collect outcome data|3|||
124822709|NCT00460408|448977321|FG000|Overall Study|Adverse Event|1|||
124822710|NCT00460408|448977322|FG001|Overall Study|Adverse Event|0|||
124822711|NCT00460408|448977323|FG002|Overall Study|Adverse Event|0|||
124822712|NCT00460408|448977324|FG003|Overall Study|Adverse Event|0|||
124822713|NCT00460408|448977321|FG000|Overall Study|Death|7|||
124822714|NCT00460408|448977322|FG001|Overall Study|Death|0|||
124822715|NCT00460408|448977323|FG002|Overall Study|Death|0|||
124822716|NCT00460408|448977324|FG003|Overall Study|Death|0|||
124822717|NCT00460408|448977321|FG000|Overall Study|Lost to Follow-up|11|||
124822718|NCT00460408|448977322|FG001|Overall Study|Lost to Follow-up|0|||
124822719|NCT00460408|448977323|FG002|Overall Study|Lost to Follow-up|1|||
124822720|NCT00460408|448977324|FG003|Overall Study|Lost to Follow-up|0|||
124822721|NCT00460408|448977321|FG000|Overall Study|Withdrawal by Subject|31|||
124822722|NCT00460408|448977322|FG001|Overall Study|Withdrawal by Subject|0|||
124822723|NCT00460408|448977323|FG002|Overall Study|Withdrawal by Subject|0|||
124822724|NCT00460408|448977324|FG003|Overall Study|Withdrawal by Subject|0|||
124822725|NCT00460408|448977321|FG000|Overall Study|Insufficient clinical response|5|||
124822726|NCT00460408|448977322|FG001|Overall Study|Insufficient clinical response|1|||
124822727|NCT00460408|448977323|FG002|Overall Study|Insufficient clinical response|5|||
124822728|NCT00460408|448977324|FG003|Overall Study|Insufficient clinical response|0|||
124822729|NCT00460408|448977321|FG000|Overall Study|Other|12|||
124822730|NCT00460408|448977322|FG001|Overall Study|Other|2|||
124822731|NCT00460408|448977323|FG002|Overall Study|Other|0|||
124822732|NCT00460408|448977324|FG003|Overall Study|Other|0|||
124822733|NCT01442493|448977325|FG000|Overall Study|withdrawn from study|3|||
124822734|NCT01442493|448977326|FG001|Overall Study|withdrawn from study|2|||
124822735|NCT01111149|448977331|FG000|Overall Study|Protocol Violation|1|||
124822736|NCT01111149|448977332|FG001|Overall Study|Protocol Violation|1|||
124822737|NCT01111149|448977333|FG002|Overall Study|Protocol Violation|2|||
124822738|NCT01111149|448977331|FG000|Overall Study|Withdrawal by Subject|1|||
124822739|NCT01111149|448977332|FG001|Overall Study|Withdrawal by Subject|0|||
124822740|NCT01111149|448977333|FG002|Overall Study|Withdrawal by Subject|2|||
124822741|NCT00759954|448977334|FG000|Overall Study|Personal reason|1|||
124822742|NCT00759954|448977335|FG001|Overall Study|Personal reason|0|||
124822743|NCT00759954|448977334|FG000|Overall Study|Adverse Event|1|||
124822744|NCT00759954|448977335|FG001|Overall Study|Adverse Event|2|||
124822745|NCT01365910|448977353|FG000|Overall Study|Withdrawal by Subject|7|||
124822746|NCT01365910|448977353|FG000|Overall Study|disease progression|18|||
124822747|NCT01365910|448977353|FG000|Overall Study|Adverse Event|3|||
124822748|NCT01365910|448977353|FG000|Overall Study|other complicating disease|1|||
124822749|NCT01365910|448977353|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
124822750|NCT03681405|448977355|FG000|Overall Study|Found to be ineligible after randomized|1|||
124822751|NCT03681405|448977356|FG001|Overall Study|Found to be ineligible after randomized|0|||
124822752|NCT00833794|448977357|FG000|Open-label Phase|Adverse Event|225|||
124822753|NCT00833794|448977358|FG001|Open-label Phase|Adverse Event|0|||
124822754|NCT00833794|448977357|FG000|Open-label Phase|Lack of Efficacy|28|||
124822755|NCT00833794|448977358|FG001|Open-label Phase|Lack of Efficacy|0|||
124822756|NCT00833794|448977357|FG000|Open-label Phase|Withdrawal by Subject|48|||
124822757|NCT00833794|448977358|FG001|Open-label Phase|Withdrawal by Subject|0|||
124822758|NCT00833794|448977357|FG000|Open-label Phase|Physician Decision|20|||
124822759|NCT00833794|448977358|FG001|Open-label Phase|Physician Decision|0|||
124822760|NCT00833794|448977357|FG000|Open-label Phase|Administrative reason|1|||
124822761|NCT00833794|448977358|FG001|Open-label Phase|Administrative reason|0|||
124822762|NCT00833794|448977357|FG000|Open-label Phase|Protocol Violation|47|||
124822763|NCT00833794|448977358|FG001|Open-label Phase|Protocol Violation|0|||
124822764|NCT00833794|448977357|FG000|Open-label Phase|Did not complete wash-out period|12|||
124822765|NCT00833794|448977358|FG001|Open-label Phase|Did not complete wash-out period|0|||
124822766|NCT00833794|448977357|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
124822767|NCT00833794|448977358|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
124822768|NCT00833794|448977357|FG000|Double-blind Phase|Adverse Event|44|||
124822769|NCT00833794|448977358|FG001|Double-blind Phase|Adverse Event|11|||
124822770|NCT00833794|448977357|FG000|Double-blind Phase|Lack of Efficacy|34|||
124822771|NCT00833794|448977358|FG001|Double-blind Phase|Lack of Efficacy|22|||
124822772|NCT00833794|448977357|FG000|Double-blind Phase|Withdrawal by Subject|23|||
124822773|NCT00833794|448977358|FG001|Double-blind Phase|Withdrawal by Subject|6|||
124822774|NCT00833794|448977357|FG000|Double-blind Phase|Physician Decision|4|||
124822775|NCT00833794|448977358|FG001|Double-blind Phase|Physician Decision|7|||
124822776|NCT00833794|448977357|FG000|Double-blind Phase|Administrative reason|1|||
124822777|NCT00833794|448977358|FG001|Double-blind Phase|Administrative reason|3|||
124822778|NCT01927367|448977360|FG000|Overall Study|Withdrawal by Subject|7|||
124822779|NCT01927367|448977361|FG001|Overall Study|Withdrawal by Subject|4|||
124822780|NCT01927367|448977360|FG000|Overall Study|No baseline data|0|||
124822781|NCT01927367|448977361|FG001|Overall Study|No baseline data|1|||
124822782|NCT00598832|448977364|FG000|Overall Study|Lack of Efficacy|3|||
124822783|NCT00598832|448977365|FG001|Overall Study|Lack of Efficacy|7|||
124822784|NCT00598832|448977364|FG000|Overall Study|Adverse Event|6|||
124822785|NCT00598832|448977365|FG001|Overall Study|Adverse Event|2|||
124822786|NCT00598832|448977364|FG000|Overall Study|Withdrawal by Subject|25|||
124822787|NCT00598832|448977365|FG001|Overall Study|Withdrawal by Subject|36|||
124638035|NCT02343939|448292567|FG004|Overall Study|Withdrew consent|2|||
124638036|NCT02343939|448292568|FG005|Overall Study|Withdrew consent|0|||
124638037|NCT02343939|448292569|FG006|Overall Study|Withdrew consent|0|||
124822788|NCT00598832|448977364|FG000|Overall Study|Protocol Violation|0|||
124822789|NCT00598832|448977365|FG001|Overall Study|Protocol Violation|2|||
124822790|NCT00598832|448977364|FG000|Overall Study|Lost to Follow-up|24|||
124822791|NCT00598832|448977365|FG001|Overall Study|Lost to Follow-up|29|||
124638038|NCT02343939|448292570|FG007|Overall Study|Withdrew consent|8|||
124638039|NCT02343939|448292571|FG008|Overall Study|Withdrew consent|6|||
124822792|NCT00598832|448977364|FG000|Overall Study|Pregnancy|2|||
124822793|NCT00598832|448977365|FG001|Overall Study|Pregnancy|2|||
124822794|NCT00598832|448977364|FG000|Overall Study|Physician Decision|1|||
124822795|NCT00598832|448977365|FG001|Overall Study|Physician Decision|4|||
124822796|NCT00598832|448977364|FG000|Overall Study|Non compliance|1|||
124822797|NCT00598832|448977365|FG001|Overall Study|Non compliance|0|||
124822798|NCT02760069|448977366|FG000|Overall Study|Withdrawal by Subject|0|||
124822799|NCT02760069|448977367|FG001|Overall Study|Withdrawal by Subject|1|||
124822800|NCT02760069|448977368|FG002|Overall Study|Withdrawal by Subject|1|||
124638040|NCT02343939|448292563|FG000|Overall Study|Treatment failure|0|||
124822801|NCT01648205|448977374|FG000|Placebo|Pregnancy|1|||
124822802|NCT01648205|448977374|FG000|Placebo|Withdrawal by Subject|1|||
124822803|NCT01648205|448977374|FG000|Placebo|Protocol Violation|2|||
124822804|NCT01648205|448977374|FG000|Ranolazine|Death|1|||
124822805|NCT01648205|448977374|FG000|Ranolazine|Withdrawal by Subject|1|||
124822806|NCT01648205|448977374|FG000|Ranolazine|Protocol Violation|3|||
124822807|NCT02142959|448977382|FG000|Overall Study|Adverse Event|1|||
124822808|NCT02142959|448977383|FG001|Overall Study|Adverse Event|0|||
124822809|NCT02142959|448977384|FG002|Overall Study|Adverse Event|0|||
124822810|NCT02142959|448977382|FG000|Overall Study|Death|0|||
124822811|NCT02142959|448977383|FG001|Overall Study|Death|1|||
124822812|NCT02142959|448977384|FG002|Overall Study|Death|0|||
124822813|NCT02142959|448977382|FG000|Overall Study|Withdrawal by Subject|3|||
124822814|NCT02142959|448977383|FG001|Overall Study|Withdrawal by Subject|1|||
124822815|NCT02142959|448977384|FG002|Overall Study|Withdrawal by Subject|3|||
124822816|NCT02142959|448977382|FG000|Overall Study|Administrative Reasons|1|||
124822817|NCT02142959|448977383|FG001|Overall Study|Administrative Reasons|0|||
124822818|NCT02142959|448977384|FG002|Overall Study|Administrative Reasons|1|||
124822819|NCT02142959|448977382|FG000|Overall Study|Missing|0|||
124822820|NCT02142959|448977383|FG001|Overall Study|Missing|1|||
124822821|NCT02142959|448977384|FG002|Overall Study|Missing|0|||
124822822|NCT02142959|448977382|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
124822823|NCT02142959|448977383|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
124822824|NCT02142959|448977384|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
124822825|NCT02142959|448977382|FG000|Overall Study|Patient didn't complete end of study visit|0|||
124822826|NCT02142959|448977383|FG001|Overall Study|Patient didn't complete end of study visit|0|||
124822827|NCT02142959|448977384|FG002|Overall Study|Patient didn't complete end of study visit|1|||
124822828|NCT03547687|448977385|FG000|Overall Study|Withdrawal by Subject|1|||
124822829|NCT03547687|448977385|FG000|Overall Study|Death|1|||
124822830|NCT00679302|448977386|FG000|Overall Study|Lost to Follow-up|8|||
124822831|NCT00679302|448977387|FG001|Overall Study|Lost to Follow-up|4|||
124822832|NCT03031678|448977389|FG000|Overall Study|Study closed prior to completion|1|||
124822833|NCT00434330|448977390|FG000|Overall Study|Adverse Event|0|||
124822834|NCT00434330|448977391|FG001|Overall Study|Adverse Event|0|||
124822835|NCT00434330|448977392|FG002|Overall Study|Adverse Event|1|||
124822836|NCT00434330|448977393|FG003|Overall Study|Adverse Event|0|||
124822837|NCT00434330|448977394|FG004|Overall Study|Adverse Event|0|||
124822838|NCT00434330|448977395|FG005|Overall Study|Adverse Event|0|||
124822839|NCT00434330|448977390|FG000|Overall Study|Death|1|||
124822840|NCT00434330|448977391|FG001|Overall Study|Death|0|||
124822841|NCT00434330|448977392|FG002|Overall Study|Death|0|||
124822842|NCT00434330|448977393|FG003|Overall Study|Death|0|||
124822843|NCT00434330|448977394|FG004|Overall Study|Death|1|||
124822844|NCT00434330|448977395|FG005|Overall Study|Death|1|||
124822845|NCT00434330|448977390|FG000|Overall Study|Withdrawal by Subject|0|||
124822846|NCT00434330|448977391|FG001|Overall Study|Withdrawal by Subject|0|||
124822847|NCT00434330|448977392|FG002|Overall Study|Withdrawal by Subject|1|||
124822848|NCT00434330|448977393|FG003|Overall Study|Withdrawal by Subject|1|||
124822849|NCT00434330|448977394|FG004|Overall Study|Withdrawal by Subject|0|||
124822850|NCT00434330|448977395|FG005|Overall Study|Withdrawal by Subject|0|||
124822851|NCT00434330|448977390|FG000|Overall Study|Renal transplant|0|||
124822852|NCT00434330|448977391|FG001|Overall Study|Renal transplant|0|||
124822853|NCT00434330|448977392|FG002|Overall Study|Renal transplant|0|||
124822854|NCT00434330|448977393|FG003|Overall Study|Renal transplant|1|||
124822855|NCT00434330|448977394|FG004|Overall Study|Renal transplant|0|||
124822856|NCT00434330|448977395|FG005|Overall Study|Renal transplant|0|||
124822857|NCT00434330|448977390|FG000|Overall Study|Subject Not Compliant With Study|0|||
124822858|NCT00434330|448977391|FG001|Overall Study|Subject Not Compliant With Study|0|||
124822859|NCT00434330|448977392|FG002|Overall Study|Subject Not Compliant With Study|1|||
124822860|NCT00434330|448977393|FG003|Overall Study|Subject Not Compliant With Study|0|||
124822861|NCT00434330|448977394|FG004|Overall Study|Subject Not Compliant With Study|0|||
124822862|NCT00434330|448977395|FG005|Overall Study|Subject Not Compliant With Study|0|||
124822863|NCT00850564|448977400|FG000|Overall Study|Withdrawal by Subject|2|||
124822864|NCT05355805|448977401|FG000|Overall Study|Lost to Follow-up|6|||
124822865|NCT05355805|448977402|FG001|Overall Study|Lost to Follow-up|11|||
124822866|NCT05355805|448977403|FG002|Overall Study|Lost to Follow-up|10|||
124638041|NCT02343939|448292564|FG001|Overall Study|Treatment failure|0|||
124638042|NCT02343939|448292565|FG002|Overall Study|Treatment failure|0|||
124638043|NCT02343939|448292566|FG003|Overall Study|Treatment failure|0|||
124822867|NCT05355805|448977404|FG003|Overall Study|Lost to Follow-up|6|||
124822868|NCT05355805|448977401|FG000|Overall Study|Decision by Sponsor|0|||
124822869|NCT05355805|448977402|FG001|Overall Study|Decision by Sponsor|0|||
124822870|NCT05355805|448977403|FG002|Overall Study|Decision by Sponsor|1|||
124822871|NCT05355805|448977404|FG003|Overall Study|Decision by Sponsor|0|||
124822872|NCT05355805|448977401|FG000|Overall Study|Withdrawal by Subject|7|||
124822873|NCT05355805|448977402|FG001|Overall Study|Withdrawal by Subject|14|||
124822874|NCT05355805|448977403|FG002|Overall Study|Withdrawal by Subject|15|||
124822875|NCT05355805|448977404|FG003|Overall Study|Withdrawal by Subject|13|||
124822876|NCT02167893|448977405|FG000|Overall Study|Investigator transferred|85|||
124822877|NCT02167893|448977405|FG000|Overall Study|Investigator health reasons|10|||
124822878|NCT02167893|448977405|FG000|Overall Study|Case report forms not collected|68|||
124822879|NCT04818840|448977406|FG000|Overall Study|Lost to Follow-up|0|||
124822880|NCT04818840|448977407|FG001|Overall Study|Lost to Follow-up|5|||
124822881|NCT04818840|448977406|FG000|Overall Study|Physician Decision|1|||
124822882|NCT04818840|448977407|FG001|Overall Study|Physician Decision|0|||
124822883|NCT04818840|448977406|FG000|Overall Study|Site Terminated by Sponsor|0|||
124822884|NCT04818840|448977407|FG001|Overall Study|Site Terminated by Sponsor|3|||
124822885|NCT04818840|448977406|FG000|Overall Study|Study Terminated by Sponsor|43|||
124822886|NCT04818840|448977407|FG001|Overall Study|Study Terminated by Sponsor|7|||
124822887|NCT04818840|448977406|FG000|Overall Study|Withdrawal by Subject|0|||
124822888|NCT04818840|448977407|FG001|Overall Study|Withdrawal by Subject|1|||
124822889|NCT02345850|448979220|FG000|Overall Study|Not transplanted|10|||
124822890|NCT02345850|448979221|FG001|Overall Study|Not transplanted|5|||
124822891|NCT02345850|448979222|FG002|Overall Study|Not transplanted|4|||
124822892|NCT02345850|448979220|FG000|Overall Study|Lost to Follow-up|2|||
124822893|NCT02345850|448979221|FG001|Overall Study|Lost to Follow-up|3|||
124822894|NCT02345850|448979222|FG002|Overall Study|Lost to Follow-up|2|||
124822895|NCT02345850|448979220|FG000|Overall Study|Withdrawal by Subject|1|||
124822896|NCT02345850|448979221|FG001|Overall Study|Withdrawal by Subject|0|||
124822897|NCT02345850|448979222|FG002|Overall Study|Withdrawal by Subject|0|||
124822898|NCT01991067|448979224|FG000|Overall Study|Lost to Follow-up|6|||
124822899|NCT01991067|448979225|FG001|Overall Study|Lost to Follow-up|5|||
124822900|NCT03909295|448979227|FG000|Overall Study|Adverse Event|2|||
124822901|NCT03909295|448979227|FG000|Overall Study|Study terminated by sponsor|50|||
124822902|NCT01411228|448979228|FG000|Overall Study|Lost to Follow-up|0|||
124822903|NCT01411228|448979229|FG001|Overall Study|Lost to Follow-up|0|||
124822904|NCT01411228|448979230|FG002|Overall Study|Lost to Follow-up|1|||
124822905|NCT01411228|448979228|FG000|Overall Study|Withdrawal by Subject|1|||
124822906|NCT01411228|448979229|FG001|Overall Study|Withdrawal by Subject|0|||
124822907|NCT01411228|448979230|FG002|Overall Study|Withdrawal by Subject|0|||
124822908|NCT01752907|448979231|FG000|Overall Study|Withdrawal by Subject|4|||
124822909|NCT01752907|448979232|FG001|Overall Study|Withdrawal by Subject|10|||
124822910|NCT01752907|448979231|FG000|Overall Study|Lost to Follow-up|2|||
124822911|NCT01752907|448979232|FG001|Overall Study|Lost to Follow-up|1|||
124822912|NCT01752907|448979231|FG000|Overall Study|Decision by Sponsor|6|||
124822913|NCT01752907|448979232|FG001|Overall Study|Decision by Sponsor|9|||
124822914|NCT02670083|448979238|FG000|Overall Study|Adverse Event|16|||
124822915|NCT02670083|448979239|FG001|Overall Study|Adverse Event|13|||
124822916|NCT02670083|448979238|FG000|Overall Study|Death|4|||
124822917|NCT02670083|448979239|FG001|Overall Study|Death|6|||
124822918|NCT02670083|448979238|FG000|Overall Study|Lost to Follow-up|2|||
124822919|NCT02670083|448979239|FG001|Overall Study|Lost to Follow-up|2|||
124822920|NCT02670083|448979238|FG000|Overall Study|Multiple Reasons|9|||
124822921|NCT02670083|448979239|FG001|Overall Study|Multiple Reasons|9|||
124822922|NCT02670083|448979238|FG000|Overall Study|Physician Decision|0|||
124822923|NCT02670083|448979239|FG001|Overall Study|Physician Decision|2|||
124822924|NCT02670083|448979238|FG000|Overall Study|Study Terminated By Sponsor|257|||
124822925|NCT02670083|448979239|FG001|Overall Study|Study Terminated By Sponsor|254|||
124822926|NCT02670083|448979238|FG000|Overall Study|Symptomatic Deterioration|0|||
124822927|NCT02670083|448979239|FG001|Overall Study|Symptomatic Deterioration|2|||
124822928|NCT02670083|448979238|FG000|Overall Study|Withdrawal by Subject|32|||
124822929|NCT02670083|448979239|FG001|Overall Study|Withdrawal by Subject|31|||
124822930|NCT02670083|448979238|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124822931|NCT02670083|448979239|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124822932|NCT02014597|448979240|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
124822933|NCT02014597|448979241|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
124822934|NCT00464087|448979244|FG000|Overall Study|No PCI per inclusion criteria|0|||
124822935|NCT00464087|448979245|FG001|Overall Study|No PCI per inclusion criteria|0|||
124822936|NCT00464087|448979246|FG002|Overall Study|No PCI per inclusion criteria|29|||
124822937|NCT02425046|448979247|FG000|Overall Study|Lost to Follow-up|52|||
124822938|NCT02425046|448979248|FG001|Overall Study|Lost to Follow-up|50|||
124822939|NCT02425046|448979249|FG002|Overall Study|Lost to Follow-up|56|||
124822940|NCT02425046|448979247|FG000|Overall Study|Withdrawal by Subject|16|||
124822941|NCT02425046|448979248|FG001|Overall Study|Withdrawal by Subject|12|||
124822942|NCT02425046|448979249|FG002|Overall Study|Withdrawal by Subject|0|||
124822943|NCT00931762|448979250|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
124822944|NCT00931762|448979250|FG000|Overall Study|Administrative Problems|5|||
124822945|NCT00931762|448979250|FG000|Overall Study|Death|1|||
124822946|NCT00931762|448979250|FG000|Overall Study|Disease Progression|3|||
124822947|NCT00931762|448979250|FG000|Overall Study|Adverse Event (s)|11|||
124822948|NCT00931762|448979250|FG000|Overall Study|Subject withdrew consent|13|||
124822949|NCT02692716|448979253|FG000|Overall Study|Lost to Follow-up|2|||
124822950|NCT02692716|448979254|FG001|Overall Study|Lost to Follow-up|5|||
124822951|NCT02692716|448979253|FG000|Overall Study|Withdrawal by Subject|3|||
124822952|NCT02692716|448979254|FG001|Overall Study|Withdrawal by Subject|1|||
124822953|NCT02782780|448979259|FG000|Overall Study|dropped out after randomization.|7|||
124822954|NCT02782780|448979260|FG001|Overall Study|dropped out after randomization.|5|||
124822955|NCT02782780|448979259|FG000|Overall Study|Protocol Violation|0|||
124822956|NCT02782780|448979260|FG001|Overall Study|Protocol Violation|2|||
124822957|NCT03562481|448979261|FG000|First Intervention|Lost to Follow-up|1|||
124822958|NCT03562481|448979262|FG001|First Intervention|Lost to Follow-up|0|||
124822959|NCT02664441|448979263|FG000|Randomization|Withdrawal by Subject|0|||
124822960|NCT02664441|448979264|FG001|Randomization|Withdrawal by Subject|1|||
124822961|NCT02664441|448979263|FG000|36-week Randomized Trial|Adverse Event|2|||
124822962|NCT02664441|448979264|FG001|36-week Randomized Trial|Adverse Event|0|||
124822963|NCT02664441|448979263|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
124822964|NCT02664441|448979264|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
124822965|NCT02664441|448979263|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
124822966|NCT02664441|448979264|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
124822967|NCT02664441|448979263|FG000|18-week Open Label Extension|Adverse Event|1|||
124822968|NCT02664441|448979264|FG001|18-week Open Label Extension|Adverse Event|0|||
124822969|NCT02664441|448979263|FG000|18-week Open Label Extension|Physician Decision|1|||
124822970|NCT02664441|448979264|FG001|18-week Open Label Extension|Physician Decision|0|||
124822971|NCT02664441|448979263|FG000|18-week Open Label Extension|Death|1|||
124822972|NCT02664441|448979264|FG001|18-week Open Label Extension|Death|0|||
124822973|NCT02664441|448979263|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
124822974|NCT02664441|448979264|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
124822975|NCT01413191|448979265|FG000|Overall Study|Lost to Follow-up|5|||
124822976|NCT01413191|448979265|FG000|Overall Study|Disease Progression|5|||
124822977|NCT01413191|448979265|FG000|Overall Study|Death|1|||
124822978|NCT03654651|448979266|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
124822979|NCT03654651|448979267|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
124822980|NCT01702454|448979268|FG000|Overall Study|Consent withdrawal|0|||
124822981|NCT01702454|448979269|FG001|Overall Study|Consent withdrawal|1|||
124822982|NCT01702454|448979268|FG000|Overall Study|Migrated/moved from study area|0|||
124822983|NCT01702454|448979269|FG001|Overall Study|Migrated/moved from study area|1|||
124822984|NCT01702454|448979268|FG000|Overall Study|Lost to Follow-up|3|||
124822985|NCT01702454|448979269|FG001|Overall Study|Lost to Follow-up|6|||
124822986|NCT03510884|448979274|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
124822987|NCT03510884|448979275|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
124822988|NCT03510884|448979276|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
124822989|NCT03510884|448979277|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
124822990|NCT03510884|448979274|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
124822991|NCT03510884|448979275|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
124822992|NCT03510884|448979276|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
124822993|NCT03510884|448979277|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
124822994|NCT03510884|448979274|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
124822995|NCT03510884|448979275|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
124822996|NCT03510884|448979276|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
124822997|NCT03510884|448979277|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
124822998|NCT03510884|448979274|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
124822999|NCT03510884|448979275|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
124823000|NCT03510884|448979276|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
124823001|NCT03510884|448979277|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
124823002|NCT03510884|448979274|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
124823003|NCT03510884|448979275|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
124823004|NCT03510884|448979276|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
124823005|NCT03510884|448979277|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
124823006|NCT03510884|448979274|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
124823007|NCT03510884|448979275|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
124823008|NCT03510884|448979276|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
124823009|NCT03510884|448979277|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
124823010|NCT03510884|448979274|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
124823011|NCT03510884|448979275|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
124823012|NCT03510884|448979276|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
124823013|NCT03510884|448979277|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
124823014|NCT03510884|448979274|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
124823015|NCT03510884|448979275|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
124823016|NCT03510884|448979276|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
124823017|NCT03510884|448979277|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
124823018|NCT03510884|448979274|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
124823019|NCT03510884|448979275|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
124823020|NCT03510884|448979276|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
124823021|NCT03510884|448979277|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
124823022|NCT03510884|448979274|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
124823023|NCT03510884|448979275|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
124823024|NCT03510884|448979276|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
124823025|NCT03510884|448979277|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
124823026|NCT00856284|448979278|FG000|Overall Study|Hyperglycemic rescue|231|||
124823027|NCT00856284|448979279|FG001|Overall Study|Hyperglycemic rescue|201|||
124823028|NCT00856284|448979280|FG002|Overall Study|Hyperglycemic rescue|235|||
124823029|NCT00856284|448979278|FG000|Overall Study|Adverse Event|60|||
124823030|NCT00856284|448979279|FG001|Overall Study|Adverse Event|74|||
124823031|NCT00856284|448979280|FG002|Overall Study|Adverse Event|82|||
124823032|NCT00856284|448979278|FG000|Overall Study|Major protocol deviation|24|||
124823033|NCT00856284|448979279|FG001|Overall Study|Major protocol deviation|16|||
124823034|NCT00856284|448979280|FG002|Overall Study|Major protocol deviation|15|||
124823035|NCT00856284|448979278|FG000|Overall Study|Lost to Follow-up|20|||
124823036|NCT00856284|448979279|FG001|Overall Study|Lost to Follow-up|22|||
124823037|NCT00856284|448979280|FG002|Overall Study|Lost to Follow-up|28|||
124823038|NCT00856284|448979278|FG000|Overall Study|Voluntary withdrawal|48|||
124823039|NCT00856284|448979279|FG001|Overall Study|Voluntary withdrawal|52|||
124823040|NCT00856284|448979280|FG002|Overall Study|Voluntary withdrawal|62|||
124823041|NCT00856284|448979278|FG000|Overall Study|Pregnancy|1|||
124823042|NCT00856284|448979279|FG001|Overall Study|Pregnancy|2|||
124823043|NCT00856284|448979280|FG002|Overall Study|Pregnancy|0|||
124823044|NCT00856284|448979278|FG000|Overall Study|Investigator discretion|9|||
124823045|NCT00856284|448979279|FG001|Overall Study|Investigator discretion|8|||
124823046|NCT00856284|448979280|FG002|Overall Study|Investigator discretion|10|||
124823047|NCT00856284|448979278|FG000|Overall Study|Other|15|||
124823048|NCT00856284|448979279|FG001|Overall Study|Other|17|||
124823049|NCT00856284|448979280|FG002|Overall Study|Other|14|||
124823050|NCT00856284|448979278|FG000|Overall Study|Randomized in error|0|||
124823051|NCT00856284|448979279|FG001|Overall Study|Randomized in error|0|||
124823052|NCT00856284|448979280|FG002|Overall Study|Randomized in error|1|||
124823053|NCT02904512|448979283|FG000|Overall Study|Withdrawal by Subject|1|||
124823054|NCT02904512|448979284|FG001|Overall Study|Withdrawal by Subject|0|||
124823055|NCT02904512|448979283|FG000|Overall Study|Transferred to ICU|1|||
124823056|NCT02904512|448979284|FG001|Overall Study|Transferred to ICU|0|||
124823057|NCT02904512|448979283|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
124823058|NCT02904512|448979284|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
124823059|NCT00267046|448979291|FG000|Overall Study|Disease progression|4|||
124823060|NCT00267046|448979292|FG001|Overall Study|Disease progression|2|||
124823061|NCT00267046|448979291|FG000|Overall Study|Chemotoxicity|2|||
124823062|NCT00267046|448979292|FG001|Overall Study|Chemotoxicity|0|||
124823063|NCT00267046|448979291|FG000|Overall Study|Open-label palifermin|2|||
124823064|NCT00267046|448979292|FG001|Overall Study|Open-label palifermin|7|||
124823065|NCT00267046|448979291|FG000|Overall Study|Surgery|3|||
124823066|NCT00267046|448979292|FG001|Overall Study|Surgery|1|||
124823067|NCT00267046|448979291|FG000|Overall Study|Withdrawal by Subject|1|||
124823068|NCT00267046|448979292|FG001|Overall Study|Withdrawal by Subject|0|||
124823069|NCT00267046|448979291|FG000|Overall Study|Radiation|0|||
124823070|NCT00267046|448979292|FG001|Overall Study|Radiation|1|||
124823071|NCT01124422|448979299|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
124823072|NCT01124422|448979300|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
124823073|NCT01124422|448979301|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
124823074|NCT01124422|448979299|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
124823075|NCT01124422|448979300|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
124823076|NCT01124422|448979301|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
124823077|NCT01124422|448979299|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
124823078|NCT01124422|448979300|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
124823079|NCT01124422|448979301|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
124823080|NCT01124422|448979299|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
124823081|NCT01124422|448979300|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
124823082|NCT01124422|448979301|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
124823083|NCT01124422|448979299|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
124823084|NCT01124422|448979300|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
124823085|NCT01124422|448979301|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
124823086|NCT01124422|448979299|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
124823087|NCT01124422|448979300|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
124823088|NCT01124422|448979301|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
124823089|NCT01124422|448979299|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
124823090|NCT01124422|448979300|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
124823091|NCT01124422|448979301|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
124823092|NCT01124422|448979299|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
124823093|NCT01124422|448979300|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
124823094|NCT01124422|448979301|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
124823095|NCT01124422|448979299|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
124823096|NCT01124422|448979300|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
124823097|NCT01124422|448979301|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
124823098|NCT01124422|448979299|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
124823099|NCT01124422|448979300|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
124823100|NCT01124422|448979301|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
124823101|NCT00137046|448979304|FG000|Overall Study|Death|2|||
124823102|NCT00137046|448979305|FG001|Overall Study|Death|1|||
124823103|NCT00137046|448979304|FG000|Overall Study|Adverse Event|16|||
124823104|NCT00137046|448979305|FG001|Overall Study|Adverse Event|5|||
124823105|NCT00137046|448979304|FG000|Overall Study|Laboratory Abnormality|2|||
124823106|NCT00137046|448979305|FG001|Overall Study|Laboratory Abnormality|0|||
124823107|NCT00137046|448979304|FG000|Overall Study|Lack of Efficacy|13|||
124823108|NCT00137046|448979305|FG001|Overall Study|Lack of Efficacy|1|||
124823109|NCT00137046|448979304|FG000|Overall Study|Lost to Follow-up|8|||
124823110|NCT00137046|448979305|FG001|Overall Study|Lost to Follow-up|24|||
124823111|NCT00137046|448979304|FG000|Overall Study|Other|23|||
124823112|NCT00137046|448979305|FG001|Overall Study|Other|19|||
124823113|NCT00137046|448979304|FG000|Overall Study|Withdrawal by Subject|33|||
124823114|NCT00137046|448979305|FG001|Overall Study|Withdrawal by Subject|42|||
124823115|NCT00137046|448979304|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
124823116|NCT00137046|448979305|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
124823117|NCT00137046|448979304|FG000|Overall Study|Withdrew prior to study treatment|1|||
124823118|NCT00137046|448979305|FG001|Overall Study|Withdrew prior to study treatment|1|||
124823119|NCT02730455|448979308|FG000|Overall Study|Death|5|||
124823120|NCT02730455|448979309|FG001|Overall Study|Death|6|||
124823121|NCT02730455|448979310|FG002|Overall Study|Death|4|||
124823122|NCT02730455|448979308|FG000|Overall Study|Consent withdrawn|2|||
124823123|NCT02730455|448979309|FG001|Overall Study|Consent withdrawn|4|||
124823124|NCT02730455|448979310|FG002|Overall Study|Consent withdrawn|1|||
124823125|NCT02730455|448979308|FG000|Overall Study|Lost to Follow-up|3|||
124823126|NCT02730455|448979309|FG001|Overall Study|Lost to Follow-up|1|||
124823127|NCT02730455|448979310|FG002|Overall Study|Lost to Follow-up|4|||
124823128|NCT02730455|448979308|FG000|Overall Study|Other|1|||
124823129|NCT02730455|448979309|FG001|Overall Study|Other|1|||
124823130|NCT02730455|448979310|FG002|Overall Study|Other|2|||
124823131|NCT02730455|448979308|FG000|Overall Study|Other|2|||
124823132|NCT02730455|448979309|FG001|Overall Study|Other|2|||
124823133|NCT02730455|448979310|FG002|Overall Study|Other|0|||
124823134|NCT03235154|448979311|FG000|Overall Study|Withdrawal by Subject|1|||
124823135|NCT03235154|448979311|FG000|Overall Study|Adverse Event|1|||
124823136|NCT03235154|448979311|FG000|Overall Study|Lost to Follow-up|2|||
124823137|NCT02725710|448979314|FG000|Overall Study|Lost to Follow-up|1|||
124823138|NCT02725710|448979315|FG001|Overall Study|Lost to Follow-up|0|||
124823139|NCT01666782|448979318|FG000|Overall Study|Received 2 doses of vaccine|0|||
124823140|NCT01666782|448979319|FG001|Overall Study|Received 2 doses of vaccine|1|||
124823141|NCT01666782|448979318|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
124823142|NCT01666782|448979319|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
124823143|NCT01691781|448979331|FG000|Overall Study|Withdrawal by Subject|4|||
124823144|NCT01691781|448979332|FG001|Overall Study|Withdrawal by Subject|3|||
124823145|NCT01691781|448979331|FG000|Overall Study|Physician Decision|1|||
124823146|NCT01691781|448979332|FG001|Overall Study|Physician Decision|1|||
124823147|NCT01691781|448979331|FG000|Overall Study|Protocol Violation|2|||
124823148|NCT01691781|448979332|FG001|Overall Study|Protocol Violation|2|||
124823149|NCT01691781|448979331|FG000|Overall Study|Adverse Event|0|||
124823150|NCT01691781|448979332|FG001|Overall Study|Adverse Event|1|||
124823151|NCT03978520|448979333|FG000|Overall Study|Adverse Event|2|||
124823152|NCT03978520|448979334|FG001|Overall Study|Adverse Event|5|||
124823153|NCT03978520|448979335|FG002|Overall Study|Adverse Event|3|||
124823154|NCT03978520|448979336|FG003|Overall Study|Adverse Event|5|||
124823155|NCT03978520|448979337|FG004|Overall Study|Adverse Event|6|||
124823156|NCT03978520|448979333|FG000|Overall Study|Withdrawal by Subject|10|||
124823157|NCT03978520|448979334|FG001|Overall Study|Withdrawal by Subject|4|||
124823158|NCT03978520|448979335|FG002|Overall Study|Withdrawal by Subject|5|||
124823159|NCT03978520|448979336|FG003|Overall Study|Withdrawal by Subject|6|||
124823160|NCT03978520|448979337|FG004|Overall Study|Withdrawal by Subject|5|||
124823161|NCT03978520|448979333|FG000|Overall Study|Lost to Follow-up|2|||
124823162|NCT03978520|448979334|FG001|Overall Study|Lost to Follow-up|2|||
124638044|NCT02343939|448292567|FG004|Overall Study|Treatment failure|0|||
124823163|NCT03978520|448979335|FG002|Overall Study|Lost to Follow-up|2|||
124823164|NCT03978520|448979336|FG003|Overall Study|Lost to Follow-up|0|||
124823165|NCT03978520|448979337|FG004|Overall Study|Lost to Follow-up|1|||
124823166|NCT03978520|448979333|FG000|Overall Study|COVID-19 infection|0|||
124823167|NCT03978520|448979334|FG001|Overall Study|COVID-19 infection|1|||
124823168|NCT03978520|448979335|FG002|Overall Study|COVID-19 infection|0|||
124823169|NCT03978520|448979336|FG003|Overall Study|COVID-19 infection|0|||
124823170|NCT03978520|448979337|FG004|Overall Study|COVID-19 infection|0|||
124823171|NCT03978520|448979333|FG000|Overall Study|Other, not specified|9|||
124823172|NCT03978520|448979334|FG001|Overall Study|Other, not specified|4|||
124823173|NCT03978520|448979335|FG002|Overall Study|Other, not specified|1|||
124823174|NCT03978520|448979336|FG003|Overall Study|Other, not specified|1|||
124823175|NCT03978520|448979337|FG004|Overall Study|Other, not specified|2|||
124823176|NCT03978520|448979333|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
124823177|NCT03978520|448979334|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
124823178|NCT03978520|448979335|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
124823179|NCT03978520|448979336|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
124823180|NCT03978520|448979337|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
124823181|NCT00230607|448979338|FG000|Overall Study|Other|3|||
124823182|NCT02547454|448979344|FG000|Overall Study|Due to hemodialysis|53|||
124823183|NCT02547454|448979344|FG000|Overall Study|Due to transplantation|1|||
124823184|NCT02547454|448979344|FG000|Overall Study|Due to no further need to treat|4|||
124823185|NCT02547454|448979344|FG000|Overall Study|Death|38|||
124823186|NCT02547454|448979344|FG000|Overall Study|Lost to Follow-up|26|||
124823187|NCT02547454|448979344|FG000|Overall Study|Other|39|||
124823188|NCT02547454|448979344|FG000|Overall Study|No data|11|||
124823189|NCT04557371|448979347|FG000|Overall Study|Covid-19-related|0|||
124823190|NCT04557371|448979348|FG001|Overall Study|Covid-19-related|1|||
124823191|NCT04557371|448979349|FG002|Overall Study|Covid-19-related|0|||
124823192|NCT04557371|448979347|FG000|Overall Study|Withdrawal by Subject|0|||
124823193|NCT04557371|448979348|FG001|Overall Study|Withdrawal by Subject|1|||
124823194|NCT04557371|448979349|FG002|Overall Study|Withdrawal by Subject|0|||
124823195|NCT04557371|448979347|FG000|Overall Study|Adverse Event|1|||
124823196|NCT04557371|448979348|FG001|Overall Study|Adverse Event|0|||
124823197|NCT04557371|448979349|FG002|Overall Study|Adverse Event|0|||
124823198|NCT03694821|448979350|FG000|Overall Study|Study terminated|4|||
124823199|NCT03694821|448979351|FG001|Overall Study|Study terminated|8|||
124823200|NCT03694821|448979352|FG002|Overall Study|Study terminated|4|||
124823201|NCT00203996|448979353|FG000|Overall Study|Lost to Follow-up|0|||
124823202|NCT00203996|448979354|FG001|Overall Study|Lost to Follow-up|0|||
124823203|NCT00203996|448979355|FG002|Overall Study|Lost to Follow-up|0|||
124823204|NCT00203996|448979356|FG003|Overall Study|Lost to Follow-up|1|||
124823205|NCT00203996|448979357|FG004|Overall Study|Lost to Follow-up|0|||
124823206|NCT00203996|448979358|FG005|Overall Study|Lost to Follow-up|0|||
124823207|NCT00203996|448979359|FG006|Overall Study|Lost to Follow-up|0|||
124823208|NCT00203996|448979360|FG007|Overall Study|Lost to Follow-up|0|||
124823209|NCT00203996|448979361|FG008|Overall Study|Lost to Follow-up|0|||
124823210|NCT00203996|448979362|FG009|Overall Study|Lost to Follow-up|0|||
124823211|NCT00203996|448979353|FG000|Overall Study|Protocol Violation|0|||
124823212|NCT00203996|448979354|FG001|Overall Study|Protocol Violation|0|||
124823213|NCT00203996|448979355|FG002|Overall Study|Protocol Violation|0|||
124823214|NCT00203996|448979356|FG003|Overall Study|Protocol Violation|6|||
124823215|NCT00203996|448979357|FG004|Overall Study|Protocol Violation|1|||
124823216|NCT00203996|448979358|FG005|Overall Study|Protocol Violation|0|||
124823217|NCT00203996|448979359|FG006|Overall Study|Protocol Violation|0|||
124823218|NCT00203996|448979360|FG007|Overall Study|Protocol Violation|0|||
124823219|NCT00203996|448979361|FG008|Overall Study|Protocol Violation|0|||
124823220|NCT00203996|448979362|FG009|Overall Study|Protocol Violation|0|||
124823221|NCT00203996|448979353|FG000|Overall Study|Physician Decision|0|||
124823222|NCT00203996|448979354|FG001|Overall Study|Physician Decision|0|||
124823223|NCT00203996|448979355|FG002|Overall Study|Physician Decision|0|||
124823224|NCT00203996|448979356|FG003|Overall Study|Physician Decision|2|||
124823225|NCT00203996|448979357|FG004|Overall Study|Physician Decision|0|||
124823226|NCT00203996|448979358|FG005|Overall Study|Physician Decision|0|||
124823227|NCT00203996|448979359|FG006|Overall Study|Physician Decision|0|||
124823228|NCT00203996|448979360|FG007|Overall Study|Physician Decision|0|||
124823229|NCT00203996|448979361|FG008|Overall Study|Physician Decision|0|||
124823230|NCT00203996|448979362|FG009|Overall Study|Physician Decision|1|||
124823231|NCT00203996|448979353|FG000|Overall Study|CPAP machine malfunction|0|||
124823232|NCT00203996|448979354|FG001|Overall Study|CPAP machine malfunction|0|||
124638045|NCT02343939|448292568|FG005|Overall Study|Treatment failure|0|||
124823233|NCT00203996|448979355|FG002|Overall Study|CPAP machine malfunction|0|||
124823234|NCT00203996|448979356|FG003|Overall Study|CPAP machine malfunction|1|||
124823235|NCT00203996|448979357|FG004|Overall Study|CPAP machine malfunction|0|||
124823236|NCT00203996|448979358|FG005|Overall Study|CPAP machine malfunction|0|||
124823237|NCT00203996|448979359|FG006|Overall Study|CPAP machine malfunction|0|||
124823238|NCT00203996|448979360|FG007|Overall Study|CPAP machine malfunction|0|||
124823239|NCT00203996|448979361|FG008|Overall Study|CPAP machine malfunction|0|||
124823240|NCT00203996|448979362|FG009|Overall Study|CPAP machine malfunction|0|||
124638046|NCT02343939|448292569|FG006|Overall Study|Treatment failure|2|||
124823241|NCT00203996|448979353|FG000|Overall Study|Scheduling issue|0|||
124823242|NCT00203996|448979354|FG001|Overall Study|Scheduling issue|0|||
124823243|NCT00203996|448979355|FG002|Overall Study|Scheduling issue|0|||
124823244|NCT00203996|448979356|FG003|Overall Study|Scheduling issue|0|||
124823245|NCT00203996|448979357|FG004|Overall Study|Scheduling issue|0|||
124823246|NCT00203996|448979358|FG005|Overall Study|Scheduling issue|0|||
124823247|NCT00203996|448979359|FG006|Overall Study|Scheduling issue|0|||
124823248|NCT00203996|448979360|FG007|Overall Study|Scheduling issue|2|||
124823249|NCT00203996|448979361|FG008|Overall Study|Scheduling issue|0|||
124823250|NCT00203996|448979362|FG009|Overall Study|Scheduling issue|0|||
124823251|NCT03064451|448979363|FG000|Overall Study|Lost to Follow-up|1|||
124823252|NCT03064451|448979363|FG000|Overall Study|Mapping Failure|4|||
124638047|NCT02343939|448292570|FG007|Overall Study|Treatment failure|1|||
124638048|NCT02343939|448292571|FG008|Overall Study|Treatment failure|0|||
124823253|NCT03064451|448979363|FG000|Overall Study|Exited prior to procedure|8|||
124823254|NCT03064451|448979363|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
124823255|NCT02700815|448981023|FG000|Overall Study|Adverse Event|0|||
124823256|NCT02700815|448981024|FG001|Overall Study|Adverse Event|6|||
124823257|NCT02700815|448981025|FG002|Overall Study|Adverse Event|2|||
124638049|NCT02343939|448292563|FG000|Overall Study|Investigator's discretion|0|||
124638050|NCT02343939|448292564|FG001|Overall Study|Investigator's discretion|0|||
124638051|NCT02343939|448292565|FG002|Overall Study|Investigator's discretion|0|||
124638052|NCT02343939|448292566|FG003|Overall Study|Investigator's discretion|1|||
124638053|NCT02343939|448292567|FG004|Overall Study|Investigator's discretion|0|||
124823258|NCT02700815|448981026|FG003|Overall Study|Adverse Event|3|||
124823259|NCT02700815|448981023|FG000|Overall Study|Lack of Efficacy|0|||
124823260|NCT02700815|448981024|FG001|Overall Study|Lack of Efficacy|0|||
124823261|NCT02700815|448981025|FG002|Overall Study|Lack of Efficacy|1|||
124823262|NCT02700815|448981026|FG003|Overall Study|Lack of Efficacy|2|||
124823263|NCT02700815|448981023|FG000|Overall Study|Lost to Follow-up|1|||
124823264|NCT02700815|448981024|FG001|Overall Study|Lost to Follow-up|0|||
124823265|NCT02700815|448981025|FG002|Overall Study|Lost to Follow-up|0|||
124823266|NCT02700815|448981026|FG003|Overall Study|Lost to Follow-up|1|||
124823267|NCT02700815|448981023|FG000|Overall Study|Refusal to continue medication|0|||
124823268|NCT02700815|448981024|FG001|Overall Study|Refusal to continue medication|1|||
124823269|NCT02700815|448981025|FG002|Overall Study|Refusal to continue medication|0|||
124823270|NCT02700815|448981026|FG003|Overall Study|Refusal to continue medication|1|||
124823271|NCT02700815|448981023|FG000|Overall Study|Withdrawal by Subject|0|||
124823272|NCT02700815|448981024|FG001|Overall Study|Withdrawal by Subject|0|||
124823273|NCT02700815|448981025|FG002|Overall Study|Withdrawal by Subject|1|||
124823274|NCT02700815|448981026|FG003|Overall Study|Withdrawal by Subject|0|||
124823275|NCT00524368|448981027|FG000|Overall Study|Adverse Event|10|||
124823276|NCT00524368|448981028|FG001|Overall Study|Adverse Event|12|||
124823277|NCT00524368|448981027|FG000|Overall Study|Lost to Follow-up|9|||
124823278|NCT00524368|448981028|FG001|Overall Study|Lost to Follow-up|13|||
124823279|NCT00524368|448981027|FG000|Overall Study|Withdrawal by Subject|4|||
124823280|NCT00524368|448981028|FG001|Overall Study|Withdrawal by Subject|5|||
124823281|NCT00524368|448981027|FG000|Overall Study|Non-compliant|8|||
124823282|NCT00524368|448981028|FG001|Overall Study|Non-compliant|9|||
124823283|NCT00524368|448981027|FG000|Overall Study|Reached a Virologic Endpoint|3|||
124823284|NCT00524368|448981028|FG001|Overall Study|Reached a Virologic Endpoint|2|||
124823285|NCT00524368|448981027|FG000|Overall Study|Sponsor's Decision|2|||
124823286|NCT00524368|448981028|FG001|Overall Study|Sponsor's Decision|0|||
124823287|NCT00524368|448981027|FG000|Overall Study|Ineligible to Continue the study|2|||
124823288|NCT00524368|448981028|FG001|Overall Study|Ineligible to Continue the study|5|||
124823289|NCT00524368|448981027|FG000|Overall Study|Other|3|||
124823290|NCT00524368|448981028|FG001|Overall Study|Other|2|||
124823291|NCT00531232|448981029|FG000|Overall Study|Investigator decision|0|||
124823292|NCT00531232|448981030|FG001|Overall Study|Investigator decision|0|||
124823293|NCT00531232|448981031|FG002|Overall Study|Investigator decision|4|||
124823294|NCT00531232|448981029|FG000|Overall Study|Participants refused further treatment|0|||
124823295|NCT00531232|448981030|FG001|Overall Study|Participants refused further treatment|1|||
124823296|NCT00531232|448981031|FG002|Overall Study|Participants refused further treatment|2|||
124823297|NCT00531232|448981029|FG000|Overall Study|Adverse events (AEs)|1|||
124823298|NCT00531232|448981030|FG001|Overall Study|Adverse events (AEs)|2|||
124823299|NCT00531232|448981031|FG002|Overall Study|Adverse events (AEs)|2|||
124638054|NCT02343939|448292568|FG005|Overall Study|Investigator's discretion|0|||
124638055|NCT02343939|448292569|FG006|Overall Study|Investigator's discretion|1|||
124638056|NCT02343939|448292570|FG007|Overall Study|Investigator's discretion|0|||
124823300|NCT00531232|448981029|FG000|Overall Study|Treatment failure|1|||
124823301|NCT00531232|448981030|FG001|Overall Study|Treatment failure|3|||
124823302|NCT00531232|448981031|FG002|Overall Study|Treatment failure|7|||
124823303|NCT00531232|448981029|FG000|Overall Study|Disease recurrence|0|||
124823304|NCT00531232|448981030|FG001|Overall Study|Disease recurrence|0|||
124823305|NCT00531232|448981031|FG002|Overall Study|Disease recurrence|1|||
124823306|NCT00531232|448981029|FG000|Overall Study|Deceased|2|||
124823307|NCT00531232|448981030|FG001|Overall Study|Deceased|2|||
124823308|NCT00531232|448981031|FG002|Overall Study|Deceased|2|||
124823309|NCT00531232|448981029|FG000|Overall Study|Withdrawal by Subject|0|||
124823310|NCT00531232|448981030|FG001|Overall Study|Withdrawal by Subject|1|||
124823311|NCT00531232|448981031|FG002|Overall Study|Withdrawal by Subject|2|||
124638057|NCT02343939|448292571|FG008|Overall Study|Investigator's discretion|0|||
124638058|NCT02343939|448292563|FG000|Overall Study|Adverse Event|0|||
124823312|NCT00531232|448981029|FG000|Overall Study|Other|0|||
124823313|NCT00531232|448981030|FG001|Overall Study|Other|0|||
124823314|NCT00531232|448981031|FG002|Overall Study|Other|5|||
124823315|NCT00609492|448981036|FG000|Overall Study|Withdrawal by Subject|0|||
124823316|NCT00609492|448981037|FG001|Overall Study|Withdrawal by Subject|2|||
124823317|NCT00609492|448981038|FG002|Overall Study|Withdrawal by Subject|3|||
124823318|NCT00609492|448981036|FG000|Overall Study|Lost to Follow-up|1|||
124823319|NCT00609492|448981037|FG001|Overall Study|Lost to Follow-up|1|||
124823320|NCT00609492|448981038|FG002|Overall Study|Lost to Follow-up|4|||
124823321|NCT00720434|448981039|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
124823322|NCT00720434|448981040|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
124823323|NCT00720434|448981041|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
124823324|NCT00720434|448981042|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
124823325|NCT00720434|448981039|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
124823326|NCT00720434|448981040|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
124823327|NCT00720434|448981041|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
124823328|NCT00720434|448981042|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
124823329|NCT00720434|448981039|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
124823330|NCT00720434|448981040|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
124823331|NCT00720434|448981041|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
124823332|NCT00720434|448981042|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
124823333|NCT00720434|448981039|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
124823334|NCT00720434|448981040|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
124823335|NCT00720434|448981041|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
124823336|NCT00720434|448981042|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
124823337|NCT00720434|448981039|FG000|Open-Label Period (Week 5-72)|Other|4|||
124823338|NCT00720434|448981040|FG001|Open-Label Period (Week 5-72)|Other|3|||
124823339|NCT00720434|448981041|FG002|Open-Label Period (Week 5-72)|Other|3|||
124823340|NCT00720434|448981042|FG003|Open-Label Period (Week 5-72)|Other|2|||
124823341|NCT02057406|448981043|FG000|Overall Study|Physician Decision|0|||
124823342|NCT02057406|448981044|FG001|Overall Study|Physician Decision|0|||
124823343|NCT02057406|448981045|FG002|Overall Study|Physician Decision|2|||
124823344|NCT02057406|448981043|FG000|Overall Study|Withdrawal by Subject|0|||
124823345|NCT02057406|448981044|FG001|Overall Study|Withdrawal by Subject|2|||
124823346|NCT02057406|448981045|FG002|Overall Study|Withdrawal by Subject|0|||
124823347|NCT02057406|448981043|FG000|Overall Study|Lost to Follow-up|0|||
124823348|NCT02057406|448981044|FG001|Overall Study|Lost to Follow-up|0|||
124823349|NCT02057406|448981045|FG002|Overall Study|Lost to Follow-up|1|||
124823350|NCT02057406|448981043|FG000|Overall Study|Death|1|||
124823351|NCT02057406|448981044|FG001|Overall Study|Death|0|||
124823352|NCT02057406|448981045|FG002|Overall Study|Death|0|||
124823353|NCT02057406|448981043|FG000|Overall Study|Protocol Violation|0|||
124823354|NCT02057406|448981044|FG001|Overall Study|Protocol Violation|1|||
124823355|NCT02057406|448981045|FG002|Overall Study|Protocol Violation|0|||
124823356|NCT02057406|448981043|FG000|Overall Study|Patient transportation issues|0|||
124823357|NCT02057406|448981044|FG001|Overall Study|Patient transportation issues|0|||
124823358|NCT02057406|448981045|FG002|Overall Study|Patient transportation issues|1|||
124823359|NCT03138889|448981048|FG000|Overall Study|Withdrawal by Subject|5|||
124823360|NCT03138889|448981049|FG001|Overall Study|Withdrawal by Subject|5|||
124823361|NCT03138889|448981050|FG002|Overall Study|Withdrawal by Subject|0|||
124823362|NCT03138889|448981051|FG003|Overall Study|Withdrawal by Subject|2|||
124823363|NCT03138889|448981052|FG004|Overall Study|Withdrawal by Subject|1|||
124823364|NCT03138889|448981053|FG005|Overall Study|Withdrawal by Subject|3|||
124823365|NCT03138889|448981054|FG006|Overall Study|Withdrawal by Subject|0|||
124823366|NCT03138889|448981055|FG007|Overall Study|Withdrawal by Subject|1|||
124823367|NCT00865124|448981058|FG000|Overall Study|Physician Decision|2|||
124823368|NCT00865124|448981059|FG001|Overall Study|Physician Decision|1|||
124823369|NCT00865124|448981060|FG002|Overall Study|Physician Decision|0|||
124823370|NCT00865124|448981058|FG000|Overall Study|Withdrawn consent|2|||
124823371|NCT00865124|448981059|FG001|Overall Study|Withdrawn consent|0|||
124823372|NCT00865124|448981060|FG002|Overall Study|Withdrawn consent|0|||
124823373|NCT03247530|448981061|FG000|Overall Study|Withdrawal by caregiver|19|||
124823374|NCT03247530|448981062|FG001|Overall Study|Withdrawal by caregiver|8|||
124823375|NCT03247530|448981063|FG002|Overall Study|Withdrawal by caregiver|10|||
124823376|NCT03247530|448981061|FG000|Overall Study|Lost to Follow-up|3|||
124823377|NCT03247530|448981062|FG001|Overall Study|Lost to Follow-up|9|||
124823378|NCT03247530|448981063|FG002|Overall Study|Lost to Follow-up|6|||
124823379|NCT03247530|448981061|FG000|Overall Study|Adverse Event|2|||
124823380|NCT03247530|448981062|FG001|Overall Study|Adverse Event|5|||
124823381|NCT03247530|448981063|FG002|Overall Study|Adverse Event|2|||
124823382|NCT03247530|448981061|FG000|Overall Study|Failure to follow procedure|1|||
124823383|NCT03247530|448981062|FG001|Overall Study|Failure to follow procedure|1|||
124823384|NCT03247530|448981063|FG002|Overall Study|Failure to follow procedure|1|||
124823385|NCT03247530|448981061|FG000|Overall Study|Withdrawal by Subject|1|||
124823386|NCT03247530|448981062|FG001|Overall Study|Withdrawal by Subject|1|||
124823387|NCT03247530|448981063|FG002|Overall Study|Withdrawal by Subject|0|||
124823388|NCT03247530|448981061|FG000|Overall Study|Study medication misuse|0|||
124823389|NCT03247530|448981062|FG001|Overall Study|Study medication misuse|1|||
124823390|NCT03247530|448981063|FG002|Overall Study|Study medication misuse|0|||
124823391|NCT03247530|448981061|FG000|Overall Study|Other, multiple categories|1|||
124823392|NCT03247530|448981062|FG001|Overall Study|Other, multiple categories|3|||
124823393|NCT03247530|448981063|FG002|Overall Study|Other, multiple categories|1|||
124823394|NCT03454893|448981065|FG000|Overall Study|Study Terminated by the Sponsor|5|||
124823395|NCT03454893|448981065|FG000|Overall Study|Did not pass screening|4|||
124823396|NCT01986985|448981070|FG000|Overall Study|Withdrawal by Subject|4|||
124823397|NCT01986985|448981070|FG000|Overall Study|Scan not completed due to malfunction|3|||
124823398|NCT03042533|448981071|FG000|Overall Study|MD left program|1|||
124823399|NCT03042533|448981072|FG001|Overall Study|MD left program|4|||
124823400|NCT03042533|448981073|FG002|Overall Study|MD left program|1|||
124823401|NCT02288559|448981075|FG000|Overall Study|Adverse Event|1|||
124823402|NCT02288559|448981076|FG001|Overall Study|Adverse Event|1|||
124823403|NCT02288559|448981077|FG002|Overall Study|Adverse Event|5|||
124823404|NCT02288559|448981078|FG003|Overall Study|Adverse Event|0|||
124823405|NCT02288559|448981075|FG000|Overall Study|Death|0|||
124823406|NCT02288559|448981076|FG001|Overall Study|Death|0|||
124823407|NCT02288559|448981077|FG002|Overall Study|Death|1|||
124823408|NCT02288559|448981078|FG003|Overall Study|Death|0|||
124823409|NCT02288559|448981075|FG000|Overall Study|Lost to Follow-up|0|||
124823410|NCT02288559|448981076|FG001|Overall Study|Lost to Follow-up|0|||
124823411|NCT02288559|448981077|FG002|Overall Study|Lost to Follow-up|0|||
124823412|NCT02288559|448981078|FG003|Overall Study|Lost to Follow-up|1|||
124823413|NCT02288559|448981075|FG000|Overall Study|Withdrawal by Subject|0|||
124823414|NCT02288559|448981076|FG001|Overall Study|Withdrawal by Subject|0|||
124823415|NCT02288559|448981077|FG002|Overall Study|Withdrawal by Subject|2|||
124823416|NCT02288559|448981078|FG003|Overall Study|Withdrawal by Subject|1|||
124823417|NCT02288559|448981075|FG000|Overall Study|Reason Not Specified|0|||
124823418|NCT02288559|448981076|FG001|Overall Study|Reason Not Specified|0|||
124823419|NCT02288559|448981077|FG002|Overall Study|Reason Not Specified|3|||
124823420|NCT02288559|448981078|FG003|Overall Study|Reason Not Specified|0|||
124823421|NCT03303079|448981079|FG000|Overall Study|Adverse Event|0|||
124823422|NCT03303079|448981080|FG001|Overall Study|Adverse Event|1|||
124823423|NCT03303079|448981081|FG002|Overall Study|Adverse Event|3|||
124823424|NCT03303079|448981079|FG000|Overall Study|Protocol Violation|5|||
124823425|NCT03303079|448981080|FG001|Overall Study|Protocol Violation|4|||
124823426|NCT03303079|448981081|FG002|Overall Study|Protocol Violation|7|||
124823427|NCT03303079|448981079|FG000|Overall Study|Withdrawal by Subject|2|||
124823428|NCT03303079|448981080|FG001|Overall Study|Withdrawal by Subject|4|||
124823429|NCT03303079|448981081|FG002|Overall Study|Withdrawal by Subject|2|||
124823430|NCT03303079|448981079|FG000|Overall Study|Other than specified|0|||
124823431|NCT03303079|448981080|FG001|Overall Study|Other than specified|2|||
124823432|NCT03303079|448981081|FG002|Overall Study|Other than specified|0|||
124823433|NCT02005445|448981082|FG000|Overall Study|Dual study enrollment|0|||
124823434|NCT02005445|448981083|FG001|Overall Study|Dual study enrollment|1|||
124823435|NCT00449540|448981085|FG000|Pretreatment Phase|No migraine experienced|66|||
124823436|NCT00449540|448981086|FG001|Pretreatment Phase|No migraine experienced|0|||
124823437|NCT00449540|448981087|FG002|Pretreatment Phase|No migraine experienced|0|||
124823438|NCT00449540|448981085|FG000|Treatment Phase|did not experience or treat migraine|0|||
124823439|NCT00449540|448981086|FG001|Treatment Phase|did not experience or treat migraine|20|||
124823440|NCT00449540|448981087|FG002|Treatment Phase|did not experience or treat migraine|17|||
124823441|NCT02709785|448981088|FG000|Overall Study|Withdrawal by Subject|1|||
124823442|NCT02709785|448981089|FG001|Overall Study|Withdrawal by Subject|2|||
124823443|NCT02709785|448981090|FG002|Overall Study|Withdrawal by Subject|1|||
124823444|NCT01961323|448981091|FG000|Overall Study|Withdrawal by Subject|7|||
124823445|NCT01961323|448981091|FG000|Overall Study|Lost to Follow-up|8|||
124823446|NCT01961323|448981091|FG000|Overall Study|screen failure|34|||
124638059|NCT02343939|448292564|FG001|Overall Study|Adverse Event|0|||
124823447|NCT02746874|448981094|FG000|Overall Study|Withdrawal by Subject|0|||
124823448|NCT02746874|448981095|FG001|Overall Study|Withdrawal by Subject|1|||
124823449|NCT02746874|448981094|FG000|Overall Study|Surgery Date Changed|0|||
124823450|NCT02746874|448981095|FG001|Overall Study|Surgery Date Changed|2|||
124823451|NCT02320149|448981098|FG000|Overall Study|Adverse Event|3|||
124823452|NCT02320149|448981099|FG001|Overall Study|Adverse Event|7|||
124823453|NCT02320149|448981098|FG000|Overall Study|Withdrawal of Consent|28|||
124823454|NCT02320149|448981099|FG001|Overall Study|Withdrawal of Consent|32|||
124823455|NCT02320149|448981098|FG000|Overall Study|Lost to Follow-up|21|||
124638060|NCT02343939|448292565|FG002|Overall Study|Adverse Event|0|||
124823456|NCT02320149|448981099|FG001|Overall Study|Lost to Follow-up|34|||
124823457|NCT02320149|448981098|FG000|Overall Study|Protocol Violation|2|||
124823458|NCT02320149|448981099|FG001|Overall Study|Protocol Violation|1|||
124823459|NCT02320149|448981098|FG000|Overall Study|Noncompliance with Study Treatment|7|||
124823460|NCT02320149|448981099|FG001|Overall Study|Noncompliance with Study Treatment|2|||
124823461|NCT02320149|448981098|FG000|Overall Study|Lack of Efficacy|0|||
124638061|NCT02343939|448292566|FG003|Overall Study|Adverse Event|0|||
124638062|NCT02343939|448292567|FG004|Overall Study|Adverse Event|0|||
124823462|NCT02320149|448981099|FG001|Overall Study|Lack of Efficacy|1|||
124823463|NCT02320149|448981098|FG000|Overall Study|Other Miscellaneous Reasons|2|||
124823464|NCT02320149|448981099|FG001|Overall Study|Other Miscellaneous Reasons|3|||
124823465|NCT01156311|448981103|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
124823466|NCT01156311|448981104|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
124823467|NCT01156311|448981105|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
124823468|NCT01156311|448981106|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
124823469|NCT01156311|448981103|FG000|2-Month Monotherapy Period|Physician Decision|0|||
124823470|NCT01156311|448981104|FG001|2-Month Monotherapy Period|Physician Decision|1|||
124823471|NCT01156311|448981105|FG002|2-Month Monotherapy Period|Physician Decision|0|||
124823472|NCT01156311|448981106|FG003|2-Month Monotherapy Period|Physician Decision|0|||
124823473|NCT01156311|448981103|FG000|2-Month Monotherapy Period|Other|1|||
124823474|NCT01156311|448981104|FG001|2-Month Monotherapy Period|Other|0|||
124823475|NCT01156311|448981105|FG002|2-Month Monotherapy Period|Other|0|||
124823476|NCT01156311|448981106|FG003|2-Month Monotherapy Period|Other|0|||
124823477|NCT01156311|448981103|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
124823478|NCT01156311|448981104|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
124823479|NCT01156311|448981105|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
124823480|NCT01156311|448981106|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
124823481|NCT01156311|448981103|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
124823482|NCT01156311|448981104|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
124823483|NCT01156311|448981105|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
124823484|NCT01156311|448981106|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
124823485|NCT01156311|448981103|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
124823486|NCT01156311|448981104|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
124823487|NCT01156311|448981105|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
124823488|NCT01156311|448981106|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
124823489|NCT01156311|448981103|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
124823490|NCT01156311|448981104|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
124823491|NCT01156311|448981105|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
124823492|NCT01156311|448981106|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
124823493|NCT01156311|448981103|FG000|6-month Add-on Therapy Period|Other|0|||
124823494|NCT01156311|448981104|FG001|6-month Add-on Therapy Period|Other|0|||
124823495|NCT01156311|448981105|FG002|6-month Add-on Therapy Period|Other|1|||
124823496|NCT01156311|448981106|FG003|6-month Add-on Therapy Period|Other|2|||
124823497|NCT01741701|448981107|FG000|Overall Study|Adverse Event|5|||
124823498|NCT01741701|448981108|FG001|Overall Study|Adverse Event|1|||
124823499|NCT01741701|448981107|FG000|Overall Study|Withdrawal by Subject|0|||
124823500|NCT01741701|448981108|FG001|Overall Study|Withdrawal by Subject|1|||
124823501|NCT00487747|448981109|FG000|Overall Study|Adverse Event|1|||
124823502|NCT00487747|448981109|FG000|Overall Study|Lost to Follow-up|9|||
124823503|NCT00487747|448981109|FG000|Overall Study|Lack of Efficacy|1|||
124823504|NCT00372112|448981114|FG000|Overall Study|Adverse Event|0|||
124823505|NCT00372112|448981115|FG001|Overall Study|Adverse Event|1|||
124823506|NCT00372112|448981116|FG002|Overall Study|Adverse Event|1|||
124823507|NCT00372112|448981117|FG003|Overall Study|Adverse Event|1|||
124823508|NCT00372112|448981114|FG000|Overall Study|Withdrawal by Subject|0|||
124823509|NCT00372112|448981115|FG001|Overall Study|Withdrawal by Subject|0|||
124823510|NCT00372112|448981116|FG002|Overall Study|Withdrawal by Subject|2|||
124823511|NCT00372112|448981117|FG003|Overall Study|Withdrawal by Subject|1|||
124823512|NCT00372112|448981114|FG000|Overall Study|Exacerbation|0|||
124823513|NCT00372112|448981115|FG001|Overall Study|Exacerbation|0|||
124823514|NCT00372112|448981116|FG002|Overall Study|Exacerbation|0|||
124823515|NCT00372112|448981117|FG003|Overall Study|Exacerbation|1|||
124823516|NCT00372112|448981114|FG000|Overall Study|PR >240 at Visit 3|0|||
124823517|NCT00372112|448981115|FG001|Overall Study|PR >240 at Visit 3|0|||
124823518|NCT00372112|448981116|FG002|Overall Study|PR >240 at Visit 3|0|||
124823519|NCT00372112|448981117|FG003|Overall Study|PR >240 at Visit 3|1|||
124823520|NCT00372112|448981114|FG000|Overall Study|Hepatitis B|1|||
124823521|NCT00372112|448981115|FG001|Overall Study|Hepatitis B|0|||
124823522|NCT00372112|448981116|FG002|Overall Study|Hepatitis B|0|||
124638063|NCT02343939|448292568|FG005|Overall Study|Adverse Event|1|||
124823523|NCT00372112|448981117|FG003|Overall Study|Hepatitis B|0|||
124823524|NCT00372112|448981114|FG000|Overall Study|Other-protocol violation|0|||
124823525|NCT00372112|448981115|FG001|Overall Study|Other-protocol violation|0|||
124823526|NCT00372112|448981116|FG002|Overall Study|Other-protocol violation|1|||
124823527|NCT00372112|448981117|FG003|Overall Study|Other-protocol violation|0|||
124823528|NCT04649060|448981132|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
124823529|NCT04649060|448981133|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
124823530|NCT04649060|448981132|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
124823531|NCT04649060|448981133|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
124638064|NCT02343939|448292569|FG006|Overall Study|Adverse Event|0|||
124823532|NCT04649060|448981132|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
124823533|NCT04649060|448981133|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
124823534|NCT04649060|448981132|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
124823535|NCT04649060|448981133|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
124823536|NCT04649060|448981132|FG000|Arm A/Arm B Treatment|Patient Request|1|||
124823537|NCT04649060|448981133|FG001|Arm A/Arm B Treatment|Patient Request|0|||
124823538|NCT04649060|448981132|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
124823539|NCT04649060|448981133|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
124823540|NCT04649060|448981132|FG000|Arm A/Arm B Treatment|Other|1|||
124823541|NCT04649060|448981133|FG001|Arm A/Arm B Treatment|Other|0|||
124823542|NCT04649060|448981132|FG000|Crossover (Arm B)|Adverse Event|0|||
124823543|NCT04649060|448981133|FG001|Crossover (Arm B)|Adverse Event|1|||
124823544|NCT04649060|448981132|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
124823545|NCT04649060|448981133|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
124823546|NCT01830972|448981134|FG000|Part II|Withdrawal by Subject|2|||
124823547|NCT01830972|448981135|FG001|Part II|Withdrawal by Subject|2|||
124823548|NCT01830972|448981134|FG000|Part III|Withdrawal by Subject|1|||
124823549|NCT01830972|448981135|FG001|Part III|Withdrawal by Subject|0|||
124823550|NCT01830972|448981134|FG000|Part III|Noncompliance|1|||
124823551|NCT01830972|448981135|FG001|Part III|Noncompliance|0|||
124823552|NCT01830972|448981134|FG000|Part IV|Withdrawal by Subject|2|||
124823553|NCT01830972|448981135|FG001|Part IV|Withdrawal by Subject|1|||
124823554|NCT01830972|448981134|FG000|Part IV|Non-Compliance|1|||
124823555|NCT01830972|448981135|FG001|Part IV|Non-Compliance|0|||
124823556|NCT01907815|448981138|FG000|Overall Study|Withdrawal by Subject|1|||
124823557|NCT01907815|448981139|FG001|Overall Study|Withdrawal by Subject|0|||
124823558|NCT02205814|448981140|FG000|Overall Study|Lost to Follow-up|0|||
124823559|NCT02205814|448981141|FG001|Overall Study|Lost to Follow-up|0|||
124823560|NCT02205814|448981142|FG002|Overall Study|Lost to Follow-up|0|||
124823561|NCT02205814|448981143|FG003|Overall Study|Lost to Follow-up|1|||
124823562|NCT02205814|448981140|FG000|Overall Study|Lack of Efficacy|1|||
124823563|NCT02205814|448981141|FG001|Overall Study|Lack of Efficacy|0|||
124823564|NCT02205814|448981142|FG002|Overall Study|Lack of Efficacy|1|||
124823565|NCT02205814|448981143|FG003|Overall Study|Lack of Efficacy|1|||
124823566|NCT02205814|448981140|FG000|Overall Study|Physician Decision|0|||
124823567|NCT02205814|448981141|FG001|Overall Study|Physician Decision|0|||
124823568|NCT02205814|448981142|FG002|Overall Study|Physician Decision|1|||
124823569|NCT02205814|448981143|FG003|Overall Study|Physician Decision|0|||
124823570|NCT02205814|448981140|FG000|Overall Study|Protocol Violation|1|||
124823571|NCT02205814|448981141|FG001|Overall Study|Protocol Violation|0|||
124823572|NCT02205814|448981142|FG002|Overall Study|Protocol Violation|0|||
124823573|NCT02205814|448981143|FG003|Overall Study|Protocol Violation|1|||
124823574|NCT02205814|448981140|FG000|Overall Study|Withdrawal by Subject|0|||
124823575|NCT02205814|448981141|FG001|Overall Study|Withdrawal by Subject|1|||
124823576|NCT02205814|448981142|FG002|Overall Study|Withdrawal by Subject|2|||
124823577|NCT02205814|448981143|FG003|Overall Study|Withdrawal by Subject|1|||
124823578|NCT02205814|448981140|FG000|Overall Study|not compliant with study procedures|0|||
124823579|NCT02205814|448981141|FG001|Overall Study|not compliant with study procedures|0|||
124823580|NCT02205814|448981142|FG002|Overall Study|not compliant with study procedures|1|||
124823581|NCT02205814|448981143|FG003|Overall Study|not compliant with study procedures|0|||
124823582|NCT01426373|448981144|FG000|Overall Study|Adverse Event|6|||
124823583|NCT01426373|448981144|FG000|Overall Study|Lost to Follow-up|14|||
124823584|NCT01426373|448981144|FG000|Overall Study|Participant Convenience|10|||
124823585|NCT01426373|448981144|FG000|Overall Study|Miscellaneous Reasons|4|||
124823586|NCT04952402|448981145|FG000|Overall Study|Lost to Follow-up|1|||
124823587|NCT04952402|448981146|FG001|Overall Study|Lost to Follow-up|3|||
124823588|NCT04952402|448981145|FG000|Overall Study|Lack Of Venous Access|0|||
124823589|NCT04952402|448981146|FG001|Overall Study|Lack Of Venous Access|1|||
124823590|NCT01018186|448981150|FG000|2-week Run-in Period|Protocol Violation|1|||
124823591|NCT01018186|448981151|FG001|2-week Run-in Period|Protocol Violation|0|||
124823592|NCT01018186|448981152|FG002|2-week Run-in Period|Protocol Violation|0|||
124823593|NCT01018186|448981153|FG003|2-week Run-in Period|Protocol Violation|0|||
124823594|NCT01018186|448981150|FG000|2-week Run-in Period|Lost to Follow-up|2|||
124823595|NCT01018186|448981151|FG001|2-week Run-in Period|Lost to Follow-up|0|||
124823596|NCT01018186|448981152|FG002|2-week Run-in Period|Lost to Follow-up|0|||
124823597|NCT01018186|448981153|FG003|2-week Run-in Period|Lost to Follow-up|0|||
124823598|NCT01018186|448981150|FG000|2-week Run-in Period|Physician Decision|3|||
124823599|NCT01018186|448981151|FG001|2-week Run-in Period|Physician Decision|0|||
124823600|NCT01018186|448981152|FG002|2-week Run-in Period|Physician Decision|0|||
124823601|NCT01018186|448981153|FG003|2-week Run-in Period|Physician Decision|0|||
124823602|NCT01018186|448981150|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
124823603|NCT01018186|448981151|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
124823604|NCT01018186|448981152|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
124823605|NCT01018186|448981153|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
124823606|NCT01018186|448981150|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
124823607|NCT01018186|448981151|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
124823608|NCT01018186|448981152|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
124823609|NCT01018186|448981153|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
124823610|NCT01018186|448981150|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
124823611|NCT01018186|448981151|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
124823612|NCT01018186|448981152|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
124823613|NCT01018186|448981153|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
124823614|NCT01018186|448981150|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
124823615|NCT01018186|448981151|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
124823616|NCT01018186|448981152|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
124823617|NCT01018186|448981153|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
124823618|NCT01018186|448981150|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
124823619|NCT01018186|448981151|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
124823620|NCT01018186|448981152|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
124823621|NCT01018186|448981153|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
124823622|NCT01018186|448981150|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
124823623|NCT01018186|448981151|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
124823624|NCT01018186|448981152|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
124823625|NCT01018186|448981153|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
124823626|NCT01018186|448981150|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
124823627|NCT01018186|448981151|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
124823628|NCT01018186|448981152|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
124823629|NCT01018186|448981153|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
124823630|NCT01018186|448981150|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
124823631|NCT01018186|448981151|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
124823632|NCT01018186|448981152|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
124823633|NCT01018186|448981153|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
124823634|NCT01018186|448981150|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
124823635|NCT01018186|448981151|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
124823636|NCT01018186|448981152|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
124823637|NCT01018186|448981153|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
124823638|NCT03049280|448981154|FG000|Overall Study|Physician Decision|1|||
124823639|NCT03552198|448981155|FG000|Overall Study|Lost to Follow-up|42|||
124823640|NCT03552198|448981156|FG001|Overall Study|Lost to Follow-up|48|||
124823641|NCT03552198|448981157|FG002|Overall Study|Lost to Follow-up|15|||
124823642|NCT03552198|448981158|FG003|Overall Study|Lost to Follow-up|19|||
124823643|NCT03552198|448981155|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
124823644|NCT03552198|448981156|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
124823645|NCT03552198|448981157|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
124823646|NCT03552198|448981158|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
124823647|NCT03552198|448981155|FG000|Overall Study|Did not receive air alerts|1|||
124823648|NCT03552198|448981156|FG001|Overall Study|Did not receive air alerts|0|||
124823649|NCT03552198|448981157|FG002|Overall Study|Did not receive air alerts|0|||
124823650|NCT03552198|448981158|FG003|Overall Study|Did not receive air alerts|1|||
124823651|NCT02326025|448981161|FG000|Overall Study|Adverse Event|3|||
124823652|NCT02326025|448981162|FG001|Overall Study|Adverse Event|0|||
124823653|NCT02326025|448981161|FG000|Overall Study|Physician Decision|1|||
124823654|NCT02326025|448981162|FG001|Overall Study|Physician Decision|2|||
124823655|NCT02326025|448981161|FG000|Overall Study|Physician and Participant Decision|1|||
124823656|NCT02326025|448981162|FG001|Overall Study|Physician and Participant Decision|0|||
124823657|NCT02326025|448981161|FG000|Overall Study|Withdrawal by Subject|0|||
124823658|NCT02326025|448981162|FG001|Overall Study|Withdrawal by Subject|2|||
124823659|NCT02326025|448981161|FG000|Overall Study|Protocol Violation|0|||
124823660|NCT02326025|448981162|FG001|Overall Study|Protocol Violation|1|||
124823661|NCT00001723|448981163|FG000|Overall Study|Lack of Efficacy|6|||
124823662|NCT00001723|448981164|FG001|Overall Study|Lack of Efficacy|7|||
124823663|NCT00001723|448981163|FG000|Overall Study|Lack of family interest|4|||
124823664|NCT00001723|448981164|FG001|Overall Study|Lack of family interest|5|||
124823665|NCT00001723|448981163|FG000|Overall Study|Lost to Follow-up|2|||
124823666|NCT00001723|448981164|FG001|Overall Study|Lost to Follow-up|2|||
124823667|NCT00001723|448981163|FG000|Overall Study|medication intolerance|1|||
124823668|NCT00001723|448981164|FG001|Overall Study|medication intolerance|2|||
124823669|NCT02643082|448981165|FG000|Period 1|Adverse Event|1|||
124823670|NCT02643082|448981166|FG001|Period 1|Adverse Event|0|||
124823671|NCT01324999|448981167|FG000|Overall Study|Adverse Event|3|||
124823672|NCT01324999|448981167|FG000|Overall Study|Withdrawal by Subject|2|||
124823673|NCT02505867|448981170|FG000|Overall Study|Lack of Efficacy|6|||
124823674|NCT02505867|448981171|FG001|Overall Study|Lack of Efficacy|6|||
124823675|NCT01862874|448981172|FG000|Overall Study|Randomized not treated|1|||
124823676|NCT01862874|448981173|FG001|Overall Study|Randomized not treated|0|||
124823677|NCT01862874|448981172|FG000|Overall Study|Adverse Event|0|||
124823678|NCT01862874|448981173|FG001|Overall Study|Adverse Event|3|||
124823679|NCT01862874|448981172|FG000|Overall Study|Lost to Follow-up|26|||
124638065|NCT02343939|448292570|FG007|Overall Study|Adverse Event|0|||
124823680|NCT01862874|448981173|FG001|Overall Study|Lost to Follow-up|29|||
124823681|NCT01862874|448981172|FG000|Overall Study|Physician Decision|5|||
124638066|NCT02343939|448292571|FG008|Overall Study|Adverse Event|0|||
124638067|NCT02343939|448292563|FG000|Overall Study|Never Treated With ENTO|0|||
124823682|NCT01862874|448981173|FG001|Overall Study|Physician Decision|3|||
124823683|NCT01862874|448981172|FG000|Overall Study|Withdrawn by parent/guardian|1|||
124823684|NCT01862874|448981173|FG001|Overall Study|Withdrawn by parent/guardian|1|||
124823685|NCT01862874|448981172|FG000|Overall Study|Withdrawal by Subject|46|||
124823686|NCT01862874|448981173|FG001|Overall Study|Withdrawal by Subject|40|||
124823687|NCT01862874|448981172|FG000|Overall Study|Death|0|||
124823688|NCT01862874|448981173|FG001|Overall Study|Death|1|||
124823689|NCT01714635|448981176|FG000|Overall Study|Discontinued|1|||
124823690|NCT01714635|448981177|FG001|Overall Study|Discontinued|0|||
124823691|NCT01714635|448981178|FG002|Overall Study|Discontinued|2|||
124823692|NCT01714635|448981176|FG000|Overall Study|Missed 6-month exam|1|||
124823693|NCT01714635|448981177|FG001|Overall Study|Missed 6-month exam|0|||
124823694|NCT01714635|448981178|FG002|Overall Study|Missed 6-month exam|0|||
124823695|NCT02860169|448981179|FG000|Part A|Withdrawal by Subject|1|||
124823696|NCT02860169|448981179|FG000|Part A|Other (Screening failure)|6|||
124823697|NCT02860169|448981179|FG000|Part A|Other (Survey not completed)|3|||
124823698|NCT02860169|448981179|FG000|Part A|Other (did not completed consent)|1|||
124823699|NCT02860169|448981179|FG000|Part B|Other (Screening failure)|10|||
124823700|NCT02860169|448981179|FG000|Part B|Withdrawal by Subject|1|||
124823701|NCT02860169|448981179|FG000|Part C|Other (Screening failure)|1|||
124823702|NCT03667924|448981180|FG000|Baseline Completed|Lost to Follow-up|0|||
124823703|NCT03667924|448981181|FG001|Baseline Completed|Lost to Follow-up|2|||
124823704|NCT03667924|448981182|FG002|Baseline Completed|Lost to Follow-up|0|||
124823705|NCT03667924|448981180|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
124823706|NCT03667924|448981181|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
124823707|NCT03667924|448981182|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
124823708|NCT03667924|448981180|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
124823709|NCT03667924|448981181|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
124823710|NCT03667924|448981182|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
124823711|NCT03667924|448981180|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
124823712|NCT03667924|448981181|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
124823713|NCT03667924|448981182|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
124823714|NCT03667924|448981180|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
124823715|NCT03667924|448981181|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
124823716|NCT03667924|448981182|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
124823717|NCT03667924|448981180|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
124823718|NCT03667924|448981181|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
124823719|NCT03667924|448981182|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
124823720|NCT03667924|448981180|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
124823721|NCT03667924|448981181|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
124823722|NCT03667924|448981182|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
124823723|NCT01937559|448981187|FG000|Overall Study|Physician Decision|3|||
124823724|NCT01937559|448981188|FG001|Overall Study|Physician Decision|3|||
124823725|NCT01937559|448981189|FG002|Overall Study|Physician Decision|0|||
124823726|NCT01937559|448981187|FG000|Overall Study|Withdrawal by Subject|6|||
124823727|NCT01937559|448981188|FG001|Overall Study|Withdrawal by Subject|4|||
124823728|NCT01937559|448981189|FG002|Overall Study|Withdrawal by Subject|0|||
124823729|NCT01937559|448981187|FG000|Overall Study|screen fail|2|||
124823730|NCT01937559|448981188|FG001|Overall Study|screen fail|4|||
124823731|NCT01937559|448981189|FG002|Overall Study|screen fail|0|||
124823732|NCT04203238|448982961|FG000|Overall Study|Withdrawal by Subject|1|||
124823733|NCT04203238|448982962|FG001|Overall Study|Withdrawal by Subject|1|||
124823734|NCT04203238|448982961|FG000|Overall Study|Covid-19|3|||
124823735|NCT04203238|448982962|FG001|Overall Study|Covid-19|0|||
124823736|NCT00733408|448982963|FG000|Overall Study|Adverse Event|4|||
124823737|NCT01134783|448982965|FG000|Overall Study|Pregnancy|16|||
124823738|NCT01134783|448982966|FG001|Overall Study|Pregnancy|8|||
124823739|NCT01134783|448982965|FG000|Overall Study|Withdrawal by Subject|15|||
124823740|NCT01134783|448982966|FG001|Overall Study|Withdrawal by Subject|9|||
124823741|NCT01134783|448982965|FG000|Overall Study|Lost to Follow-up|5|||
124823742|NCT01134783|448982966|FG001|Overall Study|Lost to Follow-up|20|||
124823743|NCT04221009|448982967|FG000|Overall Study|Withdrawal by Subject|4|||
124823744|NCT04232124|448982968|FG000|Overall Study|Lost to Follow-up|3|||
124823745|NCT02392247|448982971|FG000|Overall Study|Withdrawal by Subject|1|||
124823746|NCT02392247|448982971|FG000|Overall Study|Surgery cancelled; no data|1|||
124823747|NCT01500629|448982980|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
124823748|NCT01500629|448982981|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
124823749|NCT00588848|448982982|FG000|Overall Study|Physician Decision|0|||
124823750|NCT00588848|448982983|FG001|Overall Study|Physician Decision|3|||
124823751|NCT00589914|448982984|FG000|Overall Study|Adverse Event|19|||
124823752|NCT00589914|448982985|FG001|Overall Study|Adverse Event|10|||
124823753|NCT00589914|448982984|FG000|Overall Study|Death|2|||
124638068|NCT02343939|448292564|FG001|Overall Study|Never Treated With ENTO|0|||
124823754|NCT00589914|448982985|FG001|Overall Study|Death|0|||
124823755|NCT00589914|448982984|FG000|Overall Study|Lack of Efficacy|40|||
124823756|NCT00589914|448982985|FG001|Overall Study|Lack of Efficacy|43|||
124823757|NCT00589914|448982984|FG000|Overall Study|Lost to Follow-up|11|||
124823758|NCT00589914|448982985|FG001|Overall Study|Lost to Follow-up|18|||
124823759|NCT00589914|448982984|FG000|Overall Study|Pregnancy|1|||
124823760|NCT00589914|448982985|FG001|Overall Study|Pregnancy|0|||
124823761|NCT00589914|448982984|FG000|Overall Study|Withdrawal by Subject|55|||
124823762|NCT00589914|448982985|FG001|Overall Study|Withdrawal by Subject|49|||
124823763|NCT00589914|448982984|FG000|Overall Study|Other|22|||
124823764|NCT00589914|448982985|FG001|Overall Study|Other|17|||
124823765|NCT00531050|448982986|FG000|Part 1: Period 1|Adverse Event|0|||
124823766|NCT00531050|448982987|FG001|Part 1: Period 1|Adverse Event|1|||
124823767|NCT00531050|448982988|FG002|Part 1: Period 1|Adverse Event|0|||
124823768|NCT00531050|448982989|FG003|Part 1: Period 1|Adverse Event|0|||
124823769|NCT00531050|448982990|FG004|Part 1: Period 1|Adverse Event|0|||
124823770|NCT00531050|448982991|FG005|Part 1: Period 1|Adverse Event|0|||
124823771|NCT00531050|448982986|FG000|Part 1: Period 1|Protocol Deviation|0|||
124823772|NCT00531050|448982987|FG001|Part 1: Period 1|Protocol Deviation|0|||
124823773|NCT00531050|448982988|FG002|Part 1: Period 1|Protocol Deviation|0|||
124823774|NCT00531050|448982989|FG003|Part 1: Period 1|Protocol Deviation|1|||
124823775|NCT00531050|448982990|FG004|Part 1: Period 1|Protocol Deviation|0|||
124823776|NCT00531050|448982991|FG005|Part 1: Period 1|Protocol Deviation|0|||
124823777|NCT00531050|448982986|FG000|Part 1: Period 3|Adverse Event|1|||
124823778|NCT00531050|448982987|FG001|Part 1: Period 3|Adverse Event|0|||
124823779|NCT00531050|448982988|FG002|Part 1: Period 3|Adverse Event|0|||
124823780|NCT00531050|448982989|FG003|Part 1: Period 3|Adverse Event|0|||
124823781|NCT00531050|448982990|FG004|Part 1: Period 3|Adverse Event|0|||
124823782|NCT00531050|448982991|FG005|Part 1: Period 3|Adverse Event|0|||
124823783|NCT00531050|448982986|FG000|Part 2: Period 1|Adverse Event|0|||
124823784|NCT00531050|448982987|FG001|Part 2: Period 1|Adverse Event|0|||
124823785|NCT00531050|448982988|FG002|Part 2: Period 1|Adverse Event|0|||
124823786|NCT00531050|448982989|FG003|Part 2: Period 1|Adverse Event|0|||
124823787|NCT00531050|448982990|FG004|Part 2: Period 1|Adverse Event|0|||
124823788|NCT00531050|448982991|FG005|Part 2: Period 1|Adverse Event|1|||
124823789|NCT00531050|448982986|FG000|Part 2: Period 3|Abnormal test procedure|1|||
124823790|NCT00531050|448982987|FG001|Part 2: Period 3|Abnormal test procedure|0|||
124823791|NCT00531050|448982988|FG002|Part 2: Period 3|Abnormal test procedure|0|||
124823792|NCT00531050|448982989|FG003|Part 2: Period 3|Abnormal test procedure|0|||
124823793|NCT00531050|448982990|FG004|Part 2: Period 3|Abnormal test procedure|0|||
124823794|NCT00531050|448982991|FG005|Part 2: Period 3|Abnormal test procedure|1|||
124823795|NCT02233309|448982995|FG000|Overall Study|Physician Decision|5|||
124823796|NCT00799487|448983000|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
124823797|NCT00799487|448983001|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
124823798|NCT00799487|448983002|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
124823799|NCT00799487|448983000|FG000|Dose Adjustment Period|Adverse Event|2|||
124823800|NCT00799487|448983001|FG001|Dose Adjustment Period|Adverse Event|0|||
124823801|NCT00799487|448983002|FG002|Dose Adjustment Period|Adverse Event|0|||
124823802|NCT00799487|448983000|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
124823803|NCT00799487|448983001|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
124823804|NCT00799487|448983002|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
124823805|NCT00799487|448983000|FG000|Dose Adjustment Period|Investigator Discretion|2|||
124823806|NCT00799487|448983001|FG001|Dose Adjustment Period|Investigator Discretion|0|||
124823807|NCT00799487|448983002|FG002|Dose Adjustment Period|Investigator Discretion|0|||
124823808|NCT00799487|448983000|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
124823809|NCT00799487|448983001|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
124823810|NCT00799487|448983002|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
124823811|NCT00799487|448983000|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
124823812|NCT00799487|448983001|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
124823813|NCT00799487|448983002|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
124823814|NCT00799487|448983000|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
124823815|NCT00799487|448983001|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
124823816|NCT00799487|448983002|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
124823817|NCT00799487|448983000|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
124823818|NCT00799487|448983001|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
124823819|NCT00799487|448983002|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
124823820|NCT00799487|448983000|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
124823821|NCT00799487|448983001|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
124823822|NCT00799487|448983002|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
124823823|NCT00799487|448983000|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
124823824|NCT00799487|448983001|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
124823825|NCT00799487|448983002|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
124823826|NCT00799487|448983000|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
124823827|NCT00799487|448983001|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
124823828|NCT00799487|448983002|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
124823829|NCT00799487|448983000|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
124823830|NCT00799487|448983001|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
124823831|NCT00799487|448983002|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
124823832|NCT01402544|448983003|FG000|Overall Study|Withdrawal by Subject|6|||
124823833|NCT01828281|448983004|FG000|Overall Study|Withdrawal by Subject|1|||
124823834|NCT01828281|448983005|FG001|Overall Study|Withdrawal by Subject|0|||
124823835|NCT04876274|448983008|FG000|Overall Study|Lost to Follow-up|9|||
124823836|NCT04876274|448983009|FG001|Overall Study|Lost to Follow-up|12|||
124823837|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Death|3|||
124823838|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Death|3|||
124823839|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Death|0|||
124823840|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Death|0|||
124823841|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
124823842|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
124823843|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
124823844|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
124823845|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
124823846|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
124823847|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
124823848|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
124823849|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
124823850|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
124823851|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
124823852|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
124823853|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
124823854|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
124823855|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
124823856|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
124823857|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
124823858|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
124823859|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
124823860|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
124823861|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
124823862|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
124823863|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
124823864|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
124823865|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Other|6|||
124823866|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Other|3|||
124823867|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Other|0|||
124823868|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Other|0|||
124823869|NCT02051608|448983010|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
124823870|NCT02051608|448983011|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
124823871|NCT02051608|448983012|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
124823872|NCT02051608|448983013|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
124823873|NCT02051608|448983010|FG000|Part 2: Open-label Extension|Adverse Event|0|||
124823874|NCT02051608|448983011|FG001|Part 2: Open-label Extension|Adverse Event|0|||
124823875|NCT02051608|448983012|FG002|Part 2: Open-label Extension|Adverse Event|6|||
124823876|NCT02051608|448983013|FG003|Part 2: Open-label Extension|Adverse Event|8|||
124823877|NCT02051608|448983010|FG000|Part 2: Open-label Extension|Death|0|||
124823878|NCT02051608|448983011|FG001|Part 2: Open-label Extension|Death|0|||
124823879|NCT02051608|448983012|FG002|Part 2: Open-label Extension|Death|7|||
124823880|NCT02051608|448983013|FG003|Part 2: Open-label Extension|Death|4|||
124823881|NCT02051608|448983010|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
124823882|NCT02051608|448983011|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
124823883|NCT02051608|448983012|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
124823884|NCT02051608|448983013|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
124823885|NCT02051608|448983010|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
124638069|NCT02343939|448292565|FG002|Overall Study|Never Treated With ENTO|0|||
124638070|NCT02343939|448292566|FG003|Overall Study|Never Treated With ENTO|0|||
124823886|NCT02051608|448983011|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
124823887|NCT02051608|448983012|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
124823888|NCT02051608|448983013|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
124823889|NCT02051608|448983010|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
124638071|NCT02343939|448292567|FG004|Overall Study|Never Treated With ENTO|0|||
124638072|NCT02343939|448292568|FG005|Overall Study|Never Treated With ENTO|0|||
124823890|NCT02051608|448983011|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
124823891|NCT02051608|448983012|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
124823892|NCT02051608|448983013|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
124823893|NCT02051608|448983010|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
124823894|NCT02051608|448983011|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
124823895|NCT02051608|448983012|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
124823896|NCT02051608|448983013|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
124823897|NCT02051608|448983010|FG000|Part 2: Open-label Extension|Physician Decision|0|||
124823898|NCT02051608|448983011|FG001|Part 2: Open-label Extension|Physician Decision|0|||
124823899|NCT02051608|448983012|FG002|Part 2: Open-label Extension|Physician Decision|8|||
124823900|NCT02051608|448983013|FG003|Part 2: Open-label Extension|Physician Decision|5|||
124823901|NCT02051608|448983010|FG000|Part 2: Open-label Extension|Other|0|||
124823902|NCT02051608|448983011|FG001|Part 2: Open-label Extension|Other|0|||
124823903|NCT02051608|448983012|FG002|Part 2: Open-label Extension|Other|9|||
124823904|NCT02051608|448983013|FG003|Part 2: Open-label Extension|Other|9|||
124823905|NCT00142584|448983014|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
124823906|NCT00142584|448983015|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
124823907|NCT00142584|448983014|FG000|Overall Study|Withdrawal by Subject|30|||
124823908|NCT00142584|448983015|FG001|Overall Study|Withdrawal by Subject|16|||
124823909|NCT00142584|448983014|FG000|Overall Study|Lost to Follow-up|22|||
124823910|NCT00142584|448983015|FG001|Overall Study|Lost to Follow-up|12|||
124823911|NCT00142584|448983014|FG000|Overall Study|Adverse Event|14|||
124823912|NCT00142584|448983015|FG001|Overall Study|Adverse Event|5|||
124823913|NCT00142584|448983014|FG000|Overall Study|Protocol Violation|4|||
124823914|NCT00142584|448983015|FG001|Overall Study|Protocol Violation|7|||
124823915|NCT00142584|448983014|FG000|Overall Study|Treatment Failure|2|||
124823916|NCT00142584|448983015|FG001|Overall Study|Treatment Failure|0|||
124823917|NCT03070782|448983017|FG000|Overall Study|Adverse Event|3|||
124823918|NCT03070782|448983018|FG001|Overall Study|Adverse Event|0|||
124823919|NCT03070782|448983019|FG002|Overall Study|Adverse Event|3|||
124823920|NCT03070782|448983020|FG003|Overall Study|Adverse Event|1|||
124823921|NCT03070782|448983021|FG004|Overall Study|Adverse Event|6|||
124823922|NCT03070782|448983022|FG005|Overall Study|Adverse Event|2|||
124823923|NCT03070782|448983017|FG000|Overall Study|Withdrawal by Subject|2|||
124823924|NCT03070782|448983018|FG001|Overall Study|Withdrawal by Subject|1|||
124823925|NCT03070782|448983019|FG002|Overall Study|Withdrawal by Subject|1|||
124823926|NCT03070782|448983020|FG003|Overall Study|Withdrawal by Subject|0|||
124823927|NCT03070782|448983021|FG004|Overall Study|Withdrawal by Subject|4|||
124823928|NCT03070782|448983022|FG005|Overall Study|Withdrawal by Subject|3|||
124823929|NCT03070782|448983017|FG000|Overall Study|Reason Not Specified|2|||
124823930|NCT03070782|448983018|FG001|Overall Study|Reason Not Specified|0|||
124823931|NCT03070782|448983019|FG002|Overall Study|Reason Not Specified|0|||
124823932|NCT03070782|448983020|FG003|Overall Study|Reason Not Specified|1|||
124823933|NCT03070782|448983021|FG004|Overall Study|Reason Not Specified|2|||
124823934|NCT03070782|448983022|FG005|Overall Study|Reason Not Specified|1|||
124823935|NCT03070782|448983017|FG000|Overall Study|Ineligibility|0|||
124823936|NCT03070782|448983018|FG001|Overall Study|Ineligibility|0|||
124823937|NCT03070782|448983019|FG002|Overall Study|Ineligibility|0|||
124823938|NCT03070782|448983020|FG003|Overall Study|Ineligibility|1|||
124823939|NCT03070782|448983021|FG004|Overall Study|Ineligibility|0|||
124823940|NCT03070782|448983022|FG005|Overall Study|Ineligibility|1|||
124823941|NCT03070782|448983017|FG000|Overall Study|Pregnancy|0|||
124823942|NCT03070782|448983018|FG001|Overall Study|Pregnancy|0|||
124823943|NCT03070782|448983019|FG002|Overall Study|Pregnancy|0|||
124823944|NCT03070782|448983020|FG003|Overall Study|Pregnancy|1|||
124823945|NCT03070782|448983021|FG004|Overall Study|Pregnancy|0|||
124823946|NCT03070782|448983022|FG005|Overall Study|Pregnancy|0|||
124823947|NCT03070782|448983017|FG000|Overall Study|Investigator Judgement|0|||
124823948|NCT03070782|448983018|FG001|Overall Study|Investigator Judgement|0|||
124823949|NCT03070782|448983019|FG002|Overall Study|Investigator Judgement|0|||
124823950|NCT03070782|448983020|FG003|Overall Study|Investigator Judgement|1|||
124823951|NCT03070782|448983021|FG004|Overall Study|Investigator Judgement|0|||
124823952|NCT03070782|448983022|FG005|Overall Study|Investigator Judgement|0|||
124823953|NCT01083576|448983023|FG000|Overall Study|Treatment Failure|6|||
124823954|NCT01083576|448983024|FG001|Overall Study|Treatment Failure|1|||
124638073|NCT02343939|448292569|FG006|Overall Study|Never Treated With ENTO|1|||
124638074|NCT02343939|448292570|FG007|Overall Study|Never Treated With ENTO|2|||
124638075|NCT02343939|448292571|FG008|Overall Study|Never Treated With ENTO|0|||
124823955|NCT01948050|448983025|FG000|Overall Study|Withdrawal by Subject|0|||
124823956|NCT01948050|448983026|FG001|Overall Study|Withdrawal by Subject|1|||
124823957|NCT01314443|448983027|FG000|Overall Study|Withdrawal by Subject|2|||
124823958|NCT01314443|448983028|FG001|Overall Study|Withdrawal by Subject|1|||
124638076|NCT01580670|448292576|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
124823959|NCT01314443|448983029|FG002|Overall Study|Withdrawal by Subject|1|||
124823960|NCT01314443|448983030|FG003|Overall Study|Withdrawal by Subject|1|||
124823961|NCT01314443|448983027|FG000|Overall Study|Protocol Violation|2|||
124823962|NCT01314443|448983028|FG001|Overall Study|Protocol Violation|2|||
124823963|NCT01314443|448983029|FG002|Overall Study|Protocol Violation|1|||
124823964|NCT01314443|448983030|FG003|Overall Study|Protocol Violation|1|||
124823965|NCT00010374|448983031|FG000|Overall Study|False positive phrenic nerve test|1|||
124823966|NCT02875860|448983033|FG000|Overall Study|Withdrawal by Subject|0|||
124823967|NCT02875860|448983034|FG001|Overall Study|Withdrawal by Subject|1|||
124823968|NCT01881776|448983035|FG000|Overall Study|Lost to Follow-up|1|||
124823969|NCT01881776|448983036|FG001|Overall Study|Lost to Follow-up|2|||
124823970|NCT01881776|448983037|FG002|Overall Study|Lost to Follow-up|1|||
124823971|NCT01881776|448983035|FG000|Overall Study|Protocol Violation|0|||
124823972|NCT01881776|448983036|FG001|Overall Study|Protocol Violation|2|||
124823973|NCT01881776|448983037|FG002|Overall Study|Protocol Violation|1|||
124823974|NCT04044716|448983038|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
124823975|NCT04044716|448983039|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
124823976|NCT04044716|448983040|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
124823977|NCT04044716|448983038|FG000|Overall Study|Lost to Follow-up|2|||
124823978|NCT04044716|448983039|FG001|Overall Study|Lost to Follow-up|3|||
124823979|NCT04044716|448983040|FG002|Overall Study|Lost to Follow-up|0|||
124823980|NCT00276744|448983042|FG000|PART A|Reason unknown|98|||
124823981|NCT03060629|448983043|FG000|Overall Study|Death|4|||
124823982|NCT03060629|448983044|FG001|Overall Study|Death|5|||
124823983|NCT03060629|448983043|FG000|Overall Study|Withdrawal by Subject|50|||
124823984|NCT03060629|448983044|FG001|Overall Study|Withdrawal by Subject|35|||
124823985|NCT03060629|448983043|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
124823986|NCT03060629|448983044|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
124823987|NCT03060629|448983043|FG000|Overall Study|Participant Relocate|15|||
124823988|NCT03060629|448983044|FG001|Overall Study|Participant Relocate|15|||
124823989|NCT03060629|448983043|FG000|Overall Study|Unable to Contact Participant|34|||
124823990|NCT03060629|448983044|FG001|Overall Study|Unable to Contact Participant|23|||
124823991|NCT03060629|448983043|FG000|Overall Study|Investigator Decision|7|||
124823992|NCT03060629|448983044|FG001|Overall Study|Investigator Decision|7|||
124823993|NCT03060629|448983043|FG000|Overall Study|Study Terminated by Sponsor|1100|||
124823994|NCT03060629|448983044|FG001|Overall Study|Study Terminated by Sponsor|1123|||
124823995|NCT03060629|448983043|FG000|Overall Study|Other|4|||
124823996|NCT03060629|448983044|FG001|Overall Study|Other|4|||
124823997|NCT01782495|448983049|FG000|Overall Study|Adverse Event|0|||
124823998|NCT01782495|448983050|FG001|Overall Study|Adverse Event|0|||
124823999|NCT01782495|448983051|FG002|Overall Study|Adverse Event|0|||
124824000|NCT01782495|448983052|FG003|Overall Study|Adverse Event|0|||
124824001|NCT01782495|448983053|FG004|Overall Study|Adverse Event|0|||
124824002|NCT01782495|448983054|FG005|Overall Study|Adverse Event|0|||
124824003|NCT01782495|448983055|FG006|Overall Study|Adverse Event|0|||
124824004|NCT01782495|448983056|FG007|Overall Study|Adverse Event|2|||
124824005|NCT01782495|448983057|FG008|Overall Study|Adverse Event|0|||
124824006|NCT01782495|448983058|FG009|Overall Study|Adverse Event|0|||
124824007|NCT01782495|448983059|FG010|Overall Study|Adverse Event|0|||
124824008|NCT01782495|448983049|FG000|Overall Study|Withdrew Consent|0|||
124824009|NCT01782495|448983050|FG001|Overall Study|Withdrew Consent|1|||
124824010|NCT01782495|448983051|FG002|Overall Study|Withdrew Consent|0|||
124824011|NCT01782495|448983052|FG003|Overall Study|Withdrew Consent|0|||
124824012|NCT01782495|448983053|FG004|Overall Study|Withdrew Consent|0|||
124824013|NCT01782495|448983054|FG005|Overall Study|Withdrew Consent|0|||
124824014|NCT01782495|448983055|FG006|Overall Study|Withdrew Consent|0|||
124824015|NCT01782495|448983056|FG007|Overall Study|Withdrew Consent|1|||
124824016|NCT01782495|448983057|FG008|Overall Study|Withdrew Consent|0|||
124824017|NCT01782495|448983058|FG009|Overall Study|Withdrew Consent|0|||
124824018|NCT01782495|448983059|FG010|Overall Study|Withdrew Consent|0|||
124824019|NCT00071513|448983060|FG000|Intervention Component|Withdrawal by Subject|2|||
124824020|NCT00071513|448983061|FG001|Intervention Component|Withdrawal by Subject|3|||
124824021|NCT00071513|448983060|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
124824022|NCT00071513|448983061|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
124824023|NCT02260921|448983062|FG000|Overall Study|Adverse Event|1|||
124824024|NCT02260921|448983063|FG001|Overall Study|Adverse Event|0|||
124824025|NCT02260921|448983062|FG000|Overall Study|Lost to Follow-up|4|||
124824026|NCT02260921|448983063|FG001|Overall Study|Lost to Follow-up|3|||
124824027|NCT02260921|448983062|FG000|Overall Study|Withdraw Consent|4|||
124824028|NCT02260921|448983063|FG001|Overall Study|Withdraw Consent|1|||
124824029|NCT02260921|448983062|FG000|Overall Study|Death|1|||
124824030|NCT02260921|448983063|FG001|Overall Study|Death|0|||
124824031|NCT02260921|448983062|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
124638077|NCT01580670|448292576|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
124824032|NCT02260921|448983063|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
124638078|NCT00462709|448292577|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
124824033|NCT01244425|448983064|FG000|Overall Study|Withdrawal by Subject|2|||
124824034|NCT01244425|448983065|FG001|Overall Study|Withdrawal by Subject|2|||
124824035|NCT01244425|448983064|FG000|Overall Study|Adverse Event|1|||
124824036|NCT01244425|448983065|FG001|Overall Study|Adverse Event|1|||
124824037|NCT02743871|448983067|FG000|Overall Study|Lost to Follow-up|0|||
124824038|NCT02743871|448983068|FG001|Overall Study|Lost to Follow-up|0|||
124824039|NCT02743871|448983069|FG002|Overall Study|Lost to Follow-up|0|||
124824040|NCT02743871|448983070|FG003|Overall Study|Lost to Follow-up|1|||
124824041|NCT02743871|448983071|FG004|Overall Study|Lost to Follow-up|0|||
124824042|NCT02743871|448983072|FG005|Overall Study|Lost to Follow-up|0|||
124824043|NCT02743871|448983073|FG006|Overall Study|Lost to Follow-up|1|||
124824044|NCT02743871|448983074|FG007|Overall Study|Lost to Follow-up|0|||
124824045|NCT02743871|448983075|FG008|Overall Study|Lost to Follow-up|0|||
124824046|NCT02743871|448983076|FG009|Overall Study|Lost to Follow-up|0|||
124824047|NCT02743871|448983077|FG010|Overall Study|Lost to Follow-up|0|||
124824048|NCT02743871|448983078|FG011|Overall Study|Lost to Follow-up|2|||
124824049|NCT02743871|448983079|FG012|Overall Study|Lost to Follow-up|0|||
124824050|NCT02743871|448983080|FG013|Overall Study|Lost to Follow-up|0|||
124824051|NCT02743871|448983067|FG000|Overall Study|Withdrawal by Subject|0|||
124824052|NCT02743871|448983068|FG001|Overall Study|Withdrawal by Subject|0|||
124824053|NCT02743871|448983069|FG002|Overall Study|Withdrawal by Subject|0|||
124824054|NCT02743871|448983070|FG003|Overall Study|Withdrawal by Subject|0|||
124824055|NCT02743871|448983071|FG004|Overall Study|Withdrawal by Subject|0|||
124824056|NCT02743871|448983072|FG005|Overall Study|Withdrawal by Subject|0|||
124824057|NCT02743871|448983073|FG006|Overall Study|Withdrawal by Subject|0|||
124824058|NCT02743871|448983074|FG007|Overall Study|Withdrawal by Subject|0|||
124824059|NCT02743871|448983075|FG008|Overall Study|Withdrawal by Subject|0|||
124824060|NCT02743871|448983076|FG009|Overall Study|Withdrawal by Subject|0|||
124824061|NCT02743871|448983077|FG010|Overall Study|Withdrawal by Subject|1|||
124824062|NCT02743871|448983078|FG011|Overall Study|Withdrawal by Subject|0|||
124824063|NCT02743871|448983079|FG012|Overall Study|Withdrawal by Subject|12|||
124824064|NCT02743871|448983080|FG013|Overall Study|Withdrawal by Subject|6|||
124824065|NCT02743871|448983067|FG000|Overall Study|Adverse Event|1|||
124824066|NCT02743871|448983068|FG001|Overall Study|Adverse Event|0|||
124824067|NCT02743871|448983069|FG002|Overall Study|Adverse Event|0|||
124824068|NCT02743871|448983070|FG003|Overall Study|Adverse Event|0|||
124824069|NCT02743871|448983071|FG004|Overall Study|Adverse Event|0|||
124824070|NCT02743871|448983072|FG005|Overall Study|Adverse Event|0|||
124824071|NCT02743871|448983073|FG006|Overall Study|Adverse Event|0|||
124824072|NCT02743871|448983074|FG007|Overall Study|Adverse Event|0|||
124824073|NCT02743871|448983075|FG008|Overall Study|Adverse Event|0|||
124824074|NCT02743871|448983076|FG009|Overall Study|Adverse Event|0|||
124824075|NCT02743871|448983077|FG010|Overall Study|Adverse Event|0|||
124824076|NCT02743871|448983078|FG011|Overall Study|Adverse Event|0|||
124824077|NCT02743871|448983079|FG012|Overall Study|Adverse Event|0|||
124824078|NCT02743871|448983080|FG013|Overall Study|Adverse Event|0|||
124824079|NCT02743871|448983067|FG000|Overall Study|Other|0|||
124824080|NCT02743871|448983068|FG001|Overall Study|Other|0|||
124824081|NCT02743871|448983069|FG002|Overall Study|Other|0|||
124824082|NCT02743871|448983070|FG003|Overall Study|Other|0|||
124824083|NCT02743871|448983071|FG004|Overall Study|Other|0|||
124824084|NCT02743871|448983072|FG005|Overall Study|Other|0|||
124824085|NCT02743871|448983073|FG006|Overall Study|Other|0|||
124824086|NCT02743871|448983074|FG007|Overall Study|Other|0|||
124824087|NCT02743871|448983075|FG008|Overall Study|Other|0|||
124824088|NCT02743871|448983076|FG009|Overall Study|Other|0|||
124824089|NCT02743871|448983077|FG010|Overall Study|Other|0|||
124824090|NCT02743871|448983078|FG011|Overall Study|Other|1|||
124824091|NCT02743871|448983079|FG012|Overall Study|Other|1|||
124824092|NCT02743871|448983080|FG013|Overall Study|Other|1|||
124824093|NCT02743871|448983067|FG000|Overall Study|Protocol Violation|0|||
124824094|NCT02743871|448983068|FG001|Overall Study|Protocol Violation|0|||
124824095|NCT02743871|448983069|FG002|Overall Study|Protocol Violation|0|||
124824096|NCT02743871|448983070|FG003|Overall Study|Protocol Violation|0|||
124824097|NCT02743871|448983071|FG004|Overall Study|Protocol Violation|0|||
124824098|NCT02743871|448983072|FG005|Overall Study|Protocol Violation|0|||
124824099|NCT02743871|448983073|FG006|Overall Study|Protocol Violation|0|||
124824100|NCT02743871|448983074|FG007|Overall Study|Protocol Violation|0|||
124824101|NCT02743871|448983075|FG008|Overall Study|Protocol Violation|0|||
124824102|NCT02743871|448983076|FG009|Overall Study|Protocol Violation|0|||
124824103|NCT02743871|448983077|FG010|Overall Study|Protocol Violation|0|||
124824104|NCT02743871|448983078|FG011|Overall Study|Protocol Violation|0|||
124824105|NCT02743871|448983079|FG012|Overall Study|Protocol Violation|2|||
124824106|NCT02743871|448983080|FG013|Overall Study|Protocol Violation|0|||
124824107|NCT02848651|448983081|FG000|Overall Study|Death|85|||
124824108|NCT02848651|448983081|FG000|Overall Study|Lost to Follow-up|1|||
124824109|NCT02848651|448983081|FG000|Overall Study|Non-Compliance|1|||
124824110|NCT02848651|448983081|FG000|Overall Study|Symptomatic Deterioration|1|||
124824111|NCT02848651|448983081|FG000|Overall Study|Physician Decision|4|||
124824112|NCT02848651|448983081|FG000|Overall Study|Withdrawal by Subject|14|||
124824113|NCT00897104|448983090|FG000|Overall Study|Lost to Follow-up|12|||
124824114|NCT00897104|448983091|FG001|Overall Study|Lost to Follow-up|17|||
124824115|NCT00897104|448983092|FG002|Overall Study|Lost to Follow-up|2|||
124824116|NCT00897104|448983090|FG000|Overall Study|Pregnancy|0|||
124638079|NCT00462709|448292577|FG000|Overall Study|Lost to Follow-up|10|||
124824117|NCT00897104|448983091|FG001|Overall Study|Pregnancy|1|||
124824118|NCT00897104|448983092|FG002|Overall Study|Pregnancy|0|||
124824119|NCT00897104|448983090|FG000|Overall Study|Protocol Violation|0|||
124824120|NCT00897104|448983091|FG001|Overall Study|Protocol Violation|1|||
124824121|NCT00897104|448983092|FG002|Overall Study|Protocol Violation|0|||
124824122|NCT00897104|448983090|FG000|Overall Study|Withdrawal by Subject|23|||
124824123|NCT00897104|448983091|FG001|Overall Study|Withdrawal by Subject|27|||
124824124|NCT00897104|448983092|FG002|Overall Study|Withdrawal by Subject|3|||
124824125|NCT00897104|448983090|FG000|Overall Study|Abnormal Prestudy Labs|2|||
124824126|NCT00897104|448983091|FG001|Overall Study|Abnormal Prestudy Labs|0|||
124824127|NCT00897104|448983092|FG002|Overall Study|Abnormal Prestudy Labs|0|||
124824128|NCT00897104|448983090|FG000|Overall Study|Abnormal Baseline ECG|2|||
124824129|NCT00897104|448983091|FG001|Overall Study|Abnormal Baseline ECG|2|||
124824130|NCT00897104|448983092|FG002|Overall Study|Abnormal Baseline ECG|0|||
124824131|NCT00897104|448983090|FG000|Overall Study|Need for Concom. Med.|0|||
124824132|NCT00897104|448983091|FG001|Overall Study|Need for Concom. Med.|1|||
124824133|NCT00897104|448983092|FG002|Overall Study|Need for Concom. Med.|1|||
124824134|NCT00897104|448983090|FG000|Overall Study|Lack of Migraine Attack|20|||
124824135|NCT00897104|448983091|FG001|Overall Study|Lack of Migraine Attack|22|||
124824136|NCT00897104|448983092|FG002|Overall Study|Lack of Migraine Attack|1|||
124824137|NCT00897104|448983090|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
124824138|NCT00897104|448983091|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
124824139|NCT00897104|448983092|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
124824140|NCT00897104|448983090|FG000|Overall Study|Other|3|||
124824141|NCT00897104|448983091|FG001|Overall Study|Other|0|||
124824142|NCT00897104|448983092|FG002|Overall Study|Other|0|||
124824143|NCT00897104|448983090|FG000|Overall Study|Protocol Violation|1|||
124824144|NCT00897104|448983091|FG001|Overall Study|Protocol Violation|0|||
124824145|NCT00897104|448983092|FG002|Overall Study|Protocol Violation|0|||
124824146|NCT00897104|448983090|FG000|Overall Study|Withdrawal by Subject|0|||
124824147|NCT00897104|448983091|FG001|Overall Study|Withdrawal by Subject|0|||
124824148|NCT00897104|448983092|FG002|Overall Study|Withdrawal by Subject|1|||
124824149|NCT01059799|448983095|FG000|Overall Study|Adverse Event|2|||
124824150|NCT01059799|448983096|FG001|Overall Study|Adverse Event|3|||
124824151|NCT01059799|448983095|FG000|Overall Study|Lack of Efficacy|1|||
124824152|NCT01059799|448983096|FG001|Overall Study|Lack of Efficacy|0|||
124824153|NCT01059799|448983095|FG000|Overall Study|Protocol Violation|3|||
124824154|NCT01059799|448983096|FG001|Overall Study|Protocol Violation|2|||
124824155|NCT01059799|448983095|FG000|Overall Study|Withdrawal criteria|13|||
124824156|NCT01059799|448983096|FG001|Overall Study|Withdrawal criteria|2|||
124824157|NCT01059799|448983095|FG000|Overall Study|Other|12|||
124824158|NCT01059799|448983096|FG001|Overall Study|Other|3|||
124824159|NCT00750204|448983097|FG000|Overall Study|study halted prematurely|1|||
124824160|NCT00750204|448983098|FG001|Overall Study|study halted prematurely|1|||
124824161|NCT00662363|448983099|FG000|Overall Study|Withdrawal by Subject|6|||
124824162|NCT00662363|448983100|FG001|Overall Study|Withdrawal by Subject|5|||
124824163|NCT00662363|448983099|FG000|Overall Study|Adverse Event|0|||
124824164|NCT00662363|448983100|FG001|Overall Study|Adverse Event|3|||
124824165|NCT00662363|448983099|FG000|Overall Study|Discharged early from rehab|4|||
124824166|NCT00662363|448983100|FG001|Overall Study|Discharged early from rehab|1|||
124824167|NCT00662363|448983099|FG000|Overall Study|Protocol Violation|1|||
124824168|NCT00662363|448983100|FG001|Overall Study|Protocol Violation|1|||
124824169|NCT01428453|448983101|FG000|Overall Study|Adverse Event|2|||
124824170|NCT01428453|448983102|FG001|Overall Study|Adverse Event|7|||
124824171|NCT01428453|448983101|FG000|Overall Study|Protocol Violation|1|||
124824172|NCT01428453|448983102|FG001|Overall Study|Protocol Violation|0|||
124824173|NCT01428453|448983101|FG000|Overall Study|Lost to Follow-up|0|||
124824174|NCT01428453|448983102|FG001|Overall Study|Lost to Follow-up|1|||
124824175|NCT01428453|448983101|FG000|Overall Study|Withdrawal by Subject|3|||
124824176|NCT01428453|448983102|FG001|Overall Study|Withdrawal by Subject|1|||
124824177|NCT03789318|448983108|FG000|Overall Study|Adverse Event|0|||
124824178|NCT03789318|448983109|FG001|Overall Study|Adverse Event|0|||
124824179|NCT03789318|448983110|FG002|Overall Study|Adverse Event|1|||
124824180|NCT03789318|448983111|FG003|Overall Study|Adverse Event|1|||
124824181|NCT03789318|448983112|FG004|Overall Study|Adverse Event|0|||
124638080|NCT00462709|448292577|FG000|Overall Study|Withdrawal by Subject|8|||
124824182|NCT03789318|448983108|FG000|Overall Study|Lost to Follow-up|0|||
124824183|NCT03789318|448983109|FG001|Overall Study|Lost to Follow-up|0|||
124824184|NCT03789318|448983110|FG002|Overall Study|Lost to Follow-up|1|||
124824185|NCT03789318|448983111|FG003|Overall Study|Lost to Follow-up|0|||
124824186|NCT03789318|448983112|FG004|Overall Study|Lost to Follow-up|0|||
124824187|NCT03789318|448983108|FG000|Overall Study|Withdrawal by Subject|0|||
124824188|NCT03789318|448983109|FG001|Overall Study|Withdrawal by Subject|0|||
124824189|NCT03789318|448983110|FG002|Overall Study|Withdrawal by Subject|1|||
124638081|NCT00462709|448292577|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
124824190|NCT03789318|448983111|FG003|Overall Study|Withdrawal by Subject|0|||
124824191|NCT03789318|448983112|FG004|Overall Study|Withdrawal by Subject|0|||
124824192|NCT02480114|448983113|FG000|Overall Study|Not completing surveys|3|||
124824193|NCT02480114|448983114|FG001|Overall Study|Not completing surveys|2|||
124824194|NCT02480114|448983113|FG000|Overall Study|Withdrawal by Subject|2|||
124824195|NCT02480114|448983114|FG001|Overall Study|Withdrawal by Subject|4|||
124824196|NCT02480114|448983113|FG000|Overall Study|Disease progression|3|||
124824197|NCT02480114|448983114|FG001|Overall Study|Disease progression|0|||
124824198|NCT02480114|448983113|FG000|Overall Study|Improper completion of survey|1|||
124824199|NCT02480114|448983114|FG001|Overall Study|Improper completion of survey|1|||
124824200|NCT02480114|448983113|FG000|Overall Study|Not eligible|0|||
124824201|NCT02480114|448983114|FG001|Overall Study|Not eligible|1|||
124824202|NCT01535053|448983115|FG000|Overall Study|Ineligible|1|||
124824203|NCT01535053|448983116|FG001|Overall Study|Ineligible|2|||
124824204|NCT00512707|448983117|FG000|Overall Study|Lost to Follow-up|5|||
124824205|NCT00512707|448983118|FG001|Overall Study|Lost to Follow-up|11|||
124824206|NCT00512707|448983117|FG000|Overall Study|Developed skin irritation|2|||
124824207|NCT00512707|448983118|FG001|Overall Study|Developed skin irritation|1|||
124824208|NCT00512707|448983117|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
124824209|NCT00512707|448983118|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
124824210|NCT00512707|448983117|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
124824211|NCT00512707|448983118|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
124824212|NCT00477971|448983119|FG000|Overall Study|Disease progression|6|||
124824213|NCT00477971|448983120|FG001|Overall Study|Disease progression|0|||
124824214|NCT00477971|448983119|FG000|Overall Study|Withdrawal by Subject|3|||
124824215|NCT00477971|448983120|FG001|Overall Study|Withdrawal by Subject|1|||
124824216|NCT00477971|448983119|FG000|Overall Study|Adverse Event|3|||
124824217|NCT00477971|448983120|FG001|Overall Study|Adverse Event|0|||
124824218|NCT00477971|448983119|FG000|Overall Study|Death|2|||
124824219|NCT00477971|448983120|FG001|Overall Study|Death|4|||
124824220|NCT00477971|448983119|FG000|Overall Study|Alternative treatment|3|||
124824221|NCT00477971|448983120|FG001|Overall Study|Alternative treatment|1|||
124824222|NCT03700671|448983121|FG000|Overall Study|Lack of Efficacy|1|||
124824223|NCT03700671|448983122|FG001|Overall Study|Lack of Efficacy|2|||
124824224|NCT01317160|448983123|FG000|Overall Study|Incorrect inclusion|1|||
124824225|NCT01317160|448983124|FG001|Overall Study|Incorrect inclusion|1|||
124824226|NCT01317160|448983123|FG000|Overall Study|Lost to Follow-up|3|||
124824227|NCT01317160|448983124|FG001|Overall Study|Lost to Follow-up|3|||
124824228|NCT01317160|448983123|FG000|Overall Study|Withdrawal by Subject|0|||
124824229|NCT01317160|448983124|FG001|Overall Study|Withdrawal by Subject|2|||
124824230|NCT01774968|448983125|FG000|Overall Study|Adverse Event|4|||
124824231|NCT01774968|448983126|FG001|Overall Study|Adverse Event|4|||
124824232|NCT01774968|448983125|FG000|Overall Study|Death|0|||
124824233|NCT01774968|448983126|FG001|Overall Study|Death|1|||
124824234|NCT01774968|448983125|FG000|Overall Study|Lost to Follow-up|1|||
124824235|NCT01774968|448983126|FG001|Overall Study|Lost to Follow-up|3|||
124824236|NCT01774968|448983125|FG000|Overall Study|Physician Decision|5|||
124824237|NCT01774968|448983126|FG001|Overall Study|Physician Decision|1|||
124824238|NCT01774968|448983125|FG000|Overall Study|Protocol Violation|14|||
124824239|NCT01774968|448983126|FG001|Overall Study|Protocol Violation|13|||
124824240|NCT01774968|448983125|FG000|Overall Study|Sponsor Decision|0|||
124824241|NCT01774968|448983126|FG001|Overall Study|Sponsor Decision|2|||
124824242|NCT01774968|448983125|FG000|Overall Study|Withdrawal by Subject|6|||
124824243|NCT01774968|448983126|FG001|Overall Study|Withdrawal by Subject|11|||
124824244|NCT04405037|448983133|FG000|Overall Study|Withdrawal by Subject|1|||
124824245|NCT04405037|448983134|FG001|Overall Study|Withdrawal by Subject|0|||
124824246|NCT04405037|448983133|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
124824247|NCT04405037|448983134|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
124824248|NCT02759471|448983135|FG000|Overall Study|discomfort|2|||
124824249|NCT02879305|448983136|FG000|Overall Study|Investigator Site Closed|55|||
124824250|NCT02879305|448983137|FG001|Overall Study|Investigator Site Closed|57|||
124824251|NCT02879305|448983136|FG000|Overall Study|Withdrawal by Subject|44|||
124824252|NCT02879305|448983137|FG001|Overall Study|Withdrawal by Subject|42|||
124824253|NCT02879305|448983136|FG000|Overall Study|Lost to Follow-up|17|||
124824254|NCT02879305|448983137|FG001|Overall Study|Lost to Follow-up|12|||
124824255|NCT02879305|448983136|FG000|Overall Study|Other|1|||
124824256|NCT02879305|448983137|FG001|Overall Study|Other|0|||
124824257|NCT01955733|448984852|FG000|Period 1|Lost to Follow-up|1|||
124824258|NCT01955733|448984853|FG001|Period 1|Lost to Follow-up|0|||
124824259|NCT01955733|448984854|FG002|Period 1|Lost to Follow-up|0|||
124824260|NCT01955733|448984852|FG000|Period 2|Adverse Event|1|||
124824261|NCT01955733|448984853|FG001|Period 2|Adverse Event|0|||
124824262|NCT01955733|448984854|FG002|Period 2|Adverse Event|0|||
124638082|NCT00462709|448292577|FG000|Overall Study|Death|2|||
124824263|NCT01955733|448984852|FG000|Period 2|Physician Decision|0|||
124824264|NCT01955733|448984853|FG001|Period 2|Physician Decision|0|||
124824265|NCT01955733|448984854|FG002|Period 2|Physician Decision|1|||
124824266|NCT01955733|448984852|FG000|Period 2|Withdrawal by Subject|1|||
124824267|NCT01955733|448984853|FG001|Period 2|Withdrawal by Subject|3|||
124824268|NCT01955733|448984854|FG002|Period 2|Withdrawal by Subject|2|||
124824269|NCT01955733|448984852|FG000|Period 2|Study terminated by sponsor|8|||
124824270|NCT01955733|448984853|FG001|Period 2|Study terminated by sponsor|14|||
124824271|NCT01955733|448984854|FG002|Period 2|Study terminated by sponsor|16|||
124824272|NCT01955733|448984852|FG000|Period 2|Lost to Follow-up|2|||
124824273|NCT01955733|448984853|FG001|Period 2|Lost to Follow-up|0|||
124824274|NCT01955733|448984854|FG002|Period 2|Lost to Follow-up|0|||
124824275|NCT01955733|448984852|FG000|Period 2|Other not defined above|0|||
124824276|NCT01955733|448984853|FG001|Period 2|Other not defined above|2|||
124824277|NCT01955733|448984854|FG002|Period 2|Other not defined above|2|||
124824278|NCT02762266|448984855|FG000|Overall Study|Physician Decision|2|||
124824279|NCT02762266|448984856|FG001|Overall Study|Physician Decision|0|||
124824280|NCT01438424|448984857|FG000|Overall Study|Continuing treatment|29|||
124824281|NCT01438424|448984857|FG000|Overall Study|Minimal virologic response|95|||
124824282|NCT01438424|448984857|FG000|Overall Study|Not identified|55|||
124824283|NCT01438424|448984857|FG000|Overall Study|Withdrawal by Subject|104|||
124824284|NCT01438424|448984857|FG000|Overall Study|Progression of chronic hepatitis B|22|||
124824285|NCT01438424|448984857|FG000|Overall Study|Death|22|||
124824286|NCT01438424|448984857|FG000|Overall Study|Adverse Event|17|||
124824287|NCT01438424|448984857|FG000|Overall Study|Lost to Follow-up|17|||
124824288|NCT01438424|448984857|FG000|Overall Study|Abnormal laboratory test result|14|||
124824289|NCT01438424|448984857|FG000|Overall Study|Need for drug prohibited by protocol|14|||
124824290|NCT01438424|448984857|FG000|Overall Study|Pregnancy|7|||
124824291|NCT01438424|448984857|FG000|Overall Study|No longer met inclusion criteria|1|||
124824292|NCT01438424|448984857|FG000|Overall Study|Participant noncompliance|20|||
124824293|NCT02329730|448984860|FG000|Overall Study|Protocol Violation|0|||
124824294|NCT02329730|448984861|FG001|Overall Study|Protocol Violation|0|||
124824295|NCT02329730|448984862|FG002|Overall Study|Protocol Violation|0|||
124824296|NCT02329730|448984863|FG003|Overall Study|Protocol Violation|0|||
124824297|NCT02329730|448984864|FG004|Overall Study|Protocol Violation|2|||
124824298|NCT02329730|448984865|FG005|Overall Study|Protocol Violation|2|||
124824299|NCT02329730|448984866|FG006|Overall Study|Protocol Violation|0|||
124824300|NCT02329730|448984867|FG007|Overall Study|Protocol Violation|0|||
124824301|NCT02329730|448984868|FG008|Overall Study|Protocol Violation|0|||
124824302|NCT02329730|448984869|FG009|Overall Study|Protocol Violation|0|||
124824303|NCT02329730|448984870|FG010|Overall Study|Protocol Violation|0|||
124824304|NCT02329730|448984871|FG011|Overall Study|Protocol Violation|0|||
124824305|NCT02329730|448984860|FG000|Overall Study|Withdrawal by Subject|0|||
124824306|NCT02329730|448984861|FG001|Overall Study|Withdrawal by Subject|0|||
124824307|NCT02329730|448984862|FG002|Overall Study|Withdrawal by Subject|0|||
124824308|NCT02329730|448984863|FG003|Overall Study|Withdrawal by Subject|0|||
124824309|NCT02329730|448984864|FG004|Overall Study|Withdrawal by Subject|1|||
124824310|NCT02329730|448984865|FG005|Overall Study|Withdrawal by Subject|0|||
124824311|NCT02329730|448984866|FG006|Overall Study|Withdrawal by Subject|1|||
124824312|NCT02329730|448984867|FG007|Overall Study|Withdrawal by Subject|1|||
124824313|NCT02329730|448984868|FG008|Overall Study|Withdrawal by Subject|1|||
124824314|NCT02329730|448984869|FG009|Overall Study|Withdrawal by Subject|1|||
124824315|NCT02329730|448984870|FG010|Overall Study|Withdrawal by Subject|0|||
124824316|NCT02329730|448984871|FG011|Overall Study|Withdrawal by Subject|0|||
124824317|NCT03010254|448984874|FG000|Overall Study|Adverse Event|0|||
124824318|NCT03010254|448984875|FG001|Overall Study|Adverse Event|1|||
124824319|NCT03010254|448984874|FG000|Overall Study|Lost to Follow-up|4|||
124824320|NCT03010254|448984875|FG001|Overall Study|Lost to Follow-up|0|||
124824321|NCT03010254|448984874|FG000|Overall Study|Withdrawal by Subject|1|||
124824322|NCT03010254|448984875|FG001|Overall Study|Withdrawal by Subject|1|||
124824323|NCT03010254|448984874|FG000|Overall Study|Other|2|||
124824324|NCT03010254|448984875|FG001|Overall Study|Other|3|||
124824325|NCT01404325|448984876|FG000|Overall Study|Lost to Follow-up|1|||
124824326|NCT01404325|448984877|FG001|Overall Study|Lost to Follow-up|0|||
124824327|NCT01404325|448984876|FG000|Overall Study|Death|2|||
124824328|NCT01404325|448984877|FG001|Overall Study|Death|0|||
124824329|NCT01404325|448984876|FG000|Overall Study|Graft loss/Retransplantation|1|||
124824330|NCT01404325|448984877|FG001|Overall Study|Graft loss/Retransplantation|0|||
124824331|NCT01404325|448984876|FG000|Overall Study|non-specified reason|0|||
124824332|NCT01404325|448984877|FG001|Overall Study|non-specified reason|2|||
124824333|NCT02141282|448984883|FG000|Overall Study|Adverse event, not related to progression|8|||
124824334|NCT02141282|448984884|FG001|Overall Study|Adverse event, not related to progression|1|||
124824335|NCT02141282|448984885|FG002|Overall Study|Adverse event, not related to progression|3|||
124824336|NCT02141282|448984886|FG003|Overall Study|Adverse event, not related to progression|1|||
124824337|NCT02141282|448984883|FG000|Overall Study|Adverse event, related to progression|1|||
124638083|NCT00462709|448292577|FG000|Overall Study|Logistical reasons|2|||
124824338|NCT02141282|448984884|FG001|Overall Study|Adverse event, related to progression|0|||
124824339|NCT02141282|448984885|FG002|Overall Study|Adverse event, related to progression|2|||
124824340|NCT02141282|448984886|FG003|Overall Study|Adverse event, related to progression|0|||
124824341|NCT02141282|448984883|FG000|Overall Study|COVID-19 infection|1|||
124824342|NCT02141282|448984884|FG001|Overall Study|COVID-19 infection|0|||
124824343|NCT02141282|448984885|FG002|Overall Study|COVID-19 infection|0|||
124824344|NCT02141282|448984886|FG003|Overall Study|COVID-19 infection|0|||
124824345|NCT02141282|448984883|FG000|Overall Study|Lost to Follow-up|0|||
124824346|NCT02141282|448984884|FG001|Overall Study|Lost to Follow-up|0|||
124824347|NCT02141282|448984885|FG002|Overall Study|Lost to Follow-up|4|||
124824348|NCT02141282|448984886|FG003|Overall Study|Lost to Follow-up|2|||
124824349|NCT02141282|448984883|FG000|Overall Study|Other, not specified|14|||
124824350|NCT02141282|448984884|FG001|Overall Study|Other, not specified|11|||
124824351|NCT02141282|448984885|FG002|Overall Study|Other, not specified|23|||
124824352|NCT02141282|448984886|FG003|Overall Study|Other, not specified|9|||
124824353|NCT02141282|448984883|FG000|Overall Study|Progressive disease, Richter's|4|||
124824354|NCT02141282|448984884|FG001|Overall Study|Progressive disease, Richter's|1|||
124824355|NCT02141282|448984885|FG002|Overall Study|Progressive disease, Richter's|1|||
124824356|NCT02141282|448984886|FG003|Overall Study|Progressive disease, Richter's|1|||
124824357|NCT02141282|448984883|FG000|Overall Study|Progressive disease per protocol|12|||
124824358|NCT02141282|448984884|FG001|Overall Study|Progressive disease per protocol|7|||
124824359|NCT02141282|448984885|FG002|Overall Study|Progressive disease per protocol|9|||
124824360|NCT02141282|448984886|FG003|Overall Study|Progressive disease per protocol|2|||
124824361|NCT02141282|448984883|FG000|Overall Study|Stem cell transplant|1|||
124824362|NCT02141282|448984884|FG001|Overall Study|Stem cell transplant|0|||
124824363|NCT02141282|448984885|FG002|Overall Study|Stem cell transplant|1|||
124824364|NCT02141282|448984886|FG003|Overall Study|Stem cell transplant|0|||
124824365|NCT02141282|448984883|FG000|Overall Study|Study terminated by Sponsor|0|||
124824366|NCT02141282|448984884|FG001|Overall Study|Study terminated by Sponsor|1|||
124824367|NCT02141282|448984885|FG002|Overall Study|Study terminated by Sponsor|0|||
124824368|NCT02141282|448984886|FG003|Overall Study|Study terminated by Sponsor|0|||
124824369|NCT02141282|448984883|FG000|Overall Study|Subject non-compliance|0|||
124824370|NCT02141282|448984884|FG001|Overall Study|Subject non-compliance|0|||
124824371|NCT02141282|448984885|FG002|Overall Study|Subject non-compliance|1|||
124824372|NCT02141282|448984886|FG003|Overall Study|Subject non-compliance|0|||
124824373|NCT02141282|448984883|FG000|Overall Study|Withdrew consent|2|||
124824374|NCT02141282|448984884|FG001|Overall Study|Withdrew consent|0|||
124824375|NCT02141282|448984885|FG002|Overall Study|Withdrew consent|4|||
124824376|NCT02141282|448984886|FG003|Overall Study|Withdrew consent|0|||
124824377|NCT03312933|448984887|FG000|Overall Study|Protocol Violation|15|||
124824378|NCT03312933|448984887|FG000|Overall Study|Lost to Follow-up|36|||
124824379|NCT03312933|448984887|FG000|Overall Study|Withdrawal by Subject|3|||
124824380|NCT00224055|448984893|FG000|Overall Study|Adverse Event|9|||
124824381|NCT00224055|448984894|FG001|Overall Study|Adverse Event|3|||
124824382|NCT00224055|448984893|FG000|Overall Study|Lost to Follow-up|1|||
124824383|NCT00224055|448984894|FG001|Overall Study|Lost to Follow-up|2|||
124824384|NCT00224055|448984893|FG000|Overall Study|Protocol Violation|1|||
124824385|NCT00224055|448984894|FG001|Overall Study|Protocol Violation|1|||
124824386|NCT00224055|448984893|FG000|Overall Study|Inclusion Violation|3|||
124824387|NCT00224055|448984894|FG001|Overall Study|Inclusion Violation|6|||
124824388|NCT00224055|448984893|FG000|Overall Study|Withdrawal by Subject|0|||
124824389|NCT00224055|448984894|FG001|Overall Study|Withdrawal by Subject|2|||
124824390|NCT00224055|448984893|FG000|Overall Study|Other|1|||
124824391|NCT00224055|448984894|FG001|Overall Study|Other|0|||
124824392|NCT02068443|448984895|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
124824393|NCT02068443|448984896|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
124824394|NCT02068443|448984897|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
124824395|NCT02068443|448984895|FG000|Overall Study|Voluntary Withdrawal|4|||
124824396|NCT02068443|448984896|FG001|Overall Study|Voluntary Withdrawal|0|||
124824397|NCT02068443|448984897|FG002|Overall Study|Voluntary Withdrawal|1|||
124824398|NCT02068443|448984895|FG000|Overall Study|Lack of Efficacy|2|||
124824399|NCT02068443|448984896|FG001|Overall Study|Lack of Efficacy|1|||
124824400|NCT02068443|448984897|FG002|Overall Study|Lack of Efficacy|0|||
124824401|NCT02068443|448984895|FG000|Overall Study|Other Reason Not Specified|1|||
124824402|NCT02068443|448984896|FG001|Overall Study|Other Reason Not Specified|0|||
124824403|NCT02068443|448984897|FG002|Overall Study|Other Reason Not Specified|0|||
124824404|NCT01986855|448984898|FG000|Overall Study|Adverse Event|1|||
124824405|NCT01986855|448984899|FG001|Overall Study|Adverse Event|0|||
124824406|NCT01986855|448984900|FG002|Overall Study|Adverse Event|0|||
124824407|NCT01986855|448984898|FG000|Overall Study|Death|3|||
124824408|NCT01986855|448984899|FG001|Overall Study|Death|4|||
124824409|NCT01986855|448984900|FG002|Overall Study|Death|4|||
124824410|NCT01986855|448984898|FG000|Overall Study|Lost to Follow-up|2|||
124824411|NCT01986855|448984899|FG001|Overall Study|Lost to Follow-up|1|||
124824412|NCT01986855|448984900|FG002|Overall Study|Lost to Follow-up|0|||
124824413|NCT01986855|448984898|FG000|Overall Study|Screen Failure|0|||
124824414|NCT01986855|448984899|FG001|Overall Study|Screen Failure|1|||
124824415|NCT01986855|448984900|FG002|Overall Study|Screen Failure|0|||
124824416|NCT01986855|448984898|FG000|Overall Study|Participant Moved|0|||
124824417|NCT01986855|448984899|FG001|Overall Study|Participant Moved|0|||
124824418|NCT01986855|448984900|FG002|Overall Study|Participant Moved|2|||
124824419|NCT01986855|448984898|FG000|Overall Study|Withdrawal by Subject|7|||
124824420|NCT01986855|448984899|FG001|Overall Study|Withdrawal by Subject|8|||
124824421|NCT01986855|448984900|FG002|Overall Study|Withdrawal by Subject|5|||
124824422|NCT00664742|448984901|FG000|Overall Study|Withdrawn due to adverse events|3|||
124824423|NCT00664742|448984901|FG000|Overall Study|Withdrawal by Subject|31|||
124824424|NCT00664742|448984901|FG000|Overall Study|Lost to Follow-up|92|||
124824425|NCT04317066|448984902|FG000|Overall Study|Sponsor decision|5|||
124824426|NCT04317066|448984902|FG000|Overall Study|Death|2|||
124824427|NCT00848081|448984905|FG000|Overall Study|Adverse Event|6|||
124824428|NCT00848081|448984906|FG001|Overall Study|Adverse Event|7|||
124824429|NCT00848081|448984905|FG000|Overall Study|Protocol Violation|8|||
124824430|NCT00848081|448984906|FG001|Overall Study|Protocol Violation|5|||
124824431|NCT00848081|448984905|FG000|Overall Study|Lost to Follow-up|1|||
124824432|NCT00848081|448984906|FG001|Overall Study|Lost to Follow-up|0|||
124824433|NCT00848081|448984905|FG000|Overall Study|Physician Decision|0|||
124824434|NCT00848081|448984906|FG001|Overall Study|Physician Decision|3|||
124824435|NCT00848081|448984905|FG000|Overall Study|Withdrawal by Subject|5|||
124824436|NCT00848081|448984906|FG001|Overall Study|Withdrawal by Subject|3|||
124824437|NCT02064868|448984907|FG000|Overall Study|Lost to Follow-up|14|||
124824438|NCT02064868|448984908|FG001|Overall Study|Lost to Follow-up|8|||
124824439|NCT02064868|448984907|FG000|Overall Study|Physician Decision|1|||
124824440|NCT02064868|448984908|FG001|Overall Study|Physician Decision|0|||
124824441|NCT02064868|448984907|FG000|Overall Study|Withdrawal by Subject|14|||
124824442|NCT02064868|448984908|FG001|Overall Study|Withdrawal by Subject|3|||
124824443|NCT02064868|448984907|FG000|Overall Study|Technical Problems or Missing|5|||
124824444|NCT02064868|448984908|FG001|Overall Study|Technical Problems or Missing|2|||
124824445|NCT00754624|448984912|FG000|Overall Study|Adverse Event|16|||
124824446|NCT00754624|448984912|FG000|Overall Study|Death|1|||
124824447|NCT00754624|448984912|FG000|Overall Study|Physician Decision|8|||
124824448|NCT00754624|448984912|FG000|Overall Study|Protocol Violation|1|||
124824449|NCT00754624|448984912|FG000|Overall Study|Withdrawal by Subject|28|||
124824450|NCT00754624|448984912|FG000|Overall Study|Various|12|||
124824451|NCT00754624|448984912|FG000|Overall Study|Lost to Follow-up|3|||
124824452|NCT00418314|448984913|FG000|Overall Study|Withdrawal by Subject|1|||
124824453|NCT00418314|448984914|FG001|Overall Study|Withdrawal by Subject|2|||
124824454|NCT00710710|448984915|FG000|Overall Study|Consent withdrawn|2|||
124824455|NCT00710710|448984916|FG001|Overall Study|Consent withdrawn|2|||
124824456|NCT00710710|448984915|FG000|Overall Study|Protocol Violation|0|||
124824457|NCT00710710|448984916|FG001|Overall Study|Protocol Violation|1|||
124824458|NCT00710710|448984915|FG000|Overall Study|Adverse Event|3|||
124824459|NCT00710710|448984916|FG001|Overall Study|Adverse Event|3|||
124824460|NCT00710710|448984915|FG000|Overall Study|Progressive disease|40|||
124824461|NCT00710710|448984916|FG001|Overall Study|Progressive disease|38|||
124824462|NCT00715078|448984917|FG000|Overall Study|Death|29|||
124824463|NCT00715078|448984918|FG001|Overall Study|Death|36|||
124824464|NCT00715078|448984919|FG002|Overall Study|Death|36|||
124824465|NCT00715078|448984917|FG000|Overall Study|Withdrawal by Subject|1|||
124824466|NCT00715078|448984918|FG001|Overall Study|Withdrawal by Subject|0|||
124824467|NCT00715078|448984919|FG002|Overall Study|Withdrawal by Subject|1|||
124824468|NCT00715078|448984917|FG000|Overall Study|Unable to start due to disease prog.|0|||
124824469|NCT00715078|448984918|FG001|Overall Study|Unable to start due to disease prog.|0|||
124824470|NCT00715078|448984919|FG002|Overall Study|Unable to start due to disease prog.|1|||
124824471|NCT03263442|448984925|FG000|Inpatient Phase|Death|1|||
124824472|NCT03263442|448984926|FG001|Inpatient Phase|Death|0|||
124824473|NCT03263442|448984925|FG000|Inpatient Phase|Withdrawal by Subject|1|||
124824474|NCT03263442|448984926|FG001|Inpatient Phase|Withdrawal by Subject|0|||
124824475|NCT03263442|448984925|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
124824476|NCT03263442|448984926|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
124824477|NCT03263442|448984925|FG000|1-month Follow-Up|Lost to Follow-up|1|||
124824478|NCT03263442|448984926|FG001|1-month Follow-Up|Lost to Follow-up|0|||
124824479|NCT03263442|448984925|FG000|3-month Follow-Up|Lost to Follow-up|1|||
124824480|NCT03263442|448984926|FG001|3-month Follow-Up|Lost to Follow-up|3|||
124824481|NCT03263442|448984925|FG000|6-month Follow-Up|Lost to Follow-up|2|||
124824482|NCT03263442|448984926|FG001|6-month Follow-Up|Lost to Follow-up|2|||
124824483|NCT01463878|448984927|FG000|Overall Study|no longer met criteria for tube feed|2|||
124824484|NCT01463878|448984928|FG001|Overall Study|no longer met criteria for tube feed|2|||
124824485|NCT03804879|448984929|FG000|Overall Study|Adverse Event|3|||
124824486|NCT03804879|448984930|FG001|Overall Study|Adverse Event|0|||
124824487|NCT03804879|448984929|FG000|Overall Study|Study Terminated By Sponsor|10|||
124824488|NCT03804879|448984930|FG001|Overall Study|Study Terminated By Sponsor|12|||
124824489|NCT03804879|448984929|FG000|Overall Study|Withdrawal by Subject|3|||
124824490|NCT03804879|448984930|FG001|Overall Study|Withdrawal by Subject|1|||
124824491|NCT01585428|448984931|FG000|Overall Study|Death during treatment|1|||
124824492|NCT01585428|448984932|FG001|Overall Study|Death during treatment|0|||
124824493|NCT01084174|448984933|FG000|Overall Study|gastrointestinal symptoms|1|||
124824494|NCT01084174|448984934|FG001|Overall Study|gastrointestinal symptoms|1|||
124824495|NCT01084174|448984933|FG000|Overall Study|Eosinophilic esophagitis|0|||
124824496|NCT01084174|448984934|FG001|Overall Study|Eosinophilic esophagitis|1|||
124824497|NCT01084174|448984933|FG000|Overall Study|Anaphylaxis|0|||
124824498|NCT01084174|448984934|FG001|Overall Study|Anaphylaxis|1|||
124824499|NCT01084174|448984933|FG000|Overall Study|Participant noncompliance|0|||
124824500|NCT01084174|448984934|FG001|Overall Study|Participant noncompliance|1|||
124824501|NCT00673465|448984938|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
124638084|NCT00462709|448292577|FG000|Overall Study|Physician Decision|1|||
124824502|NCT00673465|448984939|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824503|NCT00673465|448984940|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824504|NCT00673465|448984941|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824505|NCT00673465|448984942|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
124824506|NCT00673465|448984943|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
124824507|NCT00673465|448984944|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824508|NCT00673465|448984945|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824509|NCT00673465|448984946|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824510|NCT00673465|448984947|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824511|NCT00673465|448984948|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824512|NCT00673465|448984949|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
124824513|NCT00673465|448984938|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824514|NCT00673465|448984939|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824515|NCT00673465|448984940|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824516|NCT00673465|448984941|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824517|NCT00673465|448984942|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
124824518|NCT00673465|448984943|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824519|NCT00673465|448984944|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824520|NCT00673465|448984945|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824521|NCT00673465|448984946|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824522|NCT00673465|448984947|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824523|NCT00673465|448984948|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824524|NCT00673465|448984949|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
124824525|NCT01829191|448984950|FG000|Overall Study|Relocation|0|||
124824526|NCT01829191|448984951|FG001|Overall Study|Relocation|1|||
124824527|NCT01829191|448984950|FG000|Overall Study|Lens discomfort|0|||
124824528|NCT01829191|448984951|FG001|Overall Study|Lens discomfort|3|||
124824529|NCT01829191|448984950|FG000|Overall Study|Lens handling difficulty|1|||
124824530|NCT01829191|448984951|FG001|Overall Study|Lens handling difficulty|4|||
124824531|NCT01829191|448984950|FG000|Overall Study|Protocol Violation|4|||
124824532|NCT01829191|448984951|FG001|Overall Study|Protocol Violation|1|||
124824533|NCT01829191|448984950|FG000|Overall Study|Withdrawal by Subject|2|||
124824534|NCT01829191|448984951|FG001|Overall Study|Withdrawal by Subject|3|||
124824535|NCT01829191|448984950|FG000|Overall Study|Lost to Follow-up|0|||
124824536|NCT01829191|448984951|FG001|Overall Study|Lost to Follow-up|1|||
124824537|NCT01829191|448984950|FG000|Overall Study|Subject was fit for ortho - k|0|||
124824538|NCT01829191|448984951|FG001|Overall Study|Subject was fit for ortho - k|1|||
124824539|NCT00726661|448984952|FG000|Overall Study|Lost to Follow-up|36|||
124824540|NCT00726661|448984953|FG001|Overall Study|Lost to Follow-up|11|||
124824541|NCT00726661|448984952|FG000|Overall Study|Withdrawal by Subject|17|||
124824542|NCT00726661|448984953|FG001|Overall Study|Withdrawal by Subject|13|||
124824543|NCT00726661|448984952|FG000|Overall Study|Trial terminated by sponsor|214|||
124824544|NCT00726661|448984953|FG001|Overall Study|Trial terminated by sponsor|187|||
124824545|NCT00726661|448984952|FG000|Overall Study|Death|475|||
124824546|NCT00726661|448984953|FG001|Overall Study|Death|159|||
124824547|NCT00726661|448984952|FG000|Overall Study|Physician Decision|25|||
124824548|NCT00726661|448984953|FG001|Overall Study|Physician Decision|13|||
124824549|NCT00726661|448984952|FG000|Overall Study|Other|47|||
124824550|NCT00726661|448984953|FG001|Overall Study|Other|35|||
124824551|NCT01996982|448984956|FG000|Overall Study|PI/team left institution|7|||
124824552|NCT01574326|448984957|FG000|Overall Study|Randomized but not treated|0|||
124824553|NCT01574326|448984958|FG001|Overall Study|Randomized but not treated|1|||
124824554|NCT01574326|448984957|FG000|Overall Study|Withdrawal by Participant|2|||
124824555|NCT01574326|448984958|FG001|Overall Study|Withdrawal by Participant|4|||
124824556|NCT01574326|448984957|FG000|Overall Study|Physician Decision|5|||
124824557|NCT01574326|448984958|FG001|Overall Study|Physician Decision|3|||
124824558|NCT01574326|448984957|FG000|Overall Study|Adverse Event|1|||
124824559|NCT01574326|448984958|FG001|Overall Study|Adverse Event|3|||
124824560|NCT01574326|448984957|FG000|Overall Study|Other: Mainly kidney transplant|8|||
124638085|NCT00462709|448292577|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
124638086|NCT04468347|448292578|FG000|Overall Study|Withdrawal by Subject|0|||
124638087|NCT04468347|448292579|FG001|Overall Study|Withdrawal by Subject|1|||
124638088|NCT04468347|448292580|FG002|Overall Study|Withdrawal by Subject|3|||
124638089|NCT04468347|448292581|FG003|Overall Study|Withdrawal by Subject|3|||
124638090|NCT04468347|448292578|FG000|Overall Study|Lost to Follow-up|0|||
124638091|NCT04468347|448292579|FG001|Overall Study|Lost to Follow-up|0|||
124638092|NCT04468347|448292580|FG002|Overall Study|Lost to Follow-up|1|||
124638093|NCT04468347|448292581|FG003|Overall Study|Lost to Follow-up|1|||
124638094|NCT04468347|448292578|FG000|Overall Study|Physician Decision|1|||
124824561|NCT01574326|448984958|FG001|Overall Study|Other: Mainly kidney transplant|8|||
124824562|NCT04997161|448984981|FG000|Overall Study|Study terminated by sponsor|3|||
124824563|NCT00005937|448984984|FG000|Overall Study|Lack of Efficacy|5|||
124824564|NCT01288469|448984985|FG000|Overall Study|Adverse Event|4|||
124824565|NCT01288469|448984986|FG001|Overall Study|Adverse Event|1|||
124824566|NCT01288469|448984987|FG002|Overall Study|Adverse Event|1|||
124824567|NCT01288469|448984985|FG000|Overall Study|Poor compliance to protocol|0|||
124824568|NCT01288469|448984986|FG001|Overall Study|Poor compliance to protocol|1|||
124824569|NCT01288469|448984987|FG002|Overall Study|Poor compliance to protocol|0|||
124824570|NCT01288469|448984985|FG000|Overall Study|Participant Moved|1|||
124824571|NCT01288469|448984986|FG001|Overall Study|Participant Moved|0|||
124824572|NCT01288469|448984987|FG002|Overall Study|Participant Moved|0|||
124824573|NCT01288469|448984985|FG000|Overall Study|Consent withdrawn by subject|1|||
124824574|NCT01288469|448984986|FG001|Overall Study|Consent withdrawn by subject|1|||
124824575|NCT01288469|448984987|FG002|Overall Study|Consent withdrawn by subject|1|||
124824576|NCT01288469|448984985|FG000|Overall Study|Exclusion criteria finally met|1|||
124824577|NCT01288469|448984986|FG001|Overall Study|Exclusion criteria finally met|0|||
124824578|NCT01288469|448984987|FG002|Overall Study|Exclusion criteria finally met|0|||
124824579|NCT00255047|448984988|FG000|Overall Study|Serious Adverse Events|2|||
124824580|NCT00255047|448984989|FG001|Overall Study|Serious Adverse Events|1|||
124824581|NCT00255047|448984990|FG002|Overall Study|Serious Adverse Events|2|||
124824582|NCT00255047|448984991|FG003|Overall Study|Serious Adverse Events|1|||
124824583|NCT00255047|448984988|FG000|Overall Study|Adverse Event|0|||
124824584|NCT00255047|448984989|FG001|Overall Study|Adverse Event|3|||
124824585|NCT00255047|448984990|FG002|Overall Study|Adverse Event|2|||
124824586|NCT00255047|448984991|FG003|Overall Study|Adverse Event|1|||
124824587|NCT00255047|448984988|FG000|Overall Study|Protocol Violation|13|||
124824588|NCT00255047|448984989|FG001|Overall Study|Protocol Violation|13|||
124824589|NCT00255047|448984990|FG002|Overall Study|Protocol Violation|16|||
124824590|NCT00255047|448984991|FG003|Overall Study|Protocol Violation|20|||
124824591|NCT00255047|448984988|FG000|Overall Study|Lost to Follow-up|9|||
124824592|NCT00255047|448984989|FG001|Overall Study|Lost to Follow-up|8|||
124824593|NCT00255047|448984990|FG002|Overall Study|Lost to Follow-up|5|||
124824594|NCT00255047|448984991|FG003|Overall Study|Lost to Follow-up|6|||
124824595|NCT00255047|448984988|FG000|Overall Study|Withdrawal by Subject|24|||
124824596|NCT00255047|448984989|FG001|Overall Study|Withdrawal by Subject|23|||
124824597|NCT00255047|448984990|FG002|Overall Study|Withdrawal by Subject|25|||
124824598|NCT00255047|448984991|FG003|Overall Study|Withdrawal by Subject|18|||
124824599|NCT01574612|448984992|FG000|Overall Study|Adverse Event|3|||
124824600|NCT01574612|448984992|FG000|Overall Study|non compliant with drug|2|||
124824601|NCT01574612|448984992|FG000|Overall Study|Withdrawal by Subject|1|||
124824602|NCT01574612|448984992|FG000|Overall Study|Lost to Follow-up|2|||
124824603|NCT02452398|448984993|FG000|Overall Study|Adverse Event|1|||
124824604|NCT02452398|448984993|FG000|Overall Study|Lost to Follow-up|28|||
124824605|NCT02452398|448984993|FG000|Overall Study|Physician Decision|2|||
124824606|NCT02452398|448984993|FG000|Overall Study|Withdrawal by Subject|6|||
124824607|NCT02452398|448984993|FG000|Overall Study|Moved away|4|||
124824608|NCT01957644|448984996|FG000|Overall Study|Adverse Event|4|||
124824609|NCT01957644|448984997|FG001|Overall Study|Adverse Event|2|||
124824610|NCT01957644|448984998|FG002|Overall Study|Adverse Event|0|||
124824611|NCT01957644|448984999|FG003|Overall Study|Adverse Event|0|||
124824612|NCT01957644|448985000|FG004|Overall Study|Adverse Event|1|||
124824613|NCT01957644|448984996|FG000|Overall Study|Progressive disease / relapse|0|||
124824614|NCT01957644|448984997|FG001|Overall Study|Progressive disease / relapse|1|||
124824615|NCT01957644|448984998|FG002|Overall Study|Progressive disease / relapse|0|||
124824616|NCT01957644|448984999|FG003|Overall Study|Progressive disease / relapse|1|||
124824617|NCT01957644|448985000|FG004|Overall Study|Progressive disease / relapse|0|||
124824618|NCT01957644|448984996|FG000|Overall Study|Other reason|1|||
124824619|NCT01957644|448984997|FG001|Overall Study|Other reason|2|||
124824620|NCT01957644|448984998|FG002|Overall Study|Other reason|1|||
124824621|NCT01957644|448984999|FG003|Overall Study|Other reason|1|||
124824622|NCT01957644|448985000|FG004|Overall Study|Other reason|0|||
124824623|NCT01957644|448984996|FG000|Overall Study|Withdrawal by Subject|1|||
124824624|NCT01957644|448984997|FG001|Overall Study|Withdrawal by Subject|0|||
124824625|NCT01957644|448984998|FG002|Overall Study|Withdrawal by Subject|0|||
124824626|NCT01957644|448984999|FG003|Overall Study|Withdrawal by Subject|0|||
124824627|NCT01957644|448985000|FG004|Overall Study|Withdrawal by Subject|0|||
124824628|NCT01957644|448984996|FG000|Overall Study|Protocol Violation|0|||
124824629|NCT01957644|448984997|FG001|Overall Study|Protocol Violation|1|||
124824630|NCT01957644|448984998|FG002|Overall Study|Protocol Violation|0|||
124824631|NCT01957644|448984999|FG003|Overall Study|Protocol Violation|0|||
124824632|NCT01957644|448985000|FG004|Overall Study|Protocol Violation|0|||
124824633|NCT00927784|448985001|FG000|Overall Study|Death|1|||
124824634|NCT00927784|448985002|FG001|Overall Study|Death|0|||
124824635|NCT00927784|448985001|FG000|Overall Study|Withdrawal by Subject|1|||
124638095|NCT04468347|448292579|FG001|Overall Study|Physician Decision|0|||
124824636|NCT00927784|448985002|FG001|Overall Study|Withdrawal by Subject|0|||
124638096|NCT04468347|448292580|FG002|Overall Study|Physician Decision|2|||
124824637|NCT02170051|448985003|FG000|Overall Study|Withdrawal by Subject|10|||
124824638|NCT02170051|448985004|FG001|Overall Study|Withdrawal by Subject|10|||
124824639|NCT02170051|448985003|FG000|Overall Study|Lost to Follow-up|1|||
124824640|NCT02170051|448985004|FG001|Overall Study|Lost to Follow-up|3|||
124824641|NCT01867021|448985005|FG000|Overall Study|Adverse Event|0|||
124824642|NCT01867021|448985006|FG001|Overall Study|Adverse Event|1|||
124824643|NCT01867021|448985005|FG000|Overall Study|Not Eligible|0|||
124824644|NCT01867021|448985006|FG001|Overall Study|Not Eligible|1|||
124824645|NCT01867021|448985005|FG000|Overall Study|Death|1|||
124824646|NCT01867021|448985006|FG001|Overall Study|Death|0|||
124824647|NCT01867021|448985005|FG000|Overall Study|Lost to Follow-up|0|||
124824648|NCT01867021|448985006|FG001|Overall Study|Lost to Follow-up|2|||
124824649|NCT01867021|448985005|FG000|Overall Study|Withdrawal by Subject|1|||
124824650|NCT01867021|448985006|FG001|Overall Study|Withdrawal by Subject|6|||
124824651|NCT00881712|448985007|FG000|Overall Study|Death|1|||
124824652|NCT00881712|448985008|FG001|Overall Study|Death|0|||
124824653|NCT00881712|448985009|FG002|Overall Study|Death|0|||
124824654|NCT00881712|448985007|FG000|Overall Study|Withdrawal by Subject|1|||
124824655|NCT00881712|448985008|FG001|Overall Study|Withdrawal by Subject|0|||
124824656|NCT00881712|448985009|FG002|Overall Study|Withdrawal by Subject|0|||
124824657|NCT01405742|448985017|FG000|Overall Study|Lost to Follow-up|1|||
124824658|NCT01405742|448985018|FG001|Overall Study|Lost to Follow-up|0|||
124824659|NCT03672747|448985020|FG000|Overall Study|Lost to Follow-up|1|||
124824660|NCT03672747|448985021|FG001|Overall Study|Lost to Follow-up|1|||
124824661|NCT03672747|448985022|FG002|Overall Study|Lost to Follow-up|2|||
124824662|NCT03672747|448985023|FG003|Overall Study|Lost to Follow-up|2|||
124824663|NCT03672747|448985024|FG004|Overall Study|Lost to Follow-up|2|||
124824664|NCT03672747|448985025|FG005|Overall Study|Lost to Follow-up|1|||
124824665|NCT03428360|448985026|FG000|Overall Study|Informed consent withdrawn|5|||
124824666|NCT03428360|448985026|FG000|Overall Study|Withdrawal by Subject|4|||
124824667|NCT03428360|448985026|FG000|Overall Study|Lost to Follow-up|5|||
124824668|NCT03428360|448985026|FG000|Overall Study|Physician Decision|2|||
124824669|NCT03428360|448985026|FG000|Overall Study|Informed consent withdrawn|5|||
124824670|NCT03428360|448985026|FG000|Overall Study|Study terminated by sponsor|10|||
124824671|NCT03428360|448985026|FG000|Overall Study|Non-compliant with study|1|||
124824672|NCT03428360|448985026|FG000|Overall Study|Non-compliant with study drug|3|||
124824673|NCT03428360|448985026|FG000|Overall Study|Death|3|||
124824674|NCT03428360|448985026|FG000|Overall Study|Adverse Event|1|||
124824675|NCT03428360|448985026|FG000|Overall Study|Not on antiepileptic drug|1|||
124824676|NCT01529346|448987168|FG000|Overall Study|Lost to Follow-up|2|||
124824677|NCT01529346|448987169|FG001|Overall Study|Lost to Follow-up|0|||
124824678|NCT01529346|448987170|FG002|Overall Study|Lost to Follow-up|1|||
124824679|NCT01529346|448987171|FG003|Overall Study|Lost to Follow-up|0|||
124824680|NCT01529346|448987172|FG004|Overall Study|Lost to Follow-up|0|||
124824681|NCT01529346|448987168|FG000|Overall Study|Other|0|||
124824682|NCT01529346|448987169|FG001|Overall Study|Other|1|||
124824683|NCT01529346|448987170|FG002|Overall Study|Other|1|||
124824684|NCT01529346|448987171|FG003|Overall Study|Other|0|||
124824685|NCT01529346|448987172|FG004|Overall Study|Other|0|||
124824686|NCT00386776|448987173|FG000|Overall Study|Withdrawal by Subject|8|||
124824687|NCT02902965|448987177|FG000|Overall Study|Withdrawal by Subject|10|||
124824688|NCT00232817|448987178|FG000|Overall Study|Protocol Violation|2|||
124824689|NCT00232817|448987179|FG001|Overall Study|Protocol Violation|1|||
124824690|NCT04481750|448987180|FG000|Period 1 (Fasted)|Adverse Event|0|||
124824691|NCT04481750|448987181|FG001|Period 1 (Fasted)|Adverse Event|0|||
124824692|NCT04481750|448987182|FG002|Period 1 (Fasted)|Adverse Event|1|||
124824693|NCT04481750|448987183|FG003|Period 1 (Fasted)|Adverse Event|0|||
124824694|NCT04481750|448987184|FG004|Period 1 (Fasted)|Adverse Event|0|||
124824695|NCT04481750|448987185|FG005|Period 1 (Fasted)|Adverse Event|0|||
124824696|NCT04481750|448987186|FG006|Period 1 (Fasted)|Adverse Event|0|||
124824697|NCT04481750|448987187|FG007|Period 1 (Fasted)|Adverse Event|0|||
124824698|NCT04481750|448987188|FG008|Period 1 (Fasted)|Adverse Event|0|||
124824699|NCT04481750|448987189|FG009|Period 1 (Fasted)|Adverse Event|0|||
124824700|NCT04481750|448987190|FG010|Period 1 (Fasted)|Adverse Event|0|||
124824701|NCT01594125|448987191|FG000|Overall Study|Withdrawal by Subject|1|||
124824702|NCT01594125|448987192|FG001|Overall Study|Withdrawal by Subject|0|||
124824703|NCT01594125|448987193|FG002|Overall Study|Withdrawal by Subject|0|||
124824704|NCT01594125|448987194|FG003|Overall Study|Withdrawal by Subject|1|||
124824705|NCT01594125|448987195|FG004|Overall Study|Withdrawal by Subject|0|||
124824706|NCT01594125|448987191|FG000|Overall Study|Progressive Disease|3|||
124824707|NCT01594125|448987192|FG001|Overall Study|Progressive Disease|12|||
124824708|NCT01594125|448987193|FG002|Overall Study|Progressive Disease|3|||
124824709|NCT01594125|448987194|FG003|Overall Study|Progressive Disease|3|||
124824710|NCT01594125|448987195|FG004|Overall Study|Progressive Disease|7|||
124824711|NCT01484873|448987196|FG000|Overall Study|Withdrawal by Subject|2|||
124824712|NCT02564042|448987197|FG000|Overall Study|Adverse Event|4|||
124824713|NCT02564042|448987198|FG001|Overall Study|Adverse Event|4|||
124824714|NCT02564042|448987199|FG002|Overall Study|Adverse Event|3|||
124824715|NCT02564042|448987200|FG003|Overall Study|Adverse Event|0|||
124824716|NCT02564042|448987201|FG004|Overall Study|Adverse Event|0|||
124824717|NCT02564042|448987202|FG005|Overall Study|Adverse Event|1|||
124824718|NCT02564042|448987197|FG000|Overall Study|Lost to Follow-up|1|||
124824719|NCT02564042|448987198|FG001|Overall Study|Lost to Follow-up|1|||
124824720|NCT02564042|448987199|FG002|Overall Study|Lost to Follow-up|1|||
124824721|NCT02564042|448987200|FG003|Overall Study|Lost to Follow-up|0|||
124824722|NCT02564042|448987201|FG004|Overall Study|Lost to Follow-up|1|||
124824723|NCT02564042|448987202|FG005|Overall Study|Lost to Follow-up|1|||
124824724|NCT02564042|448987197|FG000|Overall Study|Physician Decision|1|||
124824725|NCT02564042|448987198|FG001|Overall Study|Physician Decision|0|||
124824726|NCT02564042|448987199|FG002|Overall Study|Physician Decision|0|||
124824727|NCT02564042|448987200|FG003|Overall Study|Physician Decision|1|||
124824728|NCT02564042|448987201|FG004|Overall Study|Physician Decision|0|||
124824729|NCT02564042|448987202|FG005|Overall Study|Physician Decision|0|||
124824730|NCT02564042|448987197|FG000|Overall Study|Withdrawal by Subject|5|||
124824731|NCT02564042|448987198|FG001|Overall Study|Withdrawal by Subject|3|||
124824732|NCT02564042|448987199|FG002|Overall Study|Withdrawal by Subject|2|||
124824733|NCT02564042|448987200|FG003|Overall Study|Withdrawal by Subject|2|||
124824734|NCT02564042|448987201|FG004|Overall Study|Withdrawal by Subject|10|||
124824735|NCT02564042|448987202|FG005|Overall Study|Withdrawal by Subject|12|||
124824736|NCT01549392|448987203|FG000|Overall Study|Withdrawal by Subject|1|||
124824737|NCT01549392|448987204|FG001|Overall Study|Withdrawal by Subject|0|||
124824738|NCT01356966|448987205|FG000|Overall Study|Withdrawal by Subject|1|||
124824739|NCT01356966|448987206|FG001|Overall Study|Withdrawal by Subject|2|||
124824740|NCT01356966|448987205|FG000|Overall Study|Physician Decision|1|||
124824741|NCT01356966|448987206|FG001|Overall Study|Physician Decision|0|||
124824742|NCT02743806|448987207|FG000|Overall Study|Adverse Event|9|||
124824743|NCT02743806|448987207|FG000|Overall Study|Lost to Follow-up|8|||
124824744|NCT02743806|448987207|FG000|Overall Study|Voluntary Withdrawal|54|||
124824745|NCT02743806|448987207|FG000|Overall Study|Study Termination|65|||
124824746|NCT02743806|448987207|FG000|Overall Study|Pregnancy|6|||
124824747|NCT02743806|448987207|FG000|Overall Study|No Longer Clinically Benefiting|27|||
124824748|NCT02743806|448987207|FG000|Overall Study|Reason Not Specified|12|||
124824749|NCT00849381|448987209|FG000|Overall Study|Adverse Event|1|||
124824750|NCT00849381|448987209|FG000|Overall Study|Lost to Follow-up|129|||
124824751|NCT00849381|448987209|FG000|Overall Study|Protocol Violation|5|||
124824752|NCT00849381|448987209|FG000|Overall Study|Withdrawal by Subject|6|||
124824753|NCT00849381|448987209|FG000|Overall Study|Other|4|||
124824754|NCT00303498|448987210|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
124824755|NCT00303498|448987211|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
124824756|NCT00303498|448987210|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
124824757|NCT00303498|448987211|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
124824758|NCT00303498|448987210|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
124824759|NCT00303498|448987211|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
124824760|NCT00303498|448987210|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
124824761|NCT00303498|448987211|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
124824762|NCT00303498|448987210|FG000|Run-In-Phase (10 Weeks)|Other|4|||
124824763|NCT00303498|448987211|FG001|Run-In-Phase (10 Weeks)|Other|1|||
124824764|NCT00303498|448987210|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
124824765|NCT00303498|448987211|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
124824766|NCT00303498|448987210|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
124824767|NCT00303498|448987211|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
124824768|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
124824769|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
124824770|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Death|1|||
124824771|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Death|0|||
124824772|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
124824773|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
124824774|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
124824775|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
124824776|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
124824777|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
124824778|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
124824779|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
124824780|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Other|1|||
124824781|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Other|0|||
124824782|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
124824783|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
124824784|NCT00303498|448987210|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
124824785|NCT00303498|448987211|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
124638097|NCT04468347|448292581|FG003|Overall Study|Physician Decision|0|||
124824786|NCT01988103|448987217|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
124824787|NCT01988103|448987218|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
124824788|NCT01988103|448987219|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
124824789|NCT01988103|448987220|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
124824790|NCT01988103|448987221|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
124824791|NCT01988103|448987217|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
124824792|NCT01988103|448987218|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
124824793|NCT01988103|448987219|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
124824794|NCT01988103|448987220|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
124824795|NCT01988103|448987221|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
124638098|NCT04468347|448292578|FG000|Overall Study|Protocol Violation|1|||
124824796|NCT01988103|448987217|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
124824797|NCT01988103|448987218|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
124824798|NCT01988103|448987219|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
124824799|NCT01988103|448987220|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
124824800|NCT01988103|448987221|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
124824801|NCT01988103|448987217|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
124824802|NCT01988103|448987218|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
124824803|NCT01988103|448987219|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
124824804|NCT01988103|448987220|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
124824805|NCT01988103|448987221|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
124824806|NCT01988103|448987217|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
124824807|NCT01988103|448987218|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
124824808|NCT01988103|448987219|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
124824809|NCT01988103|448987220|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
124824810|NCT01988103|448987221|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
124824811|NCT01988103|448987217|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
124824812|NCT01988103|448987218|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
124824813|NCT01988103|448987219|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
124824814|NCT01988103|448987220|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
124824815|NCT01988103|448987221|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
124824816|NCT01988103|448987217|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
124824817|NCT01988103|448987218|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
124824818|NCT01988103|448987219|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
124824819|NCT01988103|448987220|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
124824820|NCT01988103|448987221|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
124824821|NCT03590041|448987222|FG000|Overall Study|Protocol Violation|4|||
124824822|NCT03590041|448987223|FG001|Overall Study|Protocol Violation|3|||
124824823|NCT03590041|448987222|FG000|Overall Study|No session data recorded|14|||
124824824|NCT03590041|448987223|FG001|Overall Study|No session data recorded|2|||
124824825|NCT02289898|448987227|FG000|Overall Study|Death|5|||
124824826|NCT02289898|448987228|FG001|Overall Study|Death|4|||
124824827|NCT02289898|448987229|FG002|Overall Study|Death|3|||
124824828|NCT02289898|448987227|FG000|Overall Study|Physician Decision|2|||
124824829|NCT02289898|448987228|FG001|Overall Study|Physician Decision|5|||
124824830|NCT02289898|448987229|FG002|Overall Study|Physician Decision|2|||
124824831|NCT02289898|448987227|FG000|Overall Study|Withdrawal by Subject|0|||
124824832|NCT02289898|448987228|FG001|Overall Study|Withdrawal by Subject|4|||
124824833|NCT02289898|448987229|FG002|Overall Study|Withdrawal by Subject|1|||
124824834|NCT02289898|448987227|FG000|Overall Study|Adverse Event|3|||
124824835|NCT02289898|448987228|FG001|Overall Study|Adverse Event|5|||
124824836|NCT02289898|448987229|FG002|Overall Study|Adverse Event|5|||
124824837|NCT02289898|448987227|FG000|Overall Study|Disease progression|34|||
124824838|NCT02289898|448987228|FG001|Overall Study|Disease progression|28|||
124824839|NCT02289898|448987229|FG002|Overall Study|Disease progression|34|||
124824840|NCT02289898|448987227|FG000|Overall Study|Use of another anticancer therapy|0|||
124824841|NCT02289898|448987228|FG001|Overall Study|Use of another anticancer therapy|0|||
124824842|NCT02289898|448987229|FG002|Overall Study|Use of another anticancer therapy|1|||
124824843|NCT02289898|448987227|FG000|Overall Study|Other|8|||
124824844|NCT02289898|448987228|FG001|Overall Study|Other|7|||
124824845|NCT02289898|448987229|FG002|Overall Study|Other|10|||
124824846|NCT00103142|448987235|FG000|Overall Study|Adverse Event|1|||
124824847|NCT00103142|448987236|FG001|Overall Study|Adverse Event|0|||
124824848|NCT00103142|448987235|FG000|Overall Study|Progression of disease|2|||
124824849|NCT00103142|448987236|FG001|Overall Study|Progression of disease|1|||
124824850|NCT02598076|448987238|FG000|Overall Study|Lost to Follow-up|2|||
124824851|NCT02598076|448987239|FG001|Overall Study|Lost to Follow-up|3|||
124824852|NCT01946425|448987240|FG000|Overall Study|Protocol Violation|1|||
124824853|NCT01946425|448987241|FG001|Overall Study|Protocol Violation|0|||
124824854|NCT01946425|448987240|FG000|Overall Study|Withdrawal by Subject|1|||
124824855|NCT01946425|448987241|FG001|Overall Study|Withdrawal by Subject|0|||
124638099|NCT04468347|448292579|FG001|Overall Study|Protocol Violation|0|||
124638100|NCT04468347|448292580|FG002|Overall Study|Protocol Violation|0|||
124824856|NCT03527966|448987242|FG000|Overall Study|Lost to Follow-up|3|||
124824857|NCT03527966|448987243|FG001|Overall Study|Lost to Follow-up|0|||
124824858|NCT00558025|448987244|FG000|Overall Study|Adverse Event|1|||
124824859|NCT00558025|448987245|FG001|Overall Study|Adverse Event|1|||
124824860|NCT00558025|448987244|FG000|Overall Study|Withdrawal by Subject|2|||
124638101|NCT04468347|448292581|FG003|Overall Study|Protocol Violation|0|||
124638102|NCT02522884|448292583|FG000|Overall Study|Withdrawal by Subject|6|||
124824861|NCT00558025|448987245|FG001|Overall Study|Withdrawal by Subject|2|||
124824862|NCT00558025|448987244|FG000|Overall Study|Protocol Violation|1|||
124824863|NCT00558025|448987245|FG001|Overall Study|Protocol Violation|0|||
124824864|NCT03315208|448987246|FG000|Overall Study|Lost to Follow-up|11|||
124824865|NCT03315208|448987247|FG001|Overall Study|Lost to Follow-up|6|||
124824866|NCT03315208|448987246|FG000|Overall Study|Withdrawal by Subject|2|||
124824867|NCT03315208|448987247|FG001|Overall Study|Withdrawal by Subject|0|||
124824868|NCT00276159|448987253|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
124824869|NCT00333866|448987256|FG000|Overall Study|Adverse Event|23|||
124824870|NCT00333866|448987257|FG001|Overall Study|Adverse Event|37|||
124824871|NCT00333866|448987258|FG002|Overall Study|Adverse Event|38|||
124824872|NCT00333866|448987259|FG003|Overall Study|Adverse Event|47|||
124824873|NCT00333866|448987256|FG000|Overall Study|Other|3|||
124824874|NCT00333866|448987257|FG001|Overall Study|Other|2|||
124824875|NCT00333866|448987258|FG002|Overall Study|Other|2|||
124824876|NCT00333866|448987259|FG003|Overall Study|Other|2|||
124824877|NCT00333866|448987256|FG000|Overall Study|Lack of Efficacy|8|||
124824878|NCT00333866|448987257|FG001|Overall Study|Lack of Efficacy|6|||
124824879|NCT00333866|448987258|FG002|Overall Study|Lack of Efficacy|3|||
124824880|NCT00333866|448987259|FG003|Overall Study|Lack of Efficacy|5|||
124824881|NCT00333866|448987256|FG000|Overall Study|Lost to Follow-up|1|||
124824882|NCT00333866|448987257|FG001|Overall Study|Lost to Follow-up|2|||
124824883|NCT00333866|448987258|FG002|Overall Study|Lost to Follow-up|2|||
124824884|NCT00333866|448987259|FG003|Overall Study|Lost to Follow-up|2|||
124824885|NCT00333866|448987256|FG000|Overall Study|Withdrawal by Subject|8|||
124824886|NCT00333866|448987257|FG001|Overall Study|Withdrawal by Subject|14|||
124824887|NCT00333866|448987258|FG002|Overall Study|Withdrawal by Subject|4|||
124824888|NCT00333866|448987259|FG003|Overall Study|Withdrawal by Subject|9|||
124824889|NCT00333866|448987256|FG000|Overall Study|Randomized but not Treated|5|||
124824890|NCT00333866|448987257|FG001|Overall Study|Randomized but not Treated|3|||
124824891|NCT00333866|448987258|FG002|Overall Study|Randomized but not Treated|2|||
124824892|NCT00333866|448987259|FG003|Overall Study|Randomized but not Treated|1|||
124824893|NCT01359449|448987272|FG000|Overall Study|Lost to Follow-up|1|||
124824894|NCT01359449|448987273|FG001|Overall Study|Lost to Follow-up|0|||
124824895|NCT01359449|448987272|FG000|Overall Study|Protocol Violation|0|||
124824896|NCT01359449|448987273|FG001|Overall Study|Protocol Violation|2|||
124824897|NCT01359449|448987272|FG000|Overall Study|Withdrawal by Subject|3|||
124824898|NCT01359449|448987273|FG001|Overall Study|Withdrawal by Subject|2|||
124824899|NCT02393547|448987275|FG000|Overall Study|Adverse Event|2|||
124824900|NCT02393547|448987275|FG000|Overall Study|Withdrawal by Subject|3|||
124824901|NCT02393547|448987275|FG000|Overall Study|Lost to Follow-up|1|||
124824902|NCT02927431|448987276|FG000|Overall Study|Withdrawal by Subject|0|||
124824903|NCT02927431|448987277|FG001|Overall Study|Withdrawal by Subject|0|||
124824904|NCT02927431|448987278|FG002|Overall Study|Withdrawal by Subject|1|||
124824905|NCT00429104|448987279|FG000|Overall Study|Protocol Violation|1|||
124824906|NCT01285310|448987281|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
124824907|NCT01285310|448987282|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
124824908|NCT01285310|448987283|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
124824909|NCT01285310|448987284|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
124824910|NCT01285310|448987285|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
124824911|NCT01285310|448987281|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
124824912|NCT01285310|448987282|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
124824913|NCT01285310|448987283|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
124824914|NCT01285310|448987284|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
124824915|NCT01285310|448987285|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
124824916|NCT01285310|448987281|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
124824917|NCT01285310|448987282|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
124824918|NCT01285310|448987283|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
124824919|NCT01285310|448987284|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
124824920|NCT01285310|448987285|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
124824921|NCT01285310|448987281|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
124824922|NCT01285310|448987282|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
124638103|NCT02522884|448292583|FG000|Overall Study|Death|3|||
124638104|NCT02522884|448292583|FG000|Overall Study|Missed 12-month Follow-up|9|||
124638105|NCT00615550|448292586|FG000|Overall Study|Lost to Follow-up|6|||
124824923|NCT01285310|448987283|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
124824924|NCT01285310|448987284|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
124824925|NCT01285310|448987285|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
124824926|NCT01285310|448987281|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
124824927|NCT01285310|448987282|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
124824928|NCT01285310|448987283|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
124824929|NCT01285310|448987284|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
124824930|NCT01285310|448987285|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
124824931|NCT01285310|448987281|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
124824932|NCT01285310|448987282|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
124824933|NCT01285310|448987283|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
124824934|NCT01285310|448987284|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
124824935|NCT01285310|448987285|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
124824936|NCT01285310|448987281|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
124824937|NCT01285310|448987282|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
124824938|NCT01285310|448987283|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
124824939|NCT01285310|448987284|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
124824940|NCT01285310|448987285|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
124824941|NCT01285310|448987281|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
124824942|NCT01285310|448987282|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
124824943|NCT01285310|448987283|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
124824944|NCT01285310|448987284|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
124824945|NCT01285310|448987285|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
124824946|NCT01285310|448987281|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
124824947|NCT01285310|448987282|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
124824948|NCT01285310|448987283|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
124824949|NCT01285310|448987284|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
124824950|NCT01285310|448987285|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
124824951|NCT01285310|448987281|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
124824952|NCT01285310|448987282|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
124824953|NCT01285310|448987283|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
124824954|NCT01285310|448987284|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
124824955|NCT01285310|448987285|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
124824956|NCT01285310|448987281|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
124824957|NCT01285310|448987282|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
124824958|NCT01285310|448987283|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
124824959|NCT01285310|448987284|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
124824960|NCT01285310|448987285|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
124824961|NCT01285310|448987281|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
124824962|NCT01285310|448987282|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
124824963|NCT01285310|448987283|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
124824964|NCT01285310|448987284|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
124824965|NCT01285310|448987285|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
124824966|NCT00143403|448987286|FG000|Overall Study|Adverse Event|3|||
124824967|NCT00143403|448987287|FG001|Overall Study|Adverse Event|8|||
124824968|NCT00143403|448987286|FG000|Overall Study|Death|1|||
124824969|NCT00143403|448987287|FG001|Overall Study|Death|0|||
124824970|NCT00143403|448987286|FG000|Overall Study|Withdrawal by Subject|3|||
124824971|NCT00143403|448987287|FG001|Overall Study|Withdrawal by Subject|12|||
124824972|NCT00143403|448987286|FG000|Overall Study|Relapse|15|||
124824973|NCT00143403|448987287|FG001|Overall Study|Relapse|7|||
124824974|NCT00143403|448987286|FG000|Overall Study|Protocol Violation|2|||
124824975|NCT00143403|448987287|FG001|Overall Study|Protocol Violation|2|||
124824976|NCT00143403|448987286|FG000|Overall Study|specified by site|4|||
124824977|NCT00143403|448987287|FG001|Overall Study|specified by site|9|||
124824978|NCT00143403|448987286|FG000|Overall Study|Randomized Not Treated|7|||
124824979|NCT00143403|448987287|FG001|Overall Study|Randomized Not Treated|8|||
124824980|NCT00514540|448987288|FG000|First-Line Chemo|Withdrawal by Subject|1|||
124824981|NCT00514540|448987288|FG000|First-Line Chemo|Protocol Violation|7|||
124824982|NCT00514540|448987288|FG000|Second-Line|Physician/Patient Decision|31|||
124824983|NCT00587639|448987289|FG000|Overall Study|Withdrawal by Subject|1|||
124824984|NCT03402386|448987290|FG000|Overall Study|Adverse Event|3|||
124824985|NCT03402386|448987290|FG000|Overall Study|Physician Decision|1|||
124824986|NCT03402386|448987290|FG000|Overall Study|Difficult to control Hb|2|||
124824987|NCT01896531|448987291|FG000|Overall Study|Death|57|||
124824988|NCT01896531|448987292|FG001|Overall Study|Death|59|||
124824989|NCT01896531|448987291|FG000|Overall Study|Lost to Follow-up|3|||
124824990|NCT01896531|448987292|FG001|Overall Study|Lost to Follow-up|0|||
124824991|NCT01896531|448987291|FG000|Overall Study|Non-compliance|0|||
124824992|NCT01896531|448987292|FG001|Overall Study|Non-compliance|1|||
124824993|NCT01896531|448987291|FG000|Overall Study|Study Ended by Sponsor|7|||
124824994|NCT01896531|448987292|FG001|Overall Study|Study Ended by Sponsor|20|||
124824995|NCT01896531|448987291|FG000|Overall Study|Withdrawal by Subject|3|||
124824996|NCT01896531|448987292|FG001|Overall Study|Withdrawal by Subject|2|||
124824997|NCT01896531|448987291|FG000|Overall Study|Death Prior to Treatment|1|||
124824998|NCT01896531|448987292|FG001|Overall Study|Death Prior to Treatment|0|||
124824999|NCT01195415|448987295|FG000|Overall Study|No repeat biopsy due to progression|2|||
124825000|NCT00533845|448987296|FG000|Overall Study|Physician Decision|1|||
124825001|NCT00533845|448987297|FG001|Overall Study|Physician Decision|0|||
124825002|NCT02956486|448987298|FG000|Core Phase|Adverse Event|51|||
124825003|NCT02956486|448987299|FG001|Core Phase|Adverse Event|88|||
124825004|NCT02956486|448987300|FG002|Core Phase|Adverse Event|0|||
124825005|NCT02956486|448987298|FG000|Core Phase|Lost to Follow-up|8|||
124825006|NCT02956486|448987299|FG001|Core Phase|Lost to Follow-up|6|||
124825007|NCT02956486|448987300|FG002|Core Phase|Lost to Follow-up|0|||
124825008|NCT02956486|448987298|FG000|Core Phase|Inadequate therapeutic effect|4|||
124825009|NCT02956486|448987299|FG001|Core Phase|Inadequate therapeutic effect|5|||
124825010|NCT02956486|448987300|FG002|Core Phase|Inadequate therapeutic effect|0|||
124825011|NCT02956486|448987298|FG000|Core Phase|Withdrawal by Subject|101|||
124825012|NCT02956486|448987299|FG001|Core Phase|Withdrawal by Subject|104|||
124825013|NCT02956486|448987300|FG002|Core Phase|Withdrawal by Subject|0|||
124825014|NCT02956486|448987298|FG000|Core Phase|Study terminated by sponsor|888|||
124825015|NCT02956486|448987299|FG001|Core Phase|Study terminated by sponsor|848|||
124825016|NCT02956486|448987300|FG002|Core Phase|Study terminated by sponsor|0|||
124825017|NCT02956486|448987298|FG000|Core Phase|Other|27|||
124825018|NCT02956486|448987299|FG001|Core Phase|Other|18|||
124825019|NCT02956486|448987300|FG002|Core Phase|Other|0|||
124825020|NCT02956486|448987298|FG000|Core Phase|Not treated|0|||
124825021|NCT02956486|448987299|FG001|Core Phase|Not treated|3|||
124825022|NCT02956486|448987300|FG002|Core Phase|Not treated|0|||
124825023|NCT02956486|448987298|FG000|Extension Phase|Adverse Event|0|||
124825024|NCT02956486|448987299|FG001|Extension Phase|Adverse Event|0|||
124825025|NCT02956486|448987300|FG002|Extension Phase|Adverse Event|2|||
124825026|NCT02956486|448987298|FG000|Extension Phase|Study terminated by sponsor|0|||
124825027|NCT02956486|448987299|FG001|Extension Phase|Study terminated by sponsor|0|||
124825028|NCT02956486|448987300|FG002|Extension Phase|Study terminated by sponsor|16|||
124825029|NCT02956486|448987298|FG000|Extension Phase|Not Treated|0|||
124825030|NCT02956486|448987299|FG001|Extension Phase|Not Treated|0|||
124825031|NCT02956486|448987300|FG002|Extension Phase|Not Treated|1|||
124825032|NCT03241342|448987301|FG000|Overall Study|Adverse Event|5|||
124825033|NCT03241342|448987302|FG001|Overall Study|Adverse Event|8|||
124825034|NCT03241342|448987303|FG002|Overall Study|Adverse Event|4|||
124825035|NCT03241342|448987301|FG000|Overall Study|Lack of Efficacy|0|||
124825036|NCT03241342|448987302|FG001|Overall Study|Lack of Efficacy|0|||
124825037|NCT03241342|448987303|FG002|Overall Study|Lack of Efficacy|1|||
124825038|NCT03241342|448987301|FG000|Overall Study|noncompliance with study drug|2|||
124825039|NCT03241342|448987302|FG001|Overall Study|noncompliance with study drug|1|||
124825040|NCT03241342|448987303|FG002|Overall Study|noncompliance with study drug|1|||
124825041|NCT03241342|448987301|FG000|Overall Study|sponsor decision|0|||
124825042|NCT03241342|448987302|FG001|Overall Study|sponsor decision|1|||
124825043|NCT03241342|448987303|FG002|Overall Study|sponsor decision|2|||
124825044|NCT03241342|448987301|FG000|Overall Study|not reported|15|||
124825045|NCT03241342|448987302|FG001|Overall Study|not reported|21|||
124825046|NCT03241342|448987303|FG002|Overall Study|not reported|19|||
124825047|NCT01846611|448987306|FG000|Overall Study|Lost to Follow-up|4|||
124825048|NCT01846611|448987307|FG001|Overall Study|Lost to Follow-up|6|||
124825049|NCT01846611|448987306|FG000|Overall Study|Withdrawal by Subject|15|||
124825050|NCT01846611|448987307|FG001|Overall Study|Withdrawal by Subject|19|||
124638106|NCT00615550|448292587|FG001|Overall Study|Lost to Follow-up|1|||
124638107|NCT00564850|448292588|FG000|Overall Study|Protocol Violation|2|||
124638108|NCT02640664|448292589|FG000|Epoch 1|Withdrawal of informed consent|1|||
124638109|NCT02640664|448292590|FG001|Epoch 1|Withdrawal of informed consent|0|||
124638110|NCT02640664|448292591|FG002|Epoch 1|Withdrawal of informed consent|0|||
124638111|NCT02640664|448292589|FG000|Epoch 1|Death|0|||
124638112|NCT02640664|448292590|FG001|Epoch 1|Death|0|||
124638113|NCT02640664|448292591|FG002|Epoch 1|Death|1|||
124638114|NCT02640664|448292589|FG000|Epoch 2|Withdrawal of informed consent|3|||
124638115|NCT02640664|448292590|FG001|Epoch 2|Withdrawal of informed consent|4|||
124638116|NCT02640664|448292591|FG002|Epoch 2|Withdrawal of informed consent|2|||
124638117|NCT02640664|448292589|FG000|Epoch 2|Subject/guardian decision|0|||
124638118|NCT02640664|448292590|FG001|Epoch 2|Subject/guardian decision|2|||
124638119|NCT02640664|448292591|FG002|Epoch 2|Subject/guardian decision|2|||
124638120|NCT02640664|448292589|FG000|Epoch 2|Lost to Follow-up|3|||
124638121|NCT02640664|448292590|FG001|Epoch 2|Lost to Follow-up|4|||
124638122|NCT02640664|448292591|FG002|Epoch 2|Lost to Follow-up|1|||
124638123|NCT02640664|448292589|FG000|Epoch 2|Death|0|||
124638124|NCT02640664|448292590|FG001|Epoch 2|Death|0|||
124638125|NCT02640664|448292591|FG002|Epoch 2|Death|1|||
124638126|NCT00314327|448292594|FG000|Overall Study|Withdrawal by Subject|1|||
124638127|NCT02741076|448292595|FG000|Overall Study|Adverse Event|0|||
124638128|NCT02741076|448292596|FG001|Overall Study|Adverse Event|1|||
124638129|NCT02741076|448292597|FG002|Overall Study|Adverse Event|1|||
124638130|NCT02741076|448292598|FG003|Overall Study|Adverse Event|0|||
124638131|NCT02741076|448292595|FG000|Overall Study|Lack of Efficacy|1|||
124638132|NCT02741076|448292596|FG001|Overall Study|Lack of Efficacy|0|||
124638133|NCT02741076|448292597|FG002|Overall Study|Lack of Efficacy|0|||
124638134|NCT02741076|448292598|FG003|Overall Study|Lack of Efficacy|0|||
124825051|NCT01846611|448987306|FG000|Overall Study|Other|19|||
124825052|NCT01846611|448987307|FG001|Overall Study|Other|18|||
124825053|NCT02671422|448987311|FG000|Overall Study|Lost to Follow-up|1|||
124825054|NCT02671422|448987311|FG000|Overall Study|Adverse Event|68|||
124825055|NCT02671422|448987311|FG000|Overall Study|Lack of Efficacy|1|||
124825056|NCT02671422|448987311|FG000|Overall Study|Lost to Follow-up|4|||
124825057|NCT02671422|448987311|FG000|Overall Study|Withdrawal by Subject|7|||
124825058|NCT02671422|448987311|FG000|Overall Study|Progressive Disease|156|||
124825059|NCT02671422|448987311|FG000|Overall Study|Worsening of Disease|4|||
124825060|NCT02671422|448987311|FG000|Overall Study|Sponsor decision|5|||
124825061|NCT02671422|448987311|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
124825062|NCT02671422|448987311|FG000|Overall Study|Not treated with Vargatef®|3|||
124825063|NCT02671422|448987311|FG000|Overall Study|Other not defined above|3|||
124825064|NCT04772755|448987312|FG000|Overall Study|Withdrawal by Subject|1|||
124825065|NCT04772755|448987313|FG001|Overall Study|Withdrawal by Subject|0|||
124825066|NCT04772755|448987312|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
124825067|NCT04772755|448987313|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
124825068|NCT01905657|448987314|FG000|Overall Study|Adverse Event|23|||
124825069|NCT01905657|448987315|FG001|Overall Study|Adverse Event|17|||
124825070|NCT01905657|448987316|FG002|Overall Study|Adverse Event|18|||
124825071|NCT01905657|448987314|FG000|Overall Study|Clinical Progression|103|||
124825072|NCT01905657|448987315|FG001|Overall Study|Clinical Progression|78|||
124825073|NCT01905657|448987316|FG002|Overall Study|Clinical Progression|59|||
124825074|NCT01905657|448987314|FG000|Overall Study|Death|40|||
124825075|NCT01905657|448987315|FG001|Overall Study|Death|43|||
124825076|NCT01905657|448987316|FG002|Overall Study|Death|47|||
124825077|NCT01905657|448987314|FG000|Overall Study|Excluded Medication|13|||
124825078|NCT01905657|448987315|FG001|Overall Study|Excluded Medication|16|||
124825079|NCT01905657|448987316|FG002|Overall Study|Excluded Medication|9|||
124825080|NCT01905657|448987314|FG000|Overall Study|Lost to Follow-up|1|||
124825081|NCT01905657|448987315|FG001|Overall Study|Lost to Follow-up|2|||
124825082|NCT01905657|448987316|FG002|Overall Study|Lost to Follow-up|1|||
124825083|NCT01905657|448987314|FG000|Overall Study|Physician Decision|5|||
124825084|NCT01905657|448987315|FG001|Overall Study|Physician Decision|8|||
124825085|NCT01905657|448987316|FG002|Overall Study|Physician Decision|12|||
124825086|NCT01905657|448987314|FG000|Overall Study|Protocol Violation|2|||
124825087|NCT01905657|448987315|FG001|Overall Study|Protocol Violation|1|||
124825088|NCT01905657|448987316|FG002|Overall Study|Protocol Violation|1|||
124825089|NCT01905657|448987314|FG000|Overall Study|Screen Failure|0|||
124825090|NCT01905657|448987315|FG001|Overall Study|Screen Failure|1|||
124825091|NCT01905657|448987316|FG002|Overall Study|Screen Failure|0|||
124825092|NCT01905657|448987314|FG000|Overall Study|Withdrawal by Subject|15|||
124825093|NCT01905657|448987315|FG001|Overall Study|Withdrawal by Subject|21|||
124825094|NCT01905657|448987316|FG002|Overall Study|Withdrawal by Subject|53|||
124825095|NCT01905657|448987314|FG000|Overall Study|Sponsor Decision|1|||
124825096|NCT01905657|448987315|FG001|Overall Study|Sponsor Decision|0|||
124825097|NCT01905657|448987316|FG002|Overall Study|Sponsor Decision|0|||
124825098|NCT02744391|448987318|FG000|Overall Study|Lost to Follow-up|9|||
124825099|NCT02744391|448987318|FG000|Overall Study|Physician Decision|2|||
124825100|NCT02744391|448987318|FG000|Overall Study|Withdrawal by Subject|3|||
124825101|NCT01996709|448987319|FG000|Overall Study|Withdrawal by Subject|1|||
124825102|NCT01996709|448987320|FG001|Overall Study|Withdrawal by Subject|0|||
124825103|NCT01996709|448987319|FG000|Overall Study|Lost to Follow-up|3|||
124825104|NCT01996709|448987320|FG001|Overall Study|Lost to Follow-up|0|||
124825105|NCT01996709|448987319|FG000|Overall Study|Subject Non-Compliant|1|||
124825106|NCT01996709|448987320|FG001|Overall Study|Subject Non-Compliant|0|||
124825107|NCT01996709|448987319|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
124825108|NCT01996709|448987320|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
124825109|NCT04702997|448987321|FG000|Overall Study|Withdrawal by Subject|1|||
124825110|NCT04702997|448987322|FG001|Overall Study|Withdrawal by Subject|1|||
124825111|NCT03915496|448987324|FG000|Overall Study|Adverse Event|2|||
124825112|NCT03915496|448987325|FG001|Overall Study|Adverse Event|1|||
124825113|NCT03915496|448987326|FG002|Overall Study|Adverse Event|2|||
124825114|NCT03032705|448987335|FG000|Overall Study|Lost to Follow-up|16|||
124825115|NCT03032705|448987336|FG001|Overall Study|Lost to Follow-up|17|||
124825116|NCT03032705|448987335|FG000|Overall Study|did not quality|6|||
124825117|NCT03032705|448987336|FG001|Overall Study|did not quality|6|||
124825118|NCT02825992|448988892|FG000|Overall Study|Withdrawal by Subject|4|||
124825119|NCT02825992|448988892|FG000|Overall Study|Lost to Follow-up|2|||
124825120|NCT02825992|448988892|FG000|Overall Study|Procedure terminated|2|||
124825121|NCT02279173|448988893|FG000|Overall Study|Protocol-specified Criteria|67|||
124825122|NCT02279173|448988893|FG000|Overall Study|Withdrawal by Subject|20|||
124825123|NCT02279173|448988893|FG000|Overall Study|Decision by Sponsor|4|||
124825124|NCT02279173|448988893|FG000|Overall Study|Lost to Follow-up|3|||
124825125|NCT00157950|448988894|FG000|Overall Study|Death|1|||
124825126|NCT00157950|448988895|FG001|Overall Study|Death|0|||
124825127|NCT02892760|448988896|FG000|Overall Study|Withdrawal by Subject|3|||
124825128|NCT01499667|448988897|FG000|Overall Study|administrative problems|4|||
124825129|NCT01499667|448988898|FG001|Overall Study|administrative problems|5|||
124825130|NCT01499667|448988899|FG002|Overall Study|administrative problems|5|||
124825131|NCT01499667|448988897|FG000|Overall Study|Protocol Violation|1|||
124825132|NCT01499667|448988898|FG001|Overall Study|Protocol Violation|3|||
124825133|NCT01499667|448988899|FG002|Overall Study|Protocol Violation|2|||
124825134|NCT01499667|448988897|FG000|Overall Study|Adverse Event|0|||
124825135|NCT01499667|448988898|FG001|Overall Study|Adverse Event|2|||
124825136|NCT01499667|448988899|FG002|Overall Study|Adverse Event|2|||
124825137|NCT01499667|448988897|FG000|Overall Study|Withdrawal by Subject|2|||
124825138|NCT01499667|448988898|FG001|Overall Study|Withdrawal by Subject|1|||
124825139|NCT01499667|448988899|FG002|Overall Study|Withdrawal by Subject|1|||
124825140|NCT01499667|448988897|FG000|Overall Study|Lack of Efficacy|2|||
124825141|NCT01499667|448988898|FG001|Overall Study|Lack of Efficacy|0|||
124825142|NCT01499667|448988899|FG002|Overall Study|Lack of Efficacy|0|||
124825143|NCT02673489|448988900|FG000|Treatment Period|Lost to Follow-up|3|||
124825144|NCT02673489|448988901|FG001|Treatment Period|Lost to Follow-up|0|||
124825145|NCT02673489|448988900|FG000|Treatment Period|Participant request to discontinue|1|||
124825146|NCT02673489|448988901|FG001|Treatment Period|Participant request to discontinue|1|||
124638135|NCT02741076|448292595|FG000|Overall Study|Withdrawal by Subject|0|||
124638136|NCT02741076|448292596|FG001|Overall Study|Withdrawal by Subject|1|||
124638137|NCT02741076|448292597|FG002|Overall Study|Withdrawal by Subject|0|||
124638138|NCT02741076|448292598|FG003|Overall Study|Withdrawal by Subject|0|||
124638139|NCT02741076|448292595|FG000|Overall Study|Sponsor Request|2|||
124638140|NCT02741076|448292596|FG001|Overall Study|Sponsor Request|3|||
124638141|NCT02741076|448292597|FG002|Overall Study|Sponsor Request|0|||
124638142|NCT02741076|448292598|FG003|Overall Study|Sponsor Request|1|||
124825147|NCT02673489|448988900|FG000|Treatment Period|Participant moved to another province|1|||
124825148|NCT02673489|448988901|FG001|Treatment Period|Participant moved to another province|0|||
124825149|NCT02673489|448988900|FG000|Treatment Period|Participant was incarcerated|0|||
124825150|NCT02673489|448988901|FG001|Treatment Period|Participant was incarcerated|1|||
124825151|NCT02673489|448988900|FG000|Treatment Period|Adverse Event|0|||
124825152|NCT02673489|448988901|FG001|Treatment Period|Adverse Event|1|||
124825153|NCT02673489|448988900|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
124825154|NCT02673489|448988901|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
124825155|NCT02673489|448988900|FG000|Follow Up Period|Unable to return for follow-up|0|||
124825156|NCT02673489|448988901|FG001|Follow Up Period|Unable to return for follow-up|1|||
124825157|NCT00293254|448988902|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
124825158|NCT00293254|448988903|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
124638143|NCT02741076|448292595|FG000|Overall Study|No additional information available|0|||
124638144|NCT02741076|448292596|FG001|Overall Study|No additional information available|0|||
124638145|NCT02741076|448292597|FG002|Overall Study|No additional information available|1|||
124825159|NCT00293254|448988902|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
124825160|NCT00293254|448988903|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
124825161|NCT00293254|448988902|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
124825162|NCT00293254|448988903|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
124825163|NCT00293254|448988902|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
124825164|NCT00293254|448988903|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
124825165|NCT00293254|448988902|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
124825166|NCT00293254|448988903|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
124825167|NCT00293254|448988902|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
124825168|NCT00293254|448988903|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
124825169|NCT00293254|448988902|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
124825170|NCT00293254|448988903|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
124825171|NCT00293254|448988902|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
124825172|NCT00293254|448988903|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
124825173|NCT00293254|448988902|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
124825174|NCT00293254|448988903|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
124825175|NCT00293254|448988902|FG000|Extension - Double-Blind Week 49-156|Death|4|||
124825176|NCT00293254|448988903|FG001|Extension - Double-Blind Week 49-156|Death|1|||
124825177|NCT00293254|448988902|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
124825178|NCT00293254|448988903|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
124825179|NCT00293254|448988902|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
124825180|NCT00293254|448988903|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
124825181|NCT00293254|448988902|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
124825182|NCT00293254|448988903|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
124825183|NCT00293254|448988902|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
124825184|NCT00293254|448988903|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
124825185|NCT00293254|448988902|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
124825186|NCT00293254|448988903|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
124825187|NCT00293254|448988902|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
124825188|NCT00293254|448988903|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
124825189|NCT00293254|448988902|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
124825190|NCT00293254|448988903|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
124825191|NCT00293254|448988902|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
124825192|NCT00293254|448988903|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
124825193|NCT00293254|448988902|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
124825194|NCT00293254|448988903|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
124825195|NCT00293254|448988902|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
124638146|NCT02741076|448292598|FG003|Overall Study|No additional information available|1|||
124825196|NCT00293254|448988903|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
124825197|NCT00293254|448988902|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
124825198|NCT00293254|448988903|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
124825199|NCT00293254|448988902|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
124825200|NCT00293254|448988903|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
124825201|NCT00293254|448988902|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
124825202|NCT00293254|448988903|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
124825203|NCT00293254|448988902|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
124825204|NCT00293254|448988903|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
124825205|NCT00293254|448988902|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
124825206|NCT00293254|448988903|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
124825207|NCT00293254|448988902|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
124825208|NCT00293254|448988903|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
124825209|NCT00293254|448988902|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
124825210|NCT00293254|448988903|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
124825211|NCT02335489|448988904|FG000|Overall Study|Sponsor terminated study|4|||
124825212|NCT02335489|448988904|FG000|Overall Study|Lost to Follow-up|1|||
124825213|NCT02335489|448988904|FG000|Overall Study|Withdrawal by Subject|2|||
124825214|NCT02335489|448988904|FG000|Overall Study|Physician Decision|2|||
124825215|NCT02335489|448988904|FG000|Overall Study|Lack of Efficacy|1|||
124825216|NCT02259582|448988905|FG000|Overall Study|Physician Decision|0|||
124825217|NCT02259582|448988906|FG001|Overall Study|Physician Decision|1|||
124825218|NCT02259582|448988907|FG002|Overall Study|Physician Decision|0|||
124825219|NCT02259582|448988905|FG000|Overall Study|Death|0|||
124825220|NCT02259582|448988906|FG001|Overall Study|Death|0|||
124825221|NCT02259582|448988907|FG002|Overall Study|Death|1|||
124825222|NCT02259582|448988905|FG000|Overall Study|Adverse Event|1|||
124825223|NCT02259582|448988906|FG001|Overall Study|Adverse Event|0|||
124825224|NCT02259582|448988907|FG002|Overall Study|Adverse Event|1|||
124825225|NCT02259582|448988905|FG000|Overall Study|Withdrawal by Subject|0|||
124825226|NCT02259582|448988906|FG001|Overall Study|Withdrawal by Subject|0|||
124825227|NCT02259582|448988907|FG002|Overall Study|Withdrawal by Subject|1|||
124825228|NCT02259582|448988905|FG000|Overall Study|Disease progression|14|||
124825229|NCT02259582|448988906|FG001|Overall Study|Disease progression|15|||
124825230|NCT02259582|448988907|FG002|Overall Study|Disease progression|17|||
124825231|NCT02259582|448988905|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
124825232|NCT02259582|448988906|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
124825233|NCT02259582|448988907|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
124825234|NCT00759863|448988908|FG000|Overall Study|Death, moved, or lost contact|20|||
124825235|NCT00759863|448988909|FG001|Overall Study|Death, moved, or lost contact|18|||
124825236|NCT00503308|448988913|FG000|Overall Study|Protocol Violation|2|||
124825237|NCT00503308|448988914|FG001|Overall Study|Protocol Violation|1|||
124825238|NCT00475176|448988915|FG000|Overall Study|Adverse Event|2|||
124825239|NCT00475176|448988915|FG000|Overall Study|Withdrawal by Subject|1|||
124825240|NCT00475176|448988915|FG000|Overall Study|Protocol Violation|1|||
124825241|NCT02436889|448988916|FG000|Overall Study|No improvement in symptoms|1|||
124825242|NCT02436889|448988917|FG001|Overall Study|No improvement in symptoms|0|||
124825243|NCT02436889|448988916|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
124825244|NCT02436889|448988917|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
124825245|NCT01034462|448988918|FG000|Overall Study|Adverse Event|7|||
124825246|NCT01034462|448988919|FG001|Overall Study|Adverse Event|17|||
124825247|NCT01034462|448988918|FG000|Overall Study|Lack of Efficacy|4|||
124825248|NCT01034462|448988919|FG001|Overall Study|Lack of Efficacy|4|||
124825249|NCT01034462|448988918|FG000|Overall Study|Protocol Violation|10|||
124825250|NCT01034462|448988919|FG001|Overall Study|Protocol Violation|7|||
124825251|NCT01034462|448988918|FG000|Overall Study|Withdrawal by Subject|9|||
124825252|NCT01034462|448988919|FG001|Overall Study|Withdrawal by Subject|8|||
124825253|NCT01034462|448988918|FG000|Overall Study|Lost to Follow-up|14|||
124825254|NCT01034462|448988919|FG001|Overall Study|Lost to Follow-up|16|||
124825255|NCT01034462|448988918|FG000|Overall Study|Other reasons|1|||
124825256|NCT01034462|448988919|FG001|Overall Study|Other reasons|2|||
124825257|NCT04273217|448988920|FG000|Overall Study|Lost to Follow-up|0|||
124825258|NCT04273217|448988921|FG001|Overall Study|Lost to Follow-up|0|||
124825259|NCT04273217|448988922|FG002|Overall Study|Lost to Follow-up|0|||
124825260|NCT04273217|448988923|FG003|Overall Study|Lost to Follow-up|0|||
124825261|NCT04273217|448988924|FG004|Overall Study|Lost to Follow-up|0|||
124825262|NCT04273217|448988925|FG005|Overall Study|Lost to Follow-up|1|||
124825263|NCT04273217|448988920|FG000|Overall Study|Participant non-compliance|0|||
124825264|NCT04273217|448988921|FG001|Overall Study|Participant non-compliance|0|||
124825265|NCT04273217|448988922|FG002|Overall Study|Participant non-compliance|0|||
124825266|NCT04273217|448988923|FG003|Overall Study|Participant non-compliance|0|||
124825267|NCT04273217|448988924|FG004|Overall Study|Participant non-compliance|1|||
124825268|NCT04273217|448988925|FG005|Overall Study|Participant non-compliance|0|||
124825269|NCT04273217|448988920|FG000|Overall Study|Positive urine drug screen|1|||
124825270|NCT04273217|448988921|FG001|Overall Study|Positive urine drug screen|0|||
124825271|NCT04273217|448988922|FG002|Overall Study|Positive urine drug screen|1|||
124825272|NCT04273217|448988923|FG003|Overall Study|Positive urine drug screen|0|||
124825273|NCT04273217|448988924|FG004|Overall Study|Positive urine drug screen|0|||
124825274|NCT04273217|448988925|FG005|Overall Study|Positive urine drug screen|1|||
124825275|NCT02618434|448988926|FG000|Overall Study|Withdrawal by Subject|0|||
124825276|NCT02618434|448988927|FG001|Overall Study|Withdrawal by Subject|2|||
124825277|NCT02618434|448988928|FG002|Overall Study|Withdrawal by Subject|3|||
124825278|NCT02618434|448988926|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
124825279|NCT02618434|448988927|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
124825280|NCT02618434|448988928|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
124825281|NCT02618434|448988926|FG000|Overall Study|Lost to Follow-up|3|||
124825282|NCT02618434|448988927|FG001|Overall Study|Lost to Follow-up|1|||
124825283|NCT02618434|448988928|FG002|Overall Study|Lost to Follow-up|3|||
124825284|NCT02618434|448988926|FG000|Overall Study|Adverse Event|1|||
124825285|NCT02618434|448988927|FG001|Overall Study|Adverse Event|0|||
124825286|NCT02618434|448988928|FG002|Overall Study|Adverse Event|12|||
124825287|NCT02618434|448988926|FG000|Overall Study|Physician Decision|0|||
124825288|NCT02618434|448988927|FG001|Overall Study|Physician Decision|1|||
124825289|NCT02618434|448988928|FG002|Overall Study|Physician Decision|0|||
124825290|NCT02618434|448988926|FG000|Overall Study|Protocol Violation|0|||
124825291|NCT02618434|448988927|FG001|Overall Study|Protocol Violation|0|||
124825292|NCT02618434|448988928|FG002|Overall Study|Protocol Violation|1|||
124825293|NCT02618434|448988926|FG000|Overall Study|Other, Multiple categories|1|||
124825294|NCT02618434|448988927|FG001|Overall Study|Other, Multiple categories|1|||
124825295|NCT02618434|448988928|FG002|Overall Study|Other, Multiple categories|1|||
124825296|NCT00022633|448988937|FG000|Overall Study|Adverse Event|11|||
124825297|NCT00022633|448988938|FG001|Overall Study|Adverse Event|1|||
124825298|NCT00022633|448988937|FG000|Overall Study|Refusal unrelated to adverse event|1|||
124825299|NCT00022633|448988938|FG001|Overall Study|Refusal unrelated to adverse event|0|||
124825300|NCT00022633|448988937|FG000|Overall Study|Progression/relapse|9|||
124825301|NCT00022633|448988938|FG001|Overall Study|Progression/relapse|2|||
124825302|NCT00022633|448988937|FG000|Overall Study|Death|4|||
124825303|NCT00022633|448988938|FG001|Overall Study|Death|0|||
124825304|NCT00022633|448988937|FG000|Overall Study|Other - not protocol specified|3|||
124825305|NCT00022633|448988938|FG001|Overall Study|Other - not protocol specified|2|||
124825306|NCT00022633|448988937|FG000|Overall Study|Ineligible|4|||
124825307|NCT00022633|448988938|FG001|Overall Study|Ineligible|0|||
124825308|NCT01276353|448988939|FG000|Double-blind|Adverse Event|2|||
124825309|NCT01276353|448988940|FG001|Double-blind|Adverse Event|0|||
124825310|NCT01276353|448988939|FG000|Double-blind|Withdrawal by Subject|1|||
124825311|NCT01276353|448988940|FG001|Double-blind|Withdrawal by Subject|0|||
124825312|NCT01276353|448988939|FG000|Extension|Adverse Event|2|||
124825313|NCT01276353|448988940|FG001|Extension|Adverse Event|5|||
124825314|NCT01276353|448988939|FG000|Extension|Withdrawal by Subject|1|||
124825315|NCT01276353|448988940|FG001|Extension|Withdrawal by Subject|2|||
124825316|NCT01276353|448988939|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
124825317|NCT01276353|448988940|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
124825318|NCT01276353|448988939|FG000|Extension|Physician Decision|1|||
124825319|NCT01276353|448988940|FG001|Extension|Physician Decision|0|||
124825320|NCT01276353|448988939|FG000|Extension|Prohibited concomitant medications|0|||
124825321|NCT01276353|448988940|FG001|Extension|Prohibited concomitant medications|1|||
124825322|NCT03325075|448988947|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
124825323|NCT03325075|448988948|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
124825324|NCT03325075|448988949|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
124825325|NCT03325075|448988950|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
124825326|NCT03325075|448988947|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
124825327|NCT03325075|448988948|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
124825328|NCT03325075|448988949|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
124825329|NCT03325075|448988950|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
124825330|NCT03325075|448988947|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
124638147|NCT02748213|448292601|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
124825331|NCT03325075|448988948|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
124825332|NCT03325075|448988949|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
124825333|NCT03325075|448988950|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
124825334|NCT00422591|448988951|FG000|Overall Study|Physician Decision|4|||
124825335|NCT00422591|448988951|FG000|Overall Study|Withdrawal by Subject|2|||
124825336|NCT02659631|448988954|FG000|Overall Study|Lost to Follow-up|0|||
124825337|NCT02659631|448988955|FG001|Overall Study|Lost to Follow-up|0|||
124825338|NCT02659631|448988956|FG002|Overall Study|Lost to Follow-up|2|||
124638148|NCT02748213|448292602|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
124825339|NCT02659631|448988957|FG003|Overall Study|Lost to Follow-up|0|||
124825340|NCT02659631|448988958|FG004|Overall Study|Lost to Follow-up|0|||
124825341|NCT02659631|448988959|FG005|Overall Study|Lost to Follow-up|1|||
124825342|NCT02659631|448988960|FG006|Overall Study|Lost to Follow-up|0|||
124825343|NCT02659631|448988961|FG007|Overall Study|Lost to Follow-up|0|||
124825344|NCT02659631|448988962|FG008|Overall Study|Lost to Follow-up|0|||
124825345|NCT02659631|448988963|FG009|Overall Study|Lost to Follow-up|0|||
124825346|NCT02659631|448988954|FG000|Overall Study|Withdrawal prior to treatment|0|||
124825347|NCT02659631|448988955|FG001|Overall Study|Withdrawal prior to treatment|0|||
124825348|NCT02659631|448988956|FG002|Overall Study|Withdrawal prior to treatment|0|||
124825349|NCT02659631|448988957|FG003|Overall Study|Withdrawal prior to treatment|0|||
124825350|NCT02659631|448988958|FG004|Overall Study|Withdrawal prior to treatment|1|||
124825351|NCT02659631|448988959|FG005|Overall Study|Withdrawal prior to treatment|0|||
124825352|NCT02659631|448988960|FG006|Overall Study|Withdrawal prior to treatment|0|||
124825353|NCT02659631|448988961|FG007|Overall Study|Withdrawal prior to treatment|0|||
124825354|NCT02659631|448988962|FG008|Overall Study|Withdrawal prior to treatment|0|||
124825355|NCT02659631|448988963|FG009|Overall Study|Withdrawal prior to treatment|0|||
124825356|NCT02659631|448988954|FG000|Overall Study|Participant refused further follow-up|0|||
124825357|NCT02659631|448988955|FG001|Overall Study|Participant refused further follow-up|0|||
124825358|NCT02659631|448988956|FG002|Overall Study|Participant refused further follow-up|0|||
124825359|NCT02659631|448988957|FG003|Overall Study|Participant refused further follow-up|1|||
124825360|NCT02659631|448988958|FG004|Overall Study|Participant refused further follow-up|0|||
124825361|NCT02659631|448988959|FG005|Overall Study|Participant refused further follow-up|0|||
124825362|NCT02659631|448988960|FG006|Overall Study|Participant refused further follow-up|0|||
124825363|NCT02659631|448988961|FG007|Overall Study|Participant refused further follow-up|0|||
124825364|NCT02659631|448988962|FG008|Overall Study|Participant refused further follow-up|1|||
124825365|NCT02659631|448988963|FG009|Overall Study|Participant refused further follow-up|0|||
124825366|NCT02659631|448988954|FG000|Overall Study|Death (follow-up phase)|1|||
124825367|NCT02659631|448988955|FG001|Overall Study|Death (follow-up phase)|2|||
124825368|NCT02659631|448988956|FG002|Overall Study|Death (follow-up phase)|1|||
124825369|NCT02659631|448988957|FG003|Overall Study|Death (follow-up phase)|1|||
124825370|NCT02659631|448988958|FG004|Overall Study|Death (follow-up phase)|3|||
124825371|NCT02659631|448988959|FG005|Overall Study|Death (follow-up phase)|2|||
124825372|NCT02659631|448988960|FG006|Overall Study|Death (follow-up phase)|0|||
124825373|NCT02659631|448988961|FG007|Overall Study|Death (follow-up phase)|3|||
124825374|NCT02659631|448988962|FG008|Overall Study|Death (follow-up phase)|1|||
124825375|NCT02659631|448988963|FG009|Overall Study|Death (follow-up phase)|0|||
124825376|NCT02659631|448988954|FG000|Overall Study|Death (treatment phase)|0|||
124825377|NCT02659631|448988955|FG001|Overall Study|Death (treatment phase)|0|||
124825378|NCT02659631|448988956|FG002|Overall Study|Death (treatment phase)|0|||
124825379|NCT02659631|448988957|FG003|Overall Study|Death (treatment phase)|0|||
124825380|NCT02659631|448988958|FG004|Overall Study|Death (treatment phase)|1|||
124825381|NCT02659631|448988959|FG005|Overall Study|Death (treatment phase)|0|||
124825382|NCT02659631|448988960|FG006|Overall Study|Death (treatment phase)|1|||
124825383|NCT02659631|448988961|FG007|Overall Study|Death (treatment phase)|0|||
124825384|NCT02659631|448988962|FG008|Overall Study|Death (treatment phase)|0|||
124825385|NCT02659631|448988963|FG009|Overall Study|Death (treatment phase)|0|||
124825386|NCT02377466|448988964|FG000|Overall Study|Other: Randomized and not treated|0|||
124825387|NCT02377466|448988965|FG001|Overall Study|Other: Randomized and not treated|2|||
124825388|NCT02485574|448988974|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
124825389|NCT00110149|448988982|FG000|Overall Study|Physician Decision|3|||
124825390|NCT00563381|448988983|FG000|Overall Study|Adverse Event|264|||
124825391|NCT00563381|448988984|FG001|Overall Study|Adverse Event|292|||
124825392|NCT00563381|448988983|FG000|Overall Study|Protocol Violation|66|||
124825393|NCT00563381|448988984|FG001|Overall Study|Protocol Violation|74|||
124825394|NCT00563381|448988983|FG000|Overall Study|Lost to Follow-up|7|||
124825395|NCT00563381|448988984|FG001|Overall Study|Lost to Follow-up|15|||
124825396|NCT00563381|448988983|FG000|Overall Study|Withdrawal by Subject|192|||
124825397|NCT00563381|448988984|FG001|Overall Study|Withdrawal by Subject|209|||
124825398|NCT00563381|448988983|FG000|Overall Study|Lack of Efficacy|32|||
124825399|NCT00563381|448988984|FG001|Overall Study|Lack of Efficacy|24|||
124825400|NCT00563381|448988983|FG000|Overall Study|Individual different reasons|24|||
124825401|NCT00563381|448988984|FG001|Overall Study|Individual different reasons|34|||
124825402|NCT00667368|448988985|FG000|Overall Study|Lost to Follow-up|176|||
124638149|NCT02748213|448292601|FG000|Overall Study|Abnormal Laboratory Test|1|||
124825403|NCT00667368|448988986|FG001|Overall Study|Lost to Follow-up|155|||
124638150|NCT02748213|448292602|FG001|Overall Study|Abnormal Laboratory Test|0|||
124638151|NCT02748213|448292601|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
124638152|NCT02748213|448292602|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
124638153|NCT02748213|448292601|FG000|Overall Study|Death|5|||
124638154|NCT02748213|448292602|FG001|Overall Study|Death|3|||
124825404|NCT00667368|448988985|FG000|Overall Study|Discontinued early|24|||
124825405|NCT00667368|448988986|FG001|Overall Study|Discontinued early|17|||
124825406|NCT00732615|448988991|FG000|Overall Study|Withdrawal by Subject|3|||
124825407|NCT00732615|448988992|FG001|Overall Study|Withdrawal by Subject|1|||
124825408|NCT00732615|448988991|FG000|Overall Study|Lost to Follow-up|0|||
124638155|NCT02748213|448292601|FG000|Overall Study|Insufficient Therapeutic Response|56|||
124825409|NCT00732615|448988992|FG001|Overall Study|Lost to Follow-up|1|||
124825410|NCT00732615|448988991|FG000|Overall Study|Adverse Event|0|||
124825411|NCT00732615|448988992|FG001|Overall Study|Adverse Event|2|||
124825412|NCT00732615|448988991|FG000|Overall Study|Physician Decision|3|||
124825413|NCT00732615|448988992|FG001|Overall Study|Physician Decision|0|||
124825414|NCT00732615|448988991|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
124825415|NCT00732615|448988992|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
124825416|NCT03566823|448988993|FG000|Overall Study|Lack of Efficacy|0|||
124825417|NCT03566823|448988994|FG001|Overall Study|Lack of Efficacy|1|||
124825418|NCT03566823|448988995|FG002|Overall Study|Lack of Efficacy|0|||
124825419|NCT03566823|448988993|FG000|Overall Study|Withdrawal by Subject|1|||
124825420|NCT03566823|448988994|FG001|Overall Study|Withdrawal by Subject|2|||
124825421|NCT03566823|448988995|FG002|Overall Study|Withdrawal by Subject|0|||
124825422|NCT03566823|448988993|FG000|Overall Study|Adverse Event|1|||
124825423|NCT03566823|448988994|FG001|Overall Study|Adverse Event|0|||
124825424|NCT03566823|448988995|FG002|Overall Study|Adverse Event|2|||
124825425|NCT01348347|448988996|FG000|Overall Study|Withdrawal by Subject|1|||
124825426|NCT01348347|448988997|FG001|Overall Study|Withdrawal by Subject|1|||
124825427|NCT01348347|448988998|FG002|Overall Study|Withdrawal by Subject|1|||
124825428|NCT01348347|448988996|FG000|Overall Study|Progressive disease|2|||
124825429|NCT01348347|448988997|FG001|Overall Study|Progressive disease|5|||
124825430|NCT01348347|448988998|FG002|Overall Study|Progressive disease|5|||
124825431|NCT00191789|448988999|FG000|Overall Study|Adverse Event|5|||
124825432|NCT00191789|448988999|FG000|Overall Study|Patient: Satisfactory Response|5|||
124825433|NCT00191789|448988999|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
124825434|NCT00191789|448988999|FG000|Overall Study|Withdrawal by Subject|4|||
124825435|NCT00191789|448988999|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
124825436|NCT00191789|448988999|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
124825437|NCT00191789|448988999|FG000|Overall Study|Death - Not Study-Drug Related|1|||
124825438|NCT01129960|448989011|FG000|Overall Study|Withdrawal by Subject|3|||
124825439|NCT01129960|448989012|FG001|Overall Study|Withdrawal by Subject|0|||
124825440|NCT01129960|448989013|FG002|Overall Study|Withdrawal by Subject|3|||
124825441|NCT01129960|448989014|FG003|Overall Study|Withdrawal by Subject|2|||
124825442|NCT01129960|448989011|FG000|Overall Study|Lack of Efficacy|1|||
124825443|NCT01129960|448989012|FG001|Overall Study|Lack of Efficacy|1|||
124825444|NCT01129960|448989013|FG002|Overall Study|Lack of Efficacy|1|||
124825445|NCT01129960|448989014|FG003|Overall Study|Lack of Efficacy|1|||
124825446|NCT01129960|448989011|FG000|Overall Study|Adverse Event|23|||
124825447|NCT01129960|448989012|FG001|Overall Study|Adverse Event|16|||
124825448|NCT01129960|448989013|FG002|Overall Study|Adverse Event|16|||
124825449|NCT01129960|448989014|FG003|Overall Study|Adverse Event|7|||
124825450|NCT01129960|448989011|FG000|Overall Study|Protocol Violation|1|||
124825451|NCT01129960|448989012|FG001|Overall Study|Protocol Violation|2|||
124825452|NCT01129960|448989013|FG002|Overall Study|Protocol Violation|3|||
124825453|NCT01129960|448989014|FG003|Overall Study|Protocol Violation|0|||
124825454|NCT01129960|448989011|FG000|Overall Study|Lost to Follow-up|0|||
124825455|NCT01129960|448989012|FG001|Overall Study|Lost to Follow-up|2|||
124825456|NCT01129960|448989013|FG002|Overall Study|Lost to Follow-up|3|||
124825457|NCT01129960|448989014|FG003|Overall Study|Lost to Follow-up|3|||
124825458|NCT01129960|448989011|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
124825459|NCT01129960|448989012|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
124825460|NCT01129960|448989013|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
124825461|NCT01129960|448989014|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
124825462|NCT01129960|448989011|FG000|Overall Study|Physician Decision|1|||
124825463|NCT01129960|448989012|FG001|Overall Study|Physician Decision|0|||
124825464|NCT01129960|448989013|FG002|Overall Study|Physician Decision|0|||
124825465|NCT01129960|448989014|FG003|Overall Study|Physician Decision|0|||
124825466|NCT01129960|448989011|FG000|Overall Study|Pregnancy|1|||
124825467|NCT01129960|448989012|FG001|Overall Study|Pregnancy|0|||
124825468|NCT01129960|448989013|FG002|Overall Study|Pregnancy|0|||
124825469|NCT01129960|448989014|FG003|Overall Study|Pregnancy|0|||
124825470|NCT00165776|448989015|FG000|Overall Study|Lack of Efficacy|0|||
124825471|NCT00165776|448989016|FG001|Overall Study|Lack of Efficacy|0|||
124825472|NCT00165776|448989017|FG002|Overall Study|Lack of Efficacy|0|||
124825473|NCT00165776|448989018|FG003|Overall Study|Lack of Efficacy|1|||
124825474|NCT00165776|448989015|FG000|Overall Study|Withdrawal by Subject|4|||
124825475|NCT00165776|448989016|FG001|Overall Study|Withdrawal by Subject|1|||
124825476|NCT00165776|448989017|FG002|Overall Study|Withdrawal by Subject|2|||
124825477|NCT00165776|448989018|FG003|Overall Study|Withdrawal by Subject|0|||
124825478|NCT00165776|448989015|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
124825479|NCT00165776|448989016|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
124825480|NCT00165776|448989017|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
124825481|NCT00165776|448989018|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
124825482|NCT02622321|448989021|FG000|Overall Study|Withdrawal by Subject|2|||
124825483|NCT02622321|448989022|FG001|Overall Study|Withdrawal by Subject|0|||
124825484|NCT02622321|448989023|FG002|Overall Study|Withdrawal by Subject|0|||
124825485|NCT02622321|448989024|FG003|Overall Study|Withdrawal by Subject|0|||
124825486|NCT02622321|448989021|FG000|Overall Study|Death|0|||
124825487|NCT02622321|448989022|FG001|Overall Study|Death|0|||
124825488|NCT02622321|448989023|FG002|Overall Study|Death|1|||
124825489|NCT02622321|448989024|FG003|Overall Study|Death|0|||
124825490|NCT02622321|448989021|FG000|Overall Study|Physician Decision|1|||
124825491|NCT02622321|448989022|FG001|Overall Study|Physician Decision|0|||
124825492|NCT02622321|448989023|FG002|Overall Study|Physician Decision|0|||
124825493|NCT02622321|448989024|FG003|Overall Study|Physician Decision|0|||
124825494|NCT00965718|448989026|FG000|Overall Study|Withdrawal by Subject|4|||
124825495|NCT00241280|448989028|FG000|Overall Study|Adverse Event|2|||
124825496|NCT00241280|448989029|FG001|Overall Study|Adverse Event|6|||
124825497|NCT00241280|448989028|FG000|Overall Study|Discomfort|11|||
124825498|NCT00241280|448989029|FG001|Overall Study|Discomfort|16|||
124825499|NCT00241280|448989028|FG000|Overall Study|Pregnancy|1|||
124825500|NCT00241280|448989029|FG001|Overall Study|Pregnancy|5|||
124825501|NCT00241280|448989028|FG000|Overall Study|Lost to Follow-up|5|||
124825502|NCT00241280|448989029|FG001|Overall Study|Lost to Follow-up|8|||
124825503|NCT00241280|448989028|FG000|Overall Study|Withdrawal by Subject|7|||
124825504|NCT00241280|448989029|FG001|Overall Study|Withdrawal by Subject|4|||
124825505|NCT00241280|448989028|FG000|Overall Study|Protocol Violation|4|||
124825506|NCT00241280|448989029|FG001|Overall Study|Protocol Violation|10|||
124825507|NCT00241280|448989028|FG000|Overall Study|Relocation|4|||
124825508|NCT00241280|448989029|FG001|Overall Study|Relocation|4|||
124825509|NCT00241280|448989028|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
124825510|NCT00241280|448989029|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
124825511|NCT00241280|448989028|FG000|Overall Study|Unsatisfactory Visual Response|1|||
124825512|NCT00241280|448989029|FG001|Overall Study|Unsatisfactory Visual Response|1|||
124825513|NCT00241280|448989028|FG000|Overall Study|Diabetic|1|||
124825514|NCT00241280|448989029|FG001|Overall Study|Diabetic|0|||
124825515|NCT00241280|448989028|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
124825516|NCT00241280|448989029|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
124825517|NCT00241280|448989028|FG000|Overall Study|Dispensed incorrect test article|1|||
124825518|NCT00241280|448989029|FG001|Overall Study|Dispensed incorrect test article|2|||
124825519|NCT00241280|448989028|FG000|Overall Study|Unacceptable Fit|0|||
124825520|NCT00241280|448989029|FG001|Overall Study|Unacceptable Fit|1|||
124825521|NCT00241280|448989028|FG000|Overall Study|Scheduling Conflict|0|||
124825522|NCT00241280|448989029|FG001|Overall Study|Scheduling Conflict|2|||
124825523|NCT00241280|448989028|FG000|Overall Study|History of Ocular Surgery|0|||
124825524|NCT00241280|448989029|FG001|Overall Study|History of Ocular Surgery|1|||
124825525|NCT00241280|448989028|FG000|Overall Study|Coating on Lens|1|||
124825526|NCT00241280|448989029|FG001|Overall Study|Coating on Lens|0|||
124825527|NCT00241280|448989028|FG000|Overall Study|Excessive Dryness|0|||
124825528|NCT00241280|448989029|FG001|Overall Study|Excessive Dryness|1|||
124825529|NCT01414855|448989032|FG000|Overall Study|Death|17|||
124825530|NCT01414855|448989032|FG000|Overall Study|Lost to Follow-up|5|||
124825531|NCT01414855|448989032|FG000|Overall Study|Withdrawal by Subject|7|||
124825532|NCT00368355|448989033|FG000|Overall Study|Adverse Event|1|||
124825533|NCT00368355|448989034|FG001|Overall Study|Adverse Event|0|||
124825534|NCT00368355|448989033|FG000|Overall Study|Death|2|||
124825535|NCT00368355|448989034|FG001|Overall Study|Death|4|||
124825536|NCT00368355|448989033|FG000|Overall Study|Relapse|6|||
124825537|NCT00368355|448989034|FG001|Overall Study|Relapse|10|||
124825538|NCT00368355|448989033|FG000|Overall Study|Subsequent transplant|0|||
124825539|NCT00368355|448989034|FG001|Overall Study|Subsequent transplant|3|||
124825540|NCT00368355|448989033|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
124825541|NCT00368355|448989034|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
124825542|NCT02999854|448989038|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
124825543|NCT02999854|448989039|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
124825544|NCT02999854|448989038|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
124825545|NCT02999854|448989039|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
124825546|NCT02999854|448989038|FG000|Active Study Phase (up to 18 Months)|Death|7|||
124825547|NCT02999854|448989039|FG001|Active Study Phase (up to 18 Months)|Death|5|||
124825548|NCT02999854|448989038|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
124825549|NCT02999854|448989039|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
124825550|NCT02999854|448989038|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
124825551|NCT02999854|448989039|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
124825552|NCT02999854|448989038|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
124825553|NCT02999854|448989039|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
124825554|NCT02999854|448989038|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
124825555|NCT02999854|448989039|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
124825556|NCT02999854|448989038|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
124825557|NCT02999854|448989039|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
124825558|NCT01013701|448989040|FG000|Overall Study|study prematurely terminated|7|||
124825559|NCT01386554|448989041|FG000|Overall Study|Lost to Follow-up|0|||
124825560|NCT01386554|448989042|FG001|Overall Study|Lost to Follow-up|0|||
124825561|NCT01386554|448989043|FG002|Overall Study|Lost to Follow-up|1|||
124825562|NCT01386554|448989041|FG000|Overall Study|Adverse Event|2|||
124825563|NCT01386554|448989042|FG001|Overall Study|Adverse Event|5|||
124825564|NCT01386554|448989043|FG002|Overall Study|Adverse Event|2|||
124825565|NCT01386554|448989041|FG000|Overall Study|Progressive disease|1|||
124825566|NCT01386554|448989042|FG001|Overall Study|Progressive disease|2|||
124825567|NCT01386554|448989043|FG002|Overall Study|Progressive disease|2|||
124825568|NCT01386554|448989041|FG000|Overall Study|Administration of live vaccines|0|||
124825569|NCT01386554|448989042|FG001|Overall Study|Administration of live vaccines|1|||
124825570|NCT01386554|448989043|FG002|Overall Study|Administration of live vaccines|0|||
124825571|NCT01386554|448989041|FG000|Overall Study|Investigator discretion|0|||
124825572|NCT01386554|448989042|FG001|Overall Study|Investigator discretion|0|||
124825573|NCT01386554|448989043|FG002|Overall Study|Investigator discretion|1|||
124825574|NCT01386554|448989041|FG000|Overall Study|Reason not collected|0|||
124825575|NCT01386554|448989042|FG001|Overall Study|Reason not collected|1|||
124825576|NCT01386554|448989043|FG002|Overall Study|Reason not collected|0|||
124825577|NCT00001596|448990692|FG000|Overall Study|Death|1|||
124825578|NCT00001596|448990693|FG001|Overall Study|Death|0|||
124825579|NCT00001596|448990692|FG000|Overall Study|Withdrawal by Subject|3|||
124825580|NCT00001596|448990693|FG001|Overall Study|Withdrawal by Subject|1|||
124825581|NCT00001596|448990692|FG000|Overall Study|Study Termination|12|||
124825582|NCT00001596|448990693|FG001|Overall Study|Study Termination|9|||
124825583|NCT00001596|448990692|FG000|Overall Study|Adverse Event|1|||
124825584|NCT00001596|448990693|FG001|Overall Study|Adverse Event|0|||
124825585|NCT00180414|448990699|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
124825586|NCT00180414|448990700|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
124825587|NCT02927080|448990701|FG000|Overall Study|Withdrawal by Subject|0|||
124825588|NCT02927080|448990702|FG001|Overall Study|Withdrawal by Subject|0|||
124825589|NCT02927080|448990703|FG002|Overall Study|Withdrawal by Subject|0|||
124825590|NCT02927080|448990704|FG003|Overall Study|Withdrawal by Subject|0|||
124825591|NCT02927080|448990705|FG004|Overall Study|Withdrawal by Subject|1|||
124825592|NCT02927080|448990706|FG005|Overall Study|Withdrawal by Subject|0|||
124825593|NCT02927080|448990707|FG006|Overall Study|Withdrawal by Subject|1|||
124825594|NCT02927080|448990708|FG007|Overall Study|Withdrawal by Subject|1|||
124825595|NCT02927080|448990709|FG008|Overall Study|Withdrawal by Subject|0|||
124825596|NCT02927080|448990710|FG009|Overall Study|Withdrawal by Subject|2|||
124825597|NCT02927080|448990701|FG000|Overall Study|Willingness to comply with protocol|0|||
124825598|NCT02927080|448990702|FG001|Overall Study|Willingness to comply with protocol|0|||
124825599|NCT02927080|448990703|FG002|Overall Study|Willingness to comply with protocol|0|||
124825600|NCT02927080|448990704|FG003|Overall Study|Willingness to comply with protocol|0|||
124825601|NCT02927080|448990705|FG004|Overall Study|Willingness to comply with protocol|0|||
124825602|NCT02927080|448990706|FG005|Overall Study|Willingness to comply with protocol|0|||
124825603|NCT02927080|448990707|FG006|Overall Study|Willingness to comply with protocol|0|||
124825604|NCT02927080|448990708|FG007|Overall Study|Willingness to comply with protocol|0|||
124825605|NCT02927080|448990709|FG008|Overall Study|Willingness to comply with protocol|0|||
124825606|NCT02927080|448990710|FG009|Overall Study|Willingness to comply with protocol|1|||
124825607|NCT02927080|448990701|FG000|Overall Study|Study terminated by Sponsor|0|||
124825608|NCT02927080|448990702|FG001|Overall Study|Study terminated by Sponsor|0|||
124825609|NCT02927080|448990703|FG002|Overall Study|Study terminated by Sponsor|0|||
124825610|NCT02927080|448990704|FG003|Overall Study|Study terminated by Sponsor|0|||
124825611|NCT02927080|448990705|FG004|Overall Study|Study terminated by Sponsor|0|||
124825612|NCT02927080|448990706|FG005|Overall Study|Study terminated by Sponsor|0|||
124825613|NCT02927080|448990707|FG006|Overall Study|Study terminated by Sponsor|6|||
124825614|NCT02927080|448990708|FG007|Overall Study|Study terminated by Sponsor|7|||
124825615|NCT02927080|448990709|FG008|Overall Study|Study terminated by Sponsor|2|||
124825616|NCT02927080|448990710|FG009|Overall Study|Study terminated by Sponsor|3|||
124825617|NCT02927080|448990701|FG000|Overall Study|Adverse Event|0|||
124825618|NCT02927080|448990702|FG001|Overall Study|Adverse Event|1|||
124825619|NCT02927080|448990703|FG002|Overall Study|Adverse Event|0|||
124825620|NCT02927080|448990704|FG003|Overall Study|Adverse Event|0|||
124825621|NCT02927080|448990705|FG004|Overall Study|Adverse Event|0|||
124825622|NCT02927080|448990706|FG005|Overall Study|Adverse Event|0|||
124825623|NCT02927080|448990707|FG006|Overall Study|Adverse Event|0|||
124825624|NCT02927080|448990708|FG007|Overall Study|Adverse Event|1|||
124825625|NCT02927080|448990709|FG008|Overall Study|Adverse Event|0|||
124825626|NCT02927080|448990710|FG009|Overall Study|Adverse Event|1|||
124638156|NCT02748213|448292602|FG001|Overall Study|Insufficient Therapeutic Response|57|||
124638157|NCT02748213|448292601|FG000|Overall Study|Violation of Selection Criteria|2|||
124825627|NCT02927080|448990701|FG000|Overall Study|Other|0|||
124825628|NCT02927080|448990702|FG001|Overall Study|Other|0|||
124825629|NCT02927080|448990703|FG002|Overall Study|Other|0|||
124825630|NCT02927080|448990704|FG003|Overall Study|Other|0|||
124825631|NCT02927080|448990705|FG004|Overall Study|Other|0|||
124825632|NCT02927080|448990706|FG005|Overall Study|Other|0|||
124825633|NCT02927080|448990707|FG006|Overall Study|Other|1|||
124825634|NCT02927080|448990708|FG007|Overall Study|Other|0|||
124825635|NCT02927080|448990709|FG008|Overall Study|Other|1|||
124825636|NCT02927080|448990710|FG009|Overall Study|Other|0|||
124825637|NCT01199289|448990711|FG000|Overall Study|Ineligibility determined|2|||
124825638|NCT01199289|448990712|FG001|Overall Study|Ineligibility determined|1|||
124825639|NCT01199289|448990713|FG002|Overall Study|Ineligibility determined|0|||
124825640|NCT01199289|448990714|FG003|Overall Study|Ineligibility determined|0|||
124825641|NCT01199289|448990711|FG000|Overall Study|Protocol Violation|1|||
124825642|NCT01199289|448990712|FG001|Overall Study|Protocol Violation|0|||
124825643|NCT01199289|448990713|FG002|Overall Study|Protocol Violation|0|||
124825644|NCT01199289|448990714|FG003|Overall Study|Protocol Violation|1|||
124825645|NCT01199289|448990711|FG000|Overall Study|Noncompliance|1|||
124825646|NCT01199289|448990712|FG001|Overall Study|Noncompliance|0|||
124825647|NCT01199289|448990713|FG002|Overall Study|Noncompliance|2|||
124825648|NCT01199289|448990714|FG003|Overall Study|Noncompliance|0|||
124825649|NCT01199289|448990711|FG000|Overall Study|Adverse Event|0|||
124825650|NCT01199289|448990712|FG001|Overall Study|Adverse Event|3|||
124825651|NCT01199289|448990713|FG002|Overall Study|Adverse Event|1|||
124825652|NCT01199289|448990714|FG003|Overall Study|Adverse Event|4|||
124825653|NCT01199289|448990711|FG000|Overall Study|Full consent withdrawn|2|||
124825654|NCT01199289|448990712|FG001|Overall Study|Full consent withdrawn|2|||
124825655|NCT01199289|448990713|FG002|Overall Study|Full consent withdrawn|2|||
124825656|NCT01199289|448990714|FG003|Overall Study|Full consent withdrawn|3|||
124825657|NCT01199289|448990711|FG000|Overall Study|Administrative decision|0|||
124825658|NCT01199289|448990712|FG001|Overall Study|Administrative decision|0|||
124825659|NCT01199289|448990713|FG002|Overall Study|Administrative decision|0|||
124825660|NCT01199289|448990714|FG003|Overall Study|Administrative decision|1|||
124825661|NCT01199289|448990711|FG000|Overall Study|Lost to Follow-up|0|||
124825662|NCT01199289|448990712|FG001|Overall Study|Lost to Follow-up|0|||
124825663|NCT01199289|448990713|FG002|Overall Study|Lost to Follow-up|0|||
124825664|NCT01199289|448990714|FG003|Overall Study|Lost to Follow-up|1|||
124825665|NCT01199289|448990711|FG000|Overall Study|Protocol-specified criteria|3|||
124825666|NCT01199289|448990712|FG001|Overall Study|Protocol-specified criteria|0|||
124825667|NCT01199289|448990713|FG002|Overall Study|Protocol-specified criteria|0|||
124825668|NCT01199289|448990714|FG003|Overall Study|Protocol-specified criteria|1|||
124825669|NCT01199289|448990711|FG000|Overall Study|Pregnancy|0|||
124825670|NCT01199289|448990712|FG001|Overall Study|Pregnancy|1|||
124825671|NCT01199289|448990713|FG002|Overall Study|Pregnancy|0|||
124825672|NCT01199289|448990714|FG003|Overall Study|Pregnancy|1|||
124825673|NCT00127712|448990718|FG000|Overall Study|Adverse Event|3|||
124825674|NCT00127712|448990719|FG001|Overall Study|Adverse Event|0|||
124825675|NCT00127712|448990718|FG000|Overall Study|Lack of GI access to continue|2|||
124825676|NCT00127712|448990719|FG001|Overall Study|Lack of GI access to continue|0|||
124825677|NCT02642614|448990720|FG000|Overall Study|Adverse Event|1|||
124825678|NCT02642614|448990721|FG001|Overall Study|Adverse Event|1|||
124825679|NCT02642614|448990722|FG002|Overall Study|Adverse Event|2|||
124825680|NCT02642614|448990723|FG003|Overall Study|Adverse Event|2|||
124825681|NCT02642614|448990720|FG000|Overall Study|Lost to Follow-up|1|||
124825682|NCT02642614|448990721|FG001|Overall Study|Lost to Follow-up|0|||
124825683|NCT02642614|448990722|FG002|Overall Study|Lost to Follow-up|0|||
124825684|NCT02642614|448990723|FG003|Overall Study|Lost to Follow-up|0|||
124825685|NCT02642614|448990720|FG000|Overall Study|Withdrawal by Subject|1|||
124825686|NCT02642614|448990721|FG001|Overall Study|Withdrawal by Subject|1|||
124825687|NCT02642614|448990722|FG002|Overall Study|Withdrawal by Subject|0|||
124825688|NCT02642614|448990723|FG003|Overall Study|Withdrawal by Subject|0|||
124825689|NCT04067544|448990724|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
124825690|NCT01320085|448990725|FG000|Overall Study|Disease Progression|26|||
124825691|NCT01320085|448990726|FG001|Overall Study|Disease Progression|93|||
124825692|NCT01320085|448990727|FG002|Overall Study|Disease Progression|17|||
124825693|NCT01320085|448990725|FG000|Overall Study|Adverse Event|12|||
124825694|NCT01320085|448990726|FG001|Overall Study|Adverse Event|20|||
124825695|NCT01320085|448990727|FG002|Overall Study|Adverse Event|5|||
124825696|NCT01320085|448990725|FG000|Overall Study|Withdrawal by Subject|2|||
124825697|NCT01320085|448990726|FG001|Overall Study|Withdrawal by Subject|4|||
124825698|NCT01320085|448990727|FG002|Overall Study|Withdrawal by Subject|1|||
124825699|NCT01320085|448990725|FG000|Overall Study|Protocol Deviation|1|||
124825700|NCT01320085|448990726|FG001|Overall Study|Protocol Deviation|0|||
124825701|NCT01320085|448990727|FG002|Overall Study|Protocol Deviation|1|||
124825702|NCT01320085|448990725|FG000|Overall Study|Administrative problems|0|||
124825703|NCT01320085|448990726|FG001|Overall Study|Administrative problems|0|||
124825704|NCT01320085|448990727|FG002|Overall Study|Administrative problems|1|||
124825705|NCT03316131|448990728|FG000|Treatment Period 2|Protocol deviation|1|||
124825706|NCT03316131|448990729|FG001|Treatment Period 2|Protocol deviation|0|||
124825707|NCT02282020|448990735|FG000|Overall Study|Objective Disease Progression|128|||
124825708|NCT02282020|448990736|FG001|Overall Study|Objective Disease Progression|30|||
124825709|NCT02282020|448990735|FG000|Overall Study|Adverse Event|18|||
124825710|NCT02282020|448990736|FG001|Overall Study|Adverse Event|15|||
124825711|NCT02282020|448990735|FG000|Overall Study|Withdrawal by Subject|7|||
124825712|NCT02282020|448990736|FG001|Overall Study|Withdrawal by Subject|10|||
124825713|NCT02282020|448990735|FG000|Overall Study|Miscellaneous|5|||
124825714|NCT02282020|448990736|FG001|Overall Study|Miscellaneous|19|||
124825715|NCT02282020|448990735|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
124825716|NCT02282020|448990736|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
124825717|NCT02282020|448990735|FG000|Overall Study|Developed Discontinuation Criteria|0|||
124825718|NCT02282020|448990736|FG001|Overall Study|Developed Discontinuation Criteria|2|||
124825719|NCT02282020|448990735|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
124825720|NCT02282020|448990736|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
124825721|NCT00100815|448990737|FG000|Overall Study|Progression|24|||
124825722|NCT00100815|448990737|FG000|Overall Study|Adverse Event|18|||
124825723|NCT00100815|448990737|FG000|Overall Study|Death|4|||
124825724|NCT00100815|448990737|FG000|Overall Study|Other|3|||
124825725|NCT01647282|448990738|FG000|Overall Study|Physician Decision|7|||
124825726|NCT01647282|448990739|FG001|Overall Study|Physician Decision|5|||
124825727|NCT00311623|448990740|FG000|Overall Study|Physician Decision|0|||
124825728|NCT00311623|448990741|FG001|Overall Study|Physician Decision|0|||
124825729|NCT00311623|448990742|FG002|Overall Study|Physician Decision|2|||
124825730|NCT03998189|448990743|FG000|Overall Study|Lack of Efficacy|0|||
124825731|NCT03998189|448990744|FG001|Overall Study|Lack of Efficacy|1|||
124825732|NCT03227029|448990745|FG000|Overall Study|Child Wheezed (no treatment)|0|||
124825733|NCT03227029|448990746|FG001|Overall Study|Child Wheezed (no treatment)|1|||
124825734|NCT03227029|448990747|FG002|Overall Study|Child Wheezed (no treatment)|0|||
124825735|NCT03227029|448990745|FG000|Overall Study|No post RSV season visit due to COVID|3|||
124825736|NCT03227029|448990746|FG001|Overall Study|No post RSV season visit due to COVID|3|||
124825737|NCT03227029|448990747|FG002|Overall Study|No post RSV season visit due to COVID|2|||
124825738|NCT03227029|448990745|FG000|Overall Study|Not able to get to clinic|0|||
124825739|NCT03227029|448990746|FG001|Overall Study|Not able to get to clinic|0|||
124825740|NCT03227029|448990747|FG002|Overall Study|Not able to get to clinic|1|||
124825741|NCT03227029|448990745|FG000|Overall Study|Withdrawal by Subject|1|||
124825742|NCT03227029|448990746|FG001|Overall Study|Withdrawal by Subject|0|||
124825743|NCT03227029|448990747|FG002|Overall Study|Withdrawal by Subject|0|||
124825744|NCT03227029|448990745|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
124825745|NCT03227029|448990746|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
124825746|NCT03227029|448990747|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
124825747|NCT03414424|448990748|FG000|Overall Study|Screened out after consent|0|||
124825748|NCT03414424|448990749|FG001|Overall Study|Screened out after consent|2|||
124825749|NCT03414424|448990748|FG000|Overall Study|Lost to Follow-up|0|||
124825750|NCT03414424|448990749|FG001|Overall Study|Lost to Follow-up|1|||
124825751|NCT01113801|448990750|FG000|Overall Study|Adverse Event|4|||
124825752|NCT01113801|448990751|FG001|Overall Study|Adverse Event|0|||
124825753|NCT01113801|448990752|FG002|Overall Study|Adverse Event|2|||
124825754|NCT01113801|448990753|FG003|Overall Study|Adverse Event|6|||
124825755|NCT01113801|448990750|FG000|Overall Study|Death|4|||
124825756|NCT01113801|448990751|FG001|Overall Study|Death|5|||
124825757|NCT01113801|448990752|FG002|Overall Study|Death|3|||
124825758|NCT01113801|448990753|FG003|Overall Study|Death|4|||
124825759|NCT01113801|448990750|FG000|Overall Study|Protocol Violation|0|||
124825760|NCT01113801|448990751|FG001|Overall Study|Protocol Violation|1|||
124825761|NCT01113801|448990752|FG002|Overall Study|Protocol Violation|0|||
124825762|NCT01113801|448990753|FG003|Overall Study|Protocol Violation|0|||
124825763|NCT01113801|448990750|FG000|Overall Study|Withdrawal by Subject|9|||
124825764|NCT01113801|448990751|FG001|Overall Study|Withdrawal by Subject|7|||
124825765|NCT01113801|448990752|FG002|Overall Study|Withdrawal by Subject|7|||
124825766|NCT01113801|448990753|FG003|Overall Study|Withdrawal by Subject|8|||
124825767|NCT01113801|448990750|FG000|Overall Study|Physician Decision|2|||
124825768|NCT01113801|448990751|FG001|Overall Study|Physician Decision|2|||
124825769|NCT01113801|448990752|FG002|Overall Study|Physician Decision|3|||
124825770|NCT01113801|448990753|FG003|Overall Study|Physician Decision|3|||
124825771|NCT01113801|448990750|FG000|Overall Study|Sponsor Decision|15|||
124825772|NCT01113801|448990751|FG001|Overall Study|Sponsor Decision|21|||
124825773|NCT01113801|448990752|FG002|Overall Study|Sponsor Decision|20|||
124825774|NCT01113801|448990753|FG003|Overall Study|Sponsor Decision|15|||
124825775|NCT01113801|448990750|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
124825776|NCT01113801|448990751|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
124825777|NCT01113801|448990752|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
124825778|NCT01113801|448990753|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
124825779|NCT00770289|448990756|FG000|Overall Study|Other|6|||
124825780|NCT00495170|448990757|FG000|Overall Study|Lost to Follow-up|9|||
124825781|NCT00495170|448990757|FG000|Overall Study|Withdrawal by Subject|3|||
124825782|NCT00495170|448990757|FG000|Overall Study|Inappropriate staging|8|||
124825783|NCT01408914|448990758|FG000|Overall Study|Could not complete tx in protocol period|5|||
124825784|NCT01408914|448990759|FG001|Overall Study|Could not complete tx in protocol period|5|||
124825785|NCT01408914|448990760|FG002|Overall Study|Could not complete tx in protocol period|6|||
124825786|NCT01408914|448990758|FG000|Overall Study|Lost to Follow-up|4|||
124825787|NCT01408914|448990759|FG001|Overall Study|Lost to Follow-up|1|||
124825788|NCT01408914|448990760|FG002|Overall Study|Lost to Follow-up|2|||
124825789|NCT01408914|448990758|FG000|Overall Study|Physician Decision|1|||
124825790|NCT01408914|448990759|FG001|Overall Study|Physician Decision|1|||
124825791|NCT01408914|448990760|FG002|Overall Study|Physician Decision|0|||
124825792|NCT01408914|448990758|FG000|Overall Study|Withdrawal by Subject|1|||
124825793|NCT01408914|448990759|FG001|Overall Study|Withdrawal by Subject|0|||
124825794|NCT01408914|448990760|FG002|Overall Study|Withdrawal by Subject|1|||
124825795|NCT01408914|448990758|FG000|Overall Study|Moved out of study jurisdiction|1|||
124825796|NCT01408914|448990759|FG001|Overall Study|Moved out of study jurisdiction|1|||
124825797|NCT01408914|448990760|FG002|Overall Study|Moved out of study jurisdiction|0|||
124825798|NCT01408914|448990758|FG000|Overall Study|Late exclusion|0|||
124825799|NCT01408914|448990759|FG001|Overall Study|Late exclusion|3|||
124825800|NCT01408914|448990760|FG002|Overall Study|Late exclusion|3|||
124825801|NCT01408914|448990758|FG000|Overall Study|Change in local TB/HIV norms|0|||
124825802|NCT01408914|448990759|FG001|Overall Study|Change in local TB/HIV norms|1|||
124825803|NCT01408914|448990760|FG002|Overall Study|Change in local TB/HIV norms|1|||
124825804|NCT00330616|448990761|FG000|Overall Study|Adverse Event|13|||
124825805|NCT00330616|448990761|FG000|Overall Study|Lack of Efficacy|1|||
124825806|NCT00330616|448990761|FG000|Overall Study|Lost to Follow-up|2|||
124825807|NCT00330616|448990761|FG000|Overall Study|Withdrawal by Subject|4|||
124825808|NCT00330616|448990761|FG000|Overall Study|Other|1|||
124825809|NCT00811473|448990766|FG000|Overall Study|Adverse Event|3|||
124825810|NCT00811473|448990767|FG001|Overall Study|Adverse Event|12|||
124825811|NCT00811473|448990766|FG000|Overall Study|Lost to Follow-up|5|||
124825812|NCT00811473|448990767|FG001|Overall Study|Lost to Follow-up|1|||
124825813|NCT00811473|448990766|FG000|Overall Study|Withdrawal by Subject|2|||
124825814|NCT00811473|448990767|FG001|Overall Study|Withdrawal by Subject|4|||
124825815|NCT00811473|448990766|FG000|Overall Study|Severe non-compliance to protocol|2|||
124825816|NCT00811473|448990767|FG001|Overall Study|Severe non-compliance to protocol|4|||
124638158|NCT02748213|448292602|FG001|Overall Study|Violation of Selection Criteria|0|||
124638159|NCT02748213|448292601|FG000|Overall Study|Protocol Violation|6|||
124638160|NCT02748213|448292602|FG001|Overall Study|Protocol Violation|4|||
124638161|NCT02748213|448292601|FG000|Overall Study|Refused Treatment*|6|||
124638162|NCT02748213|448292602|FG001|Overall Study|Refused Treatment*|6|||
124638163|NCT02748213|448292601|FG000|Overall Study|Failure to Return|1|||
124638164|NCT02748213|448292602|FG001|Overall Study|Failure to Return|0|||
124638165|NCT02748213|448292601|FG000|Overall Study|Other|30|||
124638166|NCT02748213|448292602|FG001|Overall Study|Other|29|||
124638167|NCT04200651|448292603|FG000|Overall Study|Moved to another country during follow-up|2|||
124638168|NCT04200651|448292604|FG001|Overall Study|Moved to another country during follow-up|2|||
124638169|NCT04200651|448292603|FG000|Overall Study|Lost to Follow-up|1|||
124638170|NCT04200651|448292604|FG001|Overall Study|Lost to Follow-up|3|||
124638171|NCT01500382|448292605|FG000|Washout Period|Study site went out of business|0|||
124638172|NCT01500382|448292606|FG001|Washout Period|Study site went out of business|0|||
124638173|NCT01500382|448292607|FG002|Washout Period|Study site went out of business|1|||
124638174|NCT01500382|448292608|FG003|Washout Period|Study site went out of business|0|||
124638175|NCT02640950|448294343|FG000|Overall Study|Adverse Event|1|||
124638176|NCT02640950|448294343|FG000|Overall Study|Withdrawal by Subject|1|||
124638177|NCT00154284|448294344|FG000|Overall Study|Adverse Event|6|||
124638178|NCT00154284|448294345|FG001|Overall Study|Adverse Event|9|||
124638179|NCT00154284|448294344|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124638180|NCT00154284|448294345|FG001|Overall Study|Abnormal laboratory value(s)|1|||
124638181|NCT00154284|448294344|FG000|Overall Study|Lack of Efficacy|1|||
124638182|NCT00154284|448294345|FG001|Overall Study|Lack of Efficacy|2|||
124638183|NCT00154284|448294344|FG000|Overall Study|Protocol Violation|0|||
124638184|NCT00154284|448294345|FG001|Overall Study|Protocol Violation|1|||
124638185|NCT00566020|448294346|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
124638186|NCT00566020|448294347|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
124638187|NCT00566020|448294346|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
124638188|NCT00566020|448294347|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
124638189|NCT00566020|448294346|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
124638190|NCT00566020|448294347|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
124638191|NCT00566020|448294346|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
124638192|NCT00566020|448294347|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
124638193|NCT00566020|448294346|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
124638194|NCT00566020|448294347|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
124638195|NCT00566020|448294346|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
124825817|NCT00811473|448990766|FG000|Overall Study|Lack of therapeutic response|4|||
124825818|NCT00811473|448990767|FG001|Overall Study|Lack of therapeutic response|1|||
124825819|NCT00811473|448990766|FG000|Overall Study|Condition under investigation worsened|1|||
124825820|NCT00811473|448990767|FG001|Overall Study|Condition under investigation worsened|3|||
124638196|NCT00566020|448294347|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
124638197|NCT02101736|448294348|FG000|Overall Study|Protocol Violation|3|||
124638198|NCT02101736|448294349|FG001|Overall Study|Protocol Violation|0|||
124638199|NCT02101736|448294348|FG000|Overall Study|Withdrawal by Subject|1|||
124638200|NCT02101736|448294349|FG001|Overall Study|Withdrawal by Subject|1|||
124825821|NCT00811473|448990766|FG000|Overall Study|Other 2|4|||
124825822|NCT00811473|448990767|FG001|Overall Study|Other 2|1|||
124825823|NCT00811473|448990766|FG000|Overall Study|Incorrect Enrollment|1|||
124825824|NCT00811473|448990767|FG001|Overall Study|Incorrect Enrollment|0|||
124825825|NCT00811473|448990766|FG000|Overall Study|Safety Reasons|1|||
124825826|NCT00811473|448990767|FG001|Overall Study|Safety Reasons|0|||
124825827|NCT01585194|448990771|FG000|Overall Study|Withdrawal by Subject|1|||
124825828|NCT01585194|448990771|FG000|Overall Study|Physician Decision|2|||
124825829|NCT01585194|448990771|FG000|Overall Study|Lack of insurance|1|||
124825830|NCT01957553|448990772|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
124825831|NCT01957553|448990773|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
124825832|NCT01957553|448990772|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
124825833|NCT01957553|448990773|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
124825834|NCT01957553|448990772|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
124825835|NCT01957553|448990773|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
124825836|NCT01957553|448990772|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
124825837|NCT01957553|448990773|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
124825838|NCT01957553|448990772|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
124825839|NCT01957553|448990773|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
124825840|NCT01957553|448990772|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
124825841|NCT01957553|448990773|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
124825842|NCT01957553|448990772|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
124825843|NCT01957553|448990773|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
124825844|NCT01957553|448990772|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
124825845|NCT01957553|448990773|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
124825846|NCT01957553|448990772|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
124825847|NCT01957553|448990773|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
124825848|NCT00993291|448990775|FG000|Overall Study|Withdrawal by Subject|1|||
124825849|NCT01333059|448990777|FG000|Overall Study|Physician Decision|3|||
124825850|NCT01333059|448990778|FG001|Overall Study|Physician Decision|3|||
124825851|NCT01333059|448990777|FG000|Overall Study|Protocol Violation|3|||
124825852|NCT01333059|448990778|FG001|Overall Study|Protocol Violation|0|||
124825853|NCT02733367|448990779|FG000|Overall Study|Withdrawal by Subject|6|||
124825854|NCT00748033|448990783|FG000|Overall Study|Adverse Event|0|||
124825855|NCT00748033|448990784|FG001|Overall Study|Adverse Event|1|||
124825856|NCT02049957|448990787|FG000|Overall Study|Progressive Disease|5|||
124825857|NCT02049957|448990788|FG001|Overall Study|Progressive Disease|4|||
124825858|NCT02049957|448990789|FG002|Overall Study|Progressive Disease|2|||
124825859|NCT02049957|448990790|FG003|Overall Study|Progressive Disease|2|||
124825860|NCT02049957|448990791|FG004|Overall Study|Progressive Disease|6|||
124825861|NCT02049957|448990792|FG005|Overall Study|Progressive Disease|35|||
124825862|NCT02049957|448990793|FG006|Overall Study|Progressive Disease|7|||
124825863|NCT02049957|448990794|FG007|Overall Study|Progressive Disease|26|||
124825864|NCT02049957|448990795|FG008|Overall Study|Progressive Disease|6|||
124825865|NCT02049957|448990787|FG000|Overall Study|Adverse Event|1|||
124825866|NCT02049957|448990788|FG001|Overall Study|Adverse Event|1|||
124825867|NCT02049957|448990789|FG002|Overall Study|Adverse Event|1|||
124825868|NCT02049957|448990790|FG003|Overall Study|Adverse Event|0|||
124825869|NCT02049957|448990791|FG004|Overall Study|Adverse Event|0|||
124825870|NCT02049957|448990792|FG005|Overall Study|Adverse Event|5|||
124825871|NCT02049957|448990793|FG006|Overall Study|Adverse Event|0|||
124825872|NCT02049957|448990794|FG007|Overall Study|Adverse Event|6|||
124825873|NCT02049957|448990795|FG008|Overall Study|Adverse Event|1|||
124825874|NCT02049957|448990787|FG000|Overall Study|Study Terminated by Sponsor|0|||
124825875|NCT02049957|448990788|FG001|Overall Study|Study Terminated by Sponsor|1|||
124825876|NCT02049957|448990789|FG002|Overall Study|Study Terminated by Sponsor|0|||
124825877|NCT02049957|448990790|FG003|Overall Study|Study Terminated by Sponsor|0|||
124825878|NCT02049957|448990791|FG004|Overall Study|Study Terminated by Sponsor|0|||
124825879|NCT02049957|448990792|FG005|Overall Study|Study Terminated by Sponsor|0|||
124825880|NCT02049957|448990793|FG006|Overall Study|Study Terminated by Sponsor|1|||
124825881|NCT02049957|448990794|FG007|Overall Study|Study Terminated by Sponsor|0|||
124825882|NCT02049957|448990795|FG008|Overall Study|Study Terminated by Sponsor|0|||
124825883|NCT02049957|448990787|FG000|Overall Study|Withdrawal by Subject|0|||
124825884|NCT02049957|448990788|FG001|Overall Study|Withdrawal by Subject|0|||
124825885|NCT02049957|448990789|FG002|Overall Study|Withdrawal by Subject|0|||
124825886|NCT02049957|448990790|FG003|Overall Study|Withdrawal by Subject|1|||
124825887|NCT02049957|448990791|FG004|Overall Study|Withdrawal by Subject|0|||
124825888|NCT02049957|448990792|FG005|Overall Study|Withdrawal by Subject|2|||
124825889|NCT02049957|448990793|FG006|Overall Study|Withdrawal by Subject|0|||
124825890|NCT02049957|448990794|FG007|Overall Study|Withdrawal by Subject|3|||
124825891|NCT02049957|448990795|FG008|Overall Study|Withdrawal by Subject|1|||
124825892|NCT02049957|448990787|FG000|Overall Study|Physician Decision|0|||
124825893|NCT02049957|448990788|FG001|Overall Study|Physician Decision|0|||
124825894|NCT02049957|448990789|FG002|Overall Study|Physician Decision|0|||
124825895|NCT02049957|448990790|FG003|Overall Study|Physician Decision|0|||
124825896|NCT02049957|448990791|FG004|Overall Study|Physician Decision|0|||
124825897|NCT02049957|448990792|FG005|Overall Study|Physician Decision|1|||
124825898|NCT02049957|448990793|FG006|Overall Study|Physician Decision|0|||
124825899|NCT02049957|448990794|FG007|Overall Study|Physician Decision|0|||
124825900|NCT02049957|448990795|FG008|Overall Study|Physician Decision|0|||
124825901|NCT03557151|448990796|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
124825902|NCT03557151|448990797|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
124825903|NCT03557151|448990796|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
124825904|NCT03557151|448990797|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
124825905|NCT03557151|448990796|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
124825906|NCT03557151|448990797|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
124825907|NCT01414075|448990798|FG000|Overall Study|Adverse Event|1|||
124825908|NCT01414075|448990799|FG001|Overall Study|Adverse Event|0|||
124825909|NCT01414075|448990800|FG002|Overall Study|Adverse Event|1|||
124825910|NCT01414075|448990801|FG003|Overall Study|Adverse Event|0|||
124825911|NCT01414075|448990798|FG000|Overall Study|Death|1|||
124825912|NCT01414075|448990799|FG001|Overall Study|Death|0|||
124825913|NCT01414075|448990800|FG002|Overall Study|Death|0|||
124825914|NCT01414075|448990801|FG003|Overall Study|Death|1|||
124825915|NCT01414075|448990798|FG000|Overall Study|Withdrawal by Subject|0|||
124825916|NCT01414075|448990799|FG001|Overall Study|Withdrawal by Subject|0|||
124825917|NCT01414075|448990800|FG002|Overall Study|Withdrawal by Subject|0|||
124825918|NCT01414075|448990801|FG003|Overall Study|Withdrawal by Subject|1|||
124825919|NCT01414075|448990798|FG000|Overall Study|Other than specified|1|||
124825920|NCT01414075|448990799|FG001|Overall Study|Other than specified|0|||
124825921|NCT01414075|448990800|FG002|Overall Study|Other than specified|1|||
124825922|NCT01414075|448990801|FG003|Overall Study|Other than specified|0|||
124825923|NCT01922089|448990805|FG000|Overall Study|Adverse Event|18|||
124825924|NCT01922089|448990806|FG001|Overall Study|Adverse Event|13|||
124825925|NCT01922089|448990805|FG000|Overall Study|Protocol Deviation|10|||
124825926|NCT01922089|448990806|FG001|Overall Study|Protocol Deviation|7|||
124825927|NCT01922089|448990805|FG000|Overall Study|Withdrawal by Subject|3|||
124825928|NCT01922089|448990806|FG001|Overall Study|Withdrawal by Subject|4|||
124825929|NCT01922089|448990805|FG000|Overall Study|administrative problems|4|||
124825930|NCT01922089|448990806|FG001|Overall Study|administrative problems|1|||
124825931|NCT01922089|448990805|FG000|Overall Study|Physician Decision|2|||
124825932|NCT01922089|448990806|FG001|Overall Study|Physician Decision|3|||
124825933|NCT01922089|448990805|FG000|Overall Study|Death|2|||
124825934|NCT01922089|448990806|FG001|Overall Study|Death|1|||
124825935|NCT01922089|448990805|FG000|Overall Study|Lost to Follow-up|0|||
124825936|NCT01922089|448990806|FG001|Overall Study|Lost to Follow-up|1|||
124825937|NCT04903626|448990810|FG000|Overall Study|Lost to Follow-up|6|||
124825938|NCT04903626|448990810|FG000|Overall Study|Withdrawal by Subject|1|||
124825939|NCT04903626|448990810|FG000|Overall Study|Other, Not Specified|1|||
124825940|NCT00573534|448990811|FG000|Overall Study|oppositional behavior|3|||
124825941|NCT00467259|448990817|FG000|Overall Study|Adverse Event|24|||
124825942|NCT00467259|448990818|FG001|Overall Study|Adverse Event|90|||
124825943|NCT00467259|448990817|FG000|Overall Study|Protocol Violation|1|||
124825944|NCT00467259|448990818|FG001|Overall Study|Protocol Violation|7|||
124825945|NCT00467259|448990817|FG000|Overall Study|Withdrawal by Subject|34|||
124825946|NCT00467259|448990818|FG001|Overall Study|Withdrawal by Subject|108|||
124825947|NCT00467259|448990817|FG000|Overall Study|Physician Decision|0|||
124825948|NCT00467259|448990818|FG001|Overall Study|Physician Decision|2|||
124825949|NCT00467259|448990817|FG000|Overall Study|Lost to Follow-up|14|||
124825950|NCT00467259|448990818|FG001|Overall Study|Lost to Follow-up|34|||
124825951|NCT00467259|448990817|FG000|Overall Study|Site Closed|2|||
124825952|NCT00467259|448990818|FG001|Overall Study|Site Closed|1|||
124825953|NCT04285879|448990821|FG000|Overall Study|Lost to Follow-up|1|||
124825954|NCT04285879|448990822|FG001|Overall Study|Lost to Follow-up|8|||
124825955|NCT04285879|448990821|FG000|Overall Study|medical/surgical exclusion|16|||
124825956|NCT04285879|448990822|FG001|Overall Study|medical/surgical exclusion|0|||
124825957|NCT01958008|448990824|FG000|Overall Study|Worsening of disease under study|0|||
124825958|NCT01958008|448990825|FG001|Overall Study|Worsening of disease under study|0|||
124825959|NCT01958008|448990826|FG002|Overall Study|Worsening of disease under study|1|||
124825960|NCT01958008|448990827|FG003|Overall Study|Worsening of disease under study|0|||
124825961|NCT01958008|448990824|FG000|Overall Study|Other adverse event|1|||
124825962|NCT01958008|448990825|FG001|Overall Study|Other adverse event|0|||
124825963|NCT01958008|448990826|FG002|Overall Study|Other adverse event|0|||
124825964|NCT01958008|448990827|FG003|Overall Study|Other adverse event|0|||
124825965|NCT01634360|448990828|FG000|Overall Study|Adverse Event|10|||
124825966|NCT01634360|448990829|FG001|Overall Study|Adverse Event|34|||
124825967|NCT01634360|448990828|FG000|Overall Study|subject withdrew consent|13|||
124825968|NCT01634360|448990829|FG001|Overall Study|subject withdrew consent|23|||
124825969|NCT01634360|448990828|FG000|Overall Study|Protocol Violation|1|||
124825970|NCT01634360|448990829|FG001|Overall Study|Protocol Violation|1|||
124825971|NCT01634360|448990828|FG000|Overall Study|Lack of Efficacy|4|||
124825972|NCT01634360|448990829|FG001|Overall Study|Lack of Efficacy|14|||
124825973|NCT01634360|448990828|FG000|Overall Study|Other|3|||
124825974|NCT01634360|448990829|FG001|Overall Study|Other|20|||
124825975|NCT01634360|448990828|FG000|Overall Study|Study termination by sponsor|18|||
124825976|NCT01634360|448990829|FG001|Overall Study|Study termination by sponsor|44|||
124825977|NCT02028065|448990830|FG000|Randomization Through Start Treatment|Not treated|1|||
124825978|NCT02028065|448990831|FG001|Randomization Through Start Treatment|Not treated|3|||
124825979|NCT02028065|448990832|FG002|Randomization Through Start Treatment|Not treated|3|||
124825980|NCT02028065|448990830|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
124825981|NCT02028065|448990831|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
124825982|NCT02028065|448990832|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
124825983|NCT02028065|448990830|FG000|Treatment Through Study Completion|Physician Decision|1|||
124825984|NCT02028065|448990831|FG001|Treatment Through Study Completion|Physician Decision|0|||
124825985|NCT02028065|448990832|FG002|Treatment Through Study Completion|Physician Decision|0|||
124825986|NCT02028065|448990830|FG000|Treatment Through Study Completion|Protocol Violation|1|||
124825987|NCT02028065|448990831|FG001|Treatment Through Study Completion|Protocol Violation|4|||
124825988|NCT02028065|448990832|FG002|Treatment Through Study Completion|Protocol Violation|0|||
124825989|NCT02028065|448990830|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
124825990|NCT02028065|448990831|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
124825991|NCT02028065|448990832|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
124825992|NCT02028065|448990830|FG000|Treatment Through Study Completion|Adverse Event|3|||
124825993|NCT02028065|448990831|FG001|Treatment Through Study Completion|Adverse Event|3|||
124825994|NCT02028065|448990832|FG002|Treatment Through Study Completion|Adverse Event|5|||
124825995|NCT04851314|448990833|FG000|Overall Study|Unable to complete research set-up procedures|0|||
124825996|NCT04851314|448990834|FG001|Overall Study|Unable to complete research set-up procedures|2|||
124825997|NCT04851314|448990833|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
124638201|NCT02498444|448294355|FG000|Overall Study|Withdrawal by Subject|3|||
124638202|NCT02498444|448294356|FG001|Overall Study|Withdrawal by Subject|0|||
124638203|NCT02498444|448294355|FG000|Overall Study|Physician Decision|1|||
124638204|NCT02498444|448294356|FG001|Overall Study|Physician Decision|0|||
124638205|NCT02453334|448294357|FG000|Overall Study|Death|15|||
124638206|NCT02453334|448294358|FG001|Overall Study|Death|13|||
124638207|NCT02453334|448294357|FG000|Overall Study|Adverse Event|2|||
124638208|NCT02453334|448294358|FG001|Overall Study|Adverse Event|1|||
124638209|NCT02453334|448294357|FG000|Overall Study|Lost to Follow-up|5|||
124638210|NCT02453334|448294358|FG001|Overall Study|Lost to Follow-up|9|||
124638211|NCT02453334|448294357|FG000|Overall Study|Physician Decision|1|||
124638212|NCT02453334|448294358|FG001|Overall Study|Physician Decision|0|||
124638213|NCT02453334|448294357|FG000|Overall Study|Withdrawal by Subject|17|||
124638214|NCT02453334|448294358|FG001|Overall Study|Withdrawal by Subject|13|||
124638215|NCT02453334|448294357|FG000|Overall Study|Other reason|1|||
124638216|NCT02453334|448294358|FG001|Overall Study|Other reason|4|||
124638217|NCT02476578|448294363|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
124638218|NCT02476578|448294364|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
124638219|NCT02476578|448294363|FG000|Overall Study|Lost to Follow-up|6|||
124638220|NCT02476578|448294364|FG001|Overall Study|Lost to Follow-up|13|||
124638221|NCT03018080|448294365|FG000|Overall Study|Death|12|||
124638222|NCT03018080|448294366|FG001|Overall Study|Death|19|||
124638223|NCT00026494|448294371|FG000|Overall Study|Withdrawal by Subject|1|||
124638224|NCT00026494|448294372|FG001|Overall Study|Withdrawal by Subject|0|||
124638225|NCT00026494|448294373|FG002|Overall Study|Withdrawal by Subject|1|||
124638226|NCT00026494|448294374|FG003|Overall Study|Withdrawal by Subject|0|||
124638227|NCT00026494|448294371|FG000|Overall Study|Patient non-compliance|1|||
124638228|NCT00026494|448294372|FG001|Overall Study|Patient non-compliance|0|||
124638229|NCT00026494|448294373|FG002|Overall Study|Patient non-compliance|0|||
124638230|NCT00026494|448294374|FG003|Overall Study|Patient non-compliance|0|||
124638231|NCT00026494|448294371|FG000|Overall Study|Patient not treated|0|||
124638232|NCT00026494|448294372|FG001|Overall Study|Patient not treated|0|||
124638233|NCT00026494|448294373|FG002|Overall Study|Patient not treated|2|||
124638234|NCT00026494|448294374|FG003|Overall Study|Patient not treated|0|||
124638235|NCT00026494|448294371|FG000|Overall Study|Clinical progression|0|||
124638236|NCT00026494|448294372|FG001|Overall Study|Clinical progression|0|||
124638237|NCT00026494|448294373|FG002|Overall Study|Clinical progression|3|||
124638238|NCT00026494|448294374|FG003|Overall Study|Clinical progression|0|||
124638239|NCT01684423|448294375|FG000|Overall Study|Withdrawal by Subject|0|||
124825998|NCT04851314|448990834|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
124638240|NCT01684423|448294376|FG001|Overall Study|Withdrawal by Subject|0|||
124638241|NCT01684423|448294377|FG002|Overall Study|Withdrawal by Subject|1|||
124638242|NCT01684423|448294378|FG003|Overall Study|Withdrawal by Subject|0|||
124638243|NCT01684423|448294379|FG004|Overall Study|Withdrawal by Subject|0|||
124638244|NCT01455597|448294380|FG000|Overall Study|Adverse Event|7|||
124825999|NCT00877383|448990835|FG000|Overall Study|Adverse Event|13|||
124638245|NCT01455597|448294381|FG001|Overall Study|Adverse Event|0|||
124638246|NCT01455597|448294382|FG002|Overall Study|Adverse Event|5|||
124638247|NCT01455597|448294383|FG003|Overall Study|Adverse Event|1|||
124638248|NCT01455597|448294380|FG000|Overall Study|Lack of Efficacy|0|||
124638249|NCT01455597|448294381|FG001|Overall Study|Lack of Efficacy|1|||
124826000|NCT00877383|448990836|FG001|Overall Study|Adverse Event|14|||
124826001|NCT00877383|448990835|FG000|Overall Study|Lost to Follow-up|5|||
124826002|NCT00877383|448990836|FG001|Overall Study|Lost to Follow-up|3|||
124826003|NCT00877383|448990835|FG000|Overall Study|Subject withdrew consent|3|||
124826004|NCT00877383|448990836|FG001|Overall Study|Subject withdrew consent|12|||
124826005|NCT00877383|448990835|FG000|Overall Study|Subject no longer requires study drug|2|||
124826006|NCT00877383|448990836|FG001|Overall Study|Subject no longer requires study drug|0|||
124826007|NCT00877383|448990835|FG000|Overall Study|Administrative problems|2|||
124826008|NCT00877383|448990836|FG001|Overall Study|Administrative problems|0|||
124826009|NCT00877383|448990835|FG000|Overall Study|Protocol deviation|2|||
124826010|NCT00877383|448990836|FG001|Overall Study|Protocol deviation|6|||
124826011|NCT00877383|448990835|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
124826012|NCT00877383|448990836|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124826013|NCT00877383|448990835|FG000|Overall Study|Death|1|||
124826014|NCT00877383|448990836|FG001|Overall Study|Death|2|||
124826015|NCT02107482|448990843|FG000|Overall Study|inconveinence|2|||
124826016|NCT02107482|448990843|FG000|Overall Study|Lost to Follow-up|1|||
124826017|NCT02107482|448990843|FG000|Overall Study|Lack of Efficacy|1|||
124826018|NCT04868890|448990844|FG000|Overall Study|Death|2|||
124826019|NCT04868890|448990845|FG001|Overall Study|Death|1|||
124826020|NCT04868890|448990844|FG000|Overall Study|Withdrawal by Subject|1|||
124826021|NCT04868890|448990845|FG001|Overall Study|Withdrawal by Subject|5|||
124826022|NCT00867009|448990846|FG000|Induction Period|Nonserious Adverse Event|5|||
124826023|NCT00867009|448990846|FG000|Induction Period|Serious Adverse Event|10|||
124826024|NCT00867009|448990846|FG000|Induction Period|Death due to serious adverse event|6|||
124826025|NCT00867009|448990846|FG000|Induction Period|Death due to Study Disease|4|||
124638250|NCT01455597|448294382|FG002|Overall Study|Lack of Efficacy|2|||
124638251|NCT01455597|448294383|FG003|Overall Study|Lack of Efficacy|0|||
124638252|NCT01455597|448294380|FG000|Overall Study|Lost to Follow-up|3|||
124638253|NCT01455597|448294381|FG001|Overall Study|Lost to Follow-up|0|||
124638254|NCT01455597|448294382|FG002|Overall Study|Lost to Follow-up|2|||
124638255|NCT01455597|448294383|FG003|Overall Study|Lost to Follow-up|1|||
124638256|NCT01455597|448294380|FG000|Overall Study|Withdrew Consent|6|||
124638257|NCT01455597|448294381|FG001|Overall Study|Withdrew Consent|5|||
124638258|NCT01455597|448294382|FG002|Overall Study|Withdrew Consent|8|||
124638259|NCT01455597|448294383|FG003|Overall Study|Withdrew Consent|5|||
124638260|NCT01455597|448294380|FG000|Overall Study|Reason not Specified|1|||
124638261|NCT01455597|448294381|FG001|Overall Study|Reason not Specified|2|||
124638262|NCT01455597|448294382|FG002|Overall Study|Reason not Specified|3|||
124638263|NCT01455597|448294383|FG003|Overall Study|Reason not Specified|3|||
124638264|NCT00441129|448294384|FG000|Overall Study|Withdrawal by Subject|6|||
124638265|NCT00441129|448294385|FG001|Overall Study|Withdrawal by Subject|14|||
124638266|NCT03412734|448294387|FG000|Overall Study|Incorrect labeling of samples|2|||
124638267|NCT03412734|448294388|FG001|Overall Study|Incorrect labeling of samples|0|||
124638268|NCT03412734|448294387|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
124638269|NCT03412734|448294388|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
124638270|NCT00423332|448294389|FG000|Overall Study|Adverse Event|6|||
124638271|NCT00423332|448294390|FG001|Overall Study|Adverse Event|2|||
124638272|NCT00423332|448294389|FG000|Overall Study|Withdrawal by Subject|1|||
124638273|NCT00423332|448294390|FG001|Overall Study|Withdrawal by Subject|0|||
124638274|NCT00423332|448294389|FG000|Overall Study|Condition under investigation worsened|1|||
124638275|NCT00423332|448294390|FG001|Overall Study|Condition under investigation worsened|1|||
124638276|NCT00423332|448294389|FG000|Overall Study|Progressive at Week 6|0|||
124638277|NCT00423332|448294390|FG001|Overall Study|Progressive at Week 6|1|||
124638278|NCT00423332|448294389|FG000|Overall Study|Unblinded before 12 weeks|1|||
124638279|NCT00423332|448294390|FG001|Overall Study|Unblinded before 12 weeks|3|||
124638280|NCT01136356|448294393|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
124638281|NCT01136356|448294394|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
124638282|NCT01136356|448294393|FG000|First 18-day Withdrawal|Physician Decision|1|||
124638283|NCT01136356|448294394|FG001|First 18-day Withdrawal|Physician Decision|0|||
124638284|NCT01136356|448294393|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
124638285|NCT01136356|448294394|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
124638286|NCT00402688|448294395|FG000|Overall Study|Adverse Event|12|||
124638287|NCT00402688|448294396|FG001|Overall Study|Adverse Event|9|||
124638288|NCT00402688|448294397|FG002|Overall Study|Adverse Event|3|||
124638289|NCT00402688|448294395|FG000|Overall Study|Withdrawal by Subject|3|||
124638290|NCT00402688|448294396|FG001|Overall Study|Withdrawal by Subject|1|||
124638291|NCT00402688|448294397|FG002|Overall Study|Withdrawal by Subject|1|||
124638292|NCT00402688|448294395|FG000|Overall Study|Physician Decision|0|||
124638293|NCT00402688|448294396|FG001|Overall Study|Physician Decision|0|||
124638294|NCT00402688|448294397|FG002|Overall Study|Physician Decision|1|||
124638295|NCT00402688|448294395|FG000|Overall Study|Lack of Efficacy|4|||
124826026|NCT00867009|448990846|FG000|Induction Period|Protocol Violation|1|||
124826027|NCT00867009|448990846|FG000|Induction Period|Withdrawal by Subject|8|||
124638296|NCT00402688|448294396|FG001|Overall Study|Lack of Efficacy|4|||
124826028|NCT00867009|448990846|FG000|Induction Period|Physician Decision|3|||
124826029|NCT00867009|448990846|FG000|Induction Period|Progressive Disease (PD)|25|||
124826030|NCT00867009|448990846|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
124638297|NCT00402688|448294397|FG002|Overall Study|Lack of Efficacy|5|||
124638298|NCT00402688|448294395|FG000|Overall Study|Protocol Violation|1|||
124638299|NCT00402688|448294396|FG001|Overall Study|Protocol Violation|1|||
124638300|NCT00402688|448294397|FG002|Overall Study|Protocol Violation|1|||
124826031|NCT01850524|448990851|FG000|Overall Study|Lost to Follow-up|5|||
124826032|NCT01850524|448990852|FG001|Overall Study|Lost to Follow-up|10|||
124826033|NCT01850524|448990851|FG000|Overall Study|Withdrawal by Subject|24|||
124826034|NCT01850524|448990852|FG001|Overall Study|Withdrawal by Subject|22|||
124826035|NCT01850524|448990851|FG000|Overall Study|Reason not Specified|142|||
124826036|NCT01850524|448990852|FG001|Overall Study|Reason not Specified|141|||
124826037|NCT03358290|448990854|FG000|Overall Study|Study discontinued by Sponsor|0|||
124826038|NCT03358290|448990855|FG001|Overall Study|Study discontinued by Sponsor|1|||
124826039|NCT03358290|448990856|FG002|Overall Study|Study discontinued by Sponsor|1|||
124826040|NCT03358290|448990857|FG003|Overall Study|Study discontinued by Sponsor|0|||
124826041|NCT03358290|448990858|FG004|Overall Study|Study discontinued by Sponsor|0|||
124826042|NCT03358290|448990854|FG000|Overall Study|Adverse Event|0|||
124826043|NCT03358290|448990855|FG001|Overall Study|Adverse Event|0|||
124826044|NCT03358290|448990856|FG002|Overall Study|Adverse Event|1|||
124826045|NCT03358290|448990857|FG003|Overall Study|Adverse Event|2|||
124826046|NCT03358290|448990858|FG004|Overall Study|Adverse Event|0|||
124826047|NCT03358290|448990854|FG000|Overall Study|Withdrawal by Subject|0|||
124826048|NCT03358290|448990855|FG001|Overall Study|Withdrawal by Subject|0|||
124826049|NCT03358290|448990856|FG002|Overall Study|Withdrawal by Subject|0|||
124826050|NCT03358290|448990857|FG003|Overall Study|Withdrawal by Subject|0|||
124826051|NCT03358290|448990858|FG004|Overall Study|Withdrawal by Subject|1|||
124826052|NCT04140292|448990862|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
124826053|NCT04140292|448990863|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
124826054|NCT00459667|448990864|FG000|Overall Study|Adverse Event|9|||
124826055|NCT00459667|448990865|FG001|Overall Study|Adverse Event|12|||
124826056|NCT00459667|448990866|FG002|Overall Study|Adverse Event|8|||
124826057|NCT00459667|448990864|FG000|Overall Study|Lost to Follow-up|5|||
124826058|NCT00459667|448990865|FG001|Overall Study|Lost to Follow-up|9|||
124826059|NCT00459667|448990866|FG002|Overall Study|Lost to Follow-up|3|||
124826060|NCT00459667|448990864|FG000|Overall Study|Pregnancy|1|||
124826061|NCT00459667|448990865|FG001|Overall Study|Pregnancy|1|||
124826062|NCT00459667|448990866|FG002|Overall Study|Pregnancy|1|||
124826063|NCT00459667|448990864|FG000|Overall Study|Protocol Violation|1|||
124826064|NCT00459667|448990865|FG001|Overall Study|Protocol Violation|0|||
124826065|NCT00459667|448990866|FG002|Overall Study|Protocol Violation|0|||
124826066|NCT00459667|448990864|FG000|Overall Study|Withdrawal by Subject|3|||
124826067|NCT00459667|448990865|FG001|Overall Study|Withdrawal by Subject|5|||
124826068|NCT00459667|448990866|FG002|Overall Study|Withdrawal by Subject|5|||
124826069|NCT00459667|448990864|FG000|Overall Study|Other disease modifying treatment|1|||
124826070|NCT00459667|448990865|FG001|Overall Study|Other disease modifying treatment|2|||
124826071|NCT00459667|448990866|FG002|Overall Study|Other disease modifying treatment|1|||
124826072|NCT00459667|448990864|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
124826073|NCT00459667|448990865|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
124826074|NCT00459667|448990866|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
124826075|NCT00459667|448990864|FG000|Overall Study|No treatment administered|6|||
124826076|NCT00459667|448990865|FG001|Overall Study|No treatment administered|3|||
124826077|NCT00459667|448990866|FG002|Overall Study|No treatment administered|1|||
124826078|NCT00556712|448990867|FG000|Overall Study|Adverse Event|7|||
124826079|NCT00556712|448990868|FG001|Overall Study|Adverse Event|19|||
124826080|NCT00556712|448990867|FG000|Overall Study|Death|5|||
124826081|NCT00556712|448990868|FG001|Overall Study|Death|10|||
124826082|NCT00556712|448990867|FG000|Overall Study|Progressive Disease|383|||
124826083|NCT00556712|448990868|FG001|Overall Study|Progressive Disease|320|||
124826084|NCT00556712|448990867|FG000|Overall Study|Protocol Violation|3|||
124826085|NCT00556712|448990868|FG001|Overall Study|Protocol Violation|2|||
124826086|NCT00556712|448990867|FG000|Overall Study|Refused Treatment|17|||
124826087|NCT00556712|448990868|FG001|Overall Study|Refused Treatment|16|||
124826088|NCT00556712|448990867|FG000|Overall Study|Failure to Return|2|||
124826089|NCT00556712|448990868|FG001|Overall Study|Failure to Return|3|||
124826090|NCT00556712|448990867|FG000|Overall Study|Other|2|||
124638301|NCT00402688|448294395|FG000|Overall Study|Lost to Follow-up|1|||
124826091|NCT00556712|448990868|FG001|Overall Study|Other|2|||
124826092|NCT00556712|448990867|FG000|Overall Study|Ongoing at Data Cutoff|32|||
124826093|NCT00556712|448990868|FG001|Overall Study|Ongoing at Data Cutoff|66|||
124826094|NCT04080297|448990869|FG000|Overall Study|Adverse Event|1|||
124826095|NCT04080297|448990870|FG001|Overall Study|Adverse Event|3|||
124826096|NCT04080297|448990869|FG000|Overall Study|concurrent illness|1|||
124638302|NCT00402688|448294396|FG001|Overall Study|Lost to Follow-up|0|||
124826097|NCT04080297|448990870|FG001|Overall Study|concurrent illness|0|||
124826098|NCT02626520|448990871|FG000|Overall Study|Physician Decision|1|||
124826099|NCT02626520|448990872|FG001|Overall Study|Physician Decision|1|||
124826100|NCT02626520|448990871|FG000|Overall Study|Adverse Event|0|||
124826101|NCT02626520|448990872|FG001|Overall Study|Adverse Event|4|||
124826102|NCT02626520|448990871|FG000|Overall Study|Lack of Efficacy|0|||
124826103|NCT02626520|448990872|FG001|Overall Study|Lack of Efficacy|2|||
124826104|NCT02626520|448990871|FG000|Overall Study|Did not start protocol therapy|0|||
124826105|NCT02626520|448990872|FG001|Overall Study|Did not start protocol therapy|2|||
124826106|NCT02626520|448990871|FG000|Overall Study|Study terminated|0|||
124826107|NCT02626520|448990872|FG001|Overall Study|Study terminated|1|||
124826108|NCT00353262|448990873|FG000|Overall Study|Adverse Event|8|||
124826109|NCT00353262|448990873|FG000|Overall Study|Withdrawal by Subject|2|||
124826110|NCT00353262|448990873|FG000|Overall Study|Insufficient Therapeutic Response|13|||
124826111|NCT00353262|448990873|FG000|Overall Study|Progression|1|||
124826112|NCT00353262|448990873|FG000|Overall Study|Surgery|4|||
124826113|NCT00353262|448990873|FG000|Overall Study|Break from Chemotherapy|1|||
124826114|NCT00463346|448992730|FG000|Overall Study|Withdrawal by Subject|3|||
124826115|NCT00463346|448992731|FG001|Overall Study|Withdrawal by Subject|3|||
124826116|NCT01572909|448992732|FG000|Overall Study|Adverse Event|7|||
124826117|NCT01572909|448992733|FG001|Overall Study|Adverse Event|2|||
124826118|NCT01572909|448992732|FG000|Overall Study|Death|3|||
124826119|NCT01572909|448992733|FG001|Overall Study|Death|1|||
124826120|NCT01572909|448992732|FG000|Overall Study|Lost to Follow-up|8|||
124826121|NCT01572909|448992733|FG001|Overall Study|Lost to Follow-up|7|||
124826122|NCT01572909|448992732|FG000|Overall Study|Physician Decision|1|||
124826123|NCT01572909|448992733|FG001|Overall Study|Physician Decision|1|||
124826124|NCT01572909|448992732|FG000|Overall Study|Technical Issues|1|||
124826125|NCT01572909|448992733|FG001|Overall Study|Technical Issues|0|||
124826126|NCT01572909|448992732|FG000|Overall Study|Withdrawal by Subject|12|||
124826127|NCT01572909|448992733|FG001|Overall Study|Withdrawal by Subject|11|||
124826128|NCT01572909|448992732|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
124826129|NCT01572909|448992733|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
124826130|NCT03641651|448992734|FG000|Overall Study|organizational issues at one study site|1|||
124826131|NCT04779489|448992735|FG000|Overall Study|Physician Decision|1|||
124826132|NCT00951665|448992736|FG000|Phase 1b|Adverse Event|2|||
124826133|NCT00951665|448992737|FG001|Phase 1b|Adverse Event|1|||
124826134|NCT00951665|448992738|FG002|Phase 1b|Adverse Event|0|||
124826135|NCT00951665|448992739|FG003|Phase 1b|Adverse Event|1|||
124826136|NCT00951665|448992740|FG004|Phase 1b|Adverse Event|0|||
124826137|NCT00951665|448992741|FG005|Phase 1b|Adverse Event|0|||
124826138|NCT00951665|448992736|FG000|Phase 1b|Death|1|||
124826139|NCT00951665|448992737|FG001|Phase 1b|Death|0|||
124826140|NCT00951665|448992738|FG002|Phase 1b|Death|2|||
124826141|NCT00951665|448992739|FG003|Phase 1b|Death|0|||
124826142|NCT00951665|448992740|FG004|Phase 1b|Death|0|||
124826143|NCT00951665|448992741|FG005|Phase 1b|Death|0|||
124826144|NCT00951665|448992736|FG000|Phase 1b|Physician Decision|4|||
124826145|NCT00951665|448992737|FG001|Phase 1b|Physician Decision|0|||
124826146|NCT00951665|448992738|FG002|Phase 1b|Physician Decision|1|||
124826147|NCT00951665|448992739|FG003|Phase 1b|Physician Decision|0|||
124826148|NCT00951665|448992740|FG004|Phase 1b|Physician Decision|0|||
124826149|NCT00951665|448992741|FG005|Phase 1b|Physician Decision|0|||
124826150|NCT00951665|448992736|FG000|Phase 1b|Withdrawal by Subject|0|||
124826151|NCT00951665|448992737|FG001|Phase 1b|Withdrawal by Subject|1|||
124826152|NCT00951665|448992738|FG002|Phase 1b|Withdrawal by Subject|0|||
124826153|NCT00951665|448992739|FG003|Phase 1b|Withdrawal by Subject|0|||
124826154|NCT00951665|448992740|FG004|Phase 1b|Withdrawal by Subject|0|||
124826155|NCT00951665|448992741|FG005|Phase 1b|Withdrawal by Subject|0|||
124826156|NCT00951665|448992736|FG000|Phase 1b|Disease Progression|13|||
124826157|NCT00951665|448992737|FG001|Phase 1b|Disease Progression|2|||
124826158|NCT00951665|448992738|FG002|Phase 1b|Disease Progression|14|||
124826159|NCT00951665|448992739|FG003|Phase 1b|Disease Progression|0|||
124826160|NCT00951665|448992740|FG004|Phase 1b|Disease Progression|0|||
124826161|NCT00951665|448992741|FG005|Phase 1b|Disease Progression|0|||
124826162|NCT00951665|448992736|FG000|Phase 1b|Protocol Violation|2|||
124826163|NCT00951665|448992737|FG001|Phase 1b|Protocol Violation|0|||
124826164|NCT00951665|448992738|FG002|Phase 1b|Protocol Violation|0|||
124826165|NCT00951665|448992739|FG003|Phase 1b|Protocol Violation|0|||
124826166|NCT00951665|448992740|FG004|Phase 1b|Protocol Violation|0|||
124826167|NCT00951665|448992741|FG005|Phase 1b|Protocol Violation|0|||
124826168|NCT00951665|448992736|FG000|Phase 2a|Adverse Event|0|||
124826169|NCT00951665|448992737|FG001|Phase 2a|Adverse Event|0|||
124826170|NCT00951665|448992738|FG002|Phase 2a|Adverse Event|0|||
124826171|NCT00951665|448992739|FG003|Phase 2a|Adverse Event|0|||
124826172|NCT00951665|448992740|FG004|Phase 2a|Adverse Event|2|||
124826173|NCT00951665|448992741|FG005|Phase 2a|Adverse Event|0|||
124826174|NCT00951665|448992736|FG000|Phase 2a|Death|0|||
124826175|NCT00951665|448992737|FG001|Phase 2a|Death|0|||
124826176|NCT00951665|448992738|FG002|Phase 2a|Death|0|||
124826177|NCT00951665|448992739|FG003|Phase 2a|Death|0|||
124826178|NCT00951665|448992740|FG004|Phase 2a|Death|1|||
124826179|NCT00951665|448992741|FG005|Phase 2a|Death|1|||
124826180|NCT00951665|448992736|FG000|Phase 2a|Lost to Follow-up|0|||
124826181|NCT00951665|448992737|FG001|Phase 2a|Lost to Follow-up|0|||
124826182|NCT00951665|448992738|FG002|Phase 2a|Lost to Follow-up|0|||
124826183|NCT00951665|448992739|FG003|Phase 2a|Lost to Follow-up|0|||
124826184|NCT00951665|448992740|FG004|Phase 2a|Lost to Follow-up|1|||
124826185|NCT00951665|448992741|FG005|Phase 2a|Lost to Follow-up|0|||
124826186|NCT00951665|448992736|FG000|Phase 2a|Physician Decision|0|||
124826187|NCT00951665|448992737|FG001|Phase 2a|Physician Decision|0|||
124826188|NCT00951665|448992738|FG002|Phase 2a|Physician Decision|0|||
124826189|NCT00951665|448992739|FG003|Phase 2a|Physician Decision|0|||
124826190|NCT00951665|448992740|FG004|Phase 2a|Physician Decision|0|||
124826191|NCT00951665|448992741|FG005|Phase 2a|Physician Decision|1|||
124826192|NCT00951665|448992736|FG000|Phase 2a|Withdrawal by Subject|0|||
124826193|NCT00951665|448992737|FG001|Phase 2a|Withdrawal by Subject|0|||
124826194|NCT00951665|448992738|FG002|Phase 2a|Withdrawal by Subject|0|||
124826195|NCT00951665|448992739|FG003|Phase 2a|Withdrawal by Subject|0|||
124826196|NCT00951665|448992740|FG004|Phase 2a|Withdrawal by Subject|2|||
124826197|NCT00951665|448992741|FG005|Phase 2a|Withdrawal by Subject|0|||
124826198|NCT00951665|448992736|FG000|Phase 2a|Disease Progression|0|||
124826199|NCT00951665|448992737|FG001|Phase 2a|Disease Progression|0|||
124826200|NCT00951665|448992738|FG002|Phase 2a|Disease Progression|0|||
124826201|NCT00951665|448992739|FG003|Phase 2a|Disease Progression|0|||
124826202|NCT00951665|448992740|FG004|Phase 2a|Disease Progression|6|||
124826203|NCT00951665|448992741|FG005|Phase 2a|Disease Progression|5|||
124826204|NCT02723084|448992742|FG000|Overall Study|Withdrawal by Subject|1|||
124826205|NCT02723084|448992743|FG001|Overall Study|Withdrawal by Subject|1|||
124826206|NCT02723084|448992742|FG000|Overall Study|Lost to Follow-up|3|||
124826207|NCT02723084|448992743|FG001|Overall Study|Lost to Follow-up|0|||
124826208|NCT02450903|448992746|FG000|Overall Study|Adverse Event|3|||
124826209|NCT02450903|448992746|FG000|Overall Study|Progressive disease|15|||
124826210|NCT02450903|448992746|FG000|Overall Study|Switched to commercial drug|1|||
124826211|NCT02450903|448992746|FG000|Overall Study|Subject/guardian decision|1|||
124826212|NCT01164956|448992747|FG000|Overall Study|Side Effects|1|||
124826213|NCT01164956|448992748|FG001|Overall Study|Side Effects|0|||
124826214|NCT01164956|448992749|FG002|Overall Study|Side Effects|1|||
124826215|NCT00967798|448992750|FG000|Overall Study|Withdrawal by Subject|5|||
124826216|NCT00967798|448992751|FG001|Overall Study|Withdrawal by Subject|2|||
124826217|NCT00967798|448992750|FG000|Overall Study|Lost to Follow-up|4|||
124826218|NCT00967798|448992751|FG001|Overall Study|Lost to Follow-up|1|||
124826219|NCT01409564|448992752|FG000|Overall Study|low medication compliance|4|||
124826220|NCT01409564|448992753|FG001|Overall Study|low medication compliance|3|||
124826221|NCT01409564|448992752|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
124826222|NCT01409564|448992753|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
124826223|NCT00788151|448992758|FG000|Overall Study|Other adverse event|0|||
124826224|NCT00788151|448992759|FG001|Overall Study|Other adverse event|2|||
124826225|NCT00788151|448992758|FG000|Overall Study|Protocol Violation|0|||
124826226|NCT00788151|448992759|FG001|Overall Study|Protocol Violation|1|||
124826227|NCT00788151|448992758|FG000|Overall Study|Withdrawal by Subject|13|||
124826228|NCT00788151|448992759|FG001|Overall Study|Withdrawal by Subject|6|||
124826229|NCT00788151|448992758|FG000|Overall Study|Enrolled but not treated|1|||
124826230|NCT00788151|448992759|FG001|Overall Study|Enrolled but not treated|1|||
124826231|NCT00503009|448992760|FG000|Overall Study|Protocol Violation|1|||
124826232|NCT00503009|448992761|FG001|Overall Study|Protocol Violation|0|||
124826233|NCT00503009|448992762|FG002|Overall Study|Protocol Violation|1|||
124826234|NCT00503009|448992760|FG000|Overall Study|Withdrawal by Subject|0|||
124826235|NCT00503009|448992761|FG001|Overall Study|Withdrawal by Subject|1|||
124826236|NCT00503009|448992762|FG002|Overall Study|Withdrawal by Subject|1|||
124826237|NCT00503009|448992760|FG000|Overall Study|Physician Decision|0|||
124826238|NCT00503009|448992761|FG001|Overall Study|Physician Decision|1|||
124826239|NCT00503009|448992762|FG002|Overall Study|Physician Decision|1|||
124826240|NCT01349803|448992763|FG000|Overall Study|Adverse Event|0|||
124826241|NCT01349803|448992764|FG001|Overall Study|Adverse Event|0|||
124826242|NCT01349803|448992765|FG002|Overall Study|Adverse Event|0|||
124826243|NCT01349803|448992766|FG003|Overall Study|Adverse Event|2|||
124826244|NCT01349803|448992763|FG000|Overall Study|Withdrawal by Subject|1|||
124826245|NCT01349803|448992764|FG001|Overall Study|Withdrawal by Subject|0|||
124826246|NCT01349803|448992765|FG002|Overall Study|Withdrawal by Subject|0|||
124826247|NCT01349803|448992766|FG003|Overall Study|Withdrawal by Subject|0|||
124826248|NCT01349803|448992763|FG000|Overall Study|Protocol-specified criteria|0|||
124826249|NCT01349803|448992764|FG001|Overall Study|Protocol-specified criteria|1|||
124826250|NCT01349803|448992765|FG002|Overall Study|Protocol-specified criteria|3|||
124826251|NCT01349803|448992766|FG003|Overall Study|Protocol-specified criteria|0|||
124826252|NCT02169739|448992767|FG000|Overall Study|Lost to Follow-up|0|||
124826253|NCT02169739|448992768|FG001|Overall Study|Lost to Follow-up|4|||
124826254|NCT01710033|448992769|FG000|Stage 2|Adverse Event|0|||
124826255|NCT01710033|448992770|FG001|Stage 2|Adverse Event|0|||
124826256|NCT01710033|448992771|FG002|Stage 2|Adverse Event|0|||
124826257|NCT01710033|448992772|FG003|Stage 2|Adverse Event|0|||
124826258|NCT01710033|448992773|FG004|Stage 2|Adverse Event|1|||
124826259|NCT01244906|448992778|FG000|Overall Study|Death|2|||
124826260|NCT01244906|448992778|FG000|Overall Study|Progression of disease post treatment|6|||
124826261|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
124826262|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
124826263|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
124826264|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
124826265|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
124826266|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
124826267|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
124826268|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
124826269|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
124826270|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
124826271|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
124826272|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
124826273|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
124826274|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
124826275|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
124826276|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
124826277|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
124826278|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
124826279|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
124826280|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
124826281|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
124826282|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
124826283|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
124826284|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
124826285|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
124826286|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
124826287|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
124826288|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
124826289|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
124826290|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
124826291|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
124826292|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
124826293|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
124826294|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
124826295|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
124826296|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
124826297|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
124826298|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
124826299|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
124826300|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
124826301|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
124826302|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
124826303|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
124826304|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
124826305|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
124826306|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
124826307|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
124826308|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
124826309|NCT03720470|448992783|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
124826310|NCT03720470|448992784|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
124826311|NCT03720470|448992785|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
124826312|NCT03720470|448992786|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
124826313|NCT03720470|448992787|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
124826314|NCT03720470|448992788|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
124826315|NCT03720470|448992783|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
124826316|NCT03720470|448992784|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
124826317|NCT03720470|448992785|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
124826318|NCT03720470|448992786|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
124826319|NCT03720470|448992787|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
124826320|NCT03720470|448992788|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
124826321|NCT03720470|448992783|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
124826322|NCT03720470|448992784|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
124826323|NCT03720470|448992785|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
124826324|NCT03720470|448992786|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
124826325|NCT03720470|448992787|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
124826326|NCT03720470|448992788|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
124826327|NCT03720470|448992783|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
124826328|NCT03720470|448992784|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
124826329|NCT03720470|448992785|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
124826330|NCT03720470|448992786|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
124826331|NCT03720470|448992787|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
124826332|NCT03720470|448992788|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
124826333|NCT03720470|448992783|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
124826334|NCT03720470|448992784|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
124826335|NCT03720470|448992785|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
124826336|NCT03720470|448992786|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
124826337|NCT03720470|448992787|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
124826338|NCT03720470|448992788|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
124826339|NCT03720470|448992783|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
124826340|NCT03720470|448992784|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
124826341|NCT03720470|448992785|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
124826342|NCT03720470|448992786|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
124826343|NCT03720470|448992787|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
124826344|NCT03720470|448992788|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
124826345|NCT03720470|448992783|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
124826346|NCT03720470|448992784|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
124826347|NCT03720470|448992785|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
124826348|NCT03720470|448992786|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
124826349|NCT03720470|448992787|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
124826350|NCT03720470|448992788|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
124826351|NCT03720470|448992783|FG000|Treatment Period: Final 4 Weeks|Other|0|||
124826352|NCT03720470|448992784|FG001|Treatment Period: Final 4 Weeks|Other|1|||
124826353|NCT03720470|448992785|FG002|Treatment Period: Final 4 Weeks|Other|0|||
124826354|NCT03720470|448992786|FG003|Treatment Period: Final 4 Weeks|Other|2|||
124826355|NCT03720470|448992787|FG004|Treatment Period: Final 4 Weeks|Other|1|||
124826356|NCT03720470|448992788|FG005|Treatment Period: Final 4 Weeks|Other|0|||
124826357|NCT00453921|448992789|FG000|Overall Study|Withdrawal by Subject|1|||
124826358|NCT00453921|448992790|FG001|Overall Study|Withdrawal by Subject|1|||
124826359|NCT00453921|448992791|FG002|Overall Study|Withdrawal by Subject|1|||
124826360|NCT00453921|448992792|FG003|Overall Study|Withdrawal by Subject|1|||
124826361|NCT00453921|448992789|FG000|Overall Study|Lost to Follow-up|0|||
124826362|NCT00453921|448992790|FG001|Overall Study|Lost to Follow-up|0|||
124826363|NCT00453921|448992791|FG002|Overall Study|Lost to Follow-up|1|||
124826364|NCT00453921|448992792|FG003|Overall Study|Lost to Follow-up|0|||
124826365|NCT00460031|448992793|FG000|Overall Study|Adverse Event|5|||
124826366|NCT00460031|448992793|FG000|Overall Study|Withdrawal by Subject|5|||
124826367|NCT00460031|448992793|FG000|Overall Study|Death|1|||
124826368|NCT04532099|448992794|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
124826369|NCT04532099|448992795|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
124826370|NCT04532099|448992796|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
124826371|NCT00644995|448992801|FG000|Overall Study|Lost to Follow-up|1|||
124826372|NCT00644995|448992802|FG001|Overall Study|Lost to Follow-up|4|||
124826373|NCT00644995|448992801|FG000|Overall Study|Refused|1|||
124826374|NCT00644995|448992802|FG001|Overall Study|Refused|0|||
124826375|NCT02066233|448992803|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
124826376|NCT02066233|448992804|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
124826377|NCT02772081|448992805|FG000|Overall Study|Physician Decision|1|||
124826378|NCT02772081|448992806|FG001|Overall Study|Physician Decision|1|||
124826379|NCT02772081|448992805|FG000|Overall Study|Death|1|||
124826380|NCT02772081|448992806|FG001|Overall Study|Death|1|||
124826381|NCT03103919|448992813|FG000|Overall Study|Adverse Event|2|||
124826382|NCT03103919|448992814|FG001|Overall Study|Adverse Event|2|||
124826383|NCT01291173|448992815|FG000|Overall Study|Adverse Event|0|||
124826384|NCT01291173|448992816|FG001|Overall Study|Adverse Event|3|||
124826385|NCT01291173|448992817|FG002|Overall Study|Adverse Event|1|||
124826386|NCT01291173|448992818|FG003|Overall Study|Adverse Event|3|||
124826387|NCT01291173|448992815|FG000|Overall Study|Protocol Violation|7|||
124826388|NCT01291173|448992816|FG001|Overall Study|Protocol Violation|2|||
124826389|NCT01291173|448992817|FG002|Overall Study|Protocol Violation|2|||
124826390|NCT01291173|448992818|FG003|Overall Study|Protocol Violation|5|||
124826391|NCT01291173|448992815|FG000|Overall Study|Withdrawal by Subject|6|||
124826392|NCT01291173|448992816|FG001|Overall Study|Withdrawal by Subject|4|||
124826393|NCT01291173|448992817|FG002|Overall Study|Withdrawal by Subject|4|||
124826394|NCT01291173|448992818|FG003|Overall Study|Withdrawal by Subject|2|||
124826395|NCT01291173|448992815|FG000|Overall Study|Lost to Follow-up|4|||
124826396|NCT01291173|448992816|FG001|Overall Study|Lost to Follow-up|6|||
124826397|NCT01291173|448992817|FG002|Overall Study|Lost to Follow-up|3|||
124826398|NCT01291173|448992818|FG003|Overall Study|Lost to Follow-up|2|||
124826399|NCT01291173|448992815|FG000|Overall Study|Unable to meet visit schedule|0|||
124826400|NCT01291173|448992816|FG001|Overall Study|Unable to meet visit schedule|0|||
124826401|NCT01291173|448992817|FG002|Overall Study|Unable to meet visit schedule|1|||
124826402|NCT01291173|448992818|FG003|Overall Study|Unable to meet visit schedule|0|||
124826403|NCT01291173|448992815|FG000|Overall Study|Lack of compliance|0|||
124826404|NCT01291173|448992816|FG001|Overall Study|Lack of compliance|0|||
124826405|NCT01291173|448992817|FG002|Overall Study|Lack of compliance|0|||
124826406|NCT01291173|448992818|FG003|Overall Study|Lack of compliance|1|||
124826407|NCT01291173|448992815|FG000|Overall Study|Subject was unblinded|0|||
124826408|NCT01291173|448992816|FG001|Overall Study|Subject was unblinded|0|||
124826409|NCT01291173|448992817|FG002|Overall Study|Subject was unblinded|1|||
124826410|NCT01291173|448992818|FG003|Overall Study|Subject was unblinded|0|||
124826411|NCT01291173|448992815|FG000|Overall Study|Excluded therapy|0|||
124826412|NCT01291173|448992816|FG001|Overall Study|Excluded therapy|0|||
124826413|NCT01291173|448992817|FG002|Overall Study|Excluded therapy|1|||
124826414|NCT01291173|448992818|FG003|Overall Study|Excluded therapy|0|||
124826415|NCT00390858|448992819|FG000|Overall Study|Adverse Event|6|||
124826416|NCT00390858|448992820|FG001|Overall Study|Adverse Event|2|||
124826417|NCT00390858|448992819|FG000|Overall Study|Lack of Efficacy|0|||
124826418|NCT00390858|448992820|FG001|Overall Study|Lack of Efficacy|1|||
124826419|NCT00390858|448992819|FG000|Overall Study|Withdrawal by Subject|3|||
124826420|NCT00390858|448992820|FG001|Overall Study|Withdrawal by Subject|4|||
124826421|NCT02728895|448992821|FG000|Overall Study|Other|1|||
124826422|NCT02728895|448992822|FG001|Overall Study|Other|2|||
124826423|NCT02728895|448992821|FG000|Overall Study|Withdrawal by Subject|0|||
124826424|NCT02728895|448992822|FG001|Overall Study|Withdrawal by Subject|3|||
124826425|NCT01949051|448992827|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
124826426|NCT01949051|448992828|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
124826427|NCT01949051|448992829|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
124826428|NCT01949051|448992830|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
124826429|NCT01949051|448992831|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
124826430|NCT01949051|448992832|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
124826431|NCT01949051|448992827|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
124826432|NCT01949051|448992828|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124826433|NCT01949051|448992829|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124826434|NCT01949051|448992830|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124826435|NCT01949051|448992831|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124826436|NCT01949051|448992832|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
124826437|NCT01949051|448992827|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
124826438|NCT01949051|448992828|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
124826439|NCT01949051|448992829|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
124826440|NCT01949051|448992830|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
124826441|NCT01949051|448992831|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
124826442|NCT01949051|448992832|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
124826443|NCT01949051|448992827|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
124826444|NCT01949051|448992828|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
124826445|NCT01949051|448992829|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
124826446|NCT01949051|448992830|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
124826447|NCT01949051|448992831|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
124826448|NCT01949051|448992832|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
124826449|NCT01949051|448992827|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
124826450|NCT01949051|448992828|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
124826451|NCT01949051|448992829|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
124826452|NCT01949051|448992830|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
124826453|NCT01949051|448992831|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
124826454|NCT01949051|448992832|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
124826455|NCT01506479|448992833|FG000|Overall Study|Lost to Follow-up|1|||
124826456|NCT01506479|448992834|FG001|Overall Study|Lost to Follow-up|2|||
124826457|NCT01506479|448992835|FG002|Overall Study|Lost to Follow-up|2|||
124826458|NCT01506479|448992833|FG000|Overall Study|Withdrawal by Subject|1|||
124638303|NCT00402688|448294397|FG002|Overall Study|Lost to Follow-up|2|||
124638304|NCT00402688|448294395|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
124638305|NCT00402688|448294396|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
124638306|NCT00402688|448294397|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
124638307|NCT00402688|448294395|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
124638308|NCT00402688|448294396|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
124638309|NCT00402688|448294397|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
124826459|NCT01506479|448992834|FG001|Overall Study|Withdrawal by Subject|2|||
124826460|NCT01506479|448992835|FG002|Overall Study|Withdrawal by Subject|1|||
124826461|NCT01506479|448992833|FG000|Overall Study|Missing assessment|1|||
124826462|NCT01506479|448992834|FG001|Overall Study|Missing assessment|0|||
124638310|NCT00402688|448294395|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
124638311|NCT00402688|448294396|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
124638312|NCT00402688|448294397|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
124826463|NCT01506479|448992835|FG002|Overall Study|Missing assessment|0|||
124826464|NCT01506479|448992833|FG000|Overall Study|Adverse Event|0|||
124826465|NCT01506479|448992834|FG001|Overall Study|Adverse Event|1|||
124826466|NCT01506479|448992835|FG002|Overall Study|Adverse Event|0|||
124826467|NCT01782859|448992836|FG000|Overall Study|Protocol Violation|6|||
124826468|NCT01782859|448992837|FG001|Overall Study|Protocol Violation|6|||
124826469|NCT01782859|448992836|FG000|Overall Study|Withdrawal by Subject|0|||
124826470|NCT01782859|448992837|FG001|Overall Study|Withdrawal by Subject|1|||
124826471|NCT02611778|448992840|FG000|Overall Study|Withdrawal by Subject|2|||
124826472|NCT02611778|448992841|FG001|Overall Study|Withdrawal by Subject|8|||
124826473|NCT02611778|448992840|FG000|Overall Study|Adverse Event|1|||
124826474|NCT02611778|448992841|FG001|Overall Study|Adverse Event|2|||
124826475|NCT02611778|448992840|FG000|Overall Study|Death|2|||
124826476|NCT02611778|448992841|FG001|Overall Study|Death|1|||
124826477|NCT02611778|448992840|FG000|Overall Study|Protocol Violation|1|||
124826478|NCT02611778|448992841|FG001|Overall Study|Protocol Violation|0|||
124826479|NCT02611778|448992840|FG000|Overall Study|Lost to Follow-up|3|||
124826480|NCT02611778|448992841|FG001|Overall Study|Lost to Follow-up|1|||
124826481|NCT02611778|448992840|FG000|Overall Study|Need for alternative treatment|1|||
124826482|NCT02611778|448992841|FG001|Overall Study|Need for alternative treatment|0|||
124826483|NCT02611778|448992840|FG000|Overall Study|Other Reason|2|||
124826484|NCT02611778|448992841|FG001|Overall Study|Other Reason|1|||
124826485|NCT02426892|448992842|FG000|Overall Study|Adverse Event|2|||
124826486|NCT02426892|448992842|FG000|Overall Study|Lack of Efficacy|17|||
124826487|NCT02426892|448992842|FG000|Overall Study|Withdrawal by Subject|1|||
124826488|NCT03198234|448992847|FG000|Overall Study|Relapse of primary disease|0|||
124826489|NCT03198234|448992848|FG001|Overall Study|Relapse of primary disease|1|||
124826490|NCT03198234|448992849|FG002|Overall Study|Relapse of primary disease|0|||
124826491|NCT01340898|448992850|FG000|Primary Phase|Serious Adverse Events|0|||
124826492|NCT01340898|448992851|FG001|Primary Phase|Serious Adverse Events|0|||
124826493|NCT01340898|448992852|FG002|Primary Phase|Serious Adverse Events|1|||
124826494|NCT01340898|448992850|FG000|Primary Phase|Withdrawal by Subject|8|||
124826495|NCT01340898|448992851|FG001|Primary Phase|Withdrawal by Subject|7|||
124826496|NCT01340898|448992852|FG002|Primary Phase|Withdrawal by Subject|5|||
124826497|NCT01340898|448992850|FG000|Primary Phase|Migrated/moved from study area|4|||
124826498|NCT01340898|448992851|FG001|Primary Phase|Migrated/moved from study area|1|||
124826499|NCT01340898|448992852|FG002|Primary Phase|Migrated/moved from study area|0|||
124826500|NCT01340898|448992850|FG000|Primary Phase|Lost to Follow-up|4|||
124826501|NCT01340898|448992851|FG001|Primary Phase|Lost to Follow-up|1|||
124826502|NCT01340898|448992852|FG002|Primary Phase|Lost to Follow-up|0|||
124826503|NCT01340898|448992850|FG000|Booster Phase|Withdrawal by Subject|3|||
124826504|NCT01340898|448992851|FG001|Booster Phase|Withdrawal by Subject|0|||
124826505|NCT01340898|448992852|FG002|Booster Phase|Withdrawal by Subject|4|||
124826506|NCT01340898|448992850|FG000|Booster Phase|Migrated/moved from study area|3|||
124826507|NCT01340898|448992851|FG001|Booster Phase|Migrated/moved from study area|0|||
124826508|NCT01340898|448992852|FG002|Booster Phase|Migrated/moved from study area|0|||
124826509|NCT01340898|448992850|FG000|Booster Phase|Lost to Follow-up|4|||
124826510|NCT01340898|448992851|FG001|Booster Phase|Lost to Follow-up|2|||
124826511|NCT01340898|448992852|FG002|Booster Phase|Lost to Follow-up|3|||
124826512|NCT02056340|448992853|FG000|Overall Study|Lost to Follow-up|5|||
124826513|NCT02056340|448992854|FG001|Overall Study|Lost to Follow-up|5|||
124826514|NCT02056340|448992853|FG000|Overall Study|Withdrawal by Subject|2|||
124826515|NCT02056340|448992854|FG001|Overall Study|Withdrawal by Subject|6|||
124826516|NCT02669433|448992862|FG000|Overall Study|Protocol Violation|0|||
124826517|NCT02669433|448992863|FG001|Overall Study|Protocol Violation|4|||
124826518|NCT02669433|448992864|FG002|Overall Study|Protocol Violation|1|||
124826519|NCT02669433|448992862|FG000|Overall Study|Disease Progression|1|||
124826520|NCT02669433|448992863|FG001|Overall Study|Disease Progression|0|||
124826521|NCT02669433|448992864|FG002|Overall Study|Disease Progression|0|||
124826522|NCT02669433|448992862|FG000|Overall Study|Physician Decision|1|||
124826523|NCT02669433|448992863|FG001|Overall Study|Physician Decision|1|||
124826524|NCT02669433|448992864|FG002|Overall Study|Physician Decision|0|||
124826525|NCT02669433|448992862|FG000|Overall Study|Adverse Event|6|||
124826526|NCT02669433|448992863|FG001|Overall Study|Adverse Event|7|||
124826527|NCT02669433|448992864|FG002|Overall Study|Adverse Event|10|||
124826528|NCT02669433|448992862|FG000|Overall Study|Sponsor Termination|1|||
124826529|NCT02669433|448992863|FG001|Overall Study|Sponsor Termination|0|||
124826530|NCT02669433|448992864|FG002|Overall Study|Sponsor Termination|1|||
124826531|NCT02669433|448992862|FG000|Overall Study|Withdrawal by Subject|5|||
124826532|NCT02669433|448992863|FG001|Overall Study|Withdrawal by Subject|1|||
124826533|NCT02669433|448992864|FG002|Overall Study|Withdrawal by Subject|0|||
124826534|NCT02669433|448992862|FG000|Overall Study|Withdrawal by Caregiver|1|||
124826535|NCT02669433|448992863|FG001|Overall Study|Withdrawal by Caregiver|0|||
124826536|NCT02669433|448992864|FG002|Overall Study|Withdrawal by Caregiver|2|||
124826537|NCT02669433|448992862|FG000|Overall Study|Death|0|||
124826538|NCT02669433|448992863|FG001|Overall Study|Death|1|||
124826539|NCT02669433|448992864|FG002|Overall Study|Death|1|||
124826540|NCT03128892|448992865|FG000|Overall Study|Withdrawal by Subject|2|||
124826541|NCT03128892|448992865|FG000|Overall Study|Physician Decision|1|||
124826542|NCT00459108|448992866|FG000|Overall Study|Withdrawal by Subject|5|||
124826543|NCT00459108|448992866|FG000|Overall Study|Adverse Event|3|||
124826544|NCT00459108|448992866|FG000|Overall Study|Death|2|||
124826545|NCT00459108|448992866|FG000|Overall Study|Progression|1|||
124826546|NCT03473808|448992872|FG000|Overall Study|Withdrawal by Subject|1|||
124826547|NCT02157298|448992873|FG000|Overall Study|Adverse Event|1|||
124826548|NCT02157298|448992874|FG001|Overall Study|Adverse Event|0|||
124826549|NCT02157298|448992873|FG000|Overall Study|Subject no longer meets study criteria|1|||
124826550|NCT02157298|448992874|FG001|Overall Study|Subject no longer meets study criteria|2|||
124826551|NCT02157298|448992873|FG000|Overall Study|Poor/Non-compliance|1|||
124826552|NCT02157298|448992874|FG001|Overall Study|Poor/Non-compliance|0|||
124826553|NCT02157298|448992873|FG000|Overall Study|Withdrawal by Subject|1|||
124826554|NCT02157298|448992874|FG001|Overall Study|Withdrawal by Subject|0|||
124826555|NCT01339429|448992875|FG000|Overall Study|Withdrawal by Subject|1|||
124826556|NCT01339429|448992875|FG000|Overall Study|Physician Decision|3|||
124826557|NCT01085591|448992876|FG000|Overall Study|Adverse Event|0|||
124826558|NCT01085591|448992877|FG001|Overall Study|Adverse Event|1|||
124826559|NCT01085591|448992878|FG002|Overall Study|Adverse Event|3|||
124826560|NCT01085591|448992876|FG000|Overall Study|Physician Decision|1|||
124826561|NCT01085591|448992877|FG001|Overall Study|Physician Decision|0|||
124826562|NCT01085591|448992878|FG002|Overall Study|Physician Decision|1|||
124826563|NCT01085591|448992876|FG000|Overall Study|Withdrawal by Subject|0|||
124826564|NCT01085591|448992877|FG001|Overall Study|Withdrawal by Subject|2|||
124826565|NCT01085591|448992878|FG002|Overall Study|Withdrawal by Subject|1|||
124826566|NCT01085591|448992876|FG000|Overall Study|Lost to Follow-up|0|||
124826567|NCT01085591|448992877|FG001|Overall Study|Lost to Follow-up|1|||
124826568|NCT01085591|448992878|FG002|Overall Study|Lost to Follow-up|1|||
124826569|NCT01085591|448992876|FG000|Overall Study|Protocol Violation|1|||
124826570|NCT01085591|448992877|FG001|Overall Study|Protocol Violation|1|||
124826571|NCT01085591|448992878|FG002|Overall Study|Protocol Violation|1|||
124826572|NCT01085591|448992876|FG000|Overall Study|Other|0|||
124826573|NCT01085591|448992877|FG001|Overall Study|Other|1|||
124826574|NCT01085591|448992878|FG002|Overall Study|Other|0|||
124826575|NCT01085591|448992876|FG000|Overall Study|Not Properly Consented|1|||
124826576|NCT01085591|448992877|FG001|Overall Study|Not Properly Consented|0|||
124826577|NCT01085591|448992878|FG002|Overall Study|Not Properly Consented|0|||
124826578|NCT00396591|448992879|FG000|Overall Study|Disease Progression|13|||
124826579|NCT00396591|448992879|FG000|Overall Study|Adverse Event|2|||
124826580|NCT00396591|448992879|FG000|Overall Study|Participant request|1|||
124826581|NCT00818662|448992883|FG000|Overall Study|Adverse Event|5|||
124826582|NCT00818662|448992884|FG001|Overall Study|Adverse Event|14|||
124826583|NCT00818662|448992885|FG002|Overall Study|Adverse Event|4|||
124826584|NCT00818662|448992886|FG003|Overall Study|Adverse Event|3|||
124826585|NCT00818662|448992883|FG000|Overall Study|Withdrawal by Subject|5|||
124826586|NCT00818662|448992884|FG001|Overall Study|Withdrawal by Subject|4|||
124826587|NCT00818662|448992885|FG002|Overall Study|Withdrawal by Subject|2|||
124826588|NCT00818662|448992886|FG003|Overall Study|Withdrawal by Subject|2|||
124826589|NCT00818662|448992883|FG000|Overall Study|Death|1|||
124826590|NCT00818662|448992884|FG001|Overall Study|Death|3|||
124826591|NCT00818662|448992885|FG002|Overall Study|Death|0|||
124826592|NCT00818662|448992886|FG003|Overall Study|Death|0|||
124826593|NCT00818662|448992883|FG000|Overall Study|Physician Decision|1|||
124826594|NCT00818662|448992884|FG001|Overall Study|Physician Decision|0|||
124826595|NCT00818662|448992885|FG002|Overall Study|Physician Decision|0|||
124826596|NCT00818662|448992886|FG003|Overall Study|Physician Decision|0|||
124826597|NCT00818662|448992883|FG000|Overall Study|Lost to Follow-up|0|||
124826598|NCT00818662|448992884|FG001|Overall Study|Lost to Follow-up|0|||
124826599|NCT00818662|448992885|FG002|Overall Study|Lost to Follow-up|0|||
124826600|NCT00818662|448992886|FG003|Overall Study|Lost to Follow-up|1|||
124826601|NCT00818662|448992883|FG000|Overall Study|Unwilling or Unable to Participate|4|||
124826602|NCT00818662|448992884|FG001|Overall Study|Unwilling or Unable to Participate|6|||
124826603|NCT00818662|448992885|FG002|Overall Study|Unwilling or Unable to Participate|2|||
124826604|NCT00818662|448992886|FG003|Overall Study|Unwilling or Unable to Participate|4|||
124826605|NCT00818662|448992883|FG000|Overall Study|Protocol Violation|1|||
124826606|NCT00818662|448992884|FG001|Overall Study|Protocol Violation|1|||
124826607|NCT00818662|448992885|FG002|Overall Study|Protocol Violation|0|||
124826608|NCT00818662|448992886|FG003|Overall Study|Protocol Violation|0|||
124826609|NCT00818662|448992883|FG000|Overall Study|Requires a Prohibited Medication|1|||
124826610|NCT00818662|448992884|FG001|Overall Study|Requires a Prohibited Medication|0|||
124826611|NCT00818662|448992885|FG002|Overall Study|Requires a Prohibited Medication|0|||
124826612|NCT00818662|448992886|FG003|Overall Study|Requires a Prohibited Medication|0|||
124826613|NCT00818662|448992883|FG000|Overall Study|Safety Risk|1|||
124826614|NCT00818662|448992884|FG001|Overall Study|Safety Risk|1|||
124826615|NCT00818662|448992885|FG002|Overall Study|Safety Risk|0|||
124826616|NCT00818662|448992886|FG003|Overall Study|Safety Risk|1|||
124826617|NCT00818662|448992883|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
124826618|NCT00818662|448992884|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
124826619|NCT00818662|448992885|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
124826620|NCT00818662|448992886|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
124826621|NCT00818662|448992883|FG000|Overall Study|Participant's health declined|0|||
124826622|NCT00818662|448992884|FG001|Overall Study|Participant's health declined|0|||
124826623|NCT00818662|448992885|FG002|Overall Study|Participant's health declined|0|||
124826624|NCT00818662|448992886|FG003|Overall Study|Participant's health declined|1|||
124826625|NCT00818662|448992883|FG000|Overall Study|Caregiver to pursue other treatment|0|||
124826626|NCT00818662|448992884|FG001|Overall Study|Caregiver to pursue other treatment|1|||
124826627|NCT00818662|448992885|FG002|Overall Study|Caregiver to pursue other treatment|0|||
124826628|NCT00818662|448992886|FG003|Overall Study|Caregiver to pursue other treatment|0|||
124826629|NCT00818662|448992883|FG000|Overall Study|Moving out of state|0|||
124826630|NCT00818662|448992884|FG001|Overall Study|Moving out of state|0|||
124826631|NCT00818662|448992885|FG002|Overall Study|Moving out of state|0|||
124826632|NCT00818662|448992886|FG003|Overall Study|Moving out of state|1|||
124826633|NCT00818662|448992883|FG000|Overall Study|Declined move to another study site|1|||
124826634|NCT00818662|448992884|FG001|Overall Study|Declined move to another study site|0|||
124826635|NCT00818662|448992885|FG002|Overall Study|Declined move to another study site|0|||
124826636|NCT00818662|448992886|FG003|Overall Study|Declined move to another study site|0|||
124826637|NCT00818662|448992883|FG000|Overall Study|Change in living situation|0|||
124826638|NCT00818662|448992884|FG001|Overall Study|Change in living situation|0|||
124826639|NCT00818662|448992885|FG002|Overall Study|Change in living situation|0|||
124826640|NCT00818662|448992886|FG003|Overall Study|Change in living situation|1|||
124826641|NCT00818662|448992883|FG000|Overall Study|Study partner decision|0|||
124826642|NCT00818662|448992884|FG001|Overall Study|Study partner decision|0|||
124826643|NCT00818662|448992885|FG002|Overall Study|Study partner decision|0|||
124826644|NCT00818662|448992886|FG003|Overall Study|Study partner decision|1|||
124826645|NCT00818662|448992883|FG000|Overall Study|Admitted to long term nursing care|0|||
124826646|NCT00818662|448992884|FG001|Overall Study|Admitted to long term nursing care|1|||
124826647|NCT00818662|448992885|FG002|Overall Study|Admitted to long term nursing care|0|||
124826648|NCT00818662|448992886|FG003|Overall Study|Admitted to long term nursing care|0|||
124826649|NCT01472081|448992887|FG000|Overall Study|Continuing treatment at time of analysis|1|||
124826650|NCT01472081|448992888|FG001|Overall Study|Continuing treatment at time of analysis|4|||
124826651|NCT01472081|448992889|FG002|Overall Study|Continuing treatment at time of analysis|1|||
124826652|NCT01472081|448992890|FG003|Overall Study|Continuing treatment at time of analysis|8|||
124826653|NCT01472081|448992891|FG004|Overall Study|Continuing treatment at time of analysis|9|||
124826654|NCT01472081|448992892|FG005|Overall Study|Continuing treatment at time of analysis|0|||
124826655|NCT01472081|448992887|FG000|Overall Study|Disease Progression|4|||
124826656|NCT01472081|448992888|FG001|Overall Study|Disease Progression|10|||
124826657|NCT01472081|448992889|FG002|Overall Study|Disease Progression|12|||
124826658|NCT01472081|448992890|FG003|Overall Study|Disease Progression|31|||
124826659|NCT01472081|448992891|FG004|Overall Study|Disease Progression|22|||
124826660|NCT01472081|448992892|FG005|Overall Study|Disease Progression|3|||
124826661|NCT01472081|448992887|FG000|Overall Study|Study drug toxicity|2|||
124826662|NCT01472081|448992888|FG001|Overall Study|Study drug toxicity|9|||
124826663|NCT01472081|448992889|FG002|Overall Study|Study drug toxicity|4|||
124826664|NCT01472081|448992890|FG003|Overall Study|Study drug toxicity|6|||
124826665|NCT01472081|448992891|FG004|Overall Study|Study drug toxicity|13|||
124826666|NCT01472081|448992892|FG005|Overall Study|Study drug toxicity|2|||
124826667|NCT01472081|448992887|FG000|Overall Study|Death|0|||
124826668|NCT01472081|448992888|FG001|Overall Study|Death|0|||
124826669|NCT01472081|448992889|FG002|Overall Study|Death|0|||
124826670|NCT01472081|448992890|FG003|Overall Study|Death|0|||
124826671|NCT01472081|448992891|FG004|Overall Study|Death|1|||
124826672|NCT01472081|448992892|FG005|Overall Study|Death|0|||
124826673|NCT01472081|448992887|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
124826674|NCT01472081|448992888|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
124826675|NCT01472081|448992889|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
124826676|NCT01472081|448992890|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
124826677|NCT01472081|448992891|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
124826678|NCT01472081|448992892|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
124826679|NCT01472081|448992887|FG000|Overall Study|Withdrawal by Subject|0|||
124826680|NCT01472081|448992888|FG001|Overall Study|Withdrawal by Subject|0|||
124826681|NCT01472081|448992889|FG002|Overall Study|Withdrawal by Subject|0|||
124826682|NCT01472081|448992890|FG003|Overall Study|Withdrawal by Subject|0|||
124826683|NCT01472081|448992891|FG004|Overall Study|Withdrawal by Subject|0|||
124826684|NCT01472081|448992892|FG005|Overall Study|Withdrawal by Subject|1|||
124826685|NCT01472081|448992887|FG000|Overall Study|Poor/non-compliance|0|||
124826686|NCT01472081|448992888|FG001|Overall Study|Poor/non-compliance|0|||
124826687|NCT01472081|448992889|FG002|Overall Study|Poor/non-compliance|1|||
124826688|NCT01472081|448992890|FG003|Overall Study|Poor/non-compliance|0|||
124826689|NCT01472081|448992891|FG004|Overall Study|Poor/non-compliance|1|||
124826690|NCT01472081|448992892|FG005|Overall Study|Poor/non-compliance|0|||
124826691|NCT01472081|448992887|FG000|Overall Study|No longer meets study criteria|0|||
124826692|NCT01472081|448992888|FG001|Overall Study|No longer meets study criteria|0|||
124826693|NCT01472081|448992889|FG002|Overall Study|No longer meets study criteria|1|||
124826694|NCT01472081|448992890|FG003|Overall Study|No longer meets study criteria|0|||
124826695|NCT01472081|448992891|FG004|Overall Study|No longer meets study criteria|0|||
124826696|NCT01472081|448992892|FG005|Overall Study|No longer meets study criteria|0|||
124826697|NCT01472081|448992887|FG000|Overall Study|Subject request to discontinue treatment|0|||
124826698|NCT01472081|448992888|FG001|Overall Study|Subject request to discontinue treatment|3|||
124826699|NCT01472081|448992889|FG002|Overall Study|Subject request to discontinue treatment|1|||
124826700|NCT01472081|448992890|FG003|Overall Study|Subject request to discontinue treatment|1|||
124826701|NCT01472081|448992891|FG004|Overall Study|Subject request to discontinue treatment|0|||
124826702|NCT01472081|448992892|FG005|Overall Study|Subject request to discontinue treatment|0|||
124826703|NCT03605303|448992893|FG000|Period 1|Study Terminated|2|||
124826704|NCT03605303|448992894|FG001|Period 1|Study Terminated|1|||
124826705|NCT02200445|448992897|FG000|Overall Study|Lack of Efficacy|1|||
124826706|NCT02200445|448992898|FG001|Overall Study|Lack of Efficacy|2|||
124826707|NCT02200445|448992899|FG002|Overall Study|Lack of Efficacy|2|||
124826708|NCT02200445|448992897|FG000|Overall Study|Adverse Event|0|||
124826709|NCT02200445|448992898|FG001|Overall Study|Adverse Event|2|||
124826710|NCT02200445|448992899|FG002|Overall Study|Adverse Event|0|||
124826711|NCT03334903|448992900|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
124826712|NCT03334903|448992901|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
124826713|NCT03334903|448992900|FG000|Overall Study|Protocol Violation|1|||
124826714|NCT03334903|448992901|FG001|Overall Study|Protocol Violation|3|||
124826715|NCT03334903|448992900|FG000|Overall Study|Surgery postponed|1|||
124826716|NCT03334903|448992901|FG001|Overall Study|Surgery postponed|0|||
124826717|NCT03334903|448992900|FG000|Overall Study|Adverse Event|1|||
124826718|NCT03334903|448992901|FG001|Overall Study|Adverse Event|1|||
124826719|NCT03334903|448992900|FG000|Overall Study|Withdrawal by Subject|0|||
124826720|NCT03334903|448992901|FG001|Overall Study|Withdrawal by Subject|1|||
124826721|NCT00623727|448995074|FG000|Double Blind (DB)|Adverse Event|1|||
124826722|NCT00623727|448995075|FG001|Double Blind (DB)|Adverse Event|3|||
124826723|NCT00623727|448995074|FG000|Double Blind (DB)|Physician Decision|0|||
124826724|NCT00623727|448995075|FG001|Double Blind (DB)|Physician Decision|1|||
124826725|NCT00623727|448995074|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
124826726|NCT00623727|448995075|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
124826727|NCT00623727|448995074|FG000|Double Blind (DB)|Lack of Efficacy|2|||
124826728|NCT00623727|448995075|FG001|Double Blind (DB)|Lack of Efficacy|2|||
124826729|NCT00623727|448995074|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
124826730|NCT00623727|448995075|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
124826731|NCT00623727|448995074|FG000|Double Blind (DB)|Lost to Follow-up|1|||
124826732|NCT00623727|448995075|FG001|Double Blind (DB)|Lost to Follow-up|1|||
124826733|NCT00623727|448995074|FG000|Double Blind (DB)|Protocol Violation|2|||
124826734|NCT00623727|448995075|FG001|Double Blind (DB)|Protocol Violation|2|||
124826735|NCT00623727|448995074|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
124826736|NCT00623727|448995075|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
124826737|NCT00623727|448995074|FG000|Open Label Follow-up|Study termination|0|||
124826738|NCT00623727|448995075|FG001|Open Label Follow-up|Study termination|6|||
124826739|NCT00623727|448995074|FG000|Open Label Follow-up|Participant convenience|0|||
124826740|NCT00623727|448995075|FG001|Open Label Follow-up|Participant convenience|1|||
124826741|NCT00501293|448995076|FG000|Optimization Period|Enrolled in error|1|||
124826742|NCT00501293|448995077|FG001|Optimization Period|Enrolled in error|0|||
124826743|NCT00501293|448995076|FG000|Maintenance Period|Withdrawal by Subject|14|||
124826744|NCT00501293|448995077|FG001|Maintenance Period|Withdrawal by Subject|13|||
124826745|NCT00501293|448995076|FG000|Maintenance Period|Lost to Follow-up|12|||
124826746|NCT00501293|448995077|FG001|Maintenance Period|Lost to Follow-up|7|||
124826747|NCT00501293|448995076|FG000|Maintenance Period|Adverse Event|6|||
124826748|NCT00501293|448995077|FG001|Maintenance Period|Adverse Event|6|||
124826749|NCT00501293|448995076|FG000|Maintenance Period|Protocol Violation|2|||
124826750|NCT00501293|448995077|FG001|Maintenance Period|Protocol Violation|1|||
124826751|NCT00501293|448995076|FG000|Maintenance Period|Lack of Efficacy|4|||
124826752|NCT00501293|448995077|FG001|Maintenance Period|Lack of Efficacy|1|||
124826753|NCT00501293|448995076|FG000|Maintenance Period|Noncompliant with study medication|5|||
124826754|NCT00501293|448995077|FG001|Maintenance Period|Noncompliant with study medication|0|||
124826755|NCT00501293|448995076|FG000|Maintenance Period|Went into rehabilitation|1|||
124826756|NCT00501293|448995077|FG001|Maintenance Period|Went into rehabilitation|0|||
124826757|NCT00501293|448995076|FG000|Maintenance Period|Would not wear patch|1|||
124826758|NCT00501293|448995077|FG001|Maintenance Period|Would not wear patch|0|||
124826759|NCT00501293|448995076|FG000|Maintenance Period|Application site reaction|1|||
124826760|NCT00501293|448995077|FG001|Maintenance Period|Application site reaction|0|||
124826761|NCT01104636|448995081|FG000|Overall Study|Lack of Efficacy|43|||
124826762|NCT01104636|448995081|FG000|Overall Study|Lost to Follow-up|24|||
124826763|NCT01104636|448995081|FG000|Overall Study|Withdrawal by Subject|4|||
124826764|NCT01104636|448995081|FG000|Overall Study|Other|43|||
124826765|NCT01104636|448995081|FG000|Overall Study|Study terminated by sponsor|1|||
124826766|NCT01104636|448995081|FG000|Overall Study|Pregnancy|2|||
124826767|NCT01104636|448995081|FG000|Overall Study|Adverse Event|40|||
124826768|NCT01104636|448995081|FG000|Overall Study|Ongoing|21|||
124826769|NCT01706003|448995082|FG000|Overall Study|Withdrawal by Subject|2|||
124826770|NCT01706003|448995083|FG001|Overall Study|Withdrawal by Subject|0|||
124826771|NCT01706003|448995082|FG000|Overall Study|Not scheduled|3|||
124826772|NCT01706003|448995083|FG001|Overall Study|Not scheduled|0|||
124826773|NCT01706003|448995082|FG000|Overall Study|Lost to Follow-up|6|||
124826774|NCT01706003|448995083|FG001|Overall Study|Lost to Follow-up|4|||
124826775|NCT00696696|448995086|FG000|Overall Study|Adverse Event|5|||
124826776|NCT00696696|448995086|FG000|Overall Study|Withdrawal by Subject|8|||
124826777|NCT00696696|448995086|FG000|Overall Study|Physician Decision|2|||
124826778|NCT00696696|448995086|FG000|Overall Study|Death|3|||
124826779|NCT01313767|448995092|FG000|Overall Study|Adverse Event|1|||
124826780|NCT01313767|448995093|FG001|Overall Study|Adverse Event|0|||
124826781|NCT01313767|448995092|FG000|Overall Study|Lost to Follow-up|1|||
124826782|NCT01313767|448995093|FG001|Overall Study|Lost to Follow-up|0|||
124826783|NCT01313767|448995092|FG000|Overall Study|Withdrawal by Subject|2|||
124826784|NCT01313767|448995093|FG001|Overall Study|Withdrawal by Subject|1|||
124826785|NCT01313767|448995092|FG000|Overall Study|Protocol Violation|3|||
124826786|NCT01313767|448995093|FG001|Overall Study|Protocol Violation|1|||
124826787|NCT01287897|448995099|FG000|Overall Study|Adverse Event|5|||
124826788|NCT01287897|448995100|FG001|Overall Study|Adverse Event|3|||
124826789|NCT01287897|448995101|FG002|Overall Study|Adverse Event|6|||
124826790|NCT01287897|448995102|FG003|Overall Study|Adverse Event|4|||
124826791|NCT01287897|448995099|FG000|Overall Study|Lack of Efficacy|2|||
124826792|NCT01287897|448995100|FG001|Overall Study|Lack of Efficacy|0|||
124826793|NCT01287897|448995101|FG002|Overall Study|Lack of Efficacy|0|||
124826794|NCT01287897|448995102|FG003|Overall Study|Lack of Efficacy|0|||
124826795|NCT01287897|448995099|FG000|Overall Study|Protocol Violation|1|||
124826796|NCT01287897|448995100|FG001|Overall Study|Protocol Violation|1|||
124826797|NCT01287897|448995101|FG002|Overall Study|Protocol Violation|0|||
124826798|NCT01287897|448995102|FG003|Overall Study|Protocol Violation|1|||
124826799|NCT01287897|448995099|FG000|Overall Study|Lost to Follow-up|0|||
124826800|NCT01287897|448995100|FG001|Overall Study|Lost to Follow-up|0|||
124826801|NCT01287897|448995101|FG002|Overall Study|Lost to Follow-up|2|||
124826802|NCT01287897|448995102|FG003|Overall Study|Lost to Follow-up|0|||
124826803|NCT01287897|448995099|FG000|Overall Study|Withdrawal by Subject|1|||
124826804|NCT01287897|448995100|FG001|Overall Study|Withdrawal by Subject|5|||
124826805|NCT01287897|448995101|FG002|Overall Study|Withdrawal by Subject|3|||
124826806|NCT01287897|448995102|FG003|Overall Study|Withdrawal by Subject|2|||
124826807|NCT01287897|448995099|FG000|Overall Study|Not consented properly|0|||
124826808|NCT01287897|448995100|FG001|Overall Study|Not consented properly|1|||
124826809|NCT01287897|448995101|FG002|Overall Study|Not consented properly|0|||
124826810|NCT01287897|448995102|FG003|Overall Study|Not consented properly|0|||
124826811|NCT01287897|448995099|FG000|Overall Study|Not meeting entrance criteria|1|||
124826812|NCT01287897|448995100|FG001|Overall Study|Not meeting entrance criteria|1|||
124826813|NCT01287897|448995101|FG002|Overall Study|Not meeting entrance criteria|0|||
124826814|NCT01287897|448995102|FG003|Overall Study|Not meeting entrance criteria|0|||
124826815|NCT01287897|448995099|FG000|Overall Study|Other|1|||
124826816|NCT01287897|448995100|FG001|Overall Study|Other|0|||
124826817|NCT01287897|448995101|FG002|Overall Study|Other|1|||
124826818|NCT01287897|448995102|FG003|Overall Study|Other|0|||
124826819|NCT00249444|448995103|FG000|Overall Study|Lost to Follow-up|2|||
124826820|NCT00249444|448995104|FG001|Overall Study|Lost to Follow-up|2|||
124826821|NCT00249444|448995103|FG000|Overall Study|non-compliant|9|||
124826822|NCT00249444|448995104|FG001|Overall Study|non-compliant|11|||
124826823|NCT00249444|448995103|FG000|Overall Study|Adverse Event|1|||
124826824|NCT00249444|448995104|FG001|Overall Study|Adverse Event|1|||
124826825|NCT00249444|448995103|FG000|Overall Study|life event|0|||
124826826|NCT00249444|448995104|FG001|Overall Study|life event|1|||
124826827|NCT00082355|448995105|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
124826828|NCT00082355|448995105|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
124826829|NCT00082355|448995105|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
124826830|NCT00936910|448995109|FG000|Overall Study|Lack of Efficacy|3|||
124826831|NCT00412854|448995110|FG000|Overall Study|Withdrawn due to adverse events|1|||
124826832|NCT00412854|448995111|FG001|Overall Study|Withdrawn due to adverse events|5|||
124826833|NCT00412854|448995110|FG000|Overall Study|Withdrawn for other reasons|13|||
124826834|NCT00412854|448995111|FG001|Overall Study|Withdrawn for other reasons|11|||
124826835|NCT04483011|448995115|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
124826836|NCT04483011|448995116|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
124826837|NCT03518073|448995117|FG000|Overall Study|Adverse Event|2|||
124826838|NCT03518073|448995118|FG001|Overall Study|Adverse Event|4|||
124826839|NCT03518073|448995119|FG002|Overall Study|Adverse Event|2|||
124826840|NCT03518073|448995117|FG000|Overall Study|Death|2|||
124826841|NCT03518073|448995118|FG001|Overall Study|Death|1|||
124826842|NCT03518073|448995119|FG002|Overall Study|Death|3|||
124826843|NCT03518073|448995117|FG000|Overall Study|Lost to Follow-up|1|||
124826844|NCT03518073|448995118|FG001|Overall Study|Lost to Follow-up|0|||
124826845|NCT03518073|448995119|FG002|Overall Study|Lost to Follow-up|1|||
124826846|NCT03518073|448995117|FG000|Overall Study|Physician Decision|5|||
124826847|NCT03518073|448995118|FG001|Overall Study|Physician Decision|0|||
124826848|NCT03518073|448995119|FG002|Overall Study|Physician Decision|2|||
124826849|NCT03518073|448995117|FG000|Overall Study|Progressive disease|1|||
124826850|NCT03518073|448995118|FG001|Overall Study|Progressive disease|1|||
124826851|NCT03518073|448995119|FG002|Overall Study|Progressive disease|1|||
124826852|NCT03518073|448995117|FG000|Overall Study|Protocol Violation|1|||
124826853|NCT03518073|448995118|FG001|Overall Study|Protocol Violation|0|||
124826854|NCT03518073|448995119|FG002|Overall Study|Protocol Violation|0|||
124826855|NCT03518073|448995117|FG000|Overall Study|Withdrawal by Subject|30|||
124826856|NCT03518073|448995118|FG001|Overall Study|Withdrawal by Subject|34|||
124826857|NCT03518073|448995119|FG002|Overall Study|Withdrawal by Subject|29|||
124826858|NCT03518073|448995117|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
124826859|NCT03518073|448995118|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
124826860|NCT03518073|448995119|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
124826861|NCT03518073|448995117|FG000|Overall Study|Covid-19|1|||
124826862|NCT03518073|448995118|FG001|Overall Study|Covid-19|2|||
124826863|NCT03518073|448995119|FG002|Overall Study|Covid-19|1|||
124826864|NCT03045081|448995120|FG000|Overall Study|Withdrawal by Subject|6|||
124826865|NCT03045081|448995121|FG001|Overall Study|Withdrawal by Subject|11|||
124826866|NCT01485640|448995122|FG000|Overall Study|Adverse Event|10|||
124826867|NCT01485640|448995122|FG000|Overall Study|Lack of Efficacy|2|||
124826868|NCT01485640|448995122|FG000|Overall Study|Protocol Violation|1|||
124826869|NCT01485640|448995122|FG000|Overall Study|Withdrawal by Subject|14|||
124826870|NCT01485640|448995122|FG000|Overall Study|Terminated by Sponsor|95|||
124826871|NCT01853046|448995123|FG000|Overall Study|Withdrawal by Subject|1|||
124826872|NCT01853046|448995124|FG001|Overall Study|Withdrawal by Subject|1|||
124826873|NCT01853046|448995123|FG000|Overall Study|Adverse Event|4|||
124826874|NCT01853046|448995124|FG001|Overall Study|Adverse Event|2|||
124826875|NCT01853046|448995123|FG000|Overall Study|Disease progression|13|||
124826876|NCT01853046|448995124|FG001|Overall Study|Disease progression|3|||
124826877|NCT03020407|448995131|FG000|Overall Study|Withdrawal by Subject|2|||
124826878|NCT03020407|448995132|FG001|Overall Study|Withdrawal by Subject|1|||
124826879|NCT03020407|448995131|FG000|Overall Study|Lost to Follow-up|2|||
124826880|NCT03020407|448995132|FG001|Overall Study|Lost to Follow-up|3|||
124826881|NCT03020407|448995131|FG000|Overall Study|Protocol Violation|0|||
124826882|NCT03020407|448995132|FG001|Overall Study|Protocol Violation|1|||
124826883|NCT00708162|448995133|FG000|Randomized Phase|Randomized but Not Treated|7|||
124826884|NCT00708162|448995134|FG001|Randomized Phase|Randomized but Not Treated|5|||
124826885|NCT00708162|448995133|FG000|Randomized Phase|Participant Noncompliance|40|||
124826886|NCT00708162|448995134|FG001|Randomized Phase|Participant Noncompliance|32|||
124826887|NCT00708162|448995133|FG000|Randomized Phase|Lost to Follow-up|34|||
124826888|NCT00708162|448995134|FG001|Randomized Phase|Lost to Follow-up|34|||
124826889|NCT00708162|448995133|FG000|Randomized Phase|Withdrew Consent|31|||
124826890|NCT00708162|448995134|FG001|Randomized Phase|Withdrew Consent|22|||
124826891|NCT00708162|448995133|FG000|Randomized Phase|Lack of Efficacy|14|||
124826892|NCT00708162|448995134|FG001|Randomized Phase|Lack of Efficacy|19|||
124826893|NCT00708162|448995133|FG000|Randomized Phase|Protocol Violation|10|||
124826894|NCT00708162|448995134|FG001|Randomized Phase|Protocol Violation|11|||
124826895|NCT00708162|448995133|FG000|Randomized Phase|Adverse Event|8|||
124826896|NCT00708162|448995134|FG001|Randomized Phase|Adverse Event|12|||
124826897|NCT00708162|448995133|FG000|Randomized Phase|Investigator's Discretion|7|||
124826898|NCT00708162|448995134|FG001|Randomized Phase|Investigator's Discretion|10|||
124826899|NCT00708162|448995133|FG000|Randomized Phase|Death|2|||
124826900|NCT00708162|448995134|FG001|Randomized Phase|Death|9|||
124826901|NCT00708162|448995133|FG000|Randomized Phase|Pregnancy|3|||
124826902|NCT00708162|448995134|FG001|Randomized Phase|Pregnancy|0|||
124826903|NCT00708162|448995133|FG000|Open-Label Phase|Lost to Follow-up|10|||
124826904|NCT00708162|448995134|FG001|Open-Label Phase|Lost to Follow-up|8|||
124826905|NCT00708162|448995133|FG000|Open-Label Phase|Withdrew Consent|12|||
124826906|NCT00708162|448995134|FG001|Open-Label Phase|Withdrew Consent|6|||
124638313|NCT00927862|448294398|FG000|Overall Study|Missing data needed for endpt analyses|27|||
124638314|NCT00927862|448294399|FG001|Overall Study|Missing data needed for endpt analyses|45|||
124638315|NCT00820248|448294401|FG000|Overall Study|No treated|4|||
124638316|NCT00820248|448294402|FG001|Overall Study|No treated|1|||
124826907|NCT00708162|448995133|FG000|Open-Label Phase|Participant Noncompliance|7|||
124826908|NCT00708162|448995134|FG001|Open-Label Phase|Participant Noncompliance|7|||
124638317|NCT04112043|448294403|FG000|Overall Study|Withdrawal by Subject|1|||
124826909|NCT00708162|448995133|FG000|Open-Label Phase|Lack of Efficacy|7|||
124826910|NCT00708162|448995134|FG001|Open-Label Phase|Lack of Efficacy|4|||
124826911|NCT00708162|448995133|FG000|Open-Label Phase|Investigator's Discretion|3|||
124826912|NCT00708162|448995134|FG001|Open-Label Phase|Investigator's Discretion|2|||
124826913|NCT00708162|448995133|FG000|Open-Label Phase|Death|3|||
124826914|NCT00708162|448995134|FG001|Open-Label Phase|Death|1|||
124826915|NCT00708162|448995133|FG000|Open-Label Phase|Adverse Event|1|||
124826916|NCT00708162|448995134|FG001|Open-Label Phase|Adverse Event|2|||
124826917|NCT00708162|448995133|FG000|Open-Label Phase|Other|1|||
124826918|NCT00708162|448995134|FG001|Open-Label Phase|Other|0|||
124826919|NCT02699554|448995135|FG000|Overall Study|Lost to Follow-up|9|||
124826920|NCT00708643|448995136|FG000|Overall Study|Adverse Event|0|||
124826921|NCT00708643|448995137|FG001|Overall Study|Adverse Event|1|||
124826922|NCT00065507|448995138|FG000|Overall Study|Death|16|||
124826923|NCT00065507|448995139|FG001|Overall Study|Death|17|||
124826924|NCT00065507|448995138|FG000|Overall Study|Adverse Event|4|||
124826925|NCT00065507|448995139|FG001|Overall Study|Adverse Event|3|||
124826926|NCT00065507|448995138|FG000|Overall Study|Lack of Efficacy|0|||
124826927|NCT00065507|448995139|FG001|Overall Study|Lack of Efficacy|6|||
124826928|NCT00065507|448995138|FG000|Overall Study|Poor/Non-compliance|3|||
124826929|NCT00065507|448995139|FG001|Overall Study|Poor/Non-compliance|2|||
124826930|NCT00065507|448995138|FG000|Overall Study|Lost to Follow-up|3|||
124826931|NCT00065507|448995139|FG001|Overall Study|Lost to Follow-up|0|||
124826932|NCT00065507|448995138|FG000|Overall Study|Subject Withdrew Consent|2|||
124826933|NCT00065507|448995139|FG001|Overall Study|Subject Withdrew Consent|1|||
124826934|NCT00065507|448995138|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
124826935|NCT00065507|448995139|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
124826936|NCT03635957|448995140|FG000|Run-In Period|Lost to Follow-up|1|||
124826937|NCT03635957|448995140|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
124826938|NCT00350636|448995141|FG000|Overall Study|Adverse Event|19|||
124826939|NCT00350636|448995142|FG001|Overall Study|Adverse Event|13|||
124826940|NCT00350636|448995141|FG000|Overall Study|Protocol Violation|1|||
124826941|NCT00350636|448995142|FG001|Overall Study|Protocol Violation|3|||
124826942|NCT00350636|448995141|FG000|Overall Study|Withdrawal by Subject|13|||
124826943|NCT00350636|448995142|FG001|Overall Study|Withdrawal by Subject|17|||
124826944|NCT00350636|448995141|FG000|Overall Study|Lost to Follow-up|9|||
124826945|NCT00350636|448995142|FG001|Overall Study|Lost to Follow-up|8|||
124826946|NCT00350636|448995141|FG000|Overall Study|Physician Decision|0|||
124826947|NCT00350636|448995142|FG001|Overall Study|Physician Decision|2|||
124826948|NCT00350636|448995141|FG000|Overall Study|Other|1|||
124826949|NCT00350636|448995142|FG001|Overall Study|Other|2|||
124826950|NCT01525550|448995143|FG000|Overall Study|Lost to Follow-up|8|||
124826951|NCT01525550|448995144|FG001|Overall Study|Lost to Follow-up|2|||
124826952|NCT01525550|448995143|FG000|Overall Study|Death|19|||
124826953|NCT01525550|448995144|FG001|Overall Study|Death|28|||
124826954|NCT01525550|448995143|FG000|Overall Study|Other|0|||
124826955|NCT01525550|448995144|FG001|Overall Study|Other|4|||
124826956|NCT01525550|448995143|FG000|Overall Study|Sponsor's Decision|30|||
124826957|NCT01525550|448995144|FG001|Overall Study|Sponsor's Decision|11|||
124826958|NCT01525550|448995143|FG000|Overall Study|Withdrawal by Subject|4|||
124826959|NCT01525550|448995144|FG001|Overall Study|Withdrawal by Subject|0|||
124826960|NCT04577118|448995149|FG000|Overall Study|Withdrawal by Subject|4|||
124826961|NCT03108027|448995153|FG000|Period 1|Subject/Guardian Decision|0|||
124826962|NCT03108027|448995154|FG001|Period 1|Subject/Guardian Decision|0|||
124826963|NCT03108027|448995155|FG002|Period 1|Subject/Guardian Decision|0|||
124638318|NCT04112043|448294404|FG001|Overall Study|Withdrawal by Subject|1|||
124638319|NCT04112043|448294405|FG002|Overall Study|Withdrawal by Subject|1|||
124638320|NCT04112043|448294403|FG000|Overall Study|Taking NR supplement|1|||
124638321|NCT04112043|448294404|FG001|Overall Study|Taking NR supplement|0|||
124638322|NCT04112043|448294405|FG002|Overall Study|Taking NR supplement|0|||
124638323|NCT04112043|448294403|FG000|Overall Study|Adverse Event|0|||
124638324|NCT04112043|448294404|FG001|Overall Study|Adverse Event|1|||
124638325|NCT04112043|448294405|FG002|Overall Study|Adverse Event|0|||
124638326|NCT02237196|448294406|FG000|Overall Study|Adverse Event|0|||
124638327|NCT02237196|448294407|FG001|Overall Study|Adverse Event|1|||
124638328|NCT02237196|448294408|FG002|Overall Study|Adverse Event|1|||
124638329|NCT02237196|448294409|FG003|Overall Study|Adverse Event|0|||
124638330|NCT02237196|448294406|FG000|Overall Study|Lost to Follow-up|4|||
124638331|NCT02237196|448294407|FG001|Overall Study|Lost to Follow-up|2|||
124638332|NCT02237196|448294408|FG002|Overall Study|Lost to Follow-up|4|||
124638333|NCT02237196|448294409|FG003|Overall Study|Lost to Follow-up|6|||
124638334|NCT02237196|448294406|FG000|Overall Study|Physician Decision|2|||
124638335|NCT02237196|448294407|FG001|Overall Study|Physician Decision|0|||
124638336|NCT02237196|448294408|FG002|Overall Study|Physician Decision|0|||
124638337|NCT02237196|448294409|FG003|Overall Study|Physician Decision|1|||
124638338|NCT02237196|448294406|FG000|Overall Study|Pregnancy|0|||
124638339|NCT02237196|448294407|FG001|Overall Study|Pregnancy|0|||
124638340|NCT02237196|448294408|FG002|Overall Study|Pregnancy|1|||
124638341|NCT02237196|448294409|FG003|Overall Study|Pregnancy|1|||
124826964|NCT03108027|448995156|FG003|Period 1|Subject/Guardian Decision|2|||
124826965|NCT03108027|448995157|FG004|Period 1|Subject/Guardian Decision|0|||
124826966|NCT03108027|448995158|FG005|Period 1|Subject/Guardian Decision|0|||
124826967|NCT03108027|448995153|FG000|Period 3|Adverse Event|0|||
124826968|NCT03108027|448995154|FG001|Period 3|Adverse Event|1|||
124826969|NCT03108027|448995155|FG002|Period 3|Adverse Event|0|||
124826970|NCT03108027|448995156|FG003|Period 3|Adverse Event|0|||
124826971|NCT03108027|448995157|FG004|Period 3|Adverse Event|0|||
124826972|NCT03108027|448995158|FG005|Period 3|Adverse Event|0|||
124826973|NCT00268996|448995159|FG000|Overall Study|Adverse Event|11|||
124826974|NCT00268996|448995160|FG001|Overall Study|Adverse Event|7|||
124826975|NCT00268996|448995159|FG000|Overall Study|Lost to Follow-up|3|||
124826976|NCT00268996|448995160|FG001|Overall Study|Lost to Follow-up|1|||
124826977|NCT00268996|448995159|FG000|Overall Study|Withdrawal by Subject|5|||
124826978|NCT00268996|448995160|FG001|Overall Study|Withdrawal by Subject|11|||
124826979|NCT00268996|448995159|FG000|Overall Study|Non-compliance|1|||
124826980|NCT00268996|448995160|FG001|Overall Study|Non-compliance|0|||
124826981|NCT00268996|448995159|FG000|Overall Study|Other|1|||
124826982|NCT00268996|448995160|FG001|Overall Study|Other|1|||
124826983|NCT02763189|448995163|FG000|Overall Study|Device failure|0|||
124826984|NCT02763189|448995164|FG001|Overall Study|Device failure|2|||
124826985|NCT04900220|448995166|FG000|Overall Study|Lost to Follow-up|1|||
124826986|NCT04900220|448995167|FG001|Overall Study|Lost to Follow-up|1|||
124826987|NCT01214629|448995168|FG000|Overall Study|Progressive Disease|1|||
124826988|NCT01214629|448995169|FG001|Overall Study|Progressive Disease|1|||
124826989|NCT01214629|448995170|FG002|Overall Study|Progressive Disease|0|||
124826990|NCT01214629|448995171|FG003|Overall Study|Progressive Disease|1|||
124826991|NCT01214629|448995172|FG004|Overall Study|Progressive Disease|2|||
124826992|NCT01214629|448995173|FG005|Overall Study|Progressive Disease|3|||
124826993|NCT01214629|448995174|FG006|Overall Study|Progressive Disease|1|||
124826994|NCT01214629|448995175|FG007|Overall Study|Progressive Disease|1|||
124826995|NCT01214629|448995176|FG008|Overall Study|Progressive Disease|1|||
124826996|NCT01214629|448995177|FG009|Overall Study|Progressive Disease|5|||
124826997|NCT01214629|448995178|FG010|Overall Study|Progressive Disease|1|||
124826998|NCT01214629|448995168|FG000|Overall Study|Adverse Event|0|||
124826999|NCT01214629|448995169|FG001|Overall Study|Adverse Event|0|||
124827000|NCT01214629|448995170|FG002|Overall Study|Adverse Event|0|||
124827001|NCT01214629|448995171|FG003|Overall Study|Adverse Event|1|||
124827002|NCT01214629|448995172|FG004|Overall Study|Adverse Event|0|||
124827003|NCT01214629|448995173|FG005|Overall Study|Adverse Event|1|||
124827004|NCT01214629|448995174|FG006|Overall Study|Adverse Event|0|||
124827005|NCT01214629|448995175|FG007|Overall Study|Adverse Event|0|||
124827006|NCT01214629|448995176|FG008|Overall Study|Adverse Event|0|||
124827007|NCT01214629|448995177|FG009|Overall Study|Adverse Event|1|||
124827008|NCT01214629|448995178|FG010|Overall Study|Adverse Event|0|||
124827009|NCT01214629|448995168|FG000|Overall Study|Physician Decision|0|||
124827010|NCT01214629|448995169|FG001|Overall Study|Physician Decision|0|||
124827011|NCT01214629|448995170|FG002|Overall Study|Physician Decision|0|||
124827012|NCT01214629|448995171|FG003|Overall Study|Physician Decision|0|||
124827013|NCT01214629|448995172|FG004|Overall Study|Physician Decision|0|||
124827014|NCT01214629|448995173|FG005|Overall Study|Physician Decision|0|||
124827015|NCT01214629|448995174|FG006|Overall Study|Physician Decision|0|||
124827016|NCT01214629|448995175|FG007|Overall Study|Physician Decision|0|||
124827017|NCT01214629|448995176|FG008|Overall Study|Physician Decision|0|||
124827018|NCT01214629|448995177|FG009|Overall Study|Physician Decision|0|||
124827019|NCT01214629|448995178|FG010|Overall Study|Physician Decision|1|||
124827020|NCT01214629|448995168|FG000|Overall Study|Withdrawal by Subject|0|||
124827021|NCT01214629|448995169|FG001|Overall Study|Withdrawal by Subject|0|||
124827022|NCT01214629|448995170|FG002|Overall Study|Withdrawal by Subject|0|||
124827023|NCT01214629|448995171|FG003|Overall Study|Withdrawal by Subject|0|||
124827024|NCT01214629|448995172|FG004|Overall Study|Withdrawal by Subject|0|||
124827025|NCT01214629|448995173|FG005|Overall Study|Withdrawal by Subject|0|||
124827026|NCT01214629|448995174|FG006|Overall Study|Withdrawal by Subject|0|||
124827027|NCT01214629|448995175|FG007|Overall Study|Withdrawal by Subject|0|||
124827028|NCT01214629|448995176|FG008|Overall Study|Withdrawal by Subject|0|||
124827029|NCT01214629|448995177|FG009|Overall Study|Withdrawal by Subject|1|||
124827030|NCT01214629|448995178|FG010|Overall Study|Withdrawal by Subject|0|||
124827031|NCT00576927|448995179|FG000|Clinical Assessment|Lack of Efficacy|24|||
124827032|NCT00576927|448995179|FG000|Clinical Assessment|Death|1|||
124827033|NCT00576927|448995179|FG000|Clinical Assessment|Withdrawal by Subject|10|||
124827034|NCT00576927|448995179|FG000|Clinical Assessment|Physician Decision|1|||
124827035|NCT00576927|448995179|FG000|Baseline|Physician Decision|9|||
124827036|NCT00576927|448995179|FG000|Baseline|Medication Change by PCP of subject|1|||
124827037|NCT00576927|448995179|FG000|Baseline|Withdrawal by Subject|3|||
124827038|NCT00576927|448995179|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
124827039|NCT00576927|448995179|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
124827040|NCT00576927|448995179|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
124827041|NCT00576927|448995179|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
124827042|NCT00576927|448995179|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
124638342|NCT02237196|448294406|FG000|Overall Study|Withdrawal by Subject|1|||
124827043|NCT03266094|448995180|FG000|Overall Study|Lost to Follow-up|1|||
124827044|NCT03266094|448995180|FG000|Overall Study|Withdrawal by Subject|1|||
124827045|NCT03171415|448995181|FG000|Overall Study|Lost to Follow-up|0|||
124827046|NCT03171415|448995182|FG001|Overall Study|Lost to Follow-up|0|||
124827047|NCT03171415|448995183|FG002|Overall Study|Lost to Follow-up|0|||
124827048|NCT03171415|448995184|FG003|Overall Study|Lost to Follow-up|0|||
124827049|NCT03171415|448995185|FG004|Overall Study|Lost to Follow-up|2|||
124827050|NCT03715764|448995186|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
124827051|NCT03715764|448995187|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
124827052|NCT03715764|448995186|FG000|3 Month Follow-up|Lost to Follow-up|2|||
124827053|NCT03715764|448995187|FG001|3 Month Follow-up|Lost to Follow-up|2|||
124827054|NCT03715764|448995186|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
124827055|NCT03715764|448995187|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
124827056|NCT03715764|448995186|FG000|6 Month Follow-up|Lost to Follow-up|3|||
124827057|NCT03715764|448995187|FG001|6 Month Follow-up|Lost to Follow-up|0|||
124827058|NCT03715764|448995186|FG000|12 Month Follow-up|Lost to Follow-up|2|||
124827059|NCT03715764|448995187|FG001|12 Month Follow-up|Lost to Follow-up|3|||
124827060|NCT03715764|448995186|FG000|12 Month Follow-up|Pregnancy|0|||
124827061|NCT03715764|448995187|FG001|12 Month Follow-up|Pregnancy|1|||
124827062|NCT03715764|448995186|FG000|12 Month Follow-up|Surgery|2|||
124827063|NCT03715764|448995187|FG001|12 Month Follow-up|Surgery|0|||
124827064|NCT03715764|448995186|FG000|12 Month Follow-up|Wrong address|1|||
124827065|NCT03715764|448995187|FG001|12 Month Follow-up|Wrong address|0|||
124827066|NCT03715764|448995186|FG000|12 Month Follow-up|No symptoms|1|||
124827067|NCT03715764|448995187|FG001|12 Month Follow-up|No symptoms|0|||
124827068|NCT03715764|448995186|FG000|12 Month Follow-up|Changed primary care centre|0|||
124827069|NCT03715764|448995187|FG001|12 Month Follow-up|Changed primary care centre|1|||
124827070|NCT01338493|448995190|FG000|Enrolled|Withdrawal by Subject|1|||
124827071|NCT01338493|448995190|FG000|Enrolled|Patient not implanted|4|||
124827072|NCT01338493|448995190|FG000|Discharge|Death|1|||
124827073|NCT01338493|448995190|FG000|Discharge|Missed visit|1|||
124827074|NCT01338493|448995190|FG000|6 Months Follow up|Lost to Follow-up|11|||
124827075|NCT01338493|448995190|FG000|6 Months Follow up|Missed visit|8|||
124827076|NCT01338493|448995190|FG000|12 Months Follow up|Lost to Follow-up|9|||
124827077|NCT01705652|448995191|FG000|Overall Study|Adverse Event|1|||
124827078|NCT01705652|448995192|FG001|Overall Study|Adverse Event|0|||
124827079|NCT01705652|448995191|FG000|Overall Study|Withdrawal by Subject|1|||
124827080|NCT01705652|448995192|FG001|Overall Study|Withdrawal by Subject|2|||
124827081|NCT01705652|448995191|FG000|Overall Study|non-compliance|1|||
124827082|NCT01705652|448995192|FG001|Overall Study|non-compliance|1|||
124827083|NCT00541034|448995193|FG000|Overall Study|Non-Compliance|3|||
124827084|NCT00656474|448995194|FG000|Overall Study|Other Reason|1|||
124827085|NCT01962207|448995195|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
124827086|NCT01962207|448995196|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
124827087|NCT01962207|448995197|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
124827088|NCT01962207|448995198|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
124827089|NCT01962207|448995195|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
124827090|NCT01962207|448995196|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
124827091|NCT01962207|448995197|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
124827092|NCT01962207|448995198|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
124827093|NCT01962207|448995195|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
124827094|NCT01962207|448995196|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
124827095|NCT01962207|448995197|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
124827096|NCT01962207|448995198|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
124827097|NCT01962207|448995195|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
124827098|NCT01962207|448995196|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
124827099|NCT01962207|448995197|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
124827100|NCT01962207|448995198|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
124827101|NCT01962207|448995195|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
124827102|NCT01962207|448995196|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
124827103|NCT01962207|448995197|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
124827104|NCT01962207|448995198|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
124827105|NCT01962207|448995195|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
124827106|NCT01962207|448995196|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
124827107|NCT01962207|448995197|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
124827108|NCT01962207|448995198|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
124827109|NCT02484729|448995199|FG000|Overall Study|Failure of IntelliCap Error|0|||
124827110|NCT02484729|448995200|FG001|Overall Study|Failure of IntelliCap Error|0|||
124827111|NCT02484729|448995201|FG002|Overall Study|Failure of IntelliCap Error|0|||
124827112|NCT02484729|448995202|FG003|Overall Study|Failure of IntelliCap Error|0|||
124827113|NCT02484729|448995203|FG004|Overall Study|Failure of IntelliCap Error|0|||
124827114|NCT02484729|448995204|FG005|Overall Study|Failure of IntelliCap Error|0|||
124827115|NCT02484729|448995205|FG006|Overall Study|Failure of IntelliCap Error|0|||
124827116|NCT02484729|448995206|FG007|Overall Study|Failure of IntelliCap Error|0|||
124827117|NCT02484729|448995207|FG008|Overall Study|Failure of IntelliCap Error|0|||
124827118|NCT02484729|448995208|FG009|Overall Study|Failure of IntelliCap Error|1|||
124827119|NCT01980875|448995211|FG000|Overall Study|Withdrew Consent|1|||
124827120|NCT01980875|448995212|FG001|Overall Study|Withdrew Consent|1|||
124827121|NCT01980875|448995213|FG002|Overall Study|Withdrew Consent|1|||
124827122|NCT01980875|448995211|FG000|Overall Study|Study Terminated by Sponsor|7|||
124827123|NCT01980875|448995212|FG001|Overall Study|Study Terminated by Sponsor|24|||
124638343|NCT02237196|448294407|FG001|Overall Study|Withdrawal by Subject|1|||
124827124|NCT01980875|448995213|FG002|Overall Study|Study Terminated by Sponsor|22|||
124827125|NCT01980875|448995211|FG000|Overall Study|Lost to Follow-up|0|||
124827126|NCT01980875|448995212|FG001|Overall Study|Lost to Follow-up|0|||
124827127|NCT01980875|448995213|FG002|Overall Study|Lost to Follow-up|1|||
124827128|NCT02625259|448995214|FG000|First Intervention (Day 1)|Other|0|||
124827129|NCT02625259|448995215|FG001|First Intervention (Day 1)|Other|0|||
124827130|NCT02625259|448995216|FG002|First Intervention (Day 1)|Other|1|||
124827131|NCT02625259|448995217|FG003|First Intervention (Day 1)|Other|0|||
124827132|NCT02625259|448995218|FG004|First Intervention (Day 1)|Other|0|||
124827133|NCT02625259|448995214|FG000|First Intervention (Day 1)|Adverse Event|2|||
124827134|NCT02625259|448995215|FG001|First Intervention (Day 1)|Adverse Event|1|||
124827135|NCT02625259|448995216|FG002|First Intervention (Day 1)|Adverse Event|0|||
124827136|NCT02625259|448995217|FG003|First Intervention (Day 1)|Adverse Event|0|||
124827137|NCT02625259|448995218|FG004|First Intervention (Day 1)|Adverse Event|0|||
124827138|NCT02625259|448995214|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
124638344|NCT02237196|448294408|FG002|Overall Study|Withdrawal by Subject|4|||
124638345|NCT02237196|448294409|FG003|Overall Study|Withdrawal by Subject|1|||
124638346|NCT02237196|448294406|FG000|Overall Study|Site Error|1|||
124638347|NCT02237196|448294407|FG001|Overall Study|Site Error|2|||
124638348|NCT02237196|448294408|FG002|Overall Study|Site Error|0|||
124638349|NCT02237196|448294409|FG003|Overall Study|Site Error|2|||
124638350|NCT01750697|448294412|FG000|Overall Study|Transferred Back to Local Hospital|1|||
124638351|NCT01750697|448294412|FG000|Overall Study|Physician and Family Decision|1|||
124638352|NCT01750697|448294412|FG000|Overall Study|Transferred to Adult Services|5|||
124638353|NCT01750697|448294412|FG000|Overall Study|Physician Decision|1|||
124638354|NCT01750697|448294412|FG000|Overall Study|Withdrawal by Subject|1|||
124638355|NCT03674112|448294418|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
124638356|NCT03674112|448294419|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
124638357|NCT03674112|448294418|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
124638358|NCT03674112|448294419|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
124638359|NCT03674112|448294418|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
124638360|NCT03674112|448294419|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
124638361|NCT03674112|448294418|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
124638362|NCT03674112|448294419|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
124638363|NCT03674112|448294418|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
124638364|NCT03674112|448294419|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
124638365|NCT03674112|448294418|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
124638366|NCT03674112|448294419|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
124638367|NCT03674112|448294418|FG000|Follow-Up Period (≥3 Years)|Death|2|||
124638368|NCT03674112|448294419|FG001|Follow-Up Period (≥3 Years)|Death|0|||
124638369|NCT03674112|448294418|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
124638370|NCT03674112|448294419|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
124638371|NCT00862823|448294420|FG000|First Intervention|Withdrawal by Subject|1|||
124638372|NCT00862823|448294421|FG001|First Intervention|Withdrawal by Subject|1|||
124638373|NCT01421225|448294428|FG000|Overall Study|Withdrawal by Subject|0|||
124638374|NCT01421225|448294429|FG001|Overall Study|Withdrawal by Subject|1|||
124638375|NCT02527434|448294430|FG000|Overall Study|Lost to Follow-up|2|||
124638376|NCT02527434|448294431|FG001|Overall Study|Lost to Follow-up|2|||
124638377|NCT02527434|448294432|FG002|Overall Study|Lost to Follow-up|0|||
124638378|NCT02527434|448294430|FG000|Overall Study|Death|19|||
124638379|NCT02527434|448294431|FG001|Overall Study|Death|6|||
124638380|NCT02527434|448294432|FG002|Overall Study|Death|17|||
124638381|NCT02527434|448294430|FG000|Overall Study|Withdrawal by Subject|5|||
124638382|NCT02527434|448294431|FG001|Overall Study|Withdrawal by Subject|3|||
124638383|NCT02527434|448294432|FG002|Overall Study|Withdrawal by Subject|3|||
124638384|NCT02527434|448294430|FG000|Overall Study|Reason Not Specified|1|||
124638385|NCT02527434|448294431|FG001|Overall Study|Reason Not Specified|0|||
124638386|NCT02527434|448294432|FG002|Overall Study|Reason Not Specified|0|||
124638387|NCT02527434|448294430|FG000|Overall Study|Site closure|1|||
124638388|NCT02527434|448294431|FG001|Overall Study|Site closure|0|||
124638389|NCT02527434|448294432|FG002|Overall Study|Site closure|0|||
124638390|NCT01322490|448294433|FG000|Treatment Period|Adverse Event|12|||
124638391|NCT01322490|448294434|FG001|Treatment Period|Adverse Event|18|||
124638392|NCT01322490|448294435|FG002|Treatment Period|Adverse Event|15|||
124638393|NCT01322490|448294433|FG000|Treatment Period|Death|5|||
124638394|NCT01322490|448294434|FG001|Treatment Period|Death|7|||
124638395|NCT01322490|448294435|FG002|Treatment Period|Death|3|||
124638396|NCT01322490|448294433|FG000|Treatment Period|Lack of Efficacy|89|||
124638397|NCT01322490|448294434|FG001|Treatment Period|Lack of Efficacy|100|||
124827139|NCT02625259|448995215|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
124827140|NCT02625259|448995216|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
124827141|NCT02625259|448995217|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
124827142|NCT02625259|448995218|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
124827143|NCT00665847|448995219|FG000|Overall Study|Adverse Event|8|||
124638398|NCT01322490|448294435|FG002|Treatment Period|Lack of Efficacy|112|||
124638399|NCT01322490|448294433|FG000|Treatment Period|Physician Decision|0|||
124638400|NCT01322490|448294434|FG001|Treatment Period|Physician Decision|2|||
124638401|NCT01322490|448294435|FG002|Treatment Period|Physician Decision|1|||
124638402|NCT01322490|448294433|FG000|Treatment Period|Protocol Violation|7|||
124827144|NCT00665847|448995219|FG000|Overall Study|Withdrawal by Subject|2|||
124827145|NCT00665847|448995219|FG000|Overall Study|Subject non-compliant|8|||
124827146|NCT00665847|448995219|FG000|Overall Study|Subject reached a virologic endpoint|4|||
124827147|NCT00665847|448995219|FG000|Overall Study|Resistance to TMC125|1|||
124827148|NCT00665847|448995219|FG000|Overall Study|Subject ineligible to continue the trial|1|||
124827149|NCT00665847|448995219|FG000|Overall Study|Switch to Commercial Medication|1|||
124827150|NCT00492115|448995226|FG000|Overall Study|Withdrawal by Subject|3|||
124827151|NCT00492115|448995227|FG001|Overall Study|Withdrawal by Subject|4|||
124827152|NCT03564145|448995228|FG000|Overall Study|Adverse Event|4|||
124827153|NCT03564145|448995228|FG000|Overall Study|Lost to Follow-up|21|||
124827154|NCT03564145|448995228|FG000|Overall Study|Protocol Violation|2|||
124827155|NCT03564145|448995228|FG000|Overall Study|Withdrawal by Subject|48|||
124827156|NCT03564145|448995228|FG000|Overall Study|Study Terminated by Sponsor|146|||
124827157|NCT03564145|448995228|FG000|Overall Study|Physician Decision|1|||
124827158|NCT03564145|448995228|FG000|Overall Study|Other Than Specified|1|||
124827159|NCT03564145|448995228|FG000|Overall Study|Pregnancy|1|||
124827160|NCT02663674|448995231|FG000|Overall Study|Lost to Follow-up|5|||
124827161|NCT02663674|448995232|FG001|Overall Study|Lost to Follow-up|4|||
124827162|NCT02663674|448995231|FG000|Overall Study|Withdrawal by Subject|1|||
124827163|NCT02663674|448995232|FG001|Overall Study|Withdrawal by Subject|4|||
124827164|NCT02663674|448995231|FG000|Overall Study|Physician Decision|1|||
124827165|NCT02663674|448995232|FG001|Overall Study|Physician Decision|1|||
124827166|NCT02663674|448995231|FG000|Overall Study|Other Event (Health Related)|0|||
124827167|NCT02663674|448995232|FG001|Overall Study|Other Event (Health Related)|1|||
124827168|NCT01031069|448995233|FG000|Overall Study|Serious Adverse Event|0|||
124827169|NCT01031069|448995234|FG001|Overall Study|Serious Adverse Event|1|||
124827170|NCT01031069|448995235|FG002|Overall Study|Serious Adverse Event|0|||
124827171|NCT01031069|448995236|FG003|Overall Study|Serious Adverse Event|0|||
124827172|NCT01031069|448995233|FG000|Overall Study|Withdrawal by Subject|2|||
124827173|NCT01031069|448995234|FG001|Overall Study|Withdrawal by Subject|3|||
124827174|NCT01031069|448995235|FG002|Overall Study|Withdrawal by Subject|18|||
124827175|NCT01031069|448995236|FG003|Overall Study|Withdrawal by Subject|18|||
124827176|NCT01031069|448995233|FG000|Overall Study|Migrated/moved from study area|1|||
124827177|NCT01031069|448995234|FG001|Overall Study|Migrated/moved from study area|2|||
124827178|NCT01031069|448995235|FG002|Overall Study|Migrated/moved from study area|1|||
124827179|NCT01031069|448995236|FG003|Overall Study|Migrated/moved from study area|1|||
124827180|NCT01031069|448995233|FG000|Overall Study|Lost to Follow-up|9|||
124827181|NCT01031069|448995234|FG001|Overall Study|Lost to Follow-up|5|||
124827182|NCT01031069|448995235|FG002|Overall Study|Lost to Follow-up|21|||
124827183|NCT01031069|448995236|FG003|Overall Study|Lost to Follow-up|15|||
124827184|NCT01031069|448995233|FG000|Overall Study|Other|0|||
124827185|NCT01031069|448995234|FG001|Overall Study|Other|0|||
124827186|NCT01031069|448995235|FG002|Overall Study|Other|1|||
124827187|NCT01031069|448995236|FG003|Overall Study|Other|0|||
124827188|NCT05286307|448995237|FG000|Overall Study|Incomplete outcome assessments|2|||
124827189|NCT05286307|448995238|FG001|Overall Study|Incomplete outcome assessments|1|||
124827190|NCT05286307|448995237|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
124827191|NCT05286307|448995238|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
124827192|NCT05286307|448995237|FG000|Overall Study|Lost to follow up at 6 months|25|||
124827193|NCT05286307|448995238|FG001|Overall Study|Lost to follow up at 6 months|35|||
124827194|NCT05286307|448995237|FG000|Overall Study|Study medication not available|1|||
124827195|NCT05286307|448995238|FG001|Overall Study|Study medication not available|1|||
124827196|NCT01103284|448995239|FG000|Overall Study|Death|2|||
124827197|NCT01103284|448995240|FG001|Overall Study|Death|0|||
124827198|NCT01103284|448995239|FG000|Overall Study|Lost to Follow-up|9|||
124827199|NCT01103284|448995240|FG001|Overall Study|Lost to Follow-up|10|||
124827200|NCT01103284|448995239|FG000|Overall Study|Pregnancy|3|||
124827201|NCT01103284|448995240|FG001|Overall Study|Pregnancy|1|||
124827202|NCT01103284|448995239|FG000|Overall Study|Protocol Violation|12|||
124827203|NCT01103284|448995240|FG001|Overall Study|Protocol Violation|5|||
124638403|NCT01322490|448294434|FG001|Treatment Period|Protocol Violation|5|||
124638404|NCT01322490|448294435|FG002|Treatment Period|Protocol Violation|4|||
124827204|NCT01103284|448995239|FG000|Overall Study|Adverse Event|0|||
124827205|NCT01103284|448995240|FG001|Overall Study|Adverse Event|5|||
124827206|NCT01103284|448995239|FG000|Overall Study|Withdrawal by Subject|14|||
124827207|NCT01103284|448995240|FG001|Overall Study|Withdrawal by Subject|18|||
124827208|NCT01103284|448995239|FG000|Overall Study|Dermal Hypersensitivity|0|||
124827209|NCT01103284|448995240|FG001|Overall Study|Dermal Hypersensitivity|1|||
124827210|NCT01103284|448995239|FG000|Overall Study|Termination by the Sponsor|0|||
124827211|NCT01103284|448995240|FG001|Overall Study|Termination by the Sponsor|1|||
124827212|NCT01103284|448995239|FG000|Overall Study|Not described|2|||
124827213|NCT01103284|448995240|FG001|Overall Study|Not described|1|||
124827214|NCT01103284|448995239|FG000|Overall Study|Missing CRF entries for study completion|0|||
124827215|NCT01103284|448995240|FG001|Overall Study|Missing CRF entries for study completion|2|||
124827216|NCT02057198|448996792|FG000|Overall Study|Death|0|||
124827217|NCT02057198|448996793|FG001|Overall Study|Death|0|||
124827218|NCT02057198|448996794|FG002|Overall Study|Death|1|||
124827219|NCT02057198|448996792|FG000|Overall Study|Discharged early; lost to followup|0|||
124827220|NCT02057198|448996793|FG001|Overall Study|Discharged early; lost to followup|1|||
124827221|NCT02057198|448996794|FG002|Overall Study|Discharged early; lost to followup|0|||
124827222|NCT01042236|448996801|FG000|Treatment Period 1|Adverse Event|0|||
124827223|NCT01042236|448996802|FG001|Treatment Period 1|Adverse Event|1|||
124827224|NCT01042236|448996803|FG002|Treatment Period 1|Adverse Event|0|||
124827225|NCT01042236|448996804|FG003|Treatment Period 1|Adverse Event|0|||
124827226|NCT01042236|448996805|FG004|Treatment Period 1|Adverse Event|1|||
124827227|NCT01042236|448996806|FG005|Treatment Period 1|Adverse Event|0|||
124827228|NCT01042236|448996801|FG000|Treatment Period 3|Adverse Event|0|||
124827229|NCT01042236|448996802|FG001|Treatment Period 3|Adverse Event|0|||
124827230|NCT01042236|448996803|FG002|Treatment Period 3|Adverse Event|0|||
124827231|NCT01042236|448996804|FG003|Treatment Period 3|Adverse Event|1|||
124827232|NCT01042236|448996805|FG004|Treatment Period 3|Adverse Event|0|||
124827233|NCT01042236|448996806|FG005|Treatment Period 3|Adverse Event|0|||
124827234|NCT01042236|448996801|FG000|Treatment Period 3|Protocol Violation|0|||
124827235|NCT01042236|448996802|FG001|Treatment Period 3|Protocol Violation|0|||
124827236|NCT01042236|448996803|FG002|Treatment Period 3|Protocol Violation|0|||
124827237|NCT01042236|448996804|FG003|Treatment Period 3|Protocol Violation|1|||
124827238|NCT01042236|448996805|FG004|Treatment Period 3|Protocol Violation|0|||
124827239|NCT01042236|448996806|FG005|Treatment Period 3|Protocol Violation|0|||
124827240|NCT00227903|448996809|FG000|Overall Study|Withdrawal by Subject|2|||
124827241|NCT00227903|448996810|FG001|Overall Study|Withdrawal by Subject|5|||
124827242|NCT00227903|448996809|FG000|Overall Study|Subject moved out of area|1|||
124827243|NCT00227903|448996810|FG001|Overall Study|Subject moved out of area|2|||
124827244|NCT00227903|448996809|FG000|Overall Study|Lost to Follow-up|1|||
124827245|NCT00227903|448996810|FG001|Overall Study|Lost to Follow-up|3|||
124827246|NCT00227903|448996809|FG000|Overall Study|Miscarriage|1|||
124827247|NCT00227903|448996810|FG001|Overall Study|Miscarriage|0|||
124827248|NCT01475331|448996811|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
124827249|NCT01475331|448996812|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
124827250|NCT01475331|448996811|FG000|Overall Study|excessive main duct communication|1|||
124827251|NCT01475331|448996812|FG001|Overall Study|excessive main duct communication|1|||
124827252|NCT01475331|448996811|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
124827253|NCT01475331|448996812|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
124827254|NCT01475331|448996811|FG000|Overall Study|Sign of malignancy during the procedure|2|||
124827255|NCT01475331|448996812|FG001|Overall Study|Sign of malignancy during the procedure|0|||
124827256|NCT01475331|448996811|FG000|Overall Study|cyst found to be prohibitively small|0|||
124827257|NCT01475331|448996812|FG001|Overall Study|cyst found to be prohibitively small|1|||
124827258|NCT02345811|448996814|FG000|First Intervention|Withdrawal by Subject|1|||
124827259|NCT02345811|448996815|FG001|First Intervention|Withdrawal by Subject|1|||
124827260|NCT02877082|448996816|FG000|Overall Study|Trial was closed early|5|||
124827261|NCT02489344|448996818|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
124827262|NCT02489344|448996818|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
124827263|NCT02489344|448996818|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
124827264|NCT02489344|448996818|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
124827265|NCT03480750|448996819|FG000|Overall Study|Withdrawal by Subject|0|||
124827266|NCT03480750|448996820|FG001|Overall Study|Withdrawal by Subject|1|||
124827267|NCT03480750|448996821|FG002|Overall Study|Withdrawal by Subject|0|||
124827268|NCT03480750|448996822|FG003|Overall Study|Withdrawal by Subject|0|||
124827269|NCT03480750|448996823|FG004|Overall Study|Withdrawal by Subject|0|||
124827270|NCT03480750|448996824|FG005|Overall Study|Withdrawal by Subject|0|||
124827271|NCT03480750|448996819|FG000|Overall Study|The interruption in Trientine shippment|0|||
124827272|NCT03480750|448996820|FG001|Overall Study|The interruption in Trientine shippment|0|||
124827273|NCT03480750|448996821|FG002|Overall Study|The interruption in Trientine shippment|0|||
124827274|NCT03480750|448996822|FG003|Overall Study|The interruption in Trientine shippment|0|||
124827275|NCT03480750|448996823|FG004|Overall Study|The interruption in Trientine shippment|0|||
124827276|NCT03480750|448996824|FG005|Overall Study|The interruption in Trientine shippment|1|||
124827277|NCT01132482|448996825|FG000|Overall Study|Adverse Event|1|||
124827278|NCT01132482|448996826|FG001|Overall Study|Adverse Event|0|||
124827279|NCT03683758|448996827|FG000|Overall Study|Non-study commitment conflict|1|||
124638405|NCT01322490|448294433|FG000|Treatment Period|Withdrawal by Subject|14|||
124638406|NCT01322490|448294434|FG001|Treatment Period|Withdrawal by Subject|16|||
124827280|NCT03683758|448996828|FG001|Overall Study|Non-study commitment conflict|3|||
124827281|NCT03683758|448996827|FG000|Overall Study|Illness preventing participation|1|||
124827282|NCT03683758|448996828|FG001|Overall Study|Illness preventing participation|0|||
124827283|NCT03683758|448996827|FG000|Overall Study|Adverse Event|1|||
124827284|NCT03683758|448996828|FG001|Overall Study|Adverse Event|0|||
124827285|NCT00723892|448996831|FG000|Overall Study|Participant not tracked|33|||
124827286|NCT00723892|448996832|FG001|Overall Study|Participant not tracked|35|||
124827287|NCT00723892|448996831|FG000|Overall Study|Virological criterion|24|||
124638407|NCT01322490|448294435|FG002|Treatment Period|Withdrawal by Subject|11|||
124827288|NCT00723892|448996832|FG001|Overall Study|Virological criterion|9|||
124827289|NCT00723892|448996831|FG000|Overall Study|Withdrawal by Subject|6|||
124827290|NCT00723892|448996832|FG001|Overall Study|Withdrawal by Subject|9|||
124827291|NCT00723892|448996831|FG000|Overall Study|End planned|11|||
124827292|NCT00723892|448996832|FG001|Overall Study|End planned|7|||
124827293|NCT00723892|448996831|FG000|Overall Study|Bad tolerance|5|||
124827294|NCT00723892|448996832|FG001|Overall Study|Bad tolerance|5|||
124827295|NCT00723892|448996831|FG000|Overall Study|Multiple reasons|17|||
124827296|NCT00723892|448996832|FG001|Overall Study|Multiple reasons|12|||
124827297|NCT00723892|448996831|FG000|Overall Study|Other|6|||
124827298|NCT00723892|448996832|FG001|Overall Study|Other|3|||
124827299|NCT00723892|448996831|FG000|Overall Study|Study end|1|||
124827300|NCT00723892|448996832|FG001|Overall Study|Study end|3|||
124827301|NCT00723892|448996831|FG000|Overall Study|Weight loss|1|||
124827302|NCT00723892|448996832|FG001|Overall Study|Weight loss|3|||
124827303|NCT00723892|448996831|FG000|Overall Study|Alcohol abuse|0|||
124827304|NCT00723892|448996832|FG001|Overall Study|Alcohol abuse|1|||
124827305|NCT00723892|448996831|FG000|Overall Study|Intercurrent infection|2|||
124827306|NCT00723892|448996832|FG001|Overall Study|Intercurrent infection|0|||
124827307|NCT00723892|448996831|FG000|Overall Study|Drug addiction|1|||
124827308|NCT00723892|448996832|FG001|Overall Study|Drug addiction|0|||
124827309|NCT01172847|448996835|FG000|Overall Study|Withdrawal by Subject|3|||
124827310|NCT01163279|448996836|FG000|Overall Study|Withdrawal by Subject|2|||
124827311|NCT01163279|448996837|FG001|Overall Study|Withdrawal by Subject|0|||
124827312|NCT02411292|448996839|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
124827313|NCT02411292|448996839|FG000|Overall Study|Death|2|||
124827314|NCT02411292|448996839|FG000|Overall Study|Lost to Follow-up|3|||
124827315|NCT02232425|448996842|FG000|Overall Study|Lost to Follow-up|6|||
124827316|NCT02232425|448996843|FG001|Overall Study|Lost to Follow-up|2|||
124827317|NCT02232425|448996842|FG000|Overall Study|Adverse Event|2|||
124827318|NCT02232425|448996843|FG001|Overall Study|Adverse Event|0|||
124827319|NCT02232425|448996842|FG000|Overall Study|Withdrawal by Subject|5|||
124827320|NCT02232425|448996843|FG001|Overall Study|Withdrawal by Subject|6|||
124827321|NCT02232425|448996842|FG000|Overall Study|Lack of Efficacy|1|||
124827322|NCT02232425|448996843|FG001|Overall Study|Lack of Efficacy|0|||
124827323|NCT00665353|448996844|FG000|Study Step 1|Adverse Event|1|||
124827324|NCT00665353|448996844|FG000|Study Step 1|Withdrawal by Subject|2|||
124827325|NCT00665353|448996844|FG000|Study Step 2|Lost to Follow-up|2|||
124827326|NCT00665353|448996844|FG000|Study Step 2|Lack of Efficacy|12|||
124827327|NCT01601626|448996845|FG000|Overall Study|Death|1|||
124827328|NCT01601626|448996846|FG001|Overall Study|Death|1|||
124827329|NCT01601626|448996847|FG002|Overall Study|Death|1|||
124827330|NCT01601626|448996845|FG000|Overall Study|Lost to Follow-up|1|||
124827331|NCT01601626|448996846|FG001|Overall Study|Lost to Follow-up|2|||
124827332|NCT01601626|448996847|FG002|Overall Study|Lost to Follow-up|0|||
124827333|NCT01601626|448996845|FG000|Overall Study|Unable to Get to Clinic|0|||
124827334|NCT01601626|448996846|FG001|Overall Study|Unable to Get to Clinic|1|||
124827335|NCT01601626|448996847|FG002|Overall Study|Unable to Get to Clinic|0|||
124827336|NCT01601626|448996845|FG000|Overall Study|Withdrawal by Subject|0|||
124827337|NCT01601626|448996846|FG001|Overall Study|Withdrawal by Subject|1|||
124827338|NCT01601626|448996847|FG002|Overall Study|Withdrawal by Subject|1|||
124827339|NCT01601626|448996845|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
124827340|NCT01601626|448996846|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
124827341|NCT01601626|448996847|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
124827342|NCT00498602|448996848|FG000|Overall Study|Death|0|||
124827343|NCT00498602|448996849|FG001|Overall Study|Death|0|||
124827344|NCT00498602|448996850|FG002|Overall Study|Death|0|||
124827345|NCT00498602|448996851|FG003|Overall Study|Death|0|||
124827346|NCT00498602|448996852|FG004|Overall Study|Death|0|||
124638408|NCT01322490|448294433|FG000|Treatment Period|Non-compliance with study drug|0|||
124638409|NCT01322490|448294434|FG001|Treatment Period|Non-compliance with study drug|0|||
124638410|NCT01322490|448294435|FG002|Treatment Period|Non-compliance with study drug|1|||
124827347|NCT00498602|448996853|FG005|Overall Study|Death|1|||
124827348|NCT00498602|448996854|FG006|Overall Study|Death|0|||
124827349|NCT00498602|448996848|FG000|Overall Study|Lack of Efficacy|1|||
124827350|NCT00498602|448996849|FG001|Overall Study|Lack of Efficacy|0|||
124827351|NCT00498602|448996850|FG002|Overall Study|Lack of Efficacy|0|||
124827352|NCT00498602|448996851|FG003|Overall Study|Lack of Efficacy|0|||
124827353|NCT00498602|448996852|FG004|Overall Study|Lack of Efficacy|0|||
124827354|NCT00498602|448996853|FG005|Overall Study|Lack of Efficacy|0|||
124827355|NCT00498602|448996854|FG006|Overall Study|Lack of Efficacy|0|||
124827356|NCT00498602|448996848|FG000|Overall Study|Lost to Follow-up|0|||
124827357|NCT00498602|448996849|FG001|Overall Study|Lost to Follow-up|2|||
124827358|NCT00498602|448996850|FG002|Overall Study|Lost to Follow-up|0|||
124827359|NCT00498602|448996851|FG003|Overall Study|Lost to Follow-up|2|||
124827360|NCT00498602|448996852|FG004|Overall Study|Lost to Follow-up|0|||
124827361|NCT00498602|448996853|FG005|Overall Study|Lost to Follow-up|0|||
124827362|NCT00498602|448996854|FG006|Overall Study|Lost to Follow-up|0|||
124827363|NCT00498602|448996848|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
124827364|NCT00498602|448996849|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
124827365|NCT00498602|448996850|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
124827366|NCT00498602|448996851|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
124827367|NCT00498602|448996852|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
124827368|NCT00498602|448996853|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
124827369|NCT00498602|448996854|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
124827370|NCT00498602|448996848|FG000|Overall Study|AE not related to Study Drug|1|||
124827371|NCT00498602|448996849|FG001|Overall Study|AE not related to Study Drug|3|||
124827372|NCT00498602|448996850|FG002|Overall Study|AE not related to Study Drug|0|||
124827373|NCT00498602|448996851|FG003|Overall Study|AE not related to Study Drug|0|||
124827374|NCT00498602|448996852|FG004|Overall Study|AE not related to Study Drug|2|||
124827375|NCT00498602|448996853|FG005|Overall Study|AE not related to Study Drug|2|||
124827376|NCT00498602|448996854|FG006|Overall Study|AE not related to Study Drug|1|||
124827377|NCT00498602|448996848|FG000|Overall Study|Caregiver Request|2|||
124827378|NCT00498602|448996849|FG001|Overall Study|Caregiver Request|2|||
124827379|NCT00498602|448996850|FG002|Overall Study|Caregiver Request|2|||
124827380|NCT00498602|448996851|FG003|Overall Study|Caregiver Request|0|||
124827381|NCT00498602|448996852|FG004|Overall Study|Caregiver Request|1|||
124827382|NCT00498602|448996853|FG005|Overall Study|Caregiver Request|2|||
124827383|NCT00498602|448996854|FG006|Overall Study|Caregiver Request|0|||
124827384|NCT00498602|448996848|FG000|Overall Study|Investigator Request|0|||
124827385|NCT00498602|448996849|FG001|Overall Study|Investigator Request|0|||
124827386|NCT00498602|448996850|FG002|Overall Study|Investigator Request|1|||
124827387|NCT00498602|448996851|FG003|Overall Study|Investigator Request|0|||
124827388|NCT00498602|448996852|FG004|Overall Study|Investigator Request|0|||
124827389|NCT00498602|448996853|FG005|Overall Study|Investigator Request|0|||
124827390|NCT00498602|448996854|FG006|Overall Study|Investigator Request|0|||
124827391|NCT00498602|448996848|FG000|Overall Study|Subject Request|3|||
124827392|NCT00498602|448996849|FG001|Overall Study|Subject Request|0|||
124827393|NCT00498602|448996850|FG002|Overall Study|Subject Request|1|||
124827394|NCT00498602|448996851|FG003|Overall Study|Subject Request|1|||
124827395|NCT00498602|448996852|FG004|Overall Study|Subject Request|1|||
124827396|NCT00498602|448996853|FG005|Overall Study|Subject Request|4|||
124827397|NCT00498602|448996854|FG006|Overall Study|Subject Request|1|||
124827398|NCT00498602|448996848|FG000|Overall Study|Other|2|||
124827399|NCT00498602|448996849|FG001|Overall Study|Other|3|||
124827400|NCT00498602|448996850|FG002|Overall Study|Other|1|||
124827401|NCT00498602|448996851|FG003|Overall Study|Other|0|||
124827402|NCT00498602|448996852|FG004|Overall Study|Other|0|||
124827403|NCT00498602|448996853|FG005|Overall Study|Other|3|||
124827404|NCT00498602|448996854|FG006|Overall Study|Other|0|||
124827405|NCT02632552|448996857|FG000|Overall Study|Lost to Follow-up|14|||
124827406|NCT02632552|448996858|FG001|Overall Study|Lost to Follow-up|8|||
124827407|NCT02632552|448996857|FG000|Overall Study|Withdrawal by Subject|2|||
124827408|NCT02632552|448996858|FG001|Overall Study|Withdrawal by Subject|0|||
124827409|NCT02632552|448996857|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
124827410|NCT02632552|448996858|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
124827411|NCT00546637|448996859|FG000|Overall Study|Adverse Event|46|||
124827412|NCT00546637|448996860|FG001|Overall Study|Adverse Event|20|||
124827413|NCT00546637|448996859|FG000|Overall Study|Lack of Efficacy|5|||
124827414|NCT00546637|448996860|FG001|Overall Study|Lack of Efficacy|5|||
124827415|NCT00546637|448996859|FG000|Overall Study|Lost to Follow-up|2|||
124827416|NCT00546637|448996860|FG001|Overall Study|Lost to Follow-up|2|||
124827417|NCT00546637|448996859|FG000|Overall Study|Other|10|||
124827418|NCT00546637|448996860|FG001|Overall Study|Other|12|||
124827419|NCT00546637|448996859|FG000|Overall Study|Withdrawal by Subject|7|||
124827420|NCT00546637|448996860|FG001|Overall Study|Withdrawal by Subject|9|||
124827421|NCT00546637|448996859|FG000|Overall Study|Randomized, but not treated|3|||
124827422|NCT00546637|448996860|FG001|Overall Study|Randomized, but not treated|1|||
124827423|NCT01074450|448996861|FG000|First Intervention|Emesis in Dosing Interval|0|||
124827424|NCT01074450|448996862|FG001|First Intervention|Emesis in Dosing Interval|2|||
124827425|NCT01074450|448996861|FG000|Second Intervention|Protocol Violation|1|||
124827426|NCT01074450|448996862|FG001|Second Intervention|Protocol Violation|0|||
124827427|NCT01074450|448996861|FG000|Second Intervention|Physician Decision|0|||
124827428|NCT01074450|448996862|FG001|Second Intervention|Physician Decision|1|||
124827429|NCT01846507|448996863|FG000|Overall Study|Lost to Follow-up|4|||
124827430|NCT01846507|448996863|FG000|Overall Study|Protocol Violation|1|||
124827431|NCT01846507|448996863|FG000|Overall Study|Missing data|2|||
124827432|NCT00450450|448996864|FG000|Overall Study|Death|1|||
124827433|NCT00450450|448996865|FG001|Overall Study|Death|3|||
124827434|NCT00450450|448996864|FG000|Overall Study|Relapse|2|||
124827435|NCT00450450|448996865|FG001|Overall Study|Relapse|0|||
124827436|NCT00450450|448996864|FG000|Overall Study|Missing Data|2|||
124827437|NCT00450450|448996865|FG001|Overall Study|Missing Data|0|||
124827438|NCT04984993|448996866|FG000|Overall Study|Withdrawal by Subject|8|||
124827439|NCT04984993|448996867|FG001|Overall Study|Withdrawal by Subject|2|||
124827440|NCT04984993|448996866|FG000|Overall Study|Lost to Follow-up|2|||
124827441|NCT04984993|448996867|FG001|Overall Study|Lost to Follow-up|2|||
124827442|NCT04984993|448996866|FG000|Overall Study|Both patients moved to another country|4|||
124827443|NCT04984993|448996867|FG001|Overall Study|Both patients moved to another country|0|||
124827444|NCT02865187|448996870|FG000|Overall Study|Lost to Follow-up|12|||
124827445|NCT02865187|448996871|FG001|Overall Study|Lost to Follow-up|7|||
124638411|NCT01322490|448294433|FG000|Treatment Period|Other per report|2|||
124638412|NCT01322490|448294434|FG001|Treatment Period|Other per report|2|||
124638413|NCT01322490|448294435|FG002|Treatment Period|Other per report|1|||
124638414|NCT01322490|448294433|FG000|Treatment Period|Randomized but Not Treated|3|||
124638415|NCT01322490|448294434|FG001|Treatment Period|Randomized but Not Treated|3|||
124638416|NCT01322490|448294435|FG002|Treatment Period|Randomized but Not Treated|5|||
124638417|NCT01322490|448294433|FG000|Long Term Follow-up Period|Death|235|||
124638418|NCT01322490|448294434|FG001|Long Term Follow-up Period|Death|239|||
124638419|NCT01322490|448294435|FG002|Long Term Follow-up Period|Death|236|||
124638420|NCT01322490|448294433|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
124638421|NCT01322490|448294434|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
124638422|NCT01322490|448294435|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
124638423|NCT01322490|448294433|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
124638424|NCT01322490|448294434|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
124638425|NCT01322490|448294435|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
124638426|NCT01322490|448294433|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
124638427|NCT01322490|448294434|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
124638428|NCT01322490|448294435|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
124638429|NCT01322490|448294433|FG000|Long Term Follow-up Period|Other per report|3|||
124638430|NCT01322490|448294434|FG001|Long Term Follow-up Period|Other per report|2|||
124638431|NCT01322490|448294435|FG002|Long Term Follow-up Period|Other per report|2|||
124638432|NCT01322490|448294433|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
124638433|NCT01322490|448294434|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
124638434|NCT01322490|448294435|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
124638435|NCT00568061|448294436|FG000|Overall Study|Inclusion / exclusion criteria|5|||
124638436|NCT00568061|448294437|FG001|Overall Study|Inclusion / exclusion criteria|1|||
124638437|NCT00568061|448294436|FG000|Overall Study|Adverse Event|0|||
124638438|NCT00568061|448294437|FG001|Overall Study|Adverse Event|1|||
124638439|NCT01896128|448294438|FG000|Overall Study|Withdrawal by Subject|3|||
124638440|NCT01896128|448294439|FG001|Overall Study|Withdrawal by Subject|3|||
124638441|NCT00356148|448294440|FG000|Overall Study|Reoperation within 30 days|2|||
124638442|NCT00356148|448294441|FG001|Overall Study|Reoperation within 30 days|1|||
124638443|NCT02484456|448294442|FG000|Washout Period|Withdrawal by Subject|0|||
124638444|NCT02484456|448294443|FG001|Washout Period|Withdrawal by Subject|1|||
124638445|NCT02484456|448294442|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
124638446|NCT02484456|448294443|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
124638447|NCT02484456|448294442|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
124638448|NCT02484456|448294443|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
124638449|NCT02484456|448294442|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
124638450|NCT02484456|448294443|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
124638451|NCT02693002|448294446|FG000|Overall Study|Withdrawal by Subject|1|||
124638452|NCT02693002|448294447|FG001|Overall Study|Withdrawal by Subject|0|||
124638453|NCT02064816|448294450|FG000|Overall Study|Adverse Event|3|||
124638454|NCT02064816|448294451|FG001|Overall Study|Adverse Event|2|||
124638455|NCT02064816|448294450|FG000|Overall Study|Withdrawal by Subject|2|||
124638456|NCT02064816|448294451|FG001|Overall Study|Withdrawal by Subject|1|||
124638457|NCT02064816|448294450|FG000|Overall Study|Lost to Follow-up|2|||
124638458|NCT02064816|448294451|FG001|Overall Study|Lost to Follow-up|1|||
124638459|NCT02064816|448294450|FG000|Overall Study|Therapeutic failure|0|||
124638460|NCT02064816|448294451|FG001|Overall Study|Therapeutic failure|1|||
124638461|NCT02064816|448294450|FG000|Overall Study|Other|1|||
124638462|NCT02064816|448294451|FG001|Overall Study|Other|3|||
124638463|NCT01732458|448294452|FG000|Overall Study|Lost to Follow-up|0|||
124638464|NCT01732458|448294453|FG001|Overall Study|Lost to Follow-up|2|||
124638465|NCT01732458|448294454|FG002|Overall Study|Lost to Follow-up|0|||
124638466|NCT01732458|448294455|FG003|Overall Study|Lost to Follow-up|0|||
124827446|NCT02865187|448996870|FG000|Overall Study|Adverse Event|1|||
124827447|NCT02865187|448996871|FG001|Overall Study|Adverse Event|0|||
124827448|NCT03318315|448996872|FG000|Overall Study|Lost to Follow-up|3|||
124638467|NCT01732458|448294452|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124638468|NCT01732458|448294453|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124638469|NCT01732458|448294454|FG002|Overall Study|Non-Compliance With Study Drug|1|||
124638470|NCT01732458|448294455|FG003|Overall Study|Non-Compliance With Study Drug|0|||
124638471|NCT01732458|448294452|FG000|Overall Study|Physician Decision|1|||
124827449|NCT03318315|448996873|FG001|Overall Study|Lost to Follow-up|2|||
124827450|NCT03318315|448996874|FG002|Overall Study|Lost to Follow-up|1|||
124827451|NCT03318315|448996872|FG000|Overall Study|Protocol Violation|1|||
124638472|NCT01732458|448294453|FG001|Overall Study|Physician Decision|2|||
124638473|NCT01732458|448294454|FG002|Overall Study|Physician Decision|2|||
124827452|NCT03318315|448996873|FG001|Overall Study|Protocol Violation|1|||
124827453|NCT03318315|448996874|FG002|Overall Study|Protocol Violation|1|||
124827454|NCT03318315|448996872|FG000|Overall Study|Withdrawal by Subject|0|||
124827455|NCT03318315|448996873|FG001|Overall Study|Withdrawal by Subject|0|||
124827456|NCT03318315|448996874|FG002|Overall Study|Withdrawal by Subject|2|||
124827457|NCT02436356|448996875|FG000|Overall Study|Excluded by MRI Screening|0|||
124827458|NCT02436356|448996876|FG001|Overall Study|Excluded by MRI Screening|0|||
124827459|NCT02436356|448996877|FG002|Overall Study|Excluded by MRI Screening|2|||
124827460|NCT02436356|448996875|FG000|Overall Study|Lost to Follow-up|0|||
124827461|NCT02436356|448996876|FG001|Overall Study|Lost to Follow-up|1|||
124827462|NCT02436356|448996877|FG002|Overall Study|Lost to Follow-up|0|||
124827463|NCT02436356|448996875|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
124827464|NCT02436356|448996876|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
124827465|NCT02436356|448996877|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
124827466|NCT02436356|448996875|FG000|Overall Study|Excluded due to other medical conditions|3|||
124827467|NCT02436356|448996876|FG001|Overall Study|Excluded due to other medical conditions|0|||
124827468|NCT02436356|448996877|FG002|Overall Study|Excluded due to other medical conditions|0|||
124827469|NCT02436356|448996875|FG000|Overall Study|Withdrawal by Subject|1|||
124827470|NCT02436356|448996876|FG001|Overall Study|Withdrawal by Subject|0|||
124827471|NCT02436356|448996877|FG002|Overall Study|Withdrawal by Subject|0|||
124827472|NCT00810407|448996878|FG000|Overall Study|Protocol Violation|3|||
124827473|NCT00810407|448996878|FG000|Overall Study|No Visit After First Day of Treatment|3|||
124827474|NCT00674661|448996879|FG000|Overall Study|Other|5|||
124827475|NCT00674661|448996880|FG001|Overall Study|Other|7|||
124638474|NCT01732458|448294455|FG003|Overall Study|Physician Decision|0|||
124638475|NCT01732458|448294452|FG000|Overall Study|Protocol Violation|2|||
124638476|NCT01732458|448294453|FG001|Overall Study|Protocol Violation|0|||
124638477|NCT01732458|448294454|FG002|Overall Study|Protocol Violation|0|||
124638478|NCT01732458|448294455|FG003|Overall Study|Protocol Violation|2|||
124638479|NCT01732458|448294452|FG000|Overall Study|Screen Failure|0|||
124638480|NCT01732458|448294453|FG001|Overall Study|Screen Failure|1|||
124638481|NCT01732458|448294454|FG002|Overall Study|Screen Failure|0|||
124638482|NCT01732458|448294455|FG003|Overall Study|Screen Failure|0|||
124638483|NCT03759587|448294458|FG000|Overall Study|Adverse Event|5|||
124638484|NCT03759587|448294458|FG000|Overall Study|Progressive Disease|10|||
124638485|NCT03759587|448294458|FG000|Overall Study|Site Terminated by Sponsor|3|||
124638486|NCT03759587|448294458|FG000|Overall Study|Withdrawal by Subject|1|||
124638487|NCT04615403|448294459|FG000|Overall Study|Death|1|||
124638488|NCT00665431|448294460|FG000|Overall Study|Adverse Event|16|||
124638489|NCT00665431|448294461|FG001|Overall Study|Adverse Event|22|||
124638490|NCT00665431|448294462|FG002|Overall Study|Adverse Event|6|||
124638491|NCT00665431|448294460|FG000|Overall Study|Withdrawal by Subject|17|||
124638492|NCT00665431|448294461|FG001|Overall Study|Withdrawal by Subject|25|||
124638493|NCT00665431|448294462|FG002|Overall Study|Withdrawal by Subject|15|||
124638494|NCT00665431|448294460|FG000|Overall Study|Lost to Follow-up|3|||
124638495|NCT00665431|448294461|FG001|Overall Study|Lost to Follow-up|3|||
124638496|NCT00665431|448294462|FG002|Overall Study|Lost to Follow-up|1|||
124638497|NCT00665431|448294460|FG000|Overall Study|Other|4|||
124638498|NCT00665431|448294461|FG001|Overall Study|Other|7|||
124638499|NCT00665431|448294462|FG002|Overall Study|Other|2|||
124638500|NCT00757042|448294468|FG000|Overall Study|Lost to Follow-up|0|||
124638501|NCT00757042|448294469|FG001|Overall Study|Lost to Follow-up|0|||
124638502|NCT00757042|448294470|FG002|Overall Study|Lost to Follow-up|0|||
124638503|NCT00757042|448294471|FG003|Overall Study|Lost to Follow-up|0|||
124638504|NCT00757042|448294472|FG004|Overall Study|Lost to Follow-up|0|||
124638505|NCT00757042|448294473|FG005|Overall Study|Lost to Follow-up|0|||
124827476|NCT00674661|448996879|FG000|Overall Study|Lost to Follow-up|6|||
124827477|NCT00674661|448996880|FG001|Overall Study|Lost to Follow-up|3|||
124827478|NCT00674661|448996879|FG000|Overall Study|Withdrawal by Subject|0|||
124827479|NCT00674661|448996880|FG001|Overall Study|Withdrawal by Subject|5|||
124827480|NCT02574247|448996881|FG000|Overall Study|Withdrawal by Subject|1|||
124827481|NCT02574247|448996882|FG001|Overall Study|Withdrawal by Subject|0|||
124827482|NCT02574247|448996883|FG002|Overall Study|Withdrawal by Subject|0|||
124827483|NCT02574247|448996881|FG000|Overall Study|Did not meet inclusion criteria|4|||
124827484|NCT02574247|448996882|FG001|Overall Study|Did not meet inclusion criteria|3|||
124827485|NCT02574247|448996883|FG002|Overall Study|Did not meet inclusion criteria|5|||
124638506|NCT00757042|448294474|FG006|Overall Study|Lost to Follow-up|0|||
124638507|NCT00757042|448294475|FG007|Overall Study|Lost to Follow-up|0|||
124638508|NCT00757042|448294476|FG008|Overall Study|Lost to Follow-up|1|||
124638509|NCT00757042|448294477|FG009|Overall Study|Lost to Follow-up|0|||
124638510|NCT00757042|448294478|FG010|Overall Study|Lost to Follow-up|0|||
124638511|NCT00757042|448294468|FG000|Overall Study|Ineligibility Determined|0|||
124638512|NCT00757042|448294469|FG001|Overall Study|Ineligibility Determined|0|||
124638513|NCT00757042|448294470|FG002|Overall Study|Ineligibility Determined|0|||
124638514|NCT00757042|448294471|FG003|Overall Study|Ineligibility Determined|0|||
124638515|NCT00757042|448294472|FG004|Overall Study|Ineligibility Determined|0|||
124827486|NCT01382446|448996884|FG000|Overall Study|Withdrawal by Subject|0|||
124827487|NCT01382446|448996885|FG001|Overall Study|Withdrawal by Subject|1|||
124827488|NCT01382446|448996884|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
124827489|NCT01382446|448996885|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
124827490|NCT02707991|448996886|FG000|Overall Study|Protocol Violation|1|||
124827491|NCT02707991|448996887|FG001|Overall Study|Protocol Violation|0|||
124827492|NCT02707991|448996886|FG000|Overall Study|Became ineligible|0|||
124827493|NCT02707991|448996887|FG001|Overall Study|Became ineligible|1|||
124827494|NCT04210310|448996888|FG000|Overall Study|Lost to Follow-up|32|||
124827495|NCT04210310|448996889|FG001|Overall Study|Lost to Follow-up|1|||
124827496|NCT01528254|448996893|FG000|Overall Study|Administrative problems|96|||
124827497|NCT01528254|448996894|FG001|Overall Study|Administrative problems|94|||
124827498|NCT01528254|448996893|FG000|Overall Study|Adverse Event|28|||
124827499|NCT01528254|448996894|FG001|Overall Study|Adverse Event|44|||
124827500|NCT01528254|448996893|FG000|Overall Study|Lost to Follow-up|17|||
124827501|NCT01528254|448996894|FG001|Overall Study|Lost to Follow-up|24|||
124827502|NCT01528254|448996893|FG000|Overall Study|Death|13|||
124827503|NCT01528254|448996894|FG001|Overall Study|Death|9|||
124827504|NCT01528254|448996893|FG000|Overall Study|Protocol deviation|9|||
124827505|NCT01528254|448996894|FG001|Overall Study|Protocol deviation|19|||
124827506|NCT01528254|448996893|FG000|Overall Study|New therapy for study indication|8|||
124827507|NCT01528254|448996894|FG001|Overall Study|New therapy for study indication|6|||
124827508|NCT01528254|448996893|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
124827509|NCT01528254|448996894|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
124827510|NCT01528254|448996893|FG000|Overall Study|Withdrawal by Subject|5|||
124827511|NCT01528254|448996894|FG001|Overall Study|Withdrawal by Subject|4|||
124827512|NCT01528254|448996893|FG000|Overall Study|Abnormal laboratory value(s)|3|||
124827513|NCT01528254|448996894|FG001|Overall Study|Abnormal laboratory value(s)|7|||
124827514|NCT01528254|448996893|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124827515|NCT01528254|448996894|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124827516|NCT01528254|448996893|FG000|Overall Study|No longer requires study drug|1|||
124827517|NCT01528254|448996894|FG001|Overall Study|No longer requires study drug|1|||
124638516|NCT00757042|448294473|FG005|Overall Study|Ineligibility Determined|0|||
124638517|NCT00757042|448294474|FG006|Overall Study|Ineligibility Determined|0|||
124638518|NCT00757042|448294475|FG007|Overall Study|Ineligibility Determined|0|||
124638519|NCT00757042|448294476|FG008|Overall Study|Ineligibility Determined|0|||
124638520|NCT00757042|448294477|FG009|Overall Study|Ineligibility Determined|0|||
124638521|NCT00757042|448294478|FG010|Overall Study|Ineligibility Determined|1|||
124638522|NCT00757042|448294468|FG000|Overall Study|Withdrawal by Subject|0|||
124638523|NCT00757042|448294469|FG001|Overall Study|Withdrawal by Subject|0|||
124638524|NCT00757042|448294470|FG002|Overall Study|Withdrawal by Subject|0|||
124638525|NCT00757042|448294471|FG003|Overall Study|Withdrawal by Subject|0|||
124638526|NCT00757042|448294472|FG004|Overall Study|Withdrawal by Subject|0|||
124638527|NCT00757042|448294473|FG005|Overall Study|Withdrawal by Subject|0|||
124638528|NCT00757042|448294474|FG006|Overall Study|Withdrawal by Subject|0|||
124638529|NCT00757042|448294475|FG007|Overall Study|Withdrawal by Subject|0|||
124638530|NCT00757042|448294476|FG008|Overall Study|Withdrawal by Subject|0|||
124638531|NCT00757042|448294477|FG009|Overall Study|Withdrawal by Subject|1|||
124638532|NCT00757042|448294478|FG010|Overall Study|Withdrawal by Subject|0|||
124638533|NCT01870973|448294482|FG000|Overall Study|Lost to Follow-up|10|||
124638534|NCT01870973|448294483|FG001|Overall Study|Lost to Follow-up|3|||
124638535|NCT01266291|448294485|FG000|Overall Study|Adverse Event|1|||
124638536|NCT03291431|448294486|FG000|Overall Study|Protocol Violation|2|||
124638537|NCT03291431|448294487|FG001|Overall Study|Protocol Violation|1|||
124638538|NCT03291431|448294486|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
124638539|NCT03291431|448294487|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
124638540|NCT03291431|448294486|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
124638541|NCT03291431|448294487|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
124638542|NCT00550745|448294490|FG000|Overall Study|Death|20|||
124638543|NCT00550745|448294491|FG001|Overall Study|Death|16|||
124638544|NCT00550745|448294490|FG000|Overall Study|Lost to Follow-up|45|||
124638545|NCT00550745|448294491|FG001|Overall Study|Lost to Follow-up|30|||
124638546|NCT00550745|448294490|FG000|Overall Study|Physician Decision|0|||
124638547|NCT00550745|448294491|FG001|Overall Study|Physician Decision|2|||
124638548|NCT00550745|448294490|FG000|Overall Study|Protocol Violation|4|||
124827518|NCT01166763|448996895|FG000|Overall Study|Withdrawal by Subject|3|||
124638549|NCT00550745|448294491|FG001|Overall Study|Protocol Violation|2|||
124827519|NCT04339296|448996896|FG000|Overall Study|Refuse to participate after allocation|1|||
124827520|NCT04339296|448996897|FG001|Overall Study|Refuse to participate after allocation|1|||
124827521|NCT04339296|448996896|FG000|Overall Study|Withdrew after completion of baseline|2|||
124827522|NCT04339296|448996897|FG001|Overall Study|Withdrew after completion of baseline|1|||
124638550|NCT00550745|448294490|FG000|Overall Study|Withdrawal by Subject|17|||
124638551|NCT00550745|448294491|FG001|Overall Study|Withdrawal by Subject|10|||
124638552|NCT00550745|448294490|FG000|Overall Study|Screen failure|1|||
124827523|NCT04339296|448996896|FG000|Overall Study|Lost to Follow-up|0|||
124827524|NCT04339296|448996897|FG001|Overall Study|Lost to Follow-up|4|||
124827525|NCT04339296|448996896|FG000|Overall Study|Discontinued intervention|5|||
124827526|NCT04339296|448996897|FG001|Overall Study|Discontinued intervention|3|||
124827527|NCT01909479|448996898|FG000|From Baseline to Week 26|Adverse Event|3|||
124827528|NCT01909479|448996899|FG001|From Baseline to Week 26|Adverse Event|2|||
124827529|NCT01909479|448996898|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
124827530|NCT01909479|448996899|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
124827531|NCT01909479|448996898|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
124827532|NCT01909479|448996899|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
124827533|NCT01909479|448996898|FG000|26 - 52 Weeks|Adverse Event|0|||
124827534|NCT01909479|448996899|FG001|26 - 52 Weeks|Adverse Event|1|||
124827535|NCT01909479|448996898|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
124827536|NCT01909479|448996899|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
124827537|NCT01909479|448996898|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
124827538|NCT01909479|448996899|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
124827539|NCT01909479|448996898|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
124827540|NCT01909479|448996899|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
124827541|NCT01909479|448996898|FG000|52 Weeks to End of Study|Adverse Event|2|||
124827542|NCT01909479|448996899|FG001|52 Weeks to End of Study|Adverse Event|1|||
124827543|NCT01909479|448996898|FG000|52 Weeks to End of Study|Death|0|||
124827544|NCT01909479|448996899|FG001|52 Weeks to End of Study|Death|1|||
124827545|NCT01909479|448996898|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
124827546|NCT01909479|448996899|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
124827547|NCT01909479|448996898|FG000|52 Weeks to End of Study|Protocol Violation|1|||
124827548|NCT01909479|448996899|FG001|52 Weeks to End of Study|Protocol Violation|0|||
124827549|NCT01909479|448996898|FG000|52 Weeks to End of Study|Progressive disease|1|||
124827550|NCT01909479|448996899|FG001|52 Weeks to End of Study|Progressive disease|1|||
124827551|NCT01909479|448996898|FG000|52 Weeks to End of Study|Personal reasons|2|||
124827552|NCT01909479|448996899|FG001|52 Weeks to End of Study|Personal reasons|1|||
124827553|NCT01909479|448996898|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
124827554|NCT01909479|448996899|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
124827555|NCT01909479|448996898|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
124827556|NCT01909479|448996899|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
124827557|NCT01909479|448996898|FG000|52 Weeks to End of Study|Lack of contact|1|||
124827558|NCT01909479|448996899|FG001|52 Weeks to End of Study|Lack of contact|0|||
124827559|NCT01909479|448996898|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
124827560|NCT01909479|448996899|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
124827561|NCT01909479|448996898|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
124827562|NCT01909479|448996899|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
124827563|NCT04446377|448996900|FG000|Overall Study|Withdrawal by Subject|6|||
124827564|NCT04446377|448996901|FG001|Overall Study|Withdrawal by Subject|1|||
124827565|NCT04446377|448996900|FG000|Overall Study|Physician Decision|1|||
124827566|NCT04446377|448996901|FG001|Overall Study|Physician Decision|1|||
124827567|NCT04446377|448996900|FG000|Overall Study|Lost to Follow-up|0|||
124827568|NCT04446377|448996901|FG001|Overall Study|Lost to Follow-up|2|||
124827569|NCT04446377|448996900|FG000|Overall Study|Not eligible|0|||
124827570|NCT04446377|448996901|FG001|Overall Study|Not eligible|1|||
124827571|NCT00737282|448996904|FG000|Overall Study|Study prematurely terminated|175|||
124827572|NCT02810392|448996906|FG000|Overall Study|Subject too ill to continue|1|||
124827573|NCT02810392|448996907|FG001|Overall Study|Subject too ill to continue|0|||
124827574|NCT02810392|448996906|FG000|Overall Study|COVID 19 research restrictions|0|||
124827575|NCT02810392|448996907|FG001|Overall Study|COVID 19 research restrictions|1|||
124827576|NCT00840294|448996908|FG000|Overall Study|Withdrawal by Subject|2|||
124827577|NCT00840294|448996909|FG001|Overall Study|Withdrawal by Subject|1|||
124827578|NCT00840294|448996908|FG000|Overall Study|Protocol Violation|1|||
124827579|NCT00840294|448996909|FG001|Overall Study|Protocol Violation|3|||
124827580|NCT00840294|448996908|FG000|Overall Study|Illness|0|||
124827581|NCT00840294|448996909|FG001|Overall Study|Illness|1|||
124827582|NCT01187043|448996910|FG000|Overall Study|Adverse Event|0|||
124827583|NCT01187043|448996911|FG001|Overall Study|Adverse Event|0|||
124827584|NCT01187043|448996912|FG002|Overall Study|Adverse Event|0|||
124827585|NCT01187043|448996913|FG003|Overall Study|Adverse Event|0|||
124827586|NCT01187043|448996914|FG004|Overall Study|Adverse Event|1|||
124827587|NCT01187043|448996910|FG000|Overall Study|Unable to make scheduled visits|1|||
124827588|NCT01187043|448996911|FG001|Overall Study|Unable to make scheduled visits|0|||
124827589|NCT01187043|448996912|FG002|Overall Study|Unable to make scheduled visits|4|||
124827590|NCT01187043|448996913|FG003|Overall Study|Unable to make scheduled visits|0|||
124638553|NCT00550745|448294491|FG001|Overall Study|Screen failure|0|||
124638554|NCT03850483|448294494|FG000|Treatment for Stage 1|Adverse Event|1|||
124638555|NCT03850483|448294495|FG001|Treatment for Stage 1|Adverse Event|1|||
124638556|NCT03850483|448294496|FG002|Treatment for Stage 1|Adverse Event|3|||
124638557|NCT03850483|448294497|FG003|Treatment for Stage 1|Adverse Event|0|||
124638558|NCT03850483|448294498|FG004|Treatment for Stage 1|Adverse Event|2|||
124827591|NCT01187043|448996914|FG004|Overall Study|Unable to make scheduled visits|1|||
124638559|NCT03850483|448294499|FG005|Treatment for Stage 1|Adverse Event|0|||
124827592|NCT02196558|448996915|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
124827593|NCT02196558|448996916|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
124827594|NCT02196558|448996917|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
124827595|NCT02196558|448996915|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
124827596|NCT02196558|448996916|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
124827597|NCT02196558|448996917|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
124827598|NCT02196558|448996915|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
124827599|NCT02196558|448996916|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
124827600|NCT02196558|448996917|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
124827601|NCT02196558|448996915|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
124827602|NCT02196558|448996916|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
124827603|NCT02196558|448996917|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
124827604|NCT02196558|448996915|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
124827605|NCT02196558|448996916|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
124827606|NCT02196558|448996917|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
124827607|NCT04059094|448996921|FG000|Overall Study|Adverse Event|0|||
124827608|NCT04059094|448996922|FG001|Overall Study|Adverse Event|0|||
124827609|NCT04059094|448996923|FG002|Overall Study|Adverse Event|0|||
124827610|NCT04059094|448996924|FG003|Overall Study|Adverse Event|0|||
124827611|NCT04059094|448996925|FG004|Overall Study|Adverse Event|1|||
124827612|NCT04059094|448996921|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
124827613|NCT04059094|448996922|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
124827614|NCT04059094|448996923|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
124827615|NCT04059094|448996924|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
124827616|NCT04059094|448996925|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
124827617|NCT01853826|448998652|FG000|Overall Study|Patients who switched to commercial drug|11|||
124827618|NCT01853826|448998652|FG000|Overall Study|Patient refused to continue medication|21|||
124827619|NCT01853826|448998652|FG000|Overall Study|Lost to Follow-up|2|||
124827620|NCT01853826|448998652|FG000|Overall Study|Non-compliant with protocol|4|||
124827621|NCT01853826|448998652|FG000|Overall Study|Other adverse events (AE)|62|||
124827622|NCT01853826|448998652|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
124827623|NCT01853826|448998652|FG000|Overall Study|Progressive disease|342|||
124827624|NCT01853826|448998652|FG000|Overall Study|Other than listed|13|||
124827625|NCT01853826|448998652|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
124827626|NCT02081690|448998654|FG000|Overall Study|Death|3|||
124827627|NCT02081690|448998654|FG000|Overall Study|Physician Decision|3|||
124827628|NCT02081690|448998654|FG000|Overall Study|Withdrawal by Subject|1|||
124827629|NCT00982488|448998656|FG000|Overall Study|Administrative reason by sponsor|81|||
124827630|NCT00982488|448998657|FG001|Overall Study|Administrative reason by sponsor|3|||
124827631|NCT00982488|448998658|FG002|Overall Study|Administrative reason by sponsor|11|||
124827632|NCT00982488|448998659|FG003|Overall Study|Administrative reason by sponsor|0|||
124827633|NCT00982488|448998660|FG004|Overall Study|Administrative reason by sponsor|0|||
124827634|NCT00982488|448998656|FG000|Overall Study|Adverse event unrelated to study drug|5|||
124827635|NCT00982488|448998657|FG001|Overall Study|Adverse event unrelated to study drug|1|||
124827636|NCT00982488|448998658|FG002|Overall Study|Adverse event unrelated to study drug|0|||
124827637|NCT00982488|448998659|FG003|Overall Study|Adverse event unrelated to study drug|0|||
124827638|NCT00982488|448998660|FG004|Overall Study|Adverse event unrelated to study drug|0|||
124827639|NCT00982488|448998656|FG000|Overall Study|Death|11|||
124827640|NCT00982488|448998657|FG001|Overall Study|Death|0|||
124827641|NCT00982488|448998658|FG002|Overall Study|Death|2|||
124827642|NCT00982488|448998659|FG003|Overall Study|Death|0|||
124827643|NCT00982488|448998660|FG004|Overall Study|Death|0|||
124827644|NCT00982488|448998656|FG000|Overall Study|Disease progression|30|||
124827645|NCT00982488|448998657|FG001|Overall Study|Disease progression|5|||
124827646|NCT00982488|448998658|FG002|Overall Study|Disease progression|10|||
124827647|NCT00982488|448998659|FG003|Overall Study|Disease progression|1|||
124827648|NCT00982488|448998660|FG004|Overall Study|Disease progression|1|||
124638560|NCT03850483|448294500|FG006|Treatment for Stage 1|Adverse Event|2|||
124638561|NCT03850483|448294501|FG007|Treatment for Stage 1|Adverse Event|2|||
124638562|NCT03850483|448294502|FG008|Treatment for Stage 1|Adverse Event|0|||
124827649|NCT00982488|448998656|FG000|Overall Study|Lost to Follow-up|1|||
124827650|NCT00982488|448998657|FG001|Overall Study|Lost to Follow-up|0|||
124827651|NCT00982488|448998658|FG002|Overall Study|Lost to Follow-up|0|||
124827652|NCT00982488|448998659|FG003|Overall Study|Lost to Follow-up|0|||
124638563|NCT03850483|448294503|FG009|Treatment for Stage 1|Adverse Event|0|||
124638564|NCT03850483|448294494|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
124638565|NCT03850483|448294495|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
124827653|NCT00982488|448998660|FG004|Overall Study|Lost to Follow-up|0|||
124827654|NCT00982488|448998656|FG000|Overall Study|Maximum clinical benefit|1|||
124827655|NCT00982488|448998657|FG001|Overall Study|Maximum clinical benefit|1|||
124827656|NCT00982488|448998658|FG002|Overall Study|Maximum clinical benefit|1|||
124827657|NCT00982488|448998659|FG003|Overall Study|Maximum clinical benefit|0|||
124827658|NCT00982488|448998660|FG004|Overall Study|Maximum clinical benefit|0|||
124827659|NCT00982488|448998656|FG000|Overall Study|Other|15|||
124827660|NCT00982488|448998657|FG001|Overall Study|Other|1|||
124827661|NCT00982488|448998658|FG002|Overall Study|Other|3|||
124827662|NCT00982488|448998659|FG003|Overall Study|Other|1|||
124827663|NCT00982488|448998660|FG004|Overall Study|Other|0|||
124827664|NCT00982488|448998656|FG000|Overall Study|Poor compliance/noncompliance|0|||
124827665|NCT00982488|448998657|FG001|Overall Study|Poor compliance/noncompliance|1|||
124827666|NCT00982488|448998658|FG002|Overall Study|Poor compliance/noncompliance|0|||
124827667|NCT00982488|448998659|FG003|Overall Study|Poor compliance/noncompliance|0|||
124827668|NCT00982488|448998660|FG004|Overall Study|Poor compliance/noncompliance|0|||
124827669|NCT00982488|448998656|FG000|Overall Study|Stem cell transplant|2|||
124827670|NCT00982488|448998657|FG001|Overall Study|Stem cell transplant|0|||
124827671|NCT00982488|448998658|FG002|Overall Study|Stem cell transplant|0|||
124827672|NCT00982488|448998659|FG003|Overall Study|Stem cell transplant|1|||
124827673|NCT00982488|448998660|FG004|Overall Study|Stem cell transplant|0|||
124827674|NCT00982488|448998656|FG000|Overall Study|Study drug toxicity|34|||
124827675|NCT00982488|448998657|FG001|Overall Study|Study drug toxicity|1|||
124827676|NCT00982488|448998658|FG002|Overall Study|Study drug toxicity|6|||
124827677|NCT00982488|448998659|FG003|Overall Study|Study drug toxicity|0|||
124827678|NCT00982488|448998660|FG004|Overall Study|Study drug toxicity|0|||
124827679|NCT00982488|448998656|FG000|Overall Study|Withdrawal by Subject|5|||
124827680|NCT00982488|448998657|FG001|Overall Study|Withdrawal by Subject|1|||
124827681|NCT00982488|448998658|FG002|Overall Study|Withdrawal by Subject|1|||
124827682|NCT00982488|448998659|FG003|Overall Study|Withdrawal by Subject|0|||
124827683|NCT00982488|448998660|FG004|Overall Study|Withdrawal by Subject|0|||
124827684|NCT03204981|448998661|FG000|Overall Study|Physician Decision|2|||
124827685|NCT03204981|448998661|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
124638566|NCT03850483|448294496|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
124638567|NCT03850483|448294497|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
124638568|NCT03850483|448294498|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
124638569|NCT03850483|448294499|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
124638570|NCT03850483|448294500|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
124638571|NCT03850483|448294501|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
124638572|NCT03850483|448294502|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
124638573|NCT03850483|448294503|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
124638574|NCT03850483|448294494|FG000|Treatment for Stage 1|Protocol Violation|1|||
124638575|NCT03850483|448294495|FG001|Treatment for Stage 1|Protocol Violation|0|||
124638576|NCT03850483|448294496|FG002|Treatment for Stage 1|Protocol Violation|0|||
124638577|NCT03850483|448294497|FG003|Treatment for Stage 1|Protocol Violation|0|||
124638578|NCT03850483|448294498|FG004|Treatment for Stage 1|Protocol Violation|0|||
124638579|NCT03850483|448294499|FG005|Treatment for Stage 1|Protocol Violation|0|||
124638580|NCT03850483|448294500|FG006|Treatment for Stage 1|Protocol Violation|1|||
124638581|NCT03850483|448294501|FG007|Treatment for Stage 1|Protocol Violation|0|||
124638582|NCT03850483|448294502|FG008|Treatment for Stage 1|Protocol Violation|0|||
124638583|NCT03850483|448294503|FG009|Treatment for Stage 1|Protocol Violation|0|||
124638584|NCT03850483|448294494|FG000|Treatment for Stage 1|Physician Decision|0|||
124638585|NCT03850483|448294495|FG001|Treatment for Stage 1|Physician Decision|0|||
124638586|NCT03850483|448294496|FG002|Treatment for Stage 1|Physician Decision|0|||
124638587|NCT03850483|448294497|FG003|Treatment for Stage 1|Physician Decision|0|||
124638588|NCT03850483|448294498|FG004|Treatment for Stage 1|Physician Decision|0|||
124638589|NCT03850483|448294499|FG005|Treatment for Stage 1|Physician Decision|1|||
124638590|NCT03850483|448294500|FG006|Treatment for Stage 1|Physician Decision|0|||
124638591|NCT03850483|448294501|FG007|Treatment for Stage 1|Physician Decision|0|||
124638592|NCT03850483|448294502|FG008|Treatment for Stage 1|Physician Decision|0|||
124638593|NCT03850483|448294503|FG009|Treatment for Stage 1|Physician Decision|0|||
124638594|NCT03850483|448294494|FG000|Treatment for Stage 1|Other|0|||
124638595|NCT03850483|448294495|FG001|Treatment for Stage 1|Other|0|||
124638596|NCT03850483|448294496|FG002|Treatment for Stage 1|Other|0|||
124638597|NCT03850483|448294497|FG003|Treatment for Stage 1|Other|0|||
124638598|NCT03850483|448294498|FG004|Treatment for Stage 1|Other|2|||
124638599|NCT03850483|448294499|FG005|Treatment for Stage 1|Other|1|||
124638600|NCT03850483|448294500|FG006|Treatment for Stage 1|Other|0|||
124827686|NCT00397982|448998665|FG000|Overall Study|Withdrawal by Subject|1|||
124827687|NCT00397982|448998665|FG000|Overall Study|Adverse Event|1|||
124827688|NCT00397982|448998665|FG000|Overall Study|noncompliance|1|||
124827689|NCT00397982|448998665|FG000|Overall Study|Unrelated health issues|1|||
124827690|NCT04244786|448998666|FG000|Overall Study|Adverse Event|0|||
124827691|NCT04244786|448998667|FG001|Overall Study|Adverse Event|0|||
124827692|NCT04244786|448998668|FG002|Overall Study|Adverse Event|2|||
124827693|NCT04244786|448998666|FG000|Overall Study|Withdrawal by Subject|0|||
124827694|NCT04244786|448998667|FG001|Overall Study|Withdrawal by Subject|0|||
124827695|NCT04244786|448998668|FG002|Overall Study|Withdrawal by Subject|5|||
124638601|NCT03850483|448294501|FG007|Treatment for Stage 1|Other|0|||
124638602|NCT03850483|448294502|FG008|Treatment for Stage 1|Other|0|||
124638603|NCT03850483|448294503|FG009|Treatment for Stage 1|Other|0|||
124638604|NCT03850483|448294494|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
124827696|NCT00613938|448998675|FG000|Overall Study|Withdrawal by Subject|2|||
124827697|NCT00613938|448998676|FG001|Overall Study|Withdrawal by Subject|4|||
124827698|NCT00613938|448998677|FG002|Overall Study|Withdrawal by Subject|9|||
124827699|NCT00613938|448998678|FG003|Overall Study|Withdrawal by Subject|9|||
124827700|NCT00613938|448998675|FG000|Overall Study|Adverse Event|1|||
124827701|NCT00613938|448998676|FG001|Overall Study|Adverse Event|4|||
124827702|NCT00613938|448998677|FG002|Overall Study|Adverse Event|8|||
124827703|NCT00613938|448998678|FG003|Overall Study|Adverse Event|5|||
124827704|NCT00613938|448998675|FG000|Overall Study|Lack of Efficacy|16|||
124827705|NCT00613938|448998676|FG001|Overall Study|Lack of Efficacy|18|||
124827706|NCT00613938|448998677|FG002|Overall Study|Lack of Efficacy|5|||
124827707|NCT00613938|448998678|FG003|Overall Study|Lack of Efficacy|9|||
124827708|NCT00613938|448998675|FG000|Overall Study|Other|1|||
124827709|NCT00613938|448998676|FG001|Overall Study|Other|2|||
124827710|NCT00613938|448998677|FG002|Overall Study|Other|1|||
124827711|NCT00613938|448998678|FG003|Overall Study|Other|3|||
124827712|NCT02636868|448998679|FG000|Overall Study|Death|0|||
124827713|NCT02636868|448998680|FG001|Overall Study|Death|1|||
124827714|NCT02636868|448998681|FG002|Overall Study|Death|2|||
124827715|NCT03220217|448998682|FG000|Overall Study|Withdrawal by Subject|0|||
124827716|NCT03220217|448998683|FG001|Overall Study|Withdrawal by Subject|1|||
124827717|NCT03220217|448998684|FG002|Overall Study|Withdrawal by Subject|0|||
124827718|NCT03220217|448998682|FG000|Overall Study|Subject Missed Procedure|0|||
124827719|NCT03220217|448998683|FG001|Overall Study|Subject Missed Procedure|0|||
124827720|NCT03220217|448998684|FG002|Overall Study|Subject Missed Procedure|1|||
124827721|NCT03025542|448998685|FG000|Overall Study|Adverse Event|0|||
124827722|NCT03025542|448998686|FG001|Overall Study|Adverse Event|2|||
124827723|NCT03025542|448998685|FG000|Overall Study|Lost to Follow-up|1|||
124827724|NCT03025542|448998686|FG001|Overall Study|Lost to Follow-up|0|||
124827725|NCT03025542|448998685|FG000|Overall Study|Withdrawal by Subject|1|||
124827726|NCT03025542|448998686|FG001|Overall Study|Withdrawal by Subject|0|||
124827727|NCT03745937|448998687|FG000|Overall Study|Withdrawal by Subject|0|||
124827728|NCT03745937|448998688|FG001|Overall Study|Withdrawal by Subject|0|||
124827729|NCT03745937|448998689|FG002|Overall Study|Withdrawal by Subject|0|||
124827730|NCT03745937|448998690|FG003|Overall Study|Withdrawal by Subject|1|||
124827731|NCT03745937|448998687|FG000|Overall Study|Not-specifed|0|||
124827732|NCT03745937|448998688|FG001|Overall Study|Not-specifed|1|||
124827733|NCT03745937|448998689|FG002|Overall Study|Not-specifed|0|||
124827734|NCT03745937|448998690|FG003|Overall Study|Not-specifed|1|||
124827735|NCT05024058|448998692|FG000|Treatment|Study terminated by sponsor|5|||
124827736|NCT05024058|448998693|FG001|Treatment|Study terminated by sponsor|6|||
124827737|NCT05024058|448998694|FG002|Treatment|Study terminated by sponsor|4|||
124827738|NCT05024058|448998695|FG003|Treatment|Study terminated by sponsor|2|||
124827739|NCT05024058|448998696|FG004|Treatment|Study terminated by sponsor|3|||
124827740|NCT05024058|448998697|FG005|Treatment|Study terminated by sponsor|3|||
124827741|NCT05024058|448998698|FG006|Treatment|Study terminated by sponsor|1|||
124827742|NCT05024058|448998699|FG007|Treatment|Study terminated by sponsor|3|||
124827743|NCT05024058|448998700|FG008|Treatment|Study terminated by sponsor|6|||
124827744|NCT05024058|448998701|FG009|Treatment|Study terminated by sponsor|6|||
124827745|NCT05024058|448998692|FG000|Follow-up|Withdrawal by Subject|1|||
124827746|NCT05024058|448998693|FG001|Follow-up|Withdrawal by Subject|0|||
124827747|NCT05024058|448998694|FG002|Follow-up|Withdrawal by Subject|1|||
124827748|NCT05024058|448998695|FG003|Follow-up|Withdrawal by Subject|0|||
124827749|NCT05024058|448998696|FG004|Follow-up|Withdrawal by Subject|0|||
124827750|NCT05024058|448998697|FG005|Follow-up|Withdrawal by Subject|0|||
124827751|NCT05024058|448998698|FG006|Follow-up|Withdrawal by Subject|0|||
124827752|NCT05024058|448998699|FG007|Follow-up|Withdrawal by Subject|1|||
124827753|NCT05024058|448998700|FG008|Follow-up|Withdrawal by Subject|0|||
124827754|NCT05024058|448998701|FG009|Follow-up|Withdrawal by Subject|1|||
124827755|NCT02734810|448998705|FG000|Overall Study|Adverse Event|1|||
124827756|NCT02734810|448998706|FG001|Overall Study|Adverse Event|0|||
124827757|NCT02734810|448998705|FG000|Overall Study|Lack of Efficacy|1|||
124827758|NCT02734810|448998706|FG001|Overall Study|Lack of Efficacy|0|||
124827759|NCT00488345|448998708|FG000|Overall Study|Adverse Event|0|||
124827760|NCT00488345|448998709|FG001|Overall Study|Adverse Event|1|||
124827761|NCT00488345|448998710|FG002|Overall Study|Adverse Event|1|||
124827762|NCT00488345|448998708|FG000|Overall Study|Unable to administer antibiotics at home|0|||
124827763|NCT00488345|448998709|FG001|Overall Study|Unable to administer antibiotics at home|1|||
124827764|NCT00488345|448998710|FG002|Overall Study|Unable to administer antibiotics at home|0|||
124827765|NCT00488345|448998708|FG000|Overall Study|Institutional Review Board review|0|||
124827766|NCT00488345|448998709|FG001|Overall Study|Institutional Review Board review|0|||
124827767|NCT00488345|448998710|FG002|Overall Study|Institutional Review Board review|1|||
124827768|NCT00488345|448998708|FG000|Overall Study|Surgical team recommendation|0|||
124827769|NCT00488345|448998709|FG001|Overall Study|Surgical team recommendation|1|||
124827770|NCT00488345|448998710|FG002|Overall Study|Surgical team recommendation|0|||
124827771|NCT00488345|448998708|FG000|Overall Study|Parent/legal guardian request|0|||
124827772|NCT00488345|448998709|FG001|Overall Study|Parent/legal guardian request|1|||
124827773|NCT00488345|448998710|FG002|Overall Study|Parent/legal guardian request|1|||
124827774|NCT00903617|448998713|FG000|Overall Study|Adverse Event|0|||
124827775|NCT00903617|448998714|FG001|Overall Study|Adverse Event|1|||
124827776|NCT00903617|448998715|FG002|Overall Study|Adverse Event|1|||
124827777|NCT00903617|448998716|FG003|Overall Study|Adverse Event|0|||
124827778|NCT00903617|448998713|FG000|Overall Study|Protocol-defined stopping criteria|0|||
124827779|NCT00903617|448998714|FG001|Overall Study|Protocol-defined stopping criteria|2|||
124827780|NCT00903617|448998715|FG002|Overall Study|Protocol-defined stopping criteria|0|||
124827781|NCT00903617|448998716|FG003|Overall Study|Protocol-defined stopping criteria|0|||
124827782|NCT00903617|448998713|FG000|Overall Study|Lost to Follow-up|2|||
124827783|NCT00903617|448998714|FG001|Overall Study|Lost to Follow-up|0|||
124827784|NCT00903617|448998715|FG002|Overall Study|Lost to Follow-up|1|||
124827785|NCT00903617|448998716|FG003|Overall Study|Lost to Follow-up|1|||
124827786|NCT00903617|448998713|FG000|Overall Study|Withdrawal by Subject|1|||
124827787|NCT00903617|448998714|FG001|Overall Study|Withdrawal by Subject|2|||
124827788|NCT00903617|448998715|FG002|Overall Study|Withdrawal by Subject|3|||
124827789|NCT00903617|448998716|FG003|Overall Study|Withdrawal by Subject|0|||
124827790|NCT00407563|448998717|FG000|Overall Study|Patient continues on treatment|1|||
124827791|NCT03055260|448998718|FG000|Overall Study|Withdrawal by Subject|1|||
124827792|NCT03055260|448998719|FG001|Overall Study|Withdrawal by Subject|0|||
124827793|NCT02507505|448998720|FG000|Overall Study|Withdrawal by Subject|13|||
124827794|NCT02507505|448998721|FG001|Overall Study|Withdrawal by Subject|11|||
124827795|NCT02507505|448998720|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
124827796|NCT02507505|448998721|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
124827797|NCT02507505|448998720|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
124827798|NCT02507505|448998721|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
124827799|NCT02507505|448998720|FG000|Overall Study|Death before receipt of anesthesia|0|||
124827800|NCT02507505|448998721|FG001|Overall Study|Death before receipt of anesthesia|1|||
124827801|NCT03182829|448998722|FG000|Overall Study|Protocol Violation|12|||
124827802|NCT03182829|448998723|FG001|Overall Study|Protocol Violation|12|||
124827803|NCT03182829|448998722|FG000|Overall Study|Other|4|||
124827804|NCT03182829|448998723|FG001|Overall Study|Other|3|||
124827805|NCT00254540|448998724|FG000|Overall Study|Adverse Event|6|||
124827806|NCT00254540|448998725|FG001|Overall Study|Adverse Event|7|||
124827807|NCT00254540|448998724|FG000|Overall Study|Lack of Efficacy|13|||
124827808|NCT00254540|448998725|FG001|Overall Study|Lack of Efficacy|13|||
124827809|NCT00254540|448998724|FG000|Overall Study|Death|0|||
124827810|NCT00254540|448998725|FG001|Overall Study|Death|1|||
124827811|NCT00254540|448998724|FG000|Overall Study|Laboratory Test Abnormality|0|||
124827812|NCT00254540|448998725|FG001|Overall Study|Laboratory Test Abnormality|1|||
124827813|NCT00225251|448998726|FG000|Overall Study|Withdrawal by Subject|1|||
124827814|NCT00225251|448998727|FG001|Overall Study|Withdrawal by Subject|1|||
124827815|NCT03045328|448998728|FG000|Overall Study|Withdrawal by Subject|2|||
124827816|NCT00592839|448998729|FG000|Overall Study|Withdrawal by Subject|1|||
124827817|NCT00592839|448998730|FG001|Overall Study|Withdrawal by Subject|1|||
124827818|NCT00592839|448998731|FG002|Overall Study|Withdrawal by Subject|3|||
124827819|NCT00592839|448998729|FG000|Overall Study|Protocol Violation|1|||
124827820|NCT00592839|448998730|FG001|Overall Study|Protocol Violation|1|||
124827821|NCT00592839|448998731|FG002|Overall Study|Protocol Violation|2|||
124827822|NCT00592839|448998729|FG000|Overall Study|Adverse Event|0|||
124827823|NCT00592839|448998730|FG001|Overall Study|Adverse Event|1|||
124827824|NCT00592839|448998731|FG002|Overall Study|Adverse Event|0|||
124827825|NCT00592839|448998729|FG000|Overall Study|Lost to Follow-up|0|||
124827826|NCT00592839|448998730|FG001|Overall Study|Lost to Follow-up|1|||
124827827|NCT00592839|448998731|FG002|Overall Study|Lost to Follow-up|1|||
124827828|NCT02355691|448998736|FG000|Overall Study|Loss of Research Personnel|7|||
124827829|NCT02355691|448998737|FG001|Overall Study|Loss of Research Personnel|9|||
124827830|NCT00462761|448998738|FG000|Overall Study|Adverse Event|6|||
124827831|NCT00462761|448998738|FG000|Overall Study|Withdrawal by Subject|9|||
124827832|NCT00462761|448998738|FG000|Overall Study|Physician Decision|5|||
124827833|NCT00462761|448998738|FG000|Overall Study|Disease progression|43|||
124827834|NCT00462761|448998738|FG000|Overall Study|Death|12|||
124827835|NCT00462761|448998738|FG000|Overall Study|Other|1|||
124827836|NCT03060447|448998739|FG000|Overall Study|Withdrawal by Subject|2|||
124827837|NCT03060447|448998740|FG001|Overall Study|Withdrawal by Subject|0|||
124827838|NCT03274440|448998744|FG000|Overall Study|Time commitment too great|1|||
124827839|NCT03274440|448998745|FG001|Overall Study|Time commitment too great|0|||
124827840|NCT03274440|448998746|FG002|Overall Study|Time commitment too great|0|||
124827841|NCT03274440|448998747|FG003|Overall Study|Time commitment too great|1|||
124827842|NCT03274440|448998748|FG004|Overall Study|Time commitment too great|0|||
124638605|NCT03850483|448294495|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
124827843|NCT03274440|448998749|FG005|Overall Study|Time commitment too great|0|||
124827844|NCT01110707|448998750|FG000|Overall Study|Protocol Violation|0|||
124827845|NCT01110707|448998751|FG001|Overall Study|Protocol Violation|3|||
124827846|NCT02369341|448998752|FG000|Overall Study|Migrated/moved from study area|1|||
124827847|NCT02369341|448998753|FG001|Overall Study|Migrated/moved from study area|0|||
124827848|NCT02710045|448998756|FG000|Overall Study|Death|1|||
124827849|NCT02710045|448998757|FG001|Overall Study|Death|2|||
124827850|NCT02710045|448998758|FG002|Overall Study|Death|0|||
124827851|NCT02710045|448998756|FG000|Overall Study|Withdrawal by Subject|6|||
124827852|NCT02710045|448998757|FG001|Overall Study|Withdrawal by Subject|6|||
124827853|NCT02710045|448998758|FG002|Overall Study|Withdrawal by Subject|2|||
124827854|NCT02710045|448998756|FG000|Overall Study|Protocol Violation|1|||
124827855|NCT02710045|448998757|FG001|Overall Study|Protocol Violation|2|||
124827856|NCT02710045|448998758|FG002|Overall Study|Protocol Violation|3|||
124827857|NCT02710045|448998756|FG000|Overall Study|Lost to Follow-up|3|||
124827858|NCT02710045|448998757|FG001|Overall Study|Lost to Follow-up|6|||
124827859|NCT02710045|448998758|FG002|Overall Study|Lost to Follow-up|7|||
124827860|NCT02710045|448998756|FG000|Overall Study|Physician Decision|0|||
124827861|NCT02710045|448998757|FG001|Overall Study|Physician Decision|0|||
124827862|NCT02710045|448998758|FG002|Overall Study|Physician Decision|1|||
124827863|NCT02710045|448998756|FG000|Overall Study|Poor Attendance|0|||
124827864|NCT02710045|448998757|FG001|Overall Study|Poor Attendance|1|||
124827865|NCT02710045|448998758|FG002|Overall Study|Poor Attendance|0|||
124827866|NCT03178773|448998759|FG000|Overall Study|Death|0|||
124827867|NCT03178773|448998760|FG001|Overall Study|Death|1|||
124827868|NCT03178773|448998759|FG000|Overall Study|Lost to Follow-up|29|||
124827869|NCT03178773|448998760|FG001|Overall Study|Lost to Follow-up|25|||
124827870|NCT03178773|448998759|FG000|Overall Study|Withdrawal by Subject|10|||
124827871|NCT03178773|448998760|FG001|Overall Study|Withdrawal by Subject|14|||
124827872|NCT01928329|448998765|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
124827873|NCT01928329|448998766|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
124827874|NCT01928329|448998765|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
124827875|NCT01928329|448998766|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
124827876|NCT01928329|448998765|FG000|Overall Study|Adverse Event|5|||
124827877|NCT01928329|448998766|FG001|Overall Study|Adverse Event|3|||
124827878|NCT01928329|448998765|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
124827879|NCT01928329|448998766|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
124827880|NCT01928329|448998765|FG000|Overall Study|Withdrawal by Subject|1|||
124827881|NCT01928329|448998766|FG001|Overall Study|Withdrawal by Subject|5|||
124827882|NCT01928329|448998765|FG000|Overall Study|Physician Decision|1|||
124827883|NCT01928329|448998766|FG001|Overall Study|Physician Decision|1|||
124827884|NCT03187262|448998767|FG000|Induction|Lack of Efficacy|2|||
124827885|NCT03187262|448998767|FG000|Induction|Progressive Disease|4|||
124827886|NCT03187262|448998767|FG000|Consolidation|Progressive Disease|5|||
124827887|NCT02604212|448998770|FG000|Overall Study|Study Terminated by Sponsor|2|||
124827888|NCT02604212|448998771|FG001|Overall Study|Study Terminated by Sponsor|1|||
124827889|NCT02604212|448998772|FG002|Overall Study|Study Terminated by Sponsor|3|||
124827890|NCT02604212|448998773|FG003|Overall Study|Study Terminated by Sponsor|3|||
124827891|NCT02604212|448998770|FG000|Overall Study|Withdrawal by Subject|0|||
124827892|NCT02604212|448998771|FG001|Overall Study|Withdrawal by Subject|0|||
124827893|NCT02604212|448998772|FG002|Overall Study|Withdrawal by Subject|1|||
124827894|NCT02604212|448998773|FG003|Overall Study|Withdrawal by Subject|0|||
124827895|NCT00451321|448998774|FG000|Overall Study|Lost to Follow-up|3|||
124827896|NCT00451321|448998775|FG001|Overall Study|Lost to Follow-up|3|||
124827897|NCT00451321|448998776|FG002|Overall Study|Lost to Follow-up|1|||
124827898|NCT00451321|448998777|FG003|Overall Study|Lost to Follow-up|3|||
124827899|NCT00451321|448998778|FG004|Overall Study|Lost to Follow-up|0|||
124827900|NCT00451321|448998779|FG005|Overall Study|Lost to Follow-up|1|||
124827901|NCT00451321|448998780|FG006|Overall Study|Lost to Follow-up|0|||
124827902|NCT00451321|448998781|FG007|Overall Study|Lost to Follow-up|0|||
124827903|NCT00451321|448998774|FG000|Overall Study|Withdrawal by Subject|3|||
124827904|NCT00451321|448998775|FG001|Overall Study|Withdrawal by Subject|1|||
124827905|NCT00451321|448998776|FG002|Overall Study|Withdrawal by Subject|0|||
124827906|NCT00451321|448998777|FG003|Overall Study|Withdrawal by Subject|4|||
124827907|NCT00451321|448998778|FG004|Overall Study|Withdrawal by Subject|0|||
124827908|NCT00451321|448998779|FG005|Overall Study|Withdrawal by Subject|0|||
124827909|NCT00451321|448998780|FG006|Overall Study|Withdrawal by Subject|0|||
124827910|NCT00451321|448998781|FG007|Overall Study|Withdrawal by Subject|0|||
124638606|NCT03850483|448294496|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
124827911|NCT00451321|448998774|FG000|Overall Study|Study closed/terminated|1|||
124827912|NCT00451321|448998775|FG001|Overall Study|Study closed/terminated|1|||
124827913|NCT00451321|448998776|FG002|Overall Study|Study closed/terminated|17|||
124827914|NCT00451321|448998777|FG003|Overall Study|Study closed/terminated|5|||
124827915|NCT00451321|448998778|FG004|Overall Study|Study closed/terminated|7|||
124827916|NCT00451321|448998779|FG005|Overall Study|Study closed/terminated|7|||
124638607|NCT03850483|448294497|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
124638608|NCT03850483|448294498|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
124638609|NCT03850483|448294499|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
124827917|NCT00451321|448998780|FG006|Overall Study|Study closed/terminated|5|||
124827918|NCT00451321|448998781|FG007|Overall Study|Study closed/terminated|3|||
124827919|NCT00451321|448998774|FG000|Overall Study|Sponsor decision to amend protocol|0|||
124827920|NCT00451321|448998775|FG001|Overall Study|Sponsor decision to amend protocol|0|||
124827921|NCT00451321|448998776|FG002|Overall Study|Sponsor decision to amend protocol|0|||
124827922|NCT00451321|448998777|FG003|Overall Study|Sponsor decision to amend protocol|0|||
124827923|NCT00451321|448998778|FG004|Overall Study|Sponsor decision to amend protocol|0|||
124827924|NCT00451321|448998779|FG005|Overall Study|Sponsor decision to amend protocol|1|||
124827925|NCT00451321|448998780|FG006|Overall Study|Sponsor decision to amend protocol|1|||
124827926|NCT00451321|448998781|FG007|Overall Study|Sponsor decision to amend protocol|3|||
124827927|NCT01119131|448998784|FG000|Overall Study|Adverse Event|1|||
124827928|NCT01119131|448998785|FG001|Overall Study|Adverse Event|1|||
124827929|NCT01119131|448998786|FG002|Overall Study|Adverse Event|1|||
124827930|NCT01119131|448998784|FG000|Overall Study|Non-Compliance|1|||
124827931|NCT01119131|448998785|FG001|Overall Study|Non-Compliance|0|||
124827932|NCT01119131|448998786|FG002|Overall Study|Non-Compliance|4|||
124827933|NCT01119131|448998784|FG000|Overall Study|Physician Decision|0|||
124827934|NCT01119131|448998785|FG001|Overall Study|Physician Decision|0|||
124827935|NCT01119131|448998786|FG002|Overall Study|Physician Decision|1|||
124827936|NCT00909389|448998789|FG000|Overall Study|Adverse Event|6|||
124827937|NCT00909389|448998789|FG000|Overall Study|Death|4|||
124827938|NCT00909389|448998789|FG000|Overall Study|Poor Compliance|16|||
124827939|NCT00909389|448998789|FG000|Overall Study|Lost to Follow-up|4|||
124827940|NCT00909389|448998789|FG000|Overall Study|No Information|103|||
124827941|NCT00003492|448998790|FG000|Overall Study|Not evaluable|6|||
124827942|NCT00597766|448998793|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
124827943|NCT00597766|448998794|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
124827944|NCT00597766|448998795|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
124827945|NCT00597766|448998793|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
124827946|NCT00597766|448998794|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
124827947|NCT00597766|448998795|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
124827948|NCT00847704|448998798|FG000|Overall Study|Withdrawal by Subject|1|||
124827949|NCT03036072|448998801|FG000|Overall Study|Death|0|||
124827950|NCT03036072|448998802|FG001|Overall Study|Death|1|||
124827951|NCT03036072|448998801|FG000|Overall Study|Withdrawal by Subject|0|||
124827952|NCT03036072|448998802|FG001|Overall Study|Withdrawal by Subject|1|||
124827953|NCT03036072|448998801|FG000|Overall Study|Physician Decision|0|||
124827954|NCT03036072|448998802|FG001|Overall Study|Physician Decision|1|||
124827955|NCT02111850|448998803|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827956|NCT02111850|448998804|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827957|NCT02111850|448998805|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827958|NCT02111850|448998806|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827959|NCT02111850|448998807|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
124827960|NCT02111850|448998808|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827961|NCT02111850|448998809|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827962|NCT02111850|448998810|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827963|NCT02111850|448998811|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827964|NCT02111850|448998812|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827965|NCT02111850|448998813|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
124827966|NCT00513474|448998814|FG000|Overall Study|Death|6|||
124827967|NCT00513474|448998815|FG001|Overall Study|Death|9|||
124827968|NCT00513474|448998814|FG000|Overall Study|Participant Withdrew Consent|1|||
124827969|NCT00513474|448998815|FG001|Overall Study|Participant Withdrew Consent|0|||
124827970|NCT00605813|449000825|FG000|Overall Study|Protocol Violation|25|||
124827971|NCT00573755|449000826|FG000|Overall Study|Still receiving treatment|1|||
124827972|NCT00573755|449000827|FG001|Overall Study|Still receiving treatment|0|||
124827973|NCT02132767|449000830|FG000|Overall Study|Death|3|||
124827974|NCT02132767|449000831|FG001|Overall Study|Death|2|||
124827975|NCT02132767|449000830|FG000|Overall Study|Withdrawal by Subject|10|||
124827976|NCT02132767|449000831|FG001|Overall Study|Withdrawal by Subject|9|||
124827977|NCT02132767|449000830|FG000|Overall Study|Lost to Follow-up|4|||
124827978|NCT02132767|449000831|FG001|Overall Study|Lost to Follow-up|4|||
124827979|NCT00778700|449000834|FG000|Overall Study|Adverse Event|6|||
124827980|NCT00778700|449000835|FG001|Overall Study|Adverse Event|1|||
124827981|NCT00778700|449000836|FG002|Overall Study|Adverse Event|3|||
124827982|NCT00778700|449000837|FG003|Overall Study|Adverse Event|5|||
124827983|NCT00778700|449000834|FG000|Overall Study|Protocol Violation|1|||
124827984|NCT00778700|449000835|FG001|Overall Study|Protocol Violation|1|||
124827985|NCT00778700|449000836|FG002|Overall Study|Protocol Violation|0|||
124827986|NCT00778700|449000837|FG003|Overall Study|Protocol Violation|0|||
124827987|NCT00778700|449000834|FG000|Overall Study|Subject Withdrew Consent|6|||
124827988|NCT00778700|449000835|FG001|Overall Study|Subject Withdrew Consent|4|||
124827989|NCT00778700|449000836|FG002|Overall Study|Subject Withdrew Consent|1|||
124827990|NCT00778700|449000837|FG003|Overall Study|Subject Withdrew Consent|4|||
124827991|NCT00778700|449000834|FG000|Overall Study|Lost to Follow-up|3|||
124827992|NCT00778700|449000835|FG001|Overall Study|Lost to Follow-up|1|||
124827993|NCT00778700|449000836|FG002|Overall Study|Lost to Follow-up|0|||
124827994|NCT00778700|449000837|FG003|Overall Study|Lost to Follow-up|1|||
124827995|NCT00778700|449000834|FG000|Overall Study|Reason not Specified|2|||
124827996|NCT00778700|449000835|FG001|Overall Study|Reason not Specified|0|||
124827997|NCT00778700|449000836|FG002|Overall Study|Reason not Specified|1|||
124827998|NCT00778700|449000837|FG003|Overall Study|Reason not Specified|3|||
124827999|NCT00778700|449000834|FG000|Overall Study|Other|0|||
124828000|NCT00778700|449000835|FG001|Overall Study|Other|0|||
124828001|NCT00778700|449000836|FG002|Overall Study|Other|1|||
124828002|NCT00778700|449000837|FG003|Overall Study|Other|0|||
124828003|NCT00383149|449000851|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
124828004|NCT00383149|449000851|FG000|Overall Study|Death|2|||
124828005|NCT00383149|449000851|FG000|Overall Study|Disease Progression|38|||
124828006|NCT00383149|449000851|FG000|Overall Study|Lost to Follow-up|1|||
124828007|NCT00383149|449000851|FG000|Overall Study|Other|1|||
124828008|NCT00383149|449000851|FG000|Overall Study|Study Drug Toxicity|4|||
124828009|NCT00383149|449000851|FG000|Overall Study|Request to Discontinue Treatment|4|||
124828010|NCT00383149|449000851|FG000|Overall Study|Participant Withdrew Consent|1|||
124828011|NCT00453544|449000852|FG000|Overall Study|Withdrawal by Subject|1|||
124828012|NCT00453544|449000853|FG001|Overall Study|Withdrawal by Subject|0|||
124828013|NCT00453544|449000854|FG002|Overall Study|Withdrawal by Subject|0|||
124828014|NCT00453544|449000855|FG003|Overall Study|Withdrawal by Subject|0|||
124828015|NCT00453544|449000852|FG000|Overall Study|Primary outcome measure not completed|1|||
124828016|NCT00453544|449000853|FG001|Overall Study|Primary outcome measure not completed|1|||
124828017|NCT00453544|449000854|FG002|Overall Study|Primary outcome measure not completed|0|||
124828018|NCT00453544|449000855|FG003|Overall Study|Primary outcome measure not completed|1|||
124828019|NCT02457910|449000856|FG000|Overall Study|Withdrawal by Subject|0|||
124828020|NCT02457910|449000857|FG001|Overall Study|Withdrawal by Subject|0|||
124828021|NCT02457910|449000858|FG002|Overall Study|Withdrawal by Subject|0|||
124828022|NCT02457910|449000859|FG003|Overall Study|Withdrawal by Subject|0|||
124828023|NCT02457910|449000860|FG004|Overall Study|Withdrawal by Subject|0|||
124828024|NCT02457910|449000861|FG005|Overall Study|Withdrawal by Subject|1|||
124828025|NCT02457910|449000856|FG000|Overall Study|Adverse Event|0|||
124828026|NCT02457910|449000857|FG001|Overall Study|Adverse Event|2|||
124828027|NCT02457910|449000858|FG002|Overall Study|Adverse Event|1|||
124828028|NCT02457910|449000859|FG003|Overall Study|Adverse Event|1|||
124828029|NCT02457910|449000860|FG004|Overall Study|Adverse Event|1|||
124828030|NCT02457910|449000861|FG005|Overall Study|Adverse Event|3|||
124828031|NCT02457910|449000856|FG000|Overall Study|Disease progression|3|||
124828032|NCT02457910|449000857|FG001|Overall Study|Disease progression|3|||
124828033|NCT02457910|449000858|FG002|Overall Study|Disease progression|1|||
124828034|NCT02457910|449000859|FG003|Overall Study|Disease progression|1|||
124828035|NCT02457910|449000860|FG004|Overall Study|Disease progression|4|||
124828036|NCT02457910|449000861|FG005|Overall Study|Disease progression|6|||
124828037|NCT02457910|449000856|FG000|Overall Study|Other complicating illness|0|||
124828038|NCT02457910|449000857|FG001|Overall Study|Other complicating illness|0|||
124828039|NCT02457910|449000858|FG002|Overall Study|Other complicating illness|0|||
124828040|NCT02457910|449000859|FG003|Overall Study|Other complicating illness|0|||
124828041|NCT02457910|449000860|FG004|Overall Study|Other complicating illness|0|||
124828042|NCT02457910|449000861|FG005|Overall Study|Other complicating illness|1|||
124828043|NCT02457910|449000856|FG000|Overall Study|Death|0|||
124828044|NCT02457910|449000857|FG001|Overall Study|Death|0|||
124828045|NCT02457910|449000858|FG002|Overall Study|Death|1|||
124828046|NCT02457910|449000859|FG003|Overall Study|Death|0|||
124828047|NCT02457910|449000860|FG004|Overall Study|Death|0|||
124828048|NCT02457910|449000861|FG005|Overall Study|Death|0|||
124828049|NCT03721276|449000864|FG000|Overall Study|Lost to Follow-up|5|||
124828050|NCT03721276|449000865|FG001|Overall Study|Lost to Follow-up|3|||
124828051|NCT03721276|449000864|FG000|Overall Study|Adverse Event|0|||
124828052|NCT03721276|449000865|FG001|Overall Study|Adverse Event|1|||
124828053|NCT00450333|449000866|FG000|Overall Study|Study terminated|47|||
124638610|NCT03850483|448294500|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
124638611|NCT03850483|448294501|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
124638612|NCT03850483|448294502|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
124638613|NCT03850483|448294503|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
124638614|NCT03850483|448294494|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
124638615|NCT03850483|448294495|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
124638616|NCT03850483|448294496|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
124638617|NCT03850483|448294497|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
124638618|NCT03850483|448294498|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
124828054|NCT00450333|449000867|FG001|Overall Study|Study terminated|54|||
124828055|NCT00450333|449000868|FG002|Overall Study|Study terminated|16|||
124828056|NCT00450333|449000869|FG003|Overall Study|Study terminated|21|||
124828057|NCT00450333|449000866|FG000|Overall Study|Adverse Event|1|||
124828058|NCT00450333|449000867|FG001|Overall Study|Adverse Event|7|||
124828059|NCT00450333|449000868|FG002|Overall Study|Adverse Event|2|||
124828060|NCT00450333|449000869|FG003|Overall Study|Adverse Event|2|||
124828061|NCT00450333|449000866|FG000|Overall Study|Protocol Violation|1|||
124828062|NCT00450333|449000867|FG001|Overall Study|Protocol Violation|0|||
124828063|NCT00450333|449000868|FG002|Overall Study|Protocol Violation|1|||
124828064|NCT00450333|449000869|FG003|Overall Study|Protocol Violation|0|||
124828065|NCT00450333|449000866|FG000|Overall Study|Withdrawal by Subject|1|||
124828066|NCT00450333|449000867|FG001|Overall Study|Withdrawal by Subject|0|||
124828067|NCT00450333|449000868|FG002|Overall Study|Withdrawal by Subject|3|||
124828068|NCT00450333|449000869|FG003|Overall Study|Withdrawal by Subject|0|||
124828069|NCT00450333|449000866|FG000|Overall Study|Kidney transplant|1|||
124828070|NCT00450333|449000867|FG001|Overall Study|Kidney transplant|0|||
124828071|NCT00450333|449000868|FG002|Overall Study|Kidney transplant|1|||
124828072|NCT00450333|449000869|FG003|Overall Study|Kidney transplant|3|||
124828073|NCT00450333|449000866|FG000|Overall Study|Death|3|||
124828074|NCT00450333|449000867|FG001|Overall Study|Death|2|||
124828075|NCT00450333|449000868|FG002|Overall Study|Death|2|||
124828076|NCT00450333|449000869|FG003|Overall Study|Death|2|||
124828077|NCT02375113|449000872|FG000|Overall Study|Undisclosed Reason(s).|1|||
124828078|NCT02375113|449000873|FG001|Overall Study|Undisclosed Reason(s).|1|||
124828079|NCT02375113|449000872|FG000|Overall Study|Poor adherence (<70%).|1|||
124828080|NCT02375113|449000873|FG001|Overall Study|Poor adherence (<70%).|0|||
124828081|NCT02375113|449000872|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
124828082|NCT02375113|449000873|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
124828083|NCT00416078|449000886|FG000|Overall Study|Death|3|||
124828084|NCT00416078|449000887|FG001|Overall Study|Death|4|||
124828085|NCT00416078|449000886|FG000|Overall Study|Withdrawal by Subject|3|||
124828086|NCT00416078|449000887|FG001|Overall Study|Withdrawal by Subject|2|||
124828087|NCT00416078|449000886|FG000|Overall Study|Physician Decision|1|||
124828088|NCT00416078|449000887|FG001|Overall Study|Physician Decision|0|||
124828089|NCT00416078|449000886|FG000|Overall Study|Lost to Follow-up|4|||
124828090|NCT00416078|449000887|FG001|Overall Study|Lost to Follow-up|2|||
124828091|NCT01829230|449000892|FG000|Overall Study|Protocol Violation|0|||
124828092|NCT01829230|449000893|FG001|Overall Study|Protocol Violation|2|||
124828093|NCT01829230|449000892|FG000|Overall Study|Withdrawal by Subject|0|||
124828094|NCT01829230|449000893|FG001|Overall Study|Withdrawal by Subject|1|||
124828095|NCT01829230|449000892|FG000|Overall Study|Lost to Follow-up|1|||
124638619|NCT03850483|448294499|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
124638620|NCT03850483|448294500|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
124638621|NCT03850483|448294501|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
124638622|NCT03850483|448294502|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
124638623|NCT03850483|448294503|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
124638624|NCT03850483|448294494|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
124638625|NCT03850483|448294495|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
124638626|NCT03850483|448294496|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
124638627|NCT03850483|448294497|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
124638628|NCT03850483|448294498|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
124638629|NCT03850483|448294499|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
124638630|NCT03850483|448294500|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
124638631|NCT03850483|448294501|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
124638632|NCT03850483|448294502|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
124638633|NCT03850483|448294503|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
124638634|NCT03850483|448294494|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
124638635|NCT03850483|448294495|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
124638636|NCT03850483|448294496|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
124638637|NCT03850483|448294497|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
124638638|NCT03850483|448294498|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
124638639|NCT03850483|448294499|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
124638640|NCT03850483|448294500|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
124638641|NCT03850483|448294501|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
124638642|NCT03850483|448294502|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
124638643|NCT03850483|448294503|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
124638644|NCT03850483|448294494|FG000|Treatment for Stage 1|Death|0|||
124638645|NCT03850483|448294495|FG001|Treatment for Stage 1|Death|0|||
124638646|NCT03850483|448294496|FG002|Treatment for Stage 1|Death|0|||
124638647|NCT03850483|448294497|FG003|Treatment for Stage 1|Death|0|||
124638648|NCT03850483|448294498|FG004|Treatment for Stage 1|Death|0|||
124638649|NCT03850483|448294499|FG005|Treatment for Stage 1|Death|1|||
124638650|NCT03850483|448294500|FG006|Treatment for Stage 1|Death|0|||
124638651|NCT03850483|448294501|FG007|Treatment for Stage 1|Death|0|||
124638652|NCT03850483|448294502|FG008|Treatment for Stage 1|Death|0|||
124638653|NCT03850483|448294503|FG009|Treatment for Stage 1|Death|0|||
124638654|NCT03850483|448294494|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
124638655|NCT03850483|448294495|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
124638656|NCT03850483|448294496|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
124638657|NCT03850483|448294497|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
124638658|NCT03850483|448294498|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
124638659|NCT03850483|448294499|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
124828096|NCT01829230|449000893|FG001|Overall Study|Lost to Follow-up|1|||
124828097|NCT04387435|449000897|FG000|Overall Study|Physician Decision|1|||
124828098|NCT03855280|449000898|FG000|Treatment Phase|Adverse Event|1|||
124828099|NCT03855280|449000898|FG000|Treatment Phase|Withdrawal by Subject|1|||
124828100|NCT03855280|449000898|FG000|Continuation Phase|Protocol Violation|1|||
124828101|NCT03855280|449000898|FG000|Continuation Phase|Adverse Event|1|||
124828102|NCT03855280|449000898|FG000|Continuation Phase|Sponsor Concluded Study|1|||
124828103|NCT00969150|449000903|FG000|Overall Study|Adverse Event|4|||
124828104|NCT00969150|449000904|FG001|Overall Study|Adverse Event|14|||
124828105|NCT00969150|449000903|FG000|Overall Study|Lack of Efficacy|1|||
124828106|NCT00969150|449000904|FG001|Overall Study|Lack of Efficacy|1|||
124828107|NCT00969150|449000903|FG000|Overall Study|Protocol Violation|9|||
124828108|NCT00969150|449000904|FG001|Overall Study|Protocol Violation|12|||
124828109|NCT00969150|449000903|FG000|Overall Study|Withdrawal by Subject|13|||
124828110|NCT00969150|449000904|FG001|Overall Study|Withdrawal by Subject|9|||
124828111|NCT00969150|449000903|FG000|Overall Study|Lost to Follow-up|5|||
124828112|NCT00969150|449000904|FG001|Overall Study|Lost to Follow-up|4|||
124828113|NCT00969150|449000903|FG000|Overall Study|Other reasons|1|||
124828114|NCT00969150|449000904|FG001|Overall Study|Other reasons|0|||
124828115|NCT00461682|449000908|FG000|Overall Study|Protocol Violation|1|||
124828116|NCT00883116|449000911|FG000|Overall Study|Adverse event unrelated to study drug|5|||
124828117|NCT00883116|449000912|FG001|Overall Study|Adverse event unrelated to study drug|10|||
124828118|NCT00883116|449000911|FG000|Overall Study|Death|6|||
124828119|NCT00883116|449000912|FG001|Overall Study|Death|2|||
124828120|NCT00883116|449000911|FG000|Overall Study|Disease progression|130|||
124828121|NCT00883116|449000912|FG001|Overall Study|Disease progression|128|||
124828122|NCT00883116|449000911|FG000|Overall Study|Lost to Follow-up|0|||
124828123|NCT00883116|449000912|FG001|Overall Study|Lost to Follow-up|1|||
124828124|NCT00883116|449000911|FG000|Overall Study|Maximum clinical benefit|13|||
124828125|NCT00883116|449000912|FG001|Overall Study|Maximum clinical benefit|46|||
124828126|NCT00883116|449000911|FG000|Overall Study|Not identified|3|||
124828127|NCT00883116|449000912|FG001|Overall Study|Not identified|6|||
124828128|NCT00883116|449000911|FG000|Overall Study|Study drug toxicity|36|||
124828129|NCT00883116|449000912|FG001|Overall Study|Study drug toxicity|16|||
124828130|NCT00883116|449000911|FG000|Overall Study|Withdrawal by Subject|14|||
124828131|NCT00883116|449000912|FG001|Overall Study|Withdrawal by Subject|8|||
124828132|NCT00883116|449000911|FG000|Overall Study|No longer meets study criteria|2|||
124828133|NCT00883116|449000912|FG001|Overall Study|No longer meets study criteria|2|||
124828134|NCT01361464|449000913|FG000|Overall Study|Death|1|||
124828135|NCT01361464|449000913|FG000|Overall Study|Withdrawal by Subject|2|||
124828136|NCT04128267|449000922|FG000|Overall Study|Withdrawal by Subject|6|||
124828137|NCT04128267|449000922|FG000|Overall Study|Death|2|||
124828138|NCT04128267|449000922|FG000|Overall Study|Disease progression|1|||
124828139|NCT04128267|449000922|FG000|Overall Study|Participant had other medical issues|4|||
124828140|NCT04128267|449000922|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
124828141|NCT04501666|449000923|FG000|Overall Study|Physician Decision|0|||
124828142|NCT04501666|449000924|FG001|Overall Study|Physician Decision|1|||
124828143|NCT04501666|449000923|FG000|Overall Study|Adverse Event|12|||
124828144|NCT04501666|449000924|FG001|Overall Study|Adverse Event|4|||
124828145|NCT04501666|449000923|FG000|Overall Study|Subject's request|10|||
124828146|NCT04501666|449000924|FG001|Overall Study|Subject's request|6|||
124828147|NCT04501666|449000923|FG000|Overall Study|Protocol Deviation|2|||
124828148|NCT04501666|449000924|FG001|Overall Study|Protocol Deviation|1|||
124828149|NCT04501666|449000923|FG000|Overall Study|Other-- site permanently closing|0|||
124828150|NCT04501666|449000924|FG001|Overall Study|Other-- site permanently closing|1|||
124828151|NCT03021265|449000925|FG000|Overall Study|Adverse Event|29|||
124828152|NCT03021265|449000925|FG000|Overall Study|Lack of Efficacy|3|||
124828153|NCT03021265|449000925|FG000|Overall Study|Improved|17|||
124828154|NCT03021265|449000925|FG000|Overall Study|Lost to Follow-up|67|||
124828155|NCT03021265|449000925|FG000|Overall Study|No reason given|2|||
124828156|NCT03021265|449000925|FG000|Overall Study|No visit since the first visit|4|||
124828157|NCT01722071|449000926|FG000|Overall Study|Protocol Violation|1|||
124828158|NCT01722071|449000927|FG001|Overall Study|Protocol Violation|0|||
124828159|NCT00642941|449000928|FG000|Overall Study|Physician Decision|3|||
124828160|NCT00642941|449000929|FG001|Overall Study|Physician Decision|1|||
124828161|NCT00642941|449000930|FG002|Overall Study|Physician Decision|0|||
124828162|NCT00642941|449000931|FG003|Overall Study|Physician Decision|0|||
124828163|NCT00642941|449000932|FG004|Overall Study|Physician Decision|0|||
124828164|NCT00642941|449000933|FG005|Overall Study|Physician Decision|0|||
124828165|NCT00642941|449000934|FG006|Overall Study|Physician Decision|1|||
124828166|NCT00642941|449000935|FG007|Overall Study|Physician Decision|0|||
124828167|NCT00642941|449000936|FG008|Overall Study|Physician Decision|0|||
124828168|NCT00642941|449000937|FG009|Overall Study|Physician Decision|1|||
124828169|NCT00642941|449000938|FG010|Overall Study|Physician Decision|0|||
124828170|NCT00642941|449000939|FG011|Overall Study|Physician Decision|1|||
124828171|NCT00642941|449000928|FG000|Overall Study|Death|4|||
124828172|NCT00642941|449000929|FG001|Overall Study|Death|0|||
124828173|NCT00642941|449000930|FG002|Overall Study|Death|1|||
124828174|NCT00642941|449000931|FG003|Overall Study|Death|1|||
124828175|NCT00642941|449000932|FG004|Overall Study|Death|2|||
124828176|NCT00642941|449000933|FG005|Overall Study|Death|1|||
124828177|NCT00642941|449000934|FG006|Overall Study|Death|0|||
124828178|NCT00642941|449000935|FG007|Overall Study|Death|0|||
124828179|NCT00642941|449000936|FG008|Overall Study|Death|0|||
124828180|NCT00642941|449000937|FG009|Overall Study|Death|0|||
124828181|NCT00642941|449000938|FG010|Overall Study|Death|0|||
124828182|NCT00642941|449000939|FG011|Overall Study|Death|1|||
124828183|NCT00642941|449000928|FG000|Overall Study|Study closed by Sponsor|0|||
124828184|NCT00642941|449000929|FG001|Overall Study|Study closed by Sponsor|1|||
124828185|NCT00642941|449000930|FG002|Overall Study|Study closed by Sponsor|0|||
124828186|NCT00642941|449000931|FG003|Overall Study|Study closed by Sponsor|0|||
124828187|NCT00642941|449000932|FG004|Overall Study|Study closed by Sponsor|0|||
124828188|NCT00642941|449000933|FG005|Overall Study|Study closed by Sponsor|0|||
124828189|NCT00642941|449000934|FG006|Overall Study|Study closed by Sponsor|0|||
124828190|NCT00642941|449000935|FG007|Overall Study|Study closed by Sponsor|0|||
124828191|NCT00642941|449000936|FG008|Overall Study|Study closed by Sponsor|0|||
124828192|NCT00642941|449000937|FG009|Overall Study|Study closed by Sponsor|0|||
124828193|NCT00642941|449000938|FG010|Overall Study|Study closed by Sponsor|0|||
124828194|NCT00642941|449000939|FG011|Overall Study|Study closed by Sponsor|0|||
124828195|NCT00642941|449000928|FG000|Overall Study|Withdrawal by Subject|1|||
124828196|NCT00642941|449000929|FG001|Overall Study|Withdrawal by Subject|0|||
124828197|NCT00642941|449000930|FG002|Overall Study|Withdrawal by Subject|0|||
124828198|NCT00642941|449000931|FG003|Overall Study|Withdrawal by Subject|2|||
124828199|NCT00642941|449000932|FG004|Overall Study|Withdrawal by Subject|0|||
124828200|NCT00642941|449000933|FG005|Overall Study|Withdrawal by Subject|0|||
124828201|NCT00642941|449000934|FG006|Overall Study|Withdrawal by Subject|2|||
124828202|NCT00642941|449000935|FG007|Overall Study|Withdrawal by Subject|0|||
124828203|NCT00642941|449000936|FG008|Overall Study|Withdrawal by Subject|1|||
124828204|NCT00642941|449000937|FG009|Overall Study|Withdrawal by Subject|0|||
124828205|NCT00642941|449000938|FG010|Overall Study|Withdrawal by Subject|0|||
124828206|NCT00642941|449000939|FG011|Overall Study|Withdrawal by Subject|1|||
124828207|NCT00642941|449000928|FG000|Overall Study|Protocol Violation|0|||
124828208|NCT00642941|449000929|FG001|Overall Study|Protocol Violation|0|||
124828209|NCT00642941|449000930|FG002|Overall Study|Protocol Violation|0|||
124828210|NCT00642941|449000931|FG003|Overall Study|Protocol Violation|0|||
124828211|NCT00642941|449000932|FG004|Overall Study|Protocol Violation|0|||
124828212|NCT00642941|449000933|FG005|Overall Study|Protocol Violation|0|||
124828213|NCT00642941|449000934|FG006|Overall Study|Protocol Violation|1|||
124828214|NCT00642941|449000935|FG007|Overall Study|Protocol Violation|0|||
124828215|NCT00642941|449000936|FG008|Overall Study|Protocol Violation|0|||
124828216|NCT00642941|449000937|FG009|Overall Study|Protocol Violation|0|||
124828217|NCT00642941|449000938|FG010|Overall Study|Protocol Violation|0|||
124828218|NCT00642941|449000939|FG011|Overall Study|Protocol Violation|0|||
124828219|NCT00642941|449000928|FG000|Overall Study|Adverse Event|1|||
124828220|NCT00642941|449000929|FG001|Overall Study|Adverse Event|1|||
124828221|NCT00642941|449000930|FG002|Overall Study|Adverse Event|0|||
124828222|NCT00642941|449000931|FG003|Overall Study|Adverse Event|0|||
124828223|NCT00642941|449000932|FG004|Overall Study|Adverse Event|0|||
124828224|NCT00642941|449000933|FG005|Overall Study|Adverse Event|0|||
124828225|NCT00642941|449000934|FG006|Overall Study|Adverse Event|1|||
124828226|NCT00642941|449000935|FG007|Overall Study|Adverse Event|1|||
124828227|NCT00642941|449000936|FG008|Overall Study|Adverse Event|0|||
124828228|NCT00642941|449000937|FG009|Overall Study|Adverse Event|1|||
124828229|NCT00642941|449000938|FG010|Overall Study|Adverse Event|0|||
124828230|NCT00642941|449000939|FG011|Overall Study|Adverse Event|0|||
124828231|NCT00642941|449000928|FG000|Overall Study|Other|1|||
124828232|NCT00642941|449000929|FG001|Overall Study|Other|1|||
124638660|NCT03850483|448294500|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
124638661|NCT03850483|448294501|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
124638662|NCT03850483|448294502|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
124638663|NCT03850483|448294503|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
124638664|NCT03850483|448294494|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
124638665|NCT03850483|448294495|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
124638666|NCT03850483|448294496|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
124828233|NCT00642941|449000930|FG002|Overall Study|Other|1|||
124828234|NCT00642941|449000931|FG003|Overall Study|Other|1|||
124828235|NCT00642941|449000932|FG004|Overall Study|Other|0|||
124828236|NCT00642941|449000933|FG005|Overall Study|Other|1|||
124828237|NCT00642941|449000934|FG006|Overall Study|Other|0|||
124828238|NCT00642941|449000935|FG007|Overall Study|Other|1|||
124828239|NCT00642941|449000936|FG008|Overall Study|Other|0|||
124828240|NCT00642941|449000937|FG009|Overall Study|Other|0|||
124828241|NCT00642941|449000938|FG010|Overall Study|Other|0|||
124828242|NCT00642941|449000939|FG011|Overall Study|Other|1|||
124828243|NCT00642941|449000928|FG000|Overall Study|Disease progression|60|||
124828244|NCT00642941|449000929|FG001|Overall Study|Disease progression|50|||
124828245|NCT00642941|449000930|FG002|Overall Study|Disease progression|5|||
124828246|NCT00642941|449000931|FG003|Overall Study|Disease progression|36|||
124828247|NCT00642941|449000932|FG004|Overall Study|Disease progression|23|||
124828248|NCT00642941|449000933|FG005|Overall Study|Disease progression|39|||
124828249|NCT00642941|449000934|FG006|Overall Study|Disease progression|18|||
124828250|NCT00642941|449000935|FG007|Overall Study|Disease progression|12|||
124828251|NCT00642941|449000936|FG008|Overall Study|Disease progression|10|||
124828252|NCT00642941|449000937|FG009|Overall Study|Disease progression|7|||
124828253|NCT00642941|449000938|FG010|Overall Study|Disease progression|12|||
124828254|NCT00642941|449000939|FG011|Overall Study|Disease progression|7|||
124828255|NCT01614067|449000940|FG000|Overall Study|Pregnancy|1|||
124828256|NCT01614067|449000941|FG001|Overall Study|Pregnancy|0|||
124828257|NCT01614067|449000940|FG000|Overall Study|Physician Decision|6|||
124828258|NCT01614067|449000941|FG001|Overall Study|Physician Decision|5|||
124828259|NCT01614067|449000940|FG000|Overall Study|Withdrawal by Subject|0|||
124828260|NCT01614067|449000941|FG001|Overall Study|Withdrawal by Subject|1|||
124828261|NCT01614067|449000940|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
124828262|NCT01614067|449000941|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
124828263|NCT01505868|449000942|FG000|Overall Study|Withdrawal by Subject|1|||
124828264|NCT01505868|449000943|FG001|Overall Study|Withdrawal by Subject|0|||
124828265|NCT01505868|449000944|FG002|Overall Study|Withdrawal by Subject|0|||
124828266|NCT01505868|449000945|FG003|Overall Study|Withdrawal by Subject|0|||
124828267|NCT01505868|449000946|FG004|Overall Study|Withdrawal by Subject|0|||
124828268|NCT02289079|449000947|FG000|Overall Study|Physician Decision|2|||
124828269|NCT02289079|449000948|FG001|Overall Study|Physician Decision|0|||
124828270|NCT02289079|449000947|FG000|Overall Study|Lost to Follow-up|0|||
124828271|NCT02289079|449000948|FG001|Overall Study|Lost to Follow-up|1|||
124828272|NCT00680043|449000949|FG000|Overall Study|Withdrawal by Subject|1|||
124828273|NCT00680043|449000950|FG001|Overall Study|Withdrawal by Subject|0|||
124828274|NCT00680043|449000951|FG002|Overall Study|Withdrawal by Subject|0|||
124828275|NCT00680043|449000949|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
124828276|NCT00680043|449000950|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
124828277|NCT00680043|449000951|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
124828278|NCT00680043|449000949|FG000|Overall Study|Renal Transplant|1|||
124828279|NCT00680043|449000950|FG001|Overall Study|Renal Transplant|0|||
124828280|NCT00680043|449000951|FG002|Overall Study|Renal Transplant|4|||
124828281|NCT00553150|449000952|FG000|Overall Study|Withdrawal by Subject|0|||
124828282|NCT00553150|449000953|FG001|Overall Study|Withdrawal by Subject|0|||
124828283|NCT00553150|449000954|FG002|Overall Study|Withdrawal by Subject|0|||
124828284|NCT00553150|449000955|FG003|Overall Study|Withdrawal by Subject|2|||
124828285|NCT00553150|449000952|FG000|Overall Study|Protocol Violation|0|||
124828286|NCT00553150|449000953|FG001|Overall Study|Protocol Violation|0|||
124828287|NCT00553150|449000954|FG002|Overall Study|Protocol Violation|0|||
124828288|NCT00553150|449000955|FG003|Overall Study|Protocol Violation|1|||
124828289|NCT00553150|449000952|FG000|Overall Study|Ineligible|0|||
124828290|NCT00553150|449000953|FG001|Overall Study|Ineligible|0|||
124828291|NCT00553150|449000954|FG002|Overall Study|Ineligible|0|||
124828292|NCT00553150|449000955|FG003|Overall Study|Ineligible|1|||
124828293|NCT03061331|449000956|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
124828294|NCT03061331|449000957|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
124828295|NCT02998840|449000961|FG000|Overall Study|Lost to Follow-up|1|||
124828296|NCT02998840|449000962|FG001|Overall Study|Lost to Follow-up|1|||
124828297|NCT02998840|449000963|FG002|Overall Study|Lost to Follow-up|2|||
124828298|NCT02998840|449000964|FG003|Overall Study|Lost to Follow-up|3|||
124828299|NCT02998840|449000961|FG000|Overall Study|Withdrawal by Subject|1|||
124828300|NCT02998840|449000962|FG001|Overall Study|Withdrawal by Subject|1|||
124828301|NCT02998840|449000963|FG002|Overall Study|Withdrawal by Subject|0|||
124828302|NCT02998840|449000964|FG003|Overall Study|Withdrawal by Subject|1|||
124828303|NCT02998840|449000961|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
124828304|NCT02998840|449000962|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
124828305|NCT02998840|449000963|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
124828306|NCT02998840|449000964|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
124828307|NCT01686633|449000965|FG000|Overall Study|Lack of Efficacy|33|||
124828308|NCT01686633|449000966|FG001|Overall Study|Lack of Efficacy|13|||
124828309|NCT01686633|449000967|FG002|Overall Study|Lack of Efficacy|11|||
124638667|NCT03850483|448294497|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
124638668|NCT03850483|448294498|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
124638669|NCT03850483|448294499|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
124638670|NCT03850483|448294500|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
124828310|NCT01686633|449000965|FG000|Overall Study|Withdrawal by Subject|8|||
124828311|NCT01686633|449000966|FG001|Overall Study|Withdrawal by Subject|8|||
124828312|NCT01686633|449000967|FG002|Overall Study|Withdrawal by Subject|5|||
124828313|NCT01686633|449000965|FG000|Overall Study|Physician Decision|3|||
124828314|NCT01686633|449000966|FG001|Overall Study|Physician Decision|4|||
124828315|NCT01686633|449000967|FG002|Overall Study|Physician Decision|4|||
124828316|NCT01686633|449000965|FG000|Overall Study|Adverse Event|4|||
124828317|NCT01686633|449000966|FG001|Overall Study|Adverse Event|3|||
124828318|NCT01686633|449000967|FG002|Overall Study|Adverse Event|3|||
124828319|NCT01686633|449000965|FG000|Overall Study|Protocol Violation|2|||
124828320|NCT01686633|449000966|FG001|Overall Study|Protocol Violation|3|||
124828321|NCT01686633|449000967|FG002|Overall Study|Protocol Violation|0|||
124828322|NCT01686633|449000965|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
124828323|NCT01686633|449000966|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
124828324|NCT01686633|449000967|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
124828325|NCT01686633|449000965|FG000|Overall Study|Lost to Follow-up|0|||
124828326|NCT01686633|449000966|FG001|Overall Study|Lost to Follow-up|1|||
124828327|NCT01686633|449000967|FG002|Overall Study|Lost to Follow-up|1|||
124828328|NCT00195676|449000969|FG000|Period O - Open-label Treatment|Adverse Event|82|||
124828329|NCT00195676|449000969|FG000|Period O - Open-label Treatment|Death|6|||
124828330|NCT00195676|449000969|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
124828331|NCT00195676|449000969|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
124638671|NCT03850483|448294501|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
124638672|NCT03850483|448294502|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
124638673|NCT03850483|448294503|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
124638674|NCT03850483|448294494|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
124638675|NCT03850483|448294495|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
124638676|NCT03850483|448294496|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
124638677|NCT03850483|448294497|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
124638678|NCT03850483|448294498|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
124638679|NCT03850483|448294499|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
124638680|NCT03850483|448294500|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
124638681|NCT03850483|448294501|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
124638682|NCT03850483|448294502|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
124638683|NCT03850483|448294503|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
124638684|NCT03850483|448294494|FG000|Follow-up for Stage 1|Physician Decision|0|||
124638685|NCT03850483|448294495|FG001|Follow-up for Stage 1|Physician Decision|0|||
124638686|NCT03850483|448294496|FG002|Follow-up for Stage 1|Physician Decision|0|||
124638687|NCT03850483|448294497|FG003|Follow-up for Stage 1|Physician Decision|0|||
124638688|NCT03850483|448294498|FG004|Follow-up for Stage 1|Physician Decision|1|||
124638689|NCT03850483|448294499|FG005|Follow-up for Stage 1|Physician Decision|0|||
124638690|NCT03850483|448294500|FG006|Follow-up for Stage 1|Physician Decision|1|||
124638691|NCT03850483|448294501|FG007|Follow-up for Stage 1|Physician Decision|0|||
124638692|NCT03850483|448294502|FG008|Follow-up for Stage 1|Physician Decision|0|||
124638693|NCT03850483|448294503|FG009|Follow-up for Stage 1|Physician Decision|0|||
124638694|NCT03850483|448294494|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
124638695|NCT03850483|448294495|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
124638696|NCT03850483|448294496|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
124638697|NCT03850483|448294497|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
124638698|NCT03850483|448294498|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
124638699|NCT03850483|448294499|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
124638700|NCT03850483|448294500|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
124638701|NCT03850483|448294501|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
124638702|NCT03850483|448294502|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
124638703|NCT03850483|448294503|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
124638704|NCT03850483|448294494|FG000|Follow-up for Stage 1|Adverse Event|0|||
124638705|NCT03850483|448294495|FG001|Follow-up for Stage 1|Adverse Event|0|||
124638706|NCT03850483|448294496|FG002|Follow-up for Stage 1|Adverse Event|1|||
124638707|NCT03850483|448294497|FG003|Follow-up for Stage 1|Adverse Event|0|||
124638708|NCT03850483|448294498|FG004|Follow-up for Stage 1|Adverse Event|0|||
124638709|NCT03850483|448294499|FG005|Follow-up for Stage 1|Adverse Event|1|||
124638710|NCT03850483|448294500|FG006|Follow-up for Stage 1|Adverse Event|0|||
124638711|NCT03850483|448294501|FG007|Follow-up for Stage 1|Adverse Event|0|||
124638712|NCT03850483|448294502|FG008|Follow-up for Stage 1|Adverse Event|0|||
124638713|NCT03850483|448294503|FG009|Follow-up for Stage 1|Adverse Event|0|||
124638714|NCT03850483|448294494|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
124638715|NCT03850483|448294495|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
124638716|NCT03850483|448294496|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
124638717|NCT03850483|448294497|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
124638718|NCT03850483|448294498|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
124638719|NCT03850483|448294499|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
124638720|NCT03850483|448294500|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
124638721|NCT03850483|448294501|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
124638722|NCT03850483|448294502|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
124638723|NCT03850483|448294503|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
124828332|NCT00195676|449000969|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
124638724|NCT03850483|448294494|FG000|Follow-up for Stage 1|Other|0|||
124638725|NCT03850483|448294495|FG001|Follow-up for Stage 1|Other|2|||
124638726|NCT03850483|448294496|FG002|Follow-up for Stage 1|Other|0|||
124638727|NCT03850483|448294497|FG003|Follow-up for Stage 1|Other|2|||
124638728|NCT03850483|448294498|FG004|Follow-up for Stage 1|Other|0|||
124638729|NCT03850483|448294499|FG005|Follow-up for Stage 1|Other|1|||
124638730|NCT03850483|448294500|FG006|Follow-up for Stage 1|Other|0|||
124638731|NCT03850483|448294501|FG007|Follow-up for Stage 1|Other|0|||
124828333|NCT00195676|449000969|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
124828334|NCT00195676|449000969|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
124828335|NCT00195676|449000969|FG000|Period O - Open-label Treatment|Other reasons|68|||
124828336|NCT00195676|449000969|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
124828337|NCT00195676|449000969|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
124828338|NCT00195676|449000969|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
124828339|NCT00195676|449000969|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
124828340|NCT00195676|449000969|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
124828341|NCT00195676|449000969|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
124828342|NCT00195676|449000969|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
124828343|NCT00195676|449000969|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
124828344|NCT00195676|449000969|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
124828345|NCT00195676|449000969|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
124828346|NCT00195676|449000969|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
124828347|NCT00195676|449000969|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
124828348|NCT00195676|449000969|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
124828349|NCT01189812|449000970|FG000|Overall Study|Withdrawal by Subject|2|||
124828350|NCT01189812|449000971|FG001|Overall Study|Withdrawal by Subject|3|||
124828351|NCT01189812|449000970|FG000|Overall Study|Adverse Event|1|||
124828352|NCT01189812|449000971|FG001|Overall Study|Adverse Event|0|||
124828353|NCT01189812|449000970|FG000|Overall Study|Out of Window|4|||
124828354|NCT01189812|449000971|FG001|Overall Study|Out of Window|3|||
124828355|NCT01189812|449000970|FG000|Overall Study|Moved out of State|1|||
124828356|NCT01189812|449000971|FG001|Overall Study|Moved out of State|2|||
124828357|NCT00616655|449000972|FG000|Overall Study|Adverse Event|10|||
124828358|NCT00616655|449000973|FG001|Overall Study|Adverse Event|7|||
124828359|NCT00616655|449000974|FG002|Overall Study|Adverse Event|12|||
124828360|NCT00616655|449000972|FG000|Overall Study|Lack of Efficacy|5|||
124828361|NCT00616655|449000973|FG001|Overall Study|Lack of Efficacy|5|||
124828362|NCT00616655|449000974|FG002|Overall Study|Lack of Efficacy|5|||
124828363|NCT00616655|449000972|FG000|Overall Study|Lost to Follow-up|3|||
124828364|NCT00616655|449000973|FG001|Overall Study|Lost to Follow-up|12|||
124828365|NCT00616655|449000974|FG002|Overall Study|Lost to Follow-up|10|||
124828366|NCT00616655|449000972|FG000|Overall Study|Protocol Violation|2|||
124828367|NCT00616655|449000973|FG001|Overall Study|Protocol Violation|4|||
124828368|NCT00616655|449000974|FG002|Overall Study|Protocol Violation|3|||
124828369|NCT00616655|449000972|FG000|Overall Study|Withdrawal by Subject|9|||
124828370|NCT00616655|449000973|FG001|Overall Study|Withdrawal by Subject|7|||
124828371|NCT00616655|449000974|FG002|Overall Study|Withdrawal by Subject|11|||
124828372|NCT00616655|449000972|FG000|Overall Study|Does not meet in/ex criteria|0|||
124828373|NCT00616655|449000973|FG001|Overall Study|Does not meet in/ex criteria|0|||
124828374|NCT00616655|449000974|FG002|Overall Study|Does not meet in/ex criteria|2|||
124828375|NCT00616655|449000972|FG000|Overall Study|Other|6|||
124828376|NCT00616655|449000973|FG001|Overall Study|Other|6|||
124828377|NCT00616655|449000974|FG002|Overall Study|Other|5|||
124828378|NCT03761147|449000975|FG000|Overall Study|Withdrawal by Subject|6|||
124828379|NCT03761147|449000976|FG001|Overall Study|Withdrawal by Subject|1|||
124828380|NCT03761147|449000975|FG000|Overall Study|Adverse Event|1|||
124828381|NCT03761147|449000976|FG001|Overall Study|Adverse Event|3|||
124828382|NCT00309842|449000978|FG000|Overall Study|Lost to Follow-up|1|||
124828383|NCT01026792|449000979|FG000|Overall Study|Protocol Violation|1|||
124828384|NCT00423150|449000980|FG000|Overall Study|Adverse Event|11|||
124828385|NCT00423150|449000980|FG000|Overall Study|Progression of disease being studied|69|||
124828386|NCT00423150|449000980|FG000|Overall Study|Withdrawal by Subject|1|||
124828387|NCT00423150|449000980|FG000|Overall Study|Non-compliance with protocol|1|||
124828388|NCT00423150|449000980|FG000|Overall Study|Administrative|4|||
124828389|NCT03204305|449000981|FG000|Overall Study|Lost to Follow-up|6|||
124828390|NCT03204305|449000982|FG001|Overall Study|Lost to Follow-up|4|||
124828391|NCT03204305|449000983|FG002|Overall Study|Lost to Follow-up|0|||
124828392|NCT03204305|449000984|FG003|Overall Study|Lost to Follow-up|0|||
124828393|NCT03204305|449000981|FG000|Overall Study|Physician Decision|1|||
124828394|NCT03204305|449000982|FG001|Overall Study|Physician Decision|0|||
124638732|NCT03850483|448294502|FG008|Follow-up for Stage 1|Other|0|||
124638733|NCT03850483|448294503|FG009|Follow-up for Stage 1|Other|0|||
124828395|NCT03204305|449000983|FG002|Overall Study|Physician Decision|0|||
124828396|NCT03204305|449000984|FG003|Overall Study|Physician Decision|0|||
124828397|NCT03204305|449000981|FG000|Overall Study|failure to place arterial line|2|||
124828398|NCT03204305|449000982|FG001|Overall Study|failure to place arterial line|1|||
124828399|NCT03204305|449000983|FG002|Overall Study|failure to place arterial line|0|||
124828400|NCT03204305|449000984|FG003|Overall Study|failure to place arterial line|0|||
124828401|NCT03204305|449000981|FG000|Overall Study|Withdrawal by Subject|2|||
124828402|NCT03204305|449000982|FG001|Overall Study|Withdrawal by Subject|0|||
124828403|NCT03204305|449000983|FG002|Overall Study|Withdrawal by Subject|0|||
124828404|NCT03204305|449000984|FG003|Overall Study|Withdrawal by Subject|0|||
124828405|NCT00535223|449000985|FG000|Overall Study|Withdrawal by Subject|4|||
124828406|NCT00535223|449000986|FG001|Overall Study|Withdrawal by Subject|1|||
124828407|NCT02953314|449000987|FG000|Overall Study|Adverse Event|0|||
124752838|NCT00858637|448716863|FG000|Active Comparison Phase|Physician Decision|1|||
124752839|NCT00858637|448716864|FG001|Active Comparison Phase|Physician Decision|0|||
124752840|NCT00858637|448716865|FG002|Active Comparison Phase|Physician Decision|0|||
124752841|NCT00858637|448716866|FG003|Active Comparison Phase|Physician Decision|1|||
124752842|NCT00858637|448716867|FG004|Active Comparison Phase|Physician Decision|0|||
124752843|NCT00858637|448716868|FG005|Active Comparison Phase|Physician Decision|0|||
124752844|NCT00858637|448716863|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
124752845|NCT00858637|448716864|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
124752846|NCT00858637|448716865|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
124752847|NCT00858637|448716866|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
124752848|NCT00858637|448716867|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
124752849|NCT00858637|448716868|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
124752850|NCT00858637|448716863|FG000|Active Comparison Phase|Other Reasons|1|||
124752851|NCT00858637|448716864|FG001|Active Comparison Phase|Other Reasons|0|||
124752852|NCT00858637|448716865|FG002|Active Comparison Phase|Other Reasons|0|||
124752853|NCT00858637|448716866|FG003|Active Comparison Phase|Other Reasons|1|||
124752854|NCT00858637|448716867|FG004|Active Comparison Phase|Other Reasons|0|||
124752855|NCT00858637|448716868|FG005|Active Comparison Phase|Other Reasons|0|||
124752856|NCT00858637|448716863|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
124752857|NCT00858637|448716864|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
124752858|NCT00858637|448716865|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
124752859|NCT00858637|448716866|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
124752860|NCT00858637|448716867|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
124752861|NCT00858637|448716868|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
124752862|NCT00858637|448716863|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
124752863|NCT00858637|448716864|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
124752864|NCT00858637|448716865|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
124752865|NCT00858637|448716866|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
124752866|NCT00858637|448716867|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
124752867|NCT00858637|448716868|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
124752868|NCT00835341|448716869|FG000|Overall Study|Lost to Follow-up|3|||
124752869|NCT00835341|448716870|FG001|Overall Study|Lost to Follow-up|12|||
124752870|NCT02305238|448716871|FG000|Overall Study|Death|2|||
124752871|NCT02305238|448716872|FG001|Overall Study|Death|1|||
124752872|NCT02305238|448716873|FG002|Overall Study|Death|0|||
124752873|NCT02305238|448716871|FG000|Overall Study|Progressive disease|4|||
124752874|NCT02305238|448716872|FG001|Overall Study|Progressive disease|4|||
124752875|NCT02305238|448716873|FG002|Overall Study|Progressive disease|0|||
124752876|NCT02305238|448716871|FG000|Overall Study|Logistical difficulties|1|||
124752877|NCT02305238|448716872|FG001|Overall Study|Logistical difficulties|3|||
124752878|NCT02305238|448716873|FG002|Overall Study|Logistical difficulties|0|||
124752879|NCT02305238|448716871|FG000|Overall Study|Protocol Violation|0|||
124752880|NCT02305238|448716872|FG001|Overall Study|Protocol Violation|3|||
124752881|NCT02305238|448716873|FG002|Overall Study|Protocol Violation|0|||
124752882|NCT02305238|448716871|FG000|Overall Study|Physician Decision|2|||
124752883|NCT02305238|448716872|FG001|Overall Study|Physician Decision|1|||
124752884|NCT02305238|448716873|FG002|Overall Study|Physician Decision|0|||
124752885|NCT02305238|448716871|FG000|Overall Study|Adverse Event|4|||
124752886|NCT02305238|448716872|FG001|Overall Study|Adverse Event|2|||
124752887|NCT02305238|448716873|FG002|Overall Study|Adverse Event|0|||
124752888|NCT02305238|448716871|FG000|Overall Study|Withdrawal by Subject|3|||
124752889|NCT02305238|448716872|FG001|Overall Study|Withdrawal by Subject|4|||
124752890|NCT02305238|448716873|FG002|Overall Study|Withdrawal by Subject|0|||
124752891|NCT02305238|448716871|FG000|Overall Study|Randomized failure|0|||
124752892|NCT02305238|448716872|FG001|Overall Study|Randomized failure|0|||
124752893|NCT02305238|448716873|FG002|Overall Study|Randomized failure|8|||
124752894|NCT02305238|448716871|FG000|Overall Study|Required procedure failed|0|||
124752895|NCT02305238|448716872|FG001|Overall Study|Required procedure failed|1|||
124752896|NCT02305238|448716873|FG002|Overall Study|Required procedure failed|0|||
124752897|NCT02513472|448716874|FG000|Overall Study|Radiological Disease Progression|45|||
124752898|NCT02513472|448716875|FG001|Overall Study|Radiological Disease Progression|57|||
124752899|NCT02513472|448716874|FG000|Overall Study|Clinical Disease Progression|5|||
124752900|NCT02513472|448716875|FG001|Overall Study|Clinical Disease Progression|13|||
124752901|NCT02513472|448716874|FG000|Overall Study|Adverse Event|8|||
124752902|NCT02513472|448716875|FG001|Overall Study|Adverse Event|11|||
124752903|NCT02513472|448716874|FG000|Overall Study|Withdrawal by Subject|0|||
124752904|NCT02513472|448716875|FG001|Overall Study|Withdrawal by Subject|4|||
124752905|NCT02513472|448716874|FG000|Overall Study|Subject Choice|2|||
124752906|NCT02513472|448716875|FG001|Overall Study|Subject Choice|7|||
124752907|NCT02513472|448716874|FG000|Overall Study|Treatment Completed as per Protocol|3|||
124752908|NCT02513472|448716875|FG001|Overall Study|Treatment Completed as per Protocol|3|||
124752909|NCT02513472|448716874|FG000|Overall Study|Other|3|||
124752910|NCT02513472|448716875|FG001|Overall Study|Other|6|||
124752911|NCT04565951|448716881|FG000|Overall Study|Lost to Follow-up|66|||
124752912|NCT04565951|448716882|FG001|Overall Study|Lost to Follow-up|38|||
124828408|NCT02953314|449000988|FG001|Overall Study|Adverse Event|1|||
124828409|NCT02953314|449000987|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
124828410|NCT02953314|449000988|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
124828411|NCT02335099|449000989|FG000|Treatment|Withdrawal by Subject|1|||
124828412|NCT02335099|449000990|FG001|Treatment|Withdrawal by Subject|3|||
124828413|NCT02335099|449000989|FG000|Treatment|Lost to Follow-up|2|||
124828414|NCT02335099|449000990|FG001|Treatment|Lost to Follow-up|0|||
124828415|NCT02335099|449000989|FG000|Treatment|Death|1|||
124828416|NCT02335099|449000990|FG001|Treatment|Death|0|||
124828417|NCT02335099|449000989|FG000|Treatment|Adverse Event|1|||
124828418|NCT02335099|449000990|FG001|Treatment|Adverse Event|2|||
124828419|NCT02335099|449000989|FG000|Follow-up|Death|0|||
124828420|NCT02335099|449000990|FG001|Follow-up|Death|1|||
124828421|NCT02045797|449000991|FG000|Overall Study|Adverse Event|3|||
124828422|NCT02045797|449000992|FG001|Overall Study|Adverse Event|1|||
124828423|NCT02045797|449000993|FG002|Overall Study|Adverse Event|0|||
124828424|NCT02045797|449000991|FG000|Overall Study|Lack of Efficacy|1|||
124828425|NCT02045797|449000992|FG001|Overall Study|Lack of Efficacy|0|||
124828426|NCT02045797|449000993|FG002|Overall Study|Lack of Efficacy|0|||
124828427|NCT02045797|449000991|FG000|Overall Study|Lost to Follow-up|2|||
124828428|NCT02045797|449000992|FG001|Overall Study|Lost to Follow-up|3|||
124828429|NCT02045797|449000993|FG002|Overall Study|Lost to Follow-up|1|||
124828430|NCT02045797|449000991|FG000|Overall Study|Physician Decision|0|||
124828431|NCT02045797|449000992|FG001|Overall Study|Physician Decision|1|||
124828432|NCT02045797|449000993|FG002|Overall Study|Physician Decision|0|||
124828433|NCT02045797|449000991|FG000|Overall Study|Withdrawal by Subject|1|||
124828434|NCT02045797|449000992|FG001|Overall Study|Withdrawal by Subject|2|||
124828435|NCT02045797|449000993|FG002|Overall Study|Withdrawal by Subject|0|||
124828436|NCT01765153|449000994|FG000|Training Phase 1|Format of intervention differed|1|||
124828437|NCT01765153|449000995|FG001|Training Phase 1|Format of intervention differed|0|||
124828438|NCT01765153|449000994|FG000|Training Phase 1|Poor participation in intervention|0|||
124828439|NCT01765153|449000995|FG001|Training Phase 1|Poor participation in intervention|1|||
124828440|NCT01765153|449000994|FG000|Rest Phase 1|Withdrawal by Subject|0|||
124828441|NCT01765153|449000995|FG001|Rest Phase 1|Withdrawal by Subject|1|||
124828442|NCT01765153|449000994|FG000|Training Phase 2|Withdrawal by Subject|0|||
124828443|NCT01765153|449000995|FG001|Training Phase 2|Withdrawal by Subject|1|||
124828444|NCT01765153|449000994|FG000|Rest Phase 2|Lost to Follow-up|2|||
124828445|NCT01765153|449000995|FG001|Rest Phase 2|Lost to Follow-up|1|||
124828446|NCT02554812|449001000|FG000|Overall Study|Adverse Event|2|||
124828447|NCT02554812|449001001|FG001|Overall Study|Adverse Event|5|||
124828448|NCT02554812|449001002|FG002|Overall Study|Adverse Event|3|||
124828449|NCT02554812|449001003|FG003|Overall Study|Adverse Event|0|||
124828450|NCT02554812|449001004|FG004|Overall Study|Adverse Event|5|||
124828451|NCT02554812|449001005|FG005|Overall Study|Adverse Event|0|||
124828452|NCT02554812|449001006|FG006|Overall Study|Adverse Event|1|||
124828453|NCT02554812|449001007|FG007|Overall Study|Adverse Event|6|||
124828454|NCT02554812|449001008|FG008|Overall Study|Adverse Event|2|||
124828455|NCT02554812|449001009|FG009|Overall Study|Adverse Event|2|||
124828456|NCT02554812|449001010|FG010|Overall Study|Adverse Event|1|||
124828457|NCT02554812|449001011|FG011|Overall Study|Adverse Event|2|||
124828458|NCT02554812|449001012|FG012|Overall Study|Adverse Event|0|||
124828459|NCT02554812|449001013|FG013|Overall Study|Adverse Event|3|||
124828460|NCT02554812|449001014|FG014|Overall Study|Adverse Event|2|||
124828461|NCT02554812|449001015|FG015|Overall Study|Adverse Event|1|||
124828462|NCT02554812|449001016|FG016|Overall Study|Adverse Event|0|||
124828463|NCT02554812|449001017|FG017|Overall Study|Adverse Event|1|||
124828464|NCT02554812|449001018|FG018|Overall Study|Adverse Event|0|||
124828465|NCT02554812|449001019|FG019|Overall Study|Adverse Event|0|||
124828466|NCT02554812|449001020|FG020|Overall Study|Adverse Event|0|||
124828467|NCT02554812|449001021|FG021|Overall Study|Adverse Event|2|||
124828468|NCT02554812|449001022|FG022|Overall Study|Adverse Event|1|||
124828469|NCT02554812|449001023|FG023|Overall Study|Adverse Event|1|||
124828470|NCT02554812|449001024|FG024|Overall Study|Adverse Event|1|||
124828471|NCT02554812|449001025|FG025|Overall Study|Adverse Event|2|||
124828472|NCT02554812|449001026|FG026|Overall Study|Adverse Event|1|||
124828473|NCT02554812|449001000|FG000|Overall Study|Death|1|||
124828474|NCT02554812|449001001|FG001|Overall Study|Death|2|||
124828475|NCT02554812|449001002|FG002|Overall Study|Death|2|||
124828476|NCT02554812|449001003|FG003|Overall Study|Death|2|||
124828477|NCT02554812|449001004|FG004|Overall Study|Death|0|||
124828478|NCT02554812|449001005|FG005|Overall Study|Death|1|||
124828479|NCT02554812|449001006|FG006|Overall Study|Death|1|||
124828480|NCT02554812|449001007|FG007|Overall Study|Death|1|||
124828481|NCT02554812|449001008|FG008|Overall Study|Death|0|||
124828482|NCT02554812|449001009|FG009|Overall Study|Death|0|||
124828483|NCT02554812|449001010|FG010|Overall Study|Death|0|||
124828484|NCT02554812|449001011|FG011|Overall Study|Death|0|||
124828485|NCT02554812|449001012|FG012|Overall Study|Death|0|||
124828486|NCT02554812|449001013|FG013|Overall Study|Death|0|||
124828487|NCT02554812|449001014|FG014|Overall Study|Death|1|||
124828488|NCT02554812|449001015|FG015|Overall Study|Death|1|||
124828489|NCT02554812|449001016|FG016|Overall Study|Death|1|||
124828490|NCT02554812|449001017|FG017|Overall Study|Death|0|||
124828491|NCT02554812|449001018|FG018|Overall Study|Death|1|||
124828492|NCT02554812|449001019|FG019|Overall Study|Death|2|||
124828493|NCT02554812|449001020|FG020|Overall Study|Death|0|||
124828494|NCT02554812|449001021|FG021|Overall Study|Death|1|||
124828495|NCT02554812|449001022|FG022|Overall Study|Death|1|||
124828496|NCT02554812|449001023|FG023|Overall Study|Death|0|||
124828497|NCT02554812|449001024|FG024|Overall Study|Death|0|||
124828498|NCT02554812|449001025|FG025|Overall Study|Death|0|||
124828499|NCT02554812|449001026|FG026|Overall Study|Death|0|||
124828500|NCT02554812|449001000|FG000|Overall Study|Lost to Follow-up|0|||
124828501|NCT02554812|449001001|FG001|Overall Study|Lost to Follow-up|1|||
124828502|NCT02554812|449001002|FG002|Overall Study|Lost to Follow-up|0|||
124828503|NCT02554812|449001003|FG003|Overall Study|Lost to Follow-up|0|||
124828504|NCT02554812|449001004|FG004|Overall Study|Lost to Follow-up|0|||
124828505|NCT02554812|449001005|FG005|Overall Study|Lost to Follow-up|0|||
124828506|NCT02554812|449001006|FG006|Overall Study|Lost to Follow-up|0|||
124828507|NCT02554812|449001007|FG007|Overall Study|Lost to Follow-up|0|||
124828508|NCT02554812|449001008|FG008|Overall Study|Lost to Follow-up|0|||
124828509|NCT02554812|449001009|FG009|Overall Study|Lost to Follow-up|0|||
124828510|NCT02554812|449001010|FG010|Overall Study|Lost to Follow-up|0|||
124828511|NCT02554812|449001011|FG011|Overall Study|Lost to Follow-up|0|||
124828512|NCT02554812|449001012|FG012|Overall Study|Lost to Follow-up|0|||
124828513|NCT02554812|449001013|FG013|Overall Study|Lost to Follow-up|0|||
124828514|NCT02554812|449001014|FG014|Overall Study|Lost to Follow-up|0|||
124828515|NCT02554812|449001015|FG015|Overall Study|Lost to Follow-up|0|||
124828516|NCT02554812|449001016|FG016|Overall Study|Lost to Follow-up|0|||
124828517|NCT02554812|449001017|FG017|Overall Study|Lost to Follow-up|0|||
124828518|NCT02554812|449001018|FG018|Overall Study|Lost to Follow-up|0|||
124828519|NCT02554812|449001019|FG019|Overall Study|Lost to Follow-up|0|||
124828520|NCT02554812|449001020|FG020|Overall Study|Lost to Follow-up|0|||
124828521|NCT02554812|449001021|FG021|Overall Study|Lost to Follow-up|0|||
124828522|NCT02554812|449001022|FG022|Overall Study|Lost to Follow-up|0|||
124828523|NCT02554812|449001023|FG023|Overall Study|Lost to Follow-up|0|||
124828524|NCT02554812|449001024|FG024|Overall Study|Lost to Follow-up|0|||
124828525|NCT02554812|449001025|FG025|Overall Study|Lost to Follow-up|0|||
124828526|NCT02554812|449001026|FG026|Overall Study|Lost to Follow-up|0|||
124828527|NCT02554812|449001000|FG000|Overall Study|Global deterioration of health status|4|||
124828528|NCT02554812|449001001|FG001|Overall Study|Global deterioration of health status|3|||
124828529|NCT02554812|449001002|FG002|Overall Study|Global deterioration of health status|3|||
124828530|NCT02554812|449001003|FG003|Overall Study|Global deterioration of health status|2|||
124828531|NCT02554812|449001004|FG004|Overall Study|Global deterioration of health status|5|||
124828532|NCT02554812|449001005|FG005|Overall Study|Global deterioration of health status|0|||
124828533|NCT02554812|449001006|FG006|Overall Study|Global deterioration of health status|2|||
124828534|NCT02554812|449001007|FG007|Overall Study|Global deterioration of health status|1|||
124828535|NCT02554812|449001008|FG008|Overall Study|Global deterioration of health status|1|||
124828536|NCT02554812|449001009|FG009|Overall Study|Global deterioration of health status|1|||
124828537|NCT02554812|449001010|FG010|Overall Study|Global deterioration of health status|2|||
124828538|NCT02554812|449001011|FG011|Overall Study|Global deterioration of health status|1|||
124828539|NCT02554812|449001012|FG012|Overall Study|Global deterioration of health status|0|||
124828540|NCT02554812|449001013|FG013|Overall Study|Global deterioration of health status|0|||
124828541|NCT02554812|449001014|FG014|Overall Study|Global deterioration of health status|0|||
124828542|NCT02554812|449001015|FG015|Overall Study|Global deterioration of health status|1|||
124828543|NCT02554812|449001016|FG016|Overall Study|Global deterioration of health status|0|||
124828544|NCT02554812|449001017|FG017|Overall Study|Global deterioration of health status|0|||
124828545|NCT02554812|449001018|FG018|Overall Study|Global deterioration of health status|0|||
124828546|NCT02554812|449001019|FG019|Overall Study|Global deterioration of health status|0|||
124638734|NCT03850483|448294494|FG000|Treatment for Stage 2|Adverse Event|0|||
124828547|NCT02554812|449001020|FG020|Overall Study|Global deterioration of health status|0|||
124828548|NCT02554812|449001021|FG021|Overall Study|Global deterioration of health status|0|||
124828549|NCT02554812|449001022|FG022|Overall Study|Global deterioration of health status|0|||
124828550|NCT02554812|449001023|FG023|Overall Study|Global deterioration of health status|0|||
124828551|NCT02554812|449001024|FG024|Overall Study|Global deterioration of health status|0|||
124828552|NCT02554812|449001025|FG025|Overall Study|Global deterioration of health status|0|||
124828553|NCT02554812|449001026|FG026|Overall Study|Global deterioration of health status|0|||
124828554|NCT02554812|449001000|FG000|Overall Study|Progressive disease|20|||
124828555|NCT02554812|449001001|FG001|Overall Study|Progressive disease|16|||
124828556|NCT02554812|449001002|FG002|Overall Study|Progressive disease|19|||
124828557|NCT02554812|449001003|FG003|Overall Study|Progressive disease|18|||
124828558|NCT02554812|449001004|FG004|Overall Study|Progressive disease|21|||
124828559|NCT02554812|449001005|FG005|Overall Study|Progressive disease|15|||
124828560|NCT02554812|449001006|FG006|Overall Study|Progressive disease|6|||
124828561|NCT02554812|449001007|FG007|Overall Study|Progressive disease|13|||
124828562|NCT02554812|449001008|FG008|Overall Study|Progressive disease|6|||
124828563|NCT02554812|449001009|FG009|Overall Study|Progressive disease|6|||
124828564|NCT02554812|449001010|FG010|Overall Study|Progressive disease|8|||
124828565|NCT02554812|449001011|FG011|Overall Study|Progressive disease|8|||
124828566|NCT02554812|449001012|FG012|Overall Study|Progressive disease|6|||
124828567|NCT02554812|449001013|FG013|Overall Study|Progressive disease|10|||
124828568|NCT02554812|449001014|FG014|Overall Study|Progressive disease|20|||
124828569|NCT02554812|449001015|FG015|Overall Study|Progressive disease|6|||
124828570|NCT02554812|449001016|FG016|Overall Study|Progressive disease|3|||
124828571|NCT02554812|449001017|FG017|Overall Study|Progressive disease|3|||
124828572|NCT02554812|449001018|FG018|Overall Study|Progressive disease|11|||
124828573|NCT02554812|449001019|FG019|Overall Study|Progressive disease|7|||
124828574|NCT02554812|449001020|FG020|Overall Study|Progressive disease|11|||
124828575|NCT02554812|449001021|FG021|Overall Study|Progressive disease|6|||
124828576|NCT02554812|449001022|FG022|Overall Study|Progressive disease|9|||
124828577|NCT02554812|449001023|FG023|Overall Study|Progressive disease|9|||
124828578|NCT02554812|449001024|FG024|Overall Study|Progressive disease|4|||
124828579|NCT02554812|449001025|FG025|Overall Study|Progressive disease|5|||
124828580|NCT02554812|449001026|FG026|Overall Study|Progressive disease|5|||
124828581|NCT02554812|449001000|FG000|Overall Study|Other|0|||
124828582|NCT02554812|449001001|FG001|Overall Study|Other|0|||
124828583|NCT02554812|449001002|FG002|Overall Study|Other|2|||
124828584|NCT02554812|449001003|FG003|Overall Study|Other|3|||
124828585|NCT02554812|449001004|FG004|Overall Study|Other|2|||
124828586|NCT02554812|449001005|FG005|Overall Study|Other|1|||
124828587|NCT02554812|449001006|FG006|Overall Study|Other|0|||
124828588|NCT02554812|449001007|FG007|Overall Study|Other|0|||
124828589|NCT02554812|449001008|FG008|Overall Study|Other|1|||
124828590|NCT02554812|449001009|FG009|Overall Study|Other|1|||
124828591|NCT02554812|449001010|FG010|Overall Study|Other|0|||
124828592|NCT02554812|449001011|FG011|Overall Study|Other|0|||
124828593|NCT02554812|449001012|FG012|Overall Study|Other|1|||
124828594|NCT02554812|449001013|FG013|Overall Study|Other|0|||
124828595|NCT02554812|449001014|FG014|Overall Study|Other|1|||
124828596|NCT02554812|449001015|FG015|Overall Study|Other|0|||
124828597|NCT02554812|449001016|FG016|Overall Study|Other|0|||
124828598|NCT02554812|449001017|FG017|Overall Study|Other|0|||
124828599|NCT02554812|449001018|FG018|Overall Study|Other|0|||
124828600|NCT02554812|449001019|FG019|Overall Study|Other|0|||
124828601|NCT02554812|449001020|FG020|Overall Study|Other|0|||
124828602|NCT02554812|449001021|FG021|Overall Study|Other|2|||
124828603|NCT02554812|449001022|FG022|Overall Study|Other|0|||
124828604|NCT02554812|449001023|FG023|Overall Study|Other|0|||
124828605|NCT02554812|449001024|FG024|Overall Study|Other|0|||
124828606|NCT02554812|449001025|FG025|Overall Study|Other|0|||
124828607|NCT02554812|449001026|FG026|Overall Study|Other|0|||
124828608|NCT02554812|449001000|FG000|Overall Study|Withdrawal by Subject|1|||
124828609|NCT02554812|449001001|FG001|Overall Study|Withdrawal by Subject|0|||
124828610|NCT02554812|449001002|FG002|Overall Study|Withdrawal by Subject|0|||
124828611|NCT02554812|449001003|FG003|Overall Study|Withdrawal by Subject|2|||
124828612|NCT02554812|449001004|FG004|Overall Study|Withdrawal by Subject|2|||
124828613|NCT02554812|449001005|FG005|Overall Study|Withdrawal by Subject|3|||
124828614|NCT02554812|449001006|FG006|Overall Study|Withdrawal by Subject|0|||
124828615|NCT02554812|449001007|FG007|Overall Study|Withdrawal by Subject|0|||
124828616|NCT02554812|449001008|FG008|Overall Study|Withdrawal by Subject|1|||
124828617|NCT02554812|449001009|FG009|Overall Study|Withdrawal by Subject|1|||
124828618|NCT02554812|449001010|FG010|Overall Study|Withdrawal by Subject|0|||
124828619|NCT02554812|449001011|FG011|Overall Study|Withdrawal by Subject|1|||
124828620|NCT02554812|449001012|FG012|Overall Study|Withdrawal by Subject|1|||
124828621|NCT02554812|449001013|FG013|Overall Study|Withdrawal by Subject|1|||
124828622|NCT02554812|449001014|FG014|Overall Study|Withdrawal by Subject|1|||
124828623|NCT02554812|449001015|FG015|Overall Study|Withdrawal by Subject|1|||
124828624|NCT02554812|449001016|FG016|Overall Study|Withdrawal by Subject|3|||
124828625|NCT02554812|449001017|FG017|Overall Study|Withdrawal by Subject|1|||
124828626|NCT02554812|449001018|FG018|Overall Study|Withdrawal by Subject|0|||
124828627|NCT02554812|449001019|FG019|Overall Study|Withdrawal by Subject|2|||
124828628|NCT02554812|449001020|FG020|Overall Study|Withdrawal by Subject|0|||
124828629|NCT02554812|449001021|FG021|Overall Study|Withdrawal by Subject|1|||
124828630|NCT02554812|449001022|FG022|Overall Study|Withdrawal by Subject|0|||
124828631|NCT02554812|449001023|FG023|Overall Study|Withdrawal by Subject|1|||
124828632|NCT02554812|449001024|FG024|Overall Study|Withdrawal by Subject|0|||
124828633|NCT02554812|449001025|FG025|Overall Study|Withdrawal by Subject|0|||
124828634|NCT02554812|449001026|FG026|Overall Study|Withdrawal by Subject|1|||
124828635|NCT02554812|449001000|FG000|Overall Study|Physician Decision|1|||
124828636|NCT02554812|449001001|FG001|Overall Study|Physician Decision|0|||
124828637|NCT02554812|449001002|FG002|Overall Study|Physician Decision|0|||
124828638|NCT02554812|449001003|FG003|Overall Study|Physician Decision|1|||
124828639|NCT02554812|449001004|FG004|Overall Study|Physician Decision|0|||
124828640|NCT02554812|449001005|FG005|Overall Study|Physician Decision|1|||
124828641|NCT02554812|449001006|FG006|Overall Study|Physician Decision|0|||
124828642|NCT02554812|449001007|FG007|Overall Study|Physician Decision|0|||
124828643|NCT02554812|449001008|FG008|Overall Study|Physician Decision|0|||
124828644|NCT02554812|449001009|FG009|Overall Study|Physician Decision|0|||
124828645|NCT02554812|449001010|FG010|Overall Study|Physician Decision|1|||
124828646|NCT02554812|449001011|FG011|Overall Study|Physician Decision|0|||
124828647|NCT02554812|449001012|FG012|Overall Study|Physician Decision|0|||
124828648|NCT02554812|449001013|FG013|Overall Study|Physician Decision|0|||
124828649|NCT02554812|449001014|FG014|Overall Study|Physician Decision|0|||
124828650|NCT02554812|449001015|FG015|Overall Study|Physician Decision|0|||
124828651|NCT02554812|449001016|FG016|Overall Study|Physician Decision|1|||
124828652|NCT02554812|449001017|FG017|Overall Study|Physician Decision|1|||
124828653|NCT02554812|449001018|FG018|Overall Study|Physician Decision|0|||
124828654|NCT02554812|449001019|FG019|Overall Study|Physician Decision|1|||
124828655|NCT02554812|449001020|FG020|Overall Study|Physician Decision|1|||
124828656|NCT02554812|449001021|FG021|Overall Study|Physician Decision|0|||
124828657|NCT02554812|449001022|FG022|Overall Study|Physician Decision|1|||
124828658|NCT02554812|449001023|FG023|Overall Study|Physician Decision|0|||
124828659|NCT02554812|449001024|FG024|Overall Study|Physician Decision|0|||
124828660|NCT02554812|449001025|FG025|Overall Study|Physician Decision|0|||
124828661|NCT02554812|449001026|FG026|Overall Study|Physician Decision|0|||
124828662|NCT02554812|449001000|FG000|Overall Study|Study terminated by sponsor|0|||
124828663|NCT02554812|449001001|FG001|Overall Study|Study terminated by sponsor|0|||
124828664|NCT02554812|449001002|FG002|Overall Study|Study terminated by sponsor|0|||
124828665|NCT02554812|449001003|FG003|Overall Study|Study terminated by sponsor|0|||
124828666|NCT02554812|449001004|FG004|Overall Study|Study terminated by sponsor|0|||
124828667|NCT02554812|449001005|FG005|Overall Study|Study terminated by sponsor|0|||
124828668|NCT02554812|449001006|FG006|Overall Study|Study terminated by sponsor|0|||
124828669|NCT02554812|449001007|FG007|Overall Study|Study terminated by sponsor|0|||
124828670|NCT02554812|449001008|FG008|Overall Study|Study terminated by sponsor|0|||
124828671|NCT02554812|449001009|FG009|Overall Study|Study terminated by sponsor|0|||
124828672|NCT02554812|449001010|FG010|Overall Study|Study terminated by sponsor|0|||
124828673|NCT02554812|449001011|FG011|Overall Study|Study terminated by sponsor|0|||
124828674|NCT02554812|449001012|FG012|Overall Study|Study terminated by sponsor|0|||
124828675|NCT02554812|449001013|FG013|Overall Study|Study terminated by sponsor|0|||
124828676|NCT02554812|449001014|FG014|Overall Study|Study terminated by sponsor|0|||
124828677|NCT02554812|449001015|FG015|Overall Study|Study terminated by sponsor|0|||
124828678|NCT02554812|449001016|FG016|Overall Study|Study terminated by sponsor|0|||
124828679|NCT02554812|449001017|FG017|Overall Study|Study terminated by sponsor|0|||
124828680|NCT02554812|449001018|FG018|Overall Study|Study terminated by sponsor|0|||
124828681|NCT02554812|449001019|FG019|Overall Study|Study terminated by sponsor|0|||
124828682|NCT02554812|449001020|FG020|Overall Study|Study terminated by sponsor|0|||
124828683|NCT02554812|449001021|FG021|Overall Study|Study terminated by sponsor|0|||
124828684|NCT02554812|449001022|FG022|Overall Study|Study terminated by sponsor|0|||
124828685|NCT02554812|449001023|FG023|Overall Study|Study terminated by sponsor|0|||
124828686|NCT02554812|449001024|FG024|Overall Study|Study terminated by sponsor|1|||
124828687|NCT02554812|449001025|FG025|Overall Study|Study terminated by sponsor|0|||
124828688|NCT02554812|449001026|FG026|Overall Study|Study terminated by sponsor|0|||
124828689|NCT02554812|449001000|FG000|Overall Study|No longer meets eligibility criteria|0|||
124828690|NCT02554812|449001001|FG001|Overall Study|No longer meets eligibility criteria|1|||
124828691|NCT02554812|449001002|FG002|Overall Study|No longer meets eligibility criteria|0|||
124828692|NCT02554812|449001003|FG003|Overall Study|No longer meets eligibility criteria|0|||
124828693|NCT02554812|449001004|FG004|Overall Study|No longer meets eligibility criteria|0|||
124828694|NCT02554812|449001005|FG005|Overall Study|No longer meets eligibility criteria|0|||
124828695|NCT02554812|449001006|FG006|Overall Study|No longer meets eligibility criteria|0|||
124828696|NCT02554812|449001007|FG007|Overall Study|No longer meets eligibility criteria|0|||
124828697|NCT02554812|449001008|FG008|Overall Study|No longer meets eligibility criteria|0|||
124828698|NCT02554812|449001009|FG009|Overall Study|No longer meets eligibility criteria|0|||
124828699|NCT02554812|449001010|FG010|Overall Study|No longer meets eligibility criteria|0|||
124828700|NCT02554812|449001011|FG011|Overall Study|No longer meets eligibility criteria|0|||
124828701|NCT02554812|449001012|FG012|Overall Study|No longer meets eligibility criteria|0|||
124828702|NCT02554812|449001013|FG013|Overall Study|No longer meets eligibility criteria|0|||
124828703|NCT02554812|449001014|FG014|Overall Study|No longer meets eligibility criteria|0|||
124828704|NCT02554812|449001015|FG015|Overall Study|No longer meets eligibility criteria|0|||
124828705|NCT02554812|449001016|FG016|Overall Study|No longer meets eligibility criteria|0|||
124828706|NCT02554812|449001017|FG017|Overall Study|No longer meets eligibility criteria|0|||
124828707|NCT02554812|449001018|FG018|Overall Study|No longer meets eligibility criteria|0|||
124828708|NCT02554812|449001019|FG019|Overall Study|No longer meets eligibility criteria|0|||
124828709|NCT02554812|449001020|FG020|Overall Study|No longer meets eligibility criteria|0|||
124828710|NCT02554812|449001021|FG021|Overall Study|No longer meets eligibility criteria|0|||
124638735|NCT03850483|448294495|FG001|Treatment for Stage 2|Adverse Event|0|||
124638736|NCT03850483|448294496|FG002|Treatment for Stage 2|Adverse Event|0|||
124638737|NCT03850483|448294497|FG003|Treatment for Stage 2|Adverse Event|0|||
124828711|NCT02554812|449001022|FG022|Overall Study|No longer meets eligibility criteria|0|||
124828712|NCT02554812|449001023|FG023|Overall Study|No longer meets eligibility criteria|0|||
124638738|NCT03850483|448294498|FG004|Treatment for Stage 2|Adverse Event|0|||
124828713|NCT02554812|449001024|FG024|Overall Study|No longer meets eligibility criteria|0|||
124828714|NCT02554812|449001025|FG025|Overall Study|No longer meets eligibility criteria|0|||
124828715|NCT02554812|449001026|FG026|Overall Study|No longer meets eligibility criteria|0|||
124828716|NCT00415909|449001956|FG000|Overall Study|Withdrawal by Subject|2|||
124828717|NCT00415909|449001956|FG000|Overall Study|Death|1|||
124828718|NCT03232281|449001957|FG000|Overall Study|Adverse Event|1|||
124828719|NCT03232281|449001958|FG001|Overall Study|Adverse Event|1|||
124828720|NCT03232281|449001957|FG000|Overall Study|Withdrawal by Subject|5|||
124828721|NCT03232281|449001958|FG001|Overall Study|Withdrawal by Subject|4|||
124828722|NCT03232281|449001957|FG000|Overall Study|Protocol Deviation|1|||
124828723|NCT03232281|449001958|FG001|Overall Study|Protocol Deviation|1|||
124828724|NCT02522286|449001960|FG000|Overall Study|Withdrawal by Subject|3|||
124828725|NCT02522286|449001961|FG001|Overall Study|Withdrawal by Subject|0|||
124828726|NCT02522286|449001962|FG002|Overall Study|Withdrawal by Subject|0|||
124828727|NCT02522286|449001963|FG003|Overall Study|Withdrawal by Subject|3|||
124828728|NCT00174915|449001964|FG000|Overall Study|Lost to Follow-up|19|||
124828729|NCT00174915|449001965|FG001|Overall Study|Lost to Follow-up|17|||
124828730|NCT00174915|449001966|FG002|Overall Study|Lost to Follow-up|9|||
124828731|NCT00174915|449001967|FG003|Overall Study|Lost to Follow-up|17|||
124828732|NCT00174915|449001968|FG004|Overall Study|Lost to Follow-up|10|||
124828733|NCT00174915|449001964|FG000|Overall Study|Adverse Event|18|||
124828734|NCT00174915|449001965|FG001|Overall Study|Adverse Event|16|||
124828735|NCT00174915|449001966|FG002|Overall Study|Adverse Event|11|||
124828736|NCT00174915|449001967|FG003|Overall Study|Adverse Event|18|||
124828737|NCT00174915|449001968|FG004|Overall Study|Adverse Event|5|||
124828738|NCT00174915|449001964|FG000|Overall Study|Personal Reason(s)|16|||
124828739|NCT00174915|449001965|FG001|Overall Study|Personal Reason(s)|16|||
124828740|NCT00174915|449001966|FG002|Overall Study|Personal Reason(s)|9|||
124828741|NCT00174915|449001967|FG003|Overall Study|Personal Reason(s)|9|||
124828742|NCT00174915|449001968|FG004|Overall Study|Personal Reason(s)|9|||
124828743|NCT00174915|449001964|FG000|Overall Study|Other|15|||
124828744|NCT00174915|449001965|FG001|Overall Study|Other|8|||
124828745|NCT00174915|449001966|FG002|Overall Study|Other|6|||
124828746|NCT00174915|449001967|FG003|Overall Study|Other|5|||
124828747|NCT00174915|449001968|FG004|Overall Study|Other|3|||
124828748|NCT00174915|449001964|FG000|Overall Study|Gout Flare|13|||
124828749|NCT00174915|449001965|FG001|Overall Study|Gout Flare|6|||
124828750|NCT00174915|449001966|FG002|Overall Study|Gout Flare|8|||
124828751|NCT00174915|449001967|FG003|Overall Study|Gout Flare|1|||
124828752|NCT00174915|449001968|FG004|Overall Study|Gout Flare|0|||
124828753|NCT00174915|449001964|FG000|Overall Study|Protocol Violation|6|||
124828754|NCT00174915|449001965|FG001|Overall Study|Protocol Violation|3|||
124828755|NCT00174915|449001966|FG002|Overall Study|Protocol Violation|3|||
124828756|NCT00174915|449001967|FG003|Overall Study|Protocol Violation|6|||
124828757|NCT00174915|449001968|FG004|Overall Study|Protocol Violation|3|||
124828758|NCT00174915|449001964|FG000|Overall Study|Therapeutic Failure|6|||
124828759|NCT00174915|449001965|FG001|Overall Study|Therapeutic Failure|3|||
124828760|NCT00174915|449001966|FG002|Overall Study|Therapeutic Failure|2|||
124828761|NCT00174915|449001967|FG003|Overall Study|Therapeutic Failure|1|||
124828762|NCT00174915|449001968|FG004|Overall Study|Therapeutic Failure|3|||
124828763|NCT01870583|449001975|FG000|Overall Study|Protocol Violation|0|||
124828764|NCT01870583|449001976|FG001|Overall Study|Protocol Violation|5|||
124828765|NCT01870583|449001977|FG002|Overall Study|Protocol Violation|3|||
124828766|NCT01870583|449001975|FG000|Overall Study|Lost to Follow-up|11|||
124828767|NCT01870583|449001976|FG001|Overall Study|Lost to Follow-up|13|||
124828768|NCT01870583|449001977|FG002|Overall Study|Lost to Follow-up|5|||
124828769|NCT00937157|449001978|FG000|Overall Study|Pregnancy|1|||
124828770|NCT00937157|449001978|FG000|Overall Study|Lost to Follow-up|3|||
124828771|NCT00469092|449001979|FG000|Overall Study|Adverse Event|5|||
124828772|NCT00469092|449001980|FG001|Overall Study|Adverse Event|4|||
124828773|NCT00469092|449001979|FG000|Overall Study|Lack of Efficacy|1|||
124828774|NCT00469092|449001980|FG001|Overall Study|Lack of Efficacy|0|||
124828775|NCT00469092|449001979|FG000|Overall Study|Lost to Follow-up|1|||
124828776|NCT00469092|449001980|FG001|Overall Study|Lost to Follow-up|2|||
124828777|NCT00469092|449001979|FG000|Overall Study|Protocol Violation|3|||
124828778|NCT00469092|449001980|FG001|Overall Study|Protocol Violation|3|||
124828779|NCT00469092|449001979|FG000|Overall Study|Withdrawal by Subject|4|||
124828780|NCT00469092|449001980|FG001|Overall Study|Withdrawal by Subject|4|||
124828781|NCT00469092|449001979|FG000|Overall Study|Withdrawal Criteria|3|||
124828782|NCT00469092|449001980|FG001|Overall Study|Withdrawal Criteria|4|||
124828783|NCT00469092|449001979|FG000|Overall Study|Incorrectly Randomised|4|||
124828784|NCT00469092|449001980|FG001|Overall Study|Incorrectly Randomised|3|||
124828785|NCT00469092|449001979|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
124828786|NCT00469092|449001980|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
124828787|NCT00469092|449001979|FG000|Overall Study|Use of lipid lowering drug|1|||
124828788|NCT00469092|449001980|FG001|Overall Study|Use of lipid lowering drug|0|||
124828789|NCT00469092|449001979|FG000|Overall Study|Hypoglycaemic Episodes|1|||
124828790|NCT00469092|449001980|FG001|Overall Study|Hypoglycaemic Episodes|1|||
124828791|NCT00469092|449001979|FG000|Overall Study|Abnormal lab value|1|||
124828792|NCT00469092|449001980|FG001|Overall Study|Abnormal lab value|0|||
124828793|NCT00469092|449001979|FG000|Overall Study|Use of Corticosteroid|1|||
124828794|NCT00469092|449001980|FG001|Overall Study|Use of Corticosteroid|0|||
124828795|NCT02024867|449001981|FG000|Overall Study|Protocol Violation|3|||
124828796|NCT02024867|449001982|FG001|Overall Study|Protocol Violation|3|||
124828797|NCT02024867|449001981|FG000|Overall Study|Lost to Follow-up|6|||
124828798|NCT02024867|449001982|FG001|Overall Study|Lost to Follow-up|4|||
124828799|NCT04267133|449001983|FG000|Overall Study|Withdrawal by Subject|1|||
124828800|NCT04267133|449001983|FG000|Overall Study|Adverse Event|4|||
124828801|NCT01998633|449001984|FG000|Overall Study|Death|1|||
124828802|NCT02968563|449001994|FG000|Overall Study|Adverse Event|0|||
124828803|NCT02968563|449001995|FG001|Overall Study|Adverse Event|6|||
124828804|NCT02968563|449001994|FG000|Overall Study|Death|1|||
124828805|NCT02968563|449001995|FG001|Overall Study|Death|1|||
124828806|NCT02968563|449001994|FG000|Overall Study|Lost to Follow-up|0|||
124828807|NCT02968563|449001995|FG001|Overall Study|Lost to Follow-up|1|||
124828808|NCT03992781|449001996|FG000|Overall Study|Lost to Follow-up|5|||
124828809|NCT03992781|449001996|FG000|Overall Study|Adverse Event|1|||
124828810|NCT03992781|449001996|FG000|Overall Study|Lack of Efficacy|5|||
124828811|NCT03287804|449001997|FG000|Overall Study|Death|1|||
124828812|NCT03287804|449001997|FG000|Overall Study|Physician Decision|2|||
124828813|NCT03287804|449001997|FG000|Overall Study|Progressive disease|8|||
124828814|NCT01275833|449002001|FG000|Overall Study|Study terminated|1|||
124828815|NCT01275833|449002002|FG001|Overall Study|Study terminated|1|||
124828816|NCT02733991|449002003|FG000|Overall Study|Adverse Event|1|||
124828817|NCT02733991|449002004|FG001|Overall Study|Adverse Event|0|||
124828818|NCT02733991|449002003|FG000|Overall Study|Withdrawal by Subject|0|||
124828819|NCT02733991|449002004|FG001|Overall Study|Withdrawal by Subject|5|||
124828820|NCT00857220|449002007|FG000|Overall Study|Adverse Event|35|||
124828821|NCT00857220|449002007|FG000|Overall Study|Death|1|||
124828822|NCT00857220|449002007|FG000|Overall Study|Lack of Efficacy|11|||
124828823|NCT00857220|449002007|FG000|Overall Study|Lost to Follow-up|30|||
124828824|NCT00857220|449002007|FG000|Overall Study|Physician Decision|4|||
124828825|NCT00857220|449002007|FG000|Overall Study|Protocol Violation|16|||
124828826|NCT00857220|449002007|FG000|Overall Study|Withdrawal by Subject|67|||
124828827|NCT00857220|449002007|FG000|Overall Study|Clinical Hold|6|||
124828828|NCT00857220|449002007|FG000|Overall Study|Site Closed|5|||
124828829|NCT00857220|449002007|FG000|Overall Study|Miscellaneous|8|||
124828830|NCT00680745|449002008|FG000|Overall Study|Withdrawal by Subject|8|||
124828831|NCT00680745|449002009|FG001|Overall Study|Withdrawal by Subject|3|||
124828832|NCT00680745|449002010|FG002|Overall Study|Withdrawal by Subject|2|||
124828833|NCT00680745|449002011|FG003|Overall Study|Withdrawal by Subject|8|||
124828834|NCT00680745|449002008|FG000|Overall Study|Lost to Follow-up|0|||
124828835|NCT00680745|449002009|FG001|Overall Study|Lost to Follow-up|1|||
124828836|NCT00680745|449002010|FG002|Overall Study|Lost to Follow-up|1|||
124828837|NCT00680745|449002011|FG003|Overall Study|Lost to Follow-up|0|||
124828838|NCT00680745|449002008|FG000|Overall Study|Death|1|||
124828839|NCT00680745|449002009|FG001|Overall Study|Death|0|||
124828840|NCT00680745|449002010|FG002|Overall Study|Death|1|||
124828841|NCT00680745|449002011|FG003|Overall Study|Death|0|||
124828842|NCT00680745|449002008|FG000|Overall Study|Adverse Event|5|||
124828843|NCT00680745|449002009|FG001|Overall Study|Adverse Event|3|||
124828844|NCT00680745|449002010|FG002|Overall Study|Adverse Event|3|||
124828845|NCT00680745|449002011|FG003|Overall Study|Adverse Event|3|||
124828846|NCT00680745|449002008|FG000|Overall Study|Poor/Non-compliance|0|||
124828847|NCT00680745|449002009|FG001|Overall Study|Poor/Non-compliance|3|||
124828848|NCT00680745|449002010|FG002|Overall Study|Poor/Non-compliance|0|||
124828849|NCT00680745|449002011|FG003|Overall Study|Poor/Non-compliance|0|||
124828850|NCT00680745|449002008|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
124828851|NCT00680745|449002009|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
124828852|NCT00680745|449002010|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
124828853|NCT00680745|449002011|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
124828854|NCT00680745|449002008|FG000|Overall Study|False Treatment|0|||
124828855|NCT00680745|449002009|FG001|Overall Study|False Treatment|1|||
124828856|NCT00680745|449002010|FG002|Overall Study|False Treatment|3|||
124828857|NCT00680745|449002011|FG003|Overall Study|False Treatment|0|||
124828858|NCT02612428|449002012|FG000|VTL-308|Death|14|||
124638739|NCT03850483|448294499|FG005|Treatment for Stage 2|Adverse Event|0|||
124638740|NCT03850483|448294500|FG006|Treatment for Stage 2|Adverse Event|0|||
124638741|NCT03850483|448294501|FG007|Treatment for Stage 2|Adverse Event|0|||
124638742|NCT03850483|448294502|FG008|Treatment for Stage 2|Adverse Event|0|||
124638743|NCT03850483|448294503|FG009|Treatment for Stage 2|Adverse Event|1|||
124638744|NCT03850483|448294494|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
124638745|NCT03850483|448294495|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
124828859|NCT02612428|449002013|FG001|VTL-308|Death|16|||
124828860|NCT02612428|449002012|FG000|VTL-308|Withdrawal by Subject|0|||
124828861|NCT02612428|449002013|FG001|VTL-308|Withdrawal by Subject|1|||
124828862|NCT02612428|449002012|FG000|VTL-308E|Death|9|||
124828863|NCT02612428|449002013|FG001|VTL-308E|Death|7|||
124828864|NCT02612428|449002012|FG000|VTL-308E|Lost to Follow-up|2|||
124828865|NCT02612428|449002013|FG001|VTL-308E|Lost to Follow-up|0|||
124828866|NCT00137423|449002014|FG000|Overall Study|Adverse Event|7|||
124828867|NCT00137423|449002015|FG001|Overall Study|Adverse Event|9|||
124828868|NCT00137423|449002014|FG000|Overall Study|consent withdrawn|1|||
124828869|NCT00137423|449002015|FG001|Overall Study|consent withdrawn|1|||
124828870|NCT00137423|449002014|FG000|Overall Study|Lack of Efficacy|31|||
124828871|NCT00137423|449002015|FG001|Overall Study|Lack of Efficacy|33|||
124828872|NCT00137423|449002014|FG000|Overall Study|Death|0|||
124828873|NCT00137423|449002015|FG001|Overall Study|Death|1|||
124828874|NCT02141997|449002017|FG000|Overall Study|Adverse Event|0|||
124828875|NCT02141997|449002018|FG001|Overall Study|Adverse Event|2|||
124828876|NCT02141997|449002019|FG002|Overall Study|Adverse Event|0|||
124828877|NCT02141997|449002020|FG003|Overall Study|Adverse Event|1|||
124828878|NCT02141997|449002017|FG000|Overall Study|Participant noncompliance|1|||
124828879|NCT02141997|449002018|FG001|Overall Study|Participant noncompliance|0|||
124828880|NCT02141997|449002019|FG002|Overall Study|Participant noncompliance|0|||
124828881|NCT02141997|449002020|FG003|Overall Study|Participant noncompliance|0|||
124828882|NCT02141997|449002017|FG000|Overall Study|Withdrew consent|1|||
124828883|NCT02141997|449002018|FG001|Overall Study|Withdrew consent|0|||
124828884|NCT02141997|449002019|FG002|Overall Study|Withdrew consent|3|||
124828885|NCT02141997|449002020|FG003|Overall Study|Withdrew consent|0|||
124828886|NCT02141997|449002017|FG000|Overall Study|Other|1|||
124828887|NCT02141997|449002018|FG001|Overall Study|Other|4|||
124828888|NCT02141997|449002019|FG002|Overall Study|Other|0|||
124828889|NCT02141997|449002020|FG003|Overall Study|Other|0|||
124828890|NCT04105998|449002023|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
124828891|NCT04105998|449002024|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
124828892|NCT00278109|449002028|FG000|Overall Study|Adverse Event|3|||
124828893|NCT00278109|449002028|FG000|Overall Study|social circumstances|1|||
124828894|NCT02580357|449002029|FG000|Overall Study|Lost to Follow-up|2|||
124828895|NCT02580357|449002030|FG001|Overall Study|Lost to Follow-up|0|||
124828896|NCT02580357|449002031|FG002|Overall Study|Lost to Follow-up|0|||
124828897|NCT02580357|449002029|FG000|Overall Study|Protocol Violation|1|||
124828898|NCT02580357|449002030|FG001|Overall Study|Protocol Violation|0|||
124828899|NCT02580357|449002031|FG002|Overall Study|Protocol Violation|0|||
124828900|NCT02064166|449002032|FG000|Overall Study|Adverse Event|1|||
124828901|NCT02064166|449002033|FG001|Overall Study|Adverse Event|0|||
124828902|NCT00619801|449002036|FG000|Overall Study|Lack of Efficacy|0|||
124828903|NCT00619801|449002037|FG001|Overall Study|Lack of Efficacy|1|||
124828904|NCT00619801|449002036|FG000|Overall Study|Withdrawal by Subject|1|||
124828905|NCT00619801|449002037|FG001|Overall Study|Withdrawal by Subject|1|||
124828906|NCT00619801|449002036|FG000|Overall Study|Loss of efficacy|0|||
124828907|NCT00619801|449002037|FG001|Overall Study|Loss of efficacy|1|||
124828908|NCT01106898|449002039|FG000|Overall Study|Adverse Event|6|||
124828909|NCT01698801|449002040|FG000|Treatment Phase|Adverse Event|4|||
124828910|NCT01698801|449002040|FG000|Treatment Phase|Protocol Violation|1|||
124828911|NCT01698801|449002040|FG000|Treatment Phase|Other|4|||
124828912|NCT01698801|449002040|FG000|Treatment Phase|Withdrawal by Subject|1|||
124828913|NCT01698801|449002040|FG000|Treatment Phase|Disease progression|1|||
124828914|NCT01698801|449002040|FG000|Follow Up Phase|Withdrawal by Subject|1|||
124828915|NCT01698801|449002040|FG000|Follow Up Phase|Death|4|||
124828916|NCT02062879|449002043|FG000|Overall Study|Withdrawal by Subject|4|||
124828917|NCT02062879|449002044|FG001|Overall Study|Withdrawal by Subject|1|||
124828918|NCT03251079|449002045|FG000|Overall Study|Withdrawal by Subject|1|||
124828919|NCT04219891|449002046|FG000|Overall Study|Lost to Follow-up|3|||
124828920|NCT04219891|449002046|FG000|Overall Study|Withdrawal by Subject|2|||
124828921|NCT00312494|449004178|FG000|Overall Study|Randomized; not treated with study drug|9|||
124828922|NCT00312494|449004179|FG001|Overall Study|Randomized; not treated with study drug|10|||
124828923|NCT00312494|449004180|FG002|Overall Study|Randomized; not treated with study drug|5|||
124828924|NCT00312494|449004178|FG000|Overall Study|Adverse Event|33|||
124828925|NCT00312494|449004179|FG001|Overall Study|Adverse Event|15|||
124828926|NCT00312494|449004180|FG002|Overall Study|Adverse Event|11|||
124828927|NCT00312494|449004178|FG000|Overall Study|Lack of Efficacy|4|||
124828928|NCT00312494|449004179|FG001|Overall Study|Lack of Efficacy|6|||
124828929|NCT00312494|449004180|FG002|Overall Study|Lack of Efficacy|8|||
124828930|NCT00312494|449004178|FG000|Overall Study|Laboratory abnormality|1|||
124638746|NCT03850483|448294496|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
124828931|NCT00312494|449004179|FG001|Overall Study|Laboratory abnormality|0|||
124828932|NCT00312494|449004180|FG002|Overall Study|Laboratory abnormality|0|||
124828933|NCT00312494|449004178|FG000|Overall Study|Lost to Follow-up|8|||
124638747|NCT03850483|448294497|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
124828934|NCT00312494|449004179|FG001|Overall Study|Lost to Follow-up|8|||
124828935|NCT00312494|449004180|FG002|Overall Study|Lost to Follow-up|8|||
124828936|NCT00312494|449004178|FG000|Overall Study|Withdrawal by Subject|6|||
124828937|NCT00312494|449004179|FG001|Overall Study|Withdrawal by Subject|9|||
124828938|NCT00312494|449004180|FG002|Overall Study|Withdrawal by Subject|10|||
124828939|NCT00312494|449004178|FG000|Overall Study|Other|10|||
124828940|NCT00312494|449004179|FG001|Overall Study|Other|10|||
124828941|NCT00312494|449004180|FG002|Overall Study|Other|1|||
124828942|NCT00413192|449004181|FG000|Overall Study|Disease progression|26|||
124828943|NCT00413192|449004182|FG001|Overall Study|Disease progression|31|||
124828944|NCT00413192|449004183|FG002|Overall Study|Disease progression|16|||
124828945|NCT00413192|449004184|FG003|Overall Study|Disease progression|25|||
124828946|NCT00413192|449004181|FG000|Overall Study|Toxicity|3|||
124828947|NCT00413192|449004182|FG001|Overall Study|Toxicity|2|||
124828948|NCT00413192|449004183|FG002|Overall Study|Toxicity|2|||
124828949|NCT00413192|449004184|FG003|Overall Study|Toxicity|2|||
124828950|NCT00413192|449004181|FG000|Overall Study|Withdrawal by Subject|3|||
124828951|NCT00413192|449004182|FG001|Overall Study|Withdrawal by Subject|5|||
124828952|NCT00413192|449004183|FG002|Overall Study|Withdrawal by Subject|0|||
124828953|NCT00413192|449004184|FG003|Overall Study|Withdrawal by Subject|1|||
124828954|NCT00413192|449004181|FG000|Overall Study|Intercurrent illness|0|||
124828955|NCT00413192|449004182|FG001|Overall Study|Intercurrent illness|0|||
124828956|NCT00413192|449004183|FG002|Overall Study|Intercurrent illness|0|||
124828957|NCT00413192|449004184|FG003|Overall Study|Intercurrent illness|1|||
124828958|NCT00413192|449004181|FG000|Overall Study|Intercurrent death|0|||
124828959|NCT00413192|449004182|FG001|Overall Study|Intercurrent death|1|||
124828960|NCT00413192|449004183|FG002|Overall Study|Intercurrent death|0|||
124828961|NCT00413192|449004184|FG003|Overall Study|Intercurrent death|0|||
124828962|NCT00413192|449004181|FG000|Overall Study|Other|5|||
124828963|NCT00413192|449004182|FG001|Overall Study|Other|1|||
124828964|NCT00413192|449004183|FG002|Overall Study|Other|1|||
124828965|NCT00413192|449004184|FG003|Overall Study|Other|2|||
124828966|NCT00413192|449004181|FG000|Overall Study|Not treated|0|||
124828967|NCT00413192|449004182|FG001|Overall Study|Not treated|0|||
124828968|NCT00413192|449004183|FG002|Overall Study|Not treated|0|||
124828969|NCT00413192|449004184|FG003|Overall Study|Not treated|1|||
124828970|NCT00003901|449004189|FG000|Overall Study|Adverse Event|1|||
124828971|NCT00003901|449004189|FG000|Overall Study|Withdrawal by Subject|1|||
124828972|NCT00003901|449004189|FG000|Overall Study|Ineligible|6|||
124828973|NCT00003901|449004189|FG000|Overall Study|CT Scan not within protocol requirement|2|||
124828974|NCT00003901|449004189|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
124828975|NCT00003901|449004189|FG000|Overall Study|Medical problems|6|||
124828976|NCT02268864|449004191|FG000|Overall Study|Withdrawal by Subject|2|||
124828977|NCT02268864|449004192|FG001|Overall Study|Withdrawal by Subject|0|||
124828978|NCT02268864|449004193|FG002|Overall Study|Withdrawal by Subject|0|||
124828979|NCT02268864|449004191|FG000|Overall Study|Death|0|||
124828980|NCT02268864|449004192|FG001|Overall Study|Death|1|||
124828981|NCT02268864|449004193|FG002|Overall Study|Death|0|||
124828982|NCT00742001|449004196|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
124828983|NCT00742001|449004197|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
124828984|NCT00742001|449004198|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
124828985|NCT02617511|449004199|FG000|Overall Study|Withdrawal by Subject|1|||
124828986|NCT02617511|449004200|FG001|Overall Study|Withdrawal by Subject|0|||
124828987|NCT01050257|449004201|FG000|Overall Study|Adverse Event|4|||
124828988|NCT01050257|449004202|FG001|Overall Study|Adverse Event|4|||
124828989|NCT01050257|449004203|FG002|Overall Study|Adverse Event|2|||
124828990|NCT01050257|449004201|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
124828991|NCT01050257|449004202|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
124828992|NCT01050257|449004203|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
124828993|NCT01050257|449004201|FG000|Overall Study|Withdrawal by Subject|0|||
124828994|NCT01050257|449004202|FG001|Overall Study|Withdrawal by Subject|3|||
124828995|NCT01050257|449004203|FG002|Overall Study|Withdrawal by Subject|0|||
124828996|NCT01050257|449004201|FG000|Overall Study|No reason specified|0|||
124828997|NCT01050257|449004202|FG001|Overall Study|No reason specified|0|||
124828998|NCT01050257|449004203|FG002|Overall Study|No reason specified|2|||
124828999|NCT01050257|449004201|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
124829000|NCT01050257|449004202|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
124829001|NCT01050257|449004203|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
124829002|NCT01050257|449004201|FG000|Overall Study|Violation criteria|0|||
124829003|NCT01050257|449004202|FG001|Overall Study|Violation criteria|1|||
124829004|NCT01050257|449004203|FG002|Overall Study|Violation criteria|0|||
124829005|NCT01050257|449004201|FG000|Overall Study|Failure to return|0|||
124829006|NCT01050257|449004202|FG001|Overall Study|Failure to return|2|||
124829007|NCT01050257|449004203|FG002|Overall Study|Failure to return|0|||
124829008|NCT01050257|449004201|FG000|Overall Study|Death|0|||
124829009|NCT01050257|449004202|FG001|Overall Study|Death|0|||
124829010|NCT01050257|449004203|FG002|Overall Study|Death|1|||
124829011|NCT00171223|449004204|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
124829012|NCT00171223|449004205|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
124829013|NCT00171223|449004206|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
124829014|NCT00171223|449004204|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
124829015|NCT00171223|449004205|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
124829016|NCT00171223|449004206|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
124829017|NCT00171223|449004204|FG000|Overall Study|Abnormal Procedure|1|||
124829018|NCT00171223|449004205|FG001|Overall Study|Abnormal Procedure|0|||
124829019|NCT00171223|449004206|FG002|Overall Study|Abnormal Procedure|0|||
124829020|NCT00171223|449004204|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
124829021|NCT00171223|449004205|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
124829022|NCT00171223|449004206|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
124829023|NCT00171223|449004204|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
124829024|NCT00171223|449004205|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
124829025|NCT00171223|449004206|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
124829026|NCT00171223|449004204|FG000|Overall Study|Protocol Violation|2|||
124829027|NCT00171223|449004205|FG001|Overall Study|Protocol Violation|2|||
124829028|NCT00171223|449004206|FG002|Overall Study|Protocol Violation|3|||
124829029|NCT00171223|449004204|FG000|Overall Study|Participant Withdrew Consent|12|||
124829030|NCT00171223|449004205|FG001|Overall Study|Participant Withdrew Consent|21|||
124829031|NCT00171223|449004206|FG002|Overall Study|Participant Withdrew Consent|15|||
124829032|NCT00171223|449004204|FG000|Overall Study|Lost to Follow-up|5|||
124829033|NCT00171223|449004205|FG001|Overall Study|Lost to Follow-up|2|||
124829034|NCT00171223|449004206|FG002|Overall Study|Lost to Follow-up|3|||
124829035|NCT00171223|449004204|FG000|Overall Study|Administrative Problems|4|||
124829036|NCT00171223|449004205|FG001|Overall Study|Administrative Problems|7|||
124829037|NCT00171223|449004206|FG002|Overall Study|Administrative Problems|6|||
124829038|NCT00171223|449004204|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
124829039|NCT00171223|449004205|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
124829040|NCT00171223|449004206|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
124829041|NCT00171223|449004204|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
124829042|NCT00171223|449004205|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
124829043|NCT00171223|449004206|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
124829044|NCT00730912|449004215|FG000|Overall Study|Discontinued|0|||
124829045|NCT00730912|449004216|FG001|Overall Study|Discontinued|0|||
124829046|NCT00730912|449004217|FG002|Overall Study|Discontinued|1|||
124829047|NCT03311659|449004222|FG000|Overall Study|Protocol Violation|1|||
124829048|NCT04053023|449004223|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
124829049|NCT04053023|449004224|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
124829050|NCT00071760|449004225|FG000|Overall Study|Adverse Event|2|||
124829051|NCT00071760|449004226|FG001|Overall Study|Adverse Event|1|||
124829052|NCT00071760|449004225|FG000|Overall Study|Lost to Follow-up|0|||
124829053|NCT00071760|449004226|FG001|Overall Study|Lost to Follow-up|3|||
124829054|NCT00071760|449004225|FG000|Overall Study|Protocol Violation|1|||
124829055|NCT00071760|449004226|FG001|Overall Study|Protocol Violation|0|||
124829056|NCT00071760|449004225|FG000|Overall Study|Withdrawal by Subject|0|||
124829057|NCT00071760|449004226|FG001|Overall Study|Withdrawal by Subject|1|||
124829058|NCT00071760|449004225|FG000|Overall Study|Insufficient Viral Load Response|1|||
124829059|NCT00071760|449004226|FG001|Overall Study|Insufficient Viral Load Response|1|||
124829060|NCT00071760|449004225|FG000|Overall Study|Lack of availability of RTV|1|||
124829061|NCT00071760|449004226|FG001|Overall Study|Lack of availability of RTV|0|||
124829062|NCT00071760|449004225|FG000|Overall Study|Physician Decision|2|||
124829063|NCT00071760|449004226|FG001|Overall Study|Physician Decision|1|||
124829064|NCT00071760|449004225|FG000|Overall Study|Relocation|0|||
124829065|NCT00071760|449004226|FG001|Overall Study|Relocation|1|||
124829066|NCT01994629|449004227|FG000|Overall Study|Withdrawal by Subject|1|||
124829067|NCT01994629|449004228|FG001|Overall Study|Withdrawal by Subject|0|||
124829068|NCT01994629|449004227|FG000|Overall Study|Lost to Follow-up|0|||
124829069|NCT01994629|449004228|FG001|Overall Study|Lost to Follow-up|3|||
124829070|NCT03424265|449004229|FG000|Overall Study|screening failure|1|||
124829071|NCT03424265|449004230|FG001|Overall Study|screening failure|0|||
124829072|NCT03424265|449004229|FG000|Overall Study|Withdrawal by Subject|0|||
124829073|NCT03424265|449004230|FG001|Overall Study|Withdrawal by Subject|2|||
124829074|NCT01558752|449004231|FG000|Overall Study|Physician Decision|2|||
124829075|NCT01558752|449004232|FG001|Overall Study|Physician Decision|0|||
124829076|NCT00894322|449004241|FG000|Overall Study|Withdrawal by Subject|1|||
124829077|NCT00894322|449004242|FG001|Overall Study|Withdrawal by Subject|0|||
124829078|NCT00894322|449004243|FG002|Overall Study|Withdrawal by Subject|0|||
124829079|NCT03338855|449004245|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
124829080|NCT03338855|449004246|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
124829081|NCT00511667|449004247|FG000|Overall Study|Adverse Event|1|||
124829082|NCT00511667|449004248|FG001|Overall Study|Adverse Event|0|||
124829083|NCT00511667|449004247|FG000|Overall Study|Protocol Violation|1|||
124829084|NCT00511667|449004248|FG001|Overall Study|Protocol Violation|1|||
124829085|NCT00511667|449004247|FG000|Overall Study|Withdrawal by Subject|2|||
124829086|NCT00511667|449004248|FG001|Overall Study|Withdrawal by Subject|0|||
124829087|NCT00511667|449004247|FG000|Overall Study|Site terminated|6|||
124829088|NCT00511667|449004248|FG001|Overall Study|Site terminated|1|||
124829089|NCT00511667|449004247|FG000|Overall Study|Other|2|||
124829090|NCT00511667|449004248|FG001|Overall Study|Other|1|||
124829091|NCT00056407|449004249|FG000|Overall Study|Adverse Event|282|||
124638748|NCT03850483|448294498|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
124829092|NCT00056407|449004250|FG001|Overall Study|Adverse Event|364|||
124829093|NCT00056407|449004249|FG000|Overall Study|Withdrawal by Subject|377|||
124829094|NCT00056407|449004250|FG001|Overall Study|Withdrawal by Subject|361|||
124829095|NCT00056407|449004249|FG000|Overall Study|Lost to Follow-up|123|||
124829096|NCT00056407|449004250|FG001|Overall Study|Lost to Follow-up|113|||
124829097|NCT00056407|449004249|FG000|Overall Study|Protocol Violation|104|||
124829098|NCT00056407|449004250|FG001|Overall Study|Protocol Violation|95|||
124829099|NCT00056407|449004249|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
124829100|NCT00056407|449004250|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
124829101|NCT00056407|449004249|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
124829102|NCT00056407|449004250|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
124829103|NCT00056407|449004249|FG000|Overall Study|Missing|25|||
124829104|NCT00056407|449004250|FG001|Overall Study|Missing|34|||
124829105|NCT02738450|449004251|FG000|Overall Study|Withdrawal by Subject|0|||
124829106|NCT02738450|449004252|FG001|Overall Study|Withdrawal by Subject|2|||
124829107|NCT02738450|449004253|FG002|Overall Study|Withdrawal by Subject|0|||
124829108|NCT00455429|449004260|FG000|Overall Study|Study Terminated by Sponsor|0|||
124829109|NCT00455429|449004261|FG001|Overall Study|Study Terminated by Sponsor|0|||
124829110|NCT00455429|449004262|FG002|Overall Study|Study Terminated by Sponsor|0|||
124829111|NCT00455429|449004263|FG003|Overall Study|Study Terminated by Sponsor|3|||
124829112|NCT00455429|449004260|FG000|Overall Study|Lost to Follow-up|1|||
124829113|NCT00455429|449004261|FG001|Overall Study|Lost to Follow-up|0|||
124829114|NCT00455429|449004262|FG002|Overall Study|Lost to Follow-up|0|||
124829115|NCT00455429|449004263|FG003|Overall Study|Lost to Follow-up|3|||
124829116|NCT00455429|449004260|FG000|Overall Study|Withdrawal by Subject|0|||
124829117|NCT00455429|449004261|FG001|Overall Study|Withdrawal by Subject|1|||
124829118|NCT00455429|449004262|FG002|Overall Study|Withdrawal by Subject|1|||
124829119|NCT00455429|449004263|FG003|Overall Study|Withdrawal by Subject|0|||
124829120|NCT00455429|449004260|FG000|Overall Study|Lack of Efficacy|0|||
124829121|NCT00455429|449004261|FG001|Overall Study|Lack of Efficacy|1|||
124829122|NCT00455429|449004262|FG002|Overall Study|Lack of Efficacy|0|||
124829123|NCT00455429|449004263|FG003|Overall Study|Lack of Efficacy|1|||
124829124|NCT00455429|449004260|FG000|Overall Study|Adverse Event|0|||
124829125|NCT00455429|449004261|FG001|Overall Study|Adverse Event|1|||
124829126|NCT00455429|449004262|FG002|Overall Study|Adverse Event|0|||
124829127|NCT00455429|449004263|FG003|Overall Study|Adverse Event|3|||
124829128|NCT00455429|449004260|FG000|Overall Study|Randomly assigned but not treated|0|||
124829129|NCT00455429|449004261|FG001|Overall Study|Randomly assigned but not treated|0|||
124829130|NCT00455429|449004262|FG002|Overall Study|Randomly assigned but not treated|0|||
124829131|NCT00455429|449004263|FG003|Overall Study|Randomly assigned but not treated|2|||
124829132|NCT00455429|449004260|FG000|Overall Study|Personal Reason|1|||
124829133|NCT00455429|449004261|FG001|Overall Study|Personal Reason|0|||
124829134|NCT00455429|449004262|FG002|Overall Study|Personal Reason|0|||
124829135|NCT00455429|449004263|FG003|Overall Study|Personal Reason|0|||
124829136|NCT00455429|449004260|FG000|Overall Study|Non-compliance|0|||
124829137|NCT00455429|449004261|FG001|Overall Study|Non-compliance|0|||
124829138|NCT00455429|449004262|FG002|Overall Study|Non-compliance|0|||
124829139|NCT00455429|449004263|FG003|Overall Study|Non-compliance|1|||
124829140|NCT00455429|449004260|FG000|Overall Study|Other|0|||
124829141|NCT00455429|449004261|FG001|Overall Study|Other|2|||
124829142|NCT00455429|449004262|FG002|Overall Study|Other|0|||
124829143|NCT00455429|449004263|FG003|Overall Study|Other|1|||
124829144|NCT01165554|449004264|FG000|Overall Study|Withdrawal by Subject|23|||
124829145|NCT02951156|449004271|FG000|Overall Study|Death|3|||
124829146|NCT02951156|449004272|FG001|Overall Study|Death|8|||
124829147|NCT02951156|449004273|FG002|Overall Study|Death|5|||
124829148|NCT02951156|449004271|FG000|Overall Study|Progressive disease|1|||
124829149|NCT02951156|449004272|FG001|Overall Study|Progressive disease|0|||
124829150|NCT02951156|449004273|FG002|Overall Study|Progressive disease|1|||
124829151|NCT02951156|449004271|FG000|Overall Study|Withdrawal by Subject|0|||
124829152|NCT02951156|449004272|FG001|Overall Study|Withdrawal by Subject|0|||
124829153|NCT02951156|449004273|FG002|Overall Study|Withdrawal by Subject|1|||
124829154|NCT02951156|449004271|FG000|Overall Study|Study terminated by sponsor|0|||
124829155|NCT02951156|449004272|FG001|Overall Study|Study terminated by sponsor|0|||
124829156|NCT02951156|449004273|FG002|Overall Study|Study terminated by sponsor|1|||
124829157|NCT02951156|449004271|FG000|Overall Study|Other|5|||
124829158|NCT02951156|449004272|FG001|Overall Study|Other|1|||
124829159|NCT02951156|449004273|FG002|Overall Study|Other|2|||
124829160|NCT04351087|449004274|FG000|Overall Study|Lost to Follow-up|7|||
124829161|NCT04351087|449004275|FG001|Overall Study|Lost to Follow-up|3|||
124829162|NCT04351087|449004274|FG000|Overall Study|Withdrawal by Subject|3|||
124829163|NCT04351087|449004275|FG001|Overall Study|Withdrawal by Subject|4|||
124829164|NCT04351087|449004274|FG000|Overall Study|Lack of Efficacy|3|||
124829165|NCT04351087|449004275|FG001|Overall Study|Lack of Efficacy|2|||
124829166|NCT03519347|449004278|FG000|Interventional Crossover Period 1|Death|0|||
124829167|NCT03519347|449004279|FG001|Interventional Crossover Period 1|Death|0|||
124829168|NCT03519347|449004280|FG002|Interventional Crossover Period 1|Death|0|||
124829169|NCT03519347|449004281|FG003|Interventional Crossover Period 1|Death|1|||
124829170|NCT05517382|449004282|FG000|Overall Study|Lost to Follow-up|0|||
124829171|NCT05517382|449004283|FG001|Overall Study|Lost to Follow-up|1|||
124829172|NCT01641692|449004284|FG000|Treatment Period 1|Adverse Event|1|||
124829173|NCT01641692|449004285|FG001|Treatment Period 1|Adverse Event|0|||
124829174|NCT01641692|449004286|FG002|Treatment Period 1|Adverse Event|0|||
124829175|NCT01641692|449004287|FG003|Treatment Period 1|Adverse Event|0|||
124829176|NCT01641692|449004288|FG004|Treatment Period 1|Adverse Event|0|||
124829177|NCT01641692|449004289|FG005|Treatment Period 1|Adverse Event|0|||
124829178|NCT01641692|449004290|FG006|Treatment Period 1|Adverse Event|0|||
124829179|NCT01641692|449004291|FG007|Treatment Period 1|Adverse Event|0|||
124829180|NCT01641692|449004284|FG000|Treatment Period 1|Lack of Efficacy|0|||
124829181|NCT01641692|449004285|FG001|Treatment Period 1|Lack of Efficacy|0|||
124829182|NCT01641692|449004286|FG002|Treatment Period 1|Lack of Efficacy|0|||
124829183|NCT01641692|449004287|FG003|Treatment Period 1|Lack of Efficacy|0|||
124829184|NCT01641692|449004288|FG004|Treatment Period 1|Lack of Efficacy|0|||
124829185|NCT01641692|449004289|FG005|Treatment Period 1|Lack of Efficacy|0|||
124829186|NCT01641692|449004290|FG006|Treatment Period 1|Lack of Efficacy|0|||
124829187|NCT01641692|449004291|FG007|Treatment Period 1|Lack of Efficacy|1|||
124638749|NCT03850483|448294499|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
124638750|NCT03850483|448294500|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
124638751|NCT03850483|448294501|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
124638752|NCT03850483|448294502|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
124638753|NCT03850483|448294503|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
124752913|NCT04565951|448716881|FG000|Overall Study|Withdrawal by Subject|14|||
124752914|NCT04565951|448716882|FG001|Overall Study|Withdrawal by Subject|7|||
124752915|NCT04565951|448716881|FG000|Overall Study|Death|0|||
124752916|NCT04565951|448716882|FG001|Overall Study|Death|1|||
124752917|NCT04677504|448716883|FG000|Overall Study|Death|51|||
124752918|NCT04677504|448716884|FG001|Overall Study|Death|49|||
124752919|NCT04677504|448716883|FG000|Overall Study|Progressive Disease|1|||
124752920|NCT04677504|448716884|FG001|Overall Study|Progressive Disease|0|||
124752921|NCT04677504|448716883|FG000|Overall Study|Symptomatic Deterioration|1|||
124752922|NCT04677504|448716884|FG001|Overall Study|Symptomatic Deterioration|0|||
124752923|NCT04677504|448716883|FG000|Overall Study|Withdrawal by Subject|2|||
124752924|NCT04677504|448716884|FG001|Overall Study|Withdrawal by Subject|5|||
124752925|NCT04677504|448716883|FG000|Overall Study|Study Terminated By Sponsor|28|||
124752926|NCT04677504|448716884|FG001|Overall Study|Study Terminated By Sponsor|24|||
124752927|NCT04677504|448716883|FG000|Overall Study|Adverse Event|0|||
124752928|NCT04677504|448716884|FG001|Overall Study|Adverse Event|1|||
124752929|NCT00167310|448716895|FG000|Overall Study|Protocol Violation|5|||
124752930|NCT00167310|448716896|FG001|Overall Study|Protocol Violation|3|||
124752931|NCT00167310|448716895|FG000|Overall Study|Withdrawal by Subject|3|||
124752932|NCT00167310|448716896|FG001|Overall Study|Withdrawal by Subject|7|||
124752933|NCT04371666|448716897|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
124752934|NCT04371666|448716898|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
124752935|NCT04371666|448716897|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
124752936|NCT04371666|448716898|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
124752937|NCT04371666|448716897|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
124752938|NCT04371666|448716898|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
124752939|NCT04371666|448716897|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
124752940|NCT04371666|448716898|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
124752941|NCT04371666|448716897|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
124752942|NCT04371666|448716898|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
124752943|NCT04371666|448716897|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
124752944|NCT04371666|448716898|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
124752945|NCT00445770|448716899|FG000|Overall Study|Adverse Event|9|||
124752946|NCT00445770|448716900|FG001|Overall Study|Adverse Event|15|||
124752947|NCT00445770|448716901|FG002|Overall Study|Adverse Event|19|||
124752948|NCT00445770|448716899|FG000|Overall Study|Lack of Efficacy|38|||
124752949|NCT00445770|448716900|FG001|Overall Study|Lack of Efficacy|13|||
124752950|NCT00445770|448716901|FG002|Overall Study|Lack of Efficacy|6|||
124752951|NCT00445770|448716899|FG000|Overall Study|Lost to Follow-up|0|||
124752952|NCT00445770|448716900|FG001|Overall Study|Lost to Follow-up|2|||
124752953|NCT00445770|448716901|FG002|Overall Study|Lost to Follow-up|0|||
124752954|NCT00445770|448716899|FG000|Overall Study|Other|6|||
124752955|NCT00445770|448716900|FG001|Overall Study|Other|5|||
124752956|NCT00445770|448716901|FG002|Overall Study|Other|6|||
124752957|NCT03857542|448716902|FG000|Overall Study|Adverse Event|1|||
124752958|NCT03857542|448716903|FG001|Overall Study|Adverse Event|3|||
124752959|NCT03857542|448716902|FG000|Overall Study|Withdrawal by Subject|2|||
124752960|NCT03857542|448716903|FG001|Overall Study|Withdrawal by Subject|1|||
124752961|NCT03857542|448716902|FG000|Overall Study|Lost to Follow-up|2|||
124752962|NCT03857542|448716903|FG001|Overall Study|Lost to Follow-up|1|||
124752963|NCT03857542|448716902|FG000|Overall Study|Reason not Specified|1|||
124752964|NCT03857542|448716903|FG001|Overall Study|Reason not Specified|0|||
124752965|NCT02123576|448716904|FG000|Overall Study|Adverse Event|1|||
124752966|NCT02123576|448716905|FG001|Overall Study|Adverse Event|0|||
124752967|NCT00934128|448716906|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
124752968|NCT00934128|448716907|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
124829188|NCT01641692|449004284|FG000|Treatment Period 1|Protocol Violation|1|||
124829189|NCT01641692|449004285|FG001|Treatment Period 1|Protocol Violation|0|||
124829190|NCT01641692|449004286|FG002|Treatment Period 1|Protocol Violation|0|||
124829191|NCT01641692|449004287|FG003|Treatment Period 1|Protocol Violation|0|||
124829192|NCT01641692|449004288|FG004|Treatment Period 1|Protocol Violation|2|||
124829193|NCT01641692|449004289|FG005|Treatment Period 1|Protocol Violation|0|||
124829194|NCT01641692|449004290|FG006|Treatment Period 1|Protocol Violation|0|||
124829195|NCT01641692|449004291|FG007|Treatment Period 1|Protocol Violation|0|||
124829196|NCT01641692|449004284|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
124829197|NCT01641692|449004285|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
124829198|NCT01641692|449004286|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
124829199|NCT01641692|449004287|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
124829200|NCT01641692|449004288|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
124829201|NCT01641692|449004289|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
124829202|NCT01641692|449004290|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
124829203|NCT01641692|449004291|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
124829204|NCT01641692|449004284|FG000|Treatment Period 1|Lost to Follow-up|0|||
124829205|NCT01641692|449004285|FG001|Treatment Period 1|Lost to Follow-up|0|||
124829206|NCT01641692|449004286|FG002|Treatment Period 1|Lost to Follow-up|1|||
124829207|NCT01641692|449004287|FG003|Treatment Period 1|Lost to Follow-up|0|||
124829208|NCT01641692|449004288|FG004|Treatment Period 1|Lost to Follow-up|0|||
124829209|NCT01641692|449004289|FG005|Treatment Period 1|Lost to Follow-up|0|||
124829210|NCT01641692|449004290|FG006|Treatment Period 1|Lost to Follow-up|0|||
124829211|NCT01641692|449004291|FG007|Treatment Period 1|Lost to Follow-up|0|||
124829212|NCT01641692|449004284|FG000|Treatment Period 1|Physician Decision|0|||
124829213|NCT01641692|449004285|FG001|Treatment Period 1|Physician Decision|0|||
124829214|NCT01641692|449004286|FG002|Treatment Period 1|Physician Decision|0|||
124829215|NCT01641692|449004287|FG003|Treatment Period 1|Physician Decision|0|||
124829216|NCT01641692|449004288|FG004|Treatment Period 1|Physician Decision|1|||
124829217|NCT01641692|449004289|FG005|Treatment Period 1|Physician Decision|0|||
124829218|NCT01641692|449004290|FG006|Treatment Period 1|Physician Decision|0|||
124829219|NCT01641692|449004291|FG007|Treatment Period 1|Physician Decision|0|||
124829220|NCT01641692|449004284|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124829221|NCT01641692|449004285|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124829222|NCT01641692|449004286|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124829223|NCT01641692|449004287|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124829224|NCT01641692|449004288|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124829225|NCT01641692|449004289|FG005|Treatment Period 1|Withdrawal by Subject|2|||
124829226|NCT01641692|449004290|FG006|Treatment Period 1|Withdrawal by Subject|0|||
124829227|NCT01641692|449004291|FG007|Treatment Period 1|Withdrawal by Subject|1|||
124829228|NCT01641692|449004284|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
124829229|NCT01641692|449004285|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
124829230|NCT01641692|449004286|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
124829231|NCT01641692|449004287|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
124829232|NCT01641692|449004288|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
124829233|NCT01641692|449004289|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
124829234|NCT01641692|449004290|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
124829235|NCT01641692|449004291|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
124829236|NCT01641692|449004284|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124829237|NCT01641692|449004285|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124829238|NCT01641692|449004286|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124829239|NCT01641692|449004287|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124829240|NCT01641692|449004288|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124829241|NCT01641692|449004289|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124829242|NCT01641692|449004290|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
124829243|NCT01641692|449004291|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124829244|NCT01641692|449004284|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
124829245|NCT01641692|449004285|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
124829246|NCT01641692|449004286|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
124829247|NCT01641692|449004287|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
124829248|NCT01641692|449004288|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
124829249|NCT01641692|449004289|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
124829250|NCT01641692|449004290|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
124638754|NCT03850483|448294494|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
124638755|NCT03850483|448294495|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
124829251|NCT01641692|449004291|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
124829252|NCT01641692|449004284|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
124829253|NCT01641692|449004285|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
124829254|NCT01641692|449004286|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
124638756|NCT03850483|448294496|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
124829255|NCT01641692|449004287|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
124829256|NCT01641692|449004288|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
124829257|NCT01641692|449004289|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
124829258|NCT01641692|449004290|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
124829259|NCT01641692|449004291|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
124829260|NCT01641692|449004284|FG000|Treatment Period 2|Lack of Efficacy|1|||
124829261|NCT01641692|449004285|FG001|Treatment Period 2|Lack of Efficacy|0|||
124829262|NCT01641692|449004286|FG002|Treatment Period 2|Lack of Efficacy|0|||
124829263|NCT01641692|449004287|FG003|Treatment Period 2|Lack of Efficacy|0|||
124829264|NCT01641692|449004288|FG004|Treatment Period 2|Lack of Efficacy|0|||
124829265|NCT01641692|449004289|FG005|Treatment Period 2|Lack of Efficacy|0|||
124829266|NCT01641692|449004290|FG006|Treatment Period 2|Lack of Efficacy|0|||
124829267|NCT01641692|449004291|FG007|Treatment Period 2|Lack of Efficacy|0|||
124829268|NCT01641692|449004284|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
124829269|NCT01641692|449004285|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124829270|NCT01641692|449004286|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124829271|NCT01641692|449004287|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124829272|NCT01641692|449004288|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124829273|NCT01641692|449004289|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124829274|NCT01641692|449004290|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124829275|NCT01641692|449004291|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
124829276|NCT01641692|449004284|FG000|Treatment Period 2|Lost to Follow-up|0|||
124829277|NCT01641692|449004285|FG001|Treatment Period 2|Lost to Follow-up|0|||
124829278|NCT01641692|449004286|FG002|Treatment Period 2|Lost to Follow-up|0|||
124829279|NCT01641692|449004287|FG003|Treatment Period 2|Lost to Follow-up|0|||
124829280|NCT01641692|449004288|FG004|Treatment Period 2|Lost to Follow-up|0|||
124829281|NCT01641692|449004289|FG005|Treatment Period 2|Lost to Follow-up|1|||
124829282|NCT01641692|449004290|FG006|Treatment Period 2|Lost to Follow-up|0|||
124829283|NCT01641692|449004291|FG007|Treatment Period 2|Lost to Follow-up|0|||
124829284|NCT01641692|449004284|FG000|Treatment Period 2|Withdrawal by Subject|1|||
124829285|NCT01641692|449004285|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124829286|NCT01641692|449004286|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124829287|NCT01641692|449004287|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124829288|NCT01641692|449004288|FG004|Treatment Period 2|Withdrawal by Subject|0|||
124829289|NCT01641692|449004289|FG005|Treatment Period 2|Withdrawal by Subject|1|||
124829290|NCT01641692|449004290|FG006|Treatment Period 2|Withdrawal by Subject|0|||
124829291|NCT01641692|449004291|FG007|Treatment Period 2|Withdrawal by Subject|1|||
124829292|NCT01641692|449004284|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
124829293|NCT01641692|449004285|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
124829294|NCT01641692|449004286|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
124829295|NCT01641692|449004287|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
124829296|NCT01641692|449004288|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
124829297|NCT01641692|449004289|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
124829298|NCT01641692|449004290|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
124829299|NCT01641692|449004291|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
124829300|NCT01641692|449004284|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124829301|NCT01641692|449004285|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124829302|NCT01641692|449004286|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
124829303|NCT01641692|449004287|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124829304|NCT01641692|449004288|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124829305|NCT01641692|449004289|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
124829306|NCT01641692|449004290|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124829307|NCT01641692|449004291|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
124829308|NCT01641692|449004284|FG000|Treatment Period 3|Adverse Event|0|||
124829309|NCT01641692|449004285|FG001|Treatment Period 3|Adverse Event|0|||
124829310|NCT01641692|449004286|FG002|Treatment Period 3|Adverse Event|0|||
124829311|NCT01641692|449004287|FG003|Treatment Period 3|Adverse Event|0|||
124829312|NCT01641692|449004288|FG004|Treatment Period 3|Adverse Event|0|||
124829313|NCT01641692|449004289|FG005|Treatment Period 3|Adverse Event|0|||
124829314|NCT01641692|449004290|FG006|Treatment Period 3|Adverse Event|1|||
124829315|NCT01641692|449004291|FG007|Treatment Period 3|Adverse Event|0|||
124829316|NCT01641692|449004284|FG000|Treatment Period 3|Protocol Violation|0|||
124829317|NCT01641692|449004285|FG001|Treatment Period 3|Protocol Violation|0|||
124829318|NCT01641692|449004286|FG002|Treatment Period 3|Protocol Violation|1|||
124829319|NCT01641692|449004287|FG003|Treatment Period 3|Protocol Violation|0|||
124829320|NCT01641692|449004288|FG004|Treatment Period 3|Protocol Violation|0|||
124829321|NCT01641692|449004289|FG005|Treatment Period 3|Protocol Violation|0|||
124829322|NCT01641692|449004290|FG006|Treatment Period 3|Protocol Violation|0|||
124829323|NCT01641692|449004291|FG007|Treatment Period 3|Protocol Violation|0|||
124829324|NCT01641692|449004284|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124829325|NCT01641692|449004285|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124829326|NCT01641692|449004286|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124829327|NCT01641692|449004287|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124829328|NCT01641692|449004288|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124829329|NCT01641692|449004289|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124829330|NCT01641692|449004290|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
124829331|NCT01641692|449004291|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
124829332|NCT01641692|449004284|FG000|Treatment Period 3|Lost to Follow-up|0|||
124829333|NCT01641692|449004285|FG001|Treatment Period 3|Lost to Follow-up|1|||
124829334|NCT01641692|449004286|FG002|Treatment Period 3|Lost to Follow-up|0|||
124829335|NCT01641692|449004287|FG003|Treatment Period 3|Lost to Follow-up|0|||
124829336|NCT01641692|449004288|FG004|Treatment Period 3|Lost to Follow-up|0|||
124829337|NCT01641692|449004289|FG005|Treatment Period 3|Lost to Follow-up|0|||
124829338|NCT01641692|449004290|FG006|Treatment Period 3|Lost to Follow-up|0|||
124829339|NCT01641692|449004291|FG007|Treatment Period 3|Lost to Follow-up|0|||
124829340|NCT01641692|449004284|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
124829341|NCT01641692|449004285|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
124829342|NCT01641692|449004286|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
124829343|NCT01641692|449004287|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
124829344|NCT01641692|449004288|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
124829345|NCT01641692|449004289|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
124829346|NCT01641692|449004290|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
124829347|NCT01641692|449004291|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
124829348|NCT01641692|449004284|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
124829349|NCT01641692|449004285|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
124829350|NCT01641692|449004286|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
124829351|NCT01641692|449004287|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
124829352|NCT01641692|449004288|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
124829353|NCT01641692|449004289|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
124829354|NCT01641692|449004290|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
124829355|NCT01641692|449004291|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
124829356|NCT00484939|449004298|FG000|Overall Study|Death|9|||
124829357|NCT00484939|449004299|FG001|Overall Study|Death|13|||
124829358|NCT00484939|449004298|FG000|Overall Study|Adverse Event|22|||
124829359|NCT00484939|449004299|FG001|Overall Study|Adverse Event|12|||
124829360|NCT00484939|449004298|FG000|Overall Study|Patient Withdrew Consent|19|||
124829361|NCT00484939|449004299|FG001|Overall Study|Patient Withdrew Consent|10|||
124829362|NCT00484939|449004298|FG000|Overall Study|Protocol Violation|3|||
124829363|NCT00484939|449004299|FG001|Overall Study|Protocol Violation|3|||
124829364|NCT00484939|449004298|FG000|Overall Study|Lost to Follow-up|0|||
124829365|NCT00484939|449004299|FG001|Overall Study|Lost to Follow-up|3|||
124829366|NCT00484939|449004298|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
124829367|NCT00484939|449004299|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
124829368|NCT00484939|449004298|FG000|Overall Study|Disease progression|67|||
124829369|NCT00484939|449004299|FG001|Overall Study|Disease progression|88|||
124829370|NCT00484939|449004298|FG000|Overall Study|Screen Failure|2|||
124829371|NCT00484939|449004299|FG001|Overall Study|Screen Failure|2|||
124829372|NCT00484939|449004298|FG000|Overall Study|Reason Not Specified|11|||
124829373|NCT00484939|449004299|FG001|Overall Study|Reason Not Specified|6|||
124829374|NCT04948450|449004300|FG000|Overall Study|Return home|1|||
124829375|NCT04948450|449004301|FG001|Overall Study|Return home|3|||
124829376|NCT01173718|449004320|FG000|Overall Study|Death|17|||
124829377|NCT01173718|449004320|FG000|Overall Study|Abandonment of study graft|27|||
124829378|NCT01367158|449004321|FG000|Overall Study|Withdrew consent|0|||
124829379|NCT01367158|449004322|FG001|Overall Study|Withdrew consent|2|||
124829380|NCT01367158|449004323|FG002|Overall Study|Withdrew consent|1|||
124829381|NCT01367158|449004324|FG003|Overall Study|Withdrew consent|0|||
124829382|NCT01367158|449004325|FG004|Overall Study|Withdrew consent|2|||
124829383|NCT01367158|449004326|FG005|Overall Study|Withdrew consent|0|||
124829384|NCT01367158|449004327|FG006|Overall Study|Withdrew consent|0|||
124638757|NCT03850483|448294497|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
124638758|NCT03850483|448294498|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
124829385|NCT01367158|449004328|FG007|Overall Study|Withdrew consent|1|||
124829386|NCT01367158|449004329|FG008|Overall Study|Withdrew consent|0|||
124829387|NCT01367158|449004330|FG009|Overall Study|Withdrew consent|0|||
124829388|NCT01367158|449004331|FG010|Overall Study|Withdrew consent|0|||
124829389|NCT01367158|449004321|FG000|Overall Study|Lost to Follow-up|0|||
124829390|NCT01367158|449004322|FG001|Overall Study|Lost to Follow-up|0|||
124829391|NCT01367158|449004323|FG002|Overall Study|Lost to Follow-up|0|||
124829392|NCT01367158|449004324|FG003|Overall Study|Lost to Follow-up|1|||
124829393|NCT01367158|449004325|FG004|Overall Study|Lost to Follow-up|0|||
124829394|NCT01367158|449004326|FG005|Overall Study|Lost to Follow-up|2|||
124829395|NCT01367158|449004327|FG006|Overall Study|Lost to Follow-up|0|||
124829396|NCT01367158|449004328|FG007|Overall Study|Lost to Follow-up|1|||
124829397|NCT01367158|449004329|FG008|Overall Study|Lost to Follow-up|0|||
124829398|NCT01367158|449004330|FG009|Overall Study|Lost to Follow-up|0|||
124829399|NCT01367158|449004331|FG010|Overall Study|Lost to Follow-up|1|||
124829400|NCT01367158|449004321|FG000|Overall Study|Protocol Violation|0|||
124829401|NCT01367158|449004322|FG001|Overall Study|Protocol Violation|1|||
124829402|NCT01367158|449004323|FG002|Overall Study|Protocol Violation|0|||
124829403|NCT01367158|449004324|FG003|Overall Study|Protocol Violation|0|||
124829404|NCT01367158|449004325|FG004|Overall Study|Protocol Violation|0|||
124829405|NCT01367158|449004326|FG005|Overall Study|Protocol Violation|0|||
124829406|NCT01367158|449004327|FG006|Overall Study|Protocol Violation|0|||
124829407|NCT01367158|449004328|FG007|Overall Study|Protocol Violation|0|||
124829408|NCT01367158|449004329|FG008|Overall Study|Protocol Violation|0|||
124829409|NCT01367158|449004330|FG009|Overall Study|Protocol Violation|0|||
124829410|NCT01367158|449004331|FG010|Overall Study|Protocol Violation|0|||
124829411|NCT02226003|449004333|FG000|Overall Study|Lost to Follow-up|2|||
124829412|NCT02226003|449004334|FG001|Overall Study|Lost to Follow-up|1|||
124829413|NCT02226003|449004335|FG002|Overall Study|Lost to Follow-up|3|||
124829414|NCT02226003|449004333|FG000|Overall Study|Withdrawal by Subject|0|||
124829415|NCT02226003|449004334|FG001|Overall Study|Withdrawal by Subject|0|||
124829416|NCT02226003|449004335|FG002|Overall Study|Withdrawal by Subject|3|||
124829417|NCT00296374|449004345|FG000|Overall Study|Adverse Event|14|||
124829418|NCT00296374|449004346|FG001|Overall Study|Adverse Event|10|||
124829419|NCT00296374|449004347|FG002|Overall Study|Adverse Event|7|||
124829420|NCT00296374|449004345|FG000|Overall Study|Withdrawal by Subject|3|||
124829421|NCT00296374|449004346|FG001|Overall Study|Withdrawal by Subject|5|||
124829422|NCT00296374|449004347|FG002|Overall Study|Withdrawal by Subject|11|||
124829423|NCT00296374|449004345|FG000|Overall Study|Incorrect enrollment|3|||
124829424|NCT00296374|449004346|FG001|Overall Study|Incorrect enrollment|3|||
124829425|NCT00296374|449004347|FG002|Overall Study|Incorrect enrollment|4|||
124829426|NCT00296374|449004345|FG000|Overall Study|Protocol Violation|1|||
124829427|NCT00296374|449004346|FG001|Overall Study|Protocol Violation|2|||
124829428|NCT00296374|449004347|FG002|Overall Study|Protocol Violation|3|||
124829429|NCT00296374|449004345|FG000|Overall Study|Lost to Follow-up|3|||
124829430|NCT00296374|449004346|FG001|Overall Study|Lost to Follow-up|1|||
124829431|NCT00296374|449004347|FG002|Overall Study|Lost to Follow-up|1|||
124829432|NCT00296374|449004345|FG000|Overall Study|Relocated to another state|1|||
124829433|NCT00296374|449004346|FG001|Overall Study|Relocated to another state|0|||
124829434|NCT00296374|449004347|FG002|Overall Study|Relocated to another state|0|||
124829435|NCT00296374|449004345|FG000|Overall Study|Stopped drug before end of study visit|0|||
124829436|NCT00296374|449004346|FG001|Overall Study|Stopped drug before end of study visit|1|||
124829437|NCT00296374|449004347|FG002|Overall Study|Stopped drug before end of study visit|0|||
124829438|NCT00296374|449004345|FG000|Overall Study|Nephrologist introduced ACE|0|||
124829439|NCT00296374|449004346|FG001|Overall Study|Nephrologist introduced ACE|1|||
124829440|NCT00296374|449004347|FG002|Overall Study|Nephrologist introduced ACE|0|||
124829441|NCT00296374|449004345|FG000|Overall Study|Pregnancy|0|||
124829442|NCT00296374|449004346|FG001|Overall Study|Pregnancy|0|||
124829443|NCT00296374|449004347|FG002|Overall Study|Pregnancy|2|||
124829444|NCT00296374|449004345|FG000|Overall Study|Other|0|||
124829445|NCT00296374|449004346|FG001|Overall Study|Other|0|||
124829446|NCT00296374|449004347|FG002|Overall Study|Other|1|||
124829447|NCT00670800|449005927|FG000|Overall Study|2 controls were insulin resistant|0|||
124829448|NCT00670800|449005928|FG001|Overall Study|2 controls were insulin resistant|2|||
124829449|NCT01786629|449005929|FG000|Overall Study|Lack of Efficacy|0|||
124829450|NCT01786629|449005930|FG001|Overall Study|Lack of Efficacy|4|||
124829451|NCT01786629|449005929|FG000|Overall Study|Adverse Event|0|||
124829452|NCT01786629|449005930|FG001|Overall Study|Adverse Event|1|||
124829453|NCT02926924|449005931|FG000|Overall Study|withdrawal - reason unknown|0|||
124829454|NCT02926924|449005932|FG001|Overall Study|withdrawal - reason unknown|1|||
124829455|NCT01852942|449005935|FG000|Overall Study|Physician Decision|1|||
124829456|NCT01852942|449005936|FG001|Overall Study|Physician Decision|0|||
124829457|NCT01852942|449005935|FG000|Overall Study|Death|1|||
124829458|NCT01852942|449005936|FG001|Overall Study|Death|1|||
124829459|NCT01852942|449005935|FG000|Overall Study|Withdrawal by Subject|2|||
124829460|NCT01852942|449005936|FG001|Overall Study|Withdrawal by Subject|3|||
124829461|NCT01852942|449005935|FG000|Overall Study|Lost to Follow-up|1|||
124829462|NCT01852942|449005936|FG001|Overall Study|Lost to Follow-up|2|||
124829463|NCT01921179|449005937|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
124829464|NCT01921179|449005938|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
124638759|NCT03850483|448294499|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
124829465|NCT01921179|449005937|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
124829466|NCT01921179|449005938|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
124829467|NCT04568590|449005940|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
124829468|NCT00858442|449005944|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
124829469|NCT00858442|449005945|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
124829470|NCT00202644|449005950|FG000|Overall Study|Adverse Event|12|||
124829471|NCT00202644|449005951|FG001|Overall Study|Adverse Event|13|||
124638760|NCT03850483|448294500|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
124829472|NCT00202644|449005950|FG000|Overall Study|Withdrawal by Subject|8|||
124829473|NCT00202644|449005951|FG001|Overall Study|Withdrawal by Subject|6|||
124829474|NCT00202644|449005950|FG000|Overall Study|Lack of Efficacy|6|||
124829475|NCT00202644|449005951|FG001|Overall Study|Lack of Efficacy|6|||
124829476|NCT00202644|449005950|FG000|Overall Study|Lost to Follow-up|0|||
124829477|NCT00202644|449005951|FG001|Overall Study|Lost to Follow-up|1|||
124829478|NCT00202644|449005950|FG000|Overall Study|Other|9|||
124829479|NCT00202644|449005951|FG001|Overall Study|Other|1|||
124829480|NCT02750592|449005957|FG000|Overall Study|Adverse Event|3|||
124829481|NCT02750592|449005957|FG000|Overall Study|Lack of Efficacy|2|||
124829482|NCT02981342|449005960|FG000|Overall Study|Adverse Event|0|||
124829483|NCT02981342|449005961|FG001|Overall Study|Adverse Event|0|||
124829484|NCT02981342|449005962|FG002|Overall Study|Adverse Event|0|||
124829485|NCT02981342|449005963|FG003|Overall Study|Adverse Event|1|||
124829486|NCT02981342|449005960|FG000|Overall Study|Death|0|||
124829487|NCT02981342|449005961|FG001|Overall Study|Death|9|||
124829488|NCT02981342|449005962|FG002|Overall Study|Death|9|||
124829489|NCT02981342|449005963|FG003|Overall Study|Death|4|||
124829490|NCT02981342|449005960|FG000|Overall Study|Withdrawal by Subject|0|||
124829491|NCT02981342|449005961|FG001|Overall Study|Withdrawal by Subject|0|||
124829492|NCT02981342|449005962|FG002|Overall Study|Withdrawal by Subject|3|||
124829493|NCT02981342|449005963|FG003|Overall Study|Withdrawal by Subject|1|||
124829494|NCT02981342|449005960|FG000|Overall Study|Study closed by sponsor|0|||
124829495|NCT02981342|449005961|FG001|Overall Study|Study closed by sponsor|0|||
124829496|NCT02981342|449005962|FG002|Overall Study|Study closed by sponsor|1|||
124829497|NCT02981342|449005963|FG003|Overall Study|Study closed by sponsor|1|||
124829498|NCT02981342|449005960|FG000|Overall Study|Randomized, Never Treated|0|||
124829499|NCT02981342|449005961|FG001|Overall Study|Randomized, Never Treated|1|||
124829500|NCT02981342|449005962|FG002|Overall Study|Randomized, Never Treated|0|||
124829501|NCT02981342|449005963|FG003|Overall Study|Randomized, Never Treated|7|||
124829502|NCT02981342|449005960|FG000|Overall Study|Lost to Follow-up|0|||
124829503|NCT02981342|449005961|FG001|Overall Study|Lost to Follow-up|1|||
124829504|NCT02981342|449005962|FG002|Overall Study|Lost to Follow-up|0|||
124829505|NCT02981342|449005963|FG003|Overall Study|Lost to Follow-up|0|||
124829506|NCT01372501|449005964|FG000|Overall Study|Adverse Event|4|||
124829507|NCT01372501|449005964|FG000|Overall Study|Device migration|1|||
124829508|NCT01466348|449005965|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
124829509|NCT01466348|449005966|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
124829510|NCT03989440|449005967|FG000|Overall Study|COVID-19 travel restrictions|0|||
124829511|NCT03989440|449005968|FG001|Overall Study|COVID-19 travel restrictions|0|||
124829512|NCT03989440|449005969|FG002|Overall Study|COVID-19 travel restrictions|1|||
124829513|NCT03989440|449005970|FG003|Overall Study|COVID-19 travel restrictions|0|||
124829514|NCT03989440|449005971|FG004|Overall Study|COVID-19 travel restrictions|0|||
124829515|NCT03989440|449005972|FG005|Overall Study|COVID-19 travel restrictions|0|||
124829516|NCT03989440|449005967|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
124829517|NCT03989440|449005968|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
124829518|NCT03989440|449005969|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
124829519|NCT03989440|449005970|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
124829520|NCT03989440|449005971|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
124829521|NCT03989440|449005972|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
124829522|NCT03970733|449005975|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
124829523|NCT03970733|449005976|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
124829524|NCT03970733|449005977|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
124829525|NCT03970733|449005978|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
124829526|NCT03970733|449005979|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
124829527|NCT03970733|449005975|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
124829528|NCT03970733|449005976|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
124829529|NCT03970733|449005977|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
124829530|NCT03970733|449005978|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
124829531|NCT03970733|449005979|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
124829532|NCT03970733|449005975|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
124829533|NCT03970733|449005976|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
124829534|NCT03970733|449005977|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
124829535|NCT03970733|449005978|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
124829536|NCT03970733|449005979|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
124829537|NCT03970733|449005975|FG000|Main Study Phase (18 Months)|Other|1|||
124638761|NCT03850483|448294501|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
124638762|NCT03850483|448294502|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
124638763|NCT03850483|448294503|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
124638764|NCT03850483|448294494|FG000|Treatment for Stage 2|Physician Decision|0|||
124638765|NCT03850483|448294495|FG001|Treatment for Stage 2|Physician Decision|0|||
124638766|NCT03850483|448294496|FG002|Treatment for Stage 2|Physician Decision|0|||
124829538|NCT03970733|449005976|FG001|Main Study Phase (18 Months)|Other|1|||
124829539|NCT03970733|449005977|FG002|Main Study Phase (18 Months)|Other|0|||
124829540|NCT03970733|449005978|FG003|Main Study Phase (18 Months)|Other|0|||
124638767|NCT03850483|448294497|FG003|Treatment for Stage 2|Physician Decision|0|||
124829541|NCT03970733|449005979|FG004|Main Study Phase (18 Months)|Other|0|||
124829542|NCT03970733|449005975|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
124829543|NCT03970733|449005976|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
124829544|NCT03970733|449005977|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
124829545|NCT03970733|449005978|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
124829546|NCT03970733|449005979|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
124829547|NCT02189473|449005983|FG000|Overall Study|Death|22|||
124829548|NCT02189473|449005984|FG001|Overall Study|Death|23|||
124829549|NCT02189473|449005983|FG000|Overall Study|Lost to Follow-up|1|||
124829550|NCT02189473|449005984|FG001|Overall Study|Lost to Follow-up|2|||
124829551|NCT01955161|449005985|FG000|Overall Study|Withdrawal before treatment|2|||
124829552|NCT01955161|449005986|FG001|Overall Study|Withdrawal before treatment|0|||
124829553|NCT01955161|449005987|FG002|Overall Study|Withdrawal before treatment|1|||
124829554|NCT01955161|449005985|FG000|Overall Study|Adverse Event|10|||
124829555|NCT01955161|449005986|FG001|Overall Study|Adverse Event|14|||
124829556|NCT01955161|449005987|FG002|Overall Study|Adverse Event|15|||
124829557|NCT01955161|449005985|FG000|Overall Study|Death|1|||
124829558|NCT01955161|449005986|FG001|Overall Study|Death|1|||
124829559|NCT01955161|449005987|FG002|Overall Study|Death|3|||
124829560|NCT01955161|449005985|FG000|Overall Study|Withdrawal by Subject|9|||
124829561|NCT01955161|449005986|FG001|Overall Study|Withdrawal by Subject|8|||
124829562|NCT01955161|449005987|FG002|Overall Study|Withdrawal by Subject|12|||
124829563|NCT01955161|449005985|FG000|Overall Study|Protocol Violation|2|||
124829564|NCT01955161|449005986|FG001|Overall Study|Protocol Violation|0|||
124829565|NCT01955161|449005987|FG002|Overall Study|Protocol Violation|0|||
124829566|NCT01955161|449005985|FG000|Overall Study|Other reason: physician decision|0|||
124829567|NCT01955161|449005986|FG001|Overall Study|Other reason: physician decision|1|||
124829568|NCT01955161|449005987|FG002|Overall Study|Other reason: physician decision|1|||
124829569|NCT01955161|449005985|FG000|Overall Study|Other reason: disallowed medication|1|||
124829570|NCT01955161|449005986|FG001|Overall Study|Other reason: disallowed medication|0|||
124829571|NCT01955161|449005987|FG002|Overall Study|Other reason: disallowed medication|1|||
124829572|NCT01955161|449005985|FG000|Overall Study|Other reason: caregiver unavailable|1|||
124829573|NCT01955161|449005986|FG001|Overall Study|Other reason: caregiver unavailable|0|||
124829574|NCT01955161|449005987|FG002|Overall Study|Other reason: caregiver unavailable|0|||
124829575|NCT01955161|449005985|FG000|Overall Study|Other reason: moved to nursing home|0|||
124829576|NCT01955161|449005986|FG001|Overall Study|Other reason: moved to nursing home|1|||
124829577|NCT01955161|449005987|FG002|Overall Study|Other reason: moved to nursing home|0|||
124829578|NCT01955161|449005985|FG000|Overall Study|Other reason: insufficient compliance|0|||
124829579|NCT01955161|449005986|FG001|Overall Study|Other reason: insufficient compliance|0|||
124829580|NCT01955161|449005987|FG002|Overall Study|Other reason: insufficient compliance|1|||
124829581|NCT01955161|449005985|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
124829582|NCT01955161|449005986|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
124829583|NCT01955161|449005987|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
124829584|NCT01955161|449005985|FG000|Overall Study|Other reason: patient's will|0|||
124829585|NCT01955161|449005986|FG001|Overall Study|Other reason: patient's will|0|||
124829586|NCT01955161|449005987|FG002|Overall Study|Other reason: patient's will|1|||
124829587|NCT02784821|449005990|FG000|Overall Study|Death|0|||
124829588|NCT02784821|449005991|FG001|Overall Study|Death|5|||
124829589|NCT02784821|449005992|FG002|Overall Study|Death|4|||
124829590|NCT02784821|449005993|FG003|Overall Study|Death|5|||
124829591|NCT05333900|449005994|FG000|Overall Study|Protocol Violation|0|||
124829592|NCT05333900|449005995|FG001|Overall Study|Protocol Violation|1|||
124829593|NCT05333900|449005994|FG000|Overall Study|Withdrawal by Subject|0|||
124829594|NCT05333900|449005995|FG001|Overall Study|Withdrawal by Subject|1|||
124829595|NCT05333900|449005994|FG000|Overall Study|COVID-19 Pandemic|1|||
124829596|NCT05333900|449005995|FG001|Overall Study|COVID-19 Pandemic|1|||
124829597|NCT03724812|449005998|FG000|Overall Study|Missed Visit|1|||
124829598|NCT03724812|449005998|FG000|Overall Study|Death|2|||
124829599|NCT03724812|449005998|FG000|Overall Study|Withdrawal by Subject|1|||
124638768|NCT03850483|448294498|FG004|Treatment for Stage 2|Physician Decision|0|||
124638769|NCT03850483|448294499|FG005|Treatment for Stage 2|Physician Decision|0|||
124829600|NCT01851720|449005999|FG000|Overall Study|Lost to Follow-up|0|||
124829601|NCT01851720|449006000|FG001|Overall Study|Lost to Follow-up|1|||
124829602|NCT01394523|449006001|FG000|Overall Study|Unable to place block|1|||
124829603|NCT01394523|449006002|FG001|Overall Study|Unable to place block|0|||
124829604|NCT01394523|449006003|FG002|Overall Study|Unable to place block|0|||
124829605|NCT04741074|449006006|FG000|Overall Study|Withdrawal by Subject|1|||
124829606|NCT04741074|449006007|FG001|Overall Study|Withdrawal by Subject|1|||
124829607|NCT04741074|449006006|FG000|Overall Study|Study terminated prematurely|1|||
124829608|NCT04741074|449006007|FG001|Overall Study|Study terminated prematurely|0|||
124829609|NCT02432846|449006008|FG000|Overall Study (4 Arms/Strata)|Death|3|||
124829610|NCT02432846|449006009|FG001|Overall Study (4 Arms/Strata)|Death|2|||
124829611|NCT02432846|449006010|FG002|Overall Study (4 Arms/Strata)|Death|4|||
124829612|NCT02432846|449006011|FG003|Overall Study (4 Arms/Strata)|Death|3|||
124638770|NCT03850483|448294500|FG006|Treatment for Stage 2|Physician Decision|0|||
124829613|NCT02432846|449006012|FG004|Overall Study (4 Arms/Strata)|Death|0|||
124829614|NCT02432846|449006013|FG005|Overall Study (4 Arms/Strata)|Death|0|||
124829615|NCT02432846|449006008|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
124829616|NCT02432846|449006009|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
124829617|NCT02432846|449006010|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
124829618|NCT02432846|449006011|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
124829619|NCT02432846|449006012|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
124829620|NCT02432846|449006013|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
124829621|NCT02432846|449006008|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
124829622|NCT02432846|449006009|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
124829623|NCT02432846|449006010|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
124829624|NCT02432846|449006011|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
124829625|NCT02432846|449006012|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
124829626|NCT02432846|449006013|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
124829627|NCT02432846|449006008|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
124829628|NCT02432846|449006009|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
124829629|NCT02432846|449006010|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
124829630|NCT02432846|449006011|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
124829631|NCT02432846|449006012|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
124829632|NCT02432846|449006013|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
124829633|NCT02432846|449006008|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
124829634|NCT02432846|449006009|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
124829635|NCT02432846|449006010|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
124829636|NCT02432846|449006011|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
124829637|NCT02432846|449006012|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
124829638|NCT02432846|449006013|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
124829639|NCT02432846|449006008|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
124829640|NCT02432846|449006009|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
124829641|NCT02432846|449006010|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
124829642|NCT02432846|449006011|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
124829643|NCT02432846|449006012|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
124829644|NCT02432846|449006013|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
124829645|NCT02432846|449006008|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
124829646|NCT02432846|449006009|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
124829647|NCT02432846|449006010|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
124829648|NCT02432846|449006011|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
124829649|NCT02432846|449006012|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
124829650|NCT02432846|449006013|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
124829651|NCT02432846|449006008|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
124829652|NCT02432846|449006009|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
124829653|NCT02432846|449006010|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
124829654|NCT02432846|449006011|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
124829655|NCT02432846|449006012|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
124829656|NCT02432846|449006013|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
124829657|NCT02432846|449006008|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
124829658|NCT02432846|449006009|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
124829659|NCT02432846|449006010|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
124829660|NCT02432846|449006011|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
124829661|NCT02432846|449006012|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
124829662|NCT02432846|449006013|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
124829663|NCT02432846|449006008|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
124829664|NCT02432846|449006009|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
124829665|NCT02432846|449006010|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
124829666|NCT02432846|449006011|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
124829667|NCT02432846|449006012|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
124829668|NCT02432846|449006013|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
124829669|NCT02432846|449006008|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
124829670|NCT02432846|449006009|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
124829671|NCT02432846|449006010|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
124829672|NCT02432846|449006011|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
124829673|NCT02432846|449006012|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
124638771|NCT03850483|448294501|FG007|Treatment for Stage 2|Physician Decision|0|||
124638772|NCT03850483|448294502|FG008|Treatment for Stage 2|Physician Decision|0|||
124638773|NCT03850483|448294503|FG009|Treatment for Stage 2|Physician Decision|1|||
124829674|NCT02432846|449006013|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
124976564|NCT03832595|449540001|FG000|Overall Study|Medical management without dialysis|37|||
124638774|NCT03850483|448294494|FG000|Treatment for Stage 2|Protocol Violation|0|||
124829675|NCT02432846|449006008|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
124829676|NCT02432846|449006009|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
124829677|NCT02432846|449006010|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
124829678|NCT02432846|449006011|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
124829679|NCT02432846|449006012|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
124829680|NCT02432846|449006013|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
124829681|NCT02432846|449006008|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
124829682|NCT02432846|449006009|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
124829683|NCT02432846|449006010|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
124829684|NCT02432846|449006011|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
124829685|NCT02432846|449006012|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
124829686|NCT02432846|449006013|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
124829687|NCT02432846|449006008|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
124829688|NCT02432846|449006009|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
124829689|NCT02432846|449006010|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
124829690|NCT02432846|449006011|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
124829691|NCT02432846|449006012|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
124829692|NCT02432846|449006013|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
124829693|NCT01770379|449006014|FG000|Overall Study|Technical issues|1|||
124829694|NCT01770379|449006015|FG001|Overall Study|Technical issues|0|||
124829695|NCT01770379|449006016|FG002|Overall Study|Technical issues|0|||
124829696|NCT01770379|449006014|FG000|Overall Study|Withdrawal by Subject|7|||
124829697|NCT01770379|449006015|FG001|Overall Study|Withdrawal by Subject|10|||
124829698|NCT01770379|449006016|FG002|Overall Study|Withdrawal by Subject|7|||
124829699|NCT01770379|449006014|FG000|Overall Study|study terminated by sponsor|22|||
124829700|NCT01770379|449006015|FG001|Overall Study|study terminated by sponsor|23|||
124829701|NCT01770379|449006016|FG002|Overall Study|study terminated by sponsor|22|||
124829702|NCT01770379|449006014|FG000|Overall Study|Protocol Violation|0|||
124829703|NCT01770379|449006015|FG001|Overall Study|Protocol Violation|1|||
124829704|NCT01770379|449006016|FG002|Overall Study|Protocol Violation|1|||
124829705|NCT01770379|449006014|FG000|Overall Study|Physician Decision|0|||
124829706|NCT01770379|449006015|FG001|Overall Study|Physician Decision|1|||
124829707|NCT01770379|449006016|FG002|Overall Study|Physician Decision|2|||
124829708|NCT01770379|449006014|FG000|Overall Study|Lost to Follow-up|0|||
124829709|NCT01770379|449006015|FG001|Overall Study|Lost to Follow-up|0|||
124829710|NCT01770379|449006016|FG002|Overall Study|Lost to Follow-up|2|||
124829711|NCT01770379|449006014|FG000|Overall Study|Lack of Efficacy|8|||
124829712|NCT01770379|449006015|FG001|Overall Study|Lack of Efficacy|6|||
124829713|NCT01770379|449006016|FG002|Overall Study|Lack of Efficacy|6|||
124829714|NCT01770379|449006014|FG000|Overall Study|Adverse Event|1|||
124829715|NCT01770379|449006015|FG001|Overall Study|Adverse Event|3|||
124829716|NCT01770379|449006016|FG002|Overall Study|Adverse Event|2|||
124829717|NCT03045887|449006017|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
124829718|NCT03045887|449006018|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829719|NCT03045887|449006019|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829720|NCT03045887|449006020|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829721|NCT03045887|449006021|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829722|NCT03045887|449006022|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829723|NCT03045887|449006023|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829724|NCT03045887|449006024|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829725|NCT03045887|449006025|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829726|NCT03045887|449006026|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
124829727|NCT03045887|449006017|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829728|NCT03045887|449006018|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829729|NCT03045887|449006019|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829730|NCT03045887|449006020|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
124829731|NCT03045887|449006021|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829732|NCT03045887|449006022|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829733|NCT03045887|449006023|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829734|NCT03045887|449006024|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829735|NCT03045887|449006025|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829736|NCT03045887|449006026|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
124829737|NCT03045887|449006017|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
124829738|NCT03045887|449006018|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829739|NCT03045887|449006019|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829740|NCT03045887|449006020|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829741|NCT03045887|449006021|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829742|NCT03045887|449006022|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829743|NCT03045887|449006023|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829744|NCT03045887|449006024|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829745|NCT03045887|449006025|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829746|NCT03045887|449006026|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
124829747|NCT03045887|449006017|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
124829748|NCT03045887|449006018|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
124829749|NCT03045887|449006019|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
124829750|NCT03045887|449006020|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
124829751|NCT03045887|449006021|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
124829752|NCT03045887|449006022|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
124829753|NCT03045887|449006023|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
124829754|NCT03045887|449006024|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
124829755|NCT03045887|449006025|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
124829756|NCT03045887|449006026|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
124829757|NCT03045887|449006017|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829758|NCT03045887|449006018|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829759|NCT03045887|449006019|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829760|NCT03045887|449006020|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
124829761|NCT03045887|449006021|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829762|NCT03045887|449006022|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829763|NCT03045887|449006023|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829764|NCT03045887|449006024|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829765|NCT03045887|449006025|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829766|NCT03045887|449006026|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
124829767|NCT01912287|449006028|FG000|Overall Study|Ineligible|1|||
124829768|NCT01912287|449006029|FG001|Overall Study|Ineligible|0|||
124829769|NCT01912287|449006030|FG002|Overall Study|Ineligible|1|||
124829770|NCT01912287|449006028|FG000|Overall Study|No-show|0|||
124829771|NCT01912287|449006029|FG001|Overall Study|No-show|0|||
124829772|NCT01912287|449006030|FG002|Overall Study|No-show|1|||
124829773|NCT01912287|449006028|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
124829774|NCT01912287|449006029|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
124829775|NCT01912287|449006030|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
124829776|NCT01912287|449006028|FG000|Overall Study|Felt treatment no longer needed|0|||
124829777|NCT01912287|449006029|FG001|Overall Study|Felt treatment no longer needed|1|||
124829778|NCT01912287|449006030|FG002|Overall Study|Felt treatment no longer needed|0|||
124829779|NCT01912287|449006028|FG000|Overall Study|Life circumstances|4|||
124829780|NCT01912287|449006029|FG001|Overall Study|Life circumstances|2|||
124829781|NCT01912287|449006030|FG002|Overall Study|Life circumstances|0|||
124829782|NCT01912287|449006028|FG000|Overall Study|Lost Interest|1|||
124829783|NCT01912287|449006029|FG001|Overall Study|Lost Interest|0|||
124829784|NCT01912287|449006030|FG002|Overall Study|Lost Interest|0|||
124829785|NCT01912287|449006028|FG000|Overall Study|Uknown reason - subject drop out|5|||
124829786|NCT01912287|449006029|FG001|Overall Study|Uknown reason - subject drop out|7|||
124829787|NCT01912287|449006030|FG002|Overall Study|Uknown reason - subject drop out|3|||
124829788|NCT01912287|449006028|FG000|Overall Study|Missed Assesment|1|||
124829789|NCT01912287|449006029|FG001|Overall Study|Missed Assesment|1|||
124829790|NCT01912287|449006030|FG002|Overall Study|Missed Assesment|1|||
124829791|NCT01912287|449006028|FG000|Overall Study|Scheduling/change in availability|17|||
124829792|NCT01912287|449006029|FG001|Overall Study|Scheduling/change in availability|10|||
124829793|NCT01912287|449006030|FG002|Overall Study|Scheduling/change in availability|8|||
124829794|NCT03226392|449006034|FG000|Overall Study|Protocol Deviation|1|||
124829795|NCT03226392|449006035|FG001|Overall Study|Protocol Deviation|0|||
124829796|NCT03226392|449006034|FG000|Overall Study|Physician Decision|1|||
124829797|NCT03226392|449006035|FG001|Overall Study|Physician Decision|0|||
124829798|NCT03226392|449006034|FG000|Overall Study|Lost to Follow-up|1|||
124829799|NCT03226392|449006035|FG001|Overall Study|Lost to Follow-up|0|||
124829800|NCT03226392|449006034|FG000|Overall Study|Adverse Event|1|||
124829801|NCT03226392|449006035|FG001|Overall Study|Adverse Event|0|||
124829802|NCT03226392|449006034|FG000|Overall Study|Technical Problems|0|||
124829803|NCT03226392|449006035|FG001|Overall Study|Technical Problems|2|||
124829804|NCT03226392|449006034|FG000|Overall Study|Subject/Guardian Decision|7|||
124829805|NCT03226392|449006035|FG001|Overall Study|Subject/Guardian Decision|6|||
124829806|NCT02357901|449006036|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
124829807|NCT02357901|449006037|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
124829808|NCT02357901|449006038|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
124829809|NCT02357901|449006039|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
124829810|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
124829811|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
124829812|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
124829813|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
124829814|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
124829815|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
124829816|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
124829817|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
124829818|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
124829819|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
124829820|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
124829821|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
124829822|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
124829823|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
124829824|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
124829825|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
124829826|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
124829827|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
124829828|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
124829829|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
124829830|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
124829831|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
124829832|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
124829833|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
124829834|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
124829835|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
124829836|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
124829837|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
124829838|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
124829839|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
124829840|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
124829841|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
124829842|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
124829843|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
124829844|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
124829845|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
124829846|NCT02357901|449006036|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
124829847|NCT02357901|449006037|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
124829848|NCT02357901|449006038|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
124829849|NCT02357901|449006039|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
124829850|NCT00491387|449006040|FG000|Overall Study|study terminated|20|||
124829851|NCT02631850|449006042|FG000|Treatment Period|Lost to Follow-up|0|||
124829852|NCT02631850|449006043|FG001|Treatment Period|Lost to Follow-up|1|||
124829853|NCT02631850|449006044|FG002|Treatment Period|Lost to Follow-up|0|||
124829854|NCT02631850|449006045|FG003|Treatment Period|Lost to Follow-up|0|||
124829855|NCT02631850|449006042|FG000|Treatment Period|Protocol Violation|1|||
124829856|NCT02631850|449006043|FG001|Treatment Period|Protocol Violation|0|||
124829857|NCT02631850|449006044|FG002|Treatment Period|Protocol Violation|0|||
124829858|NCT02631850|449006045|FG003|Treatment Period|Protocol Violation|0|||
124829859|NCT02631850|449006042|FG000|Treatment Period|Withdrawal by Subject|0|||
124829860|NCT02631850|449006043|FG001|Treatment Period|Withdrawal by Subject|5|||
124829861|NCT02631850|449006044|FG002|Treatment Period|Withdrawal by Subject|2|||
124829862|NCT02631850|449006045|FG003|Treatment Period|Withdrawal by Subject|2|||
124829863|NCT02631850|449006042|FG000|Treatment Period|Adverse Event|1|||
124829864|NCT02631850|449006043|FG001|Treatment Period|Adverse Event|0|||
124829865|NCT02631850|449006044|FG002|Treatment Period|Adverse Event|2|||
124829866|NCT02631850|449006045|FG003|Treatment Period|Adverse Event|3|||
124829867|NCT02631850|449006042|FG000|Treatment Period|Family medical issue|1|||
124829868|NCT02631850|449006043|FG001|Treatment Period|Family medical issue|0|||
124829869|NCT02631850|449006044|FG002|Treatment Period|Family medical issue|0|||
124829870|NCT02631850|449006045|FG003|Treatment Period|Family medical issue|0|||
124829871|NCT02631850|449006042|FG000|6 Month Follow up|Lost to Follow-up|5|||
124829872|NCT02631850|449006043|FG001|6 Month Follow up|Lost to Follow-up|8|||
124829873|NCT02631850|449006044|FG002|6 Month Follow up|Lost to Follow-up|3|||
124829874|NCT02631850|449006045|FG003|6 Month Follow up|Lost to Follow-up|5|||
124829875|NCT02631850|449006042|FG000|6 Month Follow up|Withdrawal by Subject|1|||
124829876|NCT02631850|449006043|FG001|6 Month Follow up|Withdrawal by Subject|0|||
124829877|NCT02631850|449006044|FG002|6 Month Follow up|Withdrawal by Subject|0|||
124829878|NCT02631850|449006045|FG003|6 Month Follow up|Withdrawal by Subject|2|||
124829879|NCT02631850|449006042|FG000|6 Month Follow up|Adverse Event|1|||
124829880|NCT02631850|449006043|FG001|6 Month Follow up|Adverse Event|4|||
124829881|NCT02631850|449006044|FG002|6 Month Follow up|Adverse Event|1|||
124829882|NCT02631850|449006045|FG003|6 Month Follow up|Adverse Event|3|||
124829883|NCT02631850|449006042|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
124829884|NCT02631850|449006043|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
124829885|NCT02631850|449006044|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
124829886|NCT02631850|449006045|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
124829887|NCT01086540|449006047|FG000|Overall Study|Death|3|||
124829888|NCT01086540|449006048|FG001|Overall Study|Death|1|||
124829889|NCT01086540|449006047|FG000|Overall Study|Physician Decision|2|||
124829890|NCT01086540|449006048|FG001|Overall Study|Physician Decision|1|||
124829891|NCT01086540|449006047|FG000|Overall Study|Addition of new therapy for PAH|1|||
124829892|NCT01086540|449006048|FG001|Overall Study|Addition of new therapy for PAH|0|||
124829893|NCT02278263|449006049|FG000|Overall Study|Protocol Violation|7|||
124829894|NCT02278263|449006050|FG001|Overall Study|Protocol Violation|0|||
124829895|NCT02278263|449006051|FG002|Overall Study|Protocol Violation|9|||
124829896|NCT03164928|449006052|FG000|Overall Study|Lost to Follow-up|1|||
124829897|NCT03164928|449006053|FG001|Overall Study|Lost to Follow-up|0|||
124829898|NCT01998737|449006054|FG000|Overall Study|Corrupted database|23|||
124829899|NCT01998737|449006055|FG001|Overall Study|Corrupted database|0|||
124829900|NCT00101907|449006058|FG000|Overall Study|Adverse Event|1|||
124829901|NCT00101907|449006059|FG001|Overall Study|Adverse Event|0|||
124829902|NCT00101907|449006060|FG002|Overall Study|Adverse Event|0|||
124829903|NCT00101907|449006061|FG003|Overall Study|Adverse Event|0|||
124829904|NCT00101907|449006062|FG004|Overall Study|Adverse Event|0|||
124829905|NCT00101907|449006063|FG005|Overall Study|Adverse Event|0|||
124829906|NCT00101907|449006058|FG000|Overall Study|Death|0|||
124829907|NCT00101907|449006059|FG001|Overall Study|Death|1|||
124829908|NCT00101907|449006060|FG002|Overall Study|Death|0|||
124829909|NCT00101907|449006061|FG003|Overall Study|Death|0|||
124829910|NCT00101907|449006062|FG004|Overall Study|Death|3|||
124829911|NCT00101907|449006063|FG005|Overall Study|Death|0|||
124829912|NCT00101907|449006058|FG000|Overall Study|Physician Decision|0|||
124829913|NCT00101907|449006059|FG001|Overall Study|Physician Decision|0|||
124829914|NCT00101907|449006060|FG002|Overall Study|Physician Decision|0|||
124829915|NCT00101907|449006061|FG003|Overall Study|Physician Decision|1|||
124829916|NCT00101907|449006062|FG004|Overall Study|Physician Decision|1|||
124829917|NCT00101907|449006063|FG005|Overall Study|Physician Decision|0|||
124829918|NCT00101907|449006058|FG000|Overall Study|Withdrawal by Subject|1|||
124829919|NCT00101907|449006059|FG001|Overall Study|Withdrawal by Subject|0|||
124829920|NCT00101907|449006060|FG002|Overall Study|Withdrawal by Subject|1|||
124829921|NCT00101907|449006061|FG003|Overall Study|Withdrawal by Subject|0|||
124829922|NCT00101907|449006062|FG004|Overall Study|Withdrawal by Subject|1|||
124829923|NCT00101907|449006063|FG005|Overall Study|Withdrawal by Subject|0|||
124829924|NCT01474876|449006066|FG000|Overall Study|Adverse Event|11|||
124829925|NCT01474876|449006067|FG001|Overall Study|Adverse Event|5|||
124829926|NCT01474876|449006068|FG002|Overall Study|Adverse Event|0|||
124829927|NCT01474876|449006066|FG000|Overall Study|Serious Adverse Event|2|||
124829928|NCT01474876|449006067|FG001|Overall Study|Serious Adverse Event|3|||
124829929|NCT01474876|449006068|FG002|Overall Study|Serious Adverse Event|0|||
124829930|NCT01474876|449006066|FG000|Overall Study|Lost to Follow-up|5|||
124829931|NCT01474876|449006067|FG001|Overall Study|Lost to Follow-up|4|||
124829932|NCT01474876|449006068|FG002|Overall Study|Lost to Follow-up|0|||
124829933|NCT01474876|449006066|FG000|Overall Study|Investigator's decision|28|||
124829934|NCT01474876|449006067|FG001|Overall Study|Investigator's decision|6|||
124829935|NCT01474876|449006068|FG002|Overall Study|Investigator's decision|0|||
124829936|NCT01474876|449006066|FG000|Overall Study|Patient's request|19|||
124829937|NCT01474876|449006067|FG001|Overall Study|Patient's request|5|||
124829938|NCT01474876|449006068|FG002|Overall Study|Patient's request|0|||
124829939|NCT01474876|449006066|FG000|Overall Study|Investigator's decision and pt request|1|||
124829940|NCT01474876|449006067|FG001|Overall Study|Investigator's decision and pt request|0|||
124829941|NCT01474876|449006068|FG002|Overall Study|Investigator's decision and pt request|0|||
124829942|NCT01523886|449006071|FG000|Overall Study|surgery cancelled|0|||
124829943|NCT01523886|449006072|FG001|Overall Study|surgery cancelled|1|||
124829944|NCT01721330|449006073|FG000|Overall Study|Withdrawal by Subject|0|||
124829945|NCT01721330|449006074|FG001|Overall Study|Withdrawal by Subject|1|||
124829946|NCT04736199|449007624|FG000|Overall Study|Adverse Event|28|||
124829947|NCT04736199|449007625|FG001|Overall Study|Adverse Event|22|||
124829948|NCT04736199|449007624|FG000|Overall Study|Death|9|||
124829949|NCT04736199|449007625|FG001|Overall Study|Death|3|||
124829950|NCT04736199|449007624|FG000|Overall Study|Lost to Follow-up|4|||
124829951|NCT04736199|449007625|FG001|Overall Study|Lost to Follow-up|1|||
124829952|NCT04736199|449007624|FG000|Overall Study|Physician Decision|5|||
124829953|NCT04736199|449007625|FG001|Overall Study|Physician Decision|9|||
124829954|NCT04736199|449007624|FG000|Overall Study|Withdrawal by Subject|21|||
124829955|NCT04736199|449007625|FG001|Overall Study|Withdrawal by Subject|9|||
124829956|NCT04736199|449007624|FG000|Overall Study|Progressive disease|120|||
124829957|NCT04736199|449007625|FG001|Overall Study|Progressive disease|101|||
124829958|NCT04736199|449007624|FG000|Overall Study|Subject decision|13|||
124829959|NCT04736199|449007625|FG001|Overall Study|Subject decision|13|||
124829960|NCT04736199|449007624|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
124829961|NCT04736199|449007625|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
124829962|NCT04736199|449007624|FG000|Overall Study|Additional primary malignancy|1|||
124829963|NCT04736199|449007625|FG001|Overall Study|Additional primary malignancy|0|||
124829964|NCT04736199|449007624|FG000|Overall Study|Non-compliance with study drug|0|||
124829965|NCT04736199|449007625|FG001|Overall Study|Non-compliance with study drug|1|||
124829966|NCT04736199|449007624|FG000|Overall Study|Other reason|0|||
124829967|NCT04736199|449007625|FG001|Overall Study|Other reason|1|||
124829968|NCT04736199|449007624|FG000|Overall Study|Ongoing with study drug|240|||
124829969|NCT04736199|449007625|FG001|Overall Study|Ongoing with study drug|63|||
124829970|NCT04736199|449007624|FG000|Overall Study|Study drug never administered|3|||
124829971|NCT04736199|449007625|FG001|Overall Study|Study drug never administered|0|||
124829972|NCT04318080|449007626|FG000|Overall Study|Study closed by sponsor|10|||
124829973|NCT04318080|449007627|FG001|Overall Study|Study closed by sponsor|22|||
124829974|NCT04318080|449007626|FG000|Overall Study|Death|3|||
124829975|NCT04318080|449007627|FG001|Overall Study|Death|9|||
124829976|NCT04318080|449007626|FG000|Overall Study|Withdrawal by Subject|1|||
124829977|NCT04318080|449007627|FG001|Overall Study|Withdrawal by Subject|0|||
124829978|NCT04318080|449007626|FG000|Overall Study|Protocol Deviation|1|||
124829979|NCT04318080|449007627|FG001|Overall Study|Protocol Deviation|0|||
124829980|NCT00410761|449007628|FG000|Randomized Treatment Period|Adverse Event|34|||
124829981|NCT00410761|449007629|FG001|Randomized Treatment Period|Adverse Event|3|||
124829982|NCT00410761|449007628|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
124829983|NCT00410761|449007629|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
124829984|NCT00410761|449007628|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
124829985|NCT00410761|449007629|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
124829986|NCT00410761|449007628|FG000|Randomized Treatment Period|Other|69|||
124829987|NCT00410761|449007629|FG001|Randomized Treatment Period|Other|21|||
124829988|NCT00410761|449007628|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
124829989|NCT00410761|449007629|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
124829990|NCT00410761|449007628|FG000|Open-Label Treatment Period|Adverse Event|13|||
124829991|NCT00410761|449007629|FG001|Open-Label Treatment Period|Adverse Event|15|||
124829992|NCT00410761|449007628|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
124829993|NCT00410761|449007629|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
124829994|NCT00410761|449007628|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
124829995|NCT00410761|449007629|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
124829996|NCT00410761|449007628|FG000|Open-Label Treatment Period|Other|18|||
124829997|NCT00410761|449007629|FG001|Open-Label Treatment Period|Other|9|||
124829998|NCT06308822|449007630|FG000|Overall Study|Mutation Status Not Confirmed|17|||
124829999|NCT06308822|449007630|FG000|Overall Study|Adverse Event|1|||
124830000|NCT06308822|449007630|FG000|Overall Study|Death|5|||
124830001|NCT06308822|449007630|FG000|Overall Study|Disease progression|8|||
124830002|NCT06308822|449007630|FG000|Overall Study|Withdrawal by Subject|1|||
124830003|NCT06308822|449007630|FG000|Overall Study|Physician Decision|3|||
124830004|NCT03712904|449007631|FG000|Overall Study|Death|0|||
124830005|NCT03712904|449007632|FG001|Overall Study|Death|1|||
124830006|NCT03712904|449007631|FG000|Overall Study|Withdrawal by Subject|0|||
124830007|NCT03712904|449007632|FG001|Overall Study|Withdrawal by Subject|1|||
124830008|NCT03712904|449007631|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
124830009|NCT03712904|449007632|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
124830010|NCT05608005|449007633|FG000|Overall Study|Adverse Event|2|||
124830011|NCT05608005|449007634|FG001|Overall Study|Adverse Event|1|||
124830012|NCT05608005|449007635|FG002|Overall Study|Adverse Event|3|||
124830013|NCT05608005|449007633|FG000|Overall Study|Protocol Violation|2|||
124830014|NCT05608005|449007634|FG001|Overall Study|Protocol Violation|3|||
124830015|NCT05608005|449007635|FG002|Overall Study|Protocol Violation|0|||
124830016|NCT05608005|449007633|FG000|Overall Study|Withdrawal by Subject|10|||
124830017|NCT05608005|449007634|FG001|Overall Study|Withdrawal by Subject|12|||
124830018|NCT05608005|449007635|FG002|Overall Study|Withdrawal by Subject|4|||
124830019|NCT05608005|449007633|FG000|Overall Study|Lost to Follow-up|25|||
124830020|NCT05608005|449007634|FG001|Overall Study|Lost to Follow-up|27|||
124830021|NCT05608005|449007635|FG002|Overall Study|Lost to Follow-up|15|||
124830022|NCT05608005|449007633|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
124830023|NCT05608005|449007634|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
124638775|NCT03850483|448294495|FG001|Treatment for Stage 2|Protocol Violation|0|||
124638776|NCT03850483|448294496|FG002|Treatment for Stage 2|Protocol Violation|0|||
124638777|NCT03850483|448294497|FG003|Treatment for Stage 2|Protocol Violation|0|||
124638778|NCT03850483|448294498|FG004|Treatment for Stage 2|Protocol Violation|0|||
124830024|NCT05608005|449007635|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
124830025|NCT04708886|449007636|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
124830026|NCT04708886|449007636|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
124830027|NCT03525574|449007639|FG000|Overall Study|Adverse Event|15|||
124830028|NCT03525574|449007640|FG001|Overall Study|Adverse Event|0|||
124830029|NCT03525574|449007639|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
124638779|NCT03850483|448294499|FG005|Treatment for Stage 2|Protocol Violation|0|||
124830030|NCT03525574|449007640|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
124830031|NCT03525574|449007639|FG000|Overall Study|Lost to Follow-up|4|||
124830032|NCT03525574|449007640|FG001|Overall Study|Lost to Follow-up|0|||
124830033|NCT03525574|449007639|FG000|Overall Study|Commercial drug is Available for participant|48|||
124830034|NCT03525574|449007640|FG001|Overall Study|Commercial drug is Available for participant|0|||
124830035|NCT03525574|449007639|FG000|Overall Study|Death|1|||
124638780|NCT03850483|448294500|FG006|Treatment for Stage 2|Protocol Violation|0|||
124638781|NCT03850483|448294501|FG007|Treatment for Stage 2|Protocol Violation|0|||
124638782|NCT03850483|448294502|FG008|Treatment for Stage 2|Protocol Violation|1|||
124638783|NCT03850483|448294503|FG009|Treatment for Stage 2|Protocol Violation|0|||
124638784|NCT03850483|448294494|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
124638785|NCT03850483|448294495|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
124638786|NCT03850483|448294496|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
124638787|NCT03850483|448294497|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
124638788|NCT03850483|448294498|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
124638789|NCT03850483|448294499|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
124638790|NCT03850483|448294500|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
124638791|NCT03850483|448294501|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
124638792|NCT03850483|448294502|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
124638793|NCT03850483|448294503|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
124638794|NCT03850483|448294494|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
124638795|NCT03850483|448294495|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
124638796|NCT03850483|448294496|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
124638797|NCT03850483|448294497|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
124638798|NCT03850483|448294498|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
124638799|NCT03850483|448294499|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
124638800|NCT03850483|448294500|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
124638801|NCT03850483|448294501|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
124638802|NCT03850483|448294502|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
124638803|NCT03850483|448294503|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
124638804|NCT03850483|448294494|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
124638805|NCT03850483|448294495|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
124638806|NCT03850483|448294496|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
124638807|NCT03850483|448294497|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
124638808|NCT03850483|448294498|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
124638809|NCT03850483|448294499|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
124638810|NCT03850483|448294500|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
124638811|NCT03850483|448294501|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
124638812|NCT03850483|448294502|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
124638813|NCT03850483|448294503|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
124638814|NCT03850483|448294494|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
124638815|NCT03850483|448294495|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
124638816|NCT03850483|448294496|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
124638817|NCT03850483|448294497|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
124638818|NCT03850483|448294498|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
124638819|NCT03850483|448294499|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
124638820|NCT03850483|448294500|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
124638821|NCT03850483|448294501|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
124638822|NCT03850483|448294502|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
124638823|NCT03850483|448294503|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
124638824|NCT03850483|448294494|FG000|Follow-up For Stage 2|Other|0|||
124638825|NCT03850483|448294495|FG001|Follow-up For Stage 2|Other|0|||
124638826|NCT03850483|448294496|FG002|Follow-up For Stage 2|Other|0|||
124638827|NCT03850483|448294497|FG003|Follow-up For Stage 2|Other|0|||
124638828|NCT03850483|448294498|FG004|Follow-up For Stage 2|Other|0|||
124638829|NCT03850483|448294499|FG005|Follow-up For Stage 2|Other|0|||
124638830|NCT03850483|448294500|FG006|Follow-up For Stage 2|Other|0|||
124638831|NCT03850483|448294501|FG007|Follow-up For Stage 2|Other|0|||
124830036|NCT03525574|449007640|FG001|Overall Study|Death|0|||
124830037|NCT03525574|449007639|FG000|Overall Study|Other non-compliance|2|||
124830038|NCT03525574|449007640|FG001|Overall Study|Other non-compliance|0|||
124830039|NCT03525574|449007639|FG000|Overall Study|Physician Decision|6|||
124830040|NCT03525574|449007640|FG001|Overall Study|Physician Decision|0|||
124830041|NCT03525574|449007639|FG000|Overall Study|Other|58|||
124830042|NCT03525574|449007640|FG001|Overall Study|Other|0|||
124830043|NCT03525574|449007639|FG000|Overall Study|Enrolled but never dosed|1|||
124830044|NCT03525574|449007640|FG001|Overall Study|Enrolled but never dosed|0|||
124830045|NCT03525574|449007639|FG000|Overall Study|Not enrolled in 105 study|0|||
124830046|NCT03525574|449007640|FG001|Overall Study|Not enrolled in 105 study|3|||
124638832|NCT03850483|448294502|FG008|Follow-up For Stage 2|Other|0|||
124638833|NCT03850483|448294503|FG009|Follow-up For Stage 2|Other|1|||
124638834|NCT04432831|448296431|FG000|Overall Study|Withdrawal by Subject|24|||
124638835|NCT04432831|448296432|FG001|Overall Study|Withdrawal by Subject|28|||
124638836|NCT04432831|448296433|FG002|Overall Study|Withdrawal by Subject|21|||
124638837|NCT04432831|448296431|FG000|Overall Study|Death|23|||
124830047|NCT03914326|449007643|FG000|Overall Study|Withdrawal by Subject|27|||
124830048|NCT03914326|449007644|FG001|Overall Study|Withdrawal by Subject|34|||
124830049|NCT03914326|449007643|FG000|Overall Study|Lost to Follow-up|43|||
124830050|NCT03914326|449007644|FG001|Overall Study|Lost to Follow-up|51|||
124830051|NCT03914326|449007643|FG000|Overall Study|Randomised more than once|0|||
124830052|NCT03914326|449007644|FG001|Overall Study|Randomised more than once|1|||
124830053|NCT02769247|449007651|FG000|Overall Study|Withdrawal by Subject|1|||
124830054|NCT02769247|449007652|FG001|Overall Study|Withdrawal by Subject|0|||
124830055|NCT02769247|449007653|FG002|Overall Study|Withdrawal by Subject|0|||
124830056|NCT02769247|449007654|FG003|Overall Study|Withdrawal by Subject|1|||
124830057|NCT02769247|449007651|FG000|Overall Study|Protocol Violation|0|||
124830058|NCT02769247|449007652|FG001|Overall Study|Protocol Violation|0|||
124830059|NCT02769247|449007653|FG002|Overall Study|Protocol Violation|1|||
124830060|NCT02769247|449007654|FG003|Overall Study|Protocol Violation|0|||
124830061|NCT02769247|449007651|FG000|Overall Study|Physician Decision|1|||
124830062|NCT02769247|449007652|FG001|Overall Study|Physician Decision|0|||
124830063|NCT02769247|449007653|FG002|Overall Study|Physician Decision|0|||
124830064|NCT02769247|449007654|FG003|Overall Study|Physician Decision|0|||
124830065|NCT04788953|449007655|FG000|Overall Study|Adverse Event|1|||
124830066|NCT04788953|449007656|FG001|Overall Study|Adverse Event|1|||
124830067|NCT04788953|449007655|FG000|Overall Study|Withdrawal by Subject|1|||
124830068|NCT04788953|449007656|FG001|Overall Study|Withdrawal by Subject|0|||
124830069|NCT04788953|449007655|FG000|Overall Study|Protocol Violation|0|||
124830070|NCT04788953|449007656|FG001|Overall Study|Protocol Violation|1|||
124830071|NCT02150954|449007659|FG000|Overall Study|Protocol Violation|1|||
124830072|NCT02150954|449007660|FG001|Overall Study|Protocol Violation|0|||
124830073|NCT03814746|449007664|FG000|Overall Study|Participant decision|9|||
124830074|NCT03814746|449007665|FG001|Overall Study|Participant decision|6|||
124830075|NCT03814746|449007666|FG002|Overall Study|Participant decision|15|||
124830076|NCT03814746|449007664|FG000|Overall Study|Physician Decision|2|||
124830077|NCT03814746|449007665|FG001|Overall Study|Physician Decision|2|||
124830078|NCT03814746|449007666|FG002|Overall Study|Physician Decision|4|||
124830079|NCT03814746|449007664|FG000|Overall Study|Death|2|||
124830080|NCT03814746|449007665|FG001|Overall Study|Death|2|||
124830081|NCT03814746|449007666|FG002|Overall Study|Death|2|||
124830082|NCT03814746|449007664|FG000|Overall Study|Adverse Event|2|||
124830083|NCT03814746|449007665|FG001|Overall Study|Adverse Event|2|||
124830084|NCT03814746|449007666|FG002|Overall Study|Adverse Event|1|||
124830085|NCT03814746|449007664|FG000|Overall Study|Lost to Follow-up|2|||
124830086|NCT03814746|449007665|FG001|Overall Study|Lost to Follow-up|1|||
124830087|NCT03814746|449007666|FG002|Overall Study|Lost to Follow-up|2|||
124830088|NCT03814746|449007664|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
124830089|NCT03814746|449007665|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
124830090|NCT03814746|449007666|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
124830091|NCT03814746|449007664|FG000|Overall Study|Pregnancy|0|||
124830092|NCT03814746|449007665|FG001|Overall Study|Pregnancy|1|||
124830093|NCT03814746|449007666|FG002|Overall Study|Pregnancy|1|||
124830094|NCT03814746|449007664|FG000|Overall Study|Protocol Violation|1|||
124830095|NCT03814746|449007665|FG001|Overall Study|Protocol Violation|0|||
124830096|NCT03814746|449007666|FG002|Overall Study|Protocol Violation|0|||
124830097|NCT03997383|449007671|FG000|Double-blind Treatment Period|Adverse Event|4|||
124830098|NCT03997383|449007672|FG001|Double-blind Treatment Period|Adverse Event|3|||
124830099|NCT03997383|449007671|FG000|Double-blind Treatment Period|Death|4|||
124830100|NCT03997383|449007672|FG001|Double-blind Treatment Period|Death|4|||
124830101|NCT03997383|449007671|FG000|Double-blind Treatment Period|Physician Decision|2|||
124830102|NCT03997383|449007672|FG001|Double-blind Treatment Period|Physician Decision|0|||
124830103|NCT03997383|449007671|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
124830104|NCT03997383|449007672|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
124830105|NCT03997383|449007671|FG000|Open-label Extension Period|Ongoing|148|||
124830106|NCT03997383|449007672|FG001|Open-label Extension Period|Ongoing|151|||
124830107|NCT03997383|449007671|FG000|Open-label Extension Period|Adverse Event|4|||
124830108|NCT03997383|449007672|FG001|Open-label Extension Period|Adverse Event|1|||
124830109|NCT03997383|449007671|FG000|Open-label Extension Period|Death|8|||
124830110|NCT03997383|449007672|FG001|Open-label Extension Period|Death|9|||
124830111|NCT03997383|449007671|FG000|Open-label Extension Period|Physician Decision|1|||
124830112|NCT03997383|449007672|FG001|Open-label Extension Period|Physician Decision|1|||
124830113|NCT03997383|449007671|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
124830114|NCT03997383|449007672|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
124830115|NCT03997383|449007671|FG000|Open-label Extension Period|Reason Not Specified|2|||
124830116|NCT03997383|449007672|FG001|Open-label Extension Period|Reason Not Specified|0|||
124830117|NCT03880019|449007673|FG000|Overall Study|Competing disease|1|||
124830118|NCT00326950|449007674|FG000|Overall Study|Progressive Disease|1|||
124830119|NCT01266460|449007678|FG000|Overall Study|Adverse Event|3|||
124830120|NCT01266460|449007678|FG000|Overall Study|Withdrawal by Subject|5|||
124830121|NCT01266460|449007678|FG000|Overall Study|Disease Progression|18|||
124830122|NCT01266460|449007678|FG000|Overall Study|Not otherwise specified|8|||
124830123|NCT01132547|449007683|FG000|Overall Study|Withdrawal by Subject|3|||
124830124|NCT01132547|449007684|FG001|Overall Study|Withdrawal by Subject|1|||
124830125|NCT01132547|449007683|FG000|Overall Study|Death|1|||
124830126|NCT01132547|449007684|FG001|Overall Study|Death|0|||
124830127|NCT05811234|449007685|FG000|Overall Study|Loss of Effectiveness|2|||
124830128|NCT05811234|449007685|FG000|Overall Study|Adverse Event|4|||
124830129|NCT05811234|449007685|FG000|Overall Study|Pregnancy|1|||
124830130|NCT05811234|449007685|FG000|Overall Study|Disease progression|1|||
124830131|NCT05811234|449007685|FG000|Overall Study|Withdrawal by Subject|4|||
124830132|NCT05811234|449007685|FG000|Overall Study|Lost to Follow-up|13|||
124830133|NCT05811234|449007685|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
124830134|NCT04499781|449007686|FG000|Overall Study|Lost to Follow-up|2|||
124830135|NCT04499781|449007687|FG001|Overall Study|Lost to Follow-up|3|||
124830136|NCT04499781|449007686|FG000|Overall Study|Withdrawal by Subject|2|||
124830137|NCT04499781|449007687|FG001|Overall Study|Withdrawal by Subject|0|||
124830138|NCT00227305|449007692|FG000|Overall Study|Adverse Event|40|||
124830139|NCT00227305|449007692|FG000|Overall Study|Withdrawal by Subject|42|||
124830140|NCT00227305|449007692|FG000|Overall Study|Lost to Follow-up|33|||
124830141|NCT00227305|449007692|FG000|Overall Study|Study specific discontinuation|13|||
124830142|NCT00227305|449007692|FG000|Overall Study|MOVED OUT OF AREA|3|||
124830143|NCT00227305|449007692|FG000|Overall Study|Lack of Efficacy|7|||
124830144|NCT00227305|449007692|FG000|Overall Study|Physician Decision|3|||
124830145|NCT00227305|449007692|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
124830146|NCT00227305|449007692|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
124830147|NCT00227305|449007692|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
124830148|NCT02118012|449007693|FG000|Overall Study|Adverse Event|0|||
124830149|NCT02118012|449007694|FG001|Overall Study|Adverse Event|1|||
124830150|NCT02118012|449007693|FG000|Overall Study|Physician Decision|0|||
124830151|NCT02118012|449007694|FG001|Overall Study|Physician Decision|1|||
124830152|NCT00483379|449007695|FG000|Treatment Period|Adverse Event|1|||
124830153|NCT00483379|449007696|FG001|Treatment Period|Adverse Event|0|||
124830154|NCT00483379|449007695|FG000|Treatment Period|Withdrawal by Subject|1|||
124830155|NCT00483379|449007696|FG001|Treatment Period|Withdrawal by Subject|0|||
124830156|NCT03698994|449007699|FG000|Overall Study|Adverse Event|2|||
124830157|NCT03698994|449007699|FG000|Overall Study|Death|1|||
124830158|NCT03698994|449007699|FG000|Overall Study|Physician Decision|1|||
124830159|NCT03698994|449007699|FG000|Overall Study|Withdrawal by Subject|3|||
124830160|NCT03698994|449007699|FG000|Overall Study|Progressive Disease|12|||
124830161|NCT04969224|449007700|FG000|Overall Study|Adverse Event|1|||
124830162|NCT04969224|449007700|FG000|Overall Study|Enrolled but never dosed|1|||
124830163|NCT03165110|449007701|FG000|Overall Study|Anroid phone software incompatibility|1|||
124830164|NCT05533632|449007702|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
124830165|NCT05533632|449007702|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
124830166|NCT05533632|449007702|FG000|Overall Study|Lost to Follow-up|1|||
124830167|NCT05533632|449007702|FG000|Overall Study|Withdrawal by Subject|4|||
124830168|NCT05533632|449007702|FG000|Overall Study|Adverse Event|4|||
124830169|NCT04327388|449007712|FG000|Overall Study|Adverse Event|17|||
124830170|NCT04327388|449007713|FG001|Overall Study|Adverse Event|18|||
124830171|NCT04327388|449007714|FG002|Overall Study|Adverse Event|9|||
124830172|NCT04327388|449007712|FG000|Overall Study|Other|1|||
124830173|NCT04327388|449007713|FG001|Overall Study|Other|2|||
124830174|NCT04327388|449007714|FG002|Overall Study|Other|0|||
124830175|NCT04327388|449007712|FG000|Overall Study|Randomized and not treated|2|||
124830176|NCT04327388|449007713|FG001|Overall Study|Randomized and not treated|0|||
124830177|NCT04327388|449007714|FG002|Overall Study|Randomized and not treated|2|||
124830178|NCT03051607|449007719|FG000|Overall Study|Adverse Event|66|||
124830179|NCT01603459|449007729|FG000|Overall Study|Adverse Event|5|||
124830180|NCT01603459|449007729|FG000|Overall Study|Withdrawal by Subject|5|||
124830181|NCT01603459|449007729|FG000|Overall Study|Lost to Follow-up|3|||
124830182|NCT01603459|449007729|FG000|Overall Study|Predefined discontinuation criteria|3|||
124830183|NCT01603459|449007729|FG000|Overall Study|Non-compliance|1|||
124830184|NCT01603459|449007729|FG000|Overall Study|Administrative reason|1|||
124830185|NCT00399360|449007731|FG000|Overall Study|Lost to Follow-up|2|||
124830186|NCT00399360|449007732|FG001|Overall Study|Lost to Follow-up|1|||
124830187|NCT00399360|449007733|FG002|Overall Study|Lost to Follow-up|2|||
124830188|NCT00399360|449007734|FG003|Overall Study|Lost to Follow-up|4|||
124830189|NCT00399360|449007731|FG000|Overall Study|Adverse Event|0|||
124830190|NCT00399360|449007732|FG001|Overall Study|Adverse Event|0|||
124830191|NCT00399360|449007733|FG002|Overall Study|Adverse Event|1|||
124830192|NCT00399360|449007734|FG003|Overall Study|Adverse Event|0|||
124830193|NCT00399360|449007731|FG000|Overall Study|Withdrawal by Subject|0|||
124830194|NCT00399360|449007732|FG001|Overall Study|Withdrawal by Subject|2|||
124830195|NCT00399360|449007733|FG002|Overall Study|Withdrawal by Subject|0|||
124830196|NCT00399360|449007734|FG003|Overall Study|Withdrawal by Subject|2|||
124830197|NCT01412021|449007735|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
124830198|NCT01412021|449007735|FG000|Overall Study|Treatment Prior to Approval|3|||
124830199|NCT01412021|449007735|FG000|Overall Study|Transferred to Other Hospital|9|||
124830200|NCT01166178|449007736|FG000|Overall Study|Withdrawal by Subject|1|||
124830201|NCT01166178|449007737|FG001|Overall Study|Withdrawal by Subject|0|||
124830202|NCT01166178|449007736|FG000|Overall Study|Study was terminated|20|||
124830203|NCT01166178|449007737|FG001|Overall Study|Study was terminated|8|||
124830204|NCT00529542|449007741|FG000|Overall Study|Withdrawal by Subject|1|||
124830205|NCT00529542|449007742|FG001|Overall Study|Withdrawal by Subject|0|||
124830206|NCT00529542|449007741|FG000|Overall Study|Lost to Follow-up|0|||
124830207|NCT00529542|449007742|FG001|Overall Study|Lost to Follow-up|1|||
124830208|NCT05778786|449007743|FG000|Period 1|COVID-19 Related|3|||
124830209|NCT05778786|449007744|FG001|Period 1|COVID-19 Related|3|||
124830210|NCT05778786|449007743|FG000|Period 1|Withdrew Consent during Study|1|||
124830211|NCT05778786|449007744|FG001|Period 1|Withdrew Consent during Study|0|||
124830212|NCT05778786|449007743|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
124830213|NCT05778786|449007744|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
124830214|NCT05778786|449007743|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
124830215|NCT05778786|449007744|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
124830216|NCT00099437|449008482|FG000|Overall Study|Lost to Follow-up|30|||
124830217|NCT00099437|449008483|FG001|Overall Study|Lost to Follow-up|33|||
124830218|NCT00099437|449008482|FG000|Overall Study|Death|293|||
124830219|NCT00099437|449008483|FG001|Overall Study|Death|261|||
124830220|NCT00099437|449008482|FG000|Overall Study|Withdrawal by Subject|6|||
124830221|NCT00099437|449008483|FG001|Overall Study|Withdrawal by Subject|10|||
124830222|NCT00099437|449008482|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
124830223|NCT00099437|449008483|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
124830224|NCT05413369|449008484|FG000|Overall Study|Adverse Event|1|||
124830225|NCT05413369|449008485|FG001|Overall Study|Adverse Event|1|||
124830226|NCT05413369|449008484|FG000|Overall Study|Withdrawal by Subject|13|||
124830227|NCT05413369|449008485|FG001|Overall Study|Withdrawal by Subject|4|||
124830228|NCT05413369|449008484|FG000|Overall Study|Non-compliance with study schedule|2|||
124830229|NCT05413369|449008485|FG001|Overall Study|Non-compliance with study schedule|1|||
124830230|NCT05413369|449008484|FG000|Overall Study|Other|1|||
124830231|NCT05413369|449008485|FG001|Overall Study|Other|1|||
124830232|NCT02809677|449008486|FG000|Overall Study|Withdrawal by Subject|8|||
124830233|NCT04103892|449008487|FG000|Overall Study|Adverse Event|0|||
124830234|NCT04103892|449008488|FG001|Overall Study|Adverse Event|0|||
124830235|NCT04103892|449008489|FG002|Overall Study|Adverse Event|0|||
124830236|NCT04103892|449008490|FG003|Overall Study|Adverse Event|3|||
124830237|NCT04103892|449008487|FG000|Overall Study|Lost to Follow-up|0|||
124830238|NCT04103892|449008488|FG001|Overall Study|Lost to Follow-up|0|||
124830239|NCT04103892|449008489|FG002|Overall Study|Lost to Follow-up|2|||
124830240|NCT04103892|449008490|FG003|Overall Study|Lost to Follow-up|0|||
124830241|NCT04103892|449008487|FG000|Overall Study|Protocol Violation|0|||
124830242|NCT04103892|449008488|FG001|Overall Study|Protocol Violation|0|||
124830243|NCT04103892|449008489|FG002|Overall Study|Protocol Violation|1|||
124830244|NCT04103892|449008490|FG003|Overall Study|Protocol Violation|1|||
124830245|NCT04103892|449008487|FG000|Overall Study|Withdrawal by Subject|1|||
124830246|NCT04103892|449008488|FG001|Overall Study|Withdrawal by Subject|0|||
124830247|NCT04103892|449008489|FG002|Overall Study|Withdrawal by Subject|2|||
124830248|NCT04103892|449008490|FG003|Overall Study|Withdrawal by Subject|5|||
124830249|NCT04103892|449008487|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
124830250|NCT04103892|449008488|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
124830251|NCT04103892|449008489|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
124830252|NCT04103892|449008490|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
124830253|NCT04340362|449008491|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
124830254|NCT04170348|449008496|FG000|Overall Study|Lost to Follow-up|2|||
124830255|NCT04170348|449008497|FG001|Overall Study|Lost to Follow-up|2|||
124830256|NCT04170348|449008496|FG000|Overall Study|Withdrawal by Subject|1|||
124830257|NCT04170348|449008497|FG001|Overall Study|Withdrawal by Subject|5|||
124830258|NCT04170348|449008496|FG000|Overall Study|Non-adherence|1|||
124830259|NCT04170348|449008497|FG001|Overall Study|Non-adherence|1|||
124830260|NCT04170348|449008496|FG000|Overall Study|Adverse Event|1|||
124830261|NCT04170348|449008497|FG001|Overall Study|Adverse Event|0|||
124830262|NCT05104567|449008498|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
124830263|NCT05104567|449008499|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
124830264|NCT05104567|449008500|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
124830265|NCT05104567|449008501|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
124830266|NCT05104567|449008502|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
124830267|NCT05104567|449008503|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
124830268|NCT05104567|449008504|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
124830269|NCT05104567|449008498|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
124830270|NCT05104567|449008499|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
124830271|NCT05104567|449008500|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
124830272|NCT05104567|449008501|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
124830273|NCT05104567|449008502|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
124830274|NCT05104567|449008503|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
124830275|NCT05104567|449008504|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
124830276|NCT05104567|449008498|FG000|Overall Study|Progressive disease|3|||
124830277|NCT05104567|449008499|FG001|Overall Study|Progressive disease|13|||
124830278|NCT05104567|449008500|FG002|Overall Study|Progressive disease|13|||
124830279|NCT05104567|449008501|FG003|Overall Study|Progressive disease|17|||
124830280|NCT05104567|449008502|FG004|Overall Study|Progressive disease|17|||
124830281|NCT05104567|449008503|FG005|Overall Study|Progressive disease|28|||
124830282|NCT05104567|449008504|FG006|Overall Study|Progressive disease|24|||
124830283|NCT05104567|449008498|FG000|Overall Study|Withdrawal by Subject|1|||
124830284|NCT05104567|449008499|FG001|Overall Study|Withdrawal by Subject|1|||
124830285|NCT05104567|449008500|FG002|Overall Study|Withdrawal by Subject|2|||
124830286|NCT05104567|449008501|FG003|Overall Study|Withdrawal by Subject|0|||
124830287|NCT05104567|449008502|FG004|Overall Study|Withdrawal by Subject|0|||
124830288|NCT05104567|449008503|FG005|Overall Study|Withdrawal by Subject|0|||
124830289|NCT05104567|449008504|FG006|Overall Study|Withdrawal by Subject|0|||
124830290|NCT05104567|449008498|FG000|Overall Study|Other|1|||
124638838|NCT04432831|448296432|FG001|Overall Study|Death|23|||
124638839|NCT04432831|448296433|FG002|Overall Study|Death|17|||
124638840|NCT04432831|448296431|FG000|Overall Study|Lost to Follow-up|15|||
124638841|NCT04432831|448296432|FG001|Overall Study|Lost to Follow-up|15|||
124638842|NCT04432831|448296433|FG002|Overall Study|Lost to Follow-up|12|||
124638843|NCT04432831|448296431|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
124638844|NCT04432831|448296432|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
124638845|NCT04432831|448296433|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
124638846|NCT04432831|448296431|FG000|Overall Study|Reason Not Specified|7|||
124638847|NCT04432831|448296432|FG001|Overall Study|Reason Not Specified|11|||
124638848|NCT04432831|448296433|FG002|Overall Study|Reason Not Specified|9|||
124638849|NCT04432831|448296431|FG000|Overall Study|Adverse Event|7|||
124638850|NCT04432831|448296432|FG001|Overall Study|Adverse Event|7|||
124638851|NCT04432831|448296433|FG002|Overall Study|Adverse Event|7|||
124638852|NCT04432831|448296431|FG000|Overall Study|Physician Decision|1|||
124638853|NCT04432831|448296432|FG001|Overall Study|Physician Decision|3|||
124638854|NCT04432831|448296433|FG002|Overall Study|Physician Decision|6|||
124638855|NCT04432831|448296431|FG000|Overall Study|Protocol Violation|1|||
124638856|NCT04432831|448296432|FG001|Overall Study|Protocol Violation|0|||
124638857|NCT04432831|448296433|FG002|Overall Study|Protocol Violation|2|||
124638858|NCT04432831|448296431|FG000|Overall Study|Pregnancy|0|||
124638859|NCT04432831|448296432|FG001|Overall Study|Pregnancy|1|||
124638860|NCT04432831|448296433|FG002|Overall Study|Pregnancy|0|||
124638861|NCT04432831|448296431|FG000|Overall Study|Lack of Efficacy|0|||
124638862|NCT04432831|448296432|FG001|Overall Study|Lack of Efficacy|0|||
124638863|NCT04432831|448296433|FG002|Overall Study|Lack of Efficacy|2|||
124638864|NCT01623310|448296434|FG000|Overall Study|Adverse Event|21|||
124638865|NCT01623310|448296434|FG000|Overall Study|Lost to Follow-up|18|||
124638866|NCT01623310|448296434|FG000|Overall Study|Lack of Efficacy|6|||
124638867|NCT01623310|448296434|FG000|Overall Study|Protocol Violation|6|||
124638868|NCT01623310|448296434|FG000|Overall Study|Withdrawal by Subject|25|||
124638869|NCT01623310|448296434|FG000|Overall Study|Became potentially child-bearing|1|||
124638870|NCT01623310|448296434|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
124638871|NCT01623310|448296434|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
124638872|NCT02898597|448296435|FG000|Overall Study|Protocol Violation|4|||
124638873|NCT02898597|448296436|FG001|Overall Study|Protocol Violation|2|||
124638874|NCT02898597|448296435|FG000|Overall Study|Lost to Follow-up|0|||
124638875|NCT02898597|448296436|FG001|Overall Study|Lost to Follow-up|9|||
124638876|NCT02898597|448296435|FG000|Overall Study|Death|0|||
124638877|NCT02898597|448296436|FG001|Overall Study|Death|1|||
124638878|NCT02530125|448296437|FG000|Completed Treatment|Early termination of study|1|||
124638879|NCT02530125|448296437|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
124638880|NCT00356603|448296438|FG000|Overall Study|Other|6|||
124638881|NCT00356603|448296439|FG001|Overall Study|Other|3|||
124638882|NCT01568034|448296441|FG000|Overall Study|Withdrawal by Subject|1|||
124830291|NCT05104567|449008499|FG001|Overall Study|Other|1|||
124830292|NCT05104567|449008500|FG002|Overall Study|Other|1|||
124830293|NCT05104567|449008501|FG003|Overall Study|Other|0|||
124638883|NCT01568034|448296442|FG001|Overall Study|Withdrawal by Subject|0|||
124638884|NCT01568034|448296443|FG002|Overall Study|Withdrawal by Subject|0|||
124638885|NCT01568034|448296444|FG003|Overall Study|Withdrawal by Subject|0|||
124830294|NCT05104567|449008502|FG004|Overall Study|Other|0|||
124830295|NCT05104567|449008503|FG005|Overall Study|Other|0|||
124830296|NCT05104567|449008504|FG006|Overall Study|Other|0|||
124830297|NCT01602380|449008508|FG000|Overall Study|Death|147|||
124638886|NCT00728468|448296445|FG000|Overall Study|Enrolled but not treated|1|||
124638887|NCT00728468|448296445|FG000|Overall Study|Death|1|||
124638888|NCT00728468|448296445|FG000|Overall Study|Protocol Violation|4|||
124638889|NCT00728468|448296445|FG000|Overall Study|Objective progression or relapse|9|||
124638890|NCT00728468|448296445|FG000|Overall Study|Study terminated by sponsor|1|||
124638891|NCT01262287|448296446|FG000|Overall Study|Lost to Follow-up|2|||
124830298|NCT01602380|449008509|FG001|Overall Study|Death|145|||
124830299|NCT01602380|449008508|FG000|Overall Study|Withdrawal by Subject|39|||
124830300|NCT01602380|449008509|FG001|Overall Study|Withdrawal by Subject|41|||
124830301|NCT01602380|449008508|FG000|Overall Study|Lost to Follow-up|15|||
124830302|NCT01602380|449008509|FG001|Overall Study|Lost to Follow-up|12|||
124830303|NCT01602380|449008508|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
124830304|NCT01602380|449008509|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
124830305|NCT01602380|449008508|FG000|Overall Study|Other|2|||
124830306|NCT01602380|449008509|FG001|Overall Study|Other|0|||
124830307|NCT03658538|449008510|FG000|Overall Study|Death|2|||
124830308|NCT03658538|449008511|FG001|Overall Study|Death|1|||
124830309|NCT03658538|449008510|FG000|Overall Study|Cancer diagnosis|1|||
124830310|NCT03658538|449008511|FG001|Overall Study|Cancer diagnosis|0|||
124830311|NCT03658538|449008510|FG000|Overall Study|Change residence|1|||
124830312|NCT03658538|449008511|FG001|Overall Study|Change residence|2|||
124830313|NCT03658538|449008510|FG000|Overall Study|Lost to Follow-up|3|||
124830314|NCT03658538|449008511|FG001|Overall Study|Lost to Follow-up|3|||
124830315|NCT03658538|449008510|FG000|Overall Study|Unblinded|2|||
124830316|NCT03658538|449008511|FG001|Overall Study|Unblinded|3|||
124830317|NCT03658538|449008510|FG000|Overall Study|Physician Decision|0|||
124830318|NCT03658538|449008511|FG001|Overall Study|Physician Decision|1|||
124830319|NCT03658538|449008510|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
124830320|NCT03658538|449008511|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
124830321|NCT03658538|449008510|FG000|Overall Study|Evicted from home|1|||
124830322|NCT03658538|449008511|FG001|Overall Study|Evicted from home|0|||
124830323|NCT03333044|449008512|FG000|Overall Study|Pregnancy|1|||
124830324|NCT03333044|449008513|FG001|Overall Study|Pregnancy|0|||
124830325|NCT03333044|449008514|FG002|Overall Study|Pregnancy|0|||
124830326|NCT03333044|449008512|FG000|Overall Study|Lost to Follow-up|0|||
124830327|NCT03333044|449008513|FG001|Overall Study|Lost to Follow-up|14|||
124830328|NCT03333044|449008514|FG002|Overall Study|Lost to Follow-up|6|||
124830329|NCT03188094|449008515|FG000|Overall Study|Screen failure|1|||
124830330|NCT03188094|449008516|FG001|Overall Study|Screen failure|0|||
124830331|NCT03188094|449008517|FG002|Overall Study|Screen failure|0|||
124830332|NCT03188094|449008515|FG000|Overall Study|Pregnancy|3|||
124830333|NCT03188094|449008516|FG001|Overall Study|Pregnancy|0|||
124830334|NCT03188094|449008517|FG002|Overall Study|Pregnancy|0|||
124830335|NCT03188094|449008515|FG000|Overall Study|Ineligible|1|||
124830336|NCT03188094|449008516|FG001|Overall Study|Ineligible|0|||
124830337|NCT03188094|449008517|FG002|Overall Study|Ineligible|0|||
124830338|NCT03188094|449008515|FG000|Overall Study|Lost to Follow-up|0|||
124830339|NCT03188094|449008516|FG001|Overall Study|Lost to Follow-up|0|||
124830340|NCT03188094|449008517|FG002|Overall Study|Lost to Follow-up|17|||
124830341|NCT04537234|449008521|FG000|Overall Study|Withdrawal by Subject|2|||
124830342|NCT04537234|449008522|FG001|Overall Study|Withdrawal by Subject|0|||
124830343|NCT02070744|449008525|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
124830344|NCT02070744|449008526|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
124830345|NCT02070744|449008527|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
124830346|NCT02070744|449008528|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
124830347|NCT02070744|449008529|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
124830348|NCT02070744|449008525|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
124830349|NCT02070744|449008526|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
124830350|NCT02070744|449008527|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
124830351|NCT02070744|449008528|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
124830352|NCT02070744|449008529|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
124830353|NCT02070744|449008525|FG000|OLE Phase (48 Weeks)|Other|0|||
124830354|NCT02070744|449008526|FG001|OLE Phase (48 Weeks)|Other|0|||
124830355|NCT02070744|449008527|FG002|OLE Phase (48 Weeks)|Other|0|||
124830356|NCT02070744|449008528|FG003|OLE Phase (48 Weeks)|Other|0|||
124830357|NCT02070744|449008529|FG004|OLE Phase (48 Weeks)|Other|1|||
124830358|NCT04199117|449008530|FG000|Overall Study|Withdrawal by Subject|3|||
124830359|NCT04199117|449008531|FG001|Overall Study|Withdrawal by Subject|0|||
124830360|NCT04199117|449008532|FG002|Overall Study|Withdrawal by Subject|0|||
124830361|NCT04199117|449008533|FG003|Overall Study|Withdrawal by Subject|1|||
124830362|NCT04199117|449008534|FG004|Overall Study|Withdrawal by Subject|1|||
124830363|NCT04199117|449008535|FG005|Overall Study|Withdrawal by Subject|0|||
124830364|NCT04199117|449008536|FG006|Overall Study|Withdrawal by Subject|0|||
124830365|NCT04199117|449008537|FG007|Overall Study|Withdrawal by Subject|2|||
124830366|NCT04199117|449008538|FG008|Overall Study|Withdrawal by Subject|0|||
124830367|NCT04199117|449008539|FG009|Overall Study|Withdrawal by Subject|0|||
124830368|NCT04199117|449008540|FG010|Overall Study|Withdrawal by Subject|1|||
124830369|NCT04199117|449008541|FG011|Overall Study|Withdrawal by Subject|1|||
124830370|NCT04199117|449008542|FG012|Overall Study|Withdrawal by Subject|2|||
124830371|NCT04199117|449008543|FG013|Overall Study|Withdrawal by Subject|1|||
124830372|NCT04199117|449008544|FG014|Overall Study|Withdrawal by Subject|1|||
124830373|NCT04199117|449008545|FG015|Overall Study|Withdrawal by Subject|1|||
124830374|NCT04199117|449008530|FG000|Overall Study|Death|1|||
124830375|NCT04199117|449008531|FG001|Overall Study|Death|1|||
124830376|NCT04199117|449008532|FG002|Overall Study|Death|0|||
124830377|NCT04199117|449008533|FG003|Overall Study|Death|0|||
124830378|NCT04199117|449008534|FG004|Overall Study|Death|0|||
124830379|NCT04199117|449008535|FG005|Overall Study|Death|0|||
124830380|NCT04199117|449008536|FG006|Overall Study|Death|0|||
124830381|NCT04199117|449008537|FG007|Overall Study|Death|0|||
124830382|NCT04199117|449008538|FG008|Overall Study|Death|0|||
124830383|NCT04199117|449008539|FG009|Overall Study|Death|0|||
124830384|NCT04199117|449008540|FG010|Overall Study|Death|0|||
124830385|NCT04199117|449008541|FG011|Overall Study|Death|1|||
124830386|NCT04199117|449008542|FG012|Overall Study|Death|0|||
124830387|NCT04199117|449008543|FG013|Overall Study|Death|1|||
124830388|NCT04199117|449008544|FG014|Overall Study|Death|0|||
124830389|NCT04199117|449008545|FG015|Overall Study|Death|0|||
124830390|NCT04199117|449008530|FG000|Overall Study|Withdrawal by PI|0|||
124830391|NCT04199117|449008531|FG001|Overall Study|Withdrawal by PI|0|||
124830392|NCT04199117|449008532|FG002|Overall Study|Withdrawal by PI|0|||
124830393|NCT04199117|449008533|FG003|Overall Study|Withdrawal by PI|0|||
124830394|NCT04199117|449008534|FG004|Overall Study|Withdrawal by PI|0|||
124830395|NCT04199117|449008535|FG005|Overall Study|Withdrawal by PI|0|||
124830396|NCT04199117|449008536|FG006|Overall Study|Withdrawal by PI|0|||
124830397|NCT04199117|449008537|FG007|Overall Study|Withdrawal by PI|0|||
124830398|NCT04199117|449008538|FG008|Overall Study|Withdrawal by PI|0|||
124830399|NCT04199117|449008539|FG009|Overall Study|Withdrawal by PI|0|||
124830400|NCT04199117|449008540|FG010|Overall Study|Withdrawal by PI|0|||
124830401|NCT04199117|449008541|FG011|Overall Study|Withdrawal by PI|0|||
124830402|NCT04199117|449008542|FG012|Overall Study|Withdrawal by PI|1|||
124830403|NCT04199117|449008543|FG013|Overall Study|Withdrawal by PI|0|||
124830404|NCT04199117|449008544|FG014|Overall Study|Withdrawal by PI|0|||
124830405|NCT04199117|449008545|FG015|Overall Study|Withdrawal by PI|0|||
124830406|NCT05478252|449008546|FG000|Overall Study|Withdrawal by Subject|2|||
124830407|NCT05478252|449008547|FG001|Overall Study|Withdrawal by Subject|3|||
124830408|NCT05478252|449008546|FG000|Overall Study|Lost to Follow-up|4|||
124830409|NCT05478252|449008547|FG001|Overall Study|Lost to Follow-up|2|||
124830410|NCT05478252|449008546|FG000|Overall Study|Physician Decision|1|||
124830411|NCT05478252|449008547|FG001|Overall Study|Physician Decision|1|||
124830412|NCT05478252|449008546|FG000|Overall Study|Death|1|||
124638892|NCT01262287|448296447|FG001|Overall Study|Lost to Follow-up|1|||
124638893|NCT00932373|448296448|FG000|Overall Study|Progressive disease|3|||
124638894|NCT00932373|448296449|FG001|Overall Study|Progressive disease|1|||
124638895|NCT00932373|448296450|FG002|Overall Study|Progressive disease|0|||
124638896|NCT00932373|448296451|FG003|Overall Study|Progressive disease|0|||
124638897|NCT00932373|448296452|FG004|Overall Study|Progressive disease|10|||
124638898|NCT00932373|448296453|FG005|Overall Study|Progressive disease|1|||
124638899|NCT00932373|448296454|FG006|Overall Study|Progressive disease|0|||
124638900|NCT00932373|448296455|FG007|Overall Study|Progressive disease|2|||
124638901|NCT00932373|448296456|FG008|Overall Study|Progressive disease|1|||
124638902|NCT00932373|448296457|FG009|Overall Study|Progressive disease|9|||
124638903|NCT00932373|448296458|FG010|Overall Study|Progressive disease|2|||
124638904|NCT00932373|448296448|FG000|Overall Study|Adverse Event|0|||
124638905|NCT00932373|448296449|FG001|Overall Study|Adverse Event|0|||
124638906|NCT00932373|448296450|FG002|Overall Study|Adverse Event|0|||
124638907|NCT00932373|448296451|FG003|Overall Study|Adverse Event|0|||
124638908|NCT00932373|448296452|FG004|Overall Study|Adverse Event|2|||
124638909|NCT00932373|448296453|FG005|Overall Study|Adverse Event|1|||
124638910|NCT00932373|448296454|FG006|Overall Study|Adverse Event|0|||
124638911|NCT00932373|448296455|FG007|Overall Study|Adverse Event|1|||
124638912|NCT00932373|448296456|FG008|Overall Study|Adverse Event|0|||
124638913|NCT00932373|448296457|FG009|Overall Study|Adverse Event|2|||
124638914|NCT00932373|448296458|FG010|Overall Study|Adverse Event|1|||
124638915|NCT00932373|448296448|FG000|Overall Study|Physician Decision|0|||
124638916|NCT00932373|448296449|FG001|Overall Study|Physician Decision|0|||
124638917|NCT00932373|448296450|FG002|Overall Study|Physician Decision|1|||
124638918|NCT00932373|448296451|FG003|Overall Study|Physician Decision|0|||
124638919|NCT00932373|448296452|FG004|Overall Study|Physician Decision|2|||
124830413|NCT05478252|449008547|FG001|Overall Study|Death|0|||
124830414|NCT07114198|449008554|FG000|Overall Study|Protocol Violation|1|||
124830415|NCT07114198|449008555|FG001|Overall Study|Protocol Violation|1|||
124830416|NCT00939809|449010044|FG000|Overall Study|Adverse Event|2|||
124830417|NCT00939809|449010044|FG000|Overall Study|Death|1|||
124830418|NCT01277523|449010045|FG000|Overall Study|Adverse Event|1|||
124638920|NCT00932373|448296453|FG005|Overall Study|Physician Decision|0|||
124638921|NCT00932373|448296454|FG006|Overall Study|Physician Decision|0|||
124638922|NCT00932373|448296455|FG007|Overall Study|Physician Decision|0|||
124638923|NCT00932373|448296456|FG008|Overall Study|Physician Decision|0|||
124638924|NCT00932373|448296457|FG009|Overall Study|Physician Decision|1|||
124638925|NCT00932373|448296458|FG010|Overall Study|Physician Decision|0|||
124830419|NCT01277523|449010046|FG001|Overall Study|Adverse Event|0|||
124830420|NCT01277523|449010047|FG002|Overall Study|Adverse Event|0|||
124830421|NCT01277523|449010045|FG000|Overall Study|Protocol Violation|2|||
124830422|NCT01277523|449010046|FG001|Overall Study|Protocol Violation|0|||
124830423|NCT01277523|449010047|FG002|Overall Study|Protocol Violation|0|||
124830424|NCT01277523|449010045|FG000|Overall Study|Other Reason not Defined|0|||
124830425|NCT01277523|449010046|FG001|Overall Study|Other Reason not Defined|1|||
124830426|NCT01277523|449010047|FG002|Overall Study|Other Reason not Defined|0|||
124830427|NCT01030523|449010048|FG000|Initial Study (5 Years)|Death|1|||
124830428|NCT01030523|449010049|FG001|Initial Study (5 Years)|Death|0|||
124830429|NCT01030523|449010048|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
124830430|NCT01030523|449010049|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
124830431|NCT01030523|449010048|FG000|Initial Study (5 Years)|Implant failure|1|||
124830432|NCT01030523|449010049|FG001|Initial Study (5 Years)|Implant failure|0|||
124830433|NCT01030523|449010048|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
124830434|NCT01030523|449010049|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
124830435|NCT01030523|449010048|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
124830436|NCT01030523|449010049|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
124830437|NCT01030523|449010048|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
124830438|NCT01030523|449010049|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
124830439|NCT02389998|449010054|FG000|Overall Study|car accident|1|||
124830440|NCT02389998|449010055|FG001|Overall Study|car accident|0|||
124830441|NCT05089682|449010056|FG000|Overall Study|Withdrawal by Subject|2|||
124830442|NCT01996826|449010059|FG000|Overall Study|Lost to Follow-up|6|||
124830443|NCT01996826|449010060|FG001|Overall Study|Lost to Follow-up|2|||
124830444|NCT01996826|449010059|FG000|Overall Study|Physician Decision|1|||
124830445|NCT01996826|449010060|FG001|Overall Study|Physician Decision|1|||
124830446|NCT02255981|449010062|FG000|Overall Study|Lost to Follow-up|3|||
124830447|NCT02255981|449010062|FG000|Overall Study|Withdrawal by Subject|1|||
124830448|NCT00518323|449010063|FG000|Overall Study|Lack of Efficacy|14|||
124830449|NCT00518323|449010064|FG001|Overall Study|Lack of Efficacy|2|||
124830450|NCT00518323|449010065|FG002|Overall Study|Lack of Efficacy|4|||
124830451|NCT00518323|449010066|FG003|Overall Study|Lack of Efficacy|20|||
124830452|NCT00518323|449010063|FG000|Overall Study|Withdrawal by Subject|1|||
124830453|NCT00518323|449010064|FG001|Overall Study|Withdrawal by Subject|2|||
124830454|NCT00518323|449010065|FG002|Overall Study|Withdrawal by Subject|4|||
124830455|NCT00518323|449010066|FG003|Overall Study|Withdrawal by Subject|2|||
124830456|NCT00518323|449010063|FG000|Overall Study|Lost to Follow-up|0|||
124830457|NCT00518323|449010064|FG001|Overall Study|Lost to Follow-up|2|||
124830458|NCT00518323|449010065|FG002|Overall Study|Lost to Follow-up|1|||
124830459|NCT00518323|449010066|FG003|Overall Study|Lost to Follow-up|3|||
124830460|NCT00518323|449010063|FG000|Overall Study|Adverse Event|1|||
124830461|NCT00518323|449010064|FG001|Overall Study|Adverse Event|1|||
124830462|NCT00518323|449010065|FG002|Overall Study|Adverse Event|1|||
124830463|NCT00518323|449010066|FG003|Overall Study|Adverse Event|0|||
124830464|NCT00518323|449010063|FG000|Overall Study|Prohibited medication and others|3|||
124830465|NCT00518323|449010064|FG001|Overall Study|Prohibited medication and others|1|||
124830466|NCT00518323|449010065|FG002|Overall Study|Prohibited medication and others|1|||
124830467|NCT00518323|449010066|FG003|Overall Study|Prohibited medication and others|0|||
124830468|NCT01514760|449010067|FG000|Overall Study|Lost to Follow-up|2|||
124830469|NCT02092662|449010068|FG000|Overall Study|Lost to Follow-up|13|||
124830470|NCT02092662|449010069|FG001|Overall Study|Lost to Follow-up|0|||
124830471|NCT03329690|449010072|FG000|Overall Study|Progressive disease per RECIST|85|||
124830472|NCT03329690|449010073|FG001|Overall Study|Progressive disease per RECIST|44|||
124830473|NCT03329690|449010074|FG002|Overall Study|Progressive disease per RECIST|6|||
124830474|NCT03329690|449010075|FG003|Overall Study|Progressive disease per RECIST|16|||
124830475|NCT03329690|449010076|FG004|Overall Study|Progressive disease per RECIST|20|||
124830476|NCT03329690|449010072|FG000|Overall Study|Clinical progression|7|||
124830477|NCT03329690|449010073|FG001|Overall Study|Clinical progression|4|||
124830478|NCT03329690|449010074|FG002|Overall Study|Clinical progression|1|||
124830479|NCT03329690|449010075|FG003|Overall Study|Clinical progression|1|||
124830480|NCT03329690|449010076|FG004|Overall Study|Clinical progression|1|||
124830481|NCT03329690|449010072|FG000|Overall Study|Adverse Event|22|||
124830482|NCT03329690|449010073|FG001|Overall Study|Adverse Event|4|||
124830483|NCT03329690|449010074|FG002|Overall Study|Adverse Event|0|||
124830484|NCT03329690|449010075|FG003|Overall Study|Adverse Event|1|||
124638926|NCT00932373|448296448|FG000|Overall Study|Dose limiting toxicity|0|||
124638927|NCT00932373|448296449|FG001|Overall Study|Dose limiting toxicity|0|||
124830485|NCT03329690|449010076|FG004|Overall Study|Adverse Event|2|||
124830486|NCT03329690|449010072|FG000|Overall Study|Death|2|||
124830487|NCT03329690|449010073|FG001|Overall Study|Death|0|||
124830488|NCT03329690|449010074|FG002|Overall Study|Death|0|||
124830489|NCT03329690|449010075|FG003|Overall Study|Death|1|||
124830490|NCT03329690|449010076|FG004|Overall Study|Death|0|||
124830491|NCT03329690|449010072|FG000|Overall Study|Withdrawal by Subject|2|||
124830492|NCT03329690|449010073|FG001|Overall Study|Withdrawal by Subject|3|||
124830493|NCT03329690|449010074|FG002|Overall Study|Withdrawal by Subject|0|||
124830494|NCT03329690|449010075|FG003|Overall Study|Withdrawal by Subject|1|||
124830495|NCT03329690|449010076|FG004|Overall Study|Withdrawal by Subject|0|||
124830496|NCT03329690|449010072|FG000|Overall Study|Physician Decision|1|||
124830497|NCT03329690|449010073|FG001|Overall Study|Physician Decision|0|||
124830498|NCT03329690|449010074|FG002|Overall Study|Physician Decision|0|||
124830499|NCT03329690|449010075|FG003|Overall Study|Physician Decision|0|||
124830500|NCT03329690|449010076|FG004|Overall Study|Physician Decision|1|||
124830501|NCT03329690|449010072|FG000|Overall Study|Miscellaneous|6|||
124830502|NCT03329690|449010073|FG001|Overall Study|Miscellaneous|0|||
124830503|NCT03329690|449010074|FG002|Overall Study|Miscellaneous|0|||
124830504|NCT03329690|449010075|FG003|Overall Study|Miscellaneous|0|||
124830505|NCT03329690|449010076|FG004|Overall Study|Miscellaneous|0|||
124830506|NCT03329690|449010072|FG000|Overall Study|Did not receive treatment|1|||
124830507|NCT03329690|449010073|FG001|Overall Study|Did not receive treatment|0|||
124830508|NCT03329690|449010074|FG002|Overall Study|Did not receive treatment|0|||
124830509|NCT03329690|449010075|FG003|Overall Study|Did not receive treatment|1|||
124830510|NCT03329690|449010076|FG004|Overall Study|Did not receive treatment|0|||
124830511|NCT02418468|449010078|FG000|Overall Study|Adverse Event|1|||
124830512|NCT02418468|449010079|FG001|Overall Study|Adverse Event|0|||
124830513|NCT02418468|449010078|FG000|Overall Study|Withdrawal of informed consent|1|||
124830514|NCT02418468|449010079|FG001|Overall Study|Withdrawal of informed consent|1|||
124830515|NCT02914769|449010080|FG000|Overall Study|Protocol Violation|3|||
124830516|NCT02914769|449010081|FG001|Overall Study|Protocol Violation|2|||
124830517|NCT02914769|449010080|FG000|Overall Study|Withdrawal by Subject|0|||
124830518|NCT02914769|449010081|FG001|Overall Study|Withdrawal by Subject|1|||
124830519|NCT02337907|449010084|FG000|Overall Study|Other than listed|1|||
124830520|NCT02337907|449010085|FG001|Overall Study|Other than listed|0|||
124830521|NCT02337907|449010086|FG002|Overall Study|Other than listed|0|||
124830522|NCT02337907|449010087|FG003|Overall Study|Other than listed|1|||
124830523|NCT02337907|449010088|FG004|Overall Study|Other than listed|1|||
124830524|NCT02337907|449010089|FG005|Overall Study|Other than listed|0|||
124830525|NCT02337907|449010084|FG000|Overall Study|Withdrawal by Subject|2|||
124830526|NCT02337907|449010085|FG001|Overall Study|Withdrawal by Subject|3|||
124830527|NCT02337907|449010086|FG002|Overall Study|Withdrawal by Subject|0|||
124830528|NCT02337907|449010087|FG003|Overall Study|Withdrawal by Subject|2|||
124830529|NCT02337907|449010088|FG004|Overall Study|Withdrawal by Subject|5|||
124830530|NCT02337907|449010089|FG005|Overall Study|Withdrawal by Subject|0|||
124830531|NCT02337907|449010084|FG000|Overall Study|Lost to Follow-up|0|||
124830532|NCT02337907|449010085|FG001|Overall Study|Lost to Follow-up|0|||
124830533|NCT02337907|449010086|FG002|Overall Study|Lost to Follow-up|0|||
124830534|NCT02337907|449010087|FG003|Overall Study|Lost to Follow-up|0|||
124830535|NCT02337907|449010088|FG004|Overall Study|Lost to Follow-up|0|||
124830536|NCT02337907|449010089|FG005|Overall Study|Lost to Follow-up|1|||
124830537|NCT02337907|449010084|FG000|Overall Study|Adverse Event|1|||
124830538|NCT02337907|449010085|FG001|Overall Study|Adverse Event|1|||
124830539|NCT02337907|449010086|FG002|Overall Study|Adverse Event|1|||
124830540|NCT02337907|449010087|FG003|Overall Study|Adverse Event|1|||
124830541|NCT02337907|449010088|FG004|Overall Study|Adverse Event|4|||
124830542|NCT02337907|449010089|FG005|Overall Study|Adverse Event|0|||
124830543|NCT01592344|449010093|FG000|Overall Study|Adverse Event|1|||
124830544|NCT01592344|449010094|FG001|Overall Study|Adverse Event|1|||
124830545|NCT01592344|449010093|FG000|Overall Study|Lack of Efficacy|1|||
124830546|NCT01592344|449010094|FG001|Overall Study|Lack of Efficacy|0|||
124830547|NCT01592344|449010093|FG000|Overall Study|not available at primary outcome visit|2|||
124830548|NCT01592344|449010094|FG001|Overall Study|not available at primary outcome visit|4|||
124830549|NCT02488681|449010098|FG000|Overall Study|Implant unsuccessful|7|||
124830550|NCT00720057|449010099|FG000|Overall Study|Lost to Follow-up|0|||
124830551|NCT00720057|449010100|FG001|Overall Study|Lost to Follow-up|2|||
124830552|NCT00720057|449010099|FG000|Overall Study|Protocol Violation|1|||
124830553|NCT00720057|449010100|FG001|Overall Study|Protocol Violation|0|||
124830554|NCT00720057|449010099|FG000|Overall Study|Withdrawal by Subject|0|||
124830555|NCT00720057|449010100|FG001|Overall Study|Withdrawal by Subject|1|||
124830556|NCT00613015|449010106|FG000|Overall Study|Lost to Follow-up|0|||
124830557|NCT00613015|449010107|FG001|Overall Study|Lost to Follow-up|1|||
124830558|NCT00613015|449010108|FG002|Overall Study|Lost to Follow-up|3|||
124830559|NCT00613015|449010109|FG003|Overall Study|Lost to Follow-up|3|||
124830560|NCT00613015|449010110|FG004|Overall Study|Lost to Follow-up|2|||
124830561|NCT00613015|449010111|FG005|Overall Study|Lost to Follow-up|3|||
124830562|NCT01170091|449010112|FG000|Overall Study|Missing efficacy evaluation|3|||
124830563|NCT01170091|449010112|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
124830564|NCT00391274|449010117|FG000|Overall Study|Death Due to Study Disease|55|||
124830565|NCT00391274|449010118|FG001|Overall Study|Death Due to Study Disease|45|||
124830566|NCT00391274|449010117|FG000|Overall Study|Lost to Follow-up|0|||
124830567|NCT00391274|449010118|FG001|Overall Study|Lost to Follow-up|3|||
124830568|NCT00391274|449010117|FG000|Overall Study|Physician Decision|4|||
124830569|NCT00391274|449010118|FG001|Overall Study|Physician Decision|2|||
124830570|NCT00391274|449010117|FG000|Overall Study|Withdrawal by Subject|0|||
124830571|NCT00391274|449010118|FG001|Overall Study|Withdrawal by Subject|3|||
124830572|NCT00391274|449010117|FG000|Overall Study|Death Due to Adverse Event|1|||
124830573|NCT00391274|449010118|FG001|Overall Study|Death Due to Adverse Event|3|||
124830574|NCT00391274|449010117|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
124830575|NCT00391274|449010118|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
124830576|NCT00391274|449010117|FG000|Overall Study|Death Not Study Related|0|||
124830577|NCT00391274|449010118|FG001|Overall Study|Death Not Study Related|1|||
124830578|NCT03341533|449010119|FG000|Overall Study|Withdrawal by Subject|1|||
124830579|NCT03341533|449010120|FG001|Overall Study|Withdrawal by Subject|1|||
124830580|NCT03341533|449010119|FG000|Overall Study|Not eligible after randomization|2|||
124830581|NCT03341533|449010120|FG001|Overall Study|Not eligible after randomization|1|||
124830582|NCT03447990|449010122|FG000|Overall Study|Withdrawal by Subject|0|||
124830583|NCT03447990|449010123|FG001|Overall Study|Withdrawal by Subject|0|||
124830584|NCT03447990|449010124|FG002|Overall Study|Withdrawal by Subject|0|||
124830585|NCT03447990|449010125|FG003|Overall Study|Withdrawal by Subject|0|||
124830586|NCT03447990|449010126|FG004|Overall Study|Withdrawal by Subject|0|||
124830587|NCT03447990|449010127|FG005|Overall Study|Withdrawal by Subject|0|||
124830588|NCT03447990|449010128|FG006|Overall Study|Withdrawal by Subject|1|||
124830589|NCT03559257|449010129|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
124830590|NCT03559257|449010130|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
124830591|NCT03559257|449010129|FG000|Double Blind Treatment Period|Protocol Violation|1|||
124830592|NCT03559257|449010130|FG001|Double Blind Treatment Period|Protocol Violation|4|||
124830593|NCT03559257|449010129|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
124830594|NCT03559257|449010130|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
124830595|NCT03559257|449010129|FG000|Double Blind Treatment Period|Adverse Event|0|||
124830596|NCT03559257|449010130|FG001|Double Blind Treatment Period|Adverse Event|1|||
124830597|NCT03559257|449010129|FG000|Double Blind Treatment Period|Screen Failure|0|||
124830598|NCT03559257|449010130|FG001|Double Blind Treatment Period|Screen Failure|1|||
124830599|NCT03559257|449010129|FG000|Open-label Treatment Period|Adverse Event|1|||
124830600|NCT03559257|449010130|FG001|Open-label Treatment Period|Adverse Event|4|||
124830601|NCT03559257|449010129|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
124830602|NCT03559257|449010130|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
124830603|NCT03559257|449010129|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
124830604|NCT03559257|449010130|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
124830605|NCT03559257|449010129|FG000|Open-label Treatment Period|Protocol Violation|2|||
124830606|NCT03559257|449010130|FG001|Open-label Treatment Period|Protocol Violation|0|||
124830607|NCT03559257|449010129|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
124830608|NCT03559257|449010130|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
124830609|NCT03559257|449010129|FG000|Open-label Treatment Period|Physician Decision|0|||
124830610|NCT03559257|449010130|FG001|Open-label Treatment Period|Physician Decision|1|||
124830611|NCT03630120|449010131|FG000|Overall Study|Disease progression|0|||
124830612|NCT03630120|449010132|FG001|Overall Study|Disease progression|1|||
124830613|NCT03630120|449010133|FG002|Overall Study|Disease progression|1|||
124830614|NCT03630120|449010134|FG003|Overall Study|Disease progression|1|||
124830615|NCT01519960|449010135|FG000|Overall Study|Withdrawal from the study|26|||
124830616|NCT01519960|449010136|FG001|Overall Study|Withdrawal from the study|22|||
124830617|NCT01519960|449010137|FG002|Overall Study|Withdrawal from the study|5|||
124830618|NCT01387347|449010138|FG000|Overall Study|Lost to Follow-up|2|||
124830619|NCT01387347|449010139|FG001|Overall Study|Lost to Follow-up|1|||
124830620|NCT02153112|449010142|FG000|Overall Study|Adverse Event|0|||
124830621|NCT02153112|449010143|FG001|Overall Study|Adverse Event|0|||
124830622|NCT02153112|449010144|FG002|Overall Study|Adverse Event|1|||
124830623|NCT02153112|449010145|FG003|Overall Study|Adverse Event|0|||
124830624|NCT02153112|449010146|FG004|Overall Study|Adverse Event|0|||
124830625|NCT02153112|449010147|FG005|Overall Study|Adverse Event|0|||
124830626|NCT02153112|449010148|FG006|Overall Study|Adverse Event|0|||
124830627|NCT02153112|449010149|FG007|Overall Study|Adverse Event|0|||
124830628|NCT02153112|449010150|FG008|Overall Study|Adverse Event|0|||
124830629|NCT02153112|449010151|FG009|Overall Study|Adverse Event|0|||
124830630|NCT02153112|449010142|FG000|Overall Study|Lost to Follow-up|1|||
124830631|NCT02153112|449010143|FG001|Overall Study|Lost to Follow-up|1|||
124830632|NCT02153112|449010144|FG002|Overall Study|Lost to Follow-up|0|||
124830633|NCT02153112|449010145|FG003|Overall Study|Lost to Follow-up|0|||
124830634|NCT02153112|449010146|FG004|Overall Study|Lost to Follow-up|2|||
124830635|NCT02153112|449010147|FG005|Overall Study|Lost to Follow-up|1|||
124830636|NCT02153112|449010148|FG006|Overall Study|Lost to Follow-up|1|||
124830637|NCT02153112|449010149|FG007|Overall Study|Lost to Follow-up|0|||
124830638|NCT02153112|449010150|FG008|Overall Study|Lost to Follow-up|1|||
124830639|NCT02153112|449010151|FG009|Overall Study|Lost to Follow-up|1|||
124830640|NCT02153112|449010142|FG000|Overall Study|Withdrawal by Subject|3|||
124830641|NCT02153112|449010143|FG001|Overall Study|Withdrawal by Subject|1|||
124830642|NCT02153112|449010144|FG002|Overall Study|Withdrawal by Subject|2|||
124830643|NCT02153112|449010145|FG003|Overall Study|Withdrawal by Subject|2|||
124830644|NCT02153112|449010146|FG004|Overall Study|Withdrawal by Subject|1|||
124830645|NCT02153112|449010147|FG005|Overall Study|Withdrawal by Subject|1|||
124830646|NCT02153112|449010148|FG006|Overall Study|Withdrawal by Subject|7|||
124830647|NCT02153112|449010149|FG007|Overall Study|Withdrawal by Subject|2|||
124830648|NCT02153112|449010150|FG008|Overall Study|Withdrawal by Subject|13|||
124830649|NCT02153112|449010151|FG009|Overall Study|Withdrawal by Subject|12|||
124830650|NCT02153112|449010142|FG000|Overall Study|Reason not Specified|0|||
124830651|NCT02153112|449010143|FG001|Overall Study|Reason not Specified|0|||
124830652|NCT02153112|449010144|FG002|Overall Study|Reason not Specified|0|||
124830653|NCT02153112|449010145|FG003|Overall Study|Reason not Specified|0|||
124830654|NCT02153112|449010146|FG004|Overall Study|Reason not Specified|0|||
124830655|NCT02153112|449010147|FG005|Overall Study|Reason not Specified|0|||
124830656|NCT02153112|449010148|FG006|Overall Study|Reason not Specified|0|||
124830657|NCT02153112|449010149|FG007|Overall Study|Reason not Specified|0|||
124830658|NCT02153112|449010150|FG008|Overall Study|Reason not Specified|1|||
124830659|NCT02153112|449010151|FG009|Overall Study|Reason not Specified|1|||
124830660|NCT00561080|449010152|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
124830661|NCT00561080|449010153|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
124830662|NCT00561080|449010154|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
124830663|NCT00561080|449010152|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
124830664|NCT00561080|449010153|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
124830665|NCT00561080|449010154|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
124830666|NCT00561080|449010152|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
124830667|NCT00561080|449010153|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
124830668|NCT00561080|449010154|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
124830669|NCT00561080|449010152|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
124830670|NCT00561080|449010153|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
124830671|NCT00561080|449010154|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
124830672|NCT00561080|449010152|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
124830673|NCT00561080|449010153|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
124830674|NCT00561080|449010154|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
124830675|NCT00561080|449010152|FG000|Vaccination Period (up to Month 4)|Other|0|||
124830676|NCT00561080|449010153|FG001|Vaccination Period (up to Month 4)|Other|2|||
124830677|NCT00561080|449010154|FG002|Vaccination Period (up to Month 4)|Other|1|||
124830678|NCT00561080|449010152|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
124830679|NCT00561080|449010153|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
124830680|NCT00561080|449010154|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
124830681|NCT00561080|449010152|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
124830682|NCT00561080|449010153|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
124830683|NCT00561080|449010154|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
124830684|NCT00561080|449010152|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
124830685|NCT00561080|449010153|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
124830686|NCT00561080|449010154|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
124830687|NCT00561080|449010152|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
124830688|NCT00561080|449010153|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
124830689|NCT00561080|449010154|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
124830690|NCT01498458|449010157|FG000|Overall Study|Adverse Event|4|||
124830691|NCT01498458|449010157|FG000|Overall Study|Physician Decision|3|||
124830692|NCT02446990|449010160|FG000|Overall Study|Death|485|||
124830693|NCT02446990|449010161|FG001|Overall Study|Death|458|||
124830694|NCT02446990|449010160|FG000|Overall Study|Lost to Follow-up|3|||
124830695|NCT02446990|449010161|FG001|Overall Study|Lost to Follow-up|1|||
124830696|NCT02446990|449010160|FG000|Overall Study|Physician Decision|1|||
124830697|NCT02446990|449010161|FG001|Overall Study|Physician Decision|0|||
124830698|NCT02446990|449010160|FG000|Overall Study|Withdrawal by Subject|231|||
124830699|NCT02446990|449010161|FG001|Overall Study|Withdrawal by Subject|199|||
124830700|NCT03158051|449010162|FG000|Overall Study|Lost to Follow-up|41|||
124830701|NCT03158051|449010163|FG001|Overall Study|Lost to Follow-up|47|||
124830702|NCT03158051|449010162|FG000|Overall Study|Physician Decision|6|||
124830703|NCT03158051|449010163|FG001|Overall Study|Physician Decision|7|||
124830704|NCT03158051|449010162|FG000|Overall Study|Withdrawal by Subject|24|||
124830705|NCT03158051|449010163|FG001|Overall Study|Withdrawal by Subject|15|||
124830706|NCT03158051|449010162|FG000|Overall Study|Death|0|||
124830707|NCT03158051|449010163|FG001|Overall Study|Death|1|||
124830708|NCT02738151|449010164|FG000|Overall Study|Randomized but not treated|4|||
124830709|NCT02738151|449010165|FG001|Overall Study|Randomized but not treated|1|||
124830710|NCT02738151|449010164|FG000|Overall Study|Adverse Event|4|||
124830711|NCT02738151|449010165|FG001|Overall Study|Adverse Event|5|||
124830712|NCT02738151|449010164|FG000|Overall Study|Hypoglycemia|0|||
124830713|NCT02738151|449010165|FG001|Overall Study|Hypoglycemia|1|||
124638928|NCT00932373|448296450|FG002|Overall Study|Dose limiting toxicity|0|||
124638929|NCT00932373|448296451|FG003|Overall Study|Dose limiting toxicity|0|||
124638930|NCT00932373|448296452|FG004|Overall Study|Dose limiting toxicity|0|||
124638931|NCT00932373|448296453|FG005|Overall Study|Dose limiting toxicity|1|||
124830714|NCT02738151|449010164|FG000|Overall Study|Poor Compliance to Protocol|4|||
124638932|NCT00932373|448296454|FG006|Overall Study|Dose limiting toxicity|0|||
124830715|NCT02738151|449010165|FG001|Overall Study|Poor Compliance to Protocol|3|||
124830716|NCT02738151|449010164|FG000|Overall Study|Other than specified above|11|||
124830717|NCT02738151|449010165|FG001|Overall Study|Other than specified above|21|||
124830718|NCT03649711|449010167|FG000|Overall Study|Adverse Event|0|||
124830719|NCT03649711|449010168|FG001|Overall Study|Adverse Event|1|||
124638933|NCT00932373|448296455|FG007|Overall Study|Dose limiting toxicity|0|||
124752969|NCT00934128|448716906|FG000|First Intervention (2 Hours)|Adverse Event|4|||
124752970|NCT00934128|448716907|FG001|First Intervention (2 Hours)|Adverse Event|1|||
124752971|NCT00934128|448716906|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
124752972|NCT00934128|448716907|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
124752973|NCT00934128|448716906|FG000|Washout Period (1 Hour)|Patient preference|1|||
124752974|NCT00934128|448716907|FG001|Washout Period (1 Hour)|Patient preference|3|||
124752975|NCT00934128|448716906|FG000|Washout Period (1 Hour)|Pain|1|||
124752976|NCT00934128|448716907|FG001|Washout Period (1 Hour)|Pain|0|||
124752977|NCT00934128|448716906|FG000|Washout Period (1 Hour)|Too tired|1|||
124752978|NCT00934128|448716907|FG001|Washout Period (1 Hour)|Too tired|0|||
124752979|NCT00934128|448716906|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
124752980|NCT00934128|448716907|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
124752981|NCT00934128|448716906|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
124752982|NCT00934128|448716907|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
124752983|NCT01946152|448718731|FG000|Overall Study|Adverse Event|1|||
124752984|NCT01946152|448718732|FG001|Overall Study|Adverse Event|0|||
124752985|NCT01946152|448718733|FG002|Overall Study|Adverse Event|0|||
124752986|NCT01946152|448718734|FG003|Overall Study|Adverse Event|0|||
124752987|NCT01946152|448718731|FG000|Overall Study|Withdrawal by Subject|0|||
124752988|NCT01946152|448718732|FG001|Overall Study|Withdrawal by Subject|2|||
124752989|NCT01946152|448718733|FG002|Overall Study|Withdrawal by Subject|0|||
124752990|NCT01946152|448718734|FG003|Overall Study|Withdrawal by Subject|0|||
124752991|NCT01946152|448718731|FG000|Overall Study|Progression|0|||
124752992|NCT01946152|448718732|FG001|Overall Study|Progression|1|||
124752993|NCT01946152|448718733|FG002|Overall Study|Progression|4|||
124752994|NCT01946152|448718734|FG003|Overall Study|Progression|7|||
124752995|NCT01946152|448718731|FG000|Overall Study|Physician Decision|0|||
124752996|NCT01946152|448718732|FG001|Overall Study|Physician Decision|0|||
124752997|NCT01946152|448718733|FG002|Overall Study|Physician Decision|1|||
124752998|NCT01946152|448718734|FG003|Overall Study|Physician Decision|0|||
124752999|NCT01946152|448718731|FG000|Overall Study|Second malignancy|0|||
124753000|NCT01946152|448718732|FG001|Overall Study|Second malignancy|0|||
124753001|NCT01946152|448718733|FG002|Overall Study|Second malignancy|1|||
124753002|NCT01946152|448718734|FG003|Overall Study|Second malignancy|0|||
124753003|NCT01946152|448718731|FG000|Overall Study|Adverse Event|0|||
124753004|NCT01946152|448718732|FG001|Overall Study|Adverse Event|0|||
124753005|NCT01946152|448718733|FG002|Overall Study|Adverse Event|0|||
124753006|NCT01946152|448718734|FG003|Overall Study|Adverse Event|1|||
124753007|NCT01698814|448718735|FG000|Overall Study|Adverse Event|0|||
124753008|NCT01698814|448718736|FG001|Overall Study|Adverse Event|2|||
124753009|NCT01698814|448718735|FG000|Overall Study|Lost to Follow-up|0|||
124753010|NCT01698814|448718736|FG001|Overall Study|Lost to Follow-up|1|||
124753011|NCT01698814|448718735|FG000|Overall Study|Pregnancy|1|||
124753012|NCT01698814|448718736|FG001|Overall Study|Pregnancy|0|||
124753013|NCT01698814|448718735|FG000|Overall Study|Randomized in error|1|||
124753014|NCT01698814|448718736|FG001|Overall Study|Randomized in error|0|||
124753015|NCT01061359|448718741|FG000|Overall Study|Death|32|||
124753016|NCT01061359|448718741|FG000|Overall Study|Lost to Follow-up|1072|||
124753017|NCT01061359|448718741|FG000|Overall Study|Relapse|187|||
124753018|NCT01061359|448718741|FG000|Overall Study|Secondary neoplasm|11|||
124753019|NCT04014062|448718742|FG000|Period I: Dosing|Medical Grounds|4|||
124753020|NCT04014062|448718743|FG001|Period I: Dosing|Medical Grounds|5|||
124753021|NCT04014062|448718742|FG000|Period I: Dosing|Withdrawal by Subject|3|||
124753022|NCT04014062|448718743|FG001|Period I: Dosing|Withdrawal by Subject|1|||
124753023|NCT03038126|448718744|FG000|Overall Study|Death|1|||
124753024|NCT03038126|448718745|FG001|Overall Study|Death|1|||
124753025|NCT03038126|448718744|FG000|Overall Study|Withdrawal by Subject|5|||
124753026|NCT03038126|448718745|FG001|Overall Study|Withdrawal by Subject|0|||
124753027|NCT03038126|448718744|FG000|Overall Study|Lost to Follow-up|0|||
124753028|NCT03038126|448718745|FG001|Overall Study|Lost to Follow-up|1|||
124753029|NCT03038126|448718744|FG000|Overall Study|Long Term Hospitalization|2|||
124753030|NCT03038126|448718745|FG001|Overall Study|Long Term Hospitalization|0|||
124753031|NCT03038126|448718744|FG000|Overall Study|Too Ill to Participate|1|||
124753032|NCT03038126|448718745|FG001|Overall Study|Too Ill to Participate|2|||
124753033|NCT02610777|448718746|FG000|Overall Study|Lost to Follow-up|1|||
124753034|NCT02610777|448718747|FG001|Overall Study|Lost to Follow-up|0|||
124753035|NCT02610777|448718746|FG000|Overall Study|Site Terminated by Sponsor|9|||
124753036|NCT02610777|448718747|FG001|Overall Study|Site Terminated by Sponsor|8|||
124753037|NCT02610777|448718746|FG000|Overall Study|Withdrawal by Subject|2|||
124753038|NCT02610777|448718747|FG001|Overall Study|Withdrawal by Subject|2|||
124753039|NCT02610777|448718746|FG000|Overall Study|Reason not Specified|0|||
124753040|NCT02610777|448718747|FG001|Overall Study|Reason not Specified|1|||
124753041|NCT02610777|448718746|FG000|Overall Study|Death|50|||
124753042|NCT02610777|448718747|FG001|Overall Study|Death|47|||
124753043|NCT00398567|448718751|FG000|Overall Study|Disease Progression|3|||
124753044|NCT00398567|448718752|FG001|Overall Study|Disease Progression|4|||
124753045|NCT00398567|448718753|FG002|Overall Study|Disease Progression|27|||
124753046|NCT00398567|448718751|FG000|Overall Study|Withdrawal by Subject|1|||
124830720|NCT03649711|449010169|FG002|Overall Study|Adverse Event|0|||
124830721|NCT03649711|449010167|FG000|Overall Study|Kidney Transplant|1|||
124830722|NCT03649711|449010168|FG001|Overall Study|Kidney Transplant|0|||
124830723|NCT03649711|449010169|FG002|Overall Study|Kidney Transplant|0|||
124830724|NCT00702403|449012095|FG000|From Consent to Engraftment|Progressive leukemia|6|||
124830725|NCT00702403|449012095|FG000|From Consent to Engraftment|Critically ill|2|||
124830726|NCT00702403|449012095|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
124830727|NCT00702403|449012095|FG000|From Consent to Engraftment|Myocardial infarction|1|||
124830728|NCT00702403|449012095|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
124830729|NCT00702403|449012095|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
124830730|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
124830731|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
124830732|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Non-compliance|2|||
124830733|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
124830734|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
124830735|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Suicide|1|||
124830736|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
124830737|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
124830738|NCT00702403|449012095|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
124830739|NCT02016625|449012096|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
124830740|NCT02016625|449012097|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
124830741|NCT02016625|449012096|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
124830742|NCT02016625|449012097|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
124830743|NCT02016625|449012096|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
124830744|NCT02016625|449012097|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
124830745|NCT02356783|449012099|FG000|Overall Study|Lost to Follow-up|1|||
124830746|NCT02356783|449012100|FG001|Overall Study|Lost to Follow-up|3|||
124830747|NCT00380978|449012101|FG000|Overall Study|Refused allocated intervention|0|||
124830748|NCT00380978|449012102|FG001|Overall Study|Refused allocated intervention|6|||
124830749|NCT00380978|449012101|FG000|Overall Study|Wrong study envelope|0|||
124830750|NCT00380978|449012102|FG001|Overall Study|Wrong study envelope|2|||
124830751|NCT00380978|449012101|FG000|Overall Study|Allocation prior to analgesia request|1|||
124830752|NCT00380978|449012102|FG001|Overall Study|Allocation prior to analgesia request|2|||
124830753|NCT00380978|449012101|FG000|Overall Study|Parous patient|1|||
124830754|NCT00380978|449012102|FG001|Overall Study|Parous patient|0|||
124830755|NCT04146545|449012103|FG000|Overall Study|deemed ineligible after randomization|1|||
124830756|NCT04146545|449012104|FG001|Overall Study|deemed ineligible after randomization|0|||
124830757|NCT01729754|449012105|FG000|Part 1|Adverse Event|2|||
124830758|NCT01729754|449012106|FG001|Part 1|Adverse Event|0|||
124830759|NCT01729754|449012107|FG002|Part 1|Adverse Event|0|||
124830760|NCT01729754|449012108|FG003|Part 1|Adverse Event|1|||
124830761|NCT01729754|449012109|FG004|Part 1|Adverse Event|0|||
124830762|NCT01729754|449012110|FG005|Part 1|Adverse Event|0|||
124830763|NCT01729754|449012111|FG006|Part 1|Adverse Event|2|||
124830764|NCT01729754|449012112|FG007|Part 1|Adverse Event|0|||
124830765|NCT01729754|449012113|FG008|Part 1|Adverse Event|0|||
124830766|NCT01729754|449012114|FG009|Part 1|Adverse Event|5|||
124830767|NCT01729754|449012105|FG000|Part 1|Lack of Efficacy|1|||
124830768|NCT01729754|449012106|FG001|Part 1|Lack of Efficacy|0|||
124830769|NCT01729754|449012107|FG002|Part 1|Lack of Efficacy|0|||
124830770|NCT01729754|449012108|FG003|Part 1|Lack of Efficacy|0|||
124830771|NCT01729754|449012109|FG004|Part 1|Lack of Efficacy|0|||
124830772|NCT01729754|449012110|FG005|Part 1|Lack of Efficacy|0|||
124830773|NCT01729754|449012111|FG006|Part 1|Lack of Efficacy|2|||
124830774|NCT01729754|449012112|FG007|Part 1|Lack of Efficacy|0|||
124830775|NCT01729754|449012113|FG008|Part 1|Lack of Efficacy|0|||
124638934|NCT00932373|448296456|FG008|Overall Study|Dose limiting toxicity|0|||
124638935|NCT00932373|448296457|FG009|Overall Study|Dose limiting toxicity|0|||
124638936|NCT00932373|448296458|FG010|Overall Study|Dose limiting toxicity|0|||
124830776|NCT01729754|449012114|FG009|Part 1|Lack of Efficacy|0|||
124830777|NCT01729754|449012105|FG000|Part 1|Lost to Follow-up|1|||
124830778|NCT01729754|449012106|FG001|Part 1|Lost to Follow-up|0|||
124830779|NCT01729754|449012107|FG002|Part 1|Lost to Follow-up|0|||
124830780|NCT01729754|449012108|FG003|Part 1|Lost to Follow-up|2|||
124830781|NCT01729754|449012109|FG004|Part 1|Lost to Follow-up|0|||
124830782|NCT01729754|449012110|FG005|Part 1|Lost to Follow-up|0|||
124830783|NCT01729754|449012111|FG006|Part 1|Lost to Follow-up|3|||
124830784|NCT01729754|449012112|FG007|Part 1|Lost to Follow-up|0|||
124830785|NCT01729754|449012113|FG008|Part 1|Lost to Follow-up|0|||
124830786|NCT01729754|449012114|FG009|Part 1|Lost to Follow-up|3|||
124830787|NCT01729754|449012105|FG000|Part 1|Non-compliance with Study Drug|1|||
124830788|NCT01729754|449012106|FG001|Part 1|Non-compliance with Study Drug|0|||
124830789|NCT01729754|449012107|FG002|Part 1|Non-compliance with Study Drug|0|||
124830790|NCT01729754|449012108|FG003|Part 1|Non-compliance with Study Drug|0|||
124830791|NCT01729754|449012109|FG004|Part 1|Non-compliance with Study Drug|0|||
124830792|NCT01729754|449012110|FG005|Part 1|Non-compliance with Study Drug|0|||
124830793|NCT01729754|449012111|FG006|Part 1|Non-compliance with Study Drug|0|||
124830794|NCT01729754|449012112|FG007|Part 1|Non-compliance with Study Drug|0|||
124830795|NCT01729754|449012113|FG008|Part 1|Non-compliance with Study Drug|0|||
124830796|NCT01729754|449012114|FG009|Part 1|Non-compliance with Study Drug|0|||
124638937|NCT00932373|448296448|FG000|Overall Study|Withdrawal by Subject|0|||
124638938|NCT00932373|448296449|FG001|Overall Study|Withdrawal by Subject|0|||
124638939|NCT00932373|448296450|FG002|Overall Study|Withdrawal by Subject|0|||
124638940|NCT00932373|448296451|FG003|Overall Study|Withdrawal by Subject|0|||
124638941|NCT00932373|448296452|FG004|Overall Study|Withdrawal by Subject|0|||
124638942|NCT00932373|448296453|FG005|Overall Study|Withdrawal by Subject|0|||
124638943|NCT00932373|448296454|FG006|Overall Study|Withdrawal by Subject|0|||
124638944|NCT00932373|448296455|FG007|Overall Study|Withdrawal by Subject|0|||
124638945|NCT00932373|448296456|FG008|Overall Study|Withdrawal by Subject|1|||
124638946|NCT00932373|448296457|FG009|Overall Study|Withdrawal by Subject|0|||
124638947|NCT00932373|448296458|FG010|Overall Study|Withdrawal by Subject|0|||
124638948|NCT00932373|448296448|FG000|Overall Study|Clinical progression|0|||
124638949|NCT00932373|448296449|FG001|Overall Study|Clinical progression|0|||
124638950|NCT00932373|448296450|FG002|Overall Study|Clinical progression|0|||
124638951|NCT00932373|448296451|FG003|Overall Study|Clinical progression|0|||
124638952|NCT00932373|448296452|FG004|Overall Study|Clinical progression|0|||
124638953|NCT00932373|448296453|FG005|Overall Study|Clinical progression|0|||
124638954|NCT00932373|448296454|FG006|Overall Study|Clinical progression|1|||
124638955|NCT00932373|448296455|FG007|Overall Study|Clinical progression|0|||
124638956|NCT00932373|448296456|FG008|Overall Study|Clinical progression|0|||
124638957|NCT00932373|448296457|FG009|Overall Study|Clinical progression|0|||
124638958|NCT00932373|448296458|FG010|Overall Study|Clinical progression|0|||
124638959|NCT00932373|448296448|FG000|Overall Study|Lack of Efficacy|0|||
124638960|NCT00932373|448296449|FG001|Overall Study|Lack of Efficacy|0|||
124638961|NCT00932373|448296450|FG002|Overall Study|Lack of Efficacy|0|||
124638962|NCT00932373|448296451|FG003|Overall Study|Lack of Efficacy|0|||
124638963|NCT00932373|448296452|FG004|Overall Study|Lack of Efficacy|0|||
124638964|NCT00932373|448296453|FG005|Overall Study|Lack of Efficacy|0|||
124638965|NCT00932373|448296454|FG006|Overall Study|Lack of Efficacy|0|||
124638966|NCT00932373|448296455|FG007|Overall Study|Lack of Efficacy|0|||
124638967|NCT00932373|448296456|FG008|Overall Study|Lack of Efficacy|0|||
124638968|NCT00932373|448296457|FG009|Overall Study|Lack of Efficacy|1|||
124638969|NCT00932373|448296458|FG010|Overall Study|Lack of Efficacy|0|||
124638970|NCT01637922|448296459|FG000|Overall Study|Adverse Event|0|||
124638971|NCT01637922|448296460|FG001|Overall Study|Adverse Event|1|||
124638972|NCT01637922|448296459|FG000|Overall Study|Protocol Violation|0|||
124638973|NCT01637922|448296460|FG001|Overall Study|Protocol Violation|1|||
124638974|NCT01637922|448296459|FG000|Overall Study|Withdrawal by Subject|0|||
124638975|NCT01637922|448296460|FG001|Overall Study|Withdrawal by Subject|3|||
124638976|NCT01637922|448296459|FG000|Overall Study|Lost to Follow-up|2|||
124638977|NCT01637922|448296460|FG001|Overall Study|Lost to Follow-up|0|||
124638978|NCT00638404|448296461|FG000|Overall Study|Physician Decision|8|||
124638979|NCT00638404|448296462|FG001|Overall Study|Physician Decision|0|||
124638980|NCT02492984|448296463|FG000|Overall Study|Adverse Event|1|||
124638981|NCT02492984|448296464|FG001|Overall Study|Adverse Event|0|||
124638982|NCT02492984|448296463|FG000|Overall Study|Protocol Violation|1|||
124638983|NCT02492984|448296464|FG001|Overall Study|Protocol Violation|0|||
124638984|NCT02492984|448296463|FG000|Overall Study|Withdrawal by Subject|1|||
124638985|NCT02492984|448296464|FG001|Overall Study|Withdrawal by Subject|0|||
124638986|NCT04090060|448296470|FG000|Overall Study|Lost to Follow-up|76|||
124638987|NCT04090060|448296471|FG001|Overall Study|Lost to Follow-up|77|||
124638988|NCT01164579|448296478|FG000|Overall Study|Lack of Efficacy|0|||
124638989|NCT01164579|448296479|FG001|Overall Study|Lack of Efficacy|0|||
124638990|NCT01164579|448296480|FG002|Overall Study|Lack of Efficacy|6|||
124638991|NCT01164579|448296478|FG000|Overall Study|Lost to Follow-up|1|||
124638992|NCT01164579|448296479|FG001|Overall Study|Lost to Follow-up|1|||
124638993|NCT01164579|448296480|FG002|Overall Study|Lost to Follow-up|0|||
124638994|NCT01164579|448296478|FG000|Overall Study|Withdrawal by Subject|2|||
124638995|NCT01164579|448296479|FG001|Overall Study|Withdrawal by Subject|5|||
124638996|NCT01164579|448296480|FG002|Overall Study|Withdrawal by Subject|3|||
124638997|NCT01164579|448296478|FG000|Overall Study|Protocol Violation|0|||
124638998|NCT01164579|448296479|FG001|Overall Study|Protocol Violation|1|||
124638999|NCT01164579|448296480|FG002|Overall Study|Protocol Violation|2|||
124639000|NCT01164579|448296478|FG000|Overall Study|Adverse Event|4|||
124639001|NCT01164579|448296479|FG001|Overall Study|Adverse Event|2|||
124639002|NCT01164579|448296480|FG002|Overall Study|Adverse Event|5|||
124639003|NCT01164579|448296478|FG000|Overall Study|Reason not specified|1|||
124639004|NCT01164579|448296479|FG001|Overall Study|Reason not specified|0|||
124639005|NCT01164579|448296480|FG002|Overall Study|Reason not specified|0|||
124830797|NCT01729754|449012105|FG000|Part 1|Physician Decision|0|||
124639006|NCT01464593|448296488|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
124639007|NCT00302328|448296489|FG000|Overall Study|Physician Decision|0|||
124639008|NCT00302328|448296490|FG001|Overall Study|Physician Decision|1|||
124639009|NCT00302328|448296491|FG002|Overall Study|Physician Decision|0|||
124830798|NCT01729754|449012106|FG001|Part 1|Physician Decision|0|||
124830799|NCT01729754|449012107|FG002|Part 1|Physician Decision|0|||
124830800|NCT01729754|449012108|FG003|Part 1|Physician Decision|0|||
124830801|NCT01729754|449012109|FG004|Part 1|Physician Decision|0|||
124830802|NCT01729754|449012110|FG005|Part 1|Physician Decision|0|||
124830803|NCT01729754|449012111|FG006|Part 1|Physician Decision|0|||
124830804|NCT01729754|449012112|FG007|Part 1|Physician Decision|0|||
124830805|NCT01729754|449012113|FG008|Part 1|Physician Decision|0|||
124830806|NCT01729754|449012114|FG009|Part 1|Physician Decision|4|||
124830807|NCT01729754|449012105|FG000|Part 1|Pregnancy|0|||
124830808|NCT01729754|449012106|FG001|Part 1|Pregnancy|0|||
124830809|NCT01729754|449012107|FG002|Part 1|Pregnancy|0|||
124830810|NCT01729754|449012108|FG003|Part 1|Pregnancy|1|||
124830811|NCT01729754|449012109|FG004|Part 1|Pregnancy|0|||
124830812|NCT01729754|449012110|FG005|Part 1|Pregnancy|0|||
124830813|NCT01729754|449012111|FG006|Part 1|Pregnancy|0|||
124830814|NCT01729754|449012112|FG007|Part 1|Pregnancy|0|||
124830815|NCT01729754|449012113|FG008|Part 1|Pregnancy|0|||
124830816|NCT01729754|449012114|FG009|Part 1|Pregnancy|1|||
124830817|NCT01729754|449012105|FG000|Part 1|Progressive Disease|0|||
124830818|NCT01729754|449012106|FG001|Part 1|Progressive Disease|0|||
124830819|NCT01729754|449012107|FG002|Part 1|Progressive Disease|0|||
124830820|NCT01729754|449012108|FG003|Part 1|Progressive Disease|0|||
124830821|NCT01729754|449012109|FG004|Part 1|Progressive Disease|0|||
124830822|NCT01729754|449012110|FG005|Part 1|Progressive Disease|0|||
124830823|NCT01729754|449012111|FG006|Part 1|Progressive Disease|0|||
124830824|NCT01729754|449012112|FG007|Part 1|Progressive Disease|0|||
124830825|NCT01729754|449012113|FG008|Part 1|Progressive Disease|0|||
124830826|NCT01729754|449012114|FG009|Part 1|Progressive Disease|1|||
124830827|NCT01729754|449012105|FG000|Part 1|Protocol Violation|2|||
124830828|NCT01729754|449012106|FG001|Part 1|Protocol Violation|0|||
124830829|NCT01729754|449012107|FG002|Part 1|Protocol Violation|0|||
124830830|NCT01729754|449012108|FG003|Part 1|Protocol Violation|1|||
124830831|NCT01729754|449012109|FG004|Part 1|Protocol Violation|0|||
124830832|NCT01729754|449012110|FG005|Part 1|Protocol Violation|0|||
124830833|NCT01729754|449012111|FG006|Part 1|Protocol Violation|1|||
124830834|NCT01729754|449012112|FG007|Part 1|Protocol Violation|0|||
124830835|NCT01729754|449012113|FG008|Part 1|Protocol Violation|0|||
124830836|NCT01729754|449012114|FG009|Part 1|Protocol Violation|0|||
124830837|NCT01729754|449012105|FG000|Part 1|Withdrawal by Subject|5|||
124830838|NCT01729754|449012106|FG001|Part 1|Withdrawal by Subject|0|||
124830839|NCT01729754|449012107|FG002|Part 1|Withdrawal by Subject|0|||
124830840|NCT01729754|449012108|FG003|Part 1|Withdrawal by Subject|7|||
124830841|NCT01729754|449012109|FG004|Part 1|Withdrawal by Subject|0|||
124830842|NCT01729754|449012110|FG005|Part 1|Withdrawal by Subject|0|||
124830843|NCT01729754|449012111|FG006|Part 1|Withdrawal by Subject|5|||
124830844|NCT01729754|449012112|FG007|Part 1|Withdrawal by Subject|0|||
124830845|NCT01729754|449012113|FG008|Part 1|Withdrawal by Subject|0|||
124830846|NCT01729754|449012114|FG009|Part 1|Withdrawal by Subject|6|||
124830847|NCT01729754|449012105|FG000|Part 1|Other Protocol Specified Criteria|2|||
124830848|NCT01729754|449012106|FG001|Part 1|Other Protocol Specified Criteria|0|||
124830849|NCT01729754|449012107|FG002|Part 1|Other Protocol Specified Criteria|0|||
124830850|NCT01729754|449012108|FG003|Part 1|Other Protocol Specified Criteria|0|||
124830851|NCT01729754|449012109|FG004|Part 1|Other Protocol Specified Criteria|0|||
124830852|NCT01729754|449012110|FG005|Part 1|Other Protocol Specified Criteria|0|||
124830853|NCT01729754|449012111|FG006|Part 1|Other Protocol Specified Criteria|1|||
124830854|NCT01729754|449012112|FG007|Part 1|Other Protocol Specified Criteria|0|||
124830855|NCT01729754|449012113|FG008|Part 1|Other Protocol Specified Criteria|0|||
124830856|NCT01729754|449012114|FG009|Part 1|Other Protocol Specified Criteria|4|||
124830857|NCT01729754|449012105|FG000|Part 2|Adverse Event|2|||
124830858|NCT01729754|449012106|FG001|Part 2|Adverse Event|0|||
124830859|NCT01729754|449012107|FG002|Part 2|Adverse Event|0|||
124830860|NCT01729754|449012108|FG003|Part 2|Adverse Event|0|||
124830861|NCT01729754|449012109|FG004|Part 2|Adverse Event|0|||
124830862|NCT01729754|449012110|FG005|Part 2|Adverse Event|0|||
124830863|NCT01729754|449012111|FG006|Part 2|Adverse Event|0|||
124639010|NCT01288937|448296494|FG000|Overall Study|Adverse Event|1|||
124639011|NCT01288937|448296495|FG001|Overall Study|Adverse Event|0|||
124639012|NCT02490371|448296496|FG000|Overall Study|Lost to Follow-up|1|||
124830864|NCT01729754|449012112|FG007|Part 2|Adverse Event|0|||
124830865|NCT01729754|449012113|FG008|Part 2|Adverse Event|1|||
124830866|NCT01729754|449012114|FG009|Part 2|Adverse Event|2|||
124830867|NCT01729754|449012105|FG000|Part 2|Lack of Efficacy|0|||
124830868|NCT01729754|449012106|FG001|Part 2|Lack of Efficacy|0|||
124830869|NCT01729754|449012107|FG002|Part 2|Lack of Efficacy|0|||
124830870|NCT01729754|449012108|FG003|Part 2|Lack of Efficacy|0|||
124830871|NCT01729754|449012109|FG004|Part 2|Lack of Efficacy|0|||
124830872|NCT01729754|449012110|FG005|Part 2|Lack of Efficacy|0|||
124830873|NCT01729754|449012111|FG006|Part 2|Lack of Efficacy|0|||
124830874|NCT01729754|449012112|FG007|Part 2|Lack of Efficacy|0|||
124830875|NCT01729754|449012113|FG008|Part 2|Lack of Efficacy|2|||
124830876|NCT01729754|449012114|FG009|Part 2|Lack of Efficacy|2|||
124830877|NCT01729754|449012105|FG000|Part 2|Lost to Follow-up|0|||
124830878|NCT01729754|449012106|FG001|Part 2|Lost to Follow-up|0|||
124830879|NCT01729754|449012107|FG002|Part 2|Lost to Follow-up|0|||
124830880|NCT01729754|449012108|FG003|Part 2|Lost to Follow-up|2|||
124830881|NCT01729754|449012109|FG004|Part 2|Lost to Follow-up|0|||
124830882|NCT01729754|449012110|FG005|Part 2|Lost to Follow-up|0|||
124830883|NCT01729754|449012111|FG006|Part 2|Lost to Follow-up|0|||
124830884|NCT01729754|449012112|FG007|Part 2|Lost to Follow-up|1|||
124830885|NCT01729754|449012113|FG008|Part 2|Lost to Follow-up|0|||
124830886|NCT01729754|449012114|FG009|Part 2|Lost to Follow-up|2|||
124830887|NCT01729754|449012105|FG000|Part 2|Non-Compliance with Study Drug|0|||
124830888|NCT01729754|449012106|FG001|Part 2|Non-Compliance with Study Drug|0|||
124830889|NCT01729754|449012107|FG002|Part 2|Non-Compliance with Study Drug|0|||
124830890|NCT01729754|449012108|FG003|Part 2|Non-Compliance with Study Drug|0|||
124830891|NCT01729754|449012109|FG004|Part 2|Non-Compliance with Study Drug|0|||
124830892|NCT01729754|449012110|FG005|Part 2|Non-Compliance with Study Drug|0|||
124830893|NCT01729754|449012111|FG006|Part 2|Non-Compliance with Study Drug|0|||
124830894|NCT01729754|449012112|FG007|Part 2|Non-Compliance with Study Drug|0|||
124830895|NCT01729754|449012113|FG008|Part 2|Non-Compliance with Study Drug|0|||
124830896|NCT01729754|449012114|FG009|Part 2|Non-Compliance with Study Drug|1|||
124830897|NCT01729754|449012105|FG000|Part 2|Pregnancy|0|||
124830898|NCT01729754|449012106|FG001|Part 2|Pregnancy|0|||
124830899|NCT01729754|449012107|FG002|Part 2|Pregnancy|0|||
124830900|NCT01729754|449012108|FG003|Part 2|Pregnancy|1|||
124830901|NCT01729754|449012109|FG004|Part 2|Pregnancy|0|||
124830902|NCT01729754|449012110|FG005|Part 2|Pregnancy|0|||
124830903|NCT01729754|449012111|FG006|Part 2|Pregnancy|0|||
124830904|NCT01729754|449012112|FG007|Part 2|Pregnancy|0|||
124830905|NCT01729754|449012113|FG008|Part 2|Pregnancy|0|||
124830906|NCT01729754|449012114|FG009|Part 2|Pregnancy|1|||
124830907|NCT01729754|449012105|FG000|Part 2|Withdrawal by Subject|3|||
124830908|NCT01729754|449012106|FG001|Part 2|Withdrawal by Subject|0|||
124830909|NCT01729754|449012107|FG002|Part 2|Withdrawal by Subject|0|||
124830910|NCT01729754|449012108|FG003|Part 2|Withdrawal by Subject|2|||
124830911|NCT01729754|449012109|FG004|Part 2|Withdrawal by Subject|0|||
124830912|NCT01729754|449012110|FG005|Part 2|Withdrawal by Subject|0|||
124830913|NCT01729754|449012111|FG006|Part 2|Withdrawal by Subject|0|||
124830914|NCT01729754|449012112|FG007|Part 2|Withdrawal by Subject|1|||
124830915|NCT01729754|449012113|FG008|Part 2|Withdrawal by Subject|1|||
124830916|NCT01729754|449012114|FG009|Part 2|Withdrawal by Subject|4|||
124830917|NCT01729754|449012105|FG000|Part 2|Other Protocol Specified Criteria|1|||
124830918|NCT01729754|449012106|FG001|Part 2|Other Protocol Specified Criteria|0|||
124830919|NCT01729754|449012107|FG002|Part 2|Other Protocol Specified Criteria|0|||
124830920|NCT01729754|449012108|FG003|Part 2|Other Protocol Specified Criteria|0|||
124830921|NCT01729754|449012109|FG004|Part 2|Other Protocol Specified Criteria|0|||
124830922|NCT01729754|449012110|FG005|Part 2|Other Protocol Specified Criteria|0|||
124830923|NCT01729754|449012111|FG006|Part 2|Other Protocol Specified Criteria|0|||
124830924|NCT01729754|449012112|FG007|Part 2|Other Protocol Specified Criteria|1|||
124830925|NCT01729754|449012113|FG008|Part 2|Other Protocol Specified Criteria|0|||
124830926|NCT01729754|449012114|FG009|Part 2|Other Protocol Specified Criteria|0|||
124830927|NCT01729754|449012105|FG000|Part 3|Adverse Event|0|||
124830928|NCT01729754|449012106|FG001|Part 3|Adverse Event|0|||
124830929|NCT01729754|449012107|FG002|Part 3|Adverse Event|1|||
124830930|NCT01729754|449012108|FG003|Part 3|Adverse Event|0|||
124830931|NCT01729754|449012109|FG004|Part 3|Adverse Event|0|||
124830932|NCT01729754|449012110|FG005|Part 3|Adverse Event|5|||
124830933|NCT01729754|449012111|FG006|Part 3|Adverse Event|0|||
124830934|NCT01729754|449012112|FG007|Part 3|Adverse Event|0|||
124830935|NCT01729754|449012113|FG008|Part 3|Adverse Event|0|||
124830936|NCT01729754|449012114|FG009|Part 3|Adverse Event|3|||
124830937|NCT01729754|449012105|FG000|Part 3|Death|0|||
124830938|NCT01729754|449012106|FG001|Part 3|Death|0|||
124830939|NCT01729754|449012107|FG002|Part 3|Death|0|||
124830940|NCT01729754|449012108|FG003|Part 3|Death|0|||
124830941|NCT01729754|449012109|FG004|Part 3|Death|0|||
124830942|NCT01729754|449012110|FG005|Part 3|Death|2|||
124830943|NCT01729754|449012111|FG006|Part 3|Death|0|||
124830944|NCT01729754|449012112|FG007|Part 3|Death|0|||
124830945|NCT01729754|449012113|FG008|Part 3|Death|0|||
124830946|NCT01729754|449012114|FG009|Part 3|Death|0|||
124830947|NCT01729754|449012105|FG000|Part 3|Lack of Efficacy|0|||
124830948|NCT01729754|449012106|FG001|Part 3|Lack of Efficacy|0|||
124830949|NCT01729754|449012107|FG002|Part 3|Lack of Efficacy|0|||
124830950|NCT01729754|449012108|FG003|Part 3|Lack of Efficacy|0|||
124830951|NCT01729754|449012109|FG004|Part 3|Lack of Efficacy|2|||
124830952|NCT01729754|449012110|FG005|Part 3|Lack of Efficacy|0|||
124830953|NCT01729754|449012111|FG006|Part 3|Lack of Efficacy|0|||
124830954|NCT01729754|449012112|FG007|Part 3|Lack of Efficacy|0|||
124830955|NCT01729754|449012113|FG008|Part 3|Lack of Efficacy|0|||
124830956|NCT01729754|449012114|FG009|Part 3|Lack of Efficacy|4|||
124830957|NCT01729754|449012105|FG000|Part 3|Lost to Follow-up|0|||
124830958|NCT01729754|449012106|FG001|Part 3|Lost to Follow-up|1|||
124830959|NCT01729754|449012107|FG002|Part 3|Lost to Follow-up|2|||
124830960|NCT01729754|449012108|FG003|Part 3|Lost to Follow-up|0|||
124830961|NCT01729754|449012109|FG004|Part 3|Lost to Follow-up|0|||
124830962|NCT01729754|449012110|FG005|Part 3|Lost to Follow-up|3|||
124830963|NCT01729754|449012111|FG006|Part 3|Lost to Follow-up|0|||
124830964|NCT01729754|449012112|FG007|Part 3|Lost to Follow-up|0|||
124830965|NCT01729754|449012113|FG008|Part 3|Lost to Follow-up|1|||
124830966|NCT01729754|449012114|FG009|Part 3|Lost to Follow-up|0|||
124830967|NCT01729754|449012105|FG000|Part 3|Physician Decision|0|||
124830968|NCT01729754|449012106|FG001|Part 3|Physician Decision|0|||
124830969|NCT01729754|449012107|FG002|Part 3|Physician Decision|1|||
124830970|NCT01729754|449012108|FG003|Part 3|Physician Decision|0|||
124830971|NCT01729754|449012109|FG004|Part 3|Physician Decision|0|||
124830972|NCT01729754|449012110|FG005|Part 3|Physician Decision|0|||
124830973|NCT01729754|449012111|FG006|Part 3|Physician Decision|0|||
124830974|NCT01729754|449012112|FG007|Part 3|Physician Decision|0|||
124830975|NCT01729754|449012113|FG008|Part 3|Physician Decision|0|||
124830976|NCT01729754|449012114|FG009|Part 3|Physician Decision|0|||
124830977|NCT01729754|449012105|FG000|Part 3|Withdrawal by Subject|0|||
124830978|NCT01729754|449012106|FG001|Part 3|Withdrawal by Subject|4|||
124830979|NCT01729754|449012107|FG002|Part 3|Withdrawal by Subject|1|||
124830980|NCT01729754|449012108|FG003|Part 3|Withdrawal by Subject|0|||
124830981|NCT01729754|449012109|FG004|Part 3|Withdrawal by Subject|2|||
124830982|NCT01729754|449012110|FG005|Part 3|Withdrawal by Subject|1|||
124830983|NCT01729754|449012111|FG006|Part 3|Withdrawal by Subject|0|||
124830984|NCT01729754|449012112|FG007|Part 3|Withdrawal by Subject|2|||
124830985|NCT01729754|449012113|FG008|Part 3|Withdrawal by Subject|0|||
124830986|NCT01729754|449012114|FG009|Part 3|Withdrawal by Subject|0|||
124830987|NCT01729754|449012105|FG000|Part 3|Other Protocol Specified Criteria|0|||
124830988|NCT01729754|449012106|FG001|Part 3|Other Protocol Specified Criteria|0|||
124830989|NCT01729754|449012107|FG002|Part 3|Other Protocol Specified Criteria|0|||
124830990|NCT01729754|449012108|FG003|Part 3|Other Protocol Specified Criteria|0|||
124830991|NCT01729754|449012109|FG004|Part 3|Other Protocol Specified Criteria|0|||
124830992|NCT01729754|449012110|FG005|Part 3|Other Protocol Specified Criteria|2|||
124830993|NCT01729754|449012111|FG006|Part 3|Other Protocol Specified Criteria|0|||
124830994|NCT01729754|449012112|FG007|Part 3|Other Protocol Specified Criteria|1|||
124830995|NCT01729754|449012113|FG008|Part 3|Other Protocol Specified Criteria|0|||
124830996|NCT01729754|449012114|FG009|Part 3|Other Protocol Specified Criteria|0|||
124830997|NCT00773292|449012115|FG000|Treatment 48 Weeks|Adverse Event|1|||
124830998|NCT00773292|449012115|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
124830999|NCT00192504|449012120|FG000|Overall Study|Lost to Follow-up|1|||
124831000|NCT00192504|449012121|FG001|Overall Study|Lost to Follow-up|0|||
124831001|NCT00192504|449012122|FG002|Overall Study|Lost to Follow-up|0|||
124831002|NCT00192504|449012123|FG003|Overall Study|Lost to Follow-up|0|||
124831003|NCT00192504|449012120|FG000|Overall Study|Dosing window missed|0|||
124831004|NCT00192504|449012121|FG001|Overall Study|Dosing window missed|0|||
124831005|NCT00192504|449012122|FG002|Overall Study|Dosing window missed|1|||
124831006|NCT00192504|449012123|FG003|Overall Study|Dosing window missed|0|||
124831007|NCT01139450|449012124|FG000|Overall Study|Withdrawal by Subject|7|||
124831008|NCT01139450|449012125|FG001|Overall Study|Withdrawal by Subject|10|||
124831009|NCT01139450|449012126|FG002|Overall Study|Withdrawal by Subject|13|||
124831010|NCT01139450|449012124|FG000|Overall Study|Lack of Efficacy|3|||
124831011|NCT01139450|449012125|FG001|Overall Study|Lack of Efficacy|1|||
124831012|NCT01139450|449012126|FG002|Overall Study|Lack of Efficacy|8|||
124831013|NCT01139450|449012124|FG000|Overall Study|Protocol Violation|6|||
124831014|NCT01139450|449012125|FG001|Overall Study|Protocol Violation|5|||
124831015|NCT01139450|449012126|FG002|Overall Study|Protocol Violation|2|||
124831016|NCT01139450|449012124|FG000|Overall Study|Lost to Follow-up|9|||
124831017|NCT01139450|449012125|FG001|Overall Study|Lost to Follow-up|7|||
124831018|NCT01139450|449012126|FG002|Overall Study|Lost to Follow-up|11|||
124831019|NCT01139450|449012124|FG000|Overall Study|Administrative|0|||
124831020|NCT01139450|449012125|FG001|Overall Study|Administrative|0|||
124831021|NCT01139450|449012126|FG002|Overall Study|Administrative|1|||
124831022|NCT01139450|449012124|FG000|Overall Study|Adverse Event|2|||
124831023|NCT01139450|449012125|FG001|Overall Study|Adverse Event|2|||
124831024|NCT01139450|449012126|FG002|Overall Study|Adverse Event|3|||
124831025|NCT04608500|449012127|FG000|Overall Study|Adverse Event|2|||
124831026|NCT04608500|449012128|FG001|Overall Study|Adverse Event|0|||
124639013|NCT02490371|448296497|FG001|Overall Study|Lost to Follow-up|1|||
124639014|NCT03491462|448296500|FG000|Overall Study|Lost to Follow-up|2|||
124639015|NCT03491462|448296501|FG001|Overall Study|Lost to Follow-up|0|||
124831027|NCT04608500|449012127|FG000|Overall Study|Lost to Follow-up|15|||
124831028|NCT04608500|449012128|FG001|Overall Study|Lost to Follow-up|9|||
124831029|NCT04608500|449012127|FG000|Overall Study|Participant request|11|||
124831030|NCT04608500|449012128|FG001|Overall Study|Participant request|7|||
124831031|NCT04608500|449012127|FG000|Overall Study|Protocol Violation|1|||
124639016|NCT03491462|448296500|FG000|Overall Study|Adverse Event|11|||
124831032|NCT04608500|449012128|FG001|Overall Study|Protocol Violation|0|||
124831033|NCT04608500|449012127|FG000|Overall Study|Other|6|||
124831034|NCT04608500|449012128|FG001|Overall Study|Other|2|||
124831035|NCT00542919|449012140|FG000|Overall Study|Adverse Event|1|||
124831036|NCT00542919|449012141|FG001|Overall Study|Adverse Event|5|||
124639017|NCT03491462|448296501|FG001|Overall Study|Adverse Event|1|||
124831037|NCT00542919|449012142|FG002|Overall Study|Adverse Event|1|||
124831038|NCT00542919|449012140|FG000|Overall Study|Withdrawal by Subject|1|||
124831039|NCT00542919|449012141|FG001|Overall Study|Withdrawal by Subject|0|||
124831040|NCT00542919|449012142|FG002|Overall Study|Withdrawal by Subject|3|||
124831041|NCT00542919|449012140|FG000|Overall Study|Physician Decision|2|||
124831042|NCT00542919|449012141|FG001|Overall Study|Physician Decision|2|||
124831043|NCT00542919|449012142|FG002|Overall Study|Physician Decision|1|||
124831044|NCT00542919|449012140|FG000|Overall Study|Sponsor Decision|1|||
124831045|NCT00542919|449012141|FG001|Overall Study|Sponsor Decision|0|||
124831046|NCT00542919|449012142|FG002|Overall Study|Sponsor Decision|0|||
124831047|NCT00542919|449012140|FG000|Overall Study|Lost to Follow-up|2|||
124831048|NCT00542919|449012141|FG001|Overall Study|Lost to Follow-up|0|||
124831049|NCT00542919|449012142|FG002|Overall Study|Lost to Follow-up|1|||
124831050|NCT01881230|449012143|FG000|Overall Study|Death|2|||
124831051|NCT01881230|449012144|FG001|Overall Study|Death|0|||
124831052|NCT01881230|449012145|FG002|Overall Study|Death|1|||
124831053|NCT01881230|449012143|FG000|Overall Study|Adverse Event|9|||
124831054|NCT01881230|449012144|FG001|Overall Study|Adverse Event|13|||
124831055|NCT01881230|449012145|FG002|Overall Study|Adverse Event|12|||
124831056|NCT01881230|449012143|FG000|Overall Study|Progressive Disease|31|||
124831057|NCT01881230|449012144|FG001|Overall Study|Progressive Disease|35|||
124831058|NCT01881230|449012145|FG002|Overall Study|Progressive Disease|36|||
124831059|NCT01881230|449012143|FG000|Overall Study|Symptomatic Deterioration|3|||
124831060|NCT01881230|449012144|FG001|Overall Study|Symptomatic Deterioration|3|||
124831061|NCT01881230|449012145|FG002|Overall Study|Symptomatic Deterioration|1|||
124831062|NCT01881230|449012143|FG000|Overall Study|Withdrawal by Subject|6|||
124831063|NCT01881230|449012144|FG001|Overall Study|Withdrawal by Subject|4|||
124831064|NCT01881230|449012145|FG002|Overall Study|Withdrawal by Subject|6|||
124831065|NCT01881230|449012143|FG000|Overall Study|Physician Decision|4|||
124831066|NCT01881230|449012144|FG001|Overall Study|Physician Decision|3|||
124831067|NCT01881230|449012145|FG002|Overall Study|Physician Decision|6|||
124831068|NCT01881230|449012143|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124831069|NCT01881230|449012144|FG001|Overall Study|Non-Compliance with Study Drug|2|||
124831070|NCT01881230|449012145|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124831071|NCT01881230|449012143|FG000|Overall Study|Given Commercially Available Drug|0|||
124831072|NCT01881230|449012144|FG001|Overall Study|Given Commercially Available Drug|0|||
124831073|NCT01881230|449012145|FG002|Overall Study|Given Commercially Available Drug|2|||
124831074|NCT01881230|449012143|FG000|Overall Study|Protocol Violation|1|||
124831075|NCT01881230|449012144|FG001|Overall Study|Protocol Violation|1|||
124831076|NCT01881230|449012145|FG002|Overall Study|Protocol Violation|0|||
124831077|NCT01881230|449012143|FG000|Overall Study|Miscellaneous|3|||
124831078|NCT01881230|449012144|FG001|Overall Study|Miscellaneous|3|||
124831079|NCT01881230|449012145|FG002|Overall Study|Miscellaneous|0|||
124831080|NCT01881230|449012143|FG000|Overall Study|Untreated: Other|0|||
124831081|NCT01881230|449012144|FG001|Overall Study|Untreated: Other|0|||
124831082|NCT01881230|449012145|FG002|Overall Study|Untreated: Other|1|||
124831083|NCT01881230|449012143|FG000|Overall Study|Untreated: Death|0|||
124831084|NCT01881230|449012144|FG001|Overall Study|Untreated: Death|0|||
124831085|NCT01881230|449012145|FG002|Overall Study|Untreated: Death|1|||
124831086|NCT01881230|449012143|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
124831087|NCT01881230|449012144|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
124831088|NCT01881230|449012145|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
124831089|NCT00112502|449012146|FG000|Overall Study|Withdrawal by Subject|0|||
124831090|NCT00112502|449012147|FG001|Overall Study|Withdrawal by Subject|1|||
124831091|NCT00112502|449012148|FG002|Overall Study|Withdrawal by Subject|1|||
124831092|NCT00112502|449012149|FG003|Overall Study|Withdrawal by Subject|4|||
124831093|NCT00112502|449012150|FG004|Overall Study|Withdrawal by Subject|2|||
124831094|NCT00112502|449012151|FG005|Overall Study|Withdrawal by Subject|5|||
124831095|NCT00112502|449012152|FG006|Overall Study|Withdrawal by Subject|3|||
124831096|NCT00112502|449012153|FG007|Overall Study|Withdrawal by Subject|7|||
124831097|NCT02385266|449012154|FG000|Overall Study|Withdrawal by Subject|1|||
124831098|NCT02385266|449012155|FG001|Overall Study|Withdrawal by Subject|3|||
124831099|NCT02747420|449012156|FG000|Overall Study|Lost to Follow-up|4|||
124831100|NCT02747420|449012157|FG001|Overall Study|Lost to Follow-up|2|||
124831101|NCT02747420|449012156|FG000|Overall Study|Withdrawal by Subject|3|||
124831102|NCT02747420|449012157|FG001|Overall Study|Withdrawal by Subject|2|||
124831103|NCT03662542|449012158|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
124831104|NCT03662542|449012159|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
124831105|NCT03662542|449012160|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
124831106|NCT03662542|449012161|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
124831107|NCT03662542|449012162|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
124831108|NCT03662542|449012163|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
124831109|NCT03662542|449012164|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
124831110|NCT03662542|449012165|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
124831111|NCT03662542|449012166|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
124831112|NCT03662542|449012158|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
124831113|NCT03662542|449012159|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
124831114|NCT03662542|449012160|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
124831115|NCT03662542|449012161|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
124831116|NCT03662542|449012162|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
124831117|NCT03662542|449012163|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
124831118|NCT03662542|449012164|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
124831119|NCT03662542|449012165|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
124831120|NCT03662542|449012166|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
124831121|NCT03662542|449012158|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
124831122|NCT03662542|449012159|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
124831123|NCT03662542|449012160|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
124831124|NCT03662542|449012161|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
124831125|NCT03662542|449012162|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
124831126|NCT03662542|449012163|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
124831127|NCT03662542|449012164|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
124831128|NCT03662542|449012165|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
124831129|NCT03662542|449012166|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
124831130|NCT03662542|449012158|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
124831131|NCT03662542|449012159|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
124831132|NCT03662542|449012160|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
124831133|NCT03662542|449012161|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
124831134|NCT03662542|449012162|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
124831135|NCT03662542|449012163|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
124831136|NCT03662542|449012164|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
124831137|NCT03662542|449012165|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
124831138|NCT03662542|449012166|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
124831139|NCT03662542|449012158|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
124831140|NCT03662542|449012159|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
124831141|NCT03662542|449012160|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
124831142|NCT03662542|449012161|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
124831143|NCT03662542|449012162|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
124831144|NCT03662542|449012163|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
124831145|NCT03662542|449012164|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
124831146|NCT03662542|449012165|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
124831147|NCT03662542|449012166|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
124831148|NCT03662542|449012158|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
124831149|NCT03662542|449012159|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
124831150|NCT03662542|449012160|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
124831151|NCT03662542|449012161|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
124831152|NCT03662542|449012162|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
124831153|NCT03662542|449012163|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
124831154|NCT03662542|449012164|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
124831155|NCT03662542|449012165|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
124831156|NCT03662542|449012166|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
124831157|NCT03662542|449012158|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
124831158|NCT03662542|449012159|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
124831159|NCT03662542|449012160|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
124831160|NCT03662542|449012161|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
124831161|NCT03662542|449012162|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
124831162|NCT03662542|449012163|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
124831163|NCT03662542|449012164|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
124831164|NCT03662542|449012165|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
124831165|NCT03662542|449012166|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
124831166|NCT03662542|449012158|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
124831167|NCT03662542|449012159|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
124831168|NCT03662542|449012160|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
124831169|NCT03662542|449012161|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
124831170|NCT03662542|449012162|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
124831171|NCT03662542|449012163|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
124831172|NCT03662542|449012164|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
124831173|NCT03662542|449012165|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
124831174|NCT03662542|449012166|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
124831175|NCT03662542|449012158|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
124831176|NCT03662542|449012159|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
124831177|NCT03662542|449012160|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
124831178|NCT03662542|449012161|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
124831179|NCT03662542|449012162|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
124831180|NCT03662542|449012163|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
124831181|NCT03662542|449012164|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
124831182|NCT03662542|449012165|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
124831183|NCT03662542|449012166|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
124831184|NCT03662542|449012158|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
124831185|NCT03662542|449012159|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
124831186|NCT03662542|449012160|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
124831187|NCT03662542|449012161|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
124831188|NCT03662542|449012162|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
124831189|NCT03662542|449012163|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
124831190|NCT03662542|449012164|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
124831191|NCT03662542|449012165|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
124831192|NCT03662542|449012166|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
124831193|NCT03662542|449012158|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
124831194|NCT03662542|449012159|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
124831195|NCT03662542|449012160|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
124831196|NCT03662542|449012161|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
124831197|NCT03662542|449012162|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
124831198|NCT03662542|449012163|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
124831199|NCT03662542|449012164|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
124831200|NCT03662542|449012165|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
124831201|NCT03662542|449012166|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
124831202|NCT03662542|449012158|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
124831203|NCT03662542|449012159|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
124831204|NCT03662542|449012160|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
124831205|NCT03662542|449012161|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
124831206|NCT03662542|449012162|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
124831207|NCT03662542|449012163|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
124831208|NCT03662542|449012164|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
124831209|NCT03662542|449012165|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
124831210|NCT03662542|449012166|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
124831211|NCT03662542|449012158|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
124831212|NCT03662542|449012159|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
124831213|NCT03662542|449012160|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
124831214|NCT03662542|449012161|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
124831215|NCT03662542|449012162|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
124831216|NCT03662542|449012163|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
124831217|NCT03662542|449012164|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
124831218|NCT03662542|449012165|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
124831219|NCT03662542|449012166|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
124831220|NCT01217060|449012167|FG000|Overall Study|Withdrawal by Subject|1|||
124831221|NCT03739112|449012168|FG000|Overall Study|Adverse Event|2|||
124831222|NCT03739112|449012169|FG001|Overall Study|Adverse Event|2|||
124831223|NCT03739112|449012168|FG000|Overall Study|Withdrawal by Subject|38|||
124831224|NCT03739112|449012169|FG001|Overall Study|Withdrawal by Subject|19|||
124831225|NCT03739112|449012168|FG000|Overall Study|Lost to Follow-up|31|||
124831226|NCT03739112|449012169|FG001|Overall Study|Lost to Follow-up|33|||
124831227|NCT03739112|449012168|FG000|Overall Study|Protocol Deviation|12|||
124831228|NCT03739112|449012169|FG001|Overall Study|Protocol Deviation|9|||
124831229|NCT03739112|449012168|FG000|Overall Study|Physician Decision|1|||
124831230|NCT03739112|449012169|FG001|Overall Study|Physician Decision|0|||
124831231|NCT03739112|449012168|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
124831232|NCT03739112|449012169|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
124831233|NCT03739112|449012168|FG000|Overall Study|Site went on hold|65|||
124831234|NCT03739112|449012169|FG001|Overall Study|Site went on hold|67|||
124831235|NCT03739112|449012168|FG000|Overall Study|Other than specified|8|||
124831236|NCT03739112|449012169|FG001|Overall Study|Other than specified|5|||
124831237|NCT03739112|449012168|FG000|Overall Study|Randomized but not vaccinated|31|||
124831238|NCT03739112|449012169|FG001|Overall Study|Randomized but not vaccinated|25|||
124831239|NCT03388138|449012174|FG000|Overall Study|Protocol Violation|1|||
124831240|NCT03388138|449012175|FG001|Overall Study|Protocol Violation|0|||
124831241|NCT01528072|449012176|FG000|Overall Study|Withdrawal by Subject|5|||
124831242|NCT01528072|449012176|FG000|Overall Study|Physician Decision|1|||
124831243|NCT01528072|449012176|FG000|Overall Study|Determined not eligible by AEAC|1|||
124639018|NCT03491462|448296500|FG000|Overall Study|Physician Decision|3|||
124639019|NCT03491462|448296501|FG001|Overall Study|Physician Decision|0|||
124831244|NCT01528072|449012176|FG000|Overall Study|Missed Visit|2|||
124831245|NCT01528072|449012176|FG000|Overall Study|Lost to Follow-up|5|||
124831246|NCT01528072|449012176|FG000|Overall Study|Explanted|2|||
124831247|NCT01528072|449012176|FG000|Overall Study|Site Closure|4|||
124831248|NCT01528072|449012176|FG000|Overall Study|Death|2|||
124831249|NCT01528072|449012176|FG000|Overall Study|Early Termination of Study|52|||
124831250|NCT01859494|449012179|FG000|Overall Study|Adverse Event|1|||
124831251|NCT02529137|449012184|FG000|Overall Study|Discontinuation for different reasons|8|||
124831252|NCT02063854|449012185|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
124831253|NCT02063854|449012186|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
124831254|NCT02063854|449012187|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
124639020|NCT03491462|448296500|FG000|Overall Study|Withdrawal by Subject|22|||
124831255|NCT02063854|449012188|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
124831256|NCT02063854|449012189|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
124831257|NCT02063854|449012190|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
124831258|NCT02063854|449012191|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
124831259|NCT02063854|449012185|FG000|Overall Study|Major Protocol Deviation|0|||
124831260|NCT02063854|449012186|FG001|Overall Study|Major Protocol Deviation|0|||
124831261|NCT02063854|449012187|FG002|Overall Study|Major Protocol Deviation|3|||
124831262|NCT02063854|449012188|FG003|Overall Study|Major Protocol Deviation|0|||
124831263|NCT02063854|449012189|FG004|Overall Study|Major Protocol Deviation|0|||
124831264|NCT02063854|449012190|FG005|Overall Study|Major Protocol Deviation|0|||
124831265|NCT02063854|449012191|FG006|Overall Study|Major Protocol Deviation|0|||
124831266|NCT02063854|449012185|FG000|Overall Study|Voluntary Withdrawal|2|||
124831267|NCT02063854|449012186|FG001|Overall Study|Voluntary Withdrawal|0|||
124831268|NCT02063854|449012187|FG002|Overall Study|Voluntary Withdrawal|8|||
124831269|NCT02063854|449012188|FG003|Overall Study|Voluntary Withdrawal|1|||
124831270|NCT02063854|449012189|FG004|Overall Study|Voluntary Withdrawal|3|||
124831271|NCT02063854|449012190|FG005|Overall Study|Voluntary Withdrawal|6|||
124831272|NCT02063854|449012191|FG006|Overall Study|Voluntary Withdrawal|1|||
124831273|NCT02063854|449012185|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
124831274|NCT02063854|449012186|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
124831275|NCT02063854|449012187|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
124831276|NCT02063854|449012188|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
124831277|NCT02063854|449012189|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
124831278|NCT02063854|449012190|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
124831279|NCT02063854|449012191|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
124831280|NCT02063854|449012185|FG000|Overall Study|Reason Not Specified|1|||
124831281|NCT02063854|449012186|FG001|Overall Study|Reason Not Specified|0|||
124831282|NCT02063854|449012187|FG002|Overall Study|Reason Not Specified|0|||
124831283|NCT02063854|449012188|FG003|Overall Study|Reason Not Specified|0|||
124831284|NCT02063854|449012189|FG004|Overall Study|Reason Not Specified|0|||
124831285|NCT02063854|449012190|FG005|Overall Study|Reason Not Specified|0|||
124831286|NCT02063854|449012191|FG006|Overall Study|Reason Not Specified|0|||
124831287|NCT02063854|449012185|FG000|Overall Study|Did Not Receive Study Drug|0|||
124831288|NCT02063854|449012186|FG001|Overall Study|Did Not Receive Study Drug|0|||
124831289|NCT02063854|449012187|FG002|Overall Study|Did Not Receive Study Drug|0|||
124831290|NCT02063854|449012188|FG003|Overall Study|Did Not Receive Study Drug|0|||
124831291|NCT02063854|449012189|FG004|Overall Study|Did Not Receive Study Drug|0|||
124831292|NCT02063854|449012190|FG005|Overall Study|Did Not Receive Study Drug|1|||
124831293|NCT02063854|449012191|FG006|Overall Study|Did Not Receive Study Drug|0|||
124831294|NCT01462084|449012192|FG000|Overall Study|Withdrawal by Subject|1|||
124831295|NCT01462084|449012193|FG001|Overall Study|Withdrawal by Subject|0|||
124831296|NCT01462084|449012192|FG000|Overall Study|Protocol Violation|1|||
124831297|NCT01462084|449012193|FG001|Overall Study|Protocol Violation|1|||
124831298|NCT03538158|449012194|FG000|Overall Study|Lost to Follow-up|13|||
124831299|NCT03538158|449012195|FG001|Overall Study|Lost to Follow-up|7|||
124831300|NCT03538158|449012194|FG000|Overall Study|Withdrawal by Subject|2|||
124831301|NCT03538158|449012195|FG001|Overall Study|Withdrawal by Subject|1|||
124831302|NCT00930579|449012196|FG000|Overall Study|Withdrawal by Subject|1|||
124831303|NCT00930579|449012196|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
124831304|NCT00695396|449012197|FG000|Overall Study|Study Closed Prematurely|5|||
124831305|NCT00695396|449012198|FG001|Overall Study|Study Closed Prematurely|6|||
124831306|NCT00695396|449012199|FG002|Overall Study|Study Closed Prematurely|8|||
124831307|NCT00695396|449012197|FG000|Overall Study|Withdrawal by Subject|2|||
124831308|NCT00695396|449012198|FG001|Overall Study|Withdrawal by Subject|2|||
124831309|NCT00695396|449012199|FG002|Overall Study|Withdrawal by Subject|0|||
124831310|NCT00772707|449012200|FG000|Overall Study|Withdrawn|3|||
124831311|NCT04120974|449012204|FG000|Overall Study|Death|1|||
124831312|NCT04120974|449012204|FG000|Overall Study|Physician Decision|1|||
124831313|NCT04120974|449012204|FG000|Overall Study|Lost to Follow-up|6|||
124831314|NCT03338062|449012205|FG000|Overall Study|Alternative Therapy|1|||
124831315|NCT03338062|449012206|FG001|Overall Study|Alternative Therapy|0|||
124639021|NCT03491462|448296501|FG001|Overall Study|Withdrawal by Subject|15|||
124831316|NCT04256785|449012207|FG000|Overall Study|Adverse Event|8|||
124831317|NCT04256785|449012208|FG001|Overall Study|Adverse Event|6|||
124831318|NCT04256785|449012207|FG000|Overall Study|Lack of Efficacy|3|||
124831319|NCT04256785|449012208|FG001|Overall Study|Lack of Efficacy|4|||
124639022|NCT00740792|448296502|FG000|Overall Study|Adverse Event|3|||
124831320|NCT04256785|449012207|FG000|Overall Study|Lost to Follow-up|7|||
124831321|NCT04256785|449012208|FG001|Overall Study|Lost to Follow-up|7|||
124831322|NCT04256785|449012207|FG000|Overall Study|Protocol Violation|1|||
124831323|NCT04256785|449012208|FG001|Overall Study|Protocol Violation|0|||
124831324|NCT04256785|449012207|FG000|Overall Study|Withdrawal by Subject|4|||
124831325|NCT04256785|449012208|FG001|Overall Study|Withdrawal by Subject|1|||
124831326|NCT04256785|449012207|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
124639023|NCT00740792|448296503|FG001|Overall Study|Adverse Event|1|||
124831327|NCT04256785|449012208|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
124831328|NCT03194321|449012212|FG000|Overall Study|Withdrawal by Subject|1|||
124831329|NCT03194321|449012212|FG000|Overall Study|Lost to Follow-up|1|||
124831330|NCT03194321|449012212|FG000|Overall Study|Travel for Follow-up|1|||
124831331|NCT01288287|449012214|FG000|Overall Study|Lost to Follow-up|8|||
124831332|NCT01288287|449012214|FG000|Overall Study|Withdrawal by Subject|4|||
124831333|NCT01288287|449012214|FG000|Overall Study|Lack of Efficacy|13|||
124831334|NCT01288287|449012214|FG000|Overall Study|Other Reason|13|||
124831335|NCT01288287|449012214|FG000|Overall Study|Unknown Reason|1|||
124831336|NCT01288287|449012214|FG000|Overall Study|Unknown Status|7|||
124831337|NCT00238121|449012218|FG000|Overall Study|Withdrawal by Subject|1|||
124831338|NCT00238121|449012219|FG001|Overall Study|Withdrawal by Subject|1|||
124831339|NCT00238121|449012218|FG000|Overall Study|Adverse Event|2|||
124831340|NCT00238121|449012219|FG001|Overall Study|Adverse Event|1|||
124831341|NCT01675128|449012224|FG000|Overall Study|Disease progression on study|1|||
124831342|NCT01675128|449012225|FG001|Overall Study|Disease progression on study|1|||
124831343|NCT01675128|449012226|FG002|Overall Study|Disease progression on study|1|||
124831344|NCT01675128|449012224|FG000|Overall Study|Refused further treatment|1|||
124831345|NCT01675128|449012225|FG001|Overall Study|Refused further treatment|0|||
124831346|NCT01675128|449012226|FG002|Overall Study|Refused further treatment|0|||
124831347|NCT01675128|449012224|FG000|Overall Study|Pulmonary complication; off study|0|||
124831348|NCT01675128|449012225|FG001|Overall Study|Pulmonary complication; off study|1|||
124831349|NCT01675128|449012226|FG002|Overall Study|Pulmonary complication; off study|0|||
124831350|NCT00832585|449012235|FG000|Overall Study|Withdrawal by Subject|1|||
124831351|NCT00832585|449012235|FG000|Overall Study|Lost to Follow-up|1|||
124831352|NCT01374087|449012239|FG000|Overall Study|Adverse Event|1|||
124831353|NCT01374087|449012240|FG001|Overall Study|Adverse Event|0|||
124831354|NCT01374087|449012239|FG000|Overall Study|Disease progression|2|||
124831355|NCT01374087|449012240|FG001|Overall Study|Disease progression|2|||
124831356|NCT01374087|449012239|FG000|Overall Study|Study discontinued|13|||
124831357|NCT01374087|449012240|FG001|Overall Study|Study discontinued|13|||
124831358|NCT03526458|449012241|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
124831359|NCT03526458|449012242|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
124831360|NCT03526458|449012241|FG000|Overall Study|Stone passed, surgery cancelled|2|||
124831361|NCT03526458|449012242|FG001|Overall Study|Stone passed, surgery cancelled|1|||
124831362|NCT03526458|449012241|FG000|Overall Study|Withdrawal by Subject|1|||
124831363|NCT03526458|449012242|FG001|Overall Study|Withdrawal by Subject|0|||
124831364|NCT03526458|449012241|FG000|Overall Study|Physician Decision|2|||
124831365|NCT03526458|449012242|FG001|Overall Study|Physician Decision|1|||
124831366|NCT03526458|449012241|FG000|Overall Study|Lack of equipment|1|||
124831367|NCT03526458|449012242|FG001|Overall Study|Lack of equipment|1|||
124831368|NCT00271947|449012243|FG000|Overall Study|Lost to Follow-up|1|||
124831369|NCT01782664|449012244|FG000|Overall Study|Adverse Event|2|||
124831370|NCT01782664|449012245|FG001|Overall Study|Adverse Event|2|||
124831371|NCT01782664|449012246|FG002|Overall Study|Adverse Event|2|||
124831372|NCT01782664|449012247|FG003|Overall Study|Adverse Event|2|||
124831373|NCT01782664|449012248|FG004|Overall Study|Adverse Event|0|||
124831374|NCT01782664|449012249|FG005|Overall Study|Adverse Event|0|||
124831375|NCT01782664|449012244|FG000|Overall Study|Lack of Efficacy|2|||
124831376|NCT01782664|449012245|FG001|Overall Study|Lack of Efficacy|0|||
124831377|NCT01782664|449012246|FG002|Overall Study|Lack of Efficacy|2|||
124831378|NCT01782664|449012247|FG003|Overall Study|Lack of Efficacy|2|||
124831379|NCT01782664|449012248|FG004|Overall Study|Lack of Efficacy|0|||
124831380|NCT01782664|449012249|FG005|Overall Study|Lack of Efficacy|0|||
124831381|NCT01782664|449012244|FG000|Overall Study|Protocol Violation|0|||
124831382|NCT01782664|449012245|FG001|Overall Study|Protocol Violation|1|||
124831383|NCT01782664|449012246|FG002|Overall Study|Protocol Violation|0|||
124831384|NCT01782664|449012247|FG003|Overall Study|Protocol Violation|1|||
124831385|NCT01782664|449012248|FG004|Overall Study|Protocol Violation|0|||
124831386|NCT01782664|449012249|FG005|Overall Study|Protocol Violation|0|||
124831387|NCT01782664|449012244|FG000|Overall Study|Withdrawal by Subject|2|||
124831388|NCT01782664|449012245|FG001|Overall Study|Withdrawal by Subject|2|||
124831389|NCT01782664|449012246|FG002|Overall Study|Withdrawal by Subject|0|||
124831390|NCT01782664|449012247|FG003|Overall Study|Withdrawal by Subject|0|||
124831391|NCT01782664|449012248|FG004|Overall Study|Withdrawal by Subject|0|||
124831392|NCT01782664|449012249|FG005|Overall Study|Withdrawal by Subject|0|||
124831393|NCT01522365|449012252|FG000|Overall Study|Withdrawal by Subject|1|||
124831394|NCT01522365|449012253|FG001|Overall Study|Withdrawal by Subject|1|||
124831395|NCT01522365|449012252|FG000|Overall Study|Lost to Follow-up|1|||
124831396|NCT01522365|449012253|FG001|Overall Study|Lost to Follow-up|1|||
124831397|NCT00673179|449012254|FG000|Overall Study|Toxicity/Complications|3|||
124831398|NCT00673179|449012255|FG001|Overall Study|Toxicity/Complications|0|||
124831399|NCT02466555|449012258|FG000|Overall Study|Lost to Follow-up|2|||
124831400|NCT01082965|449012259|FG000|Overall Study|Protocol Violation|0|||
124831401|NCT01082965|449012260|FG001|Overall Study|Protocol Violation|1|||
124831402|NCT01082965|449012259|FG000|Overall Study|Other|1|||
124831403|NCT01082965|449012260|FG001|Overall Study|Other|1|||
124831404|NCT02587065|449012262|FG000|Overall Study|Adverse Event|14|||
124639024|NCT00740792|448296504|FG002|Overall Study|Adverse Event|1|||
124639025|NCT00740792|448296505|FG003|Overall Study|Adverse Event|3|||
124639026|NCT00740792|448296502|FG000|Overall Study|Lack of Efficacy|1|||
124639027|NCT00740792|448296503|FG001|Overall Study|Lack of Efficacy|1|||
124639028|NCT00740792|448296504|FG002|Overall Study|Lack of Efficacy|0|||
124639029|NCT00740792|448296505|FG003|Overall Study|Lack of Efficacy|3|||
124639030|NCT00740792|448296502|FG000|Overall Study|Lost to Follow-up|2|||
124639031|NCT00740792|448296503|FG001|Overall Study|Lost to Follow-up|1|||
124639032|NCT00740792|448296504|FG002|Overall Study|Lost to Follow-up|0|||
124639033|NCT00740792|448296505|FG003|Overall Study|Lost to Follow-up|0|||
124639034|NCT00740792|448296502|FG000|Overall Study|Protocol Violation|0|||
124639035|NCT00740792|448296503|FG001|Overall Study|Protocol Violation|1|||
124639036|NCT00740792|448296504|FG002|Overall Study|Protocol Violation|0|||
124639037|NCT00740792|448296505|FG003|Overall Study|Protocol Violation|2|||
124639038|NCT00740792|448296502|FG000|Overall Study|Withdrawal by Subject|1|||
124639039|NCT00740792|448296503|FG001|Overall Study|Withdrawal by Subject|1|||
124639040|NCT00740792|448296504|FG002|Overall Study|Withdrawal by Subject|0|||
124639041|NCT00740792|448296505|FG003|Overall Study|Withdrawal by Subject|0|||
124639042|NCT00740792|448296502|FG000|Overall Study|administrative|3|||
124639043|NCT00740792|448296503|FG001|Overall Study|administrative|3|||
124639044|NCT00740792|448296504|FG002|Overall Study|administrative|8|||
124639045|NCT00740792|448296505|FG003|Overall Study|administrative|2|||
124639046|NCT01019694|448296506|FG000|Overall Study|Adverse Event|12|||
124639047|NCT01019694|448296507|FG001|Overall Study|Adverse Event|16|||
124639048|NCT01019694|448296508|FG002|Overall Study|Adverse Event|19|||
124639049|NCT01019694|448296506|FG000|Overall Study|Protocol Violation|2|||
124639050|NCT01019694|448296507|FG001|Overall Study|Protocol Violation|6|||
124639051|NCT01019694|448296508|FG002|Overall Study|Protocol Violation|4|||
124639052|NCT01019694|448296506|FG000|Overall Study|Lost to Follow-up|5|||
124639053|NCT01019694|448296507|FG001|Overall Study|Lost to Follow-up|3|||
124639054|NCT01019694|448296508|FG002|Overall Study|Lost to Follow-up|3|||
124639055|NCT01019694|448296506|FG000|Overall Study|Withdrawal by Subject|4|||
124639056|NCT01019694|448296507|FG001|Overall Study|Withdrawal by Subject|6|||
124639057|NCT01019694|448296508|FG002|Overall Study|Withdrawal by Subject|12|||
124639058|NCT01019694|448296506|FG000|Overall Study|Not treated|0|||
124639059|NCT01019694|448296507|FG001|Overall Study|Not treated|2|||
124639060|NCT01019694|448296508|FG002|Overall Study|Not treated|3|||
124639061|NCT01019694|448296506|FG000|Overall Study|Other reason (not specified)|1|||
124639062|NCT01019694|448296507|FG001|Overall Study|Other reason (not specified)|5|||
124639063|NCT01019694|448296508|FG002|Overall Study|Other reason (not specified)|6|||
124639064|NCT00685399|448296513|FG000|Treatment Period 1|Withdrawal by Subject|2|||
124639065|NCT00685399|448296514|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124639066|NCT00685399|448296515|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124639067|NCT00685399|448296516|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124639068|NCT00685399|448296517|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124639069|NCT00685399|448296518|FG005|Treatment Period 1|Withdrawal by Subject|0|||
124639070|NCT00685399|448296519|FG006|Treatment Period 1|Withdrawal by Subject|0|||
124639071|NCT00685399|448296520|FG007|Treatment Period 1|Withdrawal by Subject|0|||
124639072|NCT00685399|448296513|FG000|Treatment Period 1|Protocol Violation|1|||
124639073|NCT00685399|448296514|FG001|Treatment Period 1|Protocol Violation|0|||
124639074|NCT00685399|448296515|FG002|Treatment Period 1|Protocol Violation|0|||
124639075|NCT00685399|448296516|FG003|Treatment Period 1|Protocol Violation|0|||
124639076|NCT00685399|448296517|FG004|Treatment Period 1|Protocol Violation|0|||
124639077|NCT00685399|448296518|FG005|Treatment Period 1|Protocol Violation|0|||
124639078|NCT00685399|448296519|FG006|Treatment Period 1|Protocol Violation|0|||
124639079|NCT00685399|448296520|FG007|Treatment Period 1|Protocol Violation|0|||
124639080|NCT00685399|448296513|FG000|Treatment Period 1|Administrative|2|||
124639081|NCT00685399|448296514|FG001|Treatment Period 1|Administrative|0|||
124639082|NCT00685399|448296515|FG002|Treatment Period 1|Administrative|0|||
124639083|NCT00685399|448296516|FG003|Treatment Period 1|Administrative|0|||
124639084|NCT00685399|448296517|FG004|Treatment Period 1|Administrative|0|||
124639085|NCT00685399|448296518|FG005|Treatment Period 1|Administrative|0|||
124639086|NCT00685399|448296519|FG006|Treatment Period 1|Administrative|0|||
124639087|NCT00685399|448296520|FG007|Treatment Period 1|Administrative|0|||
124639088|NCT00685399|448296513|FG000|Treatment Period 1|Lack of Efficacy|1|||
124639089|NCT00685399|448296514|FG001|Treatment Period 1|Lack of Efficacy|0|||
124639090|NCT00685399|448296515|FG002|Treatment Period 1|Lack of Efficacy|0|||
124639091|NCT00685399|448296516|FG003|Treatment Period 1|Lack of Efficacy|0|||
124639092|NCT00685399|448296517|FG004|Treatment Period 1|Lack of Efficacy|0|||
124639093|NCT00685399|448296518|FG005|Treatment Period 1|Lack of Efficacy|0|||
124639094|NCT00685399|448296519|FG006|Treatment Period 1|Lack of Efficacy|0|||
124639095|NCT00685399|448296520|FG007|Treatment Period 1|Lack of Efficacy|0|||
124639096|NCT00685399|448296513|FG000|Treatment Period 2|Administrative Problems|0|||
124639097|NCT00685399|448296514|FG001|Treatment Period 2|Administrative Problems|2|||
124639098|NCT00685399|448296515|FG002|Treatment Period 2|Administrative Problems|1|||
124639099|NCT00685399|448296516|FG003|Treatment Period 2|Administrative Problems|0|||
124639100|NCT00685399|448296517|FG004|Treatment Period 2|Administrative Problems|0|||
124831405|NCT02587065|449012262|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
124831406|NCT02587065|449012262|FG000|Overall Study|Non-adherence to the Protocol|3|||
124831407|NCT02587065|449012262|FG000|Overall Study|Discontinuation of Study Medication|2|||
124831408|NCT02587065|449012262|FG000|Overall Study|Reason not Specified|3|||
124831409|NCT00445965|449012265|FG000|Overall Study|Adverse Event|2|||
124831410|NCT00445965|449012265|FG000|Overall Study|Physician Decision|1|||
124831411|NCT00445965|449012265|FG000|Overall Study|Enrolled but not treated|1|||
124831412|NCT00445965|449012265|FG000|Overall Study|Removed due to progressive disease|29|||
124831413|NCT02295995|449012273|FG000|Overall Study|Lost to Follow-up|5|||
124831414|NCT02295995|449012274|FG001|Overall Study|Lost to Follow-up|1|||
124831415|NCT02447081|449012275|FG000|Overall Study|Death|161|||
124831416|NCT02447081|449012275|FG000|Overall Study|Lost to Follow-up|36|||
124831417|NCT02447081|449012275|FG000|Overall Study|Visit not completed|17|||
124831418|NCT02447081|449012275|FG000|Overall Study|unsuccessful implant procedure|10|||
124831419|NCT02113956|449012279|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
124831420|NCT02113956|449012280|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
124831421|NCT02113956|449012279|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
124831422|NCT02113956|449012280|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
124639101|NCT00685399|448296518|FG005|Treatment Period 2|Administrative Problems|0|||
124639102|NCT00685399|448296519|FG006|Treatment Period 2|Administrative Problems|0|||
124639103|NCT00685399|448296520|FG007|Treatment Period 2|Administrative Problems|0|||
124639104|NCT00685399|448296513|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124639105|NCT00685399|448296514|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124639106|NCT00685399|448296515|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124639107|NCT00685399|448296516|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124639108|NCT00685399|448296517|FG004|Treatment Period 2|Withdrawal by Subject|0|||
124639109|NCT00685399|448296518|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124639110|NCT00685399|448296519|FG006|Treatment Period 2|Withdrawal by Subject|0|||
124639111|NCT00685399|448296520|FG007|Treatment Period 2|Withdrawal by Subject|2|||
124639112|NCT00685399|448296513|FG000|Treatment Period 2|Adverse Event|0|||
124639113|NCT00685399|448296514|FG001|Treatment Period 2|Adverse Event|0|||
124639114|NCT00685399|448296515|FG002|Treatment Period 2|Adverse Event|0|||
124639115|NCT00685399|448296516|FG003|Treatment Period 2|Adverse Event|0|||
124639116|NCT00685399|448296517|FG004|Treatment Period 2|Adverse Event|0|||
124639117|NCT00685399|448296518|FG005|Treatment Period 2|Adverse Event|1|||
124639118|NCT00685399|448296519|FG006|Treatment Period 2|Adverse Event|0|||
124639119|NCT00685399|448296520|FG007|Treatment Period 2|Adverse Event|0|||
124639120|NCT00685399|448296513|FG000|Treatment Period 2|Lack of Efficacy|0|||
124639121|NCT00685399|448296514|FG001|Treatment Period 2|Lack of Efficacy|10|||
124639122|NCT00685399|448296515|FG002|Treatment Period 2|Lack of Efficacy|2|||
124639123|NCT00685399|448296516|FG003|Treatment Period 2|Lack of Efficacy|0|||
124639124|NCT00685399|448296517|FG004|Treatment Period 2|Lack of Efficacy|0|||
124639125|NCT00685399|448296518|FG005|Treatment Period 2|Lack of Efficacy|1|||
124639126|NCT00685399|448296519|FG006|Treatment Period 2|Lack of Efficacy|0|||
124639127|NCT00685399|448296520|FG007|Treatment Period 2|Lack of Efficacy|0|||
124639128|NCT00685399|448296513|FG000|Extension|Administrative Issues|0|||
124639129|NCT00685399|448296514|FG001|Extension|Administrative Issues|0|||
124639130|NCT00685399|448296515|FG002|Extension|Administrative Issues|0|||
124639131|NCT00685399|448296516|FG003|Extension|Administrative Issues|1|||
124639132|NCT00685399|448296517|FG004|Extension|Administrative Issues|0|||
124639133|NCT00685399|448296518|FG005|Extension|Administrative Issues|0|||
124639134|NCT00685399|448296519|FG006|Extension|Administrative Issues|0|||
124639135|NCT00685399|448296520|FG007|Extension|Administrative Issues|0|||
124639136|NCT00685399|448296513|FG000|Extension|Withdrawal by Subject|0|||
124639137|NCT00685399|448296514|FG001|Extension|Withdrawal by Subject|0|||
124639138|NCT00685399|448296515|FG002|Extension|Withdrawal by Subject|0|||
124639139|NCT00685399|448296516|FG003|Extension|Withdrawal by Subject|1|||
124639140|NCT00685399|448296517|FG004|Extension|Withdrawal by Subject|0|||
124639141|NCT00685399|448296518|FG005|Extension|Withdrawal by Subject|0|||
124639142|NCT00685399|448296519|FG006|Extension|Withdrawal by Subject|0|||
124639143|NCT00685399|448296520|FG007|Extension|Withdrawal by Subject|0|||
124639144|NCT00685399|448296513|FG000|Extension|Protocol Violation|0|||
124639145|NCT00685399|448296514|FG001|Extension|Protocol Violation|0|||
124639146|NCT00685399|448296515|FG002|Extension|Protocol Violation|0|||
124831423|NCT02113956|449012279|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
124639147|NCT00685399|448296516|FG003|Extension|Protocol Violation|1|||
124639148|NCT00685399|448296517|FG004|Extension|Protocol Violation|0|||
124639149|NCT00685399|448296518|FG005|Extension|Protocol Violation|0|||
124639150|NCT00685399|448296519|FG006|Extension|Protocol Violation|0|||
124639151|NCT00685399|448296520|FG007|Extension|Protocol Violation|0|||
124639152|NCT00685399|448296513|FG000|Extension|Lack of Efficacy|0|||
124639153|NCT00685399|448296514|FG001|Extension|Lack of Efficacy|0|||
124639154|NCT00685399|448296515|FG002|Extension|Lack of Efficacy|0|||
124639155|NCT00685399|448296516|FG003|Extension|Lack of Efficacy|2|||
124639156|NCT00685399|448296517|FG004|Extension|Lack of Efficacy|0|||
124639157|NCT00685399|448296518|FG005|Extension|Lack of Efficacy|0|||
124639158|NCT00685399|448296519|FG006|Extension|Lack of Efficacy|0|||
124753047|NCT00398567|448718752|FG001|Overall Study|Withdrawal by Subject|0|||
124753048|NCT00398567|448718753|FG002|Overall Study|Withdrawal by Subject|4|||
124753049|NCT00398567|448718751|FG000|Overall Study|Adverse Event|0|||
124753050|NCT00398567|448718752|FG001|Overall Study|Adverse Event|0|||
124753051|NCT00398567|448718753|FG002|Overall Study|Adverse Event|2|||
124753052|NCT00398567|448718751|FG000|Overall Study|Protocol Violation|0|||
124753053|NCT00398567|448718752|FG001|Overall Study|Protocol Violation|0|||
124753054|NCT00398567|448718753|FG002|Overall Study|Protocol Violation|1|||
124753055|NCT02837029|448718754|FG000|Screening|Failed to meet screening requirements.|7|||
124753056|NCT02837029|448718755|FG001|Screening|Failed to meet screening requirements.|3|||
124753057|NCT02837029|448718756|FG002|Screening|Failed to meet screening requirements.|0|||
124753058|NCT02837029|448718754|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
124753059|NCT02837029|448718755|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
124753060|NCT02837029|448718756|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
124753061|NCT02837029|448718754|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
124753062|NCT02837029|448718755|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
124753063|NCT02837029|448718756|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
124753064|NCT02837029|448718754|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
124753065|NCT02837029|448718755|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
124753066|NCT02837029|448718756|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
124753067|NCT02837029|448718754|FG000|Cycle 2 and Beyond|Adverse Event|1|||
124753068|NCT02837029|448718755|FG001|Cycle 2 and Beyond|Adverse Event|0|||
124753069|NCT02837029|448718756|FG002|Cycle 2 and Beyond|Adverse Event|0|||
124753070|NCT02837029|448718754|FG000|2 Year Follow-up|Death|6|||
124753071|NCT02837029|448718755|FG001|2 Year Follow-up|Death|7|||
124753072|NCT02837029|448718756|FG002|2 Year Follow-up|Death|0|||
124753073|NCT02034877|448718757|FG000|Overall Study|Lost to Follow-up|0|||
124753074|NCT02034877|448718758|FG001|Overall Study|Lost to Follow-up|3|||
124753075|NCT02034877|448718757|FG000|Overall Study|No Longer Willing to Participate|0|||
124753076|NCT02034877|448718758|FG001|Overall Study|No Longer Willing to Participate|3|||
124753077|NCT04421482|448718760|FG000|Overall Study|Physician Decision|1|||
124753078|NCT04426318|448718763|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
124753079|NCT04426318|448718764|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
124753080|NCT03906071|448718765|FG000|Overall Study|Death|180|||
124753081|NCT03906071|448718766|FG001|Overall Study|Death|185|||
124753082|NCT03906071|448718765|FG000|Overall Study|Lost to Follow-up|3|||
124753083|NCT03906071|448718766|FG001|Overall Study|Lost to Follow-up|3|||
124753084|NCT03906071|448718765|FG000|Overall Study|Withdrawal by Subject|15|||
124753085|NCT03906071|448718766|FG001|Overall Study|Withdrawal by Subject|27|||
124753086|NCT03906071|448718765|FG000|Overall Study|Other|2|||
124753087|NCT03906071|448718766|FG001|Overall Study|Other|1|||
124753088|NCT01564732|448718778|FG000|Overall Study|Early termination by the study sponsor|6|||
124753089|NCT01564732|448718779|FG001|Overall Study|Early termination by the study sponsor|5|||
124753090|NCT01036321|448718782|FG000|Overall Study|Ineligible after randomization|0|||
124753091|NCT01036321|448718783|FG001|Overall Study|Ineligible after randomization|1|||
124753092|NCT01036321|448718782|FG000|Overall Study|Withdrawal by Subject|3|||
124753093|NCT01036321|448718783|FG001|Overall Study|Withdrawal by Subject|2|||
124753094|NCT01036321|448718782|FG000|Overall Study|Adverse Event|2|||
124753095|NCT01036321|448718783|FG001|Overall Study|Adverse Event|1|||
124753096|NCT01957202|448718784|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
124753097|NCT01957202|448718785|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
124753098|NCT01957202|448718786|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
124753099|NCT01957202|448718787|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
124753100|NCT01957202|448718788|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
124753101|NCT01957202|448718789|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
124753102|NCT01957202|448718790|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
124753103|NCT01957202|448718791|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
124753104|NCT01957202|448718792|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
124753105|NCT01957202|448718793|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
124753106|NCT01957202|448718794|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
124753107|NCT01957202|448718795|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
124753108|NCT01957202|448718796|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
124753109|NCT01957202|448718797|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
124753110|NCT01957202|448718798|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
124753111|NCT01957202|448718799|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
124753112|NCT01957202|448718800|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
124753113|NCT01957202|448718801|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
124753114|NCT01957202|448718784|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
124753115|NCT01957202|448718785|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
124753116|NCT01957202|448718786|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
124753117|NCT01957202|448718787|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
124753118|NCT01957202|448718788|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
124753119|NCT01957202|448718789|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
124831424|NCT02113956|449012280|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
124831425|NCT02406651|449012281|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
124831426|NCT02005250|449012283|FG000|Overall Study|Lost to Follow-up|15|||
124831427|NCT02005250|449012284|FG001|Overall Study|Lost to Follow-up|5|||
124831428|NCT02588833|449012285|FG000|Part 1|Withdrawal by Subject|1|||
124831429|NCT02588833|449012286|FG001|Part 1|Withdrawal by Subject|0|||
124831430|NCT02588833|449012285|FG000|Part 2A|Physician Decision|0|||
124831431|NCT02588833|449012286|FG001|Part 2A|Physician Decision|1|||
124831432|NCT02588833|449012285|FG000|Part 2A|Withdrawal by Subject|0|||
124831433|NCT02588833|449012286|FG001|Part 2A|Withdrawal by Subject|1|||
124831434|NCT02588833|449012285|FG000|Part 2B|Adverse Event|0|||
124831435|NCT02588833|449012286|FG001|Part 2B|Adverse Event|1|||
124831436|NCT02588833|449012285|FG000|Part 2C|Adverse Event|0|||
124831437|NCT02588833|449012286|FG001|Part 2C|Adverse Event|1|||
124831438|NCT02588833|449012285|FG000|Part 2C|Withdrawal by Subject|0|||
124831439|NCT02588833|449012286|FG001|Part 2C|Withdrawal by Subject|1|||
124831440|NCT02588833|449012285|FG000|Part 3 (Safety Follow-up)|Other|0|||
124831441|NCT02588833|449012286|FG001|Part 3 (Safety Follow-up)|Other|2|||
124831442|NCT02921776|449012287|FG000|Overall Study|patient deterioration, fatigue|2|||
124831443|NCT02921776|449012288|FG001|Overall Study|patient deterioration, fatigue|6|||
124831444|NCT02921776|449012289|FG002|Overall Study|patient deterioration, fatigue|0|||
124831445|NCT02921776|449012290|FG003|Overall Study|patient deterioration, fatigue|0|||
124831446|NCT02921776|449012291|FG004|Overall Study|patient deterioration, fatigue|0|||
124831447|NCT02921776|449012292|FG005|Overall Study|patient deterioration, fatigue|0|||
124831448|NCT02921776|449012293|FG006|Overall Study|patient deterioration, fatigue|0|||
124831449|NCT02921776|449012294|FG007|Overall Study|patient deterioration, fatigue|0|||
124831450|NCT02921776|449012287|FG000|Overall Study|Withdrawal by Subject|0|||
124831451|NCT02921776|449012288|FG001|Overall Study|Withdrawal by Subject|2|||
124831452|NCT02921776|449012289|FG002|Overall Study|Withdrawal by Subject|0|||
124831453|NCT02921776|449012290|FG003|Overall Study|Withdrawal by Subject|1|||
124831454|NCT02921776|449012291|FG004|Overall Study|Withdrawal by Subject|1|||
124831455|NCT02921776|449012292|FG005|Overall Study|Withdrawal by Subject|0|||
124831456|NCT02921776|449012293|FG006|Overall Study|Withdrawal by Subject|8|||
124831457|NCT02921776|449012294|FG007|Overall Study|Withdrawal by Subject|1|||
124831458|NCT02921776|449012287|FG000|Overall Study|Death|0|||
124831459|NCT02921776|449012288|FG001|Overall Study|Death|0|||
124831460|NCT02921776|449012289|FG002|Overall Study|Death|0|||
124831461|NCT02921776|449012290|FG003|Overall Study|Death|2|||
124831462|NCT02921776|449012291|FG004|Overall Study|Death|0|||
124831463|NCT02921776|449012292|FG005|Overall Study|Death|0|||
124831464|NCT02921776|449012293|FG006|Overall Study|Death|0|||
124831465|NCT02921776|449012294|FG007|Overall Study|Death|0|||
124831466|NCT02921776|449012287|FG000|Overall Study|extubation or early discharge|0|||
124831467|NCT02921776|449012288|FG001|Overall Study|extubation or early discharge|0|||
124831468|NCT02921776|449012289|FG002|Overall Study|extubation or early discharge|0|||
124831469|NCT02921776|449012290|FG003|Overall Study|extubation or early discharge|5|||
124831470|NCT02921776|449012291|FG004|Overall Study|extubation or early discharge|5|||
124831471|NCT02921776|449012292|FG005|Overall Study|extubation or early discharge|0|||
124831472|NCT02921776|449012293|FG006|Overall Study|extubation or early discharge|0|||
124831473|NCT02921776|449012294|FG007|Overall Study|extubation or early discharge|0|||
124831474|NCT02921776|449012287|FG000|Overall Study|Lost to Follow-up|0|||
124831475|NCT02921776|449012288|FG001|Overall Study|Lost to Follow-up|0|||
124831476|NCT02921776|449012289|FG002|Overall Study|Lost to Follow-up|0|||
124831477|NCT02921776|449012290|FG003|Overall Study|Lost to Follow-up|0|||
124831478|NCT02921776|449012291|FG004|Overall Study|Lost to Follow-up|0|||
124831479|NCT02921776|449012292|FG005|Overall Study|Lost to Follow-up|2|||
124831480|NCT02921776|449012293|FG006|Overall Study|Lost to Follow-up|3|||
124831481|NCT02921776|449012294|FG007|Overall Study|Lost to Follow-up|6|||
124831482|NCT02946047|449012295|FG000|Overall Study|Adverse Event|1|||
124831483|NCT02946047|449012296|FG001|Overall Study|Adverse Event|0|||
124831484|NCT02946047|449012297|FG002|Overall Study|Adverse Event|0|||
124831485|NCT02946047|449012298|FG003|Overall Study|Adverse Event|0|||
124831486|NCT04814433|449012302|FG000|Overall Study|Survey not returned|4|||
124831487|NCT04814433|449012303|FG001|Overall Study|Survey not returned|8|||
124831488|NCT04814433|449012304|FG002|Overall Study|Survey not returned|4|||
124831489|NCT04814433|449012305|FG003|Overall Study|Survey not returned|5|||
124831490|NCT02496533|449012306|FG000|Overall Study|Lack of data on outcome|3|||
124831491|NCT02496533|449012307|FG001|Overall Study|Lack of data on outcome|0|||
124831492|NCT02496533|449012306|FG000|Overall Study|Patient did not complete all measures|0|||
124831493|NCT02496533|449012307|FG001|Overall Study|Patient did not complete all measures|4|||
124831494|NCT02496533|449012306|FG000|Overall Study|Late for radiologic testing|0|||
124831495|NCT02496533|449012307|FG001|Overall Study|Late for radiologic testing|2|||
124831496|NCT01816893|449012309|FG000|Washout Period|Withdrawal by Subject|2|||
124831497|NCT01816893|449012310|FG001|Washout Period|Withdrawal by Subject|0|||
124639159|NCT00685399|448296520|FG007|Extension|Lack of Efficacy|0|||
124831498|NCT04729127|449014125|FG000|Overall Study|Suspended/Terminated EI Services|4|||
124831499|NCT04729127|449014126|FG001|Overall Study|Suspended/Terminated EI Services|0|||
124831500|NCT04729127|449014127|FG002|Overall Study|Suspended/Terminated EI Services|4|||
124831501|NCT04729127|449014128|FG003|Overall Study|Suspended/Terminated EI Services|6|||
124831502|NCT04729127|449014129|FG004|Overall Study|Suspended/Terminated EI Services|0|||
124831503|NCT04729127|449014130|FG005|Overall Study|Suspended/Terminated EI Services|6|||
124831504|NCT04729127|449014131|FG006|Overall Study|Suspended/Terminated EI Services|2|||
124831505|NCT04729127|449014132|FG007|Overall Study|Suspended/Terminated EI Services|0|||
124831506|NCT04729127|449014133|FG008|Overall Study|Suspended/Terminated EI Services|2|||
124831507|NCT04729127|449014125|FG000|Overall Study|Withdrawal by Subject|1|||
124831508|NCT04729127|449014126|FG001|Overall Study|Withdrawal by Subject|0|||
124831509|NCT04729127|449014127|FG002|Overall Study|Withdrawal by Subject|1|||
124831510|NCT04729127|449014128|FG003|Overall Study|Withdrawal by Subject|0|||
124831511|NCT04729127|449014129|FG004|Overall Study|Withdrawal by Subject|0|||
124831512|NCT04729127|449014130|FG005|Overall Study|Withdrawal by Subject|0|||
124831513|NCT04729127|449014131|FG006|Overall Study|Withdrawal by Subject|0|||
124831514|NCT04729127|449014132|FG007|Overall Study|Withdrawal by Subject|0|||
124831515|NCT04729127|449014133|FG008|Overall Study|Withdrawal by Subject|0|||
124831516|NCT04729127|449014125|FG000|Overall Study|Switched Agency/Setting|1|||
124831517|NCT04729127|449014126|FG001|Overall Study|Switched Agency/Setting|0|||
124831518|NCT04729127|449014127|FG002|Overall Study|Switched Agency/Setting|1|||
124831519|NCT04729127|449014128|FG003|Overall Study|Switched Agency/Setting|1|||
124831520|NCT04729127|449014129|FG004|Overall Study|Switched Agency/Setting|0|||
124831521|NCT04729127|449014130|FG005|Overall Study|Switched Agency/Setting|1|||
124831522|NCT04729127|449014131|FG006|Overall Study|Switched Agency/Setting|1|||
124831523|NCT04729127|449014132|FG007|Overall Study|Switched Agency/Setting|0|||
124831524|NCT04729127|449014133|FG008|Overall Study|Switched Agency/Setting|1|||
124831525|NCT01365507|449014134|FG000|Overall Study|Withdrawal Criteria|8|||
124831526|NCT01365507|449014135|FG001|Overall Study|Withdrawal Criteria|5|||
124831527|NCT01365507|449014134|FG000|Overall Study|Unclassified|1|||
124831528|NCT01365507|449014135|FG001|Overall Study|Unclassified|4|||
124831529|NCT02794103|449014136|FG000|Overall Study|Loss to follow up due to high sedation|3|||
124831530|NCT04782856|449014139|FG000|Overall Study|Withdrawal by Subject|0|||
124831531|NCT04782856|449014140|FG001|Overall Study|Withdrawal by Subject|1|||
124831532|NCT01465022|449014145|FG000|Overall Study|Lost to Follow-up|15|||
124831533|NCT01465022|449014146|FG001|Overall Study|Lost to Follow-up|14|||
124831534|NCT01465022|449014147|FG002|Overall Study|Lost to Follow-up|0|||
124831535|NCT01465022|449014145|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
124831536|NCT01465022|449014146|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
124831537|NCT01465022|449014147|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
124831538|NCT01465022|449014145|FG000|Overall Study|Not Randomized|0|||
124831539|NCT01465022|449014146|FG001|Overall Study|Not Randomized|0|||
124831540|NCT01465022|449014147|FG002|Overall Study|Not Randomized|70|||
124831541|NCT01327300|449014148|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
124831542|NCT01327300|449014149|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
124831543|NCT03020823|449014152|FG000|Overall Study|Physician Decision|4|||
124831544|NCT03020823|449014152|FG000|Overall Study|Lack of Efficacy|4|||
124831545|NCT03020823|449014152|FG000|Overall Study|Adverse Event|2|||
124831546|NCT04307446|449014160|FG000|Overall Study|Lost to Follow-up|2|||
124831547|NCT04307446|449014161|FG001|Overall Study|Lost to Follow-up|0|||
124831548|NCT03257631|449014167|FG000|Overall Study|Death|1|||
124831549|NCT03257631|449014168|FG001|Overall Study|Death|0|||
124831550|NCT03257631|449014169|FG002|Overall Study|Death|1|||
124831551|NCT03257631|449014170|FG003|Overall Study|Death|1|||
124831552|NCT03257631|449014167|FG000|Overall Study|Progressive Disease|10|||
124831553|NCT03257631|449014168|FG001|Overall Study|Progressive Disease|9|||
124831554|NCT03257631|449014169|FG002|Overall Study|Progressive Disease|17|||
124831555|NCT03257631|449014170|FG003|Overall Study|Progressive Disease|8|||
124831556|NCT03257631|449014167|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124831557|NCT03257631|449014168|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124831558|NCT03257631|449014169|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
124831559|NCT03257631|449014170|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
124831560|NCT03257631|449014167|FG000|Overall Study|Adverse Event|0|||
124831561|NCT03257631|449014168|FG001|Overall Study|Adverse Event|0|||
124831562|NCT03257631|449014169|FG002|Overall Study|Adverse Event|2|||
124831563|NCT03257631|449014170|FG003|Overall Study|Adverse Event|0|||
124831564|NCT02672423|449014176|FG000|Period 1|Adverse Event|0|||
124831565|NCT02672423|449014177|FG001|Period 1|Adverse Event|0|||
124831566|NCT02672423|449014178|FG002|Period 1|Adverse Event|0|||
124831567|NCT02672423|449014179|FG003|Period 1|Adverse Event|0|||
124831568|NCT02672423|449014180|FG004|Period 1|Adverse Event|1|||
124831569|NCT02672423|449014181|FG005|Period 1|Adverse Event|0|||
124831570|NCT02672423|449014182|FG006|Period 1|Adverse Event|0|||
124831571|NCT02672423|449014183|FG007|Period 1|Adverse Event|0|||
124831572|NCT02672423|449014184|FG008|Period 1|Adverse Event|0|||
124831573|NCT02672423|449014185|FG009|Period 1|Adverse Event|0|||
124831574|NCT02672423|449014176|FG000|Period 2|Withdrawal by Subject|0|||
124831575|NCT02672423|449014177|FG001|Period 2|Withdrawal by Subject|0|||
124831576|NCT02672423|449014178|FG002|Period 2|Withdrawal by Subject|1|||
124831577|NCT02672423|449014179|FG003|Period 2|Withdrawal by Subject|0|||
124831578|NCT02672423|449014180|FG004|Period 2|Withdrawal by Subject|0|||
124831579|NCT02672423|449014181|FG005|Period 2|Withdrawal by Subject|0|||
124831580|NCT02672423|449014182|FG006|Period 2|Withdrawal by Subject|0|||
124831581|NCT02672423|449014183|FG007|Period 2|Withdrawal by Subject|0|||
124831582|NCT02672423|449014184|FG008|Period 2|Withdrawal by Subject|0|||
124831583|NCT02672423|449014185|FG009|Period 2|Withdrawal by Subject|0|||
124831584|NCT02672423|449014176|FG000|Period 3|Withdrawal by Subject|0|||
124831585|NCT02672423|449014177|FG001|Period 3|Withdrawal by Subject|0|||
124831586|NCT02672423|449014178|FG002|Period 3|Withdrawal by Subject|0|||
124831587|NCT02672423|449014179|FG003|Period 3|Withdrawal by Subject|0|||
124831588|NCT02672423|449014180|FG004|Period 3|Withdrawal by Subject|0|||
124831589|NCT02672423|449014181|FG005|Period 3|Withdrawal by Subject|0|||
124831590|NCT02672423|449014182|FG006|Period 3|Withdrawal by Subject|0|||
124831591|NCT02672423|449014183|FG007|Period 3|Withdrawal by Subject|1|||
124831592|NCT02672423|449014184|FG008|Period 3|Withdrawal by Subject|0|||
124831593|NCT02672423|449014185|FG009|Period 3|Withdrawal by Subject|0|||
124831594|NCT02672423|449014176|FG000|Period 3|Physician Decision|0|||
124831595|NCT02672423|449014177|FG001|Period 3|Physician Decision|0|||
124831596|NCT02672423|449014178|FG002|Period 3|Physician Decision|0|||
124831597|NCT02672423|449014179|FG003|Period 3|Physician Decision|0|||
124831598|NCT02672423|449014180|FG004|Period 3|Physician Decision|0|||
124831599|NCT02672423|449014181|FG005|Period 3|Physician Decision|1|||
124831600|NCT02672423|449014182|FG006|Period 3|Physician Decision|0|||
124831601|NCT02672423|449014183|FG007|Period 3|Physician Decision|0|||
124831602|NCT02672423|449014184|FG008|Period 3|Physician Decision|0|||
124831603|NCT02672423|449014185|FG009|Period 3|Physician Decision|0|||
124831604|NCT01046682|449014187|FG000|Overall Study|Adverse Event|2|||
124831605|NCT01046682|449014188|FG001|Overall Study|Adverse Event|0|||
124831606|NCT01454570|449014191|FG000|Overall Study|Withdrawal by Subject|2|||
124831607|NCT01454570|449014191|FG000|Overall Study|Screen Failure|7|||
124831608|NCT00536107|449014192|FG000|Overall Study|Death|5|||
124831609|NCT00536107|449014193|FG001|Overall Study|Death|1|||
124831610|NCT00536107|449014192|FG000|Overall Study|Incorrect enrolment|1|||
124831611|NCT00536107|449014193|FG001|Overall Study|Incorrect enrolment|0|||
124831612|NCT00536107|449014192|FG000|Overall Study|Withdrawal by Subject|0|||
124831613|NCT00536107|449014193|FG001|Overall Study|Withdrawal by Subject|1|||
124831614|NCT00536107|449014192|FG000|Overall Study|Study Termination|2|||
124831615|NCT00536107|449014193|FG001|Overall Study|Study Termination|4|||
124831616|NCT00371254|449014195|FG000|Overall Study|Disease progression|13|||
124831617|NCT00371254|449014196|FG001|Overall Study|Disease progression|13|||
124831618|NCT00371254|449014195|FG000|Overall Study|Study drug toxicity|3|||
124831619|NCT00371254|449014196|FG001|Overall Study|Study drug toxicity|5|||
124831620|NCT00371254|449014195|FG000|Overall Study|Subject request|5|||
124831621|NCT00371254|449014196|FG001|Overall Study|Subject request|0|||
124831622|NCT00371254|449014195|FG000|Overall Study|Investigator Decision|2|||
124831623|NCT00371254|449014196|FG001|Overall Study|Investigator Decision|0|||
124831624|NCT00371254|449014195|FG000|Overall Study|Adverse event unrelated to study drug|0|||
124831625|NCT00371254|449014196|FG001|Overall Study|Adverse event unrelated to study drug|1|||
124831626|NCT00371254|449014195|FG000|Overall Study|Lost to Follow-up|0|||
124831627|NCT00371254|449014196|FG001|Overall Study|Lost to Follow-up|1|||
124831628|NCT00371254|449014195|FG000|Overall Study|Withdrawal by Subject|0|||
124831629|NCT00371254|449014196|FG001|Overall Study|Withdrawal by Subject|1|||
124831630|NCT02246673|449014199|FG000|Overall Study|Sponsor Decision|1|||
124831631|NCT02246673|449014200|FG001|Overall Study|Sponsor Decision|0|||
124831632|NCT02246673|449014201|FG002|Overall Study|Sponsor Decision|0|||
124831633|NCT02246673|449014202|FG003|Overall Study|Sponsor Decision|0|||
124831634|NCT02246673|449014203|FG004|Overall Study|Sponsor Decision|0|||
124831635|NCT02246673|449014199|FG000|Overall Study|Withdrawal by Subject|0|||
124831636|NCT02246673|449014200|FG001|Overall Study|Withdrawal by Subject|0|||
124831637|NCT02246673|449014201|FG002|Overall Study|Withdrawal by Subject|0|||
124831638|NCT02246673|449014202|FG003|Overall Study|Withdrawal by Subject|0|||
124831639|NCT02246673|449014203|FG004|Overall Study|Withdrawal by Subject|1|||
124831640|NCT02246673|449014199|FG000|Overall Study|Lost to Follow-up|0|||
124831641|NCT02246673|449014200|FG001|Overall Study|Lost to Follow-up|0|||
124831642|NCT02246673|449014201|FG002|Overall Study|Lost to Follow-up|0|||
124831643|NCT02246673|449014202|FG003|Overall Study|Lost to Follow-up|1|||
124831644|NCT02246673|449014203|FG004|Overall Study|Lost to Follow-up|0|||
124831645|NCT02246673|449014199|FG000|Overall Study|Protocol Violation|0|||
124831646|NCT02246673|449014200|FG001|Overall Study|Protocol Violation|0|||
124831647|NCT02246673|449014201|FG002|Overall Study|Protocol Violation|0|||
124831648|NCT02246673|449014202|FG003|Overall Study|Protocol Violation|1|||
124831649|NCT02246673|449014203|FG004|Overall Study|Protocol Violation|0|||
124831650|NCT04356963|449014205|FG000|First Session|Withdrawal by Subject|1|||
124831651|NCT04356963|449014205|FG000|Second Session|Withdrawal by Subject|3|||
124831652|NCT04356963|449014205|FG000|Second Session|Lost to Follow-up|1|||
124831653|NCT04356963|449014205|FG000|Third Session|Lost to Follow-up|6|||
124831654|NCT04356963|449014205|FG000|Third Session|Withdrawal by Subject|1|||
124831655|NCT02726074|449014211|FG000|Overall Study|Withdrawal by Subject|4|||
124831656|NCT02726074|449014211|FG000|Overall Study|Adverse Event|14|||
124831657|NCT02726074|449014211|FG000|Overall Study|Protocol Violation|3|||
124831658|NCT02726074|449014211|FG000|Overall Study|Lost to Follow-up|2|||
124831659|NCT02726074|449014211|FG000|Overall Study|Others|3|||
124831660|NCT01679002|449014212|FG000|Overall Study|Adverse Event|1|||
124831661|NCT01679002|449014213|FG001|Overall Study|Adverse Event|1|||
124831662|NCT01679002|449014214|FG002|Overall Study|Adverse Event|0|||
124831663|NCT01176266|449014215|FG000|Overall Study|Death|6|||
124831664|NCT01176266|449014215|FG000|Overall Study|Withdrawal by Subject|3|||
124831665|NCT01179477|449014216|FG000|Overall Study|Death|542|||
124831666|NCT01179477|449014216|FG000|Overall Study|Unsuccessful implant|80|||
124831667|NCT01179477|449014216|FG000|Overall Study|Non-death withdrawal|438|||
124831668|NCT01179477|449014216|FG000|Overall Study|Did not complete final visit|27|||
124831669|NCT05075850|449014224|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
124831670|NCT01265849|449014225|FG000|Overall Study|Randomized//Treatment not initiated|1|||
124831671|NCT01265849|449014226|FG001|Overall Study|Randomized//Treatment not initiated|4|||
124831672|NCT01265849|449014227|FG002|Overall Study|Randomized//Treatment not initiated|0|||
124831673|NCT01265849|449014225|FG000|Overall Study|Physician Decision|1|||
124831674|NCT01265849|449014226|FG001|Overall Study|Physician Decision|2|||
124831675|NCT01265849|449014227|FG002|Overall Study|Physician Decision|0|||
124831676|NCT01265849|449014225|FG000|Overall Study|Lost to Follow-up|18|||
124831677|NCT01265849|449014226|FG001|Overall Study|Lost to Follow-up|15|||
124831678|NCT01265849|449014227|FG002|Overall Study|Lost to Follow-up|5|||
124831679|NCT01265849|449014225|FG000|Overall Study|Not otherwise specified|1|||
124831680|NCT01265849|449014226|FG001|Overall Study|Not otherwise specified|6|||
124831681|NCT01265849|449014227|FG002|Overall Study|Not otherwise specified|1|||
124831682|NCT01265849|449014225|FG000|Overall Study|Withdrawal by Subject|25|||
124831683|NCT01265849|449014226|FG001|Overall Study|Withdrawal by Subject|34|||
124831684|NCT01265849|449014227|FG002|Overall Study|Withdrawal by Subject|13|||
124831685|NCT02154581|449014233|FG000|Overall Study|Lost to Follow-up|7|||
124831686|NCT02154581|449014234|FG001|Overall Study|Lost to Follow-up|8|||
124831687|NCT01092182|449014235|FG000|Overall Study|Death|0|||
124831688|NCT01092182|449014236|FG001|Overall Study|Death|5|||
124831689|NCT01092182|449014237|FG002|Overall Study|Death|3|||
124831690|NCT01092182|449014235|FG000|Overall Study|participant safety|1|||
124831691|NCT01092182|449014236|FG001|Overall Study|participant safety|2|||
124831692|NCT01092182|449014237|FG002|Overall Study|participant safety|0|||
124831693|NCT01092182|449014235|FG000|Overall Study|Physician Decision|0|||
124831694|NCT01092182|449014236|FG001|Overall Study|Physician Decision|6|||
124831695|NCT01092182|449014237|FG002|Overall Study|Physician Decision|0|||
124831696|NCT01092182|449014235|FG000|Overall Study|Did not meet criteria|0|||
124831697|NCT01092182|449014236|FG001|Overall Study|Did not meet criteria|0|||
124831698|NCT01092182|449014237|FG002|Overall Study|Did not meet criteria|25|||
124831699|NCT01092182|449014235|FG000|Overall Study|Non-compliance|0|||
124831700|NCT01092182|449014236|FG001|Overall Study|Non-compliance|3|||
124831701|NCT01092182|449014237|FG002|Overall Study|Non-compliance|0|||
124831702|NCT01092182|449014235|FG000|Overall Study|Participant refused follow-up|0|||
124831703|NCT01092182|449014236|FG001|Overall Study|Participant refused follow-up|2|||
124831704|NCT01092182|449014237|FG002|Overall Study|Participant refused follow-up|0|||
124831705|NCT02515045|449014240|FG000|Overall Study|Adverse Event|0|||
124831706|NCT02515045|449014241|FG001|Overall Study|Adverse Event|3|||
124831707|NCT02515045|449014242|FG002|Overall Study|Adverse Event|3|||
124831708|NCT02515045|449014240|FG000|Overall Study|Lost to Follow-up|0|||
124831709|NCT02515045|449014241|FG001|Overall Study|Lost to Follow-up|1|||
124831710|NCT02515045|449014242|FG002|Overall Study|Lost to Follow-up|1|||
124831711|NCT03255382|449014245|FG000|Overall Study|Adverse Event|3|||
124831712|NCT03255382|449014246|FG001|Overall Study|Adverse Event|0|||
124831713|NCT03255382|449014245|FG000|Overall Study|Lost to Follow-up|2|||
124831714|NCT03255382|449014246|FG001|Overall Study|Lost to Follow-up|0|||
124831715|NCT03255382|449014245|FG000|Overall Study|Withdrawal by Subject|2|||
124831716|NCT03255382|449014246|FG001|Overall Study|Withdrawal by Subject|0|||
124831717|NCT03255382|449014245|FG000|Overall Study|Other|6|||
124831718|NCT03255382|449014246|FG001|Overall Study|Other|0|||
124831719|NCT02221284|449014247|FG000|Overall Study|Case Report Forms Uncollected|56|||
124831720|NCT02221284|449014247|FG000|Overall Study|Protocol Deviation|5|||
124831721|NCT03011307|449014250|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
124831722|NCT03011307|449014251|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
124831723|NCT03011307|449014250|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
124831724|NCT03011307|449014251|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
124831725|NCT03011307|449014250|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
124831726|NCT03011307|449014251|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
124831727|NCT02677987|449014253|FG000|Overall Study|Withdrawal by Subject|3|||
124831728|NCT02677987|449014254|FG001|Overall Study|Withdrawal by Subject|0|||
124831729|NCT02677987|449014253|FG000|Overall Study|Lost to Follow-up|1|||
124831730|NCT02677987|449014254|FG001|Overall Study|Lost to Follow-up|0|||
124831731|NCT00651755|449014255|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
124831732|NCT00651755|449014256|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
124831733|NCT00651755|449014255|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
124831734|NCT00651755|449014256|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
124831735|NCT00624052|449014257|FG000|Overall Study|Adverse Event|7|||
124831736|NCT00624052|449014258|FG001|Overall Study|Adverse Event|6|||
124831737|NCT00624052|449014259|FG002|Overall Study|Adverse Event|0|||
124831738|NCT00624052|449014260|FG003|Overall Study|Adverse Event|3|||
124831739|NCT00624052|449014257|FG000|Overall Study|Lack of Efficacy|1|||
124831740|NCT00624052|449014258|FG001|Overall Study|Lack of Efficacy|1|||
124831741|NCT00624052|449014259|FG002|Overall Study|Lack of Efficacy|0|||
124831742|NCT00624052|449014260|FG003|Overall Study|Lack of Efficacy|0|||
124831743|NCT00624052|449014257|FG000|Overall Study|Lost to Follow-up|2|||
124831744|NCT00624052|449014258|FG001|Overall Study|Lost to Follow-up|3|||
124831745|NCT00624052|449014259|FG002|Overall Study|Lost to Follow-up|1|||
124831746|NCT00624052|449014260|FG003|Overall Study|Lost to Follow-up|0|||
124831747|NCT00624052|449014257|FG000|Overall Study|Non compliant with the protocol|2|||
124831748|NCT00624052|449014258|FG001|Overall Study|Non compliant with the protocol|1|||
124831749|NCT00624052|449014259|FG002|Overall Study|Non compliant with the protocol|1|||
124831750|NCT00624052|449014260|FG003|Overall Study|Non compliant with the protocol|1|||
124831751|NCT00624052|449014257|FG000|Overall Study|Consent withdrawn|3|||
124831752|NCT00624052|449014258|FG001|Overall Study|Consent withdrawn|1|||
124831753|NCT00624052|449014259|FG002|Overall Study|Consent withdrawn|1|||
124831754|NCT00624052|449014260|FG003|Overall Study|Consent withdrawn|0|||
124831755|NCT00624052|449014257|FG000|Overall Study|Changed job/ran out if meds|0|||
124831756|NCT00624052|449014258|FG001|Overall Study|Changed job/ran out if meds|2|||
124831757|NCT00624052|449014259|FG002|Overall Study|Changed job/ran out if meds|0|||
124831758|NCT00624052|449014260|FG003|Overall Study|Changed job/ran out if meds|0|||
124831759|NCT00281684|449014261|FG000|Overall Study|Lost to Follow-up|0|||
124831760|NCT00281684|449014262|FG001|Overall Study|Lost to Follow-up|0|||
124831761|NCT00281684|449014263|FG002|Overall Study|Lost to Follow-up|1|||
124831762|NCT00281684|449014264|FG003|Overall Study|Lost to Follow-up|0|||
124831763|NCT00281684|449014261|FG000|Overall Study|Withdrawal by Subject|1|||
124831764|NCT00281684|449014262|FG001|Overall Study|Withdrawal by Subject|0|||
124831765|NCT00281684|449014263|FG002|Overall Study|Withdrawal by Subject|0|||
124831766|NCT00281684|449014264|FG003|Overall Study|Withdrawal by Subject|0|||
124831767|NCT03760146|449014268|FG000|Overall Study|Adverse Event|11|||
124831768|NCT03760146|449014269|FG001|Overall Study|Adverse Event|8|||
124831769|NCT03760146|449014270|FG002|Overall Study|Adverse Event|0|||
124831770|NCT03760146|449014271|FG003|Overall Study|Adverse Event|0|||
124831771|NCT03760146|449014272|FG004|Overall Study|Adverse Event|0|||
124831772|NCT03760146|449014273|FG005|Overall Study|Adverse Event|0|||
124831773|NCT03760146|449014268|FG000|Overall Study|Death|1|||
124831774|NCT03760146|449014269|FG001|Overall Study|Death|0|||
124831775|NCT03760146|449014270|FG002|Overall Study|Death|0|||
124831776|NCT03760146|449014271|FG003|Overall Study|Death|0|||
124831777|NCT03760146|449014272|FG004|Overall Study|Death|0|||
124831778|NCT03760146|449014273|FG005|Overall Study|Death|0|||
124831779|NCT03760146|449014268|FG000|Overall Study|Lost to Follow-up|41|||
124831780|NCT03760146|449014269|FG001|Overall Study|Lost to Follow-up|28|||
124831781|NCT03760146|449014270|FG002|Overall Study|Lost to Follow-up|9|||
124831782|NCT03760146|449014271|FG003|Overall Study|Lost to Follow-up|2|||
124831783|NCT03760146|449014272|FG004|Overall Study|Lost to Follow-up|14|||
124831784|NCT03760146|449014273|FG005|Overall Study|Lost to Follow-up|8|||
124831785|NCT03760146|449014268|FG000|Overall Study|No longer met eligibility criteria|3|||
124831786|NCT03760146|449014269|FG001|Overall Study|No longer met eligibility criteria|9|||
124831787|NCT03760146|449014270|FG002|Overall Study|No longer met eligibility criteria|0|||
124831788|NCT03760146|449014271|FG003|Overall Study|No longer met eligibility criteria|0|||
124831789|NCT03760146|449014272|FG004|Overall Study|No longer met eligibility criteria|1|||
124831790|NCT03760146|449014273|FG005|Overall Study|No longer met eligibility criteria|0|||
124831791|NCT03760146|449014268|FG000|Overall Study|Protocol Violation|21|||
124831792|NCT03760146|449014269|FG001|Overall Study|Protocol Violation|13|||
124831793|NCT03760146|449014270|FG002|Overall Study|Protocol Violation|1|||
124831794|NCT03760146|449014271|FG003|Overall Study|Protocol Violation|0|||
124831795|NCT03760146|449014272|FG004|Overall Study|Protocol Violation|1|||
124831796|NCT03760146|449014273|FG005|Overall Study|Protocol Violation|0|||
124831797|NCT03760146|449014268|FG000|Overall Study|Withdrawal by Subject|19|||
124831798|NCT03760146|449014269|FG001|Overall Study|Withdrawal by Subject|20|||
124831799|NCT03760146|449014270|FG002|Overall Study|Withdrawal by Subject|1|||
124831800|NCT03760146|449014271|FG003|Overall Study|Withdrawal by Subject|0|||
124831801|NCT03760146|449014272|FG004|Overall Study|Withdrawal by Subject|1|||
124831802|NCT03760146|449014273|FG005|Overall Study|Withdrawal by Subject|0|||
124831803|NCT03839212|449014274|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
124831804|NCT00679263|449014275|FG000|Visit 2/Dose 1|Adverse Event|1|||
124831805|NCT00679263|449014276|FG001|Visit 2/Dose 1|Adverse Event|0|||
124831806|NCT00679263|449014277|FG002|Visit 2/Dose 1|Adverse Event|0|||
124831807|NCT00679263|449014275|FG000|Visit 2/Dose 1|subject not compliance|1|||
124831808|NCT00679263|449014276|FG001|Visit 2/Dose 1|subject not compliance|1|||
124831809|NCT00679263|449014277|FG002|Visit 2/Dose 1|subject not compliance|0|||
124831810|NCT01464346|449014278|FG000|Overall Study|Withdrawal by Subject|0|||
124831811|NCT01464346|449014279|FG001|Overall Study|Withdrawal by Subject|0|||
124831812|NCT01464346|449014280|FG002|Overall Study|Withdrawal by Subject|1|||
124831813|NCT03245008|449014281|FG000|Overall Study|Adverse Event|15|||
124831814|NCT03245008|449014282|FG001|Overall Study|Adverse Event|18|||
124831815|NCT03245008|449014283|FG002|Overall Study|Adverse Event|15|||
124831816|NCT03245008|449014284|FG003|Overall Study|Adverse Event|0|||
124831817|NCT03245008|449014285|FG004|Overall Study|Adverse Event|1|||
124831818|NCT03245008|449014281|FG000|Overall Study|Lack of Efficacy|0|||
124831819|NCT03245008|449014282|FG001|Overall Study|Lack of Efficacy|1|||
124831820|NCT03245008|449014283|FG002|Overall Study|Lack of Efficacy|0|||
124831821|NCT03245008|449014284|FG003|Overall Study|Lack of Efficacy|0|||
124831822|NCT03245008|449014285|FG004|Overall Study|Lack of Efficacy|0|||
124831823|NCT03245008|449014281|FG000|Overall Study|Lost to Follow-up|4|||
124831824|NCT03245008|449014282|FG001|Overall Study|Lost to Follow-up|1|||
124831825|NCT03245008|449014283|FG002|Overall Study|Lost to Follow-up|0|||
124831826|NCT03245008|449014284|FG003|Overall Study|Lost to Follow-up|0|||
124831827|NCT03245008|449014285|FG004|Overall Study|Lost to Follow-up|1|||
124831828|NCT03245008|449014281|FG000|Overall Study|Physician Decision|1|||
124831829|NCT03245008|449014282|FG001|Overall Study|Physician Decision|3|||
124831830|NCT03245008|449014283|FG002|Overall Study|Physician Decision|4|||
124831831|NCT03245008|449014284|FG003|Overall Study|Physician Decision|0|||
124831832|NCT03245008|449014285|FG004|Overall Study|Physician Decision|0|||
124831833|NCT03245008|449014281|FG000|Overall Study|Protocol Violation|0|||
124831834|NCT03245008|449014282|FG001|Overall Study|Protocol Violation|1|||
124831835|NCT03245008|449014283|FG002|Overall Study|Protocol Violation|0|||
124831836|NCT03245008|449014284|FG003|Overall Study|Protocol Violation|0|||
124831837|NCT03245008|449014285|FG004|Overall Study|Protocol Violation|0|||
124831838|NCT03245008|449014281|FG000|Overall Study|Withdrawal by Subject|20|||
124831839|NCT03245008|449014282|FG001|Overall Study|Withdrawal by Subject|19|||
124831840|NCT03245008|449014283|FG002|Overall Study|Withdrawal by Subject|11|||
124831841|NCT03245008|449014284|FG003|Overall Study|Withdrawal by Subject|0|||
124831842|NCT03245008|449014285|FG004|Overall Study|Withdrawal by Subject|0|||
124831843|NCT03245008|449014281|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
124831844|NCT03245008|449014282|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
124831845|NCT03245008|449014283|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
124831846|NCT03245008|449014284|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
124831847|NCT03245008|449014285|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
124831848|NCT03245008|449014281|FG000|Overall Study|Failure to meet randomization criteria|0|||
124831849|NCT03245008|449014282|FG001|Overall Study|Failure to meet randomization criteria|1|||
124831850|NCT03245008|449014283|FG002|Overall Study|Failure to meet randomization criteria|0|||
124831851|NCT03245008|449014284|FG003|Overall Study|Failure to meet randomization criteria|1|||
124831852|NCT03245008|449014285|FG004|Overall Study|Failure to meet randomization criteria|0|||
124831853|NCT02075658|449014286|FG000|Overall Study|Physician Decision|2|||
124831854|NCT02075658|449014287|FG001|Overall Study|Physician Decision|2|||
124831855|NCT01286012|449014288|FG000|Overall Study|Adverse Event|3|||
124831856|NCT01286012|449014289|FG001|Overall Study|Adverse Event|3|||
124831857|NCT01286012|449014288|FG000|Overall Study|Death|2|||
124831858|NCT01286012|449014289|FG001|Overall Study|Death|3|||
124831859|NCT01286012|449014288|FG000|Overall Study|Protocol Violation|1|||
124831860|NCT01286012|449014289|FG001|Overall Study|Protocol Violation|1|||
124831861|NCT01286012|449014288|FG000|Overall Study|Withdrawal by Subject|4|||
124831862|NCT01286012|449014289|FG001|Overall Study|Withdrawal by Subject|4|||
124831863|NCT01286012|449014288|FG000|Overall Study|Physician Decision|2|||
124831864|NCT01286012|449014289|FG001|Overall Study|Physician Decision|0|||
124831865|NCT01286012|449014288|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
124831866|NCT01286012|449014289|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
124831867|NCT00718328|449014290|FG000|Overall Study|Lost to Follow-up|1|||
124831868|NCT00718328|449014291|FG001|Overall Study|Lost to Follow-up|0|||
124831869|NCT01064401|449014292|FG000|Overall Study|Adverse Event|47|||
124831870|NCT01064401|449014293|FG001|Overall Study|Adverse Event|56|||
124639160|NCT00685399|448296513|FG000|Extension|Adverse Event|0|||
124639161|NCT00685399|448296514|FG001|Extension|Adverse Event|0|||
124639162|NCT00685399|448296515|FG002|Extension|Adverse Event|0|||
124639163|NCT00685399|448296516|FG003|Extension|Adverse Event|2|||
124639164|NCT00685399|448296517|FG004|Extension|Adverse Event|0|||
124639165|NCT00685399|448296518|FG005|Extension|Adverse Event|0|||
124639166|NCT00685399|448296519|FG006|Extension|Adverse Event|0|||
124639167|NCT00685399|448296520|FG007|Extension|Adverse Event|0|||
124639168|NCT01562782|448296521|FG000|Overall Study|Withdrawal by Subject|3|||
124639169|NCT01562782|448296522|FG001|Overall Study|Withdrawal by Subject|3|||
124639170|NCT01562782|448296521|FG000|Overall Study|screen failure|1|||
124639171|NCT01562782|448296522|FG001|Overall Study|screen failure|2|||
124831871|NCT01064401|449014292|FG000|Overall Study|Lack of Efficacy|46|||
124639172|NCT02049814|448296529|FG000|Overall Study|Reason not Specified|4|||
124831872|NCT01064401|449014293|FG001|Overall Study|Lack of Efficacy|23|||
124831873|NCT01064401|449014292|FG000|Overall Study|Lost to Follow-up|12|||
124831874|NCT01064401|449014293|FG001|Overall Study|Lost to Follow-up|9|||
124831875|NCT01064401|449014292|FG000|Overall Study|Consent Withdrawn|98|||
124831876|NCT01064401|449014293|FG001|Overall Study|Consent Withdrawn|80|||
124831877|NCT01064401|449014292|FG000|Overall Study|Investigator Decision|4|||
124831878|NCT01064401|449014293|FG001|Overall Study|Investigator Decision|6|||
124831879|NCT01064401|449014292|FG000|Overall Study|Death|4|||
124831880|NCT01064401|449014293|FG001|Overall Study|Death|0|||
124831881|NCT01064401|449014292|FG000|Overall Study|Pregnancy|4|||
124831882|NCT01064401|449014293|FG001|Overall Study|Pregnancy|7|||
124831883|NCT01064401|449014292|FG000|Overall Study|Noncompliance|7|||
124831884|NCT01064401|449014293|FG001|Overall Study|Noncompliance|8|||
124831885|NCT01064401|449014292|FG000|Overall Study|Site Closure|4|||
124831886|NCT01064401|449014293|FG001|Overall Study|Site Closure|5|||
124831887|NCT01064401|449014292|FG000|Overall Study|Other|2|||
124831888|NCT01064401|449014293|FG001|Overall Study|Other|1|||
124831889|NCT04007094|449014294|FG000|Overall Study|Lost to Follow-up|1|||
124831890|NCT04007094|449014295|FG001|Overall Study|Lost to Follow-up|1|||
124831891|NCT01581307|449014296|FG000|Overall Study|Withdrawal by Subject|1|||
124831892|NCT00378209|449014301|FG000|Overall Study|Progressive disease|11|||
124831893|NCT00378209|449014301|FG000|Overall Study|Adverse Event|3|||
124831894|NCT00378209|449014301|FG000|Overall Study|Initiation of non-protocol therapy|3|||
124831895|NCT00378209|449014301|FG000|Overall Study|Physician Decision|3|||
124831896|NCT00378209|449014301|FG000|Overall Study|Death|1|||
124831897|NCT00378209|449014301|FG000|Overall Study|Treatment delay|1|||
124831898|NCT01536379|449015721|FG000|Overall Study|Adverse Event|1|||
124831899|NCT01536379|449015722|FG001|Overall Study|Adverse Event|2|||
124831900|NCT01536379|449015721|FG000|Overall Study|Withdrawal by Subject|1|||
124831901|NCT01536379|449015722|FG001|Overall Study|Withdrawal by Subject|1|||
124831902|NCT04439253|449015726|FG000|Overall Study|Adverse Event|1|||
124831903|NCT04439253|449015726|FG000|Overall Study|Disease progression|2|||
124831904|NCT04439253|449015726|FG000|Overall Study|Complicating disease|1|||
124831905|NCT03971695|449015727|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
124831906|NCT03971695|449015728|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
124831907|NCT03971695|449015729|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
124831908|NCT03971695|449015730|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
124831909|NCT03971695|449015731|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
124831910|NCT03971695|449015732|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
124831911|NCT03971695|449015733|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
124831912|NCT03971695|449015734|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
124831913|NCT03971695|449015735|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
124831914|NCT03971695|449015736|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
124831915|NCT03971695|449015737|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
124831916|NCT03971695|449015738|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
124831917|NCT03971695|449015739|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
124831918|NCT04447417|449015740|FG000|Overall Study|Withdrawal by Subject|1|||
124831919|NCT04447417|449015741|FG001|Overall Study|Withdrawal by Subject|0|||
124831920|NCT04447417|449015740|FG000|Overall Study|Failure to meet inclusion criteria|1|||
124831921|NCT04447417|449015741|FG001|Overall Study|Failure to meet inclusion criteria|0|||
124831922|NCT04447417|449015740|FG000|Overall Study|Lost to Follow-up|1|||
124831923|NCT04447417|449015741|FG001|Overall Study|Lost to Follow-up|0|||
124831924|NCT02155738|449015749|FG000|Overall Study|Missing critical information|1|||
124831925|NCT02155738|449015750|FG001|Overall Study|Missing critical information|0|||
124831926|NCT02155738|449015751|FG002|Overall Study|Missing critical information|0|||
124831927|NCT02155738|449015752|FG003|Overall Study|Missing critical information|1|||
124831928|NCT01190254|449015753|FG000|Overall Study|Adverse Event|3|||
124831929|NCT01190254|449015754|FG001|Overall Study|Adverse Event|6|||
124831930|NCT01190254|449015755|FG002|Overall Study|Adverse Event|8|||
124831931|NCT01190254|449015753|FG000|Overall Study|Lack of Efficacy|7|||
124831932|NCT01190254|449015754|FG001|Overall Study|Lack of Efficacy|4|||
124831933|NCT01190254|449015755|FG002|Overall Study|Lack of Efficacy|5|||
124831934|NCT01190254|449015753|FG000|Overall Study|Lost to Follow-up|4|||
124831935|NCT01190254|449015754|FG001|Overall Study|Lost to Follow-up|2|||
124831936|NCT01190254|449015755|FG002|Overall Study|Lost to Follow-up|0|||
124831937|NCT01190254|449015753|FG000|Overall Study|Withdrawal by Subject|4|||
124831938|NCT01190254|449015754|FG001|Overall Study|Withdrawal by Subject|5|||
124831939|NCT01190254|449015755|FG002|Overall Study|Withdrawal by Subject|7|||
124831940|NCT01190254|449015753|FG000|Overall Study|Protocol Violation|2|||
124831941|NCT01190254|449015754|FG001|Overall Study|Protocol Violation|0|||
124831942|NCT01190254|449015755|FG002|Overall Study|Protocol Violation|2|||
124831943|NCT01190254|449015753|FG000|Overall Study|Did not meet protocol eligibility|1|||
124831944|NCT01190254|449015754|FG001|Overall Study|Did not meet protocol eligibility|0|||
124831945|NCT01190254|449015755|FG002|Overall Study|Did not meet protocol eligibility|0|||
124831946|NCT02603809|449015756|FG000|Overall Study|Withdrawal by Subject|4|||
124831947|NCT02603809|449015757|FG001|Overall Study|Withdrawal by Subject|1|||
124831948|NCT02603809|449015758|FG002|Overall Study|Withdrawal by Subject|2|||
124831949|NCT02603809|449015759|FG003|Overall Study|Withdrawal by Subject|3|||
124831950|NCT02603809|449015760|FG004|Overall Study|Withdrawal by Subject|3|||
124831951|NCT02603809|449015761|FG005|Overall Study|Withdrawal by Subject|4|||
124831952|NCT02603809|449015756|FG000|Overall Study|Lost to Follow-up|2|||
124831953|NCT02603809|449015757|FG001|Overall Study|Lost to Follow-up|3|||
124831954|NCT02603809|449015758|FG002|Overall Study|Lost to Follow-up|1|||
124831955|NCT02603809|449015759|FG003|Overall Study|Lost to Follow-up|4|||
124831956|NCT02603809|449015760|FG004|Overall Study|Lost to Follow-up|2|||
124831957|NCT02603809|449015761|FG005|Overall Study|Lost to Follow-up|2|||
124831958|NCT02603809|449015756|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
124831959|NCT02603809|449015757|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
124831960|NCT02603809|449015758|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
124831961|NCT02603809|449015759|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
124831962|NCT02603809|449015760|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
124831963|NCT02603809|449015761|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
124831964|NCT02603809|449015756|FG000|Overall Study|Physician Decision|0|||
124831965|NCT02603809|449015757|FG001|Overall Study|Physician Decision|0|||
124831966|NCT02603809|449015758|FG002|Overall Study|Physician Decision|0|||
124831967|NCT02603809|449015759|FG003|Overall Study|Physician Decision|1|||
124831968|NCT02603809|449015760|FG004|Overall Study|Physician Decision|2|||
124831969|NCT02603809|449015761|FG005|Overall Study|Physician Decision|1|||
124831970|NCT02603809|449015756|FG000|Overall Study|Adverse Event|3|||
124831971|NCT02603809|449015757|FG001|Overall Study|Adverse Event|0|||
124831972|NCT02603809|449015758|FG002|Overall Study|Adverse Event|2|||
124831973|NCT02603809|449015759|FG003|Overall Study|Adverse Event|2|||
124831974|NCT02603809|449015760|FG004|Overall Study|Adverse Event|1|||
124831975|NCT02603809|449015761|FG005|Overall Study|Adverse Event|1|||
124831976|NCT02603809|449015756|FG000|Overall Study|Lack of Efficacy|0|||
124831977|NCT02603809|449015757|FG001|Overall Study|Lack of Efficacy|1|||
124831978|NCT02603809|449015758|FG002|Overall Study|Lack of Efficacy|0|||
124831979|NCT02603809|449015759|FG003|Overall Study|Lack of Efficacy|0|||
124831980|NCT02603809|449015760|FG004|Overall Study|Lack of Efficacy|0|||
124831981|NCT02603809|449015761|FG005|Overall Study|Lack of Efficacy|1|||
124831982|NCT00156533|449015762|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
124831983|NCT00156533|449015763|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
124831984|NCT00156533|449015764|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
124831985|NCT00156533|449015765|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
124831986|NCT00156533|449015762|FG000|Overall Study|Withdrawal by Subject|1|||
124831987|NCT00156533|449015763|FG001|Overall Study|Withdrawal by Subject|0|||
124831988|NCT00156533|449015764|FG002|Overall Study|Withdrawal by Subject|0|||
124831989|NCT00156533|449015765|FG003|Overall Study|Withdrawal by Subject|1|||
124831990|NCT00156533|449015762|FG000|Overall Study|Failed Screening|1|||
124831991|NCT00156533|449015763|FG001|Overall Study|Failed Screening|0|||
124831992|NCT00156533|449015764|FG002|Overall Study|Failed Screening|1|||
124831993|NCT00156533|449015765|FG003|Overall Study|Failed Screening|1|||
124831994|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
124831995|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
124831996|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
124831997|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
124831998|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
124831999|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
124832000|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
124832001|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
124832002|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
124832003|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
124832004|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
124832005|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
124832006|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
124832007|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
124832008|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
124832009|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
124832010|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
124832011|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
124832012|NCT00887354|449015766|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
124832013|NCT00887354|449015767|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
124832014|NCT00887354|449015766|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
124832015|NCT00887354|449015767|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
124832016|NCT00887354|449015766|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
124832017|NCT00887354|449015767|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
124832018|NCT00887354|449015766|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
124832019|NCT00887354|449015767|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
124832020|NCT00887354|449015766|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
124832021|NCT00887354|449015767|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
124832022|NCT00887354|449015766|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
124832023|NCT00887354|449015767|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
124832024|NCT03265249|449015768|FG000|Overall Study|Withdrawal by Subject|0|||
124832025|NCT03265249|449015769|FG001|Overall Study|Withdrawal by Subject|1|||
124832026|NCT00914810|449015770|FG000|Overall Study|Withdrawal by Subject|1|||
124832027|NCT00914810|449015771|FG001|Overall Study|Withdrawal by Subject|0|||
124832028|NCT00914810|449015770|FG000|Overall Study|Relocated out of state|1|||
124832029|NCT00914810|449015771|FG001|Overall Study|Relocated out of state|0|||
124832030|NCT00914810|449015770|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
124832031|NCT00914810|449015771|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
124832032|NCT01290666|449015780|FG000|Overall Study|Lost to Follow-up|11|||
124832033|NCT01290666|449015780|FG000|Overall Study|Withdrawal by Subject|23|||
124832034|NCT01290666|449015780|FG000|Overall Study|Early Termination of Study|4|||
124832035|NCT00507442|449015783|FG000|Overall Study|Adverse Event|8|||
124832036|NCT00507442|449015784|FG001|Overall Study|Adverse Event|11|||
124832037|NCT00507442|449015785|FG002|Overall Study|Adverse Event|4|||
124832038|NCT00507442|449015786|FG003|Overall Study|Adverse Event|1|||
124832039|NCT00507442|449015783|FG000|Overall Study|Protocol Violation|0|||
124832040|NCT00507442|449015784|FG001|Overall Study|Protocol Violation|1|||
124832041|NCT00507442|449015785|FG002|Overall Study|Protocol Violation|0|||
124832042|NCT00507442|449015786|FG003|Overall Study|Protocol Violation|0|||
124832043|NCT00507442|449015783|FG000|Overall Study|Lost to Follow-up|0|||
124832044|NCT00507442|449015784|FG001|Overall Study|Lost to Follow-up|0|||
124832045|NCT00507442|449015785|FG002|Overall Study|Lost to Follow-up|1|||
124832046|NCT00507442|449015786|FG003|Overall Study|Lost to Follow-up|0|||
124832047|NCT00507442|449015783|FG000|Overall Study|Physician Decision|0|||
124832048|NCT00507442|449015784|FG001|Overall Study|Physician Decision|2|||
124832049|NCT00507442|449015785|FG002|Overall Study|Physician Decision|4|||
124832050|NCT00507442|449015786|FG003|Overall Study|Physician Decision|1|||
124832051|NCT00507442|449015783|FG000|Overall Study|Progressive Disease|2|||
124832052|NCT00507442|449015784|FG001|Overall Study|Progressive Disease|4|||
124832053|NCT00507442|449015785|FG002|Overall Study|Progressive Disease|2|||
124832054|NCT00507442|449015786|FG003|Overall Study|Progressive Disease|0|||
124832055|NCT00507442|449015783|FG000|Overall Study|Withdrawal by Subject|4|||
124832056|NCT00507442|449015784|FG001|Overall Study|Withdrawal by Subject|4|||
124832057|NCT00507442|449015785|FG002|Overall Study|Withdrawal by Subject|2|||
124832058|NCT00507442|449015786|FG003|Overall Study|Withdrawal by Subject|1|||
124832059|NCT00507442|449015783|FG000|Overall Study|Other|2|||
124832060|NCT00507442|449015784|FG001|Overall Study|Other|5|||
124832061|NCT00507442|449015785|FG002|Overall Study|Other|2|||
124832062|NCT00507442|449015786|FG003|Overall Study|Other|2|||
124832063|NCT02410954|449015791|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
124832064|NCT02410954|449015792|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
124832065|NCT02410954|449015791|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
124832066|NCT02410954|449015792|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
124832067|NCT00271609|449015793|FG000|Overall Study|Adverse Event|11|||
124832068|NCT00271609|449015794|FG001|Overall Study|Adverse Event|3|||
124832069|NCT00271609|449015793|FG000|Overall Study|Withdrawal by Subject|2|||
124832070|NCT00271609|449015794|FG001|Overall Study|Withdrawal by Subject|0|||
124832071|NCT02188589|449015795|FG000|Overall Study|Withdrawal by Subject|5|||
124832072|NCT00975481|449015798|FG000|Second Intervention Period|Adverse Event|2|||
124832073|NCT00975481|449015799|FG001|Second Intervention Period|Adverse Event|1|||
124832074|NCT00975481|449015800|FG002|Second Intervention Period|Adverse Event|0|||
124832075|NCT00975481|449015801|FG003|Second Intervention Period|Adverse Event|0|||
124832076|NCT00975481|449015802|FG004|Second Intervention Period|Adverse Event|0|||
124832077|NCT00975481|449015803|FG005|Second Intervention Period|Adverse Event|0|||
124832078|NCT00975481|449015798|FG000|Second Intervention Period|Withdrawal by Subject|0|||
124832079|NCT00975481|449015799|FG001|Second Intervention Period|Withdrawal by Subject|0|||
124832080|NCT00975481|449015800|FG002|Second Intervention Period|Withdrawal by Subject|1|||
124832081|NCT00975481|449015801|FG003|Second Intervention Period|Withdrawal by Subject|0|||
124832082|NCT00975481|449015802|FG004|Second Intervention Period|Withdrawal by Subject|0|||
124832083|NCT00975481|449015803|FG005|Second Intervention Period|Withdrawal by Subject|0|||
124832084|NCT00975481|449015798|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
124832085|NCT00975481|449015799|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
124832086|NCT00975481|449015800|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
124832087|NCT00975481|449015801|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
124832088|NCT00975481|449015802|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
124832089|NCT00975481|449015803|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
124832090|NCT00975481|449015798|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
124832091|NCT00975481|449015799|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
124832092|NCT00975481|449015800|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
124832093|NCT00975481|449015801|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
124832094|NCT00975481|449015802|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
124832095|NCT00975481|449015803|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
124832096|NCT00643682|449015804|FG000|Overall Study|did not keep appointment|522|||
124832097|NCT00643682|449015805|FG001|Overall Study|did not keep appointment|509|||
124832098|NCT01826487|449015808|FG000|Overall Study|Adverse Event|1|||
124832099|NCT01826487|449015809|FG001|Overall Study|Adverse Event|1|||
124832100|NCT01826487|449015808|FG000|Overall Study|Lost to Follow-up|1|||
124832101|NCT01826487|449015809|FG001|Overall Study|Lost to Follow-up|0|||
124832102|NCT01826487|449015808|FG000|Overall Study|Withdrawal by Subject|1|||
124832103|NCT01826487|449015809|FG001|Overall Study|Withdrawal by Subject|3|||
124832104|NCT01826487|449015808|FG000|Overall Study|Protocol Violation|1|||
124832105|NCT01826487|449015809|FG001|Overall Study|Protocol Violation|1|||
124832106|NCT01408030|449015810|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
124832107|NCT01408030|449015811|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
124832108|NCT01408030|449015812|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
124832109|NCT01408030|449015813|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
124832110|NCT01408030|449015810|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
124832111|NCT01408030|449015811|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
124832112|NCT01408030|449015812|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
124832113|NCT01408030|449015813|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
124832114|NCT01408030|449015810|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
124832115|NCT01408030|449015811|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
124832116|NCT01408030|449015812|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
124832117|NCT01408030|449015813|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
124832118|NCT01408030|449015810|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
124832119|NCT01408030|449015811|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
124832120|NCT01408030|449015812|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
124832121|NCT01408030|449015813|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
124832122|NCT01408030|449015810|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
124832123|NCT01408030|449015811|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
124832124|NCT01408030|449015812|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
124832125|NCT01408030|449015813|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
124832126|NCT01408030|449015810|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
124832127|NCT01408030|449015811|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
124832128|NCT01408030|449015812|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
124832129|NCT01408030|449015813|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
124832130|NCT01408030|449015810|FG000|Observation Phase (Off Drug)|Other|1|||
124832131|NCT01408030|449015811|FG001|Observation Phase (Off Drug)|Other|1|||
124832132|NCT01408030|449015812|FG002|Observation Phase (Off Drug)|Other|1|||
124832133|NCT01408030|449015813|FG003|Observation Phase (Off Drug)|Other|1|||
124832134|NCT03755414|449015815|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
124832135|NCT03755414|449015816|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
124832136|NCT03755414|449015817|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
124832137|NCT03755414|449015815|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
124832138|NCT03755414|449015816|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
124832139|NCT03755414|449015817|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
124832140|NCT03755414|449015815|FG000|Overall Study|Non-compliance|0|||
124832141|NCT03755414|449015816|FG001|Overall Study|Non-compliance|1|||
124832142|NCT03755414|449015817|FG002|Overall Study|Non-compliance|0|||
124832143|NCT00741039|449015825|FG000|Overall Study|Patient non-compliance|2|||
124832144|NCT00741039|449015826|FG001|Overall Study|Patient non-compliance|0|||
124832145|NCT02081079|449015827|FG000|Overall Study|Lack of Efficacy|3|||
124832146|NCT02081079|449015828|FG001|Overall Study|Lack of Efficacy|2|||
124832147|NCT02081079|449015827|FG000|Overall Study|Lost to Follow-up|1|||
124832148|NCT02081079|449015828|FG001|Overall Study|Lost to Follow-up|0|||
124832149|NCT01712854|449015829|FG000|Overall Study|Physician Decision|1|||
124832150|NCT02225743|449015833|FG000|Overall Study|Withdrawal by Subject|18|||
124832151|NCT03886220|449015836|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
124832152|NCT03886220|449015837|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
124832153|NCT03886220|449015836|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
124832154|NCT03886220|449015837|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
124832155|NCT03886220|449015836|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
124832156|NCT03886220|449015837|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
124832157|NCT00768300|449015838|FG000|Overall Study|Randomized but not treated|1|||
124832158|NCT00768300|449015839|FG001|Overall Study|Randomized but not treated|1|||
124832159|NCT00768300|449015838|FG000|Overall Study|Adverse Event|10|||
124832160|NCT00768300|449015839|FG001|Overall Study|Adverse Event|2|||
124832161|NCT00768300|449015838|FG000|Overall Study|Protocol Violation|6|||
124832162|NCT00768300|449015839|FG001|Overall Study|Protocol Violation|1|||
124832163|NCT00768300|449015838|FG000|Overall Study|Withdrawal by Subject|13|||
124832164|NCT00768300|449015839|FG001|Overall Study|Withdrawal by Subject|7|||
124832165|NCT00768300|449015838|FG000|Overall Study|Physician Decision|2|||
124832166|NCT00768300|449015839|FG001|Overall Study|Physician Decision|3|||
124832167|NCT00768300|449015838|FG000|Overall Study|Study discontinued by Sponsor|271|||
124832168|NCT00768300|449015839|FG001|Overall Study|Study discontinued by Sponsor|140|||
124832169|NCT00768300|449015838|FG000|Overall Study|Death|21|||
124832170|NCT00768300|449015839|FG001|Overall Study|Death|5|||
124832171|NCT00768300|449015838|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
124832172|NCT00768300|449015839|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
124832173|NCT00768300|449015838|FG000|Overall Study|Screen failure following randomization|1|||
124832174|NCT00768300|449015839|FG001|Overall Study|Screen failure following randomization|0|||
124832175|NCT00768300|449015838|FG000|Overall Study|Received lung transplant|1|||
124832176|NCT00768300|449015839|FG001|Overall Study|Received lung transplant|1|||
124832177|NCT00768300|449015838|FG000|Overall Study|Lost to Follow-up|0|||
124832178|NCT00768300|449015839|FG001|Overall Study|Lost to Follow-up|1|||
124832179|NCT00768300|449015838|FG000|Overall Study|Began prohibited concomitant medication|0|||
124832180|NCT00768300|449015839|FG001|Overall Study|Began prohibited concomitant medication|1|||
124832181|NCT00768300|449015838|FG000|Overall Study|Treated but never dosed with Study drug|1|||
124832182|NCT00768300|449015839|FG001|Overall Study|Treated but never dosed with Study drug|0|||
124832183|NCT00768300|449015838|FG000|Overall Study|Missing data|1|||
124832184|NCT00768300|449015839|FG001|Overall Study|Missing data|0|||
124832185|NCT02068222|449015846|FG000|Overall Study|Lost to Follow-up|1|||
124832186|NCT01120756|449015849|FG000|Overall Study|Withdrawal by Subject|1|||
124832187|NCT01120756|449015850|FG001|Overall Study|Withdrawal by Subject|1|||
124832188|NCT00698581|449015855|FG000|Overall Study|Lack of Efficacy|23|||
124832189|NCT00698581|449015856|FG001|Overall Study|Lack of Efficacy|11|||
124832190|NCT00698581|449015855|FG000|Overall Study|Withdrawal by Subject|6|||
124832191|NCT00698581|449015856|FG001|Overall Study|Withdrawal by Subject|0|||
124832192|NCT00698581|449015855|FG000|Overall Study|Other reason|9|||
124832193|NCT00698581|449015856|FG001|Overall Study|Other reason|1|||
124832194|NCT00698581|449015855|FG000|Overall Study|SAE, non-fatal|1|||
124832195|NCT00698581|449015856|FG001|Overall Study|SAE, non-fatal|0|||
124832196|NCT00698581|449015855|FG000|Overall Study|AE, non-serious non-fatal|4|||
124832197|NCT00698581|449015856|FG001|Overall Study|AE, non-serious non-fatal|0|||
124832198|NCT00698581|449015855|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
124832199|NCT00698581|449015856|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
124832200|NCT00698581|449015855|FG000|Overall Study|AE of unknown type|1|||
124832201|NCT00698581|449015856|FG001|Overall Study|AE of unknown type|0|||
124832202|NCT00449644|449015857|FG000|Overall Study|Adverse Event|0|||
124832203|NCT00449644|449015858|FG001|Overall Study|Adverse Event|0|||
124832204|NCT00449644|449015859|FG002|Overall Study|Adverse Event|3|||
124832205|NCT00449644|449015860|FG003|Overall Study|Adverse Event|5|||
124832206|NCT00449644|449015857|FG000|Overall Study|Death|1|||
124832207|NCT00449644|449015858|FG001|Overall Study|Death|0|||
124832208|NCT00449644|449015859|FG002|Overall Study|Death|6|||
124832209|NCT00449644|449015860|FG003|Overall Study|Death|1|||
124832210|NCT00449644|449015857|FG000|Overall Study|Lost to Follow-up|1|||
124832211|NCT00449644|449015858|FG001|Overall Study|Lost to Follow-up|1|||
124832212|NCT00449644|449015859|FG002|Overall Study|Lost to Follow-up|5|||
124832213|NCT00449644|449015860|FG003|Overall Study|Lost to Follow-up|3|||
124832214|NCT00449644|449015857|FG000|Overall Study|Pregnancy|0|||
124832215|NCT00449644|449015858|FG001|Overall Study|Pregnancy|0|||
124832216|NCT00449644|449015859|FG002|Overall Study|Pregnancy|3|||
124832217|NCT00449644|449015860|FG003|Overall Study|Pregnancy|2|||
124832218|NCT00449644|449015857|FG000|Overall Study|Protocol Violation|4|||
124832219|NCT00449644|449015858|FG001|Overall Study|Protocol Violation|4|||
124832220|NCT00449644|449015859|FG002|Overall Study|Protocol Violation|3|||
124832221|NCT00449644|449015860|FG003|Overall Study|Protocol Violation|7|||
124832222|NCT00449644|449015857|FG000|Overall Study|Withdrawal by Subject|3|||
124832223|NCT00449644|449015858|FG001|Overall Study|Withdrawal by Subject|4|||
124832224|NCT00449644|449015859|FG002|Overall Study|Withdrawal by Subject|6|||
124832225|NCT00449644|449015860|FG003|Overall Study|Withdrawal by Subject|7|||
124832226|NCT00449644|449015857|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
124832227|NCT00449644|449015858|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
124832228|NCT00449644|449015859|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
124832229|NCT00449644|449015860|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
124832230|NCT00449644|449015857|FG000|Overall Study|Other|1|||
124832231|NCT00449644|449015858|FG001|Overall Study|Other|4|||
124832232|NCT00449644|449015859|FG002|Overall Study|Other|1|||
124832233|NCT00449644|449015860|FG003|Overall Study|Other|0|||
124832234|NCT00449644|449015857|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
124832235|NCT00449644|449015858|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
124832236|NCT00449644|449015859|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
124832237|NCT00449644|449015860|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
124832238|NCT03642717|449015861|FG000|Overall Study|Lost to Follow-up|2|||
124832239|NCT03642717|449015861|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
124832240|NCT03642717|449015861|FG000|Overall Study|Taken study drug prior to contract date|3|||
124832241|NCT01559012|449015864|FG000|Overall Study|Withdrawal by Subject|0|||
124832242|NCT01559012|449015865|FG001|Overall Study|Withdrawal by Subject|1|||
124832243|NCT00946712|449015866|FG000|Overall Study|Adverse Event|118|||
124832244|NCT00946712|449015867|FG001|Overall Study|Adverse Event|124|||
124832245|NCT00946712|449015866|FG000|Overall Study|Disease progression|308|||
124832246|NCT00946712|449015867|FG001|Overall Study|Disease progression|404|||
124832247|NCT00946712|449015866|FG000|Overall Study|Death|21|||
124832248|NCT00946712|449015867|FG001|Overall Study|Death|22|||
124832249|NCT00946712|449015866|FG000|Overall Study|No treatment given|25|||
124832250|NCT00946712|449015867|FG001|Overall Study|No treatment given|29|||
124832251|NCT00946712|449015866|FG000|Overall Study|Other reasons|61|||
124832252|NCT00946712|449015867|FG001|Overall Study|Other reasons|73|||
124832253|NCT00946712|449015866|FG000|Overall Study|On Treatment|0|||
124832254|NCT00946712|449015867|FG001|Overall Study|On Treatment|4|||
124832255|NCT00946712|449015866|FG000|Overall Study|Ineligible|14|||
124832256|NCT00946712|449015867|FG001|Overall Study|Ineligible|6|||
124832257|NCT00302458|449015868|FG000|Overall Study|Lost to Follow-up|1|||
124832258|NCT00302458|449015868|FG000|Overall Study|Ineligible after screening|1|||
124832259|NCT00302458|449015868|FG000|Overall Study|Withdrawal by Subject|1|||
124832260|NCT02291055|449015871|FG000|Overall Study|Death|2|||
124832261|NCT02291055|449015872|FG001|Overall Study|Death|2|||
124832262|NCT02291055|449015873|FG002|Overall Study|Death|5|||
124832263|NCT02291055|449015874|FG003|Overall Study|Death|8|||
124832264|NCT02291055|449015875|FG004|Overall Study|Death|12|||
124832265|NCT02291055|449015871|FG000|Overall Study|Lost to Follow-up|0|||
124832266|NCT02291055|449015872|FG001|Overall Study|Lost to Follow-up|0|||
124832267|NCT02291055|449015873|FG002|Overall Study|Lost to Follow-up|0|||
124832268|NCT02291055|449015874|FG003|Overall Study|Lost to Follow-up|1|||
124832269|NCT02291055|449015875|FG004|Overall Study|Lost to Follow-up|2|||
124832270|NCT02291055|449015871|FG000|Overall Study|Withdrawal by Subject|3|||
124832271|NCT02291055|449015872|FG001|Overall Study|Withdrawal by Subject|1|||
124832272|NCT02291055|449015873|FG002|Overall Study|Withdrawal by Subject|1|||
124832273|NCT02291055|449015874|FG003|Overall Study|Withdrawal by Subject|5|||
124832274|NCT02291055|449015875|FG004|Overall Study|Withdrawal by Subject|10|||
124832275|NCT02291055|449015871|FG000|Overall Study|Progressive Disease|0|||
124832276|NCT02291055|449015872|FG001|Overall Study|Progressive Disease|0|||
124832277|NCT02291055|449015873|FG002|Overall Study|Progressive Disease|1|||
124832278|NCT02291055|449015874|FG003|Overall Study|Progressive Disease|4|||
124832279|NCT02291055|449015875|FG004|Overall Study|Progressive Disease|2|||
124832280|NCT02291055|449015871|FG000|Overall Study|Study Terminated by Sponsor|0|||
124832281|NCT02291055|449015872|FG001|Overall Study|Study Terminated by Sponsor|0|||
124832282|NCT02291055|449015873|FG002|Overall Study|Study Terminated by Sponsor|0|||
124832283|NCT02291055|449015874|FG003|Overall Study|Study Terminated by Sponsor|5|||
124832284|NCT02291055|449015875|FG004|Overall Study|Study Terminated by Sponsor|1|||
124832285|NCT02291055|449015871|FG000|Overall Study|Other|0|||
124832286|NCT02291055|449015872|FG001|Overall Study|Other|2|||
124832287|NCT02291055|449015873|FG002|Overall Study|Other|1|||
124832288|NCT02291055|449015874|FG003|Overall Study|Other|4|||
124832289|NCT02291055|449015875|FG004|Overall Study|Other|0|||
124832290|NCT00853723|449015876|FG000|Overall Study|Adverse Event|3|||
124832291|NCT00853723|449015877|FG001|Overall Study|Adverse Event|4|||
124832292|NCT00853723|449015878|FG002|Overall Study|Adverse Event|1|||
124832293|NCT00853723|449015876|FG000|Overall Study|Withdrawal by Subject|2|||
124832294|NCT00853723|449015877|FG001|Overall Study|Withdrawal by Subject|1|||
124832295|NCT00853723|449015878|FG002|Overall Study|Withdrawal by Subject|0|||
124832296|NCT00853723|449015876|FG000|Overall Study|Protocol Violation|1|||
124832297|NCT00853723|449015877|FG001|Overall Study|Protocol Violation|2|||
124832298|NCT00853723|449015878|FG002|Overall Study|Protocol Violation|1|||
124832299|NCT01531387|449015879|FG000|Overall Study|Early termination of study|11|||
124832300|NCT01531387|449015880|FG001|Overall Study|Early termination of study|11|||
124832301|NCT02642432|449015883|FG000|Overall Study|Adverse Event|2|||
124832302|NCT02642432|449015883|FG000|Overall Study|Withdrew Consent|1|||
124639173|NCT02049814|448296530|FG001|Overall Study|Reason not Specified|3|||
124639174|NCT02049814|448296529|FG000|Overall Study|Pregnancy|1|||
124639175|NCT02049814|448296530|FG001|Overall Study|Pregnancy|0|||
124832303|NCT02642432|449015883|FG000|Overall Study|Lost to Follow-up|2|||
124832304|NCT02642432|449015883|FG000|Overall Study|Other|3|||
124639176|NCT02049814|448296529|FG000|Overall Study|Lost to Follow-up|2|||
124832305|NCT00733746|449015884|FG000|Overall Study|Ineligible|5|||
124832306|NCT03999892|449015885|FG000|Overall Study|Lost to Follow-up|1|||
124832307|NCT01848756|449015886|FG000|Overall Study|Adverse Event|1|||
124832308|NCT01848756|449015886|FG000|Overall Study|Withdrawal by Subject|1|||
124832309|NCT01848756|449015886|FG000|Overall Study|Enrolled in Error|1|||
124639177|NCT02049814|448296530|FG001|Overall Study|Lost to Follow-up|3|||
124832310|NCT01894581|449015887|FG000|Overall Study|Withdrawal by Subject|2|||
124832311|NCT01894581|449015888|FG001|Overall Study|Withdrawal by Subject|3|||
124832312|NCT01894581|449015887|FG000|Overall Study|Screen Failure|3|||
124832313|NCT01894581|449015888|FG001|Overall Study|Screen Failure|4|||
124832314|NCT01252940|449015889|FG000|Main Study Phase|Randomized but not treated|4|||
124832315|NCT01252940|449015890|FG001|Main Study Phase|Randomized but not treated|2|||
124832316|NCT01252940|449015889|FG000|Main Study Phase|Adverse Event|3|||
124832317|NCT01252940|449015890|FG001|Main Study Phase|Adverse Event|1|||
124832318|NCT01252940|449015889|FG000|Main Study Phase|Lack of Efficacy|1|||
124832319|NCT01252940|449015890|FG001|Main Study Phase|Lack of Efficacy|0|||
124832320|NCT01252940|449015889|FG000|Main Study Phase|Lost to Follow-up|6|||
124832321|NCT01252940|449015890|FG001|Main Study Phase|Lost to Follow-up|1|||
124832322|NCT01252940|449015889|FG000|Main Study Phase|Physician Decision|1|||
124832323|NCT01252940|449015890|FG001|Main Study Phase|Physician Decision|0|||
124832324|NCT01252940|449015889|FG000|Main Study Phase|Protocol Violation|4|||
124832325|NCT01252940|449015890|FG001|Main Study Phase|Protocol Violation|2|||
124832326|NCT01252940|449015889|FG000|Main Study Phase|Withdrawal by Subject|6|||
124832327|NCT01252940|449015890|FG001|Main Study Phase|Withdrawal by Subject|5|||
124832328|NCT01252940|449015889|FG000|Main Study Phase|Subject Non-compliance|1|||
124832329|NCT01252940|449015890|FG001|Main Study Phase|Subject Non-compliance|1|||
124832330|NCT01252940|449015889|FG000|Extension Phase|Adverse Event|2|||
124832331|NCT01252940|449015890|FG001|Extension Phase|Adverse Event|1|||
124832332|NCT01252940|449015889|FG000|Extension Phase|Lack of Efficacy|1|||
124832333|NCT01252940|449015890|FG001|Extension Phase|Lack of Efficacy|0|||
124832334|NCT01252940|449015889|FG000|Extension Phase|Lost to Follow-up|5|||
124832335|NCT01252940|449015890|FG001|Extension Phase|Lost to Follow-up|0|||
124832336|NCT01252940|449015889|FG000|Extension Phase|Physician Decision|0|||
124832337|NCT01252940|449015890|FG001|Extension Phase|Physician Decision|1|||
124832338|NCT01252940|449015889|FG000|Extension Phase|Subject Non-compliance|1|||
124832339|NCT01252940|449015890|FG001|Extension Phase|Subject Non-compliance|0|||
124832340|NCT01252940|449015889|FG000|Extension Phase|Withdrawal by Subject|1|||
124832341|NCT01252940|449015890|FG001|Extension Phase|Withdrawal by Subject|1|||
124832342|NCT03759379|449017372|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
124832343|NCT03759379|449017373|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
124832344|NCT03759379|449017372|FG000|Treatment Period|Death|2|||
124832345|NCT03759379|449017373|FG001|Treatment Period|Death|3|||
124832346|NCT03759379|449017372|FG000|Treatment Period|Lost to Follow-up|1|||
124832347|NCT03759379|449017373|FG001|Treatment Period|Lost to Follow-up|0|||
124832348|NCT03759379|449017372|FG000|Treatment Period|Physician Decision|0|||
124832349|NCT03759379|449017373|FG001|Treatment Period|Physician Decision|1|||
124832350|NCT01254227|449017376|FG000|Overall Study|Withdrawal by Subject|6|||
124832351|NCT01254227|449017376|FG000|Overall Study|Lost to Follow-up|6|||
124832352|NCT01254227|449017376|FG000|Overall Study|Adverse Event|5|||
124832353|NCT01254227|449017376|FG000|Overall Study|Abnormal test procedure result|5|||
124832354|NCT01254227|449017376|FG000|Overall Study|Administrative problems|2|||
124832355|NCT01254227|449017376|FG000|Overall Study|Death|1|||
124832356|NCT01254227|449017376|FG000|Overall Study|Protocol deviation|1|||
124832357|NCT02535741|449017383|FG000|Overall Study|Adverse Event|3|||
124832358|NCT02535741|449017383|FG000|Overall Study|Withdrawal by Subject|9|||
124832359|NCT02535741|449017383|FG000|Overall Study|Lost to Follow-up|10|||
124832360|NCT02535741|449017383|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
124832361|NCT02535741|449017383|FG000|Overall Study|Missing data|6|||
124832362|NCT03873987|449017384|FG000|Overall Study|Adverse Event|1|||
124832363|NCT03873987|449017385|FG001|Overall Study|Adverse Event|0|||
124832364|NCT03873987|449017384|FG000|Overall Study|staff was unable to start a new IV line|1|||
124832365|NCT03873987|449017385|FG001|Overall Study|staff was unable to start a new IV line|0|||
124832366|NCT03873987|449017384|FG000|Overall Study|Lost to Follow-up|0|||
124832367|NCT03873987|449017385|FG001|Overall Study|Lost to Follow-up|1|||
124832368|NCT00798369|449017386|FG000|Overall Study|Subject withdrew consent|0|||
124832369|NCT00798369|449017387|FG001|Overall Study|Subject withdrew consent|0|||
124832370|NCT00798369|449017388|FG002|Overall Study|Subject withdrew consent|1|||
124832371|NCT00798369|449017389|FG003|Overall Study|Subject withdrew consent|1|||
124832372|NCT00798369|449017390|FG004|Overall Study|Subject withdrew consent|0|||
124832373|NCT00798369|449017391|FG005|Overall Study|Subject withdrew consent|2|||
124832374|NCT00798369|449017386|FG000|Overall Study|Lost to Follow-up|1|||
124832375|NCT00798369|449017387|FG001|Overall Study|Lost to Follow-up|1|||
124832376|NCT00798369|449017388|FG002|Overall Study|Lost to Follow-up|1|||
124832377|NCT00798369|449017389|FG003|Overall Study|Lost to Follow-up|0|||
124832378|NCT00798369|449017390|FG004|Overall Study|Lost to Follow-up|1|||
124832379|NCT00798369|449017391|FG005|Overall Study|Lost to Follow-up|0|||
124832380|NCT00798369|449017386|FG000|Overall Study|Adminstrative problems|0|||
124832381|NCT00798369|449017387|FG001|Overall Study|Adminstrative problems|0|||
124832382|NCT00798369|449017388|FG002|Overall Study|Adminstrative problems|0|||
124832383|NCT00798369|449017389|FG003|Overall Study|Adminstrative problems|0|||
124832384|NCT00798369|449017390|FG004|Overall Study|Adminstrative problems|0|||
124832385|NCT00798369|449017391|FG005|Overall Study|Adminstrative problems|1|||
124832386|NCT04475588|449017392|FG000|Overall Study|Adverse Event|2|||
124832387|NCT04475588|449017393|FG001|Overall Study|Adverse Event|0|||
124832388|NCT00588822|449017394|FG000|Overall Study|progression of disease|8|||
124832389|NCT02082210|449017396|FG000|Overall Study|Death|0|||
124832390|NCT02082210|449017397|FG001|Overall Study|Death|0|||
124832391|NCT02082210|449017398|FG002|Overall Study|Death|1|||
124832392|NCT02082210|449017399|FG003|Overall Study|Death|1|||
124832393|NCT02082210|449017400|FG004|Overall Study|Death|1|||
124832394|NCT02082210|449017401|FG005|Overall Study|Death|0|||
124832395|NCT02082210|449017396|FG000|Overall Study|Withdrawal by Subject|0|||
124832396|NCT02082210|449017397|FG001|Overall Study|Withdrawal by Subject|0|||
124832397|NCT02082210|449017398|FG002|Overall Study|Withdrawal by Subject|0|||
124832398|NCT02082210|449017399|FG003|Overall Study|Withdrawal by Subject|1|||
124832399|NCT02082210|449017400|FG004|Overall Study|Withdrawal by Subject|2|||
124832400|NCT02082210|449017401|FG005|Overall Study|Withdrawal by Subject|2|||
124832401|NCT02082210|449017396|FG000|Overall Study|Clinical Progression|0|||
124832402|NCT02082210|449017397|FG001|Overall Study|Clinical Progression|0|||
124832403|NCT02082210|449017398|FG002|Overall Study|Clinical Progression|0|||
124832404|NCT02082210|449017399|FG003|Overall Study|Clinical Progression|1|||
124832405|NCT02082210|449017400|FG004|Overall Study|Clinical Progression|0|||
124832406|NCT02082210|449017401|FG005|Overall Study|Clinical Progression|0|||
124832407|NCT02082210|449017396|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
124832408|NCT02082210|449017397|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
124832409|NCT02082210|449017398|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
124832410|NCT02082210|449017399|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
124832411|NCT02082210|449017400|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
124832412|NCT02082210|449017401|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
124832413|NCT02082210|449017396|FG000|Overall Study|Physician Decision|0|||
124832414|NCT02082210|449017397|FG001|Overall Study|Physician Decision|0|||
124832415|NCT02082210|449017398|FG002|Overall Study|Physician Decision|1|||
124832416|NCT02082210|449017399|FG003|Overall Study|Physician Decision|1|||
124832417|NCT02082210|449017400|FG004|Overall Study|Physician Decision|0|||
124832418|NCT02082210|449017401|FG005|Overall Study|Physician Decision|0|||
124832419|NCT02520011|449017402|FG000|Overall Study|Adverse Event|0|||
124832420|NCT02520011|449017403|FG001|Overall Study|Adverse Event|1|||
124832421|NCT02520011|449017404|FG002|Overall Study|Adverse Event|2|||
124832422|NCT02520011|449017402|FG000|Overall Study|Death|0|||
124832423|NCT02520011|449017403|FG001|Overall Study|Death|8|||
124832424|NCT02520011|449017404|FG002|Overall Study|Death|1|||
124832425|NCT02520011|449017402|FG000|Overall Study|Lack of Efficacy|4|||
124832426|NCT02520011|449017403|FG001|Overall Study|Lack of Efficacy|26|||
124832427|NCT02520011|449017404|FG002|Overall Study|Lack of Efficacy|4|||
124832428|NCT02520011|449017402|FG000|Overall Study|Physician Decision|0|||
124832429|NCT02520011|449017403|FG001|Overall Study|Physician Decision|2|||
124832430|NCT02520011|449017404|FG002|Overall Study|Physician Decision|0|||
124832431|NCT02520011|449017402|FG000|Overall Study|Withdrawal by Subject|1|||
124832432|NCT02520011|449017403|FG001|Overall Study|Withdrawal by Subject|3|||
124832433|NCT02520011|449017404|FG002|Overall Study|Withdrawal by Subject|0|||
124832434|NCT02520011|449017402|FG000|Overall Study|Protocol Deviation|0|||
124832435|NCT02520011|449017403|FG001|Overall Study|Protocol Deviation|1|||
124832436|NCT02520011|449017404|FG002|Overall Study|Protocol Deviation|0|||
124832437|NCT02520011|449017402|FG000|Overall Study|Patient went to hospice|0|||
124832438|NCT02520011|449017403|FG001|Overall Study|Patient went to hospice|1|||
124832439|NCT02520011|449017404|FG002|Overall Study|Patient went to hospice|0|||
124832440|NCT02520011|449017402|FG000|Overall Study|Progressive disease following response|0|||
124832441|NCT02520011|449017403|FG001|Overall Study|Progressive disease following response|4|||
124832442|NCT02520011|449017404|FG002|Overall Study|Progressive disease following response|2|||
124832443|NCT02436759|449017405|FG000|Overall Study|Adverse Event|3|||
124832444|NCT02436759|449017406|FG001|Overall Study|Adverse Event|0|||
124832445|NCT02436759|449017405|FG000|Overall Study|Protocol Violation|1|||
124832446|NCT02436759|449017406|FG001|Overall Study|Protocol Violation|0|||
124832447|NCT02436759|449017405|FG000|Overall Study|Withdrawal by Subject|0|||
124832448|NCT02436759|449017406|FG001|Overall Study|Withdrawal by Subject|1|||
124832449|NCT01727141|449017409|FG000|Overall Study|Physician Decision|0|||
124832450|NCT01727141|449017410|FG001|Overall Study|Physician Decision|1|||
124832451|NCT01727141|449017411|FG002|Overall Study|Physician Decision|0|||
124832452|NCT01727141|449017412|FG003|Overall Study|Physician Decision|2|||
124832453|NCT01727141|449017409|FG000|Overall Study|Lost to Follow-up|0|||
124832454|NCT01727141|449017410|FG001|Overall Study|Lost to Follow-up|2|||
124832455|NCT01727141|449017411|FG002|Overall Study|Lost to Follow-up|0|||
124832456|NCT01727141|449017412|FG003|Overall Study|Lost to Follow-up|0|||
124832457|NCT01727141|449017409|FG000|Overall Study|Death|0|||
124832458|NCT01727141|449017410|FG001|Overall Study|Death|1|||
124832459|NCT01727141|449017411|FG002|Overall Study|Death|1|||
124832460|NCT01727141|449017412|FG003|Overall Study|Death|1|||
124832461|NCT01727141|449017409|FG000|Overall Study|Protocol deviation|1|||
124832462|NCT01727141|449017410|FG001|Overall Study|Protocol deviation|1|||
124832463|NCT01727141|449017411|FG002|Overall Study|Protocol deviation|0|||
124832464|NCT01727141|449017412|FG003|Overall Study|Protocol deviation|1|||
124832465|NCT01727141|449017409|FG000|Overall Study|Withdrawal by Subject|4|||
124832466|NCT01727141|449017410|FG001|Overall Study|Withdrawal by Subject|4|||
124832467|NCT01727141|449017411|FG002|Overall Study|Withdrawal by Subject|2|||
124832468|NCT01727141|449017412|FG003|Overall Study|Withdrawal by Subject|11|||
124832469|NCT04014075|449017413|FG000|Overall Study|Progressive Disease|53|||
124832470|NCT04014075|449017413|FG000|Overall Study|Adverse Event|15|||
124832471|NCT04014075|449017413|FG000|Overall Study|Clinical Progression|4|||
124832472|NCT04014075|449017413|FG000|Overall Study|Death|2|||
124832473|NCT04014075|449017413|FG000|Overall Study|Withdrawal by Subject|2|||
124832474|NCT04014075|449017413|FG000|Overall Study|Miscellaneous|2|||
124832475|NCT04014075|449017413|FG000|Overall Study|Physician Decision|1|||
124832476|NCT03616912|449017417|FG000|Overall Study|Adverse Event|17|||
124832477|NCT03616912|449017418|FG001|Overall Study|Adverse Event|21|||
124832478|NCT03616912|449017419|FG002|Overall Study|Adverse Event|9|||
124832479|NCT03616912|449017420|FG003|Overall Study|Adverse Event|0|||
124832480|NCT03616912|449017421|FG004|Overall Study|Adverse Event|0|||
124832481|NCT03616912|449017422|FG005|Overall Study|Adverse Event|0|||
124832482|NCT03616912|449017417|FG000|Overall Study|Death|1|||
124832483|NCT03616912|449017418|FG001|Overall Study|Death|1|||
124832484|NCT03616912|449017419|FG002|Overall Study|Death|0|||
124832485|NCT03616912|449017420|FG003|Overall Study|Death|0|||
124832486|NCT03616912|449017421|FG004|Overall Study|Death|0|||
124832487|NCT03616912|449017422|FG005|Overall Study|Death|0|||
124832488|NCT03616912|449017417|FG000|Overall Study|Lack of Efficacy|13|||
124832489|NCT03616912|449017418|FG001|Overall Study|Lack of Efficacy|6|||
124832490|NCT03616912|449017419|FG002|Overall Study|Lack of Efficacy|8|||
124832491|NCT03616912|449017420|FG003|Overall Study|Lack of Efficacy|4|||
124832492|NCT03616912|449017421|FG004|Overall Study|Lack of Efficacy|5|||
124832493|NCT03616912|449017422|FG005|Overall Study|Lack of Efficacy|1|||
124832494|NCT03616912|449017417|FG000|Overall Study|Lost to Follow-up|1|||
124832495|NCT03616912|449017418|FG001|Overall Study|Lost to Follow-up|2|||
124832496|NCT03616912|449017419|FG002|Overall Study|Lost to Follow-up|3|||
124832497|NCT03616912|449017420|FG003|Overall Study|Lost to Follow-up|0|||
124832498|NCT03616912|449017421|FG004|Overall Study|Lost to Follow-up|0|||
124832499|NCT03616912|449017422|FG005|Overall Study|Lost to Follow-up|0|||
124832500|NCT03616912|449017417|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
124832501|NCT03616912|449017418|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
124832502|NCT03616912|449017419|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
124832503|NCT03616912|449017420|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
124832504|NCT03616912|449017421|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
124832505|NCT03616912|449017422|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
124832506|NCT03616912|449017417|FG000|Overall Study|Withdrawal by Subject|12|||
124832507|NCT03616912|449017418|FG001|Overall Study|Withdrawal by Subject|12|||
124832508|NCT03616912|449017419|FG002|Overall Study|Withdrawal by Subject|15|||
124832509|NCT03616912|449017420|FG003|Overall Study|Withdrawal by Subject|2|||
124832510|NCT03616912|449017421|FG004|Overall Study|Withdrawal by Subject|0|||
124832511|NCT03616912|449017422|FG005|Overall Study|Withdrawal by Subject|2|||
124832512|NCT03616912|449017417|FG000|Overall Study|Study Terminated by Sponsor|0|||
124832513|NCT03616912|449017418|FG001|Overall Study|Study Terminated by Sponsor|0|||
124832514|NCT03616912|449017419|FG002|Overall Study|Study Terminated by Sponsor|0|||
124832515|NCT03616912|449017420|FG003|Overall Study|Study Terminated by Sponsor|10|||
124832516|NCT03616912|449017421|FG004|Overall Study|Study Terminated by Sponsor|9|||
124832517|NCT03616912|449017422|FG005|Overall Study|Study Terminated by Sponsor|11|||
124832518|NCT03616912|449017417|FG000|Overall Study|Protocol Deviation|1|||
124832519|NCT03616912|449017418|FG001|Overall Study|Protocol Deviation|1|||
124832520|NCT03616912|449017419|FG002|Overall Study|Protocol Deviation|0|||
124832521|NCT03616912|449017420|FG003|Overall Study|Protocol Deviation|0|||
124832522|NCT03616912|449017421|FG004|Overall Study|Protocol Deviation|0|||
124832523|NCT03616912|449017422|FG005|Overall Study|Protocol Deviation|0|||
124832524|NCT03616912|449017417|FG000|Overall Study|Pregnancy|1|||
124832525|NCT03616912|449017418|FG001|Overall Study|Pregnancy|0|||
124832526|NCT03616912|449017419|FG002|Overall Study|Pregnancy|4|||
124832527|NCT03616912|449017420|FG003|Overall Study|Pregnancy|0|||
124832528|NCT03616912|449017421|FG004|Overall Study|Pregnancy|0|||
124639178|NCT02049814|448296529|FG000|Overall Study|Serious Protocol Violation|5|||
124639179|NCT02049814|448296530|FG001|Overall Study|Serious Protocol Violation|7|||
124639180|NCT02049814|448296529|FG000|Overall Study|Study Termination|0|||
124639181|NCT02049814|448296530|FG001|Overall Study|Study Termination|1|||
124832529|NCT03616912|449017422|FG005|Overall Study|Pregnancy|0|||
124832530|NCT03616912|449017417|FG000|Overall Study|Protocol Violation|1|||
124832531|NCT03616912|449017418|FG001|Overall Study|Protocol Violation|0|||
124832532|NCT03616912|449017419|FG002|Overall Study|Protocol Violation|2|||
124832533|NCT03616912|449017420|FG003|Overall Study|Protocol Violation|0|||
124832534|NCT03616912|449017421|FG004|Overall Study|Protocol Violation|0|||
124832535|NCT03616912|449017422|FG005|Overall Study|Protocol Violation|0|||
124832536|NCT03616912|449017417|FG000|Overall Study|Physician Decision|2|||
124832537|NCT03616912|449017418|FG001|Overall Study|Physician Decision|0|||
124832538|NCT03616912|449017419|FG002|Overall Study|Physician Decision|0|||
124832539|NCT03616912|449017420|FG003|Overall Study|Physician Decision|0|||
124832540|NCT03616912|449017421|FG004|Overall Study|Physician Decision|1|||
124832541|NCT03616912|449017422|FG005|Overall Study|Physician Decision|0|||
124832542|NCT03616912|449017417|FG000|Overall Study|Randomized But Never Treated|0|||
124639182|NCT02049814|448296529|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
124832543|NCT03616912|449017418|FG001|Overall Study|Randomized But Never Treated|2|||
124832544|NCT03616912|449017419|FG002|Overall Study|Randomized But Never Treated|0|||
124832545|NCT03616912|449017420|FG003|Overall Study|Randomized But Never Treated|0|||
124832546|NCT03616912|449017421|FG004|Overall Study|Randomized But Never Treated|0|||
124832547|NCT03616912|449017422|FG005|Overall Study|Randomized But Never Treated|0|||
124832548|NCT02584504|449017423|FG000|Double-blind Treatment|Participant withdrew consent|0|||
124832549|NCT02584504|449017424|FG001|Double-blind Treatment|Participant withdrew consent|0|||
124832550|NCT02584504|449017425|FG002|Double-blind Treatment|Participant withdrew consent|1|||
124832551|NCT02584504|449017423|FG000|Double-blind Treatment|Adverse Event|0|||
124832552|NCT02584504|449017424|FG001|Double-blind Treatment|Adverse Event|1|||
124832553|NCT02584504|449017425|FG002|Double-blind Treatment|Adverse Event|0|||
124832554|NCT02584504|449017423|FG000|Double-blind Treatment|Family Matter|0|||
124832555|NCT02584504|449017424|FG001|Double-blind Treatment|Family Matter|1|||
124832556|NCT02584504|449017425|FG002|Double-blind Treatment|Family Matter|0|||
124832557|NCT02584504|449017423|FG000|Open-label Treatment|Participant withdrew consent|0|||
124832558|NCT02584504|449017424|FG001|Open-label Treatment|Participant withdrew consent|0|||
124832559|NCT02584504|449017425|FG002|Open-label Treatment|Participant withdrew consent|4|||
124832560|NCT02584504|449017423|FG000|Open-label Treatment|Adverse Event|2|||
124832561|NCT02584504|449017424|FG001|Open-label Treatment|Adverse Event|2|||
124832562|NCT02584504|449017425|FG002|Open-label Treatment|Adverse Event|3|||
124832563|NCT02584504|449017423|FG000|Open-label Treatment|Physician Decision|0|||
124832564|NCT02584504|449017424|FG001|Open-label Treatment|Physician Decision|1|||
124832565|NCT02584504|449017425|FG002|Open-label Treatment|Physician Decision|0|||
124832566|NCT02584504|449017423|FG000|Open-label Treatment|Entered but not treated|0|||
124832567|NCT02584504|449017424|FG001|Open-label Treatment|Entered but not treated|1|||
124832568|NCT02584504|449017425|FG002|Open-label Treatment|Entered but not treated|1|||
124832569|NCT03446040|449017430|FG000|Overall Study|Disease progression|3|||
124832570|NCT03446040|449017431|FG001|Overall Study|Disease progression|3|||
124832571|NCT03446040|449017432|FG002|Overall Study|Disease progression|3|||
124832572|NCT03446040|449017433|FG003|Overall Study|Disease progression|4|||
124832573|NCT03446040|449017434|FG004|Overall Study|Disease progression|4|||
124832574|NCT03446040|449017435|FG005|Overall Study|Disease progression|6|||
124832575|NCT03446040|449017436|FG006|Overall Study|Disease progression|3|||
124832576|NCT03446040|449017437|FG007|Overall Study|Disease progression|4|||
124832577|NCT03446040|449017438|FG008|Overall Study|Disease progression|2|||
124832578|NCT03446040|449017439|FG009|Overall Study|Disease progression|4|||
124832579|NCT03446040|449017440|FG010|Overall Study|Disease progression|9|||
124832580|NCT03446040|449017441|FG011|Overall Study|Disease progression|3|||
124832581|NCT03446040|449017442|FG012|Overall Study|Disease progression|7|||
124832582|NCT03446040|449017443|FG013|Overall Study|Disease progression|7|||
124832583|NCT03446040|449017430|FG000|Overall Study|Study drug toxicity|0|||
124832584|NCT03446040|449017431|FG001|Overall Study|Study drug toxicity|0|||
124832585|NCT03446040|449017432|FG002|Overall Study|Study drug toxicity|0|||
124832586|NCT03446040|449017433|FG003|Overall Study|Study drug toxicity|0|||
124832587|NCT03446040|449017434|FG004|Overall Study|Study drug toxicity|0|||
124832588|NCT03446040|449017435|FG005|Overall Study|Study drug toxicity|0|||
124832589|NCT03446040|449017436|FG006|Overall Study|Study drug toxicity|0|||
124832590|NCT03446040|449017437|FG007|Overall Study|Study drug toxicity|0|||
124832591|NCT03446040|449017438|FG008|Overall Study|Study drug toxicity|1|||
124832592|NCT03446040|449017439|FG009|Overall Study|Study drug toxicity|0|||
124832593|NCT03446040|449017440|FG010|Overall Study|Study drug toxicity|0|||
124832594|NCT03446040|449017441|FG011|Overall Study|Study drug toxicity|0|||
124832595|NCT03446040|449017442|FG012|Overall Study|Study drug toxicity|0|||
124832596|NCT03446040|449017443|FG013|Overall Study|Study drug toxicity|0|||
124832597|NCT03446040|449017430|FG000|Overall Study|Adverse Event|0|||
124832598|NCT03446040|449017431|FG001|Overall Study|Adverse Event|0|||
124832599|NCT03446040|449017432|FG002|Overall Study|Adverse Event|0|||
124832600|NCT03446040|449017433|FG003|Overall Study|Adverse Event|0|||
124832601|NCT03446040|449017434|FG004|Overall Study|Adverse Event|0|||
124832602|NCT03446040|449017435|FG005|Overall Study|Adverse Event|2|||
124832603|NCT03446040|449017436|FG006|Overall Study|Adverse Event|0|||
124832604|NCT03446040|449017437|FG007|Overall Study|Adverse Event|0|||
124832605|NCT03446040|449017438|FG008|Overall Study|Adverse Event|1|||
124832606|NCT03446040|449017439|FG009|Overall Study|Adverse Event|0|||
124832607|NCT03446040|449017440|FG010|Overall Study|Adverse Event|0|||
124832608|NCT03446040|449017441|FG011|Overall Study|Adverse Event|0|||
124832609|NCT03446040|449017442|FG012|Overall Study|Adverse Event|0|||
124832610|NCT03446040|449017443|FG013|Overall Study|Adverse Event|0|||
124639183|NCT02049814|448296530|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
124639184|NCT02049814|448296529|FG000|Overall Study|Voluntary withdrawal|9|||
124639185|NCT02049814|448296530|FG001|Overall Study|Voluntary withdrawal|8|||
124639186|NCT01282372|448296532|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
124639187|NCT01282372|448296532|FG000|Overall Study|Lost to Follow-up|23|||
124639188|NCT01282372|448296532|FG000|Overall Study|Withdrawal by Subject|11|||
124639189|NCT01282372|448296532|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
124639190|NCT01282372|448296532|FG000|Overall Study|Death|1|||
124832611|NCT03446040|449017430|FG000|Overall Study|Death|0|||
124832612|NCT03446040|449017431|FG001|Overall Study|Death|0|||
124639191|NCT01282372|448296532|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
124639192|NCT01282372|448296532|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
124832613|NCT03446040|449017432|FG002|Overall Study|Death|0|||
124832614|NCT03446040|449017433|FG003|Overall Study|Death|0|||
124832615|NCT03446040|449017434|FG004|Overall Study|Death|0|||
124832616|NCT03446040|449017435|FG005|Overall Study|Death|0|||
124832617|NCT03446040|449017436|FG006|Overall Study|Death|0|||
124832618|NCT03446040|449017437|FG007|Overall Study|Death|0|||
124832619|NCT03446040|449017438|FG008|Overall Study|Death|0|||
124832620|NCT03446040|449017439|FG009|Overall Study|Death|0|||
124832621|NCT03446040|449017440|FG010|Overall Study|Death|1|||
124832622|NCT03446040|449017441|FG011|Overall Study|Death|0|||
124832623|NCT03446040|449017442|FG012|Overall Study|Death|0|||
124832624|NCT03446040|449017443|FG013|Overall Study|Death|2|||
124832625|NCT03446040|449017430|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
124832626|NCT03446040|449017431|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
124832627|NCT03446040|449017432|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
124832628|NCT03446040|449017433|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
124832629|NCT03446040|449017434|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
124832630|NCT03446040|449017435|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
124832631|NCT03446040|449017436|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
124832632|NCT03446040|449017437|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
124832633|NCT03446040|449017438|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
124832634|NCT03446040|449017439|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
124832635|NCT03446040|449017440|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
124832636|NCT03446040|449017441|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
124832637|NCT03446040|449017442|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
124832638|NCT03446040|449017443|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
124832639|NCT03446040|449017430|FG000|Overall Study|Participant withdrew consent|0|||
124832640|NCT03446040|449017431|FG001|Overall Study|Participant withdrew consent|0|||
124832641|NCT03446040|449017432|FG002|Overall Study|Participant withdrew consent|0|||
124832642|NCT03446040|449017433|FG003|Overall Study|Participant withdrew consent|0|||
124832643|NCT03446040|449017434|FG004|Overall Study|Participant withdrew consent|0|||
124832644|NCT03446040|449017435|FG005|Overall Study|Participant withdrew consent|1|||
124832645|NCT03446040|449017436|FG006|Overall Study|Participant withdrew consent|0|||
124832646|NCT03446040|449017437|FG007|Overall Study|Participant withdrew consent|1|||
124832647|NCT03446040|449017438|FG008|Overall Study|Participant withdrew consent|0|||
124832648|NCT03446040|449017439|FG009|Overall Study|Participant withdrew consent|0|||
124832649|NCT03446040|449017440|FG010|Overall Study|Participant withdrew consent|0|||
124832650|NCT03446040|449017441|FG011|Overall Study|Participant withdrew consent|0|||
124832651|NCT03446040|449017442|FG012|Overall Study|Participant withdrew consent|0|||
124832652|NCT03446040|449017443|FG013|Overall Study|Participant withdrew consent|0|||
124832653|NCT03446040|449017430|FG000|Overall Study|Not reported|0|||
124832654|NCT03446040|449017431|FG001|Overall Study|Not reported|0|||
124832655|NCT03446040|449017432|FG002|Overall Study|Not reported|1|||
124832656|NCT03446040|449017433|FG003|Overall Study|Not reported|0|||
124832657|NCT03446040|449017434|FG004|Overall Study|Not reported|0|||
124832658|NCT03446040|449017435|FG005|Overall Study|Not reported|0|||
124832659|NCT03446040|449017436|FG006|Overall Study|Not reported|0|||
124832660|NCT03446040|449017437|FG007|Overall Study|Not reported|0|||
124832661|NCT03446040|449017438|FG008|Overall Study|Not reported|0|||
124832662|NCT03446040|449017439|FG009|Overall Study|Not reported|0|||
124832663|NCT03446040|449017440|FG010|Overall Study|Not reported|0|||
124832664|NCT03446040|449017441|FG011|Overall Study|Not reported|0|||
124832665|NCT03446040|449017442|FG012|Overall Study|Not reported|0|||
124832666|NCT03446040|449017443|FG013|Overall Study|Not reported|0|||
124832667|NCT01652664|449017444|FG000|Overall Study|Treatment Failure|5|||
124832668|NCT01652664|449017445|FG001|Overall Study|Treatment Failure|1|||
124832669|NCT01652664|449017444|FG000|Overall Study|Inadequate IOP control|1|||
124832670|NCT01652664|449017445|FG001|Overall Study|Inadequate IOP control|0|||
124832671|NCT03036098|449017448|FG000|Pre-Treatment|Other Reasons|1|||
124832672|NCT03036098|449017449|FG001|Pre-Treatment|Other Reasons|2|||
124832673|NCT03036098|449017450|FG002|Pre-Treatment|Other Reasons|0|||
124639193|NCT01282372|448296532|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
124639194|NCT01282372|448296532|FG000|Overall Study|Adverse Event|12|||
124639195|NCT02993250|448296534|FG000|Overall Study|Lost to Follow-up|0|||
124832674|NCT03036098|449017451|FG003|Pre-Treatment|Other Reasons|5|||
124832675|NCT03036098|449017448|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
124832676|NCT03036098|449017449|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
124832677|NCT03036098|449017450|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
124832678|NCT03036098|449017451|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
124832679|NCT03036098|449017448|FG000|Pre-Treatment|Withdrawal by Subject|1|||
124832680|NCT03036098|449017449|FG001|Pre-Treatment|Withdrawal by Subject|14|||
124832681|NCT03036098|449017450|FG002|Pre-Treatment|Withdrawal by Subject|0|||
124832682|NCT03036098|449017451|FG003|Pre-Treatment|Withdrawal by Subject|5|||
124832683|NCT03036098|449017448|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
124832684|NCT03036098|449017449|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
124832685|NCT03036098|449017450|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
124832686|NCT03036098|449017451|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
124832687|NCT03036098|449017448|FG000|Treatment|Disease Progression|130|||
124832688|NCT03036098|449017449|FG001|Treatment|Disease Progression|77|||
124832689|NCT03036098|449017450|FG002|Treatment|Disease Progression|168|||
124832690|NCT03036098|449017451|FG003|Treatment|Disease Progression|50|||
124832691|NCT03036098|449017448|FG000|Treatment|Study Drug Toxicity|95|||
124832692|NCT03036098|449017449|FG001|Treatment|Study Drug Toxicity|45|||
124832693|NCT03036098|449017450|FG002|Treatment|Study Drug Toxicity|26|||
124832694|NCT03036098|449017451|FG003|Treatment|Study Drug Toxicity|22|||
124832695|NCT03036098|449017448|FG000|Treatment|Death|9|||
124832696|NCT03036098|449017449|FG001|Treatment|Death|3|||
124832697|NCT03036098|449017450|FG002|Treatment|Death|1|||
124832698|NCT03036098|449017451|FG003|Treatment|Death|2|||
124832699|NCT03036098|449017448|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
124832700|NCT03036098|449017449|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
124832701|NCT03036098|449017450|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
124832702|NCT03036098|449017451|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
124832703|NCT03036098|449017448|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
124832704|NCT03036098|449017449|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
124832705|NCT03036098|449017450|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
124832706|NCT03036098|449017451|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
124832707|NCT03036098|449017448|FG000|Treatment|Withdrawal by Subject|2|||
124832708|NCT03036098|449017449|FG001|Treatment|Withdrawal by Subject|9|||
124832709|NCT03036098|449017450|FG002|Treatment|Withdrawal by Subject|2|||
124832710|NCT03036098|449017451|FG003|Treatment|Withdrawal by Subject|4|||
124832711|NCT03036098|449017448|FG000|Treatment|Maximum Clinical Benefit|6|||
124832712|NCT03036098|449017449|FG001|Treatment|Maximum Clinical Benefit|1|||
124832713|NCT03036098|449017450|FG002|Treatment|Maximum Clinical Benefit|6|||
124832714|NCT03036098|449017451|FG003|Treatment|Maximum Clinical Benefit|10|||
124832715|NCT03036098|449017448|FG000|Treatment|Poor/Non Compliance|1|||
124832716|NCT03036098|449017449|FG001|Treatment|Poor/Non Compliance|2|||
124832717|NCT03036098|449017450|FG002|Treatment|Poor/Non Compliance|0|||
124832718|NCT03036098|449017451|FG003|Treatment|Poor/Non Compliance|1|||
124832719|NCT03036098|449017448|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
124832720|NCT03036098|449017449|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
124832721|NCT03036098|449017450|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
124832722|NCT03036098|449017451|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
124832723|NCT03036098|449017448|FG000|Treatment|Administrative Reason by Sponsor|1|||
124832724|NCT03036098|449017449|FG001|Treatment|Administrative Reason by Sponsor|0|||
124832725|NCT03036098|449017450|FG002|Treatment|Administrative Reason by Sponsor|2|||
124832726|NCT03036098|449017451|FG003|Treatment|Administrative Reason by Sponsor|1|||
124832727|NCT03036098|449017448|FG000|Treatment|Other Reasons|31|||
124832728|NCT03036098|449017449|FG001|Treatment|Other Reasons|5|||
124832729|NCT03036098|449017450|FG002|Treatment|Other Reasons|21|||
124832730|NCT03036098|449017451|FG003|Treatment|Other Reasons|8|||
124832731|NCT03036098|449017448|FG000|Treatment|Ongoing Treatment|0|||
124832732|NCT03036098|449017449|FG001|Treatment|Ongoing Treatment|0|||
124832733|NCT03036098|449017450|FG002|Treatment|Ongoing Treatment|23|||
124832734|NCT03036098|449017451|FG003|Treatment|Ongoing Treatment|0|||
124832735|NCT00464568|449017455|FG000|Overall Study|Adverse Event|2|||
124832736|NCT00885755|449017458|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
124832737|NCT00885755|449017459|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
124832738|NCT00885755|449017460|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
124832739|NCT00885755|449017458|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
124832740|NCT00885755|449017459|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
124832741|NCT00885755|449017460|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
124832742|NCT00885755|449017458|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
124832743|NCT00885755|449017459|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
124832744|NCT00885755|449017460|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
124832745|NCT00885755|449017458|FG000|Part I: Trastuzumab+Taxane|Death|0|||
124832746|NCT00885755|449017459|FG001|Part I: Trastuzumab+Taxane|Death|0|||
124832747|NCT00885755|449017460|FG002|Part I: Trastuzumab+Taxane|Death|1|||
124832748|NCT00885755|449017458|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
124832749|NCT00885755|449017459|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
124832750|NCT00885755|449017460|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
124832751|NCT04343521|449017461|FG000|Overall Study|Adverse Event|0|||
124832752|NCT04343521|449017462|FG001|Overall Study|Adverse Event|2|||
124832753|NCT04343521|449017461|FG000|Overall Study|Death|1|||
124832754|NCT04343521|449017462|FG001|Overall Study|Death|2|||
124832755|NCT04343521|449017461|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
124832756|NCT04343521|449017462|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
124832757|NCT04343521|449017461|FG000|Overall Study|Withdrawal by Subject|70|||
124832758|NCT04343521|449017462|FG001|Overall Study|Withdrawal by Subject|95|||
124832759|NCT04343521|449017461|FG000|Overall Study|Withdrawal by study team|6|||
124832760|NCT04343521|449017462|FG001|Overall Study|Withdrawal by study team|12|||
124832761|NCT00107198|449017463|FG000|Overall Study|Lack of Efficacy|28|||
124832762|NCT00107198|449017463|FG000|Overall Study|Lost to Follow-up|12|||
124832763|NCT00107198|449017463|FG000|Overall Study|Protocol Violation|1|||
124832764|NCT00107198|449017463|FG000|Overall Study|Withdrawal by Subject|6|||
124832765|NCT00107198|449017463|FG000|Overall Study|Ineligible|5|||
124832766|NCT00751348|449017464|FG000|Overall Study|Withdrawal by Subject|5|||
124832767|NCT00751348|449017465|FG001|Overall Study|Withdrawal by Subject|2|||
124832768|NCT00751348|449017464|FG000|Overall Study|Migration from study area|1|||
124832769|NCT00751348|449017465|FG001|Overall Study|Migration from study area|0|||
124832770|NCT04191382|449017466|FG000|Overall Study|Withdrawal by Subject|1|||
124832771|NCT04191382|449017467|FG001|Overall Study|Withdrawal by Subject|0|||
124832772|NCT04191382|449017468|FG002|Overall Study|Withdrawal by Subject|0|||
124832773|NCT05237206|449017469|FG000|Overall Study|screen failure-did not receive treatment|8|||
124832774|NCT05237206|449017469|FG000|Overall Study|did not receive treatment|3|||
124832775|NCT02867709|449017471|FG000|Treatment Period|Adverse Event|1|||
124832776|NCT02867709|449017472|FG001|Treatment Period|Adverse Event|1|||
124832777|NCT02867709|449017473|FG002|Treatment Period|Adverse Event|2|||
124832778|NCT02867709|449017471|FG000|Treatment Period|Withdrawal of Consent|7|||
124832779|NCT02867709|449017472|FG001|Treatment Period|Withdrawal of Consent|9|||
124832780|NCT02867709|449017473|FG002|Treatment Period|Withdrawal of Consent|8|||
124832781|NCT02867709|449017471|FG000|Treatment Period|Lost to Follow-up|17|||
124832782|NCT02867709|449017472|FG001|Treatment Period|Lost to Follow-up|20|||
124832783|NCT02867709|449017473|FG002|Treatment Period|Lost to Follow-up|20|||
124832784|NCT02867709|449017471|FG000|Treatment Period|Lack of Qualifying Event|42|||
124832785|NCT02867709|449017472|FG001|Treatment Period|Lack of Qualifying Event|55|||
124832786|NCT02867709|449017473|FG002|Treatment Period|Lack of Qualifying Event|42|||
124832787|NCT02867709|449017471|FG000|Treatment Period|Protocol Violation|3|||
124832788|NCT02867709|449017472|FG001|Treatment Period|Protocol Violation|2|||
124832789|NCT02867709|449017473|FG002|Treatment Period|Protocol Violation|3|||
124832790|NCT02867709|449017471|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
124832791|NCT02867709|449017472|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
124832792|NCT02867709|449017473|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
124832793|NCT02867709|449017471|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
124832794|NCT02867709|449017472|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
124832795|NCT02867709|449017473|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
124832796|NCT02867709|449017471|FG000|Safety Follow-up Period|Pregnancy|0|||
124832797|NCT02867709|449017472|FG001|Safety Follow-up Period|Pregnancy|1|||
124832798|NCT02867709|449017473|FG002|Safety Follow-up Period|Pregnancy|0|||
124832799|NCT02867709|449017471|FG000|Safety Follow-up Period|Protocol Violation|0|||
124832800|NCT02867709|449017472|FG001|Safety Follow-up Period|Protocol Violation|1|||
124832801|NCT02867709|449017473|FG002|Safety Follow-up Period|Protocol Violation|1|||
124832802|NCT02865915|449017477|FG000|Overall Study|Pregnancy|1|||
124832803|NCT02865915|449017478|FG001|Overall Study|Pregnancy|0|||
124832804|NCT02865915|449017477|FG000|Overall Study|Withdrawal by Subject|1|||
124832805|NCT02865915|449017478|FG001|Overall Study|Withdrawal by Subject|1|||
124832806|NCT02865915|449017477|FG000|Overall Study|Adverse Event|0|||
124832807|NCT02865915|449017478|FG001|Overall Study|Adverse Event|4|||
124832808|NCT02865915|449017477|FG000|Overall Study|Lost to Follow-up|0|||
124832809|NCT02865915|449017478|FG001|Overall Study|Lost to Follow-up|1|||
124832810|NCT02865915|449017477|FG000|Overall Study|Protocol Violation|0|||
124832811|NCT02865915|449017478|FG001|Overall Study|Protocol Violation|1|||
124832812|NCT02865915|449017477|FG000|Overall Study|Study terminated by sponsor|23|||
124832813|NCT02865915|449017478|FG001|Overall Study|Study terminated by sponsor|18|||
124832814|NCT02865915|449017477|FG000|Overall Study|Dosing group discontinued|0|||
124832815|NCT02865915|449017478|FG001|Overall Study|Dosing group discontinued|5|||
124832816|NCT00663052|449017479|FG000|Overall Study|Adverse Event|6|||
124832817|NCT00663052|449017480|FG001|Overall Study|Adverse Event|3|||
124832818|NCT00663052|449017479|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
124832819|NCT00663052|449017480|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
124832820|NCT00663052|449017479|FG000|Overall Study|Protocol Violation|1|||
124832821|NCT00663052|449017480|FG001|Overall Study|Protocol Violation|0|||
124832822|NCT00663052|449017479|FG000|Overall Study|Withdrawal by Subject|2|||
124832823|NCT00663052|449017480|FG001|Overall Study|Withdrawal by Subject|5|||
124832824|NCT00663052|449017479|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
124832825|NCT00663052|449017480|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
124832826|NCT00663052|449017479|FG000|Overall Study|Other|0|||
124832827|NCT00663052|449017480|FG001|Overall Study|Other|1|||
124832828|NCT05760300|449017481|FG000|Overall Study|Adverse Event|0|||
124832829|NCT05760300|449017482|FG001|Overall Study|Adverse Event|0|||
124832830|NCT05760300|449017483|FG002|Overall Study|Adverse Event|1|||
124832831|NCT05760300|449017484|FG003|Overall Study|Adverse Event|0|||
124832832|NCT05760300|449017481|FG000|Overall Study|Participant Decision|1|||
124832833|NCT05760300|449017482|FG001|Overall Study|Participant Decision|0|||
124832834|NCT05760300|449017483|FG002|Overall Study|Participant Decision|0|||
124832835|NCT05760300|449017484|FG003|Overall Study|Participant Decision|0|||
124832836|NCT04350788|449017502|FG000|Overall Study|Lost to Follow-up|6|||
124832837|NCT04350788|449017503|FG001|Overall Study|Lost to Follow-up|2|||
124832838|NCT04350788|449017502|FG000|Overall Study|Withdrawal by Subject|2|||
124832839|NCT04350788|449017503|FG001|Overall Study|Withdrawal by Subject|4|||
124832840|NCT04350788|449017502|FG000|Overall Study|Protocol Violation|4|||
124832841|NCT04350788|449017503|FG001|Overall Study|Protocol Violation|0|||
124832842|NCT03615105|449017504|FG000|Overall Study|Protocol Violation|1|||
124832843|NCT03615105|449017505|FG001|Overall Study|Protocol Violation|0|||
124832844|NCT03615105|449017506|FG002|Overall Study|Protocol Violation|0|||
124832845|NCT03615105|449017504|FG000|Overall Study|Death|0|||
124832846|NCT03615105|449017505|FG001|Overall Study|Death|2|||
124832847|NCT03615105|449017506|FG002|Overall Study|Death|0|||
124832848|NCT03313804|449017507|FG000|Treatment|Death|5|||
124832849|NCT03313804|449017507|FG000|Treatment|still on treatment|2|||
124832850|NCT03313804|449017507|FG000|Follow Up|still on follow up|3|||
124639196|NCT02993250|448296535|FG001|Overall Study|Lost to Follow-up|1|||
124639197|NCT01996254|448296540|FG000|Overall Study|Change in Eligibility|0|||
124639198|NCT01996254|448296541|FG001|Overall Study|Change in Eligibility|2|||
124639199|NCT01996254|448296542|FG002|Overall Study|Change in Eligibility|0|||
124639200|NCT01996254|448296540|FG000|Overall Study|Withdrawal by Subject|0|||
124639201|NCT01996254|448296541|FG001|Overall Study|Withdrawal by Subject|3|||
124639202|NCT01996254|448296542|FG002|Overall Study|Withdrawal by Subject|4|||
124639203|NCT01996254|448296540|FG000|Overall Study|Lost to Follow-up|1|||
124639204|NCT01996254|448296541|FG001|Overall Study|Lost to Follow-up|0|||
124639205|NCT01996254|448296542|FG002|Overall Study|Lost to Follow-up|4|||
124639206|NCT03348930|448296543|FG000|Washout (1 Week)|Lost to Follow-up|1|||
124639207|NCT03348930|448296544|FG001|Washout (1 Week)|Lost to Follow-up|1|||
124639208|NCT00708214|448296545|FG000|Overall Study|Other Adverse Event|3|||
124639209|NCT00708214|448296546|FG001|Overall Study|Other Adverse Event|6|||
124639210|NCT00708214|448296547|FG002|Overall Study|Other Adverse Event|2|||
124639211|NCT00708214|448296545|FG000|Overall Study|Other|0|||
124639212|NCT00708214|448296546|FG001|Overall Study|Other|1|||
124639213|NCT00708214|448296547|FG002|Overall Study|Other|1|||
124639214|NCT00708214|448296545|FG000|Overall Study|Progressive Disease|4|||
124639215|NCT00708214|448296546|FG001|Overall Study|Progressive Disease|6|||
124639216|NCT00708214|448296547|FG002|Overall Study|Progressive Disease|5|||
124832851|NCT04383743|449017508|FG000|Overall Study|Withdrawal by Subject|1|||
124832852|NCT04383743|449017508|FG000|Overall Study|Adverse Event|1|||
124832853|NCT04837131|449017509|FG000|Overall Study|Death|1|||
124832854|NCT04837131|449017509|FG000|Overall Study|Withdrawal by Subject|1|||
124832855|NCT04837131|449017509|FG000|Overall Study|Adverse Event|1|||
124832856|NCT04837131|449017509|FG000|Overall Study|Protocol Violation|1|||
124832857|NCT03482791|449017510|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
124832858|NCT03482791|449017511|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
124832859|NCT01239368|449019050|FG000|Overall Study|Principal investigator discretion|1|||
124832860|NCT01239368|449019051|FG001|Overall Study|Principal investigator discretion|0|||
124832861|NCT01239368|449019052|FG002|Overall Study|Principal investigator discretion|0|||
124832862|NCT01239368|449019053|FG003|Overall Study|Principal investigator discretion|0|||
124832863|NCT01239368|449019054|FG004|Overall Study|Principal investigator discretion|1|||
124832864|NCT01239368|449019055|FG005|Overall Study|Principal investigator discretion|2|||
124832865|NCT01239368|449019056|FG006|Overall Study|Principal investigator discretion|0|||
124832866|NCT01239368|449019057|FG007|Overall Study|Principal investigator discretion|0|||
124832867|NCT01239368|449019058|FG008|Overall Study|Principal investigator discretion|0|||
124832868|NCT01239368|449019059|FG009|Overall Study|Principal investigator discretion|1|||
124832869|NCT01239368|449019050|FG000|Overall Study|Disease progression on study|1|||
124832870|NCT01239368|449019051|FG001|Overall Study|Disease progression on study|1|||
124832871|NCT01239368|449019052|FG002|Overall Study|Disease progression on study|1|||
124832872|NCT01239368|449019053|FG003|Overall Study|Disease progression on study|1|||
124832873|NCT01239368|449019054|FG004|Overall Study|Disease progression on study|4|||
124832874|NCT01239368|449019055|FG005|Overall Study|Disease progression on study|2|||
124832875|NCT01239368|449019056|FG006|Overall Study|Disease progression on study|5|||
124832876|NCT01239368|449019057|FG007|Overall Study|Disease progression on study|0|||
124832877|NCT01239368|449019058|FG008|Overall Study|Disease progression on study|0|||
124832878|NCT01239368|449019059|FG009|Overall Study|Disease progression on study|2|||
124832879|NCT01239368|449019050|FG000|Overall Study|Refused further treatment|0|||
124832880|NCT01239368|449019051|FG001|Overall Study|Refused further treatment|0|||
124832881|NCT01239368|449019052|FG002|Overall Study|Refused further treatment|0|||
124639217|NCT02411396|448296548|FG000|Overall Study|Lost to Follow-up|31|||
124639218|NCT02411396|448296548|FG000|Overall Study|Death|10|||
124639219|NCT02865499|448296549|FG000|Baseline|Adverse Event|1|||
124639220|NCT02865499|448296549|FG000|Baseline|Withdrawal by Subject|1|||
124639221|NCT01339923|448296550|FG000|Overall Study|Adverse Event|1|||
124639222|NCT01339923|448296551|FG001|Overall Study|Adverse Event|1|||
124639223|NCT01339923|448296552|FG002|Overall Study|Adverse Event|1|||
124832882|NCT01239368|449019053|FG003|Overall Study|Refused further treatment|0|||
124832883|NCT01239368|449019054|FG004|Overall Study|Refused further treatment|0|||
124832884|NCT01239368|449019055|FG005|Overall Study|Refused further treatment|0|||
124832885|NCT01239368|449019056|FG006|Overall Study|Refused further treatment|0|||
124832886|NCT01239368|449019057|FG007|Overall Study|Refused further treatment|0|||
124832887|NCT01239368|449019058|FG008|Overall Study|Refused further treatment|0|||
124832888|NCT01239368|449019059|FG009|Overall Study|Refused further treatment|1|||
124832889|NCT01239368|449019050|FG000|Overall Study|Death|0|||
124832890|NCT01239368|449019051|FG001|Overall Study|Death|0|||
124832891|NCT01239368|449019052|FG002|Overall Study|Death|0|||
124832892|NCT01239368|449019053|FG003|Overall Study|Death|0|||
124832893|NCT01239368|449019054|FG004|Overall Study|Death|0|||
124832894|NCT01239368|449019055|FG005|Overall Study|Death|0|||
124832895|NCT01239368|449019056|FG006|Overall Study|Death|1|||
124832896|NCT01239368|449019057|FG007|Overall Study|Death|0|||
124832897|NCT01239368|449019058|FG008|Overall Study|Death|0|||
124832898|NCT01239368|449019059|FG009|Overall Study|Death|0|||
124832899|NCT02967692|449019060|FG000|Overall Study|Progressive disease|3|||
124832900|NCT02967692|449019061|FG001|Overall Study|Progressive disease|15|||
124832901|NCT02967692|449019062|FG002|Overall Study|Progressive disease|114|||
124832902|NCT02967692|449019063|FG003|Overall Study|Progressive disease|151|||
124832903|NCT02967692|449019060|FG000|Overall Study|Subject/guardian decision|1|||
124832904|NCT02967692|449019061|FG001|Overall Study|Subject/guardian decision|1|||
124832905|NCT02967692|449019062|FG002|Overall Study|Subject/guardian decision|14|||
124832906|NCT02967692|449019063|FG003|Overall Study|Subject/guardian decision|22|||
124832907|NCT02967692|449019060|FG000|Overall Study|Death|0|||
124832908|NCT02967692|449019061|FG001|Overall Study|Death|1|||
124832909|NCT02967692|449019062|FG002|Overall Study|Death|13|||
124832910|NCT02967692|449019063|FG003|Overall Study|Death|13|||
124832911|NCT02967692|449019060|FG000|Overall Study|Protocol deviation|1|||
124832912|NCT02967692|449019061|FG001|Overall Study|Protocol deviation|0|||
124832913|NCT02967692|449019062|FG002|Overall Study|Protocol deviation|1|||
124832914|NCT02967692|449019063|FG003|Overall Study|Protocol deviation|1|||
124832915|NCT02967692|449019060|FG000|Overall Study|Lost to Follow-up|0|||
124832916|NCT02967692|449019061|FG001|Overall Study|Lost to Follow-up|0|||
124832917|NCT02967692|449019062|FG002|Overall Study|Lost to Follow-up|1|||
124832918|NCT02967692|449019063|FG003|Overall Study|Lost to Follow-up|0|||
124832919|NCT02967692|449019060|FG000|Overall Study|Physician Decision|0|||
124832920|NCT02967692|449019061|FG001|Overall Study|Physician Decision|0|||
124832921|NCT02967692|449019062|FG002|Overall Study|Physician Decision|22|||
124832922|NCT02967692|449019063|FG003|Overall Study|Physician Decision|13|||
124832923|NCT02967692|449019060|FG000|Overall Study|Adverse Event|2|||
124832924|NCT02967692|449019061|FG001|Overall Study|Adverse Event|9|||
124832925|NCT02967692|449019062|FG002|Overall Study|Adverse Event|60|||
124832926|NCT02967692|449019063|FG003|Overall Study|Adverse Event|28|||
124832927|NCT02967692|449019060|FG000|Overall Study|Study terminated by sponsor|2|||
124832928|NCT02967692|449019061|FG001|Overall Study|Study terminated by sponsor|1|||
124832929|NCT02967692|449019062|FG002|Overall Study|Study terminated by sponsor|42|||
124832930|NCT02967692|449019063|FG003|Overall Study|Study terminated by sponsor|37|||
124832931|NCT01541969|449019068|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
124832932|NCT01541969|449019069|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
124832933|NCT01541969|449019068|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
124832934|NCT01541969|449019069|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
124832935|NCT01541969|449019068|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
124832936|NCT01541969|449019069|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
124832937|NCT01541969|449019068|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
124832938|NCT01541969|449019069|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
124832939|NCT01541969|449019068|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
124832940|NCT01541969|449019069|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
124832941|NCT01541969|449019068|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
124832942|NCT01541969|449019069|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
124832943|NCT01541969|449019068|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
124639224|NCT01339923|448296553|FG003|Overall Study|Adverse Event|0|||
124639225|NCT01339923|448296554|FG004|Overall Study|Adverse Event|0|||
124639226|NCT01339923|448296555|FG005|Overall Study|Adverse Event|0|||
124639227|NCT01339923|448296556|FG006|Overall Study|Adverse Event|1|||
124639228|NCT01339923|448296550|FG000|Overall Study|Inappropriate Enrollment|1|||
124639229|NCT01339923|448296551|FG001|Overall Study|Inappropriate Enrollment|0|||
124639230|NCT01339923|448296552|FG002|Overall Study|Inappropriate Enrollment|0|||
124639231|NCT01339923|448296553|FG003|Overall Study|Inappropriate Enrollment|0|||
124832944|NCT01541969|449019069|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
124832945|NCT01541969|449019068|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
124639232|NCT01339923|448296554|FG004|Overall Study|Inappropriate Enrollment|0|||
124832946|NCT01541969|449019069|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
124832947|NCT01541969|449019068|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
124832948|NCT01541969|449019069|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
124832949|NCT01541969|449019068|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
124639233|NCT01339923|448296555|FG005|Overall Study|Inappropriate Enrollment|1|||
124832950|NCT01541969|449019069|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
124832951|NCT01614990|449019070|FG000|Overall Study|Protocol Violation|1|||
124832952|NCT01614990|449019071|FG001|Overall Study|Protocol Violation|1|||
124832953|NCT01012622|449019072|FG000|Overall Study|Withdrawal by Subject|6|||
124832954|NCT01012622|449019072|FG000|Overall Study|Lost to Follow-up|5|||
124832955|NCT01012622|449019072|FG000|Overall Study|Adverse Event|7|||
124832956|NCT01012622|449019072|FG000|Overall Study|non-compliance with the drug|9|||
124832957|NCT01012622|449019072|FG000|Overall Study|Other|1|||
124832958|NCT01012622|449019072|FG000|Overall Study|screening failure|1|||
124832959|NCT01012622|449019072|FG000|Overall Study|withdrawal of consent by a parent|2|||
124832960|NCT04762680|449019073|FG000|Phase 2|Adverse Event|0|||
124832961|NCT04762680|449019074|FG001|Phase 2|Adverse Event|1|||
124832962|NCT04762680|449019075|FG002|Phase 2|Adverse Event|0|||
124832963|NCT04762680|449019076|FG003|Phase 2|Adverse Event|0|||
124832964|NCT04762680|449019077|FG004|Phase 2|Adverse Event|0|||
124832965|NCT04762680|449019078|FG005|Phase 2|Adverse Event|0|||
124832966|NCT04762680|449019079|FG006|Phase 2|Adverse Event|0|||
124832967|NCT04762680|449019080|FG007|Phase 2|Adverse Event|0|||
124832968|NCT04762680|449019081|FG008|Phase 2|Adverse Event|0|||
124832969|NCT04762680|449019082|FG009|Phase 2|Adverse Event|0|||
124832970|NCT04762680|449019083|FG010|Phase 2|Adverse Event|0|||
124832971|NCT04762680|449019084|FG011|Phase 2|Adverse Event|0|||
124832972|NCT04762680|449019085|FG012|Phase 2|Adverse Event|0|||
124832973|NCT04762680|449019086|FG013|Phase 2|Adverse Event|0|||
124832974|NCT04762680|449019087|FG014|Phase 2|Adverse Event|0|||
124832975|NCT04762680|449019088|FG015|Phase 2|Adverse Event|0|||
124832976|NCT04762680|449019089|FG016|Phase 2|Adverse Event|0|||
124832977|NCT04762680|449019090|FG017|Phase 2|Adverse Event|0|||
124832978|NCT04762680|449019091|FG018|Phase 2|Adverse Event|0|||
124832979|NCT04762680|449019092|FG019|Phase 2|Adverse Event|0|||
124832980|NCT04762680|449019093|FG020|Phase 2|Adverse Event|0|||
124832981|NCT04762680|449019094|FG021|Phase 2|Adverse Event|0|||
124832982|NCT04762680|449019073|FG000|Phase 2|Protocol Violation|5|||
124832983|NCT04762680|449019074|FG001|Phase 2|Protocol Violation|5|||
124832984|NCT04762680|449019075|FG002|Phase 2|Protocol Violation|1|||
124832985|NCT04762680|449019076|FG003|Phase 2|Protocol Violation|0|||
124832986|NCT04762680|449019077|FG004|Phase 2|Protocol Violation|0|||
124832987|NCT04762680|449019078|FG005|Phase 2|Protocol Violation|0|||
124832988|NCT04762680|449019079|FG006|Phase 2|Protocol Violation|0|||
124832989|NCT04762680|449019080|FG007|Phase 2|Protocol Violation|0|||
124832990|NCT04762680|449019081|FG008|Phase 2|Protocol Violation|0|||
124832991|NCT04762680|449019082|FG009|Phase 2|Protocol Violation|0|||
124832992|NCT04762680|449019083|FG010|Phase 2|Protocol Violation|0|||
124832993|NCT04762680|449019084|FG011|Phase 2|Protocol Violation|0|||
124832994|NCT04762680|449019085|FG012|Phase 2|Protocol Violation|0|||
124832995|NCT04762680|449019086|FG013|Phase 2|Protocol Violation|0|||
124832996|NCT04762680|449019087|FG014|Phase 2|Protocol Violation|0|||
124832997|NCT04762680|449019088|FG015|Phase 2|Protocol Violation|0|||
124832998|NCT04762680|449019089|FG016|Phase 2|Protocol Violation|0|||
124832999|NCT04762680|449019090|FG017|Phase 2|Protocol Violation|0|||
124833000|NCT04762680|449019091|FG018|Phase 2|Protocol Violation|0|||
124833001|NCT04762680|449019092|FG019|Phase 2|Protocol Violation|0|||
124833002|NCT04762680|449019093|FG020|Phase 2|Protocol Violation|0|||
124833003|NCT04762680|449019094|FG021|Phase 2|Protocol Violation|0|||
124833004|NCT04762680|449019073|FG000|Phase 2|Withdrawal by Subject|23|||
124833005|NCT04762680|449019074|FG001|Phase 2|Withdrawal by Subject|21|||
124833006|NCT04762680|449019075|FG002|Phase 2|Withdrawal by Subject|28|||
124833007|NCT04762680|449019076|FG003|Phase 2|Withdrawal by Subject|0|||
124833008|NCT04762680|449019077|FG004|Phase 2|Withdrawal by Subject|0|||
124833009|NCT04762680|449019078|FG005|Phase 2|Withdrawal by Subject|0|||
124833010|NCT04762680|449019079|FG006|Phase 2|Withdrawal by Subject|0|||
124833011|NCT04762680|449019080|FG007|Phase 2|Withdrawal by Subject|0|||
124833012|NCT04762680|449019081|FG008|Phase 2|Withdrawal by Subject|0|||
124833013|NCT04762680|449019082|FG009|Phase 2|Withdrawal by Subject|0|||
124833014|NCT04762680|449019083|FG010|Phase 2|Withdrawal by Subject|0|||
124833015|NCT04762680|449019084|FG011|Phase 2|Withdrawal by Subject|0|||
124833016|NCT04762680|449019085|FG012|Phase 2|Withdrawal by Subject|0|||
124833017|NCT04762680|449019086|FG013|Phase 2|Withdrawal by Subject|0|||
124833018|NCT04762680|449019087|FG014|Phase 2|Withdrawal by Subject|0|||
124833019|NCT04762680|449019088|FG015|Phase 2|Withdrawal by Subject|0|||
124833020|NCT04762680|449019089|FG016|Phase 2|Withdrawal by Subject|0|||
124833021|NCT04762680|449019090|FG017|Phase 2|Withdrawal by Subject|0|||
124833022|NCT04762680|449019091|FG018|Phase 2|Withdrawal by Subject|0|||
124833023|NCT04762680|449019092|FG019|Phase 2|Withdrawal by Subject|0|||
124833024|NCT04762680|449019093|FG020|Phase 2|Withdrawal by Subject|0|||
124833025|NCT04762680|449019094|FG021|Phase 2|Withdrawal by Subject|0|||
124833026|NCT04762680|449019073|FG000|Phase 2|Lost to Follow-up|14|||
124833027|NCT04762680|449019074|FG001|Phase 2|Lost to Follow-up|8|||
124833028|NCT04762680|449019075|FG002|Phase 2|Lost to Follow-up|9|||
124833029|NCT04762680|449019076|FG003|Phase 2|Lost to Follow-up|0|||
124833030|NCT04762680|449019077|FG004|Phase 2|Lost to Follow-up|0|||
124833031|NCT04762680|449019078|FG005|Phase 2|Lost to Follow-up|0|||
124833032|NCT04762680|449019079|FG006|Phase 2|Lost to Follow-up|0|||
124833033|NCT04762680|449019080|FG007|Phase 2|Lost to Follow-up|0|||
124833034|NCT04762680|449019081|FG008|Phase 2|Lost to Follow-up|0|||
124833035|NCT04762680|449019082|FG009|Phase 2|Lost to Follow-up|0|||
124833036|NCT04762680|449019083|FG010|Phase 2|Lost to Follow-up|0|||
124833037|NCT04762680|449019084|FG011|Phase 2|Lost to Follow-up|0|||
124833038|NCT04762680|449019085|FG012|Phase 2|Lost to Follow-up|0|||
124833039|NCT04762680|449019086|FG013|Phase 2|Lost to Follow-up|0|||
124833040|NCT04762680|449019087|FG014|Phase 2|Lost to Follow-up|0|||
124833041|NCT04762680|449019088|FG015|Phase 2|Lost to Follow-up|0|||
124833042|NCT04762680|449019089|FG016|Phase 2|Lost to Follow-up|0|||
124833043|NCT04762680|449019090|FG017|Phase 2|Lost to Follow-up|0|||
124833044|NCT04762680|449019091|FG018|Phase 2|Lost to Follow-up|0|||
124833045|NCT04762680|449019092|FG019|Phase 2|Lost to Follow-up|0|||
124833046|NCT04762680|449019093|FG020|Phase 2|Lost to Follow-up|0|||
124833047|NCT04762680|449019094|FG021|Phase 2|Lost to Follow-up|0|||
124833048|NCT04762680|449019073|FG000|Phase 3|Adverse Event|0|||
124833049|NCT04762680|449019074|FG001|Phase 3|Adverse Event|0|||
124833050|NCT04762680|449019075|FG002|Phase 3|Adverse Event|0|||
124833051|NCT04762680|449019076|FG003|Phase 3|Adverse Event|1|||
124833052|NCT04762680|449019077|FG004|Phase 3|Adverse Event|0|||
124833053|NCT04762680|449019078|FG005|Phase 3|Adverse Event|0|||
124833054|NCT04762680|449019079|FG006|Phase 3|Adverse Event|0|||
124833055|NCT04762680|449019080|FG007|Phase 3|Adverse Event|0|||
124833056|NCT04762680|449019081|FG008|Phase 3|Adverse Event|0|||
124833057|NCT04762680|449019082|FG009|Phase 3|Adverse Event|0|||
124833058|NCT04762680|449019083|FG010|Phase 3|Adverse Event|0|||
124833059|NCT04762680|449019084|FG011|Phase 3|Adverse Event|0|||
124833060|NCT04762680|449019085|FG012|Phase 3|Adverse Event|0|||
124833061|NCT04762680|449019086|FG013|Phase 3|Adverse Event|0|||
124833062|NCT04762680|449019087|FG014|Phase 3|Adverse Event|0|||
124833063|NCT04762680|449019088|FG015|Phase 3|Adverse Event|0|||
124833064|NCT04762680|449019089|FG016|Phase 3|Adverse Event|0|||
124833065|NCT04762680|449019090|FG017|Phase 3|Adverse Event|3|||
124833066|NCT04762680|449019091|FG018|Phase 3|Adverse Event|0|||
124833067|NCT04762680|449019092|FG019|Phase 3|Adverse Event|0|||
124833068|NCT04762680|449019093|FG020|Phase 3|Adverse Event|0|||
124833069|NCT04762680|449019094|FG021|Phase 3|Adverse Event|0|||
124833070|NCT04762680|449019073|FG000|Phase 3|Protocol Violation|0|||
124833071|NCT04762680|449019074|FG001|Phase 3|Protocol Violation|0|||
124833072|NCT04762680|449019075|FG002|Phase 3|Protocol Violation|0|||
124833073|NCT04762680|449019076|FG003|Phase 3|Protocol Violation|4|||
124833074|NCT04762680|449019077|FG004|Phase 3|Protocol Violation|1|||
124833075|NCT04762680|449019078|FG005|Phase 3|Protocol Violation|5|||
124833076|NCT04762680|449019079|FG006|Phase 3|Protocol Violation|1|||
124833077|NCT04762680|449019080|FG007|Phase 3|Protocol Violation|0|||
124833078|NCT04762680|449019081|FG008|Phase 3|Protocol Violation|0|||
124833079|NCT04762680|449019082|FG009|Phase 3|Protocol Violation|0|||
124833080|NCT04762680|449019083|FG010|Phase 3|Protocol Violation|0|||
124833081|NCT04762680|449019084|FG011|Phase 3|Protocol Violation|2|||
124833082|NCT04762680|449019085|FG012|Phase 3|Protocol Violation|3|||
124833083|NCT04762680|449019086|FG013|Phase 3|Protocol Violation|0|||
124833084|NCT04762680|449019087|FG014|Phase 3|Protocol Violation|0|||
124833085|NCT04762680|449019088|FG015|Phase 3|Protocol Violation|1|||
124833086|NCT04762680|449019089|FG016|Phase 3|Protocol Violation|0|||
124833087|NCT04762680|449019090|FG017|Phase 3|Protocol Violation|10|||
124833088|NCT04762680|449019091|FG018|Phase 3|Protocol Violation|0|||
124833089|NCT04762680|449019092|FG019|Phase 3|Protocol Violation|0|||
124833090|NCT04762680|449019093|FG020|Phase 3|Protocol Violation|0|||
124833091|NCT04762680|449019094|FG021|Phase 3|Protocol Violation|0|||
124833092|NCT04762680|449019073|FG000|Phase 3|Withdrawal by Subject|0|||
124833093|NCT04762680|449019074|FG001|Phase 3|Withdrawal by Subject|0|||
124833094|NCT04762680|449019075|FG002|Phase 3|Withdrawal by Subject|0|||
124833095|NCT04762680|449019076|FG003|Phase 3|Withdrawal by Subject|13|||
124833096|NCT04762680|449019077|FG004|Phase 3|Withdrawal by Subject|17|||
124833097|NCT04762680|449019078|FG005|Phase 3|Withdrawal by Subject|12|||
124833098|NCT04762680|449019079|FG006|Phase 3|Withdrawal by Subject|8|||
124833099|NCT04762680|449019080|FG007|Phase 3|Withdrawal by Subject|3|||
124833100|NCT04762680|449019081|FG008|Phase 3|Withdrawal by Subject|2|||
124833101|NCT04762680|449019082|FG009|Phase 3|Withdrawal by Subject|4|||
124833102|NCT04762680|449019083|FG010|Phase 3|Withdrawal by Subject|3|||
124833103|NCT04762680|449019084|FG011|Phase 3|Withdrawal by Subject|1|||
124833104|NCT04762680|449019085|FG012|Phase 3|Withdrawal by Subject|3|||
124833105|NCT04762680|449019086|FG013|Phase 3|Withdrawal by Subject|2|||
124833106|NCT04762680|449019087|FG014|Phase 3|Withdrawal by Subject|1|||
124833107|NCT04762680|449019088|FG015|Phase 3|Withdrawal by Subject|4|||
124833108|NCT04762680|449019089|FG016|Phase 3|Withdrawal by Subject|6|||
124833109|NCT04762680|449019090|FG017|Phase 3|Withdrawal by Subject|32|||
124833110|NCT04762680|449019091|FG018|Phase 3|Withdrawal by Subject|0|||
124833111|NCT04762680|449019092|FG019|Phase 3|Withdrawal by Subject|0|||
124833112|NCT04762680|449019093|FG020|Phase 3|Withdrawal by Subject|0|||
124833113|NCT04762680|449019094|FG021|Phase 3|Withdrawal by Subject|0|||
124833114|NCT04762680|449019073|FG000|Phase 3|Lost to Follow-up|0|||
124833115|NCT04762680|449019074|FG001|Phase 3|Lost to Follow-up|0|||
124833116|NCT04762680|449019075|FG002|Phase 3|Lost to Follow-up|0|||
124833117|NCT04762680|449019076|FG003|Phase 3|Lost to Follow-up|9|||
124833118|NCT04762680|449019077|FG004|Phase 3|Lost to Follow-up|22|||
124833119|NCT04762680|449019078|FG005|Phase 3|Lost to Follow-up|24|||
124833120|NCT04762680|449019079|FG006|Phase 3|Lost to Follow-up|2|||
124833121|NCT04762680|449019080|FG007|Phase 3|Lost to Follow-up|4|||
124833122|NCT04762680|449019081|FG008|Phase 3|Lost to Follow-up|6|||
124833123|NCT04762680|449019082|FG009|Phase 3|Lost to Follow-up|4|||
124833124|NCT04762680|449019083|FG010|Phase 3|Lost to Follow-up|3|||
124833125|NCT04762680|449019084|FG011|Phase 3|Lost to Follow-up|0|||
124833126|NCT04762680|449019085|FG012|Phase 3|Lost to Follow-up|5|||
124833127|NCT04762680|449019086|FG013|Phase 3|Lost to Follow-up|4|||
124833128|NCT04762680|449019087|FG014|Phase 3|Lost to Follow-up|6|||
124833129|NCT04762680|449019088|FG015|Phase 3|Lost to Follow-up|1|||
124833130|NCT04762680|449019089|FG016|Phase 3|Lost to Follow-up|1|||
124833131|NCT04762680|449019090|FG017|Phase 3|Lost to Follow-up|66|||
124833132|NCT04762680|449019091|FG018|Phase 3|Lost to Follow-up|0|||
124833133|NCT04762680|449019092|FG019|Phase 3|Lost to Follow-up|0|||
124833134|NCT04762680|449019093|FG020|Phase 3|Lost to Follow-up|0|||
124833135|NCT04762680|449019094|FG021|Phase 3|Lost to Follow-up|0|||
124833136|NCT04762680|449019073|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833137|NCT04762680|449019074|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833138|NCT04762680|449019075|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833139|NCT04762680|449019076|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833140|NCT04762680|449019077|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833141|NCT04762680|449019078|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833142|NCT04762680|449019079|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833143|NCT04762680|449019080|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833144|NCT04762680|449019081|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833145|NCT04762680|449019082|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833146|NCT04762680|449019083|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833147|NCT04762680|449019084|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833148|NCT04762680|449019085|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833149|NCT04762680|449019086|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833150|NCT04762680|449019087|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833151|NCT04762680|449019088|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833152|NCT04762680|449019089|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833153|NCT04762680|449019090|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833154|NCT04762680|449019091|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833155|NCT04762680|449019092|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833156|NCT04762680|449019093|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
124833157|NCT04762680|449019094|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
124833158|NCT04762680|449019073|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833159|NCT04762680|449019074|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833160|NCT04762680|449019075|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833161|NCT04762680|449019076|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833162|NCT04762680|449019077|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833163|NCT04762680|449019078|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833164|NCT04762680|449019079|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833165|NCT04762680|449019080|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833166|NCT04762680|449019081|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833167|NCT04762680|449019082|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833168|NCT04762680|449019083|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833169|NCT04762680|449019084|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833170|NCT04762680|449019085|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833171|NCT04762680|449019086|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833172|NCT04762680|449019087|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833173|NCT04762680|449019088|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833174|NCT04762680|449019089|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833175|NCT04762680|449019090|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833176|NCT04762680|449019091|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833177|NCT04762680|449019092|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
124833178|NCT04762680|449019093|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833179|NCT04762680|449019094|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
124833180|NCT01063764|449019098|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
124833181|NCT01063764|449019098|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
124833182|NCT01063764|449019098|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
124833183|NCT01063764|449019098|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
124833184|NCT01063764|449019098|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
124833185|NCT01063764|449019098|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
124833186|NCT01063764|449019098|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
124833187|NCT00697515|449019101|FG000|Dose Optimization Period|Adverse Event|4|||
124833188|NCT00697515|449019102|FG001|Dose Optimization Period|Adverse Event|0|||
124833189|NCT00697515|449019101|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
124833190|NCT00697515|449019102|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
124833191|NCT00697515|449019101|FG000|Dose Optimization Period|Lost to Follow-up|2|||
124833192|NCT00697515|449019102|FG001|Dose Optimization Period|Lost to Follow-up|0|||
124833193|NCT00697515|449019101|FG000|Dose Optimization Period|sponsor request|2|||
124833194|NCT00697515|449019102|FG001|Dose Optimization Period|sponsor request|0|||
124833195|NCT00697515|449019101|FG000|Dose Optimization Period|called to active duty|1|||
124833196|NCT00697515|449019102|FG001|Dose Optimization Period|called to active duty|0|||
124833197|NCT00697515|449019101|FG000|Dose Optimization Period|elevated QTc|1|||
124833198|NCT00697515|449019102|FG001|Dose Optimization Period|elevated QTc|0|||
124833199|NCT00697515|449019101|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
124833200|NCT00697515|449019102|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
124833201|NCT00697515|449019101|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
124833202|NCT00697515|449019102|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
124833203|NCT00697515|449019101|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
124833204|NCT00697515|449019102|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
124833205|NCT00697515|449019101|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
124833206|NCT00697515|449019102|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
124833207|NCT02603432|449019103|FG000|Overall Study|Adverse Event|1|||
124833208|NCT02603432|449019104|FG001|Overall Study|Adverse Event|0|||
124833209|NCT02603432|449019103|FG000|Overall Study|Death|221|||
124833210|NCT02603432|449019104|FG001|Overall Study|Death|242|||
124833211|NCT02603432|449019103|FG000|Overall Study|Lost to Follow-up|3|||
124833212|NCT02603432|449019104|FG001|Overall Study|Lost to Follow-up|9|||
124833213|NCT02603432|449019103|FG000|Overall Study|Progressive Disease|7|||
124833214|NCT02603432|449019104|FG001|Overall Study|Progressive Disease|5|||
124833215|NCT02603432|449019103|FG000|Overall Study|Withdrawal by Subject|12|||
124833216|NCT02603432|449019104|FG001|Overall Study|Withdrawal by Subject|18|||
124833217|NCT02603432|449019103|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
124833218|NCT02603432|449019104|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
124833219|NCT02603432|449019103|FG000|Overall Study|Study terminated by sponsor|74|||
124833220|NCT02603432|449019104|FG001|Overall Study|Study terminated by sponsor|75|||
124833221|NCT02603432|449019103|FG000|Overall Study|Other|13|||
124833222|NCT02603432|449019104|FG001|Overall Study|Other|0|||
124833223|NCT01957462|449019105|FG000|Test Period 1|Withdrawal by Subject|1|||
124833224|NCT01957462|449019106|FG001|Test Period 1|Withdrawal by Subject|0|||
124833225|NCT01957462|449019105|FG000|Test Period 1|Adverse Event|1|||
124833226|NCT01957462|449019106|FG001|Test Period 1|Adverse Event|0|||
124833227|NCT05954052|449019107|FG000|Overall Study|Adverse Event|1|||
124833228|NCT01856790|449019108|FG000|Closed Loop Control|Withdrawal by Subject|2|||
124833229|NCT01856790|449019108|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
124833230|NCT01124604|449019109|FG000|Overall Study|Adverse Event|10|||
124833231|NCT01124604|449019110|FG001|Overall Study|Adverse Event|1|||
124833232|NCT01124604|449019109|FG000|Overall Study|Lack of Efficacy|1|||
124833233|NCT01124604|449019110|FG001|Overall Study|Lack of Efficacy|0|||
124833234|NCT01124604|449019109|FG000|Overall Study|Withdrawal by Subject|4|||
124833235|NCT01124604|449019110|FG001|Overall Study|Withdrawal by Subject|0|||
124833236|NCT01124604|449019109|FG000|Overall Study|Disease Progression|0|||
124833237|NCT01124604|449019110|FG001|Overall Study|Disease Progression|1|||
124833238|NCT02596854|449019113|FG000|Overall Study|Withdrawn|8|||
124833239|NCT06027866|449019118|FG000|Overall Study|Withdrawal by Subject|2|||
124833240|NCT03425331|449019121|FG000|Overall Study|Withdrawal by Subject|1|||
124833241|NCT03425331|449019121|FG000|Overall Study|Death|1|||
124833242|NCT03425331|449019121|FG000|Overall Study|Adverse Event|1|||
124833243|NCT03425331|449019121|FG000|Overall Study|Disease Progression|2|||
124833244|NCT02864251|449019123|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
124833245|NCT02864251|449019124|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
124833246|NCT02864251|449019125|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
124833247|NCT02864251|449019123|FG000|Pre-Treatment|Withdrawal by Participant|0|||
124833248|NCT02864251|449019124|FG001|Pre-Treatment|Withdrawal by Participant|0|||
124833249|NCT02864251|449019125|FG002|Pre-Treatment|Withdrawal by Participant|4|||
124833250|NCT02864251|449019123|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
124833251|NCT02864251|449019124|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
124833252|NCT02864251|449019125|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
124639234|NCT01339923|448296556|FG006|Overall Study|Inappropriate Enrollment|0|||
124639235|NCT01339923|448296550|FG000|Overall Study|Lost to Follow-up|4|||
124833253|NCT02864251|449019123|FG000|Pre-Treatment|Other Reasons|0|||
124639236|NCT01339923|448296551|FG001|Overall Study|Lost to Follow-up|4|||
124639237|NCT01339923|448296552|FG002|Overall Study|Lost to Follow-up|0|||
124833254|NCT02864251|449019124|FG001|Pre-Treatment|Other Reasons|1|||
124833255|NCT02864251|449019125|FG002|Pre-Treatment|Other Reasons|1|||
124833256|NCT02864251|449019123|FG000|Treatment|Disease Progression|109|||
124833257|NCT02864251|449019124|FG001|Treatment|Disease Progression|52|||
124833258|NCT02864251|449019125|FG002|Treatment|Disease Progression|101|||
124833259|NCT02864251|449019123|FG000|Treatment|Study Drug Toxicity|9|||
124833260|NCT02864251|449019124|FG001|Treatment|Study Drug Toxicity|4|||
124833261|NCT02864251|449019125|FG002|Treatment|Study Drug Toxicity|10|||
124833262|NCT02864251|449019123|FG000|Treatment|Death|0|||
124833263|NCT02864251|449019124|FG001|Treatment|Death|2|||
124833264|NCT02864251|449019125|FG002|Treatment|Death|3|||
124833265|NCT02864251|449019123|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
124833266|NCT02864251|449019124|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
124833267|NCT02864251|449019125|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
124833268|NCT02864251|449019123|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
124833269|NCT02864251|449019124|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
124833270|NCT02864251|449019125|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
124833271|NCT02864251|449019123|FG000|Treatment|Withdrawal by Participant|8|||
124833272|NCT02864251|449019124|FG001|Treatment|Withdrawal by Participant|5|||
124833273|NCT02864251|449019125|FG002|Treatment|Withdrawal by Participant|13|||
124833274|NCT02864251|449019123|FG000|Treatment|Maximum Clinical Benefit|1|||
124833275|NCT02864251|449019124|FG001|Treatment|Maximum Clinical Benefit|0|||
124833276|NCT02864251|449019125|FG002|Treatment|Maximum Clinical Benefit|1|||
124833277|NCT02864251|449019123|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
124833278|NCT02864251|449019124|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
124833279|NCT02864251|449019125|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
124833280|NCT02864251|449019123|FG000|Treatment|Other Reasons|1|||
124833281|NCT02864251|449019124|FG001|Treatment|Other Reasons|1|||
124833282|NCT02864251|449019125|FG002|Treatment|Other Reasons|4|||
124833283|NCT02864251|449019123|FG000|Treatment|Administrative Reason by Sponsor|1|||
124833284|NCT02864251|449019124|FG001|Treatment|Administrative Reason by Sponsor|0|||
124833285|NCT02864251|449019125|FG002|Treatment|Administrative Reason by Sponsor|0|||
124833286|NCT05442554|449019126|FG000|Overall Study|Adverse Event|1|||
124833287|NCT02438722|449019128|FG000|Overall Study|Adverse Event|12|||
124833288|NCT02438722|449019129|FG001|Overall Study|Adverse Event|9|||
124833289|NCT02438722|449019128|FG000|Overall Study|Refusal unrelated to AE|2|||
124833290|NCT02438722|449019129|FG001|Overall Study|Refusal unrelated to AE|5|||
124833291|NCT02438722|449019128|FG000|Overall Study|Disease progression/relapse|46|||
124833292|NCT02438722|449019129|FG001|Overall Study|Disease progression/relapse|51|||
124833293|NCT02438722|449019128|FG000|Overall Study|Death|0|||
124833294|NCT02438722|449019129|FG001|Overall Study|Death|3|||
124833295|NCT02438722|449019128|FG000|Overall Study|Physician Decision|2|||
124833296|NCT02438722|449019129|FG001|Overall Study|Physician Decision|2|||
124833297|NCT02438722|449019128|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
124833298|NCT02438722|449019129|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
124833299|NCT02438722|449019128|FG000|Overall Study|Withdrawal by Subject|0|||
124833300|NCT02438722|449019129|FG001|Overall Study|Withdrawal by Subject|1|||
124833301|NCT02438722|449019128|FG000|Overall Study|On protocol treatment|15|||
124833302|NCT02438722|449019129|FG001|Overall Study|On protocol treatment|14|||
124833303|NCT02438722|449019128|FG000|Overall Study|Did not receive protocol treatment|5|||
124833304|NCT02438722|449019129|FG001|Overall Study|Did not receive protocol treatment|0|||
124833305|NCT05172544|449019134|FG000|Overall Study|Withdrawal by Subject|1|||
124833306|NCT05172544|449019135|FG001|Overall Study|Withdrawal by Subject|0|||
124833307|NCT05172544|449019136|FG002|Overall Study|Withdrawal by Subject|0|||
124833308|NCT05172544|449019134|FG000|Overall Study|Physician Decision|0|||
124833309|NCT05172544|449019135|FG001|Overall Study|Physician Decision|0|||
124833310|NCT05172544|449019136|FG002|Overall Study|Physician Decision|1|||
124833311|NCT04829318|449019137|FG000|Overall Study|Adverse Event|6|||
124833312|NCT04829318|449019137|FG000|Overall Study|Death|1|||
124833313|NCT04829318|449019137|FG000|Overall Study|Lost to Follow-up|1|||
124833314|NCT04829318|449019137|FG000|Overall Study|Physician Decision|1|||
124833315|NCT04829318|449019137|FG000|Overall Study|Withdrawal by Subject|19|||
124833316|NCT04829318|449019137|FG000|Overall Study|Site terminated by sponsor|1|||
124833317|NCT04829318|449019137|FG000|Overall Study|Sponsor decision|5|||
124833318|NCT04829318|449019137|FG000|Overall Study|Other|1|||
124833319|NCT01737047|449019140|FG000|Overall Study|Death|10|||
124833320|NCT01737047|449019141|FG001|Overall Study|Death|0|||
124833321|NCT01737047|449019142|FG002|Overall Study|Death|1|||
124833322|NCT01737047|449019140|FG000|Overall Study|Withdrawal by Subject|17|||
124833323|NCT01737047|449019141|FG001|Overall Study|Withdrawal by Subject|11|||
124833324|NCT01737047|449019142|FG002|Overall Study|Withdrawal by Subject|4|||
124833325|NCT03965962|449019143|FG000|Overall Study|Adverse Event|1|||
124833326|NCT03965962|449019144|FG001|Overall Study|Adverse Event|0|||
124833327|NCT03965962|449019145|FG002|Overall Study|Adverse Event|0|||
124833328|NCT03965962|449019146|FG003|Overall Study|Adverse Event|0|||
124833329|NCT03965962|449019143|FG000|Overall Study|Protocol Violation|21|||
124833330|NCT03965962|449019144|FG001|Overall Study|Protocol Violation|4|||
124833331|NCT03965962|449019145|FG002|Overall Study|Protocol Violation|10|||
124833332|NCT03965962|449019146|FG003|Overall Study|Protocol Violation|5|||
124833333|NCT03965962|449019143|FG000|Overall Study|Lost to Follow-up|0|||
124833334|NCT03965962|449019144|FG001|Overall Study|Lost to Follow-up|1|||
124833335|NCT03965962|449019145|FG002|Overall Study|Lost to Follow-up|0|||
124833336|NCT03965962|449019146|FG003|Overall Study|Lost to Follow-up|0|||
124833337|NCT03965962|449019143|FG000|Overall Study|Withdrawal by Subject|3|||
124833338|NCT03965962|449019144|FG001|Overall Study|Withdrawal by Subject|0|||
124833339|NCT03965962|449019145|FG002|Overall Study|Withdrawal by Subject|0|||
124833340|NCT03965962|449019146|FG003|Overall Study|Withdrawal by Subject|1|||
124833341|NCT00003641|449019147|FG000|Overall Study|Withdrawal by Subject|0|||
124833342|NCT00003641|449019148|FG001|Overall Study|Withdrawal by Subject|100|||
124833343|NCT00003641|449019147|FG000|Overall Study|Adverse Event|0|||
124833344|NCT00003641|449019148|FG001|Overall Study|Adverse Event|38|||
124833345|NCT00003641|449019147|FG000|Overall Study|Disease progression|0|||
124833346|NCT00003641|449019148|FG001|Overall Study|Disease progression|2|||
124833347|NCT00003641|449019147|FG000|Overall Study|Unknown/missing|0|||
124833348|NCT00003641|449019148|FG001|Overall Study|Unknown/missing|22|||
124833349|NCT00003641|449019147|FG000|Overall Study|Should not receive interferon therapy|2|||
124833350|NCT00003641|449019148|FG001|Overall Study|Should not receive interferon therapy|0|||
124833351|NCT00003641|449019147|FG000|Overall Study|Never started interferon|567|||
124833352|NCT00003641|449019148|FG001|Overall Study|Never started interferon|12|||
124833353|NCT03659916|449019149|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
124833354|NCT03659916|449019150|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
124833355|NCT03659916|449019151|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
124833356|NCT03659916|449019149|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
124833357|NCT03659916|449019150|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
124833358|NCT03659916|449019151|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
124833359|NCT03659916|449019149|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
124833360|NCT03659916|449019150|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
124833361|NCT03659916|449019151|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
124833362|NCT03659916|449019149|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
124833363|NCT03659916|449019150|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
124833364|NCT03659916|449019151|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
124833365|NCT03659916|449019149|FG000|Treatment Period (72 Weeks)|Other|1|||
124833366|NCT03659916|449019150|FG001|Treatment Period (72 Weeks)|Other|3|||
124833367|NCT03659916|449019151|FG002|Treatment Period (72 Weeks)|Other|9|||
124833368|NCT03659916|449019149|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
124833369|NCT03659916|449019150|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
124833370|NCT03659916|449019151|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
124833371|NCT03659916|449019149|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
124833372|NCT03659916|449019150|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
124833373|NCT03659916|449019151|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
124833374|NCT03659916|449019149|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
124833375|NCT03659916|449019150|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
124833376|NCT03659916|449019151|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
124833377|NCT03659916|449019149|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
124833378|NCT03659916|449019150|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
124833379|NCT03659916|449019151|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
124833380|NCT03659916|449019149|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
124833381|NCT03659916|449019150|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
124833382|NCT03659916|449019151|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
124833383|NCT03659916|449019149|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
124833384|NCT03659916|449019150|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
124833385|NCT03659916|449019151|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
124833386|NCT00878709|449019152|FG000|Overall Study|Withdrawal by Subject|197|||
124833387|NCT00878709|449019153|FG001|Overall Study|Withdrawal by Subject|120|||
124833388|NCT00878709|449019152|FG000|Overall Study|Lost to Follow-up|35|||
124833389|NCT00878709|449019153|FG001|Overall Study|Lost to Follow-up|33|||
124833390|NCT00878709|449019152|FG000|Overall Study|Other Reasons|93|||
124833391|NCT00878709|449019153|FG001|Overall Study|Other Reasons|84|||
124833392|NCT00322842|449019154|FG000|Overall Study|Withdrawal by Subject|0|||
124833393|NCT00322842|449019155|FG001|Overall Study|Withdrawal by Subject|1|||
124833394|NCT00322842|449019154|FG000|Overall Study|Lost to Follow-up|0|||
124833395|NCT00322842|449019155|FG001|Overall Study|Lost to Follow-up|1|||
124833396|NCT00322842|449019154|FG000|Overall Study|Refused transplant|1|||
124833397|NCT00322842|449019155|FG001|Overall Study|Refused transplant|0|||
124833398|NCT00322842|449019154|FG000|Overall Study|Death|1|||
124833399|NCT00322842|449019155|FG001|Overall Study|Death|0|||
124833400|NCT05214768|449019156|FG000|Induction Period|Withdrawal by Subject|1|||
124833401|NCT05214768|449019157|FG001|Induction Period|Withdrawal by Subject|0|||
124833402|NCT05214768|449019158|FG002|Induction Period|Withdrawal by Subject|0|||
124833403|NCT05214768|449019159|FG003|Induction Period|Withdrawal by Subject|0|||
124833404|NCT05214768|449019160|FG004|Induction Period|Withdrawal by Subject|0|||
124833405|NCT05214768|449019161|FG005|Induction Period|Withdrawal by Subject|0|||
124833406|NCT05214768|449019156|FG000|Induction Period|Physician Decision|1|||
124833407|NCT05214768|449019157|FG001|Induction Period|Physician Decision|0|||
124833408|NCT05214768|449019158|FG002|Induction Period|Physician Decision|0|||
124833409|NCT05214768|449019159|FG003|Induction Period|Physician Decision|0|||
124833410|NCT05214768|449019160|FG004|Induction Period|Physician Decision|0|||
124833411|NCT05214768|449019161|FG005|Induction Period|Physician Decision|0|||
124639238|NCT01339923|448296553|FG003|Overall Study|Lost to Follow-up|3|||
124833412|NCT05214768|449019156|FG000|Maintenance Period|Other Reasons|0|||
124833413|NCT05214768|449019157|FG001|Maintenance Period|Other Reasons|0|||
124833414|NCT05214768|449019158|FG002|Maintenance Period|Other Reasons|1|||
124833415|NCT05214768|449019159|FG003|Maintenance Period|Other Reasons|1|||
124833416|NCT05214768|449019160|FG004|Maintenance Period|Other Reasons|0|||
124833417|NCT05214768|449019161|FG005|Maintenance Period|Other Reasons|0|||
124833418|NCT05214768|449019156|FG000|Maintenance Period|Withdrawal by Subject|0|||
124833419|NCT05214768|449019157|FG001|Maintenance Period|Withdrawal by Subject|0|||
124833420|NCT05214768|449019158|FG002|Maintenance Period|Withdrawal by Subject|0|||
124833421|NCT05214768|449019159|FG003|Maintenance Period|Withdrawal by Subject|1|||
124833422|NCT05214768|449019160|FG004|Maintenance Period|Withdrawal by Subject|0|||
124833423|NCT05214768|449019161|FG005|Maintenance Period|Withdrawal by Subject|0|||
124833424|NCT05214768|449019156|FG000|Maintenance Period|Lack of Efficacy|0|||
124833425|NCT05214768|449019157|FG001|Maintenance Period|Lack of Efficacy|0|||
124833426|NCT05214768|449019158|FG002|Maintenance Period|Lack of Efficacy|1|||
124833427|NCT05214768|449019159|FG003|Maintenance Period|Lack of Efficacy|0|||
124833428|NCT05214768|449019160|FG004|Maintenance Period|Lack of Efficacy|1|||
124833429|NCT05214768|449019161|FG005|Maintenance Period|Lack of Efficacy|0|||
124833430|NCT05214768|449019156|FG000|Open Label Extension Period|Physician Decision|0|||
124833431|NCT05214768|449019157|FG001|Open Label Extension Period|Physician Decision|0|||
124833432|NCT05214768|449019158|FG002|Open Label Extension Period|Physician Decision|0|||
124833433|NCT05214768|449019159|FG003|Open Label Extension Period|Physician Decision|0|||
124833434|NCT05214768|449019160|FG004|Open Label Extension Period|Physician Decision|0|||
124833435|NCT05214768|449019161|FG005|Open Label Extension Period|Physician Decision|1|||
124833436|NCT05214768|449019156|FG000|Open Label Extension Period|Lack of Efficacy|0|||
124833437|NCT05214768|449019157|FG001|Open Label Extension Period|Lack of Efficacy|0|||
124833438|NCT05214768|449019158|FG002|Open Label Extension Period|Lack of Efficacy|0|||
124833439|NCT05214768|449019159|FG003|Open Label Extension Period|Lack of Efficacy|0|||
124833440|NCT05214768|449019160|FG004|Open Label Extension Period|Lack of Efficacy|0|||
124833441|NCT05214768|449019161|FG005|Open Label Extension Period|Lack of Efficacy|1|||
124833442|NCT05214768|449019156|FG000|Open Label Extension Period|Ongoing Study|0|||
124833443|NCT05214768|449019157|FG001|Open Label Extension Period|Ongoing Study|0|||
124833444|NCT05214768|449019158|FG002|Open Label Extension Period|Ongoing Study|0|||
124833445|NCT05214768|449019159|FG003|Open Label Extension Period|Ongoing Study|0|||
124833446|NCT05214768|449019160|FG004|Open Label Extension Period|Ongoing Study|0|||
124833447|NCT05214768|449019161|FG005|Open Label Extension Period|Ongoing Study|42|||
124833448|NCT05041322|449019162|FG000|Baseline|Withdrawal by Subject|1|||
124833449|NCT05041322|449019163|FG001|Baseline|Withdrawal by Subject|0|||
124833450|NCT05041322|449019162|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
124833451|NCT05041322|449019163|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
124833452|NCT05041322|449019162|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
124833453|NCT05041322|449019163|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
124833454|NCT03795298|449019164|FG000|Overall Study|Death|34|||
124833455|NCT03795298|449019165|FG001|Overall Study|Death|29|||
124833456|NCT03795298|449019164|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
124833457|NCT03795298|449019165|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
124833458|NCT03795298|449019164|FG000|Overall Study|Lost to Follow-up|28|||
124833459|NCT03795298|449019165|FG001|Overall Study|Lost to Follow-up|17|||
124833460|NCT03795298|449019164|FG000|Overall Study|Physician Decision|5|||
124833461|NCT03795298|449019165|FG001|Overall Study|Physician Decision|4|||
124833462|NCT03795298|449019164|FG000|Overall Study|Withdrawal by Subject|43|||
124833463|NCT03795298|449019165|FG001|Overall Study|Withdrawal by Subject|28|||
124833464|NCT03795298|449019164|FG000|Overall Study|Reason not reported|7|||
124833465|NCT03795298|449019165|FG001|Overall Study|Reason not reported|9|||
124833466|NCT04303780|449019166|FG000|Overall Study|Death|104|||
124833467|NCT04303780|449019167|FG001|Overall Study|Death|85|||
124833468|NCT04303780|449019166|FG000|Overall Study|Lost to Follow-up|5|||
124833469|NCT04303780|449019167|FG001|Overall Study|Lost to Follow-up|2|||
124833470|NCT04303780|449019166|FG000|Overall Study|Withdrawal by Subject|12|||
124833471|NCT04303780|449019167|FG001|Overall Study|Withdrawal by Subject|39|||
124833472|NCT04303780|449019166|FG000|Overall Study|Ongoing in study|50|||
124833473|NCT04303780|449019167|FG001|Overall Study|Ongoing in study|45|||
124833474|NCT01344161|449019169|FG000|Overall Study|Lost to Follow-up|4|||
124833475|NCT01344161|449019170|FG001|Overall Study|Lost to Follow-up|1|||
124833476|NCT01344161|449019169|FG000|Overall Study|Pregnancy|0|||
124833477|NCT01344161|449019170|FG001|Overall Study|Pregnancy|1|||
124833478|NCT01344161|449019169|FG000|Overall Study|Protocol Violation|1|||
124833479|NCT01344161|449019170|FG001|Overall Study|Protocol Violation|1|||
124833480|NCT04690751|449019171|FG000|Overall Study|Protocol Violation|0|||
124833481|NCT04690751|449019172|FG001|Overall Study|Protocol Violation|1|||
124833482|NCT04690751|449019173|FG002|Overall Study|Protocol Violation|0|||
124833483|NCT04690751|449019174|FG003|Overall Study|Protocol Violation|1|||
124833484|NCT04690751|449019175|FG004|Overall Study|Protocol Violation|2|||
124833485|NCT04690751|449019176|FG005|Overall Study|Protocol Violation|0|||
124833486|NCT04690751|449019171|FG000|Overall Study|Adverse Event|0|||
124833487|NCT04690751|449019172|FG001|Overall Study|Adverse Event|0|||
124833488|NCT04690751|449019173|FG002|Overall Study|Adverse Event|1|||
124833489|NCT04690751|449019174|FG003|Overall Study|Adverse Event|0|||
124833490|NCT04690751|449019175|FG004|Overall Study|Adverse Event|0|||
124833491|NCT04690751|449019176|FG005|Overall Study|Adverse Event|0|||
124833492|NCT04690751|449019171|FG000|Overall Study|Positive urine drug screen test|0|||
124833493|NCT04690751|449019172|FG001|Overall Study|Positive urine drug screen test|0|||
124833494|NCT04690751|449019173|FG002|Overall Study|Positive urine drug screen test|0|||
124833495|NCT04690751|449019174|FG003|Overall Study|Positive urine drug screen test|0|||
124833496|NCT04690751|449019175|FG004|Overall Study|Positive urine drug screen test|1|||
124833497|NCT04690751|449019176|FG005|Overall Study|Positive urine drug screen test|0|||
124833498|NCT04364620|449019177|FG000|Overall Study|Disease Progression|20|||
124833499|NCT04364620|449019177|FG000|Overall Study|Adverse Event|5|||
124833500|NCT04364620|449019177|FG000|Overall Study|Physician Decision|4|||
124833501|NCT04364620|449019177|FG000|Overall Study|Death|3|||
124833502|NCT04364620|449019177|FG000|Overall Study|Other|2|||
124833503|NCT04364620|449019177|FG000|Overall Study|Withdrawal by Subject|1|||
124833504|NCT04579380|449021527|FG000|Overall Study|Death|9|||
124833505|NCT04579380|449021528|FG001|Overall Study|Death|22|||
124833506|NCT04579380|449021529|FG002|Overall Study|Death|22|||
124833507|NCT04579380|449021530|FG003|Overall Study|Death|17|||
124833508|NCT04579380|449021531|FG004|Overall Study|Death|6|||
124833509|NCT04579380|449021532|FG005|Overall Study|Death|21|||
124833510|NCT04579380|449021533|FG006|Overall Study|Death|10|||
124833511|NCT04579380|449021534|FG007|Overall Study|Death|11|||
124833512|NCT04579380|449021535|FG008|Overall Study|Death|25|||
124833513|NCT04579380|449021527|FG000|Overall Study|Withdrawal by Subject|0|||
124833514|NCT04579380|449021528|FG001|Overall Study|Withdrawal by Subject|3|||
124833515|NCT04579380|449021529|FG002|Overall Study|Withdrawal by Subject|4|||
124833516|NCT04579380|449021530|FG003|Overall Study|Withdrawal by Subject|0|||
124833517|NCT04579380|449021531|FG004|Overall Study|Withdrawal by Subject|1|||
124833518|NCT04579380|449021532|FG005|Overall Study|Withdrawal by Subject|2|||
124833519|NCT04579380|449021533|FG006|Overall Study|Withdrawal by Subject|0|||
124833520|NCT04579380|449021534|FG007|Overall Study|Withdrawal by Subject|1|||
124833521|NCT04579380|449021535|FG008|Overall Study|Withdrawal by Subject|2|||
124833522|NCT04579380|449021527|FG000|Overall Study|Ongoing|2|||
124833523|NCT04579380|449021528|FG001|Overall Study|Ongoing|6|||
124833524|NCT04579380|449021529|FG002|Overall Study|Ongoing|4|||
124833525|NCT04579380|449021530|FG003|Overall Study|Ongoing|8|||
124833526|NCT04579380|449021531|FG004|Overall Study|Ongoing|5|||
124833527|NCT04579380|449021532|FG005|Overall Study|Ongoing|8|||
124833528|NCT04579380|449021533|FG006|Overall Study|Ongoing|3|||
124833529|NCT04579380|449021534|FG007|Overall Study|Ongoing|19|||
124833530|NCT04579380|449021535|FG008|Overall Study|Ongoing|6|||
124833531|NCT00066066|449021538|FG000|Overall Study|Lost to Follow-up|6|||
124833532|NCT00066066|449021539|FG001|Overall Study|Lost to Follow-up|4|||
124833533|NCT00066066|449021540|FG002|Overall Study|Lost to Follow-up|7|||
124833534|NCT00066066|449021541|FG003|Overall Study|Lost to Follow-up|4|||
124833535|NCT00066066|449021542|FG004|Overall Study|Lost to Follow-up|3|||
124833536|NCT00066066|449021543|FG005|Overall Study|Lost to Follow-up|5|||
124833537|NCT02268409|449021544|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
124833538|NCT02268409|449021544|FG000|Overall Study|Death|1|||
124833539|NCT02268409|449021544|FG000|Overall Study|Lost to Follow-up|1|||
124833540|NCT02268409|449021544|FG000|Overall Study|Protocol Violation|3|||
124833541|NCT02268409|449021544|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
124833542|NCT02268409|449021544|FG000|Overall Study|Withdrawal by Subject|5|||
124833543|NCT00489853|449021549|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
124833544|NCT00489853|449021550|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
124833545|NCT00489853|449021551|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
124833546|NCT00489853|449021549|FG000|Wash-out Period 1|Adverse Event|0|||
124833547|NCT00489853|449021550|FG001|Wash-out Period 1|Adverse Event|1|||
124833548|NCT00489853|449021551|FG002|Wash-out Period 1|Adverse Event|1|||
124833549|NCT00489853|449021549|FG000|Wash-out Period 1|Protocol Violation|0|||
124833550|NCT00489853|449021550|FG001|Wash-out Period 1|Protocol Violation|1|||
124833551|NCT00489853|449021551|FG002|Wash-out Period 1|Protocol Violation|1|||
124833552|NCT00489853|449021549|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
124833553|NCT00489853|449021550|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
124833554|NCT00489853|449021551|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
124833555|NCT00489853|449021549|FG000|Wash-out Period 2|Adverse Event|1|||
124833556|NCT00489853|449021550|FG001|Wash-out Period 2|Adverse Event|1|||
124833557|NCT00489853|449021551|FG002|Wash-out Period 2|Adverse Event|0|||
124833558|NCT00489853|449021549|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
124833559|NCT00489853|449021550|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
124833560|NCT00489853|449021551|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
124833561|NCT00489853|449021549|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
124639239|NCT01339923|448296554|FG004|Overall Study|Lost to Follow-up|1|||
124833562|NCT00489853|449021550|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
124833563|NCT00489853|449021551|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
124833564|NCT02255500|449021559|FG000|Overall Study|Withdrawal by Subject|1|||
124833565|NCT02255500|449021560|FG001|Overall Study|Withdrawal by Subject|0|||
124833566|NCT05129488|449021561|FG000|Overall Study|Protocol Violation|3|||
124833567|NCT02608268|449021562|FG000|Overall Study|Adverse Event|0|||
124833568|NCT02608268|449021563|FG001|Overall Study|Adverse Event|0|||
124833569|NCT02608268|449021564|FG002|Overall Study|Adverse Event|1|||
124833570|NCT02608268|449021565|FG003|Overall Study|Adverse Event|0|||
124833571|NCT02608268|449021566|FG004|Overall Study|Adverse Event|0|||
124833572|NCT02608268|449021567|FG005|Overall Study|Adverse Event|0|||
124833573|NCT02608268|449021568|FG006|Overall Study|Adverse Event|0|||
124833574|NCT02608268|449021569|FG007|Overall Study|Adverse Event|0|||
124833575|NCT02608268|449021570|FG008|Overall Study|Adverse Event|0|||
124833576|NCT02608268|449021571|FG009|Overall Study|Adverse Event|0|||
124833577|NCT02608268|449021572|FG010|Overall Study|Adverse Event|0|||
124833578|NCT02608268|449021573|FG011|Overall Study|Adverse Event|0|||
124833579|NCT02608268|449021574|FG012|Overall Study|Adverse Event|2|||
124833580|NCT02608268|449021575|FG013|Overall Study|Adverse Event|0|||
124833581|NCT02608268|449021576|FG014|Overall Study|Adverse Event|0|||
124833582|NCT02608268|449021577|FG015|Overall Study|Adverse Event|0|||
124833583|NCT02608268|449021578|FG016|Overall Study|Adverse Event|0|||
124833584|NCT02608268|449021579|FG017|Overall Study|Adverse Event|0|||
124833585|NCT02608268|449021580|FG018|Overall Study|Adverse Event|0|||
124833586|NCT02608268|449021581|FG019|Overall Study|Adverse Event|0|||
124833587|NCT02608268|449021582|FG020|Overall Study|Adverse Event|1|||
124833588|NCT02608268|449021583|FG021|Overall Study|Adverse Event|1|||
124833589|NCT02608268|449021584|FG022|Overall Study|Adverse Event|0|||
124833590|NCT02608268|449021585|FG023|Overall Study|Adverse Event|0|||
124833591|NCT02608268|449021586|FG024|Overall Study|Adverse Event|1|||
124833592|NCT02608268|449021587|FG025|Overall Study|Adverse Event|0|||
124833593|NCT02608268|449021588|FG026|Overall Study|Adverse Event|0|||
124833594|NCT02608268|449021589|FG027|Overall Study|Adverse Event|0|||
124833595|NCT02608268|449021590|FG028|Overall Study|Adverse Event|1|||
124833596|NCT02608268|449021591|FG029|Overall Study|Adverse Event|0|||
124833597|NCT02608268|449021562|FG000|Overall Study|Death|1|||
124833598|NCT02608268|449021563|FG001|Overall Study|Death|0|||
124833599|NCT02608268|449021564|FG002|Overall Study|Death|0|||
124833600|NCT02608268|449021565|FG003|Overall Study|Death|0|||
124833601|NCT02608268|449021566|FG004|Overall Study|Death|0|||
124833602|NCT02608268|449021567|FG005|Overall Study|Death|0|||
124833603|NCT02608268|449021568|FG006|Overall Study|Death|0|||
124833604|NCT02608268|449021569|FG007|Overall Study|Death|0|||
124833605|NCT02608268|449021570|FG008|Overall Study|Death|1|||
124833606|NCT02608268|449021571|FG009|Overall Study|Death|1|||
124833607|NCT02608268|449021572|FG010|Overall Study|Death|0|||
124833608|NCT02608268|449021573|FG011|Overall Study|Death|0|||
124833609|NCT02608268|449021574|FG012|Overall Study|Death|0|||
124833610|NCT02608268|449021575|FG013|Overall Study|Death|0|||
124833611|NCT02608268|449021576|FG014|Overall Study|Death|0|||
124833612|NCT02608268|449021577|FG015|Overall Study|Death|1|||
124833613|NCT02608268|449021578|FG016|Overall Study|Death|0|||
124833614|NCT02608268|449021579|FG017|Overall Study|Death|1|||
124833615|NCT02608268|449021580|FG018|Overall Study|Death|0|||
124833616|NCT02608268|449021581|FG019|Overall Study|Death|1|||
124833617|NCT02608268|449021582|FG020|Overall Study|Death|1|||
124833618|NCT02608268|449021583|FG021|Overall Study|Death|0|||
124833619|NCT02608268|449021584|FG022|Overall Study|Death|0|||
124833620|NCT02608268|449021585|FG023|Overall Study|Death|0|||
124833621|NCT02608268|449021586|FG024|Overall Study|Death|1|||
124833622|NCT02608268|449021587|FG025|Overall Study|Death|2|||
124833623|NCT02608268|449021588|FG026|Overall Study|Death|0|||
124833624|NCT02608268|449021589|FG027|Overall Study|Death|1|||
124833625|NCT02608268|449021590|FG028|Overall Study|Death|4|||
124833626|NCT02608268|449021591|FG029|Overall Study|Death|0|||
124833627|NCT02608268|449021562|FG000|Overall Study|Physician Decision|0|||
124833628|NCT02608268|449021563|FG001|Overall Study|Physician Decision|0|||
124833629|NCT02608268|449021564|FG002|Overall Study|Physician Decision|0|||
124833630|NCT02608268|449021565|FG003|Overall Study|Physician Decision|0|||
124833631|NCT02608268|449021566|FG004|Overall Study|Physician Decision|0|||
124833632|NCT02608268|449021567|FG005|Overall Study|Physician Decision|0|||
124833633|NCT02608268|449021568|FG006|Overall Study|Physician Decision|0|||
124833634|NCT02608268|449021569|FG007|Overall Study|Physician Decision|0|||
124833635|NCT02608268|449021570|FG008|Overall Study|Physician Decision|0|||
124833636|NCT02608268|449021571|FG009|Overall Study|Physician Decision|0|||
124833637|NCT02608268|449021572|FG010|Overall Study|Physician Decision|1|||
124833638|NCT02608268|449021573|FG011|Overall Study|Physician Decision|0|||
124833639|NCT02608268|449021574|FG012|Overall Study|Physician Decision|0|||
124833640|NCT02608268|449021575|FG013|Overall Study|Physician Decision|1|||
124833641|NCT02608268|449021576|FG014|Overall Study|Physician Decision|0|||
124833642|NCT02608268|449021577|FG015|Overall Study|Physician Decision|0|||
124833643|NCT02608268|449021578|FG016|Overall Study|Physician Decision|0|||
124833644|NCT02608268|449021579|FG017|Overall Study|Physician Decision|0|||
124833645|NCT02608268|449021580|FG018|Overall Study|Physician Decision|0|||
124833646|NCT02608268|449021581|FG019|Overall Study|Physician Decision|0|||
124833647|NCT02608268|449021582|FG020|Overall Study|Physician Decision|0|||
124833648|NCT02608268|449021583|FG021|Overall Study|Physician Decision|0|||
124833649|NCT02608268|449021584|FG022|Overall Study|Physician Decision|1|||
124833650|NCT02608268|449021585|FG023|Overall Study|Physician Decision|1|||
124833651|NCT02608268|449021586|FG024|Overall Study|Physician Decision|1|||
124833652|NCT02608268|449021587|FG025|Overall Study|Physician Decision|0|||
124833653|NCT02608268|449021588|FG026|Overall Study|Physician Decision|0|||
124833654|NCT02608268|449021589|FG027|Overall Study|Physician Decision|2|||
124833655|NCT02608268|449021590|FG028|Overall Study|Physician Decision|1|||
124833656|NCT02608268|449021591|FG029|Overall Study|Physician Decision|1|||
124833657|NCT02608268|449021562|FG000|Overall Study|Progressive disease|12|||
124833658|NCT02608268|449021563|FG001|Overall Study|Progressive disease|8|||
124833659|NCT02608268|449021564|FG002|Overall Study|Progressive disease|13|||
124833660|NCT02608268|449021565|FG003|Overall Study|Progressive disease|5|||
124833661|NCT02608268|449021566|FG004|Overall Study|Progressive disease|2|||
124833662|NCT02608268|449021567|FG005|Overall Study|Progressive disease|4|||
124833663|NCT02608268|449021568|FG006|Overall Study|Progressive disease|6|||
124833664|NCT02608268|449021569|FG007|Overall Study|Progressive disease|2|||
124833665|NCT02608268|449021570|FG008|Overall Study|Progressive disease|5|||
124833666|NCT02608268|449021571|FG009|Overall Study|Progressive disease|6|||
124833667|NCT02608268|449021572|FG010|Overall Study|Progressive disease|5|||
124833668|NCT02608268|449021573|FG011|Overall Study|Progressive disease|5|||
124833669|NCT02608268|449021574|FG012|Overall Study|Progressive disease|4|||
124833670|NCT02608268|449021575|FG013|Overall Study|Progressive disease|11|||
124833671|NCT02608268|449021576|FG014|Overall Study|Progressive disease|6|||
124833672|NCT02608268|449021577|FG015|Overall Study|Progressive disease|3|||
124833673|NCT02608268|449021578|FG016|Overall Study|Progressive disease|5|||
124833674|NCT02608268|449021579|FG017|Overall Study|Progressive disease|5|||
124833675|NCT02608268|449021580|FG018|Overall Study|Progressive disease|5|||
124833676|NCT02608268|449021581|FG019|Overall Study|Progressive disease|2|||
124833677|NCT02608268|449021582|FG020|Overall Study|Progressive disease|10|||
124833678|NCT02608268|449021583|FG021|Overall Study|Progressive disease|4|||
124833679|NCT02608268|449021584|FG022|Overall Study|Progressive disease|5|||
124833680|NCT02608268|449021585|FG023|Overall Study|Progressive disease|5|||
124833681|NCT02608268|449021586|FG024|Overall Study|Progressive disease|3|||
124833682|NCT02608268|449021587|FG025|Overall Study|Progressive disease|11|||
124833683|NCT02608268|449021588|FG026|Overall Study|Progressive disease|16|||
124833684|NCT02608268|449021589|FG027|Overall Study|Progressive disease|11|||
124833685|NCT02608268|449021590|FG028|Overall Study|Progressive disease|10|||
124833686|NCT02608268|449021591|FG029|Overall Study|Progressive disease|15|||
124833687|NCT02608268|449021562|FG000|Overall Study|Subject/guardian decision|1|||
124833688|NCT02608268|449021563|FG001|Overall Study|Subject/guardian decision|1|||
124833689|NCT02608268|449021564|FG002|Overall Study|Subject/guardian decision|2|||
124833690|NCT02608268|449021565|FG003|Overall Study|Subject/guardian decision|0|||
124833691|NCT02608268|449021566|FG004|Overall Study|Subject/guardian decision|0|||
124833692|NCT02608268|449021567|FG005|Overall Study|Subject/guardian decision|0|||
124833693|NCT02608268|449021568|FG006|Overall Study|Subject/guardian decision|0|||
124833694|NCT02608268|449021569|FG007|Overall Study|Subject/guardian decision|0|||
124833695|NCT02608268|449021570|FG008|Overall Study|Subject/guardian decision|2|||
124833696|NCT02608268|449021571|FG009|Overall Study|Subject/guardian decision|2|||
124833697|NCT02608268|449021572|FG010|Overall Study|Subject/guardian decision|0|||
124833698|NCT02608268|449021573|FG011|Overall Study|Subject/guardian decision|1|||
124833699|NCT02608268|449021574|FG012|Overall Study|Subject/guardian decision|0|||
124833700|NCT02608268|449021575|FG013|Overall Study|Subject/guardian decision|1|||
124833701|NCT02608268|449021576|FG014|Overall Study|Subject/guardian decision|0|||
124833702|NCT02608268|449021577|FG015|Overall Study|Subject/guardian decision|1|||
124833703|NCT02608268|449021578|FG016|Overall Study|Subject/guardian decision|0|||
124833704|NCT02608268|449021579|FG017|Overall Study|Subject/guardian decision|0|||
124833705|NCT02608268|449021580|FG018|Overall Study|Subject/guardian decision|1|||
124833706|NCT02608268|449021581|FG019|Overall Study|Subject/guardian decision|0|||
124833707|NCT02608268|449021582|FG020|Overall Study|Subject/guardian decision|0|||
124833708|NCT02608268|449021583|FG021|Overall Study|Subject/guardian decision|0|||
124833709|NCT02608268|449021584|FG022|Overall Study|Subject/guardian decision|1|||
124833710|NCT02608268|449021585|FG023|Overall Study|Subject/guardian decision|0|||
124833711|NCT02608268|449021586|FG024|Overall Study|Subject/guardian decision|0|||
124833712|NCT02608268|449021587|FG025|Overall Study|Subject/guardian decision|1|||
124833713|NCT02608268|449021588|FG026|Overall Study|Subject/guardian decision|1|||
124833714|NCT02608268|449021589|FG027|Overall Study|Subject/guardian decision|1|||
124639240|NCT01339923|448296555|FG005|Overall Study|Lost to Follow-up|1|||
124833715|NCT02608268|449021590|FG028|Overall Study|Subject/guardian decision|1|||
124639241|NCT01339923|448296556|FG006|Overall Study|Lost to Follow-up|5|||
124833716|NCT02608268|449021591|FG029|Overall Study|Subject/guardian decision|0|||
124833717|NCT04091646|449021596|FG000|Overall Study|Adverse Event|2|||
124833718|NCT04091646|449021597|FG001|Overall Study|Adverse Event|1|||
124639242|NCT01339923|448296550|FG000|Overall Study|Protocol Violation|0|||
124639243|NCT01339923|448296551|FG001|Overall Study|Protocol Violation|0|||
124833719|NCT04091646|449021596|FG000|Overall Study|Lost to Follow-up|6|||
124833720|NCT04091646|449021597|FG001|Overall Study|Lost to Follow-up|2|||
124833721|NCT04091646|449021596|FG000|Overall Study|Protocol Violation|0|||
124833722|NCT04091646|449021597|FG001|Overall Study|Protocol Violation|1|||
124833723|NCT04091646|449021596|FG000|Overall Study|Withdrawal by Subject|4|||
124833724|NCT04091646|449021597|FG001|Overall Study|Withdrawal by Subject|1|||
124833725|NCT04091646|449021596|FG000|Overall Study|Participant Incarcerated|1|||
124833726|NCT04091646|449021597|FG001|Overall Study|Participant Incarcerated|0|||
124833727|NCT03102918|449021598|FG000|Overall Study|Protocol Violation|1|||
124833728|NCT03102918|449021599|FG001|Overall Study|Protocol Violation|0|||
124833729|NCT04765358|449021603|FG000|Overall Study|Withdrawal by Subject|1|||
124833730|NCT02731729|449021604|FG000|Overall Study|Death|2|||
124833731|NCT02731729|449021605|FG001|Overall Study|Death|2|||
124833732|NCT02731729|449021604|FG000|Overall Study|Study terminated by Sponsor|6|||
124833733|NCT02731729|449021605|FG001|Overall Study|Study terminated by Sponsor|6|||
124833734|NCT02731729|449021604|FG000|Overall Study|Withdrawal by Subject|1|||
124833735|NCT02731729|449021605|FG001|Overall Study|Withdrawal by Subject|0|||
124833736|NCT00159588|449021606|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
124833737|NCT00159588|449021607|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
124833738|NCT00159588|449021608|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
124833739|NCT02066467|449021609|FG000|Overall Study|Did not undergo implant procedure|24|||
124833740|NCT02066467|449021609|FG000|Overall Study|Attempted to implant withoput success|43|||
124833741|NCT02066467|449021609|FG000|Overall Study|Consent ineligible|1|||
124833742|NCT02066467|449021609|FG000|Overall Study|Death|54|||
124833743|NCT02066467|449021609|FG000|Overall Study|Lost to Follow-up|51|||
124833744|NCT02066467|449021609|FG000|Overall Study|Adverse Event|20|||
124833745|NCT02066467|449021609|FG000|Overall Study|Withdrawal by Subject|16|||
124833746|NCT02066467|449021609|FG000|Overall Study|Physician Decision|2|||
124833747|NCT02066467|449021609|FG000|Overall Study|Not defined|4|||
124833748|NCT00456521|449021610|FG000|Overall Study|Adverse Event|150|||
124833749|NCT00456521|449021611|FG001|Overall Study|Adverse Event|25|||
124833750|NCT00456521|449021610|FG000|Overall Study|Withdrawal by Subject|43|||
124833751|NCT00456521|449021611|FG001|Overall Study|Withdrawal by Subject|24|||
124833752|NCT00456521|449021610|FG000|Overall Study|Lost to Follow-up|22|||
124833753|NCT00456521|449021611|FG001|Overall Study|Lost to Follow-up|17|||
124833754|NCT00456521|449021610|FG000|Overall Study|Lack of Efficacy|3|||
124833755|NCT00456521|449021611|FG001|Overall Study|Lack of Efficacy|6|||
124833756|NCT00456521|449021610|FG000|Overall Study|Protocol Violation|4|||
124833757|NCT00456521|449021611|FG001|Overall Study|Protocol Violation|0|||
124833758|NCT00456521|449021610|FG000|Overall Study|Pregnancy|1|||
124833759|NCT00456521|449021611|FG001|Overall Study|Pregnancy|1|||
124833760|NCT00456521|449021610|FG000|Overall Study|Drug non-compliance, moved, other|26|||
124833761|NCT00456521|449021611|FG001|Overall Study|Drug non-compliance, moved, other|11|||
124833762|NCT01316276|449021612|FG000|Overall Study|Death|1|||
124833763|NCT01316276|449021612|FG000|Overall Study|Adverse Event|19|||
124833764|NCT01316276|449021612|FG000|Overall Study|Withdrawal of consent|24|||
124833765|NCT01316276|449021612|FG000|Overall Study|Lost to Follow-up|1|||
124833766|NCT01316276|449021612|FG000|Overall Study|Other|22|||
124833767|NCT00605475|449021613|FG000|Overall Study|Abnormal Laboratory Values|0|||
124833768|NCT00605475|449021614|FG001|Overall Study|Abnormal Laboratory Values|0|||
124833769|NCT00605475|449021615|FG002|Overall Study|Abnormal Laboratory Values|0|||
124833770|NCT00605475|449021616|FG003|Overall Study|Abnormal Laboratory Values|0|||
124833771|NCT00605475|449021617|FG004|Overall Study|Abnormal Laboratory Values|0|||
124833772|NCT00605475|449021618|FG005|Overall Study|Abnormal Laboratory Values|0|||
124833773|NCT00605475|449021619|FG006|Overall Study|Abnormal Laboratory Values|0|||
124833774|NCT00605475|449021620|FG007|Overall Study|Abnormal Laboratory Values|0|||
124833775|NCT00605475|449021621|FG008|Overall Study|Abnormal Laboratory Values|1|||
124833776|NCT00605475|449021622|FG009|Overall Study|Abnormal Laboratory Values|0|||
124833777|NCT00605475|449021613|FG000|Overall Study|Administrative problems|0|||
124833778|NCT00605475|449021614|FG001|Overall Study|Administrative problems|0|||
124833779|NCT00605475|449021615|FG002|Overall Study|Administrative problems|0|||
124833780|NCT00605475|449021616|FG003|Overall Study|Administrative problems|0|||
124833781|NCT00605475|449021617|FG004|Overall Study|Administrative problems|0|||
124833782|NCT00605475|449021618|FG005|Overall Study|Administrative problems|0|||
124833783|NCT00605475|449021619|FG006|Overall Study|Administrative problems|1|||
124833784|NCT00605475|449021620|FG007|Overall Study|Administrative problems|0|||
124833785|NCT00605475|449021621|FG008|Overall Study|Administrative problems|0|||
124833786|NCT00605475|449021622|FG009|Overall Study|Administrative problems|0|||
124639244|NCT01339923|448296552|FG002|Overall Study|Protocol Violation|0|||
124833787|NCT00605475|449021613|FG000|Overall Study|Lost to Follow-up|0|||
124833788|NCT00605475|449021614|FG001|Overall Study|Lost to Follow-up|0|||
124833789|NCT00605475|449021615|FG002|Overall Study|Lost to Follow-up|0|||
124833790|NCT00605475|449021616|FG003|Overall Study|Lost to Follow-up|0|||
124833791|NCT00605475|449021617|FG004|Overall Study|Lost to Follow-up|0|||
124833792|NCT00605475|449021618|FG005|Overall Study|Lost to Follow-up|0|||
124833793|NCT00605475|449021619|FG006|Overall Study|Lost to Follow-up|0|||
124833794|NCT00605475|449021620|FG007|Overall Study|Lost to Follow-up|0|||
124833795|NCT00605475|449021621|FG008|Overall Study|Lost to Follow-up|1|||
124833796|NCT00605475|449021622|FG009|Overall Study|Lost to Follow-up|1|||
124833797|NCT00605475|449021613|FG000|Overall Study|Protocol Violation|0|||
124833798|NCT00605475|449021614|FG001|Overall Study|Protocol Violation|0|||
124833799|NCT00605475|449021615|FG002|Overall Study|Protocol Violation|0|||
124833800|NCT00605475|449021616|FG003|Overall Study|Protocol Violation|0|||
124833801|NCT00605475|449021617|FG004|Overall Study|Protocol Violation|1|||
124833802|NCT00605475|449021618|FG005|Overall Study|Protocol Violation|0|||
124833803|NCT00605475|449021619|FG006|Overall Study|Protocol Violation|0|||
124833804|NCT00605475|449021620|FG007|Overall Study|Protocol Violation|0|||
124833805|NCT00605475|449021621|FG008|Overall Study|Protocol Violation|0|||
124833806|NCT00605475|449021622|FG009|Overall Study|Protocol Violation|0|||
124833807|NCT00605475|449021613|FG000|Overall Study|Withdrawal by Subject|0|||
124833808|NCT00605475|449021614|FG001|Overall Study|Withdrawal by Subject|0|||
124833809|NCT00605475|449021615|FG002|Overall Study|Withdrawal by Subject|0|||
124833810|NCT00605475|449021616|FG003|Overall Study|Withdrawal by Subject|0|||
124833811|NCT00605475|449021617|FG004|Overall Study|Withdrawal by Subject|0|||
124833812|NCT00605475|449021618|FG005|Overall Study|Withdrawal by Subject|2|||
124833813|NCT00605475|449021619|FG006|Overall Study|Withdrawal by Subject|0|||
124833814|NCT00605475|449021620|FG007|Overall Study|Withdrawal by Subject|0|||
124833815|NCT00605475|449021621|FG008|Overall Study|Withdrawal by Subject|0|||
124833816|NCT00605475|449021622|FG009|Overall Study|Withdrawal by Subject|1|||
124833817|NCT00297037|449021625|FG000|Overall Study|Withdrawal by Subject|2|||
124833818|NCT00297037|449021626|FG001|Overall Study|Withdrawal by Subject|0|||
124833819|NCT00076011|449021627|FG000|Overall Study|Death|1|||
124833820|NCT00076011|449021627|FG000|Overall Study|Adverse Event|10|||
124833821|NCT00076011|449021627|FG000|Overall Study|Lack of Efficacy|25|||
124833822|NCT00076011|449021627|FG000|Overall Study|Withdrawal by Subject|1|||
124833823|NCT00076011|449021627|FG000|Overall Study|Study terminated by sponsor|3|||
124833824|NCT00076011|449021627|FG000|Overall Study|Other|11|||
124833825|NCT00076011|449021627|FG000|Overall Study|Ongoing|1|||
124833826|NCT00581776|449021628|FG000|Overall Study|Disease progression or no response|3|||
124833827|NCT03056755|449021633|FG000|Treatment- Core Phase|Progressive disease|89|||
124833828|NCT03056755|449021634|FG001|Treatment- Core Phase|Progressive disease|88|||
124833829|NCT03056755|449021635|FG002|Treatment- Core Phase|Progressive disease|90|||
124833830|NCT03056755|449021633|FG000|Treatment- Core Phase|Adverse Event|20|||
124833831|NCT03056755|449021634|FG001|Treatment- Core Phase|Adverse Event|14|||
124833832|NCT03056755|449021635|FG002|Treatment- Core Phase|Adverse Event|13|||
124833833|NCT03056755|449021633|FG000|Treatment- Core Phase|Physician Decision|7|||
124833834|NCT03056755|449021634|FG001|Treatment- Core Phase|Physician Decision|13|||
124833835|NCT03056755|449021635|FG002|Treatment- Core Phase|Physician Decision|5|||
124833836|NCT03056755|449021633|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
124833837|NCT03056755|449021634|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
124833838|NCT03056755|449021635|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
124833839|NCT03056755|449021633|FG000|Treatment- Core Phase|Death|3|||
124833840|NCT03056755|449021634|FG001|Treatment- Core Phase|Death|2|||
124833841|NCT03056755|449021635|FG002|Treatment- Core Phase|Death|4|||
124833842|NCT03056755|449021633|FG000|Treatment- Core Phase|Protocol deviation|1|||
124833843|NCT03056755|449021634|FG001|Treatment- Core Phase|Protocol deviation|1|||
124833844|NCT03056755|449021635|FG002|Treatment- Core Phase|Protocol deviation|0|||
124833845|NCT03056755|449021633|FG000|Treatment- Core Phase|Technical problems|1|||
124833846|NCT03056755|449021634|FG001|Treatment- Core Phase|Technical problems|0|||
124833847|NCT03056755|449021635|FG002|Treatment- Core Phase|Technical problems|0|||
124833848|NCT03056755|449021633|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
124833849|NCT03056755|449021634|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
124833850|NCT03056755|449021635|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
124833851|NCT03056755|449021633|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
124833852|NCT03056755|449021634|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
124833853|NCT03056755|449021635|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
124833854|NCT03056755|449021633|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
124833855|NCT03056755|449021634|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
124833856|NCT03056755|449021635|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
124833857|NCT03056755|449021633|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
124833858|NCT03056755|449021634|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
124833859|NCT03056755|449021635|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
124833860|NCT03615326|449021639|FG000|Overall Study|Death|266|||
124833861|NCT03615326|449021640|FG001|Overall Study|Death|286|||
124833862|NCT03615326|449021641|FG002|Overall Study|Death|14|||
124833863|NCT03615326|449021642|FG003|Overall Study|Death|17|||
124833864|NCT03615326|449021639|FG000|Overall Study|Lost to Follow-up|0|||
124833865|NCT03615326|449021640|FG001|Overall Study|Lost to Follow-up|1|||
124833866|NCT03615326|449021641|FG002|Overall Study|Lost to Follow-up|0|||
124833867|NCT03615326|449021642|FG003|Overall Study|Lost to Follow-up|0|||
124833868|NCT03615326|449021639|FG000|Overall Study|Withdrawal by Subject|1|||
124833869|NCT03615326|449021640|FG001|Overall Study|Withdrawal by Subject|3|||
124833870|NCT03615326|449021641|FG002|Overall Study|Withdrawal by Subject|0|||
124833871|NCT03615326|449021642|FG003|Overall Study|Withdrawal by Subject|0|||
124833872|NCT03615326|449021639|FG000|Overall Study|Participants Ongoing|83|||
124833873|NCT03615326|449021640|FG001|Overall Study|Participants Ongoing|58|||
124833874|NCT03615326|449021641|FG002|Overall Study|Participants Ongoing|6|||
124833875|NCT03615326|449021642|FG003|Overall Study|Participants Ongoing|3|||
124833876|NCT00405587|449021645|FG000|Overall Study|Death|0|||
124833877|NCT00405587|449021646|FG001|Overall Study|Death|0|||
124833878|NCT00405587|449021647|FG002|Overall Study|Death|0|||
124833879|NCT00405587|449021648|FG003|Overall Study|Death|1|||
124833880|NCT00405587|449021645|FG000|Overall Study|Disease Progression|22|||
124833881|NCT00405587|449021646|FG001|Overall Study|Disease Progression|23|||
124833882|NCT00405587|449021647|FG002|Overall Study|Disease Progression|21|||
124833883|NCT00405587|449021648|FG003|Overall Study|Disease Progression|17|||
124833884|NCT00405587|449021645|FG000|Overall Study|Physician Decision|3|||
124833885|NCT00405587|449021646|FG001|Overall Study|Physician Decision|2|||
124833886|NCT00405587|449021647|FG002|Overall Study|Physician Decision|0|||
124833887|NCT00405587|449021648|FG003|Overall Study|Physician Decision|0|||
124833888|NCT00405587|449021645|FG000|Overall Study|Adverse Event|1|||
124833889|NCT00405587|449021646|FG001|Overall Study|Adverse Event|0|||
124833890|NCT00405587|449021647|FG002|Overall Study|Adverse Event|0|||
124833891|NCT00405587|449021648|FG003|Overall Study|Adverse Event|0|||
124833892|NCT00405587|449021645|FG000|Overall Study|Lost to Follow-up|0|||
124833893|NCT00405587|449021646|FG001|Overall Study|Lost to Follow-up|1|||
124833894|NCT00405587|449021647|FG002|Overall Study|Lost to Follow-up|1|||
124833895|NCT00405587|449021648|FG003|Overall Study|Lost to Follow-up|0|||
124833896|NCT00405587|449021645|FG000|Overall Study|Radiation induced necrosis|0|||
124833897|NCT00405587|449021646|FG001|Overall Study|Radiation induced necrosis|1|||
124833898|NCT00405587|449021647|FG002|Overall Study|Radiation induced necrosis|0|||
124833899|NCT00405587|449021648|FG003|Overall Study|Radiation induced necrosis|0|||
124833900|NCT00405587|449021645|FG000|Overall Study|Withdrawal by Subject|0|||
124833901|NCT00405587|449021646|FG001|Overall Study|Withdrawal by Subject|0|||
124833902|NCT00405587|449021647|FG002|Overall Study|Withdrawal by Subject|0|||
124833903|NCT00405587|449021648|FG003|Overall Study|Withdrawal by Subject|2|||
124833904|NCT00405587|449021645|FG000|Overall Study|Participant not dosed|0|||
124833905|NCT00405587|449021646|FG001|Overall Study|Participant not dosed|1|||
124833906|NCT00405587|449021647|FG002|Overall Study|Participant not dosed|0|||
124833907|NCT00405587|449021648|FG003|Overall Study|Participant not dosed|0|||
124833908|NCT03506373|449021653|FG000|Overall Study|Adverse Event|6|||
124833909|NCT03506373|449021653|FG000|Overall Study|Withdrawal by Subject|2|||
124833910|NCT03506373|449021653|FG000|Overall Study|Disease progression|5|||
124833911|NCT03506373|449021653|FG000|Overall Study|Other|3|||
124833912|NCT02211131|449021654|FG000|Overall Study|Death|26|||
124833913|NCT02211131|449021655|FG001|Overall Study|Death|16|||
124833914|NCT02211131|449021654|FG000|Overall Study|Lost to Follow-up|4|||
124833915|NCT02211131|449021655|FG001|Overall Study|Lost to Follow-up|3|||
124833916|NCT02211131|449021654|FG000|Overall Study|Decision by Sponsor|1|||
124833917|NCT02211131|449021655|FG001|Overall Study|Decision by Sponsor|1|||
124833918|NCT02211131|449021654|FG000|Overall Study|Withdrawal by Subject|3|||
124833919|NCT02211131|449021655|FG001|Overall Study|Withdrawal by Subject|8|||
124833920|NCT02120950|449021656|FG000|Overall Study|Adverse Event|5|||
124833921|NCT02120950|449021657|FG001|Overall Study|Adverse Event|4|||
124833922|NCT02120950|449021658|FG002|Overall Study|Adverse Event|3|||
124833923|NCT02120950|449021656|FG000|Overall Study|Death|3|||
124833924|NCT02120950|449021657|FG001|Overall Study|Death|0|||
124833925|NCT02120950|449021658|FG002|Overall Study|Death|1|||
124833926|NCT02120950|449021656|FG000|Overall Study|Withdrawal by Subject|6|||
124833927|NCT02120950|449021657|FG001|Overall Study|Withdrawal by Subject|3|||
124833928|NCT02120950|449021658|FG002|Overall Study|Withdrawal by Subject|2|||
124833929|NCT02120950|449021656|FG000|Overall Study|Protocol Violation|1|||
124833930|NCT02120950|449021657|FG001|Overall Study|Protocol Violation|1|||
124833931|NCT02120950|449021658|FG002|Overall Study|Protocol Violation|7|||
124833932|NCT02120950|449021656|FG000|Overall Study|Other reasons|5|||
124833933|NCT02120950|449021657|FG001|Overall Study|Other reasons|4|||
124833934|NCT02120950|449021658|FG002|Overall Study|Other reasons|1|||
124833935|NCT02120950|449021656|FG000|Overall Study|Lost to Follow-up|0|||
124833936|NCT02120950|449021657|FG001|Overall Study|Lost to Follow-up|2|||
124833937|NCT02120950|449021658|FG002|Overall Study|Lost to Follow-up|1|||
124833938|NCT02424383|449021659|FG000|Overall Study|Withdrawal by Subject|32|||
124833939|NCT02424383|449021659|FG000|Overall Study|Death|170|||
124833940|NCT02424383|449021659|FG000|Overall Study|Sponsor's decision|3|||
124833941|NCT02424383|449021659|FG000|Overall Study|Investigator's decision|44|||
124833942|NCT02424383|449021659|FG000|Overall Study|Lost to Follow-up|81|||
124833943|NCT02424383|449021659|FG000|Overall Study|Other|7|||
124833944|NCT02424383|449021659|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
124833945|NCT01852812|449021660|FG000|Overall Study|Adverse Event|0|||
124833946|NCT01852812|449021661|FG001|Overall Study|Adverse Event|0|||
124833947|NCT01852812|449021662|FG002|Overall Study|Adverse Event|1|||
124639245|NCT01339923|448296553|FG003|Overall Study|Protocol Violation|0|||
124833948|NCT01852812|449021660|FG000|Overall Study|Non-compliance With Study Drug|0|||
124833949|NCT01852812|449021661|FG001|Overall Study|Non-compliance With Study Drug|1|||
124833950|NCT01852812|449021662|FG002|Overall Study|Non-compliance With Study Drug|0|||
124833951|NCT02250443|449021663|FG000|Overall Study|Administrative problems|7|||
124833952|NCT02250443|449021663|FG000|Overall Study|Adverse Event|3|||
124833953|NCT01549964|449021664|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
124833954|NCT01549964|449021665|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
124833955|NCT01549964|449021666|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
124833956|NCT01549964|449021667|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
124833957|NCT01549964|449021664|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
124833958|NCT01549964|449021665|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
124833959|NCT01549964|449021666|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
124833960|NCT01549964|449021667|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
124833961|NCT01549964|449021664|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
124833962|NCT01549964|449021665|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
124833963|NCT01549964|449021666|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
124833964|NCT01549964|449021667|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
124833965|NCT01549964|449021664|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
124833966|NCT01549964|449021665|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
124833967|NCT01549964|449021666|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
124833968|NCT01549964|449021667|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
124833969|NCT01549964|449021664|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
124833970|NCT01549964|449021665|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
124833971|NCT01549964|449021666|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
124833972|NCT01549964|449021667|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
124833973|NCT01549964|449021664|FG000|24-Week Treatment Period|Other|1|||
124833974|NCT01549964|449021665|FG001|24-Week Treatment Period|Other|0|||
124833975|NCT01549964|449021666|FG002|24-Week Treatment Period|Other|1|||
124833976|NCT01549964|449021667|FG003|24-Week Treatment Period|Other|0|||
124833977|NCT01549964|449021664|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
124833978|NCT01549964|449021665|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
124833979|NCT01549964|449021666|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
124833980|NCT01549964|449021667|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
124833981|NCT01549964|449021664|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
124833982|NCT01549964|449021665|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
124833983|NCT01549964|449021666|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
124833984|NCT01549964|449021667|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
124833985|NCT01549964|449021664|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
124833986|NCT01549964|449021665|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
124833987|NCT01549964|449021666|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
124833988|NCT01549964|449021667|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
124833989|NCT01549964|449021664|FG000|80-Week Extension Period|Pregnancy|0|||
124833990|NCT01549964|449021665|FG001|80-Week Extension Period|Pregnancy|0|||
124833991|NCT01549964|449021666|FG002|80-Week Extension Period|Pregnancy|1|||
124833992|NCT01549964|449021667|FG003|80-Week Extension Period|Pregnancy|0|||
124833993|NCT01549964|449021664|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
124833994|NCT01549964|449021665|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
124833995|NCT01549964|449021666|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
124833996|NCT01549964|449021667|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
124833997|NCT01549964|449021664|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
124833998|NCT01549964|449021665|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
124833999|NCT01549964|449021666|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
124834000|NCT01549964|449021667|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
124834001|NCT01549964|449021664|FG000|80-Week Extension Period|Lost to Follow-up|1|||
124834002|NCT01549964|449021665|FG001|80-Week Extension Period|Lost to Follow-up|0|||
124834003|NCT01549964|449021666|FG002|80-Week Extension Period|Lost to Follow-up|2|||
124834004|NCT01549964|449021667|FG003|80-Week Extension Period|Lost to Follow-up|1|||
124834005|NCT01549964|449021664|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
124834006|NCT01549964|449021665|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
124834007|NCT01549964|449021666|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
124834008|NCT01549964|449021667|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
124834009|NCT02290821|449021668|FG000|Overall Study|Withdrawal by Subject|1|||
124834010|NCT02290821|449021669|FG001|Overall Study|Withdrawal by Subject|1|||
124834011|NCT02290821|449021668|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
124834012|NCT02290821|449021669|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
124834013|NCT02290821|449021668|FG000|Overall Study|Lost to Follow-up|3|||
124834014|NCT02290821|449021669|FG001|Overall Study|Lost to Follow-up|2|||
124834015|NCT00728130|449021670|FG000|Overall Study|Withdrawal by Subject|1|||
124834016|NCT00728130|449021670|FG000|Overall Study|Paperwork not completed in time|1|||
124834017|NCT00728130|449021670|FG000|Overall Study|Physician Decision|1|||
124834018|NCT01154218|449021671|FG000|Third Intervention Period|Adverse Event|0|||
124834019|NCT01154218|449021672|FG001|Third Intervention Period|Adverse Event|1|||
124834020|NCT01154218|449021673|FG002|Third Intervention Period|Adverse Event|0|||
124834021|NCT01154218|449021674|FG003|Third Intervention Period|Adverse Event|0|||
124834022|NCT01154218|449021671|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
124834023|NCT01154218|449021672|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
124834024|NCT01154218|449021673|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
124834025|NCT01154218|449021674|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
124834026|NCT01154218|449021671|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
124834027|NCT01154218|449021672|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
124834028|NCT01154218|449021673|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
124834029|NCT01154218|449021674|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
124834030|NCT00362115|449021677|FG000|Overall Study|Adverse Event|0|||
124834031|NCT00362115|449021678|FG001|Overall Study|Adverse Event|1|||
124834032|NCT00362115|449021679|FG002|Overall Study|Adverse Event|1|||
124834033|NCT00362115|449021680|FG003|Overall Study|Adverse Event|1|||
124834034|NCT00362115|449021681|FG004|Overall Study|Adverse Event|2|||
124834035|NCT00362115|449021682|FG005|Overall Study|Adverse Event|2|||
124834036|NCT00362115|449021683|FG006|Overall Study|Adverse Event|1|||
124834037|NCT00362115|449021677|FG000|Overall Study|Protocol Violation|0|||
124834038|NCT00362115|449021678|FG001|Overall Study|Protocol Violation|0|||
124834039|NCT00362115|449021679|FG002|Overall Study|Protocol Violation|0|||
124834040|NCT00362115|449021680|FG003|Overall Study|Protocol Violation|0|||
124834041|NCT00362115|449021681|FG004|Overall Study|Protocol Violation|0|||
124834042|NCT00362115|449021682|FG005|Overall Study|Protocol Violation|1|||
124834043|NCT00362115|449021683|FG006|Overall Study|Protocol Violation|0|||
124834044|NCT00362115|449021677|FG000|Overall Study|Lost to Follow-up|0|||
124834045|NCT00362115|449021678|FG001|Overall Study|Lost to Follow-up|1|||
124834046|NCT00362115|449021679|FG002|Overall Study|Lost to Follow-up|0|||
124834047|NCT00362115|449021680|FG003|Overall Study|Lost to Follow-up|0|||
124834048|NCT00362115|449021681|FG004|Overall Study|Lost to Follow-up|2|||
124834049|NCT00362115|449021682|FG005|Overall Study|Lost to Follow-up|0|||
124834050|NCT00362115|449021683|FG006|Overall Study|Lost to Follow-up|1|||
124834051|NCT00362115|449021677|FG000|Overall Study|Withdrawal by Subject|1|||
124834052|NCT00362115|449021678|FG001|Overall Study|Withdrawal by Subject|3|||
124834053|NCT00362115|449021679|FG002|Overall Study|Withdrawal by Subject|1|||
124834054|NCT00362115|449021680|FG003|Overall Study|Withdrawal by Subject|0|||
124834055|NCT00362115|449021681|FG004|Overall Study|Withdrawal by Subject|1|||
124834056|NCT00362115|449021682|FG005|Overall Study|Withdrawal by Subject|3|||
124834057|NCT00362115|449021683|FG006|Overall Study|Withdrawal by Subject|4|||
124834058|NCT00362115|449021677|FG000|Overall Study|Lack of Efficacy|1|||
124834059|NCT00362115|449021678|FG001|Overall Study|Lack of Efficacy|0|||
124834060|NCT00362115|449021679|FG002|Overall Study|Lack of Efficacy|5|||
124834061|NCT00362115|449021680|FG003|Overall Study|Lack of Efficacy|2|||
124834062|NCT00362115|449021681|FG004|Overall Study|Lack of Efficacy|2|||
124834063|NCT00362115|449021682|FG005|Overall Study|Lack of Efficacy|0|||
124834064|NCT00362115|449021683|FG006|Overall Study|Lack of Efficacy|3|||
124834065|NCT00362115|449021677|FG000|Overall Study|Physician Decision|0|||
124834066|NCT00362115|449021678|FG001|Overall Study|Physician Decision|0|||
124834067|NCT00362115|449021679|FG002|Overall Study|Physician Decision|0|||
124834068|NCT00362115|449021680|FG003|Overall Study|Physician Decision|0|||
124834069|NCT00362115|449021681|FG004|Overall Study|Physician Decision|0|||
124834070|NCT00362115|449021682|FG005|Overall Study|Physician Decision|0|||
124834071|NCT00362115|449021683|FG006|Overall Study|Physician Decision|3|||
124834072|NCT00362115|449021677|FG000|Overall Study|Other|0|||
124834073|NCT00362115|449021678|FG001|Overall Study|Other|1|||
124834074|NCT00362115|449021679|FG002|Overall Study|Other|0|||
124834075|NCT00362115|449021680|FG003|Overall Study|Other|1|||
124834076|NCT00362115|449021681|FG004|Overall Study|Other|0|||
124834077|NCT00362115|449021682|FG005|Overall Study|Other|1|||
124834078|NCT00362115|449021683|FG006|Overall Study|Other|0|||
124834079|NCT00335972|449021684|FG000|Overall Study|not given treatments|0|||
124834080|NCT00335972|449021685|FG001|Overall Study|not given treatments|3|||
124834081|NCT03803774|449021686|FG000|Dose Escalation|Withdrawal by Subject|0|||
124834082|NCT03803774|449021687|FG001|Dose Escalation|Withdrawal by Subject|0|||
124639246|NCT01339923|448296554|FG004|Overall Study|Protocol Violation|0|||
124639247|NCT01339923|448296555|FG005|Overall Study|Protocol Violation|3|||
124834083|NCT03803774|449021688|FG002|Dose Escalation|Withdrawal by Subject|0|||
124834084|NCT03803774|449021689|FG003|Dose Escalation|Withdrawal by Subject|1|||
124834085|NCT03803774|449021690|FG004|Dose Escalation|Withdrawal by Subject|0|||
124834086|NCT05497284|449021698|FG000|Overall Study|Adverse Event|1|||
124834087|NCT05497284|449021699|FG001|Overall Study|Adverse Event|0|||
124834088|NCT05497284|449021698|FG000|Overall Study|Physician Decision|0|||
124834089|NCT05497284|449021699|FG001|Overall Study|Physician Decision|1|||
124834090|NCT05497284|449021698|FG000|Overall Study|Study terminated by sponsor|7|||
124639248|NCT01339923|448296556|FG006|Overall Study|Protocol Violation|1|||
124834091|NCT05497284|449021699|FG001|Overall Study|Study terminated by sponsor|4|||
124834092|NCT05497284|449021698|FG000|Overall Study|Subject Decision|0|||
124834093|NCT05497284|449021699|FG001|Overall Study|Subject Decision|1|||
124834094|NCT03878446|449021700|FG000|Overall Study|Withdrawn by parent or guardian|1|||
124834095|NCT03878446|449021701|FG001|Overall Study|Withdrawn by parent or guardian|0|||
124834096|NCT03878446|449021702|FG002|Overall Study|Withdrawn by parent or guardian|0|||
124834097|NCT03878446|449021703|FG003|Overall Study|Withdrawn by parent or guardian|0|||
124834098|NCT03878446|449021704|FG004|Overall Study|Withdrawn by parent or guardian|0|||
124834099|NCT04365556|449021705|FG000|Overall Study|No longer eligible due to treatment plan|1|||
124834100|NCT04365556|449021706|FG001|Overall Study|No longer eligible due to treatment plan|0|||
124834101|NCT04365556|449021705|FG000|Overall Study|Lost to Follow-up|3|||
124834102|NCT04365556|449021706|FG001|Overall Study|Lost to Follow-up|2|||
124834103|NCT03181399|449023563|FG000|6 Months on Treatment|Protocol non-compliance|7|||
124834104|NCT03181399|449023563|FG000|6 Months on Treatment|Adverse Event|4|||
124834105|NCT03181399|449023563|FG000|6 Months on Treatment|Tried alternative treatment|2|||
124834106|NCT03181399|449023563|FG000|6 Months on Treatment|Lost to Follow-up|2|||
124834107|NCT03181399|449023563|FG000|6 Months on Treatment|Personal reasons|1|||
124834108|NCT03181399|449023563|FG000|3 Months Off-treatment|Parent unable to travel|1|||
124834109|NCT05123222|449023564|FG000|Overall Study|Lost to Follow-up|2|||
124834110|NCT05123222|449023565|FG001|Overall Study|Lost to Follow-up|0|||
124834111|NCT05123222|449023566|FG002|Overall Study|Lost to Follow-up|0|||
124834112|NCT05123222|449023567|FG003|Overall Study|Lost to Follow-up|0|||
124834113|NCT05123222|449023564|FG000|Overall Study|Protocol Violation|0|||
124834114|NCT05123222|449023565|FG001|Overall Study|Protocol Violation|0|||
124834115|NCT05123222|449023566|FG002|Overall Study|Protocol Violation|1|||
124834116|NCT05123222|449023567|FG003|Overall Study|Protocol Violation|0|||
124834117|NCT00265343|449023568|FG000|Overall Study|Adverse Event|10|||
124834118|NCT00265343|449023569|FG001|Overall Study|Adverse Event|7|||
124834119|NCT00265343|449023568|FG000|Overall Study|Withdrawal by Subject|3|||
124834120|NCT00265343|449023569|FG001|Overall Study|Withdrawal by Subject|9|||
124834121|NCT00265343|449023568|FG000|Overall Study|Other|8|||
124834122|NCT00265343|449023569|FG001|Overall Study|Other|3|||
124834123|NCT04865354|449023570|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
124834124|NCT04865354|449023571|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
124834125|NCT04865354|449023570|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
124834126|NCT04865354|449023571|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
124834127|NCT04865354|449023570|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
124834128|NCT04865354|449023571|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
124834129|NCT00706641|449023572|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
124834130|NCT00706641|449023572|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
124834131|NCT00706641|449023572|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
124834132|NCT02515942|449023574|FG000|Overall Study|Adverse Event|5|||
124834133|NCT02515942|449023575|FG001|Overall Study|Adverse Event|0|||
124834134|NCT02515942|449023576|FG002|Overall Study|Adverse Event|0|||
124834135|NCT02515942|449023574|FG000|Overall Study|Death|0|||
124834136|NCT02515942|449023575|FG001|Overall Study|Death|0|||
124834137|NCT02515942|449023576|FG002|Overall Study|Death|1|||
124834138|NCT02515942|449023574|FG000|Overall Study|Lack of Efficacy|0|||
124834139|NCT02515942|449023575|FG001|Overall Study|Lack of Efficacy|0|||
124834140|NCT02515942|449023576|FG002|Overall Study|Lack of Efficacy|1|||
124834141|NCT02515942|449023574|FG000|Overall Study|Lost to Follow-up|2|||
124834142|NCT02515942|449023575|FG001|Overall Study|Lost to Follow-up|0|||
124834143|NCT02515942|449023576|FG002|Overall Study|Lost to Follow-up|0|||
124834144|NCT02515942|449023574|FG000|Overall Study|Withdrawal by Subject|0|||
124834145|NCT02515942|449023575|FG001|Overall Study|Withdrawal by Subject|3|||
124834146|NCT02515942|449023576|FG002|Overall Study|Withdrawal by Subject|2|||
124834147|NCT00902564|449023578|FG000|Overall Study|Withdrawal by Subject|2|||
124834148|NCT00922766|449023579|FG000|Overall Study|Death|3|||
124834149|NCT00922766|449023579|FG000|Overall Study|Withdrawal by Subject|2|||
124834150|NCT00922766|449023579|FG000|Overall Study|Other|1|||
124834151|NCT00922766|449023579|FG000|Overall Study|Adverse Event|1|||
124834152|NCT01649375|449023582|FG000|Up to Week 16|Adverse Event|2|||
124834153|NCT01649375|449023583|FG001|Up to Week 16|Adverse Event|5|||
124834154|NCT01649375|449023584|FG002|Up to Week 16|Adverse Event|4|||
124834155|NCT01649375|449023585|FG003|Up to Week 16|Adverse Event|0|||
124834156|NCT01649375|449023586|FG004|Up to Week 16|Adverse Event|0|||
124834157|NCT01649375|449023582|FG000|Up to Week 16|Lack of Efficacy|0|||
124834158|NCT01649375|449023583|FG001|Up to Week 16|Lack of Efficacy|0|||
124834159|NCT01649375|449023584|FG002|Up to Week 16|Lack of Efficacy|1|||
124834160|NCT01649375|449023585|FG003|Up to Week 16|Lack of Efficacy|0|||
124834161|NCT01649375|449023586|FG004|Up to Week 16|Lack of Efficacy|0|||
124834162|NCT01649375|449023582|FG000|Up to Week 16|Physician Decision|0|||
124834163|NCT01649375|449023583|FG001|Up to Week 16|Physician Decision|0|||
124834164|NCT01649375|449023584|FG002|Up to Week 16|Physician Decision|1|||
124834165|NCT01649375|449023585|FG003|Up to Week 16|Physician Decision|0|||
124834166|NCT01649375|449023586|FG004|Up to Week 16|Physician Decision|0|||
124834167|NCT01649375|449023582|FG000|Up to Week 16|Withdrawal by Subject|2|||
124834168|NCT01649375|449023583|FG001|Up to Week 16|Withdrawal by Subject|1|||
124834169|NCT01649375|449023584|FG002|Up to Week 16|Withdrawal by Subject|2|||
124834170|NCT01649375|449023585|FG003|Up to Week 16|Withdrawal by Subject|0|||
124834171|NCT01649375|449023586|FG004|Up to Week 16|Withdrawal by Subject|0|||
124834172|NCT01649375|449023582|FG000|Up to Week 16|Death|1|||
124834173|NCT01649375|449023583|FG001|Up to Week 16|Death|0|||
124834174|NCT01649375|449023584|FG002|Up to Week 16|Death|0|||
124834175|NCT01649375|449023585|FG003|Up to Week 16|Death|0|||
124834176|NCT01649375|449023586|FG004|Up to Week 16|Death|0|||
124834177|NCT01649375|449023582|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
124834178|NCT01649375|449023583|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
124834179|NCT01649375|449023584|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
124834180|NCT01649375|449023585|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
124834181|NCT01649375|449023586|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
124834182|NCT01649375|449023582|FG000|Week 16 up to Week 260|Non-compliance|0|||
124834183|NCT01649375|449023583|FG001|Week 16 up to Week 260|Non-compliance|1|||
124834184|NCT01649375|449023584|FG002|Week 16 up to Week 260|Non-compliance|0|||
124834185|NCT01649375|449023585|FG003|Week 16 up to Week 260|Non-compliance|1|||
124834186|NCT01649375|449023586|FG004|Week 16 up to Week 260|Non-compliance|0|||
124834187|NCT01649375|449023582|FG000|Week 16 up to Week 260|Physician Decision|0|||
124834188|NCT01649375|449023583|FG001|Week 16 up to Week 260|Physician Decision|2|||
124834189|NCT01649375|449023584|FG002|Week 16 up to Week 260|Physician Decision|0|||
124834190|NCT01649375|449023585|FG003|Week 16 up to Week 260|Physician Decision|0|||
124834191|NCT01649375|449023586|FG004|Week 16 up to Week 260|Physician Decision|0|||
124834192|NCT01649375|449023582|FG000|Week 16 up to Week 260|Technical issues|0|||
124834193|NCT01649375|449023583|FG001|Week 16 up to Week 260|Technical issues|1|||
124834194|NCT01649375|449023584|FG002|Week 16 up to Week 260|Technical issues|0|||
124834195|NCT01649375|449023585|FG003|Week 16 up to Week 260|Technical issues|1|||
124834196|NCT01649375|449023586|FG004|Week 16 up to Week 260|Technical issues|0|||
124834197|NCT01649375|449023582|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
124834198|NCT01649375|449023583|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
124834199|NCT01649375|449023584|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
124834200|NCT01649375|449023585|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
124834201|NCT01649375|449023586|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
124834202|NCT01649375|449023582|FG000|Week 16 up to Week 260|Death|1|||
124834203|NCT01649375|449023583|FG001|Week 16 up to Week 260|Death|1|||
124834204|NCT01649375|449023584|FG002|Week 16 up to Week 260|Death|0|||
124834205|NCT01649375|449023585|FG003|Week 16 up to Week 260|Death|0|||
124834206|NCT01649375|449023586|FG004|Week 16 up to Week 260|Death|0|||
124834207|NCT01649375|449023582|FG000|Week 16 up to Week 260|Adverse Event|5|||
124834208|NCT01649375|449023583|FG001|Week 16 up to Week 260|Adverse Event|2|||
124834209|NCT01649375|449023584|FG002|Week 16 up to Week 260|Adverse Event|0|||
124834210|NCT01649375|449023585|FG003|Week 16 up to Week 260|Adverse Event|3|||
124834211|NCT01649375|449023586|FG004|Week 16 up to Week 260|Adverse Event|2|||
124834212|NCT01762943|449023589|FG000|Overall Study|Physician Decision|1|||
124834213|NCT01762943|449023590|FG001|Overall Study|Physician Decision|1|||
124834214|NCT01762943|449023589|FG000|Overall Study|Protocol Violation|1|||
124834215|NCT01762943|449023590|FG001|Overall Study|Protocol Violation|0|||
124834216|NCT01762943|449023589|FG000|Overall Study|Withdrawal by Subject|2|||
124834217|NCT01762943|449023590|FG001|Overall Study|Withdrawal by Subject|1|||
124834218|NCT00539838|449023591|FG000|Overall Study|Fail to return|2|||
124834219|NCT00539838|449023592|FG001|Overall Study|Fail to return|0|||
124834220|NCT00539838|449023593|FG002|Overall Study|Fail to return|0|||
124834221|NCT00539838|449023591|FG000|Overall Study|Withdrawal by Subject|0|||
124834222|NCT00539838|449023592|FG001|Overall Study|Withdrawal by Subject|4|||
124834223|NCT00539838|449023593|FG002|Overall Study|Withdrawal by Subject|0|||
124834224|NCT00539838|449023591|FG000|Overall Study|Death|0|||
124834225|NCT00539838|449023592|FG001|Overall Study|Death|2|||
124834226|NCT00539838|449023593|FG002|Overall Study|Death|0|||
124834227|NCT00539838|449023591|FG000|Overall Study|Did not cooperate|1|||
124834228|NCT00539838|449023592|FG001|Overall Study|Did not cooperate|0|||
124834229|NCT00539838|449023593|FG002|Overall Study|Did not cooperate|1|||
124834230|NCT00539838|449023591|FG000|Overall Study|Administrative|4|||
124834231|NCT00539838|449023592|FG001|Overall Study|Administrative|0|||
124834232|NCT00539838|449023593|FG002|Overall Study|Administrative|8|||
124834233|NCT02658890|449023594|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834234|NCT02658890|449023595|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834235|NCT02658890|449023596|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834236|NCT02658890|449023597|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834237|NCT02658890|449023598|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834238|NCT02658890|449023599|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834239|NCT02658890|449023600|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834240|NCT02658890|449023601|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834241|NCT02658890|449023602|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
124834242|NCT02658890|449023603|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834243|NCT02658890|449023604|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834244|NCT02658890|449023605|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834245|NCT02658890|449023606|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834246|NCT02658890|449023607|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834247|NCT02658890|449023608|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834248|NCT02658890|449023609|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834249|NCT02658890|449023610|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834250|NCT02658890|449023611|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834251|NCT02658890|449023612|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834252|NCT02658890|449023613|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834253|NCT02658890|449023614|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834254|NCT02658890|449023615|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834255|NCT02658890|449023616|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834256|NCT02658890|449023617|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834257|NCT02658890|449023618|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834258|NCT02658890|449023619|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834259|NCT02658890|449023620|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834260|NCT02658890|449023594|FG000|Treatment Phase|Adverse Event|0|||
124834261|NCT02658890|449023595|FG001|Treatment Phase|Adverse Event|1|||
124834262|NCT02658890|449023596|FG002|Treatment Phase|Adverse Event|2|||
124834263|NCT02658890|449023597|FG003|Treatment Phase|Adverse Event|2|||
124834264|NCT02658890|449023598|FG004|Treatment Phase|Adverse Event|1|||
124834265|NCT02658890|449023599|FG005|Treatment Phase|Adverse Event|0|||
124834266|NCT02658890|449023600|FG006|Treatment Phase|Adverse Event|0|||
124834267|NCT02658890|449023601|FG007|Treatment Phase|Adverse Event|2|||
124834268|NCT02658890|449023602|FG008|Treatment Phase|Adverse Event|1|||
124834269|NCT02658890|449023603|FG009|Treatment Phase|Adverse Event|2|||
124834270|NCT02658890|449023604|FG010|Treatment Phase|Adverse Event|3|||
124834271|NCT02658890|449023605|FG011|Treatment Phase|Adverse Event|0|||
124834272|NCT02658890|449023606|FG012|Treatment Phase|Adverse Event|1|||
124834273|NCT02658890|449023607|FG013|Treatment Phase|Adverse Event|4|||
124834274|NCT02658890|449023608|FG014|Treatment Phase|Adverse Event|0|||
124834275|NCT02658890|449023609|FG015|Treatment Phase|Adverse Event|0|||
124834276|NCT02658890|449023610|FG016|Treatment Phase|Adverse Event|0|||
124834277|NCT02658890|449023611|FG017|Treatment Phase|Adverse Event|0|||
124834278|NCT02658890|449023612|FG018|Treatment Phase|Adverse Event|5|||
124834279|NCT02658890|449023613|FG019|Treatment Phase|Adverse Event|1|||
124834280|NCT02658890|449023614|FG020|Treatment Phase|Adverse Event|3|||
124834281|NCT02658890|449023615|FG021|Treatment Phase|Adverse Event|0|||
124834282|NCT02658890|449023616|FG022|Treatment Phase|Adverse Event|5|||
124834283|NCT02658890|449023617|FG023|Treatment Phase|Adverse Event|0|||
124834284|NCT02658890|449023618|FG024|Treatment Phase|Adverse Event|0|||
124834285|NCT02658890|449023619|FG025|Treatment Phase|Adverse Event|2|||
124834286|NCT02658890|449023620|FG026|Treatment Phase|Adverse Event|1|||
124834287|NCT02658890|449023594|FG000|Treatment Phase|Death|0|||
124834288|NCT02658890|449023595|FG001|Treatment Phase|Death|0|||
124834289|NCT02658890|449023596|FG002|Treatment Phase|Death|0|||
124834290|NCT02658890|449023597|FG003|Treatment Phase|Death|0|||
124834291|NCT02658890|449023598|FG004|Treatment Phase|Death|0|||
124834292|NCT02658890|449023599|FG005|Treatment Phase|Death|0|||
124834293|NCT02658890|449023600|FG006|Treatment Phase|Death|0|||
124834294|NCT02658890|449023601|FG007|Treatment Phase|Death|0|||
124834295|NCT02658890|449023602|FG008|Treatment Phase|Death|0|||
124834296|NCT02658890|449023603|FG009|Treatment Phase|Death|0|||
124834297|NCT02658890|449023604|FG010|Treatment Phase|Death|0|||
124834298|NCT02658890|449023605|FG011|Treatment Phase|Death|0|||
124834299|NCT02658890|449023606|FG012|Treatment Phase|Death|0|||
124834300|NCT02658890|449023607|FG013|Treatment Phase|Death|0|||
124834301|NCT02658890|449023608|FG014|Treatment Phase|Death|0|||
124834302|NCT02658890|449023609|FG015|Treatment Phase|Death|0|||
124834303|NCT02658890|449023610|FG016|Treatment Phase|Death|0|||
124834304|NCT02658890|449023611|FG017|Treatment Phase|Death|0|||
124834305|NCT02658890|449023612|FG018|Treatment Phase|Death|1|||
124834306|NCT02658890|449023613|FG019|Treatment Phase|Death|0|||
124834307|NCT02658890|449023614|FG020|Treatment Phase|Death|0|||
124834308|NCT02658890|449023615|FG021|Treatment Phase|Death|0|||
124834309|NCT02658890|449023616|FG022|Treatment Phase|Death|0|||
124834310|NCT02658890|449023617|FG023|Treatment Phase|Death|0|||
124834311|NCT02658890|449023618|FG024|Treatment Phase|Death|0|||
124834312|NCT02658890|449023619|FG025|Treatment Phase|Death|0|||
124834313|NCT02658890|449023620|FG026|Treatment Phase|Death|0|||
124834314|NCT02658890|449023594|FG000|Treatment Phase|Lost to Follow-up|0|||
124834315|NCT02658890|449023595|FG001|Treatment Phase|Lost to Follow-up|0|||
124834316|NCT02658890|449023596|FG002|Treatment Phase|Lost to Follow-up|0|||
124834317|NCT02658890|449023597|FG003|Treatment Phase|Lost to Follow-up|0|||
124834318|NCT02658890|449023598|FG004|Treatment Phase|Lost to Follow-up|0|||
124834319|NCT02658890|449023599|FG005|Treatment Phase|Lost to Follow-up|0|||
124834320|NCT02658890|449023600|FG006|Treatment Phase|Lost to Follow-up|1|||
124834321|NCT02658890|449023601|FG007|Treatment Phase|Lost to Follow-up|0|||
124834322|NCT02658890|449023602|FG008|Treatment Phase|Lost to Follow-up|0|||
124834323|NCT02658890|449023603|FG009|Treatment Phase|Lost to Follow-up|0|||
124834324|NCT02658890|449023604|FG010|Treatment Phase|Lost to Follow-up|0|||
124834325|NCT02658890|449023605|FG011|Treatment Phase|Lost to Follow-up|0|||
124834326|NCT02658890|449023606|FG012|Treatment Phase|Lost to Follow-up|0|||
124639249|NCT01339923|448296550|FG000|Overall Study|Unable to Classify|1|||
124834327|NCT02658890|449023607|FG013|Treatment Phase|Lost to Follow-up|0|||
124834328|NCT02658890|449023608|FG014|Treatment Phase|Lost to Follow-up|0|||
124834329|NCT02658890|449023609|FG015|Treatment Phase|Lost to Follow-up|0|||
124834330|NCT02658890|449023610|FG016|Treatment Phase|Lost to Follow-up|0|||
124834331|NCT02658890|449023611|FG017|Treatment Phase|Lost to Follow-up|0|||
124834332|NCT02658890|449023612|FG018|Treatment Phase|Lost to Follow-up|0|||
124834333|NCT02658890|449023613|FG019|Treatment Phase|Lost to Follow-up|0|||
124834334|NCT02658890|449023614|FG020|Treatment Phase|Lost to Follow-up|0|||
124834335|NCT02658890|449023615|FG021|Treatment Phase|Lost to Follow-up|0|||
124834336|NCT02658890|449023616|FG022|Treatment Phase|Lost to Follow-up|0|||
124834337|NCT02658890|449023617|FG023|Treatment Phase|Lost to Follow-up|0|||
124834338|NCT02658890|449023618|FG024|Treatment Phase|Lost to Follow-up|0|||
124834339|NCT02658890|449023619|FG025|Treatment Phase|Lost to Follow-up|0|||
124834340|NCT02658890|449023620|FG026|Treatment Phase|Lost to Follow-up|0|||
124834341|NCT02658890|449023594|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
124834342|NCT02658890|449023595|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
124834343|NCT02658890|449023596|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
124834344|NCT02658890|449023597|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
124834345|NCT02658890|449023598|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
124834346|NCT02658890|449023599|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
124834347|NCT02658890|449023600|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
124834348|NCT02658890|449023601|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
124834349|NCT02658890|449023602|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
124834350|NCT02658890|449023603|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
124834351|NCT02658890|449023604|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
124834352|NCT02658890|449023605|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
124834353|NCT02658890|449023606|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
124834354|NCT02658890|449023607|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
124834355|NCT02658890|449023608|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
124834356|NCT02658890|449023609|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
124834357|NCT02658890|449023610|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
124834358|NCT02658890|449023611|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
124834359|NCT02658890|449023612|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
124834360|NCT02658890|449023613|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
124834361|NCT02658890|449023614|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
124834362|NCT02658890|449023615|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
124834363|NCT02658890|449023616|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
124834364|NCT02658890|449023617|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
124834365|NCT02658890|449023618|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
124834366|NCT02658890|449023619|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
124834367|NCT02658890|449023620|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
124834368|NCT02658890|449023594|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
124834369|NCT02658890|449023595|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
124834370|NCT02658890|449023596|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
124834371|NCT02658890|449023597|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
124834372|NCT02658890|449023598|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
124834373|NCT02658890|449023599|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
124834374|NCT02658890|449023600|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
124834375|NCT02658890|449023601|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
124834376|NCT02658890|449023602|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
124834377|NCT02658890|449023603|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
124834378|NCT02658890|449023604|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
124834379|NCT02658890|449023605|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
124834380|NCT02658890|449023606|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
124834381|NCT02658890|449023607|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
124834382|NCT02658890|449023608|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
124834383|NCT02658890|449023609|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
124834384|NCT02658890|449023610|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
124834385|NCT02658890|449023611|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
124834386|NCT02658890|449023612|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
124834387|NCT02658890|449023613|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
124834388|NCT02658890|449023614|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
124834389|NCT02658890|449023615|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
124834390|NCT02658890|449023616|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
124834391|NCT02658890|449023617|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
124834392|NCT02658890|449023618|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
124834393|NCT02658890|449023619|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
124834394|NCT02658890|449023620|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
124639250|NCT01339923|448296551|FG001|Overall Study|Unable to Classify|0|||
124834395|NCT02658890|449023594|FG000|Treatment Phase|Other Reasons|0|||
124834396|NCT02658890|449023595|FG001|Treatment Phase|Other Reasons|0|||
124834397|NCT02658890|449023596|FG002|Treatment Phase|Other Reasons|0|||
124639251|NCT01339923|448296552|FG002|Overall Study|Unable to Classify|1|||
124639252|NCT01339923|448296553|FG003|Overall Study|Unable to Classify|0|||
124639253|NCT01339923|448296554|FG004|Overall Study|Unable to Classify|0|||
124834398|NCT02658890|449023597|FG003|Treatment Phase|Other Reasons|0|||
124639254|NCT01339923|448296555|FG005|Overall Study|Unable to Classify|1|||
124639255|NCT01339923|448296556|FG006|Overall Study|Unable to Classify|5|||
124639256|NCT01339923|448296550|FG000|Overall Study|Withdrawal by Subject|7|||
124639257|NCT01339923|448296551|FG001|Overall Study|Withdrawal by Subject|11|||
124639258|NCT01339923|448296552|FG002|Overall Study|Withdrawal by Subject|6|||
124639259|NCT01339923|448296553|FG003|Overall Study|Withdrawal by Subject|1|||
124639260|NCT01339923|448296554|FG004|Overall Study|Withdrawal by Subject|4|||
124639261|NCT01339923|448296555|FG005|Overall Study|Withdrawal by Subject|3|||
124639262|NCT01339923|448296556|FG006|Overall Study|Withdrawal by Subject|2|||
124639263|NCT01931995|448296557|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
124639264|NCT01931995|448296558|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
124639265|NCT01931995|448296557|FG000|First Intervention (1 Day)|Physician Decision|1|||
124639266|NCT01931995|448296558|FG001|First Intervention (1 Day)|Physician Decision|1|||
124639267|NCT01931995|448296557|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
124639268|NCT01931995|448296558|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
124639269|NCT00403481|448296559|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
124639270|NCT00403481|448296559|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
124639271|NCT00403481|448296559|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
124639272|NCT00403481|448296559|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
124639273|NCT00403481|448296559|FG000|Olm 40 mg|Adverse Event|2|||
124639274|NCT00403481|448296559|FG000|Olm 40 mg|Protocol Violation|1|||
124639275|NCT00403481|448296559|FG000|Olm 40 mg|Withdrawal by Subject|1|||
124639276|NCT00403481|448296559|FG000|Olm 40 mg|Other|1|||
124639277|NCT00403481|448296559|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
124639278|NCT00403481|448296559|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
124639279|NCT00403481|448296559|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
124639280|NCT00403481|448296559|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
124639281|NCT00403481|448296559|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
124639282|NCT00403481|448296559|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
124639283|NCT02099110|448296562|FG000|Overall Study|Protocol Violation|2|||
124639284|NCT02099110|448296563|FG001|Overall Study|Protocol Violation|1|||
124639285|NCT02099110|448296564|FG002|Overall Study|Protocol Violation|0|||
124639286|NCT02099110|448296565|FG003|Overall Study|Protocol Violation|3|||
124639287|NCT02099110|448296566|FG004|Overall Study|Protocol Violation|1|||
124639288|NCT02099110|448296562|FG000|Overall Study|Participant moved|1|||
124639289|NCT02099110|448296563|FG001|Overall Study|Participant moved|1|||
124639290|NCT02099110|448296564|FG002|Overall Study|Participant moved|1|||
124639291|NCT02099110|448296565|FG003|Overall Study|Participant moved|0|||
124639292|NCT02099110|448296566|FG004|Overall Study|Participant moved|2|||
124639293|NCT02099110|448296562|FG000|Overall Study|Withdrawal by Subject|7|||
124639294|NCT02099110|448296563|FG001|Overall Study|Withdrawal by Subject|11|||
124639295|NCT02099110|448296564|FG002|Overall Study|Withdrawal by Subject|13|||
124639296|NCT02099110|448296565|FG003|Overall Study|Withdrawal by Subject|9|||
124639297|NCT02099110|448296566|FG004|Overall Study|Withdrawal by Subject|13|||
124639298|NCT02099110|448296562|FG000|Overall Study|Adverse Event|3|||
124639299|NCT02099110|448296563|FG001|Overall Study|Adverse Event|5|||
124639300|NCT02099110|448296564|FG002|Overall Study|Adverse Event|2|||
124639301|NCT02099110|448296565|FG003|Overall Study|Adverse Event|3|||
124639302|NCT02099110|448296566|FG004|Overall Study|Adverse Event|2|||
124639303|NCT02099110|448296562|FG000|Overall Study|Lost to Follow-up|6|||
124639304|NCT02099110|448296563|FG001|Overall Study|Lost to Follow-up|12|||
124639305|NCT02099110|448296564|FG002|Overall Study|Lost to Follow-up|11|||
124639306|NCT02099110|448296565|FG003|Overall Study|Lost to Follow-up|5|||
124639307|NCT02099110|448296566|FG004|Overall Study|Lost to Follow-up|6|||
124639308|NCT02099110|448296562|FG000|Overall Study|Death|0|||
124639309|NCT02099110|448296563|FG001|Overall Study|Death|1|||
124639310|NCT02099110|448296564|FG002|Overall Study|Death|0|||
124639311|NCT02099110|448296565|FG003|Overall Study|Death|0|||
124639312|NCT02099110|448296566|FG004|Overall Study|Death|0|||
124639313|NCT02099110|448296562|FG000|Overall Study|Screen failure|0|||
124639314|NCT02099110|448296563|FG001|Overall Study|Screen failure|0|||
124639315|NCT02099110|448296564|FG002|Overall Study|Screen failure|0|||
124639316|NCT02099110|448296565|FG003|Overall Study|Screen failure|0|||
124639317|NCT02099110|448296566|FG004|Overall Study|Screen failure|1|||
124639318|NCT02099110|448296562|FG000|Overall Study|Non-compliance with study drug|2|||
124639319|NCT02099110|448296563|FG001|Overall Study|Non-compliance with study drug|0|||
124639320|NCT02099110|448296564|FG002|Overall Study|Non-compliance with study drug|0|||
124639321|NCT02099110|448296565|FG003|Overall Study|Non-compliance with study drug|0|||
124639322|NCT02099110|448296566|FG004|Overall Study|Non-compliance with study drug|1|||
124639323|NCT02099110|448296562|FG000|Overall Study|Physician Decision|3|||
124639324|NCT02099110|448296563|FG001|Overall Study|Physician Decision|0|||
124639325|NCT02099110|448296564|FG002|Overall Study|Physician Decision|1|||
124639326|NCT02099110|448296565|FG003|Overall Study|Physician Decision|2|||
124639327|NCT02099110|448296566|FG004|Overall Study|Physician Decision|1|||
124639328|NCT03340454|448296572|FG000|Overall Study|Lost to Follow-up|0|||
124639329|NCT03340454|448296573|FG001|Overall Study|Lost to Follow-up|4|||
124834399|NCT02658890|449023598|FG004|Treatment Phase|Other Reasons|0|||
124639330|NCT03682848|448296574|FG000|Overall Study|Withdrawal by Subject|2|||
124639331|NCT03682848|448296574|FG000|Overall Study|Site closed|5|||
124639332|NCT03682848|448296574|FG000|Overall Study|Protocol Deviation|1|||
124639333|NCT03682848|448296574|FG000|Overall Study|Adverse Event|1|||
124639334|NCT01464164|448296575|FG000|Overall Study|Screen failure|0|||
124639335|NCT01464164|448296576|FG001|Overall Study|Screen failure|1|||
124639336|NCT01464164|448296577|FG002|Overall Study|Screen failure|2|||
124639337|NCT01464164|448296578|FG003|Overall Study|Screen failure|0|||
124639338|NCT01464164|448296579|FG004|Overall Study|Screen failure|0|||
124639339|NCT01464164|448296580|FG005|Overall Study|Screen failure|0|||
124639340|NCT01464164|448296581|FG006|Overall Study|Screen failure|0|||
124639341|NCT01464164|448296575|FG000|Overall Study|Physician Decision|0|||
124639342|NCT01464164|448296576|FG001|Overall Study|Physician Decision|1|||
124639343|NCT01464164|448296577|FG002|Overall Study|Physician Decision|0|||
124639344|NCT01464164|448296578|FG003|Overall Study|Physician Decision|0|||
124639345|NCT01464164|448296579|FG004|Overall Study|Physician Decision|0|||
124639346|NCT01464164|448296580|FG005|Overall Study|Physician Decision|0|||
124639347|NCT01464164|448296581|FG006|Overall Study|Physician Decision|2|||
124639348|NCT00454363|448296582|FG000|Overall Study|Adverse Event|1|||
124639349|NCT00454363|448296583|FG001|Overall Study|Adverse Event|2|||
124639350|NCT00454363|448296582|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
124639351|NCT00454363|448296583|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
124639352|NCT00570063|448296584|FG000|Overall Study|Adverse Event|4|||
124639353|NCT00570063|448296585|FG001|Overall Study|Adverse Event|1|||
124639354|NCT00570063|448296584|FG000|Overall Study|Lack of Efficacy|0|||
124639355|NCT00570063|448296585|FG001|Overall Study|Lack of Efficacy|1|||
124639356|NCT00570063|448296584|FG000|Overall Study|Withdrawal by Subject|4|||
124639357|NCT00570063|448296585|FG001|Overall Study|Withdrawal by Subject|3|||
124639358|NCT00570063|448296584|FG000|Overall Study|Sponsor's Decision|7|||
124639359|NCT00570063|448296585|FG001|Overall Study|Sponsor's Decision|3|||
124639360|NCT00697463|448296586|FG000|Overall Study|Withdrawal by Subject|1|||
124639361|NCT03307252|448296587|FG000|Part 2, Period 1|Treatment not received|0|||
124639362|NCT03307252|448296588|FG001|Part 2, Period 1|Treatment not received|0|||
124639363|NCT03307252|448296589|FG002|Part 2, Period 1|Treatment not received|0|||
124639364|NCT03307252|448296590|FG003|Part 2, Period 1|Treatment not received|0|||
124834400|NCT02658890|449023599|FG005|Treatment Phase|Other Reasons|0|||
124834401|NCT02658890|449023600|FG006|Treatment Phase|Other Reasons|1|||
124834402|NCT02658890|449023601|FG007|Treatment Phase|Other Reasons|0|||
124834403|NCT02658890|449023602|FG008|Treatment Phase|Other Reasons|1|||
124834404|NCT02658890|449023603|FG009|Treatment Phase|Other Reasons|0|||
124834405|NCT02658890|449023604|FG010|Treatment Phase|Other Reasons|0|||
124834406|NCT02658890|449023605|FG011|Treatment Phase|Other Reasons|0|||
124834407|NCT02658890|449023606|FG012|Treatment Phase|Other Reasons|0|||
124834408|NCT02658890|449023607|FG013|Treatment Phase|Other Reasons|2|||
124834409|NCT02658890|449023608|FG014|Treatment Phase|Other Reasons|0|||
124834410|NCT02658890|449023609|FG015|Treatment Phase|Other Reasons|0|||
124834411|NCT02658890|449023610|FG016|Treatment Phase|Other Reasons|0|||
124834412|NCT02658890|449023611|FG017|Treatment Phase|Other Reasons|0|||
124834413|NCT02658890|449023612|FG018|Treatment Phase|Other Reasons|1|||
124834414|NCT02658890|449023613|FG019|Treatment Phase|Other Reasons|0|||
124834415|NCT02658890|449023614|FG020|Treatment Phase|Other Reasons|0|||
124834416|NCT02658890|449023615|FG021|Treatment Phase|Other Reasons|0|||
124834417|NCT02658890|449023616|FG022|Treatment Phase|Other Reasons|0|||
124834418|NCT02658890|449023617|FG023|Treatment Phase|Other Reasons|0|||
124834419|NCT02658890|449023618|FG024|Treatment Phase|Other Reasons|1|||
124834420|NCT02658890|449023619|FG025|Treatment Phase|Other Reasons|0|||
124834421|NCT02658890|449023620|FG026|Treatment Phase|Other Reasons|1|||
124834422|NCT02658890|449023594|FG000|Treatment Phase|Progressive Disease|6|||
124834423|NCT02658890|449023595|FG001|Treatment Phase|Progressive Disease|7|||
124834424|NCT02658890|449023596|FG002|Treatment Phase|Progressive Disease|6|||
124834425|NCT02658890|449023597|FG003|Treatment Phase|Progressive Disease|12|||
124834426|NCT02658890|449023598|FG004|Treatment Phase|Progressive Disease|6|||
124834427|NCT02658890|449023599|FG005|Treatment Phase|Progressive Disease|18|||
124834428|NCT02658890|449023600|FG006|Treatment Phase|Progressive Disease|12|||
124639365|NCT03307252|448296591|FG004|Part 2, Period 1|Treatment not received|0|||
124639366|NCT03307252|448296592|FG005|Part 2, Period 1|Treatment not received|1|||
124639367|NCT03307252|448296593|FG006|Part 2, Period 1|Treatment not received|0|||
124639368|NCT03307252|448296594|FG007|Part 2, Period 1|Treatment not received|0|||
124639369|NCT03307252|448296595|FG008|Part 2, Period 1|Treatment not received|0|||
124639370|NCT03307252|448296596|FG009|Part 2, Period 1|Treatment not received|0|||
124834429|NCT02658890|449023601|FG007|Treatment Phase|Progressive Disease|19|||
124834430|NCT02658890|449023602|FG008|Treatment Phase|Progressive Disease|26|||
124834431|NCT02658890|449023603|FG009|Treatment Phase|Progressive Disease|8|||
124834432|NCT02658890|449023604|FG010|Treatment Phase|Progressive Disease|7|||
124639371|NCT03307252|448296597|FG010|Part 2, Period 1|Treatment not received|0|||
124639372|NCT03307252|448296587|FG000|Part 2, Period 3|Other than listed|0|||
124639373|NCT03307252|448296588|FG001|Part 2, Period 3|Other than listed|0|||
124639374|NCT03307252|448296589|FG002|Part 2, Period 3|Other than listed|0|||
124834433|NCT02658890|449023605|FG011|Treatment Phase|Progressive Disease|9|||
124834434|NCT02658890|449023606|FG012|Treatment Phase|Progressive Disease|8|||
124834435|NCT02658890|449023607|FG013|Treatment Phase|Progressive Disease|29|||
124834436|NCT02658890|449023608|FG014|Treatment Phase|Progressive Disease|6|||
124834437|NCT02658890|449023609|FG015|Treatment Phase|Progressive Disease|2|||
124834438|NCT02658890|449023610|FG016|Treatment Phase|Progressive Disease|32|||
124834439|NCT02658890|449023611|FG017|Treatment Phase|Progressive Disease|14|||
124834440|NCT02658890|449023612|FG018|Treatment Phase|Progressive Disease|40|||
124834441|NCT02658890|449023613|FG019|Treatment Phase|Progressive Disease|32|||
124834442|NCT02658890|449023614|FG020|Treatment Phase|Progressive Disease|19|||
124834443|NCT02658890|449023615|FG021|Treatment Phase|Progressive Disease|30|||
124834444|NCT02658890|449023616|FG022|Treatment Phase|Progressive Disease|15|||
124834445|NCT02658890|449023617|FG023|Treatment Phase|Progressive Disease|0|||
124834446|NCT02658890|449023618|FG024|Treatment Phase|Progressive Disease|0|||
124834447|NCT02658890|449023619|FG025|Treatment Phase|Progressive Disease|14|||
124834448|NCT02658890|449023620|FG026|Treatment Phase|Progressive Disease|11|||
124834449|NCT02658890|449023594|FG000|Treatment Phase|Study Drug Toxicity|0|||
124834450|NCT02658890|449023595|FG001|Treatment Phase|Study Drug Toxicity|0|||
124834451|NCT02658890|449023596|FG002|Treatment Phase|Study Drug Toxicity|2|||
124834452|NCT02658890|449023597|FG003|Treatment Phase|Study Drug Toxicity|0|||
124834453|NCT02658890|449023598|FG004|Treatment Phase|Study Drug Toxicity|0|||
124834454|NCT02658890|449023599|FG005|Treatment Phase|Study Drug Toxicity|0|||
124834455|NCT02658890|449023600|FG006|Treatment Phase|Study Drug Toxicity|0|||
124834456|NCT02658890|449023601|FG007|Treatment Phase|Study Drug Toxicity|0|||
124834457|NCT02658890|449023602|FG008|Treatment Phase|Study Drug Toxicity|3|||
124834458|NCT02658890|449023603|FG009|Treatment Phase|Study Drug Toxicity|0|||
124834459|NCT02658890|449023604|FG010|Treatment Phase|Study Drug Toxicity|1|||
124834460|NCT02658890|449023605|FG011|Treatment Phase|Study Drug Toxicity|1|||
124834461|NCT02658890|449023606|FG012|Treatment Phase|Study Drug Toxicity|2|||
124834462|NCT02658890|449023607|FG013|Treatment Phase|Study Drug Toxicity|9|||
124834463|NCT02658890|449023608|FG014|Treatment Phase|Study Drug Toxicity|0|||
124834464|NCT02658890|449023609|FG015|Treatment Phase|Study Drug Toxicity|1|||
124834465|NCT02658890|449023610|FG016|Treatment Phase|Study Drug Toxicity|1|||
124834466|NCT02658890|449023611|FG017|Treatment Phase|Study Drug Toxicity|0|||
124834467|NCT02658890|449023612|FG018|Treatment Phase|Study Drug Toxicity|8|||
124834468|NCT02658890|449023613|FG019|Treatment Phase|Study Drug Toxicity|3|||
124834469|NCT02658890|449023614|FG020|Treatment Phase|Study Drug Toxicity|2|||
124834470|NCT02658890|449023615|FG021|Treatment Phase|Study Drug Toxicity|0|||
124834471|NCT02658890|449023616|FG022|Treatment Phase|Study Drug Toxicity|8|||
124834472|NCT02658890|449023617|FG023|Treatment Phase|Study Drug Toxicity|0|||
124834473|NCT02658890|449023618|FG024|Treatment Phase|Study Drug Toxicity|0|||
124834474|NCT02658890|449023619|FG025|Treatment Phase|Study Drug Toxicity|2|||
124834475|NCT02658890|449023620|FG026|Treatment Phase|Study Drug Toxicity|0|||
124834476|NCT02658890|449023594|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834477|NCT02658890|449023595|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834478|NCT02658890|449023596|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834479|NCT02658890|449023597|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
124834480|NCT02658890|449023598|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834481|NCT02658890|449023599|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834482|NCT02658890|449023600|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834483|NCT02658890|449023601|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834484|NCT02658890|449023602|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834485|NCT02658890|449023603|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
124834486|NCT02658890|449023604|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834487|NCT02658890|449023605|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834488|NCT02658890|449023606|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834489|NCT02658890|449023607|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834490|NCT02658890|449023608|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834491|NCT02658890|449023609|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834492|NCT02658890|449023610|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834493|NCT02658890|449023611|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834494|NCT02658890|449023612|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
124834495|NCT02658890|449023613|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834496|NCT02658890|449023614|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834497|NCT02658890|449023615|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834498|NCT02658890|449023616|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
124639375|NCT03307252|448296590|FG003|Part 2, Period 3|Other than listed|0|||
124834499|NCT02658890|449023617|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124639376|NCT03307252|448296591|FG004|Part 2, Period 3|Other than listed|1|||
124639377|NCT03307252|448296592|FG005|Part 2, Period 3|Other than listed|0|||
124834500|NCT02658890|449023618|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834501|NCT02658890|449023619|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834502|NCT02658890|449023620|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
124834503|NCT02658890|449023594|FG000|Treatment Phase|Withdrawal by Subject|0|||
124834504|NCT02658890|449023595|FG001|Treatment Phase|Withdrawal by Subject|1|||
124834505|NCT02658890|449023596|FG002|Treatment Phase|Withdrawal by Subject|0|||
124834506|NCT02658890|449023597|FG003|Treatment Phase|Withdrawal by Subject|0|||
124834507|NCT02658890|449023598|FG004|Treatment Phase|Withdrawal by Subject|0|||
124834508|NCT02658890|449023599|FG005|Treatment Phase|Withdrawal by Subject|0|||
124834509|NCT02658890|449023600|FG006|Treatment Phase|Withdrawal by Subject|1|||
124834510|NCT02658890|449023601|FG007|Treatment Phase|Withdrawal by Subject|0|||
124834511|NCT02658890|449023602|FG008|Treatment Phase|Withdrawal by Subject|0|||
124834512|NCT02658890|449023603|FG009|Treatment Phase|Withdrawal by Subject|1|||
124834513|NCT02658890|449023604|FG010|Treatment Phase|Withdrawal by Subject|0|||
124834514|NCT02658890|449023605|FG011|Treatment Phase|Withdrawal by Subject|0|||
124834515|NCT02658890|449023606|FG012|Treatment Phase|Withdrawal by Subject|1|||
124834516|NCT02658890|449023607|FG013|Treatment Phase|Withdrawal by Subject|3|||
124834517|NCT02658890|449023608|FG014|Treatment Phase|Withdrawal by Subject|0|||
124834518|NCT02658890|449023609|FG015|Treatment Phase|Withdrawal by Subject|0|||
124834519|NCT02658890|449023610|FG016|Treatment Phase|Withdrawal by Subject|1|||
124834520|NCT02658890|449023611|FG017|Treatment Phase|Withdrawal by Subject|0|||
124834521|NCT02658890|449023612|FG018|Treatment Phase|Withdrawal by Subject|4|||
124834522|NCT02658890|449023613|FG019|Treatment Phase|Withdrawal by Subject|3|||
124834523|NCT02658890|449023614|FG020|Treatment Phase|Withdrawal by Subject|0|||
124834524|NCT02658890|449023615|FG021|Treatment Phase|Withdrawal by Subject|4|||
124834525|NCT02658890|449023616|FG022|Treatment Phase|Withdrawal by Subject|1|||
124834526|NCT02658890|449023617|FG023|Treatment Phase|Withdrawal by Subject|1|||
124834527|NCT02658890|449023618|FG024|Treatment Phase|Withdrawal by Subject|0|||
124834528|NCT02658890|449023619|FG025|Treatment Phase|Withdrawal by Subject|0|||
124834529|NCT02658890|449023620|FG026|Treatment Phase|Withdrawal by Subject|0|||
124834530|NCT02474199|449023621|FG000|Overall Study|Lost to Follow-up|1|||
124834531|NCT02474199|449023622|FG001|Overall Study|Lost to Follow-up|0|||
124834532|NCT02474199|449023623|FG002|Overall Study|Lost to Follow-up|0|||
124834533|NCT02474199|449023624|FG003|Overall Study|Lost to Follow-up|0|||
124834534|NCT02474199|449023621|FG000|Overall Study|Withdrawal by Subject|1|||
124834535|NCT02474199|449023622|FG001|Overall Study|Withdrawal by Subject|2|||
124834536|NCT02474199|449023623|FG002|Overall Study|Withdrawal by Subject|0|||
124834537|NCT02474199|449023624|FG003|Overall Study|Withdrawal by Subject|1|||
124834538|NCT02474199|449023621|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
124834539|NCT02474199|449023622|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
124834540|NCT02474199|449023623|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
124834541|NCT02474199|449023624|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
124834542|NCT02474199|449023621|FG000|Overall Study|Did not meet eligibility criteria|0|||
124834543|NCT02474199|449023622|FG001|Overall Study|Did not meet eligibility criteria|0|||
124834544|NCT02474199|449023623|FG002|Overall Study|Did not meet eligibility criteria|2|||
124834545|NCT02474199|449023624|FG003|Overall Study|Did not meet eligibility criteria|2|||
124834546|NCT00952341|449023626|FG000|Cycle 1|Adverse Event|4|||
124834547|NCT00952341|449023627|FG001|Cycle 1|Adverse Event|1|||
124834548|NCT00952341|449023626|FG000|Cycle 1|Withdrawal by Subject|3|||
124834549|NCT00952341|449023627|FG001|Cycle 1|Withdrawal by Subject|8|||
124834550|NCT00952341|449023626|FG000|Cycle 1|Protocol Violation|2|||
124834551|NCT00952341|449023627|FG001|Cycle 1|Protocol Violation|1|||
124834552|NCT00952341|449023626|FG000|Cycle 1|Lost to Follow-up|11|||
124834553|NCT00952341|449023627|FG001|Cycle 1|Lost to Follow-up|2|||
124834554|NCT00952341|449023626|FG000|Cycle 1|Physician Decision|0|||
124834555|NCT00952341|449023627|FG001|Cycle 1|Physician Decision|1|||
124834556|NCT00952341|449023626|FG000|Cycle 2|Withdrawal by Subject|1|||
124834557|NCT00952341|449023627|FG001|Cycle 2|Withdrawal by Subject|1|||
124834558|NCT00952341|449023626|FG000|Cycle 2|Protocol Violation|1|||
124834559|NCT00952341|449023627|FG001|Cycle 2|Protocol Violation|0|||
124834560|NCT00952341|449023626|FG000|Cycle 2|Lost to Follow-up|6|||
124639378|NCT03307252|448296593|FG006|Part 2, Period 3|Other than listed|0|||
124639379|NCT03307252|448296594|FG007|Part 2, Period 3|Other than listed|0|||
124834561|NCT00952341|449023627|FG001|Cycle 2|Lost to Follow-up|9|||
124834562|NCT00952341|449023626|FG000|Cycle 2|Physician Decision|1|||
124834563|NCT00952341|449023627|FG001|Cycle 2|Physician Decision|1|||
124834564|NCT00952341|449023626|FG000|Cycle 2|Progressive Disease|0|||
124834565|NCT00952341|449023627|FG001|Cycle 2|Progressive Disease|1|||
124834566|NCT02419742|449023634|FG000|Overall Study|Adverse Event|2|||
124834567|NCT02419742|449023635|FG001|Overall Study|Adverse Event|0|||
124834568|NCT02419742|449023634|FG000|Overall Study|Disease Progression|0|||
124834569|NCT02419742|449023635|FG001|Overall Study|Disease Progression|1|||
124834570|NCT02419742|449023634|FG000|Overall Study|Withdrew Consent|2|||
124834571|NCT02419742|449023635|FG001|Overall Study|Withdrew Consent|1|||
124834572|NCT02419742|449023634|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
124834573|NCT02419742|449023635|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
124834574|NCT03340025|449023638|FG000|Overall Study|Lost to Follow-up|2|||
124834575|NCT03340025|449023639|FG001|Overall Study|Lost to Follow-up|2|||
124834576|NCT03897179|449023642|FG000|Overall Study|Withdrawal by Subject|1|||
124834577|NCT00704535|449023643|FG000|Overall Study|Adverse Event|2|||
124834578|NCT00704535|449023643|FG000|Overall Study|Death|2|||
124834579|NCT00704535|449023643|FG000|Overall Study|Lost to Follow-up|8|||
124834580|NCT00704535|449023643|FG000|Overall Study|Protocol Violation|10|||
124834581|NCT00704535|449023643|FG000|Overall Study|Completed status not on Case Report Form|124|||
124834582|NCT01480076|449023644|FG000|Overall Study|Run-in Failure|52|||
124834583|NCT01480076|449023644|FG000|Overall Study|Adverse Event|39|||
124834584|NCT01480076|449023644|FG000|Overall Study|Death|2|||
124834585|NCT01480076|449023644|FG000|Overall Study|Disease Progression|5|||
124834586|NCT01480076|449023644|FG000|Overall Study|Non-compliance With Study Protocol|15|||
124834587|NCT01480076|449023644|FG000|Overall Study|Withdrawal by Subject|105|||
124834588|NCT01480076|449023644|FG000|Overall Study|Lost to Follow-up|7|||
124834589|NCT01480076|449023644|FG000|Overall Study|Investigator Decision|13|||
124834590|NCT01480076|449023644|FG000|Overall Study|Other|52|||
124834591|NCT02503332|449023645|FG000|Overall Study|Adverse Event|17|||
124834592|NCT02503332|449023646|FG001|Overall Study|Adverse Event|5|||
124834593|NCT02503332|449023647|FG002|Overall Study|Adverse Event|3|||
124834594|NCT02503332|449023648|FG003|Overall Study|Adverse Event|1|||
124834595|NCT02503332|449023645|FG000|Overall Study|Investigator's Decision|5|||
124834596|NCT02503332|449023646|FG001|Overall Study|Investigator's Decision|1|||
124834597|NCT02503332|449023647|FG002|Overall Study|Investigator's Decision|0|||
124834598|NCT02503332|449023648|FG003|Overall Study|Investigator's Decision|0|||
124834599|NCT02503332|449023645|FG000|Overall Study|Sponsor's Decision|1|||
124834600|NCT02503332|449023646|FG001|Overall Study|Sponsor's Decision|0|||
124834601|NCT02503332|449023647|FG002|Overall Study|Sponsor's Decision|0|||
124834602|NCT02503332|449023648|FG003|Overall Study|Sponsor's Decision|1|||
124834603|NCT02503332|449023645|FG000|Overall Study|Subject Request|6|||
124834604|NCT02503332|449023646|FG001|Overall Study|Subject Request|5|||
124834605|NCT02503332|449023647|FG002|Overall Study|Subject Request|2|||
124834606|NCT02503332|449023648|FG003|Overall Study|Subject Request|1|||
124834607|NCT02503332|449023645|FG000|Overall Study|Death|0|||
124834608|NCT02503332|449023646|FG001|Overall Study|Death|2|||
124834609|NCT02503332|449023647|FG002|Overall Study|Death|2|||
124834610|NCT02503332|449023648|FG003|Overall Study|Death|0|||
124834611|NCT02503332|449023645|FG000|Overall Study|Other|5|||
124834612|NCT02503332|449023646|FG001|Overall Study|Other|6|||
124834613|NCT02503332|449023647|FG002|Overall Study|Other|1|||
124834614|NCT02503332|449023648|FG003|Overall Study|Other|1|||
124834615|NCT01413360|449023649|FG000|Overall Study|Lost to Follow-up|2|||
124834616|NCT01413360|449023649|FG000|Overall Study|Adverse Event|1|||
124834617|NCT00909779|449023660|FG000|Overall Study|Adverse Event|53|||
124834618|NCT00909779|449023661|FG001|Overall Study|Adverse Event|55|||
124834619|NCT00909779|449023660|FG000|Overall Study|Lack of Efficacy|7|||
124834620|NCT00909779|449023661|FG001|Overall Study|Lack of Efficacy|4|||
124834621|NCT00909779|449023660|FG000|Overall Study|Lost to Follow-up|19|||
124834622|NCT00909779|449023661|FG001|Overall Study|Lost to Follow-up|15|||
124834623|NCT00909779|449023660|FG000|Overall Study|Physician Decision|8|||
124834624|NCT00909779|449023661|FG001|Overall Study|Physician Decision|2|||
124834625|NCT00909779|449023660|FG000|Overall Study|Protocol Violation|2|||
124834626|NCT00909779|449023661|FG001|Overall Study|Protocol Violation|5|||
124834627|NCT00909779|449023660|FG000|Overall Study|Withdrawal by Subject|116|||
124834628|NCT00909779|449023661|FG001|Overall Study|Withdrawal by Subject|80|||
124834629|NCT00909779|449023660|FG000|Overall Study|Site Ceasing Operation|2|||
124834630|NCT00909779|449023661|FG001|Overall Study|Site Ceasing Operation|2|||
124834631|NCT00909779|449023660|FG000|Overall Study|Medical Monitor Decision|1|||
124834632|NCT00909779|449023661|FG001|Overall Study|Medical Monitor Decision|0|||
124834633|NCT00909779|449023660|FG000|Overall Study|Noncompliance|1|||
124834634|NCT00909779|449023661|FG001|Overall Study|Noncompliance|1|||
124834635|NCT00909779|449023660|FG000|Overall Study|Randomized in error|1|||
124639380|NCT03307252|448296595|FG008|Part 2, Period 3|Other than listed|0|||
124639381|NCT03307252|448296596|FG009|Part 2, Period 3|Other than listed|0|||
124639382|NCT03307252|448296597|FG010|Part 2, Period 3|Other than listed|0|||
124834636|NCT00909779|449023661|FG001|Overall Study|Randomized in error|1|||
124834637|NCT02016482|449023664|FG000|Period A|Adverse Event|3|||
124834638|NCT02016482|449023665|FG001|Period A|Adverse Event|5|||
124834639|NCT02016482|449023664|FG000|Period A|Withdrawal by Subject|3|||
124834640|NCT02016482|449023665|FG001|Period A|Withdrawal by Subject|4|||
124834641|NCT02016482|449023664|FG000|Period A|Lost to Follow-up|3|||
124834642|NCT02016482|449023665|FG001|Period A|Lost to Follow-up|3|||
124834643|NCT02016482|449023664|FG000|Period A|Lack of Efficacy|2|||
124834644|NCT02016482|449023665|FG001|Period A|Lack of Efficacy|1|||
124834645|NCT02016482|449023664|FG000|Period A|Other|3|||
124834646|NCT02016482|449023665|FG001|Period A|Other|0|||
124834647|NCT02016482|449023664|FG000|Period A|Protocol Violation|0|||
124834648|NCT02016482|449023665|FG001|Period A|Protocol Violation|1|||
124834649|NCT02016482|449023664|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
124834650|NCT02016482|449023665|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
124834651|NCT02016482|449023664|FG000|Period B|Withdrawal by Subject|1|||
124834652|NCT02016482|449023665|FG001|Period B|Withdrawal by Subject|1|||
124834653|NCT02016482|449023664|FG000|Period B|Lost to Follow-up|2|||
124834654|NCT02016482|449023665|FG001|Period B|Lost to Follow-up|0|||
124834655|NCT02016482|449023664|FG000|Period B|Lack of Efficacy|6|||
124834656|NCT02016482|449023665|FG001|Period B|Lack of Efficacy|4|||
124834657|NCT02016482|449023664|FG000|Period B|Other|4|||
124834658|NCT02016482|449023665|FG001|Period B|Other|0|||
124834659|NCT02016482|449023664|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
124834660|NCT02016482|449023665|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
124834661|NCT02738333|449023667|FG000|Overall Study|Death|1|||
124834662|NCT02738333|449023668|FG001|Overall Study|Death|0|||
124834663|NCT02738333|449023669|FG002|Overall Study|Death|0|||
124834664|NCT02738333|449023667|FG000|Overall Study|Lost to Follow-up|1|||
124834665|NCT02738333|449023668|FG001|Overall Study|Lost to Follow-up|0|||
124834666|NCT02738333|449023669|FG002|Overall Study|Lost to Follow-up|0|||
124834667|NCT00949325|449023670|FG000|Overall Study|Adverse Event|0|||
124834668|NCT00949325|449023671|FG001|Overall Study|Adverse Event|2|||
124834669|NCT00949325|449023672|FG002|Overall Study|Adverse Event|0|||
124834670|NCT00791518|449023673|FG000|Overall Study|Protocol Violation|93|||
124834671|NCT01520363|449023674|FG000|Overall Study|Withdrawal by Subject|2|||
124834672|NCT01520363|449023675|FG001|Overall Study|Withdrawal by Subject|0|||
124834673|NCT01498952|449023679|FG000|Overall Study|Death|2|||
124834674|NCT01498952|449023680|FG001|Overall Study|Death|2|||
124834675|NCT01498952|449023681|FG002|Overall Study|Death|0|||
124834676|NCT01498952|449023682|FG003|Overall Study|Death|0|||
124834677|NCT01498952|449023683|FG004|Overall Study|Death|0|||
124834678|NCT00579826|449023684|FG000|Overall Study|Withdrawal by Subject|5|||
124834679|NCT00579826|449023685|FG001|Overall Study|Withdrawal by Subject|3|||
124834680|NCT00454987|449023686|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
124834681|NCT00454987|449023687|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
124834682|NCT00454987|449023688|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
124834683|NCT00454987|449023686|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
124834684|NCT00454987|449023687|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
124834685|NCT00454987|449023688|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
124834686|NCT00454987|449023686|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
124834687|NCT00454987|449023687|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
124834688|NCT00454987|449023688|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
124834689|NCT02073279|449023696|FG000|Double-blind Period|Adverse Event|1|||
124834690|NCT02073279|449023697|FG001|Double-blind Period|Adverse Event|1|||
124834691|NCT02073279|449023696|FG000|Double-blind Period|Switched to another treatment|1|||
124834692|NCT02073279|449023697|FG001|Double-blind Period|Switched to another treatment|2|||
124834693|NCT02073279|449023696|FG000|Double-blind Period|Protocol Violation|0|||
124834694|NCT02073279|449023697|FG001|Double-blind Period|Protocol Violation|1|||
124834695|NCT02073279|449023696|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
124834696|NCT02073279|449023697|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
124834697|NCT02073279|449023696|FG000|Double-blind Period|Withdrawal by Subject|2|||
124834698|NCT02073279|449023697|FG001|Double-blind Period|Withdrawal by Subject|2|||
124834699|NCT02073279|449023696|FG000|Open-label Extension Period|Adverse Event|1|||
124834700|NCT02073279|449023697|FG001|Open-label Extension Period|Adverse Event|0|||
124834701|NCT02073279|449023696|FG000|Open-label Extension Period|Lack of Efficacy|1|||
124834702|NCT02073279|449023697|FG001|Open-label Extension Period|Lack of Efficacy|0|||
124834703|NCT02073279|449023696|FG000|Open-label Extension Period|Lost to Follow-up|0|||
124834704|NCT02073279|449023697|FG001|Open-label Extension Period|Lost to Follow-up|4|||
124834705|NCT02073279|449023696|FG000|Open-label Extension Period|Switched to another treatment|1|||
124834706|NCT02073279|449023697|FG001|Open-label Extension Period|Switched to another treatment|4|||
124834707|NCT02073279|449023696|FG000|Open-label Extension Period|Protocol Violation|0|||
124834708|NCT02073279|449023697|FG001|Open-label Extension Period|Protocol Violation|1|||
124834709|NCT02073279|449023696|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
124834710|NCT02073279|449023697|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
124834711|NCT02073279|449023696|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
124834712|NCT02073279|449023697|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
124834713|NCT00304356|449023698|FG000|Nitazoxanide|Physician Decision|5|||
124834714|NCT00304356|449023698|FG000|Nitazoxanide|Physician Decision|1|||
124834715|NCT00304356|449023698|FG000|Nitazoxanide|number is 0|1|||
124834716|NCT00304356|449023698|FG000|Nitazoxanide|Physician Decision|1|||
124834717|NCT00304356|449023698|FG000|Nitazoxanide|Physician Decision|1|||
124834718|NCT00304356|449023698|FG000|Nitazoxanide|Physician Decision|1|||
124834719|NCT03082599|449023700|FG000|Overall Study|Lost to Follow-up|1|||
124834720|NCT03082599|449023701|FG001|Overall Study|Lost to Follow-up|0|||
124834721|NCT00729183|449023702|FG000|Overall Study|Adverse Event|11|||
124834722|NCT00729183|449023703|FG001|Overall Study|Adverse Event|5|||
124834723|NCT00729183|449023702|FG000|Overall Study|Lack of Efficacy|0|||
124834724|NCT00729183|449023703|FG001|Overall Study|Lack of Efficacy|1|||
124834725|NCT00729183|449023702|FG000|Overall Study|Lost to Follow-up|3|||
124834726|NCT00729183|449023703|FG001|Overall Study|Lost to Follow-up|1|||
124834727|NCT00729183|449023702|FG000|Overall Study|Physician Decision|1|||
124834728|NCT00729183|449023703|FG001|Overall Study|Physician Decision|1|||
124834729|NCT00729183|449023702|FG000|Overall Study|Protocol Violation|1|||
124834730|NCT00729183|449023703|FG001|Overall Study|Protocol Violation|0|||
124834731|NCT00729183|449023702|FG000|Overall Study|Withdrawal by Subject|9|||
124834732|NCT00729183|449023703|FG001|Overall Study|Withdrawal by Subject|7|||
124834733|NCT00323115|449023706|FG000|Vaccine Administration|Adverse Event|1|||
124834734|NCT00323115|449023706|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
124834735|NCT01502423|449023708|FG000|Overall Study|Withdrawal by Subject|0|||
124834736|NCT01502423|449023709|FG001|Overall Study|Withdrawal by Subject|1|||
124834737|NCT00567892|449023710|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
124834738|NCT00567892|449023711|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
124834739|NCT00567892|449023712|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
124834740|NCT00567892|449023713|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
124834741|NCT00567892|449023710|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
124834742|NCT00567892|449023711|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
124834743|NCT00567892|449023712|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
124834744|NCT00567892|449023713|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
124834745|NCT00004888|449025511|FG000|Overall Study|Adverse Event|5|||
124834746|NCT00004888|449025512|FG001|Overall Study|Adverse Event|10|||
124834747|NCT00004888|449025511|FG000|Overall Study|Withdrawal by Subject|0|||
124834748|NCT00004888|449025512|FG001|Overall Study|Withdrawal by Subject|3|||
124834749|NCT00004888|449025511|FG000|Overall Study|Physician Decision|1|||
124834750|NCT00004888|449025512|FG001|Overall Study|Physician Decision|1|||
124834751|NCT00004888|449025511|FG000|Overall Study|Progressive Disease|4|||
124834752|NCT00004888|449025512|FG001|Overall Study|Progressive Disease|9|||
124834753|NCT00004888|449025511|FG000|Overall Study|Death without progressive disease|0|||
124834754|NCT00004888|449025512|FG001|Overall Study|Death without progressive disease|1|||
124834755|NCT00004888|449025511|FG000|Overall Study|Toxic death|1|||
124834756|NCT00004888|449025512|FG001|Overall Study|Toxic death|0|||
124834757|NCT02579265|449025513|FG000|Overall Study|Weaned off earlier than 28 days|44|||
124834758|NCT02579265|449025514|FG001|Overall Study|Weaned off earlier than 28 days|43|||
124834759|NCT02579265|449025513|FG000|Overall Study|Adverse Event|2|||
124834760|NCT02579265|449025514|FG001|Overall Study|Adverse Event|0|||
124834761|NCT02579265|449025513|FG000|Overall Study|Any other reason not specified|0|||
124834762|NCT02579265|449025514|FG001|Overall Study|Any other reason not specified|2|||
124834763|NCT02579265|449025513|FG000|Overall Study|Withdrawal by Subject|2|||
124834764|NCT02579265|449025514|FG001|Overall Study|Withdrawal by Subject|0|||
124834765|NCT02579265|449025513|FG000|Overall Study|Physician Decision|1|||
124834766|NCT02579265|449025514|FG001|Overall Study|Physician Decision|0|||
124834767|NCT02579265|449025513|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
124834768|NCT02579265|449025514|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
124834769|NCT02174848|449025518|FG000|Overall Study|Adverse Event|2|||
124834770|NCT02174848|449025519|FG001|Overall Study|Adverse Event|1|||
124834771|NCT02174848|449025518|FG000|Overall Study|Withdrawal by Subject|3|||
124834772|NCT02174848|449025519|FG001|Overall Study|Withdrawal by Subject|3|||
124834773|NCT02174848|449025518|FG000|Overall Study|Lost to Follow-up|0|||
124834774|NCT02174848|449025519|FG001|Overall Study|Lost to Follow-up|1|||
124834775|NCT02174848|449025518|FG000|Overall Study|Worsening of disease|1|||
124834776|NCT02174848|449025519|FG001|Overall Study|Worsening of disease|1|||
124834777|NCT02174848|449025518|FG000|Overall Study|Unable to comply with study requirements|1|||
124834778|NCT02174848|449025519|FG001|Overall Study|Unable to comply with study requirements|0|||
124834779|NCT00644969|449025520|FG000|Treatment Phase|Randomized, not treated|1|||
124834780|NCT00644969|449025521|FG001|Treatment Phase|Randomized, not treated|0|||
124834781|NCT00644969|449025520|FG000|Treatment Phase|Adverse Event|3|||
124834782|NCT00644969|449025521|FG001|Treatment Phase|Adverse Event|0|||
124834783|NCT00644969|449025520|FG000|Treatment Phase|Withdrawal by Subject|4|||
124834784|NCT00644969|449025521|FG001|Treatment Phase|Withdrawal by Subject|0|||
124834785|NCT00644969|449025520|FG000|Treatment Phase|Lost to Follow-up|2|||
124834786|NCT00644969|449025521|FG001|Treatment Phase|Lost to Follow-up|2|||
124834787|NCT00644969|449025520|FG000|Treatment Phase|Other|4|||
124834788|NCT00644969|449025521|FG001|Treatment Phase|Other|1|||
124834789|NCT00644969|449025520|FG000|Post Treatment Phase|Death|1|||
124834790|NCT00644969|449025521|FG001|Post Treatment Phase|Death|0|||
124834791|NCT00644969|449025520|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
124834792|NCT00644969|449025521|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
124834793|NCT00644969|449025520|FG000|Post Treatment Phase|Lost to Follow-up|4|||
124834794|NCT00644969|449025521|FG001|Post Treatment Phase|Lost to Follow-up|1|||
124834795|NCT00644969|449025520|FG000|Post Treatment Phase|Other|1|||
124834796|NCT00644969|449025521|FG001|Post Treatment Phase|Other|0|||
124834797|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
124834798|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
124834799|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
124834800|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
124834801|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
124834802|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
124834803|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
124834804|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
124834805|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
124834806|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
124834807|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
124834808|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
124834809|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
124834810|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
124834811|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
124834812|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
124834813|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
124834814|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
124834815|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
124834816|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
124834817|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
124834818|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
124834819|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
124834820|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
124834821|NCT00277212|449025522|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
124834822|NCT00277212|449025523|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
124834823|NCT00277212|449025524|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
124834824|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
124834825|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
124834826|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
124834827|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
124834828|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
124834829|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
124834830|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
124834831|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
124834832|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
124834833|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
124834834|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
124834835|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
124834836|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
124834837|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
124834838|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
124834839|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
124834840|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
124834841|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
124834842|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
124834843|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
124834844|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
124834845|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
124834846|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
124834847|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
124834848|NCT00277212|449025522|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
124834849|NCT00277212|449025523|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
124834850|NCT00277212|449025524|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
124834851|NCT03336216|449025525|FG000|Randomization|Not reported|2|||
124834852|NCT03336216|449025526|FG001|Randomization|Not reported|0|||
124834853|NCT03336216|449025527|FG002|Randomization|Not reported|1|||
124834854|NCT03336216|449025528|FG003|Randomization|Not reported|0|||
124834855|NCT03336216|449025525|FG000|Randomization|Other reasons|1|||
124834856|NCT03336216|449025526|FG001|Randomization|Other reasons|1|||
124834857|NCT03336216|449025527|FG002|Randomization|Other reasons|1|||
124834858|NCT03336216|449025528|FG003|Randomization|Other reasons|0|||
124834859|NCT03336216|449025525|FG000|Randomization|Participant no longer meets study criteria|0|||
124834860|NCT03336216|449025526|FG001|Randomization|Participant no longer meets study criteria|2|||
124639383|NCT03307252|448296587|FG000|Part 2, Period 4|Other than listed|0|||
124834861|NCT03336216|449025527|FG002|Randomization|Participant no longer meets study criteria|4|||
124639384|NCT03307252|448296588|FG001|Part 2, Period 4|Other than listed|0|||
124834862|NCT03336216|449025528|FG003|Randomization|Participant no longer meets study criteria|1|||
124834863|NCT03336216|449025525|FG000|Randomization|Lost to Follow-up|1|||
124834864|NCT03336216|449025526|FG001|Randomization|Lost to Follow-up|0|||
124834865|NCT03336216|449025527|FG002|Randomization|Lost to Follow-up|0|||
124834866|NCT03336216|449025528|FG003|Randomization|Lost to Follow-up|0|||
124834867|NCT03336216|449025525|FG000|Randomization|Participant withdrew consent|9|||
124834868|NCT03336216|449025526|FG001|Randomization|Participant withdrew consent|1|||
124834869|NCT03336216|449025527|FG002|Randomization|Participant withdrew consent|0|||
124834870|NCT03336216|449025528|FG003|Randomization|Participant withdrew consent|0|||
124834871|NCT03336216|449025525|FG000|Randomization|Adverse Event|1|||
124834872|NCT03336216|449025526|FG001|Randomization|Adverse Event|1|||
124834873|NCT03336216|449025527|FG002|Randomization|Adverse Event|0|||
124834874|NCT03336216|449025528|FG003|Randomization|Adverse Event|0|||
124834875|NCT03336216|449025525|FG000|Treatment|Adverse Event|2|||
124834876|NCT03336216|449025526|FG001|Treatment|Adverse Event|3|||
124834877|NCT03336216|449025527|FG002|Treatment|Adverse Event|4|||
124834878|NCT03336216|449025528|FG003|Treatment|Adverse Event|4|||
124834879|NCT03336216|449025525|FG000|Treatment|Participant request to discontinue treatment|2|||
124834880|NCT03336216|449025526|FG001|Treatment|Participant request to discontinue treatment|1|||
124834881|NCT03336216|449025527|FG002|Treatment|Participant request to discontinue treatment|2|||
124834882|NCT03336216|449025528|FG003|Treatment|Participant request to discontinue treatment|2|||
124834883|NCT03336216|449025525|FG000|Treatment|Participant withdrew consent|7|||
124834884|NCT03336216|449025526|FG001|Treatment|Participant withdrew consent|2|||
124834885|NCT03336216|449025527|FG002|Treatment|Participant withdrew consent|3|||
124834886|NCT03336216|449025528|FG003|Treatment|Participant withdrew consent|2|||
124834887|NCT03336216|449025525|FG000|Treatment|Death|2|||
124834888|NCT03336216|449025526|FG001|Treatment|Death|3|||
124834889|NCT03336216|449025527|FG002|Treatment|Death|3|||
124834890|NCT03336216|449025528|FG003|Treatment|Death|4|||
124834891|NCT03336216|449025525|FG000|Treatment|Participant no longer meets study criteria|0|||
124834892|NCT03336216|449025526|FG001|Treatment|Participant no longer meets study criteria|1|||
124834893|NCT03336216|449025527|FG002|Treatment|Participant no longer meets study criteria|0|||
124834894|NCT03336216|449025528|FG003|Treatment|Participant no longer meets study criteria|0|||
124834895|NCT03336216|449025525|FG000|Treatment|Other reasons|2|||
124834896|NCT03336216|449025526|FG001|Treatment|Other reasons|0|||
124834897|NCT03336216|449025527|FG002|Treatment|Other reasons|0|||
124834898|NCT03336216|449025528|FG003|Treatment|Other reasons|3|||
124834899|NCT03336216|449025525|FG000|Treatment|Disease progression|23|||
124834900|NCT03336216|449025526|FG001|Treatment|Disease progression|34|||
124834901|NCT03336216|449025527|FG002|Treatment|Disease progression|33|||
124834902|NCT03336216|449025528|FG003|Treatment|Disease progression|26|||
124834903|NCT03336216|449025525|FG000|Treatment|Study drug toxicity|0|||
124834904|NCT03336216|449025526|FG001|Treatment|Study drug toxicity|3|||
124834905|NCT03336216|449025527|FG002|Treatment|Study drug toxicity|2|||
124834906|NCT03336216|449025528|FG003|Treatment|Study drug toxicity|0|||
124834907|NCT03336216|449025525|FG000|Treatment|Adverse Event unrelated to study drug|1|||
124834908|NCT03336216|449025526|FG001|Treatment|Adverse Event unrelated to study drug|1|||
124834909|NCT03336216|449025527|FG002|Treatment|Adverse Event unrelated to study drug|1|||
124834910|NCT03336216|449025528|FG003|Treatment|Adverse Event unrelated to study drug|0|||
124834911|NCT03336216|449025525|FG000|Treatment|Disease Recurrence|1|||
124834912|NCT03336216|449025526|FG001|Treatment|Disease Recurrence|0|||
124834913|NCT03336216|449025527|FG002|Treatment|Disease Recurrence|0|||
124834914|NCT03336216|449025528|FG003|Treatment|Disease Recurrence|0|||
124834915|NCT01023581|449025534|FG000|Overall Study|Adverse Event|4|||
124834916|NCT01023581|449025535|FG001|Overall Study|Adverse Event|4|||
124834917|NCT01023581|449025536|FG002|Overall Study|Adverse Event|7|||
124834918|NCT01023581|449025537|FG003|Overall Study|Adverse Event|3|||
124834919|NCT01023581|449025538|FG004|Overall Study|Adverse Event|2|||
124834920|NCT01023581|449025539|FG005|Overall Study|Adverse Event|5|||
124834921|NCT01023581|449025540|FG006|Overall Study|Adverse Event|11|||
124834922|NCT01023581|449025534|FG000|Overall Study|Major protocol deviation|2|||
124834923|NCT01023581|449025535|FG001|Overall Study|Major protocol deviation|0|||
124834924|NCT01023581|449025536|FG002|Overall Study|Major protocol deviation|3|||
124834925|NCT01023581|449025537|FG003|Overall Study|Major protocol deviation|0|||
124834926|NCT01023581|449025538|FG004|Overall Study|Major protocol deviation|0|||
124834927|NCT01023581|449025539|FG005|Overall Study|Major protocol deviation|0|||
124834928|NCT01023581|449025540|FG006|Overall Study|Major protocol deviation|0|||
124834929|NCT01023581|449025534|FG000|Overall Study|Lost to Follow-up|4|||
124834930|NCT01023581|449025535|FG001|Overall Study|Lost to Follow-up|8|||
124834931|NCT01023581|449025536|FG002|Overall Study|Lost to Follow-up|7|||
124834932|NCT01023581|449025537|FG003|Overall Study|Lost to Follow-up|2|||
124834933|NCT01023581|449025538|FG004|Overall Study|Lost to Follow-up|5|||
124834934|NCT01023581|449025539|FG005|Overall Study|Lost to Follow-up|2|||
124834935|NCT01023581|449025540|FG006|Overall Study|Lost to Follow-up|2|||
124834936|NCT01023581|449025534|FG000|Overall Study|Withdrawal by Subject|13|||
124834937|NCT01023581|449025535|FG001|Overall Study|Withdrawal by Subject|8|||
124834938|NCT01023581|449025536|FG002|Overall Study|Withdrawal by Subject|16|||
124834939|NCT01023581|449025537|FG003|Overall Study|Withdrawal by Subject|10|||
124834940|NCT01023581|449025538|FG004|Overall Study|Withdrawal by Subject|6|||
124834941|NCT01023581|449025539|FG005|Overall Study|Withdrawal by Subject|8|||
124834942|NCT01023581|449025540|FG006|Overall Study|Withdrawal by Subject|5|||
124834943|NCT01023581|449025534|FG000|Overall Study|Pregnancy|0|||
124834944|NCT01023581|449025535|FG001|Overall Study|Pregnancy|0|||
124834945|NCT01023581|449025536|FG002|Overall Study|Pregnancy|0|||
124834946|NCT01023581|449025537|FG003|Overall Study|Pregnancy|2|||
124834947|NCT01023581|449025538|FG004|Overall Study|Pregnancy|0|||
124834948|NCT01023581|449025539|FG005|Overall Study|Pregnancy|1|||
124834949|NCT01023581|449025540|FG006|Overall Study|Pregnancy|0|||
124834950|NCT01023581|449025534|FG000|Overall Study|Lack of Efficacy|9|||
124834951|NCT01023581|449025535|FG001|Overall Study|Lack of Efficacy|3|||
124834952|NCT01023581|449025536|FG002|Overall Study|Lack of Efficacy|6|||
124834953|NCT01023581|449025537|FG003|Overall Study|Lack of Efficacy|2|||
124834954|NCT01023581|449025538|FG004|Overall Study|Lack of Efficacy|1|||
124834955|NCT01023581|449025539|FG005|Overall Study|Lack of Efficacy|2|||
124834956|NCT01023581|449025540|FG006|Overall Study|Lack of Efficacy|1|||
124834957|NCT01023581|449025534|FG000|Overall Study|Physician Decision|2|||
124834958|NCT01023581|449025535|FG001|Overall Study|Physician Decision|0|||
124834959|NCT01023581|449025536|FG002|Overall Study|Physician Decision|2|||
124834960|NCT01023581|449025537|FG003|Overall Study|Physician Decision|1|||
124834961|NCT01023581|449025538|FG004|Overall Study|Physician Decision|1|||
124834962|NCT01023581|449025539|FG005|Overall Study|Physician Decision|1|||
124834963|NCT01023581|449025540|FG006|Overall Study|Physician Decision|1|||
124834964|NCT01023581|449025534|FG000|Overall Study|Other|1|||
124834965|NCT01023581|449025535|FG001|Overall Study|Other|0|||
124834966|NCT01023581|449025536|FG002|Overall Study|Other|1|||
124834967|NCT01023581|449025537|FG003|Overall Study|Other|0|||
124834968|NCT01023581|449025538|FG004|Overall Study|Other|1|||
124834969|NCT01023581|449025539|FG005|Overall Study|Other|0|||
124834970|NCT01023581|449025540|FG006|Overall Study|Other|0|||
124834971|NCT01231581|449025541|FG000|Overall Study|Lost to Follow-up|2|||
124834972|NCT01231581|449025542|FG001|Overall Study|Lost to Follow-up|2|||
124834973|NCT01231581|449025541|FG000|Overall Study|Withdrawal by Subject|6|||
124834974|NCT01231581|449025542|FG001|Overall Study|Withdrawal by Subject|9|||
124834975|NCT01231581|449025541|FG000|Overall Study|Study Closed/Terminated|6|||
124834976|NCT01231581|449025542|FG001|Overall Study|Study Closed/Terminated|5|||
124834977|NCT01231581|449025541|FG000|Overall Study|Death|65|||
124834978|NCT01231581|449025542|FG001|Overall Study|Death|64|||
124834979|NCT01231581|449025541|FG000|Overall Study|Ongoing|1|||
124834980|NCT01231581|449025542|FG001|Overall Study|Ongoing|0|||
124834981|NCT02510794|449025543|FG000|Overall Study|Adverse Event|0|||
124834982|NCT02510794|449025544|FG001|Overall Study|Adverse Event|1|||
124834983|NCT02510794|449025545|FG002|Overall Study|Adverse Event|0|||
124834984|NCT02510794|449025546|FG003|Overall Study|Adverse Event|0|||
124834985|NCT02510794|449025543|FG000|Overall Study|Death|1|||
124834986|NCT02510794|449025544|FG001|Overall Study|Death|2|||
124834987|NCT02510794|449025545|FG002|Overall Study|Death|1|||
124834988|NCT02510794|449025546|FG003|Overall Study|Death|1|||
124834989|NCT02510794|449025543|FG000|Overall Study|Lack of Efficacy|3|||
124834990|NCT02510794|449025544|FG001|Overall Study|Lack of Efficacy|1|||
124834991|NCT02510794|449025545|FG002|Overall Study|Lack of Efficacy|1|||
124834992|NCT02510794|449025546|FG003|Overall Study|Lack of Efficacy|0|||
124834993|NCT02510794|449025543|FG000|Overall Study|Participant moved out of the area|0|||
124834994|NCT02510794|449025544|FG001|Overall Study|Participant moved out of the area|0|||
124834995|NCT02510794|449025545|FG002|Overall Study|Participant moved out of the area|0|||
124834996|NCT02510794|449025546|FG003|Overall Study|Participant moved out of the area|1|||
124834997|NCT02510794|449025543|FG000|Overall Study|Physician Decision|3|||
124834998|NCT02510794|449025544|FG001|Overall Study|Physician Decision|0|||
124834999|NCT02510794|449025545|FG002|Overall Study|Physician Decision|0|||
124835000|NCT02510794|449025546|FG003|Overall Study|Physician Decision|0|||
124835001|NCT02510794|449025543|FG000|Overall Study|Protocol Violation|0|||
124835002|NCT02510794|449025544|FG001|Overall Study|Protocol Violation|0|||
124835003|NCT02510794|449025545|FG002|Overall Study|Protocol Violation|1|||
124835004|NCT02510794|449025546|FG003|Overall Study|Protocol Violation|0|||
124835005|NCT02510794|449025543|FG000|Overall Study|Withdrawal by Subject|1|||
124835006|NCT02510794|449025544|FG001|Overall Study|Withdrawal by Subject|2|||
124835007|NCT02510794|449025545|FG002|Overall Study|Withdrawal by Subject|4|||
124639385|NCT03307252|448296589|FG002|Part 2, Period 4|Other than listed|0|||
124639386|NCT03307252|448296590|FG003|Part 2, Period 4|Other than listed|0|||
124639387|NCT03307252|448296591|FG004|Part 2, Period 4|Other than listed|0|||
124835008|NCT02510794|449025546|FG003|Overall Study|Withdrawal by Subject|3|||
124835009|NCT03090100|449025547|FG000|Overall Study|Adverse Event|9|||
124835010|NCT03090100|449025548|FG001|Overall Study|Adverse Event|11|||
124835011|NCT03090100|449025547|FG000|Overall Study|Pregnancy|1|||
124835012|NCT03090100|449025548|FG001|Overall Study|Pregnancy|1|||
124835013|NCT03090100|449025547|FG000|Overall Study|Lack of Efficacy|2|||
124835014|NCT03090100|449025548|FG001|Overall Study|Lack of Efficacy|7|||
124835015|NCT03090100|449025547|FG000|Overall Study|Lost to Follow-up|2|||
124835016|NCT03090100|449025548|FG001|Overall Study|Lost to Follow-up|2|||
124835017|NCT03090100|449025547|FG000|Overall Study|Withdrawal by Subject|7|||
124835018|NCT03090100|449025548|FG001|Overall Study|Withdrawal by Subject|19|||
124835019|NCT03090100|449025547|FG000|Overall Study|Protocol Violation|2|||
124835020|NCT03090100|449025548|FG001|Overall Study|Protocol Violation|6|||
124835021|NCT03090100|449025547|FG000|Overall Study|Non-compliance|2|||
124835022|NCT03090100|449025548|FG001|Overall Study|Non-compliance|0|||
124835023|NCT03090100|449025547|FG000|Overall Study|Other|2|||
124835024|NCT03090100|449025548|FG001|Overall Study|Other|2|||
124835025|NCT03253848|449025549|FG000|Overall Study|Adverse Event|7|||
124835026|NCT03253848|449025549|FG000|Overall Study|Death|5|||
124835027|NCT03253848|449025549|FG000|Overall Study|initiation of other treatments|3|||
124835028|NCT03253848|449025549|FG000|Overall Study|Other complicating disease|1|||
124835029|NCT03253848|449025549|FG000|Overall Study|Withdrawal by Subject|1|||
124835030|NCT03253848|449025549|FG000|Overall Study|Declining health|1|||
124835031|NCT05352815|449025550|FG000|Overall Study|Withdrawal by Subject|28|||
124835032|NCT05352815|449025551|FG001|Overall Study|Withdrawal by Subject|24|||
124835033|NCT05352815|449025550|FG000|Overall Study|Lost to Follow-up|4|||
124835034|NCT05352815|449025551|FG001|Overall Study|Lost to Follow-up|7|||
124835035|NCT05352815|449025550|FG000|Overall Study|Death|2|||
124835036|NCT05352815|449025551|FG001|Overall Study|Death|3|||
124835037|NCT05352815|449025550|FG000|Overall Study|Site closure|1|||
124835038|NCT05352815|449025551|FG001|Overall Study|Site closure|0|||
124835039|NCT02759120|449025552|FG000|Overall Study|Death|34|||
124835040|NCT02759120|449025553|FG001|Overall Study|Death|36|||
124835041|NCT02759120|449025552|FG000|Overall Study|Lost to Follow-up|4|||
124835042|NCT02759120|449025553|FG001|Overall Study|Lost to Follow-up|7|||
124835043|NCT02759120|449025552|FG000|Overall Study|Physician Decision|3|||
124835044|NCT02759120|449025553|FG001|Overall Study|Physician Decision|0|||
124835045|NCT02759120|449025552|FG000|Overall Study|Withdrawal by Subject|28|||
124835046|NCT02759120|449025553|FG001|Overall Study|Withdrawal by Subject|15|||
124835047|NCT02759120|449025552|FG000|Overall Study|Moved out of area|3|||
124835048|NCT02759120|449025553|FG001|Overall Study|Moved out of area|4|||
124835049|NCT02759120|449025552|FG000|Overall Study|Lung transplant|3|||
124835050|NCT02759120|449025553|FG001|Overall Study|Lung transplant|5|||
124835051|NCT02759120|449025552|FG000|Overall Study|Other reason not completed|10|||
124835052|NCT02759120|449025553|FG001|Overall Study|Other reason not completed|12|||
124835053|NCT04461015|449025555|FG000|Overall Study|IV access lost during the study|0|||
124835054|NCT04461015|449025556|FG001|Overall Study|IV access lost during the study|1|||
124835055|NCT04461015|449025555|FG000|Overall Study|Withdrawal by Subject|0|||
124835056|NCT04461015|449025556|FG001|Overall Study|Withdrawal by Subject|1|||
124835057|NCT05071183|449025563|FG000|Overall Study|Death|1|||
124835058|NCT05071183|449025564|FG001|Overall Study|Death|2|||
124835059|NCT05071183|449025565|FG002|Overall Study|Death|0|||
124835060|NCT05071183|449025563|FG000|Overall Study|Other Reasons|1|||
124835061|NCT05071183|449025564|FG001|Overall Study|Other Reasons|3|||
124835062|NCT05071183|449025565|FG002|Overall Study|Other Reasons|2|||
124835063|NCT02532647|449025580|FG000|Overall Study|Did not receive trial medication|1|||
124835064|NCT02532647|449025581|FG001|Overall Study|Did not receive trial medication|0|||
124835065|NCT02532647|449025582|FG002|Overall Study|Did not receive trial medication|1|||
124835066|NCT02420691|449025589|FG000|Overall Study|Adverse Event|3|||
124835067|NCT02420691|449025589|FG000|Overall Study|Withdrawal by Subject|3|||
124835068|NCT00325754|449025592|FG000|Overall Study|Adverse Event|4|||
124835069|NCT00325754|449025593|FG001|Overall Study|Adverse Event|1|||
124835070|NCT02625090|449025602|FG000|Overall Study|Participant wants to be pregnant|2|||
124835071|NCT02625090|449025602|FG000|Overall Study|For the Promoter|1|||
124835072|NCT02625090|449025602|FG000|Overall Study|Sponsor's Decision|9|||
124835073|NCT02625090|449025602|FG000|Overall Study|Somnolence|1|||
124835074|NCT02625090|449025602|FG000|Overall Study|Study terminated by Sponsor|7|||
124835075|NCT02625090|449025602|FG000|Overall Study|Negative Benefit/Risk|1|||
124835076|NCT02625090|449025602|FG000|Overall Study|Protocol Deviation|2|||
124835077|NCT02625090|449025602|FG000|Overall Study|Lack of Efficacy|16|||
124835078|NCT02625090|449025602|FG000|Overall Study|Adverse Event|3|||
124835079|NCT02439320|449025603|FG000|Overall Study|Adverse Event|0|||
124835080|NCT02439320|449025604|FG001|Overall Study|Adverse Event|2|||
124835081|NCT02439320|449025605|FG002|Overall Study|Adverse Event|0|||
124835082|NCT02439320|449025603|FG000|Overall Study|Lost to Follow-up|37|||
124835083|NCT02439320|449025604|FG001|Overall Study|Lost to Follow-up|34|||
124639388|NCT03307252|448296592|FG005|Part 2, Period 4|Other than listed|0|||
124639389|NCT03307252|448296593|FG006|Part 2, Period 4|Other than listed|1|||
124639390|NCT03307252|448296594|FG007|Part 2, Period 4|Other than listed|0|||
124639391|NCT03307252|448296595|FG008|Part 2, Period 4|Other than listed|0|||
124639392|NCT03307252|448296596|FG009|Part 2, Period 4|Other than listed|0|||
124835084|NCT02439320|449025605|FG002|Overall Study|Lost to Follow-up|42|||
124835085|NCT02439320|449025603|FG000|Overall Study|Death|0|||
124835086|NCT02439320|449025604|FG001|Overall Study|Death|1|||
124835087|NCT02439320|449025605|FG002|Overall Study|Death|0|||
124835088|NCT02439320|449025603|FG000|Overall Study|Noncompliance with Protocol|10|||
124835089|NCT02439320|449025604|FG001|Overall Study|Noncompliance with Protocol|11|||
124835090|NCT02439320|449025605|FG002|Overall Study|Noncompliance with Protocol|7|||
124835091|NCT02439320|449025603|FG000|Overall Study|Pregnancy|0|||
124835092|NCT02439320|449025604|FG001|Overall Study|Pregnancy|1|||
124835093|NCT02439320|449025605|FG002|Overall Study|Pregnancy|1|||
124835094|NCT02439320|449025603|FG000|Overall Study|Withdrawal by Subject|12|||
124835095|NCT02439320|449025604|FG001|Overall Study|Withdrawal by Subject|16|||
124835096|NCT02439320|449025605|FG002|Overall Study|Withdrawal by Subject|14|||
124835097|NCT02439320|449025603|FG000|Overall Study|Physician Decision|2|||
124835098|NCT02439320|449025604|FG001|Overall Study|Physician Decision|1|||
124835099|NCT02439320|449025605|FG002|Overall Study|Physician Decision|0|||
124835100|NCT02439320|449025603|FG000|Overall Study|Sponsor Request|0|||
124835101|NCT02439320|449025604|FG001|Overall Study|Sponsor Request|2|||
124835102|NCT02439320|449025605|FG002|Overall Study|Sponsor Request|1|||
124835103|NCT02439320|449025603|FG000|Overall Study|Randomization Failure|35|||
124835104|NCT02439320|449025604|FG001|Overall Study|Randomization Failure|46|||
124835105|NCT02439320|449025605|FG002|Overall Study|Randomization Failure|34|||
124835106|NCT02972632|449025606|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
124835107|NCT02972632|449025606|FG000|Overall Study|Lost to Follow-up|4|||
124835108|NCT02972632|449025606|FG000|Overall Study|Voluntary Withdrawal|10|||
124835109|NCT01488097|449025614|FG000|Overall Study|Lost to Follow-up|1|||
124835110|NCT01251380|449025629|FG000|Overall Study|Other (Not otherwise specified)|12|||
124835111|NCT01251380|449025629|FG000|Overall Study|Withdrawal by Subject|6|||
124835112|NCT01251380|449025629|FG000|Overall Study|Lack of Efficacy|1|||
124835113|NCT01251380|449025629|FG000|Overall Study|Adverse Event|1|||
124835114|NCT01251380|449025629|FG000|Overall Study|Lost to Follow-up|2|||
124835115|NCT02205333|449025638|FG000|Overall Study|Death|5|||
124835116|NCT02205333|449025639|FG001|Overall Study|Death|6|||
124835117|NCT02205333|449025640|FG002|Overall Study|Death|2|||
124835118|NCT02205333|449025641|FG003|Overall Study|Death|6|||
124835119|NCT02205333|449025642|FG004|Overall Study|Death|5|||
124835120|NCT02205333|449025643|FG005|Overall Study|Death|3|||
124835121|NCT02205333|449025644|FG006|Overall Study|Death|3|||
124835122|NCT02205333|449025645|FG007|Overall Study|Death|2|||
124835123|NCT02205333|449025646|FG008|Overall Study|Death|0|||
124835124|NCT02205333|449025638|FG000|Overall Study|Withdrawal by Subject|1|||
124835125|NCT02205333|449025639|FG001|Overall Study|Withdrawal by Subject|0|||
124835126|NCT02205333|449025640|FG002|Overall Study|Withdrawal by Subject|0|||
124835127|NCT02205333|449025641|FG003|Overall Study|Withdrawal by Subject|1|||
124835128|NCT02205333|449025642|FG004|Overall Study|Withdrawal by Subject|0|||
124835129|NCT02205333|449025643|FG005|Overall Study|Withdrawal by Subject|0|||
124835130|NCT02205333|449025644|FG006|Overall Study|Withdrawal by Subject|2|||
124835131|NCT02205333|449025645|FG007|Overall Study|Withdrawal by Subject|0|||
124835132|NCT02205333|449025646|FG008|Overall Study|Withdrawal by Subject|0|||
124835133|NCT01476696|449025647|FG000|Overall Study|Sponsor decision|2|||
124835134|NCT01476696|449025648|FG001|Overall Study|Sponsor decision|1|||
124835135|NCT01476696|449025649|FG002|Overall Study|Sponsor decision|0|||
124835136|NCT01476696|449025647|FG000|Overall Study|Withdrawal by Subject|1|||
124835137|NCT01476696|449025648|FG001|Overall Study|Withdrawal by Subject|0|||
124835138|NCT01476696|449025649|FG002|Overall Study|Withdrawal by Subject|0|||
124835139|NCT03054870|449025653|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
124835140|NCT03054870|449025653|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
124835141|NCT02009046|449025654|FG000|Overall Study|Lost to Follow-up|256|||
124835142|NCT02009046|449025655|FG001|Overall Study|Lost to Follow-up|206|||
124835143|NCT01324388|449025656|FG000|Part 1 of Study|Adverse Event|2|||
124835144|NCT01324388|449025657|FG001|Part 1 of Study|Adverse Event|0|||
124835145|NCT01324388|449025658|FG002|Part 1 of Study|Adverse Event|0|||
124835146|NCT01324388|449025659|FG003|Part 1 of Study|Adverse Event|0|||
124835147|NCT01324388|449025656|FG000|Part 1 of Study|Protocol Violation|1|||
124835148|NCT01324388|449025657|FG001|Part 1 of Study|Protocol Violation|2|||
124835149|NCT01324388|449025658|FG002|Part 1 of Study|Protocol Violation|0|||
124835150|NCT01324388|449025659|FG003|Part 1 of Study|Protocol Violation|0|||
124835151|NCT01324388|449025656|FG000|Part 1 of Study|Physician Decision|1|||
124835152|NCT01324388|449025657|FG001|Part 1 of Study|Physician Decision|0|||
124835153|NCT01324388|449025658|FG002|Part 1 of Study|Physician Decision|0|||
124835154|NCT01324388|449025659|FG003|Part 1 of Study|Physician Decision|0|||
124835155|NCT01324388|449025656|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
124835156|NCT01324388|449025657|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
124835157|NCT01324388|449025658|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
124835158|NCT01324388|449025659|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
124835159|NCT01324388|449025656|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
124835160|NCT01324388|449025657|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
124835161|NCT01324388|449025658|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
124835162|NCT01324388|449025659|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
124835163|NCT00973479|449025662|FG000|Overall Study|Lost to Follow-up|0|||
124835164|NCT00973479|449025663|FG001|Overall Study|Lost to Follow-up|3|||
124835165|NCT00973479|449025662|FG000|Overall Study|Death|2|||
124835166|NCT00973479|449025663|FG001|Overall Study|Death|2|||
124835167|NCT00973479|449025662|FG000|Overall Study|Withdrawal by Subject|15|||
124835168|NCT00973479|449025663|FG001|Overall Study|Withdrawal by Subject|16|||
124835169|NCT00973479|449025662|FG000|Overall Study|Lack of Efficacy|5|||
124835170|NCT00973479|449025663|FG001|Overall Study|Lack of Efficacy|7|||
124835171|NCT00973479|449025662|FG000|Overall Study|Adverse Event|12|||
124835172|NCT00973479|449025663|FG001|Overall Study|Adverse Event|32|||
124835173|NCT00973479|449025662|FG000|Overall Study|Protocol Violation|2|||
124835174|NCT00973479|449025663|FG001|Overall Study|Protocol Violation|2|||
124835175|NCT00973479|449025662|FG000|Overall Study|Other|1|||
124835176|NCT00973479|449025663|FG001|Overall Study|Other|7|||
124835177|NCT03089606|449025664|FG000|Overall Study|Progression after Cycle 1|1|||
124835178|NCT02140567|449025668|FG000|Overall Study|Problems with recording equipment|6|||
124835179|NCT02802592|449025669|FG000|Overall Study|Study terminated due to loss of funding|4|||
124835180|NCT02136576|449025670|FG000|Overall Study|Lost to Follow-up|2|||
124835181|NCT02136576|449025671|FG001|Overall Study|Lost to Follow-up|0|||
124835182|NCT02136576|449025672|FG002|Overall Study|Lost to Follow-up|0|||
124835183|NCT00537381|449025673|FG000|Overall Study|Adverse Event|13|||
124835184|NCT00537381|449025674|FG001|Overall Study|Adverse Event|9|||
124835185|NCT00537381|449025673|FG000|Overall Study|Death|3|||
124835186|NCT00537381|449025674|FG001|Overall Study|Death|3|||
124835187|NCT00537381|449025673|FG000|Overall Study|Withdrawal by Subject|5|||
124835188|NCT00537381|449025674|FG001|Overall Study|Withdrawal by Subject|14|||
124835189|NCT00537381|449025673|FG000|Overall Study|Physician Decision|7|||
124835190|NCT00537381|449025674|FG001|Overall Study|Physician Decision|6|||
124835191|NCT00537381|449025673|FG000|Overall Study|Disease Progression|9|||
124835192|NCT00537381|449025674|FG001|Overall Study|Disease Progression|18|||
124835193|NCT00537381|449025673|FG000|Overall Study|Sponsor decision|14|||
124835194|NCT00537381|449025674|FG001|Overall Study|Sponsor decision|9|||
124835195|NCT00537381|449025673|FG000|Overall Study|Other|5|||
124835196|NCT00537381|449025674|FG001|Overall Study|Other|3|||
124835197|NCT00735878|449025678|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
124835198|NCT00735878|449025679|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
124835199|NCT00735878|449025680|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
124835200|NCT00352846|449025681|FG000|Overall Study|Disease progression|0|||
124835201|NCT00352846|449025682|FG001|Overall Study|Disease progression|2|||
124835202|NCT00352846|449025681|FG000|Overall Study|Withdrawal by Subject|3|||
124835203|NCT00352846|449025682|FG001|Overall Study|Withdrawal by Subject|8|||
124835204|NCT00352846|449025681|FG000|Overall Study|Ineligible|3|||
124835205|NCT00352846|449025682|FG001|Overall Study|Ineligible|2|||
124835206|NCT00352846|449025681|FG000|Overall Study|Non-compliance|2|||
124835207|NCT00352846|449025682|FG001|Overall Study|Non-compliance|0|||
124835208|NCT00352846|449025681|FG000|Overall Study|Death|0|||
124835209|NCT00352846|449025682|FG001|Overall Study|Death|1|||
124835210|NCT01527682|449025683|FG000|Overall Study|Protocol Violation|8|||
124835211|NCT00600938|449025684|FG000|Core Study|Abnormal test procedure result(s)|3|||
124835212|NCT00600938|449025685|FG001|Core Study|Abnormal test procedure result(s)|2|||
124835213|NCT00600938|449025686|FG002|Core Study|Abnormal test procedure result(s)|0|||
124835214|NCT00600938|449025687|FG003|Core Study|Abnormal test procedure result(s)|0|||
124835215|NCT00600938|449025684|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
124835216|NCT00600938|449025685|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
124835217|NCT00600938|449025686|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
124835218|NCT00600938|449025687|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
124835219|NCT00600938|449025684|FG000|Core Study|Patient withdrew consent|7|||
124835220|NCT00600938|449025685|FG001|Core Study|Patient withdrew consent|12|||
124835221|NCT00600938|449025686|FG002|Core Study|Patient withdrew consent|0|||
124835222|NCT00600938|449025687|FG003|Core Study|Patient withdrew consent|0|||
124835223|NCT00600938|449025684|FG000|Core Study|Lost to Follow-up|3|||
124835224|NCT00600938|449025685|FG001|Core Study|Lost to Follow-up|2|||
124835225|NCT00600938|449025686|FG002|Core Study|Lost to Follow-up|0|||
124835226|NCT00600938|449025687|FG003|Core Study|Lost to Follow-up|0|||
124835227|NCT00600938|449025684|FG000|Core Study|Death|1|||
124835228|NCT00600938|449025685|FG001|Core Study|Death|1|||
124835229|NCT00600938|449025686|FG002|Core Study|Death|0|||
124835230|NCT00600938|449025687|FG003|Core Study|Death|0|||
124835231|NCT00600938|449025684|FG000|Core Study|Protocol Violation|1|||
124835232|NCT00600938|449025685|FG001|Core Study|Protocol Violation|2|||
124835233|NCT00600938|449025686|FG002|Core Study|Protocol Violation|0|||
124835234|NCT00600938|449025687|FG003|Core Study|Protocol Violation|0|||
124835235|NCT00600938|449025684|FG000|Extension Study|Adverse Event|1|||
124835236|NCT00600938|449025685|FG001|Extension Study|Adverse Event|0|||
124835237|NCT00600938|449025686|FG002|Extension Study|Adverse Event|2|||
124835238|NCT00600938|449025687|FG003|Extension Study|Adverse Event|0|||
124835239|NCT00600938|449025684|FG000|Extension Study|Abnormal test procedure results|0|||
124835240|NCT00600938|449025685|FG001|Extension Study|Abnormal test procedure results|1|||
124835241|NCT00600938|449025686|FG002|Extension Study|Abnormal test procedure results|1|||
124835242|NCT00600938|449025687|FG003|Extension Study|Abnormal test procedure results|1|||
124835243|NCT00600938|449025684|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
124835244|NCT00600938|449025685|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
124835245|NCT00600938|449025686|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
124835246|NCT00600938|449025687|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
124835247|NCT00600938|449025684|FG000|Extension Study|Withdrawal by Subject|2|||
124835248|NCT00600938|449025685|FG001|Extension Study|Withdrawal by Subject|2|||
124835249|NCT00600938|449025686|FG002|Extension Study|Withdrawal by Subject|3|||
124835250|NCT00600938|449025687|FG003|Extension Study|Withdrawal by Subject|0|||
124835251|NCT00600938|449025684|FG000|Extension Study|Lost to Follow-up|1|||
124835252|NCT00600938|449025685|FG001|Extension Study|Lost to Follow-up|1|||
124835253|NCT00600938|449025686|FG002|Extension Study|Lost to Follow-up|2|||
124835254|NCT00600938|449025687|FG003|Extension Study|Lost to Follow-up|0|||
124835255|NCT00600938|449025684|FG000|Extension Study|Death|1|||
124835256|NCT00600938|449025685|FG001|Extension Study|Death|0|||
124835257|NCT00600938|449025686|FG002|Extension Study|Death|0|||
124835258|NCT00600938|449025687|FG003|Extension Study|Death|0|||
124835259|NCT00549562|449025688|FG000|Overall Study|Adverse Event|1|||
124835260|NCT00549562|449025688|FG000|Overall Study|Lack of Efficacy|1|||
124835261|NCT04709575|449026848|FG000|Overall Study|Withdrawal by Subject|6|||
124835262|NCT04709575|449026849|FG001|Overall Study|Withdrawal by Subject|2|||
124835263|NCT04709575|449026848|FG000|Overall Study|Lost to Follow-up|2|||
124835264|NCT04709575|449026849|FG001|Overall Study|Lost to Follow-up|2|||
124835265|NCT04709575|449026848|FG000|Overall Study|Adverse Event|1|||
124835266|NCT04709575|449026849|FG001|Overall Study|Adverse Event|0|||
124835267|NCT04709575|449026848|FG000|Overall Study|Protocol Violation|1|||
124835268|NCT04709575|449026849|FG001|Overall Study|Protocol Violation|1|||
124835269|NCT04254978|449026852|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
124835270|NCT04254978|449026852|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
124835271|NCT04254978|449026852|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
124835272|NCT04254978|449026852|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
124835273|NCT04254978|449026852|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
124835274|NCT04254978|449026852|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
124835275|NCT03239470|449026855|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
124835276|NCT03239470|449026856|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
124835277|NCT00666757|449026857|FG000|Overall Study|Lost to Follow-up|39|||
124835278|NCT00666757|449026858|FG001|Overall Study|Lost to Follow-up|35|||
124835279|NCT00666757|449026857|FG000|Overall Study|Protocol Violation|23|||
124835280|NCT00666757|449026858|FG001|Overall Study|Protocol Violation|24|||
124835281|NCT00666757|449026857|FG000|Overall Study|Adverse Event|22|||
124835282|NCT00666757|449026858|FG001|Overall Study|Adverse Event|12|||
124835283|NCT00666757|449026857|FG000|Overall Study|Withdrawal by Subject|13|||
124835284|NCT00666757|449026858|FG001|Overall Study|Withdrawal by Subject|17|||
124835285|NCT00666757|449026857|FG000|Overall Study|Lack of Efficacy|3|||
124835286|NCT00666757|449026858|FG001|Overall Study|Lack of Efficacy|6|||
124835287|NCT00666757|449026857|FG000|Overall Study|Physician Decision|0|||
124835288|NCT00666757|449026858|FG001|Overall Study|Physician Decision|2|||
124835289|NCT00666757|449026857|FG000|Overall Study|Sponsor decision|0|||
124835290|NCT00666757|449026858|FG001|Overall Study|Sponsor decision|1|||
124835291|NCT01660711|449026859|FG000|Overall Study|Adverse Event|7|||
124835292|NCT01660711|449026859|FG000|Overall Study|Withdrawal by Subject|1|||
124835293|NCT05664490|449026864|FG000|Overall Study|Withdrawal by Subject|0|||
124835294|NCT05664490|449026865|FG001|Overall Study|Withdrawal by Subject|1|||
124835295|NCT05664490|449026864|FG000|Overall Study|Lost to Follow-up|14|||
124835296|NCT05664490|449026865|FG001|Overall Study|Lost to Follow-up|22|||
124835297|NCT02939560|449026866|FG000|Overall Study|Withdrawal by Subject|2|||
124835298|NCT02939560|449026866|FG000|Overall Study|Protocol Violation|1|||
124835299|NCT05694546|449026874|FG000|Overall Study|Lost to Follow-up|11|||
124835300|NCT01589445|449026875|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
124835301|NCT01589445|449026875|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
124835302|NCT01589445|449026875|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
124835303|NCT01589445|449026875|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
124835304|NCT01589445|449026875|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
124835305|NCT01589445|449026875|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
124835306|NCT01589445|449026875|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
124835307|NCT01589445|449026875|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
124835308|NCT01589445|449026875|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
124835309|NCT01589445|449026875|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
124835310|NCT01505608|449026878|FG000|Phase I|Lack of Efficacy|0|||
124835311|NCT01505608|449026879|FG001|Phase I|Lack of Efficacy|4|||
124835312|NCT01505608|449026878|FG000|Phase I|Adverse Event|0|||
124835313|NCT01505608|449026879|FG001|Phase I|Adverse Event|1|||
124835314|NCT01505608|449026878|FG000|Phase I|Withdrawal by Subject|0|||
124835315|NCT01505608|449026879|FG001|Phase I|Withdrawal by Subject|1|||
124835316|NCT01505608|449026878|FG000|Phase II|Lack of Efficacy|2|||
124835317|NCT01505608|449026879|FG001|Phase II|Lack of Efficacy|1|||
124835318|NCT01505608|449026878|FG000|Phase II|Protocol Violation|0|||
124835319|NCT01505608|449026879|FG001|Phase II|Protocol Violation|1|||
124835320|NCT02319031|449026885|FG000|Treatment Period|Death|1|||
124835321|NCT02319031|449026886|FG001|Treatment Period|Death|0|||
124835322|NCT03519971|449026891|FG000|Overall Study|Death|142|||
124835323|NCT03519971|449026892|FG001|Overall Study|Death|69|||
124835324|NCT03519971|449026891|FG000|Overall Study|Lost to Follow-up|0|||
124835325|NCT03519971|449026892|FG001|Overall Study|Lost to Follow-up|1|||
124835326|NCT03519971|449026891|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
124835327|NCT03519971|449026892|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
124835328|NCT03519971|449026891|FG000|Overall Study|Withdrawal by Subject|3|||
124835329|NCT03519971|449026892|FG001|Overall Study|Withdrawal by Subject|2|||
124835330|NCT03519971|449026891|FG000|Overall Study|Other|1|||
124835331|NCT03519971|449026892|FG001|Overall Study|Other|0|||
124835332|NCT00129129|449026893|FG000|Primary Phase|Adverse Event|2|||
124835333|NCT00129129|449026894|FG001|Primary Phase|Adverse Event|1|||
124835334|NCT00129129|449026895|FG002|Primary Phase|Adverse Event|0|||
124835335|NCT00129129|449026896|FG003|Primary Phase|Adverse Event|0|||
124835336|NCT00129129|449026897|FG004|Primary Phase|Adverse Event|0|||
124835337|NCT00129129|449026893|FG000|Primary Phase|Withdrawal by Subject|12|||
124835338|NCT00129129|449026894|FG001|Primary Phase|Withdrawal by Subject|10|||
124835339|NCT00129129|449026895|FG002|Primary Phase|Withdrawal by Subject|0|||
124835340|NCT00129129|449026896|FG003|Primary Phase|Withdrawal by Subject|0|||
124835341|NCT00129129|449026897|FG004|Primary Phase|Withdrawal by Subject|0|||
124835342|NCT00129129|449026893|FG000|Primary Phase|Migration from study area|1|||
124835343|NCT00129129|449026894|FG001|Primary Phase|Migration from study area|3|||
124835344|NCT00129129|449026895|FG002|Primary Phase|Migration from study area|0|||
124835345|NCT00129129|449026896|FG003|Primary Phase|Migration from study area|0|||
124835346|NCT00129129|449026897|FG004|Primary Phase|Migration from study area|0|||
124835347|NCT00129129|449026893|FG000|Primary Phase|Lost to Follow-up|8|||
124835348|NCT00129129|449026894|FG001|Primary Phase|Lost to Follow-up|6|||
124835349|NCT00129129|449026895|FG002|Primary Phase|Lost to Follow-up|0|||
124835350|NCT00129129|449026896|FG003|Primary Phase|Lost to Follow-up|0|||
124835351|NCT00129129|449026897|FG004|Primary Phase|Lost to Follow-up|0|||
124835352|NCT00129129|449026893|FG000|Primary Phase|Other|2|||
124835353|NCT00129129|449026894|FG001|Primary Phase|Other|5|||
124835354|NCT00129129|449026895|FG002|Primary Phase|Other|0|||
124835355|NCT00129129|449026896|FG003|Primary Phase|Other|0|||
124835356|NCT00129129|449026897|FG004|Primary Phase|Other|0|||
124835357|NCT00129129|449026893|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
124835358|NCT00129129|449026894|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
124835359|NCT00129129|449026895|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
124835360|NCT00129129|449026896|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
124835361|NCT00129129|449026897|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
124835362|NCT00129129|449026893|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
124835363|NCT00129129|449026894|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
124835364|NCT00129129|449026895|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
124835365|NCT00129129|449026896|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
124835366|NCT00129129|449026897|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
124835367|NCT00129129|449026893|FG000|Fourth Dose Phase|Migration from study area|0|||
124835368|NCT00129129|449026894|FG001|Fourth Dose Phase|Migration from study area|0|||
124835369|NCT00129129|449026895|FG002|Fourth Dose Phase|Migration from study area|0|||
124835370|NCT00129129|449026896|FG003|Fourth Dose Phase|Migration from study area|0|||
124835371|NCT00129129|449026897|FG004|Fourth Dose Phase|Migration from study area|2|||
124835372|NCT00129129|449026893|FG000|Fourth Dose Phase|Other|0|||
124835373|NCT00129129|449026894|FG001|Fourth Dose Phase|Other|0|||
124835374|NCT00129129|449026895|FG002|Fourth Dose Phase|Other|0|||
124835375|NCT00129129|449026896|FG003|Fourth Dose Phase|Other|1|||
124835376|NCT00129129|449026897|FG004|Fourth Dose Phase|Other|1|||
124835377|NCT00129129|449026893|FG000|Fourth Dose Phase|Protocol Violation|0|||
124835378|NCT00129129|449026894|FG001|Fourth Dose Phase|Protocol Violation|0|||
124835379|NCT00129129|449026895|FG002|Fourth Dose Phase|Protocol Violation|0|||
124835380|NCT00129129|449026896|FG003|Fourth Dose Phase|Protocol Violation|1|||
124835381|NCT00129129|449026897|FG004|Fourth Dose Phase|Protocol Violation|0|||
124835382|NCT01524692|449026902|FG000|Overall Study|Withdrawal by Subject|3|||
124835383|NCT01709695|449026904|FG000|Overall Study|Withdrawal by Subject|1|||
124835384|NCT01709695|449026905|FG001|Overall Study|Withdrawal by Subject|1|||
124835385|NCT02882854|449026906|FG000|Overall Study|Lost to Follow-up|1|||
124835386|NCT02882854|449026907|FG001|Overall Study|Lost to Follow-up|2|||
124835387|NCT02882854|449026906|FG000|Overall Study|Physician Decision|0|||
124835388|NCT02882854|449026907|FG001|Overall Study|Physician Decision|1|||
124835389|NCT02039674|449026911|FG000|Overall Study|Adverse Event|0|||
124835390|NCT02039674|449026912|FG001|Overall Study|Adverse Event|0|||
124835391|NCT02039674|449026913|FG002|Overall Study|Adverse Event|0|||
124835392|NCT02039674|449026914|FG003|Overall Study|Adverse Event|1|||
124835393|NCT02039674|449026915|FG004|Overall Study|Adverse Event|0|||
124835394|NCT02039674|449026916|FG005|Overall Study|Adverse Event|0|||
124835395|NCT02039674|449026917|FG006|Overall Study|Adverse Event|0|||
124835396|NCT02039674|449026918|FG007|Overall Study|Adverse Event|0|||
124835397|NCT02039674|449026919|FG008|Overall Study|Adverse Event|2|||
124835398|NCT02039674|449026920|FG009|Overall Study|Adverse Event|1|||
124835399|NCT02039674|449026921|FG010|Overall Study|Adverse Event|0|||
124835400|NCT02039674|449026922|FG011|Overall Study|Adverse Event|2|||
124835401|NCT02039674|449026923|FG012|Overall Study|Adverse Event|3|||
124835402|NCT02039674|449026924|FG013|Overall Study|Adverse Event|1|||
124835403|NCT02039674|449026911|FG000|Overall Study|Death|2|||
124835404|NCT02039674|449026912|FG001|Overall Study|Death|0|||
124835405|NCT02039674|449026913|FG002|Overall Study|Death|2|||
124835406|NCT02039674|449026914|FG003|Overall Study|Death|3|||
124835407|NCT02039674|449026915|FG004|Overall Study|Death|0|||
124835408|NCT02039674|449026916|FG005|Overall Study|Death|0|||
124835409|NCT02039674|449026917|FG006|Overall Study|Death|1|||
124835410|NCT02039674|449026918|FG007|Overall Study|Death|0|||
124835411|NCT02039674|449026919|FG008|Overall Study|Death|2|||
124835412|NCT02039674|449026920|FG009|Overall Study|Death|0|||
124835413|NCT02039674|449026921|FG010|Overall Study|Death|1|||
124835414|NCT02039674|449026922|FG011|Overall Study|Death|3|||
124835415|NCT02039674|449026923|FG012|Overall Study|Death|2|||
124835416|NCT02039674|449026924|FG013|Overall Study|Death|8|||
124835417|NCT02039674|449026911|FG000|Overall Study|Excluded Medication|1|||
124835418|NCT02039674|449026912|FG001|Overall Study|Excluded Medication|1|||
124835419|NCT02039674|449026913|FG002|Overall Study|Excluded Medication|0|||
124835420|NCT02039674|449026914|FG003|Overall Study|Excluded Medication|1|||
124835421|NCT02039674|449026915|FG004|Overall Study|Excluded Medication|0|||
124835422|NCT02039674|449026916|FG005|Overall Study|Excluded Medication|1|||
124835423|NCT02039674|449026917|FG006|Overall Study|Excluded Medication|0|||
124835424|NCT02039674|449026918|FG007|Overall Study|Excluded Medication|0|||
124835425|NCT02039674|449026919|FG008|Overall Study|Excluded Medication|2|||
124835426|NCT02039674|449026920|FG009|Overall Study|Excluded Medication|3|||
124835427|NCT02039674|449026921|FG010|Overall Study|Excluded Medication|5|||
124835428|NCT02039674|449026922|FG011|Overall Study|Excluded Medication|6|||
124835429|NCT02039674|449026923|FG012|Overall Study|Excluded Medication|8|||
124835430|NCT02039674|449026924|FG013|Overall Study|Excluded Medication|3|||
124835431|NCT02039674|449026911|FG000|Overall Study|Lost to Follow-up|0|||
124835432|NCT02039674|449026912|FG001|Overall Study|Lost to Follow-up|0|||
124835433|NCT02039674|449026913|FG002|Overall Study|Lost to Follow-up|0|||
124835434|NCT02039674|449026914|FG003|Overall Study|Lost to Follow-up|0|||
124835435|NCT02039674|449026915|FG004|Overall Study|Lost to Follow-up|1|||
124835436|NCT02039674|449026916|FG005|Overall Study|Lost to Follow-up|1|||
124835437|NCT02039674|449026917|FG006|Overall Study|Lost to Follow-up|0|||
124835438|NCT02039674|449026918|FG007|Overall Study|Lost to Follow-up|0|||
124835439|NCT02039674|449026919|FG008|Overall Study|Lost to Follow-up|0|||
124835440|NCT02039674|449026920|FG009|Overall Study|Lost to Follow-up|0|||
124835441|NCT02039674|449026921|FG010|Overall Study|Lost to Follow-up|0|||
124835442|NCT02039674|449026922|FG011|Overall Study|Lost to Follow-up|2|||
124835443|NCT02039674|449026923|FG012|Overall Study|Lost to Follow-up|2|||
124835444|NCT02039674|449026924|FG013|Overall Study|Lost to Follow-up|1|||
124835445|NCT02039674|449026911|FG000|Overall Study|Physician Decision|0|||
124835446|NCT02039674|449026912|FG001|Overall Study|Physician Decision|0|||
124835447|NCT02039674|449026913|FG002|Overall Study|Physician Decision|0|||
124835448|NCT02039674|449026914|FG003|Overall Study|Physician Decision|0|||
124835449|NCT02039674|449026915|FG004|Overall Study|Physician Decision|0|||
124835450|NCT02039674|449026916|FG005|Overall Study|Physician Decision|0|||
124835451|NCT02039674|449026917|FG006|Overall Study|Physician Decision|0|||
124835452|NCT02039674|449026918|FG007|Overall Study|Physician Decision|0|||
124835453|NCT02039674|449026919|FG008|Overall Study|Physician Decision|0|||
124835454|NCT02039674|449026920|FG009|Overall Study|Physician Decision|0|||
124835455|NCT02039674|449026921|FG010|Overall Study|Physician Decision|0|||
124835456|NCT02039674|449026922|FG011|Overall Study|Physician Decision|1|||
124835457|NCT02039674|449026923|FG012|Overall Study|Physician Decision|1|||
124835458|NCT02039674|449026924|FG013|Overall Study|Physician Decision|0|||
124835459|NCT02039674|449026911|FG000|Overall Study|Progressive Disease|8|||
124835460|NCT02039674|449026912|FG001|Overall Study|Progressive Disease|8|||
124835461|NCT02039674|449026913|FG002|Overall Study|Progressive Disease|6|||
124835462|NCT02039674|449026914|FG003|Overall Study|Progressive Disease|7|||
124835463|NCT02039674|449026915|FG004|Overall Study|Progressive Disease|9|||
124835464|NCT02039674|449026916|FG005|Overall Study|Progressive Disease|10|||
124835465|NCT02039674|449026917|FG006|Overall Study|Progressive Disease|1|||
124835466|NCT02039674|449026918|FG007|Overall Study|Progressive Disease|3|||
124835467|NCT02039674|449026919|FG008|Overall Study|Progressive Disease|6|||
124835468|NCT02039674|449026920|FG009|Overall Study|Progressive Disease|4|||
124835469|NCT02039674|449026921|FG010|Overall Study|Progressive Disease|0|||
124835470|NCT02039674|449026922|FG011|Overall Study|Progressive Disease|34|||
124835471|NCT02039674|449026923|FG012|Overall Study|Progressive Disease|34|||
124835472|NCT02039674|449026924|FG013|Overall Study|Progressive Disease|18|||
124835473|NCT02039674|449026911|FG000|Overall Study|Withdrawal by Subject|1|||
124835474|NCT02039674|449026912|FG001|Overall Study|Withdrawal by Subject|2|||
124835475|NCT02039674|449026913|FG002|Overall Study|Withdrawal by Subject|3|||
124835476|NCT02039674|449026914|FG003|Overall Study|Withdrawal by Subject|0|||
124835477|NCT02039674|449026915|FG004|Overall Study|Withdrawal by Subject|1|||
124835478|NCT02039674|449026916|FG005|Overall Study|Withdrawal by Subject|0|||
124835479|NCT02039674|449026917|FG006|Overall Study|Withdrawal by Subject|0|||
124835480|NCT02039674|449026918|FG007|Overall Study|Withdrawal by Subject|0|||
124835481|NCT02039674|449026919|FG008|Overall Study|Withdrawal by Subject|0|||
124835482|NCT02039674|449026920|FG009|Overall Study|Withdrawal by Subject|1|||
124835483|NCT02039674|449026921|FG010|Overall Study|Withdrawal by Subject|1|||
124835484|NCT02039674|449026922|FG011|Overall Study|Withdrawal by Subject|4|||
124835485|NCT02039674|449026923|FG012|Overall Study|Withdrawal by Subject|6|||
124835486|NCT02039674|449026924|FG013|Overall Study|Withdrawal by Subject|2|||
124835487|NCT02039674|449026911|FG000|Overall Study|Clinical Progression|0|||
124835488|NCT02039674|449026912|FG001|Overall Study|Clinical Progression|0|||
124835489|NCT02039674|449026913|FG002|Overall Study|Clinical Progression|0|||
124835490|NCT02039674|449026914|FG003|Overall Study|Clinical Progression|0|||
124835491|NCT02039674|449026915|FG004|Overall Study|Clinical Progression|0|||
124835492|NCT02039674|449026916|FG005|Overall Study|Clinical Progression|0|||
124835493|NCT02039674|449026917|FG006|Overall Study|Clinical Progression|1|||
124835494|NCT02039674|449026918|FG007|Overall Study|Clinical Progression|0|||
124835495|NCT02039674|449026919|FG008|Overall Study|Clinical Progression|0|||
124835496|NCT02039674|449026920|FG009|Overall Study|Clinical Progression|0|||
124835497|NCT02039674|449026921|FG010|Overall Study|Clinical Progression|0|||
124835498|NCT02039674|449026922|FG011|Overall Study|Clinical Progression|0|||
124835499|NCT02039674|449026923|FG012|Overall Study|Clinical Progression|1|||
124835500|NCT02039674|449026924|FG013|Overall Study|Clinical Progression|0|||
124835501|NCT02039674|449026911|FG000|Overall Study|Sponsor Decision|1|||
124835502|NCT02039674|449026912|FG001|Overall Study|Sponsor Decision|1|||
124835503|NCT02039674|449026913|FG002|Overall Study|Sponsor Decision|1|||
124835504|NCT02039674|449026914|FG003|Overall Study|Sponsor Decision|1|||
124835505|NCT02039674|449026915|FG004|Overall Study|Sponsor Decision|1|||
124835506|NCT02039674|449026916|FG005|Overall Study|Sponsor Decision|0|||
124835507|NCT02039674|449026917|FG006|Overall Study|Sponsor Decision|0|||
124835508|NCT02039674|449026918|FG007|Overall Study|Sponsor Decision|0|||
124835509|NCT02039674|449026919|FG008|Overall Study|Sponsor Decision|0|||
124835510|NCT02039674|449026920|FG009|Overall Study|Sponsor Decision|3|||
124835511|NCT02039674|449026921|FG010|Overall Study|Sponsor Decision|0|||
124835512|NCT02039674|449026922|FG011|Overall Study|Sponsor Decision|8|||
124835513|NCT02039674|449026923|FG012|Overall Study|Sponsor Decision|5|||
124835514|NCT02039674|449026924|FG013|Overall Study|Sponsor Decision|0|||
124835515|NCT02039674|449026911|FG000|Overall Study|Other|0|||
124835516|NCT02039674|449026912|FG001|Overall Study|Other|0|||
124835517|NCT02039674|449026913|FG002|Overall Study|Other|0|||
124835518|NCT02039674|449026914|FG003|Overall Study|Other|0|||
124835519|NCT02039674|449026915|FG004|Overall Study|Other|0|||
124835520|NCT02039674|449026916|FG005|Overall Study|Other|0|||
124835521|NCT02039674|449026917|FG006|Overall Study|Other|0|||
124835522|NCT02039674|449026918|FG007|Overall Study|Other|0|||
124835523|NCT02039674|449026919|FG008|Overall Study|Other|0|||
124835524|NCT02039674|449026920|FG009|Overall Study|Other|0|||
124835525|NCT02039674|449026921|FG010|Overall Study|Other|0|||
124835526|NCT02039674|449026922|FG011|Overall Study|Other|0|||
124835527|NCT02039674|449026923|FG012|Overall Study|Other|1|||
124835528|NCT02039674|449026924|FG013|Overall Study|Other|0|||
124835529|NCT01358357|449026925|FG000|Open Label Phase|Adverse Event|0|||
124835530|NCT01358357|449026926|FG001|Open Label Phase|Adverse Event|0|||
124835531|NCT01358357|449026927|FG002|Open Label Phase|Adverse Event|59|||
124835532|NCT01358357|449026925|FG000|Open Label Phase|Lack of Efficacy|0|||
124835533|NCT01358357|449026926|FG001|Open Label Phase|Lack of Efficacy|0|||
124835534|NCT01358357|449026927|FG002|Open Label Phase|Lack of Efficacy|107|||
124835535|NCT01358357|449026925|FG000|Open Label Phase|Lost to Follow-up|0|||
124835536|NCT01358357|449026926|FG001|Open Label Phase|Lost to Follow-up|0|||
124835537|NCT01358357|449026927|FG002|Open Label Phase|Lost to Follow-up|76|||
124835538|NCT01358357|449026925|FG000|Open Label Phase|Protocol Violation|0|||
124835539|NCT01358357|449026926|FG001|Open Label Phase|Protocol Violation|0|||
124835540|NCT01358357|449026927|FG002|Open Label Phase|Protocol Violation|45|||
124835541|NCT01358357|449026925|FG000|Open Label Phase|Withdrawal by Subject|0|||
124835542|NCT01358357|449026926|FG001|Open Label Phase|Withdrawal by Subject|0|||
124835543|NCT01358357|449026927|FG002|Open Label Phase|Withdrawal by Subject|112|||
124835544|NCT01358357|449026925|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
124835545|NCT01358357|449026926|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
124835546|NCT01358357|449026927|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
124835547|NCT01358357|449026925|FG000|Open Label Phase|Terminated at study completion|0|||
124835548|NCT01358357|449026926|FG001|Open Label Phase|Terminated at study completion|0|||
124835549|NCT01358357|449026927|FG002|Open Label Phase|Terminated at study completion|5|||
124835550|NCT01358357|449026925|FG000|Open Label Phase|Mood episode|0|||
124835551|NCT01358357|449026926|FG001|Open Label Phase|Mood episode|0|||
124835552|NCT01358357|449026927|FG002|Open Label Phase|Mood episode|42|||
124835553|NCT01358357|449026925|FG000|Double-Blind Phase|Adverse Event|8|||
124835554|NCT01358357|449026926|FG001|Double-Blind Phase|Adverse Event|5|||
124835555|NCT01358357|449026927|FG002|Double-Blind Phase|Adverse Event|0|||
124835556|NCT01358357|449026925|FG000|Double-Blind Phase|Lost to Follow-up|5|||
124835557|NCT01358357|449026926|FG001|Double-Blind Phase|Lost to Follow-up|7|||
124835558|NCT01358357|449026927|FG002|Double-Blind Phase|Lost to Follow-up|0|||
124835559|NCT01358357|449026925|FG000|Double-Blind Phase|Protocol Violation|1|||
124835560|NCT01358357|449026926|FG001|Double-Blind Phase|Protocol Violation|11|||
124835561|NCT01358357|449026927|FG002|Double-Blind Phase|Protocol Violation|0|||
124835562|NCT01358357|449026925|FG000|Double-Blind Phase|Protocol Violation|16|||
124835563|NCT01358357|449026926|FG001|Double-Blind Phase|Protocol Violation|12|||
124835564|NCT01358357|449026927|FG002|Double-Blind Phase|Protocol Violation|0|||
124835565|NCT01358357|449026925|FG000|Double-Blind Phase|Terminated at study completion|2|||
124835566|NCT01358357|449026926|FG001|Double-Blind Phase|Terminated at study completion|0|||
124835567|NCT01358357|449026927|FG002|Double-Blind Phase|Terminated at study completion|0|||
124835568|NCT01358357|449026925|FG000|Double-Blind Phase|Recurrence of mood event|48|||
124835569|NCT01358357|449026926|FG001|Double-Blind Phase|Recurrence of mood event|64|||
124835570|NCT01358357|449026927|FG002|Double-Blind Phase|Recurrence of mood event|0|||
124835571|NCT01358357|449026925|FG000|Double-Blind Phase|Administrative|0|||
124835572|NCT01358357|449026926|FG001|Double-Blind Phase|Administrative|1|||
124835573|NCT01358357|449026927|FG002|Double-Blind Phase|Administrative|0|||
124835574|NCT02590939|449026928|FG000|Overall Study|Withdrawal by Subject|3|||
124835575|NCT02590939|449026929|FG001|Overall Study|Withdrawal by Subject|1|||
124835576|NCT02590939|449026928|FG000|Overall Study|Failed the nociceptive test|2|||
124835577|NCT02590939|449026929|FG001|Overall Study|Failed the nociceptive test|1|||
124835578|NCT02347189|449026934|FG000|Overall Study|No implant attempted of study device|9|||
124835579|NCT02347189|449026934|FG000|Overall Study|No primary outcome data available|2|||
124835580|NCT00994240|449026935|FG000|Overall Study|Lost to Follow-up|3|||
124835581|NCT00994240|449026936|FG001|Overall Study|Lost to Follow-up|2|||
124835582|NCT00994240|449026935|FG000|Overall Study|Withdrawal by Subject|1|||
124835583|NCT00994240|449026936|FG001|Overall Study|Withdrawal by Subject|0|||
124835584|NCT00994240|449026935|FG000|Overall Study|study termination|2|||
124835585|NCT00994240|449026936|FG001|Overall Study|study termination|3|||
124835586|NCT03979638|449026941|FG000|Period 1|Physician Decision|1|||
124835587|NCT03979638|449026942|FG001|Period 1|Physician Decision|1|||
124835588|NCT03979638|449026941|FG000|Period 1|Withdrawal by Subject|4|||
124835589|NCT03979638|449026942|FG001|Period 1|Withdrawal by Subject|3|||
124835590|NCT03979638|449026941|FG000|Period 1|Study terminated by Sponsor|1|||
124835591|NCT03979638|449026942|FG001|Period 1|Study terminated by Sponsor|3|||
124835592|NCT03979638|449026941|FG000|Period 1|Protocol Violation|1|||
124835593|NCT03979638|449026942|FG001|Period 1|Protocol Violation|0|||
124835594|NCT03979638|449026941|FG000|Period 2|Study terminated by Sponsor|1|||
124835595|NCT03979638|449026942|FG001|Period 2|Study terminated by Sponsor|1|||
124835596|NCT04248933|449026943|FG000|Overall Study|Lost to Follow-up|9|||
124835597|NCT04248933|449026943|FG000|Overall Study|Withdrawal by Subject|2|||
124835598|NCT00578942|449026944|FG000|Overall Study|Lost to Follow-up|1|||
124835599|NCT01063595|449026956|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
124835600|NCT01063595|449026957|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
124835601|NCT01063595|449026956|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
124835602|NCT01063595|449026957|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
124835603|NCT01063595|449026956|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
124835604|NCT01063595|449026957|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
124835605|NCT01063595|449026956|FG000|First Intervention|Adverse Event|1|||
124835606|NCT01063595|449026957|FG001|First Intervention|Adverse Event|4|||
124835607|NCT01063595|449026956|FG000|First Intervention|Withdrawal by Subject|1|||
124835608|NCT01063595|449026957|FG001|First Intervention|Withdrawal by Subject|0|||
124835609|NCT01063595|449026956|FG000|First Intervention|Reason not Specified|0|||
124835610|NCT01063595|449026957|FG001|First Intervention|Reason not Specified|1|||
124835611|NCT00747435|449026958|FG000|Overall Study|Lost to Follow-up|2|||
124835612|NCT00747435|449026958|FG000|Overall Study|Withdrawal by Subject|3|||
124835613|NCT00747435|449026958|FG000|Overall Study|Still undergoing follow up|1|||
124835614|NCT04439318|449026961|FG000|Overall Study|Ineligible|1|||
124835615|NCT04439318|449026961|FG000|Overall Study|Never Started Treatment|3|||
124835616|NCT04439318|449026961|FG000|Overall Study|Adverse Event|10|||
124835617|NCT04439318|449026961|FG000|Overall Study|Death|2|||
124639393|NCT03307252|448296597|FG010|Part 2, Period 4|Other than listed|0|||
124639394|NCT03307252|448296587|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
124639395|NCT03307252|448296588|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
124639396|NCT03307252|448296589|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
124639397|NCT03307252|448296590|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
124639398|NCT03307252|448296591|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
124639399|NCT03307252|448296592|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
124639400|NCT03307252|448296593|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
124639401|NCT03307252|448296594|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
124639402|NCT03307252|448296595|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
124639403|NCT03307252|448296596|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
124639404|NCT03307252|448296597|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
124639405|NCT03482453|448296598|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
124639406|NCT03482453|448296599|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
124639407|NCT03482453|448296600|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
124639408|NCT03482453|448296601|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
124639409|NCT03482453|448296602|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
124835618|NCT04439318|449026961|FG000|Overall Study|Disease Progression|25|||
124835619|NCT04439318|449026961|FG000|Overall Study|Other Complicating Disease|2|||
124835620|NCT04439318|449026961|FG000|Overall Study|Withdrawal by Subject|4|||
124639410|NCT03482453|448296603|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
124639411|NCT03482453|448296604|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
124639412|NCT03482453|448296605|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
124639413|NCT03482453|448296606|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
124639414|NCT03482453|448296607|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
124639415|NCT03482453|448296608|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
124639416|NCT03482453|448296609|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
124639417|NCT02568189|448296610|FG000|Overall Study|Protocol Violation|0|||
124639418|NCT02568189|448296611|FG001|Overall Study|Protocol Violation|0|||
124639419|NCT02568189|448296612|FG002|Overall Study|Protocol Violation|19|||
124639420|NCT02568189|448296613|FG003|Overall Study|Protocol Violation|18|||
124639421|NCT02157376|448296614|FG000|Overall Study|Death|10|||
124639422|NCT02157376|448296615|FG001|Overall Study|Death|4|||
124639423|NCT02157376|448296614|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124639424|NCT02157376|448296615|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
124639425|NCT02157376|448296614|FG000|Overall Study|Withdrawal by Subject|3|||
124639426|NCT02157376|448296615|FG001|Overall Study|Withdrawal by Subject|8|||
124639427|NCT02157376|448296614|FG000|Overall Study|Not treated|8|||
124639428|NCT02157376|448296615|FG001|Overall Study|Not treated|3|||
124639429|NCT02157376|448296614|FG000|Overall Study|Investigator's misjudgement|1|||
124639430|NCT02157376|448296615|FG001|Overall Study|Investigator's misjudgement|2|||
124639431|NCT01074268|448296616|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
124639432|NCT01074268|448296617|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
124639433|NCT01074268|448296616|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
124639434|NCT01074268|448296617|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
124639435|NCT01074268|448296616|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
124639436|NCT01074268|448296617|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
124639437|NCT01074268|448296616|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
124639438|NCT01074268|448296617|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
124639439|NCT01074268|448296616|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
124639440|NCT01074268|448296617|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
124639441|NCT01074268|448296616|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
124639442|NCT01074268|448296617|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
124639443|NCT01074268|448296616|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
124639444|NCT01074268|448296617|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
124639445|NCT01074268|448296616|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
124639446|NCT01074268|448296617|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
124639447|NCT01074268|448296616|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
124639448|NCT01074268|448296617|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
124639449|NCT01578239|448296620|FG000|Treatment Period|Progressive Disease|19|||
124639450|NCT01578239|448296621|FG001|Treatment Period|Progressive Disease|64|||
124639451|NCT01578239|448296620|FG000|Treatment Period|Physician Decision|17|||
124639452|NCT01578239|448296621|FG001|Treatment Period|Physician Decision|17|||
124639453|NCT01578239|448296620|FG000|Treatment Period|Adverse Event|13|||
124639454|NCT01578239|448296621|FG001|Treatment Period|Adverse Event|10|||
124639455|NCT01578239|448296620|FG000|Treatment Period|Non-compliance|2|||
124639456|NCT01578239|448296621|FG001|Treatment Period|Non-compliance|0|||
124639457|NCT01578239|448296620|FG000|Treatment Period|Withdrawal by Subject|10|||
124639458|NCT01578239|448296621|FG001|Treatment Period|Withdrawal by Subject|9|||
124639459|NCT01578239|448296620|FG000|Treatment Period|Other|6|||
124639460|NCT01578239|448296621|FG001|Treatment Period|Other|1|||
124639461|NCT01578239|448296620|FG000|Long-term Follow-Up Period|Death|69|||
124639462|NCT01578239|448296621|FG001|Long-term Follow-Up Period|Death|64|||
124639463|NCT01578239|448296620|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
124639464|NCT01578239|448296621|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
124639465|NCT01578239|448296620|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
124639466|NCT01578239|448296621|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
124639467|NCT01578239|448296620|FG000|Long-term Follow-Up Period|Other|2|||
124639468|NCT01578239|448296621|FG001|Long-term Follow-Up Period|Other|2|||
124639469|NCT01031680|448296627|FG000|Overall Study|Adverse Event|8|||
124639470|NCT01031680|448296628|FG001|Overall Study|Adverse Event|3|||
124639471|NCT01031680|448296627|FG000|Overall Study|Lost to Follow-up|2|||
124639472|NCT01031680|448296628|FG001|Overall Study|Lost to Follow-up|10|||
124639473|NCT01031680|448296627|FG000|Overall Study|Withdrawal by Subject|12|||
124639474|NCT01031680|448296628|FG001|Overall Study|Withdrawal by Subject|16|||
124639475|NCT01031680|448296627|FG000|Overall Study|Death|2|||
124639476|NCT01031680|448296628|FG001|Overall Study|Death|1|||
124639477|NCT01031680|448296627|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
124639478|NCT01031680|448296628|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
124639479|NCT01031680|448296627|FG000|Overall Study|Poor/Non-compliance|5|||
124639480|NCT01031680|448296628|FG001|Overall Study|Poor/Non-compliance|6|||
124639481|NCT01031680|448296627|FG000|Overall Study|Safety|1|||
124639482|NCT01031680|448296628|FG001|Overall Study|Safety|0|||
124639483|NCT01031680|448296627|FG000|Overall Study|Incorrect Enrolment|1|||
124639484|NCT01031680|448296628|FG001|Overall Study|Incorrect Enrolment|2|||
124639485|NCT01031680|448296627|FG000|Overall Study|Administrative Reason by Sponsor|0|||
124639486|NCT01031680|448296628|FG001|Overall Study|Administrative Reason by Sponsor|1|||
124639487|NCT01031680|448296627|FG000|Overall Study|Various|0|||
124639488|NCT01031680|448296628|FG001|Overall Study|Various|2|||
124639489|NCT02654977|448296633|FG000|Overall Study|Death|1|||
124639490|NCT02654977|448296633|FG000|Overall Study|Lost to Follow-up|1|||
124639491|NCT02654977|448296633|FG000|Overall Study|Adverse Event|1|||
124639492|NCT02654977|448296633|FG000|Overall Study|Withdrawal by Subject|1|||
124639493|NCT02654977|448296633|FG000|Overall Study|Lack of Efficacy|3|||
124639494|NCT01921101|448296634|FG000|Overall Study|Death|16|||
124639495|NCT01921101|448296635|FG001|Overall Study|Death|6|||
124639496|NCT01483027|448296636|FG000|Overall Study|Administrative Reasons|2|||
124639497|NCT01483027|448296637|FG001|Overall Study|Administrative Reasons|1|||
124639498|NCT01483027|448296636|FG000|Overall Study|Withdrawal by Subject|21|||
124639499|NCT01483027|448296637|FG001|Overall Study|Withdrawal by Subject|32|||
124639500|NCT01483027|448296636|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
124639501|NCT01483027|448296637|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
124835621|NCT04439318|449026961|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
124835622|NCT04439318|449026961|FG000|Overall Study|Non-Compliance|1|||
124835623|NCT04439318|449026961|FG000|Overall Study|Still on Treatment|1|||
124835624|NCT03509675|449028549|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
124835625|NCT03509675|449028550|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
124835626|NCT03509675|449028549|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
124835627|NCT03509675|449028550|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
124835628|NCT03509675|449028549|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
124835629|NCT03509675|449028550|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
124835630|NCT03509675|449028549|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
124835631|NCT03509675|449028550|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
124835632|NCT02622828|449028551|FG000|Overall Study|participant withdrew|3|||
124835633|NCT04920123|449028555|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
124835634|NCT04920123|449028556|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
124835635|NCT04920123|449028557|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
124835636|NCT00278954|449028560|FG000|Overall Study|Adverse Event|3|||
124835637|NCT00278954|449028560|FG000|Overall Study|Lost to Follow-up|1|||
124835638|NCT00278954|449028560|FG000|Overall Study|Withdrawal by Subject|1|||
124835639|NCT03406858|449028561|FG000|Overall Study|Failure to receive treatment drug.|1|||
124835640|NCT03406858|449028561|FG000|Overall Study|ineligible|1|||
124835641|NCT01817725|449028569|FG000|Overall Study|Withdrawal by Subject|1|||
124835642|NCT03412084|449028570|FG000|Overall Study|Withdrawal by Subject|2|||
124835643|NCT03412084|449028571|FG001|Overall Study|Withdrawal by Subject|0|||
124835644|NCT03412084|449028570|FG000|Overall Study|Participant moved|1|||
124835645|NCT03412084|449028571|FG001|Overall Study|Participant moved|0|||
124835646|NCT03412084|449028570|FG000|Overall Study|Lost to Follow-up|1|||
124835647|NCT03412084|449028571|FG001|Overall Study|Lost to Follow-up|1|||
124835648|NCT00481195|449028574|FG000|Overall Study|Adverse Event|16|||
124835649|NCT00481195|449028575|FG001|Overall Study|Adverse Event|11|||
124835650|NCT00481195|449028574|FG000|Overall Study|Lack of Efficacy|1|||
124835651|NCT00481195|449028575|FG001|Overall Study|Lack of Efficacy|3|||
124835652|NCT00481195|449028574|FG000|Overall Study|Lost to Follow-up|4|||
124835653|NCT00481195|449028575|FG001|Overall Study|Lost to Follow-up|6|||
124835654|NCT00481195|449028574|FG000|Overall Study|Physician Decision|3|||
124835655|NCT00481195|449028575|FG001|Overall Study|Physician Decision|1|||
124835656|NCT00481195|449028574|FG000|Overall Study|Protocol Violation|10|||
124835657|NCT00481195|449028575|FG001|Overall Study|Protocol Violation|7|||
124835658|NCT00481195|449028574|FG000|Overall Study|Withdrawal by Subject|3|||
124835659|NCT00481195|449028575|FG001|Overall Study|Withdrawal by Subject|9|||
124835660|NCT00481195|449028574|FG000|Overall Study|Miscellaneous|2|||
124835661|NCT00481195|449028575|FG001|Overall Study|Miscellaneous|2|||
124639502|NCT01483027|448296636|FG000|Overall Study|Lost to Follow-up|1|||
124639503|NCT01483027|448296637|FG001|Overall Study|Lost to Follow-up|1|||
124639504|NCT01483027|448296636|FG000|Overall Study|Adverse Event|0|||
124835662|NCT02932904|449028576|FG000|Overall Study|Reason not Specified|1|||
124835663|NCT02932904|449028577|FG001|Overall Study|Reason not Specified|0|||
124835664|NCT02932904|449028578|FG002|Overall Study|Reason not Specified|2|||
124835665|NCT02932904|449028579|FG003|Overall Study|Reason not Specified|2|||
124835666|NCT02932904|449028576|FG000|Overall Study|Noncompliance with Study Drug|2|||
124835667|NCT02932904|449028577|FG001|Overall Study|Noncompliance with Study Drug|3|||
124639505|NCT01483027|448296637|FG001|Overall Study|Adverse Event|1|||
124639506|NCT01483027|448296636|FG000|Overall Study|Withdrawal by Subject|0|||
124639507|NCT01483027|448296637|FG001|Overall Study|Withdrawal by Subject|1|||
124639508|NCT00652626|448298404|FG000|Initial Treatment Phase|Adverse Event|0|||
124639509|NCT00652626|448298405|FG001|Initial Treatment Phase|Adverse Event|0|||
124835668|NCT02932904|449028578|FG002|Overall Study|Noncompliance with Study Drug|3|||
124835669|NCT02932904|449028579|FG003|Overall Study|Noncompliance with Study Drug|4|||
124835670|NCT02932904|449028576|FG000|Overall Study|Pregnancy|0|||
124835671|NCT02932904|449028577|FG001|Overall Study|Pregnancy|1|||
124835672|NCT02932904|449028578|FG002|Overall Study|Pregnancy|1|||
124835673|NCT02932904|449028579|FG003|Overall Study|Pregnancy|0|||
124835674|NCT02932904|449028576|FG000|Overall Study|Study Termination|0|||
124835675|NCT02932904|449028577|FG001|Overall Study|Study Termination|1|||
124835676|NCT02932904|449028578|FG002|Overall Study|Study Termination|0|||
124835677|NCT02932904|449028579|FG003|Overall Study|Study Termination|0|||
124835678|NCT02932904|449028576|FG000|Overall Study|Voluntary Withdrawal|2|||
124835679|NCT02932904|449028577|FG001|Overall Study|Voluntary Withdrawal|1|||
124835680|NCT02932904|449028578|FG002|Overall Study|Voluntary Withdrawal|4|||
124835681|NCT02932904|449028579|FG003|Overall Study|Voluntary Withdrawal|2|||
124835682|NCT02932904|449028576|FG000|Overall Study|Lost to Follow-up|5|||
124835683|NCT02932904|449028577|FG001|Overall Study|Lost to Follow-up|3|||
124835684|NCT02932904|449028578|FG002|Overall Study|Lost to Follow-up|6|||
124835685|NCT02932904|449028579|FG003|Overall Study|Lost to Follow-up|0|||
124835686|NCT02932904|449028576|FG000|Overall Study|Significant Protocol Deviation|2|||
124835687|NCT02932904|449028577|FG001|Overall Study|Significant Protocol Deviation|3|||
124835688|NCT02932904|449028578|FG002|Overall Study|Significant Protocol Deviation|6|||
124835689|NCT02932904|449028579|FG003|Overall Study|Significant Protocol Deviation|1|||
124835690|NCT02932904|449028576|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
124835691|NCT02932904|449028577|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
124835692|NCT02932904|449028578|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
124835693|NCT02932904|449028579|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
124835694|NCT02932904|449028576|FG000|Overall Study|Randomized But Not Treated|1|||
124835695|NCT02932904|449028577|FG001|Overall Study|Randomized But Not Treated|1|||
124835696|NCT02932904|449028578|FG002|Overall Study|Randomized But Not Treated|0|||
124835697|NCT02932904|449028579|FG003|Overall Study|Randomized But Not Treated|2|||
124835698|NCT03792672|449028584|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
124835699|NCT03792672|449028585|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
124835700|NCT03792672|449028586|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
124835701|NCT03792672|449028587|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
124835702|NCT03792672|449028588|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
124835703|NCT03792672|449028589|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
124835704|NCT03792672|449028584|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
124835705|NCT03792672|449028585|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
124835706|NCT03792672|449028586|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
124835707|NCT03792672|449028587|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
124835708|NCT03792672|449028588|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
124835709|NCT03792672|449028589|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
124835710|NCT03792672|449028584|FG000|Treatment Period 4 (2 Days)|Other|1|||
124835711|NCT03792672|449028585|FG001|Treatment Period 4 (2 Days)|Other|0|||
124835712|NCT03792672|449028586|FG002|Treatment Period 4 (2 Days)|Other|0|||
124835713|NCT03792672|449028587|FG003|Treatment Period 4 (2 Days)|Other|0|||
124835714|NCT03792672|449028588|FG004|Treatment Period 4 (2 Days)|Other|0|||
124835715|NCT03792672|449028589|FG005|Treatment Period 4 (2 Days)|Other|0|||
124835716|NCT01907828|449028592|FG000|Overall Study|Exclusion criteria not met|0|||
124835717|NCT01907828|449028593|FG001|Overall Study|Exclusion criteria not met|1|||
124835718|NCT01907828|449028592|FG000|Overall Study|Withdrawal by Subject|3|||
124835719|NCT01907828|449028593|FG001|Overall Study|Withdrawal by Subject|4|||
124835720|NCT01907828|449028592|FG000|Overall Study|Lost to Follow-up|3|||
124835721|NCT01907828|449028593|FG001|Overall Study|Lost to Follow-up|0|||
124835722|NCT01907828|449028592|FG000|Overall Study|Participant refused 24-month follow-up|1|||
124835723|NCT01907828|449028593|FG001|Overall Study|Participant refused 24-month follow-up|0|||
124835724|NCT01907828|449028592|FG000|Overall Study|Participant met exclusion criteria|0|||
124835725|NCT01907828|449028593|FG001|Overall Study|Participant met exclusion criteria|1|||
124835726|NCT04007523|449028596|FG000|Overall Study|Withdrawal by Subject|0|||
124835727|NCT04007523|449028597|FG001|Overall Study|Withdrawal by Subject|1|||
124835728|NCT04007523|449028598|FG002|Overall Study|Withdrawal by Subject|1|||
124835729|NCT04007523|449028599|FG003|Overall Study|Withdrawal by Subject|0|||
124835730|NCT04007523|449028596|FG000|Overall Study|ICU Transfer|0|||
124639510|NCT00652626|448298406|FG002|Initial Treatment Phase|Adverse Event|0|||
124835731|NCT04007523|449028597|FG001|Overall Study|ICU Transfer|1|||
124835732|NCT04007523|449028598|FG002|Overall Study|ICU Transfer|0|||
124835733|NCT04007523|449028599|FG003|Overall Study|ICU Transfer|0|||
124835734|NCT04007523|449028596|FG000|Overall Study|COVID hospital closure|0|||
124835735|NCT04007523|449028597|FG001|Overall Study|COVID hospital closure|0|||
124835736|NCT04007523|449028598|FG002|Overall Study|COVID hospital closure|1|||
124835737|NCT04007523|449028599|FG003|Overall Study|COVID hospital closure|2|||
124835738|NCT04007523|449028596|FG000|Overall Study|Surgery cancelled|0|||
124835739|NCT04007523|449028597|FG001|Overall Study|Surgery cancelled|0|||
124835740|NCT04007523|449028598|FG002|Overall Study|Surgery cancelled|1|||
124835741|NCT04007523|449028599|FG003|Overall Study|Surgery cancelled|1|||
124835742|NCT02197806|449028601|FG000|Overall Study|Adverse Event|0|||
124835743|NCT02197806|449028602|FG001|Overall Study|Adverse Event|1|||
124835744|NCT02197806|449028603|FG002|Overall Study|Adverse Event|0|||
124835745|NCT02197806|449028604|FG003|Overall Study|Adverse Event|1|||
124835746|NCT03774433|449028606|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
124835747|NCT00108160|449028607|FG000|Overall Study|Lost to Follow-up|25|||
124835748|NCT00108160|449028608|FG001|Overall Study|Lost to Follow-up|12|||
124835749|NCT00108160|449028607|FG000|Overall Study|Death|1|||
124835750|NCT00108160|449028608|FG001|Overall Study|Death|2|||
124835751|NCT00108160|449028607|FG000|Overall Study|Withdrawal by Subject|4|||
124835752|NCT00108160|449028608|FG001|Overall Study|Withdrawal by Subject|2|||
124835753|NCT00108160|449028607|FG000|Overall Study|Protocol Violation|9|||
124835754|NCT00108160|449028608|FG001|Overall Study|Protocol Violation|5|||
124835755|NCT01150123|449028610|FG000|Overall Study|Withdrawal by Subject|1|||
124835756|NCT01150123|449028611|FG001|Overall Study|Withdrawal by Subject|1|||
124835757|NCT01150123|449028612|FG002|Overall Study|Withdrawal by Subject|2|||
124835758|NCT01150123|449028613|FG003|Overall Study|Withdrawal by Subject|1|||
124835759|NCT01150123|449028614|FG004|Overall Study|Withdrawal by Subject|1|||
124835760|NCT01150123|449028615|FG005|Overall Study|Withdrawal by Subject|1|||
124835761|NCT01150123|449028616|FG006|Overall Study|Withdrawal by Subject|0|||
124835762|NCT01150123|449028617|FG007|Overall Study|Withdrawal by Subject|3|||
124835763|NCT01150123|449028618|FG008|Overall Study|Withdrawal by Subject|2|||
124835764|NCT01150123|449028619|FG009|Overall Study|Withdrawal by Subject|0|||
124835765|NCT01150123|449028620|FG010|Overall Study|Withdrawal by Subject|1|||
124835766|NCT01150123|449028621|FG011|Overall Study|Withdrawal by Subject|0|||
124835767|NCT01150123|449028622|FG012|Overall Study|Withdrawal by Subject|1|||
124835768|NCT01150123|449028623|FG013|Overall Study|Withdrawal by Subject|0|||
124835769|NCT01150123|449028624|FG014|Overall Study|Withdrawal by Subject|0|||
124835770|NCT01150123|449028625|FG015|Overall Study|Withdrawal by Subject|1|||
124835771|NCT01150123|449028626|FG016|Overall Study|Withdrawal by Subject|0|||
124835772|NCT01150123|449028627|FG017|Overall Study|Withdrawal by Subject|1|||
124835773|NCT01150123|449028610|FG000|Overall Study|Lost to Follow-up|2|||
124835774|NCT01150123|449028611|FG001|Overall Study|Lost to Follow-up|1|||
124835775|NCT01150123|449028612|FG002|Overall Study|Lost to Follow-up|2|||
124835776|NCT01150123|449028613|FG003|Overall Study|Lost to Follow-up|2|||
124835777|NCT01150123|449028614|FG004|Overall Study|Lost to Follow-up|2|||
124835778|NCT01150123|449028615|FG005|Overall Study|Lost to Follow-up|5|||
124835779|NCT01150123|449028616|FG006|Overall Study|Lost to Follow-up|0|||
124835780|NCT01150123|449028617|FG007|Overall Study|Lost to Follow-up|0|||
124835781|NCT01150123|449028618|FG008|Overall Study|Lost to Follow-up|3|||
124835782|NCT01150123|449028619|FG009|Overall Study|Lost to Follow-up|1|||
124835783|NCT01150123|449028620|FG010|Overall Study|Lost to Follow-up|1|||
124835784|NCT01150123|449028621|FG011|Overall Study|Lost to Follow-up|1|||
124835785|NCT01150123|449028622|FG012|Overall Study|Lost to Follow-up|2|||
124835786|NCT01150123|449028623|FG013|Overall Study|Lost to Follow-up|0|||
124835787|NCT01150123|449028624|FG014|Overall Study|Lost to Follow-up|0|||
124835788|NCT01150123|449028625|FG015|Overall Study|Lost to Follow-up|0|||
124835789|NCT01150123|449028626|FG016|Overall Study|Lost to Follow-up|0|||
124835790|NCT01150123|449028627|FG017|Overall Study|Lost to Follow-up|0|||
124835791|NCT02486042|449028632|FG000|Overall Study|Physician Decision|1|||
124835792|NCT02486042|449028633|FG001|Overall Study|Physician Decision|7|||
124835793|NCT02486042|449028632|FG000|Overall Study|Hospital transfer|2|||
124835794|NCT02486042|449028633|FG001|Overall Study|Hospital transfer|2|||
124835795|NCT02486042|449028632|FG000|Overall Study|Withdrawal by Subject|0|||
124835796|NCT02486042|449028633|FG001|Overall Study|Withdrawal by Subject|2|||
124835797|NCT01466387|449028634|FG000|Overall Study|Adverse Event|0|||
124835798|NCT01466387|449028635|FG001|Overall Study|Adverse Event|0|||
124835799|NCT01466387|449028636|FG002|Overall Study|Adverse Event|1|||
124835800|NCT01466387|449028637|FG003|Overall Study|Adverse Event|1|||
124835801|NCT01466387|449028638|FG004|Overall Study|Adverse Event|0|||
124835802|NCT01466387|449028639|FG005|Overall Study|Adverse Event|0|||
124835803|NCT01466387|449028634|FG000|Overall Study|Lost to Follow-up|0|||
124835804|NCT01466387|449028635|FG001|Overall Study|Lost to Follow-up|0|||
124835805|NCT01466387|449028636|FG002|Overall Study|Lost to Follow-up|0|||
124639511|NCT00652626|448298407|FG003|Initial Treatment Phase|Adverse Event|0|||
124639512|NCT00652626|448298408|FG004|Initial Treatment Phase|Adverse Event|1|||
124639513|NCT00652626|448298409|FG005|Initial Treatment Phase|Adverse Event|0|||
124835806|NCT01466387|449028637|FG003|Overall Study|Lost to Follow-up|0|||
124835807|NCT01466387|449028638|FG004|Overall Study|Lost to Follow-up|0|||
124835808|NCT01466387|449028639|FG005|Overall Study|Lost to Follow-up|1|||
124835809|NCT01466387|449028634|FG000|Overall Study|Protocol Violation|1|||
124835810|NCT01466387|449028635|FG001|Overall Study|Protocol Violation|0|||
124835811|NCT01466387|449028636|FG002|Overall Study|Protocol Violation|0|||
124835812|NCT01466387|449028637|FG003|Overall Study|Protocol Violation|1|||
124835813|NCT01466387|449028638|FG004|Overall Study|Protocol Violation|0|||
124835814|NCT01466387|449028639|FG005|Overall Study|Protocol Violation|0|||
124835815|NCT02968979|449028642|FG000|Overall Study|Protocol Violation|7|||
124835816|NCT02968979|449028642|FG000|Overall Study|Withdrawal by Subject|1|||
124835817|NCT04404855|449028643|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
124835818|NCT04404855|449028644|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
124835819|NCT03320564|449028645|FG000|Overall Study|Protocol Violation|1|||
124835820|NCT00788827|449028646|FG000|Overall Study|Lack of Efficacy|2|||
124835821|NCT03745144|449028653|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
124835822|NCT03745144|449028654|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
124835823|NCT03745144|449028655|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
124835824|NCT03745144|449028653|FG000|Period 1|Other|0|||
124835825|NCT03745144|449028654|FG001|Period 1|Other|0|||
124835826|NCT03745144|449028655|FG002|Period 1|Other|1|||
124835827|NCT01586819|449028656|FG000|Overall Study|Withdrawal by Subject|1|||
124835828|NCT01586819|449028657|FG001|Overall Study|Withdrawal by Subject|0|||
124835829|NCT00896337|449028658|FG000|Overall Study|Death|7|||
124835830|NCT00896337|449028658|FG000|Overall Study|Withdrawal by Subject|7|||
124835831|NCT00896337|449028658|FG000|Overall Study|Lost to Follow-up|11|||
124835832|NCT01359254|449028659|FG000|Overall Study|Death|1|||
124835833|NCT01359254|449028660|FG001|Overall Study|Death|0|||
124835834|NCT04668950|449028661|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
124835835|NCT04668950|449028662|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
124835836|NCT04668950|449028661|FG000|Overall Study|Could not confirm started study medication|15|||
124835837|NCT04668950|449028662|FG001|Overall Study|Could not confirm started study medication|15|||
124835838|NCT04668950|449028661|FG000|Overall Study|Could not confirm baseline status|6|||
124835839|NCT04668950|449028662|FG001|Overall Study|Could not confirm baseline status|2|||
124835840|NCT04668950|449028661|FG000|Overall Study|Drop out and did not start medication|15|||
124835841|NCT04668950|449028662|FG001|Overall Study|Drop out and did not start medication|17|||
124835842|NCT04668950|449028661|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
124835843|NCT04668950|449028662|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
124835844|NCT04668950|449028661|FG000|Overall Study|Other|2|||
124835845|NCT04668950|449028662|FG001|Overall Study|Other|4|||
124835846|NCT01124643|449028665|FG000|Overall Study|Death|1|||
124835847|NCT02910167|449028666|FG000|Overall Study|Adverse Event|1|||
124835848|NCT02910167|449028666|FG000|Overall Study|Lost to Follow-up|18|||
124835849|NCT04220411|449028667|FG000|Overall Study|Adverse Event|0|||
124835850|NCT04220411|449028668|FG001|Overall Study|Adverse Event|0|||
124835851|NCT04220411|449028669|FG002|Overall Study|Adverse Event|0|||
124835852|NCT04220411|449028670|FG003|Overall Study|Adverse Event|1|||
124835853|NCT02028988|449028671|FG000|Overall Study|Withdrawal by Subject|2|||
124835854|NCT02680639|449028674|FG000|Screening Period|Screen Failure|7|||
124835855|NCT02680639|449028675|FG001|Screening Period|Screen Failure|0|||
124835856|NCT02680639|449028676|FG002|Screening Period|Screen Failure|0|||
124835857|NCT02678676|449028677|FG000|Overall Study|Death|619|||
124835858|NCT02678676|449028678|FG001|Overall Study|Death|649|||
124835859|NCT02678676|449028677|FG000|Overall Study|Withdrawal by Subject|13|||
124835860|NCT02678676|449028678|FG001|Overall Study|Withdrawal by Subject|5|||
124835861|NCT02678676|449028677|FG000|Overall Study|Lost to Follow-up|171|||
124835862|NCT02678676|449028678|FG001|Overall Study|Lost to Follow-up|151|||
124835863|NCT02678676|449028677|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
124835864|NCT02678676|449028678|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
124835865|NCT04059146|449028679|FG000|Overall Study|Withdrawal by Subject|0|||
124835866|NCT04059146|449028680|FG001|Overall Study|Withdrawal by Subject|1|||
124835867|NCT00851799|449028681|FG000|Overall Study|Death|1|||
124835868|NCT00851799|449028682|FG001|Overall Study|Death|0|||
124835869|NCT00851799|449028683|FG002|Overall Study|Death|1|||
124835870|NCT00851799|449028681|FG000|Overall Study|Lost to Follow-up|5|||
124835871|NCT00851799|449028682|FG001|Overall Study|Lost to Follow-up|3|||
124835872|NCT00851799|449028683|FG002|Overall Study|Lost to Follow-up|10|||
124835873|NCT00851799|449028681|FG000|Overall Study|Not able to get to clinic|8|||
124835874|NCT00851799|449028682|FG001|Overall Study|Not able to get to clinic|5|||
124835875|NCT00851799|449028683|FG002|Overall Study|Not able to get to clinic|9|||
124835876|NCT00851799|449028681|FG000|Overall Study|Not willing to adhere to requirements|1|||
124835877|NCT00851799|449028682|FG001|Overall Study|Not willing to adhere to requirements|2|||
124835878|NCT00851799|449028683|FG002|Overall Study|Not willing to adhere to requirements|2|||
124835879|NCT00851799|449028681|FG000|Overall Study|Withdrew consent prior study completion|1|||
124835880|NCT00851799|449028682|FG001|Overall Study|Withdrew consent prior study completion|2|||
124835881|NCT00851799|449028683|FG002|Overall Study|Withdrew consent prior study completion|1|||
124835882|NCT00851799|449028681|FG000|Overall Study|Severe Debilitation|0|||
124639514|NCT00652626|448298410|FG006|Initial Treatment Phase|Adverse Event|0|||
124835883|NCT00851799|449028682|FG001|Overall Study|Severe Debilitation|1|||
124835884|NCT00851799|449028683|FG002|Overall Study|Severe Debilitation|0|||
124835885|NCT00851799|449028681|FG000|Overall Study|Completed protocol due to pregnancy|0|||
124835886|NCT00851799|449028682|FG001|Overall Study|Completed protocol due to pregnancy|0|||
124835887|NCT00851799|449028683|FG002|Overall Study|Completed protocol due to pregnancy|1|||
124835888|NCT04056195|449028687|FG000|Overall Study|Adverse Event|1|||
124835889|NCT04056195|449028688|FG001|Overall Study|Adverse Event|0|||
124835890|NCT04056195|449028689|FG002|Overall Study|Adverse Event|0|||
124835891|NCT04056195|449028687|FG000|Overall Study|Withdrawal by Subject|0|||
124835892|NCT04056195|449028688|FG001|Overall Study|Withdrawal by Subject|1|||
124835893|NCT04056195|449028689|FG002|Overall Study|Withdrawal by Subject|1|||
124639515|NCT00652626|448298404|FG000|Initial Treatment Phase|Protocol Violation|0|||
124835894|NCT04056195|449028687|FG000|Overall Study|Physician Decision|1|||
124835895|NCT04056195|449028688|FG001|Overall Study|Physician Decision|1|||
124835896|NCT04056195|449028689|FG002|Overall Study|Physician Decision|1|||
124835897|NCT01342510|449028705|FG000|Overall Study|Protocol Violation|12|||
124835898|NCT01342510|449028706|FG001|Overall Study|Protocol Violation|6|||
124835899|NCT01342510|449028707|FG002|Overall Study|Protocol Violation|13|||
124835900|NCT01342510|449028708|FG003|Overall Study|Protocol Violation|11|||
124835901|NCT01400516|449028710|FG000|Primary Trial|Withdrawal by Subject|0|||
124835902|NCT01400516|449028711|FG001|Primary Trial|Withdrawal by Subject|2|||
124835903|NCT01796197|449028719|FG000|Overall Study|Lost to Follow-up|1|||
124835904|NCT01796197|449028719|FG000|Overall Study|Lack of Efficacy|1|||
124835905|NCT01380184|449028720|FG000|Part 1 (19 Days)|Adverse Event|1|||
124835906|NCT01380184|449028720|FG000|Part 2|Adverse Event|5|||
124835907|NCT01380184|449028720|FG000|Part 2|Disease Progression|8|||
124835908|NCT01380184|449028720|FG000|Part 2|Lost to Follow-up|1|||
124835909|NCT04243538|449028721|FG000|Overall Study|Withdrawal by Subject|0|||
124835910|NCT04243538|449028722|FG001|Overall Study|Withdrawal by Subject|2|||
124835911|NCT04243538|449028721|FG000|Overall Study|Lost to Follow-up|0|||
124835912|NCT04243538|449028722|FG001|Overall Study|Lost to Follow-up|3|||
124835913|NCT03532295|449028723|FG000|Overall Study|Did not start treatment|0|||
124835914|NCT03532295|449028724|FG001|Overall Study|Did not start treatment|2|||
124835915|NCT02776917|449028725|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
124835916|NCT02558790|449030476|FG000|Overall Study|Lost to Follow-up|2|||
124835917|NCT02558790|449030476|FG000|Overall Study|Physician Decision|1|||
124835918|NCT02558790|449030476|FG000|Overall Study|Withdrawal by Subject|1|||
124835919|NCT02558790|449030476|FG000|Overall Study|Screen Fail|3|||
124835920|NCT05620576|449030486|FG000|Overall Study|Adverse Event|1|||
124835921|NCT05620576|449030487|FG001|Overall Study|Adverse Event|1|||
124835922|NCT05620576|449030486|FG000|Overall Study|Lost to Follow-up|3|||
124835923|NCT05620576|449030487|FG001|Overall Study|Lost to Follow-up|1|||
124835924|NCT05620576|449030486|FG000|Overall Study|Physician Decision|0|||
124835925|NCT05620576|449030487|FG001|Overall Study|Physician Decision|1|||
124835926|NCT05620576|449030486|FG000|Overall Study|Protocol Deviation|1|||
124835927|NCT05620576|449030487|FG001|Overall Study|Protocol Deviation|1|||
124835928|NCT05620576|449030486|FG000|Overall Study|Withdrawal by Subject|2|||
124835929|NCT05620576|449030487|FG001|Overall Study|Withdrawal by Subject|3|||
124835930|NCT01203072|449030498|FG000|Overall Study|Adverse Event|5|||
124835931|NCT01203072|449030499|FG001|Overall Study|Adverse Event|3|||
124835932|NCT01203072|449030500|FG002|Overall Study|Adverse Event|2|||
124835933|NCT01203072|449030501|FG003|Overall Study|Adverse Event|4|||
124835934|NCT01203072|449030502|FG004|Overall Study|Adverse Event|2|||
124835935|NCT01203072|449030498|FG000|Overall Study|Lack of Efficacy|1|||
124835936|NCT01203072|449030499|FG001|Overall Study|Lack of Efficacy|0|||
124835937|NCT01203072|449030500|FG002|Overall Study|Lack of Efficacy|0|||
124835938|NCT01203072|449030501|FG003|Overall Study|Lack of Efficacy|0|||
124835939|NCT01203072|449030502|FG004|Overall Study|Lack of Efficacy|0|||
124835940|NCT01203072|449030498|FG000|Overall Study|Lost to Follow-up|0|||
124835941|NCT01203072|449030499|FG001|Overall Study|Lost to Follow-up|1|||
124835942|NCT01203072|449030500|FG002|Overall Study|Lost to Follow-up|0|||
124835943|NCT01203072|449030501|FG003|Overall Study|Lost to Follow-up|0|||
124835944|NCT01203072|449030502|FG004|Overall Study|Lost to Follow-up|0|||
124835945|NCT01203072|449030498|FG000|Overall Study|Protocol Violation|2|||
124835946|NCT01203072|449030499|FG001|Overall Study|Protocol Violation|0|||
124835947|NCT01203072|449030500|FG002|Overall Study|Protocol Violation|0|||
124835948|NCT01203072|449030501|FG003|Overall Study|Protocol Violation|0|||
124835949|NCT01203072|449030502|FG004|Overall Study|Protocol Violation|1|||
124835950|NCT01203072|449030498|FG000|Overall Study|Withdrawal by Subject|2|||
124835951|NCT01203072|449030499|FG001|Overall Study|Withdrawal by Subject|2|||
124835952|NCT01203072|449030500|FG002|Overall Study|Withdrawal by Subject|1|||
124835953|NCT01203072|449030501|FG003|Overall Study|Withdrawal by Subject|2|||
124835954|NCT01203072|449030502|FG004|Overall Study|Withdrawal by Subject|3|||
124835955|NCT02286193|449030508|FG000|Overall Study|Referred: CRS unable to make contact|62|||
124835956|NCT02286193|449030508|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
124835957|NCT02286193|449030508|FG000|Overall Study|Referred: Declined service|38|||
124835958|NCT02023151|449030509|FG000|Overall Study|Lost to Follow-up|4|||
124835959|NCT04064294|449030510|FG000|Overall Study|Adverse Event|1|||
124835960|NCT04064294|449030511|FG001|Overall Study|Adverse Event|0|||
124835961|NCT04064294|449030512|FG002|Overall Study|Adverse Event|0|||
124639516|NCT00652626|448298405|FG001|Initial Treatment Phase|Protocol Violation|0|||
124639517|NCT00652626|448298406|FG002|Initial Treatment Phase|Protocol Violation|0|||
124835962|NCT03450707|449030513|FG000|Overall Study|Outside enrollment window|4|||
124835963|NCT03450707|449030514|FG001|Overall Study|Outside enrollment window|1|||
124835964|NCT03450707|449030513|FG000|Overall Study|Death|1|||
124835965|NCT03450707|449030514|FG001|Overall Study|Death|0|||
124835966|NCT03450707|449030513|FG000|Overall Study|Indication for thiamine|1|||
124835967|NCT03450707|449030514|FG001|Overall Study|Indication for thiamine|1|||
124835968|NCT03450707|449030513|FG000|Overall Study|Evidence of traumatic brain injury|1|||
124835969|NCT03450707|449030514|FG001|Overall Study|Evidence of traumatic brain injury|0|||
124835970|NCT03450707|449030513|FG000|Overall Study|Following commands|0|||
124835971|NCT03450707|449030514|FG001|Overall Study|Following commands|3|||
124835972|NCT03450707|449030513|FG000|Overall Study|Lactate < 3.5|0|||
124835973|NCT03450707|449030514|FG001|Overall Study|Lactate < 3.5|2|||
124835974|NCT03450707|449030513|FG000|Overall Study|Rearrest with ECMO|0|||
124835975|NCT03450707|449030514|FG001|Overall Study|Rearrest with ECMO|1|||
124835976|NCT03450707|449030513|FG000|Overall Study|Indication for thiamine + head CT results|0|||
124835977|NCT03450707|449030514|FG001|Overall Study|Indication for thiamine + head CT results|1|||
124835978|NCT03450707|449030513|FG000|Overall Study|Family/patient goals of care|0|||
124835979|NCT03450707|449030514|FG001|Overall Study|Family/patient goals of care|1|||
124835980|NCT03343483|449030515|FG000|Overall Study|Death|0|||
124835981|NCT03343483|449030516|FG001|Overall Study|Death|3|||
124835982|NCT03343483|449030515|FG000|Overall Study|Lost to Follow-up|9|||
124835983|NCT03343483|449030516|FG001|Overall Study|Lost to Follow-up|13|||
124835984|NCT03343483|449030515|FG000|Overall Study|Withdrawal by Subject|8|||
124835985|NCT03343483|449030516|FG001|Overall Study|Withdrawal by Subject|17|||
124835986|NCT00337103|449030517|FG000|Overall Study|Progressive Disease|414|||
124835987|NCT00337103|449030518|FG001|Overall Study|Progressive Disease|410|||
124835988|NCT00337103|449030517|FG000|Overall Study|Adverse Event|45|||
124835989|NCT00337103|449030518|FG001|Overall Study|Adverse Event|59|||
124835990|NCT00337103|449030517|FG000|Overall Study|Subject Choice|34|||
124835991|NCT00337103|449030518|FG001|Overall Study|Subject Choice|27|||
124835992|NCT00337103|449030517|FG000|Overall Study|Clinical Progression|27|||
124835993|NCT00337103|449030518|FG001|Overall Study|Clinical Progression|24|||
124835994|NCT00337103|449030517|FG000|Overall Study|Physician Decision|15|||
124835995|NCT00337103|449030518|FG001|Overall Study|Physician Decision|14|||
124835996|NCT00337103|449030517|FG000|Overall Study|Withdrawal by Subject|8|||
124835997|NCT00337103|449030518|FG001|Overall Study|Withdrawal by Subject|5|||
124835998|NCT00337103|449030517|FG000|Overall Study|Other|5|||
124835999|NCT00337103|449030518|FG001|Overall Study|Other|6|||
124836000|NCT00337103|449030517|FG000|Overall Study|Entry Criteria Not Met|4|||
124836001|NCT00337103|449030518|FG001|Overall Study|Entry Criteria Not Met|1|||
124836002|NCT00337103|449030517|FG000|Overall Study|Lost to Follow-up|1|||
124836003|NCT00337103|449030518|FG001|Overall Study|Lost to Follow-up|2|||
124639518|NCT00652626|448298407|FG003|Initial Treatment Phase|Protocol Violation|1|||
124639519|NCT00652626|448298408|FG004|Initial Treatment Phase|Protocol Violation|0|||
124639520|NCT00652626|448298409|FG005|Initial Treatment Phase|Protocol Violation|0|||
124639521|NCT00652626|448298410|FG006|Initial Treatment Phase|Protocol Violation|0|||
124639522|NCT00652626|448298404|FG000|Initial Treatment Phase|Physician Decision|0|||
124639523|NCT00652626|448298405|FG001|Initial Treatment Phase|Physician Decision|0|||
124639524|NCT00652626|448298406|FG002|Initial Treatment Phase|Physician Decision|0|||
124639525|NCT00652626|448298407|FG003|Initial Treatment Phase|Physician Decision|0|||
124639526|NCT00652626|448298408|FG004|Initial Treatment Phase|Physician Decision|1|||
124639527|NCT00652626|448298409|FG005|Initial Treatment Phase|Physician Decision|0|||
124639528|NCT00652626|448298410|FG006|Initial Treatment Phase|Physician Decision|0|||
124639529|NCT00652626|448298404|FG000|Initial Treatment Phase|Sponsor Request|0|||
124639530|NCT00652626|448298405|FG001|Initial Treatment Phase|Sponsor Request|0|||
124639531|NCT00652626|448298406|FG002|Initial Treatment Phase|Sponsor Request|1|||
124836004|NCT00337103|449030517|FG000|Overall Study|Death|1|||
124836005|NCT00337103|449030518|FG001|Overall Study|Death|0|||
124836006|NCT01577758|449030519|FG000|Dose Escalation Phase|Adverse Event|0|||
124836007|NCT01577758|449030520|FG001|Dose Escalation Phase|Adverse Event|0|||
124836008|NCT01577758|449030521|FG002|Dose Escalation Phase|Adverse Event|0|||
124836009|NCT01577758|449030522|FG003|Dose Escalation Phase|Adverse Event|0|||
124639532|NCT00652626|448298407|FG003|Initial Treatment Phase|Sponsor Request|0|||
124836010|NCT01577758|449030523|FG004|Dose Escalation Phase|Adverse Event|0|||
124836011|NCT01577758|449030524|FG005|Dose Escalation Phase|Adverse Event|2|||
124836012|NCT01577758|449030525|FG006|Dose Escalation Phase|Adverse Event|1|||
124836013|NCT01577758|449030526|FG007|Dose Escalation Phase|Adverse Event|0|||
124836014|NCT01577758|449030519|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
124836015|NCT01577758|449030520|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
124639533|NCT00652626|448298408|FG004|Initial Treatment Phase|Sponsor Request|0|||
124639534|NCT00652626|448298409|FG005|Initial Treatment Phase|Sponsor Request|0|||
124639535|NCT00652626|448298410|FG006|Initial Treatment Phase|Sponsor Request|0|||
124639536|NCT00652626|448298404|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
124639537|NCT00652626|448298405|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
124639538|NCT00652626|448298406|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
124836016|NCT01577758|449030521|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
124836017|NCT01577758|449030522|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
124639539|NCT00652626|448298407|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
124836018|NCT01577758|449030523|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
124836019|NCT01577758|449030524|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
124836020|NCT01577758|449030525|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
124836021|NCT01577758|449030526|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
124836022|NCT01577758|449030519|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
124836023|NCT01577758|449030520|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
124836024|NCT01577758|449030521|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
124836025|NCT01577758|449030522|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
124836026|NCT01577758|449030523|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
124836027|NCT01577758|449030524|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
124836028|NCT01577758|449030525|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
124836029|NCT01577758|449030526|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
124836030|NCT01577758|449030519|FG000|Dose Escalation Phase|Progression Disease|2|||
124836031|NCT01577758|449030520|FG001|Dose Escalation Phase|Progression Disease|2|||
124836032|NCT01577758|449030521|FG002|Dose Escalation Phase|Progression Disease|1|||
124836033|NCT01577758|449030522|FG003|Dose Escalation Phase|Progression Disease|2|||
124836034|NCT01577758|449030523|FG004|Dose Escalation Phase|Progression Disease|5|||
124836035|NCT01577758|449030524|FG005|Dose Escalation Phase|Progression Disease|0|||
124836036|NCT01577758|449030525|FG006|Dose Escalation Phase|Progression Disease|0|||
124836037|NCT01577758|449030526|FG007|Dose Escalation Phase|Progression Disease|0|||
124836038|NCT01577758|449030519|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
124836039|NCT01577758|449030520|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
124836040|NCT01577758|449030521|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
124836041|NCT01577758|449030522|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
124836042|NCT01577758|449030523|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
124836043|NCT01577758|449030524|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
124836044|NCT01577758|449030525|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
124836045|NCT01577758|449030526|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
124836046|NCT01577758|449030519|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
124836047|NCT01577758|449030520|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
124836048|NCT01577758|449030521|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
124836049|NCT01577758|449030522|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
124836050|NCT01577758|449030523|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
124836051|NCT01577758|449030524|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
124836052|NCT01577758|449030525|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
124836053|NCT01577758|449030526|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
124836054|NCT01577758|449030519|FG000|mCRC Expansion Phase|Progression Disease|0|||
124836055|NCT01577758|449030520|FG001|mCRC Expansion Phase|Progression Disease|0|||
124836056|NCT01577758|449030521|FG002|mCRC Expansion Phase|Progression Disease|0|||
124836057|NCT01577758|449030522|FG003|mCRC Expansion Phase|Progression Disease|0|||
124836058|NCT01577758|449030523|FG004|mCRC Expansion Phase|Progression Disease|0|||
124836059|NCT01577758|449030524|FG005|mCRC Expansion Phase|Progression Disease|0|||
124836060|NCT01577758|449030525|FG006|mCRC Expansion Phase|Progression Disease|0|||
124836061|NCT01577758|449030526|FG007|mCRC Expansion Phase|Progression Disease|19|||
124836062|NCT03387813|449030527|FG000|Overall Study|Death|40|||
124836063|NCT03387813|449030528|FG001|Overall Study|Death|37|||
124836064|NCT03387813|449030529|FG002|Overall Study|Death|190|||
124836065|NCT03387813|449030527|FG000|Overall Study|Withdrawal by Subject|9|||
124836066|NCT03387813|449030528|FG001|Overall Study|Withdrawal by Subject|19|||
124836067|NCT03387813|449030529|FG002|Overall Study|Withdrawal by Subject|32|||
124836068|NCT03387813|449030527|FG000|Overall Study|Lost to Follow-up|3|||
124836069|NCT03387813|449030528|FG001|Overall Study|Lost to Follow-up|9|||
124836070|NCT03387813|449030529|FG002|Overall Study|Lost to Follow-up|15|||
124836071|NCT03387813|449030527|FG000|Overall Study|Non-Compliance|6|||
124836072|NCT03387813|449030528|FG001|Overall Study|Non-Compliance|6|||
124836073|NCT03387813|449030529|FG002|Overall Study|Non-Compliance|31|||
124836074|NCT03387813|449030527|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
124836075|NCT03387813|449030528|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
124836076|NCT03387813|449030529|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
124836077|NCT01289847|449030530|FG000|Overall Study|Patient could not comply with visits|1|||
124836078|NCT04327999|449030535|FG000|Overall Study|Protocol Violation|1|||
124836079|NCT03975647|449030536|FG000|Overall Study|Death|71|||
124836080|NCT03975647|449030537|FG001|Overall Study|Death|63|||
124836081|NCT03975647|449030536|FG000|Overall Study|Lost to Follow-up|2|||
124836082|NCT03975647|449030537|FG001|Overall Study|Lost to Follow-up|2|||
124836083|NCT03975647|449030536|FG000|Overall Study|Subject withdrawal of consent|7|||
124639540|NCT00652626|448298408|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
124639541|NCT00652626|448298409|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
124836084|NCT03975647|449030537|FG001|Overall Study|Subject withdrawal of consent|11|||
124836085|NCT02872116|449030538|FG000|Pre-Treatment|Disease Progression|0|||
124836086|NCT02872116|449030539|FG001|Pre-Treatment|Disease Progression|1|||
124836087|NCT02872116|449030540|FG002|Pre-Treatment|Disease Progression|0|||
124836088|NCT02872116|449030538|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
124836089|NCT02872116|449030539|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
124836090|NCT02872116|449030540|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
124836091|NCT02872116|449030538|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
124836092|NCT02872116|449030539|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
124836093|NCT02872116|449030540|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
124836094|NCT02872116|449030538|FG000|Pre-Treatment|Participant withdrew consent|2|||
124836095|NCT02872116|449030539|FG001|Pre-Treatment|Participant withdrew consent|20|||
124836096|NCT02872116|449030540|FG002|Pre-Treatment|Participant withdrew consent|3|||
124836097|NCT02872116|449030538|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
124836098|NCT02872116|449030539|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
124836099|NCT02872116|449030540|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
124836100|NCT02872116|449030538|FG000|Pre-Treatment|Other reasons|1|||
124836101|NCT02872116|449030539|FG001|Pre-Treatment|Other reasons|2|||
124836102|NCT02872116|449030540|FG002|Pre-Treatment|Other reasons|2|||
124836103|NCT02872116|449030538|FG000|Treatment|Death|121|||
124836104|NCT02872116|449030539|FG001|Treatment|Death|94|||
124836105|NCT02872116|449030540|FG002|Treatment|Death|68|||
124836106|NCT02872116|449030538|FG000|Treatment|Lost to Follow-up|5|||
124836107|NCT02872116|449030539|FG001|Treatment|Lost to Follow-up|7|||
124836108|NCT02872116|449030540|FG002|Treatment|Lost to Follow-up|3|||
124836109|NCT02872116|449030538|FG000|Treatment|Participant withdrew consent|20|||
124836110|NCT02872116|449030539|FG001|Treatment|Participant withdrew consent|40|||
124836111|NCT02872116|449030540|FG002|Treatment|Participant withdrew consent|8|||
124836112|NCT02872116|449030538|FG000|Treatment|Other reasons|13|||
124836113|NCT02872116|449030539|FG001|Treatment|Other reasons|12|||
124836114|NCT02872116|449030540|FG002|Treatment|Other reasons|5|||
124836115|NCT03735667|449030541|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
124836116|NCT03735667|449030542|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
124836117|NCT03735667|449030543|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
124836118|NCT03735667|449030541|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
124836119|NCT03735667|449030542|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
124836120|NCT03735667|449030543|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
124836121|NCT03735667|449030541|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
124836122|NCT03735667|449030542|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
124836123|NCT03735667|449030543|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
124836124|NCT03735667|449030541|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
124836125|NCT03735667|449030542|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
124836126|NCT03735667|449030543|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
124836127|NCT03735667|449030541|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
124836128|NCT03735667|449030542|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
124836129|NCT03735667|449030543|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
124836130|NCT03735667|449030541|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
124836131|NCT03735667|449030542|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
124836132|NCT03735667|449030543|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
124836133|NCT03735667|449030541|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
124836134|NCT03735667|449030542|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
124836135|NCT03735667|449030543|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
124836136|NCT03735667|449030541|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
124836137|NCT03735667|449030542|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
124836138|NCT03735667|449030543|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
124836139|NCT03735667|449030541|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
124836140|NCT03735667|449030542|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
124836141|NCT03735667|449030543|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
124836142|NCT03735667|449030541|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
124836143|NCT03735667|449030542|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
124836144|NCT03735667|449030543|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
124836145|NCT03735667|449030541|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
124836146|NCT03735667|449030542|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
124836147|NCT03735667|449030543|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
124836148|NCT03735667|449030541|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
124836149|NCT03735667|449030542|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
124836150|NCT03735667|449030543|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
124836151|NCT00006478|449030547|FG000|Overall Study|Vaccine could not be produced|1|||
124836152|NCT00006478|449030547|FG000|Overall Study|Physician Decision|6|||
124836153|NCT03161483|449030551|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
124836154|NCT03161483|449030552|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
124836155|NCT03161483|449030553|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
124836156|NCT03161483|449030554|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
124836157|NCT03161483|449030551|FG000|Treatment Period|Death|1|||
124836158|NCT03161483|449030552|FG001|Treatment Period|Death|0|||
124639542|NCT00652626|448298410|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
124639543|NCT00652626|448298404|FG000|Extension Phase|Withdrawal by Subject|0|||
124836159|NCT03161483|449030553|FG002|Treatment Period|Death|0|||
124836160|NCT03161483|449030554|FG003|Treatment Period|Death|0|||
124836161|NCT03161483|449030551|FG000|Treatment Period|Adverse Event|5|||
124836162|NCT03161483|449030552|FG001|Treatment Period|Adverse Event|2|||
124836163|NCT03161483|449030553|FG002|Treatment Period|Adverse Event|1|||
124836164|NCT03161483|449030554|FG003|Treatment Period|Adverse Event|11|||
124836165|NCT03161483|449030551|FG000|Treatment Period|Pregnancy|1|||
124836166|NCT03161483|449030552|FG001|Treatment Period|Pregnancy|0|||
124836167|NCT03161483|449030553|FG002|Treatment Period|Pregnancy|0|||
124836168|NCT03161483|449030554|FG003|Treatment Period|Pregnancy|0|||
124836169|NCT03161483|449030551|FG000|Treatment Period|Lack of Efficacy|0|||
124836170|NCT03161483|449030552|FG001|Treatment Period|Lack of Efficacy|0|||
124836171|NCT03161483|449030553|FG002|Treatment Period|Lack of Efficacy|0|||
124836172|NCT03161483|449030554|FG003|Treatment Period|Lack of Efficacy|1|||
124836173|NCT03161483|449030551|FG000|Treatment Period|Withdrawal by Subject|2|||
124836174|NCT03161483|449030552|FG001|Treatment Period|Withdrawal by Subject|5|||
124836175|NCT03161483|449030553|FG002|Treatment Period|Withdrawal by Subject|2|||
124836176|NCT03161483|449030554|FG003|Treatment Period|Withdrawal by Subject|6|||
124836177|NCT03161483|449030551|FG000|Treatment Period|Lost to Follow-up|0|||
124836178|NCT03161483|449030552|FG001|Treatment Period|Lost to Follow-up|0|||
124836179|NCT03161483|449030553|FG002|Treatment Period|Lost to Follow-up|0|||
124836180|NCT03161483|449030554|FG003|Treatment Period|Lost to Follow-up|1|||
124836181|NCT03161483|449030551|FG000|Treatment Period|Protocol Violation|0|||
124836182|NCT03161483|449030552|FG001|Treatment Period|Protocol Violation|0|||
124836183|NCT03161483|449030553|FG002|Treatment Period|Protocol Violation|0|||
124836184|NCT03161483|449030554|FG003|Treatment Period|Protocol Violation|1|||
124836185|NCT03161483|449030551|FG000|Treatment Period|Other reasons|1|||
124836186|NCT03161483|449030552|FG001|Treatment Period|Other reasons|1|||
124836187|NCT03161483|449030553|FG002|Treatment Period|Other reasons|0|||
124836188|NCT03161483|449030554|FG003|Treatment Period|Other reasons|0|||
124836189|NCT02404350|449030565|FG000|Overall Study|Adverse Event|2|||
124836190|NCT02404350|449030566|FG001|Overall Study|Adverse Event|2|||
124836191|NCT02404350|449030567|FG002|Overall Study|Adverse Event|3|||
124836192|NCT02404350|449030568|FG003|Overall Study|Adverse Event|9|||
124836193|NCT02404350|449030565|FG000|Overall Study|Lack of Efficacy|3|||
124836194|NCT02404350|449030566|FG001|Overall Study|Lack of Efficacy|1|||
124836195|NCT02404350|449030567|FG002|Overall Study|Lack of Efficacy|0|||
124836196|NCT02404350|449030568|FG003|Overall Study|Lack of Efficacy|3|||
124836197|NCT02404350|449030565|FG000|Overall Study|Lost to Follow-up|2|||
124836198|NCT02404350|449030566|FG001|Overall Study|Lost to Follow-up|0|||
124836199|NCT02404350|449030567|FG002|Overall Study|Lost to Follow-up|0|||
124836200|NCT02404350|449030568|FG003|Overall Study|Lost to Follow-up|1|||
124836201|NCT02404350|449030565|FG000|Overall Study|Physician Decision|1|||
124836202|NCT02404350|449030566|FG001|Overall Study|Physician Decision|0|||
124836203|NCT02404350|449030567|FG002|Overall Study|Physician Decision|0|||
124836204|NCT02404350|449030568|FG003|Overall Study|Physician Decision|2|||
124836205|NCT02404350|449030565|FG000|Overall Study|Pregnancy|0|||
124836206|NCT02404350|449030566|FG001|Overall Study|Pregnancy|0|||
124836207|NCT02404350|449030567|FG002|Overall Study|Pregnancy|0|||
124836208|NCT02404350|449030568|FG003|Overall Study|Pregnancy|1|||
124836209|NCT02404350|449030565|FG000|Overall Study|Withdrawal by Subject|7|||
124836210|NCT02404350|449030566|FG001|Overall Study|Withdrawal by Subject|3|||
124836211|NCT02404350|449030567|FG002|Overall Study|Withdrawal by Subject|3|||
124836212|NCT02404350|449030568|FG003|Overall Study|Withdrawal by Subject|19|||
124836213|NCT02404350|449030565|FG000|Overall Study|Due to Non-compliance with treatment|0|||
124836214|NCT02404350|449030566|FG001|Overall Study|Due to Non-compliance with treatment|0|||
124836215|NCT02404350|449030567|FG002|Overall Study|Due to Non-compliance with treatment|0|||
124836216|NCT02404350|449030568|FG003|Overall Study|Due to Non-compliance with treatment|1|||
124836217|NCT02404350|449030565|FG000|Overall Study|Due to Technical problems|0|||
124836218|NCT02404350|449030566|FG001|Overall Study|Due to Technical problems|0|||
124836219|NCT02404350|449030567|FG002|Overall Study|Due to Technical problems|0|||
124836220|NCT02404350|449030568|FG003|Overall Study|Due to Technical problems|1|||
124836221|NCT04238728|449030569|FG000|Overall Study|Withdrawal by Subject|1|||
124836222|NCT04238728|449030569|FG000|Overall Study|Lost to Follow-up|2|||
124836223|NCT05389657|449030571|FG000|Overall Study|Lost to Follow-up|7|||
124836224|NCT05389657|449030572|FG001|Overall Study|Lost to Follow-up|8|||
124836225|NCT04414553|449030574|FG000|Overall Study|Lost to Follow-up|20|||
124836226|NCT01085097|449030575|FG000|Overall Study|Adverse Event|0|||
124836227|NCT01085097|449030576|FG001|Overall Study|Adverse Event|0|||
124836228|NCT01085097|449030577|FG002|Overall Study|Adverse Event|2|||
124836229|NCT01085097|449030575|FG000|Overall Study|Treatment failure|2|||
124836230|NCT01085097|449030576|FG001|Overall Study|Treatment failure|0|||
124836231|NCT01085097|449030577|FG002|Overall Study|Treatment failure|0|||
124836232|NCT00075582|449030584|FG000|Overall Study|Adverse Event|3|||
124836233|NCT00075582|449030585|FG001|Overall Study|Adverse Event|1|||
124836234|NCT00075582|449030584|FG000|Overall Study|Lack of Efficacy|4|||
124836235|NCT00075582|449030585|FG001|Overall Study|Lack of Efficacy|8|||
124836236|NCT00075582|449030584|FG000|Overall Study|Physician Decision|5|||
124836237|NCT00075582|449030585|FG001|Overall Study|Physician Decision|8|||
124836238|NCT00075582|449030584|FG000|Overall Study|Withdrawal by Subject|2|||
124836239|NCT00075582|449030585|FG001|Overall Study|Withdrawal by Subject|2|||
124836240|NCT00075582|449030584|FG000|Overall Study|Ineligible for study|36|||
124836241|NCT00075582|449030585|FG001|Overall Study|Ineligible for study|16|||
124836242|NCT02268812|449030586|FG000|Overall Study|Adverse Event|8|||
124836243|NCT02268812|449030587|FG001|Overall Study|Adverse Event|26|||
124836244|NCT02268812|449030588|FG002|Overall Study|Adverse Event|7|||
124836245|NCT02268812|449030589|FG003|Overall Study|Adverse Event|10|||
124836246|NCT02268812|449030586|FG000|Overall Study|Protocol deviation|0|||
124836247|NCT02268812|449030587|FG001|Overall Study|Protocol deviation|0|||
124836248|NCT02268812|449030588|FG002|Overall Study|Protocol deviation|1|||
124836249|NCT02268812|449030589|FG003|Overall Study|Protocol deviation|0|||
124836250|NCT02268812|449030586|FG000|Overall Study|Withdrawal by Subject|0|||
124836251|NCT02268812|449030587|FG001|Overall Study|Withdrawal by Subject|1|||
124836252|NCT02268812|449030588|FG002|Overall Study|Withdrawal by Subject|0|||
124836253|NCT02268812|449030589|FG003|Overall Study|Withdrawal by Subject|0|||
124836254|NCT02268812|449030586|FG000|Overall Study|Physician Decision|3|||
124836255|NCT02268812|449030587|FG001|Overall Study|Physician Decision|1|||
124836256|NCT02268812|449030588|FG002|Overall Study|Physician Decision|0|||
124836257|NCT02268812|449030589|FG003|Overall Study|Physician Decision|1|||
124836258|NCT02268812|449030586|FG000|Overall Study|Other|5|||
124836259|NCT02268812|449030587|FG001|Overall Study|Other|4|||
124836260|NCT02268812|449030588|FG002|Overall Study|Other|1|||
124836261|NCT02268812|449030589|FG003|Overall Study|Other|3|||
124836262|NCT05045144|449030590|FG000|Overall Study|Lost to Follow-up|3|||
124836263|NCT05045144|449030591|FG001|Overall Study|Lost to Follow-up|2|||
124836264|NCT05045144|449030592|FG002|Overall Study|Lost to Follow-up|3|||
124836265|NCT05045144|449030593|FG003|Overall Study|Lost to Follow-up|5|||
124836266|NCT05045144|449030594|FG004|Overall Study|Lost to Follow-up|13|||
124836267|NCT05045144|449030590|FG000|Overall Study|Withdrawal by Subject|0|||
124836268|NCT05045144|449030591|FG001|Overall Study|Withdrawal by Subject|1|||
124836269|NCT05045144|449030592|FG002|Overall Study|Withdrawal by Subject|0|||
124836270|NCT05045144|449030593|FG003|Overall Study|Withdrawal by Subject|0|||
124836271|NCT05045144|449030594|FG004|Overall Study|Withdrawal by Subject|0|||
124836272|NCT05045144|449030590|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124836273|NCT05045144|449030591|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124836274|NCT05045144|449030592|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
124836275|NCT05045144|449030593|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124836276|NCT05045144|449030594|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
124836277|NCT02385084|449030595|FG000|Period 2|Protocol Violation|0|||
124836278|NCT02385084|449030596|FG001|Period 2|Protocol Violation|0|||
124836279|NCT02385084|449030597|FG002|Period 2|Protocol Violation|1|||
124836280|NCT02385084|449030598|FG003|Period 2|Protocol Violation|0|||
124836281|NCT02385084|449030599|FG004|Period 2|Protocol Violation|0|||
124836282|NCT02385084|449030600|FG005|Period 2|Protocol Violation|0|||
124836283|NCT00768144|449030601|FG000|Overall Study|Adverse Event|13|||
124836284|NCT00768144|449030601|FG000|Overall Study|Progressive Disease|21|||
124836285|NCT00768144|449030601|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
124836286|NCT00768144|449030601|FG000|Overall Study|Pt Withdrew Consent|1|||
124836287|NCT02268786|449030602|FG000|Overall Study|No Euploid Embryos available|42|||
124836288|NCT02268786|449030603|FG001|Overall Study|No Euploid Embryos available|0|||
124836289|NCT02268786|449030602|FG000|Overall Study|Withdrawal by Subject|7|||
124836290|NCT02268786|449030603|FG001|Overall Study|Withdrawal by Subject|14|||
124836291|NCT02268786|449030602|FG000|Overall Study|Thaw Failure|6|||
124836292|NCT02268786|449030603|FG001|Overall Study|Thaw Failure|4|||
124836293|NCT02268786|449030602|FG000|Overall Study|Protocol Violation|1|||
124836294|NCT02268786|449030603|FG001|Overall Study|Protocol Violation|0|||
124836295|NCT00744627|449030604|FG000|Overall Study|Adverse Event|6|||
124836296|NCT00744627|449030605|FG001|Overall Study|Adverse Event|9|||
124836297|NCT00744627|449030604|FG000|Overall Study|Lack of Efficacy|7|||
124836298|NCT00744627|449030605|FG001|Overall Study|Lack of Efficacy|3|||
124836299|NCT00744627|449030604|FG000|Overall Study|Noncompliance|0|||
124836300|NCT00744627|449030605|FG001|Overall Study|Noncompliance|1|||
124836301|NCT00744627|449030604|FG000|Overall Study|Protocol Deviations|0|||
124836302|NCT00744627|449030605|FG001|Overall Study|Protocol Deviations|2|||
124836303|NCT00744627|449030604|FG000|Overall Study|Voluntary Withdrawal|9|||
124836304|NCT00744627|449030605|FG001|Overall Study|Voluntary Withdrawal|6|||
124836305|NCT00744627|449030604|FG000|Overall Study|Lost to Follow-up|2|||
124836306|NCT00744627|449030605|FG001|Overall Study|Lost to Follow-up|1|||
124836307|NCT00744627|449030604|FG000|Overall Study|Other|1|||
124836308|NCT00744627|449030605|FG001|Overall Study|Other|0|||
124836309|NCT04251221|449030606|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
124836310|NCT04251221|449030607|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
124836311|NCT00323492|449030608|FG000|Study Phase 1|Adverse Event|2|||
124836312|NCT00323492|449030609|FG001|Study Phase 1|Adverse Event|0|||
124836313|NCT00323492|449030610|FG002|Study Phase 1|Adverse Event|0|||
124836314|NCT00323492|449030608|FG000|Study Phase 2|Adverse Event|1|||
124836315|NCT00323492|449030609|FG001|Study Phase 2|Adverse Event|0|||
124836316|NCT00323492|449030610|FG002|Study Phase 2|Adverse Event|0|||
124836317|NCT00323492|449030608|FG000|Study Phase 2|Physician Decision|1|||
124836318|NCT00323492|449030609|FG001|Study Phase 2|Physician Decision|0|||
124836319|NCT00323492|449030610|FG002|Study Phase 2|Physician Decision|0|||
124836320|NCT00323492|449030608|FG000|Study Phase 2|Lost to Follow-up|1|||
124836321|NCT00323492|449030609|FG001|Study Phase 2|Lost to Follow-up|0|||
124836322|NCT00323492|449030610|FG002|Study Phase 2|Lost to Follow-up|0|||
124836323|NCT00323492|449030608|FG000|Study Phase 2|Withdrawal by Subject|0|||
124836324|NCT00323492|449030609|FG001|Study Phase 2|Withdrawal by Subject|1|||
124836325|NCT00323492|449030610|FG002|Study Phase 2|Withdrawal by Subject|0|||
124836326|NCT00323492|449030608|FG000|Study Phase 2|Noncompliance with study schedule|0|||
124836327|NCT00323492|449030609|FG001|Study Phase 2|Noncompliance with study schedule|0|||
124836328|NCT00323492|449030610|FG002|Study Phase 2|Noncompliance with study schedule|1|||
124836329|NCT00323492|449030608|FG000|Study Phase 2|Protocol Violation|1|||
124836330|NCT00323492|449030609|FG001|Study Phase 2|Protocol Violation|0|||
124836331|NCT00323492|449030610|FG002|Study Phase 2|Protocol Violation|0|||
124836332|NCT01319877|449030613|FG000|Overall Study|Lost to Follow-up|100|||
124836333|NCT01319877|449030614|FG001|Overall Study|Lost to Follow-up|37|||
124836334|NCT01319877|449030613|FG000|Overall Study|Physician Decision|2|||
124836335|NCT01319877|449030614|FG001|Overall Study|Physician Decision|0|||
124836336|NCT01319877|449030613|FG000|Overall Study|Disease Progression|2|||
124836337|NCT01319877|449030614|FG001|Overall Study|Disease Progression|2|||
124836338|NCT01319877|449030613|FG000|Overall Study|Withdrawal by Subject|0|||
124836339|NCT01319877|449030614|FG001|Overall Study|Withdrawal by Subject|1|||
124836340|NCT01319877|449030613|FG000|Overall Study|Reason Not Specified|4|||
124836341|NCT01319877|449030614|FG001|Overall Study|Reason Not Specified|5|||
124836342|NCT03560531|449030615|FG000|Overall Study|Death|4|||
124836343|NCT03560531|449030616|FG001|Overall Study|Death|1|||
124836344|NCT03560531|449030617|FG002|Overall Study|Death|1|||
124836345|NCT03560531|449030618|FG003|Overall Study|Death|2|||
124836346|NCT03560531|449030619|FG004|Overall Study|Death|6|||
124836347|NCT03560531|449030620|FG005|Overall Study|Death|1|||
124836348|NCT03560531|449030621|FG006|Overall Study|Death|4|||
124836349|NCT03560531|449030622|FG007|Overall Study|Death|8|||
124836350|NCT03560531|449030623|FG008|Overall Study|Death|1|||
124836351|NCT03560531|449030624|FG009|Overall Study|Death|3|||
124836352|NCT03560531|449030625|FG010|Overall Study|Death|2|||
124836353|NCT03560531|449030626|FG011|Overall Study|Death|0|||
124836354|NCT03560531|449030627|FG012|Overall Study|Death|4|||
124836355|NCT03560531|449030628|FG013|Overall Study|Death|1|||
124836356|NCT03560531|449030615|FG000|Overall Study|Lost to Follow-up|1|||
124836357|NCT03560531|449030616|FG001|Overall Study|Lost to Follow-up|1|||
124836358|NCT03560531|449030617|FG002|Overall Study|Lost to Follow-up|0|||
124836359|NCT03560531|449030618|FG003|Overall Study|Lost to Follow-up|0|||
124836360|NCT03560531|449030619|FG004|Overall Study|Lost to Follow-up|0|||
124836361|NCT03560531|449030620|FG005|Overall Study|Lost to Follow-up|0|||
124836362|NCT03560531|449030621|FG006|Overall Study|Lost to Follow-up|1|||
124836363|NCT03560531|449030622|FG007|Overall Study|Lost to Follow-up|0|||
124836364|NCT03560531|449030623|FG008|Overall Study|Lost to Follow-up|0|||
124836365|NCT03560531|449030624|FG009|Overall Study|Lost to Follow-up|0|||
124836366|NCT03560531|449030625|FG010|Overall Study|Lost to Follow-up|0|||
124836367|NCT03560531|449030626|FG011|Overall Study|Lost to Follow-up|0|||
124836368|NCT03560531|449030627|FG012|Overall Study|Lost to Follow-up|0|||
124836369|NCT03560531|449030628|FG013|Overall Study|Lost to Follow-up|0|||
124836370|NCT03560531|449030615|FG000|Overall Study|Withdrawal by Subject|1|||
124836371|NCT03560531|449030616|FG001|Overall Study|Withdrawal by Subject|0|||
124836372|NCT03560531|449030617|FG002|Overall Study|Withdrawal by Subject|0|||
124836373|NCT03560531|449030618|FG003|Overall Study|Withdrawal by Subject|0|||
124836374|NCT03560531|449030619|FG004|Overall Study|Withdrawal by Subject|0|||
124836375|NCT03560531|449030620|FG005|Overall Study|Withdrawal by Subject|0|||
124836376|NCT03560531|449030621|FG006|Overall Study|Withdrawal by Subject|0|||
124836377|NCT03560531|449030622|FG007|Overall Study|Withdrawal by Subject|3|||
124836378|NCT03560531|449030623|FG008|Overall Study|Withdrawal by Subject|2|||
124836379|NCT03560531|449030624|FG009|Overall Study|Withdrawal by Subject|0|||
124836380|NCT03560531|449030625|FG010|Overall Study|Withdrawal by Subject|0|||
124836381|NCT03560531|449030626|FG011|Overall Study|Withdrawal by Subject|0|||
124836382|NCT03560531|449030627|FG012|Overall Study|Withdrawal by Subject|2|||
124836383|NCT03560531|449030628|FG013|Overall Study|Withdrawal by Subject|0|||
124836384|NCT03560531|449030615|FG000|Overall Study|Study end per-protocol|1|||
124836385|NCT03560531|449030616|FG001|Overall Study|Study end per-protocol|1|||
124836386|NCT03560531|449030617|FG002|Overall Study|Study end per-protocol|2|||
124836387|NCT03560531|449030618|FG003|Overall Study|Study end per-protocol|0|||
124836388|NCT03560531|449030619|FG004|Overall Study|Study end per-protocol|1|||
124836389|NCT03560531|449030620|FG005|Overall Study|Study end per-protocol|0|||
124836390|NCT03560531|449030621|FG006|Overall Study|Study end per-protocol|0|||
124836391|NCT03560531|449030622|FG007|Overall Study|Study end per-protocol|0|||
124836392|NCT03560531|449030623|FG008|Overall Study|Study end per-protocol|0|||
124836393|NCT03560531|449030624|FG009|Overall Study|Study end per-protocol|0|||
124836394|NCT03560531|449030625|FG010|Overall Study|Study end per-protocol|0|||
124836395|NCT03560531|449030626|FG011|Overall Study|Study end per-protocol|0|||
124836396|NCT03560531|449030627|FG012|Overall Study|Study end per-protocol|0|||
124836397|NCT03560531|449030628|FG013|Overall Study|Study end per-protocol|0|||
124836398|NCT03560531|449030615|FG000|Overall Study|Early study termination by sponsor|9|||
124836399|NCT03560531|449030616|FG001|Overall Study|Early study termination by sponsor|0|||
124836400|NCT03560531|449030617|FG002|Overall Study|Early study termination by sponsor|0|||
124836401|NCT03560531|449030618|FG003|Overall Study|Early study termination by sponsor|4|||
124836402|NCT03560531|449030619|FG004|Overall Study|Early study termination by sponsor|8|||
124836403|NCT03560531|449030620|FG005|Overall Study|Early study termination by sponsor|2|||
124836404|NCT03560531|449030621|FG006|Overall Study|Early study termination by sponsor|5|||
124836405|NCT03560531|449030622|FG007|Overall Study|Early study termination by sponsor|64|||
124836406|NCT03560531|449030623|FG008|Overall Study|Early study termination by sponsor|7|||
124836407|NCT03560531|449030624|FG009|Overall Study|Early study termination by sponsor|2|||
124836408|NCT03560531|449030625|FG010|Overall Study|Early study termination by sponsor|16|||
124836409|NCT03560531|449030626|FG011|Overall Study|Early study termination by sponsor|2|||
124836410|NCT03560531|449030627|FG012|Overall Study|Early study termination by sponsor|6|||
124836411|NCT03560531|449030628|FG013|Overall Study|Early study termination by sponsor|2|||
124836412|NCT01200797|449030631|FG000|Overall Study|symptomatic deterioration|2|||
124836413|NCT01200797|449030631|FG000|Overall Study|Adverse Event|4|||
124836414|NCT01200797|449030631|FG000|Overall Study|Disease Progression|13|||
124836415|NCT00642668|449030636|FG000|Overall Study|Lost to Follow-up|1|||
124836416|NCT00642668|449030636|FG000|Overall Study|Adverse Event|2|||
124836417|NCT00642668|449030636|FG000|Overall Study|Death|2|||
124836418|NCT00642668|449030636|FG000|Overall Study|Insufficient Therapeutic Response|1|||
124836419|NCT00642668|449030636|FG000|Overall Study|Failure to Return|1|||
124836420|NCT00642668|449030636|FG000|Overall Study|Dialysis Initiation|5|||
124836421|NCT00642668|449030636|FG000|Overall Study|Blood Transfusion|2|||
124836422|NCT03608774|449030637|FG000|Overall Study|Lost to Follow-up|5|||
124836423|NCT03608774|449030638|FG001|Overall Study|Lost to Follow-up|5|||
124836424|NCT03608774|449030637|FG000|Overall Study|Withdrawal by Subject|1|||
124836425|NCT03608774|449030638|FG001|Overall Study|Withdrawal by Subject|0|||
124836426|NCT03608774|449030637|FG000|Overall Study|Protocol Violation|1|||
124836427|NCT03608774|449030638|FG001|Overall Study|Protocol Violation|0|||
124836428|NCT03608774|449030637|FG000|Overall Study|Not eligible at enrollment|0|||
124836429|NCT03608774|449030638|FG001|Overall Study|Not eligible at enrollment|1|||
124836430|NCT03608774|449030637|FG000|Overall Study|Health related event|0|||
124836431|NCT03608774|449030638|FG001|Overall Study|Health related event|1|||
124836432|NCT01177540|449030639|FG000|Overall Study|Adverse Event|1|||
124836433|NCT01177540|449030640|FG001|Overall Study|Adverse Event|0|||
124836434|NCT01623596|449030646|FG000|Overall Study|Abnormal laboratory values|2|||
124836435|NCT01623596|449030647|FG001|Overall Study|Abnormal laboratory values|0|||
124836436|NCT01623596|449030646|FG000|Overall Study|Administrative problems|9|||
124836437|NCT01623596|449030647|FG001|Overall Study|Administrative problems|13|||
124836438|NCT01623596|449030646|FG000|Overall Study|Adverse Event|20|||
124836439|NCT01623596|449030647|FG001|Overall Study|Adverse Event|29|||
124836440|NCT01623596|449030646|FG000|Overall Study|Death|0|||
124836441|NCT01623596|449030647|FG001|Overall Study|Death|2|||
124836442|NCT01623596|449030646|FG000|Overall Study|Lost to Follow-up|12|||
124836443|NCT01623596|449030647|FG001|Overall Study|Lost to Follow-up|16|||
124836444|NCT01623596|449030646|FG000|Overall Study|Withdrawal by Subject|13|||
124836445|NCT01623596|449030647|FG001|Overall Study|Withdrawal by Subject|31|||
124836446|NCT01623596|449030646|FG000|Overall Study|Patient no longer requires study drug|1|||
124836447|NCT01623596|449030647|FG001|Overall Study|Patient no longer requires study drug|0|||
124836448|NCT01623596|449030646|FG000|Overall Study|Protocol Violation|0|||
124836449|NCT01623596|449030647|FG001|Overall Study|Protocol Violation|6|||
124836450|NCT01623596|449030646|FG000|Overall Study|Lack of Efficacy|5|||
124836451|NCT01623596|449030647|FG001|Overall Study|Lack of Efficacy|3|||
124836452|NCT00699972|449032143|FG000|Overall Study|Adverse Event|7|||
124836453|NCT00699972|449032144|FG001|Overall Study|Adverse Event|9|||
124836454|NCT00699972|449032145|FG002|Overall Study|Adverse Event|24|||
124836455|NCT00699972|449032143|FG000|Overall Study|Lost to Follow-up|0|||
124836456|NCT00699972|449032144|FG001|Overall Study|Lost to Follow-up|2|||
124836457|NCT00699972|449032145|FG002|Overall Study|Lost to Follow-up|0|||
124836458|NCT00699972|449032143|FG000|Overall Study|Withdrawal by Subject|3|||
124836459|NCT00699972|449032144|FG001|Overall Study|Withdrawal by Subject|7|||
124836460|NCT00699972|449032145|FG002|Overall Study|Withdrawal by Subject|4|||
124836461|NCT00699972|449032143|FG000|Overall Study|Lack of Efficacy|2|||
124836462|NCT00699972|449032144|FG001|Overall Study|Lack of Efficacy|0|||
124836463|NCT00699972|449032145|FG002|Overall Study|Lack of Efficacy|2|||
124836464|NCT00699972|449032143|FG000|Overall Study|Administrative/Other|3|||
124836465|NCT00699972|449032144|FG001|Overall Study|Administrative/Other|1|||
124836466|NCT00699972|449032145|FG002|Overall Study|Administrative/Other|4|||
124836467|NCT00699972|449032143|FG000|Overall Study|Randomized, Not Treated|1|||
124836468|NCT00699972|449032144|FG001|Overall Study|Randomized, Not Treated|0|||
124836469|NCT00699972|449032145|FG002|Overall Study|Randomized, Not Treated|1|||
124836470|NCT01545817|449032146|FG000|Pazopanib|Disease progression|51|||
124836471|NCT01545817|449032147|FG001|Pazopanib|Disease progression|0|||
124836472|NCT01545817|449032146|FG000|Pazopanib|Adverse Event|19|||
124836473|NCT01545817|449032147|FG001|Pazopanib|Adverse Event|0|||
124836474|NCT01545817|449032146|FG000|Pazopanib|Other reason|4|||
124836475|NCT01545817|449032147|FG001|Pazopanib|Other reason|0|||
124836476|NCT01545817|449032146|FG000|Everolimus|Other reason|0|||
124836477|NCT01545817|449032147|FG001|Everolimus|Other reason|7|||
124836478|NCT01545817|449032146|FG000|Everolimus|Disease progression|0|||
124836479|NCT01545817|449032147|FG001|Everolimus|Disease progression|25|||
124836480|NCT01545817|449032146|FG000|Everolimus|Adverse Event|0|||
124836481|NCT01545817|449032147|FG001|Everolimus|Adverse Event|6|||
124836482|NCT03314584|449032163|FG000|Overall Study|Withdrawal by Subject|3|||
124836483|NCT03314584|449032164|FG001|Overall Study|Withdrawal by Subject|3|||
124836484|NCT03314584|449032163|FG000|Overall Study|Lost to Follow-up|4|||
124836485|NCT03314584|449032164|FG001|Overall Study|Lost to Follow-up|0|||
124836486|NCT04214288|449032166|FG000|Overall Study|Ongoing in the study|41|||
124836487|NCT04214288|449032167|FG001|Overall Study|Ongoing in the study|51|||
124836488|NCT04214288|449032168|FG002|Overall Study|Ongoing in the study|12|||
124836489|NCT04214288|449032169|FG003|Overall Study|Ongoing in the study|39|||
124836490|NCT04214288|449032166|FG000|Overall Study|Adverse Event|1|||
124836491|NCT04214288|449032167|FG001|Overall Study|Adverse Event|0|||
124836492|NCT04214288|449032168|FG002|Overall Study|Adverse Event|0|||
124836493|NCT04214288|449032169|FG003|Overall Study|Adverse Event|0|||
124836494|NCT04214288|449032166|FG000|Overall Study|Death|22|||
124836495|NCT04214288|449032167|FG001|Overall Study|Death|13|||
124836496|NCT04214288|449032168|FG002|Overall Study|Death|7|||
124836497|NCT04214288|449032169|FG003|Overall Study|Death|19|||
124836498|NCT04214288|449032166|FG000|Overall Study|Lost to Follow-up|1|||
124836499|NCT04214288|449032167|FG001|Overall Study|Lost to Follow-up|2|||
124836500|NCT04214288|449032168|FG002|Overall Study|Lost to Follow-up|1|||
124836501|NCT04214288|449032169|FG003|Overall Study|Lost to Follow-up|0|||
124836502|NCT04214288|449032166|FG000|Overall Study|Other|1|||
124836503|NCT04214288|449032167|FG001|Overall Study|Other|2|||
124836504|NCT04214288|449032168|FG002|Overall Study|Other|0|||
124836505|NCT04214288|449032169|FG003|Overall Study|Other|6|||
124836506|NCT04214288|449032166|FG000|Overall Study|Protocol Violation|0|||
124836507|NCT04214288|449032167|FG001|Overall Study|Protocol Violation|1|||
124836508|NCT04214288|449032168|FG002|Overall Study|Protocol Violation|0|||
124836509|NCT04214288|449032169|FG003|Overall Study|Protocol Violation|0|||
124836510|NCT04214288|449032166|FG000|Overall Study|Withdrawal by Subject|8|||
124836511|NCT04214288|449032167|FG001|Overall Study|Withdrawal by Subject|4|||
124836512|NCT04214288|449032168|FG002|Overall Study|Withdrawal by Subject|0|||
124836513|NCT04214288|449032169|FG003|Overall Study|Withdrawal by Subject|9|||
124836514|NCT01990495|449032176|FG000|Overall Study|Physician Decision|5|||
124836515|NCT01990495|449032177|FG001|Overall Study|Physician Decision|4|||
124836516|NCT01928862|449032178|FG000|Overall Study|Lost to Follow-up|1|||
124836517|NCT01928862|449032179|FG001|Overall Study|Lost to Follow-up|0|||
124836518|NCT01928862|449032180|FG002|Overall Study|Lost to Follow-up|0|||
124836519|NCT01928862|449032181|FG003|Overall Study|Lost to Follow-up|0|||
124836520|NCT01928862|449032182|FG004|Overall Study|Lost to Follow-up|1|||
124836521|NCT01478321|449032183|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
124836522|NCT01478321|449032183|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
124836523|NCT01478321|449032183|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
124836524|NCT01478321|449032183|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
124836525|NCT01478321|449032183|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
124836526|NCT01478321|449032183|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
124836527|NCT01478321|449032183|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
124836528|NCT01478321|449032183|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
124836529|NCT03168464|449032184|FG000|Overall Study|Death|9|||
124836530|NCT03168464|449032184|FG000|Overall Study|Progression of disease|6|||
124836531|NCT04649164|449032185|FG000|Overall Study|Withdrawal by Subject|1|||
124836532|NCT04649164|449032186|FG001|Overall Study|Withdrawal by Subject|1|||
124836533|NCT04649164|449032187|FG002|Overall Study|Withdrawal by Subject|2|||
124836534|NCT04649164|449032185|FG000|Overall Study|Participant's care recipient expired|0|||
124836535|NCT04649164|449032186|FG001|Overall Study|Participant's care recipient expired|0|||
124836536|NCT04649164|449032187|FG002|Overall Study|Participant's care recipient expired|2|||
124836537|NCT02053753|449032188|FG000|Overall Study|Withdrawal by Subject|2|||
124836538|NCT02053753|449032189|FG001|Overall Study|Withdrawal by Subject|4|||
124836539|NCT02053753|449032188|FG000|Overall Study|Decision by Sponsor|1|||
124836540|NCT02053753|449032189|FG001|Overall Study|Decision by Sponsor|1|||
124836541|NCT02053753|449032188|FG000|Overall Study|Lost to Follow-up|4|||
124836542|NCT02053753|449032189|FG001|Overall Study|Lost to Follow-up|3|||
124836543|NCT00634088|449032194|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
124836544|NCT00634088|449032195|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
124836545|NCT00634088|449032196|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
124836546|NCT00634088|449032197|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
124836547|NCT00634088|449032194|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
124836548|NCT00634088|449032195|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
124836549|NCT00634088|449032196|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
124836550|NCT00634088|449032197|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
124836551|NCT00634088|449032194|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
124836552|NCT00634088|449032195|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
124836553|NCT00634088|449032196|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
124836554|NCT00634088|449032197|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
124836555|NCT00634088|449032194|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
124836556|NCT00634088|449032195|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
124836557|NCT00634088|449032196|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
124836558|NCT00634088|449032197|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
124836559|NCT00634088|449032194|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
124836560|NCT00634088|449032195|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
124836561|NCT00634088|449032196|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
124836562|NCT00634088|449032197|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
124836563|NCT00634088|449032194|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
124836564|NCT00634088|449032195|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
124836565|NCT00634088|449032196|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
124836566|NCT00634088|449032197|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
124836567|NCT01256593|449032202|FG000|Overall Study|Protocol Violation|26|||
124836568|NCT01256593|449032202|FG000|Overall Study|No Drug Administration Information|2|||
124836569|NCT01256593|449032202|FG000|Overall Study|No Visit After Treatment|186|||
124836570|NCT02689258|449032210|FG000|Overall Study|Subject Non-Compliance|0|||
124836571|NCT02689258|449032211|FG001|Overall Study|Subject Non-Compliance|1|||
124836572|NCT02689258|449032212|FG002|Overall Study|Subject Non-Compliance|0|||
124836573|NCT02689258|449032213|FG003|Overall Study|Subject Non-Compliance|0|||
124836574|NCT02689258|449032214|FG004|Overall Study|Subject Non-Compliance|0|||
124836575|NCT02689258|449032215|FG005|Overall Study|Subject Non-Compliance|0|||
124836576|NCT02689258|449032216|FG006|Overall Study|Subject Non-Compliance|0|||
124836577|NCT02689258|449032217|FG007|Overall Study|Subject Non-Compliance|0|||
124836578|NCT02689258|449032218|FG008|Overall Study|Subject Non-Compliance|0|||
124836579|NCT02689258|449032219|FG009|Overall Study|Subject Non-Compliance|0|||
124836580|NCT02689258|449032220|FG010|Overall Study|Subject Non-Compliance|0|||
124836581|NCT02689258|449032221|FG011|Overall Study|Subject Non-Compliance|0|||
124836582|NCT02689258|449032210|FG000|Overall Study|Subject Refusal to Continue|0|||
124836583|NCT02689258|449032211|FG001|Overall Study|Subject Refusal to Continue|1|||
124836584|NCT02689258|449032212|FG002|Overall Study|Subject Refusal to Continue|0|||
124836585|NCT02689258|449032213|FG003|Overall Study|Subject Refusal to Continue|0|||
124836586|NCT02689258|449032214|FG004|Overall Study|Subject Refusal to Continue|0|||
124836587|NCT02689258|449032215|FG005|Overall Study|Subject Refusal to Continue|0|||
124836588|NCT02689258|449032216|FG006|Overall Study|Subject Refusal to Continue|0|||
124836589|NCT02689258|449032217|FG007|Overall Study|Subject Refusal to Continue|0|||
124836590|NCT02689258|449032218|FG008|Overall Study|Subject Refusal to Continue|1|||
124836591|NCT02689258|449032219|FG009|Overall Study|Subject Refusal to Continue|0|||
124836592|NCT02689258|449032220|FG010|Overall Study|Subject Refusal to Continue|0|||
124836593|NCT02689258|449032221|FG011|Overall Study|Subject Refusal to Continue|1|||
124836594|NCT02689258|449032210|FG000|Overall Study|Other|0|||
124836595|NCT02689258|449032211|FG001|Overall Study|Other|2|||
124836596|NCT02689258|449032212|FG002|Overall Study|Other|0|||
124836597|NCT02689258|449032213|FG003|Overall Study|Other|0|||
124836598|NCT02689258|449032214|FG004|Overall Study|Other|1|||
124836599|NCT02689258|449032215|FG005|Overall Study|Other|0|||
124836600|NCT02689258|449032216|FG006|Overall Study|Other|0|||
124836601|NCT02689258|449032217|FG007|Overall Study|Other|0|||
124836602|NCT02689258|449032218|FG008|Overall Study|Other|1|||
124836603|NCT02689258|449032219|FG009|Overall Study|Other|0|||
124836604|NCT02689258|449032220|FG010|Overall Study|Other|0|||
124836605|NCT02689258|449032221|FG011|Overall Study|Other|0|||
124836606|NCT00439556|449032224|FG000|Overall Study|Patient was taken off study for non-comp|0|||
124836607|NCT00439556|449032225|FG001|Overall Study|Patient was taken off study for non-comp|1|||
124836608|NCT00439556|449032226|FG002|Overall Study|Patient was taken off study for non-comp|0|||
124836609|NCT01498640|449032229|FG000|Overall Study|Lost to Follow-up|1|||
124836610|NCT01498640|449032229|FG000|Overall Study|Death|1|||
124836611|NCT01498640|449032229|FG000|Overall Study|Other|3|||
124836612|NCT03065244|449032236|FG000|Overall Study|Lost to Follow-up|1|||
124836613|NCT03065244|449032237|FG001|Overall Study|Lost to Follow-up|1|||
124836614|NCT03065244|449032236|FG000|Overall Study|Diagnosed with a different disease|1|||
124836615|NCT03065244|449032237|FG001|Overall Study|Diagnosed with a different disease|1|||
124836616|NCT03065244|449032236|FG000|Overall Study|Protocol Violation|0|||
124836617|NCT03065244|449032237|FG001|Overall Study|Protocol Violation|1|||
124836618|NCT03065244|449032236|FG000|Overall Study|Withdrawal by Subject|1|||
124836619|NCT03065244|449032237|FG001|Overall Study|Withdrawal by Subject|1|||
124836620|NCT03717480|449032238|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
124836621|NCT01894152|449032239|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
124836622|NCT01708174|449032240|FG000|Treatment Period|Withdrawal by Subject|1|||
124836623|NCT01708174|449032241|FG001|Treatment Period|Withdrawal by Subject|0|||
124836624|NCT01708174|449032242|FG002|Treatment Period|Withdrawal by Subject|0|||
124836625|NCT01708174|449032240|FG000|Treatment Period|Progressive disease|0|||
124836626|NCT01708174|449032241|FG001|Treatment Period|Progressive disease|1|||
124836627|NCT01708174|449032242|FG002|Treatment Period|Progressive disease|0|||
124836628|NCT01708174|449032240|FG000|Treatment Period|Death|0|||
124836629|NCT01708174|449032241|FG001|Treatment Period|Death|0|||
124836630|NCT01708174|449032242|FG002|Treatment Period|Death|1|||
124836631|NCT01708174|449032240|FG000|Treatment Period|Adverse Event|0|||
124836632|NCT01708174|449032241|FG001|Treatment Period|Adverse Event|1|||
124836633|NCT01708174|449032242|FG002|Treatment Period|Adverse Event|0|||
124836634|NCT01774786|449032243|FG000|Overall Study|Death|300|||
124836635|NCT01774786|449032244|FG001|Overall Study|Death|319|||
124836636|NCT01774786|449032243|FG000|Overall Study|Lost to Follow-up|6|||
124836637|NCT01774786|449032244|FG001|Overall Study|Lost to Follow-up|7|||
124836638|NCT01774786|449032243|FG000|Overall Study|Withdrawal by Subject|18|||
124836639|NCT01774786|449032244|FG001|Overall Study|Withdrawal by Subject|14|||
124836640|NCT01774786|449032243|FG000|Overall Study|Physician Decision|2|||
124836641|NCT01774786|449032244|FG001|Overall Study|Physician Decision|0|||
124836642|NCT01774786|449032243|FG000|Overall Study|Non-compliance|0|||
124836643|NCT01774786|449032244|FG001|Overall Study|Non-compliance|1|||
124836644|NCT01774786|449032243|FG000|Overall Study|Reason Not Specified|2|||
124836645|NCT01774786|449032244|FG001|Overall Study|Reason Not Specified|5|||
124836646|NCT02965703|449032250|FG000|Overall Study|Withdrawal by Subject|6|||
124836647|NCT02965703|449032251|FG001|Overall Study|Withdrawal by Subject|3|||
124836648|NCT02965703|449032252|FG002|Overall Study|Withdrawal by Subject|1|||
124836649|NCT02965703|449032250|FG000|Overall Study|Protocol Violation|1|||
124836650|NCT02965703|449032251|FG001|Overall Study|Protocol Violation|0|||
124836651|NCT02965703|449032252|FG002|Overall Study|Protocol Violation|0|||
124836652|NCT02965703|449032250|FG000|Overall Study|Adverse Event|1|||
124836653|NCT02965703|449032251|FG001|Overall Study|Adverse Event|1|||
124836654|NCT02965703|449032252|FG002|Overall Study|Adverse Event|0|||
124836655|NCT02965703|449032250|FG000|Overall Study|Lost to Follow-up|2|||
124836656|NCT02965703|449032251|FG001|Overall Study|Lost to Follow-up|1|||
124836657|NCT02965703|449032252|FG002|Overall Study|Lost to Follow-up|1|||
124836658|NCT02171260|449032253|FG000|Overall Study|Death|0|||
124836659|NCT02171260|449032254|FG001|Overall Study|Death|0|||
124836660|NCT02171260|449032255|FG002|Overall Study|Death|0|||
124836661|NCT02171260|449032256|FG003|Overall Study|Death|1|||
124836662|NCT02171260|449032253|FG000|Overall Study|Physician Decision|1|||
124836663|NCT02171260|449032254|FG001|Overall Study|Physician Decision|0|||
124836664|NCT02171260|449032255|FG002|Overall Study|Physician Decision|1|||
124836665|NCT02171260|449032256|FG003|Overall Study|Physician Decision|0|||
124836666|NCT02171260|449032253|FG000|Overall Study|Withdrawal by Subject|1|||
124836667|NCT02171260|449032254|FG001|Overall Study|Withdrawal by Subject|0|||
124836668|NCT02171260|449032255|FG002|Overall Study|Withdrawal by Subject|0|||
124836669|NCT02171260|449032256|FG003|Overall Study|Withdrawal by Subject|0|||
124836670|NCT02171260|449032253|FG000|Overall Study|Evidence of progressive disease|4|||
124836671|NCT02171260|449032254|FG001|Overall Study|Evidence of progressive disease|6|||
124836672|NCT02171260|449032255|FG002|Overall Study|Evidence of progressive disease|4|||
124836673|NCT02171260|449032256|FG003|Overall Study|Evidence of progressive disease|4|||
124836674|NCT01062555|449032258|FG000|Phase 1|Death|10|||
124836675|NCT01062555|449032259|FG001|Phase 1|Death|17|||
124836676|NCT01062555|449032260|FG002|Phase 1|Death|0|||
124836677|NCT01062555|449032261|FG003|Phase 1|Death|0|||
124836678|NCT01062555|449032258|FG000|Phase 1|Graft Failure|12|||
124836679|NCT01062555|449032259|FG001|Phase 1|Graft Failure|8|||
124836680|NCT01062555|449032260|FG002|Phase 1|Graft Failure|0|||
124836681|NCT01062555|449032261|FG003|Phase 1|Graft Failure|0|||
124836682|NCT01062555|449032258|FG000|Phase 1|Withdrawal by Subject|1|||
124836683|NCT01062555|449032259|FG001|Phase 1|Withdrawal by Subject|1|||
124836684|NCT01062555|449032260|FG002|Phase 1|Withdrawal by Subject|0|||
124836685|NCT01062555|449032261|FG003|Phase 1|Withdrawal by Subject|0|||
124836686|NCT01062555|449032258|FG000|Phase 2|Death|0|||
124836687|NCT01062555|449032259|FG001|Phase 2|Death|0|||
124836688|NCT01062555|449032260|FG002|Phase 2|Death|8|||
124836689|NCT01062555|449032261|FG003|Phase 2|Death|3|||
124836690|NCT01062555|449032258|FG000|Phase 2|Graft failure|0|||
124836691|NCT01062555|449032259|FG001|Phase 2|Graft failure|0|||
124639544|NCT00652626|448298405|FG001|Extension Phase|Withdrawal by Subject|0|||
124836692|NCT01062555|449032260|FG002|Phase 2|Graft failure|7|||
124836693|NCT01062555|449032261|FG003|Phase 2|Graft failure|4|||
124836694|NCT01062555|449032258|FG000|Phase 2|Withdrawal by Subject|0|||
124836695|NCT01062555|449032259|FG001|Phase 2|Withdrawal by Subject|0|||
124836696|NCT01062555|449032260|FG002|Phase 2|Withdrawal by Subject|0|||
124836697|NCT01062555|449032261|FG003|Phase 2|Withdrawal by Subject|7|||
124836698|NCT01062555|449032258|FG000|Phase 2|Protocol Violation|0|||
124836699|NCT01062555|449032259|FG001|Phase 2|Protocol Violation|0|||
124836700|NCT01062555|449032260|FG002|Phase 2|Protocol Violation|0|||
124836701|NCT01062555|449032261|FG003|Phase 2|Protocol Violation|3|||
124836702|NCT01062555|449032258|FG000|Phase 2|Physician Decision|0|||
124836703|NCT01062555|449032259|FG001|Phase 2|Physician Decision|0|||
124836704|NCT01062555|449032260|FG002|Phase 2|Physician Decision|0|||
124836705|NCT01062555|449032261|FG003|Phase 2|Physician Decision|17|||
124836706|NCT04964128|449032262|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
124836707|NCT04964128|449032262|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
124836708|NCT01471379|449032263|FG000|Overall Study|Adverse Event|1|||
124836709|NCT01471379|449032264|FG001|Overall Study|Adverse Event|0|||
124836710|NCT01471379|449032265|FG002|Overall Study|Adverse Event|0|||
124836711|NCT01471379|449032263|FG000|Overall Study|Study terminated|0|||
124836712|NCT01471379|449032264|FG001|Overall Study|Study terminated|1|||
124836713|NCT01471379|449032265|FG002|Overall Study|Study terminated|0|||
124836714|NCT02120794|449032266|FG000|Overall Study|Withdrawal by Subject|43|||
124836715|NCT02120794|449032266|FG000|Overall Study|Adverse Event|10|||
124836716|NCT02120794|449032266|FG000|Overall Study|Physician Decision|4|||
124836717|NCT02120794|449032266|FG000|Overall Study|Due to insurance coverage|1|||
124836718|NCT00026793|449032273|FG000|Overall Study|Death on study due to underlying disease|4|||
124836719|NCT00026793|449032273|FG000|Overall Study|Physician Decision|2|||
124836720|NCT00026793|449032273|FG000|Overall Study|Off study|2|||
124836721|NCT04151290|449032274|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
124836722|NCT01449526|449032275|FG000|Overall Study|Lost to Follow-up|1|||
124836723|NCT01449526|449032276|FG001|Overall Study|Lost to Follow-up|2|||
124836724|NCT01449526|449032275|FG000|Overall Study|Withdrawal by Subject|1|||
124836725|NCT01449526|449032276|FG001|Overall Study|Withdrawal by Subject|1|||
124836726|NCT01449526|449032275|FG000|Overall Study|Symptoms/complaints|0|||
124836727|NCT01449526|449032276|FG001|Overall Study|Symptoms/complaints|1|||
124836728|NCT01449526|449032275|FG000|Overall Study|Lack of Motivation|0|||
124836729|NCT01449526|449032276|FG001|Overall Study|Lack of Motivation|1|||
124836730|NCT01449526|449032275|FG000|Overall Study|Cannot maintain visits|0|||
124836731|NCT01449526|449032276|FG001|Overall Study|Cannot maintain visits|1|||
124836732|NCT01132495|449032280|FG000|Overall Study|Various reasons|40|||
124836733|NCT01132495|449032281|FG001|Overall Study|Various reasons|38|||
124836734|NCT01132495|449032282|FG002|Overall Study|Various reasons|20|||
124836735|NCT01132495|449032283|FG003|Overall Study|Various reasons|12|||
124836736|NCT00082433|449032284|FG000|Overall Study|Adverse Event|12|||
124836737|NCT00082433|449032285|FG001|Overall Study|Adverse Event|17|||
124836738|NCT00082433|449032284|FG000|Overall Study|Death|8|||
124836739|NCT00082433|449032285|FG001|Overall Study|Death|18|||
124836740|NCT00082433|449032284|FG000|Overall Study|Disease Progression/Relapse|270|||
124836741|NCT00082433|449032285|FG001|Overall Study|Disease Progression/Relapse|388|||
124836742|NCT00082433|449032284|FG000|Overall Study|Physician Decision|50|||
124836743|NCT00082433|449032285|FG001|Overall Study|Physician Decision|61|||
124836744|NCT00082433|449032284|FG000|Overall Study|Lost to Follow-up|1|||
124836745|NCT00082433|449032285|FG001|Overall Study|Lost to Follow-up|2|||
124836746|NCT00082433|449032284|FG000|Overall Study|Study Drug Toxicity|179|||
124836747|NCT00082433|449032285|FG001|Overall Study|Study Drug Toxicity|66|||
124836748|NCT00082433|449032284|FG000|Overall Study|Withdrawal by Subject|55|||
124836749|NCT00082433|449032285|FG001|Overall Study|Withdrawal by Subject|30|||
124836750|NCT00082433|449032284|FG000|Overall Study|Still On Treatment|2|||
124836751|NCT00082433|449032285|FG001|Overall Study|Still On Treatment|1|||
124836752|NCT00082433|449032284|FG000|Overall Study|Not Treated|12|||
124836753|NCT00082433|449032285|FG001|Overall Study|Not Treated|11|||
124836754|NCT00082433|449032284|FG000|Overall Study|Ineligible|2|||
124836755|NCT00082433|449032285|FG001|Overall Study|Ineligible|1|||
124836756|NCT00082433|449032284|FG000|Overall Study|Noncompliance|2|||
124836757|NCT00082433|449032285|FG001|Overall Study|Noncompliance|1|||
124836758|NCT00082433|449032284|FG000|Overall Study|New primary cancer|1|||
124836759|NCT00082433|449032285|FG001|Overall Study|New primary cancer|0|||
124836760|NCT00082433|449032284|FG000|Overall Study|Impending surgery|0|||
124836761|NCT00082433|449032285|FG001|Overall Study|Impending surgery|1|||
124836762|NCT04097821|449032286|FG000|Overall Study|Subject Decision|0|||
124836763|NCT04097821|449032287|FG001|Overall Study|Subject Decision|0|||
124836764|NCT04097821|449032288|FG002|Overall Study|Subject Decision|0|||
124836765|NCT04097821|449032289|FG003|Overall Study|Subject Decision|1|||
124836766|NCT04097821|449032290|FG004|Overall Study|Subject Decision|2|||
124836767|NCT04097821|449032291|FG005|Overall Study|Subject Decision|2|||
124836768|NCT04097821|449032292|FG006|Overall Study|Subject Decision|0|||
124836769|NCT04097821|449032293|FG007|Overall Study|Subject Decision|1|||
124836770|NCT04097821|449032286|FG000|Overall Study|Death|0|||
124836771|NCT04097821|449032287|FG001|Overall Study|Death|0|||
124836772|NCT04097821|449032288|FG002|Overall Study|Death|3|||
124836773|NCT04097821|449032289|FG003|Overall Study|Death|1|||
124836774|NCT04097821|449032290|FG004|Overall Study|Death|0|||
124836775|NCT04097821|449032291|FG005|Overall Study|Death|0|||
124836776|NCT04097821|449032292|FG006|Overall Study|Death|0|||
124836777|NCT04097821|449032293|FG007|Overall Study|Death|0|||
124836778|NCT04097821|449032286|FG000|Overall Study|Physician Decision|1|||
124836779|NCT04097821|449032287|FG001|Overall Study|Physician Decision|2|||
124836780|NCT04097821|449032288|FG002|Overall Study|Physician Decision|0|||
124836781|NCT04097821|449032289|FG003|Overall Study|Physician Decision|0|||
124836782|NCT04097821|449032290|FG004|Overall Study|Physician Decision|0|||
124836783|NCT04097821|449032291|FG005|Overall Study|Physician Decision|0|||
124836784|NCT04097821|449032292|FG006|Overall Study|Physician Decision|0|||
124836785|NCT04097821|449032293|FG007|Overall Study|Physician Decision|0|||
124836786|NCT04097821|449032286|FG000|Overall Study|Adverse Event|0|||
124836787|NCT04097821|449032287|FG001|Overall Study|Adverse Event|0|||
124836788|NCT04097821|449032288|FG002|Overall Study|Adverse Event|1|||
124836789|NCT04097821|449032289|FG003|Overall Study|Adverse Event|1|||
124836790|NCT04097821|449032290|FG004|Overall Study|Adverse Event|0|||
124836791|NCT04097821|449032291|FG005|Overall Study|Adverse Event|0|||
124836792|NCT04097821|449032292|FG006|Overall Study|Adverse Event|0|||
124836793|NCT04097821|449032293|FG007|Overall Study|Adverse Event|0|||
124836794|NCT04097821|449032286|FG000|Overall Study|New Therapy For Study Indication|0|||
124836795|NCT04097821|449032287|FG001|Overall Study|New Therapy For Study Indication|0|||
124836796|NCT04097821|449032288|FG002|Overall Study|New Therapy For Study Indication|0|||
124836797|NCT04097821|449032289|FG003|Overall Study|New Therapy For Study Indication|0|||
124836798|NCT04097821|449032290|FG004|Overall Study|New Therapy For Study Indication|0|||
124836799|NCT04097821|449032291|FG005|Overall Study|New Therapy For Study Indication|0|||
124639545|NCT00652626|448298406|FG002|Extension Phase|Withdrawal by Subject|0|||
124639546|NCT00652626|448298407|FG003|Extension Phase|Withdrawal by Subject|0|||
124639547|NCT00652626|448298408|FG004|Extension Phase|Withdrawal by Subject|0|||
124639548|NCT00652626|448298409|FG005|Extension Phase|Withdrawal by Subject|2|||
124639549|NCT00652626|448298410|FG006|Extension Phase|Withdrawal by Subject|0|||
124639550|NCT00652626|448298404|FG000|Extension Phase|Adverse Event|0|||
124639551|NCT00652626|448298405|FG001|Extension Phase|Adverse Event|0|||
124639552|NCT00652626|448298406|FG002|Extension Phase|Adverse Event|0|||
124639553|NCT00652626|448298407|FG003|Extension Phase|Adverse Event|0|||
124639554|NCT00652626|448298408|FG004|Extension Phase|Adverse Event|0|||
124639555|NCT00652626|448298409|FG005|Extension Phase|Adverse Event|2|||
124639556|NCT00652626|448298410|FG006|Extension Phase|Adverse Event|1|||
124639557|NCT00652626|448298404|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
124639558|NCT00652626|448298405|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
124639559|NCT00652626|448298406|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
124639560|NCT00652626|448298407|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
124639561|NCT00652626|448298408|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
124639562|NCT00652626|448298409|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
124639563|NCT00652626|448298410|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
124639564|NCT00652626|448298404|FG000|Extension Phase|Physician Decision|0|||
124639565|NCT00652626|448298405|FG001|Extension Phase|Physician Decision|0|||
124639566|NCT00652626|448298406|FG002|Extension Phase|Physician Decision|0|||
124639567|NCT00652626|448298407|FG003|Extension Phase|Physician Decision|0|||
124639568|NCT00652626|448298408|FG004|Extension Phase|Physician Decision|0|||
124639569|NCT00652626|448298409|FG005|Extension Phase|Physician Decision|1|||
124639570|NCT00652626|448298410|FG006|Extension Phase|Physician Decision|1|||
124639571|NCT00652626|448298404|FG000|Extension Phase|Death|0|||
124639572|NCT00652626|448298405|FG001|Extension Phase|Death|0|||
124639573|NCT00652626|448298406|FG002|Extension Phase|Death|0|||
124639574|NCT00652626|448298407|FG003|Extension Phase|Death|0|||
124639575|NCT00652626|448298408|FG004|Extension Phase|Death|0|||
124639576|NCT00652626|448298409|FG005|Extension Phase|Death|1|||
124639577|NCT00652626|448298410|FG006|Extension Phase|Death|1|||
124639578|NCT00912743|448298415|FG000|Overall Study|Adverse Event|3|||
124639579|NCT00912743|448298416|FG001|Overall Study|Adverse Event|1|||
124639580|NCT00912743|448298415|FG000|Overall Study|Lack of Efficacy|9|||
124639581|NCT00912743|448298416|FG001|Overall Study|Lack of Efficacy|18|||
124639582|NCT00912743|448298415|FG000|Overall Study|Toxicity|0|||
124639583|NCT00912743|448298416|FG001|Overall Study|Toxicity|1|||
124639584|NCT00912743|448298415|FG000|Overall Study|End of treatment form was not collected|1|||
124639585|NCT00912743|448298416|FG001|Overall Study|End of treatment form was not collected|0|||
124639586|NCT00179660|448298426|FG000|Overall Study|Adverse Event|7|||
124639587|NCT00179660|448298426|FG000|Overall Study|Lack of therapeutic effect|28|||
124639588|NCT00179660|448298426|FG000|Overall Study|Withdrawal by Subject|2|||
124639589|NCT00179660|448298426|FG000|Overall Study|Lost to Follow-up|1|||
124639590|NCT00179660|448298426|FG000|Overall Study|Death|3|||
124639591|NCT00179660|448298426|FG000|Overall Study|Other - Unspecified|9|||
124639592|NCT00178685|448298431|FG000|Overall Study|Death|3|||
124639593|NCT00178685|448298432|FG001|Overall Study|Death|3|||
124639594|NCT00178685|448298433|FG002|Overall Study|Death|6|||
124639595|NCT00178685|448298431|FG000|Overall Study|Lost to Follow-up|100|||
124639596|NCT00178685|448298432|FG001|Overall Study|Lost to Follow-up|187|||
124639597|NCT00178685|448298433|FG002|Overall Study|Lost to Follow-up|183|||
124639598|NCT00178685|448298431|FG000|Overall Study|Withdrawal by Subject|8|||
124639599|NCT00178685|448298432|FG001|Overall Study|Withdrawal by Subject|14|||
124639600|NCT00178685|448298433|FG002|Overall Study|Withdrawal by Subject|7|||
124639601|NCT00443079|448298438|FG000|Overall Study|Lost to Follow-up|0|||
124639602|NCT00443079|448298439|FG001|Overall Study|Lost to Follow-up|1|||
124639603|NCT02714595|448298440|FG000|Overall Study|Lost to Follow-up|1|||
124639604|NCT02714595|448298441|FG001|Overall Study|Lost to Follow-up|0|||
124639605|NCT02714595|448298440|FG000|Overall Study|Withdrawal by Subject|1|||
124639606|NCT02714595|448298441|FG001|Overall Study|Withdrawal by Subject|2|||
124639607|NCT02714595|448298440|FG000|Overall Study|Lack of Efficacy|0|||
124639608|NCT02714595|448298441|FG001|Overall Study|Lack of Efficacy|1|||
124836800|NCT04097821|449032292|FG006|Overall Study|New Therapy For Study Indication|1|||
124639609|NCT02714595|448298440|FG000|Overall Study|Death|30|||
124639610|NCT02714595|448298441|FG001|Overall Study|Death|9|||
124639611|NCT02714595|448298440|FG000|Overall Study|Other-Miscellaneous|0|||
124639612|NCT02714595|448298441|FG001|Overall Study|Other-Miscellaneous|1|||
124836801|NCT04097821|449032293|FG007|Overall Study|New Therapy For Study Indication|0|||
124836802|NCT04477304|449032295|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
124836803|NCT04477304|449032296|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
124836804|NCT05756790|449032297|FG000|Overall Study|Withdrawal by Subject|1|||
124836805|NCT05756790|449032298|FG001|Overall Study|Withdrawal by Subject|1|||
124836806|NCT05756790|449032299|FG002|Overall Study|Withdrawal by Subject|1|||
124836807|NCT05756790|449032300|FG003|Overall Study|Withdrawal by Subject|1|||
124836808|NCT05756790|449032301|FG004|Overall Study|Withdrawal by Subject|0|||
124836809|NCT05756790|449032302|FG005|Overall Study|Withdrawal by Subject|0|||
124836810|NCT05756790|449032297|FG000|Overall Study|Protocol Violation|0|||
124836811|NCT05756790|449032298|FG001|Overall Study|Protocol Violation|0|||
124836812|NCT05756790|449032299|FG002|Overall Study|Protocol Violation|1|||
124836813|NCT05756790|449032300|FG003|Overall Study|Protocol Violation|1|||
124836814|NCT05756790|449032301|FG004|Overall Study|Protocol Violation|0|||
124836815|NCT05756790|449032302|FG005|Overall Study|Protocol Violation|0|||
124836816|NCT05756790|449032297|FG000|Overall Study|Ineligible|0|||
124836817|NCT05756790|449032298|FG001|Overall Study|Ineligible|0|||
124836818|NCT05756790|449032299|FG002|Overall Study|Ineligible|0|||
124836819|NCT05756790|449032300|FG003|Overall Study|Ineligible|0|||
124836820|NCT05756790|449032301|FG004|Overall Study|Ineligible|2|||
124836821|NCT05756790|449032302|FG005|Overall Study|Ineligible|2|||
124836822|NCT00502697|449033606|FG000|Overall Study|Withdrawal by Subject|3|||
124836823|NCT00502697|449033607|FG001|Overall Study|Withdrawal by Subject|1|||
124836824|NCT00502697|449033606|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
124836825|NCT00502697|449033607|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
124836826|NCT00502697|449033606|FG000|Overall Study|found not to meet eligibility criteria|3|||
124836827|NCT00502697|449033607|FG001|Overall Study|found not to meet eligibility criteria|4|||
124836828|NCT00502697|449033606|FG000|Overall Study|did not meet assignment criteria|4|||
124836829|NCT00502697|449033607|FG001|Overall Study|did not meet assignment criteria|2|||
124836830|NCT00589108|449033610|FG000|Overall Study|Lost to Follow-up|1|||
124836831|NCT00589108|449033611|FG001|Overall Study|Lost to Follow-up|1|||
124836832|NCT00589108|449033612|FG002|Overall Study|Lost to Follow-up|1|||
124836833|NCT00589108|449033610|FG000|Overall Study|Death|3|||
124836834|NCT00589108|449033611|FG001|Overall Study|Death|3|||
124836835|NCT00589108|449033612|FG002|Overall Study|Death|4|||
124836836|NCT03256552|449033613|FG000|Overall Study|Protocol Violation|1|||
124836837|NCT03256552|449033613|FG000|Overall Study|Physician Decision|1|||
124836838|NCT03256552|449033613|FG000|Overall Study|Adverse Event|1|||
124836839|NCT03256552|449033613|FG000|Overall Study|Withdrawal by Subject|2|||
124836840|NCT03026257|449033619|FG000|Overall Study|Adverse Event|3|||
124836841|NCT03026257|449033620|FG001|Overall Study|Adverse Event|0|||
124836842|NCT03026257|449033621|FG002|Overall Study|Adverse Event|0|||
124836843|NCT03026257|449033622|FG003|Overall Study|Adverse Event|0|||
124836844|NCT03026257|449033623|FG004|Overall Study|Adverse Event|0|||
124836845|NCT03026257|449033624|FG005|Overall Study|Adverse Event|0|||
124836846|NCT03026257|449033619|FG000|Overall Study|Lost to Follow-up|1|||
124836847|NCT03026257|449033620|FG001|Overall Study|Lost to Follow-up|0|||
124836848|NCT03026257|449033621|FG002|Overall Study|Lost to Follow-up|0|||
124836849|NCT03026257|449033622|FG003|Overall Study|Lost to Follow-up|0|||
124836850|NCT03026257|449033623|FG004|Overall Study|Lost to Follow-up|0|||
124836851|NCT03026257|449033624|FG005|Overall Study|Lost to Follow-up|0|||
124836852|NCT03026257|449033619|FG000|Overall Study|Protocol Violation|1|||
124836853|NCT03026257|449033620|FG001|Overall Study|Protocol Violation|0|||
124836854|NCT03026257|449033621|FG002|Overall Study|Protocol Violation|0|||
124836855|NCT03026257|449033622|FG003|Overall Study|Protocol Violation|1|||
124836856|NCT03026257|449033623|FG004|Overall Study|Protocol Violation|1|||
124836857|NCT03026257|449033624|FG005|Overall Study|Protocol Violation|0|||
124836858|NCT03026257|449033619|FG000|Overall Study|Withdrawal by Subject|1|||
124836859|NCT03026257|449033620|FG001|Overall Study|Withdrawal by Subject|1|||
124836860|NCT03026257|449033621|FG002|Overall Study|Withdrawal by Subject|0|||
124836861|NCT03026257|449033622|FG003|Overall Study|Withdrawal by Subject|0|||
124836862|NCT03026257|449033623|FG004|Overall Study|Withdrawal by Subject|0|||
124836863|NCT03026257|449033624|FG005|Overall Study|Withdrawal by Subject|0|||
124836864|NCT04380857|449033625|FG000|Overall Study|Lost to Follow-up|3|||
124836865|NCT04380857|449033626|FG001|Overall Study|Lost to Follow-up|3|||
124836866|NCT00838201|449033627|FG000|Overall Study|Investigator decision, or other reasons|2|||
124836867|NCT00838201|449033628|FG001|Overall Study|Investigator decision, or other reasons|3|||
124836868|NCT00838201|449033627|FG000|Overall Study|Noncompliance|0|||
124836869|NCT00838201|449033628|FG001|Overall Study|Noncompliance|1|||
124836870|NCT00838201|449033627|FG000|Overall Study|Administrative decision|1|||
124836871|NCT00838201|449033628|FG001|Overall Study|Administrative decision|2|||
124836872|NCT00838201|449033627|FG000|Overall Study|Disease progression|3|||
124836873|NCT00838201|449033628|FG001|Overall Study|Disease progression|3|||
124836874|NCT00838201|449033627|FG000|Overall Study|Consent withdrawn|16|||
124836875|NCT00838201|449033628|FG001|Overall Study|Consent withdrawn|19|||
124836876|NCT00838201|449033627|FG000|Overall Study|Lost to Follow-up|4|||
124836877|NCT00838201|449033628|FG001|Overall Study|Lost to Follow-up|3|||
124836878|NCT00838201|449033627|FG000|Overall Study|Adverse Event|5|||
124836879|NCT00838201|449033628|FG001|Overall Study|Adverse Event|9|||
124836880|NCT00838201|449033627|FG000|Overall Study|Death|11|||
124836881|NCT00838201|449033628|FG001|Overall Study|Death|13|||
124836882|NCT06134817|449033633|FG000|Overall Study|Physician Departure - termination of study|1|||
124836883|NCT01987427|449033639|FG000|Overall Study|Adverse Event|4|||
124836884|NCT01987427|449033640|FG001|Overall Study|Adverse Event|2|||
124836885|NCT01987427|449033641|FG002|Overall Study|Adverse Event|8|||
124836886|NCT01987427|449033639|FG000|Overall Study|Lost to Follow-up|6|||
124836887|NCT01987427|449033640|FG001|Overall Study|Lost to Follow-up|6|||
124836888|NCT01987427|449033641|FG002|Overall Study|Lost to Follow-up|9|||
124836889|NCT01987427|449033639|FG000|Overall Study|Withdrawal by Subject|2|||
124836890|NCT01987427|449033640|FG001|Overall Study|Withdrawal by Subject|1|||
124836891|NCT01987427|449033641|FG002|Overall Study|Withdrawal by Subject|3|||
124836892|NCT01987427|449033639|FG000|Overall Study|Lack of Efficacy|1|||
124836893|NCT01987427|449033640|FG001|Overall Study|Lack of Efficacy|0|||
124836894|NCT01987427|449033641|FG002|Overall Study|Lack of Efficacy|0|||
124836895|NCT01987427|449033639|FG000|Overall Study|Other|1|||
124836896|NCT01987427|449033640|FG001|Overall Study|Other|1|||
124836897|NCT01987427|449033641|FG002|Overall Study|Other|0|||
124836898|NCT01073865|449033642|FG000|Overall Study|Reasons other than below|19|||
124836899|NCT01073865|449033643|FG001|Overall Study|Reasons other than below|31|||
124836900|NCT01073865|449033642|FG000|Overall Study|Lost to Follow-up|1|||
124836901|NCT01073865|449033643|FG001|Overall Study|Lost to Follow-up|1|||
124836902|NCT01073865|449033642|FG000|Overall Study|Death|3|||
124836903|NCT01073865|449033643|FG001|Overall Study|Death|2|||
124836904|NCT01073865|449033642|FG000|Overall Study|Withdrawal by Subject|5|||
124836905|NCT01073865|449033643|FG001|Overall Study|Withdrawal by Subject|5|||
124836906|NCT00805766|449033644|FG000|Screening Period|Adverse Event|1|||
124836907|NCT00805766|449033644|FG000|Screening Period|Lack of Efficacy|2|||
124836908|NCT00805766|449033644|FG000|Screening Period|Pregnancy|1|||
124836909|NCT00805766|449033644|FG000|Screening Period|Responder|2|||
124836910|NCT00805766|449033644|FG000|Increased Dose Period|Adverse Event|4|||
124836911|NCT00805766|449033644|FG000|Increased Dose Period|Lack of Efficacy|7|||
124836912|NCT00805766|449033644|FG000|Increased Dose Period|Pregnancy|1|||
124836913|NCT00805766|449033644|FG000|Increased Dose Period|Withdrawal by Subject|1|||
124836914|NCT00600756|449033645|FG000|Analysis After 6 Months|Adverse Event|43|||
124836915|NCT00600756|449033646|FG001|Analysis After 6 Months|Adverse Event|33|||
124836916|NCT00600756|449033645|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
124836917|NCT00600756|449033646|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
124836918|NCT00600756|449033645|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
124836919|NCT00600756|449033646|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
124836920|NCT00600756|449033645|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
124836921|NCT00600756|449033646|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
124836922|NCT00600756|449033645|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
124836923|NCT00600756|449033646|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
124836924|NCT00600756|449033645|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
124836925|NCT00600756|449033646|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
124836926|NCT00600756|449033645|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
124836927|NCT00600756|449033646|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
124836928|NCT00600756|449033645|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
124836929|NCT00600756|449033646|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
124836930|NCT00600756|449033645|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
124836931|NCT00600756|449033646|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
124836932|NCT00600756|449033645|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
124836933|NCT00600756|449033646|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
124836934|NCT00600756|449033645|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
124836935|NCT00600756|449033646|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
124836936|NCT00600756|449033645|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
124836937|NCT00600756|449033646|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
124836938|NCT00600756|449033645|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
124836939|NCT00600756|449033646|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
124836940|NCT00600756|449033645|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
124836941|NCT00600756|449033646|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
124836942|NCT03261947|449033648|FG000|Overall Study|Death|10|||
124836943|NCT03261947|449033649|FG001|Overall Study|Death|13|||
124836944|NCT03261947|449033650|FG002|Overall Study|Death|17|||
124836945|NCT03261947|449033651|FG003|Overall Study|Death|12|||
124836946|NCT03261947|449033652|FG004|Overall Study|Death|8|||
124836947|NCT03261947|449033648|FG000|Overall Study|Lost to Follow-up|0|||
124836948|NCT03261947|449033649|FG001|Overall Study|Lost to Follow-up|0|||
124836949|NCT03261947|449033650|FG002|Overall Study|Lost to Follow-up|2|||
124836950|NCT03261947|449033651|FG003|Overall Study|Lost to Follow-up|1|||
124836951|NCT03261947|449033652|FG004|Overall Study|Lost to Follow-up|0|||
124836952|NCT03261947|449033648|FG000|Overall Study|Withdrawal by Subject|0|||
124836953|NCT03261947|449033649|FG001|Overall Study|Withdrawal by Subject|0|||
124836954|NCT03261947|449033650|FG002|Overall Study|Withdrawal by Subject|3|||
124836955|NCT03261947|449033651|FG003|Overall Study|Withdrawal by Subject|0|||
124836956|NCT03261947|449033652|FG004|Overall Study|Withdrawal by Subject|1|||
124836957|NCT03261947|449033648|FG000|Overall Study|Site Terminated by Sponsor|0|||
124836958|NCT03261947|449033649|FG001|Overall Study|Site Terminated by Sponsor|0|||
124836959|NCT03261947|449033650|FG002|Overall Study|Site Terminated by Sponsor|4|||
124836960|NCT03261947|449033651|FG003|Overall Study|Site Terminated by Sponsor|7|||
124836961|NCT03261947|449033652|FG004|Overall Study|Site Terminated by Sponsor|5|||
124836962|NCT03261947|449033648|FG000|Overall Study|Reason not Specified|2|||
124836963|NCT03261947|449033649|FG001|Overall Study|Reason not Specified|0|||
124836964|NCT03261947|449033650|FG002|Overall Study|Reason not Specified|4|||
124836965|NCT03261947|449033651|FG003|Overall Study|Reason not Specified|1|||
124836966|NCT03261947|449033652|FG004|Overall Study|Reason not Specified|3|||
124836967|NCT03969992|449033653|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
124836968|NCT03969992|449033654|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
124836969|NCT03969992|449033655|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
124836970|NCT03969992|449033653|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
124836971|NCT03969992|449033654|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
124836972|NCT03969992|449033655|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
124836973|NCT03969992|449033653|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
124836974|NCT03969992|449033654|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
124836975|NCT03969992|449033655|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
124836976|NCT03969992|449033653|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
124836977|NCT03969992|449033654|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
124836978|NCT03969992|449033655|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
124836979|NCT03969992|449033653|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
124836980|NCT03969992|449033654|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
124836981|NCT03969992|449033655|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
124836982|NCT02063737|449033656|FG000|Overall Study|Lost to Follow-up|11|||
124836983|NCT02063737|449033657|FG001|Overall Study|Lost to Follow-up|4|||
124836984|NCT03373383|449033660|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
124836985|NCT03373383|449033661|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
124836986|NCT03373383|449033662|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
124836987|NCT03373383|449033663|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
124836988|NCT03373383|449033664|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
124836989|NCT03373383|449033660|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
124836990|NCT03373383|449033661|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
124836991|NCT03373383|449033662|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
124836992|NCT03373383|449033663|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
124836993|NCT03373383|449033664|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
124836994|NCT03373383|449033660|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
124836995|NCT03373383|449033661|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
124836996|NCT03373383|449033662|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
124836997|NCT03373383|449033663|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
124836998|NCT03373383|449033664|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
124836999|NCT03373383|449033660|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
124837000|NCT03373383|449033661|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
124837001|NCT03373383|449033662|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
124837002|NCT03373383|449033663|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
124837003|NCT03373383|449033664|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
124837004|NCT03373383|449033660|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
124837005|NCT03373383|449033661|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
124837006|NCT03373383|449033662|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
124837007|NCT03373383|449033663|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
124837008|NCT03373383|449033664|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
124837009|NCT03373383|449033660|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
124837010|NCT03373383|449033661|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
124837011|NCT03373383|449033662|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
124837012|NCT03373383|449033663|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
124837013|NCT03373383|449033664|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
124837014|NCT03373383|449033660|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
124837015|NCT03373383|449033661|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
124837016|NCT03373383|449033662|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
124837017|NCT03373383|449033663|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
124837018|NCT03373383|449033664|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
124837019|NCT03373383|449033660|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
124837020|NCT03373383|449033661|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
124837021|NCT03373383|449033662|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
124837022|NCT03373383|449033663|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
124837023|NCT03373383|449033664|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
124837024|NCT03373383|449033660|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
124837025|NCT03373383|449033661|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
124837026|NCT03373383|449033662|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
124837027|NCT03373383|449033663|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
124837028|NCT03373383|449033664|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
124837029|NCT04753164|449033668|FG000|Overall Study|Adverse Event|0|||
124837030|NCT04753164|449033669|FG001|Overall Study|Adverse Event|2|||
124837031|NCT04753164|449033668|FG000|Overall Study|Withdrawal by Subject|9|||
124837032|NCT04753164|449033669|FG001|Overall Study|Withdrawal by Subject|7|||
124837033|NCT04753164|449033668|FG000|Overall Study|Lost to Follow-up|6|||
124837034|NCT04753164|449033669|FG001|Overall Study|Lost to Follow-up|6|||
124837035|NCT04753164|449033668|FG000|Overall Study|Other|12|||
124837036|NCT04753164|449033669|FG001|Overall Study|Other|5|||
124837037|NCT00694369|449033670|FG000|Overall Study|Adverse Event|0|||
124837038|NCT00694369|449033671|FG001|Overall Study|Adverse Event|1|||
124837039|NCT00694369|449033672|FG002|Overall Study|Adverse Event|0|||
124837040|NCT00694369|449033673|FG003|Overall Study|Adverse Event|1|||
124837041|NCT00694369|449033674|FG004|Overall Study|Adverse Event|3|||
124837042|NCT00694369|449033670|FG000|Overall Study|Lost to Follow-up|0|||
124837043|NCT00694369|449033671|FG001|Overall Study|Lost to Follow-up|0|||
124837044|NCT00694369|449033672|FG002|Overall Study|Lost to Follow-up|1|||
124837045|NCT00694369|449033673|FG003|Overall Study|Lost to Follow-up|1|||
124837046|NCT00694369|449033674|FG004|Overall Study|Lost to Follow-up|0|||
124837047|NCT00694369|449033670|FG000|Overall Study|Physician Decision|0|||
124837048|NCT00694369|449033671|FG001|Overall Study|Physician Decision|0|||
124837049|NCT00694369|449033672|FG002|Overall Study|Physician Decision|0|||
124837050|NCT00694369|449033673|FG003|Overall Study|Physician Decision|0|||
124837051|NCT00694369|449033674|FG004|Overall Study|Physician Decision|1|||
124837052|NCT00694369|449033670|FG000|Overall Study|Protocol Violation|0|||
124837053|NCT00694369|449033671|FG001|Overall Study|Protocol Violation|1|||
124837054|NCT00694369|449033672|FG002|Overall Study|Protocol Violation|0|||
124837055|NCT00694369|449033673|FG003|Overall Study|Protocol Violation|0|||
124837056|NCT00694369|449033674|FG004|Overall Study|Protocol Violation|0|||
124837057|NCT00694369|449033670|FG000|Overall Study|Withdrawal by Subject|1|||
124837058|NCT00694369|449033671|FG001|Overall Study|Withdrawal by Subject|1|||
124837059|NCT00694369|449033672|FG002|Overall Study|Withdrawal by Subject|1|||
124837060|NCT00694369|449033673|FG003|Overall Study|Withdrawal by Subject|1|||
124837061|NCT00694369|449033674|FG004|Overall Study|Withdrawal by Subject|2|||
124837062|NCT00907374|449033677|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
124837063|NCT00907374|449033678|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
124837064|NCT02871739|449033681|FG000|Overall Study|Lost to Follow-up|3|||
124837065|NCT02871739|449033682|FG001|Overall Study|Lost to Follow-up|2|||
124837066|NCT02871739|449033683|FG002|Overall Study|Lost to Follow-up|0|||
124837067|NCT02871739|449033684|FG003|Overall Study|Lost to Follow-up|2|||
124837068|NCT03818516|449033685|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
124837069|NCT04372602|449033688|FG000|Overall Study|Withdrawal by Subject|1|||
124837070|NCT04372602|449033689|FG001|Overall Study|Withdrawal by Subject|1|||
124837071|NCT04372602|449033688|FG000|Overall Study|Adverse Event|0|||
124837072|NCT04372602|449033689|FG001|Overall Study|Adverse Event|1|||
124837073|NCT04372602|449033688|FG000|Overall Study|Transitioned to comfort care|0|||
124837074|NCT04372602|449033689|FG001|Overall Study|Transitioned to comfort care|1|||
124837075|NCT00594464|449033690|FG000|Overall Study|Withdrawal by Subject|1|||
124837076|NCT00594464|449033690|FG000|Overall Study|Delay in operation|2|||
124837077|NCT00775437|449033694|FG000|Overall Study|Loss of efficacy|2|||
124837078|NCT00775437|449033694|FG000|Overall Study|Withdrawal by Subject|3|||
124837079|NCT00775437|449033694|FG000|Overall Study|Lost to Follow-up|1|||
124837080|NCT01183975|449033695|FG000|Overall Study|Lost to Follow-up|73|||
124837081|NCT02907359|449033696|FG000|Overall Study|Death|234|||
124837082|NCT02907359|449033697|FG001|Overall Study|Death|117|||
124837083|NCT02907359|449033696|FG000|Overall Study|Withdrawal by Subject|6|||
124837084|NCT02907359|449033697|FG001|Overall Study|Withdrawal by Subject|11|||
124837085|NCT02907359|449033696|FG000|Overall Study|Lost to Follow-up|1|||
124837086|NCT02907359|449033697|FG001|Overall Study|Lost to Follow-up|0|||
124639613|NCT00713258|448298442|FG000|Overall Study|Adverse Event|2|||
124639614|NCT00713258|448298443|FG001|Overall Study|Adverse Event|4|||
124837087|NCT01405963|449033698|FG000|Overall Study|Moved Away|2|||
124837088|NCT01405963|449033699|FG001|Overall Study|Moved Away|0|||
124837089|NCT01405963|449033698|FG000|Overall Study|Adverse Event|0|||
124837090|NCT01405963|449033699|FG001|Overall Study|Adverse Event|1|||
124837091|NCT01405963|449033698|FG000|Overall Study|Lost to Follow-up|0|||
124837092|NCT01405963|449033699|FG001|Overall Study|Lost to Follow-up|1|||
124837093|NCT04371380|449033708|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
124837094|NCT04371380|449033709|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
124837095|NCT04371380|449033710|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
124837096|NCT00680901|449033717|FG000|Overall Study|Ongoing: On Study Treatment|1|||
124837097|NCT00680901|449033718|FG001|Overall Study|Ongoing: On Study Treatment|0|||
124837098|NCT00680901|449033717|FG000|Overall Study|Ongoing: In Follow Up|1|||
124837099|NCT00680901|449033718|FG001|Overall Study|Ongoing: In Follow Up|0|||
124837100|NCT00680901|449033717|FG000|Overall Study|Adverse Event|1|||
124837101|NCT00680901|449033718|FG001|Overall Study|Adverse Event|1|||
124837102|NCT00680901|449033717|FG000|Overall Study|Lost to Follow-up|3|||
124837103|NCT00680901|449033718|FG001|Overall Study|Lost to Follow-up|5|||
124837104|NCT00680901|449033717|FG000|Overall Study|Subject decided to withdraw from the study|4|||
124837105|NCT00680901|449033718|FG001|Overall Study|Subject decided to withdraw from the study|15|||
124837106|NCT00680901|449033717|FG000|Overall Study|Sponsor decision|1|||
124837107|NCT00680901|449033718|FG001|Overall Study|Sponsor decision|0|||
124837108|NCT00680901|449033717|FG000|Overall Study|Physician Decision|0|||
124837109|NCT00680901|449033718|FG001|Overall Study|Physician Decision|2|||
124837110|NCT00680901|449033717|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
124837111|NCT00680901|449033718|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
124837112|NCT00680901|449033717|FG000|Overall Study|Other protocol defined stopping criteria|17|||
124837113|NCT00680901|449033718|FG001|Overall Study|Other protocol defined stopping criteria|17|||
124837114|NCT04544293|449033719|FG000|Double-blind|Adverse Event|2|||
124837115|NCT04544293|449033720|FG001|Double-blind|Adverse Event|1|||
124837116|NCT04544293|449033719|FG000|Double-blind|Pregnancy|0|||
124837117|NCT04544293|449033720|FG001|Double-blind|Pregnancy|1|||
124837118|NCT04544293|449033719|FG000|Double-blind|Lost to Follow-up|0|||
124837119|NCT04544293|449033720|FG001|Double-blind|Lost to Follow-up|1|||
124837120|NCT04544293|449033719|FG000|Open-Label Extension|Study ongoing|79|||
124837121|NCT04544293|449033720|FG001|Open-Label Extension|Study ongoing|81|||
124837122|NCT01951157|449033721|FG000|Overall Study|Progressive Disease|12|||
124837123|NCT01951157|449033722|FG001|Overall Study|Progressive Disease|13|||
124837124|NCT01951157|449033723|FG002|Overall Study|Progressive Disease|10|||
124837125|NCT01951157|449033721|FG000|Overall Study|Treatment-unrelated AE|1|||
124837126|NCT01951157|449033722|FG001|Overall Study|Treatment-unrelated AE|0|||
124837127|NCT01951157|449033723|FG002|Overall Study|Treatment-unrelated AE|3|||
124837128|NCT01951157|449033721|FG000|Overall Study|Study Termination|0|||
124837129|NCT01951157|449033722|FG001|Overall Study|Study Termination|0|||
124837130|NCT01951157|449033723|FG002|Overall Study|Study Termination|1|||
124837131|NCT01951157|449033721|FG000|Overall Study|Physician Decision|5|||
124837132|NCT01951157|449033722|FG001|Overall Study|Physician Decision|3|||
124837133|NCT01951157|449033723|FG002|Overall Study|Physician Decision|2|||
124837134|NCT01951157|449033721|FG000|Overall Study|Non-treatmentrelated death|2|||
124837135|NCT01951157|449033722|FG001|Overall Study|Non-treatmentrelated death|2|||
124837136|NCT01951157|449033723|FG002|Overall Study|Non-treatmentrelated death|2|||
124837137|NCT01951157|449033721|FG000|Overall Study|No treated|0|||
124837138|NCT01951157|449033722|FG001|Overall Study|No treated|1|||
124837139|NCT01951157|449033723|FG002|Overall Study|No treated|0|||
124837140|NCT01951157|449033721|FG000|Overall Study|Treatment-related AE|2|||
124837141|NCT01951157|449033722|FG001|Overall Study|Treatment-related AE|0|||
124837142|NCT01951157|449033723|FG002|Overall Study|Treatment-related AE|4|||
124837143|NCT01951157|449033721|FG000|Overall Study|Consent withdrawn by subject|0|||
124837144|NCT01951157|449033722|FG001|Overall Study|Consent withdrawn by subject|1|||
124837145|NCT01951157|449033723|FG002|Overall Study|Consent withdrawn by subject|3|||
124837146|NCT01951157|449033721|FG000|Overall Study|Treatment-related death|0|||
124837147|NCT01951157|449033722|FG001|Overall Study|Treatment-related death|2|||
124837148|NCT01951157|449033723|FG002|Overall Study|Treatment-related death|0|||
124837149|NCT04809220|449033724|FG000|Overall Study|Adverse Event|4|||
124837150|NCT04809220|449033725|FG001|Overall Study|Adverse Event|0|||
124837151|NCT04809220|449033724|FG000|Overall Study|Death|1|||
124837152|NCT04809220|449033725|FG001|Overall Study|Death|0|||
124837153|NCT04809220|449033724|FG000|Overall Study|Lost to Follow-up|3|||
124837154|NCT04809220|449033725|FG001|Overall Study|Lost to Follow-up|0|||
124837155|NCT04809220|449033724|FG000|Overall Study|Physician Decision|0|||
124837156|NCT04809220|449033725|FG001|Overall Study|Physician Decision|1|||
124837157|NCT04809220|449033724|FG000|Overall Study|Withdrawal by Subject|9|||
124837158|NCT04809220|449033725|FG001|Overall Study|Withdrawal by Subject|5|||
124837159|NCT04809220|449033724|FG000|Overall Study|Due to long-term overseas business trips|1|||
124837160|NCT04809220|449033725|FG001|Overall Study|Due to long-term overseas business trips|0|||
124837161|NCT00329407|449033732|FG000|Overall Study|Withdrawal by Subject|1|||
124837162|NCT00978068|449033733|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
124837163|NCT00978068|449033734|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
124837164|NCT00978068|449033733|FG000|Overall Study|Death|1|||
124837165|NCT00978068|449033734|FG001|Overall Study|Death|2|||
124837166|NCT00978068|449033733|FG000|Overall Study|Lost to Follow-up|1|||
124837167|NCT00978068|449033734|FG001|Overall Study|Lost to Follow-up|2|||
124837168|NCT00978068|449033733|FG000|Overall Study|Physician Decision|0|||
124837169|NCT00978068|449033734|FG001|Overall Study|Physician Decision|1|||
124837170|NCT00978068|449033733|FG000|Overall Study|Unable to Comply with Study|0|||
124837171|NCT00978068|449033734|FG001|Overall Study|Unable to Comply with Study|2|||
124837172|NCT04258605|449033736|FG000|Overall Study|Death|1|||
124837173|NCT04258605|449033737|FG001|Overall Study|Death|0|||
124837174|NCT04258605|449033736|FG000|Overall Study|Early study termination|21|||
124837175|NCT04258605|449033737|FG001|Overall Study|Early study termination|2|||
124837176|NCT01070316|449033752|FG000|Extension Phase|Lack of Efficacy|3|||
124837177|NCT01070316|449033752|FG000|Extension Phase|Withdrawal by Subject|1|||
124837178|NCT01712256|449033753|FG000|Overall Study|Lost to Follow-up|1|||
124837179|NCT00748215|449033756|FG000|Overall Study|Withdrawal by Subject|7|||
124837180|NCT00748215|449033757|FG001|Overall Study|Withdrawal by Subject|7|||
124837181|NCT00748215|449033756|FG000|Overall Study|Treatment change|2|||
124837182|NCT00748215|449033757|FG001|Overall Study|Treatment change|1|||
124837183|NCT00748215|449033756|FG000|Overall Study|Change in patient condition|0|||
124837184|NCT00748215|449033757|FG001|Overall Study|Change in patient condition|3|||
124837185|NCT00748215|449033756|FG000|Overall Study|Non-compliant|0|||
124837186|NCT00748215|449033757|FG001|Overall Study|Non-compliant|2|||
124837187|NCT00748215|449033756|FG000|Overall Study|Adverse Event|0|||
124837188|NCT00748215|449033757|FG001|Overall Study|Adverse Event|5|||
124837189|NCT03200899|449033762|FG000|Overall Study|Lost to Follow-up|10|||
124837190|NCT03200899|449033763|FG001|Overall Study|Lost to Follow-up|23|||
124837191|NCT05083442|449035797|FG000|Overall Study|Lost to Follow-up|1|||
124837192|NCT05083442|449035798|FG001|Overall Study|Lost to Follow-up|0|||
124837193|NCT05083442|449035797|FG000|Overall Study|Lack of Efficacy|0|||
124837194|NCT05083442|449035798|FG001|Overall Study|Lack of Efficacy|1|||
124837195|NCT05083442|449035797|FG000|Overall Study|Withdrawal by Subject|1|||
124837196|NCT05083442|449035798|FG001|Overall Study|Withdrawal by Subject|3|||
124837197|NCT05083442|449035797|FG000|Overall Study|scheduling difficulties|1|||
124837198|NCT05083442|449035798|FG001|Overall Study|scheduling difficulties|2|||
124837199|NCT03711162|449035801|FG000|Overall Study|Adverse Event|5|||
124837200|NCT03711162|449035802|FG001|Overall Study|Adverse Event|2|||
124837201|NCT03711162|449035803|FG002|Overall Study|Adverse Event|4|||
124837202|NCT03711162|449035801|FG000|Overall Study|Death|11|||
124837203|NCT03711162|449035802|FG001|Overall Study|Death|7|||
124837204|NCT03711162|449035803|FG002|Overall Study|Death|8|||
124837205|NCT03711162|449035801|FG000|Overall Study|Lost to Follow-up|1|||
124837206|NCT03711162|449035802|FG001|Overall Study|Lost to Follow-up|0|||
124837207|NCT03711162|449035803|FG002|Overall Study|Lost to Follow-up|1|||
124837208|NCT03711162|449035801|FG000|Overall Study|Study Terminated by Sponsor|139|||
124837209|NCT03711162|449035802|FG001|Overall Study|Study Terminated by Sponsor|152|||
124837210|NCT03711162|449035803|FG002|Overall Study|Study Terminated by Sponsor|146|||
124837211|NCT03711162|449035801|FG000|Overall Study|Withdrawal by Subject|17|||
124837212|NCT03711162|449035802|FG001|Overall Study|Withdrawal by Subject|10|||
124837213|NCT03711162|449035803|FG002|Overall Study|Withdrawal by Subject|10|||
124837214|NCT03711162|449035801|FG000|Overall Study|Miscellaneous|1|||
124837215|NCT03711162|449035802|FG001|Overall Study|Miscellaneous|2|||
124837216|NCT03711162|449035803|FG002|Overall Study|Miscellaneous|2|||
124837217|NCT03711162|449035801|FG000|Overall Study|Not Treated|1|||
124837218|NCT03711162|449035802|FG001|Overall Study|Not Treated|0|||
124837219|NCT03711162|449035803|FG002|Overall Study|Not Treated|1|||
124837220|NCT03711162|449035801|FG000|Overall Study|Physician Decision|0|||
124837221|NCT03711162|449035802|FG001|Overall Study|Physician Decision|2|||
124837222|NCT03711162|449035803|FG002|Overall Study|Physician Decision|0|||
124837223|NCT03711162|449035801|FG000|Overall Study|Lack of Efficacy|0|||
124837224|NCT03711162|449035802|FG001|Overall Study|Lack of Efficacy|0|||
124837225|NCT03711162|449035803|FG002|Overall Study|Lack of Efficacy|2|||
124837226|NCT03711162|449035801|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
124837227|NCT03711162|449035802|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
124837228|NCT03711162|449035803|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
124837229|NCT03034954|449035807|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
124837230|NCT03034954|449035808|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
124837231|NCT05228470|449035811|FG000|Overall Study|Death|6|||
124837232|NCT05228470|449035812|FG001|Overall Study|Death|11|||
124837233|NCT05228470|449035811|FG000|Overall Study|Withdrawal by Subject|1|||
124837234|NCT05228470|449035812|FG001|Overall Study|Withdrawal by Subject|8|||
124837235|NCT05228470|449035811|FG000|Overall Study|Ongoing|1|||
124837236|NCT05228470|449035812|FG001|Overall Study|Ongoing|11|||
124837237|NCT00136084|449035813|FG000|Overall Study|Death|12|||
124837238|NCT00136084|449035814|FG001|Overall Study|Death|5|||
124639615|NCT00713258|448298442|FG000|Overall Study|Non-Compliance|2|||
124837239|NCT00136084|449035813|FG000|Overall Study|Unacceptable toxicity|8|||
124837240|NCT00136084|449035814|FG001|Overall Study|Unacceptable toxicity|11|||
124837241|NCT00136084|449035813|FG000|Overall Study|Relapse|20|||
124837242|NCT00136084|449035814|FG001|Overall Study|Relapse|23|||
124837243|NCT00136084|449035813|FG000|Overall Study|Lost to Follow-up|2|||
124837244|NCT00136084|449035814|FG001|Overall Study|Lost to Follow-up|0|||
124837245|NCT00136084|449035813|FG000|Overall Study|No Response|1|||
124837246|NCT00136084|449035814|FG001|Overall Study|No Response|2|||
124837247|NCT00136084|449035813|FG000|Overall Study|Withdrawal by Subject|5|||
124837248|NCT00136084|449035814|FG001|Overall Study|Withdrawal by Subject|1|||
124837249|NCT02449239|449035815|FG000|Induction Phase|Lack of Efficacy|64|||
124837250|NCT02449239|449035815|FG000|Induction Phase|Adverse Event|1|||
124837251|NCT02449239|449035815|FG000|Induction Phase|Lost to Follow-up|1|||
124837252|NCT02449239|449035815|FG000|Induction Phase|Protocol Violation|1|||
124837253|NCT02449239|449035815|FG000|Induction Phase|Physician Decision|1|||
124837254|NCT02449239|449035815|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
124837255|NCT02449239|449035815|FG000|Induction Phase|Withdrawal by Subject|1|||
124837256|NCT02449239|449035815|FG000|Maintenance Month 3|Lack of Efficacy|14|||
124837257|NCT02449239|449035815|FG000|Maintenance Month 6|Lack of Efficacy|10|||
124837258|NCT02449239|449035815|FG000|Maintenance Month 6|Adverse Event|2|||
124837259|NCT02449239|449035815|FG000|Maintenance Month 6|Physician Decision|1|||
124837260|NCT02449239|449035815|FG000|Maintenance Month 9|Lack of Efficacy|2|||
124837261|NCT02449239|449035815|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
124837262|NCT02449239|449035815|FG000|Maintenance Month 12|Lack of Efficacy|5|||
124837263|NCT02449239|449035815|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
124837264|NCT02449239|449035815|FG000|Maintenance Month 12|Subject moved from area|1|||
124837265|NCT02449239|449035815|FG000|Maintenance Month 15|Lack of Efficacy|1|||
124837266|NCT02449239|449035815|FG000|Maintenance Month 21|Lack of Efficacy|1|||
124837267|NCT02449239|449035815|FG000|Maintenance Month 21|Sponsor decision|1|||
124837268|NCT00394212|449035817|FG000|Overall Study|Lost to Follow-up|3|||
124837269|NCT00394212|449035818|FG001|Overall Study|Lost to Follow-up|0|||
124837270|NCT00394212|449035817|FG000|Overall Study|Withdrawal by Subject|4|||
124837271|NCT00394212|449035818|FG001|Overall Study|Withdrawal by Subject|1|||
124837272|NCT00588445|449035819|FG000|Overall Study|Protocol Violation|1|||
124837273|NCT00588445|449035819|FG000|Overall Study|Withdrawal by Subject|3|||
124837274|NCT00588445|449035819|FG000|Overall Study|Disease Progression|1|||
124837275|NCT00588445|449035819|FG000|Overall Study|Not Treated|10|||
124837276|NCT03240133|449035820|FG000|Overall Study|Withdrawal by Subject|0|||
124837277|NCT03240133|449035821|FG001|Overall Study|Withdrawal by Subject|1|||
124837278|NCT03240133|449035822|FG002|Overall Study|Withdrawal by Subject|0|||
124837279|NCT03240133|449035820|FG000|Overall Study|Adverse Event|1|||
124837280|NCT03240133|449035821|FG001|Overall Study|Adverse Event|1|||
124837281|NCT03240133|449035822|FG002|Overall Study|Adverse Event|0|||
124837282|NCT03240133|449035820|FG000|Overall Study|Rash|1|||
124837283|NCT03240133|449035821|FG001|Overall Study|Rash|0|||
124837284|NCT03240133|449035822|FG002|Overall Study|Rash|0|||
124837285|NCT03240133|449035820|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
124837286|NCT03240133|449035821|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
124837287|NCT03240133|449035822|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
124837288|NCT03240133|449035820|FG000|Overall Study|Intercurrent illness.|0|||
124837289|NCT03240133|449035821|FG001|Overall Study|Intercurrent illness.|1|||
124837290|NCT03240133|449035822|FG002|Overall Study|Intercurrent illness.|0|||
124837291|NCT03240133|449035820|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
124837292|NCT03240133|449035821|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
124837293|NCT03240133|449035822|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
124837294|NCT01176292|449035823|FG000|Overall Study|Lost to Follow-up|2|||
124837295|NCT01176292|449035824|FG001|Overall Study|Lost to Follow-up|4|||
124837296|NCT01176292|449035823|FG000|Overall Study|Adverse Event|1|||
124837297|NCT01176292|449035824|FG001|Overall Study|Adverse Event|1|||
124837298|NCT01176292|449035823|FG000|Overall Study|Physician Decision|0|||
124837299|NCT01176292|449035824|FG001|Overall Study|Physician Decision|2|||
124837300|NCT01176292|449035823|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
124837301|NCT01176292|449035824|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
124837302|NCT00997503|449035825|FG000|Overall Study|Death|53|||
124837303|NCT00997503|449035825|FG000|Overall Study|Withdrawal by Subject|76|||
124837304|NCT00997503|449035825|FG000|Overall Study|Lost to Follow-up|33|||
124837305|NCT00997503|449035825|FG000|Overall Study|Adverse Event|3|||
124837306|NCT00997503|449035825|FG000|Overall Study|Physician Decision|10|||
124837307|NCT00997503|449035825|FG000|Overall Study|Missed 12-month follow-up|85|||
124639616|NCT00713258|448298443|FG001|Overall Study|Non-Compliance|1|||
124639617|NCT00713258|448298442|FG000|Overall Study|Other|1|||
124639618|NCT00713258|448298443|FG001|Overall Study|Other|1|||
124639619|NCT01053663|448298444|FG000|Overall Study|Death|2|||
124639620|NCT01053663|448298444|FG000|Overall Study|Lost to Follow-up|1|||
124639621|NCT01053663|448298444|FG000|Overall Study|Poor IV Access|1|||
124639622|NCT01053663|448298444|FG000|Overall Study|Transferred to Another Hospital|1|||
124639623|NCT01053663|448298444|FG000|Overall Study|Negative Influenza Diagnosis|1|||
124639624|NCT03533114|448298445|FG000|Overall|Adverse Event|16|||
124639625|NCT03533114|448298446|FG001|Overall|Adverse Event|11|||
124639626|NCT03533114|448298445|FG000|Overall|Consent Withdrawal by Participant|7|||
124639627|NCT03533114|448298446|FG001|Overall|Consent Withdrawal by Participant|6|||
124639628|NCT03533114|448298445|FG000|Overall|Lack of Efficacy|5|||
124639629|NCT03533114|448298446|FG001|Overall|Lack of Efficacy|3|||
124837308|NCT00997503|449035825|FG000|Overall Study|Other reason|13|||
124837309|NCT00116831|449035826|FG000|Overall Study|Adverse Event|14|||
124837310|NCT00116831|449035827|FG001|Overall Study|Adverse Event|16|||
124837311|NCT00116831|449035826|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
124837312|NCT00116831|449035827|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
124837313|NCT00116831|449035826|FG000|Overall Study|Lost to Follow-up|8|||
124837314|NCT00116831|449035827|FG001|Overall Study|Lost to Follow-up|6|||
124837315|NCT00116831|449035826|FG000|Overall Study|Protocol Violation|3|||
124837316|NCT00116831|449035827|FG001|Overall Study|Protocol Violation|6|||
124837317|NCT00116831|449035826|FG000|Overall Study|Hypoglycaemic events|1|||
124837318|NCT00116831|449035827|FG001|Overall Study|Hypoglycaemic events|0|||
124837319|NCT00116831|449035826|FG000|Overall Study|Low haemoglobin on screening|1|||
124837320|NCT00116831|449035827|FG001|Overall Study|Low haemoglobin on screening|0|||
124837321|NCT00116831|449035826|FG000|Overall Study|Withdrawn investigational product|1|||
124837322|NCT00116831|449035827|FG001|Overall Study|Withdrawn investigational product|0|||
124837323|NCT00116831|449035826|FG000|Overall Study|Withdrawal by Subject|32|||
124837324|NCT00116831|449035827|FG001|Overall Study|Withdrawal by Subject|32|||
124837325|NCT00116831|449035826|FG000|Overall Study|Insufficient therapeutic effect|0|||
124837326|NCT00116831|449035827|FG001|Overall Study|Insufficient therapeutic effect|1|||
124837327|NCT00116831|449035826|FG000|Overall Study|Missing data for participant|1|||
124837328|NCT00116831|449035827|FG001|Overall Study|Missing data for participant|0|||
124837329|NCT01933048|449035828|FG000|Overall Study|Lost to Follow-up|15|||
124837330|NCT01933048|449035829|FG001|Overall Study|Lost to Follow-up|18|||
124837331|NCT01933048|449035828|FG000|Overall Study|personal reasons|1|||
124837332|NCT01933048|449035829|FG001|Overall Study|personal reasons|1|||
124837333|NCT01933048|449035828|FG000|Overall Study|Protocol Violation|7|||
124837334|NCT01933048|449035829|FG001|Overall Study|Protocol Violation|8|||
124837335|NCT01933048|449035828|FG000|Overall Study|Physician Decision|1|||
124837336|NCT01933048|449035829|FG001|Overall Study|Physician Decision|0|||
124837337|NCT01933048|449035828|FG000|Overall Study|unknown reasons|1|||
124837338|NCT01933048|449035829|FG001|Overall Study|unknown reasons|1|||
124837339|NCT00110812|449035830|FG000|Main Study|Death|0|||
124837340|NCT00110812|449035831|FG001|Main Study|Death|0|||
124837341|NCT00110812|449035832|FG002|Main Study|Death|2|||
124837342|NCT00110812|449035830|FG000|Main Study|Withdrawal by Subject|0|||
124837343|NCT00110812|449035831|FG001|Main Study|Withdrawal by Subject|0|||
124837344|NCT00110812|449035832|FG002|Main Study|Withdrawal by Subject|1|||
124837345|NCT00110812|449035830|FG000|Main Study|Lost to Follow-up|8|||
124837346|NCT00110812|449035831|FG001|Main Study|Lost to Follow-up|11|||
124837347|NCT00110812|449035832|FG002|Main Study|Lost to Follow-up|10|||
124837348|NCT00110812|449035830|FG000|Extended Follow-up|Death|1|||
124837349|NCT00110812|449035831|FG001|Extended Follow-up|Death|0|||
124837350|NCT00110812|449035832|FG002|Extended Follow-up|Death|3|||
124837351|NCT00110812|449035830|FG000|Extended Follow-up|Withdrawal by Subject|0|||
124837352|NCT00110812|449035831|FG001|Extended Follow-up|Withdrawal by Subject|1|||
124837353|NCT00110812|449035832|FG002|Extended Follow-up|Withdrawal by Subject|0|||
124837354|NCT00110812|449035830|FG000|Extended Follow-up|Lost to Follow-up|1|||
124837355|NCT00110812|449035831|FG001|Extended Follow-up|Lost to Follow-up|3|||
124837356|NCT00110812|449035832|FG002|Extended Follow-up|Lost to Follow-up|1|||
124837357|NCT00380393|449035833|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
124837358|NCT00380393|449035834|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
124837359|NCT00380393|449035833|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
124837360|NCT00380393|449035834|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
124837361|NCT00380393|449035833|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
124837362|NCT00380393|449035834|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
124837363|NCT00380393|449035833|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
124837364|NCT00380393|449035834|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
124837365|NCT00380393|449035833|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
124837366|NCT00380393|449035834|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
124837367|NCT00380393|449035833|FG000|Month 14|Withdrawal by Subject|9|||
124837368|NCT00380393|449035834|FG001|Month 14|Withdrawal by Subject|7|||
124837369|NCT00380393|449035833|FG000|Month 14|Death|1|||
124837370|NCT00380393|449035834|FG001|Month 14|Death|0|||
124837371|NCT00380393|449035833|FG000|Month 14|Lost to Follow-up|0|||
124837372|NCT00380393|449035834|FG001|Month 14|Lost to Follow-up|1|||
124837373|NCT00380393|449035833|FG000|Month 14|Migrated/moved from study area|39|||
124837374|NCT00380393|449035834|FG001|Month 14|Migrated/moved from study area|42|||
124837375|NCT00380393|449035833|FG000|Month 14|Protocol Violation|2|||
124837376|NCT00380393|449035834|FG001|Month 14|Protocol Violation|0|||
124837377|NCT00380393|449035833|FG000|Month 14|Others|6|||
124837378|NCT00380393|449035834|FG001|Month 14|Others|6|||
124837379|NCT02780804|449035837|FG000|Overall Study|Death|1|||
124837380|NCT02780804|449035838|FG001|Overall Study|Death|0|||
124837381|NCT02780804|449035839|FG002|Overall Study|Death|0|||
124837382|NCT02780804|449035837|FG000|Overall Study|Lack of Efficacy|5|||
124837383|NCT02780804|449035838|FG001|Overall Study|Lack of Efficacy|8|||
124837384|NCT02780804|449035839|FG002|Overall Study|Lack of Efficacy|4|||
124837385|NCT02780804|449035837|FG000|Overall Study|Physician Decision|0|||
124837386|NCT02780804|449035838|FG001|Overall Study|Physician Decision|0|||
124837387|NCT02780804|449035839|FG002|Overall Study|Physician Decision|2|||
124837388|NCT02780804|449035837|FG000|Overall Study|Withdrawal by Subject|0|||
124837389|NCT02780804|449035838|FG001|Overall Study|Withdrawal by Subject|1|||
124837390|NCT02780804|449035839|FG002|Overall Study|Withdrawal by Subject|0|||
124837391|NCT02476968|449035840|FG000|Overall Study|Other|0|||
124837392|NCT02476968|449035841|FG001|Overall Study|Other|2|||
124837393|NCT02476968|449035842|FG002|Overall Study|Other|0|||
124837394|NCT02476968|449035840|FG000|Overall Study|Lost to Follow-up|10|||
124837395|NCT02476968|449035841|FG001|Overall Study|Lost to Follow-up|0|||
124837396|NCT02476968|449035842|FG002|Overall Study|Lost to Follow-up|1|||
124837397|NCT02476968|449035840|FG000|Overall Study|Death|48|||
124837398|NCT02476968|449035841|FG001|Overall Study|Death|8|||
124837399|NCT02476968|449035842|FG002|Overall Study|Death|1|||
124837400|NCT02476968|449035840|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
124837401|NCT02476968|449035841|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124837402|NCT02476968|449035842|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
124837403|NCT02476968|449035840|FG000|Overall Study|Patient decision|37|||
124837404|NCT02476968|449035841|FG001|Overall Study|Patient decision|8|||
124837405|NCT02476968|449035842|FG002|Overall Study|Patient decision|0|||
124837406|NCT01723163|449035843|FG000|Treatment Phase|Withdrawal by Subject|14|||
124837407|NCT01723163|449035844|FG001|Treatment Phase|Withdrawal by Subject|6|||
124837408|NCT01723163|449035843|FG000|Treatment Phase|Withdrawal by PI|5|||
124837409|NCT01723163|449035844|FG001|Treatment Phase|Withdrawal by PI|1|||
124837410|NCT01723163|449035843|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
124837411|NCT01723163|449035844|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
124837412|NCT01723163|449035843|FG000|3-Month Follow-up|Unable to Contact|12|||
124837413|NCT01723163|449035844|FG001|3-Month Follow-up|Unable to Contact|19|||
124837414|NCT01723163|449035843|FG000|6-Month Follow-up|Death|1|||
124837415|NCT01723163|449035844|FG001|6-Month Follow-up|Death|0|||
124837416|NCT01723163|449035843|FG000|6-Month Follow-up|Unable to Contact|17|||
124837417|NCT01723163|449035844|FG001|6-Month Follow-up|Unable to Contact|15|||
124837418|NCT01723163|449035843|FG000|12-Month Follow-up|Death|1|||
124837419|NCT01723163|449035844|FG001|12-Month Follow-up|Death|0|||
124837420|NCT01723163|449035843|FG000|12-Month Follow-up|Unable to Contact|23|||
124837421|NCT01723163|449035844|FG001|12-Month Follow-up|Unable to Contact|28|||
124837422|NCT01859507|449035847|FG000|Overall Study|left the country|4|||
124837423|NCT01921829|449035848|FG000|Overall Study|Withdrawal by Subject|0|||
124837424|NCT01921829|449035849|FG001|Overall Study|Withdrawal by Subject|1|||
124837425|NCT04476030|449035850|FG000|Overall Study|Withdrawal by Subject|20|||
124837426|NCT04476030|449035851|FG001|Overall Study|Withdrawal by Subject|16|||
124837427|NCT04476030|449035850|FG000|Overall Study|Adverse Event|10|||
124837428|NCT04476030|449035851|FG001|Overall Study|Adverse Event|11|||
124837429|NCT04476030|449035850|FG000|Overall Study|Lost to Follow-up|7|||
124837430|NCT04476030|449035851|FG001|Overall Study|Lost to Follow-up|4|||
124837431|NCT04476030|449035850|FG000|Overall Study|Physician Decision|1|||
124837432|NCT04476030|449035851|FG001|Overall Study|Physician Decision|1|||
124837433|NCT04476030|449035850|FG000|Overall Study|Protocol Deviation|2|||
124837434|NCT04476030|449035851|FG001|Overall Study|Protocol Deviation|0|||
124837435|NCT04476030|449035850|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
124837436|NCT04476030|449035851|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
124837437|NCT04476030|449035850|FG000|Overall Study|Randomized but not Dosed|2|||
124837438|NCT04476030|449035851|FG001|Overall Study|Randomized but not Dosed|8|||
124837439|NCT02404311|449035852|FG000|Part A: Month 0-18|Death|2|||
124837440|NCT02404311|449035853|FG001|Part A: Month 0-18|Death|0|||
124837441|NCT02404311|449035854|FG002|Part A: Month 0-18|Death|0|||
124837442|NCT02404311|449035855|FG003|Part A: Month 0-18|Death|0|||
124837443|NCT02404311|449035856|FG004|Part A: Month 0-18|Death|0|||
124837444|NCT02404311|449035852|FG000|Part A: Month 0-18|Physician Decision|1|||
124837445|NCT02404311|449035853|FG001|Part A: Month 0-18|Physician Decision|0|||
124837446|NCT02404311|449035854|FG002|Part A: Month 0-18|Physician Decision|0|||
124837447|NCT02404311|449035855|FG003|Part A: Month 0-18|Physician Decision|0|||
124837448|NCT02404311|449035856|FG004|Part A: Month 0-18|Physician Decision|0|||
124837449|NCT02404311|449035852|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
124837450|NCT02404311|449035853|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
124837451|NCT02404311|449035854|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
124837452|NCT02404311|449035855|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
124837453|NCT02404311|449035856|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
124639630|NCT03533114|448298445|FG000|Overall|Lost to Follow-up|1|||
124837454|NCT02404311|449035852|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
124837455|NCT02404311|449035853|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
124837456|NCT02404311|449035854|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
124837457|NCT02404311|449035855|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
124837458|NCT02404311|449035856|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
124837459|NCT02404311|449035852|FG000|Part A: Month 0-18|HIV Infection|6|||
124837460|NCT02404311|449035853|FG001|Part A: Month 0-18|HIV Infection|2|||
124837461|NCT02404311|449035854|FG002|Part A: Month 0-18|HIV Infection|0|||
124837462|NCT02404311|449035855|FG003|Part A: Month 0-18|HIV Infection|0|||
124837463|NCT02404311|449035856|FG004|Part A: Month 0-18|HIV Infection|0|||
124837464|NCT02404311|449035852|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
124837465|NCT02404311|449035853|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
124837466|NCT02404311|449035854|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
124837467|NCT02404311|449035855|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
124837468|NCT02404311|449035856|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
124837469|NCT02256891|449035861|FG000|Overall Study|Death|0|||
124837470|NCT02256891|449035862|FG001|Overall Study|Death|2|||
124837471|NCT02256891|449035861|FG000|Overall Study|Lost to Follow-up|0|||
124837472|NCT02256891|449035862|FG001|Overall Study|Lost to Follow-up|3|||
124837473|NCT02256891|449035861|FG000|Overall Study|Physician Decision|7|||
124837474|NCT02256891|449035862|FG001|Overall Study|Physician Decision|3|||
124837475|NCT02256891|449035861|FG000|Overall Study|Screen Fail|5|||
124837476|NCT02256891|449035862|FG001|Overall Study|Screen Fail|4|||
124837477|NCT02256891|449035861|FG000|Overall Study|Equipment Malfunction|0|||
124837478|NCT02256891|449035862|FG001|Overall Study|Equipment Malfunction|1|||
124837479|NCT01344447|449035863|FG000|Overall Study|Adverse Event|1|||
124837480|NCT01344447|449035863|FG000|Overall Study|Protocol Violation|1|||
124837481|NCT01344447|449035863|FG000|Overall Study|Withdrawal by Subject|1|||
124837482|NCT01344447|449035863|FG000|Overall Study|The contrast was not seen|1|||
124837483|NCT01344447|449035863|FG000|Overall Study|Physician Decision|1|||
124837484|NCT01344447|449035863|FG000|Overall Study|MRA unsuccessful|1|||
124837485|NCT01344447|449035863|FG000|Overall Study|Bolus tracking failed|1|||
124837486|NCT01344447|449035863|FG000|Overall Study|Error of power injector|1|||
124837487|NCT00218296|449035864|FG000|Overall Study|Lost to Follow-up|9|||
124837488|NCT00218296|449035865|FG001|Overall Study|Lost to Follow-up|7|||
124837489|NCT00218296|449035864|FG000|Overall Study|Withdrawal by Subject|36|||
124837490|NCT00218296|449035865|FG001|Overall Study|Withdrawal by Subject|47|||
124837491|NCT00218296|449035864|FG000|Overall Study|Randomized but did not enter treatment|66|||
124837492|NCT00218296|449035865|FG001|Overall Study|Randomized but did not enter treatment|67|||
124837493|NCT01293240|449035871|FG000|Overall Study|Noncompliance|2|||
124837494|NCT01364428|449035879|FG000|Overall Study|Adverse Event|1|||
124837495|NCT01364428|449035880|FG001|Overall Study|Adverse Event|2|||
124837496|NCT01364428|449035879|FG000|Overall Study|Protocol Violation|2|||
124837497|NCT01364428|449035880|FG001|Overall Study|Protocol Violation|0|||
124837498|NCT01364428|449035879|FG000|Overall Study|Withdrawal Criteria|14|||
124837499|NCT01364428|449035880|FG001|Overall Study|Withdrawal Criteria|10|||
124837500|NCT01364428|449035879|FG000|Overall Study|Other|3|||
124837501|NCT01364428|449035880|FG001|Overall Study|Other|3|||
124837502|NCT00228917|449035881|FG000|Overall Study|Migrated/moved from study area|0|||
124837503|NCT00228917|449035882|FG001|Overall Study|Migrated/moved from study area|0|||
124837504|NCT00228917|449035883|FG002|Overall Study|Migrated/moved from study area|0|||
124837505|NCT00228917|449035884|FG003|Overall Study|Migrated/moved from study area|0|||
124837506|NCT00228917|449035885|FG004|Overall Study|Migrated/moved from study area|0|||
124837507|NCT00228917|449035886|FG005|Overall Study|Migrated/moved from study area|2|||
124837508|NCT00228917|449035887|FG006|Overall Study|Migrated/moved from study area|0|||
124837509|NCT00228917|449035888|FG007|Overall Study|Migrated/moved from study area|0|||
124837510|NCT03131440|449035890|FG000|Overall Study|Withdrawal by Subject|1|||
124837511|NCT03131440|449035891|FG001|Overall Study|Withdrawal by Subject|3|||
124837512|NCT03131440|449035892|FG002|Overall Study|Withdrawal by Subject|0|||
124837513|NCT03131440|449035893|FG003|Overall Study|Withdrawal by Subject|0|||
124837514|NCT03131440|449035894|FG004|Overall Study|Withdrawal by Subject|1|||
124837515|NCT03131440|449035895|FG005|Overall Study|Withdrawal by Subject|0|||
124837516|NCT03131440|449035896|FG006|Overall Study|Withdrawal by Subject|0|||
124837517|NCT03131440|449035897|FG007|Overall Study|Withdrawal by Subject|1|||
124837518|NCT03131440|449035898|FG008|Overall Study|Withdrawal by Subject|1|||
124837519|NCT03131440|449035899|FG009|Overall Study|Withdrawal by Subject|1|||
124837520|NCT03131440|449035900|FG010|Overall Study|Withdrawal by Subject|0|||
124837521|NCT03131440|449035901|FG011|Overall Study|Withdrawal by Subject|1|||
124837522|NCT03131440|449035902|FG012|Overall Study|Withdrawal by Subject|1|||
124837523|NCT03131440|449035903|FG013|Overall Study|Withdrawal by Subject|0|||
124837524|NCT03131440|449035904|FG014|Overall Study|Withdrawal by Subject|1|||
124837525|NCT03131440|449035905|FG015|Overall Study|Withdrawal by Subject|0|||
124837526|NCT03131440|449035906|FG016|Overall Study|Withdrawal by Subject|0|||
124837527|NCT03131440|449035907|FG017|Overall Study|Withdrawal by Subject|0|||
124837528|NCT03131440|449035908|FG018|Overall Study|Withdrawal by Subject|1|||
124837529|NCT03131440|449035909|FG019|Overall Study|Withdrawal by Subject|0|||
124837530|NCT03131440|449035910|FG020|Overall Study|Withdrawal by Subject|1|||
124837531|NCT03131440|449035911|FG021|Overall Study|Withdrawal by Subject|1|||
124837532|NCT03131440|449035912|FG022|Overall Study|Withdrawal by Subject|1|||
124837533|NCT03131440|449035913|FG023|Overall Study|Withdrawal by Subject|0|||
124837534|NCT03131440|449035914|FG024|Overall Study|Withdrawal by Subject|0|||
124837535|NCT03131440|449035915|FG025|Overall Study|Withdrawal by Subject|0|||
124837536|NCT03131440|449035916|FG026|Overall Study|Withdrawal by Subject|0|||
124837537|NCT03131440|449035917|FG027|Overall Study|Withdrawal by Subject|0|||
124837538|NCT03131440|449035918|FG028|Overall Study|Withdrawal by Subject|0|||
124837539|NCT03131440|449035919|FG029|Overall Study|Withdrawal by Subject|0|||
124837540|NCT03131440|449035920|FG030|Overall Study|Withdrawal by Subject|1|||
124837541|NCT03131440|449035921|FG031|Overall Study|Withdrawal by Subject|0|||
124837542|NCT03131440|449035890|FG000|Overall Study|Lost to Follow-up|0|||
124837543|NCT03131440|449035891|FG001|Overall Study|Lost to Follow-up|0|||
124837544|NCT03131440|449035892|FG002|Overall Study|Lost to Follow-up|0|||
124837545|NCT03131440|449035893|FG003|Overall Study|Lost to Follow-up|0|||
124639631|NCT03533114|448298446|FG001|Overall|Lost to Follow-up|1|||
124639632|NCT03533114|448298445|FG000|Overall|Physician Decision|0|||
124753120|NCT01957202|448718790|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
124753121|NCT01957202|448718791|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
124753122|NCT01957202|448718792|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
124753123|NCT01957202|448718793|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
124753124|NCT01957202|448718794|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
124753125|NCT01957202|448718795|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
124753126|NCT01957202|448718796|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
124753127|NCT01957202|448718797|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
124753128|NCT01957202|448718798|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
124753129|NCT01957202|448718799|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
124753130|NCT01957202|448718800|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
124753131|NCT01957202|448718801|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
124753132|NCT00381693|448718804|FG000|Overall Study|Death|1|||
124753133|NCT00381693|448718804|FG000|Overall Study|Adverse Event|4|||
124753134|NCT00381693|448718804|FG000|Overall Study|Patient Choice|1|||
124753135|NCT00381693|448718804|FG000|Overall Study|Progression|2|||
124753136|NCT02506192|448718816|FG000|Overall Study|Withdrawal by Subject|1|||
124753137|NCT02506192|448718817|FG001|Overall Study|Withdrawal by Subject|1|||
124753138|NCT01922271|448718819|FG000|WASHOUT Period|Withdrawal by Subject|1|||
124753139|NCT01922271|448718820|FG001|WASHOUT Period|Withdrawal by Subject|0|||
124753140|NCT00836186|448718823|FG000|Overall Study|Blood could not be drawn|1|||
124753141|NCT04531241|448718825|FG000|Period 1|Withdrawal by Subject|2|||
124753142|NCT04531241|448718826|FG001|Period 1|Withdrawal by Subject|0|||
124753143|NCT04531241|448718825|FG000|Period 1|Dispesed incorrect lens power|1|||
124753144|NCT04531241|448718826|FG001|Period 1|Dispesed incorrect lens power|0|||
124753145|NCT04531241|448718825|FG000|Period 1|Protocol Violation|1|||
124753146|NCT04531241|448718826|FG001|Period 1|Protocol Violation|0|||
124753147|NCT04531241|448718825|FG000|Period 1|No longer eligible|0|||
124753148|NCT04531241|448718826|FG001|Period 1|No longer eligible|1|||
124753149|NCT04531241|448718825|FG000|Period 1|Lens Discomfort|0|||
124753150|NCT04531241|448718826|FG001|Period 1|Lens Discomfort|1|||
124753151|NCT04531241|448718825|FG000|Period 2|Covid-19 Related|1|||
124753152|NCT04531241|448718826|FG001|Period 2|Covid-19 Related|1|||
124753153|NCT02576795|448718827|FG000|Overall Study|Lost to Follow-up|0|||
124753154|NCT02576795|448718828|FG001|Overall Study|Lost to Follow-up|0|||
124753155|NCT02576795|448718829|FG002|Overall Study|Lost to Follow-up|1|||
124753156|NCT02576795|448718830|FG003|Overall Study|Lost to Follow-up|0|||
124753157|NCT05232864|448718832|FG000|Overall Study|Adverse Event|0|||
124753158|NCT05232864|448718833|FG001|Overall Study|Adverse Event|1|||
124753159|NCT05232864|448718832|FG000|Overall Study|Study terminated by sponsor|16|||
124753160|NCT05232864|448718833|FG001|Overall Study|Study terminated by sponsor|14|||
124753161|NCT04765202|448718848|FG000|Overall Study|Lost to Follow-up|1|||
124753162|NCT04765202|448718849|FG001|Overall Study|Lost to Follow-up|1|||
124753163|NCT04765202|448718850|FG002|Overall Study|Lost to Follow-up|2|||
124753164|NCT04765202|448718851|FG003|Overall Study|Lost to Follow-up|2|||
124753165|NCT04765202|448718848|FG000|Overall Study|Physician Decision|0|||
124753166|NCT04765202|448718849|FG001|Overall Study|Physician Decision|0|||
124753167|NCT04765202|448718850|FG002|Overall Study|Physician Decision|1|||
124753168|NCT04765202|448718851|FG003|Overall Study|Physician Decision|1|||
124753169|NCT00465452|448718852|FG000|Overall Study|Adverse Event|1|||
124753170|NCT01635855|448718854|FG000|Overall Study|Withdrawal by Subject|4|||
124753171|NCT03828019|448718855|FG000|Overall Study|Withdrawal by Subject|3|||
124753172|NCT03828019|448718856|FG001|Overall Study|Withdrawal by Subject|8|||
124753173|NCT03828019|448718855|FG000|Overall Study|Lost to Follow-up|1|||
124753174|NCT03828019|448718856|FG001|Overall Study|Lost to Follow-up|6|||
124753175|NCT03828019|448718855|FG000|Overall Study|Incarcerated|1|||
124753176|NCT03828019|448718856|FG001|Overall Study|Incarcerated|0|||
124753177|NCT03828019|448718855|FG000|Overall Study|Adverse Event|0|||
124753178|NCT03828019|448718856|FG001|Overall Study|Adverse Event|1|||
124753179|NCT03400176|448718857|FG000|Dose Escalation|Progressive disease|1|||
124753180|NCT03400176|448718858|FG001|Dose Escalation|Progressive disease|1|||
124753181|NCT03400176|448718859|FG002|Dose Escalation|Progressive disease|0|||
124753182|NCT03400176|448718860|FG003|Dose Escalation|Progressive disease|0|||
124753183|NCT03400176|448718861|FG004|Dose Escalation|Progressive disease|1|||
124753184|NCT03400176|448718857|FG000|Dose Escalation|Patient decision|0|||
124753185|NCT03400176|448718858|FG001|Dose Escalation|Patient decision|0|||
124753186|NCT03400176|448718859|FG002|Dose Escalation|Patient decision|0|||
124753187|NCT03400176|448718860|FG003|Dose Escalation|Patient decision|0|||
124753188|NCT03400176|448718861|FG004|Dose Escalation|Patient decision|1|||
124753189|NCT03400176|448718857|FG000|Dose Expansion|Patient decision|0|||
124753190|NCT03400176|448718858|FG001|Dose Expansion|Patient decision|0|||
124753191|NCT03400176|448718859|FG002|Dose Expansion|Patient decision|0|||
124753192|NCT03400176|448718860|FG003|Dose Expansion|Patient decision|1|||
124753193|NCT03400176|448718861|FG004|Dose Expansion|Patient decision|0|||
124753194|NCT03400176|448718857|FG000|Dose Expansion|Adverse Event|0|||
124753195|NCT03400176|448718858|FG001|Dose Expansion|Adverse Event|0|||
124753196|NCT03400176|448718859|FG002|Dose Expansion|Adverse Event|0|||
124639633|NCT03533114|448298446|FG001|Overall|Physician Decision|2|||
124639634|NCT03533114|448298445|FG000|Overall|Protocol deviation|1|||
124639635|NCT03533114|448298446|FG001|Overall|Protocol deviation|1|||
124639636|NCT03533114|448298445|FG000|Overall|Failure to meet randomization criteria|1|||
124639637|NCT03533114|448298446|FG001|Overall|Failure to meet randomization criteria|2|||
124639638|NCT03533114|448298445|FG000|Overall|Non-Compliance with study drug|0|||
124753197|NCT03400176|448718860|FG003|Dose Expansion|Adverse Event|1|||
124753198|NCT03400176|448718861|FG004|Dose Expansion|Adverse Event|0|||
124753199|NCT03400176|448718857|FG000|Dose Expansion|Physician Decision|0|||
124753200|NCT03400176|448718858|FG001|Dose Expansion|Physician Decision|0|||
124753201|NCT03400176|448718859|FG002|Dose Expansion|Physician Decision|0|||
124753202|NCT03400176|448718860|FG003|Dose Expansion|Physician Decision|1|||
124753203|NCT03400176|448718861|FG004|Dose Expansion|Physician Decision|0|||
124753204|NCT03400176|448718857|FG000|Dose Expansion|Progressive disease|0|||
124753205|NCT03400176|448718858|FG001|Dose Expansion|Progressive disease|0|||
124753206|NCT03400176|448718859|FG002|Dose Expansion|Progressive disease|1|||
124753207|NCT03400176|448718860|FG003|Dose Expansion|Progressive disease|1|||
124753208|NCT03400176|448718861|FG004|Dose Expansion|Progressive disease|0|||
124753209|NCT00206440|448718862|FG000|Overall Study|Protocol Violation|1|||
124753210|NCT00206440|448718863|FG001|Overall Study|Protocol Violation|2|||
124753211|NCT00206440|448718862|FG000|Overall Study|Adverse Event|4|||
124753212|NCT00206440|448718863|FG001|Overall Study|Adverse Event|2|||
124753213|NCT01298765|448718864|FG000|Titration Period|Adverse Event|26|||
124753214|NCT01298765|448718864|FG000|Titration Period|Death|1|||
124753215|NCT01298765|448718864|FG000|Titration Period|Lack of Efficacy|21|||
124753216|NCT01298765|448718864|FG000|Titration Period|Lost to Follow-up|9|||
124753217|NCT01298765|448718864|FG000|Titration Period|Physician Decision|1|||
124753218|NCT01298765|448718864|FG000|Titration Period|Withdrawal by Subject|10|||
124753219|NCT01298765|448718864|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
124753220|NCT01298765|448718864|FG000|Long-Term Treatment Period|Adverse Event|19|||
124753221|NCT01298765|448718864|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
124753222|NCT01298765|448718864|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
124753223|NCT01298765|448718864|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
124753224|NCT01298765|448718864|FG000|Long-Term Treatment Period|Physician Decision|1|||
124753225|NCT01298765|448718864|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
124753226|NCT03302247|448718867|FG000|Overall Study|the study has closed prematurely|2|||
124753227|NCT03302247|448718867|FG000|Overall Study|Death|1|||
124753228|NCT04090242|448718868|FG000|Overall Study|Withdrawal by Subject|1|||
124753229|NCT04090242|448718869|FG001|Overall Study|Withdrawal by Subject|0|||
124753230|NCT03214406|448718870|FG000|Overall Study|did not meet enrollment criteria|9|||
124753231|NCT03214406|448718871|FG001|Overall Study|did not meet enrollment criteria|13|||
124753232|NCT03214406|448718870|FG000|Overall Study|Withdrawal by Subject|1|||
124753233|NCT03214406|448718871|FG001|Overall Study|Withdrawal by Subject|0|||
124753234|NCT03214406|448718870|FG000|Overall Study|Lost to Follow-up|0|||
124753235|NCT03214406|448718871|FG001|Overall Study|Lost to Follow-up|2|||
124753236|NCT01098305|448718875|FG000|Overall Study|Lost to Follow-up|31|||
124753237|NCT01098305|448718876|FG001|Overall Study|Lost to Follow-up|33|||
124753238|NCT03182907|448718877|FG000|Overall Study|Death|3|||
124753239|NCT03182907|448718878|FG001|Overall Study|Death|0|||
124753240|NCT03182907|448718877|FG000|Overall Study|Protocol Violation|4|||
124753241|NCT03182907|448718878|FG001|Overall Study|Protocol Violation|0|||
124753242|NCT03182907|448718877|FG000|Overall Study|Lost to Follow-up|1|||
124753243|NCT03182907|448718878|FG001|Overall Study|Lost to Follow-up|0|||
124753244|NCT03182907|448718877|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
124753245|NCT03182907|448718878|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
124753246|NCT00429169|448718879|FG000|Overall Study|Lost to Follow-up|0|||
124753247|NCT00429169|448718880|FG001|Overall Study|Lost to Follow-up|1|||
124753248|NCT00429169|448718879|FG000|Overall Study|Ineligibility discovered after entry|2|||
124753249|NCT00429169|448718880|FG001|Overall Study|Ineligibility discovered after entry|1|||
124753250|NCT01180296|448718885|FG000|Overall Study|Protocol Violation|1|||
124753251|NCT01180296|448718886|FG001|Overall Study|Protocol Violation|2|||
124753252|NCT01371552|448718891|FG000|Part 1, First 3 Days|Inconvenience|0|||
124753253|NCT01371552|448718892|FG001|Part 1, First 3 Days|Inconvenience|0|||
124753254|NCT01371552|448718893|FG002|Part 1, First 3 Days|Inconvenience|1|||
124753255|NCT01371552|448718894|FG003|Part 1, First 3 Days|Inconvenience|0|||
124753256|NCT01371552|448718895|FG004|Part 1, First 3 Days|Inconvenience|0|||
124753257|NCT01371552|448718896|FG005|Part 1, First 3 Days|Inconvenience|0|||
124753258|NCT03364309|448718897|FG000|Induction Period|Adverse Event|4|||
124753259|NCT03364309|448718898|FG001|Induction Period|Adverse Event|0|||
124753260|NCT03364309|448718899|FG002|Induction Period|Adverse Event|1|||
124753261|NCT03364309|448718900|FG003|Induction Period|Adverse Event|0|||
124753262|NCT03364309|448718901|FG004|Induction Period|Adverse Event|0|||
124753263|NCT03364309|448718902|FG005|Induction Period|Adverse Event|0|||
124753264|NCT03364309|448718903|FG006|Induction Period|Adverse Event|0|||
124837546|NCT03131440|449035894|FG004|Overall Study|Lost to Follow-up|0|||
124837547|NCT03131440|449035895|FG005|Overall Study|Lost to Follow-up|1|||
124837548|NCT03131440|449035896|FG006|Overall Study|Lost to Follow-up|0|||
124837549|NCT03131440|449035897|FG007|Overall Study|Lost to Follow-up|0|||
124837550|NCT03131440|449035898|FG008|Overall Study|Lost to Follow-up|0|||
124837551|NCT03131440|449035899|FG009|Overall Study|Lost to Follow-up|0|||
124837552|NCT03131440|449035900|FG010|Overall Study|Lost to Follow-up|0|||
124837553|NCT03131440|449035901|FG011|Overall Study|Lost to Follow-up|0|||
124837554|NCT03131440|449035902|FG012|Overall Study|Lost to Follow-up|0|||
124837555|NCT03131440|449035903|FG013|Overall Study|Lost to Follow-up|0|||
124837556|NCT03131440|449035904|FG014|Overall Study|Lost to Follow-up|0|||
124837557|NCT03131440|449035905|FG015|Overall Study|Lost to Follow-up|0|||
124837558|NCT03131440|449035906|FG016|Overall Study|Lost to Follow-up|0|||
124837559|NCT03131440|449035907|FG017|Overall Study|Lost to Follow-up|0|||
124837560|NCT03131440|449035908|FG018|Overall Study|Lost to Follow-up|0|||
124837561|NCT03131440|449035909|FG019|Overall Study|Lost to Follow-up|2|||
124837562|NCT03131440|449035910|FG020|Overall Study|Lost to Follow-up|1|||
124837563|NCT03131440|449035911|FG021|Overall Study|Lost to Follow-up|0|||
124837564|NCT03131440|449035912|FG022|Overall Study|Lost to Follow-up|1|||
124837565|NCT03131440|449035913|FG023|Overall Study|Lost to Follow-up|0|||
124837566|NCT03131440|449035914|FG024|Overall Study|Lost to Follow-up|1|||
124837567|NCT03131440|449035915|FG025|Overall Study|Lost to Follow-up|0|||
124837568|NCT03131440|449035916|FG026|Overall Study|Lost to Follow-up|0|||
124837569|NCT03131440|449035917|FG027|Overall Study|Lost to Follow-up|2|||
124837570|NCT03131440|449035918|FG028|Overall Study|Lost to Follow-up|0|||
124837571|NCT03131440|449035919|FG029|Overall Study|Lost to Follow-up|2|||
124837572|NCT03131440|449035920|FG030|Overall Study|Lost to Follow-up|0|||
124837573|NCT03131440|449035921|FG031|Overall Study|Lost to Follow-up|0|||
124837574|NCT03131440|449035890|FG000|Overall Study|Death|0|||
124837575|NCT03131440|449035891|FG001|Overall Study|Death|0|||
124837576|NCT03131440|449035892|FG002|Overall Study|Death|0|||
124837577|NCT03131440|449035893|FG003|Overall Study|Death|0|||
124837578|NCT03131440|449035894|FG004|Overall Study|Death|0|||
124837579|NCT03131440|449035895|FG005|Overall Study|Death|0|||
124837580|NCT03131440|449035896|FG006|Overall Study|Death|0|||
124837581|NCT03131440|449035897|FG007|Overall Study|Death|0|||
124837582|NCT03131440|449035898|FG008|Overall Study|Death|0|||
124837583|NCT03131440|449035899|FG009|Overall Study|Death|0|||
124837584|NCT03131440|449035900|FG010|Overall Study|Death|0|||
124837585|NCT03131440|449035901|FG011|Overall Study|Death|0|||
124837586|NCT03131440|449035902|FG012|Overall Study|Death|0|||
124837587|NCT03131440|449035903|FG013|Overall Study|Death|0|||
124837588|NCT03131440|449035904|FG014|Overall Study|Death|0|||
124837589|NCT03131440|449035905|FG015|Overall Study|Death|0|||
124837590|NCT03131440|449035906|FG016|Overall Study|Death|0|||
124837591|NCT03131440|449035907|FG017|Overall Study|Death|0|||
124837592|NCT03131440|449035908|FG018|Overall Study|Death|0|||
124837593|NCT03131440|449035909|FG019|Overall Study|Death|0|||
124837594|NCT03131440|449035910|FG020|Overall Study|Death|0|||
124837595|NCT03131440|449035911|FG021|Overall Study|Death|0|||
124837596|NCT03131440|449035912|FG022|Overall Study|Death|0|||
124837597|NCT03131440|449035913|FG023|Overall Study|Death|0|||
124837598|NCT03131440|449035914|FG024|Overall Study|Death|0|||
124837599|NCT03131440|449035915|FG025|Overall Study|Death|1|||
124837600|NCT03131440|449035916|FG026|Overall Study|Death|0|||
124837601|NCT03131440|449035917|FG027|Overall Study|Death|0|||
124837602|NCT03131440|449035918|FG028|Overall Study|Death|0|||
124837603|NCT03131440|449035919|FG029|Overall Study|Death|0|||
124837604|NCT03131440|449035920|FG030|Overall Study|Death|0|||
124837605|NCT03131440|449035921|FG031|Overall Study|Death|0|||
124837606|NCT00746941|449035924|FG000|Overall Study|Death|2|||
124837607|NCT00746941|449035925|FG001|Overall Study|Death|0|||
124837608|NCT00746941|449035926|FG002|Overall Study|Death|0|||
124837609|NCT00746941|449035927|FG003|Overall Study|Death|6|||
124837610|NCT00746941|449035924|FG000|Overall Study|Physician Decision|0|||
124837611|NCT00746941|449035925|FG001|Overall Study|Physician Decision|0|||
124837612|NCT00746941|449035926|FG002|Overall Study|Physician Decision|2|||
124837613|NCT00746941|449035927|FG003|Overall Study|Physician Decision|0|||
124837614|NCT00746941|449035924|FG000|Overall Study|Withdrawal by Subject|3|||
124837615|NCT00746941|449035925|FG001|Overall Study|Withdrawal by Subject|0|||
124837616|NCT00746941|449035926|FG002|Overall Study|Withdrawal by Subject|0|||
124837617|NCT00746941|449035927|FG003|Overall Study|Withdrawal by Subject|2|||
124837618|NCT00746941|449035924|FG000|Overall Study|Other, reason not provided|2|||
124837619|NCT00746941|449035925|FG001|Overall Study|Other, reason not provided|4|||
124837620|NCT00746941|449035926|FG002|Overall Study|Other, reason not provided|0|||
124837621|NCT00746941|449035927|FG003|Overall Study|Other, reason not provided|4|||
124837622|NCT00746941|449035924|FG000|Overall Study|Adverse Event|0|||
124837623|NCT00746941|449035925|FG001|Overall Study|Adverse Event|0|||
124837624|NCT00746941|449035926|FG002|Overall Study|Adverse Event|0|||
124837625|NCT00746941|449035927|FG003|Overall Study|Adverse Event|1|||
124837626|NCT03190889|449035933|FG000|Overall Study|Lost to Follow-up|7|||
124837627|NCT03190889|449035934|FG001|Overall Study|Lost to Follow-up|7|||
124837628|NCT03190889|449035935|FG002|Overall Study|Lost to Follow-up|3|||
124837629|NCT03190889|449035933|FG000|Overall Study|Withdrawal by Subject|1|||
124837630|NCT03190889|449035934|FG001|Overall Study|Withdrawal by Subject|1|||
124837631|NCT03190889|449035935|FG002|Overall Study|Withdrawal by Subject|2|||
124837632|NCT03190889|449035933|FG000|Overall Study|Did not complete protocol|4|||
124837633|NCT03190889|449035934|FG001|Overall Study|Did not complete protocol|9|||
124837634|NCT03190889|449035935|FG002|Overall Study|Did not complete protocol|0|||
124837635|NCT03190889|449035933|FG000|Overall Study|COVID-19|1|||
124837636|NCT03190889|449035934|FG001|Overall Study|COVID-19|0|||
124837637|NCT03190889|449035935|FG002|Overall Study|COVID-19|2|||
124837638|NCT00405548|449035936|FG000|Overall Study|Cognitive Memory problems on study day|1|||
124837639|NCT00405548|449035937|FG001|Overall Study|Cognitive Memory problems on study day|0|||
124837640|NCT00405548|449035936|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
124837641|NCT00405548|449035937|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
124837642|NCT00405548|449035936|FG000|Overall Study|Unable to self-administer shots|1|||
124837643|NCT00405548|449035937|FG001|Overall Study|Unable to self-administer shots|0|||
124837644|NCT00405548|449035936|FG000|Overall Study|Venous access failed during study day|1|||
124837645|NCT00405548|449035937|FG001|Overall Study|Venous access failed during study day|0|||
124837646|NCT00405548|449035936|FG000|Overall Study|Withdrawal by Subject|1|||
124837647|NCT00405548|449035937|FG001|Overall Study|Withdrawal by Subject|0|||
124837648|NCT02741700|449035938|FG000|Overall Study|Lost to Follow-up|17|||
124837649|NCT02741700|449035939|FG001|Overall Study|Lost to Follow-up|8|||
124837650|NCT02741700|449035938|FG000|Overall Study|Withdrawal by Subject|2|||
124837651|NCT02741700|449035939|FG001|Overall Study|Withdrawal by Subject|5|||
124837652|NCT02741700|449035938|FG000|Overall Study|Physician Decision|3|||
124837653|NCT02741700|449035939|FG001|Overall Study|Physician Decision|0|||
124837654|NCT02741700|449035938|FG000|Overall Study|Moved out of State|0|||
124837655|NCT02741700|449035939|FG001|Overall Study|Moved out of State|1|||
124837656|NCT02741700|449035938|FG000|Overall Study|Death|4|||
124837657|NCT02741700|449035939|FG001|Overall Study|Death|5|||
124837658|NCT00923559|449035940|FG000|Overall Study|Lost to Follow-up|2|||
124837659|NCT00923559|449035941|FG001|Overall Study|Lost to Follow-up|3|||
124837660|NCT00811577|449035942|FG000|Overall Study|Lost to Follow-up|7|||
124837661|NCT00811577|449035943|FG001|Overall Study|Lost to Follow-up|1|||
124837662|NCT00811577|449035942|FG000|Overall Study|Withdrawal by Subject|3|||
124837663|NCT00811577|449035943|FG001|Overall Study|Withdrawal by Subject|0|||
124837664|NCT02641379|449035946|FG000|Overall Study|Exclusion criterion during screening|1|||
124837665|NCT02641379|449035947|FG001|Overall Study|Exclusion criterion during screening|0|||
124837666|NCT02641379|449035948|FG002|Overall Study|Exclusion criterion during screening|0|||
124837667|NCT02641379|449035949|FG003|Overall Study|Exclusion criterion during screening|1|||
124837668|NCT02641379|449035950|FG004|Overall Study|Exclusion criterion during screening|2|||
124837669|NCT02641379|449035951|FG005|Overall Study|Exclusion criterion during screening|0|||
124837670|NCT02641379|449035952|FG006|Overall Study|Exclusion criterion during screening|0|||
124837671|NCT02641379|449035953|FG007|Overall Study|Exclusion criterion during screening|0|||
124837672|NCT02641379|449035954|FG008|Overall Study|Exclusion criterion during screening|0|||
124837673|NCT02641379|449035955|FG009|Overall Study|Exclusion criterion during screening|0|||
124837674|NCT02641379|449035956|FG010|Overall Study|Exclusion criterion during screening|0|||
124837675|NCT02641379|449035946|FG000|Overall Study|Withdrawal of informed consent|0|||
124837676|NCT02641379|449035947|FG001|Overall Study|Withdrawal of informed consent|1|||
124837677|NCT02641379|449035948|FG002|Overall Study|Withdrawal of informed consent|0|||
124837678|NCT02641379|449035949|FG003|Overall Study|Withdrawal of informed consent|0|||
124837679|NCT02641379|449035950|FG004|Overall Study|Withdrawal of informed consent|0|||
124837680|NCT02641379|449035951|FG005|Overall Study|Withdrawal of informed consent|0|||
124837681|NCT02641379|449035952|FG006|Overall Study|Withdrawal of informed consent|0|||
124837682|NCT02641379|449035953|FG007|Overall Study|Withdrawal of informed consent|1|||
124837683|NCT02641379|449035954|FG008|Overall Study|Withdrawal of informed consent|0|||
124837684|NCT02641379|449035955|FG009|Overall Study|Withdrawal of informed consent|0|||
124639639|NCT03533114|448298446|FG001|Overall|Non-Compliance with study drug|1|||
124639640|NCT03533114|448298445|FG000|Overall|Other|0|||
124639641|NCT03533114|448298446|FG001|Overall|Other|1|||
124639642|NCT03533114|448298445|FG000|Open Label Titration and Optimization|Adverse Event|11|||
124639643|NCT03533114|448298446|FG001|Open Label Titration and Optimization|Adverse Event|8|||
124639644|NCT03533114|448298445|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
124837685|NCT02641379|449035956|FG010|Overall Study|Withdrawal of informed consent|0|||
124837686|NCT02641379|449035946|FG000|Overall Study|Adverse Event|7|||
124837687|NCT02641379|449035947|FG001|Overall Study|Adverse Event|8|||
124837688|NCT02641379|449035948|FG002|Overall Study|Adverse Event|2|||
124837689|NCT02641379|449035949|FG003|Overall Study|Adverse Event|2|||
124837690|NCT02641379|449035950|FG004|Overall Study|Adverse Event|5|||
124837691|NCT02641379|449035951|FG005|Overall Study|Adverse Event|1|||
124837692|NCT02641379|449035952|FG006|Overall Study|Adverse Event|5|||
124837693|NCT02641379|449035953|FG007|Overall Study|Adverse Event|0|||
124837694|NCT02641379|449035954|FG008|Overall Study|Adverse Event|1|||
124639645|NCT03533114|448298446|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
124837695|NCT02641379|449035955|FG009|Overall Study|Adverse Event|1|||
124837696|NCT02641379|449035956|FG010|Overall Study|Adverse Event|5|||
124837697|NCT02641379|449035946|FG000|Overall Study|Lack of Efficacy|0|||
124837698|NCT02641379|449035947|FG001|Overall Study|Lack of Efficacy|0|||
124837699|NCT02641379|449035948|FG002|Overall Study|Lack of Efficacy|2|||
124837700|NCT02641379|449035949|FG003|Overall Study|Lack of Efficacy|0|||
124837701|NCT02641379|449035950|FG004|Overall Study|Lack of Efficacy|0|||
124837702|NCT02641379|449035951|FG005|Overall Study|Lack of Efficacy|2|||
124837703|NCT02641379|449035952|FG006|Overall Study|Lack of Efficacy|0|||
124837704|NCT02641379|449035953|FG007|Overall Study|Lack of Efficacy|5|||
124837705|NCT02641379|449035954|FG008|Overall Study|Lack of Efficacy|0|||
124837706|NCT02641379|449035955|FG009|Overall Study|Lack of Efficacy|0|||
124837707|NCT02641379|449035956|FG010|Overall Study|Lack of Efficacy|0|||
124837708|NCT02641379|449035946|FG000|Overall Study|Participant unable to attend study visit|4|||
124837709|NCT02641379|449035947|FG001|Overall Study|Participant unable to attend study visit|10|||
124837710|NCT02641379|449035948|FG002|Overall Study|Participant unable to attend study visit|1|||
124837711|NCT02641379|449035949|FG003|Overall Study|Participant unable to attend study visit|2|||
124837712|NCT02641379|449035950|FG004|Overall Study|Participant unable to attend study visit|5|||
124837713|NCT02641379|449035951|FG005|Overall Study|Participant unable to attend study visit|1|||
124837714|NCT02641379|449035952|FG006|Overall Study|Participant unable to attend study visit|1|||
124837715|NCT02641379|449035953|FG007|Overall Study|Participant unable to attend study visit|1|||
124837716|NCT02641379|449035954|FG008|Overall Study|Participant unable to attend study visit|0|||
124837717|NCT02641379|449035955|FG009|Overall Study|Participant unable to attend study visit|2|||
124837718|NCT02641379|449035956|FG010|Overall Study|Participant unable to attend study visit|0|||
124837719|NCT02641379|449035946|FG000|Overall Study|Participant's compliance|0|||
124837720|NCT02641379|449035947|FG001|Overall Study|Participant's compliance|1|||
124837721|NCT02641379|449035948|FG002|Overall Study|Participant's compliance|0|||
124837722|NCT02641379|449035949|FG003|Overall Study|Participant's compliance|1|||
124837723|NCT02641379|449035950|FG004|Overall Study|Participant's compliance|0|||
124837724|NCT02641379|449035951|FG005|Overall Study|Participant's compliance|2|||
124837725|NCT02641379|449035952|FG006|Overall Study|Participant's compliance|0|||
124837726|NCT02641379|449035953|FG007|Overall Study|Participant's compliance|0|||
124837727|NCT02641379|449035954|FG008|Overall Study|Participant's compliance|1|||
124837728|NCT02641379|449035955|FG009|Overall Study|Participant's compliance|1|||
124837729|NCT02641379|449035956|FG010|Overall Study|Participant's compliance|1|||
124837730|NCT02641379|449035946|FG000|Overall Study|Participant cannot be reached|4|||
124837731|NCT02641379|449035947|FG001|Overall Study|Participant cannot be reached|4|||
124837732|NCT02641379|449035948|FG002|Overall Study|Participant cannot be reached|0|||
124837733|NCT02641379|449035949|FG003|Overall Study|Participant cannot be reached|8|||
124837734|NCT02641379|449035950|FG004|Overall Study|Participant cannot be reached|2|||
124837735|NCT02641379|449035951|FG005|Overall Study|Participant cannot be reached|1|||
124837736|NCT02641379|449035952|FG006|Overall Study|Participant cannot be reached|0|||
124837737|NCT02641379|449035953|FG007|Overall Study|Participant cannot be reached|1|||
124837738|NCT02641379|449035954|FG008|Overall Study|Participant cannot be reached|0|||
124837739|NCT02641379|449035955|FG009|Overall Study|Participant cannot be reached|2|||
124837740|NCT02641379|449035956|FG010|Overall Study|Participant cannot be reached|1|||
124837741|NCT02641379|449035946|FG000|Overall Study|PCR positive at Week 24|15|||
124837742|NCT02641379|449035947|FG001|Overall Study|PCR positive at Week 24|21|||
124837743|NCT02641379|449035948|FG002|Overall Study|PCR positive at Week 24|62|||
124837744|NCT02641379|449035949|FG003|Overall Study|PCR positive at Week 24|0|||
124837745|NCT02641379|449035950|FG004|Overall Study|PCR positive at Week 24|0|||
124837746|NCT02641379|449035951|FG005|Overall Study|PCR positive at Week 24|6|||
124837747|NCT02641379|449035952|FG006|Overall Study|PCR positive at Week 24|3|||
124837748|NCT02641379|449035953|FG007|Overall Study|PCR positive at Week 24|8|||
124837749|NCT02641379|449035954|FG008|Overall Study|PCR positive at Week 24|0|||
124837750|NCT02641379|449035955|FG009|Overall Study|PCR positive at Week 24|1|||
124837751|NCT02641379|449035956|FG010|Overall Study|PCR positive at Week 24|0|||
124837752|NCT02641379|449035946|FG000|Overall Study|PCR positive at follow up 2|1|||
124837753|NCT02641379|449035947|FG001|Overall Study|PCR positive at follow up 2|0|||
124837754|NCT02641379|449035948|FG002|Overall Study|PCR positive at follow up 2|0|||
124837755|NCT02641379|449035949|FG003|Overall Study|PCR positive at follow up 2|0|||
124837756|NCT02641379|449035950|FG004|Overall Study|PCR positive at follow up 2|0|||
124837757|NCT02641379|449035951|FG005|Overall Study|PCR positive at follow up 2|0|||
124837758|NCT02641379|449035952|FG006|Overall Study|PCR positive at follow up 2|0|||
124837759|NCT02641379|449035953|FG007|Overall Study|PCR positive at follow up 2|0|||
124837760|NCT02641379|449035954|FG008|Overall Study|PCR positive at follow up 2|0|||
124837761|NCT02641379|449035955|FG009|Overall Study|PCR positive at follow up 2|0|||
124837762|NCT02641379|449035956|FG010|Overall Study|PCR positive at follow up 2|0|||
124837763|NCT02641379|449035946|FG000|Overall Study|Participant showed relapse|1|||
124837764|NCT02641379|449035947|FG001|Overall Study|Participant showed relapse|0|||
124837765|NCT02641379|449035948|FG002|Overall Study|Participant showed relapse|0|||
124837766|NCT02641379|449035949|FG003|Overall Study|Participant showed relapse|0|||
124837767|NCT02641379|449035950|FG004|Overall Study|Participant showed relapse|0|||
124837768|NCT02641379|449035951|FG005|Overall Study|Participant showed relapse|0|||
124837769|NCT02641379|449035952|FG006|Overall Study|Participant showed relapse|1|||
124837770|NCT02641379|449035953|FG007|Overall Study|Participant showed relapse|0|||
124837771|NCT02641379|449035954|FG008|Overall Study|Participant showed relapse|0|||
124837772|NCT02641379|449035955|FG009|Overall Study|Participant showed relapse|0|||
124837773|NCT02641379|449035956|FG010|Overall Study|Participant showed relapse|0|||
124837774|NCT02641379|449035946|FG000|Overall Study|Participant stopped study/treatment|1|||
124837775|NCT02641379|449035947|FG001|Overall Study|Participant stopped study/treatment|3|||
124837776|NCT02641379|449035948|FG002|Overall Study|Participant stopped study/treatment|1|||
124837777|NCT02641379|449035949|FG003|Overall Study|Participant stopped study/treatment|0|||
124837778|NCT02641379|449035950|FG004|Overall Study|Participant stopped study/treatment|0|||
124837779|NCT02641379|449035951|FG005|Overall Study|Participant stopped study/treatment|1|||
124837780|NCT02641379|449035952|FG006|Overall Study|Participant stopped study/treatment|2|||
124837781|NCT02641379|449035953|FG007|Overall Study|Participant stopped study/treatment|0|||
124837782|NCT02641379|449035954|FG008|Overall Study|Participant stopped study/treatment|1|||
124837783|NCT02641379|449035955|FG009|Overall Study|Participant stopped study/treatment|0|||
124837784|NCT02641379|449035956|FG010|Overall Study|Participant stopped study/treatment|0|||
124837785|NCT02641379|449035946|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
124837786|NCT02641379|449035947|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
124837787|NCT02641379|449035948|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
124837788|NCT02641379|449035949|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
124837789|NCT02641379|449035950|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
124837790|NCT02641379|449035951|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
124837791|NCT02641379|449035952|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
124837792|NCT02641379|449035953|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
124837793|NCT02641379|449035954|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
124837794|NCT02641379|449035955|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
124837795|NCT02641379|449035956|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
124837796|NCT02641379|449035946|FG000|Overall Study|Financial problems|0|||
124837797|NCT02641379|449035947|FG001|Overall Study|Financial problems|1|||
124837798|NCT02641379|449035948|FG002|Overall Study|Financial problems|0|||
124837799|NCT02641379|449035949|FG003|Overall Study|Financial problems|0|||
124837800|NCT02641379|449035950|FG004|Overall Study|Financial problems|0|||
124837801|NCT02641379|449035951|FG005|Overall Study|Financial problems|0|||
124837802|NCT02641379|449035952|FG006|Overall Study|Financial problems|0|||
124837803|NCT02641379|449035953|FG007|Overall Study|Financial problems|0|||
124837804|NCT02641379|449035954|FG008|Overall Study|Financial problems|0|||
124837805|NCT02641379|449035955|FG009|Overall Study|Financial problems|0|||
124837806|NCT02641379|449035956|FG010|Overall Study|Financial problems|0|||
124837807|NCT02641379|449035946|FG000|Overall Study|PCR positive at Week 68|0|||
124837808|NCT02641379|449035947|FG001|Overall Study|PCR positive at Week 68|1|||
124837809|NCT02641379|449035948|FG002|Overall Study|PCR positive at Week 68|0|||
124837810|NCT02641379|449035949|FG003|Overall Study|PCR positive at Week 68|0|||
124837811|NCT02641379|449035950|FG004|Overall Study|PCR positive at Week 68|0|||
124837812|NCT02641379|449035951|FG005|Overall Study|PCR positive at Week 68|0|||
124837813|NCT02641379|449035952|FG006|Overall Study|PCR positive at Week 68|0|||
124837814|NCT02641379|449035953|FG007|Overall Study|PCR positive at Week 68|0|||
124837815|NCT02641379|449035954|FG008|Overall Study|PCR positive at Week 68|0|||
124837816|NCT02641379|449035955|FG009|Overall Study|PCR positive at Week 68|0|||
124837817|NCT02641379|449035956|FG010|Overall Study|PCR positive at Week 68|0|||
124837818|NCT02641379|449035946|FG000|Overall Study|PCR positive at Week 48|0|||
124837819|NCT02641379|449035947|FG001|Overall Study|PCR positive at Week 48|1|||
124837820|NCT02641379|449035948|FG002|Overall Study|PCR positive at Week 48|0|||
124837821|NCT02641379|449035949|FG003|Overall Study|PCR positive at Week 48|0|||
124837822|NCT02641379|449035950|FG004|Overall Study|PCR positive at Week 48|0|||
124837823|NCT02641379|449035951|FG005|Overall Study|PCR positive at Week 48|0|||
124837824|NCT02641379|449035952|FG006|Overall Study|PCR positive at Week 48|0|||
124837825|NCT02641379|449035953|FG007|Overall Study|PCR positive at Week 48|0|||
124837826|NCT02641379|449035954|FG008|Overall Study|PCR positive at Week 48|0|||
124837827|NCT02641379|449035955|FG009|Overall Study|PCR positive at Week 48|0|||
124837828|NCT02641379|449035956|FG010|Overall Study|PCR positive at Week 48|0|||
124837829|NCT02641379|449035946|FG000|Overall Study|PCR not performed at Week 12|0|||
124837830|NCT02641379|449035947|FG001|Overall Study|PCR not performed at Week 12|0|||
124837831|NCT02641379|449035948|FG002|Overall Study|PCR not performed at Week 12|1|||
124837832|NCT02641379|449035949|FG003|Overall Study|PCR not performed at Week 12|0|||
124837833|NCT02641379|449035950|FG004|Overall Study|PCR not performed at Week 12|0|||
124837834|NCT02641379|449035951|FG005|Overall Study|PCR not performed at Week 12|0|||
124837835|NCT02641379|449035952|FG006|Overall Study|PCR not performed at Week 12|0|||
124837836|NCT02641379|449035953|FG007|Overall Study|PCR not performed at Week 12|0|||
124837837|NCT02641379|449035954|FG008|Overall Study|PCR not performed at Week 12|0|||
124837838|NCT02641379|449035955|FG009|Overall Study|PCR not performed at Week 12|0|||
124837839|NCT02641379|449035956|FG010|Overall Study|PCR not performed at Week 12|0|||
124837840|NCT02641379|449035946|FG000|Overall Study|No PCR at baseline|0|||
124837841|NCT02641379|449035947|FG001|Overall Study|No PCR at baseline|0|||
124837842|NCT02641379|449035948|FG002|Overall Study|No PCR at baseline|1|||
124837843|NCT02641379|449035949|FG003|Overall Study|No PCR at baseline|0|||
124837844|NCT02641379|449035950|FG004|Overall Study|No PCR at baseline|0|||
124837845|NCT02641379|449035951|FG005|Overall Study|No PCR at baseline|0|||
124837846|NCT02641379|449035952|FG006|Overall Study|No PCR at baseline|0|||
124837847|NCT02641379|449035953|FG007|Overall Study|No PCR at baseline|0|||
124837848|NCT02641379|449035954|FG008|Overall Study|No PCR at baseline|0|||
124837849|NCT02641379|449035955|FG009|Overall Study|No PCR at baseline|0|||
124837850|NCT02641379|449035956|FG010|Overall Study|No PCR at baseline|0|||
124837851|NCT02641379|449035946|FG000|Overall Study|PCR positive at Week 28|0|||
124837852|NCT02641379|449035947|FG001|Overall Study|PCR positive at Week 28|0|||
124837853|NCT02641379|449035948|FG002|Overall Study|PCR positive at Week 28|1|||
124837854|NCT02641379|449035949|FG003|Overall Study|PCR positive at Week 28|0|||
124837855|NCT02641379|449035950|FG004|Overall Study|PCR positive at Week 28|0|||
124837856|NCT02641379|449035951|FG005|Overall Study|PCR positive at Week 28|0|||
124837857|NCT02641379|449035952|FG006|Overall Study|PCR positive at Week 28|0|||
124837858|NCT02641379|449035953|FG007|Overall Study|PCR positive at Week 28|0|||
124837859|NCT02641379|449035954|FG008|Overall Study|PCR positive at Week 28|0|||
124837860|NCT02641379|449035955|FG009|Overall Study|PCR positive at Week 28|0|||
124837861|NCT02641379|449035956|FG010|Overall Study|PCR positive at Week 28|0|||
124837862|NCT02641379|449035946|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
124837863|NCT02641379|449035947|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
124837864|NCT02641379|449035948|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
124837865|NCT02641379|449035949|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
124837866|NCT02641379|449035950|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
124837867|NCT02641379|449035951|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
124837868|NCT02641379|449035952|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
124837869|NCT02641379|449035953|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
124837870|NCT02641379|449035954|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
124837871|NCT02641379|449035955|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
124837872|NCT02641379|449035956|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
124837873|NCT02641379|449035946|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
124837874|NCT02641379|449035947|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
124837875|NCT02641379|449035948|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
124837876|NCT02641379|449035949|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
124837877|NCT02641379|449035950|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
124837878|NCT02641379|449035951|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
124837879|NCT02641379|449035952|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
124837880|NCT02641379|449035953|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
124837881|NCT02641379|449035954|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
124837882|NCT02641379|449035955|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
124837883|NCT02641379|449035956|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
124837884|NCT02641379|449035946|FG000|Overall Study|Baseline viral load unavailable|0|||
124837885|NCT02641379|449035947|FG001|Overall Study|Baseline viral load unavailable|0|||
124837886|NCT02641379|449035948|FG002|Overall Study|Baseline viral load unavailable|0|||
124837887|NCT02641379|449035949|FG003|Overall Study|Baseline viral load unavailable|1|||
124837888|NCT02641379|449035950|FG004|Overall Study|Baseline viral load unavailable|0|||
124837889|NCT02641379|449035951|FG005|Overall Study|Baseline viral load unavailable|0|||
124837890|NCT02641379|449035952|FG006|Overall Study|Baseline viral load unavailable|0|||
124837891|NCT02641379|449035953|FG007|Overall Study|Baseline viral load unavailable|0|||
124837892|NCT02641379|449035954|FG008|Overall Study|Baseline viral load unavailable|0|||
124837893|NCT02641379|449035955|FG009|Overall Study|Baseline viral load unavailable|0|||
124837894|NCT02641379|449035956|FG010|Overall Study|Baseline viral load unavailable|0|||
124837895|NCT02641379|449035946|FG000|Overall Study|Blood could not be drawn|0|||
124837896|NCT02641379|449035947|FG001|Overall Study|Blood could not be drawn|0|||
124837897|NCT02641379|449035948|FG002|Overall Study|Blood could not be drawn|0|||
124837898|NCT02641379|449035949|FG003|Overall Study|Blood could not be drawn|0|||
124837899|NCT02641379|449035950|FG004|Overall Study|Blood could not be drawn|1|||
124837900|NCT02641379|449035951|FG005|Overall Study|Blood could not be drawn|0|||
124837901|NCT02641379|449035952|FG006|Overall Study|Blood could not be drawn|0|||
124837902|NCT02641379|449035953|FG007|Overall Study|Blood could not be drawn|0|||
124837903|NCT02641379|449035954|FG008|Overall Study|Blood could not be drawn|0|||
124837904|NCT02641379|449035955|FG009|Overall Study|Blood could not be drawn|0|||
124837905|NCT02641379|449035956|FG010|Overall Study|Blood could not be drawn|0|||
124837906|NCT02641379|449035946|FG000|Overall Study|Protocol Violation|0|||
124837907|NCT02641379|449035947|FG001|Overall Study|Protocol Violation|0|||
124837908|NCT02641379|449035948|FG002|Overall Study|Protocol Violation|0|||
124837909|NCT02641379|449035949|FG003|Overall Study|Protocol Violation|0|||
124837910|NCT02641379|449035950|FG004|Overall Study|Protocol Violation|2|||
124837911|NCT02641379|449035951|FG005|Overall Study|Protocol Violation|0|||
124837912|NCT02641379|449035952|FG006|Overall Study|Protocol Violation|0|||
124837913|NCT02641379|449035953|FG007|Overall Study|Protocol Violation|0|||
124837914|NCT02641379|449035954|FG008|Overall Study|Protocol Violation|1|||
124837915|NCT02641379|449035955|FG009|Overall Study|Protocol Violation|0|||
124837916|NCT02641379|449035956|FG010|Overall Study|Protocol Violation|0|||
124837917|NCT02641379|449035946|FG000|Overall Study|Participation in sili rescue study|0|||
124837918|NCT02641379|449035947|FG001|Overall Study|Participation in sili rescue study|0|||
124837919|NCT02641379|449035948|FG002|Overall Study|Participation in sili rescue study|0|||
124837920|NCT02641379|449035949|FG003|Overall Study|Participation in sili rescue study|0|||
124837921|NCT02641379|449035950|FG004|Overall Study|Participation in sili rescue study|0|||
124837922|NCT02641379|449035951|FG005|Overall Study|Participation in sili rescue study|1|||
124837923|NCT02641379|449035952|FG006|Overall Study|Participation in sili rescue study|0|||
124837924|NCT02641379|449035953|FG007|Overall Study|Participation in sili rescue study|0|||
124837925|NCT02641379|449035954|FG008|Overall Study|Participation in sili rescue study|0|||
124837926|NCT02641379|449035955|FG009|Overall Study|Participation in sili rescue study|0|||
124837927|NCT02641379|449035956|FG010|Overall Study|Participation in sili rescue study|0|||
124837928|NCT02641379|449035946|FG000|Overall Study|Lost to Follow-up|0|||
124837929|NCT02641379|449035947|FG001|Overall Study|Lost to Follow-up|0|||
124837930|NCT02641379|449035948|FG002|Overall Study|Lost to Follow-up|0|||
124837931|NCT02641379|449035949|FG003|Overall Study|Lost to Follow-up|0|||
124837932|NCT02641379|449035950|FG004|Overall Study|Lost to Follow-up|0|||
124837933|NCT02641379|449035951|FG005|Overall Study|Lost to Follow-up|0|||
124837934|NCT02641379|449035952|FG006|Overall Study|Lost to Follow-up|0|||
124837935|NCT02641379|449035953|FG007|Overall Study|Lost to Follow-up|0|||
124837936|NCT02641379|449035954|FG008|Overall Study|Lost to Follow-up|1|||
124837937|NCT02641379|449035955|FG009|Overall Study|Lost to Follow-up|0|||
124837938|NCT02641379|449035956|FG010|Overall Study|Lost to Follow-up|0|||
124837939|NCT02641379|449035946|FG000|Overall Study|Source data not found|0|||
124837940|NCT02641379|449035947|FG001|Overall Study|Source data not found|0|||
124837941|NCT02641379|449035948|FG002|Overall Study|Source data not found|0|||
124837942|NCT02641379|449035949|FG003|Overall Study|Source data not found|0|||
124837943|NCT02641379|449035950|FG004|Overall Study|Source data not found|0|||
124837944|NCT02641379|449035951|FG005|Overall Study|Source data not found|1|||
124837945|NCT02641379|449035952|FG006|Overall Study|Source data not found|0|||
124837946|NCT02641379|449035953|FG007|Overall Study|Source data not found|0|||
124837947|NCT02641379|449035954|FG008|Overall Study|Source data not found|0|||
124837948|NCT02641379|449035955|FG009|Overall Study|Source data not found|0|||
124837949|NCT02641379|449035956|FG010|Overall Study|Source data not found|0|||
124837950|NCT02641379|449035946|FG000|Overall Study|Participant showed weight reduction|0|||
124837951|NCT02641379|449035947|FG001|Overall Study|Participant showed weight reduction|0|||
124837952|NCT02641379|449035948|FG002|Overall Study|Participant showed weight reduction|0|||
124837953|NCT02641379|449035949|FG003|Overall Study|Participant showed weight reduction|0|||
124837954|NCT02641379|449035950|FG004|Overall Study|Participant showed weight reduction|0|||
124837955|NCT02641379|449035951|FG005|Overall Study|Participant showed weight reduction|0|||
124837956|NCT02641379|449035952|FG006|Overall Study|Participant showed weight reduction|0|||
124837957|NCT02641379|449035953|FG007|Overall Study|Participant showed weight reduction|1|||
124837958|NCT02641379|449035954|FG008|Overall Study|Participant showed weight reduction|0|||
124837959|NCT02641379|449035955|FG009|Overall Study|Participant showed weight reduction|0|||
124837960|NCT02641379|449035956|FG010|Overall Study|Participant showed weight reduction|0|||
124837961|NCT02641379|449035946|FG000|Overall Study|Non-response Week 12|0|||
124837962|NCT02641379|449035947|FG001|Overall Study|Non-response Week 12|0|||
124837963|NCT02641379|449035948|FG002|Overall Study|Non-response Week 12|0|||
124837964|NCT02641379|449035949|FG003|Overall Study|Non-response Week 12|0|||
124837965|NCT02641379|449035950|FG004|Overall Study|Non-response Week 12|0|||
124837966|NCT02641379|449035951|FG005|Overall Study|Non-response Week 12|0|||
124837967|NCT02641379|449035952|FG006|Overall Study|Non-response Week 12|0|||
124837968|NCT02641379|449035953|FG007|Overall Study|Non-response Week 12|1|||
124837969|NCT02641379|449035954|FG008|Overall Study|Non-response Week 12|0|||
124837970|NCT02641379|449035955|FG009|Overall Study|Non-response Week 12|0|||
124837971|NCT02641379|449035956|FG010|Overall Study|Non-response Week 12|0|||
124837972|NCT02641379|449035946|FG000|Overall Study|No 2 Log drop at Week 12|0|||
124837973|NCT02641379|449035947|FG001|Overall Study|No 2 Log drop at Week 12|0|||
124837974|NCT02641379|449035948|FG002|Overall Study|No 2 Log drop at Week 12|0|||
124837975|NCT02641379|449035949|FG003|Overall Study|No 2 Log drop at Week 12|0|||
124837976|NCT02641379|449035950|FG004|Overall Study|No 2 Log drop at Week 12|0|||
124837977|NCT02641379|449035951|FG005|Overall Study|No 2 Log drop at Week 12|0|||
124837978|NCT02641379|449035952|FG006|Overall Study|No 2 Log drop at Week 12|0|||
124837979|NCT02641379|449035953|FG007|Overall Study|No 2 Log drop at Week 12|0|||
124837980|NCT02641379|449035954|FG008|Overall Study|No 2 Log drop at Week 12|0|||
124837981|NCT02641379|449035955|FG009|Overall Study|No 2 Log drop at Week 12|0|||
124837982|NCT02641379|449035956|FG010|Overall Study|No 2 Log drop at Week 12|1|||
124837983|NCT02641379|449035946|FG000|Overall Study|Negative PCR result|0|||
124837984|NCT02641379|449035947|FG001|Overall Study|Negative PCR result|0|||
124837985|NCT02641379|449035948|FG002|Overall Study|Negative PCR result|0|||
124837986|NCT02641379|449035949|FG003|Overall Study|Negative PCR result|0|||
124837987|NCT02641379|449035950|FG004|Overall Study|Negative PCR result|0|||
124837988|NCT02641379|449035951|FG005|Overall Study|Negative PCR result|0|||
124837989|NCT02641379|449035952|FG006|Overall Study|Negative PCR result|0|||
124639646|NCT03533114|448298445|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
124837990|NCT02641379|449035953|FG007|Overall Study|Negative PCR result|0|||
124837991|NCT02641379|449035954|FG008|Overall Study|Negative PCR result|0|||
124837992|NCT02641379|449035955|FG009|Overall Study|Negative PCR result|1|||
124837993|NCT02641379|449035956|FG010|Overall Study|Negative PCR result|0|||
124837994|NCT02641379|449035946|FG000|Overall Study|Participant's PCR high|0|||
124837995|NCT02641379|449035947|FG001|Overall Study|Participant's PCR high|0|||
124837996|NCT02641379|449035948|FG002|Overall Study|Participant's PCR high|0|||
124837997|NCT02641379|449035949|FG003|Overall Study|Participant's PCR high|0|||
124837998|NCT02641379|449035950|FG004|Overall Study|Participant's PCR high|0|||
124837999|NCT02641379|449035951|FG005|Overall Study|Participant's PCR high|0|||
124838000|NCT02641379|449035952|FG006|Overall Study|Participant's PCR high|0|||
124838001|NCT02641379|449035953|FG007|Overall Study|Participant's PCR high|1|||
124838002|NCT02641379|449035954|FG008|Overall Study|Participant's PCR high|0|||
124838003|NCT02641379|449035955|FG009|Overall Study|Participant's PCR high|0|||
124838004|NCT02641379|449035956|FG010|Overall Study|Participant's PCR high|0|||
124838005|NCT02641379|449035946|FG000|Overall Study|Participant treated after Week 24|0|||
124838006|NCT02641379|449035947|FG001|Overall Study|Participant treated after Week 24|0|||
124838007|NCT02641379|449035948|FG002|Overall Study|Participant treated after Week 24|0|||
124838008|NCT02641379|449035949|FG003|Overall Study|Participant treated after Week 24|0|||
124838009|NCT02641379|449035950|FG004|Overall Study|Participant treated after Week 24|0|||
124838010|NCT02641379|449035951|FG005|Overall Study|Participant treated after Week 24|0|||
124838011|NCT02641379|449035952|FG006|Overall Study|Participant treated after Week 24|0|||
124838012|NCT02641379|449035953|FG007|Overall Study|Participant treated after Week 24|0|||
124838013|NCT02641379|449035954|FG008|Overall Study|Participant treated after Week 24|1|||
124838014|NCT02641379|449035955|FG009|Overall Study|Participant treated after Week 24|0|||
124838015|NCT02641379|449035956|FG010|Overall Study|Participant treated after Week 24|0|||
124838016|NCT02641379|449035946|FG000|Overall Study|Missing PCR result at Week 8|0|||
124838017|NCT02641379|449035947|FG001|Overall Study|Missing PCR result at Week 8|0|||
124838018|NCT02641379|449035948|FG002|Overall Study|Missing PCR result at Week 8|0|||
124838019|NCT02641379|449035949|FG003|Overall Study|Missing PCR result at Week 8|0|||
124838020|NCT02641379|449035950|FG004|Overall Study|Missing PCR result at Week 8|0|||
124838021|NCT02641379|449035951|FG005|Overall Study|Missing PCR result at Week 8|0|||
124838022|NCT02641379|449035952|FG006|Overall Study|Missing PCR result at Week 8|0|||
124838023|NCT02641379|449035953|FG007|Overall Study|Missing PCR result at Week 8|0|||
124838024|NCT02641379|449035954|FG008|Overall Study|Missing PCR result at Week 8|0|||
124838025|NCT02641379|449035955|FG009|Overall Study|Missing PCR result at Week 8|1|||
124838026|NCT02641379|449035956|FG010|Overall Study|Missing PCR result at Week 8|0|||
124838027|NCT02641379|449035946|FG000|Overall Study|PCR positive|0|||
124838028|NCT02641379|449035947|FG001|Overall Study|PCR positive|0|||
124838029|NCT02641379|449035948|FG002|Overall Study|PCR positive|0|||
124838030|NCT02641379|449035949|FG003|Overall Study|PCR positive|0|||
124838031|NCT02641379|449035950|FG004|Overall Study|PCR positive|0|||
124639647|NCT03533114|448298446|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
124639648|NCT03533114|448298445|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
124639649|NCT03533114|448298446|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
124639650|NCT03533114|448298445|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
124639651|NCT03533114|448298446|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
124639652|NCT03533114|448298445|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
124639653|NCT03533114|448298446|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
124639654|NCT03533114|448298445|FG000|Stable Dose|Adverse Event|0|||
124639655|NCT03533114|448298446|FG001|Stable Dose|Adverse Event|2|||
124639656|NCT03533114|448298445|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
124639657|NCT03533114|448298446|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
124639658|NCT03533114|448298445|FG000|Stable Dose|Lack of Efficacy|1|||
124639659|NCT03533114|448298446|FG001|Stable Dose|Lack of Efficacy|0|||
124639660|NCT03533114|448298445|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
124639661|NCT03533114|448298446|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
124639662|NCT03533114|448298445|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
124639663|NCT03533114|448298446|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
124639664|NCT03533114|448298445|FG000|Open-Label Safety Extension|Adverse Event|3|||
124639665|NCT03533114|448298446|FG001|Open-Label Safety Extension|Adverse Event|0|||
124639666|NCT03533114|448298445|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
124639667|NCT03533114|448298446|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
124639668|NCT03533114|448298445|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
124639669|NCT03533114|448298446|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
124639670|NCT03533114|448298445|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
124639671|NCT03533114|448298446|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
124639672|NCT03533114|448298445|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
124639673|NCT03533114|448298446|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
124639674|NCT01028014|448298447|FG000|Overall Study|Lost to Follow-up|1|||
124639675|NCT01028014|448298448|FG001|Overall Study|Lost to Follow-up|2|||
124838032|NCT02641379|449035951|FG005|Overall Study|PCR positive|0|||
124838033|NCT02641379|449035952|FG006|Overall Study|PCR positive|1|||
124838034|NCT02641379|449035953|FG007|Overall Study|PCR positive|0|||
124838035|NCT02641379|449035954|FG008|Overall Study|PCR positive|0|||
124838036|NCT02641379|449035955|FG009|Overall Study|PCR positive|0|||
124838037|NCT02641379|449035956|FG010|Overall Study|PCR positive|0|||
124838038|NCT01165138|449035957|FG000|Overall Study|Adverse Event|0|||
124838039|NCT01165138|449035958|FG001|Overall Study|Adverse Event|1|||
124838040|NCT01165138|449035959|FG002|Overall Study|Adverse Event|0|||
124838041|NCT01165138|449035960|FG003|Overall Study|Adverse Event|2|||
124838042|NCT01165138|449035957|FG000|Overall Study|Lack of Efficacy|0|||
124838043|NCT01165138|449035958|FG001|Overall Study|Lack of Efficacy|32|||
124838044|NCT01165138|449035959|FG002|Overall Study|Lack of Efficacy|6|||
124838045|NCT01165138|449035960|FG003|Overall Study|Lack of Efficacy|7|||
124838046|NCT01165138|449035957|FG000|Overall Study|Protocol Violation|0|||
124838047|NCT01165138|449035958|FG001|Overall Study|Protocol Violation|7|||
124838048|NCT01165138|449035959|FG002|Overall Study|Protocol Violation|0|||
124838049|NCT01165138|449035960|FG003|Overall Study|Protocol Violation|2|||
124838050|NCT01165138|449035957|FG000|Overall Study|Lost to Follow-up|0|||
124838051|NCT01165138|449035958|FG001|Overall Study|Lost to Follow-up|0|||
124838052|NCT01165138|449035959|FG002|Overall Study|Lost to Follow-up|1|||
124838053|NCT01165138|449035960|FG003|Overall Study|Lost to Follow-up|2|||
124838054|NCT01165138|449035957|FG000|Overall Study|Physician Decision|0|||
124838055|NCT01165138|449035958|FG001|Overall Study|Physician Decision|6|||
124838056|NCT01165138|449035959|FG002|Overall Study|Physician Decision|7|||
124838057|NCT01165138|449035960|FG003|Overall Study|Physician Decision|6|||
124838058|NCT01165138|449035957|FG000|Overall Study|Withdrawal by Subject|0|||
124838059|NCT01165138|449035958|FG001|Overall Study|Withdrawal by Subject|6|||
124838060|NCT01165138|449035959|FG002|Overall Study|Withdrawal by Subject|6|||
124838061|NCT01165138|449035960|FG003|Overall Study|Withdrawal by Subject|3|||
124838062|NCT04982250|449035961|FG000|Overall Study|Lost to Follow-up|0|||
124838063|NCT04982250|449035962|FG001|Overall Study|Lost to Follow-up|26|||
124838064|NCT04982250|449035963|FG002|Overall Study|Lost to Follow-up|0|||
124838065|NCT04982250|449035964|FG003|Overall Study|Lost to Follow-up|0|||
124838066|NCT04982250|449035965|FG004|Overall Study|Lost to Follow-up|72|||
124838067|NCT04982250|449035966|FG005|Overall Study|Lost to Follow-up|69|||
124838068|NCT04982250|449035961|FG000|Overall Study|Not Eligible to Enroll|0|||
124838069|NCT04982250|449035962|FG001|Overall Study|Not Eligible to Enroll|0|||
124838070|NCT04982250|449035963|FG002|Overall Study|Not Eligible to Enroll|0|||
124838071|NCT04982250|449035964|FG003|Overall Study|Not Eligible to Enroll|0|||
124838072|NCT04982250|449035965|FG004|Overall Study|Not Eligible to Enroll|10|||
124838073|NCT04982250|449035966|FG005|Overall Study|Not Eligible to Enroll|7|||
124838074|NCT01148511|449035967|FG000|Exposed to Study Drug|Protocol Violation|2|||
124838075|NCT01148511|449035968|FG001|Exposed to Study Drug|Protocol Violation|0|||
124838076|NCT01148511|449035969|FG002|Exposed to Study Drug|Protocol Violation|0|||
124838077|NCT01148511|449035967|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
124838078|NCT01148511|449035968|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
124838079|NCT01148511|449035969|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
124838080|NCT01148511|449035967|FG000|Randomized|Adverse Event|0|||
124838081|NCT01148511|449035968|FG001|Randomized|Adverse Event|1|||
124838082|NCT01148511|449035969|FG002|Randomized|Adverse Event|0|||
124838083|NCT01148511|449035967|FG000|Randomized|Protocol Violation|0|||
124838084|NCT01148511|449035968|FG001|Randomized|Protocol Violation|2|||
124838085|NCT01148511|449035969|FG002|Randomized|Protocol Violation|1|||
124838086|NCT01148511|449035967|FG000|Randomized|Lost to Follow-up|0|||
124838087|NCT01148511|449035968|FG001|Randomized|Lost to Follow-up|1|||
124838088|NCT01148511|449035969|FG002|Randomized|Lost to Follow-up|1|||
124838089|NCT01148511|449035967|FG000|Randomized|Consent withdrawal|0|||
124838090|NCT01148511|449035968|FG001|Randomized|Consent withdrawal|5|||
124838091|NCT01148511|449035969|FG002|Randomized|Consent withdrawal|3|||
124838092|NCT01148511|449035967|FG000|Randomized|Other|0|||
124838093|NCT01148511|449035968|FG001|Randomized|Other|1|||
124838094|NCT01148511|449035969|FG002|Randomized|Other|1|||
124838095|NCT01644175|449035972|FG000|Overall Study|Randomized But Not Treated|0|||
124838096|NCT01644175|449035973|FG001|Overall Study|Randomized But Not Treated|2|||
124838097|NCT01644175|449035972|FG000|Overall Study|Adverse Event|8|||
124838098|NCT01644175|449035973|FG001|Overall Study|Adverse Event|13|||
124838099|NCT01644175|449035972|FG000|Overall Study|Death|1|||
124838100|NCT01644175|449035973|FG001|Overall Study|Death|2|||
124838101|NCT01644175|449035972|FG000|Overall Study|Poor compliance to protocol|9|||
124838102|NCT01644175|449035973|FG001|Overall Study|Poor compliance to protocol|10|||
124838103|NCT01644175|449035972|FG000|Overall Study|Physician Decision|1|||
124838104|NCT01644175|449035973|FG001|Overall Study|Physician Decision|2|||
124838105|NCT01644175|449035972|FG000|Overall Study|Participant Moved|1|||
124838106|NCT01644175|449035973|FG001|Overall Study|Participant Moved|2|||
124838107|NCT01644175|449035972|FG000|Overall Study|Consent withdrawn by participant|3|||
124838108|NCT01644175|449035973|FG001|Overall Study|Consent withdrawn by participant|4|||
124838109|NCT01644175|449035972|FG000|Overall Study|Related to Autoinjector Administration|2|||
124838110|NCT01644175|449035973|FG001|Overall Study|Related to Autoinjector Administration|1|||
124838111|NCT01644175|449035972|FG000|Overall Study|Last visit outside protocol visit window|4|||
124838112|NCT01644175|449035973|FG001|Overall Study|Last visit outside protocol visit window|11|||
124838113|NCT01644175|449035972|FG000|Overall Study|Selection criteria finally not met|0|||
124838114|NCT01644175|449035973|FG001|Overall Study|Selection criteria finally not met|1|||
124838115|NCT01644175|449035972|FG000|Overall Study|Site closure|2|||
124838116|NCT01644175|449035973|FG001|Overall Study|Site closure|2|||
124838117|NCT01644175|449035972|FG000|Overall Study|Lost to Follow-up|1|||
124838118|NCT01644175|449035973|FG001|Overall Study|Lost to Follow-up|0|||
124838119|NCT01644175|449035972|FG000|Overall Study|Other than specified above|0|||
124838120|NCT01644175|449035973|FG001|Overall Study|Other than specified above|3|||
124838121|NCT02818777|449035979|FG000|Overall Study|Adverse Event|3|||
124838122|NCT01418937|449035980|FG000|Overall Study|Lost to Follow-up|5|||
124838123|NCT01418937|449035980|FG000|Overall Study|Protocol Violation|1|||
124838124|NCT01418937|449035980|FG000|Overall Study|Pregnancy|1|||
124838125|NCT01418937|449035980|FG000|Overall Study|Withdrawal by Subject|1|||
124838126|NCT01324349|449035990|FG000|Overall Study|Death|1|||
124838127|NCT01324349|449035991|FG001|Overall Study|Death|1|||
124838128|NCT01324349|449035990|FG000|Overall Study|Withdrawal by Subject|0|||
124838129|NCT01324349|449035991|FG001|Overall Study|Withdrawal by Subject|1|||
124838130|NCT02013167|449035994|FG000|Overall Study|Withdrawal by Subject|15|||
124838131|NCT02013167|449035995|FG001|Overall Study|Withdrawal by Subject|14|||
124838132|NCT02013167|449035994|FG000|Overall Study|Sponsor Decision|1|||
124838133|NCT02013167|449035995|FG001|Overall Study|Sponsor Decision|3|||
124838134|NCT02013167|449035994|FG000|Overall Study|Lost to Follow-up|0|||
124838135|NCT02013167|449035995|FG001|Overall Study|Lost to Follow-up|1|||
124838136|NCT02013167|449035994|FG000|Overall Study|Death|85|||
124838137|NCT02013167|449035995|FG001|Overall Study|Death|160|||
124838138|NCT01113879|449035996|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
124838139|NCT01113879|449035997|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
124838140|NCT04327986|449035998|FG000|Overall Study|Physician Decision|2|||
124838141|NCT04327986|449035999|FG001|Overall Study|Physician Decision|0|||
124838142|NCT04327986|449036000|FG002|Overall Study|Physician Decision|0|||
124838143|NCT04327986|449035998|FG000|Overall Study|Death|1|||
124838144|NCT04327986|449035999|FG001|Overall Study|Death|0|||
124838145|NCT04327986|449036000|FG002|Overall Study|Death|0|||
124838146|NCT01714310|449037558|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
124838147|NCT01714310|449037559|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
124838148|NCT01714310|449037560|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
124838149|NCT01714310|449037558|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
124838150|NCT01714310|449037559|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
124838151|NCT01714310|449037560|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
124838152|NCT01714310|449037558|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
124838153|NCT01714310|449037559|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
124838154|NCT01714310|449037560|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
124838155|NCT01714310|449037558|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
124838156|NCT01714310|449037559|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
124838157|NCT01714310|449037560|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
124838158|NCT00654381|449037565|FG000|1st Stage|Adverse Event|3|||
124838159|NCT00654381|449037566|FG001|1st Stage|Adverse Event|3|||
124838160|NCT00654381|449037567|FG002|1st Stage|Adverse Event|3|||
124838161|NCT00654381|449037568|FG003|1st Stage|Adverse Event|3|||
124838162|NCT00654381|449037569|FG004|1st Stage|Adverse Event|2|||
124838163|NCT00654381|449037570|FG005|1st Stage|Adverse Event|1|||
124838164|NCT00654381|449037565|FG000|1st Stage|Withdrawal by Subject|0|||
124838165|NCT00654381|449037566|FG001|1st Stage|Withdrawal by Subject|0|||
124838166|NCT00654381|449037567|FG002|1st Stage|Withdrawal by Subject|0|||
124838167|NCT00654381|449037568|FG003|1st Stage|Withdrawal by Subject|1|||
124838168|NCT00654381|449037569|FG004|1st Stage|Withdrawal by Subject|0|||
124838169|NCT00654381|449037570|FG005|1st Stage|Withdrawal by Subject|1|||
124838170|NCT00654381|449037565|FG000|1st Stage|Investigator's decision|0|||
124838171|NCT00654381|449037566|FG001|1st Stage|Investigator's decision|0|||
124838172|NCT00654381|449037567|FG002|1st Stage|Investigator's decision|0|||
124838173|NCT00654381|449037568|FG003|1st Stage|Investigator's decision|1|||
124838174|NCT00654381|449037569|FG004|1st Stage|Investigator's decision|0|||
124838175|NCT00654381|449037570|FG005|1st Stage|Investigator's decision|0|||
124838176|NCT00654381|449037565|FG000|2nd Stage|Adverse Event|2|||
124838177|NCT00654381|449037566|FG001|2nd Stage|Adverse Event|0|||
124838178|NCT00654381|449037567|FG002|2nd Stage|Adverse Event|2|||
124838179|NCT00654381|449037568|FG003|2nd Stage|Adverse Event|3|||
124838180|NCT00654381|449037569|FG004|2nd Stage|Adverse Event|7|||
124838181|NCT00654381|449037570|FG005|2nd Stage|Adverse Event|2|||
124838182|NCT00654381|449037565|FG000|2nd Stage|Withdrawal by Subject|0|||
124838183|NCT00654381|449037566|FG001|2nd Stage|Withdrawal by Subject|0|||
124838184|NCT00654381|449037567|FG002|2nd Stage|Withdrawal by Subject|0|||
124838185|NCT00654381|449037568|FG003|2nd Stage|Withdrawal by Subject|0|||
124838186|NCT00654381|449037569|FG004|2nd Stage|Withdrawal by Subject|1|||
124838187|NCT00654381|449037570|FG005|2nd Stage|Withdrawal by Subject|1|||
124838188|NCT00654381|449037565|FG000|2nd Stage|Investigator's decision|0|||
124838189|NCT00654381|449037566|FG001|2nd Stage|Investigator's decision|0|||
124838190|NCT00654381|449037567|FG002|2nd Stage|Investigator's decision|1|||
124838191|NCT00654381|449037568|FG003|2nd Stage|Investigator's decision|1|||
124838192|NCT00654381|449037569|FG004|2nd Stage|Investigator's decision|0|||
124838193|NCT00654381|449037570|FG005|2nd Stage|Investigator's decision|0|||
124838194|NCT00654381|449037565|FG000|Extension Stage|Adverse Event|1|||
124838195|NCT00654381|449037566|FG001|Extension Stage|Adverse Event|2|||
124838196|NCT00654381|449037567|FG002|Extension Stage|Adverse Event|9|||
124838197|NCT00654381|449037568|FG003|Extension Stage|Adverse Event|7|||
124838198|NCT00654381|449037569|FG004|Extension Stage|Adverse Event|1|||
124838199|NCT00654381|449037570|FG005|Extension Stage|Adverse Event|1|||
124838200|NCT00654381|449037565|FG000|Extension Stage|Protocol Violation|0|||
124838201|NCT00654381|449037566|FG001|Extension Stage|Protocol Violation|0|||
124838202|NCT00654381|449037567|FG002|Extension Stage|Protocol Violation|0|||
124838203|NCT00654381|449037568|FG003|Extension Stage|Protocol Violation|1|||
124838204|NCT00654381|449037569|FG004|Extension Stage|Protocol Violation|0|||
124838205|NCT00654381|449037570|FG005|Extension Stage|Protocol Violation|0|||
124838206|NCT00654381|449037565|FG000|Extension Stage|Lack of Efficacy|0|||
124838207|NCT00654381|449037566|FG001|Extension Stage|Lack of Efficacy|0|||
124838208|NCT00654381|449037567|FG002|Extension Stage|Lack of Efficacy|1|||
124838209|NCT00654381|449037568|FG003|Extension Stage|Lack of Efficacy|0|||
124838210|NCT00654381|449037569|FG004|Extension Stage|Lack of Efficacy|0|||
124838211|NCT00654381|449037570|FG005|Extension Stage|Lack of Efficacy|0|||
124838212|NCT00654381|449037565|FG000|Extension Stage|Withdrawal by Subject|0|||
124838213|NCT00654381|449037566|FG001|Extension Stage|Withdrawal by Subject|0|||
124838214|NCT00654381|449037567|FG002|Extension Stage|Withdrawal by Subject|1|||
124838215|NCT00654381|449037568|FG003|Extension Stage|Withdrawal by Subject|1|||
124838216|NCT00654381|449037569|FG004|Extension Stage|Withdrawal by Subject|1|||
124838217|NCT00654381|449037570|FG005|Extension Stage|Withdrawal by Subject|1|||
124838218|NCT00654381|449037565|FG000|Extension Stage|Closure of the trial site|0|||
124838219|NCT00654381|449037566|FG001|Extension Stage|Closure of the trial site|0|||
124838220|NCT00654381|449037567|FG002|Extension Stage|Closure of the trial site|0|||
124838221|NCT00654381|449037568|FG003|Extension Stage|Closure of the trial site|0|||
124838222|NCT00654381|449037569|FG004|Extension Stage|Closure of the trial site|1|||
124838223|NCT00654381|449037570|FG005|Extension Stage|Closure of the trial site|1|||
124838224|NCT04164901|449037575|FG000|Overall Study|Withdrawal by Subject|4|||
124838225|NCT04164901|449037576|FG001|Overall Study|Withdrawal by Subject|4|||
124838226|NCT00097721|449037584|FG000|Overall Study|Adverse Event|8|||
124838227|NCT00097721|449037585|FG001|Overall Study|Adverse Event|1|||
124838228|NCT00097721|449037584|FG000|Overall Study|Withdrawal by Subject|6|||
124838229|NCT00097721|449037585|FG001|Overall Study|Withdrawal by Subject|1|||
124838230|NCT00097721|449037584|FG000|Overall Study|Progressive Disease|55|||
124838231|NCT00097721|449037585|FG001|Overall Study|Progressive Disease|27|||
124838232|NCT00097721|449037584|FG000|Overall Study|Physician Decision|1|||
124838233|NCT00097721|449037585|FG001|Overall Study|Physician Decision|3|||
124838234|NCT00097721|449037584|FG000|Overall Study|Reason not given|1|||
124838235|NCT00097721|449037585|FG001|Overall Study|Reason not given|1|||
124838236|NCT01752855|449037589|FG000|Overall Study|Adverse Event|1|||
124838237|NCT01752855|449037590|FG001|Overall Study|Adverse Event|0|||
124838238|NCT01752855|449037589|FG000|Overall Study|Withdrew Consent|0|||
124838239|NCT01752855|449037590|FG001|Overall Study|Withdrew Consent|2|||
124838240|NCT01752855|449037589|FG000|Overall Study|Lack of Efficacy|0|||
124838241|NCT01752855|449037590|FG001|Overall Study|Lack of Efficacy|2|||
124838242|NCT02852265|449037595|FG000|3-month Follow-up|Lost to Follow-up|1|||
124838243|NCT02852265|449037596|FG001|3-month Follow-up|Lost to Follow-up|1|||
124838244|NCT03144180|449037598|FG000|Overall Study|STAT Delivery|1|||
124838245|NCT03144180|449037599|FG001|Overall Study|STAT Delivery|1|||
124838246|NCT03144180|449037598|FG000|Overall Study|Provider forgot to fill out forms|1|||
124838247|NCT03144180|449037599|FG001|Overall Study|Provider forgot to fill out forms|3|||
124838248|NCT03144180|449037598|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
124838249|NCT03144180|449037599|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
124838250|NCT03144180|449037598|FG000|Overall Study|Scrub tech removed tube cap|0|||
124838251|NCT03144180|449037599|FG001|Overall Study|Scrub tech removed tube cap|1|||
124838252|NCT00743652|449037600|FG000|Overall Study|Parent/Legal Guardian Request|3|||
124838253|NCT00743652|449037601|FG001|Overall Study|Parent/Legal Guardian Request|2|||
124838254|NCT00743652|449037602|FG002|Overall Study|Parent/Legal Guardian Request|2|||
124838255|NCT00743652|449037603|FG003|Overall Study|Parent/Legal Guardian Request|2|||
124838256|NCT00743652|449037604|FG004|Overall Study|Parent/Legal Guardian Request|0|||
124838257|NCT00743652|449037600|FG000|Overall Study|Adverse Event|3|||
124838258|NCT00743652|449037601|FG001|Overall Study|Adverse Event|0|||
124838259|NCT00743652|449037602|FG002|Overall Study|Adverse Event|0|||
124838260|NCT00743652|449037603|FG003|Overall Study|Adverse Event|0|||
124838261|NCT00743652|449037604|FG004|Overall Study|Adverse Event|0|||
124838262|NCT00743652|449037600|FG000|Overall Study|Death|2|||
124838263|NCT00743652|449037601|FG001|Overall Study|Death|0|||
124838264|NCT00743652|449037602|FG002|Overall Study|Death|0|||
124838265|NCT00743652|449037603|FG003|Overall Study|Death|0|||
124838266|NCT00743652|449037604|FG004|Overall Study|Death|0|||
124838267|NCT00743652|449037600|FG000|Overall Study|Investigator Request|0|||
124838268|NCT00743652|449037601|FG001|Overall Study|Investigator Request|0|||
124838269|NCT00743652|449037602|FG002|Overall Study|Investigator Request|0|||
124838270|NCT00743652|449037603|FG003|Overall Study|Investigator Request|2|||
124838271|NCT00743652|449037604|FG004|Overall Study|Investigator Request|0|||
124838272|NCT00743652|449037600|FG000|Overall Study|Other|1|||
124838273|NCT00743652|449037601|FG001|Overall Study|Other|1|||
124838274|NCT00743652|449037602|FG002|Overall Study|Other|0|||
124838275|NCT00743652|449037603|FG003|Overall Study|Other|0|||
124838276|NCT00743652|449037604|FG004|Overall Study|Other|0|||
124838277|NCT00743652|449037600|FG000|Overall Study|Lost to Follow-up|1|||
124838278|NCT00743652|449037601|FG001|Overall Study|Lost to Follow-up|0|||
124838279|NCT00743652|449037602|FG002|Overall Study|Lost to Follow-up|0|||
124838280|NCT00743652|449037603|FG003|Overall Study|Lost to Follow-up|0|||
124838281|NCT00743652|449037604|FG004|Overall Study|Lost to Follow-up|0|||
124838282|NCT02547129|449037605|FG000|Overall Study|Difficulty with ongoing infection|1|||
124838283|NCT02547129|449037606|FG001|Overall Study|Difficulty with ongoing infection|0|||
124838284|NCT03925324|449037607|FG000|Overall Study|Death|1|||
124838285|NCT03925324|449037608|FG001|Overall Study|Death|1|||
124838286|NCT00409617|449037611|FG000|Overall Study|Adverse Event|57|||
124838287|NCT00409617|449037611|FG000|Overall Study|Lack of Efficacy|54|||
124838288|NCT00409617|449037611|FG000|Overall Study|Lost to Follow-up|2|||
124838289|NCT00409617|449037611|FG000|Overall Study|Protocol Violation|24|||
124838290|NCT00409617|449037611|FG000|Overall Study|Withdrawal by Subject|8|||
124838291|NCT00409617|449037611|FG000|Overall Study|Administrative reasons|1|||
124838292|NCT00409617|449037611|FG000|Overall Study|Not described|14|||
124838293|NCT02159521|449037612|FG000|Overall Study|Enrolled but not treated|3|||
124838294|NCT02159521|449037612|FG000|Overall Study|Withdrawal by Subject|7|||
124838295|NCT02159521|449037612|FG000|Overall Study|Lost to Follow-up|6|||
124838296|NCT02159521|449037612|FG000|Overall Study|Death|1|||
124838297|NCT02159521|449037612|FG000|Overall Study|Other than specified|1|||
124838298|NCT03316885|449037617|FG000|Overall Study|Adverse Event|1|||
124838299|NCT03316885|449037617|FG000|Overall Study|Death|10|||
124838300|NCT03316885|449037617|FG000|Overall Study|Lost to Follow-up|4|||
124838301|NCT03316885|449037617|FG000|Overall Study|Withdrawal by Subject|9|||
124838302|NCT03316885|449037617|FG000|Overall Study|COVID related|8|||
124838303|NCT03216850|449037620|FG000|Overall Study|Pre-analytical error|6|||
124838304|NCT00500292|449037624|FG000|Overall Study|Adverse Event|3|||
124838305|NCT00500292|449037625|FG001|Overall Study|Adverse Event|6|||
124838306|NCT00500292|449037626|FG002|Overall Study|Adverse Event|4|||
124838307|NCT00500292|449037624|FG000|Overall Study|Condition under investigation worsened|21|||
124838308|NCT00500292|449037625|FG001|Overall Study|Condition under investigation worsened|23|||
124838309|NCT00500292|449037626|FG002|Overall Study|Condition under investigation worsened|19|||
124838310|NCT00500292|449037624|FG000|Overall Study|Withdrawal by Subject|0|||
124838311|NCT00500292|449037625|FG001|Overall Study|Withdrawal by Subject|1|||
124838312|NCT00500292|449037626|FG002|Overall Study|Withdrawal by Subject|0|||
124838313|NCT00500292|449037624|FG000|Overall Study|Other|1|||
124838314|NCT00500292|449037625|FG001|Overall Study|Other|1|||
124838315|NCT00500292|449037626|FG002|Overall Study|Other|4|||
124838316|NCT00856908|449037633|FG000|Overall Study|Lost to Follow-up|1|||
124838317|NCT00856908|449037634|FG001|Overall Study|Lost to Follow-up|0|||
124838318|NCT00962104|449037635|FG000|Overall Study|Adverse Event|10|||
124838319|NCT00962104|449037636|FG001|Overall Study|Adverse Event|3|||
124838320|NCT00962104|449037635|FG000|Overall Study|Entry Criteria Not Met|1|||
124838321|NCT00962104|449037636|FG001|Overall Study|Entry Criteria Not Met|2|||
124838322|NCT00962104|449037635|FG000|Overall Study|Lack of Efficacy|0|||
124838323|NCT00962104|449037636|FG001|Overall Study|Lack of Efficacy|1|||
124838324|NCT00962104|449037635|FG000|Overall Study|Lost to Follow-up|10|||
124838325|NCT00962104|449037636|FG001|Overall Study|Lost to Follow-up|4|||
124838326|NCT00962104|449037635|FG000|Overall Study|Physician Decision|1|||
124838327|NCT00962104|449037636|FG001|Overall Study|Physician Decision|0|||
124838328|NCT00962104|449037635|FG000|Overall Study|Protocol Violation|6|||
124838329|NCT00962104|449037636|FG001|Overall Study|Protocol Violation|8|||
124838330|NCT00962104|449037635|FG000|Overall Study|Sponsor Decision|0|||
124838331|NCT00962104|449037636|FG001|Overall Study|Sponsor Decision|1|||
124838332|NCT00962104|449037635|FG000|Overall Study|Withdrawal by Subject|10|||
124838333|NCT00962104|449037636|FG001|Overall Study|Withdrawal by Subject|6|||
124838334|NCT00962104|449037635|FG000|Overall Study|Other|2|||
124838335|NCT00962104|449037636|FG001|Overall Study|Other|0|||
124838336|NCT00842348|449037637|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
124838337|NCT00842348|449037638|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
124838338|NCT00842348|449037637|FG000|Study 729|Disease progression/death|19|||
124838339|NCT00842348|449037638|FG001|Study 729|Disease progression/death|30|||
124838340|NCT00842348|449037637|FG000|Study 729|Adverse Event|1|||
124838341|NCT00842348|449037638|FG001|Study 729|Adverse Event|1|||
124838342|NCT00842348|449037637|FG000|Study 729|Protocol Violation|1|||
124838343|NCT00842348|449037638|FG001|Study 729|Protocol Violation|1|||
124838344|NCT00842348|449037637|FG000|Study 729|Withdrawal by Subject|2|||
124838345|NCT00842348|449037638|FG001|Study 729|Withdrawal by Subject|4|||
124838346|NCT00842348|449037637|FG000|Study 729|Due to Sponsor stopping the study|1|||
124838347|NCT00842348|449037638|FG001|Study 729|Due to Sponsor stopping the study|1|||
124838348|NCT00842348|449037637|FG000|Study 729|Due to non-availability of IP|0|||
124838349|NCT00842348|449037638|FG001|Study 729|Due to non-availability of IP|1|||
124838350|NCT00842348|449037637|FG000|Study 729|Sponsor's decision|1|||
124838351|NCT00842348|449037638|FG001|Study 729|Sponsor's decision|0|||
124838352|NCT00842348|449037637|FG000|Study 729|Surgical resection|1|||
124838353|NCT00842348|449037638|FG001|Study 729|Surgical resection|0|||
124838354|NCT03274986|449037639|FG000|Overall Study|Withdrawal by Subject|0|||
124838355|NCT03274986|449037640|FG001|Overall Study|Withdrawal by Subject|1|||
124838356|NCT03274986|449037639|FG000|Overall Study|Lost to Follow-up|0|||
124838357|NCT03274986|449037640|FG001|Overall Study|Lost to Follow-up|1|||
124838358|NCT00603746|449037643|FG000|Overall Study|Adverse Event|2|||
124838359|NCT00603746|449037644|FG001|Overall Study|Adverse Event|3|||
124838360|NCT00603746|449037645|FG002|Overall Study|Adverse Event|0|||
124838361|NCT00603746|449037646|FG003|Overall Study|Adverse Event|1|||
124838362|NCT00603746|449037647|FG004|Overall Study|Adverse Event|0|||
124838363|NCT00603746|449037648|FG005|Overall Study|Adverse Event|4|||
124838364|NCT00603746|449037643|FG000|Overall Study|Lack of Efficacy|34|||
124838365|NCT00603746|449037644|FG001|Overall Study|Lack of Efficacy|11|||
124838366|NCT00603746|449037645|FG002|Overall Study|Lack of Efficacy|6|||
124838367|NCT00603746|449037646|FG003|Overall Study|Lack of Efficacy|11|||
124838368|NCT00603746|449037647|FG004|Overall Study|Lack of Efficacy|12|||
124838369|NCT00603746|449037648|FG005|Overall Study|Lack of Efficacy|8|||
124838370|NCT00603746|449037643|FG000|Overall Study|Protocol Violation|0|||
124838371|NCT00603746|449037644|FG001|Overall Study|Protocol Violation|3|||
124838372|NCT00603746|449037645|FG002|Overall Study|Protocol Violation|1|||
124838373|NCT00603746|449037646|FG003|Overall Study|Protocol Violation|0|||
124838374|NCT00603746|449037647|FG004|Overall Study|Protocol Violation|1|||
124838375|NCT00603746|449037648|FG005|Overall Study|Protocol Violation|0|||
124838376|NCT00603746|449037643|FG000|Overall Study|Lost to Follow-up|0|||
124838377|NCT00603746|449037644|FG001|Overall Study|Lost to Follow-up|1|||
124838378|NCT00603746|449037645|FG002|Overall Study|Lost to Follow-up|1|||
124838379|NCT00603746|449037646|FG003|Overall Study|Lost to Follow-up|0|||
124838380|NCT00603746|449037647|FG004|Overall Study|Lost to Follow-up|0|||
124838381|NCT00603746|449037648|FG005|Overall Study|Lost to Follow-up|0|||
124838382|NCT00603746|449037643|FG000|Overall Study|Physician Decision|1|||
124838383|NCT00603746|449037644|FG001|Overall Study|Physician Decision|0|||
124838384|NCT00603746|449037645|FG002|Overall Study|Physician Decision|0|||
124838385|NCT00603746|449037646|FG003|Overall Study|Physician Decision|0|||
124838386|NCT00603746|449037647|FG004|Overall Study|Physician Decision|1|||
124838387|NCT00603746|449037648|FG005|Overall Study|Physician Decision|0|||
124838388|NCT00603746|449037643|FG000|Overall Study|Withdrawal by Subject|1|||
124838389|NCT00603746|449037644|FG001|Overall Study|Withdrawal by Subject|0|||
124838390|NCT00603746|449037645|FG002|Overall Study|Withdrawal by Subject|0|||
124838391|NCT00603746|449037646|FG003|Overall Study|Withdrawal by Subject|1|||
124838392|NCT00603746|449037647|FG004|Overall Study|Withdrawal by Subject|3|||
124838393|NCT00603746|449037648|FG005|Overall Study|Withdrawal by Subject|1|||
124838394|NCT01524627|449037651|FG000|Overall Study|Physician Decision|0|||
124838395|NCT01524627|449037652|FG001|Overall Study|Physician Decision|1|||
124838396|NCT01524627|449037651|FG000|Overall Study|Lost to Follow-up|1|||
124838397|NCT01524627|449037652|FG001|Overall Study|Lost to Follow-up|1|||
124838398|NCT03323658|449037653|FG000|Overall Study|Adverse Event|0|||
124838399|NCT03323658|449037654|FG001|Overall Study|Adverse Event|1|||
124838400|NCT03323658|449037655|FG002|Overall Study|Adverse Event|0|||
124838401|NCT03913091|449037656|FG000|Overall Study|Lost to Follow-up|18|||
124838402|NCT03913091|449037657|FG001|Overall Study|Lost to Follow-up|11|||
124838403|NCT03913091|449037656|FG000|Overall Study|Required additional meds/surgery|1|||
124838404|NCT03913091|449037657|FG001|Overall Study|Required additional meds/surgery|2|||
124838405|NCT03913091|449037656|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
124838406|NCT03913091|449037657|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
124838407|NCT00969553|449037658|FG000|Overall Study|Progressive disease (PD)|2|||
124838408|NCT00969553|449037659|FG001|Overall Study|Progressive disease (PD)|2|||
124838409|NCT00969553|449037660|FG002|Overall Study|Progressive disease (PD)|6|||
124838410|NCT00969553|449037661|FG003|Overall Study|Progressive disease (PD)|9|||
124838411|NCT00969553|449037662|FG004|Overall Study|Progressive disease (PD)|2|||
124838412|NCT00969553|449037663|FG005|Overall Study|Progressive disease (PD)|4|||
124838413|NCT00969553|449037664|FG006|Overall Study|Progressive disease (PD)|2|||
124838414|NCT00969553|449037665|FG007|Overall Study|Progressive disease (PD)|12|||
124838415|NCT00969553|449037666|FG008|Overall Study|Progressive disease (PD)|3|||
124838416|NCT00969553|449037658|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
124838417|NCT00969553|449037659|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
124838418|NCT00969553|449037660|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
124838419|NCT00969553|449037661|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
124838420|NCT00969553|449037662|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
124838421|NCT00969553|449037663|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
124838422|NCT00969553|449037664|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
124838423|NCT00969553|449037665|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
124838424|NCT00969553|449037666|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
124838425|NCT00969553|449037658|FG000|Overall Study|Other Adverse Event|0|||
124838426|NCT00969553|449037659|FG001|Overall Study|Other Adverse Event|0|||
124838427|NCT00969553|449037660|FG002|Overall Study|Other Adverse Event|0|||
124838428|NCT00969553|449037661|FG003|Overall Study|Other Adverse Event|1|||
124838429|NCT00969553|449037662|FG004|Overall Study|Other Adverse Event|0|||
124838430|NCT00969553|449037663|FG005|Overall Study|Other Adverse Event|0|||
124838431|NCT00969553|449037664|FG006|Overall Study|Other Adverse Event|1|||
124838432|NCT00969553|449037665|FG007|Overall Study|Other Adverse Event|0|||
124838433|NCT00969553|449037666|FG008|Overall Study|Other Adverse Event|0|||
124838434|NCT00969553|449037658|FG000|Overall Study|Refused cont. medication|1|||
124838435|NCT00969553|449037659|FG001|Overall Study|Refused cont. medication|1|||
124838436|NCT00969553|449037660|FG002|Overall Study|Refused cont. medication|0|||
124838437|NCT00969553|449037661|FG003|Overall Study|Refused cont. medication|2|||
124838438|NCT00969553|449037662|FG004|Overall Study|Refused cont. medication|0|||
124838439|NCT00969553|449037663|FG005|Overall Study|Refused cont. medication|0|||
124838440|NCT00969553|449037664|FG006|Overall Study|Refused cont. medication|0|||
124838441|NCT00969553|449037665|FG007|Overall Study|Refused cont. medication|1|||
124838442|NCT00969553|449037666|FG008|Overall Study|Refused cont. medication|0|||
124838443|NCT00969553|449037658|FG000|Overall Study|Not specified above|0|||
124838444|NCT00969553|449037659|FG001|Overall Study|Not specified above|0|||
124838445|NCT00969553|449037660|FG002|Overall Study|Not specified above|0|||
124838446|NCT00969553|449037661|FG003|Overall Study|Not specified above|4|||
124838447|NCT00969553|449037662|FG004|Overall Study|Not specified above|0|||
124838448|NCT00969553|449037663|FG005|Overall Study|Not specified above|0|||
124838449|NCT00969553|449037664|FG006|Overall Study|Not specified above|1|||
124838450|NCT00969553|449037665|FG007|Overall Study|Not specified above|1|||
124838451|NCT00969553|449037666|FG008|Overall Study|Not specified above|0|||
124838452|NCT02276612|449037668|FG000|Overall Study|Death|1|||
124838453|NCT02276612|449037669|FG001|Overall Study|Death|0|||
124838454|NCT02276612|449037668|FG000|Overall Study|Pregnancy|1|||
124838455|NCT02276612|449037669|FG001|Overall Study|Pregnancy|0|||
124838456|NCT02276612|449037668|FG000|Overall Study|Withdrew Consent|1|||
124838457|NCT02276612|449037669|FG001|Overall Study|Withdrew Consent|0|||
124838458|NCT02276612|449037668|FG000|Overall Study|Lost to Follow-up|1|||
124838459|NCT02276612|449037669|FG001|Overall Study|Lost to Follow-up|0|||
124838460|NCT02196324|449037670|FG000|Overall Study|Withdrawal by Subject|8|||
124838461|NCT02196324|449037671|FG001|Overall Study|Withdrawal by Subject|4|||
124838462|NCT02196324|449037670|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
124838463|NCT02196324|449037671|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
124838464|NCT02196324|449037670|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
124838465|NCT02196324|449037671|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
124838466|NCT02196324|449037670|FG000|Overall Study|Other|1|||
124838467|NCT02196324|449037671|FG001|Overall Study|Other|0|||
124838468|NCT00692770|449037672|FG000|Overall Study|Protocol Violation|2|||
124838469|NCT00692770|449037673|FG001|Overall Study|Protocol Violation|7|||
124838470|NCT00692770|449037672|FG000|Overall Study|Withdrawal by Subject|97|||
124838471|NCT00692770|449037673|FG001|Overall Study|Withdrawal by Subject|36|||
124838472|NCT00692770|449037672|FG000|Overall Study|Adverse Event|136|||
124838473|NCT00692770|449037673|FG001|Overall Study|Adverse Event|41|||
124838474|NCT00692770|449037672|FG000|Overall Study|Death|10|||
124838475|NCT00692770|449037673|FG001|Overall Study|Death|5|||
124838476|NCT00692770|449037672|FG000|Overall Study|Lost to Follow-up|7|||
124838477|NCT00692770|449037673|FG001|Overall Study|Lost to Follow-up|3|||
124838478|NCT00692770|449037672|FG000|Overall Study|Non-compliant with study medication|11|||
124838479|NCT00692770|449037673|FG001|Overall Study|Non-compliant with study medication|5|||
124838480|NCT00692770|449037672|FG000|Overall Study|Progression by clinical judgment|2|||
124838481|NCT00692770|449037673|FG001|Overall Study|Progression by clinical judgment|3|||
124838482|NCT00692770|449037672|FG000|Overall Study|Physician decision not protocol driven|10|||
124838483|NCT00692770|449037673|FG001|Overall Study|Physician decision not protocol driven|14|||
124838484|NCT00692770|449037672|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
124639676|NCT01028014|448298449|FG002|Overall Study|Lost to Follow-up|0|||
124639677|NCT01028014|448298450|FG003|Overall Study|Lost to Follow-up|1|||
124639678|NCT01028014|448298451|FG004|Overall Study|Lost to Follow-up|1|||
124639679|NCT01028014|448298452|FG005|Overall Study|Lost to Follow-up|2|||
124639680|NCT02423343|448298453|FG000|Overall Study|Withdrawal by Subject|0|||
124639681|NCT02423343|448298454|FG001|Overall Study|Withdrawal by Subject|1|||
124639682|NCT02423343|448298455|FG002|Overall Study|Withdrawal by Subject|0|||
124639683|NCT02423343|448298456|FG003|Overall Study|Withdrawal by Subject|0|||
124753265|NCT03364309|448718904|FG007|Induction Period|Adverse Event|0|||
124753266|NCT03364309|448718905|FG008|Induction Period|Adverse Event|0|||
124753267|NCT03364309|448718906|FG009|Induction Period|Adverse Event|0|||
124753268|NCT03364309|448718907|FG010|Induction Period|Adverse Event|0|||
124753269|NCT03364309|448718908|FG011|Induction Period|Adverse Event|0|||
124753270|NCT03364309|448718909|FG012|Induction Period|Adverse Event|0|||
124753271|NCT03364309|448718910|FG013|Induction Period|Adverse Event|0|||
124753272|NCT03364309|448718911|FG014|Induction Period|Adverse Event|0|||
124753273|NCT03364309|448718912|FG015|Induction Period|Adverse Event|0|||
124753274|NCT03364309|448718913|FG016|Induction Period|Adverse Event|0|||
124838485|NCT00692770|449037673|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
124838486|NCT00692770|449037672|FG000|Overall Study|Protocol driven decision point|3|||
124838487|NCT00692770|449037673|FG001|Overall Study|Protocol driven decision point|7|||
124838488|NCT00692770|449037672|FG000|Overall Study|Completed all planned assessments|79|||
124838489|NCT00692770|449037673|FG001|Overall Study|Completed all planned assessments|101|||
124838490|NCT00692770|449037672|FG000|Overall Study|Radiological and clinical progression|8|||
124838491|NCT00692770|449037673|FG001|Overall Study|Radiological and clinical progression|8|||
124838492|NCT00692770|449037672|FG000|Overall Study|Clinical endpoint reached|16|||
124838493|NCT00692770|449037673|FG001|Overall Study|Clinical endpoint reached|43|||
124838494|NCT00692770|449037672|FG000|Overall Study|Study terminated by sponsor|2|||
124838495|NCT00692770|449037673|FG001|Overall Study|Study terminated by sponsor|2|||
124838496|NCT00692770|449037672|FG000|Overall Study|Randomized but not treated|3|||
124838497|NCT00692770|449037673|FG001|Overall Study|Randomized but not treated|4|||
124838498|NCT04248816|449037674|FG000|Overall Study|Ineligible post-randomization|7|||
124838499|NCT04248816|449037675|FG001|Overall Study|Ineligible post-randomization|21|||
124838500|NCT04248816|449037676|FG002|Overall Study|Ineligible post-randomization|25|||
124838501|NCT00262067|449037677|FG000|Overall Study|Death|190|||
124838502|NCT00262067|449037678|FG001|Overall Study|Death|89|||
124838503|NCT00262067|449037679|FG002|Overall Study|Death|186|||
124838504|NCT00262067|449037680|FG003|Overall Study|Death|99|||
124838505|NCT00262067|449037677|FG000|Overall Study|Lost to Follow-up|5|||
124838506|NCT00262067|449037678|FG001|Overall Study|Lost to Follow-up|4|||
124838507|NCT00262067|449037679|FG002|Overall Study|Lost to Follow-up|7|||
124838508|NCT00262067|449037680|FG003|Overall Study|Lost to Follow-up|5|||
124838509|NCT00262067|449037677|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
124838510|NCT00262067|449037678|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
124838511|NCT00262067|449037679|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
124838512|NCT00262067|449037680|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
124838513|NCT00262067|449037677|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
124838514|NCT00262067|449037678|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
124838515|NCT00262067|449037679|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
124838516|NCT00262067|449037680|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
124838517|NCT00655564|449037681|FG000|Overall Study|Adverse Event|1|||
124838518|NCT00655564|449037681|FG000|Overall Study|Lost to Follow-up|1|||
124838519|NCT00655564|449037681|FG000|Overall Study|Desired Alternate Therapy|1|||
124838520|NCT04536727|449037682|FG000|Overall Study|Lost to Follow-up|1|||
124838521|NCT04536727|449037683|FG001|Overall Study|Lost to Follow-up|1|||
124838522|NCT04536727|449037682|FG000|Overall Study|Death|0|||
124838523|NCT04536727|449037683|FG001|Overall Study|Death|1|||
124838524|NCT01077804|449037684|FG000|Overall Study|Unreachable|102|||
124838525|NCT01077804|449037684|FG000|Overall Study|Refused to continue|79|||
124838526|NCT01077804|449037684|FG000|Overall Study|Other|18|||
124838527|NCT00256698|449037685|FG000|Overall Study|Withdrawal by Subject|7|||
124838528|NCT00256698|449037686|FG001|Overall Study|Withdrawal by Subject|7|||
124838529|NCT00256698|449037685|FG000|Overall Study|Adverse Event|13|||
124838530|NCT00256698|449037686|FG001|Overall Study|Adverse Event|6|||
124838531|NCT00256698|449037685|FG000|Overall Study|Protocol Violation|6|||
124753275|NCT03364309|448718914|FG017|Induction Period|Adverse Event|0|||
124753276|NCT03364309|448718915|FG018|Induction Period|Adverse Event|0|||
124753277|NCT03364309|448718897|FG000|Induction Period|Withdrawal by Subject|1|||
124753278|NCT03364309|448718898|FG001|Induction Period|Withdrawal by Subject|3|||
124753279|NCT03364309|448718899|FG002|Induction Period|Withdrawal by Subject|0|||
124753280|NCT03364309|448718900|FG003|Induction Period|Withdrawal by Subject|0|||
124753281|NCT03364309|448718901|FG004|Induction Period|Withdrawal by Subject|0|||
124753282|NCT03364309|448718902|FG005|Induction Period|Withdrawal by Subject|0|||
124753283|NCT03364309|448718903|FG006|Induction Period|Withdrawal by Subject|0|||
124753284|NCT03364309|448718904|FG007|Induction Period|Withdrawal by Subject|0|||
124753285|NCT03364309|448718905|FG008|Induction Period|Withdrawal by Subject|0|||
124753286|NCT03364309|448718906|FG009|Induction Period|Withdrawal by Subject|0|||
124753287|NCT03364309|448718907|FG010|Induction Period|Withdrawal by Subject|0|||
124753288|NCT03364309|448718908|FG011|Induction Period|Withdrawal by Subject|0|||
124753289|NCT03364309|448718909|FG012|Induction Period|Withdrawal by Subject|0|||
124753290|NCT03364309|448718910|FG013|Induction Period|Withdrawal by Subject|0|||
124753291|NCT03364309|448718911|FG014|Induction Period|Withdrawal by Subject|0|||
124753292|NCT03364309|448718912|FG015|Induction Period|Withdrawal by Subject|0|||
124753293|NCT03364309|448718913|FG016|Induction Period|Withdrawal by Subject|0|||
124753294|NCT03364309|448718914|FG017|Induction Period|Withdrawal by Subject|0|||
124753295|NCT03364309|448718915|FG018|Induction Period|Withdrawal by Subject|0|||
124753296|NCT03364309|448718897|FG000|Induction Period|Lost to Follow-up|1|||
124753297|NCT03364309|448718898|FG001|Induction Period|Lost to Follow-up|0|||
124753298|NCT03364309|448718899|FG002|Induction Period|Lost to Follow-up|0|||
124753299|NCT03364309|448718900|FG003|Induction Period|Lost to Follow-up|0|||
124753300|NCT03364309|448718901|FG004|Induction Period|Lost to Follow-up|0|||
124753301|NCT03364309|448718902|FG005|Induction Period|Lost to Follow-up|0|||
124838532|NCT00256698|449037686|FG001|Overall Study|Protocol Violation|5|||
124838533|NCT00256698|449037685|FG000|Overall Study|Lost to Follow-up|1|||
124838534|NCT00256698|449037686|FG001|Overall Study|Lost to Follow-up|3|||
124838535|NCT00256698|449037685|FG000|Overall Study|disease progression|97|||
124838536|NCT00256698|449037686|FG001|Overall Study|disease progression|105|||
124838537|NCT00256698|449037685|FG000|Overall Study|still ongoing at data cut-off|41|||
124838538|NCT00256698|449037686|FG001|Overall Study|still ongoing at data cut-off|46|||
124838539|NCT00256698|449037685|FG000|Overall Study|withdrawn due to osteoporosis|1|||
124838540|NCT00256698|449037686|FG001|Overall Study|withdrawn due to osteoporosis|0|||
124838541|NCT00256698|449037685|FG000|Overall Study|Prematurely Discontinued|1|||
124838542|NCT00256698|449037686|FG001|Overall Study|Prematurely Discontinued|0|||
124838543|NCT02620046|449037688|FG000|Overall Study|Adverse Event|22|||
124838544|NCT02620046|449037689|FG001|Overall Study|Adverse Event|42|||
124838545|NCT02620046|449037688|FG000|Overall Study|Lost to Follow-up|4|||
124838546|NCT02620046|449037689|FG001|Overall Study|Lost to Follow-up|10|||
124838547|NCT02620046|449037688|FG000|Overall Study|Withdrawal by Subject|36|||
124838548|NCT02620046|449037689|FG001|Overall Study|Withdrawal by Subject|66|||
124838549|NCT02620046|449037688|FG000|Overall Study|Site Termination|3|||
124838550|NCT02620046|449037689|FG001|Overall Study|Site Termination|3|||
124838551|NCT02620046|449037688|FG000|Overall Study|Pregnancy|3|||
124838552|NCT02620046|449037689|FG001|Overall Study|Pregnancy|7|||
124838553|NCT02620046|449037688|FG000|Overall Study|Lack of Efficacy|81|||
124838554|NCT02620046|449037689|FG001|Overall Study|Lack of Efficacy|146|||
124838555|NCT02620046|449037688|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
124838556|NCT02620046|449037689|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
124838557|NCT02620046|449037688|FG000|Overall Study|Reason Not Specified|13|||
124838558|NCT02620046|449037689|FG001|Overall Study|Reason Not Specified|21|||
124838559|NCT02620046|449037688|FG000|Overall Study|Significant Protocol Deviation|0|||
124838560|NCT02620046|449037689|FG001|Overall Study|Significant Protocol Deviation|1|||
124838561|NCT03962543|449037690|FG000|Treatment Phase|Death|0|||
124838562|NCT03962543|449037691|FG001|Treatment Phase|Death|1|||
124838563|NCT03962543|449037690|FG000|Treatment Phase|Withdrawal by Subject|3|||
124838564|NCT03962543|449037691|FG001|Treatment Phase|Withdrawal by Subject|0|||
124838565|NCT03962543|449037690|FG000|Treatment Phase|Adverse Event|3|||
124838566|NCT03962543|449037691|FG001|Treatment Phase|Adverse Event|12|||
124838567|NCT03962543|449037690|FG000|Treatment Phase|Lost to Follow-up|1|||
124838568|NCT03962543|449037691|FG001|Treatment Phase|Lost to Follow-up|2|||
124838569|NCT03962543|449037690|FG000|Treatment Phase|Radiographic PD|9|||
124838570|NCT03962543|449037691|FG001|Treatment Phase|Radiographic PD|3|||
124838571|NCT03962543|449037690|FG000|Treatment Phase|Participant Decision|3|||
124838572|NCT03962543|449037691|FG001|Treatment Phase|Participant Decision|8|||
124838573|NCT03962543|449037690|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
124838574|NCT03962543|449037691|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
124838575|NCT03962543|449037690|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
124838576|NCT03962543|449037691|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
124639684|NCT02423343|448298457|FG004|Overall Study|Withdrawal by Subject|0|||
124639685|NCT02423343|448298458|FG005|Overall Study|Withdrawal by Subject|0|||
124639686|NCT02423343|448298453|FG000|Overall Study|Progressive Disease|0|||
124639687|NCT02423343|448298454|FG001|Overall Study|Progressive Disease|0|||
124639688|NCT02423343|448298455|FG002|Overall Study|Progressive Disease|0|||
124639689|NCT02423343|448298456|FG003|Overall Study|Progressive Disease|0|||
124639690|NCT02423343|448298457|FG004|Overall Study|Progressive Disease|2|||
124639691|NCT02423343|448298458|FG005|Overall Study|Progressive Disease|0|||
124639692|NCT02423343|448298453|FG000|Overall Study|Adverse Event|0|||
124639693|NCT02423343|448298454|FG001|Overall Study|Adverse Event|0|||
124639694|NCT02423343|448298455|FG002|Overall Study|Adverse Event|0|||
124639695|NCT02423343|448298456|FG003|Overall Study|Adverse Event|0|||
124639696|NCT02423343|448298457|FG004|Overall Study|Adverse Event|2|||
124639697|NCT02423343|448298458|FG005|Overall Study|Adverse Event|0|||
124639698|NCT02423343|448298453|FG000|Overall Study|Death|0|||
124639699|NCT02423343|448298454|FG001|Overall Study|Death|0|||
124639700|NCT02423343|448298455|FG002|Overall Study|Death|0|||
124639701|NCT02423343|448298456|FG003|Overall Study|Death|0|||
124639702|NCT02423343|448298457|FG004|Overall Study|Death|1|||
124639703|NCT02423343|448298458|FG005|Overall Study|Death|0|||
124639704|NCT00090493|448298459|FG000|Overall Study|Physician Decision|2|||
124639705|NCT02071706|448298460|FG000|Overall Study|Adverse Event|1|||
124639706|NCT02071706|448298460|FG000|Overall Study|Withdrawal by Subject|2|||
124838577|NCT03962543|449037690|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
124838578|NCT03962543|449037691|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
124838579|NCT03962543|449037690|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
124838580|NCT03962543|449037691|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
124838581|NCT03962543|449037690|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
124838582|NCT03962543|449037691|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
124639707|NCT01908829|448298466|FG000|Overall Study|Adverse Event|13|||
124838583|NCT03962543|449037690|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
124838584|NCT03962543|449037691|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
124838585|NCT03962543|449037690|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
124838586|NCT03962543|449037691|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
124838587|NCT03962543|449037690|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
124838588|NCT03962543|449037691|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
124838589|NCT03962543|449037690|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
124838590|NCT03962543|449037691|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
124838591|NCT03962543|449037690|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
124838592|NCT03962543|449037691|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
124838593|NCT03252522|449038940|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
124838594|NCT03252522|449038941|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
124838595|NCT03252522|449038942|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
124838596|NCT03252522|449038940|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
124838597|NCT03252522|449038941|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
124838598|NCT03252522|449038942|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
124838599|NCT03252522|449038940|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
124838600|NCT03252522|449038941|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
124838601|NCT03252522|449038942|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
124838602|NCT03252522|449038940|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
124838603|NCT03252522|449038941|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
124838604|NCT03252522|449038942|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
124838605|NCT03252522|449038940|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
124838606|NCT03252522|449038941|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
124838607|NCT03252522|449038942|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
124838608|NCT03252522|449038940|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
124838609|NCT03252522|449038941|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
124838610|NCT03252522|449038942|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
124838611|NCT03252522|449038940|FG000|Phase 2: Open Label|Adverse Event|0|||
124838612|NCT03252522|449038941|FG001|Phase 2: Open Label|Adverse Event|0|||
124838613|NCT03252522|449038942|FG002|Phase 2: Open Label|Adverse Event|2|||
124838614|NCT03252522|449038940|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
124838615|NCT03252522|449038941|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
124639708|NCT01908829|448298467|FG001|Overall Study|Adverse Event|11|||
124639709|NCT01908829|448298468|FG002|Overall Study|Adverse Event|13|||
124639710|NCT01908829|448298466|FG000|Overall Study|Lost to Follow-up|4|||
124639711|NCT01908829|448298467|FG001|Overall Study|Lost to Follow-up|2|||
124639712|NCT01908829|448298468|FG002|Overall Study|Lost to Follow-up|1|||
124639713|NCT01908829|448298466|FG000|Overall Study|Randomized no double-blind drug received|1|||
124639714|NCT01908829|448298467|FG001|Overall Study|Randomized no double-blind drug received|0|||
124639715|NCT01908829|448298468|FG002|Overall Study|Randomized no double-blind drug received|1|||
124639716|NCT01908829|448298466|FG000|Overall Study|Discontinued (no EoT page)|2|||
124639717|NCT01908829|448298467|FG001|Overall Study|Discontinued (no EoT page)|0|||
124639718|NCT01908829|448298468|FG002|Overall Study|Discontinued (no EoT page)|0|||
124639719|NCT01908829|448298466|FG000|Overall Study|Miscellaneous|0|||
124639720|NCT01908829|448298467|FG001|Overall Study|Miscellaneous|2|||
124639721|NCT01908829|448298468|FG002|Overall Study|Miscellaneous|0|||
124639722|NCT01908829|448298466|FG000|Overall Study|Protocol Violation|2|||
124639723|NCT01908829|448298467|FG001|Overall Study|Protocol Violation|2|||
124639724|NCT01908829|448298468|FG002|Overall Study|Protocol Violation|0|||
124639725|NCT01908829|448298466|FG000|Overall Study|Lack of Efficacy|1|||
124639726|NCT01908829|448298467|FG001|Overall Study|Lack of Efficacy|3|||
124639727|NCT01908829|448298468|FG002|Overall Study|Lack of Efficacy|2|||
124639728|NCT01908829|448298466|FG000|Overall Study|Withdrawal by Subject|26|||
124639729|NCT01908829|448298467|FG001|Overall Study|Withdrawal by Subject|29|||
124639730|NCT01908829|448298468|FG002|Overall Study|Withdrawal by Subject|22|||
124639731|NCT02792192|448298469|FG000|Overall Study|Death|1|||
124639732|NCT02792192|448298470|FG001|Overall Study|Death|0|||
124639733|NCT02792192|448298471|FG002|Overall Study|Death|0|||
124639734|NCT02792192|448298472|FG003|Overall Study|Death|0|||
124639735|NCT02792192|448298469|FG000|Overall Study|Informed Consent Withdrawn|4|||
124639736|NCT02792192|448298470|FG001|Overall Study|Informed Consent Withdrawn|0|||
124639737|NCT02792192|448298471|FG002|Overall Study|Informed Consent Withdrawn|0|||
124639738|NCT02792192|448298472|FG003|Overall Study|Informed Consent Withdrawn|0|||
124639739|NCT02792192|448298469|FG000|Overall Study|Physician Decision|1|||
124639740|NCT02792192|448298470|FG001|Overall Study|Physician Decision|0|||
124639741|NCT02792192|448298471|FG002|Overall Study|Physician Decision|0|||
124639742|NCT02792192|448298472|FG003|Overall Study|Physician Decision|0|||
124639743|NCT02792192|448298469|FG000|Overall Study|Progressive Disease|0|||
124639744|NCT02792192|448298470|FG001|Overall Study|Progressive Disease|1|||
124838616|NCT03252522|449038942|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
124838617|NCT02181556|449038943|FG000|Overall Study|Withdrawal by Subject|1|||
124639745|NCT02792192|448298471|FG002|Overall Study|Progressive Disease|0|||
124639746|NCT02792192|448298472|FG003|Overall Study|Progressive Disease|0|||
124838618|NCT01572038|449038944|FG000|Overall Study|Death|648|||
124639747|NCT02792192|448298469|FG000|Overall Study|Study Terminated By Sponsor|6|||
124639748|NCT02792192|448298470|FG001|Overall Study|Study Terminated By Sponsor|10|||
124639749|NCT02792192|448298471|FG002|Overall Study|Study Terminated By Sponsor|0|||
124639750|NCT02792192|448298472|FG003|Overall Study|Study Terminated By Sponsor|0|||
124639751|NCT02320058|448298473|FG000|Overall Study|Death|25|||
124639752|NCT02320058|448298474|FG001|Overall Study|Death|10|||
124639753|NCT02320058|448298473|FG000|Overall Study|Lost to Follow-up|4|||
124639754|NCT02320058|448298474|FG001|Overall Study|Lost to Follow-up|0|||
124639755|NCT02320058|448298473|FG000|Overall Study|Other reasons|4|||
124639756|NCT02320058|448298474|FG001|Overall Study|Other reasons|1|||
124639757|NCT02320058|448298473|FG000|Overall Study|Withdrawal by Subject|8|||
124639758|NCT02320058|448298474|FG001|Overall Study|Withdrawal by Subject|2|||
124639759|NCT02320058|448298473|FG000|Overall Study|Not reported|1|||
124639760|NCT02320058|448298474|FG001|Overall Study|Not reported|0|||
124639761|NCT01430403|448298475|FG000|Overall Study|Lost to Follow-up|5|||
124639762|NCT01430403|448298476|FG001|Overall Study|Lost to Follow-up|5|||
124639763|NCT01430403|448298477|FG002|Overall Study|Lost to Follow-up|3|||
124639764|NCT01430403|448298475|FG000|Overall Study|Physician Decision|1|||
124639765|NCT01430403|448298476|FG001|Overall Study|Physician Decision|0|||
124639766|NCT01430403|448298477|FG002|Overall Study|Physician Decision|0|||
124639767|NCT01430403|448298475|FG000|Overall Study|Protocol Violation|2|||
124639768|NCT01430403|448298476|FG001|Overall Study|Protocol Violation|3|||
124639769|NCT01430403|448298477|FG002|Overall Study|Protocol Violation|2|||
124639770|NCT01430403|448298475|FG000|Overall Study|Withdrawal by Subject|9|||
124639771|NCT01430403|448298476|FG001|Overall Study|Withdrawal by Subject|1|||
124639772|NCT01430403|448298477|FG002|Overall Study|Withdrawal by Subject|3|||
124639773|NCT02887248|448298478|FG000|Overall Study|Withdrawal by Subject|1|||
124639774|NCT02887248|448298478|FG000|Overall Study|Adverse Event|1|||
124639775|NCT02887248|448298478|FG000|Overall Study|Progressive Disease|1|||
124639776|NCT01166438|448298479|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
124639777|NCT01166438|448298480|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
124639778|NCT01166438|448298479|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
124639779|NCT01166438|448298480|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
124639780|NCT01166438|448298479|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
124639781|NCT01166438|448298480|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
124639782|NCT01166438|448298479|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
124639783|NCT01166438|448298480|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
124639784|NCT01166438|448298479|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
124639785|NCT01166438|448298480|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
124639786|NCT01166438|448298479|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
124639787|NCT01166438|448298480|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
124639788|NCT01377922|448298485|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
124639789|NCT01377922|448298486|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
124639790|NCT03170362|448298487|FG000|Overall Study|Death|2|||
124639791|NCT03170362|448298488|FG001|Overall Study|Death|2|||
124639792|NCT03170362|448298487|FG000|Overall Study|Withdrawal by Subject|23|||
124639793|NCT03170362|448298488|FG001|Overall Study|Withdrawal by Subject|22|||
124639794|NCT03170362|448298487|FG000|Overall Study|Lost to Follow-up|187|||
124639795|NCT03170362|448298488|FG001|Overall Study|Lost to Follow-up|167|||
124639796|NCT02347813|448298490|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
124639797|NCT02347813|448298491|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
124639798|NCT02347813|448298490|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
124639799|NCT02347813|448298491|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
124639800|NCT02837731|448298494|FG000|Allocation|Admitted to General Floor|3|||
124639801|NCT02837731|448298495|FG001|Allocation|Admitted to General Floor|4|||
124639802|NCT02837731|448298494|FG000|Allocation|Immediate surgery/withdrew|2|||
124639803|NCT02837731|448298495|FG001|Allocation|Immediate surgery/withdrew|0|||
124639804|NCT02837731|448298494|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
124639805|NCT02837731|448298495|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
124639806|NCT02837731|448298494|FG000|Allocation|Withdrawal by Subject|2|||
124639807|NCT02837731|448298495|FG001|Allocation|Withdrawal by Subject|0|||
124639808|NCT02837731|448298494|FG000|Allocation|Device not available|1|||
124639809|NCT02837731|448298495|FG001|Allocation|Device not available|0|||
124639810|NCT02837731|448298494|FG000|Allocation|Protocol not implemented|7|||
124639811|NCT02837731|448298495|FG001|Allocation|Protocol not implemented|0|||
124639812|NCT02837731|448298494|FG000|Allocation|Moribund/Do not resuscitate|2|||
124639813|NCT02837731|448298495|FG001|Allocation|Moribund/Do not resuscitate|0|||
124639814|NCT02837731|448298494|FG000|Allocation|Did not meet sepsis criteria|1|||
124639815|NCT02837731|448298495|FG001|Allocation|Did not meet sepsis criteria|2|||
124639816|NCT02837731|448298494|FG000|Allocation|Known aortic abnormalities|0|||
124639817|NCT02837731|448298495|FG001|Allocation|Known aortic abnormalities|1|||
124639818|NCT01119859|448298496|FG000|Overall Study|Adverse Event|9|||
124639819|NCT01119859|448298497|FG001|Overall Study|Adverse Event|10|||
124639820|NCT01119859|448298496|FG000|Overall Study|Death|2|||
124639821|NCT01119859|448298497|FG001|Overall Study|Death|0|||
124639822|NCT01119859|448298496|FG000|Overall Study|Insufficient therapeutic response|7|||
124639823|NCT01119859|448298497|FG001|Overall Study|Insufficient therapeutic response|14|||
124639824|NCT01119859|448298496|FG000|Overall Study|Refused treatment|3|||
124639825|NCT01119859|448298497|FG001|Overall Study|Refused treatment|6|||
124639826|NCT01119859|448298496|FG000|Overall Study|Failure to return|3|||
124639827|NCT01119859|448298497|FG001|Overall Study|Failure to return|0|||
124639828|NCT00603473|448298498|FG000|Overall Study|Adverse Event|4|||
124639829|NCT00603473|448298498|FG000|Overall Study|Lack of Efficacy|4|||
124639830|NCT00603473|448298498|FG000|Overall Study|Protocol Violation|1|||
124639831|NCT02644668|448298502|FG000|Overall Study|Adverse Event|2|||
124639832|NCT02644668|448298503|FG001|Overall Study|Adverse Event|0|||
124639833|NCT02644668|448298504|FG002|Overall Study|Adverse Event|1|||
124639834|NCT02644668|448298502|FG000|Overall Study|Protocol Violation|0|||
124639835|NCT02644668|448298503|FG001|Overall Study|Protocol Violation|0|||
124639836|NCT02644668|448298504|FG002|Overall Study|Protocol Violation|1|||
124639837|NCT02644668|448298502|FG000|Overall Study|Withdrawal by Subject|0|||
124639838|NCT02644668|448298503|FG001|Overall Study|Withdrawal by Subject|0|||
124639839|NCT02644668|448298504|FG002|Overall Study|Withdrawal by Subject|1|||
124639840|NCT01134939|448298505|FG000|Overall Study|Adverse Event|9|||
124639841|NCT01134939|448298506|FG001|Overall Study|Adverse Event|3|||
124639842|NCT01134939|448298507|FG002|Overall Study|Adverse Event|4|||
124639843|NCT01134939|448298508|FG003|Overall Study|Adverse Event|5|||
124639844|NCT01134939|448298509|FG004|Overall Study|Adverse Event|5|||
124639845|NCT01134939|448298510|FG005|Overall Study|Adverse Event|5|||
124639846|NCT01134939|448298511|FG006|Overall Study|Adverse Event|1|||
124639847|NCT01134939|448298512|FG007|Overall Study|Adverse Event|0|||
124639848|NCT01134939|448298505|FG000|Overall Study|Lack of Efficacy|2|||
124639849|NCT01134939|448298506|FG001|Overall Study|Lack of Efficacy|5|||
124639850|NCT01134939|448298507|FG002|Overall Study|Lack of Efficacy|1|||
124639851|NCT01134939|448298508|FG003|Overall Study|Lack of Efficacy|0|||
124639852|NCT01134939|448298509|FG004|Overall Study|Lack of Efficacy|3|||
124639853|NCT01134939|448298510|FG005|Overall Study|Lack of Efficacy|0|||
124639854|NCT01134939|448298511|FG006|Overall Study|Lack of Efficacy|1|||
124639855|NCT01134939|448298512|FG007|Overall Study|Lack of Efficacy|0|||
124639856|NCT01134939|448298505|FG000|Overall Study|Lost to Follow-up|2|||
124639857|NCT01134939|448298506|FG001|Overall Study|Lost to Follow-up|3|||
124639858|NCT01134939|448298507|FG002|Overall Study|Lost to Follow-up|0|||
124639859|NCT01134939|448298508|FG003|Overall Study|Lost to Follow-up|1|||
124639860|NCT01134939|448298509|FG004|Overall Study|Lost to Follow-up|2|||
124639861|NCT01134939|448298510|FG005|Overall Study|Lost to Follow-up|1|||
124639862|NCT01134939|448298511|FG006|Overall Study|Lost to Follow-up|0|||
124639863|NCT01134939|448298512|FG007|Overall Study|Lost to Follow-up|0|||
124639864|NCT01134939|448298505|FG000|Overall Study|Death|0|||
124639865|NCT01134939|448298506|FG001|Overall Study|Death|1|||
124639866|NCT01134939|448298507|FG002|Overall Study|Death|0|||
124639867|NCT01134939|448298508|FG003|Overall Study|Death|0|||
124639868|NCT01134939|448298509|FG004|Overall Study|Death|0|||
124639869|NCT01134939|448298510|FG005|Overall Study|Death|0|||
124639870|NCT01134939|448298511|FG006|Overall Study|Death|0|||
124639871|NCT01134939|448298512|FG007|Overall Study|Death|0|||
124639872|NCT01134939|448298505|FG000|Overall Study|Termination page not available|4|||
124639873|NCT01134939|448298506|FG001|Overall Study|Termination page not available|6|||
124838619|NCT01572038|449038944|FG000|Overall Study|Withdrawal by Subject|204|||
124838620|NCT01572038|449038944|FG000|Overall Study|Lost to Follow-up|81|||
124838621|NCT01572038|449038944|FG000|Overall Study|Physician Decision|20|||
124838622|NCT01572038|449038944|FG000|Overall Study|Patient Decision|14|||
124838623|NCT01572038|449038944|FG000|Overall Study|Progressive Disease|8|||
124838624|NCT01572038|449038944|FG000|Overall Study|Site Closed Before Completing Form|6|||
124838625|NCT01572038|449038944|FG000|Overall Study|Enrolled into Another Trial|3|||
124838626|NCT01572038|449038944|FG000|Overall Study|Participated in Another Trial|3|||
124639874|NCT01134939|448298507|FG002|Overall Study|Termination page not available|5|||
124639875|NCT01134939|448298508|FG003|Overall Study|Termination page not available|8|||
124639876|NCT01134939|448298509|FG004|Overall Study|Termination page not available|0|||
124639877|NCT01134939|448298510|FG005|Overall Study|Termination page not available|3|||
124639878|NCT01134939|448298511|FG006|Overall Study|Termination page not available|7|||
124639879|NCT01134939|448298512|FG007|Overall Study|Termination page not available|0|||
124639880|NCT00733421|448298513|FG000|Overall Study|Withdrawal by Subject|1|||
124838627|NCT01572038|449038944|FG000|Overall Study|Termination by Sponsor|2|||
124639881|NCT00733421|448298514|FG001|Overall Study|Withdrawal by Subject|1|||
124639882|NCT02547220|448298522|FG000|Overall Study|Withdrawal by Subject|1|||
124639883|NCT02547220|448298523|FG001|Overall Study|Withdrawal by Subject|0|||
124639884|NCT02547220|448298522|FG000|Overall Study|Study terminated by sponsor|18|||
124639885|NCT02547220|448298523|FG001|Overall Study|Study terminated by sponsor|20|||
124639886|NCT00550043|448298524|FG000|Overall Study|Adverse Event|0|||
124639887|NCT00550043|448298525|FG001|Overall Study|Adverse Event|0|||
124639888|NCT00550043|448298526|FG002|Overall Study|Adverse Event|0|||
124639889|NCT00550043|448298527|FG003|Overall Study|Adverse Event|1|||
124838628|NCT01572038|449038944|FG000|Overall Study|Patient Deterioration|1|||
124639890|NCT00550043|448298528|FG004|Overall Study|Adverse Event|1|||
124639891|NCT00550043|448298524|FG000|Overall Study|Subject Withdrew Consent|0|||
124639892|NCT00550043|448298525|FG001|Overall Study|Subject Withdrew Consent|2|||
124639893|NCT00550043|448298526|FG002|Overall Study|Subject Withdrew Consent|1|||
124838629|NCT01572038|449038944|FG000|Overall Study|Sponsor Decision|1|||
124838630|NCT01275066|449038951|FG000|Overall Study|Withdrawal by Subject|0|||
124838631|NCT01275066|449038952|FG001|Overall Study|Withdrawal by Subject|0|||
124838632|NCT01275066|449038953|FG002|Overall Study|Withdrawal by Subject|1|||
124838633|NCT01275066|449038951|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
124838634|NCT01275066|449038952|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
124838635|NCT01275066|449038953|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
124838636|NCT00850200|449038961|FG000|Overall Study|Physician Decision|2|||
124838637|NCT00850200|449038961|FG000|Overall Study|Did not recieve treatment|2|||
124838638|NCT00850200|449038961|FG000|Overall Study|Withdrawal by Subject|1|||
124838639|NCT02046148|449038965|FG000|Overall Study|Lost to Follow-up|1|||
124838640|NCT02046148|449038966|FG001|Overall Study|Lost to Follow-up|1|||
124838641|NCT02046148|449038965|FG000|Overall Study|Withdrawal by Subject|0|||
124838642|NCT02046148|449038966|FG001|Overall Study|Withdrawal by Subject|2|||
124838643|NCT00235872|449038971|FG000|Overall Study|Adverse Event|34|||
124838644|NCT00235872|449038971|FG000|Overall Study|Death|1|||
124838645|NCT00235872|449038971|FG000|Overall Study|Lost to Follow-up|1|||
124838646|NCT00235872|449038971|FG000|Overall Study|Withdrawal by Subject|50|||
124838647|NCT00235872|449038971|FG000|Overall Study|Administrative reason|61|||
124838648|NCT01446965|449038972|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
124838649|NCT01446965|449038973|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
124838650|NCT01446965|449038972|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
124838651|NCT01446965|449038973|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
124838652|NCT01232296|449038974|FG000|Overall Study|Adverse Event|24|||
124838653|NCT01232296|449038975|FG001|Overall Study|Adverse Event|12|||
124838654|NCT01232296|449038974|FG000|Overall Study|Physician Decision|1|||
124838655|NCT01232296|449038975|FG001|Overall Study|Physician Decision|1|||
124838656|NCT01232296|449038974|FG000|Overall Study|Progressive disease|43|||
124838657|NCT01232296|449038975|FG001|Overall Study|Progressive disease|61|||
124838658|NCT01232296|449038974|FG000|Overall Study|Study terminated by sponsor|0|||
124838659|NCT01232296|449038975|FG001|Overall Study|Study terminated by sponsor|1|||
124838660|NCT01232296|449038974|FG000|Overall Study|Technical problems|3|||
124838661|NCT01232296|449038975|FG001|Overall Study|Technical problems|0|||
124838662|NCT01232296|449038974|FG000|Overall Study|Subject/guardian decision|10|||
124838663|NCT01232296|449038975|FG001|Overall Study|Subject/guardian decision|2|||
124838664|NCT01232296|449038974|FG000|Overall Study|Death|1|||
124838665|NCT01232296|449038975|FG001|Overall Study|Death|6|||
124838666|NCT02871375|449038976|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
124838667|NCT02871375|449038977|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
124838668|NCT00606892|449038986|FG000|First Intervention|Protocol Violation|1|||
124838669|NCT00606892|449038987|FG001|First Intervention|Protocol Violation|4|||
124838670|NCT00794196|449038994|FG000|Overall Study|Lost to Follow-up|5|||
124838671|NCT00794196|449038995|FG001|Overall Study|Lost to Follow-up|23|||
124838672|NCT02129803|449038996|FG000|Overall Study|Protocol Violation|4|||
124838673|NCT02129803|449038997|FG001|Overall Study|Protocol Violation|0|||
124838674|NCT02129803|449038996|FG000|Overall Study|Physician Decision|0|||
124838675|NCT02129803|449038997|FG001|Overall Study|Physician Decision|1|||
124838676|NCT02129803|449038996|FG000|Overall Study|Difficulty sleeping|1|||
124838677|NCT02129803|449038997|FG001|Overall Study|Difficulty sleeping|0|||
124838678|NCT02129803|449038996|FG000|Overall Study|Morning headache|0|||
124838679|NCT02129803|449038997|FG001|Overall Study|Morning headache|1|||
124838680|NCT02129803|449038996|FG000|Overall Study|Withdrawal by Subject|1|||
124838681|NCT02129803|449038997|FG001|Overall Study|Withdrawal by Subject|1|||
124838682|NCT00149747|449038999|FG000|Overall Study|Death|1|||
124838683|NCT00149747|449039000|FG001|Overall Study|Death|0|||
124838684|NCT00149747|449038999|FG000|Overall Study|Withdrawal by Subject|3|||
124838685|NCT00149747|449039000|FG001|Overall Study|Withdrawal by Subject|3|||
124838686|NCT00850395|449039006|FG000|Overall Study|Death|1|||
124838687|NCT00850395|449039006|FG000|Overall Study|Adverse Event|1|||
124838688|NCT00850395|449039006|FG000|Overall Study|Insufficient clinical response|3|||
124838689|NCT00850395|449039006|FG000|Overall Study|Other|5|||
124838690|NCT06049043|449039007|FG000|Overall Study|Lost to Follow-up|11|||
124838691|NCT06049043|449039008|FG001|Overall Study|Lost to Follow-up|9|||
124838692|NCT02739269|449039012|FG000|Overall Study|Protocol Violation|5|||
124838693|NCT02739269|449039013|FG001|Overall Study|Protocol Violation|0|||
124838694|NCT02739269|449039012|FG000|Overall Study|Cycle cancellation|2|||
124838695|NCT02739269|449039013|FG001|Overall Study|Cycle cancellation|2|||
124838696|NCT02739269|449039012|FG000|Overall Study|Withdrawal by Subject|0|||
124838697|NCT02739269|449039013|FG001|Overall Study|Withdrawal by Subject|2|||
124838698|NCT01354496|449039014|FG000|Period 1|Adverse Event|0|||
124838699|NCT01354496|449039015|FG001|Period 1|Adverse Event|0|||
124838700|NCT01354496|449039016|FG002|Period 1|Adverse Event|1|||
124838701|NCT01354496|449039017|FG003|Period 1|Adverse Event|0|||
124838702|NCT01354496|449039018|FG004|Period 1|Adverse Event|0|||
124838703|NCT01354496|449039019|FG005|Period 1|Adverse Event|0|||
124838704|NCT01354496|449039014|FG000|Period 1|Physician Decision|0|||
124838705|NCT01354496|449039015|FG001|Period 1|Physician Decision|0|||
124838706|NCT01354496|449039016|FG002|Period 1|Physician Decision|1|||
124838707|NCT01354496|449039017|FG003|Period 1|Physician Decision|0|||
124838708|NCT01354496|449039018|FG004|Period 1|Physician Decision|0|||
124838709|NCT01354496|449039019|FG005|Period 1|Physician Decision|0|||
124838710|NCT01354496|449039014|FG000|Period 2|Adverse Event|0|||
124838711|NCT01354496|449039015|FG001|Period 2|Adverse Event|0|||
124838712|NCT01354496|449039016|FG002|Period 2|Adverse Event|0|||
124838713|NCT01354496|449039017|FG003|Period 2|Adverse Event|1|||
124838714|NCT01354496|449039018|FG004|Period 2|Adverse Event|0|||
124838715|NCT01354496|449039019|FG005|Period 2|Adverse Event|0|||
124838716|NCT01354496|449039014|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
124838717|NCT01354496|449039015|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
124838718|NCT01354496|449039016|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
124838719|NCT01354496|449039017|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
124838720|NCT01354496|449039018|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
124838721|NCT01354496|449039019|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
124838722|NCT03554291|449039020|FG000|Overall Study|Death|2|||
124838723|NCT03554291|449039021|FG001|Overall Study|Death|1|||
124838724|NCT03554291|449039020|FG000|Overall Study|Lost to Follow-up|1|||
124838725|NCT03554291|449039021|FG001|Overall Study|Lost to Follow-up|0|||
124838726|NCT03554291|449039020|FG000|Overall Study|Withdrawal by Subject|1|||
124838727|NCT03554291|449039021|FG001|Overall Study|Withdrawal by Subject|0|||
124838728|NCT03554291|449039020|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
124838729|NCT03554291|449039021|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
124838730|NCT01228747|449039022|FG000|Overall Study|Adverse Event|8|||
124838731|NCT01228747|449039023|FG001|Overall Study|Adverse Event|4|||
124838732|NCT01228747|449039022|FG000|Overall Study|Lack of Efficacy|40|||
124838733|NCT01228747|449039023|FG001|Overall Study|Lack of Efficacy|27|||
124838734|NCT01228747|449039022|FG000|Overall Study|Protocol Violation|6|||
124838735|NCT01228747|449039023|FG001|Overall Study|Protocol Violation|5|||
124838736|NCT01228747|449039022|FG000|Overall Study|Lost to Follow-up|4|||
124838737|NCT01228747|449039023|FG001|Overall Study|Lost to Follow-up|3|||
124838738|NCT01228747|449039022|FG000|Overall Study|Withdrawal by Subject|5|||
124838739|NCT01228747|449039023|FG001|Overall Study|Withdrawal by Subject|1|||
124838740|NCT01228747|449039022|FG000|Overall Study|Other Reason|2|||
124838741|NCT01228747|449039023|FG001|Overall Study|Other Reason|5|||
124838742|NCT02036502|449039024|FG000|Part 1:Dose Determination/Escalation|Death|3|||
124838743|NCT02036502|449039025|FG001|Part 1:Dose Determination/Escalation|Death|2|||
124838744|NCT02036502|449039026|FG002|Part 1:Dose Determination/Escalation|Death|0|||
124838745|NCT02036502|449039027|FG003|Part 1:Dose Determination/Escalation|Death|0|||
124838746|NCT02036502|449039028|FG004|Part 1:Dose Determination/Escalation|Death|0|||
124838747|NCT02036502|449039029|FG005|Part 1:Dose Determination/Escalation|Death|0|||
124838748|NCT02036502|449039030|FG006|Part 1:Dose Determination/Escalation|Death|0|||
124838749|NCT02036502|449039031|FG007|Part 1:Dose Determination/Escalation|Death|0|||
124838750|NCT02036502|449039024|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
124838751|NCT02036502|449039025|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
124838752|NCT02036502|449039026|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
124838753|NCT02036502|449039027|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
124838754|NCT02036502|449039028|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
124838755|NCT02036502|449039029|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
124838756|NCT02036502|449039030|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
124838757|NCT02036502|449039031|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
124838758|NCT02036502|449039024|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
124838759|NCT02036502|449039025|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
124838760|NCT02036502|449039026|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
124639894|NCT00550043|448298527|FG003|Overall Study|Subject Withdrew Consent|0|||
124639895|NCT00550043|448298528|FG004|Overall Study|Subject Withdrew Consent|0|||
124639896|NCT00550043|448298524|FG000|Overall Study|Other Reasons- Unspecified|0|||
124639897|NCT00550043|448298525|FG001|Overall Study|Other Reasons- Unspecified|1|||
124639898|NCT00550043|448298526|FG002|Overall Study|Other Reasons- Unspecified|0|||
124639899|NCT00550043|448298527|FG003|Overall Study|Other Reasons- Unspecified|1|||
124639900|NCT00550043|448298528|FG004|Overall Study|Other Reasons- Unspecified|0|||
124639901|NCT02887183|448298530|FG000|Overall Study|Adverse Event|44|||
124639902|NCT02887183|448298530|FG000|Overall Study|Death|30|||
124639903|NCT02887183|448298530|FG000|Overall Study|Pregnancy|1|||
124639904|NCT02887183|448298530|FG000|Overall Study|Protocol Violation|6|||
124639905|NCT02887183|448298530|FG000|Overall Study|Technical Problems|2|||
124639906|NCT02887183|448298530|FG000|Overall Study|Lost to Follow-up|13|||
124639907|NCT02887183|448298530|FG000|Overall Study|Physician Decision|10|||
124639908|NCT02887183|448298530|FG000|Overall Study|Withdrawal by Subject|35|||
124838761|NCT02036502|449039027|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
124838762|NCT02036502|449039028|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
124838763|NCT02036502|449039029|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
124838764|NCT02036502|449039030|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
124838765|NCT02036502|449039031|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
124838766|NCT02036502|449039024|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
124838767|NCT02036502|449039025|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
124838768|NCT02036502|449039026|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
124838769|NCT02036502|449039027|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
124838770|NCT02036502|449039028|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
124838771|NCT02036502|449039029|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
124838772|NCT02036502|449039030|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
124838773|NCT02036502|449039031|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
124838774|NCT02036502|449039024|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
124838775|NCT02036502|449039025|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
124838776|NCT02036502|449039026|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
124838777|NCT02036502|449039027|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
124838778|NCT02036502|449039028|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
124838779|NCT02036502|449039029|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
124838780|NCT02036502|449039030|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
124838781|NCT02036502|449039031|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
124838782|NCT02036502|449039024|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
124838783|NCT02036502|449039025|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
124838784|NCT02036502|449039026|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
124639909|NCT00789698|448298532|FG000|Overall Study|Lack of Efficacy|10|||
124639910|NCT00789698|448298533|FG001|Overall Study|Lack of Efficacy|4|||
124639911|NCT00789698|448298534|FG002|Overall Study|Lack of Efficacy|5|||
124639912|NCT00789698|448298535|FG003|Overall Study|Lack of Efficacy|18|||
124639913|NCT00789698|448298532|FG000|Overall Study|Adverse Event|5|||
124639914|NCT00789698|448298533|FG001|Overall Study|Adverse Event|5|||
124639915|NCT00789698|448298534|FG002|Overall Study|Adverse Event|3|||
124639916|NCT00789698|448298535|FG003|Overall Study|Adverse Event|4|||
124639917|NCT00789698|448298532|FG000|Overall Study|Lost to Follow-up|5|||
124639918|NCT00789698|448298533|FG001|Overall Study|Lost to Follow-up|5|||
124639919|NCT00789698|448298534|FG002|Overall Study|Lost to Follow-up|2|||
124639920|NCT00789698|448298535|FG003|Overall Study|Lost to Follow-up|9|||
124639921|NCT00789698|448298532|FG000|Overall Study|Protocol Violation|6|||
124639922|NCT00789698|448298533|FG001|Overall Study|Protocol Violation|1|||
124639923|NCT00789698|448298534|FG002|Overall Study|Protocol Violation|2|||
124639924|NCT00789698|448298535|FG003|Overall Study|Protocol Violation|1|||
124639925|NCT00789698|448298532|FG000|Overall Study|Withdrawal by Subject|14|||
124639926|NCT00789698|448298533|FG001|Overall Study|Withdrawal by Subject|15|||
124639927|NCT00789698|448298534|FG002|Overall Study|Withdrawal by Subject|12|||
124639928|NCT00789698|448298535|FG003|Overall Study|Withdrawal by Subject|19|||
124639929|NCT00789698|448298532|FG000|Overall Study|Administrative|0|||
124639930|NCT00789698|448298533|FG001|Overall Study|Administrative|3|||
124639931|NCT00789698|448298534|FG002|Overall Study|Administrative|3|||
124639932|NCT00789698|448298535|FG003|Overall Study|Administrative|1|||
124639933|NCT00596817|448298536|FG000|Open-label Period|Adverse Event|0|||
124639934|NCT00596817|448298537|FG001|Open-label Period|Adverse Event|49|||
124639935|NCT00596817|448298536|FG000|Open-label Period|Lack of Efficacy|0|||
124639936|NCT00596817|448298537|FG001|Open-label Period|Lack of Efficacy|33|||
124639937|NCT00596817|448298536|FG000|Open-label Period|Other Reasons|0|||
124639938|NCT00596817|448298537|FG001|Open-label Period|Other Reasons|65|||
124639939|NCT00596817|448298536|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
124639940|NCT00596817|448298537|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
124639941|NCT00596817|448298536|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
124639942|NCT00596817|448298537|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
124639943|NCT00596817|448298536|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
124639944|NCT00596817|448298537|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
124639945|NCT00596817|448298536|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
124639946|NCT00596817|448298537|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
124639947|NCT00596817|448298536|FG000|Double-blind Period|Adverse Event|5|||
124639948|NCT00596817|448298537|FG001|Double-blind Period|Adverse Event|16|||
124639949|NCT00596817|448298536|FG000|Double-blind Period|Lack of Efficacy|52|||
124639950|NCT00596817|448298537|FG001|Double-blind Period|Lack of Efficacy|28|||
124639951|NCT00596817|448298536|FG000|Double-blind Period|Non-compliance With Study Product|3|||
124838785|NCT02036502|449039027|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
124838786|NCT02036502|449039028|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
124639952|NCT00596817|448298537|FG001|Double-blind Period|Non-compliance With Study Product|4|||
124639953|NCT00596817|448298536|FG000|Double-blind Period|Protocol Violation|11|||
124639954|NCT00596817|448298537|FG001|Double-blind Period|Protocol Violation|8|||
124639955|NCT00596817|448298536|FG000|Double-blind Period|Withdrawal of Consent|7|||
124639956|NCT00596817|448298537|FG001|Double-blind Period|Withdrawal of Consent|3|||
124639957|NCT00596817|448298536|FG000|Double-blind Period|Lost to Follow-up|0|||
124639958|NCT00596817|448298537|FG001|Double-blind Period|Lost to Follow-up|2|||
124639959|NCT00596817|448298536|FG000|Double-blind Period|Other Reasons|10|||
124639960|NCT00596817|448298537|FG001|Double-blind Period|Other Reasons|18|||
124838787|NCT02036502|449039029|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
124838788|NCT02036502|449039030|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
124838789|NCT02036502|449039031|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
124838790|NCT02036502|449039024|FG000|Part 2:Dose Confirmation|Death|0|||
124838791|NCT02036502|449039025|FG001|Part 2:Dose Confirmation|Death|0|||
124838792|NCT02036502|449039026|FG002|Part 2:Dose Confirmation|Death|1|||
124838793|NCT02036502|449039027|FG003|Part 2:Dose Confirmation|Death|0|||
124838794|NCT02036502|449039028|FG004|Part 2:Dose Confirmation|Death|0|||
124838795|NCT02036502|449039029|FG005|Part 2:Dose Confirmation|Death|0|||
124838796|NCT02036502|449039030|FG006|Part 2:Dose Confirmation|Death|0|||
124838797|NCT02036502|449039031|FG007|Part 2:Dose Confirmation|Death|0|||
124838798|NCT02036502|449039024|FG000|Part 2:Dose Confirmation|Not treated|0|||
124838799|NCT02036502|449039025|FG001|Part 2:Dose Confirmation|Not treated|0|||
124838800|NCT02036502|449039026|FG002|Part 2:Dose Confirmation|Not treated|0|||
124838801|NCT02036502|449039027|FG003|Part 2:Dose Confirmation|Not treated|1|||
124838802|NCT02036502|449039028|FG004|Part 2:Dose Confirmation|Not treated|0|||
124838803|NCT02036502|449039029|FG005|Part 2:Dose Confirmation|Not treated|0|||
124838804|NCT02036502|449039030|FG006|Part 2:Dose Confirmation|Not treated|0|||
124838805|NCT02036502|449039031|FG007|Part 2:Dose Confirmation|Not treated|0|||
124838806|NCT02036502|449039024|FG000|Part 3:Dose Expansion|Adverse Event|0|||
124838807|NCT02036502|449039025|FG001|Part 3:Dose Expansion|Adverse Event|0|||
124838808|NCT02036502|449039026|FG002|Part 3:Dose Expansion|Adverse Event|0|||
124838809|NCT02036502|449039027|FG003|Part 3:Dose Expansion|Adverse Event|0|||
124838810|NCT02036502|449039028|FG004|Part 3:Dose Expansion|Adverse Event|0|||
124838811|NCT02036502|449039029|FG005|Part 3:Dose Expansion|Adverse Event|4|||
124838812|NCT02036502|449039030|FG006|Part 3:Dose Expansion|Adverse Event|0|||
124838813|NCT02036502|449039031|FG007|Part 3:Dose Expansion|Adverse Event|2|||
124838814|NCT02036502|449039024|FG000|Part 3:Dose Expansion|Death|0|||
124838815|NCT02036502|449039025|FG001|Part 3:Dose Expansion|Death|0|||
124838816|NCT02036502|449039026|FG002|Part 3:Dose Expansion|Death|0|||
124838817|NCT02036502|449039027|FG003|Part 3:Dose Expansion|Death|0|||
124838818|NCT02036502|449039028|FG004|Part 3:Dose Expansion|Death|0|||
124838819|NCT02036502|449039029|FG005|Part 3:Dose Expansion|Death|24|||
124838820|NCT02036502|449039030|FG006|Part 3:Dose Expansion|Death|0|||
124838821|NCT02036502|449039031|FG007|Part 3:Dose Expansion|Death|3|||
124838822|NCT02036502|449039024|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
124838823|NCT02036502|449039025|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
124838824|NCT02036502|449039026|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
124838825|NCT02036502|449039027|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
124838826|NCT02036502|449039028|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
124838827|NCT02036502|449039029|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
124838828|NCT02036502|449039030|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
124838829|NCT02036502|449039031|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
124838830|NCT02036502|449039024|FG000|Part 3:Dose Expansion|Physician Decision|0|||
124838831|NCT02036502|449039025|FG001|Part 3:Dose Expansion|Physician Decision|0|||
124838832|NCT02036502|449039026|FG002|Part 3:Dose Expansion|Physician Decision|0|||
124838833|NCT02036502|449039027|FG003|Part 3:Dose Expansion|Physician Decision|0|||
124838834|NCT02036502|449039028|FG004|Part 3:Dose Expansion|Physician Decision|0|||
124639961|NCT03300505|448299825|FG000|Overall Study|Death|0|||
124639962|NCT03300505|448299826|FG001|Overall Study|Death|1|||
124639963|NCT03300505|448299827|FG002|Overall Study|Death|0|||
124639964|NCT03300505|448299825|FG000|Overall Study|Withdrawal by Subject|0|||
124639965|NCT03300505|448299826|FG001|Overall Study|Withdrawal by Subject|1|||
124639966|NCT03300505|448299827|FG002|Overall Study|Withdrawal by Subject|1|||
124639967|NCT03300505|448299825|FG000|Overall Study|Sponsor Termination|0|||
124639968|NCT03300505|448299826|FG001|Overall Study|Sponsor Termination|1|||
124639969|NCT03300505|448299827|FG002|Overall Study|Sponsor Termination|0|||
124639970|NCT03300505|448299825|FG000|Overall Study|Adverse Event|0|||
124639971|NCT03300505|448299826|FG001|Overall Study|Adverse Event|0|||
124639972|NCT03300505|448299827|FG002|Overall Study|Adverse Event|2|||
124639973|NCT05119595|448299828|FG000|Overall Study|Death|1|||
124639974|NCT05119595|448299828|FG000|Overall Study|Lost to Follow-up|7|||
124639975|NCT00679029|448299829|FG000|Overall Study|Adverse Event|3|||
124639976|NCT00679029|448299829|FG000|Overall Study|Withdrawal by Subject|1|||
124639977|NCT00679029|448299829|FG000|Overall Study|Lost to Follow-up|1|||
124639978|NCT03483961|448299830|FG000|Overall Study|Lost to Follow-up|7|||
124838835|NCT02036502|449039029|FG005|Part 3:Dose Expansion|Physician Decision|1|||
124838836|NCT02036502|449039030|FG006|Part 3:Dose Expansion|Physician Decision|0|||
124838837|NCT02036502|449039031|FG007|Part 3:Dose Expansion|Physician Decision|0|||
124838838|NCT02036502|449039024|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
124838839|NCT02036502|449039025|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
124838840|NCT02036502|449039026|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
124838841|NCT02036502|449039027|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
124838842|NCT02036502|449039028|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
124639979|NCT03483961|448299831|FG001|Overall Study|Lost to Follow-up|6|||
124639980|NCT03483961|448299832|FG002|Overall Study|Lost to Follow-up|6|||
124639981|NCT03483961|448299833|FG003|Overall Study|Lost to Follow-up|6|||
124838843|NCT02036502|449039029|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
124838844|NCT02036502|449039030|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
124838845|NCT02036502|449039031|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
124838846|NCT02036502|449039024|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
124838847|NCT02036502|449039025|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
124838848|NCT02036502|449039026|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
124838849|NCT02036502|449039027|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
124838850|NCT02036502|449039028|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
124838851|NCT02036502|449039029|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
124838852|NCT02036502|449039030|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
124838853|NCT02036502|449039031|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
124838854|NCT02036502|449039024|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
124838855|NCT02036502|449039025|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
124838856|NCT02036502|449039026|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
124838857|NCT02036502|449039027|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
124838858|NCT02036502|449039028|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
124838859|NCT02036502|449039029|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
124838860|NCT02036502|449039030|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
124838861|NCT02036502|449039031|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
124838862|NCT02036502|449039024|FG000|Part 3:Dose Expansion|Not Treated|0|||
124838863|NCT02036502|449039025|FG001|Part 3:Dose Expansion|Not Treated|0|||
124838864|NCT02036502|449039026|FG002|Part 3:Dose Expansion|Not Treated|0|||
124838865|NCT02036502|449039027|FG003|Part 3:Dose Expansion|Not Treated|0|||
124838866|NCT02036502|449039028|FG004|Part 3:Dose Expansion|Not Treated|0|||
124838867|NCT02036502|449039029|FG005|Part 3:Dose Expansion|Not Treated|2|||
124838868|NCT02036502|449039030|FG006|Part 3:Dose Expansion|Not Treated|0|||
124838869|NCT02036502|449039031|FG007|Part 3:Dose Expansion|Not Treated|0|||
124838870|NCT01068509|449039032|FG000|Overall Study|Death|0|||
124838871|NCT01068509|449039033|FG001|Overall Study|Death|0|||
124838872|NCT01068509|449039034|FG002|Overall Study|Death|1|||
124838873|NCT01068509|449039032|FG000|Overall Study|Disease Progression|5|||
124838874|NCT01068509|449039033|FG001|Overall Study|Disease Progression|20|||
124838875|NCT01068509|449039034|FG002|Overall Study|Disease Progression|18|||
124838876|NCT01068509|449039032|FG000|Overall Study|Lost to Follow-up|1|||
124838877|NCT01068509|449039033|FG001|Overall Study|Lost to Follow-up|0|||
124838878|NCT01068509|449039034|FG002|Overall Study|Lost to Follow-up|0|||
124838879|NCT01068509|449039032|FG000|Overall Study|Withdrew Consent|0|||
124838880|NCT01068509|449039033|FG001|Overall Study|Withdrew Consent|1|||
124838881|NCT01068509|449039034|FG002|Overall Study|Withdrew Consent|2|||
124838882|NCT01068509|449039032|FG000|Overall Study|Reason Not Specified|0|||
124838883|NCT01068509|449039033|FG001|Overall Study|Reason Not Specified|1|||
124838884|NCT01068509|449039034|FG002|Overall Study|Reason Not Specified|0|||
124838885|NCT02442778|449039035|FG000|Overall Study|Adverse Event|2|||
124838886|NCT02442778|449039036|FG001|Overall Study|Adverse Event|6|||
124838887|NCT02442778|449039037|FG002|Overall Study|Adverse Event|6|||
124838888|NCT02442778|449039035|FG000|Overall Study|Death|0|||
124838889|NCT02442778|449039036|FG001|Overall Study|Death|2|||
124838890|NCT02442778|449039037|FG002|Overall Study|Death|0|||
124838891|NCT02442778|449039035|FG000|Overall Study|Lack of Efficacy|1|||
124838892|NCT02442778|449039036|FG001|Overall Study|Lack of Efficacy|0|||
124838893|NCT02442778|449039037|FG002|Overall Study|Lack of Efficacy|0|||
124838894|NCT02442778|449039035|FG000|Overall Study|Lost to Follow-up|1|||
124838895|NCT02442778|449039036|FG001|Overall Study|Lost to Follow-up|1|||
124838896|NCT02442778|449039037|FG002|Overall Study|Lost to Follow-up|1|||
124838897|NCT02442778|449039035|FG000|Overall Study|Non-compliance with study drug|2|||
124838898|NCT02442778|449039036|FG001|Overall Study|Non-compliance with study drug|0|||
124838899|NCT02442778|449039037|FG002|Overall Study|Non-compliance with study drug|1|||
124838900|NCT02442778|449039035|FG000|Overall Study|Physician Decision|1|||
124838901|NCT02442778|449039036|FG001|Overall Study|Physician Decision|1|||
124838902|NCT02442778|449039037|FG002|Overall Study|Physician Decision|1|||
124838903|NCT02442778|449039035|FG000|Overall Study|Protocol Deviation|3|||
124838904|NCT02442778|449039036|FG001|Overall Study|Protocol Deviation|0|||
124838905|NCT02442778|449039037|FG002|Overall Study|Protocol Deviation|1|||
124838906|NCT02442778|449039035|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
124639982|NCT03483961|448299834|FG004|Overall Study|Lost to Follow-up|6|||
124639983|NCT03483961|448299835|FG005|Overall Study|Lost to Follow-up|4|||
124838907|NCT02442778|449039036|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
124838908|NCT02442778|449039037|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
124838909|NCT02442778|449039035|FG000|Overall Study|Withdrawal by Subject|4|||
124838910|NCT02442778|449039036|FG001|Overall Study|Withdrawal by Subject|4|||
124838911|NCT02442778|449039037|FG002|Overall Study|Withdrawal by Subject|3|||
124838912|NCT02442778|449039035|FG000|Overall Study|Reason not specified|1|||
124838913|NCT02442778|449039036|FG001|Overall Study|Reason not specified|4|||
124838914|NCT02442778|449039037|FG002|Overall Study|Reason not specified|0|||
124838915|NCT00615056|449039043|FG000|Overall Study|Death|31|||
124838916|NCT00615056|449039044|FG001|Overall Study|Death|31|||
124639984|NCT03483961|448299836|FG006|Overall Study|Lost to Follow-up|4|||
124838917|NCT00615056|449039045|FG002|Overall Study|Death|21|||
124838918|NCT00615056|449039046|FG003|Overall Study|Death|23|||
124838919|NCT00615056|449039043|FG000|Overall Study|Lost to Follow-up|1|||
124838920|NCT00615056|449039044|FG001|Overall Study|Lost to Follow-up|2|||
124838921|NCT00615056|449039045|FG002|Overall Study|Lost to Follow-up|4|||
124838922|NCT00615056|449039046|FG003|Overall Study|Lost to Follow-up|5|||
124838923|NCT00615056|449039043|FG000|Overall Study|Other|13|||
124838924|NCT00615056|449039044|FG001|Overall Study|Other|15|||
124838925|NCT00615056|449039045|FG002|Overall Study|Other|10|||
124838926|NCT00615056|449039046|FG003|Overall Study|Other|7|||
124838927|NCT00615056|449039043|FG000|Overall Study|Objective progression or relapse|0|||
124838928|NCT00615056|449039044|FG001|Overall Study|Objective progression or relapse|2|||
124838929|NCT00615056|449039045|FG002|Overall Study|Objective progression or relapse|0|||
124838930|NCT00615056|449039046|FG003|Overall Study|Objective progression or relapse|0|||
124838931|NCT00615056|449039043|FG000|Overall Study|Withdrawal by Subject|0|||
124838932|NCT00615056|449039044|FG001|Overall Study|Withdrawal by Subject|1|||
124838933|NCT00615056|449039045|FG002|Overall Study|Withdrawal by Subject|1|||
124838934|NCT00615056|449039046|FG003|Overall Study|Withdrawal by Subject|0|||
124838935|NCT00615056|449039043|FG000|Overall Study|Discontinued by Sponsor|1|||
124838936|NCT00615056|449039044|FG001|Overall Study|Discontinued by Sponsor|0|||
124838937|NCT00615056|449039045|FG002|Overall Study|Discontinued by Sponsor|0|||
124838938|NCT00615056|449039046|FG003|Overall Study|Discontinued by Sponsor|0|||
124838939|NCT00615056|449039043|FG000|Overall Study|Randomized but not treated|3|||
124838940|NCT00615056|449039044|FG001|Overall Study|Randomized but not treated|0|||
124838941|NCT00615056|449039045|FG002|Overall Study|Randomized but not treated|0|||
124838942|NCT00615056|449039046|FG003|Overall Study|Randomized but not treated|0|||
124838943|NCT02849548|449039052|FG000|Overall Study|Lost to Follow-up|1|||
124838944|NCT02849548|449039053|FG001|Overall Study|Lost to Follow-up|2|||
124838945|NCT02849548|449039052|FG000|Overall Study|Protocol Violation|1|||
124838946|NCT02849548|449039053|FG001|Overall Study|Protocol Violation|0|||
124838947|NCT02357147|449039055|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
124838948|NCT02357147|449039056|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
124838949|NCT02357147|449039055|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
124838950|NCT02357147|449039056|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
124838951|NCT02357147|449039055|FG000|Combination Treatment Phase|Investigator Discretion|1|||
124838952|NCT02357147|449039056|FG001|Combination Treatment Phase|Investigator Discretion|1|||
124838953|NCT02357147|449039055|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
124838954|NCT02357147|449039056|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
124838955|NCT02357147|449039055|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
124838956|NCT02357147|449039056|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
124838957|NCT02357147|449039055|FG000|Combination Treatment Phase|Adverse Event|12|||
124838958|NCT02357147|449039056|FG001|Combination Treatment Phase|Adverse Event|4|||
124838959|NCT02357147|449039055|FG000|Combination Treatment Phase|Death|1|||
124838960|NCT02357147|449039056|FG001|Combination Treatment Phase|Death|1|||
124838961|NCT02357147|449039055|FG000|Combination Treatment Phase|Sponsor Decision|0|||
124838962|NCT02357147|449039056|FG001|Combination Treatment Phase|Sponsor Decision|12|||
124838963|NCT02357147|449039055|FG000|Combination Treatment Phase|Other|1|||
124838964|NCT02357147|449039056|FG001|Combination Treatment Phase|Other|0|||
124838965|NCT02357147|449039055|FG000|Combination Treatment Phase|Not treated|0|||
124838966|NCT02357147|449039056|FG001|Combination Treatment Phase|Not treated|2|||
124838967|NCT02357147|449039055|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
124838968|NCT02357147|449039056|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
124838969|NCT02357147|449039055|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
124838970|NCT02357147|449039056|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
124838971|NCT02357147|449039055|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
124838972|NCT02357147|449039056|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
124838973|NCT02357147|449039055|FG000|Maintenance Treatment Phase|Adverse Event|0|||
124838974|NCT02357147|449039056|FG001|Maintenance Treatment Phase|Adverse Event|3|||
124838975|NCT02357147|449039055|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
124838976|NCT02357147|449039056|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
124838977|NCT02357147|449039055|FG000|Maintenance Treatment Phase|Not Treated|1|||
124838978|NCT02357147|449039056|FG001|Maintenance Treatment Phase|Not Treated|0|||
124838979|NCT00560950|449039058|FG000|Overall Study|Lost to Follow-up|1|||
124838980|NCT00560950|449039059|FG001|Overall Study|Lost to Follow-up|0|||
124838981|NCT03264404|449040760|FG000|Overall Study|Death|2|||
124838982|NCT03264404|449040760|FG000|Overall Study|Physician Decision|1|||
124838983|NCT03264404|449040760|FG000|Overall Study|Disease Progression|28|||
124838984|NCT03264404|449040760|FG000|Overall Study|Adverse Event|1|||
124838985|NCT03264404|449040760|FG000|Overall Study|Off study prior to treatment|2|||
124838986|NCT03036566|449040761|FG000|Overall Study|Lost to Follow-up|3|||
124838987|NCT01914666|449040765|FG000|Treatment Period|Lack of Efficacy|0|||
124838988|NCT01914666|449040766|FG001|Treatment Period|Lack of Efficacy|0|||
124838989|NCT01914666|449040767|FG002|Treatment Period|Lack of Efficacy|2|||
124838990|NCT01914666|449040765|FG000|Treatment Period|Adverse Event|10|||
124838991|NCT01914666|449040766|FG001|Treatment Period|Adverse Event|4|||
124838992|NCT01914666|449040767|FG002|Treatment Period|Adverse Event|2|||
124838993|NCT01914666|449040765|FG000|Treatment Period|Withdrawal by Subject|3|||
124838994|NCT01914666|449040766|FG001|Treatment Period|Withdrawal by Subject|2|||
124838995|NCT01914666|449040767|FG002|Treatment Period|Withdrawal by Subject|2|||
124838996|NCT01914666|449040765|FG000|Treatment Period|Physician Decision|0|||
124838997|NCT01914666|449040766|FG001|Treatment Period|Physician Decision|0|||
124838998|NCT01914666|449040767|FG002|Treatment Period|Physician Decision|2|||
124838999|NCT01940120|449040768|FG000|Overall Study|Death|40|||
124839000|NCT01940120|449040768|FG000|Overall Study|Withdrawal by Subject|8|||
124839001|NCT00427635|449040769|FG000|Treatment Phase|Withdrawal by Subject|1|||
124839002|NCT00427635|449040770|FG001|Treatment Phase|Withdrawal by Subject|0|||
124839003|NCT00427635|449040769|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
124839004|NCT00427635|449040770|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
124839005|NCT03277846|449040771|FG000|Overall Study|Inpatient stay too brief|12|||
124839006|NCT03277846|449040772|FG001|Overall Study|Inpatient stay too brief|11|||
124839007|NCT01888497|449040774|FG000|Washout Period 1|Withdrawal by Subject|0|||
124839008|NCT01888497|449040775|FG001|Washout Period 1|Withdrawal by Subject|0|||
124839009|NCT01888497|449040776|FG002|Washout Period 1|Withdrawal by Subject|1|||
124839010|NCT01888497|449040777|FG003|Washout Period 1|Withdrawal by Subject|1|||
124839011|NCT01888497|449040774|FG000|Washout Period 2|Adverse Event|0|||
124839012|NCT01888497|449040775|FG001|Washout Period 2|Adverse Event|0|||
124839013|NCT01888497|449040776|FG002|Washout Period 2|Adverse Event|0|||
124839014|NCT01888497|449040777|FG003|Washout Period 2|Adverse Event|1|||
124839015|NCT01888497|449040774|FG000|Washout Period 2|Withdrawal by Subject|0|||
124839016|NCT01888497|449040775|FG001|Washout Period 2|Withdrawal by Subject|0|||
124839017|NCT01888497|449040776|FG002|Washout Period 2|Withdrawal by Subject|0|||
124839018|NCT01888497|449040777|FG003|Washout Period 2|Withdrawal by Subject|1|||
124839019|NCT04152447|449040778|FG000|Overall Study|Lost to Follow-up|1|||
124839020|NCT04152447|449040779|FG001|Overall Study|Lost to Follow-up|0|||
124839021|NCT04152447|449040778|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
124839022|NCT04152447|449040779|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
124839023|NCT04152447|449040778|FG000|Overall Study|Withdrawal by Subject|0|||
124839024|NCT04152447|449040779|FG001|Overall Study|Withdrawal by Subject|1|||
124839025|NCT04152447|449040778|FG000|Overall Study|Found ineligible after enrolling|1|||
124839026|NCT04152447|449040779|FG001|Overall Study|Found ineligible after enrolling|1|||
124839027|NCT04152447|449040778|FG000|Overall Study|Did not receive VR headset in time.|0|||
124839028|NCT04152447|449040779|FG001|Overall Study|Did not receive VR headset in time.|2|||
124839029|NCT04013191|449040780|FG000|Overall Study|Adverse Event|1|||
124839030|NCT04013191|449040781|FG001|Overall Study|Adverse Event|0|||
124839031|NCT00913744|449040786|FG000|Overall Study|Adverse Event|2|||
124839032|NCT00913744|449040787|FG001|Overall Study|Adverse Event|0|||
124839033|NCT00913744|449040786|FG000|Overall Study|Withdrawal by Subject|2|||
124839034|NCT00913744|449040787|FG001|Overall Study|Withdrawal by Subject|1|||
124839035|NCT00913744|449040786|FG000|Overall Study|Death|1|||
124839036|NCT00913744|449040787|FG001|Overall Study|Death|0|||
124839037|NCT00805935|449040788|FG000|Overall Study|Stimulation Failure|1|||
124839038|NCT00805935|449040789|FG001|Overall Study|Stimulation Failure|5|||
124839039|NCT00805935|449040790|FG002|Overall Study|Stimulation Failure|2|||
124839040|NCT00805935|449040791|FG003|Overall Study|Stimulation Failure|2|||
124839041|NCT00805935|449040788|FG000|Overall Study|Cycle cancelled|0|||
124839042|NCT00805935|449040789|FG001|Overall Study|Cycle cancelled|0|||
124839043|NCT00805935|449040790|FG002|Overall Study|Cycle cancelled|2|||
124839044|NCT00805935|449040791|FG003|Overall Study|Cycle cancelled|0|||
124839045|NCT00805935|449040788|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
124839046|NCT00805935|449040789|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
124839047|NCT00805935|449040790|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
124839048|NCT00805935|449040791|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
124839049|NCT00805935|449040788|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
124839050|NCT00805935|449040789|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
124839051|NCT00805935|449040790|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
124839052|NCT00805935|449040791|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
124839053|NCT00805935|449040788|FG000|Overall Study|Lost to Follow-up|1|||
124839054|NCT00805935|449040789|FG001|Overall Study|Lost to Follow-up|0|||
124839055|NCT00805935|449040790|FG002|Overall Study|Lost to Follow-up|0|||
124839056|NCT00805935|449040791|FG003|Overall Study|Lost to Follow-up|0|||
124839057|NCT00805935|449040788|FG000|Overall Study|No positive serum pregnancy|8|||
124839058|NCT00805935|449040789|FG001|Overall Study|No positive serum pregnancy|7|||
124839059|NCT00805935|449040790|FG002|Overall Study|No positive serum pregnancy|6|||
124839060|NCT00805935|449040791|FG003|Overall Study|No positive serum pregnancy|5|||
124839061|NCT00805935|449040788|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
124839062|NCT00805935|449040789|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
124839063|NCT00805935|449040790|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
124839064|NCT00805935|449040791|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
124839065|NCT00805935|449040788|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
124839066|NCT00805935|449040789|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
124839067|NCT00805935|449040790|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
124839068|NCT00805935|449040791|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
124839069|NCT00805935|449040788|FG000|Overall Study|Biochemical pregnancy|0|||
124839070|NCT00805935|449040789|FG001|Overall Study|Biochemical pregnancy|1|||
124839071|NCT00805935|449040790|FG002|Overall Study|Biochemical pregnancy|0|||
124839072|NCT00805935|449040791|FG003|Overall Study|Biochemical pregnancy|0|||
124839073|NCT00805935|449040788|FG000|Overall Study|Chemical pregnancy|0|||
124839074|NCT00805935|449040789|FG001|Overall Study|Chemical pregnancy|5|||
124839075|NCT00805935|449040790|FG002|Overall Study|Chemical pregnancy|3|||
124839076|NCT00805935|449040791|FG003|Overall Study|Chemical pregnancy|2|||
124839077|NCT00805935|449040788|FG000|Overall Study|Ectopic pregnancy|0|||
124839078|NCT00805935|449040789|FG001|Overall Study|Ectopic pregnancy|0|||
124839079|NCT00805935|449040790|FG002|Overall Study|Ectopic pregnancy|1|||
124839080|NCT00805935|449040791|FG003|Overall Study|Ectopic pregnancy|0|||
124839081|NCT00805935|449040788|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
124839082|NCT00805935|449040789|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
124839083|NCT00805935|449040790|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
124839084|NCT00805935|449040791|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
124839085|NCT02945410|449040792|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
124839086|NCT02945410|449040793|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
124839087|NCT02945410|449040794|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
124839088|NCT02945410|449040795|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
124839089|NCT02945410|449040796|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
124839090|NCT02945410|449040797|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
124839091|NCT02945410|449040792|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
124839092|NCT02945410|449040793|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
124839093|NCT02945410|449040794|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
124839094|NCT02945410|449040795|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
124839095|NCT02945410|449040796|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
124839096|NCT02945410|449040797|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
124839097|NCT02945410|449040792|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
124839098|NCT02945410|449040793|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
124839099|NCT02945410|449040794|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
124839100|NCT02945410|449040795|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
124839101|NCT02945410|449040796|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
124839102|NCT02945410|449040797|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
124839103|NCT01344369|449040798|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
124839104|NCT01344369|449040799|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
124839105|NCT01344369|449040798|FG000|Washout of 28 Days|Physician Decision|0|||
124839106|NCT01344369|449040799|FG001|Washout of 28 Days|Physician Decision|1|||
124839107|NCT01344369|449040798|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
124839108|NCT01344369|449040799|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
124839109|NCT03848845|449040800|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
124839110|NCT03848845|449040801|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
124839111|NCT03848845|449040802|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
124839112|NCT03848845|449040803|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
124839113|NCT03848845|449040800|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
124839114|NCT03848845|449040801|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
124839115|NCT03848845|449040802|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
124839116|NCT03848845|449040803|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
124839117|NCT03848845|449040800|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
124839118|NCT03848845|449040801|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
124839119|NCT03848845|449040802|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
124839120|NCT03848845|449040803|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
124839121|NCT03848845|449040800|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
124839122|NCT03848845|449040801|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
124839123|NCT03848845|449040802|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
124839124|NCT03848845|449040803|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
124839125|NCT01454726|449040804|FG000|Overall Study|Withdrawal by Subject|0|||
124839126|NCT01454726|449040805|FG001|Overall Study|Withdrawal by Subject|1|||
124839127|NCT04200248|449040806|FG000|Overall Study|Personal reasons|0|||
124839128|NCT04200248|449040807|FG001|Overall Study|Personal reasons|0|||
124839129|NCT04200248|449040808|FG002|Overall Study|Personal reasons|1|||
124839130|NCT04200248|449040806|FG000|Overall Study|Discontinued prior to treatment|3|||
124839131|NCT04200248|449040807|FG001|Overall Study|Discontinued prior to treatment|3|||
124839132|NCT04200248|449040808|FG002|Overall Study|Discontinued prior to treatment|2|||
124839133|NCT00934544|449040811|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
124839134|NCT00934544|449040812|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
124839135|NCT00934544|449040813|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
124839136|NCT00934544|449040811|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
124839137|NCT00934544|449040812|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
124839138|NCT00934544|449040813|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
124839139|NCT00934544|449040811|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
124839140|NCT00934544|449040812|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
124839141|NCT00934544|449040813|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
124839142|NCT00934544|449040811|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
124839143|NCT00934544|449040812|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
124839144|NCT00934544|449040813|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
124839145|NCT00934544|449040811|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
124839146|NCT00934544|449040812|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
124839147|NCT00934544|449040813|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
124839148|NCT00934544|449040811|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
124839149|NCT00934544|449040812|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
124839150|NCT00934544|449040813|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
124839151|NCT00934544|449040811|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
124839152|NCT00934544|449040812|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
124839153|NCT00934544|449040813|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
124839154|NCT00934544|449040811|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
124839155|NCT00934544|449040812|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
124839156|NCT00934544|449040813|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
124839157|NCT00934544|449040811|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
124839158|NCT00934544|449040812|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
124839159|NCT00934544|449040813|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
124839160|NCT00934544|449040811|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
124839161|NCT00934544|449040812|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
124839162|NCT00934544|449040813|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
124839163|NCT00934544|449040811|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
124839164|NCT00934544|449040812|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
124839165|NCT00934544|449040813|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
124839166|NCT00934544|449040811|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
124839167|NCT00934544|449040812|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
124839168|NCT00934544|449040813|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
124839169|NCT00934544|449040811|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
124839170|NCT00934544|449040812|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
124839171|NCT00934544|449040813|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
124839172|NCT00934544|449040811|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
124839173|NCT00934544|449040812|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
124839174|NCT00934544|449040813|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
124839175|NCT00934544|449040811|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
124839176|NCT00934544|449040812|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
124839177|NCT00934544|449040813|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
124839178|NCT00934544|449040811|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
124839179|NCT00934544|449040812|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
124839180|NCT00934544|449040813|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
124839181|NCT00302003|449040814|FG000|Overall Study|Lack of Efficacy|62|||
124839182|NCT00302003|449040814|FG000|Overall Study|Lost to Follow-up|1|||
124839183|NCT00302003|449040814|FG000|Overall Study|Physician Decision|2|||
124839184|NCT00302003|449040814|FG000|Overall Study|Withdrawal by Subject|5|||
124839185|NCT00302003|449040814|FG000|Overall Study|Ineligible|9|||
124839186|NCT00302003|449040814|FG000|Overall Study|Protocol Violation|1|||
124839187|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
124839188|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
124839189|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
124839190|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
124839191|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
124839192|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
124839193|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
124839194|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
124839195|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
124839196|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
124839197|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
124839198|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
124839199|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
124839200|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
124839201|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
124839202|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
124839203|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
124839204|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
124839205|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
124839206|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
124839207|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
124839208|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
124839209|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
124839210|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
124839211|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
124839212|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
124839213|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
124839214|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
124839215|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
124839216|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
124839217|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
124839218|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
124839219|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
124839220|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
124839221|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
124839222|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
124839223|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
124839224|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
124839225|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
124839226|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
124839227|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
124839228|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
124839229|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
124839230|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
124839231|NCT01218516|449040815|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
124839232|NCT01218516|449040816|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
124839233|NCT01218516|449040817|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
124839234|NCT01218516|449040818|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
124839235|NCT02042924|449040819|FG000|Overall Study|Early Death|1|||
124839236|NCT00283439|449040820|FG000|Overall Study|Adverse Event|0|||
124839237|NCT00283439|449040821|FG001|Overall Study|Adverse Event|0|||
124839238|NCT00283439|449040822|FG002|Overall Study|Adverse Event|0|||
124839239|NCT00283439|449040823|FG003|Overall Study|Adverse Event|1|||
124839240|NCT00283439|449040820|FG000|Overall Study|Death|0|||
124839241|NCT00283439|449040821|FG001|Overall Study|Death|0|||
124839242|NCT00283439|449040822|FG002|Overall Study|Death|1|||
124839243|NCT00283439|449040823|FG003|Overall Study|Death|0|||
124839244|NCT00283439|449040820|FG000|Overall Study|Disease progression|0|||
124839245|NCT00283439|449040821|FG001|Overall Study|Disease progression|1|||
124839246|NCT00283439|449040822|FG002|Overall Study|Disease progression|0|||
124839247|NCT00283439|449040823|FG003|Overall Study|Disease progression|0|||
124839248|NCT00283439|449040820|FG000|Overall Study|Requirement for alternative therapy|1|||
124839249|NCT00283439|449040821|FG001|Overall Study|Requirement for alternative therapy|2|||
124839250|NCT00283439|449040822|FG002|Overall Study|Requirement for alternative therapy|5|||
124839251|NCT00283439|449040823|FG003|Overall Study|Requirement for alternative therapy|2|||
124839252|NCT00283439|449040820|FG000|Overall Study|Stem cell transplant|6|||
124839253|NCT00283439|449040821|FG001|Overall Study|Stem cell transplant|6|||
124839254|NCT00283439|449040822|FG002|Overall Study|Stem cell transplant|4|||
124839255|NCT00283439|449040823|FG003|Overall Study|Stem cell transplant|3|||
124839256|NCT00283439|449040820|FG000|Overall Study|Treatment discontinued|0|||
124839257|NCT00283439|449040821|FG001|Overall Study|Treatment discontinued|2|||
124839258|NCT00283439|449040822|FG002|Overall Study|Treatment discontinued|1|||
124839259|NCT00283439|449040823|FG003|Overall Study|Treatment discontinued|3|||
124839260|NCT00283439|449040820|FG000|Overall Study|Other|1|||
124639985|NCT03483961|448299837|FG007|Overall Study|Lost to Follow-up|11|||
124839261|NCT00283439|449040821|FG001|Overall Study|Other|0|||
124839262|NCT00283439|449040822|FG002|Overall Study|Other|0|||
124839263|NCT00283439|449040823|FG003|Overall Study|Other|0|||
124839264|NCT04033003|449040825|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
124839265|NCT04033003|449040826|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
124839266|NCT04033003|449040825|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
124639986|NCT03483961|448299838|FG008|Overall Study|Lost to Follow-up|1|||
124839267|NCT04033003|449040826|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
124839268|NCT04033003|449040825|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
124839269|NCT04033003|449040826|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
124839270|NCT04033003|449040825|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
124839271|NCT04033003|449040826|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
124839272|NCT04033003|449040825|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
124839273|NCT04033003|449040826|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
124839274|NCT04033003|449040825|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
124839275|NCT04033003|449040826|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
124839276|NCT04033003|449040825|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
124839277|NCT04033003|449040826|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
124839278|NCT04033003|449040825|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
124839279|NCT04033003|449040826|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
124839280|NCT04033003|449040825|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
124839281|NCT04033003|449040826|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
124839282|NCT04033003|449040825|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
124839283|NCT04033003|449040826|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
124839284|NCT04033003|449040825|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
124839285|NCT04033003|449040826|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
124839286|NCT04033003|449040825|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
124839287|NCT04033003|449040826|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
124839288|NCT04033003|449040825|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
124839289|NCT04033003|449040826|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
124839290|NCT00430092|449040827|FG000|Overall Study|Adverse Event|0|||
124839291|NCT00430092|449040828|FG001|Overall Study|Adverse Event|0|||
124839292|NCT00430092|449040829|FG002|Overall Study|Adverse Event|1|||
124839293|NCT00430092|449040827|FG000|Overall Study|Lack of Efficacy|5|||
124839294|NCT00430092|449040828|FG001|Overall Study|Lack of Efficacy|2|||
124839295|NCT00430092|449040829|FG002|Overall Study|Lack of Efficacy|54|||
124839296|NCT00430092|449040827|FG000|Overall Study|Lost to Follow-up|1|||
124839297|NCT00430092|449040828|FG001|Overall Study|Lost to Follow-up|0|||
124839298|NCT00430092|449040829|FG002|Overall Study|Lost to Follow-up|0|||
124839299|NCT00430092|449040827|FG000|Overall Study|Protocol Violation|0|||
124839300|NCT00430092|449040828|FG001|Overall Study|Protocol Violation|1|||
124839301|NCT00430092|449040829|FG002|Overall Study|Protocol Violation|1|||
124839302|NCT00430092|449040827|FG000|Overall Study|Withdrawal by Subject|0|||
124839303|NCT00430092|449040828|FG001|Overall Study|Withdrawal by Subject|1|||
124839304|NCT00430092|449040829|FG002|Overall Study|Withdrawal by Subject|1|||
124839305|NCT00706966|449040830|FG000|Overall Study|Adverse Event|1|||
124839306|NCT03100825|449040837|FG000|Overall Study|Participant/Guardian Decision|7|||
124839307|NCT03100825|449040837|FG000|Overall Study|Physician Decision|1|||
124839308|NCT01675882|449040846|FG000|Overall Study|Adverse Event|0|||
124839309|NCT01675882|449040847|FG001|Overall Study|Adverse Event|2|||
124839310|NCT01675882|449040848|FG002|Overall Study|Adverse Event|1|||
124839311|NCT01675882|449040849|FG003|Overall Study|Adverse Event|0|||
124839312|NCT01675882|449040846|FG000|Overall Study|Participant unwilling to continue|2|||
124839313|NCT01675882|449040847|FG001|Overall Study|Participant unwilling to continue|4|||
124839314|NCT01675882|449040848|FG002|Overall Study|Participant unwilling to continue|2|||
124839315|NCT01675882|449040849|FG003|Overall Study|Participant unwilling to continue|1|||
124839316|NCT01675882|449040846|FG000|Overall Study|Lost to Follow-up|0|||
124839317|NCT01675882|449040847|FG001|Overall Study|Lost to Follow-up|1|||
124839318|NCT01675882|449040848|FG002|Overall Study|Lost to Follow-up|0|||
124839319|NCT01675882|449040849|FG003|Overall Study|Lost to Follow-up|0|||
124839320|NCT01675882|449040846|FG000|Overall Study|Non-compliance|0|||
124839321|NCT01675882|449040847|FG001|Overall Study|Non-compliance|0|||
124839322|NCT01675882|449040848|FG002|Overall Study|Non-compliance|0|||
124839323|NCT01675882|449040849|FG003|Overall Study|Non-compliance|1|||
124839324|NCT00735371|449040853|FG000|Overall Study|Adverse Event|3|||
124839325|NCT00735371|449040854|FG001|Overall Study|Adverse Event|3|||
124839326|NCT00735371|449040855|FG002|Overall Study|Adverse Event|4|||
124839327|NCT00735371|449040856|FG003|Overall Study|Adverse Event|1|||
124639987|NCT03483961|448299839|FG009|Overall Study|Lost to Follow-up|0|||
124839328|NCT00735371|449040853|FG000|Overall Study|Protocol Violation|2|||
124839329|NCT00735371|449040854|FG001|Overall Study|Protocol Violation|2|||
124839330|NCT00735371|449040855|FG002|Overall Study|Protocol Violation|0|||
124839331|NCT00735371|449040856|FG003|Overall Study|Protocol Violation|3|||
124839332|NCT00735371|449040853|FG000|Overall Study|Withdrawal by Subject|0|||
124839333|NCT00735371|449040854|FG001|Overall Study|Withdrawal by Subject|2|||
124839334|NCT00735371|449040855|FG002|Overall Study|Withdrawal by Subject|2|||
124839335|NCT00735371|449040856|FG003|Overall Study|Withdrawal by Subject|0|||
124839336|NCT00735371|449040853|FG000|Overall Study|Lost to Follow-up|1|||
124839337|NCT00735371|449040854|FG001|Overall Study|Lost to Follow-up|1|||
124839338|NCT00735371|449040855|FG002|Overall Study|Lost to Follow-up|3|||
124639988|NCT03483961|448299830|FG000|Overall Study|Withdrawal by Subject|3|||
124639989|NCT03483961|448299831|FG001|Overall Study|Withdrawal by Subject|4|||
124839339|NCT00735371|449040856|FG003|Overall Study|Lost to Follow-up|1|||
124839340|NCT00735371|449040853|FG000|Overall Study|Lack of Efficacy|4|||
124839341|NCT00735371|449040854|FG001|Overall Study|Lack of Efficacy|2|||
124839342|NCT00735371|449040855|FG002|Overall Study|Lack of Efficacy|0|||
124839343|NCT00735371|449040856|FG003|Overall Study|Lack of Efficacy|4|||
124839344|NCT00735371|449040853|FG000|Overall Study|Sponsor Decision|3|||
124839345|NCT00735371|449040854|FG001|Overall Study|Sponsor Decision|1|||
124839346|NCT00735371|449040855|FG002|Overall Study|Sponsor Decision|0|||
124839347|NCT00735371|449040856|FG003|Overall Study|Sponsor Decision|1|||
124839348|NCT00735371|449040853|FG000|Overall Study|Protocol Violation|0|||
124839349|NCT00735371|449040854|FG001|Overall Study|Protocol Violation|1|||
124839350|NCT00735371|449040855|FG002|Overall Study|Protocol Violation|2|||
124839351|NCT00735371|449040856|FG003|Overall Study|Protocol Violation|0|||
124839352|NCT00735371|449040853|FG000|Overall Study|Prior Vyvanse Exposure|1|||
124839353|NCT00735371|449040854|FG001|Overall Study|Prior Vyvanse Exposure|1|||
124839354|NCT00735371|449040855|FG002|Overall Study|Prior Vyvanse Exposure|0|||
124839355|NCT00735371|449040856|FG003|Overall Study|Prior Vyvanse Exposure|0|||
124839356|NCT00735371|449040853|FG000|Overall Study|Exclusion criteria|1|||
124839357|NCT00735371|449040854|FG001|Overall Study|Exclusion criteria|0|||
124839358|NCT00735371|449040855|FG002|Overall Study|Exclusion criteria|0|||
124839359|NCT00735371|449040856|FG003|Overall Study|Exclusion criteria|0|||
124839360|NCT00994448|449040857|FG000|Overall Study|Adverse Event|1|||
124839361|NCT00994448|449040858|FG001|Overall Study|Adverse Event|0|||
124839362|NCT00994448|449040857|FG000|Overall Study|Lost to Follow-up|5|||
124839363|NCT00994448|449040858|FG001|Overall Study|Lost to Follow-up|1|||
124839364|NCT00994448|449040857|FG000|Overall Study|Withdrawal by Subject|1|||
124839365|NCT00994448|449040858|FG001|Overall Study|Withdrawal by Subject|1|||
124839366|NCT00994448|449040857|FG000|Overall Study|Physician Decision|1|||
124839367|NCT00994448|449040858|FG001|Overall Study|Physician Decision|0|||
124839368|NCT01604343|449040859|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
124839369|NCT01604343|449040860|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
124839370|NCT01604343|449040861|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
124839371|NCT01604343|449040862|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
124839372|NCT01604343|449040863|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
124839373|NCT01604343|449040859|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
124839374|NCT01604343|449040860|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
124839375|NCT01604343|449040861|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
124839376|NCT01604343|449040862|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
124839377|NCT01604343|449040863|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
124839378|NCT01604343|449040859|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
124839379|NCT01604343|449040860|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
124839380|NCT01604343|449040861|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
124839381|NCT01604343|449040862|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
124839382|NCT01604343|449040863|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
124839383|NCT01604343|449040859|FG000|Prior to W52 Administration(Through W52)|Death|5|||
124839384|NCT01604343|449040860|FG001|Prior to W52 Administration(Through W52)|Death|0|||
124839385|NCT01604343|449040861|FG002|Prior to W52 Administration(Through W52)|Death|2|||
124839386|NCT01604343|449040862|FG003|Prior to W52 Administration(Through W52)|Death|0|||
124839387|NCT01604343|449040863|FG004|Prior to W52 Administration(Through W52)|Death|4|||
124839388|NCT01604343|449040859|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
124839389|NCT01604343|449040860|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
124839390|NCT01604343|449040861|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
124839391|NCT01604343|449040862|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
124839392|NCT01604343|449040863|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
124839393|NCT01604343|449040859|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
124839394|NCT01604343|449040860|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
124839395|NCT01604343|449040861|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
124839396|NCT01604343|449040862|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
124839397|NCT01604343|449040863|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
124839398|NCT01604343|449040859|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
124839399|NCT01604343|449040860|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
124839400|NCT01604343|449040861|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
124839401|NCT01604343|449040862|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
124839402|NCT01604343|449040863|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
124839403|NCT01604343|449040859|FG000|Prior to W52 Administration(Through W52)|Other|15|||
124839404|NCT01604343|449040860|FG001|Prior to W52 Administration(Through W52)|Other|0|||
124839405|NCT01604343|449040861|FG002|Prior to W52 Administration(Through W52)|Other|10|||
124839406|NCT01604343|449040862|FG003|Prior to W52 Administration(Through W52)|Other|0|||
124839407|NCT01604343|449040863|FG004|Prior to W52 Administration(Through W52)|Other|6|||
124839408|NCT01604343|449040859|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
124839409|NCT01604343|449040860|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
124839410|NCT01604343|449040861|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
124839411|NCT01604343|449040862|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
124839412|NCT01604343|449040863|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
124839413|NCT01604343|449040859|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
124839414|NCT01604343|449040860|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
124839415|NCT01604343|449040861|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
124839416|NCT01604343|449040862|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
124839417|NCT01604343|449040863|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
124839418|NCT01604343|449040859|FG000|Week 52 to Week 104|Adverse Event|0|||
124839419|NCT01604343|449040860|FG001|Week 52 to Week 104|Adverse Event|12|||
124839420|NCT01604343|449040861|FG002|Week 52 to Week 104|Adverse Event|26|||
124639990|NCT03483961|448299832|FG002|Overall Study|Withdrawal by Subject|5|||
124639991|NCT03483961|448299833|FG003|Overall Study|Withdrawal by Subject|3|||
124839421|NCT01604343|449040862|FG003|Week 52 to Week 104|Adverse Event|21|||
124839422|NCT01604343|449040863|FG004|Week 52 to Week 104|Adverse Event|27|||
124839423|NCT01604343|449040859|FG000|Week 52 to Week 104|Death|0|||
124839424|NCT01604343|449040860|FG001|Week 52 to Week 104|Death|4|||
124839425|NCT01604343|449040861|FG002|Week 52 to Week 104|Death|2|||
124839426|NCT01604343|449040862|FG003|Week 52 to Week 104|Death|5|||
124839427|NCT01604343|449040863|FG004|Week 52 to Week 104|Death|0|||
124839428|NCT01604343|449040859|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
124839429|NCT01604343|449040860|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
124839430|NCT01604343|449040861|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
124839431|NCT01604343|449040862|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
124839432|NCT01604343|449040863|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
124839433|NCT01604343|449040859|FG000|Week 52 to Week 104|Physician Decision|0|||
124839434|NCT01604343|449040860|FG001|Week 52 to Week 104|Physician Decision|1|||
124839435|NCT01604343|449040861|FG002|Week 52 to Week 104|Physician Decision|0|||
124839436|NCT01604343|449040862|FG003|Week 52 to Week 104|Physician Decision|0|||
124839437|NCT01604343|449040863|FG004|Week 52 to Week 104|Physician Decision|2|||
124839438|NCT01604343|449040859|FG000|Week 52 to Week 104|Pregnancy|0|||
124839439|NCT01604343|449040860|FG001|Week 52 to Week 104|Pregnancy|0|||
124839440|NCT01604343|449040861|FG002|Week 52 to Week 104|Pregnancy|1|||
124839441|NCT01604343|449040862|FG003|Week 52 to Week 104|Pregnancy|2|||
124839442|NCT01604343|449040863|FG004|Week 52 to Week 104|Pregnancy|1|||
124839443|NCT01604343|449040859|FG000|Week 52 to Week 104|Other|0|||
124839444|NCT01604343|449040860|FG001|Week 52 to Week 104|Other|11|||
124839445|NCT01604343|449040861|FG002|Week 52 to Week 104|Other|11|||
124839446|NCT01604343|449040862|FG003|Week 52 to Week 104|Other|6|||
124839447|NCT01604343|449040863|FG004|Week 52 to Week 104|Other|3|||
124839448|NCT01604343|449040859|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
124839449|NCT01604343|449040860|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
124839450|NCT01604343|449040861|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
124839451|NCT01604343|449040862|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
124839452|NCT01604343|449040863|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
124839453|NCT01604343|449040859|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
124839454|NCT01604343|449040860|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
124839455|NCT01604343|449040861|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
124839456|NCT01604343|449040862|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
124839457|NCT01604343|449040863|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
124839458|NCT01604343|449040859|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
124839459|NCT01604343|449040860|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
124839460|NCT01604343|449040861|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
124839461|NCT01604343|449040862|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
124839462|NCT01604343|449040863|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
124839463|NCT00436748|449040868|FG000|Overall Study|Ineligibility Determined|1|||
124839464|NCT00436748|449040869|FG001|Overall Study|Ineligibility Determined|1|||
124839465|NCT00436748|449040868|FG000|Overall Study|Adverse Event|0|||
124839466|NCT00436748|449040869|FG001|Overall Study|Adverse Event|2|||
124839467|NCT00436748|449040868|FG000|Overall Study|Consent Withdrawn|1|||
124839468|NCT00436748|449040869|FG001|Overall Study|Consent Withdrawn|4|||
124839469|NCT00436748|449040868|FG000|Overall Study|Administrative Decision|1|||
124839470|NCT00436748|449040869|FG001|Overall Study|Administrative Decision|0|||
124839471|NCT00436748|449040868|FG000|Overall Study|Lost to Follow-up|0|||
124839472|NCT00436748|449040869|FG001|Overall Study|Lost to Follow-up|1|||
124639992|NCT03483961|448299834|FG004|Overall Study|Withdrawal by Subject|4|||
124839473|NCT00436748|449040868|FG000|Overall Study|Protocol-specified Criteria|5|||
124839474|NCT00436748|449040869|FG001|Overall Study|Protocol-specified Criteria|4|||
124839475|NCT00436748|449040868|FG000|Overall Study|Other|3|||
124839476|NCT00436748|449040869|FG001|Overall Study|Other|0|||
124839477|NCT01610791|449040870|FG000|Overall Study|Lost to Follow-up|7|||
124839478|NCT01610791|449040870|FG000|Overall Study|Adverse Event|6|||
124839479|NCT01610791|449040870|FG000|Overall Study|Physician Decision|1|||
124839480|NCT01610791|449040870|FG000|Overall Study|Adverse event and Investigator decision|1|||
124839481|NCT01610791|449040870|FG000|Overall Study|Death|1|||
124839482|NCT01610791|449040870|FG000|Overall Study|Not determined|5|||
124839483|NCT05040152|449040873|FG000|Overall Study|Withdrawal by Subject|5|||
124839484|NCT05040152|449040874|FG001|Overall Study|Withdrawal by Subject|0|||
124839485|NCT05040152|449040873|FG000|Overall Study|Lost to Follow-up|0|||
124839486|NCT05040152|449040874|FG001|Overall Study|Lost to Follow-up|2|||
124839487|NCT00314574|449040885|FG000|Overall Study|Death|3|||
124839488|NCT00314574|449040886|FG001|Overall Study|Death|0|||
124839489|NCT00314574|449040885|FG000|Overall Study|Adverse Event|11|||
124839490|NCT00314574|449040886|FG001|Overall Study|Adverse Event|16|||
124839491|NCT00314574|449040885|FG000|Overall Study|Lost to Follow-up|19|||
124839492|NCT00314574|449040886|FG001|Overall Study|Lost to Follow-up|25|||
124839493|NCT00314574|449040885|FG000|Overall Study|Withdrawal by Subject|33|||
124839494|NCT00314574|449040886|FG001|Overall Study|Withdrawal by Subject|22|||
124839495|NCT00314574|449040885|FG000|Overall Study|Physician Decision|22|||
124839496|NCT00314574|449040886|FG001|Overall Study|Physician Decision|15|||
124839497|NCT00314574|449040885|FG000|Overall Study|Pregnancy|6|||
124839498|NCT00314574|449040886|FG001|Overall Study|Pregnancy|4|||
124839499|NCT00314574|449040885|FG000|Overall Study|Data unknown at database lock|0|||
124839500|NCT00314574|449040886|FG001|Overall Study|Data unknown at database lock|1|||
124839501|NCT00449956|449040887|FG000|Overall Study|Adverse Event|7|||
124839502|NCT00449956|449040888|FG001|Overall Study|Adverse Event|1|||
124839503|NCT00449956|449040889|FG002|Overall Study|Adverse Event|6|||
124839504|NCT00449956|449040887|FG000|Overall Study|Lack of Efficacy|0|||
124839505|NCT00449956|449040888|FG001|Overall Study|Lack of Efficacy|0|||
124839506|NCT00449956|449040889|FG002|Overall Study|Lack of Efficacy|1|||
124839507|NCT00449956|449040887|FG000|Overall Study|Protocol Violation|1|||
124839508|NCT00449956|449040888|FG001|Overall Study|Protocol Violation|1|||
124839509|NCT00449956|449040889|FG002|Overall Study|Protocol Violation|1|||
124839510|NCT00449956|449040887|FG000|Overall Study|Withdrawal by Subject|0|||
124839511|NCT00449956|449040888|FG001|Overall Study|Withdrawal by Subject|1|||
124839512|NCT00449956|449040889|FG002|Overall Study|Withdrawal by Subject|0|||
124839513|NCT00449956|449040887|FG000|Overall Study|Physician Decision|2|||
124839514|NCT00449956|449040888|FG001|Overall Study|Physician Decision|1|||
124839515|NCT00449956|449040889|FG002|Overall Study|Physician Decision|1|||
124839516|NCT02086110|449040890|FG000|Overall Study|Withdrawal by Subject|1|||
124839517|NCT02086110|449040891|FG001|Overall Study|Withdrawal by Subject|1|||
124839518|NCT01828034|449040897|FG000|Overall Study|Withdrawal by Subject|0|||
124839519|NCT01828034|449040898|FG001|Overall Study|Withdrawal by Subject|0|||
124839520|NCT01828034|449040899|FG002|Overall Study|Withdrawal by Subject|0|||
124839521|NCT01828034|449040900|FG003|Overall Study|Withdrawal by Subject|1|||
124839522|NCT01988571|449040901|FG000|Overall Study|Death|3|||
124839523|NCT01988571|449040902|FG001|Overall Study|Death|1|||
124839524|NCT01988571|449040901|FG000|Overall Study|Physician Decision|2|||
124839525|NCT01988571|449040902|FG001|Overall Study|Physician Decision|1|||
124839526|NCT01988571|449040901|FG000|Overall Study|Lost to Follow-up|3|||
124839527|NCT01988571|449040902|FG001|Overall Study|Lost to Follow-up|0|||
124839528|NCT01988571|449040901|FG000|Overall Study|Withdrawal by Subject|31|||
124839529|NCT01988571|449040902|FG001|Overall Study|Withdrawal by Subject|33|||
124839530|NCT00004412|449040903|FG000|Randomized Period|Moved to Crossover Period|3|||
124839531|NCT00004412|449040904|FG001|Randomized Period|Moved to Crossover Period|0|||
124839532|NCT00004412|449040905|FG002|Randomized Period|Moved to Crossover Period|0|||
124839533|NCT02308735|449040906|FG000|Overall Study|Physician Decision|2|||
124839534|NCT02308735|449040907|FG001|Overall Study|Physician Decision|0|||
124839535|NCT02308735|449040908|FG002|Overall Study|Physician Decision|0|||
124839536|NCT02308735|449040909|FG003|Overall Study|Physician Decision|2|||
124839537|NCT00453999|449040910|FG000|Overall Study|Adverse Event|1|||
124839538|NCT00453999|449040911|FG001|Overall Study|Adverse Event|2|||
124839539|NCT00453999|449040912|FG002|Overall Study|Adverse Event|1|||
124839540|NCT00453999|449040910|FG000|Overall Study|Lost to Follow-up|0|||
124839541|NCT00453999|449040911|FG001|Overall Study|Lost to Follow-up|1|||
124839542|NCT00453999|449040912|FG002|Overall Study|Lost to Follow-up|1|||
124839543|NCT00453999|449040910|FG000|Overall Study|Withdrawal by Subject|2|||
124839544|NCT00453999|449040911|FG001|Overall Study|Withdrawal by Subject|1|||
124839545|NCT00453999|449040912|FG002|Overall Study|Withdrawal by Subject|1|||
124839546|NCT00453999|449040910|FG000|Overall Study|Subject Request|2|||
124839547|NCT00453999|449040911|FG001|Overall Study|Subject Request|1|||
124839548|NCT00453999|449040912|FG002|Overall Study|Subject Request|0|||
124839549|NCT00696137|449040921|FG000|Overall Study|Withdrawal by Subject|2|||
124839550|NCT03742141|449040928|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
124839551|NCT02376166|449040929|FG000|Overall Study|Adverse Event|1|||
124839552|NCT02376166|449040929|FG000|Overall Study|Discontinued metformin early|2|||
124839553|NCT04180020|449040930|FG000|Overall Study|missed visit|18|||
124839554|NCT04180020|449040931|FG001|Overall Study|missed visit|16|||
124839555|NCT04180020|449040930|FG000|Overall Study|Death|2|||
124839556|NCT04180020|449040931|FG001|Overall Study|Death|3|||
124839557|NCT04180020|449040930|FG000|Overall Study|Withdrawal by Subject|1|||
124839558|NCT04180020|449040931|FG001|Overall Study|Withdrawal by Subject|5|||
124839559|NCT04180020|449040930|FG000|Overall Study|incarcerated|1|||
124839560|NCT04180020|449040931|FG001|Overall Study|incarcerated|1|||
124839561|NCT04180020|449040930|FG000|Overall Study|Physician Decision|0|||
124839562|NCT04180020|449040931|FG001|Overall Study|Physician Decision|2|||
124839563|NCT02917031|449040938|FG000|Overall Study|Reason not specified|7|||
124839564|NCT02917031|449040939|FG001|Overall Study|Reason not specified|5|||
124839565|NCT02917031|449040940|FG002|Overall Study|Reason not specified|6|||
124839566|NCT02917031|449040938|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
124839567|NCT02917031|449040939|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
124839568|NCT02917031|449040940|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
124839569|NCT02917031|449040938|FG000|Overall Study|Withdrawal by Subject|3|||
124839570|NCT02917031|449040939|FG001|Overall Study|Withdrawal by Subject|3|||
124839571|NCT02917031|449040940|FG002|Overall Study|Withdrawal by Subject|0|||
124839572|NCT02917031|449040938|FG000|Overall Study|Physician Decision|1|||
124839573|NCT02917031|449040939|FG001|Overall Study|Physician Decision|0|||
124839574|NCT02917031|449040940|FG002|Overall Study|Physician Decision|0|||
124839575|NCT02917031|449040938|FG000|Overall Study|Adverse Event|4|||
124839576|NCT02917031|449040939|FG001|Overall Study|Adverse Event|1|||
124839577|NCT02917031|449040940|FG002|Overall Study|Adverse Event|5|||
124839578|NCT02917031|449040938|FG000|Overall Study|Death|2|||
124839579|NCT02917031|449040939|FG001|Overall Study|Death|3|||
124839580|NCT02917031|449040940|FG002|Overall Study|Death|4|||
124976565|NCT03832595|449540002|FG001|Overall Study|Medical management without dialysis|1|||
124976566|NCT03277352|449540003|FG000|Overall Study|Study Terminated By Sponsor|2|||
124976567|NCT03277352|449540003|FG000|Overall Study|Withdrawal by Subject|4|||
124976568|NCT03277352|449540003|FG000|Overall Study|Death|4|||
124976569|NCT02397447|449540004|FG000|Overall Study|Lost to Follow-up|2|||
124976570|NCT02397447|449540005|FG001|Overall Study|Lost to Follow-up|2|||
124976571|NCT01435772|449540006|FG000|Overall Study|Adverse Event|1|||
124976572|NCT01435772|449540007|FG001|Overall Study|Adverse Event|0|||
124976573|NCT01435772|449540008|FG002|Overall Study|Adverse Event|2|||
124976574|NCT01435772|449540006|FG000|Overall Study|Withdrawal by Subject|0|||
124976575|NCT01435772|449540007|FG001|Overall Study|Withdrawal by Subject|1|||
124976576|NCT01435772|449540008|FG002|Overall Study|Withdrawal by Subject|3|||
124976577|NCT01435772|449540006|FG000|Overall Study|Other - study termination|2|||
124976578|NCT01435772|449540007|FG001|Overall Study|Other - study termination|2|||
124976579|NCT01435772|449540008|FG002|Overall Study|Other - study termination|10|||
124976580|NCT03238963|449540009|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
124976581|NCT03238963|449540010|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
124976582|NCT03238963|449540009|FG000|Overall Study|Withdrawal by Subject|1|||
124976583|NCT03238963|449540010|FG001|Overall Study|Withdrawal by Subject|1|||
124976584|NCT03238963|449540009|FG000|Overall Study|Lost to Follow-up|1|||
124976585|NCT03238963|449540010|FG001|Overall Study|Lost to Follow-up|0|||
124976586|NCT03238963|449540009|FG000|Overall Study|Protocol Violation|1|||
124976587|NCT03238963|449540010|FG001|Overall Study|Protocol Violation|1|||
124976588|NCT03238963|449540009|FG000|Overall Study|Adverse Event|1|||
124976589|NCT03238963|449540010|FG001|Overall Study|Adverse Event|0|||
124976590|NCT01424813|449540013|FG000|Overall Study|Withdrawal by Subject|3|||
124976591|NCT01424813|449540014|FG001|Overall Study|Withdrawal by Subject|0|||
124976592|NCT01424813|449540013|FG000|Overall Study|Protocol Violation|1|||
124976593|NCT01424813|449540014|FG001|Overall Study|Protocol Violation|0|||
124976594|NCT01424813|449540013|FG000|Overall Study|Other|1|||
124976595|NCT01424813|449540014|FG001|Overall Study|Other|2|||
124976596|NCT02614183|449540015|FG000|Double Blind Treatment Phase|Adverse Event|10|||
124976597|NCT02614183|449540016|FG001|Double Blind Treatment Phase|Adverse Event|9|||
124976598|NCT02614183|449540017|FG002|Double Blind Treatment Phase|Adverse Event|7|||
124976599|NCT02614183|449540015|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
124976600|NCT02614183|449540016|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
124976601|NCT02614183|449540017|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
124976602|NCT02614183|449540015|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
124976603|NCT02614183|449540016|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
124976604|NCT02614183|449540017|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
124976605|NCT02614183|449540015|FG000|Double Blind Treatment Phase|Physician Decision|7|||
124976606|NCT02614183|449540016|FG001|Double Blind Treatment Phase|Physician Decision|3|||
124976607|NCT02614183|449540017|FG002|Double Blind Treatment Phase|Physician Decision|2|||
124976608|NCT02614183|449540015|FG000|Double Blind Treatment Phase|Pregnancy|2|||
124976609|NCT02614183|449540016|FG001|Double Blind Treatment Phase|Pregnancy|1|||
124976610|NCT02614183|449540017|FG002|Double Blind Treatment Phase|Pregnancy|3|||
124976611|NCT02614183|449540015|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
124976612|NCT02614183|449540016|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
124976613|NCT02614183|449540017|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
124976614|NCT02614183|449540015|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
124976615|NCT02614183|449540016|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
124976616|NCT02614183|449540017|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
124976617|NCT02614183|449540015|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
124976618|NCT02614183|449540016|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
124976619|NCT02614183|449540017|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
124839581|NCT00403273|449042769|FG000|Overall Study|Lost to Follow-up|3|||
124839582|NCT00403273|449042770|FG001|Overall Study|Lost to Follow-up|2|||
124839583|NCT00403273|449042769|FG000|Overall Study|Physician Decision|0|||
124839584|NCT00403273|449042770|FG001|Overall Study|Physician Decision|1|||
124839585|NCT00403273|449042769|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
124839586|NCT00403273|449042770|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
124839587|NCT01852292|449042774|FG000|Overall Study|Untreated - did not receive study drug|3|||
124839588|NCT01852292|449042775|FG001|Overall Study|Untreated - did not receive study drug|1|||
124839589|NCT01852292|449042774|FG000|Overall Study|Death|9|||
124839590|NCT01852292|449042775|FG001|Overall Study|Death|8|||
124839591|NCT01852292|449042774|FG000|Overall Study|Patient/guardian decision|8|||
124839592|NCT01852292|449042775|FG001|Overall Study|Patient/guardian decision|4|||
124839593|NCT01852292|449042774|FG000|Overall Study|Adverse Event|8|||
124839594|NCT01852292|449042775|FG001|Overall Study|Adverse Event|11|||
124839595|NCT01852292|449042774|FG000|Overall Study|Physician Decision|6|||
124839596|NCT01852292|449042775|FG001|Overall Study|Physician Decision|2|||
124839597|NCT01852292|449042774|FG000|Overall Study|Protocol Violation|2|||
124839598|NCT01852292|449042775|FG001|Overall Study|Protocol Violation|0|||
124839599|NCT01852292|449042774|FG000|Overall Study|Non-compliance with study treatment|1|||
124839600|NCT01852292|449042775|FG001|Overall Study|Non-compliance with study treatment|0|||
124839601|NCT01852292|449042774|FG000|Overall Study|Study terminated by Sponsor|0|||
124839602|NCT01852292|449042775|FG001|Overall Study|Study terminated by Sponsor|1|||
124839603|NCT01852292|449042774|FG000|Overall Study|Progressive disease|42|||
124839604|NCT01852292|449042775|FG001|Overall Study|Progressive disease|52|||
124839605|NCT02586012|449042776|FG000|Overall Study|Withdrawal by Subject|1|||
124839606|NCT02586012|449042777|FG001|Overall Study|Withdrawal by Subject|1|||
124839607|NCT02586012|449042778|FG002|Overall Study|Withdrawal by Subject|0|||
124839608|NCT02586012|449042779|FG003|Overall Study|Withdrawal by Subject|1|||
124839609|NCT02586012|449042780|FG004|Overall Study|Withdrawal by Subject|0|||
124839610|NCT02586012|449042781|FG005|Overall Study|Withdrawal by Subject|2|||
124839611|NCT02586012|449042776|FG000|Overall Study|Protocol Violation|0|||
124839612|NCT02586012|449042777|FG001|Overall Study|Protocol Violation|0|||
124839613|NCT02586012|449042778|FG002|Overall Study|Protocol Violation|0|||
124839614|NCT02586012|449042779|FG003|Overall Study|Protocol Violation|0|||
124839615|NCT02586012|449042780|FG004|Overall Study|Protocol Violation|0|||
124839616|NCT02586012|449042781|FG005|Overall Study|Protocol Violation|1|||
124839617|NCT02586012|449042776|FG000|Overall Study|study terminated|0|||
124839618|NCT02586012|449042777|FG001|Overall Study|study terminated|2|||
124839619|NCT02586012|449042778|FG002|Overall Study|study terminated|1|||
124839620|NCT02586012|449042779|FG003|Overall Study|study terminated|1|||
124839621|NCT02586012|449042780|FG004|Overall Study|study terminated|1|||
124839622|NCT02586012|449042781|FG005|Overall Study|study terminated|0|||
124839623|NCT02388737|449042783|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
124839624|NCT02388737|449042784|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
124839625|NCT02388737|449042785|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
124839626|NCT02388737|449042783|FG000|Overall Study|Major Protocol Deviation|18|||
124839627|NCT02388737|449042784|FG001|Overall Study|Major Protocol Deviation|25|||
124839628|NCT02388737|449042785|FG002|Overall Study|Major Protocol Deviation|22|||
124839629|NCT02388737|449042783|FG000|Overall Study|Lost to Follow-up|5|||
124839630|NCT02388737|449042784|FG001|Overall Study|Lost to Follow-up|1|||
124839631|NCT02388737|449042785|FG002|Overall Study|Lost to Follow-up|4|||
124839632|NCT02388737|449042783|FG000|Overall Study|Voluntary Withdrawal|10|||
124839633|NCT02388737|449042784|FG001|Overall Study|Voluntary Withdrawal|18|||
124839634|NCT02388737|449042785|FG002|Overall Study|Voluntary Withdrawal|17|||
124839635|NCT02388737|449042783|FG000|Overall Study|Lack of Efficacy|3|||
124839636|NCT02388737|449042784|FG001|Overall Study|Lack of Efficacy|0|||
124839637|NCT02388737|449042785|FG002|Overall Study|Lack of Efficacy|3|||
124839638|NCT02388737|449042783|FG000|Overall Study|Reason Not Specified|5|||
124839639|NCT02388737|449042784|FG001|Overall Study|Reason Not Specified|5|||
124839640|NCT02388737|449042785|FG002|Overall Study|Reason Not Specified|4|||
124839641|NCT03299842|449042787|FG000|Overall Study|Caregiver withdrew consent|2|||
124839642|NCT03299842|449042787|FG000|Overall Study|Child would not keep the watch on|3|||
124839643|NCT01816139|449042788|FG000|Overall Study|Adverse Event|6|||
124839644|NCT01816139|449042789|FG001|Overall Study|Adverse Event|8|||
124839645|NCT01816139|449042788|FG000|Overall Study|Lack of Efficacy|1|||
124839646|NCT01816139|449042789|FG001|Overall Study|Lack of Efficacy|2|||
124839647|NCT01816139|449042788|FG000|Overall Study|Lost to Follow-up|5|||
124839648|NCT01816139|449042789|FG001|Overall Study|Lost to Follow-up|3|||
124839649|NCT01816139|449042788|FG000|Overall Study|Withdrew Consent|6|||
124839650|NCT01816139|449042789|FG001|Overall Study|Withdrew Consent|4|||
124839651|NCT01816139|449042788|FG000|Overall Study|Protocol Violation|6|||
124839652|NCT01816139|449042789|FG001|Overall Study|Protocol Violation|3|||
124839653|NCT01816139|449042788|FG000|Overall Study|Reason not Specified|4|||
124839654|NCT01816139|449042789|FG001|Overall Study|Reason not Specified|2|||
124839655|NCT03240575|449042792|FG000|Overall Study|Adverse Event|0|||
124839656|NCT03240575|449042793|FG001|Overall Study|Adverse Event|2|||
124839657|NCT03240575|449042794|FG002|Overall Study|Adverse Event|0|||
124839658|NCT03240575|449042795|FG003|Overall Study|Adverse Event|1|||
124839659|NCT03240575|449042792|FG000|Overall Study|Withdrawal by Subject|2|||
124839660|NCT03240575|449042793|FG001|Overall Study|Withdrawal by Subject|11|||
124839661|NCT03240575|449042794|FG002|Overall Study|Withdrawal by Subject|0|||
124839662|NCT03240575|449042795|FG003|Overall Study|Withdrawal by Subject|1|||
124839663|NCT03240575|449042792|FG000|Overall Study|Other|0|||
124639993|NCT03483961|448299835|FG005|Overall Study|Withdrawal by Subject|2|||
124639994|NCT03483961|448299836|FG006|Overall Study|Withdrawal by Subject|1|||
124639995|NCT03483961|448299837|FG007|Overall Study|Withdrawal by Subject|2|||
124639996|NCT03483961|448299838|FG008|Overall Study|Withdrawal by Subject|1|||
124639997|NCT03483961|448299839|FG009|Overall Study|Withdrawal by Subject|0|||
124639998|NCT03483961|448299830|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
124639999|NCT03483961|448299831|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
124640000|NCT03483961|448299832|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
124640001|NCT03483961|448299833|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
124640002|NCT03483961|448299834|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
124640003|NCT03483961|448299835|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
124640004|NCT03483961|448299836|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
124640005|NCT03483961|448299837|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
124640006|NCT03483961|448299838|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
124640007|NCT03483961|448299839|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
124640008|NCT03483961|448299830|FG000|Overall Study|Adverse Event|0|||
124640009|NCT03483961|448299831|FG001|Overall Study|Adverse Event|0|||
124640010|NCT03483961|448299832|FG002|Overall Study|Adverse Event|1|||
124640011|NCT03483961|448299833|FG003|Overall Study|Adverse Event|0|||
124640012|NCT03483961|448299834|FG004|Overall Study|Adverse Event|0|||
124640013|NCT03483961|448299835|FG005|Overall Study|Adverse Event|0|||
124640014|NCT03483961|448299836|FG006|Overall Study|Adverse Event|0|||
124640015|NCT03483961|448299837|FG007|Overall Study|Adverse Event|0|||
124640016|NCT03483961|448299838|FG008|Overall Study|Adverse Event|0|||
124640017|NCT03483961|448299839|FG009|Overall Study|Adverse Event|0|||
124640018|NCT01108341|448299842|FG000|Overall Study|Death|2|||
124640019|NCT01108341|448299842|FG000|Overall Study|Withdrawal by Subject|1|||
124640020|NCT01108341|448299842|FG000|Overall Study|Lost to Follow-up|1|||
124640021|NCT01108341|448299842|FG000|Overall Study|Other|1|||
124640022|NCT04402138|448299843|FG000|Overall Study|Progressive Disease|2|||
124640023|NCT04402138|448299843|FG000|Overall Study|Adverse Event|1|||
124640024|NCT03508726|448299844|FG000|Overall Study|Withdrawal by Subject|0|||
124640025|NCT03508726|448299845|FG001|Overall Study|Withdrawal by Subject|1|||
124640026|NCT04411810|448299846|FG000|Overall Study|Screen failure|1|||
124640027|NCT04411810|448299846|FG000|Overall Study|Withdrawal by Subject|1|||
124640028|NCT03981926|448299847|FG000|Overall Study|Lost to Follow-up|5|||
124640029|NCT03981926|448299848|FG001|Overall Study|Lost to Follow-up|9|||
124640030|NCT01920958|448299849|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
124640031|NCT01560234|448299850|FG000|Overall Study|Lost to Follow-up|3|||
124640032|NCT01560234|448299851|FG001|Overall Study|Lost to Follow-up|0|||
124640033|NCT01560234|448299852|FG002|Overall Study|Lost to Follow-up|1|||
124640034|NCT01560234|448299853|FG003|Overall Study|Lost to Follow-up|0|||
124640035|NCT01560234|448299854|FG004|Overall Study|Lost to Follow-up|0|||
124640036|NCT01560234|448299855|FG005|Overall Study|Lost to Follow-up|2|||
124640037|NCT01560234|448299856|FG006|Overall Study|Lost to Follow-up|0|||
124640038|NCT01560234|448299857|FG007|Overall Study|Lost to Follow-up|2|||
124640039|NCT02035202|448299859|FG000|Overall Study|Lost to Follow-up|8|||
124640040|NCT02035202|448299860|FG001|Overall Study|Lost to Follow-up|16|||
124640041|NCT02035202|448299861|FG002|Overall Study|Lost to Follow-up|2|||
124640042|NCT00083759|448299862|FG000|Overall Study|Adverse Event|5|||
124640043|NCT00083759|448299863|FG001|Overall Study|Adverse Event|3|||
124640044|NCT00083759|448299862|FG000|Overall Study|Lost to Follow-up|1|||
124640045|NCT00083759|448299863|FG001|Overall Study|Lost to Follow-up|0|||
124640046|NCT00083759|448299862|FG000|Overall Study|Death|1|||
124640047|NCT00083759|448299863|FG001|Overall Study|Death|1|||
124640048|NCT00083759|448299862|FG000|Overall Study|Inadequate Therapeutic Response|32|||
124640049|NCT00083759|448299863|FG001|Overall Study|Inadequate Therapeutic Response|35|||
124640050|NCT00083759|448299862|FG000|Overall Study|Subject Withdrew Consent|2|||
124640051|NCT00083759|448299863|FG001|Overall Study|Subject Withdrew Consent|2|||
124640052|NCT00083759|448299862|FG000|Overall Study|Non-Compliance|1|||
124640053|NCT00083759|448299863|FG001|Overall Study|Non-Compliance|0|||
124640054|NCT00083759|448299862|FG000|Overall Study|Sponsor's Discretion|28|||
124640055|NCT00083759|448299863|FG001|Overall Study|Sponsor's Discretion|29|||
124640056|NCT00083759|448299862|FG000|Overall Study|Other|14|||
124839664|NCT03240575|449042793|FG001|Overall Study|Other|1|||
124640057|NCT00083759|448299863|FG001|Overall Study|Other|13|||
124839665|NCT03240575|449042794|FG002|Overall Study|Other|0|||
124839666|NCT03240575|449042795|FG003|Overall Study|Other|0|||
124839667|NCT02342704|449042805|FG000|Overall Study|Physician Decision|0|||
124839668|NCT02342704|449042806|FG001|Overall Study|Physician Decision|3|||
124839669|NCT02342704|449042805|FG000|Overall Study|Sponsor Termination|49|||
124839670|NCT02342704|449042806|FG001|Overall Study|Sponsor Termination|43|||
124839671|NCT02342704|449042805|FG000|Overall Study|Other|0|||
124839672|NCT02342704|449042806|FG001|Overall Study|Other|1|||
124839673|NCT02342704|449042805|FG000|Overall Study|Withdrawal by Subject|1|||
124839674|NCT02342704|449042806|FG001|Overall Study|Withdrawal by Subject|0|||
124839675|NCT02342704|449042805|FG000|Overall Study|Lost to Follow-up|2|||
124839676|NCT02342704|449042806|FG001|Overall Study|Lost to Follow-up|1|||
124839677|NCT02342704|449042805|FG000|Overall Study|Adverse Event|1|||
124839678|NCT02342704|449042806|FG001|Overall Study|Adverse Event|3|||
124839679|NCT02347527|449042808|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
124839680|NCT02347527|449042809|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
124839681|NCT02347527|449042810|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
124839682|NCT02347527|449042811|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
124839683|NCT02347527|449042808|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
124839684|NCT02347527|449042809|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
124839685|NCT02347527|449042810|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
124839686|NCT02347527|449042811|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
124839687|NCT02347527|449042808|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
124839688|NCT02347527|449042809|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
124839689|NCT02347527|449042810|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
124839690|NCT02347527|449042811|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
124839691|NCT02347527|449042808|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
124839692|NCT02347527|449042809|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
124839693|NCT02347527|449042810|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
124839694|NCT02347527|449042811|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
124839695|NCT02347527|449042808|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
124839696|NCT02347527|449042809|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
124839697|NCT02347527|449042810|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
124839698|NCT02347527|449042811|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
124839699|NCT01632891|449042812|FG000|Overall Study|Lost to Follow-up|0|||
124839700|NCT01632891|449042813|FG001|Overall Study|Lost to Follow-up|1|||
124839701|NCT01632891|449042812|FG000|Overall Study|Withdrawal by Subject|1|||
124839702|NCT01632891|449042813|FG001|Overall Study|Withdrawal by Subject|0|||
124839703|NCT02919670|449042814|FG000|Overall Study|Only 17 participants met compliance|43|||
124839704|NCT02919670|449042815|FG001|Overall Study|Only 17 participants met compliance|39|||
124839705|NCT01466270|449042816|FG000|Overall Study|Withdrawal by Subject|4|||
124839706|NCT01466270|449042817|FG001|Overall Study|Withdrawal by Subject|1|||
124839707|NCT01466270|449042816|FG000|Overall Study|Physician Decision|1|||
124839708|NCT01466270|449042817|FG001|Overall Study|Physician Decision|0|||
124839709|NCT01466270|449042816|FG000|Overall Study|Lost to Follow-up|1|||
124839710|NCT01466270|449042817|FG001|Overall Study|Lost to Follow-up|3|||
124839711|NCT01466270|449042816|FG000|Overall Study|Progression|1|||
124839712|NCT01466270|449042817|FG001|Overall Study|Progression|0|||
124839713|NCT01466270|449042816|FG000|Overall Study|Toxicity|4|||
124839714|NCT01466270|449042817|FG001|Overall Study|Toxicity|1|||
124839715|NCT01466270|449042816|FG000|Overall Study|Multiple|1|||
124839716|NCT01466270|449042817|FG001|Overall Study|Multiple|1|||
124839717|NCT02118428|449042822|FG000|Overall Study|Physician Decision|0|||
124839718|NCT02118428|449042823|FG001|Overall Study|Physician Decision|1|||
124839719|NCT02118428|449042824|FG002|Overall Study|Physician Decision|0|||
124839720|NCT02118428|449042822|FG000|Overall Study|Withdrawal by Subject|2|||
124839721|NCT02118428|449042823|FG001|Overall Study|Withdrawal by Subject|2|||
124839722|NCT02118428|449042824|FG002|Overall Study|Withdrawal by Subject|0|||
124839723|NCT02118428|449042822|FG000|Overall Study|Death|7|||
124839724|NCT02118428|449042823|FG001|Overall Study|Death|5|||
124839725|NCT02118428|449042824|FG002|Overall Study|Death|0|||
124839726|NCT02118428|449042822|FG000|Overall Study|Lost to Follow-up|3|||
124839727|NCT02118428|449042823|FG001|Overall Study|Lost to Follow-up|1|||
124839728|NCT02118428|449042824|FG002|Overall Study|Lost to Follow-up|0|||
124839729|NCT02118428|449042822|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
124839730|NCT02118428|449042823|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
124839731|NCT02118428|449042824|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
124839732|NCT04171414|449042825|FG000|Overall Study|Death|1|||
124839733|NCT04171414|449042825|FG000|Overall Study|Withdrawal by Subject|1|||
124839734|NCT02884089|449042832|FG000|Period 1|Dosing error|2|||
124640058|NCT02875613|448299864|FG000|Overall Study|Withdrawal by Subject|1|||
124839735|NCT02884089|449042833|FG001|Period 1|Dosing error|2|||
124640059|NCT02875613|448299864|FG000|Overall Study|Screen Failure|1|||
124839736|NCT02884089|449042834|FG002|Period 1|Dosing error|0|||
124839737|NCT02884089|449042835|FG003|Period 1|Dosing error|0|||
124839738|NCT02884089|449042832|FG000|Washout Period 1|Lost to Follow-up|0|||
124839739|NCT02884089|449042833|FG001|Washout Period 1|Lost to Follow-up|1|||
124839740|NCT02884089|449042834|FG002|Washout Period 1|Lost to Follow-up|0|||
124839741|NCT02884089|449042835|FG003|Washout Period 1|Lost to Follow-up|1|||
124839742|NCT02884089|449042832|FG000|Washout Period 1|Withdrawal by Subject|0|||
124839743|NCT02884089|449042833|FG001|Washout Period 1|Withdrawal by Subject|1|||
124839744|NCT02884089|449042834|FG002|Washout Period 1|Withdrawal by Subject|0|||
124839745|NCT02884089|449042835|FG003|Washout Period 1|Withdrawal by Subject|0|||
124839746|NCT02884089|449042832|FG000|Period 2|Adverse Event|1|||
124839747|NCT02884089|449042833|FG001|Period 2|Adverse Event|0|||
124839748|NCT02884089|449042834|FG002|Period 2|Adverse Event|0|||
124839749|NCT02884089|449042835|FG003|Period 2|Adverse Event|0|||
124839750|NCT02884089|449042832|FG000|Period 3|Withdrawal by Subject|0|||
124839751|NCT02884089|449042833|FG001|Period 3|Withdrawal by Subject|0|||
124839752|NCT02884089|449042834|FG002|Period 3|Withdrawal by Subject|1|||
124839753|NCT02884089|449042835|FG003|Period 3|Withdrawal by Subject|0|||
124839754|NCT02884089|449042832|FG000|Washout Period 3|Withdrawal by Subject|0|||
124839755|NCT02884089|449042833|FG001|Washout Period 3|Withdrawal by Subject|0|||
124839756|NCT02884089|449042834|FG002|Washout Period 3|Withdrawal by Subject|1|||
124839757|NCT02884089|449042835|FG003|Washout Period 3|Withdrawal by Subject|0|||
124839758|NCT02884089|449042832|FG000|Washout Period 3|Lost to Follow-up|0|||
124839759|NCT02884089|449042833|FG001|Washout Period 3|Lost to Follow-up|0|||
124839760|NCT02884089|449042834|FG002|Washout Period 3|Lost to Follow-up|0|||
124839761|NCT02884089|449042835|FG003|Washout Period 3|Lost to Follow-up|1|||
124839762|NCT02884089|449042832|FG000|Period 4|Withdrawal by Subject|0|||
124839763|NCT02884089|449042833|FG001|Period 4|Withdrawal by Subject|1|||
124839764|NCT02884089|449042834|FG002|Period 4|Withdrawal by Subject|0|||
124839765|NCT02884089|449042835|FG003|Period 4|Withdrawal by Subject|0|||
124839766|NCT02884089|449042832|FG000|Period 4|Lost to Follow-up|1|||
124839767|NCT02884089|449042833|FG001|Period 4|Lost to Follow-up|0|||
124839768|NCT02884089|449042834|FG002|Period 4|Lost to Follow-up|0|||
124839769|NCT02884089|449042835|FG003|Period 4|Lost to Follow-up|0|||
124839770|NCT02884089|449042832|FG000|Follow-up Visit|Withdrawal by Subject|1|||
124839771|NCT02884089|449042833|FG001|Follow-up Visit|Withdrawal by Subject|0|||
124839772|NCT02884089|449042834|FG002|Follow-up Visit|Withdrawal by Subject|0|||
124839773|NCT02884089|449042835|FG003|Follow-up Visit|Withdrawal by Subject|1|||
124839774|NCT01631474|449042836|FG000|Overall Study|Lost to Follow-up|8|||
124839775|NCT01631474|449042837|FG001|Overall Study|Lost to Follow-up|5|||
124839776|NCT01631474|449042838|FG002|Overall Study|Lost to Follow-up|7|||
124839777|NCT01631474|449042839|FG003|Overall Study|Lost to Follow-up|5|||
124839778|NCT01631474|449042840|FG004|Overall Study|Lost to Follow-up|5|||
124839779|NCT01631474|449042836|FG000|Overall Study|Withdrawal by Subject|4|||
124839780|NCT01631474|449042837|FG001|Overall Study|Withdrawal by Subject|4|||
124839781|NCT01631474|449042838|FG002|Overall Study|Withdrawal by Subject|2|||
124839782|NCT01631474|449042839|FG003|Overall Study|Withdrawal by Subject|6|||
124839783|NCT01631474|449042840|FG004|Overall Study|Withdrawal by Subject|5|||
124839784|NCT01631474|449042836|FG000|Overall Study|Lack of Efficacy|2|||
124839785|NCT01631474|449042837|FG001|Overall Study|Lack of Efficacy|2|||
124839786|NCT01631474|449042838|FG002|Overall Study|Lack of Efficacy|0|||
124640060|NCT03645395|448299874|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
124640061|NCT03645395|448299875|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
124640062|NCT03645395|448299876|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
124640063|NCT03645395|448299877|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
124640064|NCT03645395|448299874|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
124640065|NCT03645395|448299875|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
124640066|NCT03645395|448299876|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
124640067|NCT03645395|448299877|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
124640068|NCT03645395|448299874|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
124839787|NCT01631474|449042839|FG003|Overall Study|Lack of Efficacy|0|||
124839788|NCT01631474|449042840|FG004|Overall Study|Lack of Efficacy|2|||
124839789|NCT01631474|449042836|FG000|Overall Study|Noncompliance with Study Drug|0|||
124839790|NCT01631474|449042837|FG001|Overall Study|Noncompliance with Study Drug|0|||
124839791|NCT01631474|449042838|FG002|Overall Study|Noncompliance with Study Drug|0|||
124839792|NCT01631474|449042839|FG003|Overall Study|Noncompliance with Study Drug|0|||
124839793|NCT01631474|449042840|FG004|Overall Study|Noncompliance with Study Drug|1|||
124839794|NCT01631474|449042836|FG000|Overall Study|Adverse Event|0|||
124839795|NCT01631474|449042837|FG001|Overall Study|Adverse Event|1|||
124839796|NCT01631474|449042838|FG002|Overall Study|Adverse Event|0|||
124839797|NCT01631474|449042839|FG003|Overall Study|Adverse Event|0|||
124839798|NCT01631474|449042840|FG004|Overall Study|Adverse Event|0|||
124839799|NCT02624284|449042841|FG000|Overall Study|Withdrawal by Subject|3|||
124839800|NCT02624284|449042842|FG001|Overall Study|Withdrawal by Subject|6|||
124839801|NCT02624284|449042843|FG002|Overall Study|Withdrawal by Subject|3|||
124640069|NCT03645395|448299875|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
124839802|NCT02624284|449042841|FG000|Overall Study|Protocol Violation|9|||
124839803|NCT02624284|449042842|FG001|Overall Study|Protocol Violation|10|||
124839804|NCT02624284|449042843|FG002|Overall Study|Protocol Violation|7|||
124839805|NCT02624284|449042841|FG000|Overall Study|Revealed exclusionary condition|2|||
124839806|NCT02624284|449042842|FG001|Overall Study|Revealed exclusionary condition|2|||
124839807|NCT02624284|449042843|FG002|Overall Study|Revealed exclusionary condition|0|||
124839808|NCT02624284|449042841|FG000|Overall Study|Adverse Event|0|||
124839809|NCT02624284|449042842|FG001|Overall Study|Adverse Event|0|||
124839810|NCT02624284|449042843|FG002|Overall Study|Adverse Event|1|||
124839811|NCT02487394|449042844|FG000|Phase 1|Withdrawal by Subject|0|||
124839812|NCT02487394|449042845|FG001|Phase 1|Withdrawal by Subject|1|||
124839813|NCT01641367|449042849|FG000|Cohorts|Death|18|||
124839814|NCT01641367|449042850|FG001|Cohorts|Death|1|||
124839815|NCT01641367|449042851|FG002|Cohorts|Death|2|||
124839816|NCT01641367|449042852|FG003|Cohorts|Death|0|||
124839817|NCT01641367|449042853|FG004|Cohorts|Death|1|||
124839818|NCT01641367|449042854|FG005|Cohorts|Death|1|||
124839819|NCT01641367|449042855|FG006|Cohorts|Death|0|||
124839820|NCT01641367|449042856|FG007|Cohorts|Death|0|||
124839821|NCT01641367|449042849|FG000|Cohorts|Lost to Follow-up|16|||
124839822|NCT01641367|449042850|FG001|Cohorts|Lost to Follow-up|0|||
124839823|NCT01641367|449042851|FG002|Cohorts|Lost to Follow-up|2|||
124839824|NCT01641367|449042852|FG003|Cohorts|Lost to Follow-up|0|||
124839825|NCT01641367|449042853|FG004|Cohorts|Lost to Follow-up|2|||
124839826|NCT01641367|449042854|FG005|Cohorts|Lost to Follow-up|0|||
124839827|NCT01641367|449042855|FG006|Cohorts|Lost to Follow-up|0|||
124839828|NCT01641367|449042856|FG007|Cohorts|Lost to Follow-up|0|||
124839829|NCT01641367|449042849|FG000|Randomized Adherence Intervention|Death|0|||
124839830|NCT01641367|449042850|FG001|Randomized Adherence Intervention|Death|0|||
124839831|NCT01641367|449042851|FG002|Randomized Adherence Intervention|Death|0|||
124839832|NCT01641367|449042852|FG003|Randomized Adherence Intervention|Death|0|||
124839833|NCT01641367|449042853|FG004|Randomized Adherence Intervention|Death|0|||
124839834|NCT01641367|449042854|FG005|Randomized Adherence Intervention|Death|0|||
124839835|NCT01641367|449042855|FG006|Randomized Adherence Intervention|Death|11|||
124839836|NCT01641367|449042856|FG007|Randomized Adherence Intervention|Death|12|||
124839837|NCT01641367|449042849|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
124839838|NCT01641367|449042850|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
124839839|NCT01641367|449042851|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
124839840|NCT01641367|449042852|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
124839841|NCT01641367|449042853|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
124839842|NCT01641367|449042854|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
124839843|NCT01641367|449042855|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
124839844|NCT01641367|449042856|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
124839845|NCT02586493|449042857|FG000|Overall Study|Adverse Event|4|||
124839846|NCT02586493|449042857|FG000|Overall Study|Protocol Violation|6|||
124839847|NCT02586493|449042857|FG000|Overall Study|Lost to Follow-up|1|||
124839848|NCT02586493|449042857|FG000|Overall Study|Withdrawal by Subject|1|||
124839849|NCT02711800|449042859|FG000|Overall Study|Lost to Follow-up|1|||
124839850|NCT02711800|449042859|FG000|Overall Study|Withdrawal by Subject|1|||
124839851|NCT01869192|449042860|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
124839852|NCT01869192|449042861|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
124839853|NCT01869192|449042860|FG000|Postoperative Chemotherapy|Physician Decision|0|||
124839854|NCT01869192|449042861|FG001|Postoperative Chemotherapy|Physician Decision|2|||
124839855|NCT00423891|449042862|FG000|Enrolled|Withdrawal by Subject|0|||
124839856|NCT00423891|449042863|FG001|Enrolled|Withdrawal by Subject|0|||
124839857|NCT00423891|449042864|FG002|Enrolled|Withdrawal by Subject|1|||
124839858|NCT00423891|449042862|FG000|Enrolled|Lost to Follow-up|0|||
124839859|NCT00423891|449042863|FG001|Enrolled|Lost to Follow-up|0|||
124839860|NCT00423891|449042864|FG002|Enrolled|Lost to Follow-up|1|||
124640070|NCT03645395|448299876|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
124640071|NCT03645395|448299877|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
124640072|NCT03645395|448299874|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
124640073|NCT03645395|448299875|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
124839861|NCT00423891|449042862|FG000|Enrolled|No longer met criteria|11|||
124839862|NCT00423891|449042863|FG001|Enrolled|No longer met criteria|2|||
124839863|NCT00423891|449042864|FG002|Enrolled|No longer met criteria|1|||
124839864|NCT00423891|449042862|FG000|Treatment|Withdrawal by Subject|1|||
124839865|NCT00423891|449042863|FG001|Treatment|Withdrawal by Subject|0|||
124839866|NCT00423891|449042864|FG002|Treatment|Withdrawal by Subject|0|||
124839867|NCT00423891|449042862|FG000|Treatment|Lost to Follow-up|1|||
124839868|NCT00423891|449042863|FG001|Treatment|Lost to Follow-up|0|||
124839869|NCT00423891|449042864|FG002|Treatment|Lost to Follow-up|0|||
124839870|NCT00423891|449042862|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
124839871|NCT00423891|449042863|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
124839872|NCT00423891|449042864|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
124839873|NCT00423891|449042862|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
124839874|NCT00423891|449042863|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
124839875|NCT00423891|449042864|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
124839876|NCT00414661|449042865|FG000|Overall Study|Death|2|||
124640074|NCT03645395|448299876|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
124839877|NCT00414661|449042866|FG001|Overall Study|Death|5|||
124839878|NCT00414661|449042867|FG002|Overall Study|Death|0|||
124839879|NCT00414661|449042868|FG003|Overall Study|Death|0|||
124839880|NCT00414661|449042865|FG000|Overall Study|Lost to Follow-up|1|||
124839881|NCT00414661|449042866|FG001|Overall Study|Lost to Follow-up|4|||
124839882|NCT00414661|449042867|FG002|Overall Study|Lost to Follow-up|0|||
124839883|NCT00414661|449042868|FG003|Overall Study|Lost to Follow-up|1|||
124839884|NCT00414661|449042865|FG000|Overall Study|Withdrawal by Subject|5|||
124839885|NCT00414661|449042866|FG001|Overall Study|Withdrawal by Subject|2|||
124839886|NCT00414661|449042867|FG002|Overall Study|Withdrawal by Subject|2|||
124839887|NCT00414661|449042868|FG003|Overall Study|Withdrawal by Subject|2|||
124839888|NCT00414661|449042865|FG000|Overall Study|Other|6|||
124839889|NCT00414661|449042866|FG001|Overall Study|Other|3|||
124839890|NCT00414661|449042867|FG002|Overall Study|Other|0|||
124839891|NCT00414661|449042868|FG003|Overall Study|Other|0|||
124839892|NCT00357370|449042869|FG000|Cohort 2|Lack of Efficacy|0|||
124839893|NCT00357370|449042870|FG001|Cohort 2|Lack of Efficacy|2|||
124839894|NCT00357370|449042871|FG002|Cohort 2|Lack of Efficacy|1|||
124839895|NCT00357370|449042869|FG000|Cohort 2|Adverse Event|1|||
124839896|NCT00357370|449042870|FG001|Cohort 2|Adverse Event|1|||
124839897|NCT00357370|449042871|FG002|Cohort 2|Adverse Event|1|||
124839898|NCT00357370|449042869|FG000|Cohort 2|Lost to Follow-up|0|||
124839899|NCT00357370|449042870|FG001|Cohort 2|Lost to Follow-up|1|||
124839900|NCT00357370|449042871|FG002|Cohort 2|Lost to Follow-up|0|||
124839901|NCT00357370|449042869|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
124839902|NCT00357370|449042870|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
124839903|NCT00357370|449042871|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
124839904|NCT00357370|449042869|FG000|Cohort 2|Withdrawal by Subject|0|||
124839905|NCT00357370|449042870|FG001|Cohort 2|Withdrawal by Subject|2|||
124839906|NCT00357370|449042871|FG002|Cohort 2|Withdrawal by Subject|0|||
124839907|NCT00937547|449042873|FG000|Overall Study|misdiagnosis|1|||
124839908|NCT00937547|449042874|FG001|Overall Study|misdiagnosis|6|||
124839909|NCT00937547|449042875|FG002|Overall Study|misdiagnosis|7|||
124839910|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
124839911|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
124839912|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
124839913|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
124839914|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
124839915|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
124839916|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
124839917|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
124839918|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
124839919|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
124839920|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
124839921|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
124839922|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
124839923|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
124839924|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
124839925|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
124839926|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
124839927|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
124839928|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Death|0|||
124839929|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Death|0|||
124839930|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Death|1|||
124839931|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Death|0|||
124839932|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Death|0|||
124839933|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Death|0|||
124839934|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Death|0|||
124839935|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Death|0|||
124839936|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Death|0|||
124839937|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
124839938|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
124839939|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
124839940|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
124839941|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
124839942|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
124839943|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
124839944|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
124839945|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
124839946|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
124839947|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
124839948|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
124839949|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
124839950|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
124839951|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
124839952|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
124839953|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
124839954|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
124839955|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
124839956|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
124839957|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
124839958|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
124839959|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
124839960|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
124839961|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
124839962|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
124839963|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
124839964|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
124839965|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
124839966|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
124839967|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
124839968|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
124839969|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
124839970|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
124839971|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
124839972|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
124839973|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
124839974|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
124839975|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
124839976|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
124839977|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
124839978|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
124839979|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
124839980|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
124839981|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
124839982|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
124839983|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
124839984|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
124839985|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
124839986|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
124839987|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
124839988|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
124839989|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
124839990|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
124839991|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
124839992|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
124839993|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
124839994|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
124839995|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
124839996|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
124839997|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
124839998|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
124839999|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
124840000|NCT00404352|449042877|FG000|Double Blind (up to 24 Month)|Other|0|||
124840001|NCT00404352|449042878|FG001|Double Blind (up to 24 Month)|Other|1|||
124840002|NCT00404352|449042879|FG002|Double Blind (up to 24 Month)|Other|0|||
124840003|NCT00404352|449042880|FG003|Double Blind (up to 24 Month)|Other|0|||
124840004|NCT00404352|449042881|FG004|Double Blind (up to 24 Month)|Other|0|||
124840005|NCT00404352|449042882|FG005|Double Blind (up to 24 Month)|Other|0|||
124840006|NCT00404352|449042883|FG006|Double Blind (up to 24 Month)|Other|0|||
124840007|NCT00404352|449042884|FG007|Double Blind (up to 24 Month)|Other|0|||
124840008|NCT00404352|449042885|FG008|Double Blind (up to 24 Month)|Other|0|||
124840009|NCT00404352|449042877|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
124640075|NCT03645395|448299877|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
124840010|NCT00404352|449042878|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
124840011|NCT00404352|449042879|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
124840012|NCT00404352|449042880|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
124840013|NCT00404352|449042881|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
124840014|NCT00404352|449042882|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
124840015|NCT00404352|449042883|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
124640076|NCT01057810|448299878|FG000|Overall Study|Disease progression|156|||
124640077|NCT01057810|448299879|FG001|Overall Study|Disease progression|197|||
124640078|NCT01057810|448299878|FG000|Overall Study|Study drug toxicity|5|||
124840016|NCT00404352|449042884|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
124840017|NCT00404352|449042885|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
124840018|NCT00404352|449042877|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
124840019|NCT00404352|449042878|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
124840020|NCT00404352|449042879|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
124840021|NCT00404352|449042880|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
124840022|NCT00404352|449042881|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
124840023|NCT00404352|449042882|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
124840024|NCT00404352|449042883|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
124840025|NCT00404352|449042884|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
124840026|NCT00404352|449042885|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
124840027|NCT00404352|449042877|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
124840028|NCT00404352|449042878|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
124840029|NCT00404352|449042879|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
124840030|NCT00404352|449042880|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
124840031|NCT00404352|449042881|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
124840032|NCT00404352|449042882|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
124840033|NCT00404352|449042883|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
124840034|NCT00404352|449042884|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
124840035|NCT00404352|449042885|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
124840036|NCT00404352|449042877|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
124840037|NCT00404352|449042878|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
124840038|NCT00404352|449042879|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
124840039|NCT00404352|449042880|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
124840040|NCT00404352|449042881|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
124840041|NCT00404352|449042882|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
124840042|NCT00404352|449042883|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
124840043|NCT00404352|449042884|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
124840044|NCT00404352|449042885|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
124840045|NCT00404352|449042877|FG000|Open Label (up to 24 Month)|Disease progression|0|||
124840046|NCT00404352|449042878|FG001|Open Label (up to 24 Month)|Disease progression|0|||
124840047|NCT00404352|449042879|FG002|Open Label (up to 24 Month)|Disease progression|0|||
124840048|NCT00404352|449042880|FG003|Open Label (up to 24 Month)|Disease progression|1|||
124840049|NCT00404352|449042881|FG004|Open Label (up to 24 Month)|Disease progression|0|||
124840050|NCT00404352|449042882|FG005|Open Label (up to 24 Month)|Disease progression|0|||
124840051|NCT00404352|449042883|FG006|Open Label (up to 24 Month)|Disease progression|0|||
124840052|NCT00404352|449042884|FG007|Open Label (up to 24 Month)|Disease progression|0|||
124840053|NCT00404352|449042885|FG008|Open Label (up to 24 Month)|Disease progression|0|||
124840054|NCT00404352|449042877|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
124840055|NCT00404352|449042878|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
124840056|NCT00404352|449042879|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
124840057|NCT00404352|449042880|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
124840058|NCT00404352|449042881|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
124840059|NCT00404352|449042882|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
124840060|NCT00404352|449042883|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
124840061|NCT00404352|449042884|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
124840062|NCT00404352|449042885|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
124840063|NCT00404352|449042877|FG000|Open Label Extension (up to 36 Months)|Other|0|||
124840064|NCT00404352|449042878|FG001|Open Label Extension (up to 36 Months)|Other|0|||
124840065|NCT00404352|449042879|FG002|Open Label Extension (up to 36 Months)|Other|0|||
124840066|NCT00404352|449042880|FG003|Open Label Extension (up to 36 Months)|Other|0|||
124840067|NCT00404352|449042881|FG004|Open Label Extension (up to 36 Months)|Other|0|||
124840068|NCT00404352|449042882|FG005|Open Label Extension (up to 36 Months)|Other|0|||
124840069|NCT00404352|449042883|FG006|Open Label Extension (up to 36 Months)|Other|0|||
124840070|NCT00404352|449042884|FG007|Open Label Extension (up to 36 Months)|Other|0|||
124840071|NCT00404352|449042885|FG008|Open Label Extension (up to 36 Months)|Other|2|||
124840072|NCT02346136|449042888|FG000|Overall Study|Withdrawal by Subject|7|||
124840073|NCT02346136|449042889|FG001|Overall Study|Withdrawal by Subject|5|||
124640079|NCT01057810|448299879|FG001|Overall Study|Study drug toxicity|114|||
124640080|NCT01057810|448299878|FG000|Overall Study|Adverse event unrelated to study drug|13|||
124640081|NCT01057810|448299879|FG001|Overall Study|Adverse event unrelated to study drug|29|||
124640082|NCT01057810|448299878|FG000|Overall Study|Withdrawal by Subject|10|||
124640083|NCT01057810|448299879|FG001|Overall Study|Withdrawal by Subject|25|||
124640084|NCT01057810|448299878|FG000|Overall Study|Death|2|||
124640085|NCT01057810|448299879|FG001|Overall Study|Death|12|||
124640086|NCT01057810|448299878|FG000|Overall Study|Maximum clinical benefit|5|||
124640087|NCT01057810|448299879|FG001|Overall Study|Maximum clinical benefit|5|||
124840074|NCT02346136|449042888|FG000|Overall Study|Death|1|||
124840075|NCT02346136|449042889|FG001|Overall Study|Death|0|||
124840076|NCT02346136|449042888|FG000|Overall Study|Study termination|14|||
124640088|NCT01057810|448299878|FG000|Overall Study|Poor/non-compliance|0|||
124640089|NCT01057810|448299879|FG001|Overall Study|Poor/non-compliance|1|||
124840077|NCT02346136|449042889|FG001|Overall Study|Study termination|18|||
124840078|NCT00582933|449042892|FG000|Overall Study|Physician Decision|3|||
124840079|NCT03837899|449042895|FG000|Overall Study|Death|6|||
124840080|NCT03837899|449042896|FG001|Overall Study|Death|8|||
124840081|NCT03837899|449042897|FG002|Overall Study|Death|3|||
124840082|NCT03837899|449042898|FG003|Overall Study|Death|7|||
124840083|NCT03837899|449042899|FG004|Overall Study|Death|8|||
124840084|NCT03837899|449042900|FG005|Overall Study|Death|7|||
124840085|NCT03837899|449042895|FG000|Overall Study|Moved to post-trial access program|0|||
124840086|NCT03837899|449042896|FG001|Overall Study|Moved to post-trial access program|1|||
124840087|NCT03837899|449042897|FG002|Overall Study|Moved to post-trial access program|0|||
124840088|NCT03837899|449042898|FG003|Overall Study|Moved to post-trial access program|0|||
124840089|NCT03837899|449042899|FG004|Overall Study|Moved to post-trial access program|0|||
124840090|NCT03837899|449042900|FG005|Overall Study|Moved to post-trial access program|0|||
124840091|NCT03837899|449042895|FG000|Overall Study|Other|0|||
124840092|NCT03837899|449042896|FG001|Overall Study|Other|0|||
124840093|NCT03837899|449042897|FG002|Overall Study|Other|0|||
124840094|NCT03837899|449042898|FG003|Overall Study|Other|0|||
124840095|NCT03837899|449042899|FG004|Overall Study|Other|0|||
124840096|NCT03837899|449042900|FG005|Overall Study|Other|2|||
124840097|NCT03837899|449042895|FG000|Overall Study|Lost to Follow-up|0|||
124840098|NCT03837899|449042896|FG001|Overall Study|Lost to Follow-up|1|||
124840099|NCT03837899|449042897|FG002|Overall Study|Lost to Follow-up|0|||
124840100|NCT03837899|449042898|FG003|Overall Study|Lost to Follow-up|0|||
124840101|NCT03837899|449042899|FG004|Overall Study|Lost to Follow-up|0|||
124840102|NCT03837899|449042900|FG005|Overall Study|Lost to Follow-up|0|||
124840103|NCT03837899|449042895|FG000|Overall Study|Withdrawal by Subject|0|||
124840104|NCT03837899|449042896|FG001|Overall Study|Withdrawal by Subject|0|||
124840105|NCT03837899|449042897|FG002|Overall Study|Withdrawal by Subject|0|||
124840106|NCT03837899|449042898|FG003|Overall Study|Withdrawal by Subject|1|||
124840107|NCT03837899|449042899|FG004|Overall Study|Withdrawal by Subject|0|||
124840108|NCT03837899|449042900|FG005|Overall Study|Withdrawal by Subject|0|||
124840109|NCT03837899|449042895|FG000|Overall Study|Study specific discontinuation criteria|0|||
124840110|NCT03837899|449042896|FG001|Overall Study|Study specific discontinuation criteria|1|||
124840111|NCT03837899|449042897|FG002|Overall Study|Study specific discontinuation criteria|0|||
124840112|NCT03837899|449042898|FG003|Overall Study|Study specific discontinuation criteria|0|||
124840113|NCT03837899|449042899|FG004|Overall Study|Study specific discontinuation criteria|3|||
124840114|NCT03837899|449042900|FG005|Overall Study|Study specific discontinuation criteria|1|||
124840115|NCT01465464|449042901|FG000|Overall Study|Adverse Event|96|||
124840116|NCT01465464|449042902|FG001|Overall Study|Adverse Event|49|||
124840117|NCT01465464|449042901|FG000|Overall Study|Lack of Efficacy|139|||
124840118|NCT01465464|449042902|FG001|Overall Study|Lack of Efficacy|190|||
124840119|NCT01465464|449042901|FG000|Overall Study|Physician Decision|13|||
124840120|NCT01465464|449042902|FG001|Overall Study|Physician Decision|5|||
124840121|NCT01465464|449042901|FG000|Overall Study|Protocol Violation|1|||
124840122|NCT01465464|449042902|FG001|Overall Study|Protocol Violation|1|||
124840123|NCT01465464|449042901|FG000|Overall Study|Withdrawal by Subject|46|||
124840124|NCT01465464|449042902|FG001|Overall Study|Withdrawal by Subject|30|||
124840125|NCT01465464|449042901|FG000|Overall Study|Other|9|||
124840126|NCT01465464|449042902|FG001|Overall Study|Other|3|||
124840127|NCT01465464|449042901|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
124840128|NCT01465464|449042902|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
124840129|NCT00785486|449042903|FG000|Midazolam Alone|Withdrawal by Subject|1|||
124840130|NCT01554618|449042907|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
124840131|NCT01554618|449042908|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
124840132|NCT01554618|449042907|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
124840133|NCT01554618|449042908|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
124840134|NCT01554618|449042907|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
124840135|NCT01554618|449042908|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
124840136|NCT01554618|449042907|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
124840137|NCT01554618|449042908|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
124840138|NCT01554618|449042907|FG000|Open-Label Extension Period|Physician Decision|0|||
124840139|NCT01554618|449042908|FG001|Open-Label Extension Period|Physician Decision|1|||
124840140|NCT01554618|449042907|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
124840141|NCT01554618|449042908|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
124840142|NCT01116232|449042910|FG000|Overall Study|Progressive diease|4|||
124840143|NCT02357940|449042911|FG000|Overall Study|Adverse Event|0|||
124840144|NCT02357940|449042912|FG001|Overall Study|Adverse Event|1|||
124840145|NCT02357940|449042911|FG000|Overall Study|Investigator's judgement|0|||
124840146|NCT02357940|449042912|FG001|Overall Study|Investigator's judgement|1|||
124840147|NCT02275481|449042913|FG000|Overall Study|Death|2|||
124840148|NCT02275481|449042914|FG001|Overall Study|Death|1|||
124840149|NCT02275481|449042913|FG000|Overall Study|Lost to Follow-up|2|||
124840150|NCT02275481|449042914|FG001|Overall Study|Lost to Follow-up|0|||
124840151|NCT02275481|449042913|FG000|Overall Study|Withdrawal by Subject|3|||
124840152|NCT02275481|449042914|FG001|Overall Study|Withdrawal by Subject|0|||
124840153|NCT02275481|449042913|FG000|Overall Study|all other reasons combined|2|||
124840154|NCT02275481|449042914|FG001|Overall Study|all other reasons combined|1|||
124840155|NCT02275481|449042913|FG000|Overall Study|Physician Decision|0|||
124840156|NCT02275481|449042914|FG001|Overall Study|Physician Decision|1|||
124840157|NCT03350503|449042922|FG000|Overall Study|Adverse Event|5|||
124840158|NCT03350503|449042922|FG000|Overall Study|Withdrawal by Subject|5|||
124840159|NCT03350503|449042922|FG000|Overall Study|Continuation impossible due to move|4|||
124840160|NCT03350503|449042922|FG000|Overall Study|Physician Decision|3|||
124840161|NCT00344773|449042925|FG000|Overall Study|Adverse Event|2|||
124840162|NCT00344773|449042925|FG000|Overall Study|Objective Disease Progression|16|||
124840163|NCT00344773|449042925|FG000|Overall Study|Withdrawal by Subject|1|||
124840164|NCT00344773|449042925|FG000|Overall Study|Not Eligible for the study|2|||
124840165|NCT02141074|449042927|FG000|Pre-prophylaxis|Adverse Event|3|||
124840166|NCT02141074|449042928|FG001|Pre-prophylaxis|Adverse Event|0|||
124840167|NCT02141074|449042927|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
124840168|NCT02141074|449042928|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
124840169|NCT02141074|449042927|FG000|Prophylaxis|Adverse Event|0|||
124840170|NCT02141074|449042928|FG001|Prophylaxis|Adverse Event|4|||
124840171|NCT02141074|449042927|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
124840172|NCT02141074|449042928|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
124840173|NCT02141074|449042927|FG000|Prophylaxis|Withdrawal by Subject|0|||
124840174|NCT02141074|449042928|FG001|Prophylaxis|Withdrawal by Subject|1|||
124840175|NCT06023394|449042930|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
124840176|NCT06023394|449042931|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
124840177|NCT06023394|449042930|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
124840178|NCT06023394|449042931|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
124840179|NCT06023394|449042930|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
124840180|NCT06023394|449042931|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
124840181|NCT06023394|449042930|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
124840182|NCT06023394|449042931|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
124840183|NCT02283788|449042933|FG000|Overall Study|Adverse Event|1|||
124840184|NCT02283788|449042934|FG001|Overall Study|Adverse Event|3|||
124840185|NCT02283788|449042935|FG002|Overall Study|Adverse Event|5|||
124840186|NCT02283788|449042936|FG003|Overall Study|Adverse Event|1|||
124840187|NCT02283788|449042933|FG000|Overall Study|Withdrawal by Subject|0|||
124840188|NCT02283788|449042934|FG001|Overall Study|Withdrawal by Subject|1|||
124840189|NCT02283788|449042935|FG002|Overall Study|Withdrawal by Subject|0|||
124840190|NCT02283788|449042936|FG003|Overall Study|Withdrawal by Subject|1|||
124840191|NCT02565381|449044838|FG000|Overall Study|Lost to Follow-up|1|||
124840192|NCT02565381|449044839|FG001|Overall Study|Lost to Follow-up|0|||
124840193|NCT02565381|449044840|FG002|Overall Study|Lost to Follow-up|1|||
124840194|NCT02554656|449044847|FG000|Overall Study|Protocol Violation|3|||
124840195|NCT00749463|449044852|FG000|Overall Study|Adverse Event|0|||
124840196|NCT00749463|449044853|FG001|Overall Study|Adverse Event|4|||
124840197|NCT00749463|449044854|FG002|Overall Study|Adverse Event|1|||
124840198|NCT00749463|449044852|FG000|Overall Study|Withdrawal by Subject|1|||
124840199|NCT00749463|449044853|FG001|Overall Study|Withdrawal by Subject|0|||
124840200|NCT00749463|449044854|FG002|Overall Study|Withdrawal by Subject|0|||
124840201|NCT03643562|449044861|FG000|Overall Study|Adverse Event|1|||
124840202|NCT03643562|449044862|FG001|Overall Study|Adverse Event|0|||
124840203|NCT03643562|449044861|FG000|Overall Study|Lack of Efficacy|0|||
124840204|NCT03643562|449044862|FG001|Overall Study|Lack of Efficacy|1|||
124840205|NCT03643562|449044861|FG000|Overall Study|Physician Decision|0|||
124840206|NCT03643562|449044862|FG001|Overall Study|Physician Decision|1|||
124840207|NCT03643562|449044861|FG000|Overall Study|Study Terminated by Sponsor|2|||
124840208|NCT03643562|449044862|FG001|Overall Study|Study Terminated by Sponsor|10|||
124840209|NCT03643562|449044861|FG000|Overall Study|Withdrawal by Subject|2|||
124840210|NCT03643562|449044862|FG001|Overall Study|Withdrawal by Subject|2|||
124840211|NCT03643562|449044861|FG000|Overall Study|Other than specified|3|||
124840212|NCT03643562|449044862|FG001|Overall Study|Other than specified|2|||
124840213|NCT01982253|449044863|FG000|Overall Study|Withdrawal by Subject|1|||
124840214|NCT01982253|449044864|FG001|Overall Study|Withdrawal by Subject|0|||
124840215|NCT01982253|449044865|FG002|Overall Study|Withdrawal by Subject|0|||
124840216|NCT01982253|449044863|FG000|Overall Study|Study terminated by sponsor|1|||
124840217|NCT01982253|449044864|FG001|Overall Study|Study terminated by sponsor|4|||
124840218|NCT01982253|449044865|FG002|Overall Study|Study terminated by sponsor|4|||
124840219|NCT01886833|449044870|FG000|Overall Study|IgA not available from both periods|204|||
124840220|NCT02223767|449044878|FG000|Overall Study|Withdrawal by Subject|4|||
124840221|NCT02223767|449044879|FG001|Overall Study|Withdrawal by Subject|4|||
124840222|NCT00333229|449044882|FG000|Overall Study|Lack of Efficacy|0|||
124840223|NCT00333229|449044883|FG001|Overall Study|Lack of Efficacy|1|||
124840224|NCT00348556|449044884|FG000|Overall Study|Adverse Event|1|||
124840225|NCT00240071|449044885|FG000|Overall Study|Withdrawal by Subject|3|||
124840226|NCT01944059|449044886|FG000|Overall Study|Lost to Follow-up|1|||
124840227|NCT01944059|449044886|FG000|Overall Study|Physician Decision|3|||
124840228|NCT01944059|449044886|FG000|Overall Study|Withdrawal by Subject|1|||
124840229|NCT01944059|449044886|FG000|Overall Study|Adverse Event|2|||
124840230|NCT04206293|449044897|FG000|Overall Study|Consent withdrawal|1|||
124840231|NCT01454934|449044900|FG000|Overall Study|Clinical progression|28|||
124840232|NCT01454934|449044901|FG001|Overall Study|Clinical progression|25|||
124840233|NCT01454934|449044900|FG000|Overall Study|Other|6|||
124840234|NCT01454934|449044901|FG001|Overall Study|Other|17|||
124840235|NCT01454934|449044900|FG000|Overall Study|Adverse Event|28|||
124840236|NCT01454934|449044901|FG001|Overall Study|Adverse Event|24|||
124840237|NCT01454934|449044900|FG000|Overall Study|Withdrawn consent|2|||
124840238|NCT01454934|449044901|FG001|Overall Study|Withdrawn consent|5|||
124840239|NCT01454934|449044900|FG000|Overall Study|Withdrawal by Subject|11|||
124840240|NCT01454934|449044901|FG001|Overall Study|Withdrawal by Subject|15|||
124840241|NCT01454934|449044900|FG000|Overall Study|Disease progression|194|||
124840242|NCT01454934|449044901|FG001|Overall Study|Disease progression|181|||
124840243|NCT01454934|449044900|FG000|Overall Study|Lost to Follow-up|0|||
124840244|NCT01454934|449044901|FG001|Overall Study|Lost to Follow-up|1|||
124840245|NCT01454934|449044900|FG000|Overall Study|Not treated|1|||
124840246|NCT01454934|449044901|FG001|Overall Study|Not treated|2|||
124840247|NCT01802775|449044913|FG000|Overall Study|Death|0|||
124840248|NCT01802775|449044914|FG001|Overall Study|Death|3|||
124840249|NCT01802775|449044913|FG000|Overall Study|Reason not provided|0|||
124840250|NCT01802775|449044914|FG001|Overall Study|Reason not provided|1|||
124840251|NCT01802775|449044913|FG000|Overall Study|Physician Decision|1|||
124840252|NCT01802775|449044914|FG001|Overall Study|Physician Decision|0|||
124840253|NCT01802775|449044913|FG000|Overall Study|Adverse Event|1|||
124840254|NCT01802775|449044914|FG001|Overall Study|Adverse Event|1|||
124840255|NCT01802775|449044913|FG000|Overall Study|Withdrawal by Subject|3|||
124840256|NCT01802775|449044914|FG001|Overall Study|Withdrawal by Subject|5|||
124840257|NCT01802775|449044913|FG000|Overall Study|Lost to Follow-up|1|||
124840258|NCT01802775|449044914|FG001|Overall Study|Lost to Follow-up|2|||
124840259|NCT00782210|449044922|FG000|Overall Study|Adverse Event|21|||
124840260|NCT00782210|449044923|FG001|Overall Study|Adverse Event|17|||
124840261|NCT00782210|449044924|FG002|Overall Study|Adverse Event|16|||
124840262|NCT00782210|449044922|FG000|Overall Study|Lost to Follow-up|2|||
124840263|NCT00782210|449044923|FG001|Overall Study|Lost to Follow-up|1|||
124840264|NCT00782210|449044924|FG002|Overall Study|Lost to Follow-up|2|||
124840265|NCT00782210|449044922|FG000|Overall Study|Withdrawal by Subject|11|||
124840266|NCT00782210|449044923|FG001|Overall Study|Withdrawal by Subject|8|||
124840267|NCT00782210|449044924|FG002|Overall Study|Withdrawal by Subject|11|||
124840268|NCT00782210|449044922|FG000|Overall Study|Non compliance with protocol|0|||
124840269|NCT00782210|449044923|FG001|Overall Study|Non compliance with protocol|3|||
124840270|NCT00782210|449044924|FG002|Overall Study|Non compliance with protocol|2|||
124840271|NCT00782210|449044922|FG000|Overall Study|Lack of Efficacy|13|||
124840272|NCT00782210|449044923|FG001|Overall Study|Lack of Efficacy|4|||
124840273|NCT00782210|449044924|FG002|Overall Study|Lack of Efficacy|1|||
124840274|NCT00782210|449044922|FG000|Overall Study|Other reason not described above|3|||
124840275|NCT00782210|449044923|FG001|Overall Study|Other reason not described above|2|||
124840276|NCT00782210|449044924|FG002|Overall Study|Other reason not described above|3|||
124840277|NCT00826267|449044927|FG000|Overall Study|Other Adverse Event|1|||
124840278|NCT00826267|449044928|FG001|Overall Study|Other Adverse Event|0|||
124840279|NCT00826267|449044929|FG002|Overall Study|Other Adverse Event|0|||
124840280|NCT00048542|449044943|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
124840281|NCT00048542|449044944|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
124840282|NCT00048542|449044945|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
124840283|NCT00048542|449044946|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
124840284|NCT00048542|449044947|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
124840285|NCT00048542|449044948|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
124840286|NCT00048542|449044949|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
124840287|NCT00048542|449044950|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
124840288|NCT00048542|449044943|FG000|Double-Blind Phase|Protocol Violation|0|||
124840289|NCT00048542|449044944|FG001|Double-Blind Phase|Protocol Violation|0|||
124840290|NCT00048542|449044945|FG002|Double-Blind Phase|Protocol Violation|1|||
124840291|NCT00048542|449044946|FG003|Double-Blind Phase|Protocol Violation|0|||
124840292|NCT00048542|449044947|FG004|Double-Blind Phase|Protocol Violation|0|||
124840293|NCT00048542|449044948|FG005|Double-Blind Phase|Protocol Violation|0|||
124840294|NCT00048542|449044949|FG006|Double-Blind Phase|Protocol Violation|0|||
124840295|NCT00048542|449044950|FG007|Double-Blind Phase|Protocol Violation|0|||
124840296|NCT00048542|449044943|FG000|Double-Blind Phase|Sponsor request or decision|2|||
124840297|NCT00048542|449044944|FG001|Double-Blind Phase|Sponsor request or decision|0|||
124840298|NCT00048542|449044945|FG002|Double-Blind Phase|Sponsor request or decision|0|||
124840299|NCT00048542|449044946|FG003|Double-Blind Phase|Sponsor request or decision|0|||
124840300|NCT00048542|449044947|FG004|Double-Blind Phase|Sponsor request or decision|0|||
124840301|NCT00048542|449044948|FG005|Double-Blind Phase|Sponsor request or decision|0|||
124840302|NCT00048542|449044949|FG006|Double-Blind Phase|Sponsor request or decision|0|||
124840303|NCT00048542|449044950|FG007|Double-Blind Phase|Sponsor request or decision|0|||
124840304|NCT00048542|449044943|FG000|Double-Blind Phase|Randomized in error|1|||
124840305|NCT00048542|449044944|FG001|Double-Blind Phase|Randomized in error|0|||
124840306|NCT00048542|449044945|FG002|Double-Blind Phase|Randomized in error|0|||
124840307|NCT00048542|449044946|FG003|Double-Blind Phase|Randomized in error|0|||
124840308|NCT00048542|449044947|FG004|Double-Blind Phase|Randomized in error|0|||
124840309|NCT00048542|449044948|FG005|Double-Blind Phase|Randomized in error|0|||
124840310|NCT00048542|449044949|FG006|Double-Blind Phase|Randomized in error|0|||
124840311|NCT00048542|449044950|FG007|Double-Blind Phase|Randomized in error|0|||
124840312|NCT00048542|449044943|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
124840313|NCT00048542|449044944|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
124840314|NCT00048542|449044945|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
124840315|NCT00048542|449044946|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
124840316|NCT00048542|449044947|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
124840317|NCT00048542|449044948|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
124840318|NCT00048542|449044949|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
124840319|NCT00048542|449044950|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
124840320|NCT00048542|449044943|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
124840321|NCT00048542|449044944|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
124840322|NCT00048542|449044945|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
124840323|NCT00048542|449044946|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
124840324|NCT00048542|449044947|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
124840325|NCT00048542|449044948|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
124840326|NCT00048542|449044949|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
124840327|NCT00048542|449044950|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
124840328|NCT00048542|449044943|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
124840329|NCT00048542|449044944|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
124840330|NCT00048542|449044945|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
124840331|NCT00048542|449044946|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
124840332|NCT00048542|449044947|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
124840333|NCT00048542|449044948|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
124840334|NCT00048542|449044949|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
124840335|NCT00048542|449044950|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
124840336|NCT00048542|449044943|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
124840337|NCT00048542|449044944|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
124840338|NCT00048542|449044945|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
124840339|NCT00048542|449044946|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
124840340|NCT00048542|449044947|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
124840341|NCT00048542|449044948|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
124840342|NCT00048542|449044949|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
124840343|NCT00048542|449044950|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
124840344|NCT00048542|449044943|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
124840345|NCT00048542|449044944|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
124840346|NCT00048542|449044945|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
124840347|NCT00048542|449044946|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
124840348|NCT00048542|449044947|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
124840349|NCT00048542|449044948|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
124840350|NCT00048542|449044949|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
124840351|NCT00048542|449044950|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
124840352|NCT00048542|449044943|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
124840353|NCT00048542|449044944|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
124840354|NCT00048542|449044945|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
124840355|NCT00048542|449044946|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
124840356|NCT00048542|449044947|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
124840357|NCT00048542|449044948|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
124840358|NCT00048542|449044949|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
124840359|NCT00048542|449044950|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
124840360|NCT00048542|449044943|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
124840361|NCT00048542|449044944|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
124840362|NCT00048542|449044945|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
124840363|NCT00048542|449044946|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
124840364|NCT00048542|449044947|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
124840365|NCT00048542|449044948|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
124840366|NCT00048542|449044949|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
124840367|NCT00048542|449044950|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
124840368|NCT00048542|449044943|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
124840369|NCT00048542|449044944|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
124840370|NCT00048542|449044945|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
124840371|NCT00048542|449044946|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
124840372|NCT00048542|449044947|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
124840373|NCT00048542|449044948|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
124840374|NCT00048542|449044949|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
124840375|NCT00048542|449044950|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
124840376|NCT00048542|449044943|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
124840377|NCT00048542|449044944|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
124840378|NCT00048542|449044945|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
124840379|NCT00048542|449044946|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
124840380|NCT00048542|449044947|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
124840381|NCT00048542|449044948|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
124840382|NCT00048542|449044949|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
124840383|NCT00048542|449044950|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
124840384|NCT00048542|449044943|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
124840385|NCT00048542|449044944|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
124840386|NCT00048542|449044945|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
124840387|NCT00048542|449044946|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
124840388|NCT00048542|449044947|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
124840389|NCT00048542|449044948|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
124840390|NCT00048542|449044949|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
124840391|NCT00048542|449044950|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
124840392|NCT00048542|449044943|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
124840393|NCT00048542|449044944|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
124840394|NCT00048542|449044945|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
124840395|NCT00048542|449044946|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
124840396|NCT00048542|449044947|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
124840397|NCT00048542|449044948|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
124840398|NCT00048542|449044949|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
124840399|NCT00048542|449044950|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
124840400|NCT00578175|449044951|FG000|Overall Study|Adverse Event|0|||
124840401|NCT00578175|449044952|FG001|Overall Study|Adverse Event|1|||
124840402|NCT00578175|449044953|FG002|Overall Study|Adverse Event|1|||
124840403|NCT00578175|449044951|FG000|Overall Study|Other reasons|70|||
124840404|NCT00578175|449044952|FG001|Overall Study|Other reasons|42|||
124840405|NCT00578175|449044953|FG002|Overall Study|Other reasons|23|||
124840406|NCT02272413|449044955|FG000|Randomized Through Treatment Start|Not treated|3|||
124840407|NCT02272413|449044956|FG001|Randomized Through Treatment Start|Not treated|5|||
124840408|NCT02272413|449044955|FG000|Pre-switch Period|Adverse Event|38|||
124840409|NCT02272413|449044956|FG001|Pre-switch Period|Adverse Event|37|||
124840410|NCT02272413|449044955|FG000|Pre-switch Period|Death|26|||
124840411|NCT02272413|449044956|FG001|Pre-switch Period|Death|26|||
124840412|NCT02272413|449044955|FG000|Pre-switch Period|Withdrawal by Subject|27|||
124840413|NCT02272413|449044956|FG001|Pre-switch Period|Withdrawal by Subject|15|||
124840414|NCT02272413|449044955|FG000|Pre-switch Period|Physician Decision|6|||
124840415|NCT02272413|449044956|FG001|Pre-switch Period|Physician Decision|18|||
124840416|NCT02272413|449044955|FG000|Pre-switch Period|Progressive disease|185|||
124840417|NCT02272413|449044956|FG001|Pre-switch Period|Progressive disease|173|||
124840418|NCT02272413|449044955|FG000|Pre-switch Period|Lost to Follow-up|0|||
124840419|NCT02272413|449044956|FG001|Pre-switch Period|Lost to Follow-up|2|||
124840420|NCT02272413|449044955|FG000|Pre-switch Period|Protocol Violation|1|||
124840421|NCT02272413|449044956|FG001|Pre-switch Period|Protocol Violation|0|||
124840422|NCT02272413|449044955|FG000|Pre-switch Period|Other than listed|10|||
124840423|NCT02272413|449044956|FG001|Pre-switch Period|Other than listed|11|||
124840424|NCT02272413|449044955|FG000|Post-switch Period|Adverse Event|4|||
124840425|NCT02272413|449044956|FG001|Post-switch Period|Adverse Event|4|||
124840426|NCT02272413|449044955|FG000|Post-switch Period|Death|3|||
124840427|NCT02272413|449044956|FG001|Post-switch Period|Death|2|||
124640090|NCT01057810|448299878|FG000|Overall Study|No longer met study criteria|0|||
124640091|NCT01057810|448299879|FG001|Overall Study|No longer met study criteria|1|||
124640092|NCT01057810|448299878|FG000|Overall Study|Other|7|||
124640093|NCT01057810|448299879|FG001|Overall Study|Other|14|||
124640094|NCT00267969|448299880|FG000|Controlled Period|Adverse Event|6|||
124640095|NCT00267969|448299881|FG001|Controlled Period|Adverse Event|0|||
124640096|NCT00267969|448299882|FG002|Controlled Period|Adverse Event|2|||
124640097|NCT00267969|448299883|FG003|Controlled Period|Adverse Event|0|||
124640098|NCT00267969|448299884|FG004|Controlled Period|Adverse Event|0|||
124840428|NCT02272413|449044955|FG000|Post-switch Period|Withdrawal by Subject|1|||
124840429|NCT02272413|449044956|FG001|Post-switch Period|Withdrawal by Subject|2|||
124840430|NCT02272413|449044955|FG000|Post-switch Period|Physician Decision|1|||
124840431|NCT02272413|449044956|FG001|Post-switch Period|Physician Decision|1|||
124640099|NCT00267969|448299885|FG005|Controlled Period|Adverse Event|0|||
124640100|NCT00267969|448299886|FG006|Controlled Period|Adverse Event|0|||
124640101|NCT00267969|448299880|FG000|Controlled Period|Lack of Efficacy|3|||
124640102|NCT00267969|448299881|FG001|Controlled Period|Lack of Efficacy|0|||
124640103|NCT00267969|448299882|FG002|Controlled Period|Lack of Efficacy|1|||
124640104|NCT00267969|448299883|FG003|Controlled Period|Lack of Efficacy|0|||
124640105|NCT00267969|448299884|FG004|Controlled Period|Lack of Efficacy|0|||
124640106|NCT00267969|448299885|FG005|Controlled Period|Lack of Efficacy|0|||
124640107|NCT00267969|448299886|FG006|Controlled Period|Lack of Efficacy|0|||
124640108|NCT00267969|448299880|FG000|Controlled Period|Lost to Follow-up|1|||
124640109|NCT00267969|448299881|FG001|Controlled Period|Lost to Follow-up|0|||
124640110|NCT00267969|448299882|FG002|Controlled Period|Lost to Follow-up|1|||
124640111|NCT00267969|448299883|FG003|Controlled Period|Lost to Follow-up|0|||
124640112|NCT00267969|448299884|FG004|Controlled Period|Lost to Follow-up|0|||
124640113|NCT00267969|448299885|FG005|Controlled Period|Lost to Follow-up|0|||
124840432|NCT02272413|449044955|FG000|Post-switch Period|Progressive disease|21|||
124840433|NCT02272413|449044956|FG001|Post-switch Period|Progressive disease|21|||
124840434|NCT02272413|449044955|FG000|Post-switch Period|Study terminated by sponsor|8|||
124840435|NCT02272413|449044956|FG001|Post-switch Period|Study terminated by sponsor|11|||
124840436|NCT02272413|449044955|FG000|Post-switch Period|Other than listed|4|||
124840437|NCT02272413|449044956|FG001|Post-switch Period|Other than listed|5|||
124840438|NCT02126969|449044957|FG000|Overall Study|Withdrawal by Subject|1|||
124840439|NCT02126969|449044958|FG001|Overall Study|Withdrawal by Subject|2|||
124840440|NCT01533246|449044959|FG000|Overall Study|Adverse Event|1|||
124840441|NCT01533246|449044959|FG000|Overall Study|Withdrawal by Subject|1|||
124840442|NCT01143090|449044960|FG000|Overall Study|Lack of Efficacy|2|||
124840443|NCT01143090|449044960|FG000|Overall Study|Adverse Event|17|||
124840444|NCT01143090|449044960|FG000|Overall Study|Lost to Follow-up|9|||
124840445|NCT01143090|449044960|FG000|Overall Study|Protocol Violation|2|||
124840446|NCT01143090|449044960|FG000|Overall Study|Withdrawal by Subject|18|||
124840447|NCT01143090|449044960|FG000|Overall Study|Non-compliance with study drug|1|||
124840448|NCT01143090|449044960|FG000|Overall Study|Failure to meet eligibility criteria|1|||
124840449|NCT01143090|449044960|FG000|Overall Study|Administrative|1|||
124840450|NCT01461096|449044966|FG000|Overall Study|Death|3|||
124840451|NCT01461096|449044967|FG001|Overall Study|Death|6|||
124840452|NCT01461096|449044966|FG000|Overall Study|Severe debilitation, unable to continue|1|||
124840453|NCT01461096|449044967|FG001|Overall Study|Severe debilitation, unable to continue|1|||
124840454|NCT01461096|449044966|FG000|Overall Study|Subj not able to get to clinic|15|||
124840455|NCT01461096|449044967|FG001|Overall Study|Subj not able to get to clinic|13|||
124840456|NCT01461096|449044966|FG000|Overall Study|Site is closing|27|||
124840457|NCT01461096|449044967|FG001|Overall Study|Site is closing|30|||
124840458|NCT01461096|449044966|FG000|Overall Study|Withdrawal by Subject|5|||
124840459|NCT01461096|449044967|FG001|Overall Study|Withdrawal by Subject|3|||
124840460|NCT01461096|449044966|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
124840461|NCT01461096|449044967|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
124840462|NCT01461096|449044966|FG000|Overall Study|Lost to Follow-up|8|||
124840463|NCT01461096|449044967|FG001|Overall Study|Lost to Follow-up|4|||
124840464|NCT04225923|449044976|FG000|Overall Study|Protocol Violation|1|||
124840465|NCT04225923|449044977|FG001|Overall Study|Protocol Violation|0|||
124840466|NCT04225923|449044978|FG002|Overall Study|Protocol Violation|1|||
124840467|NCT04225923|449044976|FG000|Overall Study|Withdrawal by Subject|4|||
124840468|NCT04225923|449044977|FG001|Overall Study|Withdrawal by Subject|1|||
124840469|NCT04225923|449044978|FG002|Overall Study|Withdrawal by Subject|3|||
124840470|NCT04225923|449044976|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
124840471|NCT04225923|449044977|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
124840472|NCT04225923|449044978|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
124840473|NCT01417481|449044979|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
124840474|NCT01417481|449044980|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
124840475|NCT00855309|449044981|FG000|Overall Study|patient never recieved drug|1|||
124840476|NCT00855309|449044982|FG001|Overall Study|patient never recieved drug|0|||
124840477|NCT00829296|449044983|FG000|Overall Study|Adverse Event|5|||
124840478|NCT00829296|449044984|FG001|Overall Study|Adverse Event|4|||
124840479|NCT04116710|449044988|FG000|Overall Study|Death|4|||
124840480|NCT04116710|449044989|FG001|Overall Study|Death|6|||
124840481|NCT04116710|449044990|FG002|Overall Study|Death|3|||
124840482|NCT04116710|449044991|FG003|Overall Study|Death|1|||
124840483|NCT04116710|449044988|FG000|Overall Study|Withdrawal by Subject|0|||
124840484|NCT04116710|449044989|FG001|Overall Study|Withdrawal by Subject|0|||
124840485|NCT04116710|449044990|FG002|Overall Study|Withdrawal by Subject|0|||
124840486|NCT04116710|449044991|FG003|Overall Study|Withdrawal by Subject|1|||
124840487|NCT01077960|449044994|FG000|Overall Study|Adverse Event|6|||
124840488|NCT01077960|449044994|FG000|Overall Study|Protocol Violation|3|||
124840489|NCT01077960|449044994|FG000|Overall Study|Lost to Follow-up|5|||
124640114|NCT00267969|448299886|FG006|Controlled Period|Lost to Follow-up|0|||
124640115|NCT00267969|448299880|FG000|Controlled Period|Randomized but not treated|0|||
124640116|NCT00267969|448299881|FG001|Controlled Period|Randomized but not treated|0|||
124840490|NCT01077960|449044994|FG000|Overall Study|Subject decision|1|||
124840491|NCT01077960|449044994|FG000|Overall Study|Reason unspecified|1|||
124840492|NCT01371656|449044995|FG000|Overall Study|Death|7|||
124840493|NCT01371656|449044996|FG001|Overall Study|Death|4|||
124840494|NCT01371656|449044995|FG000|Overall Study|Physician Decision|46|||
124840495|NCT01371656|449044996|FG001|Overall Study|Physician Decision|7|||
124840496|NCT01371656|449044995|FG000|Overall Study|Withdrawal by Subject|7|||
124840497|NCT01371656|449044996|FG001|Overall Study|Withdrawal by Subject|0|||
124840498|NCT01371656|449044995|FG000|Overall Study|Ineligible|4|||
124840499|NCT01371656|449044996|FG001|Overall Study|Ineligible|3|||
124840500|NCT01537783|449044997|FG000|Overall Study|Lost to Follow-up|11|||
124840501|NCT01537783|449044998|FG001|Overall Study|Lost to Follow-up|2|||
124840502|NCT00291668|449045003|FG000|Overall Study|Lack of Efficacy|1|||
124840503|NCT00291668|449045004|FG001|Overall Study|Lack of Efficacy|0|||
124840504|NCT00291668|449045005|FG002|Overall Study|Lack of Efficacy|0|||
124840505|NCT00291668|449045003|FG000|Overall Study|SAE, non-fatal|1|||
124840506|NCT00291668|449045004|FG001|Overall Study|SAE, non-fatal|1|||
124840507|NCT00291668|449045005|FG002|Overall Study|SAE, non-fatal|1|||
124840508|NCT00291668|449045003|FG000|Overall Study|AE, non-serious non-fatal|1|||
124840509|NCT00291668|449045004|FG001|Overall Study|AE, non-serious non-fatal|0|||
124840510|NCT00291668|449045005|FG002|Overall Study|AE, non-serious non-fatal|0|||
124840511|NCT00291668|449045003|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
124840512|NCT00291668|449045004|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
124840513|NCT00291668|449045005|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
124840514|NCT00313612|449045006|FG000|Overall Study|Patient never received treatment|0|||
124840515|NCT00313612|449045007|FG001|Overall Study|Patient never received treatment|1|||
124840516|NCT00451035|449045008|FG000|Overall Study|Disease progression|11|||
124840517|NCT00451035|449045008|FG000|Overall Study|Death|3|||
124840518|NCT00451035|449045008|FG000|Overall Study|New anti-neoplastic therapy|3|||
124840519|NCT01393405|449045011|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
124840520|NCT01393405|449045012|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
124840521|NCT01393405|449045013|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
124840522|NCT01393405|449045011|FG000|Induction Period (week1-16)|Adverse Event|16|||
124840523|NCT01393405|449045012|FG001|Induction Period (week1-16)|Adverse Event|0|||
124840524|NCT01393405|449045013|FG002|Induction Period (week1-16)|Adverse Event|0|||
124840525|NCT01393405|449045011|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
124840526|NCT01393405|449045012|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
124840527|NCT01393405|449045013|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
124840528|NCT01393405|449045011|FG000|Maintenance Period Week|Lack of Efficacy|0|||
124840529|NCT01393405|449045012|FG001|Maintenance Period Week|Lack of Efficacy|22|||
124840530|NCT01393405|449045013|FG002|Maintenance Period Week|Lack of Efficacy|22|||
124840531|NCT01393405|449045011|FG000|Maintenance Period Week|Adverse Event|0|||
124840532|NCT01393405|449045012|FG001|Maintenance Period Week|Adverse Event|5|||
124840533|NCT01393405|449045013|FG002|Maintenance Period Week|Adverse Event|2|||
124840534|NCT01393405|449045011|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
124840535|NCT01393405|449045012|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
124840536|NCT01393405|449045013|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
124840537|NCT01393405|449045011|FG000|Maintenance Period Week|Lost to Follow-up|0|||
124840538|NCT01393405|449045012|FG001|Maintenance Period Week|Lost to Follow-up|1|||
124840539|NCT01393405|449045013|FG002|Maintenance Period Week|Lost to Follow-up|0|||
124840540|NCT00717769|449045016|FG000|Overall Study|Adverse Event|9|||
124840541|NCT00717769|449045017|FG001|Overall Study|Adverse Event|6|||
124840542|NCT00717769|449045018|FG002|Overall Study|Adverse Event|1|||
124840543|NCT00717769|449045016|FG000|Overall Study|Lack of compliance|0|||
124840544|NCT00717769|449045017|FG001|Overall Study|Lack of compliance|2|||
124840545|NCT00717769|449045018|FG002|Overall Study|Lack of compliance|0|||
124840546|NCT00717769|449045016|FG000|Overall Study|Lost to Follow-up|3|||
124840547|NCT00717769|449045017|FG001|Overall Study|Lost to Follow-up|4|||
124840548|NCT00717769|449045018|FG002|Overall Study|Lost to Follow-up|0|||
124840549|NCT00717769|449045016|FG000|Overall Study|Lack of Efficacy|1|||
124840550|NCT00717769|449045017|FG001|Overall Study|Lack of Efficacy|2|||
124840551|NCT00717769|449045018|FG002|Overall Study|Lack of Efficacy|0|||
124840552|NCT00717769|449045016|FG000|Overall Study|Protocol Violation|0|||
124840553|NCT00717769|449045017|FG001|Overall Study|Protocol Violation|2|||
124840554|NCT00717769|449045018|FG002|Overall Study|Protocol Violation|0|||
124840555|NCT00717769|449045016|FG000|Overall Study|Sponsor decision|1|||
124840556|NCT00717769|449045017|FG001|Overall Study|Sponsor decision|0|||
124840557|NCT00717769|449045018|FG002|Overall Study|Sponsor decision|10|||
124840558|NCT00717769|449045016|FG000|Overall Study|Withdrew consent|2|||
124840559|NCT00717769|449045017|FG001|Overall Study|Withdrew consent|2|||
124840560|NCT00717769|449045018|FG002|Overall Study|Withdrew consent|0|||
124840561|NCT01399593|449045020|FG000|Overall Study|Physician Decision|1|||
124840562|NCT01399593|449045021|FG001|Overall Study|Physician Decision|0|||
124840563|NCT01399593|449045020|FG000|Overall Study|Adverse Event|1|||
124840564|NCT01399593|449045021|FG001|Overall Study|Adverse Event|0|||
124840565|NCT01399593|449045020|FG000|Overall Study|Death|1|||
124840566|NCT01399593|449045021|FG001|Overall Study|Death|1|||
124840567|NCT01399593|449045020|FG000|Overall Study|Transplantectomy|0|||
124840568|NCT01399593|449045021|FG001|Overall Study|Transplantectomy|1|||
124840569|NCT00244712|449045025|FG000|Overall Study|Adverse Event|20|||
124840570|NCT00244712|449045026|FG001|Overall Study|Adverse Event|21|||
124840571|NCT00244712|449045025|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
124840572|NCT00244712|449045026|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
124840573|NCT00244712|449045025|FG000|Overall Study|Lack of Compliance|10|||
124840574|NCT00244712|449045026|FG001|Overall Study|Lack of Compliance|11|||
124840575|NCT00244712|449045025|FG000|Overall Study|Lost to Follow-up|45|||
124840576|NCT00244712|449045026|FG001|Overall Study|Lost to Follow-up|52|||
124840577|NCT00244712|449045025|FG000|Overall Study|Withdrawal by Subject|13|||
124840578|NCT00244712|449045026|FG001|Overall Study|Withdrawal by Subject|23|||
124840579|NCT00244712|449045025|FG000|Overall Study|Protocol Violation, disease progression|13|||
124840580|NCT00244712|449045026|FG001|Overall Study|Protocol Violation, disease progression|11|||
124840581|NCT02777125|449045027|FG000|Overall Study|Consent form violation|14|||
124840582|NCT02777125|449045028|FG001|Overall Study|Consent form violation|12|||
124840583|NCT02777125|449045027|FG000|Overall Study|Assent form violation|21|||
124840584|NCT02777125|449045028|FG001|Overall Study|Assent form violation|23|||
124840585|NCT02777125|449045027|FG000|Overall Study|Protocol Violation|8|||
124840586|NCT02777125|449045028|FG001|Overall Study|Protocol Violation|12|||
124840587|NCT00574405|449046502|FG000|Overall Study|Withdrawal by Subject|3|||
124840588|NCT00574405|449046503|FG001|Overall Study|Withdrawal by Subject|2|||
124840589|NCT01336738|449046504|FG000|Overall Study|Adverse Event|0|||
124840590|NCT01336738|449046505|FG001|Overall Study|Adverse Event|3|||
124840591|NCT01336738|449046506|FG002|Overall Study|Adverse Event|2|||
124840592|NCT01336738|449046507|FG003|Overall Study|Adverse Event|1|||
124840593|NCT01336738|449046508|FG004|Overall Study|Adverse Event|3|||
124840594|NCT01336738|449046504|FG000|Overall Study|Lost to Follow-up|2|||
124840595|NCT01336738|449046505|FG001|Overall Study|Lost to Follow-up|1|||
124840596|NCT01336738|449046506|FG002|Overall Study|Lost to Follow-up|2|||
124840597|NCT01336738|449046507|FG003|Overall Study|Lost to Follow-up|2|||
124840598|NCT01336738|449046508|FG004|Overall Study|Lost to Follow-up|2|||
124840599|NCT01336738|449046504|FG000|Overall Study|Did not meet entrance criteria|0|||
124840600|NCT01336738|449046505|FG001|Overall Study|Did not meet entrance criteria|1|||
124840601|NCT01336738|449046506|FG002|Overall Study|Did not meet entrance criteria|0|||
124840602|NCT01336738|449046507|FG003|Overall Study|Did not meet entrance criteria|0|||
124840603|NCT01336738|449046508|FG004|Overall Study|Did not meet entrance criteria|0|||
124840604|NCT01336738|449046504|FG000|Overall Study|Protocol Violation|0|||
124840605|NCT01336738|449046505|FG001|Overall Study|Protocol Violation|1|||
124840606|NCT01336738|449046506|FG002|Overall Study|Protocol Violation|0|||
124840607|NCT01336738|449046507|FG003|Overall Study|Protocol Violation|0|||
124840608|NCT01336738|449046508|FG004|Overall Study|Protocol Violation|0|||
124840609|NCT01336738|449046504|FG000|Overall Study|Withdrawal by Subject|2|||
124840610|NCT01336738|449046505|FG001|Overall Study|Withdrawal by Subject|0|||
124840611|NCT01336738|449046506|FG002|Overall Study|Withdrawal by Subject|2|||
124840612|NCT01336738|449046507|FG003|Overall Study|Withdrawal by Subject|1|||
124840613|NCT01336738|449046508|FG004|Overall Study|Withdrawal by Subject|1|||
124840614|NCT01336738|449046504|FG000|Overall Study|Other|3|||
124840615|NCT01336738|449046505|FG001|Overall Study|Other|3|||
124840616|NCT01336738|449046506|FG002|Overall Study|Other|2|||
124840617|NCT01336738|449046507|FG003|Overall Study|Other|3|||
124840618|NCT01336738|449046508|FG004|Overall Study|Other|4|||
124840619|NCT02970968|449046510|FG000|Overall Study|Withdrawal by Subject|3|||
124840620|NCT02970968|449046511|FG001|Overall Study|Withdrawal by Subject|3|||
124840621|NCT02970968|449046510|FG000|Overall Study|Adverse Event|1|||
124840622|NCT02970968|449046511|FG001|Overall Study|Adverse Event|2|||
124840623|NCT02970968|449046510|FG000|Overall Study|Lost to Follow-up|1|||
124840624|NCT02970968|449046511|FG001|Overall Study|Lost to Follow-up|1|||
124840625|NCT02970968|449046510|FG000|Overall Study|Non-Compliance|0|||
124840626|NCT02970968|449046511|FG001|Overall Study|Non-Compliance|1|||
124840627|NCT03003520|449046512|FG000|Overall Study|Adverse Event|9|||
124840628|NCT03003520|449046513|FG001|Overall Study|Adverse Event|0|||
124840629|NCT03003520|449046512|FG000|Overall Study|Death|1|||
124840630|NCT03003520|449046513|FG001|Overall Study|Death|0|||
124840631|NCT03003520|449046512|FG000|Overall Study|Other reasons|4|||
124840632|NCT03003520|449046513|FG001|Overall Study|Other reasons|0|||
124640117|NCT00267969|448299882|FG002|Controlled Period|Randomized but not treated|1|||
124840633|NCT03003520|449046512|FG000|Overall Study|Withdrawal by Subject|6|||
124840634|NCT03003520|449046513|FG001|Overall Study|Withdrawal by Subject|0|||
124840635|NCT03003520|449046512|FG000|Overall Study|Progressive disease|9|||
124840636|NCT03003520|449046513|FG001|Overall Study|Progressive disease|1|||
124840637|NCT01332149|449046514|FG000|Overall Study|Adverse Event|11|||
124840638|NCT01332149|449046515|FG001|Overall Study|Adverse Event|9|||
124840639|NCT01332149|449046514|FG000|Overall Study|Other unspecified|5|||
124640118|NCT00267969|448299883|FG003|Controlled Period|Randomized but not treated|0|||
124640119|NCT00267969|448299884|FG004|Controlled Period|Randomized but not treated|0|||
124840640|NCT01332149|449046515|FG001|Overall Study|Other unspecified|7|||
124840641|NCT01332149|449046514|FG000|Overall Study|Protocol Violation|1|||
124840642|NCT01332149|449046515|FG001|Overall Study|Protocol Violation|3|||
124840643|NCT01332149|449046514|FG000|Overall Study|Withdrawal by Subject|4|||
124840644|NCT01332149|449046515|FG001|Overall Study|Withdrawal by Subject|5|||
124840645|NCT01332149|449046514|FG000|Overall Study|Lost to Follow-up|1|||
124840646|NCT01332149|449046515|FG001|Overall Study|Lost to Follow-up|1|||
124840647|NCT01332149|449046514|FG000|Overall Study|Insufficient clinical response|4|||
124840648|NCT01332149|449046515|FG001|Overall Study|Insufficient clinical response|7|||
124840649|NCT01332149|449046514|FG000|Overall Study|Did not meet entrance criteria|3|||
124840650|NCT01332149|449046515|FG001|Overall Study|Did not meet entrance criteria|4|||
124840651|NCT01332149|449046514|FG000|Overall Study|Randomized but not treated|1|||
124840652|NCT01332149|449046515|FG001|Overall Study|Randomized but not treated|2|||
124840653|NCT04615949|449046518|FG000|Overall Study|Withdrawal by Subject|2|||
124840654|NCT04615949|449046519|FG001|Overall Study|Withdrawal by Subject|4|||
124840655|NCT04615949|449046518|FG000|Overall Study|Lost to Follow-up|2|||
124840656|NCT04615949|449046519|FG001|Overall Study|Lost to Follow-up|2|||
124840657|NCT04615949|449046518|FG000|Overall Study|Death|0|||
124840658|NCT04615949|449046519|FG001|Overall Study|Death|2|||
124840659|NCT05458856|449046520|FG000|Overall Study|Withdrawal by Subject|5|||
124840660|NCT05458856|449046520|FG000|Overall Study|Death|4|||
124840661|NCT05458856|449046520|FG000|Overall Study|Protocol Deviation|3|||
124840662|NCT05458856|449046520|FG000|Overall Study|Physician Decision|1|||
124840663|NCT01920932|449046521|FG000|Overall Study|Death|1|||
124840664|NCT01920932|449046521|FG000|Overall Study|Withdrawal of consent|1|||
124840665|NCT01140477|449046522|FG000|Overall Study|Lost to Follow-up|4|||
124840666|NCT01140477|449046523|FG001|Overall Study|Lost to Follow-up|0|||
124840667|NCT01140477|449046522|FG000|Overall Study|Withdrawal by Subject|1|||
124840668|NCT01140477|449046523|FG001|Overall Study|Withdrawal by Subject|4|||
124840669|NCT01140477|449046522|FG000|Overall Study|Surgical complication preventing implant|2|||
124840670|NCT01140477|449046523|FG001|Overall Study|Surgical complication preventing implant|0|||
124840671|NCT01140477|449046522|FG000|Overall Study|Death|1|||
124840672|NCT01140477|449046523|FG001|Overall Study|Death|1|||
124840673|NCT01140477|449046522|FG000|Overall Study|Subject explanted|0|||
124840674|NCT01140477|449046523|FG001|Overall Study|Subject explanted|1|||
124840675|NCT01945489|449046528|FG000|Cycle 1|Adverse Event|2|||
124840676|NCT01945489|449046529|FG001|Cycle 1|Adverse Event|0|||
124840677|NCT01945489|449046528|FG000|Cycle 1|Lost to Follow-up|4|||
124840678|NCT01945489|449046529|FG001|Cycle 1|Lost to Follow-up|0|||
124840679|NCT01945489|449046528|FG000|Cycle 1|Personal Reasons|4|||
124840680|NCT01945489|449046529|FG001|Cycle 1|Personal Reasons|2|||
124840681|NCT01945489|449046528|FG000|Cycle 1|Protocol Violation|0|||
124840682|NCT01945489|449046529|FG001|Cycle 1|Protocol Violation|1|||
124840683|NCT01945489|449046528|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
124840684|NCT01945489|449046529|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
124840685|NCT01945489|449046528|FG000|Cycle 2|Adverse Event|1|||
124840686|NCT01945489|449046529|FG001|Cycle 2|Adverse Event|0|||
124840687|NCT01945489|449046528|FG000|Cycle 2|Lost to Follow-up|0|||
124840688|NCT01945489|449046529|FG001|Cycle 2|Lost to Follow-up|1|||
124840689|NCT00697346|449046530|FG000|Overall Study|Adverse Event|4|||
124840690|NCT00697346|449046531|FG001|Overall Study|Adverse Event|5|||
124840691|NCT00697346|449046532|FG002|Overall Study|Adverse Event|0|||
124840692|NCT00697346|449046530|FG000|Overall Study|Progressive Disease|19|||
124840693|NCT00697346|449046531|FG001|Overall Study|Progressive Disease|18|||
124840694|NCT00697346|449046532|FG002|Overall Study|Progressive Disease|0|||
124840695|NCT00697346|449046530|FG000|Overall Study|Symptomatic Deterioration|0|||
124840696|NCT00697346|449046531|FG001|Overall Study|Symptomatic Deterioration|1|||
124840697|NCT00697346|449046532|FG002|Overall Study|Symptomatic Deterioration|0|||
124840698|NCT00697346|449046530|FG000|Overall Study|Withdrawal by Subject|2|||
124840699|NCT00697346|449046531|FG001|Overall Study|Withdrawal by Subject|2|||
124840700|NCT00697346|449046532|FG002|Overall Study|Withdrawal by Subject|0|||
124840701|NCT00697346|449046530|FG000|Overall Study|Reason not Specified|3|||
124840702|NCT00697346|449046531|FG001|Overall Study|Reason not Specified|0|||
124840703|NCT00697346|449046532|FG002|Overall Study|Reason not Specified|1|||
124840704|NCT03569371|449046534|FG000|Overall Study|Lack of Efficacy|1|||
124840705|NCT03569371|449046534|FG000|Overall Study|Lost to Follow-up|1|||
124840706|NCT03569371|449046534|FG000|Overall Study|Adverse Event|1|||
124640120|NCT00267969|448299885|FG005|Controlled Period|Randomized but not treated|0|||
124640121|NCT00267969|448299886|FG006|Controlled Period|Randomized but not treated|0|||
124840707|NCT01236755|449046535|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
124840708|NCT01236755|449046535|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
124840709|NCT01236755|449046535|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
124640122|NCT00267969|448299880|FG000|Controlled Period|Other|2|||
124640123|NCT00267969|448299881|FG001|Controlled Period|Other|1|||
124840710|NCT01236755|449046535|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
124840711|NCT01539226|449046538|FG000|Overall Study|Withdrawal by Subject|24|||
124840712|NCT01539226|449046539|FG001|Overall Study|Withdrawal by Subject|54|||
124840713|NCT01539226|449046538|FG000|Overall Study|Lost to Follow-up|20|||
124840714|NCT01539226|449046539|FG001|Overall Study|Lost to Follow-up|54|||
124640124|NCT00267969|448299882|FG002|Controlled Period|Other|6|||
124840715|NCT01539226|449046538|FG000|Overall Study|Death|1|||
124840716|NCT01539226|449046539|FG001|Overall Study|Death|2|||
124840717|NCT01539226|449046538|FG000|Overall Study|Adverse Event|2|||
124840718|NCT01539226|449046539|FG001|Overall Study|Adverse Event|0|||
124840719|NCT01539226|449046538|FG000|Overall Study|Pregnancy|13|||
124840720|NCT01539226|449046539|FG001|Overall Study|Pregnancy|29|||
124840721|NCT01539226|449046538|FG000|Overall Study|inappropriate enrollment|0|||
124840722|NCT01539226|449046539|FG001|Overall Study|inappropriate enrollment|1|||
124840723|NCT01539226|449046538|FG000|Overall Study|Multiple Reasons|3|||
124840724|NCT01539226|449046539|FG001|Overall Study|Multiple Reasons|1|||
124840725|NCT01539226|449046538|FG000|Overall Study|not HIV seroconversion-related|93|||
124840726|NCT01539226|449046539|FG001|Overall Study|not HIV seroconversion-related|176|||
124840727|NCT01539226|449046538|FG000|Overall Study|HIV seroconversion-related|55|||
124840728|NCT01539226|449046539|FG001|Overall Study|HIV seroconversion-related|80|||
124840729|NCT01539226|449046538|FG000|Overall Study|Non-compliance|6|||
124840730|NCT01539226|449046539|FG001|Overall Study|Non-compliance|8|||
124840731|NCT02643251|449046540|FG000|Overall Study|Adverse Event|3|||
124840732|NCT02643251|449046541|FG001|Overall Study|Adverse Event|1|||
124840733|NCT02643251|449046540|FG000|Overall Study|Withdrawal by Subject|2|||
124840734|NCT02643251|449046541|FG001|Overall Study|Withdrawal by Subject|0|||
124840735|NCT02643251|449046540|FG000|Overall Study|Lost to Follow-up|4|||
124840736|NCT02643251|449046541|FG001|Overall Study|Lost to Follow-up|1|||
124840737|NCT02643251|449046540|FG000|Overall Study|Protocol Violation|1|||
124840738|NCT02643251|449046541|FG001|Overall Study|Protocol Violation|0|||
124840739|NCT02643251|449046540|FG000|Overall Study|PI Decision to terminate patient|1|||
124840740|NCT02643251|449046541|FG001|Overall Study|PI Decision to terminate patient|0|||
124840741|NCT02365636|449046543|FG000|Overall Study|Adverse Event|3|||
124840742|NCT02365636|449046544|FG001|Overall Study|Adverse Event|3|||
124840743|NCT02365636|449046545|FG002|Overall Study|Adverse Event|2|||
124840744|NCT02365636|449046543|FG000|Overall Study|Protocol Violation|1|||
124840745|NCT02365636|449046544|FG001|Overall Study|Protocol Violation|4|||
124840746|NCT02365636|449046545|FG002|Overall Study|Protocol Violation|0|||
124840747|NCT02365636|449046543|FG000|Overall Study|Lost to Follow-up|0|||
124840748|NCT02365636|449046544|FG001|Overall Study|Lost to Follow-up|0|||
124840749|NCT02365636|449046545|FG002|Overall Study|Lost to Follow-up|1|||
124840750|NCT02365636|449046543|FG000|Overall Study|Other|2|||
124840751|NCT02365636|449046544|FG001|Overall Study|Other|0|||
124840752|NCT02365636|449046545|FG002|Overall Study|Other|0|||
124840753|NCT00463060|449046551|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
124840754|NCT00463060|449046551|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
124840755|NCT01782313|449046552|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
124840756|NCT01782313|449046552|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
124840757|NCT01782313|449046552|FG000|Treated Cycle 3|Progressive Disease|21|||
124840758|NCT01782313|449046552|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
124840759|NCT01782313|449046552|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
124840760|NCT01782313|449046552|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
124840761|NCT01782313|449046552|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
124840762|NCT01782313|449046552|FG000|Survival Follow up|Lost to Follow-up|1|||
124840763|NCT02506816|449046553|FG000|Overall Study|Adverse Event|3|||
124840764|NCT04370691|449046560|FG000|Overall Study|Pending visit|48|||
124840765|NCT04370691|449046560|FG000|Overall Study|Have Not Reached Lower Window|15|||
124840766|NCT04370691|449046560|FG000|Overall Study|Termination|14|||
124840767|NCT04370691|449046560|FG000|Overall Study|Missed or Overdue|10|||
124840768|NCT03013543|449046564|FG000|Overall Study|Withdrawal by Subject|0|||
124840769|NCT03013543|449046565|FG001|Overall Study|Withdrawal by Subject|2|||
124840770|NCT03013543|449046566|FG002|Overall Study|Withdrawal by Subject|0|||
124840771|NCT03013543|449046567|FG003|Overall Study|Withdrawal by Subject|5|||
124840772|NCT03013543|449046568|FG004|Overall Study|Withdrawal by Subject|6|||
124840773|NCT03013543|449046569|FG005|Overall Study|Withdrawal by Subject|2|||
124840774|NCT03013543|449046570|FG006|Overall Study|Withdrawal by Subject|3|||
124840775|NCT03013543|449046571|FG007|Overall Study|Withdrawal by Subject|1|||
124840776|NCT03013543|449046572|FG008|Overall Study|Withdrawal by Subject|0|||
124840777|NCT03013543|449046573|FG009|Overall Study|Withdrawal by Subject|4|||
124840778|NCT03013543|449046564|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
124840779|NCT03013543|449046565|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
124840780|NCT03013543|449046566|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
124840781|NCT03013543|449046567|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
124640125|NCT00267969|448299883|FG003|Controlled Period|Other|0|||
124640126|NCT00267969|448299884|FG004|Controlled Period|Other|0|||
124840782|NCT03013543|449046568|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
124840783|NCT03013543|449046569|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
124640127|NCT00267969|448299885|FG005|Controlled Period|Other|0|||
124640128|NCT00267969|448299886|FG006|Controlled Period|Other|0|||
124640129|NCT00267969|448299880|FG000|After Controlled Period|Adverse Event|0|||
124840784|NCT03013543|449046570|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
124840785|NCT03013543|449046571|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
124840786|NCT03013543|449046572|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
124840787|NCT03013543|449046573|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
124840788|NCT03013543|449046564|FG000|Overall Study|Other|0|||
124840789|NCT03013543|449046565|FG001|Overall Study|Other|0|||
124840790|NCT03013543|449046566|FG002|Overall Study|Other|2|||
124840791|NCT03013543|449046567|FG003|Overall Study|Other|0|||
124840792|NCT03013543|449046568|FG004|Overall Study|Other|2|||
124840793|NCT03013543|449046569|FG005|Overall Study|Other|0|||
124840794|NCT03013543|449046570|FG006|Overall Study|Other|0|||
124840795|NCT03013543|449046571|FG007|Overall Study|Other|0|||
124840796|NCT03013543|449046572|FG008|Overall Study|Other|1|||
124840797|NCT03013543|449046573|FG009|Overall Study|Other|0|||
124840798|NCT03013543|449046564|FG000|Overall Study|Adverse Event|0|||
124840799|NCT03013543|449046565|FG001|Overall Study|Adverse Event|0|||
124840800|NCT03013543|449046566|FG002|Overall Study|Adverse Event|0|||
124840801|NCT03013543|449046567|FG003|Overall Study|Adverse Event|3|||
124840802|NCT03013543|449046568|FG004|Overall Study|Adverse Event|2|||
124840803|NCT03013543|449046569|FG005|Overall Study|Adverse Event|1|||
124840804|NCT03013543|449046570|FG006|Overall Study|Adverse Event|3|||
124840805|NCT03013543|449046571|FG007|Overall Study|Adverse Event|8|||
124840806|NCT03013543|449046572|FG008|Overall Study|Adverse Event|0|||
124840807|NCT03013543|449046573|FG009|Overall Study|Adverse Event|2|||
124840808|NCT03013543|449046564|FG000|Overall Study|Death|0|||
124840809|NCT03013543|449046565|FG001|Overall Study|Death|0|||
124840810|NCT03013543|449046566|FG002|Overall Study|Death|0|||
124840811|NCT03013543|449046567|FG003|Overall Study|Death|1|||
124840812|NCT03013543|449046568|FG004|Overall Study|Death|0|||
124840813|NCT03013543|449046569|FG005|Overall Study|Death|0|||
124840814|NCT03013543|449046570|FG006|Overall Study|Death|0|||
124840815|NCT03013543|449046571|FG007|Overall Study|Death|0|||
124840816|NCT03013543|449046572|FG008|Overall Study|Death|0|||
124840817|NCT03013543|449046573|FG009|Overall Study|Death|0|||
124840818|NCT03013543|449046564|FG000|Overall Study|Lack of Efficacy|0|||
124840819|NCT03013543|449046565|FG001|Overall Study|Lack of Efficacy|0|||
124840820|NCT03013543|449046566|FG002|Overall Study|Lack of Efficacy|0|||
124840821|NCT03013543|449046567|FG003|Overall Study|Lack of Efficacy|1|||
124840822|NCT03013543|449046568|FG004|Overall Study|Lack of Efficacy|0|||
124840823|NCT03013543|449046569|FG005|Overall Study|Lack of Efficacy|0|||
124840824|NCT03013543|449046570|FG006|Overall Study|Lack of Efficacy|0|||
124840825|NCT03013543|449046571|FG007|Overall Study|Lack of Efficacy|0|||
124840826|NCT03013543|449046572|FG008|Overall Study|Lack of Efficacy|0|||
124840827|NCT03013543|449046573|FG009|Overall Study|Lack of Efficacy|0|||
124840828|NCT03013543|449046564|FG000|Overall Study|Lost to Follow-up|0|||
124840829|NCT03013543|449046565|FG001|Overall Study|Lost to Follow-up|0|||
124840830|NCT03013543|449046566|FG002|Overall Study|Lost to Follow-up|0|||
124840831|NCT03013543|449046567|FG003|Overall Study|Lost to Follow-up|1|||
124840832|NCT03013543|449046568|FG004|Overall Study|Lost to Follow-up|0|||
124840833|NCT03013543|449046569|FG005|Overall Study|Lost to Follow-up|0|||
124840834|NCT03013543|449046570|FG006|Overall Study|Lost to Follow-up|1|||
124840835|NCT03013543|449046571|FG007|Overall Study|Lost to Follow-up|0|||
124840836|NCT03013543|449046572|FG008|Overall Study|Lost to Follow-up|0|||
124840837|NCT03013543|449046573|FG009|Overall Study|Lost to Follow-up|2|||
124840838|NCT03013543|449046564|FG000|Overall Study|Non-Compliance With Study Drug|0|||
124840839|NCT03013543|449046565|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124840840|NCT03013543|449046566|FG002|Overall Study|Non-Compliance With Study Drug|0|||
124840841|NCT03013543|449046567|FG003|Overall Study|Non-Compliance With Study Drug|0|||
124840842|NCT03013543|449046568|FG004|Overall Study|Non-Compliance With Study Drug|0|||
124840843|NCT03013543|449046569|FG005|Overall Study|Non-Compliance With Study Drug|0|||
124840844|NCT03013543|449046570|FG006|Overall Study|Non-Compliance With Study Drug|0|||
124840845|NCT03013543|449046571|FG007|Overall Study|Non-Compliance With Study Drug|0|||
124840846|NCT03013543|449046572|FG008|Overall Study|Non-Compliance With Study Drug|1|||
124840847|NCT03013543|449046573|FG009|Overall Study|Non-Compliance With Study Drug|0|||
124840848|NCT03013543|449046564|FG000|Overall Study|Physician Decision|0|||
124840849|NCT03013543|449046565|FG001|Overall Study|Physician Decision|0|||
124840850|NCT03013543|449046566|FG002|Overall Study|Physician Decision|0|||
124840851|NCT03013543|449046567|FG003|Overall Study|Physician Decision|0|||
124840852|NCT03013543|449046568|FG004|Overall Study|Physician Decision|1|||
124840853|NCT03013543|449046569|FG005|Overall Study|Physician Decision|0|||
124840854|NCT03013543|449046570|FG006|Overall Study|Physician Decision|0|||
124840855|NCT03013543|449046571|FG007|Overall Study|Physician Decision|0|||
124840856|NCT03013543|449046572|FG008|Overall Study|Physician Decision|0|||
124840857|NCT03013543|449046573|FG009|Overall Study|Physician Decision|0|||
124840858|NCT03013543|449046564|FG000|Overall Study|Protocol Violation|0|||
124840859|NCT03013543|449046565|FG001|Overall Study|Protocol Violation|0|||
124840860|NCT03013543|449046566|FG002|Overall Study|Protocol Violation|0|||
124840861|NCT03013543|449046567|FG003|Overall Study|Protocol Violation|0|||
124840862|NCT03013543|449046568|FG004|Overall Study|Protocol Violation|0|||
124840863|NCT03013543|449046569|FG005|Overall Study|Protocol Violation|0|||
124840864|NCT03013543|449046570|FG006|Overall Study|Protocol Violation|0|||
124840865|NCT03013543|449046571|FG007|Overall Study|Protocol Violation|0|||
124840866|NCT03013543|449046572|FG008|Overall Study|Protocol Violation|0|||
124840867|NCT03013543|449046573|FG009|Overall Study|Protocol Violation|1|||
124840868|NCT04960228|449046574|FG000|Overall Study|Withdrawal by Subject|216|||
124840869|NCT04960228|449046575|FG001|Overall Study|Withdrawal by Subject|35|||
124840870|NCT04960228|449046574|FG000|Overall Study|Failed attention check|69|||
124840871|NCT04960228|449046575|FG001|Overall Study|Failed attention check|148|||
124840872|NCT04960228|449046574|FG000|Overall Study|Flagged for response quality by Dynata|3|||
124840873|NCT04960228|449046575|FG001|Overall Study|Flagged for response quality by Dynata|3|||
124840874|NCT02281552|449046578|FG000|Overall Study|Medication error|1|||
124840875|NCT02281552|449046579|FG001|Overall Study|Medication error|0|||
124840876|NCT02281552|449046578|FG000|Overall Study|Insufficient clinical response|0|||
124840877|NCT02281552|449046579|FG001|Overall Study|Insufficient clinical response|1|||
124840878|NCT02281552|449046578|FG000|Overall Study|Adverse Event|3|||
124840879|NCT02281552|449046579|FG001|Overall Study|Adverse Event|9|||
124840880|NCT04365699|449046582|FG000|Overall Study|Death|2|||
124840881|NCT04365699|449046583|FG001|Overall Study|Death|5|||
124840882|NCT04365699|449046584|FG002|Overall Study|Death|15|||
124840883|NCT02540954|449046585|FG000|Overall Study|Physician Decision|3|||
124840884|NCT02540954|449046586|FG001|Overall Study|Physician Decision|1|||
124840885|NCT02540954|449046585|FG000|Overall Study|Withdrawal by Subject|6|||
124840886|NCT02540954|449046586|FG001|Overall Study|Withdrawal by Subject|5|||
124840887|NCT02540954|449046585|FG000|Overall Study|Lost to Follow-up|1|||
124840888|NCT02540954|449046586|FG001|Overall Study|Lost to Follow-up|1|||
124840889|NCT02540954|449046585|FG000|Overall Study|Adverse Event|4|||
124840890|NCT02540954|449046586|FG001|Overall Study|Adverse Event|2|||
124840891|NCT02540954|449046585|FG000|Overall Study|Death|0|||
124840892|NCT02540954|449046586|FG001|Overall Study|Death|3|||
124840893|NCT02540954|449046585|FG000|Overall Study|Treatment failure|1|||
124840894|NCT02540954|449046586|FG001|Overall Study|Treatment failure|0|||
124840895|NCT02540954|449046585|FG000|Overall Study|Other reason|4|||
124840896|NCT02540954|449046586|FG001|Overall Study|Other reason|2|||
124840897|NCT01393743|449046587|FG000|Core Study|Adverse Event|5|||
124840898|NCT01393743|449046588|FG001|Core Study|Adverse Event|9|||
124840899|NCT01393743|449046589|FG002|Core Study|Adverse Event|0|||
124840900|NCT01393743|449046587|FG000|Core Study|Lost to Follow-up|1|||
124840901|NCT01393743|449046588|FG001|Core Study|Lost to Follow-up|1|||
124840902|NCT01393743|449046589|FG002|Core Study|Lost to Follow-up|0|||
124840903|NCT01393743|449046587|FG000|Core Study|Participant's Choice|2|||
124840904|NCT01393743|449046588|FG001|Core Study|Participant's Choice|3|||
124840905|NCT01393743|449046589|FG002|Core Study|Participant's Choice|0|||
124840906|NCT01393743|449046587|FG000|Core Study|Inadequate therapeutic effect|2|||
124840907|NCT01393743|449046588|FG001|Core Study|Inadequate therapeutic effect|0|||
124840908|NCT01393743|449046589|FG002|Core Study|Inadequate therapeutic effect|0|||
124840909|NCT01393743|449046587|FG000|Extension Phase|Adverse Event|0|||
124840910|NCT01393743|449046588|FG001|Extension Phase|Adverse Event|0|||
124840911|NCT01393743|449046589|FG002|Extension Phase|Adverse Event|12|||
124840912|NCT01393743|449046587|FG000|Extension Phase|Lost to Follow-up|0|||
124840913|NCT01393743|449046588|FG001|Extension Phase|Lost to Follow-up|0|||
124840914|NCT01393743|449046589|FG002|Extension Phase|Lost to Follow-up|2|||
124840915|NCT01393743|449046587|FG000|Extension Phase|Participant choice|0|||
124840916|NCT01393743|449046588|FG001|Extension Phase|Participant choice|0|||
124840917|NCT01393743|449046589|FG002|Extension Phase|Participant choice|16|||
124840918|NCT01393743|449046587|FG000|Extension Phase|Inadequate therapeutic effect|0|||
124840919|NCT01393743|449046588|FG001|Extension Phase|Inadequate therapeutic effect|0|||
124840920|NCT01393743|449046589|FG002|Extension Phase|Inadequate therapeutic effect|7|||
124840921|NCT01393743|449046587|FG000|Extension Phase|Withdrawal by Subject|0|||
124840922|NCT01393743|449046588|FG001|Extension Phase|Withdrawal by Subject|0|||
124840923|NCT01393743|449046589|FG002|Extension Phase|Withdrawal by Subject|8|||
124840924|NCT01393743|449046587|FG000|Extension Phase|Pregnancy|0|||
124840925|NCT01393743|449046588|FG001|Extension Phase|Pregnancy|0|||
124840926|NCT01393743|449046589|FG002|Extension Phase|Pregnancy|1|||
124840927|NCT01393743|449046587|FG000|Extension Phase|Other|0|||
124840928|NCT01393743|449046588|FG001|Extension Phase|Other|0|||
124840929|NCT01393743|449046589|FG002|Extension Phase|Other|14|||
124840930|NCT02321462|449046593|FG000|Overall Study|Withdrawal by Subject|5|||
124840931|NCT02321462|449046594|FG001|Overall Study|Withdrawal by Subject|2|||
124840932|NCT02321462|449046593|FG000|Overall Study|Subject withdrawn before any treatment|1|||
124840933|NCT02321462|449046594|FG001|Overall Study|Subject withdrawn before any treatment|1|||
124840934|NCT03044197|449046604|FG000|Overall Study|Withdrawal by Subject|3|||
124840935|NCT03044197|449046605|FG001|Overall Study|Withdrawal by Subject|1|||
124840936|NCT00834912|449046610|FG000|Treatment Period 1|Adverse Event|0|||
124840937|NCT00834912|449046611|FG001|Treatment Period 1|Adverse Event|1|||
124840938|NCT00834912|449046612|FG002|Treatment Period 1|Adverse Event|0|||
124840939|NCT00834912|449046613|FG003|Treatment Period 1|Adverse Event|1|||
124840940|NCT00834912|449046614|FG004|Treatment Period 1|Adverse Event|0|||
124840941|NCT00834912|449046615|FG005|Treatment Period 1|Adverse Event|0|||
124840942|NCT00834912|449046610|FG000|Treatment Period 2|Withdrawal by Subject|0|||
124840943|NCT00834912|449046611|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124840944|NCT00834912|449046612|FG002|Treatment Period 2|Withdrawal by Subject|1|||
124840945|NCT00834912|449046613|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124840946|NCT00834912|449046614|FG004|Treatment Period 2|Withdrawal by Subject|1|||
124840947|NCT00834912|449046615|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124840948|NCT03829046|449046619|FG000|Overall Study|Withdrawal by Subject|1|||
124840949|NCT03829046|449046620|FG001|Overall Study|Withdrawal by Subject|0|||
124840950|NCT00989833|449046621|FG000|Overall Study|Lost to Follow-up|0|||
124840951|NCT00989833|449046622|FG001|Overall Study|Lost to Follow-up|1|||
124840952|NCT00989833|449046623|FG002|Overall Study|Lost to Follow-up|0|||
124840953|NCT00989833|449046621|FG000|Overall Study|Protocol Violation|1|||
124840954|NCT00989833|449046622|FG001|Overall Study|Protocol Violation|2|||
124840955|NCT00989833|449046623|FG002|Overall Study|Protocol Violation|1|||
124840956|NCT00989833|449046621|FG000|Overall Study|Withdrawal by Subject|0|||
124840957|NCT00989833|449046622|FG001|Overall Study|Withdrawal by Subject|0|||
124840958|NCT00989833|449046623|FG002|Overall Study|Withdrawal by Subject|1|||
124840959|NCT00989833|449046621|FG000|Overall Study|Incorrectly randomized|1|||
124840960|NCT00989833|449046622|FG001|Overall Study|Incorrectly randomized|0|||
124840961|NCT00989833|449046623|FG002|Overall Study|Incorrectly randomized|0|||
124840962|NCT00500370|449046635|FG000|Overall Study|Adverse Event|9|||
124840963|NCT00500370|449046636|FG001|Overall Study|Adverse Event|3|||
124840964|NCT00500370|449046635|FG000|Overall Study|Lost to Follow-up|10|||
124840965|NCT00500370|449046636|FG001|Overall Study|Lost to Follow-up|10|||
124840966|NCT00500370|449046635|FG000|Overall Study|Protocol Violation|2|||
124840967|NCT00500370|449046636|FG001|Overall Study|Protocol Violation|4|||
124840968|NCT00500370|449046635|FG000|Overall Study|Sponsor Decision|2|||
124840969|NCT00500370|449046636|FG001|Overall Study|Sponsor Decision|0|||
124840970|NCT00500370|449046635|FG000|Overall Study|Subject Decision|10|||
124840971|NCT00500370|449046636|FG001|Overall Study|Subject Decision|17|||
124840972|NCT01282424|449046637|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
124840973|NCT01282424|449046637|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
124840974|NCT01282424|449046637|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
124840975|NCT01282424|449046637|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
124840976|NCT01282424|449046637|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
124840977|NCT01282424|449046637|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
124840978|NCT01282424|449046637|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
124840979|NCT01282424|449046637|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
124840980|NCT00714259|449046638|FG000|Overall Study|Death|2|||
124840981|NCT04804813|449046639|FG000|Overall Study|Protocol Violation|2|||
124840982|NCT04804813|449046640|FG001|Overall Study|Protocol Violation|0|||
124840983|NCT04804813|449046639|FG000|Overall Study|Withdrawal by Subject|1|||
124840984|NCT04804813|449046640|FG001|Overall Study|Withdrawal by Subject|0|||
124840985|NCT05627518|449046641|FG000|Treatment Period 1|Adverse Event|0|||
124840986|NCT05627518|449046642|FG001|Treatment Period 1|Adverse Event|0|||
124840987|NCT05627518|449046643|FG002|Treatment Period 1|Adverse Event|1|||
124840988|NCT05627518|449046644|FG003|Treatment Period 1|Adverse Event|0|||
124840989|NCT05627518|449046645|FG004|Treatment Period 1|Adverse Event|0|||
124840990|NCT05627518|449046646|FG005|Treatment Period 1|Adverse Event|0|||
124840991|NCT05627518|449046647|FG006|Treatment Period 1|Adverse Event|0|||
124840992|NCT05627518|449046648|FG007|Treatment Period 1|Adverse Event|1|||
124840993|NCT05627518|449046641|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124840994|NCT05627518|449046642|FG001|Treatment Period 1|Withdrawal by Subject|0|||
124840995|NCT05627518|449046643|FG002|Treatment Period 1|Withdrawal by Subject|1|||
124840996|NCT05627518|449046644|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124840997|NCT05627518|449046645|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124840998|NCT05627518|449046646|FG005|Treatment Period 1|Withdrawal by Subject|1|||
124840999|NCT05627518|449046647|FG006|Treatment Period 1|Withdrawal by Subject|0|||
124841000|NCT05627518|449046648|FG007|Treatment Period 1|Withdrawal by Subject|0|||
124841001|NCT05627518|449046641|FG000|Treatment Period 1|Protocol Violation|0|||
124841002|NCT05627518|449046642|FG001|Treatment Period 1|Protocol Violation|0|||
124841003|NCT05627518|449046643|FG002|Treatment Period 1|Protocol Violation|0|||
124841004|NCT05627518|449046644|FG003|Treatment Period 1|Protocol Violation|0|||
124841005|NCT05627518|449046645|FG004|Treatment Period 1|Protocol Violation|0|||
124841006|NCT05627518|449046646|FG005|Treatment Period 1|Protocol Violation|0|||
124841007|NCT05627518|449046647|FG006|Treatment Period 1|Protocol Violation|6|||
124841008|NCT05627518|449046648|FG007|Treatment Period 1|Protocol Violation|6|||
124841009|NCT05627518|449046641|FG000|Treatment Period 2|Adverse Event|1|||
124841010|NCT05627518|449046642|FG001|Treatment Period 2|Adverse Event|0|||
124841011|NCT05627518|449046643|FG002|Treatment Period 2|Adverse Event|0|||
124841012|NCT05627518|449046644|FG003|Treatment Period 2|Adverse Event|0|||
124841013|NCT05627518|449046645|FG004|Treatment Period 2|Adverse Event|0|||
124841014|NCT05627518|449046646|FG005|Treatment Period 2|Adverse Event|0|||
124841015|NCT05627518|449046647|FG006|Treatment Period 2|Adverse Event|0|||
124841016|NCT05627518|449046648|FG007|Treatment Period 2|Adverse Event|0|||
124841017|NCT05627518|449046641|FG000|Treatment Period 2|Withdrawal by Subject|1|||
124841018|NCT05627518|449046642|FG001|Treatment Period 2|Withdrawal by Subject|0|||
124841019|NCT05627518|449046643|FG002|Treatment Period 2|Withdrawal by Subject|0|||
124841020|NCT05627518|449046644|FG003|Treatment Period 2|Withdrawal by Subject|0|||
124841021|NCT05627518|449046645|FG004|Treatment Period 2|Withdrawal by Subject|0|||
124841022|NCT05627518|449046646|FG005|Treatment Period 2|Withdrawal by Subject|0|||
124841023|NCT05627518|449046647|FG006|Treatment Period 2|Withdrawal by Subject|0|||
124841024|NCT05627518|449046648|FG007|Treatment Period 2|Withdrawal by Subject|0|||
124841025|NCT05084053|449048254|FG000|Epoch 1: Up to 6 Months|Withdrawal by Subject|1|||
124841026|NCT05084053|449048255|FG001|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
124841027|NCT05084053|449048256|FG002|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
124841028|NCT05084053|449048257|FG003|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
124841029|NCT05084053|449048254|FG000|Epoch 1: Up to 6 Months|Physician Decision|1|||
124841030|NCT05084053|449048255|FG001|Epoch 1: Up to 6 Months|Physician Decision|0|||
124841031|NCT05084053|449048256|FG002|Epoch 1: Up to 6 Months|Physician Decision|0|||
124841032|NCT05084053|449048257|FG003|Epoch 1: Up to 6 Months|Physician Decision|0|||
124841033|NCT05084053|449048254|FG000|Epoch 2: Up to 6 Months|Physician Decision|0|||
124841034|NCT05084053|449048255|FG001|Epoch 2: Up to 6 Months|Physician Decision|0|||
124841035|NCT05084053|449048256|FG002|Epoch 2: Up to 6 Months|Physician Decision|1|||
124841036|NCT05084053|449048257|FG003|Epoch 2: Up to 6 Months|Physician Decision|0|||
124841037|NCT00071812|449048258|FG000|24-Week Double-Blind Period|Adverse Event|2|||
124841038|NCT00071812|449048259|FG001|24-Week Double-Blind Period|Adverse Event|3|||
124841039|NCT00071812|449048260|FG002|24-Week Double-Blind Period|Adverse Event|4|||
124841040|NCT00071812|449048261|FG003|24-Week Double-Blind Period|Adverse Event|4|||
124841041|NCT00071812|449048258|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
124841042|NCT00071812|449048259|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
124841043|NCT00071812|449048260|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
124841044|NCT00071812|449048261|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
124841045|NCT00071812|449048258|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
124841046|NCT00071812|449048259|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
124841047|NCT00071812|449048260|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
124841048|NCT00071812|449048261|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
124841049|NCT00071812|449048258|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
124841050|NCT00071812|449048259|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
124841051|NCT00071812|449048260|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
124841052|NCT00071812|449048261|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
124841053|NCT00071812|449048258|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
124841054|NCT00071812|449048259|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
124841055|NCT00071812|449048260|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
124841056|NCT00071812|449048261|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
124841057|NCT00071812|449048258|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
124841058|NCT00071812|449048259|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
124841059|NCT00071812|449048260|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
124841060|NCT00071812|449048261|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
124841061|NCT00071812|449048258|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
124841062|NCT00071812|449048259|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
124841063|NCT00071812|449048260|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
124841064|NCT00071812|449048261|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
124841065|NCT00071812|449048258|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
124841066|NCT00071812|449048259|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
124841067|NCT00071812|449048260|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
124841068|NCT00071812|449048261|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
124841069|NCT00071812|449048258|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124841070|NCT00071812|449048259|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124841071|NCT00071812|449048260|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124841072|NCT00071812|449048261|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
124841073|NCT00071812|449048258|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
124841074|NCT00071812|449048259|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
124841075|NCT00071812|449048260|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
124841076|NCT00071812|449048261|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
124841077|NCT01589822|449048262|FG000|Overall Study|Withdrawal by Subject|1|||
124841078|NCT01589822|449048263|FG001|Overall Study|Withdrawal by Subject|2|||
124841079|NCT01589822|449048264|FG002|Overall Study|Withdrawal by Subject|0|||
124841080|NCT01589822|449048262|FG000|Overall Study|Death|1|||
124841081|NCT01589822|449048263|FG001|Overall Study|Death|0|||
124841082|NCT01589822|449048264|FG002|Overall Study|Death|0|||
124841083|NCT01589822|449048262|FG000|Overall Study|Missed 90 day visit|2|||
124841084|NCT01589822|449048263|FG001|Overall Study|Missed 90 day visit|1|||
124841085|NCT01589822|449048264|FG002|Overall Study|Missed 90 day visit|1|||
124841086|NCT05168475|449048265|FG000|Period 1|Protocol Violation|1|||
124841087|NCT05168475|449048265|FG000|Period 1|IMP shortage|2|||
124841088|NCT05168475|449048265|FG000|Period 1|Not randomised|2|||
124841089|NCT05168475|449048265|FG000|Period 2|IMP shortage|1|||
124841090|NCT03568942|449048268|FG000|Overall Study|Family emergency|1|||
124841091|NCT03568942|449048268|FG000|Overall Study|Lost to Follow-up|1|||
124841092|NCT00640510|449048271|FG000|Overall Study|Lack of Efficacy|0|||
124841093|NCT00640510|449048272|FG001|Overall Study|Lack of Efficacy|1|||
124841094|NCT00640510|449048271|FG000|Overall Study|Protocol Violation|1|||
124640130|NCT00267969|448299881|FG001|After Controlled Period|Adverse Event|0|||
124640131|NCT00267969|448299882|FG002|After Controlled Period|Adverse Event|0|||
124841095|NCT00640510|449048272|FG001|Overall Study|Protocol Violation|0|||
124841096|NCT00640510|449048271|FG000|Overall Study|Physician Decision|0|||
124841097|NCT00640510|449048272|FG001|Overall Study|Physician Decision|1|||
124841098|NCT01467076|449048276|FG000|Overall Study|Lost to Follow-up|1|||
124841099|NCT01467076|449048277|FG001|Overall Study|Lost to Follow-up|0|||
124841100|NCT01467076|449048278|FG002|Overall Study|Lost to Follow-up|0|||
124841101|NCT00418691|449048280|FG000|Overall Study|Lost to Follow-up|1|||
124841102|NCT00418691|449048281|FG001|Overall Study|Lost to Follow-up|2|||
124841103|NCT00418691|449048282|FG002|Overall Study|Lost to Follow-up|3|||
124841104|NCT00418691|449048280|FG000|Overall Study|Started new medication voiding entry|0|||
124841105|NCT00418691|449048281|FG001|Overall Study|Started new medication voiding entry|0|||
124841106|NCT00418691|449048282|FG002|Overall Study|Started new medication voiding entry|1|||
124841107|NCT00418691|449048280|FG000|Overall Study|Progressive Disease|1|||
124841108|NCT00418691|449048281|FG001|Overall Study|Progressive Disease|0|||
124841109|NCT00418691|449048282|FG002|Overall Study|Progressive Disease|1|||
124841110|NCT01067352|449048283|FG000|Overall Study|Withdrawal by Subject|1|||
124841111|NCT01067352|449048284|FG001|Overall Study|Withdrawal by Subject|2|||
124841112|NCT01067352|449048285|FG002|Overall Study|Withdrawal by Subject|1|||
124841113|NCT01067352|449048283|FG000|Overall Study|Physician Decision|0|||
124841114|NCT01067352|449048284|FG001|Overall Study|Physician Decision|1|||
124841115|NCT01067352|449048285|FG002|Overall Study|Physician Decision|0|||
124841116|NCT01096784|449048286|FG000|Overall Study|Withdrawal by Subject|2|||
124841117|NCT01096784|449048287|FG001|Overall Study|Withdrawal by Subject|1|||
124841118|NCT01096784|449048286|FG000|Overall Study|Adverse Event|11|||
124841119|NCT01096784|449048287|FG001|Overall Study|Adverse Event|9|||
124841120|NCT01096784|449048286|FG000|Overall Study|Protocol Deviation|2|||
124841121|NCT01096784|449048287|FG001|Overall Study|Protocol Deviation|2|||
124841122|NCT01096784|449048286|FG000|Overall Study|Administrative Decision|0|||
124841123|NCT01096784|449048287|FG001|Overall Study|Administrative Decision|1|||
124841124|NCT01096784|449048286|FG000|Overall Study|Other Unspecified|0|||
124841125|NCT01096784|449048287|FG001|Overall Study|Other Unspecified|1|||
124841126|NCT03761628|449048288|FG000|Overall Study|Withdrawal by Subject|3|||
124841127|NCT03761628|449048288|FG000|Overall Study|Physician Decision|1|||
124841128|NCT03761628|449048288|FG000|Overall Study|Pregnancy|1|||
124841129|NCT03761628|449048288|FG000|Overall Study|Lost to Follow-up|1|||
124841130|NCT03064126|449048289|FG000|Overall Study|Death|40|||
124841131|NCT03064126|449048290|FG001|Overall Study|Death|16|||
124841132|NCT03064126|449048291|FG002|Overall Study|Death|4|||
124841133|NCT03064126|449048292|FG003|Overall Study|Death|2|||
124841134|NCT03064126|449048289|FG000|Overall Study|Withdrawal by Subject|17|||
124841135|NCT03064126|449048290|FG001|Overall Study|Withdrawal by Subject|9|||
124841136|NCT03064126|449048291|FG002|Overall Study|Withdrawal by Subject|0|||
124841137|NCT03064126|449048292|FG003|Overall Study|Withdrawal by Subject|2|||
124841138|NCT03064126|449048289|FG000|Overall Study|Lost to Follow-up|7|||
124841139|NCT03064126|449048290|FG001|Overall Study|Lost to Follow-up|3|||
124841140|NCT03064126|449048291|FG002|Overall Study|Lost to Follow-up|0|||
124841141|NCT03064126|449048292|FG003|Overall Study|Lost to Follow-up|0|||
124841142|NCT03064126|449048289|FG000|Overall Study|Adverse Event|2|||
124841143|NCT03064126|449048290|FG001|Overall Study|Adverse Event|0|||
124841144|NCT03064126|449048291|FG002|Overall Study|Adverse Event|0|||
124841145|NCT03064126|449048292|FG003|Overall Study|Adverse Event|0|||
124841146|NCT03064126|449048289|FG000|Overall Study|Physician Decision|3|||
124841147|NCT03064126|449048290|FG001|Overall Study|Physician Decision|0|||
124841148|NCT03064126|449048291|FG002|Overall Study|Physician Decision|0|||
124841149|NCT03064126|449048292|FG003|Overall Study|Physician Decision|0|||
124841150|NCT03064126|449048289|FG000|Overall Study|Other reason for early termination|3|||
124841151|NCT03064126|449048290|FG001|Overall Study|Other reason for early termination|2|||
124841152|NCT03064126|449048291|FG002|Overall Study|Other reason for early termination|0|||
124841153|NCT03064126|449048292|FG003|Overall Study|Other reason for early termination|0|||
124841154|NCT03064126|449048289|FG000|Overall Study|Missed Visit|3|||
124841155|NCT03064126|449048290|FG001|Overall Study|Missed Visit|1|||
124841156|NCT03064126|449048291|FG002|Overall Study|Missed Visit|0|||
124841157|NCT03064126|449048292|FG003|Overall Study|Missed Visit|0|||
124841158|NCT02465528|449048296|FG000|Overall Study|Progressive disease|0|||
124841159|NCT02465528|449048297|FG001|Overall Study|Progressive disease|2|||
124841160|NCT02465528|449048298|FG002|Overall Study|Progressive disease|9|||
124841161|NCT02465528|449048299|FG003|Overall Study|Progressive disease|4|||
124841162|NCT02465528|449048296|FG000|Overall Study|Study terminated by sponsor|1|||
124841163|NCT02465528|449048297|FG001|Overall Study|Study terminated by sponsor|2|||
124841164|NCT02465528|449048298|FG002|Overall Study|Study terminated by sponsor|0|||
124841165|NCT02465528|449048299|FG003|Overall Study|Study terminated by sponsor|0|||
124841166|NCT02465528|449048296|FG000|Overall Study|Withdrawal by Subject|0|||
124841167|NCT02465528|449048297|FG001|Overall Study|Withdrawal by Subject|0|||
124841168|NCT02465528|449048298|FG002|Overall Study|Withdrawal by Subject|2|||
124841169|NCT02465528|449048299|FG003|Overall Study|Withdrawal by Subject|0|||
124841170|NCT02465528|449048296|FG000|Overall Study|Adverse Event|0|||
124841171|NCT02465528|449048297|FG001|Overall Study|Adverse Event|0|||
124841172|NCT02465528|449048298|FG002|Overall Study|Adverse Event|0|||
124841173|NCT02465528|449048299|FG003|Overall Study|Adverse Event|1|||
124841174|NCT02465528|449048296|FG000|Overall Study|Physician Decision|0|||
124841175|NCT02465528|449048297|FG001|Overall Study|Physician Decision|0|||
124841176|NCT02465528|449048298|FG002|Overall Study|Physician Decision|1|||
124841177|NCT02465528|449048299|FG003|Overall Study|Physician Decision|0|||
124841178|NCT03907683|449048301|FG000|Overall Study|Pregnancy|1|||
124841179|NCT03907683|449048301|FG000|Overall Study|Withdrawal by Subject|1|||
124841180|NCT02975934|449048302|FG000|Treatment Phase|Never initiated study drug|0|||
124841181|NCT02975934|449048303|FG001|Treatment Phase|Never initiated study drug|5|||
124841182|NCT02975934|449048304|FG002|Treatment Phase|Never initiated study drug|0|||
124841183|NCT02075840|449048305|FG000|Overall Study|Withdrawal by Subject|13|||
124841184|NCT02075840|449048306|FG001|Overall Study|Withdrawal by Subject|22|||
124841185|NCT02075840|449048305|FG000|Overall Study|Reason not specified|1|||
124841186|NCT02075840|449048306|FG001|Overall Study|Reason not specified|0|||
124841187|NCT02075840|449048305|FG000|Overall Study|Adverse Event|0|||
124841188|NCT02075840|449048306|FG001|Overall Study|Adverse Event|2|||
124841189|NCT02075840|449048305|FG000|Overall Study|Death|35|||
124841190|NCT02075840|449048306|FG001|Overall Study|Death|40|||
124841191|NCT02075840|449048305|FG000|Overall Study|Lost to Follow-up|3|||
124841192|NCT02075840|449048306|FG001|Overall Study|Lost to Follow-up|2|||
124841193|NCT02075840|449048305|FG000|Overall Study|Physician Decision|1|||
124841194|NCT02075840|449048306|FG001|Overall Study|Physician Decision|3|||
124841195|NCT02075840|449048305|FG000|Overall Study|Ongoing at CCOD|99|||
124841196|NCT02075840|449048306|FG001|Overall Study|Ongoing at CCOD|82|||
124841197|NCT00846742|449048307|FG000|Overall Study|Withdrawal by Subject|1|||
124841198|NCT02775344|449048308|FG000|Overall Study|No ovarian cyst identified|3|||
124841199|NCT02775344|449048309|FG001|Overall Study|No ovarian cyst identified|2|||
124841200|NCT03909165|449048318|FG000|Overall Study|Physician Decision|0|||
124841201|NCT03909165|449048319|FG001|Overall Study|Physician Decision|1|||
124841202|NCT03909165|449048320|FG002|Overall Study|Physician Decision|0|||
124841203|NCT03909165|449048321|FG003|Overall Study|Physician Decision|0|||
124841204|NCT03909165|449048322|FG004|Overall Study|Physician Decision|0|||
124841205|NCT03909165|449048318|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124841206|NCT03909165|449048319|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124841207|NCT03909165|449048320|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124841208|NCT03909165|449048321|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
124841209|NCT03909165|449048322|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
124841210|NCT03909165|449048318|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
124841211|NCT03909165|449048319|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
124841212|NCT03909165|449048320|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
124841213|NCT03909165|449048321|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
124841214|NCT03909165|449048322|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
124841215|NCT03909165|449048318|FG000|Overall Study|Previous Drug Exposure|0|||
124841216|NCT03909165|449048319|FG001|Overall Study|Previous Drug Exposure|0|||
124841217|NCT03909165|449048320|FG002|Overall Study|Previous Drug Exposure|1|||
124841218|NCT03909165|449048321|FG003|Overall Study|Previous Drug Exposure|0|||
124841219|NCT03909165|449048322|FG004|Overall Study|Previous Drug Exposure|0|||
124841220|NCT03909165|449048318|FG000|Overall Study|Early Discharge|1|||
124841221|NCT03909165|449048319|FG001|Overall Study|Early Discharge|0|||
124841222|NCT03909165|449048320|FG002|Overall Study|Early Discharge|0|||
124841223|NCT03909165|449048321|FG003|Overall Study|Early Discharge|0|||
124841224|NCT03909165|449048322|FG004|Overall Study|Early Discharge|0|||
124841225|NCT02018458|449048324|FG000|Overall Study|Death|4|||
124841226|NCT00354172|449048325|FG000|Overall Study|Did not receive transplant|1|||
124841227|NCT01800916|449048326|FG000|Test Period 1 (1 Week)|Convex product user|0|||
124841228|NCT01800916|449048327|FG001|Test Period 1 (1 Week)|Convex product user|0|||
124841229|NCT01800916|449048328|FG002|Test Period 1 (1 Week)|Convex product user|0|||
124841230|NCT01800916|449048329|FG003|Test Period 1 (1 Week)|Convex product user|1|||
124841231|NCT01800916|449048330|FG004|Test Period 1 (1 Week)|Convex product user|0|||
124841232|NCT01800916|449048331|FG005|Test Period 1 (1 Week)|Convex product user|0|||
124841233|NCT01800916|449048332|FG006|Test Period 1 (1 Week)|Convex product user|0|||
124841234|NCT01800916|449048333|FG007|Test Period 1 (1 Week)|Convex product user|0|||
124841235|NCT01800916|449048334|FG008|Test Period 1 (1 Week)|Convex product user|0|||
124841236|NCT01800916|449048326|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
124841237|NCT01800916|449048327|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
124841238|NCT01800916|449048328|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
124841239|NCT01800916|449048329|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
124841240|NCT01800916|449048330|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
124841241|NCT01800916|449048331|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
124841242|NCT01800916|449048332|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
124841243|NCT01800916|449048333|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
124841244|NCT01800916|449048334|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
124841245|NCT00727714|449048335|FG000|Overall Study|Lost to Follow-up|2|||
124841246|NCT00325234|449048336|FG000|Overall Study|Adverse Event|10|||
124841247|NCT00325234|449048337|FG001|Overall Study|Adverse Event|7|||
124841248|NCT00325234|449048336|FG000|Overall Study|Death due to Study Disease|1|||
124841249|NCT00325234|449048337|FG001|Overall Study|Death due to Study Disease|0|||
124841250|NCT00325234|449048336|FG000|Overall Study|Entry Criteria Not Met|1|||
124841251|NCT00325234|449048337|FG001|Overall Study|Entry Criteria Not Met|2|||
124841252|NCT00325234|449048336|FG000|Overall Study|Subject Decision|6|||
124841253|NCT00325234|449048337|FG001|Overall Study|Subject Decision|8|||
124841254|NCT00325234|449048336|FG000|Overall Study|Physician Decision|17|||
124841255|NCT00325234|449048337|FG001|Overall Study|Physician Decision|12|||
124841256|NCT00325234|449048336|FG000|Overall Study|Progressive Disease|34|||
124841257|NCT00325234|449048337|FG001|Overall Study|Progressive Disease|37|||
124841258|NCT01234467|449048338|FG000|Overall Study|Adverse Event|3|||
124841259|NCT01234467|449048338|FG000|Overall Study|Death|2|||
124841260|NCT01234467|449048338|FG000|Overall Study|Withdrawal by Subject|2|||
124841261|NCT01234467|449048338|FG000|Overall Study|Disease Progression|2|||
124841262|NCT01234467|449048338|FG000|Overall Study|Clinical deterioration|1|||
124841263|NCT01234467|449048338|FG000|Overall Study|Physician Decision|1|||
124841264|NCT01234467|449048338|FG000|Overall Study|Other complicating disease (stroke)|1|||
124841265|NCT01639040|449048339|FG000|Overall Study|Adverse Event|1|||
124841266|NCT01639040|449048340|FG001|Overall Study|Adverse Event|0|||
124841267|NCT01479621|449048341|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
124841268|NCT01479621|449048342|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124841269|NCT01479621|449048343|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124841270|NCT01479621|449048344|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124841271|NCT01479621|449048345|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124841272|NCT01479621|449048346|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124841273|NCT01479621|449048347|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
124841274|NCT01479621|449048341|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
124841275|NCT01479621|449048342|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124841276|NCT01479621|449048343|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124841277|NCT01479621|449048344|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124841278|NCT01479621|449048345|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124841279|NCT01479621|449048346|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124841280|NCT01479621|449048347|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
124841281|NCT01479621|449048341|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
124841282|NCT01479621|449048342|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124841283|NCT01479621|449048343|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124841284|NCT01479621|449048344|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124841285|NCT01479621|449048345|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124841286|NCT01479621|449048346|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124841287|NCT01479621|449048347|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
124841288|NCT01479621|449048341|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
124841289|NCT01479621|449048342|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124841290|NCT01479621|449048343|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124841291|NCT01479621|449048344|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124841292|NCT01479621|449048345|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124841293|NCT01479621|449048346|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124841294|NCT01479621|449048347|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
124841295|NCT01479621|449048341|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
124841296|NCT01479621|449048342|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124841297|NCT01479621|449048343|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124841298|NCT01479621|449048344|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124841299|NCT01479621|449048345|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124841300|NCT01479621|449048346|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124841301|NCT01479621|449048347|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
124841302|NCT01479621|449048341|FG000|Treatment Period|Adverse Event|0|||
124841303|NCT01479621|449048342|FG001|Treatment Period|Adverse Event|0|||
124841304|NCT01479621|449048343|FG002|Treatment Period|Adverse Event|0|||
124841305|NCT01479621|449048344|FG003|Treatment Period|Adverse Event|0|||
124841306|NCT01479621|449048345|FG004|Treatment Period|Adverse Event|1|||
124841307|NCT01479621|449048346|FG005|Treatment Period|Adverse Event|2|||
124841308|NCT01479621|449048347|FG006|Treatment Period|Adverse Event|2|||
124841309|NCT01479621|449048341|FG000|Treatment Period|Withdrawal by Subject|0|||
124841310|NCT01479621|449048342|FG001|Treatment Period|Withdrawal by Subject|4|||
124841311|NCT01479621|449048343|FG002|Treatment Period|Withdrawal by Subject|2|||
124841312|NCT01479621|449048344|FG003|Treatment Period|Withdrawal by Subject|2|||
124841313|NCT01479621|449048345|FG004|Treatment Period|Withdrawal by Subject|5|||
124841314|NCT01479621|449048346|FG005|Treatment Period|Withdrawal by Subject|5|||
124841315|NCT01479621|449048347|FG006|Treatment Period|Withdrawal by Subject|1|||
124841316|NCT01479621|449048341|FG000|Treatment Period|Physician Decision|0|||
124640132|NCT00267969|448299883|FG003|After Controlled Period|Adverse Event|7|||
124841317|NCT01479621|449048342|FG001|Treatment Period|Physician Decision|0|||
124841318|NCT01479621|449048343|FG002|Treatment Period|Physician Decision|0|||
124841319|NCT01479621|449048344|FG003|Treatment Period|Physician Decision|0|||
124841320|NCT01479621|449048345|FG004|Treatment Period|Physician Decision|1|||
124841321|NCT01479621|449048346|FG005|Treatment Period|Physician Decision|1|||
124841322|NCT01479621|449048347|FG006|Treatment Period|Physician Decision|0|||
124841323|NCT01479621|449048341|FG000|Treatment Period|Non-compliance to study drug|0|||
124841324|NCT01479621|449048342|FG001|Treatment Period|Non-compliance to study drug|1|||
124841325|NCT01479621|449048343|FG002|Treatment Period|Non-compliance to study drug|0|||
124841326|NCT01479621|449048344|FG003|Treatment Period|Non-compliance to study drug|0|||
124841327|NCT01479621|449048345|FG004|Treatment Period|Non-compliance to study drug|0|||
124841328|NCT01479621|449048346|FG005|Treatment Period|Non-compliance to study drug|0|||
124841329|NCT01479621|449048347|FG006|Treatment Period|Non-compliance to study drug|1|||
124841330|NCT01479621|449048341|FG000|Treatment Period|Protocol Violation|0|||
124841331|NCT01479621|449048342|FG001|Treatment Period|Protocol Violation|9|||
124841332|NCT01479621|449048343|FG002|Treatment Period|Protocol Violation|6|||
124841333|NCT01479621|449048344|FG003|Treatment Period|Protocol Violation|5|||
124841334|NCT01479621|449048345|FG004|Treatment Period|Protocol Violation|2|||
124841335|NCT01479621|449048346|FG005|Treatment Period|Protocol Violation|10|||
124841336|NCT01479621|449048347|FG006|Treatment Period|Protocol Violation|6|||
124841337|NCT01479621|449048341|FG000|Treatment Period|Pregnancy|0|||
124841338|NCT01479621|449048342|FG001|Treatment Period|Pregnancy|0|||
124841339|NCT01479621|449048343|FG002|Treatment Period|Pregnancy|2|||
124841340|NCT01479621|449048344|FG003|Treatment Period|Pregnancy|0|||
124841341|NCT01479621|449048345|FG004|Treatment Period|Pregnancy|0|||
124841342|NCT01479621|449048346|FG005|Treatment Period|Pregnancy|0|||
124841343|NCT01479621|449048347|FG006|Treatment Period|Pregnancy|0|||
124841344|NCT01479621|449048341|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
124841345|NCT01479621|449048342|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
124841346|NCT01479621|449048343|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
124841347|NCT01479621|449048344|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
124841348|NCT01479621|449048345|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
124841349|NCT01479621|449048346|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
124841350|NCT01479621|449048347|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
124841351|NCT01479621|449048341|FG000|Treatment Period|Lost to Follow-up|0|||
124841352|NCT01479621|449048342|FG001|Treatment Period|Lost to Follow-up|0|||
124841353|NCT01479621|449048343|FG002|Treatment Period|Lost to Follow-up|1|||
124841354|NCT01479621|449048344|FG003|Treatment Period|Lost to Follow-up|0|||
124841355|NCT01479621|449048345|FG004|Treatment Period|Lost to Follow-up|2|||
124841356|NCT01479621|449048346|FG005|Treatment Period|Lost to Follow-up|2|||
124841357|NCT01479621|449048347|FG006|Treatment Period|Lost to Follow-up|1|||
124841358|NCT01479621|449048341|FG000|Treatment Period|Met stopping criteria|0|||
124841359|NCT01479621|449048342|FG001|Treatment Period|Met stopping criteria|8|||
124841360|NCT01479621|449048343|FG002|Treatment Period|Met stopping criteria|7|||
124841361|NCT01479621|449048344|FG003|Treatment Period|Met stopping criteria|4|||
124841362|NCT01479621|449048345|FG004|Treatment Period|Met stopping criteria|9|||
124841363|NCT01479621|449048346|FG005|Treatment Period|Met stopping criteria|20|||
124841364|NCT01479621|449048347|FG006|Treatment Period|Met stopping criteria|6|||
124841365|NCT00486265|449048348|FG000|Overall Study|Adverse Event|1|||
124841366|NCT00486265|449048348|FG000|Overall Study|Lack of Efficacy|8|||
124841367|NCT01452412|449048349|FG000|Overall Study|Withdrawal by Subject|15|||
124841368|NCT01452412|449048350|FG001|Overall Study|Withdrawal by Subject|11|||
124841369|NCT01452412|449048349|FG000|Overall Study|Adverse Event|4|||
124841370|NCT01452412|449048350|FG001|Overall Study|Adverse Event|3|||
124841371|NCT01452412|449048349|FG000|Overall Study|Lost to Follow-up|5|||
124841372|NCT01452412|449048350|FG001|Overall Study|Lost to Follow-up|3|||
124841373|NCT01452412|449048349|FG000|Overall Study|Death|1|||
124841374|NCT01452412|449048350|FG001|Overall Study|Death|0|||
124841375|NCT01452412|449048349|FG000|Overall Study|Initiated dialysis|1|||
124841376|NCT01452412|449048350|FG001|Overall Study|Initiated dialysis|0|||
124841377|NCT01452412|449048349|FG000|Overall Study|Other|2|||
124841378|NCT01452412|449048350|FG001|Overall Study|Other|0|||
124841379|NCT03029624|449048351|FG000|Overall Study|Adverse Event|1|||
124841380|NCT03029624|449048351|FG000|Overall Study|Withdrawal by Subject|1|||
124841381|NCT03029624|449048351|FG000|Overall Study|Lack of Efficacy|1|||
124841382|NCT03029624|449048351|FG000|Overall Study|MRI need|2|||
124841383|NCT01640366|449048352|FG000|Overall Study|Withdrawal by Subject|1|||
124841384|NCT01640366|449048352|FG000|Overall Study|Protocol Violation|16|||
124841385|NCT01640366|449048352|FG000|Overall Study|Lost to Follow-up|5|||
124841386|NCT02722928|449048355|FG000|Overall Study|Standard CT was not as required per prot|5|||
124841387|NCT02722928|449048356|FG001|Overall Study|Standard CT was not as required per prot|13|||
124841388|NCT02722928|449048355|FG000|Overall Study|Required Intraoperative MRI|5|||
124841389|NCT02722928|449048356|FG001|Overall Study|Required Intraoperative MRI|7|||
124841390|NCT00838565|449048357|FG000|Overall Study|Withdrawal by Subject|0|||
124841391|NCT00838565|449048358|FG001|Overall Study|Withdrawal by Subject|0|||
124841392|NCT00838565|449048359|FG002|Overall Study|Withdrawal by Subject|1|||
124841393|NCT00838565|449048360|FG003|Overall Study|Withdrawal by Subject|0|||
124841394|NCT00838565|449048361|FG004|Overall Study|Withdrawal by Subject|0|||
124841395|NCT00838565|449048362|FG005|Overall Study|Withdrawal by Subject|2|||
124841396|NCT00838565|449048357|FG000|Overall Study|Other|0|||
124841397|NCT00838565|449048358|FG001|Overall Study|Other|2|||
124841398|NCT00838565|449048359|FG002|Overall Study|Other|0|||
124841399|NCT00838565|449048360|FG003|Overall Study|Other|0|||
124841400|NCT00838565|449048361|FG004|Overall Study|Other|0|||
124841401|NCT00838565|449048362|FG005|Overall Study|Other|0|||
124841402|NCT00838565|449048357|FG000|Overall Study|Randomized but not Treated|0|||
124841403|NCT00838565|449048358|FG001|Overall Study|Randomized but not Treated|1|||
124841404|NCT00838565|449048359|FG002|Overall Study|Randomized but not Treated|0|||
124841405|NCT00838565|449048360|FG003|Overall Study|Randomized but not Treated|0|||
124841406|NCT00838565|449048361|FG004|Overall Study|Randomized but not Treated|0|||
124841407|NCT00838565|449048362|FG005|Overall Study|Randomized but not Treated|0|||
124841408|NCT03571516|449048363|FG000|Overall Study|Severe diarrhea|1|||
124841409|NCT03571516|449048364|FG001|Overall Study|Severe diarrhea|0|||
124841410|NCT03571516|449048363|FG000|Overall Study|Withdrawal by Subject|0|||
124841411|NCT03571516|449048364|FG001|Overall Study|Withdrawal by Subject|1|||
124841412|NCT04011410|449048366|FG000|Overall Study|Withdrawal by Subject|1|||
124841413|NCT01838642|449048368|FG000|Overall Study|Died on study|1|||
124841414|NCT01557400|449048369|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
124841415|NCT01557400|449048369|FG000|Overall Study|Adverse Event|3|||
124841416|NCT01557400|449048369|FG000|Overall Study|Lost to Follow-up|5|||
124841417|NCT01557400|449048369|FG000|Overall Study|Withdrawal by Subject|9|||
124841418|NCT01434290|449048370|FG000|Overall Study|Protocol Violation|6|||
124841419|NCT01434290|449048371|FG001|Overall Study|Protocol Violation|3|||
124841420|NCT01434290|449048370|FG000|Overall Study|No protocol treatment|2|||
124841421|NCT01434290|449048371|FG001|Overall Study|No protocol treatment|4|||
124841422|NCT01224639|449048372|FG000|Overall Study|Withdrawal by Subject|0|||
124841423|NCT01224639|449048373|FG001|Overall Study|Withdrawal by Subject|0|||
124841424|NCT01224639|449048374|FG002|Overall Study|Withdrawal by Subject|0|||
124841425|NCT01224639|449048375|FG003|Overall Study|Withdrawal by Subject|0|||
124841426|NCT01224639|449048376|FG004|Overall Study|Withdrawal by Subject|2|||
124841427|NCT01224639|449048377|FG005|Overall Study|Withdrawal by Subject|0|||
124841428|NCT01224639|449048378|FG006|Overall Study|Withdrawal by Subject|1|||
124841429|NCT01224639|449048379|FG007|Overall Study|Withdrawal by Subject|1|||
124841430|NCT01224639|449048372|FG000|Overall Study|Adverse Event|0|||
124841431|NCT01224639|449048373|FG001|Overall Study|Adverse Event|0|||
124841432|NCT01224639|449048374|FG002|Overall Study|Adverse Event|0|||
124841433|NCT01224639|449048375|FG003|Overall Study|Adverse Event|0|||
124841434|NCT01224639|449048376|FG004|Overall Study|Adverse Event|0|||
124841435|NCT01224639|449048377|FG005|Overall Study|Adverse Event|0|||
124841436|NCT01224639|449048378|FG006|Overall Study|Adverse Event|0|||
124841437|NCT01224639|449048379|FG007|Overall Study|Adverse Event|1|||
124841438|NCT03465878|449048380|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
124841439|NCT03465878|449048381|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
124841440|NCT03465878|449048382|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
124841441|NCT03465878|449048383|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
124841442|NCT03465878|449048380|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
124841443|NCT03465878|449048381|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
124841444|NCT03465878|449048382|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
124841445|NCT03465878|449048383|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
124841446|NCT03465878|449048380|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
124841447|NCT03465878|449048381|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
124841448|NCT03465878|449048382|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
124841449|NCT03465878|449048383|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
124841450|NCT04656132|449048384|FG000|Overall Study|Lost to Follow-up|4|||
124841451|NCT04656132|449048384|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
124841452|NCT00677807|449048385|FG000|Overall Study|Adverse Event|4|||
124841453|NCT00677807|449048386|FG001|Overall Study|Adverse Event|1|||
124841454|NCT00677807|449048387|FG002|Overall Study|Adverse Event|6|||
124841455|NCT00677807|449048385|FG000|Overall Study|Lack of Efficacy|0|||
124841456|NCT00677807|449048386|FG001|Overall Study|Lack of Efficacy|0|||
124841457|NCT00677807|449048387|FG002|Overall Study|Lack of Efficacy|2|||
124841458|NCT00677807|449048385|FG000|Overall Study|Participant no longer needs study drug|0|||
124640133|NCT00267969|448299884|FG004|After Controlled Period|Adverse Event|8|||
124640134|NCT00267969|448299885|FG005|After Controlled Period|Adverse Event|23|||
124640135|NCT00267969|448299886|FG006|After Controlled Period|Adverse Event|21|||
124841459|NCT00677807|449048386|FG001|Overall Study|Participant no longer needs study drug|0|||
124841460|NCT00677807|449048387|FG002|Overall Study|Participant no longer needs study drug|1|||
124841461|NCT00677807|449048385|FG000|Overall Study|Withdrawal by Subject|10|||
124841462|NCT00677807|449048386|FG001|Overall Study|Withdrawal by Subject|3|||
124841463|NCT00677807|449048387|FG002|Overall Study|Withdrawal by Subject|6|||
124841464|NCT00677807|449048385|FG000|Overall Study|Lost to Follow-up|2|||
124841465|NCT00677807|449048386|FG001|Overall Study|Lost to Follow-up|2|||
124841466|NCT00677807|449048387|FG002|Overall Study|Lost to Follow-up|2|||
124841467|NCT00677807|449048385|FG000|Overall Study|Administrative problems|1|||
124841468|NCT00677807|449048386|FG001|Overall Study|Administrative problems|1|||
124841469|NCT00677807|449048387|FG002|Overall Study|Administrative problems|2|||
124841470|NCT00677807|449048385|FG000|Overall Study|Death|0|||
124841471|NCT00677807|449048386|FG001|Overall Study|Death|1|||
124841472|NCT00677807|449048387|FG002|Overall Study|Death|1|||
124841473|NCT00677807|449048385|FG000|Overall Study|Protocol Deviation|1|||
124841474|NCT00677807|449048386|FG001|Overall Study|Protocol Deviation|3|||
124841475|NCT00677807|449048387|FG002|Overall Study|Protocol Deviation|0|||
124841476|NCT04019041|449048388|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
124841477|NCT04019041|449048389|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
124841478|NCT04019041|449048390|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
124841479|NCT04019041|449048391|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
124841480|NCT04019041|449048392|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
124841481|NCT04019041|449048393|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
124841482|NCT04019041|449048388|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
124841483|NCT04019041|449048389|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
124841484|NCT04019041|449048390|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
124841485|NCT04019041|449048391|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
124841486|NCT04019041|449048392|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
124841487|NCT04019041|449048393|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
124841488|NCT04019041|449048388|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
124841489|NCT04019041|449048389|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
124841490|NCT04019041|449048390|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
124841491|NCT04019041|449048391|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
124841492|NCT04019041|449048392|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
124841493|NCT04019041|449048393|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
124841494|NCT04019041|449048388|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
124841495|NCT04019041|449048389|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
124841496|NCT04019041|449048390|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
124841497|NCT04019041|449048391|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
124841498|NCT04019041|449048392|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
124841499|NCT04019041|449048393|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
124841500|NCT04019041|449048388|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
124841501|NCT04019041|449048389|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
124841502|NCT04019041|449048390|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
124841503|NCT04019041|449048391|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
124841504|NCT04019041|449048392|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
124841505|NCT04019041|449048393|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
124841506|NCT04019041|449048388|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
124841507|NCT04019041|449048389|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
124841508|NCT04019041|449048390|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
124841509|NCT04019041|449048391|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
124841510|NCT04019041|449048392|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
124841511|NCT04019041|449048393|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
124841512|NCT04019041|449048388|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
124841513|NCT04019041|449048389|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
124841514|NCT04019041|449048390|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
124841515|NCT04019041|449048391|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
124841516|NCT04019041|449048392|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
124841517|NCT04019041|449048393|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
124841518|NCT04019041|449048388|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
124841519|NCT04019041|449048389|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
124841520|NCT04019041|449048390|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
124841521|NCT04019041|449048391|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
124841522|NCT04019041|449048392|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
124841523|NCT04019041|449048393|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
124841524|NCT04019041|449048388|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
124841525|NCT04019041|449048389|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
124841526|NCT04019041|449048390|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
124841527|NCT04019041|449048391|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
124841528|NCT04019041|449048392|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
124841529|NCT04019041|449048393|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
124841530|NCT00314366|449048394|FG000|Overall Study|not treated due to patient medical condi|1|||
124841531|NCT00314366|449048395|FG001|Overall Study|not treated due to patient medical condi|0|||
124841532|NCT01806896|449048397|FG000|Overall Study|Adverse Event|2|||
124841533|NCT01806896|449048398|FG001|Overall Study|Adverse Event|0|||
124841534|NCT01806896|449048397|FG000|Overall Study|Other|1|||
124841535|NCT01806896|449048398|FG001|Overall Study|Other|0|||
124841536|NCT01083433|449050029|FG000|Overall Study|Lost to Follow-up|2|||
124841537|NCT01083433|449050030|FG001|Overall Study|Lost to Follow-up|1|||
124841538|NCT01083433|449050031|FG002|Overall Study|Lost to Follow-up|1|||
124841539|NCT01083433|449050029|FG000|Overall Study|Withdrawal by Subject|0|||
124841540|NCT01083433|449050030|FG001|Overall Study|Withdrawal by Subject|5|||
124841541|NCT01083433|449050031|FG002|Overall Study|Withdrawal by Subject|3|||
124841542|NCT01083433|449050029|FG000|Overall Study|Pregnancy|0|||
124841543|NCT01083433|449050030|FG001|Overall Study|Pregnancy|0|||
124841544|NCT01083433|449050031|FG002|Overall Study|Pregnancy|1|||
124841545|NCT01581593|449050032|FG000|Overall Study|Withdrawal by Subject|1|||
124841546|NCT04982029|449050033|FG000|Overall Study|Lost to Follow-up|2|||
124841547|NCT04982029|449050034|FG001|Overall Study|Lost to Follow-up|3|||
124841548|NCT05308901|449050035|FG000|Overall Study|Death|6|||
124841549|NCT01896895|449050036|FG000|Double-blind MP|Physician Decision|0|||
124841550|NCT01896895|449050037|FG001|Double-blind MP|Physician Decision|0|||
124841551|NCT01896895|449050038|FG002|Double-blind MP|Physician Decision|1|||
124841552|NCT01896895|449050039|FG003|Double-blind MP|Physician Decision|0|||
124841553|NCT01896895|449050036|FG000|Double-blind MP|Withdrawal by Subject|0|||
124841554|NCT01896895|449050037|FG001|Double-blind MP|Withdrawal by Subject|2|||
124841555|NCT01896895|449050038|FG002|Double-blind MP|Withdrawal by Subject|1|||
124841556|NCT01896895|449050039|FG003|Double-blind MP|Withdrawal by Subject|0|||
124841557|NCT01896895|449050036|FG000|Double-blind MP|Lost to Follow-up|1|||
124841558|NCT01896895|449050037|FG001|Double-blind MP|Lost to Follow-up|0|||
124841559|NCT01896895|449050038|FG002|Double-blind MP|Lost to Follow-up|1|||
124841560|NCT01896895|449050039|FG003|Double-blind MP|Lost to Follow-up|0|||
124841561|NCT04127786|449050040|FG000|Primary Series|Adverse Event|1|||
124841562|NCT04127786|449050041|FG001|Primary Series|Adverse Event|0|||
124841563|NCT04127786|449050042|FG002|Primary Series|Adverse Event|0|||
124841564|NCT04127786|449050043|FG003|Primary Series|Adverse Event|1|||
124841565|NCT04127786|449050044|FG004|Primary Series|Adverse Event|0|||
124841566|NCT04127786|449050045|FG005|Primary Series|Adverse Event|1|||
124841567|NCT04127786|449050040|FG000|Primary Series|Protocol Violation|5|||
124841568|NCT04127786|449050041|FG001|Primary Series|Protocol Violation|3|||
124841569|NCT04127786|449050042|FG002|Primary Series|Protocol Violation|4|||
124841570|NCT04127786|449050043|FG003|Primary Series|Protocol Violation|3|||
124841571|NCT04127786|449050044|FG004|Primary Series|Protocol Violation|2|||
124841572|NCT04127786|449050045|FG005|Primary Series|Protocol Violation|0|||
124841573|NCT04127786|449050040|FG000|Primary Series|Withdrawal by Subject|0|||
124841574|NCT04127786|449050041|FG001|Primary Series|Withdrawal by Subject|0|||
124841575|NCT04127786|449050042|FG002|Primary Series|Withdrawal by Subject|0|||
124841576|NCT04127786|449050043|FG003|Primary Series|Withdrawal by Subject|1|||
124841577|NCT04127786|449050044|FG004|Primary Series|Withdrawal by Subject|0|||
124841578|NCT04127786|449050045|FG005|Primary Series|Withdrawal by Subject|0|||
124841579|NCT04127786|449050040|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
124841580|NCT04127786|449050041|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
124841581|NCT04127786|449050042|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
124841582|NCT04127786|449050043|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
124841583|NCT04127786|449050044|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
124841584|NCT04127786|449050045|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
124841585|NCT04127786|449050040|FG000|Booster Phase|Withdrawal by Subject|2|||
124841586|NCT04127786|449050041|FG001|Booster Phase|Withdrawal by Subject|0|||
124841587|NCT04127786|449050042|FG002|Booster Phase|Withdrawal by Subject|0|||
124841588|NCT04127786|449050043|FG003|Booster Phase|Withdrawal by Subject|0|||
124841589|NCT04127786|449050044|FG004|Booster Phase|Withdrawal by Subject|0|||
124841590|NCT04127786|449050045|FG005|Booster Phase|Withdrawal by Subject|0|||
124841591|NCT01904604|449050046|FG000|Overall Study|Withdrew before receiving dosing|0|||
124841592|NCT01904604|449050047|FG001|Overall Study|Withdrew before receiving dosing|1|||
124841593|NCT01904604|449050048|FG002|Overall Study|Withdrew before receiving dosing|0|||
124841594|NCT01904604|449050046|FG000|Overall Study|Non-compliance|1|||
124841595|NCT01904604|449050047|FG001|Overall Study|Non-compliance|0|||
124841596|NCT01904604|449050048|FG002|Overall Study|Non-compliance|0|||
124841597|NCT01904604|449050046|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
124841598|NCT01904604|449050047|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
124841599|NCT01904604|449050048|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
124841600|NCT01904604|449050046|FG000|Overall Study|Patch site reactions|1|||
124841601|NCT01904604|449050047|FG001|Overall Study|Patch site reactions|1|||
124841602|NCT01904604|449050048|FG002|Overall Study|Patch site reactions|0|||
124841603|NCT01904604|449050046|FG000|Overall Study|Increased syncope|0|||
124841604|NCT01904604|449050047|FG001|Overall Study|Increased syncope|1|||
124841605|NCT01904604|449050048|FG002|Overall Study|Increased syncope|0|||
124841606|NCT01904604|449050046|FG000|Overall Study|Unrelated illness|0|||
124841607|NCT01904604|449050047|FG001|Overall Study|Unrelated illness|1|||
124841608|NCT01904604|449050048|FG002|Overall Study|Unrelated illness|0|||
124841609|NCT01904604|449050046|FG000|Overall Study|Passed Week 52 OFC|1|||
124841610|NCT01904604|449050047|FG001|Overall Study|Passed Week 52 OFC|0|||
124841611|NCT01904604|449050048|FG002|Overall Study|Passed Week 52 OFC|0|||
124841612|NCT01904604|449050046|FG000|Overall Study|Withdrawal by Subject|1|||
124841613|NCT01904604|449050047|FG001|Overall Study|Withdrawal by Subject|2|||
124841614|NCT01904604|449050048|FG002|Overall Study|Withdrawal by Subject|0|||
124841615|NCT01904604|449050046|FG000|Overall Study|Participant Relocated|1|||
124841616|NCT01904604|449050047|FG001|Overall Study|Participant Relocated|1|||
124841617|NCT01904604|449050048|FG002|Overall Study|Participant Relocated|1|||
124841618|NCT01904604|449050046|FG000|Overall Study|Lost to Follow-up|0|||
124841619|NCT01904604|449050047|FG001|Overall Study|Lost to Follow-up|0|||
124841620|NCT01904604|449050048|FG002|Overall Study|Lost to Follow-up|1|||
124841621|NCT00358527|449050055|FG000|Overall Study|Adverse Event|4|||
124841622|NCT00358527|449050056|FG001|Overall Study|Adverse Event|0|||
124841623|NCT00358527|449050055|FG000|Overall Study|Withdrawal by Subject|1|||
124841624|NCT00358527|449050056|FG001|Overall Study|Withdrawal by Subject|1|||
124841625|NCT00358527|449050055|FG000|Overall Study|Non-compliance with protocol|6|||
124841626|NCT00358527|449050056|FG001|Overall Study|Non-compliance with protocol|1|||
124841627|NCT00358527|449050055|FG000|Overall Study|Administrative|2|||
124841628|NCT00358527|449050056|FG001|Overall Study|Administrative|1|||
124841629|NCT04144166|449050057|FG000|Overall Study|Discharged before study start|1|||
124841630|NCT04144166|449050057|FG000|Overall Study|Pregnancy|1|||
124841631|NCT04144166|449050057|FG000|Overall Study|Nail polish could not be removed from finger|1|||
124841632|NCT00145509|449050058|FG000|Overall Study|Adverse Event|10|||
124841633|NCT00145509|449050059|FG001|Overall Study|Adverse Event|3|||
124841634|NCT00145509|449050058|FG000|Overall Study|Lack of Efficacy|3|||
124841635|NCT00145509|449050059|FG001|Overall Study|Lack of Efficacy|1|||
124841636|NCT00145509|449050058|FG000|Overall Study|Lost to Follow-up|5|||
124841637|NCT00145509|449050059|FG001|Overall Study|Lost to Follow-up|9|||
124841638|NCT00145509|449050058|FG000|Overall Study|Withdrew Consent|2|||
124841639|NCT00145509|449050059|FG001|Overall Study|Withdrew Consent|7|||
124841640|NCT00145509|449050058|FG000|Overall Study|Reason not provided|2|||
124841641|NCT00145509|449050059|FG001|Overall Study|Reason not provided|1|||
124841642|NCT04145895|449050062|FG000|Overall Study|Physician Decision|2|||
124841643|NCT04145895|449050063|FG001|Overall Study|Physician Decision|0|||
124841644|NCT04145895|449050062|FG000|Overall Study|Withdrawal by Subject|0|||
124841645|NCT04145895|449050063|FG001|Overall Study|Withdrawal by Subject|2|||
124841646|NCT01481116|449050064|FG000|Overall Study|Adverse Event|26|||
124841647|NCT01481116|449050065|FG001|Overall Study|Adverse Event|26|||
124841648|NCT01481116|449050066|FG002|Overall Study|Adverse Event|42|||
124841649|NCT01481116|449050064|FG000|Overall Study|Major Protocol Deviation|3|||
124841650|NCT01481116|449050065|FG001|Overall Study|Major Protocol Deviation|7|||
124841651|NCT01481116|449050066|FG002|Overall Study|Major Protocol Deviation|1|||
124841652|NCT01481116|449050064|FG000|Overall Study|Lost to Follow-up|8|||
124841653|NCT01481116|449050065|FG001|Overall Study|Lost to Follow-up|12|||
124841654|NCT01481116|449050066|FG002|Overall Study|Lost to Follow-up|11|||
124841655|NCT01481116|449050064|FG000|Overall Study|Withdrawal by Subject|37|||
124841656|NCT01481116|449050065|FG001|Overall Study|Withdrawal by Subject|33|||
124841657|NCT01481116|449050066|FG002|Overall Study|Withdrawal by Subject|37|||
124841658|NCT01481116|449050064|FG000|Overall Study|Study Termination|730|||
124841659|NCT01481116|449050065|FG001|Overall Study|Study Termination|729|||
124841660|NCT01481116|449050066|FG002|Overall Study|Study Termination|713|||
124841661|NCT01481116|449050064|FG000|Overall Study|Pregnancy|0|||
124841662|NCT01481116|449050065|FG001|Overall Study|Pregnancy|0|||
124841663|NCT01481116|449050066|FG002|Overall Study|Pregnancy|1|||
124841664|NCT01481116|449050064|FG000|Overall Study|Lack of Efficacy|3|||
124841665|NCT01481116|449050065|FG001|Overall Study|Lack of Efficacy|3|||
124841666|NCT01481116|449050066|FG002|Overall Study|Lack of Efficacy|1|||
124841667|NCT01481116|449050064|FG000|Overall Study|Contraindications|1|||
124841668|NCT01481116|449050065|FG001|Overall Study|Contraindications|1|||
124640136|NCT00267969|448299880|FG000|After Controlled Period|Death|0|||
124640137|NCT00267969|448299881|FG001|After Controlled Period|Death|0|||
124640138|NCT00267969|448299882|FG002|After Controlled Period|Death|0|||
124841669|NCT01481116|449050066|FG002|Overall Study|Contraindications|0|||
124841670|NCT01481116|449050064|FG000|Overall Study|Other|1|||
124841671|NCT01481116|449050065|FG001|Overall Study|Other|1|||
124841672|NCT01481116|449050066|FG002|Overall Study|Other|0|||
124841673|NCT01481116|449050064|FG000|Overall Study|Participant Started Taking Glipizide|1|||
124841674|NCT01481116|449050065|FG001|Overall Study|Participant Started Taking Glipizide|0|||
124841675|NCT01481116|449050066|FG002|Overall Study|Participant Started Taking Glipizide|0|||
124841676|NCT01481116|449050064|FG000|Overall Study|Participant Moved Out of Area|2|||
124841677|NCT01481116|449050065|FG001|Overall Study|Participant Moved Out of Area|0|||
124640139|NCT00267969|448299883|FG003|After Controlled Period|Death|1|||
124640140|NCT00267969|448299884|FG004|After Controlled Period|Death|2|||
124841678|NCT01481116|449050066|FG002|Overall Study|Participant Moved Out of Area|1|||
124640141|NCT00267969|448299885|FG005|After Controlled Period|Death|0|||
124841679|NCT01481116|449050064|FG000|Overall Study|Participant Moved Out of Country|1|||
124841680|NCT01481116|449050065|FG001|Overall Study|Participant Moved Out of Country|0|||
124841681|NCT01481116|449050066|FG002|Overall Study|Participant Moved Out of Country|1|||
124841682|NCT01481116|449050064|FG000|Overall Study|Investigator Decision|3|||
124841683|NCT01481116|449050065|FG001|Overall Study|Investigator Decision|2|||
124841684|NCT01481116|449050066|FG002|Overall Study|Investigator Decision|1|||
124841685|NCT01481116|449050064|FG000|Overall Study|Sponsor Decision|0|||
124841686|NCT01481116|449050065|FG001|Overall Study|Sponsor Decision|1|||
124841687|NCT01481116|449050066|FG002|Overall Study|Sponsor Decision|3|||
124841688|NCT01481116|449050064|FG000|Overall Study|Non-Compliant With Study Drug|0|||
124841689|NCT01481116|449050065|FG001|Overall Study|Non-Compliant With Study Drug|1|||
124841690|NCT01481116|449050066|FG002|Overall Study|Non-Compliant With Study Drug|1|||
124841691|NCT01481116|449050064|FG000|Overall Study|Investigator's Discretion|2|||
124841692|NCT01481116|449050065|FG001|Overall Study|Investigator's Discretion|0|||
124841693|NCT01481116|449050066|FG002|Overall Study|Investigator's Discretion|0|||
124841694|NCT01481116|449050064|FG000|Overall Study|Death|2|||
124841695|NCT01481116|449050065|FG001|Overall Study|Death|1|||
124841696|NCT01481116|449050066|FG002|Overall Study|Death|0|||
124841697|NCT01481116|449050064|FG000|Overall Study|Hypoglycemic Event|4|||
124841698|NCT01481116|449050065|FG001|Overall Study|Hypoglycemic Event|0|||
124841699|NCT01481116|449050066|FG002|Overall Study|Hypoglycemic Event|0|||
124841700|NCT04904185|449050067|FG000|Overall Study|Expansion failure|1|||
124841701|NCT04904185|449050068|FG001|Overall Study|Expansion failure|0|||
124841702|NCT04904185|449050067|FG000|Overall Study|Late response on prior treatment|1|||
124841703|NCT04904185|449050068|FG001|Overall Study|Late response on prior treatment|0|||
124841704|NCT02789176|449050069|FG000|Overall Study|Death|0|||
124841705|NCT02789176|449050070|FG001|Overall Study|Death|0|||
124841706|NCT02789176|449050071|FG002|Overall Study|Death|3|||
124841707|NCT02789176|449050072|FG003|Overall Study|Death|0|||
124841708|NCT02789176|449050069|FG000|Overall Study|Withdrawal by Subject|0|||
124841709|NCT02789176|449050070|FG001|Overall Study|Withdrawal by Subject|0|||
124841710|NCT02789176|449050071|FG002|Overall Study|Withdrawal by Subject|1|||
124841711|NCT02789176|449050072|FG003|Overall Study|Withdrawal by Subject|0|||
124841712|NCT02789176|449050069|FG000|Overall Study|Lost to Follow-up|8|||
124841713|NCT02789176|449050070|FG001|Overall Study|Lost to Follow-up|2|||
124841714|NCT02789176|449050071|FG002|Overall Study|Lost to Follow-up|6|||
124841715|NCT02789176|449050072|FG003|Overall Study|Lost to Follow-up|1|||
124841716|NCT02433834|449050073|FG000|Overall Study|Protocol-specified criteria|7|||
124841717|NCT02433834|449050073|FG000|Overall Study|Protocol Violation|3|||
124841718|NCT02433834|449050073|FG000|Overall Study|Lost to Follow-up|6|||
124841719|NCT02433834|449050073|FG000|Overall Study|Withdrawal by Subject|14|||
124841720|NCT02433834|449050073|FG000|Overall Study|Adverse Event|6|||
124841721|NCT02433834|449050073|FG000|Overall Study|Physician Decision|1|||
124841722|NCT00596011|449050074|FG000|Overall Study|Withdrawal by Subject|2|||
124841723|NCT00596011|449050075|FG001|Overall Study|Withdrawal by Subject|3|||
124841724|NCT00596011|449050074|FG000|Overall Study|Adverse Event|11|||
124841725|NCT00596011|449050075|FG001|Overall Study|Adverse Event|7|||
124841726|NCT02821962|449050076|FG000|Overall Study|Lost to Follow-up|2|||
124841727|NCT02821962|449050077|FG001|Overall Study|Lost to Follow-up|0|||
124841728|NCT01956110|449050080|FG000|Overall Study|Protocol Violation|25|||
124841729|NCT01956110|449050081|FG001|Overall Study|Protocol Violation|11|||
124841730|NCT01956110|449050080|FG000|Overall Study|Adverse Event|9|||
124841731|NCT01956110|449050081|FG001|Overall Study|Adverse Event|10|||
124841732|NCT01956110|449050080|FG000|Overall Study|Personal reasons|1|||
124841733|NCT01956110|449050081|FG001|Overall Study|Personal reasons|1|||
124841734|NCT00910715|449050090|FG000|Overall Study|Lost to Follow-up|22|||
124841735|NCT00910715|449050091|FG001|Overall Study|Lost to Follow-up|26|||
124841736|NCT00910715|449050092|FG002|Overall Study|Lost to Follow-up|0|||
124841737|NCT05923229|449050093|FG000|Overall Study|Withdrawal by Subject|3|||
124841738|NCT05923229|449050094|FG001|Overall Study|Withdrawal by Subject|0|||
124841739|NCT05923229|449050093|FG000|Overall Study|Health related|2|||
124841740|NCT05923229|449050094|FG001|Overall Study|Health related|1|||
124841741|NCT05288556|449050095|FG000|Overall Study|Protocol Violation|1|||
124841742|NCT05288556|449050095|FG000|Overall Study|Withdrawal by Subject|1|||
124841743|NCT03400332|449050098|FG000|Pre-Treatment|Other reasons|0|||
124841744|NCT03400332|449050099|FG001|Pre-Treatment|Other reasons|0|||
124841745|NCT03400332|449050100|FG002|Pre-Treatment|Other reasons|0|||
124841746|NCT03400332|449050101|FG003|Pre-Treatment|Other reasons|0|||
124640142|NCT00267969|448299886|FG006|After Controlled Period|Death|1|||
124841747|NCT03400332|449050102|FG004|Pre-Treatment|Other reasons|0|||
124841748|NCT03400332|449050103|FG005|Pre-Treatment|Other reasons|0|||
124841749|NCT03400332|449050104|FG006|Pre-Treatment|Other reasons|0|||
124841750|NCT03400332|449050105|FG007|Pre-Treatment|Other reasons|0|||
124841751|NCT03400332|449050106|FG008|Pre-Treatment|Other reasons|1|||
124841752|NCT03400332|449050098|FG000|Pre-Treatment|No longer met study criteria|0|||
124841753|NCT03400332|449050099|FG001|Pre-Treatment|No longer met study criteria|0|||
124841754|NCT03400332|449050100|FG002|Pre-Treatment|No longer met study criteria|0|||
124841755|NCT03400332|449050101|FG003|Pre-Treatment|No longer met study criteria|0|||
124841756|NCT03400332|449050102|FG004|Pre-Treatment|No longer met study criteria|0|||
124841757|NCT03400332|449050103|FG005|Pre-Treatment|No longer met study criteria|0|||
124841758|NCT03400332|449050104|FG006|Pre-Treatment|No longer met study criteria|0|||
124841759|NCT03400332|449050105|FG007|Pre-Treatment|No longer met study criteria|0|||
124841760|NCT03400332|449050106|FG008|Pre-Treatment|No longer met study criteria|1|||
124841761|NCT03400332|449050098|FG000|Pre-Treatment|Withdrawal by Subject|0|||
124841762|NCT03400332|449050099|FG001|Pre-Treatment|Withdrawal by Subject|0|||
124841763|NCT03400332|449050100|FG002|Pre-Treatment|Withdrawal by Subject|0|||
124841764|NCT03400332|449050101|FG003|Pre-Treatment|Withdrawal by Subject|0|||
124841765|NCT03400332|449050102|FG004|Pre-Treatment|Withdrawal by Subject|0|||
124841766|NCT03400332|449050103|FG005|Pre-Treatment|Withdrawal by Subject|0|||
124841767|NCT03400332|449050104|FG006|Pre-Treatment|Withdrawal by Subject|0|||
124841768|NCT03400332|449050105|FG007|Pre-Treatment|Withdrawal by Subject|0|||
124841769|NCT03400332|449050106|FG008|Pre-Treatment|Withdrawal by Subject|1|||
124841770|NCT03400332|449050098|FG000|Treatment|Participant withdrew consent|2|||
124841771|NCT03400332|449050099|FG001|Treatment|Participant withdrew consent|2|||
124841772|NCT03400332|449050100|FG002|Treatment|Participant withdrew consent|0|||
124841773|NCT03400332|449050101|FG003|Treatment|Participant withdrew consent|0|||
124841774|NCT03400332|449050102|FG004|Treatment|Participant withdrew consent|3|||
124841775|NCT03400332|449050103|FG005|Treatment|Participant withdrew consent|3|||
124841776|NCT03400332|449050104|FG006|Treatment|Participant withdrew consent|1|||
124841777|NCT03400332|449050105|FG007|Treatment|Participant withdrew consent|1|||
124841778|NCT03400332|449050106|FG008|Treatment|Participant withdrew consent|1|||
124841779|NCT03400332|449050098|FG000|Treatment|Other reasons|0|||
124841780|NCT03400332|449050099|FG001|Treatment|Other reasons|1|||
124841781|NCT03400332|449050100|FG002|Treatment|Other reasons|1|||
124841782|NCT03400332|449050101|FG003|Treatment|Other reasons|0|||
124841783|NCT03400332|449050102|FG004|Treatment|Other reasons|3|||
124841784|NCT03400332|449050103|FG005|Treatment|Other reasons|1|||
124841785|NCT03400332|449050104|FG006|Treatment|Other reasons|2|||
124841786|NCT03400332|449050105|FG007|Treatment|Other reasons|0|||
124841787|NCT03400332|449050106|FG008|Treatment|Other reasons|1|||
124841788|NCT03400332|449050098|FG000|Treatment|Lost to Follow-up|0|||
124841789|NCT03400332|449050099|FG001|Treatment|Lost to Follow-up|1|||
124841790|NCT03400332|449050100|FG002|Treatment|Lost to Follow-up|0|||
124841791|NCT03400332|449050101|FG003|Treatment|Lost to Follow-up|0|||
124841792|NCT03400332|449050102|FG004|Treatment|Lost to Follow-up|0|||
124841793|NCT03400332|449050103|FG005|Treatment|Lost to Follow-up|0|||
124841794|NCT03400332|449050104|FG006|Treatment|Lost to Follow-up|0|||
124841795|NCT03400332|449050105|FG007|Treatment|Lost to Follow-up|0|||
124841796|NCT03400332|449050106|FG008|Treatment|Lost to Follow-up|0|||
124841797|NCT03400332|449050098|FG000|Treatment|Death|3|||
124841798|NCT03400332|449050099|FG001|Treatment|Death|1|||
124841799|NCT03400332|449050100|FG002|Treatment|Death|2|||
124841800|NCT03400332|449050101|FG003|Treatment|Death|3|||
124841801|NCT03400332|449050102|FG004|Treatment|Death|6|||
124841802|NCT03400332|449050103|FG005|Treatment|Death|2|||
124841803|NCT03400332|449050104|FG006|Treatment|Death|1|||
124841804|NCT03400332|449050105|FG007|Treatment|Death|3|||
124841805|NCT03400332|449050106|FG008|Treatment|Death|6|||
124841806|NCT04476017|449050109|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
124841807|NCT04476017|449050110|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
124841808|NCT02704364|449050111|FG000|Overall Study|Adverse Event|1|||
124841809|NCT02704364|449050112|FG001|Overall Study|Adverse Event|1|||
124841810|NCT02704364|449050113|FG002|Overall Study|Adverse Event|0|||
124841811|NCT02704364|449050111|FG000|Overall Study|Noncompliance with study drug|1|||
124841812|NCT02704364|449050112|FG001|Overall Study|Noncompliance with study drug|1|||
124841813|NCT02704364|449050113|FG002|Overall Study|Noncompliance with study drug|0|||
124841814|NCT02704364|449050111|FG000|Overall Study|Other|0|||
124841815|NCT02704364|449050112|FG001|Overall Study|Other|1|||
124841816|NCT02704364|449050113|FG002|Overall Study|Other|1|||
124841817|NCT04627064|449050117|FG000|Overall Study|Progressive disease|8|||
124841818|NCT04627064|449050118|FG001|Overall Study|Progressive disease|0|||
124841819|NCT04627064|449050117|FG000|Overall Study|Withdrawal by Subject|2|||
124841820|NCT04627064|449050118|FG001|Overall Study|Withdrawal by Subject|0|||
124841821|NCT04627064|449050117|FG000|Overall Study|Physician Decision|1|||
124841822|NCT04627064|449050118|FG001|Overall Study|Physician Decision|0|||
124841823|NCT04033159|449050121|FG000|Washout Period|Physician Decision|0|||
124841824|NCT04033159|449050122|FG001|Washout Period|Physician Decision|1|||
124841825|NCT04033159|449050123|FG002|Washout Period|Physician Decision|0|||
124841826|NCT04033159|449050121|FG000|Washout Period|Study terminated by Sponsor|0|||
124841827|NCT04033159|449050122|FG001|Washout Period|Study terminated by Sponsor|7|||
124841828|NCT04033159|449050123|FG002|Washout Period|Study terminated by Sponsor|0|||
124841829|NCT04033159|449050121|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
124841830|NCT04033159|449050122|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
124841831|NCT04033159|449050123|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
124841832|NCT00006489|449050126|FG000|Overall Study|Adverse Event|3|||
124841833|NCT00006489|449050127|FG001|Overall Study|Adverse Event|2|||
124841834|NCT00006489|449050128|FG002|Overall Study|Adverse Event|4|||
124841835|NCT00006489|449050129|FG003|Overall Study|Adverse Event|3|||
124841836|NCT00006489|449050126|FG000|Overall Study|Withdrawal by Subject|10|||
124841837|NCT00006489|449050127|FG001|Overall Study|Withdrawal by Subject|9|||
124841838|NCT00006489|449050128|FG002|Overall Study|Withdrawal by Subject|9|||
124841839|NCT00006489|449050129|FG003|Overall Study|Withdrawal by Subject|6|||
124841840|NCT00006489|449050126|FG000|Overall Study|Scheduling Conflict|0|||
124841841|NCT00006489|449050127|FG001|Overall Study|Scheduling Conflict|3|||
124841842|NCT00006489|449050128|FG002|Overall Study|Scheduling Conflict|2|||
124841843|NCT00006489|449050129|FG003|Overall Study|Scheduling Conflict|1|||
124841844|NCT00006489|449050126|FG000|Overall Study|Death|0|||
124841845|NCT00006489|449050127|FG001|Overall Study|Death|0|||
124841846|NCT00006489|449050128|FG002|Overall Study|Death|0|||
124841847|NCT00006489|449050129|FG003|Overall Study|Death|1|||
124841848|NCT03491150|449050135|FG000|Overall Study|Adverse Event|1|||
124841849|NCT03491150|449050136|FG001|Overall Study|Adverse Event|0|||
124841850|NCT03491150|449050135|FG000|Overall Study|Study Terminated by Sponsor|74|||
124841851|NCT03491150|449050136|FG001|Overall Study|Study Terminated by Sponsor|70|||
124841852|NCT03491150|449050135|FG000|Overall Study|Other|0|||
124841853|NCT03491150|449050136|FG001|Overall Study|Other|1|||
124841854|NCT03491150|449050135|FG000|Overall Study|Withdrawal by Subject|1|||
124841855|NCT03491150|449050136|FG001|Overall Study|Withdrawal by Subject|2|||
124841856|NCT02287896|449050148|FG000|Second Injection Visit|Withdrawal by Subject|0|||
124841857|NCT02287896|449050149|FG001|Second Injection Visit|Withdrawal by Subject|1|||
124841858|NCT00559962|449050150|FG000|Overall Study|Adverse Event|1|||
124841859|NCT00559962|449050151|FG001|Overall Study|Adverse Event|7|||
124841860|NCT00559962|449050152|FG002|Overall Study|Adverse Event|8|||
124841861|NCT00559962|449050153|FG003|Overall Study|Adverse Event|5|||
124841862|NCT00559962|449050154|FG004|Overall Study|Adverse Event|11|||
124841863|NCT00559962|449050155|FG005|Overall Study|Adverse Event|4|||
124841864|NCT00559962|449050156|FG006|Overall Study|Adverse Event|4|||
124841865|NCT00559962|449050157|FG007|Overall Study|Adverse Event|2|||
124841866|NCT00559962|449050150|FG000|Overall Study|Lost to Follow-up|0|||
124841867|NCT00559962|449050151|FG001|Overall Study|Lost to Follow-up|1|||
124841868|NCT00559962|449050152|FG002|Overall Study|Lost to Follow-up|0|||
124841869|NCT00559962|449050153|FG003|Overall Study|Lost to Follow-up|0|||
124841870|NCT00559962|449050154|FG004|Overall Study|Lost to Follow-up|0|||
124841871|NCT00559962|449050155|FG005|Overall Study|Lost to Follow-up|0|||
124841872|NCT00559962|449050156|FG006|Overall Study|Lost to Follow-up|0|||
124841873|NCT00559962|449050157|FG007|Overall Study|Lost to Follow-up|0|||
124841874|NCT00559962|449050150|FG000|Overall Study|Withdrawal by Subject|1|||
124841875|NCT00559962|449050151|FG001|Overall Study|Withdrawal by Subject|1|||
124841876|NCT00559962|449050152|FG002|Overall Study|Withdrawal by Subject|2|||
124841877|NCT00559962|449050153|FG003|Overall Study|Withdrawal by Subject|0|||
124841878|NCT00559962|449050154|FG004|Overall Study|Withdrawal by Subject|3|||
124841879|NCT00559962|449050155|FG005|Overall Study|Withdrawal by Subject|1|||
124841880|NCT00559962|449050156|FG006|Overall Study|Withdrawal by Subject|0|||
124841881|NCT00559962|449050157|FG007|Overall Study|Withdrawal by Subject|2|||
124841882|NCT00559962|449050150|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
124841883|NCT00559962|449050151|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
124841884|NCT00559962|449050152|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
124841885|NCT00559962|449050153|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
124841886|NCT00559962|449050154|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
124841887|NCT00559962|449050155|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
124841888|NCT00559962|449050156|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
124841889|NCT00559962|449050157|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
124841890|NCT00323414|449050168|FG000|Overall Study|Withdrawal by Subject|0|||
124841891|NCT00323414|449050169|FG001|Overall Study|Withdrawal by Subject|1|||
124841892|NCT02552316|449050170|FG000|Overall Study|Withdrawal by Subject|1|||
124841893|NCT02552316|449050170|FG000|Overall Study|Withdrawal due to non-compliance|1|||
124841894|NCT04382911|449050171|FG000|Overall Study|unable to be imaged prior to surgery|2|||
124841895|NCT02385799|449050172|FG000|Overall Study|Lost to Follow-up|1|||
124841896|NCT02385799|449050173|FG001|Overall Study|Lost to Follow-up|2|||
124841897|NCT02385799|449050172|FG000|Overall Study|Adverse Event|4|||
124841898|NCT02385799|449050173|FG001|Overall Study|Adverse Event|2|||
124841899|NCT02385799|449050172|FG000|Overall Study|Withdrawal by Subject|0|||
124841900|NCT02385799|449050173|FG001|Overall Study|Withdrawal by Subject|4|||
124841901|NCT00376168|449050177|FG000|Overall Study|Adverse Event|1|||
124841902|NCT00376168|449050178|FG001|Overall Study|Adverse Event|1|||
124841903|NCT00376168|449050177|FG000|Overall Study|Pregnancy|1|||
124841904|NCT00376168|449050178|FG001|Overall Study|Pregnancy|0|||
124841905|NCT02350309|449050179|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
124841906|NCT02350309|449050180|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
124841907|NCT02350309|449050181|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
124841908|NCT02350309|449050182|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
124841909|NCT02350309|449050183|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
124841910|NCT02350309|449050184|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
124841911|NCT02350309|449050179|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
124841912|NCT02350309|449050180|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
124841913|NCT02350309|449050181|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
124841914|NCT02350309|449050182|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
124841915|NCT02350309|449050183|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
124841916|NCT02350309|449050184|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
124841917|NCT00058825|449050185|FG000|Overall Study|Relapse|9|||
124841918|NCT00058825|449050185|FG000|Overall Study|Progressive Disease|5|||
124841919|NCT00058825|449050185|FG000|Overall Study|Graft Failure|5|||
124841920|NCT00058825|449050185|FG000|Overall Study|Death|3|||
124841921|NCT04399161|449050186|FG000|Overall Study|Withdrawal by Subject|1|||
124841922|NCT04399161|449050187|FG001|Overall Study|Withdrawal by Subject|0|||
124841923|NCT04399161|449050188|FG002|Overall Study|Withdrawal by Subject|2|||
124841924|NCT04399161|449050186|FG000|Overall Study|Protocol Violation|1|||
124841925|NCT04399161|449050187|FG001|Overall Study|Protocol Violation|2|||
124841926|NCT04399161|449050188|FG002|Overall Study|Protocol Violation|0|||
124841935|NCT00477672|449050193|FG000|Overall Study|Adverse Event|3|||
124841936|NCT00477672|449050194|FG001|Overall Study|Adverse Event|5|||
124841937|NCT00477672|449050195|FG002|Overall Study|Adverse Event|6|||
124841938|NCT00477672|449050193|FG000|Overall Study|Death|0|||
124841939|NCT00477672|449050194|FG001|Overall Study|Death|1|||
124841940|NCT00477672|449050195|FG002|Overall Study|Death|0|||
124841941|NCT00477672|449050193|FG000|Overall Study|Disease progression|0|||
124841942|NCT00477672|449050194|FG001|Overall Study|Disease progression|1|||
124841943|NCT00477672|449050195|FG002|Overall Study|Disease progression|0|||
124841944|NCT00477672|449050193|FG000|Overall Study|Physician Decision|1|||
124841945|NCT00477672|449050194|FG001|Overall Study|Physician Decision|0|||
124841946|NCT00477672|449050195|FG002|Overall Study|Physician Decision|0|||
124841947|NCT00477672|449050193|FG000|Overall Study|Protocol noncompliance|0|||
124841948|NCT00477672|449050194|FG001|Overall Study|Protocol noncompliance|2|||
124841949|NCT00477672|449050195|FG002|Overall Study|Protocol noncompliance|0|||
124841950|NCT00477672|449050193|FG000|Overall Study|Consent withdrawn|2|||
124841951|NCT00477672|449050194|FG001|Overall Study|Consent withdrawn|5|||
124841952|NCT00477672|449050195|FG002|Overall Study|Consent withdrawn|10|||
124841953|NCT00477672|449050193|FG000|Overall Study|Discretion of Sponsor|1|||
124841954|NCT00477672|449050194|FG001|Overall Study|Discretion of Sponsor|2|||
124841955|NCT00477672|449050195|FG002|Overall Study|Discretion of Sponsor|0|||
124841956|NCT01398956|449050202|FG000|Overall Study|Withdrawal by Subject|4|||
124841957|NCT01398956|449050202|FG000|Overall Study|AE, non-serious non-fatal|4|||
124841958|NCT01398956|449050202|FG000|Overall Study|Withdrawal Criteria No.3|1|||
124841959|NCT01398956|449050202|FG000|Overall Study|Subject moved a long distance|1|||
124841960|NCT03925727|449050212|FG000|Overall Study|Adverse Event|4|||
124841961|NCT03925727|449050213|FG001|Overall Study|Adverse Event|0|||
124841962|NCT03925727|449050214|FG002|Overall Study|Adverse Event|3|||
124841963|NCT03925727|449050212|FG000|Overall Study|Protocol Violation|1|||
124841964|NCT03925727|449050213|FG001|Overall Study|Protocol Violation|2|||
124841965|NCT03925727|449050214|FG002|Overall Study|Protocol Violation|2|||
124841966|NCT03925727|449050212|FG000|Overall Study|Withdrawal by Subject|3|||
124841967|NCT03925727|449050213|FG001|Overall Study|Withdrawal by Subject|2|||
124841968|NCT03925727|449050214|FG002|Overall Study|Withdrawal by Subject|4|||
124841969|NCT03925727|449050212|FG000|Overall Study|Administrative Reasons|3|||
124841970|NCT03925727|449050213|FG001|Overall Study|Administrative Reasons|1|||
124841971|NCT03925727|449050214|FG002|Overall Study|Administrative Reasons|2|||
124841972|NCT03925727|449050212|FG000|Overall Study|Randomized in error or Disqualified|8|||
124841973|NCT03925727|449050213|FG001|Overall Study|Randomized in error or Disqualified|1|||
124841974|NCT03925727|449050214|FG002|Overall Study|Randomized in error or Disqualified|7|||
124841975|NCT00558103|449050215|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
124841976|NCT00558103|449050216|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
124841977|NCT00558103|449050217|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
124841978|NCT00558103|449050218|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
124841979|NCT00558103|449050219|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
124841980|NCT00558103|449050220|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
124841981|NCT00558103|449050215|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
124841982|NCT00558103|449050216|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
124841983|NCT00558103|449050217|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
124841984|NCT00558103|449050218|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
124841985|NCT00558103|449050219|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
124841986|NCT00558103|449050220|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
124841987|NCT00558103|449050215|FG000|Randomized Treatment Phase|Disease Progression|1|||
124841988|NCT00558103|449050216|FG001|Randomized Treatment Phase|Disease Progression|0|||
124841989|NCT00558103|449050217|FG002|Randomized Treatment Phase|Disease Progression|1|||
124841990|NCT00558103|449050218|FG003|Randomized Treatment Phase|Disease Progression|0|||
124841991|NCT00558103|449050219|FG004|Randomized Treatment Phase|Disease Progression|0|||
124841992|NCT00558103|449050220|FG005|Randomized Treatment Phase|Disease Progression|0|||
124841993|NCT00558103|449050215|FG000|Randomized Treatment Phase|Adverse Event|0|||
124841994|NCT00558103|449050216|FG001|Randomized Treatment Phase|Adverse Event|0|||
124841995|NCT00558103|449050217|FG002|Randomized Treatment Phase|Adverse Event|0|||
124841996|NCT00558103|449050218|FG003|Randomized Treatment Phase|Adverse Event|1|||
124841997|NCT00558103|449050219|FG004|Randomized Treatment Phase|Adverse Event|1|||
124841998|NCT00558103|449050220|FG005|Randomized Treatment Phase|Adverse Event|0|||
124841999|NCT00558103|449050215|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
124842000|NCT00558103|449050216|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
124842001|NCT00558103|449050217|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
124842002|NCT00558103|449050218|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
124842003|NCT00558103|449050219|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
124842004|NCT00558103|449050220|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
124842005|NCT00558103|449050215|FG000|Monotherapy Extension Phase|Disease Progression|0|||
124842006|NCT00558103|449050216|FG001|Monotherapy Extension Phase|Disease Progression|0|||
124842007|NCT00558103|449050217|FG002|Monotherapy Extension Phase|Disease Progression|0|||
124842008|NCT00558103|449050218|FG003|Monotherapy Extension Phase|Disease Progression|0|||
124842009|NCT00558103|449050219|FG004|Monotherapy Extension Phase|Disease Progression|0|||
124842010|NCT00558103|449050220|FG005|Monotherapy Extension Phase|Disease Progression|8|||
124842011|NCT00978731|449052309|FG000|Overall Study|Death|4|||
124842012|NCT00978731|449052310|FG001|Overall Study|Death|1|||
124842013|NCT00978731|449052311|FG002|Overall Study|Death|1|||
124842014|NCT00978731|449052312|FG003|Overall Study|Death|0|||
124842015|NCT00978731|449052309|FG000|Overall Study|Lost to Follow-up|0|||
124842016|NCT00978731|449052310|FG001|Overall Study|Lost to Follow-up|0|||
124842017|NCT00978731|449052311|FG002|Overall Study|Lost to Follow-up|0|||
124842018|NCT00978731|449052312|FG003|Overall Study|Lost to Follow-up|1|||
124842019|NCT00978731|449052309|FG000|Overall Study|Adverse Event|5|||
124842020|NCT00978731|449052310|FG001|Overall Study|Adverse Event|2|||
124842021|NCT00978731|449052311|FG002|Overall Study|Adverse Event|0|||
124842022|NCT00978731|449052312|FG003|Overall Study|Adverse Event|0|||
124842023|NCT00978731|449052309|FG000|Overall Study|Participant's request|1|||
124842024|NCT00978731|449052310|FG001|Overall Study|Participant's request|0|||
124842025|NCT00978731|449052311|FG002|Overall Study|Participant's request|0|||
124842026|NCT00978731|449052312|FG003|Overall Study|Participant's request|0|||
124842027|NCT00978731|449052309|FG000|Overall Study|Administrative reason|3|||
124842028|NCT00978731|449052310|FG001|Overall Study|Administrative reason|3|||
124842029|NCT00978731|449052311|FG002|Overall Study|Administrative reason|1|||
124842030|NCT00978731|449052312|FG003|Overall Study|Administrative reason|0|||
124842031|NCT00978731|449052309|FG000|Overall Study|Deterioration without progression|0|||
124842032|NCT00978731|449052310|FG001|Overall Study|Deterioration without progression|1|||
124842033|NCT00978731|449052311|FG002|Overall Study|Deterioration without progression|0|||
124842034|NCT00978731|449052312|FG003|Overall Study|Deterioration without progression|0|||
124842035|NCT00978731|449052309|FG000|Overall Study|Disease progression/relapse|5|||
124842036|NCT00978731|449052310|FG001|Overall Study|Disease progression/relapse|4|||
124842037|NCT00978731|449052311|FG002|Overall Study|Disease progression/relapse|2|||
124842038|NCT00978731|449052312|FG003|Overall Study|Disease progression/relapse|2|||
124842039|NCT00978731|449052309|FG000|Overall Study|Study closure|3|||
124842040|NCT00978731|449052310|FG001|Overall Study|Study closure|4|||
124842041|NCT00978731|449052311|FG002|Overall Study|Study closure|1|||
124842042|NCT00978731|449052312|FG003|Overall Study|Study closure|1|||
124842043|NCT00978731|449052309|FG000|Overall Study|No response|1|||
124842044|NCT00978731|449052310|FG001|Overall Study|No response|0|||
124842045|NCT00978731|449052311|FG002|Overall Study|No response|0|||
124842046|NCT00978731|449052312|FG003|Overall Study|No response|0|||
124842047|NCT00293384|449052315|FG000|Overall Study|Non-compliance|2|||
124842048|NCT00293384|449052315|FG000|Overall Study|Missed dosage/study drug|1|||
124842049|NCT00293384|449052315|FG000|Overall Study|Ineligible|2|||
124842050|NCT00773175|449052316|FG000|Overall Study|Adverse Event|2|||
124842051|NCT00773175|449052317|FG001|Overall Study|Adverse Event|0|||
124842052|NCT00773175|449052316|FG000|Overall Study|Consent Withdrawn|0|||
124842053|NCT00773175|449052317|FG001|Overall Study|Consent Withdrawn|2|||
124842054|NCT01302964|449052318|FG000|Overall Study|Adverse Event|1|||
124842055|NCT01302964|449052319|FG001|Overall Study|Adverse Event|0|||
124842056|NCT00192075|449052322|FG000|Overall Study|Disease Progression|23|||
124842057|NCT00192075|449052323|FG001|Overall Study|Disease Progression|6|||
124842058|NCT00192075|449052322|FG000|Overall Study|Adverse Event|1|||
124842059|NCT00192075|449052323|FG001|Overall Study|Adverse Event|3|||
124842060|NCT00192075|449052322|FG000|Overall Study|Death|0|||
124842061|NCT00192075|449052323|FG001|Overall Study|Death|1|||
124842062|NCT00192075|449052322|FG000|Overall Study|Lack of Efficacy|0|||
124842063|NCT00192075|449052323|FG001|Overall Study|Lack of Efficacy|0|||
124842064|NCT00192075|449052322|FG000|Overall Study|Physician Decision|3|||
124842065|NCT00192075|449052323|FG001|Overall Study|Physician Decision|0|||
124842066|NCT00192075|449052322|FG000|Overall Study|Withdrawal by Subject|5|||
124842067|NCT00192075|449052323|FG001|Overall Study|Withdrawal by Subject|5|||
124842068|NCT00192075|449052322|FG000|Overall Study|Patient Non-Compliance|0|||
124842069|NCT00192075|449052323|FG001|Overall Study|Patient Non-Compliance|1|||
124842070|NCT00192075|449052322|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
124842071|NCT00192075|449052323|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
124842072|NCT00192075|449052322|FG000|Overall Study|Other|5|||
124842073|NCT00192075|449052323|FG001|Overall Study|Other|2|||
124842074|NCT00779675|449052324|FG000|Treatment Period|Adverse Event|87|||
124842075|NCT00779675|449052324|FG000|Treatment Period|Treatment Failure|80|||
124842076|NCT00779675|449052324|FG000|Treatment Period|Transferred to Another Study|38|||
124842077|NCT00779675|449052324|FG000|Treatment Period|Lost to Follow-up|23|||
124842078|NCT00779675|449052324|FG000|Treatment Period|Withdrawal by Subject|46|||
124842079|NCT00779675|449052324|FG000|Treatment Period|Protocol Violation|54|||
124842080|NCT00779675|449052324|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
124842081|NCT00779675|449052324|FG000|Treatment Period|Administrative|3|||
124842082|NCT00779675|449052324|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
124842083|NCT00779675|449052324|FG000|Extended Treatment Period|Protocol Violation|13|||
124842084|NCT00779675|449052324|FG000|Extended Treatment Period|Adverse Event|6|||
124842085|NCT00779675|449052324|FG000|Extended Treatment Period|Treatment Failure|11|||
124842086|NCT00779675|449052324|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
124842087|NCT00779675|449052324|FG000|Extended Treatment Period|Lost to Follow-up|6|||
124842088|NCT00355238|449052332|FG000|Overall Study|Adverse event unrelated to study drug|2|||
124842089|NCT00355238|449052333|FG001|Overall Study|Adverse event unrelated to study drug|2|||
124842090|NCT00355238|449052334|FG002|Overall Study|Adverse event unrelated to study drug|0|||
124842091|NCT00355238|449052335|FG003|Overall Study|Adverse event unrelated to study drug|1|||
124842092|NCT00355238|449052332|FG000|Overall Study|Death|1|||
124842093|NCT00355238|449052333|FG001|Overall Study|Death|0|||
124842094|NCT00355238|449052334|FG002|Overall Study|Death|0|||
124842095|NCT00355238|449052335|FG003|Overall Study|Death|0|||
124842096|NCT00355238|449052332|FG000|Overall Study|Disease progression|37|||
124842097|NCT00355238|449052333|FG001|Overall Study|Disease progression|36|||
124842098|NCT00355238|449052334|FG002|Overall Study|Disease progression|16|||
124842099|NCT00355238|449052335|FG003|Overall Study|Disease progression|11|||
124842100|NCT00355238|449052332|FG000|Overall Study|Study drug toxicity|11|||
124842101|NCT00355238|449052333|FG001|Overall Study|Study drug toxicity|7|||
124842102|NCT00355238|449052334|FG002|Overall Study|Study drug toxicity|5|||
124842103|NCT00355238|449052335|FG003|Overall Study|Study drug toxicity|2|||
124842104|NCT00355238|449052332|FG000|Overall Study|Participant withdrew consent|3|||
124842105|NCT00355238|449052333|FG001|Overall Study|Participant withdrew consent|1|||
124842106|NCT00355238|449052334|FG002|Overall Study|Participant withdrew consent|0|||
124842107|NCT00355238|449052335|FG003|Overall Study|Participant withdrew consent|0|||
124842108|NCT00355238|449052332|FG000|Overall Study|Participant request to discontinue study treatment|1|||
124842109|NCT00355238|449052333|FG001|Overall Study|Participant request to discontinue study treatment|0|||
124842110|NCT00355238|449052334|FG002|Overall Study|Participant request to discontinue study treatment|1|||
124842111|NCT00355238|449052335|FG003|Overall Study|Participant request to discontinue study treatment|0|||
124842112|NCT04300296|449052336|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
124842113|NCT04300296|449052337|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
124842114|NCT04300296|449052338|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
124842115|NCT04300296|449052339|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
124842116|NCT04300296|449052340|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
124842117|NCT04300296|449052341|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
124842118|NCT04300296|449052336|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
124842119|NCT04300296|449052337|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
124842120|NCT04300296|449052338|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
124842121|NCT04300296|449052339|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
124842122|NCT04300296|449052340|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
124842123|NCT04300296|449052341|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
124842124|NCT04300296|449052336|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
124842125|NCT04300296|449052337|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
124842126|NCT04300296|449052338|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
124842127|NCT04300296|449052339|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
124842128|NCT04300296|449052340|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
124842129|NCT04300296|449052341|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
124842130|NCT04300296|449052336|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
124842131|NCT04300296|449052337|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
124842132|NCT04300296|449052338|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
124842133|NCT04300296|449052339|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
124842134|NCT04300296|449052340|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
124842135|NCT04300296|449052341|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
124842136|NCT04300296|449052336|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
124842137|NCT04300296|449052337|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
124842138|NCT04300296|449052338|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
124842139|NCT04300296|449052339|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
124842140|NCT04300296|449052340|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
124842141|NCT04300296|449052341|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
124842142|NCT04300296|449052336|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
124842143|NCT04300296|449052337|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
124842144|NCT04300296|449052338|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
124842145|NCT04300296|449052339|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
124842146|NCT04300296|449052340|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
124842147|NCT04300296|449052341|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
124842148|NCT04300296|449052336|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
124842149|NCT04300296|449052337|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
124842150|NCT04300296|449052338|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
124842151|NCT04300296|449052339|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
124842152|NCT04300296|449052340|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
124842153|NCT04300296|449052341|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
124842154|NCT03325166|449052342|FG000|Overall Study|Adverse Event|1|||
124842155|NCT01633944|449052343|FG000|Open-label Titration Phase|Adverse Event|109|||
124842156|NCT01633944|449052344|FG001|Open-label Titration Phase|Adverse Event|0|||
124842157|NCT01633944|449052345|FG002|Open-label Titration Phase|Adverse Event|0|||
124842158|NCT01633944|449052343|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
124842159|NCT01633944|449052344|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
124842160|NCT01633944|449052345|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
124842161|NCT01633944|449052343|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
124842162|NCT01633944|449052344|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
124842163|NCT01633944|449052345|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
124842164|NCT01633944|449052343|FG000|Open-label Titration Phase|Protocol Violation|24|||
124842165|NCT01633944|449052344|FG001|Open-label Titration Phase|Protocol Violation|0|||
124842166|NCT01633944|449052345|FG002|Open-label Titration Phase|Protocol Violation|0|||
124842167|NCT01633944|449052343|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
124842168|NCT01633944|449052344|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
124842169|NCT01633944|449052345|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
124842170|NCT01633944|449052343|FG000|Open-label Titration Phase|Other|68|||
124842171|NCT01633944|449052344|FG001|Open-label Titration Phase|Other|0|||
124842172|NCT01633944|449052345|FG002|Open-label Titration Phase|Other|0|||
124842173|NCT01633944|449052343|FG000|Double-blind Treatment Phase|Adverse Event|0|||
124842174|NCT01633944|449052344|FG001|Double-blind Treatment Phase|Adverse Event|13|||
124842175|NCT01633944|449052345|FG002|Double-blind Treatment Phase|Adverse Event|7|||
124842176|NCT01633944|449052343|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
124842177|NCT01633944|449052344|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
124842178|NCT01633944|449052345|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
124842179|NCT01633944|449052343|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
124842180|NCT01633944|449052344|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
124842181|NCT01633944|449052345|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
124842182|NCT01633944|449052343|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
124842183|NCT01633944|449052344|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
124842184|NCT01633944|449052345|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
124842185|NCT01633944|449052343|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
124842186|NCT01633944|449052344|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
124842187|NCT01633944|449052345|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
124842188|NCT01633944|449052343|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
124842189|NCT01633944|449052344|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
124842190|NCT01633944|449052345|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
124842191|NCT01633944|449052343|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
124842192|NCT01633944|449052344|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
124842193|NCT01633944|449052345|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
124842194|NCT01633944|449052343|FG000|Double-blind Treatment Phase|Other|0|||
124842195|NCT01633944|449052344|FG001|Double-blind Treatment Phase|Other|7|||
124842196|NCT01633944|449052345|FG002|Double-blind Treatment Phase|Other|0|||
124842197|NCT02412631|449052349|FG000|Overall Study|Adverse Event|1|||
124842198|NCT02412631|449052350|FG001|Overall Study|Adverse Event|2|||
124842199|NCT02412631|449052349|FG000|Overall Study|Lost to Follow-up|5|||
124842200|NCT02412631|449052350|FG001|Overall Study|Lost to Follow-up|9|||
124842201|NCT02412631|449052349|FG000|Overall Study|Withdrawal by Subject|9|||
124842202|NCT02412631|449052350|FG001|Overall Study|Withdrawal by Subject|3|||
124842203|NCT02412631|449052349|FG000|Overall Study|Early stop by FDA|5|||
124842204|NCT02412631|449052350|FG001|Overall Study|Early stop by FDA|2|||
124842205|NCT02412631|449052349|FG000|Overall Study|Unspecified reason|6|||
124842206|NCT02412631|449052350|FG001|Overall Study|Unspecified reason|8|||
124842207|NCT00958776|449052351|FG000|Overall Study|Adverse Event|0|||
124842208|NCT00958776|449052352|FG001|Overall Study|Adverse Event|1|||
124842209|NCT00958776|449052351|FG000|Overall Study|Physician Decision|1|||
124842210|NCT00958776|449052352|FG001|Overall Study|Physician Decision|0|||
124842211|NCT00958776|449052351|FG000|Overall Study|Lost to Follow-up|2|||
124842212|NCT00958776|449052352|FG001|Overall Study|Lost to Follow-up|6|||
124842213|NCT00958776|449052351|FG000|Overall Study|Withdrawal by Subject|7|||
124842214|NCT00958776|449052352|FG001|Overall Study|Withdrawal by Subject|16|||
124842215|NCT00958776|449052351|FG000|Overall Study|Protocol Violation|1|||
124842216|NCT00958776|449052352|FG001|Overall Study|Protocol Violation|1|||
124842217|NCT00958776|449052351|FG000|Overall Study|Death|2|||
124842218|NCT00958776|449052352|FG001|Overall Study|Death|1|||
124842219|NCT00958776|449052351|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
124842220|NCT00958776|449052352|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
124842221|NCT00958776|449052351|FG000|Overall Study|Missing|1|||
124842222|NCT00958776|449052352|FG001|Overall Study|Missing|1|||
124842223|NCT03795610|449052354|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
124842224|NCT03795610|449052354|FG000|Overall Study|Withdrawal by Subject|1|||
124842225|NCT03795610|449052354|FG000|Overall Study|Screen Failure (Unknown)|1|||
124842226|NCT04098458|449052378|FG000|Overall Study|Death|1|||
124842227|NCT04098458|449052378|FG000|Overall Study|did not meet study inclusion criteria|3|||
124842228|NCT03762083|449052379|FG000|Overall Study|Withdrawal by Subject|2|||
124842229|NCT03762083|449052379|FG000|Overall Study|Physician Decision|1|||
124842230|NCT00116558|449052380|FG000|Overall Study|Death|11|||
124842231|NCT00116558|449052381|FG001|Overall Study|Death|5|||
124842232|NCT00116558|449052382|FG002|Overall Study|Death|3|||
124842233|NCT00116558|449052380|FG000|Overall Study|Withdrawal by Subject|17|||
124842234|NCT00116558|449052381|FG001|Overall Study|Withdrawal by Subject|3|||
124842235|NCT00116558|449052382|FG002|Overall Study|Withdrawal by Subject|12|||
124842236|NCT00116558|449052380|FG000|Overall Study|disease progression|3|||
124842237|NCT00116558|449052381|FG001|Overall Study|disease progression|7|||
124842238|NCT00116558|449052382|FG002|Overall Study|disease progression|18|||
124842239|NCT02027844|449052383|FG000|Overall Study|Withdrawal by Subject|3|||
124842240|NCT02027844|449052384|FG001|Overall Study|Withdrawal by Subject|2|||
124842241|NCT02027844|449052385|FG002|Overall Study|Withdrawal by Subject|1|||
124842242|NCT02027844|449052383|FG000|Overall Study|Lost to Follow-up|0|||
124842243|NCT02027844|449052384|FG001|Overall Study|Lost to Follow-up|2|||
124842244|NCT02027844|449052385|FG002|Overall Study|Lost to Follow-up|1|||
124842245|NCT02027844|449052383|FG000|Overall Study|Protocol Violation|0|||
124842246|NCT02027844|449052384|FG001|Overall Study|Protocol Violation|2|||
124842247|NCT02027844|449052385|FG002|Overall Study|Protocol Violation|0|||
124842248|NCT02027844|449052383|FG000|Overall Study|Incomlete data|2|||
124842249|NCT02027844|449052384|FG001|Overall Study|Incomlete data|0|||
124842250|NCT02027844|449052385|FG002|Overall Study|Incomlete data|0|||
124842251|NCT00378014|449052386|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
124842252|NCT00378014|449052387|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
124842253|NCT00378014|449052386|FG000|Core (Randomization to Month 11)|Graft loss|1|||
124842254|NCT00378014|449052387|FG001|Core (Randomization to Month 11)|Graft loss|2|||
124842255|NCT00378014|449052386|FG000|Core (Randomization to Month 11)|Death|5|||
124842256|NCT00378014|449052387|FG001|Core (Randomization to Month 11)|Death|3|||
124842257|NCT00378014|449052386|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
124842258|NCT00378014|449052387|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
124842259|NCT00378014|449052386|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
124842260|NCT00378014|449052387|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
124842261|NCT00378014|449052386|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
124842262|NCT00378014|449052387|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
124842263|NCT00378014|449052386|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
124842264|NCT00378014|449052387|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
124842265|NCT00378014|449052386|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
124842266|NCT00378014|449052387|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
124842267|NCT00378014|449052386|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
124842268|NCT00378014|449052387|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
124842269|NCT00378014|449052386|FG000|Extension (Month 12 to Month 59)|Death|1|||
124842270|NCT00378014|449052387|FG001|Extension (Month 12 to Month 59)|Death|2|||
124842271|NCT00378014|449052386|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
124842272|NCT00378014|449052387|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
124842273|NCT00378014|449052386|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
124842274|NCT00378014|449052387|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
124842275|NCT00378014|449052386|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
124842276|NCT00378014|449052387|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
124842277|NCT00378014|449052386|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
124842278|NCT00378014|449052387|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
124842279|NCT04889625|449052390|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
124842280|NCT04889625|449052391|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
124842281|NCT04889625|449052390|FG000|Period 1|Subject out of window|0|||
124842282|NCT04889625|449052391|FG001|Period 1|Subject out of window|1|||
124842283|NCT04889625|449052390|FG000|Period 1|Wrong add power dispensed|0|||
124842284|NCT04889625|449052391|FG001|Period 1|Wrong add power dispensed|1|||
124842285|NCT04889625|449052390|FG000|Period 1|Discontinued due to fitting guide error|1|||
124842286|NCT04889625|449052391|FG001|Period 1|Discontinued due to fitting guide error|1|||
124842287|NCT04889625|449052390|FG000|Period 2|Test article no longer available|1|||
124842288|NCT04889625|449052391|FG001|Period 2|Test article no longer available|0|||
124842289|NCT04889625|449052390|FG000|Period 2|Incorrect lens dispensed|1|||
124842290|NCT04889625|449052391|FG001|Period 2|Incorrect lens dispensed|0|||
124842291|NCT04889625|449052390|FG000|Period 2|Wrong add power dispensed|0|||
124842292|NCT04889625|449052391|FG001|Period 2|Wrong add power dispensed|1|||
124842293|NCT03746522|449052392|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
124842294|NCT03746522|449052393|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
124842295|NCT03746522|449052394|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
124842296|NCT03746522|449052392|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
124842297|NCT03746522|449052393|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
124842298|NCT03746522|449052394|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
124842299|NCT03746522|449052392|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
124842300|NCT03746522|449052393|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
124842301|NCT03746522|449052394|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
124842302|NCT03746522|449052392|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
124842303|NCT03746522|449052393|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
124842304|NCT03746522|449052394|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
124842305|NCT03746522|449052392|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
124842306|NCT03746522|449052393|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
124842307|NCT03746522|449052394|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
124842308|NCT03047135|449052397|FG000|Overall Study|Still being treated|3|||
124842309|NCT02659020|449052399|FG000|Overall Study|Adverse Event|0|||
124842310|NCT02659020|449052400|FG001|Overall Study|Adverse Event|0|||
124842311|NCT02659020|449052401|FG002|Overall Study|Adverse Event|0|||
124842312|NCT02659020|449052402|FG003|Overall Study|Adverse Event|2|||
124842313|NCT02659020|449052403|FG004|Overall Study|Adverse Event|0|||
124842314|NCT02659020|449052404|FG005|Overall Study|Adverse Event|0|||
124842315|NCT02659020|449052405|FG006|Overall Study|Adverse Event|2|||
124842316|NCT02659020|449052399|FG000|Overall Study|Lost to Follow-up|1|||
124842317|NCT02659020|449052400|FG001|Overall Study|Lost to Follow-up|2|||
124842318|NCT02659020|449052401|FG002|Overall Study|Lost to Follow-up|1|||
124842319|NCT02659020|449052402|FG003|Overall Study|Lost to Follow-up|6|||
124842320|NCT02659020|449052403|FG004|Overall Study|Lost to Follow-up|1|||
124842321|NCT02659020|449052404|FG005|Overall Study|Lost to Follow-up|5|||
124842322|NCT02659020|449052405|FG006|Overall Study|Lost to Follow-up|0|||
124842323|NCT02659020|449052399|FG000|Overall Study|Physician Decision|0|||
124842324|NCT02659020|449052400|FG001|Overall Study|Physician Decision|0|||
124842325|NCT02659020|449052401|FG002|Overall Study|Physician Decision|0|||
124842326|NCT02659020|449052402|FG003|Overall Study|Physician Decision|1|||
124842327|NCT02659020|449052403|FG004|Overall Study|Physician Decision|1|||
124842328|NCT02659020|449052404|FG005|Overall Study|Physician Decision|0|||
124842329|NCT02659020|449052405|FG006|Overall Study|Physician Decision|1|||
124842330|NCT02659020|449052399|FG000|Overall Study|Withdrawal by Subject|2|||
124842331|NCT02659020|449052400|FG001|Overall Study|Withdrawal by Subject|1|||
124842332|NCT02659020|449052401|FG002|Overall Study|Withdrawal by Subject|0|||
124842333|NCT02659020|449052402|FG003|Overall Study|Withdrawal by Subject|3|||
124842334|NCT02659020|449052403|FG004|Overall Study|Withdrawal by Subject|3|||
124842335|NCT02659020|449052404|FG005|Overall Study|Withdrawal by Subject|6|||
124842336|NCT02659020|449052405|FG006|Overall Study|Withdrawal by Subject|3|||
124842337|NCT02659020|449052399|FG000|Overall Study|Progressive Disease|0|||
124842338|NCT02659020|449052400|FG001|Overall Study|Progressive Disease|0|||
124842339|NCT02659020|449052401|FG002|Overall Study|Progressive Disease|0|||
124842340|NCT02659020|449052402|FG003|Overall Study|Progressive Disease|4|||
124842341|NCT02659020|449052403|FG004|Overall Study|Progressive Disease|1|||
124842342|NCT02659020|449052404|FG005|Overall Study|Progressive Disease|0|||
124842343|NCT02659020|449052405|FG006|Overall Study|Progressive Disease|2|||
124842344|NCT01585766|449052406|FG000|Overall Study|Withdrawal by Subject|0|||
124842345|NCT01585766|449052407|FG001|Overall Study|Withdrawal by Subject|1|||
124842346|NCT01585766|449052408|FG002|Overall Study|Withdrawal by Subject|1|||
124842347|NCT01585766|449052409|FG003|Overall Study|Withdrawal by Subject|0|||
124842348|NCT01585766|449052410|FG004|Overall Study|Withdrawal by Subject|0|||
124842349|NCT01585766|449052411|FG005|Overall Study|Withdrawal by Subject|0|||
124842350|NCT01585766|449052406|FG000|Overall Study|Death|0|||
124842351|NCT01585766|449052407|FG001|Overall Study|Death|1|||
124842352|NCT01585766|449052408|FG002|Overall Study|Death|0|||
124842353|NCT01585766|449052409|FG003|Overall Study|Death|0|||
124842354|NCT01585766|449052410|FG004|Overall Study|Death|0|||
124842355|NCT01585766|449052411|FG005|Overall Study|Death|0|||
124842356|NCT01585766|449052406|FG000|Overall Study|Physician Decision|0|||
124842357|NCT01585766|449052407|FG001|Overall Study|Physician Decision|0|||
124842358|NCT01585766|449052408|FG002|Overall Study|Physician Decision|1|||
124842359|NCT01585766|449052409|FG003|Overall Study|Physician Decision|0|||
124842360|NCT01585766|449052410|FG004|Overall Study|Physician Decision|0|||
124842361|NCT01585766|449052411|FG005|Overall Study|Physician Decision|0|||
124842362|NCT01120210|449052412|FG000|MAIN INFUSION|Adverse Event|1|||
124842363|NCT01120210|449052413|FG001|MAIN INFUSION|Adverse Event|0|||
124842364|NCT01120210|449052412|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
124842365|NCT01120210|449052413|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
124842366|NCT02043015|449052414|FG000|Overall Study|Lost to Follow-up|4|||
124842367|NCT02043015|449052414|FG000|Overall Study|Withdrawal by Subject|4|||
124842368|NCT02043015|449052414|FG000|Overall Study|Removed once target enrollment reached|15|||
124842369|NCT02043015|449052414|FG000|Overall Study|Participant moved away from study city|4|||
124842370|NCT02043015|449052414|FG000|Overall Study|Incarceration|1|||
124842371|NCT00974571|449052415|FG000|Overall Study|Adverse Event|31|||
124842372|NCT00974571|449052416|FG001|Overall Study|Adverse Event|4|||
124842373|NCT00974571|449052417|FG002|Overall Study|Adverse Event|27|||
124842374|NCT00974571|449052415|FG000|Overall Study|Lack of Efficacy|3|||
124842375|NCT00974571|449052416|FG001|Overall Study|Lack of Efficacy|2|||
124842376|NCT00974571|449052417|FG002|Overall Study|Lack of Efficacy|9|||
124842377|NCT00974571|449052415|FG000|Overall Study|Lost to Follow-up|2|||
124842378|NCT00974571|449052416|FG001|Overall Study|Lost to Follow-up|1|||
124842379|NCT00974571|449052417|FG002|Overall Study|Lost to Follow-up|2|||
124842380|NCT00974571|449052415|FG000|Overall Study|Protocol Violation|13|||
124842381|NCT00974571|449052416|FG001|Overall Study|Protocol Violation|4|||
124842382|NCT00974571|449052417|FG002|Overall Study|Protocol Violation|18|||
124842383|NCT00974571|449052415|FG000|Overall Study|Withdrawal by Subject|14|||
124842384|NCT00974571|449052416|FG001|Overall Study|Withdrawal by Subject|5|||
124842385|NCT00974571|449052417|FG002|Overall Study|Withdrawal by Subject|16|||
124842386|NCT00974571|449052415|FG000|Overall Study|Patient Moved|1|||
124842387|NCT00974571|449052416|FG001|Overall Study|Patient Moved|0|||
124842388|NCT00974571|449052417|FG002|Overall Study|Patient Moved|1|||
124842389|NCT00974571|449052415|FG000|Overall Study|Other|4|||
124842390|NCT00974571|449052416|FG001|Overall Study|Other|0|||
124842391|NCT00974571|449052417|FG002|Overall Study|Other|10|||
124842392|NCT01494610|449052431|FG000|Period 1|Withdrawal by Subject|1|||
124842393|NCT01494610|449052432|FG001|Period 1|Withdrawal by Subject|1|||
124842394|NCT01494610|449052431|FG000|Period 3|Adverse Event|1|||
124842395|NCT01494610|449052432|FG001|Period 3|Adverse Event|0|||
124842396|NCT01494610|449052431|FG000|Period 3|Withdrawal by Subject|1|||
124842397|NCT01494610|449052432|FG001|Period 3|Withdrawal by Subject|0|||
124842398|NCT01494610|449052431|FG000|Period 4|Protocol Violation|1|||
124842399|NCT01494610|449052432|FG001|Period 4|Protocol Violation|0|||
124842400|NCT02130765|449052439|FG000|Overall Study|Did not receive treatment|4|||
124842401|NCT02130765|449052440|FG001|Overall Study|Did not receive treatment|0|||
124842402|NCT02130765|449052441|FG002|Overall Study|Did not receive treatment|0|||
124842403|NCT02130765|449052442|FG003|Overall Study|Did not receive treatment|0|||
124842404|NCT02244580|449052446|FG000|Overall Study|No cancer tissues available|241|||
124842405|NCT01736696|449052447|FG000|Overall Study|Withdrawal by Subject|0|||
124842406|NCT01736696|449052448|FG001|Overall Study|Withdrawal by Subject|0|||
124842407|NCT01736696|449052449|FG002|Overall Study|Withdrawal by Subject|1|||
124842408|NCT01736696|449052450|FG003|Overall Study|Withdrawal by Subject|0|||
124842409|NCT01736696|449052451|FG004|Overall Study|Withdrawal by Subject|0|||
124842410|NCT01736696|449052452|FG005|Overall Study|Withdrawal by Subject|0|||
124842411|NCT01736696|449052453|FG006|Overall Study|Withdrawal by Subject|0|||
124842412|NCT02114879|449052454|FG000|Overall Study|Withdrawal by Subject|9|||
124842413|NCT02114879|449052455|FG001|Overall Study|Withdrawal by Subject|5|||
124842414|NCT02114879|449052454|FG000|Overall Study|Death|6|||
124842415|NCT02114879|449052455|FG001|Overall Study|Death|11|||
124842416|NCT02114879|449052454|FG000|Overall Study|Lost to Follow-up|4|||
124842417|NCT02114879|449052455|FG001|Overall Study|Lost to Follow-up|6|||
124842418|NCT02114879|449052454|FG000|Overall Study|Physician Decision|0|||
124842419|NCT02114879|449052455|FG001|Overall Study|Physician Decision|2|||
124842420|NCT01455012|449052456|FG000|Overall Study|Adverse Event|0|||
124842421|NCT01455012|449052457|FG001|Overall Study|Adverse Event|2|||
124842422|NCT01455012|449052456|FG000|Overall Study|Lack of Efficacy|6|||
124842423|NCT01455012|449052457|FG001|Overall Study|Lack of Efficacy|1|||
124842424|NCT01455012|449052456|FG000|Overall Study|Withdrawal by Subject|3|||
124842425|NCT01455012|449052457|FG001|Overall Study|Withdrawal by Subject|1|||
124842426|NCT01455012|449052456|FG000|Overall Study|Unknown reason|2|||
124842427|NCT01455012|449052457|FG001|Overall Study|Unknown reason|0|||
124842428|NCT00613509|449052458|FG000|Cycle 1|Adverse Event|2|||
124842429|NCT00613509|449052459|FG001|Cycle 1|Adverse Event|1|||
124842430|NCT00613509|449052458|FG000|Cycle 1|Disease Progression|2|||
124842431|NCT00613509|449052459|FG001|Cycle 1|Disease Progression|6|||
124842432|NCT00613509|449052458|FG000|Cycle 1|Unacceptable Toxicity|1|||
124842433|NCT00613509|449052459|FG001|Cycle 1|Unacceptable Toxicity|0|||
124842434|NCT00613509|449052458|FG000|Cycle 1|Other administrative reason|0|||
124842435|NCT00613509|449052459|FG001|Cycle 1|Other administrative reason|1|||
124842436|NCT01215227|449052460|FG000|Overall Study|Adverse Event|11|||
124842437|NCT01215227|449052461|FG001|Overall Study|Adverse Event|11|||
124842438|NCT01215227|449052462|FG002|Overall Study|Adverse Event|4|||
124842439|NCT01215227|449052463|FG003|Overall Study|Adverse Event|8|||
124842440|NCT01215227|449052464|FG004|Overall Study|Adverse Event|7|||
124842441|NCT01215227|449052465|FG005|Overall Study|Adverse Event|6|||
124842442|NCT01215227|449052460|FG000|Overall Study|Treatment Failure|8|||
124842443|NCT01215227|449052461|FG001|Overall Study|Treatment Failure|4|||
124842444|NCT01215227|449052462|FG002|Overall Study|Treatment Failure|1|||
124842445|NCT01215227|449052463|FG003|Overall Study|Treatment Failure|5|||
124842446|NCT01215227|449052464|FG004|Overall Study|Treatment Failure|1|||
124842447|NCT01215227|449052465|FG005|Overall Study|Treatment Failure|1|||
124842448|NCT01215227|449052460|FG000|Overall Study|Lost to Follow-up|1|||
124842449|NCT01215227|449052461|FG001|Overall Study|Lost to Follow-up|4|||
124842450|NCT01215227|449052462|FG002|Overall Study|Lost to Follow-up|1|||
124842451|NCT01215227|449052463|FG003|Overall Study|Lost to Follow-up|1|||
124842452|NCT01215227|449052464|FG004|Overall Study|Lost to Follow-up|1|||
124842453|NCT01215227|449052465|FG005|Overall Study|Lost to Follow-up|2|||
124842454|NCT01215227|449052460|FG000|Overall Study|Subject Withdrew Consent|16|||
124842455|NCT01215227|449052461|FG001|Overall Study|Subject Withdrew Consent|20|||
124842456|NCT01215227|449052462|FG002|Overall Study|Subject Withdrew Consent|7|||
124842457|NCT01215227|449052463|FG003|Overall Study|Subject Withdrew Consent|10|||
124842458|NCT01215227|449052464|FG004|Overall Study|Subject Withdrew Consent|11|||
124842459|NCT01215227|449052465|FG005|Overall Study|Subject Withdrew Consent|8|||
124842460|NCT01215227|449052460|FG000|Overall Study|Non-Compliance With Protocol|2|||
124842461|NCT01215227|449052461|FG001|Overall Study|Non-Compliance With Protocol|6|||
124842462|NCT01215227|449052462|FG002|Overall Study|Non-Compliance With Protocol|1|||
124842463|NCT01215227|449052463|FG003|Overall Study|Non-Compliance With Protocol|0|||
124842464|NCT01215227|449052464|FG004|Overall Study|Non-Compliance With Protocol|0|||
124842465|NCT01215227|449052465|FG005|Overall Study|Non-Compliance With Protocol|0|||
124842466|NCT01215227|449052460|FG000|Overall Study|Administrative|83|||
124842467|NCT01215227|449052461|FG001|Overall Study|Administrative|73|||
124842468|NCT01215227|449052462|FG002|Overall Study|Administrative|42|||
124842469|NCT01215227|449052463|FG003|Overall Study|Administrative|24|||
124842470|NCT01215227|449052464|FG004|Overall Study|Administrative|28|||
124842471|NCT01215227|449052465|FG005|Overall Study|Administrative|40|||
124842472|NCT01215227|449052460|FG000|Overall Study|Missing Status|0|||
124842473|NCT01215227|449052461|FG001|Overall Study|Missing Status|1|||
124842474|NCT01215227|449052462|FG002|Overall Study|Missing Status|0|||
124842475|NCT01215227|449052463|FG003|Overall Study|Missing Status|0|||
124842476|NCT01215227|449052464|FG004|Overall Study|Missing Status|0|||
124842477|NCT01215227|449052465|FG005|Overall Study|Missing Status|0|||
124842478|NCT01215227|449052460|FG000|Overall Study|Randomized but not treated|0|||
124842479|NCT01215227|449052461|FG001|Overall Study|Randomized but not treated|0|||
124842480|NCT01215227|449052462|FG002|Overall Study|Randomized but not treated|1|||
124842481|NCT01215227|449052463|FG003|Overall Study|Randomized but not treated|1|||
124842482|NCT01215227|449052464|FG004|Overall Study|Randomized but not treated|0|||
124842483|NCT01215227|449052465|FG005|Overall Study|Randomized but not treated|1|||
124842484|NCT02253810|449052466|FG000|Overall Study|Withdrawal by Subject|2|||
124842485|NCT02253810|449052467|FG001|Overall Study|Withdrawal by Subject|1|||
124842486|NCT02253810|449052466|FG000|Overall Study|Unknown concomitant procedure|3|||
124842487|NCT02253810|449052467|FG001|Overall Study|Unknown concomitant procedure|2|||
124842488|NCT00213148|449052474|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
124842489|NCT00213148|449052475|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
124842490|NCT00213148|449052476|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
124842491|NCT00213148|449052477|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
124842492|NCT00213148|449052478|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
124842493|NCT00213148|449052474|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
124842494|NCT00213148|449052475|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
124842495|NCT00213148|449052476|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
124842496|NCT00213148|449052477|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
124842497|NCT00213148|449052478|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
124842498|NCT00213148|449052474|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
124842499|NCT00213148|449052475|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
124842500|NCT00213148|449052476|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
124842501|NCT00213148|449052477|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
124842502|NCT00213148|449052478|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
124842503|NCT00213148|449052474|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
124842504|NCT00213148|449052475|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
124842505|NCT00213148|449052476|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
124842506|NCT00213148|449052477|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
124842507|NCT00213148|449052478|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
124842508|NCT00213148|449052474|FG000|Cycle 1 (1 Month)|Other|3|||
124842509|NCT00213148|449052475|FG001|Cycle 1 (1 Month)|Other|0|||
124842510|NCT00213148|449052476|FG002|Cycle 1 (1 Month)|Other|2|||
124842511|NCT00213148|449052477|FG003|Cycle 1 (1 Month)|Other|2|||
124842512|NCT00213148|449052478|FG004|Cycle 1 (1 Month)|Other|7|||
124842513|NCT00213148|449052474|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
124842514|NCT00213148|449052475|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
124842515|NCT00213148|449052476|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
124842516|NCT00213148|449052477|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
124842517|NCT00213148|449052478|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
124842518|NCT00213148|449052474|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
124842519|NCT00213148|449052475|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
124842520|NCT00213148|449052476|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
124842521|NCT00213148|449052477|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
124842522|NCT00213148|449052478|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
124842523|NCT00213148|449052474|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
124842524|NCT00213148|449052475|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
124842525|NCT00213148|449052476|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
124842526|NCT00213148|449052477|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
124842527|NCT00213148|449052478|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
124842528|NCT00213148|449052474|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
124842529|NCT00213148|449052475|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
124842530|NCT00213148|449052476|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
124842531|NCT00213148|449052477|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
124842532|NCT00213148|449052478|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
124842533|NCT00213148|449052474|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
124842534|NCT00213148|449052475|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
124842535|NCT00213148|449052476|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
124842536|NCT00213148|449052477|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
124842537|NCT00213148|449052478|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
124842538|NCT00213148|449052474|FG000|Cycle 2 (1 Month)|Other|2|||
124842539|NCT00213148|449052475|FG001|Cycle 2 (1 Month)|Other|1|||
124842540|NCT00213148|449052476|FG002|Cycle 2 (1 Month)|Other|2|||
124842541|NCT00213148|449052477|FG003|Cycle 2 (1 Month)|Other|8|||
124842542|NCT00213148|449052478|FG004|Cycle 2 (1 Month)|Other|7|||
124842543|NCT00213148|449052474|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
124842544|NCT00213148|449052475|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
124842545|NCT00213148|449052476|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
124842546|NCT00213148|449052477|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
124842547|NCT00213148|449052478|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
124842548|NCT00213148|449052474|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
124842549|NCT00213148|449052475|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
124842550|NCT00213148|449052476|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
124842551|NCT00213148|449052477|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
124842552|NCT00213148|449052478|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
124842553|NCT00213148|449052474|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
124842554|NCT00213148|449052475|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
124842555|NCT00213148|449052476|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
124842556|NCT00213148|449052477|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
124842557|NCT00213148|449052478|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
124842558|NCT00213148|449052474|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
124842559|NCT00213148|449052475|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
124842560|NCT00213148|449052476|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
124842561|NCT00213148|449052477|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
124842562|NCT00213148|449052478|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
124842563|NCT00213148|449052474|FG000|Cycle 3 (1 Month)|Other|0|||
124842564|NCT00213148|449052475|FG001|Cycle 3 (1 Month)|Other|0|||
124842565|NCT00213148|449052476|FG002|Cycle 3 (1 Month)|Other|1|||
124842566|NCT00213148|449052477|FG003|Cycle 3 (1 Month)|Other|1|||
124842567|NCT00213148|449052478|FG004|Cycle 3 (1 Month)|Other|0|||
124842568|NCT03400033|449052481|FG000|Overall Study|Withdrawal by Subject|1|||
124842569|NCT03400033|449052482|FG001|Overall Study|Withdrawal by Subject|2|||
124842570|NCT02469610|449052485|FG000|Overall Study|Death|1|||
124842571|NCT02469610|449052486|FG001|Overall Study|Death|0|||
124842572|NCT02469610|449052485|FG000|Overall Study|Lost to Follow-up|1|||
124842573|NCT02469610|449052486|FG001|Overall Study|Lost to Follow-up|0|||
124842574|NCT02469610|449052485|FG000|Overall Study|exclusion criteria|2|||
124842575|NCT02469610|449052486|FG001|Overall Study|exclusion criteria|1|||
124842576|NCT02434770|449052487|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
124842577|NCT02434770|449052488|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
124842578|NCT02434770|449052489|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
124842579|NCT02434770|449052487|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
124842580|NCT02434770|449052488|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
124842581|NCT02434770|449052489|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
124842582|NCT02434770|449052487|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
124842583|NCT02434770|449052488|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
124842584|NCT02434770|449052489|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
124842585|NCT02434770|449052487|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
124842586|NCT02434770|449052488|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
124842587|NCT02434770|449052489|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
124842588|NCT02434770|449052487|FG000|Week 1 to Week 18|Death|1|||
124842589|NCT02434770|449052488|FG001|Week 1 to Week 18|Death|0|||
124842590|NCT02434770|449052489|FG002|Week 1 to Week 18|Death|0|||
124842591|NCT02434770|449052487|FG000|Week 18 to Week|Lost to Follow-up|2|||
124842592|NCT02434770|449052488|FG001|Week 18 to Week|Lost to Follow-up|2|||
124842593|NCT02434770|449052489|FG002|Week 18 to Week|Lost to Follow-up|1|||
124842594|NCT02434770|449052487|FG000|Week 18 to Week|Withdrawal by Subject|0|||
124842595|NCT02434770|449052488|FG001|Week 18 to Week|Withdrawal by Subject|0|||
124842596|NCT02434770|449052489|FG002|Week 18 to Week|Withdrawal by Subject|2|||
124842597|NCT02434770|449052487|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
124842598|NCT02434770|449052488|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
124842599|NCT02434770|449052489|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
124842600|NCT01574352|449052490|FG000|Overall Study|Withdrawal by Subject|6|||
124842601|NCT01574352|449052491|FG001|Overall Study|Withdrawal by Subject|13|||
124842602|NCT01574352|449052490|FG000|Overall Study|Injury in non-camp related sport|1|||
124842603|NCT01574352|449052491|FG001|Overall Study|Injury in non-camp related sport|0|||
124842604|NCT00245765|449052492|FG000|Overall Study|Adverse Event|1|||
124842605|NCT00245765|449052493|FG001|Overall Study|Adverse Event|1|||
124842606|NCT00245765|449052494|FG002|Overall Study|Adverse Event|0|||
124640143|NCT00267969|448299880|FG000|After Controlled Period|Lack of Efficacy|0|||
124640144|NCT00267969|448299881|FG001|After Controlled Period|Lack of Efficacy|0|||
124640145|NCT00267969|448299882|FG002|After Controlled Period|Lack of Efficacy|0|||
124640146|NCT00267969|448299883|FG003|After Controlled Period|Lack of Efficacy|10|||
124640147|NCT00267969|448299884|FG004|After Controlled Period|Lack of Efficacy|6|||
124640148|NCT00267969|448299885|FG005|After Controlled Period|Lack of Efficacy|28|||
124842607|NCT00245765|449052492|FG000|Overall Study|Lack of Efficacy|14|||
124842608|NCT00245765|449052493|FG001|Overall Study|Lack of Efficacy|7|||
124842609|NCT00245765|449052494|FG002|Overall Study|Lack of Efficacy|0|||
124842610|NCT00245765|449052492|FG000|Overall Study|Lost to Follow-up|1|||
124842611|NCT00245765|449052493|FG001|Overall Study|Lost to Follow-up|2|||
124842612|NCT00245765|449052494|FG002|Overall Study|Lost to Follow-up|0|||
124842613|NCT00245765|449052492|FG000|Overall Study|Withdrawal by Subject|1|||
124842614|NCT00245765|449052493|FG001|Overall Study|Withdrawal by Subject|0|||
124842615|NCT00245765|449052494|FG002|Overall Study|Withdrawal by Subject|3|||
124842616|NCT00245765|449052492|FG000|Overall Study|Other reason|2|||
124842617|NCT00245765|449052493|FG001|Overall Study|Other reason|0|||
124842618|NCT00245765|449052494|FG002|Overall Study|Other reason|1|||
124842619|NCT00245765|449052492|FG000|Overall Study|Other|13|||
124842620|NCT00245765|449052493|FG001|Overall Study|Other|4|||
124842621|NCT00245765|449052494|FG002|Overall Study|Other|4|||
124842622|NCT00660348|449052495|FG000|Overall Study|Withdrawal by Subject|1|||
124842623|NCT00660348|449052496|FG001|Overall Study|Withdrawal by Subject|0|||
124842624|NCT03316872|449052500|FG000|Overall Study|Death|1|||
124842625|NCT04074317|449052503|FG000|Third Period|Withdrawal by Subject|0|||
124842626|NCT04074317|449052504|FG001|Third Period|Withdrawal by Subject|0|||
124842627|NCT04074317|449052505|FG002|Third Period|Withdrawal by Subject|0|||
124842628|NCT04074317|449052506|FG003|Third Period|Withdrawal by Subject|1|||
124842629|NCT04074317|449052507|FG004|Third Period|Withdrawal by Subject|0|||
124842630|NCT04074317|449052508|FG005|Third Period|Withdrawal by Subject|0|||
124842631|NCT00653224|449054438|FG000|Overall Study|Adverse Event|2|||
124842632|NCT00653224|449054439|FG001|Overall Study|Adverse Event|1|||
124842633|NCT00653224|449054438|FG000|Overall Study|Lack of Efficacy|1|||
124842634|NCT00653224|449054439|FG001|Overall Study|Lack of Efficacy|2|||
124842635|NCT00653224|449054438|FG000|Overall Study|Loss of efficacy|1|||
124842636|NCT00653224|449054439|FG001|Overall Study|Loss of efficacy|0|||
124842637|NCT00653224|449054438|FG000|Overall Study|Lost to Follow-up|1|||
124842638|NCT00653224|449054439|FG001|Overall Study|Lost to Follow-up|0|||
124640149|NCT00267969|448299886|FG006|After Controlled Period|Lack of Efficacy|15|||
124842639|NCT00653224|449054438|FG000|Overall Study|Other|2|||
124842640|NCT00653224|449054439|FG001|Overall Study|Other|4|||
124842641|NCT04482179|449054440|FG000|Overall Study|Death|1|||
124842642|NCT04482179|449054441|FG001|Overall Study|Death|0|||
124842643|NCT04482179|449054440|FG000|Overall Study|Withdrawal by Subject|1|||
124842644|NCT04482179|449054441|FG001|Overall Study|Withdrawal by Subject|0|||
124842645|NCT04709237|449054442|FG000|Overall Study|Lost to Follow-up|1|||
124842646|NCT04709237|449054443|FG001|Overall Study|Lost to Follow-up|0|||
124842647|NCT04709237|449054444|FG002|Overall Study|Lost to Follow-up|0|||
124842648|NCT02489318|449054446|FG000|Randomized|Withdrawal by Subject|0|||
124842649|NCT02489318|449054447|FG001|Randomized|Withdrawal by Subject|1|||
124842650|NCT02489318|449054446|FG000|Treated|Adverse Event|19|||
124842651|NCT02489318|449054447|FG001|Treated|Adverse Event|62|||
124842652|NCT02489318|449054446|FG000|Treated|Death|13|||
124842653|NCT02489318|449054447|FG001|Treated|Death|11|||
124842654|NCT02489318|449054446|FG000|Treated|Physician Decision|4|||
124842655|NCT02489318|449054447|FG001|Treated|Physician Decision|6|||
124842656|NCT02489318|449054446|FG000|Treated|Protocol Violation|1|||
124842657|NCT02489318|449054447|FG001|Treated|Protocol Violation|2|||
124842658|NCT02489318|449054446|FG000|Treated|Withdrawal by Subject|37|||
124842659|NCT02489318|449054447|FG001|Treated|Withdrawal by Subject|36|||
124842660|NCT02489318|449054446|FG000|Treated|Other: Progressive Disease|245|||
124842661|NCT02489318|449054447|FG001|Treated|Other: Progressive Disease|138|||
124842662|NCT02489318|449054446|FG000|Treated|Other|0|||
124842663|NCT02489318|449054447|FG001|Treated|Other|2|||
124842664|NCT02489318|449054446|FG000|Treated|Ongoing|0|||
124842665|NCT02489318|449054447|FG001|Treated|Ongoing|267|||
124842666|NCT05723770|449054448|FG000|Overall Study|Lost to Follow-up|4|||
124842667|NCT05723770|449054448|FG000|Overall Study|Withdrawal by Subject|2|||
124842668|NCT01171898|449054449|FG000|Overall Study|Death|0|||
124842669|NCT01171898|449054450|FG001|Overall Study|Death|0|||
124842670|NCT01171898|449054451|FG002|Overall Study|Death|2|||
124842671|NCT01171898|449054452|FG003|Overall Study|Death|0|||
124842672|NCT01171898|449054449|FG000|Overall Study|Lost to Follow-up|0|||
124842673|NCT01171898|449054450|FG001|Overall Study|Lost to Follow-up|1|||
124842674|NCT01171898|449054451|FG002|Overall Study|Lost to Follow-up|1|||
124842675|NCT01171898|449054452|FG003|Overall Study|Lost to Follow-up|1|||
124842676|NCT01171898|449054449|FG000|Overall Study|Withdrawal by Subject|1|||
124842677|NCT01171898|449054450|FG001|Overall Study|Withdrawal by Subject|4|||
124842678|NCT01171898|449054451|FG002|Overall Study|Withdrawal by Subject|6|||
124842679|NCT01171898|449054452|FG003|Overall Study|Withdrawal by Subject|3|||
124842680|NCT01171898|449054449|FG000|Overall Study|Terminated by Sponsor|1|||
124842681|NCT01171898|449054450|FG001|Overall Study|Terminated by Sponsor|0|||
124842682|NCT01171898|449054451|FG002|Overall Study|Terminated by Sponsor|0|||
124842683|NCT01171898|449054452|FG003|Overall Study|Terminated by Sponsor|0|||
124842684|NCT01171898|449054449|FG000|Overall Study|Ongoing|1|||
124842685|NCT01171898|449054450|FG001|Overall Study|Ongoing|9|||
124842686|NCT01171898|449054451|FG002|Overall Study|Ongoing|3|||
124842687|NCT01171898|449054452|FG003|Overall Study|Ongoing|0|||
124842688|NCT01171898|449054449|FG000|Overall Study|Other|1|||
124842689|NCT01171898|449054450|FG001|Overall Study|Other|5|||
124842690|NCT01171898|449054451|FG002|Overall Study|Other|0|||
124842691|NCT01171898|449054452|FG003|Overall Study|Other|2|||
124842692|NCT00419562|449054453|FG000|Overall Study|Lost to Follow-up|12|||
124842693|NCT00419562|449054454|FG001|Overall Study|Lost to Follow-up|13|||
124842694|NCT00419562|449054453|FG000|Overall Study|Withdrawal by Subject|20|||
124842695|NCT00419562|449054454|FG001|Overall Study|Withdrawal by Subject|18|||
124842696|NCT00419562|449054453|FG000|Overall Study|Participant Institutionalized|1|||
124842697|NCT00419562|449054454|FG001|Overall Study|Participant Institutionalized|0|||
124842698|NCT00701129|449054463|FG000|Overall Study|Death|2|||
124842699|NCT00976898|449054473|FG000|Overall Study|Protocol Violation|1|||
124842700|NCT00976898|449054473|FG000|Overall Study|Adverse Event|1|||
124842701|NCT00976898|449054473|FG000|Overall Study|Physician Decision|1|||
124842702|NCT00976898|449054473|FG000|Overall Study|Liver Transplant|1|||
124842703|NCT00976898|449054473|FG000|Overall Study|Progressive Disease|1|||
124842704|NCT05107128|449054474|FG000|Overall Study|Adverse Event|2|||
124842705|NCT05107128|449054475|FG001|Overall Study|Adverse Event|0|||
124842706|NCT05107128|449054474|FG000|Overall Study|Withdrawal by Subject|3|||
124842707|NCT05107128|449054475|FG001|Overall Study|Withdrawal by Subject|3|||
124842708|NCT05107128|449054474|FG000|Overall Study|Withdrawal of Consent|0|||
124842709|NCT05107128|449054475|FG001|Overall Study|Withdrawal of Consent|1|||
124842710|NCT05107128|449054474|FG000|Overall Study|Reason Not Specified|2|||
124842711|NCT05107128|449054475|FG001|Overall Study|Reason Not Specified|0|||
124842712|NCT01470469|449054476|FG000|Overall Study|Withdrawal by Subject|4|||
124842713|NCT01470469|449054477|FG001|Overall Study|Withdrawal by Subject|6|||
124842714|NCT01470469|449054476|FG000|Overall Study|Lack of Efficacy|1|||
124842715|NCT01470469|449054477|FG001|Overall Study|Lack of Efficacy|7|||
124842716|NCT01470469|449054476|FG000|Overall Study|Adverse Event|0|||
124842717|NCT01470469|449054477|FG001|Overall Study|Adverse Event|7|||
124842718|NCT01470469|449054476|FG000|Overall Study|Lost to Follow-up|2|||
124842719|NCT01470469|449054477|FG001|Overall Study|Lost to Follow-up|2|||
124842720|NCT01470469|449054476|FG000|Overall Study|Protocol Violation|1|||
124842721|NCT01470469|449054477|FG001|Overall Study|Protocol Violation|1|||
124842722|NCT01470469|449054476|FG000|Overall Study|Other|2|||
124842723|NCT01470469|449054477|FG001|Overall Study|Other|1|||
124842724|NCT04988295|449054478|FG000|Overall Study|Withdrawal by Subject|9|||
124842725|NCT04988295|449054479|FG001|Overall Study|Withdrawal by Subject|29|||
124842726|NCT04988295|449054480|FG002|Overall Study|Withdrawal by Subject|6|||
124842727|NCT04988295|449054481|FG003|Overall Study|Withdrawal by Subject|0|||
124842728|NCT04988295|449054478|FG000|Overall Study|Lost to Follow-up|1|||
124842729|NCT04988295|449054479|FG001|Overall Study|Lost to Follow-up|0|||
124842730|NCT04988295|449054480|FG002|Overall Study|Lost to Follow-up|0|||
124842731|NCT04988295|449054481|FG003|Overall Study|Lost to Follow-up|0|||
124842732|NCT04988295|449054478|FG000|Overall Study|Study participation ongoing|186|||
124842733|NCT04988295|449054479|FG001|Overall Study|Study participation ongoing|169|||
124842734|NCT04988295|449054480|FG002|Overall Study|Study participation ongoing|99|||
124842735|NCT04988295|449054481|FG003|Overall Study|Study participation ongoing|119|||
124842736|NCT04649151|449054482|FG000|Overall Study|Pregnancy|0|||
124842737|NCT04649151|449054483|FG001|Overall Study|Pregnancy|0|||
124842738|NCT04649151|449054484|FG002|Overall Study|Pregnancy|0|||
124842739|NCT04649151|449054485|FG003|Overall Study|Pregnancy|0|||
124842740|NCT04649151|449054486|FG004|Overall Study|Pregnancy|3|||
124842741|NCT04649151|449054482|FG000|Overall Study|Physician Decision|10|||
124842742|NCT04649151|449054483|FG001|Overall Study|Physician Decision|0|||
124842743|NCT04649151|449054484|FG002|Overall Study|Physician Decision|0|||
124842744|NCT04649151|449054485|FG003|Overall Study|Physician Decision|1|||
124842745|NCT04649151|449054486|FG004|Overall Study|Physician Decision|1|||
124842746|NCT04649151|449054482|FG000|Overall Study|Protocol Deviation|25|||
124842747|NCT04649151|449054483|FG001|Overall Study|Protocol Deviation|3|||
124842748|NCT04649151|449054484|FG002|Overall Study|Protocol Deviation|0|||
124842749|NCT04649151|449054485|FG003|Overall Study|Protocol Deviation|0|||
124842750|NCT04649151|449054486|FG004|Overall Study|Protocol Deviation|0|||
124842751|NCT04649151|449054482|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
124842752|NCT04649151|449054483|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
124842753|NCT04649151|449054484|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
124842754|NCT04649151|449054485|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
124842755|NCT04649151|449054486|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
124842756|NCT04649151|449054482|FG000|Overall Study|Withdrawal by Subject|370|||
124842757|NCT04649151|449054483|FG001|Overall Study|Withdrawal by Subject|113|||
124842758|NCT04649151|449054484|FG002|Overall Study|Withdrawal by Subject|2|||
124842759|NCT04649151|449054485|FG003|Overall Study|Withdrawal by Subject|7|||
124842760|NCT04649151|449054486|FG004|Overall Study|Withdrawal by Subject|15|||
124842761|NCT04649151|449054482|FG000|Overall Study|Adverse Event|1|||
124842762|NCT04649151|449054483|FG001|Overall Study|Adverse Event|0|||
124842763|NCT04649151|449054484|FG002|Overall Study|Adverse Event|0|||
124842764|NCT04649151|449054485|FG003|Overall Study|Adverse Event|0|||
124842765|NCT04649151|449054486|FG004|Overall Study|Adverse Event|0|||
124842766|NCT04649151|449054482|FG000|Overall Study|Lost to Follow-up|256|||
124842767|NCT04649151|449054483|FG001|Overall Study|Lost to Follow-up|29|||
124842768|NCT04649151|449054484|FG002|Overall Study|Lost to Follow-up|10|||
124842769|NCT04649151|449054485|FG003|Overall Study|Lost to Follow-up|3|||
124842770|NCT04649151|449054486|FG004|Overall Study|Lost to Follow-up|6|||
124842771|NCT04649151|449054482|FG000|Overall Study|Other than specified|59|||
124842772|NCT04649151|449054483|FG001|Overall Study|Other than specified|294|||
124842773|NCT04649151|449054484|FG002|Overall Study|Other than specified|0|||
124842774|NCT04649151|449054485|FG003|Overall Study|Other than specified|0|||
124842775|NCT04649151|449054486|FG004|Overall Study|Other than specified|4|||
124842776|NCT04649151|449054482|FG000|Overall Study|Death|0|||
124842777|NCT04649151|449054483|FG001|Overall Study|Death|0|||
124842778|NCT04649151|449054484|FG002|Overall Study|Death|0|||
124842779|NCT04649151|449054485|FG003|Overall Study|Death|0|||
124842780|NCT04649151|449054486|FG004|Overall Study|Death|1|||
124842781|NCT03752619|449054487|FG000|Overall Study|Lost to Follow-up|2|||
124842782|NCT03752619|449054488|FG001|Overall Study|Lost to Follow-up|1|||
124842783|NCT03752619|449054487|FG000|Overall Study|Withdrawal by Subject|1|||
124842784|NCT03752619|449054488|FG001|Overall Study|Withdrawal by Subject|1|||
124842785|NCT03752619|449054487|FG000|Overall Study|Adverse Event|0|||
124842786|NCT03752619|449054488|FG001|Overall Study|Adverse Event|1|||
124842787|NCT03362502|449054490|FG000|Overall Study|Death|0|||
124842788|NCT03362502|449054491|FG001|Overall Study|Death|0|||
124842789|NCT03362502|449054492|FG002|Overall Study|Death|1|||
124842790|NCT00433654|449054493|FG000|Overall Study|Death|4|||
124842791|NCT00433654|449054494|FG001|Overall Study|Death|0|||
124842792|NCT00433654|449054493|FG000|Overall Study|Missed visit|6|||
124842793|NCT00433654|449054494|FG001|Overall Study|Missed visit|3|||
124842794|NCT00433654|449054493|FG000|Overall Study|Subject not yet due for visit|4|||
124842795|NCT00433654|449054494|FG001|Overall Study|Subject not yet due for visit|0|||
124842796|NCT00433654|449054493|FG000|Overall Study|Withdrawal by Subject|1|||
124842797|NCT00433654|449054494|FG001|Overall Study|Withdrawal by Subject|2|||
124842798|NCT01428193|449054495|FG000|Overall Study|Physician Decision|1|||
124842799|NCT01428193|449054495|FG000|Overall Study|Elevated screening liver enzymes|1|||
124842800|NCT04049760|449054510|FG000|Overall Study|Withdrawal by Subject|1|||
124842801|NCT02457598|449054511|FG000|Overall Study|Progressive Disease|2|||
124842802|NCT02457598|449054512|FG001|Overall Study|Progressive Disease|2|||
124842803|NCT02457598|449054513|FG002|Overall Study|Progressive Disease|1|||
124842804|NCT02457598|449054514|FG003|Overall Study|Progressive Disease|11|||
124842805|NCT02457598|449054515|FG004|Overall Study|Progressive Disease|7|||
124842806|NCT02457598|449054516|FG005|Overall Study|Progressive Disease|3|||
124842807|NCT02457598|449054517|FG006|Overall Study|Progressive Disease|2|||
124842808|NCT02457598|449054518|FG007|Overall Study|Progressive Disease|1|||
124842809|NCT02457598|449054519|FG008|Overall Study|Progressive Disease|1|||
124842810|NCT02457598|449054520|FG009|Overall Study|Progressive Disease|2|||
124842811|NCT02457598|449054521|FG010|Overall Study|Progressive Disease|45|||
124842812|NCT02457598|449054522|FG011|Overall Study|Progressive Disease|6|||
124842813|NCT02457598|449054523|FG012|Overall Study|Progressive Disease|2|||
124842814|NCT02457598|449054524|FG013|Overall Study|Progressive Disease|2|||
124842815|NCT02457598|449054525|FG014|Overall Study|Progressive Disease|10|||
124842816|NCT02457598|449054526|FG015|Overall Study|Progressive Disease|1|||
124842817|NCT02457598|449054527|FG016|Overall Study|Progressive Disease|1|||
124842818|NCT02457598|449054511|FG000|Overall Study|Investigator's Discretion|0|||
124842819|NCT02457598|449054512|FG001|Overall Study|Investigator's Discretion|2|||
124842820|NCT02457598|449054513|FG002|Overall Study|Investigator's Discretion|2|||
124842821|NCT02457598|449054514|FG003|Overall Study|Investigator's Discretion|2|||
124842822|NCT02457598|449054515|FG004|Overall Study|Investigator's Discretion|0|||
124842823|NCT02457598|449054516|FG005|Overall Study|Investigator's Discretion|0|||
124842824|NCT02457598|449054517|FG006|Overall Study|Investigator's Discretion|0|||
124842825|NCT02457598|449054518|FG007|Overall Study|Investigator's Discretion|1|||
124842826|NCT02457598|449054519|FG008|Overall Study|Investigator's Discretion|2|||
124842827|NCT02457598|449054520|FG009|Overall Study|Investigator's Discretion|0|||
124842828|NCT02457598|449054521|FG010|Overall Study|Investigator's Discretion|10|||
124842829|NCT02457598|449054522|FG011|Overall Study|Investigator's Discretion|2|||
124842830|NCT02457598|449054523|FG012|Overall Study|Investigator's Discretion|2|||
124842831|NCT02457598|449054524|FG013|Overall Study|Investigator's Discretion|1|||
124842832|NCT02457598|449054525|FG014|Overall Study|Investigator's Discretion|5|||
124842833|NCT02457598|449054526|FG015|Overall Study|Investigator's Discretion|0|||
124842834|NCT02457598|449054527|FG016|Overall Study|Investigator's Discretion|0|||
124842835|NCT02457598|449054511|FG000|Overall Study|Study Terminated by Sponsor|0|||
124842836|NCT02457598|449054512|FG001|Overall Study|Study Terminated by Sponsor|1|||
124842837|NCT02457598|449054513|FG002|Overall Study|Study Terminated by Sponsor|0|||
124842838|NCT02457598|449054514|FG003|Overall Study|Study Terminated by Sponsor|4|||
124842839|NCT02457598|449054515|FG004|Overall Study|Study Terminated by Sponsor|1|||
124842840|NCT02457598|449054516|FG005|Overall Study|Study Terminated by Sponsor|0|||
124842841|NCT02457598|449054517|FG006|Overall Study|Study Terminated by Sponsor|1|||
124842842|NCT02457598|449054518|FG007|Overall Study|Study Terminated by Sponsor|0|||
124842843|NCT02457598|449054519|FG008|Overall Study|Study Terminated by Sponsor|0|||
124842844|NCT02457598|449054520|FG009|Overall Study|Study Terminated by Sponsor|0|||
124842845|NCT02457598|449054521|FG010|Overall Study|Study Terminated by Sponsor|4|||
124842846|NCT02457598|449054522|FG011|Overall Study|Study Terminated by Sponsor|0|||
124842847|NCT02457598|449054523|FG012|Overall Study|Study Terminated by Sponsor|1|||
124842848|NCT02457598|449054524|FG013|Overall Study|Study Terminated by Sponsor|0|||
124842849|NCT02457598|449054525|FG014|Overall Study|Study Terminated by Sponsor|8|||
124842850|NCT02457598|449054526|FG015|Overall Study|Study Terminated by Sponsor|1|||
124842851|NCT02457598|449054527|FG016|Overall Study|Study Terminated by Sponsor|0|||
124842852|NCT02457598|449054511|FG000|Overall Study|Adverse Event|0|||
124842853|NCT02457598|449054512|FG001|Overall Study|Adverse Event|1|||
124842854|NCT02457598|449054513|FG002|Overall Study|Adverse Event|1|||
124842855|NCT02457598|449054514|FG003|Overall Study|Adverse Event|4|||
124842856|NCT02457598|449054515|FG004|Overall Study|Adverse Event|1|||
124842857|NCT02457598|449054516|FG005|Overall Study|Adverse Event|0|||
124842858|NCT02457598|449054517|FG006|Overall Study|Adverse Event|0|||
124842859|NCT02457598|449054518|FG007|Overall Study|Adverse Event|1|||
124842860|NCT02457598|449054519|FG008|Overall Study|Adverse Event|0|||
124842861|NCT02457598|449054520|FG009|Overall Study|Adverse Event|1|||
124842862|NCT02457598|449054521|FG010|Overall Study|Adverse Event|6|||
124842863|NCT02457598|449054522|FG011|Overall Study|Adverse Event|0|||
124842864|NCT02457598|449054523|FG012|Overall Study|Adverse Event|0|||
124842865|NCT02457598|449054524|FG013|Overall Study|Adverse Event|1|||
124842866|NCT02457598|449054525|FG014|Overall Study|Adverse Event|2|||
124842867|NCT02457598|449054526|FG015|Overall Study|Adverse Event|0|||
124842868|NCT02457598|449054527|FG016|Overall Study|Adverse Event|0|||
124842869|NCT02457598|449054511|FG000|Overall Study|Death|0|||
124842870|NCT02457598|449054512|FG001|Overall Study|Death|0|||
124842871|NCT02457598|449054513|FG002|Overall Study|Death|0|||
124842872|NCT02457598|449054514|FG003|Overall Study|Death|3|||
124842873|NCT02457598|449054515|FG004|Overall Study|Death|0|||
124842874|NCT02457598|449054516|FG005|Overall Study|Death|1|||
124842875|NCT02457598|449054517|FG006|Overall Study|Death|0|||
124842876|NCT02457598|449054518|FG007|Overall Study|Death|0|||
124842877|NCT02457598|449054519|FG008|Overall Study|Death|0|||
124842878|NCT02457598|449054520|FG009|Overall Study|Death|0|||
124842879|NCT02457598|449054521|FG010|Overall Study|Death|3|||
124842880|NCT02457598|449054522|FG011|Overall Study|Death|0|||
124842881|NCT02457598|449054523|FG012|Overall Study|Death|0|||
124842882|NCT02457598|449054524|FG013|Overall Study|Death|1|||
124842883|NCT02457598|449054525|FG014|Overall Study|Death|2|||
124842884|NCT02457598|449054526|FG015|Overall Study|Death|0|||
124842885|NCT02457598|449054527|FG016|Overall Study|Death|1|||
124842886|NCT02457598|449054511|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842887|NCT02457598|449054512|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
124842888|NCT02457598|449054513|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842889|NCT02457598|449054514|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
124842890|NCT02457598|449054515|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842891|NCT02457598|449054516|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842892|NCT02457598|449054517|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842893|NCT02457598|449054518|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
124842894|NCT02457598|449054519|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842895|NCT02457598|449054520|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842896|NCT02457598|449054521|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
124842897|NCT02457598|449054522|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842898|NCT02457598|449054523|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842899|NCT02457598|449054524|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
124842900|NCT02457598|449054525|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
124842901|NCT02457598|449054526|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
124842902|NCT02457598|449054527|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
124842903|NCT02457598|449054511|FG000|Overall Study|Withdrew Consent|0|||
124842904|NCT02457598|449054512|FG001|Overall Study|Withdrew Consent|0|||
124842905|NCT02457598|449054513|FG002|Overall Study|Withdrew Consent|0|||
124842906|NCT02457598|449054514|FG003|Overall Study|Withdrew Consent|0|||
124842907|NCT02457598|449054515|FG004|Overall Study|Withdrew Consent|0|||
124842908|NCT02457598|449054516|FG005|Overall Study|Withdrew Consent|0|||
124842909|NCT02457598|449054517|FG006|Overall Study|Withdrew Consent|0|||
124842910|NCT02457598|449054518|FG007|Overall Study|Withdrew Consent|2|||
124842911|NCT02457598|449054519|FG008|Overall Study|Withdrew Consent|0|||
124842912|NCT02457598|449054520|FG009|Overall Study|Withdrew Consent|0|||
124842913|NCT02457598|449054521|FG010|Overall Study|Withdrew Consent|3|||
124842914|NCT02457598|449054522|FG011|Overall Study|Withdrew Consent|0|||
124842915|NCT02457598|449054523|FG012|Overall Study|Withdrew Consent|0|||
124842916|NCT02457598|449054524|FG013|Overall Study|Withdrew Consent|1|||
124842917|NCT02457598|449054525|FG014|Overall Study|Withdrew Consent|0|||
124842918|NCT02457598|449054526|FG015|Overall Study|Withdrew Consent|0|||
124842919|NCT02457598|449054527|FG016|Overall Study|Withdrew Consent|0|||
124842920|NCT02457598|449054511|FG000|Overall Study|Unacceptable Toxicity|0|||
124842921|NCT02457598|449054512|FG001|Overall Study|Unacceptable Toxicity|0|||
124842922|NCT02457598|449054513|FG002|Overall Study|Unacceptable Toxicity|0|||
124842923|NCT02457598|449054514|FG003|Overall Study|Unacceptable Toxicity|0|||
124842924|NCT02457598|449054515|FG004|Overall Study|Unacceptable Toxicity|0|||
124842925|NCT02457598|449054516|FG005|Overall Study|Unacceptable Toxicity|0|||
124842926|NCT02457598|449054517|FG006|Overall Study|Unacceptable Toxicity|0|||
124842927|NCT02457598|449054518|FG007|Overall Study|Unacceptable Toxicity|0|||
124842928|NCT02457598|449054519|FG008|Overall Study|Unacceptable Toxicity|0|||
124842929|NCT02457598|449054520|FG009|Overall Study|Unacceptable Toxicity|0|||
124842930|NCT02457598|449054521|FG010|Overall Study|Unacceptable Toxicity|1|||
124842931|NCT02457598|449054522|FG011|Overall Study|Unacceptable Toxicity|0|||
124842932|NCT02457598|449054523|FG012|Overall Study|Unacceptable Toxicity|1|||
124842933|NCT02457598|449054524|FG013|Overall Study|Unacceptable Toxicity|1|||
124842934|NCT02457598|449054525|FG014|Overall Study|Unacceptable Toxicity|1|||
124842935|NCT02457598|449054526|FG015|Overall Study|Unacceptable Toxicity|0|||
124842936|NCT02457598|449054527|FG016|Overall Study|Unacceptable Toxicity|0|||
124842937|NCT02457598|449054511|FG000|Overall Study|Intercurrent Illness|0|||
124842938|NCT02457598|449054512|FG001|Overall Study|Intercurrent Illness|0|||
124842939|NCT02457598|449054513|FG002|Overall Study|Intercurrent Illness|0|||
124842940|NCT02457598|449054514|FG003|Overall Study|Intercurrent Illness|0|||
124842941|NCT02457598|449054515|FG004|Overall Study|Intercurrent Illness|0|||
124842942|NCT02457598|449054516|FG005|Overall Study|Intercurrent Illness|0|||
124842943|NCT02457598|449054517|FG006|Overall Study|Intercurrent Illness|0|||
124842944|NCT02457598|449054518|FG007|Overall Study|Intercurrent Illness|0|||
124842945|NCT02457598|449054519|FG008|Overall Study|Intercurrent Illness|0|||
124842946|NCT02457598|449054520|FG009|Overall Study|Intercurrent Illness|0|||
124842947|NCT02457598|449054521|FG010|Overall Study|Intercurrent Illness|1|||
124842948|NCT02457598|449054522|FG011|Overall Study|Intercurrent Illness|0|||
124842949|NCT02457598|449054523|FG012|Overall Study|Intercurrent Illness|0|||
124842950|NCT02457598|449054524|FG013|Overall Study|Intercurrent Illness|0|||
124842951|NCT02457598|449054525|FG014|Overall Study|Intercurrent Illness|0|||
124842952|NCT02457598|449054526|FG015|Overall Study|Intercurrent Illness|0|||
124842953|NCT02457598|449054527|FG016|Overall Study|Intercurrent Illness|0|||
124842954|NCT02457598|449054511|FG000|Overall Study|Protocol Violation|0|||
124842955|NCT02457598|449054512|FG001|Overall Study|Protocol Violation|0|||
124842956|NCT02457598|449054513|FG002|Overall Study|Protocol Violation|0|||
124640150|NCT00267969|448299880|FG000|After Controlled Period|Lost to Follow-up|0|||
124640151|NCT00267969|448299881|FG001|After Controlled Period|Lost to Follow-up|0|||
124640152|NCT00267969|448299882|FG002|After Controlled Period|Lost to Follow-up|0|||
124640153|NCT00267969|448299883|FG003|After Controlled Period|Lost to Follow-up|5|||
124842957|NCT02457598|449054514|FG003|Overall Study|Protocol Violation|0|||
124842958|NCT02457598|449054515|FG004|Overall Study|Protocol Violation|0|||
124842959|NCT02457598|449054516|FG005|Overall Study|Protocol Violation|0|||
124640154|NCT00267969|448299884|FG004|After Controlled Period|Lost to Follow-up|8|||
124842960|NCT02457598|449054517|FG006|Overall Study|Protocol Violation|0|||
124842961|NCT02457598|449054518|FG007|Overall Study|Protocol Violation|0|||
124842962|NCT02457598|449054519|FG008|Overall Study|Protocol Violation|0|||
124842963|NCT02457598|449054520|FG009|Overall Study|Protocol Violation|0|||
124842964|NCT02457598|449054521|FG010|Overall Study|Protocol Violation|1|||
124842965|NCT02457598|449054522|FG011|Overall Study|Protocol Violation|0|||
124842966|NCT02457598|449054523|FG012|Overall Study|Protocol Violation|0|||
124842967|NCT02457598|449054524|FG013|Overall Study|Protocol Violation|0|||
124842968|NCT02457598|449054525|FG014|Overall Study|Protocol Violation|0|||
124842969|NCT02457598|449054526|FG015|Overall Study|Protocol Violation|0|||
124842970|NCT02457598|449054527|FG016|Overall Study|Protocol Violation|0|||
124842971|NCT01403974|449054528|FG000|Overall Study|Progressive disease according to RECIST|3|||
124842972|NCT01403974|449054529|FG001|Overall Study|Progressive disease according to RECIST|3|||
124842973|NCT01403974|449054530|FG002|Overall Study|Progressive disease according to RECIST|2|||
124842974|NCT01403974|449054531|FG003|Overall Study|Progressive disease according to RECIST|3|||
124842975|NCT01403974|449054532|FG004|Overall Study|Progressive disease according to RECIST|3|||
124842976|NCT01403974|449054533|FG005|Overall Study|Progressive disease according to RECIST|2|||
124842977|NCT01403974|449054534|FG006|Overall Study|Progressive disease according to RECIST|3|||
124842978|NCT01403974|449054535|FG007|Overall Study|Progressive disease according to RECIST|2|||
124842979|NCT01403974|449054536|FG008|Overall Study|Progressive disease according to RECIST|6|||
124842980|NCT01403974|449054537|FG009|Overall Study|Progressive disease according to RECIST|2|||
124842981|NCT01403974|449054538|FG010|Overall Study|Progressive disease according to RECIST|3|||
124842982|NCT01403974|449054539|FG011|Overall Study|Progressive disease according to RECIST|2|||
124842983|NCT01403974|449054540|FG012|Overall Study|Progressive disease according to RECIST|2|||
124842984|NCT01403974|449054541|FG013|Overall Study|Progressive disease according to RECIST|3|||
124842985|NCT01403974|449054542|FG014|Overall Study|Progressive disease according to RECIST|1|||
124842986|NCT01403974|449054543|FG015|Overall Study|Progressive disease according to RECIST|8|||
124842987|NCT01403974|449054528|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
124842988|NCT01403974|449054529|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
124842989|NCT01403974|449054530|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
124842990|NCT01403974|449054531|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
124842991|NCT01403974|449054532|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
124842992|NCT01403974|449054533|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
124842993|NCT01403974|449054534|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
124842994|NCT01403974|449054535|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
124842995|NCT01403974|449054536|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
124842996|NCT01403974|449054537|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
124842997|NCT01403974|449054538|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
124842998|NCT01403974|449054539|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
124842999|NCT01403974|449054540|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
124843000|NCT01403974|449054541|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
124843001|NCT01403974|449054542|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
124843002|NCT01403974|449054543|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
124843003|NCT01403974|449054528|FG000|Overall Study|Refused to continue study medication|0|||
124843004|NCT01403974|449054529|FG001|Overall Study|Refused to continue study medication|0|||
124843005|NCT01403974|449054530|FG002|Overall Study|Refused to continue study medication|0|||
124843006|NCT01403974|449054531|FG003|Overall Study|Refused to continue study medication|0|||
124843007|NCT01403974|449054532|FG004|Overall Study|Refused to continue study medication|0|||
124843008|NCT01403974|449054533|FG005|Overall Study|Refused to continue study medication|1|||
124843009|NCT01403974|449054534|FG006|Overall Study|Refused to continue study medication|0|||
124843010|NCT01403974|449054535|FG007|Overall Study|Refused to continue study medication|0|||
124843011|NCT01403974|449054536|FG008|Overall Study|Refused to continue study medication|1|||
124843012|NCT01403974|449054537|FG009|Overall Study|Refused to continue study medication|0|||
124843013|NCT01403974|449054538|FG010|Overall Study|Refused to continue study medication|1|||
124843014|NCT01403974|449054539|FG011|Overall Study|Refused to continue study medication|0|||
124843015|NCT01403974|449054540|FG012|Overall Study|Refused to continue study medication|0|||
124843016|NCT01403974|449054541|FG013|Overall Study|Refused to continue study medication|0|||
124843017|NCT01403974|449054542|FG014|Overall Study|Refused to continue study medication|0|||
124843018|NCT01403974|449054543|FG015|Overall Study|Refused to continue study medication|4|||
124843019|NCT01403974|449054528|FG000|Overall Study|Adverse Event|0|||
124843020|NCT01403974|449054529|FG001|Overall Study|Adverse Event|0|||
124843021|NCT01403974|449054530|FG002|Overall Study|Adverse Event|1|||
124843022|NCT01403974|449054531|FG003|Overall Study|Adverse Event|0|||
124843023|NCT01403974|449054532|FG004|Overall Study|Adverse Event|0|||
124843024|NCT01403974|449054533|FG005|Overall Study|Adverse Event|0|||
124843025|NCT01403974|449054534|FG006|Overall Study|Adverse Event|0|||
124843026|NCT01403974|449054535|FG007|Overall Study|Adverse Event|1|||
124843027|NCT01403974|449054536|FG008|Overall Study|Adverse Event|0|||
124843028|NCT01403974|449054537|FG009|Overall Study|Adverse Event|0|||
124843029|NCT01403974|449054538|FG010|Overall Study|Adverse Event|0|||
124843030|NCT01403974|449054539|FG011|Overall Study|Adverse Event|0|||
124843031|NCT01403974|449054540|FG012|Overall Study|Adverse Event|1|||
124843032|NCT01403974|449054541|FG013|Overall Study|Adverse Event|0|||
124843033|NCT01403974|449054542|FG014|Overall Study|Adverse Event|0|||
124843034|NCT01403974|449054543|FG015|Overall Study|Adverse Event|0|||
124843035|NCT01403974|449054528|FG000|Overall Study|Other than specified|0|||
124843036|NCT01403974|449054529|FG001|Overall Study|Other than specified|0|||
124843037|NCT01403974|449054530|FG002|Overall Study|Other than specified|0|||
124843038|NCT01403974|449054531|FG003|Overall Study|Other than specified|0|||
124843039|NCT01403974|449054532|FG004|Overall Study|Other than specified|0|||
124843040|NCT01403974|449054533|FG005|Overall Study|Other than specified|0|||
124843041|NCT01403974|449054534|FG006|Overall Study|Other than specified|0|||
124843042|NCT01403974|449054535|FG007|Overall Study|Other than specified|0|||
124843043|NCT01403974|449054536|FG008|Overall Study|Other than specified|0|||
124843044|NCT01403974|449054537|FG009|Overall Study|Other than specified|1|||
124843045|NCT01403974|449054538|FG010|Overall Study|Other than specified|0|||
124843046|NCT01403974|449054539|FG011|Overall Study|Other than specified|1|||
124843047|NCT01403974|449054540|FG012|Overall Study|Other than specified|0|||
124843048|NCT01403974|449054541|FG013|Overall Study|Other than specified|0|||
124843049|NCT01403974|449054542|FG014|Overall Study|Other than specified|0|||
124843050|NCT01403974|449054543|FG015|Overall Study|Other than specified|0|||
124843051|NCT01526889|449054544|FG000|Treatment Period|Adverse Event|2|||
124843052|NCT01526889|449054545|FG001|Treatment Period|Adverse Event|0|||
124843053|NCT01526889|449054544|FG000|Treatment Extension Period|Administrative problems|1|||
124843054|NCT01526889|449054545|FG001|Treatment Extension Period|Administrative problems|0|||
124843055|NCT02703636|449054547|FG000|Overall Study|Adverse Event|14|||
124843056|NCT02703636|449054547|FG000|Overall Study|Study stopped by sponsor|1|||
124843057|NCT02703636|449054547|FG000|Overall Study|Withdrawal by Subject|1|||
124843058|NCT00393939|449054548|FG000|Overall Study|Protocol Violation|1|||
124843059|NCT00393939|449054549|FG001|Overall Study|Protocol Violation|1|||
124843060|NCT00393939|449054548|FG000|Overall Study|Lost to Follow-up|2|||
124843061|NCT00393939|449054549|FG001|Overall Study|Lost to Follow-up|4|||
124843062|NCT00393939|449054548|FG000|Overall Study|Death|10|||
124843063|NCT00393939|449054549|FG001|Overall Study|Death|4|||
124843064|NCT00393939|449054548|FG000|Overall Study|Sponsor|5|||
124843065|NCT00393939|449054549|FG001|Overall Study|Sponsor|13|||
124843066|NCT00393939|449054548|FG000|Overall Study|Objective progression or relapse|239|||
124843067|NCT00393939|449054549|FG001|Overall Study|Objective progression or relapse|223|||
124843068|NCT00393939|449054548|FG000|Overall Study|Withdrawal by Subject|2|||
124843069|NCT00393939|449054549|FG001|Overall Study|Withdrawal by Subject|7|||
124843070|NCT00393939|449054548|FG000|Overall Study|Other|37|||
124843071|NCT00393939|449054549|FG001|Overall Study|Other|45|||
124843072|NCT04334460|449054555|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
124843073|NCT04334460|449054556|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
124843074|NCT04334460|449054555|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
124843075|NCT04334460|449054556|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
124843076|NCT00547703|449054557|FG000|Overall Study|Lost to Follow-up|1|||
124843077|NCT00547703|449054558|FG001|Overall Study|Lost to Follow-up|0|||
124843078|NCT03995953|449054561|FG000|Overall Study|Death|3|||
124843079|NCT03995953|449054562|FG001|Overall Study|Death|0|||
124843080|NCT03995953|449054563|FG002|Overall Study|Death|3|||
124843081|NCT03995953|449054564|FG003|Overall Study|Death|0|||
124843082|NCT03995953|449054565|FG004|Overall Study|Death|3|||
124843083|NCT03995953|449054566|FG005|Overall Study|Death|0|||
124843084|NCT03995953|449054567|FG006|Overall Study|Death|0|||
124843085|NCT03995953|449054568|FG007|Overall Study|Death|0|||
124843086|NCT03995953|449054569|FG008|Overall Study|Death|1|||
124843087|NCT03995953|449054570|FG009|Overall Study|Death|0|||
124843088|NCT03995953|449054571|FG010|Overall Study|Death|0|||
124843089|NCT03995953|449054572|FG011|Overall Study|Death|0|||
124843090|NCT03995953|449054561|FG000|Overall Study|Lost to Follow-up|6|||
124843091|NCT03995953|449054562|FG001|Overall Study|Lost to Follow-up|54|||
124843092|NCT03995953|449054563|FG002|Overall Study|Lost to Follow-up|3|||
124843093|NCT03995953|449054564|FG003|Overall Study|Lost to Follow-up|32|||
124843094|NCT03995953|449054565|FG004|Overall Study|Lost to Follow-up|5|||
124843095|NCT03995953|449054566|FG005|Overall Study|Lost to Follow-up|44|||
124843096|NCT03995953|449054567|FG006|Overall Study|Lost to Follow-up|0|||
124843097|NCT03995953|449054568|FG007|Overall Study|Lost to Follow-up|31|||
124843098|NCT03995953|449054569|FG008|Overall Study|Lost to Follow-up|8|||
124843099|NCT03995953|449054570|FG009|Overall Study|Lost to Follow-up|36|||
124843100|NCT03995953|449054571|FG010|Overall Study|Lost to Follow-up|5|||
124843101|NCT03995953|449054572|FG011|Overall Study|Lost to Follow-up|41|||
124843102|NCT03995953|449054561|FG000|Overall Study|Withdrawal by Subject|4|||
124843103|NCT03995953|449054562|FG001|Overall Study|Withdrawal by Subject|0|||
124843104|NCT03995953|449054563|FG002|Overall Study|Withdrawal by Subject|1|||
124843105|NCT03995953|449054564|FG003|Overall Study|Withdrawal by Subject|0|||
124843106|NCT03995953|449054565|FG004|Overall Study|Withdrawal by Subject|1|||
124843107|NCT03995953|449054566|FG005|Overall Study|Withdrawal by Subject|0|||
124640155|NCT00267969|448299885|FG005|After Controlled Period|Lost to Follow-up|9|||
124843108|NCT03995953|449054567|FG006|Overall Study|Withdrawal by Subject|1|||
124843109|NCT03995953|449054568|FG007|Overall Study|Withdrawal by Subject|0|||
124843110|NCT03995953|449054569|FG008|Overall Study|Withdrawal by Subject|3|||
124843111|NCT03995953|449054570|FG009|Overall Study|Withdrawal by Subject|0|||
124843112|NCT03995953|449054571|FG010|Overall Study|Withdrawal by Subject|3|||
124843113|NCT03995953|449054572|FG011|Overall Study|Withdrawal by Subject|0|||
124843114|NCT03995953|449054561|FG000|Overall Study|Health Issues|0|||
124843115|NCT03995953|449054562|FG001|Overall Study|Health Issues|0|||
124843116|NCT03995953|449054563|FG002|Overall Study|Health Issues|0|||
124843117|NCT03995953|449054564|FG003|Overall Study|Health Issues|0|||
124843118|NCT03995953|449054565|FG004|Overall Study|Health Issues|1|||
124843119|NCT03995953|449054566|FG005|Overall Study|Health Issues|0|||
124843120|NCT03995953|449054567|FG006|Overall Study|Health Issues|0|||
124843121|NCT03995953|449054568|FG007|Overall Study|Health Issues|0|||
124843122|NCT03995953|449054569|FG008|Overall Study|Health Issues|4|||
124843123|NCT03995953|449054570|FG009|Overall Study|Health Issues|0|||
124843124|NCT03995953|449054571|FG010|Overall Study|Health Issues|0|||
124843125|NCT03995953|449054572|FG011|Overall Study|Health Issues|0|||
124843126|NCT03995953|449054561|FG000|Overall Study|Relocated|11|||
124843127|NCT03995953|449054562|FG001|Overall Study|Relocated|0|||
124843128|NCT03995953|449054563|FG002|Overall Study|Relocated|16|||
124843129|NCT03995953|449054564|FG003|Overall Study|Relocated|0|||
124843130|NCT03995953|449054565|FG004|Overall Study|Relocated|14|||
124843131|NCT03995953|449054566|FG005|Overall Study|Relocated|0|||
124843132|NCT03995953|449054567|FG006|Overall Study|Relocated|16|||
124843133|NCT03995953|449054568|FG007|Overall Study|Relocated|0|||
124843134|NCT03995953|449054569|FG008|Overall Study|Relocated|14|||
124843135|NCT03995953|449054570|FG009|Overall Study|Relocated|0|||
124843136|NCT03995953|449054571|FG010|Overall Study|Relocated|15|||
124843137|NCT03995953|449054572|FG011|Overall Study|Relocated|0|||
124843138|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
124843139|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
124843140|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
124843141|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
124843142|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
124843143|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
124843144|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
124843145|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
124843146|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
124843147|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
124843148|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
124843149|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
124843150|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
124843151|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
124843152|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
124843153|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
124843154|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
124843155|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
124843156|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
124843157|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
124843158|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
124843159|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
124843160|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
124843161|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
124843162|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
124843163|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
124843164|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
124843165|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
124843166|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
124843167|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
124843168|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
124843169|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
124843170|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
124843171|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
124843172|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
124843173|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
124843174|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
124843175|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
124843176|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
124843177|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
124843178|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
124843179|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
124843180|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
124843181|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
124843182|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
124843183|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
124843184|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
124843185|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
124843186|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
124843187|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
124843188|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
124843189|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
124843190|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
124843191|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
124843192|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
124843193|NCT04951622|449054580|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
124843194|NCT04951622|449054581|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
124843195|NCT04951622|449054582|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
124843196|NCT04951622|449054583|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
124843197|NCT04951622|449054584|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
124843198|NCT04951622|449054580|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
124843199|NCT04951622|449054581|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
124843200|NCT04951622|449054582|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
124843201|NCT04951622|449054583|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
124843202|NCT04951622|449054584|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
124843203|NCT04951622|449054580|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
124843204|NCT04951622|449054581|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
124843205|NCT04951622|449054582|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
124843206|NCT04951622|449054583|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
124843207|NCT04951622|449054584|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
124843208|NCT04951622|449054580|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
124843209|NCT04951622|449054581|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
124843210|NCT04951622|449054582|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
124843211|NCT04951622|449054583|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
124843212|NCT04951622|449054584|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
124843213|NCT04951622|449054580|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
124843214|NCT04951622|449054581|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
124843215|NCT04951622|449054582|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
124843216|NCT04951622|449054583|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
124843217|NCT04951622|449054584|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
124843218|NCT04951622|449054580|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
124843219|NCT04951622|449054581|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
124843220|NCT04951622|449054582|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
124843221|NCT04951622|449054583|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
124843222|NCT04951622|449054584|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
124843223|NCT04951622|449054580|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
124843224|NCT04951622|449054581|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
124843225|NCT04951622|449054582|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
124843226|NCT04951622|449054583|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
124843227|NCT04951622|449054584|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
124843228|NCT04951622|449054580|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
124843229|NCT04951622|449054581|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
124843230|NCT04951622|449054582|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
124843231|NCT04951622|449054583|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
124843232|NCT04951622|449054584|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
124843233|NCT04951622|449054580|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
124843234|NCT04951622|449054581|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
124843235|NCT04951622|449054582|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
124843236|NCT04951622|449054583|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
124843237|NCT04951622|449054584|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
124843238|NCT04108208|449054585|FG000|Overall Study|Withdrawal by Subject|2|||
124640156|NCT00267969|448299886|FG006|After Controlled Period|Lost to Follow-up|10|||
124640157|NCT00267969|448299880|FG000|After Controlled Period|Other|0|||
124640158|NCT00267969|448299881|FG001|After Controlled Period|Other|0|||
124640159|NCT00267969|448299882|FG002|After Controlled Period|Other|0|||
124640160|NCT00267969|448299883|FG003|After Controlled Period|Other|13|||
124640161|NCT00267969|448299884|FG004|After Controlled Period|Other|11|||
124640162|NCT00267969|448299885|FG005|After Controlled Period|Other|22|||
124843239|NCT04108208|449054586|FG001|Overall Study|Withdrawal by Subject|6|||
124843240|NCT04108208|449054585|FG000|Overall Study|other-ongoing|20|||
124843241|NCT04108208|449054586|FG001|Overall Study|other-ongoing|40|||
124843242|NCT04108208|449054585|FG000|Overall Study|Death|1|||
124843243|NCT04108208|449054586|FG001|Overall Study|Death|4|||
124843244|NCT04108208|449054585|FG000|Overall Study|Lost to Follow-up|2|||
124843245|NCT04108208|449054586|FG001|Overall Study|Lost to Follow-up|0|||
124843246|NCT02948842|449054588|FG000|Overall Study|Withdrawal by Subject|4|||
124843247|NCT04181827|449054592|FG000|Overall Study|Ongoing|124|||
124843248|NCT04181827|449054593|FG001|Overall Study|Ongoing|157|||
124843249|NCT04181827|449054592|FG000|Overall Study|Death|82|||
124843250|NCT04181827|449054593|FG001|Overall Study|Death|50|||
124843251|NCT04181827|449054592|FG000|Overall Study|Lost to Follow-up|0|||
124843252|NCT04181827|449054593|FG001|Overall Study|Lost to Follow-up|1|||
124843253|NCT04181827|449054592|FG000|Overall Study|Withdrawal by Subject|5|||
124843254|NCT04181827|449054593|FG001|Overall Study|Withdrawal by Subject|0|||
124843255|NCT01256710|449054594|FG000|Overall Study|Death|449|||
124843256|NCT01256710|449054594|FG000|Overall Study|System Explant|67|||
124843257|NCT01256710|449054594|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
124843258|NCT01256710|449054594|FG000|Overall Study|Lost to Follow-up|67|||
124843259|NCT01256710|449054594|FG000|Overall Study|Withdrawal by Subject|29|||
124843260|NCT01256710|449054594|FG000|Overall Study|Physician Decision|9|||
124843261|NCT01256710|449054594|FG000|Overall Study|Subject Noncompliance|2|||
124843262|NCT01256710|449054594|FG000|Overall Study|Study Terminated by Sponsor|273|||
124843263|NCT02681302|449054595|FG000|Overall Study|Withdrawal by Subject|1|||
124843264|NCT02681302|449054596|FG001|Overall Study|Withdrawal by Subject|1|||
124843265|NCT02681302|449054597|FG002|Overall Study|Withdrawal by Subject|0|||
124843266|NCT02681302|449054598|FG003|Overall Study|Withdrawal by Subject|0|||
124843267|NCT02681302|449054599|FG004|Overall Study|Withdrawal by Subject|1|||
124843268|NCT02681302|449054600|FG005|Overall Study|Withdrawal by Subject|0|||
124843269|NCT02681302|449054595|FG000|Overall Study|Screen Failure|2|||
124843270|NCT02681302|449054596|FG001|Overall Study|Screen Failure|4|||
124843271|NCT02681302|449054597|FG002|Overall Study|Screen Failure|2|||
124843272|NCT02681302|449054598|FG003|Overall Study|Screen Failure|0|||
124843273|NCT02681302|449054599|FG004|Overall Study|Screen Failure|1|||
124843274|NCT02681302|449054600|FG005|Overall Study|Screen Failure|1|||
124843275|NCT02681302|449054595|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
124843276|NCT02681302|449054596|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
124843277|NCT02681302|449054597|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
124843278|NCT02681302|449054598|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
124843279|NCT02681302|449054599|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
124843280|NCT02681302|449054600|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
124843281|NCT02942017|449054601|FG000|Overall Study|Adverse Event|0|||
124843282|NCT02942017|449054602|FG001|Overall Study|Adverse Event|1|||
124843283|NCT02942017|449054601|FG000|Overall Study|Withdrawal by Subject|0|||
124843284|NCT02942017|449054602|FG001|Overall Study|Withdrawal by Subject|1|||
124843285|NCT02942017|449054601|FG000|Overall Study|Lost to Follow-up|1|||
124843286|NCT02942017|449054602|FG001|Overall Study|Lost to Follow-up|1|||
124843287|NCT02942017|449054601|FG000|Overall Study|Randomized but not dosed|1|||
124843288|NCT02942017|449054602|FG001|Overall Study|Randomized but not dosed|3|||
124843289|NCT05059600|449054605|FG000|Overall Study|Enrolled but not Treated|10|||
124843290|NCT02152995|449054606|FG000|Overall Study|Withdrawal by Subject|1|||
124843291|NCT02152995|449054607|FG001|Overall Study|Withdrawal by Subject|0|||
124843292|NCT04552587|449054609|FG000|Overall Study|Lost to Follow-up|4|||
124843293|NCT00480779|449054610|FG000|Overall Study|Other|2|||
124843294|NCT00480779|449054611|FG001|Overall Study|Other|0|||
124843295|NCT00480779|449054610|FG000|Overall Study|Job and Health-related|0|||
124843296|NCT00480779|449054611|FG001|Overall Study|Job and Health-related|3|||
124843297|NCT04907032|449054613|FG000|Overall Study|Withdrawal by Subject|7|||
124843298|NCT04907032|449054614|FG001|Overall Study|Withdrawal by Subject|1|||
124843299|NCT02741115|449054622|FG000|Overall Study|Adverse Event|1|||
124843300|NCT02741115|449054623|FG001|Overall Study|Adverse Event|0|||
124843301|NCT02741115|449054622|FG000|Overall Study|Lost to Follow-up|7|||
124843302|NCT02741115|449054623|FG001|Overall Study|Lost to Follow-up|4|||
124843303|NCT02741115|449054622|FG000|Overall Study|Withdrawal by Subject|4|||
124843304|NCT02741115|449054623|FG001|Overall Study|Withdrawal by Subject|2|||
124843305|NCT03548584|449056066|FG000|Overall Study|Lost to Follow-up|0|||
124843306|NCT03548584|449056067|FG001|Overall Study|Lost to Follow-up|0|||
124640163|NCT00267969|448299886|FG006|After Controlled Period|Other|25|||
124843307|NCT03548584|449056068|FG002|Overall Study|Lost to Follow-up|1|||
124843308|NCT03548584|449056066|FG000|Overall Study|Adverse Event|1|||
124843309|NCT03548584|449056067|FG001|Overall Study|Adverse Event|11|||
124843310|NCT03548584|449056068|FG002|Overall Study|Adverse Event|5|||
124843311|NCT03548584|449056066|FG000|Overall Study|Site Terminated by Sponsor|1|||
124843312|NCT03548584|449056067|FG001|Overall Study|Site Terminated by Sponsor|3|||
124843313|NCT03548584|449056068|FG002|Overall Study|Site Terminated by Sponsor|2|||
124843314|NCT03548584|449056066|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
124843315|NCT03548584|449056067|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
124843316|NCT03548584|449056068|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
124843317|NCT03548584|449056066|FG000|Overall Study|Lack of Efficacy|0|||
124843318|NCT03548584|449056067|FG001|Overall Study|Lack of Efficacy|1|||
124843319|NCT03548584|449056068|FG002|Overall Study|Lack of Efficacy|0|||
124843320|NCT03548584|449056066|FG000|Overall Study|Non-compliance with Study Drug|0|||
124843321|NCT03548584|449056067|FG001|Overall Study|Non-compliance with Study Drug|1|||
124843322|NCT03548584|449056068|FG002|Overall Study|Non-compliance with Study Drug|0|||
124843323|NCT03548584|449056066|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
124843324|NCT03548584|449056067|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
124843325|NCT03548584|449056068|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
124843326|NCT01101841|449056069|FG000|Overall Study|Adverse Event|15|||
124843327|NCT01101841|449056070|FG001|Overall Study|Adverse Event|15|||
124843328|NCT01101841|449056069|FG000|Overall Study|Lost to Follow-up|9|||
124843329|NCT01101841|449056070|FG001|Overall Study|Lost to Follow-up|3|||
124843330|NCT01101841|449056069|FG000|Overall Study|Withdrawal by Subject|21|||
124843331|NCT01101841|449056070|FG001|Overall Study|Withdrawal by Subject|40|||
124843332|NCT01101841|449056069|FG000|Overall Study|Protocol Violation|1|||
124843333|NCT01101841|449056070|FG001|Overall Study|Protocol Violation|1|||
124843334|NCT01101841|449056069|FG000|Overall Study|Physician Decision|0|||
124843335|NCT01101841|449056070|FG001|Overall Study|Physician Decision|2|||
124843336|NCT01101841|449056069|FG000|Overall Study|Lack of Efficacy|0|||
124843337|NCT01101841|449056070|FG001|Overall Study|Lack of Efficacy|2|||
124843338|NCT01101841|449056069|FG000|Overall Study|Other|0|||
124843339|NCT01101841|449056070|FG001|Overall Study|Other|1|||
124843340|NCT01101841|449056069|FG000|Overall Study|Suicidality Tracking Scale|3|||
124843341|NCT01101841|449056070|FG001|Overall Study|Suicidality Tracking Scale|1|||
124843342|NCT01101841|449056069|FG000|Overall Study|Eligibility Criteria|1|||
124843343|NCT01101841|449056070|FG001|Overall Study|Eligibility Criteria|2|||
124843344|NCT03633396|449056075|FG000|Overall Study|Withdrawal by Subject|4|||
124843345|NCT03633396|449056076|FG001|Overall Study|Withdrawal by Subject|4|||
124843346|NCT03633396|449056075|FG000|Overall Study|Adverse Event|1|||
124843347|NCT03633396|449056076|FG001|Overall Study|Adverse Event|1|||
124843348|NCT03633396|449056075|FG000|Overall Study|Lack of Efficacy|1|||
124843349|NCT03633396|449056076|FG001|Overall Study|Lack of Efficacy|0|||
124843350|NCT03633396|449056075|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
124843351|NCT03633396|449056076|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
124843352|NCT01012817|449056077|FG000|Overall Study|Withdrawal by Subject|0|||
124843353|NCT01012817|449056078|FG001|Overall Study|Withdrawal by Subject|0|||
124843354|NCT01012817|449056079|FG002|Overall Study|Withdrawal by Subject|0|||
124843355|NCT01012817|449056080|FG003|Overall Study|Withdrawal by Subject|1|||
124843356|NCT01012817|449056081|FG004|Overall Study|Withdrawal by Subject|0|||
124843357|NCT01012817|449056082|FG005|Overall Study|Withdrawal by Subject|0|||
124843358|NCT01012817|449056083|FG006|Overall Study|Withdrawal by Subject|0|||
124843359|NCT01012817|449056084|FG007|Overall Study|Withdrawal by Subject|1|||
124843360|NCT01012817|449056085|FG008|Overall Study|Withdrawal by Subject|0|||
124843361|NCT01012817|449056086|FG009|Overall Study|Withdrawal by Subject|0|||
124843362|NCT01012817|449056087|FG010|Overall Study|Withdrawal by Subject|1|||
124843363|NCT01012817|449056088|FG011|Overall Study|Withdrawal by Subject|1|||
124843364|NCT01012817|449056089|FG012|Overall Study|Withdrawal by Subject|0|||
124843365|NCT01012817|449056090|FG013|Overall Study|Withdrawal by Subject|1|||
124843366|NCT01012817|449056077|FG000|Overall Study|Adverse Event|0|||
124843367|NCT01012817|449056078|FG001|Overall Study|Adverse Event|0|||
124843368|NCT01012817|449056079|FG002|Overall Study|Adverse Event|0|||
124843369|NCT01012817|449056080|FG003|Overall Study|Adverse Event|0|||
124843370|NCT01012817|449056081|FG004|Overall Study|Adverse Event|0|||
124843371|NCT01012817|449056082|FG005|Overall Study|Adverse Event|1|||
124843372|NCT01012817|449056083|FG006|Overall Study|Adverse Event|0|||
124843373|NCT01012817|449056084|FG007|Overall Study|Adverse Event|0|||
124843374|NCT01012817|449056085|FG008|Overall Study|Adverse Event|0|||
124843375|NCT01012817|449056086|FG009|Overall Study|Adverse Event|0|||
124843376|NCT01012817|449056087|FG010|Overall Study|Adverse Event|1|||
124843377|NCT01012817|449056088|FG011|Overall Study|Adverse Event|0|||
124843378|NCT01012817|449056089|FG012|Overall Study|Adverse Event|0|||
124843379|NCT01012817|449056090|FG013|Overall Study|Adverse Event|1|||
124843380|NCT02143414|449056091|FG000|Induction|Adverse Event|1|||
124640164|NCT02308540|448299891|FG000|Overall Study|Lost to Follow-up|0|||
124843381|NCT02143414|449056092|FG001|Induction|Adverse Event|2|||
124843382|NCT02143414|449056091|FG000|Induction|Death|1|||
124843383|NCT02143414|449056092|FG001|Induction|Death|2|||
124843384|NCT02143414|449056091|FG000|Induction|Patient refusal|1|||
124843385|NCT02143414|449056092|FG001|Induction|Patient refusal|1|||
124843386|NCT02143414|449056091|FG000|Induction|Refractory|1|||
124843387|NCT02143414|449056092|FG001|Induction|Refractory|0|||
124843388|NCT02143414|449056091|FG000|Induction|Began alternative treatment|1|||
124843389|NCT02143414|449056092|FG001|Induction|Began alternative treatment|0|||
124843390|NCT02143414|449056091|FG000|Induction|Ineligible for postremission|5|||
124843391|NCT02143414|449056092|FG001|Induction|Ineligible for postremission|1|||
124843392|NCT02143414|449056091|FG000|Post-remission|Adverse Event|0|||
124843393|NCT02143414|449056092|FG001|Post-remission|Adverse Event|2|||
124843394|NCT02143414|449056091|FG000|Post-remission|Disease progression/relapse|5|||
124843395|NCT02143414|449056092|FG001|Post-remission|Disease progression/relapse|0|||
124843396|NCT02143414|449056091|FG000|Maintenance|Adverse Event|4|||
124843397|NCT02143414|449056092|FG001|Maintenance|Adverse Event|6|||
124843398|NCT02143414|449056091|FG000|Maintenance|Disease progression/relapse|3|||
124843399|NCT02143414|449056092|FG001|Maintenance|Disease progression/relapse|2|||
124843400|NCT02143414|449056091|FG000|Maintenance|Patient refusal|2|||
124843401|NCT02143414|449056092|FG001|Maintenance|Patient refusal|1|||
124843402|NCT02143414|449056091|FG000|Maintenance|Physician Decision|1|||
124843403|NCT02143414|449056092|FG001|Maintenance|Physician Decision|0|||
124843404|NCT02143414|449056091|FG000|Maintenance|Death|0|||
124843405|NCT02143414|449056092|FG001|Maintenance|Death|1|||
124843406|NCT02143414|449056091|FG000|Maintenance|On protocol treatment|0|||
124843407|NCT02143414|449056092|FG001|Maintenance|On protocol treatment|6|||
124843408|NCT00679341|449056097|FG000|Overall Study|Disease progression|42|||
124843409|NCT00679341|449056098|FG001|Overall Study|Disease progression|36|||
124843410|NCT00679341|449056097|FG000|Overall Study|Adverse Event|5|||
124843411|NCT00679341|449056098|FG001|Overall Study|Adverse Event|6|||
124843412|NCT00679341|449056097|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
124843413|NCT00679341|449056098|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
124843414|NCT00679341|449056097|FG000|Overall Study|Death|1|||
124843415|NCT00679341|449056098|FG001|Overall Study|Death|1|||
124843416|NCT00679341|449056097|FG000|Overall Study|Other|1|||
124843417|NCT00679341|449056098|FG001|Overall Study|Other|0|||
124843418|NCT00679341|449056097|FG000|Overall Study|Physician Decision|1|||
124843419|NCT00679341|449056098|FG001|Overall Study|Physician Decision|0|||
124843420|NCT00679341|449056097|FG000|Overall Study|Not treated|0|||
124843421|NCT00679341|449056098|FG001|Overall Study|Not treated|2|||
124843422|NCT00679341|449056097|FG000|Overall Study|Physician/patient decision to withdraw|0|||
124843423|NCT00679341|449056098|FG001|Overall Study|Physician/patient decision to withdraw|6|||
124843424|NCT01433263|449056101|FG000|Overall Study|Adverse Event|3|||
124843425|NCT01433263|449056102|FG001|Overall Study|Adverse Event|1|||
124843426|NCT01433263|449056101|FG000|Overall Study|Death|5|||
124843427|NCT01433263|449056102|FG001|Overall Study|Death|3|||
124843428|NCT01433263|449056101|FG000|Overall Study|Lost to Follow-up|0|||
124843429|NCT01433263|449056102|FG001|Overall Study|Lost to Follow-up|1|||
124843430|NCT01433263|449056101|FG000|Overall Study|Protocol Deviation|1|||
124843431|NCT01433263|449056102|FG001|Overall Study|Protocol Deviation|0|||
124843432|NCT01433263|449056101|FG000|Overall Study|Withdrawal by Subject|10|||
124843433|NCT01433263|449056102|FG001|Overall Study|Withdrawal by Subject|7|||
124843434|NCT03107988|449056103|FG000|Overall Study|Adverse Event|0|||
124843435|NCT03107988|449056104|FG001|Overall Study|Adverse Event|0|||
124843436|NCT03107988|449056105|FG002|Overall Study|Adverse Event|0|||
124843437|NCT03107988|449056106|FG003|Overall Study|Adverse Event|1|||
124843438|NCT03107988|449056107|FG004|Overall Study|Adverse Event|0|||
124843439|NCT03107988|449056108|FG005|Overall Study|Adverse Event|1|||
124843440|NCT03107988|449056109|FG006|Overall Study|Adverse Event|0|||
124843441|NCT03107988|449056110|FG007|Overall Study|Adverse Event|1|||
124843442|NCT03107988|449056111|FG008|Overall Study|Adverse Event|0|||
124843443|NCT03107988|449056112|FG009|Overall Study|Adverse Event|0|||
124843444|NCT03107988|449056113|FG010|Overall Study|Adverse Event|0|||
124843445|NCT03107988|449056114|FG011|Overall Study|Adverse Event|0|||
124843446|NCT03107988|449056115|FG012|Overall Study|Adverse Event|0|||
124843447|NCT03107988|449056103|FG000|Overall Study|Disease Progression or Relapse|1|||
124843448|NCT03107988|449056104|FG001|Overall Study|Disease Progression or Relapse|2|||
124843449|NCT03107988|449056105|FG002|Overall Study|Disease Progression or Relapse|2|||
124843450|NCT03107988|449056106|FG003|Overall Study|Disease Progression or Relapse|5|||
124843451|NCT03107988|449056107|FG004|Overall Study|Disease Progression or Relapse|1|||
124640165|NCT02308540|448299892|FG001|Overall Study|Lost to Follow-up|0|||
124640166|NCT02308540|448299893|FG002|Overall Study|Lost to Follow-up|0|||
124640167|NCT02308540|448299894|FG003|Overall Study|Lost to Follow-up|0|||
124843452|NCT03107988|449056108|FG005|Overall Study|Disease Progression or Relapse|1|||
124843453|NCT03107988|449056109|FG006|Overall Study|Disease Progression or Relapse|0|||
124843454|NCT03107988|449056110|FG007|Overall Study|Disease Progression or Relapse|0|||
124843455|NCT03107988|449056111|FG008|Overall Study|Disease Progression or Relapse|0|||
124843456|NCT03107988|449056112|FG009|Overall Study|Disease Progression or Relapse|1|||
124843457|NCT03107988|449056113|FG010|Overall Study|Disease Progression or Relapse|4|||
124843458|NCT03107988|449056114|FG011|Overall Study|Disease Progression or Relapse|0|||
124843459|NCT03107988|449056115|FG012|Overall Study|Disease Progression or Relapse|0|||
124843460|NCT03107988|449056103|FG000|Overall Study|Ineligible|0|||
124843461|NCT03107988|449056104|FG001|Overall Study|Ineligible|0|||
124843462|NCT03107988|449056105|FG002|Overall Study|Ineligible|0|||
124843463|NCT03107988|449056106|FG003|Overall Study|Ineligible|0|||
124843464|NCT03107988|449056107|FG004|Overall Study|Ineligible|0|||
124843465|NCT03107988|449056108|FG005|Overall Study|Ineligible|0|||
124843466|NCT03107988|449056109|FG006|Overall Study|Ineligible|0|||
124843467|NCT03107988|449056110|FG007|Overall Study|Ineligible|0|||
124843468|NCT03107988|449056111|FG008|Overall Study|Ineligible|1|||
124843469|NCT03107988|449056112|FG009|Overall Study|Ineligible|0|||
124843470|NCT03107988|449056113|FG010|Overall Study|Ineligible|0|||
124843471|NCT03107988|449056114|FG011|Overall Study|Ineligible|0|||
124843472|NCT03107988|449056115|FG012|Overall Study|Ineligible|0|||
124843473|NCT01359592|449056116|FG000|Initial Registration|Adverse Event|1|||
124843474|NCT01359592|449056117|FG001|Initial Registration|Adverse Event|0|||
124843475|NCT01359592|449056118|FG002|Initial Registration|Adverse Event|0|||
124843476|NCT01359592|449056119|FG003|Initial Registration|Adverse Event|0|||
124843477|NCT01359592|449056116|FG000|Initial Registration|Death|1|||
124843478|NCT01359592|449056117|FG001|Initial Registration|Death|0|||
124843479|NCT01359592|449056118|FG002|Initial Registration|Death|0|||
124843480|NCT01359592|449056119|FG003|Initial Registration|Death|0|||
124843481|NCT01359592|449056116|FG000|Initial Registration|Other reason not protocol specified|1|||
124843482|NCT01359592|449056117|FG001|Initial Registration|Other reason not protocol specified|0|||
124843483|NCT01359592|449056118|FG002|Initial Registration|Other reason not protocol specified|0|||
124843484|NCT01359592|449056119|FG003|Initial Registration|Other reason not protocol specified|0|||
124843485|NCT01359592|449056116|FG000|Initial Registration|Ineligible|26|||
124843486|NCT01359592|449056117|FG001|Initial Registration|Ineligible|0|||
124843487|NCT01359592|449056118|FG002|Initial Registration|Ineligible|0|||
124843488|NCT01359592|449056119|FG003|Initial Registration|Ineligible|0|||
124843489|NCT01359592|449056116|FG000|PET-Directed Therapy|Adverse Event|0|||
124843490|NCT01359592|449056117|FG001|PET-Directed Therapy|Adverse Event|0|||
124843491|NCT01359592|449056118|FG002|PET-Directed Therapy|Adverse Event|1|||
124843492|NCT01359592|449056119|FG003|PET-Directed Therapy|Adverse Event|0|||
124843493|NCT01359592|449056116|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
124843494|NCT01359592|449056117|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
124843495|NCT01359592|449056118|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
124843496|NCT01359592|449056119|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
124843497|NCT01359592|449056116|FG000|PET-Directed Therapy|Ineligible|0|||
124843498|NCT01359592|449056117|FG001|PET-Directed Therapy|Ineligible|0|||
124843499|NCT01359592|449056118|FG002|PET-Directed Therapy|Ineligible|24|||
124843500|NCT01359592|449056119|FG003|PET-Directed Therapy|Ineligible|0|||
124843501|NCT00326612|449056120|FG000|Overall Study|They did not have a seizure requiring tx|129|||
124843502|NCT00326612|449056121|FG001|Overall Study|They did not have a seizure requiring tx|137|||
124843503|NCT00548808|449056122|FG000|Overall Study|Lost to Follow-up|9|||
124843504|NCT00548808|449056123|FG001|Overall Study|Lost to Follow-up|3|||
124843505|NCT00548808|449056122|FG000|Overall Study|Protocol Violation|8|||
124843506|NCT00548808|449056123|FG001|Overall Study|Protocol Violation|8|||
124843507|NCT00548808|449056122|FG000|Overall Study|Withdrawal by Subject|8|||
124843508|NCT00548808|449056123|FG001|Overall Study|Withdrawal by Subject|4|||
124843509|NCT00548808|449056122|FG000|Overall Study|Physician Decision|6|||
124843510|NCT00548808|449056123|FG001|Overall Study|Physician Decision|3|||
124843511|NCT00548808|449056122|FG000|Overall Study|Adverse Event|4|||
124843512|NCT00548808|449056123|FG001|Overall Study|Adverse Event|5|||
124843513|NCT00548808|449056122|FG000|Overall Study|Death|2|||
124843514|NCT00548808|449056123|FG001|Overall Study|Death|0|||
124843515|NCT00548808|449056122|FG000|Overall Study|Entry Criteria Not Met|2|||
124843516|NCT00548808|449056123|FG001|Overall Study|Entry Criteria Not Met|2|||
124843517|NCT00548808|449056122|FG000|Overall Study|Lack of Efficacy|2|||
124843518|NCT00548808|449056123|FG001|Overall Study|Lack of Efficacy|0|||
124843519|NCT00548808|449056122|FG000|Overall Study|Sponsor Decision|1|||
124843520|NCT00548808|449056123|FG001|Overall Study|Sponsor Decision|1|||
124843521|NCT00749775|449056124|FG000|Overall Study|Protocol Violation|24|||
124843522|NCT00749775|449056124|FG000|Overall Study|Lost to Follow-up|36|||
124843523|NCT00749775|449056124|FG000|Overall Study|No visit after first day of treatment|44|||
124843524|NCT00749775|449056124|FG000|Overall Study|No drug administration|3|||
124843525|NCT01400841|449056125|FG000|Initial Study Phase (6 Months)|Death|1|||
124843526|NCT01400841|449056125|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
124843527|NCT00770120|449056126|FG000|Overall Study|Progression|31|||
124843528|NCT00770120|449056126|FG000|Overall Study|Adverse Event|11|||
124843529|NCT00770120|449056126|FG000|Overall Study|Not Protocol Specified|11|||
124843530|NCT00770120|449056126|FG000|Overall Study|Death|3|||
124843531|NCT00770120|449056126|FG000|Overall Study|Withdrawal by Subject|2|||
124843532|NCT00770120|449056126|FG000|Overall Study|Ineligible|1|||
124843533|NCT00770120|449056126|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
124843534|NCT00770120|449056126|FG000|Overall Study|Reason under Review|1|||
124843535|NCT00480636|449056127|FG000|Overall Study|Death|12|||
124843536|NCT00480636|449056127|FG000|Overall Study|Lost to Follow-up|4|||
124843537|NCT00480636|449056127|FG000|Overall Study|Other|2|||
124843538|NCT00480636|449056127|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
124843539|NCT02583256|449056130|FG000|Overall Study|Withdrawal by Subject|0|||
124843540|NCT02583256|449056131|FG001|Overall Study|Withdrawal by Subject|1|||
124843541|NCT02583256|449056132|FG002|Overall Study|Withdrawal by Subject|1|||
124843542|NCT02583256|449056133|FG003|Overall Study|Withdrawal by Subject|0|||
124843543|NCT02583256|449056130|FG000|Overall Study|Lost to Follow-up|1|||
124843544|NCT02583256|449056131|FG001|Overall Study|Lost to Follow-up|1|||
124843545|NCT02583256|449056132|FG002|Overall Study|Lost to Follow-up|0|||
124843546|NCT02583256|449056133|FG003|Overall Study|Lost to Follow-up|1|||
124843547|NCT02583256|449056130|FG000|Overall Study|Administrative/Other|2|||
124843548|NCT02583256|449056131|FG001|Overall Study|Administrative/Other|0|||
124843549|NCT02583256|449056132|FG002|Overall Study|Administrative/Other|1|||
124843550|NCT02583256|449056133|FG003|Overall Study|Administrative/Other|2|||
124843551|NCT04537806|449056134|FG000|Overall Study|Randomized but not treated|1|||
124843552|NCT04537806|449056135|FG001|Overall Study|Randomized but not treated|0|||
124843553|NCT04537806|449056134|FG000|Overall Study|Adverse Event|1|||
124843554|NCT04537806|449056135|FG001|Overall Study|Adverse Event|1|||
124843555|NCT05459129|449056136|FG000|Overall Study|Death|1|||
124843556|NCT05459129|449056137|FG001|Overall Study|Death|0|||
124843557|NCT05459129|449056136|FG000|Overall Study|Study Terminated By Sponsor|5|||
124843558|NCT05459129|449056137|FG001|Overall Study|Study Terminated By Sponsor|6|||
124843559|NCT04182100|449056138|FG000|Overall Study|Adverse Event|1|||
124843560|NCT04182100|449056138|FG000|Overall Study|Withdrawal by Subject|1|||
124843561|NCT04083976|449056140|FG000|Overall Study|Lost to Follow-up|3|||
124843562|NCT04083976|449056141|FG001|Overall Study|Lost to Follow-up|0|||
124843563|NCT04083976|449056142|FG002|Overall Study|Lost to Follow-up|0|||
124843564|NCT04083976|449056143|FG003|Overall Study|Lost to Follow-up|1|||
124843565|NCT04083976|449056140|FG000|Overall Study|Withdrawal by Subject|16|||
124843566|NCT04083976|449056141|FG001|Overall Study|Withdrawal by Subject|1|||
124843567|NCT04083976|449056142|FG002|Overall Study|Withdrawal by Subject|9|||
124843568|NCT04083976|449056143|FG003|Overall Study|Withdrawal by Subject|0|||
124843569|NCT04083976|449056140|FG000|Overall Study|Sponsor Decision|14|||
124843570|NCT04083976|449056141|FG001|Overall Study|Sponsor Decision|0|||
124843571|NCT04083976|449056142|FG002|Overall Study|Sponsor Decision|0|||
124843572|NCT04083976|449056143|FG003|Overall Study|Sponsor Decision|7|||
124843573|NCT04083976|449056140|FG000|Overall Study|Other|1|||
124843574|NCT04083976|449056141|FG001|Overall Study|Other|0|||
124843575|NCT04083976|449056142|FG002|Overall Study|Other|1|||
124843576|NCT04083976|449056143|FG003|Overall Study|Other|0|||
124843577|NCT05358821|449056144|FG000|Overall Study|Withdrawal by Subject|0|||
124843578|NCT05358821|449056145|FG001|Overall Study|Withdrawal by Subject|1|||
124843579|NCT05358821|449056146|FG002|Overall Study|Withdrawal by Subject|0|||
124843580|NCT05358821|449056144|FG000|Overall Study|Withdrawal of Consent|0|||
124843581|NCT05358821|449056145|FG001|Overall Study|Withdrawal of Consent|0|||
124843582|NCT05358821|449056146|FG002|Overall Study|Withdrawal of Consent|1|||
124843583|NCT02504372|449056147|FG000|Overall Study|Death|136|||
124843584|NCT02504372|449056148|FG001|Overall Study|Death|154|||
124843585|NCT02504372|449056147|FG000|Overall Study|Lost to Follow-up|0|||
124843586|NCT02504372|449056148|FG001|Overall Study|Lost to Follow-up|2|||
124843587|NCT02504372|449056147|FG000|Overall Study|Withdrawal of consent|25|||
124843588|NCT02504372|449056148|FG001|Overall Study|Withdrawal of consent|16|||
124843589|NCT02504372|449056147|FG000|Overall Study|Participants ongoing|429|||
124843590|NCT02504372|449056148|FG001|Overall Study|Participants ongoing|415|||
124843591|NCT03901963|449056149|FG000|Overall Study|Lost to Follow-up|1|||
124843592|NCT03901963|449056150|FG001|Overall Study|Lost to Follow-up|1|||
124843593|NCT03901963|449056149|FG000|Overall Study|Physician Decision|1|||
124843594|NCT03901963|449056150|FG001|Overall Study|Physician Decision|2|||
124843595|NCT03901963|449056149|FG000|Overall Study|Protocol Violation|1|||
124843596|NCT03901963|449056150|FG001|Overall Study|Protocol Violation|1|||
124843597|NCT03901963|449056149|FG000|Overall Study|Withdrawal by Subject|4|||
124843598|NCT03901963|449056150|FG001|Overall Study|Withdrawal by Subject|11|||
124843599|NCT03901963|449056149|FG000|Overall Study|Ongoing|84|||
124843600|NCT03901963|449056150|FG001|Overall Study|Ongoing|73|||
124843601|NCT03901963|449056149|FG000|Overall Study|Randomized but not treated|3|||
124843602|NCT03901963|449056150|FG001|Overall Study|Randomized but not treated|3|||
124843603|NCT02365597|449056162|FG000|Overall Study|Lost to Follow-up|0|||
124843604|NCT02365597|449056163|FG001|Overall Study|Lost to Follow-up|1|||
124843605|NCT02365597|449056164|FG002|Overall Study|Lost to Follow-up|0|||
124843606|NCT02365597|449056165|FG003|Overall Study|Lost to Follow-up|1|||
124843607|NCT02365597|449056162|FG000|Overall Study|Withdrawal by Subject|1|||
124843608|NCT02365597|449056163|FG001|Overall Study|Withdrawal by Subject|8|||
124843609|NCT02365597|449056164|FG002|Overall Study|Withdrawal by Subject|5|||
124843610|NCT02365597|449056165|FG003|Overall Study|Withdrawal by Subject|1|||
124843611|NCT02365597|449056162|FG000|Overall Study|Sponsor's decision|1|||
124843612|NCT02365597|449056163|FG001|Overall Study|Sponsor's decision|3|||
124843613|NCT02365597|449056164|FG002|Overall Study|Sponsor's decision|13|||
124843614|NCT02365597|449056165|FG003|Overall Study|Sponsor's decision|0|||
124843615|NCT02365597|449056162|FG000|Overall Study|Other|0|||
124843616|NCT02365597|449056163|FG001|Overall Study|Other|4|||
124843617|NCT02365597|449056164|FG002|Overall Study|Other|0|||
124843618|NCT02365597|449056165|FG003|Overall Study|Other|0|||
124843619|NCT02365597|449056162|FG000|Overall Study|Enrolled but not treated|0|||
124843620|NCT02365597|449056163|FG001|Overall Study|Enrolled but not treated|1|||
124843621|NCT02365597|449056164|FG002|Overall Study|Enrolled but not treated|1|||
124843622|NCT02365597|449056165|FG003|Overall Study|Enrolled but not treated|0|||
124843623|NCT02365597|449056162|FG000|Overall Study|Ongoing|0|||
124843624|NCT02365597|449056163|FG001|Overall Study|Ongoing|0|||
124843625|NCT02365597|449056164|FG002|Overall Study|Ongoing|0|||
124843626|NCT02365597|449056165|FG003|Overall Study|Ongoing|17|||
124843627|NCT05132127|449056166|FG000|Overall Study|Adverse Event|1|||
124843628|NCT05619692|449056167|FG000|Overall Study|Adverse Event|2|||
124843629|NCT05619692|449056168|FG001|Overall Study|Adverse Event|2|||
124843630|NCT05619692|449056167|FG000|Overall Study|Withdrawal by Participant|3|||
124843631|NCT05619692|449056168|FG001|Overall Study|Withdrawal by Participant|4|||
124843632|NCT05619692|449056167|FG000|Overall Study|Lost to Follow-up|2|||
124843633|NCT05619692|449056168|FG001|Overall Study|Lost to Follow-up|1|||
124843634|NCT05619692|449056167|FG000|Overall Study|Randomized but not treated|1|||
124843635|NCT05619692|449056168|FG001|Overall Study|Randomized but not treated|3|||
124843636|NCT01946204|449056169|FG000|Overall Study|Death|38|||
124843637|NCT01946204|449056170|FG001|Overall Study|Death|59|||
124843638|NCT01946204|449056169|FG000|Overall Study|Withdrawal by Subject|37|||
124843639|NCT01946204|449056170|FG001|Overall Study|Withdrawal by Subject|50|||
124843640|NCT01946204|449056169|FG000|Overall Study|Lost to Follow-up|3|||
124843641|NCT01946204|449056170|FG001|Overall Study|Lost to Follow-up|7|||
124843642|NCT01946204|449056169|FG000|Overall Study|Ongoing|316|||
124843643|NCT01946204|449056170|FG001|Overall Study|Ongoing|687|||
124843644|NCT01946204|449056169|FG000|Overall Study|Other|7|||
124843645|NCT01946204|449056170|FG001|Overall Study|Other|3|||
124843646|NCT03466411|449056171|FG000|Overall Study|Lost to Follow-up|0|||
124843647|NCT03466411|449056172|FG001|Overall Study|Lost to Follow-up|1|||
124843648|NCT03466411|449056173|FG002|Overall Study|Lost to Follow-up|1|||
124843649|NCT03466411|449056174|FG003|Overall Study|Lost to Follow-up|0|||
124843650|NCT03466411|449056175|FG004|Overall Study|Lost to Follow-up|0|||
124843651|NCT03466411|449056176|FG005|Overall Study|Lost to Follow-up|0|||
124843652|NCT03466411|449056177|FG006|Overall Study|Lost to Follow-up|1|||
124843653|NCT03466411|449056178|FG007|Overall Study|Lost to Follow-up|1|||
124843654|NCT03466411|449056179|FG008|Overall Study|Lost to Follow-up|0|||
124843655|NCT03466411|449056180|FG009|Overall Study|Lost to Follow-up|1|||
124843656|NCT03466411|449056181|FG010|Overall Study|Lost to Follow-up|1|||
124843657|NCT03466411|449056182|FG011|Overall Study|Lost to Follow-up|1|||
124843658|NCT03466411|449056183|FG012|Overall Study|Lost to Follow-up|0|||
124843659|NCT03466411|449056171|FG000|Overall Study|Withdrawal by Subject|14|||
124843660|NCT03466411|449056172|FG001|Overall Study|Withdrawal by Subject|7|||
124843661|NCT03466411|449056173|FG002|Overall Study|Withdrawal by Subject|8|||
124843662|NCT03466411|449056174|FG003|Overall Study|Withdrawal by Subject|4|||
124843663|NCT03466411|449056175|FG004|Overall Study|Withdrawal by Subject|6|||
124843664|NCT03466411|449056176|FG005|Overall Study|Withdrawal by Subject|3|||
124843665|NCT03466411|449056177|FG006|Overall Study|Withdrawal by Subject|6|||
124843666|NCT03466411|449056178|FG007|Overall Study|Withdrawal by Subject|9|||
124843667|NCT03466411|449056179|FG008|Overall Study|Withdrawal by Subject|6|||
124843668|NCT03466411|449056180|FG009|Overall Study|Withdrawal by Subject|11|||
124843669|NCT03466411|449056181|FG010|Overall Study|Withdrawal by Subject|14|||
124843670|NCT03466411|449056182|FG011|Overall Study|Withdrawal by Subject|12|||
124843671|NCT03466411|449056183|FG012|Overall Study|Withdrawal by Subject|7|||
124843672|NCT03466411|449056171|FG000|Overall Study|Other|1|||
124843673|NCT03466411|449056172|FG001|Overall Study|Other|1|||
124843674|NCT03466411|449056173|FG002|Overall Study|Other|0|||
124843675|NCT03466411|449056174|FG003|Overall Study|Other|1|||
124843676|NCT03466411|449056175|FG004|Overall Study|Other|2|||
124843677|NCT03466411|449056176|FG005|Overall Study|Other|0|||
124843678|NCT03466411|449056177|FG006|Overall Study|Other|0|||
124843679|NCT03466411|449056178|FG007|Overall Study|Other|0|||
124843680|NCT03466411|449056179|FG008|Overall Study|Other|0|||
124843681|NCT03466411|449056180|FG009|Overall Study|Other|1|||
124843682|NCT03466411|449056181|FG010|Overall Study|Other|2|||
124843683|NCT03466411|449056182|FG011|Overall Study|Other|0|||
124843684|NCT03466411|449056183|FG012|Overall Study|Other|0|||
124843685|NCT03466411|449056171|FG000|Overall Study|Randomized but not Treated|0|||
124843686|NCT03466411|449056172|FG001|Overall Study|Randomized but not Treated|0|||
124843687|NCT03466411|449056173|FG002|Overall Study|Randomized but not Treated|0|||
124843688|NCT03466411|449056174|FG003|Overall Study|Randomized but not Treated|0|||
124843689|NCT03466411|449056175|FG004|Overall Study|Randomized but not Treated|0|||
124843690|NCT03466411|449056176|FG005|Overall Study|Randomized but not Treated|0|||
124843691|NCT03466411|449056177|FG006|Overall Study|Randomized but not Treated|1|||
124843692|NCT03466411|449056178|FG007|Overall Study|Randomized but not Treated|0|||
124843693|NCT03466411|449056179|FG008|Overall Study|Randomized but not Treated|0|||
124843694|NCT03466411|449056180|FG009|Overall Study|Randomized but not Treated|0|||
124843695|NCT03466411|449056181|FG010|Overall Study|Randomized but not Treated|0|||
124843696|NCT03466411|449056182|FG011|Overall Study|Randomized but not Treated|0|||
124843697|NCT03466411|449056183|FG012|Overall Study|Randomized but not Treated|0|||
124843698|NCT03778931|449056184|FG000|Overall Study|Withdrawal by Subject|12|||
124843699|NCT03778931|449056185|FG001|Overall Study|Withdrawal by Subject|25|||
124843700|NCT03778931|449056184|FG000|Overall Study|Physician Decision|1|||
124843701|NCT03778931|449056185|FG001|Overall Study|Physician Decision|3|||
124843702|NCT03778931|449056184|FG000|Overall Study|Participant Noncompliance|1|||
124843703|NCT03778931|449056185|FG001|Overall Study|Participant Noncompliance|1|||
124843704|NCT03778931|449056184|FG000|Overall Study|Lost to Follow-up|4|||
124843705|NCT03778931|449056185|FG001|Overall Study|Lost to Follow-up|1|||
124843706|NCT03778931|449056184|FG000|Overall Study|Death|69|||
124843707|NCT03778931|449056185|FG001|Overall Study|Death|79|||
124843708|NCT02115282|449056186|FG000|Overall Study|Disease progression during treatment|216|||
124843709|NCT02115282|449056187|FG001|Overall Study|Disease progression during treatment|229|||
124843710|NCT02115282|449056186|FG000|Overall Study|Adverse Event|49|||
124843711|NCT02115282|449056187|FG001|Overall Study|Adverse Event|23|||
124843712|NCT02115282|449056186|FG000|Overall Study|Death|1|||
124843713|NCT02115282|449056187|FG001|Overall Study|Death|3|||
124843714|NCT02115282|449056186|FG000|Overall Study|Alternative therapy|1|||
124843715|NCT02115282|449056187|FG001|Overall Study|Alternative therapy|1|||
124843716|NCT02115282|449056186|FG000|Overall Study|Complicating disease|0|||
124843717|NCT02115282|449056187|FG001|Overall Study|Complicating disease|3|||
124843718|NCT02115282|449056186|FG000|Overall Study|Withdrawal by Subject|12|||
124843719|NCT02115282|449056187|FG001|Overall Study|Withdrawal by Subject|10|||
124843720|NCT02115282|449056186|FG000|Overall Study|Symptomatic progression/deterioration|7|||
124843721|NCT02115282|449056187|FG001|Overall Study|Symptomatic progression/deterioration|18|||
124843722|NCT02115282|449056186|FG000|Overall Study|Non-compliance|5|||
124843723|NCT02115282|449056187|FG001|Overall Study|Non-compliance|1|||
124843724|NCT02115282|449056186|FG000|Overall Study|Protocol Violation|2|||
124843725|NCT02115282|449056187|FG001|Overall Study|Protocol Violation|2|||
124843726|NCT02115282|449056186|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
124843727|NCT02115282|449056187|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
124843728|NCT02115282|449056186|FG000|Overall Study|Not start protocol therapy|9|||
124843729|NCT02115282|449056187|FG001|Overall Study|Not start protocol therapy|10|||
124843730|NCT03431350|449056188|FG000|Overall Study|ONGOING|0|||
124843731|NCT03431350|449056189|FG001|Overall Study|ONGOING|0|||
124843732|NCT03431350|449056190|FG002|Overall Study|ONGOING|2|||
124843733|NCT03431350|449056191|FG003|Overall Study|ONGOING|0|||
124843734|NCT03431350|449056192|FG004|Overall Study|ONGOING|1|||
124843735|NCT03431350|449056193|FG005|Overall Study|ONGOING|3|||
124843736|NCT03431350|449056194|FG006|Overall Study|ONGOING|0|||
124843737|NCT03431350|449056195|FG007|Overall Study|ONGOING|1|||
124843738|NCT03431350|449056196|FG008|Overall Study|ONGOING|3|||
124843739|NCT03431350|449056197|FG009|Overall Study|ONGOING|4|||
124843740|NCT03431350|449056198|FG010|Overall Study|ONGOING|2|||
124843741|NCT03431350|449056199|FG011|Overall Study|ONGOING|1|||
124843742|NCT03431350|449056188|FG000|Overall Study|Death|6|||
124843743|NCT03431350|449056189|FG001|Overall Study|Death|5|||
124843744|NCT03431350|449056190|FG002|Overall Study|Death|18|||
124843745|NCT03431350|449056191|FG003|Overall Study|Death|7|||
124843746|NCT03431350|449056192|FG004|Overall Study|Death|4|||
124843747|NCT03431350|449056193|FG005|Overall Study|Death|3|||
124843748|NCT03431350|449056194|FG006|Overall Study|Death|2|||
124843749|NCT03431350|449056195|FG007|Overall Study|Death|0|||
124843750|NCT03431350|449056196|FG008|Overall Study|Death|0|||
124843751|NCT03431350|449056197|FG009|Overall Study|Death|0|||
124843752|NCT03431350|449056198|FG010|Overall Study|Death|4|||
124843753|NCT03431350|449056199|FG011|Overall Study|Death|0|||
124843754|NCT03431350|449056188|FG000|Overall Study|Lost to Follow-up|0|||
124843755|NCT03431350|449056189|FG001|Overall Study|Lost to Follow-up|1|||
124843756|NCT03431350|449056190|FG002|Overall Study|Lost to Follow-up|0|||
124843757|NCT03431350|449056191|FG003|Overall Study|Lost to Follow-up|0|||
124843758|NCT03431350|449056192|FG004|Overall Study|Lost to Follow-up|0|||
124843759|NCT03431350|449056193|FG005|Overall Study|Lost to Follow-up|0|||
124843760|NCT03431350|449056194|FG006|Overall Study|Lost to Follow-up|0|||
124640168|NCT02308540|448299895|FG004|Overall Study|Lost to Follow-up|0|||
124640169|NCT02308540|448299896|FG005|Overall Study|Lost to Follow-up|1|||
124843761|NCT03431350|449056195|FG007|Overall Study|Lost to Follow-up|0|||
124843762|NCT03431350|449056196|FG008|Overall Study|Lost to Follow-up|0|||
124843763|NCT03431350|449056197|FG009|Overall Study|Lost to Follow-up|0|||
124843764|NCT03431350|449056198|FG010|Overall Study|Lost to Follow-up|0|||
124843765|NCT03431350|449056199|FG011|Overall Study|Lost to Follow-up|0|||
124843766|NCT03431350|449056188|FG000|Overall Study|Withdrawal by Subject|0|||
124843767|NCT03431350|449056189|FG001|Overall Study|Withdrawal by Subject|0|||
124843768|NCT03431350|449056190|FG002|Overall Study|Withdrawal by Subject|0|||
124843769|NCT03431350|449056191|FG003|Overall Study|Withdrawal by Subject|1|||
124843770|NCT03431350|449056192|FG004|Overall Study|Withdrawal by Subject|1|||
124843771|NCT03431350|449056193|FG005|Overall Study|Withdrawal by Subject|1|||
124843772|NCT03431350|449056194|FG006|Overall Study|Withdrawal by Subject|0|||
124843773|NCT03431350|449056195|FG007|Overall Study|Withdrawal by Subject|0|||
124843774|NCT03431350|449056196|FG008|Overall Study|Withdrawal by Subject|0|||
124843775|NCT03431350|449056197|FG009|Overall Study|Withdrawal by Subject|2|||
124843776|NCT03431350|449056198|FG010|Overall Study|Withdrawal by Subject|0|||
124843777|NCT03431350|449056199|FG011|Overall Study|Withdrawal by Subject|1|||
124843778|NCT03431350|449056188|FG000|Overall Study|Other|0|||
124843779|NCT03431350|449056189|FG001|Overall Study|Other|0|||
124843780|NCT03431350|449056190|FG002|Overall Study|Other|1|||
124843781|NCT03431350|449056191|FG003|Overall Study|Other|3|||
124843782|NCT03431350|449056192|FG004|Overall Study|Other|2|||
124843783|NCT03431350|449056193|FG005|Overall Study|Other|2|||
124843784|NCT03431350|449056194|FG006|Overall Study|Other|4|||
124843785|NCT03431350|449056195|FG007|Overall Study|Other|0|||
124843786|NCT03431350|449056196|FG008|Overall Study|Other|14|||
124843787|NCT03431350|449056197|FG009|Overall Study|Other|11|||
124843788|NCT03431350|449056198|FG010|Overall Study|Other|11|||
124843789|NCT03431350|449056199|FG011|Overall Study|Other|15|||
124843790|NCT04325828|449056200|FG000|Overall Study|Ongoing|26|||
124843791|NCT04602624|449056205|FG000|Overall Study|Protocol Deviation|1|||
124843792|NCT04602624|449056205|FG000|Overall Study|Withdrawal by Participant|1|||
124843793|NCT04084769|449056206|FG000|Overall Study|Protocol Violation|1|||
124843794|NCT04084769|449056207|FG001|Overall Study|Protocol Violation|3|||
124843795|NCT04084769|449056208|FG002|Overall Study|Protocol Violation|0|||
124843796|NCT04084769|449056209|FG003|Overall Study|Protocol Violation|1|||
124843797|NCT04084769|449056206|FG000|Overall Study|Withdrawal by Subject|0|||
124843798|NCT04084769|449056207|FG001|Overall Study|Withdrawal by Subject|1|||
124843799|NCT04084769|449056208|FG002|Overall Study|Withdrawal by Subject|0|||
124843800|NCT04084769|449056209|FG003|Overall Study|Withdrawal by Subject|0|||
124843801|NCT04084769|449056206|FG000|Overall Study|Withdrawal by parent/guardian|1|||
124843802|NCT04084769|449056207|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124843803|NCT04084769|449056208|FG002|Overall Study|Withdrawal by parent/guardian|0|||
124843804|NCT04084769|449056209|FG003|Overall Study|Withdrawal by parent/guardian|1|||
124843805|NCT04084769|449056206|FG000|Overall Study|Lost to Follow-up|2|||
124843806|NCT04084769|449056207|FG001|Overall Study|Lost to Follow-up|0|||
124843807|NCT04084769|449056208|FG002|Overall Study|Lost to Follow-up|0|||
124843808|NCT04084769|449056209|FG003|Overall Study|Lost to Follow-up|0|||
124843809|NCT03492177|449056210|FG000|Overall Study|Adverse Event|1|||
124843810|NCT03492177|449056211|FG001|Overall Study|Adverse Event|0|||
124843811|NCT03492177|449056212|FG002|Overall Study|Adverse Event|0|||
124843812|NCT03492177|449056210|FG000|Overall Study|Death|3|||
124843813|NCT03492177|449056211|FG001|Overall Study|Death|0|||
124843814|NCT03492177|449056212|FG002|Overall Study|Death|3|||
124843815|NCT03492177|449056210|FG000|Overall Study|Lack of Efficacy|1|||
124843816|NCT03492177|449056211|FG001|Overall Study|Lack of Efficacy|2|||
124843817|NCT03492177|449056212|FG002|Overall Study|Lack of Efficacy|0|||
124843818|NCT03492177|449056210|FG000|Overall Study|Other|1|||
124843819|NCT03492177|449056211|FG001|Overall Study|Other|0|||
124843820|NCT03492177|449056212|FG002|Overall Study|Other|0|||
124843821|NCT03492177|449056210|FG000|Overall Study|Ongoing|16|||
124843822|NCT03492177|449056211|FG001|Overall Study|Ongoing|19|||
124843823|NCT03492177|449056212|FG002|Overall Study|Ongoing|17|||
124843824|NCT06425458|449056213|FG000|Overall Study|Removed by study team|2|||
124843825|NCT06425458|449056213|FG000|Overall Study|Lost to Follow-up|5|||
124843826|NCT03945981|449056214|FG000|Overall Study|Lost to Follow-up|12|||
124843827|NCT03945981|449056214|FG000|Overall Study|Physician Decision|4|||
124843828|NCT03945981|449056214|FG000|Overall Study|Withdrawal by Subject|6|||
124843829|NCT03945981|449056214|FG000|Overall Study|Protocol Violation|1|||
124843830|NCT03665038|449056215|FG000|Overall Study|Lost to Follow-up|0|||
124843831|NCT03665038|449056216|FG001|Overall Study|Lost to Follow-up|0|||
124843832|NCT03665038|449056217|FG002|Overall Study|Lost to Follow-up|1|||
124843833|NCT04466891|449056218|FG000|Overall Study|Death|60|||
124843834|NCT04466891|449056219|FG001|Overall Study|Death|6|||
124843835|NCT04466891|449056218|FG000|Overall Study|Withdrawal by Subject|8|||
124843836|NCT04466891|449056219|FG001|Overall Study|Withdrawal by Subject|1|||
124843837|NCT04466891|449056218|FG000|Overall Study|Study terminated by sponsor|5|||
124843838|NCT04466891|449056219|FG001|Overall Study|Study terminated by sponsor|0|||
124843839|NCT04466891|449056218|FG000|Overall Study|Lost to Follow-up|2|||
124843840|NCT04466891|449056219|FG001|Overall Study|Lost to Follow-up|0|||
124843841|NCT04466891|449056218|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
124843842|NCT04466891|449056219|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
124843843|NCT00445328|449056220|FG000|Overall Study|Death|0|||
124843844|NCT00445328|449056221|FG001|Overall Study|Death|1|||
124843845|NCT00445328|449056220|FG000|Overall Study|Adverse Event|0|||
124843846|NCT00445328|449056221|FG001|Overall Study|Adverse Event|3|||
124843847|NCT00445328|449056220|FG000|Overall Study|Other|0|||
124843848|NCT00445328|449056221|FG001|Overall Study|Other|2|||
124843849|NCT00445328|449056220|FG000|Overall Study|Withdrawal by Subject|2|||
124843850|NCT00445328|449056221|FG001|Overall Study|Withdrawal by Subject|0|||
124843851|NCT00445328|449056220|FG000|Overall Study|Protocol Violation|1|||
124843852|NCT00445328|449056221|FG001|Overall Study|Protocol Violation|0|||
124843853|NCT00316199|449056224|FG000|Overall Study|Adverse Event|2|||
124843854|NCT00316199|449056224|FG000|Overall Study|Death|8|||
124843855|NCT00316199|449056224|FG000|Overall Study|Lost to Follow-up|2|||
124843856|NCT00590954|449056225|FG000|Overall Study|Inevaluable|2|||
124843857|NCT03890367|449056227|FG000|Overall Study|Withdrawal by parent/guardian|1|||
124843858|NCT03890367|449056228|FG001|Overall Study|Withdrawal by parent/guardian|3|||
124843859|NCT03890367|449056229|FG002|Overall Study|Withdrawal by parent/guardian|0|||
124843860|NCT03890367|449056227|FG000|Overall Study|Protocol deviation|2|||
124843861|NCT03890367|449056228|FG001|Overall Study|Protocol deviation|2|||
124843862|NCT03890367|449056229|FG002|Overall Study|Protocol deviation|1|||
124843863|NCT03890367|449056227|FG000|Overall Study|Lost to Follow-up|1|||
124843864|NCT03890367|449056228|FG001|Overall Study|Lost to Follow-up|1|||
124843865|NCT03890367|449056229|FG002|Overall Study|Lost to Follow-up|0|||
124843866|NCT01707004|449057782|FG000|Overall Study|Physician Decision|3|||
124843867|NCT04368429|449057783|FG000|Overall Study|Adverse Event|1|||
124843868|NCT04368429|449057784|FG001|Overall Study|Adverse Event|0|||
124843869|NCT03756558|449057787|FG000|Overall Study|Death|1|||
124843870|NCT03756558|449057787|FG000|Overall Study|Lost to Follow-up|2|||
124843871|NCT03756558|449057787|FG000|Overall Study|Withdrawal by Subject|2|||
124843872|NCT00326911|449057788|FG000|Overall Study|Hospitalization prior to treatment|0|||
124843873|NCT00326911|449057789|FG001|Overall Study|Hospitalization prior to treatment|1|||
124843874|NCT00326911|449057788|FG000|Overall Study|Physician decision prior to treatment|1|||
124843875|NCT00326911|449057789|FG001|Overall Study|Physician decision prior to treatment|0|||
124843876|NCT00326911|449057788|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
124843877|NCT00326911|449057789|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
124843878|NCT03019627|449057794|FG000|Overall Study|Adverse Event|8|||
124843879|NCT03019627|449057795|FG001|Overall Study|Adverse Event|0|||
124843880|NCT03019627|449057794|FG000|Overall Study|Unrelated to adverse event|1|||
124843881|NCT03019627|449057795|FG001|Overall Study|Unrelated to adverse event|3|||
124843882|NCT03019627|449057794|FG000|Overall Study|Lost to Follow-up|2|||
124843883|NCT03019627|449057795|FG001|Overall Study|Lost to Follow-up|1|||
124843884|NCT03019627|449057794|FG000|Overall Study|not compliance|2|||
124843885|NCT03019627|449057795|FG001|Overall Study|not compliance|2|||
124843886|NCT03019627|449057794|FG000|Overall Study|Other|2|||
124843887|NCT03019627|449057795|FG001|Overall Study|Other|2|||
124843888|NCT03364049|449057796|FG000|Overall Study|Death|6|||
124843889|NCT03364049|449057797|FG001|Overall Study|Death|4|||
124843890|NCT03364049|449057798|FG002|Overall Study|Death|5|||
124843891|NCT03364049|449057799|FG003|Overall Study|Death|14|||
124843892|NCT03364049|449057796|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
124843893|NCT03364049|449057797|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
124843894|NCT03364049|449057798|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
124843895|NCT03364049|449057799|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
124843896|NCT03364049|449057796|FG000|Overall Study|Withdrawal by Subject|0|||
124843897|NCT03364049|449057797|FG001|Overall Study|Withdrawal by Subject|1|||
124843898|NCT03364049|449057798|FG002|Overall Study|Withdrawal by Subject|1|||
124843899|NCT03364049|449057799|FG003|Overall Study|Withdrawal by Subject|1|||
124843900|NCT02953821|449057800|FG000|Overall Study|Adverse Event|0|||
124843901|NCT02953821|449057801|FG001|Overall Study|Adverse Event|4|||
124843902|NCT02953821|449057800|FG000|Overall Study|Death|1|||
124843903|NCT02953821|449057801|FG001|Overall Study|Death|0|||
124843904|NCT02953821|449057800|FG000|Overall Study|Progressive Disease|5|||
124843905|NCT02953821|449057801|FG001|Overall Study|Progressive Disease|1|||
124843906|NCT02953821|449057800|FG000|Overall Study|Lost to Follow-up|2|||
124843907|NCT02953821|449057801|FG001|Overall Study|Lost to Follow-up|0|||
124843908|NCT02953821|449057800|FG000|Overall Study|Physician Decision|1|||
124843909|NCT02953821|449057801|FG001|Overall Study|Physician Decision|1|||
124843910|NCT02953821|449057800|FG000|Overall Study|Withdrawal by Subject|3|||
124843911|NCT02953821|449057801|FG001|Overall Study|Withdrawal by Subject|3|||
124843912|NCT02953821|449057800|FG000|Overall Study|Change of address|0|||
124843913|NCT02953821|449057801|FG001|Overall Study|Change of address|1|||
124843914|NCT02953821|449057800|FG000|Overall Study|Lack of Efficacy|1|||
124843915|NCT02953821|449057801|FG001|Overall Study|Lack of Efficacy|0|||
124843916|NCT02953821|449057800|FG000|Overall Study|Out of state for indeterminate time|0|||
124843917|NCT02953821|449057801|FG001|Overall Study|Out of state for indeterminate time|1|||
124843918|NCT02953821|449057800|FG000|Overall Study|No improvement|0|||
124843919|NCT02953821|449057801|FG001|Overall Study|No improvement|1|||
124843920|NCT02953821|449057800|FG000|Overall Study|Refused follow-up visit|2|||
124843921|NCT02953821|449057801|FG001|Overall Study|Refused follow-up visit|1|||
124843922|NCT02103478|449057802|FG000|Overall Study|Adverse Event|0|||
124843923|NCT02103478|449057803|FG001|Overall Study|Adverse Event|0|||
124843924|NCT02103478|449057804|FG002|Overall Study|Adverse Event|1|||
124843925|NCT02103478|449057805|FG003|Overall Study|Adverse Event|1|||
124843926|NCT02103478|449057806|FG004|Overall Study|Adverse Event|2|||
124843927|NCT02103478|449057807|FG005|Overall Study|Adverse Event|1|||
124843928|NCT02103478|449057808|FG006|Overall Study|Adverse Event|0|||
124843929|NCT02103478|449057809|FG007|Overall Study|Adverse Event|0|||
124843930|NCT02103478|449057810|FG008|Overall Study|Adverse Event|0|||
124843931|NCT02103478|449057802|FG000|Overall Study|Death|2|||
124843932|NCT02103478|449057803|FG001|Overall Study|Death|2|||
124843933|NCT02103478|449057804|FG002|Overall Study|Death|1|||
124843934|NCT02103478|449057805|FG003|Overall Study|Death|1|||
124843935|NCT02103478|449057806|FG004|Overall Study|Death|5|||
124843936|NCT02103478|449057807|FG005|Overall Study|Death|15|||
124843937|NCT02103478|449057808|FG006|Overall Study|Death|14|||
124843938|NCT02103478|449057809|FG007|Overall Study|Death|10|||
124843939|NCT02103478|449057810|FG008|Overall Study|Death|11|||
124843940|NCT02103478|449057802|FG000|Overall Study|Progressive Disease|2|||
124843941|NCT02103478|449057803|FG001|Overall Study|Progressive Disease|1|||
124843942|NCT02103478|449057804|FG002|Overall Study|Progressive Disease|2|||
124843943|NCT02103478|449057805|FG003|Overall Study|Progressive Disease|0|||
124843944|NCT02103478|449057806|FG004|Overall Study|Progressive Disease|9|||
124843945|NCT02103478|449057807|FG005|Overall Study|Progressive Disease|1|||
124843946|NCT02103478|449057808|FG006|Overall Study|Progressive Disease|2|||
124843947|NCT02103478|449057809|FG007|Overall Study|Progressive Disease|0|||
124843948|NCT02103478|449057810|FG008|Overall Study|Progressive Disease|1|||
124843949|NCT02103478|449057802|FG000|Overall Study|Withdrawal by Subject|2|||
124843950|NCT02103478|449057803|FG001|Overall Study|Withdrawal by Subject|0|||
124843951|NCT02103478|449057804|FG002|Overall Study|Withdrawal by Subject|0|||
124843952|NCT02103478|449057805|FG003|Overall Study|Withdrawal by Subject|4|||
124843953|NCT02103478|449057806|FG004|Overall Study|Withdrawal by Subject|0|||
124843954|NCT02103478|449057807|FG005|Overall Study|Withdrawal by Subject|0|||
124843955|NCT02103478|449057808|FG006|Overall Study|Withdrawal by Subject|1|||
124843956|NCT02103478|449057809|FG007|Overall Study|Withdrawal by Subject|1|||
124843957|NCT02103478|449057810|FG008|Overall Study|Withdrawal by Subject|0|||
124843958|NCT02103478|449057802|FG000|Overall Study|Lost to Follow-up|0|||
124843959|NCT02103478|449057803|FG001|Overall Study|Lost to Follow-up|0|||
124843960|NCT02103478|449057804|FG002|Overall Study|Lost to Follow-up|0|||
124843961|NCT02103478|449057805|FG003|Overall Study|Lost to Follow-up|0|||
124843962|NCT02103478|449057806|FG004|Overall Study|Lost to Follow-up|0|||
124843963|NCT02103478|449057807|FG005|Overall Study|Lost to Follow-up|0|||
124843964|NCT02103478|449057808|FG006|Overall Study|Lost to Follow-up|0|||
124843965|NCT02103478|449057809|FG007|Overall Study|Lost to Follow-up|1|||
124843966|NCT02103478|449057810|FG008|Overall Study|Lost to Follow-up|0|||
124843967|NCT02103478|449057802|FG000|Overall Study|Other|1|||
124843968|NCT02103478|449057803|FG001|Overall Study|Other|3|||
124843969|NCT02103478|449057804|FG002|Overall Study|Other|2|||
124843970|NCT02103478|449057805|FG003|Overall Study|Other|0|||
124843971|NCT02103478|449057806|FG004|Overall Study|Other|3|||
124843972|NCT02103478|449057807|FG005|Overall Study|Other|8|||
124843973|NCT02103478|449057808|FG006|Overall Study|Other|8|||
124843974|NCT02103478|449057809|FG007|Overall Study|Other|4|||
124843975|NCT02103478|449057810|FG008|Overall Study|Other|2|||
124843976|NCT03219333|449057811|FG000|Overall Study|Withdrawal by Subject|9|||
124843977|NCT03219333|449057812|FG001|Overall Study|Withdrawal by Subject|4|||
124843978|NCT03219333|449057811|FG000|Overall Study|Lost to Follow-up|1|||
124843979|NCT03219333|449057812|FG001|Overall Study|Lost to Follow-up|1|||
124843980|NCT03219333|449057811|FG000|Overall Study|Death|104|||
124843981|NCT03219333|449057812|FG001|Overall Study|Death|72|||
124843982|NCT03219333|449057811|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
124843983|NCT03219333|449057812|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
124843984|NCT03219333|449057811|FG000|Overall Study|Other|2|||
124843985|NCT03219333|449057812|FG001|Overall Study|Other|2|||
124843986|NCT04530552|449057815|FG000|Overall Study|Physician Decision|0|||
124843987|NCT04530552|449057816|FG001|Overall Study|Physician Decision|1|||
124843988|NCT04530552|449057815|FG000|Overall Study|Withdrawal by Subject|0|||
124843989|NCT04530552|449057816|FG001|Overall Study|Withdrawal by Subject|1|||
124843990|NCT04530552|449057815|FG000|Overall Study|Adverse Event|0|||
124843991|NCT04530552|449057816|FG001|Overall Study|Adverse Event|1|||
124843992|NCT04530552|449057815|FG000|Overall Study|No surgery|0|||
124843993|NCT04530552|449057816|FG001|Overall Study|No surgery|1|||
124843994|NCT03748641|449057817|FG000|Overall Study|Ongoing|155|||
124843995|NCT03748641|449057818|FG001|Overall Study|Ongoing|148|||
124843996|NCT03748641|449057819|FG002|Overall Study|Ongoing|66|||
124843997|NCT03748641|449057820|FG003|Overall Study|Ongoing|79|||
124843998|NCT03748641|449057821|FG004|Overall Study|Ongoing|84|||
124843999|NCT03748641|449057817|FG000|Overall Study|Death|54|||
124844000|NCT03748641|449057818|FG001|Overall Study|Death|59|||
124844001|NCT03748641|449057819|FG002|Overall Study|Death|51|||
124844002|NCT03748641|449057820|FG003|Overall Study|Death|42|||
124844003|NCT03748641|449057821|FG004|Overall Study|Death|9|||
124844004|NCT03748641|449057817|FG000|Overall Study|Lost to Follow-up|0|||
124844005|NCT03748641|449057818|FG001|Overall Study|Lost to Follow-up|2|||
124844006|NCT03748641|449057819|FG002|Overall Study|Lost to Follow-up|1|||
124844007|NCT03748641|449057820|FG003|Overall Study|Lost to Follow-up|0|||
124844008|NCT03748641|449057821|FG004|Overall Study|Lost to Follow-up|0|||
124844009|NCT03748641|449057817|FG000|Overall Study|Withdrawal by Subject|3|||
124844010|NCT03748641|449057818|FG001|Overall Study|Withdrawal by Subject|2|||
124844011|NCT03748641|449057819|FG002|Overall Study|Withdrawal by Subject|5|||
124844012|NCT03748641|449057820|FG003|Overall Study|Withdrawal by Subject|3|||
124844013|NCT03748641|449057821|FG004|Overall Study|Withdrawal by Subject|2|||
124844014|NCT06034496|449057822|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
124844015|NCT06034496|449057823|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
124844016|NCT06034496|449057822|FG000|Overall Study|Withdrawal by Subject|5|||
124844017|NCT06034496|449057823|FG001|Overall Study|Withdrawal by Subject|4|||
124844018|NCT04397263|449057824|FG000|Overall Study|Withdrawal by Subject|2|||
124844019|NCT03277261|449057827|FG000|Overall Study|Adverse Event|17|||
124844020|NCT03277261|449057828|FG001|Overall Study|Adverse Event|1|||
124844021|NCT03277261|449057827|FG000|Overall Study|Participant Withdrawal of Consent|6|||
124844022|NCT03277261|449057828|FG001|Overall Study|Participant Withdrawal of Consent|15|||
124844023|NCT03277261|449057827|FG000|Overall Study|Investigator / Sponsor Decision|4|||
124844024|NCT03277261|449057828|FG001|Overall Study|Investigator / Sponsor Decision|2|||
124844025|NCT03277261|449057827|FG000|Overall Study|Pregnancy|2|||
124844026|NCT03277261|449057828|FG001|Overall Study|Pregnancy|0|||
124844027|NCT03277261|449057827|FG000|Overall Study|Lost to Follow-up|2|||
124844028|NCT03277261|449057828|FG001|Overall Study|Lost to Follow-up|2|||
124844029|NCT03277261|449057827|FG000|Overall Study|Lack of Efficacy|2|||
124844030|NCT03277261|449057828|FG001|Overall Study|Lack of Efficacy|2|||
124844031|NCT03277261|449057827|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
124844032|NCT03277261|449057828|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
124844033|NCT00499603|449057829|FG000|Overall Study|Adverse Event|0|||
124844034|NCT00499603|449057830|FG001|Overall Study|Adverse Event|1|||
124844035|NCT05179421|449057831|FG000|First Infusion Day|Adverse Event|1|||
124844036|NCT05179421|449057832|FG001|First Infusion Day|Adverse Event|0|||
124844037|NCT03473743|449057834|FG000|Overall Study|Withdrawal by Subject|0|||
124844038|NCT03473743|449057835|FG001|Overall Study|Withdrawal by Subject|0|||
124844039|NCT03473743|449057836|FG002|Overall Study|Withdrawal by Subject|0|||
124844040|NCT03473743|449057837|FG003|Overall Study|Withdrawal by Subject|0|||
124844041|NCT03473743|449057838|FG004|Overall Study|Withdrawal by Subject|0|||
124844042|NCT03473743|449057839|FG005|Overall Study|Withdrawal by Subject|0|||
124844043|NCT03473743|449057840|FG006|Overall Study|Withdrawal by Subject|0|||
124844044|NCT03473743|449057841|FG007|Overall Study|Withdrawal by Subject|3|||
124844045|NCT03473743|449057834|FG000|Overall Study|Other|0|||
124844046|NCT03473743|449057835|FG001|Overall Study|Other|0|||
124844047|NCT03473743|449057836|FG002|Overall Study|Other|0|||
124844048|NCT03473743|449057837|FG003|Overall Study|Other|1|||
124844049|NCT03473743|449057838|FG004|Overall Study|Other|0|||
124844050|NCT03473743|449057839|FG005|Overall Study|Other|0|||
124844051|NCT03473743|449057840|FG006|Overall Study|Other|0|||
124844052|NCT03473743|449057841|FG007|Overall Study|Other|0|||
124844053|NCT03473743|449057834|FG000|Overall Study|Ongoing|0|||
124844054|NCT03473743|449057835|FG001|Overall Study|Ongoing|0|||
124844055|NCT03473743|449057836|FG002|Overall Study|Ongoing|6|||
124844056|NCT03473743|449057837|FG003|Overall Study|Ongoing|8|||
124844057|NCT03473743|449057838|FG004|Overall Study|Ongoing|1|||
124844058|NCT03473743|449057839|FG005|Overall Study|Ongoing|1|||
124844059|NCT03473743|449057840|FG006|Overall Study|Ongoing|22|||
124844060|NCT03473743|449057841|FG007|Overall Study|Ongoing|24|||
124844061|NCT03473743|449057834|FG000|Overall Study|Randomized but not treated|0|||
124844062|NCT03473743|449057835|FG001|Overall Study|Randomized but not treated|0|||
124844063|NCT03473743|449057836|FG002|Overall Study|Randomized but not treated|0|||
124844064|NCT03473743|449057837|FG003|Overall Study|Randomized but not treated|0|||
124844065|NCT03473743|449057838|FG004|Overall Study|Randomized but not treated|0|||
124844066|NCT03473743|449057839|FG005|Overall Study|Randomized but not treated|0|||
124844067|NCT03473743|449057840|FG006|Overall Study|Randomized but not treated|1|||
124844068|NCT03473743|449057841|FG007|Overall Study|Randomized but not treated|1|||
124844069|NCT02052739|449057847|FG000|Overall Study|Withdrew due to Adverse Event|3|||
124844070|NCT02052739|449057848|FG001|Overall Study|Withdrew due to Adverse Event|0|||
124844071|NCT02052739|449057847|FG000|Overall Study|Participant Died|2|||
124844072|NCT02052739|449057848|FG001|Overall Study|Participant Died|1|||
124844073|NCT05267054|449057849|FG000|Overall Study|Death|13|||
124844074|NCT05267054|449057850|FG001|Overall Study|Death|14|||
124844075|NCT05267054|449057849|FG000|Overall Study|Study Ended by Sponsor|9|||
124844076|NCT05267054|449057850|FG001|Overall Study|Study Ended by Sponsor|13|||
124844077|NCT05267054|449057849|FG000|Overall Study|Lost to Follow-up|1|||
124844078|NCT05267054|449057850|FG001|Overall Study|Lost to Follow-up|1|||
124844079|NCT05267054|449057849|FG000|Overall Study|Withdrawal by Subject|1|||
124844080|NCT05267054|449057850|FG001|Overall Study|Withdrawal by Subject|1|||
124844081|NCT01552226|449057851|FG000|Overall Study|Withdrawal by Subject|4|||
124844082|NCT01552226|449057852|FG001|Overall Study|Withdrawal by Subject|4|||
124844083|NCT04697628|449057853|FG000|Overall Study|Withdrawal by Subject|17|||
124844084|NCT04697628|449057854|FG001|Overall Study|Withdrawal by Subject|23|||
124844085|NCT04697628|449057853|FG000|Overall Study|Lost to Follow-up|0|||
124844086|NCT04697628|449057854|FG001|Overall Study|Lost to Follow-up|4|||
124640170|NCT02285166|448299897|FG000|Overall Study|Case Report Forms Uncollected|564|||
124844087|NCT04697628|449057853|FG000|Overall Study|On-going in study|122|||
124844088|NCT04697628|449057854|FG001|Overall Study|On-going in study|91|||
124844089|NCT03604692|449057855|FG000|Overall Study|Investigator's Decision|0|||
124844090|NCT03604692|449057856|FG001|Overall Study|Investigator's Decision|0|||
124844091|NCT03604692|449057857|FG002|Overall Study|Investigator's Decision|0|||
124844092|NCT03604692|449057858|FG003|Overall Study|Investigator's Decision|1|||
124844093|NCT03604692|449057859|FG004|Overall Study|Investigator's Decision|0|||
124844094|NCT03604692|449057860|FG005|Overall Study|Investigator's Decision|7|||
124844095|NCT03604692|449057855|FG000|Overall Study|Withdrawal by Subject|0|||
124844096|NCT03604692|449057856|FG001|Overall Study|Withdrawal by Subject|0|||
124844097|NCT03604692|449057857|FG002|Overall Study|Withdrawal by Subject|0|||
124844098|NCT03604692|449057858|FG003|Overall Study|Withdrawal by Subject|0|||
124844099|NCT03604692|449057859|FG004|Overall Study|Withdrawal by Subject|0|||
124844100|NCT03604692|449057860|FG005|Overall Study|Withdrawal by Subject|2|||
124844101|NCT03604692|449057855|FG000|Overall Study|Progressive Disease|1|||
124844102|NCT03604692|449057856|FG001|Overall Study|Progressive Disease|0|||
124844103|NCT03604692|449057857|FG002|Overall Study|Progressive Disease|1|||
124844104|NCT03604692|449057858|FG003|Overall Study|Progressive Disease|0|||
124844105|NCT03604692|449057859|FG004|Overall Study|Progressive Disease|3|||
124844106|NCT03604692|449057860|FG005|Overall Study|Progressive Disease|4|||
124844107|NCT03604692|449057855|FG000|Overall Study|Difficulty Coming into Site|0|||
124844108|NCT03604692|449057856|FG001|Overall Study|Difficulty Coming into Site|0|||
124844109|NCT03604692|449057857|FG002|Overall Study|Difficulty Coming into Site|0|||
124844110|NCT03604692|449057858|FG003|Overall Study|Difficulty Coming into Site|0|||
124844111|NCT03604692|449057859|FG004|Overall Study|Difficulty Coming into Site|0|||
124844112|NCT03604692|449057860|FG005|Overall Study|Difficulty Coming into Site|1|||
124844113|NCT03604692|449057855|FG000|Overall Study|Death|0|||
124844114|NCT03604692|449057856|FG001|Overall Study|Death|0|||
124844115|NCT03604692|449057857|FG002|Overall Study|Death|1|||
124844116|NCT03604692|449057858|FG003|Overall Study|Death|0|||
124844117|NCT03604692|449057859|FG004|Overall Study|Death|0|||
124844118|NCT03604692|449057860|FG005|Overall Study|Death|0|||
124844119|NCT03604692|449057855|FG000|Overall Study|Drug Intolerance|0|||
124844120|NCT03604692|449057856|FG001|Overall Study|Drug Intolerance|0|||
124844121|NCT03604692|449057857|FG002|Overall Study|Drug Intolerance|0|||
124844122|NCT03604692|449057858|FG003|Overall Study|Drug Intolerance|1|||
124844123|NCT03604692|449057859|FG004|Overall Study|Drug Intolerance|0|||
124844124|NCT03604692|449057860|FG005|Overall Study|Drug Intolerance|0|||
124844125|NCT03604692|449057855|FG000|Overall Study|Noncompliance with follow-up visit|0|||
124844126|NCT03604692|449057856|FG001|Overall Study|Noncompliance with follow-up visit|0|||
124844127|NCT03604692|449057857|FG002|Overall Study|Noncompliance with follow-up visit|0|||
124844128|NCT03604692|449057858|FG003|Overall Study|Noncompliance with follow-up visit|1|||
124844129|NCT03604692|449057859|FG004|Overall Study|Noncompliance with follow-up visit|0|||
124844130|NCT03604692|449057860|FG005|Overall Study|Noncompliance with follow-up visit|0|||
124844131|NCT03604692|449057855|FG000|Overall Study|Not Treated|0|||
124844132|NCT03604692|449057856|FG001|Overall Study|Not Treated|0|||
124844133|NCT03604692|449057857|FG002|Overall Study|Not Treated|0|||
124844134|NCT03604692|449057858|FG003|Overall Study|Not Treated|0|||
124844135|NCT03604692|449057859|FG004|Overall Study|Not Treated|1|||
124844136|NCT03604692|449057860|FG005|Overall Study|Not Treated|0|||
124640171|NCT02285166|448299897|FG000|Overall Study|Protocol Deviation|402|||
124640172|NCT00384839|448299898|FG000|Overall Study|Adverse Event|4|||
124640173|NCT00384839|448299898|FG000|Overall Study|Investigator Request|1|||
124640174|NCT00384839|448299898|FG000|Overall Study|Patient Request|1|||
124640175|NCT00384839|448299898|FG000|Overall Study|Ineligible|2|||
124640176|NCT02649439|448299899|FG000|Overall Study|Switched to alternative treatment|6|||
124640177|NCT02649439|448299900|FG001|Overall Study|Switched to alternative treatment|4|||
124640178|NCT02649439|448299899|FG000|Overall Study|Patient decision|1|||
124640179|NCT02649439|448299900|FG001|Overall Study|Patient decision|0|||
124640180|NCT02649439|448299899|FG000|Overall Study|Patient going out of country|1|||
124640181|NCT02649439|448299900|FG001|Overall Study|Patient going out of country|0|||
124640182|NCT02649439|448299899|FG000|Overall Study|To start finasteride|1|||
124640183|NCT02649439|448299900|FG001|Overall Study|To start finasteride|0|||
124640184|NCT02649439|448299899|FG000|Overall Study|Physician Decision|1|||
124640185|NCT02649439|448299900|FG001|Overall Study|Physician Decision|0|||
124640186|NCT02649439|448299899|FG000|Overall Study|Disease progression on study|12|||
124640187|NCT02649439|448299900|FG001|Overall Study|Disease progression on study|13|||
124640188|NCT02649439|448299899|FG000|Overall Study|Refused further treatment|1|||
124640189|NCT02649439|448299900|FG001|Overall Study|Refused further treatment|0|||
124640190|NCT02649439|448299899|FG000|Overall Study|Refused further follow up|2|||
124640191|NCT02649439|448299900|FG001|Overall Study|Refused further follow up|7|||
124640192|NCT02649439|448299899|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
124640193|NCT02649439|448299900|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
124640194|NCT02649439|448299899|FG000|Overall Study|No treatment, per protocol|1|||
124640195|NCT02649439|448299900|FG001|Overall Study|No treatment, per protocol|0|||
124640196|NCT02649439|448299899|FG000|Overall Study|PSA DT makes ineligible|0|||
124640197|NCT02649439|448299900|FG001|Overall Study|PSA DT makes ineligible|1|||
124640198|NCT02649439|448299899|FG000|Overall Study|Rising PSA No Mets|0|||
124640199|NCT02649439|448299900|FG001|Overall Study|Rising PSA No Mets|1|||
124640200|NCT02649439|448299899|FG000|Overall Study|Rising PSA|0|||
124640201|NCT02649439|448299900|FG001|Overall Study|Rising PSA|1|||
124640202|NCT02649439|448299899|FG000|Overall Study|Signed follow up protocol|0|||
124844137|NCT00006184|449057861|FG000|Overall Study|Death|1|||
124844138|NCT00006184|449057862|FG001|Overall Study|Death|0|||
124844139|NCT01110915|449057865|FG000|Overall Study|Death|2|||
124844140|NCT01110915|449057866|FG001|Overall Study|Death|1|||
124844141|NCT01110915|449057865|FG000|Overall Study|Lost to Follow-up|1|||
124844142|NCT01110915|449057866|FG001|Overall Study|Lost to Follow-up|0|||
124844143|NCT01110915|449057865|FG000|Overall Study|Withdrawal by Subject|7|||
124844144|NCT01110915|449057866|FG001|Overall Study|Withdrawal by Subject|1|||
124844145|NCT02161718|449057869|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
124844146|NCT02161718|449057870|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
124844147|NCT02161718|449057871|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
124844148|NCT02161718|449057869|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
124844149|NCT02161718|449057870|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
124844150|NCT02161718|449057871|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
124844151|NCT02161718|449057869|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
124844152|NCT02161718|449057870|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
124844153|NCT02161718|449057871|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
124844154|NCT02161718|449057869|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
124844155|NCT02161718|449057870|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
124844156|NCT02161718|449057871|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
124844157|NCT02161718|449057869|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
124844158|NCT02161718|449057870|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
124844159|NCT02161718|449057871|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
124844160|NCT02161718|449057869|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
124844161|NCT02161718|449057870|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
124844162|NCT02161718|449057871|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
124844163|NCT02161718|449057869|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
124844164|NCT02161718|449057870|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
124844165|NCT02161718|449057871|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
124844166|NCT02161718|449057869|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
124844167|NCT02161718|449057870|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
124844168|NCT02161718|449057871|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
124844169|NCT02161718|449057869|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
124844170|NCT02161718|449057870|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
124844171|NCT02161718|449057871|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
124844172|NCT02161718|449057869|FG000|Post- Randomization Period|Lost to Follow-up|0|||
124844173|NCT02161718|449057870|FG001|Post- Randomization Period|Lost to Follow-up|9|||
124844174|NCT02161718|449057871|FG002|Post- Randomization Period|Lost to Follow-up|15|||
124844175|NCT02161718|449057869|FG000|Post- Randomization Period|Adverse Event|0|||
124844176|NCT02161718|449057870|FG001|Post- Randomization Period|Adverse Event|9|||
124844177|NCT02161718|449057871|FG002|Post- Randomization Period|Adverse Event|10|||
124844178|NCT02161718|449057869|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
124844179|NCT02161718|449057870|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
124844180|NCT02161718|449057871|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
124844181|NCT02161718|449057869|FG000|Post- Randomization Period|Physician Decision|0|||
124844182|NCT02161718|449057870|FG001|Post- Randomization Period|Physician Decision|2|||
124844183|NCT02161718|449057871|FG002|Post- Randomization Period|Physician Decision|4|||
124844184|NCT02161718|449057869|FG000|Post- Randomization Period|Protocol Violation|0|||
124844185|NCT02161718|449057870|FG001|Post- Randomization Period|Protocol Violation|2|||
124844186|NCT02161718|449057871|FG002|Post- Randomization Period|Protocol Violation|3|||
124844187|NCT02161718|449057869|FG000|Post- Randomization Period|Lack of Efficacy|0|||
124844188|NCT02161718|449057870|FG001|Post- Randomization Period|Lack of Efficacy|0|||
124844189|NCT02161718|449057871|FG002|Post- Randomization Period|Lack of Efficacy|1|||
124844190|NCT02161718|449057869|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
124844191|NCT02161718|449057870|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
124844192|NCT02161718|449057871|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
124844193|NCT02161718|449057869|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
124844194|NCT02161718|449057870|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
124844195|NCT02161718|449057871|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
124844196|NCT02161718|449057869|FG000|Post- Randomization Period|Relocation|0|||
124844197|NCT02161718|449057870|FG001|Post- Randomization Period|Relocation|3|||
124844198|NCT02161718|449057871|FG002|Post- Randomization Period|Relocation|0|||
124844199|NCT00207142|449057874|FG000|Induction Phase|Adverse Event|9|||
124844200|NCT00207142|449057875|FG001|Induction Phase|Adverse Event|0|||
124844201|NCT00207142|449057876|FG002|Induction Phase|Adverse Event|0|||
124844202|NCT00207142|449057877|FG003|Induction Phase|Adverse Event|0|||
124844203|NCT00207142|449057874|FG000|Induction Phase|Death|1|||
124844204|NCT00207142|449057875|FG001|Induction Phase|Death|0|||
124844205|NCT00207142|449057876|FG002|Induction Phase|Death|0|||
124844206|NCT00207142|449057877|FG003|Induction Phase|Death|0|||
124844207|NCT00207142|449057874|FG000|Induction Phase|Lack of Efficacy|1|||
124640203|NCT02649439|448299900|FG001|Overall Study|Signed follow up protocol|1|||
124640204|NCT01862250|448299902|FG000|Overall Study|Adverse Event|4|||
124844208|NCT00207142|449057875|FG001|Induction Phase|Lack of Efficacy|0|||
124640205|NCT02016105|448299906|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
124844209|NCT00207142|449057876|FG002|Induction Phase|Lack of Efficacy|0|||
124844210|NCT00207142|449057877|FG003|Induction Phase|Lack of Efficacy|0|||
124844211|NCT00207142|449057874|FG000|Induction Phase|Lost to Follow-up|5|||
124844212|NCT00207142|449057875|FG001|Induction Phase|Lost to Follow-up|0|||
124844213|NCT00207142|449057876|FG002|Induction Phase|Lost to Follow-up|0|||
124844214|NCT00207142|449057877|FG003|Induction Phase|Lost to Follow-up|0|||
124844215|NCT00207142|449057874|FG000|Induction Phase|Physician Decision|2|||
124844216|NCT00207142|449057875|FG001|Induction Phase|Physician Decision|0|||
124844217|NCT00207142|449057876|FG002|Induction Phase|Physician Decision|0|||
124844218|NCT00207142|449057877|FG003|Induction Phase|Physician Decision|0|||
124844219|NCT00207142|449057874|FG000|Induction Phase|Poor/noncompliance|2|||
124844220|NCT00207142|449057875|FG001|Induction Phase|Poor/noncompliance|0|||
124844221|NCT00207142|449057876|FG002|Induction Phase|Poor/noncompliance|0|||
124844222|NCT00207142|449057877|FG003|Induction Phase|Poor/noncompliance|0|||
124844223|NCT00207142|449057874|FG000|Induction Phase|Pregnancy|1|||
124844224|NCT00207142|449057875|FG001|Induction Phase|Pregnancy|0|||
124844225|NCT00207142|449057876|FG002|Induction Phase|Pregnancy|0|||
124844226|NCT00207142|449057877|FG003|Induction Phase|Pregnancy|0|||
124844227|NCT00207142|449057874|FG000|Induction Phase|Subject no longer meets study criteria|3|||
124844228|NCT00207142|449057875|FG001|Induction Phase|Subject no longer meets study criteria|0|||
124844229|NCT00207142|449057876|FG002|Induction Phase|Subject no longer meets study criteria|0|||
124844230|NCT00207142|449057877|FG003|Induction Phase|Subject no longer meets study criteria|0|||
124844231|NCT00207142|449057874|FG000|Induction Phase|Withdrawal by Subject|4|||
124844232|NCT00207142|449057875|FG001|Induction Phase|Withdrawal by Subject|0|||
124844233|NCT00207142|449057876|FG002|Induction Phase|Withdrawal by Subject|0|||
124844234|NCT00207142|449057877|FG003|Induction Phase|Withdrawal by Subject|0|||
124844235|NCT00207142|449057874|FG000|Induction Phase|Incarceration|1|||
124844236|NCT00207142|449057875|FG001|Induction Phase|Incarceration|0|||
124844237|NCT00207142|449057876|FG002|Induction Phase|Incarceration|0|||
124844238|NCT00207142|449057877|FG003|Induction Phase|Incarceration|0|||
124844239|NCT00207142|449057874|FG000|Induction Phase|Missing lab data|1|||
124844240|NCT00207142|449057875|FG001|Induction Phase|Missing lab data|0|||
124844241|NCT00207142|449057876|FG002|Induction Phase|Missing lab data|0|||
124844242|NCT00207142|449057877|FG003|Induction Phase|Missing lab data|0|||
124844243|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
124844244|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
124844245|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
124844246|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
124844247|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
124844248|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
124844249|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
124844250|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
124844251|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
124844252|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
124844253|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
124844254|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
124844255|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
124844256|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
124844257|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
124844258|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
124844259|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
124844260|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
124844261|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
124844262|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
124844263|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
124844264|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
124844265|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
124844266|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
124844267|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
124844268|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
124844269|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
124844270|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
124844271|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|Death|0|||
124844272|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|Death|0|||
124844273|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|Death|0|||
124844274|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|Death|1|||
124844275|NCT00207142|449057874|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
124844276|NCT00207142|449057875|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
124844277|NCT00207142|449057876|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
124844278|NCT00207142|449057877|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
124844279|NCT01857063|449057878|FG000|Period 1 (7 Days)|Adverse Event|0|||
124844280|NCT01857063|449057879|FG001|Period 1 (7 Days)|Adverse Event|1|||
124844281|NCT01857063|449057878|FG000|Period 1 (7 Days)|Physician Decision|1|||
124844282|NCT01857063|449057879|FG001|Period 1 (7 Days)|Physician Decision|0|||
124844283|NCT01857063|449057878|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
124844284|NCT01857063|449057879|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
124844285|NCT01857063|449057878|FG000|Period 2 (7 Days)|Adverse Event|2|||
124844286|NCT01857063|449057879|FG001|Period 2 (7 Days)|Adverse Event|1|||
124844287|NCT01857063|449057878|FG000|Period 2 (7 Days)|Physician Decision|1|||
124844288|NCT01857063|449057879|FG001|Period 2 (7 Days)|Physician Decision|1|||
124844289|NCT01857063|449057878|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
124844290|NCT01857063|449057879|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
124844291|NCT04115358|449057882|FG000|Overall Study|exfoliation|0|||
124844292|NCT04115358|449057883|FG001|Overall Study|exfoliation|0|||
124844293|NCT04115358|449057884|FG002|Overall Study|exfoliation|1|||
124844294|NCT01205165|449057885|FG000|Overall Study|Lost to Follow-up|2|||
124844295|NCT03306264|449057888|FG000|Overall Study|Death|33|||
124844296|NCT03306264|449057889|FG001|Overall Study|Death|25|||
124844297|NCT03306264|449057890|FG002|Overall Study|Death|34|||
124844298|NCT03306264|449057891|FG003|Overall Study|Death|34|||
124844299|NCT03306264|449057888|FG000|Overall Study|Complete Consent Withdrawal|4|||
124844300|NCT03306264|449057889|FG001|Overall Study|Complete Consent Withdrawal|4|||
124844301|NCT03306264|449057890|FG002|Overall Study|Complete Consent Withdrawal|1|||
124844302|NCT03306264|449057891|FG003|Overall Study|Complete Consent Withdrawal|8|||
124844303|NCT03306264|449057888|FG000|Overall Study|Lost to Follow-up|1|||
124844304|NCT03306264|449057889|FG001|Overall Study|Lost to Follow-up|0|||
124844305|NCT03306264|449057890|FG002|Overall Study|Lost to Follow-up|1|||
124844306|NCT03306264|449057891|FG003|Overall Study|Lost to Follow-up|0|||
124844307|NCT03306264|449057888|FG000|Overall Study|Rollover to ASTX727-06|10|||
124844308|NCT03306264|449057889|FG001|Overall Study|Rollover to ASTX727-06|18|||
124844309|NCT03306264|449057890|FG002|Overall Study|Rollover to ASTX727-06|4|||
124844310|NCT03306264|449057891|FG003|Overall Study|Rollover to ASTX727-06|2|||
124844311|NCT03306264|449057888|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
124844312|NCT03306264|449057889|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
124844313|NCT03306264|449057890|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
124844314|NCT03306264|449057891|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
124844315|NCT00458484|449057892|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
124844316|NCT00458484|449057893|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
124844317|NCT00458484|449057894|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
124844318|NCT00458484|449057895|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
124844319|NCT00458484|449057896|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
124844320|NCT00458484|449057897|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
124844321|NCT00458484|449057898|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
124844322|NCT04538664|449057899|FG000|Overall Study|Withdrawal by Subject|5|||
124844323|NCT04538664|449057900|FG001|Overall Study|Withdrawal by Subject|9|||
124844324|NCT04538664|449057899|FG000|Overall Study|Lost to Follow-up|2|||
124844325|NCT04538664|449057900|FG001|Overall Study|Lost to Follow-up|1|||
124844326|NCT04538664|449057899|FG000|Overall Study|Ongoing|106|||
124844327|NCT04538664|449057900|FG001|Overall Study|Ongoing|115|||
124844328|NCT04136912|449057901|FG000|Overall Study|Operational reasons|0|||
124844329|NCT04136912|449057902|FG001|Overall Study|Operational reasons|0|||
124844330|NCT04136912|449057903|FG002|Overall Study|Operational reasons|2|||
124844331|NCT02448875|449057904|FG000|Overall Study|Adverse Event|2|||
124844332|NCT02448875|449057905|FG001|Overall Study|Adverse Event|1|||
124844333|NCT02448875|449057906|FG002|Overall Study|Adverse Event|0|||
124844334|NCT02448875|449057904|FG000|Overall Study|Lost to Follow-up|1|||
124844335|NCT02448875|449057905|FG001|Overall Study|Lost to Follow-up|0|||
124844336|NCT02448875|449057906|FG002|Overall Study|Lost to Follow-up|0|||
124844337|NCT02448875|449057904|FG000|Overall Study|Investigator Decision|3|||
124844338|NCT02448875|449057905|FG001|Overall Study|Investigator Decision|0|||
124844339|NCT02448875|449057906|FG002|Overall Study|Investigator Decision|1|||
124844340|NCT02448875|449057904|FG000|Overall Study|Withdrawal by Subject|1|||
124844341|NCT02448875|449057905|FG001|Overall Study|Withdrawal by Subject|0|||
124844342|NCT02448875|449057906|FG002|Overall Study|Withdrawal by Subject|0|||
124844343|NCT03390504|449057908|FG000|Overall Study|Lost to Follow-up|2|||
124844344|NCT03390504|449057909|FG001|Overall Study|Lost to Follow-up|4|||
124844345|NCT03390504|449057910|FG002|Overall Study|Lost to Follow-up|0|||
124844346|NCT03390504|449057911|FG003|Overall Study|Lost to Follow-up|1|||
124844347|NCT03390504|449057908|FG000|Overall Study|Withdrawal by Subject|3|||
124844348|NCT03390504|449057909|FG001|Overall Study|Withdrawal by Subject|15|||
124844349|NCT03390504|449057910|FG002|Overall Study|Withdrawal by Subject|5|||
124844350|NCT03390504|449057911|FG003|Overall Study|Withdrawal by Subject|2|||
124844351|NCT03390504|449057908|FG000|Overall Study|Other|1|||
124844352|NCT03390504|449057909|FG001|Overall Study|Other|2|||
124844353|NCT03390504|449057910|FG002|Overall Study|Other|2|||
124844354|NCT03390504|449057911|FG003|Overall Study|Other|6|||
124844355|NCT03508219|449057912|FG000|Overall Study|Death|2|||
124844356|NCT03508219|449057912|FG000|Overall Study|Withdrawal by Subject|1|||
124844357|NCT03508219|449057912|FG000|Overall Study|Lost to Follow-up|4|||
124844358|NCT03508219|449057912|FG000|Overall Study|Missed visit|2|||
124844359|NCT02782949|449057915|FG000|Overall Study|Protocol Violation|1|||
124844360|NCT02782949|449057916|FG001|Overall Study|Protocol Violation|0|||
124844361|NCT02782949|449057915|FG000|Overall Study|Withdrawal by Subject|0|||
124844362|NCT02782949|449057916|FG001|Overall Study|Withdrawal by Subject|1|||
124844363|NCT05645432|449057917|FG000|Overall Study|Withdrawal by Subject|1|||
124844364|NCT03370341|449058800|FG000|Overall Study|Lost to Follow-up|0|||
124844365|NCT03370341|449058801|FG001|Overall Study|Lost to Follow-up|1|||
124844366|NCT00634647|449058803|FG000|Overall Study|death on study|3|||
124844367|NCT00634647|449058803|FG000|Overall Study|refused further treatment|3|||
124844368|NCT00634647|449058803|FG000|Overall Study|declined to participate before treatment|1|||
124844369|NCT02984020|449058804|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
124844370|NCT02984020|449058804|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
124844371|NCT02984020|449058804|FG000|Overall Study|Other significant protocol violation|2|||
124844372|NCT01700179|449058806|FG000|Overall Study|Physician Decision|2|||
124844373|NCT00667342|449058807|FG000|Overall Study|Protocol Violation|1|||
124844374|NCT00667342|449058808|FG001|Overall Study|Protocol Violation|0|||
124844375|NCT00667342|449058809|FG002|Overall Study|Protocol Violation|0|||
124844376|NCT00667342|449058807|FG000|Overall Study|Withdrawal by Subject|1|||
124844377|NCT00667342|449058808|FG001|Overall Study|Withdrawal by Subject|0|||
124844378|NCT00667342|449058809|FG002|Overall Study|Withdrawal by Subject|0|||
124844379|NCT00667342|449058807|FG000|Overall Study|Physician Decision|3|||
124844380|NCT00667342|449058808|FG001|Overall Study|Physician Decision|0|||
124844381|NCT00667342|449058809|FG002|Overall Study|Physician Decision|0|||
124844382|NCT00667342|449058807|FG000|Overall Study|Relapse or tumor progression|9|||
124844383|NCT00667342|449058808|FG001|Overall Study|Relapse or tumor progression|0|||
124844384|NCT00667342|449058809|FG002|Overall Study|Relapse or tumor progression|7|||
124844385|NCT00667342|449058807|FG000|Overall Study|Adverse Event|0|||
124844386|NCT00667342|449058808|FG001|Overall Study|Adverse Event|0|||
124844387|NCT00667342|449058809|FG002|Overall Study|Adverse Event|1|||
124844388|NCT00667342|449058807|FG000|Overall Study|Ineligible|0|||
124844389|NCT00667342|449058808|FG001|Overall Study|Ineligible|0|||
124844390|NCT00667342|449058809|FG002|Overall Study|Ineligible|1|||
124844391|NCT05220397|449058810|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
124844392|NCT05220397|449058811|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
124844393|NCT05220397|449058812|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
124844394|NCT05220397|449058813|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
124844395|NCT05220397|449058814|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
124844396|NCT05091528|449058815|FG000|Overall Study|Study Termination by Sponsor|0|||
124844397|NCT05091528|449058816|FG001|Overall Study|Study Termination by Sponsor|1|||
124844398|NCT05091528|449058817|FG002|Overall Study|Study Termination by Sponsor|0|||
124844399|NCT05091528|449058818|FG003|Overall Study|Study Termination by Sponsor|1|||
124844400|NCT04958109|449058819|FG000|Overall Study|Withdrawal by Subject|0|||
124844401|NCT04958109|449058820|FG001|Overall Study|Withdrawal by Subject|1|||
124844402|NCT04958109|449058819|FG000|Overall Study|Lost to Follow-up|0|||
124844403|NCT04958109|449058820|FG001|Overall Study|Lost to Follow-up|1|||
124844404|NCT01573624|449058823|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
124844405|NCT01573624|449058824|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
124844406|NCT01573624|449058825|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
124844407|NCT01573624|449058826|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
124844408|NCT01573624|449058827|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
124844409|NCT01573624|449058828|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
124844410|NCT01573624|449058829|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
124844411|NCT01573624|449058823|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
124844412|NCT01573624|449058824|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
124844413|NCT01573624|449058825|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
124844414|NCT01573624|449058826|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
124844415|NCT01573624|449058827|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
124844416|NCT01573624|449058828|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
124844417|NCT01573624|449058829|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
124844418|NCT01573624|449058823|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
124844419|NCT01573624|449058824|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
124844420|NCT01573624|449058825|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
124844421|NCT01573624|449058826|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
124844422|NCT01573624|449058827|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
124844423|NCT01573624|449058828|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
124844424|NCT01573624|449058829|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
124844425|NCT01573624|449058823|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
124844426|NCT01573624|449058824|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124844427|NCT01573624|449058825|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
124844428|NCT01573624|449058826|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124844429|NCT01573624|449058827|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124844430|NCT01573624|449058828|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
124844431|NCT01573624|449058829|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
124844432|NCT01573624|449058823|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
124844433|NCT01573624|449058824|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
124844434|NCT01573624|449058825|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
124844435|NCT01573624|449058826|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
124844436|NCT01573624|449058827|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
124844437|NCT01573624|449058828|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
124844438|NCT01573624|449058829|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
124844439|NCT01573624|449058823|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
124844440|NCT01573624|449058824|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
124844441|NCT01573624|449058825|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
124844442|NCT01573624|449058826|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
124844443|NCT01573624|449058827|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
124844444|NCT01573624|449058828|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
124844445|NCT01573624|449058829|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
124844446|NCT01573624|449058823|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
124844447|NCT01573624|449058824|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
124844448|NCT01573624|449058825|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
124844449|NCT01573624|449058826|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
124844450|NCT01573624|449058827|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
124844451|NCT01573624|449058828|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
124844452|NCT01573624|449058829|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
124844453|NCT01573624|449058823|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
124844454|NCT01573624|449058824|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124844455|NCT01573624|449058825|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
124844456|NCT01573624|449058826|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
124844457|NCT01573624|449058827|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124844458|NCT01573624|449058828|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124844459|NCT01573624|449058829|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
124844460|NCT01573624|449058823|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
124844461|NCT01573624|449058824|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
124844462|NCT01573624|449058825|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
124844463|NCT01573624|449058826|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
124844464|NCT01573624|449058827|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
124844465|NCT01573624|449058828|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
124844466|NCT01573624|449058829|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
124844467|NCT01573624|449058823|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
124844468|NCT01573624|449058824|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
124844469|NCT01573624|449058825|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
124844470|NCT01573624|449058826|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
124844471|NCT01573624|449058827|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
124844472|NCT01573624|449058828|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
124844473|NCT01573624|449058829|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
124844474|NCT01573624|449058823|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
124844475|NCT01573624|449058824|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
124844476|NCT01573624|449058825|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
124844477|NCT01573624|449058826|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
124844478|NCT01573624|449058827|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
124844479|NCT01573624|449058828|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
124844480|NCT01573624|449058829|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
124844481|NCT01573624|449058823|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
124844482|NCT01573624|449058824|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
124844483|NCT01573624|449058825|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
124844484|NCT01573624|449058826|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
124844485|NCT01573624|449058827|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
124844486|NCT01573624|449058828|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
124844487|NCT01573624|449058829|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
124844488|NCT01573624|449058823|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
124844489|NCT01573624|449058824|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
124844490|NCT01573624|449058825|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
124844491|NCT01573624|449058826|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
124844492|NCT01573624|449058827|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
124844493|NCT01573624|449058828|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
124844494|NCT01573624|449058829|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
124844495|NCT01573624|449058823|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
124844496|NCT01573624|449058824|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
124844497|NCT01573624|449058825|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
124844498|NCT01573624|449058826|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
124844499|NCT01573624|449058827|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
124844500|NCT01573624|449058828|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
124844501|NCT01573624|449058829|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
124844502|NCT01573624|449058823|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
124844503|NCT01573624|449058824|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
124844504|NCT01573624|449058825|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
124844505|NCT01573624|449058826|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
124844506|NCT01573624|449058827|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
124844507|NCT01573624|449058828|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
124844508|NCT01573624|449058829|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
124844509|NCT01573624|449058823|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
124844510|NCT01573624|449058824|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
124844511|NCT01573624|449058825|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
124844512|NCT01573624|449058826|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
124844513|NCT01573624|449058827|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
124844514|NCT01573624|449058828|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
124844515|NCT01573624|449058829|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
124844516|NCT01573624|449058823|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
124844517|NCT01573624|449058824|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
124844518|NCT01573624|449058825|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
124844519|NCT01573624|449058826|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
124844520|NCT01573624|449058827|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
124844521|NCT01573624|449058828|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
124844522|NCT01573624|449058829|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
124844523|NCT01573624|449058823|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
124844524|NCT01573624|449058824|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
124844525|NCT01573624|449058825|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
124844526|NCT01573624|449058826|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
124844527|NCT01573624|449058827|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
124844528|NCT01573624|449058828|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
124844529|NCT01573624|449058829|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
124844530|NCT01573624|449058823|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
124844531|NCT01573624|449058824|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
124844532|NCT01573624|449058825|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
124844533|NCT01573624|449058826|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
124844534|NCT01573624|449058827|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
124844535|NCT01573624|449058828|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
124844536|NCT01573624|449058829|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
124844537|NCT01573624|449058823|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
124844538|NCT01573624|449058824|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
124844539|NCT01573624|449058825|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
124844540|NCT01573624|449058826|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
124844541|NCT01573624|449058827|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
124844542|NCT01573624|449058828|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
124844543|NCT01573624|449058829|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
124844544|NCT01573624|449058823|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124844545|NCT01573624|449058824|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124844546|NCT01573624|449058825|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124640206|NCT02016105|448299907|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
124640207|NCT02016105|448299908|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
124640208|NCT02016105|448299909|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
124640209|NCT02016105|448299910|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
124640210|NCT02016105|448299911|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
124640211|NCT02016105|448299906|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
124844547|NCT01573624|449058826|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124844548|NCT01573624|449058827|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
124844549|NCT01573624|449058828|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
124844550|NCT01573624|449058829|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
124844551|NCT01573624|449058823|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
124844552|NCT01573624|449058824|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
124844553|NCT01573624|449058825|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
124844554|NCT01573624|449058826|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
124844555|NCT01573624|449058827|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
124844556|NCT01573624|449058828|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
124844557|NCT01573624|449058829|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
124844558|NCT01573624|449058823|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
124844559|NCT01573624|449058824|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
124844560|NCT01573624|449058825|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
124844561|NCT01573624|449058826|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
124844562|NCT01573624|449058827|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
124844563|NCT01573624|449058828|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
124844564|NCT01573624|449058829|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
124844565|NCT01573624|449058823|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
124844566|NCT01573624|449058824|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
124844567|NCT01573624|449058825|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
124844568|NCT01573624|449058826|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
124844569|NCT01573624|449058827|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
124844570|NCT01573624|449058828|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
124844571|NCT01573624|449058829|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
124844572|NCT01573624|449058823|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
124844573|NCT01573624|449058824|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
124844574|NCT01573624|449058825|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
124844575|NCT01573624|449058826|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
124844576|NCT01573624|449058827|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
124844577|NCT01573624|449058828|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
124844578|NCT01573624|449058829|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
124844579|NCT01573624|449058823|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
124844580|NCT01573624|449058824|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
124844581|NCT01573624|449058825|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
124844582|NCT01573624|449058826|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
124844583|NCT01573624|449058827|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
124844584|NCT01573624|449058828|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
124844585|NCT01573624|449058829|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
124844586|NCT01573624|449058823|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
124844587|NCT01573624|449058824|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
124844588|NCT01573624|449058825|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
124844589|NCT01573624|449058826|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
124844590|NCT01573624|449058827|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
124844591|NCT01573624|449058828|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
124844592|NCT01573624|449058829|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
124844593|NCT02257736|449058845|FG000|Overall Study|Progressive disease|365|||
124844594|NCT02257736|449058846|FG001|Overall Study|Progressive disease|327|||
124844595|NCT02257736|449058845|FG000|Overall Study|Adverse Event|45|||
124844596|NCT02257736|449058846|FG001|Overall Study|Adverse Event|56|||
124844597|NCT02257736|449058845|FG000|Overall Study|Withdrawal by Subject|21|||
124844598|NCT02257736|449058846|FG001|Overall Study|Withdrawal by Subject|38|||
124844599|NCT02257736|449058845|FG000|Overall Study|Death|11|||
124844600|NCT02257736|449058846|FG001|Overall Study|Death|6|||
124844601|NCT02257736|449058845|FG000|Overall Study|Physician Decision|5|||
124844602|NCT02257736|449058846|FG001|Overall Study|Physician Decision|9|||
124844603|NCT02257736|449058845|FG000|Overall Study|Non-Compliance with study drug|1|||
124844604|NCT02257736|449058846|FG001|Overall Study|Non-Compliance with study drug|2|||
124844605|NCT02257736|449058845|FG000|Overall Study|Protocol Violation|1|||
124844606|NCT02257736|449058846|FG001|Overall Study|Protocol Violation|0|||
124844607|NCT02257736|449058845|FG000|Overall Study|Other|1|||
124844608|NCT02257736|449058846|FG001|Overall Study|Other|7|||
124844609|NCT02257736|449058845|FG000|Overall Study|Randomized, not treated|1|||
124844610|NCT02257736|449058846|FG001|Overall Study|Randomized, not treated|2|||
124844611|NCT00308711|449058847|FG000|Overall Study|Withdrawal by Subject|1|||
124844612|NCT00308711|449058848|FG001|Overall Study|Withdrawal by Subject|0|||
124844613|NCT00308711|449058849|FG002|Overall Study|Withdrawal by Subject|1|||
124844614|NCT00308711|449058847|FG000|Overall Study|Protocol Violation|0|||
124844615|NCT00308711|449058848|FG001|Overall Study|Protocol Violation|1|||
124844616|NCT00308711|449058849|FG002|Overall Study|Protocol Violation|1|||
124844617|NCT00308711|449058847|FG000|Overall Study|Lost to Follow-up|0|||
124844618|NCT00308711|449058848|FG001|Overall Study|Lost to Follow-up|1|||
124844619|NCT00308711|449058849|FG002|Overall Study|Lost to Follow-up|0|||
124844620|NCT00308711|449058847|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
124844621|NCT00308711|449058848|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
124844622|NCT00308711|449058849|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
124844623|NCT00308711|449058847|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
124844624|NCT00308711|449058848|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
124844625|NCT00308711|449058849|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
124844626|NCT02167256|449058850|FG000|Overall Study|Adverse Event|13|||
124844627|NCT02167256|449058851|FG001|Overall Study|Adverse Event|6|||
124844628|NCT02167256|449058850|FG000|Overall Study|Withdrawal by Subject|4|||
124844629|NCT02167256|449058851|FG001|Overall Study|Withdrawal by Subject|4|||
124844630|NCT02167256|449058850|FG000|Overall Study|non-compliance|3|||
124844631|NCT02167256|449058851|FG001|Overall Study|non-compliance|0|||
124844632|NCT02167256|449058850|FG000|Overall Study|Study partner unable to participate|1|||
124844633|NCT02167256|449058851|FG001|Overall Study|Study partner unable to participate|0|||
124844634|NCT00414388|449058854|FG000|Overall Study|Adverse Event|1|||
124844635|NCT03591575|449058855|FG000|Overall Study|Adverse Event|2|||
124844636|NCT03591575|449058856|FG001|Overall Study|Adverse Event|0|||
124844637|NCT03591575|449058855|FG000|Overall Study|Withdrawal by Subject|4|||
124844638|NCT03591575|449058856|FG001|Overall Study|Withdrawal by Subject|1|||
124844639|NCT01723228|449058857|FG000|Overall Study|Adverse Event|2|||
124844640|NCT01723228|449058858|FG001|Overall Study|Adverse Event|6|||
124844641|NCT01723228|449058857|FG000|Overall Study|Withdrawal by Subject|2|||
124844642|NCT01723228|449058858|FG001|Overall Study|Withdrawal by Subject|1|||
124844643|NCT01723228|449058857|FG000|Overall Study|Protocol Violation|0|||
124844644|NCT01723228|449058858|FG001|Overall Study|Protocol Violation|2|||
124844645|NCT01723228|449058857|FG000|Overall Study|Lost to Follow-up|2|||
124844646|NCT01723228|449058858|FG001|Overall Study|Lost to Follow-up|1|||
124844647|NCT01723228|449058857|FG000|Overall Study|Other|2|||
124844648|NCT01723228|449058858|FG001|Overall Study|Other|1|||
124844649|NCT00218543|449058859|FG000|Overall Study|Lost to Follow-up|8|||
124844650|NCT00218543|449058859|FG000|Overall Study|relocated|1|||
124844651|NCT00218543|449058859|FG000|Overall Study|Withdrawal by Subject|1|||
124844652|NCT00218543|449058859|FG000|Overall Study|Physician Decision|3|||
124844653|NCT00218543|449058859|FG000|Overall Study|Adverse Event|2|||
124844654|NCT01864291|449058860|FG000|Overall Study|need for revision surgery|2|||
124844655|NCT01451424|449058861|FG000|Overall Study|Withdrawal by Subject|1|||
124844656|NCT01451424|449058862|FG001|Overall Study|Withdrawal by Subject|1|||
124844657|NCT01451424|449058863|FG002|Overall Study|Withdrawal by Subject|0|||
124844658|NCT01451424|449058864|FG003|Overall Study|Withdrawal by Subject|2|||
124844659|NCT01451424|449058861|FG000|Overall Study|Lost to Follow-up|0|||
124844660|NCT01451424|449058862|FG001|Overall Study|Lost to Follow-up|1|||
124844661|NCT01451424|449058863|FG002|Overall Study|Lost to Follow-up|0|||
124844662|NCT01451424|449058864|FG003|Overall Study|Lost to Follow-up|1|||
124844663|NCT01451424|449058861|FG000|Overall Study|Physician Decision|0|||
124844664|NCT01451424|449058862|FG001|Overall Study|Physician Decision|0|||
124844665|NCT01451424|449058863|FG002|Overall Study|Physician Decision|1|||
124844666|NCT01451424|449058864|FG003|Overall Study|Physician Decision|1|||
124844667|NCT01451424|449058861|FG000|Overall Study|Adverse Event|0|||
124844668|NCT01451424|449058862|FG001|Overall Study|Adverse Event|0|||
124844669|NCT01451424|449058863|FG002|Overall Study|Adverse Event|0|||
124844670|NCT01451424|449058864|FG003|Overall Study|Adverse Event|1|||
124844671|NCT00689481|449058865|FG000|Overall Study|Adverse Event|7|||
124844672|NCT00689481|449058866|FG001|Overall Study|Adverse Event|1|||
124844673|NCT00689481|449058865|FG000|Overall Study|Lost to Follow-up|4|||
124844674|NCT00689481|449058866|FG001|Overall Study|Lost to Follow-up|3|||
124844675|NCT00689481|449058865|FG000|Overall Study|Lack of Efficacy|4|||
124844676|NCT00689481|449058866|FG001|Overall Study|Lack of Efficacy|3|||
124844677|NCT00689481|449058865|FG000|Overall Study|Non-compliance with study treatment|1|||
124844678|NCT00689481|449058866|FG001|Overall Study|Non-compliance with study treatment|1|||
124844679|NCT00689481|449058865|FG000|Overall Study|Withdrawal by Subject|8|||
124844680|NCT00689481|449058866|FG001|Overall Study|Withdrawal by Subject|4|||
124844681|NCT00689481|449058865|FG000|Overall Study|Excluded medication started during study|0|||
124844682|NCT00689481|449058866|FG001|Overall Study|Excluded medication started during study|1|||
124844683|NCT00689481|449058865|FG000|Overall Study|Subject early term, left on vacation|0|||
124844684|NCT00689481|449058866|FG001|Overall Study|Subject early term, left on vacation|1|||
124844685|NCT02254278|449058867|FG000|Overall Study|Protocol Violation|1|||
124844686|NCT02254278|449058868|FG001|Overall Study|Protocol Violation|1|||
124844687|NCT04745689|449058870|FG000|Overall Study|Death|9|||
124844688|NCT04745689|449058871|FG001|Overall Study|Death|6|||
124844689|NCT04745689|449058870|FG000|Overall Study|Lost to Follow-up|1|||
124844690|NCT04745689|449058871|FG001|Overall Study|Lost to Follow-up|0|||
124844691|NCT04745689|449058870|FG000|Overall Study|Withdrawal by Subject|2|||
124844692|NCT04745689|449058871|FG001|Overall Study|Withdrawal by Subject|0|||
124844693|NCT04745689|449058870|FG000|Overall Study|Study terminated by sponsor|10|||
124844694|NCT04745689|449058871|FG001|Overall Study|Study terminated by sponsor|3|||
124844695|NCT03091192|449058872|FG000|Overall Study|Study terminated by sponsor|21|||
124844696|NCT03091192|449058873|FG001|Overall Study|Study terminated by sponsor|14|||
124844697|NCT03091192|449058872|FG000|Overall Study|Death|9|||
124844698|NCT03091192|449058873|FG001|Overall Study|Death|13|||
124844699|NCT03091192|449058872|FG000|Overall Study|Withdrawal by Subject|2|||
124844700|NCT03091192|449058873|FG001|Overall Study|Withdrawal by Subject|0|||
124844701|NCT03091192|449058872|FG000|Overall Study|Lost to Follow-up|1|||
124844702|NCT03091192|449058873|FG001|Overall Study|Lost to Follow-up|0|||
124844703|NCT01038778|449058876|FG000|Overall Study|Withdrawal by Subject|0|||
124844704|NCT01038778|449058877|FG001|Overall Study|Withdrawal by Subject|2|||
124844705|NCT01038778|449058878|FG002|Overall Study|Withdrawal by Subject|3|||
124844706|NCT04487080|449058879|FG000|Overall Study|Withdrawal by Subject|19|||
124844707|NCT04487080|449058880|FG001|Overall Study|Withdrawal by Subject|18|||
124844708|NCT04487080|449058881|FG002|Overall Study|Withdrawal by Subject|13|||
124844709|NCT04487080|449058879|FG000|Overall Study|Lost to Follow-up|3|||
124844710|NCT04487080|449058880|FG001|Overall Study|Lost to Follow-up|1|||
124844711|NCT04487080|449058881|FG002|Overall Study|Lost to Follow-up|0|||
124844712|NCT04487080|449058879|FG000|Overall Study|Ongoing|313|||
124844713|NCT04487080|449058880|FG001|Overall Study|Ongoing|297|||
124844714|NCT04487080|449058881|FG002|Overall Study|Ongoing|149|||
124844715|NCT03195478|449058882|FG000|Overall Study|Disease Progression|5|||
124844716|NCT03195478|449058883|FG001|Overall Study|Disease Progression|4|||
124844717|NCT03195478|449058884|FG002|Overall Study|Disease Progression|6|||
124844718|NCT03195478|449058885|FG003|Overall Study|Disease Progression|1|||
124844719|NCT03195478|449058882|FG000|Overall Study|Study Drug Toxicity|2|||
124844720|NCT03195478|449058883|FG001|Overall Study|Study Drug Toxicity|0|||
124844721|NCT03195478|449058884|FG002|Overall Study|Study Drug Toxicity|0|||
124844722|NCT03195478|449058885|FG003|Overall Study|Study Drug Toxicity|1|||
124844723|NCT03195478|449058882|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
124844724|NCT03195478|449058883|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
124844725|NCT03195478|449058884|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
124844726|NCT03195478|449058885|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
124844727|NCT03195478|449058882|FG000|Overall Study|Participant Withdrew Consent|1|||
124844728|NCT03195478|449058883|FG001|Overall Study|Participant Withdrew Consent|0|||
124844729|NCT03195478|449058884|FG002|Overall Study|Participant Withdrew Consent|0|||
124844730|NCT03195478|449058885|FG003|Overall Study|Participant Withdrew Consent|0|||
124844731|NCT03195478|449058882|FG000|Overall Study|Maximum Clinical benefit|0|||
124844732|NCT03195478|449058883|FG001|Overall Study|Maximum Clinical benefit|0|||
124844733|NCT03195478|449058884|FG002|Overall Study|Maximum Clinical benefit|1|||
124844734|NCT03195478|449058885|FG003|Overall Study|Maximum Clinical benefit|0|||
124844735|NCT03195478|449058882|FG000|Overall Study|Other Reasons|0|||
124844736|NCT03195478|449058883|FG001|Overall Study|Other Reasons|0|||
124844737|NCT03195478|449058884|FG002|Overall Study|Other Reasons|1|||
124844738|NCT03195478|449058885|FG003|Overall Study|Other Reasons|0|||
124844739|NCT01677195|449060092|FG000|Overall Study|Lost to Follow-up|14|||
124844740|NCT01677195|449060093|FG001|Overall Study|Lost to Follow-up|22|||
124844741|NCT01677195|449060094|FG002|Overall Study|Lost to Follow-up|22|||
124844742|NCT01677195|449060092|FG000|Overall Study|Withdrawal by Subject|1|||
124753302|NCT03364309|448718903|FG006|Induction Period|Lost to Follow-up|0|||
124753303|NCT03364309|448718904|FG007|Induction Period|Lost to Follow-up|0|||
124753304|NCT03364309|448718905|FG008|Induction Period|Lost to Follow-up|0|||
124753305|NCT03364309|448718906|FG009|Induction Period|Lost to Follow-up|0|||
124753306|NCT03364309|448718907|FG010|Induction Period|Lost to Follow-up|0|||
124753307|NCT03364309|448718908|FG011|Induction Period|Lost to Follow-up|0|||
124753308|NCT03364309|448718909|FG012|Induction Period|Lost to Follow-up|0|||
124753309|NCT03364309|448718910|FG013|Induction Period|Lost to Follow-up|0|||
124753310|NCT03364309|448718911|FG014|Induction Period|Lost to Follow-up|0|||
124753311|NCT03364309|448718912|FG015|Induction Period|Lost to Follow-up|0|||
124753312|NCT03364309|448718913|FG016|Induction Period|Lost to Follow-up|0|||
124753313|NCT03364309|448718914|FG017|Induction Period|Lost to Follow-up|0|||
124753314|NCT03364309|448718915|FG018|Induction Period|Lost to Follow-up|0|||
124753315|NCT03364309|448718897|FG000|Induction Period|Physician Decision|0|||
124753316|NCT03364309|448718898|FG001|Induction Period|Physician Decision|1|||
124753317|NCT03364309|448718899|FG002|Induction Period|Physician Decision|0|||
124753318|NCT03364309|448718900|FG003|Induction Period|Physician Decision|0|||
124753319|NCT03364309|448718901|FG004|Induction Period|Physician Decision|0|||
124753320|NCT03364309|448718902|FG005|Induction Period|Physician Decision|0|||
124753321|NCT03364309|448718903|FG006|Induction Period|Physician Decision|0|||
124753322|NCT03364309|448718904|FG007|Induction Period|Physician Decision|0|||
124844743|NCT01677195|449060093|FG001|Overall Study|Withdrawal by Subject|0|||
124844744|NCT01677195|449060094|FG002|Overall Study|Withdrawal by Subject|1|||
124844745|NCT01677195|449060092|FG000|Overall Study|Adverse Event|6|||
124753323|NCT03364309|448718905|FG008|Induction Period|Physician Decision|0|||
124753324|NCT03364309|448718906|FG009|Induction Period|Physician Decision|0|||
124753325|NCT03364309|448718907|FG010|Induction Period|Physician Decision|0|||
124753326|NCT03364309|448718908|FG011|Induction Period|Physician Decision|0|||
124753327|NCT03364309|448718909|FG012|Induction Period|Physician Decision|0|||
124753328|NCT03364309|448718910|FG013|Induction Period|Physician Decision|0|||
124753329|NCT03364309|448718911|FG014|Induction Period|Physician Decision|0|||
124753330|NCT03364309|448718912|FG015|Induction Period|Physician Decision|0|||
124753331|NCT03364309|448718913|FG016|Induction Period|Physician Decision|0|||
124753332|NCT03364309|448718914|FG017|Induction Period|Physician Decision|0|||
124753333|NCT03364309|448718915|FG018|Induction Period|Physician Decision|0|||
124753334|NCT03364309|448718897|FG000|Maintenance Period|Withdrawal by Subject|0|||
124753335|NCT03364309|448718898|FG001|Maintenance Period|Withdrawal by Subject|0|||
124753336|NCT03364309|448718899|FG002|Maintenance Period|Withdrawal by Subject|0|||
124753337|NCT03364309|448718900|FG003|Maintenance Period|Withdrawal by Subject|1|||
124753338|NCT03364309|448718901|FG004|Maintenance Period|Withdrawal by Subject|3|||
124753339|NCT03364309|448718902|FG005|Maintenance Period|Withdrawal by Subject|1|||
124753340|NCT03364309|448718903|FG006|Maintenance Period|Withdrawal by Subject|3|||
124753341|NCT03364309|448718904|FG007|Maintenance Period|Withdrawal by Subject|0|||
124753342|NCT03364309|448718905|FG008|Maintenance Period|Withdrawal by Subject|1|||
124753343|NCT03364309|448718906|FG009|Maintenance Period|Withdrawal by Subject|1|||
124753344|NCT03364309|448718907|FG010|Maintenance Period|Withdrawal by Subject|2|||
124753345|NCT03364309|448718908|FG011|Maintenance Period|Withdrawal by Subject|0|||
124753346|NCT03364309|448718909|FG012|Maintenance Period|Withdrawal by Subject|0|||
124753347|NCT03364309|448718910|FG013|Maintenance Period|Withdrawal by Subject|0|||
124753348|NCT03364309|448718911|FG014|Maintenance Period|Withdrawal by Subject|0|||
124753349|NCT03364309|448718912|FG015|Maintenance Period|Withdrawal by Subject|0|||
124753350|NCT03364309|448718913|FG016|Maintenance Period|Withdrawal by Subject|0|||
124753351|NCT03364309|448718914|FG017|Maintenance Period|Withdrawal by Subject|0|||
124753352|NCT03364309|448718915|FG018|Maintenance Period|Withdrawal by Subject|0|||
124753353|NCT03364309|448718897|FG000|Maintenance Period|Adverse Event|0|||
124753354|NCT03364309|448718898|FG001|Maintenance Period|Adverse Event|0|||
124753355|NCT03364309|448718899|FG002|Maintenance Period|Adverse Event|0|||
124753356|NCT03364309|448718900|FG003|Maintenance Period|Adverse Event|0|||
124753357|NCT03364309|448718901|FG004|Maintenance Period|Adverse Event|2|||
124753358|NCT03364309|448718902|FG005|Maintenance Period|Adverse Event|0|||
124753359|NCT03364309|448718903|FG006|Maintenance Period|Adverse Event|3|||
124753360|NCT03364309|448718904|FG007|Maintenance Period|Adverse Event|0|||
124753361|NCT03364309|448718905|FG008|Maintenance Period|Adverse Event|1|||
124753362|NCT03364309|448718906|FG009|Maintenance Period|Adverse Event|0|||
124753363|NCT03364309|448718907|FG010|Maintenance Period|Adverse Event|2|||
124753364|NCT03364309|448718908|FG011|Maintenance Period|Adverse Event|0|||
124753365|NCT03364309|448718909|FG012|Maintenance Period|Adverse Event|0|||
124753366|NCT03364309|448718910|FG013|Maintenance Period|Adverse Event|0|||
124753367|NCT03364309|448718911|FG014|Maintenance Period|Adverse Event|0|||
124753368|NCT03364309|448718912|FG015|Maintenance Period|Adverse Event|0|||
124753369|NCT03364309|448718913|FG016|Maintenance Period|Adverse Event|0|||
124753370|NCT03364309|448718914|FG017|Maintenance Period|Adverse Event|0|||
124753371|NCT03364309|448718915|FG018|Maintenance Period|Adverse Event|0|||
124753372|NCT03364309|448718897|FG000|Maintenance Period|Relapsed|0|||
124753373|NCT03364309|448718898|FG001|Maintenance Period|Relapsed|0|||
124753374|NCT03364309|448718899|FG002|Maintenance Period|Relapsed|0|||
124753375|NCT03364309|448718900|FG003|Maintenance Period|Relapsed|43|||
124753376|NCT03364309|448718901|FG004|Maintenance Period|Relapsed|7|||
124753377|NCT03364309|448718902|FG005|Maintenance Period|Relapsed|45|||
124753378|NCT03364309|448718903|FG006|Maintenance Period|Relapsed|10|||
124753379|NCT03364309|448718904|FG007|Maintenance Period|Relapsed|2|||
124753380|NCT03364309|448718905|FG008|Maintenance Period|Relapsed|0|||
124753381|NCT03364309|448718906|FG009|Maintenance Period|Relapsed|0|||
124753382|NCT03364309|448718907|FG010|Maintenance Period|Relapsed|0|||
124753383|NCT03364309|448718908|FG011|Maintenance Period|Relapsed|0|||
124753384|NCT03364309|448718909|FG012|Maintenance Period|Relapsed|0|||
124753385|NCT03364309|448718910|FG013|Maintenance Period|Relapsed|0|||
124753386|NCT03364309|448718911|FG014|Maintenance Period|Relapsed|0|||
124753387|NCT03364309|448718912|FG015|Maintenance Period|Relapsed|0|||
124753388|NCT03364309|448718913|FG016|Maintenance Period|Relapsed|0|||
124753389|NCT03364309|448718914|FG017|Maintenance Period|Relapsed|0|||
124753390|NCT03364309|448718915|FG018|Maintenance Period|Relapsed|0|||
124753391|NCT03364309|448718897|FG000|Maintenance Period|Lack of Efficacy|0|||
124753392|NCT03364309|448718898|FG001|Maintenance Period|Lack of Efficacy|0|||
124753393|NCT03364309|448718899|FG002|Maintenance Period|Lack of Efficacy|0|||
124753394|NCT03364309|448718900|FG003|Maintenance Period|Lack of Efficacy|0|||
124753395|NCT03364309|448718901|FG004|Maintenance Period|Lack of Efficacy|0|||
124753396|NCT03364309|448718902|FG005|Maintenance Period|Lack of Efficacy|0|||
124753397|NCT03364309|448718903|FG006|Maintenance Period|Lack of Efficacy|0|||
124753398|NCT03364309|448718904|FG007|Maintenance Period|Lack of Efficacy|0|||
124753399|NCT03364309|448718905|FG008|Maintenance Period|Lack of Efficacy|1|||
124753400|NCT03364309|448718906|FG009|Maintenance Period|Lack of Efficacy|3|||
124753401|NCT03364309|448718907|FG010|Maintenance Period|Lack of Efficacy|2|||
124753402|NCT03364309|448718908|FG011|Maintenance Period|Lack of Efficacy|0|||
124753403|NCT03364309|448718909|FG012|Maintenance Period|Lack of Efficacy|0|||
124753404|NCT03364309|448718910|FG013|Maintenance Period|Lack of Efficacy|0|||
124753405|NCT03364309|448718911|FG014|Maintenance Period|Lack of Efficacy|0|||
124753406|NCT03364309|448718912|FG015|Maintenance Period|Lack of Efficacy|0|||
124753407|NCT03364309|448718913|FG016|Maintenance Period|Lack of Efficacy|0|||
124753408|NCT03364309|448718914|FG017|Maintenance Period|Lack of Efficacy|0|||
124753409|NCT03364309|448718915|FG018|Maintenance Period|Lack of Efficacy|0|||
124753410|NCT03364309|448718897|FG000|Maintenance Period|Death|0|||
124753411|NCT03364309|448718898|FG001|Maintenance Period|Death|0|||
124753412|NCT03364309|448718899|FG002|Maintenance Period|Death|0|||
124753413|NCT03364309|448718900|FG003|Maintenance Period|Death|0|||
124753414|NCT03364309|448718901|FG004|Maintenance Period|Death|0|||
124753415|NCT03364309|448718902|FG005|Maintenance Period|Death|0|||
124753416|NCT03364309|448718903|FG006|Maintenance Period|Death|0|||
124753417|NCT03364309|448718904|FG007|Maintenance Period|Death|0|||
124753418|NCT03364309|448718905|FG008|Maintenance Period|Death|1|||
124753419|NCT03364309|448718906|FG009|Maintenance Period|Death|0|||
124753420|NCT03364309|448718907|FG010|Maintenance Period|Death|0|||
124753421|NCT03364309|448718908|FG011|Maintenance Period|Death|0|||
124753422|NCT03364309|448718909|FG012|Maintenance Period|Death|0|||
124753423|NCT03364309|448718910|FG013|Maintenance Period|Death|0|||
124753424|NCT03364309|448718911|FG014|Maintenance Period|Death|0|||
124753425|NCT03364309|448718912|FG015|Maintenance Period|Death|0|||
124753426|NCT03364309|448718913|FG016|Maintenance Period|Death|0|||
124753427|NCT03364309|448718914|FG017|Maintenance Period|Death|0|||
124753428|NCT03364309|448718915|FG018|Maintenance Period|Death|0|||
124753429|NCT03364309|448718897|FG000|Maintenance Period|Lost to Follow-up|0|||
124753430|NCT03364309|448718898|FG001|Maintenance Period|Lost to Follow-up|0|||
124753431|NCT03364309|448718899|FG002|Maintenance Period|Lost to Follow-up|0|||
124753432|NCT03364309|448718900|FG003|Maintenance Period|Lost to Follow-up|0|||
124753433|NCT03364309|448718901|FG004|Maintenance Period|Lost to Follow-up|0|||
124753434|NCT03364309|448718902|FG005|Maintenance Period|Lost to Follow-up|0|||
124753435|NCT03364309|448718903|FG006|Maintenance Period|Lost to Follow-up|0|||
124753436|NCT03364309|448718904|FG007|Maintenance Period|Lost to Follow-up|0|||
124753437|NCT03364309|448718905|FG008|Maintenance Period|Lost to Follow-up|1|||
124753438|NCT03364309|448718906|FG009|Maintenance Period|Lost to Follow-up|0|||
124753439|NCT03364309|448718907|FG010|Maintenance Period|Lost to Follow-up|0|||
124753440|NCT03364309|448718908|FG011|Maintenance Period|Lost to Follow-up|0|||
124753441|NCT03364309|448718909|FG012|Maintenance Period|Lost to Follow-up|0|||
124753442|NCT03364309|448718910|FG013|Maintenance Period|Lost to Follow-up|0|||
124753443|NCT03364309|448718911|FG014|Maintenance Period|Lost to Follow-up|0|||
124753444|NCT03364309|448718912|FG015|Maintenance Period|Lost to Follow-up|0|||
124753445|NCT03364309|448718913|FG016|Maintenance Period|Lost to Follow-up|0|||
124753446|NCT03364309|448718914|FG017|Maintenance Period|Lost to Follow-up|0|||
124753447|NCT03364309|448718915|FG018|Maintenance Period|Lost to Follow-up|0|||
124753448|NCT03364309|448718897|FG000|Maintenance Period|Miscellaneous|0|||
124753449|NCT03364309|448718898|FG001|Maintenance Period|Miscellaneous|0|||
124753450|NCT03364309|448718899|FG002|Maintenance Period|Miscellaneous|0|||
124753451|NCT03364309|448718900|FG003|Maintenance Period|Miscellaneous|0|||
124753452|NCT03364309|448718901|FG004|Maintenance Period|Miscellaneous|0|||
124753453|NCT03364309|448718902|FG005|Maintenance Period|Miscellaneous|0|||
124753454|NCT03364309|448718903|FG006|Maintenance Period|Miscellaneous|0|||
124753455|NCT03364309|448718904|FG007|Maintenance Period|Miscellaneous|0|||
124753456|NCT03364309|448718905|FG008|Maintenance Period|Miscellaneous|1|||
124753457|NCT03364309|448718906|FG009|Maintenance Period|Miscellaneous|0|||
124753458|NCT03364309|448718907|FG010|Maintenance Period|Miscellaneous|0|||
124753459|NCT03364309|448718908|FG011|Maintenance Period|Miscellaneous|0|||
124753460|NCT03364309|448718909|FG012|Maintenance Period|Miscellaneous|0|||
124753461|NCT03364309|448718910|FG013|Maintenance Period|Miscellaneous|0|||
124753462|NCT03364309|448718911|FG014|Maintenance Period|Miscellaneous|0|||
124753463|NCT03364309|448718912|FG015|Maintenance Period|Miscellaneous|0|||
124753464|NCT03364309|448718913|FG016|Maintenance Period|Miscellaneous|0|||
124753465|NCT03364309|448718914|FG017|Maintenance Period|Miscellaneous|0|||
124753466|NCT03364309|448718915|FG018|Maintenance Period|Miscellaneous|0|||
124753467|NCT03364309|448718897|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
124753468|NCT03364309|448718898|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
124753469|NCT03364309|448718899|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
124753470|NCT03364309|448718900|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
124753471|NCT03364309|448718901|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
124753472|NCT03364309|448718902|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
124753473|NCT03364309|448718903|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
124753474|NCT03364309|448718904|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
124753475|NCT03364309|448718905|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
124753476|NCT03364309|448718906|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
124753477|NCT03364309|448718907|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
124753478|NCT03364309|448718908|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
124844746|NCT01677195|449060093|FG001|Overall Study|Adverse Event|4|||
124844747|NCT01677195|449060094|FG002|Overall Study|Adverse Event|1|||
124844748|NCT01677195|449060092|FG000|Overall Study|Physician Decision|1|||
124844749|NCT01677195|449060093|FG001|Overall Study|Physician Decision|2|||
124844750|NCT01677195|449060094|FG002|Overall Study|Physician Decision|2|||
124844751|NCT01677195|449060092|FG000|Overall Study|Pregnancy|0|||
124640212|NCT02016105|448299907|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
124640213|NCT02016105|448299908|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
124640214|NCT02016105|448299909|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
124640215|NCT02016105|448299910|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
124640216|NCT02016105|448299911|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
124640217|NCT02016105|448299906|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
124640218|NCT02016105|448299907|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
124640219|NCT02016105|448299908|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
124640220|NCT02016105|448299909|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
124640221|NCT02016105|448299910|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
124640222|NCT02016105|448299911|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
124640223|NCT02016105|448299906|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
124640224|NCT02016105|448299907|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
124640225|NCT02016105|448299908|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
124640226|NCT02016105|448299909|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
124640227|NCT02016105|448299910|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
124640228|NCT02016105|448299911|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
124640229|NCT02016105|448299906|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
124640230|NCT02016105|448299907|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
124640231|NCT02016105|448299908|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
124640232|NCT02016105|448299909|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
124640233|NCT02016105|448299910|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
124640234|NCT02016105|448299911|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
124640235|NCT02016105|448299906|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
124640236|NCT02016105|448299907|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
124640237|NCT02016105|448299908|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
124640238|NCT02016105|448299909|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
124640239|NCT02016105|448299910|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
124640240|NCT02016105|448299911|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
124640241|NCT02016105|448299906|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
124640242|NCT02016105|448299907|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
124640243|NCT02016105|448299908|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
124640244|NCT02016105|448299909|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
124640245|NCT02016105|448299910|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
124640246|NCT02016105|448299911|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
124640247|NCT02016105|448299906|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
124640248|NCT02016105|448299907|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
124640249|NCT02016105|448299908|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
124640250|NCT02016105|448299909|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
124640251|NCT02016105|448299910|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
124640252|NCT02016105|448299911|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
124640253|NCT02016105|448299906|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
124640254|NCT02016105|448299907|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
124640255|NCT02016105|448299908|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
124640256|NCT02016105|448299909|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
124640257|NCT02016105|448299910|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
124640258|NCT02016105|448299911|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
124640259|NCT02016105|448299906|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
124640260|NCT02016105|448299907|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
124640261|NCT02016105|448299908|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
124640262|NCT02016105|448299909|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
124640263|NCT02016105|448299910|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
124640264|NCT02016105|448299911|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
124640265|NCT02016105|448299906|FG000|TREATMENT PERIOD 2|Death|0|||
124640266|NCT02016105|448299907|FG001|TREATMENT PERIOD 2|Death|0|||
124640267|NCT02016105|448299908|FG002|TREATMENT PERIOD 2|Death|0|||
124640268|NCT02016105|448299909|FG003|TREATMENT PERIOD 2|Death|0|||
124640269|NCT02016105|448299910|FG004|TREATMENT PERIOD 2|Death|0|||
124640270|NCT02016105|448299911|FG005|TREATMENT PERIOD 2|Death|1|||
124640271|NCT02016105|448299906|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
124640272|NCT02016105|448299907|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
124640273|NCT02016105|448299908|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
124640274|NCT02016105|448299909|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
124640275|NCT02016105|448299910|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
124640276|NCT02016105|448299911|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
124640277|NCT02016105|448299906|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
124640278|NCT02016105|448299907|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
124640279|NCT02016105|448299908|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
124640280|NCT02016105|448299909|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
124844752|NCT01677195|449060093|FG001|Overall Study|Pregnancy|1|||
124844753|NCT01677195|449060094|FG002|Overall Study|Pregnancy|0|||
124844754|NCT01677195|449060092|FG000|Overall Study|Protocol Violation|7|||
124844755|NCT01677195|449060093|FG001|Overall Study|Protocol Violation|3|||
124844756|NCT01677195|449060094|FG002|Overall Study|Protocol Violation|4|||
124844757|NCT02472756|449060096|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
124844758|NCT02472756|449060096|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
124844759|NCT02472756|449060096|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
124844760|NCT02472756|449060096|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
124844761|NCT02472756|449060096|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
124844762|NCT00110266|449060100|FG000|Overall Study|Adverse Event|27|||
124844763|NCT00110266|449060100|FG000|Overall Study|Abnormal laboratory value|15|||
124844764|NCT00110266|449060100|FG000|Overall Study|Withdrawal by Subject|16|||
124844765|NCT00110266|449060100|FG000|Overall Study|Death|17|||
124844766|NCT00110266|449060100|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124844767|NCT00110266|449060100|FG000|Overall Study|Participant condition no longer requires study drug|1|||
124844768|NCT02896400|449060101|FG000|1 Month Follow-up|Lost to Follow-up|7|||
124844769|NCT02896400|449060102|FG001|1 Month Follow-up|Lost to Follow-up|7|||
124844770|NCT02896400|449060103|FG002|1 Month Follow-up|Lost to Follow-up|5|||
124844771|NCT02896400|449060104|FG003|1 Month Follow-up|Lost to Follow-up|8|||
124844772|NCT02896400|449060105|FG004|1 Month Follow-up|Lost to Follow-up|9|||
124844773|NCT02896400|449060106|FG005|1 Month Follow-up|Lost to Follow-up|6|||
124844774|NCT02896400|449060107|FG006|1 Month Follow-up|Lost to Follow-up|5|||
124844775|NCT02896400|449060108|FG007|1 Month Follow-up|Lost to Follow-up|6|||
124844776|NCT02896400|449060109|FG008|1 Month Follow-up|Lost to Follow-up|4|||
124844777|NCT02896400|449060110|FG009|1 Month Follow-up|Lost to Follow-up|7|||
124844778|NCT02896400|449060111|FG010|1 Month Follow-up|Lost to Follow-up|5|||
124844779|NCT02896400|449060112|FG011|1 Month Follow-up|Lost to Follow-up|5|||
124844780|NCT02896400|449060113|FG012|1 Month Follow-up|Lost to Follow-up|3|||
124640281|NCT02016105|448299910|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
124640282|NCT02016105|448299911|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
124640283|NCT02016105|448299906|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
124640284|NCT02016105|448299907|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
124640285|NCT02016105|448299908|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
124640286|NCT02016105|448299909|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
124640287|NCT02016105|448299910|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
124640288|NCT02016105|448299911|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
124640289|NCT02016105|448299906|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
124640290|NCT02016105|448299907|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
124640291|NCT02016105|448299908|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
124640292|NCT02016105|448299909|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
124640293|NCT02016105|448299910|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
124640294|NCT02016105|448299911|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
124640295|NCT02016105|448299906|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
124640296|NCT02016105|448299907|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
124640297|NCT02016105|448299908|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
124640298|NCT02016105|448299909|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
124640299|NCT02016105|448299910|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
124640300|NCT02016105|448299911|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
124640301|NCT02016105|448299906|FG000|EXTENSION PERIOD|Adverse Event|0|||
124640302|NCT02016105|448299907|FG001|EXTENSION PERIOD|Adverse Event|0|||
124640303|NCT02016105|448299908|FG002|EXTENSION PERIOD|Adverse Event|2|||
124640304|NCT02016105|448299909|FG003|EXTENSION PERIOD|Adverse Event|0|||
124640305|NCT02016105|448299910|FG004|EXTENSION PERIOD|Adverse Event|1|||
124640306|NCT02016105|448299911|FG005|EXTENSION PERIOD|Adverse Event|0|||
124640307|NCT02016105|448299906|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
124640308|NCT02016105|448299907|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
124640309|NCT02016105|448299908|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
124640310|NCT02016105|448299909|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
124640311|NCT02016105|448299910|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
124640312|NCT02016105|448299911|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
124640313|NCT02016105|448299906|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
124640314|NCT02016105|448299907|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
124640315|NCT02016105|448299908|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
124640316|NCT02016105|448299909|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
124640317|NCT02016105|448299910|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
124640318|NCT02016105|448299911|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
124640319|NCT02016105|448299906|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
124640320|NCT02016105|448299907|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
124640321|NCT02016105|448299908|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
124640322|NCT02016105|448299909|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
124640323|NCT02016105|448299910|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
124640324|NCT02016105|448299911|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
124640325|NCT02247440|448299912|FG000|Overall Study|Withdrawal by Subject|1|||
124640326|NCT02247440|448299912|FG000|Overall Study|Lack of Efficacy|3|||
124640327|NCT02751450|448299916|FG000|Overall Study|Adverse Event|1|||
124844781|NCT02896400|449060114|FG013|1 Month Follow-up|Lost to Follow-up|4|||
124844782|NCT02896400|449060115|FG014|1 Month Follow-up|Lost to Follow-up|1|||
124844783|NCT02896400|449060116|FG015|1 Month Follow-up|Lost to Follow-up|2|||
124844784|NCT02896400|449060101|FG000|1 Month Follow-up|Death|0|||
124844785|NCT02896400|449060102|FG001|1 Month Follow-up|Death|0|||
124844786|NCT02896400|449060103|FG002|1 Month Follow-up|Death|0|||
124844787|NCT02896400|449060104|FG003|1 Month Follow-up|Death|0|||
124844788|NCT02896400|449060105|FG004|1 Month Follow-up|Death|0|||
124640328|NCT02751450|448299917|FG001|Overall Study|Adverse Event|0|||
124640329|NCT00562302|448299918|FG000|Overall Study|Lost to Follow-up|3|||
124640330|NCT00562302|448299919|FG001|Overall Study|Lost to Follow-up|3|||
124640331|NCT00562302|448299918|FG000|Overall Study|Adverse Event|0|||
124640332|NCT00562302|448299919|FG001|Overall Study|Adverse Event|6|||
124640333|NCT00562302|448299918|FG000|Overall Study|Non-compliance|1|||
124640334|NCT00562302|448299919|FG001|Overall Study|Non-compliance|2|||
124640335|NCT00562302|448299918|FG000|Overall Study|Withdrawal by Subject|7|||
124640336|NCT00562302|448299919|FG001|Overall Study|Withdrawal by Subject|8|||
124640337|NCT00562302|448299918|FG000|Overall Study|Death|1|||
124640338|NCT00562302|448299919|FG001|Overall Study|Death|2|||
124640339|NCT00562302|448299918|FG000|Overall Study|Lung resection prior to study completion|7|||
124640340|NCT00562302|448299919|FG001|Overall Study|Lung resection prior to study completion|7|||
124640341|NCT00562302|448299918|FG000|Overall Study|Not stated|1|||
124640342|NCT00562302|448299919|FG001|Overall Study|Not stated|4|||
124640343|NCT01290679|448299920|FG000|Overall Study|Adverse Event|2|||
124640344|NCT01290679|448299921|FG001|Overall Study|Adverse Event|0|||
124640345|NCT01290679|448299920|FG000|Overall Study|Lost to Follow-up|8|||
124640346|NCT01290679|448299921|FG001|Overall Study|Lost to Follow-up|10|||
124640347|NCT01290679|448299920|FG000|Overall Study|Protocol Violation|0|||
124640348|NCT01290679|448299921|FG001|Overall Study|Protocol Violation|1|||
124640349|NCT01290679|448299920|FG000|Overall Study|Withdrawal by Subject|6|||
124640350|NCT01290679|448299921|FG001|Overall Study|Withdrawal by Subject|5|||
124640351|NCT01290679|448299920|FG000|Overall Study|Subject Entered Another Trial|0|||
124640352|NCT01290679|448299921|FG001|Overall Study|Subject Entered Another Trial|5|||
124640353|NCT03124407|448299927|FG000|Overall Study|Lost to Follow-up|1|||
124640354|NCT03124407|448299928|FG001|Overall Study|Lost to Follow-up|0|||
124640355|NCT03124407|448299929|FG002|Overall Study|Lost to Follow-up|0|||
124640356|NCT03124407|448299930|FG003|Overall Study|Lost to Follow-up|0|||
124640357|NCT03124407|448299927|FG000|Overall Study|Adverse Event|0|||
124640358|NCT03124407|448299928|FG001|Overall Study|Adverse Event|0|||
124640359|NCT03124407|448299929|FG002|Overall Study|Adverse Event|1|||
124640360|NCT03124407|448299930|FG003|Overall Study|Adverse Event|0|||
124640361|NCT01860040|448299933|FG000|Overall Study|Withdrawal by Subject|1|||
124640362|NCT01860040|448299934|FG001|Overall Study|Withdrawal by Subject|0|||
124640363|NCT02821754|448299935|FG000|Overall Study|Procedure not required prior to amendment change|13|||
124640364|NCT02821754|448299936|FG001|Overall Study|Procedure not required prior to amendment change|11|||
124640365|NCT02821754|448299937|FG002|Overall Study|Procedure not required prior to amendment change|0|||
124640366|NCT02821754|448299935|FG000|Overall Study|Participant's Clinical status|2|||
124640367|NCT02821754|448299936|FG001|Overall Study|Participant's Clinical status|0|||
124640368|NCT02821754|448299937|FG002|Overall Study|Participant's Clinical status|0|||
124640369|NCT02821754|448299935|FG000|Overall Study|Participant removed for noncompliance|1|||
124640370|NCT02821754|448299936|FG001|Overall Study|Participant removed for noncompliance|0|||
124640371|NCT02821754|448299937|FG002|Overall Study|Participant removed for noncompliance|0|||
124640372|NCT02821754|448299935|FG000|Overall Study|Drug not available.|0|||
124640373|NCT02821754|448299936|FG001|Overall Study|Drug not available.|0|||
124640374|NCT02821754|448299937|FG002|Overall Study|Drug not available.|1|||
124640375|NCT02821754|448299935|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
124640376|NCT02821754|448299936|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
124640377|NCT02821754|448299937|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
124640378|NCT00994461|448299947|FG000|Overall Study|Adverse Event|2|||
124640379|NCT00994461|448299948|FG001|Overall Study|Adverse Event|1|||
124640380|NCT00994461|448299949|FG002|Overall Study|Adverse Event|0|||
124640381|NCT03478644|448299950|FG000|Phase 2|Withdrawal by Subject|2|||
124640382|NCT03478644|448299951|FG001|Phase 2|Withdrawal by Subject|1|||
124640383|NCT03478644|448299950|FG000|Phase 2|Lost to Follow-up|1|||
124640384|NCT03478644|448299951|FG001|Phase 2|Lost to Follow-up|0|||
124640385|NCT01029782|448299952|FG000|Overall Study|Lost to Follow-up|2|||
124640386|NCT01029782|448299953|FG001|Overall Study|Lost to Follow-up|2|||
124640387|NCT01029782|448299952|FG000|Overall Study|Diagnosis changed|1|||
124640388|NCT01029782|448299953|FG001|Overall Study|Diagnosis changed|1|||
124640389|NCT01029782|448299952|FG000|Overall Study|Adverse Event|0|||
124640390|NCT01029782|448299953|FG001|Overall Study|Adverse Event|1|||
124640391|NCT01029782|448299952|FG000|Overall Study|Physician Decision|0|||
124640392|NCT01029782|448299953|FG001|Overall Study|Physician Decision|1|||
124640393|NCT01029782|448299952|FG000|Overall Study|Protocol Violation|0|||
124640394|NCT01029782|448299953|FG001|Overall Study|Protocol Violation|2|||
124640395|NCT01029782|448299952|FG000|Overall Study|Withdrawal by Subject|0|||
124640396|NCT01029782|448299953|FG001|Overall Study|Withdrawal by Subject|1|||
124844789|NCT02896400|449060106|FG005|1 Month Follow-up|Death|0|||
124844790|NCT02896400|449060107|FG006|1 Month Follow-up|Death|0|||
124844791|NCT02896400|449060108|FG007|1 Month Follow-up|Death|0|||
124844792|NCT02896400|449060109|FG008|1 Month Follow-up|Death|0|||
124844793|NCT02896400|449060110|FG009|1 Month Follow-up|Death|0|||
124844794|NCT02896400|449060111|FG010|1 Month Follow-up|Death|0|||
124844795|NCT02896400|449060112|FG011|1 Month Follow-up|Death|0|||
124844796|NCT02896400|449060113|FG012|1 Month Follow-up|Death|0|||
124844797|NCT02896400|449060114|FG013|1 Month Follow-up|Death|0|||
124844798|NCT02896400|449060115|FG014|1 Month Follow-up|Death|0|||
124844799|NCT02896400|449060116|FG015|1 Month Follow-up|Death|1|||
124844800|NCT02896400|449060101|FG000|3 Month Follow-up|Lost to Follow-up|6|||
124844801|NCT02896400|449060102|FG001|3 Month Follow-up|Lost to Follow-up|3|||
124844802|NCT02896400|449060103|FG002|3 Month Follow-up|Lost to Follow-up|6|||
124844803|NCT02896400|449060104|FG003|3 Month Follow-up|Lost to Follow-up|11|||
124844804|NCT02896400|449060105|FG004|3 Month Follow-up|Lost to Follow-up|12|||
124844805|NCT02896400|449060106|FG005|3 Month Follow-up|Lost to Follow-up|6|||
124844806|NCT02896400|449060107|FG006|3 Month Follow-up|Lost to Follow-up|4|||
124844807|NCT02896400|449060108|FG007|3 Month Follow-up|Lost to Follow-up|3|||
124844808|NCT02896400|449060109|FG008|3 Month Follow-up|Lost to Follow-up|6|||
124844809|NCT02896400|449060110|FG009|3 Month Follow-up|Lost to Follow-up|5|||
124844810|NCT02896400|449060111|FG010|3 Month Follow-up|Lost to Follow-up|6|||
124844811|NCT02896400|449060112|FG011|3 Month Follow-up|Lost to Follow-up|6|||
124844812|NCT02896400|449060113|FG012|3 Month Follow-up|Lost to Follow-up|3|||
124844813|NCT02896400|449060114|FG013|3 Month Follow-up|Lost to Follow-up|5|||
124844814|NCT02896400|449060115|FG014|3 Month Follow-up|Lost to Follow-up|3|||
124844815|NCT02896400|449060116|FG015|3 Month Follow-up|Lost to Follow-up|2|||
124844816|NCT02896400|449060101|FG000|3 Month Follow-up|Death|0|||
124844817|NCT02896400|449060102|FG001|3 Month Follow-up|Death|0|||
124844818|NCT02896400|449060103|FG002|3 Month Follow-up|Death|0|||
124844819|NCT02896400|449060104|FG003|3 Month Follow-up|Death|0|||
124844820|NCT02896400|449060105|FG004|3 Month Follow-up|Death|0|||
124844821|NCT02896400|449060106|FG005|3 Month Follow-up|Death|0|||
124844822|NCT02896400|449060107|FG006|3 Month Follow-up|Death|0|||
124844823|NCT02896400|449060108|FG007|3 Month Follow-up|Death|0|||
124844824|NCT02896400|449060109|FG008|3 Month Follow-up|Death|0|||
124844825|NCT02896400|449060110|FG009|3 Month Follow-up|Death|0|||
124844826|NCT02896400|449060111|FG010|3 Month Follow-up|Death|0|||
124844827|NCT02896400|449060112|FG011|3 Month Follow-up|Death|0|||
124844828|NCT02896400|449060113|FG012|3 Month Follow-up|Death|0|||
124844829|NCT02896400|449060114|FG013|3 Month Follow-up|Death|1|||
124844830|NCT02896400|449060115|FG014|3 Month Follow-up|Death|1|||
124844831|NCT02896400|449060116|FG015|3 Month Follow-up|Death|0|||
124844832|NCT02896400|449060101|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
124844833|NCT02896400|449060102|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
124844834|NCT02896400|449060103|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
124844835|NCT02896400|449060104|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
124844836|NCT02896400|449060105|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
124844837|NCT02896400|449060106|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
124844838|NCT02896400|449060107|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
124844839|NCT02896400|449060108|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
124844840|NCT02896400|449060109|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
124844841|NCT02896400|449060110|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
124844842|NCT02896400|449060111|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
124844843|NCT02896400|449060112|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
124844844|NCT02896400|449060113|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
124844845|NCT02896400|449060114|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
124844846|NCT02896400|449060115|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
124640397|NCT02195869|448299955|FG000|Overall Study|cGVHD Progression|5|||
124640398|NCT02195869|448299955|FG000|Overall Study|Malignancy Progression/relapse|2|||
124844847|NCT02896400|449060116|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
124844848|NCT02896400|449060101|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
124844849|NCT02896400|449060102|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
124844850|NCT02896400|449060103|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
124844851|NCT02896400|449060104|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
124844852|NCT02896400|449060105|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
124844853|NCT02896400|449060106|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
124844854|NCT02896400|449060107|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
124844855|NCT02896400|449060108|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
124844856|NCT02896400|449060109|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
124844857|NCT02896400|449060110|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
124844858|NCT02896400|449060111|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
124844859|NCT02896400|449060112|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
124753479|NCT03364309|448718909|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
124753480|NCT03364309|448718910|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
124753481|NCT03364309|448718911|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
124753482|NCT03364309|448718912|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
124753483|NCT03364309|448718913|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
124753484|NCT03364309|448718914|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
124753485|NCT03364309|448718915|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
124753486|NCT03364309|448718897|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753487|NCT03364309|448718898|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753488|NCT03364309|448718899|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753489|NCT03364309|448718900|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753490|NCT03364309|448718901|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753491|NCT03364309|448718902|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753492|NCT03364309|448718903|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753493|NCT03364309|448718904|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753494|NCT03364309|448718905|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753495|NCT03364309|448718906|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753496|NCT03364309|448718907|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753497|NCT03364309|448718908|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753498|NCT03364309|448718909|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753499|NCT03364309|448718910|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753500|NCT03364309|448718911|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
124753501|NCT03364309|448718912|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753502|NCT03364309|448718913|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753503|NCT03364309|448718914|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753504|NCT03364309|448718915|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
124753505|NCT03364309|448718897|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
124753506|NCT03364309|448718898|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
124753507|NCT03364309|448718899|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
124753508|NCT03364309|448718900|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
124753509|NCT03364309|448718901|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
124753510|NCT03364309|448718902|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
124753511|NCT03364309|448718903|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
124753512|NCT03364309|448718904|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
124753513|NCT03364309|448718905|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
124753514|NCT03364309|448718906|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
124753515|NCT03364309|448718907|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
124753516|NCT03364309|448718908|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
124753517|NCT03364309|448718909|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
124753518|NCT03364309|448718910|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
124753519|NCT03364309|448718911|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
124753520|NCT03364309|448718912|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
124753521|NCT03364309|448718913|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
124753522|NCT03364309|448718914|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
124753523|NCT03364309|448718915|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
124753524|NCT03364309|448718897|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
124753525|NCT03364309|448718898|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
124753526|NCT03364309|448718899|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
124753527|NCT03364309|448718900|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
124753528|NCT03364309|448718901|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
124753529|NCT03364309|448718902|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
124753530|NCT03364309|448718903|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
124753531|NCT03364309|448718904|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
124753532|NCT03364309|448718905|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
124753533|NCT03364309|448718906|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
124753534|NCT03364309|448718907|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
124753535|NCT03364309|448718908|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
124753536|NCT03364309|448718909|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
124753537|NCT03364309|448718910|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
124753538|NCT03364309|448718911|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
124753539|NCT03364309|448718912|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
124753540|NCT03364309|448718913|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
124753541|NCT03364309|448718914|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
124753542|NCT03364309|448718915|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
124753543|NCT03364309|448718897|FG000|Post-Treatment Followup Period|Adverse Event|0|||
124753544|NCT03364309|448718898|FG001|Post-Treatment Followup Period|Adverse Event|0|||
124753545|NCT03364309|448718899|FG002|Post-Treatment Followup Period|Adverse Event|0|||
124753546|NCT03364309|448718900|FG003|Post-Treatment Followup Period|Adverse Event|0|||
124753547|NCT03364309|448718901|FG004|Post-Treatment Followup Period|Adverse Event|0|||
124976620|NCT02614183|449540015|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
124640399|NCT02195869|448299955|FG000|Overall Study|Adverse Event|15|||
124640400|NCT02195869|448299955|FG000|Overall Study|Withdrawal by Subject|7|||
124640401|NCT02195869|448299955|FG000|Overall Study|Physician Decision|4|||
124640402|NCT02195869|448299955|FG000|Overall Study|Study Terminated by Sponsor|7|||
124640403|NCT02195869|448299955|FG000|Overall Study|Noncompliance with study drug|2|||
124640404|NCT03056638|448301409|FG000|Overall Study|Death|1|||
124640405|NCT03056638|448301410|FG001|Overall Study|Death|0|||
124640406|NCT00610155|448301414|FG000|Period 1|Withdrawal by Subject|0|||
124640407|NCT00610155|448301415|FG001|Period 1|Withdrawal by Subject|0|||
124640408|NCT00610155|448301416|FG002|Period 1|Withdrawal by Subject|1|||
124640409|NCT00610155|448301417|FG003|Period 1|Withdrawal by Subject|0|||
124640410|NCT00610155|448301418|FG004|Period 1|Withdrawal by Subject|0|||
124640411|NCT00610155|448301419|FG005|Period 1|Withdrawal by Subject|0|||
124640412|NCT00610155|448301414|FG000|Period 3|Adverse Event|1|||
124640413|NCT00610155|448301415|FG001|Period 3|Adverse Event|0|||
124640414|NCT00610155|448301416|FG002|Period 3|Adverse Event|0|||
124640415|NCT00610155|448301417|FG003|Period 3|Adverse Event|0|||
124640416|NCT00610155|448301418|FG004|Period 3|Adverse Event|0|||
124640417|NCT00610155|448301419|FG005|Period 3|Adverse Event|0|||
124640418|NCT01718535|448301420|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
124640419|NCT01718535|448301421|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
124640420|NCT01718535|448301422|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
124640421|NCT01718535|448301423|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
124640422|NCT01718535|448301424|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
124640423|NCT01718535|448301425|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
124640424|NCT01718535|448301426|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
124640425|NCT01718535|448301427|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
124640426|NCT01718535|448301428|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
124640427|NCT01718535|448301429|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
124640428|NCT01073605|448301433|FG000|Overall Study|Ongoing at Cutoff Date|1|||
124640429|NCT01073605|448301434|FG001|Overall Study|Ongoing at Cutoff Date|1|||
124640430|NCT01073605|448301435|FG002|Overall Study|Ongoing at Cutoff Date|0|||
124640431|NCT01073605|448301433|FG000|Overall Study|Adverse Event|2|||
124640432|NCT01073605|448301434|FG001|Overall Study|Adverse Event|1|||
124640433|NCT01073605|448301435|FG002|Overall Study|Adverse Event|0|||
124640434|NCT01073605|448301433|FG000|Overall Study|Lost to Follow-up|3|||
124640435|NCT01073605|448301434|FG001|Overall Study|Lost to Follow-up|4|||
124640436|NCT01073605|448301435|FG002|Overall Study|Lost to Follow-up|9|||
124640437|NCT01073605|448301433|FG000|Overall Study|Other|25|||
124640438|NCT01073605|448301434|FG001|Overall Study|Other|21|||
124640439|NCT01073605|448301435|FG002|Overall Study|Other|29|||
124640440|NCT01073605|448301433|FG000|Overall Study|Withdrawal by Subject|31|||
124640441|NCT01073605|448301434|FG001|Overall Study|Withdrawal by Subject|39|||
124640442|NCT01073605|448301435|FG002|Overall Study|Withdrawal by Subject|22|||
124640443|NCT01073605|448301433|FG000|Overall Study|Randomized But Not Treated|0|||
124640444|NCT01073605|448301434|FG001|Overall Study|Randomized But Not Treated|1|||
124640445|NCT01073605|448301435|FG002|Overall Study|Randomized But Not Treated|1|||
124640446|NCT01284348|448301436|FG000|Overall Study|Death|1|||
124640447|NCT01284348|448301437|FG001|Overall Study|Death|1|||
124640448|NCT01284348|448301436|FG000|Overall Study|Withdrew consent|0|||
124640449|NCT01284348|448301437|FG001|Overall Study|Withdrew consent|1|||
124640450|NCT01284348|448301436|FG000|Overall Study|Status not recorded|9|||
124640451|NCT01284348|448301437|FG001|Overall Study|Status not recorded|10|||
124640452|NCT02088905|448301443|FG000|Overall Study|Withdrawal by Subject|5|||
124640453|NCT02088905|448301444|FG001|Overall Study|Withdrawal by Subject|1|||
124640454|NCT00379080|448301446|FG000|Overall Study|Withdrawal by Subject|0|||
124640455|NCT00379080|448301447|FG001|Overall Study|Withdrawal by Subject|4|||
124640456|NCT00379080|448301448|FG002|Overall Study|Withdrawal by Subject|0|||
124640457|NCT00857896|448301453|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
124640458|NCT01091662|448301455|FG000|Overall Study|Adverse Event|1|||
124640459|NCT01091662|448301456|FG001|Overall Study|Adverse Event|9|||
124640460|NCT01091662|448301455|FG000|Overall Study|Physician Decision|1|||
124640461|NCT01091662|448301456|FG001|Overall Study|Physician Decision|1|||
124640462|NCT01091662|448301455|FG000|Overall Study|Withdrawal by Subject|7|||
124640463|NCT01091662|448301456|FG001|Overall Study|Withdrawal by Subject|6|||
124640464|NCT01091662|448301455|FG000|Overall Study|met exit criteria|7|||
124640465|NCT01091662|448301456|FG001|Overall Study|met exit criteria|13|||
124640466|NCT01091662|448301455|FG000|Overall Study|met exclusion criteria|1|||
124640467|NCT01091662|448301456|FG001|Overall Study|met exclusion criteria|0|||
124640468|NCT01091662|448301455|FG000|Overall Study|Lost to Follow-up|0|||
124640469|NCT01091662|448301456|FG001|Overall Study|Lost to Follow-up|1|||
124640470|NCT01091662|448301455|FG000|Overall Study|Pregnancy|0|||
124640471|NCT01091662|448301456|FG001|Overall Study|Pregnancy|1|||
124640472|NCT01091662|448301455|FG000|Overall Study|Protocol Violation|0|||
124640473|NCT01091662|448301456|FG001|Overall Study|Protocol Violation|2|||
124640474|NCT01091662|448301455|FG000|Overall Study|unable to swallow capsule|0|||
124640475|NCT01091662|448301456|FG001|Overall Study|unable to swallow capsule|1|||
124753548|NCT03364309|448718902|FG005|Post-Treatment Followup Period|Adverse Event|0|||
124753549|NCT03364309|448718903|FG006|Post-Treatment Followup Period|Adverse Event|0|||
124753550|NCT03364309|448718904|FG007|Post-Treatment Followup Period|Adverse Event|0|||
124753551|NCT03364309|448718905|FG008|Post-Treatment Followup Period|Adverse Event|0|||
124753552|NCT03364309|448718906|FG009|Post-Treatment Followup Period|Adverse Event|0|||
124753553|NCT03364309|448718907|FG010|Post-Treatment Followup Period|Adverse Event|0|||
124753554|NCT03364309|448718908|FG011|Post-Treatment Followup Period|Adverse Event|0|||
124753555|NCT03364309|448718909|FG012|Post-Treatment Followup Period|Adverse Event|0|||
124844860|NCT02896400|449060113|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
124844861|NCT02896400|449060114|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
124844862|NCT02896400|449060115|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
124844863|NCT02896400|449060116|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
124844864|NCT01207778|449060117|FG000|Overall Study|Lost to Follow-up|0|||
124844865|NCT01207778|449060118|FG001|Overall Study|Lost to Follow-up|3|||
124844866|NCT01207778|449060119|FG002|Overall Study|Lost to Follow-up|3|||
124844867|NCT00646204|449060120|FG000|Overall Study|Adverse Event|3|||
124844868|NCT00646204|449060121|FG001|Overall Study|Adverse Event|0|||
124844869|NCT00646204|449060120|FG000|Overall Study|Withdrawal by Subject|1|||
124844870|NCT00646204|449060121|FG001|Overall Study|Withdrawal by Subject|0|||
124844871|NCT00298896|449060128|FG000|Overall Study|Death|3|||
124844872|NCT00298896|449060128|FG000|Overall Study|Physician Decision|2|||
124844873|NCT00298896|449060128|FG000|Overall Study|Intercurrent Illness|1|||
124844874|NCT00298896|449060128|FG000|Overall Study|Disease Progression|41|||
124844875|NCT00298896|449060128|FG000|Overall Study|Withdrawal by Subject|2|||
124844876|NCT00298896|449060128|FG000|Overall Study|Assigned to treatment in error|1|||
124844877|NCT02649972|449060131|FG000|Overall Study|Not treated|1|||
124753556|NCT03364309|448718910|FG013|Post-Treatment Followup Period|Adverse Event|0|||
124753557|NCT03364309|448718911|FG014|Post-Treatment Followup Period|Adverse Event|0|||
124753558|NCT03364309|448718912|FG015|Post-Treatment Followup Period|Adverse Event|0|||
124753559|NCT03364309|448718913|FG016|Post-Treatment Followup Period|Adverse Event|2|||
124753560|NCT03364309|448718914|FG017|Post-Treatment Followup Period|Adverse Event|6|||
124753561|NCT03364309|448718915|FG018|Post-Treatment Followup Period|Adverse Event|1|||
124753562|NCT03364309|448718897|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
124753563|NCT03364309|448718898|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
124753564|NCT03364309|448718899|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
124753565|NCT03364309|448718900|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
124753566|NCT03364309|448718901|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
124753567|NCT03364309|448718902|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
124753568|NCT03364309|448718903|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
124753569|NCT03364309|448718904|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
124753570|NCT03364309|448718905|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
124753571|NCT03364309|448718906|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
124753572|NCT03364309|448718907|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
124844878|NCT03285646|449060138|FG000|Overall Study|Adverse Event|1|||
124844879|NCT03285646|449060139|FG001|Overall Study|Adverse Event|0|||
124844880|NCT03285646|449060138|FG000|Overall Study|Withdrawal by Subject|10|||
124844881|NCT03285646|449060139|FG001|Overall Study|Withdrawal by Subject|2|||
124844882|NCT03285646|449060138|FG000|Overall Study|Lost to Follow-up|2|||
124844883|NCT03285646|449060139|FG001|Overall Study|Lost to Follow-up|1|||
124844884|NCT03285646|449060138|FG000|Overall Study|Investigator/Sponsor Decision|0|||
124844885|NCT03285646|449060139|FG001|Overall Study|Investigator/Sponsor Decision|1|||
124844886|NCT00503841|449060141|FG000|Overall Study|All screen failures|44|||
124844887|NCT01344057|449060142|FG000|Overall Study|Premature Withdrawal|1|||
124844888|NCT00306592|449060143|FG000|Overall Study|Adverse Event|8|||
124844889|NCT00306592|449060144|FG001|Overall Study|Adverse Event|15|||
124844890|NCT00306592|449060143|FG000|Overall Study|Lost to Follow-up|1|||
124844891|NCT00306592|449060144|FG001|Overall Study|Lost to Follow-up|0|||
124844892|NCT00306592|449060143|FG000|Overall Study|Noncompliance|0|||
124844893|NCT00306592|449060144|FG001|Overall Study|Noncompliance|2|||
124844894|NCT00306592|449060143|FG000|Overall Study|Persistent Antibodies|6|||
124844895|NCT00306592|449060144|FG001|Overall Study|Persistent Antibodies|3|||
124844896|NCT00306592|449060143|FG000|Overall Study|Voluntary|10|||
124844897|NCT00306592|449060144|FG001|Overall Study|Voluntary|6|||
124844898|NCT00306592|449060143|FG000|Overall Study|Other|5|||
124844899|NCT00306592|449060144|FG001|Overall Study|Other|10|||
124844900|NCT00306592|449060143|FG000|Overall Study|Other|1|||
124844901|NCT00306592|449060144|FG001|Overall Study|Other|2|||
124844902|NCT00306592|449060143|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
124844903|NCT00306592|449060144|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
124844904|NCT02488629|449060145|FG000|Overall Study|Lack of Efficacy|3|||
124844905|NCT02488629|449060146|FG001|Overall Study|Lack of Efficacy|1|||
124844906|NCT02488629|449060147|FG002|Overall Study|Lack of Efficacy|0|||
124844907|NCT02488629|449060148|FG003|Overall Study|Lack of Efficacy|0|||
124753573|NCT03364309|448718908|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
124753574|NCT03364309|448718909|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
124753575|NCT03364309|448718910|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
124753576|NCT03364309|448718911|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
124753577|NCT03364309|448718912|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
124753578|NCT03364309|448718913|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
124753579|NCT03364309|448718914|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
124753580|NCT03364309|448718915|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
124753581|NCT03364309|448718897|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
124753582|NCT03364309|448718898|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
124753583|NCT03364309|448718899|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
124753584|NCT03364309|448718900|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
124753585|NCT03364309|448718901|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
124753586|NCT03364309|448718902|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
124753587|NCT03364309|448718903|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
124753588|NCT03364309|448718904|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
124753589|NCT03364309|448718905|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
124753590|NCT03364309|448718906|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
124753591|NCT03364309|448718907|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
124753592|NCT03364309|448718908|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
124753593|NCT03364309|448718909|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
124753594|NCT03364309|448718910|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
124753595|NCT03364309|448718911|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
124753596|NCT03364309|448718912|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
124753597|NCT03364309|448718913|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
124753598|NCT03364309|448718914|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
124753599|NCT03364309|448718915|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
124753600|NCT03304873|448718916|FG000|Overall Study|Lost to Follow-up|1|||
124753601|NCT03304873|448718917|FG001|Overall Study|Lost to Follow-up|8|||
124753602|NCT01546688|448718918|FG000|Overall Study|Adverse Event|0|||
124753603|NCT01546688|448718919|FG001|Overall Study|Adverse Event|4|||
124753604|NCT01546688|448718918|FG000|Overall Study|Withdrawal by Subject|2|||
124753605|NCT01546688|448718919|FG001|Overall Study|Withdrawal by Subject|1|||
124753606|NCT01546688|448718918|FG000|Overall Study|Lack of Efficacy|1|||
124753607|NCT01546688|448718919|FG001|Overall Study|Lack of Efficacy|0|||
124753608|NCT01052077|448718923|FG000|Phase A|Lost to Follow-up|22|||
124753609|NCT01052077|448718924|FG001|Phase A|Lost to Follow-up|0|||
124753610|NCT01052077|448718925|FG002|Phase A|Lost to Follow-up|0|||
124753611|NCT01052077|448718926|FG003|Phase A|Lost to Follow-up|0|||
124753612|NCT01052077|448718923|FG000|Phase A|Adverse Event|32|||
124753613|NCT01052077|448718924|FG001|Phase A|Adverse Event|0|||
124753614|NCT01052077|448718925|FG002|Phase A|Adverse Event|0|||
124753615|NCT01052077|448718926|FG003|Phase A|Adverse Event|0|||
124753616|NCT01052077|448718923|FG000|Phase A|Met Withdrawal Criteria|26|||
124753617|NCT01052077|448718924|FG001|Phase A|Met Withdrawal Criteria|0|||
124753618|NCT01052077|448718925|FG002|Phase A|Met Withdrawal Criteria|0|||
124753619|NCT01052077|448718926|FG003|Phase A|Met Withdrawal Criteria|0|||
124753620|NCT01052077|448718923|FG000|Phase A|Physician Decision|10|||
124753621|NCT01052077|448718924|FG001|Phase A|Physician Decision|0|||
124753622|NCT01052077|448718925|FG002|Phase A|Physician Decision|0|||
124753623|NCT01052077|448718926|FG003|Phase A|Physician Decision|0|||
124753624|NCT01052077|448718923|FG000|Phase A|Withdrawal by Subject|29|||
124753625|NCT01052077|448718924|FG001|Phase A|Withdrawal by Subject|0|||
124753626|NCT01052077|448718925|FG002|Phase A|Withdrawal by Subject|0|||
124753627|NCT01052077|448718926|FG003|Phase A|Withdrawal by Subject|0|||
124753628|NCT01052077|448718923|FG000|Phase A|Protocol Deviation|27|||
124753629|NCT01052077|448718924|FG001|Phase A|Protocol Deviation|0|||
124753630|NCT01052077|448718925|FG002|Phase A|Protocol Deviation|0|||
124753631|NCT01052077|448718926|FG003|Phase A|Protocol Deviation|0|||
124753632|NCT01052077|448718923|FG000|Phase B|Lost to Follow-up|0|||
124753633|NCT01052077|448718924|FG001|Phase B|Lost to Follow-up|2|||
124753634|NCT01052077|448718925|FG002|Phase B|Lost to Follow-up|3|||
124753635|NCT01052077|448718926|FG003|Phase B|Lost to Follow-up|0|||
124753636|NCT01052077|448718923|FG000|Phase B|Adverse Event|0|||
124753637|NCT01052077|448718924|FG001|Phase B|Adverse Event|9|||
124753638|NCT01052077|448718925|FG002|Phase B|Adverse Event|2|||
124753639|NCT01052077|448718926|FG003|Phase B|Adverse Event|0|||
124753640|NCT01052077|448718923|FG000|Phase B|Met Withdrawal Criteria|0|||
124753641|NCT01052077|448718924|FG001|Phase B|Met Withdrawal Criteria|2|||
124753642|NCT01052077|448718925|FG002|Phase B|Met Withdrawal Criteria|1|||
124753643|NCT01052077|448718926|FG003|Phase B|Met Withdrawal Criteria|0|||
124753644|NCT01052077|448718923|FG000|Phase B|Physician Decision|0|||
124753645|NCT01052077|448718924|FG001|Phase B|Physician Decision|1|||
124753646|NCT01052077|448718925|FG002|Phase B|Physician Decision|1|||
124753647|NCT01052077|448718926|FG003|Phase B|Physician Decision|0|||
124753648|NCT01052077|448718923|FG000|Phase B|Withdrawal by Subject|0|||
124753649|NCT01052077|448718924|FG001|Phase B|Withdrawal by Subject|0|||
124753650|NCT01052077|448718925|FG002|Phase B|Withdrawal by Subject|5|||
124753651|NCT01052077|448718926|FG003|Phase B|Withdrawal by Subject|0|||
124844908|NCT02488629|449060145|FG000|Overall Study|Withdrawal by Subject|0|||
124844909|NCT02488629|449060146|FG001|Overall Study|Withdrawal by Subject|1|||
124844910|NCT02488629|449060147|FG002|Overall Study|Withdrawal by Subject|0|||
124844911|NCT02488629|449060148|FG003|Overall Study|Withdrawal by Subject|0|||
124844912|NCT02940691|449060149|FG000|Overall Study|Lost to Follow-up|5|||
124844913|NCT02940691|449060149|FG000|Overall Study|Incarceration|1|||
124844914|NCT03912233|449060150|FG000|Overall Study|Adverse Event|1|||
124844915|NCT03912233|449060151|FG001|Overall Study|Adverse Event|0|||
124844916|NCT03912233|449060152|FG002|Overall Study|Adverse Event|0|||
124844917|NCT03912233|449060153|FG003|Overall Study|Adverse Event|0|||
124844918|NCT03912233|449060154|FG004|Overall Study|Adverse Event|0|||
124844919|NCT03912233|449060155|FG005|Overall Study|Adverse Event|0|||
124844920|NCT03912233|449060150|FG000|Overall Study|Physician Decision|1|||
124844921|NCT03912233|449060151|FG001|Overall Study|Physician Decision|0|||
124844922|NCT03912233|449060152|FG002|Overall Study|Physician Decision|0|||
124844923|NCT03912233|449060153|FG003|Overall Study|Physician Decision|0|||
124844924|NCT03912233|449060154|FG004|Overall Study|Physician Decision|0|||
124844925|NCT03912233|449060155|FG005|Overall Study|Physician Decision|0|||
124844926|NCT03912233|449060150|FG000|Overall Study|Other|0|||
124844927|NCT03912233|449060151|FG001|Overall Study|Other|0|||
124844928|NCT03912233|449060152|FG002|Overall Study|Other|0|||
124844929|NCT03912233|449060153|FG003|Overall Study|Other|0|||
124844930|NCT03912233|449060154|FG004|Overall Study|Other|7|||
124844931|NCT03912233|449060155|FG005|Overall Study|Other|12|||
124844932|NCT00654628|449060156|FG000|6-week Active Treatment Period|Adverse Event|9|||
124844933|NCT00654628|449060156|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
124844934|NCT00654628|449060156|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
124753652|NCT01052077|448718923|FG000|Phase B|Protocol Deviation|0|||
124753653|NCT01052077|448718924|FG001|Phase B|Protocol Deviation|3|||
124753654|NCT01052077|448718925|FG002|Phase B|Protocol Deviation|4|||
124753655|NCT01052077|448718926|FG003|Phase B|Protocol Deviation|0|||
124753656|NCT01052077|448718923|FG000|Phase B|Lack of Efficacy|0|||
124844935|NCT00654628|449060156|FG000|6-week Active Treatment Period|Out of window period|1|||
124844936|NCT00654628|449060156|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
124844937|NCT00654628|449060156|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
124844938|NCT02177266|449060157|FG000|Overall Study|Adverse Event|0|||
124844939|NCT02177266|449060158|FG001|Overall Study|Adverse Event|1|||
124844940|NCT02177266|449060157|FG000|Overall Study|Withdrawal by Subject|1|||
124844941|NCT02177266|449060158|FG001|Overall Study|Withdrawal by Subject|0|||
124844942|NCT00546715|449060162|FG000|Overall Study|Withdrawal by Subject|0|||
124753657|NCT01052077|448718924|FG001|Phase B|Lack of Efficacy|1|||
124753658|NCT01052077|448718925|FG002|Phase B|Lack of Efficacy|0|||
124753659|NCT01052077|448718926|FG003|Phase B|Lack of Efficacy|0|||
124753660|NCT01052077|448718923|FG000|Phase A+|Lost to Follow-up|0|||
124753661|NCT01052077|448718924|FG001|Phase A+|Lost to Follow-up|0|||
124844943|NCT00546715|449060163|FG001|Overall Study|Withdrawal by Subject|1|||
124844944|NCT00546715|449060164|FG002|Overall Study|Withdrawal by Subject|0|||
124844945|NCT00546715|449060165|FG003|Overall Study|Withdrawal by Subject|0|||
124844946|NCT00723606|449060166|FG000|Overall Study|Adverse Event|2|||
124844947|NCT00723606|449060167|FG001|Overall Study|Adverse Event|5|||
124844948|NCT00723606|449060166|FG000|Overall Study|Other|2|||
124844949|NCT00723606|449060167|FG001|Overall Study|Other|0|||
124844950|NCT00723606|449060166|FG000|Overall Study|Withdrawal by Subject|0|||
124844951|NCT00723606|449060167|FG001|Overall Study|Withdrawal by Subject|2|||
124844952|NCT01502644|449060170|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
124844953|NCT01502644|449060171|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
124844954|NCT01502644|449060172|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
124844955|NCT01502644|449060173|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
124844956|NCT01502644|449060170|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
124844957|NCT01502644|449060171|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
124844958|NCT01502644|449060172|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
124844959|NCT01502644|449060173|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
124844960|NCT01502644|449060170|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
124844961|NCT01502644|449060171|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
124844962|NCT01502644|449060172|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
124844963|NCT01502644|449060173|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
124844964|NCT01502644|449060170|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
124844965|NCT01502644|449060171|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
124844966|NCT01502644|449060172|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
124844967|NCT01502644|449060173|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
124844968|NCT01502644|449060170|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
124844969|NCT01502644|449060171|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
124844970|NCT01502644|449060172|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
124640476|NCT01222520|448301457|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
124640477|NCT01222520|448301458|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
124640478|NCT01222520|448301457|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
124640479|NCT01222520|448301458|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
124640480|NCT01222520|448301457|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
124640481|NCT01222520|448301458|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
124640482|NCT01222520|448301457|FG000|Double-blind Period|Adverse Event|0|||
124640483|NCT01222520|448301458|FG001|Double-blind Period|Adverse Event|1|||
124640484|NCT01222520|448301457|FG000|Double-blind Period|Lack of Efficacy|0|||
124640485|NCT01222520|448301458|FG001|Double-blind Period|Lack of Efficacy|1|||
124640486|NCT01222520|448301457|FG000|Double-blind Period|Study medication stolen|1|||
124640487|NCT01222520|448301458|FG001|Double-blind Period|Study medication stolen|0|||
124640488|NCT04109391|448301459|FG000|Overall Study|Adverse Event|2|||
124640489|NCT04109391|448301460|FG001|Overall Study|Adverse Event|2|||
124640490|NCT04109391|448301461|FG002|Overall Study|Adverse Event|0|||
124640491|NCT04109391|448301459|FG000|Overall Study|Withdrawal by Subject|2|||
124640492|NCT04109391|448301460|FG001|Overall Study|Withdrawal by Subject|0|||
124640493|NCT04109391|448301461|FG002|Overall Study|Withdrawal by Subject|0|||
124640494|NCT04109391|448301459|FG000|Overall Study|Pregnancy|1|||
124640495|NCT04109391|448301460|FG001|Overall Study|Pregnancy|0|||
124640496|NCT04109391|448301461|FG002|Overall Study|Pregnancy|0|||
124640497|NCT04109391|448301459|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
124753662|NCT01052077|448718925|FG002|Phase A+|Lost to Follow-up|0|||
124753663|NCT01052077|448718926|FG003|Phase A+|Lost to Follow-up|8|||
124753664|NCT01052077|448718923|FG000|Phase A+|Adverse Event|0|||
124753665|NCT01052077|448718924|FG001|Phase A+|Adverse Event|0|||
124753666|NCT01052077|448718925|FG002|Phase A+|Adverse Event|0|||
124753667|NCT01052077|448718926|FG003|Phase A+|Adverse Event|4|||
124753668|NCT01052077|448718923|FG000|Phase A+|Met Withdrawal Criteria|0|||
124753669|NCT01052077|448718924|FG001|Phase A+|Met Withdrawal Criteria|0|||
124753670|NCT01052077|448718925|FG002|Phase A+|Met Withdrawal Criteria|0|||
124753671|NCT01052077|448718926|FG003|Phase A+|Met Withdrawal Criteria|2|||
124753672|NCT01052077|448718923|FG000|Phase A+|Withdrawal by Subject|0|||
124753673|NCT01052077|448718924|FG001|Phase A+|Withdrawal by Subject|0|||
124753674|NCT01052077|448718925|FG002|Phase A+|Withdrawal by Subject|0|||
124753675|NCT01052077|448718926|FG003|Phase A+|Withdrawal by Subject|7|||
124753676|NCT02465203|448718927|FG000|Overall Study|Protocol Violation|1|||
124753677|NCT02465203|448718928|FG001|Overall Study|Protocol Violation|1|||
124753678|NCT02465203|448718929|FG002|Overall Study|Protocol Violation|1|||
124753679|NCT02465203|448718927|FG000|Overall Study|Study terminated by sponsor|50|||
124753680|NCT02465203|448718928|FG001|Overall Study|Study terminated by sponsor|34|||
124753681|NCT02465203|448718929|FG002|Overall Study|Study terminated by sponsor|11|||
124753682|NCT02465203|448718927|FG000|Overall Study|New therapy for study indication|4|||
124753683|NCT02465203|448718928|FG001|Overall Study|New therapy for study indication|0|||
124753684|NCT02465203|448718929|FG002|Overall Study|New therapy for study indication|0|||
124753685|NCT02465203|448718927|FG000|Overall Study|Patient/guardian decision|1|||
124753686|NCT02465203|448718928|FG001|Overall Study|Patient/guardian decision|1|||
124753687|NCT02465203|448718929|FG002|Overall Study|Patient/guardian decision|1|||
124753688|NCT00042991|448718930|FG000|Overall Study|Adverse Event|1|||
124753689|NCT00042991|448718931|FG001|Overall Study|Adverse Event|4|||
124753690|NCT00042991|448718932|FG002|Overall Study|Adverse Event|2|||
124753691|NCT00042991|448718933|FG003|Overall Study|Adverse Event|0|||
124753692|NCT00042991|448718934|FG004|Overall Study|Adverse Event|0|||
124753693|NCT00042991|448718935|FG005|Overall Study|Adverse Event|1|||
124753694|NCT00042991|448718936|FG006|Overall Study|Adverse Event|0|||
124753695|NCT00042991|448718930|FG000|Overall Study|Withdrawal by Subject|0|||
124753696|NCT00042991|448718931|FG001|Overall Study|Withdrawal by Subject|7|||
124753697|NCT00042991|448718932|FG002|Overall Study|Withdrawal by Subject|2|||
124753698|NCT00042991|448718933|FG003|Overall Study|Withdrawal by Subject|0|||
124753699|NCT00042991|448718934|FG004|Overall Study|Withdrawal by Subject|1|||
124753700|NCT00042991|448718935|FG005|Overall Study|Withdrawal by Subject|0|||
124753701|NCT00042991|448718936|FG006|Overall Study|Withdrawal by Subject|0|||
124753702|NCT00042991|448718930|FG000|Overall Study|Disease Progression|5|||
124753703|NCT00042991|448718931|FG001|Overall Study|Disease Progression|29|||
124753704|NCT00042991|448718932|FG002|Overall Study|Disease Progression|2|||
124753705|NCT00042991|448718933|FG003|Overall Study|Disease Progression|2|||
124753706|NCT00042991|448718934|FG004|Overall Study|Disease Progression|1|||
124753707|NCT00042991|448718935|FG005|Overall Study|Disease Progression|4|||
124753708|NCT00042991|448718936|FG006|Overall Study|Disease Progression|2|||
124753709|NCT00042991|448718930|FG000|Overall Study|Alternative Therapy|0|||
124753710|NCT00042991|448718931|FG001|Overall Study|Alternative Therapy|0|||
124753711|NCT00042991|448718932|FG002|Overall Study|Alternative Therapy|0|||
124753712|NCT00042991|448718933|FG003|Overall Study|Alternative Therapy|0|||
124753713|NCT00042991|448718934|FG004|Overall Study|Alternative Therapy|1|||
124753714|NCT00042991|448718935|FG005|Overall Study|Alternative Therapy|0|||
124753715|NCT00042991|448718936|FG006|Overall Study|Alternative Therapy|0|||
124753716|NCT04072887|448718937|FG000|Overall Study|Withdrawal by Subject|3|||
124753717|NCT04072887|448718938|FG001|Overall Study|Withdrawal by Subject|8|||
124753718|NCT04072887|448718939|FG002|Overall Study|Withdrawal by Subject|1|||
124753719|NCT04072887|448718940|FG003|Overall Study|Withdrawal by Subject|3|||
124753720|NCT04072887|448718941|FG004|Overall Study|Withdrawal by Subject|3|||
124640498|NCT04109391|448301460|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
124640499|NCT04109391|448301461|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
124640500|NCT04109391|448301459|FG000|Overall Study|Lost to Follow-up|0|||
124640501|NCT04109391|448301460|FG001|Overall Study|Lost to Follow-up|0|||
124640502|NCT04109391|448301461|FG002|Overall Study|Lost to Follow-up|1|||
124640503|NCT04109391|448301459|FG000|Overall Study|Lack of Efficacy|2|||
124640504|NCT04109391|448301460|FG001|Overall Study|Lack of Efficacy|2|||
124640505|NCT04109391|448301461|FG002|Overall Study|Lack of Efficacy|3|||
124640506|NCT01089608|448301464|FG000|Overall Study|Adverse Event|0|||
124640507|NCT01089608|448301465|FG001|Overall Study|Adverse Event|4|||
124640508|NCT01089608|448301464|FG000|Overall Study|Lost to Follow-up|0|||
124640509|NCT01089608|448301465|FG001|Overall Study|Lost to Follow-up|2|||
124640510|NCT04606394|448301466|FG000|Overall Study|Withdrawal by Subject|3|||
124640511|NCT04606394|448301466|FG000|Overall Study|Exclusion criteria screen failure|12|||
124640512|NCT00955955|448301467|FG000|Overall Study|Lost to Follow-up|2|||
124640513|NCT00955955|448301468|FG001|Overall Study|Lost to Follow-up|0|||
124640514|NCT00955955|448301469|FG002|Overall Study|Lost to Follow-up|0|||
124640515|NCT03423173|448301470|FG000|Overall Study|Randomized but not vaccinated|1|||
124640516|NCT03423173|448301471|FG001|Overall Study|Randomized but not vaccinated|0|||
124640517|NCT03423173|448301472|FG002|Overall Study|Randomized but not vaccinated|2|||
124640518|NCT03423173|448301473|FG003|Overall Study|Randomized but not vaccinated|1|||
124753721|NCT04072887|448718942|FG005|Overall Study|Withdrawal by Subject|13|||
124753722|NCT04072887|448718937|FG000|Overall Study|Adverse Event|2|||
124753723|NCT04072887|448718938|FG001|Overall Study|Adverse Event|4|||
124753724|NCT04072887|448718939|FG002|Overall Study|Adverse Event|1|||
124753725|NCT04072887|448718940|FG003|Overall Study|Adverse Event|4|||
124753726|NCT04072887|448718941|FG004|Overall Study|Adverse Event|0|||
124753727|NCT04072887|448718942|FG005|Overall Study|Adverse Event|1|||
124753728|NCT04072887|448718937|FG000|Overall Study|Physician Decision|2|||
124753729|NCT04072887|448718938|FG001|Overall Study|Physician Decision|0|||
124753730|NCT04072887|448718939|FG002|Overall Study|Physician Decision|0|||
124753731|NCT04072887|448718940|FG003|Overall Study|Physician Decision|0|||
124753732|NCT04072887|448718941|FG004|Overall Study|Physician Decision|0|||
124753733|NCT04072887|448718942|FG005|Overall Study|Physician Decision|1|||
124753734|NCT04072887|448718937|FG000|Overall Study|Lost to Follow-up|1|||
124753735|NCT04072887|448718938|FG001|Overall Study|Lost to Follow-up|3|||
124753736|NCT04072887|448718939|FG002|Overall Study|Lost to Follow-up|0|||
124753737|NCT04072887|448718940|FG003|Overall Study|Lost to Follow-up|0|||
124640519|NCT03423173|448301470|FG000|Overall Study|Adverse Event|1|||
124640520|NCT03423173|448301471|FG001|Overall Study|Adverse Event|1|||
124640521|NCT03423173|448301472|FG002|Overall Study|Adverse Event|1|||
124640522|NCT03423173|448301473|FG003|Overall Study|Adverse Event|1|||
124640523|NCT03423173|448301470|FG000|Overall Study|Lost to Follow-up|10|||
124640524|NCT03423173|448301471|FG001|Overall Study|Lost to Follow-up|19|||
124640525|NCT03423173|448301472|FG002|Overall Study|Lost to Follow-up|17|||
124640526|NCT03423173|448301473|FG003|Overall Study|Lost to Follow-up|22|||
124640527|NCT03423173|448301470|FG000|Overall Study|Withdrawal of consent|4|||
124640528|NCT03423173|448301471|FG001|Overall Study|Withdrawal of consent|10|||
124640529|NCT03423173|448301472|FG002|Overall Study|Withdrawal of consent|4|||
124640530|NCT03423173|448301473|FG003|Overall Study|Withdrawal of consent|5|||
124640531|NCT03423173|448301470|FG000|Overall Study|Death|1|||
124640532|NCT03423173|448301471|FG001|Overall Study|Death|0|||
124640533|NCT03423173|448301472|FG002|Overall Study|Death|0|||
124640534|NCT03423173|448301473|FG003|Overall Study|Death|0|||
124640535|NCT03423173|448301470|FG000|Overall Study|Reason not Specified|2|||
124640536|NCT03423173|448301471|FG001|Overall Study|Reason not Specified|5|||
124640537|NCT03423173|448301472|FG002|Overall Study|Reason not Specified|3|||
124640538|NCT03423173|448301473|FG003|Overall Study|Reason not Specified|1|||
124640539|NCT02920008|448301474|FG000|Overall Study|Death|117|||
124640540|NCT02920008|448301475|FG001|Overall Study|Death|127|||
124640541|NCT02920008|448301474|FG000|Overall Study|Withdrawal by Subject|3|||
124640542|NCT02920008|448301475|FG001|Overall Study|Withdrawal by Subject|6|||
124640543|NCT02920008|448301474|FG000|Overall Study|Lost to Follow-up|0|||
124640544|NCT02920008|448301475|FG001|Overall Study|Lost to Follow-up|1|||
124640545|NCT02737930|448301476|FG000|Overall Study|Withdrawal by Subject|0|||
124640546|NCT02737930|448301477|FG001|Overall Study|Withdrawal by Subject|1|||
124640547|NCT03852264|448301478|FG000|Third Research Visit|Lost to Follow-up|1|||
124640548|NCT03852264|448301479|FG001|Third Research Visit|Lost to Follow-up|0|||
124640549|NCT03169881|448301480|FG000|Overall Study|Incomplete Follow-up|10|||
124640550|NCT03169881|448301481|FG001|Overall Study|Incomplete Follow-up|15|||
124640551|NCT03169881|448301480|FG000|Overall Study|Lost to Follow-up|18|||
124640552|NCT03169881|448301481|FG001|Overall Study|Lost to Follow-up|20|||
124753738|NCT04072887|448718941|FG004|Overall Study|Lost to Follow-up|0|||
124640553|NCT03169881|448301480|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
124640554|NCT03169881|448301481|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
124640555|NCT00839527|448301489|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
124640556|NCT00839527|448301490|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
124640557|NCT00839527|448301491|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
124640558|NCT00839527|448301489|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
124640559|NCT00839527|448301490|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
124640560|NCT00839527|448301491|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
124640561|NCT00839527|448301489|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
124640562|NCT00839527|448301490|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
124640563|NCT00839527|448301491|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
124640564|NCT00839527|448301489|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
124640565|NCT00839527|448301490|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
124640566|NCT00839527|448301491|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
124640567|NCT00839527|448301489|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
124640568|NCT00839527|448301490|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
124640569|NCT00839527|448301491|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
124640570|NCT00839527|448301489|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
124640571|NCT00839527|448301490|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
124640572|NCT00839527|448301491|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
124640573|NCT00839527|448301489|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
124640574|NCT00839527|448301490|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
124640575|NCT00839527|448301491|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
124640576|NCT00839527|448301489|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
124640577|NCT00839527|448301490|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
124640578|NCT00839527|448301491|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
124640579|NCT00839527|448301489|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
124640580|NCT00839527|448301490|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
124640581|NCT00839527|448301491|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
124640582|NCT00839527|448301489|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
124640583|NCT00839527|448301490|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
124640584|NCT00839527|448301491|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
124640585|NCT00839527|448301489|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
124640586|NCT00839527|448301490|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
124640587|NCT00839527|448301491|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
124640588|NCT00839527|448301489|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
124640589|NCT00839527|448301490|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
124640590|NCT00839527|448301491|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
124640591|NCT00839527|448301489|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
124640592|NCT00839527|448301490|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
124640593|NCT00839527|448301491|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
124640594|NCT00839527|448301489|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
124640595|NCT00839527|448301490|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
124640596|NCT00839527|448301491|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
124640597|NCT00839527|448301489|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
124640598|NCT00839527|448301490|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
124640599|NCT00839527|448301491|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
124640600|NCT00839527|448301489|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
124640601|NCT00839527|448301490|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
124640602|NCT00839527|448301491|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
124640603|NCT00839527|448301489|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
124640604|NCT00839527|448301490|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
124640605|NCT00839527|448301491|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
124640606|NCT00839527|448301489|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
124640607|NCT00839527|448301490|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
124640608|NCT00839527|448301491|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
124640609|NCT00839527|448301489|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
124640610|NCT00839527|448301490|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
124640611|NCT00839527|448301491|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
124640612|NCT00839527|448301489|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
124640613|NCT00839527|448301490|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
124640614|NCT00839527|448301491|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
124640615|NCT00839527|448301489|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
124640616|NCT00839527|448301490|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
124640617|NCT00839527|448301491|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
124753739|NCT04072887|448718942|FG005|Overall Study|Lost to Follow-up|0|||
124753740|NCT04072887|448718937|FG000|Overall Study|Death|0|||
124753741|NCT04072887|448718938|FG001|Overall Study|Death|2|||
124753742|NCT04072887|448718939|FG002|Overall Study|Death|0|||
124753743|NCT04072887|448718940|FG003|Overall Study|Death|2|||
124753744|NCT04072887|448718941|FG004|Overall Study|Death|3|||
124753745|NCT04072887|448718942|FG005|Overall Study|Death|0|||
124753746|NCT03193736|448718943|FG000|Overall Study|Death|2|||
124753747|NCT03193736|448718943|FG000|Overall Study|Withdrawal by Subject|1|||
124753748|NCT03193736|448718943|FG000|Overall Study|Lost to Follow-up|1|||
124753749|NCT03193736|448718943|FG000|Overall Study|implant not received|1|||
124753750|NCT00423449|448718944|FG000|Overall Study|Clinical Adverse Event|1|||
124753751|NCT00423449|448718945|FG001|Overall Study|Clinical Adverse Event|0|||
124753752|NCT00423449|448718946|FG002|Overall Study|Clinical Adverse Event|1|||
124844971|NCT01502644|449060173|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
124844972|NCT00637195|449060174|FG000|Overall Study|Lost to Follow-up|1|||
124844973|NCT00637195|449060175|FG001|Overall Study|Lost to Follow-up|0|||
124844974|NCT00637195|449060174|FG000|Overall Study|Other|2|||
124844975|NCT00637195|449060175|FG001|Overall Study|Other|0|||
124844976|NCT00637195|449060174|FG000|Overall Study|Withdrawal by Subject|0|||
124844977|NCT00637195|449060175|FG001|Overall Study|Withdrawal by Subject|1|||
124844978|NCT02388997|449060176|FG000|Overall Study|Adverse Event|1|||
124844979|NCT02388997|449060177|FG001|Overall Study|Adverse Event|2|||
124753753|NCT00423449|448718947|FG003|Overall Study|Clinical Adverse Event|8|||
124753754|NCT00423449|448718948|FG004|Overall Study|Clinical Adverse Event|2|||
124753755|NCT00423449|448718944|FG000|Overall Study|Death|1|||
124753756|NCT00423449|448718945|FG001|Overall Study|Death|0|||
124753757|NCT00423449|448718946|FG002|Overall Study|Death|2|||
124753758|NCT00423449|448718947|FG003|Overall Study|Death|1|||
124753759|NCT00423449|448718948|FG004|Overall Study|Death|1|||
124753760|NCT00423449|448718944|FG000|Overall Study|Progressive Disease|1|||
124753761|NCT00423449|448718945|FG001|Overall Study|Progressive Disease|3|||
124753762|NCT00423449|448718946|FG002|Overall Study|Progressive Disease|8|||
124753763|NCT00423449|448718947|FG003|Overall Study|Progressive Disease|11|||
124753764|NCT00423449|448718948|FG004|Overall Study|Progressive Disease|4|||
124753765|NCT00423449|448718944|FG000|Overall Study|Laboratory Adverse Event|0|||
124753766|NCT00423449|448718945|FG001|Overall Study|Laboratory Adverse Event|1|||
124753767|NCT00423449|448718946|FG002|Overall Study|Laboratory Adverse Event|2|||
124753768|NCT00423449|448718947|FG003|Overall Study|Laboratory Adverse Event|0|||
124753769|NCT00423449|448718948|FG004|Overall Study|Laboratory Adverse Event|0|||
124753770|NCT00423449|448718944|FG000|Overall Study|Other|0|||
124753771|NCT00423449|448718945|FG001|Overall Study|Other|0|||
124753772|NCT00423449|448718946|FG002|Overall Study|Other|0|||
124753773|NCT00423449|448718947|FG003|Overall Study|Other|1|||
124753774|NCT00423449|448718948|FG004|Overall Study|Other|0|||
124753775|NCT00423449|448718944|FG000|Overall Study|Protocol Violation|0|||
124844980|NCT02388997|449060176|FG000|Overall Study|Withdrawal by Subject|2|||
124844981|NCT02388997|449060177|FG001|Overall Study|Withdrawal by Subject|1|||
124844982|NCT02388997|449060176|FG000|Overall Study|Lung function exclusion criteria|0|||
124753776|NCT00423449|448718945|FG001|Overall Study|Protocol Violation|0|||
124753777|NCT00423449|448718946|FG002|Overall Study|Protocol Violation|2|||
124753778|NCT00423449|448718947|FG003|Overall Study|Protocol Violation|1|||
124753779|NCT00423449|448718948|FG004|Overall Study|Protocol Violation|0|||
124753780|NCT02697435|448718949|FG000|Overall Study|Withdrawal by Subject|1|||
124753781|NCT02697435|448718950|FG001|Overall Study|Withdrawal by Subject|0|||
124844983|NCT02388997|449060177|FG001|Overall Study|Lung function exclusion criteria|2|||
124844984|NCT02388997|449060176|FG000|Overall Study|Tested positive for virus during run-in|0|||
124844985|NCT02388997|449060177|FG001|Overall Study|Tested positive for virus during run-in|1|||
124844986|NCT03025828|449060178|FG000|Overall Study|Lost to Follow-up|1|||
124844987|NCT01020019|449060179|FG000|Overall Study|Lost to Follow-up|21|||
124844988|NCT01020019|449060180|FG001|Overall Study|Lost to Follow-up|18|||
124844989|NCT01020019|449060179|FG000|Overall Study|Adverse Event|1|||
124844990|NCT01020019|449060180|FG001|Overall Study|Adverse Event|5|||
124844991|NCT01020019|449060179|FG000|Overall Study|not interested in treatment|4|||
124844992|NCT01020019|449060180|FG001|Overall Study|not interested in treatment|4|||
124844993|NCT01020019|449060179|FG000|Overall Study|moving|0|||
124844994|NCT01020019|449060180|FG001|Overall Study|moving|2|||
124753782|NCT02697435|448718949|FG000|Overall Study|Physician Decision|0|||
124753783|NCT02697435|448718950|FG001|Overall Study|Physician Decision|4|||
124753784|NCT01445080|448718957|FG000|Overall Study|Adverse Event|5|||
124753785|NCT01445080|448718958|FG001|Overall Study|Adverse Event|3|||
124753786|NCT01445080|448718959|FG002|Overall Study|Adverse Event|11|||
124753787|NCT01445080|448718960|FG003|Overall Study|Adverse Event|6|||
124844995|NCT02375672|449060181|FG000|Overall Study|remain on follow up|20|||
124844996|NCT01559311|449060182|FG000|Overall Study|Protocol Violation|0|||
124844997|NCT01559311|449060183|FG001|Overall Study|Protocol Violation|0|||
124844998|NCT01559311|449060184|FG002|Overall Study|Protocol Violation|2|||
124844999|NCT01559311|449060182|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
124845000|NCT01559311|449060183|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
124845001|NCT01559311|449060184|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
124753788|NCT01445080|448718961|FG004|Overall Study|Adverse Event|2|||
124753789|NCT01445080|448718962|FG005|Overall Study|Adverse Event|3|||
124753790|NCT01445080|448718963|FG006|Overall Study|Adverse Event|0|||
124753791|NCT01445080|448718964|FG007|Overall Study|Adverse Event|3|||
124753792|NCT01445080|448718965|FG008|Overall Study|Adverse Event|10|||
124753793|NCT01445080|448718957|FG000|Overall Study|Physician Decision|0|||
124753794|NCT01445080|448718958|FG001|Overall Study|Physician Decision|0|||
124753795|NCT01445080|448718959|FG002|Overall Study|Physician Decision|1|||
124753796|NCT01445080|448718960|FG003|Overall Study|Physician Decision|0|||
124753797|NCT01445080|448718961|FG004|Overall Study|Physician Decision|0|||
124753798|NCT01445080|448718962|FG005|Overall Study|Physician Decision|3|||
124753799|NCT01445080|448718963|FG006|Overall Study|Physician Decision|2|||
124753800|NCT01445080|448718964|FG007|Overall Study|Physician Decision|2|||
124753801|NCT01445080|448718965|FG008|Overall Study|Physician Decision|0|||
124753802|NCT01445080|448718957|FG000|Overall Study|Withdrawal by Subject|1|||
124753803|NCT01445080|448718958|FG001|Overall Study|Withdrawal by Subject|0|||
124753804|NCT01445080|448718959|FG002|Overall Study|Withdrawal by Subject|0|||
124753805|NCT01445080|448718960|FG003|Overall Study|Withdrawal by Subject|1|||
124753806|NCT01445080|448718961|FG004|Overall Study|Withdrawal by Subject|0|||
124753807|NCT01445080|448718962|FG005|Overall Study|Withdrawal by Subject|0|||
124753808|NCT01445080|448718963|FG006|Overall Study|Withdrawal by Subject|0|||
124753809|NCT01445080|448718964|FG007|Overall Study|Withdrawal by Subject|0|||
124753810|NCT01445080|448718965|FG008|Overall Study|Withdrawal by Subject|2|||
124753811|NCT01445080|448718957|FG000|Overall Study|Ineligible/Inevaluable|1|||
124753812|NCT01445080|448718958|FG001|Overall Study|Ineligible/Inevaluable|2|||
124753813|NCT01445080|448718959|FG002|Overall Study|Ineligible/Inevaluable|0|||
124753814|NCT01445080|448718960|FG003|Overall Study|Ineligible/Inevaluable|1|||
124753815|NCT01445080|448718961|FG004|Overall Study|Ineligible/Inevaluable|2|||
124753816|NCT01445080|448718962|FG005|Overall Study|Ineligible/Inevaluable|3|||
124753817|NCT01445080|448718963|FG006|Overall Study|Ineligible/Inevaluable|0|||
124753818|NCT01445080|448718964|FG007|Overall Study|Ineligible/Inevaluable|0|||
124753819|NCT01445080|448718965|FG008|Overall Study|Ineligible/Inevaluable|6|||
124753820|NCT02974257|448720771|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
124753821|NCT02974257|448720772|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
124753822|NCT02974257|448720771|FG000|Overall Study|Clinical indication for thiamine|1|||
124753823|NCT02974257|448720772|FG001|Overall Study|Clinical indication for thiamine|0|||
124753824|NCT02974257|448720771|FG000|Overall Study|Already on thiamine|1|||
124753825|NCT02974257|448720772|FG001|Overall Study|Already on thiamine|0|||
124753826|NCT02974257|448720771|FG000|Overall Study|Extubated prior to study drug|0|||
124753827|NCT02974257|448720772|FG001|Overall Study|Extubated prior to study drug|1|||
124753828|NCT02974257|448720771|FG000|Overall Study|Death|0|||
124753829|NCT02974257|448720772|FG001|Overall Study|Death|1|||
124753830|NCT02828436|448720775|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
124753831|NCT02828436|448720776|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
124753832|NCT02828436|448720775|FG000|Period 1|Lost to Follow-up|0|||
124753833|NCT02828436|448720776|FG001|Period 1|Lost to Follow-up|1|||
124753834|NCT02828436|448720775|FG000|Period 2|Withdrawal by Subject|4|||
124753835|NCT02828436|448720776|FG001|Period 2|Withdrawal by Subject|0|||
124753836|NCT02828436|448720775|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
124753837|NCT02828436|448720776|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
124753838|NCT02828436|448720775|FG000|Period 2|Lost to Follow-up|1|||
124753839|NCT02828436|448720776|FG001|Period 2|Lost to Follow-up|0|||
124753840|NCT01136408|448720777|FG000|Overall Study|Adverse Event|4|||
124753841|NCT01136408|448720778|FG001|Overall Study|Adverse Event|8|||
124753842|NCT01136408|448720779|FG002|Overall Study|Adverse Event|4|||
124753843|NCT01136408|448720777|FG000|Overall Study|Protocol Violation|1|||
124753844|NCT01136408|448720778|FG001|Overall Study|Protocol Violation|1|||
124753845|NCT01136408|448720779|FG002|Overall Study|Protocol Violation|1|||
124753846|NCT02128724|448720784|FG000|Overall Study|Death|1|||
124753847|NCT02128724|448720785|FG001|Overall Study|Death|0|||
124753848|NCT02128724|448720786|FG002|Overall Study|Death|0|||
124753849|NCT02128724|448720787|FG003|Overall Study|Death|0|||
124753850|NCT02128724|448720784|FG000|Overall Study|Adverse Event|0|||
124753851|NCT02128724|448720785|FG001|Overall Study|Adverse Event|1|||
124753852|NCT02128724|448720786|FG002|Overall Study|Adverse Event|0|||
124753853|NCT02128724|448720787|FG003|Overall Study|Adverse Event|0|||
124753854|NCT02128724|448720784|FG000|Overall Study|Physician Decision|0|||
124753855|NCT02128724|448720785|FG001|Overall Study|Physician Decision|0|||
124753856|NCT02128724|448720786|FG002|Overall Study|Physician Decision|0|||
124753857|NCT02128724|448720787|FG003|Overall Study|Physician Decision|2|||
124753858|NCT02128724|448720784|FG000|Overall Study|Withdrawal by Subject|0|||
124753859|NCT02128724|448720785|FG001|Overall Study|Withdrawal by Subject|0|||
124753860|NCT02128724|448720786|FG002|Overall Study|Withdrawal by Subject|0|||
124753861|NCT02128724|448720787|FG003|Overall Study|Withdrawal by Subject|1|||
124753862|NCT03329092|448720788|FG000|Overall Study|Other|2|||
124753863|NCT03329092|448720789|FG001|Overall Study|Other|2|||
124753864|NCT03329092|448720788|FG000|Overall Study|Withdrawal by Subject|16|||
124845002|NCT01559311|449060182|FG000|Overall Study|Withdrawal by Subject|2|||
124845003|NCT01559311|449060183|FG001|Overall Study|Withdrawal by Subject|1|||
124845004|NCT01559311|449060184|FG002|Overall Study|Withdrawal by Subject|0|||
124845005|NCT01559311|449060182|FG000|Overall Study|Death|0|||
124845006|NCT01559311|449060183|FG001|Overall Study|Death|2|||
124845007|NCT01559311|449060184|FG002|Overall Study|Death|3|||
124845008|NCT01559311|449060182|FG000|Overall Study|Lost to Follow-up|0|||
124845009|NCT01559311|449060183|FG001|Overall Study|Lost to Follow-up|3|||
124845010|NCT01559311|449060184|FG002|Overall Study|Lost to Follow-up|2|||
124845011|NCT01559311|449060182|FG000|Overall Study|Adverse Event|0|||
124845012|NCT01559311|449060183|FG001|Overall Study|Adverse Event|0|||
124845013|NCT01559311|449060184|FG002|Overall Study|Adverse Event|1|||
124845014|NCT02346240|449060186|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845015|NCT02346240|449060187|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
124845016|NCT02346240|449060188|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
124845017|NCT02346240|449060189|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
124845018|NCT02346240|449060190|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845019|NCT02346240|449060191|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845020|NCT02346240|449060192|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845021|NCT02346240|449060193|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845022|NCT02346240|449060194|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845023|NCT02346240|449060195|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845024|NCT02346240|449060196|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845025|NCT02346240|449060197|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845026|NCT02346240|449060198|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845027|NCT02346240|449060199|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845028|NCT02346240|449060200|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845029|NCT02346240|449060201|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845030|NCT02346240|449060202|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845031|NCT02346240|449060203|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845032|NCT02346240|449060204|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845033|NCT02346240|449060205|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845034|NCT02346240|449060206|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845035|NCT02346240|449060207|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845036|NCT02346240|449060208|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845037|NCT02346240|449060209|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
124845038|NCT02346240|449060186|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845039|NCT02346240|449060187|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
124845040|NCT02346240|449060188|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845041|NCT02346240|449060189|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845042|NCT02346240|449060190|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845043|NCT02346240|449060191|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845044|NCT02346240|449060192|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845045|NCT02346240|449060193|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845046|NCT02346240|449060194|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845047|NCT02346240|449060195|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845048|NCT02346240|449060196|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845049|NCT02346240|449060197|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845050|NCT02346240|449060198|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845051|NCT02346240|449060199|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845052|NCT02346240|449060200|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845053|NCT02346240|449060201|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845054|NCT02346240|449060202|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845055|NCT02346240|449060203|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845056|NCT02346240|449060204|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845057|NCT02346240|449060205|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845058|NCT02346240|449060206|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845059|NCT02346240|449060207|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845060|NCT02346240|449060208|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845061|NCT02346240|449060209|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
124845062|NCT02346240|449060186|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845063|NCT02346240|449060187|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
124845064|NCT02346240|449060188|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845065|NCT02346240|449060189|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845066|NCT02346240|449060190|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845067|NCT02346240|449060191|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845068|NCT02346240|449060192|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845069|NCT02346240|449060193|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845070|NCT02346240|449060194|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845071|NCT02346240|449060195|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845072|NCT02346240|449060196|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845073|NCT02346240|449060197|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845074|NCT02346240|449060198|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845075|NCT02346240|449060199|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845076|NCT02346240|449060200|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845077|NCT02346240|449060201|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845078|NCT02346240|449060202|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845079|NCT02346240|449060203|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845080|NCT02346240|449060204|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845081|NCT02346240|449060205|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845082|NCT02346240|449060206|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845083|NCT02346240|449060207|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845084|NCT02346240|449060208|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845085|NCT02346240|449060209|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
124845086|NCT02346240|449060186|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
124845087|NCT02346240|449060187|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
124845088|NCT02346240|449060188|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
124845089|NCT02346240|449060189|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
124845090|NCT02346240|449060190|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845091|NCT02346240|449060191|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845092|NCT02346240|449060192|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845093|NCT02346240|449060193|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845094|NCT02346240|449060194|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845095|NCT02346240|449060195|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845096|NCT02346240|449060196|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845097|NCT02346240|449060197|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845098|NCT02346240|449060198|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845099|NCT02346240|449060199|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845100|NCT02346240|449060200|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845101|NCT02346240|449060201|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845102|NCT02346240|449060202|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845103|NCT02346240|449060203|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845104|NCT02346240|449060204|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845105|NCT02346240|449060205|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845106|NCT02346240|449060206|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845107|NCT02346240|449060207|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845108|NCT02346240|449060208|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845109|NCT02346240|449060209|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
124845110|NCT02346240|449060186|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
124845111|NCT02346240|449060187|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
124845112|NCT02346240|449060188|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
124845113|NCT02346240|449060189|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
124845114|NCT02346240|449060190|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845115|NCT02346240|449060191|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845116|NCT02346240|449060192|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845117|NCT02346240|449060193|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845118|NCT02346240|449060194|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845119|NCT02346240|449060195|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845120|NCT02346240|449060196|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845121|NCT02346240|449060197|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845122|NCT02346240|449060198|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845123|NCT02346240|449060199|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124753865|NCT03329092|448720789|FG001|Overall Study|Withdrawal by Subject|3|||
124753866|NCT03329092|448720788|FG000|Overall Study|Physician Decision|1|||
124753867|NCT03329092|448720789|FG001|Overall Study|Physician Decision|0|||
124753868|NCT03329092|448720788|FG000|Overall Study|Death|17|||
124753869|NCT03329092|448720789|FG001|Overall Study|Death|11|||
124753870|NCT03329092|448720788|FG000|Overall Study|Adverse Event|3|||
124753871|NCT03329092|448720789|FG001|Overall Study|Adverse Event|1|||
124753872|NCT03329092|448720788|FG000|Overall Study|Lost to Follow-up|1|||
124753873|NCT03329092|448720789|FG001|Overall Study|Lost to Follow-up|1|||
124753874|NCT05786508|448720790|FG000|Overall Study|Withdrawal by Subject|2|||
124753875|NCT05786508|448720791|FG001|Overall Study|Withdrawal by Subject|0|||
124753876|NCT04273893|448720792|FG000|Overall Study|Withdrawal by Subject|0|||
124753877|NCT04273893|448720793|FG001|Overall Study|Withdrawal by Subject|2|||
124845124|NCT02346240|449060200|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845125|NCT02346240|449060201|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845126|NCT02346240|449060202|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845127|NCT02346240|449060203|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845128|NCT02346240|449060204|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845129|NCT02346240|449060205|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845130|NCT02346240|449060206|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845131|NCT02346240|449060207|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845132|NCT02346240|449060208|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845133|NCT02346240|449060209|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
124845134|NCT02346240|449060186|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845135|NCT02346240|449060187|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
124845136|NCT02346240|449060188|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845137|NCT02346240|449060189|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
124845138|NCT02346240|449060190|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845139|NCT02346240|449060191|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845140|NCT02346240|449060192|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845141|NCT02346240|449060193|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845142|NCT02346240|449060194|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845143|NCT02346240|449060195|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845144|NCT02346240|449060196|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845145|NCT02346240|449060197|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845146|NCT02346240|449060198|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845147|NCT02346240|449060199|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845148|NCT02346240|449060200|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845149|NCT02346240|449060201|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845150|NCT02346240|449060202|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845151|NCT02346240|449060203|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845152|NCT02346240|449060204|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845153|NCT02346240|449060205|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845154|NCT02346240|449060206|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845155|NCT02346240|449060207|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845156|NCT02346240|449060208|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845157|NCT02346240|449060209|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
124845158|NCT02346240|449060186|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845159|NCT02346240|449060187|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845160|NCT02346240|449060188|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
124845161|NCT02346240|449060189|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845162|NCT02346240|449060190|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845163|NCT02346240|449060191|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845164|NCT02346240|449060192|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845165|NCT02346240|449060193|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124640618|NCT00839527|448301489|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
124640619|NCT00839527|448301490|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
124640620|NCT00839527|448301491|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
124640621|NCT00839527|448301489|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
124640622|NCT00839527|448301490|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
124640623|NCT00839527|448301491|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
124640624|NCT00839527|448301489|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
124640625|NCT00839527|448301490|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
124640626|NCT00839527|448301491|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
124640627|NCT04481789|448301492|FG000|Period 1|Withdrawal by Subject|1|||
124640628|NCT04481789|448301493|FG001|Period 1|Withdrawal by Subject|0|||
124640629|NCT04481789|448301494|FG002|Period 1|Withdrawal by Subject|0|||
124640630|NCT04481789|448301495|FG003|Period 1|Withdrawal by Subject|0|||
124640631|NCT04481789|448301496|FG004|Period 1|Withdrawal by Subject|0|||
124845166|NCT02346240|449060194|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845167|NCT02346240|449060195|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845168|NCT02346240|449060196|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845169|NCT02346240|449060197|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845170|NCT02346240|449060198|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845171|NCT02346240|449060199|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845172|NCT02346240|449060200|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845173|NCT02346240|449060201|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845174|NCT02346240|449060202|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845175|NCT02346240|449060203|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845176|NCT02346240|449060204|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845177|NCT02346240|449060205|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845178|NCT02346240|449060206|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845179|NCT02346240|449060207|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845180|NCT02346240|449060208|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845181|NCT02346240|449060209|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
124845182|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845183|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845184|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845185|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845186|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845187|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845188|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845189|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
124845190|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
124845191|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845192|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845193|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845194|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845195|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
124845196|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
124845197|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
124845198|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
124845199|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845200|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845201|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845202|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845203|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845204|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845205|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
124845206|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845207|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845208|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845209|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845210|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124640632|NCT04481789|448301497|FG005|Period 1|Withdrawal by Subject|0|||
124640633|NCT01704651|448301500|FG000|Overall Study|Pre-op withdrawal by subject|1|||
124640634|NCT01704651|448301501|FG001|Overall Study|Pre-op withdrawal by subject|1|||
124640635|NCT01704651|448301500|FG000|Overall Study|Pre-op change in treatment plan|1|||
124640636|NCT01704651|448301501|FG001|Overall Study|Pre-op change in treatment plan|4|||
124640637|NCT01704651|448301500|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
124640638|NCT01704651|448301501|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
124640639|NCT01704651|448301500|FG000|Overall Study|Post-op did not have laparotomy|2|||
124640640|NCT01704651|448301501|FG001|Overall Study|Post-op did not have laparotomy|1|||
124640641|NCT03315286|448301504|FG000|Overall Study|Lost to Follow-up|0|||
124640642|NCT03315286|448301505|FG001|Overall Study|Lost to Follow-up|3|||
124640643|NCT03315286|448301504|FG000|Overall Study|Withdrawal by Subject|1|||
124640644|NCT03315286|448301505|FG001|Overall Study|Withdrawal by Subject|0|||
124640645|NCT03315286|448301504|FG000|Overall Study|Protocol Violation|0|||
124640646|NCT03315286|448301505|FG001|Overall Study|Protocol Violation|1|||
124640647|NCT00766636|448301506|FG000|Overall Study|Withdrawal by Subject|1|||
124640648|NCT00766636|448301507|FG001|Overall Study|Withdrawal by Subject|1|||
124640649|NCT00766636|448301506|FG000|Overall Study|Incomplete Treatment|0|||
124640650|NCT00766636|448301507|FG001|Overall Study|Incomplete Treatment|1|||
124640651|NCT00766636|448301506|FG000|Overall Study|Adverse Event|1|||
124640652|NCT00766636|448301507|FG001|Overall Study|Adverse Event|0|||
124640653|NCT00766636|448301506|FG000|Overall Study|Disease Progression|1|||
124640654|NCT00766636|448301507|FG001|Overall Study|Disease Progression|0|||
124640655|NCT02477332|448301514|FG000|Overall Study|Adverse Event|0|||
124845211|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845212|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845213|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845214|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845215|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845216|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845217|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845218|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845219|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
124845220|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845221|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
124845222|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845223|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845224|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845225|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124753878|NCT04273893|448720792|FG000|Overall Study|Treatment of Disease Progression|0|||
124753879|NCT04273893|448720793|FG001|Overall Study|Treatment of Disease Progression|2|||
124753880|NCT04273893|448720792|FG000|Overall Study|Death|1|||
124753881|NCT04273893|448720793|FG001|Overall Study|Death|2|||
124753882|NCT04273893|448720792|FG000|Overall Study|Lost to Follow-up|0|||
124753883|NCT04273893|448720793|FG001|Overall Study|Lost to Follow-up|2|||
124753884|NCT04273893|448720792|FG000|Overall Study|Physician Decision|1|||
124753885|NCT04273893|448720793|FG001|Overall Study|Physician Decision|0|||
124753886|NCT01456169|448720796|FG000|Overall Study|Adverse Event|1|||
124753887|NCT01456169|448720797|FG001|Overall Study|Adverse Event|2|||
124753888|NCT01456169|448720798|FG002|Overall Study|Adverse Event|7|||
124753889|NCT01456169|448720796|FG000|Overall Study|Major Protocol Deviation|3|||
124753890|NCT01456169|448720797|FG001|Overall Study|Major Protocol Deviation|2|||
124753891|NCT01456169|448720798|FG002|Overall Study|Major Protocol Deviation|3|||
124753892|NCT01456169|448720796|FG000|Overall Study|Voluntary Withdrawal|3|||
124845226|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845227|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845228|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845229|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
124845230|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845231|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845232|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845233|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845234|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845235|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124753893|NCT01456169|448720797|FG001|Overall Study|Voluntary Withdrawal|0|||
124753894|NCT01456169|448720798|FG002|Overall Study|Voluntary Withdrawal|2|||
124753895|NCT01456169|448720796|FG000|Overall Study|Lack of Efficacy|2|||
124753896|NCT01456169|448720797|FG001|Overall Study|Lack of Efficacy|0|||
124753897|NCT01456169|448720798|FG002|Overall Study|Lack of Efficacy|0|||
124753898|NCT01456169|448720796|FG000|Overall Study|Other|1|||
124753899|NCT01456169|448720797|FG001|Overall Study|Other|1|||
124753900|NCT01456169|448720798|FG002|Overall Study|Other|0|||
124753901|NCT02598297|448720799|FG000|Overall Study|Study terminated by Sponsor|21|||
124753902|NCT02598297|448720800|FG001|Overall Study|Study terminated by Sponsor|23|||
124753903|NCT02598297|448720799|FG000|Overall Study|Adverse Event|1|||
124753904|NCT02598297|448720800|FG001|Overall Study|Adverse Event|1|||
124753905|NCT02598297|448720799|FG000|Overall Study|Physician Decision|1|||
124753906|NCT02598297|448720800|FG001|Overall Study|Physician Decision|0|||
124753907|NCT02598297|448720799|FG000|Overall Study|Subject/guardian decision|1|||
124753908|NCT02598297|448720800|FG001|Overall Study|Subject/guardian decision|0|||
124753909|NCT02598297|448720799|FG000|Overall Study|Followed for survival|1|||
124753910|NCT02598297|448720800|FG001|Overall Study|Followed for survival|0|||
124845236|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845237|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124640656|NCT02477332|448301515|FG001|Overall Study|Adverse Event|1|||
124640657|NCT02477332|448301516|FG002|Overall Study|Adverse Event|1|||
124640658|NCT02477332|448301517|FG003|Overall Study|Adverse Event|2|||
124640659|NCT02477332|448301518|FG004|Overall Study|Adverse Event|1|||
124640660|NCT02477332|448301519|FG005|Overall Study|Adverse Event|2|||
124845238|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845239|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845240|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845241|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124640661|NCT02477332|448301514|FG000|Overall Study|Lack of Efficacy|1|||
124640662|NCT02477332|448301515|FG001|Overall Study|Lack of Efficacy|2|||
124845242|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845243|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124640663|NCT02477332|448301516|FG002|Overall Study|Lack of Efficacy|1|||
124845244|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
124753911|NCT00394706|448720806|FG000|Overall Study|Withdrawal by Subject|2|||
124753912|NCT00394706|448720807|FG001|Overall Study|Withdrawal by Subject|0|||
124753913|NCT00394706|448720808|FG002|Overall Study|Withdrawal by Subject|1|||
124753914|NCT00394706|448720809|FG003|Overall Study|Withdrawal by Subject|0|||
124753915|NCT00394706|448720810|FG004|Overall Study|Withdrawal by Subject|0|||
124845245|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845246|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845247|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845248|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845249|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845250|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845251|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845252|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845253|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
124845254|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845255|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845256|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845257|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845258|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845259|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124845260|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124845261|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124845262|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124845263|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845264|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124845265|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
124845266|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845267|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
124845268|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
124845269|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
124845270|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
124845271|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845272|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845273|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845274|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124753916|NCT00394706|448720811|FG005|Overall Study|Withdrawal by Subject|2|||
124845275|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845276|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124753917|NCT00394706|448720812|FG006|Overall Study|Withdrawal by Subject|1|||
124753918|NCT00394706|448720813|FG007|Overall Study|Withdrawal by Subject|0|||
124753919|NCT00394706|448720806|FG000|Overall Study|Lost to Follow-up|2|||
124753920|NCT00394706|448720807|FG001|Overall Study|Lost to Follow-up|2|||
124753921|NCT00394706|448720808|FG002|Overall Study|Lost to Follow-up|8|||
124753922|NCT00394706|448720809|FG003|Overall Study|Lost to Follow-up|1|||
124753923|NCT00394706|448720810|FG004|Overall Study|Lost to Follow-up|2|||
124753924|NCT00394706|448720811|FG005|Overall Study|Lost to Follow-up|5|||
124753925|NCT00394706|448720812|FG006|Overall Study|Lost to Follow-up|2|||
124753926|NCT00394706|448720813|FG007|Overall Study|Lost to Follow-up|0|||
124753927|NCT02003534|448720817|FG000|Overall Study|Lost to Follow-up|47|||
124753928|NCT02652156|448720818|FG000|Overall Study|Physician Decision|1|||
124753929|NCT02652156|448720819|FG001|Overall Study|Physician Decision|0|||
124753930|NCT02652156|448720820|FG002|Overall Study|Physician Decision|0|||
124753931|NCT02342223|448720822|FG000|Overall Study|Lost to Follow-up|1|||
124753932|NCT00496080|448720825|FG000|Overall Study|Lost to Follow-up|9|||
124753933|NCT00496080|448720825|FG000|Overall Study|Surgical re-intervention|7|||
124753934|NCT00496080|448720825|FG000|Overall Study|Withdrawal by Subject|5|||
124753935|NCT00496080|448720825|FG000|Overall Study|Physician Decision|6|||
124753936|NCT01200368|448720830|FG000|Infant Series|Adverse Event|2|||
124753937|NCT01200368|448720831|FG001|Infant Series|Adverse Event|2|||
124753938|NCT01200368|448720832|FG002|Infant Series|Adverse Event|3|||
124753939|NCT01200368|448720830|FG000|Infant Series|Withdrawal by Subject|0|||
124753940|NCT01200368|448720831|FG001|Infant Series|Withdrawal by Subject|2|||
124753941|NCT01200368|448720832|FG002|Infant Series|Withdrawal by Subject|2|||
124753942|NCT01200368|448720830|FG000|Infant Series|Did not meet entrance criteria|0|||
124845277|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
124845278|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845279|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845280|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845281|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845282|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845283|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845284|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845285|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845286|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845287|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845288|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845289|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845290|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845291|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
124845292|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
124845293|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
124845294|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
124845295|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845296|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845297|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845298|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845299|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845300|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845301|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
124845302|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845303|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845304|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845305|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845306|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845307|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845308|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
124845309|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845310|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845311|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845312|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845313|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845314|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124640664|NCT02477332|448301517|FG003|Overall Study|Lack of Efficacy|2|||
124640665|NCT02477332|448301518|FG004|Overall Study|Lack of Efficacy|1|||
124640666|NCT02477332|448301519|FG005|Overall Study|Lack of Efficacy|1|||
124640667|NCT02477332|448301514|FG000|Overall Study|Non-compliance with study treatment|0|||
124640668|NCT02477332|448301515|FG001|Overall Study|Non-compliance with study treatment|1|||
124640669|NCT02477332|448301516|FG002|Overall Study|Non-compliance with study treatment|2|||
124640670|NCT02477332|448301517|FG003|Overall Study|Non-compliance with study treatment|0|||
124640671|NCT02477332|448301518|FG004|Overall Study|Non-compliance with study treatment|0|||
124640672|NCT02477332|448301519|FG005|Overall Study|Non-compliance with study treatment|0|||
124640673|NCT02477332|448301514|FG000|Overall Study|Pregnancy|0|||
124640674|NCT02477332|448301515|FG001|Overall Study|Pregnancy|0|||
124640675|NCT02477332|448301516|FG002|Overall Study|Pregnancy|0|||
124640676|NCT02477332|448301517|FG003|Overall Study|Pregnancy|1|||
124640677|NCT02477332|448301518|FG004|Overall Study|Pregnancy|0|||
124640678|NCT02477332|448301519|FG005|Overall Study|Pregnancy|0|||
124640679|NCT02477332|448301514|FG000|Overall Study|Protocol Violation|2|||
124640680|NCT02477332|448301515|FG001|Overall Study|Protocol Violation|0|||
124640681|NCT02477332|448301516|FG002|Overall Study|Protocol Violation|3|||
124640682|NCT02477332|448301517|FG003|Overall Study|Protocol Violation|3|||
124640683|NCT02477332|448301518|FG004|Overall Study|Protocol Violation|1|||
124640684|NCT02477332|448301519|FG005|Overall Study|Protocol Violation|1|||
124640685|NCT02477332|448301514|FG000|Overall Study|Technical problems|0|||
124640686|NCT02477332|448301515|FG001|Overall Study|Technical problems|0|||
124640687|NCT02477332|448301516|FG002|Overall Study|Technical problems|1|||
124640688|NCT02477332|448301517|FG003|Overall Study|Technical problems|0|||
124640689|NCT02477332|448301518|FG004|Overall Study|Technical problems|0|||
124640690|NCT02477332|448301519|FG005|Overall Study|Technical problems|0|||
124640691|NCT02477332|448301514|FG000|Overall Study|Lost to Follow-up|0|||
124640692|NCT02477332|448301515|FG001|Overall Study|Lost to Follow-up|0|||
124640693|NCT02477332|448301516|FG002|Overall Study|Lost to Follow-up|2|||
124640694|NCT02477332|448301517|FG003|Overall Study|Lost to Follow-up|0|||
124640695|NCT02477332|448301518|FG004|Overall Study|Lost to Follow-up|0|||
124640696|NCT02477332|448301519|FG005|Overall Study|Lost to Follow-up|0|||
124640697|NCT02477332|448301514|FG000|Overall Study|Physician Decision|0|||
124640698|NCT02477332|448301515|FG001|Overall Study|Physician Decision|0|||
124640699|NCT02477332|448301516|FG002|Overall Study|Physician Decision|1|||
124640700|NCT02477332|448301517|FG003|Overall Study|Physician Decision|3|||
124640701|NCT02477332|448301518|FG004|Overall Study|Physician Decision|0|||
124640702|NCT02477332|448301519|FG005|Overall Study|Physician Decision|1|||
124640703|NCT02477332|448301514|FG000|Overall Study|Withdrawal by Subject|0|||
124640704|NCT02477332|448301515|FG001|Overall Study|Withdrawal by Subject|3|||
124640705|NCT02477332|448301516|FG002|Overall Study|Withdrawal by Subject|1|||
124640706|NCT02477332|448301517|FG003|Overall Study|Withdrawal by Subject|2|||
124640707|NCT02477332|448301518|FG004|Overall Study|Withdrawal by Subject|1|||
124640708|NCT02477332|448301519|FG005|Overall Study|Withdrawal by Subject|0|||
124640709|NCT03793842|448301520|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
124640710|NCT03793842|448301521|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
124640711|NCT03793842|448301520|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
124640712|NCT03793842|448301521|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
124640713|NCT04657198|448301522|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
124640714|NCT04657198|448301523|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
124640715|NCT04657198|448301524|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
124640716|NCT02549287|448301525|FG000|Overall Study|Lost to Follow-up|65|||
124640717|NCT02549287|448301526|FG001|Overall Study|Lost to Follow-up|26|||
124640718|NCT02549287|448301525|FG000|Overall Study|Withdrawal by Subject|15|||
124640719|NCT02549287|448301526|FG001|Overall Study|Withdrawal by Subject|6|||
124640720|NCT00427921|448301532|FG000|Overall Study|Adverse Event|26|||
124640721|NCT00427921|448301532|FG000|Overall Study|Withdrawal by Subject|4|||
124640722|NCT00427921|448301532|FG000|Overall Study|Lost to Follow-up|2|||
124640723|NCT00427921|448301532|FG000|Overall Study|Other reason not specified|10|||
124640724|NCT00427921|448301532|FG000|Overall Study|Adverse Event + Hospitalization|1|||
124640725|NCT00427921|448301532|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
124640726|NCT00427921|448301532|FG000|Overall Study|Adverse Event + No Response|1|||
124640727|NCT00427921|448301532|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
124640728|NCT00427921|448301532|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
124640729|NCT00427921|448301532|FG000|Overall Study|Adverse Event + Lost Response|1|||
124640730|NCT00427921|448301532|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
124640731|NCT00427921|448301532|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
124640732|NCT00900159|448301533|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
124640733|NCT00900159|448301534|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
124640734|NCT01075256|448301535|FG000|Overall Study|Withdrawal by Subject|1|||
124640735|NCT01075256|448301536|FG001|Overall Study|Withdrawal by Subject|0|||
124640736|NCT01075256|448301537|FG002|Overall Study|Withdrawal by Subject|0|||
124640737|NCT02858583|448301540|FG000|Overall Study|Declined consent|1|||
124640738|NCT02858583|448301541|FG001|Overall Study|Declined consent|1|||
124640739|NCT00347009|448301542|FG000|Overall Study|Death|1|||
124640740|NCT00347009|448301542|FG000|Overall Study|Adverse Event|6|||
124640741|NCT00347009|448301542|FG000|Overall Study|Withdrawal by Subject|3|||
124640742|NCT00347009|448301542|FG000|Overall Study|Physician Decision|5|||
124640743|NCT00347009|448301542|FG000|Overall Study|Lost to Follow-up|4|||
124640744|NCT00347009|448301542|FG000|Overall Study|Protocol Violation|2|||
124640745|NCT00347009|448301542|FG000|Overall Study|Adverse Laboratory Experience|1|||
124640746|NCT00347009|448301542|FG000|Overall Study|Insufficient Viral Suppression|3|||
124640747|NCT00347009|448301542|FG000|Overall Study|Increased ALT/HBV DNA|1|||
124640748|NCT00347009|448301542|FG000|Overall Study|Serious Adverse Event|1|||
124640749|NCT01972438|448301544|FG000|Baseline-Month 3 Crossover Period|Death|1|||
124640750|NCT01972438|448301545|FG001|Baseline-Month 3 Crossover Period|Death|0|||
124640751|NCT01972438|448301544|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
124640752|NCT01972438|448301545|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
124640753|NCT01972438|448301544|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
124640754|NCT01972438|448301545|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
124640755|NCT01972438|448301544|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
124640756|NCT01972438|448301545|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
124640757|NCT01972438|448301544|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
124640758|NCT01972438|448301545|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
124640759|NCT01972438|448301544|FG000|Months 6-12 Study Period|Death|1|||
124640760|NCT01972438|448301545|FG001|Months 6-12 Study Period|Death|0|||
124640761|NCT01972438|448301544|FG000|Months 6-12 Study Period|Early Study Closure|2|||
124640762|NCT01972438|448301545|FG001|Months 6-12 Study Period|Early Study Closure|2|||
124640763|NCT01972438|448301544|FG000|Post Month 12 Study Period|Early Study Closure|3|||
124640764|NCT01972438|448301545|FG001|Post Month 12 Study Period|Early Study Closure|4|||
124640765|NCT00468481|448302828|FG000|Overall Study|Adverse Event|13|||
124640766|NCT00468481|448302829|FG001|Overall Study|Adverse Event|3|||
124640767|NCT00468481|448302828|FG000|Overall Study|Lost to Follow-up|25|||
124640768|NCT00468481|448302829|FG001|Overall Study|Lost to Follow-up|8|||
124640769|NCT00468481|448302828|FG000|Overall Study|Pregnancy|2|||
124640770|NCT00468481|448302829|FG001|Overall Study|Pregnancy|0|||
124640771|NCT00468481|448302828|FG000|Overall Study|Protocol Violation|18|||
124640772|NCT00468481|448302829|FG001|Overall Study|Protocol Violation|8|||
124640773|NCT00468481|448302828|FG000|Overall Study|Withdrawal by Subject|12|||
124640774|NCT00468481|448302829|FG001|Overall Study|Withdrawal by Subject|3|||
124640775|NCT00468481|448302828|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
124640776|NCT00468481|448302829|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
124640777|NCT00468481|448302828|FG000|Overall Study|Prohibited Medication|1|||
124753943|NCT01200368|448720831|FG001|Infant Series|Did not meet entrance criteria|1|||
124753944|NCT01200368|448720832|FG002|Infant Series|Did not meet entrance criteria|0|||
124753945|NCT01200368|448720830|FG000|Infant Series|Randomized, not vaccinated|0|||
124753946|NCT01200368|448720831|FG001|Infant Series|Randomized, not vaccinated|1|||
124753947|NCT01200368|448720832|FG002|Infant Series|Randomized, not vaccinated|1|||
124753948|NCT01200368|448720830|FG000|Infant Series|Other|1|||
124753949|NCT01200368|448720831|FG001|Infant Series|Other|0|||
124753950|NCT01200368|448720832|FG002|Infant Series|Other|0|||
124753951|NCT01200368|448720830|FG000|After Infant Series|Adverse Event|6|||
124753952|NCT01200368|448720831|FG001|After Infant Series|Adverse Event|6|||
124753953|NCT01200368|448720832|FG002|After Infant Series|Adverse Event|3|||
124753954|NCT01200368|448720830|FG000|After Infant Series|Withdrawal by Subject|10|||
124753955|NCT01200368|448720831|FG001|After Infant Series|Withdrawal by Subject|8|||
124753956|NCT01200368|448720832|FG002|After Infant Series|Withdrawal by Subject|4|||
124753957|NCT01200368|448720830|FG000|After Infant Series|Lost to Follow-up|1|||
124845315|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845316|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845317|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845318|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845319|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845320|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845321|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845322|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845323|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845324|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845325|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
124845326|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845327|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845328|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845329|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845330|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845331|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845332|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845333|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845334|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
124845335|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845336|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845337|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
124753958|NCT01200368|448720831|FG001|After Infant Series|Lost to Follow-up|0|||
124753959|NCT01200368|448720832|FG002|After Infant Series|Lost to Follow-up|0|||
124753960|NCT01200368|448720830|FG000|After Infant Series|Other|1|||
124845338|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845339|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
124845340|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
124845341|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845342|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845343|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845344|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845345|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845346|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124753961|NCT01200368|448720831|FG001|After Infant Series|Other|2|||
124753962|NCT01200368|448720832|FG002|After Infant Series|Other|2|||
124753963|NCT01200368|448720830|FG000|Toddler Dose|Adverse Event|0|||
124753964|NCT01200368|448720831|FG001|Toddler Dose|Adverse Event|3|||
124753965|NCT01200368|448720832|FG002|Toddler Dose|Adverse Event|1|||
124753966|NCT00570310|448720833|FG000|Overall Study|Adverse Event|1|||
124753967|NCT00570310|448720834|FG001|Overall Study|Adverse Event|2|||
124753968|NCT00570310|448720833|FG000|Overall Study|Lack of Efficacy|1|||
124753969|NCT00570310|448720834|FG001|Overall Study|Lack of Efficacy|4|||
124753970|NCT00108862|448720835|FG000|Overall Study|Death|31|||
124753971|NCT00108862|448720836|FG001|Overall Study|Death|37|||
124753972|NCT00108862|448720835|FG000|Overall Study|Withdrawal by Subject|10|||
124753973|NCT00108862|448720836|FG001|Overall Study|Withdrawal by Subject|6|||
124753974|NCT00108862|448720835|FG000|Overall Study|Lost to Follow-up|27|||
124753975|NCT00108862|448720836|FG001|Overall Study|Lost to Follow-up|19|||
124753976|NCT03534141|448720837|FG000|Overall Study|Enrolled in other clinical trial|1|||
124845347|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845348|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845349|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
124845350|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845351|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845352|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845353|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845354|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845355|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845356|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845357|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845358|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845359|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
124845360|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845361|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845362|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845363|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845364|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845365|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124640778|NCT00468481|448302829|FG001|Overall Study|Prohibited Medication|1|||
124640779|NCT00468481|448302828|FG000|Overall Study|Egg Donor|1|||
124640780|NCT00468481|448302829|FG001|Overall Study|Egg Donor|0|||
124640781|NCT00468481|448302828|FG000|Overall Study|Moved out of area|4|||
124640782|NCT00468481|448302829|FG001|Overall Study|Moved out of area|1|||
124640783|NCT00468481|448302828|FG000|Overall Study|Non-Compliance|5|||
124640784|NCT00468481|448302829|FG001|Overall Study|Non-Compliance|0|||
124640785|NCT00468481|448302828|FG000|Overall Study|Other|6|||
124640786|NCT00468481|448302829|FG001|Overall Study|Other|0|||
124640787|NCT03831113|448302830|FG000|Overall Study|Withdrawal by Subject|0|||
124640788|NCT03831113|448302831|FG001|Overall Study|Withdrawal by Subject|2|||
124640789|NCT03831113|448302830|FG000|Overall Study|Protocol Violation|0|||
124640790|NCT03831113|448302831|FG001|Overall Study|Protocol Violation|9|||
124640791|NCT01068730|448302832|FG000|Period 3|Personal reason|1|||
124640792|NCT01068730|448302833|FG001|Period 3|Personal reason|0|||
124640793|NCT01068730|448302834|FG002|Period 3|Personal reason|0|||
124640794|NCT01068730|448302835|FG003|Period 3|Personal reason|0|||
124640795|NCT01068730|448302832|FG000|Period 4|Family emergency|0|||
124640796|NCT01068730|448302833|FG001|Period 4|Family emergency|1|||
124640797|NCT01068730|448302834|FG002|Period 4|Family emergency|0|||
124640798|NCT01068730|448302835|FG003|Period 4|Family emergency|0|||
124640799|NCT01515865|448302837|FG000|Part A (Open-label)|Other|3|||
124640800|NCT01515865|448302838|FG001|Part A (Open-label)|Other|0|||
124640801|NCT01515865|448302839|FG002|Part A (Open-label)|Other|0|||
124640802|NCT01515865|448302837|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
124640803|NCT01515865|448302838|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
124640804|NCT01515865|448302839|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
124640805|NCT01515865|448302837|FG000|Part B (Open-label)|Other|1|||
124640806|NCT01515865|448302838|FG001|Part B (Open-label)|Other|0|||
124640807|NCT01515865|448302839|FG002|Part B (Open-label)|Other|0|||
124640808|NCT03691207|448302840|FG000|Overall Study|Death|41|||
124640809|NCT03691207|448302841|FG001|Overall Study|Death|26|||
124640810|NCT03691207|448302840|FG000|Overall Study|Lost to Follow-up|1|||
124640811|NCT03691207|448302841|FG001|Overall Study|Lost to Follow-up|1|||
124640812|NCT03691207|448302840|FG000|Overall Study|Withdrawal by Subject|2|||
124640813|NCT03691207|448302841|FG001|Overall Study|Withdrawal by Subject|8|||
124640814|NCT03691207|448302840|FG000|Overall Study|Sponsor decision|1|||
124640815|NCT03691207|448302841|FG001|Overall Study|Sponsor decision|7|||
124640816|NCT01736397|448302843|FG000|Overall Study|Lack of Efficacy|1|||
124640817|NCT01736397|448302844|FG001|Overall Study|Lack of Efficacy|11|||
124640818|NCT01736397|448302843|FG000|Overall Study|Withdrawal by Subject|6|||
124640819|NCT01736397|448302844|FG001|Overall Study|Withdrawal by Subject|5|||
124640820|NCT01736397|448302843|FG000|Overall Study|Lost to Follow-up|0|||
124640821|NCT01736397|448302844|FG001|Overall Study|Lost to Follow-up|1|||
124640822|NCT01736397|448302843|FG000|Overall Study|Adverse Event|6|||
124640823|NCT01736397|448302844|FG001|Overall Study|Adverse Event|3|||
124640824|NCT01736397|448302843|FG000|Overall Study|Not stated|1|||
124640825|NCT01736397|448302844|FG001|Overall Study|Not stated|4|||
124640826|NCT02448537|448302847|FG000|Overall Study|Withdrawal by Subject|1|||
124640827|NCT02448537|448302848|FG001|Overall Study|Withdrawal by Subject|1|||
124640828|NCT02448537|448302849|FG002|Overall Study|Withdrawal by Subject|1|||
124640829|NCT04696055|448302852|FG000|Overall Study|Adverse Event|10|||
124640830|NCT04696055|448302853|FG001|Overall Study|Adverse Event|2|||
124640831|NCT04696055|448302852|FG000|Overall Study|Death|4|||
124753977|NCT03534141|448720838|FG001|Overall Study|Enrolled in other clinical trial|0|||
124753978|NCT03534141|448720837|FG000|Overall Study|Liver transplant aborted after randomization|0|||
124753979|NCT03534141|448720838|FG001|Overall Study|Liver transplant aborted after randomization|2|||
124753980|NCT03534141|448720837|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
124753981|NCT03534141|448720838|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
124753982|NCT03785405|448720841|FG000|Overall Study|Adverse Event|16|||
124753983|NCT03785405|448720842|FG001|Overall Study|Adverse Event|1|||
124753984|NCT03785405|448720841|FG000|Overall Study|Death|6|||
124753985|NCT03785405|448720842|FG001|Overall Study|Death|4|||
124753986|NCT03785405|448720841|FG000|Overall Study|Guardian decision|4|||
124753987|NCT03785405|448720842|FG001|Overall Study|Guardian decision|1|||
124753988|NCT03785405|448720841|FG000|Overall Study|Lost to Follow-up|1|||
124753989|NCT03785405|448720842|FG001|Overall Study|Lost to Follow-up|0|||
124753990|NCT03785405|448720841|FG000|Overall Study|Physician Decision|8|||
124753991|NCT03785405|448720842|FG001|Overall Study|Physician Decision|5|||
124753992|NCT03785405|448720841|FG000|Overall Study|Participant decision|2|||
124753993|NCT03785405|448720842|FG001|Overall Study|Participant decision|0|||
124753994|NCT03785405|448720841|FG000|Overall Study|Other|1|||
124753995|NCT03785405|448720842|FG001|Overall Study|Other|0|||
124753996|NCT03785405|448720841|FG000|Overall Study|No treatment was received|0|||
124753997|NCT03785405|448720842|FG001|Overall Study|No treatment was received|1|||
124753998|NCT02881762|448720845|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
124753999|NCT02881762|448720846|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
124754000|NCT04137731|448720849|FG000|Overall Study|Surgery Cancellation|1|||
124754001|NCT04137731|448720850|FG001|Overall Study|Surgery Cancellation|2|||
124754002|NCT04137731|448720849|FG000|Overall Study|Withdrawal by Subject|2|||
124754003|NCT04137731|448720850|FG001|Overall Study|Withdrawal by Subject|0|||
124754004|NCT04137731|448720849|FG000|Overall Study|Protocol Violation|0|||
124754005|NCT04137731|448720850|FG001|Overall Study|Protocol Violation|1|||
124754006|NCT03983304|448720854|FG000|Overall Study|Withdrawal by Subject|5|||
124754007|NCT03983304|448720854|FG000|Overall Study|Lost to Follow-up|2|||
124754008|NCT00310817|448720855|FG000|Overall Study|AE or Death|3|||
124754009|NCT00310817|448720856|FG001|Overall Study|AE or Death|1|||
124754010|NCT00310817|448720857|FG002|Overall Study|AE or Death|0|||
124754011|NCT00310817|448720858|FG003|Overall Study|AE or Death|0|||
124754012|NCT00310817|448720855|FG000|Overall Study|Withdrawal by Subject|1|||
124754013|NCT00310817|448720856|FG001|Overall Study|Withdrawal by Subject|4|||
124754014|NCT00310817|448720857|FG002|Overall Study|Withdrawal by Subject|6|||
124754015|NCT00310817|448720858|FG003|Overall Study|Withdrawal by Subject|7|||
124754016|NCT00310817|448720855|FG000|Overall Study|Lost to Follow-up|2|||
124754017|NCT00310817|448720856|FG001|Overall Study|Lost to Follow-up|1|||
124754018|NCT00310817|448720857|FG002|Overall Study|Lost to Follow-up|0|||
124754019|NCT00310817|448720858|FG003|Overall Study|Lost to Follow-up|0|||
124754020|NCT00310817|448720855|FG000|Overall Study|Inappropriate Enrollment|1|||
124754021|NCT00310817|448720856|FG001|Overall Study|Inappropriate Enrollment|0|||
124754022|NCT00310817|448720857|FG002|Overall Study|Inappropriate Enrollment|1|||
124754023|NCT00310817|448720858|FG003|Overall Study|Inappropriate Enrollment|0|||
124754024|NCT00310817|448720855|FG000|Overall Study|Protocol Violation|1|||
124754025|NCT00310817|448720856|FG001|Overall Study|Protocol Violation|1|||
124754026|NCT00310817|448720857|FG002|Overall Study|Protocol Violation|1|||
124754027|NCT00310817|448720858|FG003|Overall Study|Protocol Violation|1|||
124754028|NCT00310817|448720855|FG000|Overall Study|Unable to classify|3|||
124754029|NCT00310817|448720856|FG001|Overall Study|Unable to classify|1|||
124754030|NCT00310817|448720857|FG002|Overall Study|Unable to classify|0|||
124754031|NCT00310817|448720858|FG003|Overall Study|Unable to classify|0|||
124754032|NCT01702246|448720859|FG000|Overall Study|Lost to Follow-up|2|||
124754033|NCT01702246|448720859|FG000|Overall Study|Withdrawal by Subject|2|||
124754034|NCT01702246|448720859|FG000|Overall Study|Physician Decision|1|||
124754035|NCT01587040|448720860|FG000|Overall Study|Protocol Violation|0|||
124754036|NCT01587040|448720861|FG001|Overall Study|Protocol Violation|0|||
124754037|NCT01587040|448720862|FG002|Overall Study|Protocol Violation|1|||
124754038|NCT01587040|448720863|FG003|Overall Study|Protocol Violation|0|||
124754039|NCT01587040|448720860|FG000|Overall Study|Adverse Event|0|||
124754040|NCT01587040|448720861|FG001|Overall Study|Adverse Event|1|||
124754041|NCT01587040|448720862|FG002|Overall Study|Adverse Event|10|||
124754042|NCT01587040|448720863|FG003|Overall Study|Adverse Event|0|||
124754043|NCT01587040|448720860|FG000|Overall Study|Disease progression|12|||
124754044|NCT01587040|448720861|FG001|Overall Study|Disease progression|1|||
124754045|NCT01587040|448720862|FG002|Overall Study|Disease progression|15|||
124754046|NCT01587040|448720863|FG003|Overall Study|Disease progression|3|||
124754047|NCT01587040|448720860|FG000|Overall Study|Other than specified|5|||
124754048|NCT01587040|448720861|FG001|Overall Study|Other than specified|1|||
124754049|NCT01587040|448720862|FG002|Overall Study|Other than specified|11|||
124754050|NCT01587040|448720863|FG003|Overall Study|Other than specified|1|||
124640832|NCT04696055|448302853|FG001|Overall Study|Death|0|||
124754051|NCT01518374|448720866|FG000|Overall Study|Withdrawal by Subject|2|||
124754052|NCT01518374|448720866|FG000|Overall Study|Protocol Violation|3|||
124754053|NCT01518374|448720866|FG000|Overall Study|Lost to Follow-up|2|||
124845366|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845367|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845368|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845369|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845370|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845371|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845372|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845373|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
124845374|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845375|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845376|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845377|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845378|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845379|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845380|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845381|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845382|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845383|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124640833|NCT04696055|448302852|FG000|Overall Study|Other|7|||
124640834|NCT04696055|448302853|FG001|Overall Study|Other|2|||
124640835|NCT04696055|448302852|FG000|Overall Study|Physician Decision|3|||
124640836|NCT04696055|448302853|FG001|Overall Study|Physician Decision|0|||
124640837|NCT04696055|448302852|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
124640838|NCT04696055|448302853|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
124640839|NCT04696055|448302852|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
124640840|NCT04696055|448302853|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
124640841|NCT04696055|448302852|FG000|Overall Study|Subject Decision|1|||
124640842|NCT04696055|448302853|FG001|Overall Study|Subject Decision|2|||
124640843|NCT04075682|448302860|FG000|Overall Study|Lost to Follow-up|5|||
124640844|NCT04075682|448302861|FG001|Overall Study|Lost to Follow-up|5|||
124640845|NCT04075682|448302862|FG002|Overall Study|Lost to Follow-up|2|||
124640846|NCT04075682|448302863|FG003|Overall Study|Lost to Follow-up|2|||
124640847|NCT04075682|448302860|FG000|Overall Study|Withdrawal by Subject|1|||
124640848|NCT04075682|448302861|FG001|Overall Study|Withdrawal by Subject|0|||
124640849|NCT04075682|448302862|FG002|Overall Study|Withdrawal by Subject|1|||
124640850|NCT04075682|448302863|FG003|Overall Study|Withdrawal by Subject|0|||
124640851|NCT04075682|448302860|FG000|Overall Study|Protocol Violation|0|||
124640852|NCT04075682|448302861|FG001|Overall Study|Protocol Violation|1|||
124640853|NCT04075682|448302862|FG002|Overall Study|Protocol Violation|1|||
124640854|NCT04075682|448302863|FG003|Overall Study|Protocol Violation|0|||
124640855|NCT04075682|448302860|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
124640856|NCT04075682|448302861|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
124640857|NCT04075682|448302862|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
124640858|NCT04075682|448302863|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
124640859|NCT04075682|448302860|FG000|Overall Study|Lost study phone the first day of study participation|0|||
124640860|NCT04075682|448302861|FG001|Overall Study|Lost study phone the first day of study participation|1|||
124640861|NCT04075682|448302862|FG002|Overall Study|Lost study phone the first day of study participation|0|||
124640862|NCT04075682|448302863|FG003|Overall Study|Lost study phone the first day of study participation|0|||
124640863|NCT00887315|448302864|FG000|Overall Study|Study termination|7|||
124640864|NCT00887315|448302865|FG001|Overall Study|Study termination|4|||
124640865|NCT00619892|448302866|FG000|Overall Study|Adverse Event|3|||
124640866|NCT00619892|448302867|FG001|Overall Study|Adverse Event|0|||
124640867|NCT00619892|448302866|FG000|Overall Study|Lost to Follow-up|0|||
124640868|NCT00619892|448302867|FG001|Overall Study|Lost to Follow-up|1|||
124640869|NCT00619892|448302866|FG000|Overall Study|Intercurrent illness|0|||
124640870|NCT00619892|448302867|FG001|Overall Study|Intercurrent illness|1|||
124640871|NCT00280397|448302868|FG000|Overall Study|Adverse Event|1|||
124640872|NCT02257489|448302871|FG000|Overall Study|Withdrawal by Subject|0|||
124640873|NCT02257489|448302872|FG001|Overall Study|Withdrawal by Subject|0|||
124640874|NCT02257489|448302873|FG002|Overall Study|Withdrawal by Subject|0|||
124640875|NCT02257489|448302874|FG003|Overall Study|Withdrawal by Subject|1|||
124640876|NCT02257489|448302875|FG004|Overall Study|Withdrawal by Subject|0|||
124640877|NCT02257489|448302876|FG005|Overall Study|Withdrawal by Subject|0|||
124640878|NCT02257489|448302877|FG006|Overall Study|Withdrawal by Subject|0|||
124640879|NCT02257489|448302878|FG007|Overall Study|Withdrawal by Subject|0|||
124640880|NCT02257489|448302879|FG008|Overall Study|Withdrawal by Subject|0|||
124640881|NCT03200704|448302881|FG000|Overall Study|Withdrawal by Subject|1|||
124640882|NCT00729157|448302883|FG000|Overall Study|Withdrawal by Subject|1|||
124845384|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
124845385|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845386|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845387|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845388|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845389|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845390|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845391|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845392|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845393|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845394|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845395|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845396|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845397|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
124845398|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845399|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124640883|NCT02217410|448302884|FG000|Overall Study|Graft Loss|0|||
124640884|NCT02217410|448302885|FG001|Overall Study|Graft Loss|0|||
124640885|NCT02217410|448302886|FG002|Overall Study|Graft Loss|2|||
124640886|NCT02217410|448302884|FG000|Overall Study|Withdrawal by Subject|0|||
124640887|NCT02217410|448302885|FG001|Overall Study|Withdrawal by Subject|0|||
124640888|NCT02217410|448302886|FG002|Overall Study|Withdrawal by Subject|2|||
124640889|NCT02217410|448302884|FG000|Overall Study|Lost to Follow-up|0|||
124640890|NCT02217410|448302885|FG001|Overall Study|Lost to Follow-up|0|||
124640891|NCT02217410|448302886|FG002|Overall Study|Lost to Follow-up|1|||
124640892|NCT02217410|448302884|FG000|Overall Study|Lack of Efficacy|0|||
124640893|NCT02217410|448302885|FG001|Overall Study|Lack of Efficacy|1|||
124640894|NCT02217410|448302886|FG002|Overall Study|Lack of Efficacy|0|||
124640895|NCT02217410|448302884|FG000|Overall Study|Physician Decision|1|||
124640896|NCT02217410|448302885|FG001|Overall Study|Physician Decision|3|||
124640897|NCT02217410|448302886|FG002|Overall Study|Physician Decision|0|||
124640898|NCT00661609|448302888|FG000|Overall Study|Adverse Event|4|||
124640899|NCT00661609|448302888|FG000|Overall Study|Death|20|||
124640900|NCT00661609|448302888|FG000|Overall Study|Withdrawal by Subject|2|||
124640901|NCT00661609|448302888|FG000|Overall Study|PI Decision|1|||
124640902|NCT00661609|448302888|FG000|Overall Study|Survival follow up stage discontinued|11|||
124640903|NCT00661609|448302888|FG000|Overall Study|Disease progression|3|||
124640904|NCT00637000|448302889|FG000|Overall Study|Withdrawal by Subject|4|||
124640905|NCT00637000|448302890|FG001|Overall Study|Withdrawal by Subject|3|||
124640906|NCT01855243|448302893|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
124640907|NCT01855243|448302894|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
124640908|NCT01855243|448302895|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
124640909|NCT03075891|448302898|FG000|Overall Study|Withdrawal by Subject|3|||
124640910|NCT03075891|448302899|FG001|Overall Study|Withdrawal by Subject|6|||
124640911|NCT03075891|448302898|FG000|Overall Study|Lost to Follow-up|1|||
124640912|NCT03075891|448302899|FG001|Overall Study|Lost to Follow-up|0|||
124640913|NCT03075891|448302898|FG000|Overall Study|Pregnancy|3|||
124640914|NCT03075891|448302899|FG001|Overall Study|Pregnancy|1|||
124640915|NCT03075891|448302898|FG000|Overall Study|visits not performed (no time)|1|||
124640916|NCT03075891|448302899|FG001|Overall Study|visits not performed (no time)|0|||
124640917|NCT03075891|448302898|FG000|Overall Study|Drug abuse relapse issue|0|||
124640918|NCT03075891|448302899|FG001|Overall Study|Drug abuse relapse issue|1|||
124640919|NCT03075891|448302898|FG000|Overall Study|Participant requiring study withdrawal|0|||
124640920|NCT03075891|448302899|FG001|Overall Study|Participant requiring study withdrawal|1|||
124640921|NCT03075891|448302898|FG000|Overall Study|Adverse event, non-fatal|1|||
124640922|NCT03075891|448302899|FG001|Overall Study|Adverse event, non-fatal|4|||
124640923|NCT00828568|448302903|FG000|Randomized|Withdrawal by Subject|1|||
124640924|NCT00828568|448302904|FG001|Randomized|Withdrawal by Subject|0|||
124640925|NCT00828568|448302905|FG002|Randomized|Withdrawal by Subject|2|||
124640926|NCT00828568|448302903|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
124640927|NCT00828568|448302904|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
124640928|NCT00828568|448302905|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
124640929|NCT00828568|448302903|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
124640930|NCT00828568|448302904|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
124640931|NCT00828568|448302905|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
124640932|NCT00828568|448302903|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
124640933|NCT00828568|448302904|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
124640934|NCT00828568|448302905|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
124640935|NCT00828568|448302903|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
124640936|NCT00828568|448302904|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
124640937|NCT00828568|448302905|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
124845400|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845401|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845402|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124754054|NCT04300309|448720867|FG000|Overall Study|Lost to Follow-up|1|||
124754055|NCT04300309|448720868|FG001|Overall Study|Lost to Follow-up|0|||
124754056|NCT03724890|448720871|FG000|Overall Study|Death|2|||
124754057|NCT03724890|448720872|FG001|Overall Study|Death|6|||
124640938|NCT00634803|448302906|FG000|Overall Study|Lost to Follow-up|6|||
124640939|NCT00634803|448302907|FG001|Overall Study|Lost to Follow-up|7|||
124640940|NCT00634803|448302908|FG002|Overall Study|Lost to Follow-up|7|||
124640941|NCT00396656|448302909|FG000|First Treatment Period|Withdrawal by Subject|0|||
124640942|NCT00396656|448302910|FG001|First Treatment Period|Withdrawal by Subject|2|||
124640943|NCT00396656|448302909|FG000|Second Treatment Period|Adverse Event|0|||
124640944|NCT00396656|448302910|FG001|Second Treatment Period|Adverse Event|1|||
124640945|NCT00364923|448302912|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
124640946|NCT00364923|448302912|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
124640947|NCT03474731|448302913|FG000|Overall Study|Withdrawal by Subject|36|||
124640948|NCT03474731|448302914|FG001|Overall Study|Withdrawal by Subject|29|||
124640949|NCT03474731|448302915|FG002|Overall Study|Withdrawal by Subject|11|||
124640950|NCT03474731|448302916|FG003|Overall Study|Withdrawal by Subject|27|||
124640951|NCT03474731|448302913|FG000|Overall Study|COVID|0|||
124640952|NCT03474731|448302914|FG001|Overall Study|COVID|23|||
124640953|NCT03474731|448302915|FG002|Overall Study|COVID|0|||
124640954|NCT03474731|448302916|FG003|Overall Study|COVID|0|||
124640955|NCT03474731|448302913|FG000|Overall Study|Participant moved from area|1|||
124640956|NCT03474731|448302914|FG001|Overall Study|Participant moved from area|0|||
124640957|NCT03474731|448302915|FG002|Overall Study|Participant moved from area|0|||
124640958|NCT03474731|448302916|FG003|Overall Study|Participant moved from area|0|||
124640959|NCT03474731|448302913|FG000|Overall Study|Lost to Follow-up|11|||
124640960|NCT03474731|448302914|FG001|Overall Study|Lost to Follow-up|3|||
124640961|NCT03474731|448302915|FG002|Overall Study|Lost to Follow-up|18|||
124640962|NCT03474731|448302916|FG003|Overall Study|Lost to Follow-up|17|||
124640963|NCT03474731|448302913|FG000|Overall Study|Death|0|||
124640964|NCT03474731|448302914|FG001|Overall Study|Death|1|||
124640965|NCT03474731|448302915|FG002|Overall Study|Death|0|||
124640966|NCT03474731|448302916|FG003|Overall Study|Death|0|||
124640967|NCT03474731|448302913|FG000|Overall Study|Participant Removed|0|||
124640968|NCT03474731|448302914|FG001|Overall Study|Participant Removed|0|||
124640969|NCT03474731|448302915|FG002|Overall Study|Participant Removed|0|||
124640970|NCT03474731|448302916|FG003|Overall Study|Participant Removed|1|||
124640971|NCT03706430|448302917|FG000|Overall Study|No A-Line placed|5|||
124640972|NCT03706430|448302917|FG000|Overall Study|Subject had gel nail polish|1|||
124640973|NCT03706430|448302917|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
124640974|NCT03706430|448302917|FG000|Overall Study|Cancelled Case|6|||
124640975|NCT03706430|448302917|FG000|Overall Study|Physician Decision|2|||
124640976|NCT00765336|448302918|FG000|Overall Study|Protocol Violation|4|||
124640977|NCT00765336|448302919|FG001|Overall Study|Protocol Violation|2|||
124640978|NCT00765336|448302918|FG000|Overall Study|Withdrawal by Subject|6|||
124640979|NCT00765336|448302919|FG001|Overall Study|Withdrawal by Subject|4|||
124640980|NCT00765336|448302918|FG000|Overall Study|Lost to Follow-up|7|||
124640981|NCT00765336|448302919|FG001|Overall Study|Lost to Follow-up|9|||
124640982|NCT00765336|448302918|FG000|Overall Study|Adverse Event|2|||
124640983|NCT00765336|448302919|FG001|Overall Study|Adverse Event|1|||
124640984|NCT00478777|448302920|FG000|Overall Study|Adverse Event|29|||
124640985|NCT00478777|448302920|FG000|Overall Study|Lack of Efficacy|23|||
124640986|NCT00478777|448302920|FG000|Overall Study|Withdrawal by Subject|4|||
124640987|NCT00478777|448302920|FG000|Overall Study|Death|3|||
124640988|NCT00478777|448302920|FG000|Overall Study|Protocol Violation|3|||
124640989|NCT00478777|448302920|FG000|Overall Study|Lost to Follow-up|3|||
124640990|NCT00478777|448302920|FG000|Overall Study|Physician Decision|1|||
124640991|NCT00478777|448302920|FG000|Overall Study|Intolerance of therapy|1|||
124640992|NCT00478777|448302920|FG000|Overall Study|Lack of compliance|1|||
124640993|NCT00478777|448302920|FG000|Overall Study|Lymphocytes infusion|1|||
124640994|NCT00478777|448302920|FG000|Overall Study|End of therapy|2|||
124640995|NCT00478777|448302920|FG000|Overall Study|Not treated with lenalidomide|6|||
124640996|NCT01218087|448302921|FG000|Overall Study|Death|2|||
124640997|NCT01218087|448302922|FG001|Overall Study|Death|1|||
124640998|NCT01218087|448302921|FG000|Overall Study|Withdrawal by Subject|5|||
124754058|NCT03724890|448720873|FG002|Overall Study|Death|3|||
124754059|NCT03724890|448720874|FG003|Overall Study|Death|5|||
124754060|NCT03724890|448720875|FG004|Overall Study|Death|2|||
124754061|NCT03724890|448720876|FG005|Overall Study|Death|0|||
124754062|NCT03724890|448720877|FG006|Overall Study|Death|2|||
124754063|NCT03724890|448720878|FG007|Overall Study|Death|3|||
124754064|NCT03724890|448720879|FG008|Overall Study|Death|4|||
124754065|NCT03724890|448720880|FG009|Overall Study|Death|2|||
124754066|NCT03724890|448720881|FG010|Overall Study|Death|2|||
124754067|NCT03724890|448720871|FG000|Overall Study|Lost to Follow-up|0|||
124845403|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845404|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845405|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845406|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845407|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845408|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845409|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845410|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845411|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845412|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
124845413|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845414|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845415|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845416|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845417|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845418|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845419|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845420|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845421|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
124845422|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845423|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845424|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845425|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845426|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845427|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845428|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845429|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845430|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845431|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845432|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845433|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845434|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845435|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845436|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
124845437|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845438|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845439|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845440|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845441|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845442|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845443|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845444|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845445|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
124845446|NCT02346240|449060186|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845447|NCT02346240|449060187|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845448|NCT02346240|449060188|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845449|NCT02346240|449060189|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845450|NCT02346240|449060190|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845451|NCT02346240|449060191|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845452|NCT02346240|449060192|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845453|NCT02346240|449060193|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845454|NCT02346240|449060194|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845455|NCT02346240|449060195|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845456|NCT02346240|449060196|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845457|NCT02346240|449060197|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845458|NCT02346240|449060198|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845459|NCT02346240|449060199|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845460|NCT02346240|449060200|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
124845461|NCT02346240|449060201|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845462|NCT02346240|449060202|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845463|NCT02346240|449060203|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845464|NCT02346240|449060204|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845465|NCT02346240|449060205|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845466|NCT02346240|449060206|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845467|NCT02346240|449060207|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845468|NCT02346240|449060208|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845469|NCT02346240|449060209|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
124845470|NCT02346240|449060186|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845471|NCT02346240|449060187|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845472|NCT02346240|449060188|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845473|NCT02346240|449060189|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845474|NCT02346240|449060190|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845475|NCT02346240|449060191|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845476|NCT02346240|449060192|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845477|NCT02346240|449060193|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845478|NCT02346240|449060194|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845479|NCT02346240|449060195|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845480|NCT02346240|449060196|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845481|NCT02346240|449060197|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845482|NCT02346240|449060198|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845483|NCT02346240|449060199|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845484|NCT02346240|449060200|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845485|NCT02346240|449060201|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845486|NCT02346240|449060202|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
124845487|NCT02346240|449060203|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
124845488|NCT02346240|449060204|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
124845489|NCT02346240|449060205|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
124845490|NCT02346240|449060206|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
124845491|NCT02346240|449060207|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
124845492|NCT02346240|449060208|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
124845493|NCT02346240|449060209|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
124845494|NCT02346240|449060186|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845495|NCT02346240|449060187|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845496|NCT02346240|449060188|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845497|NCT02346240|449060189|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845498|NCT02346240|449060190|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845499|NCT02346240|449060191|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845500|NCT02346240|449060192|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845501|NCT02346240|449060193|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845502|NCT02346240|449060194|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845503|NCT02346240|449060195|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845504|NCT02346240|449060196|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845505|NCT02346240|449060197|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845506|NCT02346240|449060198|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845507|NCT02346240|449060199|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845508|NCT02346240|449060200|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845509|NCT02346240|449060201|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845510|NCT02346240|449060202|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845511|NCT02346240|449060203|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845512|NCT02346240|449060204|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
124845513|NCT02346240|449060205|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
124845514|NCT02346240|449060206|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845515|NCT02346240|449060207|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
124845516|NCT02346240|449060208|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
124845517|NCT02346240|449060209|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
124754068|NCT03724890|448720872|FG001|Overall Study|Lost to Follow-up|3|||
124754069|NCT03724890|448720873|FG002|Overall Study|Lost to Follow-up|0|||
124754070|NCT03724890|448720874|FG003|Overall Study|Lost to Follow-up|1|||
124754071|NCT03724890|448720875|FG004|Overall Study|Lost to Follow-up|2|||
124754072|NCT03724890|448720876|FG005|Overall Study|Lost to Follow-up|2|||
124754073|NCT03724890|448720877|FG006|Overall Study|Lost to Follow-up|1|||
124754074|NCT03724890|448720878|FG007|Overall Study|Lost to Follow-up|0|||
124754075|NCT03724890|448720879|FG008|Overall Study|Lost to Follow-up|2|||
124845518|NCT02346240|449060186|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845519|NCT02346240|449060187|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845520|NCT02346240|449060188|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845521|NCT02346240|449060189|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845522|NCT02346240|449060190|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845523|NCT02346240|449060191|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845524|NCT02346240|449060192|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845525|NCT02346240|449060193|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845526|NCT02346240|449060194|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845527|NCT02346240|449060195|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845528|NCT02346240|449060196|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845529|NCT02346240|449060197|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845530|NCT02346240|449060198|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845531|NCT02346240|449060199|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845532|NCT02346240|449060200|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845533|NCT02346240|449060201|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845534|NCT02346240|449060202|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845535|NCT02346240|449060203|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845536|NCT02346240|449060204|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
124845537|NCT02346240|449060205|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845538|NCT02346240|449060206|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845539|NCT02346240|449060207|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
124845540|NCT02346240|449060208|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845541|NCT02346240|449060209|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
124845542|NCT02346240|449060186|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845543|NCT02346240|449060187|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845544|NCT02346240|449060188|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845545|NCT02346240|449060189|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845546|NCT02346240|449060190|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845547|NCT02346240|449060191|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845548|NCT02346240|449060192|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845549|NCT02346240|449060193|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845550|NCT02346240|449060194|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845551|NCT02346240|449060195|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845552|NCT02346240|449060196|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845553|NCT02346240|449060197|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845554|NCT02346240|449060198|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845555|NCT02346240|449060199|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845556|NCT02346240|449060200|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845557|NCT02346240|449060201|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845558|NCT02346240|449060202|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845559|NCT02346240|449060203|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845560|NCT02346240|449060204|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845561|NCT02346240|449060205|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845562|NCT02346240|449060206|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845563|NCT02346240|449060207|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
124845564|NCT02346240|449060208|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845565|NCT02346240|449060209|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
124845566|NCT02346240|449060186|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845567|NCT02346240|449060187|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845568|NCT02346240|449060188|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845569|NCT02346240|449060189|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845570|NCT02346240|449060190|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845571|NCT02346240|449060191|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845572|NCT02346240|449060192|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845573|NCT02346240|449060193|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845574|NCT02346240|449060194|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124640999|NCT01218087|448302922|FG001|Overall Study|Withdrawal by Subject|0|||
124845575|NCT02346240|449060195|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845576|NCT02346240|449060196|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845577|NCT02346240|449060197|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124641000|NCT01218087|448302921|FG000|Overall Study|Transferred|8|||
124641001|NCT01218087|448302922|FG001|Overall Study|Transferred|5|||
124641002|NCT00552396|448302923|FG000|Overall Study|protocol withdrawal criteria|3|||
124845578|NCT02346240|449060198|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845579|NCT02346240|449060199|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845580|NCT02346240|449060200|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845581|NCT02346240|449060201|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845582|NCT02346240|449060202|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845583|NCT02346240|449060203|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
124845584|NCT02346240|449060204|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
124845585|NCT02346240|449060205|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
124845586|NCT02346240|449060206|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
124845587|NCT02346240|449060207|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
124845588|NCT02346240|449060208|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
124845589|NCT02346240|449060209|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
124845590|NCT02346240|449060186|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845591|NCT02346240|449060187|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845592|NCT02346240|449060188|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845593|NCT02346240|449060189|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845594|NCT02346240|449060190|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845595|NCT02346240|449060191|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845596|NCT02346240|449060192|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845597|NCT02346240|449060193|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845598|NCT02346240|449060194|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845599|NCT02346240|449060195|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845600|NCT02346240|449060196|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845601|NCT02346240|449060197|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845602|NCT02346240|449060198|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845603|NCT02346240|449060199|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845604|NCT02346240|449060200|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845605|NCT02346240|449060201|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845606|NCT02346240|449060202|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845607|NCT02346240|449060203|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845608|NCT02346240|449060204|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
124845609|NCT02346240|449060205|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
124845610|NCT02346240|449060206|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
124845611|NCT02346240|449060207|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
124845612|NCT02346240|449060208|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
124845613|NCT02346240|449060209|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
124845614|NCT02346240|449060186|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845615|NCT02346240|449060187|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845616|NCT02346240|449060188|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845617|NCT02346240|449060189|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845618|NCT02346240|449060190|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845619|NCT02346240|449060191|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845620|NCT02346240|449060192|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845621|NCT02346240|449060193|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845622|NCT02346240|449060194|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845623|NCT02346240|449060195|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845624|NCT02346240|449060196|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845625|NCT02346240|449060197|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845626|NCT02346240|449060198|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845627|NCT02346240|449060199|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845628|NCT02346240|449060200|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845629|NCT02346240|449060201|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845630|NCT02346240|449060202|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845631|NCT02346240|449060203|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845632|NCT02346240|449060204|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
124845633|NCT02346240|449060205|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124641003|NCT00552396|448302924|FG001|Overall Study|protocol withdrawal criteria|3|||
124845634|NCT02346240|449060206|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
124845635|NCT02346240|449060207|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
124845636|NCT02346240|449060208|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
124845637|NCT02346240|449060209|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
124641004|NCT00552396|448302925|FG002|Overall Study|protocol withdrawal criteria|3|||
124845638|NCT02346240|449060186|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845639|NCT02346240|449060187|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845640|NCT02346240|449060188|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845641|NCT02346240|449060189|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845642|NCT02346240|449060190|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845643|NCT02346240|449060191|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845644|NCT02346240|449060192|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845645|NCT02346240|449060193|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845646|NCT02346240|449060194|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845647|NCT02346240|449060195|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845648|NCT02346240|449060196|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845649|NCT02346240|449060197|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845650|NCT02346240|449060198|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845651|NCT02346240|449060199|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845652|NCT02346240|449060200|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845653|NCT02346240|449060201|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845654|NCT02346240|449060202|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845655|NCT02346240|449060203|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845656|NCT02346240|449060204|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
124845657|NCT02346240|449060205|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845658|NCT02346240|449060206|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845659|NCT02346240|449060207|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845660|NCT02346240|449060208|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845661|NCT02346240|449060209|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
124845662|NCT03417141|449060211|FG000|Overall Study|Withdrawal by Subject|1|||
124845663|NCT03417141|449060211|FG000|Overall Study|Protocol Violation|3|||
124845664|NCT03706690|449060214|FG000|Overall Study|Withdrawal by Subject|8|||
124845665|NCT03706690|449060215|FG001|Overall Study|Withdrawal by Subject|8|||
124845666|NCT03706690|449060214|FG000|Overall Study|Death|143|||
124845667|NCT03706690|449060215|FG001|Overall Study|Death|75|||
124845668|NCT03706690|449060214|FG000|Overall Study|Ongoing at DCO|121|||
124845669|NCT03706690|449060215|FG001|Overall Study|Ongoing at DCO|52|||
124845670|NCT02098109|449060216|FG000|Overall Study|Protocol Violation|3|||
124845671|NCT02098109|449060217|FG001|Overall Study|Protocol Violation|0|||
124845672|NCT02143843|449060218|FG000|Overall Study|Adverse Event|8|||
124845673|NCT02143843|449060218|FG000|Overall Study|Lack of Efficacy|2|||
124845674|NCT02143843|449060218|FG000|Overall Study|Withdrawal by Subject|2|||
124845675|NCT01822132|449060219|FG000|Overall Study|Lost to Follow-up|4|||
124845676|NCT01822132|449060220|FG001|Overall Study|Lost to Follow-up|2|||
124845677|NCT02519712|449060223|FG000|Overall Study|Disease Relapse|1|||
124845678|NCT02519712|449060223|FG000|Overall Study|Disease Progression|1|||
124845679|NCT02519712|449060223|FG000|Overall Study|Accruals are donors|2|||
124845680|NCT00006916|449060226|FG000|Overall Study|Device not inserted|4|||
124845681|NCT00006916|449060226|FG000|Overall Study|Complication of device insertion|1|||
124845682|NCT01524770|449060230|FG000|First Intervention|Withdrawal by Subject|1|||
124845683|NCT01524770|449060231|FG001|First Intervention|Withdrawal by Subject|0|||
124845684|NCT01524770|449060230|FG000|First Intervention|Adverse Event|1|||
124845685|NCT01524770|449060231|FG001|First Intervention|Adverse Event|1|||
124845686|NCT01524770|449060230|FG000|First Intervention|Protocol Violation|1|||
124845687|NCT01524770|449060231|FG001|First Intervention|Protocol Violation|0|||
124845688|NCT02751983|449060232|FG000|Treatment|Stopped ACT, but Remained in study|2|||
124845689|NCT02751983|449060233|FG001|Treatment|Stopped ACT, but Remained in study|0|||
124845690|NCT02751983|449060232|FG000|Treatment|Discharged prior to beginning ACT|2|||
124845691|NCT02751983|449060233|FG001|Treatment|Discharged prior to beginning ACT|0|||
124845692|NCT02751983|449060232|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
124641005|NCT00552396|448302926|FG003|Overall Study|protocol withdrawal criteria|6|||
124641006|NCT00552396|448302927|FG004|Overall Study|protocol withdrawal criteria|3|||
124845693|NCT02751983|449060233|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
124845694|NCT02751983|449060232|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
124845695|NCT02751983|449060233|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
124845696|NCT02751983|449060232|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
124845697|NCT02751983|449060233|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
124845698|NCT01420081|449060234|FG000|Overall Study|Death|1|||
124845699|NCT01420081|449060235|FG001|Overall Study|Death|0|||
124845700|NCT01420081|449060236|FG002|Overall Study|Death|8|||
124845701|NCT01420081|449060237|FG003|Overall Study|Death|0|||
124845702|NCT01420081|449060238|FG004|Overall Study|Death|7|||
124845703|NCT01420081|449060239|FG005|Overall Study|Death|12|||
124641007|NCT00552396|448302928|FG005|Overall Study|protocol withdrawal criteria|3|||
124845704|NCT01420081|449060240|FG006|Overall Study|Death|0|||
124845705|NCT01420081|449060241|FG007|Overall Study|Death|1|||
124845706|NCT01420081|449060242|FG008|Overall Study|Death|1|||
124845707|NCT01420081|449060234|FG000|Overall Study|Lost to Follow-up|0|||
124845708|NCT01420081|449060235|FG001|Overall Study|Lost to Follow-up|0|||
124845709|NCT01420081|449060236|FG002|Overall Study|Lost to Follow-up|0|||
124845710|NCT01420081|449060237|FG003|Overall Study|Lost to Follow-up|0|||
124845711|NCT01420081|449060238|FG004|Overall Study|Lost to Follow-up|1|||
124845712|NCT01420081|449060239|FG005|Overall Study|Lost to Follow-up|1|||
124845713|NCT01420081|449060240|FG006|Overall Study|Lost to Follow-up|0|||
124845714|NCT01420081|449060241|FG007|Overall Study|Lost to Follow-up|0|||
124845715|NCT01420081|449060242|FG008|Overall Study|Lost to Follow-up|0|||
124845716|NCT01420081|449060234|FG000|Overall Study|Study Terminated by Sponsor|2|||
124845717|NCT01420081|449060235|FG001|Overall Study|Study Terminated by Sponsor|1|||
124845718|NCT01420081|449060236|FG002|Overall Study|Study Terminated by Sponsor|1|||
124845719|NCT01420081|449060237|FG003|Overall Study|Study Terminated by Sponsor|3|||
124845720|NCT01420081|449060238|FG004|Overall Study|Study Terminated by Sponsor|11|||
124845721|NCT01420081|449060239|FG005|Overall Study|Study Terminated by Sponsor|7|||
124845722|NCT01420081|449060240|FG006|Overall Study|Study Terminated by Sponsor|3|||
124845723|NCT01420081|449060241|FG007|Overall Study|Study Terminated by Sponsor|2|||
124845724|NCT01420081|449060242|FG008|Overall Study|Study Terminated by Sponsor|2|||
124845725|NCT01420081|449060234|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
124845726|NCT01420081|449060235|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
124845727|NCT01420081|449060236|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
124845728|NCT01420081|449060237|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
124845729|NCT01420081|449060238|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
124845730|NCT01420081|449060239|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
124845731|NCT01420081|449060240|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
124845732|NCT01420081|449060241|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
124845733|NCT01420081|449060242|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
124845734|NCT01420081|449060234|FG000|Overall Study|Other Reasons|0|||
124845735|NCT01420081|449060235|FG001|Overall Study|Other Reasons|0|||
124845736|NCT01420081|449060236|FG002|Overall Study|Other Reasons|1|||
124845737|NCT01420081|449060237|FG003|Overall Study|Other Reasons|0|||
124845738|NCT01420081|449060238|FG004|Overall Study|Other Reasons|0|||
124845739|NCT01420081|449060239|FG005|Overall Study|Other Reasons|0|||
124845740|NCT01420081|449060240|FG006|Overall Study|Other Reasons|0|||
124845741|NCT01420081|449060241|FG007|Overall Study|Other Reasons|0|||
124845742|NCT01420081|449060242|FG008|Overall Study|Other Reasons|0|||
124845743|NCT03467425|449060243|FG000|Overall Study|Adverse Event|9|||
124845744|NCT03467425|449060244|FG001|Overall Study|Adverse Event|9|||
124845745|NCT03467425|449060243|FG000|Overall Study|Lack of Efficacy|3|||
124845746|NCT03467425|449060244|FG001|Overall Study|Lack of Efficacy|1|||
124845747|NCT03467425|449060243|FG000|Overall Study|Protocol Violation|0|||
124845748|NCT03467425|449060244|FG001|Overall Study|Protocol Violation|1|||
124845749|NCT03467425|449060243|FG000|Overall Study|Lost to Follow-up|18|||
124845750|NCT03467425|449060244|FG001|Overall Study|Lost to Follow-up|25|||
124845751|NCT03467425|449060243|FG000|Overall Study|Physician Decision|2|||
124845752|NCT03467425|449060244|FG001|Overall Study|Physician Decision|1|||
124845753|NCT03467425|449060243|FG000|Overall Study|Withdrawal by Subject|15|||
124845754|NCT03467425|449060244|FG001|Overall Study|Withdrawal by Subject|17|||
124845755|NCT02318693|449060246|FG000|Overall Study|Protocol Violation|0|||
124845756|NCT02318693|449060247|FG001|Overall Study|Protocol Violation|1|||
124845757|NCT00025883|449060248|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
124845758|NCT00025883|449060248|FG000|Overall Study|no baseline data|1|||
124845759|NCT00025883|449060248|FG000|Overall Study|Death|1|||
124845760|NCT00025883|449060248|FG000|Overall Study|Adverse Event|1|||
124845761|NCT00025883|449060248|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
124845762|NCT00528528|449060254|FG000|Overall Study|Lost to Follow-up|0|||
124845763|NCT00528528|449060255|FG001|Overall Study|Lost to Follow-up|0|||
124845764|NCT00528528|449060256|FG002|Overall Study|Lost to Follow-up|1|||
124845765|NCT00528528|449060257|FG003|Overall Study|Lost to Follow-up|1|||
124845766|NCT00528528|449060254|FG000|Overall Study|Ineligible to continue the trial|0|||
124641008|NCT00552396|448302929|FG006|Overall Study|protocol withdrawal criteria|9|||
124641009|NCT01323387|448302930|FG000|Overall Study|Withdrawal by Subject|41|||
124845767|NCT00528528|449060255|FG001|Overall Study|Ineligible to continue the trial|0|||
124845768|NCT00528528|449060256|FG002|Overall Study|Ineligible to continue the trial|0|||
124845769|NCT00528528|449060257|FG003|Overall Study|Ineligible to continue the trial|1|||
124845770|NCT00528528|449060254|FG000|Overall Study|Other|0|||
124845771|NCT00528528|449060255|FG001|Overall Study|Other|1|||
124845772|NCT00528528|449060256|FG002|Overall Study|Other|0|||
124845773|NCT00528528|449060257|FG003|Overall Study|Other|0|||
124845774|NCT00528528|449060254|FG000|Overall Study|Withdrawal by Subject|3|||
124845775|NCT00528528|449060255|FG001|Overall Study|Withdrawal by Subject|2|||
124845776|NCT00528528|449060256|FG002|Overall Study|Withdrawal by Subject|1|||
124845777|NCT00528528|449060257|FG003|Overall Study|Withdrawal by Subject|1|||
124845778|NCT00528528|449060254|FG000|Overall Study|Ongoing participant|0|||
124845779|NCT00528528|449060255|FG001|Overall Study|Ongoing participant|0|||
124845780|NCT00528528|449060256|FG002|Overall Study|Ongoing participant|1|||
124845781|NCT00528528|449060257|FG003|Overall Study|Ongoing participant|0|||
124845782|NCT04197713|449060260|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
124845783|NCT04197713|449060261|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
124845784|NCT05569954|449060262|FG000|Overall Study|Lost to Follow-up|3|||
124845785|NCT05569954|449060263|FG001|Overall Study|Lost to Follow-up|4|||
124845786|NCT05569954|449060262|FG000|Overall Study|Protocol Violation|1|||
124845787|NCT05569954|449060263|FG001|Overall Study|Protocol Violation|2|||
124845788|NCT05569954|449060262|FG000|Overall Study|Withdrawal by Subject|4|||
124845789|NCT05569954|449060263|FG001|Overall Study|Withdrawal by Subject|2|||
124845790|NCT01660412|449060264|FG000|Overall Study|Protocol Violation|0|||
124845791|NCT01660412|449060265|FG001|Overall Study|Protocol Violation|3|||
124845792|NCT04579679|449060266|FG000|Overall Study|New Antitumor Therapy|6|||
124845793|NCT04579679|449060267|FG001|Overall Study|New Antitumor Therapy|4|||
124845794|NCT04579679|449060268|FG002|Overall Study|New Antitumor Therapy|7|||
124845795|NCT04579679|449060269|FG003|Overall Study|New Antitumor Therapy|0|||
124845796|NCT04579679|449060266|FG000|Overall Study|Withdrawal of Consent|1|||
124845797|NCT04579679|449060267|FG001|Overall Study|Withdrawal of Consent|1|||
124845798|NCT04579679|449060268|FG002|Overall Study|Withdrawal of Consent|2|||
124845799|NCT04579679|449060269|FG003|Overall Study|Withdrawal of Consent|4|||
124845800|NCT04579679|449060266|FG000|Overall Study|Death|2|||
124845801|NCT04579679|449060267|FG001|Overall Study|Death|2|||
124845802|NCT04579679|449060268|FG002|Overall Study|Death|2|||
124845803|NCT04579679|449060269|FG003|Overall Study|Death|0|||
124845804|NCT04579679|449060266|FG000|Overall Study|Adverse Event|0|||
124845805|NCT04579679|449060267|FG001|Overall Study|Adverse Event|4|||
124845806|NCT04579679|449060268|FG002|Overall Study|Adverse Event|0|||
124845807|NCT04579679|449060269|FG003|Overall Study|Adverse Event|0|||
124845808|NCT04579679|449060266|FG000|Overall Study|Disease Progression|9|||
124845809|NCT04579679|449060267|FG001|Overall Study|Disease Progression|13|||
124845810|NCT04579679|449060268|FG002|Overall Study|Disease Progression|7|||
124845811|NCT04579679|449060269|FG003|Overall Study|Disease Progression|0|||
124845812|NCT04579679|449060266|FG000|Overall Study|Physician Decision|0|||
124845813|NCT04579679|449060267|FG001|Overall Study|Physician Decision|0|||
124845814|NCT04579679|449060268|FG002|Overall Study|Physician Decision|1|||
124845815|NCT04579679|449060269|FG003|Overall Study|Physician Decision|0|||
124845816|NCT04579679|449060266|FG000|Overall Study|Study Terminated by Sponsor|2|||
124845817|NCT04579679|449060267|FG001|Overall Study|Study Terminated by Sponsor|7|||
124845818|NCT04579679|449060268|FG002|Overall Study|Study Terminated by Sponsor|1|||
124641010|NCT01323387|448302930|FG000|Overall Study|Radiographic Data Unavailable|1|||
124641011|NCT01323387|448302930|FG000|Overall Study|Revision|14|||
124641012|NCT01323387|448302930|FG000|Overall Study|Protocol Violation|12|||
124641013|NCT01323387|448302930|FG000|Overall Study|Randomized but Never Treated|16|||
124641014|NCT04185220|448302931|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
124754076|NCT03724890|448720880|FG009|Overall Study|Lost to Follow-up|0|||
124754077|NCT03724890|448720881|FG010|Overall Study|Lost to Follow-up|0|||
124754078|NCT03724890|448720871|FG000|Overall Study|Withdrawal by Subject|1|||
124754079|NCT03724890|448720872|FG001|Overall Study|Withdrawal by Subject|2|||
124754080|NCT03724890|448720873|FG002|Overall Study|Withdrawal by Subject|1|||
124754081|NCT03724890|448720874|FG003|Overall Study|Withdrawal by Subject|0|||
124754082|NCT03724890|448720875|FG004|Overall Study|Withdrawal by Subject|0|||
124754083|NCT03724890|448720876|FG005|Overall Study|Withdrawal by Subject|1|||
124754084|NCT03724890|448720877|FG006|Overall Study|Withdrawal by Subject|0|||
124754085|NCT03724890|448720878|FG007|Overall Study|Withdrawal by Subject|0|||
124754086|NCT03724890|448720879|FG008|Overall Study|Withdrawal by Subject|2|||
124754087|NCT03724890|448720880|FG009|Overall Study|Withdrawal by Subject|2|||
124754088|NCT03724890|448720881|FG010|Overall Study|Withdrawal by Subject|1|||
124754089|NCT03724890|448720871|FG000|Overall Study|Other|1|||
124754090|NCT03724890|448720872|FG001|Overall Study|Other|0|||
124754091|NCT03724890|448720873|FG002|Overall Study|Other|0|||
124754092|NCT03724890|448720874|FG003|Overall Study|Other|0|||
124754093|NCT03724890|448720875|FG004|Overall Study|Other|0|||
124754094|NCT03724890|448720876|FG005|Overall Study|Other|0|||
124754095|NCT03724890|448720877|FG006|Overall Study|Other|0|||
124754096|NCT03724890|448720878|FG007|Overall Study|Other|1|||
124754097|NCT03724890|448720879|FG008|Overall Study|Other|1|||
124754098|NCT03724890|448720880|FG009|Overall Study|Other|0|||
124754099|NCT03724890|448720881|FG010|Overall Study|Other|2|||
124754100|NCT04607837|448720884|FG000|Overall Study|Adverse Event|8|||
124754101|NCT04607837|448720885|FG001|Overall Study|Adverse Event|2|||
124754102|NCT04607837|448720884|FG000|Overall Study|Withdrawal by Subject|8|||
124754103|NCT04607837|448720885|FG001|Overall Study|Withdrawal by Subject|7|||
124754104|NCT04607837|448720884|FG000|Overall Study|Physician Decision|2|||
124754105|NCT04607837|448720885|FG001|Overall Study|Physician Decision|0|||
124754106|NCT04607837|448720884|FG000|Overall Study|Lack of Efficacy|2|||
124754107|NCT04607837|448720885|FG001|Overall Study|Lack of Efficacy|0|||
124845819|NCT04579679|449060269|FG003|Overall Study|Study Terminated by Sponsor|0|||
124845820|NCT04740034|449060270|FG000|Overall Study|Death|0|||
124845821|NCT04740034|449060271|FG001|Overall Study|Death|1|||
124845822|NCT04740034|449060272|FG002|Overall Study|Death|2|||
124845823|NCT04740034|449060273|FG003|Overall Study|Death|3|||
124845824|NCT04740034|449060274|FG004|Overall Study|Death|4|||
124845825|NCT04740034|449060275|FG005|Overall Study|Death|4|||
124845826|NCT04740034|449060276|FG006|Overall Study|Death|2|||
124845827|NCT04740034|449060277|FG007|Overall Study|Death|2|||
124845828|NCT04740034|449060278|FG008|Overall Study|Death|2|||
124845829|NCT04740034|449060279|FG009|Overall Study|Death|4|||
124845830|NCT04740034|449060280|FG010|Overall Study|Death|0|||
124845831|NCT04740034|449060270|FG000|Overall Study|Lost to Follow-up|0|||
124845832|NCT04740034|449060271|FG001|Overall Study|Lost to Follow-up|0|||
124845833|NCT04740034|449060272|FG002|Overall Study|Lost to Follow-up|0|||
124845834|NCT04740034|449060273|FG003|Overall Study|Lost to Follow-up|1|||
124845835|NCT04740034|449060274|FG004|Overall Study|Lost to Follow-up|2|||
124845836|NCT04740034|449060275|FG005|Overall Study|Lost to Follow-up|2|||
124845837|NCT04740034|449060276|FG006|Overall Study|Lost to Follow-up|0|||
124845838|NCT04740034|449060277|FG007|Overall Study|Lost to Follow-up|0|||
124845839|NCT04740034|449060278|FG008|Overall Study|Lost to Follow-up|0|||
124845840|NCT04740034|449060279|FG009|Overall Study|Lost to Follow-up|1|||
124845841|NCT04740034|449060280|FG010|Overall Study|Lost to Follow-up|0|||
124845842|NCT04740034|449060270|FG000|Overall Study|Withdrawal by Subject|1|||
124845843|NCT04740034|449060271|FG001|Overall Study|Withdrawal by Subject|0|||
124845844|NCT04740034|449060272|FG002|Overall Study|Withdrawal by Subject|0|||
124845845|NCT04740034|449060273|FG003|Overall Study|Withdrawal by Subject|0|||
124845846|NCT04740034|449060274|FG004|Overall Study|Withdrawal by Subject|0|||
124845847|NCT04740034|449060275|FG005|Overall Study|Withdrawal by Subject|0|||
124845848|NCT04740034|449060276|FG006|Overall Study|Withdrawal by Subject|0|||
124845849|NCT04740034|449060277|FG007|Overall Study|Withdrawal by Subject|1|||
124845850|NCT04740034|449060278|FG008|Overall Study|Withdrawal by Subject|0|||
124845851|NCT04740034|449060279|FG009|Overall Study|Withdrawal by Subject|1|||
124845852|NCT04740034|449060280|FG010|Overall Study|Withdrawal by Subject|0|||
124845853|NCT04740034|449060270|FG000|Overall Study|Decision by sponsor|0|||
124845854|NCT04740034|449060271|FG001|Overall Study|Decision by sponsor|0|||
124845855|NCT04740034|449060272|FG002|Overall Study|Decision by sponsor|1|||
124845856|NCT04740034|449060273|FG003|Overall Study|Decision by sponsor|0|||
124845857|NCT04740034|449060274|FG004|Overall Study|Decision by sponsor|0|||
124845858|NCT04740034|449060275|FG005|Overall Study|Decision by sponsor|0|||
124845859|NCT04740034|449060276|FG006|Overall Study|Decision by sponsor|1|||
124845860|NCT04740034|449060277|FG007|Overall Study|Decision by sponsor|2|||
124845861|NCT04740034|449060278|FG008|Overall Study|Decision by sponsor|1|||
124845862|NCT04740034|449060279|FG009|Overall Study|Decision by sponsor|1|||
124845863|NCT04740034|449060280|FG010|Overall Study|Decision by sponsor|2|||
124845864|NCT04346615|449062105|FG000|Overall Study|Lost to Follow-up|0|||
124845865|NCT04346615|449062106|FG001|Overall Study|Lost to Follow-up|2|||
124845866|NCT04346615|449062105|FG000|Overall Study|Withdrawal by Subject|1|||
124845867|NCT04346615|449062106|FG001|Overall Study|Withdrawal by Subject|0|||
124845868|NCT04346615|449062105|FG000|Overall Study|Death|5|||
124845869|NCT04346615|449062106|FG001|Overall Study|Death|1|||
124845870|NCT04346615|449062105|FG000|Overall Study|Other|0|||
124845871|NCT04346615|449062106|FG001|Overall Study|Other|2|||
124845872|NCT04346615|449062105|FG000|Overall Study|Randomized not treated|1|||
124845873|NCT04346615|449062106|FG001|Overall Study|Randomized not treated|0|||
124845874|NCT04524403|449062109|FG000|Overall Study|Withdrawal by Subject|10|||
124845875|NCT04524403|449062110|FG001|Overall Study|Withdrawal by Subject|3|||
124845876|NCT04524403|449062111|FG002|Overall Study|Withdrawal by Subject|8|||
124845877|NCT04524403|449062109|FG000|Overall Study|Lost to Follow-up|3|||
124845878|NCT04524403|449062110|FG001|Overall Study|Lost to Follow-up|4|||
124845879|NCT04524403|449062111|FG002|Overall Study|Lost to Follow-up|3|||
124845880|NCT04524403|449062109|FG000|Overall Study|Adverse Event|3|||
124845881|NCT04524403|449062110|FG001|Overall Study|Adverse Event|1|||
124845882|NCT04524403|449062111|FG002|Overall Study|Adverse Event|4|||
124845883|NCT04524403|449062109|FG000|Overall Study|Non-compliant with study drug|1|||
124845884|NCT04524403|449062110|FG001|Overall Study|Non-compliant with study drug|2|||
124845885|NCT04524403|449062111|FG002|Overall Study|Non-compliant with study drug|3|||
124845886|NCT04524403|449062109|FG000|Overall Study|Moved|0|||
124845887|NCT04524403|449062110|FG001|Overall Study|Moved|1|||
124845888|NCT04524403|449062111|FG002|Overall Study|Moved|0|||
124845889|NCT00533949|449062114|FG000|Overall Study|Protocol Violation|12|||
124845890|NCT00533949|449062115|FG001|Overall Study|Protocol Violation|12|||
124845891|NCT00533949|449062116|FG002|Overall Study|Protocol Violation|9|||
124845892|NCT00533949|449062117|FG003|Overall Study|Protocol Violation|9|||
124845893|NCT00533949|449062114|FG000|Overall Study|Withdrawal by Subject|3|||
124845894|NCT00533949|449062115|FG001|Overall Study|Withdrawal by Subject|2|||
124845895|NCT00533949|449062116|FG002|Overall Study|Withdrawal by Subject|1|||
124845896|NCT00533949|449062117|FG003|Overall Study|Withdrawal by Subject|1|||
124845897|NCT00727194|449062118|FG000|Screening Period|Low QMG scores|0|||
124845898|NCT00727194|449062119|FG001|Screening Period|Low QMG scores|0|||
124845899|NCT00727194|449062120|FG002|Screening Period|Low QMG scores|6|||
124845900|NCT00727194|449062118|FG000|Screening Period|Lacked AChR antibodies|0|||
124845901|NCT00727194|449062119|FG001|Screening Period|Lacked AChR antibodies|0|||
124845902|NCT00727194|449062120|FG002|Screening Period|Lacked AChR antibodies|5|||
124845903|NCT00727194|449062118|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
124845904|NCT00727194|449062119|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
124845905|NCT00727194|449062120|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
124845906|NCT00727194|449062118|FG000|Screening Period|Severe infections|0|||
124845907|NCT00727194|449062119|FG001|Screening Period|Severe infections|0|||
124845908|NCT00727194|449062120|FG002|Screening Period|Severe infections|2|||
124845909|NCT00727194|449062118|FG000|Screening Period|History of thymoma|0|||
124845910|NCT00727194|449062119|FG001|Screening Period|History of thymoma|0|||
124845911|NCT00727194|449062120|FG002|Screening Period|History of thymoma|1|||
124845912|NCT00727194|449062118|FG000|Treatment Period 2|Lack of Efficacy|0|||
124845913|NCT00727194|449062119|FG001|Treatment Period 2|Lack of Efficacy|1|||
124845914|NCT00727194|449062120|FG002|Treatment Period 2|Lack of Efficacy|0|||
124845915|NCT04269161|449062126|FG000|Overall Study|Change of modality and no longer eligible|3|||
124845916|NCT04269161|449062127|FG001|Overall Study|Change of modality and no longer eligible|3|||
124845917|NCT04269161|449062126|FG000|Overall Study|Required procedure outside of NICU|1|||
124845918|NCT04269161|449062127|FG001|Overall Study|Required procedure outside of NICU|0|||
124845919|NCT04269161|449062126|FG000|Overall Study|Equipment issue|1|||
124845920|NCT04269161|449062127|FG001|Overall Study|Equipment issue|1|||
124845921|NCT01513317|449062128|FG000|Overall Study|Withdrawal by Subject|15|||
124845922|NCT01513317|449062129|FG001|Overall Study|Withdrawal by Subject|4|||
124845923|NCT01513317|449062128|FG000|Overall Study|Death|1|||
124845924|NCT01513317|449062129|FG001|Overall Study|Death|1|||
124845925|NCT01513317|449062128|FG000|Overall Study|Study terminated by sponsor|18|||
124845926|NCT01513317|449062129|FG001|Overall Study|Study terminated by sponsor|18|||
124845927|NCT01513317|449062128|FG000|Overall Study|Other|0|||
124845928|NCT01513317|449062129|FG001|Overall Study|Other|1|||
124845929|NCT04108130|449062130|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
124845930|NCT04108130|449062131|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
124845931|NCT04108130|449062130|FG000|Overall Study|Consent Withdrawn|9|||
124845932|NCT04108130|449062131|FG001|Overall Study|Consent Withdrawn|6|||
124845933|NCT04108130|449062130|FG000|Overall Study|Surgery Cancelled|4|||
124845934|NCT04108130|449062131|FG001|Overall Study|Surgery Cancelled|4|||
124845935|NCT04108130|449062130|FG000|Overall Study|Found Ineligible for Study|4|||
124845936|NCT04108130|449062131|FG001|Overall Study|Found Ineligible for Study|3|||
124845937|NCT04108130|449062130|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
124845938|NCT04108130|449062131|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
124845939|NCT04108130|449062130|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
124845940|NCT04108130|449062131|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
124845941|NCT02610192|449062137|FG000|Overall Study|Received other treatment|8|||
124845942|NCT02610192|449062137|FG000|Overall Study|Physician Decision|1|||
124845943|NCT00279708|449062138|FG000|Overall Study|Withdrawal by Subject|2|||
124845944|NCT00279708|449062139|FG001|Overall Study|Withdrawal by Subject|3|||
124845945|NCT00279708|449062138|FG000|Overall Study|Adverse Event|1|||
124845946|NCT00279708|449062139|FG001|Overall Study|Adverse Event|1|||
124845947|NCT03354429|449062140|FG000|Overall Study|Withdrawal by Subject|8|||
124845948|NCT03354429|449062141|FG001|Overall Study|Withdrawal by Subject|7|||
124845949|NCT03354429|449062140|FG000|Overall Study|Lost to Follow-up|1|||
124845950|NCT03354429|449062141|FG001|Overall Study|Lost to Follow-up|0|||
124845951|NCT00953329|449062144|FG000|Overall Study|Lack of Efficacy|1|||
124845952|NCT01465802|449062145|FG000|Overall Study|Study terminated by sponsor|1|||
124845953|NCT01465802|449062146|FG001|Overall Study|Study terminated by sponsor|0|||
124845954|NCT01465802|449062147|FG002|Overall Study|Study terminated by sponsor|0|||
124845955|NCT01465802|449062148|FG003|Overall Study|Study terminated by sponsor|1|||
124845956|NCT01465802|449062149|FG004|Overall Study|Study terminated by sponsor|7|||
124845957|NCT01465802|449062145|FG000|Overall Study|Withdrawal by Subject|7|||
124845958|NCT01465802|449062146|FG001|Overall Study|Withdrawal by Subject|7|||
124845959|NCT01465802|449062147|FG002|Overall Study|Withdrawal by Subject|0|||
124845960|NCT01465802|449062148|FG003|Overall Study|Withdrawal by Subject|8|||
124845961|NCT01465802|449062149|FG004|Overall Study|Withdrawal by Subject|1|||
124845962|NCT01465802|449062145|FG000|Overall Study|Lost to Follow-up|1|||
124845963|NCT01465802|449062146|FG001|Overall Study|Lost to Follow-up|1|||
124845964|NCT01465802|449062147|FG002|Overall Study|Lost to Follow-up|0|||
124845965|NCT01465802|449062148|FG003|Overall Study|Lost to Follow-up|0|||
124845966|NCT01465802|449062149|FG004|Overall Study|Lost to Follow-up|0|||
124845967|NCT01465802|449062145|FG000|Overall Study|Reason not specified|9|||
124845968|NCT01465802|449062146|FG001|Overall Study|Reason not specified|4|||
124845969|NCT01465802|449062147|FG002|Overall Study|Reason not specified|0|||
124845970|NCT01465802|449062148|FG003|Overall Study|Reason not specified|10|||
124845971|NCT01465802|449062149|FG004|Overall Study|Reason not specified|2|||
124845972|NCT01465802|449062145|FG000|Overall Study|Death|15|||
124845973|NCT01465802|449062146|FG001|Overall Study|Death|12|||
124845974|NCT01465802|449062147|FG002|Overall Study|Death|0|||
124845975|NCT01465802|449062148|FG003|Overall Study|Death|10|||
124845976|NCT01465802|449062149|FG004|Overall Study|Death|2|||
124845977|NCT01340976|449062150|FG000|Overall Study|Physician Decision|2|||
124845978|NCT01340976|449062151|FG001|Overall Study|Physician Decision|0|||
124845979|NCT01340976|449062152|FG002|Overall Study|Physician Decision|1|||
124845980|NCT01340976|449062153|FG003|Overall Study|Physician Decision|1|||
124845981|NCT01340976|449062154|FG004|Overall Study|Physician Decision|1|||
124845982|NCT01340976|449062155|FG005|Overall Study|Physician Decision|0|||
124845983|NCT01340976|449062150|FG000|Overall Study|Death|0|||
124845984|NCT01340976|449062151|FG001|Overall Study|Death|1|||
124845985|NCT01340976|449062152|FG002|Overall Study|Death|0|||
124845986|NCT01340976|449062153|FG003|Overall Study|Death|0|||
124845987|NCT01340976|449062154|FG004|Overall Study|Death|0|||
124845988|NCT01340976|449062155|FG005|Overall Study|Death|0|||
124845989|NCT01340976|449062150|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
124845990|NCT01340976|449062151|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
124845991|NCT01340976|449062152|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
124845992|NCT01340976|449062153|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
124845993|NCT01340976|449062154|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
124845994|NCT01340976|449062155|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
124845995|NCT01340976|449062150|FG000|Overall Study|Withdrawal by Subject|0|||
124845996|NCT01340976|449062151|FG001|Overall Study|Withdrawal by Subject|0|||
124845997|NCT01340976|449062152|FG002|Overall Study|Withdrawal by Subject|0|||
124845998|NCT01340976|449062153|FG003|Overall Study|Withdrawal by Subject|1|||
124845999|NCT01340976|449062154|FG004|Overall Study|Withdrawal by Subject|1|||
124846000|NCT01340976|449062155|FG005|Overall Study|Withdrawal by Subject|0|||
124846001|NCT01340976|449062150|FG000|Overall Study|Other anemia treatment|1|||
124846002|NCT01340976|449062151|FG001|Overall Study|Other anemia treatment|0|||
124846003|NCT01340976|449062152|FG002|Overall Study|Other anemia treatment|2|||
124846004|NCT01340976|449062153|FG003|Overall Study|Other anemia treatment|1|||
124846005|NCT01340976|449062154|FG004|Overall Study|Other anemia treatment|0|||
124846006|NCT01340976|449062155|FG005|Overall Study|Other anemia treatment|1|||
124846007|NCT01340976|449062150|FG000|Overall Study|Adverse Event|0|||
124846008|NCT01340976|449062151|FG001|Overall Study|Adverse Event|1|||
124846009|NCT01340976|449062152|FG002|Overall Study|Adverse Event|0|||
124846010|NCT01340976|449062153|FG003|Overall Study|Adverse Event|0|||
124846011|NCT01340976|449062154|FG004|Overall Study|Adverse Event|0|||
124846012|NCT01340976|449062155|FG005|Overall Study|Adverse Event|0|||
124846013|NCT02331446|449062156|FG000|Overall Study|Lost to Follow-up|2|||
124846014|NCT02331446|449062157|FG001|Overall Study|Lost to Follow-up|1|||
124846015|NCT02331446|449062158|FG002|Overall Study|Lost to Follow-up|0|||
124846016|NCT02331446|449062159|FG003|Overall Study|Lost to Follow-up|1|||
124846017|NCT02331446|449062156|FG000|Overall Study|Personal Problem|2|||
124846018|NCT02331446|449062157|FG001|Overall Study|Personal Problem|0|||
124846019|NCT02331446|449062158|FG002|Overall Study|Personal Problem|0|||
124846020|NCT02331446|449062159|FG003|Overall Study|Personal Problem|0|||
124846021|NCT02331446|449062156|FG000|Overall Study|Disease|0|||
124846022|NCT02331446|449062157|FG001|Overall Study|Disease|2|||
124846023|NCT02331446|449062158|FG002|Overall Study|Disease|2|||
124846024|NCT02331446|449062159|FG003|Overall Study|Disease|1|||
124846025|NCT02331446|449062156|FG000|Overall Study|Physician Decision|0|||
124846026|NCT02331446|449062157|FG001|Overall Study|Physician Decision|1|||
124846027|NCT02331446|449062158|FG002|Overall Study|Physician Decision|0|||
124846028|NCT02331446|449062159|FG003|Overall Study|Physician Decision|1|||
124846029|NCT02331446|449062156|FG000|Overall Study|Lost before baseline analysis|0|||
124846030|NCT02331446|449062157|FG001|Overall Study|Lost before baseline analysis|1|||
124846031|NCT02331446|449062158|FG002|Overall Study|Lost before baseline analysis|1|||
124846032|NCT02331446|449062159|FG003|Overall Study|Lost before baseline analysis|0|||
124846033|NCT02566759|449062160|FG000|All Parts|Withdrawal by Subject|0|||
124846034|NCT02566759|449062161|FG001|All Parts|Withdrawal by Subject|1|||
124846035|NCT02566759|449062162|FG002|All Parts|Withdrawal by Subject|0|||
124846036|NCT02566759|449062163|FG003|All Parts|Withdrawal by Subject|0|||
124846037|NCT02566759|449062164|FG004|All Parts|Withdrawal by Subject|0|||
124846038|NCT02566759|449062165|FG005|All Parts|Withdrawal by Subject|0|||
124846039|NCT02566759|449062166|FG006|All Parts|Withdrawal by Subject|0|||
124846040|NCT02566759|449062167|FG007|All Parts|Withdrawal by Subject|0|||
124846041|NCT02566759|449062168|FG008|All Parts|Withdrawal by Subject|0|||
124846042|NCT02566759|449062169|FG009|All Parts|Withdrawal by Subject|0|||
124846043|NCT02566759|449062170|FG010|All Parts|Withdrawal by Subject|0|||
124846044|NCT02566759|449062171|FG011|All Parts|Withdrawal by Subject|0|||
124846045|NCT02566759|449062172|FG012|All Parts|Withdrawal by Subject|0|||
124846046|NCT02566759|449062173|FG013|All Parts|Withdrawal by Subject|0|||
124846047|NCT02566759|449062174|FG014|All Parts|Withdrawal by Subject|0|||
124846048|NCT02566759|449062175|FG015|All Parts|Withdrawal by Subject|0|||
124846049|NCT02566759|449062176|FG016|All Parts|Withdrawal by Subject|0|||
124846050|NCT02566759|449062160|FG000|All Parts|Adverse Event|0|||
124846051|NCT02566759|449062161|FG001|All Parts|Adverse Event|0|||
124846052|NCT02566759|449062162|FG002|All Parts|Adverse Event|0|||
124846053|NCT02566759|449062163|FG003|All Parts|Adverse Event|0|||
124846054|NCT02566759|449062164|FG004|All Parts|Adverse Event|0|||
124846055|NCT02566759|449062165|FG005|All Parts|Adverse Event|0|||
124846056|NCT02566759|449062166|FG006|All Parts|Adverse Event|0|||
124846057|NCT02566759|449062167|FG007|All Parts|Adverse Event|0|||
124846058|NCT02566759|449062168|FG008|All Parts|Adverse Event|0|||
124846059|NCT02566759|449062169|FG009|All Parts|Adverse Event|0|||
124846060|NCT02566759|449062170|FG010|All Parts|Adverse Event|0|||
124846061|NCT02566759|449062171|FG011|All Parts|Adverse Event|0|||
124846062|NCT02566759|449062172|FG012|All Parts|Adverse Event|1|||
124846063|NCT02566759|449062173|FG013|All Parts|Adverse Event|3|||
124846064|NCT02566759|449062174|FG014|All Parts|Adverse Event|0|||
124846065|NCT02566759|449062175|FG015|All Parts|Adverse Event|0|||
124846066|NCT02566759|449062176|FG016|All Parts|Adverse Event|0|||
124846067|NCT02566759|449062160|FG000|All Parts|Other|0|||
124846068|NCT02566759|449062161|FG001|All Parts|Other|0|||
124846069|NCT02566759|449062162|FG002|All Parts|Other|0|||
124846070|NCT02566759|449062163|FG003|All Parts|Other|0|||
124846071|NCT02566759|449062164|FG004|All Parts|Other|0|||
124846072|NCT02566759|449062165|FG005|All Parts|Other|0|||
124846073|NCT02566759|449062166|FG006|All Parts|Other|0|||
124846074|NCT02566759|449062167|FG007|All Parts|Other|0|||
124846075|NCT02566759|449062168|FG008|All Parts|Other|0|||
124846076|NCT02566759|449062169|FG009|All Parts|Other|0|||
124846077|NCT02566759|449062170|FG010|All Parts|Other|0|||
124846078|NCT02566759|449062171|FG011|All Parts|Other|0|||
124846079|NCT02566759|449062172|FG012|All Parts|Other|0|||
124846080|NCT02566759|449062173|FG013|All Parts|Other|2|||
124846081|NCT02566759|449062174|FG014|All Parts|Other|0|||
124846082|NCT02566759|449062175|FG015|All Parts|Other|0|||
124846083|NCT02566759|449062176|FG016|All Parts|Other|0|||
124846084|NCT02566759|449062160|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846085|NCT02566759|449062161|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846086|NCT02566759|449062162|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846087|NCT02566759|449062163|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846088|NCT02566759|449062164|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846089|NCT02566759|449062165|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846090|NCT02566759|449062166|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846091|NCT02566759|449062167|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846092|NCT02566759|449062168|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846093|NCT02566759|449062169|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846094|NCT02566759|449062170|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846095|NCT02566759|449062171|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846096|NCT02566759|449062172|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846097|NCT02566759|449062173|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846098|NCT02566759|449062174|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846099|NCT02566759|449062175|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
124846100|NCT02566759|449062176|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
124846101|NCT00226941|449062177|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
124846102|NCT00226941|449062178|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
124846103|NCT00226941|449062179|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
124846104|NCT00226941|449062180|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
124846105|NCT00226941|449062177|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
124846106|NCT00226941|449062178|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
124846107|NCT00226941|449062179|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
124846108|NCT00226941|449062180|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
124846109|NCT01513291|449062181|FG000|Treatment Period|Adverse Event|8|||
124846110|NCT01513291|449062182|FG001|Treatment Period|Adverse Event|4|||
124846111|NCT01513291|449062183|FG002|Treatment Period|Adverse Event|0|||
124846112|NCT01513291|449062184|FG003|Treatment Period|Adverse Event|0|||
124846113|NCT01513291|449062185|FG004|Treatment Period|Adverse Event|0|||
124846114|NCT01513291|449062181|FG000|Treatment Period|Lack of Efficacy|3|||
124846115|NCT01513291|449062182|FG001|Treatment Period|Lack of Efficacy|0|||
124846116|NCT01513291|449062183|FG002|Treatment Period|Lack of Efficacy|0|||
124846117|NCT01513291|449062184|FG003|Treatment Period|Lack of Efficacy|0|||
124846118|NCT01513291|449062185|FG004|Treatment Period|Lack of Efficacy|0|||
124846119|NCT01513291|449062181|FG000|Treatment Period|Lost to Follow-up|2|||
124846120|NCT01513291|449062182|FG001|Treatment Period|Lost to Follow-up|3|||
124846121|NCT01513291|449062183|FG002|Treatment Period|Lost to Follow-up|0|||
124846122|NCT01513291|449062184|FG003|Treatment Period|Lost to Follow-up|0|||
124846123|NCT01513291|449062185|FG004|Treatment Period|Lost to Follow-up|0|||
124846124|NCT01513291|449062181|FG000|Treatment Period|Physician Decision|1|||
124846125|NCT01513291|449062182|FG001|Treatment Period|Physician Decision|0|||
124846126|NCT01513291|449062183|FG002|Treatment Period|Physician Decision|0|||
124846127|NCT01513291|449062184|FG003|Treatment Period|Physician Decision|0|||
124846128|NCT01513291|449062185|FG004|Treatment Period|Physician Decision|0|||
124846129|NCT01513291|449062181|FG000|Treatment Period|Protocol Violation|1|||
124846130|NCT01513291|449062182|FG001|Treatment Period|Protocol Violation|2|||
124846131|NCT01513291|449062183|FG002|Treatment Period|Protocol Violation|0|||
124846132|NCT01513291|449062184|FG003|Treatment Period|Protocol Violation|0|||
124846133|NCT01513291|449062185|FG004|Treatment Period|Protocol Violation|0|||
124846134|NCT01513291|449062181|FG000|Treatment Period|Withdrawal by Subject|8|||
124846135|NCT01513291|449062182|FG001|Treatment Period|Withdrawal by Subject|5|||
124846136|NCT01513291|449062183|FG002|Treatment Period|Withdrawal by Subject|0|||
124846137|NCT01513291|449062184|FG003|Treatment Period|Withdrawal by Subject|0|||
124846138|NCT01513291|449062185|FG004|Treatment Period|Withdrawal by Subject|0|||
124846139|NCT01513291|449062181|FG000|Treatment Period|Randomized not treated|0|||
124846140|NCT01513291|449062182|FG001|Treatment Period|Randomized not treated|2|||
124846141|NCT01513291|449062183|FG002|Treatment Period|Randomized not treated|0|||
124846142|NCT01513291|449062184|FG003|Treatment Period|Randomized not treated|0|||
124846143|NCT01513291|449062185|FG004|Treatment Period|Randomized not treated|0|||
124846144|NCT01513291|449062181|FG000|Run-out Period|Lost to Follow-up|0|||
124846145|NCT01513291|449062182|FG001|Run-out Period|Lost to Follow-up|0|||
124846146|NCT01513291|449062183|FG002|Run-out Period|Lost to Follow-up|0|||
124846147|NCT01513291|449062184|FG003|Run-out Period|Lost to Follow-up|1|||
124846148|NCT01513291|449062185|FG004|Run-out Period|Lost to Follow-up|0|||
124846149|NCT01513291|449062181|FG000|Run-out Period|Withdrawal by Subject|0|||
124846150|NCT01513291|449062182|FG001|Run-out Period|Withdrawal by Subject|0|||
124846151|NCT01513291|449062183|FG002|Run-out Period|Withdrawal by Subject|0|||
124846152|NCT01513291|449062184|FG003|Run-out Period|Withdrawal by Subject|1|||
124846153|NCT01513291|449062185|FG004|Run-out Period|Withdrawal by Subject|0|||
124846154|NCT03732638|449062186|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
124846155|NCT03732638|449062187|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
124846156|NCT03732638|449062186|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
124846157|NCT03732638|449062187|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
124846158|NCT03732638|449062186|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
124846159|NCT03732638|449062187|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
124846160|NCT03732638|449062186|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
124846161|NCT03732638|449062187|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
124846162|NCT03732638|449062186|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
124846163|NCT03732638|449062187|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
124846164|NCT03732638|449062186|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
124846165|NCT03732638|449062187|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
124846166|NCT03732638|449062186|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
124846167|NCT03732638|449062187|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
124846168|NCT03732638|449062186|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
124846169|NCT03732638|449062187|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
124846170|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
124846171|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
124846172|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
124846173|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
124846174|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
124846175|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
124846176|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
124846177|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
124846178|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
124846179|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
124846180|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
124846181|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
124846182|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
124754108|NCT04607837|448720884|FG000|Overall Study|Participant terminated by sponsor|1|||
124754109|NCT04607837|448720885|FG001|Overall Study|Participant terminated by sponsor|0|||
124754110|NCT04607837|448720884|FG000|Overall Study|Disease worsening|36|||
124754111|NCT04607837|448720885|FG001|Overall Study|Disease worsening|36|||
124754112|NCT04607837|448720884|FG000|Overall Study|Other|1|||
124754113|NCT04607837|448720885|FG001|Overall Study|Other|0|||
124754114|NCT02362464|448720886|FG000|Overall Study|Switched to alternative therapy|1|||
124754115|NCT02362464|448720886|FG000|Overall Study|Refused further treatment|1|||
124754116|NCT02362464|448720886|FG000|Overall Study|Physician Decision|4|||
124754117|NCT04346654|448720887|FG000|Overall Study|Adverse Event|2|||
124754118|NCT04346654|448720888|FG001|Overall Study|Adverse Event|0|||
124754119|NCT04346654|448720887|FG000|Overall Study|Non-response|1|||
124754120|NCT04346654|448720888|FG001|Overall Study|Non-response|1|||
124754121|NCT04346654|448720887|FG000|Overall Study|Withdrawal by Subject|2|||
124754122|NCT04346654|448720888|FG001|Overall Study|Withdrawal by Subject|0|||
124754123|NCT04346654|448720887|FG000|Overall Study|Lost to Follow-up|0|||
124754124|NCT04346654|448720888|FG001|Overall Study|Lost to Follow-up|1|||
124754125|NCT04346654|448720887|FG000|Overall Study|Pregnancy|0|||
124754126|NCT04346654|448720888|FG001|Overall Study|Pregnancy|1|||
124754127|NCT05715242|448720891|FG000|Overall Study|Lost to Follow-up|0|||
124754128|NCT05715242|448720892|FG001|Overall Study|Lost to Follow-up|0|||
124754129|NCT05715242|448720893|FG002|Overall Study|Lost to Follow-up|1|||
124754130|NCT05715242|448720894|FG003|Overall Study|Lost to Follow-up|0|||
124754131|NCT05715242|448720895|FG004|Overall Study|Lost to Follow-up|0|||
124846183|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
124846184|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
124846185|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
124846186|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
124846187|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
124846188|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
124846189|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
124846190|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
124846191|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
124846192|NCT03732638|449062186|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
124846193|NCT03732638|449062187|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
124846194|NCT03732638|449062186|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
124846195|NCT03732638|449062187|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
124846196|NCT03732638|449062186|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
124846197|NCT03732638|449062187|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
124846198|NCT03732638|449062186|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
124846199|NCT03732638|449062187|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
124846200|NCT03732638|449062186|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
124846201|NCT03732638|449062187|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
124846202|NCT01358981|449062188|FG000|Period 1|Withdrawal by Subject|0|||
124846203|NCT01358981|449062189|FG001|Period 1|Withdrawal by Subject|0|||
124846204|NCT01358981|449062190|FG002|Period 1|Withdrawal by Subject|0|||
124846205|NCT01358981|449062191|FG003|Period 1|Withdrawal by Subject|1|||
124846206|NCT01358981|449062192|FG004|Period 1|Withdrawal by Subject|0|||
124846207|NCT01358981|449062193|FG005|Period 1|Withdrawal by Subject|0|||
124846208|NCT01358981|449062194|FG006|Period 1|Withdrawal by Subject|0|||
124846209|NCT03728582|449062195|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
124846210|NCT03728582|449062196|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
124846211|NCT03728582|449062195|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
124846212|NCT03728582|449062196|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
124846213|NCT01034397|449062197|FG000|Overall Study|Lack of compliance|0|||
124846214|NCT01034397|449062198|FG001|Overall Study|Lack of compliance|1|||
124846215|NCT01034397|449062197|FG000|Overall Study|Lack of Efficacy|3|||
124846216|NCT01034397|449062198|FG001|Overall Study|Lack of Efficacy|0|||
124846217|NCT01034397|449062197|FG000|Overall Study|Adverse Event|4|||
124846218|NCT01034397|449062198|FG001|Overall Study|Adverse Event|0|||
124846219|NCT01034397|449062197|FG000|Overall Study|Other|0|||
124846220|NCT01034397|449062198|FG001|Overall Study|Other|1|||
124846221|NCT01018264|449062199|FG000|Overall Study|Withdrawal by Subject|1|||
124846222|NCT01018264|449062200|FG001|Overall Study|Withdrawal by Subject|0|||
124846223|NCT01018264|449062199|FG000|Overall Study|Lost to Follow-up|0|||
124846224|NCT01018264|449062200|FG001|Overall Study|Lost to Follow-up|1|||
124846225|NCT01785524|449062201|FG000|Overall Study|Withdrawal by Subject|2|||
124846226|NCT01785524|449062202|FG001|Overall Study|Withdrawal by Subject|2|||
124846227|NCT03217136|449062207|FG000|Overall Study|Lost to Follow-up|2|||
124846228|NCT03217136|449062208|FG001|Overall Study|Lost to Follow-up|1|||
124846229|NCT03217136|449062207|FG000|Overall Study|Site Randomized Participant in Error|0|||
124846230|NCT03217136|449062208|FG001|Overall Study|Site Randomized Participant in Error|1|||
124846231|NCT03217136|449062207|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
124846232|NCT03217136|449062208|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
124846233|NCT03217136|449062207|FG000|Overall Study|Dispensing Error|1|||
124846234|NCT03217136|449062208|FG001|Overall Study|Dispensing Error|0|||
124846235|NCT03217136|449062207|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
124846236|NCT03217136|449062208|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
124846237|NCT03670810|449062211|FG000|Main Study|Adverse Event|37|||
124846238|NCT03670810|449062212|FG001|Main Study|Adverse Event|38|||
124846239|NCT03670810|449062213|FG002|Main Study|Adverse Event|3|||
124846240|NCT03670810|449062214|FG003|Main Study|Adverse Event|4|||
124846241|NCT03670810|449062215|FG004|Main Study|Adverse Event|4|||
124846242|NCT03670810|449062216|FG005|Main Study|Adverse Event|5|||
124846243|NCT03670810|449062217|FG006|Main Study|Adverse Event|0|||
124846244|NCT03670810|449062218|FG007|Main Study|Adverse Event|0|||
124846245|NCT03670810|449062219|FG008|Main Study|Adverse Event|0|||
124846246|NCT03670810|449062211|FG000|Main Study|Lack of Efficacy|8|||
124846247|NCT03670810|449062212|FG001|Main Study|Lack of Efficacy|9|||
124846248|NCT03670810|449062213|FG002|Main Study|Lack of Efficacy|3|||
124846249|NCT03670810|449062214|FG003|Main Study|Lack of Efficacy|4|||
124846250|NCT03670810|449062215|FG004|Main Study|Lack of Efficacy|0|||
124846251|NCT03670810|449062216|FG005|Main Study|Lack of Efficacy|0|||
124846252|NCT03670810|449062217|FG006|Main Study|Lack of Efficacy|0|||
124846253|NCT03670810|449062218|FG007|Main Study|Lack of Efficacy|0|||
124846254|NCT03670810|449062219|FG008|Main Study|Lack of Efficacy|0|||
124846255|NCT03670810|449062211|FG000|Main Study|Lost to Follow-up|9|||
124846256|NCT03670810|449062212|FG001|Main Study|Lost to Follow-up|7|||
124846257|NCT03670810|449062213|FG002|Main Study|Lost to Follow-up|4|||
124846258|NCT03670810|449062214|FG003|Main Study|Lost to Follow-up|6|||
124846259|NCT03670810|449062215|FG004|Main Study|Lost to Follow-up|1|||
124846260|NCT03670810|449062216|FG005|Main Study|Lost to Follow-up|0|||
124846261|NCT03670810|449062217|FG006|Main Study|Lost to Follow-up|0|||
124846262|NCT03670810|449062218|FG007|Main Study|Lost to Follow-up|0|||
124846263|NCT03670810|449062219|FG008|Main Study|Lost to Follow-up|0|||
124846264|NCT03670810|449062211|FG000|Main Study|Non-compliance with Study Drug|0|||
124846265|NCT03670810|449062212|FG001|Main Study|Non-compliance with Study Drug|2|||
124846266|NCT03670810|449062213|FG002|Main Study|Non-compliance with Study Drug|3|||
124846267|NCT03670810|449062214|FG003|Main Study|Non-compliance with Study Drug|0|||
124846268|NCT03670810|449062215|FG004|Main Study|Non-compliance with Study Drug|0|||
124846269|NCT03670810|449062216|FG005|Main Study|Non-compliance with Study Drug|0|||
124846270|NCT03670810|449062217|FG006|Main Study|Non-compliance with Study Drug|0|||
124846271|NCT03670810|449062218|FG007|Main Study|Non-compliance with Study Drug|1|||
124846272|NCT03670810|449062219|FG008|Main Study|Non-compliance with Study Drug|0|||
124846273|NCT03670810|449062211|FG000|Main Study|Physician Decision|3|||
124846274|NCT03670810|449062212|FG001|Main Study|Physician Decision|0|||
124846275|NCT03670810|449062213|FG002|Main Study|Physician Decision|1|||
124846276|NCT03670810|449062214|FG003|Main Study|Physician Decision|0|||
124846277|NCT03670810|449062215|FG004|Main Study|Physician Decision|0|||
124846278|NCT03670810|449062216|FG005|Main Study|Physician Decision|0|||
124846279|NCT03670810|449062217|FG006|Main Study|Physician Decision|1|||
124846280|NCT03670810|449062218|FG007|Main Study|Physician Decision|1|||
124846281|NCT03670810|449062219|FG008|Main Study|Physician Decision|0|||
124846282|NCT03670810|449062211|FG000|Main Study|Pregnancy|1|||
124846283|NCT03670810|449062212|FG001|Main Study|Pregnancy|2|||
124846284|NCT03670810|449062213|FG002|Main Study|Pregnancy|0|||
124846285|NCT03670810|449062214|FG003|Main Study|Pregnancy|0|||
124846286|NCT03670810|449062215|FG004|Main Study|Pregnancy|0|||
124846287|NCT03670810|449062216|FG005|Main Study|Pregnancy|0|||
124846288|NCT03670810|449062217|FG006|Main Study|Pregnancy|0|||
124846289|NCT03670810|449062218|FG007|Main Study|Pregnancy|0|||
124846290|NCT03670810|449062219|FG008|Main Study|Pregnancy|0|||
124846291|NCT03670810|449062211|FG000|Main Study|Protocol Deviation|2|||
124846292|NCT03670810|449062212|FG001|Main Study|Protocol Deviation|12|||
124846293|NCT03670810|449062213|FG002|Main Study|Protocol Deviation|8|||
124846294|NCT03670810|449062214|FG003|Main Study|Protocol Deviation|4|||
124846295|NCT03670810|449062215|FG004|Main Study|Protocol Deviation|0|||
124846296|NCT03670810|449062216|FG005|Main Study|Protocol Deviation|0|||
124846297|NCT03670810|449062217|FG006|Main Study|Protocol Deviation|0|||
124846298|NCT03670810|449062218|FG007|Main Study|Protocol Deviation|0|||
124846299|NCT03670810|449062219|FG008|Main Study|Protocol Deviation|0|||
124846300|NCT03670810|449062211|FG000|Main Study|Withdrawal by Subject|21|||
124846301|NCT03670810|449062212|FG001|Main Study|Withdrawal by Subject|21|||
124846302|NCT03670810|449062213|FG002|Main Study|Withdrawal by Subject|8|||
124846303|NCT03670810|449062214|FG003|Main Study|Withdrawal by Subject|9|||
124846304|NCT03670810|449062215|FG004|Main Study|Withdrawal by Subject|5|||
124846305|NCT03670810|449062216|FG005|Main Study|Withdrawal by Subject|2|||
124846306|NCT03670810|449062217|FG006|Main Study|Withdrawal by Subject|1|||
124846307|NCT03670810|449062218|FG007|Main Study|Withdrawal by Subject|1|||
124846308|NCT03670810|449062219|FG008|Main Study|Withdrawal by Subject|0|||
124846309|NCT03670810|449062211|FG000|Main Study|Participant did not want to take the three other treatments|1|||
124846310|NCT03670810|449062212|FG001|Main Study|Participant did not want to take the three other treatments|0|||
124846311|NCT03670810|449062213|FG002|Main Study|Participant did not want to take the three other treatments|0|||
124846312|NCT03670810|449062214|FG003|Main Study|Participant did not want to take the three other treatments|0|||
124846313|NCT03670810|449062215|FG004|Main Study|Participant did not want to take the three other treatments|0|||
124846314|NCT03670810|449062216|FG005|Main Study|Participant did not want to take the three other treatments|0|||
124846315|NCT03670810|449062217|FG006|Main Study|Participant did not want to take the three other treatments|0|||
124846316|NCT03670810|449062218|FG007|Main Study|Participant did not want to take the three other treatments|0|||
124846317|NCT03670810|449062219|FG008|Main Study|Participant did not want to take the three other treatments|0|||
124846318|NCT03670810|449062211|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
124846319|NCT03670810|449062212|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
124846320|NCT03670810|449062213|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
124846321|NCT03670810|449062214|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
124846322|NCT03670810|449062215|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
124846323|NCT03670810|449062216|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
124846324|NCT03670810|449062217|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
124846325|NCT03670810|449062218|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
124846326|NCT03670810|449062219|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
124846327|NCT03670810|449062211|FG000|Main Study|Travel and Coronavirus issues|0|||
124846328|NCT03670810|449062212|FG001|Main Study|Travel and Coronavirus issues|0|||
124846329|NCT03670810|449062213|FG002|Main Study|Travel and Coronavirus issues|0|||
124846330|NCT03670810|449062214|FG003|Main Study|Travel and Coronavirus issues|1|||
124846331|NCT03670810|449062215|FG004|Main Study|Travel and Coronavirus issues|0|||
124846332|NCT03670810|449062216|FG005|Main Study|Travel and Coronavirus issues|0|||
124846333|NCT03670810|449062217|FG006|Main Study|Travel and Coronavirus issues|0|||
124846334|NCT03670810|449062218|FG007|Main Study|Travel and Coronavirus issues|0|||
124846335|NCT03670810|449062219|FG008|Main Study|Travel and Coronavirus issues|0|||
124846336|NCT03670810|449062211|FG000|Open Label Extension|Protocol Deviation|0|||
124846337|NCT03670810|449062212|FG001|Open Label Extension|Protocol Deviation|0|||
124846338|NCT03670810|449062213|FG002|Open Label Extension|Protocol Deviation|0|||
124846339|NCT03670810|449062214|FG003|Open Label Extension|Protocol Deviation|0|||
124846340|NCT03670810|449062215|FG004|Open Label Extension|Protocol Deviation|0|||
124846341|NCT03670810|449062216|FG005|Open Label Extension|Protocol Deviation|0|||
124846342|NCT03670810|449062217|FG006|Open Label Extension|Protocol Deviation|0|||
124846343|NCT03670810|449062218|FG007|Open Label Extension|Protocol Deviation|0|||
124846344|NCT03670810|449062219|FG008|Open Label Extension|Protocol Deviation|5|||
124846345|NCT03670810|449062211|FG000|Open Label Extension|Death|0|||
124846346|NCT03670810|449062212|FG001|Open Label Extension|Death|0|||
124846347|NCT03670810|449062213|FG002|Open Label Extension|Death|0|||
124846348|NCT03670810|449062214|FG003|Open Label Extension|Death|0|||
124846349|NCT03670810|449062215|FG004|Open Label Extension|Death|0|||
124846350|NCT03670810|449062216|FG005|Open Label Extension|Death|0|||
124846351|NCT03670810|449062217|FG006|Open Label Extension|Death|0|||
124846352|NCT03670810|449062218|FG007|Open Label Extension|Death|0|||
124846353|NCT03670810|449062219|FG008|Open Label Extension|Death|1|||
124846354|NCT03670810|449062211|FG000|Open Label Extension|COVID-19|0|||
124846355|NCT03670810|449062212|FG001|Open Label Extension|COVID-19|0|||
124846356|NCT03670810|449062213|FG002|Open Label Extension|COVID-19|0|||
124846357|NCT03670810|449062214|FG003|Open Label Extension|COVID-19|0|||
124846358|NCT03670810|449062215|FG004|Open Label Extension|COVID-19|0|||
124846359|NCT03670810|449062216|FG005|Open Label Extension|COVID-19|0|||
124846360|NCT03670810|449062217|FG006|Open Label Extension|COVID-19|0|||
124846361|NCT03670810|449062218|FG007|Open Label Extension|COVID-19|0|||
124846362|NCT03670810|449062219|FG008|Open Label Extension|COVID-19|1|||
124846363|NCT03670810|449062211|FG000|Open Label Extension|Lack of Efficacy|0|||
124846364|NCT03670810|449062212|FG001|Open Label Extension|Lack of Efficacy|0|||
124846365|NCT03670810|449062213|FG002|Open Label Extension|Lack of Efficacy|0|||
124846366|NCT03670810|449062214|FG003|Open Label Extension|Lack of Efficacy|0|||
124846367|NCT03670810|449062215|FG004|Open Label Extension|Lack of Efficacy|0|||
124846368|NCT03670810|449062216|FG005|Open Label Extension|Lack of Efficacy|0|||
124846369|NCT03670810|449062217|FG006|Open Label Extension|Lack of Efficacy|0|||
124846370|NCT03670810|449062218|FG007|Open Label Extension|Lack of Efficacy|0|||
124846371|NCT03670810|449062219|FG008|Open Label Extension|Lack of Efficacy|39|||
124846372|NCT03670810|449062211|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
124846373|NCT03670810|449062212|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
124846374|NCT03670810|449062213|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
124846375|NCT03670810|449062214|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
124846376|NCT03670810|449062215|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
124846377|NCT03670810|449062216|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
124846378|NCT03670810|449062217|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
124846379|NCT03670810|449062218|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
124846380|NCT03670810|449062219|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
124846381|NCT03670810|449062211|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
124846382|NCT03670810|449062212|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
124846383|NCT03670810|449062213|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
124846384|NCT03670810|449062214|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
124641015|NCT04185220|448302932|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
124641016|NCT04185220|448302931|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
124846385|NCT03670810|449062215|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
124846386|NCT03670810|449062216|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
124846387|NCT03670810|449062217|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
124846388|NCT03670810|449062218|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
124846389|NCT03670810|449062219|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
124846390|NCT03670810|449062211|FG000|Open Label Extension|Withdrawal by Subject|0|||
124846391|NCT03670810|449062212|FG001|Open Label Extension|Withdrawal by Subject|0|||
124846392|NCT03670810|449062213|FG002|Open Label Extension|Withdrawal by Subject|0|||
124846393|NCT03670810|449062214|FG003|Open Label Extension|Withdrawal by Subject|0|||
124846394|NCT03670810|449062215|FG004|Open Label Extension|Withdrawal by Subject|0|||
124846395|NCT03670810|449062216|FG005|Open Label Extension|Withdrawal by Subject|0|||
124846396|NCT03670810|449062217|FG006|Open Label Extension|Withdrawal by Subject|0|||
124846397|NCT03670810|449062218|FG007|Open Label Extension|Withdrawal by Subject|0|||
124846398|NCT03670810|449062219|FG008|Open Label Extension|Withdrawal by Subject|46|||
124846399|NCT03670810|449062211|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
124846400|NCT03670810|449062212|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
124846401|NCT03670810|449062213|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
124846402|NCT03670810|449062214|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
124846403|NCT03670810|449062215|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
124846404|NCT03670810|449062216|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
124846405|NCT03670810|449062217|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
124846406|NCT03670810|449062218|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
124846407|NCT03670810|449062219|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
124846408|NCT03670810|449062211|FG000|Open Label Extension|Physician Decision|0|||
124846409|NCT03670810|449062212|FG001|Open Label Extension|Physician Decision|0|||
124846410|NCT03670810|449062213|FG002|Open Label Extension|Physician Decision|0|||
124846411|NCT03670810|449062214|FG003|Open Label Extension|Physician Decision|0|||
124846412|NCT03670810|449062215|FG004|Open Label Extension|Physician Decision|0|||
124846413|NCT03670810|449062216|FG005|Open Label Extension|Physician Decision|0|||
124846414|NCT03670810|449062217|FG006|Open Label Extension|Physician Decision|0|||
124846415|NCT03670810|449062218|FG007|Open Label Extension|Physician Decision|0|||
124846416|NCT03670810|449062219|FG008|Open Label Extension|Physician Decision|2|||
124846417|NCT03670810|449062211|FG000|Open Label Extension|Non-compliance with study drug|0|||
124846418|NCT03670810|449062212|FG001|Open Label Extension|Non-compliance with study drug|0|||
124846419|NCT03670810|449062213|FG002|Open Label Extension|Non-compliance with study drug|0|||
124846420|NCT03670810|449062214|FG003|Open Label Extension|Non-compliance with study drug|0|||
124846421|NCT03670810|449062215|FG004|Open Label Extension|Non-compliance with study drug|0|||
124846422|NCT03670810|449062216|FG005|Open Label Extension|Non-compliance with study drug|0|||
124846423|NCT03670810|449062217|FG006|Open Label Extension|Non-compliance with study drug|0|||
124846424|NCT03670810|449062218|FG007|Open Label Extension|Non-compliance with study drug|0|||
124846425|NCT03670810|449062219|FG008|Open Label Extension|Non-compliance with study drug|5|||
124846426|NCT03670810|449062211|FG000|Open Label Extension|Pregnancy|0|||
124846427|NCT03670810|449062212|FG001|Open Label Extension|Pregnancy|0|||
124846428|NCT03670810|449062213|FG002|Open Label Extension|Pregnancy|0|||
124846429|NCT03670810|449062214|FG003|Open Label Extension|Pregnancy|0|||
124846430|NCT03670810|449062215|FG004|Open Label Extension|Pregnancy|0|||
124846431|NCT03670810|449062216|FG005|Open Label Extension|Pregnancy|0|||
124846432|NCT03670810|449062217|FG006|Open Label Extension|Pregnancy|0|||
124846433|NCT03670810|449062218|FG007|Open Label Extension|Pregnancy|0|||
124846434|NCT03670810|449062219|FG008|Open Label Extension|Pregnancy|3|||
124846435|NCT03670810|449062211|FG000|Open Label Extension|Adverse Event|0|||
124846436|NCT03670810|449062212|FG001|Open Label Extension|Adverse Event|0|||
124846437|NCT03670810|449062213|FG002|Open Label Extension|Adverse Event|0|||
124846438|NCT03670810|449062214|FG003|Open Label Extension|Adverse Event|0|||
124846439|NCT03670810|449062215|FG004|Open Label Extension|Adverse Event|0|||
124846440|NCT03670810|449062216|FG005|Open Label Extension|Adverse Event|0|||
124846441|NCT03670810|449062217|FG006|Open Label Extension|Adverse Event|0|||
124846442|NCT03670810|449062218|FG007|Open Label Extension|Adverse Event|0|||
124846443|NCT03670810|449062219|FG008|Open Label Extension|Adverse Event|24|||
124846444|NCT03670810|449062211|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
124846445|NCT03670810|449062212|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
124846446|NCT03670810|449062213|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
124846447|NCT03670810|449062214|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
124846448|NCT03670810|449062215|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
124846449|NCT03670810|449062216|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
124846450|NCT03670810|449062217|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
124846451|NCT03670810|449062218|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
124846452|NCT03670810|449062219|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
124846453|NCT03670810|449062211|FG000|Open Label Extension|Lost to Follow-up|0|||
124846454|NCT03670810|449062212|FG001|Open Label Extension|Lost to Follow-up|0|||
124846455|NCT03670810|449062213|FG002|Open Label Extension|Lost to Follow-up|0|||
124846456|NCT03670810|449062214|FG003|Open Label Extension|Lost to Follow-up|0|||
124846457|NCT03670810|449062215|FG004|Open Label Extension|Lost to Follow-up|0|||
124846458|NCT03670810|449062216|FG005|Open Label Extension|Lost to Follow-up|0|||
124846459|NCT03670810|449062217|FG006|Open Label Extension|Lost to Follow-up|0|||
124846460|NCT03670810|449062218|FG007|Open Label Extension|Lost to Follow-up|0|||
124846461|NCT03670810|449062219|FG008|Open Label Extension|Lost to Follow-up|23|||
124846462|NCT03192150|449062220|FG000|Overall Study|Adverse Event|14|||
124846463|NCT03192150|449062221|FG001|Overall Study|Adverse Event|12|||
124846464|NCT03192150|449062220|FG000|Overall Study|Lack of Efficacy|23|||
124846465|NCT03192150|449062221|FG001|Overall Study|Lack of Efficacy|30|||
124846466|NCT03192150|449062220|FG000|Overall Study|Lost to Follow-up|1|||
124846467|NCT03192150|449062221|FG001|Overall Study|Lost to Follow-up|1|||
124846468|NCT03192150|449062220|FG000|Overall Study|Withdrawal by Subject|4|||
124846469|NCT03192150|449062221|FG001|Overall Study|Withdrawal by Subject|2|||
124846470|NCT03192150|449062220|FG000|Overall Study|Protocol Violation|5|||
124846471|NCT03192150|449062221|FG001|Overall Study|Protocol Violation|2|||
124846472|NCT03192150|449062220|FG000|Overall Study|Surgery Canceled|6|||
124846473|NCT03192150|449062221|FG001|Overall Study|Surgery Canceled|2|||
124846474|NCT03192150|449062220|FG000|Overall Study|Other-Various Administrative Reasons|2|||
124846475|NCT03192150|449062221|FG001|Overall Study|Other-Various Administrative Reasons|5|||
124846476|NCT02579616|449062222|FG000|Overall Study|Participants did not receive treatment|3|||
124846477|NCT00482391|449062223|FG000|Overall Study|Withdrawal by Subject|1|||
124846478|NCT00482391|449062223|FG000|Overall Study|Adverse Event|1|||
124846479|NCT00482391|449062223|FG000|Overall Study|Death|1|||
124846480|NCT01350128|449062238|FG000|Overall Study|Withdrawal by Subject|3|||
124846481|NCT01350128|449062238|FG000|Overall Study|Protocol discontinuation criteria|8|||
124846482|NCT01350128|449062238|FG000|Overall Study|Physician Decision|1|||
124846483|NCT01350128|449062238|FG000|Overall Study|Lost to Follow-up|2|||
124846484|NCT02644967|449062244|FG000|Overall Study|Death|26|||
124846485|NCT02644967|449062244|FG000|Overall Study|Physician Decision|1|||
124846486|NCT02644967|449062244|FG000|Overall Study|Withdrawal by Subject|2|||
124846487|NCT02644967|449062244|FG000|Overall Study|Protocol Violation|1|||
124846488|NCT02644967|449062244|FG000|Overall Study|Progressive Disease|1|||
124846489|NCT02644967|449062244|FG000|Overall Study|Study Terminated by Sponsor|4|||
124846490|NCT03323099|449062246|FG000|Overall Study|Withdrawal by Subject|6|||
124846491|NCT03323099|449062247|FG001|Overall Study|Withdrawal by Subject|12|||
124846492|NCT03323099|449062246|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
124846493|NCT03323099|449062247|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
124846494|NCT03254134|449062252|FG000|Overall Study|Not eligible patients|599|||
124846495|NCT03254134|449062253|FG001|Overall Study|Not eligible patients|3630|||
124846496|NCT00806546|449062254|FG000|Overall Study|Enrolled, not treated|35|||
124846497|NCT00806546|449062254|FG000|Overall Study|Lost to Follow-up|32|||
124846498|NCT00806546|449062254|FG000|Overall Study|Adverse Event|74|||
124846499|NCT00806546|449062254|FG000|Overall Study|Withdrawal by Subject|75|||
124846500|NCT00806546|449062254|FG000|Overall Study|Protocol Violation|49|||
124846501|NCT00806546|449062254|FG000|Overall Study|Various|42|||
124846502|NCT01247090|449062255|FG000|Overall Study|Physician Decision|1|||
124846503|NCT01247090|449062256|FG001|Overall Study|Physician Decision|0|||
124846504|NCT01247090|449062257|FG002|Overall Study|Physician Decision|0|||
124846505|NCT01247090|449062255|FG000|Overall Study|Withdrawal by Subject|0|||
124846506|NCT01247090|449062256|FG001|Overall Study|Withdrawal by Subject|1|||
124846507|NCT01247090|449062257|FG002|Overall Study|Withdrawal by Subject|0|||
124846508|NCT03385239|449062261|FG000|Overall Study|Voluntary Withdrawal|2|||
124846509|NCT03385239|449062262|FG001|Overall Study|Voluntary Withdrawal|3|||
124846510|NCT03385239|449062263|FG002|Overall Study|Voluntary Withdrawal|2|||
124846511|NCT03385239|449062264|FG003|Overall Study|Voluntary Withdrawal|3|||
124846512|NCT03385239|449062265|FG004|Overall Study|Voluntary Withdrawal|0|||
124846513|NCT03385239|449062261|FG000|Overall Study|Adverse Event|0|||
124846514|NCT03385239|449062262|FG001|Overall Study|Adverse Event|0|||
124846515|NCT03385239|449062263|FG002|Overall Study|Adverse Event|1|||
124846516|NCT03385239|449062264|FG003|Overall Study|Adverse Event|0|||
124846517|NCT03385239|449062265|FG004|Overall Study|Adverse Event|0|||
124846518|NCT03385239|449062261|FG000|Overall Study|Other|0|||
124846519|NCT03385239|449062262|FG001|Overall Study|Other|0|||
124846520|NCT03385239|449062263|FG002|Overall Study|Other|0|||
124846521|NCT03385239|449062264|FG003|Overall Study|Other|1|||
124846522|NCT03385239|449062265|FG004|Overall Study|Other|0|||
124846523|NCT01574703|449062266|FG000|Overall Study|Adverse Event|0|||
124846524|NCT01574703|449062267|FG001|Overall Study|Adverse Event|2|||
124846525|NCT01574703|449062268|FG002|Overall Study|Adverse Event|1|||
124846526|NCT01574703|449062269|FG003|Overall Study|Adverse Event|1|||
124846527|NCT01574703|449062266|FG000|Overall Study|Protocol Violation|0|||
124846528|NCT01574703|449062267|FG001|Overall Study|Protocol Violation|0|||
124641017|NCT04185220|448302932|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
124846529|NCT01574703|449062268|FG002|Overall Study|Protocol Violation|0|||
124846530|NCT01574703|449062269|FG003|Overall Study|Protocol Violation|1|||
124846531|NCT01574703|449062266|FG000|Overall Study|Unspecified Reason|27|||
124846532|NCT01574703|449062267|FG001|Overall Study|Unspecified Reason|15|||
124846533|NCT01574703|449062268|FG002|Overall Study|Unspecified Reason|20|||
124846534|NCT01574703|449062269|FG003|Overall Study|Unspecified Reason|16|||
124846535|NCT01574703|449062266|FG000|Overall Study|Withdrawal by Subject|53|||
124846536|NCT01574703|449062267|FG001|Overall Study|Withdrawal by Subject|52|||
124846537|NCT01574703|449062268|FG002|Overall Study|Withdrawal by Subject|36|||
124846538|NCT01574703|449062269|FG003|Overall Study|Withdrawal by Subject|61|||
124641018|NCT01186692|448302935|FG000|Overall Study|Not Catheterized|11|||
124846539|NCT01574703|449062266|FG000|Overall Study|Met Withdrawal Criteria|0|||
124846540|NCT01574703|449062267|FG001|Overall Study|Met Withdrawal Criteria|1|||
124846541|NCT01574703|449062268|FG002|Overall Study|Met Withdrawal Criteria|1|||
124846542|NCT01574703|449062269|FG003|Overall Study|Met Withdrawal Criteria|0|||
124846543|NCT01574703|449062266|FG000|Overall Study|Lost to Follow-up|43|||
124846544|NCT01574703|449062267|FG001|Overall Study|Lost to Follow-up|41|||
124846545|NCT01574703|449062268|FG002|Overall Study|Lost to Follow-up|46|||
124846546|NCT01574703|449062269|FG003|Overall Study|Lost to Follow-up|35|||
124846547|NCT01574703|449062266|FG000|Overall Study|Death|2|||
124846548|NCT01574703|449062267|FG001|Overall Study|Death|1|||
124846549|NCT01574703|449062268|FG002|Overall Study|Death|1|||
124846550|NCT01574703|449062269|FG003|Overall Study|Death|0|||
124846551|NCT00813358|449062272|FG000|Overall Study|Death|32|||
124846552|NCT00813358|449062272|FG000|Overall Study|Lost to Follow-up|12|||
124846553|NCT00813358|449062272|FG000|Overall Study|other endpoints|5|||
124846554|NCT00813358|449062272|FG000|Overall Study|Withdrawal by Subject|20|||
124846555|NCT01282216|449062273|FG000|Overall Study|Graft failure|0|||
124846556|NCT01282216|449062274|FG001|Overall Study|Graft failure|0|||
124846557|NCT01282216|449062275|FG002|Overall Study|Graft failure|3|||
124846558|NCT01282216|449062276|FG003|Overall Study|Graft failure|2|||
124846559|NCT01282216|449062273|FG000|Overall Study|Physician Decision|0|||
124846560|NCT01282216|449062274|FG001|Overall Study|Physician Decision|0|||
124846561|NCT01282216|449062275|FG002|Overall Study|Physician Decision|11|||
124846562|NCT01282216|449062276|FG003|Overall Study|Physician Decision|0|||
124846563|NCT01282216|449062273|FG000|Overall Study|Relapse|0|||
124846564|NCT01282216|449062274|FG001|Overall Study|Relapse|0|||
124846565|NCT01282216|449062275|FG002|Overall Study|Relapse|17|||
124846566|NCT01282216|449062276|FG003|Overall Study|Relapse|6|||
124846567|NCT01282216|449062273|FG000|Overall Study|Death|0|||
124846568|NCT01282216|449062274|FG001|Overall Study|Death|0|||
124846569|NCT01282216|449062275|FG002|Overall Study|Death|2|||
124846570|NCT01282216|449062276|FG003|Overall Study|Death|0|||
124846571|NCT03851016|449062277|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
124846572|NCT03851016|449062278|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
124846573|NCT03080961|449062279|FG000|Overall Study|Withdrawal by Subject|3|||
124846574|NCT03878134|449062280|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
124846575|NCT00586469|449062281|FG000|Overall Study|Adverse Event|0|||
124846576|NCT00586469|449062282|FG001|Overall Study|Adverse Event|1|||
124846577|NCT02908529|449062284|FG000|Overall Study|Lost to Follow-up|0|||
124846578|NCT02908529|449062285|FG001|Overall Study|Lost to Follow-up|2|||
124846579|NCT03337724|449062288|FG000|Overall Study|Reason not Specified|12|||
124846580|NCT03337724|449062289|FG001|Overall Study|Reason not Specified|21|||
124846581|NCT03337724|449062290|FG002|Overall Study|Reason not Specified|9|||
124846582|NCT03337724|449062291|FG003|Overall Study|Reason not Specified|9|||
124846583|NCT03337724|449062292|FG004|Overall Study|Reason not Specified|29|||
124846584|NCT03337724|449062288|FG000|Overall Study|Withdrawal by Subject|13|||
124846585|NCT03337724|449062289|FG001|Overall Study|Withdrawal by Subject|15|||
124846586|NCT03337724|449062290|FG002|Overall Study|Withdrawal by Subject|4|||
124846587|NCT03337724|449062291|FG003|Overall Study|Withdrawal by Subject|15|||
124846588|NCT03337724|449062292|FG004|Overall Study|Withdrawal by Subject|6|||
124846589|NCT03337724|449062288|FG000|Overall Study|Protocol Deviation|0|||
124846590|NCT03337724|449062289|FG001|Overall Study|Protocol Deviation|1|||
124846591|NCT03337724|449062290|FG002|Overall Study|Protocol Deviation|1|||
124846592|NCT03337724|449062291|FG003|Overall Study|Protocol Deviation|1|||
124846593|NCT03337724|449062292|FG004|Overall Study|Protocol Deviation|0|||
124846594|NCT03337724|449062288|FG000|Overall Study|Adverse Event|1|||
124846595|NCT03337724|449062289|FG001|Overall Study|Adverse Event|1|||
124846596|NCT03337724|449062290|FG002|Overall Study|Adverse Event|0|||
124846597|NCT03337724|449062291|FG003|Overall Study|Adverse Event|1|||
124846598|NCT03337724|449062292|FG004|Overall Study|Adverse Event|0|||
124846599|NCT03337724|449062288|FG000|Overall Study|Death|40|||
124846600|NCT03337724|449062289|FG001|Overall Study|Death|89|||
124846601|NCT03337724|449062290|FG002|Overall Study|Death|43|||
124846602|NCT03337724|449062291|FG003|Overall Study|Death|76|||
124846603|NCT03337724|449062292|FG004|Overall Study|Death|50|||
124846604|NCT03337724|449062288|FG000|Overall Study|Lost to Follow-up|5|||
124846605|NCT03337724|449062289|FG001|Overall Study|Lost to Follow-up|5|||
124846606|NCT03337724|449062290|FG002|Overall Study|Lost to Follow-up|4|||
124846607|NCT03337724|449062291|FG003|Overall Study|Lost to Follow-up|7|||
124846608|NCT03337724|449062292|FG004|Overall Study|Lost to Follow-up|4|||
124846609|NCT03337724|449062288|FG000|Overall Study|Physician Decision|16|||
124846610|NCT03337724|449062289|FG001|Overall Study|Physician Decision|34|||
124846611|NCT03337724|449062290|FG002|Overall Study|Physician Decision|14|||
124846612|NCT03337724|449062291|FG003|Overall Study|Physician Decision|34|||
124846613|NCT03337724|449062292|FG004|Overall Study|Physician Decision|13|||
124846614|NCT03337724|449062288|FG000|Overall Study|Progressive Disease|0|||
124846615|NCT03337724|449062289|FG001|Overall Study|Progressive Disease|2|||
124846616|NCT03337724|449062290|FG002|Overall Study|Progressive Disease|1|||
124846617|NCT03337724|449062291|FG003|Overall Study|Progressive Disease|2|||
124846618|NCT03337724|449062292|FG004|Overall Study|Progressive Disease|0|||
124846619|NCT03337724|449062288|FG000|Overall Study|Symptomatic Deterioration|0|||
124846620|NCT03337724|449062289|FG001|Overall Study|Symptomatic Deterioration|0|||
124846621|NCT03337724|449062290|FG002|Overall Study|Symptomatic Deterioration|0|||
124846622|NCT03337724|449062291|FG003|Overall Study|Symptomatic Deterioration|1|||
124846623|NCT03337724|449062292|FG004|Overall Study|Symptomatic Deterioration|0|||
124846624|NCT03551210|449062293|FG000|Overall Study|Adverse Event|5|||
124846625|NCT03551210|449062294|FG001|Overall Study|Adverse Event|6|||
124846626|NCT03551210|449062293|FG000|Overall Study|Withdrawal by Subject|1|||
124846627|NCT03551210|449062294|FG001|Overall Study|Withdrawal by Subject|7|||
124846628|NCT03551210|449062293|FG000|Overall Study|Needed in other antibiotic treatment|2|||
124846629|NCT03551210|449062294|FG001|Overall Study|Needed in other antibiotic treatment|5|||
124846630|NCT03551210|449062293|FG000|Overall Study|Lost to Follow-up|1|||
124846631|NCT03551210|449062294|FG001|Overall Study|Lost to Follow-up|1|||
124846632|NCT03551210|449062293|FG000|Overall Study|Absence of visit 4 and 5|1|||
124846633|NCT03551210|449062294|FG001|Overall Study|Absence of visit 4 and 5|0|||
124846634|NCT03551210|449062293|FG000|Overall Study|No drug for dispensing|0|||
124846635|NCT03551210|449062294|FG001|Overall Study|No drug for dispensing|1|||
124846636|NCT02239536|449062297|FG000|Overall Study|Non-neoplastic polyp|23|||
124846637|NCT02239536|449062298|FG001|Overall Study|Non-neoplastic polyp|17|||
124846638|NCT02564198|449064091|FG000|Overall Study|Withdrawal by Subject|2|||
124846639|NCT02564198|449064092|FG001|Overall Study|Withdrawal by Subject|4|||
124846640|NCT02564198|449064093|FG002|Overall Study|Withdrawal by Subject|0|||
124846641|NCT02564198|449064091|FG000|Overall Study|Adverse Event|0|||
124846642|NCT02564198|449064092|FG001|Overall Study|Adverse Event|1|||
124846643|NCT02564198|449064093|FG002|Overall Study|Adverse Event|0|||
124846644|NCT01440322|449064094|FG000|Overall Study|Discomfort|2|||
124846645|NCT01440322|449064095|FG001|Overall Study|Discomfort|0|||
124846646|NCT01440322|449064094|FG000|Overall Study|Biomicroscopy|1|||
124846647|NCT01440322|449064095|FG001|Overall Study|Biomicroscopy|0|||
124846648|NCT01440322|449064094|FG000|Overall Study|Symptoms and Problems|1|||
124846649|NCT01440322|449064095|FG001|Overall Study|Symptoms and Problems|0|||
124846650|NCT01440322|449064094|FG000|Overall Study|Unacceptable Subjective Vision|1|||
124846651|NCT01440322|449064095|FG001|Overall Study|Unacceptable Subjective Vision|0|||
124846652|NCT01440322|449064094|FG000|Overall Study|Other Product Related|1|||
124846653|NCT01440322|449064095|FG001|Overall Study|Other Product Related|0|||
124846654|NCT01440322|449064094|FG000|Overall Study|Unrelated Medical Problem|0|||
124846655|NCT01440322|449064095|FG001|Overall Study|Unrelated Medical Problem|1|||
124846656|NCT01440322|449064094|FG000|Overall Study|Other Non-Product Related|1|||
124846657|NCT01440322|449064095|FG001|Overall Study|Other Non-Product Related|0|||
124846658|NCT03394391|449064097|FG000|Overall Study|Lost to Follow-up|1|||
124846659|NCT03394391|449064098|FG001|Overall Study|Lost to Follow-up|2|||
124846660|NCT05044234|449064099|FG000|Overall Study|Lost to Follow-up|2|||
124846661|NCT05044234|449064100|FG001|Overall Study|Lost to Follow-up|1|||
124846662|NCT05044234|449064101|FG002|Overall Study|Lost to Follow-up|1|||
124846663|NCT05044234|449064102|FG003|Overall Study|Lost to Follow-up|2|||
124846664|NCT05044234|449064099|FG000|Overall Study|Withdrawal by Subject|6|||
124846665|NCT05044234|449064100|FG001|Overall Study|Withdrawal by Subject|4|||
124846666|NCT05044234|449064101|FG002|Overall Study|Withdrawal by Subject|5|||
124846667|NCT05044234|449064102|FG003|Overall Study|Withdrawal by Subject|8|||
124846668|NCT05044234|449064099|FG000|Overall Study|Study terminated by Sponsor|21|||
124846669|NCT05044234|449064100|FG001|Overall Study|Study terminated by Sponsor|21|||
124846670|NCT05044234|449064101|FG002|Overall Study|Study terminated by Sponsor|20|||
124846671|NCT05044234|449064102|FG003|Overall Study|Study terminated by Sponsor|14|||
124846672|NCT05044234|449064099|FG000|Overall Study|Other, not specified|0|||
124846673|NCT05044234|449064100|FG001|Overall Study|Other, not specified|0|||
124846674|NCT05044234|449064101|FG002|Overall Study|Other, not specified|1|||
124846675|NCT05044234|449064102|FG003|Overall Study|Other, not specified|2|||
124846676|NCT05044234|449064099|FG000|Overall Study|Delayed data entry|0|||
124846677|NCT05044234|449064100|FG001|Overall Study|Delayed data entry|0|||
124846678|NCT05044234|449064101|FG002|Overall Study|Delayed data entry|0|||
124846679|NCT05044234|449064102|FG003|Overall Study|Delayed data entry|1|||
124846680|NCT02896127|449064103|FG000|COMPLETED WEEK 52|Adverse Event|9|||
124846681|NCT02896127|449064104|FG001|COMPLETED WEEK 52|Adverse Event|2|||
124846682|NCT02896127|449064103|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
124846683|NCT02896127|449064104|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
124846684|NCT02896127|449064103|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
124846685|NCT02896127|449064104|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
124846686|NCT02896127|449064103|FG000|COMPLETED WEEK 52|Physician Decision|1|||
124846687|NCT02896127|449064104|FG001|COMPLETED WEEK 52|Physician Decision|1|||
124846688|NCT02896127|449064103|FG000|COMPLETED WEEK 52|Pregnancy|2|||
124846689|NCT02896127|449064104|FG001|COMPLETED WEEK 52|Pregnancy|0|||
124846690|NCT02896127|449064103|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
124846691|NCT02896127|449064104|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
124846692|NCT02896127|449064103|FG000|COMPLETED WEEK 52|Technical problems|1|||
124846693|NCT02896127|449064104|FG001|COMPLETED WEEK 52|Technical problems|0|||
124846694|NCT02896127|449064103|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
124846695|NCT02896127|449064104|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
124846696|NCT02896127|449064103|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
124846697|NCT02896127|449064104|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
124846698|NCT02896127|449064103|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
124846699|NCT02896127|449064104|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
124846700|NCT02896127|449064103|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
124846701|NCT02896127|449064104|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
124846702|NCT02896127|449064103|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
124846703|NCT02896127|449064104|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
124846704|NCT01434823|449064107|FG000|Overall Study|Incomplete data in medical record|4|||
124846705|NCT01434823|449064108|FG001|Overall Study|Incomplete data in medical record|7|||
124846706|NCT02477020|449064111|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
124846707|NCT02477020|449064112|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
124846708|NCT02477020|449064111|FG000|Overall Study|Voluntary Withdrawal|7|||
124846709|NCT02477020|449064112|FG001|Overall Study|Voluntary Withdrawal|16|||
124846710|NCT02477020|449064111|FG000|Overall Study|Reason not Specified|3|||
124846711|NCT02477020|449064112|FG001|Overall Study|Reason not Specified|1|||
124846712|NCT02477020|449064111|FG000|Overall Study|Lack of Efficacy|14|||
124846713|NCT02477020|449064112|FG001|Overall Study|Lack of Efficacy|5|||
124846714|NCT00519649|449064114|FG000|Overall Study|Withdrawal by Subject|1|||
124846715|NCT04879745|449064115|FG000|Overall Study|Lost to Follow-up|4|||
124846716|NCT04879745|449064116|FG001|Overall Study|Lost to Follow-up|1|||
124846717|NCT00120042|449064117|FG000|Overall Study|all completed protocl|0|||
124846718|NCT00120042|449064118|FG001|Overall Study|all completed protocl|0|||
124846719|NCT00120042|449064119|FG002|Overall Study|all completed protocl|0|||
124846720|NCT01126541|449064126|FG000|Overall Study|Adverse Event|0|||
124846721|NCT01126541|449064127|FG001|Overall Study|Adverse Event|2|||
124846722|NCT01126541|449064128|FG002|Overall Study|Adverse Event|4|||
124846723|NCT01126541|449064126|FG000|Overall Study|Death|0|||
124846724|NCT01126541|449064127|FG001|Overall Study|Death|1|||
124846725|NCT01126541|449064128|FG002|Overall Study|Death|0|||
124846726|NCT01126541|449064126|FG000|Overall Study|Lack of Efficacy|6|||
124846727|NCT01126541|449064127|FG001|Overall Study|Lack of Efficacy|1|||
124846728|NCT01126541|449064128|FG002|Overall Study|Lack of Efficacy|11|||
124846729|NCT01126541|449064126|FG000|Overall Study|Lost to Follow-up|1|||
124846730|NCT01126541|449064127|FG001|Overall Study|Lost to Follow-up|2|||
124846731|NCT01126541|449064128|FG002|Overall Study|Lost to Follow-up|2|||
124846732|NCT01126541|449064126|FG000|Overall Study|Withdrawal by Subject|2|||
124846733|NCT01126541|449064127|FG001|Overall Study|Withdrawal by Subject|5|||
124846734|NCT01126541|449064128|FG002|Overall Study|Withdrawal by Subject|6|||
124846735|NCT01126541|449064126|FG000|Overall Study|Protocol Violation|0|||
124846736|NCT01126541|449064127|FG001|Overall Study|Protocol Violation|0|||
124846737|NCT01126541|449064128|FG002|Overall Study|Protocol Violation|1|||
124846738|NCT01126541|449064126|FG000|Overall Study|Administrative reason or other|1|||
124846739|NCT01126541|449064127|FG001|Overall Study|Administrative reason or other|1|||
124846740|NCT01126541|449064128|FG002|Overall Study|Administrative reason or other|2|||
124846741|NCT01263873|449064131|FG000|Overall Study|One provider unable to complete numbers|1|||
124846742|NCT01263873|449064132|FG001|Overall Study|One provider unable to complete numbers|1|||
124846743|NCT06640829|449064140|FG000|Overall Study|Withdrawal by Subject|1|||
124846744|NCT06640829|449064140|FG000|Overall Study|Lost to Follow-up|1|||
124846745|NCT01859715|449064141|FG000|Overall Study|No 2nd VAS|16|||
124846746|NCT01859715|449064142|FG001|Overall Study|No 2nd VAS|8|||
124846747|NCT01859715|449064143|FG002|Overall Study|No 2nd VAS|23|||
124846748|NCT01252290|449064144|FG000|Overall Study|Withdrawal by Subject|1|||
124846749|NCT00086580|449064145|FG000|Treatment Period|Disease progression|9|||
124846750|NCT00086580|449064146|FG001|Treatment Period|Disease progression|8|||
124846751|NCT00086580|449064145|FG000|Treatment Period|Unable to comply with protocol|3|||
124846752|NCT00086580|449064146|FG001|Treatment Period|Unable to comply with protocol|1|||
124846753|NCT00086580|449064145|FG000|Treatment Period|Withdrawal by Subject|7|||
124846754|NCT00086580|449064146|FG001|Treatment Period|Withdrawal by Subject|8|||
124846755|NCT00086580|449064145|FG000|Treatment Period|Physician Decision|13|||
124846756|NCT00086580|449064146|FG001|Treatment Period|Physician Decision|7|||
124846757|NCT00086580|449064145|FG000|Treatment Period|AE - not treatment related|7|||
124846758|NCT00086580|449064146|FG001|Treatment Period|AE - not treatment related|7|||
124846759|NCT00086580|449064145|FG000|Treatment Period|Toxicity - treatment related|15|||
124846760|NCT00086580|449064146|FG001|Treatment Period|Toxicity - treatment related|15|||
124846761|NCT00086580|449064145|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
124846762|NCT00086580|449064146|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
124846763|NCT00086580|449064145|FG000|Treatment Period|Death|5|||
124846764|NCT00086580|449064146|FG001|Treatment Period|Death|7|||
124846765|NCT00086580|449064145|FG000|Treatment Period|Other|5|||
124846766|NCT00086580|449064146|FG001|Treatment Period|Other|3|||
124846767|NCT00086580|449064145|FG000|Follow-up Period|Disease progression|72|||
124846768|NCT00086580|449064146|FG001|Follow-up Period|Disease progression|99|||
124846769|NCT00086580|449064145|FG000|Follow-up Period|Unable to comply with protocol|5|||
124846770|NCT00086580|449064146|FG001|Follow-up Period|Unable to comply with protocol|0|||
124846771|NCT00086580|449064145|FG000|Follow-up Period|Withdrawal by Subject|6|||
124846772|NCT00086580|449064146|FG001|Follow-up Period|Withdrawal by Subject|6|||
124846773|NCT00086580|449064145|FG000|Follow-up Period|Physician Decision|0|||
124846774|NCT00086580|449064146|FG001|Follow-up Period|Physician Decision|1|||
124846775|NCT00086580|449064145|FG000|Follow-up Period|AE - not related|1|||
124846776|NCT00086580|449064146|FG001|Follow-up Period|AE - not related|0|||
124846777|NCT00086580|449064145|FG000|Follow-up Period|Death|13|||
124846778|NCT00086580|449064146|FG001|Follow-up Period|Death|7|||
124846779|NCT00086580|449064145|FG000|Follow-up Period|Other|7|||
124846780|NCT00086580|449064146|FG001|Follow-up Period|Other|6|||
124846781|NCT00086580|449064145|FG000|Observation Period|Unable to comply with protocol|1|||
124846782|NCT00086580|449064146|FG001|Observation Period|Unable to comply with protocol|1|||
124846783|NCT00086580|449064145|FG000|Observation Period|Withdrawal by Subject|4|||
124846784|NCT00086580|449064146|FG001|Observation Period|Withdrawal by Subject|2|||
124846785|NCT00086580|449064145|FG000|Observation Period|Death|33|||
124846786|NCT00086580|449064146|FG001|Observation Period|Death|55|||
124846787|NCT00086580|449064145|FG000|Observation Period|Other|8|||
124846788|NCT00086580|449064146|FG001|Observation Period|Other|7|||
124846789|NCT00261716|449064147|FG000|Overall Study|Withdrawal by Subject|6|||
124846790|NCT00261716|449064148|FG001|Overall Study|Withdrawal by Subject|8|||
124846791|NCT00261716|449064147|FG000|Overall Study|Lost to Follow-up|0|||
124846792|NCT00261716|449064148|FG001|Overall Study|Lost to Follow-up|2|||
124846793|NCT02075437|449064149|FG000|Overall Study|Withdrawal by Subject|5|||
124846794|NCT02075437|449064149|FG000|Overall Study|Lost to Follow-up|1|||
124846795|NCT04439240|449064150|FG000|Overall Study|Ineligible|2|||
124846796|NCT04439240|449064150|FG000|Overall Study|Never started treatment|2|||
124846797|NCT04439240|449064150|FG000|Overall Study|Adverse Event|12|||
124846798|NCT04439240|449064150|FG000|Overall Study|Death|2|||
124846799|NCT04439240|449064150|FG000|Overall Study|Disease progression|25|||
124846800|NCT04439240|449064150|FG000|Overall Study|Other diseases|2|||
124846801|NCT04439240|449064150|FG000|Overall Study|Withdrawal by Subject|3|||
124846802|NCT04439240|449064150|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
124846803|NCT04439240|449064150|FG000|Overall Study|Symptomatic decline|1|||
124846804|NCT04439240|449064150|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
124846805|NCT04439240|449064150|FG000|Overall Study|Clinical progression|1|||
124846806|NCT00673452|449064151|FG000|Acute Double-Blind Phase|Adverse Event|41|||
124846807|NCT00673452|449064152|FG001|Acute Double-Blind Phase|Adverse Event|24|||
124846808|NCT00673452|449064151|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
124846809|NCT00673452|449064152|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
124846810|NCT00673452|449064151|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
124846811|NCT00673452|449064152|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
124846812|NCT00673452|449064151|FG000|Acute Double-Blind Phase|Physician Decision|0|||
124846813|NCT00673452|449064152|FG001|Acute Double-Blind Phase|Physician Decision|6|||
124846814|NCT00673452|449064151|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
124846815|NCT00673452|449064152|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
124846816|NCT00673452|449064151|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
124846817|NCT00673452|449064152|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
124846818|NCT00673452|449064151|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
124846819|NCT00673452|449064152|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
124846820|NCT00673452|449064151|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
124846821|NCT00673452|449064152|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
124846822|NCT00673452|449064151|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
124846823|NCT00673452|449064152|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
124846824|NCT00673452|449064151|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
124846825|NCT00673452|449064152|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
124846826|NCT00673452|449064151|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
124846827|NCT00673452|449064152|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
124846828|NCT00673452|449064151|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
124846829|NCT00673452|449064152|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
124846830|NCT00673452|449064151|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
124846831|NCT00673452|449064152|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
124846832|NCT00673452|449064151|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
124846833|NCT00673452|449064152|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
124846834|NCT00673452|449064151|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
124846835|NCT00673452|449064152|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
124846836|NCT00813124|449064153|FG000|Overall Study|Death|2|||
124846837|NCT00813124|449064153|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
124846838|NCT00813124|449064153|FG000|Overall Study|Withdrawal by Subject|1|||
124846839|NCT00767676|449064154|FG000|Overall Study|Investigator error|54|||
124846840|NCT00079274|449064155|FG000|Overall Study|Withdrawal by Subject|111|||
124846841|NCT00079274|449064156|FG001|Overall Study|Withdrawal by Subject|10|||
124846842|NCT00079274|449064157|FG002|Overall Study|Withdrawal by Subject|12|||
124846843|NCT00079274|449064158|FG003|Overall Study|Withdrawal by Subject|163|||
124846844|NCT00079274|449064159|FG004|Overall Study|Withdrawal by Subject|7|||
124846845|NCT00079274|449064160|FG005|Overall Study|Withdrawal by Subject|8|||
124846846|NCT00079274|449064161|FG006|Overall Study|Withdrawal by Subject|0|||
124846847|NCT00079274|449064155|FG000|Overall Study|Adverse Event|130|||
124846848|NCT00079274|449064156|FG001|Overall Study|Adverse Event|8|||
124846849|NCT00079274|449064157|FG002|Overall Study|Adverse Event|8|||
124846850|NCT00079274|449064158|FG003|Overall Study|Adverse Event|184|||
124846851|NCT00079274|449064159|FG004|Overall Study|Adverse Event|7|||
124846852|NCT00079274|449064160|FG005|Overall Study|Adverse Event|8|||
124846853|NCT00079274|449064161|FG006|Overall Study|Adverse Event|0|||
124846854|NCT00079274|449064155|FG000|Overall Study|Recurrence|21|||
124846855|NCT00079274|449064156|FG001|Overall Study|Recurrence|0|||
124846856|NCT00079274|449064157|FG002|Overall Study|Recurrence|1|||
124846857|NCT00079274|449064158|FG003|Overall Study|Recurrence|15|||
124846858|NCT00079274|449064159|FG004|Overall Study|Recurrence|0|||
124846859|NCT00079274|449064160|FG005|Overall Study|Recurrence|2|||
124846860|NCT00079274|449064161|FG006|Overall Study|Recurrence|0|||
124846861|NCT00079274|449064155|FG000|Overall Study|Alternate Treatment|6|||
124846862|NCT00079274|449064156|FG001|Overall Study|Alternate Treatment|1|||
124846863|NCT00079274|449064157|FG002|Overall Study|Alternate Treatment|0|||
124846864|NCT00079274|449064158|FG003|Overall Study|Alternate Treatment|3|||
124846865|NCT00079274|449064159|FG004|Overall Study|Alternate Treatment|0|||
124846866|NCT00079274|449064160|FG005|Overall Study|Alternate Treatment|0|||
124846867|NCT00079274|449064161|FG006|Overall Study|Alternate Treatment|0|||
124846868|NCT00079274|449064155|FG000|Overall Study|Other Medical Problems|6|||
124846869|NCT00079274|449064156|FG001|Overall Study|Other Medical Problems|1|||
124846870|NCT00079274|449064157|FG002|Overall Study|Other Medical Problems|0|||
124846871|NCT00079274|449064158|FG003|Overall Study|Other Medical Problems|7|||
124846872|NCT00079274|449064159|FG004|Overall Study|Other Medical Problems|0|||
124846873|NCT00079274|449064160|FG005|Overall Study|Other Medical Problems|0|||
124846874|NCT00079274|449064161|FG006|Overall Study|Other Medical Problems|0|||
124846875|NCT00079274|449064155|FG000|Overall Study|Death|4|||
124846876|NCT00079274|449064156|FG001|Overall Study|Death|0|||
124846877|NCT00079274|449064157|FG002|Overall Study|Death|1|||
124846878|NCT00079274|449064158|FG003|Overall Study|Death|15|||
124846879|NCT00079274|449064159|FG004|Overall Study|Death|0|||
124846880|NCT00079274|449064160|FG005|Overall Study|Death|0|||
124846881|NCT00079274|449064161|FG006|Overall Study|Death|0|||
124846882|NCT00079274|449064155|FG000|Overall Study|Cytogenetic resistance|0|||
124846883|NCT00079274|449064156|FG001|Overall Study|Cytogenetic resistance|0|||
124846884|NCT00079274|449064157|FG002|Overall Study|Cytogenetic resistance|0|||
124846885|NCT00079274|449064158|FG003|Overall Study|Cytogenetic resistance|2|||
124846886|NCT00079274|449064159|FG004|Overall Study|Cytogenetic resistance|0|||
124846887|NCT00079274|449064160|FG005|Overall Study|Cytogenetic resistance|0|||
124846888|NCT00079274|449064161|FG006|Overall Study|Cytogenetic resistance|0|||
124846889|NCT00079274|449064155|FG000|Overall Study|Other|43|||
124846890|NCT00079274|449064156|FG001|Overall Study|Other|7|||
124846891|NCT00079274|449064157|FG002|Overall Study|Other|5|||
124846892|NCT00079274|449064158|FG003|Overall Study|Other|55|||
124846893|NCT00079274|449064159|FG004|Overall Study|Other|1|||
124846894|NCT00079274|449064160|FG005|Overall Study|Other|2|||
124846895|NCT00079274|449064161|FG006|Overall Study|Other|0|||
124846896|NCT00617240|449064162|FG000|Overall Study|Lack of Efficacy|1|||
124846897|NCT00617240|449064163|FG001|Overall Study|Lack of Efficacy|0|||
124846898|NCT01611259|449064164|FG000|Overall Study|Physician Decision|1|||
124846899|NCT01611259|449064164|FG000|Overall Study|Lack of Efficacy|2|||
124846900|NCT01611259|449064164|FG000|Overall Study|Adverse Event|4|||
124846901|NCT01611259|449064164|FG000|Overall Study|Withdrawal by Subject|7|||
124846902|NCT04936685|449064165|FG000|Overall Study|Protocol Violation|1|||
124846903|NCT04936685|449064166|FG001|Overall Study|Protocol Violation|0|||
124846904|NCT03969212|449064169|FG000|Overall Study|Adverse Event|1|||
124846905|NCT03969212|449064170|FG001|Overall Study|Adverse Event|0|||
124846906|NCT03969212|449064171|FG002|Overall Study|Adverse Event|0|||
124846907|NCT03969212|449064172|FG003|Overall Study|Adverse Event|0|||
124846908|NCT03969212|449064169|FG000|Overall Study|Lost to Follow-up|2|||
124846909|NCT03969212|449064170|FG001|Overall Study|Lost to Follow-up|2|||
124846910|NCT03969212|449064171|FG002|Overall Study|Lost to Follow-up|2|||
124846911|NCT03969212|449064172|FG003|Overall Study|Lost to Follow-up|2|||
124846912|NCT03969212|449064169|FG000|Overall Study|Protocol Violation|0|||
124846913|NCT03969212|449064170|FG001|Overall Study|Protocol Violation|0|||
124846914|NCT03969212|449064171|FG002|Overall Study|Protocol Violation|0|||
124846915|NCT03969212|449064172|FG003|Overall Study|Protocol Violation|1|||
124846916|NCT03969212|449064169|FG000|Overall Study|Withdrawal by Subject|7|||
124846917|NCT03969212|449064170|FG001|Overall Study|Withdrawal by Subject|13|||
124846918|NCT03969212|449064171|FG002|Overall Study|Withdrawal by Subject|5|||
124846919|NCT03969212|449064172|FG003|Overall Study|Withdrawal by Subject|11|||
124846920|NCT03969212|449064169|FG000|Overall Study|Physician Decision|0|||
124846921|NCT03969212|449064170|FG001|Overall Study|Physician Decision|0|||
124846922|NCT03969212|449064171|FG002|Overall Study|Physician Decision|1|||
124846923|NCT03969212|449064172|FG003|Overall Study|Physician Decision|0|||
124846924|NCT03969212|449064169|FG000|Overall Study|Reason not Specified|22|||
124846925|NCT03969212|449064170|FG001|Overall Study|Reason not Specified|23|||
124846926|NCT03969212|449064171|FG002|Overall Study|Reason not Specified|28|||
124846927|NCT03969212|449064172|FG003|Overall Study|Reason not Specified|26|||
124846928|NCT02075320|449064173|FG000|Overall Study|Withdrawal by Subject|2|||
124846929|NCT01147653|449064175|FG000|Year 2|Withdrawal by Subject|2|||
124846930|NCT01147653|449064176|FG001|Year 2|Withdrawal by Subject|3|||
124846931|NCT00353366|449064177|FG000|Overall Study|Adverse Event|8|||
124846932|NCT00353366|449064177|FG000|Overall Study|Protocol Violation|12|||
124846933|NCT00353366|449064177|FG000|Overall Study|Withdrawal by Subject|12|||
124846934|NCT00353366|449064177|FG000|Overall Study|Lost to Follow-up|92|||
124846935|NCT00353366|449064177|FG000|Overall Study|Other|19|||
124846936|NCT00259857|449064178|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
124846937|NCT00259857|449064179|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
124846938|NCT00259857|449064178|FG000|24 Months Treatment|Lost to Follow-up|0|||
124846939|NCT00259857|449064179|FG001|24 Months Treatment|Lost to Follow-up|3|||
124846940|NCT01813019|449064186|FG000|Overall Study|Adverse Event|0|||
124846941|NCT01813019|449064187|FG001|Overall Study|Adverse Event|3|||
124846942|NCT01813019|449064186|FG000|Overall Study|Withdrawal by Subject|3|||
124846943|NCT01813019|449064187|FG001|Overall Study|Withdrawal by Subject|2|||
124846944|NCT01813019|449064186|FG000|Overall Study|administrative problems|2|||
124846945|NCT01813019|449064187|FG001|Overall Study|administrative problems|0|||
124846946|NCT01813019|449064186|FG000|Overall Study|Protocol Deviation|2|||
124846947|NCT01813019|449064187|FG001|Overall Study|Protocol Deviation|1|||
124846948|NCT03075644|449064188|FG000|Overall Study|Withdrawal by Subject|1|||
124846949|NCT03075644|449064189|FG001|Overall Study|Withdrawal by Subject|1|||
124846950|NCT01458171|449064193|FG000|Overall Study|Adverse Event|1|||
124846951|NCT02214121|449064197|FG000|Part A|Patient decision|2|||
124846952|NCT02214121|449064198|FG001|Part A|Patient decision|0|||
124846953|NCT02214121|449064199|FG002|Part A|Patient decision|0|||
124846954|NCT02214121|449064197|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
124846955|NCT02214121|449064198|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
124846956|NCT02214121|449064199|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
124846957|NCT02214121|449064197|FG000|Part A|Other|1|||
124846958|NCT02214121|449064198|FG001|Part A|Other|0|||
124846959|NCT02214121|449064199|FG002|Part A|Other|0|||
124846960|NCT02214121|449064197|FG000|Part B|Patient decision|0|||
124846961|NCT02214121|449064198|FG001|Part B|Patient decision|1|||
124846962|NCT02214121|449064199|FG002|Part B|Patient decision|0|||
124846963|NCT02214121|449064197|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
124846964|NCT02214121|449064198|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
124846965|NCT02214121|449064199|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
124846966|NCT02214121|449064197|FG000|Part B|Lost to Follow-up|0|||
124846967|NCT02214121|449064198|FG001|Part B|Lost to Follow-up|0|||
124846968|NCT02214121|449064199|FG002|Part B|Lost to Follow-up|1|||
124846969|NCT00715793|449064200|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
124846970|NCT00715793|449064201|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
124846971|NCT00715793|449064200|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
124846972|NCT00715793|449064201|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
124846973|NCT01849588|449064203|FG000|Overall Study|Lack of Efficacy|3|||
124846974|NCT00094653|449064204|FG000|Overall Study|Death|306|||
124846975|NCT00094653|449064205|FG001|Overall Study|Death|100|||
124846976|NCT00094653|449064206|FG002|Overall Study|Death|119|||
124846977|NCT00094653|449064204|FG000|Overall Study|Subject Withdrew Consent|10|||
124846978|NCT00094653|449064205|FG001|Overall Study|Subject Withdrew Consent|2|||
124846979|NCT00094653|449064206|FG002|Overall Study|Subject Withdrew Consent|3|||
124846980|NCT00094653|449064204|FG000|Overall Study|Other|2|||
124846981|NCT00094653|449064205|FG001|Overall Study|Other|2|||
124846982|NCT00094653|449064206|FG002|Overall Study|Other|2|||
124846983|NCT00094653|449064204|FG000|Overall Study|Lost to Follow-up|3|||
124846984|NCT00094653|449064205|FG001|Overall Study|Lost to Follow-up|2|||
124846985|NCT00094653|449064206|FG002|Overall Study|Lost to Follow-up|1|||
124846986|NCT00094653|449064204|FG000|Overall Study|Protocol Violation|0|||
124846987|NCT00094653|449064205|FG001|Overall Study|Protocol Violation|0|||
124846988|NCT00094653|449064206|FG002|Overall Study|Protocol Violation|1|||
124846989|NCT03921411|449064207|FG000|Overall Study|Withdrawal by Subject|1|||
124846990|NCT03921411|449064207|FG000|Overall Study|Protocol Deviation|2|||
124846991|NCT03921411|449064207|FG000|Overall Study|Enrolled, but never treated|2|||
124846992|NCT03120013|449064210|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
124846993|NCT03120013|449064211|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
124846994|NCT01541826|449064213|FG000|Overall Study|Lost to Follow-up|2|||
124846995|NCT01541826|449064214|FG001|Overall Study|Lost to Follow-up|3|||
124846996|NCT01541826|449064215|FG002|Overall Study|Lost to Follow-up|0|||
124641019|NCT01186692|448302935|FG000|Overall Study|Futher testing contraindicated implant|19|||
124846997|NCT01541826|449064213|FG000|Overall Study|Withdrawal by Subject|2|||
124846998|NCT01541826|449064214|FG001|Overall Study|Withdrawal by Subject|0|||
124846999|NCT01541826|449064215|FG002|Overall Study|Withdrawal by Subject|0|||
124847000|NCT01365273|449064218|FG000|Overall Study|Lost to Follow-up|1|||
124847001|NCT01365273|449064219|FG001|Overall Study|Lost to Follow-up|0|||
124847002|NCT01365273|449064218|FG000|Overall Study|Protocol Violation|0|||
124847003|NCT01365273|449064219|FG001|Overall Study|Protocol Violation|1|||
124847004|NCT01365273|449064218|FG000|Overall Study|Physician Decision|1|||
124847005|NCT01365273|449064219|FG001|Overall Study|Physician Decision|0|||
124847006|NCT01339390|449064222|FG000|Overall Study|Death|32|||
124847007|NCT01339390|449064223|FG001|Overall Study|Death|29|||
124847008|NCT01339390|449064222|FG000|Overall Study|Lost to Follow-up|125|||
124847009|NCT01339390|449064223|FG001|Overall Study|Lost to Follow-up|127|||
124847010|NCT04847674|449064224|FG000|Overall Study|Withdrawal by Subject|0|||
124641020|NCT01186692|448302935|FG000|Overall Study|Adverse Event|2|||
124641021|NCT00767455|448302936|FG000|Overall Study|Investigator error|19|||
124641022|NCT04463251|448302937|FG000|Overall Study|Death|1|||
124641023|NCT04463251|448302938|FG001|Overall Study|Death|0|||
124641024|NCT04463251|448302939|FG002|Overall Study|Death|1|||
124641025|NCT04463251|448302937|FG000|Overall Study|Adverse Event|0|||
124641026|NCT04463251|448302938|FG001|Overall Study|Adverse Event|1|||
124641027|NCT04463251|448302939|FG002|Overall Study|Adverse Event|0|||
124641028|NCT04463251|448302937|FG000|Overall Study|Lost to Follow-up|0|||
124641029|NCT04463251|448302938|FG001|Overall Study|Lost to Follow-up|1|||
124641030|NCT04463251|448302939|FG002|Overall Study|Lost to Follow-up|0|||
124641031|NCT04463251|448302937|FG000|Overall Study|Withdrawal by Subject|0|||
124641032|NCT04463251|448302938|FG001|Overall Study|Withdrawal by Subject|2|||
124641033|NCT04463251|448302939|FG002|Overall Study|Withdrawal by Subject|2|||
124641034|NCT00022698|448302940|FG000|Overall Study|Adverse Event|5|||
124641035|NCT00022698|448302941|FG001|Overall Study|Adverse Event|9|||
124641036|NCT00022698|448302940|FG000|Overall Study|Death|0|||
124641037|NCT00022698|448302941|FG001|Overall Study|Death|2|||
124641038|NCT00022698|448302940|FG000|Overall Study|Failure to return|0|||
124641039|NCT00022698|448302941|FG001|Overall Study|Failure to return|1|||
124641040|NCT00022698|448302940|FG000|Overall Study|Refused treatment|0|||
124641041|NCT00022698|448302941|FG001|Overall Study|Refused treatment|2|||
124641042|NCT00022698|448302940|FG000|Overall Study|Insufficient therapeutic response|2|||
124641043|NCT00022698|448302941|FG001|Overall Study|Insufficient therapeutic response|14|||
124641044|NCT00022698|448302940|FG000|Overall Study|Administrative /other|1|||
124641045|NCT00022698|448302941|FG001|Overall Study|Administrative /other|7|||
124641046|NCT04520997|448302950|FG000|Overall Study|Lost to Follow-up|1|||
124641047|NCT04520997|448302951|FG001|Overall Study|Lost to Follow-up|1|||
124641048|NCT04520997|448302950|FG000|Overall Study|Withdrawal by Subject|1|||
124641049|NCT04520997|448302951|FG001|Overall Study|Withdrawal by Subject|0|||
124641050|NCT04520997|448302950|FG000|Overall Study|Not Treated|0|||
124641051|NCT04520997|448302951|FG001|Overall Study|Not Treated|1|||
124641052|NCT02981082|448302952|FG000|Overall Study|Withdrawal by Subject|2|||
124641053|NCT02981082|448302953|FG001|Overall Study|Withdrawal by Subject|0|||
124641054|NCT02981082|448302952|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
124641055|NCT02981082|448302953|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
124847011|NCT04847674|449064225|FG001|Overall Study|Withdrawal by Subject|1|||
124847012|NCT04847674|449064226|FG002|Overall Study|Withdrawal by Subject|0|||
124847013|NCT04847674|449064224|FG000|Overall Study|Lost to Follow-up|0|||
124847014|NCT04847674|449064225|FG001|Overall Study|Lost to Follow-up|0|||
124847015|NCT04847674|449064226|FG002|Overall Study|Lost to Follow-up|2|||
124847016|NCT04847674|449064224|FG000|Overall Study|Other than specified|21|||
124847017|NCT04847674|449064225|FG001|Overall Study|Other than specified|20|||
124847018|NCT04847674|449064226|FG002|Overall Study|Other than specified|20|||
124847019|NCT02563028|449064228|FG000|Overall Study|Lack of equipment|1|||
124847020|NCT02563028|449064228|FG000|Overall Study|Unable to elicit VEP post induction|1|||
124847021|NCT01462357|449064230|FG000|Overall Study|Death|0|||
124847022|NCT01462357|449064231|FG001|Overall Study|Death|0|||
124847023|NCT01462357|449064232|FG002|Overall Study|Death|1|||
124847024|NCT01462357|449064230|FG000|Overall Study|Withdrawal by Subject|3|||
124847025|NCT01462357|449064231|FG001|Overall Study|Withdrawal by Subject|11|||
124847026|NCT01462357|449064232|FG002|Overall Study|Withdrawal by Subject|3|||
124847027|NCT01462357|449064230|FG000|Overall Study|Migrated/moved from study area|2|||
124847028|NCT01462357|449064231|FG001|Overall Study|Migrated/moved from study area|3|||
124847029|NCT01462357|449064232|FG002|Overall Study|Migrated/moved from study area|1|||
124641056|NCT02981082|448302952|FG000|Overall Study|Adverse Event|0|||
124641057|NCT02981082|448302953|FG001|Overall Study|Adverse Event|1|||
124641058|NCT05367973|448302954|FG000|Overall Study|Adverse Event|0|||
124641059|NCT05367973|448302955|FG001|Overall Study|Adverse Event|2|||
124641060|NCT01314872|448302959|FG000|Treatment Period 1|Protocol Violation|2|||
124641061|NCT01314872|448302960|FG001|Treatment Period 1|Protocol Violation|1|||
124641062|NCT01314872|448302961|FG002|Treatment Period 1|Protocol Violation|1|||
124641063|NCT01314872|448302962|FG003|Treatment Period 1|Protocol Violation|0|||
124641064|NCT01314872|448302963|FG004|Treatment Period 1|Protocol Violation|1|||
124641065|NCT01314872|448302964|FG005|Treatment Period 1|Protocol Violation|0|||
124641066|NCT01314872|448302965|FG006|Treatment Period 1|Protocol Violation|0|||
124641067|NCT01314872|448302966|FG007|Treatment Period 1|Protocol Violation|0|||
124641068|NCT01314872|448302967|FG008|Treatment Period 1|Protocol Violation|0|||
124641069|NCT01314872|448302968|FG009|Treatment Period 1|Protocol Violation|1|||
124847030|NCT01462357|449064230|FG000|Overall Study|Lost to Follow-up|3|||
124847031|NCT01462357|449064231|FG001|Overall Study|Lost to Follow-up|5|||
124847032|NCT01462357|449064232|FG002|Overall Study|Lost to Follow-up|7|||
124641070|NCT01314872|448302969|FG010|Treatment Period 1|Protocol Violation|1|||
124847033|NCT00096044|449064233|FG000|Overall Study|Withdrawal by Subject|9|||
124847034|NCT00096044|449064233|FG000|Overall Study|Adverse Event|21|||
124847035|NCT00096044|449064233|FG000|Overall Study|Disease Progression|4|||
124847036|NCT00004031|449064234|FG000|Overall Study|Adverse Event|5|||
124641071|NCT01314872|448302970|FG011|Treatment Period 1|Protocol Violation|0|||
124641072|NCT01314872|448302971|FG012|Treatment Period 1|Protocol Violation|0|||
124641073|NCT01314872|448302972|FG013|Treatment Period 1|Protocol Violation|0|||
124641074|NCT01314872|448302973|FG014|Treatment Period 1|Protocol Violation|0|||
124641075|NCT01314872|448302959|FG000|Treatment Period 1|Physician Decision|0|||
124641076|NCT01314872|448302960|FG001|Treatment Period 1|Physician Decision|1|||
124641077|NCT01314872|448302961|FG002|Treatment Period 1|Physician Decision|0|||
124641078|NCT01314872|448302962|FG003|Treatment Period 1|Physician Decision|1|||
124847037|NCT00004031|449064235|FG001|Overall Study|Adverse Event|0|||
124847038|NCT00004031|449064234|FG000|Overall Study|Refusal unrelated to adverse events|2|||
124847039|NCT00004031|449064235|FG001|Overall Study|Refusal unrelated to adverse events|11|||
124847040|NCT00004031|449064234|FG000|Overall Study|Progression/relapse|9|||
124847041|NCT00004031|449064235|FG001|Overall Study|Progression/relapse|4|||
124847042|NCT00004031|449064234|FG000|Overall Study|Death|3|||
124847043|NCT00004031|449064235|FG001|Overall Study|Death|1|||
124847044|NCT00004031|449064234|FG000|Overall Study|Other- not protocol specified|3|||
124847045|NCT00004031|449064235|FG001|Overall Study|Other- not protocol specified|3|||
124847046|NCT00004031|449064234|FG000|Overall Study|Reason under review|3|||
124847047|NCT00004031|449064235|FG001|Overall Study|Reason under review|2|||
124847048|NCT01387607|449064236|FG000|Overall Study|Adverse Event|23|||
124641079|NCT01314872|448302963|FG004|Treatment Period 1|Physician Decision|0|||
124641080|NCT01314872|448302964|FG005|Treatment Period 1|Physician Decision|0|||
124847049|NCT01387607|449064237|FG001|Overall Study|Adverse Event|11|||
124847050|NCT01387607|449064236|FG000|Overall Study|Lack of Efficacy|8|||
124847051|NCT01387607|449064237|FG001|Overall Study|Lack of Efficacy|6|||
124847052|NCT01387607|449064236|FG000|Overall Study|Lost to Follow-up|2|||
124847053|NCT01387607|449064237|FG001|Overall Study|Lost to Follow-up|1|||
124847054|NCT01387607|449064236|FG000|Overall Study|No longer meets eligibility criteria|0|||
124847055|NCT01387607|449064237|FG001|Overall Study|No longer meets eligibility criteria|1|||
124847056|NCT01387607|449064236|FG000|Overall Study|Protocol Violation|1|||
124847057|NCT01387607|449064237|FG001|Overall Study|Protocol Violation|5|||
124847058|NCT01387607|449064236|FG000|Overall Study|Withdrawal by Subject|13|||
124847059|NCT01387607|449064237|FG001|Overall Study|Withdrawal by Subject|14|||
124847060|NCT01387607|449064236|FG000|Overall Study|Other|1|||
124847061|NCT01387607|449064237|FG001|Overall Study|Other|1|||
124847062|NCT01387607|449064236|FG000|Overall Study|Randomized, not treated|3|||
124641081|NCT01314872|448302965|FG006|Treatment Period 1|Physician Decision|0|||
124641082|NCT01314872|448302966|FG007|Treatment Period 1|Physician Decision|0|||
124641083|NCT01314872|448302967|FG008|Treatment Period 1|Physician Decision|0|||
124641084|NCT01314872|448302968|FG009|Treatment Period 1|Physician Decision|1|||
124641085|NCT01314872|448302969|FG010|Treatment Period 1|Physician Decision|0|||
124641086|NCT01314872|448302970|FG011|Treatment Period 1|Physician Decision|0|||
124641087|NCT01314872|448302971|FG012|Treatment Period 1|Physician Decision|0|||
124641088|NCT01314872|448302972|FG013|Treatment Period 1|Physician Decision|0|||
124641089|NCT01314872|448302973|FG014|Treatment Period 1|Physician Decision|0|||
124641090|NCT01314872|448302959|FG000|Treatment Period 1|Lack of Efficacy|1|||
124641091|NCT01314872|448302960|FG001|Treatment Period 1|Lack of Efficacy|0|||
124641092|NCT01314872|448302961|FG002|Treatment Period 1|Lack of Efficacy|0|||
124641093|NCT01314872|448302962|FG003|Treatment Period 1|Lack of Efficacy|0|||
124641094|NCT01314872|448302963|FG004|Treatment Period 1|Lack of Efficacy|0|||
124641095|NCT01314872|448302964|FG005|Treatment Period 1|Lack of Efficacy|1|||
124641096|NCT01314872|448302965|FG006|Treatment Period 1|Lack of Efficacy|0|||
124641097|NCT01314872|448302966|FG007|Treatment Period 1|Lack of Efficacy|2|||
124641098|NCT01314872|448302967|FG008|Treatment Period 1|Lack of Efficacy|0|||
124641099|NCT01314872|448302968|FG009|Treatment Period 1|Lack of Efficacy|0|||
124641100|NCT01314872|448302969|FG010|Treatment Period 1|Lack of Efficacy|0|||
124641101|NCT01314872|448302970|FG011|Treatment Period 1|Lack of Efficacy|0|||
124641102|NCT01314872|448302971|FG012|Treatment Period 1|Lack of Efficacy|0|||
124641103|NCT01314872|448302972|FG013|Treatment Period 1|Lack of Efficacy|0|||
124641104|NCT01314872|448302973|FG014|Treatment Period 1|Lack of Efficacy|0|||
124641105|NCT01314872|448302959|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
124641106|NCT01314872|448302960|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
124847063|NCT01387607|449064237|FG001|Overall Study|Randomized, not treated|6|||
124641107|NCT01314872|448302961|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
124641108|NCT01314872|448302962|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
124641109|NCT01314872|448302963|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
124847064|NCT03013491|449064239|FG000|Main Study|Death|2|||
124847065|NCT03013491|449064240|FG001|Main Study|Death|2|||
124847066|NCT03013491|449064241|FG002|Main Study|Death|5|||
124847067|NCT03013491|449064242|FG003|Main Study|Death|3|||
124847068|NCT03013491|449064243|FG004|Main Study|Death|9|||
124847069|NCT03013491|449064244|FG005|Main Study|Death|12|||
124641110|NCT01314872|448302964|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
124641111|NCT01314872|448302965|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
124641112|NCT01314872|448302966|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
124641113|NCT01314872|448302967|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
124847070|NCT03013491|449064245|FG006|Main Study|Death|3|||
124641114|NCT01314872|448302968|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
124641115|NCT01314872|448302969|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
124641116|NCT01314872|448302970|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
124641117|NCT01314872|448302971|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
124641118|NCT01314872|448302972|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
124641119|NCT01314872|448302973|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
124641120|NCT01314872|448302959|FG000|Treatment Period 1|Withdrawal by Subject|3|||
124641121|NCT01314872|448302960|FG001|Treatment Period 1|Withdrawal by Subject|1|||
124641122|NCT01314872|448302961|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124641123|NCT01314872|448302962|FG003|Treatment Period 1|Withdrawal by Subject|2|||
124641124|NCT01314872|448302963|FG004|Treatment Period 1|Withdrawal by Subject|3|||
124641125|NCT01314872|448302964|FG005|Treatment Period 1|Withdrawal by Subject|1|||
124641126|NCT01314872|448302965|FG006|Treatment Period 1|Withdrawal by Subject|3|||
124641127|NCT01314872|448302966|FG007|Treatment Period 1|Withdrawal by Subject|2|||
124641128|NCT01314872|448302967|FG008|Treatment Period 1|Withdrawal by Subject|2|||
124641129|NCT01314872|448302968|FG009|Treatment Period 1|Withdrawal by Subject|2|||
124641130|NCT01314872|448302969|FG010|Treatment Period 1|Withdrawal by Subject|1|||
124641131|NCT01314872|448302970|FG011|Treatment Period 1|Withdrawal by Subject|0|||
124641132|NCT01314872|448302971|FG012|Treatment Period 1|Withdrawal by Subject|0|||
124641133|NCT01314872|448302972|FG013|Treatment Period 1|Withdrawal by Subject|0|||
124641134|NCT01314872|448302973|FG014|Treatment Period 1|Withdrawal by Subject|0|||
124641135|NCT01314872|448302959|FG000|Treatment Period 1|Lost to Follow-up|0|||
124641136|NCT01314872|448302960|FG001|Treatment Period 1|Lost to Follow-up|1|||
124641137|NCT01314872|448302961|FG002|Treatment Period 1|Lost to Follow-up|2|||
124641138|NCT01314872|448302962|FG003|Treatment Period 1|Lost to Follow-up|2|||
124641139|NCT01314872|448302963|FG004|Treatment Period 1|Lost to Follow-up|1|||
124641140|NCT01314872|448302964|FG005|Treatment Period 1|Lost to Follow-up|1|||
124641141|NCT01314872|448302965|FG006|Treatment Period 1|Lost to Follow-up|1|||
124641142|NCT01314872|448302966|FG007|Treatment Period 1|Lost to Follow-up|1|||
124641143|NCT01314872|448302967|FG008|Treatment Period 1|Lost to Follow-up|1|||
124641144|NCT01314872|448302968|FG009|Treatment Period 1|Lost to Follow-up|0|||
124641145|NCT01314872|448302969|FG010|Treatment Period 1|Lost to Follow-up|0|||
124641146|NCT01314872|448302970|FG011|Treatment Period 1|Lost to Follow-up|0|||
124641147|NCT01314872|448302971|FG012|Treatment Period 1|Lost to Follow-up|0|||
124641148|NCT01314872|448302972|FG013|Treatment Period 1|Lost to Follow-up|0|||
124641149|NCT01314872|448302973|FG014|Treatment Period 1|Lost to Follow-up|0|||
124641150|NCT01314872|448302959|FG000|Period 2|Protocol Violation|0|||
124641151|NCT01314872|448302960|FG001|Period 2|Protocol Violation|0|||
124641152|NCT01314872|448302961|FG002|Period 2|Protocol Violation|0|||
124641153|NCT01314872|448302962|FG003|Period 2|Protocol Violation|0|||
124641154|NCT01314872|448302963|FG004|Period 2|Protocol Violation|0|||
124641155|NCT01314872|448302964|FG005|Period 2|Protocol Violation|0|||
124641156|NCT01314872|448302965|FG006|Period 2|Protocol Violation|0|||
124641157|NCT01314872|448302966|FG007|Period 2|Protocol Violation|0|||
124641158|NCT01314872|448302967|FG008|Period 2|Protocol Violation|0|||
124641159|NCT01314872|448302968|FG009|Period 2|Protocol Violation|0|||
124641160|NCT01314872|448302969|FG010|Period 2|Protocol Violation|0|||
124641161|NCT01314872|448302970|FG011|Period 2|Protocol Violation|3|||
124641162|NCT01314872|448302971|FG012|Period 2|Protocol Violation|3|||
124641163|NCT01314872|448302972|FG013|Period 2|Protocol Violation|2|||
124641164|NCT01314872|448302973|FG014|Period 2|Protocol Violation|0|||
124641165|NCT01314872|448302959|FG000|Period 2|Non-compliance with study drug|0|||
124641166|NCT01314872|448302960|FG001|Period 2|Non-compliance with study drug|0|||
124847071|NCT03013491|449064246|FG007|Main Study|Death|5|||
124847072|NCT03013491|449064247|FG008|Main Study|Death|1|||
124847073|NCT03013491|449064248|FG009|Main Study|Death|2|||
124847074|NCT03013491|449064249|FG010|Main Study|Death|4|||
124641167|NCT01314872|448302961|FG002|Period 2|Non-compliance with study drug|0|||
124641168|NCT01314872|448302962|FG003|Period 2|Non-compliance with study drug|0|||
124641169|NCT01314872|448302963|FG004|Period 2|Non-compliance with study drug|0|||
124641170|NCT01314872|448302964|FG005|Period 2|Non-compliance with study drug|0|||
124641171|NCT01314872|448302965|FG006|Period 2|Non-compliance with study drug|0|||
124641172|NCT01314872|448302966|FG007|Period 2|Non-compliance with study drug|0|||
124641173|NCT01314872|448302967|FG008|Period 2|Non-compliance with study drug|0|||
124641174|NCT01314872|448302968|FG009|Period 2|Non-compliance with study drug|0|||
124641175|NCT01314872|448302969|FG010|Period 2|Non-compliance with study drug|0|||
124641176|NCT01314872|448302970|FG011|Period 2|Non-compliance with study drug|3|||
124641177|NCT01314872|448302971|FG012|Period 2|Non-compliance with study drug|3|||
124641178|NCT01314872|448302972|FG013|Period 2|Non-compliance with study drug|1|||
124641179|NCT01314872|448302973|FG014|Period 2|Non-compliance with study drug|2|||
124641180|NCT01314872|448302959|FG000|Period 2|Lack of Efficacy|0|||
124641181|NCT01314872|448302960|FG001|Period 2|Lack of Efficacy|0|||
124641182|NCT01314872|448302961|FG002|Period 2|Lack of Efficacy|0|||
124641183|NCT01314872|448302962|FG003|Period 2|Lack of Efficacy|0|||
124641184|NCT01314872|448302963|FG004|Period 2|Lack of Efficacy|0|||
124847075|NCT03013491|449064250|FG011|Main Study|Death|1|||
124847076|NCT03013491|449064251|FG012|Main Study|Death|1|||
124847077|NCT03013491|449064252|FG013|Main Study|Death|4|||
124641185|NCT01314872|448302964|FG005|Period 2|Lack of Efficacy|0|||
124641186|NCT01314872|448302965|FG006|Period 2|Lack of Efficacy|0|||
124641187|NCT01314872|448302966|FG007|Period 2|Lack of Efficacy|0|||
124641188|NCT01314872|448302967|FG008|Period 2|Lack of Efficacy|0|||
124641189|NCT01314872|448302968|FG009|Period 2|Lack of Efficacy|0|||
124641190|NCT01314872|448302969|FG010|Period 2|Lack of Efficacy|0|||
124641191|NCT01314872|448302970|FG011|Period 2|Lack of Efficacy|7|||
124641192|NCT01314872|448302971|FG012|Period 2|Lack of Efficacy|12|||
124641193|NCT01314872|448302972|FG013|Period 2|Lack of Efficacy|9|||
124641194|NCT01314872|448302973|FG014|Period 2|Lack of Efficacy|2|||
124641195|NCT01314872|448302959|FG000|Period 2|Pregnancy|0|||
124641196|NCT01314872|448302960|FG001|Period 2|Pregnancy|0|||
124641197|NCT01314872|448302961|FG002|Period 2|Pregnancy|0|||
124641198|NCT01314872|448302962|FG003|Period 2|Pregnancy|0|||
124641199|NCT01314872|448302963|FG004|Period 2|Pregnancy|0|||
124641200|NCT01314872|448302964|FG005|Period 2|Pregnancy|0|||
124641201|NCT01314872|448302965|FG006|Period 2|Pregnancy|0|||
124641202|NCT01314872|448302966|FG007|Period 2|Pregnancy|0|||
124641203|NCT01314872|448302967|FG008|Period 2|Pregnancy|0|||
124641204|NCT01314872|448302968|FG009|Period 2|Pregnancy|0|||
124641205|NCT01314872|448302969|FG010|Period 2|Pregnancy|0|||
124641206|NCT01314872|448302970|FG011|Period 2|Pregnancy|0|||
124641207|NCT01314872|448302971|FG012|Period 2|Pregnancy|0|||
124641208|NCT01314872|448302972|FG013|Period 2|Pregnancy|0|||
124641209|NCT01314872|448302973|FG014|Period 2|Pregnancy|1|||
124641210|NCT01314872|448302959|FG000|Period 2|Study terminated by Sponsor|0|||
124641211|NCT01314872|448302960|FG001|Period 2|Study terminated by Sponsor|0|||
124641212|NCT01314872|448302961|FG002|Period 2|Study terminated by Sponsor|0|||
124641213|NCT01314872|448302962|FG003|Period 2|Study terminated by Sponsor|0|||
124641214|NCT01314872|448302963|FG004|Period 2|Study terminated by Sponsor|0|||
124641215|NCT01314872|448302964|FG005|Period 2|Study terminated by Sponsor|0|||
124641216|NCT01314872|448302965|FG006|Period 2|Study terminated by Sponsor|0|||
124641217|NCT01314872|448302966|FG007|Period 2|Study terminated by Sponsor|0|||
124641218|NCT01314872|448302967|FG008|Period 2|Study terminated by Sponsor|0|||
124641219|NCT01314872|448302968|FG009|Period 2|Study terminated by Sponsor|0|||
124641220|NCT01314872|448302969|FG010|Period 2|Study terminated by Sponsor|0|||
124641221|NCT01314872|448302970|FG011|Period 2|Study terminated by Sponsor|2|||
124641222|NCT01314872|448302971|FG012|Period 2|Study terminated by Sponsor|2|||
124641223|NCT01314872|448302972|FG013|Period 2|Study terminated by Sponsor|3|||
124641224|NCT01314872|448302973|FG014|Period 2|Study terminated by Sponsor|0|||
124641225|NCT01314872|448302959|FG000|Period 2|Adverse event, non-fatal|0|||
124641226|NCT01314872|448302960|FG001|Period 2|Adverse event, non-fatal|0|||
124641227|NCT01314872|448302961|FG002|Period 2|Adverse event, non-fatal|0|||
124641228|NCT01314872|448302962|FG003|Period 2|Adverse event, non-fatal|0|||
124847078|NCT03013491|449064253|FG014|Main Study|Death|0|||
124847079|NCT03013491|449064254|FG015|Main Study|Death|3|||
124847080|NCT03013491|449064255|FG016|Main Study|Death|5|||
124847081|NCT03013491|449064256|FG017|Main Study|Death|1|||
124847082|NCT03013491|449064257|FG018|Main Study|Death|47|||
124847083|NCT03013491|449064239|FG000|Main Study|Lost to Follow-up|0|||
124847084|NCT03013491|449064240|FG001|Main Study|Lost to Follow-up|0|||
124847085|NCT03013491|449064241|FG002|Main Study|Lost to Follow-up|1|||
124847086|NCT03013491|449064242|FG003|Main Study|Lost to Follow-up|0|||
124847087|NCT03013491|449064243|FG004|Main Study|Lost to Follow-up|1|||
124847088|NCT03013491|449064244|FG005|Main Study|Lost to Follow-up|0|||
124847089|NCT03013491|449064245|FG006|Main Study|Lost to Follow-up|0|||
124847090|NCT03013491|449064246|FG007|Main Study|Lost to Follow-up|0|||
124847091|NCT03013491|449064247|FG008|Main Study|Lost to Follow-up|0|||
124847092|NCT03013491|449064248|FG009|Main Study|Lost to Follow-up|0|||
124847093|NCT03013491|449064249|FG010|Main Study|Lost to Follow-up|0|||
124641229|NCT01314872|448302963|FG004|Period 2|Adverse event, non-fatal|0|||
124641230|NCT01314872|448302964|FG005|Period 2|Adverse event, non-fatal|0|||
124641231|NCT01314872|448302965|FG006|Period 2|Adverse event, non-fatal|0|||
124641232|NCT01314872|448302966|FG007|Period 2|Adverse event, non-fatal|0|||
124641233|NCT01314872|448302967|FG008|Period 2|Adverse event, non-fatal|0|||
124641234|NCT01314872|448302968|FG009|Period 2|Adverse event, non-fatal|0|||
124641235|NCT01314872|448302969|FG010|Period 2|Adverse event, non-fatal|0|||
124641236|NCT01314872|448302970|FG011|Period 2|Adverse event, non-fatal|13|||
124641237|NCT01314872|448302971|FG012|Period 2|Adverse event, non-fatal|16|||
124641238|NCT01314872|448302972|FG013|Period 2|Adverse event, non-fatal|24|||
124641239|NCT01314872|448302973|FG014|Period 2|Adverse event, non-fatal|9|||
124641240|NCT01314872|448302959|FG000|Period 2|Withdrawal by Subject|0|||
124641241|NCT01314872|448302960|FG001|Period 2|Withdrawal by Subject|0|||
124847094|NCT03013491|449064250|FG011|Main Study|Lost to Follow-up|0|||
124847095|NCT03013491|449064251|FG012|Main Study|Lost to Follow-up|0|||
124641242|NCT01314872|448302961|FG002|Period 2|Withdrawal by Subject|0|||
124847096|NCT03013491|449064252|FG013|Main Study|Lost to Follow-up|0|||
124641243|NCT01314872|448302962|FG003|Period 2|Withdrawal by Subject|0|||
124641244|NCT01314872|448302963|FG004|Period 2|Withdrawal by Subject|0|||
124641245|NCT01314872|448302964|FG005|Period 2|Withdrawal by Subject|0|||
124641246|NCT01314872|448302965|FG006|Period 2|Withdrawal by Subject|0|||
124641247|NCT01314872|448302966|FG007|Period 2|Withdrawal by Subject|0|||
124847097|NCT03013491|449064253|FG014|Main Study|Lost to Follow-up|0|||
124847098|NCT03013491|449064254|FG015|Main Study|Lost to Follow-up|0|||
124847099|NCT03013491|449064255|FG016|Main Study|Lost to Follow-up|0|||
124847100|NCT03013491|449064256|FG017|Main Study|Lost to Follow-up|0|||
124847101|NCT03013491|449064257|FG018|Main Study|Lost to Follow-up|3|||
124847102|NCT03013491|449064239|FG000|Main Study|Termination of the study by Sponsor|0|||
124847103|NCT03013491|449064240|FG001|Main Study|Termination of the study by Sponsor|0|||
124847104|NCT03013491|449064241|FG002|Main Study|Termination of the study by Sponsor|2|||
124847105|NCT03013491|449064242|FG003|Main Study|Termination of the study by Sponsor|0|||
124847106|NCT03013491|449064243|FG004|Main Study|Termination of the study by Sponsor|1|||
124847107|NCT03013491|449064244|FG005|Main Study|Termination of the study by Sponsor|2|||
124847108|NCT03013491|449064245|FG006|Main Study|Termination of the study by Sponsor|0|||
124847109|NCT03013491|449064246|FG007|Main Study|Termination of the study by Sponsor|0|||
124847110|NCT03013491|449064247|FG008|Main Study|Termination of the study by Sponsor|1|||
124847111|NCT03013491|449064248|FG009|Main Study|Termination of the study by Sponsor|1|||
124847112|NCT03013491|449064249|FG010|Main Study|Termination of the study by Sponsor|1|||
124847113|NCT03013491|449064250|FG011|Main Study|Termination of the study by Sponsor|2|||
124847114|NCT03013491|449064251|FG012|Main Study|Termination of the study by Sponsor|0|||
124847115|NCT03013491|449064252|FG013|Main Study|Termination of the study by Sponsor|0|||
124847116|NCT03013491|449064253|FG014|Main Study|Termination of the study by Sponsor|0|||
124847117|NCT03013491|449064254|FG015|Main Study|Termination of the study by Sponsor|0|||
124847118|NCT03013491|449064255|FG016|Main Study|Termination of the study by Sponsor|0|||
124847119|NCT03013491|449064256|FG017|Main Study|Termination of the study by Sponsor|1|||
124847120|NCT03013491|449064257|FG018|Main Study|Termination of the study by Sponsor|13|||
124847121|NCT03013491|449064239|FG000|Main Study|Withdrawal by Subject|0|||
124847122|NCT03013491|449064240|FG001|Main Study|Withdrawal by Subject|0|||
124847123|NCT03013491|449064241|FG002|Main Study|Withdrawal by Subject|0|||
124847124|NCT03013491|449064242|FG003|Main Study|Withdrawal by Subject|4|||
124847125|NCT03013491|449064243|FG004|Main Study|Withdrawal by Subject|2|||
124847126|NCT03013491|449064244|FG005|Main Study|Withdrawal by Subject|1|||
124847127|NCT03013491|449064245|FG006|Main Study|Withdrawal by Subject|0|||
124847128|NCT03013491|449064246|FG007|Main Study|Withdrawal by Subject|0|||
124847129|NCT03013491|449064247|FG008|Main Study|Withdrawal by Subject|0|||
124847130|NCT03013491|449064248|FG009|Main Study|Withdrawal by Subject|0|||
124847131|NCT03013491|449064249|FG010|Main Study|Withdrawal by Subject|1|||
124847132|NCT03013491|449064250|FG011|Main Study|Withdrawal by Subject|2|||
124847133|NCT03013491|449064251|FG012|Main Study|Withdrawal by Subject|0|||
124847134|NCT03013491|449064252|FG013|Main Study|Withdrawal by Subject|2|||
124847135|NCT03013491|449064253|FG014|Main Study|Withdrawal by Subject|0|||
124847136|NCT03013491|449064254|FG015|Main Study|Withdrawal by Subject|0|||
124847137|NCT03013491|449064255|FG016|Main Study|Withdrawal by Subject|0|||
124847138|NCT03013491|449064256|FG017|Main Study|Withdrawal by Subject|0|||
124847139|NCT03013491|449064257|FG018|Main Study|Withdrawal by Subject|18|||
124847140|NCT03013491|449064239|FG000|Main Study|Disease progression|0|||
124847141|NCT03013491|449064240|FG001|Main Study|Disease progression|0|||
124847142|NCT03013491|449064241|FG002|Main Study|Disease progression|0|||
124847143|NCT03013491|449064242|FG003|Main Study|Disease progression|1|||
124847144|NCT03013491|449064243|FG004|Main Study|Disease progression|0|||
124847145|NCT03013491|449064244|FG005|Main Study|Disease progression|0|||
124847146|NCT03013491|449064245|FG006|Main Study|Disease progression|0|||
124847147|NCT03013491|449064246|FG007|Main Study|Disease progression|0|||
124847148|NCT03013491|449064247|FG008|Main Study|Disease progression|1|||
124847149|NCT03013491|449064248|FG009|Main Study|Disease progression|0|||
124847150|NCT03013491|449064249|FG010|Main Study|Disease progression|1|||
124847151|NCT03013491|449064250|FG011|Main Study|Disease progression|0|||
124847152|NCT03013491|449064251|FG012|Main Study|Disease progression|0|||
124847153|NCT03013491|449064252|FG013|Main Study|Disease progression|0|||
124847154|NCT03013491|449064253|FG014|Main Study|Disease progression|0|||
124847155|NCT03013491|449064254|FG015|Main Study|Disease progression|0|||
124847156|NCT03013491|449064255|FG016|Main Study|Disease progression|0|||
124847157|NCT03013491|449064256|FG017|Main Study|Disease progression|0|||
124847158|NCT03013491|449064257|FG018|Main Study|Disease progression|4|||
124847159|NCT03013491|449064239|FG000|Main Study|Symptomatic deterioration|0|||
124847160|NCT03013491|449064240|FG001|Main Study|Symptomatic deterioration|0|||
124847161|NCT03013491|449064241|FG002|Main Study|Symptomatic deterioration|0|||
124847162|NCT03013491|449064242|FG003|Main Study|Symptomatic deterioration|0|||
124847163|NCT03013491|449064243|FG004|Main Study|Symptomatic deterioration|0|||
124847164|NCT03013491|449064244|FG005|Main Study|Symptomatic deterioration|1|||
124847165|NCT03013491|449064245|FG006|Main Study|Symptomatic deterioration|0|||
124847166|NCT03013491|449064246|FG007|Main Study|Symptomatic deterioration|0|||
124847167|NCT03013491|449064247|FG008|Main Study|Symptomatic deterioration|0|||
124847168|NCT03013491|449064248|FG009|Main Study|Symptomatic deterioration|0|||
124847169|NCT03013491|449064249|FG010|Main Study|Symptomatic deterioration|0|||
124847170|NCT03013491|449064250|FG011|Main Study|Symptomatic deterioration|0|||
124847171|NCT03013491|449064251|FG012|Main Study|Symptomatic deterioration|0|||
124847172|NCT03013491|449064252|FG013|Main Study|Symptomatic deterioration|0|||
124847173|NCT03013491|449064253|FG014|Main Study|Symptomatic deterioration|0|||
124847174|NCT03013491|449064254|FG015|Main Study|Symptomatic deterioration|0|||
124641248|NCT01314872|448302967|FG008|Period 2|Withdrawal by Subject|0|||
124641249|NCT01314872|448302968|FG009|Period 2|Withdrawal by Subject|0|||
124641250|NCT01314872|448302969|FG010|Period 2|Withdrawal by Subject|0|||
124641251|NCT01314872|448302970|FG011|Period 2|Withdrawal by Subject|14|||
124641252|NCT01314872|448302971|FG012|Period 2|Withdrawal by Subject|17|||
124641253|NCT01314872|448302972|FG013|Period 2|Withdrawal by Subject|12|||
124641254|NCT01314872|448302973|FG014|Period 2|Withdrawal by Subject|4|||
124641255|NCT01314872|448302959|FG000|Period 2|Lost to Follow-up|0|||
124641256|NCT01314872|448302960|FG001|Period 2|Lost to Follow-up|0|||
124641257|NCT01314872|448302961|FG002|Period 2|Lost to Follow-up|0|||
124641258|NCT01314872|448302962|FG003|Period 2|Lost to Follow-up|0|||
124641259|NCT01314872|448302963|FG004|Period 2|Lost to Follow-up|0|||
124641260|NCT01314872|448302964|FG005|Period 2|Lost to Follow-up|0|||
124641261|NCT01314872|448302965|FG006|Period 2|Lost to Follow-up|0|||
124641262|NCT01314872|448302966|FG007|Period 2|Lost to Follow-up|0|||
124641263|NCT01314872|448302967|FG008|Period 2|Lost to Follow-up|0|||
124641264|NCT01314872|448302968|FG009|Period 2|Lost to Follow-up|0|||
124641265|NCT01314872|448302969|FG010|Period 2|Lost to Follow-up|0|||
124641266|NCT01314872|448302970|FG011|Period 2|Lost to Follow-up|6|||
124641267|NCT01314872|448302971|FG012|Period 2|Lost to Follow-up|7|||
124641268|NCT01314872|448302972|FG013|Period 2|Lost to Follow-up|2|||
124641269|NCT01314872|448302973|FG014|Period 2|Lost to Follow-up|6|||
124641270|NCT03232931|448304375|FG000|Overall Study|Physician Decision|1|||
124641271|NCT03232931|448304376|FG001|Overall Study|Physician Decision|1|||
124641272|NCT03232931|448304375|FG000|Overall Study|Withdrawal by Subject|6|||
124641273|NCT03232931|448304376|FG001|Overall Study|Withdrawal by Subject|0|||
124641274|NCT03232931|448304375|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
124641275|NCT03232931|448304376|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
124641276|NCT03232931|448304375|FG000|Overall Study|Parent did not record voice|1|||
124641277|NCT03232931|448304376|FG001|Overall Study|Parent did not record voice|2|||
124641278|NCT03232931|448304375|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
124641279|NCT03232931|448304376|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
124641280|NCT04925557|448304377|FG000|Overall Study|Study closed|5|||
124641281|NCT04925557|448304378|FG001|Overall Study|Study closed|3|||
124641282|NCT05488470|448304379|FG000|Overall Study|Physician Decision|2|||
124641283|NCT05488470|448304379|FG000|Overall Study|Withdrawal by Subject|1|||
124641284|NCT05488470|448304379|FG000|Overall Study|Death|1|||
124641285|NCT00068393|448304384|FG000|Overall Study|Adverse Event|2|||
124641286|NCT00068393|448304384|FG000|Overall Study|Death|3|||
124641287|NCT00068393|448304384|FG000|Overall Study|Withdrawal by Subject|3|||
124641288|NCT00068393|448304384|FG000|Overall Study|Alternative treatment|1|||
124641289|NCT00068393|448304384|FG000|Overall Study|Quality of life worsening|1|||
124641290|NCT04981470|448304389|FG000|Overall Study|Device failure in all 4 patients|4|||
124641291|NCT04390503|448304391|FG000|Overall Study|Physician Decision|2|||
124641292|NCT04390503|448304392|FG001|Overall Study|Physician Decision|1|||
124641293|NCT04390503|448304391|FG000|Overall Study|Adverse Event|1|||
124641294|NCT04390503|448304392|FG001|Overall Study|Adverse Event|0|||
124641295|NCT00593684|448304394|FG000|Overall Study|Death|2|||
124641296|NCT00593684|448304395|FG001|Overall Study|Death|1|||
124641297|NCT00734162|448304396|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
124641298|NCT00734162|448304397|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
124641299|NCT00734162|448304398|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
124641300|NCT00734162|448304399|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
124641301|NCT00734162|448304396|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
124641302|NCT00734162|448304397|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
124641303|NCT00734162|448304398|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
124641304|NCT00734162|448304399|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
124641305|NCT00734162|448304396|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
124641306|NCT00734162|448304397|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
124641307|NCT00734162|448304398|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
124641308|NCT00734162|448304399|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
124641309|NCT00734162|448304396|FG000|Open-Label Phase|Withdrew Consent|1|||
124641310|NCT00734162|448304397|FG001|Open-Label Phase|Withdrew Consent|0|||
124641311|NCT00734162|448304398|FG002|Open-Label Phase|Withdrew Consent|1|||
124641312|NCT00734162|448304399|FG003|Open-Label Phase|Withdrew Consent|1|||
124641313|NCT00734162|448304396|FG000|Open-Label Phase|Lost to Follow-up|1|||
124641314|NCT00734162|448304397|FG001|Open-Label Phase|Lost to Follow-up|2|||
124641315|NCT00734162|448304398|FG002|Open-Label Phase|Lost to Follow-up|0|||
124641316|NCT00734162|448304399|FG003|Open-Label Phase|Lost to Follow-up|1|||
124641317|NCT00734162|448304396|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
124641318|NCT00734162|448304397|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
124641319|NCT00734162|448304398|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
124641320|NCT00734162|448304399|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
124641321|NCT00596687|448304402|FG000|Overall Study|< 24 hours of insulin treatment|8|||
124641322|NCT00596687|448304403|FG001|Overall Study|< 24 hours of insulin treatment|6|||
124641323|NCT00596687|448304402|FG000|Overall Study|continuous insulin infusion during TPN|2|||
124641324|NCT00596687|448304403|FG001|Overall Study|continuous insulin infusion during TPN|1|||
124641325|NCT00596687|448304402|FG000|Overall Study|Withdrawal by Subject|3|||
124641326|NCT00596687|448304403|FG001|Overall Study|Withdrawal by Subject|1|||
124641327|NCT00596687|448304402|FG000|Overall Study|cancelled surgery|1|||
124641328|NCT00596687|448304403|FG001|Overall Study|cancelled surgery|1|||
124641329|NCT01270464|448304406|FG000|Overall Study|Protocol Violation|4|||
124641330|NCT01270464|448304407|FG001|Overall Study|Protocol Violation|3|||
124641331|NCT01270464|448304408|FG002|Overall Study|Protocol Violation|2|||
124641332|NCT01270464|448304406|FG000|Overall Study|Lack of Efficacy|2|||
124641333|NCT01270464|448304407|FG001|Overall Study|Lack of Efficacy|3|||
124641334|NCT01270464|448304408|FG002|Overall Study|Lack of Efficacy|1|||
124641335|NCT01270464|448304406|FG000|Overall Study|Adverse Event|9|||
124641336|NCT01270464|448304407|FG001|Overall Study|Adverse Event|1|||
124641337|NCT01270464|448304408|FG002|Overall Study|Adverse Event|7|||
124641338|NCT01270464|448304406|FG000|Overall Study|Withdrawal by Subject|2|||
124641339|NCT01270464|448304407|FG001|Overall Study|Withdrawal by Subject|1|||
124641340|NCT01270464|448304408|FG002|Overall Study|Withdrawal by Subject|4|||
124641341|NCT01270464|448304406|FG000|Overall Study|Lost to Follow-up|2|||
124641342|NCT01270464|448304407|FG001|Overall Study|Lost to Follow-up|3|||
124641343|NCT01270464|448304408|FG002|Overall Study|Lost to Follow-up|1|||
124641344|NCT01270464|448304406|FG000|Overall Study|Other|1|||
124641345|NCT01270464|448304407|FG001|Overall Study|Other|1|||
124641346|NCT01270464|448304408|FG002|Overall Study|Other|3|||
124641347|NCT04725812|448304410|FG000|Overall Study|Withdrawal by Subject|1|||
124641348|NCT03969901|448304413|FG000|Overall Study|Withdrawal by parent/guardian|0|||
124641349|NCT03969901|448304414|FG001|Overall Study|Withdrawal by parent/guardian|0|||
124641350|NCT03969901|448304415|FG002|Overall Study|Withdrawal by parent/guardian|0|||
124641351|NCT03969901|448304416|FG003|Overall Study|Withdrawal by parent/guardian|0|||
124641352|NCT03969901|448304417|FG004|Overall Study|Withdrawal by parent/guardian|1|||
124641353|NCT03969901|448304418|FG005|Overall Study|Withdrawal by parent/guardian|0|||
124641354|NCT03969901|448304419|FG006|Overall Study|Withdrawal by parent/guardian|0|||
124641355|NCT03969901|448304420|FG007|Overall Study|Withdrawal by parent/guardian|1|||
124641356|NCT03969901|448304421|FG008|Overall Study|Withdrawal by parent/guardian|1|||
124641357|NCT03969901|448304422|FG009|Overall Study|Withdrawal by parent/guardian|0|||
124641358|NCT02589626|448304429|FG000|Overall Study|Other than the reason specified|1|||
124641359|NCT02589626|448304430|FG001|Overall Study|Other than the reason specified|0|||
124641360|NCT02589626|448304429|FG000|Overall Study|Withdrawal by Subject|1|||
124641361|NCT02589626|448304430|FG001|Overall Study|Withdrawal by Subject|1|||
124641362|NCT02589626|448304429|FG000|Overall Study|Adverse Event|1|||
124641363|NCT02589626|448304430|FG001|Overall Study|Adverse Event|1|||
124641364|NCT02564900|448304431|FG000|Dose Escalation|Progressive disease per RECIST|2|||
124847175|NCT03013491|449064255|FG016|Main Study|Symptomatic deterioration|0|||
124847176|NCT03013491|449064256|FG017|Main Study|Symptomatic deterioration|0|||
124847177|NCT03013491|449064257|FG018|Main Study|Symptomatic deterioration|0|||
124847178|NCT03013491|449064239|FG000|Main Study|Protocol version 8.0 approval|0|||
124847179|NCT03013491|449064240|FG001|Main Study|Protocol version 8.0 approval|0|||
124847180|NCT03013491|449064241|FG002|Main Study|Protocol version 8.0 approval|0|||
124847181|NCT03013491|449064242|FG003|Main Study|Protocol version 8.0 approval|0|||
124847182|NCT03013491|449064243|FG004|Main Study|Protocol version 8.0 approval|0|||
124847183|NCT03013491|449064244|FG005|Main Study|Protocol version 8.0 approval|0|||
124847184|NCT03013491|449064245|FG006|Main Study|Protocol version 8.0 approval|0|||
124641365|NCT02564900|448304432|FG001|Dose Escalation|Progressive disease per RECIST|3|||
124641366|NCT02564900|448304433|FG002|Dose Escalation|Progressive disease per RECIST|3|||
124641367|NCT02564900|448304434|FG003|Dose Escalation|Progressive disease per RECIST|3|||
124641368|NCT02564900|448304435|FG004|Dose Escalation|Progressive disease per RECIST|3|||
124641369|NCT02564900|448304436|FG005|Dose Escalation|Progressive disease per RECIST|1|||
124641370|NCT02564900|448304437|FG006|Dose Escalation|Progressive disease per RECIST|0|||
124641371|NCT02564900|448304438|FG007|Dose Escalation|Progressive disease per RECIST|0|||
124641372|NCT02564900|448304439|FG008|Dose Escalation|Progressive disease per RECIST|0|||
124641373|NCT02564900|448304440|FG009|Dose Escalation|Progressive disease per RECIST|0|||
124641374|NCT02564900|448304441|FG010|Dose Escalation|Progressive disease per RECIST|0|||
124641375|NCT02564900|448304442|FG011|Dose Escalation|Progressive disease per RECIST|0|||
124847185|NCT03013491|449064246|FG007|Main Study|Protocol version 8.0 approval|0|||
124641376|NCT02564900|448304443|FG012|Dose Escalation|Progressive disease per RECIST|0|||
124641377|NCT02564900|448304444|FG013|Dose Escalation|Progressive disease per RECIST|0|||
124641378|NCT02564900|448304445|FG014|Dose Escalation|Progressive disease per RECIST|0|||
124641379|NCT02564900|448304431|FG000|Dose Escalation|Ongoing|1|||
124847186|NCT03013491|449064247|FG008|Main Study|Protocol version 8.0 approval|0|||
124641380|NCT02564900|448304432|FG001|Dose Escalation|Ongoing|0|||
124641381|NCT02564900|448304433|FG002|Dose Escalation|Ongoing|0|||
124641382|NCT02564900|448304434|FG003|Dose Escalation|Ongoing|2|||
124641383|NCT02564900|448304435|FG004|Dose Escalation|Ongoing|2|||
124641384|NCT02564900|448304436|FG005|Dose Escalation|Ongoing|2|||
124641385|NCT02564900|448304437|FG006|Dose Escalation|Ongoing|0|||
124641386|NCT02564900|448304438|FG007|Dose Escalation|Ongoing|0|||
124641387|NCT02564900|448304439|FG008|Dose Escalation|Ongoing|0|||
124641388|NCT02564900|448304440|FG009|Dose Escalation|Ongoing|0|||
124641389|NCT02564900|448304441|FG010|Dose Escalation|Ongoing|0|||
124641390|NCT02564900|448304442|FG011|Dose Escalation|Ongoing|0|||
124641391|NCT02564900|448304443|FG012|Dose Escalation|Ongoing|0|||
124641392|NCT02564900|448304444|FG013|Dose Escalation|Ongoing|0|||
124641393|NCT02564900|448304445|FG014|Dose Escalation|Ongoing|0|||
124641394|NCT02564900|448304431|FG000|Dose Escalation|Adverse Event|0|||
124641395|NCT02564900|448304432|FG001|Dose Escalation|Adverse Event|0|||
124641396|NCT02564900|448304433|FG002|Dose Escalation|Adverse Event|0|||
124641397|NCT02564900|448304434|FG003|Dose Escalation|Adverse Event|1|||
124641398|NCT02564900|448304435|FG004|Dose Escalation|Adverse Event|1|||
124641399|NCT02564900|448304436|FG005|Dose Escalation|Adverse Event|3|||
124641400|NCT02564900|448304437|FG006|Dose Escalation|Adverse Event|0|||
124641401|NCT02564900|448304438|FG007|Dose Escalation|Adverse Event|0|||
124641402|NCT02564900|448304439|FG008|Dose Escalation|Adverse Event|0|||
124641403|NCT02564900|448304440|FG009|Dose Escalation|Adverse Event|0|||
124641404|NCT02564900|448304441|FG010|Dose Escalation|Adverse Event|0|||
124641405|NCT02564900|448304442|FG011|Dose Escalation|Adverse Event|0|||
124641406|NCT02564900|448304443|FG012|Dose Escalation|Adverse Event|0|||
124641407|NCT02564900|448304444|FG013|Dose Escalation|Adverse Event|0|||
124641408|NCT02564900|448304445|FG014|Dose Escalation|Adverse Event|0|||
124641409|NCT02564900|448304431|FG000|Dose Expansion|Progressive disease per RECIST|0|||
124641410|NCT02564900|448304432|FG001|Dose Expansion|Progressive disease per RECIST|0|||
124641411|NCT02564900|448304433|FG002|Dose Expansion|Progressive disease per RECIST|0|||
124641412|NCT02564900|448304434|FG003|Dose Expansion|Progressive disease per RECIST|0|||
124641413|NCT02564900|448304435|FG004|Dose Expansion|Progressive disease per RECIST|0|||
124641414|NCT02564900|448304436|FG005|Dose Expansion|Progressive disease per RECIST|0|||
124641415|NCT02564900|448304437|FG006|Dose Expansion|Progressive disease per RECIST|19|||
124641416|NCT02564900|448304438|FG007|Dose Expansion|Progressive disease per RECIST|17|||
124641417|NCT02564900|448304439|FG008|Dose Expansion|Progressive disease per RECIST|8|||
124641418|NCT02564900|448304440|FG009|Dose Expansion|Progressive disease per RECIST|16|||
124641419|NCT02564900|448304441|FG010|Dose Expansion|Progressive disease per RECIST|13|||
124641420|NCT02564900|448304442|FG011|Dose Expansion|Progressive disease per RECIST|19|||
124641421|NCT02564900|448304443|FG012|Dose Expansion|Progressive disease per RECIST|10|||
124641422|NCT02564900|448304444|FG013|Dose Expansion|Progressive disease per RECIST|13|||
124641423|NCT02564900|448304445|FG014|Dose Expansion|Progressive disease per RECIST|11|||
124641424|NCT02564900|448304431|FG000|Dose Expansion|Clinical progression|0|||
124641425|NCT02564900|448304432|FG001|Dose Expansion|Clinical progression|0|||
124641426|NCT02564900|448304433|FG002|Dose Expansion|Clinical progression|0|||
124641427|NCT02564900|448304434|FG003|Dose Expansion|Clinical progression|0|||
124641428|NCT02564900|448304435|FG004|Dose Expansion|Clinical progression|0|||
124641429|NCT02564900|448304436|FG005|Dose Expansion|Clinical progression|0|||
124641430|NCT02564900|448304437|FG006|Dose Expansion|Clinical progression|5|||
124641431|NCT02564900|448304438|FG007|Dose Expansion|Clinical progression|12|||
124641432|NCT02564900|448304439|FG008|Dose Expansion|Clinical progression|0|||
124641433|NCT02564900|448304440|FG009|Dose Expansion|Clinical progression|3|||
124641434|NCT02564900|448304441|FG010|Dose Expansion|Clinical progression|2|||
124641435|NCT02564900|448304442|FG011|Dose Expansion|Clinical progression|0|||
124641436|NCT02564900|448304443|FG012|Dose Expansion|Clinical progression|1|||
124641437|NCT02564900|448304444|FG013|Dose Expansion|Clinical progression|3|||
124641438|NCT02564900|448304445|FG014|Dose Expansion|Clinical progression|1|||
124641439|NCT02564900|448304431|FG000|Dose Expansion|Adverse Event|0|||
124641440|NCT02564900|448304432|FG001|Dose Expansion|Adverse Event|0|||
124641441|NCT02564900|448304433|FG002|Dose Expansion|Adverse Event|0|||
124641442|NCT02564900|448304434|FG003|Dose Expansion|Adverse Event|0|||
124641443|NCT02564900|448304435|FG004|Dose Expansion|Adverse Event|0|||
124641444|NCT02564900|448304436|FG005|Dose Expansion|Adverse Event|0|||
124641445|NCT02564900|448304437|FG006|Dose Expansion|Adverse Event|9|||
124641446|NCT02564900|448304438|FG007|Dose Expansion|Adverse Event|22|||
124641447|NCT02564900|448304439|FG008|Dose Expansion|Adverse Event|0|||
124847187|NCT03013491|449064248|FG009|Main Study|Protocol version 8.0 approval|0|||
124847188|NCT03013491|449064249|FG010|Main Study|Protocol version 8.0 approval|1|||
124641448|NCT02564900|448304440|FG009|Dose Expansion|Adverse Event|11|||
124847189|NCT03013491|449064250|FG011|Main Study|Protocol version 8.0 approval|0|||
124641449|NCT02564900|448304441|FG010|Dose Expansion|Adverse Event|0|||
124641450|NCT02564900|448304442|FG011|Dose Expansion|Adverse Event|5|||
124641451|NCT02564900|448304443|FG012|Dose Expansion|Adverse Event|2|||
124641452|NCT02564900|448304444|FG013|Dose Expansion|Adverse Event|2|||
124641453|NCT02564900|448304445|FG014|Dose Expansion|Adverse Event|1|||
124641454|NCT02564900|448304431|FG000|Dose Expansion|Ongoing|0|||
124641455|NCT02564900|448304432|FG001|Dose Expansion|Ongoing|0|||
124641456|NCT02564900|448304433|FG002|Dose Expansion|Ongoing|0|||
124641457|NCT02564900|448304434|FG003|Dose Expansion|Ongoing|0|||
124641458|NCT02564900|448304435|FG004|Dose Expansion|Ongoing|0|||
124641459|NCT02564900|448304436|FG005|Dose Expansion|Ongoing|0|||
124641460|NCT02564900|448304437|FG006|Dose Expansion|Ongoing|9|||
124641461|NCT02564900|448304438|FG007|Dose Expansion|Ongoing|10|||
124641462|NCT02564900|448304439|FG008|Dose Expansion|Ongoing|11|||
124641463|NCT02564900|448304440|FG009|Dose Expansion|Ongoing|3|||
124641464|NCT02564900|448304441|FG010|Dose Expansion|Ongoing|0|||
124641465|NCT02564900|448304442|FG011|Dose Expansion|Ongoing|0|||
124641466|NCT02564900|448304443|FG012|Dose Expansion|Ongoing|4|||
124641467|NCT02564900|448304444|FG013|Dose Expansion|Ongoing|0|||
124641468|NCT02564900|448304445|FG014|Dose Expansion|Ongoing|6|||
124641469|NCT02564900|448304431|FG000|Dose Expansion|Death|0|||
124641470|NCT02564900|448304432|FG001|Dose Expansion|Death|0|||
124641471|NCT02564900|448304433|FG002|Dose Expansion|Death|0|||
124641472|NCT02564900|448304434|FG003|Dose Expansion|Death|0|||
124641473|NCT02564900|448304435|FG004|Dose Expansion|Death|0|||
124641474|NCT02564900|448304436|FG005|Dose Expansion|Death|0|||
124641475|NCT02564900|448304437|FG006|Dose Expansion|Death|1|||
124641476|NCT02564900|448304438|FG007|Dose Expansion|Death|0|||
124641477|NCT02564900|448304439|FG008|Dose Expansion|Death|0|||
124641478|NCT02564900|448304440|FG009|Dose Expansion|Death|0|||
124641479|NCT02564900|448304441|FG010|Dose Expansion|Death|1|||
124641480|NCT02564900|448304442|FG011|Dose Expansion|Death|0|||
124641481|NCT02564900|448304443|FG012|Dose Expansion|Death|1|||
124641482|NCT02564900|448304444|FG013|Dose Expansion|Death|1|||
124641483|NCT02564900|448304445|FG014|Dose Expansion|Death|0|||
124641484|NCT02564900|448304431|FG000|Dose Expansion|Withdrawal by Subject|0|||
124641485|NCT02564900|448304432|FG001|Dose Expansion|Withdrawal by Subject|0|||
124641486|NCT02564900|448304433|FG002|Dose Expansion|Withdrawal by Subject|0|||
124641487|NCT02564900|448304434|FG003|Dose Expansion|Withdrawal by Subject|0|||
124641488|NCT02564900|448304435|FG004|Dose Expansion|Withdrawal by Subject|0|||
124641489|NCT02564900|448304436|FG005|Dose Expansion|Withdrawal by Subject|0|||
124641490|NCT02564900|448304437|FG006|Dose Expansion|Withdrawal by Subject|4|||
124641491|NCT02564900|448304438|FG007|Dose Expansion|Withdrawal by Subject|0|||
124641492|NCT02564900|448304439|FG008|Dose Expansion|Withdrawal by Subject|0|||
124641493|NCT02564900|448304440|FG009|Dose Expansion|Withdrawal by Subject|0|||
124641494|NCT02564900|448304441|FG010|Dose Expansion|Withdrawal by Subject|1|||
124641495|NCT02564900|448304442|FG011|Dose Expansion|Withdrawal by Subject|0|||
124641496|NCT02564900|448304443|FG012|Dose Expansion|Withdrawal by Subject|0|||
124641497|NCT02564900|448304444|FG013|Dose Expansion|Withdrawal by Subject|1|||
124641498|NCT02564900|448304445|FG014|Dose Expansion|Withdrawal by Subject|1|||
124641499|NCT02564900|448304431|FG000|Dose Expansion|Other|0|||
124641500|NCT02564900|448304432|FG001|Dose Expansion|Other|0|||
124641501|NCT02564900|448304433|FG002|Dose Expansion|Other|0|||
124641502|NCT02564900|448304434|FG003|Dose Expansion|Other|0|||
124641503|NCT02564900|448304435|FG004|Dose Expansion|Other|0|||
124641504|NCT02564900|448304436|FG005|Dose Expansion|Other|0|||
124641505|NCT02564900|448304437|FG006|Dose Expansion|Other|1|||
124641506|NCT02564900|448304438|FG007|Dose Expansion|Other|0|||
124641507|NCT02564900|448304439|FG008|Dose Expansion|Other|1|||
124641508|NCT02564900|448304440|FG009|Dose Expansion|Other|0|||
124641509|NCT02564900|448304441|FG010|Dose Expansion|Other|0|||
124641510|NCT02564900|448304442|FG011|Dose Expansion|Other|0|||
124641511|NCT02564900|448304443|FG012|Dose Expansion|Other|0|||
124641512|NCT02564900|448304444|FG013|Dose Expansion|Other|0|||
124641513|NCT02564900|448304445|FG014|Dose Expansion|Other|1|||
124641514|NCT02564900|448304431|FG000|Dose Expansion|Did not receive treatment|0|||
124641515|NCT02564900|448304432|FG001|Dose Expansion|Did not receive treatment|0|||
124641516|NCT02564900|448304433|FG002|Dose Expansion|Did not receive treatment|0|||
124641517|NCT02564900|448304434|FG003|Dose Expansion|Did not receive treatment|0|||
124641518|NCT02564900|448304435|FG004|Dose Expansion|Did not receive treatment|0|||
124641519|NCT02564900|448304436|FG005|Dose Expansion|Did not receive treatment|0|||
124641520|NCT02564900|448304437|FG006|Dose Expansion|Did not receive treatment|1|||
124641521|NCT02564900|448304438|FG007|Dose Expansion|Did not receive treatment|1|||
124641522|NCT02564900|448304439|FG008|Dose Expansion|Did not receive treatment|0|||
124641523|NCT02564900|448304440|FG009|Dose Expansion|Did not receive treatment|0|||
124641524|NCT02564900|448304441|FG010|Dose Expansion|Did not receive treatment|0|||
124641525|NCT02564900|448304442|FG011|Dose Expansion|Did not receive treatment|0|||
124641526|NCT02564900|448304443|FG012|Dose Expansion|Did not receive treatment|0|||
124641527|NCT02564900|448304444|FG013|Dose Expansion|Did not receive treatment|0|||
124641528|NCT02564900|448304445|FG014|Dose Expansion|Did not receive treatment|1|||
124641529|NCT00892151|448304446|FG000|Overall Study|Protocol Violation|1|||
124641530|NCT00930774|448304451|FG000|Overall Study|Withdrawal by Subject|1|||
124641531|NCT00930774|448304452|FG001|Overall Study|Withdrawal by Subject|9|||
124641532|NCT00930774|448304453|FG002|Overall Study|Withdrawal by Subject|2|||
124641533|NCT00930774|448304454|FG003|Overall Study|Withdrawal by Subject|0|||
124641534|NCT01680861|448304455|FG000|Early Post-transplant Period|Protocol Violation|1|||
124641535|NCT01680861|448304456|FG001|Early Post-transplant Period|Protocol Violation|1|||
124641536|NCT01940887|448304459|FG000|Year 1|Protocol Violation|0|||
124641537|NCT01940887|448304460|FG001|Year 1|Protocol Violation|1|||
124641538|NCT01940887|448304459|FG000|Year 1|Physician Decision|7|||
124641539|NCT01940887|448304460|FG001|Year 1|Physician Decision|3|||
124641540|NCT01940887|448304459|FG000|Year 1|Death|5|||
124641541|NCT01940887|448304460|FG001|Year 1|Death|3|||
124641542|NCT01940887|448304459|FG000|Year 1|Adverse Event|7|||
124641543|NCT01940887|448304460|FG001|Year 1|Adverse Event|6|||
124641544|NCT01940887|448304459|FG000|Year 1|Withdrawal by Subject|18|||
124641545|NCT01940887|448304460|FG001|Year 1|Withdrawal by Subject|9|||
124641546|NCT01940887|448304459|FG000|Year 1|Lost to Follow-up|2|||
124641547|NCT01940887|448304460|FG001|Year 1|Lost to Follow-up|1|||
124641548|NCT01940887|448304459|FG000|Year 2|Physician Decision|8|||
124641549|NCT01940887|448304460|FG001|Year 2|Physician Decision|1|||
124641550|NCT01940887|448304459|FG000|Year 2|Death|0|||
124641551|NCT01940887|448304460|FG001|Year 2|Death|2|||
124641552|NCT01940887|448304459|FG000|Year 2|Sponsor Decision, early termination|192|||
124641553|NCT01940887|448304460|FG001|Year 2|Sponsor Decision, early termination|203|||
124641554|NCT01940887|448304459|FG000|Year 2|Adverse Event|8|||
124641555|NCT01940887|448304460|FG001|Year 2|Adverse Event|2|||
124641556|NCT01940887|448304459|FG000|Year 2|Withdrawal by Subject|8|||
124641557|NCT01940887|448304460|FG001|Year 2|Withdrawal by Subject|8|||
124641558|NCT01940887|448304459|FG000|Year 2|Lost to Follow-up|1|||
124641559|NCT01940887|448304460|FG001|Year 2|Lost to Follow-up|6|||
124641560|NCT02475265|448304463|FG000|Overall Study|Physician Decision|1|||
124641561|NCT02475265|448304463|FG000|Overall Study|Withdrawal by Subject|2|||
124641562|NCT01598090|448304464|FG000|Treatment Period|Poor/non-compliance|0|||
124641563|NCT01598090|448304465|FG001|Treatment Period|Poor/non-compliance|2|||
124641564|NCT01598090|448304466|FG002|Treatment Period|Poor/non-compliance|0|||
124641565|NCT01598090|448304464|FG000|Treatment Period|No longer meet study criteria|0|||
124641566|NCT01598090|448304465|FG001|Treatment Period|No longer meet study criteria|1|||
124641567|NCT01598090|448304466|FG002|Treatment Period|No longer meet study criteria|0|||
124641568|NCT01598090|448304464|FG000|Treatment Period|Lack of Efficacy|5|||
124641569|NCT01598090|448304465|FG001|Treatment Period|Lack of Efficacy|14|||
124641570|NCT01598090|448304466|FG002|Treatment Period|Lack of Efficacy|6|||
124641571|NCT01598090|448304464|FG000|Treatment Period|Adverse Event|2|||
124641572|NCT01598090|448304465|FG001|Treatment Period|Adverse Event|33|||
124641573|NCT01598090|448304466|FG002|Treatment Period|Adverse Event|17|||
124641574|NCT01598090|448304464|FG000|Treatment Period|Other reasons|0|||
124641575|NCT01598090|448304465|FG001|Treatment Period|Other reasons|4|||
124641576|NCT01598090|448304466|FG002|Treatment Period|Other reasons|1|||
124641577|NCT01598090|448304464|FG000|Treatment Period|Withdrawal by Subject|3|||
124641578|NCT01598090|448304465|FG001|Treatment Period|Withdrawal by Subject|13|||
124641579|NCT01598090|448304466|FG002|Treatment Period|Withdrawal by Subject|10|||
124641580|NCT01598090|448304464|FG000|Treatment Period|Lost to Follow-up|1|||
124641581|NCT01598090|448304465|FG001|Treatment Period|Lost to Follow-up|5|||
124641582|NCT01598090|448304466|FG002|Treatment Period|Lost to Follow-up|1|||
124641583|NCT01598090|448304464|FG000|Follow-up Period|Death|0|||
124641584|NCT01598090|448304465|FG001|Follow-up Period|Death|1|||
124641585|NCT01598090|448304466|FG002|Follow-up Period|Death|0|||
124641586|NCT01598090|448304464|FG000|Follow-up Period|No longer required per protocol|1|||
124641587|NCT01598090|448304465|FG001|Follow-up Period|No longer required per protocol|3|||
124641588|NCT01598090|448304466|FG002|Follow-up Period|No longer required per protocol|2|||
124641589|NCT01598090|448304464|FG000|Follow-up Period|Not reported|0|||
124641590|NCT01598090|448304465|FG001|Follow-up Period|Not reported|10|||
124641591|NCT01598090|448304466|FG002|Follow-up Period|Not reported|4|||
124641592|NCT01598090|448304464|FG000|Follow-up Period|Withdrawal by Subject|0|||
124641593|NCT01598090|448304465|FG001|Follow-up Period|Withdrawal by Subject|3|||
124641594|NCT01598090|448304466|FG002|Follow-up Period|Withdrawal by Subject|2|||
124641595|NCT01598090|448304464|FG000|Follow-up Period|Other reasons|2|||
124641596|NCT01598090|448304465|FG001|Follow-up Period|Other reasons|8|||
124641597|NCT01598090|448304466|FG002|Follow-up Period|Other reasons|8|||
124641598|NCT01598090|448304464|FG000|Follow-up Period|Lost to Follow-up|2|||
124641599|NCT01598090|448304465|FG001|Follow-up Period|Lost to Follow-up|10|||
124641600|NCT01598090|448304466|FG002|Follow-up Period|Lost to Follow-up|12|||
124641601|NCT04087720|448304476|FG000|Overall Study|Withdrawal by Subject|2|||
124641602|NCT04087720|448304476|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
124641603|NCT00520533|448304479|FG000|Overall Study|Death|1|||
124641604|NCT00520533|448304479|FG000|Overall Study|Suspension of the study for safety reasons|1|||
124641605|NCT00520533|448304479|FG000|Overall Study|Withdrawal by Subject|1|||
124641606|NCT00520533|448304479|FG000|Overall Study|Physician Decision|1|||
124641607|NCT02438826|448304480|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
124641608|NCT02438826|448304481|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
124641609|NCT02438826|448304482|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
124641610|NCT02438826|448304483|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
124641611|NCT02438826|448304480|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
124641612|NCT02438826|448304481|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
124641613|NCT02438826|448304482|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
124641614|NCT02438826|448304483|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
124641615|NCT02438826|448304480|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
124641616|NCT02438826|448304481|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
124641617|NCT02438826|448304482|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
124641618|NCT02438826|448304483|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
124641619|NCT02438826|448304480|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
124641620|NCT02438826|448304481|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
124641621|NCT02438826|448304482|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
124641622|NCT02438826|448304483|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
124641623|NCT02438826|448304480|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
124641624|NCT02438826|448304481|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
124641625|NCT02438826|448304482|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
124641626|NCT02438826|448304483|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
124641627|NCT02438826|448304480|FG000|Open-Label Treatment Phase|Adverse Event|11|||
124641628|NCT02438826|448304481|FG001|Open-Label Treatment Phase|Adverse Event|6|||
124641629|NCT02438826|448304482|FG002|Open-Label Treatment Phase|Adverse Event|0|||
124641630|NCT02438826|448304483|FG003|Open-Label Treatment Phase|Adverse Event|0|||
124641631|NCT02438826|448304480|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
124641632|NCT02438826|448304481|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
124641633|NCT02438826|448304482|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
124641634|NCT02438826|448304483|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
124641635|NCT02438826|448304480|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
124641636|NCT02438826|448304481|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
124641637|NCT02438826|448304482|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
124641638|NCT02438826|448304483|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
124641639|NCT02438826|448304480|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
124641640|NCT02438826|448304481|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
124641641|NCT02438826|448304482|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
124641642|NCT02438826|448304483|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
124641643|NCT02438826|448304480|FG000|Post-Treatment Phase|Adverse Event|3|||
124641644|NCT02438826|448304481|FG001|Post-Treatment Phase|Adverse Event|0|||
124641645|NCT02438826|448304482|FG002|Post-Treatment Phase|Adverse Event|0|||
124641646|NCT02438826|448304483|FG003|Post-Treatment Phase|Adverse Event|0|||
124641647|NCT02438826|448304480|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
124641648|NCT02438826|448304481|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
124641649|NCT02438826|448304482|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
124641650|NCT02438826|448304483|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
124641651|NCT02438826|448304480|FG000|Post-Treatment Phase|Physician Decision|1|||
124641652|NCT02438826|448304481|FG001|Post-Treatment Phase|Physician Decision|0|||
124641653|NCT02438826|448304482|FG002|Post-Treatment Phase|Physician Decision|0|||
124641654|NCT02438826|448304483|FG003|Post-Treatment Phase|Physician Decision|0|||
124641655|NCT02438826|448304480|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
124641656|NCT02438826|448304481|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
124641657|NCT02438826|448304482|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
124641658|NCT02438826|448304483|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
124641659|NCT03425396|448304496|FG000|Overall Study|Lost to Follow-up|2|||
124641660|NCT03425396|448304497|FG001|Overall Study|Lost to Follow-up|5|||
124641661|NCT03425396|448304498|FG002|Overall Study|Lost to Follow-up|2|||
124641662|NCT03425396|448304499|FG003|Overall Study|Lost to Follow-up|0|||
124641663|NCT03425396|448304500|FG004|Overall Study|Lost to Follow-up|0|||
124641664|NCT03425396|448304496|FG000|Overall Study|Withdrawal by Subject|0|||
124641665|NCT03425396|448304497|FG001|Overall Study|Withdrawal by Subject|1|||
124641666|NCT03425396|448304498|FG002|Overall Study|Withdrawal by Subject|0|||
124641667|NCT03425396|448304499|FG003|Overall Study|Withdrawal by Subject|1|||
124641668|NCT03425396|448304500|FG004|Overall Study|Withdrawal by Subject|0|||
124641669|NCT03425396|448304496|FG000|Overall Study|Other|0|||
124641670|NCT03425396|448304497|FG001|Overall Study|Other|1|||
124641671|NCT03425396|448304498|FG002|Overall Study|Other|1|||
124641672|NCT03425396|448304499|FG003|Overall Study|Other|0|||
124641673|NCT03425396|448304500|FG004|Overall Study|Other|1|||
124641674|NCT03689374|448304502|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
124641675|NCT03689374|448304503|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
124641676|NCT03689374|448304504|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
124641677|NCT03689374|448304502|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
124641678|NCT03689374|448304503|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
124641679|NCT03689374|448304504|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
124641680|NCT03689374|448304502|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
124641681|NCT03689374|448304503|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
124641682|NCT03689374|448304504|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
124641683|NCT03689374|448304502|FG000|Treatment Period (Week 0 to 52)|Death|0|||
124847190|NCT03013491|449064251|FG012|Main Study|Protocol version 8.0 approval|0|||
124641684|NCT03689374|448304503|FG001|Treatment Period (Week 0 to 52)|Death|11|||
124641685|NCT03689374|448304504|FG002|Treatment Period (Week 0 to 52)|Death|1|||
124641686|NCT00078767|448305876|FG000|Overall Study|Withdrawal by Subject|1|||
124641687|NCT00078767|448305877|FG001|Overall Study|Withdrawal by Subject|1|||
124847191|NCT03013491|449064252|FG013|Main Study|Protocol version 8.0 approval|0|||
124641688|NCT00831311|448305882|FG000|Overall Study|Definitive Contraindication|3|||
124641689|NCT00831311|448305883|FG001|Overall Study|Definitive Contraindication|3|||
124641690|NCT00831311|448305882|FG000|Overall Study|Lost to Follow-up|3|||
124641691|NCT00831311|448305883|FG001|Overall Study|Lost to Follow-up|0|||
124641692|NCT00831311|448305882|FG000|Overall Study|Physician Decision|0|||
124641693|NCT00831311|448305883|FG001|Overall Study|Physician Decision|1|||
124641694|NCT00831311|448305882|FG000|Overall Study|Withdrawal by Subject|6|||
124641695|NCT00831311|448305883|FG001|Overall Study|Withdrawal by Subject|4|||
124641696|NCT05088603|448305884|FG000|Overall Study|Protocol Violation|6|||
124641697|NCT05088603|448305885|FG001|Overall Study|Protocol Violation|1|||
124641698|NCT01868438|448305886|FG000|First Intervention|Withdrawal by Subject|5|||
124641699|NCT01868438|448305887|FG001|First Intervention|Withdrawal by Subject|1|||
124641700|NCT01868438|448305886|FG000|First Intervention|Lost to Follow-up|2|||
124641701|NCT01868438|448305887|FG001|First Intervention|Lost to Follow-up|3|||
124641702|NCT01868438|448305886|FG000|First Intervention|Meeting the non-redosing criteria|0|||
124641703|NCT01868438|448305887|FG001|First Intervention|Meeting the non-redosing criteria|1|||
124641704|NCT01868438|448305886|FG000|Second Intervention|Adverse Event|3|||
124641705|NCT01868438|448305887|FG001|Second Intervention|Adverse Event|3|||
124641706|NCT00594100|448305890|FG000|Procedure|Technical Failure|9|||
124641707|NCT00594100|448305890|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
124641708|NCT00594100|448305890|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
124641709|NCT00594100|448305890|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
124641710|NCT03981900|448305891|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
124641711|NCT03981900|448305891|FG000|Overall Study|Adverse Event|5|||
124641712|NCT03981900|448305891|FG000|Overall Study|Protocol Violation|1|||
124641713|NCT03981900|448305891|FG000|Overall Study|Withdrawal by Subject|7|||
124641714|NCT03981900|448305891|FG000|Overall Study|Lost to Follow-up|46|||
124641715|NCT03981900|448305891|FG000|Overall Study|Decision of the researcher|3|||
124641716|NCT03981900|448305891|FG000|Overall Study|Death|3|||
124641717|NCT03981900|448305891|FG000|Overall Study|Other|5|||
124641718|NCT02162719|448305892|FG000|Overall Study|Death|41|||
124641719|NCT02162719|448305893|FG001|Overall Study|Death|46|||
124641720|NCT02162719|448305892|FG000|Overall Study|Lost to Follow-up|1|||
124641721|NCT02162719|448305893|FG001|Overall Study|Lost to Follow-up|3|||
124641722|NCT02162719|448305892|FG000|Overall Study|Disease Progression|2|||
124641723|NCT02162719|448305893|FG001|Overall Study|Disease Progression|1|||
124641724|NCT02162719|448305892|FG000|Overall Study|Withdrawal by Subject|8|||
124641725|NCT02162719|448305893|FG001|Overall Study|Withdrawal by Subject|2|||
124641726|NCT02162719|448305892|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
124641727|NCT02162719|448305893|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
124641728|NCT00160706|448305894|FG000|Overall Study|Adverse Event|53|||
124641729|NCT00160706|448305894|FG000|Overall Study|Adverse Event and Other Reason|105|||
124641730|NCT00160706|448305894|FG000|Overall Study|Protocol Violation|3|||
124641731|NCT00160706|448305894|FG000|Overall Study|Withdrawal by Subject|41|||
124641732|NCT00160706|448305894|FG000|Overall Study|Withdrawal by Subject and Other|12|||
124641733|NCT00160706|448305894|FG000|Overall Study|Physician Decision|10|||
124641734|NCT00160706|448305894|FG000|Overall Study|Physician Decision and Other|3|||
124641735|NCT00160706|448305894|FG000|Overall Study|Lost to Follow-up|4|||
124641736|NCT00160706|448305894|FG000|Overall Study|Lost to Follow-up and Other|1|||
124641737|NCT00160706|448305894|FG000|Overall Study|Lack of Efficacy|42|||
124641738|NCT00160706|448305894|FG000|Overall Study|Lack of Efficacy and Other|1|||
124641739|NCT00160706|448305894|FG000|Overall Study|Other Reason|11|||
124641740|NCT03214380|448305895|FG000|Lead-in|Adverse Event|3|||
124641741|NCT03214380|448305896|FG001|Lead-in|Adverse Event|0|||
124641742|NCT03214380|448305897|FG002|Lead-in|Adverse Event|0|||
124641743|NCT03214380|448305898|FG003|Lead-in|Adverse Event|1|||
124641744|NCT03214380|448305899|FG004|Lead-in|Adverse Event|0|||
124641745|NCT03214380|448305900|FG005|Lead-in|Adverse Event|0|||
124641746|NCT03214380|448305895|FG000|Lead-in|Lost to Follow-up|4|||
124641747|NCT03214380|448305896|FG001|Lead-in|Lost to Follow-up|0|||
124641748|NCT03214380|448305897|FG002|Lead-in|Lost to Follow-up|0|||
124641749|NCT03214380|448305898|FG003|Lead-in|Lost to Follow-up|1|||
124641750|NCT03214380|448305899|FG004|Lead-in|Lost to Follow-up|0|||
124641751|NCT03214380|448305900|FG005|Lead-in|Lost to Follow-up|0|||
124641752|NCT03214380|448305895|FG000|Lead-in|Eligibility Criteria|3|||
124641753|NCT03214380|448305896|FG001|Lead-in|Eligibility Criteria|0|||
124641754|NCT03214380|448305897|FG002|Lead-in|Eligibility Criteria|0|||
124847192|NCT03013491|449064253|FG014|Main Study|Protocol version 8.0 approval|0|||
124847193|NCT03013491|449064254|FG015|Main Study|Protocol version 8.0 approval|0|||
124641755|NCT03214380|448305898|FG003|Lead-in|Eligibility Criteria|0|||
124641756|NCT03214380|448305899|FG004|Lead-in|Eligibility Criteria|0|||
124641757|NCT03214380|448305900|FG005|Lead-in|Eligibility Criteria|0|||
124641758|NCT03214380|448305895|FG000|Lead-in|Physician Decision|6|||
124641759|NCT03214380|448305896|FG001|Lead-in|Physician Decision|0|||
124641760|NCT03214380|448305897|FG002|Lead-in|Physician Decision|0|||
124641761|NCT03214380|448305898|FG003|Lead-in|Physician Decision|0|||
124641762|NCT03214380|448305899|FG004|Lead-in|Physician Decision|0|||
124641763|NCT03214380|448305900|FG005|Lead-in|Physician Decision|0|||
124641764|NCT03214380|448305895|FG000|Lead-in|Protocol Deviation|7|||
124641765|NCT03214380|448305896|FG001|Lead-in|Protocol Deviation|0|||
124641766|NCT03214380|448305897|FG002|Lead-in|Protocol Deviation|0|||
124641767|NCT03214380|448305898|FG003|Lead-in|Protocol Deviation|3|||
124641768|NCT03214380|448305899|FG004|Lead-in|Protocol Deviation|0|||
124641769|NCT03214380|448305900|FG005|Lead-in|Protocol Deviation|0|||
124641770|NCT03214380|448305895|FG000|Lead-in|Withdrawal by Subject|41|||
124641771|NCT03214380|448305896|FG001|Lead-in|Withdrawal by Subject|0|||
124641772|NCT03214380|448305897|FG002|Lead-in|Withdrawal by Subject|0|||
124641773|NCT03214380|448305898|FG003|Lead-in|Withdrawal by Subject|14|||
124641774|NCT03214380|448305899|FG004|Lead-in|Withdrawal by Subject|0|||
124641775|NCT03214380|448305900|FG005|Lead-in|Withdrawal by Subject|0|||
124641776|NCT03214380|448305895|FG000|Lead-in|Family Emergency|1|||
124641777|NCT03214380|448305896|FG001|Lead-in|Family Emergency|0|||
124641778|NCT03214380|448305897|FG002|Lead-in|Family Emergency|0|||
124641779|NCT03214380|448305898|FG003|Lead-in|Family Emergency|0|||
124641780|NCT03214380|448305899|FG004|Lead-in|Family Emergency|0|||
124641781|NCT03214380|448305900|FG005|Lead-in|Family Emergency|0|||
124641782|NCT03214380|448305895|FG000|Lead-in|Natural Disaster|9|||
124641783|NCT03214380|448305896|FG001|Lead-in|Natural Disaster|0|||
124641784|NCT03214380|448305897|FG002|Lead-in|Natural Disaster|0|||
124641785|NCT03214380|448305898|FG003|Lead-in|Natural Disaster|0|||
124641786|NCT03214380|448305899|FG004|Lead-in|Natural Disaster|0|||
124641787|NCT03214380|448305900|FG005|Lead-in|Natural Disaster|0|||
124641788|NCT03214380|448305895|FG000|Lead-in|Non Compliance|1|||
124641789|NCT03214380|448305896|FG001|Lead-in|Non Compliance|0|||
124641790|NCT03214380|448305897|FG002|Lead-in|Non Compliance|0|||
124641791|NCT03214380|448305898|FG003|Lead-in|Non Compliance|0|||
124641792|NCT03214380|448305899|FG004|Lead-in|Non Compliance|0|||
124641793|NCT03214380|448305900|FG005|Lead-in|Non Compliance|0|||
124641794|NCT03214380|448305895|FG000|Lead-in|Participant Schedule|2|||
124641795|NCT03214380|448305896|FG001|Lead-in|Participant Schedule|0|||
124641796|NCT03214380|448305897|FG002|Lead-in|Participant Schedule|0|||
124641797|NCT03214380|448305898|FG003|Lead-in|Participant Schedule|0|||
124641798|NCT03214380|448305899|FG004|Lead-in|Participant Schedule|0|||
124641799|NCT03214380|448305900|FG005|Lead-in|Participant Schedule|0|||
124641800|NCT03214380|448305895|FG000|Treatment Period|Adverse Event|0|||
124641801|NCT03214380|448305896|FG001|Treatment Period|Adverse Event|1|||
124641802|NCT03214380|448305897|FG002|Treatment Period|Adverse Event|1|||
124641803|NCT03214380|448305898|FG003|Treatment Period|Adverse Event|0|||
124641804|NCT03214380|448305899|FG004|Treatment Period|Adverse Event|1|||
124641805|NCT03214380|448305900|FG005|Treatment Period|Adverse Event|0|||
124641806|NCT03214380|448305895|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
124641807|NCT03214380|448305896|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
124641808|NCT03214380|448305897|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
124641809|NCT03214380|448305898|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
124641810|NCT03214380|448305899|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
124641811|NCT03214380|448305900|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
124641812|NCT03214380|448305895|FG000|Treatment Period|Withdrawal by Subject|0|||
124641813|NCT03214380|448305896|FG001|Treatment Period|Withdrawal by Subject|10|||
124641814|NCT03214380|448305897|FG002|Treatment Period|Withdrawal by Subject|8|||
124641815|NCT03214380|448305898|FG003|Treatment Period|Withdrawal by Subject|0|||
124641816|NCT03214380|448305899|FG004|Treatment Period|Withdrawal by Subject|7|||
124641817|NCT03214380|448305900|FG005|Treatment Period|Withdrawal by Subject|11|||
124641818|NCT03214380|448305895|FG000|Treatment Period|Death|0|||
124641819|NCT03214380|448305896|FG001|Treatment Period|Death|1|||
124641820|NCT03214380|448305897|FG002|Treatment Period|Death|2|||
124641821|NCT03214380|448305898|FG003|Treatment Period|Death|0|||
124641822|NCT03214380|448305899|FG004|Treatment Period|Death|0|||
124641823|NCT03214380|448305900|FG005|Treatment Period|Death|0|||
124641824|NCT03214380|448305895|FG000|Treatment Period|Lost to Follow-up|0|||
124641825|NCT03214380|448305896|FG001|Treatment Period|Lost to Follow-up|6|||
124641826|NCT03214380|448305897|FG002|Treatment Period|Lost to Follow-up|3|||
124641827|NCT03214380|448305898|FG003|Treatment Period|Lost to Follow-up|0|||
124641828|NCT03214380|448305899|FG004|Treatment Period|Lost to Follow-up|0|||
124641829|NCT03214380|448305900|FG005|Treatment Period|Lost to Follow-up|0|||
124641830|NCT03214380|448305895|FG000|Treatment Period|Participant schedule|0|||
124641831|NCT03214380|448305896|FG001|Treatment Period|Participant schedule|0|||
124641832|NCT03214380|448305897|FG002|Treatment Period|Participant schedule|1|||
124641833|NCT03214380|448305898|FG003|Treatment Period|Participant schedule|0|||
124641834|NCT03214380|448305899|FG004|Treatment Period|Participant schedule|0|||
124641835|NCT03214380|448305900|FG005|Treatment Period|Participant schedule|0|||
124641836|NCT03214380|448305895|FG000|Treatment Period|Treatment Interruption|0|||
124641837|NCT03214380|448305896|FG001|Treatment Period|Treatment Interruption|0|||
124641838|NCT03214380|448305897|FG002|Treatment Period|Treatment Interruption|1|||
124641839|NCT03214380|448305898|FG003|Treatment Period|Treatment Interruption|0|||
124641840|NCT03214380|448305899|FG004|Treatment Period|Treatment Interruption|0|||
124641841|NCT03214380|448305900|FG005|Treatment Period|Treatment Interruption|0|||
124641842|NCT03192306|448305908|FG000|Overall Study|Did not treat cold sore during study|149|||
124641843|NCT03192306|448305909|FG001|Overall Study|Did not treat cold sore during study|143|||
124641844|NCT03192306|448305908|FG000|Overall Study|Withdrawal by Subject|1|||
124641845|NCT03192306|448305909|FG001|Overall Study|Withdrawal by Subject|1|||
124641846|NCT03192306|448305908|FG000|Overall Study|Lost to Follow-up|1|||
124641847|NCT03192306|448305909|FG001|Overall Study|Lost to Follow-up|0|||
124641848|NCT03192306|448305908|FG000|Overall Study|Protocol Violation|1|||
124641849|NCT03192306|448305909|FG001|Overall Study|Protocol Violation|1|||
124641850|NCT01289639|448305914|FG000|Overall Study|Lost to Follow-up|1|||
124641851|NCT01289639|448305915|FG001|Overall Study|Lost to Follow-up|0|||
124641852|NCT01289639|448305916|FG002|Overall Study|Lost to Follow-up|0|||
124641853|NCT02780713|448305917|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
124641854|NCT02780713|448305918|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
124641855|NCT02780713|448305919|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
124641856|NCT02780713|448305920|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
124641857|NCT02780713|448305921|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
124641858|NCT01931475|448305922|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
124641859|NCT01931475|448305923|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
124641860|NCT01931475|448305922|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
124641861|NCT01931475|448305923|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
124641862|NCT01931475|448305922|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
124641863|NCT01931475|448305923|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
124641864|NCT01931475|448305922|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
124641865|NCT01931475|448305923|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
124641866|NCT01931475|448305922|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
124641867|NCT01931475|448305923|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
124641868|NCT01931475|448305922|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
124641869|NCT01931475|448305923|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
124641870|NCT01931475|448305922|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
124641871|NCT01931475|448305923|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
124641872|NCT01931475|448305922|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
124641873|NCT01931475|448305923|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
124641874|NCT01931475|448305922|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
124641875|NCT01931475|448305923|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
124641876|NCT01931475|448305922|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
124641877|NCT01931475|448305923|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
124641878|NCT01931475|448305922|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
124641879|NCT01931475|448305923|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
124641880|NCT04292912|448305926|FG000|Overall Study|Physician Decision|1|||
124641881|NCT04292912|448305926|FG000|Overall Study|Protocol Violation|6|||
124641882|NCT05338502|448305935|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
124641883|NCT05338502|448305936|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
124641884|NCT05338502|448305937|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
124641885|NCT05338502|448305935|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
124641886|NCT05338502|448305936|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
124641887|NCT05338502|448305937|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
124641888|NCT03575793|448305942|FG000|Overall Study|Withdrawal by Subject|0|||
124641889|NCT03575793|448305943|FG001|Overall Study|Withdrawal by Subject|1|||
124641890|NCT03575793|448305942|FG000|Overall Study|Never Treated|0|||
124641891|NCT03575793|448305943|FG001|Overall Study|Never Treated|2|||
124641892|NCT01250873|448305944|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
124641893|NCT01250873|448305944|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
124641894|NCT02278939|448305945|FG000|Overall Study|lack of time|1|||
124641895|NCT02278939|448305946|FG001|Overall Study|lack of time|0|||
124641896|NCT02278939|448305945|FG000|Overall Study|Lost to Follow-up|1|||
124641897|NCT02278939|448305946|FG001|Overall Study|Lost to Follow-up|1|||
124641898|NCT02278939|448305945|FG000|Overall Study|death in family|1|||
124641899|NCT02278939|448305946|FG001|Overall Study|death in family|0|||
124641900|NCT02278939|448305945|FG000|Overall Study|family emergency unable to commit|2|||
124641901|NCT02278939|448305946|FG001|Overall Study|family emergency unable to commit|0|||
124641902|NCT01127451|448305951|FG000|Overall Study|Other|2|||
124641903|NCT01127451|448305952|FG001|Overall Study|Other|1|||
124641904|NCT01127451|448305951|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
124641905|NCT01127451|448305952|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
124641906|NCT01127451|448305951|FG000|Overall Study|Death|22|||
124641907|NCT01127451|448305952|FG001|Overall Study|Death|17|||
124641908|NCT01127451|448305951|FG000|Overall Study|Lost to Follow-up|3|||
124641909|NCT01127451|448305952|FG001|Overall Study|Lost to Follow-up|0|||
124641910|NCT01127451|448305951|FG000|Overall Study|Administrative Reason by Sponsor|2|||
124641911|NCT01127451|448305952|FG001|Overall Study|Administrative Reason by Sponsor|2|||
124641912|NCT02111577|448305953|FG000|Overall Study|Protocol Violation|2|||
124641913|NCT02111577|448305954|FG001|Overall Study|Protocol Violation|0|||
124641914|NCT02111577|448305953|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
124641915|NCT02111577|448305954|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
124641916|NCT02111577|448305953|FG000|Overall Study|Failure to produce study treatment|6|||
124641917|NCT02111577|448305954|FG001|Overall Study|Failure to produce study treatment|0|||
124641918|NCT02111577|448305953|FG000|Overall Study|Death|518|||
124641919|NCT02111577|448305954|FG001|Overall Study|Death|254|||
124641920|NCT02111577|448305953|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
124641921|NCT02111577|448305954|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
124641922|NCT02111577|448305953|FG000|Overall Study|Adverse Event|1|||
124641923|NCT02111577|448305954|FG001|Overall Study|Adverse Event|1|||
124641924|NCT02111577|448305953|FG000|Overall Study|Withdrawal by Subject|51|||
124641925|NCT02111577|448305954|FG001|Overall Study|Withdrawal by Subject|23|||
124641926|NCT02111577|448305953|FG000|Overall Study|Disease progression|0|||
124641927|NCT02111577|448305954|FG001|Overall Study|Disease progression|1|||
124641928|NCT02111577|448305953|FG000|Overall Study|Lost to Follow-up|19|||
124641929|NCT02111577|448305954|FG001|Overall Study|Lost to Follow-up|10|||
124641930|NCT04791319|448305955|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
124641931|NCT04791319|448305956|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
124641932|NCT04791319|448305957|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
124641933|NCT04791319|448305958|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
124641934|NCT04791319|448305959|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
124641935|NCT04791319|448305960|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
124641936|NCT04791319|448305961|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
124641937|NCT04791319|448305962|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
124641938|NCT04791319|448305963|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
124641939|NCT04791319|448305964|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
124641940|NCT04791319|448305965|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
124641941|NCT04791319|448305955|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
124641942|NCT04791319|448305956|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
124641943|NCT04791319|448305957|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
124641944|NCT04791319|448305958|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
124641945|NCT04791319|448305959|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
124641946|NCT04791319|448305960|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
124641947|NCT04791319|448305961|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
124641948|NCT04791319|448305962|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
124641949|NCT04791319|448305963|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
124641950|NCT04791319|448305964|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
124641951|NCT04791319|448305965|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
124641952|NCT04791319|448305955|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
124641953|NCT04791319|448305956|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
124641954|NCT04791319|448305957|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
124641955|NCT04791319|448305958|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
124641956|NCT04791319|448305959|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
124641957|NCT04791319|448305960|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
124641958|NCT04791319|448305961|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
124641959|NCT04791319|448305962|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
124641960|NCT04791319|448305963|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
124641961|NCT04791319|448305964|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
124641962|NCT04791319|448305965|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
124641963|NCT04791319|448305955|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
124641964|NCT04791319|448305956|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
124641965|NCT04791319|448305957|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
124641966|NCT04791319|448305958|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
124641967|NCT04791319|448305959|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
124641968|NCT04791319|448305960|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
124641969|NCT04791319|448305961|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
124641970|NCT04791319|448305962|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
124641971|NCT04791319|448305963|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
124641972|NCT04791319|448305964|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
124641973|NCT04791319|448305965|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
124641974|NCT04791319|448305955|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
124641975|NCT04791319|448305956|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
124641976|NCT04791319|448305957|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
124641977|NCT04791319|448305958|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
124641978|NCT04791319|448305959|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
124641979|NCT04791319|448305960|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
124847194|NCT03013491|449064255|FG016|Main Study|Protocol version 8.0 approval|0|||
124847195|NCT03013491|449064256|FG017|Main Study|Protocol version 8.0 approval|0|||
124847196|NCT03013491|449064257|FG018|Main Study|Protocol version 8.0 approval|0|||
124641980|NCT04791319|448305961|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
124641981|NCT04791319|448305962|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
124641982|NCT04791319|448305963|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
124641983|NCT04791319|448305964|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
124641984|NCT04791319|448305965|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
124641985|NCT04791319|448305955|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
124641986|NCT04791319|448305956|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
124641987|NCT04791319|448305957|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
124641988|NCT04791319|448305958|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
124641989|NCT04791319|448305959|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
124641990|NCT04791319|448305960|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
124641991|NCT04791319|448305961|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
124641992|NCT04791319|448305962|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
124641993|NCT04791319|448305963|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
124641994|NCT04791319|448305964|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
124641995|NCT04791319|448305965|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
124641996|NCT04791319|448305955|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
124641997|NCT04791319|448305956|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
124641998|NCT04791319|448305957|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
124641999|NCT04791319|448305958|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
124642000|NCT04791319|448305959|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
124642001|NCT04791319|448305960|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
124642002|NCT04791319|448305961|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
124642003|NCT04791319|448305962|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
124642004|NCT04791319|448305963|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
124642005|NCT04791319|448305964|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
124642006|NCT04791319|448305965|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
124642007|NCT04791319|448305955|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
124642008|NCT04791319|448305956|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
124642009|NCT04791319|448305957|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
124642010|NCT04791319|448305958|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
124642011|NCT04791319|448305959|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
124642012|NCT04791319|448305960|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
124642013|NCT04791319|448305961|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
124642014|NCT04791319|448305962|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
124642015|NCT04791319|448305963|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
124642016|NCT04791319|448305964|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
124642017|NCT04791319|448305965|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
124642018|NCT04791319|448305955|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
124642019|NCT04791319|448305956|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
124642020|NCT04791319|448305957|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
124642021|NCT04791319|448305958|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
124642022|NCT04791319|448305959|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
124642023|NCT04791319|448305960|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
124642024|NCT04791319|448305961|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
124642025|NCT04791319|448305962|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
124642026|NCT04791319|448305963|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
124642027|NCT04791319|448305964|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
124642028|NCT04791319|448305965|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
124642029|NCT02353442|448305966|FG000|Overall Study|Withdrawal by Subject|3|||
124642030|NCT02353442|448305967|FG001|Overall Study|Withdrawal by Subject|4|||
124642031|NCT00679289|448305969|FG000|Overall Study|Progressive disease|4|||
124642032|NCT00679289|448305970|FG001|Overall Study|Progressive disease|5|||
124642033|NCT00679289|448305971|FG002|Overall Study|Progressive disease|18|||
124642034|NCT00679289|448305969|FG000|Overall Study|Withdrawal by Subject|0|||
124642035|NCT00679289|448305970|FG001|Overall Study|Withdrawal by Subject|1|||
124642036|NCT00679289|448305971|FG002|Overall Study|Withdrawal by Subject|1|||
124642037|NCT00679289|448305969|FG000|Overall Study|Adverse Event|0|||
124642038|NCT00679289|448305970|FG001|Overall Study|Adverse Event|0|||
124642039|NCT00679289|448305971|FG002|Overall Study|Adverse Event|3|||
124642040|NCT00679289|448305969|FG000|Overall Study|Physician Decision|1|||
124847197|NCT03013491|449064239|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
124847198|NCT03013491|449064240|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
124642041|NCT00679289|448305970|FG001|Overall Study|Physician Decision|0|||
124642042|NCT00679289|448305971|FG002|Overall Study|Physician Decision|1|||
124642043|NCT01355575|448305973|FG000|Overall Study|Withdrawal by Subject|2|||
124642044|NCT02553499|448305978|FG000|Overall Study|Adverse Event|0|||
124642045|NCT02553499|448305979|FG001|Overall Study|Adverse Event|0|||
124642046|NCT02553499|448305980|FG002|Overall Study|Adverse Event|0|||
124642047|NCT02553499|448305981|FG003|Overall Study|Adverse Event|0|||
124642048|NCT02553499|448305982|FG004|Overall Study|Adverse Event|0|||
124642049|NCT02553499|448305983|FG005|Overall Study|Adverse Event|0|||
124642050|NCT02553499|448305984|FG006|Overall Study|Adverse Event|1|||
124642051|NCT02553499|448305985|FG007|Overall Study|Adverse Event|1|||
124642052|NCT02553499|448305986|FG008|Overall Study|Adverse Event|0|||
124642053|NCT02553499|448305987|FG009|Overall Study|Adverse Event|0|||
124642054|NCT02553499|448305988|FG010|Overall Study|Adverse Event|0|||
124642055|NCT02553499|448305989|FG011|Overall Study|Adverse Event|0|||
124642056|NCT02553499|448305990|FG012|Overall Study|Adverse Event|0|||
124642057|NCT02553499|448305991|FG013|Overall Study|Adverse Event|1|||
124642058|NCT02553499|448305978|FG000|Overall Study|Death|0|||
124642059|NCT02553499|448305979|FG001|Overall Study|Death|1|||
124642060|NCT02553499|448305980|FG002|Overall Study|Death|1|||
124642061|NCT02553499|448305981|FG003|Overall Study|Death|0|||
124642062|NCT02553499|448305982|FG004|Overall Study|Death|1|||
124642063|NCT02553499|448305983|FG005|Overall Study|Death|2|||
124642064|NCT02553499|448305984|FG006|Overall Study|Death|0|||
124642065|NCT02553499|448305985|FG007|Overall Study|Death|0|||
124642066|NCT02553499|448305986|FG008|Overall Study|Death|0|||
124642067|NCT02553499|448305987|FG009|Overall Study|Death|0|||
124642068|NCT02553499|448305988|FG010|Overall Study|Death|1|||
124642069|NCT02553499|448305989|FG011|Overall Study|Death|0|||
124642070|NCT02553499|448305990|FG012|Overall Study|Death|0|||
124642071|NCT02553499|448305991|FG013|Overall Study|Death|0|||
124642072|NCT02553499|448305978|FG000|Overall Study|Lost to Follow-up|0|||
124642073|NCT02553499|448305979|FG001|Overall Study|Lost to Follow-up|0|||
124642074|NCT02553499|448305980|FG002|Overall Study|Lost to Follow-up|0|||
124642075|NCT02553499|448305981|FG003|Overall Study|Lost to Follow-up|0|||
124642076|NCT02553499|448305982|FG004|Overall Study|Lost to Follow-up|0|||
124642077|NCT02553499|448305983|FG005|Overall Study|Lost to Follow-up|0|||
124642078|NCT02553499|448305984|FG006|Overall Study|Lost to Follow-up|1|||
124642079|NCT02553499|448305985|FG007|Overall Study|Lost to Follow-up|0|||
124642080|NCT02553499|448305986|FG008|Overall Study|Lost to Follow-up|0|||
124642081|NCT02553499|448305987|FG009|Overall Study|Lost to Follow-up|0|||
124642082|NCT02553499|448305988|FG010|Overall Study|Lost to Follow-up|0|||
124642083|NCT02553499|448305989|FG011|Overall Study|Lost to Follow-up|0|||
124642084|NCT02553499|448305990|FG012|Overall Study|Lost to Follow-up|0|||
124642085|NCT02553499|448305991|FG013|Overall Study|Lost to Follow-up|0|||
124642086|NCT02553499|448305978|FG000|Overall Study|Physician Decision|0|||
124642087|NCT02553499|448305979|FG001|Overall Study|Physician Decision|1|||
124642088|NCT02553499|448305980|FG002|Overall Study|Physician Decision|1|||
124642089|NCT02553499|448305981|FG003|Overall Study|Physician Decision|0|||
124642090|NCT02553499|448305982|FG004|Overall Study|Physician Decision|1|||
124642091|NCT02553499|448305983|FG005|Overall Study|Physician Decision|0|||
124642092|NCT02553499|448305984|FG006|Overall Study|Physician Decision|0|||
124642093|NCT02553499|448305985|FG007|Overall Study|Physician Decision|1|||
124642094|NCT02553499|448305986|FG008|Overall Study|Physician Decision|1|||
124642095|NCT02553499|448305987|FG009|Overall Study|Physician Decision|2|||
124642096|NCT02553499|448305988|FG010|Overall Study|Physician Decision|1|||
124642097|NCT02553499|448305989|FG011|Overall Study|Physician Decision|3|||
124642098|NCT02553499|448305990|FG012|Overall Study|Physician Decision|1|||
124642099|NCT02553499|448305991|FG013|Overall Study|Physician Decision|0|||
124642100|NCT02553499|448305978|FG000|Overall Study|Progressive Disease|0|||
124642101|NCT02553499|448305979|FG001|Overall Study|Progressive Disease|0|||
124642102|NCT02553499|448305980|FG002|Overall Study|Progressive Disease|0|||
124642103|NCT02553499|448305981|FG003|Overall Study|Progressive Disease|2|||
124642104|NCT02553499|448305982|FG004|Overall Study|Progressive Disease|1|||
124642105|NCT02553499|448305983|FG005|Overall Study|Progressive Disease|1|||
124642106|NCT02553499|448305984|FG006|Overall Study|Progressive Disease|1|||
124642107|NCT02553499|448305985|FG007|Overall Study|Progressive Disease|0|||
124642108|NCT02553499|448305986|FG008|Overall Study|Progressive Disease|0|||
124642109|NCT02553499|448305987|FG009|Overall Study|Progressive Disease|1|||
124642110|NCT02553499|448305988|FG010|Overall Study|Progressive Disease|0|||
124642111|NCT02553499|448305989|FG011|Overall Study|Progressive Disease|0|||
124642112|NCT02553499|448305990|FG012|Overall Study|Progressive Disease|2|||
124642113|NCT02553499|448305991|FG013|Overall Study|Progressive Disease|1|||
124642114|NCT02553499|448305978|FG000|Overall Study|Study Terminated by Sponsor|0|||
124642115|NCT02553499|448305979|FG001|Overall Study|Study Terminated by Sponsor|0|||
124642116|NCT02553499|448305980|FG002|Overall Study|Study Terminated by Sponsor|0|||
124642117|NCT02553499|448305981|FG003|Overall Study|Study Terminated by Sponsor|0|||
124642118|NCT02553499|448305982|FG004|Overall Study|Study Terminated by Sponsor|0|||
124642119|NCT02553499|448305983|FG005|Overall Study|Study Terminated by Sponsor|0|||
124642120|NCT02553499|448305984|FG006|Overall Study|Study Terminated by Sponsor|0|||
124642121|NCT02553499|448305985|FG007|Overall Study|Study Terminated by Sponsor|0|||
124642122|NCT02553499|448305986|FG008|Overall Study|Study Terminated by Sponsor|1|||
124754132|NCT05715242|448720896|FG005|Overall Study|Lost to Follow-up|1|||
124642123|NCT02553499|448305987|FG009|Overall Study|Study Terminated by Sponsor|0|||
124642124|NCT02553499|448305988|FG010|Overall Study|Study Terminated by Sponsor|0|||
124642125|NCT02553499|448305989|FG011|Overall Study|Study Terminated by Sponsor|0|||
124642126|NCT02553499|448305990|FG012|Overall Study|Study Terminated by Sponsor|0|||
124642127|NCT02553499|448305991|FG013|Overall Study|Study Terminated by Sponsor|0|||
124642128|NCT02553499|448305978|FG000|Overall Study|Withdrawal by Subject|2|||
124642129|NCT02553499|448305979|FG001|Overall Study|Withdrawal by Subject|0|||
124642130|NCT02553499|448305980|FG002|Overall Study|Withdrawal by Subject|0|||
124642131|NCT02553499|448305981|FG003|Overall Study|Withdrawal by Subject|0|||
124642132|NCT02553499|448305982|FG004|Overall Study|Withdrawal by Subject|0|||
124642133|NCT02553499|448305983|FG005|Overall Study|Withdrawal by Subject|0|||
124642134|NCT02553499|448305984|FG006|Overall Study|Withdrawal by Subject|0|||
124642135|NCT02553499|448305985|FG007|Overall Study|Withdrawal by Subject|1|||
124642136|NCT02553499|448305986|FG008|Overall Study|Withdrawal by Subject|1|||
124642137|NCT02553499|448305987|FG009|Overall Study|Withdrawal by Subject|0|||
124642138|NCT02553499|448305988|FG010|Overall Study|Withdrawal by Subject|1|||
124642139|NCT02553499|448305989|FG011|Overall Study|Withdrawal by Subject|0|||
124642140|NCT02553499|448305990|FG012|Overall Study|Withdrawal by Subject|0|||
124642141|NCT02553499|448305991|FG013|Overall Study|Withdrawal by Subject|0|||
124642142|NCT01726270|448305994|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
124642143|NCT01726270|448305994|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
124642144|NCT01726270|448305994|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
124642145|NCT01726270|448305994|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
124642146|NCT01726270|448305994|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
124642147|NCT01726270|448305994|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
124642148|NCT02073929|448306007|FG000|Overall Study|Lost to Follow-up|2|||
124642149|NCT02073929|448306008|FG001|Overall Study|Lost to Follow-up|1|||
124642150|NCT02073929|448306007|FG000|Overall Study|Adverse Event|2|||
124642151|NCT02073929|448306008|FG001|Overall Study|Adverse Event|1|||
124642152|NCT02073929|448306007|FG000|Overall Study|Withdrawal by Subject|0|||
124642153|NCT02073929|448306008|FG001|Overall Study|Withdrawal by Subject|1|||
124642154|NCT03319732|448306009|FG000|Overall Study|Adverse Event|40|||
124642155|NCT03319732|448306009|FG000|Overall Study|Withdrawal by Subject|50|||
124642156|NCT03319732|448306009|FG000|Overall Study|MS relapse|10|||
124642157|NCT03319732|448306009|FG000|Overall Study|reason not specified|5|||
124642158|NCT03887442|448306010|FG000|Overall Study|Adverse Event|1|||
124642159|NCT03887442|448306011|FG001|Overall Study|Adverse Event|0|||
124642160|NCT00430573|448306012|FG000|Overall Study|Withdrawal by Subject|5|||
124642161|NCT05020665|448306013|FG000|Overall Study|Study terminated by Sponsor|5|||
124642162|NCT05020665|448306014|FG001|Overall Study|Study terminated by Sponsor|4|||
124642163|NCT05020665|448306013|FG000|Overall Study|Death|2|||
124642164|NCT05020665|448306014|FG001|Overall Study|Death|1|||
124642165|NCT05020665|448306013|FG000|Overall Study|Physician Decision|0|||
124642166|NCT05020665|448306014|FG001|Overall Study|Physician Decision|1|||
124642167|NCT05020665|448306013|FG000|Overall Study|Withdrawal by Subject|0|||
124642168|NCT05020665|448306014|FG001|Overall Study|Withdrawal by Subject|1|||
124642169|NCT05020665|448306013|FG000|Overall Study|Reason not specified|1|||
124642170|NCT05020665|448306014|FG001|Overall Study|Reason not specified|0|||
124642171|NCT00072280|448306015|FG000|Treatment|Found ineligible|1|||
124642172|NCT00072280|448306016|FG001|Treatment|Found ineligible|2|||
124642173|NCT00072280|448306015|FG000|Follow-up|Early termination of study|2|||
124642174|NCT00072280|448306016|FG001|Follow-up|Early termination of study|2|||
124642175|NCT02504827|448306017|FG000|Overall Study|Could not produce sputum|1|||
124642176|NCT01732640|448306023|FG000|Overall Study|Adverse Event|0|||
124642177|NCT01732640|448306024|FG001|Overall Study|Adverse Event|1|||
124642178|NCT01732640|448306023|FG000|Overall Study|Death|0|||
124847199|NCT03013491|449064241|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
124642179|NCT01732640|448306024|FG001|Overall Study|Death|1|||
124642180|NCT00877487|448306027|FG000|Open-label Treatment Phase|Adverse Event|1|||
124642181|NCT00877487|448306028|FG001|Open-label Treatment Phase|Adverse Event|0|||
124642182|NCT00877487|448306027|FG000|Open-label Treatment Phase|Protocol Violation|3|||
124642183|NCT00877487|448306028|FG001|Open-label Treatment Phase|Protocol Violation|0|||
124642184|NCT00877487|448306027|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
124642185|NCT00877487|448306028|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
124642186|NCT00877487|448306027|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
124847200|NCT03013491|449064242|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
124847201|NCT03013491|449064243|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
124847202|NCT03013491|449064244|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
124642187|NCT00877487|448306028|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
124642188|NCT00877487|448306027|FG000|Open-label Treatment Phase|Out of country for business|1|||
124642189|NCT00877487|448306028|FG001|Open-label Treatment Phase|Out of country for business|0|||
124642190|NCT00877487|448306027|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
124642191|NCT00877487|448306028|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
124642192|NCT00877487|448306027|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
124642193|NCT00877487|448306028|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
124642194|NCT00877487|448306027|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
124642195|NCT00877487|448306028|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
124642196|NCT00877487|448306027|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
124642197|NCT00877487|448306028|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
124642198|NCT03070002|448306029|FG000|Follow up for 2 Years|Death|1|||
124642199|NCT00712543|448306030|FG000|Day 8-14|Lost to Follow-up|0|||
124642200|NCT00712543|448306031|FG001|Day 8-14|Lost to Follow-up|2|||
124642201|NCT02702388|448306032|FG000|Overall Study|Disease Progression|18|||
124642202|NCT02702388|448306033|FG001|Overall Study|Disease Progression|25|||
124642203|NCT02702388|448306032|FG000|Overall Study|Withdrawal by Subject|9|||
124642204|NCT02702388|448306033|FG001|Overall Study|Withdrawal by Subject|7|||
124642205|NCT02702388|448306032|FG000|Overall Study|Adverse Event|11|||
124642206|NCT02702388|448306033|FG001|Overall Study|Adverse Event|15|||
124642207|NCT02702388|448306032|FG000|Overall Study|Other|2|||
124642208|NCT02702388|448306033|FG001|Overall Study|Other|4|||
124642209|NCT02729051|448306034|FG000|Overall Study|Adverse Event|21|||
124642210|NCT02729051|448306035|FG001|Overall Study|Adverse Event|11|||
124642211|NCT02729051|448306034|FG000|Overall Study|Lack of Efficacy|1|||
124642212|NCT02729051|448306035|FG001|Overall Study|Lack of Efficacy|1|||
124642213|NCT02729051|448306034|FG000|Overall Study|Lost to Follow-up|1|||
124642214|NCT02729051|448306035|FG001|Overall Study|Lost to Follow-up|2|||
124642215|NCT02729051|448306034|FG000|Overall Study|Physician Decision|1|||
124642216|NCT02729051|448306035|FG001|Overall Study|Physician Decision|1|||
124642217|NCT02729051|448306034|FG000|Overall Study|Withdrawal by Subject|6|||
124642218|NCT02729051|448306035|FG001|Overall Study|Withdrawal by Subject|17|||
124642219|NCT04740827|448306045|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
124642220|NCT04740827|448306046|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
124642221|NCT04740827|448306045|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
124642222|NCT04740827|448306046|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
124642223|NCT04740827|448306045|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
124642224|NCT04740827|448306046|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
124642225|NCT04740827|448306045|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
124642226|NCT04740827|448306046|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
124642227|NCT04740827|448306045|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
124642228|NCT04740827|448306046|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
124642229|NCT04740827|448306045|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
124642230|NCT04740827|448306046|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
124642231|NCT03033602|448306047|FG000|Overall Study|Withdrawal by Subject|11|||
124642232|NCT03033602|448306048|FG001|Overall Study|Withdrawal by Subject|21|||
124642233|NCT03033602|448306047|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
124642234|NCT03033602|448306048|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
124642235|NCT01441765|448306049|FG000|Overall Study|Death|1|||
124642236|NCT01441765|448306050|FG001|Overall Study|Death|0|||
124642237|NCT01190410|448308259|FG000|Overall Study|Adverse Event|0|||
124642238|NCT01190410|448308260|FG001|Overall Study|Adverse Event|3|||
124642239|NCT01190410|448308259|FG000|Overall Study|Lack of Efficacy|0|||
124642240|NCT01190410|448308260|FG001|Overall Study|Lack of Efficacy|2|||
124642241|NCT01190410|448308259|FG000|Overall Study|Withdrawal by Subject|0|||
124642242|NCT01190410|448308260|FG001|Overall Study|Withdrawal by Subject|2|||
124642243|NCT01190410|448308259|FG000|Overall Study|Administrative decision|1|||
124642244|NCT01190410|448308260|FG001|Overall Study|Administrative decision|0|||
124642245|NCT01190410|448308259|FG000|Overall Study|PI discretion|0|||
124642246|NCT01190410|448308260|FG001|Overall Study|PI discretion|2|||
124642247|NCT01399047|448308261|FG000|Overall Study|Withdrawal by Subject|0|||
124642248|NCT01399047|448308262|FG001|Overall Study|Withdrawal by Subject|1|||
124642249|NCT01435018|448308271|FG000|Overall Study|Death|37|||
124642250|NCT01435018|448308272|FG001|Overall Study|Death|18|||
124642251|NCT01435018|448308273|FG002|Overall Study|Death|25|||
124642252|NCT01435018|448308271|FG000|Overall Study|Site is closing|4|||
124642253|NCT01435018|448308272|FG001|Overall Study|Site is closing|9|||
124642254|NCT01435018|448308273|FG002|Overall Study|Site is closing|7|||
124642255|NCT01435018|448308271|FG000|Overall Study|Withdrew consent|0|||
124642256|NCT01435018|448308272|FG001|Overall Study|Withdrew consent|3|||
124642257|NCT01435018|448308273|FG002|Overall Study|Withdrew consent|1|||
124642258|NCT01435018|448308271|FG000|Overall Study|Not willing to adhere to requirements|0|||
124642259|NCT01435018|448308272|FG001|Overall Study|Not willing to adhere to requirements|2|||
124642260|NCT01435018|448308273|FG002|Overall Study|Not willing to adhere to requirements|3|||
124642261|NCT01435018|448308271|FG000|Overall Study|Not able to get to clinic|2|||
124642262|NCT01435018|448308272|FG001|Overall Study|Not able to get to clinic|0|||
124642263|NCT01435018|448308273|FG002|Overall Study|Not able to get to clinic|2|||
124642264|NCT01435018|448308271|FG000|Overall Study|Severe debilitation, unable to continue|0|||
124642265|NCT01435018|448308272|FG001|Overall Study|Severe debilitation, unable to continue|0|||
124642266|NCT01435018|448308273|FG002|Overall Study|Severe debilitation, unable to continue|1|||
124642267|NCT01435018|448308271|FG000|Overall Study|Unable to contact participant/parent|1|||
124642268|NCT01435018|448308272|FG001|Overall Study|Unable to contact participant/parent|1|||
124642269|NCT01435018|448308273|FG002|Overall Study|Unable to contact participant/parent|1|||
124642270|NCT01435018|448308271|FG000|Overall Study|Enrollment Violation|0|||
124642271|NCT01435018|448308272|FG001|Overall Study|Enrollment Violation|1|||
124642272|NCT01435018|448308273|FG002|Overall Study|Enrollment Violation|0|||
124642273|NCT01435018|448308271|FG000|Overall Study|Never started chemotherapy|3|||
124642274|NCT01435018|448308272|FG001|Overall Study|Never started chemotherapy|0|||
124642275|NCT01435018|448308273|FG002|Overall Study|Never started chemotherapy|1|||
124642276|NCT03806933|448308274|FG000|Main Period|Physician Decision|0|||
124642277|NCT03806933|448308275|FG001|Main Period|Physician Decision|0|||
124642278|NCT03806933|448308276|FG002|Main Period|Physician Decision|0|||
124642279|NCT03806933|448308277|FG003|Main Period|Physician Decision|1|||
124642280|NCT03806933|448308274|FG000|Main Period|Pregnancy|0|||
124642281|NCT03806933|448308275|FG001|Main Period|Pregnancy|0|||
124642282|NCT03806933|448308276|FG002|Main Period|Pregnancy|1|||
124642283|NCT03806933|448308277|FG003|Main Period|Pregnancy|0|||
124642284|NCT03806933|448308274|FG000|Main Period|Withdrawal by Subject|2|||
124642285|NCT03806933|448308275|FG001|Main Period|Withdrawal by Subject|1|||
124642286|NCT03806933|448308276|FG002|Main Period|Withdrawal by Subject|1|||
124642287|NCT03806933|448308277|FG003|Main Period|Withdrawal by Subject|2|||
124642288|NCT03806933|448308274|FG000|Main Period|Lost to Follow-up|2|||
124642289|NCT03806933|448308275|FG001|Main Period|Lost to Follow-up|2|||
124642290|NCT03806933|448308276|FG002|Main Period|Lost to Follow-up|0|||
124642291|NCT03806933|448308277|FG003|Main Period|Lost to Follow-up|0|||
124642292|NCT03806933|448308274|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
124642293|NCT03806933|448308275|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
124642294|NCT03806933|448308276|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
124642295|NCT03806933|448308277|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
124642296|NCT03625466|448308278|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
124642297|NCT03625466|448308279|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
124642298|NCT03625466|448308280|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
124642299|NCT03625466|448308278|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
124642300|NCT03625466|448308279|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
124642301|NCT03625466|448308280|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
124642302|NCT03625466|448308278|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
124642303|NCT03625466|448308279|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
124642304|NCT03625466|448308280|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
124642305|NCT02282631|448308281|FG000|Overall Study|Lost to Follow-up|2|||
124642306|NCT02282631|448308282|FG001|Overall Study|Lost to Follow-up|0|||
124642307|NCT01841762|448308284|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
124642308|NCT01841762|448308284|FG000|Treatment Period|Adverse Event|16|||
124642309|NCT01841762|448308284|FG000|Treatment Period|Death|1|||
124642310|NCT01841762|448308284|FG000|Treatment Period|Withdrawal by Subject|7|||
124642311|NCT01841762|448308284|FG000|Treatment Period|Lost to Follow-up|1|||
124642312|NCT01841762|448308284|FG000|Treatment Period|Physician Decision|2|||
124642313|NCT01841762|448308284|FG000|Treatment Period|Other, including non-compliance|5|||
124642314|NCT01841762|448308284|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
124642315|NCT01841762|448308284|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
124642316|NCT01841762|448308284|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
124642317|NCT01841762|448308284|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
124642318|NCT03260244|448308285|FG000|Overall Study|Death|19|||
124642319|NCT03260244|448308285|FG000|Overall Study|Lost to Follow-up|60|||
124642320|NCT03260244|448308285|FG000|Overall Study|Withdrawal by Subject|48|||
124642321|NCT03260244|448308285|FG000|Overall Study|Procedure Not Performed|21|||
124642322|NCT03260244|448308285|FG000|Overall Study|Enrollment Criteria Not Met|31|||
124642323|NCT03260244|448308285|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
124642324|NCT03260244|448308285|FG000|Overall Study|Subject Noncompliance|6|||
124642325|NCT03260244|448308285|FG000|Overall Study|No inducible Arrhythmia|2|||
124642326|NCT03260244|448308285|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
124642327|NCT03260244|448308285|FG000|Overall Study|Screen Failure|2|||
124642328|NCT03260244|448308285|FG000|Overall Study|Treated Off Label|69|||
124642329|NCT03260244|448308285|FG000|Overall Study|No Radiofrequency Ablation|14|||
124642330|NCT00956592|448308286|FG000|Overall Study|Protocol Violation|1|||
124642331|NCT00956592|448308287|FG001|Overall Study|Protocol Violation|3|||
124642332|NCT03528369|448308291|FG000|Overall Study|Withdrawal by Subject|2|||
124642333|NCT03528369|448308292|FG001|Overall Study|Withdrawal by Subject|0|||
124642334|NCT03528369|448308293|FG002|Overall Study|Withdrawal by Subject|0|||
124642335|NCT03528369|448308291|FG000|Overall Study|Lost to Follow-up|1|||
124642336|NCT03528369|448308292|FG001|Overall Study|Lost to Follow-up|0|||
124642337|NCT03528369|448308293|FG002|Overall Study|Lost to Follow-up|0|||
124642338|NCT03528369|448308291|FG000|Overall Study|Adverse Event|0|||
124642339|NCT03528369|448308292|FG001|Overall Study|Adverse Event|1|||
124642340|NCT03528369|448308293|FG002|Overall Study|Adverse Event|0|||
124642341|NCT03555565|448308294|FG000|Overall Study|Case Report Forms Uncollected|2|||
124642342|NCT03555565|448308294|FG000|Overall Study|Protocol Deviation|13|||
124642343|NCT00394836|448308295|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
124642344|NCT00394836|448308296|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
124642345|NCT00394836|448308295|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
124642346|NCT00394836|448308296|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
124642347|NCT00394836|448308295|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
124642348|NCT00394836|448308296|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
124642349|NCT00394836|448308295|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
124642350|NCT00394836|448308296|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
124642351|NCT00394836|448308295|FG000|Teatment or Follow-up Phase|Death|0|||
124642352|NCT00394836|448308296|FG001|Teatment or Follow-up Phase|Death|1|||
124642353|NCT00394836|448308295|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
124642354|NCT00394836|448308296|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
124642355|NCT00394836|448308295|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
124642356|NCT00394836|448308296|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
124642357|NCT00394836|448308295|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
124642358|NCT00394836|448308296|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
124642359|NCT00394836|448308295|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
124642360|NCT00394836|448308296|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
124642361|NCT00394836|448308295|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
124642362|NCT00394836|448308296|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
124642363|NCT00394836|448308295|FG000|Teatment or Follow-up Phase|Non compliance|0|||
124642364|NCT00394836|448308296|FG001|Teatment or Follow-up Phase|Non compliance|1|||
124642365|NCT00394836|448308295|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
124642366|NCT00394836|448308296|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
124642367|NCT00394836|448308295|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
124642368|NCT00394836|448308296|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
124642369|NCT00394836|448308295|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
124642370|NCT00394836|448308296|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
124642371|NCT00394836|448308295|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
124642372|NCT00394836|448308296|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
124642373|NCT01163851|448308297|FG000|Overall Study|Site Closure|0|||
124642374|NCT01163851|448308298|FG001|Overall Study|Site Closure|1|||
124642375|NCT01163851|448308297|FG000|Overall Study|Enrolled but not treated|1|||
124642376|NCT01163851|448308298|FG001|Overall Study|Enrolled but not treated|0|||
124642377|NCT02028767|448308299|FG000|Treatment Period 2|Non compliant with protocol|1|||
124642378|NCT02028767|448308300|FG001|Treatment Period 2|Non compliant with protocol|0|||
124642379|NCT02028767|448308299|FG000|Treatment Period 2|Reason other than those specified above|1|||
124642380|NCT02028767|448308300|FG001|Treatment Period 2|Reason other than those specified above|0|||
124642381|NCT02042950|448308306|FG000|Overall Study|Progressive Disease|4|||
124642382|NCT02429778|448308309|FG000|Overall Study|Lost to Follow-up|2|||
124642383|NCT02429778|448308310|FG001|Overall Study|Lost to Follow-up|0|||
124642384|NCT02429778|448308309|FG000|Overall Study|Withdrawal by Subject|5|||
124642385|NCT02429778|448308310|FG001|Overall Study|Withdrawal by Subject|0|||
124642386|NCT01981954|448308317|FG000|Titration Period|Protocol Deviation|1|||
124642387|NCT01981954|448308317|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
124642388|NCT03655470|448308318|FG000|Overall Study|Lost to Follow-up|6|||
124642389|NCT03655470|448308319|FG001|Overall Study|Lost to Follow-up|7|||
124642390|NCT04590586|448308322|FG000|Overall Study|Death|7|||
124642391|NCT04590586|448308323|FG001|Overall Study|Death|1|||
124642392|NCT04590586|448308324|FG002|Overall Study|Death|37|||
124642393|NCT04590586|448308325|FG003|Overall Study|Death|34|||
124642394|NCT04590586|448308326|FG004|Overall Study|Death|19|||
124642395|NCT04590586|448308327|FG005|Overall Study|Death|3|||
124642396|NCT04590586|448308322|FG000|Overall Study|Lost to Follow-up|3|||
124642397|NCT04590586|448308323|FG001|Overall Study|Lost to Follow-up|0|||
124642398|NCT04590586|448308324|FG002|Overall Study|Lost to Follow-up|11|||
124642399|NCT04590586|448308325|FG003|Overall Study|Lost to Follow-up|11|||
124847203|NCT03013491|449064245|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
124847204|NCT03013491|449064246|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
124642400|NCT04590586|448308326|FG004|Overall Study|Lost to Follow-up|6|||
124642401|NCT04590586|448308327|FG005|Overall Study|Lost to Follow-up|0|||
124642402|NCT04590586|448308322|FG000|Overall Study|Withdrawal by Subject|0|||
124642403|NCT04590586|448308323|FG001|Overall Study|Withdrawal by Subject|0|||
124642404|NCT04590586|448308324|FG002|Overall Study|Withdrawal by Subject|6|||
124642405|NCT04590586|448308325|FG003|Overall Study|Withdrawal by Subject|0|||
124642406|NCT04590586|448308326|FG004|Overall Study|Withdrawal by Subject|3|||
124642407|NCT04590586|448308327|FG005|Overall Study|Withdrawal by Subject|0|||
124642408|NCT04590586|448308322|FG000|Overall Study|Other|3|||
124642409|NCT04590586|448308323|FG001|Overall Study|Other|0|||
124642410|NCT04590586|448308324|FG002|Overall Study|Other|1|||
124642411|NCT04590586|448308325|FG003|Overall Study|Other|1|||
124642412|NCT04590586|448308326|FG004|Overall Study|Other|2|||
124642413|NCT04590586|448308327|FG005|Overall Study|Other|1|||
124642414|NCT03063086|448308328|FG000|Overall Study|technical problems|1|||
124642415|NCT03063086|448308329|FG001|Overall Study|technical problems|0|||
124642416|NCT03063086|448308330|FG002|Overall Study|technical problems|0|||
124642417|NCT03063086|448308331|FG003|Overall Study|technical problems|0|||
124642418|NCT03063086|448308332|FG004|Overall Study|technical problems|0|||
124642419|NCT03063086|448308333|FG005|Overall Study|technical problems|0|||
124642420|NCT03063086|448308328|FG000|Overall Study|Adverse Event|1|||
124642421|NCT03063086|448308329|FG001|Overall Study|Adverse Event|1|||
124642422|NCT03063086|448308330|FG002|Overall Study|Adverse Event|1|||
124642423|NCT03063086|448308331|FG003|Overall Study|Adverse Event|1|||
124642424|NCT03063086|448308332|FG004|Overall Study|Adverse Event|0|||
124642425|NCT03063086|448308333|FG005|Overall Study|Adverse Event|0|||
124642426|NCT03063086|448308328|FG000|Overall Study|subject/guardian decision|1|||
124642427|NCT03063086|448308329|FG001|Overall Study|subject/guardian decision|0|||
124642428|NCT03063086|448308330|FG002|Overall Study|subject/guardian decision|0|||
124642429|NCT03063086|448308331|FG003|Overall Study|subject/guardian decision|0|||
124642430|NCT03063086|448308332|FG004|Overall Study|subject/guardian decision|0|||
124642431|NCT03063086|448308333|FG005|Overall Study|subject/guardian decision|0|||
124642432|NCT03063086|448308328|FG000|Overall Study|Non-compliance with study treatment|0|||
124642433|NCT03063086|448308329|FG001|Overall Study|Non-compliance with study treatment|0|||
124642434|NCT03063086|448308330|FG002|Overall Study|Non-compliance with study treatment|0|||
124642435|NCT03063086|448308331|FG003|Overall Study|Non-compliance with study treatment|1|||
124642436|NCT03063086|448308332|FG004|Overall Study|Non-compliance with study treatment|0|||
124642437|NCT03063086|448308333|FG005|Overall Study|Non-compliance with study treatment|1|||
124642438|NCT03063086|448308328|FG000|Overall Study|Physician Decision|0|||
124642439|NCT03063086|448308329|FG001|Overall Study|Physician Decision|0|||
124642440|NCT03063086|448308330|FG002|Overall Study|Physician Decision|0|||
124642441|NCT03063086|448308331|FG003|Overall Study|Physician Decision|1|||
124642442|NCT03063086|448308332|FG004|Overall Study|Physician Decision|0|||
124642443|NCT03063086|448308333|FG005|Overall Study|Physician Decision|0|||
124642444|NCT02218736|448308335|FG000|Overall Study|Withdrawal by Subject|10|||
124642445|NCT02218736|448308336|FG001|Overall Study|Withdrawal by Subject|9|||
124642446|NCT02218736|448308335|FG000|Overall Study|Protocol Violation|2|||
124642447|NCT02218736|448308336|FG001|Overall Study|Protocol Violation|0|||
124642448|NCT05481125|448308339|FG000|Overall Study|Adverse Event|1|||
124642449|NCT05481125|448308340|FG001|Overall Study|Adverse Event|0|||
124642450|NCT05481125|448308339|FG000|Overall Study|Lost to Follow-up|0|||
124642451|NCT05481125|448308340|FG001|Overall Study|Lost to Follow-up|1|||
124642452|NCT05481125|448308339|FG000|Overall Study|Withdrawal by Subject|0|||
124642453|NCT05481125|448308340|FG001|Overall Study|Withdrawal by Subject|1|||
124642454|NCT02244463|448308341|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
124642455|NCT02244463|448308342|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
124642456|NCT02244463|448308343|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
124642457|NCT02244463|448308344|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
124642458|NCT02244463|448308345|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
124642459|NCT02244463|448308346|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
124642460|NCT02244463|448308341|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
124642461|NCT02244463|448308342|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
124642462|NCT02244463|448308343|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
124642463|NCT02244463|448308344|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
124642464|NCT02244463|448308345|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
124642465|NCT02244463|448308346|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
124847205|NCT03013491|449064247|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
124847206|NCT03013491|449064248|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
124847207|NCT03013491|449064249|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
124642466|NCT02244463|448308341|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
124642467|NCT02244463|448308342|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
124642468|NCT02244463|448308343|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
124642469|NCT02244463|448308344|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
124642470|NCT02244463|448308345|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
124642471|NCT02244463|448308346|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
124642472|NCT02244463|448308341|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
124642473|NCT02244463|448308342|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
124642474|NCT02244463|448308343|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
124642475|NCT02244463|448308344|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
124642476|NCT02244463|448308345|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
124642477|NCT02244463|448308346|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
124642478|NCT02244463|448308341|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
124642479|NCT02244463|448308342|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
124642480|NCT02244463|448308343|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
124642481|NCT02244463|448308344|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
124642482|NCT02244463|448308345|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
124642483|NCT02244463|448308346|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
124642484|NCT02244463|448308341|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
124642485|NCT02244463|448308342|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
124642486|NCT02244463|448308343|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
124642487|NCT02244463|448308344|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
124642488|NCT02244463|448308345|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
124642489|NCT02244463|448308346|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
124642490|NCT02244463|448308341|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
124642491|NCT02244463|448308342|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
124642492|NCT02244463|448308343|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
124642493|NCT02244463|448308344|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
124642494|NCT02244463|448308345|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
124642495|NCT02244463|448308346|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
124642496|NCT02244463|448308341|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
124642497|NCT02244463|448308342|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
124642498|NCT02244463|448308343|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
124642499|NCT02244463|448308344|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
124642500|NCT02244463|448308345|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
124642501|NCT02244463|448308346|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
124642502|NCT02244463|448308341|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
124642503|NCT02244463|448308342|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
124642504|NCT02244463|448308343|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
124642505|NCT02244463|448308344|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
124642506|NCT02244463|448308345|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
124642507|NCT02244463|448308346|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
124642508|NCT02244463|448308341|FG000|Period 5: Phase II|Disease Progression|0|||
124642509|NCT02244463|448308342|FG001|Period 5: Phase II|Disease Progression|0|||
124642510|NCT02244463|448308343|FG002|Period 5: Phase II|Disease Progression|0|||
124642511|NCT02244463|448308344|FG003|Period 5: Phase II|Disease Progression|0|||
124642512|NCT02244463|448308345|FG004|Period 5: Phase II|Disease Progression|10|||
124642513|NCT02244463|448308346|FG005|Period 5: Phase II|Disease Progression|11|||
124642514|NCT02244463|448308341|FG000|Period 5: Phase II|Physician Decision|0|||
124642515|NCT02244463|448308342|FG001|Period 5: Phase II|Physician Decision|0|||
124642516|NCT02244463|448308343|FG002|Period 5: Phase II|Physician Decision|0|||
124642517|NCT02244463|448308344|FG003|Period 5: Phase II|Physician Decision|0|||
124642518|NCT02244463|448308345|FG004|Period 5: Phase II|Physician Decision|3|||
124642519|NCT02244463|448308346|FG005|Period 5: Phase II|Physician Decision|2|||
124642520|NCT02244463|448308341|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
124642521|NCT02244463|448308342|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
124642522|NCT02244463|448308343|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
124642523|NCT02244463|448308344|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
124642524|NCT02244463|448308345|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
124642525|NCT02244463|448308346|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
124642526|NCT02244463|448308341|FG000|Period 5: Phase II|Intercurrent Illness|0|||
124642527|NCT02244463|448308342|FG001|Period 5: Phase II|Intercurrent Illness|0|||
124642528|NCT02244463|448308343|FG002|Period 5: Phase II|Intercurrent Illness|0|||
124642529|NCT02244463|448308344|FG003|Period 5: Phase II|Intercurrent Illness|0|||
124642530|NCT02244463|448308345|FG004|Period 5: Phase II|Intercurrent Illness|2|||
124642531|NCT02244463|448308346|FG005|Period 5: Phase II|Intercurrent Illness|0|||
124642532|NCT02244463|448308341|FG000|Period 5: Phase II|Adverse Event|0|||
124642533|NCT02244463|448308342|FG001|Period 5: Phase II|Adverse Event|0|||
124642534|NCT02244463|448308343|FG002|Period 5: Phase II|Adverse Event|0|||
124642535|NCT02244463|448308344|FG003|Period 5: Phase II|Adverse Event|0|||
124642536|NCT02244463|448308345|FG004|Period 5: Phase II|Adverse Event|0|||
124642537|NCT02244463|448308346|FG005|Period 5: Phase II|Adverse Event|2|||
124642538|NCT02244463|448308341|FG000|Period 5: Phase II|Still On treatment|0|||
124642539|NCT02244463|448308342|FG001|Period 5: Phase II|Still On treatment|0|||
124642540|NCT02244463|448308343|FG002|Period 5: Phase II|Still On treatment|0|||
124642541|NCT02244463|448308344|FG003|Period 5: Phase II|Still On treatment|0|||
124642542|NCT02244463|448308345|FG004|Period 5: Phase II|Still On treatment|0|||
124642543|NCT02244463|448308346|FG005|Period 5: Phase II|Still On treatment|3|||
124642544|NCT01769508|448308347|FG000|Overall Study|Death|3|||
124642545|NCT01769508|448308347|FG000|Overall Study|Withdrawal by Subject|1|||
124642546|NCT01769508|448308347|FG000|Overall Study|Adverse Event|1|||
124642547|NCT01769508|448308347|FG000|Overall Study|Lost to Follow-up|1|||
124642548|NCT03615144|448308348|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
124642549|NCT03615144|448308349|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
124642550|NCT02587598|448308352|FG000|Overall Study|Death|4|||
124642551|NCT02587598|448308353|FG001|Overall Study|Death|8|||
124847208|NCT03013491|449064250|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
124847209|NCT03013491|449064251|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
124847210|NCT03013491|449064252|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
124847211|NCT03013491|449064253|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
124847212|NCT03013491|449064254|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
124847213|NCT03013491|449064255|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
124847214|NCT03013491|449064256|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
124847215|NCT03013491|449064257|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
124847216|NCT03013491|449064239|FG000|Main Study|Start of new anticancer therapy|0|||
124847217|NCT03013491|449064240|FG001|Main Study|Start of new anticancer therapy|0|||
124847218|NCT03013491|449064241|FG002|Main Study|Start of new anticancer therapy|0|||
124847219|NCT03013491|449064242|FG003|Main Study|Start of new anticancer therapy|0|||
124847220|NCT03013491|449064243|FG004|Main Study|Start of new anticancer therapy|0|||
124847221|NCT03013491|449064244|FG005|Main Study|Start of new anticancer therapy|0|||
124847222|NCT03013491|449064245|FG006|Main Study|Start of new anticancer therapy|0|||
124847223|NCT03013491|449064246|FG007|Main Study|Start of new anticancer therapy|0|||
124847224|NCT03013491|449064247|FG008|Main Study|Start of new anticancer therapy|0|||
124847225|NCT03013491|449064248|FG009|Main Study|Start of new anticancer therapy|0|||
124847226|NCT03013491|449064249|FG010|Main Study|Start of new anticancer therapy|0|||
124847227|NCT03013491|449064250|FG011|Main Study|Start of new anticancer therapy|0|||
124847228|NCT03013491|449064251|FG012|Main Study|Start of new anticancer therapy|0|||
124847229|NCT03013491|449064252|FG013|Main Study|Start of new anticancer therapy|0|||
124847230|NCT03013491|449064253|FG014|Main Study|Start of new anticancer therapy|0|||
124847231|NCT03013491|449064254|FG015|Main Study|Start of new anticancer therapy|0|||
124847232|NCT03013491|449064255|FG016|Main Study|Start of new anticancer therapy|0|||
124847233|NCT03013491|449064256|FG017|Main Study|Start of new anticancer therapy|0|||
124847234|NCT03013491|449064257|FG018|Main Study|Start of new anticancer therapy|2|||
124847235|NCT03013491|449064239|FG000|Long-term Extension|Disease progression|0|||
124642552|NCT02587598|448308354|FG002|Overall Study|Death|4|||
124642553|NCT02587598|448308355|FG003|Overall Study|Death|16|||
124642554|NCT02587598|448308356|FG004|Overall Study|Death|9|||
124642555|NCT02587598|448308357|FG005|Overall Study|Death|4|||
124642556|NCT02587598|448308358|FG006|Overall Study|Death|6|||
124642557|NCT02587598|448308359|FG007|Overall Study|Death|7|||
124642558|NCT02587598|448308360|FG008|Overall Study|Death|9|||
124642559|NCT02587598|448308361|FG009|Overall Study|Death|1|||
124642560|NCT02587598|448308362|FG010|Overall Study|Death|3|||
124642561|NCT02587598|448308352|FG000|Overall Study|Study Terminated by the Sponsor|0|||
124642562|NCT02587598|448308353|FG001|Overall Study|Study Terminated by the Sponsor|1|||
124642563|NCT02587598|448308354|FG002|Overall Study|Study Terminated by the Sponsor|0|||
124642564|NCT02587598|448308355|FG003|Overall Study|Study Terminated by the Sponsor|3|||
124642565|NCT02587598|448308356|FG004|Overall Study|Study Terminated by the Sponsor|0|||
124642566|NCT02587598|448308357|FG005|Overall Study|Study Terminated by the Sponsor|1|||
124642567|NCT02587598|448308358|FG006|Overall Study|Study Terminated by the Sponsor|0|||
124642568|NCT02587598|448308359|FG007|Overall Study|Study Terminated by the Sponsor|0|||
124642569|NCT02587598|448308360|FG008|Overall Study|Study Terminated by the Sponsor|0|||
124642570|NCT02587598|448308361|FG009|Overall Study|Study Terminated by the Sponsor|1|||
124642571|NCT02587598|448308362|FG010|Overall Study|Study Terminated by the Sponsor|6|||
124642572|NCT02587598|448308352|FG000|Overall Study|Reason for study withdrawal not specified|0|||
124642573|NCT02587598|448308353|FG001|Overall Study|Reason for study withdrawal not specified|1|||
124642574|NCT02587598|448308354|FG002|Overall Study|Reason for study withdrawal not specified|0|||
124642575|NCT02587598|448308355|FG003|Overall Study|Reason for study withdrawal not specified|0|||
124642576|NCT02587598|448308356|FG004|Overall Study|Reason for study withdrawal not specified|0|||
124642577|NCT02587598|448308357|FG005|Overall Study|Reason for study withdrawal not specified|0|||
124642578|NCT02587598|448308358|FG006|Overall Study|Reason for study withdrawal not specified|0|||
124642579|NCT02587598|448308359|FG007|Overall Study|Reason for study withdrawal not specified|0|||
124642580|NCT02587598|448308360|FG008|Overall Study|Reason for study withdrawal not specified|0|||
124642581|NCT02587598|448308361|FG009|Overall Study|Reason for study withdrawal not specified|0|||
124642582|NCT02587598|448308362|FG010|Overall Study|Reason for study withdrawal not specified|0|||
124642583|NCT02587598|448308352|FG000|Overall Study|Withdrawal by Subject|0|||
124642584|NCT02587598|448308353|FG001|Overall Study|Withdrawal by Subject|1|||
124642585|NCT02587598|448308354|FG002|Overall Study|Withdrawal by Subject|0|||
124642586|NCT02587598|448308355|FG003|Overall Study|Withdrawal by Subject|2|||
124642587|NCT02587598|448308356|FG004|Overall Study|Withdrawal by Subject|3|||
124642588|NCT02587598|448308357|FG005|Overall Study|Withdrawal by Subject|1|||
124642589|NCT02587598|448308358|FG006|Overall Study|Withdrawal by Subject|0|||
124642590|NCT02587598|448308359|FG007|Overall Study|Withdrawal by Subject|0|||
124642591|NCT02587598|448308360|FG008|Overall Study|Withdrawal by Subject|0|||
124642592|NCT02587598|448308361|FG009|Overall Study|Withdrawal by Subject|1|||
124642593|NCT02587598|448308362|FG010|Overall Study|Withdrawal by Subject|2|||
124642594|NCT02587598|448308352|FG000|Overall Study|Physician Decision|0|||
124642595|NCT02587598|448308353|FG001|Overall Study|Physician Decision|0|||
124642596|NCT02587598|448308354|FG002|Overall Study|Physician Decision|0|||
124642597|NCT02587598|448308355|FG003|Overall Study|Physician Decision|0|||
124642598|NCT02587598|448308356|FG004|Overall Study|Physician Decision|0|||
124642599|NCT02587598|448308357|FG005|Overall Study|Physician Decision|0|||
124642600|NCT02587598|448308358|FG006|Overall Study|Physician Decision|0|||
124642601|NCT02587598|448308359|FG007|Overall Study|Physician Decision|0|||
124642602|NCT02587598|448308360|FG008|Overall Study|Physician Decision|0|||
124642603|NCT02587598|448308361|FG009|Overall Study|Physician Decision|0|||
124642604|NCT02587598|448308362|FG010|Overall Study|Physician Decision|3|||
124642605|NCT02828124|448308365|FG000|Overall Study|Disease Progression|1|||
124642606|NCT02828124|448308366|FG001|Overall Study|Disease Progression|2|||
124642607|NCT02828124|448308367|FG002|Overall Study|Disease Progression|1|||
124642608|NCT02828124|448308368|FG003|Overall Study|Disease Progression|4|||
124642609|NCT02828124|448308365|FG000|Overall Study|AE Unrelated to Study Drug|0|||
124642610|NCT02828124|448308366|FG001|Overall Study|AE Unrelated to Study Drug|0|||
124642611|NCT02828124|448308367|FG002|Overall Study|AE Unrelated to Study Drug|0|||
124642612|NCT02828124|448308368|FG003|Overall Study|AE Unrelated to Study Drug|1|||
124642613|NCT02828124|448308365|FG000|Overall Study|Subject Withdrew Consent|0|||
124642614|NCT02828124|448308366|FG001|Overall Study|Subject Withdrew Consent|0|||
124642615|NCT02828124|448308367|FG002|Overall Study|Subject Withdrew Consent|0|||
124642616|NCT02828124|448308368|FG003|Overall Study|Subject Withdrew Consent|1|||
124642617|NCT06586788|448308371|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
124642618|NCT03514485|448308372|FG000|Overall Study|Lost to Follow-up|5|||
124642619|NCT03514485|448308373|FG001|Overall Study|Lost to Follow-up|3|||
124642620|NCT03514485|448308374|FG002|Overall Study|Lost to Follow-up|2|||
124642621|NCT03514485|448308375|FG003|Overall Study|Lost to Follow-up|0|||
124642622|NCT03514485|448308376|FG004|Overall Study|Lost to Follow-up|1|||
124642623|NCT03514485|448308377|FG005|Overall Study|Lost to Follow-up|4|||
124642624|NCT03514485|448308372|FG000|Overall Study|Withdrawal by Subject|0|||
124642625|NCT03514485|448308373|FG001|Overall Study|Withdrawal by Subject|1|||
124642626|NCT03514485|448308374|FG002|Overall Study|Withdrawal by Subject|3|||
124642627|NCT03514485|448308375|FG003|Overall Study|Withdrawal by Subject|1|||
124642628|NCT03514485|448308376|FG004|Overall Study|Withdrawal by Subject|2|||
124642629|NCT03514485|448308377|FG005|Overall Study|Withdrawal by Subject|1|||
124642630|NCT00791661|448308378|FG000|7 Day Wash-out|Adverse Event|0|||
124642631|NCT00791661|448308379|FG001|7 Day Wash-out|Adverse Event|0|||
124642632|NCT00791661|448308380|FG002|7 Day Wash-out|Adverse Event|1|||
124642633|NCT00791661|448308378|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
124642634|NCT00791661|448308379|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
124642635|NCT00791661|448308380|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
124642636|NCT00492648|448308381|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
124642637|NCT00492648|448308382|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
124642638|NCT01167881|448308385|FG000|Overall Study|Adverse Event|47|||
124642639|NCT01167881|448308386|FG001|Overall Study|Adverse Event|51|||
124642640|NCT01167881|448308385|FG000|Overall Study|Lack of Efficacy|4|||
124642641|NCT01167881|448308386|FG001|Overall Study|Lack of Efficacy|7|||
124642642|NCT01167881|448308385|FG000|Overall Study|Non compliant with protocol|9|||
124642643|NCT01167881|448308386|FG001|Overall Study|Non compliant with protocol|18|||
124642644|NCT01167881|448308385|FG000|Overall Study|Lost to Follow-up|19|||
124642645|NCT01167881|448308386|FG001|Overall Study|Lost to Follow-up|20|||
124642646|NCT01167881|448308385|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
124642647|NCT01167881|448308386|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
124642648|NCT01167881|448308385|FG000|Overall Study|Not treated|4|||
124642649|NCT01167881|448308386|FG001|Overall Study|Not treated|0|||
124642650|NCT01167881|448308385|FG000|Overall Study|Other not defined above|31|||
124642651|NCT01167881|448308386|FG001|Overall Study|Other not defined above|55|||
124642652|NCT01435460|448308387|FG000|Overall Study|Adverse Event|2|||
124847236|NCT03013491|449064240|FG001|Long-term Extension|Disease progression|0|||
124642653|NCT01435460|448308388|FG001|Overall Study|Adverse Event|1|||
124642654|NCT01435460|448308387|FG000|Overall Study|Lost to Follow-up|6|||
124642655|NCT01435460|448308388|FG001|Overall Study|Lost to Follow-up|1|||
124642656|NCT01435460|448308387|FG000|Overall Study|Withdrawal by Subject|1|||
124642657|NCT01435460|448308388|FG001|Overall Study|Withdrawal by Subject|3|||
124642658|NCT01435460|448308387|FG000|Overall Study|Protocol Violation|0|||
124642659|NCT01435460|448308388|FG001|Overall Study|Protocol Violation|1|||
124642660|NCT01435460|448308387|FG000|Overall Study|Did not meet eligibility criteria|2|||
124642661|NCT01435460|448308388|FG001|Overall Study|Did not meet eligibility criteria|0|||
124642662|NCT01706939|448308389|FG000|Pre Randomization|Screen Failure|1|||
124642663|NCT01706939|448308390|FG001|Pre Randomization|Screen Failure|0|||
124642664|NCT01706939|448308391|FG002|Pre Randomization|Screen Failure|0|||
124642665|NCT01706939|448308389|FG000|Pre Randomization|Ineligible for Randomization|1|||
124847237|NCT03013491|449064241|FG002|Long-term Extension|Disease progression|0|||
124847238|NCT03013491|449064242|FG003|Long-term Extension|Disease progression|1|||
124642666|NCT01706939|448308390|FG001|Pre Randomization|Ineligible for Randomization|0|||
124642667|NCT01706939|448308391|FG002|Pre Randomization|Ineligible for Randomization|0|||
124642668|NCT01706939|448308389|FG000|Pre Randomization|Withdrawal by Subject|1|||
124642669|NCT01706939|448308390|FG001|Pre Randomization|Withdrawal by Subject|0|||
124642670|NCT01706939|448308391|FG002|Pre Randomization|Withdrawal by Subject|0|||
124642671|NCT01706939|448308389|FG000|Randomization|Insufficient QoL survey compliance|0|||
124642672|NCT01706939|448308390|FG001|Randomization|Insufficient QoL survey compliance|1|||
124642673|NCT01706939|448308391|FG002|Randomization|Insufficient QoL survey compliance|1|||
124642674|NCT01706939|448308389|FG000|Randomization|Progression of disease|0|||
124642675|NCT01706939|448308390|FG001|Randomization|Progression of disease|2|||
124642676|NCT01706939|448308391|FG002|Randomization|Progression of disease|1|||
124642677|NCT01094301|448308394|FG000|Trial Stage|Withdrawal by Subject|1|||
124642678|NCT01094301|448308394|FG000|Implant Stage|Adverse Event|1|||
124642679|NCT01094301|448308394|FG000|Implant Stage|Protocol Violation|1|||
124642680|NCT01094301|448308394|FG000|Implant Stage|Withdrawal by Subject|2|||
124642681|NCT01094301|448308394|FG000|Implant Stage|No return of pain|4|||
124642682|NCT02235077|448308395|FG000|Overall Study|Death|5|||
124642683|NCT02235077|448308396|FG001|Overall Study|Death|7|||
124642684|NCT02235077|448308395|FG000|Overall Study|Lost to Follow-up|5|||
124642685|NCT02235077|448308396|FG001|Overall Study|Lost to Follow-up|6|||
124642686|NCT02235077|448308395|FG000|Overall Study|Withdrawal by Subject|8|||
124642687|NCT02235077|448308396|FG001|Overall Study|Withdrawal by Subject|5|||
124642688|NCT02235077|448308395|FG000|Overall Study|Physician Decision|0|||
124642689|NCT02235077|448308396|FG001|Overall Study|Physician Decision|1|||
124642690|NCT00582608|448308397|FG000|Overall Study|Not Treated|7|||
124642691|NCT00582608|448308397|FG000|Overall Study|Patient Ineligible|1|||
124642692|NCT00582608|448308397|FG000|Overall Study|Lack of accrual|4|||
124642693|NCT04013672|448308398|FG000|Overall Study|Withdrawal by Subject|3|||
124642694|NCT04013672|448308399|FG001|Overall Study|Withdrawal by Subject|0|||
124642695|NCT04013672|448308398|FG000|Overall Study|Death|1|||
124642696|NCT04013672|448308399|FG001|Overall Study|Death|0|||
124642697|NCT04013672|448308398|FG000|Overall Study|Physician Decision|5|||
124642698|NCT04013672|448308399|FG001|Overall Study|Physician Decision|0|||
124642699|NCT01868022|448308404|FG000|Overall Study|Withdrawal by Subject|0|||
124642700|NCT01868022|448308405|FG001|Overall Study|Withdrawal by Subject|0|||
124642701|NCT01868022|448308406|FG002|Overall Study|Withdrawal by Subject|1|||
124642702|NCT01868022|448308407|FG003|Overall Study|Withdrawal by Subject|1|||
124642703|NCT01868022|448308408|FG004|Overall Study|Withdrawal by Subject|0|||
124642704|NCT01868022|448308409|FG005|Overall Study|Withdrawal by Subject|0|||
124642705|NCT01868022|448308410|FG006|Overall Study|Withdrawal by Subject|0|||
124642706|NCT01868022|448308411|FG007|Overall Study|Withdrawal by Subject|1|||
124642707|NCT01868022|448308412|FG008|Overall Study|Withdrawal by Subject|0|||
124642708|NCT01868022|448308404|FG000|Overall Study|Adverse Event|0|||
124642709|NCT01868022|448308405|FG001|Overall Study|Adverse Event|0|||
124642710|NCT01868022|448308406|FG002|Overall Study|Adverse Event|0|||
124642711|NCT01868022|448308407|FG003|Overall Study|Adverse Event|0|||
124642712|NCT01868022|448308408|FG004|Overall Study|Adverse Event|2|||
124642713|NCT01868022|448308409|FG005|Overall Study|Adverse Event|0|||
124642714|NCT01868022|448308410|FG006|Overall Study|Adverse Event|0|||
124642715|NCT01868022|448308411|FG007|Overall Study|Adverse Event|2|||
124642716|NCT01868022|448308412|FG008|Overall Study|Adverse Event|2|||
124642717|NCT01868022|448308404|FG000|Overall Study|Physician Decision|0|||
124642718|NCT01868022|448308405|FG001|Overall Study|Physician Decision|0|||
124642719|NCT01868022|448308406|FG002|Overall Study|Physician Decision|0|||
124642720|NCT01868022|448308407|FG003|Overall Study|Physician Decision|0|||
124642721|NCT01868022|448308408|FG004|Overall Study|Physician Decision|0|||
124642722|NCT01868022|448308409|FG005|Overall Study|Physician Decision|1|||
124642723|NCT01868022|448308410|FG006|Overall Study|Physician Decision|0|||
124642724|NCT01868022|448308411|FG007|Overall Study|Physician Decision|2|||
124642725|NCT01868022|448308412|FG008|Overall Study|Physician Decision|0|||
124642726|NCT01868022|448308404|FG000|Overall Study|Study closed/terminated|0|||
124642727|NCT01868022|448308405|FG001|Overall Study|Study closed/terminated|0|||
124642728|NCT01868022|448308406|FG002|Overall Study|Study closed/terminated|0|||
124642729|NCT01868022|448308407|FG003|Overall Study|Study closed/terminated|0|||
124642730|NCT01868022|448308408|FG004|Overall Study|Study closed/terminated|0|||
124642731|NCT01868022|448308409|FG005|Overall Study|Study closed/terminated|0|||
124642732|NCT01868022|448308410|FG006|Overall Study|Study closed/terminated|0|||
124642733|NCT01868022|448308411|FG007|Overall Study|Study closed/terminated|1|||
124642734|NCT01868022|448308412|FG008|Overall Study|Study closed/terminated|0|||
124642735|NCT01868022|448308404|FG000|Overall Study|Ongoing|0|||
124642736|NCT01868022|448308405|FG001|Overall Study|Ongoing|0|||
124642737|NCT01868022|448308406|FG002|Overall Study|Ongoing|0|||
124642738|NCT01868022|448308407|FG003|Overall Study|Ongoing|0|||
124642739|NCT01868022|448308408|FG004|Overall Study|Ongoing|0|||
124642740|NCT01868022|448308409|FG005|Overall Study|Ongoing|0|||
124642741|NCT01868022|448308410|FG006|Overall Study|Ongoing|0|||
124642742|NCT01868022|448308411|FG007|Overall Study|Ongoing|3|||
124642743|NCT01868022|448308412|FG008|Overall Study|Ongoing|0|||
124642744|NCT03386994|448308413|FG000|Overall Study|Lung transplant|1|||
124642745|NCT03386994|448308413|FG000|Overall Study|Adverse Event|14|||
124642746|NCT03386994|448308413|FG000|Overall Study|Lost to Follow-up|4|||
124642747|NCT03386994|448308413|FG000|Overall Study|Withdrawal by Subject|3|||
124642748|NCT03386994|448308413|FG000|Overall Study|Death|16|||
124642749|NCT01217476|448308416|FG000|Overall Study|Adverse Event|6|||
124642750|NCT01217476|448308417|FG001|Overall Study|Adverse Event|1|||
124642751|NCT01217476|448308416|FG000|Overall Study|Physician Decision|0|||
124642752|NCT01217476|448308417|FG001|Overall Study|Physician Decision|1|||
124642753|NCT01217476|448308416|FG000|Overall Study|Withdrawal by Subject|3|||
124642754|NCT01217476|448308417|FG001|Overall Study|Withdrawal by Subject|3|||
124642755|NCT01217476|448308416|FG000|Overall Study|Surgery on the Target Limb|0|||
124642756|NCT01217476|448308417|FG001|Overall Study|Surgery on the Target Limb|2|||
124642757|NCT01217476|448308416|FG000|Overall Study|Protocol Deviation|1|||
124642758|NCT01217476|448308417|FG001|Overall Study|Protocol Deviation|0|||
124642759|NCT01217476|448308416|FG000|Overall Study|Other|2|||
124642760|NCT01217476|448308417|FG001|Overall Study|Other|0|||
124642761|NCT02147158|448308418|FG000|Treatment Course 1|Adverse Event|1|||
124642762|NCT02147158|448308419|FG001|Treatment Course 1|Adverse Event|4|||
124642763|NCT02147158|448308420|FG002|Treatment Course 1|Adverse Event|3|||
124642764|NCT02147158|448308421|FG003|Treatment Course 1|Adverse Event|4|||
124642765|NCT02147158|448308422|FG004|Treatment Course 1|Adverse Event|1|||
124642766|NCT02147158|448308423|FG005|Treatment Course 1|Adverse Event|2|||
124642767|NCT02147158|448308418|FG000|Treatment Course 1|Lost to Follow-up|2|||
124642768|NCT02147158|448308419|FG001|Treatment Course 1|Lost to Follow-up|4|||
124642769|NCT02147158|448308420|FG002|Treatment Course 1|Lost to Follow-up|3|||
124642770|NCT02147158|448308421|FG003|Treatment Course 1|Lost to Follow-up|3|||
124642771|NCT02147158|448308422|FG004|Treatment Course 1|Lost to Follow-up|2|||
124642772|NCT02147158|448308423|FG005|Treatment Course 1|Lost to Follow-up|4|||
124642773|NCT02147158|448308418|FG000|Treatment Course 1|Protocol Violation|0|||
124642774|NCT02147158|448308419|FG001|Treatment Course 1|Protocol Violation|0|||
124642775|NCT02147158|448308420|FG002|Treatment Course 1|Protocol Violation|1|||
124642776|NCT02147158|448308421|FG003|Treatment Course 1|Protocol Violation|1|||
124642777|NCT02147158|448308422|FG004|Treatment Course 1|Protocol Violation|0|||
124642778|NCT02147158|448308423|FG005|Treatment Course 1|Protocol Violation|0|||
124642779|NCT02147158|448308418|FG000|Treatment Course 1|Withdrawal of Consent|1|||
124642780|NCT02147158|448308419|FG001|Treatment Course 1|Withdrawal of Consent|1|||
124642781|NCT02147158|448308420|FG002|Treatment Course 1|Withdrawal of Consent|1|||
124642782|NCT02147158|448308421|FG003|Treatment Course 1|Withdrawal of Consent|5|||
124642783|NCT02147158|448308422|FG004|Treatment Course 1|Withdrawal of Consent|3|||
124642784|NCT02147158|448308423|FG005|Treatment Course 1|Withdrawal of Consent|2|||
124642785|NCT02147158|448308418|FG000|Off-Treatment Interval 1|Adverse Event|1|||
124642786|NCT02147158|448308419|FG001|Off-Treatment Interval 1|Adverse Event|0|||
124642787|NCT02147158|448308420|FG002|Off-Treatment Interval 1|Adverse Event|0|||
124642788|NCT02147158|448308421|FG003|Off-Treatment Interval 1|Adverse Event|1|||
124642789|NCT02147158|448308422|FG004|Off-Treatment Interval 1|Adverse Event|0|||
124642790|NCT02147158|448308423|FG005|Off-Treatment Interval 1|Adverse Event|0|||
124642791|NCT02147158|448308418|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
124642792|NCT02147158|448308419|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
124642793|NCT02147158|448308420|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
124642794|NCT02147158|448308421|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
124642795|NCT02147158|448308422|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
124642796|NCT02147158|448308423|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
124642797|NCT02147158|448308418|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
124642798|NCT02147158|448308419|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
124642799|NCT02147158|448308420|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
124642800|NCT02147158|448308421|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
124642801|NCT02147158|448308422|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
124642802|NCT02147158|448308423|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
124642803|NCT02147158|448308418|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
124642804|NCT02147158|448308419|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
124642805|NCT02147158|448308420|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
124642806|NCT02147158|448308421|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
124642807|NCT02147158|448308422|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
124642808|NCT02147158|448308423|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
124642809|NCT02147158|448308418|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
124642810|NCT02147158|448308419|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
124642811|NCT02147158|448308420|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
124642812|NCT02147158|448308421|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
124642813|NCT02147158|448308422|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
124642814|NCT02147158|448308423|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
124642815|NCT02147158|448308418|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
124847239|NCT03013491|449064243|FG004|Long-term Extension|Disease progression|0|||
124642816|NCT02147158|448308419|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
124642817|NCT02147158|448308420|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
124642818|NCT02147158|448308421|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
124642819|NCT02147158|448308422|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
124642820|NCT02147158|448308423|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
124642821|NCT02147158|448308418|FG000|Treatment Course 2|Adverse Event|0|||
124642822|NCT02147158|448308419|FG001|Treatment Course 2|Adverse Event|4|||
124642823|NCT02147158|448308420|FG002|Treatment Course 2|Adverse Event|2|||
124642824|NCT02147158|448308421|FG003|Treatment Course 2|Adverse Event|1|||
124642825|NCT02147158|448308422|FG004|Treatment Course 2|Adverse Event|0|||
124642826|NCT02147158|448308423|FG005|Treatment Course 2|Adverse Event|1|||
124642827|NCT02147158|448308418|FG000|Treatment Course 2|Withdrawal of Consent|0|||
124642828|NCT02147158|448308419|FG001|Treatment Course 2|Withdrawal of Consent|1|||
124642829|NCT02147158|448308420|FG002|Treatment Course 2|Withdrawal of Consent|2|||
124642830|NCT02147158|448308421|FG003|Treatment Course 2|Withdrawal of Consent|3|||
124642831|NCT02147158|448308422|FG004|Treatment Course 2|Withdrawal of Consent|0|||
124642832|NCT02147158|448308423|FG005|Treatment Course 2|Withdrawal of Consent|0|||
124642833|NCT02147158|448308418|FG000|Treatment Course 2|Lost to Follow-up|1|||
124642834|NCT02147158|448308419|FG001|Treatment Course 2|Lost to Follow-up|0|||
124642835|NCT02147158|448308420|FG002|Treatment Course 2|Lost to Follow-up|1|||
124642836|NCT02147158|448308421|FG003|Treatment Course 2|Lost to Follow-up|1|||
124642837|NCT02147158|448308422|FG004|Treatment Course 2|Lost to Follow-up|0|||
124642838|NCT02147158|448308423|FG005|Treatment Course 2|Lost to Follow-up|1|||
124642839|NCT02147158|448308418|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
124642840|NCT02147158|448308419|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
124642841|NCT02147158|448308420|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
124642842|NCT02147158|448308421|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
124642843|NCT02147158|448308422|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
124642844|NCT02147158|448308423|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
124642845|NCT02147158|448308418|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
124642846|NCT02147158|448308419|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
124642847|NCT02147158|448308420|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
124642848|NCT02147158|448308421|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
124642849|NCT02147158|448308422|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
124642850|NCT02147158|448308423|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
124642851|NCT02147158|448308418|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
124642852|NCT02147158|448308419|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
124642853|NCT02147158|448308420|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
124642854|NCT02147158|448308421|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
124642855|NCT02147158|448308422|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
124642856|NCT02147158|448308423|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
124642857|NCT02147158|448308418|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
124642858|NCT02147158|448308419|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
124642859|NCT02147158|448308420|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
124642860|NCT02147158|448308421|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
124642861|NCT02147158|448308422|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
124642862|NCT02147158|448308423|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
124642863|NCT02147158|448308418|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
124642864|NCT02147158|448308419|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
124642865|NCT02147158|448308420|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
124642866|NCT02147158|448308421|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
124642867|NCT02147158|448308422|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
124642868|NCT02147158|448308423|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
124642869|NCT04445714|448308424|FG000|Overall Study|Discontinuation of the study|14|||
124642870|NCT04445714|448308424|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
124642871|NCT04445714|448308424|FG000|Overall Study|Withdrawal of Informed Consent|8|||
124642872|NCT02805660|448308425|FG000|Overall Study|Death|5|||
124642873|NCT02805660|448308426|FG001|Overall Study|Death|2|||
124642874|NCT02805660|448308427|FG002|Overall Study|Death|9|||
124642875|NCT02805660|448308428|FG003|Overall Study|Death|5|||
124642876|NCT02805660|448308429|FG004|Overall Study|Death|0|||
124642877|NCT02805660|448308430|FG005|Overall Study|Death|14|||
124642878|NCT02805660|448308431|FG006|Overall Study|Death|12|||
124642879|NCT02805660|448308425|FG000|Overall Study|Lost to Follow-up|0|||
124642880|NCT02805660|448308426|FG001|Overall Study|Lost to Follow-up|1|||
124642881|NCT02805660|448308427|FG002|Overall Study|Lost to Follow-up|1|||
124642882|NCT02805660|448308428|FG003|Overall Study|Lost to Follow-up|2|||
124642883|NCT02805660|448308429|FG004|Overall Study|Lost to Follow-up|0|||
124642884|NCT02805660|448308430|FG005|Overall Study|Lost to Follow-up|0|||
124642885|NCT02805660|448308431|FG006|Overall Study|Lost to Follow-up|0|||
124642886|NCT02805660|448308425|FG000|Overall Study|Withdrawal by Subject|0|||
124642887|NCT02805660|448308426|FG001|Overall Study|Withdrawal by Subject|0|||
124642888|NCT02805660|448308427|FG002|Overall Study|Withdrawal by Subject|0|||
124642889|NCT02805660|448308428|FG003|Overall Study|Withdrawal by Subject|3|||
124642890|NCT02805660|448308429|FG004|Overall Study|Withdrawal by Subject|1|||
124642891|NCT02805660|448308430|FG005|Overall Study|Withdrawal by Subject|0|||
124642892|NCT02805660|448308431|FG006|Overall Study|Withdrawal by Subject|2|||
124642893|NCT02805660|448308425|FG000|Overall Study|Study terminated by Sponsor|0|||
124642894|NCT02805660|448308426|FG001|Overall Study|Study terminated by Sponsor|0|||
124642895|NCT02805660|448308427|FG002|Overall Study|Study terminated by Sponsor|1|||
124642896|NCT02805660|448308428|FG003|Overall Study|Study terminated by Sponsor|4|||
124642897|NCT02805660|448308429|FG004|Overall Study|Study terminated by Sponsor|2|||
124642898|NCT02805660|448308430|FG005|Overall Study|Study terminated by Sponsor|3|||
124642899|NCT02805660|448308431|FG006|Overall Study|Study terminated by Sponsor|1|||
124642900|NCT02805660|448308425|FG000|Overall Study|Miscellaneous|0|||
124642901|NCT02805660|448308426|FG001|Overall Study|Miscellaneous|1|||
124642902|NCT02805660|448308427|FG002|Overall Study|Miscellaneous|0|||
124642903|NCT02805660|448308428|FG003|Overall Study|Miscellaneous|4|||
124642904|NCT02805660|448308429|FG004|Overall Study|Miscellaneous|0|||
124642905|NCT02805660|448308430|FG005|Overall Study|Miscellaneous|6|||
124642906|NCT02805660|448308431|FG006|Overall Study|Miscellaneous|4|||
124642907|NCT01684943|448308432|FG000|Overall Study|Inadequate Venous Access|3|||
124642908|NCT01684943|448308433|FG001|Overall Study|Inadequate Venous Access|0|||
124642909|NCT01684943|448308434|FG002|Overall Study|Inadequate Venous Access|0|||
124642910|NCT01684943|448308432|FG000|Overall Study|Principal Investigator Determination|1|||
124642911|NCT01684943|448308433|FG001|Overall Study|Principal Investigator Determination|0|||
124642912|NCT01684943|448308434|FG002|Overall Study|Principal Investigator Determination|0|||
124642913|NCT01684943|448308432|FG000|Overall Study|Excluded from Analysis|1|||
124642914|NCT01684943|448308433|FG001|Overall Study|Excluded from Analysis|1|||
124642915|NCT01684943|448308434|FG002|Overall Study|Excluded from Analysis|1|||
124642916|NCT01684943|448308432|FG000|Overall Study|Lost to Follow-up|3|||
124642917|NCT01684943|448308433|FG001|Overall Study|Lost to Follow-up|0|||
124642918|NCT01684943|448308434|FG002|Overall Study|Lost to Follow-up|0|||
124642919|NCT01684943|448308432|FG000|Overall Study|Planning Pregnancy|1|||
124642920|NCT01684943|448308433|FG001|Overall Study|Planning Pregnancy|0|||
124642921|NCT01684943|448308434|FG002|Overall Study|Planning Pregnancy|0|||
124642922|NCT02122887|448308437|FG000|Overall Study|Withdrawal by Subject|20|||
124642923|NCT02122887|448308438|FG001|Overall Study|Withdrawal by Subject|2|||
124642924|NCT03652636|448310552|FG000|Overall Study|Withdrawal by Subject|7|||
124642925|NCT00504725|448310553|FG000|Overall Study|Protocol Violation|1|||
124642926|NCT00504725|448310554|FG001|Overall Study|Protocol Violation|0|||
124642927|NCT00769067|448310556|FG000|Overall Study|Death|89|||
124642928|NCT00769067|448310557|FG001|Overall Study|Death|86|||
124642929|NCT00769067|448310556|FG000|Overall Study|Lost to Follow-up|3|||
124642930|NCT00769067|448310557|FG001|Overall Study|Lost to Follow-up|1|||
124642931|NCT00769067|448310556|FG000|Overall Study|Study terminated by sponsor|1|||
124642932|NCT00769067|448310557|FG001|Overall Study|Study terminated by sponsor|3|||
124642933|NCT00769067|448310556|FG000|Overall Study|Other|1|||
124642934|NCT00769067|448310557|FG001|Overall Study|Other|3|||
124642935|NCT00769067|448310556|FG000|Overall Study|Withdrawal by Subject|0|||
124642936|NCT00769067|448310557|FG001|Overall Study|Withdrawal by Subject|1|||
124642937|NCT00809471|448310558|FG000|Overall Study|Protocol non-compliance|15|||
124642938|NCT00809471|448310559|FG001|Overall Study|Protocol non-compliance|15|||
124642939|NCT00809471|448310560|FG002|Overall Study|Protocol non-compliance|6|||
124642940|NCT00809471|448310558|FG000|Overall Study|Lost to Follow-up|4|||
124642941|NCT00809471|448310559|FG001|Overall Study|Lost to Follow-up|2|||
124642942|NCT00809471|448310560|FG002|Overall Study|Lost to Follow-up|9|||
124642943|NCT00809471|448310558|FG000|Overall Study|Adverse Event|0|||
124642944|NCT00809471|448310559|FG001|Overall Study|Adverse Event|2|||
124642945|NCT00809471|448310560|FG002|Overall Study|Adverse Event|2|||
124642946|NCT00809471|448310558|FG000|Overall Study|Requirement for restricted medication|1|||
124642947|NCT00809471|448310559|FG001|Overall Study|Requirement for restricted medication|1|||
124642948|NCT00809471|448310560|FG002|Overall Study|Requirement for restricted medication|0|||
124642949|NCT01942486|448310564|FG000|Overall Study|Lost to Follow-up|27|||
124642950|NCT03728426|448310565|FG000|Overall Study|Death|3|||
124642951|NCT04470544|448310568|FG000|Overall Study|Withdrawal by Subject|4|||
124642952|NCT04470544|448310569|FG001|Overall Study|Withdrawal by Subject|6|||
124642953|NCT04967885|448310572|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
124642954|NCT04967885|448310573|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
124642955|NCT04967885|448310572|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
124642956|NCT04967885|448310573|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
124642957|NCT04967885|448310572|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
124642958|NCT04967885|448310573|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
124642959|NCT04967885|448310572|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
124642960|NCT04967885|448310573|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
124642961|NCT04967885|448310572|FG000|EMI-II Intervention|Lost to Follow-up|14|||
124642962|NCT04967885|448310573|FG001|EMI-II Intervention|Lost to Follow-up|10|||
124642963|NCT00654875|448310574|FG000|Overall Study|Adverse Event|5|||
124642964|NCT00654875|448310575|FG001|Overall Study|Adverse Event|5|||
124642965|NCT00654875|448310574|FG000|Overall Study|Withdrawal by Subject|4|||
124642966|NCT00654875|448310575|FG001|Overall Study|Withdrawal by Subject|4|||
124642967|NCT00654875|448310574|FG000|Overall Study|Protocol Violation|3|||
124642968|NCT00654875|448310575|FG001|Overall Study|Protocol Violation|3|||
124642969|NCT00654875|448310574|FG000|Overall Study|Lack of Efficacy|2|||
124642970|NCT00654875|448310575|FG001|Overall Study|Lack of Efficacy|2|||
124642971|NCT00654875|448310574|FG000|Overall Study|Lost to Follow-up|1|||
124642972|NCT00654875|448310575|FG001|Overall Study|Lost to Follow-up|3|||
124642973|NCT00654875|448310574|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
124642974|NCT00654875|448310575|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
124642975|NCT00654875|448310574|FG000|Overall Study|Administrative Problems|1|||
124642976|NCT00654875|448310575|FG001|Overall Study|Administrative Problems|0|||
124642977|NCT01011465|448310576|FG000|Overall Study|Withdrawal by Subject|2|||
124642978|NCT01011465|448310577|FG001|Overall Study|Withdrawal by Subject|1|||
124642979|NCT01011465|448310578|FG002|Overall Study|Withdrawal by Subject|0|||
124642980|NCT01011465|448310579|FG003|Overall Study|Withdrawal by Subject|0|||
124642981|NCT01011465|448310580|FG004|Overall Study|Withdrawal by Subject|1|||
124642982|NCT01011465|448310581|FG005|Overall Study|Withdrawal by Subject|0|||
124642983|NCT01011465|448310582|FG006|Overall Study|Withdrawal by Subject|1|||
124642984|NCT01011465|448310583|FG007|Overall Study|Withdrawal by Subject|0|||
124642985|NCT00723008|448310586|FG000|Enrollment|Lost to Follow-up|1|||
124642986|NCT00723008|448310587|FG001|Enrollment|Lost to Follow-up|0|||
124642987|NCT00723008|448310586|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
124642988|NCT00723008|448310587|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
124642989|NCT00723008|448310586|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
124642990|NCT00723008|448310587|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
124642991|NCT00723008|448310586|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
124642992|NCT00723008|448310587|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
124642993|NCT00723008|448310586|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
124642994|NCT00723008|448310587|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
124642995|NCT00723008|448310586|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
124642996|NCT00723008|448310587|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
124642997|NCT01014988|448310590|FG000|Overall Study|Adverse Event|20|||
124642998|NCT01014988|448310591|FG001|Overall Study|Adverse Event|0|||
124642999|NCT01014988|448310592|FG002|Overall Study|Adverse Event|1|||
124643000|NCT01014988|448310593|FG003|Overall Study|Adverse Event|0|||
124643001|NCT01014988|448310594|FG004|Overall Study|Adverse Event|1|||
124643002|NCT01014988|448310595|FG005|Overall Study|Adverse Event|3|||
124643003|NCT01014988|448310590|FG000|Overall Study|Lost to Follow-up|1|||
124643004|NCT01014988|448310591|FG001|Overall Study|Lost to Follow-up|0|||
124643005|NCT01014988|448310592|FG002|Overall Study|Lost to Follow-up|1|||
124643006|NCT01014988|448310593|FG003|Overall Study|Lost to Follow-up|0|||
124643007|NCT01014988|448310594|FG004|Overall Study|Lost to Follow-up|0|||
124643008|NCT01014988|448310595|FG005|Overall Study|Lost to Follow-up|0|||
124643009|NCT01014988|448310590|FG000|Overall Study|Physician Decision|1|||
124643010|NCT01014988|448310591|FG001|Overall Study|Physician Decision|0|||
124643011|NCT01014988|448310592|FG002|Overall Study|Physician Decision|0|||
124643012|NCT01014988|448310593|FG003|Overall Study|Physician Decision|0|||
124643013|NCT01014988|448310594|FG004|Overall Study|Physician Decision|0|||
124643014|NCT01014988|448310595|FG005|Overall Study|Physician Decision|0|||
124643015|NCT01014988|448310590|FG000|Overall Study|Withdrawal by Subject|1|||
124643016|NCT01014988|448310591|FG001|Overall Study|Withdrawal by Subject|0|||
124643017|NCT01014988|448310592|FG002|Overall Study|Withdrawal by Subject|0|||
124643018|NCT01014988|448310593|FG003|Overall Study|Withdrawal by Subject|0|||
124643019|NCT01014988|448310594|FG004|Overall Study|Withdrawal by Subject|0|||
124643020|NCT01014988|448310595|FG005|Overall Study|Withdrawal by Subject|0|||
124643021|NCT01683266|448310596|FG000|Overall Study|Adverse Event|5|||
124643022|NCT01683266|448310597|FG001|Overall Study|Adverse Event|4|||
124643023|NCT01683266|448310596|FG000|Overall Study|Lack of Efficacy|5|||
124643024|NCT01683266|448310597|FG001|Overall Study|Lack of Efficacy|2|||
124643025|NCT01683266|448310596|FG000|Overall Study|Protocol Violation|13|||
124643026|NCT01683266|448310597|FG001|Overall Study|Protocol Violation|6|||
124643027|NCT01683266|448310596|FG000|Overall Study|Personal Reason|17|||
124643028|NCT01683266|448310597|FG001|Overall Study|Personal Reason|25|||
124643029|NCT01683266|448310596|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
124643030|NCT01683266|448310597|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
124643031|NCT01683266|448310596|FG000|Overall Study|Lost to Follow-up|5|||
124643032|NCT01683266|448310597|FG001|Overall Study|Lost to Follow-up|0|||
124643033|NCT01683266|448310596|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
124847240|NCT03013491|449064244|FG005|Long-term Extension|Disease progression|0|||
124847241|NCT03013491|449064245|FG006|Long-term Extension|Disease progression|0|||
124847242|NCT03013491|449064246|FG007|Long-term Extension|Disease progression|0|||
124643034|NCT01683266|448310597|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
124643035|NCT01683266|448310596|FG000|Overall Study|Nonserious Hypoglycemia|0|||
124643036|NCT01683266|448310597|FG001|Overall Study|Nonserious Hypoglycemia|3|||
124643037|NCT01683266|448310596|FG000|Overall Study|Perceived Lack of Efficacy|1|||
124643038|NCT01683266|448310597|FG001|Overall Study|Perceived Lack of Efficacy|1|||
124643039|NCT01683266|448310596|FG000|Overall Study|Possibly Hypoglycemia|1|||
124643040|NCT01683266|448310597|FG001|Overall Study|Possibly Hypoglycemia|0|||
124643041|NCT01683266|448310596|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
124643042|NCT01683266|448310597|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
124643043|NCT00886743|448310598|FG000|Overall Study|Adverse Event|3|||
124643044|NCT00886743|448310598|FG000|Overall Study|Other|1|||
124643045|NCT05217641|448310603|FG000|Overall Study|Lost to Follow-up|1|||
124643046|NCT05217641|448310604|FG001|Overall Study|Lost to Follow-up|1|||
124643047|NCT05217641|448310605|FG002|Overall Study|Lost to Follow-up|0|||
124643048|NCT05217641|448310606|FG003|Overall Study|Lost to Follow-up|1|||
124643049|NCT05217641|448310607|FG004|Overall Study|Lost to Follow-up|1|||
124643050|NCT05217641|448310608|FG005|Overall Study|Lost to Follow-up|0|||
124643051|NCT05217641|448310603|FG000|Overall Study|Withdrawal by Subject|0|||
124643052|NCT05217641|448310604|FG001|Overall Study|Withdrawal by Subject|0|||
124643053|NCT05217641|448310605|FG002|Overall Study|Withdrawal by Subject|0|||
124643054|NCT05217641|448310606|FG003|Overall Study|Withdrawal by Subject|3|||
124643055|NCT05217641|448310607|FG004|Overall Study|Withdrawal by Subject|1|||
124643056|NCT05217641|448310608|FG005|Overall Study|Withdrawal by Subject|0|||
124643057|NCT05217641|448310603|FG000|Overall Study|Other: participant did not specify reason|0|||
124643058|NCT05217641|448310604|FG001|Overall Study|Other: participant did not specify reason|0|||
124643059|NCT05217641|448310605|FG002|Overall Study|Other: participant did not specify reason|0|||
124643060|NCT05217641|448310606|FG003|Overall Study|Other: participant did not specify reason|0|||
124643061|NCT05217641|448310607|FG004|Overall Study|Other: participant did not specify reason|1|||
124643062|NCT05217641|448310608|FG005|Overall Study|Other: participant did not specify reason|0|||
124643063|NCT05217641|448310603|FG000|Overall Study|Extended Follow up|1|||
124643064|NCT05217641|448310604|FG001|Overall Study|Extended Follow up|1|||
124643065|NCT05217641|448310605|FG002|Overall Study|Extended Follow up|0|||
124643066|NCT05217641|448310606|FG003|Overall Study|Extended Follow up|0|||
124643067|NCT05217641|448310607|FG004|Overall Study|Extended Follow up|1|||
124643068|NCT05217641|448310608|FG005|Overall Study|Extended Follow up|0|||
124643069|NCT02632409|448310612|FG000|Randomized|AE unrelated to study Drug|0|||
124643070|NCT02632409|448310613|FG001|Randomized|AE unrelated to study Drug|1|||
124643071|NCT02632409|448310612|FG000|Randomized|Participant withdrew consent|2|||
124643072|NCT02632409|448310613|FG001|Randomized|Participant withdrew consent|1|||
124643073|NCT02632409|448310612|FG000|Randomized|No Longer meets study criteria|5|||
124643074|NCT02632409|448310613|FG001|Randomized|No Longer meets study criteria|0|||
124643075|NCT02632409|448310612|FG000|Randomized|other reasons|1|||
124643076|NCT02632409|448310613|FG001|Randomized|other reasons|0|||
124643077|NCT02632409|448310612|FG000|Treatment Period|Ongoing Treatment|20|||
124643078|NCT02632409|448310613|FG001|Treatment Period|Ongoing Treatment|21|||
124643079|NCT02632409|448310612|FG000|Treatment Period|Disease Recurrence|147|||
124643080|NCT02632409|448310613|FG001|Treatment Period|Disease Recurrence|90|||
124643081|NCT02632409|448310612|FG000|Treatment Period|Study Drug Toxicity|8|||
124643082|NCT02632409|448310613|FG001|Treatment Period|Study Drug Toxicity|49|||
124643083|NCT02632409|448310612|FG000|Treatment Period|Death|1|||
124643084|NCT02632409|448310613|FG001|Treatment Period|Death|0|||
124643085|NCT02632409|448310612|FG000|Treatment Period|AE unrelated to study drug|15|||
124643086|NCT02632409|448310613|FG001|Treatment Period|AE unrelated to study drug|16|||
124643087|NCT02632409|448310612|FG000|Treatment Period|Request to discontinue treatment|4|||
124643088|NCT02632409|448310613|FG001|Treatment Period|Request to discontinue treatment|19|||
124643089|NCT02632409|448310612|FG000|Treatment Period|Participant withdrew consent|7|||
124643090|NCT02632409|448310613|FG001|Treatment Period|Participant withdrew consent|5|||
124643091|NCT02632409|448310612|FG000|Treatment Period|Lost to Follow-up|0|||
124643092|NCT02632409|448310613|FG001|Treatment Period|Lost to Follow-up|1|||
124643093|NCT02632409|448310612|FG000|Treatment Period|Maximum clinical benefit|1|||
124643094|NCT02632409|448310613|FG001|Treatment Period|Maximum clinical benefit|0|||
124643095|NCT02632409|448310612|FG000|Treatment Period|No longer meets study criteria|3|||
124643096|NCT02632409|448310613|FG001|Treatment Period|No longer meets study criteria|0|||
124643097|NCT02632409|448310612|FG000|Treatment Period|Administrative Reason by sponsor|0|||
124643098|NCT02632409|448310613|FG001|Treatment Period|Administrative Reason by sponsor|1|||
124643099|NCT02632409|448310612|FG000|Treatment Period|Other Reasons|10|||
124643100|NCT02632409|448310613|FG001|Treatment Period|Other Reasons|6|||
124643101|NCT00537316|448310614|FG000|Part 1|Adverse Event|7|||
124643102|NCT00537316|448310615|FG001|Part 1|Adverse Event|11|||
124643103|NCT00537316|448310616|FG002|Part 1|Adverse Event|8|||
124643104|NCT00537316|448310617|FG003|Part 1|Adverse Event|0|||
124643105|NCT00537316|448310618|FG004|Part 1|Adverse Event|0|||
124643106|NCT00537316|448310619|FG005|Part 1|Adverse Event|0|||
124643107|NCT00537316|448310620|FG006|Part 1|Adverse Event|0|||
124643108|NCT00537316|448310614|FG000|Part 1|Protocol defined clinical event|1|||
124643109|NCT00537316|448310615|FG001|Part 1|Protocol defined clinical event|0|||
124643110|NCT00537316|448310616|FG002|Part 1|Protocol defined clinical event|0|||
124643111|NCT00537316|448310617|FG003|Part 1|Protocol defined clinical event|0|||
124643112|NCT00537316|448310618|FG004|Part 1|Protocol defined clinical event|0|||
124643113|NCT00537316|448310619|FG005|Part 1|Protocol defined clinical event|0|||
124643114|NCT00537316|448310620|FG006|Part 1|Protocol defined clinical event|0|||
124847243|NCT03013491|449064247|FG008|Long-term Extension|Disease progression|0|||
124643115|NCT00537316|448310614|FG000|Part 1|Lost to Follow-up|1|||
124643116|NCT00537316|448310615|FG001|Part 1|Lost to Follow-up|0|||
124643117|NCT00537316|448310616|FG002|Part 1|Lost to Follow-up|0|||
124643118|NCT00537316|448310617|FG003|Part 1|Lost to Follow-up|0|||
124643119|NCT00537316|448310618|FG004|Part 1|Lost to Follow-up|0|||
124643120|NCT00537316|448310619|FG005|Part 1|Lost to Follow-up|0|||
124643121|NCT00537316|448310620|FG006|Part 1|Lost to Follow-up|0|||
124643122|NCT00537316|448310614|FG000|Part 1|Withdrawal by Subject|3|||
124643123|NCT00537316|448310615|FG001|Part 1|Withdrawal by Subject|8|||
124643124|NCT00537316|448310616|FG002|Part 1|Withdrawal by Subject|4|||
124643125|NCT00537316|448310617|FG003|Part 1|Withdrawal by Subject|0|||
124643126|NCT00537316|448310618|FG004|Part 1|Withdrawal by Subject|0|||
124643127|NCT00537316|448310619|FG005|Part 1|Withdrawal by Subject|0|||
124643128|NCT00537316|448310620|FG006|Part 1|Withdrawal by Subject|0|||
124643129|NCT00537316|448310614|FG000|Part 1|Protocol Violation|1|||
124643130|NCT00537316|448310615|FG001|Part 1|Protocol Violation|5|||
124643131|NCT00537316|448310616|FG002|Part 1|Protocol Violation|1|||
124643132|NCT00537316|448310617|FG003|Part 1|Protocol Violation|0|||
124643133|NCT00537316|448310618|FG004|Part 1|Protocol Violation|0|||
124643134|NCT00537316|448310619|FG005|Part 1|Protocol Violation|0|||
124643135|NCT00537316|448310620|FG006|Part 1|Protocol Violation|0|||
124643136|NCT00537316|448310614|FG000|Part 1|Did not meet protocol eligibility|1|||
124643137|NCT00537316|448310615|FG001|Part 1|Did not meet protocol eligibility|3|||
124643138|NCT00537316|448310616|FG002|Part 1|Did not meet protocol eligibility|2|||
124643139|NCT00537316|448310617|FG003|Part 1|Did not meet protocol eligibility|0|||
124643140|NCT00537316|448310618|FG004|Part 1|Did not meet protocol eligibility|0|||
124643141|NCT00537316|448310619|FG005|Part 1|Did not meet protocol eligibility|0|||
124643142|NCT00537316|448310620|FG006|Part 1|Did not meet protocol eligibility|0|||
124643143|NCT00537316|448310614|FG000|Part 1|Administrative|0|||
124643144|NCT00537316|448310615|FG001|Part 1|Administrative|0|||
124643145|NCT00537316|448310616|FG002|Part 1|Administrative|2|||
124643146|NCT00537316|448310617|FG003|Part 1|Administrative|0|||
124643147|NCT00537316|448310618|FG004|Part 1|Administrative|0|||
124643148|NCT00537316|448310619|FG005|Part 1|Administrative|0|||
124643149|NCT00537316|448310620|FG006|Part 1|Administrative|0|||
124643150|NCT00537316|448310614|FG000|Part 2|Never entered follow-up|0|||
124643151|NCT00537316|448310615|FG001|Part 2|Never entered follow-up|0|||
124643152|NCT00537316|448310616|FG002|Part 2|Never entered follow-up|0|||
124643153|NCT00537316|448310617|FG003|Part 2|Never entered follow-up|0|||
124643154|NCT00537316|448310618|FG004|Part 2|Never entered follow-up|0|||
124643155|NCT00537316|448310619|FG005|Part 2|Never entered follow-up|0|||
124643156|NCT00537316|448310620|FG006|Part 2|Never entered follow-up|1|||
124643157|NCT00537316|448310614|FG000|Part 2|Adverse Event|4|||
124643158|NCT00537316|448310615|FG001|Part 2|Adverse Event|0|||
124643159|NCT00537316|448310616|FG002|Part 2|Adverse Event|2|||
124643160|NCT00537316|448310617|FG003|Part 2|Adverse Event|0|||
124643161|NCT00537316|448310618|FG004|Part 2|Adverse Event|0|||
124643162|NCT00537316|448310619|FG005|Part 2|Adverse Event|0|||
124643163|NCT00537316|448310620|FG006|Part 2|Adverse Event|0|||
124643164|NCT00537316|448310614|FG000|Part 2|Lost to Follow-up|1|||
124643165|NCT00537316|448310615|FG001|Part 2|Lost to Follow-up|0|||
124643166|NCT00537316|448310616|FG002|Part 2|Lost to Follow-up|2|||
124643167|NCT00537316|448310617|FG003|Part 2|Lost to Follow-up|0|||
124643168|NCT00537316|448310618|FG004|Part 2|Lost to Follow-up|0|||
124643169|NCT00537316|448310619|FG005|Part 2|Lost to Follow-up|0|||
124643170|NCT00537316|448310620|FG006|Part 2|Lost to Follow-up|0|||
124643171|NCT00537316|448310614|FG000|Part 2|Withdrawal by Subject|5|||
124643172|NCT00537316|448310615|FG001|Part 2|Withdrawal by Subject|1|||
124643173|NCT00537316|448310616|FG002|Part 2|Withdrawal by Subject|4|||
124643174|NCT00537316|448310617|FG003|Part 2|Withdrawal by Subject|0|||
124643175|NCT00537316|448310618|FG004|Part 2|Withdrawal by Subject|0|||
124643176|NCT00537316|448310619|FG005|Part 2|Withdrawal by Subject|0|||
124643177|NCT00537316|448310620|FG006|Part 2|Withdrawal by Subject|0|||
124643178|NCT00537316|448310614|FG000|Part 2|Administrative|16|||
124643179|NCT00537316|448310615|FG001|Part 2|Administrative|8|||
124643180|NCT00537316|448310616|FG002|Part 2|Administrative|24|||
124643181|NCT00537316|448310617|FG003|Part 2|Administrative|3|||
124643182|NCT00537316|448310618|FG004|Part 2|Administrative|1|||
124643183|NCT00537316|448310619|FG005|Part 2|Administrative|4|||
124643184|NCT00537316|448310620|FG006|Part 2|Administrative|1|||
124643185|NCT01867710|448310621|FG000|Overall Study|Death|25|||
124643186|NCT01867710|448310622|FG001|Overall Study|Death|15|||
124643187|NCT01867710|448310623|FG002|Overall Study|Death|27|||
124643188|NCT01867710|448310624|FG003|Overall Study|Death|20|||
124643189|NCT01867710|448310621|FG000|Overall Study|Lost to Follow-up|3|||
124643190|NCT01867710|448310622|FG001|Overall Study|Lost to Follow-up|4|||
124643191|NCT01867710|448310623|FG002|Overall Study|Lost to Follow-up|3|||
124643192|NCT01867710|448310624|FG003|Overall Study|Lost to Follow-up|2|||
124643193|NCT01867710|448310621|FG000|Overall Study|Withdrawal of consent|2|||
124643194|NCT01867710|448310622|FG001|Overall Study|Withdrawal of consent|5|||
124643195|NCT01867710|448310623|FG002|Overall Study|Withdrawal of consent|1|||
124643196|NCT01867710|448310624|FG003|Overall Study|Withdrawal of consent|2|||
124643197|NCT01867710|448310621|FG000|Overall Study|Study Terminated by Sponsor|9|||
124643198|NCT01867710|448310622|FG001|Overall Study|Study Terminated by Sponsor|13|||
124643199|NCT01867710|448310623|FG002|Overall Study|Study Terminated by Sponsor|8|||
124643200|NCT01867710|448310624|FG003|Overall Study|Study Terminated by Sponsor|16|||
124643201|NCT01867710|448310621|FG000|Overall Study|Biochemical progression|0|||
124643202|NCT01867710|448310622|FG001|Overall Study|Biochemical progression|1|||
124643203|NCT01867710|448310623|FG002|Overall Study|Biochemical progression|0|||
124643204|NCT01867710|448310624|FG003|Overall Study|Biochemical progression|0|||
124643205|NCT01867710|448310621|FG000|Overall Study|Clinical progression|0|||
124643206|NCT01867710|448310622|FG001|Overall Study|Clinical progression|0|||
124643207|NCT01867710|448310623|FG002|Overall Study|Clinical progression|1|||
124643208|NCT01867710|448310624|FG003|Overall Study|Clinical progression|0|||
124643209|NCT01867710|448310621|FG000|Overall Study|Disease progression|1|||
124643210|NCT01867710|448310622|FG001|Overall Study|Disease progression|0|||
124643211|NCT01867710|448310623|FG002|Overall Study|Disease progression|0|||
124643212|NCT01867710|448310624|FG003|Overall Study|Disease progression|0|||
124643213|NCT01867710|448310621|FG000|Overall Study|Patient decision|0|||
124643214|NCT01867710|448310622|FG001|Overall Study|Patient decision|0|||
124643215|NCT01867710|448310623|FG002|Overall Study|Patient decision|0|||
124643216|NCT01867710|448310624|FG003|Overall Study|Patient decision|1|||
124643217|NCT01867710|448310621|FG000|Overall Study|Patient to follow subsequent treatment|0|||
124643218|NCT01867710|448310622|FG001|Overall Study|Patient to follow subsequent treatment|1|||
124643219|NCT01867710|448310623|FG002|Overall Study|Patient to follow subsequent treatment|0|||
124643220|NCT01867710|448310624|FG003|Overall Study|Patient to follow subsequent treatment|0|||
124643221|NCT01867710|448310621|FG000|Overall Study|Progressive disease|1|||
124643222|NCT01867710|448310622|FG001|Overall Study|Progressive disease|0|||
124643223|NCT01867710|448310623|FG002|Overall Study|Progressive disease|0|||
124643224|NCT01867710|448310624|FG003|Overall Study|Progressive disease|0|||
124643225|NCT01867710|448310621|FG000|Overall Study|Protocol Violation|0|||
124643226|NCT01867710|448310622|FG001|Overall Study|Protocol Violation|0|||
124643227|NCT01867710|448310623|FG002|Overall Study|Protocol Violation|0|||
124643228|NCT01867710|448310624|FG003|Overall Study|Protocol Violation|1|||
124643229|NCT01867710|448310621|FG000|Overall Study|PSA-progression|0|||
124643230|NCT01867710|448310622|FG001|Overall Study|PSA-progression|1|||
124643231|NCT01867710|448310623|FG002|Overall Study|PSA-progression|0|||
124643232|NCT01867710|448310624|FG003|Overall Study|PSA-progression|0|||
124643233|NCT01867710|448310621|FG000|Overall Study|Study medication no longer effective|0|||
124643234|NCT01867710|448310622|FG001|Overall Study|Study medication no longer effective|1|||
124643235|NCT01867710|448310623|FG002|Overall Study|Study medication no longer effective|0|||
124643236|NCT01867710|448310624|FG003|Overall Study|Study medication no longer effective|0|||
124643237|NCT01062113|448310625|FG000|Overall Study|Adverse Event|1|||
124643238|NCT01062113|448310626|FG001|Overall Study|Adverse Event|0|||
124643239|NCT01062113|448310627|FG002|Overall Study|Adverse Event|0|||
124643240|NCT01062113|448310625|FG000|Overall Study|Lack of Efficacy|38|||
124643241|NCT01062113|448310626|FG001|Overall Study|Lack of Efficacy|22|||
124643242|NCT01062113|448310627|FG002|Overall Study|Lack of Efficacy|31|||
124643243|NCT01062113|448310625|FG000|Overall Study|Withdrawal by Subject|1|||
124643244|NCT01062113|448310626|FG001|Overall Study|Withdrawal by Subject|0|||
124643245|NCT01062113|448310627|FG002|Overall Study|Withdrawal by Subject|0|||
124643246|NCT03521115|448310628|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
124643247|NCT03521115|448310629|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
124643248|NCT03521115|448310628|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
124643249|NCT03521115|448310629|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
124643250|NCT01471340|448310630|FG000|Overall Study|Death|5|||
124643251|NCT01471340|448310631|FG001|Overall Study|Death|4|||
124643252|NCT01471340|448310630|FG000|Overall Study|Lost to Follow-up|0|||
124643253|NCT01471340|448310631|FG001|Overall Study|Lost to Follow-up|1|||
124643254|NCT01471340|448310630|FG000|Overall Study|Investigational site closure|0|||
124643255|NCT01471340|448310631|FG001|Overall Study|Investigational site closure|1|||
124643256|NCT01471340|448310630|FG000|Overall Study|Invalid informed consent|1|||
124643257|NCT01471340|448310631|FG001|Overall Study|Invalid informed consent|0|||
124643258|NCT00526669|448310632|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
124643259|NCT00526669|448310633|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
124643260|NCT00526669|448310632|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
124643261|NCT00526669|448310633|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
124643262|NCT00526669|448310632|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
124643263|NCT00526669|448310633|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
124643264|NCT00526669|448310632|FG000|Combined Treatment Phase|Death|0|||
124643265|NCT00526669|448310633|FG001|Combined Treatment Phase|Death|2|||
124643266|NCT03499899|448310635|FG000|Overall Study|Adverse Event|2|||
124643267|NCT03499899|448310636|FG001|Overall Study|Adverse Event|3|||
124643268|NCT03499899|448310637|FG002|Overall Study|Adverse Event|3|||
124643269|NCT03499899|448310635|FG000|Overall Study|Death|0|||
124643270|NCT03499899|448310636|FG001|Overall Study|Death|0|||
124643271|NCT03499899|448310637|FG002|Overall Study|Death|1|||
124643272|NCT03499899|448310635|FG000|Overall Study|Physician Decision|3|||
124643273|NCT03499899|448310636|FG001|Overall Study|Physician Decision|6|||
124643274|NCT03499899|448310637|FG002|Overall Study|Physician Decision|6|||
124643275|NCT03499899|448310635|FG000|Overall Study|Progressive disease|15|||
124643276|NCT03499899|448310636|FG001|Overall Study|Progressive disease|23|||
124643277|NCT03499899|448310637|FG002|Overall Study|Progressive disease|23|||
124643278|NCT03499899|448310635|FG000|Overall Study|Patient decision|0|||
124643279|NCT03499899|448310636|FG001|Overall Study|Patient decision|1|||
124643280|NCT03499899|448310637|FG002|Overall Study|Patient decision|1|||
124754133|NCT05715242|448720897|FG006|Overall Study|Lost to Follow-up|0|||
124643281|NCT03499899|448310635|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
124643282|NCT03499899|448310636|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
124643283|NCT03499899|448310637|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
124643284|NCT01893281|448310638|FG000|Overall Study|Adverse Event|1|||
124643285|NCT01893281|448310638|FG000|Overall Study|Protocol Violation|1|||
124643286|NCT01893281|448310638|FG000|Overall Study|Withdrawal by Subject|1|||
124643287|NCT04016779|448310648|FG000|Overall Study|Adverse Event|9|||
124643288|NCT04016779|448310649|FG001|Overall Study|Adverse Event|17|||
124643289|NCT04016779|448310648|FG000|Overall Study|Lack of Efficacy|4|||
124643290|NCT04016779|448310649|FG001|Overall Study|Lack of Efficacy|1|||
124643291|NCT04016779|448310648|FG000|Overall Study|Lost to Follow-up|5|||
124643292|NCT04016779|448310649|FG001|Overall Study|Lost to Follow-up|14|||
124643293|NCT04016779|448310648|FG000|Overall Study|Physician Decision|1|||
124643294|NCT04016779|448310649|FG001|Overall Study|Physician Decision|3|||
124643295|NCT04016779|448310648|FG000|Overall Study|Withdrawal by Subject|6|||
124643296|NCT04016779|448310649|FG001|Overall Study|Withdrawal by Subject|8|||
124643297|NCT04016779|448310648|FG000|Overall Study|Non-compliance with Study Drug|2|||
124643298|NCT04016779|448310649|FG001|Overall Study|Non-compliance with Study Drug|3|||
124643299|NCT04016779|448310648|FG000|Overall Study|Other, Multiple categories|17|||
124643300|NCT04016779|448310649|FG001|Overall Study|Other, Multiple categories|17|||
124643301|NCT02295020|448310650|FG000|Overall Study|Adverse Event|0|||
124643302|NCT02295020|448310651|FG001|Overall Study|Adverse Event|1|||
124643303|NCT02295020|448310650|FG000|Overall Study|Withdrawal by Subject|3|||
124643304|NCT02295020|448310651|FG001|Overall Study|Withdrawal by Subject|2|||
124643305|NCT00355147|448310654|FG000|Overall Study|Lost to Follow-up|10|||
124643306|NCT00355147|448310655|FG001|Overall Study|Lost to Follow-up|8|||
124643307|NCT00355147|448310654|FG000|Overall Study|Withdrawal by Subject|8|||
124643308|NCT00355147|448310655|FG001|Overall Study|Withdrawal by Subject|12|||
124643309|NCT00256854|448310656|FG000|Overall Study|Withdrawal by Subject|2|||
124643310|NCT00256854|448310657|FG001|Overall Study|Withdrawal by Subject|3|||
124643311|NCT00256854|448310658|FG002|Overall Study|Withdrawal by Subject|0|||
124643312|NCT00256854|448310659|FG003|Overall Study|Withdrawal by Subject|0|||
124643313|NCT00256854|448310660|FG004|Overall Study|Withdrawal by Subject|0|||
124643314|NCT00256854|448310661|FG005|Overall Study|Withdrawal by Subject|0|||
124643315|NCT00256854|448310656|FG000|Overall Study|Lack of Efficacy|1|||
124643316|NCT00256854|448310657|FG001|Overall Study|Lack of Efficacy|0|||
124643317|NCT00256854|448310658|FG002|Overall Study|Lack of Efficacy|0|||
124643318|NCT00256854|448310659|FG003|Overall Study|Lack of Efficacy|0|||
124643319|NCT00256854|448310660|FG004|Overall Study|Lack of Efficacy|0|||
124643320|NCT00256854|448310661|FG005|Overall Study|Lack of Efficacy|0|||
124643321|NCT00256854|448310656|FG000|Overall Study|Protocol Violation|0|||
124643322|NCT00256854|448310657|FG001|Overall Study|Protocol Violation|1|||
124643323|NCT00256854|448310658|FG002|Overall Study|Protocol Violation|1|||
124643324|NCT00256854|448310659|FG003|Overall Study|Protocol Violation|1|||
124643325|NCT00256854|448310660|FG004|Overall Study|Protocol Violation|0|||
124643326|NCT00256854|448310661|FG005|Overall Study|Protocol Violation|0|||
124643327|NCT00256854|448310656|FG000|Overall Study|Adverse Event|0|||
124643328|NCT00256854|448310657|FG001|Overall Study|Adverse Event|0|||
124643329|NCT00256854|448310658|FG002|Overall Study|Adverse Event|2|||
124643330|NCT00256854|448310659|FG003|Overall Study|Adverse Event|2|||
124643331|NCT00256854|448310660|FG004|Overall Study|Adverse Event|0|||
124643332|NCT00256854|448310661|FG005|Overall Study|Adverse Event|1|||
124643333|NCT00256854|448310656|FG000|Overall Study|Not compliant with the study drug|0|||
124643334|NCT00256854|448310657|FG001|Overall Study|Not compliant with the study drug|0|||
124643335|NCT00256854|448310658|FG002|Overall Study|Not compliant with the study drug|0|||
124643336|NCT00256854|448310659|FG003|Overall Study|Not compliant with the study drug|0|||
124643337|NCT00256854|448310660|FG004|Overall Study|Not compliant with the study drug|1|||
124643338|NCT00256854|448310661|FG005|Overall Study|Not compliant with the study drug|0|||
124643339|NCT05239494|448310662|FG000|Overall Study|Lost to Follow-up|1|||
124643340|NCT00937040|448310663|FG000|Overall Study|Adverse Event|5|||
124643341|NCT00937040|448310664|FG001|Overall Study|Adverse Event|8|||
124643342|NCT00937040|448310663|FG000|Overall Study|Lost to Follow-up|12|||
124643343|NCT00937040|448310664|FG001|Overall Study|Lost to Follow-up|12|||
124643344|NCT00937040|448310663|FG000|Overall Study|Protocol Violation|3|||
124643345|NCT00937040|448310664|FG001|Overall Study|Protocol Violation|0|||
124643346|NCT00937040|448310663|FG000|Overall Study|Withdrawal by Subject|13|||
124643347|NCT00937040|448310664|FG001|Overall Study|Withdrawal by Subject|7|||
124643348|NCT00937040|448310663|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
124643349|NCT00937040|448310664|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
124643350|NCT00937040|448310663|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
124643351|NCT00937040|448310664|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
124643352|NCT02294396|448310665|FG000|Overall Study|Adverse Event|26|||
124643353|NCT02294396|448310666|FG001|Overall Study|Adverse Event|25|||
124643354|NCT02294396|448310667|FG002|Overall Study|Adverse Event|21|||
124643355|NCT02294396|448310668|FG003|Overall Study|Adverse Event|24|||
124643356|NCT02294396|448310665|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
124643357|NCT02294396|448310666|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
124643358|NCT02294396|448310667|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
124643359|NCT02294396|448310668|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
124643360|NCT02294396|448310665|FG000|Overall Study|Withdrawal by Subject|8|||
124643361|NCT02294396|448310666|FG001|Overall Study|Withdrawal by Subject|6|||
124643362|NCT02294396|448310667|FG002|Overall Study|Withdrawal by Subject|6|||
124643363|NCT02294396|448310668|FG003|Overall Study|Withdrawal by Subject|8|||
124643364|NCT02294396|448310665|FG000|Overall Study|Lost to Follow-up|0|||
124643365|NCT02294396|448310666|FG001|Overall Study|Lost to Follow-up|0|||
124643366|NCT02294396|448310667|FG002|Overall Study|Lost to Follow-up|1|||
124643367|NCT02294396|448310668|FG003|Overall Study|Lost to Follow-up|1|||
124643368|NCT02294396|448310665|FG000|Overall Study|Protocol Deviation|3|||
124643369|NCT02294396|448310666|FG001|Overall Study|Protocol Deviation|2|||
124643370|NCT02294396|448310667|FG002|Overall Study|Protocol Deviation|2|||
124643371|NCT02294396|448310668|FG003|Overall Study|Protocol Deviation|1|||
124643372|NCT02294396|448310665|FG000|Overall Study|Miscellaneous|2|||
124643373|NCT02294396|448310666|FG001|Overall Study|Miscellaneous|0|||
124643374|NCT02294396|448310667|FG002|Overall Study|Miscellaneous|5|||
124643375|NCT02294396|448310668|FG003|Overall Study|Miscellaneous|2|||
124643376|NCT02120833|448310669|FG000|Overall Study|Adverse Event|1|||
124643377|NCT02120833|448310670|FG001|Overall Study|Adverse Event|0|||
124643378|NCT02120833|448310669|FG000|Overall Study|Withdrawal by Subject|2|||
124643379|NCT02120833|448310670|FG001|Overall Study|Withdrawal by Subject|0|||
124643380|NCT02120833|448310669|FG000|Overall Study|Lost to Follow-up|1|||
124643381|NCT02120833|448310670|FG001|Overall Study|Lost to Follow-up|1|||
124643382|NCT03502070|448310671|FG000|Overall Study|Withdrawal by Subject|1|||
124643383|NCT03502070|448310671|FG000|Overall Study|Screen Failure|1|||
124643384|NCT00595517|448310673|FG000|Overall Study|Adverse Event|6|||
124643385|NCT00595517|448310673|FG000|Overall Study|Withdrawal by Subject|4|||
124643386|NCT00595517|448310673|FG000|Overall Study|Protocol Violation|2|||
124643387|NCT00595517|448310673|FG000|Overall Study|Recurrence of ulcer|5|||
124643388|NCT00595517|448310673|FG000|Overall Study|usage of prohibited treatment|1|||
124643389|NCT00595517|448310673|FG000|Overall Study|No intention to attend regularly|1|||
124643390|NCT04105218|448310679|FG000|Overall Study|Withdrawal by Subject|3|||
124643391|NCT04105218|448310680|FG001|Overall Study|Withdrawal by Subject|2|||
124643392|NCT04105218|448310679|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
124643393|NCT04105218|448310680|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
124643394|NCT04105218|448310679|FG000|Overall Study|Failed screening tests|2|||
124643395|NCT04105218|448310680|FG001|Overall Study|Failed screening tests|1|||
124643396|NCT01894100|448310689|FG000|Overall Study|Lost to Follow-up|0|||
124643397|NCT01894100|448310690|FG001|Overall Study|Lost to Follow-up|1|||
124643398|NCT01894100|448310689|FG000|Overall Study|Withdrawal by Subject|3|||
124643399|NCT01894100|448310690|FG001|Overall Study|Withdrawal by Subject|0|||
124643400|NCT00586820|448310695|FG000|Overall Study|Unsuccessful PCI|1|||
124643401|NCT00586820|448310696|FG001|Overall Study|Unsuccessful PCI|0|||
124643402|NCT00101166|448310699|FG000|Overall Study|progressive disease|10|||
124643403|NCT00686829|448310700|FG000|Overall Study|Adverse Event|5|||
124643404|NCT00686829|448310700|FG000|Overall Study|Lack of Efficacy|6|||
124643405|NCT00686829|448310700|FG000|Overall Study|Lost to Follow-up|4|||
124643406|NCT00686829|448310700|FG000|Overall Study|Withdrawal by Subject|14|||
124643407|NCT00686829|448310700|FG000|Overall Study|Protocol Violation|3|||
124643408|NCT00686829|448310700|FG000|Overall Study|Sponsor discontinued VCV|47|||
124643409|NCT01672710|448310701|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
124643410|NCT01672710|448310702|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
124643411|NCT01672710|448310701|FG000|3 Month Follow up|Lost to Follow-up|2|||
124643412|NCT01672710|448310702|FG001|3 Month Follow up|Lost to Follow-up|3|||
124643413|NCT01672710|448310701|FG000|3 Month Follow up|follow up due after termination date|4|||
124643414|NCT01672710|448310702|FG001|3 Month Follow up|follow up due after termination date|1|||
124643415|NCT01905553|448312364|FG000|Period 2|Adverse Event|1|||
124643416|NCT01905553|448312365|FG001|Period 2|Adverse Event|0|||
124643417|NCT03854370|448312369|FG000|Overall Study|samples not collected|1|||
124643418|NCT03854370|448312370|FG001|Overall Study|samples not collected|1|||
124643419|NCT03854370|448312371|FG002|Overall Study|samples not collected|1|||
124643420|NCT03854370|448312372|FG003|Overall Study|samples not collected|1|||
124643421|NCT00076752|448312373|FG000|Overall Study|Death|2|||
124643422|NCT00076752|448312373|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
124643423|NCT00452673|448312376|FG000|Dose Escalation Period|Disease Progression|6|||
124643424|NCT00452673|448312377|FG001|Dose Escalation Period|Disease Progression|6|||
124643425|NCT00452673|448312378|FG002|Dose Escalation Period|Disease Progression|2|||
124643426|NCT00452673|448312379|FG003|Dose Escalation Period|Disease Progression|6|||
124643427|NCT00452673|448312380|FG004|Dose Escalation Period|Disease Progression|0|||
124643428|NCT00452673|448312376|FG000|Dose Escalation Period|study drug toxicity|1|||
124643429|NCT00452673|448312377|FG001|Dose Escalation Period|study drug toxicity|3|||
124643430|NCT00452673|448312378|FG002|Dose Escalation Period|study drug toxicity|3|||
124643431|NCT00452673|448312379|FG003|Dose Escalation Period|study drug toxicity|1|||
124643432|NCT00452673|448312380|FG004|Dose Escalation Period|study drug toxicity|0|||
124643433|NCT00452673|448312376|FG000|Dose Escalation Period|Other|0|||
124643434|NCT00452673|448312377|FG001|Dose Escalation Period|Other|0|||
124643435|NCT00452673|448312378|FG002|Dose Escalation Period|Other|1|||
124643436|NCT00452673|448312379|FG003|Dose Escalation Period|Other|0|||
124643437|NCT00452673|448312380|FG004|Dose Escalation Period|Other|0|||
124643438|NCT00452673|448312376|FG000|Dose Escalation Period|Adverse Event|0|||
124643439|NCT00452673|448312377|FG001|Dose Escalation Period|Adverse Event|0|||
124643440|NCT00452673|448312378|FG002|Dose Escalation Period|Adverse Event|0|||
124643441|NCT00452673|448312379|FG003|Dose Escalation Period|Adverse Event|1|||
124643442|NCT00452673|448312380|FG004|Dose Escalation Period|Adverse Event|0|||
124643443|NCT00452673|448312376|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
124643444|NCT00452673|448312377|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
124643445|NCT00452673|448312378|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
124643446|NCT00452673|448312379|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
124643447|NCT00452673|448312380|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
124643448|NCT00452673|448312376|FG000|Dose Expansion Period|Disease Progression|0|||
124643449|NCT00452673|448312377|FG001|Dose Expansion Period|Disease Progression|0|||
124643450|NCT00452673|448312378|FG002|Dose Expansion Period|Disease Progression|0|||
124643451|NCT00452673|448312379|FG003|Dose Expansion Period|Disease Progression|0|||
124643452|NCT00452673|448312380|FG004|Dose Expansion Period|Disease Progression|19|||
124643453|NCT00452673|448312376|FG000|Dose Expansion Period|Other|0|||
124643454|NCT00452673|448312377|FG001|Dose Expansion Period|Other|0|||
124643455|NCT00452673|448312378|FG002|Dose Expansion Period|Other|0|||
124643456|NCT00452673|448312379|FG003|Dose Expansion Period|Other|0|||
124643457|NCT00452673|448312380|FG004|Dose Expansion Period|Other|2|||
124643458|NCT02656290|448312381|FG000|Overall Study|Lost to Follow-up|1|||
124643459|NCT02656290|448312381|FG000|Overall Study|Reintervention|3|||
124643460|NCT01608087|448312384|FG000|Overall Study|Lost to Follow-up|0|||
124643461|NCT01608087|448312385|FG001|Overall Study|Lost to Follow-up|1|||
124643462|NCT01608087|448312386|FG002|Overall Study|Lost to Follow-up|0|||
124643463|NCT01608087|448312384|FG000|Overall Study|Other Reason|0|||
124643464|NCT01608087|448312385|FG001|Overall Study|Other Reason|1|||
124643465|NCT01608087|448312386|FG002|Overall Study|Other Reason|0|||
124643466|NCT04429555|448312388|FG000|Overall Study|Death|0|||
124643467|NCT04429555|448312389|FG001|Overall Study|Death|2|||
124643468|NCT04429555|448312388|FG000|Overall Study|Other|2|||
124643469|NCT04429555|448312389|FG001|Overall Study|Other|0|||
124643470|NCT00231114|448312390|FG000|Randomized|Withdrawal by Subject|6|||
124643471|NCT00231114|448312391|FG001|Randomized|Withdrawal by Subject|3|||
124643472|NCT00231114|448312390|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
124643473|NCT00231114|448312391|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
124643474|NCT00231114|448312390|FG000|Post-Treatment Period|Lost to Follow-up|6|||
124643475|NCT00231114|448312391|FG001|Post-Treatment Period|Lost to Follow-up|1|||
124643476|NCT00231114|448312390|FG000|Post-Treatment Period|Physician Decision|1|||
124643477|NCT00231114|448312391|FG001|Post-Treatment Period|Physician Decision|0|||
124643478|NCT00231114|448312390|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
124643479|NCT00231114|448312391|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
124643480|NCT02048826|448312392|FG000|Overall Study|Withdrawal by Subject|1|||
124643481|NCT02048826|448312393|FG001|Overall Study|Withdrawal by Subject|0|||
124643482|NCT00712881|448312394|FG000|Overall Study|Adverse Event|3|||
124643483|NCT00712881|448312395|FG001|Overall Study|Adverse Event|3|||
124643484|NCT00712881|448312394|FG000|Overall Study|Withdrawal by Subject|1|||
124643485|NCT00712881|448312395|FG001|Overall Study|Withdrawal by Subject|1|||
124643486|NCT00712881|448312394|FG000|Overall Study|Disease Progression|2|||
124643487|NCT00712881|448312395|FG001|Overall Study|Disease Progression|1|||
124643488|NCT00712881|448312394|FG000|Overall Study|Lost to Follow-up|1|||
124643489|NCT00712881|448312395|FG001|Overall Study|Lost to Follow-up|1|||
124643490|NCT00712881|448312394|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
124643491|NCT00712881|448312395|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
124643492|NCT00712881|448312394|FG000|Overall Study|Protocol Violation|1|||
124643493|NCT00712881|448312395|FG001|Overall Study|Protocol Violation|1|||
124643494|NCT00712881|448312394|FG000|Overall Study|Randomized but not treated|1|||
124643495|NCT00712881|448312395|FG001|Overall Study|Randomized but not treated|0|||
124643496|NCT03436693|448312397|FG000|Overall Study|Adverse Event|22|||
124643497|NCT03436693|448312398|FG001|Overall Study|Adverse Event|10|||
124643498|NCT03436693|448312397|FG000|Overall Study|Physician Decision|3|||
124643499|NCT03436693|448312398|FG001|Overall Study|Physician Decision|3|||
124643500|NCT03436693|448312397|FG000|Overall Study|Withdrawal by Subject|4|||
124643501|NCT03436693|448312398|FG001|Overall Study|Withdrawal by Subject|13|||
124643502|NCT03436693|448312397|FG000|Overall Study|Progressive Disease|1|||
124643503|NCT03436693|448312398|FG001|Overall Study|Progressive Disease|1|||
124643504|NCT00626821|448312401|FG000|Overall Study|Adverse Event|44|||
124643505|NCT00626821|448312401|FG000|Overall Study|Protocol Violation|33|||
124643506|NCT00626821|448312401|FG000|Overall Study|Withdrawal by Subject|10|||
124643507|NCT00626821|448312401|FG000|Overall Study|Physician Decision|9|||
124643508|NCT00626821|448312401|FG000|Overall Study|Product dysfunction|21|||
124643509|NCT00626821|448312401|FG000|Overall Study|other/unknown reason|104|||
124643510|NCT01082211|448312410|FG000|Overall Study|Protocol Violation|4|||
124643511|NCT01082211|448312410|FG000|Overall Study|No protocol treatment received|3|||
124643512|NCT03702010|448312415|FG000|Follow-up (30days)|Lack of Efficacy|2|||
124643513|NCT03702010|448312416|FG001|Follow-up (30days)|Lack of Efficacy|2|||
124643514|NCT01137110|448312423|FG000|Overall Study|Protocol Violation|1|||
124643515|NCT01137110|448312424|FG001|Overall Study|Protocol Violation|0|||
124643516|NCT02394340|448312431|FG000|Overall Study|Failed drug screen test|1|||
124643517|NCT02394340|448312431|FG000|Overall Study|Adverse Event|1|||
124643518|NCT02004886|448312432|FG000|Overall Study|Adverse Event|0|||
124643519|NCT02004886|448312433|FG001|Overall Study|Adverse Event|1|||
124643520|NCT02004886|448312434|FG002|Overall Study|Adverse Event|0|||
124643521|NCT02004886|448312435|FG003|Overall Study|Adverse Event|0|||
124643522|NCT02004886|448312432|FG000|Overall Study|Unable to attend future visits|1|||
124643523|NCT02004886|448312433|FG001|Overall Study|Unable to attend future visits|0|||
124643524|NCT02004886|448312434|FG002|Overall Study|Unable to attend future visits|0|||
124643525|NCT02004886|448312435|FG003|Overall Study|Unable to attend future visits|0|||
124643526|NCT01876784|448312438|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
124643527|NCT01876784|448312439|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
124643528|NCT01876784|448312438|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
124643529|NCT01876784|448312439|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
124643530|NCT01876784|448312438|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
124643531|NCT01876784|448312439|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
124643532|NCT01876784|448312438|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
124643533|NCT01876784|448312439|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
124643534|NCT01876784|448312438|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
124643535|NCT01876784|448312439|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
124643536|NCT01876784|448312438|FG000|Randomized Treatment Period (40 Months)|Death|1|||
124643537|NCT01876784|448312439|FG001|Randomized Treatment Period (40 Months)|Death|0|||
124643538|NCT01876784|448312438|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
124643539|NCT01876784|448312439|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
124643540|NCT01876784|448312438|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
124643541|NCT01876784|448312439|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
124643542|NCT01876784|448312438|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
124643543|NCT01876784|448312439|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
124643544|NCT01876784|448312438|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
124643545|NCT01876784|448312439|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
124643546|NCT01876784|448312438|FG000|Open-label Period (31 Months)|Adverse Event|2|||
124643547|NCT01876784|448312439|FG001|Open-label Period (31 Months)|Adverse Event|6|||
124643548|NCT01876784|448312438|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
124643549|NCT01876784|448312439|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
124643550|NCT01876784|448312438|FG000|Open-label Period (31 Months)|Progressive disease|4|||
124643551|NCT01876784|448312439|FG001|Open-label Period (31 Months)|Progressive disease|35|||
124643552|NCT01876784|448312438|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
124643553|NCT01876784|448312439|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
124643554|NCT01876784|448312438|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
124643555|NCT01876784|448312439|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
124643556|NCT01876784|448312438|FG000|Open-label Period (31 Months)|Death|0|||
124643557|NCT01876784|448312439|FG001|Open-label Period (31 Months)|Death|1|||
124643558|NCT01876784|448312438|FG000|Open-label Period (31 Months)|Other than specified above|9|||
124643559|NCT01876784|448312439|FG001|Open-label Period (31 Months)|Other than specified above|18|||
124643560|NCT03605862|448312440|FG000|Overall Study|Withdrawal by Subject|12|||
124643561|NCT03605862|448312441|FG001|Overall Study|Withdrawal by Subject|9|||
124643562|NCT03605862|448312440|FG000|Overall Study|Adverse Event|2|||
124643563|NCT03605862|448312441|FG001|Overall Study|Adverse Event|1|||
124643564|NCT03605862|448312440|FG000|Overall Study|Physician Decision|3|||
124643565|NCT03605862|448312441|FG001|Overall Study|Physician Decision|1|||
124643566|NCT03605862|448312440|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
124643567|NCT03605862|448312441|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
124643568|NCT03891862|448312442|FG000|Open-label Period|Adverse Event|2|||
124643569|NCT03891862|448312443|FG001|Open-label Period|Adverse Event|0|||
124643570|NCT03891862|448312444|FG002|Open-label Period|Adverse Event|0|||
124643571|NCT03891862|448312442|FG000|Open-label Period|Protocol Violation|5|||
124643572|NCT03891862|448312443|FG001|Open-label Period|Protocol Violation|0|||
124643573|NCT03891862|448312444|FG002|Open-label Period|Protocol Violation|0|||
124643574|NCT03891862|448312442|FG000|Open-label Period|Withdrawal by Subject|6|||
124643575|NCT03891862|448312443|FG001|Open-label Period|Withdrawal by Subject|0|||
124643576|NCT03891862|448312444|FG002|Open-label Period|Withdrawal by Subject|0|||
124847244|NCT03013491|449064248|FG009|Long-term Extension|Disease progression|0|||
124643577|NCT03891862|448312442|FG000|Open-label Period|Death|1|||
124643578|NCT03891862|448312443|FG001|Open-label Period|Death|0|||
124643579|NCT03891862|448312444|FG002|Open-label Period|Death|0|||
124643580|NCT03891862|448312442|FG000|Open-label Period|Lost to Follow-up|2|||
124643581|NCT03891862|448312443|FG001|Open-label Period|Lost to Follow-up|0|||
124643582|NCT03891862|448312444|FG002|Open-label Period|Lost to Follow-up|0|||
124643583|NCT03891862|448312442|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
124643584|NCT03891862|448312443|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
124643585|NCT03891862|448312444|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
124643586|NCT03891862|448312442|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
124643587|NCT03891862|448312443|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
124643588|NCT03891862|448312444|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
124643589|NCT03891862|448312442|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
124643590|NCT03891862|448312443|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
124643591|NCT03891862|448312444|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
124643592|NCT03891862|448312442|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
124643593|NCT03891862|448312443|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
124643594|NCT03891862|448312444|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
124643595|NCT01194531|448312445|FG000|Overall Study|Withdrawal by Subject|1|||
124643596|NCT01194531|448312446|FG001|Overall Study|Withdrawal by Subject|0|||
124643597|NCT01194531|448312445|FG000|Overall Study|Protocol Violation|4|||
124643598|NCT01194531|448312446|FG001|Overall Study|Protocol Violation|1|||
124643599|NCT01194531|448312445|FG000|Overall Study|Physician Decision|0|||
124643600|NCT01194531|448312446|FG001|Overall Study|Physician Decision|2|||
124643601|NCT01053962|448312447|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
124643602|NCT01053962|448312448|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
124643603|NCT01053962|448312449|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
124643604|NCT01053962|448312450|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
124643605|NCT01053962|448312451|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
124643606|NCT01053962|448312447|FG000|Pretreatment Period|Venipuncture Failure|0|||
124643607|NCT01053962|448312448|FG001|Pretreatment Period|Venipuncture Failure|0|||
124643608|NCT01053962|448312449|FG002|Pretreatment Period|Venipuncture Failure|1|||
124643609|NCT01053962|448312450|FG003|Pretreatment Period|Venipuncture Failure|0|||
124643610|NCT01053962|448312451|FG004|Pretreatment Period|Venipuncture Failure|0|||
124643611|NCT01053962|448312447|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
124643612|NCT01053962|448312448|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
124643613|NCT01053962|448312449|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
124643614|NCT01053962|448312450|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
124643615|NCT01053962|448312451|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
124643616|NCT01053962|448312447|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
124643617|NCT01053962|448312448|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
124643618|NCT01053962|448312449|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
124643619|NCT01053962|448312450|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
124643620|NCT01053962|448312451|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
124643621|NCT01053962|448312447|FG000|Treatment Period|Lack of Efficacy|0|||
124643622|NCT01053962|448312448|FG001|Treatment Period|Lack of Efficacy|0|||
124643623|NCT01053962|448312449|FG002|Treatment Period|Lack of Efficacy|0|||
124643624|NCT01053962|448312450|FG003|Treatment Period|Lack of Efficacy|0|||
124643625|NCT01053962|448312451|FG004|Treatment Period|Lack of Efficacy|1|||
124643626|NCT01053962|448312447|FG000|Treatment Period|Adverse Event|0|||
124643627|NCT01053962|448312448|FG001|Treatment Period|Adverse Event|0|||
124643628|NCT01053962|448312449|FG002|Treatment Period|Adverse Event|0|||
124643629|NCT01053962|448312450|FG003|Treatment Period|Adverse Event|0|||
124643630|NCT01053962|448312451|FG004|Treatment Period|Adverse Event|1|||
124643631|NCT01053962|448312447|FG000|Treatment Period|Withdrawal by Subject|0|||
124643632|NCT01053962|448312448|FG001|Treatment Period|Withdrawal by Subject|0|||
124643633|NCT01053962|448312449|FG002|Treatment Period|Withdrawal by Subject|0|||
124643634|NCT01053962|448312450|FG003|Treatment Period|Withdrawal by Subject|0|||
124643635|NCT01053962|448312451|FG004|Treatment Period|Withdrawal by Subject|1|||
124643636|NCT01053962|448312447|FG000|Treatment Period|Noncompliance with protocol|1|||
124847245|NCT03013491|449064249|FG010|Long-term Extension|Disease progression|0|||
124847246|NCT03013491|449064250|FG011|Long-term Extension|Disease progression|0|||
124643637|NCT01053962|448312448|FG001|Treatment Period|Noncompliance with protocol|0|||
124643638|NCT01053962|448312449|FG002|Treatment Period|Noncompliance with protocol|0|||
124643639|NCT01053962|448312450|FG003|Treatment Period|Noncompliance with protocol|0|||
124643640|NCT01053962|448312451|FG004|Treatment Period|Noncompliance with protocol|0|||
124847247|NCT03013491|449064251|FG012|Long-term Extension|Disease progression|0|||
124643641|NCT04143594|448312452|FG000|Overall Study|Withdrew consent|3|||
124643642|NCT04143594|448312453|FG001|Overall Study|Withdrew consent|10|||
124643643|NCT04143594|448312454|FG002|Overall Study|Withdrew consent|3|||
124643644|NCT04143594|448312455|FG003|Overall Study|Withdrew consent|1|||
124643645|NCT04143594|448312452|FG000|Overall Study|Lost to Follow-up|3|||
124847248|NCT03013491|449064252|FG013|Long-term Extension|Disease progression|0|||
124643646|NCT04143594|448312453|FG001|Overall Study|Lost to Follow-up|5|||
124643647|NCT04143594|448312454|FG002|Overall Study|Lost to Follow-up|11|||
124643648|NCT04143594|448312455|FG003|Overall Study|Lost to Follow-up|0|||
124643649|NCT04143594|448312452|FG000|Overall Study|Investigator's discretion|2|||
124643650|NCT04143594|448312453|FG001|Overall Study|Investigator's discretion|2|||
124643651|NCT04143594|448312454|FG002|Overall Study|Investigator's discretion|0|||
124643652|NCT04143594|448312455|FG003|Overall Study|Investigator's discretion|0|||
124643653|NCT04143594|448312452|FG000|Overall Study|Randomized but never treated|0|||
124643654|NCT04143594|448312453|FG001|Overall Study|Randomized but never treated|0|||
124643655|NCT04143594|448312454|FG002|Overall Study|Randomized but never treated|0|||
124643656|NCT04143594|448312455|FG003|Overall Study|Randomized but never treated|1|||
124643657|NCT04143594|448312452|FG000|Overall Study|Death|1|||
124643658|NCT04143594|448312453|FG001|Overall Study|Death|0|||
124643659|NCT04143594|448312454|FG002|Overall Study|Death|1|||
124643660|NCT04143594|448312455|FG003|Overall Study|Death|0|||
124643661|NCT04143594|448312452|FG000|Overall Study|Adverse Event|1|||
124643662|NCT04143594|448312453|FG001|Overall Study|Adverse Event|0|||
124643663|NCT04143594|448312454|FG002|Overall Study|Adverse Event|0|||
124643664|NCT04143594|448312455|FG003|Overall Study|Adverse Event|0|||
124643665|NCT04143594|448312452|FG000|Overall Study|Pregnancy|0|||
124643666|NCT04143594|448312453|FG001|Overall Study|Pregnancy|0|||
124643667|NCT04143594|448312454|FG002|Overall Study|Pregnancy|1|||
124643668|NCT04143594|448312455|FG003|Overall Study|Pregnancy|0|||
124643669|NCT04143594|448312452|FG000|Overall Study|Lack of Efficacy|1|||
124643670|NCT04143594|448312453|FG001|Overall Study|Lack of Efficacy|1|||
124643671|NCT04143594|448312454|FG002|Overall Study|Lack of Efficacy|0|||
124643672|NCT04143594|448312455|FG003|Overall Study|Lack of Efficacy|0|||
124643673|NCT00834639|448312457|FG000|Second Intervention|Physician Decision|0|||
124643674|NCT00834639|448312458|FG001|Second Intervention|Physician Decision|2|||
124643675|NCT04603482|448312459|FG000|Overall Study|Lost to Follow-up|15|||
124643676|NCT04603482|448312460|FG001|Overall Study|Lost to Follow-up|15|||
124643677|NCT04603482|448312461|FG002|Overall Study|Lost to Follow-up|15|||
124643678|NCT01054196|448312463|FG000|Overall Study|Physician Decision|0|||
124643679|NCT01054196|448312464|FG001|Overall Study|Physician Decision|0|||
124643680|NCT01054196|448312465|FG002|Overall Study|Physician Decision|0|||
124643681|NCT01054196|448312466|FG003|Overall Study|Physician Decision|1|||
124643682|NCT01054196|448312467|FG004|Overall Study|Physician Decision|0|||
124643683|NCT01054196|448312468|FG005|Overall Study|Physician Decision|0|||
124643684|NCT01054196|448312469|FG006|Overall Study|Physician Decision|1|||
124643685|NCT00282113|448312470|FG000|Overall Study|Removed at parents request|1|||
124643686|NCT00282113|448312471|FG001|Overall Study|Removed at parents request|0|||
124643687|NCT00282113|448312472|FG002|Overall Study|Removed at parents request|0|||
124643688|NCT02253316|448312475|FG000|Consolidation|Progression|4|||
124643689|NCT02253316|448312476|FG001|Consolidation|Progression|0|||
124643690|NCT02253316|448312477|FG002|Consolidation|Progression|0|||
124643691|NCT02253316|448312475|FG000|Consolidation|Non-Compliance|1|||
124643692|NCT02253316|448312476|FG001|Consolidation|Non-Compliance|0|||
124643693|NCT02253316|448312477|FG002|Consolidation|Non-Compliance|0|||
124643694|NCT02253316|448312475|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
124643695|NCT02253316|448312476|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
124643696|NCT02253316|448312477|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
124643697|NCT02253316|448312475|FG000|Consolidation|Secondary Malignancy|2|||
124643698|NCT02253316|448312476|FG001|Consolidation|Secondary Malignancy|0|||
124643699|NCT02253316|448312477|FG002|Consolidation|Secondary Malignancy|0|||
124643700|NCT02253316|448312475|FG000|Consolidation|Adverse Event|7|||
124643701|NCT02253316|448312476|FG001|Consolidation|Adverse Event|0|||
124643702|NCT02253316|448312477|FG002|Consolidation|Adverse Event|0|||
124643703|NCT02253316|448312475|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
124643704|NCT02253316|448312476|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
124643705|NCT02253316|448312477|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
124643706|NCT02253316|448312475|FG000|Maintenance|Physician Decision|0|||
124643707|NCT02253316|448312476|FG001|Maintenance|Physician Decision|7|||
124643708|NCT02253316|448312477|FG002|Maintenance|Physician Decision|16|||
124847249|NCT03013491|449064253|FG014|Long-term Extension|Disease progression|0|||
124643709|NCT02253316|448312475|FG000|Maintenance|Non-Compliance|0|||
124643710|NCT02253316|448312476|FG001|Maintenance|Non-Compliance|1|||
124643711|NCT02253316|448312477|FG002|Maintenance|Non-Compliance|1|||
124643712|NCT02253316|448312475|FG000|Maintenance|Secondary Malignancy|0|||
124643713|NCT02253316|448312476|FG001|Maintenance|Secondary Malignancy|2|||
124643714|NCT02253316|448312477|FG002|Maintenance|Secondary Malignancy|6|||
124643715|NCT02253316|448312475|FG000|Maintenance|Adverse Event|0|||
124643716|NCT02253316|448312476|FG001|Maintenance|Adverse Event|8|||
124643717|NCT02253316|448312477|FG002|Maintenance|Adverse Event|12|||
124643718|NCT02253316|448312475|FG000|Maintenance|Still receiving active treatment|0|||
124643719|NCT02253316|448312476|FG001|Maintenance|Still receiving active treatment|5|||
124643720|NCT02253316|448312477|FG002|Maintenance|Still receiving active treatment|0|||
124643721|NCT01046903|448312485|FG000|Overall Study|Lost to Follow-up|16|||
124643722|NCT01046903|448312485|FG000|Overall Study|Adverse Event|4|||
124643723|NCT01046903|448312485|FG000|Overall Study|Withdrawal by Subject|3|||
124643724|NCT01046903|448312485|FG000|Overall Study|Other|5|||
124643725|NCT02107859|448312486|FG000|Overall Study|Withdrawal by Subject|14|||
124643726|NCT02107859|448312486|FG000|Overall Study|Adverse Event|3|||
124643727|NCT02107859|448312486|FG000|Overall Study|Study closure|41|||
124643728|NCT02107859|448312486|FG000|Overall Study|Other than specified|3|||
124643729|NCT00135512|448312489|FG000|Overall Study|Adverse Event|56|||
124643730|NCT00135512|448312489|FG000|Overall Study|Lack of Efficacy|25|||
124643731|NCT00135512|448312489|FG000|Overall Study|Other|42|||
124643732|NCT04439214|448312490|FG000|Overall Study|Adverse Event|13|||
124643733|NCT04439214|448312490|FG000|Overall Study|Disease progression|16|||
124643734|NCT04439214|448312490|FG000|Overall Study|Death|1|||
124643735|NCT04439214|448312490|FG000|Overall Study|Withdrawal by Subject|2|||
124643736|NCT04439214|448312490|FG000|Overall Study|Declining health|1|||
124643737|NCT04439214|448312490|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
124643738|NCT04439214|448312490|FG000|Overall Study|Ineligible|5|||
124643739|NCT04152837|448312492|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
124643740|NCT04152837|448312492|FG000|Maintenance Period|Adverse Event|1|||
124643741|NCT04152837|448312492|FG000|Maintenance Period|Withdrawal by Subject|1|||
124643742|NCT04152837|448312492|FG000|Maintenance Period|Sponsor Termination of Study|2|||
124643743|NCT01668173|448312499|FG000|Overall Study|Adverse Event|3|||
124643744|NCT01668173|448312499|FG000|Overall Study|Trial suspension|4|||
124643745|NCT01295827|448312502|FG000|Overall Study|Adverse Event|1|||
124643746|NCT01295827|448312503|FG001|Overall Study|Adverse Event|2|||
124643747|NCT01295827|448312504|FG002|Overall Study|Adverse Event|2|||
124643748|NCT01295827|448312505|FG003|Overall Study|Adverse Event|1|||
124643749|NCT01295827|448312506|FG004|Overall Study|Adverse Event|1|||
124643750|NCT01295827|448312507|FG005|Overall Study|Adverse Event|4|||
124643751|NCT01295827|448312508|FG006|Overall Study|Adverse Event|15|||
124643752|NCT01295827|448312509|FG007|Overall Study|Adverse Event|49|||
124643753|NCT01295827|448312510|FG008|Overall Study|Adverse Event|22|||
124643754|NCT01295827|448312511|FG009|Overall Study|Adverse Event|7|||
124643755|NCT01295827|448312512|FG010|Overall Study|Adverse Event|50|||
124643756|NCT01295827|448312513|FG011|Overall Study|Adverse Event|21|||
124643757|NCT01295827|448312514|FG012|Overall Study|Adverse Event|0|||
124643758|NCT01295827|448312515|FG013|Overall Study|Adverse Event|0|||
124643759|NCT01295827|448312516|FG014|Overall Study|Adverse Event|0|||
124643760|NCT01295827|448312502|FG000|Overall Study|Lost to Follow-up|0|||
124643761|NCT01295827|448312503|FG001|Overall Study|Lost to Follow-up|0|||
124643762|NCT01295827|448312504|FG002|Overall Study|Lost to Follow-up|3|||
124643763|NCT01295827|448312505|FG003|Overall Study|Lost to Follow-up|0|||
124643764|NCT01295827|448312506|FG004|Overall Study|Lost to Follow-up|1|||
124643765|NCT01295827|448312507|FG005|Overall Study|Lost to Follow-up|0|||
124643766|NCT01295827|448312508|FG006|Overall Study|Lost to Follow-up|4|||
124643767|NCT01295827|448312509|FG007|Overall Study|Lost to Follow-up|8|||
124643768|NCT01295827|448312510|FG008|Overall Study|Lost to Follow-up|7|||
124643769|NCT01295827|448312511|FG009|Overall Study|Lost to Follow-up|4|||
124643770|NCT01295827|448312512|FG010|Overall Study|Lost to Follow-up|7|||
124643771|NCT01295827|448312513|FG011|Overall Study|Lost to Follow-up|3|||
124643772|NCT01295827|448312514|FG012|Overall Study|Lost to Follow-up|0|||
124643773|NCT01295827|448312515|FG013|Overall Study|Lost to Follow-up|0|||
124643774|NCT01295827|448312516|FG014|Overall Study|Lost to Follow-up|0|||
124643775|NCT01295827|448312502|FG000|Overall Study|Not Reported|0|||
124643776|NCT01295827|448312503|FG001|Overall Study|Not Reported|0|||
124643777|NCT01295827|448312504|FG002|Overall Study|Not Reported|0|||
124643778|NCT01295827|448312505|FG003|Overall Study|Not Reported|1|||
124643779|NCT01295827|448312506|FG004|Overall Study|Not Reported|0|||
124643780|NCT01295827|448312507|FG005|Overall Study|Not Reported|0|||
124643781|NCT01295827|448312508|FG006|Overall Study|Not Reported|24|||
124643782|NCT01295827|448312509|FG007|Overall Study|Not Reported|58|||
124643783|NCT01295827|448312510|FG008|Overall Study|Not Reported|41|||
124643784|NCT01295827|448312511|FG009|Overall Study|Not Reported|2|||
124643785|NCT01295827|448312512|FG010|Overall Study|Not Reported|23|||
124643786|NCT01295827|448312513|FG011|Overall Study|Not Reported|13|||
124847250|NCT03013491|449064254|FG015|Long-term Extension|Disease progression|0|||
124847251|NCT03013491|449064255|FG016|Long-term Extension|Disease progression|0|||
124847252|NCT03013491|449064256|FG017|Long-term Extension|Disease progression|0|||
124643787|NCT01295827|448312514|FG012|Overall Study|Not Reported|0|||
124643788|NCT01295827|448312515|FG013|Overall Study|Not Reported|0|||
124643789|NCT01295827|448312516|FG014|Overall Study|Not Reported|0|||
124643790|NCT01295827|448312502|FG000|Overall Study|Progressive Disease|2|||
124643791|NCT01295827|448312503|FG001|Overall Study|Progressive Disease|1|||
124643792|NCT01295827|448312504|FG002|Overall Study|Progressive Disease|5|||
124643793|NCT01295827|448312505|FG003|Overall Study|Progressive Disease|2|||
124643794|NCT01295827|448312506|FG004|Overall Study|Progressive Disease|0|||
124643795|NCT01295827|448312507|FG005|Overall Study|Progressive Disease|1|||
124643796|NCT01295827|448312508|FG006|Overall Study|Progressive Disease|87|||
124643797|NCT01295827|448312509|FG007|Overall Study|Progressive Disease|144|||
124643798|NCT01295827|448312510|FG008|Overall Study|Progressive Disease|85|||
124643799|NCT01295827|448312511|FG009|Overall Study|Progressive Disease|40|||
124643800|NCT01295827|448312512|FG010|Overall Study|Progressive Disease|175|||
124643801|NCT01295827|448312513|FG011|Overall Study|Progressive Disease|136|||
124643802|NCT01295827|448312514|FG012|Overall Study|Progressive Disease|0|||
124643803|NCT01295827|448312515|FG013|Overall Study|Progressive Disease|0|||
124643804|NCT01295827|448312516|FG014|Overall Study|Progressive Disease|0|||
124643805|NCT01295827|448312502|FG000|Overall Study|Screen Failure|0|||
124643806|NCT01295827|448312503|FG001|Overall Study|Screen Failure|0|||
124643807|NCT01295827|448312504|FG002|Overall Study|Screen Failure|0|||
124643808|NCT01295827|448312505|FG003|Overall Study|Screen Failure|0|||
124643809|NCT01295827|448312506|FG004|Overall Study|Screen Failure|0|||
124643810|NCT01295827|448312507|FG005|Overall Study|Screen Failure|0|||
124643811|NCT01295827|448312508|FG006|Overall Study|Screen Failure|2|||
124643812|NCT01295827|448312509|FG007|Overall Study|Screen Failure|2|||
124643813|NCT01295827|448312510|FG008|Overall Study|Screen Failure|2|||
124643814|NCT01295827|448312511|FG009|Overall Study|Screen Failure|0|||
124643815|NCT01295827|448312512|FG010|Overall Study|Screen Failure|1|||
124643816|NCT01295827|448312513|FG011|Overall Study|Screen Failure|0|||
124643817|NCT01295827|448312514|FG012|Overall Study|Screen Failure|0|||
124643818|NCT01295827|448312515|FG013|Overall Study|Screen Failure|0|||
124643819|NCT01295827|448312516|FG014|Overall Study|Screen Failure|0|||
124643820|NCT01295827|448312502|FG000|Overall Study|Withdrawal by Subject|1|||
124643821|NCT01295827|448312503|FG001|Overall Study|Withdrawal by Subject|0|||
124643822|NCT01295827|448312504|FG002|Overall Study|Withdrawal by Subject|2|||
124643823|NCT01295827|448312505|FG003|Overall Study|Withdrawal by Subject|0|||
124643824|NCT01295827|448312506|FG004|Overall Study|Withdrawal by Subject|0|||
124643825|NCT01295827|448312507|FG005|Overall Study|Withdrawal by Subject|1|||
124643826|NCT01295827|448312508|FG006|Overall Study|Withdrawal by Subject|13|||
124643827|NCT01295827|448312509|FG007|Overall Study|Withdrawal by Subject|35|||
124643828|NCT01295827|448312510|FG008|Overall Study|Withdrawal by Subject|11|||
124643829|NCT01295827|448312511|FG009|Overall Study|Withdrawal by Subject|2|||
124643830|NCT01295827|448312512|FG010|Overall Study|Withdrawal by Subject|18|||
124643831|NCT01295827|448312513|FG011|Overall Study|Withdrawal by Subject|13|||
124643832|NCT01295827|448312514|FG012|Overall Study|Withdrawal by Subject|0|||
124643833|NCT01295827|448312515|FG013|Overall Study|Withdrawal by Subject|0|||
124643834|NCT01295827|448312516|FG014|Overall Study|Withdrawal by Subject|0|||
124643835|NCT01295827|448312502|FG000|Overall Study|Other|0|||
124643836|NCT01295827|448312503|FG001|Overall Study|Other|0|||
124643837|NCT01295827|448312504|FG002|Overall Study|Other|0|||
124643838|NCT01295827|448312505|FG003|Overall Study|Other|0|||
124643839|NCT01295827|448312506|FG004|Overall Study|Other|0|||
124643840|NCT01295827|448312507|FG005|Overall Study|Other|0|||
124643841|NCT01295827|448312508|FG006|Overall Study|Other|1|||
124643842|NCT01295827|448312509|FG007|Overall Study|Other|1|||
124643843|NCT01295827|448312510|FG008|Overall Study|Other|1|||
124643844|NCT01295827|448312511|FG009|Overall Study|Other|0|||
124643845|NCT01295827|448312512|FG010|Overall Study|Other|2|||
124643846|NCT01295827|448312513|FG011|Overall Study|Other|0|||
124643847|NCT01295827|448312514|FG012|Overall Study|Other|0|||
124643848|NCT01295827|448312515|FG013|Overall Study|Other|0|||
124643849|NCT01295827|448312516|FG014|Overall Study|Other|0|||
124643850|NCT00746564|448312517|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
124643851|NCT01628198|448312518|FG000|Overall Study|Lost to Follow-up|7|||
124643852|NCT01628198|448312518|FG000|Overall Study|Withdrawal by Subject|10|||
124643853|NCT01628198|448312518|FG000|Overall Study|Screen failure|1|||
124643854|NCT04999163|448312530|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
124643855|NCT04999163|448312531|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
124643856|NCT04999163|448312530|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
124643857|NCT04999163|448312531|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
124643858|NCT04999163|448312530|FG000|Overall Study|Withdrawal by Subject|1|||
124643859|NCT04999163|448312531|FG001|Overall Study|Withdrawal by Subject|0|||
124643860|NCT05270395|448312532|FG000|Overall Study|Lost to Follow-up|2|||
124643861|NCT05270395|448312533|FG001|Overall Study|Lost to Follow-up|2|||
124643862|NCT05270395|448312532|FG000|Overall Study|Death|1|||
124643863|NCT05270395|448312533|FG001|Overall Study|Death|2|||
124643864|NCT05270395|448312532|FG000|Overall Study|Study Team Withdrew|1|||
124643865|NCT05270395|448312533|FG001|Overall Study|Study Team Withdrew|0|||
124643866|NCT03725761|448312534|FG000|Overall Study|still on study|1|||
124754134|NCT05715242|448720898|FG007|Overall Study|Lost to Follow-up|0|||
124754135|NCT05715242|448720899|FG008|Overall Study|Lost to Follow-up|0|||
124754136|NCT05715242|448720900|FG009|Overall Study|Lost to Follow-up|0|||
124754137|NCT05715242|448720901|FG010|Overall Study|Lost to Follow-up|0|||
124754138|NCT05715242|448720902|FG011|Overall Study|Lost to Follow-up|0|||
124754139|NCT05715242|448720903|FG012|Overall Study|Lost to Follow-up|0|||
124754140|NCT05715242|448720904|FG013|Overall Study|Lost to Follow-up|0|||
124754141|NCT05715242|448720905|FG014|Overall Study|Lost to Follow-up|0|||
124754142|NCT05715242|448720906|FG015|Overall Study|Lost to Follow-up|0|||
124754143|NCT02915978|448720907|FG000|Overall Study|Adverse Event|2|||
124754144|NCT02915978|448720908|FG001|Overall Study|Adverse Event|1|||
124754145|NCT02915978|448720909|FG002|Overall Study|Adverse Event|0|||
124754146|NCT02343406|448720915|FG000|Overall Study|Progressive disease|72|||
124754147|NCT02343406|448720916|FG001|Overall Study|Progressive disease|70|||
124754148|NCT02343406|448720917|FG002|Overall Study|Progressive disease|43|||
124754149|NCT02343406|448720918|FG003|Overall Study|Progressive disease|15|||
124754150|NCT02343406|448720919|FG004|Overall Study|Progressive disease|5|||
124754151|NCT02343406|448720915|FG000|Overall Study|Adverse Event|6|||
124754152|NCT02343406|448720916|FG001|Overall Study|Adverse Event|8|||
124754153|NCT02343406|448720917|FG002|Overall Study|Adverse Event|6|||
124754154|NCT02343406|448720918|FG003|Overall Study|Adverse Event|3|||
124754155|NCT02343406|448720919|FG004|Overall Study|Adverse Event|0|||
124754156|NCT02343406|448720915|FG000|Overall Study|Withdrawal by Subject|6|||
124754157|NCT02343406|448720916|FG001|Overall Study|Withdrawal by Subject|4|||
124754158|NCT02343406|448720917|FG002|Overall Study|Withdrawal by Subject|8|||
124754159|NCT02343406|448720918|FG003|Overall Study|Withdrawal by Subject|3|||
124754160|NCT02343406|448720919|FG004|Overall Study|Withdrawal by Subject|0|||
124754161|NCT02343406|448720915|FG000|Overall Study|Death|2|||
124754162|NCT02343406|448720916|FG001|Overall Study|Death|1|||
124754163|NCT02343406|448720917|FG002|Overall Study|Death|0|||
124754164|NCT02343406|448720918|FG003|Overall Study|Death|0|||
124754165|NCT02343406|448720919|FG004|Overall Study|Death|0|||
124754166|NCT02343406|448720915|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
124754167|NCT02343406|448720916|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
124754168|NCT02343406|448720917|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
124754169|NCT02343406|448720918|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
124754170|NCT02343406|448720919|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
124754171|NCT02343406|448720915|FG000|Overall Study|Other primary malignancy|0|||
124754172|NCT02343406|448720916|FG001|Overall Study|Other primary malignancy|1|||
124754173|NCT02343406|448720917|FG002|Overall Study|Other primary malignancy|0|||
124754174|NCT02343406|448720918|FG003|Overall Study|Other primary malignancy|0|||
124754175|NCT02343406|448720919|FG004|Overall Study|Other primary malignancy|0|||
124754176|NCT02343406|448720915|FG000|Overall Study|Other, not specified|2|||
124754177|NCT02343406|448720916|FG001|Overall Study|Other, not specified|1|||
124754178|NCT02343406|448720917|FG002|Overall Study|Other, not specified|1|||
124754179|NCT02343406|448720918|FG003|Overall Study|Other, not specified|4|||
124754180|NCT02343406|448720919|FG004|Overall Study|Other, not specified|0|||
124754181|NCT02451124|448720920|FG000|Overall Study|Withdrawal by Subject|1|||
124754182|NCT00766051|448720921|FG000|Overall Study|Withdrawal by Subject|2|||
124754183|NCT00766051|448720922|FG001|Overall Study|Withdrawal by Subject|0|||
124754184|NCT03058692|448722528|FG000|Overall Study|Lost to Follow-up|2|||
124754185|NCT03058692|448722529|FG001|Overall Study|Lost to Follow-up|1|||
124754186|NCT03058692|448722528|FG000|Overall Study|Withdrawal by Subject|1|||
124754187|NCT03058692|448722529|FG001|Overall Study|Withdrawal by Subject|1|||
124754188|NCT01392547|448722530|FG000|Overall Study|Adverse Event|2|||
124754189|NCT01392547|448722530|FG000|Overall Study|Non-compliance|2|||
124754190|NCT01392547|448722530|FG000|Overall Study|Withdrawal criteria|3|||
124754191|NCT01392547|448722530|FG000|Overall Study|Unclassified|1|||
124754192|NCT00799266|448722535|FG000|Overall Study|Adverse Event|0|||
124754193|NCT00799266|448722536|FG001|Overall Study|Adverse Event|1|||
124754194|NCT00799266|448722535|FG000|Overall Study|Subject withdrew consent|3|||
124754195|NCT00799266|448722536|FG001|Overall Study|Subject withdrew consent|0|||
124754196|NCT01362608|448722548|FG000|Overall Study|Protocol Violation|0|||
124754197|NCT01362608|448722549|FG001|Overall Study|Protocol Violation|1|||
124754198|NCT01362608|448722548|FG000|Overall Study|Lost to Follow-up|3|||
124754199|NCT01362608|448722549|FG001|Overall Study|Lost to Follow-up|1|||
124754200|NCT01362608|448722548|FG000|Overall Study|Withdrawal by Subject|1|||
124754201|NCT01362608|448722549|FG001|Overall Study|Withdrawal by Subject|2|||
124754202|NCT01362608|448722548|FG000|Overall Study|Lack of Efficacy|0|||
124754203|NCT01362608|448722549|FG001|Overall Study|Lack of Efficacy|2|||
124754204|NCT01362608|448722548|FG000|Overall Study|Adverse Event|0|||
124754205|NCT01362608|448722549|FG001|Overall Study|Adverse Event|2|||
124754206|NCT04506502|448722554|FG000|Overall Study|Withdrawal by Subject|1|||
124754207|NCT04506502|448722554|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
124754208|NCT00699608|448722555|FG000|First Intervention|Withdrawal by Subject|0|||
124754209|NCT00699608|448722556|FG001|First Intervention|Withdrawal by Subject|0|||
124754210|NCT00699608|448722557|FG002|First Intervention|Withdrawal by Subject|1|||
124754211|NCT00699608|448722558|FG003|First Intervention|Withdrawal by Subject|0|||
124754212|NCT00699608|448722559|FG004|First Intervention|Withdrawal by Subject|0|||
124754213|NCT00699608|448722560|FG005|First Intervention|Withdrawal by Subject|0|||
124754214|NCT00699608|448722555|FG000|First Intervention|Protocol Violation|0|||
124754215|NCT00699608|448722556|FG001|First Intervention|Protocol Violation|0|||
124754216|NCT00699608|448722557|FG002|First Intervention|Protocol Violation|0|||
124754217|NCT00699608|448722558|FG003|First Intervention|Protocol Violation|0|||
124754218|NCT00699608|448722559|FG004|First Intervention|Protocol Violation|1|||
124754219|NCT00699608|448722560|FG005|First Intervention|Protocol Violation|0|||
124754220|NCT00699608|448722555|FG000|Second Intervention|Adverse Event|0|||
124754221|NCT00699608|448722556|FG001|Second Intervention|Adverse Event|0|||
124754222|NCT00699608|448722557|FG002|Second Intervention|Adverse Event|1|||
124754223|NCT00699608|448722558|FG003|Second Intervention|Adverse Event|0|||
124754224|NCT00699608|448722559|FG004|Second Intervention|Adverse Event|0|||
124754225|NCT00699608|448722560|FG005|Second Intervention|Adverse Event|0|||
124754226|NCT00699608|448722555|FG000|Second Intervention|Withdrawal by Subject|0|||
124754227|NCT00699608|448722556|FG001|Second Intervention|Withdrawal by Subject|0|||
124754228|NCT00699608|448722557|FG002|Second Intervention|Withdrawal by Subject|0|||
124754229|NCT00699608|448722558|FG003|Second Intervention|Withdrawal by Subject|1|||
124754230|NCT00699608|448722559|FG004|Second Intervention|Withdrawal by Subject|0|||
124754231|NCT00699608|448722560|FG005|Second Intervention|Withdrawal by Subject|0|||
124754232|NCT03010319|448722563|FG000|Overall Study|Adverse Event|15|||
124754233|NCT03010319|448722564|FG001|Overall Study|Adverse Event|9|||
124754234|NCT03010319|448722563|FG000|Overall Study|Withdrawal by Subject|1|||
124754235|NCT03010319|448722564|FG001|Overall Study|Withdrawal by Subject|6|||
124754236|NCT03010319|448722563|FG000|Overall Study|Physician Decision|2|||
124754237|NCT03010319|448722564|FG001|Overall Study|Physician Decision|4|||
124754238|NCT03010319|448722563|FG000|Overall Study|Sponsor requested withdrawal|2|||
124754239|NCT03010319|448722564|FG001|Overall Study|Sponsor requested withdrawal|2|||
124754240|NCT03010319|448722563|FG000|Overall Study|Death|1|||
124754241|NCT03010319|448722564|FG001|Overall Study|Death|0|||
124754242|NCT03010319|448722563|FG000|Overall Study|Lost to Follow-up|0|||
124754243|NCT03010319|448722564|FG001|Overall Study|Lost to Follow-up|1|||
124754244|NCT03010319|448722563|FG000|Overall Study|Other Reason|5|||
124754245|NCT03010319|448722564|FG001|Overall Study|Other Reason|7|||
124754246|NCT04720417|448722565|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
124754247|NCT02588261|448722568|FG000|Overall Study|Study Terminated by Sponsor|157|||
124754248|NCT02588261|448722569|FG001|Overall Study|Study Terminated by Sponsor|142|||
124754249|NCT02588261|448722568|FG000|Overall Study|Protocol Deviation|1|||
124754250|NCT02588261|448722569|FG001|Overall Study|Protocol Deviation|0|||
124754251|NCT02588261|448722568|FG000|Overall Study|Death|1|||
124754252|NCT02588261|448722569|FG001|Overall Study|Death|2|||
124754253|NCT02588261|448722568|FG000|Overall Study|Withdrawal by Subject|12|||
124754254|NCT02588261|448722569|FG001|Overall Study|Withdrawal by Subject|8|||
124754255|NCT02588261|448722568|FG000|Overall Study|Noncompliance with Study Drug|0|||
124754256|NCT02588261|448722569|FG001|Overall Study|Noncompliance with Study Drug|1|||
124754257|NCT02588261|448722568|FG000|Overall Study|Miscellaneous|5|||
124754258|NCT02588261|448722569|FG001|Overall Study|Miscellaneous|4|||
124754259|NCT02588261|448722568|FG000|Overall Study|Progressive Disease|61|||
124754260|NCT02588261|448722569|FG001|Overall Study|Progressive Disease|82|||
124754261|NCT02588261|448722568|FG000|Overall Study|Adverse Event|29|||
124754262|NCT02588261|448722569|FG001|Overall Study|Adverse Event|24|||
124754263|NCT02588261|448722568|FG000|Overall Study|Lost to Follow-up|1|||
124754264|NCT02588261|448722569|FG001|Overall Study|Lost to Follow-up|0|||
124754265|NCT03781778|448722570|FG000|Overall Study|Withdrawal by Subject|2|||
124754266|NCT03781778|448722571|FG001|Overall Study|Withdrawal by Subject|2|||
124754267|NCT02287467|448722572|FG000|Overall Study|Protocol Violation|12|||
124754268|NCT02287467|448722573|FG001|Overall Study|Protocol Violation|9|||
124754269|NCT03472950|448722577|FG000|Overall Study|Lost to Follow-up|0|||
124754270|NCT03472950|448722578|FG001|Overall Study|Lost to Follow-up|1|||
124754271|NCT03472950|448722577|FG000|Overall Study|Adverse Event|0|||
124754272|NCT03472950|448722578|FG001|Overall Study|Adverse Event|3|||
124754273|NCT00517361|448722583|FG000|Overall Study|Death|6|||
124754274|NCT00517361|448722583|FG000|Overall Study|The study was terminated|5|||
124754275|NCT01076036|448722584|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
124754276|NCT00195091|448722585|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
124754277|NCT00245037|448722591|FG000|Overall Study|Death|17|||
124754278|NCT04181762|448722594|FG000|Overall Study|Adverse Event|1|||
124754279|NCT04181762|448722595|FG001|Overall Study|Adverse Event|3|||
124754280|NCT04181762|448722594|FG000|Overall Study|Lost to Follow-up|1|||
124754281|NCT04181762|448722595|FG001|Overall Study|Lost to Follow-up|1|||
124754282|NCT04181762|448722594|FG000|Overall Study|Physician Decision|1|||
124754283|NCT04181762|448722595|FG001|Overall Study|Physician Decision|3|||
124754284|NCT04181762|448722594|FG000|Overall Study|Pregnancy|0|||
124754285|NCT04181762|448722595|FG001|Overall Study|Pregnancy|1|||
124754286|NCT04181762|448722594|FG000|Overall Study|Lack of Efficacy|2|||
124754287|NCT04181762|448722595|FG001|Overall Study|Lack of Efficacy|2|||
124754288|NCT04181762|448722594|FG000|Overall Study|Study terminated by sponsor|95|||
124754289|NCT04181762|448722595|FG001|Overall Study|Study terminated by sponsor|97|||
124754290|NCT04181762|448722594|FG000|Overall Study|Subject decision|11|||
124754291|NCT04181762|448722595|FG001|Overall Study|Subject decision|4|||
124754292|NCT04181762|448722594|FG000|Overall Study|Death|1|||
124754293|NCT04181762|448722595|FG001|Overall Study|Death|1|||
124754294|NCT04181762|448722594|FG000|Overall Study|Protocol deviation|1|||
124754295|NCT04181762|448722595|FG001|Overall Study|Protocol deviation|0|||
124754296|NCT04181762|448722594|FG000|Overall Study|Withdrawal of informed consent|1|||
124754297|NCT04181762|448722595|FG001|Overall Study|Withdrawal of informed consent|3|||
124754298|NCT06964165|448722598|FG000|Overall Study|Withdrawal by Subject|0|||
124754299|NCT06964165|448722599|FG001|Overall Study|Withdrawal by Subject|1|||
124754300|NCT06964165|448722598|FG000|Overall Study|Ongoing at the time of analysis|15|||
124754301|NCT06964165|448722599|FG001|Overall Study|Ongoing at the time of analysis|14|||
124754302|NCT06964165|448722598|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
124754303|NCT06964165|448722599|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
124754304|NCT06964165|448722598|FG000|Overall Study|Participant removed due to non-compliance|0|||
124754305|NCT06964165|448722599|FG001|Overall Study|Participant removed due to non-compliance|1|||
124754306|NCT01514201|448722614|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
124754307|NCT01514201|448722615|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
124754308|NCT01514201|448722616|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
124754309|NCT01514201|448722617|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
124754310|NCT01514201|448722614|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
124754311|NCT01514201|448722615|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
124754312|NCT01514201|448722616|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
124754313|NCT01514201|448722617|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
124754314|NCT01514201|448722614|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
124754315|NCT01514201|448722615|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
124754316|NCT01514201|448722616|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
124754317|NCT01514201|448722617|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
124754318|NCT01514201|448722614|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
124754319|NCT01514201|448722615|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
124754320|NCT01514201|448722616|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
124754321|NCT01514201|448722617|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
124754322|NCT01514201|448722614|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
124754323|NCT01514201|448722615|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
124754324|NCT01514201|448722616|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
124754325|NCT01514201|448722617|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
124754326|NCT01514201|448722614|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
124754327|NCT01514201|448722615|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
124754328|NCT01514201|448722616|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
124754329|NCT01514201|448722617|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
124754330|NCT01514201|448722614|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
124754331|NCT01514201|448722615|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
124754332|NCT01514201|448722616|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
124754333|NCT01514201|448722617|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
124754334|NCT01514201|448722614|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
124754335|NCT01514201|448722615|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
124754336|NCT01514201|448722616|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
124754337|NCT01514201|448722617|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
124754338|NCT01514201|448722614|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
124754339|NCT01514201|448722615|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
124754340|NCT01514201|448722616|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
124754341|NCT01514201|448722617|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
124754342|NCT01514201|448722614|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
124754343|NCT01514201|448722615|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
124754344|NCT01514201|448722616|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
124754345|NCT01514201|448722617|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
124754346|NCT01514201|448722614|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
124754347|NCT01514201|448722615|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
124754348|NCT01514201|448722616|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
124754349|NCT01514201|448722617|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
124754350|NCT01514201|448722614|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
124754351|NCT01514201|448722615|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
124754352|NCT01514201|448722616|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
124754353|NCT01514201|448722617|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
124754354|NCT05888181|448722622|FG000|Overall Study|Lost to Follow-up|1|||
124754355|NCT05888181|448722623|FG001|Overall Study|Lost to Follow-up|1|||
124754356|NCT05888181|448722624|FG002|Overall Study|Lost to Follow-up|0|||
124754357|NCT02735343|448722628|FG000|Overall Study|screen fail|0|||
124754358|NCT02735343|448722629|FG001|Overall Study|screen fail|2|||
124754359|NCT00637416|448722630|FG000|Overall Study|Lost to Follow-up|1|||
124754360|NCT00637416|448722631|FG001|Overall Study|Lost to Follow-up|1|||
124754361|NCT00637416|448722630|FG000|Overall Study|Unable to take study drug|0|||
124754362|NCT00637416|448722631|FG001|Overall Study|Unable to take study drug|1|||
124754363|NCT02534909|448722635|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
124754364|NCT01625000|448722638|FG000|Overall Study|Physician Decision|15|||
124754365|NCT01625000|448722639|FG001|Overall Study|Physician Decision|7|||
124754366|NCT01625000|448722640|FG002|Overall Study|Physician Decision|7|||
124754367|NCT01625000|448722641|FG003|Overall Study|Physician Decision|2|||
124754368|NCT01625000|448722642|FG004|Overall Study|Physician Decision|15|||
124754369|NCT01625000|448722638|FG000|Overall Study|Protocol Violation|3|||
124754370|NCT01625000|448722639|FG001|Overall Study|Protocol Violation|10|||
124754371|NCT01625000|448722640|FG002|Overall Study|Protocol Violation|4|||
124754372|NCT01625000|448722641|FG003|Overall Study|Protocol Violation|1|||
124754373|NCT01625000|448722642|FG004|Overall Study|Protocol Violation|2|||
124754374|NCT01625000|448722638|FG000|Overall Study|Withdrawal by Subject|19|||
124754375|NCT01625000|448722639|FG001|Overall Study|Withdrawal by Subject|16|||
124754376|NCT01625000|448722640|FG002|Overall Study|Withdrawal by Subject|11|||
124754377|NCT01625000|448722641|FG003|Overall Study|Withdrawal by Subject|9|||
124754378|NCT01625000|448722642|FG004|Overall Study|Withdrawal by Subject|17|||
124754379|NCT01625000|448722638|FG000|Overall Study|Adverse Event (including Death)|15|||
124754380|NCT01625000|448722639|FG001|Overall Study|Adverse Event (including Death)|19|||
124754381|NCT01625000|448722640|FG002|Overall Study|Adverse Event (including Death)|11|||
124754382|NCT01625000|448722641|FG003|Overall Study|Adverse Event (including Death)|7|||
124754383|NCT01625000|448722642|FG004|Overall Study|Adverse Event (including Death)|21|||
124754384|NCT00566852|448722643|FG000|Overall Study|Protocol Violation|22|||
124754385|NCT00566852|448722644|FG001|Overall Study|Protocol Violation|24|||
124754386|NCT00566852|448722643|FG000|Overall Study|Death|95|||
124754387|NCT00566852|448722644|FG001|Overall Study|Death|78|||
124754388|NCT00566852|448722643|FG000|Overall Study|Withdrawal by Subject|30|||
124754389|NCT00566852|448722644|FG001|Overall Study|Withdrawal by Subject|25|||
124754390|NCT00566852|448722643|FG000|Overall Study|Patient refusal|37|||
124754391|NCT00566852|448722644|FG001|Overall Study|Patient refusal|37|||
124754392|NCT00566852|448722643|FG000|Overall Study|Not tested due to disability|6|||
124754393|NCT00566852|448722644|FG001|Overall Study|Not tested due to disability|12|||
124754394|NCT00566852|448722643|FG000|Overall Study|Missing reason not specified|1|||
124754395|NCT00566852|448722644|FG001|Overall Study|Missing reason not specified|2|||
124754396|NCT00566852|448722643|FG000|Overall Study|Missing reason not reported|16|||
124754397|NCT00566852|448722644|FG001|Overall Study|Missing reason not reported|20|||
124754398|NCT00577824|448722647|FG000|Overall Study|Adverse Event|6|||
124754399|NCT00577824|448722648|FG001|Overall Study|Adverse Event|18|||
124754400|NCT00577824|448722649|FG002|Overall Study|Adverse Event|1|||
124754401|NCT00577824|448722647|FG000|Overall Study|Patient decision|0|||
124754402|NCT00577824|448722648|FG001|Overall Study|Patient decision|1|||
124754403|NCT00577824|448722649|FG002|Overall Study|Patient decision|1|||
124754404|NCT00577824|448722647|FG000|Overall Study|Protocol Violation|1|||
124754405|NCT00577824|448722648|FG001|Overall Study|Protocol Violation|1|||
124754406|NCT00577824|448722649|FG002|Overall Study|Protocol Violation|0|||
124754407|NCT04079816|448722650|FG000|Overall Study|Request of Subject|2|||
124754408|NCT04079816|448722650|FG000|Overall Study|Unable to draw samples|1|||
124754409|NCT00362648|448722651|FG000|Overall Study|Adverse Event|12|||
124754410|NCT00362648|448722652|FG001|Overall Study|Adverse Event|21|||
124754411|NCT00362648|448722653|FG002|Overall Study|Adverse Event|1|||
124754412|NCT00362648|448722654|FG003|Overall Study|Adverse Event|0|||
124754413|NCT00362648|448722651|FG000|Overall Study|Lost to Follow-up|62|||
124754414|NCT00362648|448722652|FG001|Overall Study|Lost to Follow-up|69|||
124754415|NCT00362648|448722653|FG002|Overall Study|Lost to Follow-up|4|||
124754416|NCT00362648|448722654|FG003|Overall Study|Lost to Follow-up|3|||
124754417|NCT00362648|448722651|FG000|Overall Study|Protocol Violation|4|||
124754418|NCT00362648|448722652|FG001|Overall Study|Protocol Violation|2|||
124754419|NCT00362648|448722653|FG002|Overall Study|Protocol Violation|2|||
124754420|NCT00362648|448722654|FG003|Overall Study|Protocol Violation|2|||
124754421|NCT00362648|448722651|FG000|Overall Study|Withdrawal by Subject|48|||
124754422|NCT00362648|448722652|FG001|Overall Study|Withdrawal by Subject|42|||
124754423|NCT00362648|448722653|FG002|Overall Study|Withdrawal by Subject|2|||
124754424|NCT00362648|448722654|FG003|Overall Study|Withdrawal by Subject|6|||
124754425|NCT02123823|448722656|FG000|Overall Study|Lack of Efficacy|0|||
124754426|NCT02123823|448722657|FG001|Overall Study|Lack of Efficacy|2|||
124754427|NCT02123823|448722658|FG002|Overall Study|Lack of Efficacy|8|||
124754428|NCT02123823|448722659|FG003|Overall Study|Lack of Efficacy|10|||
124754429|NCT02123823|448722656|FG000|Overall Study|Progressive disease|3|||
124754430|NCT02123823|448722657|FG001|Overall Study|Progressive disease|19|||
124754431|NCT02123823|448722658|FG002|Overall Study|Progressive disease|52|||
124754432|NCT02123823|448722659|FG003|Overall Study|Progressive disease|53|||
124754433|NCT02123823|448722656|FG000|Overall Study|Withdrawal by Subject|0|||
124754434|NCT02123823|448722657|FG001|Overall Study|Withdrawal by Subject|0|||
124754435|NCT02123823|448722658|FG002|Overall Study|Withdrawal by Subject|7|||
124754436|NCT02123823|448722659|FG003|Overall Study|Withdrawal by Subject|2|||
124754437|NCT02123823|448722656|FG000|Overall Study|Adverse Event|0|||
124754438|NCT02123823|448722657|FG001|Overall Study|Adverse Event|0|||
124754439|NCT02123823|448722658|FG002|Overall Study|Adverse Event|3|||
124754440|NCT02123823|448722659|FG003|Overall Study|Adverse Event|5|||
124754441|NCT05870865|448722663|FG000|Randomized|Did not receive study treatment|2|||
124754442|NCT05870865|448722664|FG001|Randomized|Did not receive study treatment|4|||
124754443|NCT05870865|448722665|FG002|Randomized|Did not receive study treatment|4|||
124754444|NCT05870865|448722666|FG003|Randomized|Did not receive study treatment|3|||
124754445|NCT05870865|448722663|FG000|Treatment Period|Adverse Event|1|||
124754446|NCT05870865|448722664|FG001|Treatment Period|Adverse Event|1|||
124754447|NCT05870865|448722665|FG002|Treatment Period|Adverse Event|1|||
124754448|NCT05870865|448722666|FG003|Treatment Period|Adverse Event|1|||
124754449|NCT05870865|448722663|FG000|Treatment Period|Lost to Follow-up|0|||
124754450|NCT05870865|448722664|FG001|Treatment Period|Lost to Follow-up|1|||
124754451|NCT05870865|448722665|FG002|Treatment Period|Lost to Follow-up|2|||
124754452|NCT05870865|448722666|FG003|Treatment Period|Lost to Follow-up|0|||
124754453|NCT05870865|448722663|FG000|Treatment Period|Protocol Violation|0|||
124754454|NCT05870865|448722664|FG001|Treatment Period|Protocol Violation|0|||
124754455|NCT05870865|448722665|FG002|Treatment Period|Protocol Violation|0|||
124754456|NCT05870865|448722666|FG003|Treatment Period|Protocol Violation|1|||
124754457|NCT05870865|448722663|FG000|Treatment Period|Withdrawal by Subject|0|||
124754458|NCT05870865|448722664|FG001|Treatment Period|Withdrawal by Subject|1|||
124754459|NCT05870865|448722665|FG002|Treatment Period|Withdrawal by Subject|1|||
124754460|NCT05870865|448722666|FG003|Treatment Period|Withdrawal by Subject|1|||
124754461|NCT04752332|448722667|FG000|Overall Study|Adverse Event|3|||
124754462|NCT04752332|448722668|FG001|Overall Study|Adverse Event|1|||
124754463|NCT04752332|448722667|FG000|Overall Study|Disease Relapse|1|||
124754464|NCT04752332|448722668|FG001|Overall Study|Disease Relapse|0|||
124754465|NCT04752332|448722667|FG000|Overall Study|Non-compliance With Study Drug|2|||
124754466|NCT04752332|448722668|FG001|Overall Study|Non-compliance With Study Drug|0|||
124754467|NCT04752332|448722667|FG000|Overall Study|Physician Decision|2|||
124754468|NCT04752332|448722668|FG001|Overall Study|Physician Decision|1|||
124754469|NCT04752332|448722667|FG000|Overall Study|Protocol Violation|1|||
124754470|NCT04752332|448722668|FG001|Overall Study|Protocol Violation|1|||
124754471|NCT04752332|448722667|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
124754472|NCT04752332|448722668|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
124754473|NCT04752332|448722667|FG000|Overall Study|Study Terminated by Sponsor|10|||
124754474|NCT04752332|448722668|FG001|Overall Study|Study Terminated by Sponsor|48|||
124754475|NCT04752332|448722667|FG000|Overall Study|Withdrawal by Subject|11|||
124754476|NCT04752332|448722668|FG001|Overall Study|Withdrawal by Subject|3|||
124754477|NCT01868477|448722670|FG000|Overall Study|Adverse Event|2|||
124754478|NCT01868477|448722671|FG001|Overall Study|Adverse Event|4|||
124754479|NCT01868477|448722670|FG000|Overall Study|Disease progression|1|||
124754480|NCT01868477|448722671|FG001|Overall Study|Disease progression|1|||
124754481|NCT01868477|448722670|FG000|Overall Study|Withdrawal by Subject|1|||
124754482|NCT01868477|448722671|FG001|Overall Study|Withdrawal by Subject|0|||
124754483|NCT00856297|448722677|FG000|Overall Study|Unable to classify|2|||
124754484|NCT00856297|448722678|FG001|Overall Study|Unable to classify|0|||
124754485|NCT00856297|448722679|FG002|Overall Study|Unable to classify|0|||
124754486|NCT00856297|448722680|FG003|Overall Study|Unable to classify|0|||
124754487|NCT00856297|448722681|FG004|Overall Study|Unable to classify|0|||
124847253|NCT03013491|449064257|FG018|Long-term Extension|Disease progression|1|||
124847254|NCT03013491|449064239|FG000|Long-term Extension|Withdrawal by Subject|0|||
124847255|NCT03013491|449064240|FG001|Long-term Extension|Withdrawal by Subject|0|||
124847256|NCT03013491|449064241|FG002|Long-term Extension|Withdrawal by Subject|0|||
124847257|NCT03013491|449064242|FG003|Long-term Extension|Withdrawal by Subject|0|||
124847258|NCT03013491|449064243|FG004|Long-term Extension|Withdrawal by Subject|0|||
124847259|NCT03013491|449064244|FG005|Long-term Extension|Withdrawal by Subject|0|||
124847260|NCT03013491|449064245|FG006|Long-term Extension|Withdrawal by Subject|0|||
124847261|NCT03013491|449064246|FG007|Long-term Extension|Withdrawal by Subject|1|||
124847262|NCT03013491|449064247|FG008|Long-term Extension|Withdrawal by Subject|0|||
124847263|NCT03013491|449064248|FG009|Long-term Extension|Withdrawal by Subject|0|||
124847264|NCT03013491|449064249|FG010|Long-term Extension|Withdrawal by Subject|0|||
124847265|NCT03013491|449064250|FG011|Long-term Extension|Withdrawal by Subject|0|||
124847266|NCT03013491|449064251|FG012|Long-term Extension|Withdrawal by Subject|0|||
124847267|NCT03013491|449064252|FG013|Long-term Extension|Withdrawal by Subject|0|||
124847268|NCT03013491|449064253|FG014|Long-term Extension|Withdrawal by Subject|0|||
124847269|NCT03013491|449064254|FG015|Long-term Extension|Withdrawal by Subject|0|||
124847270|NCT03013491|449064255|FG016|Long-term Extension|Withdrawal by Subject|0|||
124847271|NCT03013491|449064256|FG017|Long-term Extension|Withdrawal by Subject|0|||
124847272|NCT03013491|449064257|FG018|Long-term Extension|Withdrawal by Subject|0|||
124847273|NCT03013491|449064239|FG000|Long-term Extension|Adverse Event|0|||
124847274|NCT03013491|449064240|FG001|Long-term Extension|Adverse Event|0|||
124847275|NCT03013491|449064241|FG002|Long-term Extension|Adverse Event|0|||
124847276|NCT03013491|449064242|FG003|Long-term Extension|Adverse Event|0|||
124847277|NCT03013491|449064243|FG004|Long-term Extension|Adverse Event|0|||
124847278|NCT03013491|449064244|FG005|Long-term Extension|Adverse Event|0|||
124847279|NCT03013491|449064245|FG006|Long-term Extension|Adverse Event|0|||
124847280|NCT03013491|449064246|FG007|Long-term Extension|Adverse Event|0|||
124847281|NCT03013491|449064247|FG008|Long-term Extension|Adverse Event|0|||
124847282|NCT03013491|449064248|FG009|Long-term Extension|Adverse Event|0|||
124847283|NCT03013491|449064249|FG010|Long-term Extension|Adverse Event|0|||
124847284|NCT03013491|449064250|FG011|Long-term Extension|Adverse Event|0|||
124847285|NCT03013491|449064251|FG012|Long-term Extension|Adverse Event|0|||
124847286|NCT03013491|449064252|FG013|Long-term Extension|Adverse Event|0|||
124847287|NCT03013491|449064253|FG014|Long-term Extension|Adverse Event|0|||
124847288|NCT03013491|449064254|FG015|Long-term Extension|Adverse Event|0|||
124847289|NCT03013491|449064255|FG016|Long-term Extension|Adverse Event|0|||
124847290|NCT03013491|449064256|FG017|Long-term Extension|Adverse Event|0|||
124847291|NCT03013491|449064257|FG018|Long-term Extension|Adverse Event|1|||
124847292|NCT03013491|449064239|FG000|Long-term Extension|Death|0|||
124847293|NCT03013491|449064240|FG001|Long-term Extension|Death|0|||
124847294|NCT03013491|449064241|FG002|Long-term Extension|Death|0|||
124847295|NCT03013491|449064242|FG003|Long-term Extension|Death|0|||
124847296|NCT03013491|449064243|FG004|Long-term Extension|Death|0|||
124847297|NCT03013491|449064244|FG005|Long-term Extension|Death|0|||
124847298|NCT03013491|449064245|FG006|Long-term Extension|Death|0|||
124847299|NCT03013491|449064246|FG007|Long-term Extension|Death|0|||
124847300|NCT03013491|449064247|FG008|Long-term Extension|Death|0|||
124847301|NCT03013491|449064248|FG009|Long-term Extension|Death|0|||
124847302|NCT03013491|449064249|FG010|Long-term Extension|Death|0|||
124847303|NCT03013491|449064250|FG011|Long-term Extension|Death|0|||
124847304|NCT03013491|449064251|FG012|Long-term Extension|Death|0|||
124847305|NCT03013491|449064252|FG013|Long-term Extension|Death|0|||
124847306|NCT03013491|449064253|FG014|Long-term Extension|Death|0|||
124847307|NCT03013491|449064254|FG015|Long-term Extension|Death|0|||
124847308|NCT03013491|449064255|FG016|Long-term Extension|Death|0|||
124847309|NCT03013491|449064256|FG017|Long-term Extension|Death|0|||
124847310|NCT03013491|449064257|FG018|Long-term Extension|Death|1|||
124847311|NCT03265119|449064258|FG000|Overall Study|Adverse Event|2|||
124847312|NCT03265119|449064259|FG001|Overall Study|Adverse Event|1|||
124847313|NCT03265119|449064258|FG000|Overall Study|Lack of Efficacy|3|||
124847314|NCT03265119|449064259|FG001|Overall Study|Lack of Efficacy|0|||
124847315|NCT03265119|449064258|FG000|Overall Study|Protocol Violation|1|||
124847316|NCT03265119|449064259|FG001|Overall Study|Protocol Violation|2|||
124847317|NCT03265119|449064258|FG000|Overall Study|Withdrawal by Subject|2|||
124847318|NCT03265119|449064259|FG001|Overall Study|Withdrawal by Subject|4|||
124847319|NCT03265119|449064258|FG000|Overall Study|Lost to Follow-up|1|||
124847320|NCT03265119|449064259|FG001|Overall Study|Lost to Follow-up|0|||
124847321|NCT03265119|449064258|FG000|Overall Study|Lack of Compliance|1|||
124847322|NCT03265119|449064259|FG001|Overall Study|Lack of Compliance|0|||
124847323|NCT03238911|449064260|FG000|Overall Study|Withdrawal by Subject|1|||
124847324|NCT03238911|449064261|FG001|Overall Study|Withdrawal by Subject|2|||
124847325|NCT03238911|449064260|FG000|Overall Study|Lost to Follow-up|2|||
124847326|NCT03238911|449064261|FG001|Overall Study|Lost to Follow-up|1|||
124847327|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
124847328|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
124847329|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
124847330|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Death|1|||
124847331|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Death|0|||
124847332|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Death|0|||
124847333|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
124847334|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
124847335|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
124847336|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
124847337|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
124847338|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
124847339|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
124847340|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
124847341|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
124847342|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
124847343|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
124847344|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
124847345|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
124847346|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
124847347|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
124847348|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
124847349|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
124847350|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
124847351|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
124847352|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
124847353|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
124847354|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
124847355|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
124847356|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
124847357|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
124847358|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
124847359|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
124847360|NCT03655236|449064262|FG000|Subject Disposition in Part 1 Period|Other|0|||
124847361|NCT03655236|449064263|FG001|Subject Disposition in Part 1 Period|Other|2|||
124847362|NCT03655236|449064264|FG002|Subject Disposition in Part 1 Period|Other|2|||
124847363|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
124847364|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
124847365|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
124847366|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
124847367|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
124847368|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
124847369|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
124847370|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
124847371|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
124847372|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
124847373|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
124847374|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
124847375|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
124847376|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
124847377|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
124847378|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
124847379|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
124847380|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
124847381|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
124847382|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
124847383|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
124847384|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
124847385|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
124847386|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
124847387|NCT03655236|449064262|FG000|Subject Disposition in Part 2 Period|Other|1|||
124847388|NCT03655236|449064263|FG001|Subject Disposition in Part 2 Period|Other|0|||
124847389|NCT03655236|449064264|FG002|Subject Disposition in Part 2 Period|Other|0|||
124847390|NCT00991302|449065942|FG000|Overall Study|Death|0|||
124847391|NCT00991302|449065943|FG001|Overall Study|Death|1|||
124847392|NCT00991302|449065942|FG000|Overall Study|Lost to Follow-up|14|||
124847393|NCT00991302|449065943|FG001|Overall Study|Lost to Follow-up|12|||
124847394|NCT01709318|449065944|FG000|Overall Study|Adverse Event|3|||
124847395|NCT01709318|449065945|FG001|Overall Study|Adverse Event|4|||
124847396|NCT01709318|449065946|FG002|Overall Study|Adverse Event|2|||
124847397|NCT01709318|449065947|FG003|Overall Study|Adverse Event|2|||
124847398|NCT01709318|449065948|FG004|Overall Study|Adverse Event|0|||
124847399|NCT01709318|449065949|FG005|Overall Study|Adverse Event|1|||
124847400|NCT01709318|449065950|FG006|Overall Study|Adverse Event|2|||
124847401|NCT01709318|449065944|FG000|Overall Study|Lost to Follow-up|2|||
124847402|NCT01709318|449065945|FG001|Overall Study|Lost to Follow-up|0|||
124847403|NCT01709318|449065946|FG002|Overall Study|Lost to Follow-up|0|||
124847404|NCT01709318|449065947|FG003|Overall Study|Lost to Follow-up|0|||
124847405|NCT01709318|449065948|FG004|Overall Study|Lost to Follow-up|1|||
124847406|NCT01709318|449065949|FG005|Overall Study|Lost to Follow-up|1|||
124847407|NCT01709318|449065950|FG006|Overall Study|Lost to Follow-up|1|||
124847408|NCT01709318|449065944|FG000|Overall Study|Non-compliance with Study Drug|0|||
124847409|NCT01709318|449065945|FG001|Overall Study|Non-compliance with Study Drug|2|||
124847410|NCT01709318|449065946|FG002|Overall Study|Non-compliance with Study Drug|1|||
124847411|NCT01709318|449065947|FG003|Overall Study|Non-compliance with Study Drug|1|||
124847412|NCT01709318|449065948|FG004|Overall Study|Non-compliance with Study Drug|0|||
124847413|NCT01709318|449065949|FG005|Overall Study|Non-compliance with Study Drug|0|||
124847414|NCT01709318|449065950|FG006|Overall Study|Non-compliance with Study Drug|2|||
124847415|NCT01709318|449065944|FG000|Overall Study|Physician Decision|0|||
124847416|NCT01709318|449065945|FG001|Overall Study|Physician Decision|0|||
124847417|NCT01709318|449065946|FG002|Overall Study|Physician Decision|0|||
124847418|NCT01709318|449065947|FG003|Overall Study|Physician Decision|0|||
124847419|NCT01709318|449065948|FG004|Overall Study|Physician Decision|0|||
124847420|NCT01709318|449065949|FG005|Overall Study|Physician Decision|0|||
124847421|NCT01709318|449065950|FG006|Overall Study|Physician Decision|1|||
124847422|NCT01709318|449065944|FG000|Overall Study|Pregnancy|0|||
124847423|NCT01709318|449065945|FG001|Overall Study|Pregnancy|0|||
124847424|NCT01709318|449065946|FG002|Overall Study|Pregnancy|0|||
124847425|NCT01709318|449065947|FG003|Overall Study|Pregnancy|0|||
124847426|NCT01709318|449065948|FG004|Overall Study|Pregnancy|1|||
124847427|NCT01709318|449065949|FG005|Overall Study|Pregnancy|0|||
124847428|NCT01709318|449065950|FG006|Overall Study|Pregnancy|0|||
124847429|NCT01709318|449065944|FG000|Overall Study|Protocol Violation|0|||
124847430|NCT01709318|449065945|FG001|Overall Study|Protocol Violation|0|||
124847431|NCT01709318|449065946|FG002|Overall Study|Protocol Violation|0|||
124847432|NCT01709318|449065947|FG003|Overall Study|Protocol Violation|0|||
124847433|NCT01709318|449065948|FG004|Overall Study|Protocol Violation|2|||
124847434|NCT01709318|449065949|FG005|Overall Study|Protocol Violation|0|||
124847435|NCT01709318|449065950|FG006|Overall Study|Protocol Violation|1|||
124847436|NCT01709318|449065944|FG000|Overall Study|Technical Problems|1|||
124847437|NCT01709318|449065945|FG001|Overall Study|Technical Problems|0|||
124847438|NCT01709318|449065946|FG002|Overall Study|Technical Problems|0|||
124847439|NCT01709318|449065947|FG003|Overall Study|Technical Problems|0|||
124847440|NCT01709318|449065948|FG004|Overall Study|Technical Problems|0|||
124847441|NCT01709318|449065949|FG005|Overall Study|Technical Problems|0|||
124847442|NCT01709318|449065950|FG006|Overall Study|Technical Problems|0|||
124847443|NCT01709318|449065944|FG000|Overall Study|Withdrawal by Subject|3|||
124847444|NCT01709318|449065945|FG001|Overall Study|Withdrawal by Subject|0|||
124847445|NCT01709318|449065946|FG002|Overall Study|Withdrawal by Subject|3|||
124847446|NCT01709318|449065947|FG003|Overall Study|Withdrawal by Subject|3|||
124847447|NCT01709318|449065948|FG004|Overall Study|Withdrawal by Subject|0|||
124847448|NCT01709318|449065949|FG005|Overall Study|Withdrawal by Subject|2|||
124847449|NCT01709318|449065950|FG006|Overall Study|Withdrawal by Subject|4|||
124847450|NCT01709318|449065944|FG000|Overall Study|Other Protocol Specified Criteria|0|||
124847451|NCT01709318|449065945|FG001|Overall Study|Other Protocol Specified Criteria|1|||
124847452|NCT01709318|449065946|FG002|Overall Study|Other Protocol Specified Criteria|0|||
124847453|NCT01709318|449065947|FG003|Overall Study|Other Protocol Specified Criteria|0|||
124847454|NCT01709318|449065948|FG004|Overall Study|Other Protocol Specified Criteria|0|||
124847455|NCT01709318|449065949|FG005|Overall Study|Other Protocol Specified Criteria|0|||
124847456|NCT01709318|449065950|FG006|Overall Study|Other Protocol Specified Criteria|0|||
124847457|NCT03042312|449065951|FG000|Overall Study|Administrative Reason|1|||
124847458|NCT03042312|449065952|FG001|Overall Study|Administrative Reason|1|||
124847459|NCT03042312|449065951|FG000|Overall Study|Adverse Event|0|||
124847460|NCT03042312|449065952|FG001|Overall Study|Adverse Event|1|||
124847461|NCT03042312|449065951|FG000|Overall Study|Lost to Follow-up|1|||
124847462|NCT03042312|449065952|FG001|Overall Study|Lost to Follow-up|3|||
124847463|NCT03042312|449065951|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
124847464|NCT03042312|449065952|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
124847465|NCT03042312|449065951|FG000|Overall Study|Withdrawal by Subject|4|||
124847466|NCT03042312|449065952|FG001|Overall Study|Withdrawal by Subject|5|||
124847467|NCT02383758|449065953|FG000|Overall Study|Withdrawal by Subject|0|||
124847468|NCT02383758|449065954|FG001|Overall Study|Withdrawal by Subject|2|||
124847469|NCT00646958|449065959|FG000|Overall Study|Lack of Efficacy|1|||
124847470|NCT00646958|449065960|FG001|Overall Study|Lack of Efficacy|0|||
124847471|NCT00646958|449065961|FG002|Overall Study|Lack of Efficacy|0|||
124847472|NCT00646958|449065959|FG000|Overall Study|Adverse Event|4|||
124847473|NCT00646958|449065960|FG001|Overall Study|Adverse Event|0|||
124847474|NCT00646958|449065961|FG002|Overall Study|Adverse Event|0|||
124847475|NCT00646958|449065959|FG000|Overall Study|Lost to Follow-up|1|||
124847476|NCT00646958|449065960|FG001|Overall Study|Lost to Follow-up|5|||
124847477|NCT00646958|449065961|FG002|Overall Study|Lost to Follow-up|7|||
124847478|NCT00646958|449065959|FG000|Overall Study|Protocol Violation|1|||
124847479|NCT00646958|449065960|FG001|Overall Study|Protocol Violation|1|||
124847480|NCT00646958|449065961|FG002|Overall Study|Protocol Violation|0|||
124847481|NCT00646958|449065959|FG000|Overall Study|Abnormal screening lab tests|1|||
124847482|NCT00646958|449065960|FG001|Overall Study|Abnormal screening lab tests|1|||
124847483|NCT00646958|449065961|FG002|Overall Study|Abnormal screening lab tests|0|||
124847484|NCT00646958|449065959|FG000|Overall Study|Withdrawal by Subject|1|||
124847485|NCT00646958|449065960|FG001|Overall Study|Withdrawal by Subject|2|||
124847486|NCT00646958|449065961|FG002|Overall Study|Withdrawal by Subject|0|||
124847487|NCT00646958|449065959|FG000|Overall Study|Did not receive study drug|2|||
124847488|NCT00646958|449065960|FG001|Overall Study|Did not receive study drug|0|||
124847489|NCT00646958|449065961|FG002|Overall Study|Did not receive study drug|2|||
124847490|NCT03085927|449065963|FG000|Overall Study|Withdrawal by Subject|1|||
124847491|NCT03085927|449065964|FG001|Overall Study|Withdrawal by Subject|4|||
124847492|NCT03085927|449065963|FG000|Overall Study|Lost to Follow-up|3|||
124847493|NCT03085927|449065964|FG001|Overall Study|Lost to Follow-up|1|||
124847494|NCT03085927|449065963|FG000|Overall Study|Death|1|||
124847495|NCT03085927|449065964|FG001|Overall Study|Death|0|||
124847496|NCT03085927|449065963|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
124847497|NCT03085927|449065964|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
124847498|NCT03085927|449065963|FG000|Overall Study|Dyad Became Ineligible|0|||
124847499|NCT03085927|449065964|FG001|Overall Study|Dyad Became Ineligible|1|||
124847500|NCT02349711|449065965|FG000|Overall Study|Withdrawal by Subject|2|||
124847501|NCT02349711|449065966|FG001|Overall Study|Withdrawal by Subject|1|||
124847502|NCT02349711|449065965|FG000|Overall Study|Lost to Follow-up|1|||
124847503|NCT02349711|449065966|FG001|Overall Study|Lost to Follow-up|1|||
124847504|NCT00194012|449065967|FG000|Randomized Phase|Lack of Efficacy|8|||
124847505|NCT00194012|449065968|FG001|Randomized Phase|Lack of Efficacy|18|||
124847506|NCT00194012|449065967|FG000|Randomized Phase|Study nonadherence|2|||
124847507|NCT00194012|449065968|FG001|Randomized Phase|Study nonadherence|1|||
124847508|NCT00194012|449065967|FG000|Randomized Phase|Withdrawal by Subject|3|||
124847509|NCT00194012|449065968|FG001|Randomized Phase|Withdrawal by Subject|3|||
124847510|NCT00194012|449065967|FG000|Randomized Phase|Adverse Event|2|||
124847511|NCT00194012|449065968|FG001|Randomized Phase|Adverse Event|1|||
124847512|NCT00194012|449065967|FG000|Randomized Phase|Participant reported having a rash|1|||
124847513|NCT00194012|449065968|FG001|Randomized Phase|Participant reported having a rash|0|||
124847514|NCT00194012|449065967|FG000|Randomized Phase|Emesis and enuresis|0|||
124847515|NCT00194012|449065968|FG001|Randomized Phase|Emesis and enuresis|1|||
124847516|NCT00194012|449065967|FG000|Randomized Phase|Oral/nasal twitching|0|||
124847517|NCT00194012|449065968|FG001|Randomized Phase|Oral/nasal twitching|1|||
124847518|NCT00194012|449065967|FG000|Open Label Extension (OLE)|Weight Gain|1|||
124847519|NCT00194012|449065968|FG001|Open Label Extension (OLE)|Weight Gain|0|||
124847520|NCT00194012|449065967|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
124847521|NCT00194012|449065968|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
124847522|NCT00194012|449065967|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
124847523|NCT00194012|449065968|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
124847524|NCT00194012|449065967|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
124847525|NCT00194012|449065968|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
124847526|NCT02200042|449065974|FG000|Overall Study|Withdrawal by Subject|0|||
124847527|NCT02200042|449065975|FG001|Overall Study|Withdrawal by Subject|1|||
124847528|NCT02097134|449065976|FG000|Overall Study|Physician Decision|4|||
124847529|NCT02097134|449065976|FG000|Overall Study|Non-Protocol Therapy|1|||
124847530|NCT02097134|449065976|FG000|Overall Study|Progressive Disease|3|||
124847531|NCT02097134|449065976|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
124847532|NCT02939404|449065981|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
124847533|NCT02939404|449065982|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
124847534|NCT02939404|449065981|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
124847535|NCT02939404|449065982|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
124847536|NCT02047110|449065986|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
124847537|NCT02047110|449065987|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
124847538|NCT02047110|449065988|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
124847539|NCT02047110|449065989|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
124847540|NCT02047110|449065986|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
124847541|NCT02047110|449065987|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
124847542|NCT02047110|449065988|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
124847543|NCT02047110|449065989|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
124847544|NCT02047110|449065986|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
124847545|NCT02047110|449065987|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
124847546|NCT02047110|449065988|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
124847547|NCT02047110|449065989|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
124847548|NCT02047110|449065986|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
124847549|NCT02047110|449065987|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
124847550|NCT02047110|449065988|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
124847551|NCT02047110|449065989|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
124847552|NCT02047110|449065986|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
124847553|NCT02047110|449065987|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
124847554|NCT02047110|449065988|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
124847555|NCT02047110|449065989|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
124847556|NCT02047110|449065986|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
124847557|NCT02047110|449065987|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
124847558|NCT02047110|449065988|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
124847559|NCT02047110|449065989|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
124847560|NCT02047110|449065986|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
124847561|NCT02047110|449065987|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
124847562|NCT02047110|449065988|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
124847563|NCT02047110|449065989|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
124847564|NCT02047110|449065986|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
124847565|NCT02047110|449065987|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
124847566|NCT02047110|449065988|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
124847567|NCT02047110|449065989|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
124847568|NCT02047110|449065986|FG000|Escape Treatment Period|Adverse Event|1|||
124847569|NCT02047110|449065987|FG001|Escape Treatment Period|Adverse Event|2|||
124847570|NCT02047110|449065988|FG002|Escape Treatment Period|Adverse Event|2|||
124847571|NCT02047110|449065989|FG003|Escape Treatment Period|Adverse Event|0|||
124847572|NCT02047110|449065986|FG000|Escape Treatment Period|Other than specified|1|||
124847573|NCT02047110|449065987|FG001|Escape Treatment Period|Other than specified|2|||
124847574|NCT02047110|449065988|FG002|Escape Treatment Period|Other than specified|0|||
124847575|NCT02047110|449065989|FG003|Escape Treatment Period|Other than specified|1|||
124847576|NCT02047110|449065986|FG000|OLE Treatment Period|Other than specified|0|||
124847577|NCT02047110|449065987|FG001|OLE Treatment Period|Other than specified|0|||
124847578|NCT02047110|449065988|FG002|OLE Treatment Period|Other than specified|1|||
124847579|NCT02047110|449065989|FG003|OLE Treatment Period|Other than specified|0|||
124847580|NCT02247349|449065990|FG000|Overall Study|Disease Progression|7|||
124847581|NCT02247349|449065991|FG001|Overall Study|Disease Progression|4|||
124847582|NCT02247349|449065992|FG002|Overall Study|Disease Progression|26|||
124847583|NCT02247349|449065993|FG003|Overall Study|Disease Progression|31|||
124847584|NCT02247349|449065994|FG004|Overall Study|Disease Progression|16|||
124847585|NCT02247349|449065995|FG005|Overall Study|Disease Progression|6|||
124847586|NCT02247349|449065990|FG000|Overall Study|Study drug toxicity|0|||
124847587|NCT02247349|449065991|FG001|Overall Study|Study drug toxicity|1|||
124847588|NCT02247349|449065992|FG002|Overall Study|Study drug toxicity|1|||
124847589|NCT02247349|449065993|FG003|Overall Study|Study drug toxicity|1|||
124847590|NCT02247349|449065994|FG004|Overall Study|Study drug toxicity|2|||
124847591|NCT02247349|449065995|FG005|Overall Study|Study drug toxicity|2|||
124847592|NCT02247349|449065990|FG000|Overall Study|Death|0|||
124847593|NCT02247349|449065991|FG001|Overall Study|Death|0|||
124847594|NCT02247349|449065992|FG002|Overall Study|Death|0|||
124847595|NCT02247349|449065993|FG003|Overall Study|Death|1|||
124847596|NCT02247349|449065994|FG004|Overall Study|Death|0|||
124847597|NCT02247349|449065995|FG005|Overall Study|Death|0|||
124847598|NCT02247349|449065990|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
124847599|NCT02247349|449065991|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
124847600|NCT02247349|449065992|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
124847601|NCT02247349|449065993|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
124847602|NCT02247349|449065994|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
124847603|NCT02247349|449065995|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
124847604|NCT02247349|449065990|FG000|Overall Study|Participant request to discontinue study treatment|0|||
124847605|NCT02247349|449065991|FG001|Overall Study|Participant request to discontinue study treatment|0|||
124847606|NCT02247349|449065992|FG002|Overall Study|Participant request to discontinue study treatment|1|||
124847607|NCT02247349|449065993|FG003|Overall Study|Participant request to discontinue study treatment|2|||
124847608|NCT02247349|449065994|FG004|Overall Study|Participant request to discontinue study treatment|1|||
124847609|NCT02247349|449065995|FG005|Overall Study|Participant request to discontinue study treatment|0|||
124847610|NCT02247349|449065990|FG000|Overall Study|Withdrawal by Subject|0|||
124847611|NCT02247349|449065991|FG001|Overall Study|Withdrawal by Subject|1|||
124847612|NCT02247349|449065992|FG002|Overall Study|Withdrawal by Subject|0|||
124847613|NCT02247349|449065993|FG003|Overall Study|Withdrawal by Subject|0|||
124847614|NCT02247349|449065994|FG004|Overall Study|Withdrawal by Subject|0|||
124847615|NCT02247349|449065995|FG005|Overall Study|Withdrawal by Subject|0|||
124847616|NCT02247349|449065990|FG000|Overall Study|Administrative reason by sponsor|0|||
124847617|NCT02247349|449065991|FG001|Overall Study|Administrative reason by sponsor|0|||
124847618|NCT02247349|449065992|FG002|Overall Study|Administrative reason by sponsor|0|||
124847619|NCT02247349|449065993|FG003|Overall Study|Administrative reason by sponsor|0|||
124847620|NCT02247349|449065994|FG004|Overall Study|Administrative reason by sponsor|1|||
124847621|NCT02247349|449065995|FG005|Overall Study|Administrative reason by sponsor|0|||
124847622|NCT02247349|449065990|FG000|Overall Study|Other reasons|0|||
124847623|NCT02247349|449065991|FG001|Overall Study|Other reasons|0|||
124847624|NCT02247349|449065992|FG002|Overall Study|Other reasons|1|||
124847625|NCT02247349|449065993|FG003|Overall Study|Other reasons|0|||
124847626|NCT02247349|449065994|FG004|Overall Study|Other reasons|0|||
124847627|NCT02247349|449065995|FG005|Overall Study|Other reasons|0|||
124847628|NCT01959581|449066000|FG000|Overall Study|Lost to Follow-up|5|||
124847629|NCT03773757|449066003|FG000|Overall Study|Withdrawal by Subject|2|||
124847630|NCT03773757|449066004|FG001|Overall Study|Withdrawal by Subject|4|||
124847631|NCT01109316|449066005|FG000|Study Period 1|Adverse Event|0|||
124847632|NCT01109316|449066006|FG001|Study Period 1|Adverse Event|0|||
124847633|NCT01109316|449066007|FG002|Study Period 1|Adverse Event|1|||
124847634|NCT01109316|449066008|FG003|Study Period 1|Adverse Event|0|||
124847635|NCT01109316|449066009|FG004|Study Period 1|Adverse Event|0|||
124847636|NCT01109316|449066010|FG005|Study Period 1|Adverse Event|0|||
124847637|NCT01109316|449066005|FG000|Study Period 1|Lost to Follow-up|0|||
124847638|NCT01109316|449066006|FG001|Study Period 1|Lost to Follow-up|0|||
124847639|NCT01109316|449066007|FG002|Study Period 1|Lost to Follow-up|1|||
124847640|NCT01109316|449066008|FG003|Study Period 1|Lost to Follow-up|1|||
124847641|NCT01109316|449066009|FG004|Study Period 1|Lost to Follow-up|0|||
124847642|NCT01109316|449066010|FG005|Study Period 1|Lost to Follow-up|0|||
124847643|NCT01109316|449066005|FG000|Study Period 1|Withdrawal by Subject|0|||
124847644|NCT01109316|449066006|FG001|Study Period 1|Withdrawal by Subject|0|||
124847645|NCT01109316|449066007|FG002|Study Period 1|Withdrawal by Subject|1|||
124847646|NCT01109316|449066008|FG003|Study Period 1|Withdrawal by Subject|0|||
124847647|NCT01109316|449066009|FG004|Study Period 1|Withdrawal by Subject|2|||
124847648|NCT01109316|449066010|FG005|Study Period 1|Withdrawal by Subject|0|||
124847649|NCT01109316|449066005|FG000|Study Period 1|Sponsor Decision|0|||
124847650|NCT01109316|449066006|FG001|Study Period 1|Sponsor Decision|0|||
124847651|NCT01109316|449066007|FG002|Study Period 1|Sponsor Decision|0|||
124847652|NCT01109316|449066008|FG003|Study Period 1|Sponsor Decision|0|||
124847653|NCT01109316|449066009|FG004|Study Period 1|Sponsor Decision|0|||
124847654|NCT01109316|449066010|FG005|Study Period 1|Sponsor Decision|2|||
124847655|NCT01109316|449066005|FG000|Study Period 2|Entry Criteria Not Met|0|||
124847656|NCT01109316|449066006|FG001|Study Period 2|Entry Criteria Not Met|1|||
124847657|NCT01109316|449066007|FG002|Study Period 2|Entry Criteria Not Met|0|||
124847658|NCT01109316|449066008|FG003|Study Period 2|Entry Criteria Not Met|0|||
124847659|NCT01109316|449066009|FG004|Study Period 2|Entry Criteria Not Met|0|||
124847660|NCT01109316|449066010|FG005|Study Period 2|Entry Criteria Not Met|0|||
124847661|NCT01109316|449066005|FG000|Study Period 2|Physician Decision|0|||
124847662|NCT01109316|449066006|FG001|Study Period 2|Physician Decision|0|||
124847663|NCT01109316|449066007|FG002|Study Period 2|Physician Decision|0|||
124847664|NCT01109316|449066008|FG003|Study Period 2|Physician Decision|1|||
124847665|NCT01109316|449066009|FG004|Study Period 2|Physician Decision|0|||
124847666|NCT01109316|449066010|FG005|Study Period 2|Physician Decision|0|||
124847667|NCT01109316|449066005|FG000|Study Period 2|Protocol Violation|1|||
124847668|NCT01109316|449066006|FG001|Study Period 2|Protocol Violation|0|||
124847669|NCT01109316|449066007|FG002|Study Period 2|Protocol Violation|0|||
124847670|NCT01109316|449066008|FG003|Study Period 2|Protocol Violation|0|||
124847671|NCT01109316|449066009|FG004|Study Period 2|Protocol Violation|0|||
124847672|NCT01109316|449066010|FG005|Study Period 2|Protocol Violation|0|||
124847673|NCT01109316|449066005|FG000|Study Period 2|Withdrawal by Subject|0|||
124847674|NCT01109316|449066006|FG001|Study Period 2|Withdrawal by Subject|0|||
124847675|NCT01109316|449066007|FG002|Study Period 2|Withdrawal by Subject|1|||
124847676|NCT01109316|449066008|FG003|Study Period 2|Withdrawal by Subject|0|||
124847677|NCT01109316|449066009|FG004|Study Period 2|Withdrawal by Subject|0|||
124847678|NCT01109316|449066010|FG005|Study Period 2|Withdrawal by Subject|1|||
124847679|NCT01109316|449066005|FG000|Study Period 3|Lost to Follow-up|0|||
124847680|NCT01109316|449066006|FG001|Study Period 3|Lost to Follow-up|0|||
124847681|NCT01109316|449066007|FG002|Study Period 3|Lost to Follow-up|0|||
124847682|NCT01109316|449066008|FG003|Study Period 3|Lost to Follow-up|0|||
124847683|NCT01109316|449066009|FG004|Study Period 3|Lost to Follow-up|1|||
124847684|NCT01109316|449066010|FG005|Study Period 3|Lost to Follow-up|0|||
124847685|NCT01109316|449066005|FG000|Study Period 3|Withdrawal by Subject|1|||
124847686|NCT01109316|449066006|FG001|Study Period 3|Withdrawal by Subject|0|||
124847687|NCT01109316|449066007|FG002|Study Period 3|Withdrawal by Subject|0|||
124847688|NCT01109316|449066008|FG003|Study Period 3|Withdrawal by Subject|0|||
124847689|NCT01109316|449066009|FG004|Study Period 3|Withdrawal by Subject|1|||
124847690|NCT01109316|449066010|FG005|Study Period 3|Withdrawal by Subject|0|||
124847691|NCT01302392|449066013|FG000|Overall Study|Lost to Follow-up|1|||
124847692|NCT01302392|449066014|FG001|Overall Study|Lost to Follow-up|0|||
124847693|NCT01302392|449066013|FG000|Overall Study|Withdrawal by Subject|6|||
124847694|NCT01302392|449066014|FG001|Overall Study|Withdrawal by Subject|1|||
124847695|NCT00670228|449066015|FG000|Overall Study|Adverse Event|1|||
124847696|NCT00670228|449066016|FG001|Overall Study|Adverse Event|0|||
124847697|NCT00670228|449066015|FG000|Overall Study|Death or MACE|0|||
124847698|NCT00670228|449066016|FG001|Overall Study|Death or MACE|1|||
124847699|NCT00670228|449066015|FG000|Overall Study|Not treated|2|||
124847700|NCT00670228|449066016|FG001|Overall Study|Not treated|2|||
124847701|NCT00670228|449066015|FG000|Overall Study|Not meeting the selection criteria|2|||
124847702|NCT00670228|449066016|FG001|Overall Study|Not meeting the selection criteria|0|||
124847703|NCT03049813|449066023|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
124847704|NCT03049813|449066024|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
124847705|NCT03049813|449066025|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
124847706|NCT03049813|449066026|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
124847707|NCT03049813|449066023|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
124847708|NCT03049813|449066024|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
124847709|NCT03049813|449066025|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
124847710|NCT03049813|449066026|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
124847711|NCT03049813|449066023|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
124847712|NCT03049813|449066024|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
124847713|NCT03049813|449066025|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
124847714|NCT03049813|449066026|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
124847715|NCT03049813|449066023|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
124847716|NCT03049813|449066024|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
124847717|NCT03049813|449066025|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
124847718|NCT03049813|449066026|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
124847719|NCT00550836|449066027|FG000|Overall Study|Withdrawal by Subject|3|||
124847720|NCT00550836|449066028|FG001|Overall Study|Withdrawal by Subject|9|||
124847721|NCT00179413|449066029|FG000|Overall Study|Adverse Event|38|||
124847722|NCT00179413|449066030|FG001|Overall Study|Adverse Event|20|||
124847723|NCT00179413|449066029|FG000|Overall Study|Withdrawal by Subject|87|||
124847724|NCT00179413|449066030|FG001|Overall Study|Withdrawal by Subject|95|||
124847725|NCT01696032|449066036|FG000|Overall Study|Withdrawal by Subject|0|||
124847726|NCT01696032|449066037|FG001|Overall Study|Withdrawal by Subject|0|||
124847727|NCT01696032|449066038|FG002|Overall Study|Withdrawal by Subject|1|||
124847728|NCT01696032|449066039|FG003|Overall Study|Withdrawal by Subject|2|||
124847729|NCT01696032|449066036|FG000|Overall Study|Death|14|||
124847730|NCT01696032|449066037|FG001|Overall Study|Death|4|||
124847731|NCT01696032|449066038|FG002|Overall Study|Death|43|||
124847732|NCT01696032|449066039|FG003|Overall Study|Death|18|||
124847733|NCT01696032|449066036|FG000|Overall Study|Lost to Follow-up|0|||
124847734|NCT01696032|449066037|FG001|Overall Study|Lost to Follow-up|1|||
124847735|NCT01696032|449066038|FG002|Overall Study|Lost to Follow-up|0|||
124847736|NCT01696032|449066039|FG003|Overall Study|Lost to Follow-up|0|||
124847737|NCT01696032|449066036|FG000|Overall Study|Database lock|0|||
124847738|NCT01696032|449066037|FG001|Overall Study|Database lock|1|||
124847739|NCT01696032|449066038|FG002|Overall Study|Database lock|7|||
124847740|NCT01696032|449066039|FG003|Overall Study|Database lock|2|||
124847741|NCT01192152|449066042|FG000|Period 1|left prematurely (while on treatment B)|0|||
124847742|NCT01192152|449066043|FG001|Period 1|left prematurely (while on treatment B)|1|||
124847743|NCT01192152|449066042|FG000|Period 3|family emergency|1|||
124847744|NCT01192152|449066043|FG001|Period 3|family emergency|0|||
124847745|NCT05013905|449066044|FG000|Overall Study|Adverse Event|1|||
124847746|NCT05013905|449066044|FG000|Overall Study|Lack of Efficacy|1|||
124847747|NCT04666259|449066046|FG000|Treatment Phase|Physician Decision|9|||
124847748|NCT04666259|449066047|FG001|Treatment Phase|Physician Decision|3|||
124847749|NCT04666259|449066048|FG002|Treatment Phase|Physician Decision|3|||
124847750|NCT04666259|449066046|FG000|Treatment Phase|Adverse Event|3|||
124847751|NCT04666259|449066047|FG001|Treatment Phase|Adverse Event|1|||
124847752|NCT04666259|449066048|FG002|Treatment Phase|Adverse Event|0|||
124847753|NCT04666259|449066046|FG000|Treatment Phase|Subject decision|1|||
124847754|NCT04666259|449066047|FG001|Treatment Phase|Subject decision|2|||
124847755|NCT04666259|449066048|FG002|Treatment Phase|Subject decision|0|||
124847756|NCT04666259|449066046|FG000|Treatment Phase|Progressive disease|0|||
124847757|NCT04666259|449066047|FG001|Treatment Phase|Progressive disease|1|||
124847758|NCT04666259|449066048|FG002|Treatment Phase|Progressive disease|0|||
124847759|NCT04666259|449066046|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
124847760|NCT04666259|449066047|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
124847761|NCT04666259|449066048|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
124847762|NCT04666259|449066046|FG000|Safety Follow-up Phase|Physician Decision|2|||
124847763|NCT04666259|449066047|FG001|Safety Follow-up Phase|Physician Decision|0|||
124847764|NCT04666259|449066048|FG002|Safety Follow-up Phase|Physician Decision|0|||
124847765|NCT04666259|449066046|FG000|Safety Follow-up Phase|Subject decision|1|||
124847766|NCT04666259|449066047|FG001|Safety Follow-up Phase|Subject decision|0|||
124847767|NCT04666259|449066048|FG002|Safety Follow-up Phase|Subject decision|0|||
124847768|NCT04666259|449066046|FG000|Safety Follow-up Phase|Death|0|||
124847769|NCT04666259|449066047|FG001|Safety Follow-up Phase|Death|1|||
124847770|NCT04666259|449066048|FG002|Safety Follow-up Phase|Death|0|||
124847771|NCT00854581|449066049|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
124847772|NCT00854581|449066049|FG000|Induction (Up to Day 21)|Death|1|||
124847773|NCT00854581|449066049|FG000|Induction (Up to Day 21)|Physician Decision|1|||
124847774|NCT00854581|449066049|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
124847775|NCT00378703|449066052|FG000|Overall Study|Disease progression|59|||
124847776|NCT00378703|449066053|FG001|Overall Study|Disease progression|43|||
124847777|NCT00378703|449066054|FG002|Overall Study|Disease progression|48|||
124847778|NCT00378703|449066055|FG003|Overall Study|Disease progression|49|||
124847779|NCT00378703|449066052|FG000|Overall Study|Adverse Event|11|||
124847780|NCT00378703|449066053|FG001|Overall Study|Adverse Event|17|||
124847781|NCT00378703|449066054|FG002|Overall Study|Adverse Event|20|||
124847782|NCT00378703|449066055|FG003|Overall Study|Adverse Event|18|||
124847783|NCT00378703|449066052|FG000|Overall Study|Death|2|||
124847784|NCT00378703|449066053|FG001|Overall Study|Death|2|||
124847785|NCT00378703|449066054|FG002|Overall Study|Death|4|||
124847786|NCT00378703|449066055|FG003|Overall Study|Death|3|||
124847787|NCT00378703|449066052|FG000|Overall Study|Withdrawal by Subject|4|||
124847788|NCT00378703|449066053|FG001|Overall Study|Withdrawal by Subject|8|||
124847789|NCT00378703|449066054|FG002|Overall Study|Withdrawal by Subject|5|||
124847790|NCT00378703|449066055|FG003|Overall Study|Withdrawal by Subject|7|||
124847791|NCT00378703|449066052|FG000|Overall Study|Physician Decision|1|||
124847792|NCT00378703|449066053|FG001|Overall Study|Physician Decision|4|||
124847793|NCT00378703|449066054|FG002|Overall Study|Physician Decision|1|||
124847794|NCT00378703|449066055|FG003|Overall Study|Physician Decision|0|||
124847795|NCT00378703|449066052|FG000|Overall Study|Alternative therapy|4|||
124847796|NCT00378703|449066053|FG001|Overall Study|Alternative therapy|2|||
124847797|NCT00378703|449066054|FG002|Overall Study|Alternative therapy|0|||
124847798|NCT00378703|449066055|FG003|Overall Study|Alternative therapy|0|||
124847799|NCT00378703|449066052|FG000|Overall Study|Other complicated disease|0|||
124847800|NCT00378703|449066053|FG001|Overall Study|Other complicated disease|2|||
124847801|NCT00378703|449066054|FG002|Overall Study|Other complicated disease|2|||
124847802|NCT00378703|449066055|FG003|Overall Study|Other complicated disease|0|||
124847803|NCT00378703|449066052|FG000|Overall Study|Symptomatic deterioration|0|||
124847804|NCT00378703|449066053|FG001|Overall Study|Symptomatic deterioration|1|||
124847805|NCT00378703|449066054|FG002|Overall Study|Symptomatic deterioration|0|||
124847806|NCT00378703|449066055|FG003|Overall Study|Symptomatic deterioration|2|||
124847807|NCT00378703|449066052|FG000|Overall Study|Surgery|1|||
124847808|NCT00378703|449066053|FG001|Overall Study|Surgery|0|||
124847809|NCT00378703|449066054|FG002|Overall Study|Surgery|0|||
124847810|NCT00378703|449066055|FG003|Overall Study|Surgery|1|||
124847811|NCT00378703|449066052|FG000|Overall Study|Joint decision of physician and patient|1|||
124847812|NCT00378703|449066053|FG001|Overall Study|Joint decision of physician and patient|0|||
124847813|NCT00378703|449066054|FG002|Overall Study|Joint decision of physician and patient|0|||
124847814|NCT00378703|449066055|FG003|Overall Study|Joint decision of physician and patient|0|||
124847815|NCT00378703|449066052|FG000|Overall Study|Adverse events and progressive disease|0|||
124847816|NCT00378703|449066053|FG001|Overall Study|Adverse events and progressive disease|0|||
124847817|NCT00378703|449066054|FG002|Overall Study|Adverse events and progressive disease|0|||
124847818|NCT00378703|449066055|FG003|Overall Study|Adverse events and progressive disease|1|||
124847819|NCT00378703|449066052|FG000|Overall Study|Relocation|0|||
124847820|NCT00378703|449066053|FG001|Overall Study|Relocation|0|||
124847821|NCT00378703|449066054|FG002|Overall Study|Relocation|1|||
124847822|NCT00378703|449066055|FG003|Overall Study|Relocation|0|||
124847823|NCT00378703|449066052|FG000|Overall Study|Ineligible|4|||
124847824|NCT00378703|449066053|FG001|Overall Study|Ineligible|7|||
124847825|NCT00378703|449066054|FG002|Overall Study|Ineligible|7|||
124847826|NCT00378703|449066055|FG003|Overall Study|Ineligible|7|||
124847827|NCT00378703|449066052|FG000|Overall Study|Never started treatment|1|||
124847828|NCT00378703|449066053|FG001|Overall Study|Never started treatment|4|||
124847829|NCT00378703|449066054|FG002|Overall Study|Never started treatment|0|||
124847830|NCT00378703|449066055|FG003|Overall Study|Never started treatment|0|||
124847831|NCT00378703|449066052|FG000|Overall Study|Other|1|||
124847832|NCT00378703|449066053|FG001|Overall Study|Other|1|||
124847833|NCT00378703|449066054|FG002|Overall Study|Other|2|||
124847834|NCT00378703|449066055|FG003|Overall Study|Other|3|||
124847835|NCT02705820|449066056|FG000|Overall Study|Death|2|||
124847836|NCT02705820|449066056|FG000|Overall Study|Disease Progression|34|||
124847837|NCT02705820|449066056|FG000|Overall Study|Clinical Deterioration|3|||
124847838|NCT05402995|449066057|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
124847839|NCT05402995|449066058|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
124847840|NCT05402995|449066059|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
124847841|NCT05402995|449066060|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
124847842|NCT01009099|449066061|FG000|Overall Study|Lost to Follow-up|1|||
124847843|NCT01009099|449066062|FG001|Overall Study|Lost to Follow-up|0|||
124847844|NCT01009099|449066061|FG000|Overall Study|Physician Decision|3|||
124847845|NCT01009099|449066062|FG001|Overall Study|Physician Decision|2|||
124847846|NCT01009099|449066061|FG000|Overall Study|Withdrawal by Subject|1|||
124847847|NCT01009099|449066062|FG001|Overall Study|Withdrawal by Subject|1|||
124847848|NCT01009099|449066061|FG000|Overall Study|Death|0|||
124847849|NCT01009099|449066062|FG001|Overall Study|Death|1|||
124847850|NCT02702401|449066063|FG000|Overall Study|Death|242|||
124847851|NCT02702401|449066064|FG001|Overall Study|Death|125|||
124847852|NCT02702401|449066063|FG000|Overall Study|Withdrawal by Subject|15|||
124847853|NCT02702401|449066064|FG001|Overall Study|Withdrawal by Subject|5|||
124847854|NCT02702401|449066063|FG000|Overall Study|Sponsor Decision|19|||
124847855|NCT02702401|449066064|FG001|Overall Study|Sponsor Decision|3|||
124847856|NCT02702401|449066063|FG000|Overall Study|Physician Decision|1|||
124847857|NCT02702401|449066064|FG001|Overall Study|Physician Decision|2|||
124847858|NCT02702401|449066063|FG000|Overall Study|Lost to Follow-up|1|||
124847859|NCT02702401|449066064|FG001|Overall Study|Lost to Follow-up|0|||
124847860|NCT04292730|449066074|FG000|Overall Study|Lost to Follow-up|8|||
124847861|NCT04292730|449066075|FG001|Overall Study|Lost to Follow-up|12|||
124847862|NCT04292730|449066076|FG002|Overall Study|Lost to Follow-up|12|||
124847863|NCT04292730|449066077|FG003|Overall Study|Lost to Follow-up|48|||
124847864|NCT04292730|449066074|FG000|Overall Study|Death|2|||
124847865|NCT04292730|449066075|FG001|Overall Study|Death|2|||
124847866|NCT04292730|449066076|FG002|Overall Study|Death|4|||
124847867|NCT04292730|449066077|FG003|Overall Study|Death|12|||
124847868|NCT04292730|449066074|FG000|Overall Study|Withdrew Consent|2|||
124847869|NCT04292730|449066075|FG001|Overall Study|Withdrew Consent|2|||
124847870|NCT04292730|449066076|FG002|Overall Study|Withdrew Consent|5|||
124847871|NCT04292730|449066077|FG003|Overall Study|Withdrew Consent|6|||
124847872|NCT04292730|449066074|FG000|Overall Study|Non-Compliance with Study Drug|0|||
124847873|NCT04292730|449066075|FG001|Overall Study|Non-Compliance with Study Drug|1|||
124847874|NCT04292730|449066076|FG002|Overall Study|Non-Compliance with Study Drug|0|||
124847875|NCT04292730|449066077|FG003|Overall Study|Non-Compliance with Study Drug|0|||
124847876|NCT04292730|449066074|FG000|Overall Study|Protocol Violation|0|||
124847877|NCT04292730|449066075|FG001|Overall Study|Protocol Violation|0|||
124847878|NCT04292730|449066076|FG002|Overall Study|Protocol Violation|1|||
124847879|NCT04292730|449066077|FG003|Overall Study|Protocol Violation|0|||
124847880|NCT04292730|449066074|FG000|Overall Study|Randomized but not Treated|8|||
124847881|NCT04292730|449066075|FG001|Overall Study|Randomized but not Treated|4|||
124847882|NCT04292730|449066076|FG002|Overall Study|Randomized but not Treated|0|||
124847883|NCT04292730|449066077|FG003|Overall Study|Randomized but not Treated|14|||
124847884|NCT01527292|449066079|FG000|Overall Study|Physician Decision|0|||
124847885|NCT01527292|449066080|FG001|Overall Study|Physician Decision|3|||
124847886|NCT01482767|449066081|FG000|Overall Study|Death|1|||
124847887|NCT01482767|449066082|FG001|Overall Study|Death|1|||
124847888|NCT01482767|449066081|FG000|Overall Study|Withdrawal by Subject|7|||
124847889|NCT01482767|449066082|FG001|Overall Study|Withdrawal by Subject|5|||
124847890|NCT01482767|449066081|FG000|Overall Study|Lost to Follow-up|12|||
124847891|NCT01482767|449066082|FG001|Overall Study|Lost to Follow-up|6|||
124847892|NCT01482767|449066081|FG000|Overall Study|Adverse Event|0|||
124847893|NCT01482767|449066082|FG001|Overall Study|Adverse Event|3|||
124847894|NCT01482767|449066081|FG000|Overall Study|Site closure|22|||
124847895|NCT01482767|449066082|FG001|Overall Study|Site closure|14|||
124847896|NCT01482767|449066081|FG000|Overall Study|Non-adherence to study requirements|4|||
124847897|NCT01482767|449066082|FG001|Overall Study|Non-adherence to study requirements|7|||
124847898|NCT01482767|449066081|FG000|Overall Study|Alternate HCV treatment|7|||
124847899|NCT01482767|449066082|FG001|Overall Study|Alternate HCV treatment|8|||
124847900|NCT01482767|449066081|FG000|Overall Study|Ineligible|0|||
124847901|NCT01482767|449066082|FG001|Overall Study|Ineligible|5|||
124847902|NCT01482767|449066081|FG000|Overall Study|Nurse error|1|||
124847903|NCT01482767|449066082|FG001|Overall Study|Nurse error|0|||
124847904|NCT01856543|449066083|FG000|Overall Study|Treatment discontinued|6|||
124847905|NCT01856543|449066084|FG001|Overall Study|Treatment discontinued|3|||
124847906|NCT01856543|449066083|FG000|Overall Study|Withdrawn before start|7|||
124847907|NCT01856543|449066084|FG001|Overall Study|Withdrawn before start|3|||
124847908|NCT01541930|449066087|FG000|Overall Study|Withdrawal by Subject|1|||
124847909|NCT02501096|449066088|FG000|Overall Study|Lost to Follow-up|0|||
124847910|NCT02501096|449066089|FG001|Overall Study|Lost to Follow-up|0|||
124847911|NCT02501096|449066090|FG002|Overall Study|Lost to Follow-up|0|||
124847912|NCT02501096|449066091|FG003|Overall Study|Lost to Follow-up|0|||
124847913|NCT02501096|449066092|FG004|Overall Study|Lost to Follow-up|1|||
124847914|NCT02501096|449066093|FG005|Overall Study|Lost to Follow-up|1|||
124847915|NCT02501096|449066094|FG006|Overall Study|Lost to Follow-up|3|||
124847916|NCT02501096|449066095|FG007|Overall Study|Lost to Follow-up|0|||
124847917|NCT02501096|449066096|FG008|Overall Study|Lost to Follow-up|0|||
124847918|NCT02501096|449066088|FG000|Overall Study|Withdrawal by Subject|1|||
124847919|NCT02501096|449066089|FG001|Overall Study|Withdrawal by Subject|0|||
124847920|NCT02501096|449066090|FG002|Overall Study|Withdrawal by Subject|7|||
124847921|NCT02501096|449066091|FG003|Overall Study|Withdrawal by Subject|13|||
124847922|NCT02501096|449066092|FG004|Overall Study|Withdrawal by Subject|2|||
124847923|NCT02501096|449066093|FG005|Overall Study|Withdrawal by Subject|2|||
124847924|NCT02501096|449066094|FG006|Overall Study|Withdrawal by Subject|2|||
124847925|NCT02501096|449066095|FG007|Overall Study|Withdrawal by Subject|3|||
124847926|NCT02501096|449066096|FG008|Overall Study|Withdrawal by Subject|0|||
124847927|NCT02501096|449066088|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
124847928|NCT02501096|449066089|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
124847929|NCT02501096|449066090|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
124847930|NCT02501096|449066091|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
124847931|NCT02501096|449066092|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
124847932|NCT02501096|449066093|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
124847933|NCT02501096|449066094|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
124847934|NCT02501096|449066095|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
124847935|NCT02501096|449066096|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
124847936|NCT02501096|449066088|FG000|Overall Study|Death|1|||
124847937|NCT02501096|449066089|FG001|Overall Study|Death|1|||
124847938|NCT02501096|449066090|FG002|Overall Study|Death|88|||
124847939|NCT02501096|449066091|FG003|Overall Study|Death|74|||
124847940|NCT02501096|449066092|FG004|Overall Study|Death|15|||
124847941|NCT02501096|449066093|FG005|Overall Study|Death|16|||
124847942|NCT02501096|449066094|FG006|Overall Study|Death|15|||
124847943|NCT02501096|449066095|FG007|Overall Study|Death|16|||
124847944|NCT02501096|449066096|FG008|Overall Study|Death|1|||
124847945|NCT04187196|449066097|FG000|Overall Study|Screen Failure|2|||
124847946|NCT04187196|449066098|FG001|Overall Study|Screen Failure|0|||
124847947|NCT03139916|449066101|FG000|Overall Study|Withdrawal by Subject|2|||
124847948|NCT03139916|449066101|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
124847949|NCT01957475|449066102|FG000|Test Period 1|Withdrawal by Subject|1|||
124847950|NCT01957475|449066103|FG001|Test Period 1|Withdrawal by Subject|0|||
124847951|NCT01957475|449066102|FG000|Test Period 1|Other|1|||
124847952|NCT01957475|449066103|FG001|Test Period 1|Other|0|||
124847953|NCT01957475|449066102|FG000|Test Period 1|Lack of Efficacy|0|||
124847954|NCT01957475|449066103|FG001|Test Period 1|Lack of Efficacy|1|||
124847955|NCT01957475|449066102|FG000|Test Period 2|Adverse Event|1|||
124847956|NCT01957475|449066103|FG001|Test Period 2|Adverse Event|0|||
124847957|NCT04587193|449066104|FG000|Overall Study|Screen failure after consent|3|||
124847958|NCT04587193|449066105|FG001|Overall Study|Screen failure after consent|0|||
124847959|NCT04587193|449066104|FG000|Overall Study|Device broke during study|3|||
124847960|NCT04587193|449066105|FG001|Overall Study|Device broke during study|2|||
124847961|NCT01552772|449066106|FG000|Overall Study|Lost to Follow-up|2|||
124847962|NCT01552772|449066106|FG000|Overall Study|Adverse Event|1|||
124847963|NCT01552772|449066106|FG000|Overall Study|Protocol Deviation|1|||
124847964|NCT02920983|449066107|FG000|Dispense 1|Unacceptable Lens Fit|0|||
124847965|NCT02920983|449066108|FG001|Dispense 1|Unacceptable Lens Fit|0|||
124847966|NCT02920983|449066109|FG002|Dispense 1|Unacceptable Lens Fit|0|||
124847967|NCT02920983|449066110|FG003|Dispense 1|Unacceptable Lens Fit|0|||
124847968|NCT02920983|449066111|FG004|Dispense 1|Unacceptable Lens Fit|1|||
124847969|NCT02920983|449066112|FG005|Dispense 1|Unacceptable Lens Fit|0|||
124847970|NCT02920983|449066107|FG000|Dispense 2|Unscceptable lens fit|1|||
124847971|NCT02920983|449066108|FG001|Dispense 2|Unscceptable lens fit|0|||
124847972|NCT02920983|449066109|FG002|Dispense 2|Unscceptable lens fit|0|||
124847973|NCT02920983|449066110|FG003|Dispense 2|Unscceptable lens fit|0|||
124847974|NCT02920983|449066111|FG004|Dispense 2|Unscceptable lens fit|1|||
124847975|NCT02920983|449066112|FG005|Dispense 2|Unscceptable lens fit|0|||
124847976|NCT02920983|449066107|FG000|Dispense 3|Unacceptable Lens Fit|1|||
124847977|NCT02920983|449066108|FG001|Dispense 3|Unacceptable Lens Fit|1|||
124847978|NCT02920983|449066109|FG002|Dispense 3|Unacceptable Lens Fit|0|||
124847979|NCT02920983|449066110|FG003|Dispense 3|Unacceptable Lens Fit|0|||
124847980|NCT02920983|449066111|FG004|Dispense 3|Unacceptable Lens Fit|1|||
124847981|NCT02920983|449066112|FG005|Dispense 3|Unacceptable Lens Fit|0|||
124847982|NCT02553421|449066117|FG000|Overall Study|Lost to Follow-up|21|||
124847983|NCT02553421|449066118|FG001|Overall Study|Lost to Follow-up|1|||
124847984|NCT02553421|449066117|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
124847985|NCT02553421|449066118|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
124847986|NCT02553421|449066117|FG000|Overall Study|Improper Device Placement|3|||
124847987|NCT02553421|449066118|FG001|Overall Study|Improper Device Placement|0|||
124847988|NCT02453594|449067221|FG000|Overall Study|Protocol Violation|0|||
124847989|NCT02453594|449067222|FG001|Overall Study|Protocol Violation|0|||
124847990|NCT02453594|449067223|FG002|Overall Study|Protocol Violation|1|||
124847991|NCT02453594|449067221|FG000|Overall Study|Cohort Was Closed|17|||
124847992|NCT02453594|449067222|FG001|Overall Study|Cohort Was Closed|21|||
124847993|NCT02453594|449067223|FG002|Overall Study|Cohort Was Closed|14|||
124847994|NCT02453594|449067221|FG000|Overall Study|Death|20|||
124847995|NCT02453594|449067222|FG001|Overall Study|Death|24|||
124847996|NCT02453594|449067223|FG002|Overall Study|Death|16|||
124847997|NCT02453594|449067221|FG000|Overall Study|Lost to Follow-up|6|||
124847998|NCT02453594|449067222|FG001|Overall Study|Lost to Follow-up|14|||
124847999|NCT02453594|449067223|FG002|Overall Study|Lost to Follow-up|2|||
124848000|NCT02453594|449067221|FG000|Overall Study|Physician Decision|2|||
124848001|NCT02453594|449067222|FG001|Overall Study|Physician Decision|4|||
124848002|NCT02453594|449067223|FG002|Overall Study|Physician Decision|0|||
124848003|NCT02453594|449067221|FG000|Overall Study|Site Terminated by Sponsor|1|||
124848004|NCT02453594|449067222|FG001|Overall Study|Site Terminated by Sponsor|0|||
124848005|NCT02453594|449067223|FG002|Overall Study|Site Terminated by Sponsor|1|||
124848006|NCT02453594|449067221|FG000|Overall Study|Transitioned to Extension Study|16|||
124848007|NCT02453594|449067222|FG001|Overall Study|Transitioned to Extension Study|9|||
124848008|NCT02453594|449067223|FG002|Overall Study|Transitioned to Extension Study|16|||
124848009|NCT02453594|449067221|FG000|Overall Study|Withdrawal by Subject|7|||
124848010|NCT02453594|449067222|FG001|Overall Study|Withdrawal by Subject|9|||
124848011|NCT02453594|449067223|FG002|Overall Study|Withdrawal by Subject|11|||
124848012|NCT04101526|449067227|FG000|Overall Study|Did not complete all sleep diary entries|0|||
124848013|NCT04101526|449067228|FG001|Overall Study|Did not complete all sleep diary entries|1|||
124848014|NCT02932891|449067229|FG000|Overall Study|Lost to Follow-up|2|||
124848015|NCT02932891|449067229|FG000|Overall Study|HPA Suppress|2|||
124848016|NCT02652624|449067230|FG000|Randomized Phase|Pregnancy|3|||
124848017|NCT02652624|449067231|FG001|Randomized Phase|Pregnancy|1|||
124848018|NCT02652624|449067230|FG000|Randomized Phase|Investigator's Discretion|0|||
124848019|NCT02652624|449067231|FG001|Randomized Phase|Investigator's Discretion|2|||
124848020|NCT02652624|449067230|FG000|Randomized Phase|Death|0|||
124848021|NCT02652624|449067231|FG001|Randomized Phase|Death|1|||
124848022|NCT02652624|449067230|FG000|Randomized Phase|Lost to Follow-up|0|||
124848023|NCT02652624|449067231|FG001|Randomized Phase|Lost to Follow-up|1|||
124848024|NCT02652624|449067230|FG000|Extension Phase|Lost to Follow-up|3|||
124848025|NCT02652624|449067231|FG001|Extension Phase|Lost to Follow-up|1|||
124848026|NCT02652624|449067230|FG000|Extension Phase|Pregnancy|1|||
124848027|NCT02652624|449067231|FG001|Extension Phase|Pregnancy|1|||
124848028|NCT02652624|449067230|FG000|Extension Phase|Adverse Event|0|||
124848029|NCT02652624|449067231|FG001|Extension Phase|Adverse Event|1|||
124848030|NCT02652624|449067230|FG000|Extension Phase|Withdrew Consent|0|||
124848031|NCT02652624|449067231|FG001|Extension Phase|Withdrew Consent|1|||
124848032|NCT01023659|449067232|FG000|Overall Study|Lost to Follow-up|73|||
124848033|NCT01023659|449067233|FG001|Overall Study|Lost to Follow-up|228|||
124848034|NCT01023659|449067234|FG002|Overall Study|Lost to Follow-up|99|||
124848035|NCT00501540|449067237|FG000|Overall Study|Death|5|||
124848036|NCT01797536|449067238|FG000|Overall Study|Adverse Event|0|||
124848037|NCT01797536|449067239|FG001|Overall Study|Adverse Event|1|||
124848038|NCT01797536|449067240|FG002|Overall Study|Adverse Event|0|||
124848039|NCT01797536|449067241|FG003|Overall Study|Adverse Event|0|||
124848040|NCT00098839|449067242|FG000|Overall Study|Adverse Event|5|||
124848041|NCT00098839|449067243|FG001|Overall Study|Adverse Event|2|||
124848042|NCT00098839|449067242|FG000|Overall Study|Death|1|||
124848043|NCT00098839|449067243|FG001|Overall Study|Death|2|||
124848044|NCT00098839|449067242|FG000|Overall Study|Physician Decision|4|||
124848045|NCT00098839|449067243|FG001|Overall Study|Physician Decision|14|||
124848046|NCT00098839|449067242|FG000|Overall Study|Withdrawal by Subject|1|||
124848047|NCT00098839|449067243|FG001|Overall Study|Withdrawal by Subject|0|||
124848048|NCT00098839|449067242|FG000|Overall Study|Refusal of further protocol therapy|3|||
124848049|NCT00098839|449067243|FG001|Overall Study|Refusal of further protocol therapy|1|||
124848050|NCT00098839|449067242|FG000|Overall Study|Relapse|6|||
124848051|NCT00098839|449067243|FG001|Overall Study|Relapse|3|||
124848052|NCT00098839|449067242|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
124848053|NCT00098839|449067243|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
124848054|NCT00098839|449067242|FG000|Overall Study|Ineligible|2|||
124848055|NCT00098839|449067243|FG001|Overall Study|Ineligible|0|||
124848056|NCT03228680|449067246|FG000|Overall Study|Adverse Event|13|||
124848057|NCT03228680|449067247|FG001|Overall Study|Adverse Event|18|||
124848058|NCT03228680|449067246|FG000|Overall Study|Randomization failure|0|||
124848059|NCT03228680|449067247|FG001|Overall Study|Randomization failure|1|||
124848060|NCT03228680|449067246|FG000|Overall Study|Withdrawal by Subject|1|||
124848061|NCT03228680|449067247|FG001|Overall Study|Withdrawal by Subject|0|||
124848062|NCT03228680|449067246|FG000|Overall Study|Other|9|||
124848063|NCT03228680|449067247|FG001|Overall Study|Other|16|||
124848064|NCT02167035|449067255|FG000|Overall Study|Adverse Event|2|||
124848065|NCT02167035|449067256|FG001|Overall Study|Adverse Event|2|||
124848066|NCT02167035|449067255|FG000|Overall Study|Lost to Follow-up|3|||
124848067|NCT02167035|449067256|FG001|Overall Study|Lost to Follow-up|3|||
124848068|NCT02167035|449067255|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
124848069|NCT02167035|449067256|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
124848070|NCT02148003|449067257|FG000|Overall Study|Failed inclusion criteria|1|||
124848071|NCT02148003|449067258|FG001|Overall Study|Failed inclusion criteria|0|||
124848072|NCT02148003|449067257|FG000|Overall Study|Met exclusion criteria|0|||
124848073|NCT02148003|449067258|FG001|Overall Study|Met exclusion criteria|1|||
124848074|NCT02148003|449067257|FG000|Overall Study|Withdrawal by Subject|0|||
124848075|NCT02148003|449067258|FG001|Overall Study|Withdrawal by Subject|1|||
124848076|NCT02489981|449067259|FG000|Overall Study|Adverse Event|21|||
124848077|NCT02489981|449067259|FG000|Overall Study|Insufficient effectiveness|16|||
124848078|NCT02489981|449067259|FG000|Overall Study|Improved|31|||
124848079|NCT02489981|449067259|FG000|Overall Study|Lost to Follow-up|31|||
124848080|NCT02489981|449067259|FG000|Overall Study|Other than listed|28|||
124848081|NCT03852316|449067264|FG000|Overall Study|Protocol Violation|1|||
124848082|NCT03852316|449067264|FG000|Overall Study|Withdrawal by Subject|2|||
124848083|NCT03852316|449067264|FG000|Overall Study|Enrolled but Device not Utilized|1|||
124848084|NCT03592641|449067265|FG000|Overall Study|Withdrawal by Subject|1|||
124848085|NCT00436280|449067266|FG000|Period 1: Induction|Adverse Event|8|||
124848086|NCT00436280|449067266|FG000|Period 1: Induction|Progressive Disease|12|||
124848087|NCT00436280|449067266|FG000|Period 1: Induction|Stable Disease|6|||
124848088|NCT00436280|449067266|FG000|Period 1: Induction|Withdrawal by Subject|1|||
124848089|NCT00436280|449067266|FG000|Period 1: Induction|Death|1|||
124848090|NCT00436280|449067266|FG000|Period 2: Consolidation|Adverse Event|1|||
124848091|NCT00436280|449067266|FG000|Period 2: Consolidation|Progressive Disease|10|||
124848092|NCT00436280|449067266|FG000|Period 2: Consolidation|Stable Disease|1|||
124848093|NCT00436280|449067266|FG000|Period 2: Consolidation|Physician Decision|2|||
124848094|NCT00436280|449067266|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
124848095|NCT00436280|449067266|FG000|Period 2: Consolidation|Death|1|||
124848096|NCT00436280|449067266|FG000|Period 3: Maintenance|Adverse Event|6|||
124848097|NCT00436280|449067266|FG000|Period 3: Maintenance|Progressive Disease|12|||
124848098|NCT01049919|449067269|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
124848099|NCT01049919|449067270|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
124848100|NCT01049919|449067269|FG000|Overall Study|Withdrawal by Subject|5|||
124848101|NCT01049919|449067270|FG001|Overall Study|Withdrawal by Subject|0|||
124848102|NCT01049919|449067269|FG000|Overall Study|Lost to Follow-up|6|||
124848103|NCT01049919|449067270|FG001|Overall Study|Lost to Follow-up|1|||
124848104|NCT01049919|449067269|FG000|Overall Study|Physician Decision|2|||
124848105|NCT01049919|449067270|FG001|Overall Study|Physician Decision|0|||
124848106|NCT01049919|449067269|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
124848107|NCT01049919|449067270|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
124848108|NCT01049919|449067269|FG000|Overall Study|Early study termination by sponsor.|2|||
124848109|NCT01049919|449067270|FG001|Overall Study|Early study termination by sponsor.|0|||
124848110|NCT01532687|449067276|FG000|Overall Study|Death|2|||
124848111|NCT01532687|449067277|FG001|Overall Study|Death|0|||
124848112|NCT01532687|449067276|FG000|Overall Study|Adverse Event|6|||
124848113|NCT01532687|449067277|FG001|Overall Study|Adverse Event|1|||
124848114|NCT01532687|449067276|FG000|Overall Study|Withdrawal by Subject|1|||
124848115|NCT01532687|449067277|FG001|Overall Study|Withdrawal by Subject|0|||
124848116|NCT01532687|449067276|FG000|Overall Study|Physician Decision|2|||
124848117|NCT01532687|449067277|FG001|Overall Study|Physician Decision|1|||
124848118|NCT01532687|449067276|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
124848119|NCT01532687|449067277|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
124848120|NCT03160703|449067278|FG000|Overall Study|Withdrawal by Subject|0|||
124848121|NCT03160703|449067279|FG001|Overall Study|Withdrawal by Subject|0|||
124848122|NCT03160703|449067280|FG002|Overall Study|Withdrawal by Subject|0|||
124848123|NCT03160703|449067281|FG003|Overall Study|Withdrawal by Subject|1|||
124848124|NCT02984995|449067282|FG000|Overall Study|Required stem cell transplant|13|||
124848125|NCT02984995|449067283|FG001|Overall Study|Required stem cell transplant|2|||
124848126|NCT02984995|449067282|FG000|Overall Study|Progressive disease|11|||
124848127|NCT02984995|449067283|FG001|Overall Study|Progressive disease|1|||
124848128|NCT02984995|449067282|FG000|Overall Study|Adverse Event|1|||
124848129|NCT02984995|449067283|FG001|Overall Study|Adverse Event|0|||
124848130|NCT00047463|449067284|FG000|Overall Study|Withdrawal by Subject|0|||
124848131|NCT00047463|449067285|FG001|Overall Study|Withdrawal by Subject|3|||
124848132|NCT01401530|449067287|FG000|Overall Study|Disease Progression|1|||
124848133|NCT01401530|449067288|FG001|Overall Study|Disease Progression|2|||
124848134|NCT01401530|449067289|FG002|Overall Study|Disease Progression|1|||
124848135|NCT01401530|449067287|FG000|Overall Study|Adverse Event|1|||
124848136|NCT01401530|449067288|FG001|Overall Study|Adverse Event|1|||
124848137|NCT01401530|449067289|FG002|Overall Study|Adverse Event|1|||
124848138|NCT01401530|449067287|FG000|Overall Study|Participant Choice|1|||
124848139|NCT01401530|449067288|FG001|Overall Study|Participant Choice|2|||
124848140|NCT01401530|449067289|FG002|Overall Study|Participant Choice|1|||
124848141|NCT01401530|449067287|FG000|Overall Study|Physician Decision|0|||
124848142|NCT01401530|449067288|FG001|Overall Study|Physician Decision|1|||
124848143|NCT01401530|449067289|FG002|Overall Study|Physician Decision|0|||
124848144|NCT02104557|449067290|FG000|Overall Study|Adverse Event|24|||
124848145|NCT02104557|449067290|FG000|Overall Study|Lost to Follow-up|34|||
124848146|NCT02104557|449067290|FG000|Overall Study|Violated the usage and dosage|14|||
124848147|NCT02104557|449067290|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
124848148|NCT02104557|449067290|FG000|Overall Study|Administered Sayana prior to the contract|1|||
124848149|NCT02104557|449067290|FG000|Overall Study|Other|17|||
124848150|NCT02104557|449067290|FG000|Overall Study|Change to other contraception methods|5|||
124848151|NCT02104557|449067290|FG000|Overall Study|Discontinuation due to no pain|1|||
124848152|NCT02104557|449067290|FG000|Overall Study|Withdrawal consent|2|||
124848153|NCT02104557|449067290|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
124848154|NCT02104557|449067290|FG000|Overall Study|Discontinuation of contraception|9|||
124848155|NCT01448850|449067292|FG000|Overall Study|Death|3|||
124848156|NCT01448850|449067293|FG001|Overall Study|Death|6|||
124848157|NCT01448850|449067292|FG000|Overall Study|Withdrawal by Subject|13|||
124848158|NCT01448850|449067293|FG001|Overall Study|Withdrawal by Subject|21|||
124848159|NCT01448850|449067292|FG000|Overall Study|Lost to Follow-up|3|||
124848160|NCT01448850|449067293|FG001|Overall Study|Lost to Follow-up|1|||
124848161|NCT01448850|449067292|FG000|Overall Study|Other|15|||
124848162|NCT01448850|449067293|FG001|Overall Study|Other|12|||
124848163|NCT00280566|449067297|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
124848164|NCT00280566|449067298|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
124848165|NCT00280566|449067299|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
124848166|NCT00280566|449067297|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
124848167|NCT00280566|449067298|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
124848168|NCT00280566|449067299|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
124848169|NCT00280566|449067297|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
124848170|NCT00280566|449067298|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
124848171|NCT00280566|449067299|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
124848172|NCT00280566|449067297|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
124848173|NCT00280566|449067298|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
124848174|NCT00280566|449067299|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
124848175|NCT00280566|449067297|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
124848176|NCT00280566|449067298|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
124848177|NCT00280566|449067299|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
124848178|NCT00280566|449067297|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
124848179|NCT00280566|449067298|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
124848180|NCT00280566|449067299|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
124848181|NCT00280566|449067297|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
124848182|NCT00280566|449067298|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
124848183|NCT00280566|449067299|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
124848184|NCT00280566|449067297|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
124848185|NCT00280566|449067298|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
124848186|NCT00280566|449067299|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
124848187|NCT00280566|449067297|FG000|Period 2 Double Blind|Adverse Event|0|||
124848188|NCT00280566|449067298|FG001|Period 2 Double Blind|Adverse Event|11|||
124848189|NCT00280566|449067299|FG002|Period 2 Double Blind|Adverse Event|15|||
124848190|NCT00280566|449067297|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
124848191|NCT00280566|449067298|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
124848192|NCT00280566|449067299|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
124848193|NCT00280566|449067297|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
124848194|NCT00280566|449067298|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
124848195|NCT00280566|449067299|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
124848196|NCT00280566|449067297|FG000|Period 2 Double Blind|miscellaneous|0|||
124848197|NCT00280566|449067298|FG001|Period 2 Double Blind|miscellaneous|10|||
124848198|NCT00280566|449067299|FG002|Period 2 Double Blind|miscellaneous|5|||
124848199|NCT04542070|449067301|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
124848200|NCT04542070|449067302|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
124848201|NCT04542070|449067303|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
124848202|NCT04542070|449067304|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
124848203|NCT04542070|449067301|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
124848204|NCT04542070|449067302|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
124848205|NCT04542070|449067303|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
124848206|NCT04542070|449067304|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
124848207|NCT04542070|449067301|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
124848208|NCT04542070|449067302|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
124848209|NCT04542070|449067303|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
124848210|NCT04542070|449067304|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
124848211|NCT04542070|449067301|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
124848212|NCT04542070|449067302|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
124848213|NCT04542070|449067303|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
124848214|NCT04542070|449067304|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
124848215|NCT04542070|449067301|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
124848216|NCT04542070|449067302|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
124848217|NCT04542070|449067303|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
124848218|NCT04542070|449067304|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
124848219|NCT04542070|449067301|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
124848220|NCT04542070|449067302|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
124848221|NCT04542070|449067303|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
124848222|NCT04542070|449067304|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
124848223|NCT04542070|449067301|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
124848224|NCT04542070|449067302|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
124848225|NCT04542070|449067303|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
124848226|NCT04542070|449067304|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
124848227|NCT04542070|449067301|FG000|Maintenance + Extension Period|Adverse Event|10|||
124848228|NCT04542070|449067302|FG001|Maintenance + Extension Period|Adverse Event|2|||
124848229|NCT04542070|449067303|FG002|Maintenance + Extension Period|Adverse Event|0|||
124848230|NCT04542070|449067304|FG003|Maintenance + Extension Period|Adverse Event|0|||
124848231|NCT04542070|449067301|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
124848232|NCT04542070|449067302|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
124848233|NCT04542070|449067303|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
124848234|NCT04542070|449067304|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
124848235|NCT04542070|449067301|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
124848236|NCT04542070|449067302|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
124848237|NCT04542070|449067303|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
124848238|NCT04542070|449067304|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
124848239|NCT04542070|449067301|FG000|Maintenance + Extension Period|Physician Decision|1|||
124848240|NCT04542070|449067302|FG001|Maintenance + Extension Period|Physician Decision|1|||
124848241|NCT04542070|449067303|FG002|Maintenance + Extension Period|Physician Decision|0|||
124848242|NCT04542070|449067304|FG003|Maintenance + Extension Period|Physician Decision|0|||
124848243|NCT04542070|449067301|FG000|Maintenance + Extension Period|Protocol Violation|2|||
124848244|NCT04542070|449067302|FG001|Maintenance + Extension Period|Protocol Violation|5|||
124848245|NCT04542070|449067303|FG002|Maintenance + Extension Period|Protocol Violation|0|||
124848246|NCT04542070|449067304|FG003|Maintenance + Extension Period|Protocol Violation|0|||
124848247|NCT04542070|449067301|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
124848248|NCT04542070|449067302|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
124848249|NCT04542070|449067303|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
124848250|NCT04542070|449067304|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
124848251|NCT04542070|449067301|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
124848252|NCT04542070|449067302|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
124848253|NCT04542070|449067303|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
124848254|NCT04542070|449067304|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
124848255|NCT04542070|449067301|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
124848256|NCT04542070|449067302|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
124848257|NCT04542070|449067303|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
124848258|NCT04542070|449067304|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
124848259|NCT04542070|449067301|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
124848260|NCT04542070|449067302|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
124848261|NCT04542070|449067303|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
124848262|NCT04542070|449067304|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
124848263|NCT04542070|449067301|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
124848264|NCT04542070|449067302|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
124848265|NCT04542070|449067303|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
124848266|NCT04542070|449067304|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
124848267|NCT04542070|449067301|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
124848268|NCT04542070|449067302|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
124848269|NCT04542070|449067303|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
124848270|NCT04542070|449067304|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
124848271|NCT04542070|449067301|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
124848272|NCT04542070|449067302|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
124848273|NCT04542070|449067303|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
124848274|NCT04542070|449067304|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
124848275|NCT02188485|449067306|FG000|Overall Study|Withdrawal by Subject|2|||
124848276|NCT02188485|449067307|FG001|Overall Study|Withdrawal by Subject|1|||
124848277|NCT02188485|449067306|FG000|Overall Study|PI withdrew, lack of capacity|0|||
124848278|NCT02188485|449067307|FG001|Overall Study|PI withdrew, lack of capacity|2|||
124848279|NCT02457325|449067311|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
124848280|NCT02457325|449067312|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
124848281|NCT00773097|449067318|FG000|Overall Study|Withdrawal by Subject|1|||
124848282|NCT00773097|449067318|FG000|Overall Study|Physician Decision|6|||
124848283|NCT02707640|449067319|FG000|Overall Study|Adverse Event|4|||
124848284|NCT02707640|449067320|FG001|Overall Study|Adverse Event|2|||
124848285|NCT02707640|449067319|FG000|Overall Study|Death|1|||
124848286|NCT02707640|449067320|FG001|Overall Study|Death|2|||
124848287|NCT02707640|449067319|FG000|Overall Study|Physician Decision|2|||
124848288|NCT02707640|449067320|FG001|Overall Study|Physician Decision|0|||
124848289|NCT02707640|449067319|FG000|Overall Study|Withdrawal by Subject|0|||
124848290|NCT02707640|449067320|FG001|Overall Study|Withdrawal by Subject|1|||
124848291|NCT02707640|449067319|FG000|Overall Study|Participant's Personal Decision|1|||
124848292|NCT02707640|449067320|FG001|Overall Study|Participant's Personal Decision|2|||
124848293|NCT02707640|449067319|FG000|Overall Study|Sponsor Discretion|1|||
124848294|NCT02707640|449067320|FG001|Overall Study|Sponsor Discretion|0|||
124848295|NCT02517905|449067321|FG000|Overall Study|Lost to Follow-up|4|||
124848296|NCT02517905|449067322|FG001|Overall Study|Lost to Follow-up|0|||
124848297|NCT02517905|449067321|FG000|Overall Study|Withdrawal by Subject|4|||
124848298|NCT02517905|449067322|FG001|Overall Study|Withdrawal by Subject|0|||
124848299|NCT02517905|449067321|FG000|Overall Study|Screen failure|2|||
124848300|NCT02517905|449067322|FG001|Overall Study|Screen failure|2|||
124848301|NCT02742103|449068734|FG000|Overall Study|Protocol Violation|1|||
124848302|NCT02742103|449068735|FG001|Overall Study|Protocol Violation|0|||
124848303|NCT02742103|449068734|FG000|Overall Study|Death|2|||
124848304|NCT02742103|449068735|FG001|Overall Study|Death|2|||
124848305|NCT02742103|449068734|FG000|Overall Study|Adverse Event|1|||
124848306|NCT02742103|449068735|FG001|Overall Study|Adverse Event|0|||
124848307|NCT02742103|449068734|FG000|Overall Study|Moved to another town|0|||
124848308|NCT02742103|449068735|FG001|Overall Study|Moved to another town|1|||
124848309|NCT02742103|449068734|FG000|Overall Study|Withdrawal by Subject|5|||
124848310|NCT02742103|449068735|FG001|Overall Study|Withdrawal by Subject|2|||
124848311|NCT00600821|449068736|FG000|Overall Study|Death|45|||
124848312|NCT00600821|449068737|FG001|Overall Study|Death|46|||
124848313|NCT00600821|449068736|FG000|Overall Study|Lost to Follow-up|2|||
124848314|NCT00600821|449068737|FG001|Overall Study|Lost to Follow-up|2|||
124848315|NCT00600821|449068736|FG000|Overall Study|Withdrawal by Subject|1|||
124848316|NCT00600821|449068737|FG001|Overall Study|Withdrawal by Subject|1|||
124848317|NCT00600821|449068736|FG000|Overall Study|Terminated by sponsor|8|||
124848318|NCT00600821|449068737|FG001|Overall Study|Terminated by sponsor|6|||
124848319|NCT00600821|449068736|FG000|Overall Study|Objective progression or relapse|0|||
124848320|NCT00600821|449068737|FG001|Overall Study|Objective progression or relapse|1|||
124848321|NCT00600821|449068736|FG000|Overall Study|Randomized but not treated|0|||
124848322|NCT00600821|449068737|FG001|Overall Study|Randomized but not treated|1|||
124848323|NCT00600821|449068736|FG000|Overall Study|Other|2|||
124848324|NCT00600821|449068737|FG001|Overall Study|Other|3|||
124848325|NCT00659646|449068743|FG000|Overall Study|Protocol Violation|12|||
124848326|NCT00659646|449068744|FG001|Overall Study|Protocol Violation|8|||
124848327|NCT00659646|449068743|FG000|Overall Study|Adverse Event|1|||
124848328|NCT00659646|449068744|FG001|Overall Study|Adverse Event|0|||
124848329|NCT00659646|449068743|FG000|Overall Study|Lost to Follow-up|1|||
124848330|NCT00659646|449068744|FG001|Overall Study|Lost to Follow-up|0|||
124848331|NCT00659646|449068743|FG000|Overall Study|protocol noncompliance after randomized|1|||
124848332|NCT00659646|449068744|FG001|Overall Study|protocol noncompliance after randomized|0|||
124848333|NCT00023673|449068745|FG000|Overall Study|Ineligible / no protocol treatment|0|||
124848334|NCT00023673|449068746|FG001|Overall Study|Ineligible / no protocol treatment|0|||
124848335|NCT00023673|449068747|FG002|Overall Study|Ineligible / no protocol treatment|0|||
124848336|NCT00023673|449068748|FG003|Overall Study|Ineligible / no protocol treatment|1|||
124848337|NCT00023673|449068745|FG000|Overall Study|Patient withdrew consent|0|||
124848338|NCT00023673|449068746|FG001|Overall Study|Patient withdrew consent|0|||
124848339|NCT00023673|449068747|FG002|Overall Study|Patient withdrew consent|0|||
124848340|NCT00023673|449068748|FG003|Overall Study|Patient withdrew consent|1|||
124848341|NCT00424372|449068758|FG000|Overall Study|Death|1|||
124848342|NCT00424372|449068758|FG000|Overall Study|Adverse Event|18|||
124848343|NCT00424372|449068758|FG000|Overall Study|Lack of Efficacy|6|||
124848344|NCT00424372|449068758|FG000|Overall Study|Withdrawal by Subject|4|||
124848345|NCT00424372|449068758|FG000|Overall Study|Protocol Violation|1|||
124848346|NCT00424372|449068758|FG000|Overall Study|Health deterioration|1|||
124848347|NCT04622254|449068759|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
124848348|NCT04622254|449068760|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
124848349|NCT04622254|449068761|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
124848350|NCT04622254|449068762|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
124848351|NCT04622254|449068763|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
124848352|NCT04622254|449068764|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
124848353|NCT04622254|449068759|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
124848354|NCT04622254|449068760|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
124848355|NCT04622254|449068761|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
124848356|NCT04622254|449068762|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
124848357|NCT04622254|449068763|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
124848358|NCT04622254|449068764|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
124848359|NCT04622254|449068759|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
124848360|NCT04622254|449068760|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
124848361|NCT04622254|449068761|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
124848362|NCT04622254|449068762|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
124848363|NCT04622254|449068763|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
124848364|NCT04622254|449068764|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
124848365|NCT04622254|449068759|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
124848366|NCT04622254|449068760|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
124848367|NCT04622254|449068761|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
124848368|NCT04622254|449068762|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
124848369|NCT04622254|449068763|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
124848370|NCT04622254|449068764|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
124848371|NCT04622254|449068759|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
124848372|NCT04622254|449068760|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
124848373|NCT04622254|449068761|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
124848374|NCT04622254|449068762|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
124848375|NCT04622254|449068763|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
124848376|NCT04622254|449068764|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
124848377|NCT04622254|449068759|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
124848378|NCT04622254|449068760|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
124848379|NCT04622254|449068761|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
124848380|NCT04622254|449068762|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
124848381|NCT04622254|449068763|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
124848382|NCT04622254|449068764|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
124848383|NCT04622254|449068759|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
124848384|NCT04622254|449068760|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
124848385|NCT04622254|449068761|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
124848386|NCT04622254|449068762|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
124848387|NCT04622254|449068763|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
124848388|NCT04622254|449068764|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
124848389|NCT04622254|449068759|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
124848390|NCT04622254|449068760|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
124848391|NCT04622254|449068761|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
124848392|NCT04622254|449068762|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
124848393|NCT04622254|449068763|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
124848394|NCT04622254|449068764|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
124848395|NCT04622254|449068759|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
124848396|NCT04622254|449068760|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
124848397|NCT04622254|449068761|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
124848398|NCT04622254|449068762|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
124848399|NCT04622254|449068763|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
124848400|NCT04622254|449068764|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
124848401|NCT04622254|449068759|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
124848402|NCT04622254|449068760|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
124848403|NCT04622254|449068761|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
124848404|NCT04622254|449068762|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
124848405|NCT04622254|449068763|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
124848406|NCT04622254|449068764|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
124848407|NCT04622254|449068759|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
124848408|NCT04622254|449068760|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
124848409|NCT04622254|449068761|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
124848410|NCT04622254|449068762|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
124848411|NCT04622254|449068763|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
124848412|NCT04622254|449068764|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
124848413|NCT00912405|449068765|FG000|Overall Study|Lost to Follow-up|5|||
124848414|NCT00796861|449068766|FG000|Overall Study|Withdrawal by Subject|2|||
124848415|NCT00796861|449068766|FG000|Overall Study|Death|2|||
124848416|NCT02370888|449068767|FG000|Overall Study|disease progression|2|||
124848417|NCT02370888|449068767|FG000|Overall Study|did not meet chimerism criteria|6|||
124848418|NCT02178475|449068768|FG000|Overall Study|Withdrawal by Subject|7|||
124848419|NCT02178475|449068768|FG000|Overall Study|Lost to Follow-up|10|||
124848420|NCT02178475|449068768|FG000|Overall Study|Death|13|||
124848421|NCT02178475|449068768|FG000|Overall Study|Protocol-specified Criteria|99|||
124848422|NCT01430585|449068769|FG000|Overall Study|Death|1|||
124848423|NCT01430585|449068769|FG000|Overall Study|Objective Progression or Relapse|3|||
124848424|NCT01430585|449068769|FG000|Overall Study|Study Terminated by Sponsor|3|||
124848425|NCT01430585|449068769|FG000|Overall Study|Other|7|||
124848426|NCT01412424|449068770|FG000|Core Treatment Period|Treatment Failure|24|||
124848427|NCT01412424|449068770|FG000|Core Treatment Period|Adverse Event|21|||
124848428|NCT01412424|449068770|FG000|Core Treatment Period|Patient Request|5|||
124848429|NCT01412424|449068770|FG000|Core Treatment Period|Lost to Follow-up|2|||
124848430|NCT01412424|449068770|FG000|Core Treatment Period|Sponsor Request|1|||
124848431|NCT01412424|449068770|FG000|Extension Treatment Period|Adverse Event|2|||
124848432|NCT01412424|449068770|FG000|Extension Treatment Period|Treatment Failure|2|||
124848433|NCT01412424|449068770|FG000|Extension Treatment Period|Patient Request|2|||
124848434|NCT04304001|449068773|FG000|Overall Study|Lost to Follow-up|13|||
124848435|NCT04304001|449068774|FG001|Overall Study|Lost to Follow-up|9|||
124848436|NCT02664038|449068780|FG000|13 Week|Lost to Follow-up|7|||
124848437|NCT02664038|449068781|FG001|13 Week|Lost to Follow-up|14|||
124848438|NCT02664038|449068780|FG000|13 Week|Withdrawal by Subject|1|||
124848439|NCT02664038|449068781|FG001|13 Week|Withdrawal by Subject|0|||
124848440|NCT02664038|449068780|FG000|26 Week|Lost to Follow-up|5|||
124848441|NCT02664038|449068781|FG001|26 Week|Lost to Follow-up|4|||
124848442|NCT02606136|449068786|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
124848443|NCT02606136|449068786|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
124848444|NCT02606136|449068786|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
124848445|NCT02606136|449068786|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
124848446|NCT03296696|449068787|FG000|Overall Study|Started Other Antitumor Therapy|1|||
124848447|NCT03296696|449068788|FG001|Overall Study|Started Other Antitumor Therapy|2|||
124848448|NCT03296696|449068789|FG002|Overall Study|Started Other Antitumor Therapy|1|||
124848449|NCT03296696|449068790|FG003|Overall Study|Started Other Antitumor Therapy|2|||
124848450|NCT03296696|449068791|FG004|Overall Study|Started Other Antitumor Therapy|1|||
124848451|NCT03296696|449068792|FG005|Overall Study|Started Other Antitumor Therapy|1|||
124848452|NCT03296696|449068793|FG006|Overall Study|Started Other Antitumor Therapy|2|||
124848453|NCT03296696|449068794|FG007|Overall Study|Started Other Antitumor Therapy|3|||
124848454|NCT03296696|449068795|FG008|Overall Study|Started Other Antitumor Therapy|1|||
124848455|NCT03296696|449068796|FG009|Overall Study|Started Other Antitumor Therapy|0|||
124848456|NCT03296696|449068787|FG000|Overall Study|Death|0|||
124848457|NCT03296696|449068788|FG001|Overall Study|Death|1|||
124848458|NCT03296696|449068789|FG002|Overall Study|Death|1|||
124848459|NCT03296696|449068790|FG003|Overall Study|Death|2|||
124848460|NCT03296696|449068791|FG004|Overall Study|Death|2|||
124848461|NCT03296696|449068792|FG005|Overall Study|Death|3|||
124848462|NCT03296696|449068793|FG006|Overall Study|Death|1|||
124848463|NCT03296696|449068794|FG007|Overall Study|Death|2|||
124848464|NCT03296696|449068795|FG008|Overall Study|Death|0|||
124848465|NCT03296696|449068796|FG009|Overall Study|Death|0|||
124848466|NCT03296696|449068787|FG000|Overall Study|Withdrawal by Subject|0|||
124848467|NCT03296696|449068788|FG001|Overall Study|Withdrawal by Subject|0|||
124848468|NCT03296696|449068789|FG002|Overall Study|Withdrawal by Subject|1|||
124848469|NCT03296696|449068790|FG003|Overall Study|Withdrawal by Subject|0|||
124848470|NCT03296696|449068791|FG004|Overall Study|Withdrawal by Subject|1|||
124848471|NCT03296696|449068792|FG005|Overall Study|Withdrawal by Subject|0|||
124848472|NCT03296696|449068793|FG006|Overall Study|Withdrawal by Subject|0|||
124848473|NCT03296696|449068794|FG007|Overall Study|Withdrawal by Subject|0|||
124848474|NCT03296696|449068795|FG008|Overall Study|Withdrawal by Subject|0|||
124848475|NCT03296696|449068796|FG009|Overall Study|Withdrawal by Subject|1|||
124848476|NCT04694131|449068800|FG000|Overall Study|Withdrawal by Subject|7|||
124848477|NCT04694131|449068800|FG000|Overall Study|Screen Failure|1|||
124848478|NCT04694131|449068800|FG000|Overall Study|High stimulation threshold|3|||
124848479|NCT04456699|449068801|FG000|Overall Study|Death|48|||
124848480|NCT04456699|449068802|FG001|Overall Study|Death|50|||
124848481|NCT04456699|449068803|FG002|Overall Study|Death|52|||
124848482|NCT04456699|449068801|FG000|Overall Study|Physician Decision|0|||
124848483|NCT04456699|449068802|FG001|Overall Study|Physician Decision|0|||
124848484|NCT04456699|449068803|FG002|Overall Study|Physician Decision|2|||
124848485|NCT04456699|449068801|FG000|Overall Study|Sponsor Decision|55|||
124848486|NCT04456699|449068802|FG001|Overall Study|Sponsor Decision|61|||
124848487|NCT04456699|449068803|FG002|Overall Study|Sponsor Decision|50|||
124848488|NCT04456699|449068801|FG000|Overall Study|Withdrawal by Subject|8|||
124848489|NCT04456699|449068802|FG001|Overall Study|Withdrawal by Subject|4|||
124848490|NCT04456699|449068803|FG002|Overall Study|Withdrawal by Subject|5|||
124848491|NCT04112810|449068804|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
124848492|NCT02357576|449068814|FG000|Treatment Period|Withdrawal by Subject|0|||
124848493|NCT02357576|449068815|FG001|Treatment Period|Withdrawal by Subject|1|||
124848494|NCT02357576|449068814|FG000|Treatment Period|Physician Decision|0|||
124848495|NCT02357576|449068815|FG001|Treatment Period|Physician Decision|1|||
124848496|NCT02357576|449068814|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
124848497|NCT02357576|449068815|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
124848498|NCT02357576|449068814|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
124848499|NCT02357576|449068815|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
124848500|NCT02357576|449068814|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
124848501|NCT02357576|449068815|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
124848502|NCT02357576|449068814|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
124848503|NCT02357576|449068815|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
124848504|NCT00699699|449068818|FG000|Overall Study|Adverse Event|36|||
124848505|NCT00699699|449068818|FG000|Overall Study|Individual different reasons|21|||
124848506|NCT01000051|449068821|FG000|Overall Study|Withdrawal by Subject|1|||
124848507|NCT01000051|449068822|FG001|Overall Study|Withdrawal by Subject|1|||
124848508|NCT01000051|449068821|FG000|Overall Study|Disease Progression|1|||
124848509|NCT01000051|449068822|FG001|Overall Study|Disease Progression|0|||
124848510|NCT01000051|449068821|FG000|Overall Study|Serious noncompliance|1|||
124848511|NCT01000051|449068822|FG001|Overall Study|Serious noncompliance|0|||
124848512|NCT00414050|449068823|FG000|Overall Study|Adverse Event|1|||
124848513|NCT00414050|449068824|FG001|Overall Study|Adverse Event|1|||
124848514|NCT00414050|449068825|FG002|Overall Study|Adverse Event|1|||
124848515|NCT00414050|449068826|FG003|Overall Study|Adverse Event|1|||
124848516|NCT00414050|449068823|FG000|Overall Study|Lost to Follow-up|2|||
124848517|NCT00414050|449068824|FG001|Overall Study|Lost to Follow-up|2|||
124848518|NCT00414050|449068825|FG002|Overall Study|Lost to Follow-up|1|||
124848519|NCT00414050|449068826|FG003|Overall Study|Lost to Follow-up|1|||
124848520|NCT00414050|449068823|FG000|Overall Study|Withdrawal by Subject|5|||
124848521|NCT00414050|449068824|FG001|Overall Study|Withdrawal by Subject|3|||
124848522|NCT00414050|449068825|FG002|Overall Study|Withdrawal by Subject|2|||
124848523|NCT00414050|449068826|FG003|Overall Study|Withdrawal by Subject|4|||
124848524|NCT00414050|449068823|FG000|Overall Study|Subject discontinued for other reason|1|||
124848525|NCT00414050|449068824|FG001|Overall Study|Subject discontinued for other reason|2|||
124848526|NCT00414050|449068825|FG002|Overall Study|Subject discontinued for other reason|2|||
124848527|NCT00414050|449068826|FG003|Overall Study|Subject discontinued for other reason|1|||
124848528|NCT00414050|449068823|FG000|Overall Study|Subject Moved|0|||
124848529|NCT00414050|449068824|FG001|Overall Study|Subject Moved|0|||
124848530|NCT00414050|449068825|FG002|Overall Study|Subject Moved|0|||
124848531|NCT00414050|449068826|FG003|Overall Study|Subject Moved|1|||
124848532|NCT03495908|449068827|FG000|Overall Study|Withdrawal by Subject|3|||
124848533|NCT03495908|449068828|FG001|Overall Study|Withdrawal by Subject|1|||
124848534|NCT03495908|449068827|FG000|Overall Study|Lost to Follow-up|1|||
124848535|NCT03495908|449068828|FG001|Overall Study|Lost to Follow-up|4|||
124848536|NCT03495908|449068827|FG000|Overall Study|Adverse Event|0|||
124848537|NCT03495908|449068828|FG001|Overall Study|Adverse Event|2|||
124848538|NCT03495908|449068827|FG000|Overall Study|Death|1|||
124848539|NCT03495908|449068828|FG001|Overall Study|Death|0|||
124848540|NCT03495908|449068827|FG000|Overall Study|Physician Decision|5|||
124848541|NCT03495908|449068828|FG001|Overall Study|Physician Decision|4|||
124848542|NCT03495908|449068827|FG000|Overall Study|No documented reason|0|||
124848543|NCT03495908|449068828|FG001|Overall Study|No documented reason|2|||
124848544|NCT01469065|449068840|FG000|Overall Study|Lack of Efficacy|0|||
124848545|NCT01469065|449068841|FG001|Overall Study|Lack of Efficacy|0|||
124848546|NCT01469065|449068842|FG002|Overall Study|Lack of Efficacy|0|||
124848547|NCT01469065|449068843|FG003|Overall Study|Lack of Efficacy|0|||
124848548|NCT01469065|449068844|FG004|Overall Study|Lack of Efficacy|1|||
124848549|NCT01469065|449068840|FG000|Overall Study|Other|0|||
124848550|NCT01469065|449068841|FG001|Overall Study|Other|1|||
124848551|NCT01469065|449068842|FG002|Overall Study|Other|0|||
124848552|NCT01469065|449068843|FG003|Overall Study|Other|0|||
124848553|NCT01469065|449068844|FG004|Overall Study|Other|0|||
124848554|NCT00578565|449068845|FG000|Overall Study|Adverse Event|3|||
124848555|NCT01752933|449068846|FG000|Treatment|Disease Progression|3|||
124848556|NCT01752933|449068847|FG001|Treatment|Disease Progression|29|||
124848557|NCT01752933|449068846|FG000|Treatment|Withdrawal by Subject|0|||
124848558|NCT01752933|449068847|FG001|Treatment|Withdrawal by Subject|5|||
124848559|NCT01752933|449068846|FG000|Treatment|Adverse Event|1|||
124848560|NCT01752933|449068847|FG001|Treatment|Adverse Event|4|||
124848561|NCT01752933|449068846|FG000|Treatment|Physician Decision|0|||
124848562|NCT01752933|449068847|FG001|Treatment|Physician Decision|3|||
124848563|NCT01752933|449068846|FG000|Treatment|Death|0|||
124848564|NCT01752933|449068847|FG001|Treatment|Death|2|||
124848565|NCT01752933|449068846|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
124848566|NCT01752933|449068847|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
124848567|NCT01752933|449068846|FG000|Treatment|Patient noncompliant|0|||
124848568|NCT01752933|449068847|FG001|Treatment|Patient noncompliant|1|||
124848569|NCT01752933|449068846|FG000|Treatment|Patient unable to travel to appointments|0|||
124848570|NCT01752933|449068847|FG001|Treatment|Patient unable to travel to appointments|1|||
124848571|NCT01752933|449068846|FG000|Overall Study and Follow-up|Death|4|||
124848572|NCT01752933|449068847|FG001|Overall Study and Follow-up|Death|34|||
124848573|NCT01752933|449068846|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
124848574|NCT01752933|449068847|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
124848575|NCT01752933|449068846|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
124848576|NCT01752933|449068847|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
124848577|NCT01752933|449068846|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
124848578|NCT01752933|449068847|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
124848579|NCT02203591|449068848|FG000|Overall Study|Did not meet treatment day baseline|147|||
124848580|NCT02203591|449068849|FG001|Overall Study|Did not meet treatment day baseline|141|||
124848581|NCT02203591|449068850|FG002|Overall Study|Did not meet treatment day baseline|150|||
124848582|NCT02203591|449068851|FG003|Overall Study|Did not meet treatment day baseline|45|||
124848583|NCT02203591|449068852|FG004|Overall Study|Did not meet treatment day baseline|33|||
124848584|NCT02203591|449068853|FG005|Overall Study|Did not meet treatment day baseline|35|||
124848585|NCT02203591|449068854|FG006|Overall Study|Did not meet treatment day baseline|29|||
124848586|NCT02203591|449068855|FG007|Overall Study|Did not meet treatment day baseline|12|||
124848587|NCT02203591|449068848|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
124848588|NCT02203591|449068849|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
124848589|NCT02203591|449068850|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
124848590|NCT02203591|449068851|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
124848591|NCT02203591|449068852|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
124848592|NCT02203591|449068853|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
124848593|NCT02203591|449068854|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
124848594|NCT02203591|449068855|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
124848595|NCT01706250|449068857|FG000|Overall Study|Lost to Follow-up|2|||
124848596|NCT01565291|449068861|FG000|Overall Study|Withdrawal by Subject|1|||
124848597|NCT01565291|449068862|FG001|Overall Study|Withdrawal by Subject|0|||
124848598|NCT03149237|449068865|FG000|Overall Study|Withdrawal by Subject|4|||
124848599|NCT03149237|449068866|FG001|Overall Study|Withdrawal by Subject|5|||
124848600|NCT04568122|449068867|FG000|Overall Study|Lost to Follow-up|48|||
124848601|NCT04568122|449068868|FG001|Overall Study|Lost to Follow-up|44|||
124848602|NCT04568122|449068869|FG002|Overall Study|Lost to Follow-up|4|||
124848603|NCT04568122|449068870|FG003|Overall Study|Lost to Follow-up|0|||
124848604|NCT04568122|449068871|FG004|Overall Study|Lost to Follow-up|0|||
124848605|NCT01227512|449068872|FG000|Overall Study|Physician Decision|6|||
124848606|NCT01227512|449068873|FG001|Overall Study|Physician Decision|6|||
124848607|NCT01227512|449068872|FG000|Overall Study|Adverse Event|4|||
124848608|NCT01227512|449068873|FG001|Overall Study|Adverse Event|3|||
124848609|NCT01227512|449068872|FG000|Overall Study|Withdrawal by Subject|3|||
124848610|NCT01227512|449068873|FG001|Overall Study|Withdrawal by Subject|0|||
124848611|NCT01227512|449068872|FG000|Overall Study|Participant met withdrawal criteria|0|||
124848612|NCT01227512|449068873|FG001|Overall Study|Participant met withdrawal criteria|1|||
124848613|NCT04497987|449068874|FG000|Overall Study|Adverse Event|1|||
124848614|NCT04497987|449068875|FG001|Overall Study|Adverse Event|0|||
124848615|NCT04497987|449068874|FG000|Overall Study|Death|21|||
124848616|NCT04497987|449068875|FG001|Overall Study|Death|13|||
124848617|NCT04497987|449068874|FG000|Overall Study|Lost to Follow-up|19|||
124848618|NCT04497987|449068875|FG001|Overall Study|Lost to Follow-up|17|||
124848619|NCT04497987|449068874|FG000|Overall Study|Other - as reported by the investigator|22|||
124848620|NCT04497987|449068875|FG001|Overall Study|Other - as reported by the investigator|16|||
124848621|NCT04497987|449068874|FG000|Overall Study|Physician Decision|1|||
124848622|NCT04497987|449068875|FG001|Overall Study|Physician Decision|0|||
124848623|NCT04497987|449068874|FG000|Overall Study|Withdrawal by Subject|35|||
124848624|NCT04497987|449068875|FG001|Overall Study|Withdrawal by Subject|21|||
124848625|NCT00512096|449068876|FG000|Overall Study|Adverse Event|2|||
124848626|NCT00512096|449068876|FG000|Overall Study|Withdrawal by Subject|2|||
124848627|NCT00512096|449068876|FG000|Overall Study|Lack of Efficacy|3|||
124848628|NCT00298038|449068877|FG000|Overall Study|Lost to Follow-up|0|||
124848629|NCT00298038|449068878|FG001|Overall Study|Lost to Follow-up|1|||
124848630|NCT00298038|449068877|FG000|Overall Study|Liver Transplant|0|||
124848631|NCT00298038|449068878|FG001|Overall Study|Liver Transplant|1|||
124848632|NCT00298038|449068877|FG000|Overall Study|Protocol Violation|1|||
124848633|NCT00298038|449068878|FG001|Overall Study|Protocol Violation|3|||
124848634|NCT00298038|449068877|FG000|Overall Study|Death|6|||
124848635|NCT00298038|449068878|FG001|Overall Study|Death|3|||
124848636|NCT00298038|449068877|FG000|Overall Study|Withdrawal by Subject|6|||
124848637|NCT00298038|449068878|FG001|Overall Study|Withdrawal by Subject|9|||
124848638|NCT00298038|449068877|FG000|Overall Study|Adverse Event|8|||
124848639|NCT00298038|449068878|FG001|Overall Study|Adverse Event|7|||
124848640|NCT00298038|449068877|FG000|Overall Study|Breakthrough overt HE episode|28|||
124848641|NCT00298038|449068878|FG001|Overall Study|Breakthrough overt HE episode|69|||
124848642|NCT00298038|449068877|FG000|Overall Study|Noncompliance|1|||
124848643|NCT00298038|449068878|FG001|Overall Study|Noncompliance|0|||
124848644|NCT00298038|449068877|FG000|Overall Study|Cocaine Abuse|1|||
124848645|NCT00298038|449068878|FG001|Overall Study|Cocaine Abuse|0|||
124848646|NCT00298038|449068877|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
124848647|NCT00298038|449068878|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
124848648|NCT02696096|449068879|FG000|Overall Study|ruled out at screening|1|||
124848649|NCT02696096|449068879|FG000|Overall Study|did not attend second fMRI|1|||
124848650|NCT01755416|449068882|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
124848651|NCT01755416|449068883|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
124848652|NCT02573324|449070898|FG000|Overall Study|Withdrawal by Subject|26|||
124848653|NCT02573324|449070899|FG001|Overall Study|Withdrawal by Subject|23|||
124848654|NCT02573324|449070900|FG002|Overall Study|Withdrawal by Subject|3|||
124848655|NCT02573324|449070898|FG000|Overall Study|Lost to Follow-up|4|||
124848656|NCT02573324|449070899|FG001|Overall Study|Lost to Follow-up|5|||
124848657|NCT02573324|449070900|FG002|Overall Study|Lost to Follow-up|0|||
124848658|NCT02573324|449070898|FG000|Overall Study|Study Terminated by Sponsor|107|||
124848659|NCT02573324|449070899|FG001|Overall Study|Study Terminated by Sponsor|89|||
124848660|NCT02573324|449070900|FG002|Overall Study|Study Terminated by Sponsor|2|||
124848661|NCT02573324|449070898|FG000|Overall Study|Death|182|||
124848662|NCT02573324|449070899|FG001|Overall Study|Death|200|||
124848663|NCT02573324|449070900|FG002|Overall Study|Death|1|||
124848664|NCT02573324|449070898|FG000|Overall Study|Other, Not Specified|20|||
124848665|NCT02573324|449070899|FG001|Overall Study|Other, Not Specified|27|||
124848666|NCT02573324|449070900|FG002|Overall Study|Other, Not Specified|0|||
124848667|NCT02573324|449070898|FG000|Overall Study|Unknown Reason|2|||
124848668|NCT02573324|449070899|FG001|Overall Study|Unknown Reason|0|||
124848669|NCT02573324|449070900|FG002|Overall Study|Unknown Reason|0|||
124848670|NCT01105533|449070901|FG000|Overall Study|Death|0|||
124848671|NCT01105533|449070902|FG001|Overall Study|Death|0|||
124848672|NCT01105533|449070903|FG002|Overall Study|Death|0|||
124848673|NCT01105533|449070904|FG003|Overall Study|Death|0|||
124848674|NCT01105533|449070905|FG004|Overall Study|Death|1|||
124848675|NCT01105533|449070906|FG005|Overall Study|Death|0|||
124848676|NCT01105533|449070907|FG006|Overall Study|Death|0|||
124848677|NCT01105533|449070908|FG007|Overall Study|Death|0|||
124848678|NCT01105533|449070909|FG008|Overall Study|Death|0|||
124848679|NCT01105533|449070901|FG000|Overall Study|Lack of Efficacy|1|||
124848680|NCT01105533|449070902|FG001|Overall Study|Lack of Efficacy|1|||
124848681|NCT01105533|449070903|FG002|Overall Study|Lack of Efficacy|3|||
124848682|NCT01105533|449070904|FG003|Overall Study|Lack of Efficacy|3|||
124848683|NCT01105533|449070905|FG004|Overall Study|Lack of Efficacy|4|||
124848684|NCT01105533|449070906|FG005|Overall Study|Lack of Efficacy|5|||
124848685|NCT01105533|449070907|FG006|Overall Study|Lack of Efficacy|3|||
124848686|NCT01105533|449070908|FG007|Overall Study|Lack of Efficacy|2|||
124848687|NCT01105533|449070909|FG008|Overall Study|Lack of Efficacy|9|||
124848688|NCT01105533|449070901|FG000|Overall Study|Adverse Event|0|||
124848689|NCT01105533|449070902|FG001|Overall Study|Adverse Event|0|||
124848690|NCT01105533|449070903|FG002|Overall Study|Adverse Event|0|||
124848691|NCT01105533|449070904|FG003|Overall Study|Adverse Event|0|||
124848692|NCT01105533|449070905|FG004|Overall Study|Adverse Event|1|||
124848693|NCT01105533|449070906|FG005|Overall Study|Adverse Event|2|||
124848694|NCT01105533|449070907|FG006|Overall Study|Adverse Event|2|||
124848695|NCT01105533|449070908|FG007|Overall Study|Adverse Event|0|||
124848696|NCT01105533|449070909|FG008|Overall Study|Adverse Event|1|||
124848697|NCT01105533|449070901|FG000|Overall Study|Other|0|||
124848698|NCT01105533|449070902|FG001|Overall Study|Other|0|||
124848699|NCT01105533|449070903|FG002|Overall Study|Other|0|||
124848700|NCT01105533|449070904|FG003|Overall Study|Other|0|||
124848701|NCT01105533|449070905|FG004|Overall Study|Other|1|||
124848702|NCT01105533|449070906|FG005|Overall Study|Other|0|||
124848703|NCT01105533|449070907|FG006|Overall Study|Other|3|||
124848704|NCT01105533|449070908|FG007|Overall Study|Other|1|||
124848705|NCT01105533|449070909|FG008|Overall Study|Other|2|||
124848706|NCT01105533|449070901|FG000|Overall Study|Physician Decision|0|||
124848707|NCT01105533|449070902|FG001|Overall Study|Physician Decision|0|||
124848708|NCT01105533|449070903|FG002|Overall Study|Physician Decision|0|||
124848709|NCT01105533|449070904|FG003|Overall Study|Physician Decision|0|||
124848710|NCT01105533|449070905|FG004|Overall Study|Physician Decision|0|||
124848711|NCT01105533|449070906|FG005|Overall Study|Physician Decision|0|||
124848712|NCT01105533|449070907|FG006|Overall Study|Physician Decision|0|||
124848713|NCT01105533|449070908|FG007|Overall Study|Physician Decision|1|||
124848714|NCT01105533|449070909|FG008|Overall Study|Physician Decision|0|||
124848715|NCT02096835|449070910|FG000|Overall Study|Withdrawal by Subject|1|||
124848716|NCT02096835|449070911|FG001|Overall Study|Withdrawal by Subject|0|||
124848717|NCT02096835|449070912|FG002|Overall Study|Withdrawal by Subject|0|||
124848718|NCT02096835|449070910|FG000|Overall Study|converted to open procedures|1|||
124848719|NCT02096835|449070911|FG001|Overall Study|converted to open procedures|0|||
124848720|NCT02096835|449070912|FG002|Overall Study|converted to open procedures|0|||
124848721|NCT02096835|449070910|FG000|Overall Study|Lost to Follow-up|1|||
124848722|NCT02096835|449070911|FG001|Overall Study|Lost to Follow-up|0|||
124848723|NCT02096835|449070912|FG002|Overall Study|Lost to Follow-up|1|||
124848724|NCT03892889|449070913|FG000|Overall Study|Adverse Event|17|||
124848725|NCT03892889|449070913|FG000|Overall Study|Lack of Efficacy|1|||
124848726|NCT03892889|449070913|FG000|Overall Study|Lost to Follow-up|46|||
124848727|NCT03892889|449070913|FG000|Overall Study|Non-compliance with study drug|22|||
124848728|NCT03892889|449070913|FG000|Overall Study|Pregnancy|1|||
124848729|NCT03892889|449070913|FG000|Overall Study|Protocol Deviation|3|||
124848730|NCT03892889|449070913|FG000|Overall Study|Withdrawal by Subject|50|||
124848731|NCT03892889|449070913|FG000|Overall Study|Withdrawal by Caregiver|1|||
124848732|NCT03892889|449070913|FG000|Overall Study|Study Terminated by Sponsor|50|||
124848733|NCT03892889|449070913|FG000|Overall Study|Physician Decision|8|||
124848734|NCT03892889|449070913|FG000|Overall Study|Reason not Specified|5|||
124848735|NCT04260191|449070914|FG000|Overall Study|Decision by Sponsor|0|||
124848736|NCT04260191|449070915|FG001|Overall Study|Decision by Sponsor|1|||
124848737|NCT04260191|449070916|FG002|Overall Study|Decision by Sponsor|0|||
124848738|NCT04260191|449070914|FG000|Overall Study|Withdrawal by Subject|1|||
124848739|NCT04260191|449070915|FG001|Overall Study|Withdrawal by Subject|0|||
124848740|NCT04260191|449070916|FG002|Overall Study|Withdrawal by Subject|3|||
124848741|NCT04260191|449070914|FG000|Overall Study|Death|4|||
124848742|NCT04260191|449070915|FG001|Overall Study|Death|3|||
124848743|NCT04260191|449070916|FG002|Overall Study|Death|2|||
124848744|NCT01643473|449070917|FG000|Overall Study|Lost to Follow-up|1|||
124848745|NCT01643473|449070918|FG001|Overall Study|Lost to Follow-up|0|||
124848746|NCT01519518|449070919|FG000|Overall Study|Consent not available|7|||
124848747|NCT01519518|449070920|FG001|Overall Study|Consent not available|10|||
124848748|NCT01312909|449070922|FG000|Overall Study|Randomized but not treated|1|||
124848749|NCT01312909|449070923|FG001|Overall Study|Randomized but not treated|3|||
124848750|NCT01312909|449070924|FG002|Overall Study|Randomized but not treated|1|||
124848751|NCT01312909|449070922|FG000|Overall Study|Adverse Event|1|||
124848752|NCT01312909|449070923|FG001|Overall Study|Adverse Event|0|||
124848753|NCT01312909|449070924|FG002|Overall Study|Adverse Event|3|||
124848754|NCT01312909|449070922|FG000|Overall Study|Protocol Violation|2|||
124848755|NCT01312909|449070923|FG001|Overall Study|Protocol Violation|0|||
124848756|NCT01312909|449070924|FG002|Overall Study|Protocol Violation|2|||
124848757|NCT01312909|449070922|FG000|Overall Study|Other|9|||
124848758|NCT01312909|449070923|FG001|Overall Study|Other|6|||
124848759|NCT01312909|449070924|FG002|Overall Study|Other|11|||
124848760|NCT01312909|449070922|FG000|Overall Study|Withdrawal by Subject|8|||
124848761|NCT01312909|449070923|FG001|Overall Study|Withdrawal by Subject|10|||
124848762|NCT01312909|449070924|FG002|Overall Study|Withdrawal by Subject|7|||
124848763|NCT01312909|449070922|FG000|Overall Study|Lost to Follow-up|21|||
124848764|NCT01312909|449070923|FG001|Overall Study|Lost to Follow-up|17|||
124848765|NCT01312909|449070924|FG002|Overall Study|Lost to Follow-up|20|||
124848766|NCT01312909|449070922|FG000|Overall Study|Insufficient clinical response|0|||
124848767|NCT01312909|449070923|FG001|Overall Study|Insufficient clinical response|0|||
124848768|NCT01312909|449070924|FG002|Overall Study|Insufficient clinical response|1|||
124848769|NCT01312909|449070922|FG000|Overall Study|Entrance criteria not met|0|||
124848770|NCT01312909|449070923|FG001|Overall Study|Entrance criteria not met|0|||
124848771|NCT01312909|449070924|FG002|Overall Study|Entrance criteria not met|2|||
124848772|NCT00938431|449070929|FG000|Overall Study|Adverse Event|5|||
124848773|NCT00938431|449070930|FG001|Overall Study|Adverse Event|8|||
124848774|NCT00938431|449070931|FG002|Overall Study|Adverse Event|6|||
124848775|NCT00938431|449070929|FG000|Overall Study|Lack of Efficacy|0|||
124848776|NCT00938431|449070930|FG001|Overall Study|Lack of Efficacy|1|||
124848777|NCT00938431|449070931|FG002|Overall Study|Lack of Efficacy|0|||
124848778|NCT00938431|449070929|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
124848779|NCT00938431|449070930|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
124848780|NCT00938431|449070931|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
124848781|NCT00938431|449070929|FG000|Overall Study|Dosing compliance issue|0|||
124848782|NCT00938431|449070930|FG001|Overall Study|Dosing compliance issue|0|||
124848783|NCT00938431|449070931|FG002|Overall Study|Dosing compliance issue|1|||
124848784|NCT00938431|449070929|FG000|Overall Study|Reached maximum dose early|0|||
124848785|NCT00938431|449070930|FG001|Overall Study|Reached maximum dose early|0|||
124848786|NCT00938431|449070931|FG002|Overall Study|Reached maximum dose early|1|||
124848787|NCT02086591|449070932|FG000|Overall Study|Adverse Event|1|||
124848788|NCT02086591|449070932|FG000|Overall Study|Withdrawal by Subject|1|||
124848789|NCT02086591|449070932|FG000|Overall Study|protocol terminated|3|||
124848790|NCT01774903|449070933|FG000|Overall Study|Adverse Event|7|||
124848791|NCT01774903|449070933|FG000|Overall Study|Withdrawal by Subject|2|||
124848792|NCT01774903|449070933|FG000|Overall Study|Lack of Efficacy|1|||
124848793|NCT01774903|449070933|FG000|Overall Study|Ineligible to continue the trial|1|||
124848794|NCT02212730|449070936|FG000|Overall Study|Tumor not of the required cell histology|1|||
124848795|NCT02212730|449070937|FG001|Overall Study|Tumor not of the required cell histology|0|||
124848796|NCT02212730|449070936|FG000|Overall Study|Withdrawal by Subject|1|||
124848797|NCT02212730|449070937|FG001|Overall Study|Withdrawal by Subject|0|||
124848798|NCT02212730|449070936|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
124848799|NCT02212730|449070937|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
124848800|NCT02880371|449070938|FG000|Phase 1b|Lost to Follow-up|1|||
124848801|NCT02880371|449070939|FG001|Phase 1b|Lost to Follow-up|0|||
124848802|NCT02880371|449070940|FG002|Phase 1b|Lost to Follow-up|0|||
124848803|NCT02880371|449070941|FG003|Phase 1b|Lost to Follow-up|0|||
124848804|NCT02880371|449070942|FG004|Phase 1b|Lost to Follow-up|0|||
124848805|NCT02880371|449070943|FG005|Phase 1b|Lost to Follow-up|0|||
124848806|NCT02880371|449070944|FG006|Phase 1b|Lost to Follow-up|0|||
124848807|NCT02880371|449070945|FG007|Phase 1b|Lost to Follow-up|0|||
124848808|NCT02880371|449070938|FG000|Phase 1b|Participants terminated by Sponsor|1|||
124848809|NCT02880371|449070939|FG001|Phase 1b|Participants terminated by Sponsor|0|||
124848810|NCT02880371|449070940|FG002|Phase 1b|Participants terminated by Sponsor|0|||
124848811|NCT02880371|449070941|FG003|Phase 1b|Participants terminated by Sponsor|0|||
124848812|NCT02880371|449070942|FG004|Phase 1b|Participants terminated by Sponsor|0|||
124848813|NCT02880371|449070943|FG005|Phase 1b|Participants terminated by Sponsor|0|||
124848814|NCT02880371|449070944|FG006|Phase 1b|Participants terminated by Sponsor|0|||
124848815|NCT02880371|449070945|FG007|Phase 1b|Participants terminated by Sponsor|0|||
124848816|NCT02880371|449070938|FG000|Phase 1b|Withdrawal by Subject|0|||
124848817|NCT02880371|449070939|FG001|Phase 1b|Withdrawal by Subject|0|||
124848818|NCT02880371|449070940|FG002|Phase 1b|Withdrawal by Subject|1|||
124848819|NCT02880371|449070941|FG003|Phase 1b|Withdrawal by Subject|0|||
124848820|NCT02880371|449070942|FG004|Phase 1b|Withdrawal by Subject|0|||
124848821|NCT02880371|449070943|FG005|Phase 1b|Withdrawal by Subject|0|||
124848822|NCT02880371|449070944|FG006|Phase 1b|Withdrawal by Subject|0|||
124848823|NCT02880371|449070945|FG007|Phase 1b|Withdrawal by Subject|0|||
124848824|NCT02880371|449070938|FG000|Phase 1b|Death|4|||
124848825|NCT02880371|449070939|FG001|Phase 1b|Death|6|||
124848826|NCT02880371|449070940|FG002|Phase 1b|Death|5|||
124848827|NCT02880371|449070941|FG003|Phase 1b|Death|1|||
124848828|NCT02880371|449070942|FG004|Phase 1b|Death|0|||
124848829|NCT02880371|449070943|FG005|Phase 1b|Death|0|||
124848830|NCT02880371|449070944|FG006|Phase 1b|Death|0|||
124848831|NCT02880371|449070945|FG007|Phase 1b|Death|0|||
124848832|NCT02880371|449070938|FG000|Phase 1b|Enrolled but not Treated|0|||
124848833|NCT02880371|449070939|FG001|Phase 1b|Enrolled but not Treated|1|||
124848834|NCT02880371|449070940|FG002|Phase 1b|Enrolled but not Treated|0|||
124848835|NCT02880371|449070941|FG003|Phase 1b|Enrolled but not Treated|0|||
124848836|NCT02880371|449070942|FG004|Phase 1b|Enrolled but not Treated|0|||
124848837|NCT02880371|449070943|FG005|Phase 1b|Enrolled but not Treated|0|||
124848838|NCT02880371|449070944|FG006|Phase 1b|Enrolled but not Treated|0|||
124848839|NCT02880371|449070945|FG007|Phase 1b|Enrolled but not Treated|0|||
124848840|NCT02880371|449070938|FG000|Phase 2|Enrolled but not Treated|0|||
124848841|NCT02880371|449070939|FG001|Phase 2|Enrolled but not Treated|0|||
124848842|NCT02880371|449070940|FG002|Phase 2|Enrolled but not Treated|0|||
124848843|NCT02880371|449070941|FG003|Phase 2|Enrolled but not Treated|0|||
124848844|NCT02880371|449070942|FG004|Phase 2|Enrolled but not Treated|0|||
124848845|NCT02880371|449070943|FG005|Phase 2|Enrolled but not Treated|1|||
124848846|NCT02880371|449070944|FG006|Phase 2|Enrolled but not Treated|1|||
124848847|NCT02880371|449070945|FG007|Phase 2|Enrolled but not Treated|0|||
124848848|NCT02880371|449070938|FG000|Phase 2|Other|0|||
124848849|NCT02880371|449070939|FG001|Phase 2|Other|0|||
124848850|NCT02880371|449070940|FG002|Phase 2|Other|0|||
124848851|NCT02880371|449070941|FG003|Phase 2|Other|0|||
124848852|NCT02880371|449070942|FG004|Phase 2|Other|0|||
124848853|NCT02880371|449070943|FG005|Phase 2|Other|1|||
124848854|NCT02880371|449070944|FG006|Phase 2|Other|2|||
124848855|NCT02880371|449070945|FG007|Phase 2|Other|1|||
124848856|NCT02880371|449070938|FG000|Phase 2|Participants terminated by Sponsor|0|||
124848857|NCT02880371|449070939|FG001|Phase 2|Participants terminated by Sponsor|0|||
124848858|NCT02880371|449070940|FG002|Phase 2|Participants terminated by Sponsor|0|||
124848859|NCT02880371|449070941|FG003|Phase 2|Participants terminated by Sponsor|0|||
124848860|NCT02880371|449070942|FG004|Phase 2|Participants terminated by Sponsor|1|||
124848861|NCT02880371|449070943|FG005|Phase 2|Participants terminated by Sponsor|6|||
124848862|NCT02880371|449070944|FG006|Phase 2|Participants terminated by Sponsor|1|||
124848863|NCT02880371|449070945|FG007|Phase 2|Participants terminated by Sponsor|5|||
124848864|NCT02880371|449070938|FG000|Phase 2|Death|0|||
124848865|NCT02880371|449070939|FG001|Phase 2|Death|0|||
124848866|NCT02880371|449070940|FG002|Phase 2|Death|0|||
124848867|NCT02880371|449070941|FG003|Phase 2|Death|0|||
124848868|NCT02880371|449070942|FG004|Phase 2|Death|1|||
124848869|NCT02880371|449070943|FG005|Phase 2|Death|10|||
124848870|NCT02880371|449070944|FG006|Phase 2|Death|20|||
124848871|NCT02880371|449070945|FG007|Phase 2|Death|5|||
124848872|NCT02880371|449070938|FG000|Phase 2|Lost to Follow-up|0|||
124848873|NCT02880371|449070939|FG001|Phase 2|Lost to Follow-up|0|||
124848874|NCT02880371|449070940|FG002|Phase 2|Lost to Follow-up|0|||
124848875|NCT02880371|449070941|FG003|Phase 2|Lost to Follow-up|0|||
124848876|NCT02880371|449070942|FG004|Phase 2|Lost to Follow-up|0|||
124848877|NCT02880371|449070943|FG005|Phase 2|Lost to Follow-up|0|||
124848878|NCT02880371|449070944|FG006|Phase 2|Lost to Follow-up|3|||
124848879|NCT02880371|449070945|FG007|Phase 2|Lost to Follow-up|0|||
124848880|NCT02880371|449070938|FG000|Phase 2|Withdrawal by Subject|0|||
124848881|NCT02880371|449070939|FG001|Phase 2|Withdrawal by Subject|0|||
124848882|NCT02880371|449070940|FG002|Phase 2|Withdrawal by Subject|0|||
124848883|NCT02880371|449070941|FG003|Phase 2|Withdrawal by Subject|0|||
124848884|NCT02880371|449070942|FG004|Phase 2|Withdrawal by Subject|0|||
124848885|NCT02880371|449070943|FG005|Phase 2|Withdrawal by Subject|1|||
124848886|NCT02880371|449070944|FG006|Phase 2|Withdrawal by Subject|1|||
124848887|NCT02880371|449070945|FG007|Phase 2|Withdrawal by Subject|0|||
124848888|NCT02880371|449070938|FG000|Phase 2|End of Study page not completed by error|0|||
124848889|NCT02880371|449070939|FG001|Phase 2|End of Study page not completed by error|0|||
124848890|NCT02880371|449070940|FG002|Phase 2|End of Study page not completed by error|0|||
124848891|NCT02880371|449070941|FG003|Phase 2|End of Study page not completed by error|0|||
124848892|NCT02880371|449070942|FG004|Phase 2|End of Study page not completed by error|0|||
124848893|NCT02880371|449070943|FG005|Phase 2|End of Study page not completed by error|1|||
124848894|NCT02880371|449070944|FG006|Phase 2|End of Study page not completed by error|0|||
124848895|NCT02880371|449070945|FG007|Phase 2|End of Study page not completed by error|0|||
124848896|NCT01777997|449070948|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
124848897|NCT01777997|449070948|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
124848898|NCT01777997|449070948|FG000|Weeks 48 to 72/96 on ART|Death|1|||
124848899|NCT01777997|449070948|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
124848900|NCT02660359|449070949|FG000|Overall Study|Protocol Deviation|0|||
124848901|NCT02660359|449070950|FG001|Overall Study|Protocol Deviation|0|||
124848902|NCT02660359|449070951|FG002|Overall Study|Protocol Deviation|1|||
124848903|NCT02660359|449070949|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
124848904|NCT02660359|449070950|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
124848905|NCT02660359|449070951|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
124848906|NCT02660359|449070949|FG000|Overall Study|Lack of Efficacy|1|||
124848907|NCT02660359|449070950|FG001|Overall Study|Lack of Efficacy|1|||
124848908|NCT02660359|449070951|FG002|Overall Study|Lack of Efficacy|1|||
124848909|NCT02660359|449070949|FG000|Overall Study|Adverse Event|0|||
124848910|NCT02660359|449070950|FG001|Overall Study|Adverse Event|1|||
124848911|NCT02660359|449070951|FG002|Overall Study|Adverse Event|0|||
124848912|NCT02660359|449070949|FG000|Overall Study|Other|2|||
124848913|NCT02660359|449070950|FG001|Overall Study|Other|1|||
124848914|NCT02660359|449070951|FG002|Overall Study|Other|3|||
124848915|NCT02660359|449070949|FG000|Overall Study|Withdrawal by Subject|7|||
124848916|NCT02660359|449070950|FG001|Overall Study|Withdrawal by Subject|5|||
124848917|NCT02660359|449070951|FG002|Overall Study|Withdrawal by Subject|8|||
124848918|NCT02660359|449070949|FG000|Overall Study|Lost to Follow-up|3|||
124848919|NCT02660359|449070950|FG001|Overall Study|Lost to Follow-up|3|||
124848920|NCT02660359|449070951|FG002|Overall Study|Lost to Follow-up|0|||
124848921|NCT02944578|449070957|FG000|Overall Study|Physician Decision|1|||
124848922|NCT02944578|449070958|FG001|Overall Study|Physician Decision|0|||
124848923|NCT02691455|449070959|FG000|Overall Study|Withdrawal by Subject|1|||
124848924|NCT02691455|449070960|FG001|Overall Study|Withdrawal by Subject|2|||
124848925|NCT02691455|449070959|FG000|Overall Study|Lost to Follow-up|15|||
124848926|NCT02691455|449070960|FG001|Overall Study|Lost to Follow-up|15|||
124848927|NCT01257204|449070961|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
124848928|NCT01257204|449070962|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
124848929|NCT01257204|449070963|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
124848930|NCT01257204|449070961|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
124848931|NCT01257204|449070962|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
124848932|NCT01257204|449070963|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
124848933|NCT01257204|449070961|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
124848934|NCT01257204|449070962|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
124848935|NCT01257204|449070963|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
124848936|NCT01257204|449070961|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
124848937|NCT01257204|449070962|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
124848938|NCT01257204|449070963|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
124848939|NCT01257204|449070961|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
124848940|NCT01257204|449070962|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
124848941|NCT01257204|449070963|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
124848942|NCT01257204|449070961|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
124848943|NCT01257204|449070962|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
124848944|NCT01257204|449070963|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
124848945|NCT01257204|449070961|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
124848946|NCT01257204|449070962|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
124848947|NCT01257204|449070963|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
124848948|NCT01257204|449070961|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
124848949|NCT01257204|449070962|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
124848950|NCT01257204|449070963|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
124848951|NCT01257204|449070961|FG000|Follow-up Period (up to Week 48)|Other|0|||
124848952|NCT01257204|449070962|FG001|Follow-up Period (up to Week 48)|Other|0|||
124848953|NCT01257204|449070963|FG002|Follow-up Period (up to Week 48)|Other|5|||
124848954|NCT00451282|449070967|FG000|Overall Study|Lost to Follow-up|6|||
124848955|NCT00451282|449070968|FG001|Overall Study|Lost to Follow-up|5|||
124848956|NCT00577122|449070969|FG000|Overall Study|Adverse Event|0|||
124848957|NCT00577122|449070970|FG001|Overall Study|Adverse Event|2|||
124848958|NCT00577122|449070969|FG000|Overall Study|Progression, relapse during active trt|6|||
124848959|NCT00577122|449070970|FG001|Overall Study|Progression, relapse during active trt|8|||
124848960|NCT00577122|449070969|FG000|Overall Study|Prog, refract disease during active trt|8|||
124848961|NCT00577122|449070970|FG001|Overall Study|Prog, refract disease during active trt|5|||
124848962|NCT00577122|449070969|FG000|Overall Study|Alternative Therapy|0|||
124848963|NCT00577122|449070970|FG001|Overall Study|Alternative Therapy|1|||
124848964|NCT00529386|449070976|FG000|Overall Study|Lost to Follow-up|1|||
124848965|NCT04532112|449070977|FG000|Overall Study|Adverse Event|3|||
124848966|NCT04532112|449070978|FG001|Overall Study|Adverse Event|0|||
124848967|NCT03348904|449070979|FG000|Overall Study|Administrative reason by the sponsor|0|||
124848968|NCT03348904|449070980|FG001|Overall Study|Administrative reason by the sponsor|1|||
124848969|NCT03348904|449070981|FG002|Overall Study|Administrative reason by the sponsor|0|||
124848970|NCT02039427|449070987|FG000|Overall Study|Duration of surgery > 3h|1|||
124848971|NCT02039427|449070988|FG001|Overall Study|Duration of surgery > 3h|1|||
124848972|NCT02039427|449070989|FG002|Overall Study|Duration of surgery > 3h|0|||
124848973|NCT02039427|449070990|FG003|Overall Study|Duration of surgery > 3h|0|||
124848974|NCT02039427|449070987|FG000|Overall Study|Withdrawal on concent|0|||
124848975|NCT02039427|449070988|FG001|Overall Study|Withdrawal on concent|0|||
124848976|NCT02039427|449070989|FG002|Overall Study|Withdrawal on concent|0|||
124848977|NCT02039427|449070990|FG003|Overall Study|Withdrawal on concent|1|||
124848978|NCT02039427|449070987|FG000|Overall Study|Cancellation of surgery|0|||
124848979|NCT02039427|449070988|FG001|Overall Study|Cancellation of surgery|0|||
124848980|NCT02039427|449070989|FG002|Overall Study|Cancellation of surgery|1|||
124848981|NCT02039427|449070990|FG003|Overall Study|Cancellation of surgery|0|||
124848982|NCT02039427|449070987|FG000|Overall Study|Loss of follow - up|1|||
124848983|NCT02039427|449070988|FG001|Overall Study|Loss of follow - up|0|||
124848984|NCT02039427|449070989|FG002|Overall Study|Loss of follow - up|2|||
124848985|NCT02039427|449070990|FG003|Overall Study|Loss of follow - up|4|||
124848986|NCT02039427|449070987|FG000|Overall Study|Steroid Use|1|||
124848987|NCT02039427|449070988|FG001|Overall Study|Steroid Use|0|||
124848988|NCT02039427|449070989|FG002|Overall Study|Steroid Use|0|||
124848989|NCT02039427|449070990|FG003|Overall Study|Steroid Use|0|||
124848990|NCT04354831|449070991|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
124848991|NCT04354831|449070992|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
124848992|NCT02732847|449070993|FG000|Overall Study|some filled early|42|||
124848993|NCT02732847|449070994|FG001|Overall Study|some filled early|42|||
124848994|NCT04027686|449070995|FG000|Overall Study|Lost to Follow-up|2|||
124848995|NCT04027686|449070996|FG001|Overall Study|Lost to Follow-up|0|||
124848996|NCT04027686|449070995|FG000|Overall Study|Withdrawal by Subject|0|||
124848997|NCT04027686|449070996|FG001|Overall Study|Withdrawal by Subject|1|||
124848998|NCT00111228|449070997|FG000|Overall Study|Withdrawal by Subject|5|||
124848999|NCT00111228|449070998|FG001|Overall Study|Withdrawal by Subject|1|||
124849000|NCT00111228|449070999|FG002|Overall Study|Withdrawal by Subject|0|||
124849001|NCT00779766|449071000|FG000|Month 24|Serious Adverse Event|2|||
124849002|NCT00779766|449071001|FG001|Month 24|Serious Adverse Event|3|||
124849003|NCT00779766|449071000|FG000|Month 24|Adverse Event|3|||
124849004|NCT00779766|449071001|FG001|Month 24|Adverse Event|3|||
124849005|NCT00779766|449071000|FG000|Month 24|Protocol Violation|3|||
124849006|NCT00779766|449071001|FG001|Month 24|Protocol Violation|1|||
124849007|NCT00779766|449071000|FG000|Month 24|Withdrawal by Subject|159|||
124849008|NCT00779766|449071001|FG001|Month 24|Withdrawal by Subject|127|||
124849009|NCT00779766|449071000|FG000|Month 24|Migrated/moved from study area|138|||
124849010|NCT00779766|449071001|FG001|Month 24|Migrated/moved from study area|162|||
124849011|NCT00779766|449071000|FG000|Month 24|Lost to Follow-up|9|||
124849012|NCT00779766|449071001|FG001|Month 24|Lost to Follow-up|9|||
124849013|NCT00779766|449071000|FG000|Month 24|Other|18|||
124849014|NCT00779766|449071001|FG001|Month 24|Other|27|||
124849015|NCT00779766|449071000|FG000|Month 48|Withdrawal by Subject|68|||
124849016|NCT00779766|449071001|FG001|Month 48|Withdrawal by Subject|63|||
124849017|NCT00779766|449071000|FG000|Month 48|Migrated/moved from study area|76|||
124849018|NCT00779766|449071001|FG001|Month 48|Migrated/moved from study area|75|||
124849019|NCT00779766|449071000|FG000|Month 48|Lost to Follow-up|29|||
124849020|NCT00779766|449071001|FG001|Month 48|Lost to Follow-up|30|||
124849021|NCT00779766|449071000|FG000|Month 48|Other|1|||
124849022|NCT00779766|449071001|FG001|Month 48|Other|0|||
124849023|NCT00779766|449071000|FG000|Month 72|Withdrawal by Subject|55|||
124849024|NCT00779766|449071001|FG001|Month 72|Withdrawal by Subject|71|||
124849025|NCT00779766|449071000|FG000|Month 72|Migrated/moved from study area|124|||
124849026|NCT00779766|449071001|FG001|Month 72|Migrated/moved from study area|109|||
124849027|NCT00779766|449071000|FG000|Month 72|Lost to Follow-up|6|||
124849028|NCT00779766|449071001|FG001|Month 72|Lost to Follow-up|8|||
124849029|NCT00779766|449071000|FG000|Month 72|Other|0|||
124849030|NCT00779766|449071001|FG001|Month 72|Other|1|||
124849031|NCT01274637|449071004|FG000|Overall Study|Withdrawal by Subject|0|||
124849032|NCT01274637|449071005|FG001|Overall Study|Withdrawal by Subject|1|||
124849033|NCT01274637|449071004|FG000|Overall Study|Lost to Follow-up|0|||
124849034|NCT01274637|449071005|FG001|Overall Study|Lost to Follow-up|1|||
124849035|NCT02170727|449071009|FG000|Overall Study|Lost to Follow-up|1|||
124849036|NCT02170727|449071010|FG001|Overall Study|Lost to Follow-up|0|||
124849037|NCT02170727|449071009|FG000|Overall Study|Withdrawal by Subject|2|||
124849038|NCT02170727|449071010|FG001|Overall Study|Withdrawal by Subject|0|||
124849039|NCT00720876|449071011|FG000|Overall Study|found to be ineligible after starting tx|2|||
124849040|NCT03304379|449071013|FG000|Overall Study|Protocol Violation|8|||
124849041|NCT03304379|449071014|FG001|Overall Study|Protocol Violation|10|||
124849042|NCT03304379|449071015|FG002|Overall Study|Protocol Violation|5|||
124849043|NCT03304379|449071016|FG003|Overall Study|Protocol Violation|0|||
124849044|NCT03304379|449071017|FG004|Overall Study|Protocol Violation|2|||
124849045|NCT03304379|449071013|FG000|Overall Study|Adverse Event|4|||
124849046|NCT03304379|449071014|FG001|Overall Study|Adverse Event|20|||
124849047|NCT03304379|449071015|FG002|Overall Study|Adverse Event|17|||
124849048|NCT03304379|449071016|FG003|Overall Study|Adverse Event|1|||
124849049|NCT03304379|449071017|FG004|Overall Study|Adverse Event|0|||
124849050|NCT03304379|449071013|FG000|Overall Study|Lack of Efficacy|17|||
124849051|NCT03304379|449071014|FG001|Overall Study|Lack of Efficacy|16|||
124849052|NCT03304379|449071015|FG002|Overall Study|Lack of Efficacy|20|||
124849053|NCT03304379|449071016|FG003|Overall Study|Lack of Efficacy|0|||
124849054|NCT03304379|449071017|FG004|Overall Study|Lack of Efficacy|0|||
124849055|NCT03304379|449071013|FG000|Overall Study|Physician Decision|6|||
124849056|NCT03304379|449071014|FG001|Overall Study|Physician Decision|10|||
124849057|NCT03304379|449071015|FG002|Overall Study|Physician Decision|6|||
124849058|NCT03304379|449071016|FG003|Overall Study|Physician Decision|9|||
124849059|NCT03304379|449071017|FG004|Overall Study|Physician Decision|10|||
124849060|NCT03304379|449071013|FG000|Overall Study|Withdrawal by Subject|26|||
124849061|NCT03304379|449071014|FG001|Overall Study|Withdrawal by Subject|58|||
124849062|NCT03304379|449071015|FG002|Overall Study|Withdrawal by Subject|66|||
124849063|NCT03304379|449071016|FG003|Overall Study|Withdrawal by Subject|3|||
124849064|NCT03304379|449071017|FG004|Overall Study|Withdrawal by Subject|5|||
124849065|NCT03304379|449071013|FG000|Overall Study|Lost to Follow-up|8|||
124849066|NCT03304379|449071014|FG001|Overall Study|Lost to Follow-up|24|||
124849067|NCT03304379|449071015|FG002|Overall Study|Lost to Follow-up|35|||
124849068|NCT03304379|449071016|FG003|Overall Study|Lost to Follow-up|4|||
124849069|NCT03304379|449071017|FG004|Overall Study|Lost to Follow-up|0|||
124849070|NCT03304379|449071013|FG000|Overall Study|Death|1|||
124849071|NCT03304379|449071014|FG001|Overall Study|Death|2|||
124849072|NCT03304379|449071015|FG002|Overall Study|Death|0|||
124849073|NCT03304379|449071016|FG003|Overall Study|Death|0|||
124849074|NCT03304379|449071017|FG004|Overall Study|Death|0|||
124849075|NCT03304379|449071013|FG000|Overall Study|Other|0|||
124849076|NCT03304379|449071014|FG001|Overall Study|Other|1|||
124849077|NCT03304379|449071015|FG002|Overall Study|Other|0|||
124849078|NCT03304379|449071016|FG003|Overall Study|Other|0|||
124849079|NCT03304379|449071017|FG004|Overall Study|Other|0|||
124849080|NCT03511560|449071028|FG000|Overall Study|Death|0|||
124849081|NCT03511560|449071029|FG001|Overall Study|Death|1|||
124849082|NCT03511560|449071028|FG000|Overall Study|Adverse Event|0|||
124849083|NCT03511560|449071029|FG001|Overall Study|Adverse Event|2|||
124849084|NCT03511560|449071028|FG000|Overall Study|Transplant cancelled|0|||
124849085|NCT03511560|449071029|FG001|Overall Study|Transplant cancelled|1|||
124849086|NCT03511560|449071028|FG000|Overall Study|Patient switched to another drug|1|||
124849087|NCT03511560|449071029|FG001|Overall Study|Patient switched to another drug|0|||
124849088|NCT02985736|449071034|FG000|Overall Study|Lost to Follow-up|3|||
124849089|NCT00382733|449071035|FG000|Overall Study|Withdrawal by Subject|0|||
124849090|NCT00382733|449071036|FG001|Overall Study|Withdrawal by Subject|1|||
124849091|NCT00382733|449071037|FG002|Overall Study|Withdrawal by Subject|0|||
124849092|NCT00382733|449071038|FG003|Overall Study|Withdrawal by Subject|0|||
124849093|NCT00382733|449071039|FG004|Overall Study|Withdrawal by Subject|0|||
124849094|NCT02185768|449071044|FG000|Overall Study|Patients were not treated|2|||
124849095|NCT02550652|449071046|FG000|Overall Study|Death|1|||
124849096|NCT02550652|449071047|FG001|Overall Study|Death|4|||
124849097|NCT02550652|449071046|FG000|Overall Study|Lack of Efficacy|1|||
124849098|NCT02550652|449071047|FG001|Overall Study|Lack of Efficacy|0|||
124849099|NCT02550652|449071046|FG000|Overall Study|Withdrawal by Subject|4|||
124849100|NCT02550652|449071047|FG001|Overall Study|Withdrawal by Subject|7|||
124849101|NCT02550652|449071046|FG000|Overall Study|Post Trial Access|1|||
124849102|NCT02550652|449071047|FG001|Overall Study|Post Trial Access|0|||
124849103|NCT02550652|449071046|FG000|Overall Study|Lost to Follow-up|1|||
124849104|NCT02550652|449071047|FG001|Overall Study|Lost to Follow-up|3|||
124849105|NCT02550652|449071046|FG000|Overall Study|Physician Decision|0|||
124849106|NCT02550652|449071047|FG001|Overall Study|Physician Decision|2|||
124849107|NCT02550652|449071046|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
124849108|NCT02550652|449071047|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
124849109|NCT03286140|449071048|FG000|Overall Study|Withdrawal by Subject|10|||
124849110|NCT03286140|449071049|FG001|Overall Study|Withdrawal by Subject|5|||
124849111|NCT03286140|449071048|FG000|Overall Study|Lost to Follow-up|5|||
124849112|NCT03286140|449071049|FG001|Overall Study|Lost to Follow-up|10|||
124849113|NCT03286140|449071048|FG000|Overall Study|Failure to comply|0|||
124849114|NCT03286140|449071049|FG001|Overall Study|Failure to comply|1|||
124849115|NCT00515827|449071050|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
124849116|NCT00515827|449071051|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
124849117|NCT00515827|449071050|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
124849118|NCT00515827|449071051|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
124849119|NCT03181542|449071052|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
124849120|NCT03181542|449071053|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
124849121|NCT04055116|449071059|FG000|First Intervention|Physician Decision|2|||
124849122|NCT04055116|449071060|FG001|First Intervention|Physician Decision|7|||
124849123|NCT02774681|449071067|FG000|Treatment on Study|Progressive Disease|7|||
124849124|NCT02774681|449071067|FG000|Follow-Up for 3 Years|Death|11|||
124849125|NCT02774681|449071067|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
124849126|NCT01069289|449071068|FG000|Overall Study|Withdrawal by Subject|15|||
124849127|NCT01069289|449071069|FG001|Overall Study|Withdrawal by Subject|26|||
124849128|NCT01069289|449071068|FG000|Overall Study|Adverse Event|21|||
124849129|NCT01069289|449071069|FG001|Overall Study|Adverse Event|28|||
124849130|NCT01069289|449071068|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
124849131|NCT01069289|449071069|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
124849132|NCT01069289|449071068|FG000|Overall Study|Severe non-compliance to protocol|3|||
124849133|NCT01069289|449071069|FG001|Overall Study|Severe non-compliance to protocol|2|||
124849134|NCT01069289|449071068|FG000|Overall Study|Due to deteriorating health condition|1|||
124849135|NCT01069289|449071069|FG001|Overall Study|Due to deteriorating health condition|0|||
124849136|NCT02047604|449071070|FG000|Overall Study|Withdrawal by Subject|0|||
124849137|NCT02047604|449071071|FG001|Overall Study|Withdrawal by Subject|0|||
124849138|NCT02047604|449071072|FG002|Overall Study|Withdrawal by Subject|0|||
124849139|NCT02047604|449071073|FG003|Overall Study|Withdrawal by Subject|0|||
124849140|NCT02047604|449071074|FG004|Overall Study|Withdrawal by Subject|1|||
124849141|NCT02047604|449071075|FG005|Overall Study|Withdrawal by Subject|1|||
124849142|NCT04035486|449071076|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
124849143|NCT04035486|449071077|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
124849144|NCT04035486|449071078|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
124849145|NCT04035486|449071079|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
124849146|NCT04035486|449071076|FG000|Overall Study|Death|6|||
124849147|NCT04035486|449071077|FG001|Overall Study|Death|3|||
124849148|NCT04035486|449071078|FG002|Overall Study|Death|70|||
124849149|NCT04035486|449071079|FG003|Overall Study|Death|77|||
124849150|NCT04035486|449071076|FG000|Overall Study|Screen Failure|0|||
124849151|NCT04035486|449071077|FG001|Overall Study|Screen Failure|0|||
124849152|NCT04035486|449071078|FG002|Overall Study|Screen Failure|1|||
124849153|NCT04035486|449071079|FG003|Overall Study|Screen Failure|1|||
124849154|NCT04035486|449071076|FG000|Overall Study|Withdrawal by Subject|1|||
124849155|NCT04035486|449071077|FG001|Overall Study|Withdrawal by Subject|1|||
124849156|NCT04035486|449071078|FG002|Overall Study|Withdrawal by Subject|11|||
124849157|NCT04035486|449071079|FG003|Overall Study|Withdrawal by Subject|9|||
124849158|NCT02556710|449073144|FG000|Overall Study|Surgical treatment|3|||
124849159|NCT02556710|449073145|FG001|Overall Study|Surgical treatment|0|||
124849160|NCT02556710|449073144|FG000|Overall Study|Required proscribed pain medication|2|||
124849161|NCT02556710|449073145|FG001|Overall Study|Required proscribed pain medication|1|||
124849162|NCT02556710|449073144|FG000|Overall Study|Lack of Efficacy|1|||
124849163|NCT02556710|449073145|FG001|Overall Study|Lack of Efficacy|0|||
124849164|NCT02556710|449073144|FG000|Overall Study|Worsening osteoarthritis|1|||
124849165|NCT02556710|449073145|FG001|Overall Study|Worsening osteoarthritis|0|||
124849166|NCT02556710|449073144|FG000|Overall Study|Moved out of state|1|||
124849167|NCT02556710|449073145|FG001|Overall Study|Moved out of state|0|||
124849168|NCT02556710|449073144|FG000|Overall Study|Missing reason|3|||
124849169|NCT02556710|449073145|FG001|Overall Study|Missing reason|1|||
124849170|NCT02556710|449073144|FG000|Overall Study|Pain as lack of efficacy|0|||
124849171|NCT02556710|449073145|FG001|Overall Study|Pain as lack of efficacy|4|||
124849172|NCT04258839|449073148|FG000|Overall Study|Adverse Event|2|||
124849173|NCT04258839|449073149|FG001|Overall Study|Adverse Event|4|||
124849174|NCT04258839|449073148|FG000|Overall Study|Lack of Efficacy|0|||
124849175|NCT04258839|449073149|FG001|Overall Study|Lack of Efficacy|2|||
124849176|NCT04258839|449073148|FG000|Overall Study|Lost to Follow-up|2|||
124849177|NCT04258839|449073149|FG001|Overall Study|Lost to Follow-up|0|||
124849178|NCT04258839|449073148|FG000|Overall Study|Withdrawal by Subject|1|||
124849179|NCT04258839|449073149|FG001|Overall Study|Withdrawal by Subject|2|||
124849180|NCT04258839|449073148|FG000|Overall Study|Withdrawal by Caregiver|5|||
124849181|NCT04258839|449073149|FG001|Overall Study|Withdrawal by Caregiver|6|||
124849182|NCT04258839|449073148|FG000|Overall Study|Reason not Specified|0|||
124849183|NCT04258839|449073149|FG001|Overall Study|Reason not Specified|1|||
124849184|NCT01607905|449073150|FG000|Overall Study|Withdrawal by participant|7|||
124849185|NCT01607905|449073151|FG001|Overall Study|Withdrawal by participant|2|||
124849186|NCT01607905|449073152|FG002|Overall Study|Withdrawal by participant|4|||
124849187|NCT01607905|449073153|FG003|Overall Study|Withdrawal by participant|6|||
124849188|NCT01607905|449073154|FG004|Overall Study|Withdrawal by participant|0|||
124849189|NCT01607905|449073155|FG005|Overall Study|Withdrawal by participant|4|||
124849190|NCT01607905|449073156|FG006|Overall Study|Withdrawal by participant|12|||
124849191|NCT01607905|449073150|FG000|Overall Study|Incidence or severity of AEs|5|||
124849192|NCT01607905|449073151|FG001|Overall Study|Incidence or severity of AEs|1|||
124849193|NCT01607905|449073152|FG002|Overall Study|Incidence or severity of AEs|1|||
124849194|NCT01607905|449073153|FG003|Overall Study|Incidence or severity of AEs|3|||
124849195|NCT01607905|449073154|FG004|Overall Study|Incidence or severity of AEs|0|||
124849196|NCT01607905|449073155|FG005|Overall Study|Incidence or severity of AEs|2|||
124849197|NCT01607905|449073156|FG006|Overall Study|Incidence or severity of AEs|8|||
124849198|NCT01607905|449073150|FG000|Overall Study|Disease progression|44|||
124849199|NCT01607905|449073151|FG001|Overall Study|Disease progression|16|||
124849200|NCT01607905|449073152|FG002|Overall Study|Disease progression|15|||
124849201|NCT01607905|449073153|FG003|Overall Study|Disease progression|11|||
124849202|NCT01607905|449073154|FG004|Overall Study|Disease progression|6|||
124849203|NCT01607905|449073155|FG005|Overall Study|Disease progression|7|||
124849204|NCT01607905|449073156|FG006|Overall Study|Disease progression|21|||
124849205|NCT01607905|449073150|FG000|Overall Study|Non-compliance with study procedures|0|||
124849206|NCT01607905|449073151|FG001|Overall Study|Non-compliance with study procedures|0|||
124849207|NCT01607905|449073152|FG002|Overall Study|Non-compliance with study procedures|0|||
124849208|NCT01607905|449073153|FG003|Overall Study|Non-compliance with study procedures|0|||
124849209|NCT01607905|449073154|FG004|Overall Study|Non-compliance with study procedures|0|||
124849210|NCT01607905|449073155|FG005|Overall Study|Non-compliance with study procedures|0|||
124849211|NCT01607905|449073156|FG006|Overall Study|Non-compliance with study procedures|1|||
124849212|NCT01607905|449073150|FG000|Overall Study|Death|1|||
124849213|NCT01607905|449073151|FG001|Overall Study|Death|1|||
124849214|NCT01607905|449073152|FG002|Overall Study|Death|1|||
124849215|NCT01607905|449073153|FG003|Overall Study|Death|1|||
124849216|NCT01607905|449073154|FG004|Overall Study|Death|0|||
124849217|NCT01607905|449073155|FG005|Overall Study|Death|0|||
124849218|NCT01607905|449073156|FG006|Overall Study|Death|3|||
124849219|NCT01607905|449073150|FG000|Overall Study|Other treatments become available|1|||
124849220|NCT01607905|449073151|FG001|Overall Study|Other treatments become available|0|||
124849221|NCT01607905|449073152|FG002|Overall Study|Other treatments become available|0|||
124849222|NCT01607905|449073153|FG003|Overall Study|Other treatments become available|0|||
124849223|NCT01607905|449073154|FG004|Overall Study|Other treatments become available|0|||
124849224|NCT01607905|449073155|FG005|Overall Study|Other treatments become available|0|||
124849225|NCT01607905|449073156|FG006|Overall Study|Other treatments become available|1|||
124849226|NCT01607905|449073150|FG000|Overall Study|Investigator discretion|0|||
124849227|NCT01607905|449073151|FG001|Overall Study|Investigator discretion|0|||
124849228|NCT01607905|449073152|FG002|Overall Study|Investigator discretion|0|||
124849229|NCT01607905|449073153|FG003|Overall Study|Investigator discretion|0|||
124849230|NCT01607905|449073154|FG004|Overall Study|Investigator discretion|0|||
124849231|NCT01607905|449073155|FG005|Overall Study|Investigator discretion|1|||
124849232|NCT01607905|449073156|FG006|Overall Study|Investigator discretion|0|||
124849233|NCT01607905|449073150|FG000|Overall Study|Other|1|||
124849234|NCT01607905|449073151|FG001|Overall Study|Other|0|||
124849235|NCT01607905|449073152|FG002|Overall Study|Other|0|||
124849236|NCT01607905|449073153|FG003|Overall Study|Other|0|||
124849237|NCT01607905|449073154|FG004|Overall Study|Other|0|||
124849238|NCT01607905|449073155|FG005|Overall Study|Other|0|||
124849239|NCT01607905|449073156|FG006|Overall Study|Other|1|||
124849240|NCT01607905|449073150|FG000|Overall Study|Randomized but not treated|1|||
124849241|NCT01607905|449073151|FG001|Overall Study|Randomized but not treated|0|||
124849242|NCT01607905|449073152|FG002|Overall Study|Randomized but not treated|0|||
124849243|NCT01607905|449073153|FG003|Overall Study|Randomized but not treated|0|||
124849244|NCT01607905|449073154|FG004|Overall Study|Randomized but not treated|1|||
124849245|NCT01607905|449073155|FG005|Overall Study|Randomized but not treated|1|||
124849246|NCT01607905|449073156|FG006|Overall Study|Randomized but not treated|0|||
124849247|NCT01602315|449073157|FG000|Overall Study|Protocol Violation|0|||
124849248|NCT01602315|449073158|FG001|Overall Study|Protocol Violation|0|||
124849249|NCT01602315|449073159|FG002|Overall Study|Protocol Violation|0|||
124849250|NCT01602315|449073160|FG003|Overall Study|Protocol Violation|0|||
124849251|NCT01602315|449073161|FG004|Overall Study|Protocol Violation|0|||
124849252|NCT01602315|449073162|FG005|Overall Study|Protocol Violation|1|||
124849253|NCT01602315|449073163|FG006|Overall Study|Protocol Violation|0|||
124849254|NCT01602315|449073157|FG000|Overall Study|Physician Decision|2|||
124849255|NCT01602315|449073158|FG001|Overall Study|Physician Decision|0|||
124849256|NCT01602315|449073159|FG002|Overall Study|Physician Decision|0|||
124849257|NCT01602315|449073160|FG003|Overall Study|Physician Decision|0|||
124849258|NCT01602315|449073161|FG004|Overall Study|Physician Decision|2|||
124849259|NCT01602315|449073162|FG005|Overall Study|Physician Decision|1|||
124849260|NCT01602315|449073163|FG006|Overall Study|Physician Decision|1|||
124849261|NCT01602315|449073157|FG000|Overall Study|Disease progression|6|||
124849262|NCT01602315|449073158|FG001|Overall Study|Disease progression|3|||
124849263|NCT01602315|449073159|FG002|Overall Study|Disease progression|10|||
124849264|NCT01602315|449073160|FG003|Overall Study|Disease progression|1|||
124849265|NCT01602315|449073161|FG004|Overall Study|Disease progression|41|||
124849266|NCT01602315|449073162|FG005|Overall Study|Disease progression|12|||
124849267|NCT01602315|449073163|FG006|Overall Study|Disease progression|15|||
124849268|NCT01602315|449073157|FG000|Overall Study|Death|1|||
124849269|NCT01602315|449073158|FG001|Overall Study|Death|1|||
124849270|NCT01602315|449073159|FG002|Overall Study|Death|1|||
124849271|NCT01602315|449073160|FG003|Overall Study|Death|1|||
124849272|NCT01602315|449073161|FG004|Overall Study|Death|7|||
124849273|NCT01602315|449073162|FG005|Overall Study|Death|2|||
124849274|NCT01602315|449073163|FG006|Overall Study|Death|2|||
124849275|NCT01602315|449073157|FG000|Overall Study|Withdrawal by Subject|2|||
124849276|NCT01602315|449073158|FG001|Overall Study|Withdrawal by Subject|0|||
124849277|NCT01602315|449073159|FG002|Overall Study|Withdrawal by Subject|2|||
124849278|NCT01602315|449073160|FG003|Overall Study|Withdrawal by Subject|0|||
124849279|NCT01602315|449073161|FG004|Overall Study|Withdrawal by Subject|6|||
124849280|NCT01602315|449073162|FG005|Overall Study|Withdrawal by Subject|0|||
124849281|NCT01602315|449073163|FG006|Overall Study|Withdrawal by Subject|1|||
124849282|NCT01602315|449073157|FG000|Overall Study|Adverse Event|5|||
124849283|NCT01602315|449073158|FG001|Overall Study|Adverse Event|1|||
124849284|NCT01602315|449073159|FG002|Overall Study|Adverse Event|5|||
124849285|NCT01602315|449073160|FG003|Overall Study|Adverse Event|4|||
124849286|NCT01602315|449073161|FG004|Overall Study|Adverse Event|15|||
124849287|NCT01602315|449073162|FG005|Overall Study|Adverse Event|3|||
124849288|NCT01602315|449073163|FG006|Overall Study|Adverse Event|9|||
124849289|NCT01602315|449073157|FG000|Overall Study|Subject/guardian decision|0|||
124849290|NCT01602315|449073158|FG001|Overall Study|Subject/guardian decision|0|||
124849291|NCT01602315|449073159|FG002|Overall Study|Subject/guardian decision|0|||
124849292|NCT01602315|449073160|FG003|Overall Study|Subject/guardian decision|0|||
124849293|NCT01602315|449073161|FG004|Overall Study|Subject/guardian decision|0|||
124849294|NCT01602315|449073162|FG005|Overall Study|Subject/guardian decision|0|||
124849295|NCT01602315|449073163|FG006|Overall Study|Subject/guardian decision|1|||
124849296|NCT01602315|449073157|FG000|Overall Study|Cross-over patients to combo treatment|0|||
124849297|NCT01602315|449073158|FG001|Overall Study|Cross-over patients to combo treatment|0|||
124849298|NCT01602315|449073159|FG002|Overall Study|Cross-over patients to combo treatment|0|||
124849299|NCT01602315|449073160|FG003|Overall Study|Cross-over patients to combo treatment|0|||
124849300|NCT01602315|449073161|FG004|Overall Study|Cross-over patients to combo treatment|0|||
124849301|NCT01602315|449073162|FG005|Overall Study|Cross-over patients to combo treatment|16|||
124849302|NCT01602315|449073163|FG006|Overall Study|Cross-over patients to combo treatment|0|||
124849303|NCT00440271|449073165|FG000|Overall Study|Protocol Violation|1|||
124849304|NCT00440271|449073166|FG001|Overall Study|Protocol Violation|1|||
124849305|NCT00440271|449073165|FG000|Overall Study|Adverse Event|0|||
124849306|NCT00440271|449073166|FG001|Overall Study|Adverse Event|1|||
124849307|NCT00440271|449073165|FG000|Overall Study|Lost to Follow-up|1|||
124849308|NCT00440271|449073166|FG001|Overall Study|Lost to Follow-up|0|||
124849309|NCT00440271|449073165|FG000|Overall Study|Withdrawal by Subject|0|||
124849310|NCT00440271|449073166|FG001|Overall Study|Withdrawal by Subject|2|||
124849311|NCT00440271|449073165|FG000|Overall Study|Lack of Efficacy|0|||
124849312|NCT00440271|449073166|FG001|Overall Study|Lack of Efficacy|1|||
124849313|NCT00440271|449073165|FG000|Overall Study|Due to closure of trial|8|||
124849314|NCT00440271|449073166|FG001|Overall Study|Due to closure of trial|10|||
124849315|NCT00440271|449073165|FG000|Overall Study|Other|2|||
124849316|NCT00440271|449073166|FG001|Overall Study|Other|0|||
124849317|NCT00723801|449073167|FG000|Overall Study|Lost to Follow-up|1|||
124849318|NCT00723801|449073168|FG001|Overall Study|Lost to Follow-up|2|||
124849319|NCT00723801|449073167|FG000|Overall Study|Protocol Violation|2|||
124849320|NCT00723801|449073168|FG001|Overall Study|Protocol Violation|1|||
124849321|NCT01565993|449073171|FG000|Overall Study|Physician Decision|0|||
124849322|NCT01565993|449073172|FG001|Overall Study|Physician Decision|3|||
124849323|NCT01824303|449073173|FG000|Randomized Study|Withdrawal by Subject|1|||
124849324|NCT01824303|449073174|FG001|Randomized Study|Withdrawal by Subject|1|||
124849325|NCT01824303|449073173|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
124849326|NCT01824303|449073174|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
124849327|NCT04086472|449073175|FG000|Overall Study|Lost to Follow-up|1|||
124849328|NCT04086472|449073176|FG001|Overall Study|Lost to Follow-up|0|||
124849329|NCT04086472|449073177|FG002|Overall Study|Lost to Follow-up|0|||
124849330|NCT04086472|449073178|FG003|Overall Study|Lost to Follow-up|0|||
124849331|NCT04086472|449073179|FG004|Overall Study|Lost to Follow-up|1|||
124849332|NCT04086472|449073175|FG000|Overall Study|Physician Decision|0|||
124849333|NCT04086472|449073176|FG001|Overall Study|Physician Decision|1|||
124849334|NCT04086472|449073177|FG002|Overall Study|Physician Decision|1|||
124849335|NCT04086472|449073178|FG003|Overall Study|Physician Decision|0|||
124849336|NCT04086472|449073179|FG004|Overall Study|Physician Decision|0|||
124849337|NCT04086472|449073175|FG000|Overall Study|Withdrawal by Subject|1|||
124849338|NCT04086472|449073176|FG001|Overall Study|Withdrawal by Subject|1|||
124849339|NCT04086472|449073177|FG002|Overall Study|Withdrawal by Subject|1|||
124849340|NCT04086472|449073178|FG003|Overall Study|Withdrawal by Subject|0|||
124849341|NCT04086472|449073179|FG004|Overall Study|Withdrawal by Subject|0|||
124849342|NCT04086472|449073175|FG000|Overall Study|Various reasons|2|||
124849343|NCT04086472|449073176|FG001|Overall Study|Various reasons|0|||
124849344|NCT04086472|449073177|FG002|Overall Study|Various reasons|0|||
124849345|NCT04086472|449073178|FG003|Overall Study|Various reasons|3|||
124849346|NCT04086472|449073179|FG004|Overall Study|Various reasons|1|||
124849347|NCT00844545|449073180|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
124849348|NCT00844545|449073180|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
124849349|NCT00844545|449073180|FG000|Extension Treatment Period|Adverse Event|2|||
124849350|NCT00844545|449073180|FG000|Post Treatment Period|Withdrawal by Subject|1|||
124849351|NCT01743092|449073181|FG000|Overall Study|Lost to Follow-up|14|||
124849352|NCT01743092|449073182|FG001|Overall Study|Lost to Follow-up|15|||
124849353|NCT03586869|449073188|FG000|Overall Study|Progressive Disease|3|||
124849354|NCT00403455|449073189|FG000|Overall Study|Withdrawal by Subject|1|||
124849355|NCT02809976|449073196|FG000|Overall Study|Lost to Follow-up|1|||
124849356|NCT02809976|449073196|FG000|Overall Study|Withdrawal by Subject|1|||
124849357|NCT00087568|449073197|FG000|Overall Study|Adverse Event|4|||
124849358|NCT00087568|449073198|FG001|Overall Study|Adverse Event|0|||
124849359|NCT00087568|449073197|FG000|Overall Study|Withdrawal by Subject|1|||
124849360|NCT00087568|449073198|FG001|Overall Study|Withdrawal by Subject|1|||
124849361|NCT00087568|449073197|FG000|Overall Study|Lost to Follow-up|1|||
124849362|NCT00087568|449073198|FG001|Overall Study|Lost to Follow-up|0|||
124849363|NCT00087568|449073197|FG000|Overall Study|Lack of Efficacy|24|||
124849364|NCT00087568|449073198|FG001|Overall Study|Lack of Efficacy|1|||
124849365|NCT04394351|449073199|FG000|Part A (16 Weeks)|Adverse Event|1|||
124849366|NCT04394351|449073200|FG001|Part A (16 Weeks)|Adverse Event|0|||
124849367|NCT04394351|449073201|FG002|Part A (16 Weeks)|Adverse Event|0|||
124849368|NCT04394351|449073202|FG003|Part A (16 Weeks)|Adverse Event|0|||
124849369|NCT04394351|449073203|FG004|Part A (16 Weeks)|Adverse Event|0|||
124849370|NCT04394351|449073204|FG005|Part A (16 Weeks)|Adverse Event|0|||
124849371|NCT04394351|449073205|FG006|Part A (16 Weeks)|Adverse Event|0|||
124849372|NCT04394351|449073206|FG007|Part A (16 Weeks)|Adverse Event|0|||
124849373|NCT04394351|449073199|FG000|Part A (16 Weeks)|Physician Decision|0|||
124849374|NCT04394351|449073200|FG001|Part A (16 Weeks)|Physician Decision|1|||
124849375|NCT04394351|449073201|FG002|Part A (16 Weeks)|Physician Decision|0|||
124849376|NCT04394351|449073202|FG003|Part A (16 Weeks)|Physician Decision|0|||
124849377|NCT04394351|449073203|FG004|Part A (16 Weeks)|Physician Decision|0|||
124849378|NCT04394351|449073204|FG005|Part A (16 Weeks)|Physician Decision|0|||
124849379|NCT04394351|449073205|FG006|Part A (16 Weeks)|Physician Decision|0|||
124849380|NCT04394351|449073206|FG007|Part A (16 Weeks)|Physician Decision|0|||
124849381|NCT04394351|449073199|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
124849382|NCT04394351|449073200|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
124849383|NCT04394351|449073201|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
124849384|NCT04394351|449073202|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
124849385|NCT04394351|449073203|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
124849386|NCT04394351|449073204|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
124849387|NCT04394351|449073205|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
124849388|NCT04394351|449073206|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
124849389|NCT04394351|449073199|FG000|Part B (36 Weeks)|Adverse Event|0|||
124849390|NCT04394351|449073200|FG001|Part B (36 Weeks)|Adverse Event|0|||
124849391|NCT04394351|449073201|FG002|Part B (36 Weeks)|Adverse Event|0|||
124849392|NCT04394351|449073202|FG003|Part B (36 Weeks)|Adverse Event|0|||
124849393|NCT04394351|449073203|FG004|Part B (36 Weeks)|Adverse Event|0|||
124849394|NCT04394351|449073204|FG005|Part B (36 Weeks)|Adverse Event|0|||
124849395|NCT04394351|449073205|FG006|Part B (36 Weeks)|Adverse Event|1|||
124849396|NCT04394351|449073206|FG007|Part B (36 Weeks)|Adverse Event|0|||
124849397|NCT02738775|449073211|FG000|Overall Study|Withdrawal by Subject|0|||
124849398|NCT02738775|449073212|FG001|Overall Study|Withdrawal by Subject|1|||
124849399|NCT02738775|449073213|FG002|Overall Study|Withdrawal by Subject|0|||
124849400|NCT02738775|449073214|FG003|Overall Study|Withdrawal by Subject|0|||
124849401|NCT02738775|449073215|FG004|Overall Study|Withdrawal by Subject|0|||
124849402|NCT02738775|449073216|FG005|Overall Study|Withdrawal by Subject|0|||
124849403|NCT02738775|449073211|FG000|Overall Study|Adverse Event|0|||
124849404|NCT02738775|449073212|FG001|Overall Study|Adverse Event|0|||
124849405|NCT02738775|449073213|FG002|Overall Study|Adverse Event|0|||
124849406|NCT02738775|449073214|FG003|Overall Study|Adverse Event|1|||
124849407|NCT02738775|449073215|FG004|Overall Study|Adverse Event|0|||
124849408|NCT02738775|449073216|FG005|Overall Study|Adverse Event|0|||
124849409|NCT02738775|449073211|FG000|Overall Study|Pregnancy|0|||
124849410|NCT02738775|449073212|FG001|Overall Study|Pregnancy|1|||
124849411|NCT02738775|449073213|FG002|Overall Study|Pregnancy|0|||
124849412|NCT02738775|449073214|FG003|Overall Study|Pregnancy|0|||
124849413|NCT02738775|449073215|FG004|Overall Study|Pregnancy|0|||
124849414|NCT02738775|449073216|FG005|Overall Study|Pregnancy|0|||
124849415|NCT02738775|449073211|FG000|Overall Study|Missing|0|||
124849416|NCT02738775|449073212|FG001|Overall Study|Missing|0|||
124849417|NCT02738775|449073213|FG002|Overall Study|Missing|0|||
124849418|NCT02738775|449073214|FG003|Overall Study|Missing|0|||
124849419|NCT02738775|449073215|FG004|Overall Study|Missing|0|||
124849420|NCT02738775|449073216|FG005|Overall Study|Missing|1|||
124849421|NCT02992899|449073217|FG000|Overall Study|Withdrawal by Subject|1|||
124849422|NCT02992899|449073218|FG001|Overall Study|Withdrawal by Subject|0|||
124849423|NCT02992899|449073217|FG000|Overall Study|Lost to Follow-up|1|||
124849424|NCT02992899|449073218|FG001|Overall Study|Lost to Follow-up|3|||
124849425|NCT04574362|449073219|FG000|Overall Study|Other|0|||
124849426|NCT04574362|449073220|FG001|Overall Study|Other|5|||
124849427|NCT04574362|449073219|FG000|Overall Study|COVID-19|0|||
124849428|NCT04574362|449073220|FG001|Overall Study|COVID-19|1|||
124849429|NCT04574362|449073219|FG000|Overall Study|Adverse Event|1|||
124849430|NCT04574362|449073220|FG001|Overall Study|Adverse Event|1|||
124849431|NCT04574362|449073219|FG000|Overall Study|Withdrawal by Subject|2|||
124849432|NCT04574362|449073220|FG001|Overall Study|Withdrawal by Subject|4|||
124849433|NCT04574362|449073219|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
124849434|NCT04574362|449073220|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
124849435|NCT04574362|449073219|FG000|Overall Study|Participant refused to come to the hospital|1|||
124849436|NCT04574362|449073220|FG001|Overall Study|Participant refused to come to the hospital|0|||
124849437|NCT04574362|449073219|FG000|Overall Study|Participant refused the visit|1|||
124849438|NCT04574362|449073220|FG001|Overall Study|Participant refused the visit|0|||
124849439|NCT04574362|449073219|FG000|Overall Study|Participant quit early because of business trip|1|||
124849440|NCT04574362|449073220|FG001|Overall Study|Participant quit early because of business trip|0|||
124849441|NCT01060384|449073221|FG000|Overall Study|Withdrawal by Subject|0|||
124849442|NCT01060384|449073222|FG001|Overall Study|Withdrawal by Subject|1|||
124849443|NCT01060384|449073223|FG002|Overall Study|Withdrawal by Subject|0|||
124849444|NCT01060384|449073224|FG003|Overall Study|Withdrawal by Subject|0|||
124849445|NCT01060384|449073225|FG004|Overall Study|Withdrawal by Subject|0|||
124849446|NCT01060384|449073221|FG000|Overall Study|Death|0|||
124849447|NCT01060384|449073222|FG001|Overall Study|Death|0|||
124849448|NCT01060384|449073223|FG002|Overall Study|Death|0|||
124849449|NCT01060384|449073224|FG003|Overall Study|Death|0|||
124849450|NCT01060384|449073225|FG004|Overall Study|Death|1|||
124849451|NCT01060384|449073221|FG000|Overall Study|Intercurrent illness|0|||
124849452|NCT01060384|449073222|FG001|Overall Study|Intercurrent illness|0|||
124849453|NCT01060384|449073223|FG002|Overall Study|Intercurrent illness|0|||
124849454|NCT01060384|449073224|FG003|Overall Study|Intercurrent illness|0|||
124849455|NCT01060384|449073225|FG004|Overall Study|Intercurrent illness|1|||
124849456|NCT00812929|449073228|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
124849457|NCT00812929|449073229|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
124849458|NCT00812929|449073230|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
124849459|NCT00812929|449073231|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
124849460|NCT00812929|449073232|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
124849461|NCT00812929|449073233|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
124849462|NCT00812929|449073234|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
124849463|NCT00812929|449073235|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
124849464|NCT00812929|449073236|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
124849465|NCT00812929|449073237|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
124849466|NCT00812929|449073228|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
124849467|NCT00812929|449073229|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
124849468|NCT00812929|449073230|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
124849469|NCT00812929|449073231|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
124849470|NCT00812929|449073232|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
124849471|NCT00812929|449073233|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
124849472|NCT00812929|449073234|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
124849473|NCT00812929|449073235|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
124849474|NCT00812929|449073236|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
124849475|NCT00812929|449073237|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
124849476|NCT00812929|449073228|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
124849477|NCT00812929|449073229|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
124849478|NCT00812929|449073230|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
124849479|NCT00812929|449073231|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
124849480|NCT00812929|449073232|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
124849481|NCT00812929|449073233|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
124849482|NCT00812929|449073234|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
124849483|NCT00812929|449073235|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
124849484|NCT00812929|449073236|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
124849485|NCT00812929|449073237|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
124849486|NCT00211081|449073239|FG000|Overall Study|Withdrawal by Subject|2|||
124849487|NCT01332305|449073240|FG000|Overall Study|Adverse Event|1|||
124849488|NCT01332305|449073241|FG001|Overall Study|Adverse Event|4|||
124849489|NCT01332305|449073242|FG002|Overall Study|Adverse Event|6|||
124849490|NCT01332305|449073243|FG003|Overall Study|Adverse Event|3|||
124849491|NCT01332305|449073244|FG004|Overall Study|Adverse Event|5|||
124849492|NCT01332305|449073240|FG000|Overall Study|Withdrawal by Subject|6|||
124849493|NCT01332305|449073241|FG001|Overall Study|Withdrawal by Subject|5|||
124849494|NCT01332305|449073242|FG002|Overall Study|Withdrawal by Subject|4|||
124849495|NCT01332305|449073243|FG003|Overall Study|Withdrawal by Subject|1|||
124849496|NCT01332305|449073244|FG004|Overall Study|Withdrawal by Subject|0|||
124849497|NCT01332305|449073240|FG000|Overall Study|Lost to Follow-up|0|||
124849498|NCT01332305|449073241|FG001|Overall Study|Lost to Follow-up|2|||
124849499|NCT01332305|449073242|FG002|Overall Study|Lost to Follow-up|3|||
124849500|NCT01332305|449073243|FG003|Overall Study|Lost to Follow-up|2|||
124849501|NCT01332305|449073244|FG004|Overall Study|Lost to Follow-up|3|||
124849502|NCT01332305|449073240|FG000|Overall Study|Protocol Violation|1|||
124849503|NCT01332305|449073241|FG001|Overall Study|Protocol Violation|2|||
124849504|NCT01332305|449073242|FG002|Overall Study|Protocol Violation|1|||
124849505|NCT01332305|449073243|FG003|Overall Study|Protocol Violation|0|||
124849506|NCT01332305|449073244|FG004|Overall Study|Protocol Violation|3|||
124849507|NCT01332305|449073240|FG000|Overall Study|Withdrawal by Sponsor|1|||
124849508|NCT01332305|449073241|FG001|Overall Study|Withdrawal by Sponsor|0|||
124849509|NCT01332305|449073242|FG002|Overall Study|Withdrawal by Sponsor|0|||
124849510|NCT01332305|449073243|FG003|Overall Study|Withdrawal by Sponsor|1|||
124849511|NCT01332305|449073244|FG004|Overall Study|Withdrawal by Sponsor|1|||
124849512|NCT01332305|449073240|FG000|Overall Study|Treatment Failure|1|||
124849513|NCT01332305|449073241|FG001|Overall Study|Treatment Failure|1|||
124849514|NCT01332305|449073242|FG002|Overall Study|Treatment Failure|0|||
124849515|NCT01332305|449073243|FG003|Overall Study|Treatment Failure|0|||
124849516|NCT01332305|449073244|FG004|Overall Study|Treatment Failure|0|||
124849517|NCT01332305|449073240|FG000|Overall Study|Physician Decision|0|||
124849518|NCT01332305|449073241|FG001|Overall Study|Physician Decision|0|||
124849519|NCT01332305|449073242|FG002|Overall Study|Physician Decision|0|||
124849520|NCT01332305|449073243|FG003|Overall Study|Physician Decision|1|||
124849521|NCT01332305|449073244|FG004|Overall Study|Physician Decision|0|||
124849522|NCT01600040|449073245|FG000|Overall Study|Withdrawal by Subject|1|||
124849523|NCT04713748|449073246|FG000|Overall Study|Not enough kits allocated|35|||
124849524|NCT00113516|449073247|FG000|Part 1|Adverse Event|6|||
124849525|NCT00113516|449073248|FG001|Part 1|Adverse Event|0|||
124849526|NCT00113516|449073247|FG000|Part 1|Death|3|||
124849527|NCT00113516|449073248|FG001|Part 1|Death|0|||
124849528|NCT00113516|449073247|FG000|Part 1|Other|3|||
124849529|NCT00113516|449073248|FG001|Part 1|Other|0|||
124849530|NCT00113516|449073247|FG000|Part 1|Withdrawal by Subject|2|||
124849531|NCT00113516|449073248|FG001|Part 1|Withdrawal by Subject|0|||
124849532|NCT00113516|449073247|FG000|Part 1|Lack of Efficacy|2|||
124849533|NCT00113516|449073248|FG001|Part 1|Lack of Efficacy|0|||
124849534|NCT00113516|449073247|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
124849535|NCT00113516|449073248|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
124849536|NCT00113516|449073247|FG000|Part 1|Laboratory Abnormality|1|||
124849537|NCT00113516|449073248|FG001|Part 1|Laboratory Abnormality|0|||
124849538|NCT00113516|449073247|FG000|Part 1|Ongoing|1|||
124849539|NCT00113516|449073248|FG001|Part 1|Ongoing|0|||
124849540|NCT00113516|449073247|FG000|Part 1|Missing|65|||
124849541|NCT00113516|449073248|FG001|Part 1|Missing|0|||
124849542|NCT00113516|449073247|FG000|Part 2|Adverse Event|0|||
124849543|NCT00113516|449073248|FG001|Part 2|Adverse Event|16|||
124849544|NCT00113516|449073247|FG000|Part 2|Death|0|||
124849545|NCT00113516|449073248|FG001|Part 2|Death|5|||
124849546|NCT00113516|449073247|FG000|Part 2|Lack of Efficacy|0|||
124849547|NCT00113516|449073248|FG001|Part 2|Lack of Efficacy|37|||
124849548|NCT00113516|449073247|FG000|Part 2|Withdrawal by Subject|0|||
124849549|NCT00113516|449073248|FG001|Part 2|Withdrawal by Subject|3|||
124849550|NCT00113516|449073247|FG000|Part 2|Other|0|||
124849551|NCT00113516|449073248|FG001|Part 2|Other|3|||
124849552|NCT00113516|449073247|FG000|Part 2|Laboratory Abnormality|0|||
124849553|NCT00113516|449073248|FG001|Part 2|Laboratory Abnormality|1|||
124849554|NCT00113516|449073247|FG000|Part 2|Ongoing|0|||
124849555|NCT00113516|449073248|FG001|Part 2|Ongoing|1|||
124849556|NCT00642304|449073249|FG000|Overall Study|Adverse Event|1|||
124849557|NCT00642304|449073249|FG000|Overall Study|Death|1|||
124849558|NCT00642304|449073249|FG000|Overall Study|Blood transfusion|2|||
124849559|NCT00642304|449073249|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
124849560|NCT00642304|449073249|FG000|Overall Study|Transplantation|1|||
124849561|NCT00812812|449073259|FG000|Overall Study|Adverse Event|2|||
124849562|NCT00812812|449073260|FG001|Overall Study|Adverse Event|1|||
124849563|NCT00812812|449073259|FG000|Overall Study|Lack of Efficacy|1|||
124849564|NCT00812812|449073260|FG001|Overall Study|Lack of Efficacy|0|||
124849565|NCT00812812|449073259|FG000|Overall Study|Lost to Follow-up|0|||
124849566|NCT00812812|449073260|FG001|Overall Study|Lost to Follow-up|1|||
124849567|NCT00812812|449073259|FG000|Overall Study|Withdrawal by Subject|0|||
124849568|NCT00812812|449073260|FG001|Overall Study|Withdrawal by Subject|2|||
124849569|NCT03755765|449073261|FG000|Overall Study|Withdrawal by Subject|2|||
124849570|NCT03755765|449073262|FG001|Overall Study|Withdrawal by Subject|4|||
124849571|NCT03755765|449073263|FG002|Overall Study|Withdrawal by Subject|4|||
124849572|NCT00678691|449073269|FG000|Overall Study|Adverse Event|6|||
124849573|NCT00678691|449073270|FG001|Overall Study|Adverse Event|4|||
124849574|NCT01599650|449073278|FG000|Overall Study|Administrative issue|1|||
124849575|NCT01599650|449073279|FG001|Overall Study|Administrative issue|0|||
124849576|NCT01599650|449073280|FG002|Overall Study|Administrative issue|1|||
124849577|NCT01599650|449073278|FG000|Overall Study|Physician Decision|2|||
124849578|NCT01599650|449073279|FG001|Overall Study|Physician Decision|0|||
124849579|NCT01599650|449073280|FG002|Overall Study|Physician Decision|7|||
124849580|NCT01599650|449073278|FG000|Overall Study|Protocol Violation|0|||
124849581|NCT01599650|449073279|FG001|Overall Study|Protocol Violation|3|||
124849582|NCT01599650|449073280|FG002|Overall Study|Protocol Violation|0|||
124849583|NCT01599650|449073278|FG000|Overall Study|Death|2|||
124849584|NCT01599650|449073279|FG001|Overall Study|Death|1|||
124849585|NCT01599650|449073280|FG002|Overall Study|Death|2|||
124849586|NCT01599650|449073278|FG000|Overall Study|Lost to Follow-up|3|||
124849587|NCT01599650|449073279|FG001|Overall Study|Lost to Follow-up|3|||
124849588|NCT01599650|449073280|FG002|Overall Study|Lost to Follow-up|3|||
124849589|NCT01599650|449073278|FG000|Overall Study|Withdrawal by Subject|11|||
124849590|NCT01599650|449073279|FG001|Overall Study|Withdrawal by Subject|11|||
124849591|NCT01599650|449073280|FG002|Overall Study|Withdrawal by Subject|10|||
124849592|NCT01599650|449073278|FG000|Overall Study|Adverse Event|3|||
124849593|NCT01599650|449073279|FG001|Overall Study|Adverse Event|8|||
124849594|NCT01599650|449073280|FG002|Overall Study|Adverse Event|4|||
124849595|NCT00684424|449073284|FG000|Overall Study|Adverse Event|1|||
124849596|NCT00684424|449073284|FG000|Overall Study|Lost to Follow-up|2|||
124849597|NCT00684424|449073284|FG000|Overall Study|Other|2|||
124849598|NCT02410811|449073285|FG000|Overall Study|Withdrawal by Subject|0|||
124849599|NCT02410811|449073286|FG001|Overall Study|Withdrawal by Subject|0|||
124849600|NCT02410811|449073287|FG002|Overall Study|Withdrawal by Subject|1|||
124849601|NCT02410811|449073288|FG003|Overall Study|Withdrawal by Subject|0|||
124849602|NCT00057746|449073289|FG000|Overall Study|Withdrawal by Subject|0|||
124849603|NCT00057746|449073290|FG001|Overall Study|Withdrawal by Subject|0|||
124849604|NCT00057746|449073291|FG002|Overall Study|Withdrawal by Subject|1|||
124849605|NCT00439140|449073294|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
124849606|NCT00439140|449073295|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
124849607|NCT00439140|449073296|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
124849608|NCT00439140|449073294|FG000|Treatment Cycle 1|Personal reasons|0|||
124849609|NCT00439140|449073295|FG001|Treatment Cycle 1|Personal reasons|2|||
124849610|NCT00439140|449073296|FG002|Treatment Cycle 1|Personal reasons|0|||
124849611|NCT00439140|449073294|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
124849612|NCT00439140|449073295|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
124849613|NCT00439140|449073296|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
124849614|NCT00439140|449073294|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
124849615|NCT00439140|449073295|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
124849616|NCT00439140|449073296|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
124849617|NCT00439140|449073294|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
124849618|NCT00439140|449073295|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
124849619|NCT00439140|449073296|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
124849620|NCT04154631|449073297|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
124849621|NCT04154631|449073298|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
124849622|NCT01466192|449073308|FG000|Overall Study|Physician Decision|1|||
124849623|NCT01466192|449073308|FG000|Overall Study|Withdrawal by Subject|3|||
124849624|NCT00700011|449073311|FG000|Overall Study|Death|0|||
124849625|NCT00700011|449073312|FG001|Overall Study|Death|1|||
124849626|NCT00678561|449073313|FG000|Overall Study|Adverse Event|0|||
124849627|NCT00678561|449073314|FG001|Overall Study|Adverse Event|1|||
124849628|NCT00678561|449073315|FG002|Overall Study|Adverse Event|1|||
124849629|NCT00678561|449073316|FG003|Overall Study|Adverse Event|0|||
124849630|NCT00678561|449073317|FG004|Overall Study|Adverse Event|1|||
124849631|NCT00678561|449073318|FG005|Overall Study|Adverse Event|0|||
124849632|NCT00678561|449073319|FG006|Overall Study|Adverse Event|0|||
124849633|NCT00678561|449073320|FG007|Overall Study|Adverse Event|0|||
124849634|NCT00678561|449073313|FG000|Overall Study|Protocol Violation|0|||
124849635|NCT00678561|449073314|FG001|Overall Study|Protocol Violation|0|||
124849636|NCT00678561|449073315|FG002|Overall Study|Protocol Violation|0|||
124849637|NCT00678561|449073316|FG003|Overall Study|Protocol Violation|0|||
124849638|NCT00678561|449073317|FG004|Overall Study|Protocol Violation|1|||
124849639|NCT00678561|449073318|FG005|Overall Study|Protocol Violation|1|||
124849640|NCT00678561|449073319|FG006|Overall Study|Protocol Violation|0|||
124849641|NCT00678561|449073320|FG007|Overall Study|Protocol Violation|0|||
124849642|NCT00678561|449073313|FG000|Overall Study|Withdrawal by Subject|0|||
124849643|NCT00678561|449073314|FG001|Overall Study|Withdrawal by Subject|0|||
124849644|NCT00678561|449073315|FG002|Overall Study|Withdrawal by Subject|0|||
124849645|NCT00678561|449073316|FG003|Overall Study|Withdrawal by Subject|0|||
124849646|NCT00678561|449073317|FG004|Overall Study|Withdrawal by Subject|0|||
124849647|NCT00678561|449073318|FG005|Overall Study|Withdrawal by Subject|0|||
124849648|NCT00678561|449073319|FG006|Overall Study|Withdrawal by Subject|0|||
124849649|NCT00678561|449073320|FG007|Overall Study|Withdrawal by Subject|1|||
124849650|NCT00437034|449073321|FG000|Overall Study|Adverse Event|1|||
124849651|NCT00437034|449073321|FG000|Overall Study|Disease progression during treatment|5|||
124849652|NCT00853658|449073323|FG000|Overall Study|Death|713|||
124849653|NCT00853658|449073324|FG001|Overall Study|Death|768|||
124849654|NCT00853658|449073325|FG002|Overall Study|Death|753|||
124849655|NCT00853658|449073323|FG000|Overall Study|Lost to Follow-up|11|||
124849656|NCT00853658|449073324|FG001|Overall Study|Lost to Follow-up|6|||
124849657|NCT00853658|449073325|FG002|Overall Study|Lost to Follow-up|11|||
124849658|NCT00853658|449073323|FG000|Overall Study|H.A. Request|26|||
124849659|NCT00853658|449073324|FG001|Overall Study|H.A. Request|23|||
124849660|NCT00853658|449073325|FG002|Overall Study|H.A. Request|19|||
124849661|NCT00853658|449073323|FG000|Overall Study|IRB request|0|||
124849662|NCT00853658|449073324|FG001|Overall Study|IRB request|0|||
124849663|NCT00853658|449073325|FG002|Overall Study|IRB request|2|||
124849664|NCT00853658|449073323|FG000|Overall Study|Vital Status known (alive) at study end|2|||
124849665|NCT00853658|449073324|FG001|Overall Study|Vital Status known (alive) at study end|3|||
124849666|NCT00853658|449073325|FG002|Overall Study|Vital Status known (alive) at study end|3|||
124849667|NCT00853658|449073323|FG000|Overall Study|Vital Status unknown at study end|1|||
124849668|NCT00853658|449073324|FG001|Overall Study|Vital Status unknown at study end|1|||
124849669|NCT00853658|449073325|FG002|Overall Study|Vital Status unknown at study end|0|||
124849670|NCT00853658|449073323|FG000|Overall Study|Vital Status at study end N/A|8|||
124849671|NCT00853658|449073324|FG001|Overall Study|Vital Status at study end N/A|10|||
124849672|NCT00853658|449073325|FG002|Overall Study|Vital Status at study end N/A|10|||
124849673|NCT00853658|449073323|FG000|Overall Study|Patient's request|21|||
124849674|NCT00853658|449073324|FG001|Overall Study|Patient's request|17|||
124849675|NCT00853658|449073325|FG002|Overall Study|Patient's request|11|||
124849676|NCT00853658|449073323|FG000|Overall Study|Missing study completion information|5|||
124849677|NCT00853658|449073324|FG001|Overall Study|Missing study completion information|4|||
124849678|NCT00853658|449073325|FG002|Overall Study|Missing study completion information|6|||
124849679|NCT01976845|449073326|FG000|Overall Study|Physician Decision|8|||
124849680|NCT01976845|449073327|FG001|Overall Study|Physician Decision|8|||
124849681|NCT01976845|449073328|FG002|Overall Study|Physician Decision|3|||
124849682|NCT03246529|449073330|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
124849683|NCT03246529|449073331|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
124849684|NCT03246529|449073332|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
124849685|NCT03246529|449073330|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
124849686|NCT03246529|449073331|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
124849687|NCT03246529|449073332|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
124849688|NCT03246529|449073330|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
124849689|NCT03246529|449073331|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
124849690|NCT03246529|449073332|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
124849691|NCT03246529|449073330|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
124849692|NCT03246529|449073331|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
124849693|NCT03246529|449073332|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
124849694|NCT03246529|449073330|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
124849695|NCT03246529|449073331|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
124849696|NCT03246529|449073332|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
124849697|NCT03246529|449073330|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
124849698|NCT03246529|449073331|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
124849699|NCT03246529|449073332|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
124849700|NCT03246529|449073330|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
124849701|NCT03246529|449073331|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
124849702|NCT03246529|449073332|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
124849703|NCT03246529|449073330|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
124849704|NCT03246529|449073331|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
124849705|NCT03246529|449073332|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
124849706|NCT03246529|449073330|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
124849707|NCT03246529|449073331|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
124849708|NCT03246529|449073332|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
124849709|NCT01209624|449073333|FG000|Overall Study|Death|2|||
124849710|NCT01209624|449073333|FG000|Overall Study|Adverse Event|13|||
124849711|NCT01209624|449073333|FG000|Overall Study|Lack of Efficacy|17|||
124849712|NCT01209624|449073333|FG000|Overall Study|Lost to Follow-up|290|||
124849713|NCT01209624|449073333|FG000|Overall Study|Other|4|||
124849714|NCT00441337|449073338|FG000|Overall Study|Disease Progression|6|||
124849715|NCT00441337|449073339|FG001|Overall Study|Disease Progression|6|||
124849716|NCT00441337|449073340|FG002|Overall Study|Disease Progression|4|||
124849717|NCT00441337|449073341|FG003|Overall Study|Disease Progression|18|||
124849718|NCT00441337|449073338|FG000|Overall Study|Lost to Follow-up|0|||
124849719|NCT00441337|449073339|FG001|Overall Study|Lost to Follow-up|0|||
124849720|NCT00441337|449073340|FG002|Overall Study|Lost to Follow-up|0|||
124849721|NCT00441337|449073341|FG003|Overall Study|Lost to Follow-up|1|||
124849722|NCT00441337|449073338|FG000|Overall Study|Sponsor Decision|0|||
124849723|NCT00441337|449073339|FG001|Overall Study|Sponsor Decision|0|||
124849724|NCT00441337|449073340|FG002|Overall Study|Sponsor Decision|1|||
124849725|NCT00441337|449073341|FG003|Overall Study|Sponsor Decision|2|||
124849726|NCT00441337|449073338|FG000|Overall Study|Did not meet inclusion criteria|0|||
124849727|NCT00441337|449073339|FG001|Overall Study|Did not meet inclusion criteria|0|||
124849728|NCT00441337|449073340|FG002|Overall Study|Did not meet inclusion criteria|1|||
124849729|NCT00441337|449073341|FG003|Overall Study|Did not meet inclusion criteria|0|||
124849730|NCT06748040|449073342|FG000|Overall Study|Death|3|||
124849731|NCT06748040|449073343|FG001|Overall Study|Death|4|||
124849732|NCT06748040|449073342|FG000|Overall Study|Lost to Follow-up|134|||
124849733|NCT06748040|449073343|FG001|Overall Study|Lost to Follow-up|132|||
124849734|NCT06748040|449073342|FG000|Overall Study|Withdrawal by Subject|3|||
124849735|NCT06748040|449073343|FG001|Overall Study|Withdrawal by Subject|5|||
124849736|NCT00827372|449075874|FG000|Overall Study|Adverse Event|5|||
124849737|NCT00827372|449075874|FG000|Overall Study|Lack of Efficacy|3|||
124849738|NCT02293005|449075875|FG000|Overall Study|Adverse Event|2|||
124849739|NCT02293005|449075875|FG000|Overall Study|Death|4|||
124849740|NCT02293005|449075875|FG000|Overall Study|Lost to Follow-up|1|||
124849741|NCT02293005|449075875|FG000|Overall Study|Withdrawal by Subject|2|||
124849742|NCT02293005|449075875|FG000|Overall Study|Progression|17|||
124849743|NCT00941733|449075880|FG000|Overall Study|Death|24|||
124849744|NCT00941733|449075881|FG001|Overall Study|Death|10|||
124849745|NCT00941733|449075880|FG000|Overall Study|Withdrawal by Subject|14|||
124849746|NCT00941733|449075881|FG001|Overall Study|Withdrawal by Subject|6|||
124849747|NCT00941733|449075880|FG000|Overall Study|Adverse Event|20|||
124849748|NCT00941733|449075881|FG001|Overall Study|Adverse Event|4|||
124849749|NCT00941733|449075880|FG000|Overall Study|Lost to Follow-up|1|||
124849750|NCT00941733|449075881|FG001|Overall Study|Lost to Follow-up|2|||
124849751|NCT00941733|449075880|FG000|Overall Study|Protocol Violation|15|||
124849752|NCT00941733|449075881|FG001|Overall Study|Protocol Violation|6|||
124849753|NCT00612066|449075884|FG000|Overall Study|Adverse Event|1|||
124849754|NCT00630877|449075885|FG000|Overall Study|Adverse Event|11|||
124849755|NCT00630877|449075886|FG001|Overall Study|Adverse Event|8|||
124849756|NCT00630877|449075887|FG002|Overall Study|Adverse Event|7|||
124849757|NCT00630877|449075885|FG000|Overall Study|Withdrawal by Subject|3|||
124849758|NCT00630877|449075886|FG001|Overall Study|Withdrawal by Subject|4|||
124849759|NCT00630877|449075887|FG002|Overall Study|Withdrawal by Subject|0|||
124849760|NCT00630877|449075885|FG000|Overall Study|Lost to Follow-up|2|||
124849761|NCT00630877|449075886|FG001|Overall Study|Lost to Follow-up|0|||
124849762|NCT00630877|449075887|FG002|Overall Study|Lost to Follow-up|0|||
124849763|NCT00630877|449075885|FG000|Overall Study|Noncompliance|2|||
124849764|NCT00630877|449075886|FG001|Overall Study|Noncompliance|3|||
124849765|NCT00630877|449075887|FG002|Overall Study|Noncompliance|1|||
124849766|NCT00630877|449075885|FG000|Overall Study|Protocol violation|1|||
124849767|NCT00630877|449075886|FG001|Overall Study|Protocol violation|0|||
124849768|NCT00630877|449075887|FG002|Overall Study|Protocol violation|1|||
124849769|NCT00630877|449075885|FG000|Overall Study|Personal reasons|0|||
124849770|NCT00630877|449075886|FG001|Overall Study|Personal reasons|0|||
124849771|NCT00630877|449075887|FG002|Overall Study|Personal reasons|1|||
124849772|NCT01529645|449075888|FG000|Overall Study|Lost to Follow-up|0|||
124849773|NCT01529645|449075889|FG001|Overall Study|Lost to Follow-up|1|||
124849774|NCT01529645|449075890|FG002|Overall Study|Lost to Follow-up|1|||
124849775|NCT01529645|449075891|FG003|Overall Study|Lost to Follow-up|1|||
124849776|NCT01529645|449075892|FG004|Overall Study|Lost to Follow-up|1|||
124849777|NCT01529645|449075893|FG005|Overall Study|Lost to Follow-up|0|||
124849778|NCT01529645|449075894|FG006|Overall Study|Lost to Follow-up|2|||
124849779|NCT01529645|449075895|FG007|Overall Study|Lost to Follow-up|0|||
124849780|NCT01529645|449075896|FG008|Overall Study|Lost to Follow-up|1|||
124849781|NCT01529645|449075897|FG009|Overall Study|Lost to Follow-up|0|||
124849782|NCT01529645|449075888|FG000|Overall Study|SAE - Premature contractions|0|||
124849783|NCT01529645|449075889|FG001|Overall Study|SAE - Premature contractions|0|||
124849784|NCT01529645|449075890|FG002|Overall Study|SAE - Premature contractions|1|||
124849785|NCT01529645|449075891|FG003|Overall Study|SAE - Premature contractions|0|||
124849786|NCT01529645|449075892|FG004|Overall Study|SAE - Premature contractions|0|||
124849787|NCT01529645|449075893|FG005|Overall Study|SAE - Premature contractions|0|||
124849788|NCT01529645|449075894|FG006|Overall Study|SAE - Premature contractions|0|||
124849789|NCT01529645|449075895|FG007|Overall Study|SAE - Premature contractions|0|||
124849790|NCT01529645|449075896|FG008|Overall Study|SAE - Premature contractions|0|||
124849791|NCT01529645|449075897|FG009|Overall Study|SAE - Premature contractions|0|||
124849792|NCT01529645|449075888|FG000|Overall Study|Withdrawal by Subject|2|||
124849793|NCT01529645|449075889|FG001|Overall Study|Withdrawal by Subject|0|||
124849794|NCT01529645|449075890|FG002|Overall Study|Withdrawal by Subject|0|||
124849795|NCT01529645|449075891|FG003|Overall Study|Withdrawal by Subject|1|||
124849796|NCT01529645|449075892|FG004|Overall Study|Withdrawal by Subject|1|||
124849797|NCT01529645|449075893|FG005|Overall Study|Withdrawal by Subject|1|||
124849798|NCT01529645|449075894|FG006|Overall Study|Withdrawal by Subject|0|||
124849799|NCT01529645|449075895|FG007|Overall Study|Withdrawal by Subject|0|||
124849800|NCT01529645|449075896|FG008|Overall Study|Withdrawal by Subject|0|||
124849801|NCT01529645|449075897|FG009|Overall Study|Withdrawal by Subject|0|||
124849802|NCT00048724|449075898|FG000|Overall Study|Adverse Event|53|||
124849803|NCT00048724|449075899|FG001|Overall Study|Adverse Event|12|||
124849804|NCT00048724|449075898|FG000|Overall Study|Withdrawal by Subject|34|||
124849805|NCT00048724|449075899|FG001|Overall Study|Withdrawal by Subject|54|||
124849806|NCT00048724|449075898|FG000|Overall Study|Lost to Follow-up|5|||
124849807|NCT00048724|449075899|FG001|Overall Study|Lost to Follow-up|5|||
124849808|NCT00048724|449075898|FG000|Overall Study|Protocol-defined Clinical Event|17|||
124849809|NCT00048724|449075899|FG001|Overall Study|Protocol-defined Clinical Event|32|||
124849810|NCT00048724|449075898|FG000|Overall Study|Noncompliance With Protocol|4|||
124849811|NCT00048724|449075899|FG001|Overall Study|Noncompliance With Protocol|12|||
124849812|NCT00048724|449075898|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
124849813|NCT00048724|449075899|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
124849814|NCT00048724|449075898|FG000|Overall Study|Administrative|1|||
124849815|NCT00048724|449075899|FG001|Overall Study|Administrative|1|||
124849816|NCT02863354|449075902|FG000|Year 1|Lost to Follow-up|1|||
124849817|NCT02863354|449075903|FG001|Year 1|Lost to Follow-up|1|||
124849818|NCT02863354|449075902|FG000|Year 1|Withdrawal by Subject|3|||
124849819|NCT02863354|449075903|FG001|Year 1|Withdrawal by Subject|0|||
124849820|NCT02863354|449075902|FG000|Year 1|Death|0|||
124849821|NCT02863354|449075903|FG001|Year 1|Death|1|||
124849822|NCT02863354|449075902|FG000|Year 2|Lost to Follow-up|2|||
124849823|NCT02863354|449075903|FG001|Year 2|Lost to Follow-up|2|||
124849824|NCT03235024|449075904|FG000|Overall Study|Adverse Event|2|||
124849825|NCT03235024|449075905|FG001|Overall Study|Adverse Event|2|||
124849826|NCT03235024|449075904|FG000|Overall Study|Death|1|||
124849827|NCT03235024|449075905|FG001|Overall Study|Death|0|||
124849828|NCT03235024|449075904|FG000|Overall Study|Lost to Follow-up|2|||
124849829|NCT03235024|449075905|FG001|Overall Study|Lost to Follow-up|5|||
124849830|NCT03235024|449075904|FG000|Overall Study|Protocol Violation|1|||
124849831|NCT03235024|449075905|FG001|Overall Study|Protocol Violation|0|||
124849832|NCT03235024|449075904|FG000|Overall Study|Withdrawal by Subject|0|||
124849833|NCT03235024|449075905|FG001|Overall Study|Withdrawal by Subject|3|||
124849834|NCT01632800|449075906|FG000|Overall Study|Subject did not fit in apparatus|1|||
124849835|NCT01243944|449075907|FG000|Overall Study|Adverse Event|15|||
124849836|NCT01243944|449075908|FG001|Overall Study|Adverse Event|13|||
124849837|NCT01243944|449075907|FG000|Overall Study|Lost to Follow-up|2|||
124849838|NCT01243944|449075908|FG001|Overall Study|Lost to Follow-up|1|||
124849839|NCT01243944|449075907|FG000|Overall Study|Physician Decision|2|||
124849840|NCT01243944|449075908|FG001|Overall Study|Physician Decision|7|||
124849841|NCT01243944|449075907|FG000|Overall Study|Disease progression|12|||
124849842|NCT01243944|449075908|FG001|Overall Study|Disease progression|11|||
124849843|NCT01243944|449075907|FG000|Overall Study|Protocol deviation|1|||
124849844|NCT01243944|449075908|FG001|Overall Study|Protocol deviation|1|||
124849845|NCT01243944|449075907|FG000|Overall Study|Participant decision|10|||
124849846|NCT01243944|449075908|FG001|Overall Study|Participant decision|15|||
124849847|NCT01243944|449075907|FG000|Overall Study|Death|2|||
124849848|NCT01243944|449075908|FG001|Overall Study|Death|3|||
124849849|NCT01243944|449075907|FG000|Overall Study|Non-compliance with study treatment|1|||
124849850|NCT01243944|449075908|FG001|Overall Study|Non-compliance with study treatment|0|||
124849851|NCT01416805|449075914|FG000|Overall Study|Lost to Follow-up|4|||
124849852|NCT01416805|449075915|FG001|Overall Study|Lost to Follow-up|4|||
124849853|NCT02802345|449075916|FG000|Overall Study|Not Treated|0|||
124849854|NCT02802345|449075917|FG001|Overall Study|Not Treated|1|||
124849855|NCT02802345|449075916|FG000|Overall Study|Adverse Event|28|||
124849856|NCT02802345|449075917|FG001|Overall Study|Adverse Event|20|||
124849857|NCT02802345|449075916|FG000|Overall Study|Withdrawal by Subject|3|||
124849858|NCT02802345|449075917|FG001|Overall Study|Withdrawal by Subject|3|||
124849859|NCT02802345|449075916|FG000|Overall Study|Protocol Violation|0|||
124849860|NCT02802345|449075917|FG001|Overall Study|Protocol Violation|1|||
124849861|NCT02802345|449075916|FG000|Overall Study|Other than listed|1|||
124849862|NCT02802345|449075917|FG001|Overall Study|Other than listed|5|||
124849863|NCT04632940|449075918|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
124849864|NCT04632940|449075919|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
124849865|NCT04632940|449075918|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
124849866|NCT04632940|449075919|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
124849867|NCT04632940|449075918|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
124849868|NCT04632940|449075919|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
124849869|NCT04632940|449075918|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
124849870|NCT04632940|449075919|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
124849871|NCT04632940|449075918|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
124849872|NCT04632940|449075919|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
124849873|NCT04632940|449075918|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
124849874|NCT04632940|449075919|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
124849875|NCT04632940|449075918|FG000|OLE Period (52 Weeks)|Other than specified|0|||
124849876|NCT04632940|449075919|FG001|OLE Period (52 Weeks)|Other than specified|1|||
124849877|NCT04632940|449075918|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
124849878|NCT04632940|449075919|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
124849879|NCT05857527|449075922|FG000|Overall Study|Withdrawal by Subject|0|||
124849880|NCT05857527|449075923|FG001|Overall Study|Withdrawal by Subject|1|||
124849881|NCT02799082|449075926|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
124849882|NCT02799082|449075927|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
124849883|NCT02799082|449075926|FG000|Overall Study|Protocol Violation|0|||
124849884|NCT02799082|449075927|FG001|Overall Study|Protocol Violation|1|||
124849885|NCT01748994|449075932|FG000|Overall Study|Lost to Follow-up|8|||
124849886|NCT01748994|449075933|FG001|Overall Study|Lost to Follow-up|6|||
124849887|NCT02520531|449075941|FG000|Overall Study|Revision of study device components|2|||
124849888|NCT02520531|449075942|FG001|Overall Study|Revision of study device components|2|||
124849889|NCT02520531|449075941|FG000|Overall Study|Death|1|||
124849890|NCT02520531|449075942|FG001|Overall Study|Death|2|||
124849891|NCT02520531|449075941|FG000|Overall Study|Lost to Follow-up|1|||
124849892|NCT02520531|449075942|FG001|Overall Study|Lost to Follow-up|1|||
124849893|NCT02520531|449075941|FG000|Overall Study|Meet exclusion criterion|0|||
124849894|NCT02520531|449075942|FG001|Overall Study|Meet exclusion criterion|1|||
124849895|NCT02520531|449075941|FG000|Overall Study|Withdrawal by Subject|1|||
124849896|NCT02520531|449075942|FG001|Overall Study|Withdrawal by Subject|0|||
124849897|NCT02520531|449075941|FG000|Overall Study|Not study device|1|||
124849898|NCT02520531|449075942|FG001|Overall Study|Not study device|0|||
124849899|NCT01723904|449075945|FG000|Overall Study|Noncompliant|3|||
124849900|NCT01723904|449075945|FG000|Overall Study|Adverse Event|5|||
124849901|NCT01723904|449075945|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
124849902|NCT03251924|449075946|FG000|Overall Study|Disease Progression|6|||
124849903|NCT03251924|449075947|FG001|Overall Study|Disease Progression|6|||
124849904|NCT03251924|449075948|FG002|Overall Study|Disease Progression|7|||
124849905|NCT03251924|449075949|FG003|Overall Study|Disease Progression|8|||
124849906|NCT03251924|449075950|FG004|Overall Study|Disease Progression|8|||
124849907|NCT03251924|449075951|FG005|Overall Study|Disease Progression|7|||
124849908|NCT03251924|449075952|FG006|Overall Study|Disease Progression|6|||
124849909|NCT03251924|449075953|FG007|Overall Study|Disease Progression|10|||
124849910|NCT03251924|449075954|FG008|Overall Study|Disease Progression|6|||
124849911|NCT03251924|449075946|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
124849912|NCT03251924|449075947|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
124849913|NCT03251924|449075948|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
124849914|NCT03251924|449075949|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
124849915|NCT03251924|449075950|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
124849916|NCT03251924|449075951|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
124849917|NCT03251924|449075952|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
124849918|NCT03251924|449075953|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
124849919|NCT03251924|449075954|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
124849920|NCT03251924|449075946|FG000|Overall Study|Death|0|||
124849921|NCT03251924|449075947|FG001|Overall Study|Death|1|||
124849922|NCT03251924|449075948|FG002|Overall Study|Death|0|||
124849923|NCT03251924|449075949|FG003|Overall Study|Death|1|||
124849924|NCT03251924|449075950|FG004|Overall Study|Death|1|||
124849925|NCT03251924|449075951|FG005|Overall Study|Death|1|||
124849926|NCT03251924|449075952|FG006|Overall Study|Death|0|||
124849927|NCT03251924|449075953|FG007|Overall Study|Death|0|||
124849928|NCT03251924|449075954|FG008|Overall Study|Death|0|||
124849929|NCT03251924|449075946|FG000|Overall Study|Study Drug Toxicity|0|||
124849930|NCT03251924|449075947|FG001|Overall Study|Study Drug Toxicity|0|||
124849931|NCT03251924|449075948|FG002|Overall Study|Study Drug Toxicity|0|||
124849932|NCT03251924|449075949|FG003|Overall Study|Study Drug Toxicity|1|||
124849933|NCT03251924|449075950|FG004|Overall Study|Study Drug Toxicity|0|||
124849934|NCT03251924|449075951|FG005|Overall Study|Study Drug Toxicity|0|||
124849935|NCT03251924|449075952|FG006|Overall Study|Study Drug Toxicity|0|||
124849936|NCT03251924|449075953|FG007|Overall Study|Study Drug Toxicity|0|||
124849937|NCT03251924|449075954|FG008|Overall Study|Study Drug Toxicity|1|||
124849938|NCT03251924|449075946|FG000|Overall Study|Other Reasons|0|||
124849939|NCT03251924|449075947|FG001|Overall Study|Other Reasons|0|||
124849940|NCT03251924|449075948|FG002|Overall Study|Other Reasons|0|||
124849941|NCT03251924|449075949|FG003|Overall Study|Other Reasons|0|||
124849942|NCT03251924|449075950|FG004|Overall Study|Other Reasons|0|||
124849943|NCT03251924|449075951|FG005|Overall Study|Other Reasons|0|||
124849944|NCT03251924|449075952|FG006|Overall Study|Other Reasons|0|||
124849945|NCT03251924|449075953|FG007|Overall Study|Other Reasons|0|||
124849946|NCT03251924|449075954|FG008|Overall Study|Other Reasons|1|||
124849947|NCT03251924|449075946|FG000|Overall Study|Participant request to discontinue study treatment|0|||
124849948|NCT03251924|449075947|FG001|Overall Study|Participant request to discontinue study treatment|0|||
124849949|NCT03251924|449075948|FG002|Overall Study|Participant request to discontinue study treatment|0|||
124849950|NCT03251924|449075949|FG003|Overall Study|Participant request to discontinue study treatment|0|||
124849951|NCT03251924|449075950|FG004|Overall Study|Participant request to discontinue study treatment|0|||
124849952|NCT03251924|449075951|FG005|Overall Study|Participant request to discontinue study treatment|0|||
124849953|NCT03251924|449075952|FG006|Overall Study|Participant request to discontinue study treatment|0|||
124849954|NCT03251924|449075953|FG007|Overall Study|Participant request to discontinue study treatment|1|||
124849955|NCT03251924|449075954|FG008|Overall Study|Participant request to discontinue study treatment|0|||
124849956|NCT01193556|449075955|FG000|Overall Study|Study termination|26|||
124849957|NCT01193556|449075956|FG001|Overall Study|Study termination|25|||
124849958|NCT02617589|449075957|FG000|Randomization|Request to Discontinue Study Treatment|1|||
124849959|NCT02617589|449075958|FG001|Randomization|Request to Discontinue Study Treatment|3|||
124849960|NCT02617589|449075957|FG000|Randomization|Participant Withdrew Consent|1|||
124849961|NCT02617589|449075958|FG001|Randomization|Participant Withdrew Consent|2|||
124849962|NCT02617589|449075957|FG000|Treatment|Other Reasons|3|||
124849963|NCT02617589|449075958|FG001|Treatment|Other Reasons|3|||
124849964|NCT02617589|449075957|FG000|Treatment|Poor/Non Compliance|1|||
124849965|NCT02617589|449075958|FG001|Treatment|Poor/Non Compliance|1|||
124849966|NCT02617589|449075957|FG000|Treatment|Maximum Clinical Benefit|0|||
124849967|NCT02617589|449075958|FG001|Treatment|Maximum Clinical Benefit|2|||
124849968|NCT02617589|449075957|FG000|Treatment|Participant Withdrew Consent|2|||
124849969|NCT02617589|449075958|FG001|Treatment|Participant Withdrew Consent|6|||
124849970|NCT02617589|449075957|FG000|Treatment|Participant Request to Discontinue|12|||
124849971|NCT02617589|449075958|FG001|Treatment|Participant Request to Discontinue|21|||
124849972|NCT02617589|449075957|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
124849973|NCT02617589|449075958|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
124849974|NCT02617589|449075957|FG000|Treatment|Death|1|||
124849975|NCT02617589|449075958|FG001|Treatment|Death|1|||
124849976|NCT02617589|449075957|FG000|Treatment|Study Drug Toxicity|27|||
124849977|NCT02617589|449075958|FG001|Treatment|Study Drug Toxicity|20|||
124849978|NCT02617589|449075957|FG000|Treatment|Disease Progression|216|||
124849979|NCT02617589|449075958|FG001|Treatment|Disease Progression|136|||
124849980|NCT00835406|449075963|FG000|Period: First Intervention|Adverse Event|0|||
124849981|NCT00835406|449075964|FG001|Period: First Intervention|Adverse Event|1|||
124849982|NCT00835406|449075963|FG000|Period: First Intervention|Withdrawal by Subject|2|||
124849983|NCT00835406|449075964|FG001|Period: First Intervention|Withdrawal by Subject|0|||
124849984|NCT00835406|449075963|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
124849985|NCT00835406|449075964|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
124849986|NCT02138214|449075967|FG000|Overall Study|Withdrawal by Subject|0|||
124849987|NCT02138214|449075968|FG001|Overall Study|Withdrawal by Subject|1|||
124849988|NCT02138214|449075969|FG002|Overall Study|Withdrawal by Subject|0|||
124849989|NCT02138214|449075967|FG000|Overall Study|Lost to Follow-up|0|||
124849990|NCT02138214|449075968|FG001|Overall Study|Lost to Follow-up|2|||
124849991|NCT02138214|449075969|FG002|Overall Study|Lost to Follow-up|4|||
124849992|NCT02138214|449075967|FG000|Overall Study|Screen Failure|0|||
124849993|NCT02138214|449075968|FG001|Overall Study|Screen Failure|1|||
124849994|NCT02138214|449075969|FG002|Overall Study|Screen Failure|0|||
124849995|NCT02158039|449075972|FG000|Overall Study|Withdrawal by Subject|1|||
124849996|NCT02158039|449075972|FG000|Overall Study|Screen Failure|9|||
124849997|NCT03509948|449075984|FG000|Overall Study|Protocol Violation|0|||
124849998|NCT03509948|449075985|FG001|Overall Study|Protocol Violation|1|||
124849999|NCT01334866|449075986|FG000|Overall Study|Withdrawal by Subject|10|||
124850000|NCT01334866|449075986|FG000|Overall Study|Lost to Follow-up|3|||
124850001|NCT01334866|449075986|FG000|Overall Study|Physician Decision|3|||
124850002|NCT01334866|449075986|FG000|Overall Study|medically necessary prior to procedure|2|||
124850003|NCT01334866|449075986|FG000|Overall Study|medically necessary post-procedure|1|||
124850004|NCT01071512|449075993|FG000|Overall Study|Adverse Event|1|||
124850005|NCT01071512|449075993|FG000|Overall Study|Development of antibodies to drug|2|||
124850006|NCT01071512|449075993|FG000|Overall Study|positive anti-JC virus antibody test|2|||
124850007|NCT00799617|449076002|FG000|Main Testosterone Trial|Randomized in error|1|||
124850008|NCT00799617|449076003|FG001|Main Testosterone Trial|Randomized in error|1|||
124850009|NCT00799617|449076002|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
124850010|NCT00799617|449076003|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
124850011|NCT00799617|449076002|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
124850012|NCT00799617|449076003|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
124850013|NCT00799617|449076002|FG000|Sexual Funtion Trial|No Baseline Data|4|||
124850014|NCT00799617|449076003|FG001|Sexual Funtion Trial|No Baseline Data|7|||
124850015|NCT00799617|449076002|FG000|Physical Function Trial|Lost to Follow-up|6|||
124850016|NCT00799617|449076003|FG001|Physical Function Trial|Lost to Follow-up|11|||
124850017|NCT00799617|449076002|FG000|Vitality Trial|Lost to Follow-up|7|||
124850018|NCT00799617|449076003|FG001|Vitality Trial|Lost to Follow-up|22|||
124850019|NCT00799617|449076002|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
124850020|NCT00799617|449076003|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
124850021|NCT00799617|449076002|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
124850022|NCT00799617|449076003|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
124850023|NCT00799617|449076002|FG000|Bone Trial|Month 12 scan not available|6|||
124850024|NCT00799617|449076003|FG001|Bone Trial|Month 12 scan not available|16|||
124850025|NCT00799617|449076002|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
124850026|NCT00799617|449076003|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
124850027|NCT00799617|449076002|FG000|Anemia Trial|Withdrawal by Subject|3|||
124850028|NCT00799617|449076003|FG001|Anemia Trial|Withdrawal by Subject|3|||
124850029|NCT04545515|449076004|FG000|Overall Study|Adverse Event|1|||
124850030|NCT04545515|449076004|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
124850031|NCT04545515|449076004|FG000|Overall Study|Commercial drug is available for participant|7|||
124850032|NCT00958880|449076005|FG000|Overall Study|Lost to Follow-up|2|||
124850033|NCT00958880|449076006|FG001|Overall Study|Lost to Follow-up|2|||
124850034|NCT01848990|449076007|FG000|Overall Study|Adverse Event|6|||
124850035|NCT01848990|449076008|FG001|Overall Study|Adverse Event|2|||
124850036|NCT01848990|449076009|FG002|Overall Study|Adverse Event|0|||
124850037|NCT01848990|449076007|FG000|Overall Study|Lost to Follow-up|6|||
124850038|NCT01848990|449076008|FG001|Overall Study|Lost to Follow-up|2|||
124850039|NCT01848990|449076009|FG002|Overall Study|Lost to Follow-up|2|||
124850040|NCT01848990|449076007|FG000|Overall Study|Protocol Violation|1|||
124850041|NCT01848990|449076008|FG001|Overall Study|Protocol Violation|1|||
124850042|NCT01848990|449076009|FG002|Overall Study|Protocol Violation|0|||
124850043|NCT01848990|449076007|FG000|Overall Study|Withdrawal by Subject|29|||
124850044|NCT01848990|449076008|FG001|Overall Study|Withdrawal by Subject|10|||
124850045|NCT01848990|449076009|FG002|Overall Study|Withdrawal by Subject|11|||
124850046|NCT01848990|449076007|FG000|Overall Study|Physician Decision|1|||
124850047|NCT01848990|449076008|FG001|Overall Study|Physician Decision|1|||
124850048|NCT01848990|449076009|FG002|Overall Study|Physician Decision|0|||
124850049|NCT01848990|449076007|FG000|Overall Study|Non Compliance|1|||
124850050|NCT01848990|449076008|FG001|Overall Study|Non Compliance|0|||
124850051|NCT01848990|449076009|FG002|Overall Study|Non Compliance|0|||
124850052|NCT01848990|449076007|FG000|Overall Study|Death|1|||
124850053|NCT01848990|449076008|FG001|Overall Study|Death|0|||
124850054|NCT01848990|449076009|FG002|Overall Study|Death|1|||
124850055|NCT01848990|449076007|FG000|Overall Study|Other|1|||
124850056|NCT01848990|449076008|FG001|Overall Study|Other|4|||
124850057|NCT01848990|449076009|FG002|Overall Study|Other|2|||
124850058|NCT01712984|449076010|FG000|Overall Study|Adverse Event|0|||
124850059|NCT01712984|449076011|FG001|Overall Study|Adverse Event|0|||
124850060|NCT01712984|449076012|FG002|Overall Study|Adverse Event|1|||
124850061|NCT01712984|449076010|FG000|Overall Study|Protocol Violation|2|||
124850062|NCT01712984|449076011|FG001|Overall Study|Protocol Violation|0|||
124850063|NCT01712984|449076012|FG002|Overall Study|Protocol Violation|1|||
124850064|NCT01712984|449076010|FG000|Overall Study|Lost to Follow-up|8|||
124850065|NCT01712984|449076011|FG001|Overall Study|Lost to Follow-up|10|||
124850066|NCT01712984|449076012|FG002|Overall Study|Lost to Follow-up|1|||
124850067|NCT01712984|449076010|FG000|Overall Study|Withdrawal by Subject|6|||
124850068|NCT01712984|449076011|FG001|Overall Study|Withdrawal by Subject|6|||
124850069|NCT01712984|449076012|FG002|Overall Study|Withdrawal by Subject|7|||
124850070|NCT02755831|449076015|FG000|Overall Study|Lost to Follow-up|3|||
124850071|NCT02755831|449076016|FG001|Overall Study|Lost to Follow-up|3|||
124850072|NCT01720069|449076017|FG000|Overall Study|Could not use e-diary correctly|0|||
124850073|NCT01720069|449076018|FG001|Overall Study|Could not use e-diary correctly|1|||
124850074|NCT01720069|449076019|FG002|Overall Study|Could not use e-diary correctly|1|||
124850075|NCT01720069|449076017|FG000|Overall Study|Randomised without baseline values|0|||
124850076|NCT01720069|449076018|FG001|Overall Study|Randomised without baseline values|0|||
124850077|NCT01720069|449076019|FG002|Overall Study|Randomised without baseline values|1|||
124850078|NCT01720069|449076017|FG000|Overall Study|Adverse Event|0|||
124850079|NCT01720069|449076018|FG001|Overall Study|Adverse Event|0|||
124850080|NCT01720069|449076019|FG002|Overall Study|Adverse Event|1|||
124850081|NCT01720069|449076017|FG000|Overall Study|Lack of Efficacy|0|||
124850082|NCT01720069|449076018|FG001|Overall Study|Lack of Efficacy|4|||
124850083|NCT01720069|449076019|FG002|Overall Study|Lack of Efficacy|0|||
124850084|NCT01720069|449076017|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
124850085|NCT01720069|449076018|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
124850086|NCT01720069|449076019|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
124850087|NCT01720069|449076017|FG000|Overall Study|Withdrawal by Subject|0|||
124850088|NCT01720069|449076018|FG001|Overall Study|Withdrawal by Subject|2|||
124850089|NCT01720069|449076019|FG002|Overall Study|Withdrawal by Subject|1|||
124850090|NCT01720069|449076017|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
124850091|NCT01720069|449076018|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
124850092|NCT01720069|449076019|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
124850093|NCT01720069|449076017|FG000|Overall Study|Non-compliance on using e-diary|0|||
124850094|NCT01720069|449076018|FG001|Overall Study|Non-compliance on using e-diary|0|||
124850095|NCT01720069|449076019|FG002|Overall Study|Non-compliance on using e-diary|1|||
124850096|NCT01720069|449076017|FG000|Overall Study|Lost to Follow-up|0|||
124850097|NCT01720069|449076018|FG001|Overall Study|Lost to Follow-up|0|||
124850098|NCT01720069|449076019|FG002|Overall Study|Lost to Follow-up|1|||
124850099|NCT00508742|449076020|FG000|Period 1: Infant Series|Adverse Event|5|||
124850100|NCT00508742|449076021|FG001|Period 1: Infant Series|Adverse Event|4|||
124850101|NCT00508742|449076020|FG000|Period 1: Infant Series|Protocol Violation|1|||
124850102|NCT00508742|449076021|FG001|Period 1: Infant Series|Protocol Violation|0|||
124850103|NCT00508742|449076020|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
124850104|NCT00508742|449076021|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
124850105|NCT00508742|449076020|FG000|Period 1: Infant Series|Physician Decision|1|||
124850106|NCT00508742|449076021|FG001|Period 1: Infant Series|Physician Decision|0|||
124850107|NCT00508742|449076020|FG000|Period 1: Infant Series|Other|4|||
124850108|NCT00508742|449076021|FG001|Period 1: Infant Series|Other|1|||
124850109|NCT00508742|449076020|FG000|Period 2: After Infant Series|Adverse Event|2|||
124850110|NCT00508742|449076021|FG001|Period 2: After Infant Series|Adverse Event|6|||
124850111|NCT00508742|449076020|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
124850112|NCT00508742|449076021|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
124850113|NCT00508742|449076020|FG000|Period 2: After Infant Series|Protocol Violation|1|||
124850114|NCT00508742|449076021|FG001|Period 2: After Infant Series|Protocol Violation|0|||
124850115|NCT00508742|449076020|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
124850116|NCT00508742|449076021|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
124850117|NCT00508742|449076020|FG000|Period 2: After Infant Series|Failed to Return|1|||
124850118|NCT00508742|449076021|FG001|Period 2: After Infant Series|Failed to Return|0|||
124850119|NCT00508742|449076020|FG000|Period 2: After Infant Series|Other|2|||
124850120|NCT00508742|449076021|FG001|Period 2: After Infant Series|Other|1|||
124850121|NCT00508742|449076020|FG000|Period 3: Toddler Dose|Adverse Event|1|||
124850122|NCT00508742|449076021|FG001|Period 3: Toddler Dose|Adverse Event|0|||
124850123|NCT00508742|449076020|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
124850124|NCT00508742|449076021|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
124850125|NCT00508742|449076020|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
124850126|NCT00508742|449076021|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
124850127|NCT00508742|449076020|FG000|Period 3: Toddler Dose|Other|5|||
124850128|NCT00508742|449076021|FG001|Period 3: Toddler Dose|Other|4|||
124850129|NCT02460224|449076026|FG000|Overall Study|Adverse Event|0|||
124850130|NCT02460224|449076027|FG001|Overall Study|Adverse Event|0|||
124850131|NCT02460224|449076028|FG002|Overall Study|Adverse Event|0|||
124850132|NCT02460224|449076029|FG003|Overall Study|Adverse Event|0|||
124850133|NCT02460224|449076030|FG004|Overall Study|Adverse Event|0|||
124850134|NCT02460224|449076031|FG005|Overall Study|Adverse Event|0|||
124850135|NCT02460224|449076032|FG006|Overall Study|Adverse Event|1|||
124850136|NCT02460224|449076033|FG007|Overall Study|Adverse Event|0|||
124850137|NCT02460224|449076034|FG008|Overall Study|Adverse Event|0|||
124850138|NCT02460224|449076035|FG009|Overall Study|Adverse Event|0|||
124850139|NCT02460224|449076036|FG010|Overall Study|Adverse Event|0|||
124850140|NCT02460224|449076037|FG011|Overall Study|Adverse Event|0|||
124850141|NCT02460224|449076038|FG012|Overall Study|Adverse Event|1|||
124850142|NCT02460224|449076039|FG013|Overall Study|Adverse Event|0|||
124850143|NCT02460224|449076040|FG014|Overall Study|Adverse Event|0|||
124850144|NCT02460224|449076041|FG015|Overall Study|Adverse Event|0|||
124850145|NCT02460224|449076042|FG016|Overall Study|Adverse Event|1|||
124850146|NCT02460224|449076043|FG017|Overall Study|Adverse Event|0|||
124850147|NCT02460224|449076044|FG018|Overall Study|Adverse Event|1|||
124850148|NCT02460224|449076045|FG019|Overall Study|Adverse Event|0|||
124850149|NCT02460224|449076046|FG020|Overall Study|Adverse Event|1|||
124850150|NCT02460224|449076047|FG021|Overall Study|Adverse Event|1|||
124850151|NCT02460224|449076048|FG022|Overall Study|Adverse Event|1|||
124850152|NCT02460224|449076049|FG023|Overall Study|Adverse Event|0|||
124850153|NCT02460224|449076050|FG024|Overall Study|Adverse Event|0|||
124850154|NCT02460224|449076051|FG025|Overall Study|Adverse Event|0|||
124850155|NCT02460224|449076052|FG026|Overall Study|Adverse Event|11|||
124850156|NCT02460224|449076053|FG027|Overall Study|Adverse Event|1|||
124850157|NCT02460224|449076054|FG028|Overall Study|Adverse Event|6|||
124850158|NCT02460224|449076026|FG000|Overall Study|Death|0|||
124850159|NCT02460224|449076027|FG001|Overall Study|Death|0|||
124850160|NCT02460224|449076028|FG002|Overall Study|Death|0|||
124850161|NCT02460224|449076029|FG003|Overall Study|Death|0|||
124850162|NCT02460224|449076030|FG004|Overall Study|Death|0|||
124850163|NCT02460224|449076031|FG005|Overall Study|Death|2|||
124850164|NCT02460224|449076032|FG006|Overall Study|Death|1|||
124850165|NCT02460224|449076033|FG007|Overall Study|Death|0|||
124850166|NCT02460224|449076034|FG008|Overall Study|Death|0|||
124850167|NCT02460224|449076035|FG009|Overall Study|Death|1|||
124850168|NCT02460224|449076036|FG010|Overall Study|Death|0|||
124850169|NCT02460224|449076037|FG011|Overall Study|Death|0|||
124850170|NCT02460224|449076038|FG012|Overall Study|Death|0|||
124850171|NCT02460224|449076039|FG013|Overall Study|Death|1|||
124850172|NCT02460224|449076040|FG014|Overall Study|Death|0|||
124850173|NCT02460224|449076041|FG015|Overall Study|Death|0|||
124850174|NCT02460224|449076042|FG016|Overall Study|Death|2|||
124850175|NCT02460224|449076043|FG017|Overall Study|Death|1|||
124850176|NCT02460224|449076044|FG018|Overall Study|Death|0|||
124850177|NCT02460224|449076045|FG019|Overall Study|Death|2|||
124850178|NCT02460224|449076046|FG020|Overall Study|Death|0|||
124850179|NCT02460224|449076047|FG021|Overall Study|Death|0|||
124850180|NCT02460224|449076048|FG022|Overall Study|Death|0|||
124850181|NCT02460224|449076049|FG023|Overall Study|Death|0|||
124850182|NCT02460224|449076050|FG024|Overall Study|Death|1|||
124850183|NCT02460224|449076051|FG025|Overall Study|Death|1|||
124850184|NCT02460224|449076052|FG026|Overall Study|Death|5|||
124850185|NCT02460224|449076053|FG027|Overall Study|Death|0|||
124850186|NCT02460224|449076054|FG028|Overall Study|Death|1|||
124850187|NCT02460224|449076026|FG000|Overall Study|Lost to Follow-up|0|||
124850188|NCT02460224|449076027|FG001|Overall Study|Lost to Follow-up|0|||
124850189|NCT02460224|449076028|FG002|Overall Study|Lost to Follow-up|0|||
124850190|NCT02460224|449076029|FG003|Overall Study|Lost to Follow-up|0|||
124850191|NCT02460224|449076030|FG004|Overall Study|Lost to Follow-up|0|||
124850192|NCT02460224|449076031|FG005|Overall Study|Lost to Follow-up|0|||
124850193|NCT02460224|449076032|FG006|Overall Study|Lost to Follow-up|0|||
124850194|NCT02460224|449076033|FG007|Overall Study|Lost to Follow-up|0|||
124850195|NCT02460224|449076034|FG008|Overall Study|Lost to Follow-up|0|||
124850196|NCT02460224|449076035|FG009|Overall Study|Lost to Follow-up|0|||
124850197|NCT02460224|449076036|FG010|Overall Study|Lost to Follow-up|0|||
124850198|NCT02460224|449076037|FG011|Overall Study|Lost to Follow-up|0|||
124850199|NCT02460224|449076038|FG012|Overall Study|Lost to Follow-up|0|||
124850200|NCT02460224|449076039|FG013|Overall Study|Lost to Follow-up|0|||
124850201|NCT02460224|449076040|FG014|Overall Study|Lost to Follow-up|0|||
124850202|NCT02460224|449076041|FG015|Overall Study|Lost to Follow-up|0|||
124850203|NCT02460224|449076042|FG016|Overall Study|Lost to Follow-up|0|||
124850204|NCT02460224|449076043|FG017|Overall Study|Lost to Follow-up|0|||
124850205|NCT02460224|449076044|FG018|Overall Study|Lost to Follow-up|0|||
124850206|NCT02460224|449076045|FG019|Overall Study|Lost to Follow-up|0|||
124850207|NCT02460224|449076046|FG020|Overall Study|Lost to Follow-up|0|||
124850208|NCT02460224|449076047|FG021|Overall Study|Lost to Follow-up|0|||
124850209|NCT02460224|449076048|FG022|Overall Study|Lost to Follow-up|1|||
124850210|NCT02460224|449076049|FG023|Overall Study|Lost to Follow-up|0|||
124850211|NCT02460224|449076050|FG024|Overall Study|Lost to Follow-up|0|||
124850212|NCT02460224|449076051|FG025|Overall Study|Lost to Follow-up|0|||
124850213|NCT02460224|449076052|FG026|Overall Study|Lost to Follow-up|0|||
124850214|NCT02460224|449076053|FG027|Overall Study|Lost to Follow-up|0|||
124850215|NCT02460224|449076054|FG028|Overall Study|Lost to Follow-up|0|||
124850216|NCT02460224|449076026|FG000|Overall Study|Physician Decision|0|||
124850217|NCT02460224|449076027|FG001|Overall Study|Physician Decision|1|||
124850218|NCT02460224|449076028|FG002|Overall Study|Physician Decision|0|||
124850219|NCT02460224|449076029|FG003|Overall Study|Physician Decision|0|||
124850220|NCT02460224|449076030|FG004|Overall Study|Physician Decision|1|||
124850221|NCT02460224|449076031|FG005|Overall Study|Physician Decision|0|||
124850222|NCT02460224|449076032|FG006|Overall Study|Physician Decision|0|||
124850223|NCT02460224|449076033|FG007|Overall Study|Physician Decision|1|||
124850224|NCT02460224|449076034|FG008|Overall Study|Physician Decision|0|||
124850225|NCT02460224|449076035|FG009|Overall Study|Physician Decision|0|||
124850226|NCT02460224|449076036|FG010|Overall Study|Physician Decision|0|||
124850227|NCT02460224|449076037|FG011|Overall Study|Physician Decision|1|||
124850228|NCT02460224|449076038|FG012|Overall Study|Physician Decision|0|||
124850229|NCT02460224|449076039|FG013|Overall Study|Physician Decision|1|||
124850230|NCT02460224|449076040|FG014|Overall Study|Physician Decision|0|||
124850231|NCT02460224|449076041|FG015|Overall Study|Physician Decision|0|||
124850232|NCT02460224|449076042|FG016|Overall Study|Physician Decision|2|||
124850233|NCT02460224|449076043|FG017|Overall Study|Physician Decision|1|||
124850234|NCT02460224|449076044|FG018|Overall Study|Physician Decision|1|||
124850235|NCT02460224|449076045|FG019|Overall Study|Physician Decision|2|||
124850236|NCT02460224|449076046|FG020|Overall Study|Physician Decision|1|||
124850237|NCT02460224|449076047|FG021|Overall Study|Physician Decision|1|||
124850238|NCT02460224|449076048|FG022|Overall Study|Physician Decision|0|||
124850239|NCT02460224|449076049|FG023|Overall Study|Physician Decision|0|||
124850240|NCT02460224|449076050|FG024|Overall Study|Physician Decision|1|||
124850241|NCT02460224|449076051|FG025|Overall Study|Physician Decision|0|||
124850242|NCT02460224|449076052|FG026|Overall Study|Physician Decision|14|||
124850243|NCT02460224|449076053|FG027|Overall Study|Physician Decision|1|||
124850244|NCT02460224|449076054|FG028|Overall Study|Physician Decision|6|||
124850245|NCT02460224|449076026|FG000|Overall Study|Progressive disease|15|||
124850246|NCT02460224|449076027|FG001|Overall Study|Progressive disease|11|||
124850247|NCT02460224|449076028|FG002|Overall Study|Progressive disease|5|||
124850248|NCT02460224|449076029|FG003|Overall Study|Progressive disease|6|||
124850249|NCT02460224|449076030|FG004|Overall Study|Progressive disease|3|||
124850250|NCT02460224|449076031|FG005|Overall Study|Progressive disease|26|||
124850251|NCT02460224|449076032|FG006|Overall Study|Progressive disease|28|||
124850252|NCT02460224|449076033|FG007|Overall Study|Progressive disease|4|||
124850253|NCT02460224|449076034|FG008|Overall Study|Progressive disease|5|||
124850254|NCT02460224|449076035|FG009|Overall Study|Progressive disease|9|||
124850255|NCT02460224|449076036|FG010|Overall Study|Progressive disease|5|||
124850256|NCT02460224|449076037|FG011|Overall Study|Progressive disease|4|||
124850257|NCT02460224|449076038|FG012|Overall Study|Progressive disease|5|||
124850258|NCT02460224|449076039|FG013|Overall Study|Progressive disease|4|||
124850259|NCT02460224|449076040|FG014|Overall Study|Progressive disease|5|||
124850260|NCT02460224|449076041|FG015|Overall Study|Progressive disease|5|||
124850261|NCT02460224|449076042|FG016|Overall Study|Progressive disease|15|||
124850262|NCT02460224|449076043|FG017|Overall Study|Progressive disease|3|||
124850263|NCT02460224|449076044|FG018|Overall Study|Progressive disease|8|||
124850264|NCT02460224|449076045|FG019|Overall Study|Progressive disease|3|||
124850265|NCT02460224|449076046|FG020|Overall Study|Progressive disease|4|||
124850266|NCT02460224|449076047|FG021|Overall Study|Progressive disease|9|||
124850267|NCT02460224|449076048|FG022|Overall Study|Progressive disease|4|||
124850268|NCT02460224|449076049|FG023|Overall Study|Progressive disease|11|||
124850269|NCT02460224|449076050|FG024|Overall Study|Progressive disease|4|||
124850270|NCT02460224|449076051|FG025|Overall Study|Progressive disease|5|||
124850271|NCT02460224|449076052|FG026|Overall Study|Progressive disease|85|||
124850272|NCT02460224|449076053|FG027|Overall Study|Progressive disease|17|||
124850273|NCT02460224|449076054|FG028|Overall Study|Progressive disease|77|||
124850274|NCT02460224|449076026|FG000|Overall Study|Subject/guardian decision|2|||
124850275|NCT02460224|449076027|FG001|Overall Study|Subject/guardian decision|0|||
124850276|NCT02460224|449076028|FG002|Overall Study|Subject/guardian decision|1|||
124850277|NCT02460224|449076029|FG003|Overall Study|Subject/guardian decision|0|||
124850278|NCT02460224|449076030|FG004|Overall Study|Subject/guardian decision|2|||
124850279|NCT02460224|449076031|FG005|Overall Study|Subject/guardian decision|2|||
124850280|NCT02460224|449076032|FG006|Overall Study|Subject/guardian decision|0|||
124850281|NCT02460224|449076033|FG007|Overall Study|Subject/guardian decision|0|||
124850282|NCT02460224|449076034|FG008|Overall Study|Subject/guardian decision|1|||
124850283|NCT02460224|449076035|FG009|Overall Study|Subject/guardian decision|1|||
124850284|NCT02460224|449076036|FG010|Overall Study|Subject/guardian decision|0|||
124850285|NCT02460224|449076037|FG011|Overall Study|Subject/guardian decision|1|||
124850286|NCT02460224|449076038|FG012|Overall Study|Subject/guardian decision|0|||
124850287|NCT02460224|449076039|FG013|Overall Study|Subject/guardian decision|0|||
124850288|NCT02460224|449076040|FG014|Overall Study|Subject/guardian decision|0|||
124850289|NCT02460224|449076041|FG015|Overall Study|Subject/guardian decision|1|||
124850290|NCT02460224|449076042|FG016|Overall Study|Subject/guardian decision|0|||
124850291|NCT02460224|449076043|FG017|Overall Study|Subject/guardian decision|1|||
124850292|NCT02460224|449076044|FG018|Overall Study|Subject/guardian decision|2|||
124850293|NCT02460224|449076045|FG019|Overall Study|Subject/guardian decision|0|||
124850294|NCT02460224|449076046|FG020|Overall Study|Subject/guardian decision|0|||
124850295|NCT02460224|449076047|FG021|Overall Study|Subject/guardian decision|1|||
124850296|NCT02460224|449076048|FG022|Overall Study|Subject/guardian decision|0|||
124850297|NCT02460224|449076049|FG023|Overall Study|Subject/guardian decision|0|||
124850298|NCT02460224|449076050|FG024|Overall Study|Subject/guardian decision|0|||
124850299|NCT02460224|449076051|FG025|Overall Study|Subject/guardian decision|0|||
124850300|NCT02460224|449076052|FG026|Overall Study|Subject/guardian decision|6|||
124850301|NCT02460224|449076053|FG027|Overall Study|Subject/guardian decision|2|||
124850302|NCT02460224|449076054|FG028|Overall Study|Subject/guardian decision|3|||
124850303|NCT03146650|449076056|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
124850304|NCT03146650|449076056|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
124850305|NCT03146650|449076056|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
124850306|NCT03146650|449076056|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
124850307|NCT03146650|449076056|FG000|2 Year Follow-up|Death|11|||
124850308|NCT03146650|449076056|FG000|2 Year Follow-up|Still in follow-up|7|||
124850309|NCT03146650|449076056|FG000|2 Year Follow-up|Lost to Follow-up|1|||
124850310|NCT03333486|449076059|FG000|Overall Study|Withdrawal by Subject|1|||
124850311|NCT03333486|449076059|FG000|Overall Study|Lost to Follow-up|1|||
124850312|NCT00774995|449076060|FG000|Overall Study|Protocol Violation|0|||
124850313|NCT00774995|449076061|FG001|Overall Study|Protocol Violation|0|||
124850314|NCT00774995|449076062|FG002|Overall Study|Protocol Violation|1|||
124850315|NCT00774995|449076063|FG003|Overall Study|Protocol Violation|0|||
124850316|NCT01818336|449077924|FG000|Overall Study|Declined retest visit|0|||
124850317|NCT01818336|449077925|FG001|Overall Study|Declined retest visit|11|||
124850318|NCT01818336|449077924|FG000|Overall Study|Lost to Follow-up|0|||
124850319|NCT01818336|449077925|FG001|Overall Study|Lost to Follow-up|1|||
124850320|NCT02139644|449077926|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
124850321|NCT02139644|449077927|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124850322|NCT02139644|449077928|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124850323|NCT02139644|449077929|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124850324|NCT02139644|449077930|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124850325|NCT02139644|449077931|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
124850326|NCT02139644|449077926|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
124850327|NCT02139644|449077927|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124850328|NCT02139644|449077928|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124850329|NCT02139644|449077929|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124850330|NCT02139644|449077930|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124850331|NCT02139644|449077931|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
124850332|NCT02139644|449077926|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
124850333|NCT02139644|449077927|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124850334|NCT02139644|449077928|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124850335|NCT02139644|449077929|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124850336|NCT02139644|449077930|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124850337|NCT02139644|449077931|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
124850338|NCT02139644|449077926|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
124850339|NCT02139644|449077927|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124850340|NCT02139644|449077928|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124850341|NCT02139644|449077929|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124850342|NCT02139644|449077930|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124850343|NCT02139644|449077931|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
124850344|NCT02139644|449077926|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
124850345|NCT02139644|449077927|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124850346|NCT02139644|449077928|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124850347|NCT02139644|449077929|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124850348|NCT02139644|449077930|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124850349|NCT02139644|449077931|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
124850350|NCT02139644|449077926|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
124850351|NCT02139644|449077927|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
124850352|NCT02139644|449077928|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
124850353|NCT02139644|449077929|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
124850354|NCT02139644|449077930|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
124850355|NCT02139644|449077931|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
124850356|NCT02139644|449077926|FG000|Run-In Period (Pre-assignment)|Other|6|||
124850357|NCT02139644|449077927|FG001|Run-In Period (Pre-assignment)|Other|0|||
124850358|NCT02139644|449077928|FG002|Run-In Period (Pre-assignment)|Other|0|||
124850359|NCT02139644|449077929|FG003|Run-In Period (Pre-assignment)|Other|0|||
124850360|NCT02139644|449077930|FG004|Run-In Period (Pre-assignment)|Other|0|||
124850361|NCT02139644|449077931|FG005|Run-In Period (Pre-assignment)|Other|0|||
124850362|NCT02139644|449077926|FG000|Treatment Period|Adverse Event|0|||
124850363|NCT02139644|449077927|FG001|Treatment Period|Adverse Event|0|||
124850364|NCT02139644|449077928|FG002|Treatment Period|Adverse Event|3|||
124850365|NCT02139644|449077929|FG003|Treatment Period|Adverse Event|2|||
124850366|NCT02139644|449077930|FG004|Treatment Period|Adverse Event|1|||
124850367|NCT02139644|449077931|FG005|Treatment Period|Adverse Event|6|||
124850368|NCT02139644|449077926|FG000|Treatment Period|Withdrawal by Subject|0|||
124850369|NCT02139644|449077927|FG001|Treatment Period|Withdrawal by Subject|0|||
124850370|NCT02139644|449077928|FG002|Treatment Period|Withdrawal by Subject|2|||
124850371|NCT02139644|449077929|FG003|Treatment Period|Withdrawal by Subject|2|||
124850372|NCT02139644|449077930|FG004|Treatment Period|Withdrawal by Subject|3|||
124850373|NCT02139644|449077931|FG005|Treatment Period|Withdrawal by Subject|2|||
124850374|NCT02139644|449077926|FG000|Treatment Period|Non-compliance|0|||
124850375|NCT02139644|449077927|FG001|Treatment Period|Non-compliance|0|||
124850376|NCT02139644|449077928|FG002|Treatment Period|Non-compliance|0|||
124850377|NCT02139644|449077929|FG003|Treatment Period|Non-compliance|1|||
124850378|NCT02139644|449077930|FG004|Treatment Period|Non-compliance|0|||
124850379|NCT02139644|449077931|FG005|Treatment Period|Non-compliance|0|||
124850380|NCT02139644|449077926|FG000|Treatment Period|Protocol Violation|0|||
124850381|NCT02139644|449077927|FG001|Treatment Period|Protocol Violation|0|||
124850382|NCT02139644|449077928|FG002|Treatment Period|Protocol Violation|0|||
124850383|NCT02139644|449077929|FG003|Treatment Period|Protocol Violation|1|||
124850384|NCT02139644|449077930|FG004|Treatment Period|Protocol Violation|1|||
124850385|NCT02139644|449077931|FG005|Treatment Period|Protocol Violation|1|||
124850386|NCT02139644|449077926|FG000|Treatment Period|Disease progression|0|||
124850387|NCT02139644|449077927|FG001|Treatment Period|Disease progression|0|||
124850388|NCT02139644|449077928|FG002|Treatment Period|Disease progression|0|||
124850389|NCT02139644|449077929|FG003|Treatment Period|Disease progression|1|||
124850390|NCT02139644|449077930|FG004|Treatment Period|Disease progression|1|||
124850391|NCT02139644|449077931|FG005|Treatment Period|Disease progression|2|||
124850392|NCT02139644|449077926|FG000|Treatment Period|Lost to Follow-up|0|||
124850393|NCT02139644|449077927|FG001|Treatment Period|Lost to Follow-up|0|||
124850394|NCT02139644|449077928|FG002|Treatment Period|Lost to Follow-up|1|||
124850395|NCT02139644|449077929|FG003|Treatment Period|Lost to Follow-up|1|||
124850396|NCT02139644|449077930|FG004|Treatment Period|Lost to Follow-up|1|||
124850397|NCT02139644|449077931|FG005|Treatment Period|Lost to Follow-up|1|||
124850398|NCT02139644|449077926|FG000|Treatment Period|Lack of Efficacy|0|||
124850399|NCT02139644|449077927|FG001|Treatment Period|Lack of Efficacy|0|||
124850400|NCT02139644|449077928|FG002|Treatment Period|Lack of Efficacy|1|||
124850401|NCT02139644|449077929|FG003|Treatment Period|Lack of Efficacy|0|||
124850402|NCT02139644|449077930|FG004|Treatment Period|Lack of Efficacy|1|||
124850403|NCT02139644|449077931|FG005|Treatment Period|Lack of Efficacy|4|||
124850404|NCT02139644|449077926|FG000|Treatment Period|Other|0|||
124850405|NCT02139644|449077927|FG001|Treatment Period|Other|3|||
124850406|NCT02139644|449077928|FG002|Treatment Period|Other|1|||
124850407|NCT02139644|449077929|FG003|Treatment Period|Other|1|||
124850408|NCT02139644|449077930|FG004|Treatment Period|Other|0|||
124850409|NCT02139644|449077931|FG005|Treatment Period|Other|1|||
124850410|NCT00608829|449077935|FG000|Overall Study|Death|6|||
124850411|NCT00608829|449077935|FG000|Overall Study|Withdrawal by Subject|4|||
124850412|NCT00608829|449077935|FG000|Overall Study|Subject refuses to follow up or return.|5|||
124850413|NCT02602288|449077936|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
124850414|NCT02602288|449077937|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
124850415|NCT02602288|449077936|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
124850416|NCT02602288|449077937|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
124850417|NCT02602288|449077936|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
124850418|NCT02602288|449077937|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
124850419|NCT02602288|449077936|FG000|12 Month Follow-up|Lost to Follow-up|0|||
124850420|NCT02602288|449077937|FG001|12 Month Follow-up|Lost to Follow-up|4|||
124850421|NCT02602288|449077936|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
124850422|NCT02602288|449077937|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
124850423|NCT01310413|449077938|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
124850424|NCT01310413|449077939|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
124850425|NCT01310413|449077940|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
124850426|NCT01310413|449077941|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
124850427|NCT01310413|449077942|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
124850428|NCT01310413|449077943|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
124850429|NCT01310413|449077944|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
124850430|NCT01310413|449077938|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
124850431|NCT01310413|449077939|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
124850432|NCT01310413|449077940|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
124850433|NCT01310413|449077941|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
124850434|NCT01310413|449077942|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
124850435|NCT01310413|449077943|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
124850436|NCT01310413|449077944|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
124850437|NCT01310413|449077938|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
124850438|NCT01310413|449077939|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
124850439|NCT01310413|449077940|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
124850440|NCT01310413|449077941|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
124850441|NCT01310413|449077942|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
124850442|NCT01310413|449077943|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
124850443|NCT01310413|449077944|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
124850444|NCT01310413|449077938|FG000|Day 0 to Day 385|Other|1|||
124850445|NCT01310413|449077939|FG001|Day 0 to Day 385|Other|0|||
124850446|NCT01310413|449077940|FG002|Day 0 to Day 385|Other|3|||
124850447|NCT01310413|449077941|FG003|Day 0 to Day 385|Other|0|||
124850448|NCT01310413|449077942|FG004|Day 0 to Day 385|Other|0|||
124850449|NCT01310413|449077943|FG005|Day 0 to Day 385|Other|0|||
124850450|NCT01310413|449077944|FG006|Day 0 to Day 385|Other|0|||
124850451|NCT01310413|449077938|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
124850452|NCT01310413|449077939|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
124850453|NCT01310413|449077940|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
124850454|NCT01310413|449077941|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
124850455|NCT01310413|449077942|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
124850456|NCT01310413|449077943|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
124850457|NCT01310413|449077944|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
124850458|NCT01310413|449077938|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
124850459|NCT01310413|449077939|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
124850460|NCT01310413|449077940|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
124850461|NCT01310413|449077941|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
124850462|NCT01310413|449077942|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
124850463|NCT01310413|449077943|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
124850464|NCT01310413|449077944|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
124850465|NCT02564471|449077945|FG000|Overall Study|Adverse Event|1|||
124850466|NCT02564471|449077946|FG001|Overall Study|Adverse Event|0|||
124850467|NCT02564471|449077947|FG002|Overall Study|Adverse Event|0|||
124850468|NCT02564471|449077948|FG003|Overall Study|Adverse Event|0|||
124850469|NCT02564471|449077945|FG000|Overall Study|Withdrawal by Subject|2|||
124850470|NCT02564471|449077946|FG001|Overall Study|Withdrawal by Subject|1|||
124850471|NCT02564471|449077947|FG002|Overall Study|Withdrawal by Subject|3|||
124850472|NCT02564471|449077948|FG003|Overall Study|Withdrawal by Subject|0|||
124850473|NCT02564471|449077945|FG000|Overall Study|Lost to Follow-up|0|||
124850474|NCT02564471|449077946|FG001|Overall Study|Lost to Follow-up|2|||
124850475|NCT02564471|449077947|FG002|Overall Study|Lost to Follow-up|0|||
124850476|NCT02564471|449077948|FG003|Overall Study|Lost to Follow-up|0|||
124850477|NCT02805257|449077949|FG000|Overall Study|Lost to Follow-up|7|||
124850478|NCT02805257|449077950|FG001|Overall Study|Lost to Follow-up|6|||
124850479|NCT02805257|449077949|FG000|Overall Study|Death|0|||
124850480|NCT02805257|449077950|FG001|Overall Study|Death|1|||
124850481|NCT02033889|449077954|FG000|Overall Study|Adverse Event|3|||
124850482|NCT02033889|449077955|FG001|Overall Study|Adverse Event|1|||
124850483|NCT02033889|449077956|FG002|Overall Study|Adverse Event|3|||
124850484|NCT02033889|449077954|FG000|Overall Study|Death|3|||
124850485|NCT02033889|449077955|FG001|Overall Study|Death|1|||
124850486|NCT02033889|449077956|FG002|Overall Study|Death|2|||
124850487|NCT02033889|449077954|FG000|Overall Study|Excluded Medication|1|||
124850488|NCT02033889|449077955|FG001|Overall Study|Excluded Medication|1|||
124850489|NCT02033889|449077956|FG002|Overall Study|Excluded Medication|0|||
124850490|NCT02033889|449077954|FG000|Overall Study|Lost to Follow-up|8|||
124850491|NCT02033889|449077955|FG001|Overall Study|Lost to Follow-up|5|||
124850492|NCT02033889|449077956|FG002|Overall Study|Lost to Follow-up|6|||
124850493|NCT02033889|449077954|FG000|Overall Study|Non-Compliance With Study Drug|1|||
124850494|NCT02033889|449077955|FG001|Overall Study|Non-Compliance With Study Drug|0|||
124850495|NCT02033889|449077956|FG002|Overall Study|Non-Compliance With Study Drug|0|||
124850496|NCT02033889|449077954|FG000|Overall Study|Physician Decision|0|||
124850497|NCT02033889|449077955|FG001|Overall Study|Physician Decision|1|||
124850498|NCT02033889|449077956|FG002|Overall Study|Physician Decision|1|||
124850499|NCT02033889|449077954|FG000|Overall Study|Participant moved|0|||
124850500|NCT02033889|449077955|FG001|Overall Study|Participant moved|1|||
124850501|NCT02033889|449077956|FG002|Overall Study|Participant moved|0|||
124850502|NCT02033889|449077954|FG000|Overall Study|Withdrawal by Subject|18|||
124850503|NCT02033889|449077955|FG001|Overall Study|Withdrawal by Subject|10|||
124850504|NCT02033889|449077956|FG002|Overall Study|Withdrawal by Subject|13|||
124850505|NCT02080091|449077957|FG000|Overall Study|Study Terminated|22|||
124850506|NCT02080091|449077957|FG000|Overall Study|Death|1|||
124850507|NCT02080091|449077957|FG000|Overall Study|Withdrawal by Subject|1|||
124850508|NCT02080091|449077957|FG000|Overall Study|Other|1|||
124850509|NCT03143829|449077958|FG000|Overall Study|Withdrawal by Subject|2|||
124850510|NCT03143829|449077959|FG001|Overall Study|Withdrawal by Subject|5|||
124850511|NCT03143829|449077958|FG000|Overall Study|Lost to Follow-up|0|||
124850512|NCT03143829|449077959|FG001|Overall Study|Lost to Follow-up|2|||
124850513|NCT03143829|449077958|FG000|Overall Study|Death|1|||
124850514|NCT03143829|449077959|FG001|Overall Study|Death|1|||
124850515|NCT03143829|449077958|FG000|Overall Study|changed treatment, no longer eligible|2|||
124850516|NCT03143829|449077959|FG001|Overall Study|changed treatment, no longer eligible|2|||
124850517|NCT02391948|449077962|FG000|6-month Assessment|Death|0|||
124850518|NCT02391948|449077963|FG001|6-month Assessment|Death|0|||
124850519|NCT02391948|449077964|FG002|6-month Assessment|Death|0|||
124850520|NCT02391948|449077965|FG003|6-month Assessment|Death|0|||
124850521|NCT02391948|449077966|FG004|6-month Assessment|Death|1|||
124850522|NCT02391948|449077962|FG000|6-month Assessment|Withdrawal by Subject|0|||
124850523|NCT02391948|449077963|FG001|6-month Assessment|Withdrawal by Subject|0|||
124850524|NCT02391948|449077964|FG002|6-month Assessment|Withdrawal by Subject|1|||
124850525|NCT02391948|449077965|FG003|6-month Assessment|Withdrawal by Subject|2|||
124850526|NCT02391948|449077966|FG004|6-month Assessment|Withdrawal by Subject|0|||
124850527|NCT02391948|449077962|FG000|6-month Assessment|Lost to Follow-up|4|||
124850528|NCT02391948|449077963|FG001|6-month Assessment|Lost to Follow-up|5|||
124850529|NCT02391948|449077964|FG002|6-month Assessment|Lost to Follow-up|2|||
124850530|NCT02391948|449077965|FG003|6-month Assessment|Lost to Follow-up|3|||
124850531|NCT02391948|449077966|FG004|6-month Assessment|Lost to Follow-up|1|||
124850532|NCT02391948|449077962|FG000|6-month Assessment|Medical issue/illness|1|||
124850533|NCT02391948|449077963|FG001|6-month Assessment|Medical issue/illness|1|||
124850534|NCT02391948|449077964|FG002|6-month Assessment|Medical issue/illness|0|||
124850535|NCT02391948|449077965|FG003|6-month Assessment|Medical issue/illness|0|||
124850536|NCT02391948|449077966|FG004|6-month Assessment|Medical issue/illness|0|||
124850537|NCT02391948|449077962|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
124850538|NCT02391948|449077963|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
124850539|NCT02391948|449077964|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
124850540|NCT02391948|449077965|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
124850541|NCT02391948|449077966|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
124850542|NCT02391948|449077962|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
124850543|NCT02391948|449077963|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
124850544|NCT02391948|449077964|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
124850545|NCT02391948|449077965|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
124850546|NCT02391948|449077966|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
124850547|NCT02391948|449077962|FG000|12-month Assessment|Death|0|||
124850548|NCT02391948|449077963|FG001|12-month Assessment|Death|0|||
124850549|NCT02391948|449077964|FG002|12-month Assessment|Death|0|||
124850550|NCT02391948|449077965|FG003|12-month Assessment|Death|1|||
124850551|NCT02391948|449077966|FG004|12-month Assessment|Death|0|||
124850552|NCT02391948|449077962|FG000|12-month Assessment|Withdrawal by Subject|1|||
124850553|NCT02391948|449077963|FG001|12-month Assessment|Withdrawal by Subject|0|||
124850554|NCT02391948|449077964|FG002|12-month Assessment|Withdrawal by Subject|0|||
124850555|NCT02391948|449077965|FG003|12-month Assessment|Withdrawal by Subject|1|||
124850556|NCT02391948|449077966|FG004|12-month Assessment|Withdrawal by Subject|0|||
124850557|NCT02391948|449077962|FG000|12-month Assessment|Lost to Follow-up|5|||
124850558|NCT02391948|449077963|FG001|12-month Assessment|Lost to Follow-up|4|||
124850559|NCT02391948|449077964|FG002|12-month Assessment|Lost to Follow-up|4|||
124850560|NCT02391948|449077965|FG003|12-month Assessment|Lost to Follow-up|4|||
124850561|NCT02391948|449077966|FG004|12-month Assessment|Lost to Follow-up|5|||
124850562|NCT02391948|449077962|FG000|12-month Assessment|Medical issue/illness|0|||
124850563|NCT02391948|449077963|FG001|12-month Assessment|Medical issue/illness|1|||
124850564|NCT02391948|449077964|FG002|12-month Assessment|Medical issue/illness|0|||
124850565|NCT02391948|449077965|FG003|12-month Assessment|Medical issue/illness|1|||
124850566|NCT02391948|449077966|FG004|12-month Assessment|Medical issue/illness|0|||
124850567|NCT02391948|449077962|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
124850568|NCT02391948|449077963|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
124850569|NCT02391948|449077964|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
124850570|NCT02391948|449077965|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
124850571|NCT02391948|449077966|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
124850572|NCT02391948|449077962|FG000|18-month Assessment|Death|0|||
124850573|NCT02391948|449077963|FG001|18-month Assessment|Death|0|||
124850574|NCT02391948|449077964|FG002|18-month Assessment|Death|0|||
124850575|NCT02391948|449077965|FG003|18-month Assessment|Death|1|||
124850576|NCT02391948|449077966|FG004|18-month Assessment|Death|1|||
124850577|NCT02391948|449077962|FG000|18-month Assessment|Withdrawal by Subject|1|||
124850578|NCT02391948|449077963|FG001|18-month Assessment|Withdrawal by Subject|0|||
124850579|NCT02391948|449077964|FG002|18-month Assessment|Withdrawal by Subject|0|||
124850580|NCT02391948|449077965|FG003|18-month Assessment|Withdrawal by Subject|1|||
124850581|NCT02391948|449077966|FG004|18-month Assessment|Withdrawal by Subject|0|||
124850582|NCT02391948|449077962|FG000|18-month Assessment|Lost to Follow-up|2|||
124850583|NCT02391948|449077963|FG001|18-month Assessment|Lost to Follow-up|6|||
124850584|NCT02391948|449077964|FG002|18-month Assessment|Lost to Follow-up|2|||
124850585|NCT02391948|449077965|FG003|18-month Assessment|Lost to Follow-up|2|||
124850586|NCT02391948|449077966|FG004|18-month Assessment|Lost to Follow-up|3|||
124850587|NCT02391948|449077962|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
124850588|NCT02391948|449077963|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
124850589|NCT02391948|449077964|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
124850590|NCT02391948|449077965|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
124850591|NCT02391948|449077966|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
124850592|NCT02391948|449077962|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
124850593|NCT02391948|449077963|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
124850594|NCT02391948|449077964|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
124850595|NCT02391948|449077965|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
124850596|NCT02391948|449077966|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
124850597|NCT02391948|449077962|FG000|24-month Assessment|Death|0|||
124850598|NCT02391948|449077963|FG001|24-month Assessment|Death|0|||
124850599|NCT02391948|449077964|FG002|24-month Assessment|Death|0|||
124850600|NCT02391948|449077965|FG003|24-month Assessment|Death|0|||
124850601|NCT02391948|449077966|FG004|24-month Assessment|Death|1|||
124850602|NCT02391948|449077962|FG000|24-month Assessment|Withdrawal by Subject|1|||
124850603|NCT02391948|449077963|FG001|24-month Assessment|Withdrawal by Subject|1|||
124850604|NCT02391948|449077964|FG002|24-month Assessment|Withdrawal by Subject|0|||
124850605|NCT02391948|449077965|FG003|24-month Assessment|Withdrawal by Subject|0|||
124850606|NCT02391948|449077966|FG004|24-month Assessment|Withdrawal by Subject|1|||
124850607|NCT02391948|449077962|FG000|24-month Assessment|Lost to Follow-up|5|||
124850608|NCT02391948|449077963|FG001|24-month Assessment|Lost to Follow-up|4|||
124850609|NCT02391948|449077964|FG002|24-month Assessment|Lost to Follow-up|0|||
124850610|NCT02391948|449077965|FG003|24-month Assessment|Lost to Follow-up|0|||
124850611|NCT02391948|449077966|FG004|24-month Assessment|Lost to Follow-up|0|||
124850612|NCT02391948|449077962|FG000|24-month Assessment|Medical issue/illness|0|||
124850613|NCT02391948|449077963|FG001|24-month Assessment|Medical issue/illness|0|||
124850614|NCT02391948|449077964|FG002|24-month Assessment|Medical issue/illness|1|||
124850615|NCT02391948|449077965|FG003|24-month Assessment|Medical issue/illness|0|||
124850616|NCT02391948|449077966|FG004|24-month Assessment|Medical issue/illness|0|||
124850617|NCT02391948|449077962|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
124850618|NCT02391948|449077963|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
124850619|NCT02391948|449077964|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
124850620|NCT02391948|449077965|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
124850621|NCT02391948|449077966|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
124850622|NCT02886572|449077969|FG000|Overall Study|Death|8|||
124850623|NCT00982319|449077972|FG000|Overall Study|Surgery date change|1|||
124850624|NCT00982319|449077973|FG001|Overall Study|Surgery date change|0|||
124850625|NCT00982319|449077972|FG000|Overall Study|Preop values out of acceptable range|1|||
124850626|NCT00982319|449077973|FG001|Overall Study|Preop values out of acceptable range|1|||
124850627|NCT00982319|449077972|FG000|Overall Study|Pregnancy|0|||
124850628|NCT00982319|449077973|FG001|Overall Study|Pregnancy|1|||
124850629|NCT01923181|449077974|FG000|Overall Study|Protocol Violation|2|||
124850630|NCT01923181|449077975|FG001|Overall Study|Protocol Violation|2|||
124850631|NCT01923181|449077976|FG002|Overall Study|Protocol Violation|0|||
124850632|NCT01923181|449077977|FG003|Overall Study|Protocol Violation|2|||
124850633|NCT01923181|449077978|FG004|Overall Study|Protocol Violation|2|||
124850634|NCT01923181|449077979|FG005|Overall Study|Protocol Violation|1|||
124850635|NCT01923181|449077980|FG006|Overall Study|Protocol Violation|1|||
124850636|NCT01923181|449077981|FG007|Overall Study|Protocol Violation|2|||
124850637|NCT01923181|449077982|FG008|Overall Study|Protocol Violation|1|||
124850638|NCT01923181|449077974|FG000|Overall Study|Withdrawal by Subject|0|||
124850639|NCT01923181|449077975|FG001|Overall Study|Withdrawal by Subject|1|||
124850640|NCT01923181|449077976|FG002|Overall Study|Withdrawal by Subject|0|||
124850641|NCT01923181|449077977|FG003|Overall Study|Withdrawal by Subject|1|||
124850642|NCT01923181|449077978|FG004|Overall Study|Withdrawal by Subject|4|||
124850643|NCT01923181|449077979|FG005|Overall Study|Withdrawal by Subject|2|||
124850644|NCT01923181|449077980|FG006|Overall Study|Withdrawal by Subject|4|||
124850645|NCT01923181|449077981|FG007|Overall Study|Withdrawal by Subject|3|||
124850646|NCT01923181|449077982|FG008|Overall Study|Withdrawal by Subject|1|||
124850647|NCT01923181|449077974|FG000|Overall Study|Other|1|||
124850648|NCT01923181|449077975|FG001|Overall Study|Other|0|||
124850649|NCT01923181|449077976|FG002|Overall Study|Other|0|||
124850650|NCT01923181|449077977|FG003|Overall Study|Other|1|||
124850651|NCT01923181|449077978|FG004|Overall Study|Other|0|||
124850652|NCT01923181|449077979|FG005|Overall Study|Other|0|||
124850653|NCT01923181|449077980|FG006|Overall Study|Other|0|||
124850654|NCT01923181|449077981|FG007|Overall Study|Other|0|||
124850655|NCT01923181|449077982|FG008|Overall Study|Other|0|||
124850656|NCT01923181|449077974|FG000|Overall Study|Lost to Follow-up|0|||
124850657|NCT01923181|449077975|FG001|Overall Study|Lost to Follow-up|3|||
124850658|NCT01923181|449077976|FG002|Overall Study|Lost to Follow-up|2|||
124850659|NCT01923181|449077977|FG003|Overall Study|Lost to Follow-up|1|||
124850660|NCT01923181|449077978|FG004|Overall Study|Lost to Follow-up|2|||
124850661|NCT01923181|449077979|FG005|Overall Study|Lost to Follow-up|1|||
124850662|NCT01923181|449077980|FG006|Overall Study|Lost to Follow-up|3|||
124850663|NCT01923181|449077981|FG007|Overall Study|Lost to Follow-up|3|||
124850664|NCT01923181|449077982|FG008|Overall Study|Lost to Follow-up|1|||
124850665|NCT01863446|449077983|FG000|Overall Study|Withdrawal by Subject|1|||
124850666|NCT01863446|449077984|FG001|Overall Study|Withdrawal by Subject|0|||
124850667|NCT01863446|449077985|FG002|Overall Study|Withdrawal by Subject|1|||
124850668|NCT01863446|449077986|FG003|Overall Study|Withdrawal by Subject|2|||
124850669|NCT01863446|449077983|FG000|Overall Study|Physician Decision|0|||
124850670|NCT01863446|449077984|FG001|Overall Study|Physician Decision|0|||
124850671|NCT01863446|449077985|FG002|Overall Study|Physician Decision|1|||
124850672|NCT01863446|449077986|FG003|Overall Study|Physician Decision|0|||
124850673|NCT03603964|449077991|FG000|Overall Study|Death|9|||
124850674|NCT03603964|449077991|FG000|Overall Study|Withdrawal by participant|7|||
124850675|NCT03603964|449077991|FG000|Overall Study|Study terminated by Sponsor|19|||
124850676|NCT00563797|449077992|FG000|Overall Study|Lost to Follow-up|7|||
124850677|NCT00563797|449077993|FG001|Overall Study|Lost to Follow-up|2|||
124850678|NCT04317586|449077994|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
124850679|NCT04317586|449077994|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
124850680|NCT00807092|449077995|FG000|Overall Study|Adverse Event|0|||
124850681|NCT00807092|449077996|FG001|Overall Study|Adverse Event|1|||
124850682|NCT00807092|449077995|FG000|Overall Study|Protocol Violation|0|||
124850683|NCT00807092|449077996|FG001|Overall Study|Protocol Violation|2|||
124850684|NCT00807092|449077995|FG000|Overall Study|Withdrawal by Subject|1|||
124850685|NCT00807092|449077996|FG001|Overall Study|Withdrawal by Subject|0|||
124850686|NCT00807092|449077995|FG000|Overall Study|CGMS data collection failed|0|||
124850687|NCT00807092|449077996|FG001|Overall Study|CGMS data collection failed|1|||
124850688|NCT04116229|449077997|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
124850689|NCT04116229|449077998|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
124850690|NCT04116229|449077997|FG000|Overall Study|Scheduling not possible.|0|||
124850691|NCT04116229|449077998|FG001|Overall Study|Scheduling not possible.|1|||
124850692|NCT01794949|449077999|FG000|Overall Study|Lost to Follow-up|1|||
124850693|NCT01794949|449078000|FG001|Overall Study|Lost to Follow-up|0|||
124850694|NCT03003676|449078001|FG000|Overall Study|Lack of Efficacy|5|||
124850695|NCT03003676|449078002|FG001|Overall Study|Lack of Efficacy|7|||
124850696|NCT03003676|449078001|FG000|Overall Study|Withdrawal by Subject|0|||
124850697|NCT03003676|449078002|FG001|Overall Study|Withdrawal by Subject|1|||
124850698|NCT03003676|449078001|FG000|Overall Study|Hepatitis B infection|1|||
124850699|NCT03003676|449078002|FG001|Overall Study|Hepatitis B infection|0|||
124850700|NCT02443298|449078009|FG000|Overall Study|Adverse Event|3|||
124850701|NCT02443298|449078010|FG001|Overall Study|Adverse Event|3|||
124850702|NCT02443298|449078009|FG000|Overall Study|Withdrawal by Subject|1|||
124850703|NCT02443298|449078010|FG001|Overall Study|Withdrawal by Subject|2|||
124850704|NCT03698773|449078015|FG000|Overall Study|Lost to Follow-up|2|||
124850705|NCT03698773|449078016|FG001|Overall Study|Lost to Follow-up|1|||
124850706|NCT00908960|449078017|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
124850707|NCT00908960|449078018|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
124850708|NCT00908960|449078019|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
124850709|NCT05074433|449078020|FG000|Overall Study|Adverse Event|0|||
124850710|NCT05074433|449078021|FG001|Overall Study|Adverse Event|2|||
124850711|NCT05074433|449078022|FG002|Overall Study|Adverse Event|0|||
124850712|NCT05074433|449078023|FG003|Overall Study|Adverse Event|1|||
124850713|NCT05074433|449078020|FG000|Overall Study|Sponsor Request|0|||
124850714|NCT05074433|449078021|FG001|Overall Study|Sponsor Request|1|||
124850715|NCT05074433|449078022|FG002|Overall Study|Sponsor Request|1|||
124850716|NCT05074433|449078023|FG003|Overall Study|Sponsor Request|0|||
124850717|NCT05074433|449078020|FG000|Overall Study|Death|1|||
124850718|NCT05074433|449078021|FG001|Overall Study|Death|0|||
124850719|NCT05074433|449078022|FG002|Overall Study|Death|0|||
124850720|NCT05074433|449078023|FG003|Overall Study|Death|0|||
124850721|NCT05074433|449078020|FG000|Overall Study|Lost to Follow-up|0|||
124850722|NCT05074433|449078021|FG001|Overall Study|Lost to Follow-up|0|||
124850723|NCT05074433|449078022|FG002|Overall Study|Lost to Follow-up|2|||
124850724|NCT05074433|449078023|FG003|Overall Study|Lost to Follow-up|0|||
124850725|NCT05074433|449078020|FG000|Overall Study|Subject Decision|8|||
124850726|NCT05074433|449078021|FG001|Overall Study|Subject Decision|6|||
124850727|NCT05074433|449078022|FG002|Overall Study|Subject Decision|4|||
124850728|NCT05074433|449078023|FG003|Overall Study|Subject Decision|5|||
124850729|NCT01158924|449078025|FG000|Overall Study|Withdrawal by Subject|1|||
124850730|NCT01158924|449078026|FG001|Overall Study|Withdrawal by Subject|2|||
124850731|NCT01158924|449078025|FG000|Overall Study|Lost to Follow-up|0|||
124850732|NCT01158924|449078026|FG001|Overall Study|Lost to Follow-up|1|||
124850733|NCT03795922|449078027|FG000|Overall Study|Adverse Event|2|||
124850734|NCT03795922|449078028|FG001|Overall Study|Adverse Event|1|||
124850735|NCT03795922|449078027|FG000|Overall Study|Withdrawal by Subject|5|||
124850736|NCT03795922|449078028|FG001|Overall Study|Withdrawal by Subject|13|||
124850737|NCT03795922|449078027|FG000|Overall Study|Lost to Follow-up|2|||
124850738|NCT03795922|449078028|FG001|Overall Study|Lost to Follow-up|3|||
124850739|NCT03795922|449078027|FG000|Overall Study|Pregnancy|0|||
124850740|NCT03795922|449078028|FG001|Overall Study|Pregnancy|1|||
124850741|NCT03795922|449078027|FG000|Overall Study|Physician Decision|1|||
124850742|NCT03795922|449078028|FG001|Overall Study|Physician Decision|2|||
124850743|NCT03795922|449078027|FG000|Overall Study|Protocol Violation|0|||
124850744|NCT03795922|449078028|FG001|Overall Study|Protocol Violation|1|||
124850745|NCT03795922|449078027|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
124850746|NCT03795922|449078028|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
124850747|NCT00705575|449078029|FG000|Overall Study|Abnormal laboratory value(s)|0|||
124850748|NCT00705575|449078030|FG001|Overall Study|Abnormal laboratory value(s)|3|||
124850749|NCT00705575|449078029|FG000|Overall Study|Abnormal test procedure result(s)|2|||
124850750|NCT00705575|449078030|FG001|Overall Study|Abnormal test procedure result(s)|12|||
124850751|NCT00705575|449078029|FG000|Overall Study|Adverse Event|11|||
124850752|NCT00705575|449078030|FG001|Overall Study|Adverse Event|15|||
124850753|NCT00705575|449078029|FG000|Overall Study|Lost to Follow-up|3|||
124850754|NCT00705575|449078030|FG001|Overall Study|Lost to Follow-up|4|||
124850755|NCT00705575|449078029|FG000|Overall Study|Protocol Violation|2|||
124850756|NCT00705575|449078030|FG001|Overall Study|Protocol Violation|2|||
124850757|NCT00705575|449078029|FG000|Overall Study|Withdrawal by Subject|5|||
124850758|NCT00705575|449078030|FG001|Overall Study|Withdrawal by Subject|10|||
124850759|NCT02822794|449078033|FG000|Overall Study|Withdrew Consent|1|||
124850760|NCT02822794|449078034|FG001|Overall Study|Withdrew Consent|0|||
124850761|NCT03056690|449078035|FG000|Overall Study|Adverse Event|3|||
124850762|NCT03056690|449078036|FG001|Overall Study|Adverse Event|2|||
124850763|NCT03056690|449078035|FG000|Overall Study|Lack of Efficacy|1|||
124850764|NCT03056690|449078036|FG001|Overall Study|Lack of Efficacy|2|||
124850765|NCT03056690|449078035|FG000|Overall Study|Lost to Follow-up|3|||
124850766|NCT03056690|449078036|FG001|Overall Study|Lost to Follow-up|2|||
124850767|NCT03056690|449078035|FG000|Overall Study|Protocol Violation|2|||
124850768|NCT03056690|449078036|FG001|Overall Study|Protocol Violation|2|||
124850769|NCT03056690|449078035|FG000|Overall Study|Withdrawal by Subject|3|||
124850770|NCT03056690|449078036|FG001|Overall Study|Withdrawal by Subject|6|||
124850771|NCT03056690|449078035|FG000|Overall Study|Non-compliance with Study Drug|1|||
124850772|NCT03056690|449078036|FG001|Overall Study|Non-compliance with Study Drug|0|||
124850773|NCT03056690|449078035|FG000|Overall Study|Miscellaneous|1|||
124850774|NCT03056690|449078036|FG001|Overall Study|Miscellaneous|2|||
124850775|NCT01591681|449078049|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
124850776|NCT01591681|449078049|FG000|Overall Study|Failed to use system during run-in|1|||
124850777|NCT00179647|449078050|FG000|Overall Study|Adverse Event|294|||
124850778|NCT00179647|449078050|FG000|Overall Study|Lack of Efficacy|478|||
124850779|NCT00179647|449078050|FG000|Overall Study|Withdrawal by Subject|83|||
124850780|NCT00179647|449078050|FG000|Overall Study|Lost to Follow-up|4|||
124850781|NCT00179647|449078050|FG000|Overall Study|Death|94|||
124850782|NCT00179647|449078050|FG000|Overall Study|Other|960|||
124850783|NCT03027466|449078051|FG000|Overall Study|Opting out of the app|1869|||
124850784|NCT03027466|449078052|FG001|Overall Study|Opting out of the app|1819|||
124850785|NCT03027466|449078053|FG002|Overall Study|Opting out of the app|1743|||
124850786|NCT03027466|449078054|FG003|Overall Study|Opting out of the app|1821|||
124850787|NCT01440946|449078055|FG000|Overall Study|Lost to Follow-up|1|||
124850788|NCT01440946|449078056|FG001|Overall Study|Lost to Follow-up|1|||
124850789|NCT01440946|449078055|FG000|Overall Study|Physician Decision|1|||
124850790|NCT01440946|449078056|FG001|Overall Study|Physician Decision|0|||
124850791|NCT02486406|449078057|FG000|Overall Study|Withdrew consent|1|||
124850792|NCT02486406|449078058|FG001|Overall Study|Withdrew consent|0|||
124850793|NCT02486406|449078059|FG002|Overall Study|Withdrew consent|0|||
124850794|NCT02486406|449078060|FG003|Overall Study|Withdrew consent|1|||
124850795|NCT02486406|449078057|FG000|Overall Study|Lost to Follow-up|1|||
124850796|NCT02486406|449078058|FG001|Overall Study|Lost to Follow-up|3|||
124850797|NCT02486406|449078059|FG002|Overall Study|Lost to Follow-up|1|||
124850798|NCT02486406|449078060|FG003|Overall Study|Lost to Follow-up|3|||
124850799|NCT02486406|449078057|FG000|Overall Study|Other, not specified|0|||
124850800|NCT02486406|449078058|FG001|Overall Study|Other, not specified|0|||
124850801|NCT02486406|449078059|FG002|Overall Study|Other, not specified|1|||
124850802|NCT02486406|449078060|FG003|Overall Study|Other, not specified|0|||
124850803|NCT01826825|449078065|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
124850804|NCT01826825|449078066|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
124850805|NCT01858194|449078067|FG000|Overall Study|Total Artificial Heart Implant|0|||
124850806|NCT01858194|449078068|FG001|Overall Study|Total Artificial Heart Implant|1|||
124850807|NCT01858194|449078067|FG000|Overall Study|Lost to Follow-up|0|||
124850808|NCT01858194|449078068|FG001|Overall Study|Lost to Follow-up|1|||
124850809|NCT03062891|449078069|FG000|Overall Study|Withdrawal by Subject|2|||
124850810|NCT03062891|449078070|FG001|Overall Study|Withdrawal by Subject|0|||
124850811|NCT03062891|449078069|FG000|Overall Study|Lost to Follow-up|50|||
124850812|NCT03062891|449078070|FG001|Overall Study|Lost to Follow-up|38|||
124850813|NCT02127307|449078071|FG000|Overall Study|Protocol Violation|36|||
124850814|NCT02127307|449078071|FG000|Overall Study|Lost to Follow-up|2|||
124850815|NCT02127307|449078071|FG000|Overall Study|Death|101|||
124850816|NCT02127307|449078071|FG000|Overall Study|Other than specified above|169|||
124850817|NCT03221257|449078072|FG000|Overall Study|Lost to Follow-up|0|||
124850818|NCT03221257|449078073|FG001|Overall Study|Lost to Follow-up|1|||
124850819|NCT03221257|449078072|FG000|Overall Study|Withdrawal by Subject|1|||
124850820|NCT03221257|449078073|FG001|Overall Study|Withdrawal by Subject|1|||
124850821|NCT01687166|449078085|FG000|Overall Study|Attempt subject|2|||
124850822|NCT01687166|449078086|FG001|Overall Study|Attempt subject|3|||
124850823|NCT01687166|449078087|FG002|Overall Study|Attempt subject|2|||
124850824|NCT01687166|449078088|FG003|Overall Study|Attempt subject|0|||
124850825|NCT01687166|449078085|FG000|Overall Study|Did not meet eligibility criteria|4|||
124850826|NCT01687166|449078086|FG001|Overall Study|Did not meet eligibility criteria|6|||
124850827|NCT01687166|449078087|FG002|Overall Study|Did not meet eligibility criteria|1|||
124850828|NCT01687166|449078088|FG003|Overall Study|Did not meet eligibility criteria|1|||
124850829|NCT01687166|449078085|FG000|Overall Study|Adverse Event|2|||
124850830|NCT01687166|449078086|FG001|Overall Study|Adverse Event|1|||
124850831|NCT01687166|449078087|FG002|Overall Study|Adverse Event|0|||
124850832|NCT01687166|449078088|FG003|Overall Study|Adverse Event|0|||
124850833|NCT01687166|449078085|FG000|Overall Study|Physician Decision|3|||
124850834|NCT01687166|449078086|FG001|Overall Study|Physician Decision|2|||
124850835|NCT01687166|449078087|FG002|Overall Study|Physician Decision|1|||
124850836|NCT01687166|449078088|FG003|Overall Study|Physician Decision|0|||
124850837|NCT01687166|449078085|FG000|Overall Study|Withdrawal by Subject|11|||
124850838|NCT01687166|449078086|FG001|Overall Study|Withdrawal by Subject|4|||
124850839|NCT01687166|449078087|FG002|Overall Study|Withdrawal by Subject|3|||
124850840|NCT01687166|449078088|FG003|Overall Study|Withdrawal by Subject|0|||
124850841|NCT01687166|449078085|FG000|Overall Study|Lost to Follow-up|2|||
124850842|NCT01687166|449078086|FG001|Overall Study|Lost to Follow-up|5|||
124850843|NCT01687166|449078087|FG002|Overall Study|Lost to Follow-up|1|||
124850844|NCT01687166|449078088|FG003|Overall Study|Lost to Follow-up|0|||
124850845|NCT01687166|449078085|FG000|Overall Study|Equipment/Device Availability|0|||
124850846|NCT01687166|449078086|FG001|Overall Study|Equipment/Device Availability|1|||
124850847|NCT01687166|449078087|FG002|Overall Study|Equipment/Device Availability|0|||
124850848|NCT01687166|449078088|FG003|Overall Study|Equipment/Device Availability|0|||
124850849|NCT01687166|449078085|FG000|Overall Study|Death|1|||
124850850|NCT01687166|449078086|FG001|Overall Study|Death|1|||
124850851|NCT01687166|449078087|FG002|Overall Study|Death|0|||
124850852|NCT01687166|449078088|FG003|Overall Study|Death|0|||
124850853|NCT01687166|449078085|FG000|Overall Study|Protocol Violation|1|||
124850854|NCT01687166|449078086|FG001|Overall Study|Protocol Violation|1|||
124850855|NCT01687166|449078087|FG002|Overall Study|Protocol Violation|1|||
124850856|NCT01687166|449078088|FG003|Overall Study|Protocol Violation|0|||
124850857|NCT01687166|449078085|FG000|Overall Study|Subject moved out of state|0|||
124850858|NCT01687166|449078086|FG001|Overall Study|Subject moved out of state|1|||
124850859|NCT01687166|449078087|FG002|Overall Study|Subject moved out of state|0|||
124850860|NCT01687166|449078088|FG003|Overall Study|Subject moved out of state|0|||
124850861|NCT01687166|449078085|FG000|Overall Study|Patient unable to be compliant|1|||
124850862|NCT01687166|449078086|FG001|Overall Study|Patient unable to be compliant|0|||
124850863|NCT01687166|449078087|FG002|Overall Study|Patient unable to be compliant|0|||
124850864|NCT01687166|449078088|FG003|Overall Study|Patient unable to be compliant|0|||
124850865|NCT01687166|449078085|FG000|Overall Study|Physician choice to use different device|1|||
124850866|NCT01687166|449078086|FG001|Overall Study|Physician choice to use different device|2|||
124850867|NCT01687166|449078087|FG002|Overall Study|Physician choice to use different device|4|||
124850868|NCT01687166|449078088|FG003|Overall Study|Physician choice to use different device|0|||
124850869|NCT01687166|449078085|FG000|Overall Study|Insurance|0|||
124850870|NCT01687166|449078086|FG001|Overall Study|Insurance|0|||
124850871|NCT01687166|449078087|FG002|Overall Study|Insurance|1|||
124850872|NCT01687166|449078088|FG003|Overall Study|Insurance|1|||
124850873|NCT02296112|449078089|FG000|Overall Study|Disease progression|7|||
124850874|NCT02296112|449078089|FG000|Overall Study|Toxicity|1|||
124850875|NCT02296112|449078089|FG000|Overall Study|Began an alternate therapy|1|||
124850876|NCT02442830|449078090|FG000|Overall Study|Technical Failure|0|||
124850877|NCT02442830|449078091|FG001|Overall Study|Technical Failure|1|||
124850878|NCT01516879|449078092|FG000|Overall Study|Withdrawal by Subject|9|||
124850879|NCT01516879|449078093|FG001|Overall Study|Withdrawal by Subject|11|||
124850880|NCT01516879|449078092|FG000|Overall Study|Death|0|||
124850881|NCT01516879|449078093|FG001|Overall Study|Death|2|||
124850882|NCT01516879|449078092|FG000|Overall Study|Lost to Follow-up|2|||
124850883|NCT01516879|449078093|FG001|Overall Study|Lost to Follow-up|11|||
124850884|NCT01516879|449078092|FG000|Overall Study|Other|5|||
124850885|NCT01516879|449078093|FG001|Overall Study|Other|10|||
124850886|NCT00183872|449078094|FG000|Overall Study|Death|3|||
124850887|NCT00183872|449078094|FG000|Overall Study|Adverse Event|9|||
124850888|NCT00183872|449078094|FG000|Overall Study|Withdrawal by Subject|2|||
124850889|NCT00183872|449078094|FG000|Overall Study|Drug delayed more than 28 days|2|||
124850890|NCT02797262|449078095|FG000|Overall Study|Withdrawal by Subject|5|||
124850891|NCT02797262|449078096|FG001|Overall Study|Withdrawal by Subject|1|||
124850892|NCT02797262|449078095|FG000|Overall Study|Lost to Follow-up|10|||
124850893|NCT02797262|449078096|FG001|Overall Study|Lost to Follow-up|7|||
124850894|NCT02797262|449078095|FG000|Overall Study|Death|1|||
124850895|NCT02797262|449078096|FG001|Overall Study|Death|2|||
124850896|NCT02797262|449078095|FG000|Overall Study|Adverse Event|1|||
124850897|NCT02797262|449078096|FG001|Overall Study|Adverse Event|0|||
124850898|NCT02797262|449078095|FG000|Overall Study|COVID-19|2|||
124850899|NCT02797262|449078096|FG001|Overall Study|COVID-19|1|||
124850900|NCT02797262|449078095|FG000|Overall Study|Out-of-country|1|||
124850901|NCT02797262|449078096|FG001|Overall Study|Out-of-country|0|||
124850902|NCT01600586|449078097|FG000|Overall Study|Physician Decision|3|||
124850903|NCT01600586|449078098|FG001|Overall Study|Physician Decision|3|||
124850904|NCT01898793|449078099|FG000|Overall Study|Death|2|||
124850905|NCT01898793|449078100|FG001|Overall Study|Death|1|||
124850906|NCT01898793|449078101|FG002|Overall Study|Death|4|||
124850907|NCT01898793|449078102|FG003|Overall Study|Death|0|||
124850908|NCT01898793|449078103|FG004|Overall Study|Death|0|||
124850909|NCT01898793|449078104|FG005|Overall Study|Death|0|||
124850910|NCT01898793|449078105|FG006|Overall Study|Death|0|||
124850911|NCT00931307|449078106|FG000|Overall Study|Lack of Efficacy|12|||
124850912|NCT00931307|449078106|FG000|Overall Study|Biomicroscopy|1|||
124850913|NCT00983814|449078107|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
124850914|NCT00983814|449078108|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
124850915|NCT00983814|449078109|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
124850916|NCT00983814|449078107|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
124850917|NCT00983814|449078108|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
124850918|NCT00983814|449078109|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
124850919|NCT00983814|449078107|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
124850920|NCT00983814|449078108|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
124850921|NCT00983814|449078109|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
124850922|NCT00983814|449078107|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
124850923|NCT00983814|449078108|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
124850924|NCT00983814|449078109|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
124850925|NCT00983814|449078107|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
124850926|NCT00983814|449078108|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
124850927|NCT00983814|449078109|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
124850928|NCT00829621|449078110|FG000|Overall Study|Death|1|||
124850929|NCT00829621|449078111|FG001|Overall Study|Death|0|||
124850930|NCT00829621|449078110|FG000|Overall Study|Lost to Follow-up|3|||
124850931|NCT00829621|449078111|FG001|Overall Study|Lost to Follow-up|4|||
124850932|NCT02766608|449079651|FG000|Overall Study|Adverse Event|27|||
124850933|NCT02766608|449079652|FG001|Overall Study|Adverse Event|22|||
124850934|NCT02766608|449079653|FG002|Overall Study|Adverse Event|17|||
124850935|NCT02766608|449079654|FG003|Overall Study|Adverse Event|13|||
124850936|NCT02766608|449079655|FG004|Overall Study|Adverse Event|12|||
124850937|NCT02766608|449079651|FG000|Overall Study|Withdrawal by Subject|21|||
124850938|NCT02766608|449079652|FG001|Overall Study|Withdrawal by Subject|20|||
124850939|NCT02766608|449079653|FG002|Overall Study|Withdrawal by Subject|24|||
124850940|NCT02766608|449079654|FG003|Overall Study|Withdrawal by Subject|13|||
124850941|NCT02766608|449079655|FG004|Overall Study|Withdrawal by Subject|10|||
124850942|NCT02766608|449079651|FG000|Overall Study|Lack of Efficacy|16|||
124850943|NCT02766608|449079652|FG001|Overall Study|Lack of Efficacy|15|||
124850944|NCT02766608|449079653|FG002|Overall Study|Lack of Efficacy|32|||
124850945|NCT02766608|449079654|FG003|Overall Study|Lack of Efficacy|8|||
124850946|NCT02766608|449079655|FG004|Overall Study|Lack of Efficacy|2|||
124850947|NCT02766608|449079651|FG000|Overall Study|Lost to Follow-up|6|||
124850948|NCT02766608|449079652|FG001|Overall Study|Lost to Follow-up|3|||
124850949|NCT02766608|449079653|FG002|Overall Study|Lost to Follow-up|5|||
124850950|NCT02766608|449079654|FG003|Overall Study|Lost to Follow-up|2|||
124850951|NCT02766608|449079655|FG004|Overall Study|Lost to Follow-up|2|||
124850952|NCT02766608|449079651|FG000|Overall Study|Physician Decision|3|||
124850953|NCT02766608|449079652|FG001|Overall Study|Physician Decision|2|||
124850954|NCT02766608|449079653|FG002|Overall Study|Physician Decision|3|||
124850955|NCT02766608|449079654|FG003|Overall Study|Physician Decision|1|||
124850956|NCT02766608|449079655|FG004|Overall Study|Physician Decision|2|||
124850957|NCT02766608|449079651|FG000|Overall Study|Protocol disc criteria|3|||
124850958|NCT02766608|449079652|FG001|Overall Study|Protocol disc criteria|3|||
124850959|NCT02766608|449079653|FG002|Overall Study|Protocol disc criteria|4|||
124850960|NCT02766608|449079654|FG003|Overall Study|Protocol disc criteria|0|||
124850961|NCT02766608|449079655|FG004|Overall Study|Protocol disc criteria|0|||
124850962|NCT02766608|449079651|FG000|Overall Study|Protocol Violation|0|||
124850963|NCT02766608|449079652|FG001|Overall Study|Protocol Violation|4|||
124850964|NCT02766608|449079653|FG002|Overall Study|Protocol Violation|4|||
124850965|NCT02766608|449079654|FG003|Overall Study|Protocol Violation|0|||
124850966|NCT02766608|449079655|FG004|Overall Study|Protocol Violation|1|||
124850967|NCT02766608|449079651|FG000|Overall Study|Administrative Reasons|3|||
124850968|NCT02766608|449079652|FG001|Overall Study|Administrative Reasons|1|||
124850969|NCT02766608|449079653|FG002|Overall Study|Administrative Reasons|1|||
124850970|NCT02766608|449079654|FG003|Overall Study|Administrative Reasons|0|||
124850971|NCT02766608|449079655|FG004|Overall Study|Administrative Reasons|0|||
124850972|NCT02066298|449079656|FG000|Overall Study|Lost to Follow-up|3|||
124850973|NCT02066298|449079657|FG001|Overall Study|Lost to Follow-up|2|||
124850974|NCT02066298|449079658|FG002|Overall Study|Lost to Follow-up|3|||
124850975|NCT02066298|449079659|FG003|Overall Study|Lost to Follow-up|2|||
124850976|NCT02066298|449079660|FG004|Overall Study|Lost to Follow-up|3|||
124850977|NCT02066298|449079661|FG005|Overall Study|Lost to Follow-up|4|||
124850978|NCT02066298|449079656|FG000|Overall Study|Withdrawal by Subject|6|||
124850979|NCT02066298|449079657|FG001|Overall Study|Withdrawal by Subject|6|||
124850980|NCT02066298|449079658|FG002|Overall Study|Withdrawal by Subject|6|||
124850981|NCT02066298|449079659|FG003|Overall Study|Withdrawal by Subject|4|||
124850982|NCT02066298|449079660|FG004|Overall Study|Withdrawal by Subject|5|||
124850983|NCT02066298|449079661|FG005|Overall Study|Withdrawal by Subject|8|||
124850984|NCT02066298|449079656|FG000|Overall Study|Physician Decision|0|||
124850985|NCT02066298|449079657|FG001|Overall Study|Physician Decision|0|||
124850986|NCT02066298|449079658|FG002|Overall Study|Physician Decision|1|||
124850987|NCT02066298|449079659|FG003|Overall Study|Physician Decision|0|||
124850988|NCT02066298|449079660|FG004|Overall Study|Physician Decision|1|||
124850989|NCT02066298|449079661|FG005|Overall Study|Physician Decision|0|||
124850990|NCT02343458|449079666|FG000|Overall Study|Adverse Event|15|||
124850991|NCT02343458|449079667|FG001|Overall Study|Adverse Event|14|||
124850992|NCT02343458|449079668|FG002|Overall Study|Adverse Event|15|||
124850993|NCT02343458|449079669|FG003|Overall Study|Adverse Event|3|||
124850994|NCT02343458|449079666|FG000|Overall Study|Lack of Efficacy|3|||
124850995|NCT02343458|449079667|FG001|Overall Study|Lack of Efficacy|8|||
124850996|NCT02343458|449079668|FG002|Overall Study|Lack of Efficacy|4|||
124850997|NCT02343458|449079669|FG003|Overall Study|Lack of Efficacy|8|||
124850998|NCT02343458|449079666|FG000|Overall Study|Withdrawal by Subject|18|||
124850999|NCT02343458|449079667|FG001|Overall Study|Withdrawal by Subject|17|||
124851000|NCT02343458|449079668|FG002|Overall Study|Withdrawal by Subject|23|||
124851001|NCT02343458|449079669|FG003|Overall Study|Withdrawal by Subject|14|||
124851002|NCT02343458|449079666|FG000|Overall Study|Physician Decision|1|||
124851003|NCT02343458|449079667|FG001|Overall Study|Physician Decision|4|||
124851004|NCT02343458|449079668|FG002|Overall Study|Physician Decision|2|||
124851005|NCT02343458|449079669|FG003|Overall Study|Physician Decision|2|||
124851006|NCT02343458|449079666|FG000|Overall Study|Lost to Follow-up|5|||
124851007|NCT02343458|449079667|FG001|Overall Study|Lost to Follow-up|5|||
124851008|NCT02343458|449079668|FG002|Overall Study|Lost to Follow-up|3|||
124851009|NCT02343458|449079669|FG003|Overall Study|Lost to Follow-up|1|||
124851010|NCT02343458|449079666|FG000|Overall Study|Protocol Violation|2|||
124851011|NCT02343458|449079667|FG001|Overall Study|Protocol Violation|5|||
124851012|NCT02343458|449079668|FG002|Overall Study|Protocol Violation|2|||
124851013|NCT02343458|449079669|FG003|Overall Study|Protocol Violation|2|||
124851014|NCT02343458|449079666|FG000|Overall Study|Protocol Specified Criteria|17|||
124851015|NCT02343458|449079667|FG001|Overall Study|Protocol Specified Criteria|13|||
124851016|NCT02343458|449079668|FG002|Overall Study|Protocol Specified Criteria|14|||
124851017|NCT02343458|449079669|FG003|Overall Study|Protocol Specified Criteria|8|||
124851018|NCT01913041|449079670|FG000|Overall Study|Protocol Violation|35|||
124851019|NCT01913041|449079670|FG000|Overall Study|Withdrawal by Subject|3|||
124851020|NCT01913041|449079670|FG000|Overall Study|Physician Decision|1|||
124851021|NCT01265953|449079672|FG000|Overall Study|Non compliance|5|||
124851022|NCT01265953|449079673|FG001|Overall Study|Non compliance|3|||
124851023|NCT01610700|449079674|FG000|Overall Study|Adverse Event|3|||
124851024|NCT01610700|449079675|FG001|Overall Study|Adverse Event|1|||
124851025|NCT01610700|449079674|FG000|Overall Study|Withdrawal by Subject|0|||
124851026|NCT01610700|449079675|FG001|Overall Study|Withdrawal by Subject|1|||
124851027|NCT01610700|449079674|FG000|Overall Study|subject took one dose of street cannabis|0|||
124851028|NCT01610700|449079675|FG001|Overall Study|subject took one dose of street cannabis|1|||
124851029|NCT02648698|449079676|FG000|Overall Study|Protocol Violation|1|||
124851030|NCT02648698|449079677|FG001|Overall Study|Protocol Violation|5|||
124851031|NCT01640301|449079678|FG000|Overall Study|Death|0|||
124851032|NCT01640301|449079679|FG001|Overall Study|Death|8|||
124851033|NCT00672477|449079682|FG000|Overall Study|Adverse Event|10|||
124851034|NCT00672477|449079683|FG001|Overall Study|Adverse Event|7|||
124851035|NCT00672477|449079682|FG000|Overall Study|Death|7|||
124851036|NCT00672477|449079683|FG001|Overall Study|Death|11|||
124851037|NCT00672477|449079682|FG000|Overall Study|Physician Decision|2|||
124851038|NCT00672477|449079683|FG001|Overall Study|Physician Decision|0|||
124851039|NCT00672477|449079682|FG000|Overall Study|Protocol Violation|1|||
124851040|NCT00672477|449079683|FG001|Overall Study|Protocol Violation|1|||
124851041|NCT00672477|449079682|FG000|Overall Study|Withdrawal by Subject|5|||
124851042|NCT00672477|449079683|FG001|Overall Study|Withdrawal by Subject|3|||
124851043|NCT00672477|449079682|FG000|Overall Study|Lack of Efficacy|1|||
124851044|NCT00672477|449079683|FG001|Overall Study|Lack of Efficacy|1|||
124851045|NCT00672477|449079682|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
124851046|NCT00672477|449079683|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
124851047|NCT02348489|449079684|FG000|Overall Study|Death|336|||
124851048|NCT02348489|449079685|FG001|Overall Study|Death|335|||
124851049|NCT02348489|449079684|FG000|Overall Study|Withdrawal by Subject|14|||
124851050|NCT02348489|449079685|FG001|Overall Study|Withdrawal by Subject|27|||
124851051|NCT02348489|449079684|FG000|Overall Study|Lost to Follow-up|3|||
124851052|NCT02348489|449079685|FG001|Overall Study|Lost to Follow-up|5|||
124851053|NCT01639001|449079686|FG000|Overall Study|Refused further follow-up|9|||
124851054|NCT01639001|449079687|FG001|Overall Study|Refused further follow-up|12|||
124851055|NCT01639001|449079686|FG000|Overall Study|Lost to Follow-up|3|||
124851056|NCT01639001|449079687|FG001|Overall Study|Lost to Follow-up|0|||
124851057|NCT01639001|449079686|FG000|Overall Study|Death|62|||
124851058|NCT01639001|449079687|FG001|Overall Study|Death|61|||
124851059|NCT01639001|449079686|FG000|Overall Study|Randomized but not treated|0|||
124851060|NCT01639001|449079687|FG001|Overall Study|Randomized but not treated|2|||
124851061|NCT01639001|449079686|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
124851062|NCT01639001|449079687|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
124851063|NCT02866682|449079688|FG000|Overall Study|Death|0|||
124851064|NCT02866682|449079689|FG001|Overall Study|Death|1|||
124851065|NCT02866682|449079688|FG000|Overall Study|Lost to Follow-up|0|||
124851066|NCT02866682|449079689|FG001|Overall Study|Lost to Follow-up|4|||
124851067|NCT02866682|449079688|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
124851068|NCT02866682|449079689|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
124851069|NCT02866682|449079688|FG000|Overall Study|Other|0|||
124851070|NCT02866682|449079689|FG001|Overall Study|Other|1|||
124851071|NCT00201006|449079690|FG000|Overall Study|Withdrawal by Subject|7|||
124851072|NCT00201006|449079691|FG001|Overall Study|Withdrawal by Subject|2|||
124851073|NCT00201006|449079692|FG002|Overall Study|Withdrawal by Subject|3|||
124851074|NCT00201006|449079690|FG000|Overall Study|Adverse Event|1|||
124851075|NCT00201006|449079691|FG001|Overall Study|Adverse Event|0|||
124851076|NCT00201006|449079692|FG002|Overall Study|Adverse Event|1|||
124851077|NCT00274716|449079696|FG000|Phase A|Other non-reported reason|4|||
124851078|NCT00274716|449079697|FG001|Phase A|Other non-reported reason|2|||
124851079|NCT00274716|449079698|FG002|Phase A|Other non-reported reason|1|||
124851080|NCT00274716|449079699|FG003|Phase A|Other non-reported reason|2|||
124851081|NCT00274716|449079700|FG004|Phase A|Other non-reported reason|0|||
124851082|NCT00274716|449079701|FG005|Phase A|Other non-reported reason|1|||
124851083|NCT00274716|449079696|FG000|Phase A|Participant moved|0|||
124851084|NCT00274716|449079697|FG001|Phase A|Participant moved|0|||
124851085|NCT00274716|449079698|FG002|Phase A|Participant moved|1|||
124851086|NCT00274716|449079699|FG003|Phase A|Participant moved|0|||
124851087|NCT00274716|449079700|FG004|Phase A|Participant moved|0|||
124851088|NCT00274716|449079701|FG005|Phase A|Participant moved|1|||
124851089|NCT00274716|449079696|FG000|Phase A|Site Terminated|0|||
124851090|NCT00274716|449079697|FG001|Phase A|Site Terminated|0|||
124851091|NCT00274716|449079698|FG002|Phase A|Site Terminated|0|||
124851092|NCT00274716|449079699|FG003|Phase A|Site Terminated|1|||
124851093|NCT00274716|449079700|FG004|Phase A|Site Terminated|0|||
124851094|NCT00274716|449079701|FG005|Phase A|Site Terminated|0|||
124851095|NCT00274716|449079696|FG000|Phase A|Protocol Violation|1|||
124851096|NCT00274716|449079697|FG001|Phase A|Protocol Violation|0|||
124851097|NCT00274716|449079698|FG002|Phase A|Protocol Violation|0|||
124851098|NCT00274716|449079699|FG003|Phase A|Protocol Violation|1|||
124851099|NCT00274716|449079700|FG004|Phase A|Protocol Violation|0|||
124851100|NCT00274716|449079701|FG005|Phase A|Protocol Violation|0|||
124851101|NCT00274716|449079696|FG000|Phase A|Met criteria for discontinuation|1|||
124851102|NCT00274716|449079697|FG001|Phase A|Met criteria for discontinuation|1|||
124851103|NCT00274716|449079698|FG002|Phase A|Met criteria for discontinuation|0|||
124851104|NCT00274716|449079699|FG003|Phase A|Met criteria for discontinuation|0|||
124851105|NCT00274716|449079700|FG004|Phase A|Met criteria for discontinuation|0|||
124851106|NCT00274716|449079701|FG005|Phase A|Met criteria for discontinuation|0|||
124851107|NCT00274716|449079696|FG000|Phase A|Withdrawal by Subject|2|||
124851108|NCT00274716|449079697|FG001|Phase A|Withdrawal by Subject|2|||
124851109|NCT00274716|449079698|FG002|Phase A|Withdrawal by Subject|1|||
124851110|NCT00274716|449079699|FG003|Phase A|Withdrawal by Subject|3|||
124851111|NCT00274716|449079700|FG004|Phase A|Withdrawal by Subject|0|||
124851112|NCT00274716|449079701|FG005|Phase A|Withdrawal by Subject|1|||
124851113|NCT00274716|449079696|FG000|Phase A|Adverse Event|2|||
124851114|NCT00274716|449079697|FG001|Phase A|Adverse Event|3|||
124851115|NCT00274716|449079698|FG002|Phase A|Adverse Event|3|||
124851116|NCT00274716|449079699|FG003|Phase A|Adverse Event|0|||
124851117|NCT00274716|449079700|FG004|Phase A|Adverse Event|2|||
124851118|NCT00274716|449079701|FG005|Phase A|Adverse Event|0|||
124851119|NCT00274716|449079696|FG000|Phase A|Completed but did not enter Phase B|1|||
124851120|NCT00274716|449079697|FG001|Phase A|Completed but did not enter Phase B|2|||
124851121|NCT00274716|449079698|FG002|Phase A|Completed but did not enter Phase B|2|||
124851122|NCT00274716|449079699|FG003|Phase A|Completed but did not enter Phase B|2|||
124851123|NCT00274716|449079700|FG004|Phase A|Completed but did not enter Phase B|1|||
124851124|NCT00274716|449079701|FG005|Phase A|Completed but did not enter Phase B|1|||
124851125|NCT00274716|449079696|FG000|Phase B|Adverse Event|0|||
124851126|NCT00274716|449079697|FG001|Phase B|Adverse Event|0|||
124851127|NCT00274716|449079698|FG002|Phase B|Adverse Event|2|||
124851128|NCT00274716|449079699|FG003|Phase B|Adverse Event|0|||
124851129|NCT00274716|449079700|FG004|Phase B|Adverse Event|0|||
124851130|NCT00274716|449079701|FG005|Phase B|Adverse Event|1|||
124851131|NCT00274716|449079696|FG000|Phase B|Protocol Violation|0|||
124851132|NCT00274716|449079697|FG001|Phase B|Protocol Violation|2|||
124851133|NCT00274716|449079698|FG002|Phase B|Protocol Violation|0|||
124851134|NCT00274716|449079699|FG003|Phase B|Protocol Violation|0|||
124851135|NCT00274716|449079700|FG004|Phase B|Protocol Violation|0|||
124851136|NCT00274716|449079701|FG005|Phase B|Protocol Violation|0|||
124851137|NCT00274716|449079696|FG000|Phase B|Withdrawal by Subject|0|||
124851138|NCT00274716|449079697|FG001|Phase B|Withdrawal by Subject|1|||
124851139|NCT00274716|449079698|FG002|Phase B|Withdrawal by Subject|0|||
124851140|NCT00274716|449079699|FG003|Phase B|Withdrawal by Subject|0|||
124851141|NCT00274716|449079700|FG004|Phase B|Withdrawal by Subject|0|||
124851142|NCT00274716|449079701|FG005|Phase B|Withdrawal by Subject|0|||
124851143|NCT00274716|449079696|FG000|Phase B|Participant moved|1|||
124851144|NCT00274716|449079697|FG001|Phase B|Participant moved|0|||
124851145|NCT00274716|449079698|FG002|Phase B|Participant moved|0|||
124851146|NCT00274716|449079699|FG003|Phase B|Participant moved|0|||
124851147|NCT00274716|449079700|FG004|Phase B|Participant moved|0|||
124851148|NCT00274716|449079701|FG005|Phase B|Participant moved|0|||
124851149|NCT00274716|449079696|FG000|Phase B|Other non-reported reason|0|||
124851150|NCT00274716|449079697|FG001|Phase B|Other non-reported reason|0|||
124851151|NCT00274716|449079698|FG002|Phase B|Other non-reported reason|1|||
124851152|NCT00274716|449079699|FG003|Phase B|Other non-reported reason|1|||
124851153|NCT00274716|449079700|FG004|Phase B|Other non-reported reason|0|||
124851154|NCT00274716|449079701|FG005|Phase B|Other non-reported reason|0|||
124851155|NCT00274716|449079696|FG000|Phase B|Lost to Follow-up|0|||
124851156|NCT00274716|449079697|FG001|Phase B|Lost to Follow-up|1|||
124851157|NCT00274716|449079698|FG002|Phase B|Lost to Follow-up|0|||
124851158|NCT00274716|449079699|FG003|Phase B|Lost to Follow-up|0|||
124851159|NCT00274716|449079700|FG004|Phase B|Lost to Follow-up|0|||
124851160|NCT00274716|449079701|FG005|Phase B|Lost to Follow-up|0|||
124851161|NCT00975975|449079704|FG000|Overall Study|Death|6|||
124851162|NCT00961259|449079705|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
124851163|NCT00961259|449079706|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
124851164|NCT00961259|449079707|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
124851165|NCT01252251|449079710|FG000|Overall Study|Withdrawal by Subject|1|||
124851166|NCT01324024|449079711|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
124851167|NCT01324024|449079712|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
124851168|NCT02057757|449079718|FG000|Overall Study|Withdrawal by Subject|3|||
124851169|NCT02057757|449079719|FG001|Overall Study|Withdrawal by Subject|5|||
124851170|NCT02057757|449079718|FG000|Overall Study|Death|2|||
124851171|NCT02057757|449079719|FG001|Overall Study|Death|0|||
124851172|NCT02057757|449079718|FG000|Overall Study|Lost to Follow-up|8|||
124851173|NCT02057757|449079719|FG001|Overall Study|Lost to Follow-up|3|||
124851174|NCT02057757|449079718|FG000|Overall Study|Non-compliance|1|||
124851175|NCT02057757|449079719|FG001|Overall Study|Non-compliance|0|||
124851176|NCT03614793|449079720|FG000|Overall Study|Lost to Follow-up|1|||
124851177|NCT03614793|449079721|FG001|Overall Study|Lost to Follow-up|2|||
124851178|NCT03614793|449079720|FG000|Overall Study|Lack of Efficacy|0|||
124851179|NCT03614793|449079721|FG001|Overall Study|Lack of Efficacy|5|||
124851180|NCT03614793|449079720|FG000|Overall Study|Withdrawal by Subject|0|||
124851181|NCT03614793|449079721|FG001|Overall Study|Withdrawal by Subject|1|||
124851182|NCT03614793|449079720|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
124851183|NCT03614793|449079721|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
124851184|NCT02082522|449079722|FG000|Overall Study|Sponsor termination|5|||
124851185|NCT02082522|449079723|FG001|Overall Study|Sponsor termination|3|||
124851186|NCT02082522|449079722|FG000|Overall Study|Withdrawal by Subject|2|||
124851187|NCT02082522|449079723|FG001|Overall Study|Withdrawal by Subject|4|||
124851188|NCT02082522|449079722|FG000|Overall Study|Death|1|||
124851189|NCT02082522|449079723|FG001|Overall Study|Death|0|||
124851190|NCT02082522|449079722|FG000|Overall Study|Lost to Follow-up|1|||
124851191|NCT02082522|449079723|FG001|Overall Study|Lost to Follow-up|0|||
124851192|NCT02082522|449079722|FG000|Overall Study|Physician Decision|3|||
124851193|NCT02082522|449079723|FG001|Overall Study|Physician Decision|1|||
124851194|NCT02082522|449079722|FG000|Overall Study|Disease progression|2|||
124851195|NCT02082522|449079723|FG001|Overall Study|Disease progression|2|||
124851196|NCT02082522|449079722|FG000|Overall Study|Chemotherapy change|1|||
124851197|NCT02082522|449079723|FG001|Overall Study|Chemotherapy change|3|||
124851198|NCT00456092|449079724|FG000|Extension Phase|Grade 2 or Greater AE|2|||
124851199|NCT00456092|449079725|FG001|Extension Phase|Grade 2 or Greater AE|2|||
124851200|NCT00456092|449079726|FG002|Extension Phase|Grade 2 or Greater AE|0|||
124851201|NCT00456092|449079727|FG003|Extension Phase|Grade 2 or Greater AE|0|||
124851202|NCT00456092|449079728|FG004|Extension Phase|Grade 2 or Greater AE|2|||
124851203|NCT00456092|449079724|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
124851204|NCT00456092|449079725|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
124851205|NCT00456092|449079726|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
124851206|NCT00456092|449079727|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
124851207|NCT00456092|449079728|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
124851208|NCT00456092|449079724|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
124851209|NCT00456092|449079725|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
124851210|NCT00456092|449079726|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
124851211|NCT00456092|449079727|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
124851212|NCT00456092|449079728|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
124851213|NCT00456092|449079724|FG000|Extension Phase|Withdrew Consent|2|||
124851214|NCT00456092|449079725|FG001|Extension Phase|Withdrew Consent|0|||
124851215|NCT00456092|449079726|FG002|Extension Phase|Withdrew Consent|0|||
124851216|NCT00456092|449079727|FG003|Extension Phase|Withdrew Consent|0|||
124851217|NCT00456092|449079728|FG004|Extension Phase|Withdrew Consent|0|||
124851218|NCT00456092|449079724|FG000|Extension Phase|Lost to Follow-up|1|||
124851219|NCT00456092|449079725|FG001|Extension Phase|Lost to Follow-up|1|||
124851220|NCT00456092|449079726|FG002|Extension Phase|Lost to Follow-up|0|||
124851221|NCT00456092|449079727|FG003|Extension Phase|Lost to Follow-up|0|||
124851222|NCT00456092|449079728|FG004|Extension Phase|Lost to Follow-up|1|||
124851223|NCT00456092|449079724|FG000|Extension Phase|Other|2|||
124851224|NCT00456092|449079725|FG001|Extension Phase|Other|0|||
124851225|NCT00456092|449079726|FG002|Extension Phase|Other|0|||
124851226|NCT00456092|449079727|FG003|Extension Phase|Other|1|||
124851227|NCT00456092|449079728|FG004|Extension Phase|Other|1|||
124851228|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
124851229|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
124851230|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
124851231|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
124851232|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
124851233|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
124851234|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
124851235|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
124851236|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
124851237|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
124851238|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
124851239|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
124851240|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
124851241|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
124851242|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
124851243|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
124851244|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
124851245|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
124851246|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
124851247|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
124851248|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
124851249|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
124851250|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
124851251|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
124851252|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
124851253|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
124851254|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
124851255|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
124851256|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
124851257|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
124851258|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
124851259|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
124851260|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
124851261|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
124851262|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
124851263|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
124851264|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
124851265|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
124851266|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
124851267|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
124851268|NCT00456092|449079724|FG000|Treatment Phase (12 Weeks)|Other|1|||
124851269|NCT00456092|449079725|FG001|Treatment Phase (12 Weeks)|Other|0|||
124851270|NCT00456092|449079726|FG002|Treatment Phase (12 Weeks)|Other|1|||
124851271|NCT00456092|449079727|FG003|Treatment Phase (12 Weeks)|Other|0|||
124851272|NCT00456092|449079728|FG004|Treatment Phase (12 Weeks)|Other|0|||
124851273|NCT02840877|449079729|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
124851274|NCT02840877|449079729|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
124851275|NCT02840877|449079729|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
124851276|NCT02840877|449079729|FG000|Baseline to 12 Weeks|Death|1|||
124851277|NCT02840877|449079729|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
124851278|NCT02840877|449079729|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
124851279|NCT02840877|449079729|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
124851280|NCT02840877|449079729|FG000|12 Weeks to 6 Months|Treatment failure|1|||
124851281|NCT02840877|449079729|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
124851282|NCT02840877|449079729|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
124851283|NCT02840877|449079729|FG000|12 Weeks to 6 Months|Death|1|||
124851284|NCT02840877|449079729|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
124851285|NCT02840877|449079729|FG000|6 Months to 18 Months|Treatment failure|7|||
124851286|NCT02840877|449079729|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
124851287|NCT02840877|449079729|FG000|6 Months to 18 Months|Moved/transferred out|6|||
124851288|NCT02840877|449079729|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
124851289|NCT02840877|449079729|FG000|6 Months to 18 Months|Death|4|||
124851290|NCT02840877|449079729|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
124851291|NCT02840877|449079729|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
124851292|NCT02840877|449079729|FG000|6 Months to 18 Months|Still in study.|14|||
124851293|NCT01168999|449079730|FG000|Overall Study|Lost to Follow-up|2|||
124851294|NCT01168999|449079731|FG001|Overall Study|Lost to Follow-up|1|||
124851295|NCT01168999|449079732|FG002|Overall Study|Lost to Follow-up|0|||
124851296|NCT01168999|449079733|FG003|Overall Study|Lost to Follow-up|0|||
124851297|NCT01276327|449079734|FG000|Overall Study|Adverse Event|1|||
124851298|NCT01276327|449079735|FG001|Overall Study|Adverse Event|3|||
124851299|NCT01276327|449079734|FG000|Overall Study|Withdrawal by Subject|1|||
124851300|NCT01276327|449079735|FG001|Overall Study|Withdrawal by Subject|0|||
124851301|NCT01047683|449079736|FG000|Overall Study|Adverse Event|3|||
124851302|NCT01047683|449079737|FG001|Overall Study|Adverse Event|1|||
124851303|NCT01047683|449079738|FG002|Overall Study|Adverse Event|0|||
124851304|NCT01047683|449079736|FG000|Overall Study|Withdrew Consent|1|||
124851305|NCT01047683|449079737|FG001|Overall Study|Withdrew Consent|4|||
124851306|NCT01047683|449079738|FG002|Overall Study|Withdrew Consent|2|||
124851307|NCT01047683|449079736|FG000|Overall Study|Lost to Follow-up|0|||
124851308|NCT01047683|449079737|FG001|Overall Study|Lost to Follow-up|1|||
124851309|NCT01047683|449079738|FG002|Overall Study|Lost to Follow-up|0|||
124851310|NCT01047683|449079736|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
124851311|NCT01047683|449079737|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
124851312|NCT01047683|449079738|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
124851313|NCT03732248|449079739|FG000|Overall Study|Withdrawal by Subject|1|||
124851314|NCT03732248|449079740|FG001|Overall Study|Withdrawal by Subject|0|||
124851315|NCT00733824|449079741|FG000|Phase I|Withdrawal by Subject|1|||
124851316|NCT00733824|449079742|FG001|Phase I|Withdrawal by Subject|0|||
124851317|NCT00733824|449079743|FG002|Phase I|Withdrawal by Subject|0|||
124851318|NCT00733824|449079744|FG003|Phase I|Withdrawal by Subject|0|||
124851319|NCT00733824|449079745|FG004|Phase I|Withdrawal by Subject|0|||
124851320|NCT02480621|449079750|FG000|Randomization|Withdrawal by Subject|1|||
124851321|NCT02480621|449079751|FG001|Randomization|Withdrawal by Subject|0|||
124851322|NCT02480621|449079750|FG000|Randomization|Surgeon did not give intervention|0|||
124851323|NCT02480621|449079751|FG001|Randomization|Surgeon did not give intervention|1|||
124851324|NCT02480621|449079750|FG000|Follow Up|Lost to Follow-up|4|||
124851325|NCT02480621|449079751|FG001|Follow Up|Lost to Follow-up|2|||
124851326|NCT00235989|449079756|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
124851327|NCT00235989|449079757|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
124851328|NCT00235989|449079758|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
124851329|NCT00235989|449079759|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
124851330|NCT00235989|449079760|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
124851331|NCT00235989|449079761|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
124851332|NCT00235989|449079756|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
124851333|NCT00235989|449079757|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
124851334|NCT00235989|449079758|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
124851335|NCT00235989|449079759|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
124851336|NCT00235989|449079760|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
124851337|NCT00235989|449079761|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
124851338|NCT00235989|449079756|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
124851339|NCT00235989|449079757|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
124851340|NCT00235989|449079758|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
124851341|NCT00235989|449079759|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
124851342|NCT00235989|449079760|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
124851343|NCT00235989|449079761|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
124851344|NCT00235989|449079756|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
124851345|NCT00235989|449079757|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
124851346|NCT00235989|449079758|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
124851347|NCT00235989|449079759|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
124851348|NCT00235989|449079760|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
124851349|NCT00235989|449079761|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
124851350|NCT00235989|449079756|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
124851351|NCT00235989|449079757|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
124851352|NCT00235989|449079758|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
124851353|NCT00235989|449079759|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
124851354|NCT00235989|449079760|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
124851355|NCT00235989|449079761|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
124851356|NCT00983580|449079765|FG000|Overall Study|Cancel Prior to treatment|1|||
124851357|NCT00983580|449079766|FG001|Overall Study|Cancel Prior to treatment|3|||
124851358|NCT00983580|449079765|FG000|Overall Study|Protocol Violation|1|||
124851359|NCT00983580|449079766|FG001|Overall Study|Protocol Violation|1|||
124851360|NCT00983580|449079765|FG000|Overall Study|Ineligible|3|||
124851361|NCT00983580|449079766|FG001|Overall Study|Ineligible|0|||
124851362|NCT01971346|449079769|FG000|Overall Study|Protocol Violation|3|||
124851363|NCT01971346|449079769|FG000|Overall Study|Lost to Follow-up|2|||
124851364|NCT01971346|449079769|FG000|Overall Study|Withdrawal by Subject|2|||
124851365|NCT01971346|449079769|FG000|Overall Study|Physician Decision|1|||
124851366|NCT01652716|449079770|FG000|Overall Study|Loss of glucose control|1|||
124851367|NCT01652716|449079771|FG001|Overall Study|Loss of glucose control|0|||
124851368|NCT01652716|449079770|FG000|Overall Study|Administrative|0|||
124851369|NCT01652716|449079771|FG001|Overall Study|Administrative|2|||
124851370|NCT01652716|449079770|FG000|Overall Study|Investigator decision|1|||
124851371|NCT01652716|449079771|FG001|Overall Study|Investigator decision|4|||
124851372|NCT01652716|449079770|FG000|Overall Study|Lost to Follow-up|12|||
124851373|NCT01652716|449079771|FG001|Overall Study|Lost to Follow-up|11|||
124851374|NCT01652716|449079770|FG000|Overall Study|Protocol Violation|2|||
124851375|NCT01652716|449079771|FG001|Overall Study|Protocol Violation|1|||
124851376|NCT01652716|449079770|FG000|Overall Study|Adverse Event|7|||
124851377|NCT01652716|449079771|FG001|Overall Study|Adverse Event|10|||
124851378|NCT01652716|449079770|FG000|Overall Study|Withdrawal by Subject|33|||
124851379|NCT01652716|449079771|FG001|Overall Study|Withdrawal by Subject|18|||
124851380|NCT00360334|449079774|FG000|Overall Study|Adverse Event|7|||
124851381|NCT00360334|449079775|FG001|Overall Study|Adverse Event|4|||
124851382|NCT00360334|449079774|FG000|Overall Study|Protocol Violation|1|||
124851383|NCT00360334|449079775|FG001|Overall Study|Protocol Violation|1|||
124851384|NCT00360334|449079774|FG000|Overall Study|Physician Decision|2|||
124851385|NCT00360334|449079775|FG001|Overall Study|Physician Decision|3|||
124851386|NCT00360334|449079774|FG000|Overall Study|Lack of Efficacy|0|||
124851387|NCT00360334|449079775|FG001|Overall Study|Lack of Efficacy|1|||
124851388|NCT00360334|449079774|FG000|Overall Study|Entry criterion not met|1|||
124851389|NCT00360334|449079775|FG001|Overall Study|Entry criterion not met|2|||
124851390|NCT00360334|449079774|FG000|Overall Study|Subject decision|8|||
124851391|NCT00360334|449079775|FG001|Overall Study|Subject decision|2|||
124851392|NCT01978184|449079778|FG000|Overall Study|Progressive disease|5|||
124851393|NCT01978184|449079779|FG001|Overall Study|Progressive disease|5|||
124851394|NCT01978184|449079778|FG000|Overall Study|Other than PDA|2|||
124851395|NCT01978184|449079779|FG001|Overall Study|Other than PDA|2|||
124851396|NCT01978184|449079778|FG000|Overall Study|Physician Decision|0|||
124851397|NCT01978184|449079779|FG001|Overall Study|Physician Decision|3|||
124851398|NCT01978184|449079778|FG000|Overall Study|Noncompliance|1|||
124851399|NCT01978184|449079779|FG001|Overall Study|Noncompliance|2|||
124851400|NCT01978184|449079778|FG000|Overall Study|Death|1|||
124851401|NCT01978184|449079779|FG001|Overall Study|Death|0|||
124851402|NCT01978184|449079778|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
124851403|NCT01978184|449079779|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
124851404|NCT02447991|449079797|FG000|Overall Study|Withdrawn by subject - no data|0|||
124851405|NCT02447991|449079798|FG001|Overall Study|Withdrawn by subject - no data|2|||
124851406|NCT02447991|449079797|FG000|Overall Study|Withdrawn by Subject - with data|4|||
124851407|NCT02447991|449079798|FG001|Overall Study|Withdrawn by Subject - with data|4|||
124851408|NCT02447991|449079797|FG000|Overall Study|Lost to Follow-up - no data|3|||
124851409|NCT02447991|449079798|FG001|Overall Study|Lost to Follow-up - no data|6|||
124851410|NCT02447991|449079797|FG000|Overall Study|Lost to follow-up - with data|0|||
124851411|NCT02447991|449079798|FG001|Overall Study|Lost to follow-up - with data|3|||
124851412|NCT02447991|449079797|FG000|Overall Study|End of study - no treatment results|3|||
124851413|NCT02447991|449079798|FG001|Overall Study|End of study - no treatment results|6|||
124851414|NCT02447991|449079797|FG000|Overall Study|End of study - partial treatment results|0|||
124851415|NCT02447991|449079798|FG001|Overall Study|End of study - partial treatment results|9|||
124851416|NCT00459134|449079799|FG000|Overall Study|Physician Decision|1|||
124851417|NCT00459134|449079800|FG001|Overall Study|Physician Decision|1|||
124851418|NCT00459134|449079799|FG000|Overall Study|Withdrawal by Subject|8|||
124851419|NCT00459134|449079800|FG001|Overall Study|Withdrawal by Subject|7|||
124851420|NCT00459134|449079799|FG000|Overall Study|Lost to Follow-up|6|||
124851421|NCT00459134|449079800|FG001|Overall Study|Lost to Follow-up|7|||
124851422|NCT00459134|449079799|FG000|Overall Study|Surgery|1|||
124851423|NCT00459134|449079800|FG001|Overall Study|Surgery|2|||
124851424|NCT00459134|449079799|FG000|Overall Study|Toxicity|4|||
124851425|NCT00459134|449079800|FG001|Overall Study|Toxicity|5|||
124851426|NCT00459134|449079799|FG000|Overall Study|Progression|1|||
124851427|NCT00459134|449079800|FG001|Overall Study|Progression|0|||
124851428|NCT00459134|449079799|FG000|Overall Study|Multiple Reasons|2|||
124851429|NCT00459134|449079800|FG001|Overall Study|Multiple Reasons|3|||
124851430|NCT03568461|449079808|FG000|Overall Study|Death|7|||
124851431|NCT03568461|449079808|FG000|Overall Study|Physician Decision|5|||
124851432|NCT03568461|449079808|FG000|Overall Study|Subject decision|5|||
124851433|NCT03568461|449079808|FG000|Overall Study|Lost to Follow-up|1|||
124851434|NCT03964454|449079809|FG000|Overall Study|Lost to Follow-up|13|||
124851435|NCT03964454|449079810|FG001|Overall Study|Lost to Follow-up|7|||
124851436|NCT03964454|449079809|FG000|Overall Study|Withdrawal by Subject|4|||
124851437|NCT03964454|449079810|FG001|Overall Study|Withdrawal by Subject|11|||
124851438|NCT03328897|449081244|FG000|Randomized-treatment Epoch|Adverse Event|4|||
124851439|NCT03328897|449081245|FG001|Randomized-treatment Epoch|Adverse Event|1|||
124851440|NCT03328897|449081246|FG002|Randomized-treatment Epoch|Adverse Event|1|||
124851441|NCT03328897|449081244|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
124851442|NCT03328897|449081245|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
124851443|NCT03328897|449081246|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
124851444|NCT03328897|449081244|FG000|Randomized-treatment Epoch|Pregnancy|3|||
124851445|NCT03328897|449081245|FG001|Randomized-treatment Epoch|Pregnancy|0|||
124851446|NCT03328897|449081246|FG002|Randomized-treatment Epoch|Pregnancy|0|||
124851447|NCT03328897|449081244|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
124851448|NCT03328897|449081245|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
124851449|NCT03328897|449081246|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
124851450|NCT03328897|449081244|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
124851451|NCT03328897|449081245|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
124851452|NCT03328897|449081246|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
124851453|NCT03328897|449081244|FG000|Follow-up Epoch|Adverse Event|4|||
124851454|NCT03328897|449081245|FG001|Follow-up Epoch|Adverse Event|0|||
124851455|NCT03328897|449081246|FG002|Follow-up Epoch|Adverse Event|1|||
124851456|NCT03328897|449081244|FG000|Follow-up Epoch|Lack of Efficacy|1|||
124851457|NCT03328897|449081245|FG001|Follow-up Epoch|Lack of Efficacy|1|||
124851458|NCT03328897|449081246|FG002|Follow-up Epoch|Lack of Efficacy|1|||
124851459|NCT03328897|449081244|FG000|Follow-up Epoch|Lost to Follow-up|0|||
124851460|NCT03328897|449081245|FG001|Follow-up Epoch|Lost to Follow-up|1|||
124851461|NCT03328897|449081246|FG002|Follow-up Epoch|Lost to Follow-up|0|||
124851462|NCT03328897|449081244|FG000|Follow-up Epoch|Pregnancy|1|||
124851463|NCT03328897|449081245|FG001|Follow-up Epoch|Pregnancy|0|||
124851464|NCT03328897|449081246|FG002|Follow-up Epoch|Pregnancy|0|||
124851465|NCT03328897|449081244|FG000|Follow-up Epoch|Patient/guardian decision|2|||
124851466|NCT03328897|449081245|FG001|Follow-up Epoch|Patient/guardian decision|1|||
124851467|NCT03328897|449081246|FG002|Follow-up Epoch|Patient/guardian decision|0|||
124851468|NCT01750268|449081248|FG000|Overall Study|Lost to Follow-up|0|||
124851469|NCT01750268|449081249|FG001|Overall Study|Lost to Follow-up|2|||
124851470|NCT01750268|449081248|FG000|Overall Study|Physician Decision|0|||
124851471|NCT01750268|449081249|FG001|Overall Study|Physician Decision|3|||
124851472|NCT01750268|449081248|FG000|Overall Study|Withdrawal by Subject|2|||
124851473|NCT01750268|449081249|FG001|Overall Study|Withdrawal by Subject|0|||
124851474|NCT01969838|449081253|FG000|Double-blind Phase|Adverse Event|10|||
124851475|NCT01969838|449081254|FG001|Double-blind Phase|Adverse Event|4|||
124851476|NCT01969838|449081255|FG002|Double-blind Phase|Adverse Event|0|||
124851477|NCT01969838|449081256|FG003|Double-blind Phase|Adverse Event|0|||
124851478|NCT01969838|449081253|FG000|Double-blind Phase|Death|5|||
124851479|NCT01969838|449081254|FG001|Double-blind Phase|Death|2|||
124851480|NCT01969838|449081255|FG002|Double-blind Phase|Death|0|||
124851481|NCT01969838|449081256|FG003|Double-blind Phase|Death|0|||
124851482|NCT01969838|449081253|FG000|Double-blind Phase|Physician Decision|5|||
124851483|NCT01969838|449081254|FG001|Double-blind Phase|Physician Decision|1|||
124851484|NCT01969838|449081255|FG002|Double-blind Phase|Physician Decision|0|||
124851485|NCT01969838|449081256|FG003|Double-blind Phase|Physician Decision|0|||
124851486|NCT01969838|449081253|FG000|Double-blind Phase|Subject Decision|4|||
124851487|NCT01969838|449081254|FG001|Double-blind Phase|Subject Decision|2|||
124851488|NCT01969838|449081255|FG002|Double-blind Phase|Subject Decision|0|||
124851489|NCT01969838|449081256|FG003|Double-blind Phase|Subject Decision|0|||
124851490|NCT01969838|449081253|FG000|Double-blind Phase|Disease Progression|2|||
124851491|NCT01969838|449081254|FG001|Double-blind Phase|Disease Progression|0|||
124851492|NCT01969838|449081255|FG002|Double-blind Phase|Disease Progression|0|||
124851493|NCT01969838|449081256|FG003|Double-blind Phase|Disease Progression|0|||
124851494|NCT01969838|449081253|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
124851495|NCT01969838|449081254|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
124851496|NCT01969838|449081255|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
124851497|NCT01969838|449081256|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
124851498|NCT01969838|449081253|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
124851499|NCT01969838|449081254|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
124851500|NCT01969838|449081255|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
124851501|NCT01969838|449081256|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
124851502|NCT01969838|449081253|FG000|Open-label Phase|Adverse Event|0|||
124851503|NCT01969838|449081254|FG001|Open-label Phase|Adverse Event|0|||
124851504|NCT01969838|449081255|FG002|Open-label Phase|Adverse Event|37|||
124851505|NCT01969838|449081256|FG003|Open-label Phase|Adverse Event|49|||
124851506|NCT01969838|449081253|FG000|Open-label Phase|Disease Progression|0|||
124851507|NCT01969838|449081254|FG001|Open-label Phase|Disease Progression|0|||
124851508|NCT01969838|449081255|FG002|Open-label Phase|Disease Progression|26|||
124851509|NCT01969838|449081256|FG003|Open-label Phase|Disease Progression|27|||
124851510|NCT01969838|449081253|FG000|Open-label Phase|Lack of Efficacy|0|||
124851511|NCT01969838|449081254|FG001|Open-label Phase|Lack of Efficacy|0|||
124851512|NCT01969838|449081255|FG002|Open-label Phase|Lack of Efficacy|17|||
124851513|NCT01969838|449081256|FG003|Open-label Phase|Lack of Efficacy|19|||
124851514|NCT01969838|449081253|FG000|Open-label Phase|Subject Decision|0|||
124851515|NCT01969838|449081254|FG001|Open-label Phase|Subject Decision|0|||
124851516|NCT01969838|449081255|FG002|Open-label Phase|Subject Decision|14|||
124851517|NCT01969838|449081256|FG003|Open-label Phase|Subject Decision|15|||
124851518|NCT01969838|449081253|FG000|Open-label Phase|Death|0|||
124851519|NCT01969838|449081254|FG001|Open-label Phase|Death|0|||
124851520|NCT01969838|449081255|FG002|Open-label Phase|Death|13|||
124851521|NCT01969838|449081256|FG003|Open-label Phase|Death|11|||
124851522|NCT01969838|449081253|FG000|Open-label Phase|Physician Decision|0|||
124851523|NCT01969838|449081254|FG001|Open-label Phase|Physician Decision|0|||
124851524|NCT01969838|449081255|FG002|Open-label Phase|Physician Decision|9|||
124851525|NCT01969838|449081256|FG003|Open-label Phase|Physician Decision|14|||
124851526|NCT01969838|449081253|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
124851527|NCT01969838|449081254|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
124851528|NCT01969838|449081255|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
124851529|NCT01969838|449081256|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
124851530|NCT03087591|449081257|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
124851531|NCT03087591|449081257|FG000|Overall Study|Withdrawal by Subject|1|||
124851532|NCT00408993|449081258|FG000|Overall Study|Adverse Event|15|||
124851533|NCT00408993|449081259|FG001|Overall Study|Adverse Event|4|||
124851534|NCT00408993|449081258|FG000|Overall Study|Protocol Violation|1|||
124851535|NCT00408993|449081259|FG001|Overall Study|Protocol Violation|6|||
124851536|NCT00408993|449081258|FG000|Overall Study|Lack of Efficacy|1|||
124851537|NCT00408993|449081259|FG001|Overall Study|Lack of Efficacy|4|||
124851538|NCT00408993|449081258|FG000|Overall Study|Withdrawal by Subject|2|||
124851539|NCT00408993|449081259|FG001|Overall Study|Withdrawal by Subject|3|||
124851540|NCT03738865|449081260|FG000|Overall Study|Withdrawal by Subject|3|||
124851541|NCT03738865|449081261|FG001|Overall Study|Withdrawal by Subject|3|||
124851542|NCT03738865|449081260|FG000|Overall Study|Adverse Event|2|||
124851543|NCT03738865|449081261|FG001|Overall Study|Adverse Event|0|||
124851544|NCT03738865|449081260|FG000|Overall Study|Physician Decision|0|||
124851545|NCT03738865|449081261|FG001|Overall Study|Physician Decision|1|||
124851546|NCT02621606|449081262|FG000|Overall Study|Withdrawal by Subject|0|||
124851547|NCT02621606|449081263|FG001|Overall Study|Withdrawal by Subject|1|||
124851548|NCT02621606|449081264|FG002|Overall Study|Withdrawal by Subject|0|||
124851549|NCT01694706|449081265|FG000|Overall Study|Adverse Event|0|||
124851550|NCT01694706|449081266|FG001|Overall Study|Adverse Event|1|||
124851551|NCT01694706|449081267|FG002|Overall Study|Adverse Event|0|||
124851552|NCT01694706|449081265|FG000|Overall Study|other reason not defined above|1|||
124851553|NCT01694706|449081266|FG001|Overall Study|other reason not defined above|0|||
124851554|NCT01694706|449081267|FG002|Overall Study|other reason not defined above|0|||
124851555|NCT02252081|449081270|FG000|Overall Study|Withdrawal by Subject|2|||
124851556|NCT02252081|449081271|FG001|Overall Study|Withdrawal by Subject|1|||
124851557|NCT02252081|449081270|FG000|Overall Study|Adverse Event|4|||
124851558|NCT02252081|449081271|FG001|Overall Study|Adverse Event|1|||
124851559|NCT02252081|449081270|FG000|Overall Study|non compliance & others|0|||
124851560|NCT02252081|449081271|FG001|Overall Study|non compliance & others|2|||
124851561|NCT03766646|449081274|FG000|Overall Study|Withdrawal by Subject|1|||
124851562|NCT03766646|449081275|FG001|Overall Study|Withdrawal by Subject|0|||
124851563|NCT03766646|449081274|FG000|Overall Study|Protocol Violation|0|||
124851564|NCT03766646|449081275|FG001|Overall Study|Protocol Violation|3|||
124851565|NCT00659269|449081295|FG000|Overall Study|Physician Decision|1|||
124851566|NCT00659269|449081296|FG001|Overall Study|Physician Decision|1|||
124851567|NCT01158222|449081297|FG000|Overall Study|Not eligible for intermediate phase|17|||
124851568|NCT01490060|449081302|FG000|Cycle 1|Change of Treatment|0|||
124851569|NCT01490060|449081303|FG001|Cycle 1|Change of Treatment|1|||
124851570|NCT01490060|449081304|FG002|Cycle 1|Change of Treatment|1|||
124851571|NCT01490060|449081305|FG003|Cycle 1|Change of Treatment|1|||
124851572|NCT01490060|449081302|FG000|Cycle 1|Insurance Denied|0|||
124851573|NCT01490060|449081303|FG001|Cycle 1|Insurance Denied|0|||
124851574|NCT01490060|449081304|FG002|Cycle 1|Insurance Denied|2|||
124851575|NCT01490060|449081305|FG003|Cycle 1|Insurance Denied|0|||
124851576|NCT01490060|449081302|FG000|Cycle 1|Withdrawal by Subject|0|||
124851577|NCT01490060|449081303|FG001|Cycle 1|Withdrawal by Subject|0|||
124851578|NCT01490060|449081304|FG002|Cycle 1|Withdrawal by Subject|0|||
124851579|NCT01490060|449081305|FG003|Cycle 1|Withdrawal by Subject|1|||
124851580|NCT01490060|449081302|FG000|Cycle 1|Treatment at Another Facility|0|||
124851581|NCT01490060|449081303|FG001|Cycle 1|Treatment at Another Facility|0|||
124851582|NCT01490060|449081304|FG002|Cycle 1|Treatment at Another Facility|0|||
124851583|NCT01490060|449081305|FG003|Cycle 1|Treatment at Another Facility|1|||
124851584|NCT01490060|449081302|FG000|Cycle 2|Change of Treatment|1|||
124851585|NCT01490060|449081303|FG001|Cycle 2|Change of Treatment|1|||
124851586|NCT01490060|449081304|FG002|Cycle 2|Change of Treatment|0|||
124851587|NCT01490060|449081305|FG003|Cycle 2|Change of Treatment|0|||
124851588|NCT01490060|449081302|FG000|Cycle 2|Non-Compliance|0|||
124851589|NCT01490060|449081303|FG001|Cycle 2|Non-Compliance|0|||
124851590|NCT01490060|449081304|FG002|Cycle 2|Non-Compliance|1|||
124851591|NCT01490060|449081305|FG003|Cycle 2|Non-Compliance|0|||
124851592|NCT01490060|449081302|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
124851593|NCT01490060|449081303|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
124851594|NCT01490060|449081304|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
124851595|NCT01490060|449081305|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
124851596|NCT01877421|449081306|FG000|Phase 2|Lost to Follow-up|0|||
124851597|NCT01877421|449081307|FG001|Phase 2|Lost to Follow-up|0|||
124851598|NCT01877421|449081308|FG002|Phase 2|Lost to Follow-up|0|||
124851599|NCT01877421|449081309|FG003|Phase 2|Lost to Follow-up|0|||
124851600|NCT01877421|449081310|FG004|Phase 2|Lost to Follow-up|0|||
124851601|NCT01877421|449081311|FG005|Phase 2|Lost to Follow-up|0|||
124851602|NCT01877421|449081312|FG006|Phase 2|Lost to Follow-up|1|||
124851603|NCT01877421|449081313|FG007|Phase 2|Lost to Follow-up|0|||
124851604|NCT01877421|449081314|FG008|Phase 2|Lost to Follow-up|0|||
124851605|NCT01877421|449081315|FG009|Phase 2|Lost to Follow-up|0|||
124851606|NCT01877421|449081316|FG010|Phase 2|Lost to Follow-up|0|||
124851607|NCT01877421|449081317|FG011|Phase 2|Lost to Follow-up|0|||
124851608|NCT01877421|449081318|FG012|Phase 2|Lost to Follow-up|0|||
124851609|NCT01877421|449081319|FG013|Phase 2|Lost to Follow-up|0|||
124851610|NCT01877421|449081320|FG014|Phase 2|Lost to Follow-up|0|||
124851611|NCT01877421|449081321|FG015|Phase 2|Lost to Follow-up|0|||
124851612|NCT01877421|449081322|FG016|Phase 2|Lost to Follow-up|0|||
124851613|NCT01877421|449081323|FG017|Phase 2|Lost to Follow-up|0|||
124851614|NCT01877421|449081306|FG000|Phase 2|Withdrawal by Subject|0|||
124851615|NCT01877421|449081307|FG001|Phase 2|Withdrawal by Subject|0|||
124851616|NCT01877421|449081308|FG002|Phase 2|Withdrawal by Subject|0|||
124851617|NCT01877421|449081309|FG003|Phase 2|Withdrawal by Subject|0|||
124851618|NCT01877421|449081310|FG004|Phase 2|Withdrawal by Subject|0|||
124851619|NCT01877421|449081311|FG005|Phase 2|Withdrawal by Subject|0|||
124851620|NCT01877421|449081312|FG006|Phase 2|Withdrawal by Subject|0|||
124851621|NCT01877421|449081313|FG007|Phase 2|Withdrawal by Subject|0|||
124851622|NCT01877421|449081314|FG008|Phase 2|Withdrawal by Subject|1|||
124851623|NCT01877421|449081315|FG009|Phase 2|Withdrawal by Subject|0|||
124851624|NCT01877421|449081316|FG010|Phase 2|Withdrawal by Subject|1|||
124851625|NCT01877421|449081317|FG011|Phase 2|Withdrawal by Subject|0|||
124851626|NCT01877421|449081318|FG012|Phase 2|Withdrawal by Subject|1|||
124851627|NCT01877421|449081319|FG013|Phase 2|Withdrawal by Subject|0|||
124851628|NCT01877421|449081320|FG014|Phase 2|Withdrawal by Subject|0|||
124851629|NCT01877421|449081321|FG015|Phase 2|Withdrawal by Subject|1|||
124851630|NCT01877421|449081322|FG016|Phase 2|Withdrawal by Subject|0|||
124851631|NCT01877421|449081323|FG017|Phase 2|Withdrawal by Subject|0|||
124851632|NCT01877421|449081306|FG000|Phase 2|Protocol Violation|0|||
124851633|NCT01877421|449081307|FG001|Phase 2|Protocol Violation|0|||
124851634|NCT01877421|449081308|FG002|Phase 2|Protocol Violation|0|||
124851635|NCT01877421|449081309|FG003|Phase 2|Protocol Violation|0|||
124851636|NCT01877421|449081310|FG004|Phase 2|Protocol Violation|0|||
124851637|NCT01877421|449081311|FG005|Phase 2|Protocol Violation|0|||
124851638|NCT01877421|449081312|FG006|Phase 2|Protocol Violation|0|||
124851639|NCT01877421|449081313|FG007|Phase 2|Protocol Violation|0|||
124851640|NCT01877421|449081314|FG008|Phase 2|Protocol Violation|0|||
124851641|NCT01877421|449081315|FG009|Phase 2|Protocol Violation|0|||
124851642|NCT01877421|449081316|FG010|Phase 2|Protocol Violation|1|||
124851643|NCT01877421|449081317|FG011|Phase 2|Protocol Violation|0|||
124851644|NCT01877421|449081318|FG012|Phase 2|Protocol Violation|0|||
124851645|NCT01877421|449081319|FG013|Phase 2|Protocol Violation|0|||
124851646|NCT01877421|449081320|FG014|Phase 2|Protocol Violation|0|||
124851647|NCT01877421|449081321|FG015|Phase 2|Protocol Violation|0|||
124851648|NCT01877421|449081322|FG016|Phase 2|Protocol Violation|0|||
124851649|NCT01877421|449081323|FG017|Phase 2|Protocol Violation|0|||
124851650|NCT00724451|449081327|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
124851651|NCT00724451|449081327|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
124851652|NCT00724451|449081327|FG000|Overall Study|Not Eligible for Treatment|431|||
124851653|NCT00724451|449081327|FG000|Overall Study|Participant Refused Treatment|89|||
124851654|NCT00724451|449081327|FG000|Overall Study|Never Started Treatment|89|||
124851655|NCT00724451|449081327|FG000|Overall Study|Unknown; No Data Sources Available|9|||
124851656|NCT00724451|449081327|FG000|Overall Study|Physician Decision|116|||
124851657|NCT00724451|449081327|FG000|Overall Study|Withdrawal by Subject|45|||
124851658|NCT00724451|449081327|FG000|Overall Study|Investigator + Participant Decision|13|||
124851659|NCT01260922|449081329|FG000|First Intervention|Withdrawal by Subject|0|||
124851660|NCT01260922|449081330|FG001|First Intervention|Withdrawal by Subject|1|||
124851661|NCT01260922|449081329|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
124851662|NCT01260922|449081330|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
124851663|NCT01260922|449081329|FG000|Second Intervention|Emesis|0|||
124851664|NCT01260922|449081330|FG001|Second Intervention|Emesis|2|||
124851665|NCT03653429|449081334|FG000|Overall Study|Physician Decision|4|||
124851666|NCT03653429|449081335|FG001|Overall Study|Physician Decision|10|||
124851667|NCT01525082|449081336|FG000|Overall Study|Death|1|||
124851668|NCT01767116|449081339|FG000|Overall Study|Lost to Follow-up|2|||
124851669|NCT01767116|449081340|FG001|Overall Study|Lost to Follow-up|2|||
124851670|NCT02141516|449081341|FG000|Overall Study|Adverse Event|0|||
124851671|NCT02141516|449081342|FG001|Overall Study|Adverse Event|1|||
124851672|NCT02141516|449081343|FG002|Overall Study|Adverse Event|0|||
124851673|NCT02141516|449081341|FG000|Overall Study|Lost to Follow-up|0|||
124851674|NCT02141516|449081342|FG001|Overall Study|Lost to Follow-up|1|||
124851675|NCT02141516|449081343|FG002|Overall Study|Lost to Follow-up|0|||
124851676|NCT02141516|449081341|FG000|Overall Study|Other|0|||
124851677|NCT02141516|449081342|FG001|Overall Study|Other|3|||
124851678|NCT02141516|449081343|FG002|Overall Study|Other|0|||
124851679|NCT00153101|449081346|FG000|Overall Study|Lost to Follow-up|14|||
124851680|NCT00153101|449081347|FG001|Overall Study|Lost to Follow-up|14|||
124851681|NCT00153101|449081348|FG002|Overall Study|Lost to Follow-up|12|||
124851682|NCT00153101|449081349|FG003|Overall Study|Lost to Follow-up|5|||
124851683|NCT00153101|449081350|FG004|Overall Study|Lost to Follow-up|5|||
124851684|NCT00153101|449081346|FG000|Overall Study|Withdrawal by Subject|3|||
124851685|NCT00153101|449081347|FG001|Overall Study|Withdrawal by Subject|4|||
124851686|NCT00153101|449081348|FG002|Overall Study|Withdrawal by Subject|3|||
124851687|NCT00153101|449081349|FG003|Overall Study|Withdrawal by Subject|3|||
124851688|NCT00153101|449081350|FG004|Overall Study|Withdrawal by Subject|5|||
124851689|NCT02610140|449081351|FG000|Randomization and Treatment Period|Radiological progression|23|||
124851690|NCT02610140|449081352|FG001|Randomization and Treatment Period|Radiological progression|15|||
124851691|NCT02610140|449081351|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
124851692|NCT02610140|449081352|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
124851693|NCT02610140|449081351|FG000|Randomization and Treatment Period|Protocol Violation|1|||
124851694|NCT02610140|449081352|FG001|Randomization and Treatment Period|Protocol Violation|0|||
124851695|NCT02610140|449081351|FG000|Randomization and Treatment Period|Physician Decision|0|||
124851696|NCT02610140|449081352|FG001|Randomization and Treatment Period|Physician Decision|1|||
124851697|NCT02610140|449081351|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
124851698|NCT02610140|449081352|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
124851699|NCT02610140|449081351|FG000|Randomization and Treatment Period|Death|7|||
124851700|NCT02610140|449081352|FG001|Randomization and Treatment Period|Death|1|||
124851701|NCT02610140|449081351|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
124851702|NCT02610140|449081352|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
124851703|NCT02610140|449081351|FG000|Randomization and Treatment Period|Adverse Event|44|||
124851704|NCT02610140|449081352|FG001|Randomization and Treatment Period|Adverse Event|13|||
124851705|NCT02610140|449081351|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
124851706|NCT02610140|449081352|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
124851707|NCT02610140|449081351|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
124851708|NCT02610140|449081352|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
124851709|NCT02610140|449081351|FG000|Randomization and Treatment Period|Not treated|3|||
124851710|NCT02610140|449081352|FG001|Randomization and Treatment Period|Not treated|10|||
124851711|NCT02610140|449081351|FG000|Safety Follow-up|Other|0|||
124851712|NCT02610140|449081352|FG001|Safety Follow-up|Other|2|||
124851713|NCT02610140|449081351|FG000|Safety Follow-up|Lost to Follow-up|1|||
124851714|NCT02610140|449081352|FG001|Safety Follow-up|Lost to Follow-up|0|||
124851715|NCT02610140|449081351|FG000|Safety Follow-up|No follow-up|5|||
124851716|NCT02610140|449081352|FG001|Safety Follow-up|No follow-up|3|||
124851717|NCT02610140|449081351|FG000|Safety Follow-up|Death|12|||
124851718|NCT02610140|449081352|FG001|Safety Follow-up|Death|2|||
124851719|NCT02610140|449081351|FG000|Safety Follow-up|Deterioration of general conditions|15|||
124851720|NCT02610140|449081352|FG001|Safety Follow-up|Deterioration of general conditions|5|||
124851721|NCT02610140|449081351|FG000|Safety Follow-up|Withdrawal by Subject|12|||
124851722|NCT02610140|449081352|FG001|Safety Follow-up|Withdrawal by Subject|12|||
124851723|NCT02610140|449081351|FG000|Active Follow-up|Progressive disease - radiological|30|||
124851724|NCT02610140|449081352|FG001|Active Follow-up|Progressive disease - radiological|22|||
124851725|NCT02610140|449081351|FG000|Active Follow-up|Death|8|||
124851726|NCT02610140|449081352|FG001|Active Follow-up|Death|1|||
124851727|NCT02610140|449081351|FG000|Active Follow-up|Withdrawal by Subject|4|||
124851728|NCT02610140|449081352|FG001|Active Follow-up|Withdrawal by Subject|0|||
124851729|NCT02610140|449081351|FG000|Active Follow-up|Progressive disease - clinical|1|||
124851730|NCT02610140|449081352|FG001|Active Follow-up|Progressive disease - clinical|2|||
124851731|NCT02610140|449081351|FG000|Active Follow-up|Deterioration of general conditions|1|||
124851732|NCT02610140|449081352|FG001|Active Follow-up|Deterioration of general conditions|0|||
124851733|NCT02610140|449081351|FG000|Active Follow-up|Ongoing but not completed|4|||
124851734|NCT02610140|449081352|FG001|Active Follow-up|Ongoing but not completed|1|||
124851735|NCT02610140|449081351|FG000|Long-term Follow-up|Death|86|||
124851736|NCT02610140|449081352|FG001|Long-term Follow-up|Death|44|||
124851737|NCT02610140|449081351|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
124851738|NCT02610140|449081352|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
124851739|NCT02610140|449081351|FG000|Long-term Follow-up|Lost to Follow-up|1|||
124851740|NCT02610140|449081352|FG001|Long-term Follow-up|Lost to Follow-up|2|||
124851741|NCT02610140|449081351|FG000|Long-term Follow-up|Ongoing but not completed|30|||
124851742|NCT02610140|449081352|FG001|Long-term Follow-up|Ongoing but not completed|17|||
124851743|NCT03169153|449081353|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
124851744|NCT03169153|449081354|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
124851745|NCT03169153|449081353|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
124851746|NCT03169153|449081354|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
124851747|NCT03169153|449081353|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
124851748|NCT03169153|449081354|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
124851749|NCT03169153|449081353|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
124851750|NCT03169153|449081354|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
124851751|NCT01975389|449081359|FG000|Overall Study|Adverse Event|10|||
124851752|NCT01975389|449081360|FG001|Overall Study|Adverse Event|6|||
124851753|NCT01975389|449081359|FG000|Overall Study|Death|61|||
124851754|NCT01975389|449081360|FG001|Overall Study|Death|54|||
124851755|NCT01975389|449081359|FG000|Overall Study|Lost to Follow-up|81|||
124851756|NCT01975389|449081360|FG001|Overall Study|Lost to Follow-up|86|||
124851757|NCT01975389|449081359|FG000|Overall Study|Withdrawal by Subject|90|||
124851758|NCT01975389|449081360|FG001|Overall Study|Withdrawal by Subject|76|||
124851759|NCT01975389|449081359|FG000|Overall Study|Other|6|||
124851760|NCT01975389|449081360|FG001|Overall Study|Other|9|||
124851761|NCT01975389|449081359|FG000|Overall Study|Randomized, not treated|4|||
124851762|NCT01975389|449081360|FG001|Overall Study|Randomized, not treated|5|||
124851763|NCT04278417|449081368|FG000|Overall Study|Withdrawal by Subject|20|||
124851764|NCT04278417|449081369|FG001|Overall Study|Withdrawal by Subject|20|||
124851765|NCT04278417|449081368|FG000|Overall Study|Progressive disease|0|||
124851766|NCT04278417|449081369|FG001|Overall Study|Progressive disease|2|||
124851767|NCT04278417|449081368|FG000|Overall Study|Physician Decision|4|||
124851768|NCT04278417|449081369|FG001|Overall Study|Physician Decision|6|||
124851769|NCT04278417|449081368|FG000|Overall Study|Lost to Follow-up|11|||
124851770|NCT04278417|449081369|FG001|Overall Study|Lost to Follow-up|13|||
124851771|NCT04278417|449081368|FG000|Overall Study|Death|8|||
124851772|NCT04278417|449081369|FG001|Overall Study|Death|9|||
124851773|NCT04278417|449081368|FG000|Overall Study|Adverse Event|3|||
124851774|NCT04278417|449081369|FG001|Overall Study|Adverse Event|5|||
124851775|NCT01603875|449081371|FG000|Overall Study|Preexisting rabies antibody|3|||
124851776|NCT01603875|449081372|FG001|Overall Study|Preexisting rabies antibody|4|||
124851777|NCT01603875|449081373|FG002|Overall Study|Preexisting rabies antibody|3|||
124851778|NCT01603875|449081371|FG000|Overall Study|Lost to Follow-up|4|||
124851779|NCT01603875|449081372|FG001|Overall Study|Lost to Follow-up|3|||
124851780|NCT01603875|449081373|FG002|Overall Study|Lost to Follow-up|6|||
124851781|NCT01603875|449081371|FG000|Overall Study|Protocol Violation|0|||
124851782|NCT01603875|449081372|FG001|Overall Study|Protocol Violation|1|||
124851783|NCT01603875|449081373|FG002|Overall Study|Protocol Violation|0|||
124851784|NCT00298831|449081374|FG000|Overall Study|Adverse Event|1|||
124851785|NCT00298831|449081374|FG000|Overall Study|Lost to Follow-up|3|||
124851786|NCT00298831|449081374|FG000|Overall Study|Withdrawal by Subject|1|||
124851787|NCT00298831|449081374|FG000|Overall Study|Participants did not receive treatment|27|||
124851788|NCT01306617|449081375|FG000|Overall Study|Adverse Event|1|||
124851789|NCT01306617|449081376|FG001|Overall Study|Adverse Event|0|||
124851790|NCT01306617|449081377|FG002|Overall Study|Adverse Event|0|||
124851791|NCT01306617|449081375|FG000|Overall Study|Virologic Failure|0|||
124851792|NCT01306617|449081376|FG001|Overall Study|Virologic Failure|0|||
124851793|NCT01306617|449081377|FG002|Overall Study|Virologic Failure|5|||
124851794|NCT01306617|449081375|FG000|Overall Study|Non-compliance|0|||
124851795|NCT01306617|449081376|FG001|Overall Study|Non-compliance|1|||
124851796|NCT01306617|449081377|FG002|Overall Study|Non-compliance|0|||
124851797|NCT04028388|449081378|FG000|Overall Study|Evaluations missing|3|||
124851798|NCT04028388|449081379|FG001|Overall Study|Evaluations missing|6|||
124851799|NCT04028388|449081378|FG000|Overall Study|Not started|2|||
124851800|NCT04028388|449081379|FG001|Overall Study|Not started|0|||
124851801|NCT01114516|449081380|FG000|Overall Study|Lost to Follow-up|2|||
124851802|NCT01114516|449081381|FG001|Overall Study|Lost to Follow-up|1|||
124851803|NCT00129259|449081382|FG000|Overall Study|Lost to Follow-up|1|||
124851804|NCT00129259|449081383|FG001|Overall Study|Lost to Follow-up|1|||
124851805|NCT00129259|449081382|FG000|Overall Study|Withdrawal by Subject|2|||
124851806|NCT00129259|449081383|FG001|Overall Study|Withdrawal by Subject|1|||
124851807|NCT00129259|449081382|FG000|Overall Study|Only available minimal phone assessments|0|||
124851808|NCT00129259|449081383|FG001|Overall Study|Only available minimal phone assessments|1|||
124851809|NCT02758236|449081384|FG000|Overall Study|Investigator discretion|43|||
124851810|NCT05789875|449081385|FG000|Overall Study|Lost to Follow-up|6|||
124851811|NCT01994395|449081386|FG000|Overall Study|Withdrawal by Subject|1|||
124851812|NCT01994395|449081387|FG001|Overall Study|Withdrawal by Subject|2|||
124851813|NCT01940705|449081388|FG000|Overall Study|Lost to Follow-up|1|||
124851814|NCT01940705|449081389|FG001|Overall Study|Lost to Follow-up|3|||
124851815|NCT01940705|449081390|FG002|Overall Study|Lost to Follow-up|2|||
124851816|NCT01940705|449081391|FG003|Overall Study|Lost to Follow-up|2|||
124851817|NCT01940705|449081388|FG000|Overall Study|Withdrawal by Subject|2|||
124851818|NCT01940705|449081389|FG001|Overall Study|Withdrawal by Subject|2|||
124851819|NCT01940705|449081390|FG002|Overall Study|Withdrawal by Subject|3|||
124851820|NCT01940705|449081391|FG003|Overall Study|Withdrawal by Subject|2|||
124851821|NCT01940705|449081388|FG000|Overall Study|Intervention not given|0|||
124851822|NCT01940705|449081389|FG001|Overall Study|Intervention not given|3|||
124851823|NCT01940705|449081390|FG002|Overall Study|Intervention not given|3|||
124851824|NCT01940705|449081391|FG003|Overall Study|Intervention not given|0|||
124851825|NCT01940705|449081388|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
124851826|NCT01940705|449081389|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
124851827|NCT01940705|449081390|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
124851828|NCT01940705|449081391|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
124851829|NCT01632579|449081394|FG000|Washout Period|Adverse Event|1|||
124851830|NCT01632579|449081395|FG001|Washout Period|Adverse Event|0|||
124851831|NCT01632579|449081396|FG002|Washout Period|Adverse Event|0|||
124851832|NCT01632579|449081397|FG003|Washout Period|Adverse Event|0|||
124851833|NCT01632579|449081398|FG004|Washout Period|Adverse Event|0|||
124851834|NCT01632579|449081399|FG005|Washout Period|Adverse Event|0|||
124851835|NCT01632579|449081400|FG006|Washout Period|Adverse Event|0|||
124851836|NCT01632579|449081401|FG007|Washout Period|Adverse Event|0|||
124851837|NCT01632579|449081402|FG008|Washout Period|Adverse Event|0|||
124851838|NCT01632579|449081394|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
124851839|NCT01632579|449081395|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
124851840|NCT01632579|449081396|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
124851841|NCT01632579|449081397|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
124851842|NCT01632579|449081398|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
124851843|NCT01632579|449081399|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
124851844|NCT01632579|449081400|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
124851845|NCT01632579|449081401|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
124851846|NCT01632579|449081402|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
124851847|NCT00818441|449081403|FG000|Overall Study|Death|69|||
124851848|NCT00818441|449081404|FG001|Overall Study|Death|26|||
124851849|NCT00818441|449081403|FG000|Overall Study|Other|5|||
124851850|NCT00818441|449081404|FG001|Overall Study|Other|0|||
124851851|NCT00818441|449081403|FG000|Overall Study|Lost to Follow-up|2|||
124851852|NCT00818441|449081404|FG001|Overall Study|Lost to Follow-up|1|||
124851853|NCT00818441|449081403|FG000|Overall Study|Withdrawal by Subject|2|||
124851854|NCT00818441|449081404|FG001|Overall Study|Withdrawal by Subject|0|||
124851855|NCT00818441|449081403|FG000|Overall Study|Adverse Event|0|||
124851856|NCT00818441|449081404|FG001|Overall Study|Adverse Event|1|||
124851857|NCT00818441|449081403|FG000|Overall Study|Study terminated by sponsor|11|||
124851858|NCT00818441|449081404|FG001|Overall Study|Study terminated by sponsor|2|||
124851859|NCT00612313|449081405|FG000|Overall Study|Withdrawal by Subject|6|||
124851860|NCT00612313|449081406|FG001|Overall Study|Withdrawal by Subject|9|||
124851861|NCT00612313|449081405|FG000|Overall Study|Lost to Follow-up|11|||
124851862|NCT00612313|449081406|FG001|Overall Study|Lost to Follow-up|4|||
124851863|NCT01337089|449083123|FG000|Overall Study|Adverse Event|237|||
124851864|NCT01337089|449083123|FG000|Overall Study|Withdrawal by Subject|129|||
124851865|NCT01337089|449083123|FG000|Overall Study|Withdrawal by Investigator|33|||
124851866|NCT01337089|449083123|FG000|Overall Study|Met Withdrawal Criteria|3|||
124851867|NCT01337089|449083123|FG000|Overall Study|Lost to Follow-up|2|||
124851868|NCT02461589|449083131|FG000|Overall Study|Withdrawal by Subject|5|||
124851869|NCT02461589|449083132|FG001|Overall Study|Withdrawal by Subject|1|||
124851870|NCT02461589|449083133|FG002|Overall Study|Withdrawal by Subject|3|||
124851871|NCT02461589|449083134|FG003|Overall Study|Withdrawal by Subject|2|||
124851872|NCT02461589|449083135|FG004|Overall Study|Withdrawal by Subject|1|||
124851873|NCT02461589|449083136|FG005|Overall Study|Withdrawal by Subject|2|||
124851874|NCT02461589|449083137|FG006|Overall Study|Withdrawal by Subject|1|||
124851875|NCT02461589|449083138|FG007|Overall Study|Withdrawal by Subject|3|||
124851876|NCT02461589|449083139|FG008|Overall Study|Withdrawal by Subject|3|||
124851877|NCT02461589|449083140|FG009|Overall Study|Withdrawal by Subject|1|||
124851878|NCT02461589|449083131|FG000|Overall Study|Lost to Follow-up|0|||
124851879|NCT02461589|449083132|FG001|Overall Study|Lost to Follow-up|0|||
124851880|NCT02461589|449083133|FG002|Overall Study|Lost to Follow-up|2|||
124851881|NCT02461589|449083134|FG003|Overall Study|Lost to Follow-up|3|||
124851882|NCT02461589|449083135|FG004|Overall Study|Lost to Follow-up|1|||
124851883|NCT02461589|449083136|FG005|Overall Study|Lost to Follow-up|1|||
124851884|NCT02461589|449083137|FG006|Overall Study|Lost to Follow-up|3|||
124851885|NCT02461589|449083138|FG007|Overall Study|Lost to Follow-up|1|||
124851886|NCT02461589|449083139|FG008|Overall Study|Lost to Follow-up|3|||
124851887|NCT02461589|449083140|FG009|Overall Study|Lost to Follow-up|1|||
124851888|NCT02461589|449083131|FG000|Overall Study|Death|0|||
124851889|NCT02461589|449083132|FG001|Overall Study|Death|0|||
124851890|NCT02461589|449083133|FG002|Overall Study|Death|0|||
124851891|NCT02461589|449083134|FG003|Overall Study|Death|0|||
124851892|NCT02461589|449083135|FG004|Overall Study|Death|0|||
124851893|NCT02461589|449083136|FG005|Overall Study|Death|0|||
124851894|NCT02461589|449083137|FG006|Overall Study|Death|0|||
124851895|NCT02461589|449083138|FG007|Overall Study|Death|1|||
124851896|NCT02461589|449083139|FG008|Overall Study|Death|0|||
124851897|NCT02461589|449083140|FG009|Overall Study|Death|0|||
124851898|NCT02461589|449083131|FG000|Overall Study|Unclassified|0|||
124851899|NCT02461589|449083132|FG001|Overall Study|Unclassified|0|||
124851900|NCT02461589|449083133|FG002|Overall Study|Unclassified|0|||
124851901|NCT02461589|449083134|FG003|Overall Study|Unclassified|0|||
124851902|NCT02461589|449083135|FG004|Overall Study|Unclassified|0|||
124851903|NCT02461589|449083136|FG005|Overall Study|Unclassified|0|||
124851904|NCT02461589|449083137|FG006|Overall Study|Unclassified|1|||
124851905|NCT02461589|449083138|FG007|Overall Study|Unclassified|0|||
124851906|NCT02461589|449083139|FG008|Overall Study|Unclassified|0|||
124851907|NCT02461589|449083140|FG009|Overall Study|Unclassified|2|||
124851908|NCT02461589|449083131|FG000|Overall Study|Missing follow-up information|1|||
124851909|NCT02461589|449083132|FG001|Overall Study|Missing follow-up information|1|||
124851910|NCT02461589|449083133|FG002|Overall Study|Missing follow-up information|0|||
124851911|NCT02461589|449083134|FG003|Overall Study|Missing follow-up information|0|||
124851912|NCT02461589|449083135|FG004|Overall Study|Missing follow-up information|0|||
124851913|NCT02461589|449083136|FG005|Overall Study|Missing follow-up information|0|||
124851914|NCT02461589|449083137|FG006|Overall Study|Missing follow-up information|1|||
124851915|NCT02461589|449083138|FG007|Overall Study|Missing follow-up information|0|||
124851916|NCT02461589|449083139|FG008|Overall Study|Missing follow-up information|0|||
124851917|NCT02461589|449083140|FG009|Overall Study|Missing follow-up information|0|||
124851918|NCT02461589|449083131|FG000|Overall Study|Withdrawal from trial before exposure|0|||
124851919|NCT02461589|449083132|FG001|Overall Study|Withdrawal from trial before exposure|0|||
124851920|NCT02461589|449083133|FG002|Overall Study|Withdrawal from trial before exposure|0|||
124851921|NCT02461589|449083134|FG003|Overall Study|Withdrawal from trial before exposure|0|||
124851922|NCT02461589|449083135|FG004|Overall Study|Withdrawal from trial before exposure|0|||
124851923|NCT02461589|449083136|FG005|Overall Study|Withdrawal from trial before exposure|0|||
124851924|NCT02461589|449083137|FG006|Overall Study|Withdrawal from trial before exposure|0|||
124851925|NCT02461589|449083138|FG007|Overall Study|Withdrawal from trial before exposure|0|||
124851926|NCT02461589|449083139|FG008|Overall Study|Withdrawal from trial before exposure|0|||
124851927|NCT02461589|449083140|FG009|Overall Study|Withdrawal from trial before exposure|1|||
124851928|NCT01978119|449083141|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
124851929|NCT01978119|449083142|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
124851930|NCT01978119|449083141|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
124851931|NCT01978119|449083142|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
124851932|NCT01978119|449083141|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
124851933|NCT01978119|449083142|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
124851934|NCT03295201|449083143|FG000|Overall Study|Lost to Follow-up|1|||
124851935|NCT03295201|449083144|FG001|Overall Study|Lost to Follow-up|1|||
124851936|NCT03295201|449083143|FG000|Overall Study|Hospital admission|0|||
124851937|NCT03295201|449083144|FG001|Overall Study|Hospital admission|1|||
124851938|NCT01465334|449083145|FG000|Overall Study|Disease Progression|1|||
124851939|NCT01465334|449083146|FG001|Overall Study|Disease Progression|0|||
124851940|NCT01465334|449083145|FG000|Overall Study|Adverse Event|1|||
124851941|NCT01465334|449083146|FG001|Overall Study|Adverse Event|0|||
124851942|NCT01465334|449083145|FG000|Overall Study|Richter's transformation|0|||
124851943|NCT01465334|449083146|FG001|Overall Study|Richter's transformation|3|||
124851944|NCT01465334|449083145|FG000|Overall Study|Refractory Disease|0|||
124851945|NCT01465334|449083146|FG001|Overall Study|Refractory Disease|3|||
124851946|NCT00572572|449083147|FG000|Overall Study|Withdrawal by Subject|3|||
124851947|NCT00572572|449083148|FG001|Overall Study|Withdrawal by Subject|6|||
124851948|NCT01831089|449083149|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
124851949|NCT01831089|449083150|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
124851950|NCT01831089|449083151|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
124851951|NCT01831089|449083152|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
124851952|NCT01831089|449083153|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
124851953|NCT01831089|449083154|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
124851954|NCT01831089|449083149|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
124851955|NCT01831089|449083150|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
124851956|NCT01831089|449083151|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
124851957|NCT01831089|449083152|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
124851958|NCT01831089|449083153|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
124851959|NCT01831089|449083154|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
124851960|NCT01831089|449083149|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
124851961|NCT01831089|449083150|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
124851962|NCT01831089|449083151|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
124851963|NCT01831089|449083152|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
124851964|NCT01831089|449083153|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
124851965|NCT01831089|449083154|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
124851966|NCT01831089|449083149|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
124851967|NCT01831089|449083150|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
124851968|NCT01831089|449083151|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
124851969|NCT01831089|449083152|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
124851970|NCT01831089|449083153|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
124851971|NCT01831089|449083154|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
124851972|NCT01831089|449083149|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
124851973|NCT01831089|449083150|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
124851974|NCT01831089|449083151|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
124851975|NCT01831089|449083152|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
124851976|NCT01831089|449083153|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
124851977|NCT01831089|449083154|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
124851978|NCT01831089|449083149|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
124851979|NCT01831089|449083150|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
124851980|NCT01831089|449083151|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
124851981|NCT01831089|449083152|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
124851982|NCT01831089|449083153|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
124851983|NCT01831089|449083154|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
124851984|NCT01831089|449083149|FG000|Cohort III: Dose Level 3|Global end of study|0|||
124851985|NCT01831089|449083150|FG001|Cohort III: Dose Level 3|Global end of study|0|||
124851986|NCT01831089|449083151|FG002|Cohort III: Dose Level 3|Global end of study|1|||
124851987|NCT01831089|449083152|FG003|Cohort III: Dose Level 3|Global end of study|0|||
124851988|NCT01831089|449083153|FG004|Cohort III: Dose Level 3|Global end of study|0|||
124851989|NCT01831089|449083154|FG005|Cohort III: Dose Level 3|Global end of study|0|||
124851990|NCT01831089|449083149|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
124851991|NCT01831089|449083150|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
124851992|NCT01831089|449083151|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
124851993|NCT01831089|449083152|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
124851994|NCT01831089|449083153|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
124851995|NCT01831089|449083154|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
124851996|NCT01831089|449083149|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
124851997|NCT01831089|449083150|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
124851998|NCT01831089|449083151|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
124851999|NCT01831089|449083152|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
124852000|NCT01831089|449083153|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
124852001|NCT01831089|449083154|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
124852002|NCT01831089|449083149|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
124852003|NCT01831089|449083150|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
124852004|NCT01831089|449083151|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
124852005|NCT01831089|449083152|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
124852006|NCT01831089|449083153|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
124852007|NCT01831089|449083154|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
124852008|NCT01831089|449083149|FG000|Cohort V: Dose Level 5|Death|0|||
124852009|NCT01831089|449083150|FG001|Cohort V: Dose Level 5|Death|0|||
124852010|NCT01831089|449083151|FG002|Cohort V: Dose Level 5|Death|0|||
124852011|NCT01831089|449083152|FG003|Cohort V: Dose Level 5|Death|0|||
124852012|NCT01831089|449083153|FG004|Cohort V: Dose Level 5|Death|1|||
124852013|NCT01831089|449083154|FG005|Cohort V: Dose Level 5|Death|0|||
124852014|NCT01831089|449083149|FG000|Cohort V: Dose Level 5|Global end of study|0|||
124852015|NCT01831089|449083150|FG001|Cohort V: Dose Level 5|Global end of study|0|||
124852016|NCT01831089|449083151|FG002|Cohort V: Dose Level 5|Global end of study|0|||
124852017|NCT01831089|449083152|FG003|Cohort V: Dose Level 5|Global end of study|0|||
124852018|NCT01831089|449083153|FG004|Cohort V: Dose Level 5|Global end of study|2|||
124852019|NCT01831089|449083154|FG005|Cohort V: Dose Level 5|Global end of study|0|||
124852020|NCT01831089|449083149|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
124852021|NCT01831089|449083150|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
124852022|NCT01831089|449083151|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
124852023|NCT01831089|449083152|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
124852024|NCT01831089|449083153|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
124852025|NCT01831089|449083154|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
124852026|NCT01831089|449083149|FG000|Cohort B: Arm B|Progressive disease|0|||
124852027|NCT01831089|449083150|FG001|Cohort B: Arm B|Progressive disease|0|||
124852028|NCT01831089|449083151|FG002|Cohort B: Arm B|Progressive disease|0|||
124852029|NCT01831089|449083152|FG003|Cohort B: Arm B|Progressive disease|0|||
124852030|NCT01831089|449083153|FG004|Cohort B: Arm B|Progressive disease|0|||
124852031|NCT01831089|449083154|FG005|Cohort B: Arm B|Progressive disease|8|||
124852032|NCT01831089|449083149|FG000|Cohort B: Arm B|Physician Decision|0|||
124852033|NCT01831089|449083150|FG001|Cohort B: Arm B|Physician Decision|0|||
124852034|NCT01831089|449083151|FG002|Cohort B: Arm B|Physician Decision|0|||
124852035|NCT01831089|449083152|FG003|Cohort B: Arm B|Physician Decision|0|||
124852036|NCT01831089|449083153|FG004|Cohort B: Arm B|Physician Decision|0|||
124852037|NCT01831089|449083154|FG005|Cohort B: Arm B|Physician Decision|2|||
124852038|NCT01831089|449083149|FG000|Cohort B: Arm B|Never treated|0|||
124852039|NCT01831089|449083150|FG001|Cohort B: Arm B|Never treated|0|||
124852040|NCT01831089|449083151|FG002|Cohort B: Arm B|Never treated|0|||
124852041|NCT01831089|449083152|FG003|Cohort B: Arm B|Never treated|0|||
124852042|NCT01831089|449083153|FG004|Cohort B: Arm B|Never treated|0|||
124852043|NCT01831089|449083154|FG005|Cohort B: Arm B|Never treated|2|||
124852044|NCT01831089|449083149|FG000|Cohort B: Arm B|Adverse Event|0|||
124852045|NCT01831089|449083150|FG001|Cohort B: Arm B|Adverse Event|0|||
124852046|NCT01831089|449083151|FG002|Cohort B: Arm B|Adverse Event|0|||
124852047|NCT01831089|449083152|FG003|Cohort B: Arm B|Adverse Event|0|||
124852048|NCT01831089|449083153|FG004|Cohort B: Arm B|Adverse Event|0|||
124852049|NCT01831089|449083154|FG005|Cohort B: Arm B|Adverse Event|1|||
124852050|NCT01831089|449083149|FG000|Cohort B: Arm B|Global end of study|0|||
124852051|NCT01831089|449083150|FG001|Cohort B: Arm B|Global end of study|0|||
124852052|NCT01831089|449083151|FG002|Cohort B: Arm B|Global end of study|0|||
124852053|NCT01831089|449083152|FG003|Cohort B: Arm B|Global end of study|0|||
124852054|NCT01831089|449083153|FG004|Cohort B: Arm B|Global end of study|0|||
124852055|NCT01831089|449083154|FG005|Cohort B: Arm B|Global end of study|1|||
124852056|NCT01958918|449083155|FG000|Overall Study|Death|1|||
124852057|NCT01958918|449083156|FG001|Overall Study|Death|3|||
124852058|NCT01958918|449083155|FG000|Overall Study|Lost to Follow-up|4|||
124852059|NCT01958918|449083156|FG001|Overall Study|Lost to Follow-up|7|||
124852060|NCT01958918|449083155|FG000|Overall Study|Withdrawal by Subject|13|||
124852061|NCT01958918|449083156|FG001|Overall Study|Withdrawal by Subject|8|||
124852062|NCT01958918|449083155|FG000|Overall Study|Lack of Efficacy|13|||
124852063|NCT01958918|449083156|FG001|Overall Study|Lack of Efficacy|10|||
124852064|NCT01958918|449083155|FG000|Overall Study|Adverse Event|12|||
124852065|NCT01958918|449083156|FG001|Overall Study|Adverse Event|12|||
124852066|NCT01958918|449083155|FG000|Overall Study|administrative problems|0|||
124852067|NCT01958918|449083156|FG001|Overall Study|administrative problems|2|||
124852068|NCT01925183|449083157|FG000|Overall Study|Adverse Event|1|||
124852069|NCT01925183|449083158|FG001|Overall Study|Adverse Event|0|||
124852070|NCT02114892|449083159|FG000|Overall Study|Lost to Follow-up|1|||
124852071|NCT02114892|449083160|FG001|Overall Study|Lost to Follow-up|2|||
124852072|NCT04327934|449083163|FG000|Overall Study|Did not qualify|7|||
124852073|NCT04327934|449083164|FG001|Overall Study|Did not qualify|4|||
124852074|NCT04327934|449083163|FG000|Overall Study|Physician Decision|0|||
124852075|NCT04327934|449083164|FG001|Overall Study|Physician Decision|1|||
124852076|NCT03525834|449083165|FG000|Overall Study|Progressive disease|1|||
124852077|NCT03095417|449083166|FG000|Overall Study|missed|1|||
124852078|NCT03095417|449083167|FG001|Overall Study|missed|2|||
124852079|NCT03095417|449083168|FG002|Overall Study|missed|0|||
124852080|NCT03095417|449083169|FG003|Overall Study|missed|1|||
124852081|NCT03095417|449083166|FG000|Overall Study|Lost to Follow-up|2|||
124852082|NCT03095417|449083167|FG001|Overall Study|Lost to Follow-up|2|||
124852083|NCT03095417|449083168|FG002|Overall Study|Lost to Follow-up|1|||
124852084|NCT03095417|449083169|FG003|Overall Study|Lost to Follow-up|0|||
124852085|NCT03095417|449083166|FG000|Overall Study|refusal|0|||
124852086|NCT03095417|449083167|FG001|Overall Study|refusal|1|||
124852087|NCT03095417|449083168|FG002|Overall Study|refusal|0|||
124852088|NCT03095417|449083169|FG003|Overall Study|refusal|1|||
124852089|NCT03095417|449083166|FG000|Overall Study|Withdrawal by Subject|8|||
124852090|NCT03095417|449083167|FG001|Overall Study|Withdrawal by Subject|2|||
124852091|NCT03095417|449083168|FG002|Overall Study|Withdrawal by Subject|5|||
124852092|NCT03095417|449083169|FG003|Overall Study|Withdrawal by Subject|4|||
124852093|NCT03095417|449083166|FG000|Overall Study|Physician Decision|1|||
124852094|NCT03095417|449083167|FG001|Overall Study|Physician Decision|2|||
124852095|NCT03095417|449083168|FG002|Overall Study|Physician Decision|2|||
124852096|NCT03095417|449083169|FG003|Overall Study|Physician Decision|2|||
124852097|NCT03095417|449083166|FG000|Overall Study|Death|1|||
124852098|NCT03095417|449083167|FG001|Overall Study|Death|2|||
124852099|NCT03095417|449083168|FG002|Overall Study|Death|1|||
124852100|NCT03095417|449083169|FG003|Overall Study|Death|3|||
124852101|NCT01410110|449083170|FG000|Overall Study|Withdrawal by Subject|4|||
124852102|NCT01410110|449083171|FG001|Overall Study|Withdrawal by Subject|2|||
124852103|NCT03783923|449083178|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
124852104|NCT03783923|449083179|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
124852105|NCT03783923|449083178|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
124852106|NCT03783923|449083179|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
124852107|NCT03783923|449083178|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
124852108|NCT03783923|449083179|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
124852109|NCT03783923|449083178|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
124852110|NCT03783923|449083179|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
124852111|NCT03783923|449083178|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
124852112|NCT03783923|449083179|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
124852113|NCT02543346|449083180|FG000|Second Priming Visit|Withdrawal by Subject|0|||
124852114|NCT02543346|449083181|FG001|Second Priming Visit|Withdrawal by Subject|2|||
124852115|NCT02543346|449083182|FG002|Second Priming Visit|Withdrawal by Subject|2|||
124852116|NCT02543346|449083183|FG003|Second Priming Visit|Withdrawal by Subject|2|||
124852117|NCT02543346|449083180|FG000|Second Priming Visit|Adverse Event|1|||
124852118|NCT02543346|449083181|FG001|Second Priming Visit|Adverse Event|0|||
124852119|NCT02543346|449083182|FG002|Second Priming Visit|Adverse Event|0|||
124852120|NCT02543346|449083183|FG003|Second Priming Visit|Adverse Event|0|||
124852121|NCT00887341|449083188|FG000|Overall Study|Refused treatment|1|||
124852122|NCT00887341|449083189|FG001|Overall Study|Refused treatment|0|||
124852123|NCT00887341|449083188|FG000|Overall Study|Withdrawal by Subject|1|||
124852124|NCT00887341|449083189|FG001|Overall Study|Withdrawal by Subject|1|||
124852125|NCT00887341|449083188|FG000|Overall Study|Adverse Event|0|||
124852126|NCT00887341|449083189|FG001|Overall Study|Adverse Event|1|||
124852127|NCT00887341|449083188|FG000|Overall Study|Lost to Follow-up|0|||
124852128|NCT00887341|449083189|FG001|Overall Study|Lost to Follow-up|1|||
124852129|NCT01649856|449083190|FG000|Overall Study|Withdrawal by Subject|14|||
124852130|NCT01649856|449083191|FG001|Overall Study|Withdrawal by Subject|14|||
124852131|NCT01649856|449083190|FG000|Overall Study|Protocol Violation|4|||
124852132|NCT01649856|449083191|FG001|Overall Study|Protocol Violation|4|||
124852133|NCT01649856|449083190|FG000|Overall Study|Treatment Failure|1|||
124852134|NCT01649856|449083191|FG001|Overall Study|Treatment Failure|1|||
124852135|NCT01649856|449083190|FG000|Overall Study|Death|69|||
124852136|NCT01649856|449083191|FG001|Overall Study|Death|34|||
124852137|NCT01649856|449083190|FG000|Overall Study|Stable or Progressed Disease|5|||
124852138|NCT01649856|449083191|FG001|Overall Study|Stable or Progressed Disease|3|||
124852139|NCT01649856|449083190|FG000|Overall Study|Lost to Follow-up|20|||
124852140|NCT01649856|449083191|FG001|Overall Study|Lost to Follow-up|16|||
124852141|NCT01649856|449083190|FG000|Overall Study|Lack of Compliance|6|||
124852142|NCT01649856|449083191|FG001|Overall Study|Lack of Compliance|1|||
124852143|NCT01649856|449083190|FG000|Overall Study|Other|20|||
124852144|NCT01649856|449083191|FG001|Overall Study|Other|5|||
124852145|NCT00622635|449083192|FG000|Treatment Period 1|Adverse Event|0|||
124852146|NCT00622635|449083193|FG001|Treatment Period 1|Adverse Event|0|||
124852147|NCT00622635|449083194|FG002|Treatment Period 1|Adverse Event|1|||
124852148|NCT00622635|449083195|FG003|Treatment Period 1|Adverse Event|0|||
124852149|NCT00622635|449083196|FG004|Treatment Period 1|Adverse Event|0|||
124852150|NCT00622635|449083197|FG005|Treatment Period 1|Adverse Event|0|||
124852151|NCT00622635|449083192|FG000|Treatment Period 1|Withdrawal by Subject|0|||
124852152|NCT00622635|449083193|FG001|Treatment Period 1|Withdrawal by Subject|1|||
124852153|NCT00622635|449083194|FG002|Treatment Period 1|Withdrawal by Subject|0|||
124852154|NCT00622635|449083195|FG003|Treatment Period 1|Withdrawal by Subject|0|||
124852155|NCT00622635|449083196|FG004|Treatment Period 1|Withdrawal by Subject|0|||
124852156|NCT00622635|449083197|FG005|Treatment Period 1|Withdrawal by Subject|0|||
124852157|NCT00622635|449083192|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
124852158|NCT00622635|449083193|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
124852159|NCT00622635|449083194|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
124852160|NCT00622635|449083195|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
124852161|NCT00622635|449083196|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
124852162|NCT00622635|449083197|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
124852163|NCT00622635|449083192|FG000|Treatment Period 2|Adverse Event|1|||
124852164|NCT00622635|449083193|FG001|Treatment Period 2|Adverse Event|0|||
124852165|NCT00622635|449083194|FG002|Treatment Period 2|Adverse Event|0|||
124852166|NCT00622635|449083195|FG003|Treatment Period 2|Adverse Event|0|||
124852167|NCT00622635|449083196|FG004|Treatment Period 2|Adverse Event|0|||
124852168|NCT00622635|449083197|FG005|Treatment Period 2|Adverse Event|0|||
124852169|NCT00622635|449083192|FG000|Treatment Period 3|Adverse Event|0|||
124852170|NCT00622635|449083193|FG001|Treatment Period 3|Adverse Event|0|||
124852171|NCT00622635|449083194|FG002|Treatment Period 3|Adverse Event|0|||
124852172|NCT00622635|449083195|FG003|Treatment Period 3|Adverse Event|2|||
124852173|NCT00622635|449083196|FG004|Treatment Period 3|Adverse Event|0|||
124852174|NCT00622635|449083197|FG005|Treatment Period 3|Adverse Event|0|||
124852175|NCT00622635|449083192|FG000|Treatment Period 3|Withdrawal by Subject|0|||
124852176|NCT00622635|449083193|FG001|Treatment Period 3|Withdrawal by Subject|0|||
124852177|NCT00622635|449083194|FG002|Treatment Period 3|Withdrawal by Subject|0|||
124852178|NCT00622635|449083195|FG003|Treatment Period 3|Withdrawal by Subject|1|||
124852179|NCT00622635|449083196|FG004|Treatment Period 3|Withdrawal by Subject|0|||
124852180|NCT00622635|449083197|FG005|Treatment Period 3|Withdrawal by Subject|0|||
124852181|NCT00281840|449083198|FG000|Overall Study|Adverse Event|12|||
124852182|NCT00281840|449083198|FG000|Overall Study|Physician Decision|6|||
124852183|NCT00281840|449083198|FG000|Overall Study|Withdrawal by Subject|3|||
124852184|NCT00281840|449083198|FG000|Overall Study|Disease Progression|2|||
124852185|NCT00281840|449083198|FG000|Overall Study|exceed maximum delay in treatment|1|||
124852186|NCT00281840|449083198|FG000|Overall Study|Complicating Disease|1|||
124852187|NCT01079234|449083204|FG000|Main: Week 0 to 26|Adverse Event|5|||
124852188|NCT01079234|449083205|FG001|Main: Week 0 to 26|Adverse Event|4|||
124852189|NCT01079234|449083206|FG002|Main: Week 0 to 26|Adverse Event|1|||
124852190|NCT01079234|449083207|FG003|Main: Week 0 to 26|Adverse Event|0|||
124852191|NCT01079234|449083204|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
124852192|NCT01079234|449083205|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
124852193|NCT01079234|449083206|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
124852194|NCT01079234|449083207|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
124852195|NCT01079234|449083204|FG000|Main: Week 0 to 26|Protocol Violation|6|||
124852196|NCT01079234|449083205|FG001|Main: Week 0 to 26|Protocol Violation|2|||
124852197|NCT01079234|449083206|FG002|Main: Week 0 to 26|Protocol Violation|4|||
124852198|NCT01079234|449083207|FG003|Main: Week 0 to 26|Protocol Violation|0|||
124852199|NCT01079234|449083204|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
124852200|NCT01079234|449083205|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
124852201|NCT01079234|449083206|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
124852202|NCT01079234|449083207|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
124852203|NCT01079234|449083204|FG000|Main: Week 0 to 26|Unclassified|7|||
124852204|NCT01079234|449083205|FG001|Main: Week 0 to 26|Unclassified|13|||
124852205|NCT01079234|449083206|FG002|Main: Week 0 to 26|Unclassified|4|||
124852206|NCT01079234|449083207|FG003|Main: Week 0 to 26|Unclassified|0|||
124852207|NCT01079234|449083204|FG000|Extension: Week 27 to 52|Adverse Event|0|||
124852208|NCT01079234|449083205|FG001|Extension: Week 27 to 52|Adverse Event|0|||
124852209|NCT01079234|449083206|FG002|Extension: Week 27 to 52|Adverse Event|1|||
124852210|NCT01079234|449083207|FG003|Extension: Week 27 to 52|Adverse Event|0|||
124852211|NCT01079234|449083204|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
124852212|NCT01079234|449083205|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
124852213|NCT01079234|449083206|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
124852214|NCT01079234|449083207|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
124852215|NCT01079234|449083204|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
124852216|NCT01079234|449083205|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
124852217|NCT01079234|449083206|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
124852218|NCT01079234|449083207|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
124852219|NCT01079234|449083204|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
124852220|NCT01079234|449083205|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
124852221|NCT01079234|449083206|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
124852222|NCT01079234|449083207|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
124852223|NCT01079234|449083204|FG000|Extension: Week 27 to 52|Unclassified|0|||
124852224|NCT01079234|449083205|FG001|Extension: Week 27 to 52|Unclassified|0|||
124852225|NCT01079234|449083206|FG002|Extension: Week 27 to 52|Unclassified|4|||
124852226|NCT01079234|449083207|FG003|Extension: Week 27 to 52|Unclassified|7|||
124852227|NCT01312961|449083213|FG000|Overall Study|Adverse Event|3|||
124852228|NCT01312961|449083214|FG001|Overall Study|Adverse Event|3|||
124852229|NCT01312961|449083213|FG000|Overall Study|Lack of Efficacy|11|||
124852230|NCT01312961|449083214|FG001|Overall Study|Lack of Efficacy|1|||
124852231|NCT01312961|449083213|FG000|Overall Study|Poor compliance to protocol|1|||
124852232|NCT01312961|449083214|FG001|Overall Study|Poor compliance to protocol|0|||
124852233|NCT01312961|449083213|FG000|Overall Study|Other than specified above|2|||
124852234|NCT01312961|449083214|FG001|Overall Study|Other than specified above|3|||
124852235|NCT00205712|449083216|FG000|Overall Study|Lost to Follow-up|0|||
124852236|NCT00205712|449083217|FG001|Overall Study|Lost to Follow-up|1|||
124852237|NCT01337297|449083225|FG000|Overall Study|They entered to single anodal tDCS|4|||
124852238|NCT01337297|449083226|FG001|Overall Study|They entered to single anodal tDCS|3|||
124852239|NCT01337297|449083225|FG000|Overall Study|Lost to Follow-up|1|||
124852240|NCT01337297|449083226|FG001|Overall Study|Lost to Follow-up|3|||
124852241|NCT02316717|449083227|FG000|Overall Study|Adverse Event|2|||
124852242|NCT02316717|449083228|FG001|Overall Study|Adverse Event|2|||
124852243|NCT02316717|449083229|FG002|Overall Study|Adverse Event|0|||
124852244|NCT02316717|449083227|FG000|Overall Study|Lost to Follow-up|1|||
124852245|NCT02316717|449083228|FG001|Overall Study|Lost to Follow-up|2|||
124852246|NCT02316717|449083229|FG002|Overall Study|Lost to Follow-up|1|||
124852247|NCT02316717|449083227|FG000|Overall Study|Non compliance|3|||
124852248|NCT02316717|449083228|FG001|Overall Study|Non compliance|1|||
124852249|NCT02316717|449083229|FG002|Overall Study|Non compliance|0|||
124852250|NCT02316717|449083227|FG000|Overall Study|Protocol Violation|2|||
124852251|NCT02316717|449083228|FG001|Overall Study|Protocol Violation|0|||
124852252|NCT02316717|449083229|FG002|Overall Study|Protocol Violation|0|||
124852253|NCT02316717|449083227|FG000|Overall Study|Withdrawal by Subject|2|||
124852254|NCT02316717|449083228|FG001|Overall Study|Withdrawal by Subject|1|||
124852255|NCT02316717|449083229|FG002|Overall Study|Withdrawal by Subject|1|||
124852256|NCT02316717|449083227|FG000|Overall Study|Death|0|||
124852257|NCT02316717|449083228|FG001|Overall Study|Death|0|||
124852258|NCT02316717|449083229|FG002|Overall Study|Death|1|||
124852259|NCT02316717|449083227|FG000|Overall Study|Physician Decision|0|||
124852260|NCT02316717|449083228|FG001|Overall Study|Physician Decision|1|||
124852261|NCT02316717|449083229|FG002|Overall Study|Physician Decision|0|||
124852262|NCT02316717|449083227|FG000|Overall Study|TBC|1|||
124852263|NCT02316717|449083228|FG001|Overall Study|TBC|0|||
124852264|NCT02316717|449083229|FG002|Overall Study|TBC|0|||
124852265|NCT02778204|449083230|FG000|Overall Study|Adverse Event|1|||
124852266|NCT02778204|449083231|FG001|Overall Study|Adverse Event|0|||
124852267|NCT02778204|449083232|FG002|Overall Study|Adverse Event|0|||
124852268|NCT02778204|449083233|FG003|Overall Study|Adverse Event|0|||
124852269|NCT02778204|449083230|FG000|Overall Study|Withdrawal by Subject|0|||
124852270|NCT02778204|449083231|FG001|Overall Study|Withdrawal by Subject|0|||
124852271|NCT02778204|449083232|FG002|Overall Study|Withdrawal by Subject|1|||
124852272|NCT02778204|449083233|FG003|Overall Study|Withdrawal by Subject|2|||
124852273|NCT02778204|449083230|FG000|Overall Study|Lost to Follow-up|1|||
124852274|NCT02778204|449083231|FG001|Overall Study|Lost to Follow-up|0|||
124852275|NCT02778204|449083232|FG002|Overall Study|Lost to Follow-up|2|||
124852276|NCT02778204|449083233|FG003|Overall Study|Lost to Follow-up|1|||
124852277|NCT02778204|449083230|FG000|Overall Study|Protocol Violation|0|||
124852278|NCT02778204|449083231|FG001|Overall Study|Protocol Violation|0|||
124852279|NCT02778204|449083232|FG002|Overall Study|Protocol Violation|1|||
124852280|NCT02778204|449083233|FG003|Overall Study|Protocol Violation|0|||
124852281|NCT02778204|449083230|FG000|Overall Study|Eligibility Violation|0|||
124852282|NCT02778204|449083231|FG001|Overall Study|Eligibility Violation|0|||
124852283|NCT02778204|449083232|FG002|Overall Study|Eligibility Violation|0|||
124852284|NCT02778204|449083233|FG003|Overall Study|Eligibility Violation|1|||
124852285|NCT04122443|449083234|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
124852286|NCT04122443|449083235|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
124852287|NCT04122443|449083236|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
124852288|NCT04122443|449083234|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
124852289|NCT04122443|449083235|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
124852290|NCT04122443|449083236|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
124852291|NCT01072201|449083237|FG000|Overall Study|Lost to Follow-up|0|||
124852292|NCT01072201|449083238|FG001|Overall Study|Lost to Follow-up|1|||
124852293|NCT02052466|449083239|FG000|Overall Study|Withdrawal by Subject|1|||
124852294|NCT02052466|449083239|FG000|Overall Study|Acromial fracture|1|||
124852295|NCT00595582|449083240|FG000|Overall Study|Pilot study that PI terminated|2|||
124852296|NCT00595582|449083240|FG000|Overall Study|Lost to Follow-up|1|||
124852297|NCT00595582|449083240|FG000|Overall Study|Adverse Event|2|||
124852298|NCT00595582|449083240|FG000|Overall Study|Physician Decision|5|||
124852299|NCT00965848|449083242|FG000|Overall Study|Protocol Violation|3|||
124852300|NCT00965848|449083243|FG001|Overall Study|Protocol Violation|0|||
124852301|NCT00965848|449083244|FG002|Overall Study|Protocol Violation|1|||
124852302|NCT00965848|449083242|FG000|Overall Study|Death|11|||
124852303|NCT00965848|449083243|FG001|Overall Study|Death|1|||
124852304|NCT00965848|449083244|FG002|Overall Study|Death|5|||
124852305|NCT00965848|449083242|FG000|Overall Study|Lost to Follow-up|0|||
124852306|NCT00965848|449083243|FG001|Overall Study|Lost to Follow-up|0|||
124852307|NCT00965848|449083244|FG002|Overall Study|Lost to Follow-up|1|||
124852308|NCT00965848|449083242|FG000|Overall Study|Withdrawal by Subject|1|||
124852309|NCT00965848|449083243|FG001|Overall Study|Withdrawal by Subject|0|||
124852310|NCT00965848|449083244|FG002|Overall Study|Withdrawal by Subject|0|||
124852311|NCT00965848|449083242|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
124852312|NCT00965848|449083243|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
124852313|NCT00965848|449083244|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
124852314|NCT00965848|449083242|FG000|Overall Study|Not Clinically Evaluable|7|||
124852315|NCT00965848|449083243|FG001|Overall Study|Not Clinically Evaluable|1|||
124852316|NCT00965848|449083244|FG002|Overall Study|Not Clinically Evaluable|1|||
124852317|NCT00965848|449083242|FG000|Overall Study|Other|5|||
124852318|NCT00965848|449083243|FG001|Overall Study|Other|0|||
124852319|NCT00965848|449083244|FG002|Overall Study|Other|1|||
124852320|NCT00555438|449083253|FG000|10 Days Post-operative|Death|4|||
124852321|NCT00555438|449083253|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
124852322|NCT00061048|449083254|FG000|Overall Study|Adverse Event|2|||
124852323|NCT00061048|449083254|FG000|Overall Study|disease progression|20|||
124852324|NCT01431508|449083255|FG000|Overall Study|Lack of Efficacy|1|||
124852325|NCT01431508|449083255|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
124852326|NCT01609556|449083260|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852327|NCT01609556|449083261|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852328|NCT01609556|449083262|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852329|NCT01609556|449083263|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852330|NCT01609556|449083264|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
124852331|NCT01609556|449083265|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852332|NCT01609556|449083266|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852333|NCT01609556|449083267|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
124852334|NCT01609556|449083268|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
124852335|NCT01609556|449083269|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852336|NCT01609556|449083270|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
124852337|NCT01609556|449083271|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
124852338|NCT01609556|449083272|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852339|NCT01609556|449083273|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852340|NCT01609556|449083274|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852341|NCT01609556|449083275|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
124852342|NCT01609556|449083260|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
124852343|NCT01609556|449083261|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
124852344|NCT01609556|449083262|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
124852345|NCT01609556|449083263|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
124852346|NCT01609556|449083264|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
124852347|NCT01609556|449083265|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
124852348|NCT01609556|449083266|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
124852349|NCT01609556|449083267|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
124852350|NCT01609556|449083268|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
124852351|NCT01609556|449083269|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
124852352|NCT01609556|449083270|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
124852353|NCT01609556|449083271|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
124852354|NCT01609556|449083272|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
124852355|NCT01609556|449083273|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
124852356|NCT01609556|449083274|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
124852357|NCT01609556|449083275|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
124852358|NCT01609556|449083260|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852359|NCT01609556|449083261|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852360|NCT01609556|449083262|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852361|NCT01609556|449083263|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852362|NCT01609556|449083264|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852363|NCT01609556|449083265|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
124852364|NCT01609556|449083266|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
124852365|NCT01609556|449083267|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852366|NCT01609556|449083268|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852367|NCT01609556|449083269|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
124852368|NCT01609556|449083270|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
124852369|NCT01609556|449083271|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
124852370|NCT01609556|449083272|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852371|NCT01609556|449083273|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852372|NCT01609556|449083274|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852373|NCT01609556|449083275|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
124852374|NCT01609556|449083260|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852375|NCT01609556|449083261|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852376|NCT01609556|449083262|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852377|NCT01609556|449083263|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852378|NCT01609556|449083264|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852379|NCT01609556|449083265|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
124852380|NCT01609556|449083266|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852381|NCT01609556|449083267|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852382|NCT01609556|449083268|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852383|NCT01609556|449083269|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852384|NCT01609556|449083270|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852385|NCT01609556|449083271|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
124852386|NCT01609556|449083272|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852387|NCT01609556|449083273|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852388|NCT01609556|449083274|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852389|NCT01609556|449083275|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
124852390|NCT01609556|449083260|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852391|NCT01609556|449083261|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852392|NCT01609556|449083262|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852393|NCT01609556|449083263|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852394|NCT01609556|449083264|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852395|NCT01609556|449083265|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
124852396|NCT01609556|449083266|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852397|NCT01609556|449083267|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852398|NCT01609556|449083268|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852399|NCT01609556|449083269|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852400|NCT01609556|449083270|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852401|NCT01609556|449083271|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852402|NCT01609556|449083272|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852403|NCT01609556|449083273|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852404|NCT01609556|449083274|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852405|NCT01609556|449083275|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
124852406|NCT01609556|449083260|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852407|NCT01609556|449083261|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852408|NCT01609556|449083262|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852409|NCT01609556|449083263|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852410|NCT01609556|449083264|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852411|NCT01609556|449083265|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852412|NCT01609556|449083266|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852413|NCT01609556|449083267|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852414|NCT01609556|449083268|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
124852415|NCT01609556|449083269|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852416|NCT01609556|449083270|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852417|NCT01609556|449083271|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852418|NCT01609556|449083272|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852419|NCT01609556|449083273|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852420|NCT01609556|449083274|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852421|NCT01609556|449083275|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
124852422|NCT01609556|449083260|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
124852423|NCT01609556|449083261|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852424|NCT01609556|449083262|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852425|NCT01609556|449083263|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852426|NCT01609556|449083264|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852427|NCT01609556|449083265|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
124852428|NCT01609556|449083266|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852429|NCT01609556|449083267|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852430|NCT01609556|449083268|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852431|NCT01609556|449083269|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852432|NCT01609556|449083270|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
124852433|NCT01609556|449083271|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852434|NCT01609556|449083272|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852435|NCT01609556|449083273|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852436|NCT01609556|449083274|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852437|NCT01609556|449083275|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
124852438|NCT01609556|449083260|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852439|NCT01609556|449083261|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852440|NCT01609556|449083262|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852441|NCT01609556|449083263|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852442|NCT01609556|449083264|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852443|NCT01609556|449083265|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852444|NCT01609556|449083266|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852445|NCT01609556|449083267|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852446|NCT01609556|449083268|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852447|NCT01609556|449083269|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852448|NCT01609556|449083270|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852449|NCT01609556|449083271|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
124852450|NCT01609556|449083272|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
124852451|NCT01609556|449083273|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
124852452|NCT01609556|449083274|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
124852453|NCT01609556|449083275|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
124852454|NCT01609556|449083260|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852455|NCT01609556|449083261|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852456|NCT01609556|449083262|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852457|NCT01609556|449083263|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852458|NCT01609556|449083264|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852459|NCT01609556|449083265|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852460|NCT01609556|449083266|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852461|NCT01609556|449083267|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852462|NCT01609556|449083268|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852463|NCT01609556|449083269|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852464|NCT01609556|449083270|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852465|NCT01609556|449083271|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
124852466|NCT01609556|449083272|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
124852467|NCT01609556|449083273|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
124852468|NCT01609556|449083274|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
124852469|NCT01609556|449083275|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
124852470|NCT01609556|449083260|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852471|NCT01609556|449083261|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852472|NCT01609556|449083262|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852473|NCT01609556|449083263|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852474|NCT01609556|449083264|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852475|NCT01609556|449083265|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852476|NCT01609556|449083266|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852477|NCT01609556|449083267|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852478|NCT01609556|449083268|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852479|NCT01609556|449083269|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852480|NCT01609556|449083270|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852481|NCT01609556|449083271|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
124852482|NCT01609556|449083272|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
124852483|NCT01609556|449083273|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
124852484|NCT01609556|449083274|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
124852485|NCT01609556|449083275|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
124852486|NCT01609556|449083260|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852487|NCT01609556|449083261|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852488|NCT01609556|449083262|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852489|NCT01609556|449083263|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852490|NCT01609556|449083264|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852491|NCT01609556|449083265|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852492|NCT01609556|449083266|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852493|NCT01609556|449083267|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852494|NCT01609556|449083268|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852495|NCT01609556|449083269|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852496|NCT01609556|449083270|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852497|NCT01609556|449083271|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852498|NCT01609556|449083272|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
124852499|NCT01609556|449083273|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852500|NCT01609556|449083274|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852501|NCT01609556|449083275|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
124852502|NCT01609556|449083260|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852503|NCT01609556|449083261|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852504|NCT01609556|449083262|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852505|NCT01609556|449083263|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852506|NCT01609556|449083264|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852507|NCT01609556|449083265|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852508|NCT01609556|449083266|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852509|NCT01609556|449083267|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852510|NCT01609556|449083268|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852511|NCT01609556|449083269|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852512|NCT01609556|449083270|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852513|NCT01609556|449083271|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
124852514|NCT01609556|449083272|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
124852515|NCT01609556|449083273|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
124852516|NCT01609556|449083274|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
124852517|NCT01609556|449083275|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
124852518|NCT01609556|449083260|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852519|NCT01609556|449083261|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852520|NCT01609556|449083262|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852521|NCT01609556|449083263|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852522|NCT01609556|449083264|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852523|NCT01609556|449083265|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852524|NCT01609556|449083266|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852525|NCT01609556|449083267|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852526|NCT01609556|449083268|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852527|NCT01609556|449083269|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852528|NCT01609556|449083270|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852529|NCT01609556|449083271|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852530|NCT01609556|449083272|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852531|NCT01609556|449083273|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852532|NCT01609556|449083274|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
124852533|NCT01609556|449083275|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
124852534|NCT01609556|449083260|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852535|NCT01609556|449083261|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852536|NCT01609556|449083262|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852537|NCT01609556|449083263|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852538|NCT01609556|449083264|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852539|NCT01609556|449083265|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852540|NCT01609556|449083266|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852541|NCT01609556|449083267|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852542|NCT01609556|449083268|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852543|NCT01609556|449083269|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852544|NCT01609556|449083270|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852545|NCT01609556|449083271|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852546|NCT01609556|449083272|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
124852547|NCT01609556|449083273|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
124852548|NCT01609556|449083274|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
124852549|NCT01609556|449083275|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
124852550|NCT01609556|449083260|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852551|NCT01609556|449083261|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852552|NCT01609556|449083262|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852553|NCT01609556|449083263|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852554|NCT01609556|449083264|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852555|NCT01609556|449083265|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852556|NCT01609556|449083266|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852557|NCT01609556|449083267|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852558|NCT01609556|449083268|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852559|NCT01609556|449083269|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852560|NCT01609556|449083270|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852561|NCT01609556|449083271|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852562|NCT01609556|449083272|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
124852563|NCT01609556|449083273|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852564|NCT01609556|449083274|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852565|NCT01609556|449083275|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
124852566|NCT04452344|449083276|FG000|Overall Study|Withdrawal by Subject|3|||
124852567|NCT04452344|449083277|FG001|Overall Study|Withdrawal by Subject|6|||
124852568|NCT04452344|449083276|FG000|Overall Study|Adverse Event|1|||
124852569|NCT04452344|449083277|FG001|Overall Study|Adverse Event|2|||
124852570|NCT04452344|449083276|FG000|Overall Study|Lost to Follow-up|2|||
124852571|NCT04452344|449083277|FG001|Overall Study|Lost to Follow-up|2|||
124852572|NCT04452344|449083276|FG000|Overall Study|No Post-Op Visit|6|||
124852573|NCT04452344|449083277|FG001|Overall Study|No Post-Op Visit|7|||
124852574|NCT00023452|449083278|FG000|Overall Study|Ineligible for Study|163|||
124852575|NCT00023452|449083279|FG001|Overall Study|Ineligible for Study|159|||
124852576|NCT00023452|449083278|FG000|Overall Study|Out of Window|129|||
124852577|NCT00023452|449083279|FG001|Overall Study|Out of Window|69|||
124852578|NCT00023452|449083278|FG000|Overall Study|Death|2|||
124852579|NCT00023452|449083279|FG001|Overall Study|Death|0|||
124852580|NCT00023452|449083278|FG000|Overall Study|Withdrawal by Subject|66|||
124852581|NCT00023452|449083279|FG001|Overall Study|Withdrawal by Subject|54|||
124852582|NCT00023452|449083278|FG000|Overall Study|Adverse Event|139|||
124852583|NCT00023452|449083279|FG001|Overall Study|Adverse Event|196|||
124852584|NCT00023452|449083278|FG000|Overall Study|Lost to Follow-up|293|||
124852585|NCT00023452|449083279|FG001|Overall Study|Lost to Follow-up|60|||
124852586|NCT00023452|449083278|FG000|Overall Study|Physician Decision|49|||
124852587|NCT00023452|449083279|FG001|Overall Study|Physician Decision|21|||
124852588|NCT00023452|449083278|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
124852589|NCT00023452|449083279|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
124852590|NCT00023452|449083278|FG000|Overall Study|Pregnant|53|||
124852591|NCT00023452|449083279|FG001|Overall Study|Pregnant|20|||
124852592|NCT00023452|449083278|FG000|Overall Study|Other|204|||
124852593|NCT00023452|449083279|FG001|Overall Study|Other|69|||
124852594|NCT03779841|449083281|FG000|Randomized Population|Did Not Receive Treatment|3|||
124852595|NCT03779841|449083282|FG001|Randomized Population|Did Not Receive Treatment|1|||
124852596|NCT03779841|449083283|FG002|Randomized Population|Did Not Receive Treatment|0|||
124852597|NCT03779841|449083281|FG000|Treated (Safety) Population|Adverse Event|1|||
124852598|NCT03779841|449083282|FG001|Treated (Safety) Population|Adverse Event|1|||
124852599|NCT03779841|449083283|FG002|Treated (Safety) Population|Adverse Event|0|||
124852600|NCT03779841|449083281|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
124852601|NCT03779841|449083282|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
124852602|NCT03779841|449083283|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
124852603|NCT03779841|449083281|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
124852604|NCT03779841|449083282|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
124852605|NCT03779841|449083283|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
124852606|NCT03779841|449083281|FG000|Treated (Safety) Population|Death|1|||
124852607|NCT03779841|449083282|FG001|Treated (Safety) Population|Death|0|||
124852608|NCT03779841|449083283|FG002|Treated (Safety) Population|Death|2|||
124852609|NCT00162136|449083284|FG000|Overall Study|Adverse Event|1|||
124852610|NCT00162136|449083284|FG000|Overall Study|Death|1|||
124852611|NCT00162136|449083284|FG000|Overall Study|Disease Progression/Relapse|23|||
124852612|NCT00162136|449083284|FG000|Overall Study|Investigator Request|5|||
124852613|NCT00162136|449083284|FG000|Overall Study|Study Drug Toxicity|4|||
124852614|NCT00162136|449083284|FG000|Overall Study|Withdrawal by Subject|1|||
124852615|NCT02788175|449083285|FG000|Overall Study|Protocol Violation|3|||
124852616|NCT02788175|449083285|FG000|Overall Study|Withdrawal by Subject|4|||
124852617|NCT02788175|449083285|FG000|Overall Study|Ineligible prior to study agent|6|||
124852618|NCT03930745|449083286|FG000|Overall Study|Lost to Follow-up|10|||
124852619|NCT03930745|449083287|FG001|Overall Study|Lost to Follow-up|5|||
124852620|NCT03930745|449083286|FG000|Overall Study|Withdrawal by Subject|1|||
124852621|NCT03930745|449083287|FG001|Overall Study|Withdrawal by Subject|2|||
124852622|NCT03930745|449083286|FG000|Overall Study|Protocol Violation|2|||
124852623|NCT03930745|449083287|FG001|Overall Study|Protocol Violation|2|||
124852624|NCT03930745|449083286|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
124852625|NCT03930745|449083287|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
124852626|NCT03930745|449083286|FG000|Overall Study|Adverse Event|0|||
124852627|NCT03930745|449083287|FG001|Overall Study|Adverse Event|1|||
124852628|NCT03930745|449083286|FG000|Overall Study|Pregnancy|0|||
124852629|NCT03930745|449083287|FG001|Overall Study|Pregnancy|1|||
124852630|NCT04095858|449083292|FG000|Overall Study|Death|1|||
124852631|NCT04095858|449083293|FG001|Overall Study|Death|0|||
124852632|NCT04095858|449083292|FG000|Overall Study|Study terminated by Sponsor|2|||
124852633|NCT04095858|449083293|FG001|Overall Study|Study terminated by Sponsor|4|||
124852634|NCT03483623|449083295|FG000|Overall Study|43 complete sets achieved|1|||
124852635|NCT02770391|449083296|FG000|Overall Study|Lost to Follow-up|2|||
124852636|NCT02770391|449083296|FG000|Overall Study|Withdrawal by Subject|1|||
124852637|NCT02770391|449083296|FG000|Overall Study|Surgery delayed unevaluable|2|||
124852638|NCT02770391|449083296|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
124852639|NCT02199691|449083297|FG000|Overall Study|Protocol Violation|3|||
124852640|NCT02199691|449083298|FG001|Overall Study|Protocol Violation|3|||
124852641|NCT02199691|449083299|FG002|Overall Study|Protocol Violation|6|||
124852642|NCT02199691|449083300|FG003|Overall Study|Protocol Violation|7|||
124852643|NCT02199691|449083297|FG000|Overall Study|Withdrawal by Subject|5|||
124852644|NCT02199691|449083298|FG001|Overall Study|Withdrawal by Subject|3|||
124852645|NCT02199691|449083299|FG002|Overall Study|Withdrawal by Subject|12|||
124852646|NCT02199691|449083300|FG003|Overall Study|Withdrawal by Subject|13|||
124852647|NCT02199691|449083297|FG000|Overall Study|Lost to Follow-up|2|||
124852648|NCT02199691|449083298|FG001|Overall Study|Lost to Follow-up|1|||
124852649|NCT02199691|449083299|FG002|Overall Study|Lost to Follow-up|9|||
124852650|NCT02199691|449083300|FG003|Overall Study|Lost to Follow-up|10|||
124852651|NCT00836875|449083306|FG000|Overall Study|Death|3|||
124852652|NCT00836875|449083307|FG001|Overall Study|Death|2|||
124852653|NCT00836875|449083306|FG000|Overall Study|Withdrawal by Subject|0|||
124852654|NCT00836875|449083307|FG001|Overall Study|Withdrawal by Subject|1|||
124852655|NCT03403634|449083310|FG000|Overall Study|Disease progression|3|||
124852656|NCT03403634|449083310|FG000|Overall Study|Did not meet eligibility criteria|4|||
124852657|NCT00428610|449083311|FG000|Overall Study|Death Due to Adverse Event|3|||
124852658|NCT00428610|449083312|FG001|Overall Study|Death Due to Adverse Event|0|||
124852659|NCT00428610|449083313|FG002|Overall Study|Death Due to Adverse Event|5|||
124852660|NCT00428610|449083311|FG000|Overall Study|Death Due to Progressive Disease|0|||
124852661|NCT00428610|449083312|FG001|Overall Study|Death Due to Progressive Disease|0|||
124852662|NCT00428610|449083313|FG002|Overall Study|Death Due to Progressive Disease|2|||
124852663|NCT00428610|449083311|FG000|Overall Study|Adverse Event|2|||
124852664|NCT00428610|449083312|FG001|Overall Study|Adverse Event|3|||
124852665|NCT00428610|449083313|FG002|Overall Study|Adverse Event|2|||
124852666|NCT00428610|449083311|FG000|Overall Study|Investigator Decision|2|||
124852667|NCT00428610|449083312|FG001|Overall Study|Investigator Decision|1|||
124852668|NCT00428610|449083313|FG002|Overall Study|Investigator Decision|1|||
124852669|NCT00428610|449083311|FG000|Overall Study|Progressive Disease|42|||
124852670|NCT00428610|449083312|FG001|Overall Study|Progressive Disease|14|||
124852671|NCT00428610|449083313|FG002|Overall Study|Progressive Disease|22|||
124852672|NCT00428610|449083311|FG000|Overall Study|Withdrawal by Subject|4|||
124852673|NCT00428610|449083312|FG001|Overall Study|Withdrawal by Subject|0|||
124852674|NCT00428610|449083313|FG002|Overall Study|Withdrawal by Subject|0|||
124852675|NCT01043874|449085724|FG000|Overall Study|Adverse Event|3|||
124852676|NCT01043874|449085724|FG000|Overall Study|Withdrawal by Subject|1|||
124852677|NCT01043874|449085724|FG000|Overall Study|Lack of Efficacy|1|||
124852678|NCT01043874|449085724|FG000|Overall Study|Administrative Problems|1|||
124852679|NCT00182689|449085730|FG000|Overall Study|Adverse Event|8|||
124852680|NCT00182689|449085731|FG001|Overall Study|Adverse Event|11|||
124852681|NCT00182689|449085730|FG000|Overall Study|Withdrawal by Subject|2|||
124852682|NCT00182689|449085731|FG001|Overall Study|Withdrawal by Subject|2|||
124852683|NCT00182689|449085730|FG000|Overall Study|Progression|27|||
124852684|NCT00182689|449085731|FG001|Overall Study|Progression|29|||
124852685|NCT00182689|449085730|FG000|Overall Study|Death|1|||
124852686|NCT00182689|449085731|FG001|Overall Study|Death|0|||
124852687|NCT00182689|449085730|FG000|Overall Study|not protocol specified|0|||
124852688|NCT00182689|449085731|FG001|Overall Study|not protocol specified|3|||
124852689|NCT00182689|449085730|FG000|Overall Study|Ineligible|1|||
124852690|NCT00182689|449085731|FG001|Overall Study|Ineligible|4|||
124852691|NCT00182689|449085730|FG000|Overall Study|Never received treatment|1|||
124852692|NCT00182689|449085731|FG001|Overall Study|Never received treatment|0|||
124852693|NCT03422003|449085732|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
124852694|NCT03422003|449085733|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
124852695|NCT03422003|449085732|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
124852696|NCT03422003|449085733|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
124852697|NCT01040871|449085736|FG000|Overall Study|Adverse Event|6|||
124852698|NCT01040871|449085737|FG001|Overall Study|Adverse Event|2|||
124852699|NCT01040871|449085736|FG000|Overall Study|Withdrawal by Subject|2|||
124852700|NCT01040871|449085737|FG001|Overall Study|Withdrawal by Subject|0|||
124852701|NCT01040871|449085736|FG000|Overall Study|Death|1|||
124852702|NCT01040871|449085737|FG001|Overall Study|Death|3|||
124852703|NCT01040871|449085736|FG000|Overall Study|Lack of Efficacy|1|||
124852704|NCT01040871|449085737|FG001|Overall Study|Lack of Efficacy|1|||
124852705|NCT01040871|449085736|FG000|Overall Study|drug supply issue|1|||
124852706|NCT01040871|449085737|FG001|Overall Study|drug supply issue|0|||
124852707|NCT01040871|449085736|FG000|Overall Study|Randomized and Not Treated|2|||
124852708|NCT01040871|449085737|FG001|Overall Study|Randomized and Not Treated|1|||
124852709|NCT00673049|449085742|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
124852710|NCT00673049|449085743|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
124852711|NCT00673049|449085744|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
124852712|NCT00673049|449085745|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
124852713|NCT00673049|449085742|FG000|Before Progression on Erlotinib|Death|235|||
124852714|NCT00673049|449085743|FG001|Before Progression on Erlotinib|Death|167|||
124852715|NCT00673049|449085744|FG002|Before Progression on Erlotinib|Death|1|||
124852716|NCT00673049|449085745|FG003|Before Progression on Erlotinib|Death|0|||
124852717|NCT00673049|449085742|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
124852718|NCT00673049|449085743|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
124852719|NCT00673049|449085744|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
124852720|NCT00673049|449085745|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
124852721|NCT00673049|449085742|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
124852722|NCT00673049|449085743|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
124852723|NCT00673049|449085744|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
124852724|NCT00673049|449085745|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
124852725|NCT00673049|449085742|FG000|Before Progression on Erlotinib|Other|1|||
124852726|NCT00673049|449085743|FG001|Before Progression on Erlotinib|Other|2|||
124852727|NCT00673049|449085744|FG002|Before Progression on Erlotinib|Other|0|||
124852728|NCT00673049|449085745|FG003|Before Progression on Erlotinib|Other|0|||
124852729|NCT00673049|449085742|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
124852730|NCT00673049|449085743|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
124852731|NCT00673049|449085744|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
124852732|NCT00673049|449085745|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
124852733|NCT00673049|449085742|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
124852734|NCT00673049|449085743|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
124852735|NCT00673049|449085744|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
124852736|NCT00673049|449085745|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
124852737|NCT00673049|449085742|FG000|After Progression on Erlotinib|Death|0|||
124852738|NCT00673049|449085743|FG001|After Progression on Erlotinib|Death|0|||
124852739|NCT00673049|449085744|FG002|After Progression on Erlotinib|Death|0|||
124852740|NCT00673049|449085745|FG003|After Progression on Erlotinib|Death|71|||
124852741|NCT00673049|449085742|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
124852742|NCT00673049|449085743|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
124852743|NCT00673049|449085744|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
124852744|NCT00673049|449085745|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
124852745|NCT00673049|449085742|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
124852746|NCT00673049|449085743|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
124852747|NCT00673049|449085744|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
124852748|NCT00673049|449085745|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
124852749|NCT00673049|449085742|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
124852750|NCT00673049|449085743|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
124852751|NCT00673049|449085744|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
124852752|NCT00673049|449085745|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
124852753|NCT01175824|449085746|FG000|Overall Study|Adverse Event|2|||
124852754|NCT01175824|449085747|FG001|Overall Study|Adverse Event|1|||
124852755|NCT01175824|449085746|FG000|Overall Study|Lack of Efficacy|2|||
124852756|NCT01175824|449085747|FG001|Overall Study|Lack of Efficacy|0|||
124852757|NCT01175824|449085746|FG000|Overall Study|Lost to Follow-up|0|||
124852758|NCT01175824|449085747|FG001|Overall Study|Lost to Follow-up|1|||
124852759|NCT01175824|449085746|FG000|Overall Study|Physician Decision|0|||
124852760|NCT01175824|449085747|FG001|Overall Study|Physician Decision|4|||
124852761|NCT01175824|449085746|FG000|Overall Study|Protocol Violation|2|||
124852762|NCT01175824|449085747|FG001|Overall Study|Protocol Violation|5|||
124852763|NCT01175824|449085746|FG000|Overall Study|Withdrawal by Subject|3|||
124852764|NCT01175824|449085747|FG001|Overall Study|Withdrawal by Subject|7|||
124852765|NCT01175824|449085746|FG000|Overall Study|Sponsor Decision|1|||
124852766|NCT01175824|449085747|FG001|Overall Study|Sponsor Decision|0|||
124852767|NCT01175824|449085746|FG000|Overall Study|Entry Criteria Not Met|6|||
124852768|NCT01175824|449085747|FG001|Overall Study|Entry Criteria Not Met|4|||
124852769|NCT00924950|449085748|FG000|Overall Study|Lost to Follow-up|2|||
124852770|NCT02979535|449085749|FG000|Overall Study|Non compliance with the protocol|78|||
124852771|NCT02979535|449085750|FG001|Overall Study|Non compliance with the protocol|82|||
124852772|NCT02979535|449085749|FG000|Overall Study|Consent withdrawn by participant|11|||
124852773|NCT02979535|449085750|FG001|Overall Study|Consent withdrawn by participant|18|||
124852774|NCT02979535|449085749|FG000|Overall Study|Lost to Follow-up|6|||
124852775|NCT02979535|449085750|FG001|Overall Study|Lost to Follow-up|1|||
124852776|NCT02530619|449085754|FG000|Registered for Study|Withdrawal by Subject|2|||
124852777|NCT02530619|449085754|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
124852778|NCT02530619|449085754|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
124852779|NCT02530619|449085754|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
124852780|NCT02530619|449085754|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
124852781|NCT02530619|449085754|FG000|Follow-up Period (6 Months)|Death|4|||
124852782|NCT02530619|449085754|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
124852783|NCT02530619|449085754|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
124852784|NCT00009737|449085756|FG000|Overall Study|Adverse Event|112|||
124852785|NCT00009737|449085757|FG001|Overall Study|Adverse Event|75|||
124852786|NCT00009737|449085756|FG000|Overall Study|Death|4|||
124852787|NCT00009737|449085757|FG001|Overall Study|Death|6|||
124852788|NCT00009737|449085756|FG000|Overall Study|Lack of Efficacy|17|||
124852789|NCT00009737|449085757|FG001|Overall Study|Lack of Efficacy|15|||
124852790|NCT00009737|449085756|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
124852791|NCT00009737|449085757|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
124852792|NCT00009737|449085756|FG000|Overall Study|Other Protocol Violation|1|||
124852793|NCT00009737|449085757|FG001|Overall Study|Other Protocol Violation|0|||
124852794|NCT00009737|449085756|FG000|Overall Study|Refused Treatment|15|||
124852795|NCT00009737|449085757|FG001|Overall Study|Refused Treatment|16|||
124852796|NCT00009737|449085756|FG000|Overall Study|Lost to Follow-up|1|||
124852797|NCT00009737|449085757|FG001|Overall Study|Lost to Follow-up|1|||
124852798|NCT00009737|449085756|FG000|Overall Study|Administrative/Other Reasons|7|||
124852799|NCT00009737|449085757|FG001|Overall Study|Administrative/Other Reasons|1|||
124852800|NCT01163682|449085761|FG000|Overall Study|Lost to Follow-up|6|||
124852801|NCT01163682|449085762|FG001|Overall Study|Lost to Follow-up|9|||
124852802|NCT00530023|449085768|FG000|Overall Study|Withdrawal by Subject|0|||
124852803|NCT00530023|449085769|FG001|Overall Study|Withdrawal by Subject|1|||
124852804|NCT00359762|449085770|FG000|Period II|Adverse Event|17|||
124852805|NCT00359762|449085771|FG001|Period II|Adverse Event|0|||
124852806|NCT00359762|449085772|FG002|Period II|Adverse Event|0|||
124852807|NCT00359762|449085773|FG003|Period II|Adverse Event|0|||
124852808|NCT00359762|449085774|FG004|Period II|Adverse Event|49|||
124852809|NCT00359762|449085770|FG000|Period II|Protocol Violation|18|||
124852810|NCT00359762|449085771|FG001|Period II|Protocol Violation|0|||
124852811|NCT00359762|449085772|FG002|Period II|Protocol Violation|0|||
124852812|NCT00359762|449085773|FG003|Period II|Protocol Violation|0|||
124852813|NCT00359762|449085774|FG004|Period II|Protocol Violation|11|||
124852814|NCT00359762|449085770|FG000|Period II|Physician Decision|17|||
124852815|NCT00359762|449085771|FG001|Period II|Physician Decision|0|||
124852816|NCT00359762|449085772|FG002|Period II|Physician Decision|0|||
124852817|NCT00359762|449085773|FG003|Period II|Physician Decision|0|||
124852818|NCT00359762|449085774|FG004|Period II|Physician Decision|23|||
124852819|NCT00359762|449085770|FG000|Period II|Death|2|||
124852820|NCT00359762|449085771|FG001|Period II|Death|0|||
124852821|NCT00359762|449085772|FG002|Period II|Death|0|||
124852822|NCT00359762|449085773|FG003|Period II|Death|0|||
124852823|NCT00359762|449085774|FG004|Period II|Death|4|||
124852824|NCT00359762|449085770|FG000|Period II|Lack of Efficacy|11|||
124852825|NCT00359762|449085771|FG001|Period II|Lack of Efficacy|0|||
124852826|NCT00359762|449085772|FG002|Period II|Lack of Efficacy|0|||
124852827|NCT00359762|449085773|FG003|Period II|Lack of Efficacy|0|||
124852828|NCT00359762|449085774|FG004|Period II|Lack of Efficacy|8|||
124852829|NCT00359762|449085770|FG000|Period II|Lost to follow up|5|||
124852830|NCT00359762|449085771|FG001|Period II|Lost to follow up|0|||
124852831|NCT00359762|449085772|FG002|Period II|Lost to follow up|0|||
124852832|NCT00359762|449085773|FG003|Period II|Lost to follow up|0|||
124852833|NCT00359762|449085774|FG004|Period II|Lost to follow up|5|||
124852834|NCT00359762|449085770|FG000|Period II|Entry Criteria Not Met|8|||
124852835|NCT00359762|449085771|FG001|Period II|Entry Criteria Not Met|0|||
124852836|NCT00359762|449085772|FG002|Period II|Entry Criteria Not Met|0|||
124852837|NCT00359762|449085773|FG003|Period II|Entry Criteria Not Met|0|||
124852838|NCT00359762|449085774|FG004|Period II|Entry Criteria Not Met|4|||
124852839|NCT00359762|449085770|FG000|Period II|Subject Decision|50|||
124852840|NCT00359762|449085771|FG001|Period II|Subject Decision|0|||
124852841|NCT00359762|449085772|FG002|Period II|Subject Decision|0|||
124852842|NCT00359762|449085773|FG003|Period II|Subject Decision|0|||
124852843|NCT00359762|449085774|FG004|Period II|Subject Decision|70|||
124852844|NCT00359762|449085770|FG000|Period III|Protocol Violation|0|||
124852845|NCT00359762|449085771|FG001|Period III|Protocol Violation|5|||
124852846|NCT00359762|449085772|FG002|Period III|Protocol Violation|3|||
124852847|NCT00359762|449085773|FG003|Period III|Protocol Violation|8|||
124852848|NCT00359762|449085774|FG004|Period III|Protocol Violation|0|||
124852849|NCT00359762|449085770|FG000|Period III|Adverse Event|0|||
124852850|NCT00359762|449085771|FG001|Period III|Adverse Event|3|||
124852851|NCT00359762|449085772|FG002|Period III|Adverse Event|4|||
124852852|NCT00359762|449085773|FG003|Period III|Adverse Event|10|||
124852853|NCT00359762|449085774|FG004|Period III|Adverse Event|0|||
124852854|NCT00359762|449085770|FG000|Period III|Physician Decision|0|||
124852855|NCT00359762|449085771|FG001|Period III|Physician Decision|5|||
124852856|NCT00359762|449085772|FG002|Period III|Physician Decision|9|||
124852857|NCT00359762|449085773|FG003|Period III|Physician Decision|15|||
124852858|NCT00359762|449085774|FG004|Period III|Physician Decision|0|||
124852859|NCT00359762|449085770|FG000|Period III|Lack of Efficacy|0|||
124852860|NCT00359762|449085771|FG001|Period III|Lack of Efficacy|7|||
124852861|NCT00359762|449085772|FG002|Period III|Lack of Efficacy|5|||
124852862|NCT00359762|449085773|FG003|Period III|Lack of Efficacy|9|||
124852863|NCT00359762|449085774|FG004|Period III|Lack of Efficacy|0|||
124852864|NCT00359762|449085770|FG000|Period III|Lost to follow up|0|||
124852865|NCT00359762|449085771|FG001|Period III|Lost to follow up|1|||
124852866|NCT00359762|449085772|FG002|Period III|Lost to follow up|1|||
124852867|NCT00359762|449085773|FG003|Period III|Lost to follow up|2|||
124852868|NCT00359762|449085774|FG004|Period III|Lost to follow up|0|||
124852869|NCT00359762|449085770|FG000|Period III|Entry Criteria Not Met|0|||
124852870|NCT00359762|449085771|FG001|Period III|Entry Criteria Not Met|1|||
124852871|NCT00359762|449085772|FG002|Period III|Entry Criteria Not Met|0|||
124852872|NCT00359762|449085773|FG003|Period III|Entry Criteria Not Met|1|||
124852873|NCT00359762|449085774|FG004|Period III|Entry Criteria Not Met|0|||
124852874|NCT00359762|449085770|FG000|Period III|Subject Decision|0|||
124852875|NCT00359762|449085771|FG001|Period III|Subject Decision|7|||
124852876|NCT00359762|449085772|FG002|Period III|Subject Decision|8|||
124852877|NCT00359762|449085773|FG003|Period III|Subject Decision|20|||
124852878|NCT00359762|449085774|FG004|Period III|Subject Decision|0|||
124852879|NCT01172938|449085778|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
124852880|NCT01172938|449085779|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
124852881|NCT01172938|449085780|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
124852882|NCT01172938|449085781|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124852883|NCT01172938|449085782|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124852884|NCT01172938|449085783|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124852885|NCT01172938|449085784|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124852886|NCT01172938|449085785|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124852887|NCT01172938|449085786|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
124852888|NCT01172938|449085778|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
124852889|NCT01172938|449085779|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
124852890|NCT01172938|449085780|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
124852891|NCT01172938|449085781|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124852892|NCT01172938|449085782|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124852893|NCT01172938|449085783|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124852894|NCT01172938|449085784|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124852895|NCT01172938|449085785|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124852896|NCT01172938|449085786|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
124852897|NCT01172938|449085778|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124852898|NCT01172938|449085779|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
124852899|NCT01172938|449085780|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
124852900|NCT01172938|449085781|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124852901|NCT01172938|449085782|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124852902|NCT01172938|449085783|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124852903|NCT01172938|449085784|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124852904|NCT01172938|449085785|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124852905|NCT01172938|449085786|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
124852906|NCT01172938|449085778|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
124852907|NCT01172938|449085779|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
124852908|NCT01172938|449085780|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
124852909|NCT01172938|449085781|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124852910|NCT01172938|449085782|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124852911|NCT01172938|449085783|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124852912|NCT01172938|449085784|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124852913|NCT01172938|449085785|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124852914|NCT01172938|449085786|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
124852915|NCT01172938|449085778|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
124852916|NCT01172938|449085779|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
124852917|NCT01172938|449085780|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
124852918|NCT01172938|449085781|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
124852919|NCT01172938|449085782|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
124852920|NCT01172938|449085783|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
124852921|NCT01172938|449085784|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
124852922|NCT01172938|449085785|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
124852923|NCT01172938|449085786|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
124852924|NCT01172938|449085778|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
124852925|NCT01172938|449085779|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124852926|NCT01172938|449085780|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124852927|NCT01172938|449085781|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124852928|NCT01172938|449085782|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124852929|NCT01172938|449085783|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124852930|NCT01172938|449085784|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124852931|NCT01172938|449085785|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124852932|NCT01172938|449085786|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
124852933|NCT01172938|449085778|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
124852934|NCT01172938|449085779|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
124852935|NCT01172938|449085780|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
124852936|NCT01172938|449085781|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
124852937|NCT01172938|449085782|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
124852938|NCT01172938|449085783|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
124852939|NCT01172938|449085784|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
124852940|NCT01172938|449085785|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
124852941|NCT01172938|449085786|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
124852942|NCT01172938|449085778|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
124852943|NCT01172938|449085779|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
124852944|NCT01172938|449085780|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
124852945|NCT01172938|449085781|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
124852946|NCT01172938|449085782|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
124852947|NCT01172938|449085783|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
124852948|NCT01172938|449085784|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
124852949|NCT01172938|449085785|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
124852950|NCT01172938|449085786|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
124852951|NCT01172938|449085778|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
124852952|NCT01172938|449085779|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
124852953|NCT01172938|449085780|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
124852954|NCT01172938|449085781|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
124852955|NCT01172938|449085782|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
124852956|NCT01172938|449085783|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
124852957|NCT01172938|449085784|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
124852958|NCT01172938|449085785|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
124852959|NCT01172938|449085786|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
124852960|NCT01172938|449085778|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
124852961|NCT01172938|449085779|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
124852962|NCT01172938|449085780|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
124852963|NCT01172938|449085781|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
124852964|NCT01172938|449085782|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
124852965|NCT01172938|449085783|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
124852966|NCT01172938|449085784|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
124852967|NCT01172938|449085785|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
124852968|NCT01172938|449085786|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
124852969|NCT01172938|449085778|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
124852970|NCT01172938|449085779|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
124852971|NCT01172938|449085780|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
124852972|NCT01172938|449085781|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
124852973|NCT01172938|449085782|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
124852974|NCT01172938|449085783|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
124852975|NCT01172938|449085784|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
124852976|NCT01172938|449085785|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
124852977|NCT01172938|449085786|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
124852978|NCT01172938|449085778|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
124852979|NCT01172938|449085779|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
124852980|NCT01172938|449085780|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
124852981|NCT01172938|449085781|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
124852982|NCT01172938|449085782|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
124852983|NCT01172938|449085783|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
124852984|NCT01172938|449085784|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
124852985|NCT01172938|449085785|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
124852986|NCT01172938|449085786|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
124852987|NCT01172938|449085778|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
124852988|NCT01172938|449085779|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
124852989|NCT01172938|449085780|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
124852990|NCT01172938|449085781|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
124852991|NCT01172938|449085782|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
124852992|NCT01172938|449085783|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
124852993|NCT01172938|449085784|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
124852994|NCT01172938|449085785|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
124852995|NCT01172938|449085786|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
124852996|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
124852997|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
124852998|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
124852999|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
124853000|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
124853001|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
124853002|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
124853003|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
124853004|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
124853005|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
124853006|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
124853007|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
124853008|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
124853009|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
124853010|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
124853011|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
124853012|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
124853013|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
124853014|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
124853015|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
124853016|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
124853017|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
124853018|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
124976621|NCT02614183|449540016|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
124853019|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
124853020|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
124853021|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
124853022|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
124853023|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
124853024|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
124853025|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
124853026|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
124853027|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
124853028|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
124853029|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
124853030|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
124853031|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
124853032|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
124853033|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
124853034|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
124853035|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
124853036|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
124853037|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
124853038|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
124853039|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
124853040|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
124853041|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
124853042|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
124853043|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
124853044|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
124853045|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
124853046|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
124853047|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
124853048|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
124853049|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
124853050|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
124853051|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
124853052|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
124853053|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
124853054|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
124853055|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
124853056|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
124853057|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
124853058|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
124853059|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
124853060|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
124853061|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
124853062|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
124853063|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
124853064|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
124853065|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
124853066|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
124853067|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
124853068|NCT01172938|449085778|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
124853069|NCT01172938|449085779|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
124853070|NCT01172938|449085780|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
124853071|NCT01172938|449085781|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
124853072|NCT01172938|449085782|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
124853073|NCT01172938|449085783|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
124853074|NCT01172938|449085784|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
124853075|NCT01172938|449085785|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
124853076|NCT01172938|449085786|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
124853077|NCT01172938|449085778|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
124853078|NCT01172938|449085779|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
124853079|NCT01172938|449085780|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
124853080|NCT01172938|449085781|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
124853081|NCT01172938|449085782|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
124853082|NCT01172938|449085783|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
124853083|NCT01172938|449085784|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
124853084|NCT01172938|449085785|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
124853085|NCT01172938|449085786|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
124853086|NCT01172938|449085778|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
124853087|NCT01172938|449085779|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
124853088|NCT01172938|449085780|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
124853089|NCT01172938|449085781|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
124853090|NCT01172938|449085782|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
124853091|NCT01172938|449085783|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
124853092|NCT01172938|449085784|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
124853093|NCT01172938|449085785|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
124853094|NCT01172938|449085786|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
124853095|NCT01172938|449085778|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
124853096|NCT01172938|449085779|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
124853097|NCT01172938|449085780|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
124853098|NCT01172938|449085781|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
124853099|NCT01172938|449085782|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
124853100|NCT01172938|449085783|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
124853101|NCT01172938|449085784|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
124853102|NCT01172938|449085785|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
124853103|NCT01172938|449085786|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
124853104|NCT01172938|449085778|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
124853105|NCT01172938|449085779|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
124853106|NCT01172938|449085780|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
124853107|NCT01172938|449085781|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
124853108|NCT01172938|449085782|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
124853109|NCT01172938|449085783|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
124853110|NCT01172938|449085784|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
124853111|NCT01172938|449085785|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
124853112|NCT01172938|449085786|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
124853113|NCT01172938|449085778|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
124853114|NCT01172938|449085779|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
124853115|NCT01172938|449085780|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
124853116|NCT01172938|449085781|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
124853117|NCT01172938|449085782|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
124853118|NCT01172938|449085783|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
124853119|NCT01172938|449085784|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
124853120|NCT01172938|449085785|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
124853121|NCT01172938|449085786|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
124853122|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
124853123|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
124853124|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
124853125|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
124853126|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
124853127|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
124853128|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
124853129|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
124853130|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
124853131|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
124853132|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
124853133|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
124853134|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
124853135|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
124853136|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
124853137|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
124853138|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
124853139|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
124853140|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
124853141|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
124853142|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
124853143|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
124853144|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
124853145|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
124853146|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
124853147|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
124853148|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
124853149|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
124853150|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
124853151|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
124853152|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
124853153|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
124853154|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
124853155|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
124853156|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
124853157|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
124853158|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
124853159|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
124853160|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
124853161|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
124853162|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
124853163|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
124853164|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
124853165|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
124853166|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
124853167|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
124853168|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
124853169|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
124853170|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
124853171|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
124853172|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
124853173|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
124853174|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
124853175|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
124853176|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
124853177|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
124853178|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
124853179|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
124853180|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
124853181|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
124853182|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
124853183|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
124853184|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
124853185|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
124853186|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
124853187|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
124853188|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
124853189|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
124853190|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
124853191|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
124853192|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
124853193|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
124853194|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
124853195|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
124853196|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
124853197|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
124853198|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
124853199|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
124853200|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
124853201|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
124853202|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
124853203|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
124853204|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
124853205|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
124853206|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
124853207|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
124853208|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
124853209|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
124853210|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
124853211|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
124853212|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
124853213|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
124853214|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
124853215|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
124853216|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
124853217|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
124853218|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
124853219|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
124853220|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
124853221|NCT01172938|449085778|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
124853222|NCT01172938|449085779|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
124853223|NCT01172938|449085780|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
124853224|NCT01172938|449085781|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
124853225|NCT01172938|449085782|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
124853226|NCT01172938|449085783|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
124853227|NCT01172938|449085784|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
124853228|NCT01172938|449085785|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
124853229|NCT01172938|449085786|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
124853230|NCT00003498|449085787|FG000|Overall Study|Not evaluable.|4|||
124853231|NCT05282004|449085791|FG000|Overall Study|Adverse Event|2|||
124853232|NCT04808609|449085792|FG000|Overall Study|Lost to Follow-up|0|||
124853233|NCT04808609|449085793|FG001|Overall Study|Lost to Follow-up|2|||
124853234|NCT04808609|449085792|FG000|Overall Study|Administrative Withdrawal|0|||
124853235|NCT04808609|449085793|FG001|Overall Study|Administrative Withdrawal|1|||
124853236|NCT01993719|449085797|FG000|First Drug Administration|Not treated|1|||
124853237|NCT01993719|449085798|FG001|First Drug Administration|Not treated|0|||
124853238|NCT01993719|449085799|FG002|First Drug Administration|Not treated|0|||
124853239|NCT01993719|449085800|FG003|First Drug Administration|Not treated|0|||
124853240|NCT01993719|449085801|FG004|First Drug Administration|Not treated|0|||
124853241|NCT04382326|449085805|FG000|Overall Study|Adverse Event, not serious|1|||
124853242|NCT04382326|449085806|FG001|Overall Study|Adverse Event, not serious|2|||
124853243|NCT04382326|449085805|FG000|Overall Study|Other|1|||
124853244|NCT04382326|449085806|FG001|Overall Study|Other|0|||
124853245|NCT04382326|449085805|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
124853246|NCT04382326|449085806|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
124853247|NCT04382326|449085805|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
124853248|NCT04382326|449085806|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
124853249|NCT04382326|449085805|FG000|Overall Study|Protocol Violation|29|||
124853250|NCT04382326|449085806|FG001|Overall Study|Protocol Violation|23|||
124853251|NCT04382326|449085805|FG000|Overall Study|Physician Decision|0|||
124853252|NCT04382326|449085806|FG001|Overall Study|Physician Decision|1|||
124853253|NCT04382326|449085805|FG000|Overall Study|Lost to Follow-up|48|||
124853254|NCT04382326|449085806|FG001|Overall Study|Lost to Follow-up|63|||
124853255|NCT04382326|449085805|FG000|Overall Study|Adverse Event, non-fatal|1|||
124853256|NCT04382326|449085806|FG001|Overall Study|Adverse Event, non-fatal|1|||
124853257|NCT03224468|449085811|FG000|Overall Study|Did not obtain MM card|53|||
124853258|NCT03224468|449085812|FG001|Overall Study|Did not obtain MM card|0|||
124853259|NCT03224468|449085811|FG000|Overall Study|Lost to Follow-up|4|||
124853260|NCT03224468|449085812|FG001|Overall Study|Lost to Follow-up|11|||
124853261|NCT03224468|449085811|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
124853262|NCT03224468|449085812|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
124853263|NCT04067141|449085813|FG000|First Intervention|Withdrawal by Subject|0|||
124853264|NCT04067141|449085814|FG001|First Intervention|Withdrawal by Subject|1|||
124853265|NCT04067141|449085813|FG000|Second Intervention|Adverse Event|0|||
124853266|NCT04067141|449085814|FG001|Second Intervention|Adverse Event|2|||
124853267|NCT01038921|449085815|FG000|Overall Study|Withdrawal by Subject|1|||
124853268|NCT01038921|449085816|FG001|Overall Study|Withdrawal by Subject|0|||
124853269|NCT01038921|449085815|FG000|Overall Study|Physician Decision|1|||
124853270|NCT01038921|449085816|FG001|Overall Study|Physician Decision|0|||
124853271|NCT02352493|449085817|FG000|Overall Study|Pregnancy|0|||
124853272|NCT02352493|449085818|FG001|Overall Study|Pregnancy|0|||
124853273|NCT02352493|449085819|FG002|Overall Study|Pregnancy|0|||
124853274|NCT02352493|449085820|FG003|Overall Study|Pregnancy|0|||
124853275|NCT02352493|449085821|FG004|Overall Study|Pregnancy|0|||
124853276|NCT02352493|449085822|FG005|Overall Study|Pregnancy|0|||
124853277|NCT02352493|449085823|FG006|Overall Study|Pregnancy|1|||
124853278|NCT02352493|449085824|FG007|Overall Study|Pregnancy|0|||
124853279|NCT02352493|449085825|FG008|Overall Study|Pregnancy|1|||
124853280|NCT02352493|449085826|FG009|Overall Study|Pregnancy|0|||
124853281|NCT02352493|449085827|FG010|Overall Study|Pregnancy|0|||
124853282|NCT02352493|449085828|FG011|Overall Study|Pregnancy|0|||
124853283|NCT02352493|449085829|FG012|Overall Study|Pregnancy|0|||
124853284|NCT02352493|449085830|FG013|Overall Study|Pregnancy|0|||
124853285|NCT02352493|449085831|FG014|Overall Study|Pregnancy|0|||
124853286|NCT02352493|449085832|FG015|Overall Study|Pregnancy|0|||
124853287|NCT02352493|449085833|FG016|Overall Study|Pregnancy|0|||
124853288|NCT02352493|449085834|FG017|Overall Study|Pregnancy|0|||
124853289|NCT02352493|449085817|FG000|Overall Study|Withdrawal by Subject|0|||
124853290|NCT02352493|449085818|FG001|Overall Study|Withdrawal by Subject|0|||
124853291|NCT02352493|449085819|FG002|Overall Study|Withdrawal by Subject|0|||
124853292|NCT02352493|449085820|FG003|Overall Study|Withdrawal by Subject|0|||
124853293|NCT02352493|449085821|FG004|Overall Study|Withdrawal by Subject|0|||
124853294|NCT02352493|449085822|FG005|Overall Study|Withdrawal by Subject|0|||
124853295|NCT02352493|449085823|FG006|Overall Study|Withdrawal by Subject|0|||
124853296|NCT02352493|449085824|FG007|Overall Study|Withdrawal by Subject|0|||
124853297|NCT02352493|449085825|FG008|Overall Study|Withdrawal by Subject|1|||
124853298|NCT02352493|449085826|FG009|Overall Study|Withdrawal by Subject|0|||
124853299|NCT02352493|449085827|FG010|Overall Study|Withdrawal by Subject|0|||
124853300|NCT02352493|449085828|FG011|Overall Study|Withdrawal by Subject|0|||
124853301|NCT02352493|449085829|FG012|Overall Study|Withdrawal by Subject|0|||
124853302|NCT02352493|449085830|FG013|Overall Study|Withdrawal by Subject|0|||
124853303|NCT02352493|449085831|FG014|Overall Study|Withdrawal by Subject|1|||
124853304|NCT02352493|449085832|FG015|Overall Study|Withdrawal by Subject|0|||
124853305|NCT02352493|449085833|FG016|Overall Study|Withdrawal by Subject|0|||
124853306|NCT02352493|449085834|FG017|Overall Study|Withdrawal by Subject|0|||
124853307|NCT02352493|449085817|FG000|Overall Study|Lost to Follow-up|0|||
124853308|NCT02352493|449085818|FG001|Overall Study|Lost to Follow-up|0|||
124853309|NCT02352493|449085819|FG002|Overall Study|Lost to Follow-up|0|||
124853310|NCT02352493|449085820|FG003|Overall Study|Lost to Follow-up|0|||
124853311|NCT02352493|449085821|FG004|Overall Study|Lost to Follow-up|0|||
124853312|NCT02352493|449085822|FG005|Overall Study|Lost to Follow-up|0|||
124853313|NCT02352493|449085823|FG006|Overall Study|Lost to Follow-up|0|||
124853314|NCT02352493|449085824|FG007|Overall Study|Lost to Follow-up|0|||
124853315|NCT02352493|449085825|FG008|Overall Study|Lost to Follow-up|0|||
124853316|NCT02352493|449085826|FG009|Overall Study|Lost to Follow-up|1|||
124853317|NCT02352493|449085827|FG010|Overall Study|Lost to Follow-up|0|||
124853318|NCT02352493|449085828|FG011|Overall Study|Lost to Follow-up|0|||
124853319|NCT02352493|449085829|FG012|Overall Study|Lost to Follow-up|1|||
124853320|NCT02352493|449085830|FG013|Overall Study|Lost to Follow-up|2|||
124853321|NCT02352493|449085831|FG014|Overall Study|Lost to Follow-up|0|||
124853322|NCT02352493|449085832|FG015|Overall Study|Lost to Follow-up|0|||
124853323|NCT02352493|449085833|FG016|Overall Study|Lost to Follow-up|0|||
124853324|NCT02352493|449085834|FG017|Overall Study|Lost to Follow-up|0|||
124853325|NCT00889421|449085835|FG000|Overall Study|Lack of Efficacy|3|||
124853326|NCT03586999|449085838|FG000|Overall Study|Lack of Efficacy|2|||
124853327|NCT04096560|449085839|FG000|Overall Study|Reason not Specified|1|||
124853328|NCT04096560|449085840|FG001|Overall Study|Reason not Specified|0|||
124853329|NCT04096560|449085841|FG002|Overall Study|Reason not Specified|0|||
124853330|NCT04096560|449085842|FG003|Overall Study|Reason not Specified|0|||
124853331|NCT04096560|449085843|FG004|Overall Study|Reason not Specified|1|||
124853332|NCT04096560|449085844|FG005|Overall Study|Reason not Specified|1|||
124853333|NCT04096560|449085845|FG006|Overall Study|Reason not Specified|1|||
124853334|NCT04096560|449085846|FG007|Overall Study|Reason not Specified|0|||
124853335|NCT04096560|449085839|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
124853336|NCT04096560|449085840|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
124853337|NCT04096560|449085841|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
124853338|NCT04096560|449085842|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
124853339|NCT04096560|449085843|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
124853340|NCT04096560|449085844|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
124853341|NCT04096560|449085845|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
124853342|NCT04096560|449085846|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
124853343|NCT04096560|449085839|FG000|Overall Study|Study Terminated by Sponsor|0|||
124853344|NCT04096560|449085840|FG001|Overall Study|Study Terminated by Sponsor|0|||
124853345|NCT04096560|449085841|FG002|Overall Study|Study Terminated by Sponsor|0|||
124853346|NCT04096560|449085842|FG003|Overall Study|Study Terminated by Sponsor|5|||
124853347|NCT04096560|449085843|FG004|Overall Study|Study Terminated by Sponsor|6|||
124853348|NCT04096560|449085844|FG005|Overall Study|Study Terminated by Sponsor|4|||
124853349|NCT04096560|449085845|FG006|Overall Study|Study Terminated by Sponsor|6|||
124853350|NCT04096560|449085846|FG007|Overall Study|Study Terminated by Sponsor|1|||
124853351|NCT04096560|449085839|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
124853352|NCT04096560|449085840|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
124853353|NCT04096560|449085841|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
124853354|NCT04096560|449085842|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
124853355|NCT04096560|449085843|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
124853356|NCT04096560|449085844|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
124853357|NCT04096560|449085845|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
124853358|NCT04096560|449085846|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
124853359|NCT02464969|449085847|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
124853360|NCT02464969|449085848|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
124853361|NCT02464969|449085847|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
124853362|NCT02464969|449085848|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
124853363|NCT02464969|449085847|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
124853364|NCT02464969|449085848|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
124853365|NCT02464969|449085847|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
124853366|NCT02464969|449085848|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
124853367|NCT02464969|449085847|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
124853368|NCT02464969|449085848|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
124853369|NCT02464969|449085847|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
124853370|NCT02464969|449085848|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
124853371|NCT02464969|449085847|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
124853372|NCT02464969|449085848|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
124853373|NCT02464969|449085847|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
124853374|NCT02464969|449085848|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
124853375|NCT02464969|449085847|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
124853376|NCT02464969|449085848|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
124853377|NCT02464969|449085847|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
124853378|NCT02464969|449085848|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
124853379|NCT02464969|449085847|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
124853380|NCT02464969|449085848|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
124853381|NCT00534352|449085849|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
124853382|NCT00534352|449085849|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
124853383|NCT00534352|449085849|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
124853384|NCT00534352|449085849|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
124853385|NCT00534352|449085849|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
124853386|NCT00534352|449085849|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
124853387|NCT02399085|449085854|FG000|Overall Study|Adverse Event|16|||
124853388|NCT02399085|449085854|FG000|Overall Study|Death|2|||
124853389|NCT02399085|449085854|FG000|Overall Study|Withdrawal by Subject|8|||
124853390|NCT02399085|449085854|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
124853391|NCT02399085|449085854|FG000|Overall Study|Physician Decision|5|||
124853392|NCT02673697|449085857|FG000|Overall Study|Adverse Event|2|||
124853393|NCT02673697|449085858|FG001|Overall Study|Adverse Event|0|||
124853394|NCT02673697|449085857|FG000|Overall Study|Death|32|||
124853395|NCT02673697|449085858|FG001|Overall Study|Death|24|||
124853396|NCT02673697|449085857|FG000|Overall Study|Lost to Follow-up|5|||
124853397|NCT02673697|449085858|FG001|Overall Study|Lost to Follow-up|2|||
124853398|NCT02673697|449085857|FG000|Overall Study|Physician Decision|2|||
124853399|NCT02673697|449085858|FG001|Overall Study|Physician Decision|1|||
124853400|NCT02673697|449085857|FG000|Overall Study|Withdrawal by Subject|10|||
124853401|NCT02673697|449085858|FG001|Overall Study|Withdrawal by Subject|7|||
124853402|NCT02673697|449085857|FG000|Overall Study|Change subj medical status|1|||
124853403|NCT02673697|449085858|FG001|Overall Study|Change subj medical status|2|||
124853404|NCT02673697|449085857|FG000|Overall Study|Explant|10|||
124853405|NCT02673697|449085858|FG001|Overall Study|Explant|5|||
124853406|NCT02673697|449085857|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
124853407|NCT02673697|449085858|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
124853408|NCT02041429|449085868|FG000|Overall Study|Progressive Disease|2|||
124853409|NCT02041429|449085869|FG001|Overall Study|Progressive Disease|2|||
124853410|NCT02041429|449085870|FG002|Overall Study|Progressive Disease|3|||
124853411|NCT02041429|449085871|FG003|Overall Study|Progressive Disease|2|||
124853412|NCT02041429|449085868|FG000|Overall Study|Toxicity|0|||
124853413|NCT02041429|449085869|FG001|Overall Study|Toxicity|1|||
124853414|NCT02041429|449085870|FG002|Overall Study|Toxicity|4|||
124853415|NCT02041429|449085871|FG003|Overall Study|Toxicity|2|||
124853416|NCT02041429|449085868|FG000|Overall Study|Withdrawal by Subject|0|||
124853417|NCT02041429|449085869|FG001|Overall Study|Withdrawal by Subject|1|||
124853418|NCT02041429|449085870|FG002|Overall Study|Withdrawal by Subject|0|||
124853419|NCT02041429|449085871|FG003|Overall Study|Withdrawal by Subject|0|||
124853420|NCT02041429|449085868|FG000|Overall Study|On Maintenance Therapy|1|||
124853421|NCT02041429|449085869|FG001|Overall Study|On Maintenance Therapy|0|||
124853422|NCT02041429|449085870|FG002|Overall Study|On Maintenance Therapy|0|||
124853423|NCT02041429|449085871|FG003|Overall Study|On Maintenance Therapy|2|||
124853424|NCT00861341|449085872|FG000|Overall Study|Withdrawal by Subject|2|||
124853425|NCT03299192|449085873|FG000|Overall Study|Fell before classes started|1|||
124853426|NCT03299192|449085874|FG001|Overall Study|Fell before classes started|0|||
124853427|NCT03299192|449085875|FG002|Overall Study|Fell before classes started|0|||
124853428|NCT03299192|449085873|FG000|Overall Study|Other|0|||
124853429|NCT03299192|449085874|FG001|Overall Study|Other|2|||
124853430|NCT03299192|449085875|FG002|Overall Study|Other|1|||
124853431|NCT01418209|449085876|FG000|Overall Study|Withdrawal by Subject|1|||
124853432|NCT01418209|449085877|FG001|Overall Study|Withdrawal by Subject|0|||
124853433|NCT01418209|449085878|FG002|Overall Study|Withdrawal by Subject|1|||
124853434|NCT01418209|449085876|FG000|Overall Study|Did not provide hot flash diary data|1|||
124853435|NCT01418209|449085877|FG001|Overall Study|Did not provide hot flash diary data|3|||
124853436|NCT01418209|449085878|FG002|Overall Study|Did not provide hot flash diary data|3|||
124853437|NCT01916304|449085883|FG000|Overall Study|Screening failure|17|||
124853438|NCT02460198|449085885|FG000|Overall Study|Adverse Event|1|||
124853439|NCT02460198|449085886|FG001|Overall Study|Adverse Event|3|||
124853440|NCT02460198|449085885|FG000|Overall Study|Death|36|||
124853441|NCT02460198|449085886|FG001|Overall Study|Death|28|||
124853442|NCT02460198|449085885|FG000|Overall Study|Lost to Follow-up|1|||
124853443|NCT02460198|449085886|FG001|Overall Study|Lost to Follow-up|1|||
124853444|NCT02460198|449085885|FG000|Overall Study|Transferred to Extension Study|15|||
124853445|NCT02460198|449085886|FG001|Overall Study|Transferred to Extension Study|15|||
124853446|NCT02460198|449085885|FG000|Overall Study|Withdrawal by Subject|2|||
124853447|NCT02460198|449085886|FG001|Overall Study|Withdrawal by Subject|4|||
124853448|NCT02460198|449085885|FG000|Overall Study|Site Terminated By Sponsor|0|||
124853449|NCT02460198|449085886|FG001|Overall Study|Site Terminated By Sponsor|1|||
124853450|NCT02460198|449085885|FG000|Overall Study|Did Not Continue on Extension Study|6|||
124853451|NCT02460198|449085886|FG001|Overall Study|Did Not Continue on Extension Study|11|||
124853452|NCT04382612|449085887|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
124853453|NCT04666441|449085888|FG000|Overall Study|Lost to Follow-up|1|||
124853454|NCT04666441|449085889|FG001|Overall Study|Lost to Follow-up|4|||
124853455|NCT04666441|449085890|FG002|Overall Study|Lost to Follow-up|1|||
124853456|NCT04666441|449085891|FG003|Overall Study|Lost to Follow-up|3|||
124853457|NCT04666441|449085892|FG004|Overall Study|Lost to Follow-up|0|||
124853458|NCT04666441|449085893|FG005|Overall Study|Lost to Follow-up|2|||
124853459|NCT04666441|449085894|FG006|Overall Study|Lost to Follow-up|2|||
124853460|NCT04666441|449085895|FG007|Overall Study|Lost to Follow-up|2|||
124853461|NCT04666441|449085888|FG000|Overall Study|Subject Decision|1|||
124853462|NCT04666441|449085889|FG001|Overall Study|Subject Decision|1|||
124853463|NCT04666441|449085890|FG002|Overall Study|Subject Decision|3|||
124853464|NCT04666441|449085891|FG003|Overall Study|Subject Decision|1|||
124853465|NCT04666441|449085892|FG004|Overall Study|Subject Decision|0|||
124853466|NCT04666441|449085893|FG005|Overall Study|Subject Decision|1|||
124853467|NCT04666441|449085894|FG006|Overall Study|Subject Decision|3|||
124853468|NCT04666441|449085895|FG007|Overall Study|Subject Decision|2|||
124853469|NCT03149328|449085896|FG000|Overall Study|Withdrawal by Subject|30|||
124853470|NCT03149328|449085897|FG001|Overall Study|Withdrawal by Subject|26|||
124853471|NCT03149328|449085896|FG000|Overall Study|Changed Dialysis Modality|18|||
124853472|NCT03149328|449085897|FG001|Overall Study|Changed Dialysis Modality|1|||
124853473|NCT03149328|449085896|FG000|Overall Study|Transplant|9|||
124853474|NCT03149328|449085897|FG001|Overall Study|Transplant|1|||
124853475|NCT03149328|449085896|FG000|Overall Study|Lost to Follow-up|25|||
124853476|NCT03149328|449085897|FG001|Overall Study|Lost to Follow-up|16|||
124853477|NCT03149328|449085896|FG000|Overall Study|Left Study Site|1|||
124853478|NCT03149328|449085897|FG001|Overall Study|Left Study Site|2|||
124853479|NCT03149328|449085896|FG000|Overall Study|Language Barrier|1|||
124853480|NCT03149328|449085897|FG001|Overall Study|Language Barrier|0|||
124853481|NCT01328002|449085898|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
124853482|NCT01328002|449085899|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
124853483|NCT01328002|449085898|FG000|Open-Label Period|Adverse Event|8|||
124853484|NCT01328002|449085899|FG001|Open-Label Period|Adverse Event|0|||
124853485|NCT01328002|449085898|FG000|Open-Label Period|Lack of Efficacy|3|||
124853486|NCT01328002|449085899|FG001|Open-Label Period|Lack of Efficacy|0|||
124853487|NCT01328002|449085898|FG000|Open-Label Period|Protocol Violation|2|||
124853488|NCT01328002|449085899|FG001|Open-Label Period|Protocol Violation|0|||
124853489|NCT01328002|449085898|FG000|Open-Label Period|Withdrawal by Subject|9|||
124853490|NCT01328002|449085899|FG001|Open-Label Period|Withdrawal by Subject|0|||
124853491|NCT01328002|449085898|FG000|Open-Label Period|Lost to Follow-up|6|||
124853492|NCT01328002|449085899|FG001|Open-Label Period|Lost to Follow-up|0|||
124853493|NCT01328002|449085898|FG000|Open-Label Period|Other Reason|2|||
124853494|NCT01328002|449085899|FG001|Open-Label Period|Other Reason|0|||
124853495|NCT01328002|449085898|FG000|Double-Blind Period|Adverse Event|1|||
124853496|NCT01328002|449085899|FG001|Double-Blind Period|Adverse Event|0|||
124853497|NCT01328002|449085898|FG000|Double-Blind Period|Lack of Efficacy|1|||
124853498|NCT01328002|449085899|FG001|Double-Blind Period|Lack of Efficacy|0|||
124853499|NCT00813761|449085900|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
124853500|NCT00813761|449085901|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
124853501|NCT00813761|449085902|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
124853502|NCT00813761|449085903|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
124853503|NCT00813761|449085900|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
124853504|NCT00813761|449085901|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
124853505|NCT00813761|449085902|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
124853506|NCT00813761|449085903|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
124853507|NCT00813761|449085900|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
124853508|NCT00813761|449085901|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
124853509|NCT00813761|449085902|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
124853510|NCT00813761|449085903|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
124853511|NCT00813761|449085900|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
124853512|NCT00813761|449085901|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
124853513|NCT00813761|449085902|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
124853514|NCT00813761|449085903|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
124853515|NCT00813761|449085900|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
124853516|NCT00813761|449085901|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
124853517|NCT00813761|449085902|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
124853518|NCT00813761|449085903|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
124853519|NCT00813761|449085900|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
124853520|NCT00813761|449085901|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
124853521|NCT00813761|449085902|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
124853522|NCT00813761|449085903|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
124853523|NCT00813761|449085900|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
124853524|NCT00813761|449085901|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
124853525|NCT00813761|449085902|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
124853526|NCT00813761|449085903|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
124853527|NCT00813761|449085900|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
124853528|NCT00813761|449085901|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
124853529|NCT00813761|449085902|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
124853530|NCT00813761|449085903|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
124853531|NCT00813761|449085900|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
124853532|NCT00813761|449085901|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
124853533|NCT00813761|449085902|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
124853534|NCT00813761|449085903|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
124853535|NCT00813761|449085900|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
124853536|NCT00813761|449085901|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
124853537|NCT00813761|449085902|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
124853538|NCT00813761|449085903|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
124853539|NCT00813761|449085900|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
124853540|NCT00813761|449085901|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
124853541|NCT00813761|449085902|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
124853542|NCT00813761|449085903|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
124853543|NCT00813761|449085900|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
124853544|NCT00813761|449085901|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
124853545|NCT00813761|449085902|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
124853546|NCT00813761|449085903|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
124853547|NCT00691210|449085904|FG000|Overall Study|Progression of Disease|0|||
124853548|NCT00691210|449085905|FG001|Overall Study|Progression of Disease|0|||
124853549|NCT00691210|449085906|FG002|Overall Study|Progression of Disease|0|||
124853550|NCT00691210|449085907|FG003|Overall Study|Progression of Disease|2|||
124853551|NCT00691210|449085908|FG004|Overall Study|Progression of Disease|0|||
124853552|NCT00691210|449085909|FG005|Overall Study|Progression of Disease|0|||
124853553|NCT00691210|449085910|FG006|Overall Study|Progression of Disease|0|||
124853554|NCT00691210|449085911|FG007|Overall Study|Progression of Disease|0|||
124853555|NCT00691210|449085904|FG000|Overall Study|Lack of Efficacy|0|||
124853556|NCT00691210|449085905|FG001|Overall Study|Lack of Efficacy|0|||
124853557|NCT00691210|449085906|FG002|Overall Study|Lack of Efficacy|0|||
124853558|NCT00691210|449085907|FG003|Overall Study|Lack of Efficacy|1|||
124853559|NCT00691210|449085908|FG004|Overall Study|Lack of Efficacy|0|||
124853560|NCT00691210|449085909|FG005|Overall Study|Lack of Efficacy|1|||
124853561|NCT00691210|449085910|FG006|Overall Study|Lack of Efficacy|0|||
124853562|NCT00691210|449085911|FG007|Overall Study|Lack of Efficacy|0|||
124853563|NCT01208233|449085912|FG000|Overall Study|Adverse Event|0|||
124853564|NCT01208233|449085913|FG001|Overall Study|Adverse Event|1|||
124853565|NCT01208233|449085914|FG002|Overall Study|Adverse Event|2|||
124853566|NCT01208233|449085915|FG003|Overall Study|Adverse Event|0|||
124853567|NCT01208233|449085916|FG004|Overall Study|Adverse Event|3|||
124853568|NCT01208233|449085917|FG005|Overall Study|Adverse Event|5|||
124853569|NCT01208233|449085912|FG000|Overall Study|Death|0|||
124853570|NCT01208233|449085913|FG001|Overall Study|Death|0|||
124853571|NCT01208233|449085914|FG002|Overall Study|Death|0|||
124853572|NCT01208233|449085915|FG003|Overall Study|Death|0|||
124853573|NCT01208233|449085916|FG004|Overall Study|Death|3|||
124853574|NCT01208233|449085917|FG005|Overall Study|Death|5|||
124853575|NCT01208233|449085912|FG000|Overall Study|Did not meet entrance criteria|2|||
124853576|NCT01208233|449085913|FG001|Overall Study|Did not meet entrance criteria|1|||
124853577|NCT01208233|449085914|FG002|Overall Study|Did not meet entrance criteria|1|||
124853578|NCT01208233|449085915|FG003|Overall Study|Did not meet entrance criteria|0|||
124853579|NCT01208233|449085916|FG004|Overall Study|Did not meet entrance criteria|1|||
124853580|NCT01208233|449085917|FG005|Overall Study|Did not meet entrance criteria|0|||
124853581|NCT01208233|449085912|FG000|Overall Study|Medication error without adverse event|0|||
124853582|NCT01208233|449085913|FG001|Overall Study|Medication error without adverse event|0|||
124853583|NCT01208233|449085914|FG002|Overall Study|Medication error without adverse event|0|||
124853584|NCT01208233|449085915|FG003|Overall Study|Medication error without adverse event|0|||
124853585|NCT01208233|449085916|FG004|Overall Study|Medication error without adverse event|0|||
124853586|NCT01208233|449085917|FG005|Overall Study|Medication error without adverse event|1|||
124853587|NCT01208233|449085912|FG000|Overall Study|Study terminated by sponsor|0|||
124853588|NCT01208233|449085913|FG001|Overall Study|Study terminated by sponsor|0|||
124853589|NCT01208233|449085914|FG002|Overall Study|Study terminated by sponsor|0|||
124853590|NCT01208233|449085915|FG003|Overall Study|Study terminated by sponsor|0|||
124853591|NCT01208233|449085916|FG004|Overall Study|Study terminated by sponsor|10|||
124853592|NCT01208233|449085917|FG005|Overall Study|Study terminated by sponsor|7|||
124853593|NCT01208233|449085912|FG000|Overall Study|Protocol Violation|0|||
124853594|NCT01208233|449085913|FG001|Overall Study|Protocol Violation|0|||
124853595|NCT01208233|449085914|FG002|Overall Study|Protocol Violation|0|||
124853596|NCT01208233|449085915|FG003|Overall Study|Protocol Violation|0|||
124853597|NCT01208233|449085916|FG004|Overall Study|Protocol Violation|3|||
124853598|NCT01208233|449085917|FG005|Overall Study|Protocol Violation|0|||
124853599|NCT01208233|449085912|FG000|Overall Study|Other|2|||
124853600|NCT01208233|449085913|FG001|Overall Study|Other|1|||
124853601|NCT01208233|449085914|FG002|Overall Study|Other|0|||
124853602|NCT01208233|449085915|FG003|Overall Study|Other|0|||
124853603|NCT01208233|449085916|FG004|Overall Study|Other|0|||
124853604|NCT01208233|449085917|FG005|Overall Study|Other|1|||
124853605|NCT01208233|449085912|FG000|Overall Study|Withdrawal by Subject|1|||
124853606|NCT01208233|449085913|FG001|Overall Study|Withdrawal by Subject|0|||
124853607|NCT01208233|449085914|FG002|Overall Study|Withdrawal by Subject|1|||
124853608|NCT01208233|449085915|FG003|Overall Study|Withdrawal by Subject|1|||
124853609|NCT01208233|449085916|FG004|Overall Study|Withdrawal by Subject|4|||
124853610|NCT01208233|449085917|FG005|Overall Study|Withdrawal by Subject|2|||
124853611|NCT00132769|449085918|FG000|Overall Study|Withdrawal by Subject|1|||
124853612|NCT00132769|449085919|FG001|Overall Study|Withdrawal by Subject|3|||
124853613|NCT00132769|449085918|FG000|Overall Study|Lack of Efficacy|7|||
124853614|NCT00132769|449085919|FG001|Overall Study|Lack of Efficacy|6|||
124853615|NCT00132769|449085918|FG000|Overall Study|Adverse Event|2|||
124853616|NCT00132769|449085919|FG001|Overall Study|Adverse Event|1|||
124853617|NCT00132769|449085918|FG000|Overall Study|Protocol Violation|1|||
124853618|NCT00132769|449085919|FG001|Overall Study|Protocol Violation|1|||
124853619|NCT00560833|449085935|FG000|Overall Study|Adverse Event|16|||
124853620|NCT00560833|449085936|FG001|Overall Study|Adverse Event|10|||
124853621|NCT00560833|449085937|FG002|Overall Study|Adverse Event|25|||
124853622|NCT00560833|449085938|FG003|Overall Study|Adverse Event|23|||
124853623|NCT00560833|449085939|FG004|Overall Study|Adverse Event|35|||
124853624|NCT00560833|449085935|FG000|Overall Study|Lost to Follow-up|0|||
124853625|NCT00560833|449085936|FG001|Overall Study|Lost to Follow-up|0|||
124853626|NCT00560833|449085937|FG002|Overall Study|Lost to Follow-up|1|||
124853627|NCT00560833|449085938|FG003|Overall Study|Lost to Follow-up|0|||
124853628|NCT00560833|449085939|FG004|Overall Study|Lost to Follow-up|0|||
124853629|NCT00560833|449085935|FG000|Overall Study|Lack of Efficacy|22|||
124853630|NCT00560833|449085936|FG001|Overall Study|Lack of Efficacy|9|||
124853631|NCT00560833|449085937|FG002|Overall Study|Lack of Efficacy|6|||
124853632|NCT00560833|449085938|FG003|Overall Study|Lack of Efficacy|4|||
124853633|NCT00560833|449085939|FG004|Overall Study|Lack of Efficacy|4|||
124853634|NCT00560833|449085935|FG000|Overall Study|Participant uncooperative|5|||
124853635|NCT00560833|449085936|FG001|Overall Study|Participant uncooperative|5|||
124853636|NCT00560833|449085937|FG002|Overall Study|Participant uncooperative|4|||
124853637|NCT00560833|449085938|FG003|Overall Study|Participant uncooperative|4|||
124853638|NCT00560833|449085939|FG004|Overall Study|Participant uncooperative|2|||
124853639|NCT00560833|449085935|FG000|Overall Study|Other|1|||
124853640|NCT00560833|449085936|FG001|Overall Study|Other|1|||
124853641|NCT00560833|449085937|FG002|Overall Study|Other|3|||
124853642|NCT00560833|449085938|FG003|Overall Study|Other|0|||
124853643|NCT00560833|449085939|FG004|Overall Study|Other|0|||
124853644|NCT00560833|449085935|FG000|Overall Study|Never received drug|0|||
124853645|NCT00560833|449085936|FG001|Overall Study|Never received drug|1|||
124853646|NCT00560833|449085937|FG002|Overall Study|Never received drug|0|||
124853647|NCT00560833|449085938|FG003|Overall Study|Never received drug|0|||
124853648|NCT00560833|449085939|FG004|Overall Study|Never received drug|1|||
124853649|NCT05350449|449085940|FG000|Overall Study|Withdrawal by Subject|4|||
124853650|NCT05350449|449085941|FG001|Overall Study|Withdrawal by Subject|8|||
124853651|NCT01076400|449087568|FG000|Overall Study|Adverse Event|2|||
124853652|NCT01076400|449087569|FG001|Overall Study|Adverse Event|0|||
124853653|NCT01076400|449087570|FG002|Overall Study|Adverse Event|0|||
124853654|NCT01076400|449087568|FG000|Overall Study|Progressive Disease|5|||
124853655|NCT01076400|449087569|FG001|Overall Study|Progressive Disease|0|||
124853656|NCT01076400|449087570|FG002|Overall Study|Progressive Disease|0|||
124853657|NCT02696850|449087573|FG000|Overall Study|Withdrawal by Subject|3|||
124853658|NCT02696850|449087574|FG001|Overall Study|Withdrawal by Subject|3|||
124853659|NCT02696850|449087573|FG000|Overall Study|Lost to Follow-up|8|||
124853660|NCT02696850|449087574|FG001|Overall Study|Lost to Follow-up|5|||
124853661|NCT03455855|449087575|FG000|Overall Study|Lost to Follow-up|4|||
124853662|NCT03455855|449087576|FG001|Overall Study|Lost to Follow-up|2|||
124853663|NCT04193202|449087577|FG000|Overall Study|Adverse Event|2|||
124853664|NCT04193202|449087578|FG001|Overall Study|Adverse Event|1|||
124853665|NCT04193202|449087577|FG000|Overall Study|Death|0|||
124853666|NCT04193202|449087578|FG001|Overall Study|Death|1|||
124853667|NCT04193202|449087577|FG000|Overall Study|Physician Decision|1|||
124853668|NCT04193202|449087578|FG001|Overall Study|Physician Decision|1|||
124853669|NCT04193202|449087577|FG000|Overall Study|Protocol Violation|2|||
124853670|NCT04193202|449087578|FG001|Overall Study|Protocol Violation|2|||
124853671|NCT04193202|449087577|FG000|Overall Study|Withdrawal by Subject|11|||
124853672|NCT04193202|449087578|FG001|Overall Study|Withdrawal by Subject|5|||
124853673|NCT00581945|449087581|FG000|Overall Study|Adverse Event|4|||
124853674|NCT00581945|449087582|FG001|Overall Study|Adverse Event|4|||
124853675|NCT00581945|449087581|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124853676|NCT00581945|449087582|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
124853677|NCT00581945|449087581|FG000|Overall Study|Withdrawal by Subject|2|||
124853678|NCT00581945|449087582|FG001|Overall Study|Withdrawal by Subject|6|||
124853679|NCT00581945|449087581|FG000|Overall Study|Death|1|||
124853680|NCT00581945|449087582|FG001|Overall Study|Death|0|||
124853681|NCT04820673|449087583|FG000|Overall Study|Adverse Event|6|||
124853682|NCT04820673|449087583|FG000|Overall Study|Due to Lack of Effectiveness|1|||
124853683|NCT04820673|449087583|FG000|Overall Study|Pregnancy|1|||
124853684|NCT04820673|449087583|FG000|Overall Study|Voluntary Withdrawal|20|||
124853685|NCT04820673|449087583|FG000|Overall Study|Lost to Follow-up|10|||
124853686|NCT00587587|449087586|FG000|Overall Study|Lost to Follow-up|6|||
124853687|NCT00587587|449087587|FG001|Overall Study|Lost to Follow-up|1|||
124853688|NCT01075321|449087595|FG000|Overall Study|Withdrawal by Subject|0|||
124853689|NCT01075321|449087596|FG001|Overall Study|Withdrawal by Subject|0|||
124853690|NCT01075321|449087597|FG002|Overall Study|Withdrawal by Subject|1|||
124853691|NCT01075321|449087598|FG003|Overall Study|Withdrawal by Subject|1|||
124853692|NCT01075321|449087595|FG000|Overall Study|Protocol Violation|0|||
124853693|NCT01075321|449087596|FG001|Overall Study|Protocol Violation|0|||
124853694|NCT01075321|449087597|FG002|Overall Study|Protocol Violation|1|||
124853695|NCT01075321|449087598|FG003|Overall Study|Protocol Violation|0|||
124853696|NCT01075321|449087595|FG000|Overall Study|Treatment Incomplete due to progression|1|||
124853697|NCT01075321|449087596|FG001|Overall Study|Treatment Incomplete due to progression|0|||
124853698|NCT01075321|449087597|FG002|Overall Study|Treatment Incomplete due to progression|0|||
124853699|NCT01075321|449087598|FG003|Overall Study|Treatment Incomplete due to progression|0|||
124853700|NCT01075321|449087595|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
124853701|NCT01075321|449087596|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
124853702|NCT01075321|449087597|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
124853703|NCT01075321|449087598|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
124853704|NCT01933334|449087602|FG000|Overall Study|Adverse Event|5|||
124853705|NCT01933334|449087603|FG001|Overall Study|Adverse Event|1|||
124853706|NCT01933334|449087602|FG000|Overall Study|Withdrawal by Subject|0|||
124853707|NCT01933334|449087603|FG001|Overall Study|Withdrawal by Subject|1|||
124853708|NCT00767000|449087604|FG000|54-week Study|Adverse Event|4|||
124853709|NCT00767000|449087605|FG001|54-week Study|Adverse Event|6|||
124853710|NCT00767000|449087606|FG002|54-week Study|Adverse Event|6|||
124853711|NCT00767000|449087607|FG003|54-week Study|Adverse Event|8|||
124853712|NCT00767000|449087608|FG004|54-week Study|Adverse Event|4|||
124853713|NCT00767000|449087604|FG000|54-week Study|Creaninine/creatinine clearance|2|||
124853714|NCT00767000|449087605|FG001|54-week Study|Creaninine/creatinine clearance|1|||
124853715|NCT00767000|449087606|FG002|54-week Study|Creaninine/creatinine clearance|2|||
124853716|NCT00767000|449087607|FG003|54-week Study|Creaninine/creatinine clearance|2|||
124853717|NCT00767000|449087608|FG004|54-week Study|Creaninine/creatinine clearance|4|||
124853718|NCT00767000|449087604|FG000|54-week Study|Hyperglycemia|0|||
124853719|NCT00767000|449087605|FG001|54-week Study|Hyperglycemia|0|||
124853720|NCT00767000|449087606|FG002|54-week Study|Hyperglycemia|1|||
124853721|NCT00767000|449087607|FG003|54-week Study|Hyperglycemia|0|||
124853722|NCT00767000|449087608|FG004|54-week Study|Hyperglycemia|1|||
124853723|NCT00767000|449087604|FG000|54-week Study|Hypoglycemia|0|||
124853724|NCT00767000|449087605|FG001|54-week Study|Hypoglycemia|1|||
124853725|NCT00767000|449087606|FG002|54-week Study|Hypoglycemia|0|||
124853726|NCT00767000|449087607|FG003|54-week Study|Hypoglycemia|0|||
124853727|NCT00767000|449087608|FG004|54-week Study|Hypoglycemia|0|||
124853728|NCT00767000|449087604|FG000|54-week Study|Interruption of study medication|0|||
124853729|NCT00767000|449087605|FG001|54-week Study|Interruption of study medication|0|||
124853730|NCT00767000|449087606|FG002|54-week Study|Interruption of study medication|1|||
124853731|NCT00767000|449087607|FG003|54-week Study|Interruption of study medication|0|||
124853732|NCT00767000|449087608|FG004|54-week Study|Interruption of study medication|0|||
124853733|NCT00767000|449087604|FG000|54-week Study|Lack of Efficacy|2|||
124853734|NCT00767000|449087605|FG001|54-week Study|Lack of Efficacy|0|||
124853735|NCT00767000|449087606|FG002|54-week Study|Lack of Efficacy|1|||
124853736|NCT00767000|449087607|FG003|54-week Study|Lack of Efficacy|0|||
124853737|NCT00767000|449087608|FG004|54-week Study|Lack of Efficacy|5|||
124853738|NCT00767000|449087604|FG000|54-week Study|Lost to Follow-up|4|||
124853739|NCT00767000|449087605|FG001|54-week Study|Lost to Follow-up|0|||
124853740|NCT00767000|449087606|FG002|54-week Study|Lost to Follow-up|1|||
124853741|NCT00767000|449087607|FG003|54-week Study|Lost to Follow-up|4|||
124853742|NCT00767000|449087608|FG004|54-week Study|Lost to Follow-up|2|||
124853743|NCT00767000|449087604|FG000|54-week Study|Physician Decision|4|||
124853744|NCT00767000|449087605|FG001|54-week Study|Physician Decision|0|||
124853745|NCT00767000|449087606|FG002|54-week Study|Physician Decision|1|||
124853746|NCT00767000|449087607|FG003|54-week Study|Physician Decision|1|||
124853747|NCT00767000|449087608|FG004|54-week Study|Physician Decision|1|||
124853748|NCT00767000|449087604|FG000|54-week Study|Progressive disease|0|||
124853749|NCT00767000|449087605|FG001|54-week Study|Progressive disease|0|||
124853750|NCT00767000|449087606|FG002|54-week Study|Progressive disease|1|||
124853751|NCT00767000|449087607|FG003|54-week Study|Progressive disease|0|||
124853752|NCT00767000|449087608|FG004|54-week Study|Progressive disease|0|||
124853753|NCT00767000|449087604|FG000|54-week Study|Protocol Violation|0|||
124853754|NCT00767000|449087605|FG001|54-week Study|Protocol Violation|0|||
124853755|NCT00767000|449087606|FG002|54-week Study|Protocol Violation|1|||
124853756|NCT00767000|449087607|FG003|54-week Study|Protocol Violation|2|||
124853757|NCT00767000|449087608|FG004|54-week Study|Protocol Violation|0|||
124853758|NCT00767000|449087604|FG000|54-week Study|Withdrawal by Subject|2|||
124853759|NCT00767000|449087605|FG001|54-week Study|Withdrawal by Subject|3|||
124853760|NCT00767000|449087606|FG002|54-week Study|Withdrawal by Subject|5|||
124853761|NCT00767000|449087607|FG003|54-week Study|Withdrawal by Subject|11|||
124853762|NCT00767000|449087608|FG004|54-week Study|Withdrawal by Subject|13|||
124853763|NCT00767000|449087604|FG000|54-week Study|Study terminated by sponsor|90|||
124853764|NCT00767000|449087605|FG001|54-week Study|Study terminated by sponsor|102|||
124853765|NCT00767000|449087606|FG002|54-week Study|Study terminated by sponsor|89|||
124853766|NCT00767000|449087607|FG003|54-week Study|Study terminated by sponsor|196|||
124853767|NCT00767000|449087608|FG004|54-week Study|Study terminated by sponsor|194|||
124853768|NCT00767000|449087604|FG000|54-week Study|Reason not reported|0|||
124853769|NCT00767000|449087605|FG001|54-week Study|Reason not reported|0|||
124853770|NCT00767000|449087606|FG002|54-week Study|Reason not reported|0|||
124853771|NCT00767000|449087607|FG003|54-week Study|Reason not reported|1|||
124853772|NCT00767000|449087608|FG004|54-week Study|Reason not reported|0|||
124853773|NCT00767000|449087604|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
124853774|NCT00767000|449087605|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
124853775|NCT00767000|449087606|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
124853776|NCT00767000|449087607|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
124853777|NCT00767000|449087608|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
124853778|NCT02039505|449087610|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
124853779|NCT02039505|449087611|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
124853780|NCT02039505|449087612|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
124853781|NCT02039505|449087613|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
124853782|NCT02039505|449087614|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
124853783|NCT02039505|449087615|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
124853784|NCT02039505|449087616|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
124853785|NCT02039505|449087610|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
124853786|NCT02039505|449087611|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
124853787|NCT02039505|449087612|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
124853788|NCT02039505|449087613|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
124853789|NCT02039505|449087614|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
124853790|NCT02039505|449087615|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
124853791|NCT02039505|449087616|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
124853792|NCT02039505|449087610|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
124853793|NCT02039505|449087611|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
124853794|NCT02039505|449087612|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
124853795|NCT02039505|449087613|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
124853796|NCT02039505|449087614|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
124853797|NCT02039505|449087615|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
124853798|NCT02039505|449087616|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
124853799|NCT02039505|449087610|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
124853800|NCT02039505|449087611|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
124853801|NCT02039505|449087612|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
124853802|NCT02039505|449087613|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
124853803|NCT02039505|449087614|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
124853804|NCT02039505|449087615|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
124853805|NCT02039505|449087616|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
124853806|NCT02039505|449087610|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
124853807|NCT02039505|449087611|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
124853808|NCT02039505|449087612|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
124853809|NCT02039505|449087613|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
124853810|NCT02039505|449087614|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
124853811|NCT02039505|449087615|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
124853812|NCT02039505|449087616|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
124853813|NCT02039505|449087610|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
124853814|NCT02039505|449087611|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
124853815|NCT02039505|449087612|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
124853816|NCT02039505|449087613|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
124853817|NCT02039505|449087614|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
124853818|NCT02039505|449087615|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
124853819|NCT02039505|449087616|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
124853820|NCT02039505|449087610|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
124853821|NCT02039505|449087611|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
124853822|NCT02039505|449087612|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
124853823|NCT02039505|449087613|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
124853824|NCT02039505|449087614|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
124853825|NCT02039505|449087615|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
124853826|NCT02039505|449087616|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
124853827|NCT02039505|449087610|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
124853828|NCT02039505|449087611|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
124853829|NCT02039505|449087612|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
124853830|NCT02039505|449087613|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
124853831|NCT02039505|449087614|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
124853832|NCT02039505|449087615|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
124853833|NCT02039505|449087616|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
124853834|NCT02039505|449087610|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
124853835|NCT02039505|449087611|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
124853836|NCT02039505|449087612|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
124853837|NCT02039505|449087613|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
124853838|NCT02039505|449087614|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
124853839|NCT02039505|449087615|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
124853840|NCT02039505|449087616|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
124853841|NCT02039505|449087610|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
124853842|NCT02039505|449087611|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
124853843|NCT02039505|449087612|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
124853844|NCT02039505|449087613|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
124853845|NCT02039505|449087614|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
124853846|NCT02039505|449087615|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
124853847|NCT02039505|449087616|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
124853848|NCT02039505|449087610|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
124853849|NCT02039505|449087611|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
124853850|NCT02039505|449087612|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
124853851|NCT02039505|449087613|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
124853852|NCT02039505|449087614|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
124853853|NCT02039505|449087615|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
124853854|NCT02039505|449087616|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
124853855|NCT00633984|449087619|FG000|Overall Study|Lost to Follow-up|0|||
124853856|NCT00633984|449087620|FG001|Overall Study|Lost to Follow-up|6|||
124853857|NCT00633984|449087619|FG000|Overall Study|Withdrawal by Subject|8|||
124853858|NCT00633984|449087620|FG001|Overall Study|Withdrawal by Subject|7|||
124853859|NCT00633984|449087619|FG000|Overall Study|Hospitalized|1|||
124853860|NCT00633984|449087620|FG001|Overall Study|Hospitalized|0|||
124853861|NCT00097591|449087621|FG000|Overall Study|Withdrawal of consent|342|||
124853862|NCT00097591|449087622|FG001|Overall Study|Withdrawal of consent|323|||
124853863|NCT00097591|449087621|FG000|Overall Study|Less than 6 months on study drug|9|||
124853864|NCT00097591|449087622|FG001|Overall Study|Less than 6 months on study drug|7|||
124853865|NCT00097591|449087621|FG000|Overall Study|Unable to attend termination visit|53|||
124853866|NCT00097591|449087622|FG001|Overall Study|Unable to attend termination visit|51|||
124853867|NCT00097591|449087621|FG000|Overall Study|Lost to follow up|6|||
124853868|NCT00097591|449087622|FG001|Overall Study|Lost to follow up|10|||
124853869|NCT00097591|449087621|FG000|Overall Study|Other|0|||
124853870|NCT00097591|449087622|FG001|Overall Study|Other|3|||
124853871|NCT01557946|449087625|FG000|Overall Study|Adverse Event|3|||
124853872|NCT01557946|449087626|FG001|Overall Study|Adverse Event|0|||
124853873|NCT01114646|449087631|FG000|Overall Study|Withdrawal by Subject|3|||
124853874|NCT01114646|449087632|FG001|Overall Study|Withdrawal by Subject|2|||
124853875|NCT00718042|449087638|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
124853876|NCT00718042|449087639|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
124853877|NCT00718042|449087640|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
124853878|NCT00718042|449087641|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
124853879|NCT00718042|449087642|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
124853880|NCT00718042|449087643|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
124853881|NCT00718042|449087638|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
124853882|NCT00718042|449087639|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
124853883|NCT00718042|449087640|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
124853884|NCT00718042|449087641|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
124853885|NCT00718042|449087642|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
124853886|NCT00718042|449087643|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
124853887|NCT00718042|449087638|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
124853888|NCT00718042|449087639|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
124853889|NCT00718042|449087640|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
124853890|NCT00718042|449087641|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
124853891|NCT00718042|449087642|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
124853892|NCT00718042|449087643|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
124853893|NCT00718042|449087638|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
124853894|NCT00718042|449087639|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
124853895|NCT00718042|449087640|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
124853896|NCT00718042|449087641|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
124853897|NCT00718042|449087642|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
124853898|NCT00718042|449087643|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
124853899|NCT00718042|449087638|FG000|Donor Follow-up|Lost to Follow-up|13|||
124853900|NCT00718042|449087639|FG001|Donor Follow-up|Lost to Follow-up|0|||
124853901|NCT00718042|449087640|FG002|Donor Follow-up|Lost to Follow-up|0|||
124853902|NCT00718042|449087641|FG003|Donor Follow-up|Lost to Follow-up|0|||
124853903|NCT00718042|449087642|FG004|Donor Follow-up|Lost to Follow-up|19|||
124853904|NCT00718042|449087643|FG005|Donor Follow-up|Lost to Follow-up|0|||
124853905|NCT00575588|449087644|FG000|Overall Study|Adverse Event|11|||
124853906|NCT00575588|449087645|FG001|Overall Study|Adverse Event|13|||
124853907|NCT00575588|449087644|FG000|Overall Study|Withdrawal by Subject|27|||
124853908|NCT00575588|449087645|FG001|Overall Study|Withdrawal by Subject|31|||
124853909|NCT00575588|449087644|FG000|Overall Study|Lost to Follow-up|1|||
124853910|NCT00575588|449087645|FG001|Overall Study|Lost to Follow-up|3|||
124853911|NCT00575588|449087644|FG000|Overall Study|Death|4|||
124853912|NCT00575588|449087645|FG001|Overall Study|Death|2|||
124853913|NCT00575588|449087644|FG000|Overall Study|Incorrect enrollment|8|||
124853914|NCT00575588|449087645|FG001|Overall Study|Incorrect enrollment|4|||
124853915|NCT00575588|449087644|FG000|Overall Study|Study specific discontinuation criteria|203|||
124853916|NCT00575588|449087645|FG001|Overall Study|Study specific discontinuation criteria|218|||
124853917|NCT00575588|449087644|FG000|Overall Study|Severe non-compliance to protocol|5|||
124853918|NCT00575588|449087645|FG001|Overall Study|Severe non-compliance to protocol|7|||
124853919|NCT00575588|449087644|FG000|Overall Study|Safety reasons|2|||
124853920|NCT00575588|449087645|FG001|Overall Study|Safety reasons|1|||
124853921|NCT00575588|449087644|FG000|Overall Study|Elevated triglyceride|1|||
124853922|NCT00575588|449087645|FG001|Overall Study|Elevated triglyceride|0|||
124853923|NCT00575588|449087644|FG000|Overall Study|Patient moved|1|||
124853924|NCT00575588|449087645|FG001|Overall Study|Patient moved|3|||
124853925|NCT00575588|449087644|FG000|Overall Study|Impossible to determine HbA1c|0|||
124853926|NCT00575588|449087645|FG001|Overall Study|Impossible to determine HbA1c|1|||
124853927|NCT00614939|449087646|FG000|Overall Study|Withdrawal by Subject|10|||
124853928|NCT00614939|449087647|FG001|Overall Study|Withdrawal by Subject|17|||
124853929|NCT00614939|449087646|FG000|Overall Study|Study specific discontinuation criteris|13|||
124853930|NCT00614939|449087647|FG001|Overall Study|Study specific discontinuation criteris|16|||
124853931|NCT00614939|449087646|FG000|Overall Study|Adverse Event|2|||
124853932|NCT00614939|449087647|FG001|Overall Study|Adverse Event|5|||
124853933|NCT00614939|449087646|FG000|Overall Study|Incorrect enrollment|1|||
124853934|NCT00614939|449087647|FG001|Overall Study|Incorrect enrollment|2|||
124853935|NCT00614939|449087646|FG000|Overall Study|Death|4|||
124853936|NCT00614939|449087647|FG001|Overall Study|Death|3|||
124853937|NCT00614939|449087646|FG000|Overall Study|Poor/non-compliance|4|||
124853938|NCT00614939|449087647|FG001|Overall Study|Poor/non-compliance|0|||
124853939|NCT00614939|449087646|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
124853940|NCT00614939|449087647|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
124853941|NCT00840970|449087648|FG000|Overall Study|Adverse Event|0|||
124853942|NCT00840970|449087649|FG001|Overall Study|Adverse Event|0|||
124853943|NCT00840970|449087650|FG002|Overall Study|Adverse Event|1|||
124853944|NCT00504829|449087651|FG000|Overall Study|Protocol Violation|6|||
124853945|NCT00504829|449087652|FG001|Overall Study|Protocol Violation|4|||
124853946|NCT00504829|449087653|FG002|Overall Study|Protocol Violation|10|||
124853947|NCT01854827|449087654|FG000|Overall Study|Death|1|||
124853948|NCT02571452|449087655|FG000|Overall Study Treatment|Protocol Violation|0|||
124853949|NCT02571452|449087656|FG001|Overall Study Treatment|Protocol Violation|1|||
124853950|NCT02571452|449087655|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
124853951|NCT02571452|449087656|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
124853952|NCT02571452|449087655|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
124853953|NCT02571452|449087656|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
124853954|NCT02660944|449087669|FG000|Overall Study|Adverse Event|3|||
124853955|NCT02660944|449087670|FG001|Overall Study|Adverse Event|4|||
124853956|NCT02660944|449087669|FG000|Overall Study|Physician Decision|3|||
124853957|NCT02660944|449087670|FG001|Overall Study|Physician Decision|1|||
124853958|NCT02660944|449087669|FG000|Overall Study|Withdrawal by Subject|5|||
124853959|NCT02660944|449087670|FG001|Overall Study|Withdrawal by Subject|3|||
124853960|NCT02660944|449087669|FG000|Overall Study|Lost to Follow-up|4|||
124853961|NCT02660944|449087670|FG001|Overall Study|Lost to Follow-up|1|||
124853962|NCT02660944|449087669|FG000|Overall Study|Subject schedule|0|||
124853963|NCT02660944|449087670|FG001|Overall Study|Subject schedule|1|||
124853964|NCT02660944|449087669|FG000|Overall Study|Exclusion criteria met|2|||
124853965|NCT02660944|449087670|FG001|Overall Study|Exclusion criteria met|0|||
124853966|NCT00833924|449087674|FG000|Overall Study|Death|21|||
124853967|NCT00833924|449087674|FG000|Overall Study|Conversion|2|||
124853968|NCT00833924|449087674|FG000|Overall Study|Lost to Follow-up|2|||
124853969|NCT00833924|449087674|FG000|Overall Study|Withdrawal by Subject|13|||
124853970|NCT00833924|449087674|FG000|Overall Study|In study follow-up|71|||
124853971|NCT01485861|449087675|FG000|Phase Ib|Death|1|||
124853972|NCT01485861|449087676|FG001|Phase Ib|Death|0|||
124853973|NCT01485861|449087677|FG002|Phase Ib|Death|0|||
124853974|NCT01485861|449087678|FG003|Phase Ib|Death|0|||
124853975|NCT01485861|449087679|FG004|Phase Ib|Death|0|||
124853976|NCT01485861|449087680|FG005|Phase Ib|Death|0|||
124853977|NCT01485861|449087675|FG000|Phase Ib|Physician Decision|1|||
124853978|NCT01485861|449087676|FG001|Phase Ib|Physician Decision|1|||
124853979|NCT01485861|449087677|FG002|Phase Ib|Physician Decision|0|||
124853980|NCT01485861|449087678|FG003|Phase Ib|Physician Decision|0|||
124853981|NCT01485861|449087679|FG004|Phase Ib|Physician Decision|0|||
124853982|NCT01485861|449087680|FG005|Phase Ib|Physician Decision|0|||
124853983|NCT01485861|449087675|FG000|Phase Ib|Adverse Event|0|||
124853984|NCT01485861|449087676|FG001|Phase Ib|Adverse Event|4|||
124853985|NCT01485861|449087677|FG002|Phase Ib|Adverse Event|0|||
124853986|NCT01485861|449087678|FG003|Phase Ib|Adverse Event|0|||
124853987|NCT01485861|449087679|FG004|Phase Ib|Adverse Event|0|||
124853988|NCT01485861|449087680|FG005|Phase Ib|Adverse Event|0|||
124853989|NCT01485861|449087675|FG000|Phase Ib|Progression of disease|5|||
124853990|NCT01485861|449087676|FG001|Phase Ib|Progression of disease|0|||
124853991|NCT01485861|449087677|FG002|Phase Ib|Progression of disease|0|||
124853992|NCT01485861|449087678|FG003|Phase Ib|Progression of disease|0|||
124853993|NCT01485861|449087679|FG004|Phase Ib|Progression of disease|0|||
124853994|NCT01485861|449087680|FG005|Phase Ib|Progression of disease|0|||
124853995|NCT01485861|449087675|FG000|Phase Ib|Other|3|||
124853996|NCT01485861|449087676|FG001|Phase Ib|Other|0|||
124853997|NCT01485861|449087677|FG002|Phase Ib|Other|0|||
124853998|NCT01485861|449087678|FG003|Phase Ib|Other|0|||
124853999|NCT01485861|449087679|FG004|Phase Ib|Other|0|||
124854000|NCT01485861|449087680|FG005|Phase Ib|Other|0|||
124854001|NCT01485861|449087675|FG000|Phase Ib|Withdrawal by Subject|4|||
124854002|NCT01485861|449087676|FG001|Phase Ib|Withdrawal by Subject|1|||
124854003|NCT01485861|449087677|FG002|Phase Ib|Withdrawal by Subject|0|||
124854004|NCT01485861|449087678|FG003|Phase Ib|Withdrawal by Subject|0|||
124854005|NCT01485861|449087679|FG004|Phase Ib|Withdrawal by Subject|0|||
124854006|NCT01485861|449087680|FG005|Phase Ib|Withdrawal by Subject|0|||
124854007|NCT01485861|449087675|FG000|Phase II|Death|0|||
124854008|NCT01485861|449087676|FG001|Phase II|Death|0|||
124854009|NCT01485861|449087677|FG002|Phase II|Death|67|||
124854010|NCT01485861|449087678|FG003|Phase II|Death|71|||
124854011|NCT01485861|449087679|FG004|Phase II|Death|68|||
124854012|NCT01485861|449087680|FG005|Phase II|Death|0|||
124854013|NCT01485861|449087675|FG000|Phase II|Progression of Disease|0|||
124854014|NCT01485861|449087676|FG001|Phase II|Progression of Disease|0|||
124854015|NCT01485861|449087677|FG002|Phase II|Progression of Disease|1|||
124854016|NCT01485861|449087678|FG003|Phase II|Progression of Disease|0|||
124854017|NCT01485861|449087679|FG004|Phase II|Progression of Disease|0|||
124854018|NCT01485861|449087680|FG005|Phase II|Progression of Disease|0|||
124854019|NCT01485861|449087675|FG000|Phase II|Other|0|||
124854020|NCT01485861|449087676|FG001|Phase II|Other|0|||
124854021|NCT01485861|449087677|FG002|Phase II|Other|0|||
124854022|NCT01485861|449087678|FG003|Phase II|Other|1|||
124854023|NCT01485861|449087679|FG004|Phase II|Other|0|||
124854024|NCT01485861|449087680|FG005|Phase II|Other|0|||
124854025|NCT01485861|449087675|FG000|Phase II|Withdrawal by Subject|0|||
124854026|NCT01485861|449087676|FG001|Phase II|Withdrawal by Subject|0|||
124854027|NCT01485861|449087677|FG002|Phase II|Withdrawal by Subject|6|||
124854028|NCT01485861|449087678|FG003|Phase II|Withdrawal by Subject|3|||
124854029|NCT01485861|449087679|FG004|Phase II|Withdrawal by Subject|4|||
124854030|NCT01485861|449087680|FG005|Phase II|Withdrawal by Subject|0|||
124854031|NCT01485861|449087675|FG000|Phase II|Lost to Follow-up|0|||
124854032|NCT01485861|449087676|FG001|Phase II|Lost to Follow-up|0|||
124854033|NCT01485861|449087677|FG002|Phase II|Lost to Follow-up|2|||
124854034|NCT01485861|449087678|FG003|Phase II|Lost to Follow-up|3|||
124854035|NCT01485861|449087679|FG004|Phase II|Lost to Follow-up|5|||
124854036|NCT01485861|449087680|FG005|Phase II|Lost to Follow-up|0|||
124854037|NCT01485861|449087675|FG000|Phase II|Study Ended|0|||
124854038|NCT01485861|449087676|FG001|Phase II|Study Ended|0|||
124854039|NCT01485861|449087677|FG002|Phase II|Study Ended|7|||
124854040|NCT01485861|449087678|FG003|Phase II|Study Ended|8|||
124854041|NCT01485861|449087679|FG004|Phase II|Study Ended|6|||
124854042|NCT01485861|449087680|FG005|Phase II|Study Ended|0|||
124854043|NCT01485861|449087675|FG000|Safety Phase|Death|0|||
124854044|NCT01485861|449087676|FG001|Safety Phase|Death|0|||
124854045|NCT01485861|449087677|FG002|Safety Phase|Death|0|||
124854046|NCT01485861|449087678|FG003|Safety Phase|Death|0|||
124854047|NCT01485861|449087679|FG004|Safety Phase|Death|0|||
124854048|NCT01485861|449087680|FG005|Safety Phase|Death|2|||
124854049|NCT01485861|449087675|FG000|Safety Phase|Adverse Event|0|||
124854050|NCT01485861|449087676|FG001|Safety Phase|Adverse Event|0|||
124854051|NCT01485861|449087677|FG002|Safety Phase|Adverse Event|0|||
124854052|NCT01485861|449087678|FG003|Safety Phase|Adverse Event|0|||
124854053|NCT01485861|449087679|FG004|Safety Phase|Adverse Event|0|||
124854054|NCT01485861|449087680|FG005|Safety Phase|Adverse Event|1|||
124854055|NCT01485861|449087675|FG000|Safety Phase|Other|0|||
124854056|NCT01485861|449087676|FG001|Safety Phase|Other|0|||
124854057|NCT01485861|449087677|FG002|Safety Phase|Other|0|||
124854058|NCT01485861|449087678|FG003|Safety Phase|Other|0|||
124854059|NCT01485861|449087679|FG004|Safety Phase|Other|0|||
124854060|NCT01485861|449087680|FG005|Safety Phase|Other|5|||
124854061|NCT01485861|449087675|FG000|Safety Phase|Progression of Disease|0|||
124854062|NCT01485861|449087676|FG001|Safety Phase|Progression of Disease|0|||
124854063|NCT01485861|449087677|FG002|Safety Phase|Progression of Disease|0|||
124854064|NCT01485861|449087678|FG003|Safety Phase|Progression of Disease|0|||
124854065|NCT01485861|449087679|FG004|Safety Phase|Progression of Disease|0|||
124854066|NCT01485861|449087680|FG005|Safety Phase|Progression of Disease|9|||
124854067|NCT01485861|449087675|FG000|Safety Phase|Withdrawal by Subject|0|||
124854068|NCT01485861|449087676|FG001|Safety Phase|Withdrawal by Subject|0|||
124854069|NCT01485861|449087677|FG002|Safety Phase|Withdrawal by Subject|0|||
124854070|NCT01485861|449087678|FG003|Safety Phase|Withdrawal by Subject|0|||
124854071|NCT01485861|449087679|FG004|Safety Phase|Withdrawal by Subject|0|||
124854072|NCT01485861|449087680|FG005|Safety Phase|Withdrawal by Subject|6|||
124854073|NCT01485861|449087675|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
124854074|NCT01485861|449087676|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
124854075|NCT01485861|449087677|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
124854076|NCT01485861|449087678|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
124854077|NCT01485861|449087679|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
124854078|NCT01485861|449087680|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
124854079|NCT04796610|449087685|FG000|Overall Study|Withdrawal by Subject|1|||
124854080|NCT04796610|449087686|FG001|Overall Study|Withdrawal by Subject|0|||
124854081|NCT04796610|449087687|FG002|Overall Study|Withdrawal by Subject|0|||
124854082|NCT04796610|449087688|FG003|Overall Study|Withdrawal by Subject|0|||
124854083|NCT04796610|449087685|FG000|Overall Study|Lost to Follow-up|2|||
124854084|NCT04796610|449087686|FG001|Overall Study|Lost to Follow-up|0|||
124854085|NCT04796610|449087687|FG002|Overall Study|Lost to Follow-up|1|||
124854086|NCT04796610|449087688|FG003|Overall Study|Lost to Follow-up|1|||
124854087|NCT02059148|449087689|FG000|Treatment 1|Protocol Violation|0|||
124854088|NCT02059148|449087690|FG001|Treatment 1|Protocol Violation|0|||
124854089|NCT02059148|449087691|FG002|Treatment 1|Protocol Violation|0|||
124854090|NCT02059148|449087692|FG003|Treatment 1|Protocol Violation|0|||
124854091|NCT02059148|449087693|FG004|Treatment 1|Protocol Violation|0|||
124854092|NCT02059148|449087694|FG005|Treatment 1|Protocol Violation|1|||
124854093|NCT00403546|449087698|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
124854094|NCT00403546|449087699|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
124854095|NCT00403546|449087700|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
124854096|NCT00403546|449087698|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
124854097|NCT00403546|449087699|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
124854098|NCT00403546|449087700|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
124854099|NCT00403546|449087698|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
124854100|NCT00403546|449087699|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
124854101|NCT00403546|449087700|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
124854102|NCT00403546|449087698|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
124854103|NCT00403546|449087699|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
124854104|NCT00403546|449087700|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
124854105|NCT00403546|449087698|FG000|Screening Phase|Screening Failure|22|||
124854106|NCT00403546|449087699|FG001|Screening Phase|Screening Failure|0|||
124854107|NCT00403546|449087700|FG002|Screening Phase|Screening Failure|0|||
124854108|NCT00403546|449087698|FG000|Screening Phase|Adverse Event|1|||
124854109|NCT00403546|449087699|FG001|Screening Phase|Adverse Event|0|||
124854110|NCT00403546|449087700|FG002|Screening Phase|Adverse Event|0|||
124854111|NCT00403546|449087698|FG000|Screening Phase|Terminated Prior to Randomization|5|||
124854112|NCT00403546|449087699|FG001|Screening Phase|Terminated Prior to Randomization|0|||
124854113|NCT00403546|449087700|FG002|Screening Phase|Terminated Prior to Randomization|0|||
124854114|NCT00403546|449087698|FG000|Randomized Trial|Early Terminations|0|||
124854115|NCT00403546|449087699|FG001|Randomized Trial|Early Terminations|17|||
124854116|NCT00403546|449087700|FG002|Randomized Trial|Early Terminations|16|||
124854117|NCT00437489|449087701|FG000|Overall Study|Study terminated by sponsor|23|||
124854118|NCT00437489|449087702|FG001|Overall Study|Study terminated by sponsor|21|||
124854119|NCT00437489|449087701|FG000|Overall Study|Lost to Follow-up|0|||
124854120|NCT00437489|449087702|FG001|Overall Study|Lost to Follow-up|1|||
124854121|NCT03893448|449087705|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
124854122|NCT03893448|449087706|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
124854123|NCT03893448|449087705|FG000|Overall Study|Physician Decision|8|||
124854124|NCT03893448|449087706|FG001|Overall Study|Physician Decision|14|||
124854125|NCT03893448|449087705|FG000|Overall Study|Lost to Follow-up|34|||
124854126|NCT03893448|449087706|FG001|Overall Study|Lost to Follow-up|27|||
124854127|NCT03893448|449087705|FG000|Overall Study|Death|1|||
124854128|NCT03893448|449087706|FG001|Overall Study|Death|0|||
124854129|NCT03321981|449087712|FG000|Overall Study|Progressive Disease (PD)|15|||
124854130|NCT03321981|449087713|FG001|Overall Study|Progressive Disease (PD)|30|||
124854131|NCT03321981|449087714|FG002|Overall Study|Progressive Disease (PD)|47|||
124854132|NCT03321981|449087712|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
124854133|NCT03321981|449087713|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
124854134|NCT03321981|449087714|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
124854135|NCT03321981|449087712|FG000|Overall Study|Adverse Event|0|||
124854136|NCT03321981|449087713|FG001|Overall Study|Adverse Event|0|||
124854137|NCT03321981|449087714|FG002|Overall Study|Adverse Event|2|||
124854138|NCT03321981|449087712|FG000|Overall Study|symptomatic deterioration|0|||
124854139|NCT03321981|449087713|FG001|Overall Study|symptomatic deterioration|1|||
124854140|NCT03321981|449087714|FG002|Overall Study|symptomatic deterioration|1|||
124854141|NCT03321981|449087712|FG000|Overall Study|Lack of compliance|0|||
124854142|NCT03321981|449087713|FG001|Overall Study|Lack of compliance|1|||
124854143|NCT03321981|449087714|FG002|Overall Study|Lack of compliance|0|||
124854144|NCT03321981|449087712|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
124854145|NCT03321981|449087713|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
124854146|NCT03321981|449087714|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
124854147|NCT03321981|449087712|FG000|Overall Study|Death|0|||
124854148|NCT03321981|449087713|FG001|Overall Study|Death|1|||
124854149|NCT03321981|449087714|FG002|Overall Study|Death|0|||
124854150|NCT03321981|449087712|FG000|Overall Study|Subject withdrawal of investigational product|0|||
124854151|NCT03321981|449087713|FG001|Overall Study|Subject withdrawal of investigational product|1|||
124854152|NCT03321981|449087714|FG002|Overall Study|Subject withdrawal of investigational product|0|||
124854153|NCT03321981|449087712|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
124854154|NCT03321981|449087713|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
124854155|NCT03321981|449087714|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
124854156|NCT03321981|449087712|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
124854157|NCT03321981|449087713|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
124854158|NCT03321981|449087714|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
124854159|NCT05061446|449087715|FG000|Overall Study|Adverse Event|2|||
124854160|NCT05061446|449087716|FG001|Overall Study|Adverse Event|0|||
124854161|NCT05061446|449087717|FG002|Overall Study|Adverse Event|0|||
124854162|NCT05061446|449087715|FG000|Overall Study|Participant no longer available due to personal reason|0|||
124854163|NCT05061446|449087716|FG001|Overall Study|Participant no longer available due to personal reason|1|||
124854164|NCT05061446|449087717|FG002|Overall Study|Participant no longer available due to personal reason|0|||
124854165|NCT03880578|449087718|FG000|Overall Study|Withdrawal by Subject|0|||
124854166|NCT03880578|449087719|FG001|Overall Study|Withdrawal by Subject|3|||
124854167|NCT03880578|449087720|FG002|Overall Study|Withdrawal by Subject|1|||
124854168|NCT03880578|449087718|FG000|Overall Study|Death|0|||
124854169|NCT03880578|449087719|FG001|Overall Study|Death|1|||
124854170|NCT03880578|449087720|FG002|Overall Study|Death|0|||
124854171|NCT04934670|449087721|FG000|Overall Study|Death|4|||
124854172|NCT04934670|449087722|FG001|Overall Study|Death|0|||
124854173|NCT04934670|449087721|FG000|Overall Study|Lost to Follow-up|1|||
124854174|NCT04934670|449087722|FG001|Overall Study|Lost to Follow-up|4|||
124854175|NCT00817089|449087724|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
124854176|NCT00817089|449087725|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
124854177|NCT00817089|449087726|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
124854178|NCT00817089|449087727|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
124854179|NCT00817089|449087724|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
124854180|NCT00817089|449087725|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
124854181|NCT00817089|449087726|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
124854182|NCT00817089|449087727|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
124854183|NCT03067441|449087728|FG000|Overall Study|Withdrawal by Subject|16|||
124854184|NCT03067441|449087729|FG001|Overall Study|Withdrawal by Subject|34|||
124854185|NCT03067441|449087728|FG000|Overall Study|Lost to Follow-up|7|||
124854186|NCT03067441|449087729|FG001|Overall Study|Lost to Follow-up|5|||
124854187|NCT03067441|449087728|FG000|Overall Study|Adverse Event|7|||
124854188|NCT03067441|449087729|FG001|Overall Study|Adverse Event|14|||
124854189|NCT03067441|449087728|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
124854190|NCT03067441|449087729|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
124854191|NCT03067441|449087728|FG000|Overall Study|Physician Decision|1|||
124854192|NCT03067441|449087729|FG001|Overall Study|Physician Decision|3|||
124854193|NCT03067441|449087728|FG000|Overall Study|Other|1|||
124854194|NCT03067441|449087729|FG001|Overall Study|Other|1|||
124854195|NCT01785602|449087730|FG000|Overall Study|Withdrawal by Subject|2|||
124854196|NCT01785602|449087731|FG001|Overall Study|Withdrawal by Subject|0|||
124854197|NCT01785602|449087730|FG000|Overall Study|Lost to Follow-up|1|||
124854198|NCT01785602|449087731|FG001|Overall Study|Lost to Follow-up|1|||
124854199|NCT01785602|449087730|FG000|Overall Study|Adverse Event|3|||
124854200|NCT01785602|449087731|FG001|Overall Study|Adverse Event|5|||
124854201|NCT01785602|449087730|FG000|Overall Study|Administrative problems|7|||
124854202|NCT01785602|449087731|FG001|Overall Study|Administrative problems|3|||
124854203|NCT04177108|449087732|FG000|Overall Study|Withdrawal by Subject|4|||
124854204|NCT04177108|449087733|FG001|Overall Study|Withdrawal by Subject|8|||
124854205|NCT04177108|449087734|FG002|Overall Study|Withdrawal by Subject|9|||
124854206|NCT04177108|449087735|FG003|Overall Study|Withdrawal by Subject|11|||
124854207|NCT04177108|449087736|FG004|Overall Study|Withdrawal by Subject|13|||
124854208|NCT04177108|449087732|FG000|Overall Study|Physician Decision|23|||
124854209|NCT04177108|449087733|FG001|Overall Study|Physician Decision|15|||
124854210|NCT04177108|449087734|FG002|Overall Study|Physician Decision|18|||
124854211|NCT04177108|449087735|FG003|Overall Study|Physician Decision|29|||
124854212|NCT04177108|449087736|FG004|Overall Study|Physician Decision|23|||
124854213|NCT04177108|449087732|FG000|Overall Study|Reason Not Specified|0|||
124854214|NCT04177108|449087733|FG001|Overall Study|Reason Not Specified|1|||
124854215|NCT04177108|449087734|FG002|Overall Study|Reason Not Specified|0|||
124854216|NCT04177108|449087735|FG003|Overall Study|Reason Not Specified|0|||
124854217|NCT04177108|449087736|FG004|Overall Study|Reason Not Specified|2|||
124854218|NCT04177108|449087732|FG000|Overall Study|Lost to Follow-up|0|||
124854219|NCT04177108|449087733|FG001|Overall Study|Lost to Follow-up|0|||
124854220|NCT04177108|449087734|FG002|Overall Study|Lost to Follow-up|1|||
124854221|NCT04177108|449087735|FG003|Overall Study|Lost to Follow-up|1|||
124854222|NCT04177108|449087736|FG004|Overall Study|Lost to Follow-up|1|||
124854223|NCT04177108|449087732|FG000|Overall Study|Death|16|||
124854224|NCT04177108|449087733|FG001|Overall Study|Death|19|||
124854225|NCT04177108|449087734|FG002|Overall Study|Death|13|||
124854226|NCT04177108|449087735|FG003|Overall Study|Death|17|||
124854227|NCT04177108|449087736|FG004|Overall Study|Death|18|||
124854228|NCT01827904|449087740|FG000|Main Study|Withdrawal by Subject|1|||
124854229|NCT01827904|449087741|FG001|Main Study|Withdrawal by Subject|0|||
124854230|NCT01827904|449087742|FG002|Main Study|Withdrawal by Subject|0|||
124854231|NCT01827904|449087740|FG000|Main Study|Adverse Event|1|||
124854232|NCT01827904|449087741|FG001|Main Study|Adverse Event|0|||
124854233|NCT01827904|449087742|FG002|Main Study|Adverse Event|0|||
124854234|NCT01827904|449087740|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
124854235|NCT01827904|449087741|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
124854236|NCT01827904|449087742|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
124854237|NCT01827904|449087740|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
124854238|NCT01827904|449087741|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
124854239|NCT01827904|449087742|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
124854240|NCT01827904|449087740|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
124854241|NCT01827904|449087741|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
124854242|NCT01827904|449087742|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
124854243|NCT01827904|449087740|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
124854244|NCT01827904|449087741|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
124854245|NCT01827904|449087742|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
124854246|NCT01827904|449087740|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
124854247|NCT01827904|449087741|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
124854248|NCT01827904|449087742|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
124854249|NCT01827904|449087740|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
124854250|NCT01827904|449087741|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
124854251|NCT01827904|449087742|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
124854252|NCT01827904|449087740|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
124854253|NCT01827904|449087741|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
124854254|NCT01827904|449087742|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
124854255|NCT01827904|449087740|FG000|Long-term Annual Follow-up|Physician Decision|1|||
124854256|NCT01827904|449087741|FG001|Long-term Annual Follow-up|Physician Decision|0|||
124854257|NCT01827904|449087742|FG002|Long-term Annual Follow-up|Physician Decision|0|||
124854258|NCT01827904|449087740|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
124854259|NCT01827904|449087741|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
124854260|NCT01827904|449087742|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
124854261|NCT01827904|449087740|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
124854262|NCT01827904|449087741|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
124854263|NCT01827904|449087742|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
124854264|NCT00101101|449087743|FG000|Overall Study|never received vaccine|20|||
124854265|NCT01800903|449087744|FG000|Second Test Period|unable to catheterise|1|||
124854266|NCT01800903|449087745|FG001|Second Test Period|unable to catheterise|0|||
124854267|NCT01800903|449087746|FG002|Second Test Period|unable to catheterise|0|||
124854268|NCT01800903|449087747|FG003|Second Test Period|unable to catheterise|0|||
124854269|NCT01800903|449087748|FG004|Second Test Period|unable to catheterise|0|||
124854270|NCT01800903|449087749|FG005|Second Test Period|unable to catheterise|0|||
124854271|NCT01181895|449087753|FG000|Overall Study|Adverse Event|3|||
124854272|NCT01181895|449087754|FG001|Overall Study|Adverse Event|1|||
124854273|NCT01181895|449087755|FG002|Overall Study|Adverse Event|1|||
124854274|NCT01181895|449087753|FG000|Overall Study|Lack of Efficacy|8|||
124854275|NCT01181895|449087754|FG001|Overall Study|Lack of Efficacy|9|||
124854276|NCT01181895|449087755|FG002|Overall Study|Lack of Efficacy|9|||
124854277|NCT01181895|449087753|FG000|Overall Study|Protocol Violation|2|||
124854278|NCT01181895|449087754|FG001|Overall Study|Protocol Violation|1|||
124854279|NCT01181895|449087755|FG002|Overall Study|Protocol Violation|0|||
124854280|NCT01181895|449087753|FG000|Overall Study|Lost to Follow-up|0|||
124854281|NCT01181895|449087754|FG001|Overall Study|Lost to Follow-up|1|||
124854282|NCT01181895|449087755|FG002|Overall Study|Lost to Follow-up|2|||
124854283|NCT01181895|449087753|FG000|Overall Study|Investigator Discretion|1|||
124854284|NCT01181895|449087754|FG001|Overall Study|Investigator Discretion|2|||
124854285|NCT01181895|449087755|FG002|Overall Study|Investigator Discretion|1|||
124854286|NCT01181895|449087753|FG000|Overall Study|Withdrawal by Subject|3|||
124854287|NCT01181895|449087754|FG001|Overall Study|Withdrawal by Subject|0|||
124854288|NCT01181895|449087755|FG002|Overall Study|Withdrawal by Subject|5|||
124854289|NCT00766415|449087758|FG000|Overall Study|Withdrawal by Subject|0|||
124854290|NCT00766415|449087759|FG001|Overall Study|Withdrawal by Subject|1|||
124854291|NCT01312467|449087760|FG000|Overall Study|Adverse Event|4|||
124854292|NCT01312467|449087760|FG000|Overall Study|Lost to Follow-up|1|||
124854293|NCT01312467|449087760|FG000|Overall Study|Withdrawal by Subject|2|||
124854294|NCT01312467|449087760|FG000|Overall Study|Deported to country of origin|1|||
124854295|NCT01312467|449087760|FG000|Overall Study|Another medical condition|1|||
124854296|NCT01312467|449087760|FG000|Overall Study|Ineligible|4|||
124854297|NCT02752048|449087763|FG000|Overall Study|Withdrawal by Subject|0|||
124854298|NCT02752048|449087764|FG001|Overall Study|Withdrawal by Subject|0|||
124854299|NCT02752048|449087765|FG002|Overall Study|Withdrawal by Subject|3|||
124854300|NCT00898677|449087768|FG000|Overall Study|Adverse Event|0|||
124854301|NCT00898677|449087769|FG001|Overall Study|Adverse Event|0|||
124854302|NCT00898677|449087770|FG002|Overall Study|Adverse Event|1|||
124854303|NCT00898677|449087771|FG003|Overall Study|Adverse Event|0|||
124854304|NCT00898677|449087768|FG000|Overall Study|Lost to Follow-up|0|||
124854305|NCT00898677|449087769|FG001|Overall Study|Lost to Follow-up|0|||
124854306|NCT00898677|449087770|FG002|Overall Study|Lost to Follow-up|2|||
124854307|NCT00898677|449087771|FG003|Overall Study|Lost to Follow-up|0|||
124854308|NCT00898677|449087768|FG000|Overall Study|Protocol Violation|1|||
124854309|NCT00898677|449087769|FG001|Overall Study|Protocol Violation|1|||
124854310|NCT00898677|449087770|FG002|Overall Study|Protocol Violation|2|||
124854311|NCT00898677|449087771|FG003|Overall Study|Protocol Violation|0|||
124854312|NCT00898677|449087768|FG000|Overall Study|Withdrawal by Subject|0|||
124854313|NCT00898677|449087769|FG001|Overall Study|Withdrawal by Subject|0|||
124854314|NCT00898677|449087770|FG002|Overall Study|Withdrawal by Subject|0|||
124854315|NCT00898677|449087771|FG003|Overall Study|Withdrawal by Subject|1|||
124854316|NCT00898677|449087768|FG000|Overall Study|Not Treated: Adverse Event|0|||
124854317|NCT00898677|449087769|FG001|Overall Study|Not Treated: Adverse Event|2|||
124854318|NCT00898677|449087770|FG002|Overall Study|Not Treated: Adverse Event|1|||
124854319|NCT00898677|449087771|FG003|Overall Study|Not Treated: Adverse Event|0|||
124854320|NCT00898677|449087768|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
124854321|NCT00898677|449087769|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
124854322|NCT00898677|449087770|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
124854323|NCT00898677|449087771|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
124854324|NCT00898677|449087768|FG000|Overall Study|Not Treated: Pregnancy|0|||
124854325|NCT00898677|449087769|FG001|Overall Study|Not Treated: Pregnancy|0|||
124854326|NCT00898677|449087770|FG002|Overall Study|Not Treated: Pregnancy|1|||
124854327|NCT00898677|449087771|FG003|Overall Study|Not Treated: Pregnancy|0|||
124854328|NCT00898677|449087768|FG000|Overall Study|Not Treated: Protocol Violation|2|||
124854329|NCT00898677|449087769|FG001|Overall Study|Not Treated: Protocol Violation|0|||
124854330|NCT00898677|449087770|FG002|Overall Study|Not Treated: Protocol Violation|2|||
124854331|NCT00898677|449087771|FG003|Overall Study|Not Treated: Protocol Violation|0|||
124854332|NCT00898677|449087768|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
124854333|NCT00898677|449087769|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
124854334|NCT00898677|449087770|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
124854335|NCT00898677|449087771|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
124854336|NCT00898677|449087768|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
124854337|NCT00898677|449087769|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
124854338|NCT00898677|449087770|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
124854339|NCT00898677|449087771|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
124854340|NCT00898677|449087768|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
124854341|NCT00898677|449087769|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
124854342|NCT00898677|449087770|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
124854343|NCT00898677|449087771|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
124854344|NCT00898677|449087768|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
124854345|NCT00898677|449087769|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
124854346|NCT00898677|449087770|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
124854347|NCT00898677|449087771|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
124854348|NCT00898677|449087768|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
124854349|NCT00898677|449087769|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
124854350|NCT00898677|449087770|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
124854351|NCT00898677|449087771|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
124854352|NCT00898677|449087768|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
124854353|NCT00898677|449087769|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
124854354|NCT00898677|449087770|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
124854355|NCT00898677|449087771|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
124854356|NCT00898677|449087768|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
124854357|NCT00898677|449087769|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
124854358|NCT00898677|449087770|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
124854359|NCT00898677|449087771|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
124854360|NCT01850004|449087778|FG000|Overall Study|Poor/Non-compliance|1|||
124854361|NCT01850004|449087778|FG000|Overall Study|Participant Withdrew Consent|9|||
124854362|NCT01850004|449087778|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
124854363|NCT01850004|449087778|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
124854364|NCT01850004|449087778|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
124854365|NCT01850004|449087778|FG000|Overall Study|Other Reasons|2|||
124854366|NCT01850004|449087778|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
124854367|NCT01850004|449087778|FG000|Overall Study|Maximum Clinical Benefit|4|||
124854368|NCT03019536|449089563|FG000|Overall Study|Withdrawal by Subject|1|||
124854369|NCT03019536|449089564|FG001|Overall Study|Withdrawal by Subject|1|||
124854370|NCT03019536|449089565|FG002|Overall Study|Withdrawal by Subject|0|||
124854371|NCT03019536|449089563|FG000|Overall Study|Adverse Event|0|||
124854372|NCT03019536|449089564|FG001|Overall Study|Adverse Event|0|||
124854373|NCT03019536|449089565|FG002|Overall Study|Adverse Event|2|||
124854374|NCT01782131|449089568|FG000|Overall Study|Death|93|||
124854375|NCT01782131|449089569|FG001|Overall Study|Death|96|||
124854376|NCT01782131|449089568|FG000|Overall Study|Lost to Follow-up|1|||
124854377|NCT01782131|449089569|FG001|Overall Study|Lost to Follow-up|3|||
124854378|NCT01782131|449089568|FG000|Overall Study|Withdrawal by Subject|10|||
124854379|NCT01782131|449089569|FG001|Overall Study|Withdrawal by Subject|10|||
124854380|NCT01782131|449089568|FG000|Overall Study|Randomized but not treated|5|||
124854381|NCT01782131|449089569|FG001|Overall Study|Randomized but not treated|5|||
124854382|NCT01782131|449089568|FG000|Overall Study|Reason not provided|0|||
124854383|NCT01782131|449089569|FG001|Overall Study|Reason not provided|1|||
124854384|NCT01627249|449089570|FG000|Overall Study|Death|3|||
124854385|NCT01627249|449089571|FG001|Overall Study|Death|5|||
124854386|NCT01627249|449089572|FG002|Overall Study|Death|3|||
124854387|NCT01627249|449089570|FG000|Overall Study|Withdrawal by Subject|12|||
124854388|NCT01627249|449089571|FG001|Overall Study|Withdrawal by Subject|6|||
124854389|NCT01627249|449089572|FG002|Overall Study|Withdrawal by Subject|9|||
124854390|NCT01627249|449089570|FG000|Overall Study|Missed Visit|1|||
124854391|NCT01627249|449089571|FG001|Overall Study|Missed Visit|1|||
124854392|NCT01627249|449089572|FG002|Overall Study|Missed Visit|0|||
124854393|NCT00796718|449089573|FG000|Overall Study|Adverse Event|2|||
124854394|NCT00796718|449089573|FG000|Overall Study|Exclusion Criteria|1|||
124854395|NCT00796718|449089573|FG000|Overall Study|Lost to Follow-up|5|||
124854396|NCT00796718|449089573|FG000|Overall Study|Withdrawal by Informed Consent|1|||
124854397|NCT03266588|449089574|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
124854398|NCT03266588|449089575|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
124854399|NCT03266588|449089576|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
124854400|NCT03266588|449089574|FG000|Observational Period|Withdrawal by Subject|44|||
124854401|NCT03266588|449089575|FG001|Observational Period|Withdrawal by Subject|22|||
124854402|NCT03266588|449089576|FG002|Observational Period|Withdrawal by Subject|13|||
124854403|NCT03266588|449089574|FG000|Observational Period|Non-compliance|18|||
124854404|NCT03266588|449089575|FG001|Observational Period|Non-compliance|12|||
124854405|NCT03266588|449089576|FG002|Observational Period|Non-compliance|10|||
124854406|NCT03266588|449089574|FG000|Observational Period|Lost to Follow-up|8|||
124854407|NCT03266588|449089575|FG001|Observational Period|Lost to Follow-up|12|||
124854408|NCT03266588|449089576|FG002|Observational Period|Lost to Follow-up|4|||
124854409|NCT03266588|449089574|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
124854410|NCT03266588|449089575|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
124854411|NCT03266588|449089576|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
124854412|NCT03266588|449089574|FG000|Observational Period|Protocol Deviation|1|||
124854413|NCT03266588|449089575|FG001|Observational Period|Protocol Deviation|0|||
124854414|NCT03266588|449089576|FG002|Observational Period|Protocol Deviation|0|||
124854415|NCT03266588|449089574|FG000|Observational Period|Other Reasons|3|||
124854416|NCT03266588|449089575|FG001|Observational Period|Other Reasons|0|||
124854417|NCT03266588|449089576|FG002|Observational Period|Other Reasons|1|||
124854418|NCT03266588|449089574|FG000|Long-term Treatment Period|Adverse Event|33|||
124854419|NCT03266588|449089575|FG001|Long-term Treatment Period|Adverse Event|17|||
124854420|NCT03266588|449089576|FG002|Long-term Treatment Period|Adverse Event|8|||
124854421|NCT03266588|449089574|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
124854422|NCT03266588|449089575|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
124854423|NCT03266588|449089576|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
124854424|NCT03266588|449089574|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
124854425|NCT03266588|449089575|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
124854426|NCT03266588|449089576|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
124854427|NCT03266588|449089574|FG000|Long-term Treatment Period|Non-Compliance|126|||
124854428|NCT03266588|449089575|FG001|Long-term Treatment Period|Non-Compliance|57|||
124854429|NCT03266588|449089576|FG002|Long-term Treatment Period|Non-Compliance|7|||
124854430|NCT03266588|449089574|FG000|Long-term Treatment Period|Pregnancy|11|||
124854431|NCT03266588|449089575|FG001|Long-term Treatment Period|Pregnancy|5|||
124854432|NCT03266588|449089576|FG002|Long-term Treatment Period|Pregnancy|0|||
124854433|NCT03266588|449089574|FG000|Long-term Treatment Period|Protocol Deviation|17|||
124854434|NCT03266588|449089575|FG001|Long-term Treatment Period|Protocol Deviation|10|||
124854435|NCT03266588|449089576|FG002|Long-term Treatment Period|Protocol Deviation|4|||
124854436|NCT03266588|449089574|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
124854437|NCT03266588|449089575|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
124854438|NCT03266588|449089576|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
124854439|NCT03266588|449089574|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
124854440|NCT03266588|449089575|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
124854441|NCT03266588|449089576|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
124854442|NCT03266588|449089574|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
124854443|NCT03266588|449089575|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
124854444|NCT03266588|449089576|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
124854445|NCT03266588|449089574|FG000|Long-term Treatment Period|Other Reasons|5|||
124854446|NCT03266588|449089575|FG001|Long-term Treatment Period|Other Reasons|0|||
124854447|NCT03266588|449089576|FG002|Long-term Treatment Period|Other Reasons|0|||
124854448|NCT03266588|449089574|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
124854449|NCT03266588|449089575|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
124854450|NCT03266588|449089576|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
124854451|NCT02627677|449089578|FG000|Overall Study|Adverse event (not progressive disease)|1|||
124854452|NCT02627677|449089579|FG001|Overall Study|Adverse event (not progressive disease)|4|||
124854453|NCT02627677|449089580|FG002|Overall Study|Adverse event (not progressive disease)|1|||
124854454|NCT02627677|449089578|FG000|Overall Study|Progressive disease|1|||
124854455|NCT02627677|449089579|FG001|Overall Study|Progressive disease|3|||
124854456|NCT02627677|449089580|FG002|Overall Study|Progressive disease|0|||
124854457|NCT02627677|449089578|FG000|Overall Study|Lack of Efficacy|1|||
124854458|NCT02627677|449089579|FG001|Overall Study|Lack of Efficacy|2|||
124854459|NCT02627677|449089580|FG002|Overall Study|Lack of Efficacy|0|||
124854460|NCT02627677|449089578|FG000|Overall Study|Lost to Follow-up|0|||
124854461|NCT02627677|449089579|FG001|Overall Study|Lost to Follow-up|0|||
124854462|NCT02627677|449089580|FG002|Overall Study|Lost to Follow-up|1|||
124854463|NCT02627677|449089578|FG000|Overall Study|Pregnancy|0|||
124854464|NCT02627677|449089579|FG001|Overall Study|Pregnancy|1|||
124854465|NCT02627677|449089580|FG002|Overall Study|Pregnancy|0|||
124854466|NCT02627677|449089578|FG000|Overall Study|Study Terminated by Sponsor|5|||
124854467|NCT02627677|449089579|FG001|Overall Study|Study Terminated by Sponsor|10|||
124854468|NCT02627677|449089580|FG002|Overall Study|Study Terminated by Sponsor|6|||
124854469|NCT02627677|449089578|FG000|Overall Study|Physician Decision|0|||
124854470|NCT02627677|449089579|FG001|Overall Study|Physician Decision|0|||
124854471|NCT02627677|449089580|FG002|Overall Study|Physician Decision|2|||
124854472|NCT02627677|449089578|FG000|Overall Study|Withdrawal by Subject|2|||
124854473|NCT02627677|449089579|FG001|Overall Study|Withdrawal by Subject|1|||
124854474|NCT02627677|449089580|FG002|Overall Study|Withdrawal by Subject|1|||
124854475|NCT02627677|449089578|FG000|Overall Study|Reason not Specified|0|||
124854476|NCT02627677|449089579|FG001|Overall Study|Reason not Specified|0|||
124854477|NCT02627677|449089580|FG002|Overall Study|Reason not Specified|1|||
124854478|NCT02627677|449089578|FG000|Overall Study|Randomized but not Treated|1|||
124854479|NCT02627677|449089579|FG001|Overall Study|Randomized but not Treated|0|||
124854480|NCT02627677|449089580|FG002|Overall Study|Randomized but not Treated|0|||
124854481|NCT00966940|449089581|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
124854482|NCT00966940|449089582|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
124854483|NCT00966940|449089581|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
124854484|NCT00966940|449089582|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
124854485|NCT01073618|449089583|FG000|Overall Study|Death|208|||
124854486|NCT01073618|449089583|FG000|Overall Study|Adverse Event|19|||
124854487|NCT01073618|449089583|FG000|Overall Study|Other|80|||
124854488|NCT02044510|449089586|FG000|Overall Study|Adverse Event|1|||
124854489|NCT02044510|449089587|FG001|Overall Study|Adverse Event|2|||
124854490|NCT02032901|449089588|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
124854491|NCT02032901|449089589|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
124854492|NCT02032901|449089588|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
124854493|NCT02032901|449089589|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
124854494|NCT00982020|449089590|FG000|Overall Study|Adverse Event|19|||
124854495|NCT00982020|449089591|FG001|Overall Study|Adverse Event|15|||
124854496|NCT00982020|449089590|FG000|Overall Study|Withdrawal by Subject|11|||
124854497|NCT00982020|449089591|FG001|Overall Study|Withdrawal by Subject|14|||
124854498|NCT00982020|449089590|FG000|Overall Study|Lost to Follow-up|5|||
124854499|NCT00982020|449089591|FG001|Overall Study|Lost to Follow-up|11|||
124854500|NCT00982020|449089590|FG000|Overall Study|Lack of Efficacy|10|||
124854501|NCT00982020|449089591|FG001|Overall Study|Lack of Efficacy|4|||
124854502|NCT00982020|449089590|FG000|Overall Study|Parent/Caregiver Decision|5|||
124854503|NCT00982020|449089591|FG001|Overall Study|Parent/Caregiver Decision|5|||
124854504|NCT00982020|449089590|FG000|Overall Study|Treatment Non-compliance|3|||
124854505|NCT00982020|449089591|FG001|Overall Study|Treatment Non-compliance|6|||
124854506|NCT00982020|449089590|FG000|Overall Study|Physician Decision|2|||
124854507|NCT00982020|449089591|FG001|Overall Study|Physician Decision|5|||
124854508|NCT00982020|449089590|FG000|Overall Study|Entry Criteria Not Met|2|||
124854509|NCT00982020|449089591|FG001|Overall Study|Entry Criteria Not Met|1|||
124854510|NCT00982020|449089590|FG000|Overall Study|Protocol Violation|0|||
124854511|NCT00982020|449089591|FG001|Overall Study|Protocol Violation|2|||
124854512|NCT00982020|449089590|FG000|Overall Study|Clinical Relapse|0|||
124854513|NCT00982020|449089591|FG001|Overall Study|Clinical Relapse|1|||
124854514|NCT01722331|449089592|FG000|Part 1|Adverse Event|5|||
124854515|NCT01722331|449089593|FG001|Part 1|Adverse Event|0|||
124854516|NCT01722331|449089594|FG002|Part 1|Adverse Event|0|||
124854517|NCT01722331|449089595|FG003|Part 1|Adverse Event|0|||
124854518|NCT01722331|449089596|FG004|Part 1|Adverse Event|0|||
124854519|NCT01722331|449089597|FG005|Part 1|Adverse Event|0|||
124854520|NCT01722331|449089598|FG006|Part 1|Adverse Event|0|||
124854521|NCT01722331|449089592|FG000|Part 1|Lack of Efficacy|0|||
124854522|NCT01722331|449089593|FG001|Part 1|Lack of Efficacy|0|||
124854523|NCT01722331|449089594|FG002|Part 1|Lack of Efficacy|1|||
124854524|NCT01722331|449089595|FG003|Part 1|Lack of Efficacy|0|||
124854525|NCT01722331|449089596|FG004|Part 1|Lack of Efficacy|2|||
124854526|NCT01722331|449089597|FG005|Part 1|Lack of Efficacy|0|||
124854527|NCT01722331|449089598|FG006|Part 1|Lack of Efficacy|0|||
124854528|NCT01722331|449089592|FG000|Part 1|Lost to Follow-up|1|||
124854529|NCT01722331|449089593|FG001|Part 1|Lost to Follow-up|0|||
124854530|NCT01722331|449089594|FG002|Part 1|Lost to Follow-up|2|||
124854531|NCT01722331|449089595|FG003|Part 1|Lost to Follow-up|0|||
124854532|NCT01722331|449089596|FG004|Part 1|Lost to Follow-up|1|||
124854533|NCT01722331|449089597|FG005|Part 1|Lost to Follow-up|0|||
124854534|NCT01722331|449089598|FG006|Part 1|Lost to Follow-up|0|||
124854535|NCT01722331|449089592|FG000|Part 1|Physician Decision|0|||
124854536|NCT01722331|449089593|FG001|Part 1|Physician Decision|0|||
124854537|NCT01722331|449089594|FG002|Part 1|Physician Decision|3|||
124854538|NCT01722331|449089595|FG003|Part 1|Physician Decision|0|||
124854539|NCT01722331|449089596|FG004|Part 1|Physician Decision|1|||
124854540|NCT01722331|449089597|FG005|Part 1|Physician Decision|0|||
124854541|NCT01722331|449089598|FG006|Part 1|Physician Decision|0|||
124854542|NCT01722331|449089592|FG000|Part 1|Pregnancy|1|||
124854543|NCT01722331|449089593|FG001|Part 1|Pregnancy|0|||
124854544|NCT01722331|449089594|FG002|Part 1|Pregnancy|0|||
124854545|NCT01722331|449089595|FG003|Part 1|Pregnancy|0|||
124854546|NCT01722331|449089596|FG004|Part 1|Pregnancy|0|||
124854547|NCT01722331|449089597|FG005|Part 1|Pregnancy|0|||
124854548|NCT01722331|449089598|FG006|Part 1|Pregnancy|0|||
124854549|NCT01722331|449089592|FG000|Part 1|Progressive Disease|0|||
124854550|NCT01722331|449089593|FG001|Part 1|Progressive Disease|0|||
124854551|NCT01722331|449089594|FG002|Part 1|Progressive Disease|0|||
124854552|NCT01722331|449089595|FG003|Part 1|Progressive Disease|0|||
124854553|NCT01722331|449089596|FG004|Part 1|Progressive Disease|1|||
124854554|NCT01722331|449089597|FG005|Part 1|Progressive Disease|0|||
124854555|NCT01722331|449089598|FG006|Part 1|Progressive Disease|0|||
124854556|NCT01722331|449089592|FG000|Part 1|Protocol Violation|1|||
124854557|NCT01722331|449089593|FG001|Part 1|Protocol Violation|0|||
124854558|NCT01722331|449089594|FG002|Part 1|Protocol Violation|0|||
124854559|NCT01722331|449089595|FG003|Part 1|Protocol Violation|0|||
124854560|NCT01722331|449089596|FG004|Part 1|Protocol Violation|1|||
124854561|NCT01722331|449089597|FG005|Part 1|Protocol Violation|0|||
124854562|NCT01722331|449089598|FG006|Part 1|Protocol Violation|0|||
124854563|NCT01722331|449089592|FG000|Part 1|Withdrawal by Subject|2|||
124854564|NCT01722331|449089593|FG001|Part 1|Withdrawal by Subject|0|||
124854565|NCT01722331|449089594|FG002|Part 1|Withdrawal by Subject|3|||
124854566|NCT01722331|449089595|FG003|Part 1|Withdrawal by Subject|0|||
124854567|NCT01722331|449089596|FG004|Part 1|Withdrawal by Subject|3|||
124854568|NCT01722331|449089597|FG005|Part 1|Withdrawal by Subject|0|||
124854569|NCT01722331|449089598|FG006|Part 1|Withdrawal by Subject|0|||
124854570|NCT01722331|449089592|FG000|Part 2|Adverse Event|3|||
124854571|NCT01722331|449089593|FG001|Part 2|Adverse Event|0|||
124854572|NCT01722331|449089594|FG002|Part 2|Adverse Event|0|||
124854573|NCT01722331|449089595|FG003|Part 2|Adverse Event|0|||
124854574|NCT01722331|449089596|FG004|Part 2|Adverse Event|0|||
124854575|NCT01722331|449089597|FG005|Part 2|Adverse Event|1|||
124854576|NCT01722331|449089598|FG006|Part 2|Adverse Event|0|||
124854577|NCT01722331|449089592|FG000|Part 2|Lack of Efficacy|3|||
124854578|NCT01722331|449089593|FG001|Part 2|Lack of Efficacy|0|||
124854579|NCT01722331|449089594|FG002|Part 2|Lack of Efficacy|11|||
124854580|NCT01722331|449089595|FG003|Part 2|Lack of Efficacy|0|||
124854581|NCT01722331|449089596|FG004|Part 2|Lack of Efficacy|0|||
124854582|NCT01722331|449089597|FG005|Part 2|Lack of Efficacy|3|||
124854583|NCT01722331|449089598|FG006|Part 2|Lack of Efficacy|3|||
124854584|NCT01722331|449089592|FG000|Part 2|Lost to Follow-up|0|||
124854585|NCT01722331|449089593|FG001|Part 2|Lost to Follow-up|0|||
124854586|NCT01722331|449089594|FG002|Part 2|Lost to Follow-up|3|||
124854587|NCT01722331|449089595|FG003|Part 2|Lost to Follow-up|0|||
124854588|NCT01722331|449089596|FG004|Part 2|Lost to Follow-up|0|||
124854589|NCT01722331|449089597|FG005|Part 2|Lost to Follow-up|1|||
124854590|NCT01722331|449089598|FG006|Part 2|Lost to Follow-up|1|||
124854591|NCT01722331|449089592|FG000|Part 2|Non-Compliance with Study Drug|1|||
124854592|NCT01722331|449089593|FG001|Part 2|Non-Compliance with Study Drug|0|||
124854593|NCT01722331|449089594|FG002|Part 2|Non-Compliance with Study Drug|1|||
124854594|NCT01722331|449089595|FG003|Part 2|Non-Compliance with Study Drug|0|||
124854595|NCT01722331|449089596|FG004|Part 2|Non-Compliance with Study Drug|0|||
124854596|NCT01722331|449089597|FG005|Part 2|Non-Compliance with Study Drug|0|||
124854597|NCT01722331|449089598|FG006|Part 2|Non-Compliance with Study Drug|0|||
124854598|NCT01722331|449089592|FG000|Part 2|Physician Decision|0|||
124854599|NCT01722331|449089593|FG001|Part 2|Physician Decision|0|||
124854600|NCT01722331|449089594|FG002|Part 2|Physician Decision|2|||
124854601|NCT01722331|449089595|FG003|Part 2|Physician Decision|0|||
124854602|NCT01722331|449089596|FG004|Part 2|Physician Decision|0|||
124854603|NCT01722331|449089597|FG005|Part 2|Physician Decision|0|||
124854604|NCT01722331|449089598|FG006|Part 2|Physician Decision|0|||
124854605|NCT01722331|449089592|FG000|Part 2|Pregnancy|0|||
124854606|NCT01722331|449089593|FG001|Part 2|Pregnancy|0|||
124854607|NCT01722331|449089594|FG002|Part 2|Pregnancy|0|||
124854608|NCT01722331|449089595|FG003|Part 2|Pregnancy|0|||
124854609|NCT01722331|449089596|FG004|Part 2|Pregnancy|0|||
124854610|NCT01722331|449089597|FG005|Part 2|Pregnancy|1|||
124854611|NCT01722331|449089598|FG006|Part 2|Pregnancy|0|||
124854612|NCT01722331|449089592|FG000|Part 2|Progressive Disease|0|||
124854613|NCT01722331|449089593|FG001|Part 2|Progressive Disease|0|||
124854614|NCT01722331|449089594|FG002|Part 2|Progressive Disease|1|||
124854615|NCT01722331|449089595|FG003|Part 2|Progressive Disease|0|||
124854616|NCT01722331|449089596|FG004|Part 2|Progressive Disease|0|||
124854617|NCT01722331|449089597|FG005|Part 2|Progressive Disease|0|||
124854618|NCT01722331|449089598|FG006|Part 2|Progressive Disease|0|||
124854619|NCT01722331|449089592|FG000|Part 2|Protocol Violation|1|||
124854620|NCT01722331|449089593|FG001|Part 2|Protocol Violation|0|||
124854621|NCT01722331|449089594|FG002|Part 2|Protocol Violation|0|||
124854622|NCT01722331|449089595|FG003|Part 2|Protocol Violation|0|||
124854623|NCT01722331|449089596|FG004|Part 2|Protocol Violation|0|||
124854624|NCT01722331|449089597|FG005|Part 2|Protocol Violation|0|||
124854625|NCT01722331|449089598|FG006|Part 2|Protocol Violation|0|||
124854626|NCT01722331|449089592|FG000|Part 2|Withdrawal by Subject|5|||
124854627|NCT01722331|449089593|FG001|Part 2|Withdrawal by Subject|0|||
124854628|NCT01722331|449089594|FG002|Part 2|Withdrawal by Subject|3|||
124854629|NCT01722331|449089595|FG003|Part 2|Withdrawal by Subject|0|||
124854630|NCT01722331|449089596|FG004|Part 2|Withdrawal by Subject|0|||
124854631|NCT01722331|449089597|FG005|Part 2|Withdrawal by Subject|2|||
124854632|NCT01722331|449089598|FG006|Part 2|Withdrawal by Subject|2|||
124854633|NCT01722331|449089592|FG000|Part 2|Other Protocol Specified Criteria|6|||
124854634|NCT01722331|449089593|FG001|Part 2|Other Protocol Specified Criteria|0|||
124854635|NCT01722331|449089594|FG002|Part 2|Other Protocol Specified Criteria|10|||
124854636|NCT01722331|449089595|FG003|Part 2|Other Protocol Specified Criteria|0|||
124854637|NCT01722331|449089596|FG004|Part 2|Other Protocol Specified Criteria|0|||
124854638|NCT01722331|449089597|FG005|Part 2|Other Protocol Specified Criteria|2|||
124854639|NCT01722331|449089598|FG006|Part 2|Other Protocol Specified Criteria|1|||
124854640|NCT01722331|449089592|FG000|Part 3|Adverse Event|2|||
124854641|NCT01722331|449089593|FG001|Part 3|Adverse Event|2|||
124854642|NCT01722331|449089594|FG002|Part 3|Adverse Event|0|||
124854643|NCT01722331|449089595|FG003|Part 3|Adverse Event|1|||
124854644|NCT01722331|449089596|FG004|Part 3|Adverse Event|0|||
124854645|NCT01722331|449089597|FG005|Part 3|Adverse Event|0|||
124854646|NCT01722331|449089598|FG006|Part 3|Adverse Event|0|||
124854647|NCT01722331|449089592|FG000|Part 3|Death|1|||
124854648|NCT01722331|449089593|FG001|Part 3|Death|0|||
124854649|NCT01722331|449089594|FG002|Part 3|Death|0|||
124854650|NCT01722331|449089595|FG003|Part 3|Death|0|||
124854651|NCT01722331|449089596|FG004|Part 3|Death|0|||
124854652|NCT01722331|449089597|FG005|Part 3|Death|0|||
124854653|NCT01722331|449089598|FG006|Part 3|Death|0|||
124854654|NCT01722331|449089592|FG000|Part 3|Lack of Efficacy|1|||
124854655|NCT01722331|449089593|FG001|Part 3|Lack of Efficacy|0|||
124854656|NCT01722331|449089594|FG002|Part 3|Lack of Efficacy|0|||
124854657|NCT01722331|449089595|FG003|Part 3|Lack of Efficacy|0|||
124854658|NCT01722331|449089596|FG004|Part 3|Lack of Efficacy|0|||
124854659|NCT01722331|449089597|FG005|Part 3|Lack of Efficacy|0|||
124854660|NCT01722331|449089598|FG006|Part 3|Lack of Efficacy|0|||
124854661|NCT01722331|449089592|FG000|Part 3|Lost to Follow-up|3|||
124854662|NCT01722331|449089593|FG001|Part 3|Lost to Follow-up|4|||
124854663|NCT01722331|449089594|FG002|Part 3|Lost to Follow-up|0|||
124854664|NCT01722331|449089595|FG003|Part 3|Lost to Follow-up|0|||
124854665|NCT01722331|449089596|FG004|Part 3|Lost to Follow-up|0|||
124854666|NCT01722331|449089597|FG005|Part 3|Lost to Follow-up|1|||
124854667|NCT01722331|449089598|FG006|Part 3|Lost to Follow-up|0|||
124854668|NCT01722331|449089592|FG000|Part 3|Non-Compliance with Study Drug|0|||
124854669|NCT01722331|449089593|FG001|Part 3|Non-Compliance with Study Drug|1|||
124854670|NCT01722331|449089594|FG002|Part 3|Non-Compliance with Study Drug|0|||
124854671|NCT01722331|449089595|FG003|Part 3|Non-Compliance with Study Drug|0|||
124854672|NCT01722331|449089596|FG004|Part 3|Non-Compliance with Study Drug|0|||
124854673|NCT01722331|449089597|FG005|Part 3|Non-Compliance with Study Drug|0|||
124854674|NCT01722331|449089598|FG006|Part 3|Non-Compliance with Study Drug|0|||
124854675|NCT01722331|449089592|FG000|Part 3|Physician Decision|1|||
124854676|NCT01722331|449089593|FG001|Part 3|Physician Decision|1|||
124854677|NCT01722331|449089594|FG002|Part 3|Physician Decision|0|||
124854678|NCT01722331|449089595|FG003|Part 3|Physician Decision|0|||
124854679|NCT01722331|449089596|FG004|Part 3|Physician Decision|0|||
124854680|NCT01722331|449089597|FG005|Part 3|Physician Decision|0|||
124854681|NCT01722331|449089598|FG006|Part 3|Physician Decision|1|||
124854682|NCT01722331|449089592|FG000|Part 3|Protocol Violation|2|||
124854683|NCT01722331|449089593|FG001|Part 3|Protocol Violation|1|||
124854684|NCT01722331|449089594|FG002|Part 3|Protocol Violation|0|||
124854685|NCT01722331|449089595|FG003|Part 3|Protocol Violation|0|||
124854686|NCT01722331|449089596|FG004|Part 3|Protocol Violation|0|||
124854687|NCT01722331|449089597|FG005|Part 3|Protocol Violation|0|||
124854688|NCT01722331|449089598|FG006|Part 3|Protocol Violation|0|||
124854689|NCT01722331|449089592|FG000|Part 3|Withdrawal by Subject|4|||
124854690|NCT01722331|449089593|FG001|Part 3|Withdrawal by Subject|7|||
124854691|NCT01722331|449089594|FG002|Part 3|Withdrawal by Subject|0|||
124854692|NCT01722331|449089595|FG003|Part 3|Withdrawal by Subject|0|||
124854693|NCT01722331|449089596|FG004|Part 3|Withdrawal by Subject|0|||
124854694|NCT01722331|449089597|FG005|Part 3|Withdrawal by Subject|2|||
124854695|NCT01722331|449089598|FG006|Part 3|Withdrawal by Subject|1|||
124854696|NCT01722331|449089592|FG000|Part 3|Other Protocol Specified Criteria|1|||
124854697|NCT01722331|449089593|FG001|Part 3|Other Protocol Specified Criteria|1|||
124854698|NCT01722331|449089594|FG002|Part 3|Other Protocol Specified Criteria|0|||
124854699|NCT01722331|449089595|FG003|Part 3|Other Protocol Specified Criteria|0|||
124854700|NCT01722331|449089596|FG004|Part 3|Other Protocol Specified Criteria|0|||
124854701|NCT01722331|449089597|FG005|Part 3|Other Protocol Specified Criteria|0|||
124854702|NCT01722331|449089598|FG006|Part 3|Other Protocol Specified Criteria|0|||
124854703|NCT00262834|449089599|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
124854704|NCT00262834|449089600|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
124854705|NCT00003457|449089601|FG000|Overall Study|Not evaluable|9|||
124854706|NCT02246998|449089605|FG000|Overall Study|Adverse Event|0|||
124854707|NCT02246998|449089606|FG001|Overall Study|Adverse Event|1|||
124854708|NCT02246998|449089607|FG002|Overall Study|Adverse Event|1|||
124854709|NCT02246998|449089608|FG003|Overall Study|Adverse Event|0|||
124854710|NCT02246998|449089605|FG000|Overall Study|Lost to Follow-up|1|||
124854711|NCT02246998|449089606|FG001|Overall Study|Lost to Follow-up|0|||
124854712|NCT02246998|449089607|FG002|Overall Study|Lost to Follow-up|0|||
124854713|NCT02246998|449089608|FG003|Overall Study|Lost to Follow-up|1|||
124854714|NCT02246998|449089605|FG000|Overall Study|Randomized but Never Dosed|1|||
124854715|NCT02246998|449089606|FG001|Overall Study|Randomized but Never Dosed|2|||
124854716|NCT02246998|449089607|FG002|Overall Study|Randomized but Never Dosed|2|||
124854717|NCT02246998|449089608|FG003|Overall Study|Randomized but Never Dosed|1|||
124854718|NCT02525133|449089611|FG000|Overall Study|Adverse Event|0|||
124854719|NCT02525133|449089612|FG001|Overall Study|Adverse Event|1|||
124854720|NCT02525133|449089611|FG000|Overall Study|Death|0|||
124854721|NCT02525133|449089612|FG001|Overall Study|Death|1|||
124854722|NCT02525133|449089611|FG000|Overall Study|did not meet randomization criteria|1|||
124854723|NCT02525133|449089612|FG001|Overall Study|did not meet randomization criteria|0|||
124854724|NCT02525133|449089611|FG000|Overall Study|Lost to Follow-up|5|||
124854725|NCT02525133|449089612|FG001|Overall Study|Lost to Follow-up|1|||
124854726|NCT02525133|449089611|FG000|Overall Study|randomized not enrolled|3|||
124854727|NCT02525133|449089612|FG001|Overall Study|randomized not enrolled|0|||
124854728|NCT02525133|449089611|FG000|Overall Study|Withdrawal by Subject|1|||
124854729|NCT02525133|449089612|FG001|Overall Study|Withdrawal by Subject|0|||
124854730|NCT01343082|449089613|FG000|The run-in Period|Not meeting criteria|3|||
124854731|NCT01343082|449089614|FG001|The run-in Period|Not meeting criteria|4|||
124854732|NCT01343082|449089615|FG002|The run-in Period|Not meeting criteria|5|||
124854733|NCT01343082|449089613|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
124854734|NCT01343082|449089614|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
124854735|NCT01343082|449089615|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
124854736|NCT01343082|449089613|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
124854737|NCT01343082|449089614|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
124854738|NCT01343082|449089615|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
124854739|NCT01343082|449089613|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
124854740|NCT01343082|449089614|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
124854741|NCT01343082|449089615|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
124854742|NCT01343082|449089613|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
124854743|NCT01343082|449089614|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
124854744|NCT01343082|449089615|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
124854745|NCT01075074|449089616|FG000|Overall Study|Surgeon changed to open incisional case|1|||
124854746|NCT01075074|449089617|FG001|Overall Study|Surgeon changed to open incisional case|2|||
124854747|NCT01075074|449089618|FG002|Overall Study|Surgeon changed to open incisional case|2|||
124854748|NCT04265755|449089619|FG000|Overall Study|Withdrawal by Subject|39|||
124854749|NCT04265755|449089619|FG000|Overall Study|Decision by sponsor|2|||
124854750|NCT04265755|449089619|FG000|Overall Study|Lost to Follow-up|11|||
124854751|NCT04265755|449089619|FG000|Overall Study|Death|1|||
124854752|NCT01575561|449089620|FG000|Overall Study|Adverse Event|9|||
124854753|NCT01575561|449089620|FG000|Overall Study|Lack of Efficacy|8|||
124854754|NCT01575561|449089620|FG000|Overall Study|Lost to Follow-up|6|||
124854755|NCT01575561|449089620|FG000|Overall Study|Protocol Violation|4|||
124854756|NCT01575561|449089620|FG000|Overall Study|Withdrawal by Subject|11|||
124854757|NCT01575561|449089620|FG000|Overall Study|administration|1|||
124854758|NCT02496884|449089621|FG000|Overall Study|Counted twice as enrolled|2|||
124854759|NCT02496884|449089622|FG001|Overall Study|Counted twice as enrolled|0|||
124854760|NCT02496884|449089623|FG002|Overall Study|Counted twice as enrolled|0|||
124854761|NCT02496884|449089624|FG003|Overall Study|Counted twice as enrolled|0|||
124854762|NCT02496884|449089621|FG000|Overall Study|Withdrawal by Subject|0|||
124854763|NCT02496884|449089622|FG001|Overall Study|Withdrawal by Subject|3|||
124854764|NCT02496884|449089623|FG002|Overall Study|Withdrawal by Subject|0|||
124854765|NCT02496884|449089624|FG003|Overall Study|Withdrawal by Subject|0|||
124854766|NCT02956629|449089625|FG000|Overall Study|Adverse Event|0|||
124854767|NCT02956629|449089626|FG001|Overall Study|Adverse Event|0|||
124854768|NCT02956629|449089627|FG002|Overall Study|Adverse Event|1|||
124854769|NCT02956629|449089628|FG003|Overall Study|Adverse Event|0|||
124854770|NCT02956629|449089629|FG004|Overall Study|Adverse Event|0|||
124854771|NCT02956629|449089630|FG005|Overall Study|Adverse Event|0|||
124854772|NCT02956629|449089625|FG000|Overall Study|Lost to Follow-up|2|||
124854773|NCT02956629|449089626|FG001|Overall Study|Lost to Follow-up|5|||
124854774|NCT02956629|449089627|FG002|Overall Study|Lost to Follow-up|3|||
124854775|NCT02956629|449089628|FG003|Overall Study|Lost to Follow-up|1|||
124854776|NCT02956629|449089629|FG004|Overall Study|Lost to Follow-up|0|||
124854777|NCT02956629|449089630|FG005|Overall Study|Lost to Follow-up|1|||
124854778|NCT02956629|449089625|FG000|Overall Study|Withdrawal by Subject|3|||
124854779|NCT02956629|449089626|FG001|Overall Study|Withdrawal by Subject|1|||
124854780|NCT02956629|449089627|FG002|Overall Study|Withdrawal by Subject|0|||
124854781|NCT02956629|449089628|FG003|Overall Study|Withdrawal by Subject|0|||
124854782|NCT02956629|449089629|FG004|Overall Study|Withdrawal by Subject|0|||
124854783|NCT02956629|449089630|FG005|Overall Study|Withdrawal by Subject|0|||
124854784|NCT01762761|449089633|FG000|Overall Study|Adverse Event|15|||
124854785|NCT01762761|449089634|FG001|Overall Study|Adverse Event|17|||
124854786|NCT01762761|449089633|FG000|Overall Study|Lack of Efficacy|9|||
124854787|NCT01762761|449089634|FG001|Overall Study|Lack of Efficacy|25|||
124854788|NCT01762761|449089633|FG000|Overall Study|Protocol Violation|1|||
124854789|NCT01762761|449089634|FG001|Overall Study|Protocol Violation|1|||
124854790|NCT01762761|449089633|FG000|Overall Study|Study closed/terminated|0|||
124854791|NCT01762761|449089634|FG001|Overall Study|Study closed/terminated|2|||
124854792|NCT01762761|449089633|FG000|Overall Study|Lost to Follow-up|3|||
124854793|NCT01762761|449089634|FG001|Overall Study|Lost to Follow-up|6|||
124854794|NCT01762761|449089633|FG000|Overall Study|Physician Decision|4|||
124854795|NCT01762761|449089634|FG001|Overall Study|Physician Decision|6|||
124854796|NCT01762761|449089633|FG000|Overall Study|Withdrawal by Subject|7|||
124854797|NCT01762761|449089634|FG001|Overall Study|Withdrawal by Subject|8|||
124854798|NCT00795600|449089641|FG000|Overall Study|Adverse Event|1|||
124854799|NCT00795600|449089642|FG001|Overall Study|Adverse Event|1|||
124854800|NCT00795600|449089641|FG000|Overall Study|Protocol Violation|1|||
124854801|NCT00795600|449089642|FG001|Overall Study|Protocol Violation|2|||
124854802|NCT00795600|449089641|FG000|Overall Study|Withdrawal by Subject|1|||
124854803|NCT00795600|449089642|FG001|Overall Study|Withdrawal by Subject|0|||
124854804|NCT00795600|449089641|FG000|Overall Study|Unclassified|1|||
124854805|NCT00795600|449089642|FG001|Overall Study|Unclassified|1|||
124854806|NCT03936244|449089643|FG000|Overall Study|Lost to Follow-up|5|||
124854807|NCT03936244|449089644|FG001|Overall Study|Lost to Follow-up|1|||
124854808|NCT03936244|449089643|FG000|Overall Study|Physician Decision|7|||
124854809|NCT03936244|449089644|FG001|Overall Study|Physician Decision|3|||
124854810|NCT01046110|449089645|FG000|Overall Study|Adverse Event|9|||
124854811|NCT01046110|449089646|FG001|Overall Study|Adverse Event|2|||
124854812|NCT01046110|449089645|FG000|Overall Study|Lack of Efficacy|0|||
124854813|NCT01046110|449089646|FG001|Overall Study|Lack of Efficacy|1|||
124854814|NCT01046110|449089645|FG000|Overall Study|Protocol Violation|7|||
124854815|NCT01046110|449089646|FG001|Overall Study|Protocol Violation|12|||
124854816|NCT01046110|449089645|FG000|Overall Study|Withdrawal Criteria|3|||
124854817|NCT01046110|449089646|FG001|Overall Study|Withdrawal Criteria|5|||
124854818|NCT01046110|449089645|FG000|Overall Study|Unclassified|36|||
124854819|NCT01046110|449089646|FG001|Overall Study|Unclassified|35|||
124854820|NCT02013765|449089651|FG000|Overall Study|Trial was terminated by sponsor|1|||
124854821|NCT01430130|449089662|FG000|Overall Study|Lost to Follow-up|1|||
124854822|NCT01430130|449089662|FG000|Overall Study|Infection on Control Side of Incision|1|||
124854823|NCT01751568|449089664|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
124854824|NCT01751568|449089665|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
124854825|NCT01751568|449089666|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
124854826|NCT04079933|449089667|FG000|Overall Study|Withdrawal by Subject|3|||
124854827|NCT04079933|449089668|FG001|Overall Study|Withdrawal by Subject|4|||
124854828|NCT04079933|449089667|FG000|Overall Study|Lost to Follow-up|0|||
124854829|NCT04079933|449089668|FG001|Overall Study|Lost to Follow-up|1|||
124854830|NCT01229436|449089669|FG000|Overall Study|Withdrawal by Subject|2|||
124854831|NCT01229436|449089669|FG000|Overall Study|Lost to Follow-up|3|||
124854832|NCT05101252|449089670|FG000|Overall Study|Unsatisfactory Test Article|1|||
124854833|NCT05101252|449089671|FG001|Overall Study|Unsatisfactory Test Article|0|||
124854834|NCT05101252|449089670|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
124854835|NCT05101252|449089671|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
124854836|NCT05101252|449089670|FG000|Overall Study|Withdrew Consent during study|0|||
124854837|NCT05101252|449089671|FG001|Overall Study|Withdrew Consent during study|1|||
124854838|NCT05101252|449089670|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
124854839|NCT05101252|449089671|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
124854840|NCT01459796|449089672|FG000|Overall Study|Non compliance with protocol|2|||
124854841|NCT01459796|449089673|FG001|Overall Study|Non compliance with protocol|4|||
124854842|NCT01459796|449089672|FG000|Overall Study|Adverse Event|5|||
124854843|NCT01459796|449089673|FG001|Overall Study|Adverse Event|5|||
124854844|NCT01459796|449089672|FG000|Overall Study|Withdrawal by Subject|6|||
124854845|NCT01459796|449089673|FG001|Overall Study|Withdrawal by Subject|3|||
124854846|NCT01459796|449089672|FG000|Overall Study|Lost to Follow-up|5|||
124854847|NCT01459796|449089673|FG001|Overall Study|Lost to Follow-up|4|||
124854848|NCT01459796|449089672|FG000|Overall Study|Reason unspecified|1|||
124854849|NCT01459796|449089673|FG001|Overall Study|Reason unspecified|2|||
124854850|NCT01459796|449089672|FG000|Overall Study|Decision by the sponsor|75|||
124854851|NCT01459796|449089673|FG001|Overall Study|Decision by the sponsor|108|||
124854852|NCT00345579|449089677|FG000|Overall Study|Adverse Event|9|||
124854853|NCT00345579|449089678|FG001|Overall Study|Adverse Event|6|||
124854854|NCT00345579|449089677|FG000|Overall Study|Protocol Violation|14|||
124854855|NCT00345579|449089678|FG001|Overall Study|Protocol Violation|5|||
124854856|NCT00345579|449089677|FG000|Overall Study|Withdrawal by Subject|50|||
124854857|NCT00345579|449089678|FG001|Overall Study|Withdrawal by Subject|17|||
124854858|NCT00345579|449089677|FG000|Overall Study|Lost to Follow-up|82|||
124854859|NCT00345579|449089678|FG001|Overall Study|Lost to Follow-up|36|||
124854860|NCT00345579|449089677|FG000|Overall Study|Other|9|||
124854861|NCT00345579|449089678|FG001|Overall Study|Other|1|||
124854862|NCT01731171|449089679|FG000|Overall Study|Withdrawal by Subject|4|||
124854863|NCT01731171|449089680|FG001|Overall Study|Withdrawal by Subject|1|||
124854864|NCT01731171|449089679|FG000|Overall Study|Lost to Follow-up|3|||
124854865|NCT01731171|449089680|FG001|Overall Study|Lost to Follow-up|2|||
124854866|NCT01731171|449089679|FG000|Overall Study|Moved out of Area|0|||
124854867|NCT01731171|449089680|FG001|Overall Study|Moved out of Area|2|||
124854868|NCT01731171|449089679|FG000|Overall Study|Terminated for Lack of Adherence|0|||
124854869|NCT01731171|449089680|FG001|Overall Study|Terminated for Lack of Adherence|1|||
124854870|NCT01731171|449089679|FG000|Overall Study|Terminated for Safety Reasons|0|||
124854871|NCT01731171|449089680|FG001|Overall Study|Terminated for Safety Reasons|1|||
124854872|NCT00413413|449089681|FG000|Single-Blind|Adverse Event|0|||
124854873|NCT00413413|449089682|FG001|Single-Blind|Adverse Event|9|||
124854874|NCT00413413|449089683|FG002|Single-Blind|Adverse Event|0|||
124854875|NCT00413413|449089681|FG000|Single-Blind|Lack of Efficacy|0|||
124854876|NCT00413413|449089682|FG001|Single-Blind|Lack of Efficacy|5|||
124854877|NCT00413413|449089683|FG002|Single-Blind|Lack of Efficacy|0|||
124854878|NCT00413413|449089681|FG000|Single-Blind|Subject no longer requires study drug|0|||
124854879|NCT00413413|449089682|FG001|Single-Blind|Subject no longer requires study drug|151|||
124854880|NCT00413413|449089683|FG002|Single-Blind|Subject no longer requires study drug|0|||
124854881|NCT00413413|449089681|FG000|Single-Blind|Protocol Violation|0|||
124854882|NCT00413413|449089682|FG001|Single-Blind|Protocol Violation|16|||
124854883|NCT00413413|449089683|FG002|Single-Blind|Protocol Violation|0|||
124854884|NCT00413413|449089681|FG000|Single-Blind|Withdrawal by Subject|0|||
124854885|NCT00413413|449089682|FG001|Single-Blind|Withdrawal by Subject|27|||
124854886|NCT00413413|449089683|FG002|Single-Blind|Withdrawal by Subject|0|||
124854887|NCT00413413|449089681|FG000|Single-Blind|Lost to Follow-up|0|||
124854888|NCT00413413|449089682|FG001|Single-Blind|Lost to Follow-up|8|||
124854889|NCT00413413|449089683|FG002|Single-Blind|Lost to Follow-up|0|||
124854890|NCT00413413|449089681|FG000|Double-Blind|Adverse Event|6|||
124854891|NCT00413413|449089682|FG001|Double-Blind|Adverse Event|0|||
124854892|NCT00413413|449089683|FG002|Double-Blind|Adverse Event|5|||
124854893|NCT00413413|449089681|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
124854894|NCT00413413|449089682|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
124854895|NCT00413413|449089683|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
124854896|NCT00413413|449089681|FG000|Double-Blind|Protocol deviation|1|||
124854897|NCT00413413|449089682|FG001|Double-Blind|Protocol deviation|2|||
124854898|NCT00413413|449089683|FG002|Double-Blind|Protocol deviation|1|||
124854899|NCT00413413|449089681|FG000|Double-Blind|Subject withdrew consent|4|||
124854900|NCT00413413|449089682|FG001|Double-Blind|Subject withdrew consent|6|||
124854901|NCT00413413|449089683|FG002|Double-Blind|Subject withdrew consent|9|||
124854902|NCT00413413|449089681|FG000|Double-Blind|Lost to Follow-up|3|||
124854903|NCT00413413|449089682|FG001|Double-Blind|Lost to Follow-up|4|||
124854904|NCT00413413|449089683|FG002|Double-Blind|Lost to Follow-up|2|||
124854905|NCT02604589|449089690|FG000|Overall Study|catheter dislodgement|0|||
124854906|NCT02604589|449089691|FG001|Overall Study|catheter dislodgement|0|||
124854907|NCT02604589|449089692|FG002|Overall Study|catheter dislodgement|1|||
124854908|NCT01592708|449089708|FG000|Overall Study|Protocol Violation|3|||
124854909|NCT01592708|449089709|FG001|Overall Study|Protocol Violation|0|||
124854910|NCT03136068|449091789|FG000|Overall Study|Lost to Follow-up|1|||
124854911|NCT03136068|449091790|FG001|Overall Study|Lost to Follow-up|1|||
124854912|NCT03136068|449091789|FG000|Overall Study|Protocol Violation|1|||
124854913|NCT03136068|449091790|FG001|Overall Study|Protocol Violation|0|||
124854914|NCT00432380|449091796|FG000|Overall Study|Migrated/moved from study area|3|||
124854915|NCT00432380|449091797|FG001|Overall Study|Migrated/moved from study area|4|||
124854916|NCT00432380|449091798|FG002|Overall Study|Migrated/moved from study area|1|||
124854917|NCT00432380|449091796|FG000|Overall Study|Adverse Event|1|||
124854918|NCT00432380|449091797|FG001|Overall Study|Adverse Event|0|||
124854919|NCT00432380|449091798|FG002|Overall Study|Adverse Event|0|||
124854920|NCT01071395|449091806|FG000|Overall Study|Withdrawal by Subject|2|||
124854921|NCT01071395|449091807|FG001|Overall Study|Withdrawal by Subject|1|||
124854922|NCT01071395|449091806|FG000|Overall Study|Adverse Event|3|||
124854923|NCT01071395|449091807|FG001|Overall Study|Adverse Event|1|||
124854924|NCT01539291|449091808|FG000|Study GS-US-312-0116|Adverse Event|9|||
124854925|NCT01539291|449091809|FG001|Study GS-US-312-0116|Adverse Event|0|||
124854926|NCT01539291|449091810|FG002|Study GS-US-312-0116|Adverse Event|0|||
124854927|NCT01539291|449091811|FG003|Study GS-US-312-0116|Adverse Event|0|||
124854928|NCT01539291|449091808|FG000|Study GS-US-312-0116|Physician Decision|1|||
124854929|NCT01539291|449091809|FG001|Study GS-US-312-0116|Physician Decision|0|||
124854930|NCT01539291|449091810|FG002|Study GS-US-312-0116|Physician Decision|0|||
124854931|NCT01539291|449091811|FG003|Study GS-US-312-0116|Physician Decision|0|||
124854932|NCT01539291|449091808|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
124854933|NCT01539291|449091809|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
124854934|NCT01539291|449091810|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
124854935|NCT01539291|449091811|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
124854936|NCT01539291|449091808|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
124854937|NCT01539291|449091809|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
124854938|NCT01539291|449091810|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
124854939|NCT01539291|449091811|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
124854940|NCT01539291|449091808|FG000|Study GS-US-312-0116|Other|1|||
124854941|NCT01539291|449091809|FG001|Study GS-US-312-0116|Other|0|||
124854942|NCT01539291|449091810|FG002|Study GS-US-312-0116|Other|0|||
124854943|NCT01539291|449091811|FG003|Study GS-US-312-0116|Other|0|||
124854944|NCT01539291|449091808|FG000|Study GS-US-312-0117|Adverse Event|22|||
124854945|NCT01539291|449091809|FG001|Study GS-US-312-0117|Adverse Event|1|||
124854946|NCT01539291|449091810|FG002|Study GS-US-312-0117|Adverse Event|9|||
124854947|NCT01539291|449091811|FG003|Study GS-US-312-0117|Adverse Event|12|||
124854948|NCT01539291|449091808|FG000|Study GS-US-312-0117|Physician Decision|9|||
124854949|NCT01539291|449091809|FG001|Study GS-US-312-0117|Physician Decision|0|||
124854950|NCT01539291|449091810|FG002|Study GS-US-312-0117|Physician Decision|6|||
124854951|NCT01539291|449091811|FG003|Study GS-US-312-0117|Physician Decision|4|||
124854952|NCT01539291|449091808|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
124854953|NCT01539291|449091809|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
124854954|NCT01539291|449091810|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
124854955|NCT01539291|449091811|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
124854956|NCT01539291|449091808|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
124854957|NCT01539291|449091809|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
124854958|NCT01539291|449091810|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
124854959|NCT01539291|449091811|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
124854960|NCT01539291|449091808|FG000|Study GS-US-312-0117|Other|2|||
124854961|NCT01539291|449091809|FG001|Study GS-US-312-0117|Other|1|||
124854962|NCT01539291|449091810|FG002|Study GS-US-312-0117|Other|1|||
124854963|NCT01539291|449091811|FG003|Study GS-US-312-0117|Other|1|||
124854964|NCT02239510|449091812|FG000|Overall Study|Lost to Follow-up|2|||
124854965|NCT02239510|449091813|FG001|Overall Study|Lost to Follow-up|1|||
124854966|NCT00466193|449091814|FG000|Overall Study|Adverse Event|0|||
124854967|NCT00466193|449091815|FG001|Overall Study|Adverse Event|1|||
124854968|NCT00466193|449091814|FG000|Overall Study|Lost to Follow-up|2|||
124854969|NCT00466193|449091815|FG001|Overall Study|Lost to Follow-up|4|||
124854970|NCT00466193|449091814|FG000|Overall Study|Physician Decision|1|||
124854971|NCT00466193|449091815|FG001|Overall Study|Physician Decision|0|||
124854972|NCT00466193|449091814|FG000|Overall Study|Protocol Violation|1|||
124854973|NCT00466193|449091815|FG001|Overall Study|Protocol Violation|1|||
124854974|NCT00466193|449091814|FG000|Overall Study|Withdrawal by Subject|7|||
124854975|NCT00466193|449091815|FG001|Overall Study|Withdrawal by Subject|2|||
124854976|NCT00466193|449091814|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
124854977|NCT00466193|449091815|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
124854978|NCT01054729|449091816|FG000|Overall Study|Randomized but Not Treated|0|||
124854979|NCT01054729|449091817|FG001|Overall Study|Randomized but Not Treated|1|||
124854980|NCT01054729|449091818|FG002|Overall Study|Randomized but Not Treated|0|||
124854981|NCT01054729|449091819|FG003|Overall Study|Randomized but Not Treated|0|||
124854982|NCT01054729|449091816|FG000|Overall Study|Adverse Event|1|||
124854983|NCT01054729|449091817|FG001|Overall Study|Adverse Event|1|||
124854984|NCT01054729|449091818|FG002|Overall Study|Adverse Event|2|||
124854985|NCT01054729|449091819|FG003|Overall Study|Adverse Event|1|||
124854986|NCT01054729|449091816|FG000|Overall Study|Withdrawal by Subject|1|||
124854987|NCT01054729|449091817|FG001|Overall Study|Withdrawal by Subject|0|||
124854988|NCT01054729|449091818|FG002|Overall Study|Withdrawal by Subject|1|||
124854989|NCT01054729|449091819|FG003|Overall Study|Withdrawal by Subject|0|||
124854990|NCT01054729|449091816|FG000|Overall Study|Lost to Follow-up|0|||
124854991|NCT01054729|449091817|FG001|Overall Study|Lost to Follow-up|1|||
124854992|NCT01054729|449091818|FG002|Overall Study|Lost to Follow-up|0|||
124854993|NCT01054729|449091819|FG003|Overall Study|Lost to Follow-up|0|||
124854994|NCT01054729|449091816|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
124854995|NCT01054729|449091817|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
124854996|NCT01054729|449091818|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
124854997|NCT01054729|449091819|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
124854998|NCT01054729|449091816|FG000|Overall Study|Non-responder|1|||
124854999|NCT01054729|449091817|FG001|Overall Study|Non-responder|0|||
124855000|NCT01054729|449091818|FG002|Overall Study|Non-responder|1|||
124855001|NCT01054729|449091819|FG003|Overall Study|Non-responder|1|||
124855002|NCT01054729|449091816|FG000|Overall Study|PEG/RBV Non-responder|1|||
124855003|NCT01054729|449091817|FG001|Overall Study|PEG/RBV Non-responder|0|||
124855004|NCT01054729|449091818|FG002|Overall Study|PEG/RBV Non-responder|1|||
124855005|NCT01054729|449091819|FG003|Overall Study|PEG/RBV Non-responder|0|||
124855006|NCT01054729|449091816|FG000|Overall Study|Personal/Obligations|0|||
124855007|NCT01054729|449091817|FG001|Overall Study|Personal/Obligations|1|||
124855008|NCT01054729|449091818|FG002|Overall Study|Personal/Obligations|0|||
124855009|NCT01054729|449091819|FG003|Overall Study|Personal/Obligations|0|||
124855010|NCT01054729|449091816|FG000|Overall Study|Subject moved|0|||
124855011|NCT01054729|449091817|FG001|Overall Study|Subject moved|0|||
124855012|NCT01054729|449091818|FG002|Overall Study|Subject moved|1|||
124855013|NCT01054729|449091819|FG003|Overall Study|Subject moved|0|||
124855014|NCT01054729|449091816|FG000|Overall Study|Lack of Efficacy|0|||
124855015|NCT01054729|449091817|FG001|Overall Study|Lack of Efficacy|0|||
124855016|NCT01054729|449091818|FG002|Overall Study|Lack of Efficacy|0|||
124855017|NCT01054729|449091819|FG003|Overall Study|Lack of Efficacy|1|||
124855018|NCT01375049|449091820|FG000|Overall Study|Adverse Event|2|||
124855019|NCT01375049|449091820|FG000|Overall Study|Lost to Follow-up|1|||
124855020|NCT01375049|449091820|FG000|Overall Study|Withdrawal by Subject|2|||
124855021|NCT01375049|449091820|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
124855022|NCT01175382|449091823|FG000|Overall Study|Lost to Follow-up|4|||
124855023|NCT01175382|449091824|FG001|Overall Study|Lost to Follow-up|3|||
124855024|NCT01175382|449091825|FG002|Overall Study|Lost to Follow-up|1|||
124855025|NCT01175382|449091823|FG000|Overall Study|Physician Decision|0|||
124855026|NCT01175382|449091824|FG001|Overall Study|Physician Decision|1|||
124855027|NCT01175382|449091825|FG002|Overall Study|Physician Decision|0|||
124855028|NCT01175382|449091823|FG000|Overall Study|Withdrawal by Subject|0|||
124855029|NCT01175382|449091824|FG001|Overall Study|Withdrawal by Subject|0|||
124855030|NCT01175382|449091825|FG002|Overall Study|Withdrawal by Subject|1|||
124855031|NCT01175382|449091823|FG000|Overall Study|No longer having problem|1|||
124855032|NCT01175382|449091824|FG001|Overall Study|No longer having problem|0|||
124855033|NCT01175382|449091825|FG002|Overall Study|No longer having problem|1|||
124855034|NCT01175382|449091823|FG000|Overall Study|Unable/unwilling to attend visits|3|||
124855035|NCT01175382|449091824|FG001|Overall Study|Unable/unwilling to attend visits|1|||
124855036|NCT01175382|449091825|FG002|Overall Study|Unable/unwilling to attend visits|2|||
124855037|NCT01175382|449091823|FG000|Overall Study|Unwilling to follow protocol|0|||
124855038|NCT01175382|449091824|FG001|Overall Study|Unwilling to follow protocol|1|||
124855039|NCT01175382|449091825|FG002|Overall Study|Unwilling to follow protocol|0|||
124855040|NCT01175382|449091823|FG000|Overall Study|Unable to tolerate study meds|0|||
124855041|NCT01175382|449091824|FG001|Overall Study|Unable to tolerate study meds|1|||
124855042|NCT01175382|449091825|FG002|Overall Study|Unable to tolerate study meds|1|||
124855043|NCT00774787|449091826|FG000|Overall Study|Lost to Follow-up|1|||
124855044|NCT02554773|449091827|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
124855045|NCT02554773|449091828|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
124855046|NCT02554773|449091827|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
124855047|NCT02554773|449091828|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
124855048|NCT02554773|449091827|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
124855049|NCT02554773|449091828|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
124855050|NCT02554773|449091827|FG000|Original Dose Regimen (SAS 1)|Death|1|||
124855051|NCT02554773|449091828|FG001|Original Dose Regimen (SAS 1)|Death|0|||
124855052|NCT02554773|449091827|FG000|Original Dose Regimen (SAS 1)|Other|4|||
124855053|NCT02554773|449091828|FG001|Original Dose Regimen (SAS 1)|Other|0|||
124855054|NCT02554773|449091827|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
124855055|NCT02554773|449091828|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
124855056|NCT02554773|449091827|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
124855057|NCT02554773|449091828|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
124855058|NCT02554773|449091827|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
124855059|NCT02554773|449091828|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
124855060|NCT02554773|449091827|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
124855061|NCT02554773|449091828|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
124855062|NCT02031276|449091831|FG000|Period 1 Double-blind IV|Adverse Event|6|||
124855063|NCT02031276|449091832|FG001|Period 1 Double-blind IV|Adverse Event|5|||
124855064|NCT02031276|449091833|FG002|Period 1 Double-blind IV|Adverse Event|1|||
124855065|NCT02031276|449091831|FG000|Period 1 Double-blind IV|Other|0|||
124855066|NCT02031276|449091832|FG001|Period 1 Double-blind IV|Other|1|||
124855067|NCT02031276|449091833|FG002|Period 1 Double-blind IV|Other|0|||
124855068|NCT02031276|449091831|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
124855069|NCT02031276|449091832|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
124855070|NCT02031276|449091833|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
124855071|NCT02031276|449091831|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
124855072|NCT02031276|449091832|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
124855073|NCT02031276|449091833|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
124855074|NCT02031276|449091831|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
124855075|NCT02031276|449091832|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
124855076|NCT02031276|449091833|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
124855077|NCT02031276|449091831|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
124855078|NCT02031276|449091832|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
124855079|NCT02031276|449091833|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
124855080|NCT02031276|449091831|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
124855081|NCT02031276|449091832|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
124855082|NCT02031276|449091833|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
124855083|NCT02031276|449091831|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
124855084|NCT02031276|449091832|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
124855085|NCT02031276|449091833|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
124855086|NCT02031276|449091831|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
124855087|NCT02031276|449091832|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
124855088|NCT02031276|449091833|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
124855089|NCT01148810|449091834|FG000|Overall Study|Adverse Event|0|||
124855090|NCT01148810|449091835|FG001|Overall Study|Adverse Event|2|||
124855091|NCT01148810|449091834|FG000|Overall Study|Lack of Efficacy|0|||
124855092|NCT01148810|449091835|FG001|Overall Study|Lack of Efficacy|1|||
124855093|NCT01148810|449091834|FG000|Overall Study|Withdrawal by Subject|0|||
124855094|NCT01148810|449091835|FG001|Overall Study|Withdrawal by Subject|2|||
124855095|NCT01148810|449091834|FG000|Overall Study|Protocol Violation|1|||
124855096|NCT01148810|449091835|FG001|Overall Study|Protocol Violation|0|||
124855097|NCT01854554|449091836|FG000|Overall Study|Denial of Insurance Coverage|12|||
124855098|NCT01854554|449091837|FG001|Overall Study|Denial of Insurance Coverage|0|||
124855099|NCT01854554|449091836|FG000|Overall Study|Decided to get treatment locally|1|||
124855100|NCT01854554|449091837|FG001|Overall Study|Decided to get treatment locally|5|||
124855101|NCT01854554|449091836|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
124855102|NCT01854554|449091837|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
124855103|NCT01854554|449091836|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
124855104|NCT01854554|449091837|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
124855105|NCT01854554|449091836|FG000|Overall Study|Progression|0|||
124855106|NCT01854554|449091837|FG001|Overall Study|Progression|1|||
124855107|NCT01854554|449091836|FG000|Overall Study|Lost to Follow-up|0|||
124855108|NCT01854554|449091837|FG001|Overall Study|Lost to Follow-up|1|||
124855109|NCT02613481|449091842|FG000|Overall Study|Lost to Follow-up|7|||
124855110|NCT02613481|449091842|FG000|Overall Study|Withdrawal by Subject|2|||
124855111|NCT01033747|449091843|FG000|Overall Study|Adverse Event|9|||
124855112|NCT01033747|449091844|FG001|Overall Study|Adverse Event|4|||
124855113|NCT01033747|449091843|FG000|Overall Study|Abnormal Laboratory Value|1|||
124855114|NCT01033747|449091844|FG001|Overall Study|Abnormal Laboratory Value|0|||
124855115|NCT01033747|449091843|FG000|Overall Study|Abnormal test procedure|0|||
124855116|NCT01033747|449091844|FG001|Overall Study|Abnormal test procedure|1|||
124855117|NCT01033747|449091843|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
124855118|NCT01033747|449091844|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
124855119|NCT01033747|449091843|FG000|Overall Study|Protocol Violation|1|||
124855120|NCT01033747|449091844|FG001|Overall Study|Protocol Violation|0|||
124855121|NCT01033747|449091843|FG000|Overall Study|Withdrawal by Subject|9|||
124855122|NCT01033747|449091844|FG001|Overall Study|Withdrawal by Subject|6|||
124855123|NCT01033747|449091843|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
124855124|NCT01033747|449091844|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
124855125|NCT01033747|449091843|FG000|Overall Study|Stopped at end of Extension 1|2|||
124855126|NCT01033747|449091844|FG001|Overall Study|Stopped at end of Extension 1|0|||
124855127|NCT00844194|449091845|FG000|Overall Study|Adverse Event|17|||
124855128|NCT00844194|449091846|FG001|Overall Study|Adverse Event|5|||
124855129|NCT00844194|449091845|FG000|Overall Study|Protocol Violation|1|||
124855130|NCT00844194|449091846|FG001|Overall Study|Protocol Violation|1|||
124855131|NCT00844194|449091845|FG000|Overall Study|Lost to Follow-up|1|||
124855132|NCT00844194|449091846|FG001|Overall Study|Lost to Follow-up|1|||
124855133|NCT00844194|449091845|FG000|Overall Study|Withdrawal by Subject|2|||
124855134|NCT00844194|449091846|FG001|Overall Study|Withdrawal by Subject|1|||
124855135|NCT00844194|449091845|FG000|Overall Study|Lack of Efficacy|3|||
124855136|NCT00844194|449091846|FG001|Overall Study|Lack of Efficacy|0|||
124855137|NCT00844194|449091845|FG000|Overall Study|Other reason (not specified)|1|||
124855138|NCT00844194|449091846|FG001|Overall Study|Other reason (not specified)|0|||
124855139|NCT02647658|449091847|FG000|Overall Study|Consent refusal|15|||
124855140|NCT02647658|449091848|FG001|Overall Study|Consent refusal|24|||
124855141|NCT00803023|449091849|FG000|Overall Study|Adverse Event|5|||
124855142|NCT00803023|449091850|FG001|Overall Study|Adverse Event|4|||
124855143|NCT00803023|449091851|FG002|Overall Study|Adverse Event|8|||
124855144|NCT00803023|449091852|FG003|Overall Study|Adverse Event|6|||
124855145|NCT00803023|449091849|FG000|Overall Study|Withdrawal by Subject|0|||
124855146|NCT00803023|449091850|FG001|Overall Study|Withdrawal by Subject|2|||
124855147|NCT00803023|449091851|FG002|Overall Study|Withdrawal by Subject|0|||
124855148|NCT00803023|449091852|FG003|Overall Study|Withdrawal by Subject|0|||
124855149|NCT00803023|449091849|FG000|Overall Study|Lost to Follow-up|0|||
124855150|NCT00803023|449091850|FG001|Overall Study|Lost to Follow-up|1|||
124855151|NCT00803023|449091851|FG002|Overall Study|Lost to Follow-up|2|||
124855152|NCT00803023|449091852|FG003|Overall Study|Lost to Follow-up|1|||
124855153|NCT00803023|449091849|FG000|Overall Study|Lack of Efficacy|0|||
124855154|NCT00803023|449091850|FG001|Overall Study|Lack of Efficacy|1|||
124855155|NCT00803023|449091851|FG002|Overall Study|Lack of Efficacy|1|||
124855156|NCT00803023|449091852|FG003|Overall Study|Lack of Efficacy|1|||
124855157|NCT01542528|449091857|FG000|Overall Study|Lost to Follow-up|2|||
124855158|NCT01542528|449091858|FG001|Overall Study|Lost to Follow-up|1|||
124855159|NCT01542528|449091857|FG000|Overall Study|Physician Decision|1|||
124855160|NCT01542528|449091858|FG001|Overall Study|Physician Decision|0|||
124855161|NCT01542528|449091857|FG000|Overall Study|Withdrawal by Subject|9|||
124855162|NCT01542528|449091858|FG001|Overall Study|Withdrawal by Subject|6|||
124855163|NCT01931839|449091861|FG000|Overall Study|Death|0|||
124855164|NCT01931839|449091862|FG001|Overall Study|Death|1|||
124855165|NCT01931839|449091863|FG002|Overall Study|Death|2|||
124855166|NCT01931839|449091864|FG003|Overall Study|Death|0|||
124855167|NCT01931839|449091865|FG004|Overall Study|Death|0|||
124855168|NCT01931839|449091866|FG005|Overall Study|Death|0|||
124855169|NCT01931839|449091867|FG006|Overall Study|Death|0|||
124855170|NCT01931839|449091861|FG000|Overall Study|Physician Decision|1|||
124855171|NCT01931839|449091862|FG001|Overall Study|Physician Decision|0|||
124855172|NCT01931839|449091863|FG002|Overall Study|Physician Decision|1|||
124855173|NCT01931839|449091864|FG003|Overall Study|Physician Decision|0|||
124855174|NCT01931839|449091865|FG004|Overall Study|Physician Decision|0|||
124855175|NCT01931839|449091866|FG005|Overall Study|Physician Decision|0|||
124855176|NCT01931839|449091867|FG006|Overall Study|Physician Decision|1|||
124855177|NCT01931839|449091861|FG000|Overall Study|Withdrawal of consent|0|||
124855178|NCT01931839|449091862|FG001|Overall Study|Withdrawal of consent|0|||
124855179|NCT01931839|449091863|FG002|Overall Study|Withdrawal of consent|0|||
124855180|NCT01931839|449091864|FG003|Overall Study|Withdrawal of consent|0|||
124855181|NCT01931839|449091865|FG004|Overall Study|Withdrawal of consent|1|||
124855182|NCT01931839|449091866|FG005|Overall Study|Withdrawal of consent|0|||
124855183|NCT01931839|449091867|FG006|Overall Study|Withdrawal of consent|0|||
124855184|NCT01931839|449091861|FG000|Overall Study|Adverse Event|9|||
124855185|NCT01931839|449091862|FG001|Overall Study|Adverse Event|4|||
124855186|NCT01931839|449091863|FG002|Overall Study|Adverse Event|1|||
124855187|NCT01931839|449091864|FG003|Overall Study|Adverse Event|3|||
124855188|NCT01931839|449091865|FG004|Overall Study|Adverse Event|0|||
124855189|NCT01931839|449091866|FG005|Overall Study|Adverse Event|0|||
124855190|NCT01931839|449091867|FG006|Overall Study|Adverse Event|1|||
124855191|NCT01931839|449091861|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
124855192|NCT01931839|449091862|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
124855193|NCT01931839|449091863|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
124855194|NCT01931839|449091864|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
124855195|NCT01931839|449091865|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
124855196|NCT01931839|449091866|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
124855197|NCT01931839|449091867|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
124855198|NCT01931839|449091861|FG000|Overall Study|Other non-compliance|15|||
124855199|NCT01931839|449091862|FG001|Overall Study|Other non-compliance|9|||
124855200|NCT01931839|449091863|FG002|Overall Study|Other non-compliance|12|||
124855201|NCT01931839|449091864|FG003|Overall Study|Other non-compliance|3|||
124855202|NCT01931839|449091865|FG004|Overall Study|Other non-compliance|0|||
124855203|NCT01931839|449091866|FG005|Overall Study|Other non-compliance|3|||
124855204|NCT01931839|449091867|FG006|Overall Study|Other non-compliance|0|||
124855205|NCT01931839|449091861|FG000|Overall Study|Lost to Follow-up|1|||
124855206|NCT01931839|449091862|FG001|Overall Study|Lost to Follow-up|2|||
124855207|NCT01931839|449091863|FG002|Overall Study|Lost to Follow-up|4|||
124855208|NCT01931839|449091864|FG003|Overall Study|Lost to Follow-up|5|||
124855209|NCT01931839|449091865|FG004|Overall Study|Lost to Follow-up|0|||
124855210|NCT01931839|449091866|FG005|Overall Study|Lost to Follow-up|0|||
124855211|NCT01931839|449091867|FG006|Overall Study|Lost to Follow-up|0|||
124855212|NCT01931839|449091861|FG000|Overall Study|Other|4|||
124855213|NCT01931839|449091862|FG001|Overall Study|Other|2|||
124855214|NCT01931839|449091863|FG002|Overall Study|Other|6|||
124855215|NCT01931839|449091864|FG003|Overall Study|Other|0|||
124855216|NCT01931839|449091865|FG004|Overall Study|Other|0|||
124855217|NCT01931839|449091866|FG005|Overall Study|Other|0|||
124855218|NCT01931839|449091867|FG006|Overall Study|Other|0|||
124855219|NCT01992536|449091869|FG000|Overall Study|Administrative Reason|0|||
124855220|NCT01992536|449091870|FG001|Overall Study|Administrative Reason|0|||
124855221|NCT01992536|449091871|FG002|Overall Study|Administrative Reason|0|||
124855222|NCT01992536|449091872|FG003|Overall Study|Administrative Reason|0|||
124855223|NCT01992536|449091873|FG004|Overall Study|Administrative Reason|0|||
124855224|NCT01992536|449091874|FG005|Overall Study|Administrative Reason|0|||
124855225|NCT01992536|449091875|FG006|Overall Study|Administrative Reason|7|||
124855226|NCT01992536|449091876|FG007|Overall Study|Administrative Reason|0|||
124855227|NCT01992536|449091877|FG008|Overall Study|Administrative Reason|0|||
124855228|NCT01992536|449091878|FG009|Overall Study|Administrative Reason|0|||
124855229|NCT01992536|449091869|FG000|Overall Study|Lost to Follow-up|4|||
124855230|NCT01992536|449091870|FG001|Overall Study|Lost to Follow-up|2|||
124855231|NCT01992536|449091871|FG002|Overall Study|Lost to Follow-up|1|||
124855232|NCT01992536|449091872|FG003|Overall Study|Lost to Follow-up|0|||
124855233|NCT01992536|449091873|FG004|Overall Study|Lost to Follow-up|0|||
124855234|NCT01992536|449091874|FG005|Overall Study|Lost to Follow-up|1|||
124855235|NCT01992536|449091875|FG006|Overall Study|Lost to Follow-up|0|||
124855236|NCT01992536|449091876|FG007|Overall Study|Lost to Follow-up|0|||
124855237|NCT01992536|449091877|FG008|Overall Study|Lost to Follow-up|1|||
124855238|NCT01992536|449091878|FG009|Overall Study|Lost to Follow-up|1|||
124855239|NCT01992536|449091869|FG000|Overall Study|Withdrawal by Subject|0|||
124855240|NCT01992536|449091870|FG001|Overall Study|Withdrawal by Subject|1|||
124855241|NCT01992536|449091871|FG002|Overall Study|Withdrawal by Subject|0|||
124855242|NCT01992536|449091872|FG003|Overall Study|Withdrawal by Subject|2|||
124855243|NCT01992536|449091873|FG004|Overall Study|Withdrawal by Subject|0|||
124855244|NCT01992536|449091874|FG005|Overall Study|Withdrawal by Subject|0|||
124855245|NCT01992536|449091875|FG006|Overall Study|Withdrawal by Subject|0|||
124855246|NCT01992536|449091876|FG007|Overall Study|Withdrawal by Subject|0|||
124855247|NCT01992536|449091877|FG008|Overall Study|Withdrawal by Subject|0|||
124855248|NCT01992536|449091878|FG009|Overall Study|Withdrawal by Subject|0|||
124855249|NCT01709227|449091882|FG000|Overall Study|Physician Decision|1|||
124855250|NCT01709227|449091883|FG001|Overall Study|Physician Decision|0|||
124855251|NCT01709227|449091882|FG000|Overall Study|Pleural Peritoneal communication|0|||
124855252|NCT01709227|449091883|FG001|Overall Study|Pleural Peritoneal communication|9|||
124855253|NCT03669081|449091884|FG000|Overall Study|Data could not be validated|1|||
124855254|NCT03669081|449091885|FG001|Overall Study|Data could not be validated|1|||
124855255|NCT00389324|449091887|FG000|Run-In Phase|Adverse Event|1|||
124855256|NCT00389324|449091887|FG000|Run-In Phase|Lost to Follow-up|1|||
124855257|NCT00389324|449091887|FG000|Run-In Phase|Withdrawal by Subject|1|||
124855258|NCT00389324|449091887|FG000|Subcutaneous Phase|Adverse Event|2|||
124855259|NCT00389324|449091887|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
124855260|NCT00389324|449091887|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
124855261|NCT00389324|449091887|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
124855262|NCT02317575|449091888|FG000|Period 1|Difficulty with venous cannulation|0|||
124855263|NCT02317575|449091889|FG001|Period 1|Difficulty with venous cannulation|1|||
124855264|NCT02317575|449091890|FG002|Period 1|Difficulty with venous cannulation|0|||
124855265|NCT02317575|449091891|FG003|Period 1|Difficulty with venous cannulation|0|||
124855266|NCT02317575|449091892|FG004|Period 1|Difficulty with venous cannulation|0|||
124855267|NCT02317575|449091888|FG000|Period 1|Withdrawal by Subject|1|||
124855268|NCT02317575|449091889|FG001|Period 1|Withdrawal by Subject|0|||
124855269|NCT02317575|449091890|FG002|Period 1|Withdrawal by Subject|0|||
124855270|NCT02317575|449091891|FG003|Period 1|Withdrawal by Subject|0|||
124855271|NCT02317575|449091892|FG004|Period 1|Withdrawal by Subject|0|||
124855272|NCT01921348|449091893|FG000|Overall Study|Withdrawal by Subject|1|||
124855273|NCT01921348|449091894|FG001|Overall Study|Withdrawal by Subject|0|||
124855274|NCT01921348|449091893|FG000|Overall Study|Lost to Follow-up|0|||
124855275|NCT01921348|449091894|FG001|Overall Study|Lost to Follow-up|2|||
124855276|NCT04788147|449091901|FG000|Overall Study|Screen Failure|3|||
124855277|NCT04788147|449091902|FG001|Overall Study|Screen Failure|10|||
124855278|NCT04788147|449091901|FG000|Overall Study|Incomplete RMRS image session|2|||
124855279|NCT04788147|449091902|FG001|Overall Study|Incomplete RMRS image session|0|||
124855280|NCT00781326|449091903|FG000|Phase I|Adverse Event|1|||
124855281|NCT00781326|449091903|FG000|Phase I|Withdrawal by Subject|1|||
124855282|NCT00781326|449091903|FG000|Phase I|Physician Decision|2|||
124855283|NCT02266381|449091904|FG000|Overall Study|Physician Decision|3|||
124855284|NCT02266381|449091905|FG001|Overall Study|Physician Decision|5|||
124855285|NCT02266381|449091906|FG002|Overall Study|Physician Decision|4|||
124855286|NCT02401672|449091907|FG000|Overall Study|Withdrawal by Subject|1|||
124855287|NCT02401672|449091908|FG001|Overall Study|Withdrawal by Subject|3|||
124855288|NCT00701051|449091909|FG000|Screening|Failed Screening|40|||
124855289|NCT00701051|449091910|FG001|Screening|Failed Screening|0|||
124855290|NCT00701051|449091911|FG002|Screening|Failed Screening|0|||
124855291|NCT00701051|449091909|FG000|Screening|Time conflicts|19|||
124855292|NCT00701051|449091910|FG001|Screening|Time conflicts|0|||
124855293|NCT00701051|449091911|FG002|Screening|Time conflicts|0|||
124855294|NCT00701051|449091909|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
124855295|NCT00701051|449091910|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
124855296|NCT00701051|449091911|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
124855297|NCT03207750|449091922|FG000|Overall Study|Adverse Event|3|||
124855298|NCT03207750|449091923|FG001|Overall Study|Adverse Event|2|||
124855299|NCT03207750|449091922|FG000|Overall Study|Lost to Follow-up|21|||
124855300|NCT03207750|449091923|FG001|Overall Study|Lost to Follow-up|29|||
124855301|NCT03207750|449091922|FG000|Overall Study|Protocol Violation|0|||
124855302|NCT03207750|449091923|FG001|Overall Study|Protocol Violation|1|||
124855303|NCT03207750|449091922|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
124855304|NCT03207750|449091923|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
124855305|NCT03207750|449091922|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
124855306|NCT03207750|449091923|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
124855307|NCT03207750|449091922|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
124855308|NCT03207750|449091923|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
124855309|NCT03207750|449091922|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
124855310|NCT03207750|449091923|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
124855311|NCT03207750|449091922|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
124855312|NCT03207750|449091923|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
124855313|NCT00793910|449091924|FG000|Overall Study|discarded study pills|0|||
124855314|NCT00793910|449091925|FG001|Overall Study|discarded study pills|1|||
124855315|NCT00793910|449091924|FG000|Overall Study|did not pick up medications|1|||
124855316|NCT00793910|449091925|FG001|Overall Study|did not pick up medications|1|||
124855317|NCT00793910|449091924|FG000|Overall Study|ineligible based on entry criteria|2|||
124855318|NCT00793910|449091925|FG001|Overall Study|ineligible based on entry criteria|3|||
124855319|NCT00793910|449091924|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
124855320|NCT00793910|449091925|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
124855321|NCT00793910|449091924|FG000|Overall Study|Withdrawal by Subject|0|||
124855322|NCT00793910|449091925|FG001|Overall Study|Withdrawal by Subject|1|||
124855323|NCT01700946|449091926|FG000|Overall Study|Lost to Follow-up|1|||
124855324|NCT01700946|449091927|FG001|Overall Study|Lost to Follow-up|0|||
124855325|NCT01700946|449091926|FG000|Overall Study|Physician Decision|7|||
124855326|NCT01700946|449091927|FG001|Overall Study|Physician Decision|12|||
124855327|NCT01700946|449091926|FG000|Overall Study|Withdrawal by Subject|0|||
124855328|NCT01700946|449091927|FG001|Overall Study|Withdrawal by Subject|2|||
124855329|NCT01700946|449091926|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
124855330|NCT01700946|449091927|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
124855331|NCT01700946|449091926|FG000|Overall Study|Relapse|2|||
124855332|NCT01700946|449091927|FG001|Overall Study|Relapse|1|||
124855333|NCT01700946|449091926|FG000|Overall Study|Unacceptable toxicity|1|||
124855334|NCT01700946|449091927|FG001|Overall Study|Unacceptable toxicity|0|||
124855335|NCT03634579|449091930|FG000|Overall Study|study termination|9|||
124855336|NCT04111497|449091931|FG000|Overall Study|relapse of primary disease|1|||
124855337|NCT04111497|449091931|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
124855338|NCT03321019|449091932|FG000|Overall Study|Withdrawal by Subject|0|||
124855339|NCT03321019|449091933|FG001|Overall Study|Withdrawal by Subject|6|||
124855340|NCT03321019|449091932|FG000|Overall Study|Lost to Follow-up|0|||
124855341|NCT03321019|449091933|FG001|Overall Study|Lost to Follow-up|22|||
124855342|NCT03433456|449091937|FG000|Overall Study|Death|1|||
124855343|NCT03433456|449091938|FG001|Overall Study|Death|1|||
124855344|NCT03433456|449091937|FG000|Overall Study|Lost to Follow-up|14|||
124855345|NCT03433456|449091938|FG001|Overall Study|Lost to Follow-up|11|||
124855346|NCT03433456|449091937|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
124855347|NCT03433456|449091938|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
124855348|NCT03694548|449091939|FG000|Part A Survey|Protocol Violation|3|||
124855349|NCT03694548|449091940|FG001|Part A Survey|Protocol Violation|3|||
124855350|NCT03694548|449091941|FG002|Part A Survey|Protocol Violation|0|||
124855351|NCT03694548|449091939|FG000|Part B Yoga Program|Protocol Violation|0|||
124855352|NCT03694548|449091940|FG001|Part B Yoga Program|Protocol Violation|0|||
124855353|NCT03694548|449091941|FG002|Part B Yoga Program|Protocol Violation|3|||
124855354|NCT03694548|449091939|FG000|Part B Yoga Program|Did not attend intervention|0|||
124855355|NCT03694548|449091940|FG001|Part B Yoga Program|Did not attend intervention|0|||
124855356|NCT03694548|449091941|FG002|Part B Yoga Program|Did not attend intervention|8|||
124855357|NCT04496258|449091942|FG000|Overall Study|Withdrawal by Subject|2|||
124855358|NCT04496258|449091943|FG001|Overall Study|Withdrawal by Subject|1|||
124855359|NCT04102501|449091944|FG000|Overall Study|Withdrawal by Subject|7|||
124855360|NCT04102501|449091945|FG001|Overall Study|Withdrawal by Subject|9|||
124855361|NCT04102501|449091944|FG000|Overall Study|Adverse Event|1|||
124855362|NCT04102501|449091945|FG001|Overall Study|Adverse Event|3|||
124855363|NCT01427712|449091946|FG000|Overall Study|Transfer to a different hospital|2|||
124855364|NCT01427712|449091946|FG000|Overall Study|Lost to Follow-up|1|||
124855365|NCT01427712|449091946|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
124855366|NCT01427712|449091946|FG000|Overall Study|Failure to visit|1|||
124855367|NCT00968617|449091948|FG000|Overall Study|Study terminated by sponsor|6|||
124855368|NCT01024387|449091954|FG000|Overall Study|Radiographic Progression|29|||
124855369|NCT01024387|449091954|FG000|Overall Study|Symptomatic Progression|10|||
124855370|NCT01024387|449091954|FG000|Overall Study|Physician Decision|5|||
124855371|NCT01024387|449091954|FG000|Overall Study|Withdrawal by Subject|5|||
124855372|NCT01024387|449091954|FG000|Overall Study|Death|2|||
124855373|NCT01024387|449091954|FG000|Overall Study|Prolonged Treatment Delay|1|||
124855374|NCT01024387|449091954|FG000|Overall Study|Adverse Event|3|||
124855375|NCT01024387|449091954|FG000|Overall Study|Other|5|||
124855376|NCT03864900|449091955|FG000|Overall Study|Withdrawal by Subject|1|||
124855377|NCT03864900|449091956|FG001|Overall Study|Withdrawal by Subject|1|||
124855378|NCT03864900|449091955|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
124855379|NCT03864900|449091956|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
124855380|NCT03191903|449091957|FG000|Overall Study|Withdrawal by Subject|6|||
124855381|NCT03191903|449091958|FG001|Overall Study|Withdrawal by Subject|5|||
124855382|NCT03191903|449091959|FG002|Overall Study|Withdrawal by Subject|4|||
124855383|NCT03191903|449091957|FG000|Overall Study|Adverse Event|1|||
124855384|NCT03191903|449091958|FG001|Overall Study|Adverse Event|0|||
124855385|NCT03191903|449091959|FG002|Overall Study|Adverse Event|0|||
124855386|NCT01578551|449091962|FG000|Overall Study|Adverse Event|1|||
124855387|NCT01578551|449091963|FG001|Overall Study|Adverse Event|0|||
124855388|NCT04369469|449091970|FG000|Overall Study|Lost to Follow-up|2|||
124855389|NCT04369469|449091971|FG001|Overall Study|Lost to Follow-up|4|||
124855390|NCT04369469|449091970|FG000|Overall Study|Physician Decision|2|||
124855391|NCT04369469|449091971|FG001|Overall Study|Physician Decision|1|||
124855392|NCT04369469|449091970|FG000|Overall Study|Withdrawal by Subject|2|||
124855393|NCT04369469|449091971|FG001|Overall Study|Withdrawal by Subject|3|||
124855394|NCT04369469|449091970|FG000|Overall Study|Adverse Event|1|||
124855395|NCT04369469|449091971|FG001|Overall Study|Adverse Event|0|||
124855396|NCT04369469|449091970|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
124855397|NCT04369469|449091971|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
124855398|NCT04369469|449091970|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
124855399|NCT04369469|449091971|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
124855400|NCT04369469|449091970|FG000|Overall Study|Unable to Provide Consent|0|||
124855401|NCT04369469|449091971|FG001|Overall Study|Unable to Provide Consent|1|||
124855402|NCT01344460|449091974|FG000|Overall Study|Withdrawal by Subject|1|||
124855403|NCT01344460|449091974|FG000|Overall Study|Lost to Follow-up|2|||
124855404|NCT03283670|449091975|FG000|Placebo Gas|Withdrawal by Subject|2|||
124855405|NCT03283670|449091975|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
124855406|NCT03283670|449091975|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
124855407|NCT03823651|449091982|FG000|Overall Study|Death|5|||
124855408|NCT03823651|449091983|FG001|Overall Study|Death|0|||
124855409|NCT03823651|449091982|FG000|Overall Study|Physician Decision|1|||
124855410|NCT03823651|449091983|FG001|Overall Study|Physician Decision|0|||
124855411|NCT03823651|449091982|FG000|Overall Study|Caregiver to patient who died|0|||
124855412|NCT03823651|449091983|FG001|Overall Study|Caregiver to patient who died|5|||
124855413|NCT03823651|449091982|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
124855414|NCT03823651|449091983|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
124855415|NCT03864614|449091984|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
124855416|NCT03864614|449091985|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
124855417|NCT03864614|449091986|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
124855418|NCT03864614|449091987|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
124855419|NCT03864614|449091984|FG000|Overall Study|Withdrawal by Subject|72|||
124855420|NCT03864614|449091985|FG001|Overall Study|Withdrawal by Subject|100|||
124855421|NCT03864614|449091986|FG002|Overall Study|Withdrawal by Subject|1|||
124855422|NCT03864614|449091987|FG003|Overall Study|Withdrawal by Subject|21|||
124855423|NCT03864614|449091984|FG000|Overall Study|Lost to Follow-up|45|||
124855424|NCT03864614|449091985|FG001|Overall Study|Lost to Follow-up|54|||
124855425|NCT03864614|449091986|FG002|Overall Study|Lost to Follow-up|0|||
124855426|NCT03864614|449091987|FG003|Overall Study|Lost to Follow-up|9|||
124855427|NCT03864614|449091984|FG000|Overall Study|Adverse Event|42|||
124855428|NCT03864614|449091985|FG001|Overall Study|Adverse Event|30|||
124855429|NCT03864614|449091986|FG002|Overall Study|Adverse Event|1|||
124855430|NCT03864614|449091987|FG003|Overall Study|Adverse Event|9|||
124855431|NCT03864614|449091984|FG000|Overall Study|Protocol Deviation|6|||
124855432|NCT03864614|449091985|FG001|Overall Study|Protocol Deviation|26|||
124855433|NCT03864614|449091986|FG002|Overall Study|Protocol Deviation|0|||
124855434|NCT03864614|449091987|FG003|Overall Study|Protocol Deviation|1|||
124855435|NCT03864614|449091984|FG000|Overall Study|Physician Decision|7|||
124855436|NCT03864614|449091985|FG001|Overall Study|Physician Decision|10|||
124855437|NCT03864614|449091986|FG002|Overall Study|Physician Decision|1|||
124855438|NCT03864614|449091987|FG003|Overall Study|Physician Decision|5|||
124855439|NCT03864614|449091984|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
124855440|NCT03864614|449091985|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
124855441|NCT03864614|449091986|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
124855442|NCT03864614|449091987|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
124855443|NCT03864614|449091984|FG000|Overall Study|Sponsor Decision|1|||
124855444|NCT03864614|449091985|FG001|Overall Study|Sponsor Decision|2|||
124855445|NCT03864614|449091986|FG002|Overall Study|Sponsor Decision|0|||
124855446|NCT03864614|449091987|FG003|Overall Study|Sponsor Decision|0|||
124855447|NCT03864614|449091984|FG000|Overall Study|Pregnancy|0|||
124855448|NCT03864614|449091985|FG001|Overall Study|Pregnancy|1|||
124855449|NCT03864614|449091986|FG002|Overall Study|Pregnancy|0|||
124855450|NCT03864614|449091987|FG003|Overall Study|Pregnancy|0|||
124855451|NCT03864614|449091984|FG000|Overall Study|Other|7|||
124855452|NCT03864614|449091985|FG001|Overall Study|Other|9|||
124855453|NCT03864614|449091986|FG002|Overall Study|Other|1|||
124855454|NCT03864614|449091987|FG003|Overall Study|Other|4|||
124855455|NCT03864614|449091984|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
124855456|NCT03864614|449091985|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
124855457|NCT03864614|449091986|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
124855458|NCT03864614|449091987|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
124855459|NCT03859323|449093843|FG000|Overall Study|Lost to Follow-up|0|||
124855460|NCT03859323|449093844|FG001|Overall Study|Lost to Follow-up|0|||
124855461|NCT03859323|449093845|FG002|Overall Study|Lost to Follow-up|0|||
124855462|NCT03859323|449093846|FG003|Overall Study|Lost to Follow-up|0|||
124855463|NCT03859323|449093847|FG004|Overall Study|Lost to Follow-up|0|||
124855464|NCT03859323|449093848|FG005|Overall Study|Lost to Follow-up|0|||
124855465|NCT03859323|449093849|FG006|Overall Study|Lost to Follow-up|1|||
124855466|NCT03859323|449093850|FG007|Overall Study|Lost to Follow-up|0|||
124855467|NCT03859323|449093851|FG008|Overall Study|Lost to Follow-up|0|||
124855468|NCT03859323|449093852|FG009|Overall Study|Lost to Follow-up|0|||
124855469|NCT03859323|449093853|FG010|Overall Study|Lost to Follow-up|0|||
124855470|NCT03859323|449093854|FG011|Overall Study|Lost to Follow-up|0|||
124855471|NCT03859323|449093855|FG012|Overall Study|Lost to Follow-up|0|||
124855472|NCT03859323|449093843|FG000|Overall Study|Withdrawal by Subject|0|||
124855473|NCT03859323|449093844|FG001|Overall Study|Withdrawal by Subject|0|||
124855474|NCT03859323|449093845|FG002|Overall Study|Withdrawal by Subject|1|||
124855475|NCT03859323|449093846|FG003|Overall Study|Withdrawal by Subject|0|||
124855476|NCT03859323|449093847|FG004|Overall Study|Withdrawal by Subject|0|||
124855477|NCT03859323|449093848|FG005|Overall Study|Withdrawal by Subject|1|||
124855478|NCT03859323|449093849|FG006|Overall Study|Withdrawal by Subject|0|||
124855479|NCT03859323|449093850|FG007|Overall Study|Withdrawal by Subject|0|||
124855480|NCT03859323|449093851|FG008|Overall Study|Withdrawal by Subject|0|||
124855481|NCT03859323|449093852|FG009|Overall Study|Withdrawal by Subject|1|||
124855482|NCT03859323|449093853|FG010|Overall Study|Withdrawal by Subject|1|||
124855483|NCT03859323|449093854|FG011|Overall Study|Withdrawal by Subject|2|||
124855484|NCT03859323|449093855|FG012|Overall Study|Withdrawal by Subject|1|||
124855485|NCT03859323|449093843|FG000|Overall Study|Pregnancy|0|||
124855486|NCT03859323|449093844|FG001|Overall Study|Pregnancy|0|||
124855487|NCT03859323|449093845|FG002|Overall Study|Pregnancy|0|||
124855488|NCT03859323|449093846|FG003|Overall Study|Pregnancy|0|||
124855489|NCT03859323|449093847|FG004|Overall Study|Pregnancy|0|||
124855490|NCT03859323|449093848|FG005|Overall Study|Pregnancy|0|||
124855491|NCT03859323|449093849|FG006|Overall Study|Pregnancy|0|||
124855492|NCT03859323|449093850|FG007|Overall Study|Pregnancy|0|||
124855493|NCT03859323|449093851|FG008|Overall Study|Pregnancy|0|||
124855494|NCT03859323|449093852|FG009|Overall Study|Pregnancy|1|||
124855495|NCT03859323|449093853|FG010|Overall Study|Pregnancy|0|||
124855496|NCT03859323|449093854|FG011|Overall Study|Pregnancy|0|||
124855497|NCT03859323|449093855|FG012|Overall Study|Pregnancy|0|||
124855498|NCT01404312|449093858|FG000|Overall Study|Death|21|||
124855499|NCT01404312|449093859|FG001|Overall Study|Death|27|||
124855500|NCT01404312|449093858|FG000|Overall Study|Withdrawal by Subject|15|||
124855501|NCT01404312|449093859|FG001|Overall Study|Withdrawal by Subject|18|||
124855502|NCT01404312|449093858|FG000|Overall Study|Participant Unable to get to clinic|93|||
124855503|NCT01404312|449093859|FG001|Overall Study|Participant Unable to get to clinic|103|||
124855504|NCT01404312|449093858|FG000|Overall Study|Lost to Follow-up|115|||
124855505|NCT01404312|449093859|FG001|Overall Study|Lost to Follow-up|111|||
124855506|NCT01404312|449093858|FG000|Overall Study|Site closed|22|||
124855507|NCT01404312|449093859|FG001|Overall Study|Site closed|21|||
124855508|NCT01404312|449093858|FG000|Overall Study|Participant not willing to adhere to req|31|||
124855509|NCT01404312|449093859|FG001|Overall Study|Participant not willing to adhere to req|29|||
124855510|NCT01404312|449093858|FG000|Overall Study|Severe debilitation, unable to continue|1|||
124855511|NCT01404312|449093859|FG001|Overall Study|Severe debilitation, unable to continue|2|||
124855512|NCT04419493|449093860|FG000|Wash-out After Period 1|Adverse Event|1|||
124855513|NCT04419493|449093861|FG001|Wash-out After Period 1|Adverse Event|2|||
124855514|NCT04419493|449093862|FG002|Wash-out After Period 1|Adverse Event|1|||
124855515|NCT04419493|449093863|FG003|Wash-out After Period 1|Adverse Event|0|||
124855516|NCT00524134|449093864|FG000|Overall Study|Withdrawal by Subject|1|||
124855517|NCT00524134|449093864|FG000|Overall Study|Physician Decision|1|||
124855518|NCT00129987|449093865|FG000|1st Educational Session|Withdrawal by Subject|141|||
124855519|NCT00129987|449093866|FG001|1st Educational Session|Withdrawal by Subject|109|||
124855520|NCT00129987|449093865|FG000|1 Year|Withdrawal by Subject|32|||
124855521|NCT00129987|449093866|FG001|1 Year|Withdrawal by Subject|21|||
124855522|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
124855523|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
124855524|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
124855525|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
124855526|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Adverse Event|5|||
124855527|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Adverse Event|3|||
124855528|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Adverse Event|4|||
124855529|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Adverse Event|10|||
124855530|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
124855531|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
124855532|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
124855533|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
124855534|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
124855535|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
124855536|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
124855537|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
124855538|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Pregnancy|5|||
124855539|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Pregnancy|0|||
124855540|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Pregnancy|3|||
124855541|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Pregnancy|2|||
124855542|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Non-compliance|1|||
124855543|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Non-compliance|4|||
124855544|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Non-compliance|0|||
124855545|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Non-compliance|3|||
124855546|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Other|0|||
124855547|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Other|3|||
124855548|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Other|3|||
124855549|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Other|1|||
124855550|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
124855551|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
124855552|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
124855553|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
124855554|NCT01760954|449093870|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
124855555|NCT01760954|449093871|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
124855556|NCT01760954|449093872|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
124855557|NCT01760954|449093873|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
124855558|NCT01760954|449093870|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
124855559|NCT01760954|449093871|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
124855560|NCT01760954|449093872|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
124855561|NCT01760954|449093873|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
124855562|NCT01760954|449093870|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
124855563|NCT01760954|449093871|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
124855564|NCT01760954|449093872|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
124855565|NCT01760954|449093873|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
124855566|NCT01760954|449093870|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
124855567|NCT01760954|449093871|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
124855568|NCT01760954|449093872|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
124855569|NCT01760954|449093873|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
124855570|NCT01760954|449093870|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
124855571|NCT01760954|449093871|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
124855572|NCT01760954|449093872|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
124855573|NCT01760954|449093873|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
124855574|NCT01760954|449093870|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
124855575|NCT01760954|449093871|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
124855576|NCT01760954|449093872|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
124855577|NCT01760954|449093873|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
124855578|NCT01760954|449093870|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
124855579|NCT01760954|449093871|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
124855580|NCT01760954|449093872|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
124855581|NCT01760954|449093873|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
124855582|NCT03320070|449093874|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
124855583|NCT03320070|449093875|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
124855584|NCT03320070|449093874|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
124855585|NCT03320070|449093875|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
124855586|NCT03320070|449093874|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
124855587|NCT03320070|449093875|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
124855588|NCT03320070|449093874|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
124855589|NCT03320070|449093875|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
124855590|NCT03320070|449093874|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
124855591|NCT03320070|449093875|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
124855592|NCT03320070|449093874|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
124855593|NCT03320070|449093875|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
124855594|NCT00996996|449093876|FG000|Overall Study|Progressive Disease|10|||
124855595|NCT00996996|449093876|FG000|Overall Study|Non-compliance|8|||
124855596|NCT00996996|449093876|FG000|Overall Study|Lost to Follow-up|9|||
124855597|NCT00996996|449093876|FG000|Overall Study|Death|5|||
124855598|NCT00996996|449093876|FG000|Overall Study|Did Not Receive Study Medications|1|||
124855599|NCT02819726|449093877|FG000|Part A (All Participants)|Lost to Follow-up|0|||
124855600|NCT02819726|449093878|FG001|Part A (All Participants)|Lost to Follow-up|1|||
124855601|NCT02819726|449093879|FG002|Part A (All Participants)|Lost to Follow-up|0|||
124855602|NCT02819726|449093880|FG003|Part A (All Participants)|Lost to Follow-up|0|||
124855603|NCT02819726|449093877|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
124855604|NCT02819726|449093878|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
124855605|NCT02819726|449093879|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
124855606|NCT02819726|449093880|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
124855607|NCT02819726|449093877|FG000|Part A (All Participants)|Protocol non-compliance|3|||
124855608|NCT02819726|449093878|FG001|Part A (All Participants)|Protocol non-compliance|4|||
124855609|NCT02819726|449093879|FG002|Part A (All Participants)|Protocol non-compliance|5|||
124855610|NCT02819726|449093880|FG003|Part A (All Participants)|Protocol non-compliance|0|||
124855611|NCT02819726|449093877|FG000|Part B (All Participants)|Lost to Follow-up|1|||
124855612|NCT02819726|449093878|FG001|Part B (All Participants)|Lost to Follow-up|1|||
124855613|NCT02819726|449093879|FG002|Part B (All Participants)|Lost to Follow-up|2|||
124855614|NCT02819726|449093880|FG003|Part B (All Participants)|Lost to Follow-up|2|||
124855615|NCT02819726|449093877|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
124855616|NCT02819726|449093878|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
124855617|NCT02819726|449093879|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
124855618|NCT02819726|449093880|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
124855619|NCT02819726|449093877|FG000|Part B (All Participants)|Protocol non-compliance|0|||
124855620|NCT02819726|449093878|FG001|Part B (All Participants)|Protocol non-compliance|0|||
124855621|NCT02819726|449093879|FG002|Part B (All Participants)|Protocol non-compliance|1|||
124855622|NCT02819726|449093880|FG003|Part B (All Participants)|Protocol non-compliance|0|||
124855623|NCT00406029|449093881|FG000|Overall Study|Adverse Event|12|||
124855624|NCT00406029|449093882|FG001|Overall Study|Adverse Event|2|||
124855625|NCT00406029|449093883|FG002|Overall Study|Adverse Event|5|||
124855626|NCT00406029|449093884|FG003|Overall Study|Adverse Event|10|||
124855627|NCT00406029|449093885|FG004|Overall Study|Adverse Event|7|||
124855628|NCT00406029|449093881|FG000|Overall Study|Withdrawal by Subject|3|||
124855629|NCT00406029|449093882|FG001|Overall Study|Withdrawal by Subject|4|||
124855630|NCT00406029|449093883|FG002|Overall Study|Withdrawal by Subject|2|||
124855631|NCT00406029|449093884|FG003|Overall Study|Withdrawal by Subject|2|||
124855632|NCT00406029|449093885|FG004|Overall Study|Withdrawal by Subject|0|||
124855633|NCT00406029|449093881|FG000|Overall Study|Protocol Violation|1|||
124855634|NCT00406029|449093882|FG001|Overall Study|Protocol Violation|2|||
124855635|NCT00406029|449093883|FG002|Overall Study|Protocol Violation|0|||
124855636|NCT00406029|449093884|FG003|Overall Study|Protocol Violation|2|||
124855637|NCT00406029|449093885|FG004|Overall Study|Protocol Violation|0|||
124855638|NCT00406029|449093881|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
124855639|NCT00406029|449093882|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
124855640|NCT00406029|449093883|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
124855641|NCT00406029|449093884|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
124855642|NCT00406029|449093885|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
124855643|NCT00406029|449093881|FG000|Overall Study|Randomized in Error|0|||
124855644|NCT00406029|449093882|FG001|Overall Study|Randomized in Error|0|||
124855645|NCT00406029|449093883|FG002|Overall Study|Randomized in Error|2|||
124855646|NCT00406029|449093884|FG003|Overall Study|Randomized in Error|3|||
124855647|NCT00406029|449093885|FG004|Overall Study|Randomized in Error|1|||
124855648|NCT02162810|449093886|FG000|Overall Study|Protocol Violation|1|||
124855649|NCT02162810|449093887|FG001|Overall Study|Protocol Violation|0|||
124855650|NCT02162810|449093886|FG000|Overall Study|patients did not report compliance|4|||
124855651|NCT02162810|449093887|FG001|Overall Study|patients did not report compliance|1|||
124855652|NCT02223390|449093888|FG000|Overall Study|Lost to Follow-up|9|||
124855653|NCT02223390|449093889|FG001|Overall Study|Lost to Follow-up|4|||
124855654|NCT02843568|449093894|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
124855655|NCT02843568|449093895|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
124855656|NCT02843568|449093894|FG000|Overall Study|Death|3|||
124855657|NCT02843568|449093895|FG001|Overall Study|Death|3|||
124855658|NCT02843568|449093894|FG000|Overall Study|Withdrawal by Subject|1|||
124855659|NCT02843568|449093895|FG001|Overall Study|Withdrawal by Subject|1|||
124855660|NCT02843568|449093894|FG000|Overall Study|Lost to Follow-up|2|||
124855661|NCT02843568|449093895|FG001|Overall Study|Lost to Follow-up|0|||
124855662|NCT01255358|449093896|FG000|Overall Study|Adverse Event|2|||
124855663|NCT01255358|449093896|FG000|Overall Study|Protocol Violation|2|||
124855664|NCT00096941|449093908|FG000|Overall Study|disease progression|3|||
124855665|NCT00022516|449093909|FG000|Overall Study|Adverse Event|0|||
124855666|NCT00022516|449093910|FG001|Overall Study|Adverse Event|59|||
124855667|NCT00022516|449093909|FG000|Overall Study|Lack of Efficacy|0|||
124855668|NCT00022516|449093910|FG001|Overall Study|Lack of Efficacy|27|||
124855669|NCT00022516|449093909|FG000|Overall Study|Physician Decision|0|||
124855670|NCT00022516|449093910|FG001|Overall Study|Physician Decision|1|||
124855671|NCT00022516|449093909|FG000|Overall Study|Protocol Violation|1|||
124855672|NCT00022516|449093910|FG001|Overall Study|Protocol Violation|3|||
124855673|NCT00022516|449093909|FG000|Overall Study|Withdrawal by Subject|2|||
124855674|NCT00022516|449093910|FG001|Overall Study|Withdrawal by Subject|113|||
124855675|NCT00022516|449093909|FG000|Overall Study|Incomplete documentation|0|||
124855676|NCT00022516|449093910|FG001|Overall Study|Incomplete documentation|27|||
124855677|NCT02056301|449093913|FG000|Overall Study|Protocol Violation|1|||
124855678|NCT02056301|449093914|FG001|Overall Study|Protocol Violation|2|||
124855679|NCT02056301|449093913|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
124855680|NCT02056301|449093914|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
124855681|NCT02056301|449093913|FG000|Overall Study|Withdrawal by Subject|0|||
124855682|NCT02056301|449093914|FG001|Overall Study|Withdrawal by Subject|1|||
124855683|NCT02056301|449093913|FG000|Overall Study|Issues with epidural|0|||
124855684|NCT02056301|449093914|FG001|Overall Study|Issues with epidural|3|||
124855685|NCT02209324|449093915|FG000|Overall Study|Adverse Event|2|||
124855686|NCT02209324|449093915|FG000|Overall Study|Lack of Efficacy|1|||
124855687|NCT02209324|449093915|FG000|Overall Study|Lost to Follow-up|1|||
124855688|NCT02209324|449093915|FG000|Overall Study|Physician Decision|3|||
124855689|NCT02209324|449093915|FG000|Overall Study|Protocol Violation|14|||
124855690|NCT02209324|449093915|FG000|Overall Study|Withdrawal by Subject|8|||
124855691|NCT02209324|449093915|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
124855692|NCT02209324|449093915|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
124855693|NCT02209324|449093915|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
124855694|NCT01198600|449093916|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
124855695|NCT01198600|449093917|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
124855696|NCT01198600|449093918|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
124855697|NCT01198600|449093919|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
124855698|NCT01198600|449093916|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
124855699|NCT01198600|449093917|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
124855700|NCT01198600|449093918|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
124855701|NCT01198600|449093919|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
124855702|NCT01198600|449093916|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
124855703|NCT01198600|449093917|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
124855704|NCT01198600|449093918|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
124855705|NCT01198600|449093919|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
124855706|NCT01198600|449093916|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
124855707|NCT01198600|449093917|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
124855708|NCT01198600|449093918|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
124855709|NCT01198600|449093919|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
124855710|NCT01198600|449093916|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
124855711|NCT01198600|449093917|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
124855712|NCT01198600|449093918|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
124855713|NCT01198600|449093919|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
124855714|NCT01198600|449093916|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
124855715|NCT01198600|449093917|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
124855716|NCT01198600|449093918|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
124855717|NCT01198600|449093919|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
124855718|NCT01198600|449093916|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
124855719|NCT01198600|449093917|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
124855720|NCT01198600|449093918|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
124855721|NCT01198600|449093919|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
124855722|NCT04798586|449093920|FG000|Overall Study|Death|2|||
124855723|NCT01669343|449093921|FG000|Part A: All Patients|Withdrawal by Subject|7|||
124855724|NCT01669343|449093921|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
124855725|NCT01669343|449093921|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
124855726|NCT01669343|449093921|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
124855727|NCT01669343|449093921|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
124855728|NCT04433767|449093922|FG000|Overall Study|Adverse Event|1|||
124855729|NCT00439777|449093927|FG000|Treatment Period|Death|29|||
124855730|NCT00439777|449093928|FG001|Treatment Period|Death|21|||
124855731|NCT00439777|449093927|FG000|Treatment Period|Study terminated by sponsor|125|||
124855732|NCT00439777|449093928|FG001|Treatment Period|Study terminated by sponsor|132|||
124855733|NCT00439777|449093927|FG000|Treatment Period|Site closed by investigator|0|||
124855734|NCT00439777|449093928|FG001|Treatment Period|Site closed by investigator|1|||
124855735|NCT00439777|449093927|FG000|Treatment Period|Did not take study treatment|7|||
124855736|NCT00439777|449093928|FG001|Treatment Period|Did not take study treatment|8|||
124855737|NCT00439777|449093927|FG000|Treatment Period|Adverse Event|111|||
124855738|NCT00439777|449093928|FG001|Treatment Period|Adverse Event|92|||
124855739|NCT00439777|449093927|FG000|Treatment Period|Protocol Violation|23|||
124855740|NCT00439777|449093928|FG001|Treatment Period|Protocol Violation|30|||
124855741|NCT00439777|449093927|FG000|Treatment Period|Withdrawal by Subject|66|||
124855742|NCT00439777|449093928|FG001|Treatment Period|Withdrawal by Subject|118|||
124855743|NCT00439777|449093927|FG000|Treatment Period|Lack of Efficacy|1|||
124855744|NCT00439777|449093928|FG001|Treatment Period|Lack of Efficacy|4|||
124855745|NCT00439777|449093927|FG000|Treatment Period|Lost to Follow-up|8|||
124855746|NCT00439777|449093928|FG001|Treatment Period|Lost to Follow-up|10|||
124855747|NCT00439777|449093927|FG000|Treatment Period|Protocol driven decision point|1|||
124855748|NCT00439777|449093928|FG001|Treatment Period|Protocol driven decision point|3|||
124855749|NCT00439777|449093927|FG000|Treatment Period|Physician Decision|7|||
124855750|NCT00439777|449093928|FG001|Treatment Period|Physician Decision|18|||
124855751|NCT00439777|449093927|FG000|Treatment Period|Clinical endpoint reached|26|||
124855752|NCT00439777|449093928|FG001|Treatment Period|Clinical endpoint reached|13|||
124855753|NCT00439777|449093927|FG000|Treatment Period|Technical problems|3|||
124855754|NCT00439777|449093928|FG001|Treatment Period|Technical problems|1|||
124855755|NCT00439777|449093927|FG000|Treatment Period|Participant convenience|12|||
124855756|NCT00439777|449093928|FG001|Treatment Period|Participant convenience|8|||
124855757|NCT00439777|449093927|FG000|Observational Period|Protocol Violation|0|||
124855758|NCT00439777|449093928|FG001|Observational Period|Protocol Violation|2|||
124855759|NCT00439777|449093927|FG000|Observational Period|Withdrawal by Subject|9|||
124855760|NCT00439777|449093928|FG001|Observational Period|Withdrawal by Subject|5|||
124855761|NCT00439777|449093927|FG000|Observational Period|Lost to Follow-up|1|||
124855762|NCT00439777|449093928|FG001|Observational Period|Lost to Follow-up|11|||
124855763|NCT00439777|449093927|FG000|Observational Period|Death|27|||
124855764|NCT00439777|449093928|FG001|Observational Period|Death|20|||
124855765|NCT00439777|449093927|FG000|Observational Period|Study terminated by sponsor|3|||
124855766|NCT00439777|449093928|FG001|Observational Period|Study terminated by sponsor|1|||
124855767|NCT00439777|449093927|FG000|Observational Period|Protocol driven decision point|0|||
124855768|NCT00439777|449093928|FG001|Observational Period|Protocol driven decision point|1|||
124855769|NCT00439777|449093927|FG000|Observational Period|Lack of Efficacy|1|||
124855770|NCT00439777|449093928|FG001|Observational Period|Lack of Efficacy|0|||
124855771|NCT00439777|449093927|FG000|Observational Period|Technical problems|0|||
124855772|NCT00439777|449093928|FG001|Observational Period|Technical problems|1|||
124855773|NCT00661492|449093929|FG000|Overall Study|Adverse Event|16|||
124855774|NCT00661492|449093930|FG001|Overall Study|Adverse Event|13|||
124855775|NCT00661492|449093929|FG000|Overall Study|Disease Progression|44|||
124855776|NCT00661492|449093930|FG001|Overall Study|Disease Progression|14|||
124855777|NCT00661492|449093929|FG000|Overall Study|Patient Request|6|||
124855778|NCT00661492|449093930|FG001|Overall Study|Patient Request|1|||
124855779|NCT00661492|449093929|FG000|Overall Study|Investigator Request|1|||
124855780|NCT00661492|449093930|FG001|Overall Study|Investigator Request|0|||
124855781|NCT00661492|449093929|FG000|Overall Study|Lost to Follow-up|0|||
124855782|NCT00661492|449093930|FG001|Overall Study|Lost to Follow-up|1|||
124855783|NCT00661492|449093929|FG000|Overall Study|Other|1|||
124855784|NCT00661492|449093930|FG001|Overall Study|Other|0|||
124855785|NCT03855189|449093931|FG000|Overall Study|Adverse Event|5|||
124855786|NCT03855189|449093932|FG001|Overall Study|Adverse Event|2|||
124855787|NCT03855189|449093933|FG002|Overall Study|Adverse Event|4|||
124855788|NCT03855189|449093931|FG000|Overall Study|Treatment Failure|1|||
124855789|NCT03855189|449093932|FG001|Overall Study|Treatment Failure|1|||
124855790|NCT03855189|449093933|FG002|Overall Study|Treatment Failure|2|||
124855791|NCT03855189|449093931|FG000|Overall Study|Noncompliance with Protocol|0|||
124855792|NCT03855189|449093932|FG001|Overall Study|Noncompliance with Protocol|1|||
124855793|NCT03855189|449093933|FG002|Overall Study|Noncompliance with Protocol|0|||
124855794|NCT03855189|449093931|FG000|Overall Study|Did Not Return|4|||
124855795|NCT03855189|449093932|FG001|Overall Study|Did Not Return|3|||
124855796|NCT03855189|449093933|FG002|Overall Study|Did Not Return|0|||
124855797|NCT01143259|449093934|FG000|Overall Study|Withdrawal by Subject|3|||
124855798|NCT01143259|449093935|FG001|Overall Study|Withdrawal by Subject|2|||
124855799|NCT01143259|449093934|FG000|Overall Study|Protocol Violation|13|||
124855800|NCT01143259|449093935|FG001|Overall Study|Protocol Violation|9|||
124855801|NCT01143259|449093934|FG000|Overall Study|Screen Failure|7|||
124855802|NCT01143259|449093935|FG001|Overall Study|Screen Failure|9|||
124855803|NCT00099983|449093936|FG000|Overall Study|Lost to Follow-up|2|||
124855804|NCT00099983|449093937|FG001|Overall Study|Lost to Follow-up|3|||
124855805|NCT00099983|449093936|FG000|Overall Study|Missing Source Documents|14|||
124855806|NCT00099983|449093937|FG001|Overall Study|Missing Source Documents|15|||
124855807|NCT00099983|449093936|FG000|Overall Study|Withdrawal by Subject|3|||
124855808|NCT00099983|449093937|FG001|Overall Study|Withdrawal by Subject|2|||
124855809|NCT00099983|449093936|FG000|Overall Study|Adverse Event|1|||
124855810|NCT00099983|449093937|FG001|Overall Study|Adverse Event|1|||
124855811|NCT00099983|449093936|FG000|Overall Study|Lack of Efficacy|0|||
124855812|NCT00099983|449093937|FG001|Overall Study|Lack of Efficacy|1|||
124855813|NCT00099983|449093936|FG000|Overall Study|Unable to return for appointments|1|||
124855814|NCT00099983|449093937|FG001|Overall Study|Unable to return for appointments|1|||
124855815|NCT00099983|449093936|FG000|Overall Study|Moved|1|||
124855816|NCT00099983|449093937|FG001|Overall Study|Moved|0|||
124855817|NCT00099983|449093936|FG000|Overall Study|Other psychiatric problem|1|||
124855818|NCT00099983|449093937|FG001|Overall Study|Other psychiatric problem|0|||
124855819|NCT00099983|449093936|FG000|Overall Study|Incarcerated|0|||
124855820|NCT00099983|449093937|FG001|Overall Study|Incarcerated|1|||
124855821|NCT00099983|449093936|FG000|Overall Study|Intolerant of burden of visits|0|||
124855822|NCT00099983|449093937|FG001|Overall Study|Intolerant of burden of visits|1|||
124855823|NCT00099983|449093936|FG000|Overall Study|Other issue|1|||
124855824|NCT00099983|449093937|FG001|Overall Study|Other issue|0|||
124855825|NCT02641080|449093938|FG000|Overall Study|Physician Decision|2|||
124855826|NCT02641080|449093939|FG001|Overall Study|Physician Decision|0|||
124855827|NCT02641080|449093938|FG000|Overall Study|Withdrawal by Subject|0|||
124855828|NCT02641080|449093939|FG001|Overall Study|Withdrawal by Subject|1|||
124855829|NCT02641080|449093938|FG000|Overall Study|Rehab Center denied use of pumps|0|||
124855830|NCT02641080|449093939|FG001|Overall Study|Rehab Center denied use of pumps|3|||
124855831|NCT02641080|449093938|FG000|Overall Study|Lost to Follow-up|0|||
124855832|NCT02641080|449093939|FG001|Overall Study|Lost to Follow-up|3|||
124855833|NCT00803634|449093940|FG000|Overall Study|Withdrew Consent|1|||
124855834|NCT00803634|449093941|FG001|Overall Study|Withdrew Consent|0|||
124855835|NCT00803634|449093940|FG000|Overall Study|Lost to Follow-up|2|||
124855836|NCT00803634|449093941|FG001|Overall Study|Lost to Follow-up|3|||
124855837|NCT00803634|449093940|FG000|Overall Study|Death|3|||
124855838|NCT00803634|449093941|FG001|Overall Study|Death|2|||
124855839|NCT04307186|449093944|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
124855840|NCT04307186|449093944|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
124855841|NCT04307186|449093944|FG000|Washout 3-14 Days|Progressive disease|1|||
124855842|NCT04307186|449093944|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
124855843|NCT04307186|449093944|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
124855844|NCT03238001|449093948|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
124855845|NCT03238001|449093948|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
124855846|NCT03238001|449093948|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
124855847|NCT03238001|449093948|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
124855848|NCT03238001|449093948|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
124855849|NCT03238001|449093948|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
124855850|NCT03238001|449093948|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
124855851|NCT03238001|449093948|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
124855852|NCT03165045|449093949|FG000|Visit 1|No registration after visit 1|9|||
124855853|NCT03165045|449093949|FG000|Visit 1|No treatment documented|10|||
124855854|NCT03165045|449093949|FG000|Visit 1|No visit 1|10|||
124855855|NCT03165045|449093949|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
124855856|NCT03165045|449093949|FG000|Visit 2|No available total CCQ score at all|29|||
124855857|NCT03165045|449093949|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
124855858|NCT00759109|449093950|FG000|Overall Study|Adverse Event|17|||
124855859|NCT00759109|449093951|FG001|Overall Study|Adverse Event|12|||
124855860|NCT00759109|449093950|FG000|Overall Study|Inability to comply|1|||
124855861|NCT00759109|449093951|FG001|Overall Study|Inability to comply|1|||
124855862|NCT00759109|449093950|FG000|Overall Study|Withdrawal by Subject|9|||
124855863|NCT00759109|449093951|FG001|Overall Study|Withdrawal by Subject|5|||
124855864|NCT00759109|449093950|FG000|Overall Study|Death|4|||
124855865|NCT00759109|449093951|FG001|Overall Study|Death|3|||
124855866|NCT00759109|449093950|FG000|Overall Study|Lost to Follow-up|4|||
124855867|NCT00759109|449093951|FG001|Overall Study|Lost to Follow-up|6|||
124855868|NCT00759109|449093950|FG000|Overall Study|Started new therapy|2|||
124855869|NCT00759109|449093951|FG001|Overall Study|Started new therapy|6|||
124855870|NCT00759109|449093950|FG000|Overall Study|HCV RNA negative|1|||
124855871|NCT00759109|449093951|FG001|Overall Study|HCV RNA negative|0|||
124855872|NCT00759109|449093950|FG000|Overall Study|Participant moved to a different city|0|||
124855873|NCT00759109|449093951|FG001|Overall Study|Participant moved to a different city|1|||
124855874|NCT00759109|449093950|FG000|Overall Study|Participant had a liver transplant|0|||
124855875|NCT00759109|449093951|FG001|Overall Study|Participant had a liver transplant|1|||
124855876|NCT00759109|449093950|FG000|Overall Study|Lost during study|1|||
124855877|NCT00759109|449093951|FG001|Overall Study|Lost during study|0|||
124855878|NCT01866709|449093955|FG000|Overall Study|Adverse Event|1|||
124855879|NCT01866709|449093956|FG001|Overall Study|Adverse Event|0|||
124855880|NCT03791398|449093957|FG000|Overall Study|Progression of Disease Under Study|2|||
124855881|NCT03791398|449093958|FG001|Overall Study|Progression of Disease Under Study|0|||
124855882|NCT03791398|449093959|FG002|Overall Study|Progression of Disease Under Study|0|||
124855883|NCT02207829|449093960|FG000|Overall Study|Adverse Event|10|||
124855884|NCT02207829|449093961|FG001|Overall Study|Adverse Event|9|||
124855885|NCT02207829|449093960|FG000|Overall Study|Lack of Efficacy|7|||
124855886|NCT02207829|449093961|FG001|Overall Study|Lack of Efficacy|5|||
124855887|NCT02207829|449093960|FG000|Overall Study|Lost to Follow-up|2|||
124855888|NCT02207829|449093961|FG001|Overall Study|Lost to Follow-up|2|||
124855889|NCT02207829|449093960|FG000|Overall Study|Protocol deviation|5|||
124855890|NCT02207829|449093961|FG001|Overall Study|Protocol deviation|4|||
124855891|NCT02207829|449093960|FG000|Overall Study|Withdrew consent|18|||
124855892|NCT02207829|449093961|FG001|Overall Study|Withdrew consent|14|||
124855893|NCT00766376|449093962|FG000|Overall Study|Withdrawal by Subject|27|||
124855894|NCT00927927|449093968|FG000|Overall Study|Withdrawal by Subject|0|||
124855895|NCT00927927|449093969|FG001|Overall Study|Withdrawal by Subject|0|||
124855896|NCT00927927|449093970|FG002|Overall Study|Withdrawal by Subject|0|||
124855897|NCT00927927|449093971|FG003|Overall Study|Withdrawal by Subject|0|||
124855898|NCT00927927|449093972|FG004|Overall Study|Withdrawal by Subject|0|||
124855899|NCT00927927|449093973|FG005|Overall Study|Withdrawal by Subject|0|||
124855900|NCT00927927|449093974|FG006|Overall Study|Withdrawal by Subject|0|||
124855901|NCT00927927|449093975|FG007|Overall Study|Withdrawal by Subject|2|||
124855902|NCT00927927|449093976|FG008|Overall Study|Withdrawal by Subject|0|||
124855903|NCT00927927|449093977|FG009|Overall Study|Withdrawal by Subject|0|||
124855904|NCT00927927|449093978|FG010|Overall Study|Withdrawal by Subject|0|||
124855905|NCT00927927|449093979|FG011|Overall Study|Withdrawal by Subject|2|||
124855906|NCT00927927|449093980|FG012|Overall Study|Withdrawal by Subject|0|||
124855907|NCT00927927|449093981|FG013|Overall Study|Withdrawal by Subject|0|||
124855908|NCT00927927|449093982|FG014|Overall Study|Withdrawal by Subject|0|||
124855909|NCT01110239|449093987|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
124855910|NCT01110239|449093988|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
124855911|NCT01110239|449093989|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
124855912|NCT01110239|449093990|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
124855913|NCT01110239|449093987|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
124855914|NCT01110239|449093988|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
124855915|NCT01110239|449093989|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
124855916|NCT01110239|449093990|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
124855917|NCT00080223|449093993|FG000|Overall Study|Adverse Event|23|||
124855918|NCT00080223|449093993|FG000|Overall Study|Death|21|||
124855919|NCT00080223|449093993|FG000|Overall Study|Withdrawal by Subject|13|||
124855920|NCT00080223|449093993|FG000|Overall Study|Lung Transplantation|9|||
124855921|NCT00080223|449093993|FG000|Overall Study|Non-compliance With Study Treatment|7|||
124855922|NCT00080223|449093993|FG000|Overall Study|Participant unwilling to continue|2|||
124855923|NCT00080223|449093993|FG000|Overall Study|Physician Decision|1|||
124855924|NCT05204134|449093996|FG000|Overall Study|Withdrawal by Subject|3|||
124855925|NCT05204134|449093996|FG000|Overall Study|Physician Decision|1|||
124855926|NCT03135522|449093997|FG000|Overall Study|Adverse Event|1|||
124855927|NCT03135522|449093998|FG001|Overall Study|Adverse Event|0|||
124855928|NCT03099382|449093999|FG000|Overall Study|Protocol Violation|2|||
124855929|NCT03099382|449094000|FG001|Overall Study|Protocol Violation|3|||
124855930|NCT00499369|449094001|FG000|Overall Study|Adverse Event|2|||
124855931|NCT00499369|449094002|FG001|Overall Study|Adverse Event|2|||
124855932|NCT00499369|449094003|FG002|Overall Study|Adverse Event|3|||
124855933|NCT00499369|449094004|FG003|Overall Study|Adverse Event|1|||
124855934|NCT00499369|449094005|FG004|Overall Study|Adverse Event|2|||
124855935|NCT00499369|449094001|FG000|Overall Study|Withdrawal by Subject|0|||
124855936|NCT00499369|449094002|FG001|Overall Study|Withdrawal by Subject|1|||
124855937|NCT00499369|449094003|FG002|Overall Study|Withdrawal by Subject|1|||
124855938|NCT00499369|449094004|FG003|Overall Study|Withdrawal by Subject|0|||
124855939|NCT00499369|449094005|FG004|Overall Study|Withdrawal by Subject|0|||
124855940|NCT00499369|449094001|FG000|Overall Study|Progression|10|||
124855941|NCT00499369|449094002|FG001|Overall Study|Progression|12|||
124855942|NCT00499369|449094003|FG002|Overall Study|Progression|9|||
124855943|NCT00499369|449094004|FG003|Overall Study|Progression|6|||
124855944|NCT00499369|449094005|FG004|Overall Study|Progression|10|||
124855945|NCT00499369|449094001|FG000|Overall Study|Death|0|||
124855946|NCT00499369|449094002|FG001|Overall Study|Death|1|||
124855947|NCT00499369|449094003|FG002|Overall Study|Death|0|||
124855948|NCT00499369|449094004|FG003|Overall Study|Death|0|||
124855949|NCT00499369|449094005|FG004|Overall Study|Death|0|||
124855950|NCT00499369|449094001|FG000|Overall Study|Not protocol specified|2|||
124855951|NCT00499369|449094002|FG001|Overall Study|Not protocol specified|0|||
124855952|NCT00499369|449094003|FG002|Overall Study|Not protocol specified|3|||
124855953|NCT00499369|449094004|FG003|Overall Study|Not protocol specified|1|||
124855954|NCT00499369|449094005|FG004|Overall Study|Not protocol specified|0|||
124855955|NCT00499369|449094001|FG000|Overall Study|Ineligible|2|||
124855956|NCT00499369|449094002|FG001|Overall Study|Ineligible|2|||
124855957|NCT00499369|449094003|FG002|Overall Study|Ineligible|1|||
124855958|NCT00499369|449094004|FG003|Overall Study|Ineligible|1|||
124855959|NCT00499369|449094005|FG004|Overall Study|Ineligible|0|||
124855960|NCT01802411|449094006|FG000|Overall Study|Death|2|||
124855961|NCT01802411|449094007|FG001|Overall Study|Death|1|||
124855962|NCT01802411|449094006|FG000|Overall Study|Adverse Event|2|||
124855963|NCT01802411|449094007|FG001|Overall Study|Adverse Event|7|||
124855964|NCT01802411|449094006|FG000|Overall Study|Lack of Efficacy|8|||
124855965|NCT01802411|449094007|FG001|Overall Study|Lack of Efficacy|10|||
124855966|NCT01802411|449094006|FG000|Overall Study|Withdrawal by Subject|0|||
124855967|NCT01802411|449094007|FG001|Overall Study|Withdrawal by Subject|2|||
124855968|NCT01802411|449094006|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
124855969|NCT01802411|449094007|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
124855970|NCT01802411|449094006|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
124855971|NCT01802411|449094007|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
124855972|NCT01802411|449094006|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
124855973|NCT01802411|449094007|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
124855974|NCT03285477|449094010|FG000|Treatment and Response Assessment Period|Death|1|||
124855975|NCT03285477|449094011|FG001|Treatment and Response Assessment Period|Death|0|||
124855976|NCT03285477|449094010|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
124855977|NCT03285477|449094011|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
124855978|NCT03285477|449094010|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
124855979|NCT03285477|449094011|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
124855980|NCT03285477|449094010|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
124855981|NCT03285477|449094011|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
124855982|NCT03285477|449094010|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
124855983|NCT03285477|449094011|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
124855984|NCT00852397|449094014|FG000|Overall Study|Adverse Event|4|||
124855985|NCT00852397|449094015|FG001|Overall Study|Adverse Event|6|||
124855986|NCT00852397|449094016|FG002|Overall Study|Adverse Event|4|||
124855987|NCT00852397|449094014|FG000|Overall Study|Death|0|||
124855988|NCT00852397|449094015|FG001|Overall Study|Death|0|||
124855989|NCT00852397|449094016|FG002|Overall Study|Death|1|||
124855990|NCT00852397|449094014|FG000|Overall Study|Withdrawal by Subject|4|||
124855991|NCT00852397|449094015|FG001|Overall Study|Withdrawal by Subject|1|||
124855992|NCT00852397|449094016|FG002|Overall Study|Withdrawal by Subject|2|||
124855993|NCT00852397|449094014|FG000|Overall Study|Study terminated by sponsor|2|||
124855994|NCT00852397|449094015|FG001|Overall Study|Study terminated by sponsor|1|||
124855995|NCT00852397|449094016|FG002|Overall Study|Study terminated by sponsor|6|||
124855996|NCT00852397|449094014|FG000|Overall Study|Difficulty in study site visit|1|||
124855997|NCT00852397|449094015|FG001|Overall Study|Difficulty in study site visit|0|||
124855998|NCT00852397|449094016|FG002|Overall Study|Difficulty in study site visit|0|||
124855999|NCT00852397|449094014|FG000|Overall Study|Protocol Violation|0|||
124856000|NCT00852397|449094015|FG001|Overall Study|Protocol Violation|0|||
124856001|NCT00852397|449094016|FG002|Overall Study|Protocol Violation|1|||
124856002|NCT02345512|449094017|FG000|Overall Study|Adverse Event|1|||
124856003|NCT02345512|449094017|FG000|Overall Study|Withdrawal by Subject|1|||
124856004|NCT02663817|449094018|FG000|Overall Study|Screen failure|2|||
124856005|NCT01438541|449094019|FG000|Overall Study|Physician Decision|1|||
124856006|NCT01438541|449094019|FG000|Overall Study|Withdrawal by Subject|1|||
124856007|NCT01438541|449094019|FG000|Overall Study|discharge from the hospital|5|||
124856008|NCT01968434|449094022|FG000|Overall Study|Lost to Follow-up|3|||
124856009|NCT01968434|449094023|FG001|Overall Study|Lost to Follow-up|6|||
124856010|NCT02091167|449094025|FG000|Overall Study|Lost to Follow-up|0|||
124856011|NCT02091167|449094026|FG001|Overall Study|Lost to Follow-up|2|||
124856012|NCT00489970|449096042|FG000|Persistence Year 9|Lost to Follow-up|2|||
124856013|NCT00489970|449096043|FG001|Persistence Year 9|Lost to Follow-up|2|||
124856014|NCT00489970|449096044|FG002|Persistence Year 9|Lost to Follow-up|3|||
124856015|NCT00489970|449096042|FG000|Persistence Year 9|Other|1|||
124856016|NCT00489970|449096043|FG001|Persistence Year 9|Other|0|||
124856017|NCT00489970|449096044|FG002|Persistence Year 9|Other|2|||
124856018|NCT00116805|449096045|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
124856019|NCT00116805|449096046|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
124856020|NCT00116805|449096045|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
124856021|NCT00116805|449096046|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
124856022|NCT00116805|449096045|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
124856023|NCT00116805|449096046|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
124856024|NCT00116805|449096045|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
124856025|NCT00116805|449096046|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
124856026|NCT00116805|449096045|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
124856027|NCT00116805|449096046|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
124856028|NCT00116805|449096045|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
124856029|NCT00116805|449096046|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
124856030|NCT00116805|449096045|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
124856031|NCT00116805|449096046|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
124856032|NCT00116805|449096045|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
124856033|NCT00116805|449096046|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
124856034|NCT00116805|449096045|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
124856035|NCT00116805|449096046|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
124856036|NCT00116805|449096045|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
124856037|NCT00116805|449096046|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
124856038|NCT00116805|449096045|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
124856039|NCT00116805|449096046|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
124856040|NCT00116805|449096045|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
124856041|NCT00116805|449096046|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
124856042|NCT00116805|449096045|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
124856043|NCT00116805|449096046|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
124856044|NCT00116805|449096045|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
124856045|NCT00116805|449096046|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
124856046|NCT00116805|449096045|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
124856047|NCT00116805|449096046|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
124856048|NCT00116805|449096045|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
124856049|NCT00116805|449096046|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
124856050|NCT00116805|449096045|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
124856051|NCT00116805|449096046|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
124856052|NCT00116805|449096045|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
124856053|NCT00116805|449096046|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
124856054|NCT00116805|449096045|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
124856055|NCT00116805|449096046|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
124856056|NCT00116805|449096045|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
124856057|NCT00116805|449096046|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
124856058|NCT00116805|449096045|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
124856059|NCT00116805|449096046|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
124856060|NCT00116805|449096045|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
124856061|NCT00116805|449096046|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
124856062|NCT00116805|449096045|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
124856063|NCT00116805|449096046|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
124856064|NCT00116805|449096045|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
124856065|NCT00116805|449096046|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
124856066|NCT00116805|449096045|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
124856067|NCT00116805|449096046|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
124856068|NCT00116805|449096045|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
124856069|NCT00116805|449096046|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
124856070|NCT00116805|449096045|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
124856071|NCT00116805|449096046|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
124856072|NCT00116805|449096045|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
124856073|NCT00116805|449096046|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
124856074|NCT00116805|449096045|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
124856075|NCT00116805|449096046|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
124856076|NCT00116805|449096045|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
124856077|NCT00116805|449096046|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
124856078|NCT00116805|449096045|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
124856079|NCT00116805|449096046|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
124856080|NCT00116805|449096045|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
124856081|NCT00116805|449096046|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
124856082|NCT00116805|449096045|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
124856083|NCT00116805|449096046|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
124856084|NCT00116805|449096045|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
124856085|NCT00116805|449096046|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
124856086|NCT00116805|449096045|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
124856087|NCT00116805|449096046|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
124856088|NCT00116805|449096045|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
124856089|NCT00116805|449096046|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
124856090|NCT00116805|449096045|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
124856091|NCT00116805|449096046|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
124856092|NCT00116805|449096045|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
124856093|NCT00116805|449096046|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
124856094|NCT00116805|449096045|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
124856095|NCT00116805|449096046|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
124856096|NCT00116805|449096045|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
124856097|NCT00116805|449096046|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
124856098|NCT00116805|449096045|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
124856099|NCT00116805|449096046|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
124856100|NCT00116805|449096045|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
124856101|NCT00116805|449096046|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
124856102|NCT00116805|449096045|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
124856103|NCT00116805|449096046|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
124856104|NCT00116805|449096045|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
124856105|NCT00116805|449096046|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
124856106|NCT00116805|449096045|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
124856107|NCT00116805|449096046|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
124856108|NCT02707055|449096053|FG000|Phase 1|Withdrawal by Subject|1|||
124856109|NCT02707055|449096054|FG001|Phase 1|Withdrawal by Subject|2|||
124856110|NCT02707055|449096053|FG000|Phase 1|Physician Decision|0|||
124856111|NCT02707055|449096054|FG001|Phase 1|Physician Decision|1|||
124856112|NCT02707055|449096053|FG000|Phase 2|Adverse Event|1|||
124856113|NCT02707055|449096054|FG001|Phase 2|Adverse Event|2|||
124856114|NCT03564496|449096055|FG000|Overall Study|Withdrawal by Subject|1|||
124856115|NCT03564496|449096056|FG001|Overall Study|Withdrawal by Subject|1|||
124856116|NCT03564496|449096057|FG002|Overall Study|Withdrawal by Subject|0|||
124856117|NCT03564496|449096055|FG000|Overall Study|Screen failure|0|||
124856118|NCT03564496|449096056|FG001|Overall Study|Screen failure|3|||
124856119|NCT03564496|449096057|FG002|Overall Study|Screen failure|0|||
124856120|NCT01159938|449096058|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
124856121|NCT01159938|449096059|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
124856122|NCT01159938|449096060|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
124856123|NCT01159938|449096061|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
124856124|NCT01159938|449096062|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
124856125|NCT00317772|449096066|FG000|Overall Study|Adverse Event|0|||
124856126|NCT00317772|449096067|FG001|Overall Study|Adverse Event|0|||
124856127|NCT00317772|449096068|FG002|Overall Study|Adverse Event|0|||
124856128|NCT00317772|449096069|FG003|Overall Study|Adverse Event|2|||
124856129|NCT00317772|449096066|FG000|Overall Study|Disease Progression|2|||
124856130|NCT00317772|449096067|FG001|Overall Study|Disease Progression|2|||
124856131|NCT00317772|449096068|FG002|Overall Study|Disease Progression|1|||
124856132|NCT00317772|449096069|FG003|Overall Study|Disease Progression|7|||
124856133|NCT00353704|449096082|FG000|Overall Study|Protocol Violation|3|||
124856134|NCT00353704|449096083|FG001|Overall Study|Protocol Violation|1|||
124856135|NCT04495374|449096084|FG000|Overall Study|Protocol Violation|2|||
124856136|NCT04495374|449096085|FG001|Overall Study|Protocol Violation|1|||
124856137|NCT02473614|449096086|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
124856138|NCT02473614|449096087|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
124856139|NCT01303627|449096088|FG000|Overall Study|the failure while performing URS|0|||
124856140|NCT01303627|449096089|FG001|Overall Study|the failure while performing URS|1|||
124856141|NCT02416791|449096091|FG000|6 Months|Lost to Follow-up|0|||
124856142|NCT02416791|449096092|FG001|6 Months|Lost to Follow-up|0|||
124856143|NCT02416791|449096093|FG002|6 Months|Lost to Follow-up|1|||
124856144|NCT01054820|449096094|FG000|Overall Study|Withdrawal by Subject|2|||
124856145|NCT01154166|449096096|FG000|Overall Study|Adverse Event|14|||
124856146|NCT01154166|449096097|FG001|Overall Study|Adverse Event|9|||
124856147|NCT01154166|449096096|FG000|Overall Study|Lost to Follow-up|1|||
124856148|NCT01154166|449096097|FG001|Overall Study|Lost to Follow-up|1|||
124856149|NCT01154166|449096096|FG000|Overall Study|Protocol Violation|4|||
124856150|NCT01154166|449096097|FG001|Overall Study|Protocol Violation|1|||
124856151|NCT01154166|449096096|FG000|Overall Study|Withdrawal by Subject|10|||
124856152|NCT01154166|449096097|FG001|Overall Study|Withdrawal by Subject|1|||
124856153|NCT01154166|449096096|FG000|Overall Study|Lack of Efficacy|3|||
124856154|NCT01154166|449096097|FG001|Overall Study|Lack of Efficacy|0|||
124856155|NCT01154166|449096096|FG000|Overall Study|Disease Progression|1|||
124856156|NCT01154166|449096097|FG001|Overall Study|Disease Progression|0|||
124856157|NCT01154166|449096096|FG000|Overall Study|Poor Compliance|1|||
124856158|NCT01154166|449096097|FG001|Overall Study|Poor Compliance|0|||
124856159|NCT04121962|449096100|FG000|Overall Study|Lost to Follow-up|42|||
124856160|NCT04121962|449096101|FG001|Overall Study|Lost to Follow-up|39|||
124856161|NCT02019719|449096102|FG000|Overall Study|Adverse Event|1|||
124856162|NCT02019719|449096103|FG001|Overall Study|Adverse Event|0|||
124856163|NCT02019719|449096104|FG002|Overall Study|Adverse Event|0|||
124856164|NCT02019719|449096105|FG003|Overall Study|Adverse Event|1|||
124856165|NCT02019719|449096106|FG004|Overall Study|Adverse Event|1|||
124856166|NCT02019719|449096102|FG000|Overall Study|Protocol Violation|1|||
124856167|NCT02019719|449096103|FG001|Overall Study|Protocol Violation|1|||
124856168|NCT02019719|449096104|FG002|Overall Study|Protocol Violation|0|||
124856169|NCT02019719|449096105|FG003|Overall Study|Protocol Violation|0|||
124856170|NCT02019719|449096106|FG004|Overall Study|Protocol Violation|0|||
124856171|NCT02019719|449096102|FG000|Overall Study|Protocol defined stopping criteria|2|||
124856172|NCT02019719|449096103|FG001|Overall Study|Protocol defined stopping criteria|0|||
124856173|NCT02019719|449096104|FG002|Overall Study|Protocol defined stopping criteria|0|||
124856174|NCT02019719|449096105|FG003|Overall Study|Protocol defined stopping criteria|1|||
124856175|NCT02019719|449096106|FG004|Overall Study|Protocol defined stopping criteria|1|||
124856176|NCT02019719|449096102|FG000|Overall Study|Physician Decision|2|||
124856177|NCT02019719|449096103|FG001|Overall Study|Physician Decision|0|||
124856178|NCT02019719|449096104|FG002|Overall Study|Physician Decision|0|||
124856179|NCT02019719|449096105|FG003|Overall Study|Physician Decision|0|||
124856180|NCT02019719|449096106|FG004|Overall Study|Physician Decision|0|||
124856181|NCT04535037|449096107|FG000|Overall Study|Protocol Violation|1|||
124856182|NCT04535037|449096108|FG001|Overall Study|Protocol Violation|0|||
124856183|NCT04535037|449096107|FG000|Overall Study|Withdrawal by Subject|8|||
124856184|NCT04535037|449096108|FG001|Overall Study|Withdrawal by Subject|9|||
124856185|NCT04535037|449096107|FG000|Overall Study|Migrated / moved from the study area|1|||
124856186|NCT04535037|449096108|FG001|Overall Study|Migrated / moved from the study area|4|||
124856187|NCT04535037|449096107|FG000|Overall Study|Other|2|||
124856188|NCT04535037|449096108|FG001|Overall Study|Other|5|||
124856189|NCT02731131|449096116|FG000|Overall Study|Psychiatric Disorder|0|||
124856190|NCT02731131|449096117|FG001|Overall Study|Psychiatric Disorder|1|||
124856191|NCT02731131|449096116|FG000|Overall Study|Refused Therapy|0|||
124856192|NCT02731131|449096117|FG001|Overall Study|Refused Therapy|1|||
124856193|NCT02348216|449096118|FG000|Overall Study|Death|5|||
124856194|NCT02348216|449096119|FG001|Overall Study|Death|53|||
124856195|NCT02348216|449096120|FG002|Overall Study|Death|11|||
124856196|NCT02348216|449096121|FG003|Overall Study|Death|20|||
124856197|NCT02348216|449096122|FG004|Overall Study|Death|16|||
124856198|NCT02348216|449096123|FG005|Overall Study|Death|32|||
124856199|NCT02348216|449096124|FG006|Overall Study|Death|17|||
124856200|NCT02348216|449096118|FG000|Overall Study|Full consent withdrawal|0|||
124856201|NCT02348216|449096119|FG001|Overall Study|Full consent withdrawal|0|||
124856202|NCT02348216|449096120|FG002|Overall Study|Full consent withdrawal|0|||
124856203|NCT02348216|449096121|FG003|Overall Study|Full consent withdrawal|1|||
124856204|NCT02348216|449096122|FG004|Overall Study|Full consent withdrawal|3|||
124856205|NCT02348216|449096123|FG005|Overall Study|Full consent withdrawal|0|||
124856206|NCT02348216|449096124|FG006|Overall Study|Full consent withdrawal|3|||
124856207|NCT02348216|449096118|FG000|Overall Study|Lost to Follow-up|0|||
124856208|NCT02348216|449096119|FG001|Overall Study|Lost to Follow-up|5|||
124856209|NCT02348216|449096120|FG002|Overall Study|Lost to Follow-up|2|||
124856210|NCT02348216|449096121|FG003|Overall Study|Lost to Follow-up|0|||
124856211|NCT02348216|449096122|FG004|Overall Study|Lost to Follow-up|1|||
124856212|NCT02348216|449096123|FG005|Overall Study|Lost to Follow-up|1|||
124856213|NCT02348216|449096124|FG006|Overall Study|Lost to Follow-up|1|||
124856214|NCT02348216|449096118|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
124856215|NCT02348216|449096119|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
124856216|NCT02348216|449096120|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
124856217|NCT02348216|449096121|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
124856218|NCT02348216|449096122|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
124856219|NCT02348216|449096123|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
124856220|NCT02348216|449096124|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
124856221|NCT02348216|449096118|FG000|Overall Study|Reason not specified|2|||
124856222|NCT02348216|449096119|FG001|Overall Study|Reason not specified|19|||
124856223|NCT02348216|449096120|FG002|Overall Study|Reason not specified|11|||
124856224|NCT02348216|449096121|FG003|Overall Study|Reason not specified|17|||
124856225|NCT02348216|449096122|FG004|Overall Study|Reason not specified|21|||
124856226|NCT02348216|449096123|FG005|Overall Study|Reason not specified|17|||
124856227|NCT02348216|449096124|FG006|Overall Study|Reason not specified|19|||
124856228|NCT00765245|449096125|FG000|Overall Study|disease progression|3|||
124856229|NCT00765245|449096126|FG001|Overall Study|disease progression|2|||
124856230|NCT00765245|449096125|FG000|Overall Study|Withdrawal by Subject|3|||
124856231|NCT00765245|449096126|FG001|Overall Study|Withdrawal by Subject|0|||
124856232|NCT00765245|449096125|FG000|Overall Study|Adverse Event|5|||
124856233|NCT00765245|449096126|FG001|Overall Study|Adverse Event|0|||
124856234|NCT00765245|449096125|FG000|Overall Study|Physician Decision|1|||
124856235|NCT00765245|449096126|FG001|Overall Study|Physician Decision|0|||
124856236|NCT00765245|449096125|FG000|Overall Study|Death|1|||
124856237|NCT00765245|449096126|FG001|Overall Study|Death|0|||
124856238|NCT01181921|449096130|FG000|Overall Study|Lost to Follow-up|1|||
124856239|NCT04408469|449096131|FG000|Overall Study|Lost to Follow-up|6|||
124856240|NCT04408469|449096132|FG001|Overall Study|Lost to Follow-up|9|||
124856241|NCT04408469|449096131|FG000|Overall Study|Withdrawal by Subject|6|||
124856242|NCT04408469|449096132|FG001|Overall Study|Withdrawal by Subject|1|||
124856243|NCT04408469|449096131|FG000|Overall Study|Dismissal due to ineligibility|0|||
124856244|NCT04408469|449096132|FG001|Overall Study|Dismissal due to ineligibility|1|||
124856245|NCT04321460|449096135|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
124856246|NCT04321460|449096136|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
124856247|NCT01308749|449096143|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
124856248|NCT01308749|449096144|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
124856249|NCT01308749|449096143|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
124856250|NCT01308749|449096144|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
124856251|NCT01308749|449096143|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
124856252|NCT01308749|449096144|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
124856253|NCT02519504|449096145|FG000|Overall Study|Protocol Violation|6|||
124856254|NCT02519504|449096146|FG001|Overall Study|Protocol Violation|5|||
124856255|NCT02519504|449096145|FG000|Overall Study|Ineligible for direct testing|12|||
124856256|NCT02519504|449096146|FG001|Overall Study|Ineligible for direct testing|12|||
124856257|NCT02519504|449096145|FG000|Overall Study|Did not participate in direct testing|95|||
124856258|NCT02519504|449096146|FG001|Overall Study|Did not participate in direct testing|86|||
124856259|NCT04726709|449096147|FG000|Overall Study|Withdrawal by Subject|2|||
124856260|NCT04726709|449096148|FG001|Overall Study|Withdrawal by Subject|2|||
124856261|NCT02546544|449096149|FG000|Overall Study|Disease Progression|14|||
124856262|NCT02546544|449096149|FG000|Overall Study|Adverse Event|1|||
124856263|NCT02546544|449096149|FG000|Overall Study|Withdrawal by Subject|1|||
124856264|NCT02548962|449096150|FG000|Overall Study|Withdrawal by Subject|1|||
124856265|NCT02548962|449096151|FG001|Overall Study|Withdrawal by Subject|0|||
124856266|NCT01197950|449096152|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
124856267|NCT01197950|449096153|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
124856268|NCT01197950|449096154|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
124856269|NCT04831736|449096155|FG000|Overall Study|Withdrawal by Subject|0|||
124856270|NCT04831736|449096156|FG001|Overall Study|Withdrawal by Subject|1|||
124856271|NCT01666002|449096159|FG000|Overall Study|Lost to Follow-up|5|||
124856272|NCT01666002|449096160|FG001|Overall Study|Lost to Follow-up|0|||
124856273|NCT02159482|449096161|FG000|Overall Study|Withdrawal by Subject|2|||
124856274|NCT02159482|449096161|FG000|Overall Study|Physician Decision|3|||
124856275|NCT02828111|449096164|FG000|Overall Study|Withdrawal by Subject|0|||
124856276|NCT02828111|449096165|FG001|Overall Study|Withdrawal by Subject|0|||
124856277|NCT02828111|449096166|FG002|Overall Study|Withdrawal by Subject|2|||
124856278|NCT02828111|449096167|FG003|Overall Study|Withdrawal by Subject|0|||
124856279|NCT02828111|449096168|FG004|Overall Study|Withdrawal by Subject|0|||
124856280|NCT02828111|449096164|FG000|Overall Study|Lost to Follow-up|0|||
124856281|NCT02828111|449096165|FG001|Overall Study|Lost to Follow-up|0|||
124856282|NCT02828111|449096166|FG002|Overall Study|Lost to Follow-up|0|||
124856283|NCT02828111|449096167|FG003|Overall Study|Lost to Follow-up|1|||
124856284|NCT02828111|449096168|FG004|Overall Study|Lost to Follow-up|1|||
124856285|NCT03465540|449096171|FG000|Overall Study|Withdrawal by Subject|0|||
124856286|NCT03465540|449096172|FG001|Overall Study|Withdrawal by Subject|0|||
124856287|NCT03465540|449096173|FG002|Overall Study|Withdrawal by Subject|1|||
124856288|NCT03465540|449096174|FG003|Overall Study|Withdrawal by Subject|1|||
124856289|NCT03465540|449096175|FG004|Overall Study|Withdrawal by Subject|1|||
124856290|NCT03465540|449096176|FG005|Overall Study|Withdrawal by Subject|0|||
124856291|NCT03465540|449096171|FG000|Overall Study|Lost to Follow-up|0|||
124856292|NCT03465540|449096172|FG001|Overall Study|Lost to Follow-up|1|||
124856293|NCT03465540|449096173|FG002|Overall Study|Lost to Follow-up|0|||
124856294|NCT03465540|449096174|FG003|Overall Study|Lost to Follow-up|0|||
124856295|NCT03465540|449096175|FG004|Overall Study|Lost to Follow-up|1|||
124856296|NCT03465540|449096176|FG005|Overall Study|Lost to Follow-up|0|||
124856297|NCT03465540|449096171|FG000|Overall Study|Death|1|||
124856298|NCT03465540|449096172|FG001|Overall Study|Death|1|||
124856299|NCT03465540|449096173|FG002|Overall Study|Death|0|||
124856300|NCT03465540|449096174|FG003|Overall Study|Death|2|||
124856301|NCT03465540|449096175|FG004|Overall Study|Death|0|||
124856302|NCT03465540|449096176|FG005|Overall Study|Death|2|||
124856303|NCT03465540|449096171|FG000|Overall Study|Protocol specified criteria|0|||
124856304|NCT03465540|449096172|FG001|Overall Study|Protocol specified criteria|2|||
124856305|NCT03465540|449096173|FG002|Overall Study|Protocol specified criteria|2|||
124856306|NCT03465540|449096174|FG003|Overall Study|Protocol specified criteria|0|||
124856307|NCT03465540|449096175|FG004|Overall Study|Protocol specified criteria|2|||
124856308|NCT03465540|449096176|FG005|Overall Study|Protocol specified criteria|0|||
124856309|NCT02844946|449096177|FG000|Overall Study|Lost to Follow-up|7|||
124856310|NCT02844946|449096178|FG001|Overall Study|Lost to Follow-up|0|||
124856311|NCT00736996|449096179|FG000|Overall Study|Lost to Follow-up|1|||
124856312|NCT00736996|449096180|FG001|Overall Study|Lost to Follow-up|9|||
124856313|NCT00736996|449096181|FG002|Overall Study|Lost to Follow-up|2|||
124856314|NCT02806986|449096182|FG000|Treatment Stage 1|Adverse Event|1|||
124856315|NCT02806986|449096182|FG000|Treatment Stage 2|Adverse Event|3|||
124856316|NCT02806986|449096182|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
124856317|NCT00462384|449096183|FG000|Overall Study|Adverse Event|2|||
124856318|NCT00462384|449096183|FG000|Overall Study|Death|2|||
124856319|NCT00462384|449096183|FG000|Overall Study|Withdrawal by Subject|1|||
124856320|NCT00462384|449096183|FG000|Overall Study|Other|4|||
124856321|NCT02667912|449096184|FG000|Overall Study|Death|3|||
124856322|NCT02667912|449096185|FG001|Overall Study|Death|1|||
124856323|NCT02667912|449096184|FG000|Overall Study|Withdrawal by Subject|1|||
124856324|NCT02667912|449096185|FG001|Overall Study|Withdrawal by Subject|2|||
124856325|NCT02667912|449096184|FG000|Overall Study|Withdrawal by Subject|1|||
124856326|NCT02667912|449096185|FG001|Overall Study|Withdrawal by Subject|0|||
124856327|NCT04443218|449096186|FG000|Overall Study|Exited study for other reasons|9|||
124856328|NCT04443218|449096186|FG000|Overall Study|Withdrawal by Subject|1|||
124856329|NCT04443218|449096186|FG000|Overall Study|Lost to Follow-up|4|||
124856330|NCT04443218|449096186|FG000|Overall Study|Death|19|||
124856331|NCT00346034|449096187|FG000|Overall Study|Adverse Event|34|||
124856332|NCT00346034|449096187|FG000|Overall Study|Lack of Efficacy|8|||
124856333|NCT00346034|449096187|FG000|Overall Study|Withdrawal by Subject|13|||
124856334|NCT00346034|449096187|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
124856335|NCT00346034|449096187|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
124856336|NCT04000165|449096188|FG000|Overall Study|Physician Decision|1|||
124856337|NCT04000165|449096188|FG000|Overall Study|Withdrawal by Subject|1|||
124856338|NCT05799495|449096189|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
124856339|NCT05799495|449096190|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
124856340|NCT05799495|449096191|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
124856341|NCT05799495|449096192|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
124856342|NCT05799495|449096189|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
124856343|NCT05799495|449096190|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
124856344|NCT05799495|449096191|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
124856345|NCT05799495|449096192|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
124856346|NCT05799495|449096189|FG000|Treatment (Up to 5 Days)|Other|0|||
124856347|NCT05799495|449096190|FG001|Treatment (Up to 5 Days)|Other|1|||
124856348|NCT05799495|449096191|FG002|Treatment (Up to 5 Days)|Other|0|||
124856349|NCT05799495|449096192|FG003|Treatment (Up to 5 Days)|Other|0|||
124856350|NCT05799495|449096189|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
124856351|NCT05799495|449096190|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
124856352|NCT05799495|449096191|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
124856353|NCT05799495|449096192|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
124856354|NCT05799495|449096189|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
124856355|NCT05799495|449096190|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
124856356|NCT05799495|449096191|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
124856357|NCT05799495|449096192|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
124856358|NCT05799495|449096189|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
124856359|NCT05799495|449096190|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
124856360|NCT05799495|449096191|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
124856361|NCT05799495|449096192|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
124856362|NCT03105362|449096193|FG000|Overall Study|Withdrawal by Subject|1|||
124856363|NCT03105362|449096193|FG000|Overall Study|Lost to Follow-up|1|||
124856364|NCT02371369|449096195|FG000|Part 1|Physician Decision|0|||
124856365|NCT02371369|449096196|FG001|Part 1|Physician Decision|3|||
124856366|NCT02371369|449096195|FG000|Part 1|Adverse Event|8|||
124856367|NCT02371369|449096196|FG001|Part 1|Adverse Event|0|||
124856368|NCT02371369|449096195|FG000|Part 1|Withdrawal by Subject|1|||
124856369|NCT02371369|449096196|FG001|Part 1|Withdrawal by Subject|6|||
124856370|NCT02371369|449096195|FG000|Part 1|Disease progression|0|||
124856371|NCT02371369|449096196|FG001|Part 1|Disease progression|1|||
124856372|NCT02371369|449096195|FG000|Part 1|Protocol Violation|0|||
124856373|NCT02371369|449096196|FG001|Part 1|Protocol Violation|1|||
124856374|NCT02371369|449096195|FG000|Part 2|Adverse Event|6|||
124856375|NCT02371369|449096196|FG001|Part 2|Adverse Event|5|||
124856376|NCT02371369|449096195|FG000|Part 2|Withdrawal by Subject|16|||
124856377|NCT02371369|449096196|FG001|Part 2|Withdrawal by Subject|6|||
124856378|NCT02371369|449096195|FG000|Part 2|Investigator decision|1|||
124856379|NCT02371369|449096196|FG001|Part 2|Investigator decision|2|||
124856380|NCT02371369|449096195|FG000|Part 2|Death|0|||
124856381|NCT02371369|449096196|FG001|Part 2|Death|1|||
124856382|NCT02371369|449096195|FG000|Part 2|Disease progression|1|||
124856383|NCT02371369|449096196|FG001|Part 2|Disease progression|0|||
124856384|NCT02371369|449096195|FG000|Part 2|Subject Noncompliance|1|||
124856385|NCT02371369|449096196|FG001|Part 2|Subject Noncompliance|0|||
124856386|NCT02371369|449096195|FG000|Part 2|Lost to Follow-up|1|||
124856387|NCT02371369|449096196|FG001|Part 2|Lost to Follow-up|1|||
124856388|NCT02371369|449096195|FG000|Part 2|Subject transitioned to commercial supply|6|||
124856389|NCT02371369|449096196|FG001|Part 2|Subject transitioned to commercial supply|4|||
124856390|NCT02371369|449096195|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
124856391|NCT02371369|449096196|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
124856392|NCT02371369|449096195|FG000|Part 2|Surgical resection of tumor|1|||
124856393|NCT02371369|449096196|FG001|Part 2|Surgical resection of tumor|1|||
124856394|NCT02371369|449096195|FG000|Part 2|Other|0|||
124856395|NCT02371369|449096196|FG001|Part 2|Other|1|||
124856396|NCT00503685|449096201|FG000|Overall Study|Adverse Event|0|||
124856397|NCT00503685|449096202|FG001|Overall Study|Adverse Event|0|||
124856398|NCT00503685|449096203|FG002|Overall Study|Adverse Event|2|||
124856399|NCT00503685|449096201|FG000|Overall Study|Withdrawal by Subject|0|||
124856400|NCT00503685|449096202|FG001|Overall Study|Withdrawal by Subject|1|||
124856401|NCT00503685|449096203|FG002|Overall Study|Withdrawal by Subject|0|||
124856402|NCT00503685|449096201|FG000|Overall Study|Protocol Violation|0|||
124856403|NCT00503685|449096202|FG001|Overall Study|Protocol Violation|1|||
124856404|NCT00503685|449096203|FG002|Overall Study|Protocol Violation|0|||
124856405|NCT00503685|449096201|FG000|Overall Study|Eligibility Criteria Not Met|0|||
124856406|NCT00503685|449096202|FG001|Overall Study|Eligibility Criteria Not Met|1|||
124856407|NCT00503685|449096203|FG002|Overall Study|Eligibility Criteria Not Met|0|||
124856408|NCT02838017|449096205|FG000|Overall Study|Lost to Follow-up|14|||
124856409|NCT02838017|449096206|FG001|Overall Study|Lost to Follow-up|11|||
124856410|NCT02120924|449096207|FG000|Overall Study|Lack of Efficacy|1|||
124856411|NCT02120924|449096208|FG001|Overall Study|Lack of Efficacy|2|||
124856412|NCT02120924|449096209|FG002|Overall Study|Lack of Efficacy|3|||
124856413|NCT02120924|449096207|FG000|Overall Study|Adverse Event|0|||
124856414|NCT02120924|449096208|FG001|Overall Study|Adverse Event|1|||
124856415|NCT02120924|449096209|FG002|Overall Study|Adverse Event|3|||
124856416|NCT02120924|449096207|FG000|Overall Study|Withdrawal by Subject|16|||
124856417|NCT02120924|449096208|FG001|Overall Study|Withdrawal by Subject|20|||
124856418|NCT02120924|449096209|FG002|Overall Study|Withdrawal by Subject|8|||
124856419|NCT02120924|449096207|FG000|Overall Study|Lost to Follow-up|14|||
124856420|NCT02120924|449096208|FG001|Overall Study|Lost to Follow-up|14|||
124856421|NCT02120924|449096209|FG002|Overall Study|Lost to Follow-up|11|||
124856422|NCT02120924|449096207|FG000|Overall Study|Pregnancy|2|||
124856423|NCT02120924|449096208|FG001|Overall Study|Pregnancy|0|||
124856424|NCT02120924|449096209|FG002|Overall Study|Pregnancy|0|||
124856425|NCT02120924|449096207|FG000|Overall Study|Protocol Violation|3|||
124856426|NCT02120924|449096208|FG001|Overall Study|Protocol Violation|7|||
124856427|NCT02120924|449096209|FG002|Overall Study|Protocol Violation|2|||
124856428|NCT02120924|449096207|FG000|Overall Study|Physician Decision|0|||
124856429|NCT02120924|449096208|FG001|Overall Study|Physician Decision|1|||
124856430|NCT02120924|449096209|FG002|Overall Study|Physician Decision|1|||
124856431|NCT02120924|449096207|FG000|Overall Study|Death|1|||
124856432|NCT02120924|449096208|FG001|Overall Study|Death|0|||
124856433|NCT02120924|449096209|FG002|Overall Study|Death|0|||
124856434|NCT02120924|449096207|FG000|Overall Study|Compliance with IP|5|||
124856435|NCT02120924|449096208|FG001|Overall Study|Compliance with IP|1|||
124856436|NCT02120924|449096209|FG002|Overall Study|Compliance with IP|1|||
124856437|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
124856438|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
124856439|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
124856440|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
124856441|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
124856442|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
124856443|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
124856444|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
124856445|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
124856446|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
124856447|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
124856448|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
124856449|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
124856450|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
124856451|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
124856452|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
124856453|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
124856454|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
124856455|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
124856456|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
124856457|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
124856458|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
124856459|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
124856460|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
124856461|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
124856462|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
124856463|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
124856464|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
124856465|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
124856466|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
124856467|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
124856468|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
124856469|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
124856470|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
124856471|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
124856472|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
124856473|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
124856474|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
124856475|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
124856476|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
124856477|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
124856478|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
124856479|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
124856480|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
124856481|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
124856482|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
124856483|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
124856484|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
124856485|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
124856486|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
124856487|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
124856488|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
124856489|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
124856490|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
124856491|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
124856492|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
124856493|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
124856494|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
124856495|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
124856496|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
124856497|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
124856498|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
124856499|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
124856500|NCT01884350|449096210|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
124856501|NCT01884350|449096211|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
124856502|NCT01884350|449096212|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
124856503|NCT01059617|449096213|FG000|Overall Study|Other|7|||
124856504|NCT01059617|449096214|FG001|Overall Study|Other|1|||
124856505|NCT01059617|449096215|FG002|Overall Study|Other|8|||
124856506|NCT01059617|449096216|FG003|Overall Study|Other|6|||
124856507|NCT00074282|449097979|FG000|Step 1|Adverse Event|32|||
124856508|NCT00074282|449097980|FG001|Step 1|Adverse Event|0|||
124856509|NCT00074282|449097981|FG002|Step 1|Adverse Event|0|||
124856510|NCT00074282|449097979|FG000|Step 1|Death|6|||
124856511|NCT00074282|449097980|FG001|Step 1|Death|0|||
124856512|NCT00074282|449097981|FG002|Step 1|Death|0|||
124856513|NCT00074282|449097979|FG000|Step 1|Withdrawal by Subject|7|||
124856514|NCT00074282|449097980|FG001|Step 1|Withdrawal by Subject|0|||
124856515|NCT00074282|449097981|FG002|Step 1|Withdrawal by Subject|0|||
124856516|NCT00074282|449097979|FG000|Step 1|Disease progression|2|||
124856517|NCT00074282|449097980|FG001|Step 1|Disease progression|0|||
124856518|NCT00074282|449097981|FG002|Step 1|Disease progression|0|||
124856519|NCT00074282|449097979|FG000|Step 1|Alternative therapy|2|||
124856520|NCT00074282|449097980|FG001|Step 1|Alternative therapy|0|||
124856521|NCT00074282|449097981|FG002|Step 1|Alternative therapy|0|||
124856522|NCT00074282|449097979|FG000|Step 1|Other complicating disease|2|||
124856523|NCT00074282|449097980|FG001|Step 1|Other complicating disease|0|||
124856524|NCT00074282|449097981|FG002|Step 1|Other complicating disease|0|||
124856525|NCT00074282|449097979|FG000|Step 1|Physician Decision|1|||
124856526|NCT00074282|449097980|FG001|Step 1|Physician Decision|0|||
124856527|NCT00074282|449097981|FG002|Step 1|Physician Decision|0|||
124856528|NCT00074282|449097979|FG000|Step 1|Ineligible|4|||
124856529|NCT00074282|449097980|FG001|Step 1|Ineligible|0|||
124856530|NCT00074282|449097981|FG002|Step 1|Ineligible|0|||
124856531|NCT00074282|449097979|FG000|Step 1|Never started treatment|2|||
124856532|NCT00074282|449097980|FG001|Step 1|Never started treatment|0|||
124856533|NCT00074282|449097981|FG002|Step 1|Never started treatment|0|||
124856534|NCT00074282|449097979|FG000|Step 2|Adverse Event|0|||
124856535|NCT00074282|449097980|FG001|Step 2|Adverse Event|2|||
124856536|NCT00074282|449097981|FG002|Step 2|Adverse Event|12|||
124856537|NCT00074282|449097979|FG000|Step 2|Disease progression|0|||
124856538|NCT00074282|449097980|FG001|Step 2|Disease progression|0|||
124856539|NCT00074282|449097981|FG002|Step 2|Disease progression|5|||
124856540|NCT00074282|449097979|FG000|Step 2|Death|0|||
124856541|NCT00074282|449097980|FG001|Step 2|Death|0|||
124856542|NCT00074282|449097981|FG002|Step 2|Death|3|||
124856543|NCT00074282|449097979|FG000|Step 2|Withdrawal by Subject|0|||
124856544|NCT00074282|449097980|FG001|Step 2|Withdrawal by Subject|0|||
124856545|NCT00074282|449097981|FG002|Step 2|Withdrawal by Subject|2|||
124856546|NCT00074282|449097979|FG000|Step 2|Physician Decision|0|||
124856547|NCT00074282|449097980|FG001|Step 2|Physician Decision|0|||
124856548|NCT00074282|449097981|FG002|Step 2|Physician Decision|1|||
124856549|NCT00074282|449097979|FG000|Step 2|Ineligible|0|||
124856550|NCT00074282|449097980|FG001|Step 2|Ineligible|0|||
124856551|NCT00074282|449097981|FG002|Step 2|Ineligible|1|||
124856552|NCT00464542|449097982|FG000|Pre-treatment|Withdrawal by Subject|2|||
124856553|NCT01773226|449097984|FG000|Overall Study|Withdrawal by Subject|1|||
124856554|NCT02055352|449097989|FG000|Overall Study|Adverse Event|0|||
124856555|NCT02055352|449097990|FG001|Overall Study|Adverse Event|1|||
124856556|NCT02055352|449097989|FG000|Overall Study|Non-eligible|0|||
124856557|NCT02055352|449097990|FG001|Overall Study|Non-eligible|1|||
124856558|NCT02055352|449097989|FG000|Overall Study|Poor compliance|1|||
124856559|NCT02055352|449097990|FG001|Overall Study|Poor compliance|1|||
124856560|NCT02055352|449097989|FG000|Overall Study|Death|1|||
124856561|NCT02055352|449097990|FG001|Overall Study|Death|2|||
124856562|NCT02055352|449097989|FG000|Overall Study|Patient decision|1|||
124856563|NCT02055352|449097990|FG001|Overall Study|Patient decision|1|||
124856564|NCT02055352|449097989|FG000|Overall Study|Use of prohibited treatment|0|||
124856565|NCT02055352|449097990|FG001|Overall Study|Use of prohibited treatment|3|||
124856566|NCT02055352|449097989|FG000|Overall Study|AE, study drug would be detrimental|1|||
124856567|NCT02055352|449097990|FG001|Overall Study|AE, study drug would be detrimental|3|||
124856568|NCT02055352|449097989|FG000|Overall Study|Withdrawal of informed consent|1|||
124856569|NCT02055352|449097990|FG001|Overall Study|Withdrawal of informed consent|0|||
124856570|NCT02055352|449097989|FG000|Overall Study|Reason unknown|1|||
124856571|NCT02055352|449097990|FG001|Overall Study|Reason unknown|5|||
124856572|NCT03794089|449097997|FG000|Overall Study|Lost to Follow-up|4|||
124856573|NCT03794089|449097998|FG001|Overall Study|Lost to Follow-up|1|||
124856574|NCT03794089|449097997|FG000|Overall Study|Withdrawal by Subject|2|||
124856575|NCT03794089|449097998|FG001|Overall Study|Withdrawal by Subject|0|||
124856576|NCT03985423|449097999|FG000|Overall Study|Adverse Event|1|||
124856577|NCT03985423|449097999|FG000|Overall Study|Death|2|||
124856578|NCT03985423|449097999|FG000|Overall Study|Physician Decision|1|||
124856579|NCT03985423|449097999|FG000|Overall Study|Withdrawal by Subject|2|||
124856580|NCT03985423|449097999|FG000|Overall Study|Lack of insurance and citizenship|1|||
124856581|NCT01045447|449098010|FG000|Overall Study|Adverse Event|0|||
124856582|NCT01045447|449098011|FG001|Overall Study|Adverse Event|1|||
124856583|NCT01045447|449098010|FG000|Overall Study|Lack of Efficacy|3|||
124856584|NCT01045447|449098011|FG001|Overall Study|Lack of Efficacy|1|||
124856585|NCT01045447|449098010|FG000|Overall Study|Protocol Violation|6|||
124856586|NCT01045447|449098011|FG001|Overall Study|Protocol Violation|3|||
124856587|NCT01045447|449098010|FG000|Overall Study|Withdrawal Criteria|10|||
124856588|NCT01045447|449098011|FG001|Overall Study|Withdrawal Criteria|10|||
124856589|NCT01045447|449098010|FG000|Overall Study|Unclassified|17|||
124856590|NCT01045447|449098011|FG001|Overall Study|Unclassified|13|||
124856591|NCT02318329|449098016|FG000|Overall Study|Progressive Disease|2|||
124856592|NCT02318329|449098017|FG001|Overall Study|Progressive Disease|3|||
124856593|NCT02318329|449098018|FG002|Overall Study|Progressive Disease|2|||
124856594|NCT02318329|449098019|FG003|Overall Study|Progressive Disease|3|||
124856595|NCT02318329|449098020|FG004|Overall Study|Progressive Disease|3|||
124856596|NCT02318329|449098021|FG005|Overall Study|Progressive Disease|3|||
124856597|NCT02318329|449098022|FG006|Overall Study|Progressive Disease|1|||
124856598|NCT02318329|449098023|FG007|Overall Study|Progressive Disease|1|||
124856599|NCT02318329|449098024|FG008|Overall Study|Progressive Disease|5|||
124856600|NCT02318329|449098025|FG009|Overall Study|Progressive Disease|39|||
124856601|NCT02318329|449098016|FG000|Overall Study|Death|0|||
124856602|NCT02318329|449098017|FG001|Overall Study|Death|0|||
124856603|NCT02318329|449098018|FG002|Overall Study|Death|0|||
124856604|NCT02318329|449098019|FG003|Overall Study|Death|0|||
124856605|NCT02318329|449098020|FG004|Overall Study|Death|0|||
124856606|NCT02318329|449098021|FG005|Overall Study|Death|0|||
124856607|NCT02318329|449098022|FG006|Overall Study|Death|0|||
124856608|NCT02318329|449098023|FG007|Overall Study|Death|0|||
124856609|NCT02318329|449098024|FG008|Overall Study|Death|0|||
124856610|NCT02318329|449098025|FG009|Overall Study|Death|5|||
124856611|NCT02318329|449098016|FG000|Overall Study|Lost to Follow-up|0|||
124856612|NCT02318329|449098017|FG001|Overall Study|Lost to Follow-up|0|||
124856613|NCT02318329|449098018|FG002|Overall Study|Lost to Follow-up|0|||
124856614|NCT02318329|449098019|FG003|Overall Study|Lost to Follow-up|0|||
124856615|NCT02318329|449098020|FG004|Overall Study|Lost to Follow-up|0|||
124856616|NCT02318329|449098021|FG005|Overall Study|Lost to Follow-up|0|||
124856617|NCT02318329|449098022|FG006|Overall Study|Lost to Follow-up|0|||
124856618|NCT02318329|449098023|FG007|Overall Study|Lost to Follow-up|0|||
124856619|NCT02318329|449098024|FG008|Overall Study|Lost to Follow-up|0|||
124856620|NCT02318329|449098025|FG009|Overall Study|Lost to Follow-up|1|||
124856621|NCT02318329|449098016|FG000|Overall Study|Withdrawal by Subject|0|||
124856622|NCT02318329|449098017|FG001|Overall Study|Withdrawal by Subject|0|||
124856623|NCT02318329|449098018|FG002|Overall Study|Withdrawal by Subject|0|||
124856624|NCT02318329|449098019|FG003|Overall Study|Withdrawal by Subject|0|||
124856625|NCT02318329|449098020|FG004|Overall Study|Withdrawal by Subject|0|||
124856626|NCT02318329|449098021|FG005|Overall Study|Withdrawal by Subject|0|||
124856627|NCT02318329|449098022|FG006|Overall Study|Withdrawal by Subject|0|||
124856628|NCT02318329|449098023|FG007|Overall Study|Withdrawal by Subject|0|||
124856629|NCT02318329|449098024|FG008|Overall Study|Withdrawal by Subject|0|||
124856630|NCT02318329|449098025|FG009|Overall Study|Withdrawal by Subject|6|||
124856631|NCT02318329|449098016|FG000|Overall Study|Other|1|||
124856632|NCT02318329|449098017|FG001|Overall Study|Other|1|||
124856633|NCT02318329|449098018|FG002|Overall Study|Other|1|||
124856634|NCT02318329|449098019|FG003|Overall Study|Other|0|||
124856635|NCT02318329|449098020|FG004|Overall Study|Other|0|||
124856636|NCT02318329|449098021|FG005|Overall Study|Other|0|||
124856637|NCT02318329|449098022|FG006|Overall Study|Other|0|||
124856638|NCT02318329|449098023|FG007|Overall Study|Other|0|||
124856639|NCT02318329|449098024|FG008|Overall Study|Other|1|||
124856640|NCT02318329|449098025|FG009|Overall Study|Other|1|||
124856641|NCT00086346|449098026|FG000|Randomization|Did not receive test article|4|||
124856642|NCT00086346|449098027|FG001|Randomization|Did not receive test article|4|||
124856643|NCT00086346|449098026|FG000|Patients Dosed With Test Article|Adverse Event|94|||
124856644|NCT00086346|449098027|FG001|Patients Dosed With Test Article|Adverse Event|11|||
124856645|NCT00086346|449098026|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
124856646|NCT00086346|449098027|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
124856647|NCT00086346|449098026|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
124856648|NCT00086346|449098027|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
124856649|NCT00086346|449098026|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
124856650|NCT00086346|449098027|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
124856651|NCT00086346|449098026|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
124856652|NCT00086346|449098027|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
124856653|NCT00086346|449098026|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
124856654|NCT00086346|449098027|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
124856655|NCT03268811|449098028|FG000|Overall Study|Adverse Event|0|||
124856656|NCT03268811|449098029|FG001|Overall Study|Adverse Event|1|||
124856657|NCT01055639|449098030|FG000|Overall Study|Adverse Event|0|||
124856658|NCT01055639|449098031|FG001|Overall Study|Adverse Event|1|||
124856659|NCT01055639|449098030|FG000|Overall Study|Lack of Efficacy|0|||
124856660|NCT01055639|449098031|FG001|Overall Study|Lack of Efficacy|1|||
124856661|NCT01055639|449098030|FG000|Overall Study|Lost to Follow-up|8|||
124856662|NCT01055639|449098031|FG001|Overall Study|Lost to Follow-up|11|||
124856663|NCT01055639|449098030|FG000|Overall Study|Protocol Violation|5|||
124856664|NCT01055639|449098031|FG001|Overall Study|Protocol Violation|5|||
124856665|NCT01055639|449098030|FG000|Overall Study|Withdrawal by Subject|8|||
124856666|NCT01055639|449098031|FG001|Overall Study|Withdrawal by Subject|11|||
124856667|NCT00562159|449098032|FG000|Overall Study|Adverse Event|11|||
124856668|NCT00562159|449098033|FG001|Overall Study|Adverse Event|8|||
124856669|NCT00562159|449098032|FG000|Overall Study|Lost to Follow-up|5|||
124856670|NCT00562159|449098033|FG001|Overall Study|Lost to Follow-up|4|||
124856671|NCT00562159|449098032|FG000|Overall Study|Withdrawal by Subject|9|||
124856672|NCT00562159|449098033|FG001|Overall Study|Withdrawal by Subject|8|||
124856673|NCT00562159|449098032|FG000|Overall Study|Protocol Violation|12|||
124856674|NCT00562159|449098033|FG001|Overall Study|Protocol Violation|12|||
124856675|NCT00562159|449098032|FG000|Overall Study|Did not meet protocol eligibility|1|||
124856676|NCT00562159|449098033|FG001|Overall Study|Did not meet protocol eligibility|1|||
124856677|NCT02417246|449098034|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
124856678|NCT02417246|449098035|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
124856679|NCT02417246|449098034|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
124856680|NCT02417246|449098035|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
124856681|NCT02417246|449098034|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
124856682|NCT02417246|449098035|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
124856683|NCT02417246|449098034|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
124856684|NCT02417246|449098035|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
124856685|NCT01233817|449098039|FG000|Overall Study|Lost to Follow-up|1|||
124856686|NCT01233817|449098039|FG000|Overall Study|Withdrawal by Subject|2|||
124856687|NCT01248884|449098040|FG000|Overall Study|Withdrawal by Subject|1|||
124856688|NCT01248884|449098041|FG001|Overall Study|Withdrawal by Subject|3|||
124856689|NCT01248884|449098042|FG002|Overall Study|Withdrawal by Subject|1|||
124856690|NCT01248884|449098040|FG000|Overall Study|Adverse Event|1|||
124856691|NCT01248884|449098041|FG001|Overall Study|Adverse Event|0|||
124856692|NCT01248884|449098042|FG002|Overall Study|Adverse Event|0|||
124856693|NCT02511431|449098043|FG000|Treatment|Lost to Follow-up|0|||
124856694|NCT02511431|449098044|FG001|Treatment|Lost to Follow-up|0|||
124856695|NCT02511431|449098045|FG002|Treatment|Lost to Follow-up|1|||
124856696|NCT02511431|449098046|FG003|Treatment|Lost to Follow-up|0|||
124856697|NCT02511431|449098047|FG004|Treatment|Lost to Follow-up|0|||
124856698|NCT02511431|449098048|FG005|Treatment|Lost to Follow-up|1|||
124856699|NCT04479618|449098049|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
124856700|NCT04479618|449098050|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
124856701|NCT04479618|449098051|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
124856702|NCT04479618|449098049|FG000|Overall Study|Lack of Efficacy|1|||
124856703|NCT04479618|449098050|FG001|Overall Study|Lack of Efficacy|0|||
124856704|NCT04479618|449098051|FG002|Overall Study|Lack of Efficacy|0|||
124856705|NCT04479618|449098049|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
124856706|NCT04479618|449098050|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
124856707|NCT04479618|449098051|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
124856708|NCT04479618|449098049|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
124856709|NCT04479618|449098050|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
124856710|NCT04479618|449098051|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
124856711|NCT04479618|449098049|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
124856712|NCT04479618|449098050|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
124856713|NCT04479618|449098051|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
124856714|NCT04479618|449098049|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
124856715|NCT04479618|449098050|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
124856716|NCT04479618|449098051|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
124856717|NCT01202773|449098052|FG000|Overall Study|Adverse Event|4|||
124856718|NCT01202773|449098053|FG001|Overall Study|Adverse Event|5|||
124856719|NCT01202773|449098054|FG002|Overall Study|Adverse Event|5|||
124856720|NCT01202773|449098052|FG000|Overall Study|Lack of Efficacy|5|||
124856721|NCT01202773|449098053|FG001|Overall Study|Lack of Efficacy|4|||
124856722|NCT01202773|449098054|FG002|Overall Study|Lack of Efficacy|9|||
124856723|NCT01202773|449098052|FG000|Overall Study|Entry Criteria Not Met|2|||
124856724|NCT01202773|449098053|FG001|Overall Study|Entry Criteria Not Met|0|||
124856725|NCT01202773|449098054|FG002|Overall Study|Entry Criteria Not Met|1|||
124856726|NCT01202773|449098052|FG000|Overall Study|Lost to Follow-up|1|||
124856727|NCT01202773|449098053|FG001|Overall Study|Lost to Follow-up|2|||
124856728|NCT01202773|449098054|FG002|Overall Study|Lost to Follow-up|2|||
124856729|NCT01202773|449098052|FG000|Overall Study|Withdrawal by Subject|13|||
124856730|NCT01202773|449098053|FG001|Overall Study|Withdrawal by Subject|6|||
124856731|NCT01202773|449098054|FG002|Overall Study|Withdrawal by Subject|5|||
124856732|NCT01202773|449098052|FG000|Overall Study|Physician Decision|2|||
124856733|NCT01202773|449098053|FG001|Overall Study|Physician Decision|0|||
124856734|NCT01202773|449098054|FG002|Overall Study|Physician Decision|0|||
124856735|NCT01202773|449098052|FG000|Overall Study|Protocol Violation|11|||
124856736|NCT01202773|449098053|FG001|Overall Study|Protocol Violation|6|||
124856737|NCT01202773|449098054|FG002|Overall Study|Protocol Violation|10|||
124856738|NCT01202773|449098052|FG000|Overall Study|Sponsor Decision|19|||
124856739|NCT01202773|449098053|FG001|Overall Study|Sponsor Decision|20|||
124856740|NCT01202773|449098054|FG002|Overall Study|Sponsor Decision|23|||
124856741|NCT04827212|449098061|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
124856742|NCT04827212|449098062|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
124856743|NCT04827212|449098061|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
124856744|NCT04827212|449098062|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
124856745|NCT04360824|449098065|FG000|Overall Study|Withdrawal by Subject|2|||
124856746|NCT04360824|449098066|FG001|Overall Study|Withdrawal by Subject|1|||
124856747|NCT04360824|449098065|FG000|Overall Study|Did not receive assigned treatment|1|||
124856748|NCT04360824|449098066|FG001|Overall Study|Did not receive assigned treatment|3|||
124856749|NCT00320216|449098067|FG000|Overall Study|Adverse Event|0|||
124856750|NCT00320216|449098068|FG001|Overall Study|Adverse Event|6|||
124856751|NCT00320216|449098069|FG002|Overall Study|Adverse Event|0|||
124856752|NCT00320216|449098070|FG003|Overall Study|Adverse Event|2|||
124856753|NCT00320216|449098071|FG004|Overall Study|Adverse Event|2|||
124856754|NCT00320216|449098067|FG000|Overall Study|Lack of Efficacy|6|||
124856755|NCT00320216|449098068|FG001|Overall Study|Lack of Efficacy|2|||
124856756|NCT00320216|449098069|FG002|Overall Study|Lack of Efficacy|1|||
124856757|NCT00320216|449098070|FG003|Overall Study|Lack of Efficacy|0|||
124856758|NCT00320216|449098071|FG004|Overall Study|Lack of Efficacy|1|||
124856759|NCT00320216|449098067|FG000|Overall Study|Lost to Follow-up|3|||
124856760|NCT00320216|449098068|FG001|Overall Study|Lost to Follow-up|0|||
124856761|NCT00320216|449098069|FG002|Overall Study|Lost to Follow-up|0|||
124856762|NCT00320216|449098070|FG003|Overall Study|Lost to Follow-up|0|||
124856763|NCT00320216|449098071|FG004|Overall Study|Lost to Follow-up|0|||
124856764|NCT00320216|449098067|FG000|Overall Study|Other|7|||
124856765|NCT00320216|449098068|FG001|Overall Study|Other|2|||
124856766|NCT00320216|449098069|FG002|Overall Study|Other|5|||
124856767|NCT00320216|449098070|FG003|Overall Study|Other|1|||
124856768|NCT00320216|449098071|FG004|Overall Study|Other|3|||
124856769|NCT02265705|449098072|FG000|Treatment Period Week 0-24|Adverse Event|3|||
124856770|NCT02265705|449098073|FG001|Treatment Period Week 0-24|Adverse Event|2|||
124856771|NCT02265705|449098074|FG002|Treatment Period Week 0-24|Adverse Event|0|||
124856772|NCT02265705|449098075|FG003|Treatment Period Week 0-24|Adverse Event|0|||
124856773|NCT02265705|449098076|FG004|Treatment Period Week 0-24|Adverse Event|0|||
124856774|NCT02265705|449098077|FG005|Treatment Period Week 0-24|Adverse Event|0|||
124856775|NCT02265705|449098078|FG006|Treatment Period Week 0-24|Adverse Event|0|||
124856776|NCT02265705|449098072|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
124856777|NCT02265705|449098073|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
124856778|NCT02265705|449098074|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
124856779|NCT02265705|449098075|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
124856780|NCT02265705|449098076|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
124856781|NCT02265705|449098077|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
124856782|NCT02265705|449098078|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
124856783|NCT02265705|449098072|FG000|Treatment Period Week 0-24|Physician Decision|1|||
124856784|NCT02265705|449098073|FG001|Treatment Period Week 0-24|Physician Decision|0|||
124856785|NCT02265705|449098074|FG002|Treatment Period Week 0-24|Physician Decision|0|||
124856786|NCT02265705|449098075|FG003|Treatment Period Week 0-24|Physician Decision|0|||
124856787|NCT02265705|449098076|FG004|Treatment Period Week 0-24|Physician Decision|0|||
124856788|NCT02265705|449098077|FG005|Treatment Period Week 0-24|Physician Decision|0|||
124856789|NCT02265705|449098078|FG006|Treatment Period Week 0-24|Physician Decision|0|||
124856790|NCT02265705|449098072|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
124856791|NCT02265705|449098073|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
124856792|NCT02265705|449098074|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
124856793|NCT02265705|449098075|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
124856794|NCT02265705|449098076|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
124856795|NCT02265705|449098077|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
124856796|NCT02265705|449098078|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
124856797|NCT02265705|449098072|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
124856798|NCT02265705|449098073|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
124856799|NCT02265705|449098074|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
124856800|NCT02265705|449098075|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
124856801|NCT02265705|449098076|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
124856802|NCT02265705|449098077|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
124856803|NCT02265705|449098078|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
124856804|NCT02265705|449098072|FG000|Rescue Period|Withdrawal by Subject|0|||
124856805|NCT02265705|449098073|FG001|Rescue Period|Withdrawal by Subject|0|||
124856806|NCT02265705|449098074|FG002|Rescue Period|Withdrawal by Subject|1|||
124856807|NCT02265705|449098075|FG003|Rescue Period|Withdrawal by Subject|0|||
124856808|NCT02265705|449098076|FG004|Rescue Period|Withdrawal by Subject|0|||
124856809|NCT02265705|449098077|FG005|Rescue Period|Withdrawal by Subject|0|||
124856810|NCT02265705|449098078|FG006|Rescue Period|Withdrawal by Subject|0|||
124856811|NCT02265705|449098072|FG000|Rescue Period|Death|0|||
124856812|NCT02265705|449098073|FG001|Rescue Period|Death|0|||
124856813|NCT02265705|449098074|FG002|Rescue Period|Death|1|||
124856814|NCT02265705|449098075|FG003|Rescue Period|Death|0|||
124856815|NCT02265705|449098076|FG004|Rescue Period|Death|0|||
124856816|NCT02265705|449098077|FG005|Rescue Period|Death|0|||
124856817|NCT02265705|449098078|FG006|Rescue Period|Death|0|||
124856818|NCT02265705|449098072|FG000|Rescue Period|Lack of Efficacy|0|||
124856819|NCT02265705|449098073|FG001|Rescue Period|Lack of Efficacy|0|||
124856820|NCT02265705|449098074|FG002|Rescue Period|Lack of Efficacy|1|||
124856821|NCT02265705|449098075|FG003|Rescue Period|Lack of Efficacy|0|||
124856822|NCT02265705|449098076|FG004|Rescue Period|Lack of Efficacy|0|||
124856823|NCT02265705|449098077|FG005|Rescue Period|Lack of Efficacy|0|||
124856824|NCT02265705|449098078|FG006|Rescue Period|Lack of Efficacy|0|||
124856825|NCT02265705|449098072|FG000|Open Label Period|Adverse Event|0|||
124856826|NCT02265705|449098073|FG001|Open Label Period|Adverse Event|0|||
124856827|NCT02265705|449098074|FG002|Open Label Period|Adverse Event|0|||
124856828|NCT02265705|449098075|FG003|Open Label Period|Adverse Event|2|||
124856829|NCT02265705|449098076|FG004|Open Label Period|Adverse Event|2|||
124856830|NCT02265705|449098077|FG005|Open Label Period|Adverse Event|0|||
124856831|NCT02265705|449098078|FG006|Open Label Period|Adverse Event|0|||
124856832|NCT02265705|449098072|FG000|Open Label Period|Physician Decision|0|||
124856833|NCT02265705|449098073|FG001|Open Label Period|Physician Decision|0|||
124856834|NCT02265705|449098074|FG002|Open Label Period|Physician Decision|0|||
124856835|NCT02265705|449098075|FG003|Open Label Period|Physician Decision|0|||
124856836|NCT02265705|449098076|FG004|Open Label Period|Physician Decision|1|||
124856837|NCT02265705|449098077|FG005|Open Label Period|Physician Decision|0|||
124856838|NCT02265705|449098078|FG006|Open Label Period|Physician Decision|0|||
124856839|NCT02265705|449098072|FG000|Open Label Period|Withdrawal by Subject|0|||
124856840|NCT02265705|449098073|FG001|Open Label Period|Withdrawal by Subject|0|||
124856841|NCT02265705|449098074|FG002|Open Label Period|Withdrawal by Subject|0|||
124856842|NCT02265705|449098075|FG003|Open Label Period|Withdrawal by Subject|0|||
124856843|NCT02265705|449098076|FG004|Open Label Period|Withdrawal by Subject|2|||
124856844|NCT02265705|449098077|FG005|Open Label Period|Withdrawal by Subject|0|||
124856845|NCT02265705|449098078|FG006|Open Label Period|Withdrawal by Subject|0|||
124856846|NCT02265705|449098072|FG000|Follow-up Period|Sponsor Decision|0|||
124856847|NCT02265705|449098073|FG001|Follow-up Period|Sponsor Decision|0|||
124856848|NCT02265705|449098074|FG002|Follow-up Period|Sponsor Decision|0|||
124856849|NCT02265705|449098075|FG003|Follow-up Period|Sponsor Decision|0|||
124856850|NCT02265705|449098076|FG004|Follow-up Period|Sponsor Decision|0|||
124856851|NCT02265705|449098077|FG005|Follow-up Period|Sponsor Decision|1|||
124856852|NCT02265705|449098078|FG006|Follow-up Period|Sponsor Decision|6|||
124856853|NCT02265705|449098072|FG000|Follow-up Period|Adverse Event|0|||
124856854|NCT02265705|449098073|FG001|Follow-up Period|Adverse Event|0|||
124856855|NCT02265705|449098074|FG002|Follow-up Period|Adverse Event|0|||
124856856|NCT02265705|449098075|FG003|Follow-up Period|Adverse Event|0|||
124856857|NCT02265705|449098076|FG004|Follow-up Period|Adverse Event|0|||
124856858|NCT02265705|449098077|FG005|Follow-up Period|Adverse Event|0|||
124856859|NCT02265705|449098078|FG006|Follow-up Period|Adverse Event|3|||
124856860|NCT02265705|449098072|FG000|Follow-up Period|Physician Decision|0|||
124856861|NCT02265705|449098073|FG001|Follow-up Period|Physician Decision|0|||
124856862|NCT02265705|449098074|FG002|Follow-up Period|Physician Decision|0|||
124856863|NCT02265705|449098075|FG003|Follow-up Period|Physician Decision|0|||
124856864|NCT02265705|449098076|FG004|Follow-up Period|Physician Decision|0|||
124856865|NCT02265705|449098077|FG005|Follow-up Period|Physician Decision|0|||
124856866|NCT02265705|449098078|FG006|Follow-up Period|Physician Decision|1|||
124856867|NCT02265705|449098072|FG000|Follow-up Period|Withdrawal by Subject|0|||
124856868|NCT02265705|449098073|FG001|Follow-up Period|Withdrawal by Subject|0|||
124856869|NCT02265705|449098074|FG002|Follow-up Period|Withdrawal by Subject|0|||
124856870|NCT02265705|449098075|FG003|Follow-up Period|Withdrawal by Subject|0|||
124856871|NCT02265705|449098076|FG004|Follow-up Period|Withdrawal by Subject|0|||
124856872|NCT02265705|449098077|FG005|Follow-up Period|Withdrawal by Subject|0|||
124856873|NCT02265705|449098078|FG006|Follow-up Period|Withdrawal by Subject|1|||
124856874|NCT00377676|449098080|FG000|Overall Study|Adverse Event|498|||
124856875|NCT00377676|449098081|FG001|Overall Study|Adverse Event|107|||
124856876|NCT00377676|449098080|FG000|Overall Study|Protocol Violation|33|||
124856877|NCT00377676|449098081|FG001|Overall Study|Protocol Violation|27|||
124856878|NCT00377676|449098080|FG000|Overall Study|Death|5|||
124856879|NCT00377676|449098081|FG001|Overall Study|Death|2|||
124856880|NCT00377676|449098080|FG000|Overall Study|Withdrawal by Subject|187|||
124856881|NCT00377676|449098081|FG001|Overall Study|Withdrawal by Subject|72|||
124856882|NCT00377676|449098080|FG000|Overall Study|Lost to Follow-up|120|||
124856883|NCT00377676|449098081|FG001|Overall Study|Lost to Follow-up|56|||
124856884|NCT00377676|449098080|FG000|Overall Study|Other|118|||
124856885|NCT00377676|449098081|FG001|Overall Study|Other|58|||
124856886|NCT00779246|449098086|FG000|Overall Study|Missing sufficient data for analysis|33|||
124856887|NCT00779246|449098087|FG001|Overall Study|Missing sufficient data for analysis|53|||
124856888|NCT00941603|449098095|FG000|Overall Study|Adverse Event|10|||
124856889|NCT00941603|449098096|FG001|Overall Study|Adverse Event|15|||
124856890|NCT00941603|449098097|FG002|Overall Study|Adverse Event|5|||
124856891|NCT00941603|449098098|FG003|Overall Study|Adverse Event|1|||
124856892|NCT00941603|449098099|FG004|Overall Study|Adverse Event|4|||
124856893|NCT00941603|449098100|FG005|Overall Study|Adverse Event|0|||
124856894|NCT00941603|449098095|FG000|Overall Study|Lost to Follow-up|0|||
124856895|NCT00941603|449098096|FG001|Overall Study|Lost to Follow-up|0|||
124856896|NCT00941603|449098097|FG002|Overall Study|Lost to Follow-up|0|||
124856897|NCT00941603|449098098|FG003|Overall Study|Lost to Follow-up|1|||
124856898|NCT00941603|449098099|FG004|Overall Study|Lost to Follow-up|0|||
124856899|NCT00941603|449098100|FG005|Overall Study|Lost to Follow-up|2|||
124856900|NCT00941603|449098095|FG000|Overall Study|Withdrawal by Subject|0|||
124856901|NCT00941603|449098096|FG001|Overall Study|Withdrawal by Subject|0|||
124856902|NCT00941603|449098097|FG002|Overall Study|Withdrawal by Subject|0|||
124856903|NCT00941603|449098098|FG003|Overall Study|Withdrawal by Subject|2|||
124856904|NCT00941603|449098099|FG004|Overall Study|Withdrawal by Subject|0|||
124856905|NCT00941603|449098100|FG005|Overall Study|Withdrawal by Subject|1|||
124856906|NCT00941603|449098095|FG000|Overall Study|Protocol Violation|0|||
124856907|NCT00941603|449098096|FG001|Overall Study|Protocol Violation|1|||
124856908|NCT00941603|449098097|FG002|Overall Study|Protocol Violation|0|||
124856909|NCT00941603|449098098|FG003|Overall Study|Protocol Violation|0|||
124856910|NCT00941603|449098099|FG004|Overall Study|Protocol Violation|0|||
124856911|NCT00941603|449098100|FG005|Overall Study|Protocol Violation|0|||
124856912|NCT00941603|449098095|FG000|Overall Study|Did not meet protocol eligibility|1|||
124856913|NCT00941603|449098096|FG001|Overall Study|Did not meet protocol eligibility|0|||
124856914|NCT00941603|449098097|FG002|Overall Study|Did not meet protocol eligibility|0|||
124856915|NCT00941603|449098098|FG003|Overall Study|Did not meet protocol eligibility|0|||
124856916|NCT00941603|449098099|FG004|Overall Study|Did not meet protocol eligibility|0|||
124856917|NCT00941603|449098100|FG005|Overall Study|Did not meet protocol eligibility|0|||
124856918|NCT02014116|449098101|FG000|Overall Study|Progressive Disease|3|||
124856919|NCT02014116|449098102|FG001|Overall Study|Progressive Disease|4|||
124856920|NCT02014116|449098103|FG002|Overall Study|Progressive Disease|2|||
124856921|NCT02014116|449098104|FG003|Overall Study|Progressive Disease|6|||
124856922|NCT02014116|449098105|FG004|Overall Study|Progressive Disease|1|||
124856923|NCT02014116|449098106|FG005|Overall Study|Progressive Disease|13|||
124856924|NCT02014116|449098107|FG006|Overall Study|Progressive Disease|1|||
124856925|NCT02014116|449098108|FG007|Overall Study|Progressive Disease|3|||
124856926|NCT02014116|449098109|FG008|Overall Study|Progressive Disease|7|||
124856927|NCT02014116|449098101|FG000|Overall Study|Adverse Event|0|||
124856928|NCT02014116|449098102|FG001|Overall Study|Adverse Event|0|||
124856929|NCT02014116|449098103|FG002|Overall Study|Adverse Event|0|||
124856930|NCT02014116|449098104|FG003|Overall Study|Adverse Event|0|||
124856931|NCT02014116|449098105|FG004|Overall Study|Adverse Event|1|||
124856932|NCT02014116|449098106|FG005|Overall Study|Adverse Event|0|||
124856933|NCT02014116|449098107|FG006|Overall Study|Adverse Event|0|||
124856934|NCT02014116|449098108|FG007|Overall Study|Adverse Event|1|||
124856935|NCT02014116|449098109|FG008|Overall Study|Adverse Event|0|||
124856936|NCT02014116|449098101|FG000|Overall Study|Lost to Follow-up|0|||
124856937|NCT02014116|449098102|FG001|Overall Study|Lost to Follow-up|0|||
124856938|NCT02014116|449098103|FG002|Overall Study|Lost to Follow-up|0|||
124856939|NCT02014116|449098104|FG003|Overall Study|Lost to Follow-up|0|||
124856940|NCT02014116|449098105|FG004|Overall Study|Lost to Follow-up|0|||
124856941|NCT02014116|449098106|FG005|Overall Study|Lost to Follow-up|1|||
124856942|NCT02014116|449098107|FG006|Overall Study|Lost to Follow-up|0|||
124856943|NCT02014116|449098108|FG007|Overall Study|Lost to Follow-up|0|||
124856944|NCT02014116|449098109|FG008|Overall Study|Lost to Follow-up|1|||
124856945|NCT02014116|449098101|FG000|Overall Study|Death|0|||
124856946|NCT02014116|449098102|FG001|Overall Study|Death|0|||
124856947|NCT02014116|449098103|FG002|Overall Study|Death|0|||
124856948|NCT02014116|449098104|FG003|Overall Study|Death|0|||
124856949|NCT02014116|449098105|FG004|Overall Study|Death|0|||
124856950|NCT02014116|449098106|FG005|Overall Study|Death|0|||
124856951|NCT02014116|449098107|FG006|Overall Study|Death|0|||
124856952|NCT02014116|449098108|FG007|Overall Study|Death|1|||
124856953|NCT02014116|449098109|FG008|Overall Study|Death|1|||
124856954|NCT02014116|449098101|FG000|Overall Study|Withdrawal by Subject|0|||
124856955|NCT02014116|449098102|FG001|Overall Study|Withdrawal by Subject|0|||
124856956|NCT02014116|449098103|FG002|Overall Study|Withdrawal by Subject|1|||
124856957|NCT02014116|449098104|FG003|Overall Study|Withdrawal by Subject|1|||
124856958|NCT02014116|449098105|FG004|Overall Study|Withdrawal by Subject|0|||
124856959|NCT02014116|449098106|FG005|Overall Study|Withdrawal by Subject|1|||
124856960|NCT02014116|449098107|FG006|Overall Study|Withdrawal by Subject|0|||
124856961|NCT02014116|449098108|FG007|Overall Study|Withdrawal by Subject|0|||
124856962|NCT02014116|449098109|FG008|Overall Study|Withdrawal by Subject|0|||
124856963|NCT02014116|449098101|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
124856964|NCT02014116|449098102|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
124856965|NCT02014116|449098103|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
124856966|NCT02014116|449098104|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
124856967|NCT02014116|449098105|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
124856968|NCT02014116|449098106|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
124856969|NCT02014116|449098107|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
124856970|NCT02014116|449098108|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
124856971|NCT02014116|449098109|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
124856972|NCT02014116|449098101|FG000|Overall Study|Physician Decision|0|||
124856973|NCT02014116|449098102|FG001|Overall Study|Physician Decision|0|||
124856974|NCT02014116|449098103|FG002|Overall Study|Physician Decision|0|||
124856975|NCT02014116|449098104|FG003|Overall Study|Physician Decision|0|||
124856976|NCT02014116|449098105|FG004|Overall Study|Physician Decision|0|||
124856977|NCT02014116|449098106|FG005|Overall Study|Physician Decision|0|||
124856978|NCT02014116|449098107|FG006|Overall Study|Physician Decision|0|||
124856979|NCT02014116|449098108|FG007|Overall Study|Physician Decision|0|||
124856980|NCT02014116|449098109|FG008|Overall Study|Physician Decision|1|||
124856981|NCT01753193|449098110|FG000|Overall Study|Withdrawal by Subject|23|||
124856982|NCT01753193|449098110|FG000|Overall Study|Lost to Follow-up|6|||
124856983|NCT01753193|449098110|FG000|Overall Study|Death|1|||
124856984|NCT01753193|449098110|FG000|Overall Study|Other|16|||
124856985|NCT00383435|449098111|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
124856986|NCT00383435|449098112|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
124856987|NCT00383435|449098113|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
124856988|NCT00383435|449098114|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
124856989|NCT00383435|449098115|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
124856990|NCT00383435|449098111|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
124856991|NCT00383435|449098112|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
124856992|NCT00383435|449098113|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
124856993|NCT00383435|449098114|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
124856994|NCT00383435|449098115|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
124856995|NCT00383435|449098111|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
124856996|NCT00383435|449098112|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
124856997|NCT00383435|449098113|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
124856998|NCT00383435|449098114|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
124856999|NCT00383435|449098115|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
124857000|NCT00383435|449098111|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
124857001|NCT00383435|449098112|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
124857002|NCT00383435|449098113|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
124857003|NCT00383435|449098114|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
124857004|NCT00383435|449098115|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
124857005|NCT00383435|449098111|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
124857006|NCT00383435|449098112|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
124857007|NCT00383435|449098113|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
124857008|NCT00383435|449098114|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
124857009|NCT00383435|449098115|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
124857010|NCT00383435|449098111|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
124857011|NCT00383435|449098112|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
124857012|NCT00383435|449098113|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
124857013|NCT00383435|449098114|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
124857014|NCT00383435|449098115|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
124857015|NCT00383435|449098111|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
124857016|NCT00383435|449098112|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
124857017|NCT00383435|449098113|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
124857018|NCT00383435|449098114|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
124857019|NCT00383435|449098115|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
124857020|NCT00383435|449098111|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
124857021|NCT00383435|449098112|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
124857022|NCT00383435|449098113|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
124857023|NCT00383435|449098114|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
124857024|NCT00383435|449098115|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
124857025|NCT00383435|449098111|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
124857026|NCT00383435|449098112|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
124857027|NCT00383435|449098113|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
124857028|NCT00383435|449098114|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
124857029|NCT00383435|449098115|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
124857030|NCT00383435|449098111|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
124857031|NCT00383435|449098112|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
124857032|NCT00383435|449098113|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
124857033|NCT00383435|449098114|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
124857034|NCT00383435|449098115|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
124857035|NCT00383435|449098111|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
124857036|NCT00383435|449098112|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
124857037|NCT00383435|449098113|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
124857038|NCT00383435|449098114|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
124857039|NCT00383435|449098115|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
124857040|NCT00383435|449098111|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
124857041|NCT00383435|449098112|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
124857042|NCT00383435|449098113|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
124857043|NCT00383435|449098114|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
124857044|NCT00383435|449098115|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
124857045|NCT00383435|449098111|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
124857046|NCT00383435|449098112|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
124857047|NCT00383435|449098113|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
124857048|NCT00383435|449098114|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
124857049|NCT00383435|449098115|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
124857050|NCT00383435|449098111|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
124857051|NCT00383435|449098112|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
124857052|NCT00383435|449098113|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
124857053|NCT00383435|449098114|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
124857054|NCT00383435|449098115|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
124857055|NCT00383435|449098111|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
124857056|NCT00383435|449098112|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
124857057|NCT00383435|449098113|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
124857058|NCT00383435|449098114|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
124857059|NCT00383435|449098115|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
124857060|NCT00383435|449098111|FG000|26-Week Treatment Safety Extension|Administrative|1|||
124857061|NCT00383435|449098112|FG001|26-Week Treatment Safety Extension|Administrative|1|||
124857062|NCT00383435|449098113|FG002|26-Week Treatment Safety Extension|Administrative|0|||
124857063|NCT00383435|449098114|FG003|26-Week Treatment Safety Extension|Administrative|1|||
124857064|NCT00383435|449098115|FG004|26-Week Treatment Safety Extension|Administrative|0|||
124857065|NCT00583557|449098116|FG000|Overall Study|Withdrawal by Subject|18|||
124857066|NCT00583557|449098116|FG000|Overall Study|Adverse Event|9|||
124857067|NCT00583557|449098116|FG000|Overall Study|Lack of Efficacy|31|||
124857068|NCT00583557|449098116|FG000|Overall Study|Lack of Compliance|5|||
124857069|NCT00583557|449098116|FG000|Overall Study|Other|5|||
124857070|NCT00583557|449098116|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
124857071|NCT01131312|449098117|FG000|Overall Study|Lost to Follow-up|425|||
124857072|NCT01131312|449098118|FG001|Overall Study|Lost to Follow-up|229|||
124857073|NCT01131312|449098119|FG002|Overall Study|Lost to Follow-up|351|||
124857074|NCT02682264|449098120|FG000|Overall Study|Withdrawal by Subject|56|||
124857075|NCT02682264|449098121|FG001|Overall Study|Withdrawal by Subject|45|||
124857076|NCT02682264|449098120|FG000|Overall Study|Lost to Follow-up|49|||
124857077|NCT02682264|449098121|FG001|Overall Study|Lost to Follow-up|41|||
124857078|NCT02682264|449098120|FG000|Overall Study|Lack of Efficacy|14|||
124857079|NCT02682264|449098121|FG001|Overall Study|Lack of Efficacy|16|||
124857080|NCT02682264|449098120|FG000|Overall Study|Withdrawal by Parent|6|||
124857081|NCT02682264|449098121|FG001|Overall Study|Withdrawal by Parent|7|||
124857082|NCT02682264|449098120|FG000|Overall Study|Adverse Event|9|||
124857083|NCT02682264|449098121|FG001|Overall Study|Adverse Event|0|||
124857084|NCT02682264|449098120|FG000|Overall Study|Noncompliance with study drug|1|||
124857085|NCT02682264|449098121|FG001|Overall Study|Noncompliance with study drug|4|||
124857086|NCT02682264|449098120|FG000|Overall Study|Pregnancy|1|||
124857087|NCT02682264|449098121|FG001|Overall Study|Pregnancy|2|||
124857088|NCT02682264|449098120|FG000|Overall Study|Recovery|1|||
124857089|NCT02682264|449098121|FG001|Overall Study|Recovery|2|||
124857090|NCT02682264|449098120|FG000|Overall Study|Progressive Disease|1|||
124857091|NCT02682264|449098121|FG001|Overall Study|Progressive Disease|0|||
124857092|NCT02682264|449098120|FG000|Overall Study|Technical Problems|0|||
124857093|NCT02682264|449098121|FG001|Overall Study|Technical Problems|1|||
124857094|NCT02682264|449098120|FG000|Overall Study|Moved abroad and unable to continue|0|||
124857095|NCT02682264|449098121|FG001|Overall Study|Moved abroad and unable to continue|3|||
124857096|NCT02682264|449098120|FG000|Overall Study|Stopped test article application|0|||
124857097|NCT02682264|449098121|FG001|Overall Study|Stopped test article application|1|||
124857098|NCT03264989|449098126|FG000|Overall Study|Lost to Follow-up|1|||
124857099|NCT03264989|449098127|FG001|Overall Study|Lost to Follow-up|0|||
124857100|NCT03264989|449098126|FG000|Overall Study|New Therapy for study Indication|1|||
124857101|NCT03264989|449098127|FG001|Overall Study|New Therapy for study Indication|0|||
124857102|NCT03264989|449098126|FG000|Overall Study|Protocol Violation|0|||
124857103|NCT03264989|449098127|FG001|Overall Study|Protocol Violation|1|||
124857104|NCT03264989|449098126|FG000|Overall Study|Patient decision|13|||
124857105|NCT03264989|449098127|FG001|Overall Study|Patient decision|0|||
124857106|NCT03264989|449098126|FG000|Overall Study|Physician Decision|6|||
124857107|NCT03264989|449098127|FG001|Overall Study|Physician Decision|4|||
124857108|NCT03264989|449098126|FG000|Overall Study|Adverse Event|2|||
124857109|NCT03264989|449098127|FG001|Overall Study|Adverse Event|1|||
124857110|NCT03264989|449098126|FG000|Overall Study|Death|1|||
124857111|NCT03264989|449098127|FG001|Overall Study|Death|1|||
124857112|NCT03264989|449098126|FG000|Overall Study|Pregnancy|2|||
124857113|NCT03264989|449098127|FG001|Overall Study|Pregnancy|0|||
124857114|NCT03264989|449098126|FG000|Overall Study|End of Study|19|||
124857115|NCT03264989|449098127|FG001|Overall Study|End of Study|5|||
124857116|NCT00797667|449098128|FG000|Overall Study|Lack of Efficacy|0|||
124857117|NCT00797667|449098129|FG001|Overall Study|Lack of Efficacy|1|||
124857118|NCT00797667|449098130|FG002|Overall Study|Lack of Efficacy|0|||
124857119|NCT00797667|449098128|FG000|Overall Study|Lost to Follow-up|8|||
124857120|NCT00797667|449098129|FG001|Overall Study|Lost to Follow-up|12|||
124857121|NCT00797667|449098130|FG002|Overall Study|Lost to Follow-up|2|||
124857122|NCT00797667|449098128|FG000|Overall Study|Physician Decision|3|||
124857123|NCT00797667|449098129|FG001|Overall Study|Physician Decision|1|||
124857124|NCT00797667|449098130|FG002|Overall Study|Physician Decision|0|||
124857125|NCT00797667|449098128|FG000|Overall Study|Pregnancy|2|||
124857126|NCT00797667|449098129|FG001|Overall Study|Pregnancy|0|||
124857127|NCT00797667|449098130|FG002|Overall Study|Pregnancy|0|||
124857128|NCT00797667|449098128|FG000|Overall Study|Protocol Violation|2|||
124857129|NCT00797667|449098129|FG001|Overall Study|Protocol Violation|7|||
124857130|NCT00797667|449098130|FG002|Overall Study|Protocol Violation|0|||
124857131|NCT00797667|449098128|FG000|Overall Study|Study Terminated by Sponsor|217|||
124857132|NCT00797667|449098129|FG001|Overall Study|Study Terminated by Sponsor|216|||
124857133|NCT00797667|449098130|FG002|Overall Study|Study Terminated by Sponsor|115|||
124857134|NCT00797667|449098128|FG000|Overall Study|Withdrawal by Subject|9|||
124857135|NCT00797667|449098129|FG001|Overall Study|Withdrawal by Subject|14|||
124857136|NCT00797667|449098130|FG002|Overall Study|Withdrawal by Subject|2|||
124857137|NCT00797667|449098128|FG000|Overall Study|Adverse Event|19|||
124857138|NCT00797667|449098129|FG001|Overall Study|Adverse Event|8|||
124857139|NCT00797667|449098130|FG002|Overall Study|Adverse Event|8|||
124857140|NCT01986829|449098131|FG000|Overall Study|Death|1|||
124857141|NCT01775137|449098132|FG000|Overall Study|Death|1|||
124857142|NCT01775137|449098132|FG000|Overall Study|Protocol deviation|2|||
124857143|NCT01775137|449098132|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
124857144|NCT01775137|449098132|FG000|Overall Study|Adverse Event|1|||
124857145|NCT01775137|449098132|FG000|Overall Study|Withdrawal by participants|5|||
124857146|NCT03029208|449098133|FG000|Overall Study|Withdrawal by Subject|2|||
124857147|NCT03029208|449098134|FG001|Overall Study|Withdrawal by Subject|3|||
124857148|NCT03029208|449098133|FG000|Overall Study|Lost to Follow-up|0|||
124857149|NCT03029208|449098134|FG001|Overall Study|Lost to Follow-up|1|||
124857150|NCT01732835|449098135|FG000|6-month Primary Endpoint|Did not receive device|19|||
124857151|NCT01732835|449098135|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
124857152|NCT01732835|449098135|FG000|6-month Primary Endpoint|Adverse Event|3|||
124857153|NCT01732835|449098135|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
124857154|NCT01732835|449098135|FG000|2-year Extended Follow-up|Adverse Event|3|||
124857155|NCT01732835|449098135|FG000|2-year Extended Follow-up|Death|1|||
124857156|NCT02334748|449098136|FG000|Overall Study|Adverse Event|1|||
124857157|NCT02334748|449098136|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
124857158|NCT02334748|449098136|FG000|Overall Study|Patient no longer required study drug|2|||
124857159|NCT02334748|449098136|FG000|Overall Study|Lack of Efficacy|4|||
124857160|NCT00305058|449098137|FG000|Overall Study|Participant too young|1|||
124857161|NCT00305058|449098138|FG001|Overall Study|Participant too young|0|||
124857162|NCT00305058|449098137|FG000|Overall Study|Missing data collection instrument|3|||
124857163|NCT00305058|449098138|FG001|Overall Study|Missing data collection instrument|2|||
124857164|NCT00305058|449098137|FG000|Overall Study|Missing outcome data|3|||
124857165|NCT00305058|449098138|FG001|Overall Study|Missing outcome data|2|||
124857166|NCT03965052|449098142|FG000|Overall Study|Protocol Violation|1|||
124857167|NCT03965052|449098143|FG001|Overall Study|Protocol Violation|0|||
124857168|NCT01910519|449098147|FG000|Overall Study|Withdrawal by Subject|2|||
124857169|NCT01910519|449098148|FG001|Overall Study|Withdrawal by Subject|0|||
124857170|NCT01910519|449098147|FG000|Overall Study|Adverse Event|2|||
124857171|NCT01910519|449098148|FG001|Overall Study|Adverse Event|0|||
124857172|NCT04266028|449098149|FG000|Overall Study|Adverse Event|0|||
124857173|NCT04266028|449098150|FG001|Overall Study|Adverse Event|0|||
124857174|NCT04266028|449098151|FG002|Overall Study|Adverse Event|1|||
124857175|NCT04266028|449098152|FG003|Overall Study|Adverse Event|0|||
124857176|NCT04266028|449098153|FG004|Overall Study|Adverse Event|1|||
124857177|NCT04266028|449098154|FG005|Overall Study|Adverse Event|0|||
124857178|NCT04266028|449098155|FG006|Overall Study|Adverse Event|2|||
124857179|NCT04266028|449098156|FG007|Overall Study|Adverse Event|0|||
124857180|NCT04266028|449098149|FG000|Overall Study|temporary halt of the study|0|||
124857181|NCT04266028|449098150|FG001|Overall Study|temporary halt of the study|0|||
124857182|NCT04266028|449098151|FG002|Overall Study|temporary halt of the study|0|||
124857183|NCT04266028|449098152|FG003|Overall Study|temporary halt of the study|0|||
124857184|NCT04266028|449098153|FG004|Overall Study|temporary halt of the study|0|||
124857185|NCT04266028|449098154|FG005|Overall Study|temporary halt of the study|0|||
124857186|NCT04266028|449098155|FG006|Overall Study|temporary halt of the study|2|||
124857187|NCT04266028|449098156|FG007|Overall Study|temporary halt of the study|1|||
124857188|NCT04266028|449098149|FG000|Overall Study|Onset of birch pollen season|0|||
124857189|NCT04266028|449098150|FG001|Overall Study|Onset of birch pollen season|0|||
124857190|NCT04266028|449098151|FG002|Overall Study|Onset of birch pollen season|0|||
124857191|NCT04266028|449098152|FG003|Overall Study|Onset of birch pollen season|0|||
124857192|NCT04266028|449098153|FG004|Overall Study|Onset of birch pollen season|1|||
124857193|NCT04266028|449098154|FG005|Overall Study|Onset of birch pollen season|0|||
124857194|NCT04266028|449098155|FG006|Overall Study|Onset of birch pollen season|0|||
124857195|NCT04266028|449098156|FG007|Overall Study|Onset of birch pollen season|0|||
124857196|NCT02863991|449098157|FG000|Overall Study|Death|0|||
124857197|NCT02863991|449098158|FG001|Overall Study|Death|3|||
124857198|NCT02863991|449098157|FG000|Overall Study|Lack of Efficacy|0|||
124857199|NCT02863991|449098158|FG001|Overall Study|Lack of Efficacy|1|||
124857200|NCT02863991|449098157|FG000|Overall Study|Study Terminated|2|||
124857201|NCT02863991|449098158|FG001|Overall Study|Study Terminated|8|||
124857202|NCT03096782|449098162|FG000|Overall Study|Death|1|||
124857203|NCT03096782|449098162|FG000|Overall Study|Participant Relapsed|1|||
124857204|NCT00993447|449099994|FG000|Overall Study|Withdrawal by Subject|23|||
124857205|NCT00993447|449099995|FG001|Overall Study|Withdrawal by Subject|8|||
124857206|NCT00993447|449099994|FG000|Overall Study|Protocol Violation|12|||
124857207|NCT00993447|449099995|FG001|Overall Study|Protocol Violation|8|||
124857208|NCT00993447|449099994|FG000|Overall Study|Lost to Follow-up|1|||
124857209|NCT00993447|449099995|FG001|Overall Study|Lost to Follow-up|3|||
124857210|NCT00993447|449099994|FG000|Overall Study|Adverse Event|1|||
124857211|NCT00993447|449099995|FG001|Overall Study|Adverse Event|0|||
124857212|NCT00970502|449099996|FG000|Overall Study|Withdrawal by Subject|1|||
124857213|NCT03811912|449099997|FG000|Overall Study|Withdrew Consent|4|||
124857214|NCT03811912|449099998|FG001|Overall Study|Withdrew Consent|2|||
124857215|NCT00566228|449099999|FG000|Overall Study|Withdrawal by Subject|1|||
124857216|NCT00566228|449100000|FG001|Overall Study|Withdrawal by Subject|0|||
124857217|NCT00566228|449099999|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
124857218|NCT00566228|449100000|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
124857219|NCT00566228|449099999|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
124857220|NCT00566228|449100000|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
124857221|NCT00566228|449099999|FG000|Overall Study|progressed before infusion could occur|0|||
124857222|NCT00566228|449100000|FG001|Overall Study|progressed before infusion could occur|1|||
124857223|NCT03521635|449100001|FG000|Overall Study|Adverse Event|1|||
124857224|NCT03521635|449100002|FG001|Overall Study|Adverse Event|1|||
124857225|NCT03521635|449100001|FG000|Overall Study|Refused to complete study visit|1|||
124857226|NCT03521635|449100002|FG001|Overall Study|Refused to complete study visit|0|||
124857227|NCT03521635|449100001|FG000|Overall Study|Refused to continue trial medication|2|||
124857228|NCT03521635|449100002|FG001|Overall Study|Refused to continue trial medication|2|||
124857229|NCT03521635|449100001|FG000|Overall Study|Lost to Follow-up|0|||
124857230|NCT03521635|449100002|FG001|Overall Study|Lost to Follow-up|1|||
124857231|NCT03521635|449100001|FG000|Overall Study|Meet exclusion criteria|0|||
124857232|NCT03521635|449100002|FG001|Overall Study|Meet exclusion criteria|1|||
124857233|NCT03521635|449100001|FG000|Overall Study|Patient not taken study medicine|0|||
124857234|NCT03521635|449100002|FG001|Overall Study|Patient not taken study medicine|1|||
124857235|NCT02244944|449100003|FG000|Overall Study|Withdrawal by Subject|1|||
124857236|NCT02244944|449100003|FG000|Overall Study|Study Terminated|1|||
124857237|NCT00512135|449100006|FG000|Overall Study|Not Treated|5|||
124857238|NCT00512135|449100006|FG000|Overall Study|Lack of Efficacy|2|||
124857239|NCT00512135|449100006|FG000|Overall Study|Adverse Event|6|||
124857240|NCT00512135|449100006|FG000|Overall Study|Withdrawal by Subject|22|||
124857241|NCT00512135|449100006|FG000|Overall Study|Lost to Follow-up|27|||
124857242|NCT00512135|449100006|FG000|Overall Study|Other|22|||
124857243|NCT01659021|449100007|FG000|Main Study|Adverse Event|2|||
124857244|NCT01659021|449100008|FG001|Main Study|Adverse Event|3|||
124857245|NCT01659021|449100007|FG000|Main Study|Lost to Follow-up|1|||
124857246|NCT01659021|449100008|FG001|Main Study|Lost to Follow-up|0|||
124857247|NCT01659021|449100007|FG000|Main Study|Unknown Reasons|2|||
124857248|NCT01659021|449100008|FG001|Main Study|Unknown Reasons|1|||
124857249|NCT01659021|449100007|FG000|Main Study|Physician Decision|34|||
124857250|NCT01659021|449100008|FG001|Main Study|Physician Decision|16|||
124857251|NCT01659021|449100007|FG000|Main Study|Withdrawal by Subject|19|||
124857252|NCT01659021|449100008|FG001|Main Study|Withdrawal by Subject|16|||
124857253|NCT01659021|449100007|FG000|Main Study|Study Terminated by Sponsor|16|||
124857254|NCT01659021|449100008|FG001|Main Study|Study Terminated by Sponsor|1|||
124857255|NCT01659021|449100007|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
124857256|NCT01659021|449100008|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
124857257|NCT01659021|449100007|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
124857258|NCT01659021|449100008|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
124857259|NCT01205685|449100009|FG000|Overall Study|Disease Progression|10|||
124857260|NCT01205685|449100009|FG000|Overall Study|Withdrawal by Subject|1|||
124857261|NCT03058679|449100013|FG000|Baseline to Week 6|Lost to Follow-up|3|||
124857262|NCT03058679|449100014|FG001|Baseline to Week 6|Lost to Follow-up|2|||
124857263|NCT03058679|449100013|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
124857264|NCT03058679|449100014|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
124857265|NCT03058679|449100013|FG000|Baseline to Week 6|Adverse Event|6|||
124857266|NCT03058679|449100014|FG001|Baseline to Week 6|Adverse Event|6|||
124857267|NCT03058679|449100013|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
124857268|NCT03058679|449100014|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
124857269|NCT03058679|449100013|FG000|Baseline to Week 6|Difficulty following the diet|0|||
124857270|NCT03058679|449100014|FG001|Baseline to Week 6|Difficulty following the diet|2|||
124857271|NCT03058679|449100013|FG000|Baseline to Week 6|Physician Decision|1|||
124857272|NCT03058679|449100014|FG001|Baseline to Week 6|Physician Decision|0|||
124857273|NCT03058679|449100013|FG000|Week 6 to Week 12|Change in medication|5|||
124857274|NCT03058679|449100014|FG001|Week 6 to Week 12|Change in medication|7|||
124857275|NCT03058679|449100013|FG000|Week 6 to Week 12|Adverse Event|4|||
124857276|NCT03058679|449100014|FG001|Week 6 to Week 12|Adverse Event|3|||
124857277|NCT03058679|449100013|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
124857278|NCT03058679|449100014|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
124857279|NCT03058679|449100013|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
124857280|NCT03058679|449100014|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
124857281|NCT00599326|449100023|FG000|Overall Study|Lost to Follow-up|1|||
124857282|NCT00599326|449100023|FG000|Overall Study|Noncompliant|1|||
124857283|NCT00784810|449100026|FG000|Overall Study|Adverse Event|32|||
124857284|NCT00784810|449100027|FG001|Overall Study|Adverse Event|20|||
124857285|NCT00784810|449100026|FG000|Overall Study|Lack of Efficacy|14|||
124857286|NCT00784810|449100027|FG001|Overall Study|Lack of Efficacy|11|||
124857287|NCT00784810|449100026|FG000|Overall Study|Withdrawal by Subject|11|||
124857288|NCT00784810|449100027|FG001|Overall Study|Withdrawal by Subject|9|||
124857289|NCT00784810|449100026|FG000|Overall Study|Administrative|5|||
124857290|NCT00784810|449100027|FG001|Overall Study|Administrative|8|||
124857291|NCT00784810|449100026|FG000|Overall Study|Lost to Follow-up|1|||
124857292|NCT00784810|449100027|FG001|Overall Study|Lost to Follow-up|1|||
124857293|NCT02862106|449100028|FG000|Overall Study|Adverse Event|4|||
124857294|NCT02862106|449100029|FG001|Overall Study|Adverse Event|0|||
124857295|NCT02862106|449100028|FG000|Overall Study|Protocol Violation|16|||
124857296|NCT02862106|449100029|FG001|Overall Study|Protocol Violation|1|||
124857297|NCT02862106|449100028|FG000|Overall Study|Lost to Follow-up|15|||
124857298|NCT02862106|449100029|FG001|Overall Study|Lost to Follow-up|5|||
124857299|NCT02862106|449100028|FG000|Overall Study|Withdrawal by Subject|2|||
124857300|NCT02862106|449100029|FG001|Overall Study|Withdrawal by Subject|0|||
124857301|NCT02862106|449100028|FG000|Overall Study|Subjects moved to other city|1|||
124857302|NCT02862106|449100029|FG001|Overall Study|Subjects moved to other city|0|||
124857303|NCT04137380|449100034|FG000|Overall Study|Physician Decision|0|||
124857304|NCT04137380|449100035|FG001|Overall Study|Physician Decision|0|||
124857305|NCT04137380|449100036|FG002|Overall Study|Physician Decision|0|||
124857306|NCT04137380|449100037|FG003|Overall Study|Physician Decision|1|||
124857307|NCT04137380|449100038|FG004|Overall Study|Physician Decision|0|||
124857308|NCT04137380|449100039|FG005|Overall Study|Physician Decision|0|||
124857309|NCT04137380|449100040|FG006|Overall Study|Physician Decision|0|||
124857310|NCT00563784|449100041|FG000|Overall Study|Withdrawal by Subject|2|||
124857311|NCT00563784|449100041|FG000|Overall Study|Screen Failures|20|||
124857312|NCT03434119|449100045|FG000|Overall Study|Randomized but not treated|1|||
124857313|NCT03434119|449100046|FG001|Overall Study|Randomized but not treated|0|||
124857314|NCT03434119|449100045|FG000|Overall Study|Adverse Event|1|||
124857315|NCT03434119|449100046|FG001|Overall Study|Adverse Event|0|||
124857316|NCT03434119|449100045|FG000|Overall Study|Poor Compliance to Protocol|0|||
124857317|NCT03434119|449100046|FG001|Overall Study|Poor Compliance to Protocol|1|||
124857318|NCT03434119|449100045|FG000|Overall Study|Study Terminated by Sponsor|91|||
124857319|NCT03434119|449100046|FG001|Overall Study|Study Terminated by Sponsor|102|||
124857320|NCT03434119|449100045|FG000|Overall Study|Withdrawal by Subject|7|||
124857321|NCT03434119|449100046|FG001|Overall Study|Withdrawal by Subject|5|||
124857322|NCT03434119|449100045|FG000|Overall Study|Other than specified|7|||
124857323|NCT03434119|449100046|FG001|Overall Study|Other than specified|5|||
124857324|NCT00304070|449100047|FG000|Overall Study|Death|0|||
124857325|NCT00304070|449100048|FG001|Overall Study|Death|0|||
124857326|NCT00304070|449100049|FG002|Overall Study|Death|3|||
124857327|NCT00304070|449100047|FG000|Overall Study|Lost to Follow-up|0|||
124857328|NCT00304070|449100048|FG001|Overall Study|Lost to Follow-up|0|||
124857329|NCT00304070|449100049|FG002|Overall Study|Lost to Follow-up|1|||
124857330|NCT00304070|449100047|FG000|Overall Study|Physician Decision|0|||
124857331|NCT00304070|449100048|FG001|Overall Study|Physician Decision|0|||
124857332|NCT00304070|449100049|FG002|Overall Study|Physician Decision|3|||
124857333|NCT00304070|449100047|FG000|Overall Study|Withdrawal by Subject|0|||
124857334|NCT00304070|449100048|FG001|Overall Study|Withdrawal by Subject|0|||
124857335|NCT00304070|449100049|FG002|Overall Study|Withdrawal by Subject|1|||
124857336|NCT00304070|449100047|FG000|Overall Study|Progressive Disease|3|||
124857337|NCT00304070|449100048|FG001|Overall Study|Progressive Disease|7|||
124857338|NCT00304070|449100049|FG002|Overall Study|Progressive Disease|4|||
124857339|NCT03579459|449100050|FG000|Overall Study|Adverse Event|7|||
124857340|NCT03579459|449100051|FG001|Overall Study|Adverse Event|6|||
124857341|NCT03579459|449100052|FG002|Overall Study|Adverse Event|2|||
124857342|NCT03579459|449100053|FG003|Overall Study|Adverse Event|6|||
124857343|NCT03579459|449100050|FG000|Overall Study|Death|1|||
124857344|NCT03579459|449100051|FG001|Overall Study|Death|0|||
124857345|NCT03579459|449100052|FG002|Overall Study|Death|1|||
124857346|NCT03579459|449100053|FG003|Overall Study|Death|2|||
124857347|NCT03579459|449100050|FG000|Overall Study|Lost to Follow-up|6|||
124857348|NCT03579459|449100051|FG001|Overall Study|Lost to Follow-up|2|||
124857349|NCT03579459|449100052|FG002|Overall Study|Lost to Follow-up|4|||
124857350|NCT03579459|449100053|FG003|Overall Study|Lost to Follow-up|1|||
124857351|NCT03579459|449100050|FG000|Overall Study|Physician Decision|0|||
124857352|NCT03579459|449100051|FG001|Overall Study|Physician Decision|1|||
124857353|NCT03579459|449100052|FG002|Overall Study|Physician Decision|0|||
124857354|NCT03579459|449100053|FG003|Overall Study|Physician Decision|1|||
124857355|NCT03579459|449100050|FG000|Overall Study|Protocol Violation|1|||
124857356|NCT03579459|449100051|FG001|Overall Study|Protocol Violation|2|||
124857357|NCT03579459|449100052|FG002|Overall Study|Protocol Violation|3|||
124857358|NCT03579459|449100053|FG003|Overall Study|Protocol Violation|5|||
124857359|NCT03579459|449100050|FG000|Overall Study|Withdrawal by Subject|12|||
124857360|NCT03579459|449100051|FG001|Overall Study|Withdrawal by Subject|8|||
124857361|NCT03579459|449100052|FG002|Overall Study|Withdrawal by Subject|11|||
124857362|NCT03579459|449100053|FG003|Overall Study|Withdrawal by Subject|8|||
124857363|NCT03579459|449100050|FG000|Overall Study|Medication error without associated adverse event|2|||
124857364|NCT03579459|449100051|FG001|Overall Study|Medication error without associated adverse event|1|||
124857365|NCT03579459|449100052|FG002|Overall Study|Medication error without associated adverse event|1|||
124857366|NCT03579459|449100053|FG003|Overall Study|Medication error without associated adverse event|0|||
124857367|NCT03579459|449100050|FG000|Overall Study|Other|0|||
124857368|NCT03579459|449100051|FG001|Overall Study|Other|1|||
124857369|NCT03579459|449100052|FG002|Overall Study|Other|1|||
124857370|NCT03579459|449100053|FG003|Overall Study|Other|0|||
124857371|NCT03579459|449100050|FG000|Overall Study|Randomized not vaccinated|0|||
124857372|NCT03579459|449100051|FG001|Overall Study|Randomized not vaccinated|2|||
124857373|NCT03579459|449100052|FG002|Overall Study|Randomized not vaccinated|0|||
124857374|NCT03579459|449100053|FG003|Overall Study|Randomized not vaccinated|1|||
124857375|NCT00148343|449100054|FG000|Overall Study|Withdrawal by Subject|12|||
124857376|NCT00148343|449100055|FG001|Overall Study|Withdrawal by Subject|7|||
124857377|NCT00148343|449100054|FG000|Overall Study|Physician Decision|3|||
124857378|NCT00148343|449100055|FG001|Overall Study|Physician Decision|4|||
124857379|NCT02528214|449100060|FG000|Overall Study|Protocol Violation|0|||
124857380|NCT02528214|449100061|FG001|Overall Study|Protocol Violation|1|||
124857381|NCT02528214|449100060|FG000|Overall Study|Adverse Event|0|||
124857382|NCT02528214|449100061|FG001|Overall Study|Adverse Event|1|||
124857383|NCT02528214|449100060|FG000|Overall Study|Other than specified above|0|||
124857384|NCT02528214|449100061|FG001|Overall Study|Other than specified above|1|||
124857385|NCT03447769|449100063|FG000|Overall Study|Progressive disease|138|||
124857386|NCT03447769|449100064|FG001|Overall Study|Progressive disease|148|||
124857387|NCT03447769|449100063|FG000|Overall Study|Study terminated by Sponsor|60|||
124857388|NCT03447769|449100064|FG001|Overall Study|Study terminated by Sponsor|44|||
124857389|NCT03447769|449100063|FG000|Overall Study|Adverse Event|34|||
124857390|NCT03447769|449100064|FG001|Overall Study|Adverse Event|31|||
124857391|NCT03447769|449100063|FG000|Overall Study|Patient decision|27|||
124857392|NCT03447769|449100064|FG001|Overall Study|Patient decision|27|||
124857393|NCT03447769|449100063|FG000|Overall Study|Protocol deviation|4|||
124857394|NCT03447769|449100064|FG001|Overall Study|Protocol deviation|6|||
124857395|NCT03447769|449100063|FG000|Overall Study|Death|2|||
124857396|NCT03447769|449100064|FG001|Overall Study|Death|7|||
124857397|NCT03447769|449100063|FG000|Overall Study|Technical problems|1|||
124857398|NCT03447769|449100064|FG001|Overall Study|Technical problems|0|||
124857399|NCT03447769|449100063|FG000|Overall Study|Lost to Follow-up|0|||
124857400|NCT03447769|449100064|FG001|Overall Study|Lost to Follow-up|1|||
124857401|NCT03447769|449100063|FG000|Overall Study|Physician Decision|13|||
124857402|NCT03447769|449100064|FG001|Overall Study|Physician Decision|5|||
124857403|NCT01343407|449100065|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
124857404|NCT01343407|449100066|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
124857405|NCT01343407|449100067|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
124857406|NCT01343407|449100068|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
124857407|NCT01343407|449100069|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
124857408|NCT01343407|449100070|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
124857409|NCT01343407|449100065|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
124857410|NCT01343407|449100066|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
124857411|NCT01343407|449100067|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
124857412|NCT01343407|449100068|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
124857413|NCT01343407|449100069|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
124857414|NCT01343407|449100070|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
124857415|NCT03950739|449100071|FG000|Treatment Phase|Adverse Event|2|||
124857416|NCT03950739|449100071|FG000|Optional Extension Phase|Death|1|||
124857417|NCT03950739|449100071|FG000|Optional Extension Phase|Progressive Disease|5|||
124857418|NCT03950739|449100071|FG000|Optional Extension Phase|Adverse Event|7|||
124857419|NCT03950739|449100071|FG000|Optional Extension Phase|Lost to Follow-up|2|||
124857420|NCT03950739|449100071|FG000|Optional Extension Phase|Site Closure|2|||
124857421|NCT03950739|449100071|FG000|Optional Extension Phase|Pregnancy|1|||
124857422|NCT02504866|449100073|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
124857423|NCT02504866|449100074|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
124857424|NCT02504866|449100075|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
124857425|NCT01343056|449100078|FG000|Overall Study|Lost to Follow-up|7|||
124857426|NCT01343056|449100079|FG001|Overall Study|Lost to Follow-up|5|||
124857427|NCT01343056|449100080|FG002|Overall Study|Lost to Follow-up|3|||
124857428|NCT01343056|449100081|FG003|Overall Study|Lost to Follow-up|9|||
124857429|NCT03231371|449100082|FG000|Overall Study|Withdrawal by Subject|1|||
124857430|NCT03231371|449100082|FG000|Overall Study|chose or were ineligible to have MRI|12|||
124857431|NCT02493361|449100088|FG000|Overall Study|Withdrawal by Subject|3|||
124857432|NCT01046643|449100089|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
124857433|NCT01046643|449100090|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
124857434|NCT01046643|449100091|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
124857435|NCT01046643|449100092|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
124857436|NCT00553267|449100103|FG000|Overall Study|Adverse Event|8|||
124857437|NCT00553267|449100104|FG001|Overall Study|Adverse Event|10|||
124857438|NCT00553267|449100105|FG002|Overall Study|Adverse Event|5|||
124857439|NCT00553267|449100103|FG000|Overall Study|Non compliant with protocol|3|||
124857440|NCT00553267|449100104|FG001|Overall Study|Non compliant with protocol|3|||
124857441|NCT00553267|449100105|FG002|Overall Study|Non compliant with protocol|2|||
124857442|NCT00553267|449100103|FG000|Overall Study|Lost to Follow-up|0|||
124857443|NCT00553267|449100104|FG001|Overall Study|Lost to Follow-up|0|||
124857444|NCT00553267|449100105|FG002|Overall Study|Lost to Follow-up|1|||
124857445|NCT00553267|449100103|FG000|Overall Study|Consent withdrawn|2|||
124857446|NCT00553267|449100104|FG001|Overall Study|Consent withdrawn|3|||
124857447|NCT00553267|449100105|FG002|Overall Study|Consent withdrawn|1|||
124857448|NCT00553267|449100103|FG000|Overall Study|Specified category|1|||
124857449|NCT00553267|449100104|FG001|Overall Study|Specified category|2|||
124857450|NCT00553267|449100105|FG002|Overall Study|Specified category|1|||
124857451|NCT01310036|449100106|FG000|Overall Study|Administrative/other|10|||
124857452|NCT01310036|449100106|FG000|Overall Study|Withdrew Consent|11|||
124857453|NCT01310036|449100106|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
124857454|NCT01310036|449100106|FG000|Overall Study|Progression of Disease|164|||
124857455|NCT01310036|449100106|FG000|Overall Study|Death|1|||
124857456|NCT01310036|449100106|FG000|Overall Study|Adverse event or intercurrent illness|12|||
124857457|NCT01175668|449100107|FG000|Overall Study|Withdrawal by Subject|2|||
124857458|NCT01175668|449100108|FG001|Overall Study|Withdrawal by Subject|0|||
124857459|NCT00096135|449100114|FG000|Overall Study|Physician Decision|20|||
124857460|NCT00096135|449100115|FG001|Overall Study|Physician Decision|4|||
124857461|NCT00096135|449100114|FG000|Overall Study|Refusal of further protocol therapy|4|||
124857462|NCT00096135|449100115|FG001|Overall Study|Refusal of further protocol therapy|1|||
124857463|NCT00096135|449100114|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
124857464|NCT00096135|449100115|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
124857465|NCT00096135|449100114|FG000|Overall Study|Other, specify|15|||
124857466|NCT00096135|449100115|FG001|Overall Study|Other, specify|3|||
124857467|NCT00096135|449100114|FG000|Overall Study|Ineligible|2|||
124857468|NCT00096135|449100115|FG001|Overall Study|Ineligible|0|||
124857469|NCT01568047|449100117|FG000|Overall Study|Ineligibility|1|||
124857470|NCT01568047|449100118|FG001|Overall Study|Ineligibility|0|||
124857471|NCT01568047|449100119|FG002|Overall Study|Ineligibility|0|||
124857472|NCT01568047|449100120|FG003|Overall Study|Ineligibility|0|||
124857473|NCT01568047|449100117|FG000|Overall Study|Withdrawal by Subject|0|||
124857474|NCT01568047|449100118|FG001|Overall Study|Withdrawal by Subject|1|||
124857475|NCT01568047|449100119|FG002|Overall Study|Withdrawal by Subject|0|||
124857476|NCT01568047|449100120|FG003|Overall Study|Withdrawal by Subject|0|||
124857477|NCT01568047|449100117|FG000|Overall Study|Adverse Event|0|||
124857478|NCT01568047|449100118|FG001|Overall Study|Adverse Event|0|||
124857479|NCT01568047|449100119|FG002|Overall Study|Adverse Event|1|||
124857480|NCT01568047|449100120|FG003|Overall Study|Adverse Event|1|||
124857481|NCT00874029|449100121|FG000|Overall Study|Withdrawal by Subject|10|||
124857482|NCT00874029|449100121|FG000|Overall Study|Pregnancy|4|||
124857483|NCT00874029|449100121|FG000|Overall Study|Physician Decision|1|||
124857484|NCT00874029|449100121|FG000|Overall Study|Adverse Event|1|||
124857485|NCT00874029|449100121|FG000|Overall Study|Lost to Follow-up|5|||
124857486|NCT03359096|449100122|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
124857487|NCT03359096|449100123|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
124857488|NCT03359096|449100122|FG000|First Intervention (4 Weeks)|Death|1|||
124857489|NCT03359096|449100123|FG001|First Intervention (4 Weeks)|Death|0|||
124857490|NCT03359096|449100122|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
124857491|NCT03359096|449100123|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
124857492|NCT00856583|449100124|FG000|Overall Study|Lack of Efficacy|389|||
124857493|NCT00856583|449100125|FG001|Overall Study|Lack of Efficacy|377|||
124857494|NCT00856583|449100124|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
124857495|NCT00856583|449100125|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
124857496|NCT00856583|449100124|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
124857497|NCT00856583|449100125|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
124857498|NCT00856583|449100124|FG000|Overall Study|Non-compliance|305|||
124857499|NCT00856583|449100125|FG001|Overall Study|Non-compliance|262|||
124857500|NCT00856583|449100124|FG000|Overall Study|Withdrawal by Subject|1092|||
124857501|NCT00856583|449100125|FG001|Overall Study|Withdrawal by Subject|919|||
124857502|NCT00856583|449100124|FG000|Overall Study|Physician Decision|59|||
124857503|NCT00856583|449100125|FG001|Overall Study|Physician Decision|82|||
124857504|NCT00856583|449100124|FG000|Overall Study|Pregnancy|14|||
124857505|NCT00856583|449100125|FG001|Overall Study|Pregnancy|5|||
124857506|NCT00856583|449100124|FG000|Overall Study|Other|92|||
124857507|NCT00856583|449100125|FG001|Overall Study|Other|104|||
124857508|NCT00856583|449100124|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
124857509|NCT00856583|449100125|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
124857510|NCT01944046|449100129|FG000|Randomized to DB|Adverse Event|5|||
124857511|NCT01944046|449100130|FG001|Randomized to DB|Adverse Event|2|||
124857512|NCT01944046|449100129|FG000|Randomized to DB|Clinical Worsening|3|||
124857513|NCT01944046|449100130|FG001|Randomized to DB|Clinical Worsening|2|||
124857514|NCT01944046|449100129|FG000|Randomized to DB|Lost to Follow-up|3|||
124857515|NCT01944046|449100130|FG001|Randomized to DB|Lost to Follow-up|3|||
124857516|NCT01944046|449100129|FG000|Randomized to DB|Withdrawal by Subject|2|||
124857517|NCT01944046|449100130|FG001|Randomized to DB|Withdrawal by Subject|4|||
124857518|NCT01944046|449100129|FG000|Randomized to DB|Physician Decision|1|||
124857519|NCT01944046|449100130|FG001|Randomized to DB|Physician Decision|2|||
124857520|NCT01944046|449100129|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
124857521|NCT01944046|449100130|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
124857522|NCT01944046|449100129|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
124857523|NCT01944046|449100130|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
124857524|NCT01944046|449100129|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
124857525|NCT01944046|449100130|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
124857526|NCT01944046|449100129|FG000|Open Label Eligible and Consented|Adverse Event|6|||
124857527|NCT01944046|449100130|FG001|Open Label Eligible and Consented|Adverse Event|1|||
124857528|NCT01944046|449100129|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
124857529|NCT01944046|449100130|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
124857530|NCT01944046|449100129|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
124857531|NCT01944046|449100130|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
124857532|NCT02328326|449100134|FG000|Overall Study|Withdrawal by Subject|10|||
124857533|NCT02328326|449100135|FG001|Overall Study|Withdrawal by Subject|3|||
124857534|NCT02328326|449100134|FG000|Overall Study|Death|2|||
124857535|NCT02328326|449100135|FG001|Overall Study|Death|1|||
124857536|NCT02328326|449100134|FG000|Overall Study|Lost to Follow-up|10|||
124857537|NCT02328326|449100135|FG001|Overall Study|Lost to Follow-up|4|||
124857538|NCT06281548|449100147|FG000|Overall Study|Lost to Follow-up|3|||
124857539|NCT01618838|449100148|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
124857540|NCT00288587|449100149|FG000|Overall Study|Death|4|||
124857541|NCT00288587|449100150|FG001|Overall Study|Death|4|||
124857542|NCT00288587|449100149|FG000|Overall Study|Transplant|0|||
124857543|NCT00288587|449100150|FG001|Overall Study|Transplant|3|||
124857544|NCT00288587|449100149|FG000|Overall Study|Adverse Event|0|||
124857545|NCT00288587|449100150|FG001|Overall Study|Adverse Event|1|||
124857546|NCT00288587|449100149|FG000|Overall Study|Physician Decision|0|||
124857547|NCT00288587|449100150|FG001|Overall Study|Physician Decision|2|||
124857548|NCT00288587|449100149|FG000|Overall Study|Severe Aortic Stenosis|1|||
124857549|NCT00288587|449100150|FG001|Overall Study|Severe Aortic Stenosis|0|||
124857550|NCT04401579|449102031|FG000|Overall Study|Death|23|||
124857551|NCT04401579|449102032|FG001|Overall Study|Death|36|||
124857552|NCT04401579|449102031|FG000|Overall Study|Lost to Follow-up|40|||
124857553|NCT04401579|449102032|FG001|Overall Study|Lost to Follow-up|41|||
124857554|NCT04401579|449102031|FG000|Overall Study|Withdrawal by Subject|8|||
124857555|NCT04401579|449102032|FG001|Overall Study|Withdrawal by Subject|16|||
124857556|NCT04401579|449102031|FG000|Overall Study|Physician Decision|1|||
124857557|NCT04401579|449102032|FG001|Overall Study|Physician Decision|2|||
124857558|NCT04401579|449102031|FG000|Overall Study|Became ineligible after enrollment|1|||
124857559|NCT04401579|449102032|FG001|Overall Study|Became ineligible after enrollment|1|||
124857560|NCT04401579|449102031|FG000|Overall Study|Enrolled but treatment not administered|7|||
124857561|NCT04401579|449102032|FG001|Overall Study|Enrolled but treatment not administered|9|||
124857562|NCT04401579|449102031|FG000|Overall Study|Adverse Event|2|||
124857563|NCT04401579|449102032|FG001|Overall Study|Adverse Event|1|||
124857564|NCT04401579|449102031|FG000|Overall Study|Scheduling error|1|||
124857565|NCT04401579|449102032|FG001|Overall Study|Scheduling error|2|||
124857566|NCT04401579|449102031|FG000|Overall Study|Transferred to another hospital|1|||
124857567|NCT04401579|449102032|FG001|Overall Study|Transferred to another hospital|2|||
124857568|NCT01438411|449102033|FG000|Overall Study|Adverse Event|8|||
124857569|NCT01438411|449102033|FG000|Overall Study|Lost to Follow-up|1|||
124857570|NCT01438411|449102033|FG000|Overall Study|Lack of Efficacy|1|||
124857571|NCT01438411|449102033|FG000|Overall Study|Withdrawal by Subject|3|||
124857572|NCT01863680|449102034|FG000|Overall Study|Adverse Event|17|||
124857573|NCT01863680|449102034|FG000|Overall Study|Risk of OHSS|17|||
124857574|NCT01863680|449102034|FG000|Overall Study|Spontaneous pregnancy|2|||
124857575|NCT01863680|449102034|FG000|Overall Study|Withdrawal by Subject|1|||
124857576|NCT01863680|449102034|FG000|Overall Study|Did not undergo IVF/ET|14|||
124857577|NCT01863680|449102034|FG000|Overall Study|Other|6|||
124857578|NCT00618514|449102035|FG000|Overall Study|Lost to Follow-up|11|||
124857579|NCT00618514|449102036|FG001|Overall Study|Lost to Follow-up|12|||
124857580|NCT00618514|449102037|FG002|Overall Study|Lost to Follow-up|4|||
124857581|NCT02053350|449102038|FG000|Overall Study|Withdrawal by Subject|1|||
124857582|NCT02053350|449102038|FG000|Overall Study|Adverse Event|4|||
124857583|NCT02367911|449102043|FG000|Overall Study|Withdrawal by Subject|3|||
124857584|NCT02367911|449102044|FG001|Overall Study|Withdrawal by Subject|2|||
124857585|NCT02367911|449102043|FG000|Overall Study|Lost to Follow-up|2|||
124857586|NCT02367911|449102044|FG001|Overall Study|Lost to Follow-up|2|||
124857587|NCT00902304|449102045|FG000|Overall Study|Adverse Event|4|||
124857588|NCT00902304|449102046|FG001|Overall Study|Adverse Event|10|||
124857589|NCT00902304|449102047|FG002|Overall Study|Adverse Event|25|||
124857590|NCT00902304|449102045|FG000|Overall Study|Investigator discretion|3|||
124857591|NCT00902304|449102046|FG001|Overall Study|Investigator discretion|5|||
124857592|NCT00902304|449102047|FG002|Overall Study|Investigator discretion|13|||
124857593|NCT00902304|449102045|FG000|Overall Study|Lost to Follow-up|7|||
124857594|NCT00902304|449102046|FG001|Overall Study|Lost to Follow-up|7|||
124857595|NCT00902304|449102047|FG002|Overall Study|Lost to Follow-up|7|||
124857596|NCT00902304|449102045|FG000|Overall Study|Protocol Violation|9|||
124857597|NCT00902304|449102046|FG001|Overall Study|Protocol Violation|18|||
124857598|NCT00902304|449102047|FG002|Overall Study|Protocol Violation|20|||
124857599|NCT00902304|449102045|FG000|Overall Study|Withdrawal by Subject|32|||
124857600|NCT00902304|449102046|FG001|Overall Study|Withdrawal by Subject|22|||
124857601|NCT00902304|449102047|FG002|Overall Study|Withdrawal by Subject|43|||
124857602|NCT00902304|449102045|FG000|Overall Study|includes pregnancy|3|||
124857603|NCT00902304|449102046|FG001|Overall Study|includes pregnancy|9|||
124857604|NCT00902304|449102047|FG002|Overall Study|includes pregnancy|2|||
124857605|NCT01153633|449102048|FG000|Overall Study|Protocol Violation|1|||
124857606|NCT01153633|449102049|FG001|Overall Study|Protocol Violation|1|||
124857607|NCT01153633|449102048|FG000|Overall Study|Therapeutic failure|3|||
124857608|NCT01153633|449102049|FG001|Overall Study|Therapeutic failure|3|||
124857609|NCT00384085|449102050|FG000|Overall Study|Adverse Event|5|||
124857610|NCT00384085|449102051|FG001|Overall Study|Adverse Event|5|||
124857611|NCT00384085|449102052|FG002|Overall Study|Adverse Event|4|||
124857612|NCT00384085|449102050|FG000|Overall Study|Lack of Efficacy|0|||
124857613|NCT00384085|449102051|FG001|Overall Study|Lack of Efficacy|3|||
124857614|NCT00384085|449102052|FG002|Overall Study|Lack of Efficacy|2|||
124857615|NCT00384085|449102050|FG000|Overall Study|No longer Requires Study Treatment|1|||
124857616|NCT00384085|449102051|FG001|Overall Study|No longer Requires Study Treatment|0|||
124857617|NCT00384085|449102052|FG002|Overall Study|No longer Requires Study Treatment|1|||
124857618|NCT00384085|449102050|FG000|Overall Study|Protocol Violation|2|||
124857619|NCT00384085|449102051|FG001|Overall Study|Protocol Violation|2|||
124857620|NCT00384085|449102052|FG002|Overall Study|Protocol Violation|2|||
124857621|NCT00384085|449102050|FG000|Overall Study|Lost to Follow-up|9|||
124857622|NCT00384085|449102051|FG001|Overall Study|Lost to Follow-up|9|||
124857623|NCT00384085|449102052|FG002|Overall Study|Lost to Follow-up|10|||
124857624|NCT00384085|449102050|FG000|Overall Study|Progressive Disease|0|||
124857625|NCT00384085|449102051|FG001|Overall Study|Progressive Disease|1|||
124857626|NCT00384085|449102052|FG002|Overall Study|Progressive Disease|0|||
124857627|NCT00384085|449102050|FG000|Overall Study|Withdrawal by Subject|14|||
124857628|NCT00384085|449102051|FG001|Overall Study|Withdrawal by Subject|19|||
124857629|NCT00384085|449102052|FG002|Overall Study|Withdrawal by Subject|29|||
124857630|NCT00384085|449102050|FG000|Overall Study|Patient non-compliant|4|||
124857631|NCT00384085|449102051|FG001|Overall Study|Patient non-compliant|4|||
124857632|NCT00384085|449102052|FG002|Overall Study|Patient non-compliant|5|||
124857633|NCT00384085|449102050|FG000|Overall Study|Physician Decision|1|||
124857634|NCT00384085|449102051|FG001|Overall Study|Physician Decision|0|||
124857635|NCT00384085|449102052|FG002|Overall Study|Physician Decision|0|||
124857636|NCT00384085|449102050|FG000|Overall Study|Loss of site personnel|1|||
124857637|NCT00384085|449102051|FG001|Overall Study|Loss of site personnel|0|||
124857638|NCT00384085|449102052|FG002|Overall Study|Loss of site personnel|1|||
124857639|NCT00384085|449102050|FG000|Overall Study|Sponsor decision|1|||
124857640|NCT00384085|449102051|FG001|Overall Study|Sponsor decision|2|||
124857641|NCT00384085|449102052|FG002|Overall Study|Sponsor decision|1|||
124857642|NCT00384085|449102050|FG000|Overall Study|Patient moved|1|||
124857643|NCT00384085|449102051|FG001|Overall Study|Patient moved|0|||
124857644|NCT00384085|449102052|FG002|Overall Study|Patient moved|1|||
124857645|NCT00384085|449102050|FG000|Overall Study|Patient required surgery|0|||
124857646|NCT00384085|449102051|FG001|Overall Study|Patient required surgery|1|||
124857647|NCT00384085|449102052|FG002|Overall Study|Patient required surgery|0|||
124857648|NCT00352365|449102055|FG000|Induction Therapy|Adverse Event|7|||
124857649|NCT00352365|449102055|FG000|Induction Therapy|Progression/Relapse|8|||
124857650|NCT00352365|449102055|FG000|Induction Therapy|Death|7|||
124857651|NCT00352365|449102055|FG000|Induction Therapy|Not protocol specified|1|||
124857652|NCT00352365|449102055|FG000|Induction Therapy|Not eligible|3|||
124857653|NCT00352365|449102055|FG000|Induction Therapy|Death before starting protocol therapy|1|||
124857654|NCT00352365|449102055|FG000|Maintenance Therapy|Progression/Relapse|3|||
124857655|NCT00352365|449102055|FG000|Maintenance Therapy|Death|2|||
124857656|NCT00352365|449102055|FG000|Maintenance Therapy|Not protocol specified|3|||
124857657|NCT00352365|449102055|FG000|Maintenance Therapy|Not eligible|4|||
124857658|NCT00987467|449102059|FG000|Overall Study|Lost to Follow-up|2|||
124857659|NCT02646423|449102060|FG000|Overall Study|Adverse Event|5|||
124857660|NCT02646423|449102061|FG001|Overall Study|Adverse Event|7|||
124857661|NCT02646423|449102060|FG000|Overall Study|Ineligible|2|||
124857662|NCT02646423|449102061|FG001|Overall Study|Ineligible|1|||
124857663|NCT02807948|449102062|FG000|Overall Study|Physician Decision|1|||
124857664|NCT02807948|449102063|FG001|Overall Study|Physician Decision|0|||
124857665|NCT02624804|449102064|FG000|Overall Study|Screen Failure|5|||
124857666|NCT01227889|449102068|FG000|Randomized Phase (RP)|Adverse Event|13|||
124857667|NCT01227889|449102069|FG001|Randomized Phase (RP)|Adverse Event|0|||
124857668|NCT01227889|449102068|FG000|Randomized Phase (RP)|Physician Decision|13|||
124857669|NCT01227889|449102069|FG001|Randomized Phase (RP)|Physician Decision|5|||
124857670|NCT01227889|449102068|FG000|Randomized Phase (RP)|Progressive Disease|135|||
124857671|NCT01227889|449102069|FG001|Randomized Phase (RP)|Progressive Disease|52|||
124857672|NCT01227889|449102068|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
124857673|NCT01227889|449102069|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
124857674|NCT01227889|449102068|FG000|Randomized Phase (RP)|Missing|1|||
124857675|NCT01227889|449102069|FG001|Randomized Phase (RP)|Missing|3|||
124857676|NCT01227889|449102068|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
124857677|NCT01227889|449102069|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
124857678|NCT01227889|449102068|FG000|Crossover Phase|Adverse Event|0|||
124857679|NCT01227889|449102069|FG001|Crossover Phase|Adverse Event|1|||
124857680|NCT01227889|449102068|FG000|Crossover Phase|Physician Decision|0|||
124857681|NCT01227889|449102069|FG001|Crossover Phase|Physician Decision|3|||
124857682|NCT01227889|449102068|FG000|Crossover Phase|Progressive Disease|0|||
124857683|NCT01227889|449102069|FG001|Crossover Phase|Progressive Disease|31|||
124857684|NCT01227889|449102068|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
124857685|NCT01227889|449102069|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
124857686|NCT01227889|449102068|FG000|Crossover Phase|Withdrawal by Subject|0|||
124857687|NCT01227889|449102069|FG001|Crossover Phase|Withdrawal by Subject|1|||
124857688|NCT03073603|449102072|FG000|Overall Study|Noncompliance|3|||
124857689|NCT03073603|449102073|FG001|Overall Study|Noncompliance|1|||
124857690|NCT03073603|449102072|FG000|Overall Study|Adverse Event|5|||
124857691|NCT03073603|449102073|FG001|Overall Study|Adverse Event|3|||
124857692|NCT03073603|449102072|FG000|Overall Study|Physician Decision|1|||
124857693|NCT03073603|449102073|FG001|Overall Study|Physician Decision|2|||
124857694|NCT03073603|449102072|FG000|Overall Study|Required treatment not allowed by protocol|1|||
124857695|NCT03073603|449102073|FG001|Overall Study|Required treatment not allowed by protocol|0|||
124857696|NCT03073603|449102072|FG000|Overall Study|Financial or insurance-related|8|||
124857697|NCT03073603|449102073|FG001|Overall Study|Financial or insurance-related|0|||
124857698|NCT03073603|449102072|FG000|Overall Study|Withdrawal by Subject|0|||
124857699|NCT03073603|449102073|FG001|Overall Study|Withdrawal by Subject|1|||
124857700|NCT03073603|449102072|FG000|Overall Study|Discontinued DMT|4|||
124857701|NCT03073603|449102073|FG001|Overall Study|Discontinued DMT|0|||
124857702|NCT03073603|449102072|FG000|Overall Study|Restarted DMT|0|||
124857703|NCT03073603|449102073|FG001|Overall Study|Restarted DMT|1|||
124857704|NCT02553330|449102076|FG000|Overall Study|Study Terminated by Sponsor|2|||
124857705|NCT02553330|449102077|FG001|Overall Study|Study Terminated by Sponsor|13|||
124857706|NCT02553330|449102078|FG002|Overall Study|Study Terminated by Sponsor|12|||
124857707|NCT02553330|449102076|FG000|Overall Study|Withdrawal by Subject|3|||
124857708|NCT02553330|449102077|FG001|Overall Study|Withdrawal by Subject|19|||
124857709|NCT02553330|449102078|FG002|Overall Study|Withdrawal by Subject|21|||
124857710|NCT02553330|449102076|FG000|Overall Study|Other|0|||
124857711|NCT02553330|449102077|FG001|Overall Study|Other|1|||
124857712|NCT02553330|449102078|FG002|Overall Study|Other|0|||
124857713|NCT02553330|449102076|FG000|Overall Study|Non compliance to study treatment|0|||
124857714|NCT02553330|449102077|FG001|Overall Study|Non compliance to study treatment|1|||
124857715|NCT02553330|449102078|FG002|Overall Study|Non compliance to study treatment|0|||
124857716|NCT02553330|449102076|FG000|Overall Study|Adverse Event|0|||
124857717|NCT02553330|449102077|FG001|Overall Study|Adverse Event|1|||
124857718|NCT02553330|449102078|FG002|Overall Study|Adverse Event|0|||
124857719|NCT02553330|449102076|FG000|Overall Study|Lost to Follow-up|0|||
124857720|NCT02553330|449102077|FG001|Overall Study|Lost to Follow-up|4|||
124857721|NCT02553330|449102078|FG002|Overall Study|Lost to Follow-up|4|||
124857722|NCT03551938|449102081|FG000|3-Month Follow Up|Lost to Follow-up|39|||
124857723|NCT03551938|449102082|FG001|3-Month Follow Up|Lost to Follow-up|38|||
124857724|NCT03551938|449102081|FG000|6-Month Follow Up|Lost to Follow-up|46|||
124857725|NCT03551938|449102082|FG001|6-Month Follow Up|Lost to Follow-up|42|||
124857726|NCT03551938|449102081|FG000|9-Month Follow Up|Lost to Follow-up|44|||
124857727|NCT03551938|449102082|FG001|9-Month Follow Up|Lost to Follow-up|43|||
124857728|NCT02079805|449102085|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
124857729|NCT02079805|449102086|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
124857730|NCT02079805|449102085|FG000|Overall Study|Voluntary Withdrawal|0|||
124857731|NCT02079805|449102086|FG001|Overall Study|Voluntary Withdrawal|1|||
124857732|NCT02347761|449102087|FG000|All Collected|Death|1|||
124857733|NCT02347761|449102088|FG001|All Collected|Death|0|||
124857734|NCT02347761|449102089|FG002|All Collected|Death|0|||
124857735|NCT02347761|449102087|FG000|All Collected|Lost to Follow-up|3|||
124857736|NCT02347761|449102088|FG001|All Collected|Lost to Follow-up|2|||
124857737|NCT02347761|449102089|FG002|All Collected|Lost to Follow-up|3|||
124857738|NCT02347761|449102087|FG000|All Collected|Withdrawal by Subject|11|||
124857739|NCT02347761|449102088|FG001|All Collected|Withdrawal by Subject|11|||
124857740|NCT02347761|449102089|FG002|All Collected|Withdrawal by Subject|22|||
124857741|NCT02347761|449102087|FG000|All Collected|invetigator disretion|2|||
124857742|NCT02347761|449102088|FG001|All Collected|invetigator disretion|0|||
124857743|NCT02347761|449102089|FG002|All Collected|invetigator disretion|0|||
124857744|NCT02347761|449102087|FG000|All Collected|instillation site pain|0|||
124857745|NCT02347761|449102088|FG001|All Collected|instillation site pain|0|||
124857746|NCT02347761|449102089|FG002|All Collected|instillation site pain|1|||
124857747|NCT02347761|449102087|FG000|All Collected|exacerbation of COPD|0|||
124857748|NCT02347761|449102088|FG001|All Collected|exacerbation of COPD|0|||
124857749|NCT02347761|449102089|FG002|All Collected|exacerbation of COPD|1|||
124857750|NCT02347761|449102087|FG000|All Collected|moved/travel|0|||
124857751|NCT02347761|449102088|FG001|All Collected|moved/travel|1|||
124857752|NCT02347761|449102089|FG002|All Collected|moved/travel|0|||
124857753|NCT02347761|449102087|FG000|On Study Treatment|Lack of Efficacy|2|||
124857754|NCT02347761|449102088|FG001|On Study Treatment|Lack of Efficacy|3|||
124857755|NCT02347761|449102089|FG002|On Study Treatment|Lack of Efficacy|4|||
124857756|NCT02347761|449102087|FG000|On Study Treatment|non-compliance with study medication|0|||
124857757|NCT02347761|449102088|FG001|On Study Treatment|non-compliance with study medication|0|||
124857758|NCT02347761|449102089|FG002|On Study Treatment|non-compliance with study medication|2|||
124857759|NCT02347761|449102087|FG000|On Study Treatment|Withdrawal by Subject|7|||
124857760|NCT02347761|449102088|FG001|On Study Treatment|Withdrawal by Subject|3|||
124857761|NCT02347761|449102089|FG002|On Study Treatment|Withdrawal by Subject|5|||
124857762|NCT02347761|449102087|FG000|On Study Treatment|move/travel|2|||
124857763|NCT02347761|449102088|FG001|On Study Treatment|move/travel|6|||
124857764|NCT02347761|449102089|FG002|On Study Treatment|move/travel|5|||
124857765|NCT02347761|449102087|FG000|On Study Treatment|dissastisfaction with device|2|||
124857766|NCT02347761|449102088|FG001|On Study Treatment|dissastisfaction with device|1|||
124857767|NCT02347761|449102089|FG002|On Study Treatment|dissastisfaction with device|4|||
124857768|NCT02347761|449102087|FG000|On Study Treatment|Lost to Follow-up|2|||
124857769|NCT02347761|449102088|FG001|On Study Treatment|Lost to Follow-up|1|||
124857770|NCT02347761|449102089|FG002|On Study Treatment|Lost to Follow-up|1|||
124857771|NCT02347761|449102087|FG000|On Study Treatment|investigator discretion|2|||
124857772|NCT02347761|449102088|FG001|On Study Treatment|investigator discretion|0|||
124857773|NCT02347761|449102089|FG002|On Study Treatment|investigator discretion|0|||
124857774|NCT02347761|449102087|FG000|On Study Treatment|durg not working|0|||
124857775|NCT02347761|449102088|FG001|On Study Treatment|durg not working|1|||
124857776|NCT02347761|449102089|FG002|On Study Treatment|durg not working|1|||
124857777|NCT02347761|449102087|FG000|On Study Treatment|Adverse Event|10|||
124857778|NCT02347761|449102088|FG001|On Study Treatment|Adverse Event|8|||
124857779|NCT02347761|449102089|FG002|On Study Treatment|Adverse Event|20|||
124857780|NCT03879798|449102090|FG000|Overall Study|Adverse Event|0|||
124857781|NCT03879798|449102091|FG001|Overall Study|Adverse Event|0|||
124857782|NCT03879798|449102092|FG002|Overall Study|Adverse Event|0|||
124857783|NCT03879798|449102093|FG003|Overall Study|Adverse Event|0|||
124857784|NCT03879798|449102094|FG004|Overall Study|Adverse Event|0|||
124857785|NCT03879798|449102095|FG005|Overall Study|Adverse Event|1|||
124857786|NCT03879798|449102090|FG000|Overall Study|Lack of Efficacy|0|||
124857787|NCT03879798|449102091|FG001|Overall Study|Lack of Efficacy|0|||
124857788|NCT03879798|449102092|FG002|Overall Study|Lack of Efficacy|0|||
124857789|NCT03879798|449102093|FG003|Overall Study|Lack of Efficacy|0|||
124857790|NCT03879798|449102094|FG004|Overall Study|Lack of Efficacy|0|||
124857791|NCT03879798|449102095|FG005|Overall Study|Lack of Efficacy|1|||
124857792|NCT03879798|449102090|FG000|Overall Study|Withdrawal by Subject|0|||
124857793|NCT03879798|449102091|FG001|Overall Study|Withdrawal by Subject|0|||
124857794|NCT03879798|449102092|FG002|Overall Study|Withdrawal by Subject|0|||
124857795|NCT03879798|449102093|FG003|Overall Study|Withdrawal by Subject|0|||
124857796|NCT03879798|449102094|FG004|Overall Study|Withdrawal by Subject|0|||
124857797|NCT03879798|449102095|FG005|Overall Study|Withdrawal by Subject|1|||
124857798|NCT03625570|449102096|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
124857799|NCT03625570|449102097|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
124857800|NCT03625570|449102096|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
124857801|NCT03625570|449102097|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
124857802|NCT03625570|449102096|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
124857803|NCT03625570|449102097|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
124857804|NCT01040130|449102105|FG000|Overall Study|Adverse Event|1|||
124857805|NCT01040130|449102106|FG001|Overall Study|Adverse Event|1|||
124857806|NCT01040130|449102107|FG002|Overall Study|Adverse Event|0|||
124857807|NCT01040130|449102108|FG003|Overall Study|Adverse Event|5|||
124857808|NCT01040130|449102109|FG004|Overall Study|Adverse Event|0|||
124857809|NCT01040130|449102110|FG005|Overall Study|Adverse Event|3|||
124857810|NCT01040130|449102105|FG000|Overall Study|Protocol Violation|0|||
124857811|NCT01040130|449102106|FG001|Overall Study|Protocol Violation|0|||
124857812|NCT01040130|449102107|FG002|Overall Study|Protocol Violation|2|||
124857813|NCT01040130|449102108|FG003|Overall Study|Protocol Violation|0|||
124857814|NCT01040130|449102109|FG004|Overall Study|Protocol Violation|0|||
124857815|NCT01040130|449102110|FG005|Overall Study|Protocol Violation|0|||
124857816|NCT01040130|449102105|FG000|Overall Study|Withdrawal by Subject|0|||
124857817|NCT01040130|449102106|FG001|Overall Study|Withdrawal by Subject|2|||
124857818|NCT01040130|449102107|FG002|Overall Study|Withdrawal by Subject|0|||
124857819|NCT01040130|449102108|FG003|Overall Study|Withdrawal by Subject|0|||
124857820|NCT01040130|449102109|FG004|Overall Study|Withdrawal by Subject|0|||
124857821|NCT01040130|449102110|FG005|Overall Study|Withdrawal by Subject|1|||
124857822|NCT01040130|449102105|FG000|Overall Study|Other reasons not listed above|2|||
124857823|NCT01040130|449102106|FG001|Overall Study|Other reasons not listed above|0|||
124857824|NCT01040130|449102107|FG002|Overall Study|Other reasons not listed above|0|||
124857825|NCT01040130|449102108|FG003|Overall Study|Other reasons not listed above|0|||
124857826|NCT01040130|449102109|FG004|Overall Study|Other reasons not listed above|0|||
124857827|NCT01040130|449102110|FG005|Overall Study|Other reasons not listed above|0|||
124857828|NCT02937545|449102114|FG000|Overall Study|Withdrawal by Subject|1|||
124857829|NCT02937545|449102115|FG001|Overall Study|Withdrawal by Subject|2|||
124857830|NCT02937545|449102116|FG002|Overall Study|Withdrawal by Subject|6|||
124857831|NCT02937545|449102117|FG003|Overall Study|Withdrawal by Subject|7|||
124857832|NCT02937545|449102114|FG000|Overall Study|Lost to Follow-up|1|||
124857833|NCT02937545|449102115|FG001|Overall Study|Lost to Follow-up|0|||
124857834|NCT02937545|449102116|FG002|Overall Study|Lost to Follow-up|0|||
124857835|NCT02937545|449102117|FG003|Overall Study|Lost to Follow-up|0|||
124857836|NCT02007577|449102118|FG000|Overall Study|Adverse Event|1|||
124857837|NCT02007577|449102119|FG001|Overall Study|Adverse Event|0|||
124857838|NCT02007577|449102118|FG000|Overall Study|Withdrawal by Subject|0|||
124857839|NCT02007577|449102119|FG001|Overall Study|Withdrawal by Subject|1|||
124857840|NCT02504294|449102120|FG000|Overall Study|Adverse Event|15|||
124857841|NCT02504294|449102121|FG001|Overall Study|Adverse Event|12|||
124857842|NCT02504294|449102120|FG000|Overall Study|Withdrawal by Subject|7|||
124857843|NCT02504294|449102121|FG001|Overall Study|Withdrawal by Subject|1|||
124857844|NCT02504294|449102120|FG000|Overall Study|Protocol Violation|27|||
124857845|NCT02504294|449102121|FG001|Overall Study|Protocol Violation|26|||
124857846|NCT02504294|449102120|FG000|Overall Study|Physician Decision|1|||
124857847|NCT02504294|449102121|FG001|Overall Study|Physician Decision|2|||
124857848|NCT02504294|449102120|FG000|Overall Study|Lost to Follow-up|6|||
124857849|NCT02504294|449102121|FG001|Overall Study|Lost to Follow-up|7|||
124857850|NCT02252211|449102122|FG000|Overall Study|Adverse Event|0|||
124857851|NCT02252211|449102123|FG001|Overall Study|Adverse Event|1|||
124857852|NCT02252211|449102124|FG002|Overall Study|Adverse Event|0|||
124857853|NCT02252211|449102122|FG000|Overall Study|Progressive disease|3|||
124857854|NCT02252211|449102123|FG001|Overall Study|Progressive disease|2|||
124857855|NCT02252211|449102124|FG002|Overall Study|Progressive disease|0|||
124857856|NCT02252211|449102122|FG000|Overall Study|Withdrawal by Subject|1|||
124857857|NCT02252211|449102123|FG001|Overall Study|Withdrawal by Subject|0|||
124857858|NCT02252211|449102124|FG002|Overall Study|Withdrawal by Subject|0|||
124857859|NCT02252211|449102122|FG000|Overall Study|Serious Adverse Event During Screening|1|||
124857860|NCT02252211|449102123|FG001|Overall Study|Serious Adverse Event During Screening|0|||
124857861|NCT02252211|449102124|FG002|Overall Study|Serious Adverse Event During Screening|1|||
124857862|NCT01985126|449102125|FG000|Overall Study|Death|15|||
124857863|NCT01985126|449102126|FG001|Overall Study|Death|69|||
124857864|NCT01985126|449102125|FG000|Overall Study|Lost to Follow-up|0|||
124857865|NCT01985126|449102126|FG001|Overall Study|Lost to Follow-up|8|||
124857866|NCT01985126|449102125|FG000|Overall Study|Study Terminated By Sponsor|1|||
124857867|NCT01985126|449102126|FG001|Overall Study|Study Terminated By Sponsor|22|||
124857868|NCT01985126|449102125|FG000|Overall Study|Withdrawal by Subject|2|||
124857869|NCT01985126|449102126|FG001|Overall Study|Withdrawal by Subject|7|||
124857870|NCT00968669|449102127|FG000|Overall Study|Lost to Follow-up|5|||
124857871|NCT00968669|449102128|FG001|Overall Study|Lost to Follow-up|2|||
124857872|NCT00968669|449102129|FG002|Overall Study|Lost to Follow-up|1|||
124857873|NCT00968669|449102130|FG003|Overall Study|Lost to Follow-up|4|||
124857874|NCT00968669|449102127|FG000|Overall Study|Withdrawal by Subject|9|||
124857875|NCT00968669|449102128|FG001|Overall Study|Withdrawal by Subject|7|||
124857876|NCT00968669|449102129|FG002|Overall Study|Withdrawal by Subject|5|||
124857877|NCT00968669|449102130|FG003|Overall Study|Withdrawal by Subject|3|||
124857878|NCT00968669|449102127|FG000|Overall Study|Pregnancy|0|||
124857879|NCT00968669|449102128|FG001|Overall Study|Pregnancy|0|||
124857880|NCT00968669|449102129|FG002|Overall Study|Pregnancy|2|||
124857881|NCT00968669|449102130|FG003|Overall Study|Pregnancy|0|||
124857882|NCT00968669|449102127|FG000|Overall Study|AE|1|||
124857883|NCT00968669|449102128|FG001|Overall Study|AE|0|||
124857884|NCT00968669|449102129|FG002|Overall Study|AE|0|||
124857885|NCT00968669|449102130|FG003|Overall Study|AE|0|||
124857886|NCT00968669|449102127|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
124857887|NCT00968669|449102128|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
124857888|NCT00968669|449102129|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
124857889|NCT00968669|449102130|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
124857890|NCT00968669|449102127|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
124857891|NCT00968669|449102128|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
124857892|NCT00968669|449102129|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
124857893|NCT00968669|449102130|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
124857894|NCT00968669|449102127|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
124857895|NCT00968669|449102128|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
124857896|NCT00968669|449102129|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
124857897|NCT00968669|449102130|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
124857898|NCT00968669|449102127|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
124857899|NCT00968669|449102128|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
124857900|NCT00968669|449102129|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
124857901|NCT00968669|449102130|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
124857902|NCT00968669|449102127|FG000|Overall Study|EARLY WITHDRAWAL|0|||
124857903|NCT00968669|449102128|FG001|Overall Study|EARLY WITHDRAWAL|1|||
124857904|NCT00968669|449102129|FG002|Overall Study|EARLY WITHDRAWAL|0|||
124857905|NCT00968669|449102130|FG003|Overall Study|EARLY WITHDRAWAL|0|||
124857906|NCT00968669|449102127|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
124857907|NCT00968669|449102128|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
124857908|NCT00968669|449102129|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
124857909|NCT00968669|449102130|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
124857910|NCT00968669|449102127|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
124857911|NCT00968669|449102128|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
124857912|NCT00968669|449102129|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
124857913|NCT00968669|449102130|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
124857914|NCT00968669|449102127|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
124857915|NCT00968669|449102128|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
124857916|NCT00968669|449102129|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
124857917|NCT00968669|449102130|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
124857918|NCT00968669|449102127|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
124857919|NCT00968669|449102128|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
124857920|NCT00968669|449102129|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
124857921|NCT00968669|449102130|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
124857922|NCT00968669|449102127|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
124857923|NCT00968669|449102128|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
124857924|NCT00968669|449102129|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
124857925|NCT00968669|449102130|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
124857926|NCT00968669|449102127|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
124857927|NCT00968669|449102128|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
124857928|NCT00968669|449102129|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
124857929|NCT00968669|449102130|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
124857930|NCT00968669|449102127|FG000|Overall Study|SPONSOR DECISION|0|||
124857931|NCT00968669|449102128|FG001|Overall Study|SPONSOR DECISION|1|||
124857932|NCT00968669|449102129|FG002|Overall Study|SPONSOR DECISION|0|||
124857933|NCT00968669|449102130|FG003|Overall Study|SPONSOR DECISION|0|||
124857934|NCT00968669|449102127|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
124857935|NCT00968669|449102128|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
124857936|NCT00968669|449102129|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
124857937|NCT00968669|449102130|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
124857938|NCT00968669|449102127|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
124857939|NCT00968669|449102128|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
124857940|NCT00968669|449102129|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
124857941|NCT00968669|449102130|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
124857942|NCT00968669|449102127|FG000|Overall Study|SUBJECT INCARCERATED|0|||
124857943|NCT00968669|449102128|FG001|Overall Study|SUBJECT INCARCERATED|1|||
124857944|NCT00968669|449102129|FG002|Overall Study|SUBJECT INCARCERATED|0|||
124857945|NCT00968669|449102130|FG003|Overall Study|SUBJECT INCARCERATED|0|||
124857946|NCT00968669|449102127|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
124857947|NCT00968669|449102128|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
124857948|NCT00968669|449102129|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
124857949|NCT00968669|449102130|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
124857950|NCT00968669|449102127|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
124857951|NCT00968669|449102128|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
124857952|NCT00968669|449102129|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
124857953|NCT00968669|449102130|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
124857954|NCT00144339|449102133|FG000|Overall Study|Adverse Event|746|||
124857955|NCT00144339|449102134|FG001|Overall Study|Adverse Event|627|||
124857956|NCT00144339|449102133|FG000|Overall Study|Protocol Violation|75|||
124857957|NCT00144339|449102134|FG001|Overall Study|Protocol Violation|48|||
124857958|NCT00144339|449102133|FG000|Overall Study|Withdrawal by Subject|403|||
124857959|NCT00144339|449102134|FG001|Overall Study|Withdrawal by Subject|300|||
124857960|NCT00144339|449102133|FG000|Overall Study|Lost to Follow-up|76|||
124857961|NCT00144339|449102134|FG001|Overall Study|Lost to Follow-up|64|||
124857962|NCT00144339|449102133|FG000|Overall Study|Other|58|||
124857963|NCT00144339|449102134|FG001|Overall Study|Other|60|||
124857964|NCT01109992|449102135|FG000|Overall Study|Withdrawal by Subject|0|||
124857965|NCT01109992|449102136|FG001|Overall Study|Withdrawal by Subject|1|||
124857966|NCT01109992|449102135|FG000|Overall Study|Movement during rest scan.|0|||
124857967|NCT01109992|449102136|FG001|Overall Study|Movement during rest scan.|1|||
124857968|NCT02338362|449102137|FG000|Overall Study|Withdrawal by Subject|1|||
124857969|NCT02338362|449102138|FG001|Overall Study|Withdrawal by Subject|1|||
124857970|NCT00690755|449102139|FG000|Overall Study|Physician Decision|2|||
124857971|NCT00690755|449102140|FG001|Overall Study|Physician Decision|0|||
124857972|NCT00690755|449102141|FG002|Overall Study|Physician Decision|46|||
124857973|NCT00690755|449102142|FG003|Overall Study|Physician Decision|5|||
124857974|NCT00690755|449102143|FG004|Overall Study|Physician Decision|0|||
124857975|NCT00690755|449102144|FG005|Overall Study|Physician Decision|4|||
124857976|NCT00690755|449102145|FG006|Overall Study|Physician Decision|0|||
124857977|NCT00784043|449102146|FG000|Overall Study|Withdrawal by Subject|8|||
124857978|NCT00784043|449102147|FG001|Overall Study|Withdrawal by Subject|5|||
124857979|NCT00784043|449102146|FG000|Overall Study|Protocol Terminated|23|||
124857980|NCT00784043|449102147|FG001|Overall Study|Protocol Terminated|1|||
124857981|NCT03538626|449102148|FG000|Overall Study|Withdrawal by Subject|0|||
124857982|NCT03538626|449102149|FG001|Overall Study|Withdrawal by Subject|1|||
124857983|NCT03538626|449102150|FG002|Overall Study|Withdrawal by Subject|0|||
124857984|NCT03538626|449102151|FG003|Overall Study|Withdrawal by Subject|0|||
124857985|NCT03538626|449102152|FG004|Overall Study|Withdrawal by Subject|0|||
124857986|NCT03538626|449102153|FG005|Overall Study|Withdrawal by Subject|0|||
124857987|NCT03538626|449102154|FG006|Overall Study|Withdrawal by Subject|0|||
124857988|NCT03538626|449102155|FG007|Overall Study|Withdrawal by Subject|0|||
124857989|NCT03538626|449102148|FG000|Overall Study|Lost to Follow-up|0|||
124857990|NCT03538626|449102149|FG001|Overall Study|Lost to Follow-up|0|||
124857991|NCT03538626|449102150|FG002|Overall Study|Lost to Follow-up|0|||
124857992|NCT03538626|449102151|FG003|Overall Study|Lost to Follow-up|0|||
124857993|NCT03538626|449102152|FG004|Overall Study|Lost to Follow-up|0|||
124857994|NCT03538626|449102153|FG005|Overall Study|Lost to Follow-up|0|||
124857995|NCT03538626|449102154|FG006|Overall Study|Lost to Follow-up|1|||
124857996|NCT03538626|449102155|FG007|Overall Study|Lost to Follow-up|0|||
124857997|NCT01434602|449102160|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
124857998|NCT01434602|449102161|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
124857999|NCT01434602|449102162|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
124858000|NCT01434602|449102163|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
124858001|NCT01434602|449102164|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
124858002|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
124858003|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
124858004|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
124858005|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
124858006|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
124858007|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
124858008|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
124858009|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
124858010|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
124858011|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
124858012|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
124858013|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
124858014|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
124858015|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
124858016|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
124858017|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
124858018|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
124858019|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
124858020|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
124858021|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
124858022|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
124858023|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
124858024|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
124858025|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
124858026|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
124858027|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
124858028|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
124858029|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
124858030|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
124858031|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
124858032|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
124858033|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
124858034|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
124858035|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
124858036|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
124858037|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
124858038|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
124858039|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
124858040|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
124858041|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
124858042|NCT01434602|449102160|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
124858043|NCT01434602|449102161|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
124858044|NCT01434602|449102162|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
124858045|NCT01434602|449102163|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
124858046|NCT01434602|449102164|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
124858047|NCT00499889|449102178|FG000|Overall Study|Infection prior to treatment|1|||
124858048|NCT00345397|449102182|FG000|Overall Study|Death|1|||
124858049|NCT03351049|449102185|FG000|Overall Study|Withdrawal|26|||
124858050|NCT03351049|449102186|FG001|Overall Study|Withdrawal|22|||
124858051|NCT03832192|449102191|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
124858052|NCT03832192|449102192|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
124858053|NCT03738150|449102193|FG000|Base Study|Withdrawal by Subject|1|||
124858054|NCT03738150|449102193|FG000|Extension Study|Withdrawal by Subject|1|||
124858055|NCT01898195|449102198|FG000|Smoking Abstinence|Did not have good measurements|35|||
124858056|NCT01898195|449102199|FG001|Smoking Abstinence|Did not have good measurements|38|||
124858057|NCT01898195|449102200|FG002|Smoking Abstinence|Did not have good measurements|36|||
124858058|NCT02720484|449102202|FG000|Treatment on Study|Adverse Event|1|||
124858059|NCT02720484|449102202|FG000|Treatment on Study|Withdrawal by Subject|1|||
124858060|NCT02720484|449102202|FG000|Treatment on Study|Progressive Disease|4|||
124858061|NCT02720484|449102202|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
124858062|NCT02720484|449102202|FG000|Follow Up for 2 Years|Death|3|||
124858063|NCT02720484|449102202|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
124858064|NCT05070897|449102206|FG000|Overall Study|Protocol Violation|123|||
124858065|NCT05070897|449102207|FG001|Overall Study|Protocol Violation|68|||
124858066|NCT01617629|449102210|FG000|Overall Study|Death|2|||
124858067|NCT01617629|449102210|FG000|Overall Study|Investigator's Clinical Judgement|1|||
124858068|NCT01617629|449102210|FG000|Overall Study|Reason Not Specified|1|||
124858069|NCT01617629|449102210|FG000|Overall Study|Participant Withdrew Consent|2|||
124858070|NCT01337245|449102211|FG000|Overall Study|Lost to Follow-up|1|||
124858071|NCT01663636|449102212|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
124858072|NCT01663636|449102213|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
124858073|NCT03832946|449102214|FG000|Overall Study|Adverse Event|3|||
124858074|NCT03832946|449102215|FG001|Overall Study|Adverse Event|1|||
124858075|NCT03832946|449102214|FG000|Overall Study|Lost to Follow-up|1|||
124858076|NCT03832946|449102215|FG001|Overall Study|Lost to Follow-up|0|||
124858077|NCT03832946|449102214|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
124858078|NCT03832946|449102215|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
124858079|NCT03832946|449102214|FG000|Overall Study|Lack of Efficacy|1|||
124858080|NCT03832946|449102215|FG001|Overall Study|Lack of Efficacy|0|||
124858081|NCT03832946|449102214|FG000|Overall Study|Withdrawal by Subject|12|||
124858082|NCT03832946|449102215|FG001|Overall Study|Withdrawal by Subject|9|||
124858083|NCT00136955|449103979|FG000|Overall Study|Adverse Event|8|||
124858084|NCT00136955|449103979|FG000|Overall Study|Lost to Follow-up|1|||
124858085|NCT00136955|449103979|FG000|Overall Study|Withdrawal by Subject|2|||
124858086|NCT00136955|449103979|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
124858087|NCT00773968|449103981|FG000|Overall Study|Adverse Event|2|||
124858088|NCT00773968|449103981|FG000|Overall Study|Death|1|||
124858089|NCT00773968|449103981|FG000|Overall Study|Failure to Return|2|||
124858090|NCT00773968|449103981|FG000|Overall Study|Lack of Efficacy|3|||
124858091|NCT00773968|449103981|FG000|Overall Study|Protocol Violation|1|||
124858092|NCT00773968|449103981|FG000|Overall Study|Withdrawal by Subject|11|||
124858093|NCT00773968|449103981|FG000|Overall Study|Screen Failure|17|||
124858094|NCT00773968|449103981|FG000|Overall Study|Other|8|||
124858095|NCT04579757|449103982|FG000|Overall Study|Adverse Event|0|||
124858096|NCT04579757|449103983|FG001|Overall Study|Adverse Event|0|||
124858097|NCT04579757|449103984|FG002|Overall Study|Adverse Event|0|||
124858098|NCT04579757|449103985|FG003|Overall Study|Adverse Event|2|||
124858099|NCT04579757|449103986|FG004|Overall Study|Adverse Event|1|||
124858100|NCT04579757|449103987|FG005|Overall Study|Adverse Event|1|||
124858101|NCT04579757|449103988|FG006|Overall Study|Adverse Event|0|||
124858102|NCT04579757|449103989|FG007|Overall Study|Adverse Event|0|||
124858103|NCT04579757|449103990|FG008|Overall Study|Adverse Event|0|||
124858104|NCT04579757|449103982|FG000|Overall Study|Death|4|||
124858105|NCT04579757|449103983|FG001|Overall Study|Death|1|||
124858106|NCT04579757|449103984|FG002|Overall Study|Death|14|||
124858107|NCT04579757|449103985|FG003|Overall Study|Death|3|||
124858108|NCT04579757|449103986|FG004|Overall Study|Death|2|||
124858109|NCT04579757|449103987|FG005|Overall Study|Death|7|||
124858110|NCT04579757|449103988|FG006|Overall Study|Death|0|||
124858111|NCT04579757|449103989|FG007|Overall Study|Death|1|||
124858112|NCT04579757|449103990|FG008|Overall Study|Death|3|||
124858113|NCT04579757|449103982|FG000|Overall Study|Physician Decision|0|||
124858114|NCT04579757|449103983|FG001|Overall Study|Physician Decision|0|||
124858115|NCT04579757|449103984|FG002|Overall Study|Physician Decision|0|||
124858116|NCT04579757|449103985|FG003|Overall Study|Physician Decision|2|||
124858117|NCT04579757|449103986|FG004|Overall Study|Physician Decision|1|||
124858118|NCT04579757|449103987|FG005|Overall Study|Physician Decision|1|||
124858119|NCT04579757|449103988|FG006|Overall Study|Physician Decision|1|||
124858120|NCT04579757|449103989|FG007|Overall Study|Physician Decision|0|||
124858121|NCT04579757|449103990|FG008|Overall Study|Physician Decision|0|||
124858122|NCT04579757|449103982|FG000|Overall Study|Study Terminated By Sponsor|0|||
124858123|NCT04579757|449103983|FG001|Overall Study|Study Terminated By Sponsor|0|||
124858124|NCT04579757|449103984|FG002|Overall Study|Study Terminated By Sponsor|0|||
124858125|NCT04579757|449103985|FG003|Overall Study|Study Terminated By Sponsor|0|||
124858126|NCT04579757|449103986|FG004|Overall Study|Study Terminated By Sponsor|2|||
124858127|NCT04579757|449103987|FG005|Overall Study|Study Terminated By Sponsor|0|||
124858128|NCT04579757|449103988|FG006|Overall Study|Study Terminated By Sponsor|0|||
124858129|NCT04579757|449103989|FG007|Overall Study|Study Terminated By Sponsor|2|||
124858130|NCT04579757|449103990|FG008|Overall Study|Study Terminated By Sponsor|0|||
124858131|NCT04579757|449103982|FG000|Overall Study|Withdrawal by Subject|1|||
124858132|NCT04579757|449103983|FG001|Overall Study|Withdrawal by Subject|1|||
124858133|NCT04579757|449103984|FG002|Overall Study|Withdrawal by Subject|0|||
124858134|NCT04579757|449103985|FG003|Overall Study|Withdrawal by Subject|0|||
124858135|NCT04579757|449103986|FG004|Overall Study|Withdrawal by Subject|2|||
124858136|NCT04579757|449103987|FG005|Overall Study|Withdrawal by Subject|1|||
124858137|NCT04579757|449103988|FG006|Overall Study|Withdrawal by Subject|0|||
124858138|NCT04579757|449103989|FG007|Overall Study|Withdrawal by Subject|3|||
124858139|NCT04579757|449103990|FG008|Overall Study|Withdrawal by Subject|0|||
124858140|NCT04579757|449103982|FG000|Overall Study|Radiological or Clinical PD|1|||
124858141|NCT04579757|449103983|FG001|Overall Study|Radiological or Clinical PD|4|||
124858142|NCT04579757|449103984|FG002|Overall Study|Radiological or Clinical PD|1|||
124858143|NCT04579757|449103985|FG003|Overall Study|Radiological or Clinical PD|3|||
124858144|NCT04579757|449103986|FG004|Overall Study|Radiological or Clinical PD|9|||
124858145|NCT04579757|449103987|FG005|Overall Study|Radiological or Clinical PD|4|||
124858146|NCT04579757|449103988|FG006|Overall Study|Radiological or Clinical PD|2|||
124858147|NCT04579757|449103989|FG007|Overall Study|Radiological or Clinical PD|2|||
124858148|NCT04579757|449103990|FG008|Overall Study|Radiological or Clinical PD|0|||
124858149|NCT04579757|449103982|FG000|Overall Study|Start of New Therapy|0|||
124858150|NCT04579757|449103983|FG001|Overall Study|Start of New Therapy|0|||
124858151|NCT04579757|449103984|FG002|Overall Study|Start of New Therapy|0|||
124858152|NCT04579757|449103985|FG003|Overall Study|Start of New Therapy|0|||
124858153|NCT04579757|449103986|FG004|Overall Study|Start of New Therapy|2|||
124858154|NCT04579757|449103987|FG005|Overall Study|Start of New Therapy|1|||
124858155|NCT04579757|449103988|FG006|Overall Study|Start of New Therapy|0|||
124858156|NCT04579757|449103989|FG007|Overall Study|Start of New Therapy|0|||
124858157|NCT04579757|449103990|FG008|Overall Study|Start of New Therapy|0|||
124858158|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Adverse Event|5|||
124858159|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Adverse Event|8|||
124858160|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Adverse Event|4|||
124858161|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Adverse Event|8|||
124858162|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
124858163|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
124858164|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
124858165|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
124858166|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
124858167|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
124858168|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
124858169|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
124858170|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Physician Decision|1|||
124858171|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Physician Decision|0|||
124858172|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Physician Decision|0|||
124858173|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Physician Decision|0|||
124858174|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
124858175|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
124858176|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
124858177|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
124858178|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Pregnancy|0|||
124858179|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Pregnancy|1|||
124858180|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Pregnancy|0|||
124858181|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Pregnancy|0|||
124858182|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
124858183|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
124858184|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
124858185|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
124858186|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Death|0|||
124858187|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Death|1|||
124858188|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Death|0|||
124858189|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Death|0|||
124858190|NCT00071487|449103991|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
124858191|NCT00071487|449103992|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
124858192|NCT00071487|449103993|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
124858193|NCT00071487|449103994|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
124858194|NCT00071487|449103991|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
124858195|NCT00071487|449103992|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
124858196|NCT00071487|449103993|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
124858197|NCT00071487|449103994|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
124858198|NCT00071487|449103991|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
124858199|NCT00071487|449103992|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
124858200|NCT00071487|449103993|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
124858201|NCT00071487|449103994|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
124858202|NCT00071487|449103991|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124858203|NCT00071487|449103992|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124858204|NCT00071487|449103993|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
124858205|NCT00071487|449103994|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
124858206|NCT00071487|449103991|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
124858207|NCT00071487|449103992|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
124858208|NCT00071487|449103993|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
124858209|NCT00071487|449103994|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
124858210|NCT00071487|449103991|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
124858211|NCT00071487|449103992|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
124858212|NCT00071487|449103993|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
124858213|NCT00071487|449103994|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
124858214|NCT00071487|449103991|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
124858215|NCT00071487|449103992|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
124858216|NCT00071487|449103993|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
124858217|NCT00071487|449103994|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
124858218|NCT03725982|449103995|FG000|First Intervention|Withdrawal by Subject|0|||
124858219|NCT03725982|449103996|FG001|First Intervention|Withdrawal by Subject|1|||
124858220|NCT03725982|449103995|FG000|First Intervention|Physician Decision|1|||
124858221|NCT03725982|449103996|FG001|First Intervention|Physician Decision|1|||
124858222|NCT01262651|449103997|FG000|Overall Study|Adverse Event|40|||
124858223|NCT01262651|449103998|FG001|Overall Study|Adverse Event|35|||
124858224|NCT01262651|449103997|FG000|Overall Study|Withdrawal by Subject|15|||
124858225|NCT01262651|449103998|FG001|Overall Study|Withdrawal by Subject|11|||
124858226|NCT01262651|449103997|FG000|Overall Study|Withdrawal by Investigator|2|||
124858227|NCT01262651|449103998|FG001|Overall Study|Withdrawal by Investigator|2|||
124858228|NCT01262651|449103997|FG000|Overall Study|Met Withdrawal Criteria|1|||
124858229|NCT01262651|449103998|FG001|Overall Study|Met Withdrawal Criteria|0|||
124858230|NCT04743908|449104001|FG000|Overall Study|Death|1|||
124858231|NCT04743908|449104002|FG001|Overall Study|Death|0|||
124858232|NCT04743908|449104001|FG000|Overall Study|Lost to Follow-up|181|||
124858233|NCT04743908|449104002|FG001|Overall Study|Lost to Follow-up|180|||
124858234|NCT04743908|449104001|FG000|Overall Study|Withdrawal by Subject|1|||
124858235|NCT04743908|449104002|FG001|Overall Study|Withdrawal by Subject|2|||
124858236|NCT04969783|449104003|FG000|Overall Study|Lost to Follow-up|2|||
124858237|NCT04969783|449104004|FG001|Overall Study|Lost to Follow-up|0|||
124858238|NCT04969783|449104003|FG000|Overall Study|Withdrawal by Subject|4|||
124858239|NCT04969783|449104004|FG001|Overall Study|Withdrawal by Subject|0|||
124858240|NCT04969783|449104003|FG000|Overall Study|Physician Decision|6|||
124858241|NCT04969783|449104004|FG001|Overall Study|Physician Decision|0|||
124858242|NCT04837482|449104005|FG000|Period 2|Withdrawal by Subject|0|||
124858243|NCT04837482|449104006|FG001|Period 2|Withdrawal by Subject|1|||
124858244|NCT00328510|449104007|FG000|Overall Study|Gag disorder, could not use frame|4|||
124858245|NCT00328510|449104008|FG001|Overall Study|Gag disorder, could not use frame|0|||
124858246|NCT00328510|449104007|FG000|Overall Study|Dentition problems, could not use frame|1|||
124858247|NCT00328510|449104008|FG001|Overall Study|Dentition problems, could not use frame|0|||
124858248|NCT00328510|449104007|FG000|Overall Study|Withdrawal by Subject|4|||
124858249|NCT00328510|449104008|FG001|Overall Study|Withdrawal by Subject|2|||
124858250|NCT00328510|449104007|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
124858251|NCT00328510|449104008|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
124858252|NCT00328510|449104007|FG000|Overall Study|Treatment changed to a single fraction|1|||
124858253|NCT00328510|449104008|FG001|Overall Study|Treatment changed to a single fraction|1|||
124858254|NCT03701555|449104016|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
124858255|NCT03701555|449104017|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
124858256|NCT03701555|449104018|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
124858257|NCT03701555|449104019|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
124858258|NCT03701555|449104020|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
124858259|NCT03701555|449104021|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
124858260|NCT03701555|449104022|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
124858261|NCT03701555|449104023|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
124858262|NCT03701555|449104024|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
124858263|NCT03701555|449104025|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
124858264|NCT03701555|449104026|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
124858265|NCT03701555|449104027|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
124858266|NCT03701555|449104028|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
124858267|NCT03701555|449104029|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
124858268|NCT03701555|449104030|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
124858269|NCT03701555|449104031|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
124858270|NCT03701555|449104032|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
124858271|NCT03701555|449104033|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
124858272|NCT03701555|449104034|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
124858273|NCT03701555|449104035|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
124858274|NCT03701555|449104036|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
124858275|NCT03701555|449104037|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
124858276|NCT03701555|449104038|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
124858277|NCT03701555|449104039|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
124858278|NCT03701555|449104040|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
124858279|NCT03701555|449104041|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
124858280|NCT03701555|449104042|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
124858281|NCT03701555|449104043|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
124858282|NCT03701555|449104044|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
124858283|NCT03701555|449104045|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
124858284|NCT03701555|449104046|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
124858285|NCT03701555|449104047|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
124858286|NCT03701555|449104048|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
124858287|NCT03701555|449104049|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
124858288|NCT03701555|449104050|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
124858289|NCT03701555|449104051|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
124858290|NCT03701555|449104016|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
124858291|NCT03701555|449104017|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
124858292|NCT03701555|449104018|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
124858293|NCT03701555|449104019|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
124858294|NCT03701555|449104020|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
124858295|NCT03701555|449104021|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
124858296|NCT03701555|449104022|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
124858297|NCT03701555|449104023|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
124858298|NCT03701555|449104024|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
124858299|NCT03701555|449104025|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
124858300|NCT03701555|449104026|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
124858301|NCT03701555|449104027|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
124858302|NCT03701555|449104028|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
124858303|NCT03701555|449104029|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
124858304|NCT03701555|449104030|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
124858305|NCT03701555|449104031|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
124858306|NCT03701555|449104032|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
124858307|NCT03701555|449104033|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
124858308|NCT03701555|449104034|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
124858309|NCT03701555|449104035|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
124858310|NCT03701555|449104036|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
124858311|NCT03701555|449104037|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
124858312|NCT03701555|449104038|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
124858313|NCT03701555|449104039|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
124858314|NCT03701555|449104040|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
124858315|NCT03701555|449104041|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
124858316|NCT03701555|449104042|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
124858317|NCT03701555|449104043|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
124858318|NCT03701555|449104044|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
124858319|NCT03701555|449104045|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
124858320|NCT03701555|449104046|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
124858321|NCT03701555|449104047|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
124858322|NCT03701555|449104048|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
124858323|NCT03701555|449104049|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
124858324|NCT03701555|449104050|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
124858325|NCT03701555|449104051|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
124858326|NCT03701555|449104016|FG000|Part 2 (Day 1)|Other|0|||
124858327|NCT03701555|449104017|FG001|Part 2 (Day 1)|Other|0|||
124858328|NCT03701555|449104018|FG002|Part 2 (Day 1)|Other|0|||
124858329|NCT03701555|449104019|FG003|Part 2 (Day 1)|Other|0|||
124858330|NCT03701555|449104020|FG004|Part 2 (Day 1)|Other|0|||
124858331|NCT03701555|449104021|FG005|Part 2 (Day 1)|Other|0|||
124858332|NCT03701555|449104022|FG006|Part 2 (Day 1)|Other|0|||
124858333|NCT03701555|449104023|FG007|Part 2 (Day 1)|Other|0|||
124858334|NCT03701555|449104024|FG008|Part 2 (Day 1)|Other|0|||
124858335|NCT03701555|449104025|FG009|Part 2 (Day 1)|Other|0|||
124858336|NCT03701555|449104026|FG010|Part 2 (Day 1)|Other|3|||
124858337|NCT03701555|449104027|FG011|Part 2 (Day 1)|Other|1|||
124858338|NCT03701555|449104028|FG012|Part 2 (Day 1)|Other|0|||
124858339|NCT03701555|449104029|FG013|Part 2 (Day 1)|Other|1|||
124858340|NCT03701555|449104030|FG014|Part 2 (Day 1)|Other|0|||
124858341|NCT03701555|449104031|FG015|Part 2 (Day 1)|Other|2|||
124858342|NCT03701555|449104032|FG016|Part 2 (Day 1)|Other|2|||
124858343|NCT03701555|449104033|FG017|Part 2 (Day 1)|Other|0|||
124858344|NCT03701555|449104034|FG018|Part 2 (Day 1)|Other|0|||
124858345|NCT03701555|449104035|FG019|Part 2 (Day 1)|Other|0|||
124858346|NCT03701555|449104036|FG020|Part 2 (Day 1)|Other|0|||
124858347|NCT03701555|449104037|FG021|Part 2 (Day 1)|Other|0|||
124858348|NCT03701555|449104038|FG022|Part 2 (Day 1)|Other|0|||
124858349|NCT03701555|449104039|FG023|Part 2 (Day 1)|Other|0|||
124858350|NCT03701555|449104040|FG024|Part 2 (Day 1)|Other|0|||
124858351|NCT03701555|449104041|FG025|Part 2 (Day 1)|Other|0|||
124858352|NCT03701555|449104042|FG026|Part 2 (Day 1)|Other|0|||
124858353|NCT03701555|449104043|FG027|Part 2 (Day 1)|Other|0|||
124858354|NCT03701555|449104044|FG028|Part 2 (Day 1)|Other|0|||
124858355|NCT03701555|449104045|FG029|Part 2 (Day 1)|Other|0|||
124858356|NCT03701555|449104046|FG030|Part 2 (Day 1)|Other|0|||
124858357|NCT03701555|449104047|FG031|Part 2 (Day 1)|Other|0|||
124858358|NCT03701555|449104048|FG032|Part 2 (Day 1)|Other|0|||
124858359|NCT03701555|449104049|FG033|Part 2 (Day 1)|Other|0|||
124858360|NCT03701555|449104050|FG034|Part 2 (Day 1)|Other|0|||
124858361|NCT03701555|449104051|FG035|Part 2 (Day 1)|Other|0|||
124858362|NCT03701555|449104016|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
124858363|NCT03701555|449104017|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
124858364|NCT03701555|449104018|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
124858365|NCT03701555|449104019|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
124858366|NCT03701555|449104020|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
124858367|NCT03701555|449104021|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
124858368|NCT03701555|449104022|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
124858369|NCT03701555|449104023|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
124858370|NCT03701555|449104024|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
124858371|NCT03701555|449104025|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
124858372|NCT03701555|449104026|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
124858373|NCT03701555|449104027|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
124858374|NCT03701555|449104028|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
124858375|NCT03701555|449104029|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
124858376|NCT03701555|449104030|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
124858377|NCT03701555|449104031|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
124858378|NCT03701555|449104032|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
124858379|NCT03701555|449104033|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
124858380|NCT03701555|449104034|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
124858381|NCT03701555|449104035|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
124858382|NCT03701555|449104036|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
124858383|NCT03701555|449104037|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
124858384|NCT03701555|449104038|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
124858385|NCT03701555|449104039|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
124858386|NCT03701555|449104040|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
124858387|NCT03701555|449104041|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
124858388|NCT03701555|449104042|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
124858389|NCT03701555|449104043|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
124858390|NCT03701555|449104044|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
124858391|NCT03701555|449104045|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
124858392|NCT03701555|449104046|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
124858393|NCT03701555|449104047|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
124858394|NCT03701555|449104048|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
124858395|NCT03701555|449104049|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
124858396|NCT03701555|449104050|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
124858397|NCT03701555|449104051|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
124858398|NCT03701555|449104016|FG000|Part 3 (Day 1)|Subject Decision|0|||
124858399|NCT03701555|449104017|FG001|Part 3 (Day 1)|Subject Decision|0|||
124858400|NCT03701555|449104018|FG002|Part 3 (Day 1)|Subject Decision|0|||
124858401|NCT03701555|449104019|FG003|Part 3 (Day 1)|Subject Decision|0|||
124858402|NCT03701555|449104020|FG004|Part 3 (Day 1)|Subject Decision|0|||
124858403|NCT03701555|449104021|FG005|Part 3 (Day 1)|Subject Decision|0|||
124858404|NCT03701555|449104022|FG006|Part 3 (Day 1)|Subject Decision|0|||
124858405|NCT03701555|449104023|FG007|Part 3 (Day 1)|Subject Decision|0|||
124858406|NCT03701555|449104024|FG008|Part 3 (Day 1)|Subject Decision|0|||
124858407|NCT03701555|449104025|FG009|Part 3 (Day 1)|Subject Decision|0|||
124858408|NCT03701555|449104026|FG010|Part 3 (Day 1)|Subject Decision|0|||
124858409|NCT03701555|449104027|FG011|Part 3 (Day 1)|Subject Decision|0|||
124858410|NCT03701555|449104028|FG012|Part 3 (Day 1)|Subject Decision|0|||
124858411|NCT03701555|449104029|FG013|Part 3 (Day 1)|Subject Decision|0|||
124858412|NCT03701555|449104030|FG014|Part 3 (Day 1)|Subject Decision|0|||
124858413|NCT03701555|449104031|FG015|Part 3 (Day 1)|Subject Decision|0|||
124858414|NCT03701555|449104032|FG016|Part 3 (Day 1)|Subject Decision|0|||
124858415|NCT03701555|449104033|FG017|Part 3 (Day 1)|Subject Decision|0|||
124858416|NCT03701555|449104034|FG018|Part 3 (Day 1)|Subject Decision|0|||
124858417|NCT03701555|449104035|FG019|Part 3 (Day 1)|Subject Decision|0|||
124858418|NCT03701555|449104036|FG020|Part 3 (Day 1)|Subject Decision|0|||
124858419|NCT03701555|449104037|FG021|Part 3 (Day 1)|Subject Decision|0|||
124858420|NCT03701555|449104038|FG022|Part 3 (Day 1)|Subject Decision|0|||
124858421|NCT03701555|449104039|FG023|Part 3 (Day 1)|Subject Decision|0|||
124858422|NCT03701555|449104040|FG024|Part 3 (Day 1)|Subject Decision|0|||
124858423|NCT03701555|449104041|FG025|Part 3 (Day 1)|Subject Decision|0|||
124858424|NCT03701555|449104042|FG026|Part 3 (Day 1)|Subject Decision|1|||
124858425|NCT03701555|449104043|FG027|Part 3 (Day 1)|Subject Decision|0|||
124858426|NCT03701555|449104044|FG028|Part 3 (Day 1)|Subject Decision|0|||
124858427|NCT03701555|449104045|FG029|Part 3 (Day 1)|Subject Decision|0|||
124858428|NCT03701555|449104046|FG030|Part 3 (Day 1)|Subject Decision|0|||
124858429|NCT03701555|449104047|FG031|Part 3 (Day 1)|Subject Decision|2|||
124858430|NCT03701555|449104048|FG032|Part 3 (Day 1)|Subject Decision|1|||
124858431|NCT03701555|449104049|FG033|Part 3 (Day 1)|Subject Decision|1|||
124858432|NCT03701555|449104050|FG034|Part 3 (Day 1)|Subject Decision|0|||
124858433|NCT03701555|449104051|FG035|Part 3 (Day 1)|Subject Decision|0|||
124858434|NCT03701555|449104016|FG000|Part 3 (Day 1)|Other|0|||
124858435|NCT03701555|449104017|FG001|Part 3 (Day 1)|Other|0|||
124858436|NCT03701555|449104018|FG002|Part 3 (Day 1)|Other|0|||
124858437|NCT03701555|449104019|FG003|Part 3 (Day 1)|Other|0|||
124858438|NCT03701555|449104020|FG004|Part 3 (Day 1)|Other|0|||
124858439|NCT03701555|449104021|FG005|Part 3 (Day 1)|Other|0|||
124858440|NCT03701555|449104022|FG006|Part 3 (Day 1)|Other|0|||
124858441|NCT03701555|449104023|FG007|Part 3 (Day 1)|Other|0|||
124858442|NCT03701555|449104024|FG008|Part 3 (Day 1)|Other|0|||
124858443|NCT03701555|449104025|FG009|Part 3 (Day 1)|Other|0|||
124858444|NCT03701555|449104026|FG010|Part 3 (Day 1)|Other|0|||
124858445|NCT03701555|449104027|FG011|Part 3 (Day 1)|Other|0|||
124858446|NCT03701555|449104028|FG012|Part 3 (Day 1)|Other|0|||
124858447|NCT03701555|449104029|FG013|Part 3 (Day 1)|Other|0|||
124858448|NCT03701555|449104030|FG014|Part 3 (Day 1)|Other|0|||
124858449|NCT03701555|449104031|FG015|Part 3 (Day 1)|Other|0|||
124858450|NCT03701555|449104032|FG016|Part 3 (Day 1)|Other|0|||
124858451|NCT03701555|449104033|FG017|Part 3 (Day 1)|Other|0|||
124858452|NCT03701555|449104034|FG018|Part 3 (Day 1)|Other|0|||
124858453|NCT03701555|449104035|FG019|Part 3 (Day 1)|Other|0|||
124858454|NCT03701555|449104036|FG020|Part 3 (Day 1)|Other|0|||
124858455|NCT03701555|449104037|FG021|Part 3 (Day 1)|Other|0|||
124858456|NCT03701555|449104038|FG022|Part 3 (Day 1)|Other|0|||
124858457|NCT03701555|449104039|FG023|Part 3 (Day 1)|Other|0|||
124858458|NCT03701555|449104040|FG024|Part 3 (Day 1)|Other|1|||
124858459|NCT03701555|449104041|FG025|Part 3 (Day 1)|Other|1|||
124858460|NCT03701555|449104042|FG026|Part 3 (Day 1)|Other|0|||
124858461|NCT03701555|449104043|FG027|Part 3 (Day 1)|Other|0|||
124858462|NCT03701555|449104044|FG028|Part 3 (Day 1)|Other|0|||
124858463|NCT03701555|449104045|FG029|Part 3 (Day 1)|Other|1|||
124858464|NCT03701555|449104046|FG030|Part 3 (Day 1)|Other|1|||
124858465|NCT03701555|449104047|FG031|Part 3 (Day 1)|Other|0|||
124858466|NCT03701555|449104048|FG032|Part 3 (Day 1)|Other|1|||
124858467|NCT03701555|449104049|FG033|Part 3 (Day 1)|Other|1|||
124858468|NCT03701555|449104050|FG034|Part 3 (Day 1)|Other|0|||
124858469|NCT03701555|449104051|FG035|Part 3 (Day 1)|Other|0|||
124858470|NCT04757649|449104052|FG000|Overall Study|Withdrawal by Subject|1|||
124858471|NCT04757649|449104052|FG000|Overall Study|Adverse Event|1|||
124858472|NCT01286779|449104053|FG000|Overall Study|Withdrawal by Subject|9|||
124858473|NCT01286779|449104053|FG000|Overall Study|Protocol Violation|5|||
124858474|NCT01286779|449104053|FG000|Overall Study|Physician Decision|2|||
124858475|NCT01286779|449104053|FG000|Overall Study|Participant had scheduled surgery|1|||
124858476|NCT01286779|449104053|FG000|Overall Study|Participant moved to another country|1|||
124858477|NCT01286779|449104053|FG000|Overall Study|Discontinued by sponsor|1|||
124858478|NCT02896855|449104054|FG000|Overall Study|Death|50|||
124858479|NCT02896855|449104055|FG001|Overall Study|Death|40|||
124858480|NCT02896855|449104054|FG000|Overall Study|Lost to Follow-up|15|||
124858481|NCT02896855|449104055|FG001|Overall Study|Lost to Follow-up|9|||
124858482|NCT02896855|449104054|FG000|Overall Study|Withdrawal by Subject|7|||
124858483|NCT02896855|449104055|FG001|Overall Study|Withdrawal by Subject|4|||
124858484|NCT02370602|449104056|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
124858485|NCT02370602|449104057|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
124858486|NCT02370602|449104058|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
124858487|NCT02370602|449104059|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
124858488|NCT02370602|449104060|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
124858489|NCT02370602|449104061|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
124858490|NCT01296568|449104062|FG000|Continued Access Phase|Lost to Follow-up|1|||
124858491|NCT01296568|449104062|FG000|Continued Access Phase|Withdrawal by Subject|1|||
124858492|NCT01296568|449104062|FG000|Continued Access Phase|Disease Progression|1|||
124858493|NCT00237744|449104063|FG000|Overall Study|Withdrawal by Subject|3|||
124858494|NCT00237744|449104064|FG001|Overall Study|Withdrawal by Subject|1|||
124858495|NCT00237744|449104065|FG002|Overall Study|Withdrawal by Subject|0|||
124858496|NCT00574080|449104066|FG000|Overall Study|Death|10|||
124858497|NCT00574080|449104067|FG001|Overall Study|Death|10|||
124858498|NCT00407537|449104068|FG000|Overall Study|Death|5|||
124858499|NCT00407537|449104069|FG001|Overall Study|Death|2|||
124858500|NCT00407537|449104068|FG000|Overall Study|Adverse Event|36|||
124858501|NCT00407537|449104069|FG001|Overall Study|Adverse Event|0|||
124858502|NCT00407537|449104068|FG000|Overall Study|Lost to Follow-up|12|||
124858503|NCT00407537|449104069|FG001|Overall Study|Lost to Follow-up|19|||
124858504|NCT00407537|449104068|FG000|Overall Study|Other|6|||
124858505|NCT00407537|449104069|FG001|Overall Study|Other|7|||
124858506|NCT00407537|449104068|FG000|Overall Study|Withdrawal by Subject|34|||
124858507|NCT00407537|449104069|FG001|Overall Study|Withdrawal by Subject|16|||
124858508|NCT01519206|449104070|FG000|Overall Study|Lost to Follow-up|3|||
124858509|NCT01519206|449104070|FG000|Overall Study|Missed Visit|2|||
124858510|NCT04139317|449104071|FG000|Overall Study|Adverse Event|10|||
124858511|NCT04139317|449104072|FG001|Overall Study|Adverse Event|2|||
124858512|NCT04139317|449104071|FG000|Overall Study|Death|6|||
124858513|NCT04139317|449104072|FG001|Overall Study|Death|4|||
124858514|NCT04139317|449104071|FG000|Overall Study|Lost to Follow-up|1|||
124858515|NCT04139317|449104072|FG001|Overall Study|Lost to Follow-up|0|||
124858516|NCT04139317|449104071|FG000|Overall Study|Physician Decision|3|||
124858517|NCT04139317|449104072|FG001|Overall Study|Physician Decision|1|||
124858518|NCT04139317|449104071|FG000|Overall Study|Progressive Disease|19|||
124858519|NCT04139317|449104072|FG001|Overall Study|Progressive Disease|9|||
124858520|NCT04139317|449104071|FG000|Overall Study|Subject Decision|2|||
124858521|NCT04139317|449104072|FG001|Overall Study|Subject Decision|2|||
124858522|NCT06027216|449104075|FG000|Overall Study|Did not qualify|8|||
124858523|NCT05348681|449104076|FG000|Overall Study|Study terminated by Sponsor|8|||
124858524|NCT05348681|449104077|FG001|Overall Study|Study terminated by Sponsor|3|||
124858525|NCT05348681|449104076|FG000|Overall Study|Withdrawal by Subject|1|||
124858526|NCT05348681|449104077|FG001|Overall Study|Withdrawal by Subject|1|||
124858527|NCT05348681|449104076|FG000|Overall Study|Lost to Follow-up|1|||
124858528|NCT05348681|449104077|FG001|Overall Study|Lost to Follow-up|1|||
124858529|NCT05348681|449104076|FG000|Overall Study|Adverse Event|1|||
124858530|NCT05348681|449104077|FG001|Overall Study|Adverse Event|0|||
124858531|NCT05348681|449104076|FG000|Overall Study|Other|2|||
124858532|NCT05348681|449104077|FG001|Overall Study|Other|1|||
124858533|NCT03646513|449104081|FG000|Overall Study|Premature study termination|4|||
124858534|NCT00782340|449104082|FG000|Open Label Titration|Adverse Event|12|||
124858535|NCT00782340|449104083|FG001|Open Label Titration|Adverse Event|0|||
124858536|NCT00782340|449104084|FG002|Open Label Titration|Adverse Event|0|||
124858537|NCT00782340|449104082|FG000|Open Label Titration|Treatment failure|50|||
124858538|NCT00782340|449104083|FG001|Open Label Titration|Treatment failure|0|||
124858539|NCT00782340|449104084|FG002|Open Label Titration|Treatment failure|0|||
124858540|NCT00782340|449104082|FG000|Open Label Titration|Protocol Violation|5|||
124858541|NCT00782340|449104083|FG001|Open Label Titration|Protocol Violation|0|||
124858542|NCT00782340|449104084|FG002|Open Label Titration|Protocol Violation|0|||
124858543|NCT00782340|449104082|FG000|Open Label Titration|Withdrawal by Subject|5|||
124858544|NCT00782340|449104083|FG001|Open Label Titration|Withdrawal by Subject|0|||
124858545|NCT00782340|449104084|FG002|Open Label Titration|Withdrawal by Subject|0|||
124858546|NCT00782340|449104082|FG000|Open Label Titration|Enrollment capped|16|||
124858547|NCT00782340|449104083|FG001|Open Label Titration|Enrollment capped|0|||
124858548|NCT00782340|449104084|FG002|Open Label Titration|Enrollment capped|0|||
124858549|NCT00782340|449104082|FG000|Open Label Titration|Did not meet responder criteria|2|||
124858550|NCT00782340|449104083|FG001|Open Label Titration|Did not meet responder criteria|0|||
124858551|NCT00782340|449104084|FG002|Open Label Titration|Did not meet responder criteria|0|||
124858552|NCT00782340|449104082|FG000|Open Label Titration|Lost to Follow-up|5|||
124858553|NCT00782340|449104083|FG001|Open Label Titration|Lost to Follow-up|0|||
124858554|NCT00782340|449104084|FG002|Open Label Titration|Lost to Follow-up|0|||
124858555|NCT00782340|449104082|FG000|Open Label Titration|Randomized in error|6|||
124858556|NCT00782340|449104083|FG001|Open Label Titration|Randomized in error|0|||
124858557|NCT00782340|449104084|FG002|Open Label Titration|Randomized in error|0|||
124858558|NCT02219932|449104089|FG000|Overall Study|Other|5|||
124858559|NCT02219932|449104090|FG001|Overall Study|Other|11|||
124858560|NCT02219932|449104089|FG000|Overall Study|Death|1|||
124858561|NCT02219932|449104090|FG001|Overall Study|Death|1|||
124858562|NCT02219932|449104089|FG000|Overall Study|Investigator Decision|0|||
124858563|NCT02219932|449104090|FG001|Overall Study|Investigator Decision|1|||
124858564|NCT02219932|449104089|FG000|Overall Study|Consent Withdrawn|11|||
124858565|NCT02219932|449104090|FG001|Overall Study|Consent Withdrawn|7|||
124858566|NCT02219932|449104089|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
124858567|NCT02219932|449104090|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
124858568|NCT02219932|449104089|FG000|Overall Study|Protocol Violation|10|||
124858569|NCT02219932|449104090|FG001|Overall Study|Protocol Violation|6|||
124858570|NCT02219932|449104089|FG000|Overall Study|Pregnancy|1|||
124858571|NCT02219932|449104090|FG001|Overall Study|Pregnancy|0|||
124858572|NCT02219932|449104089|FG000|Overall Study|Lost to Follow-up|4|||
124858573|NCT02219932|449104090|FG001|Overall Study|Lost to Follow-up|2|||
124858574|NCT02219932|449104089|FG000|Overall Study|Adverse Event|23|||
124858575|NCT02219932|449104090|FG001|Overall Study|Adverse Event|21|||
124858576|NCT00093145|449104092|FG000|Overall Study|Unacceptable Toxicity Only|2|||
124858577|NCT00093145|449104092|FG000|Overall Study|Physician Decision|5|||
124858578|NCT00093145|449104092|FG000|Overall Study|Withdrawal by Subject|9|||
124858579|NCT00093145|449104092|FG000|Overall Study|Other|1|||
124858580|NCT04389840|449104093|FG000|Overall Study|Adverse Event|0|||
124858581|NCT04389840|449104094|FG001|Overall Study|Adverse Event|0|||
124858582|NCT04389840|449104095|FG002|Overall Study|Adverse Event|0|||
124858583|NCT04389840|449104096|FG003|Overall Study|Adverse Event|1|||
124858584|NCT04389840|449104097|FG004|Overall Study|Adverse Event|0|||
124858585|NCT04389840|449104098|FG005|Overall Study|Adverse Event|0|||
124858586|NCT04389840|449104093|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
124858587|NCT04389840|449104094|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
124858588|NCT04389840|449104095|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
124858589|NCT04389840|449104096|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
124858590|NCT04389840|449104097|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
124858591|NCT04389840|449104098|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
124858592|NCT04389840|449104093|FG000|Overall Study|Death|0|||
124858593|NCT04389840|449104094|FG001|Overall Study|Death|1|||
124858594|NCT04389840|449104095|FG002|Overall Study|Death|0|||
124858595|NCT04389840|449104096|FG003|Overall Study|Death|0|||
124858596|NCT04389840|449104097|FG004|Overall Study|Death|0|||
124858597|NCT04389840|449104098|FG005|Overall Study|Death|0|||
124858598|NCT01953926|449104101|FG000|Overall Study|Withdrawal by Subject|23|||
124858599|NCT01953926|449104102|FG001|Overall Study|Withdrawal by Subject|3|||
124858600|NCT01953926|449104103|FG002|Overall Study|Withdrawal by Subject|3|||
124858601|NCT01953926|449104104|FG003|Overall Study|Withdrawal by Subject|5|||
124858602|NCT01953926|449104105|FG004|Overall Study|Withdrawal by Subject|6|||
124858603|NCT01953926|449104106|FG005|Overall Study|Withdrawal by Subject|0|||
124858604|NCT01953926|449104107|FG006|Overall Study|Withdrawal by Subject|1|||
124858605|NCT01953926|449104101|FG000|Overall Study|Physician Decision|1|||
124858606|NCT01953926|449104102|FG001|Overall Study|Physician Decision|0|||
124858607|NCT01953926|449104103|FG002|Overall Study|Physician Decision|0|||
124858608|NCT01953926|449104104|FG003|Overall Study|Physician Decision|0|||
124858609|NCT01953926|449104105|FG004|Overall Study|Physician Decision|2|||
124858610|NCT01953926|449104106|FG005|Overall Study|Physician Decision|0|||
124858611|NCT01953926|449104107|FG006|Overall Study|Physician Decision|0|||
124858612|NCT01953926|449104101|FG000|Overall Study|Lost to Follow-up|18|||
124858613|NCT01953926|449104102|FG001|Overall Study|Lost to Follow-up|3|||
124858614|NCT01953926|449104103|FG002|Overall Study|Lost to Follow-up|0|||
124858615|NCT01953926|449104104|FG003|Overall Study|Lost to Follow-up|5|||
124858616|NCT01953926|449104105|FG004|Overall Study|Lost to Follow-up|3|||
124858617|NCT01953926|449104106|FG005|Overall Study|Lost to Follow-up|0|||
124858618|NCT01953926|449104107|FG006|Overall Study|Lost to Follow-up|0|||
124858619|NCT01953926|449104101|FG000|Overall Study|Protocol Violation|1|||
124858620|NCT01953926|449104102|FG001|Overall Study|Protocol Violation|0|||
124858621|NCT01953926|449104103|FG002|Overall Study|Protocol Violation|0|||
124858622|NCT01953926|449104104|FG003|Overall Study|Protocol Violation|0|||
124858623|NCT01953926|449104105|FG004|Overall Study|Protocol Violation|0|||
124858624|NCT01953926|449104106|FG005|Overall Study|Protocol Violation|0|||
124858625|NCT01953926|449104107|FG006|Overall Study|Protocol Violation|0|||
124858626|NCT01953926|449104101|FG000|Overall Study|Other, Disease progression|2|||
124858627|NCT01953926|449104102|FG001|Overall Study|Other, Disease progression|1|||
124858628|NCT01953926|449104103|FG002|Overall Study|Other, Disease progression|0|||
124858629|NCT01953926|449104104|FG003|Overall Study|Other, Disease progression|0|||
124858630|NCT01953926|449104105|FG004|Overall Study|Other, Disease progression|1|||
124858631|NCT01953926|449104106|FG005|Overall Study|Other, Disease progression|0|||
124858632|NCT01953926|449104107|FG006|Overall Study|Other, Disease progression|0|||
124858633|NCT01953926|449104101|FG000|Overall Study|Discontinuation of study by sponsor|41|||
124858634|NCT01953926|449104102|FG001|Overall Study|Discontinuation of study by sponsor|7|||
124858635|NCT01953926|449104103|FG002|Overall Study|Discontinuation of study by sponsor|5|||
124858636|NCT01953926|449104104|FG003|Overall Study|Discontinuation of study by sponsor|12|||
124858637|NCT01953926|449104105|FG004|Overall Study|Discontinuation of study by sponsor|46|||
124858638|NCT01953926|449104106|FG005|Overall Study|Discontinuation of study by sponsor|5|||
124858639|NCT01953926|449104107|FG006|Overall Study|Discontinuation of study by sponsor|6|||
124858640|NCT01953926|449104101|FG000|Overall Study|Not Treated|1|||
124858641|NCT01953926|449104102|FG001|Overall Study|Not Treated|0|||
124858642|NCT01953926|449104103|FG002|Overall Study|Not Treated|1|||
124858643|NCT01953926|449104104|FG003|Overall Study|Not Treated|0|||
124858644|NCT01953926|449104105|FG004|Overall Study|Not Treated|0|||
124858645|NCT01953926|449104106|FG005|Overall Study|Not Treated|0|||
124858646|NCT01953926|449104107|FG006|Overall Study|Not Treated|0|||
124858647|NCT01272934|449104111|FG000|Overall Study|Adverse Event|0|||
124858648|NCT01272934|449104112|FG001|Overall Study|Adverse Event|1|||
124858649|NCT01272934|449104111|FG000|Overall Study|Abnormal Laboratory Value|0|||
124858650|NCT01272934|449104112|FG001|Overall Study|Abnormal Laboratory Value|1|||
124858651|NCT00214136|449104113|FG000|Overall Study|Death|5|||
124858652|NCT04287920|449104114|FG000|Overall Study|Lost to Follow-up|1|||
124858653|NCT04287920|449104115|FG001|Overall Study|Lost to Follow-up|1|||
124858654|NCT04287920|449104114|FG000|Overall Study|Withdrawal by Subject|0|||
124858655|NCT04287920|449104115|FG001|Overall Study|Withdrawal by Subject|3|||
124858656|NCT04313634|449104116|FG000|Overall Study|Adverse Event|2|||
124858657|NCT04313634|449104117|FG001|Overall Study|Adverse Event|2|||
124858658|NCT04313634|449104118|FG002|Overall Study|Adverse Event|0|||
124858659|NCT04313634|449104116|FG000|Overall Study|Withdrawal by Subject|1|||
124858660|NCT04313634|449104117|FG001|Overall Study|Withdrawal by Subject|0|||
124858661|NCT04313634|449104118|FG002|Overall Study|Withdrawal by Subject|1|||
124858662|NCT04313634|449104116|FG000|Overall Study|Protocol Violation|0|||
124858663|NCT04313634|449104117|FG001|Overall Study|Protocol Violation|0|||
124858664|NCT04313634|449104118|FG002|Overall Study|Protocol Violation|1|||
124858665|NCT03585244|449104125|FG000|Overall Study|Withdrawal by Subject|15|||
124858666|NCT01764945|449104128|FG000|Overall Study|Adverse Event|0|||
124858667|NCT01764945|449104129|FG001|Overall Study|Adverse Event|1|||
124858668|NCT01764945|449104130|FG002|Overall Study|Adverse Event|0|||
124858669|NCT01764945|449104131|FG003|Overall Study|Adverse Event|0|||
124858670|NCT01764945|449104132|FG004|Overall Study|Adverse Event|0|||
124858671|NCT01764945|449104133|FG005|Overall Study|Adverse Event|0|||
124858672|NCT01764945|449104134|FG006|Overall Study|Adverse Event|1|||
124858673|NCT01764945|449104135|FG007|Overall Study|Adverse Event|0|||
124858674|NCT05077267|449104136|FG000|Treatment Period|Lost to Follow-up|0|||
124858675|NCT05077267|449104137|FG001|Treatment Period|Lost to Follow-up|1|||
124858676|NCT05077267|449104138|FG002|Treatment Period|Lost to Follow-up|0|||
124858677|NCT05077267|449104136|FG000|Treatment Period|Withdrawal by Subject|0|||
124858678|NCT05077267|449104137|FG001|Treatment Period|Withdrawal by Subject|1|||
124858679|NCT05077267|449104138|FG002|Treatment Period|Withdrawal by Subject|0|||
124858680|NCT05077267|449104136|FG000|Follow-up Period|Lost to Follow-up|0|||
124858681|NCT05077267|449104137|FG001|Follow-up Period|Lost to Follow-up|5|||
124858682|NCT05077267|449104138|FG002|Follow-up Period|Lost to Follow-up|7|||
124858683|NCT05077267|449104136|FG000|Follow-up Period|Withdrawal by Subject|0|||
124858684|NCT05077267|449104137|FG001|Follow-up Period|Withdrawal by Subject|2|||
124858685|NCT05077267|449104138|FG002|Follow-up Period|Withdrawal by Subject|5|||
124858686|NCT05077267|449104136|FG000|Follow-up Period|Study terminated by sponsor|0|||
124858687|NCT05077267|449104137|FG001|Follow-up Period|Study terminated by sponsor|27|||
124858688|NCT05077267|449104138|FG002|Follow-up Period|Study terminated by sponsor|23|||
124858689|NCT05077267|449104136|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
124858690|NCT05077267|449104137|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
124858691|NCT05077267|449104138|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
124858692|NCT05077267|449104136|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
124858693|NCT05077267|449104137|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
124858694|NCT05077267|449104138|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
124858695|NCT02911948|449104139|FG000|Overall Study|Protocol Violation|0|||
124858696|NCT02911948|449104140|FG001|Overall Study|Protocol Violation|1|||
124858697|NCT02911948|449104139|FG000|Overall Study|Withdrawal by Subject|0|||
124858698|NCT02911948|449104140|FG001|Overall Study|Withdrawal by Subject|2|||
124858699|NCT02911948|449104139|FG000|Overall Study|Lack of Efficacy|0|||
124858700|NCT02911948|449104140|FG001|Overall Study|Lack of Efficacy|1|||
124858701|NCT02911948|449104139|FG000|Overall Study|Unclassified|0|||
124858702|NCT02911948|449104140|FG001|Overall Study|Unclassified|3|||
124858703|NCT00142909|449104145|FG000|Randomization|Various Reasons|7|||
124858704|NCT00142909|449104146|FG001|Randomization|Various Reasons|10|||
124858705|NCT00142909|449104145|FG000|Medications Begin|Protocol Violation|2|||
124858706|NCT00142909|449104146|FG001|Medications Begin|Protocol Violation|0|||
124858707|NCT00142909|449104145|FG000|Medications Begin|Withdrawal by Subject|5|||
124858708|NCT00142909|449104146|FG001|Medications Begin|Withdrawal by Subject|3|||
124858709|NCT00142909|449104145|FG000|Medications Begin|Withdrawal by Subject|2|||
124858710|NCT00142909|449104146|FG001|Medications Begin|Withdrawal by Subject|0|||
124858711|NCT01307501|449104147|FG000|Overall Study|Treatment Failure|1|||
124858712|NCT01307501|449104147|FG000|Overall Study|Death|20|||
124858713|NCT01307501|449104147|FG000|Overall Study|Lost to Follow-up|1|||
124858714|NCT01307501|449104147|FG000|Overall Study|Starting Hospice|1|||
124858715|NCT02005471|449104148|FG000|Main Study|Adverse Event|0|||
124858716|NCT02005471|449104149|FG001|Main Study|Adverse Event|1|||
124858717|NCT02005471|449104150|FG002|Main Study|Adverse Event|0|||
124858718|NCT02005471|449104151|FG003|Main Study|Adverse Event|0|||
124858719|NCT02005471|449104148|FG000|Main Study|Death|83|||
124858720|NCT02005471|449104149|FG001|Main Study|Death|52|||
124858721|NCT02005471|449104150|FG002|Main Study|Death|0|||
124858722|NCT02005471|449104151|FG003|Main Study|Death|0|||
124858723|NCT02005471|449104148|FG000|Main Study|Lost to Follow-up|4|||
124858724|NCT02005471|449104149|FG001|Main Study|Lost to Follow-up|5|||
124858725|NCT02005471|449104150|FG002|Main Study|Lost to Follow-up|0|||
124858726|NCT02005471|449104151|FG003|Main Study|Lost to Follow-up|0|||
124858727|NCT02005471|449104148|FG000|Main Study|Physician Decision|3|||
124858728|NCT02005471|449104149|FG001|Main Study|Physician Decision|1|||
124858729|NCT02005471|449104150|FG002|Main Study|Physician Decision|0|||
124858730|NCT02005471|449104151|FG003|Main Study|Physician Decision|0|||
124858731|NCT02005471|449104148|FG000|Main Study|Withdrawal by Subject|26|||
124858732|NCT02005471|449104149|FG001|Main Study|Withdrawal by Subject|11|||
124858733|NCT02005471|449104150|FG002|Main Study|Withdrawal by Subject|0|||
124858734|NCT02005471|449104151|FG003|Main Study|Withdrawal by Subject|0|||
124858735|NCT02005471|449104148|FG000|Main Study|Reason not Specified|0|||
124858736|NCT02005471|449104149|FG001|Main Study|Reason not Specified|6|||
124858737|NCT02005471|449104150|FG002|Main Study|Reason not Specified|0|||
124858738|NCT02005471|449104151|FG003|Main Study|Reason not Specified|0|||
124858739|NCT02005471|449104148|FG000|Main Study|Randomized but not Dosed|8|||
124858740|NCT02005471|449104149|FG001|Main Study|Randomized but not Dosed|0|||
124858741|NCT02005471|449104150|FG002|Main Study|Randomized but not Dosed|0|||
124858742|NCT02005471|449104151|FG003|Main Study|Randomized but not Dosed|0|||
124858743|NCT02005471|449104148|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
124858744|NCT02005471|449104149|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
124858745|NCT02005471|449104150|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
124858746|NCT02005471|449104151|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
124858747|NCT02005471|449104148|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
124858748|NCT02005471|449104149|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
124858749|NCT02005471|449104150|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
124858750|NCT02005471|449104151|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
124858751|NCT02005471|449104148|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
124858752|NCT02005471|449104149|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
124858753|NCT02005471|449104150|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
124858754|NCT02005471|449104151|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
124858755|NCT03478891|449104152|FG000|Overall Study|Enrolled, but product never administered|0|||
124858756|NCT03478891|449104153|FG001|Overall Study|Enrolled, but product never administered|0|||
124858757|NCT03478891|449104154|FG002|Overall Study|Enrolled, but product never administered|1|||
124858758|NCT03478891|449104152|FG000|Overall Study|Moved from area|0|||
124858759|NCT03478891|449104153|FG001|Overall Study|Moved from area|0|||
124858760|NCT03478891|449104154|FG002|Overall Study|Moved from area|1|||
124858761|NCT03478891|449104152|FG000|Overall Study|Lost to Follow-up|1|||
124858762|NCT03478891|449104153|FG001|Overall Study|Lost to Follow-up|0|||
124858763|NCT03478891|449104154|FG002|Overall Study|Lost to Follow-up|1|||
124858764|NCT03662750|449104155|FG000|Overall Study|Withdrawal by Subject|1|||
124858765|NCT00932893|449104156|FG000|Overall Study|Death|115|||
124858766|NCT00932893|449104157|FG001|Overall Study|Death|24|||
124858767|NCT00932893|449104156|FG000|Overall Study|Lost to Follow-up|8|||
124858768|NCT00932893|449104157|FG001|Overall Study|Lost to Follow-up|0|||
124858769|NCT00932893|449104156|FG000|Overall Study|Withdrawal by Subject|5|||
124858770|NCT00932893|449104157|FG001|Overall Study|Withdrawal by Subject|2|||
124858771|NCT00932893|449104156|FG000|Overall Study|Other|5|||
124858772|NCT00932893|449104157|FG001|Overall Study|Other|144|||
124858773|NCT04450264|449106040|FG000|Overall Study|Incomplete survey|13|||
124858774|NCT04450264|449106041|FG001|Overall Study|Incomplete survey|19|||
124858775|NCT04295564|449106042|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
124858776|NCT04295564|449106043|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
124858777|NCT01682460|449106044|FG000|Overall Study|Withdrawal by Subject|2|||
124858778|NCT01682460|449106044|FG000|Overall Study|Did not meet inclusion criteria|2|||
124858779|NCT05349617|449106046|FG000|Overall Study|Death|1|||
124858780|NCT05349617|449106047|FG001|Overall Study|Death|1|||
124858781|NCT05349617|449106046|FG000|Overall Study|Lost to Follow-up|3|||
124858782|NCT05349617|449106047|FG001|Overall Study|Lost to Follow-up|8|||
124858783|NCT05349617|449106046|FG000|Overall Study|Withdrawal by Subject|2|||
124858784|NCT05349617|449106047|FG001|Overall Study|Withdrawal by Subject|10|||
124858785|NCT00724282|449106048|FG000|Overall Study|Withdrawal by Subject|3|||
124858786|NCT00724282|449106048|FG000|Overall Study|Physician Decision|1|||
124858787|NCT01159691|449106049|FG000|Overall Study|Lost to Follow-up|2|||
124858788|NCT01159691|449106049|FG000|Overall Study|Unknown reasons|1|||
124858789|NCT01159691|449106049|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
124858790|NCT01159691|449106049|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
124858791|NCT01159691|449106049|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
124858792|NCT01159691|449106049|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
124858793|NCT01159691|449106049|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
124858794|NCT01159691|449106049|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
124858795|NCT01928719|449106050|FG000|Overall Study|Lost to Follow-up|26|||
124858796|NCT01928719|449106051|FG001|Overall Study|Lost to Follow-up|11|||
124858797|NCT01928719|449106050|FG000|Overall Study|Withdrawal by Subject|22|||
124858798|NCT01928719|449106051|FG001|Overall Study|Withdrawal by Subject|7|||
124858799|NCT01928719|449106050|FG000|Overall Study|Protocol Violation|3|||
124858800|NCT01928719|449106051|FG001|Overall Study|Protocol Violation|1|||
124858801|NCT01928719|449106050|FG000|Overall Study|Adverse Event|1|||
124858802|NCT01928719|449106051|FG001|Overall Study|Adverse Event|0|||
124858803|NCT05732454|449106057|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
124858804|NCT05732454|449106058|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
124858805|NCT05732454|449106057|FG000|Part 1: DB Period|Adverse Event|1|||
124858806|NCT05732454|449106058|FG001|Part 1: DB Period|Adverse Event|0|||
124858807|NCT05732454|449106057|FG000|Part 1: DB Period|Lost to Follow-up|1|||
124858808|NCT05732454|449106058|FG001|Part 1: DB Period|Lost to Follow-up|0|||
124858809|NCT05732454|449106057|FG000|Part 1: DB Period|Protocol Violation|0|||
124858810|NCT05732454|449106058|FG001|Part 1: DB Period|Protocol Violation|1|||
124858811|NCT05732454|449106057|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
124858812|NCT05732454|449106058|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
124858813|NCT05732454|449106057|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
124858814|NCT05732454|449106058|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
124858815|NCT05732454|449106057|FG000|Part 1: OLE Period|Adverse Event|0|||
124858816|NCT05732454|449106058|FG001|Part 1: OLE Period|Adverse Event|1|||
124858817|NCT05732454|449106057|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
124858818|NCT05732454|449106058|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
124858819|NCT00377819|449106062|FG000|Overall Study|Adverse Event|2|||
124858820|NCT00377819|449106063|FG001|Overall Study|Adverse Event|3|||
124858821|NCT00377819|449106062|FG000|Overall Study|Withdrawal by Subject|10|||
124858822|NCT00377819|449106063|FG001|Overall Study|Withdrawal by Subject|4|||
124858823|NCT00377819|449106062|FG000|Overall Study|Death|0|||
124858824|NCT00377819|449106063|FG001|Overall Study|Death|1|||
124858825|NCT00377819|449106062|FG000|Overall Study|Lost to Follow-up|0|||
124858826|NCT00377819|449106063|FG001|Overall Study|Lost to Follow-up|1|||
124858827|NCT00377819|449106062|FG000|Overall Study|Protocol Violation|1|||
124858828|NCT00377819|449106063|FG001|Overall Study|Protocol Violation|1|||
124858829|NCT02091726|449106064|FG000|Overall Study|Lost to Follow-up|6|||
124858830|NCT03727750|449106065|FG000|Overall Study|Death|45|||
124858831|NCT03727750|449106065|FG000|Overall Study|Withdrawal by Subject|2|||
124858832|NCT03727750|449106065|FG000|Overall Study|Lost to Follow-up|1|||
124858833|NCT03727750|449106065|FG000|Overall Study|Other|1|||
124858834|NCT00823719|449106073|FG000|Overall Study|Adverse Event|1|||
124858835|NCT00823719|449106074|FG001|Overall Study|Adverse Event|2|||
124858836|NCT00823719|449106073|FG000|Overall Study|Physician Decision|1|||
124858837|NCT00823719|449106074|FG001|Overall Study|Physician Decision|4|||
124858838|NCT00823719|449106073|FG000|Overall Study|Withdrawal by Subject|0|||
124858839|NCT00823719|449106074|FG001|Overall Study|Withdrawal by Subject|1|||
124858840|NCT00823719|449106073|FG000|Overall Study|Disease Progression|4|||
124858841|NCT00823719|449106074|FG001|Overall Study|Disease Progression|4|||
124858842|NCT01380327|449106078|FG000|Overall Study|Lost to Follow-up|0|||
124858843|NCT01380327|449106079|FG001|Overall Study|Lost to Follow-up|1|||
124858844|NCT01380327|449106080|FG002|Overall Study|Lost to Follow-up|1|||
124858845|NCT01380327|449106078|FG000|Overall Study|Protocol Violation|3|||
124858846|NCT01380327|449106079|FG001|Overall Study|Protocol Violation|2|||
124858847|NCT01380327|449106080|FG002|Overall Study|Protocol Violation|3|||
124858848|NCT01380327|449106078|FG000|Overall Study|Withdrawal by Subject|0|||
124858849|NCT01380327|449106079|FG001|Overall Study|Withdrawal by Subject|0|||
124858850|NCT01380327|449106080|FG002|Overall Study|Withdrawal by Subject|1|||
124858851|NCT01380327|449106078|FG000|Overall Study|Housing situation precluded ability to k|0|||
124858852|NCT01380327|449106079|FG001|Overall Study|Housing situation precluded ability to k|0|||
124858853|NCT01380327|449106080|FG002|Overall Study|Housing situation precluded ability to k|1|||
124858854|NCT01380327|449106078|FG000|Overall Study|Questionable onset of epilepsy|0|||
124858855|NCT01380327|449106079|FG001|Overall Study|Questionable onset of epilepsy|0|||
124858856|NCT01380327|449106080|FG002|Overall Study|Questionable onset of epilepsy|1|||
124858857|NCT00586105|449106081|FG000|Overall Study|Adverse Event|4|||
124858858|NCT00586105|449106081|FG000|Overall Study|Death|2|||
124858859|NCT00586105|449106081|FG000|Overall Study|Protocol Violation|1|||
124858860|NCT00586105|449106081|FG000|Overall Study|Withdrawal by Subject|3|||
124858861|NCT00586105|449106081|FG000|Overall Study|Disease progression|19|||
124858862|NCT00586105|449106081|FG000|Overall Study|Switched to commercial drug|9|||
124858863|NCT00586105|449106081|FG000|Overall Study|Reason not reported|1|||
124858864|NCT03835533|449106082|FG000|Overall Study|Death|5|||
124858865|NCT03835533|449106083|FG001|Overall Study|Death|10|||
124858866|NCT03835533|449106084|FG002|Overall Study|Death|9|||
124858867|NCT03835533|449106082|FG000|Overall Study|Withdrawal by Subject|2|||
124858868|NCT03835533|449106083|FG001|Overall Study|Withdrawal by Subject|2|||
124858869|NCT03835533|449106084|FG002|Overall Study|Withdrawal by Subject|2|||
124858870|NCT03835533|449106082|FG000|Overall Study|Lost to Follow-up|1|||
124858871|NCT03835533|449106083|FG001|Overall Study|Lost to Follow-up|0|||
124858872|NCT03835533|449106084|FG002|Overall Study|Lost to Follow-up|0|||
124858873|NCT03867734|449106085|FG000|Overall Study|Lost to Follow-up|2|||
124858874|NCT01136291|449106086|FG000|Overall Study|Lost to Follow-up|1|||
124858875|NCT01136291|449106087|FG001|Overall Study|Lost to Follow-up|1|||
124858876|NCT02308033|449106090|FG000|Overall Study|Normal Gram stain at Baseline|13|||
124858877|NCT02308033|449106091|FG001|Overall Study|Normal Gram stain at Baseline|10|||
124858878|NCT02308033|449106090|FG000|Overall Study|Positive for STD at Baseline|7|||
124858879|NCT02308033|449106091|FG001|Overall Study|Positive for STD at Baseline|4|||
124858880|NCT02308033|449106090|FG000|Overall Study|Lost to Follow-up|6|||
124858881|NCT02308033|449106091|FG001|Overall Study|Lost to Follow-up|5|||
124858882|NCT01870843|449106094|FG000|Overall Study|Adverse Event|10|||
124858883|NCT01870843|449106094|FG000|Overall Study|Lost to Follow-up|24|||
124858884|NCT01870843|449106094|FG000|Overall Study|Death|1|||
124858885|NCT01870843|449106094|FG000|Overall Study|Withdrawal by Subject|18|||
124858886|NCT03021187|449106095|FG000|Overall Study|Death|0|||
124858887|NCT03021187|449106096|FG001|Overall Study|Death|0|||
124858888|NCT03021187|449106097|FG002|Overall Study|Death|3|||
124858889|NCT03021187|449106098|FG003|Overall Study|Death|0|||
124858890|NCT03021187|449106095|FG000|Overall Study|Withdrawal by Subject|0|||
124858891|NCT03021187|449106096|FG001|Overall Study|Withdrawal by Subject|6|||
124858892|NCT03021187|449106097|FG002|Overall Study|Withdrawal by Subject|2|||
124858893|NCT03021187|449106098|FG003|Overall Study|Withdrawal by Subject|5|||
124858894|NCT03021187|449106095|FG000|Overall Study|Lost to Follow-up|10|||
124858895|NCT03021187|449106096|FG001|Overall Study|Lost to Follow-up|3|||
124858896|NCT03021187|449106097|FG002|Overall Study|Lost to Follow-up|1|||
124858897|NCT03021187|449106098|FG003|Overall Study|Lost to Follow-up|4|||
124858898|NCT01664078|449106099|FG000|Overall Study|Death|9|||
124858899|NCT01664078|449106099|FG000|Overall Study|Withdrawal by Subject|4|||
124858900|NCT01664078|449106099|FG000|Overall Study|Lost to Follow-up|2|||
124858901|NCT01664078|449106099|FG000|Overall Study|missed 5 year visit|1|||
124858902|NCT01664078|449106099|FG000|Overall Study|Other|53|||
124858903|NCT00718718|449106100|FG000|Prior to Week 12|Adverse Event|0|||
124858904|NCT00718718|449106101|FG001|Prior to Week 12|Adverse Event|0|||
124858905|NCT00718718|449106102|FG002|Prior to Week 12|Adverse Event|0|||
124858906|NCT00718718|449106103|FG003|Prior to Week 12|Adverse Event|0|||
124858907|NCT00718718|449106104|FG004|Prior to Week 12|Adverse Event|0|||
124858908|NCT00718718|449106105|FG005|Prior to Week 12|Adverse Event|0|||
124858909|NCT00718718|449106106|FG006|Prior to Week 12|Adverse Event|0|||
124858910|NCT00718718|449106107|FG007|Prior to Week 12|Adverse Event|1|||
124858911|NCT00718718|449106108|FG008|Prior to Week 12|Adverse Event|1|||
124858912|NCT00718718|449106109|FG009|Prior to Week 12|Adverse Event|0|||
124858913|NCT00718718|449106100|FG000|Prior to Week 12|Withdrawal by Subject|0|||
124858914|NCT00718718|449106101|FG001|Prior to Week 12|Withdrawal by Subject|0|||
124858915|NCT00718718|449106102|FG002|Prior to Week 12|Withdrawal by Subject|0|||
124858916|NCT00718718|449106103|FG003|Prior to Week 12|Withdrawal by Subject|0|||
124858917|NCT00718718|449106104|FG004|Prior to Week 12|Withdrawal by Subject|3|||
124858918|NCT00718718|449106105|FG005|Prior to Week 12|Withdrawal by Subject|0|||
124858919|NCT00718718|449106106|FG006|Prior to Week 12|Withdrawal by Subject|1|||
124858920|NCT00718718|449106107|FG007|Prior to Week 12|Withdrawal by Subject|1|||
124858921|NCT00718718|449106108|FG008|Prior to Week 12|Withdrawal by Subject|1|||
124858922|NCT00718718|449106109|FG009|Prior to Week 12|Withdrawal by Subject|0|||
124858923|NCT00718718|449106100|FG000|Prior to Week 12|Other|1|||
124858924|NCT00718718|449106101|FG001|Prior to Week 12|Other|0|||
124858925|NCT00718718|449106102|FG002|Prior to Week 12|Other|1|||
124858926|NCT00718718|449106103|FG003|Prior to Week 12|Other|0|||
124858927|NCT00718718|449106104|FG004|Prior to Week 12|Other|0|||
124858928|NCT00718718|449106105|FG005|Prior to Week 12|Other|0|||
124858929|NCT00718718|449106106|FG006|Prior to Week 12|Other|0|||
124858930|NCT00718718|449106107|FG007|Prior to Week 12|Other|0|||
124858931|NCT00718718|449106108|FG008|Prior to Week 12|Other|0|||
124858932|NCT00718718|449106109|FG009|Prior to Week 12|Other|0|||
124858933|NCT00718718|449106100|FG000|Week 12 to End of Study|Adverse Event|0|||
124858934|NCT00718718|449106101|FG001|Week 12 to End of Study|Adverse Event|0|||
124858935|NCT00718718|449106102|FG002|Week 12 to End of Study|Adverse Event|0|||
124858936|NCT00718718|449106103|FG003|Week 12 to End of Study|Adverse Event|0|||
124858937|NCT00718718|449106104|FG004|Week 12 to End of Study|Adverse Event|0|||
124858938|NCT00718718|449106105|FG005|Week 12 to End of Study|Adverse Event|0|||
124858939|NCT00718718|449106106|FG006|Week 12 to End of Study|Adverse Event|0|||
124858940|NCT00718718|449106107|FG007|Week 12 to End of Study|Adverse Event|1|||
124858941|NCT00718718|449106108|FG008|Week 12 to End of Study|Adverse Event|0|||
124858942|NCT00718718|449106109|FG009|Week 12 to End of Study|Adverse Event|0|||
124858943|NCT00718718|449106100|FG000|Week 12 to End of Study|Death|0|||
124858944|NCT00718718|449106101|FG001|Week 12 to End of Study|Death|0|||
124858945|NCT00718718|449106102|FG002|Week 12 to End of Study|Death|0|||
124858946|NCT00718718|449106103|FG003|Week 12 to End of Study|Death|0|||
124858947|NCT00718718|449106104|FG004|Week 12 to End of Study|Death|0|||
124858948|NCT00718718|449106105|FG005|Week 12 to End of Study|Death|1|||
124858949|NCT00718718|449106106|FG006|Week 12 to End of Study|Death|0|||
124858950|NCT00718718|449106107|FG007|Week 12 to End of Study|Death|0|||
124858951|NCT00718718|449106108|FG008|Week 12 to End of Study|Death|0|||
124858952|NCT00718718|449106109|FG009|Week 12 to End of Study|Death|0|||
124858953|NCT00718718|449106100|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
124858954|NCT00718718|449106101|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
124858955|NCT00718718|449106102|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
124858956|NCT00718718|449106103|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
124858957|NCT00718718|449106104|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
124858958|NCT00718718|449106105|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
124858959|NCT00718718|449106106|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
124858960|NCT00718718|449106107|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
124858961|NCT00718718|449106108|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
124858962|NCT00718718|449106109|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
124858963|NCT00718718|449106100|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
124858964|NCT00718718|449106101|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
124858965|NCT00718718|449106102|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
124858966|NCT00718718|449106103|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
124858967|NCT00718718|449106104|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
124858968|NCT00718718|449106105|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
124858969|NCT00718718|449106106|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
124858970|NCT00718718|449106107|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
124858971|NCT00718718|449106108|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
124858972|NCT00718718|449106109|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
124858973|NCT00718718|449106100|FG000|Week 12 to End of Study|Other|0|||
124858974|NCT00718718|449106101|FG001|Week 12 to End of Study|Other|1|||
124858975|NCT00718718|449106102|FG002|Week 12 to End of Study|Other|0|||
124858976|NCT00718718|449106103|FG003|Week 12 to End of Study|Other|1|||
124858977|NCT00718718|449106104|FG004|Week 12 to End of Study|Other|0|||
124858978|NCT00718718|449106105|FG005|Week 12 to End of Study|Other|0|||
124858979|NCT00718718|449106106|FG006|Week 12 to End of Study|Other|1|||
124858980|NCT00718718|449106107|FG007|Week 12 to End of Study|Other|0|||
124858981|NCT00718718|449106108|FG008|Week 12 to End of Study|Other|0|||
124858982|NCT00718718|449106109|FG009|Week 12 to End of Study|Other|0|||
124858983|NCT04558346|449106118|FG000|Overall Study|Withdrawal by Subject|2|||
124858984|NCT04558346|449106119|FG001|Overall Study|Withdrawal by Subject|0|||
124858985|NCT04558346|449106118|FG000|Overall Study|Lost to Follow-up|0|||
124858986|NCT04558346|449106119|FG001|Overall Study|Lost to Follow-up|1|||
124858987|NCT04558346|449106118|FG000|Overall Study|Adverse Event|0|||
124858988|NCT04558346|449106119|FG001|Overall Study|Adverse Event|1|||
124858989|NCT01462344|449106120|FG000|Overall Study|Withdrawal by Subject|245|||
124858990|NCT01462344|449106121|FG001|Overall Study|Withdrawal by Subject|226|||
124858991|NCT01462344|449106120|FG000|Overall Study|Adverse Event|24|||
124858992|NCT01462344|449106121|FG001|Overall Study|Adverse Event|23|||
124858993|NCT01462344|449106120|FG000|Overall Study|Asthma Exacerbation|34|||
124858994|NCT01462344|449106121|FG001|Overall Study|Asthma Exacerbation|35|||
124858995|NCT01462344|449106120|FG000|Overall Study|Lack of Efficacy|5|||
124858996|NCT01462344|449106121|FG001|Overall Study|Lack of Efficacy|6|||
124858997|NCT01462344|449106120|FG000|Overall Study|Protocol Violation|68|||
124858998|NCT01462344|449106121|FG001|Overall Study|Protocol Violation|53|||
124858999|NCT01462344|449106120|FG000|Overall Study|Lost to Follow-up|7|||
124859000|NCT01462344|449106121|FG001|Overall Study|Lost to Follow-up|7|||
124859001|NCT00724971|449106122|FG000|Overall Study|Adverse Event|5|||
124859002|NCT00724971|449106122|FG000|Overall Study|Withdrawal by Subject|1|||
124859003|NCT01003249|449106123|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
124859004|NCT01003249|449106124|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
124859005|NCT01003249|449106123|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
124859006|NCT01003249|449106124|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
124859007|NCT01003249|449106123|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
124859008|NCT01003249|449106124|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
124859009|NCT01003249|449106123|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
124859010|NCT01003249|449106124|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
124859011|NCT01962974|449106127|FG000|Overall Study|Study termination|7|||
124859012|NCT01692197|449106128|FG000|Overall Study|Failed Screening|3|||
124859013|NCT02276482|449106136|FG000|Overall Study|Adverse Event|1|||
124859014|NCT02276482|449106137|FG001|Overall Study|Adverse Event|0|||
124859015|NCT02276482|449106136|FG000|Overall Study|Withdrawal by Subject|1|||
124859016|NCT02276482|449106137|FG001|Overall Study|Withdrawal by Subject|0|||
124859017|NCT02276482|449106136|FG000|Overall Study|Gram-negative infection|1|||
124859018|NCT02276482|449106137|FG001|Overall Study|Gram-negative infection|0|||
124859019|NCT02276482|449106136|FG000|Overall Study|Reason not specified|0|||
124859020|NCT02276482|449106137|FG001|Overall Study|Reason not specified|1|||
124859021|NCT01165281|449106143|FG000|Overall Study|Adverse Event|12|||
124859022|NCT01165281|449106144|FG001|Overall Study|Adverse Event|14|||
124859023|NCT01165281|449106143|FG000|Overall Study|Death|3|||
124859024|NCT01165281|449106144|FG001|Overall Study|Death|4|||
124859025|NCT01165281|449106143|FG000|Overall Study|Lack of Efficacy|4|||
124859026|NCT01165281|449106144|FG001|Overall Study|Lack of Efficacy|1|||
124859027|NCT01165281|449106143|FG000|Overall Study|Lost to Follow-up|0|||
124859028|NCT01165281|449106144|FG001|Overall Study|Lost to Follow-up|1|||
124859029|NCT01165281|449106143|FG000|Overall Study|Physician Decision|8|||
124859030|NCT01165281|449106144|FG001|Overall Study|Physician Decision|1|||
124859031|NCT01165281|449106143|FG000|Overall Study|Protocol Violation|6|||
124859032|NCT01165281|449106144|FG001|Overall Study|Protocol Violation|5|||
124859033|NCT01165281|449106143|FG000|Overall Study|Withdrawal by Subject|8|||
124859034|NCT01165281|449106144|FG001|Overall Study|Withdrawal by Subject|7|||
124859035|NCT01165281|449106143|FG000|Overall Study|Noncompliance with Study Drug|1|||
124859036|NCT01165281|449106144|FG001|Overall Study|Noncompliance with Study Drug|4|||
124859037|NCT01165281|449106143|FG000|Overall Study|Progressive Disease|10|||
124859038|NCT01165281|449106144|FG001|Overall Study|Progressive Disease|14|||
124859039|NCT01165281|449106143|FG000|Overall Study|Other|6|||
124859040|NCT01165281|449106144|FG001|Overall Study|Other|0|||
124859041|NCT00363766|449106149|FG000|Overall Study|Progressive Disease|15|||
124859042|NCT00363766|449106150|FG001|Overall Study|Progressive Disease|9|||
124859043|NCT00363766|449106149|FG000|Overall Study|Adverse Event|10|||
124859044|NCT00363766|449106150|FG001|Overall Study|Adverse Event|2|||
124859045|NCT00363766|449106149|FG000|Overall Study|Disease Related Death|1|||
124859046|NCT00363766|449106150|FG001|Overall Study|Disease Related Death|3|||
124859047|NCT00363766|449106149|FG000|Overall Study|Not Disease Related Death|3|||
124859048|NCT00363766|449106150|FG001|Overall Study|Not Disease Related Death|4|||
124859049|NCT00363766|449106149|FG000|Overall Study|Withdrawal by Subject|2|||
124859050|NCT00363766|449106150|FG001|Overall Study|Withdrawal by Subject|0|||
124859051|NCT00363766|449106149|FG000|Overall Study|Physician Decision|1|||
124859052|NCT00363766|449106150|FG001|Overall Study|Physician Decision|2|||
124859053|NCT00558285|449106151|FG000|Overall Study|Adverse Event|1|||
124859054|NCT00558285|449106152|FG001|Overall Study|Adverse Event|1|||
124859055|NCT00558285|449106153|FG002|Overall Study|Adverse Event|4|||
124859056|NCT00558285|449106154|FG003|Overall Study|Adverse Event|1|||
124859057|NCT00558285|449106155|FG004|Overall Study|Adverse Event|2|||
124859058|NCT00558285|449106151|FG000|Overall Study|Abnormal test procedure result(s)|1|||
124859059|NCT00558285|449106152|FG001|Overall Study|Abnormal test procedure result(s)|0|||
124859060|NCT00558285|449106153|FG002|Overall Study|Abnormal test procedure result(s)|0|||
124859061|NCT00558285|449106154|FG003|Overall Study|Abnormal test procedure result(s)|0|||
124859062|NCT00558285|449106155|FG004|Overall Study|Abnormal test procedure result(s)|0|||
124859063|NCT00558285|449106151|FG000|Overall Study|Subject withdrew consent|2|||
124859064|NCT00558285|449106152|FG001|Overall Study|Subject withdrew consent|0|||
124859065|NCT00558285|449106153|FG002|Overall Study|Subject withdrew consent|1|||
124859066|NCT00558285|449106154|FG003|Overall Study|Subject withdrew consent|1|||
124859067|NCT00558285|449106155|FG004|Overall Study|Subject withdrew consent|1|||
124859068|NCT00558285|449106151|FG000|Overall Study|Lost to Follow-up|1|||
124859069|NCT00558285|449106152|FG001|Overall Study|Lost to Follow-up|1|||
124859070|NCT00558285|449106153|FG002|Overall Study|Lost to Follow-up|0|||
124859071|NCT00558285|449106154|FG003|Overall Study|Lost to Follow-up|0|||
124859072|NCT00558285|449106155|FG004|Overall Study|Lost to Follow-up|0|||
124859073|NCT00558285|449106151|FG000|Overall Study|Administrative problems|0|||
124859074|NCT00558285|449106152|FG001|Overall Study|Administrative problems|0|||
124859075|NCT00558285|449106153|FG002|Overall Study|Administrative problems|0|||
124859076|NCT00558285|449106154|FG003|Overall Study|Administrative problems|1|||
124859077|NCT00558285|449106155|FG004|Overall Study|Administrative problems|1|||
124859078|NCT00558285|449106151|FG000|Overall Study|Protocol deviation|1|||
124859079|NCT00558285|449106152|FG001|Overall Study|Protocol deviation|1|||
124859080|NCT00558285|449106153|FG002|Overall Study|Protocol deviation|0|||
124859081|NCT00558285|449106154|FG003|Overall Study|Protocol deviation|1|||
124859082|NCT00558285|449106155|FG004|Overall Study|Protocol deviation|0|||
124859083|NCT02730819|449106156|FG000|Overall Study|Lost to Follow-up|9|||
124859084|NCT02121847|449106158|FG000|Overall Study|Administrative Reasons|1|||
124859085|NCT02121847|449106158|FG000|Overall Study|Adverse Event|2|||
124859086|NCT01660906|449106159|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
124859087|NCT00809757|449106165|FG000|Overall Study|Adverse Event|2|||
124859088|NCT00809757|449106166|FG001|Overall Study|Adverse Event|3|||
124859089|NCT00809757|449106167|FG002|Overall Study|Adverse Event|3|||
124859090|NCT00809757|449106165|FG000|Overall Study|Lost to Follow-up|0|||
124859091|NCT00809757|449106166|FG001|Overall Study|Lost to Follow-up|0|||
124859092|NCT00809757|449106167|FG002|Overall Study|Lost to Follow-up|1|||
124859093|NCT00809757|449106165|FG000|Overall Study|Protocol Violation|1|||
124859094|NCT00809757|449106166|FG001|Overall Study|Protocol Violation|1|||
124859095|NCT00809757|449106167|FG002|Overall Study|Protocol Violation|1|||
124859096|NCT00809757|449106165|FG000|Overall Study|Withdrawal by Subject|2|||
124859097|NCT00809757|449106166|FG001|Overall Study|Withdrawal by Subject|1|||
124859098|NCT00809757|449106167|FG002|Overall Study|Withdrawal by Subject|3|||
124859099|NCT00809757|449106165|FG000|Overall Study|Subject Uncooperative|1|||
124859100|NCT00809757|449106166|FG001|Overall Study|Subject Uncooperative|0|||
124859101|NCT00809757|449106167|FG002|Overall Study|Subject Uncooperative|2|||
124859102|NCT00809757|449106165|FG000|Overall Study|Noncompliance with Medication|0|||
124859103|NCT00809757|449106166|FG001|Overall Study|Noncompliance with Medication|0|||
124859104|NCT00809757|449106167|FG002|Overall Study|Noncompliance with Medication|1|||
124859105|NCT00253864|449106168|FG000|Overall Study|Lost to Follow-up|5|||
124859106|NCT00253864|449106169|FG001|Overall Study|Lost to Follow-up|8|||
124859107|NCT00659334|449106170|FG000|Overall Study|Screen Failure|8|||
124859108|NCT00659334|449106171|FG001|Overall Study|Screen Failure|5|||
124859109|NCT00659334|449106172|FG002|Overall Study|Screen Failure|0|||
124859110|NCT00659334|449106173|FG003|Overall Study|Screen Failure|0|||
124859111|NCT00659334|449106174|FG004|Overall Study|Screen Failure|0|||
124859112|NCT00659334|449106175|FG005|Overall Study|Screen Failure|0|||
124859113|NCT00659334|449106176|FG006|Overall Study|Screen Failure|1|||
124859114|NCT01174342|449106180|FG000|Overall Study|Conversion to cesarean section|4|||
124859115|NCT01410448|449106181|FG000|Overall Study|No conversion to everolimus|0|||
124859116|NCT01410448|449106182|FG001|Overall Study|No conversion to everolimus|24|||
124859117|NCT01410448|449106181|FG000|Overall Study|Graft loss|4|||
124859118|NCT01410448|449106182|FG001|Overall Study|Graft loss|1|||
124859119|NCT01410448|449106181|FG000|Overall Study|Administrative issues|2|||
124859120|NCT01410448|449106182|FG001|Overall Study|Administrative issues|1|||
124859121|NCT01410448|449106181|FG000|Overall Study|Lost to Follow-up|1|||
124859122|NCT01410448|449106182|FG001|Overall Study|Lost to Follow-up|0|||
124859123|NCT01410448|449106181|FG000|Overall Study|Withdrawal by Subject|3|||
124859124|NCT01410448|449106182|FG001|Overall Study|Withdrawal by Subject|2|||
124859125|NCT01410448|449106181|FG000|Overall Study|Protocol Violation|0|||
124859126|NCT01410448|449106182|FG001|Overall Study|Protocol Violation|4|||
124859127|NCT01410448|449106181|FG000|Overall Study|Death|2|||
124859128|NCT01410448|449106182|FG001|Overall Study|Death|3|||
124859129|NCT01308580|449106183|FG000|Overall Study|Lost to Follow-up|12|||
124859130|NCT01308580|449106184|FG001|Overall Study|Lost to Follow-up|7|||
124859131|NCT00360529|449106185|FG000|Overall Study|Adverse Event|10|||
124859132|NCT00360529|449106186|FG001|Overall Study|Adverse Event|23|||
124859133|NCT00360529|449106187|FG002|Overall Study|Adverse Event|33|||
124859134|NCT00360529|449106185|FG000|Overall Study|Protocol Violation|3|||
124859135|NCT00360529|449106186|FG001|Overall Study|Protocol Violation|3|||
124859136|NCT00360529|449106187|FG002|Overall Study|Protocol Violation|11|||
124859137|NCT00360529|449106185|FG000|Overall Study|Lost to Follow-up|14|||
124859138|NCT00360529|449106186|FG001|Overall Study|Lost to Follow-up|10|||
124859139|NCT00360529|449106187|FG002|Overall Study|Lost to Follow-up|13|||
124859140|NCT00360529|449106185|FG000|Overall Study|Withdrawal by Subject|22|||
124859141|NCT00360529|449106186|FG001|Overall Study|Withdrawal by Subject|14|||
124859142|NCT00360529|449106187|FG002|Overall Study|Withdrawal by Subject|18|||
124859143|NCT00360529|449106185|FG000|Overall Study|Lack of Efficacy|8|||
124859144|NCT00360529|449106186|FG001|Overall Study|Lack of Efficacy|6|||
124859145|NCT00360529|449106187|FG002|Overall Study|Lack of Efficacy|5|||
124859146|NCT00360529|449106185|FG000|Overall Study|Reason discontinued not explained above|4|||
124859147|NCT00360529|449106186|FG001|Overall Study|Reason discontinued not explained above|9|||
124859148|NCT00360529|449106187|FG002|Overall Study|Reason discontinued not explained above|11|||
124859149|NCT03712917|449106188|FG000|Overall Study|Pregnancy|0|||
124859150|NCT03712917|449106189|FG001|Overall Study|Pregnancy|0|||
124859151|NCT03712917|449106190|FG002|Overall Study|Pregnancy|1|||
124859152|NCT03712917|449106188|FG000|Overall Study|Adverse Event|0|||
124859153|NCT03712917|449106189|FG001|Overall Study|Adverse Event|4|||
124859154|NCT03712917|449106190|FG002|Overall Study|Adverse Event|3|||
124859155|NCT03712917|449106188|FG000|Overall Study|Lost to Follow-up|9|||
124859156|NCT03712917|449106189|FG001|Overall Study|Lost to Follow-up|4|||
124859157|NCT03712917|449106190|FG002|Overall Study|Lost to Follow-up|5|||
124859158|NCT01218438|449106191|FG000|Epoch 1|Physician Decision|2|||
124859159|NCT01218438|449106191|FG000|Epoch 1|Adverse Event|1|||
124859160|NCT01218438|449106191|FG000|Epoch 3|Withdrawal by Subject|3|||
124859161|NCT01218438|449106191|FG000|Epoch 3|Adverse Event|1|||
124859162|NCT01218438|449106191|FG000|Epoch 4|Physician Decision|1|||
124859163|NCT01218438|449106191|FG000|Epoch 4|Withdrawal by Subject|2|||
124859164|NCT01218646|449106193|FG000|Overall Study|Adverse Event|0|||
124859165|NCT01218646|449106194|FG001|Overall Study|Adverse Event|0|||
124859166|NCT01218646|449106195|FG002|Overall Study|Adverse Event|1|||
124859167|NCT01218646|449106196|FG003|Overall Study|Adverse Event|0|||
124859168|NCT01218646|449106193|FG000|Overall Study|Lost to Follow-up|1|||
124859169|NCT01218646|449106194|FG001|Overall Study|Lost to Follow-up|0|||
124859170|NCT01218646|449106195|FG002|Overall Study|Lost to Follow-up|0|||
124859171|NCT01218646|449106196|FG003|Overall Study|Lost to Follow-up|0|||
124859172|NCT01218646|449106193|FG000|Overall Study|Protocol Violation|0|||
124859173|NCT01218646|449106194|FG001|Overall Study|Protocol Violation|0|||
124859174|NCT01218646|449106195|FG002|Overall Study|Protocol Violation|1|||
124859175|NCT01218646|449106196|FG003|Overall Study|Protocol Violation|1|||
124859176|NCT05437510|449106199|FG000|Overall Study|Adverse Event|1|||
124859177|NCT05437510|449106200|FG001|Overall Study|Adverse Event|1|||
124859178|NCT05437510|449106199|FG000|Overall Study|Protocol Deviation|1|||
124859179|NCT05437510|449106200|FG001|Overall Study|Protocol Deviation|6|||
124859180|NCT05437510|449106199|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
124859181|NCT05437510|449106200|FG001|Overall Study|Withdrawal by Parent/Guardian|22|||
124859182|NCT05437510|449106199|FG000|Overall Study|Lost to Follow-up|219|||
124859183|NCT05437510|449106200|FG001|Overall Study|Lost to Follow-up|289|||
124859184|NCT05437510|449106199|FG000|Overall Study|Ongoing in the Study Extension|1387|||
124859185|NCT05437510|449106200|FG001|Overall Study|Ongoing in the Study Extension|1352|||
124859186|NCT05706506|449108225|FG000|Overall Study|Adverse Event|1|||
124859187|NCT05706506|449108225|FG000|Overall Study|Withdrawal by Subject|4|||
124859188|NCT05706506|449108225|FG000|Overall Study|Lost to Follow-up|2|||
124859189|NCT05706506|449108225|FG000|Overall Study|Inadvertent Enrolment|12|||
124859190|NCT05706506|449108225|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
124859191|NCT05706506|449108225|FG000|Overall Study|Participant Moved Out of State|1|||
124859192|NCT00838110|449108226|FG000|Overall Study|Death|0|||
124859193|NCT00838110|449108227|FG001|Overall Study|Death|0|||
124859194|NCT00838110|449108228|FG002|Overall Study|Death|1|||
124859195|NCT00838110|449108229|FG003|Overall Study|Death|2|||
124859196|NCT00838110|449108226|FG000|Overall Study|Adverse Event|11|||
124859197|NCT00838110|449108227|FG001|Overall Study|Adverse Event|10|||
124859198|NCT00838110|449108228|FG002|Overall Study|Adverse Event|8|||
124859199|NCT00838110|449108229|FG003|Overall Study|Adverse Event|7|||
124859200|NCT00838110|449108226|FG000|Overall Study|Withdrawal by Subject|5|||
124859201|NCT00838110|449108227|FG001|Overall Study|Withdrawal by Subject|6|||
124859202|NCT00838110|449108228|FG002|Overall Study|Withdrawal by Subject|3|||
124859203|NCT00838110|449108229|FG003|Overall Study|Withdrawal by Subject|4|||
124859204|NCT00838110|449108226|FG000|Overall Study|Other|3|||
124859205|NCT00838110|449108227|FG001|Overall Study|Other|3|||
124859206|NCT00838110|449108228|FG002|Overall Study|Other|3|||
124859207|NCT00838110|449108229|FG003|Overall Study|Other|2|||
124859208|NCT00838110|449108226|FG000|Overall Study|Protocol Violation|0|||
124859209|NCT00838110|449108227|FG001|Overall Study|Protocol Violation|2|||
124859210|NCT00838110|449108228|FG002|Overall Study|Protocol Violation|1|||
124859211|NCT00838110|449108229|FG003|Overall Study|Protocol Violation|1|||
124859212|NCT00838110|449108226|FG000|Overall Study|Lost to Follow-up|3|||
124859213|NCT00838110|449108227|FG001|Overall Study|Lost to Follow-up|0|||
124859214|NCT00838110|449108228|FG002|Overall Study|Lost to Follow-up|0|||
124859215|NCT00838110|449108229|FG003|Overall Study|Lost to Follow-up|0|||
124859216|NCT00838110|449108226|FG000|Overall Study|Did not meet eligibility criteria|0|||
124859217|NCT00838110|449108227|FG001|Overall Study|Did not meet eligibility criteria|0|||
124859218|NCT00838110|449108228|FG002|Overall Study|Did not meet eligibility criteria|1|||
124859219|NCT00838110|449108229|FG003|Overall Study|Did not meet eligibility criteria|2|||
124859220|NCT00838110|449108226|FG000|Overall Study|Randomized but not treated|0|||
124859221|NCT00838110|449108227|FG001|Overall Study|Randomized but not treated|1|||
124859222|NCT00838110|449108228|FG002|Overall Study|Randomized but not treated|0|||
124859223|NCT00838110|449108229|FG003|Overall Study|Randomized but not treated|0|||
124859224|NCT03240588|449108231|FG000|Overall Study|Death|3|||
124859225|NCT03240588|449108232|FG001|Overall Study|Death|0|||
124859226|NCT03240588|449108233|FG002|Overall Study|Death|0|||
124859227|NCT03240588|449108231|FG000|Overall Study|Adverse Event|5|||
124859228|NCT03240588|449108232|FG001|Overall Study|Adverse Event|4|||
124859229|NCT03240588|449108233|FG002|Overall Study|Adverse Event|0|||
124859230|NCT03240588|449108231|FG000|Overall Study|Lost to Follow-up|9|||
124859231|NCT03240588|449108232|FG001|Overall Study|Lost to Follow-up|4|||
124859232|NCT03240588|449108233|FG002|Overall Study|Lost to Follow-up|0|||
124859233|NCT03240588|449108231|FG000|Overall Study|Physician Decision|3|||
124859234|NCT03240588|449108232|FG001|Overall Study|Physician Decision|2|||
124859235|NCT03240588|449108233|FG002|Overall Study|Physician Decision|0|||
124859236|NCT03240588|449108231|FG000|Overall Study|Did not meet eligibility criteria|0|||
124859237|NCT03240588|449108232|FG001|Overall Study|Did not meet eligibility criteria|6|||
124859238|NCT03240588|449108233|FG002|Overall Study|Did not meet eligibility criteria|0|||
124859239|NCT03240588|449108231|FG000|Overall Study|No longer meets protocol criteria|12|||
124859240|NCT03240588|449108232|FG001|Overall Study|No longer meets protocol criteria|7|||
124859241|NCT03240588|449108233|FG002|Overall Study|No longer meets protocol criteria|0|||
124859242|NCT03240588|449108231|FG000|Overall Study|Withdrawal by Subject|60|||
124859243|NCT03240588|449108232|FG001|Overall Study|Withdrawal by Subject|52|||
124859244|NCT03240588|449108233|FG002|Overall Study|Withdrawal by Subject|7|||
124859245|NCT03240588|449108231|FG000|Overall Study|Other, additional details not available.|0|||
124859246|NCT03240588|449108232|FG001|Overall Study|Other, additional details not available.|12|||
124859247|NCT03240588|449108233|FG002|Overall Study|Other, additional details not available.|1|||
124859248|NCT03240588|449108231|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
124859249|NCT03240588|449108232|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
124859250|NCT03240588|449108233|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
124859251|NCT03240588|449108231|FG000|Overall Study|Closure of study|55|||
124859252|NCT03240588|449108232|FG001|Overall Study|Closure of study|3|||
124859253|NCT03240588|449108233|FG002|Overall Study|Closure of study|0|||
124859254|NCT03240588|449108231|FG000|Overall Study|Subject non-compliance|23|||
124859255|NCT03240588|449108232|FG001|Overall Study|Subject non-compliance|2|||
124859256|NCT03240588|449108233|FG002|Overall Study|Subject non-compliance|1|||
124859257|NCT03240588|449108231|FG000|Overall Study|Device Deficiency|1|||
124859258|NCT03240588|449108232|FG001|Overall Study|Device Deficiency|0|||
124859259|NCT03240588|449108233|FG002|Overall Study|Device Deficiency|0|||
124859260|NCT03240588|449108231|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
124859261|NCT03240588|449108232|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
124859262|NCT03240588|449108233|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
124859263|NCT01914926|449108234|FG000|Overall Study|Adverse Event|1|||
124859264|NCT01914926|449108235|FG001|Overall Study|Adverse Event|0|||
124859265|NCT01914926|449108234|FG000|Overall Study|uncooperative, agitated and removed|0|||
124859266|NCT01914926|449108235|FG001|Overall Study|uncooperative, agitated and removed|1|||
124859267|NCT00467870|449108236|FG000|Overall Study|Adverse Event|13|||
124859268|NCT00467870|449108237|FG001|Overall Study|Adverse Event|9|||
124859269|NCT00467870|449108238|FG002|Overall Study|Adverse Event|1|||
124859270|NCT00467870|449108239|FG003|Overall Study|Adverse Event|15|||
124859271|NCT00467870|449108240|FG004|Overall Study|Adverse Event|15|||
124859272|NCT00467870|449108241|FG005|Overall Study|Adverse Event|1|||
124859273|NCT00467870|449108236|FG000|Overall Study|Protocol Violation|2|||
124859274|NCT00467870|449108237|FG001|Overall Study|Protocol Violation|1|||
124859275|NCT00467870|449108238|FG002|Overall Study|Protocol Violation|1|||
124859276|NCT00467870|449108239|FG003|Overall Study|Protocol Violation|2|||
124859277|NCT00467870|449108240|FG004|Overall Study|Protocol Violation|0|||
124859278|NCT00467870|449108241|FG005|Overall Study|Protocol Violation|0|||
124859279|NCT00467870|449108236|FG000|Overall Study|Withdrawal by Subject|14|||
124859280|NCT00467870|449108237|FG001|Overall Study|Withdrawal by Subject|21|||
124859281|NCT00467870|449108238|FG002|Overall Study|Withdrawal by Subject|0|||
124859282|NCT00467870|449108239|FG003|Overall Study|Withdrawal by Subject|9|||
124859283|NCT00467870|449108240|FG004|Overall Study|Withdrawal by Subject|10|||
124859284|NCT00467870|449108241|FG005|Overall Study|Withdrawal by Subject|1|||
124859285|NCT00467870|449108236|FG000|Overall Study|Lost to Follow-up|5|||
124859286|NCT00467870|449108237|FG001|Overall Study|Lost to Follow-up|3|||
124859287|NCT00467870|449108238|FG002|Overall Study|Lost to Follow-up|1|||
124859288|NCT00467870|449108239|FG003|Overall Study|Lost to Follow-up|1|||
124859289|NCT00467870|449108240|FG004|Overall Study|Lost to Follow-up|3|||
124859290|NCT00467870|449108241|FG005|Overall Study|Lost to Follow-up|0|||
124859291|NCT00467870|449108236|FG000|Overall Study|Subject Non-compliance|3|||
124859292|NCT00467870|449108237|FG001|Overall Study|Subject Non-compliance|4|||
124859293|NCT00467870|449108238|FG002|Overall Study|Subject Non-compliance|0|||
124859294|NCT00467870|449108239|FG003|Overall Study|Subject Non-compliance|1|||
124859295|NCT00467870|449108240|FG004|Overall Study|Subject Non-compliance|5|||
124859296|NCT00467870|449108241|FG005|Overall Study|Subject Non-compliance|0|||
124859297|NCT00467870|449108236|FG000|Overall Study|Other/Unknown|8|||
124859298|NCT00467870|449108237|FG001|Overall Study|Other/Unknown|5|||
124859299|NCT00467870|449108238|FG002|Overall Study|Other/Unknown|1|||
124859300|NCT00467870|449108239|FG003|Overall Study|Other/Unknown|5|||
124859301|NCT00467870|449108240|FG004|Overall Study|Other/Unknown|4|||
124859302|NCT00467870|449108241|FG005|Overall Study|Other/Unknown|0|||
124859303|NCT00321919|449108242|FG000|Overall Study|Adverse Event|17|||
124859304|NCT00321919|449108243|FG001|Overall Study|Adverse Event|10|||
124859305|NCT00321919|449108242|FG000|Overall Study|Death|21|||
124859306|NCT00321919|449108243|FG001|Overall Study|Death|17|||
124859307|NCT00321919|449108242|FG000|Overall Study|Insufficient Therapeutic Response|1|||
124859308|NCT00321919|449108243|FG001|Overall Study|Insufficient Therapeutic Response|0|||
124859309|NCT00321919|449108242|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
124859310|NCT00321919|449108243|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
124859311|NCT00321919|449108242|FG000|Overall Study|Refused Treatment|23|||
124859312|NCT00321919|449108243|FG001|Overall Study|Refused Treatment|14|||
124859313|NCT00321919|449108242|FG000|Overall Study|Other Protocol Violation|2|||
124859314|NCT00321919|449108243|FG001|Overall Study|Other Protocol Violation|3|||
124859315|NCT00321919|449108242|FG000|Overall Study|Failure to Return|3|||
124859316|NCT00321919|449108243|FG001|Overall Study|Failure to Return|1|||
124859317|NCT00321919|449108242|FG000|Overall Study|Other withdrawal reason|7|||
124859318|NCT00321919|449108243|FG001|Overall Study|Other withdrawal reason|6|||
124859319|NCT02261363|449108244|FG000|Overall Study|Lost to Follow-up|21|||
124859320|NCT01517802|449108245|FG000|Overall Study|Death|1|||
124859321|NCT02590354|449108246|FG000|Phase 1|Active hepatitis B or C infection|1|||
124859322|NCT02590354|449108246|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
124859323|NCT02590354|449108246|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
124859324|NCT02590354|449108246|FG000|Phase 1|Subject does not want to participate|20|||
124859325|NCT02590354|449108246|FG000|Phase 1|Lost to Follow-up|1|||
124859326|NCT02590354|449108246|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
124859327|NCT00760929|449108247|FG000|Overall Study|Adverse Event|2|||
124859328|NCT00760929|449108248|FG001|Overall Study|Adverse Event|0|||
124859329|NCT00760929|449108249|FG002|Overall Study|Adverse Event|6|||
124859330|NCT00760929|449108250|FG003|Overall Study|Adverse Event|10|||
124859331|NCT00760929|449108247|FG000|Overall Study|Lack of Efficacy|0|||
124859332|NCT00760929|449108248|FG001|Overall Study|Lack of Efficacy|2|||
124859333|NCT00760929|449108249|FG002|Overall Study|Lack of Efficacy|1|||
124859334|NCT00760929|449108250|FG003|Overall Study|Lack of Efficacy|0|||
124859335|NCT00760929|449108247|FG000|Overall Study|Withdrawal by Subject|1|||
124859336|NCT00760929|449108248|FG001|Overall Study|Withdrawal by Subject|0|||
124859337|NCT00760929|449108249|FG002|Overall Study|Withdrawal by Subject|9|||
124859338|NCT00760929|449108250|FG003|Overall Study|Withdrawal by Subject|1|||
124859339|NCT00760929|449108247|FG000|Overall Study|Lost to Follow-up|0|||
124859340|NCT00760929|449108248|FG001|Overall Study|Lost to Follow-up|0|||
124859341|NCT00760929|449108249|FG002|Overall Study|Lost to Follow-up|1|||
124859342|NCT00760929|449108250|FG003|Overall Study|Lost to Follow-up|0|||
124859343|NCT00760929|449108247|FG000|Overall Study|Progression of Disease|21|||
124859344|NCT00760929|449108248|FG001|Overall Study|Progression of Disease|26|||
124859345|NCT00760929|449108249|FG002|Overall Study|Progression of Disease|38|||
124859346|NCT00760929|449108250|FG003|Overall Study|Progression of Disease|42|||
124859347|NCT00760929|449108247|FG000|Overall Study|Other|2|||
124859348|NCT00760929|449108248|FG001|Overall Study|Other|0|||
124859349|NCT00760929|449108249|FG002|Overall Study|Other|2|||
124859350|NCT00760929|449108250|FG003|Overall Study|Other|1|||
124859351|NCT00760929|449108247|FG000|Overall Study|Death|0|||
124859352|NCT00760929|449108248|FG001|Overall Study|Death|0|||
124859353|NCT00760929|449108249|FG002|Overall Study|Death|1|||
124859354|NCT00760929|449108250|FG003|Overall Study|Death|0|||
124859355|NCT00760929|449108247|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
124859356|NCT00760929|449108248|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
124859357|NCT00760929|449108249|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
124859358|NCT00760929|449108250|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
124859359|NCT02099838|449108251|FG000|Overall Study|Death|1|||
124859360|NCT02099838|449108252|FG001|Overall Study|Death|0|||
124859361|NCT02099838|449108251|FG000|Overall Study|Lost to Follow-up|3|||
124859362|NCT02099838|449108252|FG001|Overall Study|Lost to Follow-up|1|||
124859363|NCT02099838|449108251|FG000|Overall Study|Withdrawal by Subject|0|||
124859364|NCT02099838|449108252|FG001|Overall Study|Withdrawal by Subject|1|||
124859365|NCT02301143|449108253|FG000|Induction Period|Enrolled But Not Treated|1|||
124859366|NCT02301143|449108254|FG001|Induction Period|Enrolled But Not Treated|0|||
124859367|NCT02301143|449108253|FG000|Induction Period|Death|1|||
124859368|NCT02301143|449108254|FG001|Induction Period|Death|0|||
124859369|NCT02301143|449108253|FG000|Induction Period|Adverse Event|22|||
124859370|NCT02301143|449108254|FG001|Induction Period|Adverse Event|0|||
124859371|NCT02301143|449108253|FG000|Induction Period|Progressive Disease|8|||
124859372|NCT02301143|449108254|FG001|Induction Period|Progressive Disease|0|||
124859373|NCT02301143|449108253|FG000|Induction Period|Withdrawal by Subject|3|||
124859374|NCT02301143|449108254|FG001|Induction Period|Withdrawal by Subject|0|||
124859375|NCT02301143|449108253|FG000|Induction Period|Noncompliance with Study Drug|1|||
124859376|NCT02301143|449108254|FG001|Induction Period|Noncompliance with Study Drug|0|||
124859377|NCT02301143|449108253|FG000|Induction Period|Physician Decision|4|||
124859378|NCT02301143|449108254|FG001|Induction Period|Physician Decision|0|||
124859379|NCT02301143|449108253|FG000|Induction Period|Symptomatic Deterioration|2|||
124859380|NCT02301143|449108254|FG001|Induction Period|Symptomatic Deterioration|0|||
124859381|NCT02301143|449108253|FG000|Induction Period|Protocol Violation|2|||
124859382|NCT02301143|449108254|FG001|Induction Period|Protocol Violation|0|||
124859383|NCT02301143|449108253|FG000|Induction Period|Other|1|||
124859384|NCT02301143|449108254|FG001|Induction Period|Other|0|||
124859385|NCT02301143|449108253|FG000|Investigator's Choice|Adverse Event|0|||
124859386|NCT02301143|449108254|FG001|Investigator's Choice|Adverse Event|3|||
124859387|NCT02301143|449108253|FG000|Investigator's Choice|Progressive Disease|0|||
124859388|NCT02301143|449108254|FG001|Investigator's Choice|Progressive Disease|3|||
124859389|NCT02301143|449108253|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
124859390|NCT02301143|449108254|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
124859391|NCT02301143|449108253|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
124859392|NCT02301143|449108254|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
124859393|NCT02301143|449108253|FG000|Investigator's Choice|Other|0|||
124859394|NCT02301143|449108254|FG001|Investigator's Choice|Other|1|||
124859395|NCT02301143|449108253|FG000|Investigator's Choice|Unresectable Surgery|0|||
124859396|NCT02301143|449108254|FG001|Investigator's Choice|Unresectable Surgery|1|||
124859397|NCT02536508|449108257|FG000|Overall Study|Withdrawal by Subject|18|||
124859398|NCT02536508|449108258|FG001|Overall Study|Withdrawal by Subject|13|||
124859399|NCT02536508|449108259|FG002|Overall Study|Withdrawal by Subject|7|||
124859400|NCT02536508|449108257|FG000|Overall Study|Adverse Event|14|||
124859401|NCT02536508|449108258|FG001|Overall Study|Adverse Event|13|||
124859402|NCT02536508|449108259|FG002|Overall Study|Adverse Event|6|||
124859403|NCT02536508|449108257|FG000|Overall Study|Lost to Follow-up|12|||
124859404|NCT02536508|449108258|FG001|Overall Study|Lost to Follow-up|4|||
124859405|NCT02536508|449108259|FG002|Overall Study|Lost to Follow-up|0|||
124859406|NCT02536508|449108257|FG000|Overall Study|Lack of Efficacy|3|||
124859407|NCT02536508|449108258|FG001|Overall Study|Lack of Efficacy|5|||
124859408|NCT02536508|449108259|FG002|Overall Study|Lack of Efficacy|4|||
124859409|NCT02536508|449108257|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
124859410|NCT02536508|449108258|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
124859411|NCT02536508|449108259|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
124859412|NCT02536508|449108257|FG000|Overall Study|Physician Decision|0|||
124859413|NCT02536508|449108258|FG001|Overall Study|Physician Decision|4|||
124859414|NCT02536508|449108259|FG002|Overall Study|Physician Decision|2|||
124859415|NCT02536508|449108257|FG000|Overall Study|Major Protocol Deviation|2|||
124859416|NCT02536508|449108258|FG001|Overall Study|Major Protocol Deviation|2|||
124859417|NCT02536508|449108259|FG002|Overall Study|Major Protocol Deviation|2|||
124859418|NCT02536508|449108257|FG000|Overall Study|Administrative Reasons|0|||
124859419|NCT02536508|449108258|FG001|Overall Study|Administrative Reasons|1|||
124859420|NCT02536508|449108259|FG002|Overall Study|Administrative Reasons|0|||
124859421|NCT02460991|449108263|FG000|Overall Study|Withdrawal by Subject|0|||
124859422|NCT02460991|449108264|FG001|Overall Study|Withdrawal by Subject|2|||
124859423|NCT00434057|449108265|FG000|Overall Study|Withdrawal by Subject|1|||
124859424|NCT02473952|449108266|FG000|Overall Study|Adverse Event|2|||
124859425|NCT02473952|449108267|FG001|Overall Study|Adverse Event|2|||
124859426|NCT02473952|449108266|FG000|Overall Study|Withdrawal by Subject|0|||
124859427|NCT02473952|449108267|FG001|Overall Study|Withdrawal by Subject|6|||
124859428|NCT00455195|449108268|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
124859429|NCT00455195|449108269|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
124859430|NCT00455195|449108268|FG000|Double-blind Study AGLU02704|Death|1|||
124859431|NCT00455195|449108269|FG001|Double-blind Study AGLU02704|Death|0|||
124859432|NCT00455195|449108268|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
124859433|NCT00455195|449108269|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
124859434|NCT00455195|449108268|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
124859435|NCT00455195|449108269|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
124859436|NCT02117570|449108270|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
124859437|NCT02117570|449108271|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
124859438|NCT02117570|449108272|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
124859439|NCT02117570|449108270|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
124859440|NCT02117570|449108271|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
124859441|NCT02117570|449108272|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
124859442|NCT02117570|449108270|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
124859443|NCT02117570|449108271|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
124859444|NCT02117570|449108272|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
124859445|NCT02117570|449108270|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
124859446|NCT02117570|449108271|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
124859447|NCT02117570|449108272|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
124859448|NCT02117570|449108270|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
124859449|NCT02117570|449108271|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
124859450|NCT02117570|449108272|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
124859451|NCT02117570|449108270|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
124859452|NCT02117570|449108271|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
124859453|NCT02117570|449108272|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
124859454|NCT02117570|449108270|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
124859455|NCT02117570|449108271|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
124859456|NCT02117570|449108272|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
124859457|NCT02508311|449108275|FG000|Overall Study|Withdrawal by Subject|1|||
124859458|NCT02508311|449108276|FG001|Overall Study|Withdrawal by Subject|0|||
124859459|NCT02169674|449108277|FG000|Overall Study|Withdrawal by Subject|2|||
124859460|NCT02169674|449108278|FG001|Overall Study|Withdrawal by Subject|1|||
124859461|NCT02169674|449108277|FG000|Overall Study|Seroprotected|30|||
124859462|NCT02169674|449108278|FG001|Overall Study|Seroprotected|76|||
124859463|NCT02169674|449108277|FG000|Overall Study|Lost to Follow-up|0|||
124859464|NCT02169674|449108278|FG001|Overall Study|Lost to Follow-up|1|||
124859465|NCT03349710|449108279|FG000|Treatment Period|Death|0|||
124859466|NCT03349710|449108280|FG001|Treatment Period|Death|0|||
124859467|NCT03349710|449108281|FG002|Treatment Period|Death|1|||
124859468|NCT03349710|449108282|FG003|Treatment Period|Death|0|||
124859469|NCT03349710|449108279|FG000|Treatment Period|Disease Progression|0|||
124859470|NCT03349710|449108280|FG001|Treatment Period|Disease Progression|2|||
124859471|NCT03349710|449108281|FG002|Treatment Period|Disease Progression|0|||
124859472|NCT03349710|449108282|FG003|Treatment Period|Disease Progression|1|||
124859473|NCT03349710|449108279|FG000|Treatment Period|Study Drug Toxicity|1|||
124859474|NCT03349710|449108280|FG001|Treatment Period|Study Drug Toxicity|0|||
124859475|NCT03349710|449108281|FG002|Treatment Period|Study Drug Toxicity|1|||
124859476|NCT03349710|449108282|FG003|Treatment Period|Study Drug Toxicity|1|||
124859477|NCT03349710|449108279|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
124859478|NCT03349710|449108280|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
124859479|NCT03349710|449108281|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
124859480|NCT03349710|449108282|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
124859481|NCT03349710|449108279|FG000|Treatment Period|admin reason by sponsor|0|||
124859482|NCT03349710|449108280|FG001|Treatment Period|admin reason by sponsor|7|||
124859483|NCT03349710|449108281|FG002|Treatment Period|admin reason by sponsor|0|||
124859484|NCT03349710|449108282|FG003|Treatment Period|admin reason by sponsor|19|||
124859485|NCT03349710|449108279|FG000|Treatment Period|Other Reason|2|||
124859486|NCT03349710|449108280|FG001|Treatment Period|Other Reason|0|||
124859487|NCT03349710|449108281|FG002|Treatment Period|Other Reason|2|||
124859488|NCT03349710|449108282|FG003|Treatment Period|Other Reason|1|||
124859489|NCT03349710|449108279|FG000|Treatment Period|completed|6|||
124859490|NCT03349710|449108280|FG001|Treatment Period|completed|0|||
124859491|NCT03349710|449108281|FG002|Treatment Period|completed|18|||
124859492|NCT03349710|449108282|FG003|Treatment Period|completed|1|||
124859493|NCT03349710|449108279|FG000|Treatment Period|participant request to discontinue|0|||
124859494|NCT03349710|449108280|FG001|Treatment Period|participant request to discontinue|0|||
124859495|NCT03349710|449108281|FG002|Treatment Period|participant request to discontinue|4|||
124859496|NCT03349710|449108282|FG003|Treatment Period|participant request to discontinue|0|||
124859497|NCT03349710|449108279|FG000|Treatment Period|participant withdrew consent|1|||
124859498|NCT03349710|449108280|FG001|Treatment Period|participant withdrew consent|0|||
124859499|NCT03349710|449108281|FG002|Treatment Period|participant withdrew consent|0|||
124859500|NCT03349710|449108282|FG003|Treatment Period|participant withdrew consent|0|||
124859501|NCT04258020|449108287|FG000|Overall Study|Withdrawal by Subject|1|||
124859502|NCT04258020|449108288|FG001|Overall Study|Withdrawal by Subject|0|||
124859503|NCT00833989|449108293|FG000|Overall Study|Physician Decision|0|||
124859504|NCT00833989|449108294|FG001|Overall Study|Physician Decision|0|||
124859505|NCT00833989|449108295|FG002|Overall Study|Physician Decision|0|||
124859506|NCT00833989|449108296|FG003|Overall Study|Physician Decision|1|||
124859507|NCT00833989|449108293|FG000|Overall Study|Withdrawal by Subject|3|||
124859508|NCT00833989|449108294|FG001|Overall Study|Withdrawal by Subject|0|||
124859509|NCT00833989|449108295|FG002|Overall Study|Withdrawal by Subject|1|||
124859510|NCT00833989|449108296|FG003|Overall Study|Withdrawal by Subject|1|||
124859511|NCT02105948|449108304|FG000|Overall Study|Adverse Event|10|||
124859512|NCT02105948|449108305|FG001|Overall Study|Adverse Event|7|||
124859513|NCT02105948|449108306|FG002|Overall Study|Adverse Event|11|||
124859514|NCT02105948|449108307|FG003|Overall Study|Adverse Event|11|||
124859515|NCT02105948|449108304|FG000|Overall Study|Lack of Efficacy|0|||
124859516|NCT02105948|449108305|FG001|Overall Study|Lack of Efficacy|1|||
124859517|NCT02105948|449108306|FG002|Overall Study|Lack of Efficacy|3|||
124859518|NCT02105948|449108307|FG003|Overall Study|Lack of Efficacy|2|||
124859519|NCT02105948|449108304|FG000|Overall Study|Lost to Follow-up|0|||
124859520|NCT02105948|449108305|FG001|Overall Study|Lost to Follow-up|0|||
124859521|NCT02105948|449108306|FG002|Overall Study|Lost to Follow-up|2|||
124859522|NCT02105948|449108307|FG003|Overall Study|Lost to Follow-up|1|||
124859523|NCT02105948|449108304|FG000|Overall Study|Physician Decision|2|||
124859524|NCT02105948|449108305|FG001|Overall Study|Physician Decision|2|||
124859525|NCT02105948|449108306|FG002|Overall Study|Physician Decision|2|||
124859526|NCT02105948|449108307|FG003|Overall Study|Physician Decision|2|||
124859527|NCT02105948|449108304|FG000|Overall Study|Withdrawal by Subject|15|||
124859528|NCT02105948|449108305|FG001|Overall Study|Withdrawal by Subject|10|||
124859529|NCT02105948|449108306|FG002|Overall Study|Withdrawal by Subject|10|||
124859530|NCT02105948|449108307|FG003|Overall Study|Withdrawal by Subject|11|||
124859531|NCT01587651|449108312|FG000|Overall Study|Adverse Event|0|||
124859532|NCT01587651|449108313|FG001|Overall Study|Adverse Event|1|||
124859533|NCT01587651|449108314|FG002|Overall Study|Adverse Event|0|||
124859534|NCT01587651|449108312|FG000|Overall Study|Protocol Violation|0|||
124859535|NCT01587651|449108313|FG001|Overall Study|Protocol Violation|1|||
124859536|NCT01587651|449108314|FG002|Overall Study|Protocol Violation|1|||
124859537|NCT01587651|449108312|FG000|Overall Study|Withdrawal by Subject|0|||
124859538|NCT01587651|449108313|FG001|Overall Study|Withdrawal by Subject|1|||
124859539|NCT01587651|449108314|FG002|Overall Study|Withdrawal by Subject|0|||
124859540|NCT00355082|449108315|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
124859541|NCT00355082|449108316|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
124859542|NCT00355082|449108317|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
124859543|NCT00355082|449108315|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
124859544|NCT00355082|449108316|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
124859545|NCT00355082|449108317|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
124859546|NCT00355082|449108315|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
124859547|NCT00355082|449108316|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
124859548|NCT00355082|449108317|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
124859549|NCT00355082|449108315|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
124859550|NCT00355082|449108316|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
124859551|NCT00355082|449108317|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
124859552|NCT00355082|449108315|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
124859553|NCT00355082|449108316|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
124859554|NCT00355082|449108317|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
124859555|NCT00355082|449108315|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
124859556|NCT00355082|449108316|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
124859557|NCT00355082|449108317|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
124859558|NCT00355082|449108315|FG000|Continuation Phase|Adverse Event|2|||
124859559|NCT00355082|449108316|FG001|Continuation Phase|Adverse Event|0|||
124859560|NCT00355082|449108317|FG002|Continuation Phase|Adverse Event|1|||
124859561|NCT00355082|449108315|FG000|Continuation Phase|Lost to Follow-up|2|||
124859562|NCT00355082|449108316|FG001|Continuation Phase|Lost to Follow-up|0|||
124859563|NCT00355082|449108317|FG002|Continuation Phase|Lost to Follow-up|1|||
124859564|NCT00355082|449108315|FG000|Continuation Phase|Protocol Violation|1|||
124859565|NCT00355082|449108316|FG001|Continuation Phase|Protocol Violation|0|||
124859566|NCT00355082|449108317|FG002|Continuation Phase|Protocol Violation|1|||
124859567|NCT00355082|449108315|FG000|Continuation Phase|Withdrawal by Subject|4|||
124859568|NCT00355082|449108316|FG001|Continuation Phase|Withdrawal by Subject|0|||
124859569|NCT00355082|449108317|FG002|Continuation Phase|Withdrawal by Subject|0|||
124859570|NCT00355082|449108315|FG000|Continuation Phase|Lack of Efficacy|5|||
124859571|NCT00355082|449108316|FG001|Continuation Phase|Lack of Efficacy|0|||
124859572|NCT00355082|449108317|FG002|Continuation Phase|Lack of Efficacy|0|||
124859573|NCT00355082|449108315|FG000|Continuation Phase|Site Closed by Sponsor|8|||
124859574|NCT00355082|449108316|FG001|Continuation Phase|Site Closed by Sponsor|0|||
124859575|NCT00355082|449108317|FG002|Continuation Phase|Site Closed by Sponsor|0|||
124859576|NCT00355082|449108315|FG000|Continuation Phase|Scheduling Error|1|||
124859577|NCT00355082|449108316|FG001|Continuation Phase|Scheduling Error|0|||
124859578|NCT00355082|449108317|FG002|Continuation Phase|Scheduling Error|0|||
124859579|NCT00355082|449108315|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
124859580|NCT00355082|449108316|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
124859581|NCT00355082|449108317|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
124859582|NCT04323436|449108318|FG000|Overall Study|Adverse Event|7|||
124859583|NCT04323436|449108319|FG001|Overall Study|Adverse Event|0|||
124859584|NCT04323436|449108320|FG002|Overall Study|Adverse Event|0|||
124859585|NCT04323436|449108318|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
124859586|NCT04323436|449108319|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
124859587|NCT04323436|449108320|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
124859588|NCT04323436|449108318|FG000|Overall Study|Death|1|||
124859589|NCT04323436|449108319|FG001|Overall Study|Death|0|||
124859590|NCT04323436|449108320|FG002|Overall Study|Death|0|||
124859591|NCT04323436|449108318|FG000|Overall Study|Physician Decision|2|||
124859592|NCT04323436|449108319|FG001|Overall Study|Physician Decision|0|||
124859593|NCT04323436|449108320|FG002|Overall Study|Physician Decision|0|||
124859594|NCT04323436|449108318|FG000|Overall Study|Progressive disease|10|||
124859595|NCT04323436|449108319|FG001|Overall Study|Progressive disease|0|||
124859596|NCT04323436|449108320|FG002|Overall Study|Progressive disease|0|||
124859597|NCT04323436|449108318|FG000|Overall Study|Subject decision|3|||
124859598|NCT04323436|449108319|FG001|Overall Study|Subject decision|0|||
124859599|NCT04323436|449108320|FG002|Overall Study|Subject decision|0|||
124859600|NCT01660763|449108324|FG000|Overall Study|Lack of Efficacy|45|||
124859601|NCT01660763|449108325|FG001|Overall Study|Lack of Efficacy|50|||
124859602|NCT01660763|449108324|FG000|Overall Study|Adverse Event|22|||
124859603|NCT01660763|449108325|FG001|Overall Study|Adverse Event|7|||
124859604|NCT01660763|449108324|FG000|Overall Study|Protocol Violation|1|||
124859605|NCT01660763|449108325|FG001|Overall Study|Protocol Violation|0|||
124859606|NCT01660763|449108324|FG000|Overall Study|Withdrawal by Subject|4|||
124859607|NCT01660763|449108325|FG001|Overall Study|Withdrawal by Subject|0|||
124859608|NCT01660763|449108324|FG000|Overall Study|Patient ready for early discharge|28|||
124859609|NCT01660763|449108325|FG001|Overall Study|Patient ready for early discharge|4|||
124859610|NCT03325712|449108326|FG000|Overall Study|Protocol Violation|0|||
124859611|NCT03325712|449108327|FG001|Overall Study|Protocol Violation|0|||
124859612|NCT03325712|449108328|FG002|Overall Study|Protocol Violation|0|||
124859613|NCT03325712|449108329|FG003|Overall Study|Protocol Violation|0|||
124859614|NCT03325712|449108330|FG004|Overall Study|Protocol Violation|1|||
124859615|NCT03325712|449108331|FG005|Overall Study|Protocol Violation|0|||
124859616|NCT03325712|449108332|FG006|Overall Study|Protocol Violation|0|||
124859617|NCT03325712|449108333|FG007|Overall Study|Protocol Violation|0|||
124859618|NCT03325712|449108326|FG000|Overall Study|Adverse Event|0|||
124859619|NCT03325712|449108327|FG001|Overall Study|Adverse Event|0|||
124859620|NCT03325712|449108328|FG002|Overall Study|Adverse Event|0|||
124859621|NCT03325712|449108329|FG003|Overall Study|Adverse Event|0|||
124859622|NCT03325712|449108330|FG004|Overall Study|Adverse Event|1|||
124859623|NCT03325712|449108331|FG005|Overall Study|Adverse Event|0|||
124859624|NCT03325712|449108332|FG006|Overall Study|Adverse Event|0|||
124859625|NCT03325712|449108333|FG007|Overall Study|Adverse Event|0|||
124859626|NCT02265237|449108335|FG000|As Treated (Overall Study)|Adverse Event|1|||
124859627|NCT02265237|449108336|FG001|As Treated (Overall Study)|Adverse Event|1|||
124859628|NCT02265237|449108337|FG002|As Treated (Overall Study)|Adverse Event|0|||
124859629|NCT02265237|449108338|FG003|As Treated (Overall Study)|Adverse Event|0|||
124859630|NCT02265237|449108335|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
124859631|NCT02265237|449108336|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
124859632|NCT02265237|449108337|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
124859633|NCT02265237|449108338|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
124859634|NCT02265237|449108335|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
124859635|NCT02265237|449108336|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
124859636|NCT02265237|449108337|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
124859637|NCT02265237|449108338|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
124859638|NCT02265237|449108335|FG000|As Treated (Overall Study)|Other|2|||
124859639|NCT02265237|449108336|FG001|As Treated (Overall Study)|Other|0|||
124859640|NCT02265237|449108337|FG002|As Treated (Overall Study)|Other|3|||
124859641|NCT02265237|449108338|FG003|As Treated (Overall Study)|Other|1|||
124859642|NCT01178853|449108340|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
124859643|NCT01178853|449108341|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
124859644|NCT01178853|449108340|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
124859645|NCT01178853|449108341|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
124859646|NCT01178853|449108340|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
124859647|NCT01178853|449108341|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
124859648|NCT01178853|449108340|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
124859649|NCT01178853|449108341|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
124859650|NCT01178853|449108340|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
124859651|NCT01178853|449108341|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
124859652|NCT03550313|449108342|FG000|Overall Study|Adverse Event|0|||
124859653|NCT03550313|449108343|FG001|Overall Study|Adverse Event|1|||
124859654|NCT03550313|449108344|FG002|Overall Study|Adverse Event|0|||
124859655|NCT03550313|449108342|FG000|Overall Study|Lost to Follow-up|5|||
124859656|NCT03550313|449108343|FG001|Overall Study|Lost to Follow-up|7|||
124859657|NCT03550313|449108344|FG002|Overall Study|Lost to Follow-up|12|||
124859658|NCT03550313|449108342|FG000|Overall Study|Study terminated by sponsor|44|||
124859659|NCT03550313|449108343|FG001|Overall Study|Study terminated by sponsor|37|||
124859660|NCT03550313|449108344|FG002|Overall Study|Study terminated by sponsor|48|||
124859661|NCT03550313|449108342|FG000|Overall Study|No longer met eligibility criteria|3|||
124859662|NCT03550313|449108343|FG001|Overall Study|No longer met eligibility criteria|5|||
124859663|NCT03550313|449108344|FG002|Overall Study|No longer met eligibility criteria|6|||
124859664|NCT03550313|449108342|FG000|Overall Study|Withdrawal by parent/guardian|20|||
124859665|NCT03550313|449108343|FG001|Overall Study|Withdrawal by parent/guardian|18|||
124859666|NCT03550313|449108344|FG002|Overall Study|Withdrawal by parent/guardian|26|||
124859667|NCT03550313|449108342|FG000|Overall Study|Other|4|||
124859668|NCT03550313|449108343|FG001|Overall Study|Other|2|||
124859669|NCT03550313|449108344|FG002|Overall Study|Other|2|||
124859670|NCT03550313|449108342|FG000|Overall Study|Randomized but not vaccinated|3|||
124859671|NCT03550313|449108343|FG001|Overall Study|Randomized but not vaccinated|23|||
124859672|NCT03550313|449108344|FG002|Overall Study|Randomized but not vaccinated|2|||
124859673|NCT03550313|449108342|FG000|Overall Study|Sites terminated due to quality issues|18|||
124859674|NCT03550313|449108343|FG001|Overall Study|Sites terminated due to quality issues|17|||
124859675|NCT03550313|449108344|FG002|Overall Study|Sites terminated due to quality issues|18|||
124859676|NCT00839072|449108345|FG000|First Intervention Period|Withdrawal by Subject|1|||
124859677|NCT00839072|449108346|FG001|First Intervention Period|Withdrawal by Subject|0|||
124859678|NCT00839072|449108345|FG000|First Intervention Period|Adverse Event|1|||
124859679|NCT00839072|449108346|FG001|First Intervention Period|Adverse Event|1|||
124859680|NCT00839072|449108345|FG000|Second Intervention Period|Withdrawal by Subject|1|||
124859681|NCT00839072|449108346|FG001|Second Intervention Period|Withdrawal by Subject|0|||
124859682|NCT00380068|449108348|FG000|Overall Study|Adverse Event|40|||
124859683|NCT00380068|449108348|FG000|Overall Study|Withdrawal by Subject|10|||
124859684|NCT00380068|449108348|FG000|Overall Study|Not compliant|6|||
124859685|NCT00380068|449108348|FG000|Overall Study|Lost to Follow-up|1|||
124859686|NCT00380068|449108348|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
124859687|NCT00380068|449108348|FG000|Overall Study|Lung transplant|3|||
124859688|NCT00380068|449108348|FG000|Overall Study|Physician Decision|2|||
124859689|NCT00380068|449108348|FG000|Overall Study|Partipant moved away|1|||
124859690|NCT00380068|449108348|FG000|Overall Study|Lack of Efficacy|5|||
124859691|NCT01297062|449108349|FG000|Overall Study|Adverse Event|2|||
124859692|NCT01297062|449108350|FG001|Overall Study|Adverse Event|0|||
124859693|NCT01297062|449108351|FG002|Overall Study|Adverse Event|1|||
124859694|NCT01297062|449108352|FG003|Overall Study|Adverse Event|0|||
124859695|NCT01297062|449108353|FG004|Overall Study|Adverse Event|0|||
124859696|NCT01297062|449108354|FG005|Overall Study|Adverse Event|0|||
124859697|NCT01297062|449108355|FG006|Overall Study|Adverse Event|0|||
124859698|NCT01297062|449108349|FG000|Overall Study|Physician Decision|1|||
124859699|NCT01297062|449108350|FG001|Overall Study|Physician Decision|0|||
124859700|NCT01297062|449108351|FG002|Overall Study|Physician Decision|1|||
124859701|NCT01297062|449108352|FG003|Overall Study|Physician Decision|0|||
124859702|NCT01297062|449108353|FG004|Overall Study|Physician Decision|0|||
124859703|NCT01297062|449108354|FG005|Overall Study|Physician Decision|0|||
124859704|NCT01297062|449108355|FG006|Overall Study|Physician Decision|6|||
124859705|NCT01297062|449108349|FG000|Overall Study|Protocol Violation|0|||
124859706|NCT01297062|449108350|FG001|Overall Study|Protocol Violation|0|||
124859707|NCT01297062|449108351|FG002|Overall Study|Protocol Violation|0|||
124859708|NCT01297062|449108352|FG003|Overall Study|Protocol Violation|0|||
124859709|NCT01297062|449108353|FG004|Overall Study|Protocol Violation|1|||
124859710|NCT01297062|449108354|FG005|Overall Study|Protocol Violation|0|||
124859711|NCT01297062|449108355|FG006|Overall Study|Protocol Violation|0|||
124859712|NCT01297062|449108349|FG000|Overall Study|Subject Decision|1|||
124859713|NCT01297062|449108350|FG001|Overall Study|Subject Decision|1|||
124859714|NCT01297062|449108351|FG002|Overall Study|Subject Decision|0|||
124859715|NCT01297062|449108352|FG003|Overall Study|Subject Decision|1|||
124859716|NCT01297062|449108353|FG004|Overall Study|Subject Decision|1|||
124859717|NCT01297062|449108354|FG005|Overall Study|Subject Decision|1|||
124859718|NCT01297062|449108355|FG006|Overall Study|Subject Decision|2|||
124859719|NCT01458574|449108356|FG000|Overall Study|Adverse Event|5|||
124859720|NCT01458574|449108357|FG001|Overall Study|Adverse Event|9|||
124859721|NCT01458574|449108358|FG002|Overall Study|Adverse Event|7|||
124859722|NCT01458574|449108356|FG000|Overall Study|Lack of Efficacy|70|||
124859723|NCT01458574|449108357|FG001|Overall Study|Lack of Efficacy|53|||
124859724|NCT01458574|449108358|FG002|Overall Study|Lack of Efficacy|132|||
124859725|NCT01458574|449108356|FG000|Overall Study|Lost to Follow-up|3|||
124859726|NCT01458574|449108357|FG001|Overall Study|Lost to Follow-up|2|||
124859727|NCT01458574|449108358|FG002|Overall Study|Lost to Follow-up|1|||
124859728|NCT01458574|449108356|FG000|Overall Study|Pregnancy|1|||
124859729|NCT01458574|449108357|FG001|Overall Study|Pregnancy|1|||
124859730|NCT01458574|449108358|FG002|Overall Study|Pregnancy|0|||
124859731|NCT01458574|449108356|FG000|Overall Study|Protocol Violation|0|||
124859732|NCT01458574|449108357|FG001|Overall Study|Protocol Violation|1|||
124859733|NCT01458574|449108358|FG002|Overall Study|Protocol Violation|0|||
124859734|NCT01458574|449108356|FG000|Overall Study|Withdrawal by Subject|6|||
124859735|NCT01458574|449108357|FG001|Overall Study|Withdrawal by Subject|3|||
124859736|NCT01458574|449108358|FG002|Overall Study|Withdrawal by Subject|5|||
124859737|NCT01458574|449108356|FG000|Overall Study|Other|2|||
124859738|NCT01458574|449108357|FG001|Overall Study|Other|1|||
124859739|NCT01458574|449108358|FG002|Overall Study|Other|0|||
124859740|NCT01458574|449108356|FG000|Overall Study|Randomized but not treated|0|||
124859741|NCT01458574|449108357|FG001|Overall Study|Randomized but not treated|1|||
124859742|NCT01458574|449108358|FG002|Overall Study|Randomized but not treated|0|||
124859743|NCT02125786|449108359|FG000|Overall Study|Still in Follow-up|3|||
124859744|NCT02125786|449108359|FG000|Overall Study|Screen Failure|2|||
124859745|NCT02125786|449108359|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
124859746|NCT02125786|449108359|FG000|Overall Study|Progressive Disease|44|||
124859747|NCT02125786|449108359|FG000|Overall Study|Death|8|||
124859748|NCT04964089|449108360|FG000|Overall Study|Adverse Event|8|||
124859749|NCT04964089|449108361|FG001|Overall Study|Adverse Event|6|||
124859750|NCT04964089|449108360|FG000|Overall Study|Non-compliance with study schedule|1|||
124859751|NCT04964089|449108361|FG001|Overall Study|Non-compliance with study schedule|0|||
124859752|NCT04964089|449108360|FG000|Overall Study|Withdrawal by Subject|6|||
124859753|NCT04964089|449108361|FG001|Overall Study|Withdrawal by Subject|5|||
124859754|NCT04964089|449108360|FG000|Overall Study|Lost to Follow-up|1|||
124859755|NCT04964089|449108361|FG001|Overall Study|Lost to Follow-up|1|||
124859756|NCT04964089|449108360|FG000|Overall Study|Progressive disease|4|||
124859757|NCT04964089|449108361|FG001|Overall Study|Progressive disease|0|||
124859758|NCT04964089|449108360|FG000|Overall Study|Physician Decision|1|||
124859759|NCT04964089|449108361|FG001|Overall Study|Physician Decision|0|||
124859760|NCT04964089|449108360|FG000|Overall Study|Participant did not want to continue study treatment|1|||
124859761|NCT04964089|449108361|FG001|Overall Study|Participant did not want to continue study treatment|0|||
124859762|NCT04964089|449108360|FG000|Overall Study|Participant moved to different state|1|||
124859763|NCT04964089|449108361|FG001|Overall Study|Participant moved to different state|0|||
124859764|NCT04964089|449108360|FG000|Overall Study|Participant decided to discontinue|0|||
124859765|NCT04964089|449108361|FG001|Overall Study|Participant decided to discontinue|1|||
124859766|NCT01682837|449108362|FG000|Baseline|Withdrawal by Subject|5|||
124859767|NCT01196975|449108363|FG000|Overall Study|Adverse Event|2|||
124859768|NCT01196975|449108364|FG001|Overall Study|Adverse Event|2|||
124859769|NCT01196975|449108365|FG002|Overall Study|Adverse Event|0|||
124859770|NCT01196975|449108366|FG003|Overall Study|Adverse Event|0|||
124859771|NCT01196975|449108367|FG004|Overall Study|Adverse Event|2|||
124859772|NCT01196975|449108363|FG000|Overall Study|Withdrawal by Subject|2|||
124859773|NCT01196975|449108364|FG001|Overall Study|Withdrawal by Subject|1|||
124859774|NCT01196975|449108365|FG002|Overall Study|Withdrawal by Subject|0|||
124859775|NCT01196975|449108366|FG003|Overall Study|Withdrawal by Subject|1|||
124859776|NCT01196975|449108367|FG004|Overall Study|Withdrawal by Subject|0|||
124859777|NCT01196975|449108363|FG000|Overall Study|Lost to Follow-up|11|||
124859778|NCT01196975|449108364|FG001|Overall Study|Lost to Follow-up|6|||
124859779|NCT01196975|449108365|FG002|Overall Study|Lost to Follow-up|5|||
124859780|NCT01196975|449108366|FG003|Overall Study|Lost to Follow-up|5|||
124859781|NCT01196975|449108367|FG004|Overall Study|Lost to Follow-up|11|||
124859782|NCT01365494|449108368|FG000|Overall Study|Adverse Event|1|||
124859783|NCT01365494|449108369|FG001|Overall Study|Adverse Event|0|||
124859784|NCT01365494|449108368|FG000|Overall Study|Withdrawal by Subject|0|||
124859785|NCT01365494|449108369|FG001|Overall Study|Withdrawal by Subject|1|||
124859786|NCT01365494|449108368|FG000|Overall Study|Lost to Follow-up|1|||
124859787|NCT01365494|449108369|FG001|Overall Study|Lost to Follow-up|2|||
124859788|NCT03086447|449108374|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
124859789|NCT03086447|449108375|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
124859790|NCT03086447|449108374|FG000|Overall Study|Lost Lens|2|||
124859791|NCT03086447|449108375|FG001|Overall Study|Lost Lens|5|||
124859792|NCT03086447|449108374|FG000|Overall Study|Product quality complaint|0|||
124859793|NCT03086447|449108375|FG001|Overall Study|Product quality complaint|1|||
124859794|NCT03086447|449108374|FG000|Overall Study|Lens Damage|1|||
124859795|NCT03086447|449108375|FG001|Overall Study|Lens Damage|6|||
124859796|NCT03086447|449108374|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
124859797|NCT03086447|449108375|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
124859798|NCT03086447|449108374|FG000|Overall Study|Test Article No Longer Available|1|||
124859799|NCT03086447|449108375|FG001|Overall Study|Test Article No Longer Available|0|||
124859800|NCT03086447|449108374|FG000|Overall Study|Protocol Violation|2|||
124859801|NCT03086447|449108375|FG001|Overall Study|Protocol Violation|4|||
124859802|NCT03086447|449108374|FG000|Overall Study|Lost to Follow-up|0|||
124859803|NCT03086447|449108375|FG001|Overall Study|Lost to Follow-up|1|||
124859804|NCT03086447|449108374|FG000|Overall Study|Adverse Event|3|||
124859805|NCT03086447|449108375|FG001|Overall Study|Adverse Event|0|||
124859806|NCT03086447|449108374|FG000|Overall Study|Lens Discomfort|2|||
124859807|NCT03086447|449108375|FG001|Overall Study|Lens Discomfort|1|||
124859808|NCT03394924|449108379|FG000|Overall Study|Adverse Event|0|||
124859809|NCT03394924|449108380|FG001|Overall Study|Adverse Event|5|||
124859810|NCT03394924|449108381|FG002|Overall Study|Adverse Event|0|||
124859811|NCT03394924|449108379|FG000|Overall Study|Withdrawal by Subject|2|||
124859812|NCT03394924|449108380|FG001|Overall Study|Withdrawal by Subject|0|||
124859813|NCT03394924|449108381|FG002|Overall Study|Withdrawal by Subject|0|||
124859814|NCT03394924|449108379|FG000|Overall Study|Lost to Follow-up|0|||
124859815|NCT03394924|449108380|FG001|Overall Study|Lost to Follow-up|1|||
124859816|NCT03394924|449108381|FG002|Overall Study|Lost to Follow-up|0|||
124859817|NCT03394924|449108379|FG000|Overall Study|Did not meet all inclusion criteria|1|||
124859818|NCT03394924|449108380|FG001|Overall Study|Did not meet all inclusion criteria|0|||
124859819|NCT03394924|449108381|FG002|Overall Study|Did not meet all inclusion criteria|0|||
124859820|NCT03588572|449108384|FG000|Visitation 1|Lack of Efficacy|1|||
124859821|NCT03588572|449108385|FG001|Visitation 1|Lack of Efficacy|1|||
124859822|NCT03588572|449108384|FG000|Visitation 2|Lost to Follow-up|1|||
124859823|NCT03588572|449108385|FG001|Visitation 2|Lost to Follow-up|1|||
124859824|NCT03588572|449108384|FG000|Visitation 2|Lack of Efficacy|0|||
124859825|NCT03588572|449108385|FG001|Visitation 2|Lack of Efficacy|1|||
124859826|NCT03588572|449108384|FG000|Visitation 2|Withdrawal by Subject|1|||
124859827|NCT03588572|449108385|FG001|Visitation 2|Withdrawal by Subject|0|||
124859828|NCT03588572|449108384|FG000|Visitation 3|Lost to Follow-up|1|||
124859829|NCT03588572|449108385|FG001|Visitation 3|Lost to Follow-up|1|||
124859830|NCT03588572|449108384|FG000|Visitation 3|Physician Decision|1|||
124859831|NCT03588572|449108385|FG001|Visitation 3|Physician Decision|1|||
124859832|NCT03588572|449108384|FG000|Visitation 3|Withdrawal by Subject|1|||
124859833|NCT03588572|449108385|FG001|Visitation 3|Withdrawal by Subject|0|||
124859834|NCT00364858|449108388|FG000|Overall Study|Adverse Event|1|||
124859835|NCT00364858|449108389|FG001|Overall Study|Adverse Event|5|||
124859836|NCT00364858|449108388|FG000|Overall Study|Withdrawal by Subject|1|||
124859837|NCT00364858|449108389|FG001|Overall Study|Withdrawal by Subject|1|||
124859838|NCT00364858|449108388|FG000|Overall Study|Pregnancy|1|||
124859839|NCT00364858|449108389|FG001|Overall Study|Pregnancy|1|||
124859840|NCT00364858|449108388|FG000|Overall Study|Clinical failure|2|||
124859841|NCT00364858|449108389|FG001|Overall Study|Clinical failure|13|||
124859842|NCT00364858|449108388|FG000|Overall Study|Discontinuation at baseline|1|||
124859843|NCT00364858|449108389|FG001|Overall Study|Discontinuation at baseline|0|||
124859844|NCT00364858|449108388|FG000|Overall Study|Non-compliant|1|||
124859845|NCT00364858|449108389|FG001|Overall Study|Non-compliant|0|||
124859846|NCT00364858|449108388|FG000|Overall Study|Return to Q2 regimen|0|||
124859847|NCT00364858|449108389|FG001|Overall Study|Return to Q2 regimen|1|||
124859848|NCT00364858|449108388|FG000|Overall Study|Clinical baseline issue|0|||
124859849|NCT00364858|449108389|FG001|Overall Study|Clinical baseline issue|1|||
124859850|NCT00627705|449108390|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
124859851|NCT00627705|449108391|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
124859852|NCT00627705|449108390|FG000|Overall Study|Adverse Event|1|||
124859853|NCT00627705|449108391|FG001|Overall Study|Adverse Event|0|||
124859854|NCT00627705|449108390|FG000|Overall Study|Withdrawal by Subject|0|||
124859855|NCT00627705|449108391|FG001|Overall Study|Withdrawal by Subject|2|||
124859856|NCT00627705|449108390|FG000|Overall Study|Lost to Follow-up|0|||
124859857|NCT00627705|449108391|FG001|Overall Study|Lost to Follow-up|1|||
124859858|NCT02535065|449108400|FG000|Overall Study|Death|13|||
124859859|NCT02535065|449108400|FG000|Overall Study|Lost to Follow-up|1|||
124859860|NCT02535065|449108400|FG000|Overall Study|Withdrawal by Subject|6|||
124859861|NCT00110617|449108401|FG000|Overall Study|Adverse Event|2|||
124859862|NCT00110617|449108402|FG001|Overall Study|Adverse Event|4|||
124859863|NCT00110617|449108401|FG000|Overall Study|Abnormal Laboratory Value|4|||
124859864|NCT00110617|449108402|FG001|Overall Study|Abnormal Laboratory Value|2|||
124859865|NCT00110617|449108401|FG000|Overall Study|Lack of Efficacy|1|||
124859866|NCT00110617|449108402|FG001|Overall Study|Lack of Efficacy|0|||
124859867|NCT00110617|449108401|FG000|Overall Study|Patient no longer requires study drug|1|||
124859868|NCT00110617|449108402|FG001|Overall Study|Patient no longer requires study drug|0|||
124859869|NCT00110617|449108401|FG000|Overall Study|Protocol Violation|5|||
124859870|NCT00110617|449108402|FG001|Overall Study|Protocol Violation|0|||
124859871|NCT00110617|449108401|FG000|Overall Study|Withdrawal by Subject|10|||
124859872|NCT00110617|449108402|FG001|Overall Study|Withdrawal by Subject|4|||
124859873|NCT00110617|449108401|FG000|Overall Study|Lost to Follow-up|9|||
124859874|NCT00110617|449108402|FG001|Overall Study|Lost to Follow-up|1|||
124859875|NCT00110617|449108401|FG000|Overall Study|Administrative problems|6|||
124859876|NCT00110617|449108402|FG001|Overall Study|Administrative problems|5|||
124859877|NCT00110617|449108401|FG000|Overall Study|Death|1|||
124859878|NCT00110617|449108402|FG001|Overall Study|Death|1|||
124859879|NCT00110617|449108401|FG000|Overall Study|Did not receive study drug|0|||
124859880|NCT00110617|449108402|FG001|Overall Study|Did not receive study drug|12|||
124859881|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
124859882|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
124859883|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
124859884|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
124859885|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
124859886|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
124859887|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
124859888|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
124859889|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
124859890|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
124859891|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
124859892|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
124859893|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
124859894|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
124859895|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
124859896|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
124859897|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
124859898|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
124859899|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
124859900|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
124859901|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
124859902|NCT01781572|449108403|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
124859903|NCT01781572|449108404|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
124859904|NCT01781572|449108405|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
124859905|NCT01781572|449108403|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
124859906|NCT01781572|449108404|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
124859907|NCT01781572|449108405|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
124859908|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
124859909|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
124859910|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
124859911|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
124859912|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
124859913|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
124859914|NCT01781572|449108403|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
124859915|NCT01781572|449108404|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
124859916|NCT01781572|449108405|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
124859917|NCT01781572|449108403|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
124859918|NCT01781572|449108404|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
124859919|NCT01781572|449108405|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
124859920|NCT01781572|449108403|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
124859921|NCT01781572|449108404|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
124859922|NCT01781572|449108405|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
124859923|NCT01781572|449108403|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
124859924|NCT01781572|449108404|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
124859925|NCT01781572|449108405|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
124859926|NCT01781572|449108403|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
124859927|NCT01781572|449108404|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
124859928|NCT01781572|449108405|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
124859929|NCT01781572|449108403|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
124859930|NCT01781572|449108404|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
124859931|NCT01781572|449108405|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
124859932|NCT01781572|449108403|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
124859933|NCT01781572|449108404|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
124859934|NCT01781572|449108405|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
124859935|NCT00045110|449108406|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
124859936|NCT00045110|449108407|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
124859937|NCT00045110|449108408|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
124859938|NCT00045110|449108406|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
124859939|NCT00045110|449108407|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
124859940|NCT00045110|449108408|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
124859941|NCT00045110|449108406|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
124859942|NCT00045110|449108407|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
124859943|NCT00045110|449108408|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
124859944|NCT00660010|449108409|FG000|Overall Study|Withdrawal by Subject|2|||
124859945|NCT00660010|449108409|FG000|Overall Study|Lost to Follow-up|3|||
124859946|NCT00660010|449108409|FG000|Overall Study|Adverse Event|1|||
124859947|NCT00660010|449108409|FG000|Overall Study|Noncompliance with visit schedule|3|||
124859948|NCT04827576|449110066|FG000|Overall Study|Death|5|||
124859949|NCT04827576|449110067|FG001|Overall Study|Death|17|||
124859950|NCT04827576|449110068|FG002|Overall Study|Death|17|||
124859951|NCT04827576|449110069|FG003|Overall Study|Death|32|||
124859952|NCT04827576|449110066|FG000|Overall Study|Study Terminated by Sponsor|2|||
124859953|NCT04827576|449110067|FG001|Overall Study|Study Terminated by Sponsor|9|||
124859954|NCT04827576|449110068|FG002|Overall Study|Study Terminated by Sponsor|7|||
124859955|NCT04827576|449110069|FG003|Overall Study|Study Terminated by Sponsor|5|||
124859956|NCT04827576|449110066|FG000|Overall Study|Investigator's Discretion|1|||
124859957|NCT04827576|449110067|FG001|Overall Study|Investigator's Discretion|0|||
124859958|NCT04827576|449110068|FG002|Overall Study|Investigator's Discretion|2|||
124859959|NCT04827576|449110069|FG003|Overall Study|Investigator's Discretion|5|||
124859960|NCT04827576|449110066|FG000|Overall Study|Withdrew Consent|0|||
124859961|NCT04827576|449110067|FG001|Overall Study|Withdrew Consent|3|||
124859962|NCT04827576|449110068|FG002|Overall Study|Withdrew Consent|0|||
124859963|NCT04827576|449110069|FG003|Overall Study|Withdrew Consent|0|||
124859964|NCT04827576|449110066|FG000|Overall Study|Lost to Follow-up|1|||
124859965|NCT04827576|449110067|FG001|Overall Study|Lost to Follow-up|0|||
124859966|NCT04827576|449110068|FG002|Overall Study|Lost to Follow-up|0|||
124859967|NCT04827576|449110069|FG003|Overall Study|Lost to Follow-up|0|||
124859968|NCT03069482|449110070|FG000|Overall Study|Lost to Follow-up|0|||
124859969|NCT03069482|449110071|FG001|Overall Study|Lost to Follow-up|1|||
124859970|NCT03069482|449110070|FG000|Overall Study|Physician Decision|1|||
124859971|NCT03069482|449110071|FG001|Overall Study|Physician Decision|0|||
124859972|NCT04537923|449110072|FG000|Overall Study|Adverse Event|2|||
124859973|NCT04537923|449110073|FG001|Overall Study|Adverse Event|1|||
124859974|NCT04537923|449110074|FG002|Overall Study|Adverse Event|2|||
124859975|NCT04537923|449110075|FG003|Overall Study|Adverse Event|4|||
124859976|NCT04537923|449110072|FG000|Overall Study|Death|3|||
124859977|NCT04537923|449110073|FG001|Overall Study|Death|3|||
124859978|NCT04537923|449110074|FG002|Overall Study|Death|1|||
124859979|NCT04537923|449110075|FG003|Overall Study|Death|11|||
124859980|NCT04537923|449110072|FG000|Overall Study|Lost to Follow-up|1|||
124859981|NCT04537923|449110073|FG001|Overall Study|Lost to Follow-up|2|||
124859982|NCT04537923|449110074|FG002|Overall Study|Lost to Follow-up|1|||
124859983|NCT04537923|449110075|FG003|Overall Study|Lost to Follow-up|6|||
124859984|NCT04537923|449110072|FG000|Overall Study|Physician Decision|1|||
124859985|NCT04537923|449110073|FG001|Overall Study|Physician Decision|0|||
124859986|NCT04537923|449110074|FG002|Overall Study|Physician Decision|2|||
124859987|NCT04537923|449110075|FG003|Overall Study|Physician Decision|5|||
124859988|NCT04537923|449110072|FG000|Overall Study|Pregnancy|1|||
124859989|NCT04537923|449110073|FG001|Overall Study|Pregnancy|0|||
124859990|NCT04537923|449110074|FG002|Overall Study|Pregnancy|0|||
124859991|NCT04537923|449110075|FG003|Overall Study|Pregnancy|0|||
124859992|NCT04537923|449110072|FG000|Overall Study|Withdrawal by Subject|4|||
124859993|NCT04537923|449110073|FG001|Overall Study|Withdrawal by Subject|4|||
124859994|NCT04537923|449110074|FG002|Overall Study|Withdrawal by Subject|4|||
124859995|NCT04537923|449110075|FG003|Overall Study|Withdrawal by Subject|58|||
124859996|NCT04537923|449110072|FG000|Overall Study|Missed study visits|2|||
124859997|NCT04537923|449110073|FG001|Overall Study|Missed study visits|0|||
124859998|NCT04537923|449110074|FG002|Overall Study|Missed study visits|0|||
124859999|NCT04537923|449110075|FG003|Overall Study|Missed study visits|3|||
124860000|NCT04537923|449110072|FG000|Overall Study|Sponsor's decision|0|||
124860001|NCT04537923|449110073|FG001|Overall Study|Sponsor's decision|0|||
124860002|NCT04537923|449110074|FG002|Overall Study|Sponsor's decision|1|||
124860003|NCT04537923|449110075|FG003|Overall Study|Sponsor's decision|1|||
124860004|NCT04537923|449110072|FG000|Overall Study|Safety reasons|1|||
124860005|NCT04537923|449110073|FG001|Overall Study|Safety reasons|0|||
124860006|NCT04537923|449110074|FG002|Overall Study|Safety reasons|0|||
124860007|NCT04537923|449110075|FG003|Overall Study|Safety reasons|0|||
124860008|NCT01261611|449110076|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
124860009|NCT01261611|449110077|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
124860010|NCT01261611|449110078|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
124860011|NCT01261611|449110076|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
124860012|NCT01261611|449110077|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
124860013|NCT01261611|449110078|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
124860014|NCT01261611|449110076|FG000|Treatment Cycle 1|Adverse Event|0|||
124860015|NCT01261611|449110077|FG001|Treatment Cycle 1|Adverse Event|1|||
124860016|NCT01261611|449110078|FG002|Treatment Cycle 1|Adverse Event|0|||
124860017|NCT01261611|449110076|FG000|Treatment Cycle 1|Protocol Violation|0|||
124860018|NCT01261611|449110077|FG001|Treatment Cycle 1|Protocol Violation|0|||
124860019|NCT01261611|449110078|FG002|Treatment Cycle 1|Protocol Violation|2|||
124860020|NCT01261611|449110076|FG000|Treatment Cycle 2|Completed study|4|||
124860021|NCT01261611|449110077|FG001|Treatment Cycle 2|Completed study|0|||
124860022|NCT01261611|449110078|FG002|Treatment Cycle 2|Completed study|0|||
124860023|NCT01261611|449110076|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
124860024|NCT01261611|449110077|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
124860025|NCT01261611|449110078|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
124860026|NCT01261611|449110076|FG000|Treatment Cycle 2|Adverse Event|1|||
124860027|NCT01261611|449110077|FG001|Treatment Cycle 2|Adverse Event|0|||
124860028|NCT01261611|449110078|FG002|Treatment Cycle 2|Adverse Event|0|||
124860029|NCT01261611|449110076|FG000|Treatment Cycle 2|Protocol Violation|2|||
124860030|NCT01261611|449110077|FG001|Treatment Cycle 2|Protocol Violation|0|||
124860031|NCT01261611|449110078|FG002|Treatment Cycle 2|Protocol Violation|0|||
124860032|NCT01261611|449110076|FG000|Treatment Cycle 2|Not otherwise specified|2|||
124860033|NCT01261611|449110077|FG001|Treatment Cycle 2|Not otherwise specified|0|||
124860034|NCT01261611|449110078|FG002|Treatment Cycle 2|Not otherwise specified|0|||
124860035|NCT01261611|449110076|FG000|Treatment Cycle 3|Completed study|24|||
124860036|NCT01261611|449110077|FG001|Treatment Cycle 3|Completed study|0|||
124860037|NCT01261611|449110078|FG002|Treatment Cycle 3|Completed study|0|||
124860038|NCT01261611|449110076|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
124860039|NCT01261611|449110077|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
124860040|NCT01261611|449110078|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
124860041|NCT01261611|449110076|FG000|Treatment Cycle 3|Adverse Event|1|||
124860042|NCT01261611|449110077|FG001|Treatment Cycle 3|Adverse Event|0|||
124860043|NCT01261611|449110078|FG002|Treatment Cycle 3|Adverse Event|0|||
124860044|NCT01261611|449110076|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
124860045|NCT01261611|449110077|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
124860046|NCT01261611|449110078|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
124860047|NCT01261611|449110076|FG000|Treatment Cycle 4|Completed study|87|||
124860048|NCT01261611|449110077|FG001|Treatment Cycle 4|Completed study|0|||
124860049|NCT01261611|449110078|FG002|Treatment Cycle 4|Completed study|0|||
124860050|NCT01261611|449110076|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
124860051|NCT01261611|449110077|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
124860052|NCT01261611|449110078|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
124860053|NCT01261611|449110076|FG000|Treatment Cycle 4|Adverse Event|1|||
124860054|NCT01261611|449110077|FG001|Treatment Cycle 4|Adverse Event|0|||
124860055|NCT01261611|449110078|FG002|Treatment Cycle 4|Adverse Event|0|||
124860056|NCT01261611|449110076|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
124860057|NCT01261611|449110077|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
124860058|NCT01261611|449110078|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
124860059|NCT01261611|449110076|FG000|Treatment Cycle 4|Not otherwise specified|3|||
124860060|NCT01261611|449110077|FG001|Treatment Cycle 4|Not otherwise specified|0|||
124860061|NCT01261611|449110078|FG002|Treatment Cycle 4|Not otherwise specified|0|||
124860062|NCT01261611|449110076|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
124860063|NCT01261611|449110077|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
124860064|NCT01261611|449110078|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
124860065|NCT01261611|449110076|FG000|Treatment Cycle 5|Adverse Event|1|||
124860066|NCT01261611|449110077|FG001|Treatment Cycle 5|Adverse Event|0|||
124860067|NCT01261611|449110078|FG002|Treatment Cycle 5|Adverse Event|0|||
124860068|NCT01261611|449110076|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
124860069|NCT01261611|449110077|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
124860070|NCT01261611|449110078|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
124860071|NCT02527798|449110079|FG000|Overall Study|Physician Decision|1|||
124860072|NCT02527798|449110080|FG001|Overall Study|Physician Decision|0|||
124860073|NCT02527798|449110081|FG002|Overall Study|Physician Decision|1|||
124860074|NCT02527798|449110082|FG003|Overall Study|Physician Decision|1|||
124860075|NCT02527798|449110083|FG004|Overall Study|Physician Decision|0|||
124860076|NCT02527798|449110084|FG005|Overall Study|Physician Decision|0|||
124860077|NCT02527798|449110079|FG000|Overall Study|Death|0|||
124860078|NCT02527798|449110080|FG001|Overall Study|Death|0|||
124860079|NCT02527798|449110081|FG002|Overall Study|Death|1|||
124860080|NCT02527798|449110082|FG003|Overall Study|Death|0|||
124860081|NCT02527798|449110083|FG004|Overall Study|Death|0|||
124860082|NCT02527798|449110084|FG005|Overall Study|Death|0|||
124860083|NCT02527798|449110079|FG000|Overall Study|Withdrawal by Subject|0|||
124860084|NCT02527798|449110080|FG001|Overall Study|Withdrawal by Subject|1|||
124860085|NCT02527798|449110081|FG002|Overall Study|Withdrawal by Subject|2|||
124860086|NCT02527798|449110082|FG003|Overall Study|Withdrawal by Subject|0|||
124860087|NCT02527798|449110083|FG004|Overall Study|Withdrawal by Subject|0|||
124860088|NCT02527798|449110084|FG005|Overall Study|Withdrawal by Subject|0|||
124860089|NCT02527798|449110079|FG000|Overall Study|Reason undisclosed|1|||
124860090|NCT02527798|449110080|FG001|Overall Study|Reason undisclosed|0|||
124860091|NCT02527798|449110081|FG002|Overall Study|Reason undisclosed|1|||
124860092|NCT02527798|449110082|FG003|Overall Study|Reason undisclosed|0|||
124860093|NCT02527798|449110083|FG004|Overall Study|Reason undisclosed|0|||
124860094|NCT02527798|449110084|FG005|Overall Study|Reason undisclosed|0|||
124860095|NCT02527798|449110079|FG000|Overall Study|Did not receive intervention|1|||
124860096|NCT02527798|449110080|FG001|Overall Study|Did not receive intervention|1|||
124860097|NCT02527798|449110081|FG002|Overall Study|Did not receive intervention|0|||
124860098|NCT02527798|449110082|FG003|Overall Study|Did not receive intervention|0|||
124860099|NCT02527798|449110083|FG004|Overall Study|Did not receive intervention|0|||
124860100|NCT02527798|449110084|FG005|Overall Study|Did not receive intervention|0|||
124860101|NCT00920426|449110087|FG000|ITZ111451|Adverse Event|1|||
124860102|NCT00920426|449110088|FG001|ITZ111451|Adverse Event|0|||
124860103|NCT00920426|449110089|FG002|ITZ111451|Adverse Event|0|||
124860104|NCT00920426|449110090|FG003|ITZ111451|Adverse Event|0|||
124860105|NCT01432366|449110093|FG000|Overall Study|Non-Responder|7|||
124860106|NCT01432366|449110093|FG000|Overall Study|Adverse Event|8|||
124860107|NCT01432366|449110093|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
124860108|NCT01432366|449110093|FG000|Overall Study|Pregnancy|1|||
124860109|NCT01432366|449110093|FG000|Overall Study|Lost to Follow-up|13|||
124860110|NCT01432366|449110093|FG000|Overall Study|Lack of Efficacy|1|||
124860111|NCT01432366|449110093|FG000|Overall Study|Site Closed|20|||
124860112|NCT01432366|449110093|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
124860113|NCT01432366|449110093|FG000|Overall Study|Other|14|||
124860114|NCT01275625|449110099|FG000|Overall Study|Death|1|||
124860115|NCT01275625|449110099|FG000|Overall Study|Lack of Efficacy|2|||
124860116|NCT01275625|449110099|FG000|Overall Study|Lost to Follow-up|1|||
124860117|NCT01275625|449110099|FG000|Overall Study|Withdrawal by Subject|3|||
124860118|NCT01275625|449110099|FG000|Overall Study|Protocol Violation|1|||
124860119|NCT01275625|449110099|FG000|Overall Study|Adverse Event|4|||
124860120|NCT01275625|449110099|FG000|Overall Study|Other|1|||
124860121|NCT01349569|449110100|FG000|Overall Study|Lack of Efficacy|4|||
124860122|NCT02105116|449110101|FG000|Overall Study|not eligible for step 2 of trial|5|||
124860123|NCT02105116|449110101|FG000|Overall Study|Death|1|||
124860124|NCT00263666|449110102|FG000|Overall Study|Adverse Event|6|||
124860125|NCT00263666|449110103|FG001|Overall Study|Adverse Event|8|||
124860126|NCT00263666|449110102|FG000|Overall Study|Lost to Follow-up|1|||
124860127|NCT00263666|449110103|FG001|Overall Study|Lost to Follow-up|2|||
124860128|NCT00263666|449110102|FG000|Overall Study|Withdrawal by Subject|0|||
124860129|NCT00263666|449110103|FG001|Overall Study|Withdrawal by Subject|1|||
124860130|NCT00896168|449110104|FG000|Overall Study|Adverse Event|4|||
124860131|NCT00896168|449110105|FG001|Overall Study|Adverse Event|7|||
124860132|NCT00896168|449110104|FG000|Overall Study|Treatment failure|8|||
124860133|NCT00896168|449110105|FG001|Overall Study|Treatment failure|10|||
124860134|NCT00896168|449110104|FG000|Overall Study|Lost to Follow-up|1|||
124860135|NCT00896168|449110105|FG001|Overall Study|Lost to Follow-up|1|||
124860136|NCT00896168|449110104|FG000|Overall Study|Other|1|||
124860137|NCT00896168|449110105|FG001|Overall Study|Other|1|||
124860138|NCT02492100|449110106|FG000|Overall Study|Death|1|||
124860139|NCT01003899|449110110|FG000|Overall Study|Other Adverse Event|8|||
124860140|NCT01003899|449110110|FG000|Overall Study|Not entered|4|||
124860141|NCT01003899|449110110|FG000|Overall Study|Not treated|1|||
124860142|NCT01003899|449110110|FG000|Overall Study|Progressive disease|34|||
124860143|NCT02489500|449110114|FG000|Overall Study|Death|1|||
124860144|NCT02489500|449110115|FG001|Overall Study|Death|1|||
124860145|NCT02863926|449110116|FG000|Overall Study|Physician Decision|1|||
124860146|NCT02863926|449110117|FG001|Overall Study|Physician Decision|0|||
124860147|NCT02863926|449110116|FG000|Overall Study|Lost to Follow-up|1|||
124860148|NCT02863926|449110117|FG001|Overall Study|Lost to Follow-up|1|||
124860149|NCT01259713|449110118|FG000|Overall Study|Adverse Event|54|||
124860150|NCT01259713|449110119|FG001|Overall Study|Adverse Event|23|||
124860151|NCT01259713|449110118|FG000|Overall Study|Death Not Related to IFI|8|||
124860152|NCT01259713|449110119|FG001|Overall Study|Death Not Related to IFI|1|||
124860153|NCT01259713|449110118|FG000|Overall Study|Investigators Discretion|14|||
124860154|NCT01259713|449110119|FG001|Overall Study|Investigators Discretion|6|||
124860155|NCT01259713|449110118|FG000|Overall Study|Lack of Efficacy|2|||
124860156|NCT01259713|449110119|FG001|Overall Study|Lack of Efficacy|0|||
124860157|NCT01259713|449110118|FG000|Overall Study|Protocol Violation|5|||
124860158|NCT01259713|449110119|FG001|Overall Study|Protocol Violation|4|||
124860159|NCT01259713|449110118|FG000|Overall Study|Subject Withdrew Consent|12|||
124860160|NCT01259713|449110119|FG001|Overall Study|Subject Withdrew Consent|7|||
124860161|NCT03422250|449110120|FG000|Intervention|Adverse Event|0|||
124860162|NCT03422250|449110121|FG001|Intervention|Adverse Event|1|||
124860163|NCT03422250|449110122|FG002|Intervention|Adverse Event|0|||
124860164|NCT03422250|449110123|FG003|Intervention|Adverse Event|1|||
124860165|NCT03422250|449110120|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
124860166|NCT03422250|449110121|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
124860167|NCT03422250|449110122|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
124860168|NCT03422250|449110123|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
124860169|NCT03422250|449110120|FG000|Follow-up|Withdrawal by Subject|0|||
124860170|NCT03422250|449110121|FG001|Follow-up|Withdrawal by Subject|0|||
124860171|NCT03422250|449110122|FG002|Follow-up|Withdrawal by Subject|0|||
124860172|NCT03422250|449110123|FG003|Follow-up|Withdrawal by Subject|1|||
124860173|NCT03422250|449110120|FG000|Follow-up|Adverse Event|0|||
124860174|NCT03422250|449110121|FG001|Follow-up|Adverse Event|0|||
124860175|NCT03422250|449110122|FG002|Follow-up|Adverse Event|0|||
124860176|NCT03422250|449110123|FG003|Follow-up|Adverse Event|1|||
124860177|NCT06111742|449110132|FG000|Overall Study|Did not receive intervention|1|||
124860178|NCT06111742|449110133|FG001|Overall Study|Did not receive intervention|0|||
124860179|NCT06111742|449110134|FG002|Overall Study|Did not receive intervention|0|||
124860180|NCT06111742|449110132|FG000|Overall Study|Withdrawal by Subject|2|||
124860181|NCT06111742|449110133|FG001|Overall Study|Withdrawal by Subject|0|||
124860182|NCT06111742|449110134|FG002|Overall Study|Withdrawal by Subject|0|||
124860183|NCT01917526|449110135|FG000|Overall Study|Protocol Violation|1|||
124860184|NCT01917526|449110136|FG001|Overall Study|Protocol Violation|1|||
124860185|NCT04717596|449110137|FG000|Overall Study|Withdrawal by Subject|4|||
124860186|NCT02864082|449110139|FG000|Overall Study|Adverse Event|1|||
124860187|NCT02864082|449110140|FG001|Overall Study|Adverse Event|1|||
124860188|NCT02864082|449110139|FG000|Overall Study|Lost to Follow-up|0|||
124860189|NCT02864082|449110140|FG001|Overall Study|Lost to Follow-up|1|||
124860190|NCT02864082|449110139|FG000|Overall Study|Withdrawal by Subject|2|||
124860191|NCT02864082|449110140|FG001|Overall Study|Withdrawal by Subject|2|||
124860192|NCT01127178|449110141|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
124860193|NCT01127178|449110142|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
124860194|NCT01127178|449110141|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
124860195|NCT01127178|449110142|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
124860196|NCT01127178|449110141|FG000|Dose Escalation: Treatment Phase|Other|2|||
124860197|NCT01127178|449110142|FG001|Dose Escalation: Treatment Phase|Other|0|||
124860198|NCT01127178|449110141|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
124860199|NCT01127178|449110142|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
124860200|NCT01127178|449110141|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
124860201|NCT01127178|449110142|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
124860202|NCT01127178|449110141|FG000|Dose Escalation: Extension Phase|Other|1|||
124860203|NCT01127178|449110142|FG001|Dose Escalation: Extension Phase|Other|0|||
124860204|NCT03621696|449110143|FG000|Overall Study|Not eligible|0|||
124860205|NCT03621696|449110144|FG001|Overall Study|Not eligible|0|||
124860206|NCT03621696|449110145|FG002|Overall Study|Not eligible|0|||
124860207|NCT03621696|449110146|FG003|Overall Study|Not eligible|5|||
124860208|NCT03621696|449110143|FG000|Overall Study|Withdrawal by Subject|1|||
124860209|NCT03621696|449110144|FG001|Overall Study|Withdrawal by Subject|1|||
124860210|NCT03621696|449110145|FG002|Overall Study|Withdrawal by Subject|1|||
124860211|NCT03621696|449110146|FG003|Overall Study|Withdrawal by Subject|0|||
124860212|NCT03621696|449110143|FG000|Overall Study|Physician Decision|0|||
124860213|NCT03621696|449110144|FG001|Overall Study|Physician Decision|0|||
124860214|NCT03621696|449110145|FG002|Overall Study|Physician Decision|1|||
124860215|NCT03621696|449110146|FG003|Overall Study|Physician Decision|0|||
124860216|NCT04349553|449110147|FG000|Overall Study|Withdrawal by Subject|1|||
124860217|NCT04349553|449110148|FG001|Overall Study|Withdrawal by Subject|0|||
124860218|NCT04349553|449110149|FG002|Overall Study|Withdrawal by Subject|1|||
124860219|NCT04349553|449110150|FG003|Overall Study|Withdrawal by Subject|0|||
124860220|NCT02063724|449110151|FG000|Overall Study|Disease progression|1|||
124860221|NCT01715805|449110152|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
124860222|NCT01715805|449110153|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
124860223|NCT01715805|449110154|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
124860224|NCT01715805|449110155|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
124860225|NCT01715805|449110152|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
124860226|NCT01715805|449110153|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
124860227|NCT01715805|449110154|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
124860228|NCT01715805|449110155|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
124860229|NCT01715805|449110152|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
124860230|NCT01715805|449110153|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
124860231|NCT01715805|449110154|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
124860232|NCT01715805|449110155|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
124860233|NCT01715805|449110152|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
124860234|NCT01715805|449110153|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
124860235|NCT01715805|449110154|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
124860236|NCT01715805|449110155|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
124860237|NCT01715805|449110152|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
124860238|NCT01715805|449110153|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
124860239|NCT01715805|449110154|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
124860240|NCT01715805|449110155|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
124860241|NCT01715805|449110152|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
124860242|NCT01715805|449110153|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
124860243|NCT01715805|449110154|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
124860244|NCT01715805|449110155|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
124860245|NCT01715805|449110152|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
124860246|NCT01715805|449110153|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
124860247|NCT01715805|449110154|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
124860248|NCT01715805|449110155|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
124860249|NCT01715805|449110152|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
124860250|NCT01715805|449110153|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
124860251|NCT01715805|449110154|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
124860252|NCT01715805|449110155|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
124860253|NCT01715805|449110152|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
124860254|NCT01715805|449110153|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
124860255|NCT01715805|449110154|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
124860256|NCT01715805|449110155|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
124860257|NCT01715805|449110152|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
124860258|NCT01715805|449110153|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
124860259|NCT01715805|449110154|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
124860260|NCT01715805|449110155|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
124860261|NCT01715805|449110152|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
124860262|NCT01715805|449110153|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
124860263|NCT01715805|449110154|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
124860264|NCT01715805|449110155|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
124860265|NCT01715805|449110152|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
124860266|NCT01715805|449110153|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
124860267|NCT01715805|449110154|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
124860268|NCT01715805|449110155|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
124860269|NCT01715805|449110152|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
124860270|NCT01715805|449110153|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
124860271|NCT01715805|449110154|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
124860272|NCT01715805|449110155|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
124860273|NCT01715805|449110152|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
124860274|NCT01715805|449110153|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
124860275|NCT01715805|449110154|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
124860276|NCT01715805|449110155|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
124860277|NCT05177770|449110158|FG000|Overall Study|Death|4|||
124860278|NCT05177770|449110158|FG000|Overall Study|Withdrawal by Subject|1|||
124860279|NCT05177770|449110158|FG000|Overall Study|Adverse Event prior to dosing|1|||
124860280|NCT02365467|449110159|FG000|Overall Study|Death|3|||
124860281|NCT02043782|449110160|FG000|Period 1|Adverse Event|0|||
124860282|NCT02043782|449110161|FG001|Period 1|Adverse Event|0|||
124860283|NCT02043782|449110162|FG002|Period 1|Adverse Event|1|||
124860284|NCT02043782|449110163|FG003|Period 1|Adverse Event|0|||
124860285|NCT02043782|449110164|FG004|Period 1|Adverse Event|0|||
124860286|NCT02043782|449110165|FG005|Period 1|Adverse Event|0|||
124860287|NCT00709722|449110166|FG000|Overall Study|Adverse Event|1|||
124860288|NCT04667117|449110167|FG000|Investigational Period|Lost to Follow-up|0|||
124860289|NCT04667117|449110168|FG001|Investigational Period|Lost to Follow-up|0|||
124860290|NCT04667117|449110169|FG002|Investigational Period|Lost to Follow-up|1|||
124860291|NCT04667117|449110167|FG000|Investigational Period|Protocol Deviation|0|||
124860292|NCT04667117|449110168|FG001|Investigational Period|Protocol Deviation|1|||
124860293|NCT04667117|449110169|FG002|Investigational Period|Protocol Deviation|0|||
124860294|NCT04667117|449110167|FG000|Extension Period|Lost to Follow-up|1|||
124860295|NCT04667117|449110168|FG001|Extension Period|Lost to Follow-up|0|||
124860296|NCT04667117|449110169|FG002|Extension Period|Lost to Follow-up|0|||
124860297|NCT01306162|449110170|FG000|Period 1|Adverse Event|0|||
124860298|NCT01306162|449110171|FG001|Period 1|Adverse Event|0|||
124860299|NCT01306162|449110172|FG002|Period 1|Adverse Event|0|||
124860300|NCT01306162|449110173|FG003|Period 1|Adverse Event|1|||
124860301|NCT01306162|449110170|FG000|Washout 1|Non-compliance to protocol|0|||
124860302|NCT01306162|449110171|FG001|Washout 1|Non-compliance to protocol|1|||
124860303|NCT01306162|449110172|FG002|Washout 1|Non-compliance to protocol|0|||
124860304|NCT01306162|449110173|FG003|Washout 1|Non-compliance to protocol|0|||
124860305|NCT02959437|449110179|FG000|Overall Study|Death|33|||
124860306|NCT02959437|449110180|FG001|Overall Study|Death|3|||
124860307|NCT02959437|449110181|FG002|Overall Study|Death|0|||
124860308|NCT02959437|449110182|FG003|Overall Study|Death|0|||
124860309|NCT02959437|449110179|FG000|Overall Study|Lost to Follow-up|3|||
124860310|NCT02959437|449110180|FG001|Overall Study|Lost to Follow-up|1|||
124860311|NCT02959437|449110181|FG002|Overall Study|Lost to Follow-up|0|||
124860312|NCT02959437|449110182|FG003|Overall Study|Lost to Follow-up|0|||
124860313|NCT02959437|449110179|FG000|Overall Study|Withdrawal by Subject|11|||
124860314|NCT02959437|449110180|FG001|Overall Study|Withdrawal by Subject|3|||
124860315|NCT02959437|449110181|FG002|Overall Study|Withdrawal by Subject|0|||
124860316|NCT02959437|449110182|FG003|Overall Study|Withdrawal by Subject|0|||
124860317|NCT02959437|449110179|FG000|Overall Study|Progressive Disease|9|||
124860318|NCT02959437|449110180|FG001|Overall Study|Progressive Disease|1|||
124860319|NCT02959437|449110181|FG002|Overall Study|Progressive Disease|0|||
124860320|NCT02959437|449110182|FG003|Overall Study|Progressive Disease|0|||
124860321|NCT02959437|449110179|FG000|Overall Study|Study Terminated by Sponsor|4|||
124860322|NCT02959437|449110180|FG001|Overall Study|Study Terminated by Sponsor|0|||
124860323|NCT02959437|449110181|FG002|Overall Study|Study Terminated by Sponsor|0|||
124860324|NCT02959437|449110182|FG003|Overall Study|Study Terminated by Sponsor|0|||
124860325|NCT02959437|449110179|FG000|Overall Study|Other Unspecified|2|||
124860326|NCT02959437|449110180|FG001|Overall Study|Other Unspecified|0|||
124860327|NCT02959437|449110181|FG002|Overall Study|Other Unspecified|0|||
124860328|NCT02959437|449110182|FG003|Overall Study|Other Unspecified|0|||
124860329|NCT01949480|449110188|FG000|Overall Study|Physician Decision|5|||
124860330|NCT01949480|449110189|FG001|Overall Study|Physician Decision|8|||
124860331|NCT02372396|449110190|FG000|Overall Study|Lost to Follow-up|7|||
124860332|NCT02372396|449110191|FG001|Overall Study|Lost to Follow-up|9|||
124860333|NCT02952924|449110196|FG000|Overall Study|Protocol Violation|0|||
124860334|NCT02952924|449110197|FG001|Overall Study|Protocol Violation|0|||
124860335|NCT02952924|449110198|FG002|Overall Study|Protocol Violation|0|||
124860336|NCT02952924|449110199|FG003|Overall Study|Protocol Violation|0|||
124860337|NCT02952924|449110200|FG004|Overall Study|Protocol Violation|0|||
124860338|NCT02952924|449110201|FG005|Overall Study|Protocol Violation|0|||
124860339|NCT02952924|449110202|FG006|Overall Study|Protocol Violation|0|||
124860340|NCT02952924|449110203|FG007|Overall Study|Protocol Violation|0|||
124860341|NCT02952924|449110204|FG008|Overall Study|Protocol Violation|0|||
124860342|NCT02952924|449110205|FG009|Overall Study|Protocol Violation|0|||
124860343|NCT02952924|449110206|FG010|Overall Study|Protocol Violation|0|||
124860344|NCT02952924|449110207|FG011|Overall Study|Protocol Violation|0|||
124860345|NCT02952924|449110208|FG012|Overall Study|Protocol Violation|0|||
124860346|NCT02952924|449110209|FG013|Overall Study|Protocol Violation|0|||
124860347|NCT02952924|449110210|FG014|Overall Study|Protocol Violation|0|||
124860348|NCT02952924|449110211|FG015|Overall Study|Protocol Violation|0|||
124860349|NCT02952924|449110212|FG016|Overall Study|Protocol Violation|0|||
124860350|NCT02952924|449110213|FG017|Overall Study|Protocol Violation|0|||
124860351|NCT02952924|449110214|FG018|Overall Study|Protocol Violation|0|||
124860352|NCT02952924|449110215|FG019|Overall Study|Protocol Violation|1|||
124860353|NCT02952924|449110216|FG020|Overall Study|Protocol Violation|0|||
124860354|NCT02952924|449110217|FG021|Overall Study|Protocol Violation|0|||
124860355|NCT02952924|449110196|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
124860356|NCT02952924|449110197|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
124860357|NCT02952924|449110198|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
124860358|NCT02952924|449110199|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
124860359|NCT02952924|449110200|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
124860360|NCT02952924|449110201|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
124860361|NCT02952924|449110202|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
124860362|NCT02952924|449110203|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
124860363|NCT02952924|449110204|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
124860364|NCT02952924|449110205|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
124860365|NCT02952924|449110206|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
124860366|NCT02952924|449110207|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
124860367|NCT02952924|449110208|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
124860368|NCT02952924|449110209|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
124860369|NCT02952924|449110210|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
124860370|NCT02952924|449110211|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
124860371|NCT02952924|449110212|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
124860372|NCT02952924|449110213|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
124860373|NCT02952924|449110214|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
124860374|NCT02952924|449110215|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
124860375|NCT02952924|449110216|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
124860376|NCT02952924|449110217|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
124860377|NCT02952924|449110196|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860378|NCT02952924|449110197|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860379|NCT02952924|449110198|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860380|NCT02952924|449110199|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860381|NCT02952924|449110200|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860382|NCT02952924|449110201|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860383|NCT02952924|449110202|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860384|NCT02952924|449110203|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860385|NCT02952924|449110204|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860386|NCT02952924|449110205|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860387|NCT02952924|449110206|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860388|NCT02952924|449110207|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860389|NCT02952924|449110208|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860390|NCT02952924|449110209|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860391|NCT02952924|449110210|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860392|NCT02952924|449110211|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860393|NCT02952924|449110212|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860394|NCT02952924|449110213|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860395|NCT02952924|449110214|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860396|NCT02952924|449110215|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860397|NCT02952924|449110216|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
124860398|NCT02952924|449110217|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
124860399|NCT02952924|449110196|FG000|Overall Study|Noncompliance with study drug|0|||
124860400|NCT02952924|449110197|FG001|Overall Study|Noncompliance with study drug|0|||
124860401|NCT02952924|449110198|FG002|Overall Study|Noncompliance with study drug|0|||
124860402|NCT02952924|449110199|FG003|Overall Study|Noncompliance with study drug|0|||
124860403|NCT02952924|449110200|FG004|Overall Study|Noncompliance with study drug|0|||
124860404|NCT02952924|449110201|FG005|Overall Study|Noncompliance with study drug|0|||
124860405|NCT02952924|449110202|FG006|Overall Study|Noncompliance with study drug|0|||
124860406|NCT02952924|449110203|FG007|Overall Study|Noncompliance with study drug|0|||
124860407|NCT02952924|449110204|FG008|Overall Study|Noncompliance with study drug|0|||
124860408|NCT02952924|449110205|FG009|Overall Study|Noncompliance with study drug|0|||
124860409|NCT02952924|449110206|FG010|Overall Study|Noncompliance with study drug|0|||
124860410|NCT02952924|449110207|FG011|Overall Study|Noncompliance with study drug|0|||
124860411|NCT02952924|449110208|FG012|Overall Study|Noncompliance with study drug|0|||
124860412|NCT02952924|449110209|FG013|Overall Study|Noncompliance with study drug|0|||
124860413|NCT02952924|449110210|FG014|Overall Study|Noncompliance with study drug|0|||
124860414|NCT02952924|449110211|FG015|Overall Study|Noncompliance with study drug|0|||
124860415|NCT02952924|449110212|FG016|Overall Study|Noncompliance with study drug|0|||
124860416|NCT02952924|449110213|FG017|Overall Study|Noncompliance with study drug|0|||
124860417|NCT02952924|449110214|FG018|Overall Study|Noncompliance with study drug|0|||
124860418|NCT02952924|449110215|FG019|Overall Study|Noncompliance with study drug|0|||
124860419|NCT02952924|449110216|FG020|Overall Study|Noncompliance with study drug|0|||
124860420|NCT02952924|449110217|FG021|Overall Study|Noncompliance with study drug|1|||
124860421|NCT02232893|449110222|FG000|Overall Study|Withdrawal by Subject|4|||
124860422|NCT02232893|449110223|FG001|Overall Study|Withdrawal by Subject|1|||
124860423|NCT02232893|449110222|FG000|Overall Study|Adverse Event|0|||
124860424|NCT02232893|449110223|FG001|Overall Study|Adverse Event|1|||
124860425|NCT02232893|449110222|FG000|Overall Study|Sponsor request early termination|0|||
124860426|NCT02232893|449110223|FG001|Overall Study|Sponsor request early termination|1|||
124860427|NCT02232893|449110222|FG000|Overall Study|Developed exclusion criteria|0|||
124860428|NCT02232893|449110223|FG001|Overall Study|Developed exclusion criteria|1|||
124860429|NCT02232893|449110222|FG000|Overall Study|Other|0|||
124860430|NCT02232893|449110223|FG001|Overall Study|Other|3|||
124860431|NCT01358526|449110224|FG000|Open-label Titration Period|Adverse Event|95|||
124860432|NCT01358526|449110225|FG001|Open-label Titration Period|Adverse Event|0|||
124860433|NCT01358526|449110226|FG002|Open-label Titration Period|Adverse Event|0|||
124860434|NCT01358526|449110224|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
124860435|NCT01358526|449110225|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
124860436|NCT01358526|449110226|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
124860437|NCT01358526|449110224|FG000|Open-label Titration Period|Lost to Follow-up|25|||
124860438|NCT01358526|449110225|FG001|Open-label Titration Period|Lost to Follow-up|0|||
124860439|NCT01358526|449110226|FG002|Open-label Titration Period|Lost to Follow-up|0|||
124860440|NCT01358526|449110224|FG000|Open-label Titration Period|Lack of Efficacy|107|||
124860441|NCT01358526|449110225|FG001|Open-label Titration Period|Lack of Efficacy|0|||
124860442|NCT01358526|449110226|FG002|Open-label Titration Period|Lack of Efficacy|0|||
124860443|NCT01358526|449110224|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
124860444|NCT01358526|449110225|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
124860445|NCT01358526|449110226|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
124860446|NCT01358526|449110224|FG000|Open-label Titration Period|Administrative|8|||
124860447|NCT01358526|449110225|FG001|Open-label Titration Period|Administrative|0|||
124860448|NCT01358526|449110226|FG002|Open-label Titration Period|Administrative|0|||
124860449|NCT01358526|449110224|FG000|Open-label Titration Period|Did not qualify|178|||
124860450|NCT01358526|449110225|FG001|Open-label Titration Period|Did not qualify|0|||
124860451|NCT01358526|449110226|FG002|Open-label Titration Period|Did not qualify|0|||
124860452|NCT01358526|449110224|FG000|Double-blind Phase|Adverse Event|0|||
124860453|NCT01358526|449110225|FG001|Double-blind Phase|Adverse Event|24|||
124860454|NCT01358526|449110226|FG002|Double-blind Phase|Adverse Event|23|||
124860455|NCT01358526|449110224|FG000|Double-blind Phase|Withdrawal by Subject|0|||
124860456|NCT01358526|449110225|FG001|Double-blind Phase|Withdrawal by Subject|10|||
124860457|NCT01358526|449110226|FG002|Double-blind Phase|Withdrawal by Subject|8|||
124860458|NCT01358526|449110224|FG000|Double-blind Phase|Lost to Follow-up|0|||
124860459|NCT01358526|449110225|FG001|Double-blind Phase|Lost to Follow-up|4|||
124860460|NCT01358526|449110226|FG002|Double-blind Phase|Lost to Follow-up|1|||
124860461|NCT01358526|449110224|FG000|Double-blind Phase|Lack of Efficacy|0|||
124860462|NCT01358526|449110225|FG001|Double-blind Phase|Lack of Efficacy|31|||
124860463|NCT01358526|449110226|FG002|Double-blind Phase|Lack of Efficacy|73|||
124860464|NCT01358526|449110224|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
124860465|NCT01358526|449110225|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
124860466|NCT01358526|449110226|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
124860467|NCT01358526|449110224|FG000|Double-blind Phase|Administrative|0|||
124860468|NCT01358526|449110225|FG001|Double-blind Phase|Administrative|6|||
124860469|NCT01358526|449110226|FG002|Double-blind Phase|Administrative|10|||
124860470|NCT00156065|449112754|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
124860471|NCT00156065|449112755|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
124860472|NCT00156065|449112756|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
124860473|NCT00156065|449112754|FG000|Overall Study|Adverse Event|8|||
124860474|NCT00156065|449112755|FG001|Overall Study|Adverse Event|11|||
124860475|NCT00156065|449112756|FG002|Overall Study|Adverse Event|4|||
124860476|NCT00156065|449112754|FG000|Overall Study|Lack of Efficacy|2|||
124860477|NCT00156065|449112755|FG001|Overall Study|Lack of Efficacy|9|||
124860478|NCT00156065|449112756|FG002|Overall Study|Lack of Efficacy|3|||
124860479|NCT00156065|449112754|FG000|Overall Study|Withdrawal by Subject|13|||
124860480|NCT00156065|449112755|FG001|Overall Study|Withdrawal by Subject|26|||
124860481|NCT00156065|449112756|FG002|Overall Study|Withdrawal by Subject|16|||
124860482|NCT00156065|449112754|FG000|Overall Study|Lost to Follow-up|5|||
124860483|NCT00156065|449112755|FG001|Overall Study|Lost to Follow-up|7|||
124860484|NCT00156065|449112756|FG002|Overall Study|Lost to Follow-up|1|||
124860485|NCT00156065|449112754|FG000|Overall Study|Other|2|||
124860486|NCT00156065|449112755|FG001|Overall Study|Other|9|||
124860487|NCT00156065|449112756|FG002|Overall Study|Other|3|||
124860488|NCT04745169|449112757|FG000|Overall Study|Kidney transplantation|1|||
124860489|NCT04745169|449112757|FG000|Overall Study|Participant health problems|3|||
124860490|NCT04745169|449112757|FG000|Overall Study|Physician Decision|2|||
124860491|NCT01292603|449112758|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
124860492|NCT01292603|449112759|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
124860493|NCT01292603|449112760|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
124860494|NCT01292603|449112761|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
124860495|NCT01292603|449112762|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
124860496|NCT01292603|449112763|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
124860497|NCT01292603|449112758|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
124860498|NCT01292603|449112759|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
124860499|NCT01292603|449112760|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
124860500|NCT01292603|449112761|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
124860501|NCT01292603|449112762|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
124860502|NCT01292603|449112763|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
124860503|NCT01292603|449112758|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
124860504|NCT01292603|449112759|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
124860505|NCT01292603|449112760|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
124860506|NCT01292603|449112761|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
124860507|NCT01292603|449112762|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
124860508|NCT01292603|449112763|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
124860509|NCT01292603|449112758|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
124860510|NCT01292603|449112759|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
124860511|NCT01292603|449112760|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
124860512|NCT01292603|449112761|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
124860513|NCT01292603|449112762|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
124860514|NCT01292603|449112763|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
124860515|NCT01292603|449112758|FG000|Part 1: Regular Follow-Up Period|Death|3|||
124860516|NCT01292603|449112759|FG001|Part 1: Regular Follow-Up Period|Death|1|||
124860517|NCT01292603|449112760|FG002|Part 1: Regular Follow-Up Period|Death|3|||
124860518|NCT01292603|449112761|FG003|Part 1: Regular Follow-Up Period|Death|1|||
124860519|NCT01292603|449112762|FG004|Part 1: Regular Follow-Up Period|Death|0|||
124860520|NCT01292603|449112763|FG005|Part 1: Regular Follow-Up Period|Death|0|||
124860521|NCT01292603|449112758|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
124860522|NCT01292603|449112759|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
124860523|NCT01292603|449112760|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
124860524|NCT01292603|449112761|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
124860525|NCT01292603|449112762|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
124860526|NCT01292603|449112763|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
124860527|NCT01292603|449112758|FG000|Part 2: Dose Confirmation Period|Death|0|||
124860528|NCT01292603|449112759|FG001|Part 2: Dose Confirmation Period|Death|0|||
124860529|NCT01292603|449112760|FG002|Part 2: Dose Confirmation Period|Death|0|||
124860530|NCT01292603|449112761|FG003|Part 2: Dose Confirmation Period|Death|0|||
124860531|NCT01292603|449112762|FG004|Part 2: Dose Confirmation Period|Death|1|||
124860532|NCT01292603|449112763|FG005|Part 2: Dose Confirmation Period|Death|0|||
124860533|NCT01292603|449112758|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
124860534|NCT01292603|449112759|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
124860535|NCT01292603|449112760|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
124860536|NCT01292603|449112761|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
124860537|NCT01292603|449112762|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
124860538|NCT01292603|449112763|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
124860539|NCT01292603|449112758|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
124860540|NCT01292603|449112759|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
124860541|NCT01292603|449112760|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
124860542|NCT01292603|449112761|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
124860543|NCT01292603|449112762|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
124860544|NCT01292603|449112763|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
124860545|NCT01292603|449112758|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
124860546|NCT01292603|449112759|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
124860547|NCT01292603|449112760|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
124860548|NCT01292603|449112761|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
124860549|NCT01292603|449112762|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
124860550|NCT01292603|449112763|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
124860551|NCT01292603|449112758|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
124860552|NCT01292603|449112759|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
124860553|NCT01292603|449112760|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
124860554|NCT01292603|449112761|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
124860555|NCT01292603|449112762|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
124860556|NCT01292603|449112763|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
124860557|NCT01292603|449112758|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
124860558|NCT01292603|449112759|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
124860559|NCT01292603|449112760|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
124860560|NCT01292603|449112761|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
124860561|NCT01292603|449112762|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
124860562|NCT01292603|449112763|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
124860563|NCT01292603|449112758|FG000|Part 2: Regular Follow-Up|Death|0|||
124860564|NCT01292603|449112759|FG001|Part 2: Regular Follow-Up|Death|0|||
124860565|NCT01292603|449112760|FG002|Part 2: Regular Follow-Up|Death|0|||
124860566|NCT01292603|449112761|FG003|Part 2: Regular Follow-Up|Death|0|||
124860567|NCT01292603|449112762|FG004|Part 2: Regular Follow-Up|Death|6|||
124860568|NCT01292603|449112763|FG005|Part 2: Regular Follow-Up|Death|3|||
124860569|NCT01292603|449112758|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
124860570|NCT01292603|449112759|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
124860571|NCT01292603|449112760|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
124860572|NCT01292603|449112761|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
124860573|NCT01292603|449112762|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
124860574|NCT01292603|449112763|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
124860575|NCT01292603|449112758|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
124860576|NCT01292603|449112759|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
124860577|NCT01292603|449112760|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
124860578|NCT01292603|449112761|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
124860579|NCT01292603|449112762|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
124860580|NCT01292603|449112763|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
124860581|NCT01292603|449112758|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
124860582|NCT01292603|449112759|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
124860583|NCT01292603|449112760|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
124860584|NCT01292603|449112761|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
124860585|NCT01292603|449112762|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
124860586|NCT01292603|449112763|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
124860587|NCT01292603|449112758|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
124860588|NCT01292603|449112759|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
124860589|NCT01292603|449112760|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
124860590|NCT01292603|449112761|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
124860591|NCT01292603|449112762|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
124860592|NCT01292603|449112763|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
124860593|NCT01292603|449112758|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
124860594|NCT01292603|449112759|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
124860595|NCT01292603|449112760|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
124860596|NCT01292603|449112761|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
124860597|NCT01292603|449112762|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
124860598|NCT01292603|449112763|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
124860599|NCT01292603|449112758|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
124860600|NCT01292603|449112759|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
124860601|NCT01292603|449112760|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
124860602|NCT01292603|449112761|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
124860603|NCT01292603|449112762|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
124860604|NCT01292603|449112763|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
124860605|NCT01292603|449112758|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
124860606|NCT01292603|449112759|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
124860607|NCT01292603|449112760|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
124860608|NCT01292603|449112761|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
124860609|NCT01292603|449112762|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
124860610|NCT01292603|449112763|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
124860611|NCT01292603|449112758|FG000|Overall Survival Status|Death|3|||
124860612|NCT01292603|449112759|FG001|Overall Survival Status|Death|1|||
124860613|NCT01292603|449112760|FG002|Overall Survival Status|Death|3|||
124860614|NCT01292603|449112761|FG003|Overall Survival Status|Death|1|||
124860615|NCT01292603|449112762|FG004|Overall Survival Status|Death|16|||
124860616|NCT01292603|449112763|FG005|Overall Survival Status|Death|10|||
124860617|NCT01808690|449112764|FG000|Overall Study|Withdrawal by Subject|1|||
124860618|NCT01808690|449112765|FG001|Overall Study|Withdrawal by Subject|2|||
124860619|NCT03870763|449112766|FG000|Overall Study|Study terminated by sponsor|0|||
124860620|NCT03870763|449112767|FG001|Overall Study|Study terminated by sponsor|2|||
124860621|NCT03870763|449112768|FG002|Overall Study|Study terminated by sponsor|0|||
124860622|NCT03870763|449112766|FG000|Overall Study|Withdrawal by Subject|0|||
124860623|NCT03870763|449112767|FG001|Overall Study|Withdrawal by Subject|1|||
124860624|NCT03870763|449112768|FG002|Overall Study|Withdrawal by Subject|0|||
124860625|NCT03870763|449112766|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
124860626|NCT03870763|449112767|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
124860627|NCT03870763|449112768|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
124860628|NCT02891187|449112769|FG000|Overall Study|Lost to Follow-up|1|||
124860629|NCT02891187|449112770|FG001|Overall Study|Lost to Follow-up|2|||
124860630|NCT03586648|449112773|FG000|Period 1|Withdrawal by Subject|0|||
124860631|NCT03586648|449112774|FG001|Period 1|Withdrawal by Subject|1|||
124860632|NCT03586648|449112773|FG000|Period 1|Lost to Follow-up|1|||
124860633|NCT03586648|449112774|FG001|Period 1|Lost to Follow-up|1|||
124860634|NCT03586648|449112773|FG000|Period 1|Adverse Event|1|||
124860635|NCT03586648|449112774|FG001|Period 1|Adverse Event|0|||
124860636|NCT03586648|449112773|FG000|Period 1|Study related symptoms or complaints|2|||
124860637|NCT03586648|449112774|FG001|Period 1|Study related symptoms or complaints|1|||
124860638|NCT03586648|449112773|FG000|Period 1|Physician Decision|0|||
124860639|NCT03586648|449112774|FG001|Period 1|Physician Decision|1|||
124860640|NCT03586648|449112773|FG000|Period 2|Adverse Event|1|||
124860641|NCT03586648|449112774|FG001|Period 2|Adverse Event|0|||
124860642|NCT02041195|449112775|FG000|Overall Study|Adverse Event|1|||
124860643|NCT02041195|449112776|FG001|Overall Study|Adverse Event|2|||
124860644|NCT02041195|449112777|FG002|Overall Study|Adverse Event|0|||
124860645|NCT02041195|449112778|FG003|Overall Study|Adverse Event|0|||
124860646|NCT02041195|449112779|FG004|Overall Study|Adverse Event|0|||
124860647|NCT02041195|449112780|FG005|Overall Study|Adverse Event|0|||
124860648|NCT02041195|449112781|FG006|Overall Study|Adverse Event|3|||
124860649|NCT02041195|449112782|FG007|Overall Study|Adverse Event|0|||
124860650|NCT02041195|449112775|FG000|Overall Study|Withdrawal by Subject|1|||
124860651|NCT02041195|449112776|FG001|Overall Study|Withdrawal by Subject|0|||
124860652|NCT02041195|449112777|FG002|Overall Study|Withdrawal by Subject|0|||
124860653|NCT02041195|449112778|FG003|Overall Study|Withdrawal by Subject|0|||
124860654|NCT02041195|449112779|FG004|Overall Study|Withdrawal by Subject|0|||
124860655|NCT02041195|449112780|FG005|Overall Study|Withdrawal by Subject|0|||
124860656|NCT02041195|449112781|FG006|Overall Study|Withdrawal by Subject|4|||
124860657|NCT02041195|449112782|FG007|Overall Study|Withdrawal by Subject|3|||
124860658|NCT02041195|449112775|FG000|Overall Study|Unable to comply with study visits|0|||
124860659|NCT02041195|449112776|FG001|Overall Study|Unable to comply with study visits|1|||
124860660|NCT02041195|449112777|FG002|Overall Study|Unable to comply with study visits|0|||
124860661|NCT02041195|449112778|FG003|Overall Study|Unable to comply with study visits|0|||
124860662|NCT02041195|449112779|FG004|Overall Study|Unable to comply with study visits|1|||
124860663|NCT02041195|449112780|FG005|Overall Study|Unable to comply with study visits|0|||
124860664|NCT02041195|449112781|FG006|Overall Study|Unable to comply with study visits|0|||
124860665|NCT02041195|449112782|FG007|Overall Study|Unable to comply with study visits|0|||
124860666|NCT02395120|449112783|FG000|Overall Study|Missed follow-up dental exam|57|||
124860667|NCT02395120|449112784|FG001|Overall Study|Missed follow-up dental exam|62|||
124860668|NCT02395120|449112785|FG002|Overall Study|Missed follow-up dental exam|6|||
124860669|NCT02395120|449112786|FG003|Overall Study|Missed follow-up dental exam|6|||
124860670|NCT02395120|449112787|FG004|Overall Study|Missed follow-up dental exam|51|||
124860671|NCT00674986|449112789|FG000|Overall Study|Adverse Event|2|||
124860672|NCT00674986|449112790|FG001|Overall Study|Adverse Event|1|||
124860673|NCT00674986|449112789|FG000|Overall Study|Subject withdrew consent|12|||
124860674|NCT00674986|449112790|FG001|Overall Study|Subject withdrew consent|19|||
124860675|NCT00674986|449112789|FG000|Overall Study|Lost to Follow-up|25|||
124860676|NCT00674986|449112790|FG001|Overall Study|Lost to Follow-up|53|||
124860677|NCT00674986|449112789|FG000|Overall Study|Other reasons|4|||
124860678|NCT00674986|449112790|FG001|Overall Study|Other reasons|8|||
124860679|NCT02526693|449112791|FG000|Overall Study|Physician Decision|3|||
124860680|NCT02526693|449112792|FG001|Overall Study|Physician Decision|1|||
124860681|NCT01585103|449112794|FG000|Overall Study|Unable to swallow Cytosponge|6|||
124860682|NCT03581305|449112796|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
124860683|NCT03581305|449112797|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
124860684|NCT03581305|449112796|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
124860685|NCT03581305|449112797|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
124860686|NCT03581305|449112796|FG000|Serotonergic Study|Withdrawal by Subject|5|||
124860687|NCT03581305|449112797|FG001|Serotonergic Study|Withdrawal by Subject|1|||
124860688|NCT01798927|449112800|FG000|Overall Study|Withdrawal by Subject|1|||
124860689|NCT03750552|449112801|FG000|Overall Study|Adverse Event|5|||
124860690|NCT03750552|449112802|FG001|Overall Study|Adverse Event|1|||
124860691|NCT03750552|449112801|FG000|Overall Study|Withdrawal by Subject|1|||
124860692|NCT03750552|449112802|FG001|Overall Study|Withdrawal by Subject|1|||
124860693|NCT03750552|449112801|FG000|Overall Study|Other|2|||
124860694|NCT03750552|449112802|FG001|Overall Study|Other|0|||
124860695|NCT00626522|449112803|FG000|Overall Study|Protocol Violation|0|||
124860696|NCT00626522|449112804|FG001|Overall Study|Protocol Violation|0|||
124860697|NCT00626522|449112805|FG002|Overall Study|Protocol Violation|0|||
124860698|NCT00626522|449112806|FG003|Overall Study|Protocol Violation|0|||
124860699|NCT00626522|449112807|FG004|Overall Study|Protocol Violation|1|||
124860700|NCT00626522|449112808|FG005|Overall Study|Protocol Violation|0|||
124860701|NCT00626522|449112803|FG000|Overall Study|Adverse Event|2|||
124860702|NCT00626522|449112804|FG001|Overall Study|Adverse Event|1|||
124860703|NCT00626522|449112805|FG002|Overall Study|Adverse Event|2|||
124860704|NCT00626522|449112806|FG003|Overall Study|Adverse Event|0|||
124860705|NCT00626522|449112807|FG004|Overall Study|Adverse Event|1|||
124860706|NCT00626522|449112808|FG005|Overall Study|Adverse Event|1|||
124860707|NCT00626522|449112803|FG000|Overall Study|Withdrawal by Subject|2|||
124860708|NCT00626522|449112804|FG001|Overall Study|Withdrawal by Subject|5|||
124860709|NCT00626522|449112805|FG002|Overall Study|Withdrawal by Subject|5|||
124860710|NCT00626522|449112806|FG003|Overall Study|Withdrawal by Subject|0|||
124860711|NCT00626522|449112807|FG004|Overall Study|Withdrawal by Subject|4|||
124860712|NCT00626522|449112808|FG005|Overall Study|Withdrawal by Subject|1|||
124860713|NCT00626522|449112803|FG000|Overall Study|COPD exacerbation|0|||
124860714|NCT00626522|449112804|FG001|Overall Study|COPD exacerbation|0|||
124860715|NCT00626522|449112805|FG002|Overall Study|COPD exacerbation|0|||
124860716|NCT00626522|449112806|FG003|Overall Study|COPD exacerbation|1|||
124860717|NCT00626522|449112807|FG004|Overall Study|COPD exacerbation|1|||
124860718|NCT00626522|449112808|FG005|Overall Study|COPD exacerbation|0|||
124860719|NCT00626522|449112803|FG000|Overall Study|Lost to Follow-up|0|||
124860720|NCT00626522|449112804|FG001|Overall Study|Lost to Follow-up|1|||
124860721|NCT00626522|449112805|FG002|Overall Study|Lost to Follow-up|0|||
124860722|NCT00626522|449112806|FG003|Overall Study|Lost to Follow-up|0|||
124860723|NCT00626522|449112807|FG004|Overall Study|Lost to Follow-up|0|||
124860724|NCT00626522|449112808|FG005|Overall Study|Lost to Follow-up|0|||
124860725|NCT00626522|449112803|FG000|Overall Study|Inconsistent reason reported|1|||
124860726|NCT00626522|449112804|FG001|Overall Study|Inconsistent reason reported|0|||
124860727|NCT00626522|449112805|FG002|Overall Study|Inconsistent reason reported|0|||
124860728|NCT00626522|449112806|FG003|Overall Study|Inconsistent reason reported|0|||
124860729|NCT00626522|449112807|FG004|Overall Study|Inconsistent reason reported|0|||
124860730|NCT00626522|449112808|FG005|Overall Study|Inconsistent reason reported|0|||
124860731|NCT00626522|449112803|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
124860732|NCT00626522|449112804|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
124860733|NCT00626522|449112805|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
124860734|NCT00626522|449112806|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
124860735|NCT00626522|449112807|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
124860736|NCT00626522|449112808|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
124860737|NCT01490632|449112811|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
124860738|NCT01490632|449112812|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
124860739|NCT01490632|449112813|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
124860740|NCT01490632|449112814|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
124860741|NCT01490632|449112815|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
124860742|NCT01490632|449112816|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
124860743|NCT01490632|449112817|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
124860744|NCT01490632|449112818|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
124860745|NCT01490632|449112819|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
124860746|NCT01490632|449112820|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
124860747|NCT01490632|449112821|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
124860748|NCT01490632|449112822|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
124860749|NCT01490632|449112823|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
124860750|NCT01490632|449112824|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
124860751|NCT01490632|449112825|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
124860752|NCT01490632|449112826|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
124860753|NCT01490632|449112827|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
124860754|NCT01490632|449112828|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
124860755|NCT01490632|449112829|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
124860756|NCT01490632|449112830|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
124860757|NCT01490632|449112811|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
124860758|NCT01490632|449112812|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
124860759|NCT01490632|449112813|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
124860760|NCT01490632|449112814|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
124860761|NCT01490632|449112815|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860762|NCT01490632|449112816|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860763|NCT01490632|449112817|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860764|NCT01490632|449112818|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860765|NCT01490632|449112819|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860766|NCT01490632|449112820|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860767|NCT01490632|449112821|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860768|NCT01490632|449112822|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860769|NCT01490632|449112823|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860770|NCT01490632|449112824|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860771|NCT01490632|449112825|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860772|NCT01490632|449112826|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860773|NCT01490632|449112827|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860774|NCT01490632|449112828|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860775|NCT01490632|449112829|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860776|NCT01490632|449112830|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
124860777|NCT01490632|449112811|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860778|NCT01490632|449112812|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860779|NCT01490632|449112813|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
124860780|NCT01490632|449112814|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
124860781|NCT01490632|449112815|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
124860782|NCT01490632|449112816|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860783|NCT01490632|449112817|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860784|NCT01490632|449112818|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860785|NCT01490632|449112819|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860786|NCT01490632|449112820|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860787|NCT01490632|449112821|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860788|NCT01490632|449112822|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860789|NCT01490632|449112823|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860790|NCT01490632|449112824|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860791|NCT01490632|449112825|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860792|NCT01490632|449112826|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860793|NCT01490632|449112827|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860794|NCT01490632|449112828|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860795|NCT01490632|449112829|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860796|NCT01490632|449112830|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
124860797|NCT01490632|449112811|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
124860798|NCT01490632|449112812|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
124860799|NCT01490632|449112813|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
124860800|NCT01490632|449112814|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
124860801|NCT01490632|449112815|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
124860802|NCT01490632|449112816|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
124860803|NCT01490632|449112817|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
124860804|NCT01490632|449112818|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
124860805|NCT01490632|449112819|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
124860806|NCT01490632|449112820|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
124860807|NCT01490632|449112821|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
124860808|NCT01490632|449112822|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
124860809|NCT01490632|449112823|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
124860810|NCT01490632|449112824|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
124860811|NCT01490632|449112825|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
124860812|NCT01490632|449112826|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
124860813|NCT01490632|449112827|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
124860814|NCT01490632|449112828|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
124860815|NCT01490632|449112829|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
124860816|NCT01490632|449112830|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
124860817|NCT01490632|449112811|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
124860818|NCT01490632|449112812|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860819|NCT01490632|449112813|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860820|NCT01490632|449112814|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860821|NCT01490632|449112815|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860822|NCT01490632|449112816|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860823|NCT01490632|449112817|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860824|NCT01490632|449112818|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860825|NCT01490632|449112819|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860826|NCT01490632|449112820|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860827|NCT01490632|449112821|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860828|NCT01490632|449112822|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860829|NCT01490632|449112823|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860830|NCT01490632|449112824|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860831|NCT01490632|449112825|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860832|NCT01490632|449112826|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860833|NCT01490632|449112827|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860834|NCT01490632|449112828|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860835|NCT01490632|449112829|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860836|NCT01490632|449112830|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
124860837|NCT01490632|449112811|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
124860838|NCT01490632|449112812|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
124860839|NCT01490632|449112813|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860840|NCT01490632|449112814|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
124860841|NCT01490632|449112815|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
124860842|NCT01490632|449112816|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860843|NCT01490632|449112817|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860844|NCT01490632|449112818|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860845|NCT01490632|449112819|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860846|NCT01490632|449112820|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860847|NCT01490632|449112821|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860848|NCT01490632|449112822|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860849|NCT01490632|449112823|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860850|NCT01490632|449112824|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860851|NCT01490632|449112825|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860852|NCT01490632|449112826|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860853|NCT01490632|449112827|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860854|NCT01490632|449112828|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860855|NCT01490632|449112829|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860856|NCT01490632|449112830|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
124860857|NCT01490632|449112811|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860858|NCT01490632|449112812|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860859|NCT01490632|449112813|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860860|NCT01490632|449112814|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860861|NCT01490632|449112815|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
124860862|NCT01490632|449112816|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860863|NCT01490632|449112817|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860864|NCT01490632|449112818|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860865|NCT01490632|449112819|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860866|NCT01490632|449112820|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860867|NCT01490632|449112821|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860868|NCT01490632|449112822|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860869|NCT01490632|449112823|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860870|NCT01490632|449112824|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860871|NCT01490632|449112825|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860872|NCT01490632|449112826|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860873|NCT01490632|449112827|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860874|NCT01490632|449112828|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860875|NCT01490632|449112829|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860876|NCT01490632|449112830|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
124860877|NCT01490632|449112811|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860878|NCT01490632|449112812|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860879|NCT01490632|449112813|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860880|NCT01490632|449112814|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860881|NCT01490632|449112815|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860882|NCT01490632|449112816|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
124860883|NCT01490632|449112817|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
124860884|NCT01490632|449112818|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860885|NCT01490632|449112819|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860886|NCT01490632|449112820|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
124860887|NCT01490632|449112821|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
124860888|NCT01490632|449112822|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
124860889|NCT01490632|449112823|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860890|NCT01490632|449112824|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860891|NCT01490632|449112825|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860892|NCT01490632|449112826|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860893|NCT01490632|449112827|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860894|NCT01490632|449112828|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860895|NCT01490632|449112829|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860896|NCT01490632|449112830|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
124860897|NCT01490632|449112811|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860898|NCT01490632|449112812|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860899|NCT01490632|449112813|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860900|NCT01490632|449112814|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860901|NCT01490632|449112815|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860902|NCT01490632|449112816|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860903|NCT01490632|449112817|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
124860904|NCT01490632|449112818|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860905|NCT01490632|449112819|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
124860906|NCT01490632|449112820|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
124860907|NCT01490632|449112821|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
124860908|NCT01490632|449112822|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860909|NCT01490632|449112823|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860910|NCT01490632|449112824|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860911|NCT01490632|449112825|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860912|NCT01490632|449112826|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860913|NCT01490632|449112827|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860914|NCT01490632|449112828|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860915|NCT01490632|449112829|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860916|NCT01490632|449112830|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
124860917|NCT01490632|449112811|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860918|NCT01490632|449112812|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860919|NCT01490632|449112813|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860920|NCT01490632|449112814|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860921|NCT01490632|449112815|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860922|NCT01490632|449112816|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860923|NCT01490632|449112817|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
124860924|NCT01490632|449112818|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860925|NCT01490632|449112819|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860926|NCT01490632|449112820|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
124860927|NCT01490632|449112821|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860928|NCT01490632|449112822|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860929|NCT01490632|449112823|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860930|NCT01490632|449112824|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860931|NCT01490632|449112825|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860932|NCT01490632|449112826|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860933|NCT01490632|449112827|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860934|NCT01490632|449112828|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860935|NCT01490632|449112829|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860936|NCT01490632|449112830|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
124860937|NCT01490632|449112811|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860938|NCT01490632|449112812|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860939|NCT01490632|449112813|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860940|NCT01490632|449112814|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860941|NCT01490632|449112815|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860942|NCT01490632|449112816|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860943|NCT01490632|449112817|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
124860944|NCT01490632|449112818|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860945|NCT01490632|449112819|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860946|NCT01490632|449112820|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860947|NCT01490632|449112821|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860948|NCT01490632|449112822|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860949|NCT01490632|449112823|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860950|NCT01490632|449112824|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860951|NCT01490632|449112825|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860952|NCT01490632|449112826|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860953|NCT01490632|449112827|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860954|NCT01490632|449112828|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860955|NCT01490632|449112829|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860956|NCT01490632|449112830|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
124860957|NCT01490632|449112811|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860958|NCT01490632|449112812|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860959|NCT01490632|449112813|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860960|NCT01490632|449112814|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860961|NCT01490632|449112815|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860962|NCT01490632|449112816|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
124860963|NCT01490632|449112817|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860964|NCT01490632|449112818|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860965|NCT01490632|449112819|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860966|NCT01490632|449112820|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860967|NCT01490632|449112821|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860968|NCT01490632|449112822|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860969|NCT01490632|449112823|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860970|NCT01490632|449112824|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860971|NCT01490632|449112825|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860972|NCT01490632|449112826|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860973|NCT01490632|449112827|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860974|NCT01490632|449112828|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860975|NCT01490632|449112829|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860976|NCT01490632|449112830|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
124860977|NCT01490632|449112811|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860978|NCT01490632|449112812|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860979|NCT01490632|449112813|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860980|NCT01490632|449112814|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860981|NCT01490632|449112815|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860982|NCT01490632|449112816|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860983|NCT01490632|449112817|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
124860984|NCT01490632|449112818|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860985|NCT01490632|449112819|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
124860986|NCT01490632|449112820|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860987|NCT01490632|449112821|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
124860988|NCT01490632|449112822|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
124860989|NCT01490632|449112823|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860990|NCT01490632|449112824|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860991|NCT01490632|449112825|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860992|NCT01490632|449112826|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860993|NCT01490632|449112827|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860994|NCT01490632|449112828|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860995|NCT01490632|449112829|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860996|NCT01490632|449112830|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
124860997|NCT01490632|449112811|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124860998|NCT01490632|449112812|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124860999|NCT01490632|449112813|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861000|NCT01490632|449112814|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861001|NCT01490632|449112815|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861002|NCT01490632|449112816|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
124861003|NCT01490632|449112817|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
124861004|NCT01490632|449112818|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
124861005|NCT01490632|449112819|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
124861006|NCT01490632|449112820|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
124861007|NCT01490632|449112821|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
124861008|NCT01490632|449112822|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
124861009|NCT01490632|449112823|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861010|NCT01490632|449112824|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861011|NCT01490632|449112825|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861012|NCT01490632|449112826|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861013|NCT01490632|449112827|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861014|NCT01490632|449112828|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861015|NCT01490632|449112829|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861016|NCT01490632|449112830|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
124861017|NCT01490632|449112811|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861018|NCT01490632|449112812|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861019|NCT01490632|449112813|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861020|NCT01490632|449112814|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861021|NCT01490632|449112815|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861022|NCT01490632|449112816|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861023|NCT01490632|449112817|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861024|NCT01490632|449112818|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861025|NCT01490632|449112819|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861026|NCT01490632|449112820|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861027|NCT01490632|449112821|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861028|NCT01490632|449112822|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861029|NCT01490632|449112823|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861030|NCT01490632|449112824|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861031|NCT01490632|449112825|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
124861032|NCT01490632|449112826|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
124861033|NCT01490632|449112827|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861034|NCT01490632|449112828|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861035|NCT01490632|449112829|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861036|NCT01490632|449112830|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
124861037|NCT01490632|449112811|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861038|NCT01490632|449112812|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861039|NCT01490632|449112813|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861040|NCT01490632|449112814|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861041|NCT01490632|449112815|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861042|NCT01490632|449112816|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861043|NCT01490632|449112817|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861044|NCT01490632|449112818|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861045|NCT01490632|449112819|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861046|NCT01490632|449112820|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861047|NCT01490632|449112821|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861048|NCT01490632|449112822|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861049|NCT01490632|449112823|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861050|NCT01490632|449112824|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
124861051|NCT01490632|449112825|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861052|NCT01490632|449112826|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861053|NCT01490632|449112827|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861054|NCT01490632|449112828|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861055|NCT01490632|449112829|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861056|NCT01490632|449112830|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
124861057|NCT01490632|449112811|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861058|NCT01490632|449112812|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861059|NCT01490632|449112813|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861060|NCT01490632|449112814|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861061|NCT01490632|449112815|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861062|NCT01490632|449112816|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861063|NCT01490632|449112817|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861064|NCT01490632|449112818|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861065|NCT01490632|449112819|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861066|NCT01490632|449112820|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861067|NCT01490632|449112821|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861068|NCT01490632|449112822|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861069|NCT01490632|449112823|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861070|NCT01490632|449112824|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861071|NCT01490632|449112825|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
124861072|NCT01490632|449112826|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
124861073|NCT01490632|449112827|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861074|NCT01490632|449112828|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861075|NCT01490632|449112829|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861076|NCT01490632|449112830|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
124861077|NCT01490632|449112811|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861078|NCT01490632|449112812|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861079|NCT01490632|449112813|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861080|NCT01490632|449112814|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861081|NCT01490632|449112815|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861082|NCT01490632|449112816|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861083|NCT01490632|449112817|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861084|NCT01490632|449112818|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861085|NCT01490632|449112819|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861086|NCT01490632|449112820|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861087|NCT01490632|449112821|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861088|NCT01490632|449112822|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861089|NCT01490632|449112823|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
124861090|NCT01490632|449112824|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
124861091|NCT01490632|449112825|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
124861092|NCT01490632|449112826|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
124861093|NCT01490632|449112827|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861094|NCT01490632|449112828|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861095|NCT01490632|449112829|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861096|NCT01490632|449112830|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
124861097|NCT01490632|449112811|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
124861098|NCT01490632|449112812|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
124861099|NCT01490632|449112813|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
124861100|NCT01490632|449112814|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
124861101|NCT01490632|449112815|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
124861102|NCT01490632|449112816|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
124861103|NCT01490632|449112817|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
124861104|NCT01490632|449112818|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
124861105|NCT01490632|449112819|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
124861106|NCT01490632|449112820|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
124861107|NCT01490632|449112821|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
124861108|NCT01490632|449112822|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
124861109|NCT01490632|449112823|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
124861110|NCT01490632|449112824|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
124861111|NCT01490632|449112825|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
124861112|NCT01490632|449112826|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
124861113|NCT01490632|449112827|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
124861114|NCT01490632|449112828|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
124861115|NCT01490632|449112829|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
124861116|NCT01490632|449112830|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
124861117|NCT01490632|449112811|FG000|Part D: Re-Treatment Period|Death|0|||
124861118|NCT01490632|449112812|FG001|Part D: Re-Treatment Period|Death|0|||
124861119|NCT01490632|449112813|FG002|Part D: Re-Treatment Period|Death|0|||
124861120|NCT01490632|449112814|FG003|Part D: Re-Treatment Period|Death|0|||
124861121|NCT01490632|449112815|FG004|Part D: Re-Treatment Period|Death|0|||
124861122|NCT01490632|449112816|FG005|Part D: Re-Treatment Period|Death|0|||
124861123|NCT01490632|449112817|FG006|Part D: Re-Treatment Period|Death|0|||
124861124|NCT01490632|449112818|FG007|Part D: Re-Treatment Period|Death|0|||
124861125|NCT01490632|449112819|FG008|Part D: Re-Treatment Period|Death|0|||
124861126|NCT01490632|449112820|FG009|Part D: Re-Treatment Period|Death|0|||
124861127|NCT01490632|449112821|FG010|Part D: Re-Treatment Period|Death|0|||
124861128|NCT01490632|449112822|FG011|Part D: Re-Treatment Period|Death|0|||
124861129|NCT01490632|449112823|FG012|Part D: Re-Treatment Period|Death|0|||
124861130|NCT01490632|449112824|FG013|Part D: Re-Treatment Period|Death|0|||
124861131|NCT01490632|449112825|FG014|Part D: Re-Treatment Period|Death|0|||
124861132|NCT01490632|449112826|FG015|Part D: Re-Treatment Period|Death|0|||
124861133|NCT01490632|449112827|FG016|Part D: Re-Treatment Period|Death|0|||
124861134|NCT01490632|449112828|FG017|Part D: Re-Treatment Period|Death|0|||
124861135|NCT01490632|449112829|FG018|Part D: Re-Treatment Period|Death|1|||
124861136|NCT01490632|449112830|FG019|Part D: Re-Treatment Period|Death|0|||
124861137|NCT01490632|449112811|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861138|NCT01490632|449112812|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861139|NCT01490632|449112813|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861140|NCT01490632|449112814|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861141|NCT01490632|449112815|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861142|NCT01490632|449112816|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861143|NCT01490632|449112817|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861144|NCT01490632|449112818|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861145|NCT01490632|449112819|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861146|NCT01490632|449112820|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861147|NCT01490632|449112821|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861148|NCT01490632|449112822|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861149|NCT01490632|449112823|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861150|NCT01490632|449112824|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861151|NCT01490632|449112825|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861152|NCT01490632|449112826|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861153|NCT01490632|449112827|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
124861154|NCT01490632|449112828|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
124861155|NCT01490632|449112829|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
124861156|NCT01490632|449112830|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
124861157|NCT01490632|449112811|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861158|NCT01490632|449112812|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861159|NCT01490632|449112813|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861160|NCT01490632|449112814|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861161|NCT01490632|449112815|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861162|NCT01490632|449112816|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861163|NCT01490632|449112817|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861164|NCT01490632|449112818|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861165|NCT01490632|449112819|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861166|NCT01490632|449112820|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861167|NCT01490632|449112821|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861168|NCT01490632|449112822|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861169|NCT01490632|449112823|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861170|NCT01490632|449112824|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861171|NCT01490632|449112825|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861172|NCT01490632|449112826|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861173|NCT01490632|449112827|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861174|NCT01490632|449112828|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861175|NCT01490632|449112829|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
124861176|NCT01490632|449112830|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
124861177|NCT01490632|449112811|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
124861178|NCT01490632|449112812|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
124861179|NCT01490632|449112813|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
124861180|NCT01490632|449112814|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
124861181|NCT01490632|449112815|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
124861182|NCT01490632|449112816|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
124861183|NCT01490632|449112817|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
124861184|NCT01490632|449112818|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
124861185|NCT01490632|449112819|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
124861186|NCT01490632|449112820|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
124861187|NCT01490632|449112821|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
124861188|NCT01490632|449112822|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
124861189|NCT01490632|449112823|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
124861190|NCT01490632|449112824|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
124861191|NCT01490632|449112825|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
124861192|NCT01490632|449112826|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
124861193|NCT01490632|449112827|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
124861194|NCT01490632|449112828|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
124861195|NCT01490632|449112829|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
124861196|NCT01490632|449112830|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
124861197|NCT01490632|449112811|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
124861198|NCT01490632|449112812|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
124861199|NCT01490632|449112813|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
124861200|NCT01490632|449112814|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
124861201|NCT01490632|449112815|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
124861202|NCT01490632|449112816|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
124861203|NCT01490632|449112817|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
124861204|NCT01490632|449112818|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
124861205|NCT01490632|449112819|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
124861206|NCT01490632|449112820|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
124861207|NCT01490632|449112821|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
124861208|NCT01490632|449112822|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
124861209|NCT01490632|449112823|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
124861210|NCT01490632|449112824|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
124861211|NCT01490632|449112825|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
124861212|NCT01490632|449112826|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
124861213|NCT01490632|449112827|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
124861214|NCT01490632|449112828|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
124861215|NCT01490632|449112829|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
124861216|NCT01490632|449112830|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
124861217|NCT01490632|449112811|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861218|NCT01490632|449112812|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861219|NCT01490632|449112813|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861220|NCT01490632|449112814|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861221|NCT01490632|449112815|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861222|NCT01490632|449112816|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861223|NCT01490632|449112817|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861224|NCT01490632|449112818|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861225|NCT01490632|449112819|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861226|NCT01490632|449112820|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861227|NCT01490632|449112821|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861228|NCT01490632|449112822|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861229|NCT01490632|449112823|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861230|NCT01490632|449112824|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861231|NCT01490632|449112825|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861232|NCT01490632|449112826|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861233|NCT01490632|449112827|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
124861234|NCT01490632|449112828|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
124861235|NCT01490632|449112829|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
124861236|NCT01490632|449112830|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
124861237|NCT03822533|449112831|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
124861238|NCT03822533|449112832|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
124861239|NCT03822533|449112831|FG000|3 Month Follow-up|Lost to Follow-up|2|||
124861240|NCT03822533|449112832|FG001|3 Month Follow-up|Lost to Follow-up|2|||
124861241|NCT03822533|449112831|FG000|6 Month Follow-up|Lost to Follow-up|3|||
124861242|NCT03822533|449112832|FG001|6 Month Follow-up|Lost to Follow-up|0|||
124861243|NCT03822533|449112831|FG000|12 Month Follow-up|Lost to Follow-up|2|||
124861244|NCT03822533|449112832|FG001|12 Month Follow-up|Lost to Follow-up|3|||
124861245|NCT03822533|449112831|FG000|12 Month Follow-up|Pregnancy|0|||
124861246|NCT03822533|449112832|FG001|12 Month Follow-up|Pregnancy|1|||
124861247|NCT03822533|449112831|FG000|12 Month Follow-up|Surgery|2|||
124861248|NCT03822533|449112832|FG001|12 Month Follow-up|Surgery|0|||
124861249|NCT03822533|449112831|FG000|12 Month Follow-up|Wrong address|1|||
124861250|NCT03822533|449112832|FG001|12 Month Follow-up|Wrong address|0|||
124861251|NCT03822533|449112831|FG000|12 Month Follow-up|No symptoms|1|||
124861252|NCT03822533|449112832|FG001|12 Month Follow-up|No symptoms|0|||
124861253|NCT03822533|449112831|FG000|12 Month Follow-up|Changed primary care center|0|||
124861254|NCT03822533|449112832|FG001|12 Month Follow-up|Changed primary care center|1|||
124861255|NCT02349295|449112834|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
124861256|NCT02349295|449112835|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
124861257|NCT02349295|449112836|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
124861258|NCT02349295|449112837|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861259|NCT02349295|449112838|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861260|NCT02349295|449112839|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861261|NCT02349295|449112840|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861262|NCT02349295|449112841|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861263|NCT02349295|449112842|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861264|NCT02349295|449112843|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861265|NCT02349295|449112844|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861266|NCT02349295|449112845|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861267|NCT02349295|449112846|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861268|NCT02349295|449112847|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
124861269|NCT02349295|449112834|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
124861270|NCT02349295|449112835|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
124861271|NCT02349295|449112836|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
124861272|NCT02349295|449112837|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861273|NCT02349295|449112838|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861274|NCT02349295|449112839|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861275|NCT02349295|449112840|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861276|NCT02349295|449112841|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861277|NCT02349295|449112842|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861278|NCT02349295|449112843|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861279|NCT02349295|449112844|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861280|NCT02349295|449112845|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861281|NCT02349295|449112846|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861282|NCT02349295|449112847|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
124861283|NCT02349295|449112834|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
124861284|NCT02349295|449112835|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
124861285|NCT02349295|449112836|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
124861286|NCT02349295|449112837|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861287|NCT02349295|449112838|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861288|NCT02349295|449112839|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861289|NCT02349295|449112840|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861290|NCT02349295|449112841|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861291|NCT02349295|449112842|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861292|NCT02349295|449112843|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861293|NCT02349295|449112844|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861294|NCT02349295|449112845|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861295|NCT02349295|449112846|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861296|NCT02349295|449112847|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
124861297|NCT02349295|449112834|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
124861298|NCT02349295|449112835|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
124861299|NCT02349295|449112836|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
124861300|NCT02349295|449112837|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861301|NCT02349295|449112838|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861302|NCT02349295|449112839|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861303|NCT02349295|449112840|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861304|NCT02349295|449112841|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861305|NCT02349295|449112842|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861306|NCT02349295|449112843|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861307|NCT02349295|449112844|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861308|NCT02349295|449112845|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861309|NCT02349295|449112846|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861310|NCT02349295|449112847|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
124861311|NCT02349295|449112834|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861312|NCT02349295|449112835|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
124861313|NCT02349295|449112836|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
124861314|NCT02349295|449112837|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861315|NCT02349295|449112838|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861316|NCT02349295|449112839|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861317|NCT02349295|449112840|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861318|NCT02349295|449112841|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861319|NCT02349295|449112842|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861320|NCT02349295|449112843|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861321|NCT02349295|449112844|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861322|NCT02349295|449112845|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861323|NCT02349295|449112846|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861324|NCT02349295|449112847|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
124861325|NCT02349295|449112834|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
124861326|NCT02349295|449112835|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
124861327|NCT02349295|449112836|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
124861328|NCT02349295|449112837|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
124861329|NCT02349295|449112838|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
124861330|NCT02349295|449112839|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
124861331|NCT02349295|449112840|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
124861332|NCT02349295|449112841|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
124861333|NCT02349295|449112842|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
124861334|NCT02349295|449112843|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
124861335|NCT02349295|449112844|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
124861336|NCT02349295|449112845|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
124861337|NCT02349295|449112846|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
124861338|NCT02349295|449112847|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
124861339|NCT02349295|449112834|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861340|NCT02349295|449112835|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861341|NCT02349295|449112836|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861342|NCT02349295|449112837|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861343|NCT02349295|449112838|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861344|NCT02349295|449112839|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861345|NCT02349295|449112840|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861346|NCT02349295|449112841|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
124861347|NCT02349295|449112842|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
124861348|NCT02349295|449112843|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
124861349|NCT02349295|449112844|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
124861350|NCT02349295|449112845|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861351|NCT02349295|449112846|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861352|NCT02349295|449112847|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
124861353|NCT02349295|449112834|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861354|NCT02349295|449112835|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861355|NCT02349295|449112836|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861356|NCT02349295|449112837|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861357|NCT02349295|449112838|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861358|NCT02349295|449112839|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861359|NCT02349295|449112840|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861360|NCT02349295|449112841|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
124861361|NCT02349295|449112842|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
124861362|NCT02349295|449112843|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
124861363|NCT02349295|449112844|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
124861364|NCT02349295|449112845|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861365|NCT02349295|449112846|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861366|NCT02349295|449112847|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
124861367|NCT02349295|449112834|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861368|NCT02349295|449112835|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861369|NCT02349295|449112836|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861370|NCT02349295|449112837|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861371|NCT02349295|449112838|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861372|NCT02349295|449112839|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861373|NCT02349295|449112840|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861374|NCT02349295|449112841|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
124861375|NCT02349295|449112842|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861376|NCT02349295|449112843|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
124861377|NCT02349295|449112844|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861378|NCT02349295|449112845|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861379|NCT02349295|449112846|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861380|NCT02349295|449112847|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
124861381|NCT02349295|449112834|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
124861382|NCT02349295|449112835|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
124861383|NCT02349295|449112836|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
124861384|NCT02349295|449112837|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
124861385|NCT02349295|449112838|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
124861386|NCT02349295|449112839|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
124861387|NCT02349295|449112840|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
124861388|NCT02349295|449112841|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
124861389|NCT02349295|449112842|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
124861390|NCT02349295|449112843|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
124861391|NCT02349295|449112844|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
124861392|NCT02349295|449112845|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
124861393|NCT02349295|449112846|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
124861394|NCT02349295|449112847|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
124861395|NCT02349295|449112834|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861396|NCT02349295|449112835|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861397|NCT02349295|449112836|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861398|NCT02349295|449112837|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861399|NCT02349295|449112838|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861400|NCT02349295|449112839|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861401|NCT02349295|449112840|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861402|NCT02349295|449112841|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
124861403|NCT02349295|449112842|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
124861404|NCT02349295|449112843|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
124861405|NCT02349295|449112844|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
124861406|NCT02349295|449112845|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861407|NCT02349295|449112846|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861408|NCT02349295|449112847|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
124861409|NCT02349295|449112834|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861410|NCT02349295|449112835|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861411|NCT02349295|449112836|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861412|NCT02349295|449112837|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861413|NCT02349295|449112838|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861414|NCT02349295|449112839|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861415|NCT02349295|449112840|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861416|NCT02349295|449112841|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
124861417|NCT02349295|449112842|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
124861418|NCT02349295|449112843|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861419|NCT02349295|449112844|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861420|NCT02349295|449112845|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861421|NCT02349295|449112846|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861422|NCT02349295|449112847|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
124861423|NCT02349295|449112834|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861424|NCT02349295|449112835|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861425|NCT02349295|449112836|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861426|NCT02349295|449112837|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861427|NCT02349295|449112838|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861428|NCT02349295|449112839|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861429|NCT02349295|449112840|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861430|NCT02349295|449112841|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
124861431|NCT02349295|449112842|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
124861432|NCT02349295|449112843|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861433|NCT02349295|449112844|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861434|NCT02349295|449112845|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861435|NCT02349295|449112846|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861436|NCT02349295|449112847|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
124861437|NCT02349295|449112834|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861438|NCT02349295|449112835|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861439|NCT02349295|449112836|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861440|NCT02349295|449112837|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861441|NCT02349295|449112838|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861442|NCT02349295|449112839|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861443|NCT02349295|449112840|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861444|NCT02349295|449112841|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861445|NCT02349295|449112842|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861446|NCT02349295|449112843|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861447|NCT02349295|449112844|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
124861448|NCT02349295|449112845|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
124861449|NCT02349295|449112846|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
124861450|NCT02349295|449112847|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
124861451|NCT02349295|449112834|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861452|NCT02349295|449112835|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861453|NCT02349295|449112836|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861454|NCT02349295|449112837|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861455|NCT02349295|449112838|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861456|NCT02349295|449112839|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861457|NCT02349295|449112840|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861458|NCT02349295|449112841|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861459|NCT02349295|449112842|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861460|NCT02349295|449112843|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861461|NCT02349295|449112844|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861462|NCT02349295|449112845|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
124861463|NCT02349295|449112846|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
124861464|NCT02349295|449112847|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
124861465|NCT02349295|449112834|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861466|NCT02349295|449112835|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861467|NCT02349295|449112836|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861468|NCT02349295|449112837|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861469|NCT02349295|449112838|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861470|NCT02349295|449112839|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861471|NCT02349295|449112840|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861472|NCT02349295|449112841|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861473|NCT02349295|449112842|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861474|NCT02349295|449112843|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861475|NCT02349295|449112844|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861476|NCT02349295|449112845|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
124861477|NCT02349295|449112846|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
124861478|NCT02349295|449112847|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
124861479|NCT02349295|449112834|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861480|NCT02349295|449112835|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861481|NCT02349295|449112836|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861482|NCT02349295|449112837|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861483|NCT02349295|449112838|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861484|NCT02349295|449112839|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861485|NCT02349295|449112840|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861486|NCT02349295|449112841|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861487|NCT02349295|449112842|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861488|NCT02349295|449112843|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861489|NCT02349295|449112844|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861490|NCT02349295|449112845|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
124861491|NCT02349295|449112846|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861492|NCT02349295|449112847|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
124861493|NCT02349295|449112834|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861494|NCT02349295|449112835|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861495|NCT02349295|449112836|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861496|NCT02349295|449112837|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861497|NCT02349295|449112838|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861498|NCT02349295|449112839|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861499|NCT02349295|449112840|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861500|NCT02349295|449112841|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861501|NCT02349295|449112842|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861502|NCT02349295|449112843|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861503|NCT02349295|449112844|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861504|NCT02349295|449112845|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
124861505|NCT02349295|449112846|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861506|NCT02349295|449112847|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
124861507|NCT02148250|449112850|FG000|Screening|Withdrawal by Subject|5|||
124861508|NCT02148250|449112851|FG001|Screening|Withdrawal by Subject|0|||
124861509|NCT00695903|449112856|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
124861510|NCT00695903|449112857|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
124861511|NCT00695903|449112856|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
124861512|NCT00695903|449112857|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
124861513|NCT00695903|449112856|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
124861514|NCT00695903|449112857|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
124861515|NCT00695903|449112856|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
124861516|NCT00695903|449112857|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
124861517|NCT00695903|449112856|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
124861518|NCT00695903|449112857|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
124861519|NCT00695903|449112856|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
124861520|NCT00695903|449112857|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
124861521|NCT00695903|449112856|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
124861522|NCT00695903|449112857|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
124861523|NCT00695903|449112856|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
124861524|NCT00695903|449112857|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
124861525|NCT00695903|449112856|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
124861526|NCT00695903|449112857|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
124861527|NCT04723576|449112858|FG000|Overall Study|Withdrawal by Subject|2133|||
124861528|NCT04723576|449112859|FG001|Overall Study|Withdrawal by Subject|3234|||
124861529|NCT02097472|449112860|FG000|Received Vaccination 2|Adverse Event|0|||
124861530|NCT02097472|449112861|FG001|Received Vaccination 2|Adverse Event|0|||
124861531|NCT02097472|449112862|FG002|Received Vaccination 2|Adverse Event|0|||
124861532|NCT02097472|449112863|FG003|Received Vaccination 2|Adverse Event|0|||
124861533|NCT02097472|449112864|FG004|Received Vaccination 2|Adverse Event|0|||
124861534|NCT02097472|449112865|FG005|Received Vaccination 2|Adverse Event|0|||
124861535|NCT02097472|449112866|FG006|Received Vaccination 2|Adverse Event|1|||
124861536|NCT02097472|449112867|FG007|Received Vaccination 2|Adverse Event|0|||
124861537|NCT03966157|449112868|FG000|Overall Study|Physician Decision|1|||
124861538|NCT03966157|449112869|FG001|Overall Study|Physician Decision|0|||
124861539|NCT03305016|449112870|FG000|Overall Study|Withdrawal by Subject|2|||
124861540|NCT01362140|449112871|FG000|Overall Study|Noncompliance|1|||
124861541|NCT01362140|449112872|FG001|Overall Study|Noncompliance|0|||
124861542|NCT01362140|449112871|FG000|Overall Study|Adverse Event|2|||
124861543|NCT01362140|449112872|FG001|Overall Study|Adverse Event|2|||
124861544|NCT01362140|449112871|FG000|Overall Study|Withdrawal by Subject|3|||
124861545|NCT01362140|449112872|FG001|Overall Study|Withdrawal by Subject|3|||
124861546|NCT01362140|449112871|FG000|Overall Study|Administrative Decision|0|||
124861547|NCT01362140|449112872|FG001|Overall Study|Administrative Decision|1|||
124861548|NCT01362140|449112871|FG000|Overall Study|Death|2|||
124861549|NCT01362140|449112872|FG001|Overall Study|Death|1|||
124861550|NCT01362140|449112871|FG000|Overall Study|Other|1|||
124861551|NCT01362140|449112872|FG001|Overall Study|Other|1|||
124861552|NCT01362140|449112871|FG000|Overall Study|Protocol-specified Criteria|1|||
124861553|NCT01362140|449112872|FG001|Overall Study|Protocol-specified Criteria|2|||
124861554|NCT01362140|449112871|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
124861555|NCT01362140|449112872|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
124861556|NCT06476366|449112874|FG000|Overall Study|Lost to Follow-up|1|||
124861557|NCT06476366|449112875|FG001|Overall Study|Lost to Follow-up|3|||
124861558|NCT06476366|449112874|FG000|Overall Study|Adverse Event|1|||
124861559|NCT06476366|449112875|FG001|Overall Study|Adverse Event|0|||
124861560|NCT02310750|449112880|FG000|HP Period 1|Lost to Follow-up|0|||
124861561|NCT02310750|449112881|FG001|HP Period 1|Lost to Follow-up|0|||
124861562|NCT02310750|449112882|FG002|HP Period 1|Lost to Follow-up|0|||
124861563|NCT02310750|449112883|FG003|HP Period 1|Lost to Follow-up|0|||
124861564|NCT02310750|449112884|FG004|HP Period 1|Lost to Follow-up|0|||
124861565|NCT02310750|449112885|FG005|HP Period 1|Lost to Follow-up|0|||
124861566|NCT02310750|449112886|FG006|HP Period 1|Lost to Follow-up|1|||
124861567|NCT02310750|449112887|FG007|HP Period 1|Lost to Follow-up|0|||
124861568|NCT02310750|449112888|FG008|HP Period 1|Lost to Follow-up|0|||
124861569|NCT02310750|449112889|FG009|HP Period 1|Lost to Follow-up|0|||
124861570|NCT02310750|449112890|FG010|HP Period 1|Lost to Follow-up|0|||
124861571|NCT02310750|449112891|FG011|HP Period 1|Lost to Follow-up|0|||
124861572|NCT02310750|449112892|FG012|HP Period 1|Lost to Follow-up|0|||
124861573|NCT02310750|449112893|FG013|HP Period 1|Lost to Follow-up|0|||
124861574|NCT02310750|449112894|FG014|HP Period 1|Lost to Follow-up|0|||
124861575|NCT02310750|449112895|FG015|HP Period 1|Lost to Follow-up|0|||
124861576|NCT02310750|449112880|FG000|HP Period 1|Withdrawal by Subject|1|||
124861577|NCT02310750|449112881|FG001|HP Period 1|Withdrawal by Subject|0|||
124861578|NCT02310750|449112882|FG002|HP Period 1|Withdrawal by Subject|0|||
124861579|NCT02310750|449112883|FG003|HP Period 1|Withdrawal by Subject|1|||
124861580|NCT02310750|449112884|FG004|HP Period 1|Withdrawal by Subject|0|||
124861581|NCT02310750|449112885|FG005|HP Period 1|Withdrawal by Subject|0|||
124861582|NCT02310750|449112886|FG006|HP Period 1|Withdrawal by Subject|0|||
124861583|NCT02310750|449112887|FG007|HP Period 1|Withdrawal by Subject|0|||
124861584|NCT02310750|449112888|FG008|HP Period 1|Withdrawal by Subject|0|||
124861585|NCT02310750|449112889|FG009|HP Period 1|Withdrawal by Subject|0|||
124861586|NCT02310750|449112890|FG010|HP Period 1|Withdrawal by Subject|0|||
124861587|NCT02310750|449112891|FG011|HP Period 1|Withdrawal by Subject|0|||
124861588|NCT02310750|449112892|FG012|HP Period 1|Withdrawal by Subject|0|||
124861589|NCT02310750|449112893|FG013|HP Period 1|Withdrawal by Subject|0|||
124861590|NCT02310750|449112894|FG014|HP Period 1|Withdrawal by Subject|0|||
124861591|NCT02310750|449112895|FG015|HP Period 1|Withdrawal by Subject|0|||
124861592|NCT02310750|449112880|FG000|HP Washout 1|Lost to Follow-up|0|||
124861593|NCT02310750|449112881|FG001|HP Washout 1|Lost to Follow-up|0|||
124861594|NCT02310750|449112882|FG002|HP Washout 1|Lost to Follow-up|1|||
124861595|NCT02310750|449112883|FG003|HP Washout 1|Lost to Follow-up|1|||
124861596|NCT02310750|449112884|FG004|HP Washout 1|Lost to Follow-up|2|||
124861597|NCT02310750|449112885|FG005|HP Washout 1|Lost to Follow-up|2|||
124861598|NCT02310750|449112886|FG006|HP Washout 1|Lost to Follow-up|3|||
124861599|NCT02310750|449112887|FG007|HP Washout 1|Lost to Follow-up|0|||
124861600|NCT02310750|449112888|FG008|HP Washout 1|Lost to Follow-up|0|||
124861601|NCT02310750|449112889|FG009|HP Washout 1|Lost to Follow-up|0|||
124861602|NCT02310750|449112890|FG010|HP Washout 1|Lost to Follow-up|0|||
124861603|NCT02310750|449112891|FG011|HP Washout 1|Lost to Follow-up|0|||
124861604|NCT02310750|449112892|FG012|HP Washout 1|Lost to Follow-up|0|||
124861605|NCT02310750|449112893|FG013|HP Washout 1|Lost to Follow-up|0|||
124861606|NCT02310750|449112894|FG014|HP Washout 1|Lost to Follow-up|0|||
124861607|NCT02310750|449112895|FG015|HP Washout 1|Lost to Follow-up|0|||
124861608|NCT02310750|449112880|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861609|NCT02310750|449112881|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861610|NCT02310750|449112882|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861611|NCT02310750|449112883|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
124861612|NCT02310750|449112884|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861613|NCT02310750|449112885|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
124861614|NCT02310750|449112886|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861615|NCT02310750|449112887|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861616|NCT02310750|449112888|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
124861617|NCT02310750|449112889|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
124861618|NCT02310750|449112890|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861619|NCT02310750|449112891|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861620|NCT02310750|449112892|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861621|NCT02310750|449112893|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861622|NCT02310750|449112894|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861623|NCT02310750|449112895|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
124861624|NCT02310750|449112880|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861625|NCT02310750|449112881|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861626|NCT02310750|449112882|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861627|NCT02310750|449112883|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861628|NCT02310750|449112884|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861629|NCT02310750|449112885|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861630|NCT02310750|449112886|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861631|NCT02310750|449112887|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861632|NCT02310750|449112888|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861633|NCT02310750|449112889|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
124861634|NCT02310750|449112890|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861635|NCT02310750|449112891|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861636|NCT02310750|449112892|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861637|NCT02310750|449112893|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861638|NCT02310750|449112894|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861639|NCT02310750|449112895|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
124861640|NCT02310750|449112880|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861641|NCT02310750|449112881|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861642|NCT02310750|449112882|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861643|NCT02310750|449112883|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861644|NCT02310750|449112884|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861645|NCT02310750|449112885|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861646|NCT02310750|449112886|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861647|NCT02310750|449112887|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
124861648|NCT02310750|449112888|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
124861649|NCT02310750|449112889|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
124861650|NCT02310750|449112890|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861651|NCT02310750|449112891|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861652|NCT02310750|449112892|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861653|NCT02310750|449112893|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861654|NCT02310750|449112894|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861655|NCT02310750|449112895|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
124861656|NCT02310750|449112880|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861657|NCT02310750|449112881|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861658|NCT02310750|449112882|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861659|NCT02310750|449112883|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861660|NCT02310750|449112884|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861661|NCT02310750|449112885|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861662|NCT02310750|449112886|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861663|NCT02310750|449112887|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
124861664|NCT02310750|449112888|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
124861665|NCT02310750|449112889|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861666|NCT02310750|449112890|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861667|NCT02310750|449112891|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861668|NCT02310750|449112892|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861669|NCT02310750|449112893|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861670|NCT02310750|449112894|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861671|NCT02310750|449112895|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
124861672|NCT02310750|449112880|FG000|HP Washout 2|Lost to Follow-up|0|||
124861673|NCT02310750|449112881|FG001|HP Washout 2|Lost to Follow-up|0|||
124861674|NCT02310750|449112882|FG002|HP Washout 2|Lost to Follow-up|0|||
124861675|NCT02310750|449112883|FG003|HP Washout 2|Lost to Follow-up|0|||
124861676|NCT02310750|449112884|FG004|HP Washout 2|Lost to Follow-up|1|||
124861677|NCT02310750|449112885|FG005|HP Washout 2|Lost to Follow-up|0|||
124861678|NCT02310750|449112886|FG006|HP Washout 2|Lost to Follow-up|7|||
124861679|NCT02310750|449112887|FG007|HP Washout 2|Lost to Follow-up|0|||
124861680|NCT02310750|449112888|FG008|HP Washout 2|Lost to Follow-up|0|||
124861681|NCT02310750|449112889|FG009|HP Washout 2|Lost to Follow-up|0|||
124861682|NCT02310750|449112890|FG010|HP Washout 2|Lost to Follow-up|0|||
124861683|NCT02310750|449112891|FG011|HP Washout 2|Lost to Follow-up|0|||
124861684|NCT02310750|449112892|FG012|HP Washout 2|Lost to Follow-up|0|||
124861685|NCT02310750|449112893|FG013|HP Washout 2|Lost to Follow-up|0|||
124861686|NCT02310750|449112894|FG014|HP Washout 2|Lost to Follow-up|0|||
124861687|NCT02310750|449112895|FG015|HP Washout 2|Lost to Follow-up|0|||
124861688|NCT01226745|449112896|FG000|Overall Study|Did not complete schedule of assessments|8|||
124861689|NCT01226745|449112897|FG001|Overall Study|Did not complete schedule of assessments|3|||
124861690|NCT01226745|449112898|FG002|Overall Study|Did not complete schedule of assessments|6|||
124861691|NCT01226745|449112899|FG003|Overall Study|Did not complete schedule of assessments|0|||
124861692|NCT01226745|449112900|FG004|Overall Study|Did not complete schedule of assessments|0|||
124861693|NCT01226745|449112901|FG005|Overall Study|Did not complete schedule of assessments|1|||
124861694|NCT01226745|449112896|FG000|Overall Study|Lost to Follow-up|2|||
124861695|NCT01226745|449112897|FG001|Overall Study|Lost to Follow-up|6|||
124861696|NCT01226745|449112898|FG002|Overall Study|Lost to Follow-up|6|||
124861697|NCT01226745|449112899|FG003|Overall Study|Lost to Follow-up|1|||
124861698|NCT01226745|449112900|FG004|Overall Study|Lost to Follow-up|1|||
124861699|NCT01226745|449112901|FG005|Overall Study|Lost to Follow-up|2|||
124861700|NCT01226745|449112896|FG000|Overall Study|Death|1|||
124861701|NCT01226745|449112897|FG001|Overall Study|Death|0|||
124861702|NCT01226745|449112898|FG002|Overall Study|Death|0|||
124861703|NCT01226745|449112899|FG003|Overall Study|Death|0|||
124861704|NCT01226745|449112900|FG004|Overall Study|Death|0|||
124861705|NCT01226745|449112901|FG005|Overall Study|Death|1|||
124861706|NCT01226745|449112896|FG000|Overall Study|Other|6|||
124861707|NCT01226745|449112897|FG001|Overall Study|Other|7|||
124861708|NCT01226745|449112898|FG002|Overall Study|Other|8|||
124861709|NCT01226745|449112899|FG003|Overall Study|Other|4|||
124861710|NCT01226745|449112900|FG004|Overall Study|Other|3|||
124861711|NCT01226745|449112901|FG005|Overall Study|Other|1|||
124861712|NCT01435577|449112904|FG000|Overall Study|Adverse Event|10|||
124861713|NCT01435577|449112905|FG001|Overall Study|Adverse Event|0|||
124861714|NCT01435577|449112904|FG000|Overall Study|Lack of Efficacy|7|||
124861715|NCT01435577|449112905|FG001|Overall Study|Lack of Efficacy|51|||
124861716|NCT01435577|449112904|FG000|Overall Study|Alternative treatment started|0|||
124861717|NCT01435577|449112905|FG001|Overall Study|Alternative treatment started|1|||
124861718|NCT01934218|449112906|FG000|Double-blind Phase|Adverse Event|8|||
124861719|NCT01934218|449112907|FG001|Double-blind Phase|Adverse Event|8|||
124861720|NCT01934218|449112906|FG000|Double-blind Phase|Lack of Efficacy|6|||
124861721|NCT01934218|449112907|FG001|Double-blind Phase|Lack of Efficacy|7|||
124861722|NCT01934218|449112906|FG000|Double-blind Phase|Lost to Follow-up|7|||
124861723|NCT01934218|449112907|FG001|Double-blind Phase|Lost to Follow-up|14|||
124861724|NCT01934218|449112906|FG000|Double-blind Phase|Physician Decision|1|||
124861725|NCT01934218|449112907|FG001|Double-blind Phase|Physician Decision|2|||
124861726|NCT01934218|449112906|FG000|Double-blind Phase|Protocol Violation|4|||
124861727|NCT01934218|449112907|FG001|Double-blind Phase|Protocol Violation|0|||
124861728|NCT01934218|449112906|FG000|Double-blind Phase|Withdrawal by Subject|16|||
124861729|NCT01934218|449112907|FG001|Double-blind Phase|Withdrawal by Subject|13|||
124861730|NCT01934218|449112906|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
124861731|NCT01934218|449112907|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
124861732|NCT01934218|449112906|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
124861733|NCT01934218|449112907|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
124861734|NCT01934218|449112906|FG000|Open-Label Phase|Adverse Event|2|||
124861735|NCT01934218|449112907|FG001|Open-Label Phase|Adverse Event|4|||
124861736|NCT01934218|449112906|FG000|Open-Label Phase|Lack of Efficacy|1|||
124861737|NCT01934218|449112907|FG001|Open-Label Phase|Lack of Efficacy|4|||
124861738|NCT01934218|449112906|FG000|Open-Label Phase|Lost to Follow-up|4|||
124861739|NCT01934218|449112907|FG001|Open-Label Phase|Lost to Follow-up|2|||
124861740|NCT01934218|449112906|FG000|Open-Label Phase|Physician Decision|1|||
124861741|NCT01934218|449112907|FG001|Open-Label Phase|Physician Decision|0|||
124861742|NCT01934218|449112906|FG000|Open-Label Phase|Protocol Violation|1|||
124861743|NCT01934218|449112907|FG001|Open-Label Phase|Protocol Violation|0|||
124861744|NCT01934218|449112906|FG000|Open-Label Phase|Withdrawal by Subject|13|||
124861745|NCT01934218|449112907|FG001|Open-Label Phase|Withdrawal by Subject|11|||
124861746|NCT01934218|449112906|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
124861747|NCT01934218|449112907|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
124861748|NCT01934218|449112906|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
124861749|NCT01934218|449112907|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
124861750|NCT01939028|449112910|FG000|Overall Study|Withdrawal by Subject|5|||
124861751|NCT01939028|449112910|FG000|Overall Study|Physician Decision|7|||
124861752|NCT00700401|449112915|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
124861753|NCT00700401|449112915|FG000|Overall Study|Adverse Event|5|||
124861754|NCT00700401|449112915|FG000|Overall Study|Refused Treatment|2|||
124861755|NCT00700401|449112915|FG000|Overall Study|Lost to Follow-up|1|||
124861756|NCT00700401|449112915|FG000|Overall Study|Treatment never started|1|||
124861757|NCT00700401|449112915|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
124861758|NCT00700401|449112915|FG000|Overall Study|Withdrawal by Subject|2|||
124861759|NCT01220557|449112916|FG000|Overall Study|Lost to Follow-up|5|||
124861760|NCT01220557|449112917|FG001|Overall Study|Lost to Follow-up|3|||
124861761|NCT01220557|449112916|FG000|Overall Study|attended less than 6 lessons|1|||
124861762|NCT01220557|449112917|FG001|Overall Study|attended less than 6 lessons|2|||
124861763|NCT01650259|449112918|FG000|Overall Study|Improvement|105|||
124861764|NCT01650259|449112919|FG001|Overall Study|Improvement|0|||
124861765|NCT01650259|449112918|FG000|Overall Study|Adverse Event|127|||
124861766|NCT01650259|449112919|FG001|Overall Study|Adverse Event|0|||
124861767|NCT01650259|449112918|FG000|Overall Study|Lack of Efficacy|143|||
124861768|NCT01650259|449112919|FG001|Overall Study|Lack of Efficacy|0|||
124861769|NCT01650259|449112918|FG000|Overall Study|Lost to Follow-up|435|||
124861770|NCT01650259|449112919|FG001|Overall Study|Lost to Follow-up|0|||
124861771|NCT01650259|449112918|FG000|Overall Study|Patients had no visit after entry|70|||
124861772|NCT01650259|449112919|FG001|Overall Study|Patients had no visit after entry|0|||
124861773|NCT01650259|449112918|FG000|Overall Study|CRF not collected|98|||
124861774|NCT01650259|449112919|FG001|Overall Study|CRF not collected|82|||
124861775|NCT01650259|449112918|FG000|Overall Study|Not treated|1|||
124861776|NCT01650259|449112919|FG001|Overall Study|Not treated|7|||
124861777|NCT01650259|449112918|FG000|Overall Study|Other than listed|64|||
124861778|NCT01650259|449112919|FG001|Overall Study|Other than listed|146|||
124861779|NCT04782323|449112920|FG000|Overall Study|Death|1|||
124861780|NCT04782323|449112921|FG001|Overall Study|Death|0|||
124861781|NCT04782323|449112922|FG002|Overall Study|Death|0|||
124861782|NCT04782323|449112923|FG003|Overall Study|Death|0|||
124861783|NCT04782323|449112924|FG004|Overall Study|Death|1|||
124861784|NCT04782323|449112925|FG005|Overall Study|Death|1|||
124861785|NCT04782323|449112926|FG006|Overall Study|Death|1|||
124861786|NCT04782323|449112927|FG007|Overall Study|Death|0|||
124861787|NCT04782323|449112920|FG000|Overall Study|Withdrawal by Subject|0|||
124861788|NCT04782323|449112921|FG001|Overall Study|Withdrawal by Subject|0|||
124861789|NCT04782323|449112922|FG002|Overall Study|Withdrawal by Subject|1|||
124861790|NCT04782323|449112923|FG003|Overall Study|Withdrawal by Subject|0|||
124861791|NCT04782323|449112924|FG004|Overall Study|Withdrawal by Subject|0|||
124861792|NCT04782323|449112925|FG005|Overall Study|Withdrawal by Subject|1|||
124861793|NCT04782323|449112926|FG006|Overall Study|Withdrawal by Subject|0|||
124861794|NCT04782323|449112927|FG007|Overall Study|Withdrawal by Subject|1|||
124861795|NCT04782323|449112920|FG000|Overall Study|Lost to Follow-up|0|||
124861796|NCT04782323|449112921|FG001|Overall Study|Lost to Follow-up|1|||
124861797|NCT04782323|449112922|FG002|Overall Study|Lost to Follow-up|1|||
124861798|NCT04782323|449112923|FG003|Overall Study|Lost to Follow-up|0|||
124861799|NCT04782323|449112924|FG004|Overall Study|Lost to Follow-up|0|||
124861800|NCT04782323|449112925|FG005|Overall Study|Lost to Follow-up|1|||
124861801|NCT04782323|449112926|FG006|Overall Study|Lost to Follow-up|1|||
124861802|NCT04782323|449112927|FG007|Overall Study|Lost to Follow-up|2|||
124861803|NCT04782323|449112920|FG000|Overall Study|randomization in error|1|||
124861804|NCT04782323|449112921|FG001|Overall Study|randomization in error|0|||
124861805|NCT04782323|449112922|FG002|Overall Study|randomization in error|0|||
124861806|NCT04782323|449112923|FG003|Overall Study|randomization in error|0|||
124861807|NCT04782323|449112924|FG004|Overall Study|randomization in error|0|||
124861808|NCT04782323|449112925|FG005|Overall Study|randomization in error|0|||
124861809|NCT04782323|449112926|FG006|Overall Study|randomization in error|0|||
124861810|NCT04782323|449112927|FG007|Overall Study|randomization in error|0|||
124861811|NCT02663128|449112932|FG000|Period 2|Physician Decision|0|||
124861812|NCT02663128|449112933|FG001|Period 2|Physician Decision|0|||
124861813|NCT02663128|449112934|FG002|Period 2|Physician Decision|0|||
124861814|NCT02663128|449112935|FG003|Period 2|Physician Decision|0|||
124861815|NCT02663128|449112936|FG004|Period 2|Physician Decision|1|||
124861816|NCT02663128|449112937|FG005|Period 2|Physician Decision|0|||
124861817|NCT02715765|449112946|FG000|Overall Study|Study Termination|3|||
124861818|NCT02715765|449112947|FG001|Overall Study|Study Termination|0|||
124861819|NCT02715765|449112948|FG002|Overall Study|Study Termination|0|||
124861820|NCT03387852|449112952|FG000|Overall Study|Adverse event (AE)|3|||
124861821|NCT03387852|449112953|FG001|Overall Study|Adverse event (AE)|0|||
124861822|NCT03387852|449112954|FG002|Overall Study|Adverse event (AE)|2|||
124861823|NCT03387852|449112955|FG003|Overall Study|Adverse event (AE)|0|||
124861824|NCT03387852|449112952|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
124861825|NCT03387852|449112953|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
124861826|NCT03387852|449112954|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
124861827|NCT03387852|449112955|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
124861828|NCT03387852|449112952|FG000|Overall Study|Withdrawal by participant|1|||
124861829|NCT03387852|449112953|FG001|Overall Study|Withdrawal by participant|1|||
124861830|NCT03387852|449112954|FG002|Overall Study|Withdrawal by participant|3|||
124861831|NCT03387852|449112955|FG003|Overall Study|Withdrawal by participant|2|||
124861832|NCT03387852|449112952|FG000|Overall Study|Other- Unspecified|1|||
124861833|NCT03387852|449112953|FG001|Overall Study|Other- Unspecified|1|||
124861834|NCT03387852|449112954|FG002|Overall Study|Other- Unspecified|2|||
124861835|NCT03387852|449112955|FG003|Overall Study|Other- Unspecified|1|||
124861836|NCT03387852|449112952|FG000|Overall Study|Poor compliance to protocol|0|||
124861837|NCT03387852|449112953|FG001|Overall Study|Poor compliance to protocol|0|||
124861838|NCT03387852|449112954|FG002|Overall Study|Poor compliance to protocol|0|||
124861839|NCT03387852|449112955|FG003|Overall Study|Poor compliance to protocol|1|||
124861840|NCT03387852|449112952|FG000|Overall Study|Randomized and not treated|0|||
124861841|NCT03387852|449112953|FG001|Overall Study|Randomized and not treated|0|||
124861842|NCT03387852|449112954|FG002|Overall Study|Randomized and not treated|0|||
124861843|NCT03387852|449112955|FG003|Overall Study|Randomized and not treated|1|||
124861844|NCT02194621|449112966|FG000|Overall Study|6 withdrew prior to randomization|2|||
124861845|NCT02194621|449112967|FG001|Overall Study|6 withdrew prior to randomization|2|||
124861846|NCT02194621|449112968|FG002|Overall Study|6 withdrew prior to randomization|2|||
124861847|NCT02194621|449112966|FG000|Overall Study|Withdrawal by Subject|4|||
124861848|NCT02194621|449112967|FG001|Overall Study|Withdrawal by Subject|4|||
124861849|NCT02194621|449112968|FG002|Overall Study|Withdrawal by Subject|7|||
124861850|NCT02763384|449112969|FG000|Overall Study|Physician Decision|1|||
124861851|NCT02763384|449112969|FG000|Overall Study|Rapid decline - went on hospice|1|||
124861852|NCT02493127|449112970|FG000|Overall Study|Lost to Follow-up|1|||
124861853|NCT02493127|449112971|FG001|Overall Study|Lost to Follow-up|1|||
124861854|NCT03034577|449112973|FG000|Overall Study|Withdrawal by Subject|6|||
124861855|NCT03034577|449112974|FG001|Overall Study|Withdrawal by Subject|9|||
124861856|NCT03034577|449112973|FG000|Overall Study|Lost to Follow-up|25|||
124861857|NCT03034577|449112974|FG001|Overall Study|Lost to Follow-up|26|||
124861858|NCT04177758|449112975|FG000|Overall Study|Lost to Follow-up|19|||
124861859|NCT04177758|449112976|FG001|Overall Study|Lost to Follow-up|11|||
124861860|NCT03156023|449112980|FG000|Overall Study|Withdrawal by Subject|1|||
124861861|NCT03156023|449112981|FG001|Overall Study|Withdrawal by Subject|0|||
124861862|NCT03156023|449112982|FG002|Overall Study|Withdrawal by Subject|2|||
124861863|NCT03156023|449112983|FG003|Overall Study|Withdrawal by Subject|1|||
124861864|NCT03156023|449112984|FG004|Overall Study|Withdrawal by Subject|1|||
124861865|NCT03156023|449112980|FG000|Overall Study|Lost to Follow-up|0|||
124861866|NCT03156023|449112981|FG001|Overall Study|Lost to Follow-up|0|||
124861867|NCT03156023|449112982|FG002|Overall Study|Lost to Follow-up|0|||
124861868|NCT03156023|449112983|FG003|Overall Study|Lost to Follow-up|0|||
124861869|NCT03156023|449112984|FG004|Overall Study|Lost to Follow-up|1|||
124861870|NCT02010060|449112985|FG000|Overall Study|Lost to Follow-up|1|||
124861871|NCT02010060|449112986|FG001|Overall Study|Lost to Follow-up|2|||
124861872|NCT02010060|449112987|FG002|Overall Study|Lost to Follow-up|2|||
124861873|NCT02010060|449112985|FG000|Overall Study|Injury|0|||
124861874|NCT02010060|449112986|FG001|Overall Study|Injury|1|||
124861875|NCT02010060|449112987|FG002|Overall Study|Injury|0|||
124861876|NCT00726752|449112988|FG000|Overall Study|Lack of Efficacy|6|||
124861877|NCT00791765|449115259|FG000|Weeks 1 to 12|Adverse Event|0|||
124861878|NCT00791765|449115260|FG001|Weeks 1 to 12|Adverse Event|1|||
124861879|NCT00791765|449115259|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
124861880|NCT00791765|449115260|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
124861881|NCT00791765|449115259|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
124861882|NCT00791765|449115260|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
124861883|NCT00791765|449115259|FG000|Weeks 1 to 12|Physician Decision|1|||
124861884|NCT00791765|449115260|FG001|Weeks 1 to 12|Physician Decision|0|||
124861885|NCT00791765|449115259|FG000|Weeks 1 to 12|Disease progression|3|||
124861886|NCT00791765|449115260|FG001|Weeks 1 to 12|Disease progression|0|||
124861887|NCT00791765|449115259|FG000|Weeks 1 to 12|Ineligibility determined|0|||
124861888|NCT00791765|449115260|FG001|Weeks 1 to 12|Ineligibility determined|3|||
124861889|NCT00791765|449115259|FG000|Weeks 13 to 24|Protocol deviation|2|||
124861890|NCT00791765|449115260|FG001|Weeks 13 to 24|Protocol deviation|0|||
124861891|NCT00791765|449115259|FG000|Weeks 13 to 24|Adverse Event|0|||
124861892|NCT00791765|449115260|FG001|Weeks 13 to 24|Adverse Event|3|||
124861893|NCT00791765|449115259|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
124861894|NCT00791765|449115260|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
124861895|NCT00791765|449115259|FG000|Weeks 13 to 24|Disease progression|0|||
124861896|NCT00791765|449115260|FG001|Weeks 13 to 24|Disease progression|1|||
124861897|NCT00791765|449115259|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
124861898|NCT00791765|449115260|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
124861899|NCT00791765|449115259|FG000|Weeks 13 to 24|Other|0|||
124861900|NCT00791765|449115260|FG001|Weeks 13 to 24|Other|1|||
124861901|NCT00907153|449115276|FG000|Overall Study|Lost to Follow-up|1|||
124861902|NCT00907153|449115277|FG001|Overall Study|Lost to Follow-up|1|||
124861903|NCT00907153|449115276|FG000|Overall Study|Withdrawal by Subject|1|||
124861904|NCT00907153|449115277|FG001|Overall Study|Withdrawal by Subject|3|||
124861905|NCT04546581|449115278|FG000|Overall Study|Adverse Event|9|||
124861906|NCT04546581|449115279|FG001|Overall Study|Adverse Event|3|||
124861907|NCT04546581|449115278|FG000|Overall Study|Physician Decision|0|||
124861908|NCT04546581|449115279|FG001|Overall Study|Physician Decision|1|||
124861909|NCT04546581|449115278|FG000|Overall Study|Protocol Violation|1|||
124861910|NCT04546581|449115279|FG001|Overall Study|Protocol Violation|2|||
124861911|NCT04546581|449115278|FG000|Overall Study|Withdrawal by Subject|3|||
124861912|NCT04546581|449115279|FG001|Overall Study|Withdrawal by Subject|7|||
124861913|NCT03147248|449115280|FG000|Overall Study|Adverse Event|0|||
124861914|NCT03147248|449115281|FG001|Overall Study|Adverse Event|2|||
124861915|NCT03147248|449115282|FG002|Overall Study|Adverse Event|2|||
124861916|NCT03147248|449115283|FG003|Overall Study|Adverse Event|2|||
124861917|NCT03147248|449115284|FG004|Overall Study|Adverse Event|6|||
124861918|NCT03147248|449115285|FG005|Overall Study|Adverse Event|11|||
124861919|NCT03147248|449115280|FG000|Overall Study|Disease progression|1|||
124861920|NCT03147248|449115281|FG001|Overall Study|Disease progression|0|||
124861921|NCT03147248|449115282|FG002|Overall Study|Disease progression|0|||
124861922|NCT03147248|449115283|FG003|Overall Study|Disease progression|0|||
124861923|NCT03147248|449115284|FG004|Overall Study|Disease progression|0|||
124861924|NCT03147248|449115285|FG005|Overall Study|Disease progression|2|||
124861925|NCT03147248|449115280|FG000|Overall Study|Withdrawal by Subject|0|||
124861926|NCT03147248|449115281|FG001|Overall Study|Withdrawal by Subject|0|||
124861927|NCT03147248|449115282|FG002|Overall Study|Withdrawal by Subject|0|||
124861928|NCT03147248|449115283|FG003|Overall Study|Withdrawal by Subject|0|||
124861929|NCT03147248|449115284|FG004|Overall Study|Withdrawal by Subject|12|||
124861930|NCT03147248|449115285|FG005|Overall Study|Withdrawal by Subject|9|||
124861931|NCT03147248|449115280|FG000|Overall Study|Protocol Violation|0|||
124861932|NCT03147248|449115281|FG001|Overall Study|Protocol Violation|0|||
124861933|NCT03147248|449115282|FG002|Overall Study|Protocol Violation|0|||
124861934|NCT03147248|449115283|FG003|Overall Study|Protocol Violation|0|||
124861935|NCT03147248|449115284|FG004|Overall Study|Protocol Violation|2|||
124861936|NCT03147248|449115285|FG005|Overall Study|Protocol Violation|0|||
124861937|NCT03147248|449115280|FG000|Overall Study|Lost to Follow-up|0|||
124861938|NCT03147248|449115281|FG001|Overall Study|Lost to Follow-up|0|||
124861939|NCT03147248|449115282|FG002|Overall Study|Lost to Follow-up|0|||
124861940|NCT03147248|449115283|FG003|Overall Study|Lost to Follow-up|0|||
124861941|NCT03147248|449115284|FG004|Overall Study|Lost to Follow-up|2|||
124861942|NCT03147248|449115285|FG005|Overall Study|Lost to Follow-up|0|||
124861943|NCT03147248|449115280|FG000|Overall Study|Pregnancy|0|||
124861944|NCT03147248|449115281|FG001|Overall Study|Pregnancy|0|||
124861945|NCT03147248|449115282|FG002|Overall Study|Pregnancy|0|||
124861946|NCT03147248|449115283|FG003|Overall Study|Pregnancy|0|||
124861947|NCT03147248|449115284|FG004|Overall Study|Pregnancy|1|||
124861948|NCT03147248|449115285|FG005|Overall Study|Pregnancy|0|||
124861949|NCT03147248|449115280|FG000|Overall Study|Death|0|||
124861950|NCT03147248|449115281|FG001|Overall Study|Death|0|||
124861951|NCT03147248|449115282|FG002|Overall Study|Death|0|||
124861952|NCT03147248|449115283|FG003|Overall Study|Death|0|||
124861953|NCT03147248|449115284|FG004|Overall Study|Death|0|||
124861954|NCT03147248|449115285|FG005|Overall Study|Death|4|||
124861955|NCT03147248|449115280|FG000|Overall Study|Physician Decision|0|||
124861956|NCT03147248|449115281|FG001|Overall Study|Physician Decision|0|||
124861957|NCT03147248|449115282|FG002|Overall Study|Physician Decision|0|||
124861958|NCT03147248|449115283|FG003|Overall Study|Physician Decision|0|||
124861959|NCT03147248|449115284|FG004|Overall Study|Physician Decision|2|||
124861960|NCT03147248|449115285|FG005|Overall Study|Physician Decision|4|||
124861961|NCT03147248|449115280|FG000|Overall Study|Prolonged Dosing Interval|0|||
124861962|NCT03147248|449115281|FG001|Overall Study|Prolonged Dosing Interval|0|||
124861963|NCT03147248|449115282|FG002|Overall Study|Prolonged Dosing Interval|0|||
124861964|NCT03147248|449115283|FG003|Overall Study|Prolonged Dosing Interval|0|||
124861965|NCT03147248|449115284|FG004|Overall Study|Prolonged Dosing Interval|1|||
124861966|NCT03147248|449115285|FG005|Overall Study|Prolonged Dosing Interval|1|||
124861967|NCT02062632|449115286|FG000|Overall Study|No treatment data|1|||
124861968|NCT02280044|449115289|FG000|Overall Study|Planned alternate|0|||
124861969|NCT02280044|449115290|FG001|Overall Study|Planned alternate|2|||
124861970|NCT02332720|449115298|FG000|Part A and Part B|Lost to Follow-up|1|||
124861971|NCT02332720|449115299|FG001|Part A and Part B|Lost to Follow-up|0|||
124861972|NCT02332720|449115300|FG002|Part A and Part B|Lost to Follow-up|0|||
124861973|NCT02332720|449115301|FG003|Part A and Part B|Lost to Follow-up|0|||
124861974|NCT02332720|449115302|FG004|Part A and Part B|Lost to Follow-up|0|||
124861975|NCT02332720|449115303|FG005|Part A and Part B|Lost to Follow-up|2|||
124861976|NCT02332720|449115304|FG006|Part A and Part B|Lost to Follow-up|1|||
124861977|NCT02332720|449115305|FG007|Part A and Part B|Lost to Follow-up|1|||
124861978|NCT02332720|449115306|FG008|Part A and Part B|Lost to Follow-up|0|||
124861979|NCT02332720|449115307|FG009|Part A and Part B|Lost to Follow-up|0|||
124861980|NCT02332720|449115308|FG010|Part A and Part B|Lost to Follow-up|0|||
124861981|NCT02332720|449115309|FG011|Part A and Part B|Lost to Follow-up|0|||
124861982|NCT02332720|449115310|FG012|Part A and Part B|Lost to Follow-up|0|||
124861983|NCT02332720|449115311|FG013|Part A and Part B|Lost to Follow-up|0|||
124861984|NCT02332720|449115312|FG014|Part A and Part B|Lost to Follow-up|0|||
124861985|NCT02332720|449115313|FG015|Part A and Part B|Lost to Follow-up|1|||
124861986|NCT02332720|449115314|FG016|Part A and Part B|Lost to Follow-up|0|||
124861987|NCT02332720|449115315|FG017|Part A and Part B|Lost to Follow-up|0|||
124861988|NCT02332720|449115316|FG018|Part A and Part B|Lost to Follow-up|0|||
124861989|NCT02332720|449115317|FG019|Part A and Part B|Lost to Follow-up|0|||
124861990|NCT02332720|449115318|FG020|Part A and Part B|Lost to Follow-up|0|||
124861991|NCT02332720|449115319|FG021|Part A and Part B|Lost to Follow-up|0|||
124861992|NCT02332720|449115320|FG022|Part A and Part B|Lost to Follow-up|0|||
124861993|NCT02332720|449115298|FG000|Part A and Part B|Adverse Event|0|||
124861994|NCT02332720|449115299|FG001|Part A and Part B|Adverse Event|0|||
124861995|NCT02332720|449115300|FG002|Part A and Part B|Adverse Event|0|||
124861996|NCT02332720|449115301|FG003|Part A and Part B|Adverse Event|0|||
124861997|NCT02332720|449115302|FG004|Part A and Part B|Adverse Event|0|||
124861998|NCT02332720|449115303|FG005|Part A and Part B|Adverse Event|0|||
124861999|NCT02332720|449115304|FG006|Part A and Part B|Adverse Event|0|||
124862000|NCT02332720|449115305|FG007|Part A and Part B|Adverse Event|0|||
124862001|NCT02332720|449115306|FG008|Part A and Part B|Adverse Event|0|||
124862002|NCT02332720|449115307|FG009|Part A and Part B|Adverse Event|0|||
124862003|NCT02332720|449115308|FG010|Part A and Part B|Adverse Event|0|||
124862004|NCT02332720|449115309|FG011|Part A and Part B|Adverse Event|0|||
124862005|NCT02332720|449115310|FG012|Part A and Part B|Adverse Event|0|||
124862006|NCT02332720|449115311|FG013|Part A and Part B|Adverse Event|0|||
124862007|NCT02332720|449115312|FG014|Part A and Part B|Adverse Event|0|||
124862008|NCT02332720|449115313|FG015|Part A and Part B|Adverse Event|0|||
124862009|NCT02332720|449115314|FG016|Part A and Part B|Adverse Event|0|||
124862010|NCT02332720|449115315|FG017|Part A and Part B|Adverse Event|1|||
124862011|NCT02332720|449115316|FG018|Part A and Part B|Adverse Event|0|||
124862012|NCT02332720|449115317|FG019|Part A and Part B|Adverse Event|0|||
124862013|NCT02332720|449115318|FG020|Part A and Part B|Adverse Event|0|||
124862014|NCT02332720|449115319|FG021|Part A and Part B|Adverse Event|0|||
124862015|NCT02332720|449115320|FG022|Part A and Part B|Adverse Event|0|||
124862016|NCT02332720|449115298|FG000|Part A and Part B|Physician Decision|0|||
124862017|NCT02332720|449115299|FG001|Part A and Part B|Physician Decision|0|||
124862018|NCT02332720|449115300|FG002|Part A and Part B|Physician Decision|0|||
124862019|NCT02332720|449115301|FG003|Part A and Part B|Physician Decision|0|||
124862020|NCT02332720|449115302|FG004|Part A and Part B|Physician Decision|0|||
124862021|NCT02332720|449115303|FG005|Part A and Part B|Physician Decision|0|||
124862022|NCT02332720|449115304|FG006|Part A and Part B|Physician Decision|0|||
124862023|NCT02332720|449115305|FG007|Part A and Part B|Physician Decision|0|||
124862024|NCT02332720|449115306|FG008|Part A and Part B|Physician Decision|0|||
124862025|NCT02332720|449115307|FG009|Part A and Part B|Physician Decision|0|||
124862026|NCT02332720|449115308|FG010|Part A and Part B|Physician Decision|0|||
124862027|NCT02332720|449115309|FG011|Part A and Part B|Physician Decision|0|||
124862028|NCT02332720|449115310|FG012|Part A and Part B|Physician Decision|0|||
124862029|NCT02332720|449115311|FG013|Part A and Part B|Physician Decision|0|||
124862030|NCT02332720|449115312|FG014|Part A and Part B|Physician Decision|0|||
124862031|NCT02332720|449115313|FG015|Part A and Part B|Physician Decision|0|||
124862032|NCT02332720|449115314|FG016|Part A and Part B|Physician Decision|0|||
124862033|NCT02332720|449115315|FG017|Part A and Part B|Physician Decision|0|||
124862034|NCT02332720|449115316|FG018|Part A and Part B|Physician Decision|1|||
124862035|NCT02332720|449115317|FG019|Part A and Part B|Physician Decision|0|||
124862036|NCT02332720|449115318|FG020|Part A and Part B|Physician Decision|0|||
124862037|NCT02332720|449115319|FG021|Part A and Part B|Physician Decision|0|||
124862038|NCT02332720|449115320|FG022|Part A and Part B|Physician Decision|0|||
124862039|NCT02332720|449115298|FG000|Part A and Part B|Withdrawal by Subject|0|||
124862040|NCT02332720|449115299|FG001|Part A and Part B|Withdrawal by Subject|0|||
124862041|NCT02332720|449115300|FG002|Part A and Part B|Withdrawal by Subject|0|||
124862042|NCT02332720|449115301|FG003|Part A and Part B|Withdrawal by Subject|0|||
124862043|NCT02332720|449115302|FG004|Part A and Part B|Withdrawal by Subject|0|||
124862044|NCT02332720|449115303|FG005|Part A and Part B|Withdrawal by Subject|1|||
124862045|NCT02332720|449115304|FG006|Part A and Part B|Withdrawal by Subject|0|||
124862046|NCT02332720|449115305|FG007|Part A and Part B|Withdrawal by Subject|0|||
124862047|NCT02332720|449115306|FG008|Part A and Part B|Withdrawal by Subject|0|||
124862048|NCT02332720|449115307|FG009|Part A and Part B|Withdrawal by Subject|0|||
124862049|NCT02332720|449115308|FG010|Part A and Part B|Withdrawal by Subject|0|||
124862050|NCT02332720|449115309|FG011|Part A and Part B|Withdrawal by Subject|0|||
124862051|NCT02332720|449115310|FG012|Part A and Part B|Withdrawal by Subject|0|||
124862052|NCT02332720|449115311|FG013|Part A and Part B|Withdrawal by Subject|0|||
124862053|NCT02332720|449115312|FG014|Part A and Part B|Withdrawal by Subject|0|||
124862054|NCT02332720|449115313|FG015|Part A and Part B|Withdrawal by Subject|0|||
124862055|NCT02332720|449115314|FG016|Part A and Part B|Withdrawal by Subject|0|||
124862056|NCT02332720|449115315|FG017|Part A and Part B|Withdrawal by Subject|0|||
124862057|NCT02332720|449115316|FG018|Part A and Part B|Withdrawal by Subject|0|||
124862058|NCT02332720|449115317|FG019|Part A and Part B|Withdrawal by Subject|1|||
124862059|NCT02332720|449115318|FG020|Part A and Part B|Withdrawal by Subject|0|||
124862060|NCT02332720|449115319|FG021|Part A and Part B|Withdrawal by Subject|0|||
124862061|NCT02332720|449115320|FG022|Part A and Part B|Withdrawal by Subject|0|||
124862062|NCT03832010|449115321|FG000|Overall Study|Withdrawal by Subject|2|||
124862063|NCT03832010|449115322|FG001|Overall Study|Withdrawal by Subject|1|||
124862064|NCT03832010|449115323|FG002|Overall Study|Withdrawal by Subject|0|||
124862065|NCT03832010|449115321|FG000|Overall Study|Lost to Follow-up|2|||
124862066|NCT03832010|449115322|FG001|Overall Study|Lost to Follow-up|1|||
124862067|NCT03832010|449115323|FG002|Overall Study|Lost to Follow-up|1|||
124862068|NCT01412944|449115324|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
124862069|NCT01412944|449115325|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
124862070|NCT01412944|449115326|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
124862071|NCT01412944|449115327|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
124862072|NCT01412944|449115328|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
124862073|NCT01412944|449115329|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
124862074|NCT01412944|449115324|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
124862075|NCT01412944|449115325|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
124862076|NCT01412944|449115326|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
124862077|NCT01412944|449115327|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
124862078|NCT01412944|449115328|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
124862079|NCT01412944|449115329|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
124862080|NCT01412944|449115324|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
124862081|NCT01412944|449115325|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
124862082|NCT01412944|449115326|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
124862083|NCT01412944|449115327|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
124862084|NCT01412944|449115328|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
124862085|NCT01412944|449115329|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
124862086|NCT01412944|449115324|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
124862087|NCT01412944|449115325|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
124862088|NCT01412944|449115326|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
124862089|NCT01412944|449115327|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
124862090|NCT01412944|449115328|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
124862091|NCT01412944|449115329|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
124862092|NCT01412944|449115324|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
124862093|NCT01412944|449115325|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
124862094|NCT01412944|449115326|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
124862095|NCT01412944|449115327|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
124862096|NCT01412944|449115328|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
124862097|NCT01412944|449115329|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
124862098|NCT01412944|449115324|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
124862099|NCT01412944|449115325|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
124862100|NCT01412944|449115326|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
124862101|NCT01412944|449115327|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
124862102|NCT01412944|449115328|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
124862103|NCT01412944|449115329|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
124862104|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
124862105|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
124862106|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
124862107|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
124862108|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
124862109|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
124862110|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Adverse Event|0|||
124862111|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Adverse Event|0|||
124862112|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Adverse Event|0|||
124862113|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Adverse Event|0|||
124862114|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Adverse Event|1|||
124862115|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Adverse Event|0|||
124862116|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
124862117|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
124862118|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
124862119|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
124862120|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
124862121|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
124862122|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862123|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862124|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862125|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862126|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862127|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
124862128|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862129|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862130|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862131|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862132|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
124862133|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862134|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
124862135|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
124862136|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
124862137|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
124862138|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
124862139|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
124862140|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
124862141|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
124862142|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
124862143|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
124862144|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
124862145|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
124862146|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862147|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
124862148|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862149|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862150|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862151|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
124862152|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862153|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
124862154|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862155|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862156|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862157|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
124862158|NCT01412944|449115324|FG000|Entire: IV + Maintenance|Adverse Event|0|||
124862159|NCT01412944|449115325|FG001|Entire: IV + Maintenance|Adverse Event|1|||
124862160|NCT01412944|449115326|FG002|Entire: IV + Maintenance|Adverse Event|0|||
124862161|NCT01412944|449115327|FG003|Entire: IV + Maintenance|Adverse Event|0|||
124862162|NCT01412944|449115328|FG004|Entire: IV + Maintenance|Adverse Event|0|||
124862163|NCT01412944|449115329|FG005|Entire: IV + Maintenance|Adverse Event|0|||
124862164|NCT01990950|449115330|FG000|Overall Study|Death|3|||
124862165|NCT01990950|449115330|FG000|Overall Study|Lost to Follow-up|2|||
124862166|NCT01990950|449115330|FG000|Overall Study|Withdrawal by Subject|6|||
124862167|NCT00922428|449115331|FG000|Overall Study|retrospective/extremely implausible data|2|||
124862168|NCT00922428|449115331|FG000|Overall Study|no medication use or questionable use|13|||
124862169|NCT01343368|449115332|FG000|Overall Study|Death|1|||
124862170|NCT01343368|449115333|FG001|Overall Study|Death|0|||
124862171|NCT01343368|449115332|FG000|Overall Study|Lost to Follow-up|1|||
124862172|NCT01343368|449115333|FG001|Overall Study|Lost to Follow-up|0|||
124862173|NCT00321854|449115334|FG000|Overall Study|Adverse Event|41|||
124862174|NCT00321854|449115335|FG001|Overall Study|Adverse Event|43|||
124862175|NCT00321854|449115334|FG000|Overall Study|Lack of Efficacy|9|||
124862176|NCT00321854|449115335|FG001|Overall Study|Lack of Efficacy|14|||
124862177|NCT00321854|449115334|FG000|Overall Study|Protocol Violation|6|||
124862178|NCT00321854|449115335|FG001|Overall Study|Protocol Violation|5|||
124862179|NCT00321854|449115334|FG000|Overall Study|Lost to Follow-up|0|||
124862180|NCT00321854|449115335|FG001|Overall Study|Lost to Follow-up|2|||
124862181|NCT00321854|449115334|FG000|Overall Study|Withdrawal by Subject|6|||
124862182|NCT00321854|449115335|FG001|Overall Study|Withdrawal by Subject|17|||
124862183|NCT00321854|449115334|FG000|Overall Study|Other|1|||
124862184|NCT00321854|449115335|FG001|Overall Study|Other|1|||
124862185|NCT03204279|449115336|FG000|Overall Study|Withdrawal by Subject|0|||
124862186|NCT03204279|449115337|FG001|Overall Study|Withdrawal by Subject|1|||
124862187|NCT02119416|449115338|FG000|Overall Study|Protocol Violation|1|||
124862188|NCT02119416|449115339|FG001|Overall Study|Protocol Violation|1|||
124862189|NCT02119416|449115340|FG002|Overall Study|Protocol Violation|1|||
124862190|NCT02119416|449115338|FG000|Overall Study|wrong pubertal stage|1|||
124862191|NCT02119416|449115339|FG001|Overall Study|wrong pubertal stage|0|||
124862192|NCT02119416|449115340|FG002|Overall Study|wrong pubertal stage|1|||
124862193|NCT02384759|449115344|FG000|Overall Study|Patients not treated|3|||
124862194|NCT02384759|449115345|FG001|Overall Study|Patients not treated|2|||
124862195|NCT03043664|449115346|FG000|Overall Study|Lost to Follow-up|1|||
124862196|NCT03593655|449115348|FG000|First Product Use Period|Withdrawal by Subject|1|||
124862197|NCT03593655|449115349|FG001|First Product Use Period|Withdrawal by Subject|1|||
124862198|NCT03593655|449115348|FG000|First Product Use Period|Lost to Follow-up|1|||
124862199|NCT03593655|449115349|FG001|First Product Use Period|Lost to Follow-up|3|||
124862200|NCT03593655|449115348|FG000|Second Product Use Period|Withdrawal by Subject|1|||
124862201|NCT03593655|449115349|FG001|Second Product Use Period|Withdrawal by Subject|1|||
124862202|NCT03593655|449115348|FG000|Second Product Use Period|Lost to Follow-up|1|||
124862203|NCT03593655|449115349|FG001|Second Product Use Period|Lost to Follow-up|0|||
124862204|NCT03593655|449115348|FG000|Third Product Use Period|Lost to Follow-up|1|||
124862205|NCT03593655|449115349|FG001|Third Product Use Period|Lost to Follow-up|2|||
124862206|NCT03593655|449115348|FG000|Third Product Use Period|Physician Decision|0|||
124862207|NCT03593655|449115349|FG001|Third Product Use Period|Physician Decision|1|||
124862208|NCT03593655|449115348|FG000|Third Product Use Period|Withdrawal by Subject|0|||
124862209|NCT03593655|449115349|FG001|Third Product Use Period|Withdrawal by Subject|1|||
124862210|NCT03732209|449115354|FG000|Overall Study|Lost to Follow-up|4|||
124862211|NCT03732209|449115355|FG001|Overall Study|Lost to Follow-up|4|||
124862212|NCT03732209|449115354|FG000|Overall Study|Withdrawal by Subject|8|||
124862213|NCT03732209|449115355|FG001|Overall Study|Withdrawal by Subject|9|||
124862214|NCT05046795|449115356|FG000|Overall Study|Adverse Event|13|||
124862215|NCT05046795|449115357|FG001|Overall Study|Adverse Event|15|||
124862216|NCT05046795|449115356|FG000|Overall Study|Withdrawal by Subject|4|||
124862217|NCT05046795|449115357|FG001|Overall Study|Withdrawal by Subject|7|||
124862218|NCT05046795|449115356|FG000|Overall Study|Physician Decision|1|||
124862219|NCT05046795|449115357|FG001|Overall Study|Physician Decision|2|||
124862220|NCT05046795|449115356|FG000|Overall Study|Protocol Violation|1|||
124862221|NCT05046795|449115357|FG001|Overall Study|Protocol Violation|2|||
124862222|NCT05046795|449115356|FG000|Overall Study|Death|1|||
124862223|NCT05046795|449115357|FG001|Overall Study|Death|0|||
124862224|NCT05046795|449115356|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
124862225|NCT05046795|449115357|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
124862226|NCT03759873|449115360|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
124862227|NCT03759873|449115361|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
124862228|NCT03759873|449115362|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
124862229|NCT03759873|449115363|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
124862230|NCT03759873|449115360|FG000|Overall Study|Moved outside eligible area|0|||
124862231|NCT03759873|449115361|FG001|Overall Study|Moved outside eligible area|2|||
124862232|NCT03759873|449115362|FG002|Overall Study|Moved outside eligible area|0|||
124862233|NCT03759873|449115363|FG003|Overall Study|Moved outside eligible area|0|||
124862234|NCT03759873|449115360|FG000|Overall Study|Withdrawal by Subject|0|||
124862235|NCT03759873|449115361|FG001|Overall Study|Withdrawal by Subject|0|||
124862236|NCT03759873|449115362|FG002|Overall Study|Withdrawal by Subject|1|||
124862237|NCT03759873|449115363|FG003|Overall Study|Withdrawal by Subject|0|||
124862238|NCT03579563|449115364|FG000|Overall Study|Lost to Follow-up|0|||
124862239|NCT03579563|449115365|FG001|Overall Study|Lost to Follow-up|0|||
124862240|NCT03579563|449115366|FG002|Overall Study|Lost to Follow-up|0|||
124862241|NCT03579563|449115367|FG003|Overall Study|Lost to Follow-up|0|||
124862242|NCT03579563|449115368|FG004|Overall Study|Lost to Follow-up|1|||
124862243|NCT03579563|449115369|FG005|Overall Study|Lost to Follow-up|0|||
124862244|NCT03579563|449115364|FG000|Overall Study|Lack of Efficacy|1|||
124862245|NCT03579563|449115365|FG001|Overall Study|Lack of Efficacy|1|||
124862246|NCT03579563|449115366|FG002|Overall Study|Lack of Efficacy|4|||
124862247|NCT03579563|449115367|FG003|Overall Study|Lack of Efficacy|1|||
124862248|NCT03579563|449115368|FG004|Overall Study|Lack of Efficacy|2|||
124862249|NCT03579563|449115369|FG005|Overall Study|Lack of Efficacy|3|||
124862250|NCT03579563|449115364|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
124862251|NCT03579563|449115365|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
124862252|NCT03579563|449115366|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
124862253|NCT03579563|449115367|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
124862254|NCT03579563|449115368|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
124862255|NCT03579563|449115369|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
124862256|NCT03579563|449115364|FG000|Overall Study|Time/distance concern|0|||
124862257|NCT03579563|449115365|FG001|Overall Study|Time/distance concern|0|||
124862258|NCT03579563|449115366|FG002|Overall Study|Time/distance concern|1|||
124862259|NCT03579563|449115367|FG003|Overall Study|Time/distance concern|0|||
124862260|NCT03579563|449115368|FG004|Overall Study|Time/distance concern|0|||
124862261|NCT03579563|449115369|FG005|Overall Study|Time/distance concern|1|||
124862262|NCT03579563|449115364|FG000|Overall Study|COVID shutdown|2|||
124862263|NCT03579563|449115365|FG001|Overall Study|COVID shutdown|3|||
124862264|NCT03579563|449115366|FG002|Overall Study|COVID shutdown|4|||
124862265|NCT03579563|449115367|FG003|Overall Study|COVID shutdown|3|||
124862266|NCT03579563|449115368|FG004|Overall Study|COVID shutdown|1|||
124862267|NCT03579563|449115369|FG005|Overall Study|COVID shutdown|2|||
124862268|NCT03579563|449115364|FG000|Overall Study|Protocol administration error|1|||
124862269|NCT03579563|449115365|FG001|Overall Study|Protocol administration error|0|||
124862270|NCT03579563|449115366|FG002|Overall Study|Protocol administration error|1|||
124862271|NCT03579563|449115367|FG003|Overall Study|Protocol administration error|0|||
124862272|NCT03579563|449115368|FG004|Overall Study|Protocol administration error|1|||
124862273|NCT03579563|449115369|FG005|Overall Study|Protocol administration error|5|||
124862274|NCT02647359|449115370|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
124862275|NCT02647359|449115371|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
124862276|NCT02647359|449115370|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
124862277|NCT02647359|449115371|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
124862278|NCT02647359|449115370|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
124862279|NCT02647359|449115371|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
124862280|NCT02647359|449115370|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
124862281|NCT02647359|449115371|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
124862282|NCT02647359|449115370|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
124862283|NCT02647359|449115371|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
124862284|NCT02647359|449115370|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
124862285|NCT02647359|449115371|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
124862286|NCT02513563|449115372|FG000|Overall Study|Death|4|||
124862287|NCT02513563|449115372|FG000|Overall Study|Withdrawal by Subject|4|||
124862288|NCT02513563|449115372|FG000|Overall Study|Physician Decision|1|||
124862289|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
124862290|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
124862291|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
124862292|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
124862293|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
124862294|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
124862295|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
124862296|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
124862297|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
124862298|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
124862299|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
124862300|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
124862301|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
124862302|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
124862303|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
124862304|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
124862305|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
124862306|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
124862307|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
124862308|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
124862309|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
124862310|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
124862311|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
124862312|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
124862313|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
124862314|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
124862315|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
124862316|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
124862317|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
124862318|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
124862319|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
124862320|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
124862321|NCT04818346|449115376|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
124862322|NCT04818346|449115377|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
124862323|NCT04818346|449115378|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
124862324|NCT04818346|449115379|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
124862325|NCT04818346|449115376|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
124862326|NCT04818346|449115377|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
124862327|NCT04818346|449115378|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
124862328|NCT04818346|449115379|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
124862329|NCT04818346|449115376|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
124862330|NCT04818346|449115377|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
124862331|NCT04818346|449115378|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
124862332|NCT04818346|449115379|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
124862333|NCT04818346|449115376|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
124862334|NCT04818346|449115377|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
124862335|NCT04818346|449115378|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
124862336|NCT04818346|449115379|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
124862337|NCT04818346|449115376|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
124862338|NCT04818346|449115377|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
124862339|NCT04818346|449115378|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
124862340|NCT04818346|449115379|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
124862341|NCT04818346|449115376|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
124862342|NCT04818346|449115377|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
124862343|NCT04818346|449115378|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
124862344|NCT04818346|449115379|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
124862345|NCT04818346|449115376|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
124862346|NCT04818346|449115377|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
124862347|NCT04818346|449115378|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
124862348|NCT04818346|449115379|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
124862349|NCT03150056|449115380|FG000|Overall Study|Withdrawal by Subject|0|||
124862350|NCT03150056|449115381|FG001|Overall Study|Withdrawal by Subject|0|||
124862351|NCT03150056|449115382|FG002|Overall Study|Withdrawal by Subject|0|||
124862352|NCT03150056|449115383|FG003|Overall Study|Withdrawal by Subject|0|||
124862353|NCT03150056|449115384|FG004|Overall Study|Withdrawal by Subject|0|||
124862354|NCT03150056|449115385|FG005|Overall Study|Withdrawal by Subject|2|||
124862355|NCT03150056|449115380|FG000|Overall Study|Study terminated by Sponsor|1|||
124862356|NCT03150056|449115381|FG001|Overall Study|Study terminated by Sponsor|3|||
124862357|NCT03150056|449115382|FG002|Overall Study|Study terminated by Sponsor|1|||
124862358|NCT03150056|449115383|FG003|Overall Study|Study terminated by Sponsor|1|||
124862359|NCT03150056|449115384|FG004|Overall Study|Study terminated by Sponsor|5|||
124862360|NCT03150056|449115385|FG005|Overall Study|Study terminated by Sponsor|6|||
124862361|NCT03150056|449115380|FG000|Overall Study|Death|9|||
124862362|NCT03150056|449115381|FG001|Overall Study|Death|2|||
124862363|NCT03150056|449115382|FG002|Overall Study|Death|2|||
124862364|NCT03150056|449115383|FG003|Overall Study|Death|7|||
124862365|NCT03150056|449115384|FG004|Overall Study|Death|8|||
124862366|NCT03150056|449115385|FG005|Overall Study|Death|10|||
124862367|NCT00965523|449115386|FG000|Study 221|Progressive Disease|4|||
124862368|NCT00965523|449115386|FG000|Study 221|Physician Decision|3|||
124862369|NCT00965523|449115386|FG000|Study 224|Progressive Disease|5|||
124862370|NCT00965523|449115386|FG000|Study 224|Physician Decision|1|||
124862371|NCT01581281|449115388|FG000|Overall Study|Early Study Closure|15|||
124862372|NCT01581281|449115389|FG001|Overall Study|Early Study Closure|6|||
124862373|NCT01581281|449115390|FG002|Overall Study|Early Study Closure|12|||
124862374|NCT02187991|449115391|FG000|Overall Study|Adverse Event|13|||
124862375|NCT02187991|449115392|FG001|Overall Study|Adverse Event|14|||
124862376|NCT02187991|449115393|FG002|Overall Study|Adverse Event|3|||
124862377|NCT02187991|449115394|FG003|Overall Study|Adverse Event|2|||
124862378|NCT02187991|449115391|FG000|Overall Study|Withdrawal by Subject|9|||
124862379|NCT02187991|449115392|FG001|Overall Study|Withdrawal by Subject|6|||
124862380|NCT02187991|449115393|FG002|Overall Study|Withdrawal by Subject|3|||
124862381|NCT02187991|449115394|FG003|Overall Study|Withdrawal by Subject|2|||
124862382|NCT02187991|449115391|FG000|Overall Study|Physician Decision|4|||
124862383|NCT02187991|449115392|FG001|Overall Study|Physician Decision|4|||
124862384|NCT02187991|449115393|FG002|Overall Study|Physician Decision|0|||
124862385|NCT02187991|449115394|FG003|Overall Study|Physician Decision|2|||
124862386|NCT02187991|449115391|FG000|Overall Study|Other, unrelated complication|7|||
124862387|NCT02187991|449115392|FG001|Overall Study|Other, unrelated complication|1|||
124862388|NCT02187991|449115393|FG002|Overall Study|Other, unrelated complication|1|||
124862389|NCT02187991|449115394|FG003|Overall Study|Other, unrelated complication|2|||
124862390|NCT02187991|449115391|FG000|Overall Study|Death|1|||
124862391|NCT02187991|449115392|FG001|Overall Study|Death|3|||
124862392|NCT02187991|449115393|FG002|Overall Study|Death|0|||
124862393|NCT02187991|449115394|FG003|Overall Study|Death|0|||
124862394|NCT03273946|449115400|FG000|Overall Study|Withdrawal by Subject|5|||
124862395|NCT03273946|449115400|FG000|Overall Study|Unwillingness of the guardian|1|||
124862396|NCT03273946|449115400|FG000|Overall Study|Participant refused to use the drug|2|||
124862397|NCT03273946|449115400|FG000|Overall Study|Participant relative refused to use drug|1|||
124862398|NCT00092131|449115402|FG000|Treatment Period I|Adverse Event|1|||
124862399|NCT00092131|449115403|FG001|Treatment Period I|Adverse Event|0|||
124862400|NCT00092131|449115402|FG000|Treatment Period II|Adverse Event|0|||
124862401|NCT00092131|449115403|FG001|Treatment Period II|Adverse Event|1|||
124862402|NCT01808313|449115406|FG000|Overall Study|Adverse Event|5|||
124862403|NCT01808313|449115406|FG000|Overall Study|Protocol Violation|2|||
124862404|NCT01808313|449115406|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
124862405|NCT01808313|449115406|FG000|Overall Study|Lost to Follow-up|1|||
124862406|NCT01808313|449115406|FG000|Overall Study|Physician Decision|1|||
124862407|NCT01954017|449115414|FG000|Overall Study|Adverse Event|0|||
124862408|NCT01954017|449115415|FG001|Overall Study|Adverse Event|0|||
124862409|NCT01954017|449115416|FG002|Overall Study|Adverse Event|1|||
124862410|NCT01954017|449115414|FG000|Overall Study|Death|2|||
124862411|NCT01954017|449115415|FG001|Overall Study|Death|1|||
124862412|NCT01954017|449115416|FG002|Overall Study|Death|1|||
124862413|NCT01954017|449115414|FG000|Overall Study|Withdrawal by Subject|0|||
124862414|NCT01954017|449115415|FG001|Overall Study|Withdrawal by Subject|1|||
124862415|NCT01954017|449115416|FG002|Overall Study|Withdrawal by Subject|0|||
124862416|NCT01954017|449115414|FG000|Overall Study|Protocol Violation|0|||
124862417|NCT01954017|449115415|FG001|Overall Study|Protocol Violation|3|||
124862418|NCT01954017|449115416|FG002|Overall Study|Protocol Violation|2|||
124862419|NCT01954017|449115414|FG000|Overall Study|Necrotizing enterocolitis|1|||
124862420|NCT01954017|449115415|FG001|Overall Study|Necrotizing enterocolitis|0|||
124862421|NCT01954017|449115416|FG002|Overall Study|Necrotizing enterocolitis|1|||
124862422|NCT01954017|449115414|FG000|Overall Study|Enteral intake stopped >7 days|0|||
124862423|NCT01954017|449115415|FG001|Overall Study|Enteral intake stopped >7 days|1|||
124862424|NCT01954017|449115416|FG002|Overall Study|Enteral intake stopped >7 days|1|||
124862425|NCT01954017|449115414|FG000|Overall Study|All other reasons|2|||
124862426|NCT01954017|449115415|FG001|Overall Study|All other reasons|2|||
124862427|NCT01954017|449115416|FG002|Overall Study|All other reasons|7|||
124862428|NCT04598152|449115417|FG000|Overall Study|Lost to Follow-up|0|||
124862429|NCT04598152|449115418|FG001|Overall Study|Lost to Follow-up|1|||
124862430|NCT03346759|449115429|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
124862431|NCT03346759|449115430|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
124862432|NCT03346759|449115429|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
124862433|NCT03346759|449115430|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
124862434|NCT03346759|449115429|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
124862435|NCT03346759|449115430|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
124862436|NCT03277313|449115431|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
124862437|NCT03277313|449115432|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
124862438|NCT03277313|449115431|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
124862439|NCT03277313|449115432|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
124862440|NCT03277313|449115431|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
124862441|NCT03277313|449115432|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
124862442|NCT03277313|449115431|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
124862443|NCT03277313|449115432|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
124862444|NCT03277313|449115431|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
124862445|NCT03277313|449115432|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
124862446|NCT02132611|449115436|FG000|Overall Study|Death|2|||
124862447|NCT02096900|449115437|FG000|Overall Study|Did not receive medication|3|||
124862448|NCT02096900|449115438|FG001|Overall Study|Did not receive medication|1|||
124862449|NCT02096900|449115437|FG000|Overall Study|Surgery cancelled- medication received|1|||
124862450|NCT02096900|449115438|FG001|Overall Study|Surgery cancelled- medication received|1|||
124862451|NCT05819749|449115448|FG000|Overall Study|Lost to Follow-up|1|||
124862452|NCT01877408|449117028|FG000|Overall Study|Lost to Follow-up|0|||
124862453|NCT01877408|449117029|FG001|Overall Study|Lost to Follow-up|2|||
124862454|NCT00377234|449117030|FG000|Overall Study|Adverse Event|14|||
124862455|NCT00377234|449117031|FG001|Overall Study|Adverse Event|17|||
124862456|NCT00377234|449117030|FG000|Overall Study|Withdrawal by Subject|11|||
124862457|NCT00377234|449117031|FG001|Overall Study|Withdrawal by Subject|9|||
124862458|NCT00377234|449117030|FG000|Overall Study|Lost to Follow-up|4|||
124862459|NCT00377234|449117031|FG001|Overall Study|Lost to Follow-up|2|||
124862460|NCT00377234|449117030|FG000|Overall Study|Administrative|2|||
124862461|NCT00377234|449117031|FG001|Overall Study|Administrative|1|||
124862462|NCT00377234|449117030|FG000|Overall Study|Not assigned|3|||
124862463|NCT00377234|449117031|FG001|Overall Study|Not assigned|2|||
124862464|NCT01880424|449117032|FG000|Overall Study|Adverse Event|7|||
124862465|NCT01880424|449117033|FG001|Overall Study|Adverse Event|6|||
124862466|NCT01880424|449117032|FG000|Overall Study|Lack of Efficacy|1|||
124862467|NCT01880424|449117033|FG001|Overall Study|Lack of Efficacy|4|||
124862468|NCT01880424|449117032|FG000|Overall Study|Lost to Follow-up|3|||
124862469|NCT01880424|449117033|FG001|Overall Study|Lost to Follow-up|2|||
124862470|NCT01880424|449117032|FG000|Overall Study|Protocol Violation|11|||
124862471|NCT01880424|449117033|FG001|Overall Study|Protocol Violation|13|||
124862472|NCT01880424|449117032|FG000|Overall Study|Withdrawal by Subject|10|||
124862473|NCT01880424|449117033|FG001|Overall Study|Withdrawal by Subject|30|||
124862474|NCT01880424|449117032|FG000|Overall Study|Other|1|||
124862475|NCT01880424|449117033|FG001|Overall Study|Other|0|||
124862476|NCT01983293|449117036|FG000|Overall Study|Withdrawal by Subject|29|||
124862477|NCT01983293|449117037|FG001|Overall Study|Withdrawal by Subject|15|||
124862478|NCT01983293|449117036|FG000|Overall Study|Missing 12-month visit|3|||
124862479|NCT01983293|449117037|FG001|Overall Study|Missing 12-month visit|3|||
124862480|NCT01983293|449117036|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
124862481|NCT01983293|449117037|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
124862482|NCT01747772|449117038|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
124862483|NCT01944631|449117042|FG000|Overall Study|Adverse Event|1|||
124862484|NCT01944631|449117043|FG001|Overall Study|Adverse Event|0|||
124862485|NCT01944631|449117042|FG000|Overall Study|Lost to Follow-up|3|||
124862486|NCT01944631|449117043|FG001|Overall Study|Lost to Follow-up|1|||
124862487|NCT01944631|449117042|FG000|Overall Study|Withdrawal by Subject|0|||
124862488|NCT01944631|449117043|FG001|Overall Study|Withdrawal by Subject|1|||
124862489|NCT02388724|449117045|FG000|Overall Study|Reason not Specified|0|||
124862490|NCT02388724|449117046|FG001|Overall Study|Reason not Specified|1|||
124862491|NCT02388724|449117045|FG000|Overall Study|Major Protocol Deviation|3|||
124862492|NCT02388724|449117046|FG001|Overall Study|Major Protocol Deviation|3|||
124862493|NCT02388724|449117045|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
124862494|NCT02388724|449117046|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
124862495|NCT02388724|449117045|FG000|Overall Study|Voluntary Withdrawal|6|||
124862496|NCT02388724|449117046|FG001|Overall Study|Voluntary Withdrawal|5|||
124862497|NCT02388724|449117045|FG000|Overall Study|Randomized but not Treated|0|||
124862498|NCT02388724|449117046|FG001|Overall Study|Randomized but not Treated|2|||
124862499|NCT02605954|449117048|FG000|Overall Study|Adverse Event|5|||
124862500|NCT02605954|449117049|FG001|Overall Study|Adverse Event|1|||
124862501|NCT02605954|449117048|FG000|Overall Study|Investigator's Discretion|1|||
124862502|NCT02605954|449117049|FG001|Overall Study|Investigator's Discretion|0|||
124862503|NCT02605954|449117048|FG000|Overall Study|Non-Compliance with Study Drug|1|||
124862504|NCT02605954|449117049|FG001|Overall Study|Non-Compliance with Study Drug|0|||
124862505|NCT02605954|449117048|FG000|Overall Study|Withdrew Consent|2|||
124862506|NCT02605954|449117049|FG001|Overall Study|Withdrew Consent|2|||
124862507|NCT02605954|449117048|FG000|Overall Study|Lost to Follow-up|3|||
124862508|NCT02605954|449117049|FG001|Overall Study|Lost to Follow-up|0|||
124862509|NCT02605954|449117048|FG000|Overall Study|Randomized but not treated|0|||
124862510|NCT02605954|449117049|FG001|Overall Study|Randomized but not treated|1|||
124862511|NCT00856856|449117053|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
124862512|NCT00856856|449117053|FG000|4-year Clinical Follow-up|Missed visit|1|||
124862513|NCT02696317|449117056|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
124862514|NCT02696317|449117057|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
124862515|NCT02696317|449117056|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
124862516|NCT02696317|449117057|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
124862517|NCT00413153|449117058|FG000|Overall Study|Withdrawal by Subject|1|||
124862518|NCT00413153|449117059|FG001|Overall Study|Withdrawal by Subject|1|||
124862519|NCT00413153|449117058|FG000|Overall Study|Adverse Event|1|||
124862520|NCT00413153|449117059|FG001|Overall Study|Adverse Event|0|||
124862521|NCT02277106|449117060|FG000|Stage 2|Adverse Event|0|||
124862522|NCT02277106|449117061|FG001|Stage 2|Adverse Event|0|||
124862523|NCT02277106|449117062|FG002|Stage 2|Adverse Event|1|||
124862524|NCT01669629|449117064|FG000|Period 1|protocol deviation|1|||
124862525|NCT01669629|449117065|FG001|Period 1|protocol deviation|2|||
124862526|NCT01221597|449117066|FG000|Overall Study|Adverse Event|4|||
124862527|NCT01221597|449117067|FG001|Overall Study|Adverse Event|1|||
124862528|NCT01221597|449117066|FG000|Overall Study|Withdrawal by Subject|20|||
124862529|NCT01221597|449117067|FG001|Overall Study|Withdrawal by Subject|6|||
124862530|NCT01221597|449117066|FG000|Overall Study|Lost to Follow-up|6|||
124862531|NCT01221597|449117067|FG001|Overall Study|Lost to Follow-up|5|||
124862532|NCT01221597|449117066|FG000|Overall Study|Protocol Violation|1|||
124862533|NCT01221597|449117067|FG001|Overall Study|Protocol Violation|0|||
124862534|NCT01221597|449117066|FG000|Overall Study|Other|3|||
124862535|NCT01221597|449117067|FG001|Overall Study|Other|4|||
124862536|NCT01221597|449117066|FG000|Overall Study|Death|2|||
124862537|NCT01221597|449117067|FG001|Overall Study|Death|0|||
124862538|NCT00487162|449117070|FG000|Overall Study|Adverse Event|0|||
124862539|NCT00487162|449117071|FG001|Overall Study|Adverse Event|1|||
124862540|NCT00487162|449117070|FG000|Overall Study|Physician Decision|0|||
124862541|NCT00487162|449117071|FG001|Overall Study|Physician Decision|1|||
124862542|NCT00487162|449117070|FG000|Overall Study|Withdrawal by Subject|2|||
124862543|NCT00487162|449117071|FG001|Overall Study|Withdrawal by Subject|3|||
124862544|NCT02278328|449117072|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
124862545|NCT02278328|449117073|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
124862546|NCT02278328|449117074|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
124862547|NCT02278328|449117072|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
124862548|NCT02278328|449117073|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
124862549|NCT02278328|449117074|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
124862550|NCT02278328|449117072|FG000|Neuropsych Screening|incomplete consent|0|||
124862551|NCT02278328|449117073|FG001|Neuropsych Screening|incomplete consent|0|||
124862552|NCT02278328|449117074|FG002|Neuropsych Screening|incomplete consent|2|||
124862553|NCT03834779|449117080|FG000|Overall Study|Death|1|||
124862554|NCT03834779|449117081|FG001|Overall Study|Death|2|||
124862555|NCT03834779|449117080|FG000|Overall Study|Lost to Follow-up|6|||
124862556|NCT03834779|449117081|FG001|Overall Study|Lost to Follow-up|4|||
124862557|NCT01059565|449117082|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
124862558|NCT01059565|449117083|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
124862559|NCT01059565|449117082|FG000|24-Week Randomized Phase|Adverse Event|5|||
124862560|NCT01059565|449117083|FG001|24-Week Randomized Phase|Adverse Event|0|||
124862561|NCT01059565|449117082|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
124862562|NCT01059565|449117083|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
124862563|NCT01059565|449117082|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
124862564|NCT01059565|449117083|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
124862565|NCT01059565|449117082|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
124862566|NCT01059565|449117083|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
124862567|NCT01059565|449117082|FG000|24-Week Open-Label Phase|Adverse Event|2|||
124862568|NCT01059565|449117083|FG001|24-Week Open-Label Phase|Adverse Event|0|||
124862569|NCT01059565|449117082|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
124862570|NCT01059565|449117083|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
124862571|NCT01059565|449117082|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
124862572|NCT01059565|449117083|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
124862573|NCT01059565|449117082|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
124862574|NCT01059565|449117083|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
124862575|NCT01059565|449117082|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
124862576|NCT01059565|449117083|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
124862577|NCT01059565|449117082|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
124862578|NCT01059565|449117083|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
124862579|NCT03638141|449117089|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
124862580|NCT03526250|449117092|FG000|Overall Study|Adverse Event|4|||
124862581|NCT03526250|449117092|FG000|Overall Study|Progressive Disease|16|||
124862582|NCT03526250|449117092|FG000|Overall Study|No Treatment|3|||
124862583|NCT00522275|449117095|FG000|Overall Study|Adverse Event|35|||
124862584|NCT00522275|449117095|FG000|Overall Study|Lack of Efficacy|80|||
124862585|NCT00522275|449117095|FG000|Overall Study|Subject withdrew consent|16|||
124862586|NCT00522275|449117095|FG000|Overall Study|Protocol deviation|1|||
124862587|NCT00522275|449117095|FG000|Overall Study|Unsatisfactory compliance|11|||
124862588|NCT00522275|449117095|FG000|Overall Study|Lost to Follow-up|8|||
124862589|NCT00522275|449117095|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
124862590|NCT00522275|449117095|FG000|Overall Study|Other: Subject is pregnant|2|||
124862591|NCT00522275|449117095|FG000|Overall Study|Other: Subject relocated|2|||
124862592|NCT00522275|449117095|FG000|Overall Study|Other: Subject arrested|1|||
124862593|NCT00522275|449117095|FG000|Overall Study|Other: Site / clinic closed|4|||
124862594|NCT00522275|449117095|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
124862595|NCT00522275|449117095|FG000|Overall Study|Other: Sponsor request|2|||
124862596|NCT00522275|449117095|FG000|Overall Study|Other: Subject ran out of medication|1|||
124862597|NCT00522275|449117095|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
124862598|NCT02576067|449117096|FG000|Overall Study|Death|0|||
124862599|NCT02576067|449117097|FG001|Overall Study|Death|1|||
124862600|NCT02576067|449117096|FG000|Overall Study|Lack of Efficacy|1|||
124862601|NCT02576067|449117097|FG001|Overall Study|Lack of Efficacy|0|||
124862602|NCT02576067|449117096|FG000|Overall Study|Lost to Follow-up|11|||
124862603|NCT02576067|449117097|FG001|Overall Study|Lost to Follow-up|0|||
124862604|NCT02576067|449117096|FG000|Overall Study|Withdrawal by Subject|11|||
124862605|NCT02576067|449117097|FG001|Overall Study|Withdrawal by Subject|2|||
124862606|NCT02576067|449117096|FG000|Overall Study|study closure of main CIRT trial)|0|||
124862607|NCT02576067|449117097|FG001|Overall Study|study closure of main CIRT trial)|8|||
124862608|NCT02576067|449117096|FG000|Overall Study|not randomized, failed run-in|7|||
124862609|NCT02576067|449117097|FG001|Overall Study|not randomized, failed run-in|0|||
124862610|NCT02576067|449117096|FG000|Overall Study|screen failure/ re-enrolled|0|||
124862611|NCT02576067|449117097|FG001|Overall Study|screen failure/ re-enrolled|25|||
124862612|NCT02576067|449117096|FG000|Overall Study|Physician Decision|4|||
124862613|NCT02576067|449117097|FG001|Overall Study|Physician Decision|0|||
124862614|NCT04773587|449117098|FG000|Overall Study|Lost to Follow-up|11|||
124862615|NCT04773587|449117099|FG001|Overall Study|Lost to Follow-up|3|||
124862616|NCT04773587|449117098|FG000|Overall Study|Adverse Event|6|||
124862617|NCT04773587|449117099|FG001|Overall Study|Adverse Event|3|||
124862618|NCT04773587|449117098|FG000|Overall Study|Lack of Efficacy|5|||
124862619|NCT04773587|449117099|FG001|Overall Study|Lack of Efficacy|2|||
124862620|NCT04773587|449117098|FG000|Overall Study|Withdrawal by Subject|4|||
124862621|NCT04773587|449117099|FG001|Overall Study|Withdrawal by Subject|5|||
124862622|NCT04773587|449117098|FG000|Overall Study|Noncompliance|1|||
124862623|NCT04773587|449117099|FG001|Overall Study|Noncompliance|0|||
124862624|NCT04773587|449117098|FG000|Overall Study|Protocol Violation|1|||
124862625|NCT04773587|449117099|FG001|Overall Study|Protocol Violation|0|||
124862626|NCT04773587|449117098|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
124862627|NCT04773587|449117099|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
124862628|NCT02372409|449117100|FG000|Overall Study|Lost to Follow-up|1|||
124862629|NCT02372409|449117101|FG001|Overall Study|Lost to Follow-up|0|||
124862630|NCT02372409|449117100|FG000|Overall Study|Disease progression|1|||
124862631|NCT02372409|449117101|FG001|Overall Study|Disease progression|1|||
124862632|NCT00622167|449117103|FG000|Overall Study|Did not meet angiographic criteria|20|||
124862633|NCT03674177|449117107|FG000|Overall Study|Lost to Follow-up|2|||
124862634|NCT03674177|449117108|FG001|Overall Study|Lost to Follow-up|1|||
124862635|NCT03674177|449117109|FG002|Overall Study|Lost to Follow-up|0|||
124862636|NCT03674177|449117110|FG003|Overall Study|Lost to Follow-up|2|||
124862637|NCT00714168|449117111|FG000|Overall Study|Pregnancy|5|||
124862638|NCT00714168|449117112|FG001|Overall Study|Pregnancy|4|||
124862639|NCT00714168|449117111|FG000|Overall Study|Lost to Follow-up|32|||
124862640|NCT00714168|449117112|FG001|Overall Study|Lost to Follow-up|50|||
124862641|NCT00714168|449117111|FG000|Overall Study|Relocation|4|||
124862642|NCT00714168|449117112|FG001|Overall Study|Relocation|3|||
124862643|NCT00714168|449117111|FG000|Overall Study|Non-study medical condition|3|||
124862644|NCT00714168|449117112|FG001|Overall Study|Non-study medical condition|2|||
124862645|NCT03230916|449117116|FG000|Overall Study|Withdrawal by Subject|0|||
124862646|NCT03230916|449117117|FG001|Overall Study|Withdrawal by Subject|0|||
124862647|NCT03230916|449117118|FG002|Overall Study|Withdrawal by Subject|0|||
124862648|NCT03230916|449117119|FG003|Overall Study|Withdrawal by Subject|0|||
124862649|NCT03230916|449117120|FG004|Overall Study|Withdrawal by Subject|0|||
124862650|NCT03230916|449117121|FG005|Overall Study|Withdrawal by Subject|1|||
124862651|NCT03230916|449117122|FG006|Overall Study|Withdrawal by Subject|0|||
124862652|NCT03230916|449117123|FG007|Overall Study|Withdrawal by Subject|0|||
124862653|NCT03230916|449117124|FG008|Overall Study|Withdrawal by Subject|0|||
124862654|NCT03230916|449117125|FG009|Overall Study|Withdrawal by Subject|0|||
124862655|NCT03230916|449117126|FG010|Overall Study|Withdrawal by Subject|0|||
124862656|NCT01128413|449117128|FG000|Overall Study|Withdrawal by Subject|1|||
124862657|NCT01128413|449117129|FG001|Overall Study|Withdrawal by Subject|0|||
124862658|NCT01128413|449117128|FG000|Overall Study|NICOM Monitor Problems|2|||
124862659|NCT01128413|449117129|FG001|Overall Study|NICOM Monitor Problems|1|||
124862660|NCT01128413|449117128|FG000|Overall Study|Pt made DNR|1|||
124862661|NCT01128413|449117129|FG001|Overall Study|Pt made DNR|0|||
124862662|NCT03077724|449117131|FG000|Overall Study|Lost to Follow-up|5|||
124862663|NCT03077724|449117132|FG001|Overall Study|Lost to Follow-up|1|||
124862664|NCT03077724|449117131|FG000|Overall Study|Withdrawal by Subject|3|||
124862665|NCT03077724|449117132|FG001|Overall Study|Withdrawal by Subject|1|||
124862666|NCT04370054|449117135|FG000|Treatment Phase|Lost to Follow-up|1|||
124862667|NCT04370054|449117135|FG000|Treatment Phase|Withdrawal by Subject|1|||
124862668|NCT04370054|449117135|FG000|Follow-Up Phase|Ongoing|75|||
124862669|NCT00722761|449117136|FG000|Overall Study|Lost to Follow-up|1|||
124862670|NCT00722761|449117137|FG001|Overall Study|Lost to Follow-up|4|||
124862671|NCT00722761|449117136|FG000|Overall Study|Withdrawal by Subject|5|||
124862672|NCT00722761|449117137|FG001|Overall Study|Withdrawal by Subject|2|||
124862673|NCT02075593|449117139|FG000|Overall Study|Withdrawal by Subject|1|||
124862674|NCT02522494|449118972|FG000|Overall Study|Lost to Follow-up|6|||
124862675|NCT02522494|449118973|FG001|Overall Study|Lost to Follow-up|2|||
124862676|NCT02522494|449118972|FG000|Overall Study|Withdrawal by Subject|1|||
124862677|NCT02522494|449118973|FG001|Overall Study|Withdrawal by Subject|0|||
124862678|NCT02522494|449118972|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
124862679|NCT02522494|449118973|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
124862680|NCT02522494|449118972|FG000|Overall Study|Participant did not watch the video|1|||
124862681|NCT02522494|449118973|FG001|Overall Study|Participant did not watch the video|0|||
124862682|NCT02522494|449118972|FG000|Overall Study|Death|0|||
124862683|NCT02522494|449118973|FG001|Overall Study|Death|1|||
124862684|NCT02239679|449118974|FG000|Overall Study|Lost to Follow-up|1|||
124862685|NCT02239679|449118975|FG001|Overall Study|Lost to Follow-up|0|||
124862686|NCT02239679|449118976|FG002|Overall Study|Lost to Follow-up|0|||
124862687|NCT02239679|449118974|FG000|Overall Study|Withdrawal by Subject|2|||
124862688|NCT02239679|449118975|FG001|Overall Study|Withdrawal by Subject|3|||
124862689|NCT02239679|449118976|FG002|Overall Study|Withdrawal by Subject|1|||
124862690|NCT02047045|449118980|FG000|Baseline|Withdrawal by Subject|3|||
124862691|NCT02047045|449118981|FG001|Baseline|Withdrawal by Subject|2|||
124862692|NCT02047045|449118980|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
124862693|NCT02047045|449118981|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
124862694|NCT02047045|449118980|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
124862695|NCT02047045|449118981|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
124862696|NCT02047045|449118980|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
124862697|NCT02047045|449118981|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
124862698|NCT02047045|449118980|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
124862699|NCT02047045|449118981|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
124862700|NCT02047045|449118980|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
124862701|NCT02047045|449118981|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
124862702|NCT02047045|449118980|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
124862703|NCT02047045|449118981|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
124862704|NCT02047045|449118980|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
124862705|NCT02047045|449118981|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
124862706|NCT02047045|449118980|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
124862707|NCT02047045|449118981|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
124862708|NCT03214367|449118982|FG000|Lead-in Period|Withdrawal by Subject|50|||
124862709|NCT03214367|449118983|FG001|Lead-in Period|Withdrawal by Subject|0|||
124862710|NCT03214367|449118984|FG002|Lead-in Period|Withdrawal by Subject|0|||
124862711|NCT03214367|449118985|FG003|Lead-in Period|Withdrawal by Subject|0|||
124862712|NCT03214367|449118986|FG004|Lead-in Period|Withdrawal by Subject|2|||
124862713|NCT03214367|449118987|FG005|Lead-in Period|Withdrawal by Subject|0|||
124862714|NCT03214367|449118988|FG006|Lead-in Period|Withdrawal by Subject|0|||
124862715|NCT03214367|449118989|FG007|Lead-in Period|Withdrawal by Subject|0|||
124862716|NCT03214367|449118982|FG000|Lead-in Period|Adverse Event|3|||
124862717|NCT03214367|449118983|FG001|Lead-in Period|Adverse Event|0|||
124862718|NCT03214367|449118984|FG002|Lead-in Period|Adverse Event|0|||
124862719|NCT03214367|449118985|FG003|Lead-in Period|Adverse Event|0|||
124862720|NCT03214367|449118986|FG004|Lead-in Period|Adverse Event|0|||
124862721|NCT03214367|449118987|FG005|Lead-in Period|Adverse Event|0|||
124862722|NCT03214367|449118988|FG006|Lead-in Period|Adverse Event|0|||
124862723|NCT03214367|449118989|FG007|Lead-in Period|Adverse Event|0|||
124862724|NCT03214367|449118982|FG000|Lead-in Period|Lost to Follow-up|12|||
124862725|NCT03214367|449118983|FG001|Lead-in Period|Lost to Follow-up|0|||
124862726|NCT03214367|449118984|FG002|Lead-in Period|Lost to Follow-up|0|||
124862727|NCT03214367|449118985|FG003|Lead-in Period|Lost to Follow-up|0|||
124862728|NCT03214367|449118986|FG004|Lead-in Period|Lost to Follow-up|0|||
124862729|NCT03214367|449118987|FG005|Lead-in Period|Lost to Follow-up|0|||
124862730|NCT03214367|449118988|FG006|Lead-in Period|Lost to Follow-up|0|||
124862731|NCT03214367|449118989|FG007|Lead-in Period|Lost to Follow-up|0|||
124862732|NCT03214367|449118982|FG000|Lead-in Period|Sponsor Decision|11|||
124862733|NCT03214367|449118983|FG001|Lead-in Period|Sponsor Decision|0|||
124862734|NCT03214367|449118984|FG002|Lead-in Period|Sponsor Decision|0|||
124862735|NCT03214367|449118985|FG003|Lead-in Period|Sponsor Decision|0|||
124862736|NCT03214367|449118986|FG004|Lead-in Period|Sponsor Decision|0|||
124862737|NCT03214367|449118987|FG005|Lead-in Period|Sponsor Decision|0|||
124862738|NCT03214367|449118988|FG006|Lead-in Period|Sponsor Decision|0|||
124862739|NCT03214367|449118989|FG007|Lead-in Period|Sponsor Decision|0|||
124862740|NCT03214367|449118982|FG000|Lead-in Period|Physician Decision|12|||
124862741|NCT03214367|449118983|FG001|Lead-in Period|Physician Decision|0|||
124862742|NCT03214367|449118984|FG002|Lead-in Period|Physician Decision|0|||
124862743|NCT03214367|449118985|FG003|Lead-in Period|Physician Decision|0|||
124862744|NCT03214367|449118986|FG004|Lead-in Period|Physician Decision|0|||
124862745|NCT03214367|449118987|FG005|Lead-in Period|Physician Decision|0|||
124862746|NCT03214367|449118988|FG006|Lead-in Period|Physician Decision|0|||
124862747|NCT03214367|449118989|FG007|Lead-in Period|Physician Decision|0|||
124862748|NCT03214367|449118982|FG000|Lead-in Period|Protocol Violation|5|||
124862749|NCT03214367|449118983|FG001|Lead-in Period|Protocol Violation|0|||
124862750|NCT03214367|449118984|FG002|Lead-in Period|Protocol Violation|0|||
124862751|NCT03214367|449118985|FG003|Lead-in Period|Protocol Violation|0|||
124862752|NCT03214367|449118986|FG004|Lead-in Period|Protocol Violation|0|||
124862753|NCT03214367|449118987|FG005|Lead-in Period|Protocol Violation|0|||
124862754|NCT03214367|449118988|FG006|Lead-in Period|Protocol Violation|0|||
124862755|NCT03214367|449118989|FG007|Lead-in Period|Protocol Violation|0|||
124862756|NCT03214367|449118982|FG000|Lead-in Period|Treatment Interruption|1|||
124862757|NCT03214367|449118983|FG001|Lead-in Period|Treatment Interruption|0|||
124862758|NCT03214367|449118984|FG002|Lead-in Period|Treatment Interruption|0|||
124862759|NCT03214367|449118985|FG003|Lead-in Period|Treatment Interruption|0|||
124862760|NCT03214367|449118986|FG004|Lead-in Period|Treatment Interruption|0|||
124862761|NCT03214367|449118987|FG005|Lead-in Period|Treatment Interruption|0|||
124862762|NCT03214367|449118988|FG006|Lead-in Period|Treatment Interruption|0|||
124862763|NCT03214367|449118989|FG007|Lead-in Period|Treatment Interruption|0|||
124862764|NCT03214367|449118982|FG000|Treatment Period|Adverse Event|0|||
124862765|NCT03214367|449118983|FG001|Treatment Period|Adverse Event|1|||
124862766|NCT03214367|449118984|FG002|Treatment Period|Adverse Event|4|||
124862767|NCT03214367|449118985|FG003|Treatment Period|Adverse Event|2|||
124862768|NCT03214367|449118986|FG004|Treatment Period|Adverse Event|0|||
124862769|NCT03214367|449118987|FG005|Treatment Period|Adverse Event|0|||
124862770|NCT03214367|449118988|FG006|Treatment Period|Adverse Event|0|||
124862771|NCT03214367|449118989|FG007|Treatment Period|Adverse Event|0|||
124862772|NCT03214367|449118982|FG000|Treatment Period|Death|0|||
124862773|NCT03214367|449118983|FG001|Treatment Period|Death|1|||
124862774|NCT03214367|449118984|FG002|Treatment Period|Death|1|||
124862775|NCT03214367|449118985|FG003|Treatment Period|Death|1|||
124862776|NCT03214367|449118986|FG004|Treatment Period|Death|0|||
124862777|NCT03214367|449118987|FG005|Treatment Period|Death|0|||
124862778|NCT03214367|449118988|FG006|Treatment Period|Death|0|||
124862779|NCT03214367|449118989|FG007|Treatment Period|Death|0|||
124862780|NCT03214367|449118982|FG000|Treatment Period|Lost to Follow-up|0|||
124862781|NCT03214367|449118983|FG001|Treatment Period|Lost to Follow-up|5|||
124862782|NCT03214367|449118984|FG002|Treatment Period|Lost to Follow-up|3|||
124862783|NCT03214367|449118985|FG003|Treatment Period|Lost to Follow-up|2|||
124862784|NCT03214367|449118986|FG004|Treatment Period|Lost to Follow-up|0|||
124862785|NCT03214367|449118987|FG005|Treatment Period|Lost to Follow-up|2|||
124862786|NCT03214367|449118988|FG006|Treatment Period|Lost to Follow-up|1|||
124862787|NCT03214367|449118989|FG007|Treatment Period|Lost to Follow-up|0|||
124862788|NCT03214367|449118982|FG000|Treatment Period|Sponsor Decision|0|||
124862789|NCT03214367|449118983|FG001|Treatment Period|Sponsor Decision|3|||
124862790|NCT03214367|449118984|FG002|Treatment Period|Sponsor Decision|0|||
124862791|NCT03214367|449118985|FG003|Treatment Period|Sponsor Decision|0|||
124862792|NCT03214367|449118986|FG004|Treatment Period|Sponsor Decision|0|||
124862793|NCT03214367|449118987|FG005|Treatment Period|Sponsor Decision|0|||
124862794|NCT03214367|449118988|FG006|Treatment Period|Sponsor Decision|0|||
124862795|NCT03214367|449118989|FG007|Treatment Period|Sponsor Decision|0|||
124862796|NCT03214367|449118982|FG000|Treatment Period|Physician Decision|0|||
124862797|NCT03214367|449118983|FG001|Treatment Period|Physician Decision|1|||
124862798|NCT03214367|449118984|FG002|Treatment Period|Physician Decision|2|||
124862799|NCT03214367|449118985|FG003|Treatment Period|Physician Decision|0|||
124862800|NCT03214367|449118986|FG004|Treatment Period|Physician Decision|0|||
124862801|NCT03214367|449118987|FG005|Treatment Period|Physician Decision|0|||
124862802|NCT03214367|449118988|FG006|Treatment Period|Physician Decision|0|||
124862803|NCT03214367|449118989|FG007|Treatment Period|Physician Decision|0|||
124862804|NCT03214367|449118982|FG000|Treatment Period|Protocol Violation|0|||
124862805|NCT03214367|449118983|FG001|Treatment Period|Protocol Violation|3|||
124862806|NCT03214367|449118984|FG002|Treatment Period|Protocol Violation|0|||
124862807|NCT03214367|449118985|FG003|Treatment Period|Protocol Violation|0|||
124862808|NCT03214367|449118986|FG004|Treatment Period|Protocol Violation|0|||
124862809|NCT03214367|449118987|FG005|Treatment Period|Protocol Violation|0|||
124862810|NCT03214367|449118988|FG006|Treatment Period|Protocol Violation|0|||
124862811|NCT03214367|449118989|FG007|Treatment Period|Protocol Violation|0|||
124862812|NCT03214367|449118982|FG000|Treatment Period|Withdrawal by Subject|0|||
124862813|NCT03214367|449118983|FG001|Treatment Period|Withdrawal by Subject|20|||
124862814|NCT03214367|449118984|FG002|Treatment Period|Withdrawal by Subject|23|||
124862815|NCT03214367|449118985|FG003|Treatment Period|Withdrawal by Subject|14|||
124862816|NCT03214367|449118986|FG004|Treatment Period|Withdrawal by Subject|0|||
124862817|NCT03214367|449118987|FG005|Treatment Period|Withdrawal by Subject|1|||
124862818|NCT03214367|449118988|FG006|Treatment Period|Withdrawal by Subject|1|||
124862819|NCT03214367|449118989|FG007|Treatment Period|Withdrawal by Subject|1|||
124862820|NCT03508843|449118990|FG000|Overall Study|Withdrawal by Subject|1|||
124862821|NCT03508843|449118990|FG000|Overall Study|technical difficulties|2|||
124862822|NCT00765843|449118991|FG000|Overall Study|Lost to Follow-up|1|||
124862823|NCT00765843|449118992|FG001|Overall Study|Lost to Follow-up|3|||
124862824|NCT00765843|449118993|FG002|Overall Study|Lost to Follow-up|2|||
124862825|NCT00765843|449118991|FG000|Overall Study|did not return to receive intervention|0|||
124862826|NCT00765843|449118992|FG001|Overall Study|did not return to receive intervention|1|||
124862827|NCT00765843|449118993|FG002|Overall Study|did not return to receive intervention|0|||
124862828|NCT00765843|449118991|FG000|Overall Study|Adverse Event|0|||
124862829|NCT00765843|449118992|FG001|Overall Study|Adverse Event|0|||
124862830|NCT00765843|449118993|FG002|Overall Study|Adverse Event|1|||
124862831|NCT03555396|449118994|FG000|Overall Study|Death|3|||
124862832|NCT03555396|449118995|FG001|Overall Study|Death|1|||
124862833|NCT03555396|449118994|FG000|Overall Study|Lost to Follow-up|0|||
124862834|NCT03555396|449118995|FG001|Overall Study|Lost to Follow-up|2|||
124862835|NCT00448539|449118998|FG000|Overall Study|Medication non-compliance|4|||
124862836|NCT00448539|449118999|FG001|Overall Study|Medication non-compliance|1|||
124862837|NCT00448539|449118998|FG000|Overall Study|Protocol Violation|1|||
124862838|NCT00448539|449118999|FG001|Overall Study|Protocol Violation|0|||
124862839|NCT00448539|449118998|FG000|Overall Study|Request of the investigator or sponsor|67|||
124862840|NCT00448539|449118999|FG001|Overall Study|Request of the investigator or sponsor|54|||
124862841|NCT00448539|449118998|FG000|Overall Study|Withdrawal by Subject|20|||
124862842|NCT00448539|449118999|FG001|Overall Study|Withdrawal by Subject|24|||
124862843|NCT00448539|449118998|FG000|Overall Study|Diary non-compliance|1|||
124862844|NCT00448539|449118999|FG001|Overall Study|Diary non-compliance|0|||
124862845|NCT00448539|449118998|FG000|Overall Study|Adverse Event|9|||
124862846|NCT00448539|449118999|FG001|Overall Study|Adverse Event|26|||
124862847|NCT00448539|449118998|FG000|Overall Study|Lack of Efficacy|27|||
124862848|NCT00448539|449118999|FG001|Overall Study|Lack of Efficacy|40|||
124862849|NCT00448539|449118998|FG000|Overall Study|Miscellaneous|2|||
124862850|NCT00448539|449118999|FG001|Overall Study|Miscellaneous|1|||
124862851|NCT00448539|449118998|FG000|Overall Study|Change of meds|2|||
124862852|NCT00448539|449118999|FG001|Overall Study|Change of meds|3|||
124862853|NCT00448539|449118998|FG000|Overall Study|Lost to Follow-up|1|||
124862854|NCT00448539|449118999|FG001|Overall Study|Lost to Follow-up|3|||
124862855|NCT02103439|449119000|FG000|Overall Study|Adverse Event|0|||
124862856|NCT02103439|449119001|FG001|Overall Study|Adverse Event|2|||
124862857|NCT02103439|449119000|FG000|Overall Study|Withdrawal by Subject|3|||
124862858|NCT02103439|449119001|FG001|Overall Study|Withdrawal by Subject|1|||
124862859|NCT04955639|449119003|FG000|Overall Study|Withdrawal by Subject|2|||
124862860|NCT04955639|449119004|FG001|Overall Study|Withdrawal by Subject|2|||
124862861|NCT04955639|449119003|FG000|Overall Study|Week 26 survey not completed|2|||
124862862|NCT04955639|449119004|FG001|Overall Study|Week 26 survey not completed|2|||
124862863|NCT04447404|449119005|FG000|Overall Study|Death|2|||
124862864|NCT04447404|449119006|FG001|Overall Study|Death|0|||
124862865|NCT01369342|449119007|FG000|Overall Study|Withdrawal by Subject|7|||
124862866|NCT01369342|449119008|FG001|Overall Study|Withdrawal by Subject|7|||
124862867|NCT01369342|449119009|FG002|Overall Study|Withdrawal by Subject|2|||
124862868|NCT01369342|449119007|FG000|Overall Study|Lost to Follow-up|5|||
124862869|NCT01369342|449119008|FG001|Overall Study|Lost to Follow-up|2|||
124862870|NCT01369342|449119009|FG002|Overall Study|Lost to Follow-up|1|||
124862871|NCT01369342|449119007|FG000|Overall Study|Not Treated|1|||
124862872|NCT01369342|449119008|FG001|Overall Study|Not Treated|0|||
124862873|NCT01369342|449119009|FG002|Overall Study|Not Treated|0|||
124862874|NCT01816594|449119010|FG000|Overall Study|Local Progress|0|||
124862875|NCT01816594|449119011|FG001|Overall Study|Local Progress|2|||
124862876|NCT01816594|449119010|FG000|Overall Study|Adverse Event|9|||
124862877|NCT01816594|449119011|FG001|Overall Study|Adverse Event|0|||
124862878|NCT01816594|449119010|FG000|Overall Study|Withdrawal by Subject|1|||
124862879|NCT01816594|449119011|FG001|Overall Study|Withdrawal by Subject|0|||
124862880|NCT01816594|449119010|FG000|Overall Study|Physician Decision|1|||
124862881|NCT01816594|449119011|FG001|Overall Study|Physician Decision|0|||
124862882|NCT03905655|449119012|FG000|Overall Study|Adverse Event|1|||
124862883|NCT03905655|449119013|FG001|Overall Study|Adverse Event|0|||
124862884|NCT03905655|449119014|FG002|Overall Study|Adverse Event|1|||
124862885|NCT03905655|449119015|FG003|Overall Study|Adverse Event|1|||
124862886|NCT01064739|449119016|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
124862887|NCT03667053|449119019|FG000|Overall Study|Withdrawal by Subject|1|||
124862888|NCT03667053|449119020|FG001|Overall Study|Withdrawal by Subject|0|||
124862889|NCT03667053|449119021|FG002|Overall Study|Withdrawal by Subject|0|||
124862890|NCT01292928|449119022|FG000|Overall Study|Death|8|||
124862891|NCT01292928|449119022|FG000|Overall Study|Withdrawal by Subject|8|||
124862892|NCT01292928|449119022|FG000|Overall Study|Lost to Follow-up|6|||
124862893|NCT01292928|449119022|FG000|Overall Study|Physician Decision|2|||
124862894|NCT00130533|449119023|FG000|Overall Study|Withdrawal by Subject|33|||
124862895|NCT00130533|449119024|FG001|Overall Study|Withdrawal by Subject|6|||
124862896|NCT00130533|449119023|FG000|Overall Study|Adverse Event|34|||
124862897|NCT00130533|449119024|FG001|Overall Study|Adverse Event|1|||
124862898|NCT00130533|449119023|FG000|Overall Study|Disease relapse|9|||
124862899|NCT00130533|449119024|FG001|Overall Study|Disease relapse|13|||
124862900|NCT00130533|449119023|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
124862901|NCT00130533|449119024|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
124862902|NCT00130533|449119023|FG000|Overall Study|Death|4|||
124862903|NCT00130533|449119024|FG001|Overall Study|Death|2|||
124862904|NCT00130533|449119023|FG000|Overall Study|Protocol Violation|5|||
124862905|NCT00130533|449119024|FG001|Overall Study|Protocol Violation|1|||
124862906|NCT00130533|449119023|FG000|Overall Study|Lost to Follow-up|1|||
124862907|NCT00130533|449119024|FG001|Overall Study|Lost to Follow-up|1|||
124862908|NCT00130533|449119023|FG000|Overall Study|Sponsor´s decision|2|||
124862909|NCT00130533|449119024|FG001|Overall Study|Sponsor´s decision|0|||
124862910|NCT00130533|449119023|FG000|Overall Study|Second Primary Malignancy|0|||
124862911|NCT00130533|449119024|FG001|Overall Study|Second Primary Malignancy|1|||
124862912|NCT00130533|449119023|FG000|Overall Study|Other|12|||
124862913|NCT00130533|449119024|FG001|Overall Study|Other|5|||
124862914|NCT03263429|449119025|FG000|Overall Study|Withdrawal by Subject|0|||
124862915|NCT03263429|449119026|FG001|Overall Study|Withdrawal by Subject|1|||
124862916|NCT03263429|449119027|FG002|Overall Study|Withdrawal by Subject|0|||
124862917|NCT03263429|449119025|FG000|Overall Study|Follow-Up Period Completed|0|||
124862918|NCT03263429|449119026|FG001|Overall Study|Follow-Up Period Completed|2|||
124862919|NCT03263429|449119027|FG002|Overall Study|Follow-Up Period Completed|0|||
124862920|NCT03263429|449119025|FG000|Overall Study|Death|3|||
124862921|NCT03263429|449119026|FG001|Overall Study|Death|5|||
124862922|NCT03263429|449119027|FG002|Overall Study|Death|16|||
124862923|NCT03263429|449119025|FG000|Overall Study|Participant unable to return|0|||
124862924|NCT03263429|449119026|FG001|Overall Study|Participant unable to return|0|||
124862925|NCT03263429|449119027|FG002|Overall Study|Participant unable to return|1|||
124862926|NCT03263429|449119025|FG000|Overall Study|Study Closed|0|||
124862927|NCT03263429|449119026|FG001|Overall Study|Study Closed|0|||
124862928|NCT03263429|449119027|FG002|Overall Study|Study Closed|1|||
124862929|NCT01605617|449119028|FG000|First Intervention|Adverse Event|0|||
124862930|NCT01605617|449119029|FG001|First Intervention|Adverse Event|1|||
124862931|NCT01605617|449119028|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
124862932|NCT01605617|449119029|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
124862933|NCT01314118|449119035|FG000|Overall Study|Adverse Event|9|||
124862934|NCT01314118|449119035|FG000|Overall Study|Progressive disease|27|||
124862935|NCT01314118|449119035|FG000|Overall Study|Physician Decision|11|||
124862936|NCT01314118|449119035|FG000|Overall Study|Death|4|||
124862937|NCT01314118|449119035|FG000|Overall Study|Protocol Violation|5|||
124862938|NCT01314118|449119035|FG000|Overall Study|Withdrawal by Subject|11|||
124862939|NCT01314118|449119035|FG000|Overall Study|Other|2|||
124862940|NCT01314118|449119035|FG000|Overall Study|Ongoing|62|||
124862941|NCT05545072|449119036|FG000|Overall Study|Lost to Follow-up|1|||
124862942|NCT05545072|449119037|FG001|Overall Study|Lost to Follow-up|0|||
124862943|NCT05545072|449119036|FG000|Overall Study|Study ended prematurely due to funding|2|||
124862944|NCT05545072|449119037|FG001|Overall Study|Study ended prematurely due to funding|2|||
124862945|NCT05585307|449119038|FG000|Overall Study|Lost to Follow-up|0|||
124862946|NCT05585307|449119039|FG001|Overall Study|Lost to Follow-up|0|||
124862947|NCT05585307|449119040|FG002|Overall Study|Lost to Follow-up|0|||
124862948|NCT05585307|449119041|FG003|Overall Study|Lost to Follow-up|0|||
124862949|NCT05585307|449119042|FG004|Overall Study|Lost to Follow-up|0|||
124862950|NCT05585307|449119043|FG005|Overall Study|Lost to Follow-up|0|||
124862951|NCT05585307|449119044|FG006|Overall Study|Lost to Follow-up|1|||
124862952|NCT05585307|449119045|FG007|Overall Study|Lost to Follow-up|0|||
124862953|NCT04420221|449119051|FG000|Overall Study|Withdrawal by Subject|0|||
124862954|NCT04420221|449119052|FG001|Overall Study|Withdrawal by Subject|0|||
124862955|NCT04420221|449119053|FG002|Overall Study|Withdrawal by Subject|0|||
124862956|NCT04420221|449119054|FG003|Overall Study|Withdrawal by Subject|0|||
124862957|NCT04420221|449119055|FG004|Overall Study|Withdrawal by Subject|0|||
124862958|NCT04420221|449119056|FG005|Overall Study|Withdrawal by Subject|20|||
124862959|NCT04420221|449119057|FG006|Overall Study|Withdrawal by Subject|5|||
124862960|NCT04420221|449119051|FG000|Overall Study|Other|0|||
124862961|NCT04420221|449119052|FG001|Overall Study|Other|0|||
124862962|NCT04420221|449119053|FG002|Overall Study|Other|0|||
124862963|NCT04420221|449119054|FG003|Overall Study|Other|0|||
124862964|NCT04420221|449119055|FG004|Overall Study|Other|0|||
124862965|NCT04420221|449119056|FG005|Overall Study|Other|1|||
124862966|NCT04420221|449119057|FG006|Overall Study|Other|1|||
124862967|NCT04420221|449119051|FG000|Overall Study|Lost to Follow-up|0|||
124862968|NCT04420221|449119052|FG001|Overall Study|Lost to Follow-up|0|||
124862969|NCT04420221|449119053|FG002|Overall Study|Lost to Follow-up|0|||
124862970|NCT04420221|449119054|FG003|Overall Study|Lost to Follow-up|0|||
124862971|NCT04420221|449119055|FG004|Overall Study|Lost to Follow-up|0|||
124862972|NCT04420221|449119056|FG005|Overall Study|Lost to Follow-up|3|||
124862973|NCT04420221|449119057|FG006|Overall Study|Lost to Follow-up|2|||
124862974|NCT04420221|449119051|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
124862975|NCT04420221|449119052|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
124862976|NCT04420221|449119053|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
124862977|NCT04420221|449119054|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
124862978|NCT04420221|449119055|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
124862979|NCT04420221|449119056|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
124862980|NCT04420221|449119057|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
124862981|NCT01618864|449119058|FG000|Overall Study|Withdrawal by Subject|2|||
124862982|NCT01618864|449119058|FG000|Overall Study|Lost to Follow-up|2|||
124862983|NCT02085408|449119062|FG000|Step 1: Induction|Disease Progression|19|||
124862984|NCT02085408|449119063|FG001|Step 1: Induction|Disease Progression|19|||
124862985|NCT02085408|449119062|FG000|Step 1: Induction|Adverse Event|18|||
124862986|NCT02085408|449119063|FG001|Step 1: Induction|Adverse Event|17|||
124862987|NCT02085408|449119062|FG000|Step 1: Induction|Death|33|||
124862988|NCT02085408|449119063|FG001|Step 1: Induction|Death|30|||
124862989|NCT02085408|449119062|FG000|Step 1: Induction|Withdrawal by Subject|16|||
124862990|NCT02085408|449119063|FG001|Step 1: Induction|Withdrawal by Subject|8|||
124862991|NCT02085408|449119062|FG000|Step 1: Induction|Alternative Therapy|15|||
124862992|NCT02085408|449119063|FG001|Step 1: Induction|Alternative Therapy|19|||
124862993|NCT02085408|449119062|FG000|Step 1: Induction|Complicating Disease|2|||
124862994|NCT02085408|449119063|FG001|Step 1: Induction|Complicating Disease|3|||
124862995|NCT02085408|449119062|FG000|Step 1: Induction|Other|27|||
124862996|NCT02085408|449119063|FG001|Step 1: Induction|Other|39|||
124862997|NCT02085408|449119062|FG000|Step 1: Induction|Never started treatment|6|||
124862998|NCT02085408|449119063|FG001|Step 1: Induction|Never started treatment|4|||
124862999|NCT02085408|449119062|FG000|Step 2: Consolidation|Disease Progression|5|||
124863000|NCT02085408|449119063|FG001|Step 2: Consolidation|Disease Progression|20|||
124863001|NCT02085408|449119062|FG000|Step 2: Consolidation|Adverse Event|9|||
124863002|NCT02085408|449119063|FG001|Step 2: Consolidation|Adverse Event|8|||
124863003|NCT02085408|449119062|FG000|Step 2: Consolidation|Death|4|||
124863004|NCT02085408|449119063|FG001|Step 2: Consolidation|Death|3|||
124863005|NCT02085408|449119062|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
124863006|NCT02085408|449119063|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
124863007|NCT02085408|449119062|FG000|Step 2: Consolidation|Alternative Therapy|9|||
124863008|NCT02085408|449119063|FG001|Step 2: Consolidation|Alternative Therapy|3|||
124863009|NCT02085408|449119062|FG000|Step 2: Consolidation|Complicating Disease|0|||
124863010|NCT02085408|449119063|FG001|Step 2: Consolidation|Complicating Disease|2|||
124863011|NCT02085408|449119062|FG000|Step 2: Consolidation|Other|6|||
124863012|NCT02085408|449119063|FG001|Step 2: Consolidation|Other|6|||
124863013|NCT02085408|449119062|FG000|Step 2: Consolidation|Never started treatment|4|||
124863014|NCT02085408|449119063|FG001|Step 2: Consolidation|Never started treatment|3|||
124863015|NCT02085408|449119062|FG000|Step 3: Maintenance|Disease Progression|13|||
124863016|NCT02085408|449119063|FG001|Step 3: Maintenance|Disease Progression|11|||
124863017|NCT02085408|449119062|FG000|Step 3: Maintenance|Adverse Event|2|||
124863018|NCT02085408|449119063|FG001|Step 3: Maintenance|Adverse Event|4|||
124863019|NCT02085408|449119062|FG000|Step 3: Maintenance|Death|1|||
124863020|NCT02085408|449119063|FG001|Step 3: Maintenance|Death|2|||
124863021|NCT02085408|449119062|FG000|Step 3: Maintenance|Alternative Therapy|1|||
124863022|NCT02085408|449119063|FG001|Step 3: Maintenance|Alternative Therapy|1|||
124863023|NCT02085408|449119062|FG000|Step 3: Maintenance|Complicating Disease|0|||
124863024|NCT02085408|449119063|FG001|Step 3: Maintenance|Complicating Disease|1|||
124863025|NCT02085408|449119062|FG000|Step 3: Maintenance|Other|3|||
124863026|NCT02085408|449119063|FG001|Step 3: Maintenance|Other|2|||
124863027|NCT02085408|449119062|FG000|Step 3: Maintenance|Never started treatment|5|||
124863028|NCT02085408|449119063|FG001|Step 3: Maintenance|Never started treatment|1|||
124863029|NCT01672801|449119069|FG000|Overall Study|Screen Failure|0|||
124863030|NCT01672801|449119070|FG001|Overall Study|Screen Failure|1|||
124863031|NCT02273141|449119073|FG000|Overall Study|Adverse Event|0|||
124863032|NCT02273141|449119074|FG001|Overall Study|Adverse Event|1|||
124863033|NCT02273141|449119073|FG000|Overall Study|Lost to Follow-up|1|||
124863034|NCT02273141|449119074|FG001|Overall Study|Lost to Follow-up|3|||
124863035|NCT02273141|449119073|FG000|Overall Study|Withdrawal by Subject|10|||
124863036|NCT02273141|449119074|FG001|Overall Study|Withdrawal by Subject|15|||
124863037|NCT02273141|449119073|FG000|Overall Study|Various|6|||
124863038|NCT02273141|449119074|FG001|Overall Study|Various|6|||
124863039|NCT00492284|449119075|FG000|Overall Study|Adverse Event|0|||
124863040|NCT00492284|449119076|FG001|Overall Study|Adverse Event|1|||
124863041|NCT00492284|449119077|FG002|Overall Study|Adverse Event|1|||
124863042|NCT00492284|449119078|FG003|Overall Study|Adverse Event|2|||
124863043|NCT00492284|449119075|FG000|Overall Study|Lost to Follow-up|0|||
124863044|NCT00492284|449119076|FG001|Overall Study|Lost to Follow-up|0|||
124863045|NCT00492284|449119077|FG002|Overall Study|Lost to Follow-up|3|||
124863046|NCT00492284|449119078|FG003|Overall Study|Lost to Follow-up|1|||
124863047|NCT00492284|449119075|FG000|Overall Study|Death|0|||
124863048|NCT00492284|449119076|FG001|Overall Study|Death|3|||
124863049|NCT00492284|449119077|FG002|Overall Study|Death|2|||
124863050|NCT00492284|449119078|FG003|Overall Study|Death|5|||
124863051|NCT00492284|449119075|FG000|Overall Study|Withdrawal by Subject|1|||
124863052|NCT00492284|449119076|FG001|Overall Study|Withdrawal by Subject|0|||
124863053|NCT00492284|449119077|FG002|Overall Study|Withdrawal by Subject|0|||
124863054|NCT00492284|449119078|FG003|Overall Study|Withdrawal by Subject|2|||
124863055|NCT01556438|449119079|FG000|Overall Study|Adverse Event|4|||
124863056|NCT01556438|449119080|FG001|Overall Study|Adverse Event|2|||
124863057|NCT01556438|449119079|FG000|Overall Study|Sponsor Decision|0|||
124863058|NCT01556438|449119080|FG001|Overall Study|Sponsor Decision|2|||
124863059|NCT01556438|449119079|FG000|Overall Study|Progressive Disease|0|||
124863060|NCT01556438|449119080|FG001|Overall Study|Progressive Disease|6|||
124863061|NCT01556438|449119079|FG000|Overall Study|Death|0|||
124863062|NCT01556438|449119080|FG001|Overall Study|Death|1|||
124863063|NCT00529399|449119081|FG000|Overall Study|Lost to Follow-up|1|||
124863064|NCT00529399|449119082|FG001|Overall Study|Lost to Follow-up|0|||
124863065|NCT00529399|449119083|FG002|Overall Study|Lost to Follow-up|1|||
124863066|NCT00529399|449119081|FG000|Overall Study|Withdrawal by Subject|1|||
124863067|NCT00529399|449119082|FG001|Overall Study|Withdrawal by Subject|0|||
124863068|NCT00529399|449119083|FG002|Overall Study|Withdrawal by Subject|1|||
124863069|NCT00529399|449119081|FG000|Overall Study|Non-compliant|0|||
124863070|NCT00529399|449119082|FG001|Overall Study|Non-compliant|1|||
124863071|NCT00529399|449119083|FG002|Overall Study|Non-compliant|0|||
124863072|NCT02734212|449119085|FG000|Overall Study|Lost to Follow-up|5|||
124863073|NCT02734212|449119086|FG001|Overall Study|Lost to Follow-up|10|||
124863074|NCT04313881|449119087|FG000|Overall Study|Death|138|||
124863075|NCT04313881|449119088|FG001|Overall Study|Death|126|||
124863076|NCT04313881|449119087|FG000|Overall Study|Study terminated by sponsor|108|||
124863077|NCT04313881|449119088|FG001|Overall Study|Study terminated by sponsor|129|||
124863078|NCT04313881|449119087|FG000|Overall Study|Consent withdrawn|19|||
124863079|NCT04313881|449119088|FG001|Overall Study|Consent withdrawn|15|||
124863080|NCT04313881|449119087|FG000|Overall Study|Reason not Specified|3|||
124863081|NCT04313881|449119088|FG001|Overall Study|Reason not Specified|1|||
124863082|NCT04732286|449119092|FG000|Overall Study|Progressive Disease|2|||
124863083|NCT04732286|449119092|FG000|Overall Study|Physician Decision|1|||
124863084|NCT04732286|449119092|FG000|Overall Study|Study Terminated by Sponsor|31|||
124863085|NCT04732286|449119092|FG000|Overall Study|Withdrawal by Subject|10|||
124863086|NCT04732286|449119092|FG000|Overall Study|Non-compliance With Study Drug|1|||
124863087|NCT04732286|449119092|FG000|Overall Study|Lost to Follow-up|4|||
124863088|NCT04732286|449119092|FG000|Overall Study|Death|51|||
124863089|NCT01910129|449119096|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
124863090|NCT01910129|449119097|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
124863091|NCT01910129|449119098|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
124863092|NCT01910129|449119096|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
124863093|NCT01910129|449119097|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
124863094|NCT01910129|449119098|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
124863095|NCT03595904|449119100|FG000|Overall Study|Protocol Violation|3|||
124863096|NCT03595904|449119101|FG001|Overall Study|Protocol Violation|1|||
124863097|NCT03595904|449119100|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
124863098|NCT03595904|449119101|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
124863099|NCT03595904|449119100|FG000|Overall Study|Insurance complications|1|||
124863100|NCT03595904|449119101|FG001|Overall Study|Insurance complications|0|||
124863101|NCT03595904|449119100|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
124863102|NCT03595904|449119101|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
124863103|NCT01392560|449119102|FG000|Overall Study|Adverse Event|2|||
124863104|NCT01392560|449119102|FG000|Overall Study|not entered|8|||
124863105|NCT01392560|449119102|FG000|Overall Study|discontinued during placebo run-in|2|||
124863106|NCT04764396|449119115|FG000|Overall Study|Physician Decision|1|||
124863107|NCT04764396|449119116|FG001|Overall Study|Physician Decision|0|||
124863108|NCT02653482|449119117|FG000|Overall Study|Death|1|||
124863109|NCT02653482|449119118|FG001|Overall Study|Death|1|||
124863110|NCT04657211|449119119|FG000|Overall Study|Withdrawal by Subject|21|||
124863111|NCT04657211|449119119|FG000|Overall Study|Lost to Follow-up|113|||
124863112|NCT04657211|449119119|FG000|Overall Study|Death|47|||
124863113|NCT04657211|449119119|FG000|Overall Study|Transfer to another institution|21|||
124863114|NCT04657211|449119119|FG000|Overall Study|Other|29|||
124863115|NCT03776136|449119120|FG000|Overall Study|Death|85|||
124863116|NCT03776136|449119120|FG000|Overall Study|Withdrawal by Subject|3|||
124863117|NCT03776136|449119120|FG000|Overall Study|Sponsor Decision|15|||
124863118|NCT00613951|449119121|FG000|Overall Study|Adverse Event|1|||
124863119|NCT00613951|449119122|FG001|Overall Study|Adverse Event|0|||
124863120|NCT00613951|449119123|FG002|Overall Study|Adverse Event|1|||
124863121|NCT00613951|449119121|FG000|Overall Study|Lack of Efficacy|0|||
124863122|NCT00613951|449119122|FG001|Overall Study|Lack of Efficacy|1|||
124863123|NCT00613951|449119123|FG002|Overall Study|Lack of Efficacy|1|||
124863124|NCT00613951|449119121|FG000|Overall Study|Protocol Violation|1|||
124863125|NCT00613951|449119122|FG001|Overall Study|Protocol Violation|1|||
124863126|NCT00613951|449119123|FG002|Overall Study|Protocol Violation|1|||
124863127|NCT00613951|449119121|FG000|Overall Study|Unclassified|5|||
124863128|NCT00613951|449119122|FG001|Overall Study|Unclassified|3|||
124863129|NCT00613951|449119123|FG002|Overall Study|Unclassified|2|||
124863130|NCT01329029|449119128|FG000|Overall Study|Withdrawal by Subject|117|||
124863131|NCT01329029|449119129|FG001|Overall Study|Withdrawal by Subject|87|||
124863132|NCT01329029|449119128|FG000|Overall Study|Adverse Event|82|||
124863133|NCT01329029|449119129|FG001|Overall Study|Adverse Event|29|||
124863134|NCT01329029|449119128|FG000|Overall Study|Death|16|||
124863135|NCT01329029|449119129|FG001|Overall Study|Death|19|||
124863136|NCT01329029|449119128|FG000|Overall Study|Other|14|||
124863137|NCT01329029|449119129|FG001|Overall Study|Other|20|||
124863138|NCT01329029|449119128|FG000|Overall Study|COPD Exacerbation|11|||
124863139|NCT01329029|449119129|FG001|Overall Study|COPD Exacerbation|18|||
124863140|NCT01329029|449119128|FG000|Overall Study|Physician Decision|16|||
124863141|NCT01329029|449119129|FG001|Overall Study|Physician Decision|13|||
124863142|NCT01329029|449119128|FG000|Overall Study|Lost to Follow-up|8|||
124863143|NCT01329029|449119129|FG001|Overall Study|Lost to Follow-up|5|||
124863144|NCT01329029|449119128|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
124863145|NCT01329029|449119129|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
124863146|NCT00680407|449119133|FG000|Overall Study|Lost to Follow-up|3|||
124863147|NCT00680407|449119134|FG001|Overall Study|Lost to Follow-up|3|||
124863148|NCT00680407|449119135|FG002|Overall Study|Lost to Follow-up|1|||
124863149|NCT00680407|449119133|FG000|Overall Study|Withdrawal by Subject|5|||
124863150|NCT00680407|449119134|FG001|Overall Study|Withdrawal by Subject|2|||
124863151|NCT00680407|449119135|FG002|Overall Study|Withdrawal by Subject|2|||
124863152|NCT06167031|449119136|FG000|Overall Study|Lost to Follow-up|5|||
124863153|NCT06167031|449119137|FG001|Overall Study|Lost to Follow-up|1|||
124863154|NCT01266642|449119138|FG000|Overall Study|Protocol Violation|0|||
124863155|NCT01266642|449119139|FG001|Overall Study|Protocol Violation|1|||
124863156|NCT00924287|449120966|FG000|Overall Study|Death|1|||
124863157|NCT02621931|449120967|FG000|Overall Study|Death|0|||
124863158|NCT02621931|449120968|FG001|Overall Study|Death|1|||
124863159|NCT02621931|449120969|FG002|Overall Study|Death|0|||
124863160|NCT02621931|449120967|FG000|Overall Study|Adverse Event|8|||
124863161|NCT02621931|449120968|FG001|Overall Study|Adverse Event|5|||
124863162|NCT02621931|449120969|FG002|Overall Study|Adverse Event|7|||
124863163|NCT02621931|449120967|FG000|Overall Study|Withdrawal by Subject|12|||
124863164|NCT02621931|449120968|FG001|Overall Study|Withdrawal by Subject|10|||
124863165|NCT02621931|449120969|FG002|Overall Study|Withdrawal by Subject|11|||
124863166|NCT02621931|449120967|FG000|Overall Study|Protocol Violation|2|||
124863167|NCT02621931|449120968|FG001|Overall Study|Protocol Violation|2|||
124863168|NCT02621931|449120969|FG002|Overall Study|Protocol Violation|2|||
124863169|NCT02621931|449120967|FG000|Overall Study|Pregnancy|2|||
124863170|NCT02621931|449120968|FG001|Overall Study|Pregnancy|0|||
124863171|NCT02621931|449120969|FG002|Overall Study|Pregnancy|0|||
124863172|NCT02621931|449120967|FG000|Overall Study|Noncompliance to study procedures|0|||
124863173|NCT02621931|449120968|FG001|Overall Study|Noncompliance to study procedures|1|||
124863174|NCT02621931|449120969|FG002|Overall Study|Noncompliance to study procedures|2|||
124863175|NCT02621931|449120967|FG000|Overall Study|Lost to Follow-up|8|||
124863176|NCT02621931|449120968|FG001|Overall Study|Lost to Follow-up|7|||
124863177|NCT02621931|449120969|FG002|Overall Study|Lost to Follow-up|10|||
124863178|NCT02621931|449120967|FG000|Overall Study|Lack of Efficacy|0|||
124863179|NCT02621931|449120968|FG001|Overall Study|Lack of Efficacy|0|||
124863180|NCT02621931|449120969|FG002|Overall Study|Lack of Efficacy|1|||
124863181|NCT02621931|449120967|FG000|Overall Study|Other|1|||
124863182|NCT02621931|449120968|FG001|Overall Study|Other|1|||
124863183|NCT02621931|449120969|FG002|Overall Study|Other|3|||
124863184|NCT01912612|449120970|FG000|Overall Study|Adverse Event|4|||
124863185|NCT01912612|449120971|FG001|Overall Study|Adverse Event|0|||
124863186|NCT01912612|449120972|FG002|Overall Study|Adverse Event|0|||
124863187|NCT01912612|449120970|FG000|Overall Study|Withdrew consent|1|||
124863188|NCT01912612|449120971|FG001|Overall Study|Withdrew consent|0|||
124863189|NCT01912612|449120972|FG002|Overall Study|Withdrew consent|0|||
124863190|NCT01912612|449120970|FG000|Overall Study|Study design change|0|||
124863191|NCT01912612|449120971|FG001|Overall Study|Study design change|0|||
124863192|NCT01912612|449120972|FG002|Overall Study|Study design change|3|||
124863193|NCT01588184|449120973|FG000|Overall Study|Death|1|||
124863194|NCT01588184|449120974|FG001|Overall Study|Death|0|||
124863195|NCT01588184|449120975|FG002|Overall Study|Death|0|||
124863196|NCT01588184|449120976|FG003|Overall Study|Death|1|||
124863197|NCT01588184|449120977|FG004|Overall Study|Death|1|||
124863198|NCT01588184|449120978|FG005|Overall Study|Death|1|||
124863199|NCT01588184|449120973|FG000|Overall Study|Withdrawal by Subject|2|||
124863200|NCT01588184|449120974|FG001|Overall Study|Withdrawal by Subject|4|||
124863201|NCT01588184|449120975|FG002|Overall Study|Withdrawal by Subject|0|||
124863202|NCT01588184|449120976|FG003|Overall Study|Withdrawal by Subject|1|||
124863203|NCT01588184|449120977|FG004|Overall Study|Withdrawal by Subject|0|||
124863204|NCT01588184|449120978|FG005|Overall Study|Withdrawal by Subject|0|||
124863205|NCT01588184|449120973|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
124863206|NCT01588184|449120974|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
124863207|NCT01588184|449120975|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
124863208|NCT01588184|449120976|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
124863209|NCT01588184|449120977|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
124863210|NCT01588184|449120978|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
124863211|NCT01588184|449120973|FG000|Overall Study|multiple reasons|0|||
124863212|NCT01588184|449120974|FG001|Overall Study|multiple reasons|3|||
124863213|NCT01588184|449120975|FG002|Overall Study|multiple reasons|0|||
124863214|NCT01588184|449120976|FG003|Overall Study|multiple reasons|1|||
124863215|NCT01588184|449120977|FG004|Overall Study|multiple reasons|0|||
124863216|NCT01588184|449120978|FG005|Overall Study|multiple reasons|0|||
124863217|NCT05912400|449120980|FG000|Overall Study|Lost to Follow-up|1|||
124863218|NCT05912400|449120981|FG001|Overall Study|Lost to Follow-up|0|||
124863219|NCT05912400|449120980|FG000|Overall Study|Physician Decision|6|||
124863220|NCT05912400|449120981|FG001|Overall Study|Physician Decision|0|||
124863221|NCT05912400|449120980|FG000|Overall Study|Withdrawal by Subject|1|||
124863222|NCT05912400|449120981|FG001|Overall Study|Withdrawal by Subject|0|||
124863223|NCT03461003|449120986|FG000|Overall Study|Lost to Follow-up|2|||
124863224|NCT03461003|449120987|FG001|Overall Study|Lost to Follow-up|2|||
124863225|NCT03461003|449120986|FG000|Overall Study|Withdrawal by Subject|3|||
124863226|NCT03461003|449120987|FG001|Overall Study|Withdrawal by Subject|1|||
124863227|NCT03489304|449120988|FG000|Overall Study|Lost to Follow-up|4|||
124863228|NCT02566031|449120996|FG000|Overall Study|Patient/guardian decision|14|||
124863229|NCT02566031|449120997|FG001|Overall Study|Patient/guardian decision|7|||
124863230|NCT02566031|449120996|FG000|Overall Study|Protocol deviation|2|||
124863231|NCT02566031|449120997|FG001|Overall Study|Protocol deviation|3|||
124863232|NCT02566031|449120996|FG000|Overall Study|Adverse Event|3|||
124863233|NCT02566031|449120997|FG001|Overall Study|Adverse Event|1|||
124863234|NCT02566031|449120996|FG000|Overall Study|Lost to Follow-up|1|||
124863235|NCT02566031|449120997|FG001|Overall Study|Lost to Follow-up|1|||
124863236|NCT02479412|449121000|FG000|Overall Study|Adverse Event|0|||
124863237|NCT02479412|449121001|FG001|Overall Study|Adverse Event|0|||
124863238|NCT02479412|449121002|FG002|Overall Study|Adverse Event|1|||
124863239|NCT02479412|449121003|FG003|Overall Study|Adverse Event|0|||
124863240|NCT02479412|449121004|FG004|Overall Study|Adverse Event|0|||
124863241|NCT02479412|449121005|FG005|Overall Study|Adverse Event|0|||
124863242|NCT02479412|449121006|FG006|Overall Study|Adverse Event|0|||
124863243|NCT02479412|449121007|FG007|Overall Study|Adverse Event|0|||
124863244|NCT02479412|449121008|FG008|Overall Study|Adverse Event|0|||
124863245|NCT02479412|449121000|FG000|Overall Study|Study-specific withdrawal criteria|0|||
124863246|NCT02479412|449121001|FG001|Overall Study|Study-specific withdrawal criteria|0|||
124863247|NCT02479412|449121002|FG002|Overall Study|Study-specific withdrawal criteria|1|||
124863248|NCT02479412|449121003|FG003|Overall Study|Study-specific withdrawal criteria|1|||
124863249|NCT02479412|449121004|FG004|Overall Study|Study-specific withdrawal criteria|0|||
124863250|NCT02479412|449121005|FG005|Overall Study|Study-specific withdrawal criteria|0|||
124863251|NCT02479412|449121006|FG006|Overall Study|Study-specific withdrawal criteria|0|||
124863252|NCT02479412|449121007|FG007|Overall Study|Study-specific withdrawal criteria|1|||
124863253|NCT02479412|449121008|FG008|Overall Study|Study-specific withdrawal criteria|1|||
124863254|NCT02479412|449121000|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
124863255|NCT02479412|449121001|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
124863256|NCT02479412|449121002|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
124863257|NCT02479412|449121003|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
124863258|NCT02479412|449121004|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
124863259|NCT02479412|449121005|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
124863260|NCT02479412|449121006|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
124863261|NCT02479412|449121007|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
124863262|NCT02479412|449121008|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
124863263|NCT04969250|449121009|FG000|Overall Study|Protocol Violation|0|||
124863264|NCT04969250|449121010|FG001|Overall Study|Protocol Violation|2|||
124863265|NCT04969250|449121011|FG002|Overall Study|Protocol Violation|3|||
124863266|NCT04969250|449121012|FG003|Overall Study|Protocol Violation|8|||
124863267|NCT04969250|449121009|FG000|Overall Study|Withdrawal by Subject|0|||
124863268|NCT04969250|449121010|FG001|Overall Study|Withdrawal by Subject|1|||
124863269|NCT04969250|449121011|FG002|Overall Study|Withdrawal by Subject|0|||
124863270|NCT04969250|449121012|FG003|Overall Study|Withdrawal by Subject|0|||
124863271|NCT04642638|449121018|FG000|Overall Study|Withdrawal by Subject|23|||
124863272|NCT04642638|449121019|FG001|Overall Study|Withdrawal by Subject|29|||
124863273|NCT04642638|449121020|FG002|Overall Study|Withdrawal by Subject|9|||
124863274|NCT04642638|449121021|FG003|Overall Study|Withdrawal by Subject|7|||
124863275|NCT04642638|449121022|FG004|Overall Study|Withdrawal by Subject|61|||
124863276|NCT04642638|449121023|FG005|Overall Study|Withdrawal by Subject|27|||
124863277|NCT04642638|449121018|FG000|Overall Study|Lost to Follow-up|17|||
124863278|NCT04642638|449121019|FG001|Overall Study|Lost to Follow-up|18|||
124863279|NCT04642638|449121020|FG002|Overall Study|Lost to Follow-up|5|||
124863280|NCT04642638|449121021|FG003|Overall Study|Lost to Follow-up|5|||
124863281|NCT04642638|449121022|FG004|Overall Study|Lost to Follow-up|6|||
124863282|NCT04642638|449121023|FG005|Overall Study|Lost to Follow-up|3|||
124863283|NCT04642638|449121018|FG000|Overall Study|Adverse Event|0|||
124863284|NCT04642638|449121019|FG001|Overall Study|Adverse Event|0|||
124863285|NCT04642638|449121020|FG002|Overall Study|Adverse Event|1|||
124863286|NCT04642638|449121021|FG003|Overall Study|Adverse Event|0|||
124863287|NCT04642638|449121022|FG004|Overall Study|Adverse Event|10|||
124863288|NCT04642638|449121023|FG005|Overall Study|Adverse Event|3|||
124863289|NCT04642638|449121018|FG000|Overall Study|Reason Not Specified|1|||
124863290|NCT04642638|449121019|FG001|Overall Study|Reason Not Specified|4|||
124863291|NCT04642638|449121020|FG002|Overall Study|Reason Not Specified|0|||
124863292|NCT04642638|449121021|FG003|Overall Study|Reason Not Specified|0|||
124863293|NCT04642638|449121022|FG004|Overall Study|Reason Not Specified|38|||
124863294|NCT04642638|449121023|FG005|Overall Study|Reason Not Specified|16|||
124863295|NCT04642638|449121018|FG000|Overall Study|Physician Decision|0|||
124863296|NCT04642638|449121019|FG001|Overall Study|Physician Decision|0|||
124863297|NCT04642638|449121020|FG002|Overall Study|Physician Decision|0|||
124863298|NCT04642638|449121021|FG003|Overall Study|Physician Decision|0|||
124863299|NCT04642638|449121022|FG004|Overall Study|Physician Decision|2|||
124863300|NCT04642638|449121023|FG005|Overall Study|Physician Decision|1|||
124863301|NCT04642638|449121018|FG000|Overall Study|Protocol Deviation|0|||
124863302|NCT04642638|449121019|FG001|Overall Study|Protocol Deviation|0|||
124863303|NCT04642638|449121020|FG002|Overall Study|Protocol Deviation|0|||
124863304|NCT04642638|449121021|FG003|Overall Study|Protocol Deviation|0|||
124863305|NCT04642638|449121022|FG004|Overall Study|Protocol Deviation|1|||
124863306|NCT04642638|449121023|FG005|Overall Study|Protocol Deviation|3|||
124863307|NCT04642638|449121018|FG000|Overall Study|Study Terminated|0|||
124863308|NCT04642638|449121019|FG001|Overall Study|Study Terminated|0|||
124863309|NCT04642638|449121020|FG002|Overall Study|Study Terminated|0|||
124863310|NCT04642638|449121021|FG003|Overall Study|Study Terminated|0|||
124863311|NCT04642638|449121022|FG004|Overall Study|Study Terminated|484|||
124863312|NCT04642638|449121023|FG005|Overall Study|Study Terminated|250|||
124863313|NCT04642638|449121018|FG000|Overall Study|Pregnancy|0|||
124863314|NCT04642638|449121019|FG001|Overall Study|Pregnancy|0|||
124863315|NCT04642638|449121020|FG002|Overall Study|Pregnancy|0|||
124863316|NCT04642638|449121021|FG003|Overall Study|Pregnancy|0|||
124863317|NCT04642638|449121022|FG004|Overall Study|Pregnancy|1|||
124863318|NCT04642638|449121023|FG005|Overall Study|Pregnancy|0|||
124863319|NCT00511004|449121024|FG000|Overall Study|Lost to Follow-up|0|||
124863320|NCT00511004|449121025|FG001|Overall Study|Lost to Follow-up|0|||
124863321|NCT00511004|449121026|FG002|Overall Study|Lost to Follow-up|4|||
124863322|NCT00990652|449121027|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
124863323|NCT00990652|449121027|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
124863324|NCT03695172|449121028|FG000|Overall Study|Withdrawal by Subject|1|||
124863325|NCT03695172|449121029|FG001|Overall Study|Withdrawal by Subject|1|||
124863326|NCT03695172|449121030|FG002|Overall Study|Withdrawal by Subject|0|||
124863327|NCT00727272|449121046|FG000|Washout Period A|Adverse Event|0|||
124863328|NCT00727272|449121047|FG001|Washout Period A|Adverse Event|0|||
124863329|NCT00727272|449121048|FG002|Washout Period A|Adverse Event|1|||
124863330|NCT00727272|449121046|FG000|Washout Period B|Withdrawal by Subject|0|||
124863331|NCT00727272|449121047|FG001|Washout Period B|Withdrawal by Subject|0|||
124863332|NCT00727272|449121048|FG002|Washout Period B|Withdrawal by Subject|1|||
124863333|NCT00651664|449121049|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
124863334|NCT00651664|449121050|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
124863335|NCT00651664|449121051|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
124863336|NCT00651664|449121052|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
124863337|NCT00651664|449121053|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
124863338|NCT00651664|449121054|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
124863339|NCT00651664|449121055|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
124863340|NCT00651664|449121056|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
124863341|NCT00651664|449121057|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
124863342|NCT00651664|449121058|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
124863343|NCT00651664|449121049|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
124863344|NCT00651664|449121050|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
124863345|NCT00651664|449121051|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
124863346|NCT00651664|449121052|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
124863347|NCT00651664|449121053|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
124863348|NCT00651664|449121054|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
124863349|NCT00651664|449121055|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
124863350|NCT00651664|449121056|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
124863351|NCT00651664|449121057|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
124863352|NCT00651664|449121058|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
124863353|NCT00651664|449121049|FG000|Overall Study|Progressive Disease|3|||
124863354|NCT00651664|449121050|FG001|Overall Study|Progressive Disease|3|||
124863355|NCT00651664|449121051|FG002|Overall Study|Progressive Disease|3|||
124863356|NCT00651664|449121052|FG003|Overall Study|Progressive Disease|12|||
124863357|NCT00651664|449121053|FG004|Overall Study|Progressive Disease|4|||
124863358|NCT00651664|449121054|FG005|Overall Study|Progressive Disease|1|||
124863359|NCT00651664|449121055|FG006|Overall Study|Progressive Disease|3|||
124863360|NCT00651664|449121056|FG007|Overall Study|Progressive Disease|6|||
124863361|NCT00651664|449121057|FG008|Overall Study|Progressive Disease|5|||
124863362|NCT00651664|449121058|FG009|Overall Study|Progressive Disease|5|||
124863363|NCT00651664|449121049|FG000|Overall Study|Patient Declined Further Treatment|0|||
124863364|NCT00651664|449121050|FG001|Overall Study|Patient Declined Further Treatment|0|||
124863365|NCT00651664|449121051|FG002|Overall Study|Patient Declined Further Treatment|0|||
124863366|NCT00651664|449121052|FG003|Overall Study|Patient Declined Further Treatment|1|||
124863367|NCT00651664|449121053|FG004|Overall Study|Patient Declined Further Treatment|1|||
124863368|NCT00651664|449121054|FG005|Overall Study|Patient Declined Further Treatment|1|||
124863369|NCT00651664|449121055|FG006|Overall Study|Patient Declined Further Treatment|0|||
124863370|NCT00651664|449121056|FG007|Overall Study|Patient Declined Further Treatment|0|||
124863371|NCT00651664|449121057|FG008|Overall Study|Patient Declined Further Treatment|0|||
124863372|NCT00651664|449121058|FG009|Overall Study|Patient Declined Further Treatment|1|||
124863373|NCT00651664|449121049|FG000|Overall Study|Symptomatic Deterioration|0|||
124863374|NCT00651664|449121050|FG001|Overall Study|Symptomatic Deterioration|0|||
124863375|NCT00651664|449121051|FG002|Overall Study|Symptomatic Deterioration|0|||
124863376|NCT00651664|449121052|FG003|Overall Study|Symptomatic Deterioration|1|||
124863377|NCT00651664|449121053|FG004|Overall Study|Symptomatic Deterioration|0|||
124863378|NCT00651664|449121054|FG005|Overall Study|Symptomatic Deterioration|0|||
124863379|NCT00651664|449121055|FG006|Overall Study|Symptomatic Deterioration|1|||
124863380|NCT00651664|449121056|FG007|Overall Study|Symptomatic Deterioration|0|||
124863381|NCT00651664|449121057|FG008|Overall Study|Symptomatic Deterioration|1|||
124863382|NCT00651664|449121058|FG009|Overall Study|Symptomatic Deterioration|0|||
124863383|NCT00651664|449121049|FG000|Overall Study|Reason not Specified|0|||
124863384|NCT00651664|449121050|FG001|Overall Study|Reason not Specified|0|||
124863385|NCT00651664|449121051|FG002|Overall Study|Reason not Specified|0|||
124863386|NCT00651664|449121052|FG003|Overall Study|Reason not Specified|0|||
124863387|NCT00651664|449121053|FG004|Overall Study|Reason not Specified|0|||
124863388|NCT00651664|449121054|FG005|Overall Study|Reason not Specified|0|||
124863389|NCT00651664|449121055|FG006|Overall Study|Reason not Specified|1|||
124863390|NCT00651664|449121056|FG007|Overall Study|Reason not Specified|0|||
124863391|NCT00651664|449121057|FG008|Overall Study|Reason not Specified|0|||
124863392|NCT00651664|449121058|FG009|Overall Study|Reason not Specified|0|||
124863393|NCT00688636|449121061|FG000|Overall Study|Adverse Event|2|||
124863394|NCT00688636|449121062|FG001|Overall Study|Adverse Event|1|||
124863395|NCT01572727|449121063|FG000|Overall Study|Adverse Event|43|||
124863396|NCT01572727|449121064|FG001|Overall Study|Adverse Event|15|||
124863397|NCT01572727|449121063|FG000|Overall Study|Lost to Follow-up|1|||
124863398|NCT01572727|449121064|FG001|Overall Study|Lost to Follow-up|1|||
124863399|NCT01572727|449121063|FG000|Overall Study|Physician Decision|23|||
124863400|NCT01572727|449121064|FG001|Overall Study|Physician Decision|9|||
124863401|NCT01572727|449121063|FG000|Overall Study|Progressive disease|59|||
124863402|NCT01572727|449121064|FG001|Overall Study|Progressive disease|82|||
124863403|NCT01572727|449121063|FG000|Overall Study|Protocol Violation|0|||
124863404|NCT01572727|449121064|FG001|Overall Study|Protocol Violation|1|||
124863405|NCT01572727|449121063|FG000|Overall Study|Study terminated by sponsor|61|||
124863406|NCT01572727|449121064|FG001|Overall Study|Study terminated by sponsor|83|||
124863407|NCT01572727|449121063|FG000|Overall Study|Parent/guardian decision|14|||
124863408|NCT01572727|449121064|FG001|Overall Study|Parent/guardian decision|9|||
124863409|NCT01572727|449121063|FG000|Overall Study|Death|2|||
124863410|NCT01572727|449121064|FG001|Overall Study|Death|2|||
124863411|NCT01572727|449121063|FG000|Overall Study|Untreated|4|||
124863412|NCT01572727|449121064|FG001|Overall Study|Untreated|7|||
124863413|NCT04053764|449121065|FG000|Overall Study|Withdrawal by Subject|6|||
124863414|NCT04053764|449121066|FG001|Overall Study|Withdrawal by Subject|2|||
124863415|NCT04053764|449121065|FG000|Overall Study|Physician Decision|2|||
124863416|NCT04053764|449121066|FG001|Overall Study|Physician Decision|1|||
124863417|NCT04053764|449121065|FG000|Overall Study|Adverse Event|1|||
124863418|NCT04053764|449121066|FG001|Overall Study|Adverse Event|0|||
124863419|NCT04053764|449121065|FG000|Overall Study|Pregnancy|1|||
124863420|NCT04053764|449121066|FG001|Overall Study|Pregnancy|0|||
124863421|NCT02384954|449121067|FG000|Phase 1|Progressive Disease|2|||
124863422|NCT02384954|449121068|FG001|Phase 1|Progressive Disease|0|||
124863423|NCT02384954|449121069|FG002|Phase 1|Progressive Disease|1|||
124863424|NCT02384954|449121070|FG003|Phase 1|Progressive Disease|1|||
124863425|NCT02384954|449121071|FG004|Phase 1|Progressive Disease|0|||
124863426|NCT02384954|449121072|FG005|Phase 1|Progressive Disease|0|||
124863427|NCT02384954|449121073|FG006|Phase 1|Progressive Disease|0|||
124863428|NCT02384954|449121074|FG007|Phase 1|Progressive Disease|0|||
124863429|NCT02384954|449121075|FG008|Phase 1|Progressive Disease|0|||
124863430|NCT02384954|449121067|FG000|Phase 1|Adverse Event|0|||
124863431|NCT02384954|449121068|FG001|Phase 1|Adverse Event|0|||
124863432|NCT02384954|449121069|FG002|Phase 1|Adverse Event|1|||
124863433|NCT02384954|449121070|FG003|Phase 1|Adverse Event|0|||
124863434|NCT02384954|449121071|FG004|Phase 1|Adverse Event|0|||
124863435|NCT02384954|449121072|FG005|Phase 1|Adverse Event|0|||
124863436|NCT02384954|449121073|FG006|Phase 1|Adverse Event|0|||
124863437|NCT02384954|449121074|FG007|Phase 1|Adverse Event|0|||
124863438|NCT02384954|449121075|FG008|Phase 1|Adverse Event|0|||
124863439|NCT02384954|449121067|FG000|Phase 2|Progressive Disease|0|||
124863440|NCT02384954|449121068|FG001|Phase 2|Progressive Disease|0|||
124863441|NCT02384954|449121069|FG002|Phase 2|Progressive Disease|0|||
124863442|NCT02384954|449121070|FG003|Phase 2|Progressive Disease|0|||
124863443|NCT02384954|449121071|FG004|Phase 2|Progressive Disease|0|||
124863444|NCT02384954|449121072|FG005|Phase 2|Progressive Disease|0|||
124863445|NCT02384954|449121073|FG006|Phase 2|Progressive Disease|0|||
124863446|NCT02384954|449121074|FG007|Phase 2|Progressive Disease|1|||
124863447|NCT02384954|449121075|FG008|Phase 2|Progressive Disease|2|||
124863448|NCT02384954|449121067|FG000|Phase 2|Adverse Event|0|||
124863449|NCT02384954|449121068|FG001|Phase 2|Adverse Event|0|||
124863450|NCT02384954|449121069|FG002|Phase 2|Adverse Event|0|||
124863451|NCT02384954|449121070|FG003|Phase 2|Adverse Event|0|||
124863452|NCT02384954|449121071|FG004|Phase 2|Adverse Event|0|||
124863453|NCT02384954|449121072|FG005|Phase 2|Adverse Event|0|||
124863454|NCT02384954|449121073|FG006|Phase 2|Adverse Event|0|||
124863455|NCT02384954|449121074|FG007|Phase 2|Adverse Event|1|||
124863456|NCT02384954|449121075|FG008|Phase 2|Adverse Event|1|||
124863457|NCT02384954|449121067|FG000|Phase 2|Failure to meet continuation criteria|0|||
124863458|NCT02384954|449121068|FG001|Phase 2|Failure to meet continuation criteria|0|||
124863459|NCT02384954|449121069|FG002|Phase 2|Failure to meet continuation criteria|0|||
124863460|NCT02384954|449121070|FG003|Phase 2|Failure to meet continuation criteria|0|||
124863461|NCT02384954|449121071|FG004|Phase 2|Failure to meet continuation criteria|0|||
124863462|NCT02384954|449121072|FG005|Phase 2|Failure to meet continuation criteria|0|||
124863463|NCT02384954|449121073|FG006|Phase 2|Failure to meet continuation criteria|0|||
124863464|NCT02384954|449121074|FG007|Phase 2|Failure to meet continuation criteria|1|||
124863465|NCT02384954|449121075|FG008|Phase 2|Failure to meet continuation criteria|0|||
124863466|NCT01474681|449121079|FG000|Overall Study|Death|0|||
124863467|NCT01474681|449121080|FG001|Overall Study|Death|3|||
124863468|NCT01474681|449121081|FG002|Overall Study|Death|2|||
124863469|NCT01474681|449121082|FG003|Overall Study|Death|6|||
124863470|NCT03998618|449121083|FG000|Overall Study|Death|7|||
124863471|NCT03998618|449121084|FG001|Overall Study|Death|11|||
124863472|NCT03998618|449121083|FG000|Overall Study|hospice enrollment|3|||
124863473|NCT03998618|449121084|FG001|Overall Study|hospice enrollment|3|||
124863474|NCT03998618|449121083|FG000|Overall Study|Not feeling well/health problems|3|||
124863475|NCT03998618|449121084|FG001|Overall Study|Not feeling well/health problems|5|||
124863476|NCT03998618|449121083|FG000|Overall Study|Lost to Follow-up|6|||
124863477|NCT03998618|449121084|FG001|Overall Study|Lost to Follow-up|6|||
124863478|NCT03998618|449121083|FG000|Overall Study|Withdrawal by Subject|0|||
124863479|NCT03998618|449121084|FG001|Overall Study|Withdrawal by Subject|4|||
124863480|NCT00319098|449121085|FG000|Overall Study|Serious adverse event|3|||
124863481|NCT00319098|449121086|FG001|Overall Study|Serious adverse event|0|||
124863482|NCT00319098|449121085|FG000|Overall Study|Adverse Event|20|||
124863483|NCT00319098|449121086|FG001|Overall Study|Adverse Event|1|||
124863484|NCT00319098|449121085|FG000|Overall Study|Withdrawal by Subject|37|||
124863485|NCT00319098|449121086|FG001|Overall Study|Withdrawal by Subject|8|||
124863486|NCT00319098|449121085|FG000|Overall Study|Migrated/moved from study area|2|||
124863487|NCT00319098|449121086|FG001|Overall Study|Migrated/moved from study area|1|||
124863488|NCT00319098|449121085|FG000|Overall Study|Lost to Follow-up|37|||
124863489|NCT00319098|449121086|FG001|Overall Study|Lost to Follow-up|13|||
124863490|NCT00319098|449121085|FG000|Overall Study|Others|33|||
124863491|NCT00319098|449121086|FG001|Overall Study|Others|8|||
124863492|NCT00319098|449121085|FG000|Overall Study|Protocol Violation|3|||
124863493|NCT00319098|449121086|FG001|Overall Study|Protocol Violation|1|||
124863494|NCT00295750|449121091|FG000|Overall Study|Adverse Event|19|||
124863495|NCT00295750|449121092|FG001|Overall Study|Adverse Event|15|||
124863496|NCT00295750|449121093|FG002|Overall Study|Adverse Event|12|||
124863497|NCT00295750|449121091|FG000|Overall Study|Lack of Efficacy|1|||
124863498|NCT00295750|449121092|FG001|Overall Study|Lack of Efficacy|1|||
124863499|NCT00295750|449121093|FG002|Overall Study|Lack of Efficacy|0|||
124863500|NCT00295750|449121091|FG000|Overall Study|Lost to Follow-up|1|||
124863501|NCT00295750|449121092|FG001|Overall Study|Lost to Follow-up|4|||
124863502|NCT00295750|449121093|FG002|Overall Study|Lost to Follow-up|1|||
124863503|NCT00295750|449121091|FG000|Overall Study|Taking prohibited therapy|2|||
124863504|NCT00295750|449121092|FG001|Overall Study|Taking prohibited therapy|3|||
124863505|NCT00295750|449121093|FG002|Overall Study|Taking prohibited therapy|2|||
124863506|NCT00295750|449121091|FG000|Overall Study|Administrative errors|2|||
124863507|NCT00295750|449121092|FG001|Overall Study|Administrative errors|4|||
124863508|NCT00295750|449121093|FG002|Overall Study|Administrative errors|5|||
124863509|NCT00295750|449121091|FG000|Overall Study|Trial drug errors|1|||
124863510|NCT00295750|449121092|FG001|Overall Study|Trial drug errors|1|||
124863511|NCT00295750|449121093|FG002|Overall Study|Trial drug errors|0|||
124863512|NCT00295750|449121091|FG000|Overall Study|Disease progression|2|||
124863513|NCT00295750|449121092|FG001|Overall Study|Disease progression|1|||
124863514|NCT00295750|449121093|FG002|Overall Study|Disease progression|0|||
124863515|NCT00295750|449121091|FG000|Overall Study|Personal reasons|0|||
124863516|NCT00295750|449121092|FG001|Overall Study|Personal reasons|1|||
124863517|NCT00295750|449121093|FG002|Overall Study|Personal reasons|0|||
124863518|NCT00295750|449121091|FG000|Overall Study|Randomized but never received trial drug|4|||
124863519|NCT00295750|449121092|FG001|Overall Study|Randomized but never received trial drug|3|||
124863520|NCT00295750|449121093|FG002|Overall Study|Randomized but never received trial drug|3|||
124863521|NCT00295750|449121091|FG000|Overall Study|Withdrawal by Subject|9|||
124863522|NCT00295750|449121092|FG001|Overall Study|Withdrawal by Subject|4|||
124863523|NCT00295750|449121093|FG002|Overall Study|Withdrawal by Subject|7|||
124863524|NCT00295750|449121091|FG000|Overall Study|Protocol Violation|2|||
124863525|NCT00295750|449121092|FG001|Overall Study|Protocol Violation|4|||
124863526|NCT00295750|449121093|FG002|Overall Study|Protocol Violation|2|||
124863527|NCT00936858|449121095|FG000|Overall Study|Death|3|||
124863528|NCT00936858|449121095|FG000|Overall Study|Progression|29|||
124863529|NCT00936858|449121095|FG000|Overall Study|Withdrawal by Subject|5|||
124863530|NCT00936858|449121095|FG000|Overall Study|Adverse Event|1|||
124863531|NCT00936858|449121095|FG000|Overall Study|Physician Decision|7|||
124863532|NCT00936858|449121095|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
124863533|NCT00936858|449121095|FG000|Overall Study|Lost to Follow-up|1|||
124863534|NCT02199028|449121106|FG000|Week 1|Adverse Event|1|||
124863535|NCT02199028|449121107|FG001|Week 1|Adverse Event|0|||
124863536|NCT02199028|449121106|FG000|Week 3|Adverse Event|1|||
124863537|NCT02199028|449121107|FG001|Week 3|Adverse Event|0|||
124863538|NCT01881126|449121108|FG000|Overall Study|Non-compliance|1|||
124863539|NCT01881126|449121109|FG001|Overall Study|Non-compliance|1|||
124863540|NCT01881126|449121108|FG000|Overall Study|Adverse Event|0|||
124863541|NCT01881126|449121109|FG001|Overall Study|Adverse Event|1|||
124863542|NCT02341417|449121114|FG000|Overall Study|Withdrawal by Subject|0|||
124863543|NCT02341417|449121115|FG001|Overall Study|Withdrawal by Subject|2|||
124863544|NCT02341417|449121116|FG002|Overall Study|Withdrawal by Subject|0|||
124863545|NCT02341417|449121114|FG000|Overall Study|Decision by sponsor|2|||
124863546|NCT02341417|449121115|FG001|Overall Study|Decision by sponsor|0|||
124863547|NCT02341417|449121116|FG002|Overall Study|Decision by sponsor|0|||
124863548|NCT02341417|449121114|FG000|Overall Study|Death|0|||
124863549|NCT02341417|449121115|FG001|Overall Study|Death|0|||
124863550|NCT02341417|449121116|FG002|Overall Study|Death|1|||
124863551|NCT04403698|449121118|FG000|Overall Study|Adverse Event|1|||
124863552|NCT04403698|449121119|FG001|Overall Study|Adverse Event|1|||
124863553|NCT04403698|449121118|FG000|Overall Study|Lost to Follow-up|1|||
124863554|NCT04403698|449121119|FG001|Overall Study|Lost to Follow-up|0|||
124863555|NCT04403698|449121118|FG000|Overall Study|Protocol Violation|0|||
124863556|NCT04403698|449121119|FG001|Overall Study|Protocol Violation|1|||
124863557|NCT03152552|449121120|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
124863558|NCT03152552|449121121|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
124863559|NCT03152552|449121122|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
124863560|NCT03152552|449121123|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
124863561|NCT03152552|449121124|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
124863562|NCT03152552|449121120|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
124863563|NCT03152552|449121121|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
124863564|NCT03152552|449121122|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
124863565|NCT03152552|449121123|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
124863566|NCT03152552|449121124|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
124863567|NCT03152552|449121120|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
124863568|NCT03152552|449121121|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
124863569|NCT03152552|449121122|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
124863570|NCT03152552|449121123|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
124863571|NCT03152552|449121124|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
124863572|NCT03152552|449121120|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124863573|NCT03152552|449121121|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124863574|NCT03152552|449121122|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
124863575|NCT03152552|449121123|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124863576|NCT03152552|449121124|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
124863577|NCT03152552|449121120|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
124863578|NCT03152552|449121121|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
124863579|NCT03152552|449121122|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
124863580|NCT03152552|449121123|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
124863581|NCT03152552|449121124|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
124863582|NCT03152552|449121120|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
124863583|NCT03152552|449121121|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
124863584|NCT03152552|449121122|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
124863585|NCT03152552|449121123|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
124863586|NCT03152552|449121124|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
124863587|NCT03152552|449121120|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
124863588|NCT03152552|449121121|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
124863589|NCT03152552|449121122|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
124863590|NCT03152552|449121123|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
124863591|NCT03152552|449121124|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
124863592|NCT04899349|449121130|FG000|Overall Study|Study terminated by Sponsor|2|||
124863593|NCT04899349|449121131|FG001|Overall Study|Study terminated by Sponsor|0|||
124863594|NCT01857531|449121132|FG000|Overall Study|Withdrawal by Subject|4|||
124863595|NCT04656847|449121136|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
124863596|NCT03301051|449121137|FG000|Overall Study|Adverse Event|0|||
124863597|NCT03301051|449121138|FG001|Overall Study|Adverse Event|4|||
124863598|NCT03301051|449121137|FG000|Overall Study|Withdrawal by Subject|59|||
124863599|NCT03301051|449121138|FG001|Overall Study|Withdrawal by Subject|65|||
124863600|NCT03301051|449121137|FG000|Overall Study|Lost to Follow-up|263|||
124863601|NCT03301051|449121138|FG001|Overall Study|Lost to Follow-up|282|||
124863602|NCT03301051|449121137|FG000|Overall Study|Protocol Violation|1|||
124863603|NCT03301051|449121138|FG001|Overall Study|Protocol Violation|3|||
124863604|NCT03301051|449121137|FG000|Overall Study|Physician Decision|1|||
124863605|NCT03301051|449121138|FG001|Overall Study|Physician Decision|3|||
124863606|NCT03301051|449121137|FG000|Overall Study|Death|1|||
124863607|NCT03301051|449121138|FG001|Overall Study|Death|1|||
124863608|NCT03301051|449121137|FG000|Overall Study|Miscellaneous|8|||
124863609|NCT03301051|449121138|FG001|Overall Study|Miscellaneous|4|||
124863610|NCT03301051|449121137|FG000|Overall Study|Randomized, not vaccinated|13|||
124863611|NCT03301051|449121138|FG001|Overall Study|Randomized, not vaccinated|10|||
124863612|NCT00047879|449121139|FG000|Overall Study|Progressive disease|4|||
124863613|NCT00047879|449121140|FG001|Overall Study|Progressive disease|3|||
124863614|NCT00435370|449121141|FG000|Overall Study|Adverse Event|8|||
124863615|NCT00435370|449121142|FG001|Overall Study|Adverse Event|8|||
124863616|NCT00435370|449121141|FG000|Overall Study|Withdrawal by Subject|10|||
124863617|NCT00435370|449121142|FG001|Overall Study|Withdrawal by Subject|10|||
124863618|NCT00435370|449121141|FG000|Overall Study|Antipsychotic medication changed|4|||
124863619|NCT00435370|449121142|FG001|Overall Study|Antipsychotic medication changed|2|||
124863620|NCT01965834|449121143|FG000|Overall Study|Lack of Efficacy|4|||
124863621|NCT03943095|449121144|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
124863622|NCT03943095|449121145|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
124863623|NCT03943095|449121144|FG000|Overall Study|Withdrawal by Subject|1|||
124863624|NCT03943095|449121145|FG001|Overall Study|Withdrawal by Subject|0|||
124863625|NCT00710424|449121151|FG000|Overall Study|Adverse Event|30|||
124863626|NCT00710424|449121152|FG001|Overall Study|Adverse Event|12|||
124863627|NCT00710424|449121151|FG000|Overall Study|Lack of Efficacy|4|||
124863628|NCT00710424|449121152|FG001|Overall Study|Lack of Efficacy|5|||
124863629|NCT00710424|449121151|FG000|Overall Study|Withdrawal by Subject|5|||
124863630|NCT00710424|449121152|FG001|Overall Study|Withdrawal by Subject|3|||
124863631|NCT00710424|449121151|FG000|Overall Study|Lost to Follow-up|0|||
124863632|NCT00710424|449121152|FG001|Overall Study|Lost to Follow-up|1|||
124863633|NCT00710424|449121151|FG000|Overall Study|Refused medication, no side effects|1|||
124863634|NCT00710424|449121152|FG001|Overall Study|Refused medication, no side effects|0|||
124863635|NCT00710424|449121151|FG000|Overall Study|Non-compliance with stable analgesia|1|||
124863636|NCT00710424|449121152|FG001|Overall Study|Non-compliance with stable analgesia|0|||
124863637|NCT00710424|449121151|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
124863638|NCT00710424|449121152|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
124863639|NCT00710424|449121151|FG000|Overall Study|Subject thought medication changed|1|||
124863640|NCT00710424|449121152|FG001|Overall Study|Subject thought medication changed|0|||
124863641|NCT00710424|449121151|FG000|Overall Study|Ceased treatment due to travel|1|||
124863642|NCT00710424|449121152|FG001|Overall Study|Ceased treatment due to travel|0|||
124863643|NCT00710424|449121151|FG000|Overall Study|Subject preferred paracetamol|0|||
124863644|NCT00710424|449121152|FG001|Overall Study|Subject preferred paracetamol|1|||
124863645|NCT00710424|449121151|FG000|Overall Study|Felt good so stopped treatment|0|||
124863646|NCT00710424|449121152|FG001|Overall Study|Felt good so stopped treatment|1|||
124863647|NCT01962493|449121153|FG000|Overall Study|Adverse Event|1|||
124863648|NCT01962493|449121154|FG001|Overall Study|Adverse Event|2|||
124863649|NCT01962493|449121153|FG000|Overall Study|Protocol Violation|0|||
124863650|NCT01962493|449121154|FG001|Overall Study|Protocol Violation|1|||
124863651|NCT01962493|449121153|FG000|Overall Study|Withdrawal by Subject|4|||
124863652|NCT01962493|449121154|FG001|Overall Study|Withdrawal by Subject|2|||
124863653|NCT06273774|449121155|FG000|Overall Study|Participant was out of state.|0|||
124863654|NCT06273774|449121156|FG001|Overall Study|Participant was out of state.|0|||
124863655|NCT06273774|449121157|FG002|Overall Study|Participant was out of state.|0|||
124863656|NCT06273774|449121158|FG003|Overall Study|Participant was out of state.|0|||
124863657|NCT06273774|449121159|FG004|Overall Study|Participant was out of state.|0|||
124863658|NCT06273774|449121160|FG005|Overall Study|Participant was out of state.|1|||
124863659|NCT06273774|449121155|FG000|Overall Study|Lost to Follow-up|0|||
124863660|NCT06273774|449121156|FG001|Overall Study|Lost to Follow-up|0|||
124863661|NCT06273774|449121157|FG002|Overall Study|Lost to Follow-up|0|||
124863662|NCT06273774|449121158|FG003|Overall Study|Lost to Follow-up|0|||
124863663|NCT06273774|449121159|FG004|Overall Study|Lost to Follow-up|1|||
124863664|NCT06273774|449121160|FG005|Overall Study|Lost to Follow-up|0|||
124863665|NCT04414696|449121165|FG000|3-month Follow up|Withdrawal by Subject|1|||
124863666|NCT04414696|449121166|FG001|3-month Follow up|Withdrawal by Subject|0|||
124863667|NCT04414696|449121165|FG000|3-month Follow up|Lost to Follow-up|22|||
124863668|NCT04414696|449121166|FG001|3-month Follow up|Lost to Follow-up|23|||
124863669|NCT04414696|449121165|FG000|6-month Follow up|Withdrawal by Subject|1|||
124863670|NCT04414696|449121166|FG001|6-month Follow up|Withdrawal by Subject|2|||
124863671|NCT04414696|449121165|FG000|6-month Follow up|Lost to Follow-up|5|||
124863672|NCT04414696|449121166|FG001|6-month Follow up|Lost to Follow-up|2|||
124863673|NCT01625897|449123465|FG000|Overall Study|Adverse Event|27|||
124863674|NCT01625897|449123466|FG001|Overall Study|Adverse Event|10|||
124863675|NCT01625897|449123465|FG000|Overall Study|Physician Decision|0|||
124863676|NCT01625897|449123466|FG001|Overall Study|Physician Decision|1|||
124863677|NCT01625897|449123465|FG000|Overall Study|Withdrawal by Subject|25|||
124863678|NCT01625897|449123466|FG001|Overall Study|Withdrawal by Subject|3|||
124863679|NCT02985866|449123469|FG000|Overall Study|Poor CGM data|1|||
124863680|NCT02985866|449123470|FG001|Overall Study|Poor CGM data|1|||
124863681|NCT02008890|449123471|FG000|Period 1|Withdrawal by Subject|7|||
124863682|NCT02008890|449123472|FG001|Period 1|Withdrawal by Subject|7|||
124863683|NCT02008890|449123473|FG002|Period 1|Withdrawal by Subject|5|||
124863684|NCT02008890|449123474|FG003|Period 1|Withdrawal by Subject|0|||
124863685|NCT02008890|449123475|FG004|Period 1|Withdrawal by Subject|0|||
124863686|NCT02008890|449123471|FG000|Period 1|Pregnancy|1|||
124863687|NCT02008890|449123472|FG001|Period 1|Pregnancy|0|||
124863688|NCT02008890|449123473|FG002|Period 1|Pregnancy|0|||
124863689|NCT02008890|449123474|FG003|Period 1|Pregnancy|0|||
124863690|NCT02008890|449123475|FG004|Period 1|Pregnancy|0|||
124863691|NCT02008890|449123471|FG000|Period 1|Physician Decision|1|||
124863692|NCT02008890|449123472|FG001|Period 1|Physician Decision|0|||
124863693|NCT02008890|449123473|FG002|Period 1|Physician Decision|1|||
124863694|NCT02008890|449123474|FG003|Period 1|Physician Decision|0|||
124863695|NCT02008890|449123475|FG004|Period 1|Physician Decision|0|||
124863696|NCT02008890|449123471|FG000|Period 1|Adverse Event|6|||
124863697|NCT02008890|449123472|FG001|Period 1|Adverse Event|8|||
124863698|NCT02008890|449123473|FG002|Period 1|Adverse Event|6|||
124863699|NCT02008890|449123474|FG003|Period 1|Adverse Event|0|||
124863700|NCT02008890|449123475|FG004|Period 1|Adverse Event|0|||
124863701|NCT02008890|449123471|FG000|Period 2|Adverse Event|12|||
124863702|NCT02008890|449123472|FG001|Period 2|Adverse Event|7|||
124863703|NCT02008890|449123473|FG002|Period 2|Adverse Event|0|||
124863704|NCT02008890|449123474|FG003|Period 2|Adverse Event|5|||
124863705|NCT02008890|449123475|FG004|Period 2|Adverse Event|5|||
124863706|NCT02008890|449123471|FG000|Period 2|Withdrawal by Subject|11|||
124863707|NCT02008890|449123472|FG001|Period 2|Withdrawal by Subject|8|||
124863708|NCT02008890|449123473|FG002|Period 2|Withdrawal by Subject|0|||
124863709|NCT02008890|449123474|FG003|Period 2|Withdrawal by Subject|7|||
124863710|NCT02008890|449123475|FG004|Period 2|Withdrawal by Subject|2|||
124863711|NCT02008890|449123471|FG000|Period 2|Physician Decision|4|||
124863712|NCT02008890|449123472|FG001|Period 2|Physician Decision|0|||
124863713|NCT02008890|449123473|FG002|Period 2|Physician Decision|0|||
124863714|NCT02008890|449123474|FG003|Period 2|Physician Decision|2|||
124863715|NCT02008890|449123475|FG004|Period 2|Physician Decision|1|||
124863716|NCT02008890|449123471|FG000|Period 2|Lost to Follow-up|0|||
124863717|NCT02008890|449123472|FG001|Period 2|Lost to Follow-up|0|||
124863718|NCT02008890|449123473|FG002|Period 2|Lost to Follow-up|1|||
124863719|NCT02008890|449123474|FG003|Period 2|Lost to Follow-up|0|||
124863720|NCT02008890|449123475|FG004|Period 2|Lost to Follow-up|0|||
124863721|NCT02008890|449123471|FG000|Extension Period|Withdrawal by Subject|3|||
124863722|NCT02008890|449123472|FG001|Extension Period|Withdrawal by Subject|2|||
124863723|NCT02008890|449123473|FG002|Extension Period|Withdrawal by Subject|0|||
124863724|NCT02008890|449123474|FG003|Extension Period|Withdrawal by Subject|4|||
124863725|NCT02008890|449123475|FG004|Extension Period|Withdrawal by Subject|2|||
124863726|NCT02008890|449123471|FG000|Extension Period|Lost to Follow-up|1|||
124863727|NCT02008890|449123472|FG001|Extension Period|Lost to Follow-up|0|||
124863728|NCT02008890|449123473|FG002|Extension Period|Lost to Follow-up|0|||
124863729|NCT02008890|449123474|FG003|Extension Period|Lost to Follow-up|0|||
124863730|NCT02008890|449123475|FG004|Extension Period|Lost to Follow-up|0|||
124863731|NCT02008890|449123471|FG000|Extension Period|Adverse Event|1|||
124863732|NCT02008890|449123472|FG001|Extension Period|Adverse Event|3|||
124863733|NCT02008890|449123473|FG002|Extension Period|Adverse Event|0|||
124863734|NCT02008890|449123474|FG003|Extension Period|Adverse Event|0|||
124863735|NCT02008890|449123475|FG004|Extension Period|Adverse Event|2|||
124863736|NCT02207816|449123476|FG000|Overall Study|Serious Adverse Event|0|||
124863737|NCT02207816|449123477|FG001|Overall Study|Serious Adverse Event|5|||
124863738|NCT02207816|449123478|FG002|Overall Study|Serious Adverse Event|2|||
124863739|NCT02207816|449123476|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
124863740|NCT02207816|449123477|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
124863741|NCT02207816|449123478|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
124863742|NCT02207816|449123476|FG000|Overall Study|Withdrawal by Subject|4|||
124863743|NCT02207816|449123477|FG001|Overall Study|Withdrawal by Subject|9|||
124863744|NCT02207816|449123478|FG002|Overall Study|Withdrawal by Subject|7|||
124863745|NCT02207816|449123476|FG000|Overall Study|Migrated/Moved From Study Area|41|||
124863746|NCT02207816|449123477|FG001|Overall Study|Migrated/Moved From Study Area|60|||
124863747|NCT02207816|449123478|FG002|Overall Study|Migrated/Moved From Study Area|51|||
124863748|NCT02207816|449123476|FG000|Overall Study|Lost to Follow-up|3|||
124863749|NCT02207816|449123477|FG001|Overall Study|Lost to Follow-up|9|||
124863750|NCT02207816|449123478|FG002|Overall Study|Lost to Follow-up|1|||
124863751|NCT02207816|449123476|FG000|Overall Study|Other|1|||
124863752|NCT02207816|449123477|FG001|Overall Study|Other|2|||
124863753|NCT02207816|449123478|FG002|Overall Study|Other|4|||
124863754|NCT00686166|449123479|FG000|Overall Study|Adverse Event|7|||
124863755|NCT00686166|449123479|FG000|Overall Study|Withdrawal by Subject|1|||
124863756|NCT00686166|449123479|FG000|Overall Study|Progression/Relapse|1|||
124863757|NCT00686166|449123479|FG000|Overall Study|Death|1|||
124863758|NCT00686166|449123479|FG000|Overall Study|Not Protocol Specified|1|||
124863759|NCT00686166|449123479|FG000|Overall Study|Ineligible|5|||
124863760|NCT00686166|449123479|FG000|Overall Study|Did not begin protocol therapy|4|||
124863761|NCT00360308|449123480|FG000|Overall Study|Adverse Event|15|||
124863762|NCT00360308|449123481|FG001|Overall Study|Adverse Event|14|||
124863763|NCT00360308|449123482|FG002|Overall Study|Adverse Event|25|||
124863764|NCT00360308|449123480|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
124863765|NCT00360308|449123481|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
124863766|NCT00360308|449123482|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
124863767|NCT00360308|449123480|FG000|Overall Study|Protocol Violation|2|||
124863768|NCT00360308|449123481|FG001|Overall Study|Protocol Violation|1|||
124863769|NCT00360308|449123482|FG002|Overall Study|Protocol Violation|2|||
124863770|NCT00360308|449123480|FG000|Overall Study|Withdrawal by Subject|11|||
124863771|NCT00360308|449123481|FG001|Overall Study|Withdrawal by Subject|7|||
124863772|NCT00360308|449123482|FG002|Overall Study|Withdrawal by Subject|14|||
124863773|NCT00360308|449123480|FG000|Overall Study|Lack of Efficacy|3|||
124863774|NCT00360308|449123481|FG001|Overall Study|Lack of Efficacy|0|||
124863775|NCT00360308|449123482|FG002|Overall Study|Lack of Efficacy|2|||
124863776|NCT00360308|449123480|FG000|Overall Study|Other|2|||
124863777|NCT00360308|449123481|FG001|Overall Study|Other|1|||
124863778|NCT00360308|449123482|FG002|Overall Study|Other|1|||
124863779|NCT00360308|449123480|FG000|Overall Study|Study termination by sponsor|43|||
124863780|NCT00360308|449123481|FG001|Overall Study|Study termination by sponsor|55|||
124863781|NCT00360308|449123482|FG002|Overall Study|Study termination by sponsor|44|||
124863782|NCT01217073|449123483|FG000|Base Period|Adverse Event|1|||
124863783|NCT01217073|449123484|FG001|Base Period|Adverse Event|0|||
124863784|NCT01217073|449123485|FG002|Base Period|Adverse Event|1|||
124863785|NCT01217073|449123486|FG003|Base Period|Adverse Event|0|||
124863786|NCT01217073|449123487|FG004|Base Period|Adverse Event|4|||
124863787|NCT01217073|449123488|FG005|Base Period|Adverse Event|1|||
124863788|NCT01217073|449123489|FG006|Base Period|Adverse Event|0|||
124863789|NCT01217073|449123490|FG007|Base Period|Adverse Event|0|||
124863790|NCT01217073|449123483|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
124863791|NCT01217073|449123484|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
124863792|NCT01217073|449123485|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
124863793|NCT01217073|449123486|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
124863794|NCT01217073|449123487|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
124863795|NCT01217073|449123488|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
124863796|NCT01217073|449123489|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
124863797|NCT01217073|449123490|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
124863798|NCT01217073|449123483|FG000|Base Period|Excluded medication|0|||
124863799|NCT01217073|449123484|FG001|Base Period|Excluded medication|0|||
124863800|NCT01217073|449123485|FG002|Base Period|Excluded medication|0|||
124863801|NCT01217073|449123486|FG003|Base Period|Excluded medication|0|||
124863802|NCT01217073|449123487|FG004|Base Period|Excluded medication|1|||
124863803|NCT01217073|449123488|FG005|Base Period|Excluded medication|0|||
124863804|NCT01217073|449123489|FG006|Base Period|Excluded medication|0|||
124863805|NCT01217073|449123490|FG007|Base Period|Excluded medication|0|||
124863806|NCT01217073|449123483|FG000|Base Period|Lack of Efficacy|0|||
124863807|NCT01217073|449123484|FG001|Base Period|Lack of Efficacy|0|||
124863808|NCT01217073|449123485|FG002|Base Period|Lack of Efficacy|0|||
124863809|NCT01217073|449123486|FG003|Base Period|Lack of Efficacy|0|||
124863810|NCT01217073|449123487|FG004|Base Period|Lack of Efficacy|0|||
124863811|NCT01217073|449123488|FG005|Base Period|Lack of Efficacy|1|||
124863812|NCT01217073|449123489|FG006|Base Period|Lack of Efficacy|0|||
124863813|NCT01217073|449123490|FG007|Base Period|Lack of Efficacy|0|||
124863814|NCT01217073|449123483|FG000|Base Period|Lost to Follow-up|0|||
124863815|NCT01217073|449123484|FG001|Base Period|Lost to Follow-up|0|||
124863816|NCT01217073|449123485|FG002|Base Period|Lost to Follow-up|1|||
124863817|NCT01217073|449123486|FG003|Base Period|Lost to Follow-up|1|||
124863818|NCT01217073|449123487|FG004|Base Period|Lost to Follow-up|3|||
124863819|NCT01217073|449123488|FG005|Base Period|Lost to Follow-up|0|||
124863820|NCT01217073|449123489|FG006|Base Period|Lost to Follow-up|0|||
124863821|NCT01217073|449123490|FG007|Base Period|Lost to Follow-up|0|||
124863822|NCT01217073|449123483|FG000|Base Period|Physician Decision|0|||
124863823|NCT01217073|449123484|FG001|Base Period|Physician Decision|0|||
124863824|NCT01217073|449123485|FG002|Base Period|Physician Decision|0|||
124863825|NCT01217073|449123486|FG003|Base Period|Physician Decision|0|||
124863826|NCT01217073|449123487|FG004|Base Period|Physician Decision|1|||
124863827|NCT01217073|449123488|FG005|Base Period|Physician Decision|0|||
124863828|NCT01217073|449123489|FG006|Base Period|Physician Decision|0|||
124863829|NCT01217073|449123490|FG007|Base Period|Physician Decision|0|||
124863830|NCT01217073|449123483|FG000|Base Period|Protocol Violation|1|||
124863831|NCT01217073|449123484|FG001|Base Period|Protocol Violation|0|||
124863832|NCT01217073|449123485|FG002|Base Period|Protocol Violation|0|||
124863833|NCT01217073|449123486|FG003|Base Period|Protocol Violation|0|||
124863834|NCT01217073|449123487|FG004|Base Period|Protocol Violation|1|||
124863835|NCT01217073|449123488|FG005|Base Period|Protocol Violation|2|||
124863836|NCT01217073|449123489|FG006|Base Period|Protocol Violation|0|||
124863837|NCT01217073|449123490|FG007|Base Period|Protocol Violation|0|||
124863838|NCT01217073|449123483|FG000|Base Period|Withdrawal by Subject|4|||
124863839|NCT01217073|449123484|FG001|Base Period|Withdrawal by Subject|5|||
124863840|NCT01217073|449123485|FG002|Base Period|Withdrawal by Subject|5|||
124863841|NCT01217073|449123486|FG003|Base Period|Withdrawal by Subject|1|||
124863842|NCT01217073|449123487|FG004|Base Period|Withdrawal by Subject|5|||
124863843|NCT01217073|449123488|FG005|Base Period|Withdrawal by Subject|5|||
124863844|NCT01217073|449123489|FG006|Base Period|Withdrawal by Subject|0|||
124863845|NCT01217073|449123490|FG007|Base Period|Withdrawal by Subject|0|||
124863846|NCT01217073|449123483|FG000|Extension Period|Adverse Event|0|||
124863847|NCT01217073|449123484|FG001|Extension Period|Adverse Event|0|||
124863848|NCT01217073|449123485|FG002|Extension Period|Adverse Event|0|||
124863849|NCT01217073|449123486|FG003|Extension Period|Adverse Event|0|||
124863850|NCT01217073|449123487|FG004|Extension Period|Adverse Event|0|||
124863851|NCT01217073|449123488|FG005|Extension Period|Adverse Event|0|||
124863852|NCT01217073|449123489|FG006|Extension Period|Adverse Event|19|||
124863853|NCT01217073|449123490|FG007|Extension Period|Adverse Event|5|||
124863854|NCT01217073|449123483|FG000|Extension Period|ALT/AST|0|||
124863855|NCT01217073|449123484|FG001|Extension Period|ALT/AST|0|||
124863856|NCT01217073|449123485|FG002|Extension Period|ALT/AST|0|||
124863857|NCT01217073|449123486|FG003|Extension Period|ALT/AST|0|||
124863858|NCT01217073|449123487|FG004|Extension Period|ALT/AST|0|||
124863859|NCT01217073|449123488|FG005|Extension Period|ALT/AST|0|||
124863860|NCT01217073|449123489|FG006|Extension Period|ALT/AST|2|||
124863861|NCT01217073|449123490|FG007|Extension Period|ALT/AST|0|||
124863862|NCT01217073|449123483|FG000|Extension Period|Contraindication to study medication|0|||
124863863|NCT01217073|449123484|FG001|Extension Period|Contraindication to study medication|0|||
124863864|NCT01217073|449123485|FG002|Extension Period|Contraindication to study medication|0|||
124863865|NCT01217073|449123486|FG003|Extension Period|Contraindication to study medication|0|||
124863866|NCT01217073|449123487|FG004|Extension Period|Contraindication to study medication|0|||
124863867|NCT01217073|449123488|FG005|Extension Period|Contraindication to study medication|0|||
124863868|NCT01217073|449123489|FG006|Extension Period|Contraindication to study medication|1|||
124863869|NCT01217073|449123490|FG007|Extension Period|Contraindication to study medication|0|||
124863870|NCT01217073|449123483|FG000|Extension Period|Creatinine/eGFR|0|||
124863871|NCT01217073|449123484|FG001|Extension Period|Creatinine/eGFR|0|||
124863872|NCT01217073|449123485|FG002|Extension Period|Creatinine/eGFR|0|||
124863873|NCT01217073|449123486|FG003|Extension Period|Creatinine/eGFR|0|||
124863874|NCT01217073|449123487|FG004|Extension Period|Creatinine/eGFR|0|||
124863875|NCT01217073|449123488|FG005|Extension Period|Creatinine/eGFR|0|||
124863876|NCT01217073|449123489|FG006|Extension Period|Creatinine/eGFR|11|||
124863877|NCT01217073|449123490|FG007|Extension Period|Creatinine/eGFR|1|||
124863878|NCT01217073|449123483|FG000|Extension Period|Death|0|||
124863879|NCT01217073|449123484|FG001|Extension Period|Death|0|||
124863880|NCT01217073|449123485|FG002|Extension Period|Death|0|||
124863881|NCT01217073|449123486|FG003|Extension Period|Death|0|||
124863882|NCT01217073|449123487|FG004|Extension Period|Death|0|||
124863883|NCT01217073|449123488|FG005|Extension Period|Death|0|||
124863884|NCT01217073|449123489|FG006|Extension Period|Death|1|||
124863885|NCT01217073|449123490|FG007|Extension Period|Death|0|||
124863886|NCT01217073|449123483|FG000|Extension Period|Excluded medication|0|||
124863887|NCT01217073|449123484|FG001|Extension Period|Excluded medication|0|||
124863888|NCT01217073|449123485|FG002|Extension Period|Excluded medication|0|||
124863889|NCT01217073|449123486|FG003|Extension Period|Excluded medication|0|||
124863890|NCT01217073|449123487|FG004|Extension Period|Excluded medication|0|||
124863891|NCT01217073|449123488|FG005|Extension Period|Excluded medication|0|||
124863892|NCT01217073|449123489|FG006|Extension Period|Excluded medication|2|||
124863893|NCT01217073|449123490|FG007|Extension Period|Excluded medication|0|||
124863894|NCT01217073|449123483|FG000|Extension Period|Lack of Efficacy|0|||
124863895|NCT01217073|449123484|FG001|Extension Period|Lack of Efficacy|0|||
124863896|NCT01217073|449123485|FG002|Extension Period|Lack of Efficacy|0|||
124863897|NCT01217073|449123486|FG003|Extension Period|Lack of Efficacy|0|||
124863898|NCT01217073|449123487|FG004|Extension Period|Lack of Efficacy|0|||
124863899|NCT01217073|449123488|FG005|Extension Period|Lack of Efficacy|0|||
124863900|NCT01217073|449123489|FG006|Extension Period|Lack of Efficacy|3|||
124863901|NCT01217073|449123490|FG007|Extension Period|Lack of Efficacy|0|||
124863902|NCT01217073|449123483|FG000|Extension Period|Lost to Follow-up|0|||
124863903|NCT01217073|449123484|FG001|Extension Period|Lost to Follow-up|0|||
124863904|NCT01217073|449123485|FG002|Extension Period|Lost to Follow-up|0|||
124863905|NCT01217073|449123486|FG003|Extension Period|Lost to Follow-up|0|||
124863906|NCT01217073|449123487|FG004|Extension Period|Lost to Follow-up|0|||
124863907|NCT01217073|449123488|FG005|Extension Period|Lost to Follow-up|0|||
124863908|NCT01217073|449123489|FG006|Extension Period|Lost to Follow-up|9|||
124863909|NCT01217073|449123490|FG007|Extension Period|Lost to Follow-up|1|||
124863910|NCT01217073|449123483|FG000|Extension Period|Non-compliance with study drug|0|||
124863911|NCT01217073|449123484|FG001|Extension Period|Non-compliance with study drug|0|||
124863912|NCT01217073|449123485|FG002|Extension Period|Non-compliance with study drug|0|||
124863913|NCT01217073|449123486|FG003|Extension Period|Non-compliance with study drug|0|||
124863914|NCT01217073|449123487|FG004|Extension Period|Non-compliance with study drug|0|||
124863915|NCT01217073|449123488|FG005|Extension Period|Non-compliance with study drug|0|||
124863916|NCT01217073|449123489|FG006|Extension Period|Non-compliance with study drug|0|||
124863917|NCT01217073|449123490|FG007|Extension Period|Non-compliance with study drug|1|||
124863918|NCT01217073|449123483|FG000|Extension Period|Physician Decision|0|||
124863919|NCT01217073|449123484|FG001|Extension Period|Physician Decision|0|||
124863920|NCT01217073|449123485|FG002|Extension Period|Physician Decision|0|||
124863921|NCT01217073|449123486|FG003|Extension Period|Physician Decision|0|||
124863922|NCT01217073|449123487|FG004|Extension Period|Physician Decision|0|||
124863923|NCT01217073|449123488|FG005|Extension Period|Physician Decision|0|||
124863924|NCT01217073|449123489|FG006|Extension Period|Physician Decision|4|||
124863925|NCT01217073|449123490|FG007|Extension Period|Physician Decision|1|||
124863926|NCT01217073|449123483|FG000|Extension Period|Protocol Violation|0|||
124863927|NCT01217073|449123484|FG001|Extension Period|Protocol Violation|0|||
124863928|NCT01217073|449123485|FG002|Extension Period|Protocol Violation|0|||
124863929|NCT01217073|449123486|FG003|Extension Period|Protocol Violation|0|||
124863930|NCT01217073|449123487|FG004|Extension Period|Protocol Violation|0|||
124863931|NCT01217073|449123488|FG005|Extension Period|Protocol Violation|0|||
124863932|NCT01217073|449123489|FG006|Extension Period|Protocol Violation|2|||
124863933|NCT01217073|449123490|FG007|Extension Period|Protocol Violation|1|||
124863934|NCT01217073|449123483|FG000|Extension Period|Site discontinued study participation|0|||
124863935|NCT01217073|449123484|FG001|Extension Period|Site discontinued study participation|0|||
124863936|NCT01217073|449123485|FG002|Extension Period|Site discontinued study participation|0|||
124863937|NCT01217073|449123486|FG003|Extension Period|Site discontinued study participation|0|||
124863938|NCT01217073|449123487|FG004|Extension Period|Site discontinued study participation|0|||
124863939|NCT01217073|449123488|FG005|Extension Period|Site discontinued study participation|0|||
124863940|NCT01217073|449123489|FG006|Extension Period|Site discontinued study participation|7|||
124863941|NCT01217073|449123490|FG007|Extension Period|Site discontinued study participation|2|||
124863942|NCT01217073|449123483|FG000|Extension Period|Withdrawal by Subject|0|||
124863943|NCT01217073|449123484|FG001|Extension Period|Withdrawal by Subject|0|||
124863944|NCT01217073|449123485|FG002|Extension Period|Withdrawal by Subject|0|||
124863945|NCT01217073|449123486|FG003|Extension Period|Withdrawal by Subject|0|||
124863946|NCT01217073|449123487|FG004|Extension Period|Withdrawal by Subject|0|||
124863947|NCT01217073|449123488|FG005|Extension Period|Withdrawal by Subject|0|||
124863948|NCT01217073|449123489|FG006|Extension Period|Withdrawal by Subject|30|||
124863949|NCT01217073|449123490|FG007|Extension Period|Withdrawal by Subject|8|||
124863950|NCT02564523|449123491|FG000|Overall Study|Withdrawal by Subject|3|||
124863951|NCT02564523|449123492|FG001|Overall Study|Withdrawal by Subject|0|||
124863952|NCT02564523|449123493|FG002|Overall Study|Withdrawal by Subject|1|||
124863953|NCT02564523|449123494|FG003|Overall Study|Withdrawal by Subject|0|||
124863954|NCT02564523|449123495|FG004|Overall Study|Withdrawal by Subject|1|||
124863955|NCT02564523|449123496|FG005|Overall Study|Withdrawal by Subject|0|||
124863956|NCT02564523|449123497|FG006|Overall Study|Withdrawal by Subject|1|||
124863957|NCT02564523|449123498|FG007|Overall Study|Withdrawal by Subject|0|||
124863958|NCT02564523|449123499|FG008|Overall Study|Withdrawal by Subject|0|||
124863959|NCT02564523|449123500|FG009|Overall Study|Withdrawal by Subject|0|||
124863960|NCT02564523|449123501|FG010|Overall Study|Withdrawal by Subject|1|||
124863961|NCT02564523|449123502|FG011|Overall Study|Withdrawal by Subject|0|||
124863962|NCT02564523|449123503|FG012|Overall Study|Withdrawal by Subject|1|||
124863963|NCT02564523|449123504|FG013|Overall Study|Withdrawal by Subject|0|||
124863964|NCT02564523|449123505|FG014|Overall Study|Withdrawal by Subject|0|||
124863965|NCT02564523|449123506|FG015|Overall Study|Withdrawal by Subject|0|||
124863966|NCT02564523|449123507|FG016|Overall Study|Withdrawal by Subject|0|||
124863967|NCT02564523|449123508|FG017|Overall Study|Withdrawal by Subject|0|||
124863968|NCT02564523|449123491|FG000|Overall Study|Adverse Event|0|||
124863969|NCT02564523|449123492|FG001|Overall Study|Adverse Event|0|||
124863970|NCT02564523|449123493|FG002|Overall Study|Adverse Event|0|||
124863971|NCT02564523|449123494|FG003|Overall Study|Adverse Event|0|||
124863972|NCT02564523|449123495|FG004|Overall Study|Adverse Event|0|||
124863973|NCT02564523|449123496|FG005|Overall Study|Adverse Event|0|||
124863974|NCT02564523|449123497|FG006|Overall Study|Adverse Event|0|||
124863975|NCT02564523|449123498|FG007|Overall Study|Adverse Event|0|||
124863976|NCT02564523|449123499|FG008|Overall Study|Adverse Event|0|||
124863977|NCT02564523|449123500|FG009|Overall Study|Adverse Event|0|||
124863978|NCT02564523|449123501|FG010|Overall Study|Adverse Event|0|||
124863979|NCT02564523|449123502|FG011|Overall Study|Adverse Event|0|||
124863980|NCT02564523|449123503|FG012|Overall Study|Adverse Event|0|||
124863981|NCT02564523|449123504|FG013|Overall Study|Adverse Event|0|||
124863982|NCT02564523|449123505|FG014|Overall Study|Adverse Event|0|||
124863983|NCT02564523|449123506|FG015|Overall Study|Adverse Event|0|||
124863984|NCT02564523|449123507|FG016|Overall Study|Adverse Event|0|||
124863985|NCT02564523|449123508|FG017|Overall Study|Adverse Event|1|||
124863986|NCT02564523|449123491|FG000|Overall Study|Death|0|||
124863987|NCT02564523|449123492|FG001|Overall Study|Death|0|||
124863988|NCT02564523|449123493|FG002|Overall Study|Death|0|||
124863989|NCT02564523|449123494|FG003|Overall Study|Death|0|||
124863990|NCT02564523|449123495|FG004|Overall Study|Death|0|||
124863991|NCT02564523|449123496|FG005|Overall Study|Death|0|||
124863992|NCT02564523|449123497|FG006|Overall Study|Death|1|||
124863993|NCT02564523|449123498|FG007|Overall Study|Death|0|||
124863994|NCT02564523|449123499|FG008|Overall Study|Death|0|||
124863995|NCT02564523|449123500|FG009|Overall Study|Death|0|||
124863996|NCT02564523|449123501|FG010|Overall Study|Death|1|||
124863997|NCT02564523|449123502|FG011|Overall Study|Death|0|||
124863998|NCT02564523|449123503|FG012|Overall Study|Death|0|||
124863999|NCT02564523|449123504|FG013|Overall Study|Death|0|||
124864000|NCT02564523|449123505|FG014|Overall Study|Death|0|||
124864001|NCT02564523|449123506|FG015|Overall Study|Death|0|||
124864002|NCT02564523|449123507|FG016|Overall Study|Death|0|||
124864003|NCT02564523|449123508|FG017|Overall Study|Death|0|||
124864004|NCT02564523|449123491|FG000|Overall Study|Lost to Follow-up|2|||
124864005|NCT02564523|449123492|FG001|Overall Study|Lost to Follow-up|1|||
124864006|NCT02564523|449123493|FG002|Overall Study|Lost to Follow-up|4|||
124864007|NCT02564523|449123494|FG003|Overall Study|Lost to Follow-up|0|||
124864008|NCT02564523|449123495|FG004|Overall Study|Lost to Follow-up|1|||
124864009|NCT02564523|449123496|FG005|Overall Study|Lost to Follow-up|0|||
124864010|NCT02564523|449123497|FG006|Overall Study|Lost to Follow-up|1|||
124864011|NCT02564523|449123498|FG007|Overall Study|Lost to Follow-up|0|||
124864012|NCT02564523|449123499|FG008|Overall Study|Lost to Follow-up|0|||
124864013|NCT02564523|449123500|FG009|Overall Study|Lost to Follow-up|0|||
124864014|NCT02564523|449123501|FG010|Overall Study|Lost to Follow-up|0|||
124864015|NCT02564523|449123502|FG011|Overall Study|Lost to Follow-up|1|||
124864016|NCT02564523|449123503|FG012|Overall Study|Lost to Follow-up|1|||
124864017|NCT02564523|449123504|FG013|Overall Study|Lost to Follow-up|0|||
124864018|NCT02564523|449123505|FG014|Overall Study|Lost to Follow-up|0|||
124864019|NCT02564523|449123506|FG015|Overall Study|Lost to Follow-up|0|||
124864020|NCT02564523|449123507|FG016|Overall Study|Lost to Follow-up|0|||
124864021|NCT02564523|449123508|FG017|Overall Study|Lost to Follow-up|0|||
124864022|NCT02564523|449123491|FG000|Overall Study|Physician Decision|0|||
124864023|NCT02564523|449123492|FG001|Overall Study|Physician Decision|0|||
124864024|NCT02564523|449123493|FG002|Overall Study|Physician Decision|0|||
124864025|NCT02564523|449123494|FG003|Overall Study|Physician Decision|0|||
124864026|NCT02564523|449123495|FG004|Overall Study|Physician Decision|1|||
124864027|NCT02564523|449123496|FG005|Overall Study|Physician Decision|0|||
124864028|NCT02564523|449123497|FG006|Overall Study|Physician Decision|0|||
124864029|NCT02564523|449123498|FG007|Overall Study|Physician Decision|0|||
124864030|NCT02564523|449123499|FG008|Overall Study|Physician Decision|0|||
124864031|NCT02564523|449123500|FG009|Overall Study|Physician Decision|0|||
124864032|NCT02564523|449123501|FG010|Overall Study|Physician Decision|1|||
124864033|NCT02564523|449123502|FG011|Overall Study|Physician Decision|0|||
124864034|NCT02564523|449123503|FG012|Overall Study|Physician Decision|0|||
124864035|NCT02564523|449123504|FG013|Overall Study|Physician Decision|0|||
124864036|NCT02564523|449123505|FG014|Overall Study|Physician Decision|0|||
124864037|NCT02564523|449123506|FG015|Overall Study|Physician Decision|0|||
124864038|NCT02564523|449123507|FG016|Overall Study|Physician Decision|0|||
124864039|NCT02564523|449123508|FG017|Overall Study|Physician Decision|0|||
124864040|NCT02564523|449123491|FG000|Overall Study|Protocol Violation|2|||
124864041|NCT02564523|449123492|FG001|Overall Study|Protocol Violation|2|||
124864042|NCT02564523|449123493|FG002|Overall Study|Protocol Violation|5|||
124864043|NCT02564523|449123494|FG003|Overall Study|Protocol Violation|0|||
124864044|NCT02564523|449123495|FG004|Overall Study|Protocol Violation|1|||
124864045|NCT02564523|449123496|FG005|Overall Study|Protocol Violation|0|||
124864046|NCT02564523|449123497|FG006|Overall Study|Protocol Violation|0|||
124864047|NCT02564523|449123498|FG007|Overall Study|Protocol Violation|0|||
124864048|NCT02564523|449123499|FG008|Overall Study|Protocol Violation|0|||
124864049|NCT02564523|449123500|FG009|Overall Study|Protocol Violation|0|||
124864050|NCT02564523|449123501|FG010|Overall Study|Protocol Violation|0|||
124864051|NCT02564523|449123502|FG011|Overall Study|Protocol Violation|0|||
124864052|NCT02564523|449123503|FG012|Overall Study|Protocol Violation|0|||
124864053|NCT02564523|449123504|FG013|Overall Study|Protocol Violation|0|||
124864054|NCT02564523|449123505|FG014|Overall Study|Protocol Violation|0|||
124864055|NCT02564523|449123506|FG015|Overall Study|Protocol Violation|0|||
124864056|NCT02564523|449123507|FG016|Overall Study|Protocol Violation|0|||
124864057|NCT02564523|449123508|FG017|Overall Study|Protocol Violation|0|||
124864058|NCT02564523|449123491|FG000|Overall Study|Other|3|||
124864059|NCT02564523|449123492|FG001|Overall Study|Other|0|||
124864060|NCT02564523|449123493|FG002|Overall Study|Other|0|||
124864061|NCT02564523|449123494|FG003|Overall Study|Other|1|||
124864062|NCT02564523|449123495|FG004|Overall Study|Other|0|||
124864063|NCT02564523|449123496|FG005|Overall Study|Other|0|||
124864064|NCT02564523|449123497|FG006|Overall Study|Other|0|||
124864065|NCT02564523|449123498|FG007|Overall Study|Other|0|||
124864066|NCT02564523|449123499|FG008|Overall Study|Other|0|||
124864067|NCT02564523|449123500|FG009|Overall Study|Other|0|||
124864068|NCT02564523|449123501|FG010|Overall Study|Other|0|||
124864069|NCT02564523|449123502|FG011|Overall Study|Other|0|||
124864070|NCT02564523|449123503|FG012|Overall Study|Other|0|||
124864071|NCT02564523|449123504|FG013|Overall Study|Other|0|||
124864072|NCT02564523|449123505|FG014|Overall Study|Other|0|||
124864073|NCT02564523|449123506|FG015|Overall Study|Other|0|||
124864074|NCT02564523|449123507|FG016|Overall Study|Other|0|||
124864075|NCT02564523|449123508|FG017|Overall Study|Other|0|||
124864076|NCT04862143|449123523|FG000|Overall Study|Adverse Event|1|||
124864077|NCT04862143|449123523|FG000|Overall Study|Study terminated by sponsor|1|||
124864078|NCT03031938|449123524|FG000|Overall Study|Death|1|||
124864079|NCT03031938|449123525|FG001|Overall Study|Death|0|||
124864080|NCT00454051|449123526|FG000|Overall Study|Adverse Event|1|||
124864081|NCT00454051|449123527|FG001|Overall Study|Adverse Event|2|||
124864082|NCT00454051|449123526|FG000|Overall Study|Withdrawal by Subject|1|||
124864083|NCT00454051|449123527|FG001|Overall Study|Withdrawal by Subject|0|||
124864084|NCT00454051|449123526|FG000|Overall Study|Protocol Violation|1|||
124864085|NCT00454051|449123527|FG001|Overall Study|Protocol Violation|1|||
124864086|NCT01571362|449123528|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
124864087|NCT01571362|449123529|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
124864088|NCT01571362|449123530|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
124864089|NCT01571362|449123528|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
124864090|NCT01571362|449123529|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
124864091|NCT01571362|449123530|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
124864092|NCT01571362|449123528|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
124864093|NCT01571362|449123529|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
124864094|NCT01571362|449123530|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
124864095|NCT01571362|449123528|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
124864096|NCT01571362|449123529|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
124864097|NCT01571362|449123530|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
124864098|NCT01571362|449123528|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
124864099|NCT01571362|449123529|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
124864100|NCT01571362|449123530|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
124864101|NCT01571362|449123528|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
124864102|NCT01571362|449123529|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
124864103|NCT01571362|449123530|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
124864104|NCT01571362|449123528|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
124864105|NCT01571362|449123529|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
124864106|NCT01571362|449123530|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
124864107|NCT01571362|449123528|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
124864108|NCT01571362|449123529|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
124864109|NCT01571362|449123530|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
124864110|NCT01571362|449123528|FG000|Double-Blind Treatment Period|Adverse Event|0|||
124864111|NCT01571362|449123529|FG001|Double-Blind Treatment Period|Adverse Event|9|||
124864112|NCT01571362|449123530|FG002|Double-Blind Treatment Period|Adverse Event|14|||
124864113|NCT01571362|449123528|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
124864114|NCT01571362|449123529|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
124864115|NCT01571362|449123530|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
124864116|NCT01571362|449123528|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
124864117|NCT01571362|449123529|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
124864118|NCT01571362|449123530|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
124864119|NCT01571362|449123528|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
124864120|NCT01571362|449123529|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
124864121|NCT01571362|449123530|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
124864122|NCT01491854|449123541|FG000|Overall Study|mainly due to premature termination|93|||
124864123|NCT01491854|449123541|FG000|Overall Study|Death|1|||
124864124|NCT01491854|449123541|FG000|Overall Study|Withdrawal by Subject|3|||
124864125|NCT01491854|449123541|FG000|Overall Study|Lost to Follow-up|33|||
124864126|NCT00121238|449123543|FG000|Overall Study|disease progression before intervention|1|||
124864127|NCT00121238|449123543|FG000|Overall Study|Protocol Violation|2|||
124864128|NCT01026974|449123555|FG000|Overall Study|Withdrawal by Subject|0|||
124864129|NCT01026974|449123556|FG001|Overall Study|Withdrawal by Subject|1|||
124864130|NCT01026974|449123557|FG002|Overall Study|Withdrawal by Subject|7|||
124864131|NCT01026974|449123558|FG003|Overall Study|Withdrawal by Subject|2|||
124864132|NCT01026974|449123555|FG000|Overall Study|Lost to Follow-up|1|||
124864133|NCT01026974|449123556|FG001|Overall Study|Lost to Follow-up|1|||
124864134|NCT01026974|449123557|FG002|Overall Study|Lost to Follow-up|4|||
124864135|NCT01026974|449123558|FG003|Overall Study|Lost to Follow-up|0|||
124864136|NCT01026974|449123555|FG000|Overall Study|Adverse Event|0|||
124864137|NCT01026974|449123556|FG001|Overall Study|Adverse Event|0|||
124864138|NCT01026974|449123557|FG002|Overall Study|Adverse Event|0|||
124864139|NCT01026974|449123558|FG003|Overall Study|Adverse Event|1|||
124864140|NCT01026974|449123555|FG000|Overall Study|Inappropriate enrollment|0|||
124864141|NCT01026974|449123556|FG001|Overall Study|Inappropriate enrollment|0|||
124864142|NCT01026974|449123557|FG002|Overall Study|Inappropriate enrollment|1|||
124864143|NCT01026974|449123558|FG003|Overall Study|Inappropriate enrollment|0|||
124864144|NCT00325468|449123560|FG000|Overall Study|Adverse Event|1|||
124864145|NCT00325468|449123561|FG001|Overall Study|Adverse Event|1|||
124864146|NCT00325468|449123562|FG002|Overall Study|Adverse Event|0|||
124864147|NCT00325468|449123563|FG003|Overall Study|Adverse Event|5|||
124864148|NCT00325468|449123564|FG004|Overall Study|Adverse Event|1|||
124864149|NCT00325468|449123560|FG000|Overall Study|Death|2|||
124864150|NCT00325468|449123561|FG001|Overall Study|Death|0|||
124864151|NCT00325468|449123562|FG002|Overall Study|Death|2|||
124864152|NCT00325468|449123563|FG003|Overall Study|Death|4|||
124864153|NCT00325468|449123564|FG004|Overall Study|Death|0|||
124864154|NCT00325468|449123560|FG000|Overall Study|Lost to Follow-up|0|||
124864155|NCT00325468|449123561|FG001|Overall Study|Lost to Follow-up|0|||
124864156|NCT00325468|449123562|FG002|Overall Study|Lost to Follow-up|1|||
124864157|NCT00325468|449123563|FG003|Overall Study|Lost to Follow-up|2|||
124864158|NCT00325468|449123564|FG004|Overall Study|Lost to Follow-up|2|||
124864159|NCT00325468|449123560|FG000|Overall Study|Physician Decision|1|||
124864160|NCT00325468|449123561|FG001|Overall Study|Physician Decision|1|||
124864161|NCT00325468|449123562|FG002|Overall Study|Physician Decision|0|||
124864162|NCT00325468|449123563|FG003|Overall Study|Physician Decision|1|||
124864163|NCT00325468|449123564|FG004|Overall Study|Physician Decision|0|||
124864164|NCT00325468|449123560|FG000|Overall Study|Withdrawal by Subject|3|||
124864165|NCT00325468|449123561|FG001|Overall Study|Withdrawal by Subject|1|||
124864166|NCT00325468|449123562|FG002|Overall Study|Withdrawal by Subject|0|||
124864167|NCT00325468|449123563|FG003|Overall Study|Withdrawal by Subject|14|||
124864168|NCT00325468|449123564|FG004|Overall Study|Withdrawal by Subject|4|||
124864169|NCT00325468|449123560|FG000|Overall Study|site closure etc|4|||
124864170|NCT00325468|449123561|FG001|Overall Study|site closure etc|2|||
124864171|NCT00325468|449123562|FG002|Overall Study|site closure etc|1|||
124864172|NCT00325468|449123563|FG003|Overall Study|site closure etc|8|||
124864173|NCT00325468|449123564|FG004|Overall Study|site closure etc|1|||
124864174|NCT03280121|449123565|FG000|Overall Study|Physician Decision|1|||
124864175|NCT03280121|449123565|FG000|Overall Study|Lost to Follow-up|1|||
124864176|NCT03280121|449123565|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
124864177|NCT02701985|449123566|FG000|Overall Study|Withdrawal by Subject|1|||
124864178|NCT02701985|449123567|FG001|Overall Study|Withdrawal by Subject|1|||
124864179|NCT02701985|449123566|FG000|Overall Study|Lost to Follow-up|1|||
124864180|NCT02701985|449123567|FG001|Overall Study|Lost to Follow-up|0|||
124864181|NCT02701985|449123566|FG000|Overall Study|Death|1|||
124864182|NCT02701985|449123567|FG001|Overall Study|Death|0|||
124864183|NCT02701985|449123566|FG000|Overall Study|Adverse Event|0|||
124864184|NCT02701985|449123567|FG001|Overall Study|Adverse Event|5|||
124864185|NCT01640808|449123568|FG000|Overall Study|Unable to continue dynamic CT|14|||
124864186|NCT01640808|449123569|FG001|Overall Study|Unable to continue dynamic CT|4|||
124864187|NCT01640808|449123568|FG000|Overall Study|Withdrawal by Subject|12|||
124864188|NCT01640808|449123569|FG001|Overall Study|Withdrawal by Subject|4|||
124864189|NCT01640808|449123568|FG000|Overall Study|Lost to Follow-up|4|||
124864190|NCT01640808|449123569|FG001|Overall Study|Lost to Follow-up|0|||
124864191|NCT01640808|449123568|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
124864192|NCT01640808|449123569|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
124864193|NCT01640808|449123568|FG000|Overall Study|Administration of anticancer drugs|2|||
124864194|NCT01640808|449123569|FG001|Overall Study|Administration of anticancer drugs|1|||
124864195|NCT01640808|449123568|FG000|Overall Study|Physician Decision|19|||
124864196|NCT01640808|449123569|FG001|Overall Study|Physician Decision|5|||
124864197|NCT01640808|449123568|FG000|Overall Study|Randomized but not treated|4|||
124864198|NCT01640808|449123569|FG001|Overall Study|Randomized but not treated|2|||
124864199|NCT04391023|449123570|FG000|Overall Study|Withdrawal by Subject|2|||
124864200|NCT04391023|449123571|FG001|Overall Study|Withdrawal by Subject|2|||
124864201|NCT04009291|449123572|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
124864202|NCT04009291|449123573|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
124864203|NCT04009291|449123574|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
124864204|NCT04009291|449123575|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
124864205|NCT04009291|449123576|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
124864206|NCT04009291|449123572|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
124864207|NCT04009291|449123573|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
124864208|NCT04009291|449123574|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
124864209|NCT04009291|449123575|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
124864210|NCT04009291|449123576|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
124864211|NCT02189798|449123577|FG000|Extended Use Phase|Withdrawal by Subject|0|||
124864212|NCT02189798|449123578|FG001|Extended Use Phase|Withdrawal by Subject|4|||
124864213|NCT02189798|449123577|FG000|Extended Use Phase|Physician Decision|1|||
124864214|NCT02189798|449123578|FG001|Extended Use Phase|Physician Decision|0|||
124864215|NCT02189798|449123577|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
124864216|NCT02189798|449123578|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
124864217|NCT02189798|449123577|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
124864218|NCT02189798|449123578|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
124864219|NCT02189798|449123577|FG000|Extended Use Phase|Travel Issues|2|||
124864220|NCT02189798|449123578|FG001|Extended Use Phase|Travel Issues|1|||
124864221|NCT02189798|449123577|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
124864222|NCT02189798|449123578|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
124864223|NCT02834780|449123579|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
124864224|NCT02834780|449123580|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
124864225|NCT02834780|449123581|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
124864226|NCT02834780|449123582|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
124864227|NCT02834780|449123583|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
124864228|NCT02834780|449123584|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
124864229|NCT02834780|449123585|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
124864230|NCT02834780|449123586|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
124864231|NCT02834780|449123587|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
124864232|NCT02834780|449123588|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
124864233|NCT02834780|449123589|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
124864234|NCT02834780|449123590|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
124864235|NCT02834780|449123591|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
124864236|NCT02834780|449123579|FG000|Overall Study|Withdrawal by Subject|0|||
124864237|NCT02834780|449123580|FG001|Overall Study|Withdrawal by Subject|0|||
124864238|NCT02834780|449123581|FG002|Overall Study|Withdrawal by Subject|1|||
124864239|NCT02834780|449123582|FG003|Overall Study|Withdrawal by Subject|0|||
124864240|NCT02834780|449123583|FG004|Overall Study|Withdrawal by Subject|0|||
124864241|NCT02834780|449123584|FG005|Overall Study|Withdrawal by Subject|0|||
124864242|NCT02834780|449123585|FG006|Overall Study|Withdrawal by Subject|0|||
124864243|NCT02834780|449123586|FG007|Overall Study|Withdrawal by Subject|0|||
124864244|NCT02834780|449123587|FG008|Overall Study|Withdrawal by Subject|0|||
124864245|NCT02834780|449123588|FG009|Overall Study|Withdrawal by Subject|0|||
124864246|NCT02834780|449123589|FG010|Overall Study|Withdrawal by Subject|1|||
124864247|NCT02834780|449123590|FG011|Overall Study|Withdrawal by Subject|0|||
124864248|NCT02834780|449123591|FG012|Overall Study|Withdrawal by Subject|0|||
124864249|NCT02834780|449123579|FG000|Overall Study|Adverse Event|0|||
124864250|NCT02834780|449123580|FG001|Overall Study|Adverse Event|0|||
124864251|NCT02834780|449123581|FG002|Overall Study|Adverse Event|0|||
124864252|NCT02834780|449123582|FG003|Overall Study|Adverse Event|0|||
124864253|NCT02834780|449123583|FG004|Overall Study|Adverse Event|1|||
124864254|NCT02834780|449123584|FG005|Overall Study|Adverse Event|0|||
124864255|NCT02834780|449123585|FG006|Overall Study|Adverse Event|1|||
124864256|NCT02834780|449123586|FG007|Overall Study|Adverse Event|1|||
124864257|NCT02834780|449123587|FG008|Overall Study|Adverse Event|0|||
124864258|NCT02834780|449123588|FG009|Overall Study|Adverse Event|2|||
124864259|NCT02834780|449123589|FG010|Overall Study|Adverse Event|0|||
124864260|NCT02834780|449123590|FG011|Overall Study|Adverse Event|3|||
124864261|NCT02834780|449123591|FG012|Overall Study|Adverse Event|2|||
124864262|NCT02834780|449123579|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
124864263|NCT02834780|449123580|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
124864264|NCT02834780|449123581|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
124864265|NCT02834780|449123582|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
124864266|NCT02834780|449123583|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
124864267|NCT02834780|449123584|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
124864268|NCT02834780|449123585|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
124864269|NCT02834780|449123586|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
124864270|NCT02834780|449123587|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
124864271|NCT02834780|449123588|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
124864272|NCT02834780|449123589|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
124864273|NCT02834780|449123590|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
124864274|NCT02834780|449123591|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
124864275|NCT02834780|449123579|FG000|Overall Study|Other|1|||
124864276|NCT02834780|449123580|FG001|Overall Study|Other|0|||
124864277|NCT02834780|449123581|FG002|Overall Study|Other|1|||
124864278|NCT02834780|449123582|FG003|Overall Study|Other|2|||
124864279|NCT02834780|449123583|FG004|Overall Study|Other|0|||
124864280|NCT02834780|449123584|FG005|Overall Study|Other|0|||
124864281|NCT02834780|449123585|FG006|Overall Study|Other|0|||
124864282|NCT02834780|449123586|FG007|Overall Study|Other|0|||
124864283|NCT02834780|449123587|FG008|Overall Study|Other|0|||
124864284|NCT02834780|449123588|FG009|Overall Study|Other|0|||
124864285|NCT02834780|449123589|FG010|Overall Study|Other|0|||
124864286|NCT02834780|449123590|FG011|Overall Study|Other|0|||
124864287|NCT02834780|449123591|FG012|Overall Study|Other|1|||
124864288|NCT03449030|449123592|FG000|Overall Study|Withdrawal by Subject|0|||
124864289|NCT03449030|449123593|FG001|Overall Study|Withdrawal by Subject|0|||
124864290|NCT03449030|449123594|FG002|Overall Study|Withdrawal by Subject|0|||
124864291|NCT03449030|449123595|FG003|Overall Study|Withdrawal by Subject|1|||
124864292|NCT03449030|449123596|FG004|Overall Study|Withdrawal by Subject|1|||
124864293|NCT03449030|449123597|FG005|Overall Study|Withdrawal by Subject|1|||
124864294|NCT03449030|449123598|FG006|Overall Study|Withdrawal by Subject|1|||
124864295|NCT03449030|449123599|FG007|Overall Study|Withdrawal by Subject|2|||
124864296|NCT03449030|449123600|FG008|Overall Study|Withdrawal by Subject|0|||
124864297|NCT03449030|449123601|FG009|Overall Study|Withdrawal by Subject|0|||
124864298|NCT03449030|449123592|FG000|Overall Study|Symptomatic Deterioration|0|||
124864299|NCT03449030|449123593|FG001|Overall Study|Symptomatic Deterioration|1|||
124864300|NCT03449030|449123594|FG002|Overall Study|Symptomatic Deterioration|0|||
124864301|NCT03449030|449123595|FG003|Overall Study|Symptomatic Deterioration|0|||
124864302|NCT03449030|449123596|FG004|Overall Study|Symptomatic Deterioration|0|||
124864303|NCT03449030|449123597|FG005|Overall Study|Symptomatic Deterioration|1|||
124864304|NCT03449030|449123598|FG006|Overall Study|Symptomatic Deterioration|1|||
124864305|NCT03449030|449123599|FG007|Overall Study|Symptomatic Deterioration|0|||
124864306|NCT03449030|449123600|FG008|Overall Study|Symptomatic Deterioration|2|||
124864307|NCT03449030|449123601|FG009|Overall Study|Symptomatic Deterioration|0|||
124864308|NCT03449030|449123592|FG000|Overall Study|Progressive Disease|1|||
124864309|NCT03449030|449123593|FG001|Overall Study|Progressive Disease|0|||
124864310|NCT03449030|449123594|FG002|Overall Study|Progressive Disease|1|||
124864311|NCT03449030|449123595|FG003|Overall Study|Progressive Disease|4|||
124864312|NCT03449030|449123596|FG004|Overall Study|Progressive Disease|5|||
124864313|NCT03449030|449123597|FG005|Overall Study|Progressive Disease|3|||
124864314|NCT03449030|449123598|FG006|Overall Study|Progressive Disease|0|||
124864315|NCT03449030|449123599|FG007|Overall Study|Progressive Disease|1|||
124864316|NCT03449030|449123600|FG008|Overall Study|Progressive Disease|1|||
124864317|NCT03449030|449123601|FG009|Overall Study|Progressive Disease|1|||
124864318|NCT03449030|449123592|FG000|Overall Study|Adverse Event|0|||
124864319|NCT03449030|449123593|FG001|Overall Study|Adverse Event|0|||
124864320|NCT03449030|449123594|FG002|Overall Study|Adverse Event|0|||
124864321|NCT03449030|449123595|FG003|Overall Study|Adverse Event|0|||
124864322|NCT03449030|449123596|FG004|Overall Study|Adverse Event|0|||
124864323|NCT03449030|449123597|FG005|Overall Study|Adverse Event|2|||
124864324|NCT03449030|449123598|FG006|Overall Study|Adverse Event|0|||
124864325|NCT03449030|449123599|FG007|Overall Study|Adverse Event|0|||
124864326|NCT03449030|449123600|FG008|Overall Study|Adverse Event|0|||
124864327|NCT03449030|449123601|FG009|Overall Study|Adverse Event|0|||
124864328|NCT03449030|449123592|FG000|Overall Study|Death|0|||
124864329|NCT03449030|449123593|FG001|Overall Study|Death|0|||
124864330|NCT03449030|449123594|FG002|Overall Study|Death|0|||
124864331|NCT03449030|449123595|FG003|Overall Study|Death|0|||
124864332|NCT03449030|449123596|FG004|Overall Study|Death|1|||
124864333|NCT03449030|449123597|FG005|Overall Study|Death|0|||
124864334|NCT03449030|449123598|FG006|Overall Study|Death|0|||
124864335|NCT03449030|449123599|FG007|Overall Study|Death|0|||
124864336|NCT03449030|449123600|FG008|Overall Study|Death|0|||
124864337|NCT03449030|449123601|FG009|Overall Study|Death|0|||
124864338|NCT02415400|449123602|FG000|Overall Study|Adverse Event|0|||
124864339|NCT02415400|449123603|FG001|Overall Study|Adverse Event|1|||
124864340|NCT02415400|449123604|FG002|Overall Study|Adverse Event|1|||
124864341|NCT02415400|449123605|FG003|Overall Study|Adverse Event|2|||
124864342|NCT02415400|449123602|FG000|Overall Study|Participant request to stop therapy|4|||
124864343|NCT02415400|449123603|FG001|Overall Study|Participant request to stop therapy|3|||
124864344|NCT02415400|449123604|FG002|Overall Study|Participant request to stop therapy|8|||
124864345|NCT02415400|449123605|FG003|Overall Study|Participant request to stop therapy|6|||
124864346|NCT02415400|449123602|FG000|Overall Study|Participant withdrew consent|14|||
124864347|NCT02415400|449123603|FG001|Overall Study|Participant withdrew consent|12|||
124864348|NCT02415400|449123604|FG002|Overall Study|Participant withdrew consent|30|||
124864349|NCT02415400|449123605|FG003|Overall Study|Participant withdrew consent|21|||
124864350|NCT02415400|449123602|FG000|Overall Study|Death|39|||
124864351|NCT02415400|449123603|FG001|Overall Study|Death|41|||
124864352|NCT02415400|449123604|FG002|Overall Study|Death|35|||
124864353|NCT02415400|449123605|FG003|Overall Study|Death|42|||
124864354|NCT02415400|449123602|FG000|Overall Study|Lost to Follow-up|3|||
124864355|NCT02415400|449123603|FG001|Overall Study|Lost to Follow-up|3|||
124864356|NCT02415400|449123604|FG002|Overall Study|Lost to Follow-up|2|||
124864357|NCT02415400|449123605|FG003|Overall Study|Lost to Follow-up|5|||
124864358|NCT02415400|449123602|FG000|Overall Study|Poor/Non-Compliance|0|||
124864359|NCT02415400|449123603|FG001|Overall Study|Poor/Non-Compliance|1|||
124864360|NCT02415400|449123604|FG002|Overall Study|Poor/Non-Compliance|3|||
124864361|NCT02415400|449123605|FG003|Overall Study|Poor/Non-Compliance|4|||
124864362|NCT02415400|449123602|FG000|Overall Study|Participant no longer meets criteria|2|||
124864363|NCT02415400|449123603|FG001|Overall Study|Participant no longer meets criteria|0|||
124864364|NCT02415400|449123604|FG002|Overall Study|Participant no longer meets criteria|0|||
124864365|NCT02415400|449123605|FG003|Overall Study|Participant no longer meets criteria|1|||
124864366|NCT02415400|449123602|FG000|Overall Study|Participant doesn't answer phone|1|||
124864367|NCT02415400|449123603|FG001|Overall Study|Participant doesn't answer phone|0|||
124864368|NCT02415400|449123604|FG002|Overall Study|Participant doesn't answer phone|0|||
124864369|NCT02415400|449123605|FG003|Overall Study|Participant doesn't answer phone|0|||
124864370|NCT02415400|449123602|FG000|Overall Study|Participant wanted home visits|1|||
124864371|NCT02415400|449123603|FG001|Overall Study|Participant wanted home visits|0|||
124864372|NCT02415400|449123604|FG002|Overall Study|Participant wanted home visits|0|||
124864373|NCT02415400|449123605|FG003|Overall Study|Participant wanted home visits|0|||
124864374|NCT02415400|449123602|FG000|Overall Study|Randomized in error|2|||
124864375|NCT02415400|449123603|FG001|Overall Study|Randomized in error|0|||
124864376|NCT02415400|449123604|FG002|Overall Study|Randomized in error|0|||
124864377|NCT02415400|449123605|FG003|Overall Study|Randomized in error|0|||
124864378|NCT02415400|449123602|FG000|Overall Study|No study drug on site|0|||
124864379|NCT02415400|449123603|FG001|Overall Study|No study drug on site|1|||
124864380|NCT02415400|449123604|FG002|Overall Study|No study drug on site|0|||
124864381|NCT02415400|449123605|FG003|Overall Study|No study drug on site|0|||
124864382|NCT02415400|449123602|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
124864383|NCT02415400|449123603|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
124864384|NCT02415400|449123604|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
124864385|NCT02415400|449123605|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
124864386|NCT02415400|449123602|FG000|Overall Study|Coagulation values cannot be set|0|||
124864387|NCT02415400|449123603|FG001|Overall Study|Coagulation values cannot be set|0|||
124864388|NCT02415400|449123604|FG002|Overall Study|Coagulation values cannot be set|1|||
124864389|NCT02415400|449123605|FG003|Overall Study|Coagulation values cannot be set|0|||
124864390|NCT02415400|449123602|FG000|Overall Study|State regulations prevent participation|0|||
124864391|NCT02415400|449123603|FG001|Overall Study|State regulations prevent participation|0|||
124864392|NCT02415400|449123604|FG002|Overall Study|State regulations prevent participation|1|||
124864393|NCT02415400|449123605|FG003|Overall Study|State regulations prevent participation|0|||
124864394|NCT02415400|449123602|FG000|Overall Study|Poor treatment monitoring|0|||
124864395|NCT02415400|449123603|FG001|Overall Study|Poor treatment monitoring|0|||
124864396|NCT02415400|449123604|FG002|Overall Study|Poor treatment monitoring|1|||
124864397|NCT02415400|449123605|FG003|Overall Study|Poor treatment monitoring|0|||
124864398|NCT02415400|449123602|FG000|Overall Study|Participant in jail|0|||
124864399|NCT02415400|449123603|FG001|Overall Study|Participant in jail|0|||
124864400|NCT02415400|449123604|FG002|Overall Study|Participant in jail|1|||
124864401|NCT02415400|449123605|FG003|Overall Study|Participant in jail|0|||
124864402|NCT02415400|449123602|FG000|Overall Study|Investigator decision|0|||
124864403|NCT02415400|449123603|FG001|Overall Study|Investigator decision|0|||
124864404|NCT02415400|449123604|FG002|Overall Study|Investigator decision|1|||
124864405|NCT02415400|449123605|FG003|Overall Study|Investigator decision|1|||
124864406|NCT02415400|449123602|FG000|Overall Study|Site closure; participant won't transfer|0|||
124864407|NCT02415400|449123603|FG001|Overall Study|Site closure; participant won't transfer|0|||
124864408|NCT02415400|449123604|FG002|Overall Study|Site closure; participant won't transfer|0|||
124864409|NCT02415400|449123605|FG003|Overall Study|Site closure; participant won't transfer|1|||
124864410|NCT02270450|449123606|FG000|Overall Study|Refusal unrelated to adverse event|3|||
124864411|NCT02270450|449123607|FG001|Overall Study|Refusal unrelated to adverse event|1|||
124864412|NCT02270450|449123608|FG002|Overall Study|Refusal unrelated to adverse event|5|||
124864413|NCT02270450|449123609|FG003|Overall Study|Refusal unrelated to adverse event|14|||
124864414|NCT02270450|449123606|FG000|Overall Study|Progression/relapse|1|||
124864415|NCT02270450|449123607|FG001|Overall Study|Progression/relapse|2|||
124864416|NCT02270450|449123608|FG002|Overall Study|Progression/relapse|4|||
124864417|NCT02270450|449123609|FG003|Overall Study|Progression/relapse|9|||
124864418|NCT02270450|449123606|FG000|Overall Study|Death|19|||
124864419|NCT02270450|449123607|FG001|Overall Study|Death|19|||
124864420|NCT02270450|449123608|FG002|Overall Study|Death|31|||
124864421|NCT02270450|449123609|FG003|Overall Study|Death|59|||
124864422|NCT02363738|449123610|FG000|Overall Study|Adverse Event|5|||
124864423|NCT02363738|449123611|FG001|Overall Study|Adverse Event|2|||
124864424|NCT02363738|449123610|FG000|Overall Study|Lack of Efficacy|1|||
124864425|NCT02363738|449123611|FG001|Overall Study|Lack of Efficacy|2|||
124864426|NCT02363738|449123610|FG000|Overall Study|Lost to Follow-up|2|||
124864427|NCT02363738|449123611|FG001|Overall Study|Lost to Follow-up|1|||
124864428|NCT03282227|449123614|FG000|Overall Study|Exposure Goals Achieved|60|||
124864429|NCT03282227|449123614|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
124864430|NCT03282227|449123614|FG000|Overall Study|Adverse Event|15|||
124864431|NCT03282227|449123614|FG000|Overall Study|Lost to Follow-up|21|||
124864432|NCT03282227|449123614|FG000|Overall Study|Withdrawal by Subject|20|||
124864433|NCT03282227|449123614|FG000|Overall Study|Lack of Efficacy|12|||
124864434|NCT03282227|449123614|FG000|Overall Study|Sponsor decision|3|||
124864435|NCT03282227|449123614|FG000|Overall Study|Physician Decision|2|||
124864436|NCT03282227|449123614|FG000|Overall Study|Pregnancy|2|||
124864437|NCT03282227|449123614|FG000|Overall Study|Other|1|||
124864438|NCT04330638|449123615|FG000|Overall Study|Adverse Event|9|||
124864439|NCT04330638|449123616|FG001|Overall Study|Adverse Event|10|||
124864440|NCT04330638|449123617|FG002|Overall Study|Adverse Event|15|||
124864441|NCT04330638|449123618|FG003|Overall Study|Adverse Event|6|||
124864442|NCT04330638|449123619|FG004|Overall Study|Adverse Event|10|||
124864443|NCT04330638|449123620|FG005|Overall Study|Adverse Event|5|||
124864444|NCT04330638|449123615|FG000|Overall Study|Other|2|||
124864445|NCT04330638|449123616|FG001|Overall Study|Other|2|||
124864446|NCT04330638|449123617|FG002|Overall Study|Other|5|||
124864447|NCT04330638|449123618|FG003|Overall Study|Other|1|||
124864448|NCT04330638|449123619|FG004|Overall Study|Other|3|||
124864449|NCT04330638|449123620|FG005|Overall Study|Other|2|||
124864450|NCT04330638|449123615|FG000|Overall Study|Withdrawal by Subject|4|||
124864451|NCT04330638|449123616|FG001|Overall Study|Withdrawal by Subject|0|||
124864452|NCT04330638|449123617|FG002|Overall Study|Withdrawal by Subject|0|||
124864453|NCT04330638|449123618|FG003|Overall Study|Withdrawal by Subject|0|||
124864454|NCT04330638|449123619|FG004|Overall Study|Withdrawal by Subject|0|||
124864455|NCT04330638|449123620|FG005|Overall Study|Withdrawal by Subject|0|||
124864456|NCT04330638|449123615|FG000|Overall Study|Lost to Follow-up|3|||
124864457|NCT04330638|449123616|FG001|Overall Study|Lost to Follow-up|2|||
124864458|NCT04330638|449123617|FG002|Overall Study|Lost to Follow-up|3|||
124864459|NCT04330638|449123618|FG003|Overall Study|Lost to Follow-up|2|||
124864460|NCT04330638|449123619|FG004|Overall Study|Lost to Follow-up|3|||
124864461|NCT04330638|449123620|FG005|Overall Study|Lost to Follow-up|0|||
124864462|NCT00989287|449123623|FG000|Overall Study|Adverse Event|1|||
124864463|NCT00989287|449123624|FG001|Overall Study|Adverse Event|0|||
124864464|NCT00989287|449123623|FG000|Overall Study|Lost to Follow-up|0|||
124864465|NCT00989287|449123624|FG001|Overall Study|Lost to Follow-up|1|||
124864466|NCT03743038|449123625|FG000|Overall Study|Physician Decision|1|||
124864467|NCT01300546|449123626|FG000|Overall Study|Withdrawal by Subject|1|||
124864468|NCT01300546|449123627|FG001|Overall Study|Withdrawal by Subject|0|||
124864469|NCT01300546|449123626|FG000|Overall Study|Lost to Follow-up|0|||
124864470|NCT01300546|449123627|FG001|Overall Study|Lost to Follow-up|2|||
124864471|NCT01300546|449123626|FG000|Overall Study|Lack of Efficacy|0|||
124864472|NCT01300546|449123627|FG001|Overall Study|Lack of Efficacy|3|||
124864473|NCT01300546|449123626|FG000|Overall Study|Adverse Event|0|||
124864474|NCT01300546|449123627|FG001|Overall Study|Adverse Event|1|||
124864475|NCT02820623|449123628|FG000|Overall Study|Withdrawal by Subject|1|||
124864476|NCT02820623|449123629|FG001|Overall Study|Withdrawal by Subject|3|||
124864477|NCT02820623|449123630|FG002|Overall Study|Withdrawal by Subject|3|||
124864478|NCT02820623|449123628|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
124864479|NCT02820623|449123629|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
124864480|NCT02820623|449123630|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
124864481|NCT02820623|449123628|FG000|Overall Study|Therapist unable to enroll clients|1|||
124864482|NCT02820623|449123629|FG001|Overall Study|Therapist unable to enroll clients|1|||
124864483|NCT02820623|449123630|FG002|Overall Study|Therapist unable to enroll clients|3|||
124864484|NCT02820623|449123628|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
124864485|NCT02820623|449123629|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
124864486|NCT02820623|449123630|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
124864487|NCT00617344|449123632|FG000|Overall Study|Serious adverse event|1|||
124864488|NCT00617344|449123633|FG001|Overall Study|Serious adverse event|0|||
124864489|NCT00617344|449123634|FG002|Overall Study|Serious adverse event|0|||
124864490|NCT00617344|449123632|FG000|Overall Study|Other Adverse Event|1|||
124864491|NCT00617344|449123633|FG001|Overall Study|Other Adverse Event|1|||
124864492|NCT00617344|449123634|FG002|Overall Study|Other Adverse Event|0|||
124864493|NCT00617344|449123632|FG000|Overall Study|Protocol Violation|10|||
124864494|NCT00617344|449123633|FG001|Overall Study|Protocol Violation|8|||
124864495|NCT00617344|449123634|FG002|Overall Study|Protocol Violation|5|||
124864496|NCT00617344|449123632|FG000|Overall Study|Lost to Follow-up|5|||
124864497|NCT00617344|449123633|FG001|Overall Study|Lost to Follow-up|4|||
124864498|NCT00617344|449123634|FG002|Overall Study|Lost to Follow-up|1|||
124864499|NCT00617344|449123632|FG000|Overall Study|Withdrawal by Subject|8|||
124864500|NCT00617344|449123633|FG001|Overall Study|Withdrawal by Subject|9|||
124864501|NCT00617344|449123634|FG002|Overall Study|Withdrawal by Subject|2|||
124864502|NCT01864564|449123639|FG000|Overall Study|Lost to Follow-up|17|||
124864503|NCT01864564|449123640|FG001|Overall Study|Lost to Follow-up|23|||
124864504|NCT01864564|449123639|FG000|Overall Study|Withdrawal by Subject|20|||
124864505|NCT01864564|449123640|FG001|Overall Study|Withdrawal by Subject|11|||
124864506|NCT01864564|449123639|FG000|Overall Study|Protocol Violation|0|||
124864507|NCT01864564|449123640|FG001|Overall Study|Protocol Violation|27|||
124864508|NCT01864564|449123639|FG000|Overall Study|not reported|0|||
124864509|NCT01864564|449123640|FG001|Overall Study|not reported|34|||
124864510|NCT02269670|449123641|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
124864511|NCT00941330|449123642|FG000|Overall Study|Other|1|||
124864512|NCT00941330|449123643|FG001|Overall Study|Other|0|||
124864513|NCT00941330|449123642|FG000|Overall Study|Physician Decision|0|||
124864514|NCT00941330|449123643|FG001|Overall Study|Physician Decision|2|||
124864515|NCT02693665|449123644|FG000|Overall Study|Death|3|||
124864516|NCT02693665|449123645|FG001|Overall Study|Death|2|||
124864517|NCT02693665|449123644|FG000|Overall Study|Lost to Follow-up|7|||
124864518|NCT02693665|449123645|FG001|Overall Study|Lost to Follow-up|3|||
124864519|NCT02693665|449123644|FG000|Overall Study|Protocol Violation|1|||
124864520|NCT02693665|449123645|FG001|Overall Study|Protocol Violation|0|||
124864521|NCT02693665|449123644|FG000|Overall Study|Withdrawal by Subject|2|||
124864522|NCT02693665|449123645|FG001|Overall Study|Withdrawal by Subject|0|||
124864523|NCT02693665|449123644|FG000|Overall Study|patient wanted to leave it behind|1|||
124864524|NCT02693665|449123645|FG001|Overall Study|patient wanted to leave it behind|0|||
124864525|NCT02693665|449123644|FG000|Overall Study|anxiety|1|||
124864526|NCT02693665|449123645|FG001|Overall Study|anxiety|0|||
124864527|NCT02693665|449123644|FG000|Overall Study|family issues|1|||
124864528|NCT02693665|449123645|FG001|Overall Study|family issues|0|||
124864529|NCT02693665|449123644|FG000|Overall Study|no reason given|1|||
124864530|NCT02693665|449123645|FG001|Overall Study|no reason given|0|||
124864531|NCT00655980|449123647|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
124864532|NCT00655980|449123648|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
124864533|NCT00655980|449123649|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
124864534|NCT04439110|449123650|FG000|Overall Study|Ineligible|2|||
124864535|NCT04439110|449123650|FG000|Overall Study|Adverse Event|4|||
124864536|NCT04439110|449123650|FG000|Overall Study|Death|2|||
124864537|NCT04439110|449123650|FG000|Overall Study|Disease proression|25|||
124864538|NCT04439110|449123650|FG000|Overall Study|Withdrawal by Subject|1|||
124864539|NCT04439110|449123650|FG000|Overall Study|Alternative therapy|1|||
124864540|NCT04439110|449123650|FG000|Overall Study|Other complicating disease|1|||
124864541|NCT04439110|449123650|FG000|Overall Study|Personal reasons|1|||
124864542|NCT04439110|449123650|FG000|Overall Study|Still on treatment|1|||
124864543|NCT00127608|449123653|FG000|Overall Study|VZV DNA negative|1|||
124864544|NCT05245864|449123654|FG000|Overall Study|Withdrawal by Subject|1|||
124864545|NCT05245864|449123655|FG001|Overall Study|Withdrawal by Subject|1|||
124864546|NCT02811861|449125619|FG000|Overall Study|Radiological Disease Progression|123|||
124864547|NCT02811861|449125620|FG001|Overall Study|Radiological Disease Progression|97|||
124864548|NCT02811861|449125621|FG002|Overall Study|Radiological Disease Progression|174|||
124864549|NCT02811861|449125619|FG000|Overall Study|Clinical Disease Progression|20|||
124864550|NCT02811861|449125620|FG001|Overall Study|Clinical Disease Progression|19|||
124864551|NCT02811861|449125621|FG002|Overall Study|Clinical Disease Progression|22|||
124864552|NCT02811861|449125619|FG000|Overall Study|Adverse Event|63|||
124864553|NCT02811861|449125620|FG001|Overall Study|Adverse Event|60|||
124864554|NCT02811861|449125621|FG002|Overall Study|Adverse Event|41|||
124864555|NCT02811861|449125619|FG000|Overall Study|Lost to Follow-up|0|||
124864556|NCT02811861|449125620|FG001|Overall Study|Lost to Follow-up|0|||
124864557|NCT02811861|449125621|FG002|Overall Study|Lost to Follow-up|1|||
124864558|NCT02811861|449125619|FG000|Overall Study|Subject Choice|29|||
124864559|NCT02811861|449125620|FG001|Overall Study|Subject Choice|17|||
124864560|NCT02811861|449125621|FG002|Overall Study|Subject Choice|23|||
124864561|NCT02811861|449125619|FG000|Overall Study|Withdrawal by Subject|4|||
124864562|NCT02811861|449125620|FG001|Overall Study|Withdrawal by Subject|4|||
124864563|NCT02811861|449125621|FG002|Overall Study|Withdrawal by Subject|9|||
124864564|NCT02811861|449125619|FG000|Overall Study|Other|4|||
124864565|NCT02811861|449125620|FG001|Overall Study|Other|13|||
124864566|NCT02811861|449125621|FG002|Overall Study|Other|3|||
124864567|NCT02811861|449125619|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
124864568|NCT02811861|449125620|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
124864569|NCT02811861|449125621|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
124864570|NCT02811861|449125619|FG000|Overall Study|Randomized but not treated|2|||
124864571|NCT02811861|449125620|FG001|Overall Study|Randomized but not treated|3|||
124864572|NCT02811861|449125621|FG002|Overall Study|Randomized but not treated|17|||
124864573|NCT02925455|449125622|FG000|Overall Study|Withdrawal by Subject|2|||
124864574|NCT02925455|449125623|FG001|Overall Study|Withdrawal by Subject|0|||
124864575|NCT03912259|449125626|FG000|Overall Study|Adverse Event (AE)|2|||
124864576|NCT03912259|449125627|FG001|Overall Study|Adverse Event (AE)|4|||
124864577|NCT03912259|449125626|FG000|Overall Study|Lack of Efficacy|4|||
124864578|NCT03912259|449125627|FG001|Overall Study|Lack of Efficacy|1|||
124864579|NCT03912259|449125626|FG000|Overall Study|Withdrawal by Subject|11|||
124864580|NCT03912259|449125627|FG001|Overall Study|Withdrawal by Subject|1|||
124864581|NCT01549613|449125628|FG000|Overall Study|Lost to Follow-up|11|||
124864582|NCT01549613|449125629|FG001|Overall Study|Lost to Follow-up|11|||
124864583|NCT02216123|449125630|FG000|Overall Study|Lost to Follow-up|4|||
124864584|NCT02216123|449125631|FG001|Overall Study|Lost to Follow-up|2|||
124864585|NCT02216123|449125630|FG000|Overall Study|Withdrawal by Subject|2|||
124864586|NCT02216123|449125631|FG001|Overall Study|Withdrawal by Subject|0|||
124864587|NCT03162224|449125634|FG000|Overall Study|Death|4|||
124864588|NCT03162224|449125635|FG001|Overall Study|Death|5|||
124864589|NCT03162224|449125636|FG002|Overall Study|Death|8|||
124864590|NCT03162224|449125634|FG000|Overall Study|Withdrawal by Subject|1|||
124864591|NCT03162224|449125635|FG001|Overall Study|Withdrawal by Subject|0|||
124864592|NCT03162224|449125636|FG002|Overall Study|Withdrawal by Subject|1|||
124864593|NCT03162224|449125634|FG000|Overall Study|Lost to Follow-up|0|||
124864594|NCT03162224|449125635|FG001|Overall Study|Lost to Follow-up|1|||
124864595|NCT03162224|449125636|FG002|Overall Study|Lost to Follow-up|0|||
124864596|NCT03162224|449125634|FG000|Overall Study|Other|6|||
124864597|NCT03162224|449125635|FG001|Overall Study|Other|2|||
124864598|NCT03162224|449125636|FG002|Overall Study|Other|1|||
124864599|NCT04066114|449125637|FG000|Overall Study|Adverse Event|1|||
124864600|NCT04066114|449125638|FG001|Overall Study|Adverse Event|0|||
124864601|NCT04066114|449125639|FG002|Overall Study|Adverse Event|0|||
124864602|NCT04066114|449125637|FG000|Overall Study|Withdrawal by Subject|1|||
124864603|NCT04066114|449125638|FG001|Overall Study|Withdrawal by Subject|0|||
124864604|NCT04066114|449125639|FG002|Overall Study|Withdrawal by Subject|0|||
124864605|NCT04066114|449125637|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
124864606|NCT04066114|449125638|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
124864607|NCT04066114|449125639|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
124864608|NCT00254982|449125640|FG000|Overall Study|Other|2|||
124864609|NCT00254982|449125641|FG001|Overall Study|Other|1|||
124864610|NCT00254982|449125640|FG000|Overall Study|Lack of Efficacy|5|||
124864611|NCT00254982|449125641|FG001|Overall Study|Lack of Efficacy|3|||
124864612|NCT00254982|449125640|FG000|Overall Study|Lost to Follow-up|5|||
124864613|NCT00254982|449125641|FG001|Overall Study|Lost to Follow-up|3|||
124864614|NCT00254982|449125640|FG000|Overall Study|Adverse Event|18|||
124864615|NCT00254982|449125641|FG001|Overall Study|Adverse Event|16|||
124864616|NCT00254982|449125640|FG000|Overall Study|Withdrawal by Subject|1|||
124864617|NCT00254982|449125641|FG001|Overall Study|Withdrawal by Subject|1|||
124864618|NCT00254982|449125640|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
124864619|NCT00254982|449125641|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
124864620|NCT00254982|449125640|FG000|Overall Study|Protocol deviation|1|||
124864621|NCT00254982|449125641|FG001|Overall Study|Protocol deviation|1|||
124864622|NCT00254982|449125640|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
124864623|NCT00254982|449125641|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
124864624|NCT00254982|449125640|FG000|Overall Study|Malignancy|0|||
124864625|NCT00254982|449125641|FG001|Overall Study|Malignancy|2|||
124864626|NCT00254982|449125640|FG000|Overall Study|Opportunistic infection|1|||
124864627|NCT00254982|449125641|FG001|Overall Study|Opportunistic infection|0|||
124864628|NCT00254982|449125640|FG000|Overall Study|Abnormal liver function tests|2|||
124864629|NCT00254982|449125641|FG001|Overall Study|Abnormal liver function tests|1|||
124864630|NCT03117738|449125644|FG000|Overall Study|Withdrawal by Subject|3|||
124864631|NCT03117738|449125645|FG001|Overall Study|Withdrawal by Subject|1|||
124864632|NCT03117738|449125644|FG000|Overall Study|Lost to Follow-up|1|||
124864633|NCT03117738|449125645|FG001|Overall Study|Lost to Follow-up|4|||
124864634|NCT04004611|449125646|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
124864635|NCT04004611|449125647|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
124864636|NCT04004611|449125648|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
124864637|NCT04004611|449125649|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
124864638|NCT04004611|449125650|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
124864639|NCT04004611|449125651|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
124864640|NCT04004611|449125652|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
124864641|NCT04004611|449125653|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
124864642|NCT04004611|449125654|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
124864643|NCT04004611|449125646|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
124864644|NCT04004611|449125647|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
124864645|NCT04004611|449125648|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
124864646|NCT04004611|449125649|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
124864647|NCT04004611|449125650|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
124864648|NCT04004611|449125651|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
124864649|NCT04004611|449125652|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
124864650|NCT04004611|449125653|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
124864651|NCT04004611|449125654|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
124864652|NCT04004611|449125646|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
124864653|NCT04004611|449125647|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
124864654|NCT04004611|449125648|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
124864655|NCT04004611|449125649|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
124864656|NCT04004611|449125650|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
124864657|NCT04004611|449125651|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
124864658|NCT04004611|449125652|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
124864659|NCT04004611|449125653|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
124864660|NCT04004611|449125654|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
124864661|NCT04004611|449125646|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
124864662|NCT04004611|449125647|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
124864663|NCT04004611|449125648|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
124864664|NCT04004611|449125649|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
124864665|NCT04004611|449125650|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
124864666|NCT04004611|449125651|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
124864667|NCT04004611|449125652|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
124864668|NCT04004611|449125653|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
124864669|NCT04004611|449125654|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
124864670|NCT04004611|449125646|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
124864671|NCT04004611|449125647|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
124864672|NCT04004611|449125648|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
124864673|NCT04004611|449125649|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
124864674|NCT04004611|449125650|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
124864675|NCT04004611|449125651|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
124864676|NCT04004611|449125652|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
124864677|NCT04004611|449125653|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
124864678|NCT04004611|449125654|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
124864679|NCT04004611|449125646|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
124864680|NCT04004611|449125647|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
124864681|NCT04004611|449125648|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
124864682|NCT04004611|449125649|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
124864683|NCT04004611|449125650|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
124864684|NCT04004611|449125651|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
124864685|NCT04004611|449125652|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
124864686|NCT04004611|449125653|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
124864687|NCT04004611|449125654|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
124864688|NCT04420689|449125655|FG000|Overall Study|COVID-19 related hospitalization|0|||
124864689|NCT04420689|449125656|FG001|Overall Study|COVID-19 related hospitalization|0|||
124864690|NCT04420689|449125657|FG002|Overall Study|COVID-19 related hospitalization|0|||
124864691|NCT04420689|449125658|FG003|Overall Study|COVID-19 related hospitalization|0|||
124864692|NCT04420689|449125659|FG004|Overall Study|COVID-19 related hospitalization|1|||
124864693|NCT04420689|449125660|FG005|Overall Study|COVID-19 related hospitalization|0|||
124864694|NCT04420689|449125661|FG006|Overall Study|COVID-19 related hospitalization|0|||
124864695|NCT04420689|449125655|FG000|Overall Study|Physician Decision|0|||
124864696|NCT04420689|449125656|FG001|Overall Study|Physician Decision|0|||
124864697|NCT04420689|449125657|FG002|Overall Study|Physician Decision|0|||
124864698|NCT04420689|449125658|FG003|Overall Study|Physician Decision|0|||
124864699|NCT04420689|449125659|FG004|Overall Study|Physician Decision|0|||
124864700|NCT04420689|449125660|FG005|Overall Study|Physician Decision|1|||
124864701|NCT04420689|449125661|FG006|Overall Study|Physician Decision|0|||
124864702|NCT00515502|449125662|FG000|Treatment Period 1|Adverse Event|0|||
124864703|NCT00515502|449125663|FG001|Treatment Period 1|Adverse Event|0|||
124864704|NCT00515502|449125664|FG002|Treatment Period 1|Adverse Event|0|||
124864705|NCT00515502|449125665|FG003|Treatment Period 1|Adverse Event|0|||
124864706|NCT00515502|449125666|FG004|Treatment Period 1|Adverse Event|0|||
124864707|NCT00515502|449125667|FG005|Treatment Period 1|Adverse Event|0|||
124864708|NCT00515502|449125668|FG006|Treatment Period 1|Adverse Event|1|||
124864709|NCT00515502|449125669|FG007|Treatment Period 1|Adverse Event|0|||
124864710|NCT00515502|449125670|FG008|Treatment Period 1|Adverse Event|1|||
124864711|NCT00515502|449125671|FG009|Treatment Period 1|Adverse Event|0|||
124864712|NCT00515502|449125672|FG010|Treatment Period 1|Adverse Event|0|||
124864713|NCT00515502|449125673|FG011|Treatment Period 1|Adverse Event|1|||
124864714|NCT00515502|449125662|FG000|Treatment Period 2|Adverse Event|0|||
124864715|NCT00515502|449125663|FG001|Treatment Period 2|Adverse Event|1|||
124864716|NCT00515502|449125664|FG002|Treatment Period 2|Adverse Event|0|||
124864717|NCT00515502|449125665|FG003|Treatment Period 2|Adverse Event|0|||
124864718|NCT00515502|449125666|FG004|Treatment Period 2|Adverse Event|0|||
124864719|NCT00515502|449125667|FG005|Treatment Period 2|Adverse Event|0|||
124864720|NCT00515502|449125668|FG006|Treatment Period 2|Adverse Event|0|||
124864721|NCT00515502|449125669|FG007|Treatment Period 2|Adverse Event|0|||
124864722|NCT00515502|449125670|FG008|Treatment Period 2|Adverse Event|0|||
124864723|NCT00515502|449125671|FG009|Treatment Period 2|Adverse Event|0|||
124864724|NCT00515502|449125672|FG010|Treatment Period 2|Adverse Event|0|||
124864725|NCT00515502|449125673|FG011|Treatment Period 2|Adverse Event|0|||
124864726|NCT02732938|449125677|FG000|Overall Study|Death|0|||
124864727|NCT02732938|449125678|FG001|Overall Study|Death|11|||
124864728|NCT02732938|449125679|FG002|Overall Study|Death|0|||
124864729|NCT02732938|449125677|FG000|Overall Study|Randomized but did not receive treatment|0|||
124864730|NCT02732938|449125678|FG001|Overall Study|Randomized but did not receive treatment|1|||
124864731|NCT02732938|449125679|FG002|Overall Study|Randomized but did not receive treatment|0|||
124864732|NCT02732938|449125677|FG000|Overall Study|Refused further follow-up|1|||
124864733|NCT02732938|449125678|FG001|Overall Study|Refused further follow-up|0|||
124864734|NCT02732938|449125679|FG002|Overall Study|Refused further follow-up|0|||
124864735|NCT02732938|449125677|FG000|Overall Study|Study terminated by sponsor|3|||
124864736|NCT02732938|449125678|FG001|Overall Study|Study terminated by sponsor|6|||
124864737|NCT02732938|449125679|FG002|Overall Study|Study terminated by sponsor|0|||
124864738|NCT03927950|449125680|FG000|Overall Study|Adverse Event|9|||
124864739|NCT03647501|449125681|FG000|Overall Study|Lost to Follow-up|1|||
124864740|NCT03647501|449125682|FG001|Overall Study|Lost to Follow-up|1|||
124864741|NCT03647501|449125681|FG000|Overall Study|Withdrawal by Subject|0|||
124864742|NCT03647501|449125682|FG001|Overall Study|Withdrawal by Subject|1|||
124864743|NCT04530448|449125683|FG000|Overall Study|Physician Decision|3|||
124864744|NCT04530448|449125684|FG001|Overall Study|Physician Decision|0|||
124864745|NCT01613248|449125685|FG000|Overall Study|Adverse Event|0|||
124864746|NCT01613248|449125686|FG001|Overall Study|Adverse Event|0|||
124864747|NCT01613248|449125687|FG002|Overall Study|Adverse Event|0|||
124864748|NCT01613248|449125688|FG003|Overall Study|Adverse Event|1|||
124864749|NCT01613248|449125689|FG004|Overall Study|Adverse Event|0|||
124864750|NCT01613248|449125690|FG005|Overall Study|Adverse Event|0|||
124864751|NCT01613248|449125685|FG000|Overall Study|Withdrawal by Subject|3|||
124864752|NCT01613248|449125686|FG001|Overall Study|Withdrawal by Subject|2|||
124864753|NCT01613248|449125687|FG002|Overall Study|Withdrawal by Subject|2|||
124864754|NCT01613248|449125688|FG003|Overall Study|Withdrawal by Subject|5|||
124864755|NCT01613248|449125689|FG004|Overall Study|Withdrawal by Subject|0|||
124864756|NCT01613248|449125690|FG005|Overall Study|Withdrawal by Subject|1|||
124864757|NCT01613248|449125685|FG000|Overall Study|Lost to Follow-up|5|||
124864758|NCT01613248|449125686|FG001|Overall Study|Lost to Follow-up|7|||
124864759|NCT01613248|449125687|FG002|Overall Study|Lost to Follow-up|4|||
124864760|NCT01613248|449125688|FG003|Overall Study|Lost to Follow-up|8|||
124864761|NCT01613248|449125689|FG004|Overall Study|Lost to Follow-up|4|||
124864762|NCT01613248|449125690|FG005|Overall Study|Lost to Follow-up|2|||
124864763|NCT01613248|449125685|FG000|Overall Study|Study Terminated by Sponsor|4|||
124864764|NCT01613248|449125686|FG001|Overall Study|Study Terminated by Sponsor|6|||
124864765|NCT01613248|449125687|FG002|Overall Study|Study Terminated by Sponsor|8|||
124864766|NCT01613248|449125688|FG003|Overall Study|Study Terminated by Sponsor|8|||
124864767|NCT01613248|449125689|FG004|Overall Study|Study Terminated by Sponsor|9|||
124864768|NCT01613248|449125690|FG005|Overall Study|Study Terminated by Sponsor|11|||
124864769|NCT01613248|449125685|FG000|Overall Study|Physician Decision|8|||
124864770|NCT01613248|449125686|FG001|Overall Study|Physician Decision|8|||
124864771|NCT01613248|449125687|FG002|Overall Study|Physician Decision|9|||
124864772|NCT01613248|449125688|FG003|Overall Study|Physician Decision|4|||
124864773|NCT01613248|449125689|FG004|Overall Study|Physician Decision|7|||
124864774|NCT01613248|449125690|FG005|Overall Study|Physician Decision|6|||
124864775|NCT01613248|449125685|FG000|Overall Study|Lack of Qualifying Event|9|||
124864776|NCT01613248|449125686|FG001|Overall Study|Lack of Qualifying Event|11|||
124864777|NCT01613248|449125687|FG002|Overall Study|Lack of Qualifying Event|10|||
124864778|NCT01613248|449125688|FG003|Overall Study|Lack of Qualifying Event|11|||
124864779|NCT01613248|449125689|FG004|Overall Study|Lack of Qualifying Event|15|||
124864780|NCT01613248|449125690|FG005|Overall Study|Lack of Qualifying Event|18|||
124864781|NCT01613248|449125685|FG000|Overall Study|Pregnancy|0|||
124864782|NCT01613248|449125686|FG001|Overall Study|Pregnancy|0|||
124864783|NCT01613248|449125687|FG002|Overall Study|Pregnancy|0|||
124864784|NCT01613248|449125688|FG003|Overall Study|Pregnancy|1|||
124864785|NCT01613248|449125689|FG004|Overall Study|Pregnancy|0|||
124864786|NCT01613248|449125690|FG005|Overall Study|Pregnancy|0|||
124864787|NCT01433354|449125692|FG000|Overall Study|Adverse Event|6|||
124864788|NCT01433354|449125692|FG000|Overall Study|Lost to Follow-up|1|||
124864789|NCT01433354|449125692|FG000|Overall Study|Administrative problems|90|||
124864790|NCT01433354|449125692|FG000|Overall Study|Protocol Violation|2|||
124864791|NCT01433354|449125692|FG000|Overall Study|Lack of Efficacy|17|||
124864792|NCT01433354|449125692|FG000|Overall Study|Subject Withdrew Consent|3|||
124864793|NCT02015676|449125699|FG000|Overall Study|Adverse Event|2|||
124864794|NCT02015676|449125700|FG001|Overall Study|Adverse Event|18|||
124864795|NCT02015676|449125701|FG002|Overall Study|Adverse Event|0|||
124864796|NCT02015676|449125699|FG000|Overall Study|Lack of Efficacy|2|||
124864797|NCT02015676|449125700|FG001|Overall Study|Lack of Efficacy|4|||
124864798|NCT02015676|449125701|FG002|Overall Study|Lack of Efficacy|0|||
124864799|NCT02015676|449125699|FG000|Overall Study|Protocol Violation|1|||
124864800|NCT02015676|449125700|FG001|Overall Study|Protocol Violation|0|||
124864801|NCT02015676|449125701|FG002|Overall Study|Protocol Violation|0|||
124864802|NCT02015676|449125699|FG000|Overall Study|Withdrawal by Subject|1|||
124864803|NCT02015676|449125700|FG001|Overall Study|Withdrawal by Subject|7|||
124864804|NCT02015676|449125701|FG002|Overall Study|Withdrawal by Subject|1|||
124864805|NCT02015676|449125699|FG000|Overall Study|Administrative reasons|0|||
124864806|NCT02015676|449125700|FG001|Overall Study|Administrative reasons|3|||
124864807|NCT02015676|449125701|FG002|Overall Study|Administrative reasons|1|||
124864808|NCT02015676|449125699|FG000|Overall Study|Death|0|||
124864809|NCT02015676|449125700|FG001|Overall Study|Death|1|||
124864810|NCT02015676|449125701|FG002|Overall Study|Death|0|||
124864811|NCT02015676|449125699|FG000|Overall Study|Disease progression|3|||
124864812|NCT02015676|449125700|FG001|Overall Study|Disease progression|1|||
124864813|NCT02015676|449125701|FG002|Overall Study|Disease progression|1|||
124864814|NCT02013622|449125707|FG000|Overall Study|Lost to Follow-up|10|||
124864815|NCT02013622|449125707|FG000|Overall Study|Adverse Event|3|||
124864816|NCT02013622|449125707|FG000|Overall Study|Met Withdrawal Criteria|3|||
124864817|NCT02013622|449125707|FG000|Overall Study|Withdrawal by Subject|6|||
124864818|NCT02013622|449125707|FG000|Overall Study|Protocol Deviation|1|||
124864819|NCT02013622|449125707|FG000|Overall Study|Lack of Efficacy|1|||
124864820|NCT04307004|449125715|FG000|Randomization 1|Withdrawal by Subject|25|||
124864821|NCT04307004|449125716|FG001|Randomization 1|Withdrawal by Subject|26|||
124864822|NCT04307004|449125717|FG002|Randomization 1|Withdrawal by Subject|0|||
124864823|NCT04307004|449125718|FG003|Randomization 1|Withdrawal by Subject|0|||
124864824|NCT04307004|449125715|FG000|Randomization 2|Withdrawal by Subject|0|||
124864825|NCT04307004|449125716|FG001|Randomization 2|Withdrawal by Subject|0|||
124864826|NCT04307004|449125717|FG002|Randomization 2|Withdrawal by Subject|28|||
124864827|NCT04307004|449125718|FG003|Randomization 2|Withdrawal by Subject|23|||
124864828|NCT02081846|449125719|FG000|Overall Study|Withdrawal by Subject|1|||
124864829|NCT02081846|449125720|FG001|Overall Study|Withdrawal by Subject|0|||
124864830|NCT02081846|449125719|FG000|Overall Study|invalid consent|1|||
124864831|NCT02081846|449125720|FG001|Overall Study|invalid consent|0|||
124864832|NCT02576678|449125721|FG000|Overall Study|Adverse Event|0|||
124864833|NCT02576678|449125722|FG001|Overall Study|Adverse Event|0|||
124864834|NCT02576678|449125723|FG002|Overall Study|Adverse Event|2|||
124864835|NCT02576678|449125721|FG000|Overall Study|Withdrawal by Subject|3|||
124864836|NCT02576678|449125722|FG001|Overall Study|Withdrawal by Subject|1|||
124864837|NCT02576678|449125723|FG002|Overall Study|Withdrawal by Subject|2|||
124864838|NCT02576678|449125721|FG000|Overall Study|Lost to Follow-up|0|||
124864839|NCT02576678|449125722|FG001|Overall Study|Lost to Follow-up|0|||
124864840|NCT02576678|449125723|FG002|Overall Study|Lost to Follow-up|1|||
124864841|NCT02576678|449125721|FG000|Overall Study|Miscellaneous|2|||
124864842|NCT02576678|449125722|FG001|Overall Study|Miscellaneous|0|||
124864843|NCT02576678|449125723|FG002|Overall Study|Miscellaneous|0|||
124864844|NCT02251990|449125727|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
124864845|NCT02251990|449125728|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
124864846|NCT02251990|449125727|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
124864847|NCT02251990|449125728|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
124864848|NCT02251990|449125727|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
124864849|NCT02251990|449125728|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
124864850|NCT02251990|449125727|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
124864851|NCT02251990|449125728|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
124864852|NCT02251990|449125727|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
124864853|NCT02251990|449125728|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
124864854|NCT02251990|449125727|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
124864855|NCT02251990|449125728|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
124864856|NCT03265600|449125729|FG000|Overall Study|Lost to Follow-up|17|||
124864857|NCT03265600|449125730|FG001|Overall Study|Lost to Follow-up|5|||
124864858|NCT03265600|449125729|FG000|Overall Study|Withdrawal by Subject|4|||
124864859|NCT03265600|449125730|FG001|Overall Study|Withdrawal by Subject|2|||
124864860|NCT03265600|449125729|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
124864861|NCT03265600|449125730|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
124864862|NCT02293538|449125731|FG000|Overall Study|Adverse Event|0|||
124864863|NCT02293538|449125732|FG001|Overall Study|Adverse Event|1|||
124864864|NCT02293538|449125731|FG000|Overall Study|Lost to Follow-up|1|||
124864865|NCT02293538|449125732|FG001|Overall Study|Lost to Follow-up|0|||
124864866|NCT02293538|449125731|FG000|Overall Study|Withdrawal by Subject|0|||
124864867|NCT02293538|449125732|FG001|Overall Study|Withdrawal by Subject|1|||
124864868|NCT00322348|449125736|FG000|Overall Study|Adverse Event|0|||
124864869|NCT00322348|449125737|FG001|Overall Study|Adverse Event|1|||
124864870|NCT00322348|449125736|FG000|Overall Study|Withdrawal by Subject|1|||
124864871|NCT00322348|449125737|FG001|Overall Study|Withdrawal by Subject|4|||
124864872|NCT00322348|449125736|FG000|Overall Study|Lost to Follow-up|1|||
124864873|NCT00322348|449125737|FG001|Overall Study|Lost to Follow-up|0|||
124864874|NCT00322348|449125736|FG000|Overall Study|Death|0|||
124864875|NCT00322348|449125737|FG001|Overall Study|Death|2|||
124864876|NCT00322348|449125736|FG000|Overall Study|Disease Progression|30|||
124864877|NCT00322348|449125737|FG001|Overall Study|Disease Progression|25|||
124864878|NCT00322348|449125736|FG000|Overall Study|Reasons not specified|5|||
124864879|NCT00322348|449125737|FG001|Overall Study|Reasons not specified|1|||
124864880|NCT01090453|449125740|FG000|Overall Study|Withdrawal by Subject|1|||
124864881|NCT01090453|449125741|FG001|Overall Study|Withdrawal by Subject|2|||
124864882|NCT01090453|449125740|FG000|Overall Study|Lost to Follow-up|7|||
124864883|NCT01090453|449125741|FG001|Overall Study|Lost to Follow-up|7|||
124864884|NCT01090453|449125740|FG000|Overall Study|Non serious AEs|1|||
124864885|NCT01090453|449125741|FG001|Overall Study|Non serious AEs|0|||
124864886|NCT01090453|449125740|FG000|Overall Study|Protocol Violation|2|||
124864887|NCT01090453|449125741|FG001|Overall Study|Protocol Violation|0|||
124864888|NCT01090453|449125740|FG000|Overall Study|Other|2|||
124864889|NCT01090453|449125741|FG001|Overall Study|Other|4|||
124864890|NCT01090453|449125740|FG000|Overall Study|Eligibility Criteria|0|||
124864891|NCT01090453|449125741|FG001|Overall Study|Eligibility Criteria|1|||
124864892|NCT00729833|449125742|FG000|Overall Study|Death|5|||
124864893|NCT00729833|449125743|FG001|Overall Study|Death|1|||
124864894|NCT00729833|449125744|FG002|Overall Study|Death|3|||
124864895|NCT00729833|449125745|FG003|Overall Study|Death|5|||
124864896|NCT00729833|449125742|FG000|Overall Study|Study Terminated by Sponsor|0|||
124864897|NCT00729833|449125743|FG001|Overall Study|Study Terminated by Sponsor|0|||
124864898|NCT00729833|449125744|FG002|Overall Study|Study Terminated by Sponsor|1|||
124864899|NCT00729833|449125745|FG003|Overall Study|Study Terminated by Sponsor|0|||
124864900|NCT00729833|449125742|FG000|Overall Study|Lost to Follow-up|1|||
124864901|NCT00729833|449125743|FG001|Overall Study|Lost to Follow-up|0|||
124864902|NCT00729833|449125744|FG002|Overall Study|Lost to Follow-up|0|||
124864903|NCT00729833|449125745|FG003|Overall Study|Lost to Follow-up|0|||
124864904|NCT00729833|449125742|FG000|Overall Study|Withdrawal by Subject|3|||
124864905|NCT00729833|449125743|FG001|Overall Study|Withdrawal by Subject|1|||
124864906|NCT00729833|449125744|FG002|Overall Study|Withdrawal by Subject|3|||
124864907|NCT00729833|449125745|FG003|Overall Study|Withdrawal by Subject|0|||
124864908|NCT00729833|449125742|FG000|Overall Study|Unspecified Reasons|11|||
124864909|NCT00729833|449125743|FG001|Overall Study|Unspecified Reasons|5|||
124864910|NCT00729833|449125744|FG002|Overall Study|Unspecified Reasons|5|||
124864911|NCT00729833|449125745|FG003|Overall Study|Unspecified Reasons|1|||
124864912|NCT00695669|449125746|FG000|Overall Study|Adverse Event|0|||
124864913|NCT00695669|449125747|FG001|Overall Study|Adverse Event|0|||
124864914|NCT00695669|449125748|FG002|Overall Study|Adverse Event|2|||
124864915|NCT00695669|449125749|FG003|Overall Study|Adverse Event|0|||
124864916|NCT00695669|449125746|FG000|Overall Study|Lost to Follow-up|4|||
124864917|NCT00695669|449125747|FG001|Overall Study|Lost to Follow-up|4|||
124864918|NCT00695669|449125748|FG002|Overall Study|Lost to Follow-up|1|||
124864919|NCT00695669|449125749|FG003|Overall Study|Lost to Follow-up|4|||
124864920|NCT05045625|449125750|FG000|Overall Study|Lost to Follow-up|3|||
124864921|NCT00417079|449125751|FG000|Overall Study|Disease progression|267|||
124864922|NCT00417079|449125752|FG001|Overall Study|Disease progression|180|||
124864923|NCT00417079|449125751|FG000|Overall Study|Adverse Event|32|||
124864924|NCT00417079|449125752|FG001|Overall Study|Adverse Event|67|||
124864925|NCT00417079|449125751|FG000|Overall Study|Non-compliance to protocol|0|||
124864926|NCT00417079|449125752|FG001|Overall Study|Non-compliance to protocol|1|||
124864927|NCT00417079|449125751|FG000|Overall Study|Lost to Follow-up|2|||
124864928|NCT00417079|449125752|FG001|Overall Study|Lost to Follow-up|0|||
124864929|NCT00417079|449125751|FG000|Overall Study|Withdrawal by Subject|17|||
124864930|NCT00417079|449125752|FG001|Overall Study|Withdrawal by Subject|8|||
124864931|NCT00417079|449125751|FG000|Overall Study|Not treated|6|||
124864932|NCT00417079|449125752|FG001|Overall Study|Not treated|7|||
124864933|NCT00417079|449125751|FG000|Overall Study|Screened failure|2|||
124864934|NCT00417079|449125752|FG001|Overall Study|Screened failure|1|||
124864935|NCT00417079|449125751|FG000|Overall Study|Investigator's decision|1|||
124864936|NCT00417079|449125752|FG001|Overall Study|Investigator's decision|4|||
124864937|NCT00417079|449125751|FG000|Overall Study|Non-confirmed Disease progression|1|||
124864938|NCT00417079|449125752|FG001|Overall Study|Non-confirmed Disease progression|1|||
124864939|NCT00417079|449125751|FG000|Overall Study|Clinical deterioration|1|||
124864940|NCT00417079|449125752|FG001|Overall Study|Clinical deterioration|0|||
124864941|NCT00417079|449125751|FG000|Overall Study|Screening error|2|||
124864942|NCT00417079|449125752|FG001|Overall Study|Screening error|1|||
124864943|NCT00417079|449125751|FG000|Overall Study|Withdrawal by subject's family|0|||
124864944|NCT00417079|449125752|FG001|Overall Study|Withdrawal by subject's family|1|||
124864945|NCT00417079|449125751|FG000|Overall Study|Patient unable to come to the clinic|0|||
124864946|NCT00417079|449125752|FG001|Overall Study|Patient unable to come to the clinic|1|||
124864947|NCT00417079|449125751|FG000|Overall Study|abnormal liver function tests|0|||
124864948|NCT00417079|449125752|FG001|Overall Study|abnormal liver function tests|1|||
124864949|NCT03570619|449125763|FG000|Overall Study|Adverse Event|2|||
124864950|NCT03570619|449125764|FG001|Overall Study|Adverse Event|0|||
124864951|NCT03570619|449125765|FG002|Overall Study|Adverse Event|1|||
124864952|NCT03570619|449125763|FG000|Overall Study|new diagnosis of new malignancy|1|||
124864953|NCT03570619|449125764|FG001|Overall Study|new diagnosis of new malignancy|0|||
124864954|NCT03570619|449125765|FG002|Overall Study|new diagnosis of new malignancy|0|||
124864955|NCT03570619|449125763|FG000|Overall Study|Physician Decision|1|||
124864956|NCT03570619|449125764|FG001|Overall Study|Physician Decision|1|||
124864957|NCT03570619|449125765|FG002|Overall Study|Physician Decision|0|||
124864958|NCT03570619|449125763|FG000|Overall Study|Withdrawal by Subject|0|||
124864959|NCT03570619|449125764|FG001|Overall Study|Withdrawal by Subject|2|||
124864960|NCT03570619|449125765|FG002|Overall Study|Withdrawal by Subject|0|||
124864961|NCT01022762|449125767|FG000|Overall Study|Adverse Event|3|||
124864962|NCT01022762|449125768|FG001|Overall Study|Adverse Event|1|||
124864963|NCT01022762|449125767|FG000|Overall Study|Lack of Efficacy|0|||
124864964|NCT01022762|449125768|FG001|Overall Study|Lack of Efficacy|1|||
124864965|NCT01022762|449125767|FG000|Overall Study|Protocol Violation|7|||
124864966|NCT01022762|449125768|FG001|Overall Study|Protocol Violation|6|||
124864967|NCT01022762|449125767|FG000|Overall Study|Unclassified|12|||
124864968|NCT01022762|449125768|FG001|Overall Study|Unclassified|20|||
124864969|NCT01302119|449125769|FG000|Overall Study|Withdrawal by Subject|30|||
124864970|NCT01302119|449125770|FG001|Overall Study|Withdrawal by Subject|20|||
124864971|NCT01302119|449125769|FG000|Overall Study|Lost to Follow-up|10|||
124864972|NCT01302119|449125770|FG001|Overall Study|Lost to Follow-up|4|||
124864973|NCT01302119|449125769|FG000|Overall Study|Adverse Event|2|||
124864974|NCT01302119|449125770|FG001|Overall Study|Adverse Event|1|||
124864975|NCT01302119|449125769|FG000|Overall Study|Non-compliance|4|||
124864976|NCT01302119|449125770|FG001|Overall Study|Non-compliance|2|||
124864977|NCT01302119|449125769|FG000|Overall Study|Non-specific|4|||
124864978|NCT01302119|449125770|FG001|Overall Study|Non-specific|1|||
124864979|NCT03336619|449125772|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
124864980|NCT03336619|449125773|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
124864981|NCT03336619|449125772|FG000|Overall Study|Withdrawal by Subject|17|||
124864982|NCT03336619|449125773|FG001|Overall Study|Withdrawal by Subject|16|||
124864983|NCT03336619|449125772|FG000|Overall Study|Adverse Event|2|||
124864984|NCT03336619|449125773|FG001|Overall Study|Adverse Event|5|||
124864985|NCT03336619|449125772|FG000|Overall Study|Physician Decision|3|||
124864986|NCT03336619|449125773|FG001|Overall Study|Physician Decision|0|||
124864987|NCT00744653|449125778|FG000|Overall Study|antineoplastic treatment|11|||
124864988|NCT00744653|449125778|FG000|Overall Study|Death|1|||
124864989|NCT00744653|449125778|FG000|Overall Study|Lost to Follow-up|1|||
124864990|NCT00744653|449125778|FG000|Overall Study|Physician Decision|3|||
124864991|NCT03826667|449125781|FG000|Overall Study|Protocol deviation|21|||
124864992|NCT00679939|449125783|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
124864993|NCT00679939|449125784|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
124864994|NCT00679939|449125783|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
124864995|NCT00679939|449125784|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
124864996|NCT00679939|449125783|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
124864997|NCT00679939|449125784|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
124864998|NCT00679939|449125783|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
124864999|NCT00679939|449125784|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
124865000|NCT00679939|449125783|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
124865001|NCT00679939|449125784|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
124865002|NCT00679939|449125783|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
124865003|NCT00679939|449125784|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
124865004|NCT00679939|449125783|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
124865005|NCT00679939|449125784|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
124865006|NCT00679939|449125783|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
124865007|NCT00679939|449125784|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
124865008|NCT00679939|449125783|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
124865009|NCT00679939|449125784|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
124865010|NCT00679939|449125783|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
124865011|NCT00679939|449125784|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
124865012|NCT05608629|449125786|FG000|Overall Study|Lost to Follow-up|2|||
124865013|NCT00983073|449125787|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
124865014|NCT00983073|449125787|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
124865015|NCT00983073|449125787|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
124865016|NCT00983073|449125787|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
124865017|NCT00983073|449125787|FG000|Titration and Optimal Dose Period|Other reason|4|||
124865018|NCT00983073|449125787|FG000|Maintenance Period|Adverse Event|5|||
124865019|NCT00983073|449125787|FG000|Maintenance Period|Withdrawal by Subject|2|||
124865020|NCT00983073|449125787|FG000|Maintenance Period|Lack of Efficacy|2|||
124865021|NCT00983073|449125787|FG000|Maintenance Period|Other Reason|7|||
124865022|NCT01453595|449125788|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
124865023|NCT01453595|449125789|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
124865024|NCT01453595|449125790|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
124865025|NCT02962908|449125793|FG000|Overall Study|Lost to Follow-up|0|||
124865026|NCT02962908|449125794|FG001|Overall Study|Lost to Follow-up|3|||
124865027|NCT02962908|449125795|FG002|Overall Study|Lost to Follow-up|0|||
124865028|NCT02962908|449125796|FG003|Overall Study|Lost to Follow-up|1|||
124865029|NCT02962908|449125793|FG000|Overall Study|Withdrawal by Subject|0|||
124865030|NCT02962908|449125794|FG001|Overall Study|Withdrawal by Subject|3|||
124865031|NCT02962908|449125795|FG002|Overall Study|Withdrawal by Subject|0|||
124865032|NCT02962908|449125796|FG003|Overall Study|Withdrawal by Subject|2|||
124865033|NCT02962908|449125793|FG000|Overall Study|Protocol Violation|0|||
124865034|NCT02962908|449125794|FG001|Overall Study|Protocol Violation|1|||
124865035|NCT02962908|449125795|FG002|Overall Study|Protocol Violation|0|||
124865036|NCT02962908|449125796|FG003|Overall Study|Protocol Violation|0|||
124865037|NCT02962908|449125793|FG000|Overall Study|Physician Decision|0|||
124865038|NCT02962908|449125794|FG001|Overall Study|Physician Decision|1|||
124865039|NCT02962908|449125795|FG002|Overall Study|Physician Decision|0|||
124865040|NCT02962908|449125796|FG003|Overall Study|Physician Decision|0|||
124865041|NCT00936390|449125797|FG000|Overall Study|Protocol Violation|21|||
124865042|NCT00936390|449125798|FG001|Overall Study|Protocol Violation|25|||
124865043|NCT04348604|449125799|FG000|Week 8|Withdrawal by Subject|1|||
124865044|NCT04348604|449125800|FG001|Week 8|Withdrawal by Subject|1|||
124865045|NCT04348604|449125799|FG000|Week 8|Lost to Follow-up|1|||
124865046|NCT04348604|449125800|FG001|Week 8|Lost to Follow-up|2|||
124865047|NCT04348604|449125799|FG000|Week 8|Suspended|0|||
124865048|NCT04348604|449125800|FG001|Week 8|Suspended|1|||
124865049|NCT04348604|449125799|FG000|Week 12|Lost to Follow-up|1|||
124865050|NCT04348604|449125800|FG001|Week 12|Lost to Follow-up|2|||
124865051|NCT04348604|449125799|FG000|Week 12|Withdrawal by Subject|1|||
124865052|NCT04348604|449125800|FG001|Week 12|Withdrawal by Subject|0|||
124865053|NCT04348604|449125799|FG000|Week 24|Lost to Follow-up|2|||
124865054|NCT04348604|449125800|FG001|Week 24|Lost to Follow-up|1|||
124865055|NCT02097108|449125801|FG000|Overall Study|Adverse Event|1|||
124865056|NCT02097108|449125801|FG000|Overall Study|patient was abroad for 6 months|1|||
124865057|NCT00506493|449125804|FG000|Overall Study|Death|6|||
124865058|NCT00506493|449125804|FG000|Overall Study|Withdrawal by Subject|5|||
124865059|NCT00955357|449126922|FG000|Titration Phase|Adverse Event|9|||
124865060|NCT00955357|449126923|FG001|Titration Phase|Adverse Event|46|||
124865061|NCT00955357|449126922|FG000|Titration Phase|Lack of Efficacy|0|||
124865062|NCT00955357|449126923|FG001|Titration Phase|Lack of Efficacy|2|||
124865063|NCT00955357|449126922|FG000|Titration Phase|Protocol Violation|3|||
124865064|NCT00955357|449126923|FG001|Titration Phase|Protocol Violation|7|||
124865065|NCT00955357|449126922|FG000|Titration Phase|Lost to Follow-up|1|||
124865066|NCT00955357|449126923|FG001|Titration Phase|Lost to Follow-up|3|||
124865067|NCT00955357|449126922|FG000|Titration Phase|Withdrawal by Subject|3|||
124865068|NCT00955357|449126923|FG001|Titration Phase|Withdrawal by Subject|5|||
124865069|NCT00955357|449126922|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
124865070|NCT00955357|449126923|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
124865071|NCT00955357|449126922|FG000|Titration Phase|Study medication not tolerated|0|||
124865072|NCT00955357|449126923|FG001|Titration Phase|Study medication not tolerated|1|||
124865073|NCT00955357|449126922|FG000|Titration Phase|Non compliance to study procedures|0|||
124865074|NCT00955357|449126923|FG001|Titration Phase|Non compliance to study procedures|1|||
124865075|NCT00955357|449126922|FG000|Maintenance Phase|Adverse Event|3|||
124865076|NCT00955357|449126923|FG001|Maintenance Phase|Adverse Event|23|||
124865077|NCT00955357|449126922|FG000|Maintenance Phase|Lack of Efficacy|0|||
124865078|NCT00955357|449126923|FG001|Maintenance Phase|Lack of Efficacy|4|||
124865079|NCT00955357|449126922|FG000|Maintenance Phase|Protocol Violation|2|||
124865080|NCT00955357|449126923|FG001|Maintenance Phase|Protocol Violation|6|||
124865081|NCT00955357|449126922|FG000|Maintenance Phase|Lost to Follow-up|2|||
124865082|NCT00955357|449126923|FG001|Maintenance Phase|Lost to Follow-up|7|||
124865083|NCT00955357|449126922|FG000|Maintenance Phase|Withdrawal by Subject|4|||
124865084|NCT00955357|449126923|FG001|Maintenance Phase|Withdrawal by Subject|4|||
124865085|NCT00955357|449126922|FG000|Maintenance Phase|Patient moving out of area|0|||
124865086|NCT00955357|449126923|FG001|Maintenance Phase|Patient moving out of area|1|||
124865087|NCT00955357|449126922|FG000|Maintenance Phase|Non compliance to study procedures|1|||
124865088|NCT00955357|449126923|FG001|Maintenance Phase|Non compliance to study procedures|0|||
124865089|NCT00868439|449126938|FG000|Overall Study|Adverse Event|4|||
124865090|NCT00868439|449126939|FG001|Overall Study|Adverse Event|3|||
124865091|NCT00868439|449126938|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
124865092|NCT00868439|449126939|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
124865093|NCT00868439|449126938|FG000|Overall Study|Death|0|||
124865094|NCT00868439|449126939|FG001|Overall Study|Death|1|||
124865095|NCT00868439|449126938|FG000|Overall Study|Protocol Violation|1|||
124865096|NCT00868439|449126939|FG001|Overall Study|Protocol Violation|1|||
124865097|NCT00868439|449126938|FG000|Overall Study|Physician Decision|1|||
124865098|NCT00868439|449126939|FG001|Overall Study|Physician Decision|0|||
124865099|NCT00868439|449126938|FG000|Overall Study|Withdrawal by Subject|0|||
124865100|NCT00868439|449126939|FG001|Overall Study|Withdrawal by Subject|1|||
124865101|NCT00971048|449126943|FG000|Overall Study|Protocol Violation|1|||
124865102|NCT00971048|449126944|FG001|Overall Study|Protocol Violation|2|||
124865103|NCT00971048|449126945|FG002|Overall Study|Protocol Violation|0|||
124865104|NCT00971048|449126946|FG003|Overall Study|Protocol Violation|1|||
124865105|NCT00971048|449126943|FG000|Overall Study|Adverse Event|0|||
124865106|NCT00971048|449126944|FG001|Overall Study|Adverse Event|0|||
124865107|NCT00971048|449126945|FG002|Overall Study|Adverse Event|1|||
124865108|NCT00971048|449126946|FG003|Overall Study|Adverse Event|0|||
124865109|NCT00971048|449126943|FG000|Overall Study|Physician Decision|0|||
124865110|NCT00971048|449126944|FG001|Overall Study|Physician Decision|0|||
124865111|NCT00971048|449126945|FG002|Overall Study|Physician Decision|0|||
124865112|NCT00971048|449126946|FG003|Overall Study|Physician Decision|1|||
124865113|NCT03321396|449126951|FG000|Overall Study|Physician Decision|1|||
124865114|NCT01540851|449126955|FG000|Overall Study|Lost to Follow-up|14|||
124865115|NCT01540851|449126956|FG001|Overall Study|Lost to Follow-up|15|||
124865116|NCT01540851|449126955|FG000|Overall Study|Withdrawal by Subject|7|||
124865117|NCT01540851|449126956|FG001|Overall Study|Withdrawal by Subject|3|||
124865118|NCT00937924|449126959|FG000|Overall Study|Lost to Follow-up|44|||
124865119|NCT00937924|449126960|FG001|Overall Study|Lost to Follow-up|44|||
124865120|NCT00937924|449126961|FG002|Overall Study|Lost to Follow-up|41|||
124865121|NCT00224874|449126962|FG000|Overall Study|Withdrawal by Subject|0|||
124865122|NCT00224874|449126963|FG001|Overall Study|Withdrawal by Subject|0|||
124865123|NCT00224874|449126964|FG002|Overall Study|Withdrawal by Subject|1|||
124865124|NCT00224874|449126965|FG003|Overall Study|Withdrawal by Subject|0|||
124865125|NCT03644186|449126970|FG000|Overall Study|Withdrawal by Subject|1|||
124865126|NCT03644186|449126971|FG001|Overall Study|Withdrawal by Subject|1|||
124865127|NCT02192502|449126973|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
124865128|NCT02192502|449126974|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
124865129|NCT02192502|449126973|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
124865130|NCT02192502|449126974|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
124865131|NCT02192502|449126973|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
124865132|NCT02192502|449126974|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
124865133|NCT01381692|449126975|FG000|Overall Study|Adverse Event|1|||
124865134|NCT01381692|449126976|FG001|Overall Study|Adverse Event|0|||
124865135|NCT01381692|449126977|FG002|Overall Study|Adverse Event|0|||
124865136|NCT01381692|449126978|FG003|Overall Study|Adverse Event|0|||
124865137|NCT01381692|449126979|FG004|Overall Study|Adverse Event|0|||
124865138|NCT01381692|449126980|FG005|Overall Study|Adverse Event|0|||
124865139|NCT01869491|449126981|FG000|Overall Study|Adverse Event|3|||
124865140|NCT01869491|449126982|FG001|Overall Study|Adverse Event|5|||
124865141|NCT01869491|449126981|FG000|Overall Study|Lack of Efficacy|0|||
124865142|NCT01869491|449126982|FG001|Overall Study|Lack of Efficacy|3|||
124865143|NCT01869491|449126981|FG000|Overall Study|Withdrawal by Subject|6|||
124865144|NCT01869491|449126982|FG001|Overall Study|Withdrawal by Subject|7|||
124865145|NCT01869491|449126981|FG000|Overall Study|Lost to Follow-up|11|||
124865146|NCT01869491|449126982|FG001|Overall Study|Lost to Follow-up|9|||
124865147|NCT01869491|449126981|FG000|Overall Study|No further need of investigational product|1|||
124865148|NCT01869491|449126982|FG001|Overall Study|No further need of investigational product|0|||
124865149|NCT01270347|449126983|FG000|Core Phase|Adverse Event|1|||
124865150|NCT01270347|449126984|FG001|Core Phase|Adverse Event|6|||
124865151|NCT01270347|449126983|FG000|Core Phase|Withdrawal by Subject|1|||
124865152|NCT01270347|449126984|FG001|Core Phase|Withdrawal by Subject|2|||
124865153|NCT01270347|449126983|FG000|Core Phase|Lost to Follow-up|0|||
124865154|NCT01270347|449126984|FG001|Core Phase|Lost to Follow-up|1|||
124865155|NCT01270347|449126983|FG000|Core Phase|Miscellaneous|8|||
124865156|NCT01270347|449126984|FG001|Core Phase|Miscellaneous|14|||
124865157|NCT01270347|449126983|FG000|Extension Phase|Adverse Event|1|||
124865158|NCT01270347|449126984|FG001|Extension Phase|Adverse Event|3|||
124865159|NCT01270347|449126983|FG000|Extension Phase|Withdrawal by Subject|3|||
124865160|NCT01270347|449126984|FG001|Extension Phase|Withdrawal by Subject|4|||
124865161|NCT01270347|449126983|FG000|Extension Phase|Miscellaneous|2|||
124865162|NCT01270347|449126984|FG001|Extension Phase|Miscellaneous|2|||
124865163|NCT02195986|449126989|FG000|Overall Study|Adverse Event|3|||
124865164|NCT02195986|449126990|FG001|Overall Study|Adverse Event|0|||
124865165|NCT02195986|449126991|FG002|Overall Study|Adverse Event|0|||
124865166|NCT02195986|449126989|FG000|Overall Study|Withdrawal by Subject|0|||
124865167|NCT02195986|449126990|FG001|Overall Study|Withdrawal by Subject|3|||
124865168|NCT02195986|449126991|FG002|Overall Study|Withdrawal by Subject|0|||
124865169|NCT02195986|449126989|FG000|Overall Study|Family Emergency|0|||
124865170|NCT02195986|449126990|FG001|Overall Study|Family Emergency|0|||
124865171|NCT02195986|449126991|FG002|Overall Study|Family Emergency|1|||
124865172|NCT02195986|449126989|FG000|Overall Study|Protocol Violation|0|||
124865173|NCT02195986|449126990|FG001|Overall Study|Protocol Violation|1|||
124865174|NCT02195986|449126991|FG002|Overall Study|Protocol Violation|1|||
124865175|NCT02195986|449126989|FG000|Overall Study|Non-compliance|0|||
124865176|NCT02195986|449126990|FG001|Overall Study|Non-compliance|1|||
124865177|NCT02195986|449126991|FG002|Overall Study|Non-compliance|0|||
124865178|NCT02491671|449127004|FG000|Overall Study|Adverse Event|6|||
124865179|NCT02491671|449127005|FG001|Overall Study|Adverse Event|8|||
124865180|NCT02491671|449127004|FG000|Overall Study|Death|0|||
124865181|NCT02491671|449127005|FG001|Overall Study|Death|2|||
124865182|NCT02491671|449127004|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
124865183|NCT02491671|449127005|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
124865184|NCT00535730|449127006|FG000|Overall Study|Adverse Event|1|||
124865185|NCT00535730|449127007|FG001|Overall Study|Adverse Event|1|||
124865186|NCT00535730|449127006|FG000|Overall Study|Lost to Follow-up|0|||
124865187|NCT00535730|449127007|FG001|Overall Study|Lost to Follow-up|1|||
124865188|NCT00535730|449127006|FG000|Overall Study|Physician Decision|0|||
124865189|NCT00535730|449127007|FG001|Overall Study|Physician Decision|1|||
124865190|NCT00535730|449127006|FG000|Overall Study|Protocol Violation|1|||
124865191|NCT00535730|449127007|FG001|Overall Study|Protocol Violation|0|||
124865192|NCT00535730|449127006|FG000|Overall Study|Withdrawal by Subject|0|||
124865193|NCT00535730|449127007|FG001|Overall Study|Withdrawal by Subject|4|||
124865194|NCT04072159|449127016|FG000|Overall Study|Lost to Follow-up|6|||
124865195|NCT04072159|449127017|FG001|Overall Study|Lost to Follow-up|6|||
124865196|NCT04072159|449127016|FG000|Overall Study|Withdrawal by Subject|2|||
124865197|NCT04072159|449127017|FG001|Overall Study|Withdrawal by Subject|0|||
124865198|NCT04084314|449127020|FG000|Overall Study|Subject/guardian decision|91|||
124865199|NCT04084314|449127020|FG000|Overall Study|Adverse Event|24|||
124865200|NCT04084314|449127020|FG000|Overall Study|Lost to Follow-up|19|||
124865201|NCT04084314|449127020|FG000|Overall Study|New therapy for study indication|9|||
124865202|NCT04084314|449127020|FG000|Overall Study|Pregnancy|9|||
124865203|NCT04084314|449127020|FG000|Overall Study|Withdrawal of informed consent|8|||
124865204|NCT04084314|449127020|FG000|Overall Study|Physician Decision|4|||
124865205|NCT04084314|449127020|FG000|Overall Study|Protocol Deviation|3|||
124865206|NCT00802074|449127023|FG000|Overall Study|Adverse Event|1|||
124865207|NCT00802074|449127024|FG001|Overall Study|Adverse Event|1|||
124865208|NCT00802074|449127025|FG002|Overall Study|Adverse Event|1|||
124865209|NCT00802074|449127026|FG003|Overall Study|Adverse Event|0|||
124865210|NCT00802074|449127027|FG004|Overall Study|Adverse Event|0|||
124865211|NCT00802074|449127028|FG005|Overall Study|Adverse Event|0|||
124865212|NCT00802074|449127023|FG000|Overall Study|Withdrawal by Subject|1|||
124865213|NCT00802074|449127024|FG001|Overall Study|Withdrawal by Subject|0|||
124865214|NCT00802074|449127025|FG002|Overall Study|Withdrawal by Subject|0|||
124865215|NCT00802074|449127026|FG003|Overall Study|Withdrawal by Subject|0|||
124865216|NCT00802074|449127027|FG004|Overall Study|Withdrawal by Subject|0|||
124865217|NCT00802074|449127028|FG005|Overall Study|Withdrawal by Subject|0|||
124865218|NCT02298192|449127031|FG000|Overall Study|Unclassified|3|||
124865219|NCT02298192|449127032|FG001|Overall Study|Unclassified|2|||
124865220|NCT02298192|449127031|FG000|Overall Study|Withdrawal criteria|2|||
124865221|NCT02298192|449127032|FG001|Overall Study|Withdrawal criteria|0|||
124865222|NCT02298192|449127031|FG000|Overall Study|Withdrawal by Subject|6|||
124865223|NCT02298192|449127032|FG001|Overall Study|Withdrawal by Subject|1|||
124865224|NCT02298192|449127031|FG000|Overall Study|Lost to Follow-up|2|||
124865225|NCT02298192|449127032|FG001|Overall Study|Lost to Follow-up|1|||
124865226|NCT02298192|449127031|FG000|Overall Study|Adverse Event|6|||
124865227|NCT02298192|449127032|FG001|Overall Study|Adverse Event|2|||
124865228|NCT01371851|449127033|FG000|Overall Study|Lost to Follow-up|5|||
124865229|NCT01371851|449127034|FG001|Overall Study|Lost to Follow-up|8|||
124865230|NCT01371851|449127033|FG000|Overall Study|was arrested and put in jail|0|||
124865231|NCT01371851|449127034|FG001|Overall Study|was arrested and put in jail|1|||
124865232|NCT01371851|449127033|FG000|Overall Study|non study related adverse event|1|||
124865233|NCT01371851|449127034|FG001|Overall Study|non study related adverse event|0|||
124865234|NCT01371851|449127033|FG000|Overall Study|Blood Pressure outside study parameters|2|||
124865235|NCT01371851|449127034|FG001|Overall Study|Blood Pressure outside study parameters|0|||
124865236|NCT00833638|449127035|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
124865237|NCT00833638|449127036|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
124865238|NCT00833638|449127037|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
124865239|NCT00833638|449127035|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
124865240|NCT00833638|449127036|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
124865241|NCT00833638|449127037|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
124865242|NCT00833638|449127035|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
124865243|NCT00833638|449127036|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
124865244|NCT00833638|449127037|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
124865245|NCT00833638|449127035|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
124865246|NCT00833638|449127036|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
124865247|NCT00833638|449127037|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
124865248|NCT00833638|449127035|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
124865249|NCT00833638|449127036|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
124865250|NCT00833638|449127037|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
124865251|NCT00833638|449127035|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
124865252|NCT00833638|449127036|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
124865253|NCT00833638|449127037|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
124865254|NCT00833638|449127035|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
124865255|NCT00833638|449127036|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
124865256|NCT00833638|449127037|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
124865257|NCT00833638|449127035|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
124865258|NCT00833638|449127036|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
124865259|NCT00833638|449127037|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
124865260|NCT00833638|449127035|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
124865261|NCT00833638|449127036|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
124865262|NCT00833638|449127037|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
124865263|NCT01669122|449127038|FG000|Period I|Lost to Follow-up|1|||
124865264|NCT01669122|449127038|FG000|Washout Period II|Protocol Violation|2|||
124865265|NCT03543254|449127039|FG000|Overall Study|Lost to Follow-up|1|||
124865266|NCT01261338|449127040|FG000|Overall Study|Withdrawal by Subject|3|||
124865267|NCT01261338|449127041|FG001|Overall Study|Withdrawal by Subject|2|||
124865268|NCT00234065|449127042|FG000|Overall Study|Adverse Event|268|||
124865269|NCT00234065|449127043|FG001|Overall Study|Adverse Event|166|||
124865270|NCT00234065|449127042|FG000|Overall Study|Withdrawal by Subject|73|||
124865271|NCT00234065|449127043|FG001|Overall Study|Withdrawal by Subject|56|||
124865272|NCT00234065|449127042|FG000|Overall Study|Physician Decision|23|||
124865273|NCT00234065|449127043|FG001|Overall Study|Physician Decision|22|||
124865274|NCT00234065|449127042|FG000|Overall Study|Not Classified|111|||
124865275|NCT00234065|449127043|FG001|Overall Study|Not Classified|112|||
124865276|NCT05374421|449127044|FG000|Overall Study|Withdrawal by Subject|3|||
124865277|NCT05374421|449127045|FG001|Overall Study|Withdrawal by Subject|4|||
124865278|NCT05132699|449127046|FG000|Overall Study|Withdrawal by Subject|3|||
124865279|NCT05132699|449127047|FG001|Overall Study|Withdrawal by Subject|0|||
124865280|NCT02899728|449127048|FG000|Overall Study|Withdrawal by Subject|1|||
124865281|NCT02899728|449127049|FG001|Overall Study|Withdrawal by Subject|1|||
124865282|NCT05557942|449127050|FG000|Overall Study|Death|0|||
124865283|NCT05557942|449127051|FG001|Overall Study|Death|0|||
124865284|NCT05557942|449127052|FG002|Overall Study|Death|0|||
124865285|NCT05557942|449127053|FG003|Overall Study|Death|2|||
124865286|NCT05557942|449127054|FG004|Overall Study|Death|1|||
124865287|NCT05557942|449127055|FG005|Overall Study|Death|1|||
124865288|NCT05557942|449127050|FG000|Overall Study|Physician Decision|1|||
124865289|NCT05557942|449127051|FG001|Overall Study|Physician Decision|1|||
124865290|NCT05557942|449127052|FG002|Overall Study|Physician Decision|2|||
124865291|NCT05557942|449127053|FG003|Overall Study|Physician Decision|3|||
124865292|NCT05557942|449127054|FG004|Overall Study|Physician Decision|0|||
124865293|NCT05557942|449127055|FG005|Overall Study|Physician Decision|2|||
124865294|NCT05557942|449127050|FG000|Overall Study|Study terminated by sponsor|17|||
124865295|NCT05557942|449127051|FG001|Overall Study|Study terminated by sponsor|17|||
124865296|NCT05557942|449127052|FG002|Overall Study|Study terminated by sponsor|14|||
124865297|NCT05557942|449127053|FG003|Overall Study|Study terminated by sponsor|40|||
124865298|NCT05557942|449127054|FG004|Overall Study|Study terminated by sponsor|45|||
124865299|NCT05557942|449127055|FG005|Overall Study|Study terminated by sponsor|37|||
124865300|NCT05557942|449127050|FG000|Overall Study|Protocol Violation|0|||
124865301|NCT05557942|449127051|FG001|Overall Study|Protocol Violation|0|||
124865302|NCT05557942|449127052|FG002|Overall Study|Protocol Violation|0|||
124865303|NCT05557942|449127053|FG003|Overall Study|Protocol Violation|0|||
124865304|NCT05557942|449127054|FG004|Overall Study|Protocol Violation|0|||
124865305|NCT05557942|449127055|FG005|Overall Study|Protocol Violation|1|||
124865306|NCT05557942|449127050|FG000|Overall Study|Withdrawal by Subject|0|||
124865307|NCT05557942|449127051|FG001|Overall Study|Withdrawal by Subject|0|||
124865308|NCT05557942|449127052|FG002|Overall Study|Withdrawal by Subject|0|||
124865309|NCT05557942|449127053|FG003|Overall Study|Withdrawal by Subject|0|||
124865310|NCT05557942|449127054|FG004|Overall Study|Withdrawal by Subject|2|||
124865311|NCT05557942|449127055|FG005|Overall Study|Withdrawal by Subject|0|||
124865312|NCT02477618|449127056|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
124865313|NCT02477618|449127057|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
124865314|NCT02477618|449127056|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
124865315|NCT02477618|449127057|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
124865316|NCT02477618|449127056|FG000|Overall Study|Adverse Event|1|||
124865317|NCT02477618|449127057|FG001|Overall Study|Adverse Event|1|||
124865318|NCT02477618|449127056|FG000|Overall Study|Transferred Away from Study Site|1|||
124865319|NCT02477618|449127057|FG001|Overall Study|Transferred Away from Study Site|0|||
124865320|NCT02477618|449127056|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
124865321|NCT02477618|449127057|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
124865322|NCT05540522|449127061|FG000|Overall Study|Adverse Event|1|||
124865323|NCT05540522|449127062|FG001|Overall Study|Adverse Event|0|||
124865324|NCT05540522|449127063|FG002|Overall Study|Adverse Event|2|||
124865325|NCT05540522|449127064|FG003|Overall Study|Adverse Event|5|||
124865326|NCT05540522|449127061|FG000|Overall Study|Lost to Follow-up|487|||
124865327|NCT05540522|449127062|FG001|Overall Study|Lost to Follow-up|427|||
124865328|NCT05540522|449127063|FG002|Overall Study|Lost to Follow-up|146|||
124865329|NCT05540522|449127064|FG003|Overall Study|Lost to Follow-up|166|||
124865330|NCT05540522|449127061|FG000|Overall Study|Physician Decision|11|||
124865331|NCT05540522|449127062|FG001|Overall Study|Physician Decision|19|||
124865332|NCT05540522|449127063|FG002|Overall Study|Physician Decision|8|||
124865333|NCT05540522|449127064|FG003|Overall Study|Physician Decision|13|||
124865334|NCT05540522|449127061|FG000|Overall Study|Pregnancy|1|||
124865335|NCT05540522|449127062|FG001|Overall Study|Pregnancy|0|||
124865336|NCT05540522|449127063|FG002|Overall Study|Pregnancy|0|||
124865337|NCT05540522|449127064|FG003|Overall Study|Pregnancy|0|||
124865338|NCT05540522|449127061|FG000|Overall Study|Protocol Violation|3|||
124865339|NCT05540522|449127062|FG001|Overall Study|Protocol Violation|1|||
124865340|NCT05540522|449127063|FG002|Overall Study|Protocol Violation|9|||
124865341|NCT05540522|449127064|FG003|Overall Study|Protocol Violation|7|||
124865342|NCT05540522|449127061|FG000|Overall Study|Withdrawal by Subject|168|||
124865343|NCT05540522|449127062|FG001|Overall Study|Withdrawal by Subject|134|||
124865344|NCT05540522|449127063|FG002|Overall Study|Withdrawal by Subject|331|||
124865345|NCT05540522|449127064|FG003|Overall Study|Withdrawal by Subject|322|||
124865346|NCT05540522|449127061|FG000|Overall Study|Death|7|||
124865347|NCT05540522|449127062|FG001|Overall Study|Death|9|||
124865348|NCT05540522|449127063|FG002|Overall Study|Death|49|||
124865349|NCT05540522|449127064|FG003|Overall Study|Death|46|||
124865350|NCT05540522|449127061|FG000|Overall Study|Not vaccinated|34|||
124865351|NCT05540522|449127062|FG001|Overall Study|Not vaccinated|53|||
124865352|NCT05540522|449127063|FG002|Overall Study|Not vaccinated|57|||
124865353|NCT05540522|449127064|FG003|Overall Study|Not vaccinated|50|||
124865354|NCT05540522|449127061|FG000|Overall Study|No longer meets eligibility criteria|0|||
124865355|NCT05540522|449127062|FG001|Overall Study|No longer meets eligibility criteria|0|||
124865356|NCT05540522|449127063|FG002|Overall Study|No longer meets eligibility criteria|3|||
124865357|NCT05540522|449127064|FG003|Overall Study|No longer meets eligibility criteria|2|||
124865358|NCT05540522|449127061|FG000|Overall Study|Other (Unspecified)|8|||
124865359|NCT05540522|449127062|FG001|Overall Study|Other (Unspecified)|10|||
124865360|NCT05540522|449127063|FG002|Overall Study|Other (Unspecified)|4|||
124865361|NCT05540522|449127064|FG003|Overall Study|Other (Unspecified)|2|||
124865362|NCT03754803|449127065|FG000|Overall Study|Withdrawal by Subject|2|||
124865363|NCT05239039|449127066|FG000|Overall Study|Withdrawal by Subject|0|||
124865364|NCT05239039|449127067|FG001|Overall Study|Withdrawal by Subject|1|||
124976622|NCT02614183|449540017|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
124976623|NCT02614183|449540015|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
124976624|NCT02614183|449540016|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
124976625|NCT02614183|449540017|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
124976626|NCT02614183|449540015|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
124976627|NCT02614183|449540016|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
124976628|NCT02614183|449540017|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
124976629|NCT02614183|449540015|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
124976630|NCT02614183|449540016|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
124976631|NCT02614183|449540017|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
